Gene	"Gene synonym"	Ensembl	"Gene description"	Uniprot	Chromosome	Position	"Protein class"	"Biological process"	"Molecular function"	"Disease involvement"	Evidence	"HPA evidence"	"UniProt evidence"	"NeXtProt evidence"	"RNA tissue specificity"	"RNA tissue distribution"	"RNA tissue specificity score"	"RNA tissue specific nTPM"	"RNA single cell type specificity"	"RNA single cell type distribution"	"RNA single cell type specificity score"	"RNA single cell type specific nTPM"	"RNA cancer specificity"	"RNA cancer distribution"	"RNA cancer specificity score"	"RNA cancer specific FPKM"	"RNA brain regional specificity"	"RNA brain regional distribution"	"RNA brain regional specificity score"	"RNA brain regional specific nTPM"	"RNA blood cell specificity"	"RNA blood cell distribution"	"RNA blood cell specificity score"	"RNA blood cell specific nTPM"	"RNA blood lineage specificity"	"RNA blood lineage distribution"	"RNA blood lineage specificity score"	"RNA blood lineage specific nTPM"	"RNA cell line specificity"	"RNA cell line distribution"	"RNA cell line specificity score"	"RNA cell line specific nTPM"	"RNA mouse brain regional specificity"	"RNA mouse brain regional distribution"	"RNA mouse brain regional specificity score"	"RNA mouse brain regional specific nTPM"	"RNA pig brain regional specificity"	"RNA pig brain regional distribution"	"RNA pig brain regional specificity score"	"RNA pig brain regional specific nTPM"	Antibody	"Reliability (IH)"	"Reliability (Mouse Brain)"	"Reliability (IF)"	"Subcellular location"	"Secretome location"	"CCD Protein"	"CCD Transcript"	"Blood concentration - Conc. blood IM [pg/L]"	"Blood concentration - Conc. blood MS [pg/L]"	"Blood expression cluster"	"Tissue expression cluster"	"Cell line expression cluster"	"Single cell expression cluster"	"Subcellular main location"	"Subcellular additional location"	"Antibody RRID"	"Pathology prognostics - Breast cancer"	"Pathology prognostics - Cervical cancer"	"Pathology prognostics - Colorectal cancer"	"Pathology prognostics - Endometrial cancer"	"Pathology prognostics - Glioma"	"Pathology prognostics - Head and neck cancer"	"Pathology prognostics - Liver cancer"	"Pathology prognostics - Lung cancer"	"Pathology prognostics - Melanoma"	"Pathology prognostics - Ovarian cancer"	"Pathology prognostics - Pancreatic cancer"	"Pathology prognostics - Prostate cancer"	"Pathology prognostics - Renal cancer"	"Pathology prognostics - Stomach cancer"	"Pathology prognostics - Testis cancer"	"Pathology prognostics - Thyroid cancer"	"Pathology prognostics - Urothelial cancer"	"Tissue RNA - adipose tissue [nTPM]"	"Tissue RNA - adrenal gland [nTPM]"	"Tissue RNA - amygdala [nTPM]"	"Tissue RNA - appendix [nTPM]"	"Tissue RNA - basal ganglia [nTPM]"	"Tissue RNA - bone marrow [nTPM]"	"Tissue RNA - breast [nTPM]"	"Tissue RNA - cerebellum [nTPM]"	"Tissue RNA - cerebral cortex [nTPM]"	"Tissue RNA - cervix [nTPM]"	"Tissue RNA - choroid plexus [nTPM]"	"Tissue RNA - colon [nTPM]"	"Tissue RNA - duodenum [nTPM]"	"Tissue RNA - endometrium 1 [nTPM]"	"Tissue RNA - epididymis [nTPM]"	"Tissue RNA - esophagus [nTPM]"	"Tissue RNA - fallopian tube [nTPM]"	"Tissue RNA - gallbladder [nTPM]"	"Tissue RNA - heart muscle [nTPM]"	"Tissue RNA - hippocampal formation [nTPM]"	"Tissue RNA - hypothalamus [nTPM]"	"Tissue RNA - kidney [nTPM]"	"Tissue RNA - liver [nTPM]"	"Tissue RNA - lung [nTPM]"	"Tissue RNA - lymph node [nTPM]"	"Tissue RNA - medulla oblongata [nTPM]"	"Tissue RNA - midbrain [nTPM]"	"Tissue RNA - ovary [nTPM]"	"Tissue RNA - pancreas [nTPM]"	"Tissue RNA - parathyroid gland [nTPM]"	"Tissue RNA - pituitary gland [nTPM]"	"Tissue RNA - placenta [nTPM]"	"Tissue RNA - pons [nTPM]"	"Tissue RNA - prostate [nTPM]"	"Tissue RNA - rectum [nTPM]"	"Tissue RNA - retina [nTPM]"	"Tissue RNA - salivary gland [nTPM]"	"Tissue RNA - seminal vesicle [nTPM]"	"Tissue RNA - skeletal muscle [nTPM]"	"Tissue RNA - skin 1 [nTPM]"	"Tissue RNA - small intestine [nTPM]"	"Tissue RNA - smooth muscle [nTPM]"	"Tissue RNA - spinal cord [nTPM]"	"Tissue RNA - spleen [nTPM]"	"Tissue RNA - stomach 1 [nTPM]"	"Tissue RNA - testis [nTPM]"	"Tissue RNA - thalamus [nTPM]"	"Tissue RNA - thymus [nTPM]"	"Tissue RNA - thyroid gland [nTPM]"	"Tissue RNA - tongue [nTPM]"	"Tissue RNA - tonsil [nTPM]"	"Tissue RNA - urinary bladder [nTPM]"	"Tissue RNA - vagina [nTPM]"	"Tissue RNA - white matter [nTPM]"	"Cell RNA - A-431 [nTPM]"	"Cell RNA - A549 [nTPM]"	"Cell RNA - AF22 [nTPM]"	"Cell RNA - AN3-CA [nTPM]"	"Cell RNA - ASC diff [nTPM]"	"Cell RNA - ASC TERT1 [nTPM]"	"Cell RNA - BEWO [nTPM]"	"Cell RNA - BJ [nTPM]"	"Cell RNA - BJ hTERT+ [nTPM]"	"Cell RNA - BJ hTERT+ SV40 Large T+ [nTPM]"	"Cell RNA - BJ hTERT+ SV40 Large T+ RasG12V [nTPM]"	"Cell RNA - CACO-2 [nTPM]"	"Cell RNA - CAPAN-2 [nTPM]"	"Cell RNA - Daudi [nTPM]"	"Cell RNA - EFO-21 [nTPM]"	"Cell RNA - fHDF/TERT166 [nTPM]"	"Cell RNA - GAMG [nTPM]"	"Cell RNA - HaCaT [nTPM]"	"Cell RNA - HAP1 [nTPM]"	"Cell RNA - HBEC3-KT [nTPM]"	"Cell RNA - HBF TERT88 [nTPM]"	"Cell RNA - HDLM-2 [nTPM]"	"Cell RNA - HEK 293 [nTPM]"	"Cell RNA - HEL [nTPM]"	"Cell RNA - HeLa [nTPM]"	"Cell RNA - Hep G2 [nTPM]"	"Cell RNA - HHSteC [nTPM]"	"Cell RNA - HL-60 [nTPM]"	"Cell RNA - HMC-1 [nTPM]"	"Cell RNA - HSkMC [nTPM]"	"Cell RNA - hTCEpi [nTPM]"	"Cell RNA - hTEC/SVTERT24-B [nTPM]"	"Cell RNA - hTERT-HME1 [nTPM]"	"Cell RNA - hTERT-RPE1 [nTPM]"	"Cell RNA - HUVEC TERT2 [nTPM]"	"Cell RNA - JURKAT [nTPM]"	"Cell RNA - K-562 [nTPM]"	"Cell RNA - Karpas-707 [nTPM]"	"Cell RNA - LHCN-M2 [nTPM]"	"Cell RNA - MCF7 [nTPM]"	"Cell RNA - MOLT-4 [nTPM]"	"Cell RNA - NB-4 [nTPM]"	"Cell RNA - NTERA-2 [nTPM]"	"Cell RNA - OE19 [nTPM]"	"Cell RNA - PC-3 [nTPM]"	"Cell RNA - REH [nTPM]"	"Cell RNA - RH-30 [nTPM]"	"Cell RNA - RPMI-8226 [nTPM]"	"Cell RNA - RPTEC TERT1 [nTPM]"	"Cell RNA - RT4 [nTPM]"	"Cell RNA - SCLC-21H [nTPM]"	"Cell RNA - SH-SY5Y [nTPM]"	"Cell RNA - SiHa [nTPM]"	"Cell RNA - SK-BR-3 [nTPM]"	"Cell RNA - SK-MEL-30 [nTPM]"	"Cell RNA - SuSa [nTPM]"	"Cell RNA - T-47d [nTPM]"	"Cell RNA - THP-1 [nTPM]"	"Cell RNA - TIME [nTPM]"	"Cell RNA - U-138 MG [nTPM]"	"Cell RNA - U-2 OS [nTPM]"	"Cell RNA - U-2197 [nTPM]"	"Cell RNA - U-251 MG [nTPM]"	"Cell RNA - U-266/70 [nTPM]"	"Cell RNA - U-266/84 [nTPM]"	"Cell RNA - U-698 [nTPM]"	"Cell RNA - U-87 MG [nTPM]"	"Cell RNA - U-937 [nTPM]"	"Cell RNA - WM-115 [nTPM]"	"Blood RNA - basophil [nTPM]"	"Blood RNA - classical monocyte [nTPM]"	"Blood RNA - eosinophil [nTPM]"	"Blood RNA - gdT-cell [nTPM]"	"Blood RNA - intermediate monocyte [nTPM]"	"Blood RNA - MAIT T-cell [nTPM]"	"Blood RNA - memory B-cell [nTPM]"	"Blood RNA - memory CD4 T-cell [nTPM]"	"Blood RNA - memory CD8 T-cell [nTPM]"	"Blood RNA - myeloid DC [nTPM]"	"Blood RNA - naive B-cell [nTPM]"	"Blood RNA - naive CD4 T-cell [nTPM]"	"Blood RNA - naive CD8 T-cell [nTPM]"	"Blood RNA - neutrophil [nTPM]"	"Blood RNA - NK-cell [nTPM]"	"Blood RNA - non-classical monocyte [nTPM]"	"Blood RNA - plasmacytoid DC [nTPM]"	"Blood RNA - T-reg [nTPM]"	"Blood RNA - total PBMC [nTPM]"	"Brain RNA - amygdala [nTPM]"	"Brain RNA - basal ganglia [nTPM]"	"Brain RNA - cerebellum [nTPM]"	"Brain RNA - cerebral cortex [nTPM]"	"Brain RNA - hippocampal formation [nTPM]"	"Brain RNA - hypothalamus [nTPM]"	"Brain RNA - medulla oblongata [nTPM]"	"Brain RNA - midbrain [nTPM]"	"Brain RNA - pons [nTPM]"	"Brain RNA - spinal cord [nTPM]"	"Brain RNA - thalamus [nTPM]"	"Brain RNA - white matter [nTPM]"	"Single Cell Type RNA - Adipocytes [nTPM]"	"Single Cell Type RNA - Alveolar cells type 1 [nTPM]"	"Single Cell Type RNA - Alveolar cells type 2 [nTPM]"	"Single Cell Type RNA - Astrocytes [nTPM]"	"Single Cell Type RNA - B-cells [nTPM]"	"Single Cell Type RNA - Basal keratinocytes [nTPM]"	"Single Cell Type RNA - Basal prostatic cells [nTPM]"	"Single Cell Type RNA - Basal respiratory cells [nTPM]"	"Single Cell Type RNA - Basal squamous epithelial cells [nTPM]"	"Single Cell Type RNA - Bipolar cells [nTPM]"	"Single Cell Type RNA - Breast glandular cells [nTPM]"	"Single Cell Type RNA - Breast myoepithelial cells [nTPM]"	"Single Cell Type RNA - Cardiomyocytes [nTPM]"	"Single Cell Type RNA - Cholangiocytes [nTPM]"	"Single Cell Type RNA - Club cells [nTPM]"	"Single Cell Type RNA - Collecting duct cells [nTPM]"	"Single Cell Type RNA - Cone photoreceptor cells [nTPM]"	"Single Cell Type RNA - Cytotrophoblasts [nTPM]"	"Single Cell Type RNA - dendritic cells [nTPM]"	"Single Cell Type RNA - Distal enterocytes [nTPM]"	"Single Cell Type RNA - Distal tubular cells [nTPM]"	"Single Cell Type RNA - Ductal cells [nTPM]"	"Single Cell Type RNA - Early spermatids [nTPM]"	"Single Cell Type RNA - Endometrial ciliated cells [nTPM]"	"Single Cell Type RNA - Endometrial stromal cells [nTPM]"	"Single Cell Type RNA - Endothelial cells [nTPM]"	"Single Cell Type RNA - Enteroendocrine cells [nTPM]"	"Single Cell Type RNA - Erythroid cells [nTPM]"	"Single Cell Type RNA - Excitatory neurons [nTPM]"	"Single Cell Type RNA - Exocrine glandular cells [nTPM]"	"Single Cell Type RNA - Extravillous trophoblasts [nTPM]"	"Single Cell Type RNA - Fibroblasts [nTPM]"	"Single Cell Type RNA - Gastric mucus-secreting cells [nTPM]"	"Single Cell Type RNA - Glandular and luminal cells [nTPM]"	"Single Cell Type RNA - granulocytes [nTPM]"	"Single Cell Type RNA - Granulosa cells [nTPM]"	"Single Cell Type RNA - Hepatic stellate cells [nTPM]"	"Single Cell Type RNA - Hepatocytes [nTPM]"	"Single Cell Type RNA - Hofbauer cells [nTPM]"	"Single Cell Type RNA - Horizontal cells [nTPM]"	"Single Cell Type RNA - Inhibitory neurons [nTPM]"	"Single Cell Type RNA - Intestinal goblet cells [nTPM]"	"Single Cell Type RNA - Ionocytes [nTPM]"	"Single Cell Type RNA - Kupffer cells [nTPM]"	"Single Cell Type RNA - Langerhans cells [nTPM]"	"Single Cell Type RNA - Late spermatids [nTPM]"	"Single Cell Type RNA - Leydig cells [nTPM]"	"Single Cell Type RNA - Macrophages [nTPM]"	"Single Cell Type RNA - Melanocytes [nTPM]"	"Single Cell Type RNA - Microglial cells [nTPM]"	"Single Cell Type RNA - monocytes [nTPM]"	"Single Cell Type RNA - Muller glia cells [nTPM]"	"Single Cell Type RNA - NK-cells [nTPM]"	"Single Cell Type RNA - Oligodendrocyte precursor cells [nTPM]"	"Single Cell Type RNA - Oligodendrocytes [nTPM]"	"Single Cell Type RNA - Pancreatic endocrine cells [nTPM]"	"Single Cell Type RNA - Paneth cells [nTPM]"	"Single Cell Type RNA - Peritubular cells [nTPM]"	"Single Cell Type RNA - Plasma cells [nTPM]"	"Single Cell Type RNA - Prostatic glandular cells [nTPM]"	"Single Cell Type RNA - Proximal enterocytes [nTPM]"	"Single Cell Type RNA - Proximal tubular cells [nTPM]"	"Single Cell Type RNA - Respiratory ciliated cells [nTPM]"	"Single Cell Type RNA - Rod photoreceptor cells [nTPM]"	"Single Cell Type RNA - Sertoli cells [nTPM]"	"Single Cell Type RNA - Skeletal myocytes [nTPM]"	"Single Cell Type RNA - Smooth muscle cells [nTPM]"	"Single Cell Type RNA - Spermatocytes [nTPM]"	"Single Cell Type RNA - Spermatogonia [nTPM]"	"Single Cell Type RNA - Squamous epithelial cells [nTPM]"	"Single Cell Type RNA - Suprabasal keratinocytes [nTPM]"	"Single Cell Type RNA - Syncytiotrophoblasts [nTPM]"	"Single Cell Type RNA - T-cells [nTPM]"	"Single Cell Type RNA - Theca cells [nTPM]"	"Single Cell Type RNA - Undifferentiated cells [nTPM]"	"Single Cell Type RNA - Urothelial cells [nTPM]"
AADAC	"CES5A1, DAC"	ENSG00000114771	"Arylacetamide deacetylase"	P22760	3	151814073-151828488	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adrenal gland: 224.9;intestine: 241.7;liver: 946.7"	"Group enriched"	"Detected in some"	8	"Hepatocytes: 687.7;Proximal enterocytes: 460.5"	"Cancer enriched"	"Detected in many"	22	"liver cancer: 153.4"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A549: 9.5;ASC diff: 4.2;EFO-21: 4.6;HBEC3-KT: 4.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA002911	Approved					NA	NA				"Cluster 85: Liver - Metabolism"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 2: Hepatocytes - Metabolism"			"HPA002911: AB_1078074"	"unprognostic (1.26e-1)"	"unprognostic (1.82e-2)"	"unprognostic (8.11e-2)"	"unprognostic (4.41e-2)"		"unprognostic (9.23e-2)"	"unprognostic (7.82e-2)"	"unprognostic (2.15e-1)"	"unprognostic (9.89e-2)"	"prognostic favorable (5.58e-6)"	"prognostic unfavorable (5.02e-4)"			"prognostic unfavorable (2.19e-4)"	"unprognostic (1.22e-1)"		"unprognostic (1.27e-1)"	8.2	224.9	0.0	0.4	0.0	0.0	5.0	0.0	0.1	0.1	0.2	0.3	220.9	0.2	0.0	2.7	0.6	27.4	0.7	0.0	0.0	0.2	946.7	9.1	0.3	0.0	0.1	0.1	36.7	0.0	0.0	1.5	0.0	0.1	0.2	0.0	1.3	0.0	0.0	13.8	241.7	0.0	0.0	0.2	52.3	0.8	0.1	0.4	0.3	0.0	2.5	0.7	0.4	0.0	0.0	9.5	0.0	0.0	4.2	0.1	0.2	0.0	0.0	0.0	0.0	0.8	0.0	0.1	4.6	0.0	0.0	0.2	0.0	4.8	0.0	0.0	0.0	0.0	0.0	0.4	0.4	0.5	0.1	0.1	0.1	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.0	0.1	1.0	0.4	0.1	0.3	1.7	0.0	1.7	0.1	1.2	0.2	0.0	0.0	0.0	0.0	0.0	1.7	0.0	2.0	0.9	0.0	0.3	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	6.5	0.0	14.3	0.0	0.7	0.3	0.0	4.4	0.0	0.0	0.0	0.0	1.1	71.4	8.7	0.0	0.0	0.1	0.3	0.0	0.0	0.2	0.3	1.8	0.1	0.7	0.0	2.7	0.0	51.9	0.0	39.3	53.5	0.2	0.0	0.0	5.0	687.7	0.2	0.0	0.0	9.6	0.0	14.8	0.3	0.0	0.0	0.1	3.6	0.0	0.0	0.0	0.0	0.0	0.0	3.9	10.0	0.0	0.1	0.2	460.5	0.0	2.9	0.0	0.0	0.0	3.4	0.0	0.1	1.4	3.4	0.3	0.7	0.3	18.4	0.2
ABHD10	FLJ11342	ENSG00000144827	"Abhydrolase domain containing 10, depalmitoylase"	Q9NUJ1	3	111979010-111993368	"Enzymes, Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036991, HPA036992, HPA066081"	Supported		Approved	Mitochondria	"Intracellular and membrane"	No	No		71000	"Cluster 46: Basophils - DNA binding"	"Cluster 7: Kidney - Transmembrane transport"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 39: Non-specific - Basic cellular processes"	Mitochondria		"HPA036991: AB_2675420, HPA036992: AB_10672345, HPA066081: AB_2685610"	"unprognostic (1.65e-1)"	"prognostic favorable (7.57e-4)"	"unprognostic (1.61e-1)"	"unprognostic (1.63e-1)"	"unprognostic (1.05e-1)"	"unprognostic (1.30e-2)"	"unprognostic (8.95e-2)"	"unprognostic (1.14e-1)"	"unprognostic (8.50e-2)"	"unprognostic (1.69e-2)"	"unprognostic (1.70e-1)"	"unprognostic (3.91e-2)"	"prognostic favorable (4.72e-9)"	"unprognostic (1.59e-2)"	"unprognostic (1.72e-1)"	"unprognostic (4.18e-3)"	"unprognostic (2.76e-2)"	11.0	21.9	23.0	10.6	25.3	10.9	15.0	24.5	29.3	11.3	22.9	14.1	11.7	11.1	50.8	8.2	14.9	10.1	25.0	23.9	24.6	49.4	34.4	10.1	17.9	23.5	23.2	19.8	13.7	16.7	27.9	10.8	23.7	20.4	14.7	27.0	25.5	13.7	14.1	10.0	10.3	10.0	24.4	14.6	14.9	16.4	26.3	21.8	31.1	19.6	16.2	9.5	8.3	25.3	40.2	34.1	36.4	12.0	20.5	27.5	19.8	41.4	21.5	33.0	31.7	35.3	22.4	36.0	22.6	17.2	22.7	21.6	16.3	23.0	44.9	12.1	20.6	29.7	15.4	30.7	16.3	60.3	30.4	16.9	16.7	17.0	42.4	22.7	35.9	42.1	13.9	14.9	36.7	13.7	56.9	27.9	23.7	43.8	53.2	50.9	23.4	16.7	34.6	17.1	24.6	17.9	33.2	23.7	39.8	14.3	26.8	21.8	20.6	19.7	25.3	14.4	21.7	23.6	9.0	61.4	20.1	32.4	21.5	29.4	16.5	25.2	9.8	21.6	16.8	26.2	12.2	11.3	28.1	21.6	15.4	13.9	2.5	11.4	17.3	17.8	13.2	16.1	23.0	25.3	24.5	29.3	23.9	24.6	23.5	23.2	23.7	24.4	26.3	25.3	9.1	0.0	7.2	11.1	19.7	7.0	10.2	12.1	14.2	21.8	12.7	10.9	26.1	7.2	12.4	11.0	8.4	19.2	16.1	7.0	35.2	5.2	1.0	11.1	10.3	8.8	12.1	24.2	16.0	7.8	14.9	12.3	12.8	6.8	9.5	9.5	10.0	26.2	14.1	42.1	16.2	13.4	6.1	19.5	7.0	3.0	10.5	11.0	10.6	15.0	10.7	20.4	12.3	14.6	15.6	5.4	4.0	7.5	25.0	5.1	7.0	42.5	19.5	16.2	0.0	7.9	8.9	29.7	37.0	13.6	8.2	5.5	14.6	19.2	12.1	4.5
ABHD12	"ABHD12A, BEM46L2, C20orf22, dJ965G21.2, DKFZP434P106"	ENSG00000100997	"Abhydrolase domain containing 12, lysophospholipase"	Q8N2K0	20	25294742-25390835	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Lipid metabolism"	Hydrolase	"Cataract, Deafness, Disease variant, Neuropathy, Retinitis pigmentosa"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"Karpas-707: 315.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA026866	Uncertain					NA	NA			"Cluster 26: Non-specific - Mitochondria"	"Cluster 22: Non-specific - Unknown function"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 53: Intestinal epithelial cells - Unknown function"			"HPA026866: AB_1844446"	"prognostic unfavorable (3.81e-5)"	"prognostic favorable (1.30e-5)"	"unprognostic (1.32e-1)"	"unprognostic (8.74e-2)"	"unprognostic (3.67e-2)"	"unprognostic (6.56e-2)"	"prognostic unfavorable (7.18e-4)"	"unprognostic (8.51e-2)"	"unprognostic (7.91e-3)"	"unprognostic (2.08e-1)"	"unprognostic (4.08e-2)"	"unprognostic (8.46e-2)"	"unprognostic (1.36e-3)"	"unprognostic (2.45e-1)"	"unprognostic (4.65e-2)"	"unprognostic (1.55e-1)"	"unprognostic (8.11e-3)"	29.5	33.0	55.7	27.4	67.3	26.5	26.9	70.0	64.7	32.1	35.9	37.0	47.0	25.3	133.1	50.0	24.8	33.4	30.5	77.3	58.2	45.5	29.8	32.6	30.8	70.9	64.6	30.6	117.8	55.3	42.1	29.6	73.3	35.5	36.4	30.8	36.9	39.9	13.3	52.4	52.8	23.6	66.0	22.0	55.0	19.2	71.8	23.4	80.8	14.8	41.5	37.2	35.1	96.9	67.2	148.3	41.6	50.9	79.6	47.1	93.3	97.0	84.5	73.7	84.6	90.1	93.0	21.8	53.3	77.0	155.1	116.5	44.4	56.8	62.8	22.7	41.9	33.3	46.8	128.4	59.3	33.3	71.6	58.7	42.0	85.4	44.1	95.7	33.2	37.8	25.8	315.3	72.8	142.5	51.8	31.0	29.4	77.8	96.8	39.2	95.3	195.0	43.4	145.7	46.6	39.7	75.4	198.9	133.8	72.3	67.4	47.6	44.6	98.3	63.0	57.1	54.0	38.8	36.1	33.4	61.8	38.7	57.3	15.8	18.8	17.3	9.9	17.0	7.5	3.8	10.2	13.7	17.9	5.1	8.9	8.9	3.6	15.4	17.7	17.0	10.4	8.6	55.7	67.3	70.0	64.7	77.3	58.2	70.9	64.6	73.3	66.0	71.8	96.9	20.7	6.4	6.5	19.2	13.8	17.7	32.0	9.8	19.4	34.5	19.6	19.7	16.6	30.0	13.7	27.6	10.4	91.6	22.2	97.0	27.4	33.7	53.0	24.9	18.1	17.5	34.0	14.5	37.7	34.3	95.2	22.9	35.2	28.3	10.2	26.9	15.0	19.5	114.1	42.1	46.0	28.9	20.3	37.8	43.8	107.1	16.1	62.4	33.8	42.2	58.7	44.1	23.7	50.8	67.5	22.9	77.7	20.7	39.3	31.6	126.7	24.6	13.1	23.3	26.3	13.8	19.5	19.9	37.7	27.2	18.3	130.8	18.0	19.6	33.3	35.2
ABHD16A	"BAT5, D6S82E, NG26"	ENSG00000204427	"Abhydrolase domain containing 16A, phospholipase"	O95870	6	31686955-31703356	"Enzymes, Predicted membrane proteins"	"Lipid metabolism"	Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"AN3-CA: 41.2;OE19: 42.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA058606	Approved					NA	NA		37000	"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 72: Non-specific - Transcription"	"Cluster 21: OE19 - Mitochondria"	"Cluster 59: Non-specific - Transcription"			"HPA058606: AB_2683774"	"unprognostic (1.44e-1)"	"unprognostic (1.10e-1)"	"unprognostic (7.26e-2)"	"prognostic unfavorable (2.63e-4)"	"unprognostic (3.14e-1)"	"unprognostic (1.76e-1)"	"unprognostic (2.24e-1)"	"unprognostic (8.75e-2)"	"unprognostic (1.07e-1)"	"unprognostic (6.17e-3)"	"unprognostic (1.97e-3)"	"unprognostic (6.02e-2)"	"unprognostic (1.30e-2)"	"unprognostic (9.35e-2)"	"unprognostic (1.81e-1)"	"unprognostic (5.11e-3)"	"unprognostic (1.60e-3)"	16.2	22.1	1.1	11.7	1.3	6.7	13.3	1.2	4.1	20.5	0.9	20.9	0.0	21.5	19.0	21.1	18.9	9.9	17.4	1.2	1.2	17.0	30.0	16.0	13.0	1.6	2.0	15.0	18.7	5.8	40.0	7.9	1.4	19.6	7.3	6.7	17.4	4.2	35.0	12.9	17.6	0.0	1.5	18.5	21.5	31.6	1.5	4.5	21.3	0.0	0.0	20.7	15.0	1.5	0.0	15.7	0.0	41.2	29.0	11.7	0.0	14.5	16.2	16.5	15.6	0.0	26.1	16.5	33.7	21.2	0.0	0.0	0.0	19.7	9.0	16.0	12.7	0.0	0.0	0.0	34.7	0.0	0.0	12.1	0.0	0.0	0.0	0.0	0.0	13.3	0.0	0.3	0.0	0.0	0.0	0.5	0.0	42.4	0.0	0.7	0.0	29.3	21.0	0.0	0.2	20.0	0.9	0.5	0.4	0.0	0.0	0.0	14.9	19.6	14.5	0.0	0.0	10.5	21.1	8.5	13.6	0.1	16.1	2.5	6.8	8.4	4.1	8.9	1.9	2.8	1.2	4.2	6.2	2.8	3.5	2.7	13.3	5.9	0.5	4.1	4.1	6.3	1.1	1.3	1.2	4.1	1.2	1.2	1.6	2.0	1.4	1.5	1.5	1.5	1.2	0.0	8.2	11.4	10.7	0.4	0.3	1.7	15.4	1.2	1.5	1.0	0.5	0.0	1.6	0.0	0.0	3.9	2.2	12.0	3.9	18.3	1.3	1.4	1.7	2.7	12.5	14.9	13.4	13.3	1.5	5.3	12.2	1.2	1.3	0.5	0.7	0.8	3.3	0.0	14.6	9.7	2.0	2.2	2.1	0.4	0.9	8.8	3.6	13.1	8.1	1.0	5.2	15.6	21.1	12.7	16.0	0.4	16.4	0.4	16.5	0.7	1.7	1.4	0.0	0.7	4.9	2.5	1.6	16.8	1.0	5.3	7.6	0.2	12.1	0.3
ABHD17A	"C19orf27, FAM108A1, MGC5244"	ENSG00000129968	"Abhydrolase domain containing 17A, depalmitoylase"	Q96GS6	19	1876810-1885496	"Enzymes, Predicted intracellular proteins, Transporters"		Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"dendritic cells: 338.2;NK-cells: 383.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"U-266/70: 90.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA043270, HPA047226, HPA069225"	Uncertain		Approved	"Nuclear speckles,Vesicles"		NA	NA			"Cluster 37: B-cells - Transcription"	"Cluster 35: Non-specific - Unknown function"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 63: NK-cells & T-cells - Immune response"	Vesicles	"Nuclear speckles"	"HPA043270: AB_2678401, HPA047226: AB_2679991, HPA069225: "	"unprognostic (3.77e-2)"	"unprognostic (1.85e-1)"	"unprognostic (3.57e-2)"	"prognostic favorable (1.73e-4)"	"unprognostic (3.70e-2)"	"prognostic favorable (6.46e-4)"	"unprognostic (1.69e-2)"	"unprognostic (1.92e-2)"	"unprognostic (5.09e-1)"	"unprognostic (1.44e-1)"	"prognostic favorable (1.76e-5)"	"unprognostic (1.29e-2)"	"unprognostic (1.85e-3)"	"unprognostic (1.17e-1)"	"unprognostic (2.71e-1)"	"unprognostic (3.17e-1)"	"unprognostic (1.60e-2)"	49.8	51.5	61.3	8.8	50.0	13.4	44.1	53.0	104.9	43.9	16.0	50.3	13.6	46.5	2.1	63.6	42.3	4.1	79.9	70.8	36.6	47.3	42.9	52.7	10.7	66.9	54.2	41.7	42.9	7.5	45.1	11.6	60.6	52.5	2.0	1.9	40.4	8.2	56.9	73.3	41.8	3.2	56.3	69.3	45.4	33.4	61.4	8.6	43.0	10.7	3.9	45.3	45.9	56.9	43.0	14.7	6.0	16.7	7.8	9.6	32.5	28.6	8.8	8.4	7.7	7.4	7.5	21.1	11.3	8.3	1.9	26.9	3.0	11.8	1.2	48.9	61.8	15.9	6.7	19.2	10.7	16.4	50.9	10.5	8.8	4.9	3.4	5.5	16.2	20.6	27.6	23.9	6.1	24.1	28.3	31.0	31.2	8.3	32.3	32.8	14.3	32.0	5.9	9.4	19.4	43.9	14.8	16.0	29.8	2.4	16.6	28.3	31.3	9.4	21.4	38.1	28.3	90.8	58.8	18.2	20.6	21.0	15.5	1.6	1.0	4.2	5.2	0.6	3.8	3.7	2.3	3.5	1.0	1.4	2.5	2.7	1.1	3.1	0.6	1.0	2.4	0.9	61.3	50.0	53.0	104.9	70.8	36.6	66.9	54.2	60.6	56.3	61.4	56.9	125.3	3.2	5.8	13.4	35.6	32.2	21.5	10.4	12.5	41.2	43.9	35.6	4.0	24.3	12.1	14.7	39.6	77.8	338.2	61.8	9.8	31.0	6.4	28.4	43.7	67.6	30.5	22.3	12.8	37.8	43.2	29.8	29.6	37.8	10.2	31.6	65.0	21.5	66.3	55.5	12.5	34.9	12.2	36.1	28.7	6.4	30.1	42.8	26.6	19.7	35.0	66.0	383.1	5.0	63.1	42.7	31.9	36.5	58.7	25.9	38.6	19.5	7.5	35.5	13.1	31.0	44.1	16.3	20.7	21.2	45.9	65.7	117.1	66.1	34.0	32.3
ABHD17B	"C9orf77, CGI-67, FAM108B1"	ENSG00000107362	"Abhydrolase domain containing 17B, depalmitoylase"	Q5VST6	9	71862452-71911193	"Enzymes, Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Oligodendrocytes: 136.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"REH: 63.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA047862	Uncertain					NA	NA			"Cluster 26: Non-specific - Mitochondria"	"Cluster 20: Retina & Lymphoid tissues - Unknown function"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 46: Photoreceptor cells - Phototransduction"			"HPA047862: AB_10959595"	"unprognostic (7.47e-2)"	"unprognostic (4.41e-2)"	"unprognostic (4.03e-3)"	"unprognostic (5.59e-2)"	"unprognostic (5.57e-2)"	"unprognostic (8.53e-3)"	"unprognostic (9.44e-2)"	"unprognostic (6.84e-2)"	"unprognostic (5.46e-2)"	"unprognostic (3.44e-2)"	"unprognostic (3.49e-2)"	"unprognostic (1.74e-1)"	"prognostic favorable (2.59e-4)"	"unprognostic (4.33e-2)"	"unprognostic (2.12e-1)"	"unprognostic (3.06e-3)"	"unprognostic (1.34e-2)"	8.3	7.2	14.5	6.9	25.7	19.1	7.9	18.9	21.3	9.3	7.7	10.4	16.0	9.2	4.1	16.0	8.6	8.2	6.8	14.8	17.3	11.7	12.3	8.8	10.9	19.0	19.6	7.0	6.1	10.4	5.9	7.2	19.2	9.2	10.0	25.5	10.7	4.3	16.4	12.1	13.4	8.5	19.2	8.4	7.4	11.6	18.6	33.1	8.0	10.2	10.1	12.9	10.8	42.4	11.2	11.6	26.7	15.0	12.8	8.6	19.0	12.1	14.8	11.5	9.4	3.8	7.4	25.1	10.0	9.3	9.8	22.5	27.5	8.9	12.5	13.7	11.8	15.3	19.4	11.8	8.9	18.6	24.2	10.5	11.7	10.5	9.4	10.2	14.5	48.2	12.4	13.0	9.4	6.0	50.6	14.9	36.1	15.9	13.9	63.3	19.0	0.2	12.6	25.5	15.9	17.5	12.3	14.3	11.0	19.2	4.8	14.5	11.7	10.5	12.4	19.5	9.9	11.0	14.8	21.0	8.7	13.4	5.1	3.5	1.9	1.9	1.3	0.6	1.2	1.9	1.7	1.9	2.2	4.2	1.3	1.9	1.2	3.2	0.6	2.6	2.5	0.8	14.5	25.7	18.9	21.3	14.8	17.3	19.0	19.6	19.2	19.2	18.6	42.4	16.1	6.4	6.3	17.6	20.2	17.1	29.4	7.4	12.0	16.9	9.7	7.2	8.8	7.2	10.1	5.5	12.5	10.7	33.0	31.5	11.7	8.7	25.0	20.9	12.4	11.7	8.9	7.4	30.8	5.7	8.2	7.6	16.8	13.0	17.2	7.8	12.1	9.4	6.1	5.0	29.1	32.8	6.1	7.7	16.6	9.6	11.5	11.1	5.4	11.2	8.8	27.5	19.6	37.7	136.7	4.6	19.5	10.5	11.4	20.5	21.8	10.7	17.2	57.8	0.0	24.7	13.7	32.2	18.5	15.2	9.8	7.3	20.0	5.3	13.1	54.2
ABHD17C	FAM108C1	ENSG00000136379	"Abhydrolase domain containing 17C, depalmitoylase"	Q6PCB6	15	80679684-80755621	"Enzymes, Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"intestine: 65.3"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 201.4;Intestinal goblet cells: 103.7;Urothelial cells: 86.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"OE19: 127.1;RT4: 102.6;SK-MEL-30: 119.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA048890	Uncertain					NA	NA			"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 37: Intestine - Unknown function"	"Cluster 21: OE19 - Mitochondria"	"Cluster 53: Intestinal epithelial cells - Unknown function"			"HPA048890: AB_2680546"	"unprognostic (3.60e-1)"	"unprognostic (5.07e-2)"	"unprognostic (1.58e-1)"	"unprognostic (2.19e-2)"	"unprognostic (7.51e-2)"	"unprognostic (1.20e-1)"	"unprognostic (1.59e-2)"	"unprognostic (2.32e-1)"	"unprognostic (1.40e-1)"	"unprognostic (2.59e-2)"	"unprognostic (5.08e-3)"	"unprognostic (2.87e-1)"	"unprognostic (1.23e-3)"	"unprognostic (5.75e-2)"	"unprognostic (2.91e-1)"	"unprognostic (1.35e-1)"	"unprognostic (1.89e-3)"	2.5	4.7	17.6	10.3	17.7	5.9	11.7	14.3	18.4	19.3	13.6	65.3	23.3	6.1	2.1	46.5	10.9	6.3	4.2	19.2	16.3	15.6	5.6	19.5	7.2	16.4	16.2	2.0	7.9	7.0	6.0	4.7	14.5	18.1	56.2	16.8	23.6	3.4	1.8	18.7	30.6	5.5	17.0	8.1	36.0	5.2	18.2	5.6	8.0	2.8	23.0	28.7	21.3	16.2	26.4	24.7	15.7	19.8	5.7	11.6	26.8	24.9	93.0	20.7	20.0	20.6	57.7	8.7	9.9	26.4	14.7	52.7	44.1	23.0	18.5	62.0	25.0	0.1	17.7	22.1	9.9	8.0	12.3	24.9	27.1	15.0	7.4	17.9	22.6	9.1	0.2	10.8	12.1	73.3	0.7	0.8	23.3	127.1	9.2	17.4	13.4	24.5	17.0	102.6	13.9	5.7	19.8	33.7	119.9	6.8	16.8	13.5	7.7	12.8	10.5	14.1	22.4	0.8	0.3	8.6	8.3	71.6	14.3	0.0	0.0	0.0	0.7	0.0	0.5	0.3	0.5	0.7	0.1	0.0	0.0	0.1	0.0	0.0	0.1	0.3	0.0	0.1	17.6	17.7	14.3	18.4	19.2	16.3	16.4	16.2	14.5	17.0	18.2	16.2	2.0	12.8	12.5	32.3	1.4	7.1	13.2	14.3	9.6	4.8	15.7	9.4	5.3	17.2	11.1	7.3	8.4	2.2	2.8	201.4	45.0	6.5	0.3	13.4	7.8	6.9	14.5	0.8	18.4	8.9	5.8	3.1	39.8	35.4	0.0	3.0	6.4	6.0	1.1	10.1	20.1	103.7	10.2	1.3	1.5	0.7	1.2	5.9	8.8	6.5	1.4	4.8	0.0	12.1	3.1	28.1	58.6	0.0	2.4	34.5	46.3	5.6	10.5	22.4	0.0	1.0	2.0	0.7	6.0	19.3	22.7	1.0	2.6	19.6	53.2	86.1
ABHD2	LABH2	ENSG00000140526	"Abhydrolase domain containing 2, acylglycerol lipase"	P08910	15	89087459-89202355	"Enzymes, Predicted membrane proteins"	"Lipid degradation, Lipid metabolism"	"Hydrolase, Serine esterase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 331.8;Hepatocytes: 402.5;Late spermatids: 462.1;Oligodendrocyte precursor cells: 421.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"eosinophil: 69.8;neutrophil: 52.2"	"Low lineage specificity"	"Detected in all"			"Cell line enriched"	"Detected in all"	4	"HEL: 340.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA005999	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 85: Liver - Metabolism"	"Cluster 36: HEL - Hemostasis"	"Cluster 2: Hepatocytes - Metabolism"	Cytosol	Nucleoplasm	"HPA005999: AB_1078080"	"unprognostic (6.60e-2)"	"unprognostic (1.18e-1)"	"unprognostic (1.08e-1)"	"unprognostic (3.00e-2)"	"unprognostic (2.16e-1)"	"unprognostic (1.56e-1)"	"unprognostic (2.26e-1)"	"unprognostic (1.67e-1)"	"unprognostic (3.34e-1)"	"unprognostic (3.67e-3)"	"unprognostic (3.41e-3)"	"unprognostic (1.80e-1)"	"prognostic favorable (2.18e-7)"	"unprognostic (4.17e-1)"	"unprognostic (3.07e-2)"	"unprognostic (1.34e-2)"	"unprognostic (1.60e-1)"	18.5	36.3	20.0	20.2	20.9	34.9	22.5	40.2	27.2	19.5	130.3	21.1	47.9	20.7	56.1	17.4	23.4	47.2	36.1	29.0	20.3	22.4	137.6	45.3	14.7	13.3	32.4	24.5	57.9	18.4	14.0	11.1	13.5	44.2	18.9	14.5	12.7	18.6	21.8	13.1	35.9	22.4	11.0	24.6	72.9	52.0	24.2	15.5	17.1	46.3	16.1	31.1	9.6	16.4	33.0	62.3	14.7	16.3	29.2	39.0	8.2	21.4	62.5	19.8	18.6	15.7	55.3	9.4	23.9	27.4	54.1	42.6	32.4	26.4	28.0	48.1	15.8	340.5	14.0	12.8	14.8	24.2	74.4	20.1	18.6	70.1	45.5	33.7	25.3	20.7	30.3	27.4	56.3	13.3	15.0	5.8	6.6	76.9	18.1	20.7	32.2	71.9	27.0	51.5	25.2	39.0	41.4	19.4	34.4	13.5	21.7	18.6	38.6	70.9	23.7	24.2	55.8	23.5	49.3	10.9	58.2	21.5	55.4	8.4	13.4	69.8	3.5	11.3	2.1	2.4	3.2	3.4	7.1	2.2	3.2	3.2	52.2	11.2	17.8	5.7	8.7	6.9	20.0	20.9	40.2	27.2	29.0	20.3	13.3	32.4	13.5	11.0	24.2	16.4	43.4	96.1	118.1	87.5	10.7	18.6	47.3	27.0	7.4	25.5	26.6	17.8	52.0	130.1	82.1	42.3	18.8	4.6	53.7	65.9	1.9	48.9	331.8	28.3	36.8	27.7	48.7	40.8	103.6	85.2	7.7	26.6	103.0	25.9	60.7	18.5	21.0	402.5	40.8	20.2	114.7	58.7	87.5	59.2	26.6	462.1	32.9	67.3	58.7	46.9	46.4	45.5	36.0	421.2	54.4	106.4	38.0	59.8	27.4	171.1	53.1	18.0	158.0	14.7	78.9	36.1	53.4	119.8	13.2	20.8	17.5	2.6	24.5	35.2	38.7	117.5
ABHD3	LABH3	ENSG00000158201	"Abhydrolase domain containing 3, phospholipase"	Q8WU67	18	21650901-21704780	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"	"Lipid metabolism, Phospholipid metabolism"	"Hydrolase, Serine esterase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 187.7;Paneth cells: 126.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"REH: 209.6;RPMI-8226: 233.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA010729	Approved		Approved	"Nucleoplasm,Vesicles,Plasma membrane"		NA	NA			"Cluster 9: Neutrophils - Innate immune response"	"Cluster 9: Intestine - Unknown function"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 53: Intestinal epithelial cells - Unknown function"	"Nucleoplasm, Plasma membrane"	Vesicles	"HPA010729: AB_1844449"	"unprognostic (1.46e-1)"	"unprognostic (4.61e-2)"	"unprognostic (2.37e-2)"	"unprognostic (3.52e-1)"	"unprognostic (8.46e-2)"	"unprognostic (3.14e-3)"	"unprognostic (3.54e-3)"	"unprognostic (1.52e-1)"	"prognostic unfavorable (8.52e-4)"	"unprognostic (6.21e-2)"	"unprognostic (1.98e-1)"	"unprognostic (6.37e-2)"	"unprognostic (1.73e-1)"	"unprognostic (2.15e-2)"	"unprognostic (1.00e-1)"	"unprognostic (3.98e-2)"	"unprognostic (4.58e-2)"	17.1	7.3	13.3	25.2	13.8	17.6	15.7	16.8	21.9	12.6	23.2	63.5	44.1	8.1	9.1	18.1	12.0	20.8	7.5	13.2	14.0	14.5	39.3	15.7	29.8	14.2	15.6	12.5	12.3	16.0	11.4	19.8	16.2	11.1	65.7	5.8	14.5	6.2	14.4	6.3	56.3	9.7	13.2	24.0	35.6	6.3	16.2	21.4	22.9	7.9	25.8	15.3	12.8	15.9	29.0	20.6	19.8	12.7	12.3	8.2	0.1	18.6	7.6	13.1	17.6	21.6	29.1	82.3	33.2	6.2	58.6	93.6	32.5	15.3	18.1	52.1	21.9	9.0	35.7	37.5	18.7	39.6	28.9	7.3	17.7	19.2	8.8	6.5	8.7	28.0	23.4	47.9	11.6	11.7	38.5	43.6	9.7	92.1	47.8	209.6	15.0	233.5	36.4	27.6	16.6	7.5	42.5	37.6	11.2	21.3	11.7	68.9	6.9	12.7	18.2	22.6	29.3	53.1	37.5	84.9	16.1	50.9	29.4	89.3	24.7	29.3	25.3	44.4	19.8	16.2	22.7	24.8	15.2	12.6	18.2	23.2	81.6	18.6	61.8	10.2	44.9	24.3	13.3	13.8	16.8	21.9	13.2	14.0	14.2	15.6	16.2	13.2	16.2	15.9	8.4	9.6	9.3	42.4	22.8	33.4	40.8	21.6	18.2	14.3	12.9	6.2	4.6	40.0	25.4	3.7	47.9	30.6	24.4	187.7	1.9	52.9	4.1	32.6	9.9	9.5	36.4	10.3	27.2	27.5	22.7	10.6	32.1	49.4	11.4	1.2	10.4	31.6	68.5	0.0	30.9	57.9	52.9	31.9	47.2	1.5	7.5	26.4	32.0	33.7	29.6	7.8	26.8	17.1	10.7	51.1	126.6	6.4	45.5	32.0	93.8	8.8	40.8	15.7	13.1	6.8	13.2	4.1	9.7	22.4	15.2	94.3	38.3	5.4	36.8	36.8
ABHD6		ENSG00000163686	"Abhydrolase domain containing 6, acylglycerol lipase"	Q9BV23	3	58237532-58295693	"Enzymes, Metabolic proteins, Predicted membrane proteins"	"Lipid metabolism"	Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 64.9"	"Cell type enhanced"	"Detected in many"		"Hepatocytes: 60.6;Oligodendrocytes: 88.6;Proximal enterocytes: 55.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA017283, HPA073225"	Uncertain		Approved	Nucleoplasm,Vesicles		NA	NA			"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 45: Intestine - Brush border"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 2: Hepatocytes - Metabolism"	Vesicles	Nucleoplasm	"HPA017283: AB_1844452, HPA073225: AB_2686583"	"unprognostic (4.20e-2)"	"unprognostic (7.92e-2)"	"prognostic favorable (1.13e-4)"	"unprognostic (2.35e-2)"	"unprognostic (1.16e-2)"	"unprognostic (3.00e-1)"	"unprognostic (5.45e-2)"	"unprognostic (1.15e-2)"	"unprognostic (9.54e-2)"	"unprognostic (1.11e-3)"	"unprognostic (1.34e-2)"	"unprognostic (1.94e-1)"	"prognostic favorable (1.11e-11)"	"unprognostic (1.94e-1)"	"unprognostic (2.41e-1)"	"unprognostic (2.72e-1)"	"unprognostic (6.31e-2)"	12.2	12.9	24.0	6.4	33.9	0.9	8.9	34.1	32.4	4.4	19.4	12.7	39.5	6.1	14.7	6.4	9.1	5.8	5.7	31.6	26.9	35.6	64.9	8.5	8.0	31.7	32.3	5.0	2.7	8.9	16.6	6.4	31.7	5.5	11.1	9.2	4.0	14.3	4.6	25.5	52.3	9.2	28.8	35.0	12.9	3.9	35.5	5.5	9.1	5.4	7.6	5.8	5.9	49.8	3.5	12.0	1.8	8.5	23.2	4.2	21.2	8.9	8.1	9.2	12.5	6.9	4.8	6.6	0.8	4.7	28.5	9.9	8.3	3.9	8.4	11.3	4.2	5.7	8.1	9.7	7.8	1.7	28.1	3.9	18.4	8.8	3.8	10.6	5.0	10.6	6.8	15.0	7.2	2.6	11.7	0.7	6.1	28.5	27.3	4.2	3.8	14.8	14.5	4.8	10.8	4.4	9.9	5.1	19.0	3.7	3.6	4.5	5.8	6.6	7.0	16.6	10.8	4.2	13.5	0.3	17.1	16.9	9.3	0.0	2.2	1.7	1.6	7.4	1.5	3.6	0.9	1.9	3.7	2.5	0.9	1.1	0.0	0.7	5.2	5.4	1.2	1.0	24.0	33.9	34.1	32.4	31.6	26.9	31.7	32.3	31.7	28.8	35.5	49.8	27.1	0.0	1.8	11.4	13.6	8.7	3.0	2.7	6.2	13.3	2.1	1.5	5.6	5.7	4.9	3.7	4.2	2.0	7.7	11.2	1.9	3.0	1.0	9.8	7.9	14.1	0.0	5.7	33.6	1.9	0.9	2.9	7.7	1.5	11.4	10.1	21.4	60.6	8.9	15.2	34.3	4.0	0.0	16.7	20.0	0.7	6.8	12.1	3.6	11.2	11.5	11.2	6.2	37.7	88.6	1.9	1.4	8.2	2.0	1.8	55.1	17.4	13.8	3.3	0.0	2.9	3.9	0.5	2.2	6.9	24.6	0.5	5.1	16.0	5.8	2.0
ACAA2	DSAEC	ENSG00000167315	"Acetyl-CoA acyltransferase 2"	P42765	18	49782164-49813953	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Fatty acid metabolism, Lipid metabolism"	"Acyltransferase, Hydrolase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 1011.9"	"Cell type enhanced"	"Detected in all"		"Distal enterocytes: 331.1;Hepatocytes: 810.5;Proximal tubular cells: 708.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA042303	Approved		Supported	Mitochondria		NA	NA		3800000	"Cluster 16: MAIT-cells - Unknown function"	"Cluster 85: Liver - Metabolism"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Mitochondria		"HPA042303: AB_10794046"	"unprognostic (7.94e-2)"	"unprognostic (3.14e-2)"	"unprognostic (2.20e-3)"	"prognostic unfavorable (8.53e-4)"	"unprognostic (2.92e-2)"	"unprognostic (2.28e-2)"	"unprognostic (7.63e-2)"	"unprognostic (1.70e-1)"	"unprognostic (7.97e-2)"	"unprognostic (8.03e-3)"	"unprognostic (1.72e-1)"	"unprognostic (3.84e-1)"	"prognostic favorable (1.36e-10)"	"unprognostic (1.39e-1)"	"unprognostic (2.24e-1)"	"unprognostic (8.26e-3)"	"unprognostic (3.41e-1)"	126.3	74.2	56.9	44.4	64.9	32.5	79.1	63.7	63.9	24.9	68.4	168.7	170.0	29.0	29.8	30.3	24.4	46.9	223.7	53.2	59.8	378.2	1011.9	48.9	36.6	65.1	61.4	34.8	54.1	35.1	34.9	29.6	64.0	26.4	109.6	31.9	20.3	34.0	165.3	28.0	165.2	44.5	62.8	33.6	37.4	37.7	64.3	39.9	55.8	236.6	31.9	41.6	28.6	64.2	3.9	70.5	110.0	97.5	129.9	69.5	57.4	35.2	52.4	53.6	41.2	146.3	58.9	61.1	73.5	117.5	56.7	4.8	176.8	21.0	51.4	190.5	50.4	45.5	79.0	171.4	62.5	0.7	78.3	91.7	6.7	84.8	26.2	44.6	90.0	87.7	42.5	54.7	147.5	81.8	2.7	89.7	101.5	24.8	26.7	150.8	233.0	217.6	177.7	2.8	163.4	130.9	2.7	76.2	5.6	82.1	45.7	60.0	48.1	49.8	60.5	67.8	36.4	112.3	139.7	157.3	35.0	85.7	47.1	53.0	87.4	96.1	99.2	106.5	123.0	43.2	58.3	88.7	103.2	36.3	50.2	73.2	8.3	120.0	108.1	50.1	76.4	112.7	56.9	64.9	63.7	63.9	53.2	59.8	65.1	61.4	64.0	62.8	64.3	64.2	28.4	38.5	47.3	11.8	31.4	3.6	14.2	15.5	11.4	6.7	25.0	25.5	189.9	234.4	23.7	55.2	4.2	36.5	48.2	331.1	295.4	148.5	71.2	7.9	33.9	30.0	40.1	53.6	1.7	45.7	56.0	47.3	23.9	7.7	45.1	63.3	41.4	810.5	109.6	1.7	4.6	73.0	24.4	64.8	18.5	153.9	48.1	50.6	19.6	13.1	57.2	62.2	106.1	4.5	8.7	101.8	161.2	37.2	41.2	9.8	226.6	708.0	26.4	29.5	19.7	42.1	34.9	51.1	42.7	11.1	4.8	27.0	52.2	93.0	144.8	9.6
ACE	"ACE1, CD143, DCP1"	ENSG00000159640	"Angiotensin I converting enzyme"	P12821	17	63477061-63498380	"Candidate cardiovascular disease genes, CD markers, Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins"		"Carboxypeptidase, Hydrolase, Metalloprotease, Protease"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 265.1;testis: 101.9"	"Group enriched"	"Detected in many"	20	"Early spermatids: 543.6;Late spermatids: 1322.9;Proximal enterocytes: 1172.8"	"Low cancer specificity"	"Detected in all"			"Region enhanced"	"Detected in many"		"basal ganglia: 8.1"	"Immune cell enhanced"	"Detected in single"		"memory B-cell: 1.0"	"Low lineage specificity"	"Detected in single"			"Group enriched"	"Detected in many"	4	"ASC TERT1: 63.3;HUVEC TERT2: 33.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB002426, CAB002921, HPA029298, HPA069790"	Enhanced		Approved	Vesicles	"Secreted to blood"	NA	NA	104000000	170000000	"Cluster 43: B-cells - Humoral immune response"	"Cluster 56: Intestine - Transmembrane transport"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 45: Enterocytes - Digestion"	Vesicles		"CAB002426: AB_442052, CAB002921: , HPA029298: AB_10960255, HPA069790: AB_2686197"	"unprognostic (4.72e-2)"	"unprognostic (4.16e-1)"	"unprognostic (1.93e-3)"	"unprognostic (6.06e-2)"	"unprognostic (2.78e-1)"	"unprognostic (1.35e-2)"	"unprognostic (4.37e-1)"	"unprognostic (1.54e-1)"	"unprognostic (1.56e-1)"	"unprognostic (1.25e-2)"	"unprognostic (3.13e-2)"	"unprognostic (2.38e-1)"	"unprognostic (7.66e-2)"	"unprognostic (9.07e-2)"	"unprognostic (1.66e-1)"	"unprognostic (1.08e-1)"	"unprognostic (2.76e-2)"	13.4	4.9	1.7	4.8	8.1	0.1	8.1	0.2	2.5	18.1	0.5	11.2	176.4	8.1	3.5	4.1	6.3	8.2	10.4	1.3	1.0	10.8	1.9	49.0	4.9	1.3	0.9	1.9	6.2	18.7	9.2	11.6	1.3	8.9	6.1	0.4	7.6	23.8	16.1	3.8	265.1	9.6	0.8	2.8	8.3	101.9	2.0	0.8	19.2	10.0	2.1	5.5	3.8	1.1	0.0	0.0	0.0	0.0	2.6	63.3	0.6	2.4	4.7	0.0	0.0	0.9	5.1	1.3	1.8	11.4	0.1	0.0	3.1	0.0	0.0	0.0	1.4	6.6	0.0	0.0	1.4	0.0	0.0	4.2	0.0	0.1	0.0	1.2	33.8	0.0	5.8	0.0	0.1	1.1	0.0	1.4	0.4	11.7	0.7	0.1	0.5	0.9	0.0	0.0	8.2	5.6	0.0	0.0	0.0	1.3	2.9	0.4	0.0	0.1	0.2	0.5	0.1	0.0	0.0	0.0	1.0	0.0	0.5	0.0	0.0	0.0	0.1	0.1	0.2	1.0	0.5	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	1.7	8.1	0.2	2.5	1.3	1.0	1.3	0.9	1.3	0.8	2.0	1.1	50.0	0.0	3.3	0.0	0.5	1.5	2.6	0.1	1.2	4.0	3.6	1.9	2.1	1.5	0.7	0.0	0.0	0.1	0.3	11.9	0.0	5.9	543.6	10.8	8.0	34.7	18.0	0.0	4.7	0.4	0.1	11.5	2.0	36.3	7.0	24.1	3.6	0.8	4.2	0.0	1.8	39.8	0.0	33.7	3.5	1322.9	4.4	13.6	3.6	4.7	0.0	1.8	0.0	1.0	0.2	0.7	40.9	2.6	0.1	4.2	1172.8	21.7	0.0	1.1	0.0	2.0	4.2	13.5	6.4	0.2	0.1	0.1	2.2	0.3	26.2	2.1
ACE2		ENSG00000130234	"Angiotensin I converting enzyme 2"	Q9BYF1	X	15494566-15607236	"Enzymes, Metabolic proteins, Predicted membrane proteins, Predicted secreted proteins, Transporters"	"Host-virus interaction"	"Carboxypeptidase, Host cell receptor for virus entry, Hydrolase, Metalloprotease, Protease, Receptor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"gallbladder: 65.5;intestine: 242.2;kidney: 87.6"	"Cell type enriched"	"Detected in many"	5	"Proximal enterocytes: 294.8"	"Group enriched"	"Detected in many"	4	"colorectal cancer: 13.9;renal cancer: 26.9"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"NB-4: 1.2;NTERA-2: 1.2;SuSa: 1.9"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"HPA000288, CAB026174, CAB026213, CAB080024, CAB080025, CAB080027, CAB080028"	Enhanced				"Secreted to blood"	NA	NA		400000		"Cluster 87: Intestine & Kidney - Transmembrane transport"	"Cluster 5: NTERA-2 - Transcription"	"Cluster 45: Enterocytes - Digestion"			"CAB026174: , CAB026213: , CAB080024: AB_10864415, CAB080025: AB_2809589, CAB080027: AB_2665870, CAB080028: AB_2665871, HPA000288: AB_1078160"	"unprognostic (1.40e-1)"	"unprognostic (7.26e-2)"	"unprognostic (2.76e-2)"	"unprognostic (5.71e-2)"	"unprognostic (2.51e-1)"	"unprognostic (5.26e-2)"	"prognostic favorable (4.21e-4)"	"unprognostic (2.34e-2)"	"unprognostic (6.74e-3)"	"unprognostic (2.54e-3)"	"unprognostic (1.00e-1)"	"unprognostic (1.74e-1)"	"prognostic favorable (2.12e-5)"	"unprognostic (1.94e-1)"	"unprognostic (9.62e-2)"	"unprognostic (2.11e-1)"	"unprognostic (7.10e-2)"	8.9	0.5	0.1	1.4	0.1	0.6	4.3	0.4	0.3	0.6	1.9	9.9	183.3	0.5	0.5	1.8	1.5	65.5	42.7	0.2	0.2	87.6	5.7	0.8	0.4	0.2	0.2	1.8	2.5	1.5	0.1	1.2	0.2	0.4	5.9	0.3	1.4	4.1	0.7	0.3	242.2	0.5	0.1	0.1	2.6	49.7	0.2	0.5	4.5	0.5	0.2	0.8	1.2	0.2	0.0	0.0	0.3	0.0	0.2	0.0	0.8	0.1	0.0	0.2	0.2	0.2	0.3	0.4	0.3	0.0	0.3	0.7	0.0	0.0	0.4	0.0	0.1	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.1	0.0	0.1	0.0	0.2	0.0	0.5	1.2	1.2	0.0	0.0	0.3	0.2	0.5	0.2	0.4	0.2	0.9	0.0	0.4	0.0	1.9	0.4	0.4	0.1	0.0	0.0	0.3	0.4	0.1	0.5	0.5	0.0	0.0	0.2	0.1	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.1	0.0	0.2	0.1	0.1	0.4	0.3	0.2	0.2	0.2	0.2	0.2	0.1	0.2	0.2	0.4	0.0	0.5	1.3	1.4	0.1	0.5	5.0	0.0	0.0	1.6	0.0	11.2	55.8	2.6	0.0	0.0	4.2	0.1	22.9	3.9	1.2	0.5	1.1	0.3	1.0	7.2	0.0	0.8	0.8	0.3	4.6	0.0	0.6	0.0	3.9	0.0	0.9	0.8	0.0	0.8	8.2	0.0	0.0	0.0	1.4	8.4	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.9	5.1	6.0	0.0	1.0	294.8	48.8	2.0	0.0	19.7	0.0	8.9	1.1	1.0	0.0	0.1	12.7	0.3	0.1	10.6	2.2
ACER1	ASAH3	ENSG00000167769	"Alkaline ceramidase 1"	Q8TDN7	19	6306142-6333612	"Enzymes, Metabolic proteins, Predicted membrane proteins"	"Lipid metabolism, Sphingolipid metabolism"	Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	7	"skin 1: 88.1"	"Cell type enhanced"	"Detected in some"		"Excitatory neurons: 2.7;Inhibitory neurons: 2.1;Melanocytes: 1.8;Spermatocytes: 1.7;Suprabasal keratinocytes: 5.8"	"Group enriched"	"Detected in some"	7	"head and neck cancer: 1.0;melanoma: 2.2;prostate cancer: 0.6"	"Not detected"	"Not detected"			"Low immune cell specificity"	"Detected in some"			"Lineage enriched"	"Detected in single"	4	"T-cells: 1.2"	"Cell line enhanced"	"Detected in single"		"T-47d: 2.9"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"									NA	NA			"Cluster 35: T-regs - Unknown function"	"Cluster 61: Skin - Cornification"	"Cluster 6: T47d - Mammary gland"	"Cluster 51: Myeloid cells - Hemostasis"				"unprognostic (1.13e-2)"	"unprognostic (2.87e-4)"		"unprognostic (5.04e-2)"	"unprognostic (6.18e-2)"	"unprognostic (8.16e-4)"	"unprognostic (7.27e-4)"	"unprognostic (2.17e-2)"	"unprognostic (1.61e-1)"	"unprognostic (1.99e-1)"	"unprognostic (1.02e-4)"	"unprognostic (1.02e-1)"	"unprognostic (1.30e-5)"	"unprognostic (2.11e-1)"	"unprognostic (4.44e-2)"	"unprognostic (4.22e-1)"	"unprognostic (2.24e-1)"	0.1	0.1	0.1	0.1	0.1	0.1	3.3	0.4	0.2	3.4	0.3	0.0	0.0	0.2	0.2	12.2	0.2	0.0	0.0	0.1	0.1	0.0	0.5	0.0	0.5	0.1	0.1	0.3	0.0	0.0	0.1	0.0	0.2	1.7	0.0	0.0	3.2	0.1	0.5	88.1	0.2	0.1	0.0	0.3	0.0	1.1	0.2	1.3	0.0	0.0	0.7	0.0	5.4	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	2.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	1.2	0.5	0.0	0.1	0.7	0.7	0.1	0.3	0.0	0.1	0.8	0.2	0.1	0.1	0.4	0.2	0.1	0.1	0.1	0.1	0.2	0.0	0.2	0.2	0.0	0.0	0.0	0.7	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.1	0.2	0.0	0.0	2.7	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	2.1	0.0	0.0	0.0	0.5	0.1	0.9	1.0	1.8	0.0	0.0	0.0	0.0	1.0	0.5	0.1	0.0	0.7	0.0	0.2	0.0	0.0	0.0	0.0	0.0	1.0	0.0	1.7	1.0	0.0	5.8	0.0	0.4	0.0	0.0	0.1
ACER2	"ALKCDase2, ASAH3L, FLJ41587"	ENSG00000177076	"Alkaline ceramidase 2"	Q5QJU3	9	19409009-19452505	"Enzymes, Metabolic proteins, Predicted membrane proteins"	"Lipid metabolism, Sphingolipid metabolism"	Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"stomach 1: 61.8;urinary bladder: 39.2"	"Cell type enhanced"	"Detected in some"		"Excitatory neurons: 19.7;Gastric mucus-secreting cells: 21.9;Inhibitory neurons: 10.3;Microglial cells: 26.2;Oligodendrocytes: 7.0"	"Cancer enhanced"	"Detected in many"		"urothelial cancer: 15.6"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	5	"BEWO: 29.7;RT4: 73.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"									NA	NA			"Cluster 7: Monocytes - Unknown function"	"Cluster 4: Stomach - Digestion"	"Cluster 15: RT4 - Unknown function"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"				"unprognostic (1.94e-1)"	"unprognostic (2.29e-1)"	"unprognostic (2.06e-1)"	"unprognostic (2.30e-1)"	"unprognostic (1.57e-1)"	"unprognostic (1.69e-1)"	"unprognostic (1.19e-1)"	"unprognostic (3.95e-2)"	"unprognostic (2.03e-1)"	"unprognostic (3.90e-1)"	"unprognostic (1.34e-1)"	"unprognostic (1.73e-1)"	"unprognostic (2.13e-2)"	"unprognostic (1.52e-1)"	"unprognostic (1.09e-1)"	"unprognostic (7.42e-2)"	"unprognostic (8.46e-3)"	6.9	1.4	4.5	1.1	3.4	0.6	5.0	2.7	5.0	1.7	2.0	3.3	4.5	1.4	4.2	2.2	3.7	1.7	2.9	4.4	3.1	1.9	2.4	2.2	1.0	3.2	3.1	1.0	6.8	2.5	1.1	9.7	4.3	3.7	4.3	3.8	1.9	4.5	1.2	5.9	2.7	1.3	2.8	1.4	61.8	1.9	5.9	2.4	2.5	1.0	1.3	39.2	1.7	3.7	1.2	2.0	3.9	2.0	6.2	0.5	29.7	2.1	1.4	0.7	1.0	0.6	1.9	1.3	0.7	0.3	0.4	4.5	0.8	5.8	1.5	2.4	1.1	2.1	1.6	3.0	1.3	0.5	2.0	1.8	5.6	2.2	2.4	0.6	6.2	2.1	3.1	3.8	2.0	1.7	3.6	1.8	3.1	11.1	0.9	3.2	1.0	0.7	0.6	73.6	6.9	1.8	0.4	2.2	0.5	9.3	2.7	2.5	3.1	0.5	1.5	0.6	0.9	1.4	1.7	1.4	0.6	1.5	1.3	0.0	0.0	0.0	0.1	0.5	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.1	4.5	3.4	2.7	5.0	4.4	3.1	3.2	3.1	4.3	2.8	5.9	3.7	3.2	0.0	0.0	1.0	0.7	0.3	0.4	0.1	0.6	1.0	0.3	0.4	0.1	0.0	0.1	0.0	2.1	0.5	0.4	0.0	0.0	0.1	2.6	0.3	0.2	0.8	0.0	0.8	19.7	0.0	0.6	0.3	21.9	0.4	0.0	0.0	1.4	0.0	0.1	0.0	10.3	0.0	0.0	0.0	0.0	4.0	0.3	0.2	0.0	26.2	0.0	0.6	0.0	5.5	7.0	0.1	0.0	0.0	0.4	0.2	0.0	0.1	0.1	0.6	0.0	0.6	0.4	0.4	0.4	0.8	0.0	4.0	0.3	0.0	0.0	1.1
ACER3	"APHC, FLJ11238, PHCA"	ENSG00000078124	"Alkaline ceramidase 3"	Q9NUN7	11	76860859-77026797	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted membrane proteins"	"Lipid metabolism, Sphingolipid metabolism"	Hydrolase	"Disease variant, Leukodystrophy"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Oligodendrocyte precursor cells: 159.3;Oligodendrocytes: 335.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA070087	Approved					NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"			"HPA070087: AB_2732147"	"unprognostic (1.32e-1)"	"unprognostic (1.51e-1)"	"unprognostic (9.54e-3)"	"unprognostic (1.37e-1)"	"unprognostic (4.06e-2)"	"unprognostic (1.34e-1)"	"prognostic unfavorable (2.49e-4)"	"unprognostic (7.13e-2)"	"unprognostic (2.35e-3)"	"unprognostic (8.45e-3)"	"unprognostic (1.30e-1)"	"unprognostic (3.68e-3)"	"prognostic unfavorable (2.73e-4)"	"unprognostic (5.24e-2)"	"unprognostic (3.37e-1)"	"unprognostic (9.88e-2)"	"unprognostic (7.97e-2)"	10.9	3.0	6.2	4.8	8.5	3.0	5.4	8.5	9.3	5.2	4.0	6.4	6.2	4.2	3.1	6.9	4.1	3.2	3.4	6.3	8.5	4.7	2.5	8.0	4.2	8.6	7.1	2.3	2.9	3.5	2.1	6.2	9.5	4.1	5.5	2.3	4.2	2.3	1.6	2.9	4.6	3.9	8.4	5.6	3.4	6.0	7.3	2.2	3.3	1.2	3.8	4.5	4.4	12.0	7.3	7.7	6.4	7.6	29.2	14.0	5.7	11.2	10.7	8.2	9.2	6.0	7.3	6.4	8.4	8.0	10.3	12.9	10.9	10.6	10.0	8.6	4.3	9.0	4.8	3.6	8.1	9.3	15.0	6.3	5.0	11.8	10.9	4.8	16.8	5.8	6.1	4.2	9.9	5.9	0.7	6.2	3.6	19.3	8.8	4.3	22.8	5.0	6.8	7.2	2.2	5.5	13.9	12.6	3.5	4.9	10.7	5.1	22.2	8.2	6.4	23.3	8.3	3.1	7.1	8.6	5.1	4.7	8.9	0.1	4.3	2.5	0.7	3.1	0.8	1.2	0.5	0.9	4.6	0.4	0.3	0.4	0.9	0.2	2.4	1.5	1.2	1.6	6.2	8.5	8.5	9.3	6.3	8.5	8.6	7.1	9.5	8.4	7.3	12.0	32.4	41.7	35.0	52.9	11.5	31.9	21.4	17.0	33.0	18.8	11.3	11.0	7.5	11.5	27.6	9.2	10.4	13.6	11.3	54.6	7.9	15.5	66.8	6.3	29.0	29.4	2.4	13.5	65.0	17.6	7.5	17.0	26.0	11.5	83.5	30.9	27.8	10.0	44.4	43.7	71.9	30.5	18.3	64.1	67.1	31.7	20.2	64.0	17.8	61.8	40.0	11.3	12.3	159.3	335.1	18.6	37.9	25.9	8.6	15.6	20.0	15.3	12.3	10.0	6.6	17.0	21.0	69.8	25.9	26.3	16.8	26.8	15.2	7.2	20.1	24.1
ACHE	YT	ENSG00000087085	"Acetylcholinesterase (Cartwright blood group)"	P22303	7	100889994-100896974	"Blood group antigen proteins, Enzymes, FDA approved drug targets, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Neurotransmitter degradation"	"Blood group antigen, Hydrolase, Serine esterase"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	8	"brain: 98.2;skeletal muscle: 163.2;tongue: 48.0"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 86.2;Erythroid cells: 37.7;Exocrine glandular cells: 39.7;Horizontal cells: 55.5;Paneth cells: 118.3;Proximal enterocytes: 45.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BEWO: 7.9;CACO-2: 13.0;K-562: 13.9;Karpas-707: 19.7;U-2 OS: 6.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA027098			Approved	"Golgi apparatus,Vesicles"	"Intracellular and membrane"	NA	NA		990000		"Cluster 80: Striated muscle - Unknown function"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 53: Intestinal epithelial cells - Unknown function"	"Golgi apparatus"	Vesicles	"HPA027098: AB_2672111"	"unprognostic (2.23e-1)"	"unprognostic (9.44e-2)"	"unprognostic (2.71e-2)"	"unprognostic (5.80e-3)"	"prognostic unfavorable (5.27e-4)"	"unprognostic (2.49e-1)"	"unprognostic (2.54e-1)"	"unprognostic (1.36e-2)"	"unprognostic (2.48e-2)"	"unprognostic (8.92e-2)"	"unprognostic (2.65e-2)"	"unprognostic (1.78e-1)"	"prognostic unfavorable (3.88e-5)"	"unprognostic (2.95e-1)"	"unprognostic (2.59e-2)"	"unprognostic (9.28e-2)"	"unprognostic (8.38e-2)"	1.4	4.7	20.9	2.2	16.8	7.9	2.0	37.1	32.5	5.0	0.0	7.6	4.9	2.6	0.2	2.3	3.2	1.3	12.5	8.0	98.2	8.8	4.1	4.4	3.5	66.1	54.2	4.6	4.3	4.7	8.3	0.7	72.7	8.1	1.8	5.7	7.1	1.6	163.2	1.3	9.1	0.5	26.2	3.5	2.4	3.9	58.1	3.6	2.3	48.0	1.5	1.4	3.7	10.5	0.0	0.2	0.2	0.2	0.3	0.0	7.9	0.3	0.0	0.1	0.2	13.0	0.1	0.0	0.6	0.0	1.2	0.6	2.0	0.1	0.0	4.6	0.5	0.2	0.1	0.2	0.1	0.0	0.4	0.5	0.1	0.1	0.0	0.0	0.0	0.1	13.9	19.7	0.1	4.3	0.0	0.2	1.1	0.3	0.3	0.0	0.1	0.0	0.1	0.0	0.8	1.5	0.1	0.8	0.0	2.9	0.0	0.0	0.2	0.5	6.0	0.2	0.1	0.0	0.2	0.0	0.1	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	20.9	16.8	37.1	32.5	8.0	98.2	66.1	54.2	72.7	26.2	58.1	10.5	0.5	0.0	0.0	3.3	0.5	0.8	20.9	0.9	6.2	13.5	2.9	1.1	6.4	5.7	0.4	0.0	0.0	8.2	0.9	86.2	0.0	10.5	0.0	0.5	1.5	2.1	3.5	37.7	4.7	39.7	2.6	3.0	1.5	2.4	0.0	7.4	2.2	0.4	0.8	55.5	9.7	12.0	0.0	0.3	6.6	0.4	0.6	1.7	1.8	1.0	4.6	11.4	0.0	8.5	0.8	20.1	118.3	0.7	1.8	20.4	45.6	1.1	0.1	6.8	0.0	13.5	4.9	4.1	8.0	1.7	1.0	7.1	0.6	1.4	4.6	15.2
ACOT1	"ACH2, CTE-1, LACH2"	ENSG00000184227	"Acyl-CoA thioesterase 1"	Q86TX2	14	73537143-73543796	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Fatty acid metabolism, Lipid metabolism"	"Hydrolase, Serine esterase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 44.4"	"Cell type enhanced"	"Detected in some"		"Astrocytes: 10.7;Cardiomyocytes: 51.5;Excitatory neurons: 13.8;Inhibitory neurons: 12.0;Oligodendrocyte precursor cells: 8.5;Oligodendrocytes: 15.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"Hep G2: 30.5;T-47d: 49.8"									HPA043705	Approved		Approved	Mitochondria		NA	NA			"Cluster 22: NK-cells - Unknown function"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 6: T47d - Mammary gland"	"Cluster 54: Cardiomyocytes - Muscle contraction"	Mitochondria		"HPA043705: AB_2678626"	"unprognostic (4.74e-3)"	"unprognostic (3.81e-3)"	"unprognostic (7.65e-2)"	"unprognostic (8.66e-2)"	"unprognostic (1.22e-1)"	"unprognostic (1.29e-1)"	"unprognostic (4.54e-2)"	"unprognostic (1.29e-2)"	"unprognostic (1.53e-1)"	"unprognostic (1.73e-2)"	"unprognostic (1.84e-1)"	"unprognostic (4.16e-1)"	"prognostic favorable (5.09e-8)"	"unprognostic (1.35e-3)"	"unprognostic (4.60e-2)"	"unprognostic (1.75e-1)"	"unprognostic (1.43e-1)"	15.1	12.9	10.4	3.6	10.2	2.4	13.0	9.3	11.3	5.7	8.4	12.9	10.8	13.2	11.6	3.4	7.3	3.5	18.6	10.1	9.7	25.9	44.4	7.3	2.3	9.2	10.1	3.5	3.0	2.2	2.0	2.9	9.6	5.6	5.4	2.9	5.1	9.3	19.6	8.9	11.8	20.9	9.5	2.6	6.4	4.2	11.1	2.5	3.6	29.3	2.1	9.5	4.0	9.6	10.7	9.0	3.3	0.7	15.2	9.1	0.1	2.9	8.5	7.0	12.6	3.9	6.9	0.0	0.4	5.8	0.9	6.0	0.0	1.4	3.4	4.5	2.8	4.6	2.8	30.5	14.4	0.1	5.1	12.0	0.6	5.6	0.0	0.7	3.2	0.0	0.0	0.0	5.5	4.7	0.6	1.0	3.4	1.4	4.9	9.5	6.8	0.2	6.9	8.7	4.9	6.4	9.0	20.2	12.2	0.9	49.8	9.9	4.2	5.2	7.5	4.2	0.7	0.1	0.0	2.6	6.2	0.0	6.8	0.7	0.9	0.7	4.1	1.1	3.5	2.6	3.9	3.4	3.8	1.9	3.5	3.9	0.1	3.5	1.1	2.2	5.1	2.6	10.4	10.2	9.3	11.3	10.1	9.7	9.2	10.1	9.6	9.5	11.1	9.6	0.2	0.0	3.2	10.7	0.0	0.0	0.1	0.6	1.8	0.0	0.4	0.4	51.5	0.0	0.4	0.0	0.0	0.7	1.3	0.2	0.0	0.4	0.6	0.3	0.3	0.7	0.0	2.7	13.8	8.0	0.3	2.6	0.0	0.3	0.0	0.1	0.0	1.1	0.9	0.0	12.0	0.0	2.0	0.3	0.0	0.0	0.0	0.5	1.8	3.7	0.0	0.0	0.0	8.5	15.1	2.6	0.0	0.4	0.3	0.0	0.0	3.7	0.3	0.0	0.0	0.0	3.6	0.1	0.2	0.6	0.0	0.8	0.2	0.0	0.2	0.0
ACOT11	"BFIT, BFIT1, KIAA0707, STARD14, THEA, THEM1"	ENSG00000162390	"Acyl-CoA thioesterase 11"	Q8WXI4	1	54542257-54639192	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Fatty acid metabolism, Lipid metabolism"	"Hydrolase, Serine esterase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"choroid plexus: 44.4;intestine: 36.0"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 134.8;Distal enterocytes: 71.3;Late spermatids: 150.6;Proximal enterocytes: 106.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"eosinophil: 4.6"	"Lineage enriched"	"Detected in single"	6	"granulocytes: 4.6"	"Cell line enhanced"	"Detected in many"		"HaCaT: 18.9;OE19: 27.3;RT4: 40.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA041047	Enhanced		Supported	Cytosol		NA	NA			"Cluster 49: Eosinophils - Unknown function"	"Cluster 88: Choroid plexus - Transmembrane transport"	"Cluster 15: RT4 - Unknown function"	"Cluster 31: Spermatids - Spermatogenesis"	Cytosol		"HPA041047: AB_2677273"	"unprognostic (9.73e-2)"	"unprognostic (1.28e-1)"	"prognostic favorable (9.37e-4)"	"unprognostic (3.61e-4)"	"unprognostic (5.42e-2)"	"unprognostic (1.94e-1)"	"unprognostic (2.20e-3)"	"unprognostic (5.12e-4)"	"unprognostic (1.05e-1)"	"unprognostic (2.84e-2)"	"unprognostic (9.60e-2)"	"unprognostic (1.02e-1)"	"prognostic favorable (3.07e-8)"	"unprognostic (5.89e-2)"	"unprognostic (1.08e-1)"	"unprognostic (3.83e-2)"	"unprognostic (8.49e-3)"	1.4	3.4	4.6	2.4	5.9	3.7	1.1	7.0	5.2	3.8	44.4	13.8	36.0	2.6	3.1	15.9	3.0	2.4	30.4	5.4	4.9	16.3	1.2	1.9	1.7	7.1	12.3	5.2	3.1	21.2	8.0	1.5	6.1	3.5	11.6	7.9	9.4	3.4	9.2	2.8	29.3	2.5	3.6	1.5	11.1	2.5	7.6	0.6	10.1	10.6	3.3	6.5	6.3	3.9	6.7	4.2	2.0	1.2	0.8	1.9	3.4	3.7	0.2	1.1	0.8	6.4	16.9	1.4	5.6	3.0	4.0	18.9	0.8	3.3	0.6	3.9	1.4	16.0	6.2	2.7	0.3	1.8	2.1	2.0	3.7	0.4	1.6	1.7	3.4	1.1	0.9	1.9	4.0	2.0	0.7	2.4	3.3	27.3	0.9	1.2	11.1	1.5	0.7	40.1	4.2	4.2	1.8	1.2	0.8	6.8	1.6	5.1	3.5	2.5	2.4	1.7	1.4	1.9	1.0	1.5	1.2	11.7	1.3	1.1	0.6	4.6	0.3	0.3	0.3	0.3	0.3	0.2	0.7	0.5	0.4	0.4	1.3	0.4	0.5	0.4	0.3	0.3	4.6	5.9	7.0	5.2	5.4	4.9	7.1	12.3	6.1	3.6	7.6	3.9	0.5	0.0	7.8	134.8	1.4	4.8	16.6	7.3	2.8	46.4	3.4	0.9	24.7	10.0	7.2	25.8	0.0	2.0	0.2	71.3	11.7	4.4	22.6	11.4	1.7	2.1	47.5	3.0	11.7	2.6	6.2	3.5	33.6	14.1	15.2	3.3	3.9	0.4	8.3	15.2	6.0	38.8	10.2	8.0	7.4	150.6	13.7	6.1	8.8	10.3	2.9	46.4	0.0	19.6	3.9	4.7	37.0	17.7	0.5	6.6	106.1	48.0	8.5	5.3	0.0	19.1	2.5	0.6	1.0	5.3	2.8	2.5	1.2	16.4	44.8	26.3
ACOT12	"Cach, STARD15, THEAL"	ENSG00000172497	"Acyl-CoA thioesterase 12"	Q8WYK0	5	81329996-81394179	"Enzymes, Metabolic proteins, Predicted intracellular proteins, Transporters"	"Fatty acid metabolism, Lipid metabolism"	"Hydrolase, Serine esterase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	36	"liver: 100.7"	"Cell type enriched"	"Detected in some"	4	"Hepatocytes: 36.2"	"Cancer enriched"	"Detected in single"	76	"liver cancer: 13.9"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			HPA037723			Approved	"Nucleoplasm,Cytokinetic bridge,Cytosol"		Yes	NA				"Cluster 62: Liver - Hemostasis"		"Cluster 2: Hepatocytes - Metabolism"	Cytosol	"Nucleoplasm, Cytokinetic bridge"	"HPA037723: AB_10672606"	"unprognostic (6.06e-2)"				"unprognostic (1.39e-1)"		"prognostic favorable (5.30e-4)"		"unprognostic (7.68e-2)"	"unprognostic (8.22e-2)"	"unprognostic (5.68e-3)"	"unprognostic (2.46e-1)"	"unprognostic (6.86e-2)"	"unprognostic (1.46e-2)"	"unprognostic (3.07e-1)"	"unprognostic (1.06e-1)"		0.0	0.0	0.6	0.0	0.7	0.0	0.0	0.0	0.5	0.1	0.0	0.0	0.3	0.0	0.3	0.0	0.0	0.0	0.0	0.3	0.5	2.7	100.7	0.0	0.0	0.3	0.3	0.0	0.0	0.0	0.0	0.1	0.6	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.2	0.6	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.4	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.7	0.0	0.5	0.3	0.5	0.3	0.3	0.6	0.0	0.6	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	2.8	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.1	0.0	8.0	0.7	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.4	36.2	0.5	0.0	1.2	0.0	0.0	1.4	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.4	0.0	0.0	3.4	4.2	0.0	0.0	0.0	0.4	0.0	0.6	0.2	0.0	0.0	0.0	0.1	0.0	0.1	0.0
ACOT13	"HT012, THEM2"	ENSG00000112304	"Acyl-CoA thioesterase 13"	Q9NPJ3	6	24667035-24705065	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 30.6"	"Cell type enhanced"	"Detected in all"		"Early spermatids: 847.1;Proximal tubular cells: 525.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA019881, HPA057134"	Enhanced		Approved	"Cell Junctions"		NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 16: U-266 - Nucleosome"	"Cluster 29: Early spermatids - Spermatogenesis"	"Cell Junctions"		"HPA019881: AB_1857978, HPA057134: "	"unprognostic (3.61e-1)"	"unprognostic (1.62e-1)"	"unprognostic (6.02e-2)"	"unprognostic (1.80e-2)"	"unprognostic (9.57e-2)"	"unprognostic (1.21e-1)"	"unprognostic (1.19e-1)"	"unprognostic (1.19e-1)"	"unprognostic (1.71e-1)"	"prognostic favorable (2.53e-6)"	"unprognostic (3.67e-2)"	"unprognostic (1.64e-2)"	"unprognostic (7.16e-2)"	"unprognostic (5.97e-2)"	"unprognostic (4.86e-2)"	"unprognostic (1.50e-1)"	"unprognostic (2.13e-2)"	6.3	6.1	7.2	4.8	7.5	3.4	3.8	7.9	7.3	3.4	6.0	9.1	6.5	3.1	3.7	3.4	3.6	4.9	12.0	6.6	7.8	19.2	30.6	4.6	5.2	7.2	7.8	3.9	6.6	7.2	5.1	3.0	7.4	6.5	7.4	9.6	5.0	3.3	12.2	5.5	6.1	3.1	7.1	4.8	5.5	7.0	8.2	5.1	5.7	10.3	3.4	3.5	3.1	7.4	5.9	7.6	7.6	13.6	10.5	13.1	4.2	4.8	5.8	3.5	5.4	10.1	7.5	11.1	16.2	5.5	18.4	6.4	6.7	9.7	5.4	17.4	6.2	10.4	7.7	7.0	5.3	6.7	4.6	7.6	9.4	4.7	9.0	8.5	8.3	11.3	17.0	5.7	7.0	6.1	12.1	12.9	5.1	11.7	5.9	10.4	6.6	14.0	11.7	5.4	15.0	5.2	5.7	19.1	14.1	8.8	13.2	5.5	9.7	6.2	3.5	1.7	4.6	10.7	29.3	11.1	6.5	23.8	19.1	4.8	5.3	3.6	4.4	5.7	6.1	6.9	4.9	5.0	4.7	4.9	5.7	5.1	6.2	4.6	5.8	3.7	5.3	4.8	7.2	7.5	7.9	7.3	6.6	7.8	7.2	7.8	7.4	7.1	8.2	7.4	27.9	67.3	41.7	19.6	19.7	17.2	26.6	66.4	18.8	18.7	29.4	32.3	94.6	45.8	46.9	31.3	16.7	56.8	22.6	88.4	158.5	43.2	847.1	34.0	31.3	24.0	54.7	37.2	12.1	40.2	31.1	26.2	23.9	31.8	14.5	30.3	21.4	215.5	86.7	5.0	14.3	85.8	67.1	24.5	23.7	131.5	19.6	35.0	26.6	14.0	68.9	41.7	18.6	15.6	18.7	29.2	130.7	24.0	25.4	23.2	47.1	525.2	56.8	31.8	26.3	50.6	64.2	117.1	27.3	19.5	23.4	40.0	20.5	43.4	69.4	28.6
ACOT2	"Mte1, ZAP128"	ENSG00000119673	"Acyl-CoA thioesterase 2"	P49753	14	73567620-73575658	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Fatty acid metabolism, Lipid metabolism"	"Hydrolase, Serine esterase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 118.9"	"Cell type enhanced"	"Detected in many"		"Cardiomyocytes: 50.0;Exocrine glandular cells: 33.2;Proximal tubular cells: 36.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"Hep G2: 62.4"									"HPA043705, HPA060170"	Enhanced		Approved	Mitochondria		NA	NA			"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 59: Non-specific - Transcription"	Mitochondria		"HPA043705: AB_2678626, HPA060170: AB_2732642"	"unprognostic (4.44e-3)"	"unprognostic (1.68e-2)"	"unprognostic (3.17e-1)"	"unprognostic (8.66e-2)"	"unprognostic (1.78e-1)"	"unprognostic (1.55e-1)"	"unprognostic (2.78e-2)"	"unprognostic (6.61e-2)"	"unprognostic (4.10e-2)"	"unprognostic (9.21e-2)"	"unprognostic (6.42e-2)"	"unprognostic (1.64e-1)"	"prognostic favorable (2.28e-6)"	"unprognostic (1.66e-3)"	"unprognostic (1.04e-1)"	"unprognostic (1.52e-1)"	"unprognostic (4.35e-1)"	92.3	47.7	10.0	7.0	10.3	5.6	48.9	9.2	12.4	17.1	12.2	42.2	24.7	42.9	10.7	10.9	24.1	6.1	94.5	10.1	9.5	49.4	118.9	17.3	4.7	8.8	9.4	11.7	12.8	22.4	8.3	4.4	8.2	17.8	11.1	4.1	17.8	11.1	114.0	13.1	24.5	22.8	9.2	11.4	22.5	12.0	13.0	3.7	14.5	50.0	3.3	31.2	13.3	9.0	22.8	25.0	4.9	22.1	21.3	7.9	1.0	13.7	31.5	21.9	28.6	18.1	12.6	0.1	9.7	7.0	10.3	12.7	0.0	1.2	11.4	33.1	31.6	16.0	7.6	62.4	14.5	0.1	43.3	19.5	0.0	7.6	0.1	21.0	9.5	0.0	0.0	0.1	18.7	7.4	2.5	18.2	7.5	2.3	37.8	37.2	21.9	0.3	8.0	9.5	21.6	27.3	33.1	24.3	29.6	2.1	51.1	12.7	17.0	17.9	47.2	11.8	13.0	0.0	0.1	9.5	15.8	0.1	18.2	3.5	5.9	3.1	22.1	7.0	15.8	15.0	20.2	16.6	21.9	12.4	17.8	19.9	0.2	15.3	6.5	13.6	31.3	13.6	10.0	10.3	9.2	12.4	10.1	9.5	8.8	9.4	8.2	9.2	13.0	9.0	4.3	0.0	6.4	3.3	6.6	1.7	1.0	5.9	16.5	1.1	5.2	4.2	50.0	7.2	3.0	7.3	10.4	6.1	3.0	20.1	13.7	20.9	1.5	1.4	1.9	4.0	15.7	8.4	2.9	33.2	3.2	7.0	11.7	2.1	13.4	1.9	4.2	27.7	14.9	1.7	3.1	15.5	10.2	3.8	1.6	1.1	5.9	5.6	5.4	1.0	18.5	5.5	7.2	3.0	1.7	21.8	8.6	8.2	7.9	0.4	27.5	36.5	3.3	4.9	6.6	1.4	9.8	0.3	4.8	8.5	0.4	8.2	5.8	1.7	18.8	0.4
ACOT4	"FLJ31235, PTE-Ib, PTE2B"	ENSG00000177465	"Acyl-CoA thioesterase 4"	Q8N9L9	14	73591873-73595766	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Fatty acid metabolism, Lipid metabolism"	"Hydrolase, Serine esterase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"kidney: 15.0;liver: 16.8"	"Cell type enhanced"	"Detected in many"		"Hepatocytes: 26.4;Proximal tubular cells: 59.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"CAPAN-2: 17.6;MCF7: 14.1;SK-BR-3: 27.9;T-47d: 69.7"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			HPA000779	Enhanced					NA	NA			"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 81: Kidney & Liver - Metabolism"	"Cluster 6: T47d - Mammary gland"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"			"HPA000779: AB_1078093"	"unprognostic (2.29e-3)"	"unprognostic (2.53e-3)"	"unprognostic (2.30e-1)"	"unprognostic (2.29e-3)"	"unprognostic (1.16e-1)"	"unprognostic (2.11e-1)"	"unprognostic (2.25e-2)"	"unprognostic (3.10e-2)"	"unprognostic (1.72e-2)"	"unprognostic (9.56e-2)"	"prognostic unfavorable (1.77e-4)"	"unprognostic (3.95e-1)"	"prognostic favorable (8.43e-5)"	"unprognostic (2.47e-1)"	"unprognostic (1.92e-1)"	"unprognostic (7.31e-2)"	"unprognostic (1.73e-1)"	4.9	1.4	3.7	1.1	3.7	0.6	4.6	4.2	4.3	3.9	2.4	3.0	4.3	0.8	2.6	1.5	0.9	0.9	0.9	3.6	2.9	15.0	16.8	3.6	1.3	3.1	2.7	0.9	1.5	1.0	0.4	1.8	3.3	1.4	3.4	0.8	1.7	1.8	0.6	0.6	3.3	1.5	2.5	1.5	2.0	2.2	2.9	1.0	1.3	0.6	1.3	1.2	0.9	3.2	10.7	2.9	0.3	0.1	1.3	0.6	0.0	0.6	0.0	0.7	1.2	0.3	17.6	0.0	0.6	1.0	0.0	1.1	0.0	0.1	0.1	5.8	0.1	0.0	3.5	0.0	2.0	0.0	9.5	0.8	1.3	0.3	0.0	0.1	0.2	0.0	0.0	0.0	0.6	14.1	0.3	1.9	0.9	3.7	2.8	0.0	0.0	0.0	0.4	5.2	1.5	0.3	6.9	27.9	2.1	0.1	69.7	10.5	0.2	0.0	6.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.6	11.5	0.0	1.4	14.7	0.6	7.3	2.1	6.9	8.4	0.4	3.3	4.0	8.5	0.0	7.2	0.2	0.9	7.2	5.3	3.7	3.7	4.2	4.3	3.6	2.9	3.1	2.7	3.3	2.5	2.9	3.2	0.4	0.0	2.7	1.0	1.0	0.3	1.1	3.8	1.2	0.2	5.5	4.2	1.7	7.2	2.8	11.0	0.0	15.9	3.6	8.3	15.6	4.2	1.8	4.1	1.1	0.5	0.0	0.0	1.4	9.2	13.8	1.5	3.1	5.6	5.7	4.1	0.0	26.4	11.2	1.7	0.8	3.2	8.2	3.0	0.3	5.3	0.3	2.1	0.0	1.9	1.0	0.7	11.3	0.5	0.3	6.2	2.6	0.4	1.5	1.1	15.7	59.8	2.9	0.5	0.0	1.5	1.1	3.2	15.8	2.6	0.3	4.5	5.1	0.4	2.6	1.3
ACOT7	"ACH1, ACT, BACH, CTE-II, hBACH, LACH1, MGC1126"	ENSG00000097021	"Acyl-CoA thioesterase 7"	O00154	1	6264269-6393767	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Fatty acid metabolism, Lipid metabolism"	"Hydrolase, Serine esterase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 128.7"	"Cell type enhanced"	"Detected in many"		"granulocytes: 137.2;Late spermatids: 160.8;Proximal enterocytes: 179.4;Proximal tubular cells: 253.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"NK-cell: 40.2;plasmacytoid DC: 35.7"	"Group enriched"	"Detected in many"	5	"dendritic cells: 35.7;NK-cells: 40.2"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA025735, HPA025762"	Enhanced		Supported	Nucleoplasm,Cytosol		No	No		26000	"Cluster 40: NK-cells - Unknown function"	"Cluster 45: Intestine - Brush border"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Cytosol	Nucleoplasm	"HPA025735: AB_1844523, HPA025762: AB_1844524"	"unprognostic (3.94e-2)"	"unprognostic (1.74e-1)"	"unprognostic (7.09e-2)"	"unprognostic (4.33e-2)"	"unprognostic (4.10e-2)"	"unprognostic (5.06e-2)"	"prognostic unfavorable (2.31e-5)"	"prognostic unfavorable (1.29e-4)"	"unprognostic (2.35e-2)"	"unprognostic (4.05e-2)"	"unprognostic (1.15e-1)"	"unprognostic (1.73e-1)"	"prognostic unfavorable (2.55e-6)"	"unprognostic (2.68e-2)"	"unprognostic (1.45e-1)"	"unprognostic (9.06e-2)"	"unprognostic (3.72e-2)"	11.3	20.4	72.8	18.7	72.8	14.7	9.9	56.2	108.2	17.8	16.7	32.7	55.1	18.2	5.5	35.0	11.0	8.2	17.3	75.1	107.2	47.8	22.0	17.9	22.4	96.1	88.5	11.2	9.0	3.8	65.1	10.4	128.7	12.9	21.4	24.5	11.9	6.9	5.2	27.1	56.1	23.5	46.9	20.7	19.2	38.1	83.9	28.3	6.1	4.7	19.4	18.0	23.5	68.4	117.6	100.0	96.6	104.6	21.7	35.6	36.4	98.6	50.6	142.7	85.1	347.7	37.0	142.4	70.6	80.4	110.3	113.0	156.9	263.2	53.2	126.0	136.7	75.2	74.4	124.9	88.7	88.8	59.9	32.1	49.6	118.2	139.2	38.1	81.2	174.8	62.3	29.8	76.8	136.6	187.0	94.0	48.5	116.9	228.2	219.9	110.6	95.6	80.9	44.2	52.6	149.1	88.9	134.5	317.9	47.3	47.9	41.2	133.0	129.1	75.4	129.6	158.9	24.9	110.6	202.1	81.8	153.7	80.3	0.0	0.3	0.2	7.3	1.2	1.8	2.1	5.8	6.2	5.4	0.7	2.0	3.9	0.7	40.2	0.9	35.7	8.2	5.3	72.8	72.8	56.2	108.2	75.1	107.2	96.1	88.5	128.7	46.9	83.9	68.4	3.4	6.4	16.4	9.4	4.9	31.7	16.5	24.2	12.5	46.8	4.1	7.5	9.8	8.6	14.9	9.2	10.4	20.9	14.4	45.4	15.6	22.7	95.5	4.0	6.1	19.1	4.8	26.5	38.6	7.2	29.7	11.5	19.9	7.6	137.2	13.2	8.6	16.8	30.1	47.1	38.9	110.2	36.7	4.8	85.9	160.8	3.7	13.4	39.2	5.6	15.7	12.8	8.2	22.6	21.0	23.2	41.8	7.2	9.3	9.5	179.4	253.7	7.1	24.4	0.0	6.7	17.6	37.8	28.0	26.2	29.5	17.2	21.7	13.7	51.3	19.6
ACOT8	"hACTE-III, hTE, NAP1, PTE-2, PTE1"	ENSG00000101473	"Acyl-CoA thioesterase 8"	O14734	20	45841721-45857405	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Fatty acid metabolism, Host-virus interaction, Lipid metabolism, Peroxisome biogenesis"	"Hydrolase, Serine esterase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Distal enterocytes: 104.2;Late spermatids: 90.3;Proximal enterocytes: 105.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB010261	Approved		Supported	Vesicles,Mitochondria		NA	NA			"Cluster 31: Non-specific - Inflammatory response"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Vesicles	Mitochondria	"CAB010261: AB_2221664"	"unprognostic (2.36e-2)"	"unprognostic (6.95e-2)"	"unprognostic (2.12e-1)"	"unprognostic (1.28e-2)"	"unprognostic (2.13e-1)"	"unprognostic (4.27e-1)"	"unprognostic (1.03e-3)"	"unprognostic (2.92e-2)"	"unprognostic (4.70e-1)"	"unprognostic (1.72e-1)"	"unprognostic (2.28e-2)"	"unprognostic (2.03e-2)"	"prognostic favorable (3.18e-4)"	"unprognostic (2.79e-1)"	"unprognostic (1.23e-1)"	"unprognostic (4.61e-2)"	"unprognostic (2.98e-1)"	8.3	31.7	27.8	8.6	29.8	18.1	7.6	28.2	35.2	9.3	24.3	18.5	21.1	8.5	11.0	17.5	10.7	9.2	28.1	29.8	28.6	21.3	26.0	11.0	12.6	27.0	28.5	8.0	15.6	15.1	15.4	7.1	28.7	12.7	12.8	9.2	12.8	5.9	28.7	17.0	20.5	6.4	26.0	12.3	21.3	20.2	28.7	13.1	11.4	17.8	9.7	11.0	10.4	28.1	16.8	20.2	6.8	13.4	18.3	11.0	11.7	11.1	9.5	15.1	13.7	29.2	22.7	20.8	48.2	16.3	35.4	32.3	13.0	27.8	6.6	15.5	22.3	21.2	25.1	28.5	16.9	19.9	19.3	12.9	21.3	15.1	10.9	22.6	9.4	23.6	18.8	24.2	11.0	47.4	28.7	27.0	11.8	32.4	52.2	14.0	12.2	37.6	16.5	19.1	23.1	10.8	24.9	61.7	39.5	10.6	34.4	48.8	11.6	37.9	8.5	19.5	18.9	20.7	33.8	14.0	46.3	21.2	20.8	34.3	34.3	43.6	24.8	34.6	21.8	27.5	23.2	21.9	36.7	27.9	20.0	21.6	25.0	16.3	34.2	23.3	31.9	26.7	27.8	29.8	28.2	35.2	29.8	28.6	27.0	28.5	28.7	26.0	28.7	28.1	8.2	35.3	14.1	5.9	17.9	6.1	12.3	21.9	8.6	19.2	9.8	10.9	9.3	11.5	17.7	12.9	16.7	34.2	11.8	104.2	64.6	21.6	38.5	14.2	10.4	10.9	19.2	17.0	12.3	21.0	20.9	11.4	19.9	14.0	14.0	27.6	11.4	25.5	27.8	8.4	12.0	37.3	10.2	18.6	7.1	90.3	9.9	17.5	10.6	3.7	27.5	17.8	34.0	5.0	9.6	21.6	68.4	8.6	21.3	11.3	105.4	81.5	27.1	22.8	13.1	5.8	12.8	27.0	10.2	16.1	8.0	19.4	13.9	37.6	30.3	16.0
ACP1	"HAAP, LMW-PTP, LMWPTP"	ENSG00000143727	"Acid phosphatase 1"	P24666	2	264140-278283	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"		"Hydrolase, Protein phosphatase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in all"	5	"Early spermatids: 1061.1;Late spermatids: 2128.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											HPA016754	Approved		Approved	Nucleoplasm,Cytosol		NA	NA		2000000	"Cluster 44: Non-specific - Transcription"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 34: Spermatids - Unknown function"	Nucleoplasm	Cytosol	"HPA016754: AB_1844505"	"unprognostic (1.15e-1)"	"unprognostic (1.36e-1)"	"unprognostic (1.37e-2)"	"unprognostic (6.25e-3)"	"unprognostic (1.06e-2)"	"unprognostic (1.43e-1)"	"prognostic unfavorable (6.67e-6)"	"unprognostic (2.45e-1)"	"prognostic unfavorable (3.04e-4)"	"unprognostic (9.72e-3)"	"unprognostic (4.89e-2)"	"unprognostic (2.71e-2)"	"unprognostic (7.10e-2)"	"unprognostic (2.88e-2)"	"unprognostic (3.39e-2)"	"unprognostic (1.92e-1)"	"unprognostic (2.44e-2)"	41.2	104.0	43.1	45.5	47.6	91.9	64.7	43.9	54.0	43.4	63.9	61.4	64.0	46.6	69.3	43.3	57.9	45.4	57.3	49.4	47.1	78.1	106.4	46.8	66.2	43.4	44.2	59.2	94.1	73.9	59.2	61.7	44.3	52.1	64.7	72.7	71.1	44.2	76.6	41.3	60.7	41.5	44.9	44.7	67.1	46.1	45.3	66.2	63.7	74.9	61.9	47.5	36.4	50.2	78.3	112.5	177.4	97.4	76.1	77.1	142.2	92.6	97.7	91.9	80.8	151.7	78.5	48.8	70.7	85.1	114.6	76.5	169.4	97.0	82.3	118.7	157.9	142.3	99.0	348.5	105.7	162.5	80.4	78.7	90.5	81.9	102.3	95.5	105.8	176.9	145.1	95.1	110.9	103.1	178.5	161.3	214.1	204.7	111.7	118.2	176.1	114.5	144.2	110.5	191.6	191.3	56.0	137.6	196.3	115.0	82.1	89.8	88.9	101.3	65.2	84.0	142.6	123.8	261.2	150.4	120.0	138.9	123.7	65.4	61.6	57.2	88.8	75.2	118.1	106.6	100.4	103.2	57.3	97.2	118.1	115.2	10.9	121.5	80.2	65.3	117.6	115.0	43.1	47.6	43.9	54.0	49.4	47.1	43.4	44.2	44.3	44.9	45.3	50.2	62.5	44.8	96.7	9.1	102.6	79.2	105.3	173.4	51.8	53.1	118.8	130.0	84.9	131.5	119.6	68.0	8.4	207.1	101.3	81.9	270.1	226.7	1061.1	113.1	56.2	70.6	82.5	291.5	20.4	169.0	279.7	74.2	54.6	85.5	70.3	95.9	56.0	115.8	141.1	28.6	21.0	125.1	126.1	72.0	66.3	2128.2	94.4	74.6	81.8	16.9	117.8	92.2	152.4	19.6	26.0	174.4	109.2	92.2	106.4	187.0	174.2	306.6	128.1	56.9	92.1	42.5	87.0	122.6	137.4	87.4	91.2	187.7	86.0	124.4	143.9	148.3
ACP2	LAP	ENSG00000134575	"Acid phosphatase 2, lysosomal"	P11117	11	47239302-47248906	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"		Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Hepatocytes: 89.3;Hofbauer cells: 113.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"intermediate monocyte: 69.9"	"Lineage enriched"	"Detected in all"	5	"monocytes: 69.9"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"									NA	NA		12000	"Cluster 51: Monocytes - Innate immune response"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 4: Macrophages - Innate immune response"				"unprognostic (5.27e-3)"	"unprognostic (1.56e-1)"	"unprognostic (3.86e-2)"	"prognostic favorable (1.04e-4)"	"unprognostic (7.90e-3)"	"unprognostic (2.93e-1)"	"unprognostic (6.16e-3)"	"unprognostic (1.09e-1)"	"unprognostic (2.63e-1)"	"unprognostic (3.28e-3)"	"unprognostic (2.64e-3)"	"unprognostic (5.42e-2)"	"unprognostic (1.07e-2)"	"unprognostic (1.79e-1)"	"unprognostic (1.20e-1)"	"unprognostic (8.68e-3)"	"unprognostic (1.57e-1)"	25.2	36.6	17.3	22.9	17.1	6.4	21.8	17.0	18.5	16.5	22.1	23.3	42.9	15.8	29.8	14.3	14.1	19.6	21.7	19.8	26.0	27.4	80.5	21.4	29.4	20.8	19.6	11.1	45.9	21.3	21.3	28.7	23.1	25.4	18.1	11.9	50.3	18.3	14.0	11.4	31.9	16.9	16.9	29.1	24.8	12.2	22.0	13.7	19.3	14.8	15.3	22.0	13.1	17.2	16.5	33.5	31.9	28.2	28.1	13.6	24.4	26.6	47.1	47.5	49.4	23.3	26.3	4.3	21.9	34.2	14.3	23.7	16.9	24.6	22.5	85.5	29.1	11.1	48.1	24.6	38.4	16.4	27.1	34.1	15.2	24.6	14.5	28.3	34.9	14.1	20.3	33.9	31.5	26.8	13.4	14.2	21.5	24.8	20.0	10.8	43.1	36.2	34.9	37.6	16.7	26.0	36.8	80.1	19.2	16.3	49.0	14.0	21.0	23.9	19.8	31.4	38.4	28.1	40.0	3.6	35.0	8.2	37.6	12.5	16.9	7.2	12.3	69.9	9.4	2.5	7.6	11.1	15.1	1.5	6.6	5.7	2.8	9.7	48.2	0.6	8.3	10.9	17.3	17.1	17.0	18.5	19.8	26.0	20.8	19.6	23.1	16.9	22.0	17.2	13.3	19.2	18.6	6.2	5.6	4.1	9.3	42.2	10.2	14.4	13.5	9.1	9.2	21.5	29.4	18.4	6.2	41.3	2.6	37.6	9.8	50.6	1.8	7.7	15.6	18.3	15.0	13.5	6.9	60.1	33.3	15.3	17.3	12.1	12.0	10.7	45.7	89.3	113.5	11.8	8.9	26.7	22.4	80.0	3.9	3.5	5.0	33.8	24.9	3.7	29.8	20.6	7.2	8.5	4.3	33.5	29.5	10.5	21.1	10.9	55.3	33.4	19.2	11.9	19.7	8.1	14.5	11.8	19.1	9.5	2.4	29.3	5.8	25.2	14.3	8.6
ACP3	"ACP-3, ACPP, PAP, TM-PAP"	ENSG00000014257	"Acid phosphatase 3"	P15309	3	132317369-132368298	"Cancer-related genes, Enzymes, FDA approved drug targets, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins"		Hydrolase	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	76	"prostate: 3643.7"	"Group enriched"	"Detected in some"	5	"Cytotrophoblasts: 13.9;Hofbauer cells: 4.7;Syncytiotrophoblasts: 8.9"	"Cancer enriched"	"Detected in many"	275	"prostate cancer: 1227.2"	"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in many"		"eosinophil: 139.7"	"Lineage enhanced"	"Detected in many"		"granulocytes: 139.7"	"Cell line enhanced"	"Detected in many"		"BJ hTERT+: 17.7;OE19: 22.3;RPMI-8226: 58.0;U-698: 17.2;U-87 MG: 14.9"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"CAB000071, HPA004335, HPA063916"	Enhanced				"Secreted to blood"	NA	NA	460000	480000	"Cluster 45: Eosinophils - Innate immune response"	"Cluster 51: Non-specific - Unknown function"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 47: Cytotrophoblasts - Unknown function"			"CAB000071: , HPA004335: AB_1079684, HPA063916: AB_2685152"	"unprognostic (6.67e-2)"	"unprognostic (4.70e-2)"	"unprognostic (1.76e-1)"	"unprognostic (7.77e-2)"	"unprognostic (1.74e-1)"	"unprognostic (2.58e-2)"	"unprognostic (2.46e-1)"	"unprognostic (7.41e-2)"	"unprognostic (1.81e-1)"	"unprognostic (3.78e-3)"	"unprognostic (2.14e-1)"	"unprognostic (5.95e-2)"	"unprognostic (9.38e-2)"	"unprognostic (1.35e-1)"	"unprognostic (1.18e-1)"	"unprognostic (3.91e-2)"	"unprognostic (1.71e-1)"	3.1	5.4	0.9	7.3	1.3	17.5	3.4	0.9	0.9	6.3	1.2	3.6	3.1	1.4	17.2	47.7	2.2	1.5	0.6	1.2	1.5	28.9	1.4	4.5	1.9	1.5	1.3	1.1	2.7	3.9	0.5	10.8	1.5	3643.7	6.5	0.4	10.6	0.8	0.2	27.0	3.4	1.8	1.0	1.8	3.2	2.4	1.0	1.0	2.4	0.2	6.5	1.8	12.1	1.7	0.5	0.1	0.0	0.0	0.2	0.9	11.7	0.3	17.7	0.1	0.0	0.4	0.4	10.6	0.8	0.0	0.1	4.8	0.0	0.1	0.0	0.1	0.5	2.0	0.4	0.2	0.2	7.3	0.1	1.1	1.6	0.1	0.0	0.2	0.0	0.0	0.1	2.7	0.2	0.1	0.0	13.5	0.7	22.3	2.1	0.1	0.0	58.0	5.0	6.5	0.0	4.1	0.1	2.0	0.6	1.7	0.3	6.5	0.0	0.1	0.1	2.5	0.1	0.8	0.4	17.2	14.9	12.7	0.2	0.1	30.2	139.7	0.2	26.9	0.2	0.7	0.0	0.0	35.3	0.0	0.0	0.0	26.4	2.6	25.8	2.4	0.0	10.1	0.9	1.3	0.9	0.9	1.2	1.5	1.5	1.3	1.5	1.0	1.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	13.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.8	1.3	0.0	0.0	0.0	0.0	0.0	0.0	4.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.9	0.0	0.0	0.0	0.0
ACP4	ACPT	ENSG00000142513	"Acid phosphatase 4"	Q9BZG2	19	50790415-50795219	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted membrane proteins"		Hydrolase	"Amelogenesis imperfecta, Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"skin 1: 1.2;testis: 3.7"	"Not detected"	"Not detected"			"Low cancer specificity"	"Detected in single"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HEK 293: 1.5;U-266/84: 2.0"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"									NA	NA				"Cluster 27: Brain & Skin - Unknown function"	"Cluster 16: U-266 - Nucleosome"					"unprognostic (9.41e-2)"	"unprognostic (1.86e-1)"	"unprognostic (4.00e-3)"	"unprognostic (3.70e-3)"	"unprognostic (7.62e-2)"	"unprognostic (3.18e-2)"	"unprognostic (3.89e-3)"	"unprognostic (5.46e-2)"	"unprognostic (2.47e-1)"	"unprognostic (5.59e-2)"	"unprognostic (3.96e-1)"	"unprognostic (1.45e-1)"	"unprognostic (2.37e-3)"	"unprognostic (2.36e-1)"	"unprognostic (4.40e-1)"	"unprognostic (1.02e-1)"	"unprognostic (1.32e-1)"	0.0	0.0	0.2	0.0	0.1	0.5	0.0	0.8	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.1	0.0	0.0	0.0	0.0	3.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.5	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.7	0.0	0.3	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.5	1.5	0.0	0.5	0.2	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.9	0.0	0.3	0.2	0.4	0.1	0.2	0.5	0.3	0.1	0.2	0.0	0.5	0.1	0.2	0.1	0.1	0.2	0.0	0.0	0.3	0.0	0.2	0.2	0.2	0.1	0.2	2.0	0.2	0.2	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.8	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0
ACP5	"HPAP, TRAP"	ENSG00000102575	"Acid phosphatase 5, tartrate resistant"	P13686	19	11574660-11579008	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"		Hydrolase	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lung: 174.1"	"Cell type enhanced"	"Detected in many"		"Hepatic stellate cells: 426.9;Hofbauer cells: 426.7;Macrophages: 298.2;Proximal tubular cells: 145.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"memory B-cell: 200.1"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"BEWO: 41.1;K-562: 30.4;RPMI-8226: 41.4;SK-MEL-30: 127.6;U-138 MG: 102.9"	"Low region specificity"	"Detected in single"			"Not detected"	"Not detected"			"CAB002584, HPA057655, HPA059463"	Enhanced		Uncertain	Cytosol	"Intracellular and membrane"	NA	NA		4000000	"Cluster 19: B-cells - Humoral immune response"	"Cluster 64: Macrophages - Immune response"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 4: Macrophages - Innate immune response"	Cytosol		"CAB002584: AB_564039, HPA057655: AB_2683490, HPA059463: AB_2684028"	"unprognostic (4.27e-2)"	"unprognostic (2.05e-2)"	"unprognostic (2.93e-1)"	"unprognostic (8.60e-3)"	"unprognostic (2.96e-1)"	"unprognostic (1.95e-2)"	"unprognostic (5.21e-2)"	"unprognostic (5.17e-3)"	"unprognostic (5.13e-2)"	"unprognostic (3.80e-1)"	"unprognostic (3.66e-3)"	"unprognostic (9.09e-2)"	"unprognostic (1.39e-2)"	"unprognostic (1.03e-1)"	"unprognostic (1.17e-1)"	"unprognostic (1.05e-1)"	"unprognostic (1.19e-1)"	9.4	6.0	2.2	42.4	3.9	9.4	25.6	2.5	21.4	34.7	3.0	46.4	31.9	19.2	7.8	23.4	8.6	26.7	5.1	1.9	3.9	74.0	32.5	174.1	87.1	4.1	3.1	20.3	11.9	2.4	1.3	13.3	6.0	19.6	36.4	20.1	14.3	7.0	1.4	24.9	30.2	13.3	4.1	43.5	38.7	4.0	15.7	25.4	3.0	5.0	43.6	33.1	11.3	5.7	10.2	1.1	0.0	0.2	0.5	0.0	41.1	1.1	25.8	0.0	0.1	0.4	0.3	1.4	1.8	9.0	5.9	0.3	0.0	4.5	0.1	12.1	0.8	0.3	0.0	5.0	1.4	0.1	0.6	0.0	4.1	0.4	0.0	0.0	0.0	0.0	30.4	0.2	0.0	2.3	0.9	1.4	0.8	0.3	0.7	0.4	1.8	41.4	0.0	0.4	0.7	1.0	0.0	0.0	127.6	1.1	0.2	0.4	0.9	102.9	1.2	1.8	0.3	0.7	5.7	0.6	23.7	0.1	4.0	0.4	35.3	76.6	15.8	36.1	8.8	200.1	26.0	19.6	7.3	110.9	35.3	20.2	10.4	13.3	36.3	62.5	67.8	36.4	2.2	3.9	2.5	21.4	1.9	3.9	4.1	3.1	6.0	4.1	15.7	5.7	2.2	9.6	7.8	0.0	75.7	10.3	11.0	21.8	25.0	18.3	14.6	18.4	1.4	15.7	5.7	7.3	18.8	33.4	21.2	7.0	9.8	1.8	0.2	0.7	9.1	30.9	3.0	24.5	0.0	11.3	32.7	19.8	10.7	0.9	63.7	0.8	426.9	8.4	426.7	1.7	0.0	4.7	10.2	106.0	68.6	0.7	1.8	298.2	14.2	1.0	79.8	48.5	8.2	0.0	0.1	4.4	20.4	12.0	33.4	14.5	12.7	145.8	2.5	41.4	0.0	0.4	2.8	0.1	0.2	14.6	11.1	26.1	29.5	0.1	6.7	6.1
ACP6	"ACPL1, LPAP"	ENSG00000162836	"Acid phosphatase 6, lysophosphatidic"	Q9NPH0	1	147629652-147670524	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Lipid metabolism, Phospholipid metabolism"	Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 74.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"OE19: 108.9;RPTEC TERT1: 119.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA028560	Uncertain				"Intracellular and membrane"	NA	NA		64000	"Cluster 35: T-regs - Unknown function"	"Cluster 1: Thyroid gland - Transcription"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 64: Astrocytes - Nervous system maintenance"			"HPA028560: AB_10602427"	"unprognostic (3.17e-2)"	"unprognostic (3.01e-2)"	"unprognostic (3.50e-1)"	"unprognostic (1.87e-2)"	"unprognostic (3.85e-1)"	"unprognostic (8.50e-3)"	"unprognostic (3.36e-3)"	"unprognostic (1.00e-1)"	"unprognostic (6.32e-2)"	"unprognostic (1.30e-2)"	"unprognostic (3.09e-1)"	"unprognostic (1.06e-1)"	"unprognostic (4.52e-2)"	"unprognostic (3.94e-1)"	"unprognostic (8.07e-2)"	"unprognostic (1.26e-1)"	"prognostic favorable (6.44e-4)"	6.3	13.6	6.2	4.2	6.3	5.0	17.8	5.6	6.6	11.8	7.9	11.4	7.4	8.3	16.2	7.8	12.7	6.8	8.4	5.9	6.3	17.5	13.2	7.3	3.9	6.3	6.9	9.3	11.0	21.9	15.2	4.2	6.2	12.6	9.7	3.6	10.4	11.2	6.7	9.3	8.8	6.0	6.0	6.0	12.4	5.7	6.1	7.9	15.2	6.0	6.9	11.2	6.7	5.7	21.1	8.5	7.1	12.7	4.5	4.3	20.2	4.8	14.8	14.8	17.5	10.2	31.9	6.1	17.4	10.4	11.4	35.6	9.6	32.0	15.4	8.2	16.1	21.9	11.8	19.4	13.2	3.9	0.8	6.3	23.3	7.7	15.4	17.6	15.2	30.2	10.5	3.4	17.0	15.8	16.5	10.0	17.0	108.9	62.9	11.7	6.1	70.9	119.7	41.3	5.8	7.1	17.5	12.5	36.5	15.9	20.3	6.0	10.7	4.6	8.6	0.9	15.1	13.4	21.3	2.8	8.7	0.3	25.8	0.1	2.3	13.4	4.6	0.8	7.9	2.6	7.5	6.1	5.4	2.8	8.2	7.0	3.5	0.3	0.3	3.4	14.8	2.7	6.2	6.3	5.6	6.6	5.9	6.3	6.3	6.9	6.2	6.0	6.1	5.7	2.1	19.2	13.9	74.4	2.9	1.1	6.1	7.4	7.4	3.1	6.3	6.3	7.0	10.0	6.7	16.5	0.0	19.7	7.0	3.7	17.6	7.5	6.0	9.1	2.3	2.4	9.1	4.2	14.2	15.3	7.2	2.4	10.7	9.4	1.3	15.2	5.3	10.9	4.6	0.0	20.6	8.5	8.2	4.8	6.7	1.5	5.9	2.9	3.6	15.0	3.4	8.8	4.1	18.1	10.4	18.7	5.4	4.1	3.8	4.9	6.3	14.4	11.9	1.1	13.1	5.7	7.7	7.5	4.7	9.1	1.3	8.1	9.6	7.3	8.5	5.8
ACP7	"FLJ16165, PAPL, PAPL1"	ENSG00000183760	"Acid phosphatase 7, tartrate resistant (putative)"	Q6ZNF0	19	39083913-39111493	"Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted secreted proteins"		Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	6	"brain: 6.6;lymphoid tissue: 2.6;skin 1: 6.0"	"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"cervical cancer: 0.8;head and neck cancer: 2.6;lung cancer: 1.4;melanoma: 1.0;urothelial cancer: 1.0"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"GAMG: 33.3;U-87 MG: 45.5"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			HPA042613	Uncertain				"Secreted - unknown location"	NA	NA				"Cluster 27: Brain & Skin - Unknown function"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 50: Fibroblasts - ECM organization"			"HPA042613: AB_10963214"	"unprognostic (6.35e-2)"	"unprognostic (1.97e-1)"	"unprognostic (1.48e-1)"	"unprognostic (6.74e-3)"	"unprognostic (1.92e-3)"	"unprognostic (1.41e-1)"	"unprognostic (3.41e-1)"	"unprognostic (4.94e-3)"	"unprognostic (2.66e-1)"	"unprognostic (2.15e-1)"	"unprognostic (1.50e-1)"	"unprognostic (9.81e-2)"	"unprognostic (1.51e-5)"	"unprognostic (4.36e-3)"	"unprognostic (5.08e-2)"	"unprognostic (2.31e-2)"	"unprognostic (2.42e-1)"	0.0	0.0	1.7	0.0	3.3	0.0	0.2	6.6	2.7	0.7	0.8	0.0	0.0	0.0	0.4	0.7	0.0	0.2	0.0	2.0	2.2	0.0	0.0	0.0	0.0	3.9	3.7	0.0	0.0	0.3	0.0	0.0	3.8	0.3	0.0	0.0	0.5	0.0	0.0	6.0	0.0	0.0	2.0	0.0	0.1	0.0	3.0	0.0	0.0	0.0	2.6	0.1	0.6	4.1	5.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.2	0.6	0.8	0.4	5.2	0.0	0.0	0.0	33.3	0.3	0.0	1.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	9.5	0.3	0.0	0.1	0.0	0.0	0.0	0.2	2.0	0.0	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	6.1	1.1	0.0	0.0	0.0	0.0	0.0	45.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	3.3	6.6	2.7	2.0	2.2	3.9	3.7	3.8	2.0	3.0	4.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.2	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.1
ACR		ENSG00000100312	Acrosin	P10323	22	50738196-50745339	"Enzymes, Predicted secreted proteins"		"Hydrolase, Protease, Serine protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	29	"testis: 86.7"	"Group enriched"	"Detected in some"	33	"Early spermatids: 492.2;Late spermatids: 134.8;Spermatocytes: 216.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"Not detected"	"Not detected"			HPA048687	Enhanced				"Secreted in male reproductive system"	NA	NA				"Cluster 83: Testis - Spermatogenesis"		"Cluster 66: Spermatocytes - Spermatogenesis"			"HPA048687: AB_2680494"	"unprognostic (1.71e-1)"	"unprognostic (1.26e-1)"	"unprognostic (1.04e-1)"	"unprognostic (6.27e-3)"	"unprognostic (3.58e-2)"	"unprognostic (8.04e-2)"	"unprognostic (3.30e-3)"	"unprognostic (5.41e-2)"	"unprognostic (1.51e-1)"	"unprognostic (2.28e-1)"	"unprognostic (1.34e-2)"	"unprognostic (2.12e-1)"	"unprognostic (1.48e-1)"	"unprognostic (1.23e-2)"	"unprognostic (1.71e-1)"	"unprognostic (2.27e-1)"	"unprognostic (1.25e-1)"	2.6	0.2	0.4	0.0	0.5	0.0	2.0	0.4	0.5	0.8	2.6	0.5	0.1	1.1	0.7	0.4	1.1	0.2	1.0	0.4	0.3	0.9	0.8	2.0	0.0	0.3	0.3	0.3	0.2	0.0	0.5	0.1	0.5	0.6	0.0	0.1	0.6	0.2	0.8	0.8	0.5	0.2	0.4	3.0	0.3	86.7	0.4	0.0	0.6	0.0	0.0	0.6	0.7	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.5	0.4	0.5	0.4	0.3	0.3	0.3	0.5	0.4	0.4	0.4	8.4	0.0	0.0	0.3	0.0	0.1	0.0	0.0	2.2	0.0	0.3	0.6	0.5	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	492.2	0.4	0.1	4.7	3.0	0.0	0.2	0.0	0.0	0.1	0.0	0.2	0.0	0.0	7.5	0.1	0.1	0.0	0.2	0.8	0.0	0.0	0.0	134.8	3.4	0.2	0.0	0.0	0.0	0.0	0.0	0.5	0.2	0.0	0.8	2.6	0.0	0.0	1.2	0.4	0.0	0.0	6.6	0.3	0.1	216.9	2.5	0.3	0.0	0.0	0.0	0.1	1.5	0.2
ACY1		ENSG00000243989	"Aminoacylase 1"	Q03154	3	51983340-51989197	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"		Hydrolase	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	9	"intestine: 181.5;kidney: 449.9;liver: 274.9"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 31.6;Gastric mucus-secreting cells: 32.6;Proximal enterocytes: 144.8;Proximal tubular cells: 92.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"Hep G2: 128.0"									"CAB003695, HPA036174, HPA036175"	Enhanced					NA	NA		23000000	"Cluster 27: Non-specific - Gene expression"	"Cluster 87: Intestine & Kidney - Transmembrane transport"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"			"CAB003695: AB_425286, HPA036174: AB_2674988, HPA036175: AB_2674989"	"unprognostic (4.28e-2)"	"unprognostic (1.89e-1)"	"unprognostic (2.10e-1)"	"unprognostic (2.48e-3)"	"unprognostic (3.15e-1)"	"unprognostic (6.51e-2)"	"unprognostic (2.82e-2)"	"unprognostic (1.47e-1)"	"unprognostic (1.05e-2)"	"unprognostic (6.08e-2)"	"unprognostic (2.36e-2)"	"unprognostic (2.70e-2)"	"prognostic favorable (2.93e-4)"	"unprognostic (3.57e-1)"	"unprognostic (3.75e-1)"	"unprognostic (7.88e-2)"	"prognostic favorable (6.77e-4)"	19.2	24.0	5.6	7.3	5.7	8.8	20.7	6.4	7.3	13.9	11.6	30.6	181.5	4.3	21.8	10.7	13.0	10.7	14.5	5.1	6.0	449.9	274.9	9.2	7.2	6.5	5.9	4.8	8.7	28.2	4.7	9.7	6.6	14.3	30.5	1.9	16.4	11.1	20.2	8.2	138.2	6.9	6.7	8.1	23.6	3.2	6.1	5.1	21.0	34.6	9.2	12.5	7.1	6.6	15.9	26.2	13.2	34.1	28.9	39.4	40.5	12.6	28.2	29.4	14.9	41.2	67.9	7.2	12.2	22.0	13.2	20.0	14.7	81.2	11.5	21.8	10.7	25.3	13.9	128.0	49.7	19.8	21.0	48.0	67.2	25.4	69.1	25.8	11.5	14.6	47.1	23.9	29.9	35.2	0.6	38.9	23.4	92.1	39.3	8.0	14.1	63.5	74.5	50.8	16.9	18.2	12.6	62.6	29.5	7.5	42.3	27.9	7.1	22.0	21.9	24.8	18.8	61.7	16.9	12.1	28.1	42.9	29.0	9.1	15.7	0.4	10.7	15.1	5.7	7.4	2.6	4.5	21.2	6.1	4.1	4.7	0.0	20.4	6.4	2.8	3.8	9.7	5.6	5.7	6.4	7.3	5.1	6.0	6.5	5.9	6.6	6.7	6.1	6.6	0.5	3.2	3.2	0.0	4.9	0.6	1.0	1.9	17.1	0.2	2.7	1.3	0.2	1.5	2.5	5.5	0.0	3.9	0.3	31.6	9.8	16.6	0.2	0.2	0.9	0.9	2.4	15.8	0.0	8.3	4.5	4.3	32.6	0.6	7.0	0.2	1.1	13.1	1.9	0.0	0.0	11.2	4.1	1.9	0.3	0.8	0.6	4.2	0.0	0.0	9.3	0.8	1.0	0.0	0.0	16.4	23.3	0.0	14.9	0.6	144.8	92.0	1.7	1.1	0.0	0.6	2.0	0.1	0.2	18.5	0.4	4.1	2.6	1.0	14.5	0.4
ACY3	"ACY-3, HCBP1, MGC9740"	ENSG00000132744	"Aminoacylase 3"	Q96HD9	11	67642555-67650730	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Host-virus interaction"	Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"intestine: 77.7;kidney: 58.2;liver: 33.8;pancreas: 22.2"	"Group enriched"	"Detected in many"	8	"Proximal enterocytes: 255.7;Proximal tubular cells: 437.6"	"Cancer enhanced"	"Detected in many"		"renal cancer: 24.8"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"non-classical monocyte: 34.1"	"Group enriched"	"Detected in many"	5	"dendritic cells: 8.7;monocytes: 34.1"	"Cell line enhanced"	"Detected in some"		"CACO-2: 9.6;CAPAN-2: 15.3;Daudi: 57.7;OE19: 15.3;RPMI-8226: 9.8"	"Low region specificity"	"Detected in all"							"HPA039219, HPA048187"	Enhanced					NA	NA		13000	"Cluster 51: Monocytes - Innate immune response"	"Cluster 87: Intestine & Kidney - Transmembrane transport"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"			"HPA039219: AB_10671872, HPA048187: AB_2680306"	"unprognostic (8.37e-3)"	"unprognostic (1.29e-1)"	"unprognostic (1.04e-1)"	"prognostic favorable (4.80e-4)"	"unprognostic (1.07e-1)"	"unprognostic (1.99e-2)"	"unprognostic (1.38e-2)"	"unprognostic (1.43e-1)"	"unprognostic (7.37e-4)"	"unprognostic (2.44e-3)"	"unprognostic (1.15e-1)"	"unprognostic (3.21e-1)"	"unprognostic (2.63e-3)"	"unprognostic (1.07e-1)"	"unprognostic (8.24e-2)"	"unprognostic (2.68e-2)"	"unprognostic (1.48e-3)"	0.1	0.1	4.0	4.2	3.0	1.4	0.9	3.6	3.5	10.5	2.0	6.7	77.7	0.5	0.8	0.8	0.9	1.9	0.0	4.1	5.0	58.2	33.8	0.2	7.0	5.0	3.5	0.2	22.2	0.4	0.3	0.2	4.3	0.6	4.5	0.0	2.4	0.4	0.0	0.2	70.8	0.3	5.7	1.4	11.9	0.1	5.1	1.9	0.1	0.0	8.9	0.3	0.1	4.6	0.2	1.4	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	9.6	15.3	57.7	0.6	0.0	1.4	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.0	5.4	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.5	0.0	0.1	2.1	2.5	0.0	15.3	0.0	1.8	0.0	9.8	0.0	0.0	0.0	0.1	0.3	1.3	0.1	0.0	0.1	2.8	0.2	0.0	0.1	0.0	0.0	0.0	0.1	1.0	0.0	6.4	0.5	0.0	0.7	0.0	0.2	7.6	0.7	1.3	0.4	0.2	3.8	1.4	1.3	0.9	0.0	3.9	34.1	8.7	0.0	1.9	4.0	3.0	3.6	3.5	4.1	5.0	5.0	3.5	4.3	5.7	5.1	4.6	0.1	0.0	1.7	0.0	4.7	0.0	0.1	0.7	0.0	0.0	1.6	2.2	0.5	8.6	1.6	22.0	0.0	0.2	0.1	9.2	31.3	4.1	0.0	0.5	0.2	0.1	1.2	0.0	0.0	10.4	0.3	0.1	19.4	0.9	0.0	0.0	0.0	25.3	2.2	0.0	0.0	40.8	0.0	0.6	0.9	0.0	0.0	3.0	5.4	10.3	0.4	0.0	0.0	0.0	0.0	5.7	10.6	0.0	3.3	0.5	255.7	437.6	0.6	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.1	2.7	0.1	14.7	0.9
ACYP1		ENSG00000119640	"Acylphosphatase 1"	P07311	14	75053237-75069483	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Respiratory ciliated cells: 137.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA034944	Approved		Approved	Nucleoplasm,Cytosol		NA	NA		89000	"Cluster 27: Non-specific - Gene expression"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 49: Ciliated cells - Cilium organization"	Cytosol	Nucleoplasm	"HPA034944: AB_10669898"	"prognostic favorable (1.17e-4)"	"unprognostic (3.83e-3)"	"unprognostic (1.92e-1)"	"unprognostic (5.90e-2)"	"unprognostic (1.26e-1)"	"unprognostic (1.85e-1)"	"prognostic unfavorable (6.14e-7)"	"unprognostic (5.48e-2)"	"unprognostic (4.40e-1)"	"unprognostic (1.64e-2)"	"unprognostic (1.37e-3)"	"unprognostic (3.56e-2)"	"unprognostic (4.74e-2)"	"unprognostic (6.69e-3)"	"unprognostic (9.39e-2)"	"unprognostic (1.07e-1)"	"unprognostic (5.32e-3)"	13.7	38.4	46.2	15.2	48.6	21.1	22.1	49.9	65.5	17.3	50.8	21.5	15.6	14.4	36.7	20.8	29.6	10.2	17.0	45.0	54.0	29.1	9.6	19.7	27.7	50.7	49.7	13.6	12.4	21.1	36.5	15.3	51.8	17.3	26.9	44.0	15.8	15.0	34.0	35.0	21.1	15.6	46.6	16.5	19.3	26.9	50.4	39.7	30.1	21.1	28.1	16.1	17.6	56.0	78.9	43.1	60.9	37.4	24.5	26.6	32.6	44.7	17.2	45.5	63.5	42.8	86.9	86.5	26.4	18.2	25.7	68.1	39.9	19.1	73.8	127.8	49.3	57.6	123.6	32.1	14.3	36.6	56.8	14.9	27.7	61.5	30.0	28.8	60.0	80.9	45.2	103.0	60.0	52.3	82.7	67.7	18.6	67.6	40.8	64.7	80.8	41.2	62.2	39.0	112.0	44.5	29.5	20.8	74.2	29.1	44.5	35.4	27.3	29.5	55.6	61.3	48.4	23.8	52.4	94.6	46.1	42.5	32.8	5.3	2.8	17.5	10.9	6.2	12.7	13.7	18.3	12.9	5.1	14.1	15.4	14.5	1.2	14.0	10.5	10.3	24.6	6.7	46.2	48.6	49.9	65.5	45.0	54.0	50.7	49.7	51.8	46.6	50.4	56.0	18.5	6.4	9.1	17.0	18.2	28.7	44.4	54.1	30.1	38.6	20.8	24.0	21.2	31.5	28.9	66.2	12.5	27.3	18.7	24.5	39.2	20.6	31.6	89.2	18.4	26.5	30.1	47.5	17.8	18.7	33.7	22.7	13.7	17.8	12.0	19.8	10.4	5.7	22.3	43.7	25.0	25.2	73.2	6.6	11.7	11.0	16.8	12.3	39.2	15.9	10.1	23.2	16.5	16.1	44.4	20.2	20.6	16.6	16.9	20.2	16.7	22.3	137.9	32.4	26.3	11.1	31.5	89.8	14.1	23.8	24.0	13.7	22.3	20.4	33.8	34.4
ACYP2		ENSG00000170634	"Acylphosphatase 2"	P14621	2	53970838-54305300	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 207.4;tongue: 163.2"	"Cell type enhanced"	"Detected in all"		"Cardiomyocytes: 162.6;Excitatory neurons: 158.8;Oligodendrocytes: 180.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA035301	Uncertain		Approved	Nucleoplasm	"Intracellular and membrane"	NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	Nucleoplasm		"HPA035301: AB_10670291"	"unprognostic (1.19e-1)"	"unprognostic (2.84e-2)"	"unprognostic (3.40e-1)"	"unprognostic (2.16e-1)"	"unprognostic (6.90e-3)"	"unprognostic (6.21e-2)"	"unprognostic (2.03e-3)"	"unprognostic (3.17e-1)"	"unprognostic (5.22e-2)"	"unprognostic (7.83e-3)"	"unprognostic (3.64e-3)"	"unprognostic (1.16e-1)"	"unprognostic (6.66e-2)"	"unprognostic (2.13e-1)"	"unprognostic (1.97e-1)"	"unprognostic (3.24e-1)"	"unprognostic (2.24e-2)"	19.5	42.8	64.9	5.4	72.9	7.1	15.7	74.8	85.4	10.6	61.5	14.3	7.4	11.5	12.8	10.4	11.6	8.5	63.4	63.9	72.8	14.5	28.0	10.6	10.9	69.5	68.8	9.3	12.7	13.6	26.2	6.5	70.3	14.4	5.3	24.1	15.2	9.2	207.4	9.9	9.0	7.9	70.4	12.7	12.9	10.2	70.4	10.7	12.6	163.2	8.4	14.0	10.7	76.9	11.7	5.9	6.0	4.4	23.7	17.3	3.7	11.5	9.7	8.3	7.3	1.5	7.1	21.5	33.0	12.6	7.8	8.5	3.3	10.8	7.4	14.4	13.1	13.4	6.3	16.3	8.5	12.7	6.3	13.6	19.3	5.6	9.5	15.2	3.9	9.8	5.5	11.5	17.9	7.6	7.5	17.0	5.9	8.4	6.7	5.4	4.7	12.2	18.8	10.6	17.6	10.0	17.4	10.0	5.7	1.9	3.4	13.2	10.9	11.5	10.6	3.5	11.1	21.4	12.5	10.2	16.3	24.3	12.4	41.2	14.0	26.1	16.9	13.0	15.4	29.0	16.6	16.1	20.3	26.9	20.1	16.4	11.5	18.6	13.5	33.4	16.3	11.3	64.9	72.9	74.8	85.4	63.9	72.8	69.5	68.8	70.3	70.4	70.4	76.9	21.7	16.0	17.9	84.9	30.6	20.5	41.9	52.8	18.8	15.5	49.7	65.7	162.6	34.3	32.0	18.4	10.4	13.6	27.9	24.5	62.6	24.3	86.8	29.5	23.6	23.1	30.6	14.5	158.8	38.1	6.1	21.0	26.0	19.5	19.7	17.6	30.7	74.2	31.9	28.6	134.1	21.9	36.7	40.0	28.5	64.7	13.4	25.4	23.2	59.0	26.1	90.1	24.7	67.8	180.1	29.9	18.8	30.9	36.4	27.4	29.1	55.6	32.2	31.6	52.6	30.8	30.0	22.9	9.8	28.9	21.3	10.3	22.7	29.7	18.6	45.0
ADA	ADA1	ENSG00000196839	"Adenosine deaminase"	P00813	20	44619522-44652233	"Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Cell adhesion, Nucleotide metabolism"	Hydrolase	"Disease variant, FDA approved drug targets, Hereditary hemolytic anemia, SCID"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	8	"intestine: 507.2;lymphoid tissue: 259.0"	"Cell type enhanced"	"Detected in many"		"dendritic cells: 76.4;Extravillous trophoblasts: 128.2;NK-cells: 56.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"intermediate monocyte: 168.5;NK-cell: 94.5;non-classical monocyte: 362.8;plasmacytoid DC: 218.6"	"Group enriched"	"Detected in all"	4	"dendritic cells: 218.6;monocytes: 362.8;NK-cells: 94.5"	"Group enriched"	"Detected in many"	5	"JURKAT: 570.9;MOLT-4: 1915.5"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA001399, CAB004307, HPA023884"	Enhanced		Supported	"Plasma membrane,Cytosol"		No	No		470000	"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 9: Intestine - Unknown function"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 38: Extravillous trophoblasts - Unknown function"	"Plasma membrane"	Cytosol	"CAB004307: AB_626634, HPA001399: AB_1078099, HPA023884: AB_1844573"	"unprognostic (4.30e-2)"	"unprognostic (6.89e-2)"	"unprognostic (3.96e-2)"	"prognostic unfavorable (1.23e-7)"	"unprognostic (9.33e-2)"	"unprognostic (9.07e-3)"	"prognostic unfavorable (6.77e-5)"	"prognostic unfavorable (2.20e-4)"	"unprognostic (1.59e-1)"	"unprognostic (2.16e-1)"	"unprognostic (3.66e-2)"	"unprognostic (3.48e-1)"	"prognostic unfavorable (2.94e-14)"	"unprognostic (2.29e-1)"	"unprognostic (1.04e-2)"	"unprognostic (1.53e-1)"	"unprognostic (1.82e-1)"	16.6	6.3	6.9	18.5	8.2	20.2	10.9	6.8	9.4	7.3	5.6	5.7	507.2	3.8	1.7	9.0	5.6	9.2	17.8	6.9	7.0	3.3	4.4	6.2	33.4	7.2	8.2	2.1	5.3	1.5	1.3	4.6	7.2	4.3	3.6	0.3	4.7	2.8	5.3	6.0	17.9	5.7	6.1	17.5	46.0	2.4	8.7	259.0	5.8	6.4	26.4	9.3	5.4	8.8	14.0	37.7	19.2	13.2	35.6	48.7	30.5	13.7	7.8	13.2	9.3	17.5	14.8	38.4	15.8	17.9	24.7	2.2	13.2	55.1	7.3	2.9	17.2	7.8	6.6	13.5	15.0	6.3	20.3	234.3	23.2	5.1	9.0	12.6	50.3	570.9	20.4	30.7	6.0	33.1	1915.5	28.9	5.2	17.2	13.5	102.3	25.8	95.0	2.3	0.0	0.7	9.3	20.2	4.4	24.2	24.0	4.5	19.1	16.9	10.1	18.6	20.5	2.8	40.1	27.3	82.3	3.5	32.5	9.0	0.5	9.8	1.2	43.3	168.5	27.8	7.5	35.5	51.0	35.2	7.6	27.3	38.6	2.5	94.5	362.8	218.6	29.8	57.4	6.9	8.2	6.8	9.4	6.9	7.0	7.2	8.2	7.2	6.1	8.7	8.8	18.2	0.0	1.9	2.9	13.5	12.9	3.4	10.0	13.6	0.0	2.7	3.2	2.1	0.0	4.8	1.8	0.0	2.9	76.4	0.8	0.0	3.7	0.4	0.7	9.1	17.0	0.0	10.7	0.2	19.7	128.2	19.7	14.8	0.8	0.0	3.5	7.1	3.6	28.5	0.0	0.2	1.5	10.2	20.8	25.5	1.8	42.3	27.6	8.8	3.7	37.4	3.8	56.7	0.5	9.4	10.7	0.3	2.6	31.4	6.0	0.7	3.0	2.4	0.0	13.1	1.9	14.1	0.3	6.2	12.9	13.9	3.7	30.9	6.8	4.9	2.7
ADA2	"ADGF, CECR1, IDGFL"	ENSG00000093072	"Adenosine deaminase 2"	Q9NZK5	22	17178790-17258235	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted secreted proteins"		"Heparin-binding, Hydrolase"	"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 106.3"	"Cell type enhanced"	"Detected in many"		"Endometrial ciliated cells: 27.6;Glandular and luminal cells: 22.0;Hofbauer cells: 57.6;Macrophages: 62.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"CAPAN-2: 23.7;EFO-21: 21.4;HUVEC TERT2: 24.0;Karpas-707: 44.9;MOLT-4: 38.9;U-266/70: 23.8;U-937: 39.6"					"Low region specificity"	"Detected in all"			HPA007888	Uncertain				"Secreted to blood"	NA	NA		58000000	"Cluster 25: Monocytes - Inflammatory response"	"Cluster 16: Immune cells - Immune response"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 41: Macrophages - Immune response"			"HPA007888: AB_1078495"	"unprognostic (1.03e-3)"	"unprognostic (2.00e-3)"	"unprognostic (6.59e-2)"	"unprognostic (2.50e-1)"	"unprognostic (1.48e-2)"	"unprognostic (7.01e-3)"	"unprognostic (4.48e-2)"	"unprognostic (3.09e-3)"	"unprognostic (3.80e-2)"	"prognostic favorable (9.26e-4)"	"prognostic favorable (8.91e-4)"	"unprognostic (1.41e-1)"	"unprognostic (1.49e-1)"	"unprognostic (4.86e-3)"	"unprognostic (1.96e-2)"	"unprognostic (4.83e-2)"	"unprognostic (2.51e-1)"	14.0	11.3	8.3	39.4	9.9	22.8	17.6	10.6	7.9	22.0	20.5	28.3	18.1	19.9	2.7	12.0	51.5	32.1	39.6	7.8	10.9	14.5	21.1	54.9	47.3	16.3	11.4	12.1	13.9	5.4	22.5	15.2	14.7	15.4	34.3	11.0	15.6	17.1	3.4	4.7	26.1	23.4	13.7	106.3	19.6	18.4	12.9	53.7	16.9	4.3	60.7	34.7	6.5	21.1	0.0	0.0	6.4	0.0	0.2	0.8	0.3	2.3	0.1	0.0	0.0	0.0	23.7	6.0	21.4	7.2	0.0	0.5	0.2	0.0	0.0	0.1	0.0	1.1	0.0	0.1	4.0	0.3	0.3	11.3	0.1	0.0	0.1	0.1	24.0	9.0	0.1	44.9	0.9	0.0	38.9	1.1	17.8	0.0	0.1	1.2	0.0	6.5	0.0	9.3	10.9	0.1	0.1	0.0	0.0	19.1	0.2	9.7	3.0	0.1	0.2	0.0	0.0	23.8	2.3	1.7	0.0	39.6	0.0	17.5	212.9	11.3	34.6	204.9	26.8	25.8	27.4	34.1	139.1	19.7	31.6	32.4	10.5	44.9	176.1	57.4	17.2	170.7	8.3	9.9	10.6	7.9	7.8	10.9	16.3	11.4	14.7	13.7	12.9	21.1	8.7	0.0	16.8	0.0	7.2	0.0	0.0	0.0	0.0	0.0	5.1	4.2	0.0	0.0	11.2	5.5	0.0	0.4	13.7	0.0	7.9	1.7	0.0	27.6	6.6	2.2	0.0	0.0	0.0	5.2	0.9	2.1	0.0	22.0	5.1	12.6	0.0	0.0	57.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	62.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	12.4	0.0	0.0	3.1	15.3	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.8	8.2	3.1	0.0	0.0
ADAM10	"CD156C, HsT18717, kuz, MADM"	ENSG00000137845	"ADAM metallopeptidase domain 10"	O14672	15	58588809-58749791	"Cancer-related genes, CD markers, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Notch signaling pathway"	"Hydrolase, Metalloprotease, Protease"	"Alzheimer disease, Amyloidosis, Cancer-related genes, Disease variant, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Oligodendrocytes: 377.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"U-2197: 296.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB001709, HPA050670"	Approved		Supported	"Vesicles,Plasma membrane"	"Intracellular and membrane"	NA	NA		690000	"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 3: T-cells - Adaptive immune response"	"Cluster 18: U-2197 - ECM organization"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	"Vesicles, Plasma membrane"		"CAB001709: , HPA050670: "	"unprognostic (1.43e-1)"	"unprognostic (1.38e-1)"	"unprognostic (2.77e-1)"	"unprognostic (5.04e-2)"	"unprognostic (3.09e-1)"	"unprognostic (2.70e-3)"	"unprognostic (7.48e-2)"	"prognostic unfavorable (8.46e-5)"	"unprognostic (3.99e-2)"	"unprognostic (1.19e-1)"	"prognostic unfavorable (1.90e-4)"	"unprognostic (6.69e-2)"	"unprognostic (2.57e-2)"	"unprognostic (2.57e-3)"	"unprognostic (9.14e-2)"	"unprognostic (2.09e-2)"	"unprognostic (1.60e-2)"	14.9	8.7	11.4	19.0	18.6	18.7	15.2	20.2	15.0	16.0	9.7	22.2	15.9	16.3	7.7	15.4	13.9	18.9	12.1	12.2	12.7	18.0	16.1	21.0	22.2	18.2	17.6	14.1	8.8	7.9	8.2	29.0	17.5	25.2	17.2	10.8	9.3	12.2	6.1	16.9	17.5	13.3	13.7	29.0	20.3	8.5	15.5	42.7	28.6	7.1	16.4	28.0	10.4	25.2	48.4	88.5	27.6	31.2	34.8	49.8	70.0	39.0	116.0	28.6	39.1	39.9	62.6	22.7	118.0	35.2	49.2	95.9	16.8	43.5	37.0	30.1	19.3	38.7	35.1	42.1	40.8	25.0	103.8	44.4	30.0	19.9	29.2	41.1	55.6	45.0	24.5	57.9	50.4	15.4	89.5	32.0	40.2	15.4	14.6	36.4	91.6	57.1	66.6	121.4	29.9	20.3	44.0	52.8	73.1	60.0	30.4	55.0	41.4	37.1	41.2	296.6	39.6	30.7	70.7	23.5	54.1	50.8	67.3	30.9	36.2	19.2	12.8	41.1	19.2	8.3	12.7	11.6	23.6	9.6	12.7	10.8	51.5	17.7	48.6	10.2	18.2	25.8	11.4	18.6	20.2	15.0	12.2	12.7	18.2	17.6	17.5	13.7	15.5	25.2	60.1	83.3	50.8	83.2	37.9	26.6	30.7	33.3	33.0	22.7	61.6	30.9	40.0	30.0	46.7	80.9	27.1	35.6	69.4	79.0	1.9	56.0	21.2	39.5	56.4	72.5	36.1	20.8	106.1	31.8	57.8	36.1	53.0	74.0	30.3	31.5	71.4	36.2	63.8	45.4	96.2	43.6	36.7	90.1	28.9	19.4	18.0	77.9	46.2	147.1	69.0	30.6	44.3	75.9	377.6	48.9	48.1	17.0	51.0	89.1	45.1	23.7	41.2	33.4	13.1	34.4	42.8	20.3	17.8	39.5	22.3	26.5	51.3	34.1	39.5	83.9
ADAM17	"CD156B, cSVP, TACE"	ENSG00000151694	"ADAM metallopeptidase domain 17"	P78536	2	9488486-9556732	"CD markers, Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Notch signaling pathway"	"Hydrolase, Metalloprotease, Protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Suprabasal keratinocytes: 154.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA010738, HPA051575"	Approved		Supported	Cytosol		NA	NA		300000	"Cluster 7: Monocytes - Unknown function"	"Cluster 57: Non-specific - Angiogenesis"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 41: Macrophages - Immune response"	Cytosol		"HPA010738: AB_1078100, HPA051575: AB_2681539"	"unprognostic (2.28e-1)"	"unprognostic (1.29e-3)"	"unprognostic (1.28e-1)"	"unprognostic (3.51e-3)"	"unprognostic (1.57e-1)"	"unprognostic (5.15e-2)"	"unprognostic (2.12e-3)"	"unprognostic (1.55e-1)"	"unprognostic (4.09e-2)"	"unprognostic (3.69e-1)"	"unprognostic (3.53e-3)"	"unprognostic (3.13e-1)"	"unprognostic (3.82e-3)"	"unprognostic (8.63e-2)"	"unprognostic (2.61e-1)"	"unprognostic (4.48e-2)"	"prognostic unfavorable (4.23e-5)"	10.3	5.5	8.7	9.1	8.6	5.8	10.4	7.8	10.6	8.7	9.5	5.4	4.1	7.2	11.4	10.0	6.5	9.0	6.7	8.6	9.4	4.7	4.6	14.6	8.5	9.7	8.3	8.9	4.1	7.9	4.2	20.1	9.4	4.0	6.8	4.5	6.2	6.3	6.9	11.1	6.1	8.6	8.3	9.3	5.1	9.9	9.1	9.6	6.6	6.8	12.7	10.4	7.1	10.4	10.0	18.2	23.2	25.9	45.9	34.7	45.4	8.6	25.4	16.1	24.6	19.2	31.6	33.4	18.1	18.8	42.1	21.9	16.4	29.4	22.6	8.4	12.1	15.8	14.7	13.9	68.0	20.7	17.8	41.2	32.2	25.1	47.5	26.6	46.0	8.7	30.0	12.3	17.3	8.7	8.5	23.4	19.2	13.7	4.6	14.3	21.6	20.5	25.8	18.7	11.7	28.6	14.9	16.5	30.1	27.0	6.6	19.4	29.0	25.5	12.0	19.1	22.1	15.1	17.5	29.6	20.2	11.1	31.1	5.0	3.7	2.8	1.0	3.7	1.9	1.7	0.9	1.1	2.3	0.9	0.9	1.0	5.5	1.2	2.5	0.7	1.1	0.9	8.7	8.6	7.8	10.6	8.6	9.4	9.7	8.3	9.4	8.3	9.1	10.4	53.8	48.1	66.9	19.6	34.5	130.0	48.2	37.0	19.9	25.2	40.8	26.4	3.6	27.1	38.8	31.3	54.2	29.8	37.7	20.7	5.9	23.7	72.1	30.0	32.0	45.1	19.7	16.8	66.7	19.4	45.1	44.1	13.7	51.5	30.9	31.3	41.4	13.5	34.6	10.1	46.2	13.8	12.2	80.4	84.5	16.0	19.0	76.9	40.9	42.2	40.3	12.9	16.5	26.7	41.5	20.9	18.3	16.1	23.2	57.2	12.9	7.0	37.2	41.4	39.5	79.4	27.3	35.7	35.2	33.7	154.7	56.0	30.1	17.7	15.4	104.3
ADAMTS13	"C9orf8, DKFZp434C2322, FLJ42993, MGC118899, MGC118900, TTP, vWF-CP, VWFCP"	ENSG00000160323	"ADAM metallopeptidase with thrombospondin type 1 motif 13"	Q76LX8	9	133414358-133459402	"Disease related genes, Enzymes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted secreted proteins"	"Blood coagulation, Hemostasis"	"Hydrolase, Metalloprotease, Protease"	"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"liver: 63.8"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 16.0;Early spermatids: 19.3;Excitatory neurons: 12.4;Inhibitory neurons: 12.4;Late spermatids: 13.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA042014, HPA042844, HPA052077"	Approved		Approved	Vesicles	"Secreted to blood"	NA	NA	1300000000	120000000	"Cluster 34: Basophils - Unknown function"	"Cluster 15: Liver - Metabolism"	"Cluster 6: T47d - Mammary gland"	"Cluster 29: Early spermatids - Spermatogenesis"	Vesicles		"HPA042014: AB_2677798, HPA042844: AB_2678200, HPA052077: "	"unprognostic (1.09e-1)"	"unprognostic (1.45e-1)"	"unprognostic (8.75e-4)"	"unprognostic (1.49e-2)"	"unprognostic (1.83e-1)"	"unprognostic (3.02e-1)"	"unprognostic (4.76e-2)"	"unprognostic (2.54e-1)"	"unprognostic (2.33e-2)"	"unprognostic (1.88e-1)"	"unprognostic (4.52e-5)"	"unprognostic (1.11e-1)"	"unprognostic (9.91e-2)"	"unprognostic (4.78e-2)"	"unprognostic (3.57e-1)"	"unprognostic (1.82e-2)"	"unprognostic (2.30e-3)"	2.5	2.8	6.9	0.5	7.3	0.6	2.8	7.6	10.0	5.0	5.3	4.3	3.2	4.2	2.9	2.4	5.7	1.2	6.0	7.1	6.2	9.6	63.8	2.8	0.9	7.0	6.7	6.7	6.2	1.5	12.5	0.8	7.1	6.4	0.9	1.1	2.5	1.4	4.3	2.6	4.4	0.6	6.3	2.6	9.8	13.5	7.2	0.8	6.1	1.4	0.5	4.4	3.1	7.1	0.0	0.8	1.9	2.6	1.5	1.3	0.8	0.7	0.5	0.2	0.3	0.3	2.1	0.2	0.9	0.4	0.6	0.3	0.1	0.4	0.1	1.2	1.7	0.2	0.9	0.4	1.1	0.0	0.7	3.6	0.9	0.2	0.7	1.2	0.1	1.3	0.0	0.8	0.3	3.3	0.0	0.9	2.0	1.1	1.1	0.2	0.2	0.9	0.8	0.8	1.3	4.0	1.4	0.6	1.2	3.9	3.7	0.4	0.5	1.5	0.8	0.9	0.0	1.7	0.3	0.3	1.1	0.2	1.6	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.9	7.3	7.6	10.0	7.1	6.2	7.0	6.7	7.1	6.3	7.2	7.1	0.9	0.0	2.0	16.0	1.2	0.3	0.3	0.9	0.0	1.7	1.4	1.9	4.2	4.3	2.4	0.0	0.0	0.2	0.2	1.0	1.9	0.6	19.3	3.6	1.6	0.9	1.2	0.0	12.4	0.4	0.3	1.5	4.6	3.3	0.0	3.0	5.0	1.6	0.2	3.3	12.4	1.3	0.0	0.6	0.0	13.6	0.9	0.3	0.0	7.5	0.0	1.7	0.0	2.0	5.5	0.3	3.0	1.5	0.4	0.4	1.5	0.9	0.7	1.8	0.0	0.4	0.7	6.0	3.9	0.3	0.4	0.1	0.5	1.7	0.9	0.3
ADAMTS2	"ADAM-TS2, ADAMTS-3, hPCPNI, NPI, PCINP"	ENSG00000087116	"ADAM metallopeptidase with thrombospondin type 1 motif 2"	O95450	5	179110853-179345461	"Disease related genes, Enzymes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted secreted proteins"	"Collagen degradation"	"Hydrolase, Metalloprotease, Protease"	"Ehlers-Danlos syndrome"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Endometrial stromal cells: 32.2;Excitatory neurons: 17.9;Fibroblasts: 30.7;Hepatic stellate cells: 17.2;Kupffer cells: 71.4;Sertoli cells: 26.3;Smooth muscle cells: 20.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"ASC diff: 36.0;ASC TERT1: 35.8;BJ: 31.4;fHDF/TERT166: 39.3;HHSteC: 115.5;HSkMC: 94.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA028363, HPA028444"	Uncertain		Approved	"Vesicles,Plasma membrane"	"Secreted to extracellular matrix"	NA	NA		2000000		"Cluster 64: Macrophages - Immune response"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 50: Fibroblasts - ECM organization"	"Plasma membrane"	Vesicles	"HPA028363: , HPA028444: AB_10601964"	"unprognostic (6.78e-2)"	"unprognostic (7.83e-2)"	"unprognostic (1.13e-1)"	"unprognostic (5.50e-2)"	"unprognostic (8.85e-3)"	"unprognostic (4.80e-2)"	"unprognostic (1.09e-1)"	"unprognostic (2.22e-2)"	"unprognostic (1.58e-1)"	"unprognostic (1.91e-2)"	"unprognostic (2.08e-1)"	"unprognostic (2.45e-1)"	"prognostic unfavorable (1.71e-8)"	"unprognostic (1.32e-3)"	"unprognostic (1.03e-2)"	"unprognostic (7.16e-3)"	"unprognostic (1.48e-2)"	36.9	10.9	0.8	2.4	4.2	0.3	22.7	0.9	3.5	20.6	0.9	10.5	1.4	21.7	0.5	5.5	15.5	6.1	22.3	0.5	0.9	7.5	15.8	29.6	1.8	4.5	3.3	12.1	5.8	0.4	15.1	9.7	4.2	9.0	1.4	0.2	5.3	1.8	2.9	9.4	11.6	9.1	0.2	38.4	9.3	3.9	2.5	0.4	6.8	0.8	0.6	15.0	16.7	2.2	0.0	0.0	0.1	0.7	36.0	35.8	0.0	31.4	5.4	11.5	12.4	0.1	0.0	0.0	0.2	39.3	0.7	0.1	1.8	0.0	5.1	0.0	1.5	0.0	0.1	2.3	115.5	0.0	0.0	94.4	0.0	3.3	0.0	0.0	0.0	0.0	0.0	0.0	8.2	0.0	0.1	0.8	0.8	0.0	0.1	0.0	0.0	0.3	0.0	0.0	5.9	1.2	0.1	0.0	0.4	1.9	0.0	10.7	0.0	19.1	3.0	24.5	0.0	0.3	0.0	0.0	0.9	0.3	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.1	0.0	0.0	0.3	0.1	0.0	0.1	0.0	0.0	0.8	4.2	0.9	3.5	0.5	0.9	4.5	3.3	4.2	0.2	2.5	2.2	3.3	0.0	1.1	1.6	0.1	2.2	0.4	0.0	2.2	0.3	0.2	5.2	1.5	1.5	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	1.3	0.9	32.2	1.4	0.0	0.0	17.9	0.0	0.3	30.7	0.0	0.8	1.3	6.5	17.2	0.5	5.1	0.0	8.5	0.0	0.0	71.4	4.4	3.4	5.0	10.4	0.0	4.7	0.3	0.1	0.0	3.0	2.4	0.5	0.0	12.8	0.1	0.4	0.0	0.2	0.0	0.0	26.3	4.7	20.4	2.1	4.8	0.2	2.7	0.0	0.4	0.6	0.0	0.1
ADAMTS4	"ADAMTS-2, ADMP-1, KIAA0688"	ENSG00000158859	"ADAM metallopeptidase with thrombospondin type 1 motif 4"	O75173	1	161184302-161199054	"Cancer-related genes, Enzymes, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins, Transporters"		"Hydrolase, Metalloprotease, Protease"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 116.8;ovary: 95.9"	"Cell type enhanced"	"Detected in many"		"Adipocytes: 80.3;Endothelial cells: 115.5;Fibroblasts: 88.8;Oligodendrocytes: 56.0;Sertoli cells: 52.6;Smooth muscle cells: 313.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in single"	8	"plasmacytoid DC: 4.4"	"Lineage enriched"	"Detected in single"	8	"dendritic cells: 4.4"	"Cell line enhanced"	"Detected in some"		"hTEC/SVTERT24-B: 11.8;HUVEC TERT2: 14.4;SH-SY5Y: 7.9;TIME: 12.2;U-138 MG: 7.4;U-251 MG: 10.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB025876, HPA051296, HPA068374"	Uncertain		Supported	"Nuclear speckles"	"Secreted to extracellular matrix"	NA	NA		11000	"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 57: Non-specific - Angiogenesis"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 48: Smooth muscle cells - ECM organization"	"Nuclear speckles"		"CAB025876: , HPA051296: AB_2681426, HPA068374: AB_2685978"	"unprognostic (2.70e-2)"	"unprognostic (8.10e-3)"	"unprognostic (3.00e-3)"	"unprognostic (2.75e-1)"	"unprognostic (9.95e-3)"	"unprognostic (1.19e-1)"	"unprognostic (1.07e-1)"	"prognostic unfavorable (5.00e-4)"	"unprognostic (1.20e-2)"	"unprognostic (9.59e-3)"	"unprognostic (2.48e-2)"	"unprognostic (1.59e-1)"	"prognostic unfavorable (7.27e-7)"	"unprognostic (1.10e-2)"	"unprognostic (1.04e-1)"	"unprognostic (1.44e-3)"	"unprognostic (3.13e-2)"	116.8	9.8	6.1	16.3	31.5	0.7	43.4	31.1	19.2	16.4	5.8	18.2	0.8	15.0	0.2	6.2	34.6	14.3	53.6	8.1	15.2	26.0	8.7	50.3	1.6	38.2	29.6	95.9	9.0	2.1	13.0	3.2	31.6	16.9	2.0	1.5	5.2	0.5	13.3	5.0	9.4	10.5	28.3	1.8	22.8	1.8	26.2	1.1	21.3	0.4	0.3	31.8	12.2	48.0	0.0	0.0	0.2	0.1	6.4	4.0	0.6	5.4	0.2	0.5	3.0	0.2	0.2	0.2	4.4	1.7	0.0	0.1	0.0	0.0	1.9	0.1	0.3	0.2	0.5	1.3	0.6	0.0	0.1	4.5	0.0	11.8	0.1	0.0	14.4	0.1	0.2	0.3	0.4	0.1	0.0	0.2	5.3	0.0	0.0	0.1	5.1	0.1	0.0	0.1	0.1	7.9	0.0	0.1	0.1	0.3	0.2	0.5	12.2	7.4	0.1	0.4	10.8	0.2	0.1	0.1	2.2	0.1	0.1	0.5	0.1	0.1	0.2	0.0	0.1	0.1	0.1	0.1	0.0	0.2	0.1	0.1	0.4	0.2	0.0	4.4	0.2	0.1	6.1	31.5	31.1	19.2	8.1	15.2	38.2	29.6	31.6	28.3	26.2	48.0	80.3	0.0	4.1	0.0	0.2	31.2	3.2	0.0	2.2	2.2	8.6	5.5	5.5	0.0	0.6	0.0	0.0	0.3	0.5	0.2	0.0	0.3	0.0	0.3	13.0	115.5	0.0	0.0	0.4	0.0	0.3	88.8	0.5	0.5	0.0	0.3	43.2	0.9	1.0	3.3	0.1	0.0	0.0	1.0	32.6	0.2	0.3	3.2	35.6	2.8	1.0	0.5	0.0	0.0	56.0	0.0	0.0	1.2	0.7	9.8	0.0	0.1	0.0	1.0	52.6	21.2	313.7	2.7	0.6	2.7	19.0	0.4	3.7	1.6	0.3	7.7
ADAR	"ADAR1, G1P1, IFI4"	ENSG00000160710	"Adenosine deaminase RNA specific"	P55265	1	154581695-154628013	"Disease related genes, Enzymes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Antiviral defense, Immunity, Innate immunity, mRNA processing, RNA-mediated gene silencing"	"DNA-binding, Hydrolase, RNA-binding"	"Aicardi-Goutieres syndrome, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003890, HPA051519, CAB056157"	Enhanced		Enhanced	Nucleoplasm,Nucleoli		No	No			"Cluster 52: Eosinophils - Transcription"	"Cluster 34: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 52: Non-specific - Transcription"	Nucleoli	Nucleoplasm	"CAB056157: AB_2665578, HPA003890: AB_1078103, HPA051519: AB_2681520"	"unprognostic (3.46e-1)"	"unprognostic (8.11e-2)"	"unprognostic (1.42e-1)"	"unprognostic (1.83e-2)"	"unprognostic (2.38e-1)"	"unprognostic (9.37e-2)"	"unprognostic (2.07e-2)"	"unprognostic (6.97e-2)"	"unprognostic (2.03e-1)"	"unprognostic (2.90e-1)"	"unprognostic (4.13e-2)"	"unprognostic (7.16e-2)"	"prognostic unfavorable (7.30e-5)"	"unprognostic (3.44e-1)"	"unprognostic (1.49e-1)"	"unprognostic (9.00e-2)"	"unprognostic (3.94e-2)"	41.9	44.7	30.4	57.2	29.9	47.1	41.1	18.0	35.1	49.4	16.3	42.9	46.4	50.2	26.3	37.9	50.3	45.6	36.1	31.5	40.0	51.7	56.1	54.6	66.1	32.1	33.8	54.9	40.6	62.8	53.9	46.5	34.8	42.8	44.4	47.9	59.4	43.0	18.8	39.9	52.8	56.6	39.2	73.5	40.3	34.4	37.8	85.2	47.1	27.6	65.0	50.5	40.0	25.5	93.2	103.1	84.4	104.8	87.4	88.5	97.8	59.5	132.7	209.8	183.4	87.8	85.3	162.6	97.7	98.7	112.4	85.4	111.9	115.5	109.8	159.1	52.3	84.9	66.2	48.4	96.7	122.8	83.8	86.2	84.7	100.4	104.1	81.2	104.5	112.4	82.4	111.6	72.0	107.8	165.0	43.3	139.7	125.5	74.6	140.1	74.2	131.2	67.6	106.1	84.8	100.2	104.4	167.9	126.2	128.1	113.4	148.2	94.3	67.5	68.5	58.8	71.5	132.9	179.0	177.6	70.2	78.4	81.0	7.8	8.1	15.0	10.8	9.9	10.2	9.0	10.6	11.2	7.8	5.8	9.8	10.0	29.1	8.6	9.4	6.3	9.1	7.4	30.4	29.9	18.0	35.1	31.5	40.0	32.1	33.8	34.8	39.2	37.8	25.5	73.3	83.3	51.2	37.5	80.5	33.3	39.4	39.9	32.5	94.5	43.6	36.6	22.1	45.8	44.0	47.8	95.9	41.2	103.0	73.3	9.8	49.2	4.2	48.9	61.0	86.7	63.1	45.2	44.8	66.9	57.8	49.1	56.6	52.4	62.1	88.6	84.9	93.8	53.5	168.2	53.2	53.9	34.6	104.1	43.9	13.1	73.7	78.0	19.6	32.8	110.2	37.9	126.7	38.2	39.7	69.6	62.7	59.0	87.5	61.1	86.7	42.5	50.0	80.2	52.6	40.1	45.2	11.4	35.0	37.9	40.3	31.5	85.6	66.5	56.2	53.8
ADARB1	"ADAR2, ADAR2a, ADAR2a-L1, ADAR2a-L2, ADAR2a-L3, ADAR2b, ADAR2c, ADAR2d, ADAR2g, DRABA2, DRADA2, hRED1, RED1"	ENSG00000197381	"Adenosine deaminase RNA specific B1"	P78563	21	45073853-45226560	"Disease related genes, Enzymes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Antiviral defense, Immunity, Innate immunity, mRNA processing"	"Hydrolase, RNA-binding"	"Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Bipolar cells: 62.9;Excitatory neurons: 54.1;Horizontal cells: 69.0;Inhibitory neurons: 85.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HeLa: 65.8;HHSteC: 65.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA029645			Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 57: Non-specific - Angiogenesis"	"Cluster 20: HeLa - Mitochondria"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Nucleoplasm	Cytosol	"HPA029645: AB_10602106"	"unprognostic (2.69e-1)"	"unprognostic (7.65e-2)"	"prognostic unfavorable (8.16e-5)"	"unprognostic (1.82e-2)"	"unprognostic (1.07e-2)"	"unprognostic (9.07e-2)"	"unprognostic (3.29e-2)"	"unprognostic (6.97e-2)"	"unprognostic (3.82e-2)"	"unprognostic (1.23e-2)"	"unprognostic (1.28e-1)"	"unprognostic (3.44e-1)"	"prognostic unfavorable (3.56e-4)"	"unprognostic (4.57e-2)"	"unprognostic (3.06e-1)"	"unprognostic (2.73e-2)"	"unprognostic (2.38e-2)"	15.4	7.0	14.9	10.3	13.2	5.2	11.4	39.1	26.5	14.7	29.6	35.7	3.0	23.0	6.3	7.4	13.6	8.1	10.1	20.0	17.9	9.5	7.0	35.2	13.4	30.6	17.2	7.8	6.1	9.3	6.1	12.3	30.8	17.9	4.8	28.6	6.8	8.1	13.6	15.9	10.8	11.7	8.7	16.1	19.0	4.5	22.7	5.7	6.6	11.8	8.7	60.4	11.9	12.7	7.0	1.0	5.3	6.2	6.3	4.3	7.2	4.6	7.6	14.4	9.0	10.9	1.1	2.2	12.1	22.6	7.9	0.6	7.8	19.1	15.9	1.7	7.0	15.2	65.8	7.2	65.7	10.5	7.2	23.7	8.1	5.1	14.9	5.4	15.4	20.4	3.5	0.8	42.2	5.1	6.8	10.0	8.6	3.4	10.1	2.0	5.0	7.1	3.2	2.3	30.6	8.2	36.4	1.6	11.6	8.5	3.5	8.2	16.3	4.7	5.7	19.4	17.5	6.6	3.1	1.8	4.3	24.1	25.8	0.7	0.0	2.4	0.4	0.2	0.8	1.0	1.1	0.7	0.0	2.6	0.7	0.6	0.1	0.3	0.2	1.0	0.8	0.2	14.9	13.2	39.1	26.5	20.0	17.9	30.6	17.2	30.8	8.7	22.7	12.7	29.0	0.0	1.1	10.7	12.0	11.1	2.9	3.4	2.8	62.9	6.2	7.1	21.6	1.5	1.9	0.0	12.5	0.5	5.9	0.9	0.0	1.3	2.7	1.6	8.8	21.2	0.0	2.1	54.1	0.5	1.2	9.4	2.6	1.6	8.2	5.5	14.3	6.3	5.9	69.0	85.7	0.9	0.0	3.4	4.9	2.9	3.7	3.2	5.4	37.5	5.0	34.2	2.1	16.1	4.8	1.0	0.1	5.7	4.0	5.5	0.3	2.7	0.7	16.0	0.0	32.9	12.7	11.4	17.7	1.5	7.2	1.0	13.7	1.4	1.2	2.3
ADAT1		ENSG00000065457	"Adenosine deaminase tRNA specific 1"	Q9BUB4	16	75596868-75623300	"Enzymes, Predicted intracellular proteins"	"tRNA processing"	Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in all"	5	"Early spermatids: 101.9;Late spermatids: 213.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA040713, HPA040903"	Approved		Supported	Nucleoplasm		NA	NA			"Cluster 44: Non-specific - Transcription"	"Cluster 43: Testis - Unknown function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 25: Spermatids - Spermatogenesis"	Nucleoplasm		"HPA040713: AB_10795371, HPA040903: AB_10794071"	"unprognostic (7.71e-3)"	"unprognostic (5.35e-2)"	"unprognostic (7.62e-2)"	"unprognostic (9.00e-2)"	"unprognostic (9.99e-2)"	"unprognostic (4.69e-2)"	"unprognostic (4.54e-2)"	"unprognostic (6.65e-3)"	"unprognostic (3.38e-1)"	"unprognostic (1.14e-2)"	"unprognostic (9.75e-2)"	"unprognostic (2.97e-1)"	"unprognostic (4.60e-3)"	"unprognostic (7.21e-2)"	"unprognostic (4.92e-1)"	"unprognostic (5.58e-3)"	"unprognostic (8.27e-2)"	13.8	16.4	11.0	9.5	11.1	7.8	14.1	11.5	15.1	12.0	10.5	11.6	5.1	14.0	12.7	11.7	11.8	6.6	11.5	10.8	10.5	19.8	18.5	12.8	10.8	11.5	11.2	10.3	12.6	14.6	14.2	7.3	11.7	15.3	9.1	9.6	12.1	8.6	9.5	14.1	14.0	6.0	10.6	20.4	12.0	26.9	11.5	11.8	14.8	5.2	8.7	13.1	11.6	13.0	14.7	23.1	15.0	15.5	26.4	20.3	11.5	20.2	21.0	26.1	17.7	15.4	22.4	15.7	19.8	20.6	14.0	17.6	16.4	25.0	24.6	11.7	8.6	8.8	16.0	13.3	21.2	19.6	19.6	21.7	23.8	42.7	32.1	7.5	23.1	24.7	13.7	7.6	21.2	35.9	18.8	14.3	12.2	19.8	10.7	23.6	12.1	21.5	24.6	22.0	18.1	18.6	47.8	12.2	11.2	15.0	24.6	9.3	16.3	32.4	14.6	17.1	16.9	15.1	24.3	58.9	16.3	15.6	28.5	8.5	4.3	11.5	8.5	6.4	11.3	7.9	7.3	11.3	5.8	7.3	4.5	6.3	4.9	10.8	9.9	4.6	9.0	6.2	11.0	11.1	11.5	15.1	10.8	10.5	11.5	11.2	11.7	10.6	11.5	13.0	9.9	9.6	5.8	2.3	11.6	4.6	5.9	5.7	6.8	13.5	10.7	6.6	5.6	11.5	6.6	7.3	27.1	11.8	9.8	6.8	17.6	8.6	101.9	11.8	8.2	11.9	14.4	16.0	6.0	7.6	8.9	6.4	8.6	10.5	8.2	12.6	6.1	10.5	10.3	13.5	6.4	4.7	10.2	14.4	10.6	213.0	9.9	10.2	3.6	2.8	12.8	7.8	15.5	3.0	8.0	9.8	3.3	7.9	8.1	8.3	6.9	11.3	9.9	21.6	6.6	6.8	7.0	17.5	13.4	8.4	5.4	9.7	14.8	12.9	9.1	7.6
ADAT2	"DEADC1, dJ20N2.1, TAD2"	ENSG00000189007	"Adenosine deaminase tRNA specific 2"	Q7Z6V5	6	143422832-143450695	"Enzymes, Predicted intracellular proteins"	"tRNA processing"	Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA035479	Approved		Approved	"Nucleoplasm,Golgi apparatus,Cytosol"		NA	NA			"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 32: U-937 - Innate immune response"	"Cluster 32: Non-specific - Translation"	"Golgi apparatus"	"Nucleoplasm, Cytosol"	"HPA035479: AB_10611672"	"unprognostic (2.24e-1)"	"unprognostic (3.07e-3)"	"unprognostic (1.55e-1)"	"unprognostic (8.20e-2)"	"unprognostic (3.05e-2)"	"unprognostic (8.58e-2)"	"unprognostic (1.07e-3)"	"unprognostic (3.31e-2)"	"unprognostic (1.34e-1)"	"unprognostic (7.30e-2)"	"unprognostic (1.27e-1)"	"unprognostic (1.25e-2)"	"unprognostic (9.28e-5)"	"unprognostic (4.88e-2)"	"unprognostic (6.96e-2)"	"unprognostic (7.29e-2)"	"unprognostic (4.08e-2)"	6.8	8.8	1.4	3.1	1.3	5.4	6.3	1.9	1.5	6.3	1.8	7.8	3.1	4.8	1.4	10.3	6.1	1.2	3.4	1.3	1.2	7.7	12.0	8.5	4.2	1.2	1.2	5.8	10.5	1.5	6.6	1.1	1.3	7.3	4.1	1.4	5.4	1.1	3.1	8.9	8.8	1.7	1.0	10.7	8.9	2.8	1.5	1.9	8.6	0.7	3.5	6.5	7.9	1.4	1.8	1.6	2.2	7.2	1.7	5.3	2.7	2.6	1.1	1.6	2.2	4.0	4.4	7.0	2.7	1.7	1.7	5.8	4.3	4.1	3.4	3.5	9.2	10.4	7.3	8.3	2.1	15.0	4.6	2.4	6.0	3.2	6.3	1.8	3.7	6.5	11.3	5.4	2.7	2.5	6.0	7.6	2.5	2.6	2.8	7.0	5.7	5.6	3.0	1.9	4.7	3.1	2.1	6.0	1.8	1.2	2.4	5.0	3.4	2.6	1.9	5.6	4.8	5.9	4.2	4.9	2.7	13.0	2.8	0.0	0.2	0.0	0.6	0.3	0.8	0.5	0.5	0.5	0.6	0.3	0.7	1.0	0.1	0.4	0.0	0.6	1.3	0.4	1.4	1.3	1.9	1.5	1.3	1.2	1.2	1.2	1.3	1.0	1.5	1.4	4.6	6.4	12.9	8.8	6.9	6.6	4.3	4.1	6.2	3.7	5.6	6.3	4.0	5.7	4.1	1.8	0.0	2.4	11.9	4.3	3.9	5.6	1.2	2.7	11.1	4.8	4.2	14.9	11.2	4.1	2.6	5.3	12.2	5.9	7.6	7.1	3.9	5.2	4.9	1.7	10.4	6.0	4.1	4.3	6.1	1.6	6.8	5.3	5.4	7.5	2.1	1.9	8.2	12.5	4.2	6.6	2.4	3.4	4.2	6.8	1.6	1.4	2.1	4.3	0.0	5.1	5.1	2.4	5.6	9.8	9.2	0.8	8.9	6.2	8.8	4.5
ADPRH	ARH1	ENSG00000144843	"ADP-ribosylarginine hydrolase"	P54922	3	119579268-119589945	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Macrophages: 14.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HDLM-2: 23.9;HEL: 17.1;HMC-1: 18.5;Karpas-707: 25.3;U-266/70: 24.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB001701, HPA036961"	Approved		Approved	"Nucleoplasm,Nuclear membrane"		NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 16: Immune cells - Immune response"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 4: Macrophages - Innate immune response"	"Nuclear membrane"	Nucleoplasm	"CAB001701: , HPA036961: AB_2675405"	"prognostic favorable (2.42e-4)"	"unprognostic (2.29e-1)"	"unprognostic (4.77e-1)"	"unprognostic (2.39e-2)"	"unprognostic (3.38e-2)"	"unprognostic (2.65e-1)"	"unprognostic (3.06e-2)"	"unprognostic (2.63e-1)"	"unprognostic (4.24e-2)"	"unprognostic (3.31e-3)"	"unprognostic (1.88e-1)"	"unprognostic (1.71e-1)"	"unprognostic (6.04e-2)"	"unprognostic (2.60e-3)"	"unprognostic (8.87e-2)"	"unprognostic (2.03e-1)"	"unprognostic (4.35e-2)"	10.6	6.2	3.0	7.3	3.3	3.4	7.9	3.3	4.2	6.9	9.2	5.5	2.3	6.0	4.9	4.0	4.2	6.9	8.5	2.9	3.5	4.9	3.1	13.5	11.0	4.6	3.4	1.9	6.7	8.0	2.0	11.3	4.4	6.1	4.1	6.6	5.1	9.3	11.8	2.6	5.4	9.2	4.2	11.9	3.9	2.4	4.6	5.9	5.8	9.9	13.0	6.5	3.4	4.9	2.4	3.0	0.7	0.0	2.4	2.7	0.0	2.1	0.4	1.8	2.3	0.9	2.0	0.6	0.9	3.2	0.1	0.2	2.0	0.0	1.7	23.9	0.2	17.1	0.4	0.0	3.9	0.1	18.5	4.0	0.1	0.9	0.1	0.8	7.3	0.0	1.6	25.3	11.0	0.7	0.0	4.1	6.9	0.2	5.8	0.0	8.2	1.1	1.0	0.9	0.5	0.1	0.0	0.1	6.4	1.0	4.4	10.6	6.0	0.0	1.1	4.6	0.4	24.5	5.8	0.1	3.0	0.0	4.6	13.9	18.7	19.1	0.8	17.2	0.8	11.0	1.9	1.7	11.2	6.8	0.2	0.7	0.6	5.3	13.9	9.8	14.3	7.5	3.0	3.3	3.3	4.2	2.9	3.5	4.6	3.4	4.4	4.2	4.6	4.9	12.6	9.6	8.6	0.3	5.0	0.8	0.7	0.4	0.0	0.5	1.5	1.9	4.7	2.8	2.7	3.7	4.2	5.8	5.0	0.3	1.9	3.6	0.7	0.2	0.9	9.9	0.0	2.7	0.1	3.2	3.8	2.1	2.6	0.5	10.8	2.5	7.1	1.6	9.4	0.0	0.2	0.2	2.0	12.2	11.1	0.5	0.3	14.8	1.8	4.7	10.2	0.8	4.1	0.0	0.6	2.1	0.5	3.0	3.9	0.7	0.0	1.3	2.1	4.3	0.0	3.6	3.9	0.4	0.6	0.1	0.9	11.8	1.2	0.7	0.2	0.2
ADPRM	"C17orf48, MDS006"	ENSG00000170222	"ADP-ribose/CDP-alcohol diphosphatase, manganese dependent"	Q3LIE5	17	10697594-10711558	"Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins"		Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Rod photoreceptor cells: 34.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA023265, HPA023820"	Approved					NA	NA			"Cluster 32: T-cells - Unknown function"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 32: Non-specific - Translation"			"HPA023265: AB_1845590, HPA023820: AB_1845591"	"unprognostic (7.58e-3)"	"prognostic favorable (1.69e-4)"	"unprognostic (1.42e-1)"	"prognostic favorable (2.38e-5)"	"unprognostic (2.49e-1)"	"unprognostic (1.30e-1)"	"unprognostic (1.31e-1)"	"unprognostic (1.35e-1)"	"unprognostic (1.43e-2)"	"unprognostic (1.43e-1)"	"unprognostic (6.26e-3)"	"unprognostic (2.97e-1)"	"unprognostic (6.53e-3)"	"unprognostic (2.65e-2)"	"unprognostic (1.83e-1)"	"unprognostic (4.77e-2)"	"unprognostic (5.97e-2)"	6.7	4.6	1.9	4.9	2.2	6.6	6.6	2.0	2.3	6.8	1.7	5.1	3.1	6.4	3.7	4.4	4.8	4.7	3.6	1.9	2.1	4.5	6.8	3.9	6.9	1.9	1.8	7.8	6.9	3.1	3.9	2.6	1.9	7.7	3.2	9.9	4.7	3.5	9.2	5.4	6.0	2.8	2.0	5.8	7.9	4.0	2.2	7.0	6.5	6.4	5.6	4.8	5.2	2.4	3.8	2.8	3.9	5.0	8.8	11.1	1.9	7.2	7.7	5.2	7.5	1.5	1.7	7.1	3.3	7.5	2.2	3.0	1.8	5.2	6.4	4.4	5.4	3.5	2.9	4.3	14.7	2.6	4.3	13.7	7.5	5.6	7.8	8.0	9.6	7.8	3.4	0.6	6.8	1.1	2.8	4.5	4.2	2.5	1.5	3.1	2.7	1.9	9.1	2.5	0.7	5.2	3.5	1.3	8.2	4.7	3.6	5.0	9.8	2.9	2.3	3.6	4.2	1.6	1.1	1.1	6.9	3.6	6.1	2.6	2.5	4.7	2.4	2.6	3.5	5.9	6.2	4.1	3.1	7.2	13.0	8.5	2.3	4.1	2.3	1.7	5.9	3.9	1.9	2.2	2.0	2.3	1.9	2.1	1.9	1.8	1.9	2.0	2.2	2.4	5.8	3.2	2.0	6.5	17.6	5.2	11.7	17.4	8.0	11.7	5.9	6.0	2.7	4.3	8.9	1.8	18.8	7.2	6.4	3.8	3.9	8.4	10.2	1.9	3.9	5.7	4.8	6.7	6.0	8.3	7.3	6.6	4.6	2.4	14.0	4.4	7.1	9.8	6.7	3.3	6.9	7.5	2.0	9.5	5.1	5.2	15.8	6.0	10.6	1.9	11.1	13.5	6.2	8.0	8.1	8.1	4.6	8.2	3.6	12.7	14.9	8.5	4.1	34.3	6.6	6.6	14.0	12.5	10.2	4.4	4.7	8.2	13.0	4.4	5.6	11.4
ADPRS	"ADPRHL2, ARH3, FLJ20446"	ENSG00000116863	"ADP-ribosylserine hydrolase"	Q9NX46	1	36088892-36093932	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"DNA damage, DNA repair"	Hydrolase	"Disease variant, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in some"	6	"Cytotrophoblasts: 79.2;Extravillous trophoblasts: 40.7;Hofbauer cells: 51.6;Syncytiotrophoblasts: 70.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA026641, HPA027104, HPA027141"	Approved		Enhanced	Nucleoplasm	"Intracellular and membrane"	NA	NA		54000	"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 47: Cytotrophoblasts - Unknown function"	Nucleoplasm		"HPA026641: , HPA027104: AB_10601330, HPA027141: AB_1844619"	"unprognostic (3.22e-3)"	"unprognostic (5.10e-2)"	"unprognostic (2.95e-2)"	"unprognostic (1.61e-2)"	"unprognostic (5.98e-2)"	"unprognostic (2.09e-1)"	"prognostic unfavorable (2.10e-7)"	"unprognostic (3.71e-2)"	"unprognostic (2.63e-1)"	"unprognostic (5.34e-2)"	"unprognostic (3.17e-2)"	"unprognostic (7.80e-2)"	"prognostic unfavorable (3.71e-4)"	"unprognostic (4.37e-2)"	"unprognostic (9.31e-2)"	"unprognostic (3.65e-2)"	"unprognostic (4.74e-2)"	19.0	36.7	28.4	16.0	30.0	19.7	18.5	31.3	30.3	20.7	33.4	19.6	15.6	17.6	15.0	36.1	33.5	13.3	20.7	28.6	29.1	27.7	22.4	20.6	21.5	32.5	29.7	19.7	17.9	17.6	17.7	20.8	31.2	19.9	12.4	9.1	20.9	16.3	34.4	34.1	16.8	16.4	31.9	23.1	17.6	28.7	29.7	20.9	19.4	21.8	20.2	21.3	22.2	33.9	54.3	22.4	26.2	37.2	23.6	17.1	37.3	39.4	32.9	62.1	60.9	26.8	47.7	38.4	37.5	39.5	32.0	32.9	33.4	60.5	37.0	27.7	41.8	34.9	27.0	36.3	44.4	40.2	19.9	20.3	45.4	56.5	24.5	47.2	39.9	36.2	30.8	30.9	29.6	26.0	40.9	60.5	56.5	31.8	46.0	32.9	27.6	38.8	56.5	43.8	32.1	50.8	28.9	29.9	65.9	34.4	30.9	34.3	27.6	35.7	37.0	50.1	53.0	39.8	41.2	34.2	51.7	39.6	22.4	40.6	58.3	65.8	43.4	74.1	41.5	43.5	47.6	50.8	71.4	51.5	47.7	40.3	57.1	47.9	77.7	44.8	43.4	57.8	28.4	30.0	31.3	30.3	28.6	29.1	32.5	29.7	31.2	31.9	29.7	33.9	3.5	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.5	0.0	0.0	0.0	0.0	79.2	6.2	0.0	0.0	0.0	0.0	0.0	0.0	2.7	0.0	0.0	0.0	0.0	40.7	6.4	0.0	0.0	0.0	0.0	0.0	0.0	51.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.5	0.0	0.0	0.0	0.0	70.6	1.3	0.0	0.0	0.0
AFMID	"DKFZp686F03259, KF"	ENSG00000183077	Arylformamidase	Q63HM1	17	78187317-78207701	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Tryptophan catabolism"	Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 173.2"	"Cell type enhanced"	"Detected in many"		"Hepatocytes: 118.3;Proximal tubular cells: 105.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"classical monocyte: 6.4;intermediate monocyte: 16.7;memory B-cell: 5.4;myeloid DC: 7.6;non-classical monocyte: 11.0;plasmacytoid DC: 5.1"	"Group enriched"	"Detected in all"	5	"B-cells: 5.4;dendritic cells: 7.6;monocytes: 16.7"	"Cell line enhanced"	"Detected in all"		"Hep G2: 186.5"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA023861, HPA026536"	Uncertain		Approved	Mitochondria		NA	NA			"Cluster 7: Monocytes - Unknown function"	"Cluster 15: Liver - Metabolism"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Mitochondria		"HPA023861: AB_1844636, HPA026536: AB_1844637"	"unprognostic (3.55e-2)"	"unprognostic (1.54e-2)"	"unprognostic (1.53e-1)"	"unprognostic (2.65e-3)"	"unprognostic (2.06e-1)"	"unprognostic (4.73e-2)"	"unprognostic (2.78e-1)"	"unprognostic (1.83e-1)"	"unprognostic (1.49e-3)"	"unprognostic (1.53e-2)"	"unprognostic (5.78e-2)"	"unprognostic (9.59e-3)"	"unprognostic (9.12e-2)"	"unprognostic (1.80e-2)"	"unprognostic (1.43e-1)"	"unprognostic (1.94e-1)"	"unprognostic (7.79e-2)"	14.6	7.6	52.8	11.7	76.1	10.8	65.5	67.3	66.2	15.2	35.5	15.8	17.9	15.3	13.9	18.7	22.9	19.0	22.5	52.6	60.5	88.8	173.2	27.1	12.0	74.4	71.3	31.9	59.3	9.1	9.1	26.7	66.8	28.3	18.8	4.0	38.7	18.4	19.2	32.9	15.5	13.4	56.6	14.6	22.1	13.2	68.6	8.9	15.0	14.4	13.4	13.2	19.0	114.8	21.3	29.4	25.4	23.3	27.9	32.5	13.7	29.8	16.8	20.4	24.5	31.5	17.2	65.8	19.2	22.8	11.9	17.8	43.5	26.0	28.5	41.9	34.6	53.2	35.2	186.5	24.4	44.4	26.2	43.8	26.9	23.9	31.0	33.5	38.8	19.6	54.7	22.4	16.0	20.9	34.0	67.2	20.9	51.1	49.8	38.3	25.9	79.2	27.9	19.3	56.2	41.5	25.5	75.5	24.4	25.1	22.8	42.3	19.3	31.2	20.5	19.9	21.4	33.8	24.2	68.0	25.7	21.5	8.2	1.7	6.4	0.8	0.7	16.7	1.2	5.4	1.1	1.2	7.6	2.1	0.6	0.6	1.8	1.9	11.0	5.1	1.1	1.8	52.8	76.1	67.3	66.2	52.6	60.5	74.4	71.3	66.8	56.6	68.6	114.8	17.9	16.0	16.0	0.7	9.7	26.4	19.8	11.5	79.6	1.2	44.7	34.3	13.2	58.6	12.1	64.4	4.2	12.9	2.1	15.1	17.6	11.5	0.2	21.3	14.5	16.7	13.1	11.3	7.7	8.5	11.2	18.6	23.9	23.8	2.5	9.5	17.9	118.3	10.1	1.7	4.0	26.8	10.2	20.9	20.7	2.7	22.4	21.9	30.2	6.5	8.8	1.6	2.1	3.0	74.2	7.8	27.6	21.8	25.4	15.7	17.8	105.8	14.7	1.7	0.0	15.2	18.1	1.5	13.3	52.1	41.1	11.5	4.3	21.6	30.6	14.5
AGA	ASRG	ENSG00000038002	Aspartylglucosaminidase	P20933	4	177430774-177442437	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"		"Hydrolase, Protease"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"BJ hTERT+: 77.5;Karpas-707: 111.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA031415, HPA031417"	Enhanced				"Intracellular and membrane"	NA	NA		36000000	"Cluster 45: Eosinophils - Innate immune response"	"Cluster 30: Epididymis - Antimicrobial activity"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 55: Plasma cells - Humoral immune response"			"HPA031415: AB_10603578, HPA031417: AB_10670967"	"unprognostic (8.76e-2)"	"unprognostic (1.56e-1)"	"unprognostic (2.22e-3)"	"unprognostic (2.11e-3)"	"unprognostic (2.70e-2)"	"prognostic unfavorable (8.61e-4)"	"prognostic unfavorable (1.99e-4)"	"unprognostic (3.79e-1)"	"unprognostic (6.44e-2)"	"unprognostic (4.23e-2)"	"unprognostic (4.28e-2)"	"unprognostic (1.09e-1)"	"unprognostic (7.49e-2)"	"unprognostic (2.07e-1)"	"unprognostic (3.49e-1)"	"unprognostic (7.42e-2)"	"unprognostic (1.47e-2)"	9.4	13.3	8.1	9.1	10.4	15.4	21.1	9.8	12.0	9.2	16.2	13.1	9.6	8.6	30.2	15.9	8.4	13.1	7.5	8.4	9.9	15.3	18.7	11.6	12.2	11.4	9.1	10.2	15.1	17.1	6.1	8.4	11.4	11.8	13.1	6.6	14.9	9.8	9.0	20.6	12.4	9.5	9.5	10.3	16.2	13.2	8.6	11.1	15.8	5.8	15.6	10.9	8.2	13.7	5.4	11.9	13.3	18.8	14.9	13.2	9.0	39.5	77.5	20.1	24.8	6.2	26.2	26.9	7.2	30.0	9.7	6.5	11.3	13.0	39.4	17.3	7.5	11.2	11.9	17.3	10.0	19.6	7.4	9.6	22.5	14.7	6.5	18.0	18.7	11.4	10.3	111.6	8.0	14.6	15.9	12.0	5.2	10.5	12.2	5.0	5.4	4.0	20.5	12.9	7.3	16.4	11.9	10.3	32.2	9.9	23.3	39.8	6.1	13.9	12.3	6.6	15.2	21.2	17.4	14.0	22.3	22.0	16.0	26.4	15.3	23.9	15.6	27.5	17.9	13.9	16.6	18.8	14.8	12.9	14.8	21.3	3.3	12.7	35.8	15.8	17.8	15.1	8.1	10.4	9.8	12.0	8.4	9.9	11.4	9.1	11.4	9.5	8.6	13.7	12.6	12.8	13.5	2.6	20.5	24.0	17.4	26.9	12.5	3.9	19.8	16.9	7.5	15.7	21.7	14.7	2.1	26.3	17.6	8.4	5.9	28.2	13.6	8.9	8.5	10.9	5.4	7.8	3.7	31.3	32.0	16.0	13.7	12.5	14.0	13.9	8.2	23.5	23.1	6.7	2.3	18.2	14.2	15.4	23.3	9.2	11.1	15.9	39.2	2.8	23.8	19.1	11.3	3.5	19.3	21.4	9.1	9.8	48.8	13.4	15.1	22.1	10.5	4.8	0.0	8.4	14.1	35.8	36.6	23.7	27.3	22.7	22.5	14.1	13.6	17.7
AGL		ENSG00000162688	"Amylo-alpha-1, 6-glucosidase, 4-alpha-glucanotransferase"	P35573	1	99850361-99924023	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted membrane proteins"	"Glycogen biosynthesis"	"Glycosidase, Glycosyltransferase, Hydrolase, Multifunctional enzyme, Transferase"	"Disease variant, Glycogen storage disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	5	"skeletal muscle: 257.6;tongue: 212.0"	"Cell type enhanced"	"Detected in all"		"Muller glia cells: 160.5;Theca cells: 159.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA028498, HPA054340"	Approved		Supported	"Nucleoplasm,Nuclear bodies,Cytosol"		NA	NA		450000	"Cluster 15: NK-cells - Transcription"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 5: Muller glia cells - Visual perception"	Nucleoplasm	"Nuclear bodies, Cytosol"	"HPA028498: AB_10600975, HPA054340: AB_2682455"	"unprognostic (2.90e-1)"	"unprognostic (5.34e-2)"	"unprognostic (3.99e-3)"	"unprognostic (2.18e-2)"	"unprognostic (6.46e-3)"	"unprognostic (5.13e-2)"	"unprognostic (1.12e-1)"	"unprognostic (1.92e-2)"	"unprognostic (9.37e-3)"	"unprognostic (1.11e-1)"	"unprognostic (8.10e-3)"	"unprognostic (7.61e-2)"	"prognostic favorable (1.73e-10)"	"unprognostic (6.38e-2)"	"unprognostic (2.89e-1)"	"unprognostic (1.15e-1)"	"unprognostic (7.13e-2)"	11.9	6.7	4.1	7.1	4.9	6.1	9.1	6.9	5.6	6.1	6.0	10.0	8.8	7.3	7.6	16.4	5.4	5.2	22.8	3.7	5.1	13.3	42.8	5.9	7.3	4.7	5.6	5.9	4.3	17.6	4.5	11.7	4.4	13.8	10.6	23.3	7.7	9.6	257.6	5.3	7.1	9.7	4.9	8.0	7.7	4.7	4.8	7.9	10.5	212.0	8.5	8.9	5.0	5.6	20.4	5.9	7.0	11.4	11.0	10.4	23.4	6.3	9.2	5.5	9.8	22.3	6.8	26.4	11.7	10.8	4.9	11.3	40.5	12.4	10.2	14.2	12.9	15.5	18.9	12.4	7.3	13.7	8.9	12.8	7.9	7.5	6.2	7.5	8.5	9.2	26.3	2.0	5.5	6.2	16.3	4.3	10.9	8.9	7.7	0.0	2.3	1.3	16.3	26.7	17.2	12.1	18.2	17.3	9.9	12.8	12.6	9.0	9.4	6.6	9.3	8.9	6.3	7.3	6.1	30.5	11.7	3.6	3.5	0.0	0.4	1.4	1.5	0.6	1.4	1.0	1.1	1.0	0.9	1.0	1.1	1.1	0.5	2.4	0.3	0.8	1.3	0.8	4.1	4.9	6.9	5.6	3.7	5.1	4.7	5.6	4.4	4.9	4.8	5.6	12.8	22.4	26.8	96.6	28.5	10.6	18.1	24.6	18.2	34.6	18.8	18.0	119.6	18.6	25.8	16.5	54.2	107.9	18.8	23.2	23.5	13.7	1.2	18.8	23.6	13.9	16.8	15.6	45.6	12.9	20.3	28.5	31.1	18.6	10.8	45.0	14.6	111.0	17.9	52.2	56.0	15.8	12.2	19.1	8.8	2.5	10.2	13.5	16.0	23.4	14.1	160.5	21.6	36.2	34.4	17.7	14.3	21.4	20.4	13.0	15.2	19.2	26.0	46.9	6.6	41.4	18.4	8.7	11.9	40.0	9.2	29.1	25.7	159.1	23.5	20.1
AGMAT	FLJ23384	ENSG00000116771	Agmatinase	Q9BSE5	1	15571699-15585051	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Putrescine biosynthesis, Spermidine biosynthesis"	Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"kidney: 133.9;liver: 62.1;skeletal muscle: 34.2"	"Cell type enriched"	"Detected in many"	7	"Proximal tubular cells: 306.8"	"Group enriched"	"Detected in all"	5	"colorectal cancer: 18.5;liver cancer: 25.3;renal cancer: 11.2;stomach cancer: 11.1"	"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in many"			"Group enriched"	"Detected in many"	4	"B-cells: 4.1;T-cells: 8.4"	"Cell line enhanced"	"Detected in many"		"CACO-2: 36.7;Hep G2: 92.6;RPMI-8226: 22.3"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"HPA026443, HPA028321"	Enhanced					NA	NA		240000	"Cluster 20: T-cells - T-cell receptor"	"Cluster 81: Kidney & Liver - Metabolism"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"			"HPA026443: AB_1844644, HPA028321: AB_10600779"	"unprognostic (2.27e-2)"	"unprognostic (3.45e-1)"	"unprognostic (1.79e-3)"	"unprognostic (3.60e-2)"	"unprognostic (8.72e-2)"	"unprognostic (6.66e-3)"	"unprognostic (9.48e-2)"	"unprognostic (1.19e-2)"	"unprognostic (2.06e-2)"	"unprognostic (2.37e-2)"	"unprognostic (1.13e-2)"	"unprognostic (2.35e-1)"	"prognostic favorable (5.13e-4)"	"unprognostic (4.43e-3)"	"unprognostic (2.44e-1)"	"unprognostic (1.33e-1)"	"unprognostic (2.45e-2)"	0.4	1.1	1.3	3.2	1.2	1.0	0.3	1.6	1.5	0.5	1.1	9.2	17.9	0.5	0.3	0.5	0.3	0.5	0.1	1.1	1.3	133.9	62.1	0.2	4.0	0.7	0.6	0.1	0.6	2.2	0.3	0.2	0.8	0.5	6.8	0.4	4.6	0.1	34.2	0.4	13.4	0.7	0.4	1.6	1.8	0.7	0.9	2.1	0.5	6.1	4.1	0.8	0.1	1.2	7.7	6.3	0.5	0.3	0.1	0.8	0.2	1.3	1.4	0.8	0.5	36.7	5.1	0.1	0.2	0.9	0.2	0.2	0.0	0.0	0.9	7.6	0.1	5.2	5.1	92.6	0.9	4.0	0.2	0.9	0.4	2.4	0.0	0.6	0.7	0.1	0.1	10.3	1.9	8.6	0.2	4.0	8.1	6.5	3.7	0.1	0.0	22.3	0.2	2.2	1.5	1.1	10.9	0.4	1.3	0.4	1.5	8.2	1.1	0.3	0.3	2.1	0.1	0.3	6.1	5.0	0.4	0.1	0.2	1.2	0.3	0.2	2.1	0.3	2.6	4.1	4.5	2.4	0.2	2.7	8.4	5.0	1.4	0.5	0.2	0.4	6.4	2.0	1.3	1.2	1.6	1.5	1.1	1.3	0.7	0.6	0.8	0.4	0.9	1.2	0.2	0.0	0.0	1.0	5.9	0.3	1.7	0.5	0.0	1.3	0.5	0.9	0.6	2.8	0.3	3.7	0.0	0.9	0.5	7.4	31.3	1.1	9.4	1.2	1.1	0.6	1.2	2.1	1.9	0.9	0.8	0.7	5.1	2.1	0.0	1.4	1.8	42.5	1.1	3.3	2.2	9.6	2.0	2.9	0.8	4.2	0.3	2.0	1.8	3.7	1.9	1.0	5.2	0.5	0.4	2.3	6.0	0.0	2.0	1.7	27.0	306.8	1.4	2.4	0.0	4.7	0.5	1.6	3.5	1.2	0.6	0.8	5.0	3.4	18.9	3.0
AGO2	"CASC7, EIF2C2, hAGO2, LINC00980, Q10"	ENSG00000123908	"Argonaute RISC catalytic component 2"	Q9UKV8	8	140520156-140635633	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"RNA-mediated gene silencing, Transcription, Transcription regulation, Translation regulation"	"Endonuclease, Hydrolase, Nuclease, Repressor, Ribonucleoprotein, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB019309, HPA067849"	Approved		Supported	"Cytosol,Cytoplasmic bodies"		NA	NA		65000	"Cluster 50: Neutrophils - Cellular senescence"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 44: Endometrium - Transcription"	"Cytoplasmic bodies"	Cytosol	"CAB019309: , HPA067849: "	"unprognostic (2.75e-2)"	"unprognostic (1.79e-3)"	"unprognostic (1.27e-1)"	"prognostic unfavorable (1.21e-4)"	"unprognostic (2.46e-1)"	"unprognostic (2.15e-1)"	"unprognostic (1.49e-3)"	"unprognostic (8.86e-2)"	"unprognostic (2.21e-1)"	"unprognostic (8.50e-2)"	"unprognostic (3.47e-2)"	"unprognostic (2.73e-1)"	"prognostic unfavorable (1.82e-5)"	"unprognostic (1.32e-1)"	"unprognostic (2.77e-1)"	"unprognostic (1.32e-1)"	"unprognostic (3.02e-1)"	7.8	4.1	6.9	6.2	11.5	11.3	5.9	12.4	9.2	6.9	2.4	8.6	3.2	7.7	5.9	6.3	8.3	5.1	7.3	5.7	11.4	5.9	3.8	9.1	6.1	14.0	10.1	9.5	5.0	7.0	8.0	5.8	11.3	5.8	4.0	6.8	4.8	4.6	17.5	8.5	6.2	5.2	5.9	5.2	6.6	3.3	10.8	7.6	6.3	9.1	5.4	6.6	6.7	19.2	18.9	15.2	15.3	17.6	9.9	11.5	12.9	11.6	8.4	5.1	6.3	17.0	5.5	21.5	14.1	11.3	5.5	12.4	26.2	12.5	11.3	12.2	13.7	25.2	28.7	11.0	8.9	10.5	8.2	7.9	11.0	14.1	14.6	7.0	12.0	13.4	26.9	13.2	16.8	28.5	18.2	8.3	11.4	12.9	26.3	18.5	12.9	9.7	6.5	19.3	18.0	13.0	18.1	6.1	12.8	15.7	15.7	15.1	16.9	8.8	24.5	14.0	18.9	11.5	4.0	14.7	6.5	18.7	13.2	0.7	0.8	0.2	0.8	0.7	0.9	0.4	0.8	0.7	0.7	0.7	0.8	0.8	2.2	0.8	0.8	0.5	0.7	0.6	6.9	11.5	12.4	9.2	5.7	11.4	14.0	10.1	11.3	5.9	10.8	19.2	30.8	22.4	25.1	50.3	40.7	21.9	74.8	5.7	17.6	26.5	34.5	24.5	22.2	8.6	22.6	14.7	43.8	46.5	63.1	14.8	7.9	25.6	21.2	73.1	54.3	37.8	24.2	122.9	32.6	18.2	21.5	44.3	28.5	129.4	17.1	31.6	27.5	14.6	14.9	42.1	36.4	19.1	2.0	26.0	48.5	14.9	37.3	53.0	5.4	32.8	36.0	26.1	32.0	51.3	83.2	37.9	18.6	46.3	46.6	115.0	12.7	9.4	15.4	29.7	32.9	65.9	44.5	3.1	4.0	31.8	23.9	79.1	49.1	12.0	19.3	100.1
AGO3	"EIF2C3, FLJ12765, hAGO3"	ENSG00000126070	"Argonaute RISC catalytic component 3"	Q9H9G7	1	35930718-36072500	"Enzymes, Predicted intracellular proteins"	"RNA-mediated gene silencing, Translation regulation"	"Endonuclease, Hydrolase, Nuclease, Ribonucleoprotein, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Oligodendrocytes: 155.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA048342, HPA067849, HPA075436"	Uncertain		Supported	"Nucleoplasm,Cytosol,Cytoplasmic bodies"		NA	NA			"Cluster 49: Eosinophils - Unknown function"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 52: Non-specific - Transcription"	"Cytoplasmic bodies"	"Nucleoplasm, Cytosol"	"HPA048342: AB_2680365, HPA067849: , HPA075436: AB_2686750"	"unprognostic (4.10e-2)"	"unprognostic (7.10e-2)"	"unprognostic (4.94e-2)"	"prognostic unfavorable (5.70e-4)"	"unprognostic (1.89e-2)"	"unprognostic (2.12e-2)"	"unprognostic (4.39e-4)"	"unprognostic (5.14e-2)"	"unprognostic (2.37e-3)"	"unprognostic (1.30e-1)"	"unprognostic (4.97e-2)"	"unprognostic (2.96e-2)"	"unprognostic (9.28e-3)"	"unprognostic (1.61e-1)"	"unprognostic (4.45e-2)"	"unprognostic (9.06e-2)"	"unprognostic (1.81e-1)"	3.6	2.8	4.5	2.6	8.4	7.4	2.9	6.9	6.9	3.3	7.4	3.0	1.4	2.9	3.2	2.7	2.7	1.9	3.4	4.6	6.9	2.5	4.3	3.5	3.0	8.5	7.2	3.7	2.9	3.3	6.2	3.5	7.4	3.2	2.0	5.1	2.5	2.2	3.2	3.8	2.5	2.7	6.8	2.8	2.8	5.6	8.0	3.3	3.2	4.4	3.1	3.0	3.0	14.0	6.6	4.4	5.5	4.4	7.5	4.6	6.7	5.2	5.4	7.9	8.4	4.9	7.2	7.2	6.5	5.4	9.1	5.3	5.9	3.8	10.5	9.9	3.7	8.8	8.3	3.7	4.0	8.5	7.2	2.2	3.4	11.4	7.2	3.1	6.8	7.4	9.8	10.2	7.0	2.5	6.5	4.6	9.6	3.4	7.8	7.5	7.4	7.1	2.5	6.2	6.7	4.2	9.4	2.3	3.3	8.3	3.5	3.5	5.4	5.5	13.9	4.9	6.4	5.6	10.5	9.9	2.8	5.4	5.4	9.8	4.3	13.2	4.9	4.1	3.1	6.5	3.1	3.4	4.8	6.4	4.4	4.3	13.0	5.4	6.1	4.2	3.4	2.3	4.5	8.4	6.9	6.9	4.6	6.9	8.5	7.2	7.4	6.8	8.0	14.0	32.2	86.6	43.2	80.6	32.6	38.7	35.9	17.8	35.3	69.1	26.1	17.8	19.1	17.2	23.0	25.8	112.6	11.8	36.6	13.2	0.0	15.8	56.0	26.6	43.0	33.8	46.7	18.7	103.8	12.2	14.8	42.3	19.9	35.6	55.9	31.6	36.8	24.7	16.4	42.1	101.1	16.0	20.3	31.7	45.1	76.7	37.9	29.7	23.2	70.3	36.9	35.2	27.8	141.8	155.9	17.3	9.1	41.3	24.7	41.1	15.0	8.8	17.5	89.6	19.7	64.4	29.9	37.5	22.1	20.0	33.5	12.9	35.3	31.0	17.5	27.9
AHCY	SAHH	ENSG00000101444	Adenosylhomocysteinase	P23526	20	34280268-34311802	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"One-carbon metabolism"	Hydrolase	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Proximal tubular cells: 275.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041225, HPA044675"	Approved		Supported	Cytosol		NA	NA		5000000	"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Cytosol		"HPA041225: AB_2677371, HPA044675: AB_2679041"	"unprognostic (3.35e-1)"	"unprognostic (2.17e-1)"	"unprognostic (2.41e-2)"	"unprognostic (1.32e-2)"	"unprognostic (7.74e-2)"	"unprognostic (3.15e-2)"	"unprognostic (7.34e-3)"	"unprognostic (1.10e-1)"	"unprognostic (8.88e-2)"	"unprognostic (2.61e-1)"	"unprognostic (4.21e-2)"	"unprognostic (1.24e-1)"	"unprognostic (5.27e-2)"	"unprognostic (2.06e-1)"	"unprognostic (1.20e-1)"	"unprognostic (1.88e-1)"	"unprognostic (2.93e-3)"	44.9	56.7	38.5	34.3	41.1	59.3	71.0	41.7	40.1	69.2	45.2	61.8	72.7	55.8	65.7	140.9	75.8	31.1	67.1	38.8	42.8	155.5	187.4	41.5	45.4	42.1	42.2	116.4	161.5	65.5	45.4	39.5	43.3	83.9	58.0	24.6	57.7	49.6	109.3	50.9	54.8	43.6	42.5	39.9	75.8	82.0	42.5	51.7	95.1	63.6	55.9	59.3	66.9	44.6	270.8	345.9	143.6	254.7	163.6	174.8	164.4	108.1	153.9	235.5	186.1	942.0	226.2	417.0	188.0	139.4	152.0	301.2	340.7	606.4	150.3	55.6	207.6	503.9	157.3	612.7	175.5	238.1	158.3	364.1	271.2	146.9	233.8	125.9	162.9	152.0	250.1	102.7	126.8	285.2	313.3	224.2	185.0	343.0	332.7	231.8	364.6	294.1	212.7	188.3	247.8	164.8	216.1	252.6	364.5	112.8	380.3	217.9	104.5	203.3	215.5	104.1	207.6	151.7	239.0	252.3	150.2	144.4	111.3	9.0	32.9	1.0	8.9	60.7	15.0	20.5	13.0	11.5	48.8	19.4	13.8	16.1	2.7	11.6	40.8	55.1	16.4	28.2	38.5	41.1	41.7	40.1	38.8	42.8	42.1	42.2	43.3	42.5	42.5	44.6	13.2	41.7	23.2	5.5	35.3	36.7	88.2	106.1	68.9	11.7	77.6	82.0	47.8	44.3	43.2	27.6	0.0	109.0	31.4	36.6	58.7	73.5	76.5	30.9	110.6	27.1	21.0	60.8	9.0	82.4	165.3	35.6	83.6	42.8	21.0	42.8	19.6	70.4	115.7	11.8	8.4	73.5	30.5	52.2	32.4	187.4	42.6	34.5	26.6	2.8	26.4	42.4	5.2	5.0	16.4	60.4	41.2	40.6	66.2	95.8	51.4	275.0	17.9	15.2	13.1	27.8	34.6	43.5	45.3	100.8	39.5	91.9	19.8	84.3	117.1	82.6
AHCYL2	"IRBIT2, KIAA0828, long-IRBIT"	ENSG00000158467	"Adenosylhomocysteinase like 2"	Q96HN2	7	129225023-129430211	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"One-carbon metabolism"	Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	5	"choroid plexus: 488.0;intestine: 177.4"	"Cell type enhanced"	"Detected in all"		"Astrocytes: 567.4;Distal enterocytes: 334.0;Excitatory neurons: 131.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enriched"	"Detected in all"	8	"HDLM-2: 235.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA053128	Uncertain		Approved	Nucleoplasm,Cytosol		NA	NA		500000	"Cluster 40: NK-cells - Unknown function"	"Cluster 88: Choroid plexus - Transmembrane transport"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Cytosol	Nucleoplasm	"HPA053128: AB_2682050"	"unprognostic (1.57e-1)"	"unprognostic (2.91e-1)"	"unprognostic (8.52e-3)"	"unprognostic (1.71e-3)"	"unprognostic (7.44e-3)"	"prognostic favorable (4.17e-4)"	"unprognostic (8.85e-2)"	"unprognostic (1.43e-1)"	"unprognostic (3.35e-1)"	"unprognostic (2.74e-1)"	"unprognostic (1.63e-1)"	"unprognostic (6.79e-3)"	"prognostic favorable (1.08e-7)"	"unprognostic (4.70e-3)"	"unprognostic (2.46e-1)"	"unprognostic (7.21e-2)"	"unprognostic (2.62e-1)"	7.1	10.2	25.4	15.6	35.9	3.2	8.4	27.2	34.4	10.6	488.0	157.4	57.8	9.1	7.2	9.6	7.4	55.8	4.6	47.3	32.5	28.5	7.7	65.8	10.8	30.3	28.1	11.4	13.7	19.2	21.3	12.1	22.5	9.3	177.4	57.8	30.6	7.0	37.3	24.3	38.6	11.8	27.8	7.0	41.9	10.5	39.0	9.4	42.6	27.7	9.4	16.1	7.6	25.2	8.7	13.5	25.4	15.3	6.8	9.9	5.4	6.8	9.4	7.5	6.6	7.9	5.7	5.3	6.9	7.4	15.9	6.0	12.8	10.7	8.3	235.7	16.0	12.4	14.5	6.4	4.0	9.3	15.4	9.1	13.5	6.0	9.1	12.7	15.1	10.1	5.8	28.7	9.9	8.2	13.7	12.1	12.7	8.6	9.5	9.0	6.9	14.4	15.0	11.5	11.6	7.3	15.5	6.5	9.3	21.0	6.1	6.6	8.6	6.4	3.6	16.9	7.2	12.0	14.6	7.2	16.4	9.8	9.9	0.1	0.4	0.7	0.3	0.9	0.4	0.3	0.5	0.2	0.4	0.1	0.4	0.1	0.1	1.3	0.4	0.1	1.8	0.2	25.4	35.9	27.2	34.4	47.3	32.5	30.3	28.1	22.5	27.8	39.0	25.2	4.7	60.9	98.6	567.4	9.3	15.6	5.1	7.2	31.3	10.8	4.8	4.3	7.3	18.6	16.4	5.5	6.2	12.5	2.2	334.0	11.7	4.5	61.7	5.9	5.3	5.2	9.1	3.4	131.2	5.3	2.9	3.6	30.1	8.7	5.7	6.0	5.7	6.0	4.7	5.0	115.5	32.9	6.1	10.0	6.1	30.6	4.1	7.3	24.9	99.3	7.7	91.0	2.1	127.2	77.5	6.2	71.8	6.8	7.4	6.2	27.0	17.1	8.7	5.9	6.6	5.1	4.3	5.1	2.3	17.8	9.8	15.2	7.3	8.3	46.1	15.1
AICDA	"AID, ARP2, CDA2, HIGM2"	ENSG00000111732	"Activation induced cytidine deaminase"	Q9GZX7	12	8602170-8612867	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"mRNA processing"	Hydrolase	"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	10	"lymphoid tissue: 15.4"	"Cell type enhanced"	"Detected in single"		"Proximal enterocytes: 2.6"	"Cancer enhanced"	"Detected in single"		"testis cancer: 0.8"	"Low region specificity"	"Detected in single"			"Group enriched"	"Detected in some"	5	"memory B-cell: 1.9;naive B-cell: 3.8"	"Lineage enriched"	"Detected in single"	6	"B-cells: 3.8"	"Group enriched"	"Detected in some"	7	"Daudi: 142.5;U-698: 118.4"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"									NA	NA			"Cluster 19: B-cells - Humoral immune response"	"Cluster 16: Immune cells - Immune response"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 50: Fibroblasts - ECM organization"				"unprognostic (2.71e-2)"	"unprognostic (1.39e-2)"		"unprognostic (7.76e-2)"	"unprognostic (1.68e-1)"	"unprognostic (8.73e-3)"		"unprognostic (1.11e-1)"	"unprognostic (4.05e-2)"	"unprognostic (9.69e-2)"	"unprognostic (1.96e-2)"		"unprognostic (4.04e-6)"	"unprognostic (8.82e-2)"	"unprognostic (1.28e-1)"	"unprognostic (4.21e-1)"	"unprognostic (4.65e-1)"	0.2	0.1	0.4	3.7	0.3	0.6	0.0	1.2	0.6	0.0	0.1	0.2	0.2	0.2	0.2	0.2	0.0	0.5	0.3	0.3	0.1	0.0	0.1	0.2	15.4	0.2	0.3	0.0	0.1	0.0	0.0	0.3	0.3	0.0	0.1	0.2	0.3	0.0	1.4	0.3	0.8	0.0	0.0	0.7	0.2	0.2	0.3	0.4	0.2	0.0	12.0	0.1	0.1	0.6	0.1	0.0	0.1	0.2	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.1	142.5	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.1	5.3	0.2	0.1	0.0	2.0	19.8	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.2	0.0	0.0	0.0	0.2	0.2	0.0	0.2	0.2	0.5	0.1	0.2	0.1	0.1	0.0	0.2	0.1	0.1	1.3	0.1	0.1	0.6	0.1	0.4	0.5	0.1	0.0	0.1	118.4	0.0	0.3	0.1	0.5	0.2	0.1	0.1	0.1	0.0	1.9	0.1	0.0	0.1	3.8	0.1	0.1	0.6	0.1	0.1	0.2	0.1	0.2	0.4	0.3	1.2	0.6	0.3	0.1	0.2	0.3	0.3	0.0	0.3	0.6	0.2	0.0	0.6	0.0	0.9	0.3	0.6	0.0	0.0	0.4	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.1	0.2	0.0	0.0	0.0	0.0	0.3	0.9	0.0	0.6	0.0	0.0	0.4	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.8	0.1	0.0	0.4	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	2.6	0.2	0.0	0.7	0.0	0.8	0.1	0.0	0.4	0.0	0.1	0.0	0.3	0.0	0.1	0.3
ALG13	"CDG1S, CXorf45, FLJ23018, GLT28D1, MDS031, TDRD13, YGL047W"	ENSG00000101901	"ALG13 UDP-N-acetylglucosaminyltransferase subunit"	Q9NP73	X	111665811-111760649	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"Ubl conjugation pathway"	"Glycosyltransferase, Hydrolase, Multifunctional enzyme, Protease, Thiol protease, Transferase"	"Congenital disorder of glycosylation, Disease variant, Epilepsy"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA002853, HPA005498"	Approved		Approved	Vesicles,Cytosol		NA	NA		11000000	"Cluster 34: Basophils - Unknown function"	"Cluster 34: Non-specific - Transcription"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 24: Non-specific - Transcription regulation"	Vesicles	Cytosol	"HPA002853: AB_1078131, HPA005498: "	"unprognostic (4.13e-1)"	"unprognostic (1.80e-1)"	"unprognostic (2.45e-2)"	"unprognostic (1.51e-1)"	"unprognostic (6.97e-2)"	"unprognostic (6.14e-2)"	"unprognostic (2.74e-1)"	"unprognostic (6.55e-3)"	"unprognostic (2.26e-2)"	"unprognostic (3.39e-3)"	"unprognostic (1.73e-2)"	"unprognostic (4.62e-3)"	"prognostic unfavorable (1.10e-6)"	"unprognostic (1.19e-1)"	"unprognostic (1.29e-2)"	"unprognostic (9.70e-2)"	"unprognostic (2.45e-2)"	15.1	17.9	10.5	18.8	11.7	16.6	18.3	11.5	19.0	17.2	12.3	18.2	13.7	16.1	20.5	14.7	15.4	16.4	13.2	10.2	13.8	21.0	23.8	13.8	23.4	12.6	12.1	15.8	14.7	23.4	17.9	14.1	13.3	17.7	19.4	11.8	15.6	13.4	9.2	19.4	17.3	17.5	11.4	18.5	15.5	17.4	11.8	17.3	18.2	9.9	20.1	21.3	14.7	16.6	22.3	24.4	21.8	13.8	13.8	19.6	12.3	17.7	18.3	22.4	27.5	24.9	23.1	19.5	33.0	24.7	46.5	12.6	26.1	12.5	23.5	14.4	17.6	10.7	26.1	28.4	20.3	19.5	40.5	23.6	22.8	18.0	38.6	23.3	24.8	21.8	23.9	53.5	22.5	55.8	16.4	17.6	19.9	66.3	33.6	12.8	13.9	26.7	36.6	34.0	13.1	19.1	25.2	15.2	16.3	21.7	13.6	18.5	16.7	19.2	9.7	24.9	34.4	25.8	47.1	31.5	20.5	25.5	15.2	39.5	15.8	16.6	9.5	16.3	9.3	10.6	10.6	9.2	18.5	12.1	13.0	10.8	3.0	4.6	12.9	9.5	14.6	9.6	10.5	11.7	11.5	19.0	10.2	13.8	12.6	12.1	13.3	11.4	11.8	16.6	50.9	16.0	30.8	33.6	127.9	35.2	65.8	53.5	33.6	15.1	33.9	31.6	18.7	22.8	36.0	18.4	10.4	27.3	73.9	39.2	45.0	37.4	21.1	48.2	31.1	37.4	26.5	27.1	64.7	52.1	39.1	34.6	37.2	47.9	109.8	15.7	28.2	28.4	42.5	11.8	57.4	49.0	46.8	39.2	52.3	9.4	21.5	56.1	28.4	83.4	41.8	16.0	29.9	41.7	77.5	58.0	55.6	16.1	60.4	46.9	38.5	55.5	35.3	16.5	26.3	38.7	46.2	32.6	22.4	26.5	35.4	48.7	71.1	28.8	32.8	64.6
ALLC	ALC	ENSG00000151360	Allantoicase	Q8N6M5	2	3658200-3702671	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		Hydrolase		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Tissue enriched"	"Detected in single"	17	"testis: 16.5"	"Cell type enriched"	"Detected in some"	4	"Early spermatids: 140.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	19	"U-266/84: 6.1"	"Not detected"	"Not detected"													NA	NA				"Cluster 83: Testis - Spermatogenesis"	"Cluster 16: U-266 - Nucleosome"	"Cluster 29: Early spermatids - Spermatogenesis"							"unprognostic (5.47e-2)"	"unprognostic (3.24e-2)"		"unprognostic (2.91e-3)"	"unprognostic (4.75e-1)"	"unprognostic (2.17e-1)"	"unprognostic (1.06e-1)"	"unprognostic (9.83e-3)"	"unprognostic (5.42e-2)"	"unprognostic (1.74e-4)"	"unprognostic (1.01e-2)"	"unprognostic (2.73e-1)"			0.0	0.1	0.1	0.0	0.2	0.0	0.0	0.1	0.1	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.1	0.1	0.1	0.4	0.6	0.0	0.0	0.1	0.1	0.2	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	16.5	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	140.7	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.5	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	33.2	3.4	0.1	1.8	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	22.2	0.0	0.0	0.0	0.5	0.0	0.0	13.1	0.0	0.1	5.1	1.5	0.0	0.0	0.0	0.0	0.1	0.0	0.0
ALPG	"ALPPL2, GCAP"	ENSG00000163286	"Alkaline phosphatase, germ cell"	P10696	2	232406844-232410714	"Enzymes, FDA approved drug targets, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"		Hydrolase	"FDA approved drug targets"	"Evidence at protein level"	"No human protein/transcript evidence"	"Evidence at transcript level"	"Evidence at protein level"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cancer enhanced"	"Detected in many"		"endometrial cancer: 49.1;testis cancer: 64.8"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"CAPAN-2: 33.9;HaCaT: 24.9;SuSa: 38.3"									"CAB020698, HPA038764, HPA038765, HPA051699"	Approved		Approved	"Plasma membrane"	"Intracellular and membrane"	NA	NA					"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 44: Endometrium - Transcription"	"Plasma membrane"		"CAB020698: , HPA038764: AB_2676194, HPA038765: AB_2676195, HPA051699: AB_2681577"		"unprognostic (1.39e-1)"	"unprognostic (6.63e-3)"	"unprognostic (1.27e-2)"		"unprognostic (2.89e-1)"		"unprognostic (1.46e-1)"		"unprognostic (1.26e-1)"	"unprognostic (1.69e-3)"			"unprognostic (1.65e-1)"	"unprognostic (2.67e-1)"		"unprognostic (6.72e-3)"	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.4	0.0	0.1	0.0	0.3	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	6.7	0.0	0.0	0.0	0.0	0.7	33.9	0.0	0.0	0.0	0.0	24.9	0.2	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	3.3	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.5	0.3	0.0	38.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0
ALPI	IAP	ENSG00000163295	"Alkaline phosphatase, intestinal"	P09923	2	232456125-232460753	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	138	"intestine: 141.2"	"Cell type enriched"	"Detected in some"	8	"Proximal enterocytes: 290.1"	"Cancer enhanced"	"Detected in many"		"liver cancer: 4.7;renal cancer: 3.6"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	13	"CACO-2: 4.8"									"HPA038764, HPA038765, HPA051699"	Supported		Approved	"Plasma membrane"	"Intracellular and membrane"	NA	NA		130000		"Cluster 56: Intestine - Transmembrane transport"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 45: Enterocytes - Digestion"	"Plasma membrane"		"HPA038764: AB_2676194, HPA038765: AB_2676195, HPA051699: AB_2681577"			"unprognostic (1.01e-1)"	"unprognostic (7.71e-2)"			"unprognostic (4.14e-2)"			"unprognostic (1.47e-1)"	"unprognostic (9.57e-4)"		"unprognostic (8.07e-2)"	"unprognostic (1.71e-1)"	"unprognostic (9.99e-2)"			0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.4	141.2	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.8	0.0	0.0	0.0	0.0	0.0	128.1	0.6	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	4.8	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	33.5	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	18.0	0.0	0.0	0.0	290.1	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.5	0.0
ALPL	"HOPS, TNALP, TNAP, TNSALP"	ENSG00000162551	"Alkaline phosphatase, biomineralization associated"	P05186	1	21509397-21578410	"Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	Biomineralization	Hydrolase	"Cancer-related genes, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"adrenal gland: 60.7"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 2: 92.0;Breast myoepithelial cells: 32.4;Glandular and luminal cells: 43.3;Hepatic stellate cells: 40.7;Hepatocytes: 30.1;Proximal tubular cells: 43.9;Rod photoreceptor cells: 34.2"	"Cancer enhanced"	"Detected in all"		"testis cancer: 199.6"	"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in some"	90	"neutrophil: 379.1"	"Lineage enriched"	"Detected in many"	139	"granulocytes: 379.1"	"Cell line enhanced"	"Detected in many"		"HSkMC: 176.9;hTEC/SVTERT24-B: 141.2;LHCN-M2: 103.7;NTERA-2: 41.2;SCLC-21H: 88.2;SuSa: 48.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA007105, HPA008765, CAB020829"	Enhanced		Approved	Cytosol	"Intracellular and membrane"	NA	NA		13000000	"Cluster 9: Neutrophils - Innate immune response"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 11: Alveolar cells - Smell perception"	Cytosol		"CAB020829: , HPA007105: AB_1078137, HPA008765: AB_1078138"	"unprognostic (3.89e-2)"	"unprognostic (1.27e-1)"	"unprognostic (5.57e-2)"	"unprognostic (1.19e-1)"	"prognostic unfavorable (7.57e-4)"	"unprognostic (3.05e-3)"	"unprognostic (6.50e-3)"	"unprognostic (1.01e-1)"	"prognostic unfavorable (7.08e-4)"	"unprognostic (1.17e-2)"	"unprognostic (2.48e-3)"	"unprognostic (1.74e-1)"	"unprognostic (7.28e-2)"	"unprognostic (1.73e-2)"	"unprognostic (2.27e-1)"	"unprognostic (9.70e-3)"	"unprognostic (2.58e-1)"	24.7	60.7	19.5	27.9	16.7	4.2	22.9	18.0	25.8	3.4	26.0	5.0	2.6	5.8	1.3	4.1	10.4	3.9	16.4	17.8	18.8	45.7	56.3	54.9	6.4	21.7	17.7	2.8	3.9	3.3	9.3	3.1	22.4	7.1	1.5	18.8	6.4	9.2	1.1	4.2	7.5	3.5	18.2	45.5	4.7	4.2	21.3	1.5	8.6	5.7	5.9	9.7	3.3	17.3	0.0	0.2	5.2	0.2	0.8	6.6	11.4	0.4	2.4	0.9	1.5	1.0	0.0	2.4	7.7	0.0	0.1	0.1	31.3	0.2	0.6	0.0	2.1	0.0	3.5	3.9	1.8	0.0	0.7	176.9	0.0	141.2	0.5	0.0	0.0	0.0	0.2	0.0	103.7	0.0	0.1	0.0	41.2	0.2	0.0	0.0	3.8	0.2	0.1	0.0	88.2	1.2	0.0	0.1	0.3	48.1	0.2	0.0	0.0	5.2	4.3	0.1	0.0	0.3	0.0	0.1	0.9	0.0	0.8	0.0	0.0	4.2	0.0	0.0	0.0	2.7	0.0	0.0	0.0	0.5	0.0	0.0	379.1	0.0	0.0	0.0	0.0	0.1	19.5	16.7	18.0	25.8	17.8	18.8	21.7	17.7	22.4	18.2	21.3	17.3	25.9	3.2	92.0	0.3	3.8	0.1	0.6	8.2	0.6	2.5	6.6	32.4	2.1	2.8	17.6	0.0	0.0	0.1	0.1	0.0	7.9	0.0	1.4	15.0	2.2	26.5	0.0	5.7	0.9	0.0	0.3	6.8	0.0	43.3	7.6	10.6	40.7	30.1	0.1	1.7	0.3	0.0	12.2	1.6	0.3	8.5	0.3	1.0	0.0	18.7	0.0	6.0	0.0	6.0	0.2	0.0	0.0	0.0	0.3	1.7	0.0	43.9	3.6	34.2	0.0	0.3	5.1	0.4	14.0	0.2	0.4	1.5	1.0	8.0	0.0	0.3
ALPP	"PALP, PLAP"	ENSG00000163283	"Alkaline phosphatase, placental"	P05187	2	232378724-232382889	"Cancer-related genes, Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"		Hydrolase	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	7	"cervix: 17.8;placenta: 34.6"	"Group enriched"	"Detected in some"	4	"Alveolar cells type 1: 12.8;Glandular and luminal cells: 5.0;Syncytiotrophoblasts: 6.7"	"Cancer enhanced"	"Detected in many"		"endometrial cancer: 15.3"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	6	"HaCaT: 381.0;SiHa: 103.6"									"CAB026327, HPA038764, HPA038765, HPA051699"	Enhanced		Approved	"Plasma membrane"	"Intracellular and membrane"	NA	NA				"Cluster 28: Placenta - Pregnancy"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 44: Endometrium - Transcription"	"Plasma membrane"		"CAB026327: , HPA038764: AB_2676194, HPA038765: AB_2676195, HPA051699: AB_2681577"		"unprognostic (4.86e-2)"	"unprognostic (5.19e-3)"	"unprognostic (6.67e-3)"		"unprognostic (2.60e-1)"		"unprognostic (2.44e-3)"		"unprognostic (1.26e-2)"	"prognostic unfavorable (4.33e-4)"	"unprognostic (1.44e-1)"		"unprognostic (4.09e-1)"	"unprognostic (2.12e-1)"		"unprognostic (1.27e-2)"	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.1	17.8	0.0	0.0	0.0	0.2	0.0	0.0	1.6	0.0	0.0	0.1	0.0	0.0	0.0	3.9	0.0	0.1	0.0	0.0	0.0	0.0	0.0	34.6	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.6	0.0	0.0	0.0	0.0	0.0	5.2	0.0	0.0	0.0	0.0	0.5	42.9	0.0	0.1	0.0	0.1	381.0	0.0	0.0	0.0	0.0	0.2	0.0	7.5	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.1	3.2	0.0	0.0	0.0	0.0	0.0	2.0	0.0	0.0	103.6	35.3	0.0	3.5	0.0	0.0	0.0	0.0	2.7	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.0	0.1	0.0	0.1	0.0	0.0	0.1	0.1	12.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	1.8	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	1.6	0.4	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	5.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.1	0.1	0.1	0.0	0.0	6.7	0.1	0.2	0.0	0.0
AMDHD1	MGC35366	ENSG00000139344	"Amidohydrolase domain containing 1"	Q96NU7	12	95943331-95968720	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Histidine metabolism"	Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 60.7;skeletal muscle: 27.3"	"Cell type enriched"	"Detected in many"	4	"Hepatocytes: 132.5"	"Cancer enriched"	"Detected in many"	14	"liver cancer: 23.4"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"A-431: 46.6;HMC-1: 47.7;Karpas-707: 61.2;SiHa: 40.5;SK-BR-3: 46.1;U-266/70: 49.1;U-266/84: 62.8"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"HPA039720, HPA040149"	Uncertain		Approved	"Nucleoplasm,Plasma membrane,Cytosol"		No	NA		1400000	"Cluster 27: Non-specific - Gene expression"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 15: Hepatocytes - Hemostasis"	Cytosol	"Nucleoplasm, Plasma membrane"	"HPA039720: AB_10672967, HPA040149: "	"unprognostic (4.81e-2)"	"unprognostic (2.91e-1)"	"unprognostic (1.53e-1)"	"unprognostic (2.09e-2)"	"unprognostic (1.80e-2)"	"unprognostic (2.88e-2)"	"unprognostic (2.33e-2)"	"unprognostic (6.62e-3)"	"unprognostic (1.06e-1)"	"unprognostic (7.01e-2)"	"unprognostic (3.35e-3)"	"unprognostic (1.17e-1)"	"unprognostic (4.63e-3)"	"unprognostic (3.98e-2)"	"unprognostic (1.70e-1)"	"unprognostic (4.08e-3)"	"unprognostic (2.61e-1)"	1.8	11.7	8.2	6.5	11.2	6.1	0.4	5.5	11.8	0.3	6.9	1.4	5.1	3.0	0.4	2.6	0.7	1.7	1.7	7.6	6.9	5.8	60.7	2.3	4.4	15.5	8.6	1.4	3.3	0.7	0.5	2.0	9.5	2.8	0.2	1.8	2.0	0.2	27.3	5.8	5.0	0.6	2.7	5.9	4.8	13.1	8.0	0.6	0.9	0.9	0.4	0.3	0.2	15.4	46.6	9.5	0.8	5.8	0.0	0.0	10.0	1.5	0.5	0.7	1.4	3.9	5.8	4.0	4.2	0.0	2.6	8.2	0.3	0.0	0.3	16.0	1.7	4.2	7.9	9.4	0.0	5.9	47.7	0.0	0.4	0.8	0.1	0.2	0.3	3.9	2.7	61.2	0.0	6.8	3.7	10.8	4.4	1.8	2.2	7.8	0.3	5.3	0.0	4.3	4.9	6.9	40.5	46.1	5.2	0.2	4.6	8.4	0.0	5.8	19.1	8.0	5.4	49.1	62.8	6.3	3.8	12.2	6.9	0.2	0.6	1.7	0.5	0.6	0.4	0.6	0.2	0.6	0.5	0.3	0.3	0.4	0.4	2.3	1.8	0.2	0.1	0.5	8.2	11.2	5.5	11.8	7.6	6.9	15.5	8.6	9.5	2.7	8.0	15.4	1.1	0.0	0.5	0.3	2.0	0.4	0.2	0.0	0.0	0.1	1.1	1.0	0.6	1.5	0.6	3.7	0.0	0.9	1.7	0.0	3.9	0.2	0.9	0.1	0.0	0.8	1.8	8.0	0.7	1.1	0.1	0.1	0.0	0.0	0.0	0.2	8.6	132.5	4.4	1.7	0.3	0.1	0.0	5.7	1.3	0.1	0.3	1.8	3.6	0.0	0.7	1.8	2.1	4.0	2.0	0.2	0.0	0.0	0.7	0.0	0.4	31.0	0.0	0.0	0.0	0.8	0.0	1.5	1.9	0.0	0.3	0.3	1.4	0.3	0.4	0.1
AMDHD2	CGI-14	ENSG00000162066	"Amidohydrolase domain containing 2"	Q9Y303	16	2520357-2531422	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Carbohydrate metabolism"	Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 64.1;Hofbauer cells: 127.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041184, HPA041321"	Enhanced		Approved	Nucleoli,Cytosol		No	No		110000	"Cluster 31: Non-specific - Inflammatory response"	"Cluster 71: Testis - DNA repair"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 66: Spermatocytes - Spermatogenesis"	"Nucleoli, Cytosol"		"HPA041184: AB_10803998, HPA041321: AB_10795588"	"unprognostic (1.20e-1)"	"prognostic favorable (5.19e-4)"	"unprognostic (7.86e-3)"	"unprognostic (2.39e-1)"	"unprognostic (1.70e-2)"	"unprognostic (1.37e-1)"	"unprognostic (1.48e-2)"	"unprognostic (2.14e-1)"	"unprognostic (3.28e-1)"	"unprognostic (1.66e-1)"	"unprognostic (1.88e-2)"	"unprognostic (8.68e-2)"	"unprognostic (1.30e-1)"	"unprognostic (8.37e-2)"	"unprognostic (4.71e-2)"	"unprognostic (1.66e-1)"	"unprognostic (1.20e-1)"	14.7	20.2	2.7	5.6	3.4	5.5	13.7	2.4	4.8	12.9	2.8	12.6	9.1	12.2	0.7	10.6	10.8	4.3	7.0	3.3	2.0	18.7	13.8	12.2	7.9	3.4	3.1	9.3	8.2	3.1	8.5	4.5	2.8	10.8	0.8	0.4	13.7	3.2	8.8	15.4	17.3	1.4	2.4	26.1	9.9	37.0	4.2	3.7	12.1	1.3	1.9	10.9	9.8	4.3	9.6	11.7	3.1	6.7	3.5	2.5	15.4	9.0	3.4	7.4	9.0	8.7	16.9	4.4	4.4	1.7	14.0	9.3	1.7	2.5	0.2	6.0	7.8	6.6	13.8	12.7	12.9	4.6	16.8	6.6	2.5	4.9	0.8	1.8	4.0	12.5	14.3	9.3	3.1	19.0	7.8	11.7	6.7	0.8	10.1	29.6	4.4	14.0	2.4	5.4	10.3	9.9	5.7	13.1	21.4	0.5	13.1	1.5	6.9	7.4	11.3	14.3	4.7	15.7	14.1	8.9	8.1	9.5	7.4	9.5	3.3	9.6	4.8	7.5	3.8	6.4	3.5	2.9	1.2	4.1	2.7	2.4	8.4	3.1	9.9	9.9	3.8	2.9	2.7	3.4	2.4	4.8	3.3	2.0	3.4	3.1	2.8	2.4	4.2	4.3	8.0	3.2	11.6	1.3	16.7	8.9	5.2	3.2	4.0	10.3	13.6	11.6	2.5	10.0	5.2	5.5	6.2	16.7	16.4	16.2	5.9	30.3	64.1	6.0	4.1	8.3	12.6	11.0	1.6	17.0	27.1	9.9	7.1	5.2	7.0	13.1	18.2	11.9	127.0	23.5	1.1	12.8	6.1	47.6	12.1	27.4	10.5	28.9	19.6	1.9	26.9	11.0	20.6	0.5	0.8	14.5	26.4	6.4	11.5	4.1	59.4	48.9	9.1	13.0	0.0	7.8	8.4	52.9	16.3	5.1	8.9	27.9	13.2	7.6	10.4	4.2
AMPD1	"MAD, MADA"	ENSG00000116748	"Adenosine monophosphate deaminase 1"	P23109	1	114673090-114695618	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"Nucleotide metabolism"	Hydrolase	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	23	"skeletal muscle: 559.2;tongue: 211.4"	"Group enriched"	"Detected in some"	6	"Plasma cells: 43.8;Skeletal myocytes: 13.3"	"Cancer enhanced"	"Detected in single"		"head and neck cancer: 0.8"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	29	"U-266/70: 8.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA026478, HPA028080"	Enhanced				"Intracellular and membrane"	NA	NA		38000	"Cluster 37: B-cells - Transcription"	"Cluster 33: Striated muscle - Muscle contraction"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 37: Myocytes - Muscle contraction"			"HPA026478: AB_10599969, HPA028080: AB_10600776"	"unprognostic (1.98e-3)"	"unprognostic (1.43e-3)"	"unprognostic (8.75e-3)"	"unprognostic (8.03e-2)"		"unprognostic (1.95e-2)"		"unprognostic (5.61e-3)"	"unprognostic (8.21e-2)"	"unprognostic (4.29e-3)"	"unprognostic (2.48e-1)"	"unprognostic (2.26e-1)"	"unprognostic (1.36e-5)"	"unprognostic (1.68e-1)"	"unprognostic (3.70e-1)"	"unprognostic (3.36e-1)"	"unprognostic (4.02e-1)"	0.1	0.1	0.0	0.5	0.0	0.3	3.0	0.0	0.0	0.2	0.0	5.6	16.4	0.2	0.0	5.8	0.4	0.2	0.1	0.0	0.0	0.0	0.1	0.7	0.5	0.0	0.0	1.0	0.1	0.3	0.0	0.0	0.0	3.5	5.5	0.0	4.4	0.9	559.2	0.0	7.5	0.1	0.0	1.6	3.7	0.1	0.0	0.4	0.1	211.4	2.9	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.7	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.7	0.5	0.0	0.0	0.0	0.0	0.1	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.6	0.0	0.1	0.1	0.0	0.0	0.6	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.4	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	1.5	0.0	0.0	1.8	1.9	0.0	0.0	0.0	3.0	4.2	0.0	0.0	0.0	43.8	0.0	0.0	0.0	0.0	0.0	0.0	13.3	0.2	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.1
AMPD2	SPG63	ENSG00000116337	"Adenosine monophosphate deaminase 2"	Q01433	1	109616104-109632051	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"Nucleotide metabolism"	Hydrolase	"Disease variant, Hereditary spastic paraplegia, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Cone photoreceptor cells: 62.6;Horizontal cells: 52.2;Macrophages: 52.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"classical monocyte: 19.4;eosinophil: 19.2;intermediate monocyte: 40.7;myeloid DC: 18.9;neutrophil: 61.1;non-classical monocyte: 44.6"	"Group enriched"	"Detected in all"	5	"dendritic cells: 18.9;granulocytes: 61.1;monocytes: 44.6"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA027137, HPA045760"	Approved		Enhanced	Cytosol		NA	NA		230000	"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 26: Pituitary gland - Hormone signaling"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 41: Macrophages - Immune response"	Cytosol		"HPA027137: AB_2672129, HPA045760: AB_2679443"	"unprognostic (2.78e-2)"	"unprognostic (1.21e-1)"	"unprognostic (1.50e-1)"	"unprognostic (1.43e-3)"	"unprognostic (9.01e-2)"	"unprognostic (5.25e-2)"	"unprognostic (3.91e-3)"	"unprognostic (1.71e-1)"	"unprognostic (4.02e-1)"	"unprognostic (1.23e-1)"	"unprognostic (8.10e-3)"	"unprognostic (1.50e-1)"	"prognostic unfavorable (3.78e-10)"	"unprognostic (9.16e-2)"	"unprognostic (2.03e-1)"	"unprognostic (1.35e-2)"	"unprognostic (1.60e-1)"	9.3	17.5	31.2	12.0	41.6	28.6	7.4	22.9	34.7	13.1	36.6	7.5	10.7	11.5	4.1	7.2	13.1	8.8	7.2	34.8	37.0	10.5	16.2	13.4	7.6	34.7	31.7	17.5	10.0	9.4	45.8	7.6	33.6	10.8	4.1	10.5	9.2	12.0	3.3	8.5	10.8	7.1	27.9	19.0	8.6	4.3	39.3	4.9	10.6	1.5	5.9	7.5	11.4	29.0	20.6	22.5	20.5	20.1	18.0	18.7	8.6	25.6	57.2	24.9	25.0	19.1	7.0	10.5	21.8	39.1	16.0	11.3	15.8	20.0	13.4	13.0	20.7	46.0	15.6	19.3	24.9	15.7	45.7	23.3	13.2	32.5	24.1	28.2	26.7	17.0	17.4	13.0	16.0	23.2	26.7	29.0	20.6	17.1	22.9	18.6	15.8	17.3	24.2	8.7	19.3	22.4	17.4	19.8	24.6	5.7	10.4	16.2	16.7	27.7	39.0	33.7	25.4	48.4	28.4	12.1	50.8	25.9	35.1	0.5	19.4	19.2	5.3	40.7	8.0	5.3	5.2	4.9	18.9	2.7	6.4	5.1	61.1	4.3	44.6	2.6	4.0	12.3	31.2	41.6	22.9	34.7	34.8	37.0	34.7	31.7	33.6	27.9	39.3	29.0	3.6	3.2	5.5	13.7	9.4	8.9	5.4	5.0	9.1	41.0	8.8	11.4	3.2	12.8	5.4	0.0	62.6	4.9	10.0	4.2	7.9	9.8	3.5	4.4	9.4	7.1	17.5	5.0	13.3	11.2	8.6	12.6	14.3	5.5	3.8	11.0	6.1	20.5	10.8	52.2	17.6	9.6	2.0	42.1	42.0	1.3	13.1	52.5	5.4	6.5	16.1	10.5	6.2	12.1	10.6	10.3	3.0	21.4	11.1	11.1	6.1	4.5	4.2	7.2	13.1	8.8	10.6	4.2	3.8	7.9	8.1	2.6	15.4	8.5	10.7	4.0
AMPD3		ENSG00000133805	"Adenosine monophosphate deaminase 3"	Q01432	11	10308313-10507579	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Nucleotide metabolism"	Hydrolase	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 62.9;skeletal muscle: 73.3"	"Cell type enhanced"	"Detected in many"		"Oligodendrocytes: 111.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"BJ hTERT+: 44.2;CAPAN-2: 34.6;HMC-1: 36.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038662, HPA047408"	Uncertain		Approved	"Nuclear membrane"		NA	NA		77000	"Cluster 49: Eosinophils - Unknown function"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	"Nuclear membrane"		"HPA038662: AB_2676136, HPA047408: AB_2680034"	"unprognostic (2.24e-1)"	"unprognostic (3.88e-3)"	"unprognostic (1.44e-2)"	"prognostic favorable (2.37e-4)"	"unprognostic (1.89e-2)"	"unprognostic (1.71e-3)"	"unprognostic (2.91e-3)"	"unprognostic (1.25e-1)"	"unprognostic (7.83e-2)"	"unprognostic (2.26e-1)"	"unprognostic (1.84e-2)"	"unprognostic (4.68e-1)"	"unprognostic (3.06e-2)"	"unprognostic (7.07e-2)"	"unprognostic (4.42e-2)"	"unprognostic (2.98e-1)"	"unprognostic (2.12e-2)"	4.2	19.6	10.8	20.7	22.5	62.9	3.0	19.1	15.3	6.0	10.8	4.9	6.5	4.2	4.0	7.6	11.1	6.4	2.9	10.4	15.9	7.8	1.8	6.9	17.6	21.1	20.5	2.6	3.3	24.1	18.2	4.1	20.5	7.4	6.6	7.5	6.4	3.5	73.3	15.6	7.8	4.4	14.0	12.1	6.7	1.8	21.4	13.9	3.6	9.3	20.3	9.7	7.9	30.2	14.1	2.0	0.5	0.2	7.1	5.0	0.8	12.4	44.2	3.0	3.1	6.9	34.6	5.1	1.2	5.7	11.9	8.6	0.2	11.8	8.8	12.7	0.5	12.5	1.8	1.0	2.4	17.2	36.0	18.5	17.9	6.0	7.7	7.5	1.4	8.3	19.4	5.3	10.1	0.5	10.2	22.3	1.6	1.1	12.2	3.7	15.9	18.2	0.6	11.5	5.1	2.6	2.7	0.4	0.8	1.0	0.4	5.8	3.4	13.7	0.2	9.6	0.5	4.8	2.9	5.5	15.7	16.9	0.3	9.5	6.4	19.4	2.2	3.9	5.4	7.7	3.3	2.6	4.2	5.3	3.6	2.5	8.4	3.8	1.7	2.7	2.1	2.8	10.8	22.5	19.1	15.3	10.4	15.9	21.1	20.5	20.5	14.0	21.4	30.2	0.5	0.0	3.9	5.2	14.3	12.5	10.6	8.1	4.0	23.6	1.6	1.8	6.3	5.7	9.8	14.7	2.1	0.9	1.6	1.9	17.6	2.9	7.3	14.0	1.7	1.6	10.2	20.2	11.9	1.6	1.5	8.1	3.1	2.9	12.0	0.9	1.1	0.7	14.5	0.0	7.0	3.9	20.3	15.2	7.6	20.6	0.9	18.3	3.6	28.1	14.0	6.5	1.0	5.0	111.8	6.3	3.0	0.0	1.7	26.5	4.9	0.8	24.2	1.3	0.0	12.3	1.9	0.4	0.6	2.2	12.5	1.2	6.6	0.3	2.2	16.8
AMY2A	AMY2	ENSG00000243480	"Amylase alpha 2A"	P04746	1	103616811-103625780	"Enzymes, FDA approved drug targets, Metabolic proteins, Predicted secreted proteins"	"Carbohydrate metabolism"	"Glycosidase, Hydrolase"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	1983	"pancreas: 148689.6"	"Cell type enriched"	"Detected in some"	114	"Exocrine glandular cells: 1016.0"	"Cancer enriched"	"Detected in single"	2010	"pancreatic cancer: 200.3"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											"HPA045394, HPA045399, CAB045960, HPA046980"	Enhanced				"Secreted to digestive system"	NA	NA				"Cluster 25: Pancreas - Digestion"		"Cluster 1: Pancreatic cells - Digestion"			"CAB045960: AB_2226891, HPA045394: AB_2679311, HPA045399: AB_2679313, HPA046980: AB_2679889"					"unprognostic (3.27e-1)"					"unprognostic (1.78e-3)"	"unprognostic (3.24e-2)"			"unprognostic (1.29e-1)"		"unprognostic (2.13e-2)"		6.0	1.3	1.2	2.8	1.3	0.3	3.9	0.7	1.4	3.3	0.6	1.7	22.5	2.9	0.1	2.3	0.8	0.0	26.6	1.2	0.9	1.5	4.7	1.0	5.4	0.8	0.9	74.9	148689.6	0.1	1.5	8.3	0.8	2.1	0.0	0.6	30.0	0.0	1.5	1.4	10.7	0.0	0.7	1.7	2.2	1.2	0.9	0.0	1.1	0.0	0.0	0.5	1.2	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	1.3	0.7	1.4	1.2	0.9	0.8	0.9	0.8	0.7	0.9	1.0	0.1	0.0	0.0	2.0	0.0	0.0	1.0	0.1	0.0	0.0	0.0	0.0	1.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	1.1	2.1	0.0	0.0	0.2	0.0	0.0	1.3	1016.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.8	0.0	0.2	0.0	0.0	4.6	0.0	0.0	0.0	0.1	8.9	0.0	0.0	0.0	0.1	0.0	0.0	1.1	0.0	0.0	0.2	0.1	0.4	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.6
AMY2B	AMY2	ENSG00000240038	"Amylase alpha 2B"	P19961	1	103553815-103579534	"Enzymes, Metabolic proteins, Plasma proteins, Predicted secreted proteins"	"Carbohydrate metabolism"	"Glycosidase, Hydrolase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	122	"pancreas: 31246.7"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 56.2;Excitatory neurons: 61.2;Exocrine glandular cells: 148.0;Inhibitory neurons: 48.4;Oligodendrocytes: 41.8"	"Cancer enriched"	"Detected in many"	15	"pancreatic cancer: 25.1"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"classical monocyte: 5.0"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"ASC TERT1: 9.8;EFO-21: 10.3"									"HPA045394, HPA045399, HPA046980"	Supported				"Secreted to digestive system"	NA	NA		77000000	"Cluster 25: Monocytes - Inflammatory response"	"Cluster 25: Pancreas - Digestion"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 1: Pancreatic cells - Digestion"			"HPA045394: AB_2679311, HPA045399: AB_2679313, HPA046980: AB_2679889"	"unprognostic (8.69e-4)"	"unprognostic (3.71e-3)"	"unprognostic (6.41e-2)"	"unprognostic (9.75e-2)"	"unprognostic (1.32e-1)"	"unprognostic (1.51e-4)"	"unprognostic (1.21e-2)"	"unprognostic (1.63e-2)"	"unprognostic (2.13e-1)"	"unprognostic (1.98e-1)"	"unprognostic (1.07e-1)"	"unprognostic (2.49e-2)"	"unprognostic (7.41e-3)"	"unprognostic (1.55e-2)"	"unprognostic (5.74e-2)"	"unprognostic (4.22e-1)"	"unprognostic (3.12e-4)"	35.4	24.8	29.5	11.2	34.8	13.4	34.9	39.9	38.6	40.8	19.7	33.0	16.5	22.7	20.2	13.1	50.3	14.1	40.9	27.9	29.5	59.4	39.0	30.2	20.0	27.7	29.1	40.0	31246.7	14.9	36.8	6.9	27.1	35.3	11.9	69.8	256.2	14.6	63.7	42.6	31.7	9.8	26.3	34.8	18.1	5.2	30.6	12.6	63.5	25.2	13.8	29.3	25.8	30.0	0.0	0.5	1.1	0.0	5.6	9.8	1.1	0.8	0.8	0.6	1.5	0.0	0.2	1.0	10.3	0.3	0.0	1.2	0.1	1.3	1.4	1.3	1.6	1.9	4.5	0.8	0.8	2.5	2.6	6.7	6.7	0.8	1.2	1.8	0.2	3.0	0.0	3.2	0.9	0.0	1.9	0.5	0.1	0.1	1.4	0.5	0.0	4.7	5.7	2.0	2.8	0.6	2.4	1.1	0.8	1.8	0.1	1.4	0.8	0.3	0.9	0.5	0.7	3.5	0.1	0.3	1.9	1.8	0.2	0.0	5.0	1.0	0.4	2.5	0.3	1.0	0.1	0.2	1.6	0.9	0.6	0.2	1.2	0.1	2.2	0.5	0.2	1.2	29.5	34.8	39.9	38.6	27.9	29.5	27.7	29.1	27.1	26.3	30.6	30.0	2.8	12.8	20.1	56.2	3.2	4.7	4.2	1.4	0.6	11.7	2.9	2.7	7.2	2.8	11.2	1.8	33.3	0.4	2.4	3.6	0.0	1.3	7.3	1.1	0.6	2.7	4.9	1.3	61.2	148.0	0.4	3.2	2.0	0.7	3.8	0.5	2.2	6.5	1.6	10.1	48.4	2.5	0.0	9.4	3.5	2.7	2.5	3.4	5.4	11.2	4.0	3.1	2.1	22.1	41.8	1.3	2.7	1.9	1.4	1.5	4.3	0.8	14.6	15.4	0.0	1.0	2.5	1.5	0.9	0.4	3.0	0.3	1.7	0.4	2.2	1.6
ANPEP	"CD13, gp150, LAP1, p150, PEPN"	ENSG00000166825	"Alanyl aminopeptidase, membrane"	P15144	15	89784895-89815401	"CD markers, Enzymes, Metabolic proteins, Plasma proteins, Predicted membrane proteins"	"Angiogenesis, Differentiation, Host-virus interaction"	"Aminopeptidase, Developmental protein, Host cell receptor for virus entry, Hydrolase, Metalloprotease, Protease, Receptor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	6	"intestine: 2384.1;pancreas: 675.0"	"Cell type enriched"	"Detected in many"	14	"Proximal enterocytes: 6315.2"	"Low cancer specificity"	"Detected in all"			"Group enriched"	"Detected in all"	5	"cerebral cortex: 9.2;thalamus: 17.4"	"Immune cell enriched"	"Detected in many"	4	"neutrophil: 227.1"	"Lineage enriched"	"Detected in many"	4	"granulocytes: 227.1"	"Cell line enhanced"	"Detected in many"		"ASC diff: 613.7;ASC TERT1: 764.2;BJ: 738.4;BJ hTERT+: 1135.6;fHDF/TERT166: 703.8;HMC-1: 660.3;HSkMC: 670.0;HUVEC TERT2: 874.8;TIME: 815.1;U-2197: 891.4"	"Low region specificity"	"Detected in all"			"Region enriched"	"Detected in many"	5	"spinal cord: 14.8"	"CAB002417, HPA004625"	Enhanced		Supported	"Plasma membrane"		NA	NA		1200000000	"Cluster 9: Neutrophils - Innate immune response"	"Cluster 56: Intestine - Transmembrane transport"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 45: Enterocytes - Digestion"	"Plasma membrane"		"CAB002417: AB_563491, HPA004625: AB_2667199"	"unprognostic (6.31e-2)"	"unprognostic (7.94e-3)"	"unprognostic (6.91e-2)"	"unprognostic (2.16e-1)"	"unprognostic (2.50e-1)"	"unprognostic (1.13e-1)"	"unprognostic (2.23e-2)"	"unprognostic (1.89e-1)"	"unprognostic (2.50e-1)"	"unprognostic (7.73e-2)"	"unprognostic (5.28e-3)"	"unprognostic (3.96e-1)"	"unprognostic (4.04e-3)"	"unprognostic (3.20e-2)"	"unprognostic (2.01e-2)"	"unprognostic (4.61e-3)"	"unprognostic (1.99e-2)"	55.4	7.0	1.6	36.6	1.6	103.4	55.9	1.3	9.2	41.4	3.4	266.8	2384.1	3.6	1.7	4.8	8.0	120.3	6.9	1.3	1.5	249.7	271.8	34.3	12.8	1.5	2.1	1.9	675.0	0.8	1.9	33.1	2.5	94.0	59.9	0.0	42.1	5.5	2.5	32.5	1970.6	29.7	1.3	25.9	8.0	2.0	17.4	7.1	8.2	3.8	4.7	16.8	15.0	1.2	0.1	45.6	0.0	0.5	613.7	764.2	6.2	738.4	1135.6	95.3	81.6	5.8	0.4	0.2	8.4	703.8	0.0	0.6	5.6	0.2	38.6	0.1	0.1	137.3	4.6	122.8	352.0	11.4	660.3	670.0	1.4	302.3	0.3	4.4	874.8	0.0	3.8	0.8	37.8	0.1	0.6	355.4	1.9	0.0	49.9	0.3	0.1	9.5	449.2	0.0	1.2	7.2	0.1	1.3	0.1	1.8	0.5	72.1	815.1	385.3	0.6	891.4	0.1	0.4	0.1	0.1	0.9	0.9	20.5	22.2	56.3	41.1	0.1	27.4	0.0	0.2	0.0	0.0	26.2	0.2	0.0	0.0	227.1	0.0	49.7	0.7	0.0	25.7	1.6	1.6	1.3	9.2	1.3	1.5	1.5	2.1	2.5	1.3	17.4	1.2	2.4	0.0	3.0	0.0	5.2	9.9	2.8	1.4	0.6	0.0	35.7	12.8	1.2	391.7	19.7	20.2	0.0	13.0	0.7	429.8	43.0	15.4	0.2	0.5	10.1	8.4	3.0	6.6	0.3	386.2	16.3	31.0	0.0	0.4	24.1	0.3	79.2	192.4	37.5	0.0	0.3	199.6	2.0	54.1	63.2	0.2	2.8	71.9	3.6	0.0	38.3	0.0	0.0	0.0	0.1	75.5	316.9	1.5	2.1	20.9	6315.2	435.0	3.3	0.0	26.3	0.8	8.1	0.3	0.5	0.2	5.8	6.4	3.7	187.8	290.9	1.4
AOAH		ENSG00000136250	"Acyloxyacyl hydrolase"	P28039	7	36512941-36724549	"Enzymes, Metabolic proteins, Predicted secreted proteins"	"Lipid metabolism"	Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 43.3;lymphoid tissue: 64.9"	"Cell type enhanced"	"Detected in many"		"dendritic cells: 77.9;Kupffer cells: 119.7;Macrophages: 77.1;Microglial cells: 233.3;monocytes: 67.5;NK-cells: 90.6;T-cells: 54.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"classical monocyte: 298.5"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in some"		"GAMG: 4.8;NB-4: 26.5;THP-1: 20.2;U-937: 8.9"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			"HPA021666, HPA026716"	Approved		Uncertain	Vesicles	"Secreted to blood"	NA	NA			"Cluster 25: Monocytes - Inflammatory response"	"Cluster 2: Immune cells - Immune response"	"Cluster 24: NB-4 - Immune response"	"Cluster 63: NK-cells & T-cells - Immune response"	Vesicles		"HPA021666: AB_2670799, HPA026716: AB_2671960"	"unprognostic (3.55e-2)"	"unprognostic (4.03e-3)"	"unprognostic (4.45e-2)"	"unprognostic (3.58e-1)"	"unprognostic (6.06e-2)"	"unprognostic (4.78e-2)"	"unprognostic (2.40e-1)"	"unprognostic (3.14e-3)"	"unprognostic (5.42e-2)"	"unprognostic (6.02e-2)"	"unprognostic (3.36e-2)"	"unprognostic (1.05e-1)"	"unprognostic (1.46e-3)"	"unprognostic (1.75e-1)"	"unprognostic (1.92e-3)"	"unprognostic (2.38e-1)"	"unprognostic (1.35e-1)"	7.5	5.1	2.4	33.7	2.2	43.3	3.8	2.1	3.1	5.7	4.7	10.4	9.5	2.8	1.5	3.3	3.5	15.6	2.0	2.1	3.6	1.9	13.2	12.7	35.1	6.6	5.1	2.6	1.5	1.5	0.9	11.2	5.7	2.5	13.3	0.8	3.7	2.8	0.5	0.8	12.1	9.3	4.0	64.9	7.0	1.3	5.1	13.9	1.8	0.9	15.1	13.9	1.3	8.6	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.8	0.6	0.0	0.0	0.0	3.8	0.0	0.3	0.1	0.0	0.0	2.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.6	26.5	0.1	0.0	0.0	0.5	0.0	0.3	0.4	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	20.2	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	8.9	0.0	1.8	298.5	97.8	43.6	251.9	9.0	2.6	2.2	30.7	183.1	0.3	4.8	37.3	97.9	106.8	113.2	2.7	0.7	207.3	2.4	2.2	2.1	3.1	2.1	3.6	6.6	5.1	5.7	4.0	5.1	8.6	1.3	0.0	9.6	1.3	3.6	0.8	0.1	0.0	0.0	1.1	0.6	1.7	0.5	1.5	2.5	0.0	0.0	0.2	77.9	9.2	1.9	0.3	0.6	0.4	0.3	1.4	15.5	16.0	12.4	0.0	0.2	3.1	2.6	0.4	5.1	0.7	2.5	0.9	32.8	0.0	8.1	0.3	0.0	119.7	20.3	1.2	0.0	77.1	0.0	233.3	67.5	2.8	90.6	12.1	38.6	0.0	3.8	0.4	13.6	0.1	0.3	0.5	0.7	0.3	0.0	0.3	0.5	0.0	0.1	0.4	0.3	0.1	54.1	0.6	0.9	0.2
APEH	"D3F15S2, D3S48E, DNF15S2"	ENSG00000164062	"Acylaminoacyl-peptide hydrolase"	P13798	3	49674014-49683971	"Enzymes, Plasma proteins, Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA029700, HPA029701, HPA029702, HPA029703"	Enhanced		Enhanced	Cytosol		No	No		2300000	"Cluster 27: Non-specific - Gene expression"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Cytosol		"HPA029700: AB_10599278, HPA029701: AB_10600333, HPA029702: AB_10602411, HPA029703: AB_10601348"	"unprognostic (4.93e-2)"	"unprognostic (5.42e-2)"	"unprognostic (6.04e-3)"	"unprognostic (2.71e-1)"	"unprognostic (9.32e-2)"	"unprognostic (8.20e-2)"	"unprognostic (3.65e-2)"	"unprognostic (2.48e-1)"	"unprognostic (5.89e-2)"	"unprognostic (8.03e-2)"	"unprognostic (3.21e-1)"	"unprognostic (4.30e-2)"	"prognostic favorable (3.32e-10)"	"unprognostic (2.11e-2)"	"unprognostic (1.12e-1)"	"unprognostic (4.34e-2)"	"unprognostic (7.67e-2)"	21.7	43.6	18.0	30.7	18.0	42.3	26.8	17.9	22.8	24.8	27.7	48.5	48.6	19.7	24.7	40.2	33.7	22.3	40.6	17.7	19.9	65.8	63.3	26.8	35.2	19.2	21.3	24.6	34.8	63.0	38.3	31.9	24.3	31.0	51.7	12.9	34.0	29.5	103.8	32.8	35.1	28.1	16.8	27.2	35.5	18.7	20.0	37.3	48.6	103.9	43.4	35.0	21.2	16.7	101.2	79.2	84.2	110.8	71.3	48.3	113.6	64.2	79.3	87.4	91.2	130.1	101.7	127.1	70.0	71.7	78.9	89.8	95.1	143.4	64.2	61.9	41.0	138.8	123.4	105.1	72.0	145.5	204.7	55.0	106.5	49.2	101.4	85.5	78.7	86.4	86.6	59.8	86.0	90.8	105.3	76.6	50.4	140.5	75.3	38.4	72.8	165.1	169.9	226.7	40.4	71.2	72.4	166.7	78.9	61.0	112.1	77.2	36.1	53.8	93.0	83.6	86.8	69.8	54.5	77.7	91.7	104.1	78.7	57.9	43.0	52.8	44.8	47.6	34.8	33.3	36.3	41.9	43.6	27.6	37.9	37.4	13.6	39.0	47.6	35.1	50.4	51.9	18.0	18.0	17.9	22.8	17.7	19.9	19.2	21.3	24.3	16.8	20.0	16.7	5.4	41.7	25.3	7.5	20.1	8.7	23.3	50.2	11.4	6.8	20.8	15.9	46.8	30.0	39.4	27.6	12.5	83.7	16.5	83.2	43.0	44.4	6.4	16.6	13.8	9.0	26.5	43.8	4.8	34.7	64.8	16.4	41.8	20.5	23.5	20.0	13.2	74.7	51.1	8.4	4.7	47.1	63.1	35.9	11.9	10.9	15.2	23.2	21.4	2.8	26.8	30.4	27.8	3.0	2.0	39.0	35.8	13.5	39.4	18.0	85.4	80.7	19.4	11.1	13.1	10.6	25.2	33.2	28.5	30.6	9.2	62.1	23.9	28.5	74.0	23.7
APOBEC1	"APOBEC-1, BEDP, CDAR1, HEPR"	ENSG00000111701	"Apolipoprotein B mRNA editing enzyme catalytic subunit 1"	P41238	12	7649400-7665908	"Enzymes, Predicted intracellular proteins"	"mRNA processing"	Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	25	"intestine: 29.0"	"Cell type enriched"	"Detected in some"	5	"Proximal enterocytes: 153.8"	"Group enriched"	"Detected in some"	9	"colorectal cancer: 6.2;pancreatic cancer: 6.1;stomach cancer: 3.5"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	25	"CAPAN-2: 1.7;OE19: 4.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"									NA	NA				"Cluster 56: Intestine - Transmembrane transport"	"Cluster 21: OE19 - Mitochondria"	"Cluster 45: Enterocytes - Digestion"						"unprognostic (2.35e-1)"					"unprognostic (3.80e-4)"			"unprognostic (7.96e-3)"			"unprognostic (1.79e-1)"	"unprognostic (4.38e-1)"			0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	29.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	26.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	4.3	0.0	0.0	0.0	0.0	0.0	6.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	1.3	0.0	0.0	2.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	10.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	3.2	28.2	0.0	0.0	0.0	153.8	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.4	0.0	0.0	0.0	0.0	0.0	4.9	0.0
APOBEC2	"ARCD1, ARP1"	ENSG00000124701	"Apolipoprotein B mRNA editing enzyme catalytic subunit 2"	Q9Y235	6	41053202-41064891	"Enzymes, Predicted intracellular proteins"	"mRNA processing"	Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"heart muscle: 203.7;skeletal muscle: 853.2;tongue: 288.0"	"Cell type enhanced"	"Detected in some"		"Bipolar cells: 15.8;Cardiomyocytes: 103.5;Early spermatids: 25.7;Exocrine glandular cells: 21.8;Extravillous trophoblasts: 18.1;Late spermatids: 25.1;Skeletal myocytes: 36.7"	"Cancer enhanced"	"Detected in some"		"head and neck cancer: 3.7;pancreatic cancer: 4.9"	"Low region specificity"	"Detected in some"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in single"		"CACO-2: 2.8"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in many"			"HPA014252, HPA017957"	Enhanced					NA	NA			"Cluster 6: Non-specific - Transcription"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 37: Myocytes - Muscle contraction"			"HPA014252: AB_1844932, HPA017957: AB_1844933"	"unprognostic (5.05e-2)"	"unprognostic (5.55e-2)"	"unprognostic (1.87e-1)"	"unprognostic (2.77e-1)"	"unprognostic (2.51e-2)"	"unprognostic (8.16e-3)"	"unprognostic (1.43e-1)"	"unprognostic (7.22e-2)"	"unprognostic (1.24e-1)"	"unprognostic (2.50e-2)"	"unprognostic (1.21e-1)"	"unprognostic (3.87e-1)"	"unprognostic (2.01e-2)"	"unprognostic (7.02e-2)"	"unprognostic (3.69e-1)"	"unprognostic (1.31e-3)"	"unprognostic (2.19e-2)"	0.2	0.8	0.3	0.3	0.9	1.1	0.3	0.4	0.7	0.0	0.2	0.8	1.4	0.1	0.0	12.0	0.1	0.1	203.7	0.2	0.4	0.4	0.1	0.5	0.3	1.0	0.6	0.1	12.7	0.0	0.1	0.7	0.8	7.7	0.1	5.7	12.7	0.0	853.2	1.1	1.2	2.1	0.5	0.2	12.6	2.7	0.7	10.9	0.3	288.0	0.0	0.3	0.1	1.7	0.0	0.0	0.1	0.1	0.0	0.0	0.6	0.0	0.0	0.0	0.0	2.8	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.2	0.0	0.3	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.5	0.2	0.1	0.0	0.0	0.1	0.4	0.0	0.4	0.0	0.2	0.2	0.0	0.0	0.0	0.4	0.2	0.0	0.0	0.1	0.7	0.0	0.0	0.1	0.0	0.1	0.1	0.0	0.7	0.1	0.3	0.1	0.1	0.0	0.8	0.6	1.3	1.6	0.5	1.4	2.1	1.5	1.7	0.4	1.9	1.6	1.8	0.6	0.6	0.9	2.2	1.6	0.1	0.3	0.9	0.4	0.7	0.2	0.4	1.0	0.6	0.8	0.5	0.7	1.7	0.0	0.0	0.0	1.0	0.0	0.3	0.7	1.0	0.0	15.8	0.0	0.0	103.5	0.0	0.0	0.0	2.1	1.6	0.1	0.0	0.0	8.0	25.7	0.0	0.0	1.2	0.0	0.0	0.5	21.8	18.1	2.3	8.6	0.1	0.0	0.0	0.0	0.0	0.4	1.7	0.5	0.1	0.0	0.3	0.3	25.1	0.3	0.1	1.8	0.0	0.0	0.9	0.0	2.0	3.7	2.2	0.0	0.0	0.0	0.0	0.5	2.0	0.0	3.1	0.0	36.7	2.0	1.1	0.2	0.0	0.0	1.4	0.1	0.0	0.0	0.0
APOBEC3A	"ARP3, PHRBN"	ENSG00000128383	"Apolipoprotein B mRNA editing enzyme catalytic subunit 3A"	P31941	22	38952741-38992778	"Enzymes, Predicted intracellular proteins"	"Antiviral defense, Immunity, Innate immunity"	Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"bone marrow: 93.9;lymphoid tissue: 48.3;urinary bladder: 24.4"	"Cell type enriched"	"Detected in many"	4	"Urothelial cells: 426.0"	"Group enriched"	"Detected in many"	4	"cervical cancer: 11.3;head and neck cancer: 15.8"	"Low region specificity"	"Detected in some"			"Immune cell enhanced"	"Detected in many"		"intermediate monocyte: 1014.5"	"Lineage enriched"	"Detected in many"	8	"monocytes: 1014.5"	"Not detected"	"Not detected"											"HPA043237, HPA056980, HPA066719"	Approved		Uncertain	Nucleoplasm		NA	NA			"Cluster 7: Monocytes - Unknown function"	"Cluster 40: Neutrophils - Inflammatory response"		"Cluster 19: Monocytes & Neutrophils - Innate immune response"	Nucleoplasm		"HPA043237: AB_10795980, HPA056980: AB_2683298, HPA066719: AB_2685711"	"unprognostic (6.45e-3)"	"unprognostic (1.44e-2)"	"unprognostic (1.12e-1)"	"unprognostic (5.21e-3)"	"unprognostic (1.31e-1)"	"unprognostic (2.72e-2)"	"unprognostic (1.91e-1)"	"unprognostic (1.91e-1)"	"unprognostic (3.52e-1)"	"unprognostic (2.59e-3)"	"unprognostic (9.01e-3)"	"unprognostic (2.00e-1)"	"unprognostic (1.13e-2)"	"unprognostic (1.76e-1)"	"unprognostic (4.98e-2)"	"unprognostic (3.41e-1)"	"unprognostic (1.91e-1)"	7.9	0.4	0.5	20.9	0.5	93.9	0.8	0.7	1.1	2.2	0.8	1.5	1.4	0.4	0.3	12.2	4.2	6.3	1.4	0.9	0.5	0.7	2.0	13.4	1.1	0.6	0.4	0.2	1.5	0.4	0.3	3.5	0.7	0.4	0.6	0.2	6.7	0.3	0.5	0.6	0.8	1.7	0.3	48.3	1.1	0.2	0.5	2.4	1.0	3.7	21.1	24.4	10.3	1.0	0.1	0.0	0.1	0.6	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.3	0.0	0.0	0.5	0.1	0.1	0.0	0.1	0.0	0.0	0.4	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.7	0.0	0.1	0.1	0.0	0.1	0.1	0.0	0.1	0.1	0.1	0.0	0.2	0.2	0.0	0.0	0.3	0.0	0.0	0.2	0.0	0.4	0.1	0.1	0.1	0.1	0.1	0.2	0.2	0.3	0.6	0.3	34.7	223.9	8.4	0.7	1014.5	1.5	3.1	0.6	0.7	10.4	0.8	0.7	0.7	121.7	0.9	298.5	1.3	1.0	149.1	0.5	0.5	0.7	1.1	0.9	0.5	0.6	0.4	0.7	0.3	0.5	1.0	0.7	28.9	33.6	0.0	0.5	1.3	16.0	1.8	0.0	0.6	0.7	0.3	0.1	0.0	24.1	1.8	4.2	0.3	0.2	17.5	0.0	0.1	0.6	0.5	0.2	1.4	0.0	8.0	0.0	0.2	0.3	6.3	0.0	0.6	25.9	0.3	0.7	0.4	14.9	0.0	0.0	0.0	2.0	18.8	41.4	0.1	0.3	91.3	16.0	0.0	17.9	0.8	2.1	0.0	0.0	1.3	27.4	0.4	15.6	6.7	4.5	0.2	10.7	0.8	0.0	1.0	1.2	0.1	0.4	48.7	6.8	0.3	3.1	0.2	1.7	426.0
APOBEC3B	"FLJ21201, PHRBNL"	ENSG00000179750	"Apolipoprotein B mRNA editing enzyme catalytic subunit 3B"	Q9UH17	22	38982347-38992804	"Cancer-related genes, Enzymes, Predicted intracellular proteins"	"Antiviral defense, Immunity, Innate immunity"	"Hydrolase, RNA-binding"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 28.4;intestine: 12.1"	"Cell type enhanced"	"Detected in many"		"Basal respiratory cells: 11.8;Ductal cells: 14.7;Erythroid cells: 14.1;Plasma cells: 26.2;Urothelial cells: 11.4"	"Low cancer specificity"	"Detected in all"			"Not detected"	"Not detected"			"Immune cell enhanced"	"Detected in many"		"memory B-cell: 7.2"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"A-431: 256.0;Karpas-707: 283.6"									"HPA056980, HPA066719"			Approved	Nucleoplasm		NA	NA			"Cluster 19: B-cells - Humoral immune response"	"Cluster 67: Neutrophils - Humoral immune response"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 55: Plasma cells - Humoral immune response"	Nucleoplasm		"HPA056980: AB_2683298, HPA066719: AB_2685711"	"unprognostic (2.92e-2)"	"prognostic favorable (2.58e-5)"	"unprognostic (4.29e-2)"	"unprognostic (1.19e-1)"	"unprognostic (2.50e-1)"	"unprognostic (1.35e-1)"	"unprognostic (1.69e-2)"	"unprognostic (2.18e-1)"	"unprognostic (1.35e-1)"	"unprognostic (6.36e-2)"	"unprognostic (1.08e-2)"	"unprognostic (5.88e-2)"	"prognostic unfavorable (2.78e-4)"	"unprognostic (8.47e-2)"	"unprognostic (2.98e-2)"	"unprognostic (2.70e-1)"	"unprognostic (1.04e-1)"	0.9	1.2	0.1	5.7	0.1	28.4	2.0	0.1	0.2	1.2	0.1	12.1	7.3	1.0	0.4	3.0	0.7	1.1	0.8	0.1	0.1	2.7	1.1	1.9	5.9	0.1	0.1	0.7	3.3	1.2	0.2	1.6	0.1	0.4	12.0	0.3	2.8	0.2	0.4	2.1	4.3	1.4	0.1	6.4	4.1	0.3	0.2	2.5	1.3	0.2	8.6	7.6	1.5	0.2	256.0	28.0	10.5	68.1	1.5	6.0	18.6	23.0	19.7	43.0	56.5	54.7	46.6	3.0	20.4	22.9	63.0	108.2	1.3	4.5	43.1	92.1	2.5	72.5	5.6	14.0	0.7	61.7	43.0	2.3	0.5	45.1	2.2	8.9	17.0	0.0	41.6	283.6	68.1	6.9	0.2	35.3	0.3	24.6	25.2	1.8	105.0	95.6	9.1	42.2	1.8	0.0	0.0	0.3	16.0	1.8	33.0	18.1	10.2	48.0	81.9	7.5	0.7	62.8	18.0	0.3	34.4	68.2	100.7	0.4	1.0	0.0	0.2	4.9	0.0	7.2	0.5	0.3	0.6	3.1	0.0	0.3	1.4	1.7	1.7	0.0	2.8	3.5	0.1	0.1	0.1	0.2	0.1	0.1	0.1	0.1	0.1	0.1	0.2	0.2	0.0	0.0	1.7	0.0	2.2	5.4	3.2	11.8	0.6	0.0	1.5	0.5	0.3	0.0	8.1	0.0	0.0	1.0	0.4	4.6	0.0	14.7	0.0	5.9	0.6	0.2	0.0	14.1	0.0	1.8	1.8	0.8	3.1	5.3	0.0	0.8	0.4	0.0	2.1	0.0	0.0	0.4	10.2	1.2	6.3	0.0	0.0	2.3	7.2	0.0	1.4	0.0	0.0	0.0	0.0	6.0	9.9	0.0	26.2	1.4	0.4	0.3	9.3	0.0	0.0	0.0	0.9	0.0	0.0	4.2	3.3	0.8	0.5	0.1	1.6	11.4
APOBEC3C	"APOBEC1L, ARDC2, ARDC4, ARP5, bK150C2.3, PBI"	ENSG00000244509	"Apolipoprotein B mRNA editing enzyme catalytic subunit 3C"	Q9NRW3	22	39014257-39020352	"Enzymes, Predicted intracellular proteins"	"Antiviral defense, Host-virus interaction, Immunity, Innate immunity"	Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"NK-cells: 117.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"											"CAB033048, HPA071523"	Approved		Approved	"Intermediate filaments"		NA	NA			"Cluster 51: Monocytes - Innate immune response"	"Cluster 34: Non-specific - Transcription"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 63: NK-cells & T-cells - Immune response"	"Intermediate filaments"		"CAB033048: AB_2057401, HPA071523: AB_2686409"	"unprognostic (1.79e-3)"	"prognostic favorable (1.08e-5)"	"unprognostic (4.32e-3)"	"unprognostic (3.20e-3)"	"unprognostic (4.68e-2)"	"unprognostic (2.13e-1)"	"unprognostic (5.18e-2)"	"unprognostic (2.55e-1)"	"unprognostic (1.10e-1)"	"unprognostic (1.08e-3)"	"unprognostic (7.40e-2)"	"unprognostic (4.10e-2)"	"prognostic unfavorable (8.91e-10)"	"unprognostic (5.92e-2)"	"unprognostic (1.11e-1)"	"unprognostic (4.10e-1)"	"unprognostic (3.52e-3)"	12.3	36.2	3.1	31.1	3.2	31.4	12.3	3.1	4.0	23.1	3.5	20.2	14.0	22.6	51.7	22.7	56.0	18.4	24.0	3.0	3.5	6.0	7.0	20.6	57.8	5.0	3.6	38.2	5.1	10.5	3.8	11.6	5.1	25.9	33.1	3.4	22.1	36.1	2.7	19.8	17.4	30.8	4.5	36.5	18.1	29.4	3.9	25.2	15.2	11.3	67.8	27.6	17.3	6.5	39.4	38.1	6.3	73.9	40.2	82.6	32.4	28.3	54.9	41.0	54.5	36.8	43.7	115.5	18.6	56.1	26.2	39.4	6.5	120.2	39.5	44.3	32.0	111.8	1.6	30.6	43.5	73.4	107.1	90.5	68.1	54.0	13.3	20.4	23.0	0.9	69.9	142.3	83.0	0.4	29.6	39.8	9.8	0.5	82.8	51.1	16.9	96.6	27.2	51.4	1.9	4.9	40.9	0.2	21.7	15.9	0.2	26.8	11.9	21.8	37.1	11.9	12.4	38.6	42.7	9.5	66.9	47.1	58.8	86.6	104.4	277.0	309.1	220.6	212.6	241.6	164.7	276.9	106.9	249.1	54.0	196.9	14.1	196.9	247.8	86.9	168.9	173.6	3.1	3.2	3.1	4.0	3.0	3.5	5.0	3.6	5.1	4.5	3.9	6.5	3.3	3.2	16.2	0.0	68.8	25.2	45.4	44.1	24.5	0.2	16.4	8.9	23.0	28.6	18.4	7.3	0.0	4.3	60.2	56.6	0.0	31.6	3.2	11.0	16.4	9.6	26.4	57.2	0.0	1.3	1.4	26.5	5.6	15.6	57.0	78.6	30.0	1.2	61.9	0.0	0.0	17.8	28.5	49.0	37.3	9.3	57.8	34.2	44.4	0.0	65.1	24.4	117.4	0.5	0.0	11.5	16.6	38.0	55.4	18.9	3.2	1.3	13.6	0.8	26.3	11.9	20.1	1.5	1.5	9.7	16.3	1.9	67.7	53.5	18.8	41.9
APOBEC3D	"APOBEC3DE, APOBEC3E, ARP6"	ENSG00000243811	"Apolipoprotein B mRNA editing enzyme catalytic subunit 3D"	Q96AK3	22	39021113-39033277	"Enzymes, Predicted intracellular proteins"	"Antiviral defense, Immunity, Innate immunity"	Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 15.3"	"Cell type enhanced"	"Detected in many"		"B-cells: 6.7;NK-cells: 9.2;Plasma cells: 6.4;T-cells: 8.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HMC-1: 11.8;Karpas-707: 46.7"									HPA055116	Approved					NA	NA			"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 16: Immune cells - Immune response"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 63: NK-cells & T-cells - Immune response"			"HPA055116: AB_2682701"	"prognostic favorable (2.51e-5)"	"prognostic favorable (1.31e-4)"	"unprognostic (2.69e-2)"	"prognostic favorable (4.47e-4)"	"unprognostic (2.62e-2)"	"unprognostic (3.06e-2)"	"unprognostic (2.46e-1)"	"unprognostic (1.18e-1)"	"unprognostic (4.52e-2)"	"unprognostic (2.45e-2)"	"unprognostic (4.50e-2)"	"unprognostic (1.69e-1)"	"prognostic unfavorable (3.76e-7)"	"unprognostic (4.76e-2)"	"unprognostic (6.00e-2)"	"unprognostic (1.06e-2)"	"prognostic favorable (3.01e-4)"	1.7	2.2	1.2	8.6	1.2	2.5	1.8	1.5	1.2	3.5	1.1	3.5	3.8	3.3	3.0	1.7	5.2	4.1	1.2	1.0	0.9	1.6	1.2	3.3	15.3	1.6	1.2	4.1	0.5	1.1	0.9	2.2	1.3	2.6	4.3	0.3	2.8	2.3	0.9	1.4	5.3	2.4	1.3	12.0	5.3	2.4	1.1	7.7	1.9	1.2	13.8	4.6	2.7	1.4	0.5	0.0	0.3	2.1	3.1	5.5	1.9	0.3	3.3	3.9	4.4	0.9	5.3	6.1	0.9	4.4	2.5	0.6	0.3	0.0	1.4	11.1	1.2	10.7	0.1	0.0	8.3	1.5	11.8	3.6	0.5	6.3	0.0	0.0	2.9	9.0	2.7	46.7	0.2	0.0	5.2	3.4	0.8	0.0	0.5	4.3	0.3	0.1	0.0	0.0	0.1	0.3	0.2	0.1	1.7	1.4	0.1	0.5	1.1	0.1	1.2	0.6	0.0	3.2	3.9	0.8	1.6	3.3	1.5	4.8	1.3	3.5	8.0	3.5	5.2	6.7	5.8	7.3	0.8	6.8	2.7	3.6	1.7	4.9	6.5	5.4	5.8	3.4	1.2	1.2	1.5	1.2	1.0	0.9	1.6	1.2	1.3	1.3	1.1	1.4	0.9	3.2	0.5	0.0	6.7	1.0	1.5	0.9	0.0	0.2	0.3	0.6	0.4	5.7	1.1	1.8	0.0	1.3	3.8	3.0	0.0	0.2	0.5	1.0	0.8	1.9	1.8	1.7	0.0	0.2	0.7	1.8	2.6	0.6	0.0	1.1	2.5	0.2	2.5	0.0	0.0	3.6	0.0	3.4	1.0	0.0	3.1	1.1	3.6	2.8	1.2	0.3	9.2	0.5	0.0	0.2	0.1	1.9	6.4	1.4	1.3	0.3	2.7	0.5	0.0	0.9	1.4	0.2	0.4	0.2	0.9	0.5	8.7	0.8	2.1	2.6
APOBEC3F	"ARP8, BK150C2.4.MRNA, KA6"	ENSG00000128394	"Apolipoprotein B mRNA editing enzyme catalytic subunit 3F"	Q8IUX4	22	39040604-39055972	"Enzymes, Predicted intracellular proteins"	"Antiviral defense, Immunity, Innate immunity"	Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"Karpas-707: 19.9"									HPA073637			Uncertain	Nucleoplasm,Cytosol		NA	NA			"Cluster 37: B-cells - Transcription"	"Cluster 34: Non-specific - Transcription"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 63: NK-cells & T-cells - Immune response"	"Nucleoplasm, Cytosol"		"HPA073637: "	"unprognostic (1.38e-3)"	"unprognostic (1.28e-3)"	"unprognostic (4.63e-2)"	"unprognostic (1.63e-2)"	"unprognostic (6.16e-2)"	"unprognostic (3.51e-2)"	"unprognostic (3.90e-2)"	"unprognostic (1.42e-1)"	"unprognostic (6.03e-2)"	"unprognostic (1.34e-2)"	"unprognostic (1.57e-1)"	"unprognostic (1.88e-1)"	"unprognostic (2.06e-3)"	"unprognostic (9.36e-2)"	"unprognostic (3.21e-2)"	"unprognostic (1.49e-1)"	"prognostic favorable (8.28e-4)"	2.2	6.3	2.2	9.2	2.1	3.3	2.5	2.2	2.7	4.0	3.4	3.5	3.7	4.1	6.3	2.4	8.3	3.5	5.5	2.0	2.2	3.4	2.9	3.4	15.7	3.1	2.6	8.8	3.0	5.2	3.4	2.2	2.8	4.8	2.8	1.1	4.9	5.2	0.6	1.6	3.8	4.5	2.3	11.9	4.8	8.2	2.5	5.3	3.0	1.3	14.5	4.5	3.2	2.9	4.9	4.2	1.8	6.2	4.9	7.1	2.2	4.2	6.9	8.8	14.0	3.9	9.1	12.9	4.1	8.9	7.7	6.5	1.7	6.0	3.8	11.7	5.3	16.5	0.5	2.5	8.6	3.6	7.0	9.5	3.0	5.0	1.5	5.1	8.5	3.5	1.3	19.9	4.8	3.9	4.0	2.7	0.8	0.5	0.7	6.1	0.7	2.5	8.1	6.6	0.9	1.5	4.7	1.2	2.5	3.5	4.7	1.9	2.3	2.0	5.0	0.4	2.0	3.4	1.7	0.5	5.6	1.9	3.1	3.2	4.7	9.4	8.5	9.1	9.8	27.7	5.6	9.0	6.0	34.2	3.4	5.6	3.1	14.6	14.5	4.6	8.4	7.4	2.2	2.1	2.2	2.7	2.0	2.2	3.1	2.6	2.8	2.3	2.5	2.9	1.6	0.0	0.5	0.0	9.8	0.9	4.9	6.3	2.2	0.0	2.1	2.2	5.9	8.6	4.2	0.0	0.0	2.0	7.6	0.8	1.9	7.4	2.4	4.8	3.8	2.6	1.2	2.1	0.1	3.9	1.4	2.9	2.6	3.6	2.5	11.0	3.6	1.6	5.9	0.0	0.0	2.2	4.1	2.2	1.4	5.2	5.0	2.8	5.4	2.8	5.3	2.2	8.2	0.5	0.0	4.8	3.6	6.4	9.6	4.5	0.5	5.3	4.6	0.2	0.0	1.0	2.6	0.3	0.4	1.6	0.9	1.6	5.4	7.8	1.5	5.9
APOBEC3H	ARP10	ENSG00000100298	"Apolipoprotein B mRNA editing enzyme catalytic subunit 3H"	Q6NTF7	22	39097224-39104067	"Enzymes, Predicted intracellular proteins"	"Antiviral defense, Immunity, Innate immunity"	Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"Cytotrophoblasts: 6.6;dendritic cells: 9.6;Hofbauer cells: 4.9;monocytes: 10.5;NK-cells: 6.2;T-cells: 20.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Group enriched"	"Detected in many"	9	"gdT-cell: 23.2;MAIT T-cell: 9.4;memory CD4 T-cell: 12.1;memory CD8 T-cell: 19.4;naive CD8 T-cell: 8.9;NK-cell: 19.7;T-reg: 11.9"	"Group enriched"	"Detected in many"	13	"NK-cells: 19.7;T-cells: 23.2"	"Cell line enhanced"	"Detected in some"		"Daudi: 2.8;HDLM-2: 2.7;Karpas-707: 6.9;U-266/70: 4.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA021492, HPA058565"	Approved		Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 16: Immune cells - Immune response"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 63: NK-cells & T-cells - Immune response"	"Nucleoplasm, Cytosol"		"HPA021492: AB_10964888, HPA058565: "	"unprognostic (7.09e-3)"	"prognostic favorable (1.20e-4)"	"unprognostic (1.05e-1)"	"unprognostic (6.81e-4)"	"unprognostic (3.40e-1)"	"unprognostic (1.54e-3)"	"unprognostic (2.30e-2)"	"unprognostic (1.36e-2)"	"unprognostic (2.17e-1)"	"unprognostic (3.83e-2)"	"unprognostic (5.07e-2)"	"unprognostic (5.36e-2)"	"prognostic unfavorable (8.73e-12)"	"unprognostic (1.05e-1)"	"unprognostic (1.03e-1)"	"unprognostic (6.55e-3)"	"prognostic favorable (8.43e-7)"	0.7	0.8	0.3	2.3	0.5	3.6	0.6	1.0	0.7	0.7	0.0	1.8	0.5	0.8	3.6	1.1	1.3	1.6	0.5	0.3	0.3	0.8	0.6	2.4	3.8	0.7	0.4	0.5	0.3	0.6	0.7	1.0	0.6	0.7	3.3	0.6	0.9	1.5	0.6	0.5	1.2	1.2	0.2	3.1	0.9	1.6	0.5	2.9	0.7	0.0	2.1	1.4	0.6	0.5	0.0	0.5	0.0	0.0	0.0	0.2	2.0	0.0	0.1	0.2	0.0	0.0	0.2	2.8	1.0	0.3	0.0	0.1	0.0	0.6	0.0	2.7	0.3	0.7	0.1	0.0	0.2	0.0	2.0	1.8	1.6	0.2	0.2	0.2	0.0	0.1	0.0	6.9	0.9	0.9	1.4	0.2	0.0	0.0	0.0	1.6	0.0	0.2	0.0	1.3	0.0	0.0	0.1	0.0	0.0	1.0	0.1	0.5	0.0	0.0	0.1	0.0	0.0	4.8	0.7	0.2	0.2	1.2	0.1	0.1	0.3	0.0	23.2	0.5	9.4	1.4	12.1	19.4	0.2	0.4	0.6	8.9	0.0	19.7	1.6	0.0	11.9	4.7	0.3	0.5	1.0	0.7	0.3	0.3	0.7	0.4	0.6	0.2	0.5	0.5	0.4	0.0	4.2	0.0	1.6	0.1	0.6	0.9	1.2	0.0	0.2	0.3	0.1	0.0	2.4	0.0	0.0	6.6	9.6	0.1	0.0	0.2	0.0	0.2	0.1	0.3	0.0	0.4	0.3	0.0	0.6	0.1	0.5	0.1	3.8	0.1	0.4	0.2	4.9	0.0	0.2	0.0	2.0	1.0	0.6	0.5	0.0	1.0	0.0	0.0	10.5	0.0	6.2	0.0	0.1	0.0	0.0	0.0	2.7	0.1	0.0	0.1	0.3	0.0	0.0	0.4	0.9	0.1	0.2	0.2	0.0	1.5	20.8	0.0	0.0	0.5
APTX	"AOA, AOA1, AXA1, EAOH, EOAHA, FLJ20157"	ENSG00000137074	Aprataxin	Q7Z2E3	9	32886601-33025130	"Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins"	"DNA damage, DNA repair"	"DNA-binding, Hydrolase"	"Disease variant, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA064930	Supported		Supported	Nucleoplasm,Nucleoli		No	No			"Cluster 27: Non-specific - Gene expression"	"Cluster 27: Brain & Skin - Unknown function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 23: Spermatids - Flagellum & Golgi organization"	"Nucleoplasm, Nucleoli"		"HPA064930: AB_2685386"	"unprognostic (9.18e-2)"	"unprognostic (2.65e-2)"	"unprognostic (3.61e-2)"	"unprognostic (1.73e-2)"	"unprognostic (4.04e-1)"	"unprognostic (8.16e-2)"	"unprognostic (2.26e-2)"	"unprognostic (1.00e-1)"	"unprognostic (1.32e-2)"	"unprognostic (2.78e-3)"	"unprognostic (3.48e-3)"	"unprognostic (3.49e-2)"	"prognostic favorable (6.01e-5)"	"unprognostic (7.87e-2)"	"unprognostic (1.34e-1)"	"unprognostic (1.13e-1)"	"unprognostic (6.50e-2)"	9.7	14.8	14.6	7.0	14.8	11.0	10.4	14.8	20.2	9.1	13.9	10.2	8.6	8.6	7.6	14.7	8.9	4.9	9.9	14.8	15.0	13.6	15.6	9.3	8.1	14.7	14.6	8.5	9.6	12.1	7.6	7.8	15.0	9.6	11.2	8.0	9.0	6.6	9.8	15.3	8.3	8.6	14.2	8.9	9.7	14.7	15.2	9.3	7.0	6.9	11.0	10.4	9.6	15.0	36.2	26.1	18.4	17.1	19.0	17.4	25.6	24.8	26.0	28.7	31.5	35.1	12.7	27.8	14.6	21.1	18.4	19.4	33.7	32.8	35.1	39.2	11.2	17.9	32.5	37.8	24.4	29.4	15.1	23.8	36.3	32.5	37.9	16.9	26.8	20.2	27.0	24.2	26.0	15.6	24.4	43.2	33.5	24.4	29.0	21.2	14.4	21.5	25.2	21.2	15.6	11.1	21.4	18.0	15.5	17.9	23.0	11.4	17.7	16.2	21.1	29.9	25.0	11.1	21.2	27.5	23.4	23.8	13.2	3.3	14.7	13.4	12.2	15.6	15.2	16.3	12.8	14.6	17.6	16.1	16.0	12.1	5.9	23.1	21.7	15.2	17.3	16.1	14.6	14.8	14.8	20.2	14.8	15.0	14.7	14.6	15.0	14.2	15.2	15.0	14.8	19.2	29.0	31.3	16.9	16.7	23.1	32.9	22.2	15.2	17.9	17.0	14.9	21.5	23.1	9.2	10.4	27.7	15.1	12.6	29.4	25.3	55.6	19.7	18.3	13.3	16.8	20.0	27.3	28.2	27.7	15.6	19.4	18.1	16.5	17.8	8.9	21.4	18.8	13.5	29.0	15.3	34.6	14.7	9.9	48.7	13.4	15.0	14.2	15.9	19.3	18.3	15.5	23.6	43.0	31.9	6.8	10.5	28.3	24.0	13.9	31.7	25.4	16.6	13.1	13.5	20.2	42.2	26.9	25.8	21.2	27.9	15.9	20.5	16.3	23.1
AQR	"fSAP164, IBP160, KIAA0560"	ENSG00000021776	"Aquarius intron-binding spliceosomal factor"	O60306	15	34851782-34969742	"Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"mRNA processing, mRNA splicing"	"Helicase, Hydrolase, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Cone photoreceptor cells: 114.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA040624, HPA055647"			Enhanced	Nucleoplasm		No	No			"Cluster 46: Basophils - DNA binding"	"Cluster 69: Cerebellum - Gene expression regulation"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 52: Non-specific - Transcription"	Nucleoplasm		"HPA040624: AB_2677050, HPA055647: AB_2682874"	"unprognostic (1.73e-1)"	"unprognostic (3.71e-2)"	"unprognostic (2.97e-1)"	"unprognostic (1.32e-2)"	"unprognostic (1.03e-1)"	"unprognostic (9.04e-2)"	"unprognostic (4.25e-2)"	"unprognostic (1.90e-1)"	"unprognostic (5.95e-2)"	"unprognostic (2.65e-1)"	"unprognostic (1.14e-2)"	"unprognostic (1.48e-1)"	"prognostic favorable (4.83e-4)"	"unprognostic (2.97e-1)"	"unprognostic (2.47e-1)"	"unprognostic (3.84e-1)"	"unprognostic (3.13e-2)"	3.7	3.9	4.5	3.4	5.7	4.0	5.9	7.8	5.2	5.7	3.9	4.2	3.4	4.5	4.1	3.5	4.4	3.1	2.7	4.7	5.0	5.2	4.0	3.6	4.2	4.1	4.7	5.0	4.1	5.2	2.5	4.4	4.5	4.0	4.2	8.0	3.3	3.7	2.8	4.2	3.6	3.8	4.5	4.7	3.8	5.6	4.9	7.0	5.4	3.5	4.7	4.0	3.5	5.8	5.3	13.5	8.7	9.3	11.6	10.7	4.5	6.4	8.1	8.3	7.4	6.1	3.2	4.3	4.0	10.8	5.4	8.2	14.8	9.1	9.1	6.1	6.0	13.8	11.4	5.6	6.6	11.3	6.2	8.4	5.9	6.5	6.9	7.7	7.1	3.3	9.9	4.2	8.3	3.6	6.6	7.5	8.7	12.2	5.5	8.9	15.0	4.3	8.3	9.2	9.5	7.4	10.3	9.7	2.3	7.6	6.9	8.7	9.3	6.1	3.4	4.3	5.7	5.0	6.6	8.5	7.7	9.6	6.3	3.6	2.0	1.2	2.6	2.2	2.3	1.6	2.3	2.6	1.7	2.3	2.3	2.6	1.0	2.1	1.4	2.3	2.0	1.4	4.5	5.7	7.8	5.2	4.7	5.0	4.1	4.7	4.5	4.5	4.9	5.8	27.0	12.8	26.0	45.4	27.9	9.6	13.7	17.0	15.4	28.6	19.9	15.6	14.7	17.2	28.1	14.7	114.7	16.4	31.4	18.2	3.9	13.4	38.2	20.6	26.7	24.1	13.2	21.0	39.8	14.3	14.4	18.6	20.4	22.1	24.1	28.8	31.1	18.5	14.9	25.2	44.0	19.1	12.2	18.6	5.1	8.4	20.8	21.8	16.0	29.0	27.9	14.3	22.6	42.3	42.2	18.5	12.1	18.4	22.9	18.8	17.4	12.9	27.1	41.1	6.6	42.8	16.9	19.4	22.2	22.4	9.7	13.3	27.0	46.5	21.6	13.5
ARG1		ENSG00000118520	"Arginase 1"	P05089	6	131470832-131584332	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Adaptive immunity, Arginine metabolism, Immunity, Innate immunity, Urea cycle"	Hydrolase	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"liver: 1203.5"	"Cell type enriched"	"Detected in some"	22	"Hepatocytes: 991.4"	"Cancer enriched"	"Detected in some"	45	"liver cancer: 167.7"	"Low region specificity"	"Detected in single"			"Immune cell enriched"	"Detected in some"	5	"neutrophil: 44.9"	"Lineage enriched"	"Detected in many"	5	"granulocytes: 44.9"	"Cell line enhanced"	"Detected in single"		"HL-60: 1.4"	"Region enhanced"	"Detected in single"		"cerebellum: 2.4"	"Low region specificity"	"Detected in all"			"HPA003595, CAB009434, HPA024006, CAB056159, CAB080011"	Enhanced					NA	NA		9500000	"Cluster 9: Neutrophils - Innate immune response"	"Cluster 60: Liver - Hemostasis & Lipid metabolism"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 2: Hepatocytes - Metabolism"			"CAB009434: AB_2058955, CAB056159: AB_2665582, CAB080011: , HPA003595: AB_1078190, HPA024006: AB_1844987"	"unprognostic (2.00e-1)"	"unprognostic (2.09e-1)"	"unprognostic (2.49e-1)"	"unprognostic (1.74e-1)"	"unprognostic (9.95e-2)"	"unprognostic (7.96e-2)"	"unprognostic (7.73e-2)"	"unprognostic (1.68e-1)"	"unprognostic (1.22e-1)"	"unprognostic (1.56e-2)"	"unprognostic (7.55e-3)"	"unprognostic (8.35e-2)"	"unprognostic (1.25e-2)"	"unprognostic (2.90e-2)"	"unprognostic (2.75e-1)"	"unprognostic (1.11e-2)"	"unprognostic (1.79e-2)"	2.2	0.2	0.1	0.3	0.2	292.0	4.8	1.0	0.5	0.3	0.2	0.2	0.0	0.1	0.0	2.1	1.9	0.0	0.8	0.3	0.2	0.3	1203.5	6.5	0.3	0.4	0.2	0.2	0.4	0.0	0.2	1.7	0.3	0.3	0.0	0.3	0.9	0.0	0.5	92.8	0.3	0.2	0.1	20.6	0.4	0.1	0.2	1.2	0.5	0.6	0.7	0.2	2.2	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.1	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.5	0.0	1.4	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.3	0.0	0.1	0.0	0.0	0.1	0.0	0.1	0.0	0.1	0.1	1.0	0.1	0.0	0.2	0.7	0.3	44.9	0.0	0.9	0.2	9.3	0.4	0.1	0.2	1.0	0.5	0.3	0.2	0.4	0.2	0.3	0.1	0.2	0.2	0.0	0.0	0.0	0.3	2.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	17.2	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.3	0.1	0.1	1.5	0.0	43.6	0.5	0.0	0.0	0.0	0.0	0.1	0.0	0.0	23.2	991.4	0.0	0.0	0.1	0.1	0.0	27.6	0.0	0.6	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.1
ARG2		ENSG00000081181	"Arginase 2"	P78540	14	67619920-67651708	"Cancer-related genes, Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Adaptive immunity, Arginine metabolism, Immunity, Innate immunity, Urea cycle"	Hydrolase	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"parathyroid gland: 220.0;prostate: 108.5;thyroid gland: 105.0"	"Cell type enhanced"	"Detected in many"		"Basal prostatic cells: 190.1;Collecting duct cells: 165.5;Glandular and luminal cells: 145.2;Proximal tubular cells: 220.9;Syncytiotrophoblasts: 601.3;Urothelial cells: 165.2"	"Cancer enhanced"	"Detected in all"		"prostate cancer: 49.9"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"HAP1: 58.2"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA000663, CAB009435"	Enhanced		Supported	Mitochondria		NA	NA			"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 18: Syncytiotrophoblasts - Pregnancy hormone signaling"	Mitochondria		"CAB009435: AB_2059089, HPA000663: AB_1078192"	"unprognostic (8.74e-3)"	"unprognostic (3.06e-2)"	"unprognostic (1.35e-2)"	"unprognostic (2.29e-1)"	"unprognostic (2.30e-1)"	"unprognostic (9.13e-2)"	"unprognostic (1.10e-2)"	"unprognostic (3.43e-3)"	"unprognostic (4.62e-3)"	"unprognostic (5.37e-2)"	"unprognostic (4.66e-3)"	"unprognostic (1.72e-1)"	"unprognostic (9.39e-2)"	"unprognostic (4.26e-1)"	"unprognostic (2.31e-1)"	"unprognostic (4.34e-1)"	"unprognostic (1.26e-1)"	2.8	7.3	5.6	2.9	6.1	0.5	4.8	6.9	13.9	17.0	7.9	2.7	3.7	7.0	3.6	16.3	1.8	9.3	3.4	6.3	11.6	64.0	3.8	3.8	0.5	6.4	7.7	18.7	5.0	220.0	45.6	8.8	9.2	108.5	1.4	22.3	17.0	5.8	35.7	2.1	15.3	3.7	5.1	0.9	3.2	3.4	6.5	3.0	105.0	52.6	1.7	17.8	9.9	5.6	8.9	1.5	14.4	9.4	2.1	0.1	20.1	6.7	17.4	20.6	34.5	36.3	4.5	14.6	1.9	4.3	9.4	2.1	58.2	26.8	24.9	0.7	14.6	6.7	2.6	41.9	6.2	1.8	37.8	1.1	33.6	10.2	49.7	1.6	35.4	37.7	19.4	0.1	1.4	4.4	2.5	1.4	27.2	4.0	0.5	0.8	2.0	16.8	16.8	14.3	31.5	12.2	4.2	4.2	6.4	32.9	15.1	1.2	7.3	6.4	15.9	0.7	5.0	1.3	2.4	4.9	12.8	7.5	10.9	0.1	0.4	0.7	0.3	0.1	0.1	0.2	0.1	0.3	0.5	0.7	0.2	0.2	0.6	0.1	0.4	0.0	0.9	1.0	5.6	6.1	6.9	13.9	6.3	11.6	6.4	7.7	9.2	5.1	6.5	5.6	3.9	0.0	5.8	5.5	8.4	8.8	190.1	17.0	7.4	5.2	41.6	28.7	6.3	4.3	20.3	165.5	10.4	86.5	14.6	9.0	37.2	8.4	16.5	75.1	18.7	5.9	36.8	8.8	20.3	3.3	6.2	5.6	37.8	145.2	7.0	23.9	2.9	1.3	14.7	10.1	41.8	24.5	12.2	0.6	3.6	3.2	0.3	9.3	10.6	7.5	0.9	40.5	1.0	9.0	9.2	5.0	5.0	0.4	5.7	95.4	72.8	220.9	3.0	17.6	6.6	6.2	8.9	8.4	3.4	9.7	5.4	601.3	15.1	2.2	8.7	165.2
ARSA		ENSG00000100299	"Arylsulfatase A"	P15289	22	50622754-50628173	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"		Hydrolase	"Disease variant, Ichthyosis, Leukodystrophy, Metachromatic leukodystrophy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Late spermatids: 127.5;Plasma cells: 132.0;Proximal enterocytes: 93.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"Karpas-707: 80.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA005554, CAB025183"	Enhanced		Uncertain	"Golgi apparatus,Cytosol"	"Intracellular and membrane"	NA	NA		5600000	"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 71: Testis - DNA repair"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 55: Plasma cells - Humoral immune response"	"Golgi apparatus"	Cytosol	"CAB025183: , HPA005554: AB_1078220"	"unprognostic (1.55e-1)"	"unprognostic (1.97e-1)"	"unprognostic (4.07e-2)"	"prognostic favorable (2.96e-5)"	"unprognostic (4.66e-2)"	"unprognostic (4.40e-1)"	"unprognostic (1.43e-2)"	"unprognostic (1.15e-1)"	"unprognostic (3.61e-2)"	"unprognostic (2.16e-1)"	"unprognostic (4.47e-2)"	"unprognostic (2.76e-1)"	"unprognostic (9.90e-2)"	"unprognostic (1.41e-2)"	"unprognostic (1.34e-1)"	"unprognostic (1.87e-1)"	"unprognostic (7.73e-3)"	28.8	25.1	14.4	15.6	18.0	18.4	27.2	16.8	21.8	21.3	27.5	31.3	30.8	22.4	8.6	28.1	25.1	15.7	33.0	14.9	15.2	31.4	42.8	29.1	19.8	20.0	15.9	11.3	46.7	11.7	34.7	10.9	19.1	28.9	8.2	4.4	39.6	16.2	25.3	17.5	33.8	6.5	16.3	44.5	30.3	54.0	19.4	9.8	32.3	5.1	9.5	23.9	24.7	21.0	8.5	11.0	5.3	10.9	41.8	21.8	13.5	13.0	15.9	5.7	9.3	3.3	12.9	5.3	8.2	22.9	10.8	12.8	1.2	12.3	1.0	2.7	8.0	3.4	14.3	12.5	28.3	5.2	32.7	26.0	24.4	9.5	6.3	19.9	12.8	11.5	3.5	80.4	12.1	9.6	4.6	5.8	1.7	9.0	11.2	4.0	0.4	26.7	9.9	13.5	2.5	8.2	18.2	17.2	10.1	5.1	7.7	6.6	22.1	3.8	15.1	14.9	4.1	18.4	1.9	4.5	11.7	4.3	13.6	10.4	27.7	36.1	17.3	33.3	15.1	10.4	12.4	14.2	22.7	12.5	7.3	10.0	60.4	8.9	43.2	32.1	18.2	16.3	14.4	18.0	16.8	21.8	14.9	15.2	20.0	15.9	19.1	16.3	19.4	21.0	22.8	6.4	12.9	24.5	22.2	4.7	14.0	23.8	18.8	5.3	18.9	13.1	8.0	27.1	15.5	12.9	4.2	11.5	14.0	85.4	1.9	29.4	62.4	24.4	10.3	13.4	36.7	9.7	9.4	21.3	19.9	19.6	41.3	21.3	6.3	15.3	8.2	28.6	36.8	6.7	8.6	30.6	14.2	29.0	9.5	127.5	10.8	29.2	17.8	10.3	28.7	10.3	8.2	8.0	11.9	24.2	75.2	6.0	132.0	10.8	93.9	22.7	21.2	7.2	0.0	6.6	9.9	48.3	4.1	18.3	5.5	13.3	17.2	7.2	25.0	16.1
ARSB		ENSG00000113273	"Arylsulfatase B"	P15848	5	78777209-78986087	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"		Hydrolase	"Disease variant, Ichthyosis, Leukodystrophy, Metachromatic leukodystrophy, Mucopolysaccharidosis"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 40.8;Excitatory neurons: 37.4;Inhibitory neurons: 42.5;Microglial cells: 40.3;Oligodendrocyte precursor cells: 71.4;Oligodendrocytes: 56.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"eosinophil: 25.6"	"Group enriched"	"Detected in many"	7	"dendritic cells: 7.8;granulocytes: 25.6;monocytes: 8.3"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA037770, HPA037771"	Approved		Approved	"Golgi apparatus"	"Intracellular and membrane"	NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 7: Kidney - Transmembrane transport"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 68: Oligodendrocytes - Mixed function"	"Golgi apparatus"		"HPA037770: AB_10671719, HPA037771: AB_10671720"	"unprognostic (1.61e-1)"	"unprognostic (1.02e-1)"	"unprognostic (1.97e-2)"	"unprognostic (1.09e-2)"	"unprognostic (7.34e-2)"	"unprognostic (2.65e-1)"	"unprognostic (8.69e-3)"	"unprognostic (3.77e-2)"	"unprognostic (1.22e-1)"	"unprognostic (7.20e-2)"	"unprognostic (1.74e-1)"	"unprognostic (3.59e-2)"	"unprognostic (2.48e-2)"	"unprognostic (9.57e-3)"	"unprognostic (9.88e-2)"	"unprognostic (6.54e-3)"	"prognostic unfavorable (3.42e-4)"	6.9	4.5	3.9	8.1	3.9	8.1	2.6	3.1	4.6	5.3	4.2	5.5	3.1	6.4	3.5	4.8	2.9	7.3	8.3	4.7	3.6	21.3	7.6	7.0	5.4	4.6	5.3	2.2	4.6	6.6	2.5	11.5	4.0	5.0	8.2	6.7	3.1	6.6	3.8	2.1	3.6	14.1	4.3	5.2	3.9	2.6	5.2	2.6	4.2	4.3	4.8	8.0	2.3	5.0	5.0	11.3	18.6	6.3	41.9	16.4	16.7	29.2	23.0	18.9	23.0	9.9	8.4	6.5	31.5	25.5	29.0	3.9	7.0	7.4	18.5	55.6	6.2	9.2	11.2	40.1	9.7	10.5	10.4	19.4	2.4	19.7	6.5	15.6	22.4	3.9	2.0	12.9	19.6	9.2	5.8	19.3	5.6	1.1	6.7	7.7	10.9	5.9	12.0	6.2	6.8	15.9	20.3	6.2	12.1	12.7	6.9	26.2	16.2	17.5	10.4	7.6	26.4	14.8	28.0	7.2	21.6	21.4	40.3	19.0	8.3	25.6	1.0	6.7	0.6	2.0	0.4	0.4	7.8	1.3	0.3	0.5	4.6	0.2	5.6	5.7	0.7	2.7	3.9	3.9	3.1	4.6	4.7	3.6	4.6	5.3	4.0	4.3	5.2	5.0	3.9	0.0	2.0	40.8	5.1	0.8	1.4	1.3	0.6	3.7	1.6	1.0	7.2	1.5	0.7	3.7	6.2	2.2	5.5	1.4	3.9	3.7	0.5	1.9	7.2	4.5	1.2	16.2	37.4	9.2	5.1	6.6	2.6	9.0	0.0	6.3	13.6	3.8	16.7	6.7	42.5	6.0	0.0	25.2	14.3	0.5	4.4	15.9	14.2	40.3	16.1	3.6	2.1	71.4	56.2	4.0	3.0	3.8	8.1	2.2	0.5	18.8	2.5	2.7	6.6	5.0	4.4	2.2	3.1	0.7	1.3	2.6	3.4	1.6	2.2	1.3
ARSG	KIAA1001	ENSG00000141337	"Arylsulfatase G"	Q96EG1	17	68259182-68422731	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"		Hydrolase	"Deafness, Disease variant, Retinitis pigmentosa, Usher syndrome"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"epididymis: 30.2"	"Cell type enhanced"	"Detected in many"		"Cone photoreceptor cells: 54.2;NK-cells: 42.2;Rod photoreceptor cells: 59.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA023245, HPA023285"	Enhanced				"Intracellular and membrane"	NA	NA		4400000	"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 30: Epididymis - Antimicrobial activity"	"Cluster 6: T47d - Mammary gland"	"Cluster 9: Photoreceptor cells - Phototransduction"			"HPA023245: AB_1845056, HPA023285: AB_1845057"	"unprognostic (3.66e-2)"	"unprognostic (1.48e-1)"	"unprognostic (1.78e-1)"	"unprognostic (1.61e-1)"	"unprognostic (9.02e-2)"	"unprognostic (3.67e-3)"	"unprognostic (4.11e-1)"	"unprognostic (1.14e-3)"	"unprognostic (5.18e-2)"	"unprognostic (5.47e-2)"	"unprognostic (6.11e-7)"	"unprognostic (4.24e-3)"	"prognostic favorable (7.04e-4)"	"unprognostic (1.87e-2)"	"unprognostic (3.68e-2)"	"unprognostic (3.18e-2)"	"unprognostic (1.49e-1)"	2.6	4.6	1.5	2.9	2.0	3.4	5.5	6.6	2.0	3.5	8.6	2.2	1.1	3.8	30.2	4.4	6.6	2.1	4.9	1.1	2.9	3.0	2.5	2.4	3.9	2.5	3.6	6.2	2.3	1.2	5.3	2.6	3.6	2.0	1.1	7.8	3.3	5.5	3.7	4.5	1.9	2.1	0.7	4.9	2.6	2.1	2.1	2.5	7.5	3.0	3.6	2.0	2.0	1.4	1.4	1.7	1.3	2.1	7.0	4.3	5.7	1.9	5.7	2.7	1.3	0.7	3.2	3.3	4.8	2.5	1.1	0.2	2.2	0.7	1.0	4.8	2.0	1.8	1.8	5.4	5.7	5.1	3.6	1.6	1.3	0.7	2.8	7.2	3.1	5.0	1.0	9.5	1.2	6.2	5.9	4.1	2.0	0.6	1.6	0.2	1.0	8.8	4.1	0.9	7.0	0.6	2.3	5.5	12.1	2.7	13.5	6.1	3.3	4.2	0.4	1.6	0.7	10.5	5.8	5.0	3.3	6.4	1.6	7.1	8.5	6.5	6.3	6.1	4.4	4.0	4.2	6.0	7.7	2.2	4.2	6.0	12.8	4.3	5.2	1.2	4.7	5.4	1.5	2.0	6.6	2.0	1.1	2.9	2.5	3.6	3.6	0.7	2.1	1.4	4.9	3.2	2.7	11.8	7.7	4.0	5.0	4.7	0.0	23.8	9.2	3.8	2.7	8.6	4.8	12.9	54.2	8.1	11.2	3.6	9.8	3.2	0.4	8.7	9.2	8.6	1.8	5.3	18.8	4.7	23.8	24.3	2.6	11.7	3.8	6.4	17.5	3.0	9.2	26.9	26.0	5.2	0.0	6.9	10.7	1.3	13.4	8.4	23.2	12.2	16.0	9.4	42.2	7.1	2.7	2.3	10.9	23.0	11.1	10.0	2.4	12.8	4.3	59.6	6.6	8.7	5.5	1.4	3.6	6.0	3.8	16.8	13.6	9.3	2.3	8.8
ASAH1	"AC, ACDase, ASAH, FLJ21558, PHP32"	ENSG00000104763	"N-acylsphingosine amidohydrolase 1"	Q13510	8	18055992-18084998	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"Lipid metabolism, Sphingolipid metabolism"	Hydrolase	"Disease variant, Epilepsy, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"heart muscle: 573.9"	"Cell type enhanced"	"Detected in all"		"Cardiomyocytes: 777.0;Hofbauer cells: 921.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"ASC diff: 392.8;SK-MEL-30: 590.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA005468	Supported				"Intracellular and membrane"	NA	NA		400000	"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 44: Heart - Cardiac muscle contraction"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 4: Macrophages - Innate immune response"			"HPA005468: AB_1845062"	"unprognostic (1.99e-1)"	"unprognostic (1.86e-1)"	"unprognostic (4.15e-3)"	"unprognostic (9.23e-2)"	"unprognostic (4.69e-2)"	"unprognostic (4.63e-2)"	"unprognostic (2.25e-2)"	"unprognostic (4.29e-3)"	"unprognostic (2.44e-1)"	"unprognostic (4.85e-2)"	"unprognostic (1.89e-1)"	"unprognostic (3.03e-2)"	"prognostic favorable (3.08e-8)"	"unprognostic (1.95e-1)"	"unprognostic (3.91e-2)"	"unprognostic (6.54e-3)"	"unprognostic (7.36e-3)"	214.3	71.9	50.1	51.6	51.5	107.7	95.8	62.1	50.8	98.5	62.6	84.3	54.7	55.8	131.5	73.2	70.4	99.1	573.9	49.9	66.2	204.0	60.9	190.3	65.9	66.0	59.4	50.1	49.6	117.8	83.6	121.5	69.0	84.3	87.0	79.5	66.6	77.9	66.0	52.6	56.8	61.7	66.3	85.4	61.2	18.2	59.1	26.0	325.5	70.7	57.7	112.8	54.8	102.2	48.1	66.4	25.9	63.3	392.8	46.0	39.2	48.2	67.3	23.0	41.0	35.4	66.1	30.2	60.3	54.5	159.1	62.6	15.0	25.3	28.4	22.9	38.9	134.4	46.7	96.7	107.5	27.7	140.7	100.2	86.5	33.6	22.9	53.2	6.2	50.6	24.3	61.7	67.9	46.0	15.5	48.3	30.3	105.2	40.5	19.4	25.5	41.4	112.0	273.0	40.4	55.0	43.8	145.2	590.5	35.6	47.9	31.3	43.6	30.3	43.1	55.8	23.7	75.5	184.3	22.0	89.5	61.3	24.6	285.2	455.4	318.7	47.6	676.4	43.1	83.9	35.5	36.1	175.1	65.9	40.8	37.9	627.6	60.5	731.4	33.0	43.7	407.2	50.1	51.5	62.1	50.8	49.9	66.2	66.0	59.4	69.0	66.3	59.1	102.2	98.5	317.3	405.0	36.9	92.8	58.6	83.3	103.7	35.3	97.5	105.6	87.8	777.0	100.1	280.9	450.6	45.9	177.4	67.6	83.4	60.7	150.6	2.8	85.7	51.5	79.7	98.1	106.3	49.8	104.1	65.2	122.0	43.3	133.8	257.0	49.3	134.6	50.6	921.2	77.4	53.2	99.3	201.4	564.3	89.9	6.0	88.6	524.6	318.4	56.2	259.2	532.6	53.5	49.8	49.0	64.7	125.5	105.7	87.4	87.8	77.6	304.2	147.3	88.0	177.5	74.5	157.0	14.0	63.6	84.9	64.2	148.2	61.3	53.4	89.7	139.9
ASAH2		ENSG00000188611	"N-acylsphingosine amidohydrolase 2"	Q9NR71	10	50182778-50279720	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Apoptosis, Lipid metabolism, Sphingolipid metabolism"	Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	10	"intestine: 81.5"	"Cell type enhanced"	"Detected in some"		"Late spermatids: 12.5;Muller glia cells: 9.0;Proximal enterocytes: 17.1;Sertoli cells: 6.6"	"Low cancer specificity"	"Detected in single"			"Region enhanced"	"Detected in many"		"cerebellum: 8.1"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"							HPA061171	Supported		Approved	"Focal adhesion sites"	"Intracellular and membrane"	NA	NA		2200000	"Cluster 32: T-cells - Unknown function"	"Cluster 56: Intestine - Transmembrane transport"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 45: Enterocytes - Digestion"	"Focal adhesion sites"		"HPA061171: AB_2684442"	"unprognostic (3.59e-2)"	"unprognostic (3.63e-2)"	"unprognostic (1.66e-1)"	"unprognostic (3.84e-2)"	"unprognostic (3.66e-1)"	"unprognostic (4.48e-2)"	"unprognostic (2.25e-2)"	"unprognostic (1.08e-1)"	"unprognostic (1.65e-2)"	"unprognostic (4.33e-2)"	"unprognostic (2.17e-1)"	"unprognostic (1.14e-1)"	"unprognostic (8.29e-2)"	"unprognostic (1.86e-2)"	"unprognostic (5.64e-2)"	"unprognostic (3.22e-1)"	"unprognostic (1.02e-3)"	0.4	0.8	0.0	0.2	1.1	0.0	0.5	8.1	0.4	0.7	0.1	0.8	81.5	0.8	0.5	0.7	0.8	0.3	0.8	0.1	0.4	0.5	2.9	0.6	0.3	3.2	2.9	0.8	1.4	0.6	0.6	0.6	2.2	0.4	0.4	7.3	0.6	0.2	0.8	0.7	64.6	1.2	1.5	0.2	5.0	0.8	0.6	0.5	0.7	0.4	0.1	0.5	0.4	0.6	1.2	0.9	1.0	1.4	1.8	0.7	1.3	1.2	0.9	2.5	2.2	0.7	3.0	0.0	1.4	1.9	2.0	1.1	1.4	0.4	3.0	1.6	2.5	0.9	2.2	1.9	1.1	0.3	0.1	0.2	1.7	4.3	4.8	0.3	0.5	0.0	1.7	0.8	1.7	1.1	1.0	0.0	3.2	0.0	2.7	0.0	4.2	1.1	1.3	0.2	1.8	4.8	1.7	1.2	2.1	2.4	1.0	0.7	1.4	1.2	2.8	3.2	4.0	1.2	0.1	0.0	3.5	0.0	1.1	0.0	0.0	0.0	0.1	0.0	0.4	0.2	0.0	0.3	0.0	0.0	0.3	0.4	0.0	0.0	0.0	0.2	0.1	0.0	0.0	1.1	8.1	0.4	0.1	0.4	3.2	2.9	2.2	1.5	0.6	0.6	0.1	0.0	0.0	0.7	0.0	0.4	0.3	0.4	0.0	2.8	0.4	0.3	3.8	0.0	0.9	0.0	2.1	0.4	1.4	0.5	0.0	0.9	4.8	0.1	0.2	0.5	0.0	3.2	1.1	1.6	0.3	0.6	0.0	0.2	0.0	0.2	0.4	2.1	0.2	1.7	1.5	1.8	0.0	0.0	0.0	12.5	1.2	0.0	0.0	0.0	0.0	9.0	1.0	0.0	0.2	1.6	0.1	1.5	0.0	0.3	17.1	1.0	0.7	2.1	6.6	0.6	0.9	1.9	0.9	0.0	0.1	0.3	0.5	0.2	1.2	0.2
ASCC3	"ASC1p200, dJ121G13.4, dJ467N11.1, HELIC1, RNAH"	ENSG00000112249	"Activating signal cointegrator 1 complex subunit 3"	Q8N3C0	6	100508194-100881372	"Enzymes, Predicted intracellular proteins"	"DNA damage, DNA repair, Transcription, Transcription regulation"	"Helicase, Hydrolase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Excitatory neurons: 166.0;Inhibitory neurons: 166.2;Oligodendrocyte precursor cells: 150.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA031608, HPA031609, HPA031610"	Enhanced		Supported	"Golgi apparatus,Cytosol"		NA	NA			"Cluster 6: Non-specific - Transcription"	"Cluster 34: Non-specific - Transcription"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Cytosol	"Golgi apparatus"	"HPA031608: AB_10599970, HPA031609: AB_10600777, HPA031610: AB_10611526"	"unprognostic (6.79e-2)"	"unprognostic (1.46e-2)"	"unprognostic (2.96e-3)"	"unprognostic (1.12e-1)"	"unprognostic (9.70e-3)"	"unprognostic (4.56e-2)"	"unprognostic (1.50e-1)"	"unprognostic (5.14e-2)"	"unprognostic (4.02e-1)"	"unprognostic (3.34e-1)"	"unprognostic (5.08e-3)"	"unprognostic (1.16e-1)"	"unprognostic (9.91e-2)"	"unprognostic (1.90e-1)"	"unprognostic (1.56e-1)"	"unprognostic (1.01e-1)"	"unprognostic (1.55e-2)"	6.0	6.6	4.1	10.0	5.3	11.2	9.2	6.6	4.2	10.2	7.7	9.3	8.2	7.9	8.5	8.4	5.8	7.5	6.5	3.9	5.2	5.0	12.5	7.1	10.1	4.7	4.3	5.9	6.4	10.7	6.2	12.9	5.1	9.2	11.3	5.7	6.3	8.1	6.0	7.2	8.5	8.5	4.7	8.3	8.6	8.6	4.6	12.7	7.2	5.4	11.0	14.8	7.4	6.0	16.8	21.1	30.1	18.6	32.9	41.7	48.0	71.5	45.5	24.1	27.6	43.3	13.0	52.1	14.4	48.3	19.0	37.6	26.2	63.5	38.7	35.2	23.2	38.7	36.0	27.8	30.1	41.0	28.5	38.1	31.7	35.4	44.2	22.6	45.1	20.5	47.1	23.0	67.3	16.5	21.1	12.7	15.9	31.8	16.4	24.7	23.3	18.7	23.7	46.6	20.2	15.3	30.1	26.7	12.5	53.3	14.7	23.2	64.2	26.9	20.6	23.3	30.4	9.9	11.3	46.4	19.4	30.6	29.0	6.2	2.7	1.8	4.3	4.3	5.2	4.2	3.8	4.0	2.9	5.7	4.3	4.2	0.2	4.4	3.8	6.4	3.1	1.4	4.1	5.3	6.6	4.2	3.9	5.2	4.7	4.3	5.1	4.7	4.6	6.0	32.7	32.1	24.9	58.1	45.4	25.5	41.3	33.3	19.4	27.0	24.1	24.0	32.0	20.0	37.7	3.7	22.9	24.4	49.0	17.3	11.7	23.1	11.3	30.1	77.3	25.2	13.8	20.8	166.0	25.1	66.3	32.2	46.9	35.0	22.1	29.9	10.4	30.3	17.7	28.6	166.2	22.8	22.4	17.2	12.5	3.7	23.0	27.5	5.4	103.0	26.2	14.6	29.9	150.8	132.3	28.6	14.4	17.3	66.4	66.9	17.5	10.6	32.0	31.1	6.6	39.6	30.0	50.2	30.3	38.2	27.4	38.0	43.7	42.6	23.5	65.4
ASMTL		ENSG00000169093	"Acetylserotonin O-methyltransferase like"	O95671	X	1403139-1453762	"Enzymes, Predicted intracellular proteins"	"Nucleotide metabolism"	"Hydrolase, Methyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Horizontal cells: 92.5;monocytes: 106.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HMC-1: 131.0"					"Low region specificity"	"Detected in all"			"HPA003630, HPA021865"	Supported		Enhanced	Cytosol		NA	NA		17000	"Cluster 31: Non-specific - Inflammatory response"	"Cluster 72: Non-specific - Transcription"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 3: Monocytes - Immune response regulation"	Cytosol		"HPA003630: AB_1078230, HPA021865: AB_1845099"	"unprognostic (3.89e-2)"	"unprognostic (1.14e-3)"	"unprognostic (2.28e-1)"	"unprognostic (1.87e-2)"	"unprognostic (7.99e-2)"	"unprognostic (9.05e-2)"	"unprognostic (8.17e-2)"	"unprognostic (5.23e-2)"	"unprognostic (8.40e-2)"	"unprognostic (1.24e-1)"	"unprognostic (1.91e-3)"	"unprognostic (7.24e-2)"	"unprognostic (3.26e-3)"	"unprognostic (9.70e-2)"	"unprognostic (8.38e-2)"	"unprognostic (2.91e-1)"	"unprognostic (2.20e-1)"	28.1	21.8	15.6	15.7	15.1	17.4	26.8	15.1	20.3	29.1	23.0	30.8	11.7	29.4	14.3	15.1	28.6	13.6	34.5	15.7	16.5	23.1	32.1	18.3	21.4	20.4	18.4	33.9	23.6	22.4	31.0	11.2	18.3	26.8	7.8	9.4	24.8	23.4	23.8	27.7	20.6	12.2	15.9	24.1	23.1	13.0	16.6	20.0	29.5	15.3	12.4	25.1	22.9	18.0	14.0	24.0	28.0	21.4	16.5	25.5	38.9	16.3	21.3	18.2	23.2	22.0	16.5	24.6	9.0	21.5	19.7	5.1	7.4	7.9	11.4	36.7	23.9	21.4	17.0	26.6	37.5	10.1	131.0	33.9	13.4	13.9	13.4	20.3	21.7	18.7	11.0	19.3	14.6	52.4	43.5	39.6	33.9	12.9	15.0	35.2	26.7	60.0	12.8	7.6	1.1	13.2	21.9	27.8	20.7	18.9	6.4	13.4	28.6	15.2	16.5	29.0	6.1	24.8	8.0	62.9	19.3	14.5	4.6	45.7	25.5	65.9	28.8	30.9	25.6	24.2	26.1	26.9	22.0	37.7	22.5	17.7	37.2	52.9	22.5	42.1	31.4	23.2	15.6	15.1	15.1	20.3	15.7	16.5	20.4	18.4	18.3	15.9	16.6	18.0	20.6	12.8	9.4	5.2	19.3	18.4	25.3	17.2	23.3	17.7	16.4	17.4	21.3	10.0	9.9	14.7	4.2	33.4	28.8	16.1	27.4	15.2	0.9	8.8	14.3	19.5	14.4	7.4	8.3	17.1	24.1	23.8	14.8	10.4	54.6	27.0	17.9	30.8	20.3	92.5	6.7	17.9	8.2	12.3	31.0	2.8	26.1	18.8	12.4	9.4	106.2	17.1	26.8	5.0	7.1	10.9	18.3	43.2	21.8	22.1	19.9	34.2	11.1	12.6	32.9	21.4	23.2	2.5	8.2	22.3	15.6	66.4	20.4	21.9	20.4	18.4
ASPA	"ACY2, ASP"	ENSG00000108381	Aspartoacylase	P45381	17	3472374-3503405	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"		Hydrolase	"Disease variant, Leukodystrophy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 69.0;kidney: 38.2"	"Cell type enhanced"	"Detected in many"		"Leydig cells: 49.7;Melanocytes: 46.2;Oligodendrocytes: 217.0;Peritubular cells: 48.2;Proximal enterocytes: 37.5;Proximal tubular cells: 74.8"	"Cancer enhanced"	"Detected in some"		"renal cancer: 7.7"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"ASC diff: 5.4;ASC TERT1: 4.1;CACO-2: 3.8;HSkMC: 7.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA022142, HPA022145"	Enhanced		Supported	Cytosol		NA	NA			"Cluster 11: Basophils - Unknown function"	"Cluster 45: Intestine - Brush border"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	Cytosol		"HPA022142: AB_1845102, HPA022145: AB_1845103"	"unprognostic (4.42e-2)"	"unprognostic (4.79e-2)"	"unprognostic (2.02e-2)"	"unprognostic (2.79e-3)"	"unprognostic (4.36e-2)"	"unprognostic (5.01e-1)"	"unprognostic (1.08e-3)"	"unprognostic (3.57e-1)"	"unprognostic (4.17e-1)"	"unprognostic (3.43e-1)"	"unprognostic (5.27e-2)"	"unprognostic (6.27e-2)"	"unprognostic (1.25e-1)"	"unprognostic (7.07e-4)"	"unprognostic (2.77e-1)"	"unprognostic (4.68e-1)"	"unprognostic (1.49e-1)"	13.9	4.3	25.9	1.8	46.4	1.8	4.1	27.6	40.9	7.5	14.2	4.3	11.2	4.5	6.0	4.9	5.5	3.6	2.7	25.8	27.7	38.2	15.0	3.5	1.5	30.4	35.4	2.9	1.0	0.8	0.8	3.5	29.5	4.1	4.9	2.8	1.8	5.0	11.9	5.2	15.6	3.1	24.7	5.4	4.4	6.6	42.4	0.6	2.1	15.0	0.7	6.3	4.3	69.0	0.2	0.1	0.5	0.5	5.4	4.1	0.3	0.2	0.1	0.2	0.1	3.8	0.2	0.6	0.2	0.7	0.3	0.3	0.3	0.1	0.2	2.0	0.1	0.4	0.7	0.2	0.5	0.4	0.4	7.5	0.3	0.4	0.1	0.1	0.1	0.4	0.3	1.1	0.2	0.2	0.2	0.6	0.4	0.2	0.3	0.3	0.3	0.6	0.2	1.1	0.4	0.3	1.1	0.3	0.9	0.4	0.3	0.2	0.4	0.6	0.4	0.4	0.3	0.7	0.4	0.4	0.2	0.4	0.5	1.1	0.1	0.2	0.2	0.1	0.2	0.2	0.2	0.2	0.1	0.3	0.2	0.2	0.7	0.3	0.1	0.2	0.1	0.0	25.9	46.4	27.6	40.9	25.8	27.7	30.4	35.4	29.5	24.7	42.4	69.0	5.1	9.6	1.5	12.1	0.1	5.2	1.5	1.6	6.2	5.5	2.1	0.8	1.3	2.8	1.0	25.8	0.0	0.0	0.0	0.3	7.9	0.2	5.0	0.1	4.1	1.1	2.4	2.7	0.6	0.2	0.1	15.0	2.0	0.2	0.0	0.1	3.9	11.5	0.2	8.4	0.4	0.8	2.0	0.8	1.5	2.5	49.7	0.8	46.2	3.7	0.0	4.1	0.0	1.5	217.0	0.0	2.5	48.2	0.2	0.4	37.5	74.8	0.1	0.5	0.0	8.5	11.6	11.1	0.6	0.7	1.7	0.1	0.4	28.3	1.8	2.7
ASPG	C14orf76	ENSG00000166183	Asparaginase	Q86U10	14	104085686-104115582	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Lipid degradation, Lipid metabolism"	"Acyltransferase, Hydrolase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"heart muscle: 102.4;liver: 151.1"	"Cell type enhanced"	"Detected in many"		"Cardiomyocytes: 21.4;Distal enterocytes: 21.2;Granulosa cells: 66.8;Hepatocytes: 93.9;Proximal tubular cells: 49.7"	"Cancer enhanced"	"Detected in many"		"liver cancer: 4.4"	"Low region specificity"	"Detected in single"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			HPA069761	Enhanced					NA	NA				"Cluster 85: Liver - Metabolism"		"Cluster 40: Granulosa cells - Unknown function"			"HPA069761: AB_2686191"	"unprognostic (1.45e-2)"	"unprognostic (7.43e-3)"	"unprognostic (2.38e-3)"	"unprognostic (1.30e-1)"	"unprognostic (7.23e-2)"	"unprognostic (1.74e-2)"	"unprognostic (1.72e-2)"	"unprognostic (3.47e-2)"	"unprognostic (1.98e-1)"	"unprognostic (2.20e-1)"	"unprognostic (2.50e-1)"	"unprognostic (1.10e-1)"	"unprognostic (8.75e-2)"	"unprognostic (7.98e-2)"	"unprognostic (3.85e-1)"	"unprognostic (1.52e-2)"	"unprognostic (2.32e-2)"	1.1	1.4	0.1	0.2	0.2	0.0	0.7	0.0	0.4	5.4	0.2	4.7	1.5	2.2	1.1	34.0	6.2	0.1	102.4	0.3	0.3	12.8	151.1	2.3	0.0	0.4	0.6	11.4	0.2	0.8	2.3	1.8	0.2	0.3	1.9	0.3	2.8	0.1	0.5	9.9	0.5	1.2	0.0	0.2	3.1	1.1	1.1	0.1	5.9	0.0	3.7	2.3	9.6	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.3	0.5	0.2	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.8	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.2	0.2	0.0	0.2	0.1	0.6	0.5	0.4	0.3	0.0	0.0	0.2	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.4	0.3	0.3	0.4	0.6	0.2	0.0	1.1	0.0	0.0	6.4	1.7	0.3	0.5	1.8	0.2	0.7	0.0	1.1	0.6	0.8	21.4	2.8	2.4	0.0	0.0	0.2	0.0	21.2	3.9	0.0	0.4	0.7	0.1	0.5	1.8	0.0	0.1	0.2	0.2	4.3	4.6	0.7	0.0	66.8	3.6	93.9	0.2	5.0	0.1	16.0	0.0	1.6	0.3	0.7	0.0	0.4	0.0	0.0	0.0	0.4	0.0	0.0	0.2	0.4	7.6	1.2	0.0	0.1	0.9	49.7	1.6	0.3	0.0	0.0	0.6	0.3	1.5	8.4	9.1	0.5	0.3	3.9	5.4	3.0
ASRGL1	"ALP, ALP1, FLJ22316"	ENSG00000162174	"Asparaginase and isoaspartyl peptidase 1"	Q7L266	11	62337448-62393412	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Hydrolase, Protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 112.7;cervix: 121.7;testis: 100.5"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 372.5;Endometrial ciliated cells: 414.6;Glandular and luminal cells: 437.1;Late spermatids: 597.6;Proximal tubular cells: 214.1;Spermatocytes: 534.3"	"Cancer enhanced"	"Detected in all"		"endometrial cancer: 53.4"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"basophil: 277.9;eosinophil: 269.5"	"Lineage enriched"	"Detected in all"	4	"granulocytes: 277.9"	"Cell line enhanced"	"Detected in many"		"EFO-21: 85.2;HAP1: 83.9;SCLC-21H: 112.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA029725, HPA055572, CAB070192"	Enhanced		Approved	"Nucleoplasm,Microtubules,Cytokinetic bridge"		Yes	NA			"Cluster 2: Granulocytes - Unknown function"	"Cluster 49: Ciliated cells - Cilium organization"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 44: Endometrium - Transcription"	Microtubules	"Nucleoplasm, Cytokinetic bridge"	"CAB070192: AB_2665720, HPA029725: AB_10602328, HPA055572: AB_2682854"	"unprognostic (1.14e-1)"	"unprognostic (8.38e-3)"	"prognostic favorable (6.14e-4)"	"prognostic favorable (1.56e-5)"	"unprognostic (5.35e-2)"	"unprognostic (8.19e-2)"	"prognostic unfavorable (9.46e-4)"	"unprognostic (8.67e-2)"	"unprognostic (1.85e-1)"	"unprognostic (3.54e-2)"	"unprognostic (2.71e-1)"	"unprognostic (4.44e-1)"	"prognostic favorable (4.32e-7)"	"unprognostic (2.28e-2)"	"unprognostic (1.53e-1)"	"unprognostic (5.43e-3)"	"unprognostic (1.40e-1)"	13.8	3.7	94.2	6.5	95.4	14.4	12.0	92.5	103.5	121.7	71.7	14.2	6.8	26.4	3.1	2.1	68.1	11.2	6.2	87.1	93.3	42.5	10.2	25.8	5.6	87.5	102.7	1.8	13.4	2.3	21.2	3.2	87.6	23.8	17.1	17.8	13.2	7.2	7.3	2.9	9.5	4.4	83.4	4.7	15.1	100.5	112.7	10.3	6.7	3.0	4.7	4.3	2.0	90.0	2.4	19.5	20.9	27.2	0.1	0.0	16.4	2.3	0.8	3.6	3.5	32.0	8.5	1.9	85.2	0.3	9.3	1.8	83.9	0.7	4.2	2.6	34.4	1.2	28.1	23.5	0.6	24.0	30.8	0.8	0.2	1.6	0.4	1.3	39.4	47.8	24.5	21.5	0.9	37.5	65.3	15.9	28.5	13.6	15.2	26.1	12.5	11.8	73.3	5.9	112.3	16.1	16.4	28.2	14.4	21.2	15.0	12.1	2.0	0.4	15.4	1.2	9.5	32.8	33.6	3.0	0.8	12.3	9.7	277.9	68.6	269.5	2.8	50.8	1.9	2.4	1.0	3.3	39.7	1.5	2.3	3.4	16.3	11.5	38.5	7.2	0.8	24.2	94.2	95.4	92.5	103.5	87.1	93.3	87.5	102.7	87.6	83.4	112.7	90.0	29.2	6.4	27.8	56.8	5.2	3.4	2.5	2.2	0.6	24.4	13.8	6.6	2.4	42.9	4.1	22.0	33.3	2.3	3.2	14.0	133.1	30.3	372.5	414.6	39.9	31.2	47.2	14.1	13.9	22.3	2.4	4.0	19.9	437.1	80.9	16.6	49.2	3.7	25.0	16.8	18.6	67.4	6.1	11.4	6.4	597.6	8.7	26.9	1.8	9.4	10.5	80.8	4.1	15.1	22.0	7.8	7.5	7.2	13.9	35.4	2.9	214.1	5.4	37.1	13.1	7.7	6.1	534.3	48.6	0.1	1.3	0.8	7.8	10.8	36.0	15.9
ATIC	"AICARFT, IMPCHASE, PURH"	ENSG00000138363	"5-aminoimidazole-4-carboxamide ribonucleotide formyltransferase/IMP cyclohydrolase"	P31939	2	215311956-215349773	"Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Purine biosynthesis"	"Hydrolase, Multifunctional enzyme, Transferase"	"Cancer-related genes, Disease variant, Epilepsy, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Cytotrophoblasts: 171.4;Extravillous trophoblasts: 166.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB013462, HPA021012"	Supported		Approved	"Plasma membrane,Cytosol"		NA	NA		3900000	"Cluster 44: Non-specific - Transcription"	"Cluster 3: T-cells - Adaptive immune response"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 38: Extravillous trophoblasts - Unknown function"	Cytosol	"Plasma membrane"	"CAB013462: , HPA021012: AB_1845169"	"unprognostic (1.41e-2)"	"unprognostic (2.18e-1)"	"unprognostic (1.13e-2)"	"unprognostic (8.46e-2)"	"unprognostic (2.90e-1)"	"unprognostic (3.81e-2)"	"prognostic unfavorable (1.99e-7)"	"unprognostic (1.86e-2)"	"unprognostic (5.07e-2)"	"unprognostic (1.83e-1)"	"unprognostic (6.31e-3)"	"unprognostic (9.21e-2)"	"prognostic unfavorable (8.77e-4)"	"unprognostic (1.00e-1)"	"unprognostic (1.30e-1)"	"unprognostic (4.18e-2)"	"unprognostic (4.39e-3)"	24.8	26.0	19.8	31.7	23.4	26.4	33.9	21.4	23.5	22.2	18.8	36.4	32.0	30.0	20.3	19.4	29.4	20.4	21.3	19.6	21.5	32.7	34.6	18.0	44.9	20.5	21.5	32.0	26.2	29.6	18.6	37.3	23.3	28.7	47.5	19.1	18.8	38.4	43.2	23.8	27.2	37.0	21.0	27.6	24.5	20.1	22.9	41.8	22.5	25.4	51.8	29.1	17.6	27.5	102.2	133.8	85.1	144.0	112.5	113.2	40.6	105.4	91.9	117.4	134.9	278.6	157.3	149.6	122.8	110.0	164.5	106.7	187.8	157.0	169.5	113.4	189.3	179.1	108.7	271.5	145.4	226.1	92.0	98.4	119.8	154.7	188.5	82.0	79.7	144.5	237.0	124.4	166.3	178.7	203.4	112.1	330.3	167.4	84.9	185.8	117.3	133.4	126.4	146.5	129.3	87.8	84.3	103.1	124.3	189.2	169.7	82.9	70.2	96.0	101.2	127.3	65.8	160.3	195.7	300.1	85.6	124.5	146.8	12.6	16.4	0.4	34.6	23.5	59.1	56.6	49.0	53.8	36.3	39.9	50.0	46.9	1.8	55.4	21.1	31.7	50.2	29.0	19.8	23.4	21.4	23.5	19.6	21.5	20.5	21.5	23.3	21.0	22.9	27.5	7.2	12.8	19.3	18.6	34.7	15.0	28.2	55.0	30.7	10.0	18.2	16.1	21.1	28.6	33.3	23.9	4.2	171.4	23.3	17.6	27.4	45.2	1.1	20.7	28.2	6.1	19.2	32.2	15.4	49.3	166.3	25.3	22.4	20.8	25.3	32.9	5.3	22.2	52.4	10.1	15.4	33.8	26.4	14.4	10.8	1.7	23.9	20.2	30.2	2.8	26.1	21.3	26.8	16.6	25.7	32.4	28.5	34.3	36.3	24.0	18.8	52.7	27.3	14.7	26.3	19.2	29.0	3.3	43.8	24.6	8.5	95.4	29.8	40.7	58.4	18.1
ATRX	"JMS, MRX52, RAD54, XH2, XNP"	ENSG00000085224	"ATRX chromatin remodeler"	P46100	X	77504880-77786233	"Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Transcription factors"	"DNA damage, DNA repair, Transcription, Transcription regulation"	"Chromatin regulator, DNA-binding, Helicase, Hydrolase"	"Cancer-related genes, Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA001906, CAB009372, HPA064684, CAB068176"	Supported		Supported	"Nuclear bodies"		NA	NA			"Cluster 6: Non-specific - Transcription"	"Cluster 69: Cerebellum - Gene expression regulation"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 52: Non-specific - Transcription"	"Nuclear bodies"		"CAB009372: AB_2061023, CAB068176: AB_2665665, HPA001906: AB_1078249, HPA064684: AB_2685321"	"unprognostic (1.77e-2)"	"unprognostic (1.55e-1)"	"unprognostic (6.65e-2)"	"unprognostic (4.37e-2)"	"unprognostic (1.67e-1)"	"unprognostic (9.69e-2)"	"unprognostic (8.11e-2)"	"unprognostic (1.15e-2)"	"unprognostic (6.04e-2)"	"unprognostic (2.35e-2)"	"unprognostic (1.09e-1)"	"unprognostic (5.80e-2)"	"unprognostic (5.14e-3)"	"unprognostic (1.50e-1)"	"unprognostic (6.19e-2)"	"unprognostic (1.76e-2)"	"unprognostic (2.24e-1)"	18.0	15.9	17.3	17.6	20.4	29.9	18.1	32.9	20.4	18.0	21.4	12.7	11.2	21.2	14.8	13.3	11.8	14.7	15.5	19.2	19.8	16.9	13.2	13.4	22.6	15.0	20.1	24.9	13.4	23.2	8.5	16.6	16.6	19.2	13.5	26.8	14.0	14.8	19.1	15.6	10.9	15.6	16.4	22.8	16.5	6.6	22.6	25.7	20.0	26.9	18.6	14.1	9.9	19.7	36.0	55.1	60.1	45.0	31.8	38.1	21.2	29.4	27.3	21.8	25.9	19.6	30.7	48.5	29.9	32.5	39.9	30.0	44.6	18.1	37.5	27.3	30.8	29.3	67.2	16.2	16.1	38.4	10.2	25.5	20.2	32.2	30.4	29.4	41.9	30.3	34.9	53.3	29.3	27.6	30.2	25.0	42.0	17.6	42.5	48.6	76.3	26.0	25.6	46.4	33.1	55.5	60.5	23.1	21.9	37.2	18.6	20.8	55.8	32.8	76.1	34.4	21.0	16.3	52.9	42.1	23.0	30.9	27.8	44.0	10.5	22.7	26.0	13.3	25.2	31.2	24.0	20.9	8.1	32.4	24.6	20.1	33.2	23.2	20.0	20.7	22.2	9.7	17.3	20.4	32.9	20.4	19.2	19.8	15.0	20.1	16.6	16.4	22.6	19.7	201.0	160.3	230.1	157.4	176.6	92.4	112.2	71.3	114.9	220.1	87.8	86.7	277.8	60.1	101.5	71.7	212.7	72.2	176.9	49.0	23.5	91.8	4.7	103.1	195.5	162.8	126.8	105.8	197.8	83.1	51.0	134.3	114.2	137.3	113.1	261.4	97.8	56.7	70.9	158.2	246.9	78.0	69.2	87.0	101.6	12.7	162.4	113.1	62.2	195.8	149.0	112.3	183.4	202.5	237.1	92.0	47.6	208.0	183.9	120.8	49.2	37.2	102.6	245.4	92.1	174.7	160.0	19.8	52.8	78.7	84.4	59.8	158.0	312.4	73.3	112.0
ATXN3	"ATX3, JOS, MJD, SCA3"	ENSG00000066427	"Ataxin 3"	P54252	14	92044496-92106621	"Disease related genes, Enzymes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Transcription, Transcription regulation, Ubl conjugation pathway"	"Hydrolase, Protease, Thiol protease"	"Neurodegeneration, Spinocerebellar ataxia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB021976, HPA024123, HPA069338"	Uncertain		Approved	"Nucleoplasm,Nucleoli,Plasma membrane"		NA	NA			"Cluster 14: Monocytes - Unknown function"	"Cluster 84: Esophagus - Epithelial cell function"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 52: Non-specific - Transcription"	"Nucleoplasm, Nucleoli"	"Plasma membrane"	"CAB021976: , HPA024123: AB_1845133, HPA069338: AB_2686124"	"unprognostic (1.06e-2)"	"unprognostic (2.93e-1)"	"unprognostic (1.22e-1)"	"unprognostic (3.67e-2)"	"unprognostic (5.76e-2)"	"unprognostic (1.57e-1)"	"unprognostic (1.42e-1)"	"unprognostic (9.85e-3)"	"unprognostic (1.69e-1)"	"unprognostic (6.75e-2)"	"unprognostic (1.04e-2)"	"unprognostic (3.06e-2)"	"unprognostic (2.03e-2)"	"unprognostic (8.94e-3)"	"unprognostic (4.22e-1)"	"unprognostic (1.64e-1)"	"unprognostic (1.11e-1)"	9.0	5.9	3.8	5.7	4.2	9.9	6.8	4.9	5.0	7.5	3.3	7.3	3.7	6.4	4.3	10.3	6.0	6.5	5.3	3.6	5.0	5.6	9.6	6.8	7.7	6.2	5.7	7.1	4.5	6.4	4.0	7.0	6.2	6.0	6.8	3.9	5.8	5.5	3.3	12.9	4.8	8.6	4.3	5.6	5.2	9.3	4.3	8.0	5.9	5.9	9.8	9.0	8.0	4.9	8.6	16.7	14.6	13.6	20.9	20.1	28.4	9.7	15.4	11.9	16.5	12.3	23.2	17.6	18.5	15.8	14.1	14.6	11.6	21.0	26.3	20.0	3.5	7.4	8.0	18.2	17.3	13.5	12.6	16.5	18.1	20.9	21.8	15.9	18.7	19.4	10.1	12.5	18.2	33.1	14.0	11.9	10.4	28.5	13.6	11.0	27.0	9.9	15.3	19.4	5.3	8.8	23.1	9.5	13.3	19.6	18.1	9.1	10.0	11.7	17.0	7.5	5.2	10.8	19.8	16.2	8.3	12.9	6.9	13.5	14.3	10.8	6.1	16.5	7.4	7.7	7.0	6.9	16.2	10.6	7.8	8.8	12.2	8.7	23.0	9.3	8.1	6.3	3.8	4.2	4.9	5.0	3.6	5.0	6.2	5.7	6.2	4.3	4.3	4.9	55.0	16.0	12.4	33.6	27.6	25.4	28.6	29.8	19.4	35.4	16.9	18.4	19.3	15.7	20.0	42.3	50.1	20.3	31.5	13.8	15.6	25.8	19.8	20.3	34.9	53.0	16.1	30.3	36.1	17.3	29.8	34.6	18.3	22.5	24.6	25.9	49.6	21.1	22.4	26.9	28.6	16.4	12.2	35.1	27.2	26.8	67.7	30.0	23.2	28.1	48.0	20.4	29.9	39.2	51.5	19.6	16.1	65.1	20.1	31.9	16.6	17.7	16.0	46.7	46.0	51.9	38.2	39.1	57.2	21.6	30.3	25.3	28.8	24.8	18.9	28.2
ATXN3L	MJDL	ENSG00000123594	"Ataxin 3 like"	Q9H3M9	X	13318236-13320399	"Enzymes, Predicted intracellular proteins"	"Transcription, Transcription regulation, Ubl conjugation pathway"	"Hydrolase, Protease, Thiol protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	21	"testis: 3.3"	"Group enriched"	"Detected in some"	86	"Early spermatids: 68.4;Late spermatids: 192.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											"HPA024123, HPA027539"	Uncertain					NA	NA				"Cluster 74: Testis - Spermatogenesis"		"Cluster 31: Spermatids - Spermatogenesis"			"HPA024123: AB_1845133, HPA027539: AB_10602435"																		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	68.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	192.4	0.9	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0
BAAT	BAT	ENSG00000136881	"Bile acid-CoA:amino acid N-acyltransferase"	Q14032	9	101354182-101385400	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"Fatty acid metabolism, Lipid metabolism"	"Acyltransferase, Hydrolase, Serine esterase, Transferase"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	41	"liver: 721.0"	"Cell type enriched"	"Detected in some"	10	"Hepatocytes: 996.7"	"Cancer enriched"	"Detected in many"	42	"liver cancer: 181.1"	"Low region specificity"	"Detected in single"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A549: 3.4;CACO-2: 1.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA021251, HPA021330"	Enhanced		Uncertain	Vesicles		NA	NA		520000		"Cluster 60: Liver - Hemostasis & Lipid metabolism"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 2: Hepatocytes - Metabolism"	Vesicles		"HPA021251: AB_1845247, HPA021330: AB_2670674"	"unprognostic (2.53e-2)"	"unprognostic (1.81e-1)"	"unprognostic (9.97e-2)"	"unprognostic (9.33e-2)"	"unprognostic (7.75e-3)"	"unprognostic (4.68e-2)"	"prognostic favorable (4.97e-4)"	"unprognostic (2.14e-2)"	"unprognostic (6.19e-2)"	"unprognostic (4.43e-4)"	"unprognostic (3.65e-1)"	"unprognostic (2.15e-1)"	"prognostic unfavorable (4.24e-7)"	"unprognostic (1.74e-1)"	"unprognostic (2.12e-1)"	"unprognostic (2.17e-2)"	"unprognostic (1.75e-1)"	0.1	0.0	0.5	0.0	0.5	1.2	0.0	0.5	1.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	17.4	0.1	0.5	0.4	0.3	721.0	0.4	0.0	0.4	0.3	0.0	0.9	0.0	0.0	0.0	0.5	0.0	0.0	0.2	0.0	0.0	1.1	0.0	0.1	0.0	0.1	0.2	0.0	0.0	0.3	0.0	0.0	0.7	0.0	0.0	0.0	0.8	0.0	3.4	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.1	1.6	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.1	0.0	0.8	0.0	0.2	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.2	0.3	0.1	0.0	0.1	0.1	0.1	0.4	0.8	0.2	0.0	0.3	0.0	0.1	0.0	0.1	0.1	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.5	0.5	1.0	0.5	0.4	0.4	0.3	0.5	0.1	0.3	0.8	0.3	0.0	0.0	0.7	2.4	0.0	0.1	0.0	0.0	1.1	0.3	0.1	0.7	91.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.2	0.1	0.0	0.1	0.7	0.0	16.0	9.7	0.2	0.0	0.1	0.0	0.1	0.0	0.0	12.1	996.7	0.0	0.0	7.2	0.0	0.0	18.2	0.0	0.0	0.0	0.1	0.0	1.9	0.0	0.1	0.0	3.0	0.9	1.8	0.1	0.0	0.0	0.0	0.3	0.3	0.0	0.2	0.0	0.5	0.1	0.3	0.2	0.0	0.0	0.0	1.0	0.1	0.4	0.0
BACE1	BACE	ENSG00000186318	"Beta-secretase 1"	P56817	11	117285207-117316259	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins, Transporters"		"Aspartyl protease, Hydrolase, Protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	4	"brain: 119.1;pancreas: 271.5"	"Cell type enhanced"	"Detected in many"		"Cone photoreceptor cells: 118.9;Early spermatids: 99.9;Late spermatids: 343.0;Oligodendrocytes: 99.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"fHDF/TERT166: 88.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB016358	Approved		Supported	"Plasma membrane"		NA	NA				"Cluster 22: Non-specific - Unknown function"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 31: Spermatids - Spermatogenesis"	"Plasma membrane"		"CAB016358: AB_626716"	"unprognostic (7.96e-3)"	"unprognostic (8.05e-2)"	"unprognostic (3.55e-2)"	"unprognostic (3.05e-3)"	"unprognostic (8.94e-2)"	"unprognostic (3.39e-1)"	"unprognostic (1.03e-1)"	"unprognostic (2.60e-1)"	"unprognostic (4.54e-2)"	"unprognostic (8.04e-2)"	"unprognostic (8.09e-2)"	"unprognostic (1.09e-1)"	"unprognostic (1.12e-1)"	"unprognostic (1.35e-2)"	"unprognostic (1.16e-1)"	"unprognostic (1.27e-1)"	"prognostic unfavorable (6.76e-4)"	15.4	16.0	34.3	8.0	68.5	3.3	11.7	68.7	44.0	18.3	11.9	13.7	6.1	19.7	8.8	13.5	15.9	19.1	11.4	34.3	44.5	14.8	25.6	14.4	5.1	89.7	67.0	20.5	271.5	18.5	10.7	13.8	76.6	13.4	7.6	44.7	11.0	18.3	12.5	11.4	7.7	21.3	61.6	12.4	9.8	11.2	59.9	3.8	12.2	9.1	5.0	12.4	14.3	119.1	11.5	10.7	22.9	37.3	80.9	82.3	1.0	62.9	44.4	24.4	19.0	4.5	16.4	1.4	14.6	88.3	18.4	17.9	24.3	12.1	20.5	3.1	12.1	6.0	17.3	5.1	36.5	2.5	1.7	68.1	20.2	29.7	31.8	68.0	21.4	3.8	2.7	1.1	46.5	33.4	2.5	2.1	15.5	10.6	25.9	6.4	11.6	1.6	12.2	5.9	31.7	36.7	22.5	2.6	5.9	23.5	26.2	7.6	31.4	45.2	5.0	48.2	19.4	0.7	1.0	1.1	23.8	2.0	34.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	34.3	68.5	68.7	44.0	34.3	44.5	89.7	67.0	76.6	61.6	59.9	119.1	12.1	19.2	10.1	16.3	0.3	4.7	4.1	3.4	9.1	53.7	8.7	9.0	8.7	18.6	13.3	5.5	118.9	1.0	0.1	2.0	5.9	7.4	99.9	5.1	32.1	8.3	21.7	1.7	24.9	20.0	1.3	19.5	3.1	8.9	2.5	15.8	6.8	38.6	9.4	57.2	32.0	5.1	2.0	17.2	7.7	343.0	19.3	7.9	3.6	14.0	4.0	17.9	0.0	22.1	99.8	4.3	6.3	22.2	0.1	2.4	1.7	6.3	3.4	55.2	6.6	18.1	14.2	3.4	1.7	10.6	3.4	0.8	1.2	68.0	4.5	3.4
BACE2	"AEPLC, ALP56, CEAP1, DRAP"	ENSG00000182240	"Beta-secretase 2"	Q9Y5Z0	21	41167801-41282530	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins, Transporters"		"Aspartyl protease, Hydrolase, Protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"salivary gland: 26.8"	"Cell type enhanced"	"Detected in many"		"Prostatic glandular cells: 290.4;Syncytiotrophoblasts: 514.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	6	"basophil: 2.9;eosinophil: 5.2"	"Lineage enriched"	"Detected in single"	8	"granulocytes: 5.2"	"Cell line enhanced"	"Detected in many"		"OE19: 73.8;SK-BR-3: 53.3;SK-MEL-30: 52.6;WM-115: 46.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA035416	Approved				"Intracellular and membrane"	NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 24: Salivary gland - Salivary secretion"	"Cluster 17: WM-115 - Nervous system development"	"Cluster 18: Syncytiotrophoblasts - Pregnancy hormone signaling"			"HPA035416: AB_2732467"	"unprognostic (1.71e-2)"	"prognostic unfavorable (1.11e-4)"	"unprognostic (5.23e-2)"	"unprognostic (8.12e-3)"	"prognostic unfavorable (5.86e-4)"	"unprognostic (1.52e-2)"	"unprognostic (2.58e-2)"	"unprognostic (2.64e-3)"	"unprognostic (7.24e-2)"	"unprognostic (2.49e-1)"	"unprognostic (3.46e-2)"	"unprognostic (8.50e-2)"	"unprognostic (1.22e-1)"	"unprognostic (4.04e-1)"	"unprognostic (2.10e-1)"	"unprognostic (2.76e-2)"	"unprognostic (5.83e-2)"	10.0	1.6	2.1	4.3	3.1	0.6	7.7	4.4	2.6	6.1	9.4	7.3	3.5	8.7	1.9	9.4	6.3	8.3	6.2	2.0	4.1	9.8	1.7	4.3	3.1	6.7	3.8	2.7	13.1	2.3	1.5	2.9	5.1	8.3	4.5	0.3	26.8	2.6	2.2	5.0	4.5	4.7	5.5	4.7	22.9	1.0	4.1	1.1	4.6	2.2	3.6	6.7	5.6	8.7	27.4	2.1	12.6	0.0	2.5	2.1	0.1	6.3	0.0	3.9	3.8	0.0	9.6	0.1	12.2	7.1	7.2	8.1	0.0	13.6	1.4	0.0	12.6	6.2	3.3	0.0	1.0	0.0	14.4	5.5	2.8	0.5	2.7	20.9	12.1	6.4	0.0	0.1	6.0	6.1	3.4	0.0	8.5	73.8	12.1	1.0	0.0	9.8	11.5	2.5	0.4	0.1	0.5	53.3	52.6	1.0	12.0	0.1	15.8	7.3	5.3	6.5	10.9	0.1	0.1	0.0	17.8	0.0	46.2	2.9	0.0	5.2	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	2.1	3.1	4.4	2.6	2.0	4.1	6.7	3.8	5.1	5.5	4.1	8.7	55.0	12.8	15.9	11.8	28.6	18.5	91.6	25.6	42.7	0.8	40.3	33.8	9.7	123.0	72.5	20.2	2.1	127.6	0.5	40.5	93.9	146.3	24.3	65.4	19.8	90.2	18.5	22.1	11.7	105.2	64.2	34.0	186.6	115.8	90.7	6.7	35.3	1.0	28.0	0.0	7.5	86.2	44.7	17.0	8.2	16.0	14.3	3.6	179.7	20.6	2.9	3.1	0.0	9.5	46.0	86.6	23.9	18.8	3.2	290.4	7.3	1.4	76.5	0.8	0.0	15.9	23.6	0.6	1.4	43.5	11.8	514.7	6.2	8.7	56.6	134.2
BAP1	"hucep-6, KIAA0272, UCHL2"	ENSG00000163930	"BRCA1 associated protein 1"	Q92560	3	52401008-52410008	"Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Ubl conjugation pathway"	"Chromatin regulator, Hydrolase, Protease, Thiol protease"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 103.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004322, HPA028814, HPA028815, HPA055560"	Approved		Enhanced	Nucleoplasm,Cytosol		NA	NA			"Cluster 50: Neutrophils - Cellular senescence"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 34: Spermatids - Unknown function"	Nucleoplasm	Cytosol	"CAB004322: AB_626723, HPA028814: AB_10602393, HPA028815: AB_2672785, HPA055560: AB_2682850"	"unprognostic (1.52e-1)"	"unprognostic (7.96e-2)"	"unprognostic (1.96e-2)"	"unprognostic (6.04e-2)"	"unprognostic (1.74e-1)"	"unprognostic (2.55e-2)"	"unprognostic (9.41e-3)"	"unprognostic (8.53e-3)"	"unprognostic (1.33e-1)"	"unprognostic (3.15e-1)"	"unprognostic (4.64e-3)"	"unprognostic (3.30e-3)"	"prognostic favorable (3.29e-7)"	"unprognostic (6.37e-2)"	"unprognostic (1.91e-1)"	"unprognostic (5.54e-2)"	"unprognostic (2.92e-1)"	45.2	63.5	97.6	25.0	99.2	73.9	42.9	78.9	135.5	39.1	71.4	47.7	21.6	40.5	23.1	59.3	36.0	25.7	57.0	114.1	83.3	57.3	65.2	46.0	29.4	81.2	85.7	43.9	52.7	40.2	36.9	24.6	81.7	50.0	24.1	20.1	43.0	22.5	74.7	73.4	43.4	23.8	79.9	54.2	48.1	140.0	89.2	33.1	49.1	43.5	27.9	44.6	41.7	90.5	39.1	43.1	52.2	44.8	50.1	31.4	59.3	37.8	50.1	62.4	48.0	52.5	35.8	55.7	18.3	54.7	69.3	31.4	55.7	63.0	37.9	55.1	51.4	68.6	94.4	53.2	45.7	65.6	58.5	48.0	80.1	68.5	36.1	33.3	50.3	107.7	59.9	48.3	44.5	33.7	79.1	89.5	58.0	31.0	52.8	33.7	41.7	55.8	37.4	61.2	19.8	63.6	46.1	13.7	56.9	29.2	37.7	90.6	52.5	54.1	49.3	66.0	70.9	71.7	101.6	81.2	58.5	68.2	66.1	2.9	3.2	5.4	5.4	2.8	2.6	3.2	4.3	4.4	2.2	4.1	3.1	4.0	7.4	2.2	2.2	5.6	4.2	2.7	97.6	99.2	78.9	135.5	114.1	83.3	81.2	85.7	81.7	79.9	89.2	90.5	13.5	0.0	16.0	8.1	12.2	31.6	10.5	13.2	23.3	16.6	16.4	12.6	23.6	11.5	10.2	25.8	0.0	14.0	17.7	23.2	11.7	13.5	103.4	9.2	12.4	14.7	10.8	8.2	7.5	16.7	15.8	13.6	14.8	13.6	21.0	18.1	14.6	29.2	12.6	10.1	7.7	16.6	6.1	17.4	10.7	48.0	10.2	12.0	12.4	5.6	15.2	16.1	16.5	7.1	6.7	15.8	16.5	11.7	16.2	11.7	13.3	18.5	8.2	12.3	19.7	14.7	14.2	37.8	13.9	23.0	23.4	12.0	12.2	15.9	19.8	9.6
BCHE	"CHE1, CHE2, E1"	ENSG00000114200	Butyrylcholinesterase	P06276	3	165772904-165837462	"Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"		"Hydrolase, Serine esterase"	"Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	13	"liver: 525.1"	"Group enriched"	"Detected in many"	9	"Hepatocytes: 420.3;Oligodendrocyte precursor cells: 210.1"	"Group enriched"	"Detected in many"	6	"glioma: 24.0;liver cancer: 13.7;melanoma: 18.9"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in many"	9	"Karpas-707: 785.6"	"Low region specificity"	"Detected in all"							HPA001560	Approved				"Secreted to blood"	NA	NA		9400000000		"Cluster 60: Liver - Hemostasis & Lipid metabolism"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 2: Hepatocytes - Metabolism"			"HPA001560: AB_1078271"	"unprognostic (4.74e-2)"	"unprognostic (2.00e-1)"	"unprognostic (9.21e-4)"	"unprognostic (8.19e-8)"	"unprognostic (2.66e-2)"	"prognostic unfavorable (1.06e-4)"	"unprognostic (1.44e-1)"	"unprognostic (5.04e-2)"	"unprognostic (6.15e-2)"	"unprognostic (9.59e-2)"	"unprognostic (5.15e-2)"	"unprognostic (3.65e-2)"	"unprognostic (3.18e-3)"	"unprognostic (4.46e-5)"	"unprognostic (2.17e-2)"	"unprognostic (5.92e-2)"	"unprognostic (4.26e-4)"	30.4	11.6	9.3	2.7	7.4	0.0	4.7	7.5	12.0	22.0	5.0	36.1	4.7	41.0	24.3	25.8	36.2	6.0	9.7	7.9	7.3	4.9	525.1	10.9	0.2	7.9	9.4	3.7	2.3	0.1	1.8	0.0	7.8	12.5	16.1	8.8	1.9	32.3	2.7	8.7	10.6	29.7	7.4	5.9	3.5	1.3	12.2	2.9	1.3	5.1	0.1	11.3	5.1	9.4	0.0	2.1	82.1	0.1	0.2	0.0	0.1	0.0	1.5	0.6	7.3	0.0	0.1	0.3	30.7	0.0	0.0	0.5	5.7	0.4	5.8	0.4	0.8	0.0	0.0	0.0	6.3	0.2	0.4	23.5	1.4	0.0	8.1	25.3	3.6	30.0	0.0	785.6	0.0	0.0	0.0	0.1	2.1	0.0	0.8	0.0	28.4	67.3	0.7	0.0	0.0	0.8	0.1	0.0	46.5	0.0	34.0	0.2	0.0	19.3	0.5	0.0	8.3	3.5	0.0	1.6	8.2	0.2	84.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.3	7.4	7.5	12.0	7.9	7.3	7.9	9.4	7.8	7.4	12.2	9.4	5.8	0.0	0.0	1.0	0.7	5.5	0.9	0.0	1.8	1.4	0.0	0.1	9.0	15.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	30.6	0.0	0.7	3.4	0.0	8.0	3.0	0.0	0.0	22.0	0.5	0.0	0.0	0.2	8.9	420.3	0.1	1.7	10.5	0.4	0.0	4.7	1.5	8.7	2.1	0.3	19.6	3.7	0.0	31.7	0.0	210.1	16.1	0.0	0.0	0.0	0.0	0.2	0.0	3.7	0.0	1.2	0.0	0.8	6.5	0.3	0.3	0.6	3.4	0.0	1.1	0.1	0.0	0.1
BLM	"BS, RECQ2, RECQL3"	ENSG00000197299	"BLM RecQ like helicase"	P54132	15	90717346-90816166	"Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"DNA damage, DNA repair, DNA replication"	"DNA-binding, Helicase, Hydrolase"	"Cancer-related genes, Disease variant, Dwarfism"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"bone marrow: 5.7;lymphoid tissue: 7.9;salivary gland: 7.8"	"Cell type enhanced"	"Detected in many"		"Erythroid cells: 18.3;Oligodendrocyte precursor cells: 58.3;Plasma cells: 20.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA005689	Approved		Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	Nucleoplasm	Cytosol	"HPA005689: AB_1845372"	"unprognostic (2.77e-1)"	"unprognostic (3.82e-3)"	"unprognostic (4.03e-2)"	"unprognostic (2.98e-2)"	"unprognostic (4.75e-2)"	"unprognostic (9.89e-2)"	"unprognostic (6.12e-5)"	"unprognostic (2.82e-2)"	"unprognostic (4.55e-3)"	"unprognostic (5.24e-3)"	"unprognostic (1.80e-3)"	"unprognostic (9.12e-2)"	"unprognostic (1.55e-15)"	"unprognostic (6.53e-3)"	"unprognostic (6.55e-2)"	"unprognostic (2.43e-1)"	"unprognostic (1.83e-2)"	0.3	0.2	0.9	3.6	1.1	5.7	0.5	2.3	0.9	0.1	0.3	1.4	1.0	0.4	0.4	0.6	0.3	0.3	0.3	0.8	1.1	0.1	0.1	0.4	6.4	1.2	1.4	0.1	0.2	0.0	0.6	1.2	1.1	0.1	1.7	2.4	7.8	0.0	0.5	0.4	1.6	0.4	1.0	1.6	1.1	2.2	0.9	7.9	0.3	0.1	6.2	1.0	0.2	1.0	13.0	14.4	20.4	12.6	0.1	0.9	14.6	9.4	3.2	11.1	13.4	11.7	10.1	35.1	5.9	2.6	14.1	20.4	25.7	7.1	15.1	19.1	20.5	36.4	14.8	3.9	0.0	33.7	17.3	0.3	0.1	10.6	4.7	1.3	7.9	16.9	32.7	9.9	11.0	7.4	28.3	14.5	22.2	24.9	4.2	25.4	39.1	14.7	2.3	18.9	14.6	14.7	8.5	11.5	4.8	18.1	7.2	23.4	3.7	8.6	13.6	9.6	21.0	6.4	30.4	39.5	5.6	25.8	15.7	1.7	0.6	2.6	1.6	0.8	2.6	4.6	1.4	2.1	0.7	2.3	1.0	1.1	0.7	3.1	1.0	0.7	3.2	0.9	0.9	1.1	2.3	0.9	0.8	1.1	1.2	1.4	1.1	1.0	0.9	1.0	0.9	3.2	8.9	1.0	12.9	0.3	0.5	0.5	0.6	3.6	1.3	1.0	7.9	0.0	4.2	0.0	2.1	5.5	6.9	2.2	1.9	1.0	2.7	1.3	1.3	2.0	0.0	18.3	0.7	0.7	6.8	1.8	3.6	1.7	13.3	8.1	2.2	0.6	5.7	0.0	8.6	1.3	0.0	7.7	1.3	1.6	0.0	7.7	0.0	7.5	2.7	1.7	10.3	58.3	2.6	1.2	0.3	0.4	20.6	0.7	0.2	0.0	5.4	7.1	0.0	0.9	1.7	17.1	12.9	2.2	0.6	1.0	10.2	0.7	4.0	0.4
BLMH	BH	ENSG00000108578	"Bleomycin hydrolase"	Q13867	17	30248203-30292056	"Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins"		"Hydrolase, Protease, Thiol protease"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skin 1: 130.3"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039548, HPA064307"	Enhanced		Supported	"Nucleoplasm,Nuclear bodies,Cytosol"		No	No		42000000	"Cluster 16: MAIT-cells - Unknown function"	"Cluster 31: Skin - Epidermis development"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 24: Non-specific - Transcription regulation"	"Nucleoplasm, Nuclear bodies, Cytosol"		"HPA039548: AB_10805479, HPA064307: AB_2685241"	"unprognostic (6.85e-2)"	"unprognostic (2.79e-1)"	"unprognostic (1.48e-1)"	"unprognostic (2.46e-1)"	"unprognostic (1.76e-1)"	"unprognostic (2.54e-2)"	"unprognostic (3.91e-3)"	"unprognostic (2.07e-1)"	"unprognostic (2.05e-3)"	"unprognostic (6.69e-3)"	"unprognostic (1.95e-3)"	"unprognostic (2.14e-2)"	"unprognostic (2.14e-2)"	"unprognostic (1.22e-3)"	"unprognostic (1.05e-1)"	"unprognostic (1.34e-1)"	"unprognostic (1.44e-1)"	20.6	13.5	13.4	18.2	15.0	18.1	20.4	15.9	17.6	19.1	14.5	18.8	12.4	21.2	21.1	28.3	14.7	18.4	15.6	13.5	15.2	22.0	14.0	16.0	26.0	15.6	14.1	13.9	26.8	21.7	9.7	27.4	15.4	14.4	15.4	14.7	15.6	14.4	28.8	130.3	18.3	22.4	14.7	20.6	16.2	15.9	14.2	36.3	16.5	19.0	26.9	17.9	21.5	16.2	40.3	62.9	61.5	41.6	40.6	43.8	27.8	36.5	24.0	59.1	50.8	93.2	11.9	119.5	63.3	31.1	26.1	27.1	135.5	52.8	50.1	31.5	101.4	73.5	54.6	80.0	58.3	136.1	43.2	50.5	3.5	46.5	26.5	47.1	87.2	98.2	157.9	47.6	24.6	31.0	168.1	98.6	57.2	0.0	29.2	143.0	154.5	78.9	46.8	35.6	135.1	48.4	32.6	63.2	42.2	106.6	42.9	68.5	54.5	35.0	69.2	16.0	66.0	55.8	124.1	159.3	26.7	0.2	47.6	0.0	8.8	1.5	15.3	6.2	25.3	6.5	18.2	20.2	10.1	7.3	16.4	17.8	1.2	16.3	3.3	10.1	20.0	9.9	13.4	15.0	15.9	17.6	13.5	15.2	15.6	14.1	15.4	14.7	14.2	16.2	21.0	3.2	12.6	13.4	8.8	15.9	16.7	10.6	19.4	20.2	10.3	6.6	17.8	12.8	4.0	11.0	12.5	49.6	15.6	7.6	7.9	17.4	8.4	7.4	28.2	24.0	18.0	22.5	19.0	14.2	38.0	18.3	11.2	7.0	43.8	30.5	25.7	6.9	25.0	13.5	20.9	8.4	6.1	18.9	7.1	6.6	16.1	13.0	10.6	18.7	12.2	9.9	22.6	29.1	22.6	7.2	9.6	24.8	20.0	13.0	11.5	20.0	5.5	15.7	6.6	12.9	19.7	14.9	29.1	24.0	12.6	27.5	20.9	34.8	11.5	7.6
BMP1	"BMP-1, PCOLC"	ENSG00000168487	"Bone morphogenetic protein 1"	P13497	8	22165140-22212326	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted secreted proteins"	"Chondrogenesis, Differentiation, Osteogenesis"	"Cytokine, Developmental protein, Growth factor, Hydrolase, Metalloprotease, Protease"	"Disease variant, Osteogenesis imperfecta"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Alveolar cells type 2: 69.3;Endometrial stromal cells: 52.8;Smooth muscle cells: 43.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA014572	Enhanced				"Secreted to extracellular matrix"	NA	NA		9200000	"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 86: Liver & Placenta - Transport via ER"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 33: Fibroblasts - ECM organization"			"HPA014572: AB_1845390"	"unprognostic (1.24e-1)"	"unprognostic (8.01e-2)"	"unprognostic (3.75e-2)"	"unprognostic (5.89e-2)"	"unprognostic (1.34e-2)"	"unprognostic (6.76e-2)"	"unprognostic (9.53e-2)"	"unprognostic (2.64e-3)"	"unprognostic (1.66e-1)"	"unprognostic (9.75e-3)"	"unprognostic (7.05e-3)"	"unprognostic (3.14e-2)"	"prognostic unfavorable (3.37e-9)"	"unprognostic (2.11e-2)"	"unprognostic (6.57e-2)"	"unprognostic (1.50e-3)"	"unprognostic (3.34e-2)"	11.7	17.4	3.8	6.3	4.6	1.4	9.0	4.7	4.4	15.6	4.9	8.1	4.8	12.7	3.9	7.0	11.8	9.8	5.9	4.3	3.9	7.7	14.7	8.3	1.7	5.0	4.1	5.9	4.4	3.4	3.4	27.3	4.1	9.6	5.3	0.6	3.7	6.1	3.4	6.2	5.9	14.4	4.3	5.0	4.3	2.4	4.2	1.5	10.0	3.1	1.8	10.4	10.3	4.4	15.2	20.4	7.4	30.2	47.8	41.8	23.2	54.1	50.1	33.8	27.6	5.1	27.4	3.7	32.0	56.9	18.9	51.2	5.1	27.8	6.5	3.6	6.9	6.7	24.5	7.9	31.7	2.9	14.3	49.8	26.5	25.2	11.4	78.3	31.4	5.2	7.1	10.6	19.6	4.6	1.4	3.0	4.7	17.0	8.3	6.4	8.2	15.2	26.7	4.1	2.8	10.6	52.5	3.1	13.4	20.4	5.0	8.3	41.4	17.0	18.4	32.3	23.9	4.0	2.2	0.6	23.8	10.1	28.0	0.0	0.4	0.0	0.6	0.1	0.3	0.0	0.1	0.2	0.0	0.0	0.0	0.3	0.0	0.2	0.1	0.2	0.0	0.1	3.8	4.6	4.7	4.4	4.3	3.9	5.0	4.1	4.1	4.3	4.2	4.4	12.5	6.4	69.3	5.5	0.8	6.2	5.2	22.6	4.0	2.6	5.0	6.1	4.9	2.8	6.7	5.5	0.0	3.3	3.2	31.9	0.0	25.1	0.7	3.1	52.8	14.1	3.0	0.8	3.5	8.2	9.5	28.7	1.1	5.7	15.2	13.9	14.6	20.1	4.3	1.7	2.7	6.2	0.0	3.4	6.1	1.1	10.2	5.4	10.6	4.7	1.0	2.2	3.1	6.6	6.7	15.3	18.6	10.9	2.8	4.7	13.2	4.1	2.2	1.1	26.3	6.4	43.7	1.5	4.0	6.5	5.3	24.4	3.3	34.2	10.7	8.0
BPNT1		ENSG00000162813	"3'(2'), 5'-bisphosphate nucleotidase 1"	O95861	1	220057482-220090462	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Distal enterocytes: 55.5;Proximal enterocytes: 56.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"Daudi: 183.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA048461	Approved		Approved	"Nuclear speckles"		NA	NA		420000	"Cluster 44: Non-specific - Transcription"	"Cluster 9: Intestine - Unknown function"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 45: Enterocytes - Digestion"	"Nuclear speckles"		"HPA048461: AB_2680404"	"unprognostic (6.42e-2)"	"unprognostic (4.69e-2)"	"unprognostic (2.78e-2)"	"unprognostic (1.02e-1)"	"unprognostic (5.19e-3)"	"unprognostic (7.65e-2)"	"unprognostic (2.07e-2)"	"unprognostic (3.00e-1)"	"unprognostic (2.44e-1)"	"unprognostic (1.66e-1)"	"unprognostic (6.69e-2)"	"unprognostic (2.87e-1)"	"prognostic favorable (6.38e-4)"	"unprognostic (1.82e-2)"	"unprognostic (6.58e-2)"	"unprognostic (2.91e-1)"	"unprognostic (1.35e-1)"	16.2	20.8	6.5	18.2	7.8	4.6	20.3	7.5	9.1	18.1	7.3	37.7	43.9	13.9	13.0	14.7	17.6	21.2	17.7	7.3	6.8	31.5	25.0	17.6	34.2	7.6	6.8	17.9	7.7	21.5	10.9	13.2	7.1	13.8	32.2	15.5	17.3	11.9	9.3	10.3	45.7	18.3	7.5	14.6	19.7	14.8	6.7	17.7	20.8	11.3	44.3	15.8	9.9	10.0	37.5	30.3	22.1	17.5	40.6	33.3	35.4	48.0	25.0	42.9	38.3	40.1	70.7	183.9	64.8	33.2	19.1	26.1	45.8	42.3	34.5	68.8	51.2	33.3	34.6	48.3	23.8	90.4	29.9	31.8	20.7	61.0	25.3	28.0	35.9	54.1	62.3	18.4	43.4	21.2	51.9	24.3	18.9	32.0	37.1	36.5	62.9	54.0	55.5	49.2	40.2	33.6	60.1	71.5	43.0	22.1	56.5	31.7	54.2	25.4	19.5	36.7	60.8	31.3	81.6	85.0	22.0	33.6	56.8	20.6	9.2	6.1	12.3	10.0	9.4	20.8	12.8	12.7	10.9	16.5	15.0	11.2	1.1	14.0	9.9	13.3	14.6	9.7	6.5	7.8	7.5	9.1	7.3	6.8	7.6	6.8	7.1	7.5	6.7	10.0	9.3	28.9	23.9	3.6	12.7	3.3	12.5	22.0	3.4	13.7	9.1	6.2	10.5	11.5	23.4	14.7	10.4	13.1	11.6	55.5	13.7	18.7	2.5	10.3	7.7	7.7	19.2	5.5	8.4	15.6	14.1	7.8	7.7	9.7	3.8	12.1	7.9	12.6	9.8	6.7	10.8	14.5	32.6	7.5	3.6	3.1	9.6	7.2	10.6	1.9	8.0	10.8	15.5	10.1	13.0	18.9	28.5	13.5	10.3	6.3	56.9	29.5	14.5	12.0	13.1	5.6	8.7	15.5	11.8	8.2	5.1	25.2	9.6	25.0	17.2	12.7
BPNT2	"FLJ20421, gPAPP, IMPA3, IMPAD1"	ENSG00000104331	"3'(2'), 5'-bisphosphate nucleotidase 2"	Q9NX62	8	56957931-56993867	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"		Hydrolase	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"Adipocytes: 22.6;Cardiomyocytes: 53.8;Cytotrophoblasts: 18.0;dendritic cells: 16.2;Extravillous trophoblasts: 91.8;Hofbauer cells: 26.6;Syncytiotrophoblasts: 33.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA009411	Supported		Supported	"Nucleoplasm,Golgi apparatus,Cytosol"		NA	NA		480000	"Cluster 27: Non-specific - Gene expression"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 24: Non-specific - Transcription regulation"	"Golgi apparatus"	"Nucleoplasm, Cytosol"	"HPA009411: AB_1079138"	"unprognostic (1.62e-2)"	"unprognostic (7.89e-3)"	"unprognostic (6.58e-2)"	"unprognostic (6.42e-2)"	"unprognostic (2.00e-1)"	"unprognostic (8.59e-2)"	"unprognostic (1.88e-1)"	"unprognostic (1.67e-2)"	"unprognostic (2.09e-1)"	"unprognostic (4.53e-2)"	"unprognostic (4.24e-3)"	"unprognostic (1.41e-1)"	"unprognostic (1.43e-2)"	"unprognostic (1.68e-3)"	"unprognostic (2.89e-1)"	"unprognostic (1.68e-1)"	"unprognostic (1.05e-1)"	37.6	37.3	14.8	16.1	19.9	12.4	19.3	19.2	19.8	25.5	8.9	17.4	13.3	21.9	16.2	19.1	13.4	16.5	29.4	16.0	17.9	23.4	36.2	17.2	12.3	17.2	17.6	11.8	19.6	35.6	13.7	24.9	17.7	31.0	17.6	19.7	21.9	23.6	37.4	14.3	12.7	25.7	15.3	15.5	16.9	16.5	18.0	15.4	27.1	30.1	13.3	22.4	12.2	29.3	42.4	34.5	26.0	26.9	78.2	53.3	35.7	62.9	60.9	44.1	38.3	17.4	29.2	26.3	47.0	67.3	31.2	33.7	31.8	42.5	65.0	36.4	22.7	51.4	23.0	31.2	48.5	33.0	35.1	43.2	41.6	39.7	63.9	40.8	59.5	24.3	22.5	46.1	48.9	22.1	40.6	19.8	19.2	48.1	12.7	27.9	23.4	29.7	46.0	24.9	10.1	28.1	35.3	42.9	36.3	27.1	38.4	23.9	50.1	59.3	34.2	59.2	45.8	47.5	42.5	27.8	81.0	27.0	37.3	1.8	0.9	0.5	0.9	0.6	0.7	0.7	0.6	0.5	0.7	0.9	0.6	1.1	2.5	3.2	2.6	1.0	0.4	0.3	14.8	19.9	19.2	19.8	16.0	17.9	17.2	17.6	17.7	15.3	18.0	29.3	22.6	0.0	0.0	0.0	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	53.8	0.0	0.0	0.0	0.0	18.0	16.2	0.0	0.0	0.0	0.0	0.0	0.0	6.3	0.0	0.0	0.0	0.0	91.8	14.4	0.0	0.0	0.0	0.0	0.0	0.0	26.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.1	0.0	0.0	0.0	0.0	33.8	1.8	0.0	0.0	0.0
BRIP1	"BACH1, FANCJ, OF"	ENSG00000136492	"BRCA1 interacting protein C-terminal helicase 1"	Q9BX63	17	61679139-61863528	"Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins"	"DNA damage, DNA repair"	"Helicase, Hydrolase"	"Cancer-related genes, Disease variant, Fanconi anemia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"bone marrow: 7.2;lymphoid tissue: 5.9;testis: 7.0"	"Group enriched"	"Detected in many"	12	"Early spermatids: 186.2;Late spermatids: 194.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"MCF7: 88.9"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA005474	Approved		Supported	"Nucleoplasm,Nuclear membrane"		NA	Yes			"Cluster 26: Non-specific - Mitochondria"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 23: Spermatids - Flagellum & Golgi organization"	"Nucleoplasm, Nuclear membrane"		"HPA005474: AB_2667333"	"unprognostic (1.88e-1)"	"unprognostic (1.55e-2)"	"prognostic favorable (3.45e-5)"	"unprognostic (6.85e-4)"	"unprognostic (3.09e-1)"	"prognostic favorable (3.62e-4)"	"unprognostic (2.60e-3)"	"unprognostic (5.60e-2)"	"unprognostic (5.66e-3)"	"unprognostic (6.71e-2)"	"unprognostic (1.50e-3)"	"unprognostic (2.75e-2)"	"unprognostic (3.41e-12)"	"unprognostic (1.19e-2)"	"unprognostic (2.25e-1)"	"unprognostic (3.96e-2)"	"unprognostic (3.62e-3)"	0.3	0.3	0.8	1.7	0.6	7.2	0.9	1.3	0.9	0.4	0.0	1.7	2.0	0.8	0.4	1.5	0.3	0.6	0.1	0.5	0.2	0.3	1.6	0.4	2.8	0.3	0.0	1.1	0.3	0.1	0.0	0.8	0.4	0.4	1.9	0.5	0.4	0.2	0.1	2.0	1.9	0.9	0.0	0.7	0.9	7.0	0.2	5.9	0.3	0.1	3.3	0.7	0.6	0.8	26.6	9.4	25.0	14.1	0.9	2.1	5.5	23.6	13.3	24.6	31.8	9.5	8.0	14.9	5.2	4.9	7.7	9.2	12.8	4.5	33.3	3.8	15.8	15.5	14.4	10.5	0.2	20.3	8.8	0.6	0.4	20.2	5.1	3.4	5.0	14.8	11.6	10.5	14.4	88.9	32.5	6.7	5.3	5.9	7.3	19.7	50.1	7.1	3.0	12.8	10.0	24.2	9.4	3.0	3.3	9.1	8.3	7.3	4.5	36.9	26.5	13.5	26.6	6.3	13.3	16.6	7.3	9.3	8.8	1.0	0.1	0.4	0.1	0.0	0.1	0.5	0.3	0.1	0.1	0.6	0.4	0.2	0.3	0.1	0.1	0.1	1.0	0.1	0.8	0.6	1.3	0.9	0.5	0.2	0.3	0.0	0.4	0.0	0.2	0.8	0.2	0.0	0.5	1.0	1.6	2.3	1.3	0.8	0.6	0.3	1.1	1.8	0.6	0.0	4.0	0.0	0.0	2.0	2.0	1.8	0.0	0.3	186.2	0.7	1.7	0.8	0.0	7.4	4.6	0.2	3.0	2.0	2.0	1.6	0.0	15.5	0.4	3.4	1.7	0.0	3.3	1.8	0.0	0.8	1.1	194.1	1.2	1.0	3.6	2.8	0.6	0.2	1.0	1.5	1.0	0.8	0.1	1.2	4.8	0.4	1.4	0.2	0.8	0.2	0.0	2.5	1.8	12.1	6.0	2.9	0.4	0.3	2.3	2.1	4.7	0.7
BST1	CD157	ENSG00000109743	"Bone marrow stromal cell antigen 1"	Q10588	4	15703065-15738313	"CD markers, Enzymes, FDA approved drug targets, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"		"Hydrolase, Transferase"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	4	"bone marrow: 139.8;intestine: 48.6"	"Cell type enhanced"	"Detected in many"		"Hofbauer cells: 40.8;Macrophages: 33.3;monocytes: 80.1;Proximal enterocytes: 79.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in many"		"classical monocyte: 257.7;neutrophil: 292.7"	"Group enriched"	"Detected in many"	95	"dendritic cells: 78.9;granulocytes: 292.7;monocytes: 257.7"	"Cell line enhanced"	"Detected in many"		"THP-1: 76.0;TIME: 40.4;U-937: 52.5;WM-115: 44.8"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA050121	Uncertain				"Intracellular and membrane"	NA	NA		190000000	"Cluster 25: Monocytes - Inflammatory response"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 43: THP-1 - Innate immune response"	"Cluster 19: Monocytes & Neutrophils - Innate immune response"			"HPA050121: AB_2681025"	"unprognostic (2.95e-1)"	"unprognostic (3.61e-1)"	"unprognostic (1.27e-1)"	"unprognostic (4.00e-2)"	"unprognostic (7.49e-2)"	"unprognostic (2.89e-1)"	"unprognostic (4.55e-2)"	"unprognostic (2.70e-1)"	"unprognostic (1.75e-1)"	"unprognostic (1.84e-1)"	"unprognostic (1.08e-1)"	"unprognostic (4.06e-2)"	"unprognostic (4.83e-3)"	"unprognostic (1.94e-3)"	"unprognostic (3.11e-1)"	"unprognostic (1.57e-2)"	"unprognostic (1.95e-1)"	21.2	2.7	1.9	13.7	2.1	139.8	9.4	2.1	4.7	11.0	1.6	8.3	48.6	6.3	2.9	4.6	7.9	18.2	19.1	2.1	2.0	17.0	8.5	12.7	7.1	1.9	1.4	9.3	3.1	1.7	1.3	13.7	2.2	3.7	9.7	1.0	3.9	4.6	2.7	5.0	29.3	9.7	0.8	18.6	3.2	2.7	3.0	3.9	4.9	6.8	3.5	16.8	7.4	3.3	0.6	10.5	1.2	1.0	28.8	7.0	1.6	21.0	2.1	20.4	22.2	0.3	12.1	0.8	1.9	12.2	0.6	0.3	3.3	0.5	17.2	0.8	0.7	5.6	0.8	0.6	6.7	7.2	15.1	5.7	1.5	12.9	1.0	0.9	3.0	5.0	0.7	0.5	12.5	0.3	2.3	4.3	2.7	0.9	2.2	0.8	1.8	0.5	0.5	0.6	1.4	4.3	0.4	0.7	14.2	1.2	0.5	76.0	40.4	0.6	1.0	7.9	1.1	0.6	0.2	0.7	2.7	52.5	44.8	41.8	257.7	20.8	1.1	97.4	1.7	2.2	0.9	0.8	78.9	0.9	1.1	0.7	292.7	0.4	73.9	26.6	1.0	109.8	1.9	2.1	2.1	4.7	2.1	2.0	1.9	1.4	2.2	0.8	3.0	3.3	5.4	3.2	3.7	1.3	0.3	4.6	0.8	0.1	1.8	0.6	1.2	2.0	1.5	2.8	1.0	1.8	0.0	16.0	5.5	3.7	1.9	4.4	4.4	8.0	9.9	3.8	1.2	2.5	0.7	2.5	24.0	22.5	0.0	16.2	15.9	20.6	6.4	2.1	40.8	0.0	0.7	8.1	0.0	26.3	11.5	1.2	3.1	33.3	14.2	3.7	80.1	0.6	3.1	0.5	3.6	1.1	11.9	2.2	0.4	0.6	79.0	9.6	3.0	0.2	6.6	3.9	15.5	2.5	1.4	1.7	3.0	7.1	1.8	1.4	23.2	3.3
BTD		ENSG00000169814	Biotinidase	P43251	3	15601341-15722311	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted secreted proteins"		Hydrolase	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 95.9"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA052275	Uncertain				"Secreted to blood"	NA	NA		2800000000	"Cluster 2: Granulocytes - Unknown function"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 66: Spermatocytes - Spermatogenesis"			"HPA052275: AB_2681782"	"unprognostic (6.04e-2)"	"unprognostic (2.42e-1)"	"unprognostic (9.37e-3)"	"unprognostic (5.84e-2)"	"unprognostic (2.13e-1)"	"unprognostic (1.95e-2)"	"unprognostic (6.37e-3)"	"unprognostic (4.26e-2)"	"unprognostic (3.29e-2)"	"unprognostic (1.23e-2)"	"unprognostic (1.05e-2)"	"unprognostic (1.29e-1)"	"prognostic favorable (2.60e-9)"	"unprognostic (2.44e-2)"	"unprognostic (4.90e-2)"	"unprognostic (1.67e-3)"	"unprognostic (3.73e-2)"	25.3	16.7	10.7	8.0	12.7	13.1	16.4	20.2	12.6	13.7	11.0	15.9	46.1	13.2	62.4	9.9	18.3	19.9	10.2	11.5	10.3	37.6	95.9	15.9	9.6	12.0	10.0	25.3	44.1	27.7	5.9	17.0	12.6	19.5	17.0	35.2	16.0	21.1	7.8	9.5	30.7	14.1	10.3	11.3	24.4	18.2	9.9	10.6	26.8	11.4	10.4	14.3	7.5	19.1	9.2	22.0	7.8	7.3	51.7	15.3	39.6	15.4	18.4	16.2	28.3	10.1	21.5	4.1	16.3	31.6	7.1	9.7	5.3	16.7	18.7	7.6	11.7	12.9	28.8	24.8	12.7	8.8	14.7	18.3	16.9	42.9	5.1	39.7	30.5	5.9	8.7	32.3	44.7	11.1	4.5	8.2	8.5	16.9	13.0	5.9	18.4	27.9	16.5	17.7	5.3	11.8	17.9	5.2	24.4	15.1	19.9	11.3	24.3	20.5	13.6	19.1	10.1	8.9	11.4	4.1	21.4	7.7	14.4	74.1	20.7	44.9	22.9	19.6	21.0	14.7	23.3	19.2	21.4	13.1	19.7	15.4	19.8	15.0	15.8	24.9	28.8	16.5	10.7	12.7	20.2	12.6	11.5	10.3	12.0	10.0	12.6	10.3	9.9	19.1	14.9	6.4	11.0	11.8	11.7	5.9	12.4	25.0	6.2	13.5	9.1	7.9	6.0	45.8	16.7	18.4	18.8	25.3	19.7	9.9	5.9	21.1	31.0	9.5	6.0	9.1	7.2	4.0	6.6	28.5	22.4	14.5	9.7	5.7	5.1	8.9	20.3	63.3	14.9	5.0	12.2	8.5	16.2	8.2	5.9	17.9	32.3	9.2	10.6	5.6	8.7	19.2	6.2	27.2	23.9	12.0	17.9	18.0	16.6	6.3	52.1	32.0	19.8	54.1	13.1	8.5	8.6	45.3	7.5	7.7	5.5	23.1	13.6	17.4	8.9	9.5
C1S		ENSG00000182326	"Complement C1s"	P09871	12	6988259-7071032	"Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Complement pathway, Immunity, Innate immunity"	"Hydrolase, Protease, Serine protease"	"Disease variant, Ehlers-Danlos syndrome, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	5	"liver: 2915.2"	"Cell type enhanced"	"Detected in many"		"Fibroblasts: 687.0;Hepatocytes: 2795.1;Leydig cells: 1193.2;Peritubular cells: 640.1"	"Cancer enhanced"	"Detected in all"		"liver cancer: 276.7"	"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in single"	7	"neutrophil: 2.2"	"Lineage enriched"	"Detected in single"	18	"granulocytes: 2.2"	"Cell line enhanced"	"Detected in many"		"ASC diff: 769.5;ASC TERT1: 1012.7;BJ hTERT+: 336.1;HSkMC: 540.2"	"Not detected"	"Not detected"							"CAB016722, HPA018852"	Supported		Approved	Nucleoplasm,Cytosol	"Secreted to blood"	NA	NA	93000000000	14000000000	"Cluster 1: Neutrophils - Mixed function"	"Cluster 62: Liver - Hemostasis"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 2: Hepatocytes - Metabolism"	Nucleoplasm	Cytosol	"CAB016722: , HPA018852: AB_1847112"	"unprognostic (2.72e-3)"	"unprognostic (7.31e-2)"	"unprognostic (9.37e-2)"	"unprognostic (1.39e-2)"	"unprognostic (1.05e-2)"	"unprognostic (9.63e-2)"	"prognostic favorable (7.73e-4)"	"unprognostic (6.38e-2)"	"unprognostic (1.16e-1)"	"unprognostic (6.14e-2)"	"unprognostic (1.57e-1)"	"unprognostic (1.85e-2)"	"prognostic unfavorable (7.44e-15)"	"unprognostic (2.02e-2)"	"unprognostic (5.68e-3)"	"unprognostic (1.19e-2)"	"unprognostic (5.39e-2)"	416.4	136.1	26.4	207.7	28.5	1.7	252.5	27.1	43.1	309.2	36.7	192.4	84.6	209.0	147.2	152.9	315.4	543.8	191.5	25.4	34.8	60.2	2915.2	224.9	209.2	44.3	31.7	485.9	62.1	21.8	33.1	52.9	31.2	174.4	215.2	9.7	96.9	139.1	57.0	104.1	154.2	251.8	30.9	168.5	150.1	90.0	30.9	88.1	139.0	154.7	192.5	455.7	189.8	31.3	0.2	18.6	1.2	10.2	769.5	1012.7	4.5	143.3	336.1	74.7	135.7	0.9	2.0	0.5	19.7	179.6	20.2	1.1	0.3	2.1	6.7	0.7	0.7	0.5	5.6	48.2	230.3	1.8	0.9	540.2	2.8	60.2	4.4	94.2	0.1	0.2	0.4	0.1	9.9	0.0	0.4	1.6	10.3	0.0	0.6	0.2	1.1	1.5	3.1	2.5	0.8	0.9	86.6	1.8	2.1	17.4	0.1	0.0	0.5	34.2	2.6	133.8	0.2	0.6	0.5	0.8	73.6	1.2	2.5	0.3	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.0	26.4	28.5	27.1	43.1	25.4	34.8	44.3	31.7	31.2	30.9	30.9	31.3	37.6	16.0	41.0	9.4	5.7	76.2	18.9	22.2	23.9	0.9	4.5	15.4	21.5	171.6	15.5	3.7	0.0	3.7	0.7	0.1	1.9	285.2	6.6	8.7	272.4	30.6	0.0	112.2	2.9	42.9	2.5	687.0	11.2	7.3	5.1	25.7	93.5	2795.1	8.1	5.0	1.7	0.0	2.0	62.8	103.7	29.9	1193.2	6.4	88.9	19.7	1.0	15.2	0.0	1.5	0.6	31.7	0.1	640.1	1.8	9.7	0.0	7.1	4.6	1.1	138.1	34.9	127.6	6.3	5.3	6.3	53.8	2.6	12.8	30.7	0.2	5.2
C2		ENSG00000166278	"Complement C2"	P06681	6	31897785-31945672	"Disease related genes, Enzymes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted secreted proteins"	"Complement pathway, Immunity, Innate immunity"	"Hydrolase, Protease, Serine protease"	"Age-related macular degeneration, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	6	"liver: 477.9"	"Group enriched"	"Detected in many"	4	"Alveolar cells type 2: 142.4;Hepatocytes: 380.3;Hofbauer cells: 282.7;Kupffer cells: 99.3"	"Cancer enriched"	"Detected in all"	9	"liver cancer: 100.2"	"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	4	"intermediate monocyte: 21.1;non-classical monocyte: 25.9"	"Lineage enriched"	"Detected in single"	35	"monocytes: 25.9"	"Cell line enriched"	"Detected in some"	5	"Karpas-707: 284.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			CAB016775	Supported				"Secreted to blood"	NA	NA		34000000000	"Cluster 51: Monocytes - Innate immune response"	"Cluster 60: Liver - Hemostasis & Lipid metabolism"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 15: Hepatocytes - Hemostasis"			"CAB016775: "	"unprognostic (2.05e-1)"	"unprognostic (1.22e-1)"	"unprognostic (7.68e-2)"	"unprognostic (1.49e-3)"	"unprognostic (7.40e-2)"	"unprognostic (3.34e-2)"	"unprognostic (1.36e-2)"	"unprognostic (8.88e-3)"	"unprognostic (3.02e-1)"	"unprognostic (2.59e-3)"	"unprognostic (3.27e-2)"	"unprognostic (3.15e-3)"	"prognostic unfavorable (2.64e-7)"	"unprognostic (2.05e-1)"	"unprognostic (4.42e-2)"	"unprognostic (7.37e-2)"	"unprognostic (2.55e-2)"	42.6	12.1	0.8	27.6	1.0	3.2	11.7	0.9	1.4	8.1	1.7	14.3	16.7	7.0	1.3	7.6	12.0	23.0	8.5	0.7	1.1	23.2	477.9	80.0	27.8	3.0	2.6	5.3	1.9	0.9	3.8	48.4	3.0	5.4	13.0	0.4	9.1	0.9	2.1	5.8	30.2	23.6	2.1	46.3	12.0	4.1	3.7	5.5	3.3	2.7	12.5	23.6	5.3	2.1	0.3	0.1	0.1	0.6	0.1	0.0	6.8	0.5	0.3	0.4	0.3	0.4	0.3	0.6	3.5	1.0	0.6	0.5	0.1	0.0	0.3	0.2	0.4	0.3	0.4	52.8	1.1	0.1	0.7	2.7	0.3	0.6	0.1	0.6	0.0	0.7	0.5	284.0	0.0	0.0	0.4	0.5	0.3	0.1	0.0	0.2	16.5	3.0	0.0	0.1	0.3	0.3	2.6	0.3	0.2	0.3	0.2	9.5	0.2	0.2	0.7	0.5	0.1	0.9	31.6	2.7	0.8	0.9	0.1	0.1	5.6	0.0	0.1	21.1	0.1	0.0	0.0	0.0	0.7	0.1	0.1	0.1	0.5	0.1	25.9	0.0	0.0	2.2	0.8	1.0	0.9	1.4	0.7	1.1	3.0	2.6	3.0	2.1	3.7	2.1	2.1	25.6	142.4	2.6	1.9	3.3	1.1	2.0	0.6	1.4	1.3	1.3	0.6	25.8	11.2	1.8	0.0	2.1	0.1	1.8	0.0	0.6	0.3	1.5	18.7	1.9	2.4	10.7	6.6	2.7	2.7	19.8	3.1	1.3	3.8	0.2	21.0	380.3	282.7	1.7	6.3	11.3	0.0	99.3	5.0	1.3	6.8	32.6	3.6	7.5	7.3	0.1	0.0	1.0	1.7	4.5	33.1	1.2	0.4	4.0	55.2	35.7	9.4	0.9	0.0	5.6	3.5	0.8	1.4	0.7	2.8	4.0	2.0	0.5	15.8	4.5
CAD	GATD4	ENSG00000084774	"Carbamoyl-phosphate synthetase 2, aspartate transcarbamylase, and dihydroorotase"	P27708	2	27217369-27243943	"Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Pyrimidine biosynthesis"	"Allosteric enzyme, Hydrolase, Ligase, Multifunctional enzyme, Transferase"	"Cancer-related genes, Congenital disorder of glycosylation, Disease variant, Epilepsy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB007781, HPA065158, HPA069341"	Supported		Supported	Cytosol		NA	No		260000	"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 52: Non-specific - Transcription"	Cytosol		"CAB007781: AB_562057, HPA065158: , HPA069341: AB_2686125"	"unprognostic (1.69e-1)"	"unprognostic (7.34e-2)"	"unprognostic (1.49e-1)"	"unprognostic (4.71e-3)"	"unprognostic (2.55e-1)"	"unprognostic (1.92e-1)"	"prognostic unfavorable (1.72e-11)"	"unprognostic (1.25e-1)"	"unprognostic (2.22e-1)"	"unprognostic (2.37e-1)"	"unprognostic (1.01e-1)"	"unprognostic (6.11e-2)"	"prognostic unfavorable (1.82e-4)"	"unprognostic (6.94e-2)"	"unprognostic (1.75e-1)"	"unprognostic (1.14e-1)"	"unprognostic (5.93e-3)"	15.0	13.5	12.7	12.4	14.1	9.0	14.9	12.7	15.5	19.8	12.2	16.5	8.5	23.8	9.9	19.2	19.3	7.7	11.6	12.3	12.8	18.0	27.8	12.3	14.9	13.8	13.5	22.3	22.3	5.9	18.7	7.5	14.5	15.2	7.8	5.0	12.3	8.8	10.3	18.7	16.1	11.9	12.7	20.1	14.0	22.2	14.2	11.6	15.8	5.9	10.5	16.9	15.8	15.2	75.2	66.4	28.9	58.4	46.1	37.6	22.9	31.0	21.4	38.3	27.0	75.7	29.2	66.4	27.4	28.5	29.6	41.4	85.7	41.1	28.5	43.8	69.2	95.2	55.0	40.0	23.0	75.7	46.2	28.8	33.1	55.7	63.0	17.8	41.6	60.6	68.3	36.0	34.2	74.8	48.7	112.0	69.7	31.3	49.7	84.0	86.5	69.5	28.6	37.6	57.9	29.1	43.3	30.5	37.4	21.3	23.9	31.3	37.7	57.7	47.5	45.5	63.5	74.0	51.8	135.2	23.3	71.7	51.0	0.0	0.8	0.4	3.1	1.5	2.5	3.4	4.4	5.2	1.9	3.1	2.8	2.8	0.5	2.7	0.9	3.4	5.9	2.0	12.7	14.1	12.7	15.5	12.3	12.8	13.8	13.5	14.5	12.7	14.2	15.2	4.2	3.2	3.9	12.7	5.3	3.7	4.3	5.0	5.7	10.6	7.1	8.6	8.3	10.0	4.7	1.8	16.7	5.9	3.9	3.9	0.0	6.1	1.5	2.9	7.9	5.1	6.6	9.7	5.6	3.7	6.6	7.0	6.1	4.3	4.5	16.9	3.3	6.6	7.7	6.7	5.7	5.8	0.0	3.0	1.9	1.9	6.2	3.6	3.6	6.5	4.7	4.1	5.2	8.5	7.4	5.9	1.9	9.8	7.3	8.0	2.5	2.0	3.5	6.8	0.0	8.2	5.2	5.6	12.1	6.2	3.4	2.2	5.1	9.7	7.5	2.2
CANT1	"SCAN-1, SHAPY"	ENSG00000171302	"Calcium activated nucleotidase 1"	Q8WVQ1	17	78991716-79009867	"Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"		Hydrolase	"Cancer-related genes, Disease variant, Dwarfism"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Distal enterocytes: 139.5;Intestinal goblet cells: 155.6;Syncytiotrophoblasts: 101.5;Undifferentiated cells: 100.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"OE19: 445.4;T-47d: 282.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA019627, HPA019639, HPA022818"	Enhanced		Supported	"Golgi apparatus"		NA	Yes		3300000	"Cluster 52: Eosinophils - Transcription"	"Cluster 37: Intestine - Unknown function"	"Cluster 21: OE19 - Mitochondria"	"Cluster 27: Mucus-secreting cells - Mucin production"	"Golgi apparatus"		"HPA019627: AB_1845969, HPA019639: AB_1845970, HPA022818: AB_1845971"	"unprognostic (1.98e-2)"	"unprognostic (2.49e-2)"	"unprognostic (1.50e-2)"	"unprognostic (5.36e-2)"	"unprognostic (2.13e-2)"	"unprognostic (2.21e-2)"	"prognostic unfavorable (1.41e-4)"	"prognostic unfavorable (2.90e-4)"	"unprognostic (1.76e-1)"	"unprognostic (9.00e-2)"	"unprognostic (3.30e-1)"	"unprognostic (2.49e-1)"	"prognostic unfavorable (6.21e-4)"	"unprognostic (7.04e-2)"	"unprognostic (5.06e-2)"	"unprognostic (1.16e-1)"	"unprognostic (7.23e-2)"	15.8	23.9	10.4	24.7	12.4	19.1	25.4	13.6	11.3	32.3	13.8	89.2	51.9	17.4	8.7	44.8	18.2	25.2	17.0	11.1	12.6	16.1	17.3	16.4	15.2	14.6	14.5	14.6	19.6	24.5	17.5	25.9	13.9	71.8	82.8	7.4	62.7	32.4	14.9	14.9	55.5	15.5	13.8	26.5	51.1	20.7	14.5	14.7	13.9	12.4	15.1	16.7	21.7	17.8	106.5	112.1	31.9	46.3	29.7	35.2	38.9	66.0	51.3	66.7	55.9	53.8	99.6	25.3	36.1	46.1	83.0	53.7	27.1	49.8	68.4	43.0	46.4	33.7	34.1	45.9	25.0	33.0	51.6	33.7	32.4	62.7	34.2	40.9	116.1	42.5	42.3	43.2	46.4	58.4	50.2	19.8	22.1	445.4	103.1	27.6	51.8	29.8	29.8	53.5	45.6	45.4	33.9	227.2	50.2	50.3	282.6	38.6	56.6	101.9	90.5	46.4	83.1	48.9	43.8	24.3	64.4	24.9	65.3	6.3	4.0	8.7	5.5	4.4	5.7	3.9	4.3	4.8	3.8	2.5	4.1	4.1	17.4	3.1	3.0	2.7	3.6	4.6	10.4	12.4	13.6	11.3	11.1	12.6	14.6	14.5	13.9	13.8	14.5	17.8	12.6	28.9	20.6	5.9	11.8	16.6	15.3	16.8	6.8	6.4	49.9	16.3	13.3	14.3	15.1	12.9	14.6	36.6	8.9	139.5	3.9	34.7	14.0	10.7	13.1	16.3	51.0	15.2	4.1	28.8	39.4	13.5	38.2	19.0	5.7	20.0	41.7	14.4	24.9	5.0	5.2	155.6	16.2	12.4	9.5	15.7	11.8	14.2	14.2	3.7	18.1	8.1	11.3	5.0	10.2	37.7	55.8	7.5	16.6	33.4	39.4	6.7	9.7	8.7	6.6	9.5	13.3	23.9	5.8	12.0	13.1	101.5	11.1	11.3	100.2	19.4
CAPN1	"CANP, CANPL1, muCANP, muCL"	ENSG00000014216	"Calpain 1"	P07384	11	65180566-65212006	"Disease related genes, Enzymes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"		"Hydrolase, Protease, Thiol protease"	"Disease variant, Hereditary spastic paraplegia, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"esophagus: 276.2"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"RT4: 516.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA005992	Enhanced		Supported	Cytosol		NA	NA		9100000	"Cluster 46: Basophils - DNA binding"	"Cluster 84: Esophagus - Epithelial cell function"	"Cluster 15: RT4 - Unknown function"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Cytosol		"HPA005992: AB_1845924"	"unprognostic (2.07e-1)"	"unprognostic (2.15e-1)"	"unprognostic (2.69e-1)"	"unprognostic (1.40e-1)"	"unprognostic (4.06e-2)"	"unprognostic (1.10e-1)"	"unprognostic (1.91e-2)"	"unprognostic (2.48e-2)"	"unprognostic (7.23e-2)"	"unprognostic (2.23e-2)"	"prognostic unfavorable (4.30e-4)"	"unprognostic (3.33e-1)"	"prognostic favorable (7.06e-8)"	"unprognostic (5.70e-3)"	"unprognostic (1.51e-1)"	"unprognostic (1.86e-1)"	"unprognostic (2.98e-1)"	44.8	43.1	27.8	51.9	26.1	66.5	48.4	29.7	30.1	80.9	28.3	78.6	80.4	56.3	27.5	276.2	92.3	55.5	53.1	27.7	33.0	53.1	44.3	56.9	57.0	41.4	31.5	44.5	71.7	36.6	40.8	56.2	43.4	62.1	57.6	9.6	118.7	67.4	84.8	125.1	88.1	45.3	33.9	50.2	65.5	6.1	37.9	49.5	71.5	55.3	86.4	83.4	117.4	27.4	285.6	147.9	42.9	97.2	77.9	104.3	127.0	84.1	144.2	103.0	74.9	94.8	250.2	71.2	136.0	179.3	111.1	409.8	60.9	366.9	32.2	76.4	44.1	170.8	80.4	93.7	76.2	40.6	228.0	107.3	196.8	85.9	43.2	92.6	178.5	50.6	103.1	55.9	87.4	181.8	83.1	130.6	120.5	145.2	133.8	80.7	43.0	43.2	138.1	516.5	76.2	55.7	87.4	331.4	80.3	45.8	142.8	77.9	147.1	73.1	50.5	159.0	38.5	33.8	26.9	86.6	127.5	48.8	82.3	87.6	57.5	77.9	39.4	51.2	31.0	30.8	30.7	35.8	48.4	31.7	17.6	24.9	33.1	34.8	30.4	38.1	35.9	74.8	27.8	26.1	29.7	30.1	27.7	33.0	41.4	31.5	43.4	33.9	37.9	27.4	27.3	25.6	27.9	21.5	39.6	59.9	127.3	120.5	56.9	10.7	44.7	36.6	22.0	74.4	81.0	77.3	20.9	238.5	61.4	184.2	39.2	180.5	0.5	41.9	26.3	31.3	44.3	58.3	15.9	115.8	111.7	39.6	57.6	58.2	46.9	48.6	37.9	36.7	88.7	21.9	15.2	76.9	59.0	51.2	34.0	2.0	43.5	67.1	48.0	14.0	112.7	38.5	61.8	6.6	1.9	179.4	124.1	50.8	17.7	78.6	155.6	34.6	71.1	16.2	39.5	25.3	36.7	0.5	2.8	102.0	68.9	196.6	40.2	35.4	125.3	156.6
CAPN2	"CANPL2, CANPml, mCANP"	ENSG00000162909	"Calpain 2"	P17655	1	223701593-223776018	"Enzymes, Plasma proteins, Predicted intracellular proteins"		"Hydrolase, Protease, Thiol protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"TIME: 858.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA024470	Approved	Approved	Supported	Cytosol		NA	NA		2800000	"Cluster 39: Non-specific - mRNA processing"	"Cluster 46: Fibroblasts - ECM organization"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 16: Pancreatic endocrine cells - Mixed function"	Cytosol		"HPA024470: AB_1845925"	"unprognostic (2.77e-2)"	"unprognostic (1.27e-3)"	"unprognostic (2.03e-1)"	"unprognostic (3.39e-2)"	"unprognostic (2.12e-1)"	"unprognostic (3.32e-2)"	"unprognostic (1.59e-1)"	"unprognostic (1.10e-1)"	"unprognostic (2.85e-1)"	"unprognostic (1.96e-1)"	"prognostic unfavorable (2.50e-4)"	"unprognostic (1.21e-1)"	"prognostic favorable (2.19e-4)"	"unprognostic (1.61e-1)"	"unprognostic (2.63e-1)"	"unprognostic (2.62e-1)"	"prognostic unfavorable (6.21e-4)"	118.8	93.9	40.2	64.9	50.0	40.9	92.4	45.3	39.6	110.4	29.4	140.1	46.2	67.7	58.0	134.3	120.5	119.7	71.8	36.9	42.7	115.2	31.2	182.5	35.5	51.9	46.1	83.2	55.1	136.3	28.0	68.3	46.6	47.5	131.4	19.2	151.2	91.2	82.2	41.6	58.5	87.3	43.4	42.5	130.4	26.3	49.1	27.0	80.9	81.6	54.3	85.6	89.3	49.3	419.9	263.7	79.2	54.9	257.6	356.6	79.4	383.9	541.3	267.2	151.1	209.2	323.6	0.4	125.0	417.1	209.1	255.1	86.3	593.1	243.4	109.8	95.2	7.8	124.9	25.6	232.3	21.5	13.9	193.3	187.3	416.6	217.8	472.3	537.1	0.1	123.2	106.8	789.3	8.6	1.0	19.4	45.5	49.7	346.3	35.4	262.4	7.3	454.9	24.3	17.7	94.7	198.1	524.2	122.8	189.7	80.9	98.7	858.1	252.7	212.0	220.6	498.4	32.5	66.8	1.4	625.3	46.2	284.7	7.9	118.6	7.2	106.8	77.9	89.8	34.4	72.6	103.2	163.9	16.6	22.9	62.2	6.1	24.5	73.7	7.4	81.7	136.6	40.2	50.0	45.3	39.6	36.9	42.7	51.9	46.1	46.6	43.4	49.1	49.3	240.0	394.2	134.9	82.9	42.3	47.3	136.6	197.5	38.7	12.0	35.7	32.8	38.4	115.8	264.4	53.3	33.3	24.4	72.4	356.0	181.9	271.4	94.5	70.0	52.7	125.3	24.6	6.9	13.3	195.9	92.0	105.0	103.5	93.3	27.8	47.8	35.7	9.7	38.9	13.5	23.1	104.4	242.1	50.0	239.3	232.8	77.3	86.4	112.1	22.5	66.0	22.6	78.2	48.7	21.6	373.0	191.5	68.8	83.3	237.7	104.1	23.6	288.8	18.0	39.5	85.0	107.9	3.4	3.3	67.5	27.6	8.2	83.5	63.5	98.2	268.2
CAPN3	"CANP3, LGMD2, LGMD2A, nCL-1, p94"	ENSG00000092529	"Calpain 3"	P20807	15	42359498-42412949	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"		"Hydrolase, Protease, Thiol protease"	"Disease variant, Limb-girdle muscular dystrophy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 279.2;skeletal muscle: 905.9;tongue: 377.4"	"Group enriched"	"Detected in many"	5	"Early spermatids: 512.5;Late spermatids: 183.6;Melanocytes: 482.0;Oligodendrocytes: 220.2"	"Cancer enriched"	"Detected in some"	10	"melanoma: 9.1"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Cell line enriched"	"Detected in many"	27	"SK-MEL-30: 238.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA040052	Enhanced					NA	NA			"Cluster 1: Neutrophils - Mixed function"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 23: Spermatids - Flagellum & Golgi organization"			"HPA040052: AB_2676821"	"unprognostic (1.06e-2)"	"unprognostic (1.31e-1)"	"unprognostic (4.00e-2)"	"unprognostic (8.71e-2)"	"unprognostic (1.53e-1)"	"unprognostic (1.72e-2)"	"unprognostic (2.11e-4)"	"unprognostic (3.12e-3)"	"unprognostic (2.82e-1)"	"unprognostic (2.47e-1)"	"unprognostic (2.37e-3)"	"unprognostic (3.26e-2)"	"unprognostic (3.91e-4)"	"unprognostic (5.56e-3)"	"unprognostic (2.43e-1)"	"unprognostic (8.93e-3)"	"unprognostic (1.38e-1)"	13.5	8.8	136.1	4.0	206.6	47.6	14.1	194.2	243.3	18.8	113.0	13.3	3.1	11.2	163.7	14.5	13.7	4.5	16.1	142.9	159.9	93.6	36.9	21.5	7.0	212.0	194.9	15.7	8.7	2.4	11.3	3.0	212.1	16.0	5.3	7.5	18.6	5.2	905.9	54.9	14.0	4.7	155.2	19.1	8.9	30.8	187.8	3.4	10.7	377.4	5.1	11.7	15.5	279.2	0.5	0.3	0.6	1.1	8.8	6.1	0.6	2.6	1.9	0.5	0.8	1.2	0.5	0.2	0.9	1.6	0.4	3.7	0.4	3.5	0.3	0.9	0.8	0.8	0.8	4.1	0.6	1.0	1.5	4.7	3.7	0.8	0.7	1.5	0.1	0.7	0.2	1.8	0.7	0.1	0.2	1.2	0.4	0.2	0.9	1.1	0.4	1.9	1.9	1.3	0.4	0.1	0.2	0.5	238.0	1.0	0.0	5.4	0.9	0.3	0.4	2.6	0.7	1.5	2.1	0.2	0.4	2.4	1.8	0.5	1.0	0.1	0.7	0.2	0.8	0.3	0.1	0.3	0.5	0.5	0.1	0.9	0.9	0.6	0.1	0.5	0.4	0.6	136.1	206.6	194.2	243.3	142.9	159.9	212.0	194.9	212.1	155.2	187.8	279.2	0.5	12.8	34.5	16.0	2.9	20.1	0.8	2.2	3.4	2.2	0.4	0.3	0.4	1.5	4.4	1.8	2.1	0.7	1.4	2.0	1.9	0.1	512.5	0.5	0.6	2.2	0.0	0.0	4.0	0.0	0.6	1.6	3.6	0.7	1.3	0.4	2.2	8.7	32.7	0.0	5.2	1.8	2.0	4.4	11.6	183.6	5.3	2.9	482.0	13.1	2.5	3.7	2.1	4.5	220.2	0.0	5.4	3.4	0.6	0.9	2.4	59.5	2.6	3.9	0.0	13.8	1.6	15.9	4.7	1.6	8.5	3.3	1.8	1.2	2.3	0.8
CAPN8	nCL-2	ENSG00000203697	"Calpain 8"	A6NHC0	1	223538007-223665723	"Enzymes, Predicted intracellular proteins"		"Hydrolase, Protease, Thiol protease"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	9	"stomach 1: 291.1"	"Cell type enriched"	"Detected in many"	6	"Gastric mucus-secreting cells: 910.8"	"Cancer enhanced"	"Detected in many"		"pancreatic cancer: 28.8"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	12	"OE19: 125.9;RT4: 76.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA073939			Approved	"Nucleoplasm,Nuclear membrane,Vesicles"		No	NA				"Cluster 4: Stomach - Digestion"	"Cluster 21: OE19 - Mitochondria"	"Cluster 16: Pancreatic endocrine cells - Mixed function"	"Nucleoplasm, Nuclear membrane, Vesicles"		"HPA073939: AB_2686646"	"unprognostic (4.87e-3)"	"unprognostic (2.58e-1)"	"unprognostic (1.89e-1)"	"unprognostic (2.06e-2)"	"unprognostic (1.32e-2)"	"unprognostic (1.49e-1)"	"unprognostic (7.97e-3)"	"unprognostic (1.19e-1)"	"unprognostic (1.26e-1)"	"unprognostic (8.08e-2)"	"unprognostic (2.72e-3)"	"unprognostic (3.55e-1)"	"unprognostic (4.12e-6)"	"unprognostic (6.95e-2)"	"unprognostic (5.59e-2)"	"unprognostic (3.83e-2)"	"unprognostic (5.44e-3)"	0.3	0.2	4.7	6.3	1.0	0.1	14.9	0.1	1.7	1.1	2.3	23.6	8.0	0.1	11.1	0.6	1.3	14.3	0.0	2.3	3.6	1.7	0.3	21.3	0.1	2.7	1.5	0.2	2.9	0.0	0.1	0.3	1.1	2.9	33.0	0.3	8.5	1.4	0.8	2.3	4.6	1.1	2.0	0.3	291.1	0.6	1.8	0.0	0.2	0.0	0.3	12.3	0.7	2.5	1.5	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.1	0.8	0.0	4.6	0.0	0.1	0.0	0.2	8.3	0.0	3.6	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.3	0.0	0.4	0.0	0.1	0.1	0.0	0.0	0.0	0.1	0.0	1.0	0.2	0.0	0.2	125.9	3.8	0.1	0.0	0.0	1.3	76.8	1.2	0.0	0.0	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.2	4.7	1.0	0.1	1.7	2.3	3.6	2.7	1.5	1.1	2.0	1.8	2.5	0.4	28.9	131.7	1.6	1.8	0.1	6.5	1.9	0.0	0.0	19.9	7.9	2.6	10.0	55.9	25.8	0.0	0.2	0.2	90.9	0.0	3.8	2.3	2.0	0.3	0.7	3.0	0.0	0.6	21.6	0.0	0.3	910.8	2.1	10.8	5.2	0.0	0.3	0.6	0.0	0.1	61.9	4.1	0.0	0.8	6.7	1.8	1.8	0.0	0.0	0.0	0.0	1.0	0.0	0.1	36.1	42.6	3.4	3.5	4.0	2.1	1.5	15.0	0.0	0.0	0.3	0.8	0.4	1.0	0.0	0.0	0.1	1.4	2.9	21.2	31.2
CASP1	"ICE, IL1BC"	ENSG00000137752	"Caspase 1"	P29466	11	105025443-105035250	"Cancer-related genes, Enzymes, Predicted intracellular proteins"	Apoptosis	"Hydrolase, Protease, Thiol protease"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"intestine: 126.0;lymphoid tissue: 91.0"	"Cell type enhanced"	"Detected in many"		"Kupffer cells: 125.3;Langerhans cells: 120.7;Macrophages: 136.6;monocytes: 185.6;Proximal enterocytes: 116.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"BJ hTERT+: 112.7;HBEC3-KT: 53.8;HHSteC: 58.2;U-937: 136.2"	"Region enhanced"	"Detected in all"		"olfactory bulb: 18.4"	"Low region specificity"	"Detected in all"			"CAB002685, HPA003056"	Approved		Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 14: B-cells - Humoral immune response"	"Cluster 32: U-937 - Innate immune response"	"Cluster 19: Monocytes & Neutrophils - Innate immune response"	Cytosol	Nucleoplasm	"CAB002685: , HPA003056: AB_1846037"	"unprognostic (1.21e-3)"	"unprognostic (3.02e-1)"	"unprognostic (9.47e-3)"	"unprognostic (1.43e-1)"	"unprognostic (1.47e-1)"	"unprognostic (1.21e-1)"	"unprognostic (5.24e-2)"	"unprognostic (1.97e-1)"	"unprognostic (1.66e-1)"	"unprognostic (6.67e-2)"	"unprognostic (2.75e-2)"	"unprognostic (1.35e-1)"	"prognostic unfavorable (3.11e-4)"	"unprognostic (9.03e-2)"	"unprognostic (2.30e-2)"	"unprognostic (3.18e-1)"	"unprognostic (5.19e-2)"	20.4	10.5	8.7	59.1	8.8	36.3	21.9	9.3	14.6	11.9	9.8	47.7	124.6	8.7	12.0	27.2	12.3	27.4	12.2	8.5	9.6	13.3	21.6	48.3	52.1	11.2	9.4	11.7	6.4	2.7	5.0	30.0	11.1	13.0	49.7	1.1	20.8	12.5	6.2	30.9	126.0	20.8	10.7	91.0	22.5	2.4	10.7	23.2	7.8	7.3	35.5	35.7	19.4	11.9	1.3	0.3	0.0	5.3	5.8	12.1	1.0	5.7	112.7	14.0	38.5	0.2	0.7	18.7	2.3	6.6	25.7	8.1	0.0	53.8	3.3	12.3	0.0	0.9	0.7	1.3	58.2	22.1	0.2	20.9	37.4	11.4	30.3	36.2	6.1	0.3	0.2	0.0	3.4	0.0	0.6	30.7	0.0	0.1	0.3	18.1	0.4	14.9	0.3	8.9	0.4	0.4	16.9	1.1	26.2	0.1	1.2	50.1	7.2	12.8	0.6	1.2	1.6	0.1	5.4	0.1	8.1	136.2	2.7	83.8	246.1	134.9	132.9	359.9	178.5	40.2	92.7	115.8	220.2	35.5	50.2	82.7	220.0	63.0	383.0	7.7	129.0	213.3	8.7	8.8	9.3	14.6	8.5	9.6	11.2	9.4	11.1	10.7	10.7	11.9	26.3	19.2	30.0	0.0	27.2	26.0	42.5	91.5	14.2	0.1	5.8	23.0	2.9	8.6	37.7	11.0	0.0	2.1	34.1	33.1	1.9	23.3	0.2	5.8	2.5	24.0	6.0	10.3	0.2	12.9	1.3	17.8	11.7	3.4	15.8	0.2	22.9	3.1	96.5	0.0	0.0	50.6	14.2	125.3	120.7	1.3	3.4	136.6	5.4	12.2	185.6	0.1	64.9	0.0	0.1	5.3	73.4	3.4	20.0	8.7	116.0	2.2	28.4	0.2	0.0	1.0	8.1	0.0	0.1	17.9	22.3	1.1	58.4	3.3	90.5	43.6
CASP10	"FLICE-2, MCH4"	ENSG00000003400	"Caspase 10"	Q92851	2	201182898-201229406	"Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins"	Apoptosis	"Hydrolase, Protease, Thiol protease"	"Cancer-related genes, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 71.3;NK-cells: 44.3;Paneth cells: 44.5;Plasma cells: 49.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HUVEC TERT2: 25.3"					"Low region specificity"	"Detected in all"			"CAB003780, HPA017059"	Approved		Approved	"Golgi apparatus,Vesicles"		NA	NA			"Cluster 24: B-cells - Unknown function"	"Cluster 86: Liver & Placenta - Transport via ER"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 53: Intestinal epithelial cells - Unknown function"	"Golgi apparatus"	Vesicles	"CAB003780: AB_289592, HPA017059: AB_1846040"	"unprognostic (4.01e-2)"	"unprognostic (8.24e-2)"	"unprognostic (4.80e-1)"	"unprognostic (1.28e-3)"	"unprognostic (4.74e-2)"	"unprognostic (2.25e-1)"	"prognostic unfavorable (8.54e-4)"	"unprognostic (1.73e-2)"	"unprognostic (1.48e-2)"	"unprognostic (3.68e-2)"	"unprognostic (1.91e-1)"	"unprognostic (1.04e-1)"	"prognostic unfavorable (6.05e-7)"	"unprognostic (3.23e-2)"	"unprognostic (2.19e-2)"	"unprognostic (4.49e-2)"	"unprognostic (1.38e-2)"	8.8	2.4	5.7	9.2	5.5	19.5	6.5	4.5	5.8	4.0	4.4	13.2	21.8	3.3	6.2	8.8	5.4	7.4	6.7	4.7	5.1	8.1	6.2	11.5	8.9	6.0	5.0	1.6	4.8	2.3	1.3	9.6	5.8	3.9	13.4	1.3	5.4	3.1	4.9	5.7	18.4	5.1	5.6	22.6	10.2	1.2	7.3	8.7	5.3	2.8	10.4	9.0	5.1	5.4	4.4	3.5	0.3	0.4	0.1	0.3	7.5	0.7	4.6	0.4	1.8	4.6	9.8	0.5	7.0	2.5	1.7	2.9	0.2	2.3	1.3	2.1	4.8	12.2	4.0	15.1	1.6	8.3	12.7	0.5	2.0	5.3	0.4	0.3	25.3	5.1	14.9	17.4	0.4	0.3	15.9	7.8	0.6	6.0	2.4	8.8	0.5	18.4	8.7	6.2	0.2	0.1	4.1	0.2	1.9	3.0	0.2	7.8	10.0	0.4	0.8	3.4	0.2	18.7	12.1	0.5	4.5	6.3	0.2	5.9	11.7	0.7	6.4	16.5	5.6	8.2	5.2	3.6	6.5	7.7	7.2	6.4	2.1	8.5	19.3	6.6	1.2	7.2	5.7	5.5	4.5	5.8	4.7	5.1	6.0	5.0	5.8	5.6	7.3	5.4	20.7	19.2	10.0	0.3	15.8	6.0	2.7	10.6	5.2	0.0	1.3	0.9	1.8	8.6	9.4	9.2	0.0	1.1	20.5	71.3	1.9	16.2	1.2	7.7	7.4	29.7	2.4	14.9	0.3	10.4	0.7	4.2	26.5	12.0	7.6	0.8	26.4	7.1	9.4	0.0	0.5	21.6	4.1	26.6	17.5	0.0	0.6	16.2	7.2	33.7	22.0	0.5	44.3	0.0	0.9	8.6	44.5	0.0	49.7	2.5	26.1	8.7	24.4	0.4	0.0	2.9	2.2	0.1	0.1	6.6	4.5	0.4	12.9	4.1	16.4	10.3
CASP2	"ICH1, MGC2181, NEDD2, PPP1R57"	ENSG00000106144	"Caspase 2"	P42575	7	143288215-143307696	"Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins"	Apoptosis	"Hydrolase, Protease, Thiol protease"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Late spermatids: 51.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"CAB012175, HPA050678"	Approved		Approved	Nucleoplasm		NA	Yes			"Cluster 38: Basophils - Unknown function"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 34: Spermatids - Unknown function"	Nucleoplasm		"CAB012175: , HPA050678: AB_2681214"	"unprognostic (6.96e-2)"	"prognostic favorable (7.38e-4)"	"unprognostic (2.74e-2)"	"unprognostic (7.51e-2)"	"unprognostic (4.24e-2)"	"unprognostic (2.39e-2)"	"prognostic unfavorable (2.34e-4)"	"unprognostic (1.74e-2)"	"unprognostic (1.34e-2)"	"prognostic favorable (2.89e-4)"	"unprognostic (1.91e-2)"	"unprognostic (1.64e-1)"	"prognostic unfavorable (5.01e-6)"	"unprognostic (2.66e-3)"	"unprognostic (9.48e-2)"	"unprognostic (1.19e-1)"	"unprognostic (1.64e-1)"	10.3	6.6	6.0	13.9	6.7	40.2	10.5	7.8	6.7	11.8	6.7	11.1	10.7	10.2	9.6	15.3	10.3	7.0	8.4	5.9	6.2	9.1	6.4	10.4	22.0	7.2	6.4	9.3	8.4	11.1	5.3	12.4	7.7	7.6	12.7	7.7	11.9	6.3	3.9	17.4	15.4	9.4	5.9	19.0	9.6	9.1	6.9	27.5	8.8	5.0	27.1	7.5	11.2	10.0	27.5	25.4	28.8	51.0	15.1	17.5	15.4	27.7	13.0	25.4	27.8	26.0	31.3	52.0	25.9	18.4	19.4	27.3	29.4	22.6	34.0	45.8	22.5	31.2	40.4	18.3	8.4	60.7	37.4	13.0	18.1	31.0	11.0	11.3	22.0	41.3	26.3	32.6	27.5	27.5	109.1	64.4	36.5	27.4	26.3	79.1	14.6	32.6	15.1	23.3	31.5	34.2	54.8	24.3	17.3	19.6	26.3	23.4	24.1	22.5	15.5	40.7	28.1	27.0	28.5	59.4	24.9	72.6	41.1	69.2	17.9	17.2	24.5	21.7	24.2	25.7	33.3	25.3	17.3	28.8	24.3	28.3	21.7	24.2	34.1	21.1	38.9	15.3	6.0	6.7	7.8	6.7	5.9	6.2	7.2	6.4	7.7	5.9	6.9	10.0	14.1	9.6	8.3	4.2	17.4	15.2	7.0	9.4	6.2	4.8	19.0	13.5	6.2	17.2	7.0	7.3	8.4	20.0	19.3	8.7	3.9	8.1	36.6	10.8	17.9	16.4	10.7	9.7	11.2	7.7	14.6	9.3	8.2	20.1	10.1	22.7	18.2	7.2	10.1	6.7	8.8	11.5	0.0	16.9	23.3	51.0	11.8	12.2	21.4	4.7	20.8	4.4	13.4	4.5	22.4	9.4	5.9	8.2	13.0	5.8	9.1	4.2	4.9	15.4	0.0	8.3	10.9	13.7	25.9	16.1	13.8	5.7	16.7	9.3	15.5	7.0
CASP3	"apopain, CPP32, CPP32B, Yama"	ENSG00000164305	"Caspase 3"	P42574	4	184627696-184649509	"Cancer-related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins"	Apoptosis	"Hydrolase, Protease, Thiol protease"	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Plasma cells: 118.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in all"	7	"basophil: 571.0;eosinophil: 408.6"	"Lineage enriched"	"Detected in all"	8	"granulocytes: 571.0"	"Cell line enhanced"	"Detected in all"		"Karpas-707: 259.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB000091, HPA002643, CAB008381"	Enhanced		Approved	Nucleoplasm,Mitochondria		NA	NA		94000	"Cluster 2: Granulocytes - Unknown function"	"Cluster 9: Intestine - Unknown function"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 55: Plasma cells - Humoral immune response"	Mitochondria	Nucleoplasm	"CAB000091: , CAB008381: AB_590737, HPA002643: AB_1846048"	"unprognostic (1.38e-1)"	"unprognostic (1.06e-1)"	"unprognostic (2.21e-2)"	"prognostic favorable (2.24e-4)"	"unprognostic (2.29e-3)"	"unprognostic (3.58e-2)"	"unprognostic (9.57e-3)"	"unprognostic (5.86e-2)"	"unprognostic (3.56e-2)"	"unprognostic (1.12e-2)"	"unprognostic (1.70e-2)"	"unprognostic (2.41e-1)"	"prognostic unfavorable (2.30e-5)"	"unprognostic (1.41e-2)"	"unprognostic (5.74e-3)"	"unprognostic (1.30e-1)"	"unprognostic (4.05e-3)"	16.3	12.1	11.3	26.6	10.9	32.8	16.3	18.6	11.4	12.7	10.0	34.2	54.1	12.7	12.9	27.7	9.2	19.9	14.7	10.8	12.2	8.5	22.0	12.8	43.4	10.8	11.5	8.9	13.4	9.0	8.8	26.1	11.4	11.3	33.9	12.7	13.2	10.6	13.9	16.1	41.8	15.3	11.6	23.0	31.2	9.3	11.3	39.0	10.6	14.1	41.9	24.4	12.0	13.0	31.0	16.7	65.3	31.6	39.4	52.2	37.6	90.2	67.7	61.9	35.4	30.7	25.2	42.4	13.9	44.1	29.2	25.5	52.1	32.1	69.7	109.9	28.7	68.2	12.9	71.4	47.3	55.9	62.3	71.7	38.3	39.3	31.4	44.4	77.6	43.1	57.2	259.8	64.5	13.2	89.1	51.8	65.1	33.7	20.9	63.6	30.8	41.2	52.9	49.3	37.1	40.5	39.1	35.1	52.1	64.3	19.2	35.9	54.1	28.2	25.9	21.1	42.4	118.9	121.6	29.2	34.2	38.5	40.9	571.0	26.1	408.6	32.1	43.3	34.4	26.0	29.5	46.3	33.3	18.6	22.2	32.8	35.6	62.0	71.0	26.5	64.1	47.5	11.3	10.9	18.6	11.4	10.8	12.2	10.8	11.5	11.4	11.6	11.3	13.0	28.6	19.2	15.8	26.4	32.3	48.7	22.2	34.1	35.9	18.6	21.7	17.0	17.5	5.7	36.3	12.9	0.0	46.9	54.8	37.4	13.7	18.4	9.6	24.9	17.1	26.6	18.0	62.3	9.6	23.7	33.6	19.5	24.5	24.9	17.7	24.8	21.0	15.3	23.9	13.5	12.6	37.6	44.7	27.0	17.4	4.0	7.5	33.3	30.2	13.1	41.5	15.4	37.0	11.1	18.4	25.0	18.8	7.5	118.6	20.1	26.6	8.4	30.4	11.3	13.1	19.0	20.8	7.9	16.4	34.6	28.6	51.4	43.8	23.1	24.4	36.7
CASP4	"ICE(rel)II, ICH-2, TX"	ENSG00000196954	"Caspase 4"	P49662	11	104942866-104969366	"Cancer-related genes, Enzymes, Predicted intracellular proteins"	"Immunity, Inflammatory response, Innate immunity, Necrosis"	"Hydrolase, Protease, Thiol protease"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"											"HPA027588, CAB037167"	Approved		Approved	"Plasma membrane,Cytosol"	"Intracellular and membrane"	NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 64: Macrophages - Immune response"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 63: NK-cells & T-cells - Immune response"	Cytosol	"Plasma membrane"	"CAB037167: AB_258864, HPA027588: AB_10603781"	"unprognostic (1.19e-2)"	"unprognostic (3.73e-1)"	"unprognostic (3.44e-1)"	"unprognostic (1.99e-2)"	"unprognostic (7.19e-3)"	"unprognostic (2.63e-2)"	"unprognostic (1.26e-2)"	"unprognostic (1.56e-2)"	"unprognostic (5.31e-2)"	"unprognostic (2.71e-1)"	"unprognostic (2.38e-3)"	"unprognostic (8.39e-3)"	"prognostic unfavorable (3.27e-11)"	"unprognostic (6.75e-2)"	"unprognostic (1.34e-1)"	"unprognostic (1.79e-2)"	"unprognostic (4.08e-3)"	45.7	21.7	7.0	69.4	7.2	48.5	44.4	7.4	12.4	26.4	8.6	27.6	62.4	18.4	33.1	47.7	34.9	50.1	17.8	7.5	8.0	33.3	54.1	61.3	80.2	9.7	8.1	43.2	52.5	4.7	11.0	70.2	8.7	21.7	30.7	2.0	55.2	15.5	7.5	46.7	58.8	32.2	8.3	71.1	42.4	4.9	9.0	57.2	15.6	18.1	82.1	76.5	30.5	8.7	33.8	9.5	0.0	12.9	58.2	140.4	27.8	68.0	103.2	80.5	117.0	22.4	128.5	22.3	123.1	71.5	110.4	52.7	0.0	94.3	78.8	22.4	0.4	53.1	7.4	55.8	158.2	48.5	19.2	122.6	127.0	97.9	144.4	104.7	143.8	0.5	1.3	0.0	64.4	2.8	26.1	46.7	0.0	71.6	28.2	21.4	21.5	14.2	64.9	46.2	0.6	0.4	60.8	31.6	49.3	0.7	11.9	62.5	93.2	84.4	30.4	80.8	40.5	0.0	0.0	0.3	42.2	105.5	63.4	136.4	292.0	50.6	208.9	312.9	224.8	141.9	155.6	193.9	205.5	144.4	93.4	138.5	667.2	226.2	255.4	35.4	257.9	410.9	7.0	7.2	7.4	12.4	7.5	8.0	9.7	8.1	8.7	8.3	9.0	8.7	78.1	60.9	60.8	0.3	87.4	55.8	63.3	130.1	21.1	0.0	40.8	48.4	5.6	47.1	107.0	22.0	0.0	129.1	80.4	12.4	15.6	157.5	0.6	35.9	27.7	73.0	20.9	12.4	0.0	189.9	103.0	53.6	33.1	45.7	34.8	32.6	82.1	34.7	116.7	0.0	0.2	37.8	73.2	168.0	81.2	2.1	29.2	105.2	30.2	23.4	141.5	1.9	177.1	1.5	0.2	148.5	8.6	20.7	50.5	31.1	85.4	41.1	86.1	0.4	6.6	38.1	34.2	0.2	0.5	25.8	45.9	115.9	102.1	36.8	32.9	80.0
CASP5	ICE(rel)III	ENSG00000137757	"Caspase 5"	P51878	11	104994235-105023168	"Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins"	Apoptosis	"Hydrolase, Protease, Thiol protease"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"brain: 5.0;intestine: 16.8;lymphoid tissue: 14.6"	"Cell type enhanced"	"Detected in some"		"Distal enterocytes: 31.4;Paneth cells: 18.7;Proximal enterocytes: 17.2;Undifferentiated cells: 7.3"	"Group enriched"	"Detected in some"	7	"colorectal cancer: 3.9;stomach cancer: 1.3"	"Region enhanced"	"Detected in some"		"cerebral cortex: 5.0"	"Group enriched"	"Detected in some"	13	"intermediate monocyte: 18.1;neutrophil: 13.0;non-classical monocyte: 41.2"	"Group enriched"	"Detected in many"	15	"granulocytes: 13.0;monocytes: 41.2"	"Cell line enriched"	"Detected in single"	6	"HHSteC: 3.7"															NA	NA			"Cluster 51: Monocytes - Innate immune response"	"Cluster 9: Intestine - Unknown function"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 53: Intestinal epithelial cells - Unknown function"				"unprognostic (4.30e-2)"	"unprognostic (8.86e-2)"	"unprognostic (1.07e-1)"	"unprognostic (4.74e-2)"	"unprognostic (1.66e-1)"	"unprognostic (5.22e-2)"	"unprognostic (9.90e-2)"	"unprognostic (8.29e-3)"	"unprognostic (1.47e-1)"	"unprognostic (4.38e-3)"	"unprognostic (7.39e-3)"	"unprognostic (3.25e-1)"	"unprognostic (1.82e-9)"	"unprognostic (7.30e-2)"	"unprognostic (2.67e-3)"	"unprognostic (1.87e-1)"	"unprognostic (1.50e-1)"	0.7	0.1	0.5	14.6	0.6	0.2	0.1	0.5	5.0	0.2	0.6	15.6	10.0	0.1	0.2	0.1	0.2	0.4	0.1	0.5	0.5	0.2	0.2	1.6	0.9	0.7	0.8	0.1	0.0	0.0	0.1	0.9	1.5	0.1	12.9	0.0	0.1	0.1	0.0	0.0	16.8	1.8	0.6	2.7	0.1	0.3	0.8	0.1	0.1	0.4	0.3	2.2	0.1	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.3	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	3.7	0.0	0.0	0.1	0.4	0.0	0.1	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	18.1	0.1	0.1	0.0	0.0	1.8	0.0	0.0	0.1	13.0	0.0	41.2	0.5	0.0	1.4	0.5	0.6	0.5	5.0	0.5	0.5	0.7	0.8	1.5	0.6	0.8	0.9	0.0	3.2	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	31.4	0.0	2.3	0.7	0.0	0.0	0.1	0.0	0.0	0.1	0.2	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	5.3	0.0	4.7	0.4	0.7	0.0	4.8	0.0	1.9	2.4	0.0	0.0	0.0	0.1	0.1	18.7	0.0	0.0	0.0	17.2	0.0	0.8	0.0	0.0	0.2	0.1	0.5	0.7	0.0	0.0	0.0	0.3	0.0	7.3	0.1
CASP6	MCH2	ENSG00000138794	"Caspase 6"	P55212	4	109688622-109703583	"Cancer-related genes, Enzymes, Predicted intracellular proteins"	Apoptosis	"Hydrolase, Protease, Thiol protease"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"intestine: 40.8"	"Cell type enhanced"	"Detected in many"		"Granulosa cells: 112.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"Karpas-707: 76.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB003775, HPA011337, HPA024303"	Enhanced		Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 20: T-cells - T-cell receptor"	"Cluster 9: Intestine - Unknown function"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 40: Granulosa cells - Unknown function"	Cytosol	Nucleoplasm	"CAB003775: AB_562064, HPA011337: AB_1846053, HPA024303: AB_1846052"	"unprognostic (1.07e-1)"	"unprognostic (1.91e-1)"	"prognostic favorable (2.64e-5)"	"unprognostic (1.45e-2)"	"unprognostic (1.90e-1)"	"unprognostic (1.46e-1)"	"unprognostic (3.03e-3)"	"unprognostic (9.87e-2)"	"unprognostic (2.73e-2)"	"unprognostic (2.59e-3)"	"unprognostic (1.15e-2)"	"unprognostic (6.78e-2)"	"unprognostic (2.44e-1)"	"unprognostic (8.74e-3)"	"unprognostic (2.18e-1)"	"unprognostic (2.41e-1)"	"prognostic favorable (9.93e-4)"	6.5	6.7	3.9	8.4	4.0	10.8	10.5	4.3	5.4	7.6	4.0	35.3	40.8	7.7	5.1	7.4	7.6	9.3	5.6	3.8	4.0	11.5	18.1	7.8	9.6	3.7	3.7	8.3	13.3	4.8	4.2	4.8	3.8	9.1	31.5	3.0	8.6	6.5	3.3	10.7	36.8	7.4	3.8	8.0	15.8	1.8	3.7	11.5	8.5	2.4	7.7	8.1	7.0	4.3	26.6	8.4	16.5	14.8	11.0	11.2	24.3	15.3	9.2	12.4	13.4	13.8	50.3	2.7	16.4	14.7	17.3	12.1	19.7	21.8	8.4	43.5	13.0	22.8	7.1	12.9	9.4	23.5	15.7	12.6	15.1	12.4	2.8	17.1	22.9	30.1	29.9	76.1	19.2	13.7	62.0	14.4	12.7	17.1	16.1	20.5	10.8	13.3	39.6	24.8	17.2	13.2	15.0	25.7	8.8	19.6	11.0	8.0	20.3	12.8	14.6	6.6	16.7	11.4	23.0	2.8	17.1	26.9	7.1	16.3	6.9	8.9	6.3	6.9	7.0	6.1	23.8	12.3	8.8	8.6	28.0	16.1	1.4	7.5	11.2	11.6	24.8	9.4	3.9	4.0	4.3	5.4	3.8	4.0	3.7	3.7	3.8	3.8	3.7	4.3	10.5	16.0	14.6	5.2	7.7	10.8	10.2	26.7	12.0	6.9	23.6	16.0	4.1	28.6	23.2	20.2	6.2	20.9	7.6	54.0	9.8	40.8	2.6	19.8	9.5	12.2	59.2	19.7	6.4	46.4	41.1	13.4	18.3	23.3	10.1	112.3	9.7	20.4	19.8	0.0	7.3	53.9	32.6	8.7	9.3	1.7	12.8	14.5	1.8	2.8	17.9	16.0	6.2	5.5	5.8	45.9	52.5	9.8	8.8	7.4	71.7	35.7	18.6	1.3	6.6	7.6	12.3	1.9	8.6	10.8	11.6	5.7	17.5	12.4	74.2	8.0
CASP7	"CMH-1, ICE-LAP3, MCH3"	ENSG00000165806	"Caspase 7"	P55210	10	113679162-113730907	"Cancer-related genes, Enzymes, Predicted intracellular proteins"	Apoptosis	"Hydrolase, Protease, Thiol protease"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 229.1;Paneth cells: 113.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			CAB025563	Enhanced					NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 9: Intestine - Unknown function"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 53: Intestinal epithelial cells - Unknown function"			"CAB025563: "	"prognostic favorable (2.11e-4)"	"unprognostic (3.18e-2)"	"unprognostic (2.82e-2)"	"unprognostic (2.18e-1)"	"unprognostic (2.85e-1)"	"unprognostic (1.33e-1)"	"unprognostic (2.63e-3)"	"unprognostic (3.96e-1)"	"unprognostic (2.04e-1)"	"unprognostic (1.22e-2)"	"unprognostic (1.07e-1)"	"unprognostic (2.35e-2)"	"prognostic unfavorable (5.90e-4)"	"unprognostic (5.45e-3)"	"unprognostic (2.62e-1)"	"unprognostic (2.86e-1)"	"unprognostic (4.33e-3)"	21.0	10.3	11.8	26.2	12.2	8.4	18.6	11.5	20.4	18.4	12.8	75.1	65.3	16.3	10.5	15.4	17.9	16.8	11.3	11.8	12.0	19.6	23.6	24.9	16.9	12.3	12.5	16.2	22.4	10.4	7.0	20.9	11.9	21.3	58.2	6.8	34.1	12.3	13.8	17.4	68.1	18.5	11.4	17.5	45.5	6.8	12.8	19.8	10.2	14.5	18.4	31.6	16.1	12.8	28.9	29.4	24.1	13.0	43.4	37.5	16.7	32.9	49.9	56.1	69.7	22.4	51.0	30.1	19.0	29.8	21.1	24.8	30.4	24.2	39.5	46.9	41.0	19.6	22.0	38.0	28.9	20.9	24.7	24.5	15.9	32.0	13.3	25.0	75.4	28.2	5.3	39.8	21.1	38.2	51.1	16.0	4.4	31.7	17.3	51.7	98.0	18.1	44.8	21.4	1.9	14.4	24.9	35.5	17.6	23.1	43.1	18.4	37.8	12.8	24.1	13.5	27.7	30.7	20.1	0.8	13.1	38.7	14.3	22.9	14.7	11.7	11.1	21.3	9.5	11.5	9.2	14.1	10.4	9.2	7.1	9.7	2.6	7.4	18.5	1.4	14.0	9.8	11.8	12.2	11.5	20.4	11.8	12.0	12.3	12.5	11.9	11.4	12.8	12.8	36.3	9.6	12.3	27.4	13.8	19.8	21.2	26.0	13.1	0.6	15.8	9.9	2.5	11.5	26.2	22.0	0.0	12.4	10.3	229.1	11.7	46.1	0.3	21.0	22.9	23.8	9.6	4.0	1.6	39.0	25.5	16.2	30.1	13.5	12.7	10.9	17.2	15.6	17.0	0.0	1.1	81.1	28.5	12.8	6.9	0.6	9.6	18.4	7.2	10.3	68.9	7.9	13.4	1.0	0.8	37.2	113.4	4.1	21.5	42.6	88.0	25.9	42.8	1.7	19.7	12.3	16.3	2.9	28.2	13.3	14.8	10.9	15.7	5.2	50.7	39.0
CASP8	"Casp-8, FLICE, MACH, MCH5"	ENSG00000064012	"Caspase 8"	Q14790	2	201233443-201287711	"Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins"	"Apoptosis, Host-virus interaction"	"Hydrolase, Protease, Thiol protease"	"Cancer-related genes, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 66.6"	"Cell type enhanced"	"Detected in many"		"dendritic cells: 107.4;NK-cells: 132.8;Plasma cells: 73.4;T-cells: 86.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA001302, CAB002047, HPA005688, HPA006191"	Approved		Supported	Nucleoplasm,Cytosol		No	No			"Cluster 5: Granulocytes - Unknown function"	"Cluster 2: Immune cells - Immune response"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 24: Non-specific - Transcription regulation"	Cytosol	Nucleoplasm	"CAB002047: AB_563465, HPA001302: AB_1846057, HPA005688: AB_1846056, HPA006191: AB_2667535"	"unprognostic (5.21e-3)"	"unprognostic (2.10e-1)"	"unprognostic (1.83e-2)"	"unprognostic (9.69e-3)"	"unprognostic (2.09e-1)"	"unprognostic (5.60e-2)"	"prognostic unfavorable (3.02e-4)"	"unprognostic (2.10e-1)"	"unprognostic (4.79e-2)"	"prognostic favorable (1.25e-4)"	"unprognostic (7.75e-2)"	"unprognostic (5.11e-2)"	"prognostic unfavorable (1.27e-6)"	"unprognostic (7.67e-3)"	"unprognostic (2.43e-1)"	"unprognostic (2.53e-1)"	"unprognostic (4.53e-3)"	11.5	10.2	1.7	28.6	2.0	66.6	13.9	1.3	2.1	9.6	4.2	16.1	20.5	8.5	13.2	12.9	14.1	13.2	5.2	2.1	1.8	10.7	14.1	19.6	37.7	3.4	3.0	7.7	7.8	2.9	3.4	9.9	2.7	6.9	17.6	4.6	8.4	7.3	3.3	12.1	26.0	9.9	2.4	37.1	15.9	4.3	2.6	24.4	7.9	3.0	29.7	18.0	8.6	2.4	33.6	26.6	7.7	22.2	20.7	29.7	12.0	13.8	13.2	16.0	26.2	36.1	54.9	3.7	29.6	10.7	28.7	16.2	17.2	16.1	31.3	21.1	15.4	31.0	21.9	35.1	17.1	25.6	33.8	25.9	38.0	30.1	23.9	13.4	15.1	26.9	28.6	69.1	14.7	13.1	32.1	25.9	12.6	17.5	23.7	24.7	15.9	55.4	30.8	35.3	2.3	1.1	17.9	29.8	18.0	7.0	8.0	19.1	19.6	17.3	18.0	9.0	10.9	63.1	30.2	21.2	25.3	33.1	16.6	76.1	39.5	77.1	70.7	51.2	66.0	40.9	57.8	75.9	41.6	24.0	37.0	47.2	153.6	70.6	51.5	18.6	75.0	40.6	1.7	2.0	1.3	2.1	2.1	1.8	3.4	3.0	2.7	2.4	2.6	2.4	8.5	25.6	26.7	0.7	50.0	7.5	13.0	6.1	10.2	2.1	12.9	9.3	2.5	10.0	13.0	5.5	10.4	8.5	107.4	37.0	15.6	12.3	5.9	25.6	8.1	10.1	4.2	10.5	2.5	8.4	12.1	9.5	19.4	27.2	24.6	10.4	5.3	11.7	11.9	0.0	1.3	15.2	4.1	25.3	15.7	1.9	2.5	25.0	7.2	10.3	35.6	0.2	132.8	1.0	0.5	11.2	30.1	0.7	73.4	9.7	22.3	23.6	14.2	0.4	0.0	4.5	3.7	0.8	0.4	13.1	7.7	3.4	86.9	10.6	17.4	12.7
CASP9	"APAF-3, ICE-LAP6, MCH6, PPP1R56"	ENSG00000132906	"Caspase 9"	P55211	1	15490832-15526534	"Cancer-related genes, Enzymes, Predicted intracellular proteins"	Apoptosis	"Hydrolase, Protease, Thiol protease"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Syncytiotrophoblasts: 35.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA001473, CAB004348, HPA046488"	Approved		Approved	Mitochondria		NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 35: Non-specific - Unknown function"	"Cluster 20: HeLa - Mitochondria"	"Cluster 41: Macrophages - Immune response"	Mitochondria		"CAB004348: AB_673489, HPA001473: AB_1078401, HPA046488: AB_2679670"	"prognostic favorable (5.91e-4)"	"unprognostic (2.42e-1)"	"unprognostic (8.94e-3)"	"unprognostic (7.84e-2)"	"unprognostic (1.93e-2)"	"unprognostic (8.54e-3)"	"unprognostic (1.90e-3)"	"unprognostic (6.75e-2)"	"unprognostic (2.58e-1)"	"unprognostic (1.29e-1)"	"unprognostic (9.09e-2)"	"unprognostic (1.98e-1)"	"unprognostic (1.39e-2)"	"unprognostic (2.35e-1)"	"unprognostic (3.21e-2)"	"unprognostic (5.48e-2)"	"prognostic favorable (1.67e-5)"	12.0	50.8	14.1	7.0	14.5	11.5	8.9	16.1	18.8	19.3	13.3	11.8	6.4	14.4	12.5	14.1	22.5	9.4	16.4	14.2	13.0	20.7	14.8	10.8	6.9	14.8	14.2	57.6	37.8	12.0	32.4	7.1	14.1	19.2	5.3	12.3	8.9	9.8	12.7	5.5	11.0	6.6	13.6	10.6	12.4	25.9	14.6	8.7	25.9	9.4	7.9	12.9	12.8	17.1	10.4	17.8	4.6	8.9	11.0	5.4	5.3	7.5	9.9	11.1	12.7	12.5	10.1	13.4	16.2	7.5	13.1	4.2	10.5	8.2	11.7	5.9	11.6	9.8	32.8	10.8	10.8	10.6	11.5	9.7	11.5	15.3	3.8	8.3	8.7	13.3	20.4	13.4	5.8	5.2	3.3	8.6	5.9	11.3	8.2	7.4	13.4	16.4	12.3	6.7	4.4	9.0	9.6	1.8	15.6	12.1	5.7	7.9	4.8	13.8	5.8	15.6	5.1	13.3	21.5	16.3	8.9	9.9	5.0	54.2	24.7	54.8	11.0	17.4	8.2	21.3	6.6	7.6	25.1	30.0	3.1	4.8	36.3	29.3	18.9	11.4	6.9	15.0	14.1	14.5	16.1	18.8	14.2	13.0	14.8	14.2	14.1	13.6	14.6	17.1	2.8	3.2	3.7	18.3	17.1	2.9	8.2	5.0	4.6	3.2	7.0	4.7	9.3	11.5	7.3	18.4	6.2	17.0	8.0	7.0	1.9	7.5	12.6	10.9	5.2	3.3	3.0	5.7	7.9	9.1	10.8	5.6	12.8	7.6	1.3	5.7	4.2	4.7	9.5	5.0	9.9	6.3	6.1	4.8	12.9	5.5	2.1	12.9	0.0	6.5	4.8	7.5	10.3	9.5	8.8	8.4	7.3	3.8	9.9	4.0	9.8	7.2	8.9	6.3	0.0	5.3	9.7	16.4	7.1	6.0	2.4	35.7	6.4	7.9	5.6	7.4
CD38		ENSG00000004468	"CD38 molecule"	P28907	4	15778275-15853232	"Cancer-related genes, CD markers, Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Hydrolase, Receptor, Transferase"	"Cancer-related genes, Diabetes mellitus"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 63.3"	"Cell type enriched"	"Detected in many"	4	"Plasma cells: 378.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"NK-cell: 18.3"	"Group enriched"	"Detected in all"	5	"B-cells: 9.9;dendritic cells: 5.8;NK-cells: 18.3"	"Cell line enhanced"	"Detected in some"		"Daudi: 128.0;Karpas-707: 34.7;MOLT-4: 32.6;REH: 26.0;RPMI-8226: 20.9;U-266/70: 26.9;U-698: 24.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB002493, HPA022132, CAB025255, HPA052381"	Enhanced		Supported	"Plasma membrane"		NA	NA			"Cluster 48: NK-cells - Unknown function"	"Cluster 3: T-cells - Adaptive immune response"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 55: Plasma cells - Humoral immune response"	"Plasma membrane"		"CAB002493: AB_563556, CAB025255: , HPA022132: AB_1846300, HPA052381: AB_2681807"	"unprognostic (1.27e-2)"	"unprognostic (8.06e-3)"	"unprognostic (1.06e-2)"	"prognostic favorable (9.68e-4)"	"unprognostic (1.13e-1)"	"unprognostic (1.82e-3)"	"unprognostic (2.74e-1)"	"unprognostic (8.51e-2)"	"unprognostic (5.87e-2)"	"unprognostic (6.15e-6)"	"unprognostic (5.23e-1)"	"unprognostic (4.34e-1)"	"unprognostic (6.63e-6)"	"unprognostic (1.79e-1)"	"unprognostic (5.74e-2)"	"unprognostic (2.12e-2)"	"unprognostic (2.13e-1)"	3.1	2.4	2.5	13.1	3.8	13.6	2.0	2.7	2.5	0.7	0.9	4.5	5.8	0.9	1.2	1.1	3.0	1.9	3.8	3.5	6.6	0.8	3.3	6.3	23.4	3.3	5.5	0.7	0.3	0.1	1.8	0.5	3.4	13.2	3.5	0.2	2.6	19.7	21.4	0.3	5.3	1.4	2.8	17.0	3.0	1.0	3.9	63.3	2.0	3.4	18.0	6.8	0.5	4.6	0.0	11.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.3	0.0	0.0	128.0	0.0	0.0	0.4	0.1	0.2	0.0	0.1	0.0	0.0	0.2	0.1	0.0	0.0	0.2	0.0	0.1	0.1	0.0	0.0	0.0	0.0	17.0	0.2	34.7	0.0	0.0	32.6	7.9	0.2	0.0	0.0	26.0	0.1	20.9	0.0	0.0	0.2	1.5	0.0	0.2	0.5	0.3	0.1	5.7	0.5	0.0	0.1	0.1	0.0	26.9	0.2	24.3	0.4	6.2	0.3	0.1	1.9	0.1	1.2	2.4	0.3	9.9	1.5	1.2	4.7	7.7	2.4	1.9	1.4	18.3	1.9	5.8	2.4	4.4	2.5	3.8	2.7	2.5	3.5	6.6	3.3	5.5	3.4	2.8	3.9	4.6	0.8	3.2	15.1	86.5	59.7	0.0	0.4	0.6	0.6	0.1	0.1	0.0	1.0	0.0	11.6	0.0	10.4	0.2	33.8	0.2	0.0	0.0	2.5	4.0	1.4	2.7	0.0	78.6	0.4	0.0	0.2	2.7	2.0	0.3	38.2	0.8	2.9	4.3	4.4	0.0	0.4	1.3	0.0	44.3	0.8	0.7	0.0	17.7	7.2	5.6	3.1	0.0	79.3	1.0	1.8	0.0	0.3	0.0	378.4	8.1	0.2	0.1	42.5	0.1	13.1	1.5	7.6	2.9	1.7	1.6	0.0	0.5	26.5	0.0	1.6	0.2
CDA	CDD	ENSG00000158825	"Cytidine deaminase"	P32320	1	20589086-20618903	"Enzymes, FDA approved drug targets, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"		Hydrolase	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 193.5;esophagus: 87.1;liver: 86.7"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 364.9;Hepatocytes: 107.8;Pancreatic endocrine cells: 120.2;Paneth cells: 400.5;Proximal enterocytes: 137.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"neutrophil: 1234.7"	"Lineage enriched"	"Detected in many"	6	"granulocytes: 1234.7"	"Cell line enhanced"	"Detected in many"		"A-431: 200.3;CAPAN-2: 141.9;HeLa: 207.1;PC-3: 107.0;SiHa: 249.9;U-937: 96.9"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA064202	Enhanced		Approved	Nucleoplasm		NA	NA		3700000	"Cluster 1: Neutrophils - Mixed function"	"Cluster 67: Neutrophils - Humoral immune response"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Nucleoplasm		"HPA064202: AB_2685211"	"unprognostic (2.38e-1)"	"prognostic unfavorable (5.05e-4)"	"unprognostic (2.86e-1)"	"unprognostic (2.56e-1)"	"unprognostic (8.02e-2)"	"unprognostic (3.84e-3)"	"unprognostic (1.47e-1)"	"unprognostic (1.68e-3)"	"unprognostic (2.64e-1)"	"unprognostic (4.01e-2)"	"prognostic unfavorable (8.56e-5)"	"unprognostic (2.94e-2)"	"unprognostic (5.03e-2)"	"unprognostic (8.47e-3)"	"unprognostic (2.81e-1)"	"unprognostic (3.38e-1)"	"unprognostic (1.89e-3)"	7.1	3.0	8.0	9.6	8.1	193.5	3.7	8.3	10.6	19.7	7.4	23.7	6.4	5.3	5.5	87.1	6.4	4.3	6.7	7.9	8.3	14.0	86.7	7.1	1.5	9.0	8.2	1.5	0.8	3.2	1.2	10.8	9.5	4.3	27.8	0.5	15.0	3.1	1.7	17.1	16.3	11.3	8.3	23.4	2.1	1.0	8.9	2.0	4.5	6.4	4.4	5.5	38.5	8.7	200.3	21.4	0.0	0.0	0.2	5.5	0.0	16.7	4.3	4.1	16.2	1.0	141.9	0.0	8.1	30.8	8.7	63.9	4.5	46.8	10.7	0.1	3.9	0.0	207.1	34.4	1.4	0.0	0.0	8.8	8.9	31.4	0.0	0.5	2.7	0.0	0.0	0.0	1.6	0.2	0.0	1.0	0.1	24.7	107.0	0.0	0.1	3.4	1.5	0.0	0.1	0.0	249.9	0.0	0.3	2.2	0.0	4.3	3.4	0.2	8.3	18.5	1.2	0.0	0.1	0.0	2.4	96.9	0.0	216.2	207.2	471.1	0.5	124.7	0.8	0.1	0.4	0.9	12.7	0.2	0.3	0.4	1234.7	0.4	110.8	3.1	0.7	86.8	8.0	8.1	8.3	10.6	7.9	8.3	9.0	8.2	9.5	8.3	8.9	8.7	9.9	3.2	1.1	0.3	1.2	1.5	0.1	2.4	0.0	0.2	0.2	0.3	2.6	1.5	2.7	5.5	0.0	1.1	0.0	364.9	43.0	7.5	0.8	2.1	2.6	42.7	0.0	6.1	0.2	1.5	6.4	9.1	0.0	20.3	0.0	0.0	47.2	107.8	5.9	0.0	0.3	23.1	85.5	60.7	0.9	1.0	0.3	36.6	0.0	5.6	61.5	0.1	0.0	0.5	0.0	120.2	400.5	0.0	3.0	2.1	137.6	0.6	0.4	0.1	0.0	1.3	1.3	0.0	1.2	6.3	1.1	2.5	1.7	0.0	19.8	0.8
CDADC1	NYD-SP15	ENSG00000102543	"Cytidine and dCMP deaminase domain containing 1"	Q9BWV3	13	49247925-49293485	"Enzymes, Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 174.6;Late spermatids: 77.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in many"	5	"basophil: 9.9"	"Lineage enriched"	"Detected in many"	5	"granulocytes: 9.9"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA047615, HPA058314"	Uncertain		Approved	Nucleoplasm		No	No			"Cluster 18: Basophils - Vesicular transport"	"Cluster 7: Kidney - Transmembrane transport"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 34: Spermatids - Unknown function"	Nucleoplasm		"HPA047615: AB_2680104, HPA058314: AB_2683677"	"unprognostic (2.81e-1)"	"unprognostic (2.64e-1)"	"unprognostic (2.20e-1)"	"unprognostic (2.86e-1)"	"unprognostic (2.75e-1)"	"unprognostic (1.11e-2)"	"unprognostic (1.58e-3)"	"prognostic favorable (6.03e-4)"	"unprognostic (7.68e-2)"	"unprognostic (6.06e-2)"	"unprognostic (2.35e-3)"	"unprognostic (1.89e-1)"	"prognostic favorable (1.19e-5)"	"unprognostic (3.35e-2)"	"unprognostic (5.92e-3)"	"unprognostic (5.40e-2)"	"unprognostic (8.27e-3)"	5.0	6.8	4.9	2.3	4.5	6.3	4.2	5.8	6.5	4.0	5.8	4.7	3.1	3.8	5.1	3.2	4.2	2.7	4.3	4.5	5.5	9.5	8.1	3.5	3.1	4.9	5.4	4.5	2.7	5.5	3.2	2.0	5.1	3.9	3.2	5.2	3.4	4.4	4.4	2.2	3.0	3.7	4.7	4.1	3.9	7.9	5.6	4.3	9.4	5.2	2.6	3.5	3.6	5.4	2.1	2.6	2.2	2.7	10.8	5.9	1.1	5.0	3.1	2.5	2.6	2.6	1.7	2.9	1.0	2.2	2.4	3.6	4.6	2.2	3.2	6.3	3.7	3.3	2.5	2.7	4.7	6.3	1.7	4.1	5.5	2.3	3.0	4.4	3.7	5.6	2.1	2.1	3.2	0.7	6.0	5.1	0.8	3.6	2.2	4.0	2.4	2.9	3.6	0.7	1.3	1.1	3.4	2.1	2.9	1.4	1.5	5.4	2.8	1.3	2.4	3.5	2.4	0.6	2.4	1.8	1.1	7.2	3.7	9.9	1.1	0.9	1.4	0.9	1.5	0.4	1.0	1.9	0.8	0.6	0.9	1.3	1.2	1.2	1.8	0.8	1.6	0.9	4.9	4.5	5.8	6.5	4.5	5.5	4.9	5.4	5.1	4.7	5.6	5.4	12.4	6.4	12.4	9.4	6.6	8.0	7.3	10.7	11.4	12.7	8.5	9.7	15.0	5.7	8.6	18.4	12.5	4.6	19.1	4.7	9.8	5.3	174.6	12.6	14.6	8.7	6.7	10.3	16.0	10.7	10.9	17.1	6.6	6.0	24.7	10.0	11.7	11.5	6.2	3.3	21.4	6.9	4.1	9.1	8.3	77.7	15.8	9.9	7.2	3.7	5.4	25.9	9.2	14.1	12.4	6.7	5.7	14.3	10.6	7.3	7.9	25.4	18.9	12.2	0.0	15.3	17.8	39.3	15.5	7.7	5.4	2.5	14.1	17.2	6.0	5.7
CDC14A	"cdc14, Cdc14A1, Cdc14A2, DFNB105, DFNB32"	ENSG00000079335	"Cell division cycle 14A"	Q9UNH5	1	100345001-100520277	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Cell cycle, Cell division, Hearing"	"Hydrolase, Protein phosphatase"	"Deafness, Disease variant, Non-syndromic deafness"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 28.2"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 145.9;Early spermatids: 171.5;Late spermatids: 191.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"K-562: 44.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA023783	Approved		Supported	"Nucleoplasm,Nuclear bodies,Cytosol"		NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 34: Spermatids - Unknown function"	Nucleoplasm	"Nuclear bodies, Cytosol"	"HPA023783: AB_1846352"	"unprognostic (3.72e-2)"	"unprognostic (2.38e-2)"	"unprognostic (1.84e-2)"	"unprognostic (2.98e-2)"	"unprognostic (1.54e-3)"	"unprognostic (1.38e-1)"	"unprognostic (9.27e-4)"	"unprognostic (4.88e-3)"	"unprognostic (6.30e-2)"	"unprognostic (3.97e-3)"	"unprognostic (8.83e-2)"	"unprognostic (1.23e-1)"	"unprognostic (1.79e-3)"	"unprognostic (6.29e-2)"	"unprognostic (2.04e-1)"	"unprognostic (1.49e-2)"	"unprognostic (6.66e-2)"	3.6	1.5	3.9	4.6	3.1	15.5	11.3	2.7	4.2	5.4	5.2	6.0	7.3	5.3	2.7	2.2	13.0	3.3	2.3	3.7	4.5	6.3	1.8	5.9	7.2	4.3	4.9	4.6	2.0	6.0	3.6	5.1	3.3	7.6	6.0	5.5	3.4	3.0	2.6	3.8	10.7	4.7	3.5	6.7	5.8	28.2	3.6	6.4	5.8	2.8	4.4	4.4	3.3	3.2	3.3	2.6	8.1	9.3	2.9	2.1	5.7	4.1	2.7	3.9	3.1	8.9	2.7	1.6	3.0	2.4	3.2	2.5	5.6	2.3	4.0	3.4	13.7	5.8	2.3	2.9	1.1	7.8	9.8	1.8	0.6	4.3	1.4	2.0	7.0	3.3	44.7	4.8	5.8	1.4	6.3	8.7	5.1	2.1	3.3	6.8	10.6	1.7	2.8	7.2	1.5	2.7	4.3	4.1	5.6	3.9	1.9	10.0	3.1	2.2	4.9	3.8	2.5	2.4	0.9	2.5	2.7	7.3	1.3	12.2	3.6	9.0	6.9	3.3	12.5	4.5	10.9	8.2	3.5	2.9	10.2	5.5	5.4	4.4	2.3	6.2	6.0	4.1	3.9	3.1	2.7	4.2	3.7	4.5	4.3	4.9	3.3	3.5	3.6	3.2	14.1	3.2	5.5	145.9	10.6	3.7	4.5	1.7	4.6	0.4	15.8	11.0	6.6	0.0	4.4	1.8	4.2	2.7	23.2	18.4	0.0	3.0	171.5	48.3	11.8	13.5	4.8	3.8	4.3	1.9	1.0	7.0	6.6	51.1	15.2	4.8	7.1	1.0	2.8	0.0	1.4	4.0	2.0	5.5	7.3	191.7	5.0	11.1	5.4	51.5	9.3	11.4	6.2	53.8	3.6	3.1	11.2	0.7	13.5	5.2	22.9	2.5	22.5	3.8	0.0	6.2	6.0	2.3	3.6	4.9	2.4	2.2	44.1	3.0	3.7	4.1
CDC14B	"Cdc14B1, Cdc14B2, CDC14B3, hCDC14B"	ENSG00000081377	"Cell division cycle 14B"	O60729	9	96490241-96619843	"Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins"	"DNA damage, DNA repair"	"Hydrolase, Protein phosphatase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 27.3"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 86.5;Excitatory neurons: 83.5;Inhibitory neurons: 110.2;Oligodendrocyte precursor cells: 156.9;Oligodendrocytes: 273.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in many"	5	"basophil: 10.4"	"Lineage enriched"	"Detected in many"	5	"granulocytes: 10.4"	"Cell line enhanced"	"Detected in many"		"ASC TERT1: 30.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA064747			Supported	Nucleoplasm		NA	NA			"Cluster 34: Basophils - Unknown function"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	Nucleoplasm		"HPA064747: AB_2732719"	"unprognostic (5.69e-2)"	"unprognostic (9.09e-2)"	"unprognostic (3.50e-2)"	"unprognostic (8.08e-3)"	"unprognostic (4.24e-1)"	"unprognostic (1.19e-2)"	"unprognostic (1.11e-2)"	"unprognostic (4.49e-2)"	"unprognostic (1.63e-2)"	"unprognostic (2.27e-2)"	"unprognostic (2.35e-1)"	"unprognostic (2.75e-1)"	"prognostic favorable (2.97e-10)"	"unprognostic (2.01e-2)"	"unprognostic (2.61e-1)"	"prognostic unfavorable (2.82e-4)"	"unprognostic (7.40e-2)"	4.3	2.3	11.1	1.1	15.8	3.0	3.0	6.1	11.7	2.9	1.4	3.1	2.8	1.3	2.0	1.4	4.2	2.9	5.0	5.2	6.9	5.5	10.3	3.0	0.9	11.0	12.1	3.4	4.6	6.9	1.1	2.0	11.4	3.3	3.3	1.7	1.8	4.1	0.7	0.8	3.3	1.7	10.4	0.8	6.1	9.3	11.4	2.9	8.5	1.4	1.2	4.1	0.8	27.3	7.4	4.1	4.2	4.4	20.2	30.1	11.6	5.3	7.0	3.5	5.6	14.0	11.6	0.0	5.0	11.3	8.4	8.1	6.1	4.0	4.1	1.9	5.8	1.1	1.5	11.2	3.3	0.0	0.2	12.4	2.1	3.7	3.4	4.0	0.7	0.0	4.4	0.8	4.8	3.5	0.0	1.2	7.9	8.4	3.6	0.0	2.6	0.2	5.4	11.3	1.3	6.6	3.7	1.1	2.0	14.2	0.9	2.3	2.2	3.5	4.1	9.0	3.9	0.1	0.0	0.0	3.7	0.0	8.3	10.4	0.0	2.2	2.0	0.0	1.0	1.1	0.8	1.5	0.0	0.4	1.4	0.9	0.0	0.1	0.0	0.0	1.1	0.6	11.1	15.8	6.1	11.7	5.2	6.9	11.0	12.1	11.4	10.4	11.4	27.3	4.0	6.4	8.8	86.5	3.7	9.1	8.9	4.4	9.1	7.2	8.4	6.1	17.9	11.5	11.4	9.2	8.4	6.4	2.3	7.1	7.9	5.5	36.9	27.4	7.5	6.2	2.4	0.4	83.5	6.5	3.0	17.3	21.4	33.9	14.5	2.9	6.8	31.2	11.3	8.4	110.2	9.0	8.2	1.6	6.7	33.3	9.0	5.5	8.8	56.2	2.4	12.8	2.1	156.9	273.9	8.6	7.3	11.7	8.3	10.8	16.9	17.0	15.7	12.4	26.3	18.6	15.7	10.8	7.3	4.7	7.7	3.4	4.4	1.2	8.6	13.2
CDC14C	"CDC14B2, CDC14Bretro, CDC14CP, MGC26484"	ENSG00000218305	"Cell division cycle 14C"	A4D256	7	48919765-48927454	"Enzymes, Predicted membrane proteins"		"Hydrolase, Protein phosphatase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"retina: 2.0;testis: 7.2"	"Cell type enhanced"	"Detected in some"		"Alveolar cells type 2: 1.1;Oligodendrocyte precursor cells: 1.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA064747			Uncertain	Nucleoplasm		NA	NA						"Cluster 68: Oligodendrocytes - Mixed function"	Nucleoplasm		"HPA064747: AB_2732719"					"unprognostic (1.95e-1)"									"unprognostic (1.75e-1)"				0.1	0.0	0.3	0.2	0.3	0.4	0.1	0.9	0.4	0.0	0.3	0.1	0.2	0.1	0.1	0.0	0.0	0.1	0.0	0.5	0.4	0.0	0.1	0.1	0.1	0.2	0.3	0.1	0.2	0.0		0.1	0.2	0.1	0.1	2.0	0.1	0.0	0.1	0.2	0.1	0.0	0.0	0.2	0.1	7.2	0.5	0.0	0.1	0.0	0.0	0.0		0.4	0.2	0.3	0.2	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.1	0.6	0.2	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.4	0.0	0.0	0.0	0.2	0.2	0.0	0.0	0.1	0.0	0.1	0.0	0.1	0.3	0.1	0.1	0.0	0.0	0.1	0.5	0.1	0.1	0.1	0.1	0.1	0.1	0.4	0.2	0.2	0.1	0.1	0.1	0.5	0.1	0.1	0.1	0.0	0.1	0.2	0.2	0.1	0.0	0.4	0.3	0.2	0.2	0.1	0.0	0.2	0.2	0.0	0.3	0.3	0.9	0.4	0.5	0.4	0.2	0.3	0.2	0.0	0.5	0.4	0.0	0.0	1.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
CDC25A		ENSG00000164045	"Cell division cycle 25A"	P30304	3	48157146-48188417	"Cancer-related genes, Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis"	"Hydrolase, Protein phosphatase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 15.3;lymphoid tissue: 8.8;testis: 13.3"	"Cell type enhanced"	"Detected in many"		"Cardiomyocytes: 111.2;Early spermatids: 18.3;Late spermatids: 31.8;Spermatogonia: 16.3"	"Cancer enhanced"	"Detected in many"		"testis cancer: 19.0"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA005855, HPA008803"			Approved	"Nucleoplasm,Golgi apparatus"		NA	Yes			"Cluster 43: B-cells - Humoral immune response"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 54: Cardiomyocytes - Muscle contraction"	Nucleoplasm	"Golgi apparatus"	"HPA005855: AB_1846364, HPA008803: "	"unprognostic (1.49e-1)"	"unprognostic (8.13e-2)"	"unprognostic (1.20e-2)"	"unprognostic (1.43e-3)"	"unprognostic (2.14e-1)"	"unprognostic (9.51e-2)"	"unprognostic (7.05e-7)"	"unprognostic (1.35e-2)"	"unprognostic (4.32e-3)"	"unprognostic (8.92e-3)"	"unprognostic (4.41e-2)"	"unprognostic (9.09e-2)"	"unprognostic (4.41e-3)"	"unprognostic (1.57e-3)"	"unprognostic (1.07e-1)"	"unprognostic (1.29e-1)"	"unprognostic (2.72e-1)"	0.7	0.9	0.8	3.3	0.8	15.3	1.1	0.7	1.0	0.6	0.7	3.5	2.0	0.6	0.9	2.4	0.2	0.3	0.4	0.8	2.0	0.7	0.8	0.3	4.4	1.1	1.9	2.2	0.7	0.8	0.8	2.6	1.7	0.6	3.9	2.0	0.8	0.6	0.4	0.6	1.8	1.1	0.8	2.0	0.9	13.3	2.0	8.8	1.8	0.3	5.6	0.9	0.9	0.7	22.2	10.7	50.0	27.2	1.7	3.2	34.2	29.9	11.3	36.7	29.6	46.8	11.2	64.9	11.4	8.0	23.4	16.3	86.6	20.6	38.6	21.4	45.1	83.8	19.0	23.1	1.7	59.4	23.4	1.7	3.1	45.8	19.6	4.6	14.1	47.8	67.6	33.6	20.1	11.8	74.8	46.6	73.4	20.2	24.2	33.2	32.9	35.1	9.5	20.7	23.5	28.8	18.6	21.6	9.5	31.7	11.3	41.9	7.2	18.0	27.7	20.3	41.4	16.7	54.2	101.5	13.5	65.2	15.5	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.8	0.7	1.0	0.8	2.0	1.1	1.9	1.7	0.8	2.0	0.7	0.3	0.0	0.0	1.0	1.1	0.4	0.4	0.8	1.8	0.5	1.2	1.0	111.2	0.0	0.1	0.0	2.1	4.2	0.2	2.4	0.0	0.4	18.3	0.5	0.9	2.7	1.2	8.0	0.2	0.9	7.4	1.5	1.5	1.3	0.0	4.6	1.4	0.3	3.1	0.0	0.5	2.0	0.0	0.6	0.9	31.8	1.5	0.5	0.0	0.0	0.1	1.1	0.0	0.5	0.0	1.1	0.8	1.9	13.0	0.7	0.4	0.4	0.2	0.4	0.0	0.1	2.2	14.5	16.3	4.3	0.0	0.3	0.6	2.4	4.1	0.5
CDC25B		ENSG00000101224	"Cell division cycle 25B"	P30305	20	3786772-3806121	"Cancer-related genes, Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis"	"Hydrolase, Protein phosphatase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Group enriched"	"Detected in all"	4	"B-cells: 7.2;NK-cells: 18.1;T-cells: 28.2"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038892, HPA038893, HPA075215"	Enhanced		Uncertain	"Vesicles,Mitotic spindle"		Yes	Yes			"Cluster 20: T-cells - T-cell receptor"	"Cluster 64: Macrophages - Immune response"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 63: NK-cells & T-cells - Immune response"	Vesicles	"Mitotic spindle"	"HPA038892: AB_2676258, HPA038893: AB_2676259, HPA075215: "	"unprognostic (4.69e-2)"	"unprognostic (5.74e-2)"	"unprognostic (2.93e-2)"	"prognostic unfavorable (4.76e-4)"	"unprognostic (1.13e-1)"	"unprognostic (4.23e-1)"	"prognostic unfavorable (1.19e-4)"	"unprognostic (1.31e-2)"	"unprognostic (4.92e-2)"	"unprognostic (2.74e-1)"	"unprognostic (1.67e-1)"	"unprognostic (6.03e-2)"	"prognostic unfavorable (2.94e-13)"	"unprognostic (1.15e-1)"	"unprognostic (2.38e-1)"	"unprognostic (3.94e-1)"	"unprognostic (9.46e-2)"	29.2	15.6	30.5	28.8	32.4	29.4	25.1	39.2	33.2	41.7	23.2	37.6	14.4	35.0	9.4	27.1	31.5	17.9	16.3	27.6	32.5	31.3	24.8	78.4	47.6	31.3	29.9	37.4	12.8	3.8	45.7	31.1	30.2	25.4	11.3	7.8	16.7	8.9	10.5	21.8	41.2	14.2	27.4	56.1	30.1	12.4	30.9	44.7	41.8	6.3	32.8	35.8	30.2	35.8	129.6	273.2	36.5	60.0	43.8	43.0	19.3	63.3	95.3	103.1	75.9	49.2	182.9	91.3	27.5	65.4	253.5	183.5	50.6	105.8	50.2	36.2	54.4	49.4	88.5	59.6	178.4	38.6	25.0	41.1	85.0	95.4	115.7	35.6	58.4	44.2	33.3	232.7	63.1	105.5	119.0	57.7	27.3	90.9	116.9	62.0	102.6	67.5	73.2	12.2	25.8	56.9	148.6	140.8	78.1	31.7	48.1	20.4	48.6	55.1	66.2	101.5	85.0	57.8	97.8	36.8	28.1	38.0	54.6	3.9	2.4	0.0	22.7	3.4	21.3	5.8	22.6	23.3	2.4	7.2	18.6	21.6	0.3	18.1	1.7	1.3	28.2	11.2	30.5	32.4	39.2	33.2	27.6	32.5	31.3	29.9	30.2	27.4	30.9	35.8	14.0	9.6	21.7	18.6	21.7	11.2	6.0	10.9	7.4	14.4	4.8	5.5	8.6	8.6	4.5	7.3	2.1	11.9	30.6	5.8	0.0	9.9	0.7	2.7	20.6	27.1	7.8	32.6	39.2	4.8	17.7	15.7	17.3	5.4	1.3	11.5	14.3	13.7	30.4	3.3	38.0	10.4	12.2	14.8	9.4	1.1	7.2	12.4	17.8	6.5	8.8	8.3	44.3	22.6	13.2	15.0	4.3	9.1	49.6	6.0	5.5	11.1	3.7	2.6	0.0	26.5	14.0	2.3	12.3	10.3	11.2	3.6	36.4	7.1	10.9	4.4
CDC25C	"CDC25, PPP1R60"	ENSG00000158402	"Cell division cycle 25C"	P30307	5	138285269-138338355	"Cancer-related genes, Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Cell cycle, Cell division, Host-virus interaction, Mitosis"	"Hydrolase, Protein phosphatase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"bone marrow: 5.8;lymphoid tissue: 8.9;testis: 18.1"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 41.4;Late spermatids: 42.1;Spermatocytes: 53.6;Spermatogonia: 13.0"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in many"			"CAB003800, HPA066991"	Approved		Enhanced	"Nuclear speckles"		No	Yes			"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 12: Non-specific - Cell cycle regulation"	"Nuclear speckles"		"CAB003800: AB_562081, HPA066991: AB_2685760"	"unprognostic (2.45e-3)"	"unprognostic (5.89e-3)"	"prognostic favorable (2.49e-4)"	"unprognostic (9.72e-3)"	"unprognostic (2.17e-1)"	"unprognostic (1.53e-1)"	"prognostic unfavorable (3.03e-6)"	"prognostic unfavorable (4.38e-4)"	"unprognostic (5.56e-2)"	"unprognostic (2.08e-1)"	"unprognostic (1.70e-3)"	"unprognostic (1.00e-1)"	"unprognostic (0.00e+0)"	"unprognostic (5.04e-2)"	"unprognostic (1.43e-1)"	"unprognostic (2.59e-1)"	"unprognostic (3.06e-1)"	0.2	0.2	0.2	2.1	0.2	5.8	0.7	0.3	0.3	0.3	0.2	3.4	3.0	0.4	0.2	1.4	0.2	0.2	0.1	0.2	0.2	0.1	0.5	0.3	3.2	0.2	0.3	0.0	0.4	0.1	0.1	1.2	0.2	0.2	4.1	0.1	0.3	0.1	0.0	1.4	3.0	0.8	0.1	0.9	1.1	18.1	0.2	8.9	0.1	0.0	4.6	0.5	0.5	0.2	27.9	11.0	38.4	28.9	0.9	3.6	9.9	16.4	17.5	36.2	50.3	27.3	52.8	13.3	13.8	10.1	40.5	14.9	31.7	25.9	34.9	11.1	21.5	9.6	15.0	21.2	0.3	6.3	10.0	0.8	0.9	22.0	18.0	3.8	24.6	28.9	14.8	24.2	22.9	15.5	19.3	16.7	9.7	22.3	12.2	11.9	34.2	15.0	6.4	8.4	19.2	11.9	36.8	11.0	16.9	32.6	18.7	13.9	7.2	19.9	16.8	13.9	26.5	15.0	13.4	13.0	8.3	14.3	15.6	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.5	0.0	0.0	0.6	0.1	0.2	0.2	0.3	0.3	0.2	0.2	0.2	0.3	0.2	0.1	0.2	0.2	0.1	0.0	0.0	1.3	0.9	0.6	0.3	1.1	1.8	0.0	0.9	0.8	0.3	0.0	0.2	0.0	0.0	5.0	0.5	1.8	0.0	0.1	41.4	0.4	0.9	0.6	0.0	9.5	1.3	0.0	6.9	1.1	3.6	1.2	0.0	5.5	1.4	0.4	2.7	0.0	1.0	3.9	2.0	0.6	0.5	42.1	1.8	1.2	0.0	1.0	0.6	0.0	0.0	1.0	0.3	0.0	1.4	0.4	4.5	0.3	0.9	0.1	0.1	0.0	0.0	0.2	0.9	53.6	13.0	4.3	0.4	1.4	0.6	0.2	4.9	0.6
CDC42	"CDC42Hs, G25K"	ENSG00000070831	"Cell division cycle 42"	P60953	1	22025511-22101360	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, RAS pathway related proteins"	"Differentiation, Neurogenesis"	Hydrolase	"Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004360, HPA069590"	Approved		Supported	"Microtubules,Cytokinetic bridge"		Yes	No		2700000	"Cluster 49: Eosinophils - Unknown function"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 10: Non-specific - Unknown function"	"Microtubules, Cytokinetic bridge"		"CAB004360: AB_627233, HPA069590: AB_2732138"	"unprognostic (9.40e-2)"	"unprognostic (1.37e-1)"	"unprognostic (9.45e-3)"	"unprognostic (5.11e-2)"	"unprognostic (1.73e-1)"	"unprognostic (9.72e-2)"	"prognostic unfavorable (5.28e-5)"	"unprognostic (1.09e-1)"	"unprognostic (7.92e-3)"	"unprognostic (1.86e-2)"	"unprognostic (3.90e-2)"	"unprognostic (9.41e-2)"	"unprognostic (9.72e-3)"	"unprognostic (2.71e-1)"	"unprognostic (3.88e-2)"	"unprognostic (6.38e-2)"	"unprognostic (2.09e-1)"	177.4	116.1	91.7	160.2	96.5	402.9	142.7	100.1	113.8	128.6	98.4	198.2	142.3	131.3	99.8	162.3	124.8	131.7	117.0	95.2	108.8	158.8	153.5	154.1	167.9	115.5	103.7	105.9	82.5	128.4	59.6	170.3	108.4	108.3	185.4	95.9	103.8	107.5	119.9	132.0	156.9	175.0	107.4	157.5	159.9	64.2	102.2	157.7	110.6	120.9	216.8	194.8	114.9	127.1	341.9	146.4	272.2	222.0	295.0	306.4	274.2	347.3	318.8	365.5	336.2	178.0	374.5	253.1	272.8	416.7	136.2	210.7	241.1	369.3	431.1	332.4	180.1	438.1	184.5	225.4	259.1	388.5	350.5	285.6	396.6	341.0	195.2	234.7	535.6	157.8	250.8	273.4	430.2	135.6	242.9	307.5	170.2	242.9	179.3	199.6	297.6	243.3	316.2	301.3	183.4	175.8	293.4	228.7	263.4	296.3	242.3	219.1	466.3	265.3	265.2	349.3	207.8	148.6	355.9	305.8	234.5	419.3	277.6	244.3	200.6	255.1	142.4	282.3	144.3	108.0	152.0	146.7	162.3	103.4	109.5	143.5	308.3	145.0	352.2	107.2	157.4	244.8	91.7	96.5	100.1	113.8	95.2	108.8	115.5	103.7	108.4	107.4	102.2	127.1	502.1	60.9	51.8	20.9	301.0	450.6	385.5	266.0	136.1	119.1	281.1	179.6	86.9	231.6	168.0	312.6	18.8	349.6	470.1	434.9	375.6	441.3	38.0	350.5	356.5	307.7	300.4	243.0	58.5	441.9	499.6	225.2	152.4	425.8	163.6	138.2	277.0	230.9	439.2	106.0	71.0	315.4	187.2	585.4	875.2	41.3	157.8	443.4	423.4	53.4	654.9	102.5	286.3	41.7	72.9	570.5	369.7	177.1	192.9	323.1	283.1	578.2	176.2	65.2	236.7	174.2	308.3	155.3	116.2	176.6	556.6	551.6	379.2	178.6	286.7	469.6
CDKN3	"CDI1, KAP"	ENSG00000100526	"Cyclin dependent kinase inhibitor 3"	Q16667	14	54396849-54420218	"Disease related genes, Enzymes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"Cell cycle"	"Hydrolase, Protein phosphatase"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"testis: 207.0"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 2630.9;Late spermatids: 659.4;Spermatocytes: 606.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"T-reg: 18.8"	"Group enriched"	"Detected in all"	6	"NK-cells: 6.4;T-cells: 18.8"	"Low cell line specificity"	"Detected in all"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"CAB005285, HPA039311, HPA058874"			Enhanced	Cytosol		NA	Yes			"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 29: Early spermatids - Spermatogenesis"	Cytosol		"CAB005285: AB_2078884, HPA039311: , HPA058874: AB_2683842"	"unprognostic (3.46e-2)"	"unprognostic (9.95e-2)"	"unprognostic (5.79e-2)"	"unprognostic (6.78e-3)"	"unprognostic (2.73e-1)"	"unprognostic (6.08e-2)"	"unprognostic (1.51e-3)"	"prognostic unfavorable (4.52e-4)"	"unprognostic (2.50e-3)"	"unprognostic (2.85e-3)"	"prognostic unfavorable (7.46e-4)"	"unprognostic (5.89e-2)"	"prognostic unfavorable (0.00e+0)"	"unprognostic (1.71e-1)"	"unprognostic (7.30e-2)"	"unprognostic (7.92e-2)"	"unprognostic (4.31e-2)"	3.4	1.6	2.8	12.2	2.7	43.4	3.4	5.0	4.2	2.2	3.4	13.9	12.4	2.8	0.4	10.2	1.3	2.9	5.3	2.9	3.1	2.0	2.4	2.1	28.4	2.5	2.7	1.3	1.1	0.5	1.6	6.7	3.3	1.6	16.9	2.6	3.3	0.7	3.0	5.9	12.6	7.4	2.1	4.9	5.0	207.0	3.5	30.9	1.7	4.1	30.0	5.8	4.1	2.6	276.7	102.5	74.0	78.2	12.5	15.3	46.5	63.1	97.0	135.8	146.9	81.8	136.5	139.9	44.4	96.7	135.9	195.9	114.6	78.3	245.6	169.5	59.3	65.8	69.0	126.8	10.1	86.2	47.6	5.4	4.9	84.3	138.3	44.4	88.4	129.8	36.1	162.2	159.8	186.9	118.1	67.9	27.9	254.7	216.4	72.7	66.6	29.7	70.5	56.9	30.6	42.0	118.7	67.4	52.5	54.6	142.9	69.4	33.0	59.2	195.8	91.7	155.0	38.6	47.4	91.4	98.6	120.4	110.9	0.0	1.3	1.3	1.6	1.7	0.7	2.1	5.5	4.8	1.8	0.9	2.9	2.3	1.0	6.4	1.2	1.5	18.8	3.1	2.8	2.7	5.0	4.2	2.9	3.1	2.5	2.7	3.3	2.1	3.5	2.6	1.4	0.0	0.0	0.7	10.5	9.3	4.3	9.7	4.6	3.2	6.4	11.6	9.7	0.0	2.4	1.8	2.1	42.6	2.7	7.3	0.0	3.5	2630.9	2.7	3.5	6.8	7.8	125.5	2.5	2.4	35.0	10.2	9.2	3.5	7.0	31.3	6.1	3.1	37.7	5.0	3.9	17.9	4.1	9.8	8.8	659.4	21.5	8.9	1.8	1.0	2.9	1.7	0.0	0.0	0.2	1.9	7.2	10.5	41.0	4.0	3.4	2.8	0.2	2.9	0.0	3.0	20.5	606.9	39.8	22.5	6.5	4.1	8.3	3.9	31.2	5.3
CEL	"BSSL, MODY8"	ENSG00000170835	"Carboxyl ester lipase"	P19835	9	133061981-133071861	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted secreted proteins"	"Lipid degradation, Lipid metabolism"	"Hydrolase, Serine esterase"	"Diabetes mellitus"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	548	"pancreas: 110578.0"	"Group enriched"	"Detected in many"	10	"Breast glandular cells: 390.7;Exocrine glandular cells: 943.6"	"Cancer enriched"	"Detected in many"	29	"pancreatic cancer: 469.3"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"JURKAT: 7.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA008023, HPA052701"	Enhanced				"Secreted to digestive system"	NA	NA		110000		"Cluster 25: Pancreas - Digestion"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 30: Mammary glandular cells - Lactation"			"HPA008023: AB_1846509, HPA052701: AB_2681921"	"prognostic unfavorable (4.14e-4)"	"unprognostic (2.30e-2)"	"unprognostic (4.49e-2)"	"unprognostic (3.14e-2)"	"unprognostic (2.22e-1)"	"unprognostic (2.48e-1)"	"unprognostic (1.49e-1)"	"unprognostic (6.27e-2)"	"unprognostic (3.04e-2)"	"unprognostic (1.47e-2)"	"unprognostic (2.51e-1)"	"unprognostic (5.55e-2)"	"unprognostic (2.26e-3)"	"unprognostic (2.98e-1)"	"unprognostic (4.41e-1)"	"unprognostic (4.37e-2)"	"unprognostic (1.02e-1)"	10.0	3.0	3.1	2.2	3.2	0.9	10.4	4.8	4.5	6.4	13.5	2.9	21.6	3.2	200.8	7.1	11.1	0.4	22.0	4.1	2.7	7.5	6.4	2.1	4.1	2.9	2.8	57.2	110578.0	0.3	201.7	7.1	3.0	5.1	1.3	1.1	19.9	3.3	2.2	5.5	9.2	0.5	2.5	3.4	18.5	2.5	3.0	1.9	2.5	0.4	0.6	3.4	3.4	3.0	0.3	0.8	3.1	1.9	1.0	0.7	3.1	0.6	0.3	0.4	0.6	0.9	0.6	0.9	1.5	0.6	0.5	2.2	0.7	5.9	0.2	1.9	1.2	1.6	0.5	2.1	0.4	0.7	5.9	1.5	3.8	0.5	0.3	1.3	0.6	7.5	1.0	0.8	0.5	1.3	0.9	3.2	5.2	0.7	1.0	1.8	0.9	0.7	0.4	2.7	5.3	1.3	0.7	0.7	0.3	4.5	1.0	2.9	0.4	1.5	2.0	1.7	0.4	0.4	3.4	0.7	0.0	1.6	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.1	3.2	4.8	4.5	4.1	2.7	2.9	2.8	3.0	2.5	3.0	3.0	1.5	0.0	0.0	1.0	0.7	0.0	1.7	0.8	1.2	1.0	390.7	4.4	2.1	1.5	0.5	0.0	0.0	0.1	1.8	2.5	3.9	1.7	0.5	62.4	0.8	0.9	0.0	0.0	2.0	943.6	0.1	0.4	0.0	1.3	0.0	4.7	0.0	0.1	0.0	0.0	1.4	0.8	26.4	0.0	0.3	3.6	0.3	1.0	0.0	0.0	6.7	0.9	0.0	1.0	0.7	27.7	0.1	0.0	0.0	0.4	10.6	0.1	2.3	0.8	0.0	0.2	1.4	0.2	0.1	2.0	0.3	0.4	0.5	6.0	5.1	3.0
CELA1	ELA1	ENSG00000139610	"Chymotrypsin like elastase 1"	Q9UNI1	12	51328442-51346679	"Enzymes, Predicted intracellular proteins, Predicted secreted proteins"		"Hydrolase, Protease, Serine protease"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"adrenal gland: 2.2;pancreas: 6.6"	"Cell type enhanced"	"Detected in some"		"Exocrine glandular cells: 16.6;Extravillous trophoblasts: 2.9;Kupffer cells: 7.9;NK-cells: 3.1"	"Cancer enhanced"	"Detected in single"		"testis cancer: 0.5"	"Not detected"	"Not detected"			"Immune cell enhanced"	"Detected in many"		"basophil: 12.4;naive CD4 T-cell: 12.3"	"Group enriched"	"Detected in many"	8	"granulocytes: 12.4;T-cells: 12.3"	"Cell line enriched"	"Detected in some"	4	"BEWO: 5.4"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"								"Secreted - unknown location"	NA	NA			"Cluster 41: Basophils - Cellular respiration"	"Cluster 25: Pancreas - Digestion"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 1: Pancreatic cells - Digestion"				"unprognostic (3.54e-2)"	"unprognostic (1.64e-1)"		"unprognostic (4.73e-2)"	"unprognostic (2.73e-1)"	"unprognostic (1.70e-1)"		"unprognostic (1.52e-1)"		"unprognostic (1.13e-1)"	"unprognostic (3.59e-2)"		"unprognostic (3.83e-3)"	"unprognostic (2.52e-1)"	"unprognostic (1.46e-1)"			0.0	2.2	0.0	0.2	0.1	0.2	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.8	0.1	0.0	0.0	6.6	0.0	0.0	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.2	0.1	0.5	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	5.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	12.4	1.6	0.1	1.0	0.8	0.4	0.3	2.7	0.8	1.0	0.0	12.3	5.9	0.2	0.2	1.0	0.0	0.3	1.2	0.0	0.1	0.0	0.2	0.1	0.0	0.1	0.0	0.1	0.0	0.1	0.1	0.0	0.0	0.5	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.4	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	16.6	2.9	0.0	0.0	0.0	0.0	0.0	0.4	0.1	0.8	0.0	0.1	0.0	0.0	7.9	0.0	0.0	0.0	1.4	0.0	0.0	1.8	0.0	3.1	0.0	0.1	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.9	0.0	0.0	0.5	1.4	0.2	0.0	0.0
CELA2A	ELA2A	ENSG00000142615	"Chymotrypsin like elastase 2A"	P08217	1	15456728-15472091	"Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted secreted proteins"		"Hydrolase, Protease, Serine protease"	"Diabetes mellitus, Disease variant, Obesity"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	2325	"pancreas: 162732.5"	"Cell type enriched"	"Detected in some"	34	"Exocrine glandular cells: 7828.2"	"Cancer enriched"	"Detected in single"	3818	"pancreatic cancer: 463.9"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"HMC-1: 1.2"														"Secreted to digestive system"	NA	NA		2700000		"Cluster 25: Pancreas - Digestion"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 1: Pancreatic cells - Digestion"				"unprognostic (9.78e-2)"	"unprognostic (3.33e-2)"		"unprognostic (5.60e-2)"	"unprognostic (5.27e-2)"	"unprognostic (3.63e-3)"		"unprognostic (2.35e-1)"	"unprognostic (4.14e-1)"	"unprognostic (1.96e-2)"	"unprognostic (1.38e-1)"	"unprognostic (2.48e-1)"	"unprognostic (3.94e-9)"	"unprognostic (4.10e-2)"		"unprognostic (3.42e-1)"	"unprognostic (3.55e-2)"	7.9	5.5	0.0	2.6	0.0	1.1	4.4	0.2	0.1	3.9	0.0	2.0	18.5	2.1	0.0	2.3	1.1	0.0	26.9	0.0	0.0	1.6	5.8	1.2	4.3	0.0	0.0	70.0	162732.5	0.0	1.3	10.2	0.0	2.7	0.0	0.0	28.0	0.0	1.6	2.2	8.7	0.0	0.0	2.2	15.4	2.0	0.0	0.0	1.1	0.0	0.0	0.9	1.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.3	0.0	0.0	0.0	0.1	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	5.8	0.1	0.3	0.3	0.3	0.0	0.0	1.1	7828.2	0.0	0.2	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.4	0.0	0.0	1.3	0.0	0.0	20.7	0.0	0.0	0.0	0.1	227.5	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.8	0.9	0.0	0.0	0.0	0.0	0.0	0.1	1.6	0.0	0.1
CELA2B	"ELA2B, RP11-265F14.2"	ENSG00000215704	"Chymotrypsin like elastase 2B"	P08218	1	15465909-15491395	"Enzymes, Predicted intracellular proteins, Predicted secreted proteins"		"Hydrolase, Protease, Serine protease"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	1672	"pancreas: 20446.9"	"Cell type enriched"	"Detected in some"	73	"Exocrine glandular cells: 1227.6"	"Cancer enriched"	"Detected in single"	574	"pancreatic cancer: 69.9"	"Group enriched"	"Detected in some"	4	"cerebellum: 2.0;cerebral cortex: 3.2"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	5	"U-138 MG: 3.9"														"Secreted to digestive system"	NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 25: Pancreas - Digestion"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 1: Pancreatic cells - Digestion"				"unprognostic (4.36e-3)"	"unprognostic (5.45e-2)"	"unprognostic (6.66e-2)"	"unprognostic (5.31e-3)"	"unprognostic (4.47e-3)"	"unprognostic (1.37e-3)"	"unprognostic (4.66e-2)"	"unprognostic (6.32e-2)"	"unprognostic (2.73e-1)"	"unprognostic (2.44e-1)"	"unprognostic (2.94e-1)"	"unprognostic (3.85e-2)"	"unprognostic (1.22e-6)"	"unprognostic (2.47e-1)"	"unprognostic (6.67e-2)"	"unprognostic (1.88e-1)"	"unprognostic (7.80e-2)"	1.1	3.0	0.0	0.5	0.0	1.0	0.6	2.0	3.2	0.4	0.0	0.2	3.7	0.4	0.1	0.3	0.1	0.6	4.5	0.3	0.6	0.2	0.6	0.3	1.2	0.2	0.2	12.2	20446.9	0.0	0.1	1.2	0.0	0.3	0.0	1.7	3.4	0.0	0.3	1.0	2.4	0.0	0.0	0.3	1.2	0.7	0.4	0.0	0.8	0.0	0.0	0.1	0.1	0.3	0.0	0.6	0.4	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.2	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.3	0.5	0.8	0.4	0.1	0.0	0.1	0.5	0.0	0.0	0.0	0.0	0.3	0.0	0.6	0.1	0.4	0.0	0.0	0.0	0.0	0.1	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.2	0.1	0.0	0.0	3.9	0.0	0.0	0.0	0.3	0.0	0.1	0.1	0.0	0.0	0.9	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.0	3.2	0.3	0.6	0.2	0.2	0.0	0.0	0.4	0.3	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.3	0.1	0.0	0.0	0.0	0.0	1.4	1227.6	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.5	0.1	16.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.5	0.0	0.0
CELA3A	"ELA3, ELA3A"	ENSG00000142789	"Chymotrypsin like elastase 3A"	P09093	1	22001657-22012542	"Enzymes, Predicted intracellular proteins, Predicted secreted proteins"		"Hydrolase, Protease, Serine protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	2216	"pancreas: 262614.2"	"Cell type enriched"	"Detected in some"	56	"Exocrine glandular cells: 34710.4"	"Cancer enriched"	"Detected in some"	2497	"pancreatic cancer: 1481.6"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	28	"MOLT-4: 24.9"									"HPA028086, HPA045650"	Supported		Approved	Cytosol	"Secreted to digestive system"	NA	NA				"Cluster 25: Pancreas - Digestion"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 1: Pancreatic cells - Digestion"	Cytosol		"HPA028086: AB_2672482, HPA045650: AB_2679407"			"unprognostic (1.27e-1)"	"unprognostic (2.71e-1)"							"unprognostic (1.79e-1)"			"unprognostic (6.32e-2)"	"unprognostic (2.67e-1)"			20.0	4.5	0.0	3.0	0.0	2.8	11.6	0.0	0.0	12.9	0.0	4.5	21.3	4.1	0.0	7.4	3.0	0.1	44.6	0.0	0.0	4.1	13.5	3.0	6.0	0.0	0.0	118.5	262614.2	0.0	6.9	14.9	0.0	8.8	0.0	0.0	44.0	0.0	3.9	5.2	12.2	0.0	0.0	6.3	47.7	3.2	0.0	0.3	3.1	0.0	0.0	2.9	4.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	24.9	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.1	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	25.5	40.7	0.1	0.0	0.6	0.0	0.0	0.1	34710.4	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	197.1	0.3	2.4	0.0	0.0	94.0	0.0	0.0	0.0	0.0	619.0	1.1	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	2.8	0.2	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0
CELA3B	"CBPP, ELA3B"	ENSG00000219073	"Chymotrypsin like elastase 3B"	P08861	1	21977022-21998642	"Enzymes, Predicted intracellular proteins, Predicted secreted proteins"		"Hydrolase, Protease, Serine protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	2088	"pancreas: 49621.1"	"Cell type enriched"	"Detected in some"	45	"Exocrine glandular cells: 14881.1"	"Cancer enriched"	"Detected in single"	1218	"pancreatic cancer: 408.8"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											"HPA028086, HPA045650"	Supported		Approved	Cytosol	"Secreted to digestive system"	NA	NA				"Cluster 25: Pancreas - Digestion"		"Cluster 1: Pancreatic cells - Digestion"	Cytosol		"HPA028086: AB_2672482, HPA045650: AB_2679407"			"unprognostic (2.89e-1)"	"unprognostic (4.01e-3)"						"unprognostic (6.53e-3)"	"unprognostic (1.30e-1)"	"unprognostic (1.29e-1)"		"unprognostic (6.40e-2)"				9.0	1.8	0.0	0.6	0.0	0.8	4.5	0.0	0.0	4.4	0.0	1.8	6.2	1.6	0.1	2.6	1.2	0.0	8.4	0.0	0.0	1.6	5.0	1.2	1.1	0.0	0.0	23.7	49621.1	0.0	2.2	3.4	0.0	3.1	0.1	0.0	9.5	0.0	1.6	1.9	2.6	0.0	0.0	2.3	17.2	2.4	0.0	0.0	1.2	0.0	0.0	1.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	12.7	0.0	10.4	78.6	0.3	0.0	0.6	0.0	0.0	0.2	14881.1	0.0	0.0	0.0	0.4	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.5	0.0	0.0	0.0	309.9	0.9	0.9	0.0	0.0	60.4	0.0	0.0	0.0	0.2	325.6	16.0	0.7	0.0	0.0	5.7	0.0	0.0	0.0	0.0	0.0	1.3	0.3	0.2	0.0	0.0	0.0	0.0	0.0	0.6	0.0
CEMIP	"HYBID, IR2155535, KIAA1199, TMEM2L"	ENSG00000103888	"Cell migration inducing hyaluronidase 1"	Q8WUJ3	15	80779343-80951776	"Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"		"Glycosidase, Hydrolase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"choroid plexus: 25.3;endometrium 1: 31.9"	"Group enriched"	"Detected in some"	5	"Excitatory neurons: 62.5;Inhibitory neurons: 40.0;Microglial cells: 101.2"	"Cancer enhanced"	"Detected in all"		"colorectal cancer: 21.3"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"BJ: 204.1;BJ hTERT+: 321.8;fHDF/TERT166: 258.7;HSkMC: 169.3;hTERT-RPE1: 187.6;U-138 MG: 90.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"								"Secreted in other tissues"	NA	NA		1700000	"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 42: Ciliated cells - Cilium & Cell projection"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"				"unprognostic (1.14e-3)"	"unprognostic (6.80e-2)"	"unprognostic (5.95e-2)"	"unprognostic (3.15e-3)"	"unprognostic (3.49e-3)"	"unprognostic (6.80e-2)"	"unprognostic (5.47e-2)"	"unprognostic (1.22e-1)"	"unprognostic (7.49e-2)"	"unprognostic (1.53e-1)"	"unprognostic (7.24e-2)"	"unprognostic (1.36e-1)"	"unprognostic (5.27e-10)"	"unprognostic (1.82e-2)"	"unprognostic (1.93e-1)"	"unprognostic (1.34e-1)"	"prognostic unfavorable (2.65e-4)"	5.7	1.7	1.6	11.2	8.8	1.5	0.8	5.5	11.1	13.3	25.3	1.3	0.8	31.9	6.9	6.4	6.2	2.1	1.9	2.4	3.5	0.9	0.8	15.0	9.5	3.0	1.7	4.7	1.0	1.5	8.0	2.6	2.4	2.0	1.8	4.1	1.9	1.6	0.4	5.9	1.6	0.6	5.1	1.8	0.9	2.9	4.4	0.3	3.9	0.0	4.7	14.0	2.6	3.1	0.7	7.7	1.5	1.1	0.5	2.8	0.9	204.1	321.8	5.4	4.1	2.4	1.0	1.0	0.6	258.7	0.9	4.9	0.0	0.7	1.1	0.6	1.9	0.7	1.3	17.1	1.9	0.5	1.0	169.3	0.2	39.6	0.2	187.6	0.0	1.0	1.0	0.8	4.8	4.7	0.7	0.5	1.0	68.9	9.2	1.2	0.3	0.9	0.0	3.5	12.7	0.4	3.5	0.5	17.7	2.7	1.0	0.4	1.0	90.6	0.9	6.8	3.5	0.8	0.7	1.2	9.6	1.8	6.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.1	0.0	1.6	8.8	5.5	11.1	2.4	3.5	3.0	1.7	2.4	5.1	4.4	3.1	0.1	0.0	1.5	2.9	0.1	0.0	0.3	0.0	11.4	2.9	0.0	0.1	1.2	0.0	4.3	0.0	6.2	0.2	0.0	1.1	0.0	0.1	1.0	0.7	4.3	1.6	4.8	0.0	62.5	0.4	0.2	4.3	0.0	7.0	1.3	0.1	0.4	0.0	0.4	3.3	40.0	0.5	0.0	0.0	0.0	0.6	0.3	0.9	0.0	101.2	0.0	0.4	0.0	6.6	8.2	0.7	0.1	0.0	0.1	2.7	0.0	0.1	0.0	3.0	0.0	0.4	0.8	0.2	0.7	1.0	0.0	0.3	0.1	0.1	0.8	0.9
CEMIP2	TMEM2	ENSG00000135048	"Cell migration inducing hyaluronidase 2"	Q9UHN6	9	71683366-71816690	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"	Angiogenesis	"Developmental protein, Glycosidase, Hydrolase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"parathyroid gland: 92.5;placenta: 79.6"	"Cell type enhanced"	"Detected in some"		"Adipocytes: 105.8;dendritic cells: 378.1;Glandular and luminal cells: 137.3;Plasma cells: 155.1;Syncytiotrophoblasts: 89.8;T-cells: 86.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"AF22: 143.4;BEWO: 117.4;OE19: 144.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA017080, HPA044889"	Approved		Supported	"Vesicles,Plasma membrane,Cytosol"		NA	NA		150000	"Cluster 45: Eosinophils - Innate immune response"	"Cluster 86: Liver & Placenta - Transport via ER"	"Cluster 21: OE19 - Mitochondria"	"Cluster 24: Non-specific - Transcription regulation"	"Plasma membrane"	"Vesicles, Cytosol"	"HPA017080: , HPA044889: AB_10962641"	"unprognostic (2.06e-1)"	"unprognostic (1.12e-1)"	"unprognostic (3.85e-2)"	"unprognostic (1.01e-2)"	"unprognostic (6.15e-3)"	"unprognostic (1.21e-2)"	"unprognostic (2.93e-2)"	"unprognostic (3.53e-1)"	"unprognostic (3.29e-2)"	"unprognostic (1.92e-1)"	"unprognostic (1.57e-2)"	"unprognostic (2.33e-1)"	"prognostic unfavorable (1.31e-4)"	"unprognostic (1.13e-2)"	"unprognostic (2.33e-1)"	"unprognostic (7.59e-2)"	"unprognostic (1.16e-1)"	25.1	5.4	9.7	24.8	6.5	29.7	11.1	9.7	8.3	5.1	15.0	24.2	27.2	7.2	2.7	6.6	5.6	41.5	7.7	19.0	2.8	10.4	60.2	35.0	23.1	4.1	3.6	2.2	19.3	92.5	4.6	79.6	4.9	7.0	28.0	17.3	11.1	8.0	4.8	6.1	23.7	11.7	4.1	15.9	33.2	6.8	8.2	18.6	9.4	8.6	20.7	32.0	3.4	5.5	22.5	85.0	143.4	6.6	13.7	22.9	117.4	81.7	48.7	51.6	40.5	24.3	31.3	0.4	20.0	18.8	11.6	35.2	38.6	9.9	73.2	2.5	11.2	38.9	20.9	68.7	23.9	0.4	9.8	28.0	11.4	38.9	8.1	14.0	68.2	3.3	4.7	10.2	28.8	15.1	4.1	0.6	28.2	144.3	8.6	3.3	39.9	2.4	31.6	60.4	6.3	0.6	19.3	12.5	20.5	45.2	8.8	1.3	30.3	33.7	38.3	17.4	39.3	1.8	37.8	0.9	6.1	3.9	43.7	0.1	1.3	3.1	1.4	1.1	0.3	0.4	1.5	1.3	0.5	3.0	2.1	1.0	2.3	0.3	1.0	0.1	2.3	0.9	9.7	6.5	9.7	8.3	19.0	2.8	4.1	3.6	4.9	4.1	8.2	5.5	105.8	0.0	0.0	0.0	47.6	0.0	0.0	0.0	0.0	0.0	58.7	46.7	0.0	0.0	0.0	14.7	0.0	47.9	378.1	0.0	0.0	20.2	0.0	42.1	24.2	14.7	0.0	0.0	0.0	36.2	14.4	4.3	0.0	137.3	0.0	3.8	0.0	0.0	46.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	18.3	0.0	0.0	0.6	0.0	0.0	0.0	0.0	30.8	0.0	0.0	155.1	0.0	0.0	11.6	0.0	0.0	0.0	0.0	10.7	0.0	0.0	0.0	0.0	89.8	86.1	3.1	0.0	0.0
CES1	"CEH, CES1A1, CES1A2, CES2, HMSE, HMSE1, SES1"	ENSG00000198848	"Carboxylesterase 1"	P23141	16	55802851-55833337	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"		"Hydrolase, Serine esterase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	9	"liver: 2517.1"	"Group enriched"	"Detected in many"	7	"Cholangiocytes: 613.4;Hepatocytes: 2420.8"	"Cancer enriched"	"Detected in all"	6	"liver cancer: 711.4"	"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in many"	16	"classical monocyte: 109.6;myeloid DC: 114.5"	"Group enriched"	"Detected in many"	22	"dendritic cells: 114.5;monocytes: 109.6"	"Group enriched"	"Detected in some"	5	"Hep G2: 700.9;THP-1: 688.0"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA012023, HPA046717"	Enhanced		Supported	"Endoplasmic reticulum"	"Intracellular and membrane"	No	NA		40000000	"Cluster 25: Monocytes - Inflammatory response"	"Cluster 60: Liver - Hemostasis & Lipid metabolism"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 2: Hepatocytes - Metabolism"	"Endoplasmic reticulum"		"HPA012023: AB_1846554, HPA046717: AB_2679770"	"unprognostic (1.04e-2)"	"unprognostic (9.85e-2)"	"unprognostic (2.94e-1)"	"unprognostic (1.28e-1)"	"unprognostic (1.55e-3)"	"unprognostic (7.46e-3)"	"unprognostic (1.51e-1)"	"unprognostic (1.42e-1)"	"unprognostic (3.51e-1)"	"unprognostic (5.74e-2)"	"unprognostic (4.62e-2)"	"unprognostic (3.29e-2)"	"unprognostic (1.91e-2)"	"unprognostic (5.32e-2)"	"unprognostic (1.92e-1)"	"unprognostic (2.87e-1)"	"prognostic unfavorable (9.92e-4)"	94.9	14.1	0.9	3.2	1.2	27.0	43.6	0.8	1.8	26.6	3.7	82.3	24.0	60.4	7.5	41.1	54.6	272.9	66.1	1.0	1.4	6.7	2517.1	167.8	1.8	2.3	1.2	20.3	8.8	0.7	3.7	8.5	1.5	39.2	12.3	2.9	41.4	36.4	5.2	14.0	27.4	40.4	1.0	41.0	56.1	7.8	1.1	2.5	9.9	9.4	1.0	57.7	17.7	1.1	0.7	4.4	0.0	0.0	90.8	0.6	3.1	0.3	0.0	0.0	0.0	43.5	0.0	0.0	19.4	0.0	1.4	0.0	0.0	0.0	0.0	0.2	0.0	0.4	0.9	700.9	0.0	1.3	0.1	0.2	0.3	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	40.8	0.1	0.6	0.0	0.0	1.5	6.7	0.0	0.5	0.0	0.1	3.2	0.1	1.1	0.9	0.0	688.0	0.1	0.0	0.4	0.2	0.5	2.2	0.1	1.0	0.0	151.7	0.0	0.0	109.6	0.5	4.5	6.1	1.5	1.1	0.7	5.0	114.5	1.2	0.7	1.1	0.6	0.3	1.6	6.8	0.4	58.0	0.9	1.2	0.8	1.8	1.0	1.4	2.3	1.2	1.5	1.0	1.1	1.1	2.0	16.0	67.6	0.0	11.3	16.7	5.3	6.8	1.2	0.0	1.2	8.1	0.8	613.4	31.5	16.5	0.0	0.5	12.2	0.1	0.0	15.4	79.6	1.0	10.6	8.9	37.5	177.7	0.0	18.7	2.2	57.4	1.1	0.2	6.3	0.0	66.0	2420.8	18.1	0.0	0.0	12.2	4.1	107.3	26.7	197.8	18.6	58.7	39.2	1.0	39.6	10.4	7.2	0.0	0.0	0.9	1.3	98.9	1.8	1.5	0.6	0.9	169.0	0.9	0.0	9.8	9.8	1.0	2.3	20.6	11.6	0.8	16.9	0.9	0.7	2.6
CES2	"CE-2, CES2A1, iCE"	ENSG00000172831	"Carboxylesterase 2"	O00748	16	66934444-66945096	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Hydrolase, Serine esterase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"intestine: 703.3;liver: 345.7"	"Cell type enhanced"	"Detected in all"		"Distal enterocytes: 794.4;Hepatocytes: 518.5;Paneth cells: 519.2;Proximal enterocytes: 2529.8;Undifferentiated cells: 499.5"	"Cancer enhanced"	"Detected in all"		"liver cancer: 104.4"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Not detected"	"Not detected"							"HPA018897, HPA074629"	Enhanced		Approved	"Endoplasmic reticulum,Golgi apparatus,Cytosol"	"Intracellular and membrane"	NA	NA		6400000	"Cluster 44: Non-specific - Transcription"	"Cluster 41: Intestine & Liver - Lipid metabolism"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 45: Enterocytes - Digestion"	"Golgi apparatus"	"Endoplasmic reticulum, Cytosol"	"HPA018897: AB_1846558, HPA074629: "	"unprognostic (8.15e-3)"	"unprognostic (1.82e-2)"	"unprognostic (1.32e-1)"	"unprognostic (2.67e-3)"	"unprognostic (2.74e-2)"	"unprognostic (1.38e-1)"	"unprognostic (5.80e-2)"	"unprognostic (1.31e-1)"	"unprognostic (6.93e-2)"	"unprognostic (7.99e-2)"	"unprognostic (1.73e-3)"	"unprognostic (2.66e-2)"	"prognostic favorable (1.50e-5)"	"unprognostic (8.01e-2)"	"unprognostic (1.53e-1)"	"unprognostic (4.14e-2)"	"unprognostic (1.38e-1)"	18.8	38.1	21.2	18.1	20.6	6.3	13.5	24.1	23.0	22.0	25.6	191.2	703.3	14.6	14.4	132.7	17.9	19.5	51.4	22.1	20.6	96.5	345.7	15.6	11.9	20.8	20.8	17.0	14.4	38.0	15.7	10.1	20.6	16.7	178.8	16.2	32.9	15.0	33.8	32.7	576.5	19.7	20.0	12.4	41.6	9.3	20.9	13.1	27.9	14.3	20.8	13.7	33.5	20.5	11.6	16.6	18.4	25.9	19.5	17.9	14.5	15.9	25.8	17.6	22.1	17.3	23.5	15.7	14.3	20.9	13.3	35.4	14.2	39.8	15.3	10.7	18.9	14.4	9.6	44.2	26.3	21.6	26.3	25.4	82.5	26.0	46.7	24.6	14.1	11.3	22.2	10.9	35.7	9.1	17.7	21.4	10.8	16.3	18.8	20.9	19.1	19.8	60.7	18.6	11.6	16.0	50.9	12.6	14.5	8.1	21.0	26.5	17.5	22.4	12.6	15.3	11.1	23.3	24.0	18.4	36.7	17.3	17.4	4.1	5.4	1.6	5.1	3.8	4.5	3.0	4.1	5.8	4.5	3.1	4.8	4.5	1.6	4.3	4.1	4.3	3.2	3.1	21.2	20.6	24.1	23.0	22.1	20.6	20.8	20.8	20.6	20.0	20.9	20.5	13.2	32.1	24.6	8.8	18.8	19.5	13.5	32.8	39.3	31.2	12.4	18.3	33.6	115.8	19.8	53.3	20.9	16.1	12.9	794.4	37.2	24.6	2.1	26.9	15.0	14.1	24.1	7.8	7.0	33.8	5.7	15.3	60.6	33.7	27.3	80.7	28.5	518.5	19.6	28.6	9.7	196.0	18.3	37.0	9.6	2.3	18.6	15.3	10.6	10.3	19.5	19.0	21.6	8.0	5.9	51.8	519.2	18.0	8.5	19.1	2529.8	176.0	85.4	24.2	32.9	19.5	15.2	47.2	19.7	116.1	20.5	13.5	13.0	22.1	499.5	16.7
CES3	"ES31, FLJ21736"	ENSG00000172828	"Carboxylesterase 3"	Q6UWW8	16	66961245-66975149	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Hydrolase, Serine esterase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 38.2;liver: 52.5;skeletal muscle: 24.7"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 120.1;Granulosa cells: 58.5;Hepatocytes: 53.4;Intestinal goblet cells: 32.0;Paneth cells: 67.0;Proximal enterocytes: 66.0;Undifferentiated cells: 44.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"AN3-CA: 7.4;Daudi: 8.5;JURKAT: 13.5;U-937: 7.2"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA041008, HPA041307"	Approved		Approved	"Nuclear membrane,Endoplasmic reticulum"	"Intracellular and membrane"	NA	NA		1200000	"Cluster 52: Eosinophils - Transcription"	"Cluster 41: Intestine & Liver - Lipid metabolism"	"Cluster 32: U-937 - Innate immune response"	"Cluster 53: Intestinal epithelial cells - Unknown function"	"Nuclear membrane, Endoplasmic reticulum"		"HPA041008: AB_2677247, HPA041307: AB_2677400"	"unprognostic (3.91e-3)"	"unprognostic (1.22e-1)"	"unprognostic (1.94e-2)"	"unprognostic (8.99e-3)"	"unprognostic (9.32e-2)"	"unprognostic (7.84e-4)"	"prognostic favorable (7.26e-5)"	"unprognostic (5.67e-3)"	"unprognostic (1.52e-1)"	"unprognostic (2.17e-1)"	"unprognostic (6.43e-2)"	"unprognostic (1.84e-2)"	"unprognostic (1.19e-2)"	"unprognostic (2.18e-2)"	"unprognostic (2.75e-1)"	"unprognostic (3.31e-2)"	"unprognostic (7.41e-2)"	0.8	0.5	3.1	3.2	2.7	0.9	2.3	2.5	2.9	1.3	1.3	38.2	30.0	0.7	0.2	4.2	2.9	0.9	0.7	3.8	2.0	12.2	52.5	0.7	0.3	3.3	2.7	0.6	4.1	1.0	1.9	0.6	3.5	0.5	31.3	0.6	12.0	0.3	24.7	1.2	23.7	1.2	1.4	0.4	7.7	1.1	2.2	0.2	0.4	1.5	0.2	0.1	0.8	2.2	0.4	3.1	0.3	7.4	0.2	0.2	1.2	0.2	0.2	0.3	0.5	0.5	3.8	8.5	2.4	0.0	0.2	0.6	1.1	0.5	0.1	1.5	5.5	4.3	1.3	2.6	0.0	0.9	0.7	0.3	0.9	0.8	0.1	0.2	0.0	13.5	2.8	1.7	0.3	1.1	1.4	1.4	1.5	2.6	0.4	1.3	0.7	1.3	0.1	0.4	0.4	0.8	0.2	5.8	0.2	0.6	5.0	6.5	0.3	0.4	2.4	0.7	0.2	0.9	3.6	1.3	0.3	7.2	0.2	0.2	0.1	0.7	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.1	0.1	0.1	0.4	0.0	0.0	0.0	0.1	0.0	3.1	2.7	2.5	2.9	3.8	2.0	3.3	2.7	3.5	1.4	2.2	2.2	0.1	3.2	6.7	0.7	0.4	0.5	0.0	1.3	1.2	0.2	9.1	5.7	1.4	2.8	0.9	0.0	0.0	0.0	0.0	120.1	0.0	0.2	0.5	3.2	0.3	0.2	19.7	0.0	1.8	0.9	0.0	0.2	11.7	4.4	1.3	58.5	0.4	53.4	0.3	0.0	2.9	32.0	0.0	3.2	0.9	5.4	0.0	0.9	0.0	0.0	0.0	0.4	0.0	1.5	0.1	1.0	67.0	1.2	0.1	0.1	66.0	9.9	4.8	0.2	0.0	0.6	0.2	2.3	2.9	1.1	0.3	0.0	0.4	0.1	44.3	0.2
CES5A	"CAUXIN, CES4C1, CES5, CES7, FLJ31547"	ENSG00000159398	"Carboxylesterase 5A"	Q6NT32	16	55846154-55956031	"Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted secreted proteins"		"Hydrolase, Serine esterase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	17	"epididymis: 67.5"	"Cell type enhanced"	"Detected in some"		"Cholangiocytes: 1.5;Collecting duct cells: 5.5;Excitatory neurons: 1.4;Hepatocytes: 6.9;Oligodendrocyte precursor cells: 2.0;Oligodendrocytes: 4.0"	"Cancer enriched"	"Detected in single"	5	"liver cancer: 0.6"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	46	"U-266/70: 7.9"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"								"Secreted in male reproductive system"	NA	NA				"Cluster 30: Epididymis - Antimicrobial activity"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 2: Hepatocytes - Metabolism"							"unprognostic (2.07e-1)"	"unprognostic (2.55e-1)"	"unprognostic (6.34e-2)"	"unprognostic (4.82e-2)"		"unprognostic (3.78e-1)"	"unprognostic (2.33e-1)"	"unprognostic (3.12e-2)"		"unprognostic (1.72e-7)"	"unprognostic (1.55e-2)"	"unprognostic (2.27e-1)"			0.0	0.0	0.2	0.0	0.5	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.0	67.5	0.0	0.0	0.6	0.1	0.1	0.2	0.0	3.9	0.0	0.0	0.3	0.3	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.7	0.4	0.0	0.6	0.0	0.0	0.2	0.0	0.0	0.3	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.5	0.2	0.2	0.1	0.2	0.3	0.3	0.2	0.2	0.2	0.3	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	1.5	0.0	5.5	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.9	0.0	0.0	1.3	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.0	4.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
CFB	"BF, BFD, H2-Bf"	ENSG00000243649	"Complement factor B"	P00751	6	31945650-31952084	"Disease related genes, Enzymes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted secreted proteins"	"Complement alternate pathway, Immunity, Innate immunity"	"Hydrolase, Protease, Serine protease"	"Age-related macular degeneration, Disease variant, Hemolytic uremic syndrome"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	18	"liver: 2613.2"	"Cell type enhanced"	"Detected in many"		"Ductal cells: 873.6;Exocrine glandular cells: 197.3;Hepatocytes: 284.0;Pancreatic endocrine cells: 318.0;Proximal enterocytes: 139.7"	"Cancer enhanced"	"Detected in all"		"liver cancer: 78.3"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"ASC diff: 15.0;ASC TERT1: 23.0;EFO-21: 25.1;fHDF/TERT166: 14.1;HSkMC: 19.1;U-87 MG: 10.1"					"Low region specificity"	"Detected in all"			"HPA000951, HPA001817, HPA001832, CAB016381"	Supported		Approved	"Endoplasmic reticulum,Vesicles,Cell Junctions"	"Secreted to blood"	NA	NA	879000000	120000000000	"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 62: Liver - Hemostasis"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 1: Pancreatic cells - Digestion"	"Endoplasmic reticulum, Vesicles"	"Cell Junctions"	"CAB016381: AB_627562, HPA000951: AB_2797216, HPA001817: AB_1078779, HPA001832: AB_1078778"	"prognostic favorable (2.76e-5)"	"unprognostic (1.02e-1)"	"unprognostic (1.44e-1)"	"unprognostic (7.94e-2)"	"unprognostic (1.82e-2)"	"unprognostic (8.56e-2)"	"unprognostic (8.08e-3)"	"unprognostic (8.81e-2)"	"unprognostic (3.51e-1)"	"unprognostic (2.26e-2)"	"unprognostic (1.32e-2)"	"unprognostic (6.57e-2)"	"prognostic unfavorable (1.53e-5)"	"unprognostic (1.36e-1)"	"unprognostic (5.13e-2)"	"unprognostic (1.05e-2)"	"unprognostic (3.68e-2)"	143.7	18.0	3.6	32.8	3.6	0.1	28.5	3.4	9.9	16.3	3.9	22.3	28.1	8.2	14.2	24.1	53.7	0.8	42.6	3.7	3.4	58.7	2613.2	39.2	4.2	4.1	3.7	9.9	51.8	0.2	17.7	5.0	3.8	60.3	14.5	1.4	43.3	0.0	3.0	7.7	73.1	48.3	3.4	12.9	54.5	2.1	3.7	1.9	15.5	0.7	6.7	17.8	9.2	3.6	0.5	1.9	0.1	0.0	15.0	23.0	0.1	0.0	0.2	1.1	0.0	0.1	8.6	0.1	25.1	14.1	0.6	6.0	0.0	1.8	1.2	1.0	0.3	0.7	0.4	0.5	0.0	1.0	0.4	19.1	0.4	0.6	0.5	1.3	0.2	0.1	0.3	0.7	0.1	0.2	0.1	0.3	0.4	0.0	0.4	0.3	0.3	1.3	1.7	0.5	0.0	0.1	0.0	1.3	0.0	0.0	0.0	0.2	0.0	3.4	1.2	0.4	0.4	0.7	2.1	1.0	10.1	0.6	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	3.6	3.6	3.4	9.9	3.7	3.4	4.1	3.7	3.8	3.4	3.7	3.6	1.0	0.0	16.9	0.0	2.6	0.8	0.9	64.8	11.4	0.3	4.9	0.9	0.4	44.3	127.3	5.5	0.0	0.1	0.0	3.7	3.9	873.6	0.0	1.9	0.4	3.9	2.4	16.0	0.2	197.3	0.2	34.6	20.9	1.2	0.0	0.0	11.7	284.0	1.0	0.0	0.2	8.5	18.3	19.7	1.0	0.0	2.8	1.1	0.0	5.6	18.1	0.4	0.0	0.0	0.0	318.0	10.6	0.0	0.1	8.6	139.7	17.1	75.4	0.7	0.0	1.0	12.6	0.1	0.1	3.9	1.8	1.6	1.6	0.0	12.4	4.5
CFD	"ADN, DF, PFD"	ENSG00000197766	"Complement factor D"	P00746	19	859664-863641	"Disease related genes, Enzymes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted secreted proteins"	"Complement alternate pathway, Immunity, Innate immunity"	"Hydrolase, Protease, Serine protease"	"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 1496.7;breast: 993.2"	"Group enriched"	"Detected in many"	6	"Fibroblasts: 9365.5;Leydig cells: 5032.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"basophil: 297.6"	"Lineage enriched"	"Detected in all"	5	"granulocytes: 297.6"	"Group enriched"	"Detected in many"	5	"ASC diff: 197.4;THP-1: 342.2"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"								"Secreted to blood"	NA	NA	732000000	4400000000	"Cluster 2: Granulocytes - Unknown function"	"Cluster 82: Adipose tissue - ECM organization"	"Cluster 43: THP-1 - Innate immune response"	"Cluster 50: Fibroblasts - ECM organization"				"unprognostic (3.00e-2)"	"unprognostic (6.09e-2)"	"unprognostic (2.44e-1)"	"unprognostic (1.22e-3)"	"unprognostic (6.92e-2)"	"unprognostic (5.28e-2)"	"unprognostic (8.11e-3)"	"unprognostic (2.48e-1)"	"unprognostic (1.46e-2)"	"unprognostic (8.10e-2)"	"prognostic favorable (1.77e-4)"	"unprognostic (9.53e-2)"	"prognostic unfavorable (7.09e-4)"	"unprognostic (1.23e-1)"	"unprognostic (4.55e-2)"	"unprognostic (1.92e-2)"	"unprognostic (9.75e-2)"	1496.7	33.3	1.5	9.6	1.6	10.7	993.2	1.2	2.4	597.4	3.7	324.8	23.5	58.4	2.4	212.8	258.0	9.6	854.2	1.7	2.3	18.1	8.7	363.3	2.1	3.3	2.3	74.3	41.4	1.7	9.0	14.5	3.6	277.8	10.9	0.6	247.3	6.3	197.0	488.6	248.4	4.0	2.6	28.6	263.8	51.8	2.9	3.6	332.3	26.9	0.8	848.3	729.8	5.8	3.9	5.2	0.6	2.2	197.4	26.2	9.5	0.8	0.0	0.0	0.0	0.8	0.4	0.2	5.7	0.0	0.5	3.0	1.8	0.5	0.0	5.7	14.5	0.5	12.3	3.8	3.6	2.5	4.9	8.7	0.2	0.1	0.0	0.8	0.0	4.5	11.9	0.9	0.0	2.6	0.6	49.2	1.0	4.5	16.1	1.3	0.5	5.2	0.3	1.2	1.8	1.8	5.5	1.9	0.5	0.6	7.5	342.2	0.4	0.2	5.1	2.9	0.6	7.8	4.7	0.4	0.2	20.8	0.2	297.6	41.2	127.8	8.4	55.5	13.2	5.7	4.2	10.2	14.5	1.4	9.7	9.7	112.0	1.3	57.3	1.8	4.7	37.8	1.5	1.6	1.2	2.4	1.7	2.3	3.3	2.3	3.6	2.6	2.9	5.8	857.8	9.6	23.3	0.0	19.2	785.5	49.0	10.1	17.1	2.9	107.3	120.1	55.5	21.5	30.9	18.4	2.1	36.6	40.0	33.1	11.7	7.7	27.1	23.1	593.3	114.8	4.2	8.2	0.2	0.0	32.9	9365.5	113.6	15.9	17.1	0.9	30.4	2.6	272.4	1.7	0.4	8.7	0.0	424.7	1145.2	89.6	5032.4	442.5	642.1	4.7	303.6	1.3	21.6	0.0	0.1	2.9	64.8	283.2	41.0	19.7	4.3	3.4	28.4	6.5	0.0	414.3	530.2	11.4	21.3	28.6	735.9	34.3	82.8	1.2	21.0	233.2
CFI	"C3b-INA, FI, IF, KAF"	ENSG00000205403	"Complement factor I"	P05156	4	109740694-109801999	"Disease related genes, Enzymes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted secreted proteins"	"Complement pathway, Host-virus interaction, Immunity, Innate immunity"	"Hydrolase, Protease, Serine protease"	"Age-related macular degeneration, Disease variant, Hemolytic uremic syndrome"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"liver: 1098.8"	"Cell type enhanced"	"Detected in many"		"Cholangiocytes: 108.7;Hepatocytes: 592.5;Muller glia cells: 147.8;Proximal tubular cells: 223.6"	"Cancer enhanced"	"Detected in all"		"liver cancer: 90.2"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"CAPAN-2: 106.1;Hep G2: 179.8;HSkMC: 67.4;RPTEC TERT1: 190.6"									"HPA001143, CAB016777, HPA024061"	Supported				"Secreted to blood"	NA	NA		12000000000		"Cluster 85: Liver - Metabolism"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"			"CAB016777: , HPA001143: AB_1078555, HPA024061: AB_1847129"	"unprognostic (1.04e-1)"	"unprognostic (5.79e-2)"	"unprognostic (1.68e-1)"	"unprognostic (6.32e-2)"	"unprognostic (1.55e-2)"	"unprognostic (8.58e-2)"	"unprognostic (2.95e-2)"	"unprognostic (3.00e-1)"	"unprognostic (2.00e-2)"	"unprognostic (5.42e-3)"	"unprognostic (1.41e-1)"	"unprognostic (3.61e-1)"	"unprognostic (8.63e-2)"	"unprognostic (1.29e-1)"	"unprognostic (3.42e-2)"	"unprognostic (1.74e-1)"	"prognostic unfavorable (6.06e-4)"	45.1	50.2	8.1	12.6	8.2	0.1	17.4	7.7	13.2	36.8	10.4	7.4	38.0	39.2	80.3	9.3	74.0	73.0	25.0	8.3	9.6	224.9	1098.8	50.7	8.9	15.6	10.2	32.1	26.0	3.1	8.4	24.1	10.7	8.3	6.4	53.0	15.0	26.7	3.9	2.7	22.3	24.3	10.5	33.1	14.4	8.8	9.2	2.3	14.5	4.6	7.5	34.1	8.3	10.6	0.0	0.6	0.0	0.3	0.0	0.2	0.1	1.5	1.4	0.1	0.2	0.0	106.1	0.0	32.9	0.0	0.5	0.0	0.0	0.0	0.0	34.8	0.7	0.0	0.4	179.8	6.2	0.3	0.0	67.4	0.0	0.1	0.0	3.6	4.8	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	190.6	0.5	0.0	0.3	1.6	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.4	0.6	0.0	0.0	0.0	0.1	18.8	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.1	8.2	7.7	13.2	8.3	9.6	15.6	10.2	10.7	10.5	9.2	10.6	48.1	12.8	50.9	3.6	4.0	1.0	12.2	15.2	0.6	3.4	2.1	5.6	2.3	108.7	36.2	64.4	2.1	0.1	0.3	1.7	31.3	69.3	0.2	34.1	46.4	57.7	0.0	2.7	0.3	30.9	0.2	34.3	8.2	33.6	3.8	72.1	55.0	592.5	0.7	1.7	0.2	1.9	0.0	16.7	1.5	0.8	16.8	2.0	0.0	4.7	1.6	147.8	0.0	0.0	0.3	30.8	2.4	0.0	0.0	3.8	17.0	223.6	8.4	7.3	0.0	1.3	9.4	1.6	0.5	1.9	1.1	0.3	3.4	18.5	4.1	12.6
CHD1		ENSG00000153922	"Chromodomain helicase DNA binding protein 1"	O14646	5	98853985-98929007	"Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Chromatin regulator, DNA-binding, Helicase, Hydrolase"	"Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 69.6"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA022236	Approved		Approved	"Nucleoplasm,Nucleoli fibrillar center"		NA	NA			"Cluster 6: Non-specific - Transcription"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 41: Macrophages - Immune response"	"Nucleoplasm, Nucleoli fibrillar center"		"HPA022236: AB_2670915"	"unprognostic (2.63e-1)"	"unprognostic (2.31e-1)"	"unprognostic (1.09e-2)"	"unprognostic (4.11e-2)"	"unprognostic (7.79e-2)"	"unprognostic (7.15e-2)"	"unprognostic (6.50e-2)"	"unprognostic (1.00e-2)"	"unprognostic (1.79e-1)"	"unprognostic (2.88e-1)"	"unprognostic (4.94e-2)"	"unprognostic (3.15e-1)"	"prognostic unfavorable (7.25e-6)"	"unprognostic (2.69e-1)"	"unprognostic (3.33e-1)"	"unprognostic (1.52e-1)"	"unprognostic (1.17e-1)"	14.7	10.3	6.9	17.8	7.3	69.6	9.2	17.9	14.1	8.0	8.8	10.5	9.8	12.7	7.0	7.9	8.1	15.0	5.4	6.1	8.3	8.3	13.2	9.4	13.7	9.7	7.7	14.1	10.0	9.4	4.8	14.2	8.8	8.2	10.3	14.9	5.4	7.1	9.7	6.2	9.5	9.0	7.4	15.7	8.2	18.1	7.3	49.6	8.8	9.0	13.8	12.4	5.9	9.3	23.0	20.7	47.5	32.3	15.7	16.1	41.3	23.2	15.1	18.4	23.8	25.9	17.3	19.3	22.0	13.5	29.8	18.6	37.6	25.6	38.2	30.5	28.2	34.2	25.8	19.8	17.3	33.3	25.5	14.0	10.2	32.0	32.2	12.5	22.6	62.0	42.0	28.9	18.7	18.5	66.4	14.4	32.0	7.2	24.8	55.7	33.2	29.2	16.0	21.6	22.1	18.9	29.8	15.4	37.9	24.6	15.0	22.6	25.7	39.3	21.2	24.9	41.6	20.0	22.6	40.0	21.5	32.6	24.2	13.1	7.1	10.1	5.4	6.6	6.9	9.4	5.1	5.3	6.5	8.3	7.0	5.6	14.4	7.4	6.8	4.7	5.9	2.0	6.9	7.3	17.9	14.1	6.1	8.3	9.7	7.7	8.8	7.4	7.3	9.3	87.2	48.1	72.2	35.3	145.3	155.5	99.0	26.6	115.5	39.3	85.9	56.1	29.9	22.8	57.4	36.8	43.8	53.9	203.6	64.0	7.9	36.5	101.0	84.3	114.3	79.5	31.8	40.8	50.9	32.0	38.4	104.6	50.0	107.3	89.2	45.2	40.0	30.6	35.6	33.7	59.8	31.2	16.2	65.8	145.9	19.8	32.3	169.7	67.6	90.9	89.1	20.5	59.8	66.4	72.1	35.3	51.4	19.2	121.0	82.6	28.1	15.5	45.3	49.5	46.0	173.8	113.5	67.1	54.6	74.1	188.5	90.3	148.2	49.9	39.4	75.4
CHD1L	ALC1	ENSG00000131778	"Chromodomain helicase DNA binding protein 1 like"	Q86WJ1	1	147242654-147295765	"Enzymes, Predicted intracellular proteins"	"DNA damage, DNA repair"	"Helicase, Hydrolase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Oligodendrocytes: 80.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA027789, HPA028670"	Enhanced		Supported	Nucleoplasm		NA	NA			"Cluster 28: Myeloid DCs - Unknown function"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	Nucleoplasm		"HPA027789: AB_10601099, HPA028670: AB_10601257"	"unprognostic (1.07e-1)"	"unprognostic (3.93e-2)"	"unprognostic (1.97e-1)"	"unprognostic (3.49e-1)"	"unprognostic (1.78e-1)"	"unprognostic (2.58e-2)"	"prognostic unfavorable (3.07e-4)"	"unprognostic (1.86e-2)"	"unprognostic (7.83e-2)"	"unprognostic (1.39e-2)"	"unprognostic (4.97e-2)"	"unprognostic (8.21e-2)"	"prognostic unfavorable (1.31e-9)"	"unprognostic (5.51e-2)"	"unprognostic (3.52e-1)"	"unprognostic (2.74e-2)"	"unprognostic (1.16e-1)"	14.4	14.9	19.2	11.9	20.4	17.1	14.6	20.0	28.0	14.6	17.8	16.4	14.4	19.1	9.4	12.7	17.3	6.7	10.8	18.6	18.9	16.5	33.7	17.5	13.1	19.7	19.6	10.9	13.1	19.8	20.1	9.4	19.3	16.4	15.1	4.9	11.6	8.9	12.8	14.4	19.3	16.1	20.3	27.1	15.8	19.5	20.0	14.9	10.6	11.2	11.1	13.1	11.7	20.9	40.0	34.0	28.0	21.2	25.1	21.4	29.6	38.7	31.4	30.4	29.1	30.6	29.2	49.9	15.4	33.9	21.9	37.7	31.2	35.3	30.6	53.6	40.6	43.8	27.5	87.0	31.5	58.9	24.0	25.6	15.1	30.2	31.1	27.9	34.1	51.5	56.0	19.8	44.3	42.2	39.8	43.1	46.9	80.0	47.4	48.8	35.1	41.1	32.2	30.7	16.6	36.4	32.4	39.2	30.8	46.3	21.7	99.3	34.5	19.2	33.2	18.2	49.0	14.9	22.4	37.9	46.7	19.6	33.3	11.3	8.7	3.2	8.7	7.9	8.1	11.7	7.4	6.6	20.3	14.2	6.9	7.9	0.4	10.0	9.2	17.5	5.4	8.2	19.2	20.4	20.0	28.0	18.6	18.9	19.7	19.6	19.3	20.3	20.0	20.9	7.7	12.8	15.6	45.7	27.1	11.5	10.0	8.8	15.9	7.2	12.5	8.5	6.5	11.5	16.4	5.5	6.2	21.7	17.1	15.4	21.5	10.0	21.2	6.4	12.5	11.1	9.0	43.7	48.3	8.2	19.1	12.6	21.4	9.8	21.5	25.1	5.3	33.7	21.8	1.7	40.8	16.7	16.2	16.1	20.7	25.6	7.2	25.5	16.0	36.5	15.9	14.5	12.3	60.8	80.7	10.3	14.4	11.3	14.4	10.8	13.0	12.9	16.1	9.3	6.6	11.9	12.5	38.3	27.4	20.9	10.4	11.8	13.4	18.8	19.7	9.1
CHD2	"DKFZp547I1315, DKFZp686E01200, DKFZp781D1727, FLJ38614"	ENSG00000173575	"Chromodomain helicase DNA binding protein 2"	O14647	15	92900189-93027996	"Disease related genes, Enzymes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Myogenesis, Transcription, Transcription regulation"	"Chromatin regulator, DNA-binding, Helicase, Hydrolase"	"Disease variant, Epilepsy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA060744, HPA060960"	Enhanced		Enhanced	Nucleoplasm		NA	NA			"Cluster 1: Neutrophils - Mixed function"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 44: Endometrium - Transcription"	Nucleoplasm		"HPA060744: AB_2684353, HPA060960: AB_2684398"	"unprognostic (1.65e-2)"	"unprognostic (2.43e-1)"	"unprognostic (2.14e-2)"	"unprognostic (5.98e-2)"	"unprognostic (2.12e-2)"	"unprognostic (3.10e-2)"	"unprognostic (2.67e-2)"	"unprognostic (7.85e-2)"	"unprognostic (7.51e-3)"	"unprognostic (1.14e-1)"	"unprognostic (2.84e-1)"	"unprognostic (1.79e-2)"	"unprognostic (4.64e-2)"	"unprognostic (1.16e-1)"	"unprognostic (1.58e-1)"	"unprognostic (3.15e-1)"	"unprognostic (1.70e-2)"	13.9	12.3	22.7	20.7	25.5	73.5	20.4	42.0	32.7	15.7	32.0	15.2	14.8	19.4	29.1	14.6	16.2	15.6	12.0	21.3	24.7	16.9	15.4	21.6	26.4	29.0	23.3	26.1	19.6	18.2	16.6	20.5	24.5	20.4	14.8	30.8	21.2	13.4	17.4	18.8	18.7	13.3	22.1	23.3	17.7	20.8	25.9	27.0	26.3	14.7	25.4	13.7	16.1	27.6	21.3	11.6	30.6	13.6	17.9	45.3	23.0	19.4	20.0	13.0	16.1	14.5	27.4	5.2	16.1	17.3	22.1	31.1	17.6	19.5	18.0	0.1	10.6	25.3	26.1	12.9	24.6	27.1	19.0	28.7	23.0	15.5	31.1	26.8	22.4	36.7	26.8	57.1	19.9	13.1	14.2	14.0	19.5	10.5	12.6	19.9	27.6	28.4	13.3	28.5	16.8	18.1	34.2	12.3	25.9	30.6	14.1	22.6	36.2	10.7	13.9	9.3	12.8	53.4	23.2	21.6	15.9	15.9	9.4	35.9	10.8	27.7	22.1	6.6	21.8	48.7	21.5	20.5	7.4	39.6	30.1	22.1	53.7	20.6	13.4	27.9	24.9	10.9	22.7	25.5	42.0	32.7	21.3	24.7	29.0	23.3	24.5	22.1	25.9	27.6	59.3	70.5	176.3	182.2	137.8	164.3	112.3	102.3	153.7	71.4	62.6	46.5	42.3	37.1	137.3	46.0	91.8	30.7	116.3	59.6	3.9	36.1	56.5	96.9	61.7	58.6	59.3	65.4	161.5	38.3	28.5	64.5	96.4	189.8	99.3	70.7	25.0	34.9	24.8	57.2	146.2	54.9	91.6	55.1	297.4	39.2	34.8	89.5	96.0	119.9	50.7	34.2	48.4	140.8	155.9	64.2	61.6	37.6	133.0	110.0	39.9	11.5	93.9	82.2	32.9	52.7	64.4	15.3	14.7	125.2	180.7	60.5	153.2	42.9	51.5	143.6
CHD3	"Mi-2a, Mi2-ALPHA, ZFH"	ENSG00000170004	"Chromodomain helicase DNA binding protein 3"	Q12873	17	7884796-7912760	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Chromatin regulator, DNA-binding, Helicase, Hydrolase"	"Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA043368, HPA076524"	Supported		Supported	"Nucleoplasm,Nucleoli,Centriolar satellite"		No	No			"Cluster 27: Non-specific - Gene expression"	"Cluster 51: Non-specific - Unknown function"	"Cluster 20: HeLa - Mitochondria"	"Cluster 44: Endometrium - Transcription"	"Nucleoplasm, Nucleoli"	"Centriolar satellite"	"HPA043368: AB_2678448, HPA076524: AB_2686804"	"unprognostic (1.77e-2)"	"unprognostic (8.01e-2)"	"prognostic unfavorable (2.43e-4)"	"prognostic favorable (7.68e-5)"	"unprognostic (1.53e-1)"	"unprognostic (8.11e-3)"	"unprognostic (2.54e-1)"	"unprognostic (1.11e-1)"	"unprognostic (2.83e-2)"	"unprognostic (5.25e-3)"	"prognostic favorable (8.36e-4)"	"unprognostic (9.11e-2)"	"unprognostic (8.31e-2)"	"unprognostic (3.98e-2)"	"unprognostic (1.50e-1)"	"unprognostic (8.90e-3)"	"unprognostic (2.20e-3)"	28.2	29.3	19.9	35.0	27.9	42.7	28.4	0.0	39.9	71.6	0.0	55.3	16.7	63.9	31.2	35.1	56.8	27.8	21.2	35.8	7.0	38.3	5.7	32.4	41.3	4.9	2.4	60.0	34.8	44.7	47.7	16.6	1.1	68.7	22.1	19.0	40.3	38.0	8.0	32.7	34.6	45.0	3.1	31.5	36.3	20.9	8.0	58.2	44.9	9.1	36.7	41.2	42.8	21.4	44.9	108.7	61.6	81.2	72.2	60.9	32.8	51.7	66.1	40.8	43.5	21.1	36.7	122.8	38.3	73.0	34.0	59.6	117.7	52.5	53.0	65.5	67.2	62.7	148.5	2.7	38.3	17.8	112.1	79.2	27.5	55.4	36.9	108.7	76.9	54.1	41.5	2.0	38.8	42.6	48.2	19.6	9.8	45.3	40.3	137.8	82.1	19.3	40.0	107.7	41.9	56.3	126.4	47.9	24.6	16.9	55.7	27.1	99.7	89.4	68.8	22.3	72.5	8.8	1.6	68.3	46.1	47.4	77.6	1.7	2.6	3.3	4.1	1.4	3.6	1.1	4.2	4.0	1.3	1.2	4.6	3.1	2.8	3.2	3.2	3.0	2.5	2.5	19.9	27.9	0.0	39.9	35.8	7.0	4.9	2.4	1.1	3.1	8.0	21.4	20.9	32.1	63.2	10.4	19.6	36.6	47.6	21.1	65.4	60.7	43.8	34.2	14.3	17.2	35.2	80.9	8.4	16.8	57.3	39.8	17.6	22.9	11.3	48.6	51.9	29.4	56.8	19.1	20.6	23.4	20.5	39.9	31.1	70.7	39.9	59.7	22.9	2.7	9.0	45.4	25.2	17.0	12.2	24.7	34.7	18.5	44.4	26.7	8.8	6.5	43.7	12.4	59.8	12.1	2.5	20.9	10.8	57.2	17.4	55.5	10.9	9.7	24.8	17.3	26.3	31.8	43.5	25.5	46.8	52.8	20.5	16.4	62.9	52.0	30.3	60.3
CHD4	"Mi-2b, Mi2-BETA"	ENSG00000111642	"Chromodomain helicase DNA binding protein 4"	Q14839	12	6570082-6614524	"Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Chromatin regulator, DNA-binding, Helicase, Hydrolase"	"Cancer-related genes, Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											HPA012008	Supported		Enhanced	Nucleoplasm		NA	NA			"Cluster 6: Non-specific - Transcription"	"Cluster 63: T-cells - Adaptive immune response"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 10: Non-specific - Unknown function"	Nucleoplasm		"HPA012008: AB_1846633"	"unprognostic (6.11e-2)"	"unprognostic (2.26e-2)"	"unprognostic (1.71e-2)"	"unprognostic (6.40e-3)"	"unprognostic (8.99e-2)"	"unprognostic (3.36e-3)"	"prognostic unfavorable (6.03e-6)"	"unprognostic (2.66e-2)"	"unprognostic (1.05e-1)"	"unprognostic (6.85e-2)"	"unprognostic (3.15e-1)"	"unprognostic (3.94e-1)"	"unprognostic (2.06e-1)"	"unprognostic (3.33e-1)"	"unprognostic (1.82e-1)"	"unprognostic (9.84e-2)"	"unprognostic (1.66e-1)"	34.5	45.6	22.9	38.6	30.7	44.4	31.9	24.6	30.1	39.4	20.6	45.7	26.5	47.8	44.9	35.4	37.7	31.1	41.4	19.7	26.1	39.3	31.6	35.3	46.3	27.3	29.2	40.9	37.7	58.3	33.5	42.2	28.0	28.4	35.4	44.9	33.8	44.1	50.0	45.8	35.5	49.9	22.6	39.0	38.5	34.2	29.6	90.7	54.6	38.7	56.6	42.2	34.4	27.4	86.7	79.7	187.6	72.1	76.6	84.7	110.4	92.9	93.4	102.3	93.5	130.6	66.6	184.9	36.0	107.5	66.1	76.0	179.1	104.5	135.7	139.9	92.7	258.5	122.0	83.3	67.1	207.2	119.1	82.9	51.7	99.1	68.7	128.2	122.2	101.6	209.0	91.0	98.7	111.8	196.6	67.8	184.7	82.5	72.7	166.4	114.9	103.6	64.2	101.6	88.8	114.6	121.1	136.0	92.9	205.4	61.3	121.3	114.4	103.4	217.4	76.3	111.5	144.0	91.8	230.2	68.7	125.8	79.5	12.3	6.8	8.7	9.3	7.7	9.6	8.8	8.4	9.3	6.9	11.3	10.6	10.3	10.8	12.2	8.0	14.4	15.9	5.6	22.9	30.7	24.6	30.1	19.7	26.1	27.3	29.2	28.0	22.6	29.6	27.4	68.2	60.9	119.7	56.2	82.8	68.6	47.4	42.4	76.2	109.9	77.5	61.2	132.9	58.6	67.2	88.3	70.9	48.2	106.0	58.1	13.7	84.6	76.4	128.1	153.3	78.9	97.1	64.4	26.1	71.9	46.1	67.7	47.9	123.7	85.9	73.0	56.0	69.2	69.0	139.7	21.4	66.6	54.9	51.9	78.3	59.1	65.9	68.9	48.0	25.3	66.7	71.4	56.7	24.6	55.5	95.8	36.4	74.4	69.0	49.4	45.8	38.3	82.1	57.8	52.6	112.1	98.1	102.6	111.6	78.9	67.6	68.0	85.1	83.7	72.1	47.4
CHD5		ENSG00000116254	"Chromodomain helicase DNA binding protein 5"	Q8TDI0	1	6101787-6180321	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Differentiation, Neurogenesis, Spermatogenesis, Transcription, Transcription regulation"	"Chromatin regulator, DNA-binding, Helicase, Hydrolase"	"Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	6	"brain: 59.0;pituitary gland: 57.3;testis: 31.8"	"Cell type enhanced"	"Detected in some"		"Bipolar cells: 84.3;Early spermatids: 217.8;Excitatory neurons: 80.4;Horizontal cells: 225.4;Inhibitory neurons: 56.2;Late spermatids: 113.2;Rod photoreceptor cells: 49.9"	"Cancer enhanced"	"Detected in single"		"glioma: 0.7"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"SCLC-21H: 12.9;U-2 OS: 5.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA015809			Supported	"Nucleoplasm,Nuclear speckles,Cytosol"		NA	NA				"Cluster 78: Testis - Spermatogenesis"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 62: Horizontal cells - Visual perception"	"Nucleoplasm, Nuclear speckles"	Cytosol	"HPA015809: "	"unprognostic (5.03e-4)"	"unprognostic (1.89e-1)"	"unprognostic (2.47e-3)"	"unprognostic (9.40e-6)"	"unprognostic (1.91e-2)"	"unprognostic (2.98e-2)"	"unprognostic (1.06e-1)"	"unprognostic (1.09e-1)"	"unprognostic (2.97e-2)"	"unprognostic (1.95e-2)"	"unprognostic (6.64e-4)"	"unprognostic (1.34e-1)"	"unprognostic (1.34e-4)"	"unprognostic (1.16e-1)"	"unprognostic (1.63e-1)"	"unprognostic (1.96e-1)"	"unprognostic (1.98e-1)"	0.2	4.1	31.8	0.2	40.1	0.0	0.1	0.0	59.0	0.4	0.0	1.1	0.2	0.4	0.0	0.3	0.4	0.1	0.4	34.3	13.6	2.4	0.1	0.3	0.0	3.9	11.1	0.5	0.4	0.9	57.3	0.0	4.4	0.9	0.2	7.9	0.2	2.2	0.2	0.3	0.4	0.1	0.9	0.1	1.0	31.8	10.2	0.3	0.1	0.0	0.0	0.7	0.6	31.1	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.5	0.6	0.0	0.1	0.1	0.1	0.0	0.0	0.1	0.1	2.0	0.0	0.0	0.0	0.1	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.4	0.2	1.2	0.0	0.1	0.2	1.1	0.0	0.0	0.0	0.0	12.9	0.2	0.1	0.0	0.0	0.0	2.3	0.0	0.0	0.1	5.7	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	31.8	40.1	0.0	59.0	34.3	13.6	3.9	11.1	4.4	0.9	10.2	31.1	0.0	0.0	0.0	5.5	0.1	0.1	0.1	0.0	0.0	84.3	0.1	0.3	2.1	0.0	0.0	3.7	12.5	0.0	0.1	0.2	0.0	0.0	217.8	0.0	0.2	0.6	0.0	0.0	80.4	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	225.4	56.2	0.0	0.0	0.0	0.3	113.2	0.9	0.1	0.0	2.8	0.0	2.0	0.0	4.5	3.7	0.3	0.0	0.4	0.0	0.2	0.0	0.1	0.0	49.9	0.0	0.2	0.5	4.5	17.8	0.0	0.4	0.0	0.1	0.1	0.0	0.0
CHD6	"CHD5, dJ620E11.1, FLJ22369, KIAA1335, RIGB"	ENSG00000124177	"Chromodomain helicase DNA binding protein 6"	Q8TD26	20	41402083-41618384	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Host-virus interaction, Transcription, Transcription regulation"	"Chromatin regulator, DNA-binding, Helicase, Hydrolase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA015543			Supported	Nucleoplasm		NA	NA			"Cluster 6: Non-specific - Transcription"	"Cluster 21: Non-specific - Transcription"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 52: Non-specific - Transcription"	Nucleoplasm		"HPA015543: "	"unprognostic (5.13e-3)"	"unprognostic (1.85e-1)"	"unprognostic (1.17e-1)"	"unprognostic (1.27e-1)"	"unprognostic (6.66e-2)"	"unprognostic (1.36e-1)"	"unprognostic (4.72e-3)"	"prognostic favorable (3.42e-4)"	"unprognostic (1.17e-1)"	"unprognostic (3.17e-1)"	"unprognostic (4.75e-2)"	"unprognostic (1.14e-1)"	"unprognostic (2.12e-3)"	"unprognostic (6.66e-2)"	"unprognostic (3.41e-1)"	"unprognostic (1.00e-1)"	"unprognostic (1.14e-2)"	7.2	7.7	10.2	6.9	11.4	13.5	12.4	17.5	13.0	9.5	6.0	7.1	4.0	12.7	12.4	6.1	10.0	7.2	8.0	8.5	13.1	7.2	6.8	7.5	8.4	11.7	10.9	16.2	8.1	16.2	7.9	8.4	14.2	12.2	6.1	15.7	8.4	9.3	5.5	8.7	6.1	8.9	7.3	8.2	7.4	7.1	11.0	17.2	13.6	7.8	8.2	8.1	8.8	12.9	8.4	9.8	20.6	9.2	11.5	11.7	13.3	7.2	14.8	12.6	15.2	13.5	6.7	10.0	12.7	12.4	14.2	12.2	12.9	12.4	14.3	3.2	6.3	13.7	9.1	13.2	6.5	10.9	6.6	11.8	11.3	9.2	10.1	13.5	11.0	13.7	11.0	10.4	9.9	23.3	17.3	11.8	6.8	5.2	16.5	13.2	24.2	7.1	7.9	19.3	18.6	12.8	22.1	5.8	14.2	14.9	9.9	8.1	12.7	19.8	9.6	10.0	6.3	9.9	8.6	12.8	8.7	5.2	6.2	20.2	6.0	7.5	8.1	6.1	8.2	8.5	7.0	6.9	5.2	10.6	9.4	8.0	0.9	10.2	10.0	11.4	6.0	2.4	10.2	11.4	17.5	13.0	8.5	13.1	11.7	10.9	14.2	7.3	11.0	12.9	42.2	48.1	30.8	148.2	42.8	18.1	38.6	30.3	37.0	140.4	39.5	34.7	56.6	30.0	34.4	22.0	93.8	34.2	53.3	14.5	21.5	24.4	14.5	50.3	65.3	36.5	60.6	19.6	143.2	15.8	28.2	33.8	19.9	76.0	21.5	65.1	34.2	21.1	16.5	151.4	179.0	35.9	42.7	27.7	44.7	20.3	49.7	27.5	17.8	87.1	40.8	62.2	39.1	182.9	160.6	15.4	16.0	45.5	32.3	30.3	4.1	13.9	35.6	133.8	19.7	71.0	44.4	20.6	61.9	21.8	17.2	32.7	45.5	40.4	24.5	32.9
CHD7	"CRG, FLJ20357, FLJ20361, KIAA1416"	ENSG00000171316	"Chromodomain helicase DNA binding protein 7"	Q9P2D1	8	60678740-60868028	"Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"rRNA processing, Transcription, Transcription regulation"	"Chromatin regulator, DNA-binding, Helicase, Hydrolase"	"Cancer-related genes, Disease variant, Hypogonadotropic hypogonadism, Kallmann syndrome"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 71.5"	"Cell type enhanced"	"Detected in many"		"Cone photoreceptor cells: 241.8;Oligodendrocyte precursor cells: 298.6;Oligodendrocytes: 255.7;Rod photoreceptor cells: 198.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Group enriched"	"Detected in many"	15	"B-cells: 14.9;granulocytes: 17.6;T-cells: 6.6"	"Cell line enhanced"	"Detected in many"		"AF22: 51.5;SCLC-21H: 46.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA053075			Supported	Nucleoplasm,Nucleoli		NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 69: Cerebellum - Gene expression regulation"	"Cluster 12: NES - Nervous system development"	"Cluster 9: Photoreceptor cells - Phototransduction"	Nucleoplasm	Nucleoli	"HPA053075: AB_2682035"	"unprognostic (3.77e-2)"	"unprognostic (3.28e-3)"	"unprognostic (3.17e-2)"	"prognostic unfavorable (5.34e-5)"	"unprognostic (9.59e-2)"	"unprognostic (1.14e-1)"	"unprognostic (1.86e-3)"	"unprognostic (3.41e-2)"	"unprognostic (3.06e-1)"	"unprognostic (2.73e-1)"	"unprognostic (2.46e-1)"	"unprognostic (1.33e-1)"	"unprognostic (9.09e-2)"	"unprognostic (9.21e-2)"	"unprognostic (1.75e-1)"	"unprognostic (8.20e-2)"	"unprognostic (2.17e-1)"	3.6	1.9	10.3	3.9	17.2	22.1	3.5	71.5	11.0	2.0	2.5	4.6	4.6	2.2	2.2	4.9	2.3	1.9	3.8	9.4	11.5	3.8	3.2	4.6	5.8	19.7	17.2	1.0	4.4	5.3	6.1	4.3	18.8	2.7	4.0	23.7	3.9	1.7	10.4	5.2	6.4	1.7	11.4	5.6	3.5	2.9	15.6	2.6	4.1	4.1	5.7	3.4	3.2	17.7	8.0	4.0	51.5	9.2	0.1	0.0	16.2	0.4	0.1	1.8	1.6	10.0	7.3	15.5	0.9	0.1	2.3	4.8	26.7	7.9	1.6	5.9	14.3	36.5	7.0	13.2	2.1	11.1	6.5	1.0	5.9	0.0	8.5	3.1	7.7	12.5	2.7	13.4	1.2	8.3	17.5	12.7	35.4	8.1	1.8	36.0	12.1	5.0	4.1	9.1	46.9	23.2	1.4	5.9	14.9	18.0	10.5	10.5	9.0	0.5	8.3	0.5	4.3	14.2	8.7	23.7	3.0	1.2	13.4	14.9	0.4	17.6	3.2	0.2	4.1	10.1	3.6	1.1	0.1	14.9	6.6	2.4	9.3	0.0	0.8	0.8	0.3	0.6	10.3	17.2	71.5	11.0	9.4	11.5	19.7	17.2	18.8	11.4	15.6	17.7	35.9	32.1	17.5	68.6	64.3	30.3	35.9	10.8	9.6	36.3	16.6	14.6	35.8	27.1	20.7	16.5	241.8	8.2	17.4	31.8	1.9	17.7	15.9	34.0	4.1	40.5	87.3	3.8	6.8	11.3	8.6	6.4	28.5	37.6	41.0	39.8	21.4	12.6	14.9	70.7	17.8	39.9	32.6	10.8	10.4	8.9	0.9	13.6	21.4	118.0	13.9	121.3	15.5	298.6	255.7	16.9	27.4	0.4	29.1	42.9	17.4	5.4	20.4	198.5	0.0	49.7	9.8	8.0	12.9	25.5	32.4	6.2	21.4	3.0	34.1	35.8
CHD8	"DUPLIN, HELSNF1, KIAA1564"	ENSG00000100888	"Chromodomain helicase DNA binding protein 8"	Q9HCK8	14	21385194-21456126	"Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Transcription, Transcription regulation, Wnt signaling pathway"	"Activator, Chromatin regulator, DNA-binding, Helicase, Hydrolase, Repressor"	"Autism, Autism spectrum disorder, Cancer-related genes, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA052186, HPA076133"			Enhanced	Nucleoplasm		NA	NA			"Cluster 19: B-cells - Humoral immune response"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 52: Non-specific - Transcription"	Nucleoplasm		"HPA052186: AB_2681754, HPA076133: "	"unprognostic (3.45e-1)"	"unprognostic (9.71e-2)"	"unprognostic (3.31e-1)"	"unprognostic (2.67e-1)"	"unprognostic (1.14e-1)"	"unprognostic (3.43e-1)"	"prognostic unfavorable (4.94e-4)"	"unprognostic (7.31e-2)"	"unprognostic (9.22e-2)"	"prognostic favorable (8.35e-4)"	"unprognostic (1.64e-1)"	"unprognostic (2.63e-2)"	"unprognostic (2.54e-3)"	"unprognostic (2.88e-1)"	"unprognostic (9.24e-2)"	"unprognostic (2.51e-1)"	"unprognostic (8.07e-3)"	12.5	11.9	11.2	13.5	12.5	35.3	14.8	16.3	13.2	12.4	10.5	14.0	9.4	14.8	11.1	14.9	12.9	10.1	12.0	11.1	12.2	11.7	9.6	13.7	18.0	11.4	11.6	17.1	13.6	22.3	13.1	11.7	11.1	13.2	12.3	14.8	13.6	12.1	15.7	22.3	14.7	14.8	11.5	15.8	14.2	12.9	12.5	25.4	14.8	12.7	17.5	12.8	12.9	13.6	31.2	39.6	43.6	20.7	27.7	23.6	24.9	24.4	28.4	36.5	35.4	35.0	26.3	51.4	14.8	33.1	28.4	37.2	54.9	35.1	46.0	39.3	24.2	46.3	27.6	43.5	25.7	64.6	40.4	32.8	27.2	40.9	29.7	28.6	33.4	40.2	32.4	26.7	28.0	33.9	46.1	26.0	33.4	30.9	34.3	42.0	32.9	17.4	27.3	57.9	30.9	30.7	37.5	29.8	21.8	39.7	20.7	30.5	36.4	29.2	23.0	17.8	29.1	30.3	38.4	50.3	12.1	23.2	29.6	9.1	3.8	9.8	5.5	3.8	6.4	4.2	4.9	5.6	2.7	11.2	5.0	4.4	7.9	7.8	6.7	6.1	4.7	2.7	11.2	12.5	16.3	13.2	11.1	12.2	11.4	11.6	11.1	11.5	12.5	13.6	27.6	38.5	56.3	27.4	32.2	12.6	11.3	15.9	23.3	33.3	21.9	22.6	19.6	24.3	32.6	33.1	27.1	14.7	40.0	16.8	1.9	21.8	3.4	32.5	37.9	25.5	27.1	27.8	41.0	23.6	12.3	24.0	27.5	39.5	28.4	41.7	13.9	14.9	17.5	23.5	40.2	16.0	8.2	20.1	9.3	4.1	16.1	25.3	10.6	20.6	27.1	18.9	32.0	29.7	33.1	26.5	13.9	17.7	32.4	16.1	12.0	7.4	28.8	24.3	0.0	32.1	26.2	29.2	25.1	24.6	16.6	12.3	31.4	34.1	16.8	12.7
CHD9	"BC022889, FLJ12178, KIAA0308"	ENSG00000177200	"Chromodomain helicase DNA binding protein 9"	Q3L8U1	16	53055033-53329150	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Chromatin regulator, DNA-binding, Helicase, Hydrolase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Cone photoreceptor cells: 502.5;Rod photoreceptor cells: 766.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA042053, HPA049420, HPA066155"	Approved		Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 6: Non-specific - Transcription"	"Cluster 69: Cerebellum - Gene expression regulation"	"Cluster 14: REH - Unknown function"	"Cluster 46: Photoreceptor cells - Phototransduction"	Nucleoplasm	Cytosol	"HPA042053: AB_2677823, HPA049420: AB_2680758, HPA066155: "	"unprognostic (3.57e-2)"	"unprognostic (3.73e-2)"	"unprognostic (3.44e-3)"	"unprognostic (2.42e-1)"	"unprognostic (4.34e-2)"	"unprognostic (4.35e-2)"	"unprognostic (1.24e-1)"	"unprognostic (1.68e-1)"	"unprognostic (7.75e-3)"	"unprognostic (2.87e-2)"	"unprognostic (3.39e-1)"	"unprognostic (2.35e-2)"	"prognostic favorable (1.84e-4)"	"unprognostic (4.96e-2)"	"unprognostic (1.74e-1)"	"unprognostic (5.09e-2)"	"unprognostic (2.87e-1)"	7.4	6.6	13.6	6.0	19.3	21.7	11.5	31.1	9.4	10.1	2.1	8.1	5.4	9.7	6.2	7.7	9.0	8.1	7.1	6.4	17.1	11.1	6.9	7.0	6.9	13.3	17.1	12.7	6.4	10.2	5.0	8.7	16.9	8.4	7.8	28.9	8.5	8.7	7.2	6.3	5.7	7.9	10.1	7.7	9.6	4.9	14.2	9.9	12.2	12.8	6.7	7.1	6.2	17.6	10.4	12.0	25.0	20.8	20.0	28.6	4.4	18.0	13.8	9.9	4.3	6.8	9.1	14.0	11.3	16.8	6.9	12.5	14.0	10.4	14.0	5.0	10.2	18.4	12.0	4.6	13.5	25.3	15.8	19.9	9.5	15.2	18.3	12.9	14.7	8.3	22.2	4.5	13.0	4.2	13.1	5.9	9.6	3.1	8.7	46.2	28.8	5.8	6.4	9.7	10.4	11.7	16.6	5.4	12.3	9.7	6.0	12.0	28.3	18.1	8.9	6.6	12.0	13.1	9.7	21.9	13.2	11.3	17.9	102.0	25.5	27.5	15.7	21.9	24.5	38.9	10.7	17.6	16.2	46.6	8.5	12.0	8.6	38.3	39.4	126.7	6.1	5.4	13.6	19.3	31.1	9.4	6.4	17.1	13.3	17.1	16.9	10.1	14.2	17.6	146.3	70.5	74.7	426.4	111.5	57.2	123.4	107.7	96.8	318.9	81.3	89.9	39.0	55.8	81.5	90.1	502.5	17.4	112.1	80.8	46.9	60.4	16.4	71.8	109.3	97.5	87.6	67.7	272.9	36.7	31.2	117.2	109.1	69.9	96.7	121.8	107.4	66.4	69.0	220.4	297.3	89.7	69.2	67.8	50.7	19.1	108.4	88.6	67.6	319.5	89.3	153.3	98.9	462.4	312.0	39.0	100.5	123.4	70.3	98.2	76.1	60.8	72.3	766.6	59.2	157.2	106.1	105.7	50.9	75.4	75.0	24.9	60.5	89.3	72.1	83.4
CHIA	"AMCase, CHIT2, TSA1902"	ENSG00000134216	"Chitinase acidic"	Q9BZP6	1	111290851-111320566	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Apoptosis, Carbohydrate metabolism, Chitin degradation, Immunity, Inflammatory response, Polysaccharide degradation"	"Glycosidase, Hydrolase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	31	"stomach 1: 327.5"	"Cell type enriched"	"Detected in some"	5	"Alveolar cells type 2: 34.6"	"Group enriched"	"Detected in some"	4	"lung cancer: 1.8;stomach cancer: 2.0;thyroid cancer: 0.5"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"ASC diff: 1.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA059193	Approved				"Intracellular and membrane"	NA	NA			"Cluster 21: B-cells - Adaptive immune response"	"Cluster 4: Stomach - Digestion"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 11: Alveolar cells - Smell perception"			"HPA059193: AB_2683942"				"unprognostic (8.00e-2)"	"unprognostic (7.08e-2)"			"unprognostic (2.02e-2)"					"unprognostic (4.99e-2)"	"unprognostic (7.93e-2)"	"unprognostic (1.46e-1)"	"unprognostic (1.06e-2)"		0.3	0.2	0.1	0.0	0.2	0.0	0.1	0.1	0.3	0.2	0.0	0.0	0.0	0.6	0.5	1.6	0.3	0.0	0.1	0.1	0.1	0.1	0.2	10.6	0.3	0.2	0.1	0.1	0.2	2.0	1.9	0.0	0.1	0.0	0.0	0.0	0.1	0.5	0.0	0.1	0.0	0.0	0.1	0.0	327.5	0.5	0.1	0.0	0.5	0.0	0.2	0.0	0.0	0.2	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.1	0.3	0.1	0.1	0.2	0.1	0.1	0.1	0.1	0.2	0.0	0.0	34.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	2.7	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.6	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.6	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.6	0.0	0.0
CHIT1	"CHI3, CHIT"	ENSG00000133063	"Chitinase 1"	Q13231	1	203212827-203273641	"Candidate cardiovascular disease genes, Enzymes, Metabolic proteins, Plasma proteins, Predicted secreted proteins"	"Carbohydrate metabolism, Chitin degradation, Polysaccharide degradation"	"Glycosidase, Hydrolase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 49.8;lung: 36.4;lymphoid tissue: 21.7"	"Cell type enriched"	"Detected in some"	10	"Hofbauer cells: 40.6"	"Cancer enhanced"	"Detected in many"		"testis cancer: 31.9"	"Region enriched"	"Detected in some"	6	"cerebral cortex: 12.4"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA010575, HPA074844"	Enhanced				"Secreted to blood"	NA	NA	26400000	57000000	"Cluster 1: Neutrophils - Mixed function"	"Cluster 40: Neutrophils - Inflammatory response"		"Cluster 4: Macrophages - Innate immune response"			"HPA010575: AB_1078512, HPA074844: "	"unprognostic (5.80e-3)"	"prognostic favorable (2.02e-4)"	"unprognostic (2.58e-2)"	"unprognostic (2.19e-1)"	"unprognostic (7.87e-2)"	"unprognostic (2.28e-2)"	"unprognostic (7.55e-2)"	"unprognostic (6.36e-3)"	"unprognostic (1.17e-1)"	"unprognostic (3.25e-2)"	"unprognostic (1.38e-1)"	"unprognostic (1.03e-1)"	"unprognostic (1.56e-3)"	"unprognostic (3.37e-1)"	"unprognostic (1.52e-1)"	"unprognostic (1.06e-1)"	"unprognostic (2.95e-1)"	13.6	0.3	0.2	0.4	0.2	49.8	8.3	0.0	12.4	8.1	0.0	1.2	0.0	3.6	0.1	0.0	0.1	0.4	0.2	0.2	0.0	0.1	0.7	36.4	21.7	0.4	0.2	0.5	2.1	0.0	0.0	0.7	1.3	1.0	1.0	0.0	0.4	0.0	0.2	0.4	0.8	0.0	0.4	5.7	0.5	0.0	0.3	3.4	1.3	0.0	1.1	0.1	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.2	0.0	0.0	0.4	0.2	0.2	0.0	12.4	0.2	0.0	0.4	0.2	1.3	0.4	0.3	2.2	0.0	0.0	0.0	0.0	1.0	0.0	0.1	0.2	0.0	0.0	0.2	0.3	0.8	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.1	0.0	0.5	0.4	0.0	0.1	0.0	0.0	0.0	0.0	40.6	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	3.9	0.0	0.0	0.6	0.0	0.0	0.5	0.1	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.3	0.1	0.1	0.0	0.0
CLPP		ENSG00000125656	"Caseinolytic mitochondrial matrix peptidase proteolytic subunit"	Q16740	19	6361531-6370242	"Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins"		"Hydrolase, Protease, Serine protease"	"Deafness, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Late spermatids: 229.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA010649	Supported		Supported	Mitochondria		NA	NA		8500	"Cluster 20: T-cells - T-cell receptor"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 10: Non-specific - Unknown function"	Mitochondria		"HPA010649: AB_1078538"	"unprognostic (2.28e-1)"	"unprognostic (7.14e-2)"	"unprognostic (2.82e-1)"	"unprognostic (4.34e-2)"	"unprognostic (2.17e-2)"	"unprognostic (1.15e-2)"	"unprognostic (6.17e-3)"	"unprognostic (7.43e-2)"	"unprognostic (2.76e-1)"	"unprognostic (1.31e-1)"	"prognostic favorable (6.50e-4)"	"unprognostic (1.21e-1)"	"unprognostic (5.65e-2)"	"unprognostic (6.97e-2)"	"unprognostic (1.83e-1)"	"unprognostic (1.03e-1)"	"unprognostic (5.86e-3)"	48.6	65.8	52.0	41.5	51.5	42.9	45.1	52.2	63.8	39.1	58.0	46.6	47.4	41.1	17.8	56.1	40.1	20.8	78.0	50.9	52.7	60.5	90.7	39.7	47.7	52.8	52.4	38.5	53.6	36.6	44.5	25.4	49.5	41.0	22.9	15.6	48.3	31.2	146.8	47.5	43.6	25.1	51.8	45.6	55.6	45.2	54.5	45.2	36.1	59.3	35.6	44.6	37.9	53.9	146.7	98.2	61.2	113.9	38.7	54.8	62.4	76.9	59.5	112.2	102.5	87.2	48.9	124.1	122.8	61.3	61.1	83.1	63.5	109.1	38.5	133.8	189.3	95.8	82.2	122.9	106.6	90.7	129.8	73.4	74.4	78.9	82.9	69.7	113.9	188.5	97.5	174.5	72.3	192.8	153.1	104.5	93.2	100.6	207.8	108.6	73.2	206.2	81.2	79.4	99.3	95.9	48.9	123.8	133.0	36.7	67.3	130.6	76.9	70.5	69.7	180.7	156.0	235.4	225.3	137.2	103.5	132.9	117.3	29.4	82.6	47.8	112.0	79.6	133.5	119.5	159.4	139.6	102.4	131.5	138.4	137.4	62.1	126.5	55.5	155.5	207.2	162.6	52.0	51.5	52.2	63.8	50.9	52.7	52.8	52.4	49.5	51.8	54.5	53.9	39.6	22.4	35.2	8.1	45.9	44.9	59.5	90.8	38.1	31.0	47.6	57.9	45.8	55.8	46.2	44.1	12.5	72.2	43.7	56.0	144.8	88.8	105.5	27.6	43.1	51.6	35.3	54.9	5.4	96.6	113.6	42.4	36.2	35.0	26.0	63.1	61.8	89.6	81.3	21.9	7.5	50.9	54.9	38.9	35.0	229.8	42.6	38.7	55.2	4.7	70.6	46.6	46.4	4.5	9.5	101.9	67.7	43.2	82.4	89.5	110.9	189.0	44.5	24.6	13.1	30.0	79.9	67.7	48.1	56.5	37.1	57.7	65.3	95.1	65.4	65.4
CLYBL	CLB	ENSG00000125246	"Citramalyl-CoA lyase"	Q8N0X4	13	99606669-99897134	"Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins"		"Hydrolase, Lyase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 109.7"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 84.9;Distal tubular cells: 138.9;Hepatocytes: 84.1;Proximal tubular cells: 144.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"OE19: 56.1;SCLC-21H: 53.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039959, HPA040691"	Enhanced					NA	NA		7300	"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"			"HPA039959: AB_10793857, HPA040691: AB_10794746"	"unprognostic (1.25e-2)"	"unprognostic (1.94e-1)"	"unprognostic (2.30e-3)"	"unprognostic (7.57e-3)"	"unprognostic (3.69e-1)"	"unprognostic (2.90e-2)"	"unprognostic (1.57e-3)"	"unprognostic (2.91e-1)"	"unprognostic (2.10e-1)"	"unprognostic (2.34e-1)"	"unprognostic (2.49e-2)"	"unprognostic (2.85e-1)"	"prognostic favorable (6.66e-16)"	"unprognostic (3.74e-2)"	"unprognostic (5.41e-2)"	"unprognostic (4.78e-2)"	"unprognostic (7.82e-2)"	7.1	16.2	11.4	5.5	11.8	5.1	10.5	24.4	12.7	7.7	35.3	20.6	25.0	6.5	13.0	11.3	7.9	6.9	22.6	12.6	8.6	66.0	109.7	5.6	10.4	9.1	9.0	5.7	9.8	14.4	6.7	3.7	7.3	6.9	21.9	7.3	12.3	8.9	43.3	9.3	23.5	6.4	5.6	8.6	8.7	9.3	10.7	5.8	12.3	69.5	10.8	7.4	6.9	8.8	0.4	2.3	16.6	7.5	7.6	7.0	3.6	0.8	1.6	1.4	2.6	0.3	12.4	3.0	4.8	1.0	3.2	3.9	1.5	2.8	1.8	15.3	2.4	19.2	4.9	11.8	5.2	10.4	1.3	3.8	8.3	0.2	6.4	1.6	2.2	15.7	2.7	9.8	1.6	4.3	4.7	14.3	10.8	56.1	3.4	6.0	0.7	7.1	16.6	1.1	53.1	8.1	3.4	3.8	3.6	5.9	8.0	13.2	0.3	0.7	1.9	1.4	2.7	22.3	4.7	0.6	11.3	14.9	2.3	1.7	4.5	0.5	9.9	10.0	12.0	14.5	17.4	13.9	9.4	15.7	13.3	15.8	0.6	14.2	4.8	10.3	24.2	7.7	11.4	11.8	24.4	12.7	12.6	8.6	9.1	9.0	7.3	5.6	10.7	8.8	7.4	6.4	5.0	84.9	8.6	5.5	9.1	18.4	8.6	2.3	8.9	11.3	36.1	21.5	10.9	14.7	2.1	14.3	9.2	17.9	138.9	11.6	1.6	6.1	4.1	6.2	1.2	2.5	30.6	8.1	3.2	5.9	5.6	4.4	6.3	7.1	4.6	84.1	7.6	0.0	25.6	11.5	10.2	6.7	4.5	4.8	2.1	5.4	16.0	48.7	4.4	6.5	7.2	21.6	9.5	4.0	13.8	4.1	3.8	4.3	23.1	144.7	4.1	5.0	0.0	7.6	18.1	3.0	10.5	6.9	6.3	7.4	8.3	13.6	19.1	6.7
CMA1		ENSG00000092009	"Chymase 1"	P23946	14	24505353-24508265	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"		"Hydrolase, Protease, Serine protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"breast: 18.5"	"Cell type enriched"	"Detected in some"	28	"granulocytes: 53.8"	"Low cancer specificity"	"Detected in some"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"CAB000363, HPA052634"	Enhanced		Supported	"Cytosol,Cytoplasmic bodies"	"Secreted to blood"	NA	NA	3000000		"Cluster 35: T-regs - Unknown function"	"Cluster 46: Fibroblasts - ECM organization"		"Cluster 60: Granulocytes - Receptor signaling"	"Cytoplasmic bodies"	Cytosol	"CAB000363: AB_2083616, HPA052634: AB_2681892"	"unprognostic (1.37e-1)"	"unprognostic (2.27e-3)"	"unprognostic (2.04e-1)"			"unprognostic (7.07e-3)"	"unprognostic (1.48e-2)"	"unprognostic (1.19e-1)"	"unprognostic (5.79e-2)"	"unprognostic (2.21e-1)"	"unprognostic (8.91e-3)"	"unprognostic (4.19e-3)"	"unprognostic (1.29e-4)"	"unprognostic (2.52e-3)"	"unprognostic (7.78e-2)"	"unprognostic (7.37e-2)"	"unprognostic (4.98e-3)"	9.0	0.0	0.2	3.7	0.1	0.2	18.5	0.0	0.2	4.6	0.3	8.7	0.6	3.1	4.3	10.2	0.9	7.3	1.6	0.1	0.2	0.2	0.5	1.5	1.8	0.5	0.3	0.1	1.6	0.6	0.2	0.1	0.3	1.0	8.3	0.0	4.7	1.3	0.9	9.0	5.8	2.2	0.3	0.2	1.5	0.9	0.2	3.0	0.4	3.0	2.4	11.1	0.9	0.2	0.0	0.0	0.3	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.2	0.2	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.1	0.5	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.1	0.0	0.2	0.1	0.2	0.5	0.3	0.3	0.3	0.2	0.2	0.0	0.0	1.9	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	53.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.1	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.4	0.0	0.7	0.0	0.1	0.0
CNDP1	"CN1, CPGL2, HsT2308, MGC10825"	ENSG00000150656	"Carnosine dipeptidase 1"	Q96KN2	18	74534500-74587212	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"		"Carboxypeptidase, Hydrolase, Metalloprotease, Protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	7	"brain: 85.6"	"Cell type enriched"	"Detected in some"	10	"Oligodendrocytes: 361.7"	"Cancer enhanced"	"Detected in some"		"glioma: 4.4"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	38	"U-266/84: 15.4"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA008933, HPA073283"	Enhanced				"Secreted to blood"	NA	NA		2100000000		"Cluster 70: Brain - Nervous system development"	"Cluster 16: U-266 - Nucleosome"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"			"HPA008933: AB_1847033, HPA073283: "	"unprognostic (7.43e-3)"	"unprognostic (6.00e-2)"	"unprognostic (8.55e-3)"	"unprognostic (3.93e-1)"	"unprognostic (1.32e-1)"	"unprognostic (2.17e-2)"	"unprognostic (8.04e-3)"	"unprognostic (1.12e-2)"	"unprognostic (2.81e-1)"	"unprognostic (1.16e-1)"	"unprognostic (1.16e-1)"	"unprognostic (1.66e-1)"	"unprognostic (6.90e-3)"	"unprognostic (1.14e-1)"	"unprognostic (3.30e-2)"	"unprognostic (1.33e-1)"	"unprognostic (1.28e-1)"	0.0	0.0	27.4	0.0	74.2	0.1	0.0	80.4	39.0	0.0	6.0	0.0	1.3	0.0	0.7	0.0	0.0	0.1	0.0	30.5	51.3	0.5	12.9	0.0	0.0	85.6	76.9	0.0	0.0	0.0	0.2	0.0	74.3	0.1	0.0	0.1	0.0	0.1	1.4	0.1	0.2	0.0	39.7	0.0	0.0	0.3	74.9	0.0	0.2	0.0	0.0	0.0	0.0	80.7	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	15.4	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	27.4	74.2	80.4	39.0	30.5	51.3	85.6	76.9	74.3	39.7	74.9	80.7	0.2	0.0	0.0	0.3	0.2	0.1	0.4	0.2	0.0	0.6	0.5	0.3	0.7	0.0	0.1	0.0	0.0	0.1	0.0	0.1	0.0	0.1	8.6	0.5	0.2	0.2	0.0	2.7	1.2	0.2	0.0	0.3	0.0	1.5	0.0	0.2	0.7	35.1	0.1	0.0	1.5	0.7	0.0	1.2	1.1	3.1	0.0	0.2	0.0	1.0	0.0	0.5	0.0	3.0	361.7	0.2	0.1	0.0	0.0	0.4	0.4	24.5	0.0	1.0	0.0	0.6	0.2	1.0	0.4	0.0	0.3	0.0	0.4	0.0	0.5	0.2
CNDP2	"CN2, CPGL, FLJ10830, HsT2298, PEPA"	ENSG00000133313	"Carnosine dipeptidase 2"	Q96KP4	18	74495816-74523454	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"		"Carboxypeptidase, Hydrolase, Metalloprotease, Protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Glandular and luminal cells: 334.7;Proximal enterocytes: 629.1;Proximal tubular cells: 487.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"Karpas-707: 458.7;RPMI-8226: 616.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB026196, HPA036898, HPA036899"	Enhanced		Enhanced	Nucleoplasm,Cytosol		NA	NA		2600000	"Cluster 27: Non-specific - Gene expression"	"Cluster 87: Intestine & Kidney - Transmembrane transport"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	"Nucleoplasm, Cytosol"		"CAB026196: , HPA036898: AB_2675370, HPA036899: AB_2675371"	"unprognostic (2.81e-2)"	"unprognostic (9.96e-2)"	"unprognostic (3.28e-1)"	"unprognostic (1.19e-3)"	"unprognostic (2.57e-2)"	"unprognostic (5.06e-2)"	"unprognostic (2.84e-2)"	"unprognostic (5.35e-2)"	"unprognostic (1.49e-1)"	"unprognostic (9.31e-2)"	"unprognostic (1.56e-3)"	"unprognostic (1.15e-1)"	"prognostic favorable (3.50e-6)"	"unprognostic (2.37e-3)"	"unprognostic (4.65e-3)"	"unprognostic (1.51e-1)"	"unprognostic (1.34e-1)"	54.8	40.7	125.3	75.0	147.0	25.1	60.4	139.4	156.9	136.8	113.0	83.6	190.1	44.2	122.8	78.4	140.8	94.4	63.7	123.7	133.2	327.3	261.1	82.3	86.3	143.1	137.4	34.4	100.7	58.5	48.0	75.4	144.7	122.5	79.5	42.1	57.4	101.7	26.6	47.0	255.0	37.9	140.4	137.0	103.5	20.9	143.9	52.5	159.1	22.4	82.2	94.5	47.4	157.6	64.6	85.0	60.5	57.4	72.2	42.5	252.3	66.0	61.7	88.3	87.4	49.6	67.1	80.3	81.4	72.1	69.0	95.0	92.7	124.9	62.7	121.3	36.7	80.2	42.1	79.6	104.6	158.7	119.3	64.5	93.9	76.4	136.6	50.1	78.3	94.6	86.3	458.7	59.1	71.6	84.9	75.6	91.0	42.4	50.3	91.3	69.4	616.6	346.1	264.1	65.3	34.2	51.6	360.2	91.6	143.0	151.5	64.0	82.5	93.9	79.5	21.2	45.2	85.5	380.6	108.1	63.6	113.8	80.2	37.1	115.4	49.0	77.6	166.3	84.4	102.4	61.6	72.2	185.1	110.5	65.5	72.4	15.9	124.6	174.1	161.3	94.5	135.7	125.3	147.0	139.4	156.9	123.7	133.2	143.1	137.4	144.7	140.4	143.9	157.6	39.2	73.7	62.7	16.6	55.7	9.2	40.3	48.6	12.5	33.6	76.5	36.4	26.9	77.2	56.8	119.5	16.7	157.9	47.8	99.0	187.9	168.1	3.3	187.7	49.7	49.6	65.3	23.3	8.8	154.7	130.9	23.5	63.7	334.7	12.0	34.0	40.0	119.8	216.3	43.7	10.8	82.9	75.3	122.9	24.9	4.1	18.6	79.0	17.8	13.1	90.8	86.6	55.6	15.6	51.7	108.9	103.5	16.6	44.4	65.2	629.1	487.6	73.3	31.6	13.1	15.2	22.3	8.3	7.2	27.1	9.7	109.0	38.2	32.8	99.8	53.8
CNOT6	"CCR4, Ccr4a, KIAA1194"	ENSG00000113300	"CCR4-NOT transcription complex subunit 6"	Q9ULM6	5	180494379-180578358	"Enzymes, Predicted intracellular proteins"	"RNA-mediated gene silencing, Transcription, Transcription regulation, Translation regulation"	"Activator, Exonuclease, Hydrolase, Nuclease, RNA-binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA044568	Approved		Approved	Cytosol		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 20: Retina & Lymphoid tissues - Unknown function"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 52: Non-specific - Transcription"	Cytosol		"HPA044568: AB_10797257"	"unprognostic (9.41e-3)"	"unprognostic (1.40e-1)"	"unprognostic (2.03e-3)"	"unprognostic (2.55e-1)"	"unprognostic (1.41e-1)"	"unprognostic (2.59e-1)"	"prognostic unfavorable (3.61e-7)"	"unprognostic (1.31e-1)"	"unprognostic (1.10e-2)"	"unprognostic (1.85e-2)"	"unprognostic (2.50e-2)"	"unprognostic (2.35e-2)"	"unprognostic (1.79e-2)"	"unprognostic (1.25e-1)"	"unprognostic (1.26e-1)"	"unprognostic (4.03e-2)"	"unprognostic (3.57e-2)"	6.6	6.5	8.7	12.0	9.1	11.9	9.5	16.1	8.8	8.0	10.1	10.0	12.1	9.2	8.6	11.5	9.4	7.3	6.2	7.9	9.3	10.0	5.1	9.7	11.4	8.9	8.7	9.4	6.6	8.7	5.6	11.8	7.9	9.4	11.5	17.5	7.1	7.4	5.2	9.3	11.9	8.1	8.4	10.0	10.1	13.5	9.2	19.7	9.0	7.4	14.0	11.4	8.0	9.4	24.9	29.6	59.2	47.5	9.6	10.9	61.0	17.9	12.0	23.2	27.5	36.1	35.7	26.2	26.5	11.8	32.2	25.5	50.0	59.4	27.1	77.5	25.2	28.6	38.4	23.4	14.3	33.6	20.1	9.3	28.1	17.1	36.1	21.6	28.6	30.2	30.9	24.5	21.8	51.1	43.0	20.2	17.5	25.0	13.9	39.1	29.6	18.6	25.6	48.5	43.0	36.4	30.1	39.7	26.2	28.7	49.9	33.5	31.4	24.5	28.1	18.0	32.0	16.0	30.9	27.4	23.4	45.3	20.6	0.7	0.8	1.2	1.2	1.4	1.3	0.6	1.0	0.7	0.8	0.7	1.4	1.4	0.8	0.7	2.3	0.8	0.8	0.6	8.7	9.1	16.1	8.8	7.9	9.3	8.9	8.7	7.9	8.4	9.2	9.4	12.4	28.9	13.4	16.3	11.9	21.7	6.4	12.9	15.9	18.0	19.5	11.7	11.4	14.3	12.4	11.0	22.9	9.4	21.9	17.1	1.9	11.0	6.4	32.3	22.3	13.2	14.5	27.8	27.2	9.3	12.8	11.8	11.2	21.1	2.5	29.7	13.6	5.7	12.5	18.5	24.9	13.8	6.1	16.2	15.4	9.3	13.1	14.4	10.6	18.7	20.1	13.5	26.8	30.2	33.4	17.6	8.4	18.8	15.5	17.3	12.1	13.1	20.2	17.5	26.3	11.7	13.1	38.6	48.7	23.2	22.3	11.5	16.2	12.8	16.5	19.9
CNOT6L	"Ccr4b, DKFZp434K098"	ENSG00000138767	"CCR4-NOT transcription complex subunit 6 like"	Q96LI5	4	77713387-77819615	"Enzymes, Predicted intracellular proteins"	"mRNA processing, RNA-mediated gene silencing, Transcription, Transcription regulation, Translation regulation"	"Exonuclease, Hydrolase, Nuclease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"dendritic cells: 366.6;T-cells: 240.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA042688	Uncertain		Supported	Cytosol		NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 3: T-cells - Adaptive immune response"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 24: Non-specific - Transcription regulation"	Cytosol		"HPA042688: AB_10794384"	"unprognostic (3.91e-1)"	"unprognostic (1.95e-2)"	"unprognostic (7.91e-3)"	"unprognostic (4.10e-2)"	"unprognostic (2.56e-1)"	"unprognostic (3.72e-2)"	"unprognostic (8.79e-2)"	"unprognostic (1.09e-1)"	"unprognostic (5.06e-2)"	"unprognostic (6.86e-2)"	"unprognostic (3.55e-2)"	"unprognostic (1.50e-1)"	"prognostic favorable (1.69e-4)"	"unprognostic (4.51e-2)"	"unprognostic (7.95e-2)"	"unprognostic (1.06e-1)"	"unprognostic (1.91e-3)"	11.8	9.5	6.9	22.4	7.7	29.5	13.4	14.4	8.1	12.4	6.1	12.9	13.1	11.1	9.8	16.6	11.6	14.0	6.1	6.4	10.1	13.2	19.6	11.6	36.1	7.5	7.7	13.6	19.9	17.8	6.0	22.5	7.1	11.7	15.5	12.9	12.6	12.2	7.2	13.7	13.6	14.5	8.2	23.6	14.7	11.2	11.5	49.5	14.4	8.6	38.5	15.7	8.4	9.0	17.0	9.6	12.5	9.1	14.7	13.6	13.1	13.1	17.8	11.9	15.9	3.5	18.3	26.5	15.4	18.9	8.6	10.9	17.5	18.7	14.9	28.4	10.0	25.4	9.8	10.3	9.1	24.0	22.9	8.1	22.7	12.1	24.3	10.9	38.2	21.2	22.7	38.0	13.9	9.0	52.3	14.0	6.2	13.4	3.2	12.4	38.4	21.5	12.5	13.5	16.0	7.2	23.3	20.1	7.9	15.4	6.8	13.7	35.6	10.9	11.5	19.9	7.3	48.1	21.0	35.1	12.3	11.9	8.6	21.4	4.4	10.6	9.4	7.0	9.9	5.5	7.2	7.7	4.4	7.2	6.7	8.2	6.9	8.2	10.3	6.4	6.4	4.1	6.9	7.7	14.4	8.1	6.4	10.1	7.5	7.7	7.1	8.2	11.5	9.0	93.0	22.4	21.0	34.3	101.1	57.9	13.3	15.9	59.2	39.5	30.5	20.8	16.7	31.5	24.0	36.8	39.6	31.1	366.6	16.9	60.7	8.2	4.7	30.1	24.6	54.0	26.3	31.5	74.8	12.4	8.6	25.1	26.5	46.2	38.0	22.1	45.3	32.6	17.1	32.0	70.7	29.8	14.2	41.0	50.1	3.7	18.6	50.0	24.9	105.9	39.2	19.3	128.8	68.9	60.7	11.0	16.1	12.8	178.5	33.9	28.4	26.3	17.0	43.5	32.9	26.6	29.2	49.4	39.9	44.7	66.1	24.4	240.0	37.9	24.1	26.7
CNOT7	CAF1	ENSG00000198791	"CCR4-NOT transcription complex subunit 7"	Q9UIV1	8	17224966-17246878	"Enzymes, Predicted intracellular proteins"	"RNA-mediated gene silencing, Transcription, Transcription regulation, Translation regulation"	"Exonuclease, Hydrolase, Nuclease, Repressor, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA069543			Supported	"Nuclear bodies"		NA	NA			"Cluster 44: Non-specific - Transcription"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 46: Photoreceptor cells - Phototransduction"	"Nuclear bodies"		"HPA069543: AB_2686148"	"unprognostic (1.55e-1)"	"unprognostic (4.49e-2)"	"prognostic favorable (4.99e-4)"	"unprognostic (4.61e-2)"	"unprognostic (8.45e-2)"	"unprognostic (3.10e-2)"	"unprognostic (1.44e-3)"	"unprognostic (4.54e-2)"	"unprognostic (6.83e-2)"	"unprognostic (4.09e-3)"	"unprognostic (2.51e-1)"	"unprognostic (1.74e-1)"	"unprognostic (3.49e-2)"	"unprognostic (1.72e-1)"	"unprognostic (4.51e-1)"	"unprognostic (2.24e-1)"	"unprognostic (2.52e-1)"	31.9	32.7	21.6	39.8	25.4	51.0	42.1	35.0	30.7	28.0	20.5	43.0	38.3	39.5	45.1	43.7	36.3	35.7	38.2	24.2	26.8	50.8	48.8	33.0	52.2	19.7	23.3	42.1	36.0	62.6	26.2	43.1	20.3	32.7	43.8	78.0	38.5	29.5	78.9	27.8	38.4	36.6	21.5	39.0	32.0	52.0	24.4	80.2	60.0	72.2	64.9	45.0	20.4	24.0	77.3	93.6	138.1	103.1	57.0	59.6	95.3	97.6	82.5	110.4	97.5	110.2	60.4	106.1	103.9	85.9	177.5	60.3	147.0	122.9	160.2	44.1	71.0	139.9	68.6	119.9	73.2	95.3	82.8	57.3	99.7	94.3	100.3	102.0	133.7	138.2	119.1	114.9	112.9	60.2	234.7	88.2	152.6	144.4	72.0	126.1	102.7	79.9	95.6	167.6	173.6	115.9	68.6	60.3	114.4	112.9	72.5	79.2	90.8	82.0	116.5	92.4	110.8	59.3	208.2	189.5	76.9	88.7	82.8	138.0	93.9	109.5	80.2	116.6	95.3	133.3	109.7	95.7	113.5	135.3	136.6	110.0	84.5	106.5	105.1	101.3	134.8	130.1	21.6	25.4	35.0	30.7	24.2	26.8	19.7	23.3	20.3	21.5	24.4	24.0	46.9	32.1	40.3	15.0	100.4	90.9	65.2	82.5	100.7	114.9	77.1	64.0	58.2	61.5	48.2	62.5	93.8	88.4	74.5	31.0	97.8	79.0	86.5	50.7	37.1	56.8	94.1	60.5	39.1	72.5	115.1	45.9	40.2	53.5	44.9	72.2	69.3	67.2	69.7	25.2	32.1	69.6	81.4	73.5	58.7	33.9	40.7	59.4	26.6	28.1	83.7	68.5	76.2	23.1	34.8	79.3	58.1	40.6	84.0	93.8	52.6	113.9	56.6	219.2	78.9	51.6	56.2	95.9	100.7	90.7	86.0	85.5	77.6	55.3	70.5	84.3
CNOT8	"CAF1, CALIF, hCAF1, POP2"	ENSG00000155508	"CCR4-NOT transcription complex subunit 8"	Q9UFF9	5	154857553-154876792	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"RNA-mediated gene silencing, Transcription, Transcription regulation, Translation regulation"	"Exonuclease, Hydrolase, Nuclease, Repressor, RNA-binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 124.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA051398	Approved					NA	NA			"Cluster 2: Granulocytes - Unknown function"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 32: U-937 - Innate immune response"	"Cluster 23: Spermatids - Flagellum & Golgi organization"			"HPA051398: AB_2681468"	"unprognostic (2.51e-1)"	"unprognostic (4.26e-1)"	"unprognostic (1.69e-2)"	"unprognostic (1.48e-1)"	"unprognostic (1.68e-2)"	"unprognostic (1.13e-1)"	"prognostic unfavorable (5.33e-4)"	"unprognostic (1.19e-1)"	"unprognostic (3.62e-2)"	"unprognostic (2.35e-2)"	"unprognostic (1.79e-2)"	"unprognostic (2.80e-1)"	"unprognostic (3.32e-3)"	"unprognostic (2.19e-1)"	"unprognostic (1.84e-1)"	"unprognostic (3.66e-2)"	"prognostic favorable (6.41e-4)"	62.3	39.9	35.5	38.4	36.5	118.3	46.5	37.0	43.3	42.0	47.4	41.2	33.5	33.8	36.9	26.6	29.5	29.9	26.1	34.5	35.1	28.9	29.2	49.3	58.7	37.7	36.5	30.2	22.8	40.0	18.3	42.2	38.4	28.8	46.6	25.0	35.1	28.1	21.7	41.7	37.0	32.0	38.8	49.8	30.8	39.0	39.4	69.7	35.6	26.0	53.1	35.9	29.8	40.6	33.4	36.6	64.3	71.2	60.6	55.1	49.1	51.4	55.9	54.8	83.9	47.7	73.5	58.9	61.8	43.6	43.2	36.2	45.2	62.3	61.8	29.3	47.4	49.8	55.7	42.9	38.5	114.3	86.5	37.5	54.5	49.0	42.2	57.0	68.5	81.5	44.6	43.1	58.4	39.4	100.3	118.5	35.6	39.4	21.4	85.7	55.2	61.6	43.7	44.5	50.9	74.4	68.0	54.2	64.9	35.7	50.4	92.7	52.9	57.1	35.3	32.2	34.0	41.4	56.8	91.0	40.1	89.5	36.1	277.6	127.3	269.5	72.3	91.6	79.8	79.9	87.4	86.9	133.2	81.5	115.5	84.6	126.2	91.7	74.6	70.5	107.8	169.6	35.5	36.5	37.0	43.3	34.5	35.1	37.7	36.5	38.4	38.8	39.4	40.6	29.1	19.2	39.7	14.7	39.8	31.9	16.5	37.4	23.9	12.1	23.4	17.5	12.8	12.8	31.5	16.5	0.0	32.5	37.5	17.8	17.6	25.1	124.5	21.5	36.7	35.1	27.6	37.0	15.2	20.2	44.6	28.8	18.8	23.0	17.7	33.2	28.2	13.8	27.1	18.5	11.4	32.1	26.4	49.1	47.1	54.6	45.4	32.5	28.4	26.2	51.2	12.1	23.7	15.1	23.3	31.5	18.7	38.0	21.3	24.2	22.6	13.0	19.9	8.0	6.6	19.6	25.7	29.6	23.1	21.1	41.8	22.8	38.1	29.8	27.7	27.2
CNP		ENSG00000173786	"2',3'-cyclic nucleotide 3' phosphodiesterase"	P09543	17	41966763-41977740	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"		"Hydrolase, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	7	"brain: 1395.7"	"Cell type enriched"	"Detected in all"	4	"Oligodendrocytes: 555.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"plasmacytoid DC: 149.4"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Region enriched"	"Detected in all"	4	"white matter: 1789.4"	"Low region specificity"	"Detected in all"			"CAB002672, HPA023266, HPA023278, HPA023280, HPA023338"	Enhanced	Supported	Supported	"Plasma membrane"		NA	NA		46000	"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 70: Brain - Nervous system development"	"Cluster 17: WM-115 - Nervous system development"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	"Plasma membrane"		"CAB002672: , HPA023266: AB_1847058, HPA023278: AB_1847060, HPA023280: AB_1847061, HPA023338: AB_1847062"	"unprognostic (2.17e-1)"	"unprognostic (4.48e-2)"	"unprognostic (3.85e-3)"	"unprognostic (1.41e-1)"	"unprognostic (3.09e-1)"	"unprognostic (9.71e-2)"	"unprognostic (2.58e-3)"	"unprognostic (2.08e-1)"	"unprognostic (2.23e-1)"	"unprognostic (1.62e-1)"	"unprognostic (5.76e-3)"	"unprognostic (1.87e-1)"	"unprognostic (2.99e-3)"	"unprognostic (1.60e-1)"	"unprognostic (1.55e-1)"	"unprognostic (8.86e-2)"	"unprognostic (1.10e-3)"	34.4	33.5	493.1	31.2	889.6	23.4	29.6	715.5	681.5	41.7	193.5	56.9	21.4	33.5	36.7	63.4	28.9	32.6	25.3	505.1	577.0	58.1	44.8	21.7	35.7	839.4	761.8	32.2	27.8	23.7	28.1	23.5	793.8	41.5	18.4	20.5	47.2	37.2	26.3	34.3	31.4	30.3	644.6	25.8	29.8	16.7	791.1	31.2	24.7	22.2	35.1	37.3	40.5	1395.7	56.9	92.4	85.8	106.6	71.7	67.2	38.5	70.1	102.5	171.1	191.5	73.0	49.6	59.0	54.3	88.5	88.1	95.0	58.3	44.6	59.0	59.7	76.8	56.7	59.3	127.7	76.9	56.7	49.6	111.0	31.5	94.1	22.8	61.9	79.4	58.0	42.4	46.4	60.6	35.1	148.5	50.9	20.7	29.8	66.5	91.4	126.7	58.7	45.7	55.7	50.9	69.5	85.7	127.0	155.5	41.6	57.2	82.3	80.2	66.6	73.7	92.3	81.9	53.4	66.6	47.5	66.1	42.9	266.4	18.7	38.2	23.4	21.5	40.7	17.2	28.0	18.8	17.4	33.8	19.2	16.6	19.6	7.7	23.5	34.0	149.4	22.4	33.0	493.1	889.6	715.5	681.5	505.1	577.0	839.4	761.8	793.8	644.6	791.1	1395.7	26.6	16.0	12.7	14.4	19.0	16.7	17.5	10.4	16.5	22.0	29.5	24.0	13.0	20.0	19.5	35.0	6.2	30.6	53.2	39.9	125.2	46.3	1.3	19.1	27.1	24.8	19.7	25.2	6.8	41.7	50.2	27.7	17.9	21.3	9.5	20.2	20.3	32.3	39.8	50.5	9.5	16.2	18.3	17.0	14.5	4.0	38.8	20.3	55.2	14.0	25.0	84.7	23.7	45.2	555.6	35.5	19.0	36.1	27.8	21.7	19.0	80.5	12.8	25.4	32.9	36.6	29.4	5.1	16.0	30.9	18.9	13.0	16.9	33.3	20.6	17.4
CPA1	CPA	ENSG00000091704	"Carboxypeptidase A1"	P15085	7	130380339-130388114	"Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted secreted proteins"		"Carboxypeptidase, Hydrolase, Metalloprotease, Protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	2326	"pancreas: 237498.3"	"Cell type enriched"	"Detected in some"	19	"Exocrine glandular cells: 10133.0"	"Cancer enriched"	"Detected in some"	639	"pancreatic cancer: 1377.7"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	5	"AN3-CA: 11.8"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"HPA021836, CAB025197, HPA052215"	Enhanced				"Secreted to digestive system"	NA	NA		110000000		"Cluster 25: Pancreas - Digestion"	"Cluster 23: AN3-CA - Transcription regulation"	"Cluster 1: Pancreatic cells - Digestion"			"CAB025197: , HPA021836: AB_1846005, HPA052215: AB_2681764"	"unprognostic (8.41e-2)"			"unprognostic (9.24e-4)"	"unprognostic (5.22e-2)"	"unprognostic (1.76e-1)"	"unprognostic (3.97e-1)"	"unprognostic (1.76e-1)"		"unprognostic (2.27e-1)"	"unprognostic (1.15e-2)"	"unprognostic (1.35e-1)"	"unprognostic (1.34e-6)"	"unprognostic (4.99e-1)"	"unprognostic (1.67e-1)"	"unprognostic (2.16e-1)"	"unprognostic (4.37e-2)"	27.9	4.8	0.2	5.6	0.2	4.7	13.6	0.1	0.2	11.9	1.2	4.5	33.6	5.0	0.1	6.9	3.7	0.2	43.5	0.2	0.3	4.6	12.9	3.3	8.7	0.1	0.1	102.1	237498.3	0.0	5.0	18.4	0.1	6.9	0.0	0.2	39.5	0.1	4.7	6.6	20.8	0.4	0.2	7.7	21.3	5.4	0.2	0.1	3.0	0.4	0.0	2.8	4.0	0.4	0.0	0.0	0.0	11.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.4	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	2.1	0.4	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	1.7	0.0	0.2	0.0	1.5	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.1	0.2	0.2	0.3	0.1	0.1	0.1	0.2	0.2	0.4	0.1	3.2	0.0	0.3	0.0	0.0	0.5	0.0	0.0	0.0	0.1	0.9	0.4	0.0	0.0	0.0	0.0	0.3	0.0	0.0	5.9	12.0	1.9	0.0	0.1	0.1	0.0	0.0	0.0	10133.0	0.0	3.6	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	7.6	0.9	1.2	0.0	1.0	44.5	2.1	0.0	0.0	0.0	527.2	0.0	0.7	0.0	0.4	0.0	0.0	0.0	0.1	0.0	16.2	2.7	0.9	5.5	0.0	0.0	1.6	0.0	2.5	0.0	0.1
CPA2		ENSG00000158516	"Carboxypeptidase A2"	P48052	7	130266863-130289798	"Enzymes, Metabolic proteins, Predicted secreted proteins"		"Carboxypeptidase, Hydrolase, Metalloprotease, Protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	416	"pancreas: 45360.2"	"Cell type enriched"	"Detected in some"	10	"Exocrine glandular cells: 4973.8"	"Cancer enriched"	"Detected in many"	60	"pancreatic cancer: 411.4"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AN3-CA: 2.2;CACO-2: 3.8;RH-30: 3.0;SCLC-21H: 1.6"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"HPA020342, HPA021317"	Enhanced		Approved	"Golgi apparatus"	"Secreted to digestive system"	NA	NA		1500000		"Cluster 25: Pancreas - Digestion"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 1: Pancreatic cells - Digestion"	"Golgi apparatus"		"HPA020342: AB_1846007, HPA021317: AB_1846008"	"unprognostic (1.12e-1)"	"unprognostic (3.97e-1)"	"unprognostic (4.21e-2)"	"unprognostic (1.82e-2)"	"unprognostic (1.38e-1)"	"unprognostic (6.76e-2)"		"unprognostic (4.65e-2)"	"unprognostic (1.08e-1)"	"unprognostic (1.40e-1)"	"unprognostic (1.84e-1)"	"unprognostic (2.66e-1)"	"unprognostic (3.84e-5)"	"unprognostic (7.52e-2)"	"unprognostic (1.42e-1)"	"unprognostic (7.12e-2)"	"unprognostic (8.48e-2)"	5.5	1.0	0.3	0.7	0.8	0.4	2.6	1.0	0.9	1.9	0.2	1.3	17.4	0.8	0.1	1.5	0.7	0.0	8.4	0.3	0.6	0.9	2.6	0.7	1.4	2.8	1.3	19.7	45360.2	0.0	1.4	3.2	2.5	1.5	0.4	0.8	7.8	0.0	0.8	1.1	30.6	0.0	1.2	1.2	108.9	2.2	1.1	0.1	0.6	0.0	0.0	0.5	0.8	3.1	0.0	0.0	0.4	2.2	0.0	0.0	0.0	0.0	0.0	0.3	0.0	3.8	0.0	0.0	0.5	0.0	0.3	0.0	0.7	0.0	0.0	0.5	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.4	0.0	0.2	0.0	3.0	0.0	0.0	0.3	1.6	0.0	0.1	0.0	1.0	0.1	0.0	0.1	0.0	0.0	0.6	0.4	0.3	0.0	0.4	0.1	0.4	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.8	1.0	0.9	0.3	0.6	2.8	1.3	2.5	1.2	1.1	3.1	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.3	0.4	0.0	0.0	0.0	0.0	0.3	0.0	0.6	1.9	8.1	4.3	0.0	0.0	0.9	0.0	0.0	0.1	4973.8	0.0	0.2	4.6	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.5	0.0	0.0	0.0	10.5	0.3	0.5	0.0	0.0	13.9	4.6	0.0	0.5	1.0	471.3	52.9	0.0	0.0	0.0	9.9	0.0	0.0	0.3	0.0	0.0	1.3	0.4	2.0	0.0	0.1	0.3	0.0	0.2	1.5	0.2
CPA3		ENSG00000163751	"Carboxypeptidase A3"	P15088	3	148865296-148897203	"Enzymes, Metabolic proteins, Plasma proteins, Predicted secreted proteins"		"Carboxypeptidase, Hydrolase, Metalloprotease, Protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"gallbladder: 112.0;lung: 86.3"	"Cell type enriched"	"Detected in some"	26	"granulocytes: 4422.8"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Immune cell enriched"	"Detected in single"	1534	"basophil: 1115.4"	"Lineage enriched"	"Detected in single"	5518	"granulocytes: 1115.4"	"Cell line enriched"	"Detected in some"	45	"HEL: 303.3"	"Not detected"	"Not detected"							"HPA006479, HPA008689, CAB020712"	Enhanced		Approved	"Nucleoplasm,Golgi apparatus"	"Secreted to blood"	NA	NA			"Cluster 38: Basophils - Unknown function"	"Cluster 12: Smooth muscle tissue - Mixed function"	"Cluster 36: HEL - Hemostasis"	"Cluster 60: Granulocytes - Receptor signaling"	"Golgi apparatus"	Nucleoplasm	"CAB020712: , HPA006479: AB_1078396, HPA008689: AB_1846009"	"unprognostic (1.07e-1)"	"unprognostic (3.03e-2)"	"unprognostic (2.66e-3)"	"unprognostic (9.13e-3)"	"unprognostic (3.50e-1)"	"unprognostic (1.18e-3)"	"unprognostic (2.47e-1)"	"unprognostic (1.57e-2)"	"unprognostic (2.14e-1)"	"unprognostic (9.51e-2)"	"unprognostic (1.89e-1)"	"unprognostic (5.30e-3)"	"unprognostic (3.50e-3)"	"unprognostic (5.18e-3)"	"unprognostic (3.24e-2)"	"unprognostic (1.74e-1)"	"unprognostic (1.69e-3)"	18.2	2.6	0.0	19.9	0.4	25.7	20.9	0.0	0.0	59.4	0.3	39.2	27.3	26.1	19.3	41.1	6.6	112.0	6.2	0.0	0.0	3.3	2.7	86.3	11.2	0.0	0.0	0.9	21.0	2.8	0.9	1.7	0.0	18.5	56.6	0.0	12.1	15.1	1.6	17.7	45.9	25.7	0.0	1.1	45.3	3.8	0.0	14.9	0.9	10.2	15.1	54.0	10.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	2.6	4.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.7	0.0	0.0	303.3	0.0	0.0	0.2	0.2	6.7	0.2	0.0	0.1	0.3	0.5	3.8	0.0	0.1	0.0	1.8	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.2	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1115.4	0.0	0.7	0.0	0.1	0.0	0.1	0.1	0.0	0.1	0.0	0.0	0.1	0.4	0.0	0.2	0.0	0.0	2.9	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	32.1	163.9	0.0	0.5	1.7	0.4	0.0	0.0	0.0	0.0	0.0	0.3	0.0	17.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	3.7	0.0	16.0	0.0	1.6	0.0	3.5	0.5	0.0	4422.8	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	5.0	1.8	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	6.7	0.3	0.0	0.0	8.7	0.0	0.0	0.2	0.3	0.0	0.0	0.0	1.3	0.0	41.7	0.0	0.0	0.3
CPB1		ENSG00000153002	"Carboxypeptidase B1"	P15086	3	148791102-148860187	"Enzymes, Plasma proteins, Predicted secreted proteins"		"Carboxypeptidase, Hydrolase, Metalloprotease, Protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	1970	"pancreas: 226925.8"	"Cell type enriched"	"Detected in some"	12	"Exocrine glandular cells: 7306.0"	"Group enriched"	"Detected in some"	312	"breast cancer: 293.8;pancreatic cancer: 641.4"	"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in many"		"basophil: 4.0"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"HDLM-2: 1.0;U-2 OS: 1.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"CAB026158, HPA038069, HPA046340"	Enhanced				"Secreted to digestive system"	NA	NA		88000000	"Cluster 17: Basophils - Unknown function"	"Cluster 25: Pancreas - Digestion"	"Cluster 9: U-2 OS - Unknown function"	"Cluster 1: Pancreatic cells - Digestion"			"CAB026158: , HPA038069: AB_2675816, HPA046340: AB_2679628"	"unprognostic (6.90e-2)"	"unprognostic (3.79e-2)"	"unprognostic (3.34e-2)"	"unprognostic (2.64e-2)"	"unprognostic (5.58e-2)"	"unprognostic (3.27e-2)"	"unprognostic (6.26e-4)"	"unprognostic (1.90e-1)"	"unprognostic (1.82e-1)"	"unprognostic (1.07e-1)"	"unprognostic (7.59e-2)"	"unprognostic (4.51e-2)"	"unprognostic (5.50e-8)"	"unprognostic (3.08e-1)"	"unprognostic (1.60e-1)"		"unprognostic (4.93e-2)"	15.7	83.0	0.4	5.1	1.7	2.5	78.3	0.6	1.4	6.0	0.1	2.6	31.2	4.7	0.3	3.5	1.8	0.1	40.8	0.6	0.8	2.0	7.1	1.7	8.1	1.0	1.2	115.1	226925.8	0.0	2.1	13.7	1.1	4.7	4.5	0.0	36.3	0.0	2.2	2.8	17.2	0.0	0.4	19.2	28.3	2.9	1.2	0.1	1.6	0.0	0.0	1.4	2.0	3.3	0.0	0.0	0.0	0.0	0.9	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.9	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.5	0.0	0.9	0.2	0.0	0.0	0.0	4.0	0.3	0.5	1.3	0.4	0.9	0.4	0.5	1.1	0.1	0.7	0.3	1.4	1.9	1.4	0.5	0.5	0.3	0.4	0.4	1.7	0.6	1.4	0.6	0.8	1.0	1.2	1.1	0.4	1.2	3.3	2.2	0.0	0.0	1.0	0.0	0.6	0.5	0.0	0.0	0.0	8.7	1.9	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	11.6	11.2	0.0	0.1	1.1	164.9	1.3	0.3	7306.0	0.0	36.8	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.2	0.2	0.0	0.0	1.0	2.5	0.6	1.5	0.0	0.0	18.1	0.0	0.0	0.0	29.8	590.0	0.1	0.0	0.0	4.6	0.0	0.0	0.0	0.0	0.0	4.2	2.5	0.0	1.1	0.1	0.3	0.3	0.3	1.1	0.2	0.2
CPB2	"CPU, PCPB, TAFI"	ENSG00000080618	"Carboxypeptidase B2"	Q96IY4	13	46053186-46105033	"Enzymes, FDA approved drug targets, Plasma proteins, Predicted secreted proteins"	"Blood coagulation, Fibrinolysis, Hemostasis"	"Carboxypeptidase, Hydrolase, Metalloprotease, Protease"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	84	"liver: 1484.1"	"Cell type enriched"	"Detected in some"	7	"Hepatocytes: 1332.7"	"Cancer enriched"	"Detected in some"	112	"liver cancer: 268.4"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	86	"Hep G2: 173.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA004146	Approved				"Secreted to blood"	NA	NA		8500000000		"Cluster 60: Liver - Hemostasis & Lipid metabolism"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 2: Hepatocytes - Metabolism"			"HPA004146: AB_1078397"	"unprognostic (3.44e-2)"	"unprognostic (1.25e-1)"	"unprognostic (2.94e-2)"	"unprognostic (1.89e-2)"	"unprognostic (7.69e-2)"	"unprognostic (1.17e-2)"	"prognostic favorable (2.06e-4)"	"unprognostic (1.89e-1)"	"unprognostic (2.74e-1)"	"unprognostic (2.48e-1)"	"unprognostic (3.17e-2)"	"unprognostic (4.83e-2)"	"unprognostic (3.20e-3)"	"unprognostic (1.34e-1)"	"unprognostic (7.10e-2)"	"unprognostic (3.34e-2)"	"unprognostic (9.61e-2)"	0.1	0.0	0.5	0.1	3.1	0.7	0.1	0.6	1.8	0.0	0.0	0.0	0.0	0.0	6.3	0.0	0.0	4.8	0.0	0.5	1.4	0.4	1484.1	17.6	0.1	1.7	2.0	0.0	0.5	0.0	0.0	0.0	2.5	0.1	0.0	0.4	0.1	0.2	0.2	0.1	0.1	0.0	0.3	0.4	0.1	0.2	2.2	0.0	0.1	0.0	0.0	0.0	0.0	5.1	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.4	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.3	0.0	0.6	0.3	173.2	0.0	0.5	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.2	0.2	0.0	0.1	0.2	0.2	0.2	0.0	0.0	0.0	0.5	0.2	0.0	0.1	0.0	0.1	0.1	0.0	2.0	0.1	0.1	0.1	0.0	0.1	0.1	0.0	0.0	0.2	0.5	0.3	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.5	3.1	0.6	1.8	0.5	1.4	1.7	2.0	2.5	0.3	2.2	5.1	0.0	3.2	27.0	3.9	1.7	0.0	0.0	0.0	0.0	0.0	0.4	0.1	0.1	190.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.3	0.1	1.0	0.0	10.7	4.0	0.0	0.0	0.1	0.0	0.3	0.0	0.0	15.7	1332.7	0.1	0.0	5.3	0.0	0.0	22.7	0.0	0.1	0.0	0.0	0.0	1.0	0.0	0.0	0.0	13.0	36.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0
CPD	GP180	ENSG00000108582	"Carboxypeptidase D"	O75976	17	30378927-30469989	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"		"Carboxypeptidase, Hydrolase, Metalloprotease, Protease"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"neutrophil: 25.0"	"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA052796, HPA055465"	Approved		Approved	"Nucleoplasm,Nuclear membrane,Nuclear speckles"		NA	NA		1700000	"Cluster 9: Neutrophils - Innate immune response"	"Cluster 1: Thyroid gland - Transcription"	"Cluster 21: OE19 - Mitochondria"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"	"Nucleoplasm, Nuclear speckles"	"Nuclear membrane"	"HPA052796: AB_2681953, HPA055465: AB_2682823"	"unprognostic (1.05e-1)"	"unprognostic (1.31e-1)"	"unprognostic (3.05e-2)"	"unprognostic (3.62e-2)"	"unprognostic (6.13e-2)"	"unprognostic (1.65e-1)"	"unprognostic (7.97e-3)"	"unprognostic (4.45e-2)"	"unprognostic (2.07e-2)"	"unprognostic (2.96e-1)"	"unprognostic (1.62e-1)"	"unprognostic (3.16e-1)"	"unprognostic (1.58e-1)"	"unprognostic (3.74e-2)"	"unprognostic (7.25e-2)"	"unprognostic (3.36e-1)"	"unprognostic (1.08e-1)"	25.9	7.4	10.8	19.7	13.1	32.2	20.5	15.4	25.6	40.9	9.4	18.0	20.3	15.8	13.2	12.1	23.0	31.8	9.1	11.8	13.0	19.7	25.4	18.2	7.9	19.5	13.3	7.8	15.7	28.5	6.1	30.3	17.8	16.8	20.1	14.9	44.8	11.2	8.1	8.2	19.8	23.3	18.3	9.3	37.3	41.3	13.5	8.3	57.6	14.0	9.9	18.3	7.1	28.0	39.4	58.9	50.0	51.6	51.0	95.9	18.0	53.1	77.2	36.0	43.9	69.6	24.9	5.1	65.8	61.3	45.6	27.6	32.7	67.1	60.3	18.7	46.7	11.2	32.5	43.2	61.8	73.8	28.3	172.3	29.4	46.2	44.3	59.7	74.3	16.5	22.1	56.1	29.2	7.7	23.9	20.3	14.1	89.8	13.4	22.6	57.8	15.3	67.3	44.2	12.5	31.5	63.4	54.0	27.6	58.0	51.2	50.4	89.2	35.7	23.3	56.2	51.3	22.5	50.0	16.1	45.6	47.2	30.9	4.5	7.7	8.4	4.1	3.6	4.5	0.2	2.1	3.5	4.4	0.4	1.6	2.0	25.0	2.7	3.2	0.5	1.5	3.6	10.8	13.1	15.4	25.6	11.8	13.0	19.5	13.3	17.8	18.3	13.5	28.0	124.4	32.1	23.9	28.4	7.5	22.0	34.2	99.2	21.6	30.8	34.9	18.8	13.7	155.8	129.5	29.5	45.9	24.8	35.9	37.8	1.9	32.4	96.1	21.9	24.9	51.9	32.3	15.6	62.9	24.8	11.1	25.6	72.4	35.2	24.1	21.6	56.0	93.9	15.9	47.1	57.1	69.0	85.5	31.2	20.4	56.0	16.8	33.7	30.2	90.9	32.9	13.4	29.9	45.8	164.5	32.8	26.4	16.1	38.1	58.5	50.1	18.5	84.2	33.8	0.0	21.3	23.4	31.0	21.0	21.1	18.6	24.1	35.6	14.2	34.4	50.7
CPE		ENSG00000109472	"Carboxypeptidase E"	P16870	4	165361194-165498547	"Enzymes, Plasma proteins, Predicted intracellular proteins"		"Carboxypeptidase, Hydrolase, Metalloprotease, Protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 643.3;retina: 741.7"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 727.4;Bipolar cells: 569.1;Cone photoreceptor cells: 621.3;Enteroendocrine cells: 587.4;Leydig cells: 500.8;Muller glia cells: 530.9;Peritubular cells: 621.0;Rod photoreceptor cells: 803.3;Sertoli cells: 854.6;Smooth muscle cells: 519.4"	"Cancer enhanced"	"Detected in all"		"glioma: 240.2"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"Hep G2: 311.6;SCLC-21H: 418.2;SiHa: 629.0;SuSa: 342.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003819, CAB024907"	Supported		Approved	Nucleoplasm,Vesicles,Centrosome	"Intracellular and membrane"	NA	NA		600000		"Cluster 77: Retina - Visual perception"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 48: Smooth muscle cells - ECM organization"	Centrosome	"Nucleoplasm, Vesicles"	"CAB024907: , HPA003819: AB_2667054"	"unprognostic (1.84e-1)"	"unprognostic (5.64e-3)"	"unprognostic (1.61e-1)"	"unprognostic (1.70e-2)"	"unprognostic (2.51e-1)"	"unprognostic (1.44e-2)"	"unprognostic (1.65e-1)"	"unprognostic (9.52e-2)"	"unprognostic (2.91e-3)"	"unprognostic (9.01e-2)"	"unprognostic (4.84e-3)"	"unprognostic (5.56e-3)"	"prognostic unfavorable (2.60e-4)"	"unprognostic (4.35e-3)"	"unprognostic (1.46e-1)"	"unprognostic (2.26e-1)"	"prognostic unfavorable (2.12e-4)"	138.1	151.7	554.8	20.5	593.0	1.8	97.5	550.9	604.0	53.9	311.9	44.6	22.0	67.7	404.6	74.8	88.6	65.7	100.7	584.3	643.3	68.4	26.7	50.1	37.5	417.0	494.2	104.0	170.4	89.9	328.4	7.7	456.2	295.1	36.8	741.7	104.5	84.7	56.2	45.1	30.7	83.3	448.3	11.6	80.2	146.2	578.2	68.8	179.7	47.5	35.2	33.8	73.4	446.2	0.2	8.4	54.4	10.5	41.4	4.5	2.4	0.1	21.5	8.1	16.5	0.0	0.5	0.0	15.8	0.6	1.9	1.2	20.4	4.4	4.7	0.3	78.6	0.0	21.6	311.6	3.0	0.3	0.5	102.3	21.5	0.3	0.4	104.0	0.2	0.0	0.1	2.1	11.2	15.4	0.4	2.7	34.4	0.2	12.1	0.3	0.2	1.1	0.7	3.4	418.2	138.0	629.0	77.9	0.0	342.6	46.7	1.9	0.0	16.7	42.5	1.5	1.5	23.5	0.6	2.2	15.5	0.7	5.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	554.8	593.0	550.9	604.0	584.3	643.3	417.0	494.2	456.2	448.3	578.2	446.2	87.1	0.0	5.6	727.4	0.6	26.1	81.7	10.3	66.0	569.1	25.6	52.1	54.5	54.3	5.0	22.0	621.3	0.6	1.4	2.9	0.0	19.7	6.7	2.2	12.1	130.4	587.4	2.7	234.8	1.8	0.3	249.0	31.6	1.3	0.0	8.6	274.2	15.1	1.0	70.7	129.0	16.2	38.7	5.4	41.2	23.3	500.8	6.3	87.2	94.6	1.0	530.9	0.0	211.6	23.0	12.4	3.7	621.0	0.7	434.6	10.2	12.7	1.2	803.3	854.6	14.1	519.4	19.7	13.3	14.0	20.9	0.8	5.5	15.4	4.0	18.9
CPM		ENSG00000135678	"Carboxypeptidase M"	P14384	12	68842197-68971570	"Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"		"Carboxypeptidase, Hydrolase, Metalloprotease, Protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 156.1"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 359.0;Alveolar cells type 2: 362.2;Kupffer cells: 368.5;Sertoli cells: 762.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"classical monocyte: 21.0;intermediate monocyte: 14.5;myeloid DC: 16.6;non-classical monocyte: 7.4"	"Group enriched"	"Detected in many"	5	"dendritic cells: 16.6;monocytes: 21.0"	"Group enriched"	"Detected in many"	4	"ASC diff: 71.1;ASC TERT1: 50.0;HSkMC: 91.2;SiHa: 68.9;THP-1: 26.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA002657, HPA077243"	Enhanced		Uncertain	Vesicles		NA	NA		7100000	"Cluster 25: Monocytes - Inflammatory response"	"Cluster 82: Adipose tissue - ECM organization"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 4: Macrophages - Innate immune response"	Vesicles		"HPA002657: AB_1078398, HPA077243: "	"unprognostic (1.74e-1)"	"unprognostic (3.11e-1)"	"unprognostic (2.88e-3)"	"prognostic favorable (1.00e-4)"	"unprognostic (4.58e-2)"	"unprognostic (8.61e-2)"	"unprognostic (1.57e-2)"	"unprognostic (2.01e-1)"	"unprognostic (8.42e-2)"	"unprognostic (1.40e-1)"	"unprognostic (1.35e-1)"	"unprognostic (1.42e-1)"	"unprognostic (1.47e-3)"	"unprognostic (8.58e-2)"	"unprognostic (6.85e-2)"	"unprognostic (2.59e-2)"	"unprognostic (1.06e-1)"	156.1	11.5	6.4	14.4	13.3	3.5	40.2	10.1	10.5	14.4	3.8	33.5	4.4	23.9	0.9	10.1	16.2	16.1	4.6	7.6	10.2	41.3	26.5	59.3	16.1	19.3	11.5	18.0	13.0	12.0	1.0	70.1	11.9	14.7	26.6	6.7	4.1	2.8	5.8	21.7	5.9	6.4	7.5	19.4	15.3	5.4	28.0	4.3	7.5	9.7	10.5	9.3	5.7	23.5	0.1	4.0	0.1	0.0	71.1	50.0	0.7	9.8	1.1	1.7	2.3	3.2	4.1	0.5	9.6	1.4	4.1	0.0	1.4	2.7	4.1	0.1	2.7	0.0	15.1	0.3	0.4	1.2	1.9	91.2	0.6	1.0	2.0	8.6	0.0	0.3	0.0	0.1	7.3	1.7	0.0	0.7	1.7	0.0	5.2	3.1	0.6	0.0	7.2	5.9	0.4	0.2	68.9	10.7	7.9	5.5	1.2	26.5	0.2	1.2	7.5	0.5	0.2	0.4	0.5	13.1	4.3	13.1	5.9	0.6	21.0	0.1	0.2	14.5	0.0	1.8	1.5	0.1	16.6	3.5	0.9	0.2	1.6	0.5	7.4	1.1	1.9	7.3	6.4	13.3	10.1	10.5	7.6	10.2	19.3	11.5	11.9	7.5	28.0	23.5	83.3	359.0	362.2	34.6	4.9	12.4	3.5	6.1	0.6	3.3	7.8	8.9	2.6	135.8	70.1	51.5	0.0	32.3	1.1	97.5	29.4	57.9	16.6	100.9	8.3	29.0	10.8	3.6	1.2	212.5	59.9	14.1	4.6	237.1	112.5	6.7	73.9	36.6	134.6	0.0	1.3	28.7	0.0	368.5	36.3	17.5	105.0	202.2	10.6	19.7	23.3	68.9	1.0	23.1	161.8	68.0	65.9	79.0	2.4	38.7	1.9	63.7	16.4	5.7	762.6	7.2	126.9	0.6	3.9	2.4	9.9	172.4	14.5	46.3	32.7	2.8
CPN1		ENSG00000120054	"Carboxypeptidase N subunit 1"	P15169	10	100042193-100081869	"Disease related genes, Enzymes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted secreted proteins"		"Carboxypeptidase, Hydrolase, Metalloprotease, Protease"	"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	54	"liver: 81.6"	"Cell type enriched"	"Detected in some"	4	"Hepatocytes: 37.2"	"Group enriched"	"Detected in some"	12	"liver cancer: 26.6;melanoma: 7.9"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	17	"SK-MEL-30: 141.8"	"Low region specificity"	"Detected in some"			"Not detected"	"Not detected"								"Secreted to blood"	NA	NA		13000000000		"Cluster 62: Liver - Hemostasis"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 15: Hepatocytes - Hemostasis"						"unprognostic (2.97e-2)"	"unprognostic (2.23e-2)"			"unprognostic (3.93e-2)"		"unprognostic (1.64e-1)"		"unprognostic (6.75e-2)"		"unprognostic (2.93e-2)"	"unprognostic (5.26e-2)"	"unprognostic (2.63e-1)"			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	81.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.5	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	141.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	3.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	37.2	0.0	0.0	0.4	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	7.6	4.4	0.0	0.0	0.1	0.1	0.0	0.2	0.0
CPPED1	"CSTP1, FLJ11151"	ENSG00000103381	"Calcineurin like phosphoesterase domain containing 1"	Q9BRF8	16	12659799-12803887	"Enzymes, Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Cytotrophoblasts: 105.2;monocytes: 127.4;Syncytiotrophoblasts: 131.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"neutrophil: 674.2"	"Group enriched"	"Detected in all"	28	"dendritic cells: 168.5;granulocytes: 674.2;monocytes: 320.8"	"Cell line enhanced"	"Detected in many"		"Hep G2: 144.2;HMC-1: 129.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA040938, HPA041970"	Uncertain		Supported	"Plasma membrane,Cytosol"		No	No		470000	"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 64: Macrophages - Immune response"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 19: Monocytes & Neutrophils - Innate immune response"	Cytosol	"Plasma membrane"	"HPA040938: AB_10673443, HPA041970: AB_2677774"	"prognostic unfavorable (9.72e-4)"	"unprognostic (1.70e-1)"	"unprognostic (2.04e-3)"	"unprognostic (1.05e-2)"	"unprognostic (1.13e-3)"	"unprognostic (3.86e-2)"	"unprognostic (1.35e-1)"	"unprognostic (8.67e-2)"	"unprognostic (1.23e-1)"	"unprognostic (3.26e-2)"	"unprognostic (6.26e-2)"	"unprognostic (3.64e-1)"	"prognostic favorable (1.62e-9)"	"unprognostic (5.05e-2)"	"unprognostic (1.25e-1)"	"unprognostic (2.48e-3)"	"unprognostic (2.40e-2)"	12.5	9.4	9.1	19.3	14.1	14.0	8.2	13.0	11.4	11.0	7.3	13.3	21.3	7.9	5.1	25.2	7.1	11.2	10.1	8.3	13.3	33.7	34.4	13.7	11.7	14.0	13.1	7.6	4.8	3.9	4.1	18.5	14.4	11.1	14.8	3.7	13.1	8.6	8.2	6.5	21.4	12.9	11.3	29.8	8.7	15.5	12.2	9.2	13.2	9.6	16.6	11.5	8.8	17.3	5.0	29.7	3.3	7.7	12.0	25.3	0.5	54.1	14.5	28.4	23.1	14.5	15.2	7.3	54.6	39.6	12.5	0.4	0.0	13.5	29.3	17.0	8.2	62.5	4.2	144.2	7.4	0.1	129.9	25.4	3.0	2.5	20.2	0.1	43.1	9.9	22.1	4.3	70.4	6.3	5.6	29.1	8.7	2.4	4.2	11.9	18.8	15.6	43.0	9.4	15.3	10.0	0.2	48.5	20.0	15.3	10.5	13.7	65.0	40.6	8.5	0.2	0.1	0.1	1.0	11.6	9.1	31.7	8.8	57.1	224.0	146.1	9.1	320.0	7.8	10.8	7.6	10.0	168.5	8.4	2.4	5.7	674.2	13.5	320.8	41.1	13.8	129.7	9.1	14.1	13.0	11.4	8.3	13.3	14.0	13.1	14.4	11.3	12.2	17.3	12.3	9.6	16.7	8.1	8.7	4.6	3.4	4.9	4.6	3.3	4.7	4.7	10.7	10.0	11.4	14.7	8.4	105.2	18.5	9.2	60.7	43.1	3.6	5.3	13.5	16.7	6.0	31.7	13.1	12.8	15.6	12.6	4.1	9.4	54.4	8.1	7.5	45.8	47.1	10.1	10.2	9.3	6.1	80.3	30.7	4.1	15.5	59.0	7.2	30.0	127.4	13.5	8.2	21.1	70.9	31.9	18.3	24.0	4.4	3.2	40.6	66.0	13.4	6.1	26.3	17.6	11.9	2.5	9.9	14.8	4.5	131.9	8.3	13.6	15.4	1.7
CTDNEP1	"DULLARD, HSA011916, NET56"	ENSG00000175826	"CTD nuclear envelope phosphatase 1"	O95476	17	7243591-7252491	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"		"Hydrolase, Protein phosphatase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 410.0"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA037439, HPA066466"	Uncertain		Approved	"Lipid droplets"		NA	NA			"Cluster 31: Non-specific - Inflammatory response"	"Cluster 59: Non-specific - Translation"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 7: Non-specific - Mitochondria"	"Lipid droplets"		"HPA037439: AB_10601264, HPA066466: AB_2732745"	"unprognostic (7.11e-2)"	"unprognostic (7.78e-2)"	"unprognostic (1.33e-2)"	"prognostic favorable (6.45e-4)"	"unprognostic (3.12e-1)"	"unprognostic (2.13e-1)"	"unprognostic (4.61e-2)"	"unprognostic (1.50e-2)"	"unprognostic (2.98e-1)"	"unprognostic (9.90e-2)"	"prognostic favorable (1.81e-4)"	"unprognostic (3.37e-1)"	"unprognostic (2.77e-3)"	"unprognostic (1.73e-1)"	"unprognostic (1.43e-1)"	"unprognostic (9.97e-2)"	"unprognostic (2.02e-2)"	99.7	94.2	53.0	41.4	52.5	48.8	91.4	49.2	55.1	102.4	51.2	89.8	36.4	97.6	37.1	105.2	88.2	32.1	119.0	49.9	49.0	85.5	69.1	91.6	45.9	55.9	52.7	103.4	98.5	44.4	83.8	41.1	51.2	81.8	46.7	29.7	82.6	33.6	410.0	114.7	93.8	45.0	50.5	115.9	95.4	66.5	55.8	56.2	81.2	179.2	61.8	88.2	87.0	52.8	86.2	123.9	68.4	73.7	105.0	128.0	52.5	62.4	102.8	97.4	83.1	59.6	57.7	80.6	65.6	111.5	68.6	70.5	90.8	95.4	108.6	118.5	74.6	55.2	79.7	104.1	96.5	63.3	100.3	103.4	113.8	111.9	118.3	99.9	105.2	76.2	50.9	56.3	93.3	53.4	77.3	67.0	48.3	75.7	50.9	85.3	61.3	62.6	77.9	44.1	26.3	75.5	49.8	48.9	69.8	67.6	46.3	51.5	61.6	70.9	61.3	57.5	119.4	49.2	46.0	40.6	91.5	85.8	75.1	4.2	6.3	11.0	5.5	6.7	4.4	7.8	5.2	5.9	4.6	7.4	4.0	5.9	8.4	4.1	4.5	9.7	5.7	2.3	53.0	52.5	49.2	55.1	49.9	49.0	55.9	52.7	51.2	50.5	55.8	52.8	48.0	25.6	23.2	12.7	47.1	47.2	42.4	36.1	19.9	44.8	73.9	70.1	13.1	37.1	33.5	40.5	22.9	66.1	68.3	84.5	11.7	63.7	4.8	50.0	59.9	47.2	73.7	18.5	14.7	85.2	129.9	43.5	22.4	68.5	20.3	71.3	44.6	35.6	90.6	30.3	17.0	79.6	22.4	104.4	62.2	7.9	57.8	69.8	28.4	14.0	69.2	47.9	59.8	11.6	21.9	84.5	52.1	47.0	41.3	58.3	62.8	34.8	25.8	35.4	26.3	42.5	51.4	23.7	35.5	32.5	67.1	83.2	41.3	68.3	69.6	61.8
CTDP1	FCP1	ENSG00000060069	"CTD phosphatase subunit 1"	Q9Y5B0	18	79679803-79754510	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis"	"Hydrolase, Protein phosphatase"	"Cataract, Neuropathy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"Early spermatids: 113.1;Late spermatids: 123.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"eosinophil: 3.2"	"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB032641, HPA040394, HPA070389"	Approved		Approved	Nucleoplasm,Vesicles		NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 71: Testis - DNA repair"	"Cluster 24: NB-4 - Immune response"	"Cluster 65: Plasmacytoid DCs - Unknown function"	Nucleoplasm	Vesicles	"CAB032641: AB_2261235, HPA040394: AB_10794029, HPA070389: AB_2732155"	"unprognostic (1.71e-1)"	"unprognostic (1.75e-1)"	"unprognostic (1.37e-1)"	"prognostic favorable (6.43e-4)"	"unprognostic (2.64e-2)"	"unprognostic (7.99e-2)"	"unprognostic (3.47e-3)"	"unprognostic (1.83e-1)"	"unprognostic (2.54e-1)"	"unprognostic (1.15e-1)"	"unprognostic (5.21e-3)"	"unprognostic (1.99e-2)"	"prognostic favorable (5.51e-5)"	"unprognostic (5.16e-2)"	"unprognostic (8.58e-2)"	"unprognostic (2.85e-2)"	"unprognostic (4.74e-2)"	9.3	7.4	3.8	7.2	3.9	13.7	8.9	3.3	4.2	7.8	4.1	11.1	7.2	10.4	1.4	10.7	8.1	4.0	7.2	3.3	3.3	7.9	9.5	9.3	8.7	5.3	4.2	5.0	9.0	3.3	6.9	4.2	4.0	8.2	3.1	1.5	9.5	3.9	11.9	20.5	10.9	3.1	3.3	13.5	9.9	22.2	4.0	6.5	8.0	3.1	3.7	9.6	8.6	4.4	13.4	14.0	7.7	11.0	6.0	5.0	25.9	9.6	6.1	7.6	7.5	9.4	8.0	17.2	4.2	5.6	9.1	16.4	6.6	8.8	3.1	16.9	12.4	8.5	6.6	12.9	8.7	37.6	20.5	8.4	8.3	8.1	3.8	4.6	9.2	12.2	11.2	8.1	3.0	11.5	25.4	29.5	12.7	4.2	19.1	20.7	10.1	20.0	5.6	13.1	12.0	12.4	10.2	9.8	13.9	5.8	8.0	21.7	12.9	12.9	19.4	5.3	9.7	7.4	27.6	16.1	11.0	18.8	9.3	0.0	0.4	3.2	0.5	0.4	0.4	0.2	0.4	0.8	0.6	0.1	0.5	0.3	1.0	1.1	0.4	0.1	0.1	0.2	3.8	3.9	3.3	4.2	3.3	3.3	5.3	4.2	4.0	3.3	4.0	4.4	7.4	0.0	4.1	3.6	9.2	8.5	5.0	4.0	11.4	9.5	7.7	6.5	3.8	4.3	4.5	3.7	14.6	8.8	24.2	20.0	1.9	5.4	113.1	18.6	8.0	7.5	6.0	13.5	7.7	7.2	8.0	4.8	19.9	24.0	7.0	7.8	6.4	5.7	8.8	23.5	6.6	16.6	6.1	7.5	9.5	123.2	7.8	13.8	7.2	6.5	6.5	6.5	19.6	3.0	8.9	10.2	14.9	10.5	15.2	11.8	10.0	6.8	9.6	14.8	0.0	5.9	7.4	18.0	10.5	10.5	10.1	19.0	18.3	8.0	11.7	12.6
CTDSP1	"NLIIF, SCP1"	ENSG00000144579	"CTD small phosphatase 1"	Q9GZU7	2	218398256-218405941	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"		"Hydrolase, Protein phosphatase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"NK-cells: 184.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA062654			Supported	Nucleoplasm		NA	NA			"Cluster 10: Basophils - Unknown function"	"Cluster 85: Liver - Metabolism"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 63: NK-cells & T-cells - Immune response"	Nucleoplasm		"HPA062654: AB_2684819"	"unprognostic (1.97e-2)"	"unprognostic (4.02e-2)"	"unprognostic (1.67e-3)"	"unprognostic (2.62e-2)"	"unprognostic (1.49e-1)"	"unprognostic (1.82e-2)"	"unprognostic (3.90e-2)"	"unprognostic (8.69e-2)"	"unprognostic (2.98e-1)"	"unprognostic (6.38e-2)"	"unprognostic (3.70e-1)"	"unprognostic (1.79e-1)"	"unprognostic (2.58e-1)"	"unprognostic (6.67e-2)"	"unprognostic (2.62e-1)"	"unprognostic (7.01e-2)"	"unprognostic (1.57e-1)"	84.5	55.4	42.1	43.0	47.8	53.1	76.5	41.6	42.2	82.4	40.6	72.2	56.7	80.2	31.9	71.8	74.3	46.7	79.4	36.8	38.8	83.2	118.6	74.5	49.2	55.6	47.0	82.3	79.1	56.9	28.4	77.7	44.6	104.6	44.7	8.7	65.3	57.2	60.0	71.4	75.9	48.4	45.3	92.7	88.3	16.9	45.5	48.0	78.9	53.7	45.4	82.6	70.4	43.2	29.8	37.8	21.8	71.9	58.1	53.8	80.0	38.9	56.2	37.2	32.0	49.7	72.7	18.0	33.0	69.8	25.3	59.1	32.4	47.2	19.0	63.8	25.5	68.3	48.6	67.0	69.4	42.9	89.3	61.5	56.7	28.3	31.7	58.3	55.5	27.5	56.5	62.6	39.9	84.0	37.5	122.1	15.5	47.6	37.8	51.4	30.8	39.2	47.7	36.6	14.5	36.4	34.4	72.9	38.6	27.4	40.8	101.1	48.5	58.7	35.0	45.4	17.4	40.1	28.1	42.6	52.3	39.7	33.2	54.2	30.4	74.1	24.3	24.7	15.5	7.8	14.7	15.8	15.9	7.2	9.3	12.4	56.4	17.3	26.3	5.4	13.8	21.2	42.1	47.8	41.6	42.2	36.8	38.8	55.6	47.0	44.6	45.3	45.5	43.2	65.0	44.8	40.0	15.0	43.0	27.3	29.1	24.7	37.5	14.6	34.8	34.5	35.1	58.6	23.7	31.3	2.1	42.7	70.5	95.0	33.2	36.6	1.9	15.1	35.1	43.4	21.7	52.6	0.7	42.7	43.3	44.7	45.3	27.7	18.3	23.0	67.5	57.3	39.3	6.7	1.0	53.5	12.2	83.2	28.1	4.6	59.4	59.9	33.8	14.0	56.9	55.6	184.4	13.0	12.9	38.5	43.1	44.0	35.7	39.8	85.1	51.1	10.0	28.0	26.3	36.0	44.8	1.7	8.7	37.8	20.3	54.3	55.1	29.4	41.5	30.2
CTDSP2	"OS4, PSR2, SCP2"	ENSG00000175215	"CTD small phosphatase 2"	O14595	12	57819927-57846729	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Hydrolase, Protein phosphatase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enriched"	"Detected in all"	5	"RH-30: 1208.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA052607	Uncertain		Approved	Nucleoplasm,Mitochondria		NA	NA			"Cluster 5: Granulocytes - Unknown function"	"Cluster 52: Non-specific - Ribosome"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Nucleoplasm	Mitochondria	"HPA052607: AB_2681883"	"unprognostic (7.09e-2)"	"unprognostic (2.45e-1)"	"unprognostic (1.84e-2)"	"unprognostic (3.07e-2)"	"unprognostic (4.39e-1)"	"unprognostic (5.57e-2)"	"unprognostic (1.05e-3)"	"unprognostic (2.45e-2)"	"unprognostic (1.04e-1)"	"unprognostic (1.06e-2)"	"unprognostic (1.12e-1)"	"unprognostic (4.15e-1)"	"unprognostic (7.38e-3)"	"unprognostic (5.50e-2)"	"unprognostic (6.50e-2)"	"unprognostic (2.18e-1)"	"unprognostic (3.11e-1)"	90.9	82.5	66.8	65.4	80.0	45.7	81.8	79.7	69.3	84.0	61.0	108.9	54.3	96.4	51.4	67.0	89.9	64.7	72.4	64.6	63.0	66.2	58.8	113.9	66.1	90.7	80.6	107.3	119.4	68.2	40.3	94.3	76.5	70.1	83.2	30.1	109.1	82.8	122.3	88.9	77.0	94.8	71.4	75.5	89.9	32.3	74.3	104.8	68.1	102.8	77.5	85.2	71.8	83.4	83.1	35.4	165.6	105.8	145.6	248.8	55.0	87.4	165.1	85.2	75.4	45.6	131.5	101.3	98.1	187.5	33.2	64.8	70.0	85.3	88.8	34.2	29.7	140.3	54.4	37.0	135.4	64.3	78.3	239.7	88.9	77.3	65.1	181.9	135.0	60.6	74.5	172.9	43.4	38.2	69.1	38.3	84.3	52.5	44.4	91.0	1208.7	133.2	66.2	118.6	31.1	68.3	122.1	69.4	105.3	100.2	125.8	110.4	109.3	75.0	80.8	85.6	31.5	51.4	59.6	120.3	84.4	58.5	59.7	12.6	9.1	14.4	6.1	8.5	7.2	6.6	8.6	7.1	8.7	6.0	9.8	7.6	17.2	8.2	7.6	7.2	6.2	7.4	66.8	80.0	79.7	69.3	64.6	63.0	90.7	80.6	76.5	71.4	74.3	83.4	50.9	73.7	42.7	31.3	28.5	67.6	45.2	34.6	51.8	19.0	51.2	36.6	34.0	78.6	27.6	47.8	16.7	43.7	48.8	151.1	15.6	72.9	52.2	33.4	51.2	59.3	48.7	50.1	15.8	135.0	41.4	51.0	20.4	50.1	24.7	44.2	86.4	59.1	42.3	20.2	11.0	39.4	16.2	76.1	43.5	151.9	51.9	39.5	42.7	16.9	81.9	44.4	42.2	17.6	27.9	105.8	49.3	48.5	30.3	70.4	57.5	30.6	18.4	11.2	72.3	49.2	53.3	6.3	25.1	39.6	76.1	56.2	34.3	34.8	37.3	99.2
CTDSPL	"C3orf8, HYA22, PSR1, RBSP3, SCP3"	ENSG00000144677	"CTD small phosphatase like"	O15194	3	37861880-37984469	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"		"Hydrolase, Protein phosphatase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 170.4;Excitatory neurons: 189.3;Inhibitory neurons: 126.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"hTCEpi: 132.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA048325	Approved		Approved	Nucleoplasm,Vesicles		NA	NA			"Cluster 1: Neutrophils - Mixed function"	"Cluster 31: Skin - Epidermis development"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	Vesicles	Nucleoplasm	"HPA048325: AB_2680359"	"unprognostic (7.35e-2)"	"unprognostic (1.36e-1)"	"unprognostic (1.21e-1)"	"unprognostic (6.48e-3)"	"unprognostic (1.73e-1)"	"unprognostic (3.35e-2)"	"unprognostic (1.66e-3)"	"unprognostic (4.30e-2)"	"unprognostic (1.96e-1)"	"unprognostic (2.55e-1)"	"unprognostic (2.98e-3)"	"unprognostic (1.20e-1)"	"prognostic favorable (6.22e-14)"	"unprognostic (3.48e-2)"	"unprognostic (6.84e-2)"	"unprognostic (1.94e-1)"	"unprognostic (2.67e-2)"	21.1	9.2	19.4	6.3	20.6	10.0	28.1	24.3	23.2	20.3	17.1	33.4	14.3	20.2	14.0	23.8	17.9	29.3	29.4	18.8	17.3	39.7	21.5	27.2	4.1	19.2	17.7	19.6	15.8	12.0	10.7	31.7	16.6	26.5	30.2	3.2	27.1	31.3	21.2	52.9	17.6	23.2	18.1	17.3	31.7	10.6	19.5	7.2	14.0	19.9	5.5	26.4	19.1	17.3	44.5	18.9	7.6	24.0	29.2	41.0	57.2	30.0	37.0	20.1	23.5	27.4	35.3	0.2	17.9	36.9	8.4	36.3	19.2	56.1	16.0	0.1	15.1	27.2	18.8	63.1	26.4	0.0	6.4	21.5	132.3	21.2	25.5	22.4	28.2	12.0	8.9	0.0	33.7	13.7	11.1	0.1	31.5	17.7	2.7	12.3	14.9	0.2	63.3	28.7	6.3	19.9	16.5	28.7	33.5	30.5	28.1	7.3	23.2	14.4	20.4	27.3	19.1	0.6	0.2	0.2	15.8	14.8	27.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.4	0.0	0.0	0.0	0.0	2.1	19.4	20.6	24.3	23.2	18.8	17.3	19.2	17.7	16.6	18.1	19.5	17.3	26.8	67.3	27.6	170.4	1.2	30.1	17.0	17.7	27.9	10.1	25.7	59.4	42.2	65.8	25.7	23.9	0.0	34.7	1.0	35.6	23.5	14.2	21.5	7.6	17.6	22.4	45.2	7.8	189.3	4.7	9.9	32.4	10.2	27.2	1.3	15.7	22.9	18.1	7.2	10.1	126.3	18.5	2.0	13.3	6.5	51.3	71.7	11.3	8.8	22.5	1.4	9.5	1.0	87.4	48.8	14.2	17.9	98.2	0.4	15.5	9.1	19.7	12.4	1.7	26.3	55.4	40.4	10.0	16.9	17.7	28.7	9.4	2.0	65.8	42.0	14.4
CTRB1	CTRB	ENSG00000168925	"Chymotrypsinogen B1"	P17538	16	75218988-75226338	"Enzymes, Predicted intracellular proteins, Predicted secreted proteins"	Digestion	"Hydrolase, Protease, Serine protease"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	2384	"pancreas: 133851.7"	"Cell type enriched"	"Detected in some"	21	"Exocrine glandular cells: 31269.6"	"Cancer enriched"	"Detected in some"	1905	"pancreatic cancer: 962.5"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"EFO-21: 2.2;HDLM-2: 1.6"														"Secreted to digestive system"	NA	NA				"Cluster 25: Pancreas - Digestion"	"Cluster 38: EFO-21 - Unknown function"	"Cluster 1: Pancreatic cells - Digestion"								"unprognostic (1.76e-1)"				"unprognostic (2.62e-1)"	"unprognostic (3.55e-1)"	"unprognostic (1.57e-1)"	"unprognostic (5.22e-2)"	"unprognostic (4.43e-3)"	"unprognostic (2.96e-1)"		"unprognostic (1.17e-2)"		25.5	5.1	0.2	2.1	0.2	1.0	9.5	0.5	0.3	10.4	0.0	4.3	16.6	4.2	0.5	6.8	3.0	0.0	22.3	0.0	0.0	4.4	13.2	2.9	2.6	0.1	0.1	56.1	133851.7	0.0	7.2	6.5	0.1	5.6	0.0	0.0	22.3	0.2	3.8	5.8	8.9	0.0	0.0	11.7	7.6	3.4	0.1	0.0	2.8	0.1	0.0	2.4	3.4	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	2.2	0.0	0.1	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.9	0.1	0.7	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.5	0.3	0.0	0.0	0.1	0.1	0.1	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	39.7	0.0	0.1	0.1	2.0	0.0	0.0	0.1	31269.6	0.0	0.1	0.0	0.1	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	151.9	0.0	0.0	0.0	0.1	1430.4	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	7.9	0.0	0.2	0.0	0.0	0.0	0.0	1.2	0.0	0.0
CTRB2		ENSG00000168928	"Chymotrypsinogen B2"	Q6GPI1	16	75204103-75207161	"Enzymes, Predicted intracellular proteins, Predicted secreted proteins"	Digestion	"Hydrolase, Protease, Serine protease"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	2443	"pancreas: 98661.0"	"Cell type enriched"	"Detected in some"	9	"Exocrine glandular cells: 53114.3"	"Cancer enriched"	"Detected in single"	1696	"pancreatic cancer: 540.0"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"EFO-21: 2.4;U-2 OS: 5.8;U-251 MG: 1.6;U-266/84: 1.8;U-698: 1.6"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"								"Secreted to digestive system"	NA	NA				"Cluster 25: Pancreas - Digestion"	"Cluster 9: U-2 OS - Unknown function"	"Cluster 1: Pancreatic cells - Digestion"					"unprognostic (9.41e-4)"			"unprognostic (2.20e-1)"	"unprognostic (1.28e-2)"		"unprognostic (2.10e-1)"	"unprognostic (2.92e-2)"	"unprognostic (2.77e-1)"	"unprognostic (5.95e-2)"	"unprognostic (9.56e-2)"	"unprognostic (3.54e-3)"	"unprognostic (7.06e-2)"	"unprognostic (2.17e-1)"	"unprognostic (7.57e-2)"		27.8	4.8	0.2	1.5	0.2	1.8	9.1	0.4	0.3	8.2	0.0	4.4	9.1	4.7	0.1	6.6	3.7	0.2	13.7	0.1	0.2	4.5	12.8	3.1	2.8	0.2	0.1	40.3	98661.0	0.0	5.7	5.6	0.2	11.8	0.0	0.0	16.7	0.1	3.7	5.2	6.6	0.0	0.1	7.2	8.1	3.7	0.2	0.0	3.1	0.0	0.0	2.8	4.8	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	2.4	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	5.8	0.0	1.6	0.0	1.8	1.6	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.4	0.3	0.1	0.2	0.2	0.1	0.2	0.1	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	108.8	2.0	0.3	0.0	1.5	0.0	0.0	0.0	53114.3	0.1	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	7.9	0.3	6.0	0.0	0.0	215.5	0.0	0.0	0.0	0.0	5324.0	0.0	0.7	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	30.2	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.1
CTRC	"CLCR, ELA4"	ENSG00000162438	"Chymotrypsin C"	Q99895	1	15438442-15449242	"Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted secreted proteins"		"Hydrolase, Protease, Serine protease"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	3927	"pancreas: 25708.5"	"Cell type enriched"	"Detected in some"	9	"Exocrine glandular cells: 6566.4"	"Cancer enriched"	"Detected in some"	168	"pancreatic cancer: 236.0"	"Not detected"	"Not detected"			"Immune cell enhanced"	"Detected in single"		"basophil: 1.0"	"Low lineage specificity"	"Detected in single"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA046920	Enhanced				"Secreted to digestive system"	NA	NA			"Cluster 11: Basophils - Unknown function"	"Cluster 25: Pancreas - Digestion"		"Cluster 1: Pancreatic cells - Digestion"			"HPA046920: AB_2679865"	"unprognostic (2.62e-2)"	"unprognostic (2.58e-1)"	"unprognostic (1.34e-1)"	"unprognostic (2.81e-1)"	"unprognostic (8.60e-2)"	"unprognostic (1.06e-1)"	"unprognostic (1.02e-1)"	"unprognostic (1.23e-1)"	"unprognostic (2.94e-2)"	"unprognostic (7.60e-2)"	"unprognostic (3.34e-1)"	"unprognostic (2.00e-1)"	"unprognostic (9.55e-11)"	"unprognostic (4.98e-2)"	"unprognostic (1.84e-1)"	"unprognostic (1.50e-1)"	"unprognostic (5.99e-3)"	6.5	1.2	0.2	0.2	0.2	0.7	2.9	0.7	0.3	2.7	0.2	1.2	1.1	1.3	0.1	1.9	0.8	0.0	2.3	0.3	0.1	1.2	3.5	1.0	0.3	0.1	0.1	5.6	25708.5	0.0	1.5	0.7	0.2	1.8	0.0	0.1	2.1	0.0	1.0	2.1	1.7	0.0	0.0	2.0	2.3	1.0	0.2	0.0	1.0	0.0	0.0	0.6	1.0	0.2	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.3	0.1	0.1	0.0	0.0	0.2	0.2	0.7	0.3	0.3	0.1	0.1	0.1	0.2	0.0	0.2	0.2	0.2	0.0	0.5	0.0	0.1	0.1	0.2	0.2	0.0	0.0	0.1	0.0	0.4	0.0	0.1	0.0	0.0	0.1	0.7	0.0	0.0	17.3	0.0	0.6	1.0	0.7	0.0	0.0	0.2	6566.4	0.1	0.2	0.0	2.1	0.0	0.2	0.0	0.0	0.1	0.0	0.2	0.2	0.0	0.0	0.9	0.0	0.0	1.1	1.8	0.0	24.3	0.0	1.0	0.0	0.0	673.8	0.0	0.0	0.1	0.3	0.4	0.1	0.0	0.0	0.0	1.3	3.5	0.0	0.0	0.0	0.3	0.0	0.3	0.0	0.1	0.3
CTSA	"GSL, PPGB"	ENSG00000064601	"Cathepsin A"	P10619	20	45890144-45898824	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"		"Carboxypeptidase, Hydrolase, Protease"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"adrenal gland: 368.3"	"Cell type enhanced"	"Detected in all"		"Distal enterocytes: 445.6;Proximal enterocytes: 301.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"ASC diff: 856.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB024930, HPA031068, HPA072487"	Enhanced		Enhanced	Vesicles	"Intracellular and membrane"	NA	NA		28000000	"Cluster 45: Eosinophils - Innate immune response"	"Cluster 87: Intestine & Kidney - Transmembrane transport"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 51: Myeloid cells - Hemostasis"	Vesicles		"CAB024930: , HPA031068: AB_10601205, HPA072487: "	"unprognostic (8.61e-2)"	"unprognostic (3.37e-1)"	"unprognostic (4.30e-2)"	"unprognostic (2.13e-1)"	"unprognostic (6.42e-2)"	"unprognostic (2.21e-1)"	"prognostic unfavorable (1.95e-4)"	"unprognostic (6.33e-2)"	"unprognostic (9.53e-3)"	"unprognostic (7.19e-2)"	"unprognostic (1.83e-1)"	"unprognostic (6.85e-2)"	"unprognostic (7.57e-2)"	"unprognostic (1.09e-1)"	"unprognostic (6.05e-2)"	"unprognostic (1.71e-1)"	"unprognostic (8.40e-2)"	80.4	368.3	56.8	75.3	58.1	75.6	61.9	63.6	65.6	47.6	96.0	178.6	100.9	55.1	39.0	60.4	39.3	89.7	97.2	59.7	63.8	188.1	95.7	90.9	61.6	62.6	59.1	62.2	52.9	104.4	43.8	76.4	61.4	38.5	170.4	44.0	61.3	48.4	56.0	95.2	109.2	67.3	59.4	108.5	63.3	33.5	70.2	23.0	47.4	61.7	58.8	82.8	49.2	68.4	111.9	114.1	17.6	89.2	856.5	438.6	47.0	150.3	424.0	169.6	217.5	214.4	291.8	24.1	176.2	299.9	638.1	168.6	55.9	105.6	95.7	47.6	53.6	54.3	53.4	375.9	187.3	98.0	240.9	349.0	123.6	107.9	22.5	421.9	190.1	28.2	61.0	355.1	186.9	232.1	25.8	82.4	19.4	172.6	272.1	37.8	107.3	135.7	138.2	96.7	36.9	37.8	263.2	450.3	444.4	51.5	108.5	141.8	172.5	335.0	76.2	178.9	123.7	162.1	238.5	15.7	599.3	128.6	142.4	480.7	305.9	530.5	44.9	168.8	185.5	42.0	75.6	78.3	102.4	25.7	26.6	39.8	152.4	81.2	120.1	40.6	155.4	378.1	56.8	58.1	63.6	65.6	59.7	63.8	62.6	59.1	61.4	59.4	70.2	68.4	53.7	35.3	32.6	26.1	38.2	24.2	38.9	88.8	17.6	58.4	18.4	15.9	12.6	65.8	64.1	71.7	60.5	104.1	27.5	445.6	39.2	246.0	3.3	22.3	39.5	56.0	54.0	22.1	20.4	166.4	109.2	86.8	29.6	62.4	9.5	50.8	102.1	67.9	297.1	47.1	25.2	74.5	95.6	177.1	25.1	4.8	32.9	273.1	112.1	12.2	135.6	86.6	37.0	7.1	10.2	135.0	216.0	27.4	41.9	18.6	301.8	245.8	34.2	46.1	26.3	33.7	54.5	15.3	31.9	24.0	22.9	144.1	49.1	91.3	113.9	36.2
CTSB		ENSG00000164733	"Cathepsin B"	P07858	8	11842524-11869533	"Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted secreted proteins"		"Hydrolase, Protease, Thiol protease"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Hofbauer cells: 2744.5;Kupffer cells: 1774.9;Macrophages: 1224.3"	"Cancer enriched"	"Detected in all"	5	"thyroid cancer: 1446.9"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in all"	4	"basophil: 390.6;classical monocyte: 610.1;intermediate monocyte: 467.3;myeloid DC: 287.4;non-classical monocyte: 307.6;plasmacytoid DC: 410.1"	"Group enriched"	"Detected in all"	6	"dendritic cells: 410.1;granulocytes: 390.6;monocytes: 610.1"	"Cell line enhanced"	"Detected in all"		"BJ hTERT+: 1607.5;fHDF/TERT166: 1436.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB000457, HPA018156, HPA048998"	Enhanced		Supported	Nucleoli,Vesicles	"Secreted to blood"	NA	NA		100000000	"Cluster 25: Monocytes - Inflammatory response"	"Cluster 72: Non-specific - Transcription"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 4: Macrophages - Innate immune response"	Vesicles	Nucleoli	"CAB000457: , HPA018156: AB_1846069, HPA048998: "	"unprognostic (5.74e-2)"	"unprognostic (4.32e-2)"	"unprognostic (1.38e-2)"	"unprognostic (2.17e-2)"	"unprognostic (2.98e-3)"	"unprognostic (5.96e-2)"	"unprognostic (1.36e-2)"	"unprognostic (1.07e-1)"	"unprognostic (2.82e-2)"	"unprognostic (1.06e-1)"	"unprognostic (7.61e-2)"	"unprognostic (8.30e-2)"	"unprognostic (2.85e-1)"	"unprognostic (7.39e-2)"	"unprognostic (4.12e-2)"	"prognostic favorable (5.76e-4)"	"prognostic unfavorable (9.02e-4)"	443.9	304.5	65.6	399.7	71.2	87.0	249.0	65.9	77.2	583.2	101.0	312.4	120.8	379.2	116.9	421.6	368.4	230.6	447.0	64.7	95.5	420.6	497.2	428.9	289.6	100.4	90.8	169.1	135.4	79.6	156.8	253.2	107.4	255.5	159.3	33.6	437.3	156.6	237.4	184.7	260.2	316.1	91.9	521.1	194.3	33.2	204.5	60.9	1150.7	99.3	104.0	431.9	477.8	159.2	66.6	283.4	4.0	94.9	657.3	754.5	128.3	885.0	1607.5	258.4	299.5	10.3	294.4	1.5	32.2	1436.1	419.3	279.5	65.3	157.1	195.6	25.9	52.6	58.8	10.0	397.1	479.2	7.7	73.7	296.4	532.2	327.2	427.3	611.5	33.4	20.2	81.7	260.7	194.6	62.5	6.5	23.1	16.3	839.7	91.3	33.6	39.3	202.7	2.6	121.1	4.9	68.6	165.1	68.6	514.6	110.1	97.8	68.7	922.4	766.5	111.9	129.9	259.3	182.7	178.5	4.8	432.5	22.9	249.4	390.6	610.1	90.6	26.3	467.3	35.4	44.1	79.0	31.5	287.4	38.8	48.3	21.5	97.8	31.3	307.6	410.1	78.7	703.7	65.6	71.2	65.9	77.2	64.7	95.5	100.4	90.8	107.4	91.9	204.5	159.2	87.7	109.0	171.4	17.6	54.8	54.7	441.6	563.2	54.7	55.2	94.1	74.5	320.1	165.8	331.7	114.0	41.7	279.4	122.4	147.9	27.4	294.6	15.6	105.8	240.1	163.0	154.7	210.2	36.2	238.2	341.7	155.0	44.4	183.5	179.4	105.9	204.2	239.5	2744.5	58.9	42.8	94.2	158.7	1774.9	436.5	18.5	76.4	1224.3	161.9	70.3	373.1	117.4	24.7	19.1	12.9	363.9	154.0	92.9	47.3	295.5	198.6	351.8	180.8	40.0	39.5	39.4	149.9	10.8	21.0	160.3	40.5	649.6	56.0	32.1	139.6	321.4
CTSC	"DPP1, PALS, PLS"	ENSG00000109861	"Cathepsin C"	P53634	11	88265069-88359684	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"		"Hydrolase, Protease, Thiol protease"	"Disease variant, Palmoplantar keratoderma"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Basal respiratory cells: 900.7;Club cells: 471.8;Hofbauer cells: 1100.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"BJ hTERT+: 1078.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB025364, HPA066610, HPA068434"	Enhanced		Supported	Vesicles	"Intracellular and membrane"	No	No		19000000	"Cluster 51: Monocytes - Innate immune response"	"Cluster 19: Lung - Lung function"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"	Vesicles		"CAB025364: , HPA066610: AB_2685694, HPA068434: AB_2685989"	"unprognostic (4.05e-2)"	"unprognostic (1.35e-1)"	"unprognostic (1.50e-1)"	"unprognostic (1.10e-1)"	"unprognostic (3.70e-2)"	"unprognostic (1.45e-2)"	"prognostic unfavorable (9.30e-5)"	"unprognostic (1.62e-1)"	"unprognostic (1.04e-1)"	"unprognostic (1.56e-2)"	"unprognostic (3.11e-2)"	"unprognostic (3.35e-1)"	"prognostic favorable (4.80e-4)"	"unprognostic (2.93e-1)"	"unprognostic (4.35e-2)"	"unprognostic (8.10e-2)"	"unprognostic (4.07e-2)"	173.2	60.7	9.9	185.1	9.6	71.7	63.4	11.1	24.9	77.9	14.2	143.1	121.0	43.9	28.5	63.3	54.0	182.0	38.5	9.5	10.1	234.7	82.0	272.6	243.7	14.0	11.9	22.1	52.2	42.4	39.3	253.3	13.3	26.0	191.5	3.7	131.6	28.9	18.8	29.6	128.8	88.9	11.5	197.2	73.6	22.8	19.5	63.7	43.6	31.9	140.6	176.3	43.3	21.3	80.3	75.9	27.6	69.9	103.7	286.1	218.4	626.5	1078.4	372.8	270.3	194.7	361.3	117.3	278.9	365.2	84.3	133.6	50.4	269.2	341.9	204.7	82.8	144.5	188.0	233.5	140.2	188.9	108.7	419.1	198.8	284.5	697.4	302.1	377.6	122.3	155.3	145.4	54.8	14.8	89.1	295.1	172.2	551.5	244.9	113.6	30.7	227.0	451.3	106.6	8.8	66.8	81.2	114.9	80.6	185.4	27.9	152.7	149.3	23.5	190.5	156.8	364.6	61.9	81.0	122.9	56.8	435.8	122.4	85.5	203.8	309.7	230.1	415.6	194.9	47.2	99.6	198.2	209.9	26.3	49.5	115.3	215.0	200.5	582.9	425.0	162.7	243.3	9.9	9.6	11.1	24.9	9.5	10.1	14.0	11.9	13.3	11.5	19.5	21.3	78.6	22.4	88.1	0.3	40.8	30.1	7.3	900.7	33.6	1.5	15.9	14.6	4.4	52.9	471.8	40.5	0.0	414.1	330.6	37.9	29.4	29.8	1.6	13.4	135.6	94.8	11.4	29.7	3.0	90.6	159.2	114.4	39.8	21.2	75.3	25.5	26.4	15.8	1100.6	0.0	8.2	19.4	158.7	344.7	200.7	7.9	198.5	391.7	48.0	61.8	185.4	0.5	299.7	13.6	0.4	44.8	72.3	25.6	78.5	8.5	20.2	166.4	93.7	0.8	59.2	4.4	150.8	3.0	11.1	43.3	27.1	227.3	170.6	286.7	44.9	16.1
CTSD	"CLN10, CPSD"	ENSG00000117984	"Cathepsin D"	P07339	11	1752752-1764573	"Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted secreted proteins"		"Aspartyl protease, Hydrolase, Protease"	"Alzheimer disease, Cancer-related genes, Disease variant, Neurodegeneration, Neuronal ceroid lipofuscinosis"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Distal enterocytes: 1475.9;Hofbauer cells: 3763.5;Macrophages: 1512.6;Proximal enterocytes: 1699.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"CAPAN-2: 2596.6;hTERT-RPE1: 2780.1;SK-BR-3: 2488.5"									"CAB000109, HPA003001"	Supported				"Secreted to blood"	NA	NA		370000000	"Cluster 25: Monocytes - Inflammatory response"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 4: Macrophages - Innate immune response"			"CAB000109: , HPA003001: AB_1078404"	"unprognostic (9.95e-2)"	"unprognostic (1.62e-1)"	"prognostic unfavorable (2.46e-4)"	"unprognostic (1.09e-1)"	"unprognostic (1.71e-3)"	"unprognostic (2.65e-2)"	"unprognostic (9.40e-3)"	"unprognostic (1.11e-1)"	"unprognostic (1.52e-1)"	"unprognostic (1.12e-3)"	"unprognostic (1.59e-1)"	"unprognostic (1.86e-2)"	"prognostic favorable (4.93e-5)"	"unprognostic (8.98e-2)"	"unprognostic (3.39e-2)"	"unprognostic (2.13e-2)"	"unprognostic (1.60e-1)"	318.6	734.6	147.0	204.9	181.9	499.0	244.0	186.0	156.5	270.8	672.7	298.0	387.6	170.7	82.8	319.4	171.6	438.4	444.1	187.8	223.6	691.6	464.8	539.6	241.0	247.6	206.6	130.7	284.8	137.3	131.5	180.7	228.6	138.2	153.4	48.3	422.1	231.7	590.3	340.9	398.3	105.0	188.9	442.0	287.2	88.9	334.4	78.1	182.1	178.2	123.1	296.4	307.5	367.1	204.6	578.9	51.4	246.2	586.5	206.3	112.1	149.4	362.2	161.8	182.8	147.5	2596.6	49.2	376.8	285.8	1265.6	1072.2	63.7	142.6	35.8	206.7	222.9	70.4	92.5	196.5	736.2	171.4	787.7	350.9	621.6	82.5	136.9	2780.1	128.2	62.1	89.2	267.6	263.3	832.6	47.0	110.9	153.1	719.7	247.9	62.5	72.5	191.2	586.6	610.8	84.2	94.8	173.3	2488.5	535.0	68.6	1022.8	232.6	170.3	556.8	92.9	79.0	216.7	432.0	382.3	26.8	867.7	468.6	509.6	211.2	578.7	170.1	156.5	309.9	90.6	28.8	72.1	110.3	144.5	18.8	82.5	107.4	319.5	192.3	265.2	120.3	89.2	489.1	147.0	181.9	186.0	156.5	187.8	223.6	247.6	206.6	228.6	188.9	334.4	367.1	139.3	112.2	228.6	48.3	62.8	72.0	223.5	473.2	71.7	168.6	108.9	113.8	251.9	314.5	459.5	548.1	110.5	211.7	156.1	1475.9	109.5	911.4	3.3	118.1	67.4	128.3	159.6	132.6	18.3	370.1	165.0	157.0	237.5	203.4	474.3	119.4	695.7	678.9	3763.5	264.2	25.2	418.2	498.5	1187.8	67.5	14.6	108.4	1512.6	227.7	20.6	382.6	179.0	256.4	27.2	42.2	392.3	832.5	128.2	122.5	111.7	1699.4	311.8	270.3	102.1	111.7	70.7	135.2	26.6	63.5	141.2	82.1	471.3	155.0	96.0	399.1	357.8
CTSE		ENSG00000196188	"Cathepsin E"	P14091	1	206008535-206023909	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Aspartyl protease, Hydrolase, Protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"stomach 1: 1168.3"	"Cell type enhanced"	"Detected in some"		"Alveolar cells type 1: 105.8;Exocrine glandular cells: 262.8;Gastric mucus-secreting cells: 553.5;Pancreatic endocrine cells: 260.0;Paneth cells: 208.9"	"Cancer enhanced"	"Detected in many"		"pancreatic cancer: 297.4;stomach cancer: 200.8"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	46	"OE19: 1799.1"	"Not detected"	"Not detected"							"HPA012674, HPA012940, CAB032687"	Enhanced		Approved	Vesicles	"Intracellular and membrane"	NA	NA				"Cluster 4: Stomach - Digestion"	"Cluster 21: OE19 - Mitochondria"	"Cluster 16: Pancreatic endocrine cells - Mixed function"	Vesicles		"CAB032687: AB_637901, HPA012674: , HPA012940: AB_2668773"	"unprognostic (1.17e-2)"	"unprognostic (2.45e-1)"	"unprognostic (1.31e-2)"	"unprognostic (2.72e-2)"		"unprognostic (1.35e-2)"	"unprognostic (2.52e-3)"	"unprognostic (1.45e-1)"	"unprognostic (3.29e-2)"	"unprognostic (2.87e-2)"	"unprognostic (1.20e-2)"	"unprognostic (1.39e-1)"	"unprognostic (6.37e-3)"	"unprognostic (1.42e-1)"	"unprognostic (5.45e-2)"	"unprognostic (2.61e-2)"	"prognostic favorable (5.26e-5)"	0.3	0.0	0.1	9.5	0.1	30.0	0.0	0.5	0.3	0.0	0.1	15.3	229.8	0.3	1.7	0.8	1.1	15.0	0.3	0.1	0.1	0.2	0.2	49.7	0.5	0.3	0.1	0.1	3.7	0.0	1.1	1.3	0.3	0.2	25.7	0.1	0.0	1.6	0.0	0.1	55.5	0.3	0.1	0.6	1168.3	0.1	0.3	0.5	8.9	0.0	10.7	5.8	0.2	0.5	0.3	0.0	0.0	0.0	0.0	0.0	20.2	0.0	0.0	0.0	0.0	0.8	0.8	0.0	3.8	0.0	0.7	0.6	0.0	0.0	0.0	0.0	0.0	0.7	0.2	2.4	0.0	1.0	3.9	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.2	0.1	0.0	0.0	0.8	1.5	0.7	1799.1	0.1	0.4	0.0	0.8	0.7	39.4	0.2	0.5	0.0	0.0	0.4	0.1	0.1	0.1	0.0	0.0	0.7	0.0	0.2	0.3	0.0	0.1	0.0	0.0	0.2	0.5	0.1	0.0	0.1	0.1	0.1	0.2	0.1	0.1	0.1	0.3	0.2	0.1	0.6	0.2	0.1	0.2	0.1	0.0	0.1	0.1	0.5	0.3	0.1	0.1	0.3	0.1	0.3	0.1	0.3	0.5	0.0	105.8	27.9	0.0	0.6	0.0	0.1	0.6	0.0	0.0	0.0	0.0	0.5	10.0	42.3	0.0	0.0	0.0	0.0	34.1	0.0	52.0	0.0	0.3	0.0	0.3	2.4	60.6	0.0	262.8	0.1	14.7	553.5	0.6	0.0	0.0	0.0	0.2	0.2	0.0	0.0	21.1	0.0	0.3	0.0	0.0	0.0	0.9	0.0	0.0	1.6	0.0	0.0	0.0	0.1	260.0	208.9	0.0	0.7	0.1	4.0	0.1	7.3	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.5	0.1	10.4	0.4
CTSF	"CATSF, CLN13"	ENSG00000174080	"Cathepsin F"	Q9UBX1	11	66563464-66568879	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"		"Hydrolase, Protease, Thiol protease"	"Disease variant, Neurodegeneration, Neuronal ceroid lipofuscinosis"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Late spermatids: 320.9;Muller glia cells: 196.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"SiHa: 23.1;SK-MEL-30: 59.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB002141, HPA031431"	Approved		Supported	"Endoplasmic reticulum,Vesicles,Plasma membrane"	"Intracellular and membrane"	NA	NA		5800000	"Cluster 15: NK-cells - Transcription"	"Cluster 35: Non-specific - Unknown function"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 5: Muller glia cells - Visual perception"	Vesicles	"Endoplasmic reticulum, Plasma membrane"	"CAB002141: AB_563471, HPA031431: "	"unprognostic (1.52e-2)"	"unprognostic (1.08e-1)"	"unprognostic (1.03e-1)"	"unprognostic (7.22e-3)"	"unprognostic (2.25e-2)"	"unprognostic (6.72e-2)"	"unprognostic (2.67e-2)"	"unprognostic (2.76e-2)"	"unprognostic (3.69e-1)"	"unprognostic (4.14e-1)"	"unprognostic (1.69e-2)"	"unprognostic (9.12e-2)"	"prognostic favorable (8.92e-7)"	"unprognostic (1.36e-2)"	"unprognostic (1.28e-1)"	"unprognostic (3.89e-1)"	"unprognostic (2.42e-1)"	57.8	70.0	68.1	0.8	76.3	0.3	62.2	74.5	74.0	78.8	90.2	76.7	3.0	89.2	21.9	15.6	70.8	10.0	100.2	63.2	74.2	46.9	66.0	32.9	3.6	75.0	70.3	99.1	31.7	20.0	43.3	3.8	68.4	53.5	3.5	26.2	55.7	17.1	91.9	44.4	29.5	12.2	77.2	25.0	54.3	109.7	71.0	3.0	40.6	27.6	3.0	56.6	58.7	86.6	0.0	17.0	3.1	5.4	14.2	8.6	3.4	13.0	11.4	6.3	2.3	0.0	2.2	0.0	21.3	10.4	0.0	1.2	6.8	2.6	4.8	3.7	0.0	0.5	7.0	0.0	9.9	0.3	4.4	22.3	9.1	0.8	1.6	13.7	3.8	2.0	5.4	1.6	5.2	4.6	0.1	1.7	0.9	3.7	9.7	0.0	0.0	1.5	7.1	0.3	4.3	6.9	23.1	0.3	59.5	0.3	7.4	0.6	3.3	1.8	2.9	1.5	1.2	21.2	0.2	0.0	2.2	0.0	2.9	0.0	0.4	0.3	3.9	0.6	4.1	1.5	3.5	4.6	0.6	1.4	6.4	4.1	0.1	4.6	0.2	0.9	1.3	2.2	68.1	76.3	74.5	74.0	63.2	74.2	75.0	70.3	68.4	77.2	71.0	86.6	36.6	12.8	15.6	31.3	5.9	39.8	62.4	8.5	37.5	107.9	45.3	80.6	57.9	41.5	7.4	36.8	41.7	31.6	9.6	0.6	15.6	13.1	163.3	1.7	22.8	27.2	12.0	11.4	26.5	7.5	9.5	118.1	8.2	5.3	9.5	52.1	56.0	67.8	14.9	134.6	31.3	3.1	18.3	21.5	32.8	320.9	145.7	13.1	156.5	12.2	3.1	196.6	17.5	21.6	29.4	5.9	3.2	121.9	12.9	50.5	1.3	44.7	3.3	77.9	78.9	62.0	45.9	169.6	43.3	3.6	25.3	23.7	9.5	30.7	4.3	32.9
CTSG	CG	ENSG00000100448	"Cathepsin G"	P08311	14	24573518-24576250	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"		"Antibiotic, Antimicrobial, Hydrolase, Protease, Serine protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	154	"bone marrow: 5352.9"	"Cell type enriched"	"Detected in some"	16	"granulocytes: 534.9"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enriched"	"Detected in some"	7	"THP-1: 8681.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"CAB000110, HPA047737"	Enhanced				"Intracellular and membrane"	NA	NA		330000	"Cluster 33: Neutrophils - Chromatin organization"	"Cluster 67: Neutrophils - Humoral immune response"	"Cluster 43: THP-1 - Innate immune response"	"Cluster 60: Granulocytes - Receptor signaling"			"CAB000110: , HPA047737: AB_2680140"	"unprognostic (1.67e-1)"	"unprognostic (2.57e-2)"	"unprognostic (6.92e-2)"	"unprognostic (1.08e-1)"		"prognostic favorable (1.57e-4)"	"unprognostic (4.05e-2)"	"unprognostic (4.13e-2)"	"unprognostic (3.06e-1)"	"unprognostic (2.42e-1)"	"unprognostic (2.60e-2)"	"unprognostic (2.05e-2)"	"unprognostic (1.63e-3)"	"unprognostic (1.07e-2)"	"unprognostic (1.09e-1)"	"unprognostic (1.37e-1)"	"prognostic unfavorable (8.91e-4)"	23.4	0.1	0.0	13.5	0.0	5352.9	25.4	0.0	0.0	16.6	0.0	25.5	5.8	9.6	10.2	22.1	2.7	25.9	3.7	0.0	0.0	2.3	3.6	11.6	6.5	0.0	0.0	0.5	3.5	1.5	1.0	2.9	0.0	3.7	25.5	0.0	11.5	4.8	1.8	28.0	18.1	7.7	0.0	16.9	4.9	3.2	0.0	26.0	0.8	7.6	6.0	34.8	4.1	0.0	6.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.4	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	303.1	0.8	0.0	0.0	0.0	0.0	0.0	0.0	33.2	0.0	0.1	0.0	0.0	3.6	41.5	0.0	0.0	0.0	0.0	0.6	0.1	0.0	0.0	0.0	0.0	1.2	0.0	3.6	0.0	0.0	8681.4	0.0	0.0	0.3	0.0	5.3	0.0	0.8	2.8	0.0	1287.5	0.1	0.0	6.0	0.0	1.1	1.0	0.0	0.0	0.9	3.4	5.4	0.0	0.0	1.7	7.3	5.0	0.0	6.5	0.0	19.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	12.8	33.3	0.0	0.2	6.4	0.0	0.0	0.0	0.0	0.0	0.0	2.5	0.0	2.5	0.0	0.0	0.0	0.1	0.0	0.0	0.0	6.3	0.0	0.0	2.4	0.0	1.3	0.0	0.0	0.1	1.0	0.0	0.0	534.9	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.6	11.1	9.1	0.0	1.5	5.4	0.0	1.8	0.0	2.1	0.0	0.0	0.0	0.0	0.0	5.3	0.0	0.0	0.0	0.7	0.0	0.0	0.2	1.3	0.3	1.7	0.0	4.0	0.0	5.1	0.0	0.4	0.0
CTSH	"ACC-4, ACC-5, ACC4, ACC5, CPSB"	ENSG00000103811	"Cathepsin H"	P09668	15	78921058-78949574	"Cancer-related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"		"Hydrolase, Protease, Thiol protease"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lung: 349.6"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 2: 1569.9;Proximal tubular cells: 523.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"classical monocyte: 208.5;intermediate monocyte: 137.7;memory B-cell: 83.3;myeloid DC: 183.6;naive B-cell: 56.0;non-classical monocyte: 94.8"	"Group enriched"	"Detected in all"	5	"B-cells: 83.3;dendritic cells: 183.6;monocytes: 208.5"	"Cell line enhanced"	"Detected in many"		"CAPAN-2: 306.4;HaCaT: 228.2;HDLM-2: 183.0;OE19: 197.4;RT4: 362.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB000458, HPA003524"	Enhanced		Supported	"Vesicles,Cytosol,Cytoplasmic bodies"	"Intracellular and membrane"	NA	NA		8700000	"Cluster 25: Monocytes - Inflammatory response"	"Cluster 87: Intestine & Kidney - Transmembrane transport"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 11: Alveolar cells - Smell perception"	"Vesicles, Cytosol, Cytoplasmic bodies"		"CAB000458: , HPA003524: AB_1846075"	"unprognostic (6.47e-2)"	"unprognostic (4.65e-3)"	"unprognostic (1.05e-1)"	"prognostic favorable (6.90e-4)"	"unprognostic (4.37e-2)"	"unprognostic (1.93e-1)"	"unprognostic (7.18e-2)"	"unprognostic (3.30e-3)"	"unprognostic (2.22e-1)"	"unprognostic (5.96e-2)"	"unprognostic (4.10e-2)"	"unprognostic (3.89e-2)"	"unprognostic (6.63e-3)"	"unprognostic (3.83e-1)"	"unprognostic (4.42e-2)"	"unprognostic (2.70e-3)"	"unprognostic (1.79e-3)"	34.3	36.4	29.4	100.6	30.2	36.9	48.8	29.9	47.1	112.8	31.4	32.5	77.8	46.7	26.8	37.9	57.6	104.6	51.3	29.6	32.9	238.2	89.5	349.6	191.8	30.8	31.4	30.0	75.5	77.6	10.1	25.7	31.5	59.7	27.3	4.7	63.0	70.7	16.3	48.4	56.7	43.1	30.7	51.8	93.9	10.1	32.7	51.8	27.7	37.7	131.3	202.2	30.6	32.4	122.0	10.0	1.2	30.5	5.4	0.5	20.3	8.6	3.0	13.9	7.0	17.6	306.4	34.6	12.6	0.0	13.5	228.2	5.2	52.6	10.1	183.0	0.4	3.0	1.3	38.4	12.1	0.4	7.1	5.6	10.7	0.2	0.0	59.4	1.0	5.9	76.0	0.0	17.9	2.8	32.6	87.8	8.9	197.4	4.9	0.3	0.4	5.9	49.9	362.1	2.6	5.2	41.5	27.8	75.4	10.1	12.5	48.0	16.4	0.2	6.2	0.0	5.3	0.8	92.4	19.5	0.1	89.2	12.3	0.0	208.5	2.0	7.6	137.7	29.7	83.3	20.5	7.4	183.6	56.0	1.8	3.8	8.7	3.2	94.8	22.9	18.3	147.5	29.4	30.2	29.9	47.1	29.6	32.9	30.8	31.4	31.5	30.7	32.7	32.4	169.8	237.2	1569.9	59.1	127.4	24.2	280.7	363.9	30.1	1.3	45.5	41.7	26.2	358.9	258.7	367.8	4.2	19.8	8.1	9.1	84.1	225.0	25.3	67.0	86.0	124.5	9.1	3.0	2.2	142.0	39.6	53.8	106.0	42.8	32.8	2.7	14.3	115.5	256.7	0.0	2.9	18.6	101.7	177.8	259.6	22.6	73.0	350.4	80.0	15.9	360.9	22.6	5.2	1.5	1.1	84.6	16.0	6.0	155.8	112.0	153.0	523.2	261.6	6.6	19.7	4.5	22.3	12.3	56.4	41.6	18.6	23.4	29.4	17.8	40.1	340.4
CTSK	"CTSO, CTSO2, PKND, PYCD"	ENSG00000143387	"Cathepsin K"	P43235	1	150794880-150809577	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"		"Hydrolase, Protease, Thiol protease"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"cervix: 420.6"	"Cell type enhanced"	"Detected in many"		"Fibroblasts: 372.4;Langerhans cells: 123.6;Leydig cells: 119.0;Melanocytes: 97.8;Peritubular cells: 149.7;Theca cells: 80.9"	"Low cancer specificity"	"Detected in all"			"Region enriched"	"Detected in all"	6	"cerebral cortex: 18.1"	"Immune cell enhanced"	"Detected in some"		"classical monocyte: 1.8"	"Lineage enriched"	"Detected in single"	4	"monocytes: 1.8"	"Group enriched"	"Detected in many"	9	"ASC diff: 2284.0;ASC TERT1: 813.2;BJ hTERT+: 1949.1"	"Low region specificity"	"Detected in all"							HPA050346			Supported	Vesicles	"Intracellular and membrane"	NA	NA			"Cluster 25: Monocytes - Inflammatory response"	"Cluster 46: Fibroblasts - ECM organization"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 50: Fibroblasts - ECM organization"	Vesicles		"HPA050346: AB_2681101"	"unprognostic (1.48e-1)"	"unprognostic (9.29e-2)"	"unprognostic (1.21e-1)"	"unprognostic (7.61e-3)"	"unprognostic (5.08e-2)"	"unprognostic (6.57e-2)"	"unprognostic (1.02e-1)"	"unprognostic (6.60e-2)"	"unprognostic (2.11e-1)"	"unprognostic (1.01e-1)"	"unprognostic (1.49e-1)"	"unprognostic (3.54e-2)"	"prognostic unfavorable (7.12e-5)"	"unprognostic (6.07e-3)"	"unprognostic (2.98e-2)"	"unprognostic (5.93e-3)"	"unprognostic (6.41e-2)"	224.1	12.5	2.7	33.1	2.8	3.1	227.7	2.9	18.1	420.6	16.4	68.6	13.8	334.0	44.9	46.0	74.0	299.2	35.8	2.7	2.6	12.7	9.0	36.4	42.1	2.7	2.7	78.4	10.6	6.1	14.6	18.9	2.6	34.1	61.8	6.9	53.3	38.0	15.7	219.8	63.8	141.6	2.8	20.2	41.7	15.1	2.7	12.3	34.7	46.3	48.7	210.5	176.2	2.9	0.7	0.3	1.4	0.8	2284.0	813.2	1.0	55.2	1949.1	3.3	8.3	0.3	0.3	0.4	0.6	129.8	0.0	0.6	0.3	0.4	1.2	0.4	0.4	1.4	0.5	0.0	11.0	0.2	1.3	156.5	1.7	50.5	0.7	137.6	4.2	0.6	0.4	1.4	1.5	1.4	0.0	3.0	10.2	1.0	0.0	0.2	0.1	0.1	3.2	0.1	0.6	2.9	0.4	0.0	29.3	3.9	1.0	1.5	1.0	0.7	0.5	0.6	0.6	2.3	1.7	3.6	184.1	0.0	9.9	0.0	1.8	0.2	0.0	1.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.1	0.3	0.2	0.4	0.6	2.7	2.8	2.9	18.1	2.7	2.6	2.7	2.7	2.6	2.8	2.7	2.9	17.9	3.2	4.6	2.6	1.1	68.8	0.5	1.6	2.2	12.1	3.7	9.5	2.0	1.5	3.9	3.7	4.2	1.3	2.8	1.5	0.0	1.0	0.9	2.5	59.0	10.2	1.2	0.8	5.0	0.2	2.5	372.4	11.2	3.8	0.0	77.5	14.6	0.5	21.4	3.3	7.7	1.6	8.2	4.6	123.6	4.4	119.0	8.7	97.8	7.5	4.9	2.7	3.1	7.1	2.5	1.4	1.4	149.7	0.8	1.0	1.4	0.1	2.2	7.7	13.1	4.5	33.9	1.4	1.0	2.6	59.1	1.0	5.4	80.9	1.0	0.7
CTSL	"CTSL1, FLJ31037"	ENSG00000135047	"Cathepsin L"	P07711	9	87724051-87731469	"Cancer-related genes, Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"		"Hydrolase, Protease, Thiol protease"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"placenta: 563.6"	"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 1081.6;Extravillous trophoblasts: 1012.3;Hepatic stellate cells: 580.4;Hofbauer cells: 1105.7;Macrophages: 537.2;Syncytiotrophoblasts: 1543.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	10	"intermediate monocyte: 128.1;non-classical monocyte: 195.2"	"Lineage enriched"	"Detected in many"	12	"monocytes: 195.2"	"Cell line enhanced"	"Detected in many"		"ASC TERT1: 2305.0;HSkMC: 1061.0"					"Low region specificity"	"Detected in all"			"CAB000459, HPA070413"	Enhanced		Approved	"Golgi apparatus,Vesicles"	"Intracellular and membrane"	NA	NA		17000000	"Cluster 51: Monocytes - Innate immune response"	"Cluster 86: Liver & Placenta - Transport via ER"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 4: Macrophages - Innate immune response"	"Golgi apparatus, Vesicles"		"CAB000459: AB_2292484, HPA070413: "	"unprognostic (1.05e-1)"	"unprognostic (1.01e-1)"	"unprognostic (1.24e-2)"	"unprognostic (1.53e-1)"	"prognostic unfavorable (3.73e-4)"	"unprognostic (1.19e-3)"	"unprognostic (8.12e-3)"	"prognostic unfavorable (5.15e-5)"	"unprognostic (2.09e-1)"	"unprognostic (3.15e-1)"	"unprognostic (6.80e-2)"	"unprognostic (3.21e-1)"	"prognostic favorable (4.34e-4)"	"unprognostic (5.64e-3)"	"unprognostic (2.26e-2)"	"unprognostic (1.72e-1)"	"unprognostic (7.11e-3)"	232.4	86.6	49.2	136.0	55.4	84.8	110.0	52.9	67.5	69.5	67.9	110.3	39.7	108.1	81.6	33.3	108.4	85.0	112.5	47.0	52.3	207.3	333.5	154.9	101.1	54.4	54.0	96.4	61.9	151.1	69.5	563.6	57.5	68.2	58.8	32.3	77.6	91.7	71.9	39.8	57.1	125.2	52.4	124.4	71.4	80.1	112.2	33.0	76.1	79.8	49.4	209.8	48.0	59.6	88.1	423.0	32.6	55.3	514.0	2305.0	198.4	267.2	781.8	232.2	300.6	43.0	86.3	0.0	128.9	355.4	754.0	67.5	49.8	86.0	198.4	1.9	37.8	18.1	111.2	105.1	352.6	0.1	51.4	1061.0	138.9	373.7	134.9	186.6	194.9	0.0	162.5	0.7	326.6	115.6	0.5	9.9	67.7	128.6	77.5	21.6	21.5	0.6	158.6	39.0	42.8	50.6	62.1	133.5	312.3	177.9	14.5	97.9	296.9	190.8	104.7	750.6	125.9	18.5	84.1	0.9	692.6	0.2	67.9	0.3	13.5	0.6	0.3	128.1	0.0	0.0	6.6	0.1	7.9	0.1	16.7	1.3	0.5	0.2	195.2	0.3	1.7	10.1	49.2	55.4	52.9	67.5	47.0	52.3	54.4	54.0	57.5	52.4	112.2	59.6	86.1	41.7	52.9	15.3	11.2	37.7	82.1	58.0	15.4	43.8	12.2	33.4	96.8	87.2	46.4	75.4	18.8	1081.6	0.3	16.3	27.4	91.8	5.3	48.1	119.9	110.0	11.5	251.2	18.6	93.4	1012.3	261.7	10.2	27.6	29.7	63.6	580.4	122.6	1105.7	13.5	24.0	8.5	20.3	206.9	105.4	17.4	156.9	537.2	64.0	14.0	16.2	79.5	0.0	17.6	31.7	67.2	5.6	187.3	1.9	34.5	8.0	138.3	67.3	45.4	92.1	176.9	136.3	207.4	60.5	6.8	34.0	1543.6	10.8	30.8	11.7	44.8
CTSO	CTSO1	ENSG00000256043	"Cathepsin O"	P43234	4	155921580-155953912	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Hydrolase, Protease, Thiol protease"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"ASC TERT1: 37.1;HSkMC: 44.6;Karpas-707: 85.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA002041	Approved				"Intracellular and membrane"	NA	NA		25000	"Cluster 44: Non-specific - Transcription"	"Cluster 85: Liver - Metabolism"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 50: Fibroblasts - ECM organization"			"HPA002041: AB_1078408"	"unprognostic (3.96e-3)"	"unprognostic (1.62e-2)"	"unprognostic (1.03e-1)"	"unprognostic (1.33e-2)"	"unprognostic (9.10e-3)"	"unprognostic (2.55e-1)"	"unprognostic (3.80e-3)"	"unprognostic (2.07e-1)"	"unprognostic (6.62e-2)"	"unprognostic (1.33e-1)"	"unprognostic (2.20e-1)"	"unprognostic (1.05e-1)"	"unprognostic (7.55e-2)"	"unprognostic (4.87e-3)"	"unprognostic (4.73e-2)"	"unprognostic (1.11e-1)"	"unprognostic (1.79e-1)"	19.1	31.5	8.0	17.8	8.0	5.0	31.9	6.2	11.8	36.7	7.9	19.6	32.8	37.2	36.1	16.7	36.9	40.7	20.2	7.8	7.6	34.5	98.8	36.8	24.5	7.1	7.5	28.0	19.9	24.5	9.6	41.2	6.9	29.8	23.2	5.2	22.1	32.2	6.7	10.0	34.0	30.7	7.0	39.7	15.5	9.4	7.4	14.1	34.5	17.8	17.9	28.0	15.4	7.6	0.8	0.6	4.1	3.7	17.3	37.1	0.2	1.6	18.3	3.3	5.7	0.4	14.4	0.2	1.2	6.8	1.2	0.1	0.2	0.1	2.6	1.6	0.1	0.4	0.5	0.2	18.1	1.4	0.2	44.6	3.5	2.2	1.8	25.6	3.5	0.7	0.3	85.8	11.7	0.7	1.1	0.4	0.7	0.6	0.7	4.8	0.5	1.0	16.8	7.5	0.5	4.3	2.4	9.3	2.3	2.0	4.2	2.6	3.0	13.3	0.7	0.4	2.3	8.3	0.2	0.2	24.4	0.3	18.6	5.3	0.9	0.6	1.2	0.7	3.0	1.2	1.4	0.8	0.4	1.5	1.6	2.0	0.7	3.0	0.9	1.0	3.3	1.4	8.0	8.0	6.2	11.8	7.8	7.6	7.1	7.5	6.9	7.0	7.4	7.6	29.3	38.5	20.8	15.0	19.9	10.5	13.1	11.3	12.0	10.4	20.1	13.0	5.0	44.3	14.3	25.8	2.1	20.5	19.6	15.6	13.7	24.6	0.4	20.9	34.6	28.2	6.7	8.6	1.7	20.7	7.7	51.5	8.6	27.3	8.8	25.0	43.2	58.1	16.3	5.0	1.7	7.9	8.2	29.2	23.7	1.5	30.4	21.4	30.2	7.5	26.5	17.0	22.6	36.7	5.4	12.7	6.3	25.2	7.0	17.5	21.1	10.7	14.5	1.9	19.7	34.0	24.6	0.3	2.1	5.9	9.1	10.5	14.5	14.3	6.6	9.5
CTSS		ENSG00000163131	"Cathepsin S"	P25774	1	150730079-150765957	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"		"Hydrolase, Protease, Thiol protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 137.0;lymphoid tissue: 164.8"	"Cell type enhanced"	"Detected in many"		"Hofbauer cells: 698.6;Kupffer cells: 2230.8;Macrophages: 1316.2;monocytes: 2312.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"classical monocyte: 2483.4"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"CAPAN-2: 81.6;HMC-1: 187.5;U-698: 387.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB000460, HPA002988"	Supported		Approved	Vesicles	"Intracellular and membrane"	NA	NA		23000000	"Cluster 25: Monocytes - Inflammatory response"	"Cluster 64: Macrophages - Immune response"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 19: Monocytes & Neutrophils - Innate immune response"	Vesicles		"CAB000460: , HPA002988: AB_1078409"	"unprognostic (7.81e-2)"	"unprognostic (9.04e-2)"	"unprognostic (3.23e-2)"	"unprognostic (3.93e-2)"	"unprognostic (1.52e-1)"	"unprognostic (1.12e-2)"	"unprognostic (1.11e-1)"	"unprognostic (1.23e-1)"	"unprognostic (1.59e-1)"	"unprognostic (6.00e-3)"	"unprognostic (1.46e-1)"	"unprognostic (3.89e-1)"	"unprognostic (6.24e-2)"	"unprognostic (7.50e-2)"	"unprognostic (4.14e-2)"	"unprognostic (2.13e-1)"	"unprognostic (2.47e-3)"	40.0	16.7	4.0	87.8	4.5	137.0	20.3	4.8	7.1	9.4	8.0	83.6	60.2	7.8	5.7	16.5	17.8	29.1	10.6	3.4	5.5	9.3	40.4	88.4	71.7	11.8	8.0	4.9	11.3	2.3	4.7	23.6	11.2	9.1	59.4	3.4	23.9	7.3	4.1	7.1	64.6	16.3	7.7	164.8	42.6	3.8	10.4	20.1	11.5	9.0	38.5	42.9	10.0	16.1	3.7	10.9	0.2	0.3	1.2	1.4	0.7	0.4	8.6	0.9	1.3	1.2	81.6	44.3	5.7	1.2	15.3	2.1	0.2	0.7	0.5	26.9	0.2	29.0	1.1	0.8	0.2	33.6	187.5	2.6	0.1	6.6	1.5	0.5	6.3	0.6	3.4	45.0	2.4	0.3	0.4	22.5	0.2	0.1	0.3	14.9	4.6	49.8	10.7	8.7	0.3	0.4	1.1	2.3	0.8	0.3	0.4	49.8	9.1	6.2	1.3	0.8	1.2	27.8	2.2	387.3	28.5	35.2	2.3	20.9	2483.4	218.0	41.3	1735.3	51.1	139.5	46.6	50.9	571.0	138.8	45.0	40.8	1022.2	41.8	1655.1	106.8	77.4	2577.6	4.0	4.5	4.8	7.1	3.4	5.5	11.8	8.0	11.2	7.7	10.4	16.1	37.6	109.0	158.7	1.6	255.3	17.0	31.3	72.0	4.6	2.3	21.0	8.9	5.3	74.4	143.4	42.3	12.5	3.7	198.0	549.2	0.0	183.6	6.6	126.9	8.6	44.1	42.4	22.5	10.3	177.0	5.7	34.4	71.9	39.0	106.8	9.5	60.3	30.6	698.6	0.0	9.5	205.7	73.2	2230.8	316.4	3.0	5.3	1316.2	56.9	27.2	2312.9	0.5	137.0	0.5	0.9	200.9	466.5	2.2	121.4	20.6	210.8	4.7	488.9	4.9	19.7	5.6	13.3	0.2	0.5	12.4	15.5	6.2	108.9	66.0	237.8	113.3
CTSV	"CTSL2, CTSU"	ENSG00000136943	"Cathepsin V"	O60911	9	97029677-97156556	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Hydrolase, Protease, Thiol protease"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	10	"lymphoid tissue: 643.6"	"Cell type enhanced"	"Detected in many"		"Basal respiratory cells: 63.7;Cytotrophoblasts: 122.3;Extravillous trophoblasts: 153.0;Granulosa cells: 54.2;Syncytiotrophoblasts: 67.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Immune cell enriched"	"Detected in some"	4	"plasmacytoid DC: 15.1"	"Lineage enriched"	"Detected in many"	4	"dendritic cells: 15.1"	"Group enriched"	"Detected in many"	8	"BEWO: 592.6;SuSa: 739.0"					"Low region specificity"	"Detected in all"			CAB017112	Uncertain		Approved	"Nucleoplasm,Nucleoli fibrillar center,Plasma membrane,Cytosol"	"Intracellular and membrane"	NA	NA		370000	"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 63: T-cells - Adaptive immune response"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 38: Extravillous trophoblasts - Unknown function"	"Nucleoli fibrillar center, Cytosol"	"Nucleoplasm, Plasma membrane"	"CAB017112: "	"unprognostic (2.40e-1)"	"unprognostic (2.74e-2)"	"unprognostic (1.50e-1)"	"prognostic favorable (8.41e-4)"	"unprognostic (7.29e-2)"	"unprognostic (5.59e-2)"	"prognostic unfavorable (2.83e-5)"	"unprognostic (7.04e-3)"	"unprognostic (6.06e-2)"	"unprognostic (1.39e-2)"	"prognostic unfavorable (2.87e-4)"	"unprognostic (1.86e-2)"	"unprognostic (1.78e-1)"	"unprognostic (2.41e-2)"	"unprognostic (1.33e-1)"	"unprognostic (3.04e-3)"	"prognostic unfavorable (2.39e-4)"	0.2	0.2	0.6	0.3	0.7	0.3	5.8	0.8	1.6	43.1	0.8	2.9	1.1	2.8	1.7	19.8	1.3	0.5	0.1	0.6	0.5	21.3	0.2	0.9	0.1	0.7	0.6	0.2	2.1	1.4	1.5	16.8	0.6	0.7	3.2	17.2	9.4	0.1	0.7	52.5	0.4	0.8	0.5	0.2	2.8	65.8	0.6	643.6	1.3	0.1	6.0	0.4	20.1	1.0	37.1	5.2	12.1	33.1	0.6	0.0	592.6	0.5	0.0	7.1	4.7	81.0	37.7	0.3	2.8	0.5	50.5	67.2	58.8	43.9	9.7	0.1	4.4	0.8	1.9	3.1	0.2	0.1	3.3	0.0	9.2	1.5	0.8	0.9	2.4	8.5	0.5	0.2	14.4	15.2	0.9	0.3	76.2	78.9	10.7	0.0	27.3	0.1	11.4	3.7	2.4	3.6	39.1	13.1	13.2	739.0	21.1	3.2	0.0	1.0	23.6	0.2	3.5	5.7	20.6	0.8	1.6	0.4	4.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.1	0.1	0.0	0.2	3.3	0.0	15.1	0.0	0.1	0.6	0.7	0.8	1.6	0.6	0.5	0.7	0.6	0.6	0.5	0.6	1.0	0.9	0.0	1.1	0.3	0.9	30.3	13.0	63.7	19.9	4.6	13.1	9.9	1.3	0.0	17.4	1.8	10.4	122.3	6.9	4.7	1.9	1.8	2.6	15.0	2.9	1.8	1.8	0.0	0.6	0.8	153.0	3.2	0.0	24.0	0.0	54.2	0.4	0.0	13.6	0.0	0.9	1.5	10.2	0.8	3.0	8.2	4.1	2.4	0.0	0.0	0.2	6.5	0.0	0.0	3.5	0.5	10.5	1.2	0.0	8.1	0.1	22.1	4.2	36.6	6.6	1.4	3.6	46.7	33.7	8.2	11.9	67.3	0.5	0.7	4.2	8.4
CTSZ	CTSX	ENSG00000101160	"Cathepsin Z"	Q9UBR2	20	58985686-59008238	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"		"Hydrolase, Protease, Thiol protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Hofbauer cells: 1078.9;Langerhans cells: 983.5;Macrophages: 652.3;monocytes: 723.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"fHDF/TERT166: 542.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB025114, HPA049876, HPA053504"	Supported		Supported	Vesicles	"Intracellular and membrane"	NA	NA		88000000	"Cluster 49: Eosinophils - Unknown function"	"Cluster 64: Macrophages - Immune response"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 41: Macrophages - Immune response"	Vesicles		"CAB025114: , HPA049876: AB_2680927, HPA053504: AB_2682172"	"unprognostic (7.30e-2)"	"unprognostic (3.98e-2)"	"unprognostic (4.07e-2)"	"unprognostic (1.11e-3)"	"unprognostic (8.25e-3)"	"unprognostic (1.15e-1)"	"unprognostic (4.12e-2)"	"unprognostic (6.59e-2)"	"unprognostic (1.59e-1)"	"unprognostic (1.22e-1)"	"unprognostic (1.33e-1)"	"unprognostic (5.33e-2)"	"prognostic unfavorable (5.72e-5)"	"unprognostic (1.96e-1)"	"unprognostic (6.92e-2)"	"unprognostic (1.19e-1)"	"unprognostic (2.04e-1)"	178.1	117.8	18.9	208.8	21.8	99.8	137.0	20.5	32.0	92.1	59.6	173.8	215.4	87.3	13.4	53.1	88.9	89.4	152.6	15.3	33.9	125.6	356.4	233.3	271.5	31.6	23.5	71.0	89.4	91.8	112.5	118.7	27.9	87.8	77.1	4.1	181.0	66.3	58.7	58.5	226.0	97.9	26.2	234.4	88.2	24.6	47.2	57.1	122.3	54.6	91.3	146.3	69.0	45.4	205.4	139.8	1.1	1.1	114.2	124.2	106.5	291.0	225.4	187.4	152.3	231.6	324.6	96.5	213.9	542.1	0.5	160.1	51.4	257.5	30.2	362.1	13.6	80.3	169.0	0.8	137.3	9.0	331.0	130.9	127.8	83.1	62.4	34.8	281.3	1.1	74.0	48.7	90.0	1.1	1.3	70.6	11.5	43.5	158.2	2.9	0.4	135.7	86.3	25.5	2.7	1.7	222.4	258.4	0.8	19.5	131.9	148.4	420.5	1.4	161.8	209.0	2.0	253.7	172.0	18.2	2.8	207.9	0.4	1.2	1.5	1.6	0.6	1.4	0.4	1.1	0.6	0.4	1.1	1.4	0.7	0.8	1.6	0.5	2.9	1.8	0.3	0.7	18.9	21.8	20.5	32.0	15.3	33.9	31.6	23.5	27.9	26.2	47.2	45.4	132.1	16.0	5.3	5.9	119.8	50.3	64.5	33.8	24.5	6.7	67.4	99.6	21.7	62.9	14.1	71.7	0.0	38.2	104.8	303.6	23.5	176.0	3.5	52.9	47.7	82.2	27.1	63.3	5.3	42.4	104.8	71.5	19.4	71.3	10.8	68.4	62.8	363.0	1078.9	11.8	3.0	56.6	26.4	334.0	983.5	6.0	13.1	652.3	101.4	23.4	723.6	58.6	21.6	2.5	2.5	82.6	217.5	13.9	96.3	50.6	339.8	90.0	18.8	5.0	46.0	67.5	74.5	3.7	4.8	14.5	41.5	41.3	33.4	3.3	99.7	52.7
CYLD	"CYLD1, KIAA0849, USPL2"	ENSG00000083799	"CYLD lysine 63 deubiquitinase"	Q9NQC7	16	50742050-50801935	"Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"Cell cycle, Immunity, Innate immunity, Ubl conjugation pathway, Wnt signaling pathway"	"Hydrolase, Protease, Thiol protease"	"Cancer-related genes, Disease variant, Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 94.3"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HDLM-2: 136.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB011713, HPA050095"	Approved		Supported	"Nucleoplasm,Centriolar satellite"		Yes	No			"Cluster 10: Basophils - Unknown function"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 24: Non-specific - Transcription regulation"	"Centriolar satellite"	Nucleoplasm	"CAB011713: AB_731794, HPA050095: AB_2681013"	"unprognostic (9.83e-2)"	"unprognostic (1.17e-2)"	"unprognostic (5.01e-2)"	"unprognostic (2.83e-2)"	"unprognostic (3.84e-1)"	"unprognostic (5.06e-2)"	"unprognostic (3.87e-2)"	"unprognostic (3.24e-2)"	"unprognostic (9.46e-2)"	"unprognostic (1.11e-1)"	"unprognostic (1.18e-2)"	"unprognostic (2.32e-1)"	"unprognostic (1.03e-1)"	"unprognostic (1.07e-1)"	"unprognostic (3.43e-2)"	"unprognostic (6.83e-2)"	"unprognostic (8.42e-2)"	14.3	22.0	23.9	38.8	23.5	94.3	13.6	17.9	18.2	13.0	22.3	16.3	16.1	15.1	12.1	23.3	11.0	20.5	20.1	17.3	23.3	14.2	21.0	21.5	53.4	21.3	27.8	15.4	15.2	23.0	15.4	15.4	23.6	16.3	19.3	22.0	18.9	16.0	34.3	15.2	16.2	16.8	21.6	39.0	19.9	38.3	32.7	35.6	24.9	20.5	48.4	24.1	12.9	24.2	26.9	8.3	9.4	10.6	14.3	21.0	8.7	39.1	56.7	39.9	23.4	6.9	12.5	30.7	13.7	38.3	43.4	10.3	11.3	23.7	58.7	136.6	16.6	15.5	15.3	5.8	29.1	15.4	69.5	23.0	18.6	48.1	50.1	37.7	16.3	21.3	6.6	26.1	56.4	4.0	14.4	22.3	10.1	8.5	13.3	13.4	18.8	29.4	12.9	9.1	12.0	9.2	33.1	11.2	9.8	14.3	11.0	18.9	18.6	67.2	15.4	23.4	15.9	68.0	68.4	33.2	49.3	16.7	14.7	64.6	15.2	38.3	18.1	17.7	21.8	17.2	27.1	24.5	18.3	11.1	24.4	19.4	32.3	25.7	18.8	11.0	37.3	19.5	23.9	23.5	17.9	18.2	17.3	23.3	21.3	27.8	23.6	21.6	32.7	24.2	28.8	44.8	31.8	31.6	87.7	120.1	59.5	32.2	40.9	89.2	35.5	26.0	34.4	21.5	32.9	18.4	93.8	6.8	84.1	28.3	5.9	20.0	48.2	22.5	24.9	36.0	31.1	26.1	51.9	19.1	4.4	37.3	22.4	47.1	80.5	21.4	27.8	25.5	21.5	67.3	54.7	10.7	30.5	40.0	127.6	31.3	25.4	66.4	74.7	57.1	63.7	23.3	70.0	51.8	119.2	18.0	22.4	21.1	79.7	66.4	15.4	13.9	23.3	48.3	6.6	54.2	30.5	59.2	15.2	64.3	155.6	4.1	119.5	21.3	14.8	66.7
DAGLB	"DAGLBETA, KCCR13L"	ENSG00000164535	"Diacylglycerol lipase beta"	Q8NCG7	7	6409126-6484190	"Enzymes, Metabolic proteins, Predicted membrane proteins"	"Lipid degradation, Lipid metabolism"	Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA069377			Supported	"Nucleoplasm,Plasma membrane"		No	No			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 44: Endometrium - Transcription"	"Plasma membrane"	Nucleoplasm	"HPA069377: AB_2686132"	"unprognostic (2.39e-1)"	"unprognostic (4.61e-2)"	"unprognostic (2.13e-3)"	"unprognostic (1.42e-1)"	"unprognostic (9.04e-3)"	"unprognostic (3.68e-2)"	"unprognostic (1.78e-3)"	"unprognostic (2.36e-1)"	"unprognostic (2.22e-1)"	"prognostic unfavorable (7.18e-5)"	"unprognostic (1.25e-1)"	"unprognostic (1.24e-1)"	"prognostic unfavorable (1.54e-4)"	"unprognostic (2.18e-1)"	"unprognostic (1.14e-1)"	"unprognostic (1.93e-1)"	"unprognostic (1.81e-2)"	7.3	15.6	9.9	6.7	9.9	15.0	6.6	7.3	11.1	7.0	5.9	6.7	7.6	5.8	3.6	8.0	5.9	6.4	5.6	11.2	8.8	4.9	7.9	9.3	7.4	9.7	7.7	7.9	6.9	7.0	4.3	8.7	8.0	5.3	5.0	3.4	7.7	4.5	13.3	12.4	7.6	5.8	8.4	8.5	7.1	5.5	8.1	8.1	7.5	7.0	6.7	5.8	7.3	10.7	21.6	23.9	10.9	14.3	16.1	12.5	8.4	29.8	21.3	26.6	28.7	13.6	24.4	12.3	12.5	15.4	64.8	32.4	17.8	16.7	15.2	5.8	11.7	6.6	26.9	9.4	17.3	18.8	10.1	11.3	27.2	17.9	17.5	10.7	11.7	15.6	18.2	6.1	15.9	16.2	6.7	26.9	39.6	11.3	18.5	57.4	12.7	25.5	16.8	8.1	13.5	8.4	17.7	26.7	5.3	17.2	19.0	34.7	14.4	22.4	41.9	28.1	13.9	6.2	11.2	10.4	11.3	28.9	28.2	10.8	22.8	22.0	6.2	21.3	5.5	8.2	4.8	4.1	28.6	4.7	11.4	6.7	10.2	3.9	19.5	5.0	4.3	12.2	9.9	9.9	7.3	11.1	11.2	8.8	9.7	7.7	8.0	8.4	8.1	10.7	6.5	9.6	12.6	5.9	7.9	16.8	3.6	6.2	12.0	4.5	5.7	5.7	3.1	4.3	5.0	5.5	2.1	5.1	4.8	12.2	0.0	7.0	0.4	10.3	6.8	9.0	2.4	13.3	13.8	6.2	8.9	5.4	19.4	19.9	3.8	5.5	8.9	8.0	17.2	0.0	9.2	5.8	6.1	16.1	17.4	1.7	6.2	16.3	5.4	26.2	15.8	1.4	7.2	2.5	6.5	12.2	8.0	2.2	5.0	5.7	10.6	1.6	3.8	4.3	0.0	4.0	5.0	8.5	7.1	9.4	13.4	12.4	6.7	7.4	7.6	4.3
DCP2	NUDT20	ENSG00000172795	"Decapping mRNA 2"	Q8IU60	5	112976702-113022195	"Enzymes, Predicted intracellular proteins"	"Nonsense-mediated mRNA decay"	"Hydrolase, RNA-binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB011677, HPA057676"	Approved		Approved	"Nucleoplasm,Cell Junctions,Cytoplasmic bodies"		NA	NA			"Cluster 18: Basophils - Vesicular transport"	"Cluster 66: Lymphoid tissue - Immune response regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 19: Monocytes & Neutrophils - Innate immune response"	"Nucleoplasm, Cytoplasmic bodies"	"Cell Junctions"	"CAB011677: AB_731858, HPA057676: AB_2683500"	"unprognostic (2.76e-1)"	"unprognostic (3.27e-1)"	"unprognostic (2.79e-1)"	"unprognostic (3.09e-1)"	"unprognostic (1.28e-1)"	"unprognostic (3.86e-3)"	"prognostic unfavorable (4.84e-4)"	"unprognostic (1.87e-1)"	"unprognostic (3.64e-2)"	"unprognostic (6.26e-2)"	"unprognostic (1.15e-1)"	"unprognostic (9.30e-2)"	"prognostic unfavorable (2.66e-5)"	"unprognostic (8.39e-2)"	"unprognostic (2.84e-1)"	"unprognostic (3.25e-2)"	"unprognostic (5.75e-2)"	4.6	4.0	5.9	8.1	6.0	14.0	6.9	9.8	5.7	6.0	6.6	3.9	3.7	4.3	3.4	4.1	4.7	3.5	3.4	5.9	7.2	4.8	4.7	6.9	12.6	5.5	4.9	6.7	3.3	3.1	3.7	12.1	5.8	4.4	4.1	7.4	5.3	3.5	4.8	5.8	5.1	3.3	4.5	10.2	4.0	3.8	8.5	17.9	3.7	3.9	12.3	4.4	5.2	5.1	6.4	5.6	24.1	19.0	4.5	5.3	37.0	6.7	4.3	7.2	9.8	25.0	13.1	32.2	8.5	3.2	5.6	7.9	27.6	7.1	8.8	9.0	11.0	29.5	4.6	9.9	5.4	20.1	15.3	4.8	5.3	8.4	9.0	6.9	12.5	24.8	22.7	12.0	6.1	8.1	29.6	19.6	20.8	4.0	2.9	27.0	22.7	12.2	10.5	15.4	5.6	11.4	8.3	8.8	11.3	24.1	25.3	24.4	7.7	7.8	13.9	4.4	8.8	8.8	19.8	23.6	4.7	26.0	6.3	14.0	4.9	3.7	3.0	6.1	4.2	3.8	3.7	3.0	5.1	2.5	3.4	3.7	9.4	3.5	7.3	2.9	4.3	2.6	5.9	6.0	9.8	5.7	5.9	7.2	5.5	4.9	5.8	4.5	8.5	5.1	30.0	19.2	16.8	16.0	50.7	27.8	19.9	22.3	31.9	24.7	43.5	26.4	12.4	8.6	24.1	20.2	79.2	66.7	65.0	11.6	19.6	11.2	24.3	21.7	38.1	28.9	16.2	41.9	25.5	11.8	49.6	25.7	17.3	25.7	19.6	66.7	28.5	7.0	31.7	28.6	34.1	8.9	20.3	78.1	41.5	53.8	19.0	57.4	26.6	56.2	90.7	36.9	35.0	26.7	28.8	17.3	10.6	10.9	27.1	33.3	13.8	14.4	22.7	34.6	6.6	16.5	32.3	36.6	29.5	20.0	26.6	64.4	50.1	52.0	13.1	48.8
DCPS	"HINT-5, HINT5, HSL1, HSPC015"	ENSG00000110063	"Decapping enzyme, scavenger"	Q96C86	11	126304060-126350005	"Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins"	"mRNA processing, mRNA splicing"	Hydrolase	"Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 50.7"	"Cell type enhanced"	"Detected in many"		"Plasma cells: 101.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"plasmacytoid DC: 46.6"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"OE19: 79.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039632, HPA058597"	Supported		Supported	Nucleoplasm,Cytosol		NA	NA		1200000	"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 85: Liver - Metabolism"	"Cluster 21: OE19 - Mitochondria"	"Cluster 55: Plasma cells - Humoral immune response"	Nucleoplasm	Cytosol	"HPA039632: AB_10794200, HPA058597: AB_2683770"	"unprognostic (1.45e-1)"	"unprognostic (5.48e-3)"	"unprognostic (1.76e-1)"	"unprognostic (3.55e-2)"	"unprognostic (5.22e-2)"	"unprognostic (1.26e-1)"	"unprognostic (1.96e-1)"	"unprognostic (2.90e-1)"	"unprognostic (5.57e-2)"	"unprognostic (1.91e-2)"	"unprognostic (4.83e-2)"	"unprognostic (5.00e-2)"	"unprognostic (5.25e-2)"	"unprognostic (2.24e-2)"	"unprognostic (8.04e-2)"	"unprognostic (7.67e-2)"	"unprognostic (3.40e-2)"	8.3	11.4	2.8	7.4	4.0	12.1	8.5	5.0	4.5	10.9	8.1	10.1	4.7	11.0	4.1	11.3	8.6	16.0	9.9	3.9	3.2	13.5	50.7	9.0	12.1	3.3	3.4	9.2	12.1	3.5	8.2	4.0	2.9	8.1	5.9	6.3	12.0	5.3	14.6	11.3	9.4	5.5	2.7	17.3	8.7	6.1	3.6	8.9	7.5	5.8	9.6	13.3	9.2	3.4	13.9	8.5	10.2	19.8	7.9	11.2	8.9	6.5	10.3	11.5	10.8	17.5	29.1	19.5	28.0	12.2	7.5	16.2	14.4	24.4	5.9	35.8	7.1	27.1	9.9	14.7	18.8	33.3	25.4	12.5	14.0	16.0	17.6	5.9	14.1	17.0	11.6	34.8	11.2	21.6	21.1	41.5	8.0	79.8	28.7	13.7	13.8	40.6	11.4	15.1	16.1	11.0	20.3	21.1	15.8	6.3	33.8	22.1	9.3	18.7	7.3	8.9	13.7	13.4	14.6	20.0	6.0	51.0	46.7	4.2	10.5	4.3	9.3	15.2	7.8	13.0	8.5	9.7	16.6	8.6	6.4	6.7	1.3	8.9	15.3	46.6	15.4	8.9	2.8	4.0	5.0	4.5	3.9	3.2	3.3	3.4	2.9	2.7	3.6	3.4	14.2	12.8	11.2	6.2	31.2	6.9	16.4	38.7	8.0	6.7	12.2	17.1	5.0	47.1	18.8	42.3	0.0	39.9	35.3	6.4	56.7	19.7	8.1	11.1	12.1	12.4	7.3	14.5	5.8	29.2	43.8	15.9	11.2	23.2	17.1	9.8	8.6	31.4	29.2	3.3	6.0	12.0	28.5	14.1	11.7	2.2	17.1	16.8	17.8	2.8	15.3	10.1	22.6	2.5	4.6	17.1	14.9	18.4	101.1	8.7	6.1	15.0	15.7	9.4	19.7	10.8	14.6	14.8	24.9	18.3	8.9	27.1	24.3	16.2	14.4	24.0
DCTD		ENSG00000129187	"DCMP deaminase"	P32321	4	182890060-182917936	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Nucleotide biosynthesis"	"Allosteric enzyme, Hydrolase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA035894	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 16: Pancreatic endocrine cells - Mixed function"	"Nucleoplasm, Cytosol"		"HPA035894: AB_10673488"	"unprognostic (1.26e-1)"	"unprognostic (9.80e-3)"	"unprognostic (3.15e-2)"	"unprognostic (3.78e-3)"	"unprognostic (3.13e-3)"	"unprognostic (2.20e-2)"	"unprognostic (2.01e-2)"	"unprognostic (4.59e-3)"	"unprognostic (2.62e-2)"	"unprognostic (1.80e-1)"	"unprognostic (1.40e-2)"	"unprognostic (1.20e-1)"	"prognostic favorable (1.81e-4)"	"unprognostic (1.35e-1)"	"unprognostic (1.59e-1)"	"unprognostic (3.89e-2)"	"unprognostic (1.12e-1)"	50.8	83.8	39.0	41.6	40.3	29.5	46.7	40.1	44.8	48.9	51.1	41.4	33.1	47.8	29.7	61.2	49.0	54.7	40.6	39.8	43.6	48.9	79.8	41.2	45.2	43.0	42.8	65.8	54.9	61.8	46.9	36.7	40.2	39.9	40.9	25.1	44.6	41.7	41.7	39.3	36.3	46.4	43.8	50.3	54.1	21.8	42.6	42.2	100.8	32.9	49.6	50.1	45.6	46.0	97.8	87.4	88.4	81.3	129.6	176.7	115.0	184.1	163.0	128.7	79.7	89.2	183.0	33.5	44.3	179.9	87.1	47.3	65.5	114.9	117.1	163.8	50.4	155.9	50.4	109.1	139.5	153.3	93.3	149.8	120.8	113.6	117.8	129.6	112.2	73.1	157.4	324.5	175.6	71.5	100.1	94.7	70.0	39.8	79.3	107.3	62.2	65.8	107.9	115.1	86.7	54.3	86.7	73.8	87.4	81.2	56.7	78.8	131.7	105.7	81.7	52.0	142.0	124.5	72.9	42.8	117.4	98.5	127.1	68.6	47.9	45.2	61.0	58.8	76.8	71.0	52.6	62.7	55.0	48.6	51.6	54.6	3.3	73.7	60.2	42.4	50.6	55.6	39.0	40.3	40.1	44.8	39.8	43.6	43.0	42.8	40.2	43.8	42.6	46.0	31.6	12.8	19.5	8.8	31.7	25.4	34.4	35.4	37.5	4.9	39.4	34.2	24.3	38.6	21.5	33.1	4.2	19.0	26.6	16.8	37.2	68.8	7.0	19.7	41.6	30.9	14.5	27.1	10.7	54.5	26.8	42.3	15.8	22.3	22.8	36.2	30.0	45.2	53.8	3.3	11.7	28.5	18.3	38.8	32.1	18.0	44.1	29.4	26.6	9.4	34.8	37.4	25.7	3.0	3.1	75.5	18.5	35.3	27.6	46.1	19.3	45.8	18.7	5.5	32.9	25.8	34.6	10.2	15.4	54.5	23.0	7.3	27.6	42.4	31.3	42.3
DCTPP1	"CDA03, MGC5627, RS21C6, XTP3TPA"	ENSG00000179958	"DCTP pyrophosphatase 1"	Q9H773	16	30423615-30430030	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA002832	Uncertain		Supported	Nucleoplasm,Cytosol		NA	Yes		61000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 53: Intestinal epithelial cells - Unknown function"	"Nucleoplasm, Cytosol"		"HPA002832: AB_1080615"	"prognostic unfavorable (1.64e-5)"	"unprognostic (1.61e-1)"	"unprognostic (1.99e-3)"	"unprognostic (1.17e-2)"	"unprognostic (1.36e-1)"	"unprognostic (4.09e-2)"	"prognostic unfavorable (6.28e-4)"	"unprognostic (2.23e-1)"	"unprognostic (1.07e-1)"	"unprognostic (4.35e-2)"	"unprognostic (2.43e-2)"	"unprognostic (3.65e-2)"	"prognostic favorable (9.71e-9)"	"unprognostic (1.10e-3)"	"unprognostic (8.78e-3)"	"unprognostic (1.10e-2)"	"unprognostic (2.53e-1)"	21.0	21.4	17.6	27.4	18.4	22.2	30.5	18.7	22.5	18.6	18.9	56.4	32.0	18.6	20.0	28.3	28.1	19.5	31.1	18.4	19.5	39.7	21.8	16.2	35.5	18.1	17.6	14.0	24.9	32.1	10.3	16.0	19.0	21.8	58.4	12.2	25.5	19.3	44.7	25.1	27.7	20.5	18.4	27.8	24.3	9.1	18.1	24.5	20.1	36.9	35.7	27.0	19.1	19.4	124.7	149.8	66.8	85.8	18.4	24.1	61.9	58.4	35.1	87.4	87.9	114.7	103.4	168.1	119.1	36.8	54.9	95.9	141.4	115.1	103.5	89.2	221.0	98.3	61.5	150.3	24.1	177.0	144.2	28.6	64.8	96.4	55.6	25.4	88.7	88.2	125.8	57.4	61.5	217.8	210.0	189.9	88.8	124.2	119.2	293.1	74.8	218.1	98.9	80.2	141.4	80.4	39.0	137.7	55.3	41.5	118.4	73.9	45.9	66.0	59.1	85.8	107.2	36.9	118.4	217.5	43.8	145.7	79.6	70.6	36.7	38.1	54.0	70.0	75.8	146.7	68.4	61.4	86.7	128.7	60.9	59.0	4.6	76.1	79.2	94.6	76.4	81.0	17.6	18.4	18.7	22.5	18.4	19.5	18.1	17.6	19.0	18.4	18.1	19.4	34.0	19.2	15.2	0.7	38.2	90.2	53.3	92.5	33.6	23.3	45.8	48.9	34.8	51.5	37.9	44.1	8.4	103.2	22.7	130.3	127.2	135.6	13.4	32.6	29.9	47.4	38.5	29.6	2.6	124.8	101.0	28.3	27.5	66.5	31.1	40.2	31.1	23.2	76.9	15.2	2.7	142.3	73.2	21.0	49.1	45.1	19.6	26.9	48.0	1.0	73.2	25.0	23.7	2.5	4.4	89.0	115.8	19.9	24.1	86.9	68.8	76.7	27.8	21.4	19.7	23.7	40.0	3.3	44.8	39.4	80.3	27.8	28.3	53.8	168.5	45.7
DDAH1	DDAH	ENSG00000153904	"Dimethylarginine dimethylaminohydrolase 1"	O94760	1	85318481-85578363	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 131.8;kidney: 124.8"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 364.4;Excitatory neurons: 197.4;Oligodendrocyte precursor cells: 182.4;Proximal tubular cells: 283.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"fHDF/TERT166: 239.4;LHCN-M2: 179.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA006308, HPA071064"	Enhanced		Approved	"Nucleoli,Plasma membrane,Cytosol"		NA	NA		350000		"Cluster 7: Kidney - Transmembrane transport"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	"Plasma membrane, Cytosol"	Nucleoli	"HPA006308: AB_1847532, HPA071064: "	"unprognostic (1.44e-2)"	"unprognostic (2.43e-1)"	"prognostic favorable (5.99e-4)"	"unprognostic (6.82e-2)"	"unprognostic (1.04e-1)"	"unprognostic (1.62e-2)"	"unprognostic (2.55e-1)"	"unprognostic (3.85e-2)"	"unprognostic (2.57e-1)"	"unprognostic (1.02e-2)"	"unprognostic (3.62e-2)"	"unprognostic (1.56e-1)"	"prognostic favorable (5.21e-6)"	"unprognostic (5.37e-2)"	"unprognostic (9.06e-2)"	"unprognostic (5.81e-2)"	"unprognostic (1.56e-2)"	10.3	28.6	95.9	12.8	100.9	0.6	18.8	61.5	131.8	22.4	73.4	45.1	40.1	10.8	76.5	12.6	36.5	25.5	17.4	102.0	77.3	124.8	79.5	26.4	2.6	58.6	84.8	2.9	27.5	21.1	6.3	11.6	62.6	28.5	45.3	34.6	17.7	18.6	30.4	5.6	39.7	16.5	59.5	10.6	29.7	19.1	106.6	1.0	28.9	14.0	2.0	19.2	2.6	80.3	63.1	7.6	36.0	6.9	84.1	78.0	9.2	155.9	120.0	63.6	75.6	89.9	16.5	0.1	39.2	239.4	38.3	17.8	79.7	15.0	93.0	0.3	29.5	0.2	22.3	31.8	40.9	57.6	3.2	60.5	2.0	50.4	24.9	85.5	75.9	0.0	0.1	6.0	179.7	7.5	3.0	0.3	25.5	124.6	22.6	0.0	63.1	0.9	113.4	46.3	59.2	115.0	18.0	56.3	9.1	38.7	29.6	4.9	107.7	31.6	27.0	11.7	57.8	0.0	0.1	0.2	1.6	0.1	19.5	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	95.9	100.9	61.5	131.8	102.0	77.3	58.6	84.8	62.6	59.5	106.6	80.3	14.1	35.3	43.4	364.4	2.6	13.8	4.6	6.8	5.7	4.5	31.2	13.8	11.8	61.5	13.6	69.9	4.2	2.7	0.4	75.3	125.2	15.9	22.5	36.9	9.8	7.5	34.2	2.7	197.4	31.2	0.9	13.9	47.9	24.2	0.0	59.3	8.2	102.8	1.1	0.0	51.0	86.9	8.2	2.2	5.5	25.6	15.8	2.4	12.4	23.4	0.6	68.4	0.0	182.4	9.6	44.5	69.4	74.9	0.0	33.6	68.7	283.3	36.5	9.4	13.1	15.3	18.6	4.6	5.4	32.6	14.3	0.8	2.5	13.5	106.7	8.3
DDAH2	G6A	ENSG00000213722	"Dimethylarginine dimethylaminohydrolase 2"	O95865	6	31727038-31730617	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 386.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"MCF7: 63.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA012389, HPA012509"	Uncertain		Supported	Mitochondria		NA	NA		1500000	"Cluster 31: Non-specific - Inflammatory response"	"Cluster 89: Fibroblasts - ECM organization"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Mitochondria		"HPA012389: , HPA012509: AB_1847533"	"unprognostic (2.29e-2)"	"unprognostic (1.38e-1)"	"unprognostic (4.49e-2)"	"unprognostic (2.39e-1)"	"unprognostic (1.44e-1)"	"unprognostic (7.67e-2)"	"unprognostic (1.50e-2)"	"unprognostic (1.10e-1)"	"unprognostic (2.62e-1)"	"unprognostic (8.78e-2)"	"unprognostic (1.01e-1)"	"unprognostic (1.09e-1)"	"unprognostic (1.02e-1)"	"unprognostic (9.42e-2)"	"unprognostic (2.32e-1)"	"unprognostic (2.24e-2)"	"unprognostic (2.72e-2)"	96.5	17.2	26.6	12.0	24.7	10.8	81.2	24.2	44.7	131.5	26.1	72.2	4.4	94.4	8.7	39.0	80.5	44.0	63.2	23.9	33.5	67.1	32.1	62.3	20.6	31.8	28.2	67.7	16.5	17.5	26.0	18.3	28.1	65.2	7.7	5.8	58.2	27.0	13.4	67.7	38.9	11.9	32.0	49.4	35.4	13.4	27.4	9.6	65.1	4.5	7.8	61.0	91.0	30.9	2.0	20.1	0.7	28.5	17.0	26.6	3.8	0.0	10.6	10.9	7.3	40.4	6.7	0.4	24.4	26.5	0.9	2.4	0.5	9.7	1.9	0.0	14.2	1.9	7.8	22.4	18.2	0.3	1.5	18.8	1.2	12.2	0.9	3.7	33.3	14.1	0.4	11.1	4.8	63.0	1.5	27.5	4.1	4.3	12.2	0.2	0.9	10.5	21.6	0.5	1.5	5.7	0.0	4.7	27.4	2.9	37.7	7.8	0.1	16.9	24.7	11.2	0.0	4.1	12.8	3.3	11.3	5.9	4.3	141.3	15.4	135.0	14.8	37.4	5.8	49.7	4.0	5.3	26.8	39.6	2.7	3.4	27.8	29.2	44.9	93.9	4.1	11.4	26.6	24.7	24.2	44.7	23.9	33.5	31.8	28.2	28.1	32.0	27.4	30.9	102.3	28.9	14.7	10.4	76.8	66.9	88.7	49.6	56.3	4.5	132.8	96.0	39.5	62.9	36.9	82.8	29.2	15.5	84.4	386.3	178.1	148.2	83.1	62.6	94.2	101.2	150.0	20.4	0.3	32.3	37.3	154.1	33.1	75.0	113.3	121.7	94.9	31.9	223.2	0.0	0.3	71.5	109.9	139.7	301.2	23.6	180.5	95.7	103.2	14.0	64.2	120.9	40.2	4.5	2.7	85.1	299.5	153.1	24.5	95.2	61.5	165.8	50.5	25.7	105.2	122.7	153.0	4.1	12.5	35.8	59.2	18.1	41.1	21.3	104.6	67.0
DDX1	DBP-RB	ENSG00000079785	"DEAD-box helicase 1"	Q92499	2	15591178-15634346	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Antiviral defense, Host-virus interaction, Immunity, Innate immunity, mRNA processing, Transcription, Transcription regulation, tRNA processing"	"Activator, DNA-binding, Exonuclease, Helicase, Hydrolase, Nuclease, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Cardiomyocytes: 362.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB012280, HPA034502, HPA034503"	Enhanced		Supported	Nucleoplasm,Cytosol		NA	NA		86000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 39: Non-specific - Basic cellular processes"	Nucleoplasm	Cytosol	"CAB012280: , HPA034502: AB_10794321, HPA034503: AB_10795025"	"unprognostic (9.94e-2)"	"unprognostic (2.95e-2)"	"unprognostic (3.07e-2)"	"unprognostic (8.36e-3)"	"unprognostic (9.28e-3)"	"unprognostic (1.56e-2)"	"prognostic unfavorable (9.09e-9)"	"unprognostic (2.55e-1)"	"unprognostic (2.05e-1)"	"unprognostic (4.81e-3)"	"unprognostic (3.89e-2)"	"unprognostic (2.03e-1)"	"prognostic favorable (9.69e-4)"	"unprognostic (3.80e-1)"	"unprognostic (1.34e-1)"	"unprognostic (4.94e-2)"	"unprognostic (1.20e-3)"	52.8	53.4	32.6	39.0	33.5	37.8	61.7	36.1	44.2	49.9	39.6	54.3	45.0	45.4	48.0	56.5	42.4	31.7	97.6	33.8	37.1	76.7	62.0	38.9	35.3	36.8	32.6	45.7	59.0	89.5	46.7	50.9	36.0	44.6	58.0	55.5	52.9	47.8	157.9	50.3	46.0	56.5	34.7	33.8	50.5	42.5	35.3	47.0	62.3	134.2	46.8	48.4	41.0	36.3	84.1	127.1	172.3	126.2	148.1	125.5	193.3	176.8	142.6	165.1	135.9	203.0	80.7	221.8	80.4	202.8	120.9	118.8	245.5	166.8	170.7	94.6	154.3	244.5	150.6	241.8	110.2	204.5	102.3	101.2	105.9	140.6	129.6	100.8	151.0	98.4	253.4	61.8	161.9	112.2	110.3	126.7	221.0	205.6	104.4	125.0	276.8	152.6	178.9	161.9	136.6	169.3	124.3	118.0	154.8	123.2	83.6	77.5	133.7	132.1	139.8	84.2	197.2	84.5	169.3	296.2	120.5	153.7	128.4	32.4	34.5	20.3	31.0	42.0	33.2	28.6	35.8	37.0	38.8	30.5	39.9	35.8	3.0	38.5	42.0	30.1	38.1	34.1	32.6	33.5	36.1	44.2	33.8	37.1	36.8	32.6	36.0	34.7	35.3	36.3	41.3	80.1	57.6	25.8	34.9	40.3	57.2	96.4	31.9	58.9	50.3	41.5	362.7	67.2	78.6	90.1	52.1	112.1	29.0	43.7	142.8	112.3	23.1	49.2	69.6	57.2	52.1	64.2	52.1	120.3	108.5	67.0	28.5	51.2	57.0	49.3	47.5	123.0	53.4	45.4	48.6	69.8	83.4	30.3	19.7	19.5	72.7	28.1	49.8	29.0	41.2	60.1	55.6	45.8	49.0	107.2	52.4	78.2	32.8	31.3	74.5	170.2	80.6	75.9	59.2	51.3	94.6	174.0	76.8	30.0	42.3	80.2	30.7	73.5	74.1	36.6
DDX10	"Dbp4, HRH-J8"	ENSG00000178105	"DEAD-box helicase 10"	Q13206	11	108665069-108940927	"Cancer-related genes, Enzymes, Predicted intracellular proteins"		"Helicase, Hydrolase, RNA-binding"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Proximal tubular cells: 133.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"U-698: 162.3"	"Low region specificity"	"Detected in all"							HPA004691	Approved		Approved	Nucleoli		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Nucleoli		"HPA004691: AB_1078629"	"unprognostic (9.49e-2)"	"unprognostic (9.32e-2)"	"unprognostic (1.34e-1)"	"unprognostic (2.58e-1)"	"unprognostic (7.97e-2)"	"unprognostic (1.48e-2)"	"prognostic unfavorable (2.52e-5)"	"unprognostic (2.86e-2)"	"unprognostic (1.23e-2)"	"unprognostic (1.06e-1)"	"prognostic unfavorable (5.75e-4)"	"unprognostic (1.00e-1)"	"prognostic favorable (2.14e-5)"	"unprognostic (5.20e-2)"	"unprognostic (1.98e-1)"	"unprognostic (4.64e-1)"	"unprognostic (2.43e-3)"	7.3	6.8	3.7	6.8	3.9	6.3	9.2	4.2	5.1	7.9	1.6	6.6	5.0	10.4	7.3	7.3	8.5	5.0	6.1	4.4	3.0	11.7	7.0	5.3	8.5	2.2	3.3	10.6	7.5	7.6	4.5	7.8	2.8	7.0	7.7	11.1	6.2	6.8	7.1	7.6	4.7	9.9	2.0	7.2	5.8	15.8	3.7	8.4	7.8	4.7	8.8	10.3	6.9	4.0	21.3	20.7	19.3	27.0	18.5	15.0	20.0	22.6	12.2	26.7	26.3	59.3	30.6	71.8	41.3	17.3	28.7	23.5	55.4	27.3	37.8	27.8	25.0	48.5	11.6	22.3	33.0	49.9	22.4	13.5	21.0	30.4	37.6	15.9	24.6	18.4	70.0	7.8	26.7	14.0	42.7	42.5	24.8	40.0	31.0	35.9	31.3	67.9	16.3	18.2	35.2	18.4	31.7	27.4	12.3	25.4	33.4	17.7	26.0	27.8	28.3	26.8	30.9	11.7	22.0	162.3	9.5	59.7	28.7	1.6	4.4	1.2	7.8	6.7	10.8	10.5	7.0	9.6	8.5	12.0	7.4	7.2	0.4	10.1	6.8	8.0	6.3	4.4	3.7	3.9	4.2	5.1	4.4	3.0	2.2	3.3	2.8	2.0	3.7	4.0	20.2	16.0	28.8	29.0	23.7	28.4	24.5	11.0	28.5	21.1	14.9	11.9	20.5	12.8	17.6	3.7	95.9	24.3	19.8	9.7	19.6	18.7	47.2	16.9	31.4	24.3	15.0	11.6	84.7	21.3	21.3	26.3	15.3	23.3	14.5	28.1	10.4	11.0	14.7	18.5	75.9	9.7	6.1	8.8	12.0	10.9	29.5	15.4	7.2	51.5	20.6	8.9	27.8	67.3	59.5	17.2	5.7	21.4	13.2	24.8	3.7	133.3	13.1	25.1	13.1	32.6	20.3	63.0	45.8	19.3	29.0	25.9	17.7	26.6	15.6	14.8
DDX11	"CHL1, CHLR1, KRG2, WABS"	ENSG00000013573	"DEAD/H-box helicase 11"	Q96FC9	12	31073860-31104799	"Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins"	"DNA damage, DNA repair, DNA replication, Host-virus interaction, Transcription, Transcription regulation"	"Activator, Developmental protein, DNA-binding, Helicase, Hydrolase, RNA-binding"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Rod photoreceptor cells: 25.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			HPA065197	Supported		Supported	Nucleoplasm,Nucleoli		No	Yes			"Cluster 27: Non-specific - Gene expression"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 5: NTERA-2 - Transcription"	"Cluster 12: Non-specific - Cell cycle regulation"	Nucleoplasm	Nucleoli	"HPA065197: AB_2685430"	"unprognostic (6.10e-2)"	"unprognostic (1.48e-2)"	"unprognostic (1.02e-1)"	"unprognostic (5.09e-2)"	"unprognostic (1.45e-1)"	"unprognostic (2.79e-3)"	"prognostic unfavorable (2.40e-4)"	"unprognostic (4.87e-2)"	"unprognostic (3.89e-3)"	"unprognostic (3.53e-1)"	"unprognostic (5.66e-2)"	"unprognostic (1.25e-1)"	"prognostic unfavorable (5.23e-8)"	"unprognostic (1.89e-2)"	"unprognostic (3.64e-2)"	"unprognostic (1.02e-1)"	"unprognostic (8.03e-3)"	5.9	6.4	6.0	10.2	6.8	29.2	7.2	6.9	7.3	10.7	7.1	9.6	8.0	7.5	4.3	9.5	8.0	5.9	5.3	6.0	6.1	9.2	9.3	6.1	13.2	6.9	6.4	11.0	17.5	5.8	9.4	5.4	6.9	10.0	10.1	6.6	8.6	5.3	10.6	16.7	13.4	3.6	6.1	13.8	9.6	8.8	6.7	24.0	8.0	6.6	11.1	6.9	9.8	6.9	36.5	35.0	42.2	34.5	5.8	11.0	58.7	21.8	10.4	25.2	28.5	44.1	58.6	49.2	23.9	10.8	23.6	35.0	31.7	28.9	21.3	43.4	66.6	47.4	71.0	25.4	2.1	37.4	35.0	11.9	13.0	32.6	24.8	16.9	12.6	55.2	26.6	103.3	17.6	30.9	64.5	60.7	84.0	39.9	19.5	55.0	53.3	66.2	13.3	38.5	30.2	21.7	23.4	33.2	10.4	65.0	27.3	25.5	8.2	22.0	42.1	42.2	40.0	39.4	29.6	95.3	24.6	32.5	20.3	0.0	1.3	0.8	2.0	1.2	1.5	2.5	1.9	1.5	1.5	2.6	2.0	2.6	0.5	2.2	4.4	2.4	2.0	1.3	6.0	6.8	6.9	7.3	6.0	6.1	6.9	6.4	6.9	6.1	6.7	6.9	10.1	3.2	9.5	1.6	9.0	6.0	4.0	6.0	2.2	9.4	8.3	7.1	2.5	4.3	6.0	0.0	14.6	7.6	8.8	7.8	0.0	2.0	1.7	5.5	8.9	5.4	0.0	15.3	2.5	3.3	7.5	5.7	9.7	7.4	5.7	15.6	6.1	7.7	5.2	8.4	3.6	6.5	10.2	4.1	5.4	1.3	7.2	4.4	7.2	3.7	3.5	2.7	4.1	1.5	1.7	3.2	2.7	4.5	17.2	6.0	2.3	1.4	6.7	25.8	0.0	4.9	4.8	5.3	18.0	5.5	6.5	2.6	8.4	4.1	9.5	5.1
DDX17	P72	ENSG00000100201	"DEAD-box helicase 17"	Q92841	22	38483438-38507660	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Antiviral defense, Immunity, mRNA processing, mRNA splicing, RNA-mediated gene silencing, rRNA processing, Transcription, Transcription regulation"	"Helicase, Hydrolase, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB024908, HPA063142"	Supported		Supported	"Nuclear speckles"	"Intracellular and membrane"	NA	NA		420000	"Cluster 1: Neutrophils - Mixed function"	"Cluster 51: Non-specific - Unknown function"	"Cluster 12: NES - Nervous system development"	"Cluster 52: Non-specific - Transcription"	"Nuclear speckles"		"CAB024908: , HPA063142: AB_2684949"	"unprognostic (1.46e-2)"	"unprognostic (5.99e-3)"	"unprognostic (4.24e-3)"	"unprognostic (6.67e-2)"	"unprognostic (1.06e-2)"	"unprognostic (1.02e-2)"	"unprognostic (1.36e-2)"	"prognostic favorable (6.06e-4)"	"unprognostic (1.17e-1)"	"unprognostic (5.51e-1)"	"unprognostic (2.52e-2)"	"unprognostic (2.73e-2)"	"unprognostic (1.89e-2)"	"unprognostic (2.19e-2)"	"unprognostic (1.76e-1)"	"unprognostic (4.31e-2)"	"unprognostic (3.19e-3)"	181.2	172.4	142.0	124.3	160.1	74.5	198.5	150.9	178.4	248.7	174.8	233.8	107.8	216.1	255.3	150.4	248.1	121.1	168.7	143.5	152.1	247.2	152.8	202.2	186.4	152.8	149.4	298.8	214.0	144.7	309.9	158.8	155.3	234.4	114.2	342.0	188.4	123.3	184.8	197.0	227.2	119.7	146.8	293.0	192.1	91.1	148.2	215.2	300.0	106.6	158.2	204.4	201.5	196.5	122.0	79.9	237.6	141.8	148.2	166.0	120.7	104.3	85.9	118.3	121.2	89.0	100.5	225.8	65.8	119.5	82.9	133.2	212.5	127.9	145.9	202.5	142.1	140.4	175.8	133.5	153.4	192.9	170.8	122.3	183.7	86.8	142.9	211.7	153.3	109.6	139.7	255.3	116.0	75.6	128.7	164.0	148.0	172.1	51.6	218.0	122.9	137.1	141.2	132.6	134.1	75.3	155.0	125.9	161.2	180.5	110.0	148.4	140.8	125.7	77.6	80.0	79.3	203.7	130.3	183.4	156.7	123.1	154.2	6.7	8.1	9.5	7.6	7.9	8.9	9.0	7.1	7.3	7.0	7.2	5.7	6.8	16.6	5.1	8.7	10.5	9.1	6.0	142.0	160.1	150.9	178.4	143.5	152.1	152.8	149.4	155.3	146.8	148.2	196.5	252.6	214.7	325.5	483.8	241.9	223.6	206.1	129.3	158.2	448.3	300.7	195.3	147.2	180.1	223.5	283.3	352.3	127.6	297.5	172.8	33.2	111.7	44.4	280.0	293.4	250.4	236.1	177.1	198.9	90.2	99.9	207.5	216.1	234.2	200.7	505.3	233.8	205.3	113.9	321.4	242.1	191.6	146.5	200.6	194.8	49.1	323.7	197.7	154.7	253.9	235.1	223.4	304.9	334.3	553.3	104.7	153.1	278.7	213.1	193.5	154.8	89.8	270.8	559.4	289.3	260.5	213.6	136.4	74.2	120.4	279.9	139.4	218.6	293.7	147.0	255.3
DDX18	"Has1, MrDb"	ENSG00000088205	"DEAD-box helicase 18"	Q9NVP1	2	117814691-117832377	"Enzymes, Plasma proteins, Predicted intracellular proteins"		"Helicase, Hydrolase, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"U-698: 376.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035400, HPA041056"	Approved		Enhanced	"Nucleoli,Nucleoli rim,Mitotic chromosome"		Yes	No		17000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 34: Non-specific - Transcription"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 39: Non-specific - Basic cellular processes"	"Nucleoli, Nucleoli rim, Mitotic chromosome"		"HPA035400: AB_10672091, HPA041056: AB_2677277"	"unprognostic (1.44e-1)"	"unprognostic (2.22e-2)"	"unprognostic (5.63e-2)"	"prognostic unfavorable (2.64e-4)"	"unprognostic (2.06e-1)"	"unprognostic (1.77e-3)"	"prognostic unfavorable (3.07e-4)"	"unprognostic (8.80e-2)"	"unprognostic (1.66e-3)"	"unprognostic (1.44e-1)"	"unprognostic (1.42e-2)"	"unprognostic (4.94e-2)"	"unprognostic (8.51e-2)"	"unprognostic (1.45e-1)"	"unprognostic (1.53e-1)"	"unprognostic (7.28e-2)"	"unprognostic (5.65e-2)"	25.3	21.4	14.9	30.2	15.9	21.8	32.7	16.1	18.0	23.4	15.1	28.3	22.4	30.0	22.9	24.8	23.6	22.2	21.2	14.1	15.9	27.0	35.2	24.8	41.1	15.7	15.2	25.5	21.1	21.4	10.8	26.2	16.1	23.2	31.0	19.4	19.3	23.0	18.6	22.9	23.4	26.3	16.6	32.3	22.8	20.6	15.1	34.5	30.2	18.3	41.7	33.2	17.3	19.0	94.0	41.9	61.3	55.5	35.5	31.9	101.0	54.7	43.0	73.7	64.6	104.2	60.6	137.8	85.9	45.6	68.0	71.1	120.3	70.7	108.0	70.6	83.9	132.0	36.9	105.1	49.5	178.4	66.0	33.4	63.9	93.7	94.3	37.6	44.9	70.3	146.5	58.4	57.1	58.6	98.2	92.6	154.4	79.1	62.3	84.4	95.8	121.3	48.8	55.2	58.8	99.3	62.7	69.2	73.4	62.1	43.9	96.7	34.9	65.6	96.5	46.8	99.5	66.3	87.9	376.0	48.2	82.9	30.1	11.7	23.0	16.3	24.9	28.9	32.0	37.4	29.8	28.9	20.7	30.3	35.6	31.7	5.8	29.7	33.1	33.7	25.7	32.1	14.9	15.9	16.1	18.0	14.1	15.9	15.7	15.2	16.1	16.6	15.1	19.0	144.4	96.1	62.5	24.8	153.9	192.7	114.4	149.4	100.2	150.5	82.8	94.5	50.4	101.5	103.8	121.4	83.4	110.3	140.6	69.0	117.4	125.4	17.1	92.2	125.1	109.1	56.9	76.4	24.3	115.2	120.9	98.2	63.2	102.8	110.3	71.8	107.1	195.6	87.9	82.4	28.0	108.0	109.9	104.8	100.8	17.7	106.6	100.6	92.5	20.6	117.1	70.3	135.9	26.7	39.1	130.0	68.8	103.8	103.3	118.1	53.3	186.5	90.6	132.9	65.7	158.7	110.1	138.6	129.9	81.4	160.5	88.8	143.2	67.4	114.6	65.3
DDX19A	"DDX19L, FLJ11126"	ENSG00000168872	"DEAD-box helicase 19A"	Q9NUU7	16	70346861-70373383	"Enzymes, Predicted intracellular proteins, Transporters"		"Helicase, Hydrolase, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA045252, HPA066668"	Approved		Uncertain	Nucleoplasm		NA	NA			"Cluster 44: Non-specific - Transcription"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 52: Non-specific - Transcription"	Nucleoplasm		"HPA045252: AB_10961128, HPA066668: "	"unprognostic (3.11e-2)"	"unprognostic (1.93e-1)"	"unprognostic (9.07e-2)"	"unprognostic (3.95e-2)"	"unprognostic (2.18e-2)"	"prognostic unfavorable (2.38e-4)"	"prognostic unfavorable (8.05e-5)"	"unprognostic (1.45e-1)"	"unprognostic (1.59e-1)"	"unprognostic (1.67e-1)"	"unprognostic (1.30e-1)"	"unprognostic (5.87e-2)"	"unprognostic (1.24e-1)"	"unprognostic (2.01e-2)"	"unprognostic (1.49e-1)"	"unprognostic (3.01e-2)"	"unprognostic (6.68e-3)"	20.1	19.1	11.3	14.2	12.0	12.6	17.6	12.5	12.6	16.3	12.6	21.4	10.3	20.8	14.1	19.8	17.2	16.0	22.9	11.1	12.4	17.5	21.8	15.6	19.1	12.2	12.2	21.7	17.3	24.8	11.9	23.6	12.6	15.4	15.0	12.6	14.5	20.8	58.4	16.4	14.0	26.9	12.1	15.2	16.9	7.4	12.7	21.0	20.3	38.5	20.5	22.3	14.5	12.5	36.5	39.9	42.4	43.8	60.8	41.7	39.6	45.8	46.7	70.0	54.1	60.9	27.5	60.4	41.8	49.2	34.1	41.6	75.3	45.2	60.4	20.0	41.1	31.7	32.0	75.5	55.0	56.9	26.3	51.0	31.7	65.3	49.8	35.1	46.3	43.5	77.6	15.6	42.6	53.0	62.2	47.8	68.6	43.6	24.6	79.2	27.9	84.8	42.3	23.0	35.1	45.8	115.3	25.4	35.6	43.8	47.4	35.5	31.0	49.0	39.2	31.4	43.9	44.6	70.5	132.7	32.8	50.8	50.5	9.3	8.6	4.7	7.3	8.0	6.7	5.3	6.4	7.2	10.5	5.8	7.0	7.4	0.8	7.1	7.6	5.9	6.0	7.0	11.3	12.0	12.5	12.6	11.1	12.4	12.2	12.2	12.6	12.1	12.7	12.5	14.8	16.0	20.7	15.3	19.1	9.9	21.2	8.6	14.8	35.0	10.4	11.0	18.0	22.8	17.5	11.0	33.3	23.0	12.7	8.2	9.8	14.7	3.2	14.7	18.6	15.6	14.4	21.0	23.4	13.8	16.3	16.0	7.1	15.2	17.7	18.0	12.5	19.5	14.0	23.5	25.7	10.1	2.0	14.2	9.5	2.0	26.1	11.2	10.6	2.8	19.2	15.6	27.8	8.5	10.9	14.0	9.5	12.4	19.8	23.0	8.7	13.3	12.8	32.3	26.3	14.7	15.1	14.7	15.7	16.3	10.2	17.2	16.3	18.0	13.6	16.0
DDX19B	"DBP5, DDX19"	ENSG00000157349	"DEAD-box helicase 19B"	Q9UMR2	16	70289663-70335305	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Transporters"		"Helicase, Hydrolase, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 207.8;Spermatocytes: 101.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB037229, CAB037284, HPA046380, HPA066668"	Approved		Uncertain	Nucleoplasm		NA	NA			"Cluster 44: Non-specific - Transcription"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 66: Spermatocytes - Spermatogenesis"	Nucleoplasm		"CAB037229: AB_1840791, CAB037284: AB_1840792, HPA046380: AB_2679645, HPA066668: "	"unprognostic (2.91e-2)"	"unprognostic (5.37e-2)"	"unprognostic (6.48e-2)"	"unprognostic (3.55e-2)"	"unprognostic (3.98e-2)"	"unprognostic (4.05e-2)"	"unprognostic (2.93e-2)"	"unprognostic (1.98e-2)"	"unprognostic (1.40e-1)"	"unprognostic (1.05e-1)"	"unprognostic (6.33e-2)"	"unprognostic (4.07e-1)"	"unprognostic (7.95e-2)"	"unprognostic (2.19e-1)"	"unprognostic (3.50e-1)"	"unprognostic (1.04e-1)"	"unprognostic (6.32e-2)"	26.9	20.5	8.2	14.8	8.3	29.5	23.8	13.5	9.2	15.7	9.4	18.9	18.9	16.3	13.2	18.6	16.6	15.2	17.7	7.9	8.4	20.5	40.0	19.2	22.1	8.4	8.4	15.7	21.0	19.0	14.4	14.8	8.6	16.1	23.3	19.4	19.0	17.5	31.7	32.3	19.5	20.1	8.3	18.1	22.1	45.9	8.3	23.0	20.0	23.0	25.7	20.0	16.2	9.8	5.3	31.8	44.3	40.3	23.9	31.6	38.0	25.3	36.0	54.6	56.6	67.7	38.5	41.9	23.5	32.2	22.3	31.2	0.2	14.7	56.1	17.7	28.5	25.0	20.0	56.5	51.4	53.7	22.9	39.3	28.0	41.5	31.2	22.5	42.5	12.7	25.1	17.3	33.7	37.1	0.1	77.0	27.6	19.9	13.1	73.9	23.8	59.9	33.2	29.5	29.0	37.1	60.0	13.7	33.1	19.3	30.5	47.1	25.8	25.8	22.6	21.6	23.6	37.6	20.7	96.4	8.7	41.1	33.8	80.6	46.4	42.0	46.5	61.1	45.0	45.8	41.3	50.6	44.6	45.3	36.4	35.1	8.7	52.6	40.2	14.2	77.8	54.6	8.2	8.3	13.5	9.2	7.9	8.4	8.4	8.4	8.6	8.3	8.3	9.8	16.7	12.8	21.8	7.5	21.4	9.4	16.5	20.3	11.4	18.4	12.4	11.2	8.0	14.3	20.8	11.0	12.5	19.7	19.5	25.4	31.3	42.3	207.8	10.6	8.1	19.6	22.0	8.6	11.7	66.1	24.4	16.7	13.7	10.6	11.4	13.8	12.5	15.5	29.3	10.1	12.4	18.4	16.2	21.0	21.6	46.7	20.8	17.1	3.6	6.5	33.6	17.0	28.8	7.5	11.0	45.8	35.3	15.8	13.2	28.6	49.3	23.5	24.4	17.9	13.1	9.7	13.7	101.7	7.4	9.2	10.4	31.6	19.0	13.9	22.2	20.4
DDX20	"DP103, GEMIN3"	ENSG00000064703	"DEAD-box helicase 20"	Q9UHI6	1	111754832-111775602	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"mRNA processing, mRNA splicing"	"DNA-binding, Helicase, Hydrolase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	6	"testis: 52.8"	"Group enriched"	"Detected in all"	5	"Early spermatids: 738.2;Late spermatids: 718.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in single"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA005516, CAB015427"	Enhanced		Supported	"Nucleoplasm,Nuclear bodies,Cytosol"	"Intracellular and membrane"	NA	NA			"Cluster 44: Non-specific - Transcription"	"Cluster 83: Testis - Spermatogenesis"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 34: Spermatids - Unknown function"	"Nucleoplasm, Nuclear bodies"	Cytosol	"CAB015427: AB_629518, HPA005516: AB_1849612"	"unprognostic (3.71e-2)"	"unprognostic (5.25e-2)"	"prognostic favorable (9.85e-5)"	"unprognostic (8.73e-2)"	"unprognostic (2.51e-2)"	"unprognostic (7.09e-2)"	"prognostic unfavorable (6.35e-6)"	"unprognostic (1.17e-1)"	"unprognostic (5.87e-2)"	"unprognostic (7.46e-3)"	"unprognostic (4.21e-1)"	"unprognostic (5.22e-2)"	"unprognostic (1.05e-3)"	"unprognostic (2.60e-2)"	"unprognostic (2.01e-1)"	"unprognostic (4.23e-1)"	"unprognostic (1.30e-2)"	4.6	3.6	0.8	1.3	0.7	2.3	4.3	0.4	0.9	4.2	0.3	3.9	0.5	4.8	0.9	3.3	4.5	1.6	3.6	0.8	0.7	3.0	2.6	3.2	3.0	0.7	0.8	4.3	3.6	2.5	1.9	2.4	0.5	3.0	1.9	0.8	3.3	2.5	8.8	3.6	4.3	2.8	0.5	4.8	3.8	52.8	0.6	3.7	3.2	1.8	4.2	4.0	3.3	1.3	7.0	3.8	7.1	7.3	4.7	5.0	7.0	3.3	9.1	16.3	18.6	5.8	4.5	17.7	5.2	6.4	3.9	5.8	13.5	9.4	18.2	7.3	9.2	7.4	3.2	3.0	4.6	8.4	6.1	3.0	10.4	9.2	12.2	2.4	12.8	7.2	10.8	5.9	12.0	6.5	11.8	0.9	14.1	5.2	8.5	11.3	12.7	5.3	4.8	5.2	11.7	9.5	6.7	7.0	12.7	5.7	7.0	8.5	3.5	7.9	8.2	13.2	8.6	1.2	5.3	12.3	7.5	8.1	18.5	14.9	6.2	6.0	8.2	5.6	10.7	9.3	9.1	8.4	6.8	9.1	10.6	8.6	3.4	9.1	6.6	3.5	10.0	6.9	0.8	0.7	0.4	0.9	0.8	0.7	0.7	0.8	0.5	0.5	0.6	1.3	8.5	12.8	9.4	6.8	13.0	10.8	9.7	6.0	9.6	14.3	6.5	6.6	7.7	5.7	10.0	5.5	2.1	10.2	9.4	2.9	3.9	9.5	738.2	8.1	12.0	9.3	4.2	5.9	7.4	6.9	7.5	6.9	5.1	5.4	7.6	12.3	5.7	5.9	9.3	6.7	7.7	5.8	8.2	7.2	7.0	718.9	16.4	7.3	1.8	3.7	7.5	6.9	6.2	3.0	3.6	6.3	2.3	13.2	9.0	5.2	3.0	7.6	11.8	10.4	6.6	9.7	11.7	121.7	26.3	7.0	7.2	5.1	11.1	14.0	6.6	5.5
DDX21	"GURDB, RH-II/GU"	ENSG00000165732	"DExD-box helicase 21"	Q9NR30	10	68956170-68985068	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Antiviral defense, Immunity, Innate immunity, rRNA processing, Transcription"	"Helicase, Hydrolase, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Suprabasal keratinocytes: 589.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036592, HPA036593"	Enhanced		Enhanced	"Nucleoplasm,Nucleoli rim,Mitotic chromosome"		Yes	No		40000	"Cluster 45: Eosinophils - Innate immune response"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 39: Non-specific - Basic cellular processes"	"Nucleoli rim, Mitotic chromosome"	Nucleoplasm	"HPA036592: AB_10673625, HPA036593: AB_2675208"	"unprognostic (3.04e-1)"	"unprognostic (6.81e-3)"	"unprognostic (1.13e-2)"	"unprognostic (1.21e-2)"	"unprognostic (1.75e-2)"	"unprognostic (6.71e-3)"	"unprognostic (1.34e-2)"	"unprognostic (1.99e-2)"	"unprognostic (1.29e-1)"	"unprognostic (1.92e-1)"	"prognostic unfavorable (3.12e-4)"	"unprognostic (1.64e-1)"	"unprognostic (1.39e-2)"	"unprognostic (9.33e-2)"	"unprognostic (5.41e-2)"	"unprognostic (1.24e-2)"	"unprognostic (5.74e-3)"	55.9	27.9	7.9	52.7	8.8	103.5	36.2	8.9	9.3	22.0	7.7	26.5	25.5	25.2	13.4	40.3	24.0	32.4	21.9	7.4	9.7	30.0	42.1	31.5	50.0	10.8	10.1	20.1	45.7	24.5	12.9	38.0	11.0	19.0	32.0	8.1	20.5	17.5	47.9	30.1	21.8	28.4	10.7	30.2	26.4	22.5	8.8	33.6	25.1	26.9	51.0	81.7	23.5	11.3	194.4	112.5	64.5	199.7	56.7	74.4	135.6	129.8	104.3	163.8	138.3	366.7	128.8	289.5	77.8	108.2	77.2	168.1	250.4	161.8	217.5	90.7	176.1	203.2	76.9	153.3	121.2	488.9	184.7	76.8	205.2	196.2	324.5	76.1	121.3	106.8	393.8	140.5	116.8	88.1	192.9	106.1	176.3	91.8	236.8	170.1	105.3	143.0	108.2	102.7	132.5	141.6	116.6	254.8	155.5	76.8	144.9	101.1	125.6	95.5	136.0	129.8	230.7	160.4	228.2	418.2	79.3	362.4	66.5	7.6	10.9	20.4	8.7	17.1	15.9	14.0	11.4	11.8	13.0	12.3	10.6	11.8	4.9	9.4	21.2	12.1	9.2	7.5	7.9	8.8	8.9	9.3	7.4	9.7	10.8	10.1	11.0	10.7	8.8	11.3	199.4	102.5	141.6	8.1	243.7	550.2	346.2	103.8	174.2	25.9	159.9	113.7	74.2	94.4	144.1	71.7	41.7	80.8	139.5	134.0	72.4	141.2	50.8	116.7	260.7	196.7	86.7	98.6	18.5	187.8	151.8	162.2	120.8	201.8	168.5	57.1	104.2	215.3	112.4	25.2	16.0	202.7	67.1	154.5	266.8	19.7	89.5	199.1	124.5	12.2	138.1	25.8	64.9	13.6	18.2	222.9	77.7	77.1	148.9	465.3	59.9	128.2	72.8	29.8	26.3	302.6	174.9	105.5	114.8	224.8	589.7	137.5	159.6	99.4	210.7	375.5
DDX23	"prp28, PRPF28, SNRNP100, U5-100K"	ENSG00000174243	"DEAD-box helicase 23"	Q9BUQ8	12	48829756-48852842	"Enzymes, Predicted intracellular proteins"	"mRNA processing, mRNA splicing"	"Helicase, Hydrolase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038680, HPA039037"	Approved		Supported	Nucleoplasm,Nucleoli		NA	NA		21000	"Cluster 2: Granulocytes - Unknown function"	"Cluster 52: Non-specific - Ribosome"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 63: NK-cells & T-cells - Immune response"	"Nucleoplasm, Nucleoli"		"HPA038680: AB_10795401, HPA039037: AB_2676317"	"unprognostic (1.32e-3)"	"unprognostic (8.90e-2)"	"unprognostic (8.92e-2)"	"unprognostic (7.12e-2)"	"unprognostic (5.34e-2)"	"unprognostic (1.47e-1)"	"prognostic unfavorable (3.03e-5)"	"unprognostic (3.54e-2)"	"unprognostic (5.68e-2)"	"unprognostic (2.19e-2)"	"unprognostic (1.69e-1)"	"unprognostic (8.34e-2)"	"unprognostic (5.94e-2)"	"unprognostic (9.78e-2)"	"unprognostic (6.88e-2)"	"unprognostic (2.59e-2)"	"unprognostic (1.44e-1)"	33.2	30.7	28.7	36.9	30.8	26.5	33.1	29.7	29.6	35.3	33.1	39.3	33.5	35.1	25.0	37.5	35.4	25.4	30.1	28.0	29.9	33.0	43.0	33.8	46.6	30.7	29.9	40.6	36.7	34.5	28.4	33.7	29.7	36.1	37.6	27.8	37.3	29.7	54.4	39.2	41.2	34.0	30.1	47.6	38.3	26.7	30.8	63.3	32.9	35.8	48.1	36.1	34.7	30.4	74.0	165.1	76.6	81.5	74.7	51.4	81.3	89.1	68.1	98.9	62.5	162.0	95.7	92.5	95.6	74.4	93.3	64.9	168.1	81.1	84.0	146.1	89.2	122.7	139.0	73.8	40.3	125.3	106.9	49.9	71.7	105.1	62.6	67.6	82.4	80.4	165.6	80.3	72.9	102.1	119.8	118.2	114.4	104.0	77.4	125.9	90.7	73.5	58.3	101.9	94.1	54.9	89.4	101.0	38.4	78.0	99.0	113.7	74.5	74.4	54.1	37.2	71.8	60.1	89.8	109.5	63.3	86.8	41.8	20.9	11.8	21.9	19.3	13.6	19.6	12.6	14.1	17.5	11.3	10.5	13.5	16.6	12.2	12.8	9.8	11.9	14.3	12.0	28.7	30.8	29.7	29.6	28.0	29.9	30.7	29.9	29.7	30.1	30.8	30.4	22.7	25.6	36.5	11.8	25.5	12.9	13.7	12.7	25.6	17.5	18.6	19.4	20.0	22.8	25.8	12.9	25.0	25.9	30.7	33.0	15.6	25.9	14.4	24.4	25.2	27.2	13.9	21.7	6.9	38.9	29.1	19.2	25.5	26.6	18.3	29.8	17.9	18.7	19.1	15.2	8.7	26.6	16.2	13.2	10.3	6.3	24.5	16.5	14.2	9.4	25.5	26.2	35.0	7.5	8.4	33.9	32.3	22.2	32.0	26.7	24.3	12.5	34.4	26.1	19.7	20.8	20.0	43.8	33.1	24.4	15.2	26.5	28.6	21.1	27.3	21.6
DDX24		ENSG00000089737	"DEAD-box helicase 24"	Q9GZR7	14	94048287-94081212	"Enzymes, Plasma proteins, Predicted intracellular proteins"		"Helicase, Hydrolase, RNA-binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA002554	Uncertain		Approved	Nucleoli,Cytosol		NA	NA			"Cluster 34: Basophils - Unknown function"	"Cluster 72: Non-specific - Transcription"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 24: Non-specific - Transcription regulation"	"Nucleoli, Cytosol"		"HPA002554: AB_1078631"	"unprognostic (7.48e-2)"	"unprognostic (3.02e-2)"	"unprognostic (8.95e-2)"	"unprognostic (2.12e-1)"	"unprognostic (2.31e-1)"	"unprognostic (4.06e-3)"	"unprognostic (8.81e-2)"	"unprognostic (2.66e-3)"	"unprognostic (2.77e-1)"	"unprognostic (2.28e-2)"	"unprognostic (1.60e-3)"	"unprognostic (4.13e-2)"	"prognostic favorable (3.06e-9)"	"prognostic unfavorable (2.89e-4)"	"unprognostic (6.15e-2)"	"unprognostic (1.23e-1)"	"unprognostic (5.66e-2)"	80.7	130.5	23.3	3.9	24.2	23.5	75.2	25.9	29.7	80.0	24.5	85.8	3.7	93.1	37.2	48.9	81.4	6.7	114.3	24.3	23.9	61.2	43.4	69.4	10.4	31.2	25.2	87.3	49.8	7.0	109.0	2.8	25.4	69.9	3.8	8.0	53.9	4.9	123.9	67.4	59.6	4.1	23.9	75.9	66.1	114.3	25.2	8.0	73.5	4.2	9.1	80.2	65.9	26.2	6.5	1.8	11.5	7.5	6.8	8.8	2.7	17.6	14.5	22.4	20.0	2.2	4.0	29.8	6.4	3.9	6.7	4.1	11.9	1.1	24.5	13.0	0.7	15.8	4.3	9.9	5.7	23.0	6.8	1.4	6.6	4.1	3.9	7.5	3.7	5.6	8.5	8.2	9.6	18.2	7.0	19.6	7.6	1.9	0.2	9.3	26.6	3.5	17.0	2.4	9.1	8.4	17.3	4.2	8.5	1.8	6.8	8.1	11.3	6.4	4.4	8.2	5.3	3.4	24.8	31.5	9.2	12.3	5.1	9.5	2.1	1.7	3.0	1.7	0.8	1.7	1.6	1.8	1.2	2.3	3.0	3.0	1.5	3.8	1.8	1.9	2.1	3.0	23.3	24.2	25.9	29.7	24.3	23.9	31.2	25.2	25.4	23.9	25.2	26.2	164.7	169.9	160.6	45.4	245.9	182.8	186.6	147.4	171.4	184.7	86.6	94.7	228.3	64.3	146.4	147.1	131.3	94.0	332.8	74.1	272.0	147.0	98.2	244.0	248.2	142.2	97.5	75.5	62.9	98.9	72.6	189.0	95.8	201.0	154.9	251.5	109.6	103.4	85.1	232.2	73.6	89.0	118.0	92.1	147.4	67.4	231.5	143.5	99.6	45.0	158.0	133.4	122.6	31.7	56.1	91.0	67.4	244.8	225.6	116.4	70.7	242.3	160.4	200.5	164.3	185.0	198.0	506.5	435.9	127.6	145.6	157.1	342.1	305.9	74.9	123.7
DDX25	GRTH	ENSG00000109832	"DEAD-box helicase 25"	Q9UHL0	11	125903348-125943702	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Differentiation, mRNA transport, Spermatogenesis, Translation regulation, Transport"	"Developmental protein, Helicase, Hydrolase, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	4	"testis: 91.4"	"Group enriched"	"Detected in some"	4	"Early spermatids: 332.1;Spermatocytes: 266.3"	"Cancer enhanced"	"Detected in some"		"glioma: 1.0"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"JURKAT: 16.1;NTERA-2: 10.8;SCLC-21H: 8.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA020137	Enhanced		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 11: Basophils - Unknown function"	"Cluster 77: Retina - Visual perception"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 66: Spermatocytes - Spermatogenesis"	Nucleoplasm	Cytosol	"HPA020137: AB_1847552"	"unprognostic (5.78e-3)"	"unprognostic (9.75e-3)"	"unprognostic (7.93e-2)"	"unprognostic (5.09e-3)"	"unprognostic (1.11e-2)"	"unprognostic (1.78e-2)"	"unprognostic (1.54e-1)"	"unprognostic (2.91e-3)"	"unprognostic (6.24e-5)"	"unprognostic (2.57e-1)"	"unprognostic (2.44e-3)"	"unprognostic (3.89e-1)"	"unprognostic (3.44e-3)"	"unprognostic (1.44e-1)"	"unprognostic (1.76e-1)"	"unprognostic (9.72e-2)"	"unprognostic (1.69e-1)"	0.4	2.7	15.0	0.1	16.1	0.3	0.3	12.4	17.0	0.3	4.0	0.4	0.4	0.3	0.2	0.1	0.6	0.1	0.0	14.3	16.7	2.6	0.3	0.2	0.1	8.7	10.4	0.6	1.4	1.7	14.9	0.2	10.6	0.2	0.1	21.8	0.2	0.4	0.1	1.1	0.1	0.0	7.6	0.3	0.4	91.4	15.0	0.6	4.7	0.1	0.1	0.0	0.2	13.5	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.7	0.0	0.2	0.1	1.2	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.4	0.0	0.0	0.0	0.0	16.1	0.0	0.2	0.0	0.5	1.7	0.0	10.8	0.5	0.0	0.4	0.0	0.0	0.0	0.1	8.7	1.9	0.1	0.0	1.7	1.4	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.1	0.0	0.0	0.6	0.6	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.4	0.2	0.0	0.1	0.0	0.0	15.0	16.1	12.4	17.0	14.3	16.7	8.7	10.4	10.6	7.6	15.0	13.5	0.2	0.0	0.5	16.0	0.5	0.1	0.8	0.0	2.2	18.0	0.1	0.8	1.1	0.0	0.0	0.0	16.7	0.1	0.0	0.0	3.9	0.3	332.1	0.2	0.0	1.0	0.0	0.0	18.0	0.2	0.2	0.4	0.0	0.1	0.0	2.3	0.4	0.5	0.1	16.8	23.1	0.0	0.0	0.0	0.3	66.0	3.7	0.4	0.0	1.9	0.0	20.2	0.0	15.6	3.1	0.1	0.0	4.9	0.0	0.5	0.0	2.7	0.0	16.6	0.0	0.2	0.3	266.3	28.6	0.4	0.0	0.0	0.1	4.0	0.0	0.2
DDX28	"FLJ11282, MDDX28"	ENSG00000182810	"DEAD-box helicase 28"	Q9NUL7	16	68020916-68023232	"Enzymes, Predicted intracellular proteins"	"Ribosome biogenesis"	"Helicase, Hydrolase, RNA-binding, rRNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Syncytiotrophoblasts: 99.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041911, HPA053585"	Approved		Supported	Nucleoli,Mitochondria,Cytosol		No	No			"Cluster 27: Non-specific - Gene expression"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 18: Syncytiotrophoblasts - Pregnancy hormone signaling"	"Mitochondria, Cytosol"	Nucleoli	"HPA041911: AB_10794161, HPA053585: AB_2682200"	"unprognostic (8.11e-2)"	"unprognostic (1.18e-1)"	"unprognostic (6.10e-3)"	"unprognostic (8.03e-2)"	"unprognostic (1.58e-1)"	"unprognostic (8.69e-2)"	"unprognostic (8.46e-2)"	"unprognostic (9.58e-2)"	"unprognostic (2.19e-1)"	"unprognostic (7.63e-2)"	"unprognostic (8.14e-3)"	"unprognostic (8.53e-2)"	"prognostic favorable (2.07e-10)"	"unprognostic (1.58e-2)"	"unprognostic (6.21e-2)"	"unprognostic (2.23e-1)"	"unprognostic (2.47e-1)"	5.8	10.0	3.9	4.8	4.1	16.8	5.6	4.0	4.3	3.9	4.0	5.7	3.9	6.0	5.1	8.2	5.0	2.8	8.3	4.1	4.7	6.4	8.7	4.3	7.7	4.0	3.9	5.5	5.6	7.0	3.6	4.7	4.3	3.5	4.3	1.6	5.0	3.5	15.4	9.7	7.0	3.7	4.0	9.0	6.3	9.7	4.1	5.6	4.0	7.7	6.4	5.5	4.3	4.1	10.2	14.7	7.1	8.5	9.5	5.3	16.5	6.9	9.8	16.4	11.6	14.4	15.5	37.6	10.2	8.3	9.0	17.9	10.1	16.1	9.6	5.1	16.7	13.6	7.4	14.9	12.8	21.7	14.1	10.3	17.2	13.5	12.4	5.7	9.2	24.9	24.5	5.7	7.4	22.4	22.9	30.0	17.2	10.2	10.7	22.1	6.6	40.3	11.6	11.4	14.8	9.9	27.6	7.8	15.3	8.0	14.9	23.1	7.0	7.3	6.3	10.6	11.2	12.8	16.9	36.7	9.0	16.4	10.1	24.0	22.3	27.4	17.0	22.4	18.7	14.3	15.6	18.5	20.8	19.0	24.2	18.2	7.2	21.5	23.4	10.2	16.0	20.8	3.9	4.1	4.0	4.3	4.1	4.7	4.0	3.9	4.3	4.0	4.1	4.1	4.4	6.4	6.8	0.7	10.9	9.2	14.2	11.7	8.0	5.6	4.8	4.3	4.1	8.6	8.3	3.7	0.0	27.9	4.0	2.9	13.7	12.0	6.6	5.4	4.4	5.7	4.8	9.5	0.9	9.7	12.5	4.4	5.1	5.4	3.8	8.0	6.8	11.6	17.1	3.3	1.0	3.5	6.1	8.5	3.1	4.0	5.0	6.8	7.2	0.0	13.3	7.5	25.7	0.5	1.4	7.4	4.2	3.4	4.2	5.7	2.0	19.7	5.3	4.3	13.1	4.4	9.4	22.7	14.1	6.7	10.7	99.9	7.6	12.5	6.1	8.8
DDX31	"FLJ13633, FLJ14578, FLJ23349, PPP1R25"	ENSG00000125485	"DEAD-box helicase 31"	Q9H8H2	9	132592997-132670401	"Enzymes, Predicted intracellular proteins"		"Helicase, Hydrolase, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Oligodendrocyte precursor cells: 26.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA020891			Supported	"Nucleoli,Golgi apparatus,Vesicles"		NA	NA			"Cluster 22: NK-cells - Unknown function"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 68: Oligodendrocytes - Mixed function"	Nucleoli	"Golgi apparatus, Vesicles"	"HPA020891: "	"unprognostic (5.71e-2)"	"unprognostic (1.76e-2)"	"unprognostic (2.56e-1)"	"unprognostic (7.91e-2)"	"unprognostic (5.79e-2)"	"unprognostic (9.94e-2)"	"prognostic unfavorable (1.68e-7)"	"unprognostic (1.34e-1)"	"unprognostic (2.02e-2)"	"unprognostic (1.66e-1)"	"unprognostic (3.90e-2)"	"unprognostic (9.57e-3)"	"unprognostic (4.57e-3)"	"unprognostic (2.24e-2)"	"unprognostic (1.22e-1)"	"unprognostic (1.38e-1)"	"unprognostic (2.03e-1)"	3.9	3.8	3.3	5.3	3.9	4.2	6.3	8.8	3.2	4.8	4.0	3.9	3.1	4.5	5.0	5.7	5.2	3.6	3.3	2.8	3.7	6.0	5.5	4.5	6.6	5.1	3.8	9.9	5.8	5.4	4.2	3.5	5.7	5.4	4.7	3.2	8.2	4.3	6.1	8.4	4.2	4.2	2.9	4.8	4.0	6.0	3.6	5.5	13.8	4.2	7.2	5.2	4.9	4.7	12.4	22.2	10.8	14.4	12.4	11.1	20.4	12.9	12.2	19.2	14.5	24.9	24.1	29.9	11.2	11.7	20.8	33.5	32.8	14.6	15.4	18.4	12.3	16.4	19.5	13.1	14.9	29.7	12.8	9.9	19.5	19.7	27.5	7.5	12.7	22.1	30.6	11.4	16.1	26.3	20.6	15.9	26.2	35.4	22.2	21.4	19.3	34.6	17.5	11.4	18.8	13.5	23.4	20.2	18.0	12.2	42.8	8.4	11.1	32.5	15.0	18.7	19.8	5.5	18.8	23.5	12.0	18.2	25.2	0.0	1.1	1.2	3.1	1.6	2.4	2.1	2.9	2.4	2.5	2.7	3.6	2.7	0.2	2.0	1.1	1.6	2.0	1.7	3.3	3.9	8.8	3.2	2.8	3.7	5.1	3.8	5.7	2.9	3.6	4.7	3.3	6.4	6.0	16.6	7.2	5.6	4.5	3.0	9.1	4.3	5.9	8.1	4.4	0.0	10.2	7.3	4.2	5.7	4.7	3.6	1.9	6.2	4.1	3.9	6.6	3.6	24.6	1.7	9.7	5.4	6.8	4.4	4.1	4.6	1.3	6.1	2.9	4.1	5.2	1.7	13.9	5.8	6.1	2.9	1.8	3.0	18.0	2.9	1.8	5.6	4.5	1.7	8.2	26.7	17.1	5.9	1.2	13.2	5.7	5.8	0.7	7.1	5.7	3.7	0.0	4.1	3.4	14.0	13.7	8.8	6.3	3.0	5.0	5.7	6.1	3.5
DDX39A	"BAT1L, DDX39, DDXL, URH49"	ENSG00000123136	"DExD-box helicase 39A"	O00148	19	14408798-14419383	"Enzymes, Predicted intracellular proteins"	"mRNA processing, mRNA splicing"	"Helicase, Hydrolase, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 147.8"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 308.4;Late spermatids: 283.3;Spermatocytes: 307.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA055334	Approved		Approved	"Nuclear speckles"		NA	NA		200000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 66: Lymphoid tissue - Immune response regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	"Nuclear speckles"		"HPA055334: AB_2682787"	"unprognostic (1.31e-1)"	"prognostic favorable (6.86e-4)"	"unprognostic (2.41e-1)"	"unprognostic (1.10e-1)"	"unprognostic (1.12e-1)"	"unprognostic (5.20e-2)"	"unprognostic (2.55e-3)"	"unprognostic (1.92e-1)"	"unprognostic (1.87e-1)"	"unprognostic (8.81e-2)"	"unprognostic (1.64e-1)"	"unprognostic (3.09e-2)"	"prognostic unfavorable (1.50e-10)"	"unprognostic (1.55e-3)"	"unprognostic (8.57e-2)"	"unprognostic (3.92e-1)"	"unprognostic (7.38e-3)"	28.2	21.6	17.1	49.6	20.7	105.5	24.7	21.9	23.0	22.1	18.0	26.4	28.6	21.9	8.7	39.3	18.2	13.6	24.9	17.0	18.6	21.0	21.9	25.1	76.2	21.9	19.8	14.9	15.7	10.2	15.5	18.1	22.0	16.8	20.2	4.7	19.0	8.8	20.7	24.4	33.8	15.1	19.0	55.7	27.2	147.8	20.5	80.4	20.5	12.7	65.1	25.9	22.7	25.2	198.8	175.9	87.8	147.2	32.4	22.4	73.5	84.8	48.0	176.1	105.7	183.3	98.7	375.0	87.5	71.1	101.0	114.8	215.7	135.9	74.3	129.0	127.3	408.5	201.0	133.1	55.1	225.1	164.0	30.1	30.6	113.1	47.0	25.4	89.1	134.4	253.4	150.3	95.7	270.9	375.4	320.1	147.9	208.8	280.4	248.9	139.7	212.0	62.5	179.6	181.5	98.2	64.3	127.8	98.6	54.3	138.0	216.5	83.1	144.5	92.7	245.7	192.6	156.0	313.0	399.3	167.1	232.2	148.9	33.2	92.8	29.6	120.1	107.9	106.2	132.5	96.0	96.3	131.1	125.8	83.1	90.1	27.0	84.1	94.3	82.7	153.0	135.5	17.1	20.7	21.9	23.0	17.0	18.6	21.9	19.8	22.0	19.0	20.5	25.2	55.6	16.0	21.4	4.9	90.0	76.0	43.6	53.0	50.1	10.5	30.0	24.8	10.9	21.5	27.4	5.5	0.0	60.6	75.1	60.5	37.2	55.3	308.4	26.6	30.6	53.0	25.7	88.1	3.1	67.2	117.9	33.3	87.7	44.5	93.0	32.7	26.0	12.9	90.5	11.8	3.5	55.4	26.4	48.6	85.2	283.3	26.4	62.7	49.8	4.7	56.7	16.2	50.4	4.0	9.2	53.5	42.7	18.8	115.6	44.5	41.7	26.0	21.1	4.9	19.7	24.8	62.0	307.5	95.4	69.4	71.0	59.9	78.7	32.1	63.8	34.2
DDX39B	"BAT1, D6S81E, UAP56"	ENSG00000198563	"DExD-box helicase 39B"	Q13838	6	31530219-31542448	"Enzymes, Plasma proteins, Predicted intracellular proteins, Transporters"	"mRNA processing, mRNA splicing, mRNA transport, Transport"	"Helicase, Hydrolase, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HEK 293: 352.9;hTERT-HME1: 244.9;K-562: 255.5;NB-4: 254.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB034012, HPA055334, HPA058450"	Enhanced		Enhanced	"Nuclear speckles"		NA	NA		270000	"Cluster 32: T-cells - Unknown function"	"Cluster 72: Non-specific - Transcription"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 52: Non-specific - Transcription"	"Nuclear speckles"		"CAB034012: AB_2243237, HPA055334: AB_2682787, HPA058450: AB_2683721"	"unprognostic (2.78e-2)"	"unprognostic (1.30e-2)"	"unprognostic (6.86e-3)"	"unprognostic (3.44e-2)"	"unprognostic (3.22e-2)"	"unprognostic (5.13e-3)"	"unprognostic (2.89e-2)"	"unprognostic (1.19e-2)"	"unprognostic (4.89e-3)"	"unprognostic (1.25e-1)"	"unprognostic (2.81e-2)"	"unprognostic (3.53e-3)"	"prognostic unfavorable (1.11e-6)"	"unprognostic (2.85e-1)"	"unprognostic (1.72e-1)"	"unprognostic (1.90e-2)"	"prognostic favorable (1.43e-5)"	130.5	138.3	11.9	23.7	12.3	5.5	125.0	12.8	13.1	147.7	12.0	126.6	3.0	127.6	103.5	105.9	133.9	6.2	141.8	11.4	12.4	123.0	125.9	117.5	34.5	14.4	12.5	173.0	187.5	7.9	125.0	14.6	12.6	141.8	16.6	34.3	103.1	30.3	181.6	104.3	134.1	9.5	13.5	178.1	117.0	59.8	12.0	40.1	133.4	60.4	26.4	118.6	113.2	14.6	9.0	130.9	37.7	19.7	121.4	78.1	24.7	9.6	11.5	28.8	25.4	13.3	17.8	24.3	75.0	145.0	106.3	16.5	42.8	223.1	26.7	8.1	352.9	19.9	14.3	28.7	13.2	35.1	18.8	129.0	117.8	28.9	244.9	131.0	18.3	157.0	255.5	7.1	24.1	6.3	22.7	254.1	17.2	18.3	13.0	17.9	41.6	10.8	143.5	11.8	18.4	151.2	26.3	9.0	15.6	35.7	6.5	36.5	10.3	3.7	13.9	3.6	26.7	68.2	78.9	229.9	2.3	39.5	16.6	2.5	6.4	4.8	4.8	7.6	6.4	4.2	6.9	6.7	9.3	6.2	10.2	8.8	4.3	5.2	4.6	7.7	7.1	5.6	11.9	12.3	12.8	13.1	11.4	12.4	14.4	12.5	12.6	13.5	12.0	14.6	31.5	22.4	36.9	0.0	43.9	14.4	41.9	13.2	35.9	21.3	21.8	15.7	4.0	5.7	22.2	3.7	22.9	13.9	58.1	15.2	5.9	9.7	1.4	23.0	37.8	26.5	17.3	26.3	0.0	8.2	11.8	28.0	64.2	32.4	37.2	58.3	13.2	6.9	9.8	15.2	0.0	11.7	12.2	14.8	14.4	2.6	16.1	34.9	8.8	0.0	17.1	8.5	66.9	0.0	0.0	10.4	11.7	11.7	44.5	23.0	17.5	5.1	31.5	27.2	26.3	57.9	35.2	6.4	6.7	44.2	13.5	17.0	50.3	79.6	12.7	33.9
DDX3X	"DBX, DDX14, DDX3, HLP2"	ENSG00000215301	"DEAD-box helicase 3 X-linked"	O00571	X	41333348-41364472	"Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Apoptosis, Chromosome partition, Host-virus interaction, Immunity, Innate immunity, Ribosome biogenesis, Transcription, Transcription regulation, Translation regulation"	"DNA-binding, Helicase, Hydrolase, RNA-binding"	"Cancer-related genes, Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Late spermatids: 887.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA001648, HPA005631, HPA059585"	Supported	Supported	Approved	Nucleoplasm,Cytosol		NA	NA		260000	"Cluster 18: Basophils - Vesicular transport"	"Cluster 52: Non-specific - Ribosome"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 7: Non-specific - Mitochondria"	Cytosol	Nucleoplasm	"HPA001648: AB_1078635, HPA005631: AB_1078633, HPA059585: AB_2684073"	"unprognostic (2.42e-2)"	"unprognostic (1.11e-1)"	"unprognostic (8.01e-3)"	"unprognostic (1.66e-1)"	"unprognostic (8.12e-2)"	"unprognostic (6.43e-2)"	"unprognostic (1.17e-3)"	"unprognostic (1.88e-1)"	"unprognostic (9.80e-2)"	"unprognostic (1.40e-1)"	"unprognostic (3.25e-2)"	"unprognostic (2.05e-1)"	"unprognostic (1.51e-1)"	"unprognostic (2.95e-1)"	"unprognostic (4.77e-1)"	"unprognostic (9.44e-2)"	"unprognostic (2.93e-2)"	164.7	123.2	28.7	113.3	29.9	146.1	99.8	31.9	37.3	102.4	38.8	85.6	80.7	123.4	39.1	107.6	108.8	111.0	96.4	27.0	36.0	110.5	130.6	103.5	118.7	33.6	29.8	108.1	76.9	133.0	52.5	107.3	34.2	68.7	75.8	81.9	72.9	64.8	126.9	91.2	81.6	145.1	32.4	103.2	84.4	43.0	30.9	169.6	104.3	112.5	111.5	153.3	97.7	34.7	230.5	225.6	236.3	122.3	273.6	211.1	136.4	150.6	239.3	167.1	132.3	238.8	141.4	2.5	103.9	185.8	212.4	149.4	292.2	235.0	248.3	130.2	232.9	132.6	237.6	152.1	140.5	253.8	236.4	159.1	150.9	278.4	270.3	204.1	258.3	131.5	258.4	134.5	158.9	157.8	163.0	83.2	212.2	121.3	114.2	187.8	223.3	182.6	143.7	279.1	147.1	220.0	352.3	184.3	194.3	248.9	158.9	172.4	224.5	159.6	166.3	178.7	188.2	153.6	194.0	215.7	161.5	156.1	151.5	50.8	39.0	30.7	23.3	35.3	33.5	21.0	23.3	26.3	34.7	13.0	25.4	25.3	54.0	30.7	39.4	11.7	24.8	37.8	28.7	29.9	31.9	37.3	27.0	36.0	33.6	29.8	34.2	32.4	30.9	34.7	466.5	86.6	150.0	66.9	280.1	264.3	160.5	63.7	191.8	77.1	295.1	237.6	158.0	81.5	96.5	58.8	131.3	94.6	415.2	231.1	43.0	64.3	370.6	261.1	237.7	238.5	183.7	113.0	43.8	85.6	95.1	191.8	178.9	290.1	165.5	180.6	144.2	174.5	123.1	60.6	47.1	161.4	71.2	208.7	269.1	887.5	66.5	319.0	128.1	47.8	112.2	90.0	79.3	44.7	63.1	114.1	156.7	62.8	241.8	145.0	234.9	87.3	102.5	127.1	72.3	351.4	210.1	30.6	57.7	212.6	333.4	172.9	342.4	144.8	129.1	225.8
DDX3Y	DBY	ENSG00000067048	"DEAD-box helicase 3 Y-linked"	O15523	Y	12904108-12920478	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"		"DNA-binding, Helicase, Hydrolase, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 96.0"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 275.5;Late spermatids: 575.3"	"Low cancer specificity"	"Detected in many"			"Region enriched"	"Detected in all"	6	"cerebral cortex: 31.8"	"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"Daudi: 153.7;HEL: 156.8;U-266/84: 133.1;U-698: 112.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA001648, HPA005631, HPA059583"	Enhanced	Supported	Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 39: Non-specific - mRNA processing"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 25: Spermatids - Spermatogenesis"	Cytosol	Nucleoplasm	"HPA001648: AB_1078635, HPA005631: AB_1078633, HPA059583: "			"unprognostic (3.89e-2)"		"unprognostic (1.70e-1)"	"prognostic favorable (4.70e-5)"	"unprognostic (6.50e-2)"	"unprognostic (4.74e-2)"	"unprognostic (2.22e-2)"		"unprognostic (4.17e-2)"	"unprognostic (3.37e-2)"	"unprognostic (9.61e-2)"	"unprognostic (2.58e-3)"	"unprognostic (1.74e-1)"	"unprognostic (2.66e-2)"	"unprognostic (7.87e-2)"	29.0	26.1	2.8	15.2	2.9	96.0	20.7	5.5	31.8	0.0	6.6	25.8	12.0	0.0	26.8	18.5	0.0	18.7	19.1	2.7	5.5	23.7	22.0	27.4	9.6	2.8	3.3	0.1	14.8	12.4	25.1	22.1	3.2	33.6	24.0	23.6	18.5	31.3	19.9	20.2	25.9	0.0	2.3	26.5	19.8	70.1	3.8	0.0	22.0	28.1	23.6	22.0	0.0	4.6	0.7	28.3	0.0	0.0	0.0	0.0	20.0	69.3	49.9	35.9	44.0	0.2	0.0	153.7	0.1	69.5	0.0	0.0	0.0	0.0	63.2	38.8	0.0	156.8	0.0	46.5	34.2	0.1	0.1	37.4	43.4	0.0	0.0	0.0	0.0	15.2	0.2	0.1	43.1	0.2	61.8	0.2	27.1	0.0	0.0	0.0	18.0	28.2	38.2	41.5	44.5	0.1	0.1	0.2	51.4	43.5	0.0	36.5	49.1	55.0	0.3	0.1	45.8	78.7	133.1	112.8	6.9	0.1	0.0	1.5	3.8	3.2	4.4	3.9	4.0	3.2	3.3	3.7	4.9	2.7	3.9	3.5	3.5	3.4	2.4	1.4	3.0	3.2	2.8	2.9	5.5	31.8	2.7	5.5	2.8	3.3	3.2	2.3	3.8	4.6	0.1	48.1	75.8	10.1	58.0	94.1	92.7	37.5	89.4	53.8	0.0	0.0	26.0	10.0	41.2	9.2	41.7	38.3	13.3	5.6	5.9	13.9	275.5	0.0	0.0	56.5	16.0	24.6	19.7	0.2	18.9	63.4	56.1	0.0	92.9	0.0	42.1	9.1	20.1	42.1	15.7	9.3	10.2	64.1	127.5	575.3	38.8	58.2	26.6	5.6	27.8	53.7	26.8	4.0	5.7	5.0	8.8	39.5	54.7	70.8	10.5	13.9	101.2	49.3	19.7	56.2	39.2	67.2	70.1	43.8	80.4	37.8	66.2	0.0	8.1	75.0
DDX4	VASA	ENSG00000152670	"DEAD-box helicase 4"	Q9NQI0	5	55738017-55817157	"Enzymes, Predicted intracellular proteins"	"Differentiation, Meiosis, RNA-mediated gene silencing, Spermatogenesis"	"Developmental protein, Helicase, Hydrolase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	102	"testis: 149.7"	"Group enriched"	"Detected in some"	4	"Early spermatids: 565.1;Late spermatids: 184.1;Spermatocytes: 320.9"	"Cancer enriched"	"Detected in single"	37	"testis cancer: 3.0"	"Region enhanced"	"Detected in single"		"white matter: 1.4"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BEWO: 1.8;PC-3: 1.0"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"CAB026170, HPA037763, HPA037764"	Enhanced		Approved	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA				"Cluster 74: Testis - Spermatogenesis"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 29: Early spermatids - Spermatogenesis"	"Nucleoplasm, Plasma membrane, Cytosol"		"CAB026170: , HPA037763: AB_2675652, HPA037764: AB_2675653"	"unprognostic (1.49e-1)"	"unprognostic (1.15e-2)"		"unprognostic (1.54e-1)"	"unprognostic (2.58e-1)"	"unprognostic (3.80e-2)"	"unprognostic (3.03e-1)"	"unprognostic (5.35e-2)"	"unprognostic (3.91e-1)"	"unprognostic (3.77e-2)"	"unprognostic (3.28e-1)"	"unprognostic (5.73e-2)"	"unprognostic (5.43e-7)"	"unprognostic (4.84e-2)"	"unprognostic (1.12e-1)"	"unprognostic (5.60e-2)"	"unprognostic (1.55e-1)"	0.0	0.0	0.1	0.0	0.4	0.0	0.0	0.0	0.7	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.2	0.3	0.1	0.1	0.4	0.0	0.1	0.0	0.2	0.1	0.0	0.1	0.1	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	149.7	0.3	0.3	0.0	0.0	0.5	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	1.0	0.0	0.0	0.0	0.2	0.1	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.4	0.0	0.7	0.2	0.1	0.3	0.1	0.2	0.0	0.3	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	565.1	0.0	0.0	0.4	0.0	0.0	3.9	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.8	0.0	12.2	0.0	0.0	184.1	5.6	0.5	0.0	1.0	0.0	0.0	0.0	1.5	8.7	0.1	0.0	3.8	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	320.9	83.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0
DDX41	"ABS, MGC8828"	ENSG00000183258	"DEAD-box helicase 41"	Q9UJV9	5	177511577-177516961	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"mRNA processing, mRNA splicing"	"Helicase, Hydrolase, RNA-binding"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA017911, HPA048803"	Supported		Supported	Nucleoplasm,Nucleoli		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 59: Non-specific - Translation"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 10: Non-specific - Unknown function"	Nucleoplasm	Nucleoli	"HPA017911: AB_1847558, HPA048803: AB_2680527"	"unprognostic (2.52e-1)"	"unprognostic (1.51e-1)"	"unprognostic (7.57e-2)"	"unprognostic (1.02e-1)"	"unprognostic (2.34e-1)"	"unprognostic (2.61e-2)"	"unprognostic (4.21e-3)"	"unprognostic (2.60e-2)"	"unprognostic (1.92e-1)"	"unprognostic (1.25e-1)"	"unprognostic (2.89e-2)"	"unprognostic (4.47e-2)"	"prognostic unfavorable (2.21e-6)"	"unprognostic (1.41e-1)"	"unprognostic (1.22e-1)"	"unprognostic (2.23e-1)"	"unprognostic (1.75e-1)"	26.5	29.0	15.1	28.7	16.1	22.3	25.4	13.1	21.9	26.1	13.7	26.5	24.8	25.2	16.8	33.7	30.6	18.3	18.9	17.8	14.2	26.8	27.1	24.5	24.7	15.8	13.7	28.6	23.5	31.2	18.0	22.8	16.0	22.3	19.3	14.6	28.7	19.1	43.4	35.0	28.7	20.1	12.8	26.7	26.7	17.9	16.2	24.3	29.0	20.3	25.0	24.8	27.6	16.4	62.1	71.4	42.4	44.9	43.4	45.2	125.1	58.4	35.1	47.1	36.1	107.7	61.3	67.2	83.3	57.6	67.6	47.8	57.2	128.5	33.2	175.4	68.0	90.5	70.8	66.5	52.5	89.3	82.3	48.7	47.0	45.3	59.0	43.5	53.4	68.1	72.3	50.0	55.6	135.5	80.6	45.9	62.0	59.0	61.3	72.7	48.1	86.2	50.5	78.8	45.0	41.9	64.6	83.2	56.5	27.1	54.6	110.2	51.3	74.4	42.8	43.6	87.6	49.6	75.9	120.1	81.3	100.1	47.0	14.3	31.4	22.3	18.3	28.5	23.5	17.0	18.3	16.8	27.2	14.4	14.6	18.8	9.2	25.8	31.4	11.2	18.8	25.6	15.1	16.1	13.1	21.9	17.8	14.2	15.8	13.7	16.0	12.8	16.2	16.4	17.0	25.6	17.8	7.8	20.6	21.0	22.9	37.9	18.2	16.9	17.5	16.5	9.0	25.8	24.3	9.2	2.1	46.6	22.9	22.9	41.1	42.1	11.2	16.1	16.5	22.3	11.4	25.2	6.0	39.6	63.2	17.6	17.3	19.2	29.8	21.3	16.1	18.0	48.8	8.4	6.4	27.0	18.3	23.5	15.4	22.9	14.9	22.2	12.4	4.7	34.6	23.9	20.6	5.0	3.9	33.5	23.9	21.1	23.2	19.0	29.5	40.1	20.5	10.3	13.1	14.5	29.0	24.5	26.7	26.2	20.3	37.5	19.0	25.6	31.0	22.7
DDX42	"RHELP, RNAHP, SF3b125, SF3B8"	ENSG00000198231	"DEAD-box helicase 42"	Q86XP3	17	63773603-63819317	"Enzymes, Plasma proteins, Predicted intracellular proteins"		"Helicase, Hydrolase, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA023447, HPA023571, HPA025941"	Approved		Enhanced	"Nuclear speckles"		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 52: Non-specific - Ribosome"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 10: Non-specific - Unknown function"	"Nuclear speckles"		"HPA023447: AB_1847560, HPA023571: AB_1847561, HPA025941: AB_1847562"	"unprognostic (3.46e-1)"	"unprognostic (7.11e-2)"	"unprognostic (8.44e-2)"	"unprognostic (1.29e-1)"	"unprognostic (2.49e-2)"	"unprognostic (3.17e-2)"	"prognostic unfavorable (2.84e-4)"	"unprognostic (1.06e-1)"	"unprognostic (4.73e-2)"	"unprognostic (1.90e-1)"	"unprognostic (2.54e-2)"	"unprognostic (1.34e-2)"	"prognostic unfavorable (9.26e-4)"	"unprognostic (3.02e-1)"	"unprognostic (2.42e-1)"	"unprognostic (7.35e-2)"	"unprognostic (1.55e-2)"	43.5	32.6	27.4	30.5	29.4	37.3	42.7	26.2	29.7	38.5	21.6	42.9	31.3	42.4	39.0	32.6	44.0	30.2	35.3	25.8	30.8	30.0	34.8	35.8	40.6	29.9	30.1	54.7	54.4	39.9	29.2	36.5	28.9	39.3	36.4	39.3	47.3	40.7	59.2	39.6	33.5	43.1	29.0	37.2	37.1	39.8	30.7	40.1	34.2	42.7	47.1	39.5	30.6	26.5	87.4	89.9	79.2	81.3	78.2	62.7	85.0	83.4	74.6	74.7	72.9	84.7	55.9	120.8	32.0	94.3	62.4	68.2	90.3	74.3	98.5	35.9	59.1	91.0	92.0	104.2	77.1	106.9	59.7	80.3	69.2	67.9	81.6	63.5	75.2	61.6	103.2	49.7	77.0	71.3	102.8	59.3	75.8	69.4	47.4	88.7	135.8	62.3	68.2	101.3	49.5	93.9	63.2	112.3	74.1	110.7	77.2	87.1	80.5	109.9	67.0	45.3	99.4	55.6	47.9	109.5	56.4	58.1	58.9	1.9	2.2	6.9	3.7	2.2	4.2	2.8	3.0	3.7	2.9	5.3	3.6	3.7	2.0	4.5	4.3	1.8	2.1	1.9	27.4	29.4	26.2	29.7	25.8	30.8	29.9	30.1	28.9	29.0	30.7	26.5	41.5	80.1	60.4	24.2	34.7	31.2	24.4	24.5	48.9	40.9	37.0	38.0	49.5	30.0	49.0	36.8	37.5	33.3	29.3	27.0	13.7	30.4	9.2	64.9	68.0	41.8	40.7	33.0	33.6	27.1	24.4	42.2	32.1	72.0	30.4	82.1	30.0	34.5	23.2	50.5	30.3	37.8	28.5	32.7	26.1	12.7	48.7	29.6	14.2	21.5	55.5	46.6	32.0	18.1	26.7	41.1	25.3	50.4	36.7	39.0	26.5	23.5	65.5	46.7	39.5	63.2	51.8	68.5	63.1	52.7	29.7	27.4	32.7	71.3	33.8	32.4
DDX43	"CT13, DKFZp434H2114, HAGE"	ENSG00000080007	"DEAD-box helicase 43"	Q9NXZ2	6	73394828-73417566	"Enzymes, Predicted intracellular proteins"		"Helicase, Hydrolase, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	7	"placenta: 4.9;testis: 19.5"	"Group enriched"	"Detected in many"	6	"Spermatocytes: 50.6;Spermatogonia: 41.5"	"Cancer enriched"	"Detected in many"	15	"testis cancer: 13.0"	"Not detected"	"Not detected"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"BEWO: 8.0;CAPAN-2: 13.8;HHSteC: 3.7;MCF7: 2.6;U-2 OS: 8.7"									HPA031381	Enhanced					NA	NA			"Cluster 24: B-cells - Unknown function"	"Cluster 83: Testis - Spermatogenesis"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 20: Spermatogonia & Spermatocytes - Spermatogenesis"			"HPA031381: AB_10601885"	"unprognostic (4.03e-3)"	"unprognostic (8.20e-2)"	"unprognostic (2.06e-1)"	"unprognostic (1.01e-1)"	"unprognostic (2.19e-1)"	"unprognostic (3.59e-4)"	"unprognostic (1.64e-2)"	"unprognostic (3.11e-2)"	"unprognostic (1.20e-1)"	"unprognostic (2.15e-1)"	"unprognostic (3.12e-1)"	"unprognostic (3.08e-1)"	"unprognostic (1.19e-3)"	"unprognostic (1.02e-1)"	"unprognostic (2.68e-1)"	"unprognostic (1.58e-1)"	"unprognostic (8.78e-2)"	1.0	0.4	0.3	0.5	0.4	0.7	0.9	0.4	0.4	0.6	0.3	0.9	1.2	0.8	0.0	0.9	0.4	1.2	0.7	0.2	0.4	0.8	0.3	1.0	0.8	0.7	0.5	1.1	1.3	0.0	0.4	4.9	0.8	1.4	0.5	0.4	1.8	1.8	0.2	1.2	0.8	0.8	0.4	0.8	1.7	19.5	0.5	0.2	1.4	0.3	0.6	1.0	0.4	0.8	0.0	0.0	0.0	0.0	0.0	0.0	8.0	0.5	0.0	0.0	0.0	0.1	13.8	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	3.7	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.6	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	8.7	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.9	1.0	0.3	0.7	0.8	0.7	0.9	0.2	1.0	0.4	0.1	0.2	0.6	0.2	0.0	0.4	0.2	0.3	0.4	0.4	0.4	0.2	0.4	0.7	0.5	0.8	0.4	0.5	0.8	2.1	3.2	5.4	0.3	1.0	2.7	0.9	3.4	0.0	0.3	0.8	0.9	0.8	1.5	2.5	0.0	0.0	7.2	2.6	0.5	0.0	0.4	5.1	2.1	0.5	2.4	0.0	0.0	0.3	1.0	3.2	1.7	0.0	2.4	0.0	0.1	0.4	0.1	2.7	0.0	0.3	0.3	4.1	0.8	1.5	5.0	2.1	1.5	3.6	0.0	0.6	0.5	6.2	0.0	2.0	1.5	0.0	1.2	0.7	0.3	0.3	1.5	1.4	1.1	0.0	1.7	1.3	50.6	41.5	0.0	1.4	6.0	2.1	0.2	0.3	0.8
DDX46	"FLJ25329, KIAA0801, Prp5, PRPF5"	ENSG00000145833	"DEAD-box helicase 46"	Q7L014	5	134758771-134855133	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"mRNA processing, mRNA splicing"	"Helicase, Hydrolase, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036554, HPA057501"	Supported		Supported	"Nucleoli fibrillar center,Nuclear speckles"		NA	NA		13000	"Cluster 6: Non-specific - Transcription"	"Cluster 34: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 52: Non-specific - Transcription"	"Nuclear speckles"	"Nucleoli fibrillar center"	"HPA036554: AB_10673621, HPA057501: AB_2683449"	"unprognostic (1.88e-1)"	"unprognostic (1.21e-1)"	"prognostic favorable (9.01e-6)"	"unprognostic (7.00e-2)"	"unprognostic (3.37e-2)"	"unprognostic (1.71e-2)"	"unprognostic (2.04e-3)"	"unprognostic (1.07e-1)"	"unprognostic (1.60e-2)"	"unprognostic (5.05e-2)"	"unprognostic (9.21e-2)"	"unprognostic (6.02e-2)"	"unprognostic (9.70e-3)"	"unprognostic (4.36e-2)"	"unprognostic (4.35e-2)"	"unprognostic (1.64e-2)"	"unprognostic (4.50e-2)"	16.5	14.6	7.6	23.9	8.8	23.1	17.7	16.1	10.8	16.3	11.4	17.3	17.0	19.8	12.3	17.5	15.0	13.4	13.4	6.8	11.2	18.8	17.7	15.8	25.6	10.0	8.4	18.5	20.8	18.4	11.1	15.7	9.2	15.5	20.7	18.0	16.8	12.1	35.2	19.4	18.7	17.6	5.4	20.6	20.0	16.3	10.0	32.1	18.7	22.9	26.6	18.2	15.6	10.3	87.1	78.0	54.4	71.1	20.8	23.2	75.0	56.8	43.7	58.8	65.6	119.2	61.7	108.9	47.7	38.3	62.3	52.5	80.9	54.2	68.7	73.8	73.3	131.0	84.7	48.5	18.0	120.5	67.8	21.0	28.9	62.1	34.8	24.9	47.3	85.9	113.6	45.3	44.1	41.5	104.2	46.9	75.2	50.1	34.8	89.7	142.0	54.8	32.0	73.9	64.2	61.3	79.4	37.2	42.7	63.0	58.3	68.0	59.0	61.8	43.2	47.9	114.0	35.6	103.2	140.2	42.8	112.0	40.0	55.6	31.9	48.2	30.7	29.2	28.0	38.1	30.4	31.3	25.3	43.4	30.9	31.5	55.9	32.3	27.5	38.5	29.7	17.8	7.6	8.8	16.1	10.8	6.8	11.2	10.0	8.4	9.2	5.4	10.0	10.3	102.4	76.9	131.5	35.9	123.6	113.8	121.5	102.7	68.9	131.5	80.6	79.4	69.3	64.3	94.9	103.0	83.4	133.7	142.3	91.3	56.7	100.5	53.4	111.4	155.8	104.7	92.2	90.6	38.7	107.9	160.4	85.1	69.3	115.9	101.2	122.3	76.8	113.1	94.4	121.1	41.2	112.4	63.1	119.3	113.2	26.7	111.9	103.4	56.9	21.5	178.5	79.9	194.7	28.1	57.6	130.7	62.6	113.2	134.7	139.5	79.2	84.1	74.5	176.0	98.6	114.9	115.2	246.3	275.7	81.0	137.0	157.2	131.8	114.5	112.7	144.1
DDX47	"DKFZp564O176, FLJ30012, HQ0256, RRP3"	ENSG00000213782	"DEAD-box helicase 47"	Q9H0S4	12	12813316-12829981	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Apoptosis, mRNA processing, mRNA splicing, rRNA processing"	"Helicase, Hydrolase, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Ductal cells: 22.6;Exocrine glandular cells: 17.8;Pancreatic endocrine cells: 19.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA014855	Approved		Supported	Nucleoli		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 5: NTERA-2 - Transcription"	"Cluster 59: Non-specific - Transcription"	Nucleoli		"HPA014855: AB_1847567"	"unprognostic (3.14e-2)"	"unprognostic (1.21e-1)"	"unprognostic (2.11e-1)"	"unprognostic (1.75e-2)"	"unprognostic (2.38e-1)"	"unprognostic (4.91e-2)"	"unprognostic (5.84e-4)"	"unprognostic (1.96e-1)"	"unprognostic (1.11e-2)"	"unprognostic (1.13e-3)"	"unprognostic (2.79e-1)"	"unprognostic (3.49e-3)"	"unprognostic (6.55e-9)"	"unprognostic (1.68e-1)"	"unprognostic (1.27e-1)"	"unprognostic (3.24e-1)"	"unprognostic (8.20e-6)"	28.8	24.1	23.2	22.7	23.7	41.2	32.1	24.6	30.8	27.8	24.5	29.3	18.2	30.8	22.3	29.1	29.8	19.9	23.0	22.6	24.0	32.1	37.8	24.8	32.7	23.8	23.6	35.6	30.8	36.5	17.5	28.9	24.1	26.4	26.3	16.9	24.5	29.0	44.6	30.5	21.7	33.4	24.4	23.4	29.3	23.1	23.2	35.5	33.3	41.7	39.8	47.6	25.5	25.2	161.7	68.3	65.6	53.7	63.1	61.7	111.8	67.8	77.0	141.0	131.0	104.1	101.0	82.4	25.9	92.2	87.4	102.6	95.2	78.0	157.7	117.2	68.1	75.5	45.3	59.7	53.5	87.0	46.5	60.0	72.4	84.0	68.8	110.7	110.4	63.9	74.3	18.2	78.3	57.7	71.0	60.1	288.7	74.4	41.4	77.7	127.2	50.0	86.5	114.2	28.6	72.5	82.3	52.1	69.2	161.4	21.4	64.9	49.9	56.5	136.5	36.8	103.4	25.2	49.1	148.1	60.2	44.9	66.8	10.5	32.9	8.4	46.6	43.8	55.5	48.0	40.9	43.2	56.8	44.9	53.0	51.5	3.8	40.6	44.4	33.3	43.4	35.8	23.2	23.7	24.6	30.8	22.6	24.0	23.8	23.6	24.1	24.4	23.2	25.2	5.1	3.2	8.2	9.1	8.4	2.2	2.7	2.4	14.2	0.6	1.4	1.0	0.1	0.0	8.5	0.0	0.0	1.7	2.3	3.2	1.9	22.6	0.1	3.0	4.1	4.3	4.8	3.4	8.2	17.8	1.9	3.2	4.6	5.7	12.0	0.9	1.1	0.9	0.9	0.0	9.4	4.2	2.0	1.0	1.6	0.4	0.6	2.5	0.0	12.2	9.7	0.9	2.1	8.0	12.6	19.0	4.2	0.4	12.3	1.9	2.8	1.1	6.3	1.6	6.6	1.6	3.4	0.7	0.7	9.0	1.8	1.4	6.2	0.6	6.5	2.8
DDX49	"Dbp8, FLJ10432"	ENSG00000105671	"DEAD-box helicase 49"	Q9Y6V7	19	18919705-18929189	"Enzymes, Predicted intracellular proteins"		"Helicase, Hydrolase, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Late spermatids: 103.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041870, HPA048093"	Enhanced		Approved	Mitochondria		NA	NA			"Cluster 44: Non-specific - Transcription"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 39: Non-specific - Basic cellular processes"	Mitochondria		"HPA041870: AB_2677717, HPA048093: AB_2680262"	"unprognostic (3.51e-1)"	"prognostic favorable (2.01e-6)"	"unprognostic (2.28e-2)"	"unprognostic (1.28e-1)"	"unprognostic (8.56e-2)"	"unprognostic (1.60e-2)"	"prognostic unfavorable (7.05e-4)"	"unprognostic (4.12e-2)"	"unprognostic (2.41e-3)"	"unprognostic (8.67e-2)"	"unprognostic (6.46e-3)"	"unprognostic (5.13e-2)"	"prognostic unfavorable (7.44e-5)"	"unprognostic (3.93e-2)"	"unprognostic (2.99e-2)"	"unprognostic (4.97e-2)"	"unprognostic (3.24e-1)"	16.5	17.7	17.1	13.9	17.3	23.3	15.5	17.9	22.1	16.0	14.0	17.4	15.7	15.9	5.9	25.9	13.9	7.9	18.2	18.2	16.5	15.6	24.9	13.7	16.1	17.1	16.0	14.6	20.1	12.6	11.3	13.4	16.7	16.4	7.4	4.8	18.0	10.8	33.6	27.1	14.8	9.9	17.7	16.1	15.7	19.2	17.3	14.1	13.6	13.6	10.3	17.5	17.5	19.3	46.5	47.4	19.0	61.3	28.1	21.1	71.0	29.2	19.8	50.9	40.1	54.6	45.8	60.6	86.7	29.1	16.1	39.4	42.9	39.8	14.8	18.9	110.5	29.9	49.9	48.6	63.5	77.5	40.1	44.4	35.9	40.7	41.9	14.4	23.3	46.9	58.2	43.1	18.2	104.4	56.6	37.9	62.7	50.3	112.8	62.8	31.5	65.9	27.4	28.2	67.2	69.7	38.2	36.6	48.2	9.8	39.2	37.6	29.5	24.3	27.9	92.0	48.7	55.5	73.0	57.1	31.1	88.8	39.3	17.1	21.9	16.7	14.8	26.2	12.0	9.1	11.0	11.1	31.1	9.8	10.9	12.1	8.6	19.5	18.1	13.7	18.0	12.7	17.1	17.3	17.9	22.1	18.2	16.5	17.1	16.0	16.7	17.7	17.3	19.3	15.6	3.2	10.0	4.9	20.5	22.6	18.7	28.0	14.8	19.5	25.2	29.1	13.8	27.1	20.5	18.4	4.2	46.5	27.0	48.0	37.2	35.0	37.2	18.8	26.5	15.3	25.8	18.3	7.4	52.2	50.3	19.0	19.4	24.7	18.4	25.1	7.5	14.8	33.5	10.1	7.6	31.5	30.5	21.0	22.0	103.0	21.5	18.8	26.6	4.7	28.5	18.3	29.9	6.0	8.2	29.8	30.7	19.9	29.5	21.5	48.0	25.0	12.5	24.1	19.7	21.1	26.9	33.4	31.8	29.5	28.3	42.1	20.8	38.1	39.4	21.5
DDX5	"G17P1, HLR1, p68"	ENSG00000108654	"DEAD-box helicase 5"	P17844	17	64498254-64508199	"Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins"	"Biological rhythms, mRNA processing, mRNA splicing, Transcription, Transcription regulation"	"Helicase, Hydrolase, RNA-binding"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB005868, HPA020043, HPA071154"	Supported		Supported	Nucleoplasm,Nucleoli		No	No		310000	"Cluster 18: Basophils - Vesicular transport"	"Cluster 34: Non-specific - Transcription"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 52: Non-specific - Transcription"	"Nucleoplasm, Nucleoli"		"CAB005868: AB_446484, HPA020043: AB_1847572, HPA071154: "	"unprognostic (6.64e-2)"	"unprognostic (6.98e-2)"	"prognostic favorable (2.12e-4)"	"unprognostic (8.94e-2)"	"unprognostic (5.08e-2)"	"unprognostic (9.85e-2)"	"unprognostic (5.80e-2)"	"unprognostic (1.61e-2)"	"unprognostic (3.17e-2)"	"unprognostic (4.71e-2)"	"unprognostic (3.03e-3)"	"unprognostic (1.44e-1)"	"unprognostic (4.00e-1)"	"unprognostic (2.08e-1)"	"unprognostic (2.37e-1)"	"unprognostic (2.17e-1)"	"unprognostic (9.28e-3)"	202.9	124.0	75.2	75.7	80.0	219.5	163.4	93.4	91.3	190.4	122.8	176.8	36.1	181.7	61.9	136.9	181.2	186.4	109.8	83.6	83.8	113.6	157.5	185.9	124.7	85.5	79.7	134.2	83.3	177.7	118.9	119.4	79.0	122.8	157.7	211.7	112.0	144.8	165.7	130.6	116.3	274.6	65.4	127.5	137.1	88.7	83.2	272.5	172.8	107.5	157.5	228.2	128.9	100.2	204.7	85.5	353.1	144.4	316.2	316.7	134.1	221.4	349.8	306.9	300.3	98.2	105.3	299.7	102.0	364.8	238.1	87.1	361.6	291.5	428.2	107.7	76.0	211.2	84.5	81.6	216.6	383.9	186.3	301.4	306.8	270.2	264.1	241.5	362.2	303.6	174.3	247.3	284.0	108.7	520.4	44.8	159.5	294.5	32.0	310.1	286.7	239.1	201.8	145.6	151.0	305.7	181.5	167.6	284.0	326.5	138.5	132.1	158.2	123.0	146.3	170.0	207.3	112.2	283.9	622.0	166.6	140.5	184.2	232.6	160.6	170.0	117.2	143.3	149.8	111.5	105.4	125.4	148.5	106.3	107.6	109.4	86.6	112.2	197.1	85.5	135.9	319.9	75.2	80.0	93.4	91.3	83.6	83.8	85.5	79.7	79.0	65.4	83.2	100.2	990.8	535.2	690.9	200.8	909.4	879.5	1536.4	837.0	618.1	403.5	433.3	393.7	249.6	346.0	855.7	369.6	335.7	439.9	1284.6	521.5	334.6	476.2	603.0	1021.9	987.2	767.7	664.1	309.7	187.9	419.2	371.3	733.5	452.1	1288.8	874.3	647.9	528.7	254.3	445.8	420.6	165.7	475.9	801.5	577.8	629.4	136.9	415.4	833.2	432.2	280.1	800.2	587.1	777.5	291.6	325.7	464.2	598.6	437.8	661.5	537.7	552.6	287.5	737.9	550.4	493.0	1437.7	961.5	407.6	399.1	466.4	746.0	887.3	1043.4	745.0	424.7	1056.4
DDX50	"GU2, GUB, MGC3199, RH-II/GuB"	ENSG00000107625	"DExD-box helicase 50"	Q9BQ39	10	68901286-68946847	"Enzymes, Plasma proteins, Predicted intracellular proteins"		"Helicase, Hydrolase, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA037388, HPA037389, HPA058196"	Approved		Enhanced	Nucleoli		NA	NA			"Cluster 39: Non-specific - mRNA processing"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 10: Non-specific - Unknown function"	Nucleoli		"HPA037388: AB_10671752, HPA037389: AB_2675450, HPA058196: AB_2683635"	"unprognostic (2.05e-1)"	"unprognostic (3.36e-1)"	"unprognostic (9.90e-2)"	"unprognostic (9.75e-2)"	"unprognostic (1.29e-1)"	"unprognostic (1.23e-1)"	"unprognostic (1.47e-3)"	"unprognostic (2.62e-1)"	"unprognostic (1.97e-1)"	"unprognostic (8.78e-2)"	"unprognostic (4.57e-2)"	"unprognostic (1.44e-1)"	"unprognostic (4.22e-3)"	"unprognostic (1.22e-2)"	"unprognostic (2.38e-2)"	"unprognostic (4.91e-2)"	"unprognostic (1.02e-1)"	21.5	16.9	12.3	19.0	12.4	17.3	25.5	14.6	13.9	24.5	14.2	25.1	13.1	27.3	18.1	19.9	22.5	17.4	18.6	12.5	13.5	19.1	16.3	15.9	27.7	12.1	12.2	30.4	20.9	23.1	21.9	22.1	12.3	19.7	17.9	23.3	15.8	22.5	20.9	17.7	16.3	27.3	12.5	19.7	17.5	25.8	13.3	30.6	25.7	20.7	27.4	23.7	20.0	14.0	48.3	30.6	53.8	67.0	45.4	58.6	33.5	50.2	56.7	45.7	42.5	69.3	41.3	62.4	29.4	45.7	27.9	41.5	53.4	38.0	58.0	54.6	38.5	33.6	30.0	31.0	45.6	71.7	40.5	45.9	38.2	43.7	120.7	79.3	37.3	52.8	60.8	37.5	57.0	39.7	67.6	67.7	31.3	46.7	67.3	58.0	60.6	11.4	35.5	28.7	36.9	50.2	36.5	43.0	57.1	50.2	50.6	45.3	32.0	35.1	40.0	39.5	69.5	49.7	47.6	52.8	37.6	72.8	20.9	9.2	10.6	15.0	18.5	16.7	22.9	16.8	22.8	19.4	14.0	17.1	24.1	21.9	3.4	20.6	13.6	12.4	21.8	15.0	12.3	12.4	14.6	13.9	12.5	13.5	12.1	12.2	12.3	12.5	13.3	14.0	27.8	19.2	21.7	21.2	50.5	11.9	35.4	34.6	36.5	44.2	21.1	23.1	27.4	30.0	31.5	20.2	39.6	40.6	36.0	11.4	56.7	28.7	80.3	25.2	41.6	30.3	16.2	29.5	37.5	25.1	39.3	32.2	22.4	22.8	43.0	30.3	23.2	16.2	23.2	37.0	36.4	19.2	26.4	21.6	9.1	20.0	36.4	21.3	12.4	22.5	41.2	22.7	51.5	28.1	29.5	22.8	14.3	39.1	46.3	30.1	11.1	41.3	26.7	55.1	19.7	35.8	53.5	72.8	58.4	31.7	14.3	41.2	40.8	35.4	21.4	20.7
DDX51		ENSG00000185163	"DEAD-box helicase 51"	Q8N8A6	12	132136594-132144319	"Enzymes, Predicted intracellular proteins"	"Ribosome biogenesis, rRNA processing"	"Helicase, Hydrolase, RNA-binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA039503	Uncertain		Approved	Nucleoplasm,Nucleoli,Cytosol		NA	NA				"Cluster 50: Non-specific - Ribosome"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 52: Non-specific - Transcription"	"Nucleoplasm, Nucleoli"	Cytosol	"HPA039503: AB_10796328"	"unprognostic (2.84e-3)"	"unprognostic (1.69e-2)"	"unprognostic (1.43e-1)"	"unprognostic (2.84e-1)"	"unprognostic (8.66e-2)"	"unprognostic (4.00e-2)"	"prognostic unfavorable (4.73e-4)"	"unprognostic (1.13e-1)"	"unprognostic (1.42e-1)"	"unprognostic (4.88e-1)"	"unprognostic (3.05e-3)"	"unprognostic (5.31e-2)"	"unprognostic (3.97e-2)"	"unprognostic (2.48e-1)"	"unprognostic (4.69e-2)"	"unprognostic (3.28e-1)"	"unprognostic (1.65e-3)"	8.5	7.1	4.6	1.9	4.7	4.3	8.6	4.5	5.8	9.7	3.3	8.6	1.6	8.5	2.4	7.2	10.5	1.0	6.8	4.8	4.0	9.3	6.9	6.8	2.5	4.5	4.3	12.9	11.2	1.9	8.7	1.3	4.7	8.7	1.4	2.6	6.9	2.3	9.7	12.0	8.0	1.7	4.2	9.6	8.1	6.7	4.2	2.3	8.5	1.4	1.9	9.3	8.0	5.1	4.1	6.5	2.7	3.4	2.5	2.4	5.0	3.1	1.8	4.5	1.9	4.0	2.0	7.2	2.6	1.9	1.0	4.2	6.7	5.0	2.2	1.7	6.5	8.5	3.8	1.3	3.0	6.0	4.7	2.1	3.6	2.5	2.3	5.0	2.4	7.8	6.4	2.3	1.3	4.1	7.4	12.2	4.7	3.4	11.0	8.6	3.6	7.9	3.1	3.2	6.5	3.4	3.4	4.8	3.5	2.2	4.2	5.5	4.2	1.7	5.1	4.1	7.2	6.4	4.0	8.2	3.5	4.5	4.0	0.1	0.1	0.1	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.2	0.1	0.1	0.2	0.1	0.1	0.2	0.0	0.1	4.6	4.7	4.5	5.8	4.8	4.0	4.5	4.3	4.7	4.2	4.2	5.1	9.5	3.2	17.3	5.2	8.4	12.5	10.1	2.9	7.4	28.5	9.9	10.4	4.5	10.0	9.0	3.7	25.0	6.7	12.9	7.6	1.9	4.1	1.0	6.4	9.2	8.6	8.4	5.0	22.1	5.3	6.4	9.5	9.7	8.8	6.3	18.2	6.8	7.3	5.6	33.7	17.1	11.1	0.0	6.3	8.0	1.1	8.4	6.4	10.6	11.2	4.6	11.7	11.3	8.0	9.0	6.0	8.0	8.2	8.4	11.3	3.3	3.4	4.4	28.0	0.0	17.7	9.1	7.0	11.1	6.3	14.1	4.1	11.1	17.2	12.8	6.8
DDX52	ROK1	ENSG00000278053	"DExD-box helicase 52"	Q9Y2R4	17	37609739-37643446	"Enzymes, Predicted intracellular proteins"		"Helicase, Hydrolase, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 245.1;Glandular and luminal cells: 360.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA056173	Uncertain		Supported	Nucleoplasm,Nucleoli		NA	NA			"Cluster 33: Neutrophils - Chromatin organization"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 44: Endometrium - Transcription"	"Nucleoplasm, Nucleoli"		"HPA056173: AB_2683056"	"unprognostic (1.05e-2)"	"unprognostic (1.85e-1)"	"prognostic favorable (9.41e-4)"	"unprognostic (4.26e-2)"	"unprognostic (9.96e-3)"	"unprognostic (6.77e-2)"	"prognostic unfavorable (2.44e-6)"	"unprognostic (5.10e-2)"	"unprognostic (2.94e-2)"	"unprognostic (2.79e-1)"	"unprognostic (7.50e-2)"	"unprognostic (2.43e-1)"	"unprognostic (2.36e-1)"	"unprognostic (6.95e-2)"	"unprognostic (5.58e-1)"	"unprognostic (1.26e-2)"	"unprognostic (1.28e-1)"	1.8	2.5	1.6	1.0	1.6	4.2	1.7	2.3	2.0	2.0	2.1	2.2	2.0	2.2	3.9	3.1	1.6	1.8	1.8	1.6	1.7	2.6	2.8	1.8	2.1	1.7	1.6	1.5	2.9	2.2	1.4	1.7	1.9	1.7	2.2	2.1	1.9	1.7	2.5	2.8	3.3	1.8	1.4	2.0	2.4	1.8	1.7	1.5	1.3	1.8	2.1	2.4	1.9	2.2	4.7	10.2	1.0	9.4	5.2	4.6	4.0	6.3	5.4	8.1	7.7	6.6	1.7	2.8	4.2	4.3	1.5	4.4	10.5	7.2	11.0	6.5	12.8	5.9	6.6	4.6	5.1	7.8	3.1	4.5	7.6	5.5	6.3	4.1	9.4	2.7	0.9	1.7	4.7	1.6	11.9	4.3	5.4	2.6	0.8	7.3	8.4	4.9	9.9	5.8	6.6	5.5	7.5	1.8	5.2	5.0	3.3	6.1	6.7	6.6	4.2	3.6	7.3	2.2	3.8	4.9	5.3	4.6	5.2	0.9	0.5	0.7	0.8	0.7	0.6	0.6	0.8	0.6	0.4	0.6	0.7	0.9	0.4	0.8	0.4	1.2	0.5	0.2	1.6	1.6	2.3	2.0	1.6	1.7	1.7	1.6	1.9	1.4	1.7	2.2	28.5	41.7	19.7	17.3	29.4	34.5	33.9	41.2	26.2	34.0	25.4	22.7	33.3	18.6	41.4	27.6	33.3	35.4	47.4	28.7	35.2	76.6	245.1	105.8	77.7	32.3	26.3	42.7	19.4	52.3	31.1	28.1	29.6	360.4	27.3	40.8	28.5	37.2	26.1	47.1	19.3	30.1	34.6	25.8	12.6	97.8	24.5	24.1	17.8	19.7	53.8	26.0	33.0	29.7	23.0	56.8	20.5	24.0	25.4	35.8	35.7	40.2	32.0	36.0	26.3	26.7	34.1	29.6	56.0	33.4	33.2	25.0	30.3	43.7	46.8	49.5
DDX53	"CAGE, CT26"	ENSG00000184735	"DEAD-box helicase 53"	Q86TM3	X	22999960-23003589	"Enzymes, Predicted intracellular proteins"		"Helicase, Hydrolase, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	38	"brain: 2.1;testis: 5.4"	"Cell type enriched"	"Detected in some"	5	"Early spermatids: 62.6"	"Cancer enriched"	"Detected in single"	4	"testis cancer: 0.7"	"Region enriched"	"Detected in single"	7	"cerebellum: 2.1"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"GAMG: 3.2;K-562: 4.6;RPMI-8226: 2.4;U-2197: 1.4;U-266/84: 10.5"									HPA003186			Supported	Nucleoplasm,Nucleoli,Cytosol		NA	NA				"Cluster 78: Testis - Spermatogenesis"	"Cluster 16: U-266 - Nucleosome"	"Cluster 23: Spermatids - Flagellum & Golgi organization"	Nucleoplasm	"Nucleoli, Cytosol"	"HPA003186: AB_1078637"														"unprognostic (5.76e-1)"	"unprognostic (1.12e-1)"			0.0	0.0	0.2	0.0	0.2	0.0	0.0	2.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	3.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	1.4	0.0	0.3	10.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	2.1	0.2	0.0	0.1	0.1	0.3	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	62.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	11.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	10.9	9.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0
DDX54	"APR-5, DP97, MGC2835"	ENSG00000123064	"DEAD-box helicase 54"	Q8TDD1	12	113157173-113185479	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Helicase, Hydrolase, RNA-binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA028244, HPA070786"	Approved		Approved	"Nucleoplasm,Nucleoli,Golgi apparatus"		NA	NA			"Cluster 44: Non-specific - Transcription"	"Cluster 59: Non-specific - Translation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 39: Non-specific - Basic cellular processes"	"Nucleoplasm, Nucleoli, Golgi apparatus"		"HPA028244: AB_10603885, HPA070786: AB_2686311"	"unprognostic (1.61e-2)"	"unprognostic (1.14e-1)"	"unprognostic (1.23e-1)"	"unprognostic (8.54e-2)"	"unprognostic (8.57e-2)"	"unprognostic (6.39e-2)"	"prognostic unfavorable (1.39e-4)"	"unprognostic (2.23e-2)"	"unprognostic (1.03e-1)"	"unprognostic (1.08e-1)"	"unprognostic (1.01e-1)"	"unprognostic (4.83e-2)"	"unprognostic (1.15e-1)"	"unprognostic (2.29e-2)"	"unprognostic (2.01e-1)"	"unprognostic (2.22e-1)"	"unprognostic (1.24e-1)"	19.6	21.7	7.4	28.9	8.6	38.8	18.7	8.0	9.7	20.0	12.0	17.9	26.8	21.4	5.6	24.0	21.1	13.3	17.8	7.4	7.3	16.2	20.8	17.0	28.5	8.9	8.1	23.2	30.3	20.7	8.4	16.8	9.3	16.2	11.4	7.3	19.7	15.8	53.9	24.7	21.0	13.5	7.7	21.5	21.8	9.2	9.2	21.3	19.0	20.4	16.5	19.9	18.2	9.0	82.7	84.0	30.8	57.1	20.2	24.1	79.3	43.8	40.3	58.3	31.9	87.1	39.0	105.8	49.7	36.8	43.4	59.8	55.0	56.8	22.0	61.3	67.7	64.0	45.1	60.3	35.3	107.5	72.1	39.8	44.1	56.7	34.7	47.7	48.4	63.2	94.2	37.1	30.4	75.8	93.0	152.4	72.1	57.6	59.2	68.2	45.6	107.8	31.7	84.3	39.8	36.0	61.8	93.4	39.9	25.2	80.4	82.6	36.3	49.2	54.8	59.1	92.7	53.3	66.4	119.5	43.4	59.0	52.9	13.0	11.3	2.9	12.6	16.7	13.1	12.4	11.5	12.6	14.5	11.3	11.6	12.9	0.6	13.1	11.7	10.9	10.1	12.7	7.4	8.6	8.0	9.7	7.4	7.3	8.9	8.1	9.3	7.7	9.2	9.0	19.1	32.1	29.8	6.5	39.4	17.3	35.9	26.4	34.7	20.5	28.2	24.3	14.5	21.5	24.1	12.9	2.1	63.9	30.6	29.2	25.4	44.5	1.2	23.3	21.8	25.7	28.2	33.4	5.9	49.9	57.2	23.2	26.0	28.5	25.3	35.6	17.9	38.2	38.6	26.9	4.3	31.5	24.4	35.9	20.9	2.4	29.5	22.3	12.4	6.5	29.5	26.8	51.5	2.0	4.8	43.0	33.4	24.0	35.0	52.9	49.3	50.5	12.8	18.1	6.6	28.7	24.9	14.8	20.1	39.5	19.6	72.4	33.3	56.8	43.8	38.0
DDX55	KIAA1595	ENSG00000111364	"DEAD-box helicase 55"	Q8NHQ9	12	123602077-123620943	"Enzymes, Predicted intracellular proteins"		"Helicase, Hydrolase, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Late spermatids: 74.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039962, HPA044101"	Approved		Enhanced	Nucleoplasm,Nucleoli,Cytosol		NA	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 24: NB-4 - Immune response"	"Cluster 34: Spermatids - Unknown function"	"Nucleoplasm, Nucleoli"	Cytosol	"HPA039962: AB_2676774, HPA044101: AB_2678810"	"unprognostic (1.14e-1)"	"unprognostic (2.30e-2)"	"unprognostic (2.29e-1)"	"unprognostic (3.71e-3)"	"unprognostic (1.92e-1)"	"unprognostic (2.31e-1)"	"prognostic unfavorable (2.11e-9)"	"unprognostic (1.60e-1)"	"unprognostic (4.49e-2)"	"unprognostic (7.39e-2)"	"unprognostic (1.23e-1)"	"unprognostic (1.67e-3)"	"prognostic unfavorable (8.97e-12)"	"unprognostic (9.15e-3)"	"unprognostic (2.94e-1)"	"unprognostic (3.47e-2)"	"unprognostic (1.23e-3)"	11.0	10.3	11.1	10.4	11.1	20.3	11.1	13.2	19.5	12.1	11.2	9.7	7.6	9.6	7.7	11.1	12.2	5.6	6.9	10.7	11.4	12.3	14.7	8.4	13.8	11.5	10.8	13.1	15.4	6.5	11.3	7.7	11.6	11.4	8.8	12.6	9.5	6.3	6.4	13.6	10.8	7.1	9.9	14.9	9.7	9.6	11.3	10.3	9.1	3.4	10.7	10.7	11.1	12.9	20.5	28.4	21.4	21.7	18.0	14.2	32.2	24.8	9.1	21.6	14.8	32.5	14.6	30.2	19.3	10.9	19.5	24.4	32.8	18.4	25.1	22.8	29.7	40.8	34.0	24.3	13.7	50.7	30.7	12.0	19.2	25.7	29.5	16.7	15.8	23.9	42.3	15.5	15.5	21.1	50.0	68.2	33.3	23.6	27.9	37.1	22.7	19.7	15.2	34.8	25.3	21.0	20.2	25.9	35.0	17.7	46.2	32.4	16.3	18.6	24.5	30.6	31.2	28.4	37.4	54.2	17.7	35.8	32.4	3.4	9.1	7.8	11.4	10.6	12.4	13.9	11.1	12.3	7.7	10.7	14.9	13.9	5.2	13.3	6.4	13.2	9.9	8.6	11.1	11.1	13.2	19.5	10.7	11.4	11.5	10.8	11.6	9.9	11.3	12.9	13.3	22.4	13.9	15.7	14.2	11.0	13.4	13.9	9.6	20.2	9.6	14.9	2.5	8.6	11.7	7.3	22.9	13.8	26.3	5.9	7.9	12.2	45.1	9.0	18.4	12.0	7.2	19.6	13.4	12.0	17.4	12.0	11.2	7.2	25.3	16.4	7.1	9.4	14.3	15.2	16.5	15.9	10.2	7.1	7.4	74.8	17.1	9.0	7.2	12.2	9.9	16.1	15.5	6.6	14.3	13.3	7.6	14.7	13.8	13.3	5.9	6.3	12.3	28.1	6.6	10.5	14.1	21.9	18.6	12.5	16.9	7.7	14.2	14.0	10.2	11.0
DDX56	NOH61	ENSG00000136271	"DEAD-box helicase 56"	Q9NY93	7	44565804-44575051	"Enzymes, Predicted intracellular proteins"	"Ribosome biogenesis, rRNA processing"	"Helicase, Hydrolase, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA019749, CAB037320"	Uncertain		Supported	"Nucleoli,Mitotic chromosome"		Yes	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 73: Brain - Neuropeptide signaling"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 39: Non-specific - Basic cellular processes"	Nucleoli	"Mitotic chromosome"	"CAB037320: , HPA019749: AB_1847579"	"unprognostic (3.28e-1)"	"unprognostic (1.05e-1)"	"unprognostic (5.00e-2)"	"unprognostic (1.93e-1)"	"unprognostic (6.08e-3)"	"unprognostic (2.12e-3)"	"prognostic unfavorable (1.38e-5)"	"unprognostic (5.17e-2)"	"unprognostic (2.76e-1)"	"unprognostic (7.07e-2)"	"unprognostic (1.00e-2)"	"unprognostic (6.01e-3)"	"prognostic unfavorable (8.41e-7)"	"unprognostic (2.60e-1)"	"unprognostic (2.88e-2)"	"unprognostic (1.50e-1)"	"unprognostic (4.90e-2)"	21.3	21.8	24.8	21.5	25.6	16.6	17.1	25.5	29.0	19.2	25.3	18.6	20.8	15.4	17.3	25.9	27.2	15.8	20.3	25.1	25.3	16.2	30.1	15.7	29.4	25.6	25.2	22.1	28.2	27.1	7.9	20.1	25.7	18.2	15.7	7.3	24.6	20.2	27.4	32.2	16.4	21.2	25.2	19.5	20.8	10.4	25.2	24.5	23.5	21.5	27.1	28.4	7.3	26.0	69.5	118.8	32.0	70.0	36.6	40.3	62.3	60.9	43.7	107.6	83.9	139.2	90.7	109.8	65.0	59.4	143.5	111.4	70.9	97.5	38.5	45.9	99.2	64.3	90.9	86.1	59.9	77.0	66.4	57.9	78.8	105.8	82.2	35.5	62.0	55.8	150.2	42.8	78.3	103.7	67.3	104.4	108.8	127.8	103.6	70.7	54.3	76.7	69.8	65.4	68.8	90.6	64.2	199.4	58.9	21.3	120.6	105.5	52.4	71.0	86.0	52.6	155.1	88.7	135.0	167.1	75.2	115.1	146.1	36.3	50.8	21.1	37.6	66.3	47.7	48.3	40.9	41.6	63.8	55.0	49.2	38.7	3.6	63.2	67.7	34.8	44.9	59.7	24.8	25.6	25.5	29.0	25.1	25.3	25.6	25.2	25.7	25.2	25.2	26.0	21.5	16.0	29.0	13.1	22.8	17.1	23.9	45.1	21.1	26.6	18.4	14.7	12.3	11.5	40.3	22.0	14.6	57.0	19.1	29.0	27.4	39.4	41.4	21.0	21.1	26.4	18.5	35.8	6.1	32.3	48.5	24.6	30.5	20.6	28.5	35.3	16.8	30.1	35.4	6.7	8.0	24.9	38.7	13.2	17.5	37.5	21.1	17.9	14.2	3.7	28.8	22.4	23.7	6.6	6.2	37.5	18.8	19.9	18.2	24.8	37.2	63.0	31.8	26.9	13.1	22.4	25.1	36.2	25.6	30.1	19.9	47.2	23.6	40.3	36.8	21.3
DDX58	"DKFZp434J1111, FLJ13599, RIG-1, RIG-I, RIG1"	ENSG00000107201	"DExD/H-box helicase 58"	O95786	9	32455302-32526208	"Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins"	"Antiviral defense, Host-virus interaction, Immunity, Innate immunity"	"Helicase, Hydrolase, RNA-binding"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Adipocytes: 41.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"neutrophil: 1.3"	"Low lineage specificity"	"Detected in single"			"Group enriched"	"Detected in many"	4	"BJ hTERT+ SV40 Large T+: 79.0;BJ hTERT+ SV40 Large T+ RasG12V: 76.0;GAMG: 22.8"									"CAB012643, HPA047193, HPA073217"	Approved		Supported	"Plasma membrane,Cytosol"		No	No			"Cluster 1: Neutrophils - Mixed function"	"Cluster 16: Immune cells - Immune response"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	"Plasma membrane, Cytosol"		"CAB012643: , HPA047193: AB_2679978, HPA073217: "	"unprognostic (1.10e-1)"	"unprognostic (4.65e-2)"	"unprognostic (6.56e-2)"	"prognostic unfavorable (5.46e-4)"	"unprognostic (2.45e-1)"	"unprognostic (2.37e-1)"	"unprognostic (8.15e-2)"	"unprognostic (4.57e-2)"	"unprognostic (2.82e-1)"	"unprognostic (6.48e-3)"	"unprognostic (1.00e-2)"	"unprognostic (3.35e-1)"	"prognostic unfavorable (4.66e-4)"	"unprognostic (2.22e-2)"	"unprognostic (3.68e-2)"	"unprognostic (1.05e-2)"	"unprognostic (1.26e-1)"	6.3	4.9	3.5	7.5	2.9	1.3	6.0	3.0	4.3	7.1	3.1	6.3	2.9	5.6	4.7	6.4	4.4	6.0	4.1	2.7	3.6	5.5	6.3	7.1	7.4	5.2	3.7	4.6	5.7	2.5	5.2	5.7	4.0	4.2	5.3	2.3	10.0	3.5	4.8	7.8	7.1	5.7	6.5	9.2	4.8	2.8	3.6	15.6	4.3	1.7	5.2	5.1	5.3	2.9	4.3	2.4	2.5	2.2	7.5	6.4	2.7	2.1	14.6	79.0	76.0	2.4	1.4	0.4	2.7	2.7	22.8	2.8	2.3	1.3	11.4	7.4	0.9	1.1	2.4	3.5	5.0	1.4	4.5	4.9	1.3	6.9	1.3	4.2	14.3	1.5	1.8	1.0	6.6	0.6	3.8	12.4	1.8	0.6	2.0	2.4	3.1	0.0	11.6	0.6	2.0	0.3	1.7	1.7	12.6	1.7	3.5	0.9	13.4	1.5	0.9	1.7	1.1	0.0	0.3	0.9	2.6	3.3	2.1	0.0	0.1	0.3	0.2	0.1	0.3	0.2	0.3	0.0	0.0	0.2	0.2	0.2	1.3	0.4	0.2	0.0	0.2	0.0	3.5	2.9	3.0	4.3	2.7	3.6	5.2	3.7	4.0	6.5	3.6	2.9	41.7	22.4	8.8	20.5	13.9	4.2	5.1	7.2	13.6	4.1	5.8	5.1	5.1	5.7	6.7	1.8	2.1	5.6	13.9	13.8	0.0	19.5	2.7	12.9	8.7	23.6	3.0	5.7	10.4	12.2	7.6	13.9	21.9	20.3	5.1	16.8	9.3	6.7	5.6	6.7	13.2	4.6	4.1	7.3	4.6	0.4	6.5	11.6	0.0	39.4	12.3	6.4	21.6	31.2	17.5	16.2	7.7	6.0	9.1	4.9	16.9	7.2	7.3	2.5	6.6	16.8	13.1	0.5	2.3	10.9	5.4	2.5	17.8	10.4	2.6	5.3
DDX59	"DKFZP564B1023, ZNHIT5"	ENSG00000118197	"DEAD-box helicase 59"	Q5T1V6	1	200623896-200669907	"Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins"		"Helicase, Hydrolase, RNA-binding"	"Ciliopathy, Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA047166	Approved		Approved	"Nucleoplasm,Actin filaments"		NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 50: Non-specific - Ribosome"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 38: Extravillous trophoblasts - Unknown function"	"Nucleoplasm, Actin filaments"		"HPA047166: AB_2679966"	"unprognostic (1.99e-1)"	"unprognostic (1.60e-1)"	"unprognostic (3.44e-2)"	"unprognostic (4.87e-2)"	"unprognostic (1.18e-2)"	"unprognostic (1.13e-1)"	"unprognostic (3.05e-2)"	"unprognostic (4.83e-2)"	"unprognostic (3.40e-3)"	"unprognostic (2.43e-3)"	"unprognostic (4.16e-1)"	"unprognostic (2.16e-1)"	"prognostic unfavorable (9.02e-4)"	"unprognostic (1.62e-1)"	"unprognostic (1.65e-1)"	"unprognostic (6.66e-2)"	"unprognostic (5.98e-2)"	15.4	16.1	13.5	14.2	15.4	33.1	26.5	17.1	18.8	16.2	15.6	14.2	10.2	17.6	20.0	13.5	15.5	12.2	13.3	14.0	14.7	16.4	17.8	14.5	17.0	16.0	15.0	17.6	18.8	15.0	11.3	18.7	17.3	15.2	15.0	17.4	14.4	13.2	32.8	26.2	14.3	14.1	16.3	22.4	12.1	11.0	15.1	22.0	16.2	20.1	16.9	15.0	14.7	17.8	17.5	20.1	22.6	19.0	10.1	17.4	49.9	19.1	17.4	20.5	16.5	6.3	20.2	17.9	9.5	15.7	16.4	16.2	13.0	19.4	14.5	56.8	13.3	13.6	26.4	18.6	20.2	19.5	24.0	18.8	29.1	15.4	41.7	16.7	15.9	24.8	17.4	25.9	20.1	20.0	12.0	29.0	23.8	10.5	16.3	10.1	15.5	34.7	21.9	19.8	13.8	35.7	30.8	31.7	35.6	28.8	27.3	27.3	14.4	17.1	9.5	16.8	20.0	19.5	27.2	23.5	16.3	12.2	30.0	33.3	12.4	24.7	15.1	11.1	12.4	14.9	12.5	13.8	10.6	14.8	12.7	11.8	22.9	16.4	22.0	11.8	19.8	10.2	13.5	15.4	17.1	18.8	14.0	14.7	16.0	15.0	17.3	16.3	15.1	17.8	22.5	19.2	20.1	8.8	19.9	16.2	13.1	16.1	24.5	4.3	10.0	13.2	18.4	7.2	10.6	7.3	2.1	22.2	14.6	9.8	15.6	8.8	2.4	14.6	13.3	16.7	1.2	10.5	4.5	8.2	28.0	14.9	6.6	12.8	20.8	7.1	14.3	7.3	13.0	6.7	6.1	11.0	14.2	12.0	13.0	1.1	8.1	16.1	5.4	8.4	18.5	8.3	25.7	19.1	10.3	8.8	7.9	13.5	13.1	12.0	8.0	11.6	10.8	6.7	0.0	22.8	15.7	14.2	20.0	12.9	15.6	43.8	18.9	9.3	8.5	11.1
DDX6	"HLR2, RCK, Rck/p54"	ENSG00000110367	"DEAD-box helicase 6"	P26196	11	118747763-118791164	"Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"		"Helicase, Hydrolase, RNA-binding"	"Cancer-related genes, Disease variant, Mental retardation, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004668, HPA024201, HPA026644"	Approved		Supported	"Cytosol,Cytoplasmic bodies"		NA	NA		19000	"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 34: Non-specific - Transcription"	"Cluster 36: HEL - Hemostasis"	"Cluster 24: Non-specific - Transcription regulation"	"Cytoplasmic bodies"	Cytosol	"CAB004668: AB_436960, HPA024201: AB_10603562, HPA026644: AB_1847582"	"unprognostic (1.26e-1)"	"unprognostic (1.40e-1)"	"unprognostic (1.89e-1)"	"unprognostic (3.40e-2)"	"unprognostic (4.12e-2)"	"unprognostic (5.82e-2)"	"prognostic unfavorable (6.56e-4)"	"unprognostic (3.43e-1)"	"unprognostic (1.48e-2)"	"unprognostic (1.16e-1)"	"unprognostic (1.00e-1)"	"unprognostic (7.76e-2)"	"unprognostic (1.98e-1)"	"unprognostic (4.91e-3)"	"unprognostic (1.88e-1)"	"unprognostic (9.58e-2)"	"unprognostic (4.55e-2)"	31.5	28.4	29.1	34.9	36.0	69.0	34.9	50.7	31.9	33.2	12.7	30.0	23.7	30.5	30.5	33.1	29.1	23.6	37.2	31.5	35.4	30.6	34.2	27.3	49.0	28.4	29.3	48.8	30.7	28.3	17.3	31.6	25.2	32.9	27.9	48.7	32.4	29.2	43.2	27.2	26.2	30.6	29.9	45.4	29.9	28.8	37.1	54.9	37.5	41.9	60.9	30.0	21.9	36.6	33.9	50.4	73.6	71.7	64.0	64.8	47.2	45.6	62.0	43.0	40.4	72.1	50.9	77.6	47.1	78.8	44.3	53.2	88.8	69.1	69.0	62.7	17.4	154.5	30.8	57.1	42.0	110.9	55.8	67.1	49.5	63.5	100.8	54.8	69.1	53.2	72.5	110.4	59.2	96.8	81.0	52.1	53.3	50.1	33.6	89.3	59.2	60.1	50.1	92.7	48.7	63.9	84.7	67.2	28.5	56.2	79.2	44.2	81.2	67.2	38.4	39.8	47.6	34.1	47.8	91.7	26.8	52.2	59.2	13.8	4.8	13.2	10.2	6.2	12.3	12.1	10.0	10.8	5.1	12.0	12.2	11.0	19.0	8.3	12.4	7.1	9.9	6.8	29.1	36.0	50.7	31.9	31.5	35.4	28.4	29.3	25.2	29.9	37.1	36.6	84.6	60.9	57.9	37.9	140.1	30.2	75.2	31.3	69.4	82.2	49.8	43.2	116.9	42.9	41.4	44.1	50.1	38.4	184.0	58.6	31.3	32.2	4.2	77.3	81.5	64.6	85.7	88.2	57.3	35.5	36.5	55.6	42.3	91.7	52.5	54.2	61.8	41.5	38.3	62.2	60.9	59.8	42.7	66.9	44.3	10.5	54.0	70.1	33.8	68.4	75.9	90.0	119.4	50.3	80.9	51.2	57.0	45.1	106.0	49.8	57.2	41.3	35.9	91.3	39.5	92.6	69.7	71.1	76.8	73.4	30.5	76.5	130.2	48.8	53.1	78.2
DDX60	FLJ20035	ENSG00000137628	"DExD/H-box helicase 60"	Q8IY21	4	168216291-168318883	"Enzymes, Predicted intracellular proteins"	"Antiviral defense, Immunity, Innate immunity"	"Helicase, Hydrolase, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"stomach 1: 40.8"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 57.6;Gastric mucus-secreting cells: 90.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"BJ hTERT+ SV40 Large T+: 27.4;BJ hTERT+ SV40 Large T+ RasG12V: 26.1"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			HPA046952	Approved		Supported	"Intermediate filaments,Cytosol"		No	No			"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 4: Stomach - Digestion"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Cytosol	"Intermediate filaments"	"HPA046952: AB_10963572"	"unprognostic (4.05e-2)"	"unprognostic (2.87e-1)"	"unprognostic (7.22e-3)"	"unprognostic (7.71e-2)"	"unprognostic (2.30e-1)"	"unprognostic (2.65e-2)"	"unprognostic (1.50e-2)"	"unprognostic (3.15e-2)"	"unprognostic (3.06e-1)"	"unprognostic (8.69e-3)"	"prognostic unfavorable (3.35e-4)"	"unprognostic (1.65e-1)"	"unprognostic (4.03e-2)"	"unprognostic (2.48e-1)"	"unprognostic (3.02e-1)"	"unprognostic (3.20e-2)"	"unprognostic (2.44e-1)"	8.2	6.0	2.3	9.8	2.6	5.6	7.2	2.0	2.4	9.6	2.6	17.4	13.3	7.7	4.8	3.5	7.1	9.7	5.9	1.9	2.4	6.7	9.4	11.4	9.8	4.8	2.3	11.0	4.0	6.4	4.0	11.5	2.9	6.0	15.7	3.3	21.3	5.8	2.4	6.5	12.3	6.1	5.1	17.4	40.8	3.4	3.2	15.4	6.3	3.5	6.8	6.8	5.6	3.1	8.3	1.1	4.2	1.4	2.9	10.4	5.3	2.3	14.9	27.4	26.1	0.0	20.2	0.0	1.4	3.1	12.6	6.6	0.5	4.1	8.7	6.1	0.3	12.9	7.3	0.0	9.9	3.8	3.3	7.2	1.7	6.7	1.2	7.1	10.1	4.8	0.0	2.0	3.4	0.3	6.2	2.5	0.4	0.4	2.1	5.1	1.5	0.0	5.3	4.6	0.8	0.7	5.4	1.3	18.8	0.3	1.0	5.1	8.9	2.1	1.5	0.9	2.0	1.6	0.3	0.0	6.6	6.1	6.1	1.6	1.2	1.2	4.2	2.5	4.8	1.4	3.2	4.1	1.1	1.4	3.3	3.7	0.6	3.7	3.0	0.0	3.0	1.8	2.3	2.6	2.0	2.4	1.9	2.4	4.8	2.3	2.9	5.1	3.2	3.1	32.4	35.3	6.5	14.0	12.2	4.2	4.8	6.2	5.7	0.8	3.9	3.2	8.6	11.5	11.5	12.9	0.0	7.6	13.4	57.6	5.9	8.2	3.3	11.8	10.5	22.8	3.0	8.4	0.7	6.8	10.4	11.6	90.2	10.2	27.3	16.2	14.3	4.0	6.2	0.0	1.3	22.4	2.0	4.1	2.8	2.2	8.1	13.5	3.6	25.3	9.3	7.4	17.5	27.6	1.3	12.0	14.9	9.4	3.1	4.1	11.0	4.2	15.3	2.9	6.6	10.0	9.0	1.1	1.0	2.2	2.7	2.9	17.2	18.4	6.0	3.7
DDX60L	FLJ31033	ENSG00000181381	"DExD/H-box 60 like"	Q5H9U9	4	168356735-168537786	"Enzymes, Predicted intracellular proteins"		"Helicase, Hydrolase, RNA-binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 51.1"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"neutrophil: 32.8"	"Group enriched"	"Detected in all"	4	"granulocytes: 32.8;monocytes: 13.1"	"Cell line enhanced"	"Detected in many"		"BJ hTERT+ SV40 Large T+: 44.0"									"HPA043211, HPA055501"	Approved		Approved	"Plasma membrane,Cytosol"		NA	NA			"Cluster 14: Monocytes - Unknown function"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 19: Monocytes & Neutrophils - Innate immune response"	"Plasma membrane, Cytosol"		"HPA043211: AB_10794390, HPA055501: AB_2682838"	"unprognostic (8.86e-2)"	"unprognostic (2.77e-1)"	"unprognostic (1.16e-1)"	"unprognostic (2.45e-1)"	"unprognostic (2.38e-1)"	"unprognostic (3.20e-2)"	"unprognostic (1.05e-1)"	"unprognostic (7.94e-2)"	"unprognostic (1.78e-1)"	"unprognostic (4.19e-2)"	"prognostic unfavorable (3.04e-5)"	"unprognostic (1.70e-1)"	"prognostic unfavorable (2.94e-4)"	"unprognostic (1.13e-1)"	"unprognostic (8.80e-2)"	"unprognostic (8.93e-2)"	"unprognostic (1.69e-1)"	6.9	2.8	2.9	15.8	3.1	51.1	5.8	2.4	4.4	6.6	3.5	9.1	8.7	6.7	2.1	3.2	5.4	9.2	3.5	2.4	5.0	2.2	8.2	10.1	9.6	9.6	3.9	5.3	3.1	3.0	0.4	20.7	5.5	3.8	9.0	6.3	9.0	3.2	1.0	3.0	11.0	7.4	9.3	12.8	13.5	2.2	7.8	15.5	3.5	3.6	7.3	5.9	0.7	5.7	12.3	7.1	2.7	1.1	6.9	19.9	13.3	12.0	25.3	44.0	30.4	0.1	28.0	0.2	0.6	12.2	23.9	4.7	1.2	7.3	12.8	7.0	1.0	27.0	8.1	0.7	8.4	11.1	6.5	5.6	2.1	15.9	1.4	9.2	31.5	6.0	0.5	0.3	28.6	0.3	10.0	7.0	0.6	1.1	5.9	5.4	6.1	0.0	4.2	7.1	0.5	3.6	21.4	2.6	12.2	0.5	1.9	15.3	34.1	2.4	15.6	5.6	4.2	11.2	1.9	0.1	7.8	32.2	3.4	2.4	5.9	5.4	3.7	9.1	5.1	1.2	3.7	3.8	3.6	2.0	2.9	3.3	32.8	2.7	13.1	0.0	5.5	2.5	2.9	3.1	2.4	4.4	2.4	5.0	9.6	3.9	5.5	9.3	7.8	5.7	29.0	9.6	6.7	11.4	14.7	1.0	2.6	3.9	3.4	1.7	11.2	3.3	8.3	2.8	5.1	3.7	22.9	6.1	16.0	24.0	0.0	7.6	15.7	8.5	15.6	18.9	0.0	5.9	1.5	10.1	39.4	13.0	44.4	7.1	8.8	20.3	6.1	6.6	26.1	0.0	5.5	14.1	10.2	23.8	6.0	4.4	3.4	46.2	0.0	33.7	35.6	2.9	24.7	28.6	2.4	26.4	31.5	4.1	6.0	2.1	13.2	3.7	11.5	19.4	6.6	7.1	5.7	0.7	1.4	4.3	2.4	7.1	24.1	12.2	4.5	2.0
DESI2	"C1orf121, CGI-146, DESI-2, FAM152A, FLJ21998, PNAS-4, PPPDE1"	ENSG00000121644	"Desumoylating isopeptidase 2"	Q9BSY9	1	244653103-244709033	"Enzymes, Predicted intracellular proteins"	"Ubl conjugation pathway"	"Hydrolase, Protease"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 171.8;Spermatocytes: 192.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA049950			Approved	Vesicles		NA	NA			"Cluster 37: B-cells - Transcription"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 66: Spermatocytes - Spermatogenesis"	Vesicles		"HPA049950: AB_2680969"	"unprognostic (1.13e-1)"	"unprognostic (2.07e-1)"	"unprognostic (1.05e-1)"	"unprognostic (3.09e-1)"	"unprognostic (1.96e-1)"	"unprognostic (5.40e-2)"	"unprognostic (1.95e-2)"	"unprognostic (7.62e-2)"	"unprognostic (1.38e-3)"	"unprognostic (1.51e-1)"	"unprognostic (4.47e-3)"	"unprognostic (1.45e-1)"	"prognostic unfavorable (4.25e-5)"	"unprognostic (4.52e-2)"	"unprognostic (8.27e-2)"	"unprognostic (2.27e-2)"	"unprognostic (9.49e-2)"	17.1	13.6	7.7	13.6	10.7	17.1	14.0	13.0	8.4	18.4	13.1	16.4	16.0	22.7	13.6	16.2	13.3	17.8	16.4	7.4	7.9	11.8	12.8	23.2	17.9	7.7	8.0	13.6	9.3	13.9	7.1	18.6	7.4	14.4	18.2	16.2	11.1	15.6	24.1	15.2	13.3	22.3	8.1	11.7	15.6	54.8	8.3	19.7	23.3	23.6	19.1	18.4	12.0	8.1	68.1	24.3	47.0	40.8	52.8	54.8	61.7	40.8	65.9	36.9	33.9	43.8	31.0	121.8	53.8	47.7	21.5	29.5	58.1	43.1	50.5	43.1	53.6	31.0	17.5	33.0	46.2	52.8	36.1	38.4	57.3	49.3	61.6	35.6	52.8	52.8	48.4	63.7	56.2	11.7	49.6	28.0	109.0	62.7	67.7	36.9	71.9	46.0	28.4	27.6	42.5	57.2	55.4	26.4	47.7	37.7	27.6	39.0	59.7	41.7	45.4	57.4	68.5	69.4	94.1	69.8	33.8	55.7	78.0	2.5	1.7	5.6	2.1	2.1	2.1	5.2	2.2	3.0	2.7	2.7	2.9	2.8	1.4	2.2	2.3	2.4	3.2	0.7	7.7	10.7	13.0	8.4	7.4	7.9	7.7	8.0	7.4	8.1	8.3	8.1	32.7	86.6	60.4	17.9	31.0	55.3	41.3	23.0	38.7	43.2	21.5	26.3	22.1	27.1	25.5	18.4	20.9	29.8	36.1	28.1	21.5	19.8	171.8	32.0	39.6	36.2	15.6	21.7	18.4	33.4	40.0	44.2	28.5	25.0	7.0	28.7	25.7	21.5	23.8	40.4	23.1	19.0	26.4	23.3	27.1	101.5	34.8	27.2	16.0	18.7	25.5	23.8	28.8	35.7	26.9	34.3	28.6	51.9	34.5	69.5	17.0	16.5	17.6	25.1	39.5	41.7	50.2	192.7	105.4	42.4	41.3	43.2	31.2	38.4	25.4	55.5
DHX15	"DBP1, DDX15, HRH2, PRP43, PRPF43, PrPp43p"	ENSG00000109606	"DEAH-box helicase 15"	O43143	4	24517441-24584554	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"mRNA processing, mRNA splicing"	"Helicase, Hydrolase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA047047	Approved		Enhanced	"Nuclear speckles"		NA	NA		130000	"Cluster 44: Non-specific - Transcription"	"Cluster 34: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 10: Non-specific - Unknown function"	"Nuclear speckles"		"HPA047047: AB_2679916"	"unprognostic (4.46e-3)"	"unprognostic (2.47e-2)"	"prognostic favorable (5.74e-4)"	"unprognostic (3.35e-1)"	"unprognostic (5.30e-2)"	"unprognostic (5.74e-2)"	"unprognostic (2.06e-3)"	"unprognostic (5.53e-3)"	"unprognostic (1.51e-1)"	"unprognostic (1.39e-1)"	"unprognostic (3.60e-2)"	"unprognostic (8.68e-3)"	"unprognostic (7.77e-3)"	"unprognostic (2.51e-3)"	"unprognostic (2.19e-1)"	"unprognostic (1.59e-1)"	"unprognostic (5.41e-3)"	40.3	35.7	17.0	51.2	23.2	78.5	50.7	30.5	22.6	41.3	29.4	48.8	36.8	44.5	30.2	43.9	38.5	35.6	33.3	18.4	20.9	45.7	44.7	37.1	60.2	20.9	20.3	43.8	47.7	52.1	21.6	55.0	22.0	39.5	57.9	40.1	37.7	35.9	43.0	42.1	37.9	48.0	20.8	40.0	44.7	33.5	20.2	79.8	40.0	42.2	70.9	65.6	34.7	29.0	135.0	129.1	209.4	104.6	100.6	97.4	124.7	153.0	133.9	157.8	155.5	132.0	158.5	245.4	91.8	126.2	183.7	109.8	272.1	184.1	243.7	90.6	129.0	213.3	134.7	107.3	59.2	222.3	140.9	82.2	108.4	154.3	103.1	100.8	133.9	113.4	203.4	96.2	181.3	101.3	293.7	148.2	228.4	133.4	115.8	190.4	245.3	114.6	187.1	190.2	179.0	111.9	118.7	112.8	109.1	149.0	123.8	113.7	123.5	132.8	87.5	101.6	181.4	72.1	130.2	289.3	89.1	177.9	161.8	57.5	29.6	28.5	28.8	30.8	39.7	28.7	32.0	33.7	39.0	29.9	33.2	32.2	13.9	37.1	38.5	25.8	38.6	28.5	17.0	23.2	30.5	22.6	18.4	20.9	20.9	20.3	22.0	20.8	20.2	29.0	51.2	76.9	57.4	40.1	53.4	98.7	68.3	58.0	56.3	30.2	50.1	36.7	28.1	35.8	70.6	27.6	22.9	72.7	44.9	79.8	37.2	59.3	32.6	61.7	53.2	53.6	60.5	58.9	51.4	41.8	69.7	55.5	79.5	97.3	57.0	47.4	42.8	48.4	44.7	26.9	50.8	69.3	36.7	46.9	53.2	16.5	39.4	50.2	48.0	49.6	48.0	24.4	34.0	61.3	99.1	57.1	41.2	40.3	51.0	73.1	33.2	34.8	55.6	32.1	26.3	59.6	69.4	72.9	46.3	60.4	100.0	88.2	49.3	34.0	71.2	89.4
DHX16	"DBP2, DDX16, Prp2, PRPF2"	ENSG00000204560	"DEAH-box helicase 16"	O60231	6	30653119-30673006	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"mRNA processing, mRNA splicing"	"Helicase, Hydrolase"	"Disease variant, Neuropathy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 92.7;Spermatocytes: 86.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA051455	Supported		Supported	Nucleoplasm		NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 71: Testis - DNA repair"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 66: Spermatocytes - Spermatogenesis"	Nucleoplasm		"HPA051455: AB_2681491"	"unprognostic (7.04e-2)"	"unprognostic (1.37e-1)"	"unprognostic (7.29e-2)"	"unprognostic (7.46e-2)"	"unprognostic (1.48e-1)"	"unprognostic (1.94e-1)"	"unprognostic (4.36e-3)"	"unprognostic (1.13e-1)"	"unprognostic (2.66e-2)"	"unprognostic (3.11e-1)"	"unprognostic (8.58e-2)"	"unprognostic (1.24e-2)"	"unprognostic (9.77e-3)"	"unprognostic (4.42e-2)"	"unprognostic (1.51e-1)"	"unprognostic (2.64e-1)"	"unprognostic (8.73e-3)"	24.3	28.2	5.4	13.8	6.3	11.3	26.0	6.3	6.8	27.7	8.3	29.5	18.8	25.5	8.6	27.2	26.6	11.3	26.6	5.3	6.0	34.9	36.5	25.4	18.1	6.3	5.9	26.2	35.0	16.0	28.6	10.5	6.4	30.1	10.3	14.4	32.0	12.8	45.0	28.8	37.5	12.5	5.2	40.3	28.3	46.8	6.6	17.1	38.2	17.6	12.7	24.8	26.8	6.4	31.9	17.9	20.3	38.7	26.8	15.7	27.0	33.0	30.7	47.6	44.3	35.8	15.9	25.5	24.2	31.1	39.6	34.0	47.0	24.1	35.5	35.4	15.5	27.2	25.5	17.9	21.4	65.9	40.4	17.6	22.7	47.3	30.1	16.5	16.9	36.9	44.4	29.3	26.7	29.0	22.4	20.8	21.4	20.9	12.1	38.5	17.4	28.2	18.4	24.0	27.9	19.7	30.8	37.4	32.0	20.3	29.5	24.7	11.8	31.2	21.3	27.4	46.3	29.9	49.9	20.2	15.7	36.8	40.4	10.5	11.2	18.6	7.4	14.7	9.5	7.7	9.1	7.9	11.1	5.9	7.4	5.8	11.4	14.8	16.4	9.8	7.4	7.5	5.4	6.3	6.3	6.8	5.3	6.0	6.3	5.9	6.4	5.2	6.6	6.4	13.0	22.4	20.9	4.6	16.9	10.8	11.7	11.3	16.5	13.9	10.0	9.9	14.6	10.0	20.2	5.5	39.6	19.2	14.4	18.3	9.8	15.7	92.7	25.2	18.0	11.8	6.0	14.9	4.3	18.6	20.1	11.6	26.5	15.8	42.3	11.1	8.6	9.7	13.9	5.0	4.1	14.6	8.2	12.6	12.8	49.3	14.3	14.4	5.4	5.6	20.3	11.6	15.5	2.5	5.2	22.9	23.1	12.4	22.1	9.3	18.0	9.8	31.4	51.1	19.7	16.2	19.2	86.9	32.6	14.7	10.7	19.2	19.5	11.4	12.8	9.5
DHX29	DDX29	ENSG00000067248	"DExH-box helicase 29"	Q7Z478	5	55256055-55307694	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Protein biosynthesis"	"Helicase, Hydrolase, Initiation factor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038317, HPA038318"	Approved		Approved	Cytosol	"Intracellular and membrane"	NA	NA			"Cluster 6: Non-specific - Transcription"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Cytosol		"HPA038317: AB_10673169, HPA038318: AB_10672589"	"unprognostic (3.43e-2)"	"unprognostic (5.09e-1)"	"unprognostic (2.21e-2)"	"unprognostic (1.19e-1)"	"unprognostic (1.17e-1)"	"unprognostic (2.80e-1)"	"unprognostic (2.37e-3)"	"unprognostic (1.72e-1)"	"unprognostic (6.66e-2)"	"unprognostic (1.76e-2)"	"unprognostic (3.79e-2)"	"unprognostic (1.30e-1)"	"unprognostic (4.57e-3)"	"unprognostic (4.01e-1)"	"unprognostic (3.85e-1)"	"unprognostic (4.78e-3)"	"unprognostic (9.40e-2)"	10.6	10.6	5.3	9.7	5.7	6.7	12.0	9.1	7.0	12.5	6.7	12.1	7.2	11.4	6.8	12.7	9.5	8.9	10.7	5.7	5.1	16.9	13.1	9.4	9.5	5.0	5.0	8.9	11.7	18.7	10.4	11.4	5.1	13.4	9.8	8.7	10.3	12.0	24.2	11.6	8.4	12.6	5.5	7.9	10.4	7.4	5.1	10.0	15.4	14.8	9.7	12.0	10.3	7.1	36.7	25.5	20.9	27.2	32.3	28.2	25.6	38.9	30.9	28.2	28.7	21.3	23.0	20.7	34.9	44.5	35.8	26.0	34.0	37.1	40.5	9.1	19.4	18.8	21.6	14.6	18.3	13.3	19.6	23.8	23.0	29.9	17.2	18.5	37.9	16.5	24.4	15.0	33.4	25.9	21.4	11.1	17.5	10.5	27.1	10.9	31.8	35.7	23.0	25.3	19.6	12.5	37.4	21.3	18.6	20.5	28.7	21.7	32.9	25.9	20.2	22.8	27.4	13.2	24.1	29.0	29.9	23.0	29.1	68.6	22.5	24.3	18.0	24.4	20.4	27.3	22.5	20.0	17.5	26.3	25.0	21.6	20.6	24.5	30.1	36.8	21.9	8.9	5.3	5.7	9.1	7.0	5.7	5.1	5.0	5.0	5.1	5.5	5.1	7.1	44.5	70.5	42.6	34.0	35.2	37.6	37.5	71.8	39.3	81.6	44.9	49.8	73.6	41.5	69.4	64.4	41.7	68.3	39.5	34.4	54.8	61.4	54.8	37.4	61.5	40.7	38.4	68.4	47.3	61.7	54.6	52.7	35.7	36.5	31.6	39.0	22.9	45.0	41.2	42.1	46.9	36.4	63.1	26.0	26.6	16.6	46.6	41.5	28.4	28.1	50.7	35.7	35.0	42.7	54.9	61.9	27.3	53.0	57.0	53.2	35.2	105.2	35.9	83.6	52.6	52.8	54.2	117.5	108.1	50.1	47.5	81.3	36.1	106.4	39.9	43.3
DHX30	"DDX30, FLJ11214, KIAA0890"	ENSG00000132153	"DExH-box helicase 30"	Q7L2E3	3	47802909-47850195	"Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins"	"Ribosome biogenesis"	"Helicase, Hydrolase, RNA-binding"	"Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA034806	Supported		Supported	Mitochondria,Cytosol		NA	NA			"Cluster 44: Non-specific - Transcription"	"Cluster 43: Testis - Unknown function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 66: Spermatocytes - Spermatogenesis"	Mitochondria	Cytosol	"HPA034806: AB_10601364"	"unprognostic (2.00e-1)"	"unprognostic (8.37e-2)"	"unprognostic (3.27e-1)"	"unprognostic (2.14e-2)"	"unprognostic (3.04e-1)"	"unprognostic (1.62e-1)"	"unprognostic (1.27e-3)"	"unprognostic (1.14e-1)"	"unprognostic (1.16e-1)"	"unprognostic (1.74e-1)"	"unprognostic (1.10e-3)"	"unprognostic (1.42e-2)"	"prognostic favorable (1.37e-6)"	"unprognostic (4.12e-2)"	"unprognostic (1.43e-1)"	"unprognostic (2.81e-1)"	"unprognostic (2.22e-1)"	22.6	24.6	23.7	17.1	23.3	22.2	22.9	21.4	26.3	26.4	24.8	26.8	16.2	27.6	10.4	23.6	24.8	14.9	28.8	23.5	22.4	26.8	25.2	21.3	20.1	24.0	23.5	27.9	24.1	28.9	32.1	17.5	24.6	26.6	10.9	12.7	21.6	18.2	37.1	27.6	22.3	15.9	20.3	27.3	25.2	54.2	23.8	23.3	24.8	21.0	14.3	25.2	22.8	24.2	21.9	52.3	54.5	56.2	24.6	20.2	35.3	39.0	33.4	65.1	46.5	56.9	42.6	66.4	32.0	37.0	51.2	30.3	73.7	52.1	23.1	49.6	86.1	59.6	76.0	58.6	40.7	56.0	58.3	33.0	33.4	68.1	49.7	28.4	44.0	57.5	82.0	40.6	31.8	57.1	82.2	59.3	60.7	30.2	84.0	44.6	30.6	62.2	32.0	53.6	41.6	61.6	39.6	54.1	31.1	25.0	38.5	58.8	32.2	40.6	51.0	46.7	73.9	56.2	75.3	61.8	42.8	48.3	49.9	14.1	10.7	7.8	16.2	10.6	12.4	10.4	12.4	16.3	13.9	8.7	11.7	12.7	1.6	9.6	11.6	7.9	15.3	14.7	23.7	23.3	21.4	26.3	23.5	22.4	24.0	23.5	24.6	20.3	23.8	24.2	31.1	38.5	46.7	30.7	34.7	18.1	25.7	38.7	39.3	49.0	34.6	35.6	38.1	32.9	34.1	51.5	43.8	41.7	33.1	37.6	66.5	37.8	129.5	59.2	31.7	32.4	40.1	38.5	32.8	36.3	22.8	26.7	42.3	33.2	23.5	40.7	27.5	50.8	35.9	58.9	36.6	25.8	40.7	29.6	17.6	123.8	24.8	24.4	19.6	13.1	32.5	46.3	28.8	22.1	28.7	46.0	41.0	30.1	39.9	28.6	40.5	83.5	49.9	52.8	32.9	27.3	28.6	145.4	50.2	33.5	19.9	29.6	29.7	36.6	38.5	26.3
DHX32	"DDX32, DHLP1, FLJ10694, FLJ10889"	ENSG00000089876	"DEAH-box helicase 32 (putative)"	Q7L7V1	10	125836337-125896436	"Enzymes, Predicted intracellular proteins"		"Helicase, Hydrolase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 101.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA048872	Approved					NA	NA			"Cluster 37: B-cells - Transcription"	"Cluster 24: Salivary gland - Salivary secretion"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 27: Mucus-secreting cells - Mucin production"			"HPA048872: AB_2680540"	"unprognostic (1.05e-1)"	"unprognostic (3.02e-1)"	"unprognostic (3.97e-2)"	"unprognostic (6.40e-2)"	"unprognostic (2.40e-1)"	"unprognostic (3.57e-1)"	"unprognostic (1.55e-2)"	"unprognostic (9.88e-2)"	"unprognostic (2.85e-1)"	"unprognostic (6.89e-3)"	"prognostic unfavorable (9.49e-5)"	"prognostic unfavorable (6.34e-4)"	"unprognostic (4.61e-3)"	"unprognostic (5.03e-2)"	"unprognostic (8.62e-2)"	"unprognostic (1.98e-1)"	"unprognostic (2.49e-1)"	12.6	18.5	11.5	9.0	12.9	7.2	20.6	12.7	12.8	14.9	23.6	30.6	17.5	11.6	13.7	25.2	12.7	10.9	35.5	11.0	12.2	16.4	15.3	14.6	6.9	12.9	12.5	25.7	30.4	20.1	10.0	15.4	12.8	17.8	36.0	21.6	23.8	11.9	21.3	24.8	17.8	12.5	12.8	9.4	33.7	33.0	13.6	8.9	14.7	21.3	12.7	17.2	16.4	14.7	70.0	37.8	25.0	51.6	32.4	29.9	44.6	30.3	69.8	27.1	30.2	8.9	67.4	0.3	22.2	35.4	29.9	49.9	11.5	50.9	22.2	35.2	22.5	8.6	18.3	13.6	36.0	17.0	27.4	29.6	52.3	26.6	59.3	48.4	39.9	0.4	24.3	0.3	26.3	31.5	0.3	26.7	19.0	34.2	25.9	0.3	40.6	15.1	39.4	32.1	3.4	18.2	28.1	49.7	42.6	32.5	18.3	14.9	36.0	21.0	12.8	27.0	27.0	26.4	27.5	0.6	37.9	0.4	11.0	0.1	1.7	1.8	1.4	1.8	1.1	4.6	0.6	0.5	1.2	2.0	2.7	1.1	0.0	2.7	0.9	0.7	0.2	0.5	11.5	12.9	12.7	12.8	11.0	12.2	12.9	12.5	12.8	12.8	13.6	14.7	11.7	16.0	17.2	31.3	6.5	5.0	14.8	10.0	9.6	13.5	12.0	9.9	25.4	12.8	15.3	7.3	22.9	19.4	4.0	41.8	15.6	32.4	101.8	19.7	20.2	13.9	4.2	16.2	20.3	37.7	29.8	9.8	38.2	24.7	11.4	27.1	6.8	10.6	12.1	11.8	27.9	48.2	14.2	6.7	2.4	28.3	10.5	7.4	7.2	9.4	8.2	29.1	2.1	23.6	30.2	54.5	22.2	17.0	9.0	25.0	14.6	13.9	22.1	15.2	13.1	14.4	11.2	51.3	5.9	13.2	7.0	44.2	4.6	22.9	22.5	26.1
DHX33	"DDX33, DKFZp762F2011, FLJ21972"	ENSG00000005100	"DEAH-box helicase 33"	Q9H6R0	17	5440917-5468982	"Enzymes, Predicted intracellular proteins"		"Helicase, Hydrolase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 81.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA073875	Supported		Supported	Nucleoli		NA	NA			"Cluster 33: Neutrophils - Chromatin organization"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 29: Early spermatids - Spermatogenesis"	Nucleoli		"HPA073875: AB_2686638"	"unprognostic (4.96e-2)"	"unprognostic (1.35e-1)"	"unprognostic (3.41e-2)"	"unprognostic (2.51e-2)"	"unprognostic (9.24e-2)"	"unprognostic (1.90e-1)"	"unprognostic (1.49e-2)"	"unprognostic (6.15e-2)"	"unprognostic (3.11e-2)"	"unprognostic (3.80e-1)"	"unprognostic (2.10e-1)"	"prognostic unfavorable (6.10e-4)"	"unprognostic (1.03e-1)"	"unprognostic (4.66e-1)"	"unprognostic (3.55e-1)"	"unprognostic (4.69e-2)"	"unprognostic (3.37e-2)"	6.2	5.9	5.5	6.3	5.8	4.4	7.0	5.1	6.0	5.4	3.9	5.3	4.8	6.4	4.1	6.2	5.8	4.1	4.5	5.7	4.9	5.2	7.8	4.4	6.0	4.9	5.2	5.6	6.7	7.6	3.9	6.3	4.8	5.4	5.6	6.4	5.6	5.4	8.0	6.9	5.0	5.9	5.0	6.0	5.5	4.5	5.7	5.2	5.1	5.6	5.9	6.5	5.4	5.5	19.0	27.7	17.4	31.1	7.2	14.4	21.6	18.4	11.4	27.6	22.1	17.6	8.1	46.7	12.5	15.1	11.0	22.0	35.4	28.7	35.3	15.0	34.1	18.5	22.4	30.0	14.1	24.9	15.9	12.2	17.3	29.8	40.4	8.3	20.9	22.0	24.9	22.3	15.5	13.4	25.5	13.6	38.5	12.5	14.0	33.5	25.5	25.3	12.8	14.7	15.1	21.7	19.2	16.4	28.0	14.6	12.8	12.9	19.5	19.0	20.2	15.3	39.6	8.3	9.5	23.5	13.6	29.1	27.7	0.2	0.9	0.5	0.5	0.4	0.5	0.7	0.6	0.3	0.4	0.8	0.6	0.6	0.6	0.8	0.3	0.9	0.4	0.2	5.5	5.8	5.1	6.0	5.7	4.9	4.9	5.2	4.8	5.0	5.7	5.5	11.4	12.8	8.6	6.5	8.6	21.0	15.3	8.6	19.9	15.6	18.3	15.7	16.3	17.2	9.9	7.3	20.9	8.3	10.2	8.5	1.9	9.3	81.8	7.6	23.3	16.2	9.1	23.3	14.5	15.3	10.1	13.7	10.7	12.7	3.8	21.0	13.2	28.1	6.3	13.5	15.2	10.9	2.0	16.9	8.7	11.3	7.8	9.9	14.2	6.5	6.8	13.3	9.2	11.6	13.0	12.1	5.1	9.8	10.4	20.9	5.9	5.9	6.1	10.5	0.0	25.1	11.5	10.6	15.7	22.0	19.9	5.1	6.6	19.7	11.9	14.9
DHX34	"DDX34, KIAA0134"	ENSG00000134815	"DExH-box helicase 34"	Q14147	19	47349315-47382704	"Enzymes, Predicted intracellular proteins"		"Helicase, Hydrolase, RNA-binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Late spermatids: 65.8;Spermatocytes: 39.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in many"	6	"neutrophil: 11.7"	"Lineage enriched"	"Detected in many"	6	"granulocytes: 11.7"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA042159, HPA043558"	Uncertain		Approved	Nucleoplasm		NA	NA			"Cluster 50: Neutrophils - Cellular senescence"	"Cluster 71: Testis - DNA repair"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 31: Spermatids - Spermatogenesis"	Nucleoplasm		"HPA042159: AB_10963066, HPA043558: AB_10961262"	"unprognostic (1.26e-1)"	"unprognostic (5.17e-2)"	"unprognostic (1.05e-1)"	"unprognostic (1.64e-1)"	"unprognostic (1.08e-1)"	"unprognostic (3.06e-3)"	"prognostic unfavorable (8.63e-6)"	"unprognostic (9.14e-2)"	"unprognostic (4.74e-2)"	"unprognostic (5.11e-2)"	"unprognostic (4.76e-3)"	"unprognostic (2.02e-2)"	"prognostic unfavorable (3.16e-6)"	"unprognostic (7.38e-2)"	"unprognostic (1.59e-1)"	"unprognostic (2.72e-1)"	"unprognostic (7.21e-3)"	5.8	6.7	6.2	5.6	6.3	11.3	5.8	6.7	10.4	9.0	6.0	6.0	3.7	6.7	2.3	7.6	7.9	2.6	5.4	6.1	5.7	7.6	10.1	8.6	4.2	6.9	6.0	10.3	6.8	3.1	9.1	3.2	6.0	8.1	1.9	2.9	5.8	3.6	7.4	7.5	5.7	3.0	5.0	12.0	5.6	22.1	6.2	3.7	8.4	2.2	2.9	7.7	7.5	7.7	10.8	27.8	6.7	13.1	5.7	3.9	12.7	8.4	2.8	8.5	7.6	17.8	10.3	16.5	8.3	4.7	9.1	15.4	9.3	11.1	4.3	13.8	25.4	17.3	16.1	13.7	6.4	13.5	7.1	5.0	8.8	14.3	8.0	5.4	5.7	7.4	29.2	6.9	5.7	12.8	13.5	33.6	13.9	14.0	16.4	14.6	5.3	10.0	4.6	14.3	11.9	7.3	10.3	10.1	6.8	7.5	9.2	8.6	6.5	9.9	12.7	6.3	15.0	10.5	15.5	15.1	7.9	9.7	11.8	1.0	1.8	0.7	1.0	1.8	1.0	0.9	0.8	1.5	1.7	1.1	1.2	0.5	11.7	0.8	1.5	1.3	0.6	1.1	6.2	6.3	6.7	10.4	6.1	5.7	6.9	6.0	6.0	5.0	6.2	7.7	1.8	6.4	5.8	8.5	4.4	7.5	5.7	2.4	4.0	8.1	5.4	3.0	3.6	2.8	3.5	7.3	2.1	4.9	8.6	4.2	0.0	4.8	26.1	5.9	4.4	3.6	3.6	4.2	11.0	3.3	5.7	3.6	6.6	7.3	3.8	10.5	2.9	6.6	7.6	0.0	10.1	4.7	4.1	8.2	18.1	65.8	5.3	13.3	1.8	2.8	5.4	1.6	1.0	7.1	10.4	3.6	2.2	4.9	3.5	7.4	4.1	1.9	6.0	5.7	6.6	3.4	4.0	39.1	16.9	4.3	7.2	5.1	3.9	4.3	6.3	6.4
DHX35	"C20orf15, DDX35, FLJ22759, KAIA0875"	ENSG00000101452	"DEAH-box helicase 35"	Q9H5Z1	20	38962299-39039723	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"mRNA processing, mRNA splicing"	"Helicase, Hydrolase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 23.5;Inhibitory neurons: 21.5;Oligodendrocyte precursor cells: 22.6;Oligodendrocytes: 24.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA054451, HPA062700"	Uncertain		Approved	"Nucleoplasm,Nuclear bodies,Centrosome"		No	No			"Cluster 39: Non-specific - mRNA processing"	"Cluster 12: Smooth muscle tissue - Mixed function"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	"Nuclear bodies"	"Nucleoplasm, Centrosome"	"HPA054451: AB_2682491, HPA062700: AB_2684838"	"unprognostic (8.31e-2)"	"unprognostic (2.34e-2)"	"unprognostic (5.51e-2)"	"prognostic unfavorable (4.25e-5)"	"unprognostic (1.29e-2)"	"unprognostic (8.38e-2)"	"prognostic unfavorable (5.63e-6)"	"unprognostic (9.83e-2)"	"unprognostic (2.21e-1)"	"unprognostic (6.22e-2)"	"unprognostic (4.47e-2)"	"unprognostic (5.67e-2)"	"unprognostic (8.57e-2)"	"unprognostic (1.88e-2)"	"unprognostic (1.66e-1)"	"unprognostic (1.11e-1)"	"unprognostic (3.31e-1)"	6.6	4.2	4.2	4.5	4.9	9.8	6.0	4.4	5.2	10.1	3.1	16.7	6.2	11.2	8.0	8.1	8.5	5.6	10.2	4.5	3.9	6.0	4.8	5.3	6.7	4.1	4.3	7.9	3.7	7.0	3.8	5.2	4.1	8.1	8.6	6.0	5.1	7.2	8.2	6.9	7.9	8.1	3.8	4.8	8.0	6.6	4.2	6.4	5.1	6.3	5.4	11.9	7.0	5.1	10.3	8.4	15.9	6.6	6.0	7.8	11.3	6.0	10.3	13.5	9.9	29.1	9.0	11.4	10.4	11.4	10.4	16.0	11.0	17.5	13.2	2.9	5.2	15.4	14.3	16.7	7.2	18.4	7.7	9.0	11.3	11.7	10.9	8.3	6.1	19.4	16.0	6.5	7.2	8.2	30.0	14.0	9.1	18.5	13.5	14.5	23.2	9.5	5.0	11.8	13.9	11.1	16.4	9.6	15.4	9.9	13.3	14.7	6.0	19.1	10.6	7.8	12.6	6.5	9.2	12.3	10.9	8.2	10.4	0.0	3.0	1.2	2.9	2.7	2.9	2.5	2.4	3.1	4.0	2.9	4.5	2.4	0.6	3.9	2.4	1.4	1.7	2.9	4.2	4.9	4.4	5.2	4.5	3.9	4.1	4.3	4.1	3.8	4.2	5.1	5.4	0.0	3.7	16.0	3.8	0.5	1.4	2.2	7.4	5.1	2.3	3.0	6.7	4.3	4.8	1.8	4.2	3.7	4.1	4.2	1.9	2.4	3.7	2.5	6.6	3.8	5.4	5.5	23.5	1.1	2.4	3.8	7.7	3.2	8.2	6.1	5.7	7.0	5.0	5.0	21.5	6.3	4.1	4.7	4.0	0.8	6.2	3.3	3.6	14.0	3.6	3.3	6.2	22.6	24.8	2.0	5.8	6.4	4.9	2.7	4.6	2.2	4.3	4.7	0.0	4.7	3.9	1.9	9.4	4.5	2.0	3.0	4.5	4.9	5.4	1.1
DHX36	"DDX36, KIAA1488, MLEL1, RHAU"	ENSG00000174953	"DEAH-box helicase 36"	Q9H2U1	3	154272546-154324487	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"	"Antiviral defense, Differentiation, Immunity, Innate immunity, Transcription, Transcription regulation, Translation regulation, Transport"	"Activator, Developmental protein, DNA-binding, Helicase, Hydrolase, Repressor, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 547.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035398, HPA035399"	Approved		Supported	Nucleoplasm,Mitochondria,Cytosol		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 29: Early spermatids - Spermatogenesis"	Nucleoplasm	"Mitochondria, Cytosol"	"HPA035398: , HPA035399: AB_10670115"	"unprognostic (8.04e-2)"	"unprognostic (1.46e-1)"	"unprognostic (1.86e-1)"	"unprognostic (3.50e-3)"	"unprognostic (2.67e-2)"	"unprognostic (3.22e-1)"	"unprognostic (8.80e-3)"	"unprognostic (1.03e-1)"	"unprognostic (7.51e-2)"	"unprognostic (1.26e-1)"	"unprognostic (3.94e-2)"	"unprognostic (3.90e-2)"	"unprognostic (2.72e-1)"	"unprognostic (5.09e-2)"	"unprognostic (5.27e-1)"	"unprognostic (4.96e-2)"	"unprognostic (1.37e-1)"	17.7	14.4	5.6	17.3	8.6	16.3	16.4	8.9	7.3	13.9	6.3	12.0	12.6	18.3	11.6	14.8	14.4	15.5	16.9	5.6	8.1	18.6	20.0	13.7	21.7	7.0	7.5	19.0	16.0	29.1	14.9	19.0	7.2	17.3	13.7	17.0	11.7	16.4	58.9	12.0	12.8	17.1	6.9	15.2	16.0	34.4	6.9	21.7	23.1	31.6	20.5	17.2	11.0	10.0	63.8	42.6	56.6	32.7	26.1	36.3	28.1	40.6	40.5	45.2	53.5	43.7	49.7	61.3	64.0	35.8	41.7	40.1	53.8	34.4	70.6	59.3	35.6	44.5	34.8	25.0	44.2	62.7	37.4	41.3	28.5	48.6	59.1	24.5	39.4	37.3	42.6	34.3	42.2	31.0	52.2	13.7	75.4	33.6	40.5	53.4	47.6	88.8	32.1	44.4	52.7	56.1	42.3	44.4	59.7	38.3	45.5	31.5	44.9	47.1	29.6	44.6	82.1	63.6	43.9	87.5	38.1	32.2	51.1	1.2	1.5	1.8	3.7	1.5	2.3	2.6	3.2	2.5	1.3	3.1	2.9	3.1	0.6	2.6	3.5	3.3	3.1	0.6	5.6	8.6	8.9	7.3	5.6	8.1	7.0	7.5	7.2	6.9	6.9	10.0	95.6	57.7	92.9	45.4	123.6	92.9	146.6	56.6	81.4	152.2	61.8	62.6	60.8	67.2	83.5	60.7	129.3	138.0	179.3	43.8	39.2	71.2	547.0	73.4	147.9	82.0	92.0	68.5	53.5	62.8	69.9	97.6	66.8	104.2	103.8	86.7	72.8	80.5	62.0	154.8	60.2	57.4	73.2	73.7	85.2	335.5	110.6	83.0	53.4	37.5	88.5	86.4	113.3	59.3	55.4	66.5	49.9	121.5	97.6	132.2	40.4	54.4	52.3	128.6	78.9	130.6	88.8	197.4	135.1	65.3	83.1	370.1	152.0	114.2	58.1	128.4
DHX37	"DDX37, Dhr1, KIAA1517, MGC2695, MGC4322"	ENSG00000150990	"DEAH-box helicase 37"	Q8IY37	12	124946825-124989131	"Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins"		"Helicase, Hydrolase"	"Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA047607	Approved		Approved	"Nuclear membrane"		NA	NA			"Cluster 39: Non-specific - mRNA processing"	"Cluster 50: Non-specific - Ribosome"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 39: Non-specific - Basic cellular processes"	"Nuclear membrane"		"HPA047607: AB_2680101"	"unprognostic (1.83e-1)"	"unprognostic (1.12e-1)"	"unprognostic (3.10e-1)"	"unprognostic (1.32e-1)"	"unprognostic (1.27e-1)"	"unprognostic (2.11e-1)"	"prognostic unfavorable (9.54e-10)"	"unprognostic (2.38e-2)"	"unprognostic (5.14e-2)"	"unprognostic (2.90e-2)"	"unprognostic (2.07e-1)"	"unprognostic (3.16e-2)"	"unprognostic (8.28e-3)"	"unprognostic (1.40e-2)"	"unprognostic (2.27e-1)"	"unprognostic (2.85e-2)"	"unprognostic (2.73e-1)"	4.3	3.2	2.9	6.8	3.4	8.8	3.6	3.0	3.6	3.5	1.4	3.4	4.4	3.8	1.3	4.7	3.4	2.8	3.6	2.9	2.5	3.3	3.0	2.8	7.4	4.1	3.6	4.5	6.6	2.6	1.6	2.9	3.4	3.3	1.6	0.5	4.3	2.6	10.8	4.0	3.8	2.5	3.0	5.2	3.9	2.6	3.2	4.6	3.2	4.9	3.9	5.0	3.6	4.3	17.3	45.5	5.2	21.9	6.7	6.6	27.4	13.8	7.3	19.5	11.6	44.7	9.4	37.5	24.6	11.4	19.7	21.9	19.8	15.6	4.5	32.7	38.2	23.0	13.8	23.7	13.4	27.7	30.5	8.8	10.8	24.3	4.0	7.2	10.0	17.4	44.4	7.5	7.5	23.9	29.5	28.5	39.2	15.1	36.4	31.4	11.0	21.5	8.6	22.6	17.6	11.1	14.0	16.3	16.0	5.1	19.3	19.5	13.1	16.1	20.2	20.0	27.6	31.6	33.2	44.0	15.1	22.2	27.2	0.0	1.5	0.0	1.6	1.7	1.4	1.8	1.3	1.6	1.4	1.4	0.9	1.4	0.0	0.9	0.8	1.1	0.7	1.4	2.9	3.4	3.0	3.6	2.9	2.5	4.1	3.6	3.4	3.0	3.2	4.3	5.5	3.2	5.2	3.3	10.3	4.2	3.4	2.8	4.0	3.5	6.2	5.3	3.8	2.8	4.1	0.0	0.0	4.1	6.7	8.8	3.9	4.8	1.7	5.3	9.6	5.7	9.0	5.0	3.0	6.2	6.0	4.8	8.2	7.8	6.3	9.3	2.2	6.2	5.4	13.5	2.0	7.1	6.1	7.2	2.5	2.0	5.3	4.9	0.0	1.9	6.6	2.2	6.2	3.0	4.0	9.0	2.2	2.6	9.2	4.9	2.8	4.7	4.1	2.1	6.6	7.1	3.8	1.5	5.6	8.0	4.0	2.9	7.7	5.9	9.3	4.0
DHX38	"DDX38, hPrp16, KIAA0224, PRP16, PRPF16"	ENSG00000140829	"DEAH-box helicase 38"	Q92620	16	72093613-72112912	"Disease related genes, Enzymes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"mRNA processing, mRNA splicing"	"Helicase, Hydrolase"	"Disease variant, Retinitis pigmentosa"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041347, HPA041604"	Uncertain		Supported	Nucleoplasm		NA	NA			"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 59: Non-specific - Translation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 52: Non-specific - Transcription"	Nucleoplasm		"HPA041347: AB_10796571, HPA041604: AB_2677577"	"unprognostic (2.38e-1)"	"unprognostic (1.89e-1)"	"unprognostic (1.24e-2)"	"unprognostic (3.25e-2)"	"unprognostic (1.07e-1)"	"unprognostic (1.01e-1)"	"unprognostic (6.32e-3)"	"unprognostic (8.50e-3)"	"unprognostic (6.97e-2)"	"unprognostic (1.45e-1)"	"unprognostic (7.92e-2)"	"unprognostic (1.28e-3)"	"unprognostic (4.20e-3)"	"unprognostic (2.68e-1)"	"unprognostic (9.46e-2)"	"unprognostic (2.40e-1)"	"unprognostic (2.40e-2)"	25.8	18.7	22.4	22.8	24.4	39.7	23.8	22.2	24.7	25.1	25.9	24.8	19.6	25.5	10.7	24.2	23.8	15.0	27.0	21.5	21.6	19.6	24.0	23.9	27.8	23.2	23.2	30.6	20.2	22.9	19.3	18.6	22.5	20.9	16.1	13.2	21.1	14.4	39.9	27.6	27.3	17.6	22.2	30.4	22.5	21.3	23.5	24.2	22.8	21.4	23.1	23.7	22.9	25.0	38.5	55.0	39.4	21.9	33.4	25.8	51.1	33.6	32.6	49.1	37.8	66.4	37.5	50.5	29.2	50.9	27.0	48.6	46.3	45.8	38.0	25.3	50.0	38.7	48.9	92.5	30.8	46.9	66.7	35.6	41.2	66.1	47.4	25.9	42.9	35.7	58.9	22.9	30.6	112.8	43.9	53.1	49.7	23.9	30.9	55.8	27.1	49.9	24.0	35.6	35.6	38.9	43.8	20.3	24.5	22.5	36.8	38.4	49.4	46.6	40.8	34.8	37.3	56.2	47.6	96.7	43.9	32.1	37.5	7.1	6.2	7.1	11.3	8.3	9.8	8.1	6.8	8.2	6.2	6.0	7.4	7.9	6.4	8.8	5.1	5.5	8.6	5.5	22.4	24.4	22.2	24.7	21.5	21.6	23.2	23.2	22.5	22.2	23.5	25.0	22.5	25.6	34.3	13.7	24.4	12.2	11.0	9.5	20.5	30.7	12.0	13.6	8.6	20.0	22.0	14.7	16.7	15.0	33.3	28.5	0.0	14.5	9.0	19.3	23.0	22.3	30.5	16.8	6.7	20.6	14.3	17.1	28.1	23.6	43.0	24.0	15.0	13.6	14.9	30.3	6.1	24.8	6.1	15.2	13.9	11.0	28.9	20.3	8.8	5.6	16.9	17.9	19.6	8.0	11.1	23.7	17.1	25.2	22.4	12.7	21.1	8.6	19.0	35.3	19.7	25.6	19.1	25.5	17.8	18.5	12.8	20.4	28.2	20.6	23.4	12.6
DHX40	"ARG147, DDX40, FLJ22060, PAD"	ENSG00000108406	"DEAH-box helicase 40"	Q8IX18	17	59565558-59608345	"Enzymes, Predicted intracellular proteins"		"Helicase, Hydrolase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Spermatocytes: 103.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA044350	Uncertain		Approved	Nucleoplasm		NA	NA			"Cluster 49: Eosinophils - Unknown function"	"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 52: Non-specific - Transcription"	Nucleoplasm		"HPA044350: AB_10960560"	"unprognostic (1.58e-2)"	"unprognostic (3.10e-1)"	"prognostic favorable (4.05e-5)"	"unprognostic (4.09e-2)"	"unprognostic (5.23e-2)"	"unprognostic (2.84e-1)"	"unprognostic (4.57e-3)"	"unprognostic (7.53e-3)"	"unprognostic (2.86e-2)"	"unprognostic (1.80e-1)"	"unprognostic (7.23e-2)"	"unprognostic (3.08e-1)"	"unprognostic (9.48e-3)"	"unprognostic (2.22e-1)"	"unprognostic (1.25e-2)"	"unprognostic (1.11e-1)"	"unprognostic (3.10e-1)"	17.9	22.0	14.9	12.9	15.7	26.5	26.9	16.9	16.6	22.1	25.1	15.4	14.6	25.7	21.1	17.4	27.3	17.1	18.2	14.3	17.7	32.9	14.9	18.7	16.3	15.1	16.9	32.3	21.1	57.7	21.7	19.7	16.0	21.3	17.1	21.5	17.0	21.6	17.4	21.2	13.9	20.8	15.5	15.5	16.7	29.8	15.1	25.0	30.6	22.3	18.4	19.2	13.5	20.9	28.7	51.7	64.0	42.5	39.4	39.5	36.0	25.3	48.2	37.9	42.8	20.5	28.0	37.7	69.3	37.2	40.0	20.9	46.5	36.2	58.6	29.9	68.8	34.3	35.1	23.4	30.7	42.3	15.3	31.2	33.1	32.3	31.4	62.3	42.0	36.2	29.3	33.9	26.5	53.5	51.8	26.4	24.8	36.0	37.8	48.8	45.1	42.3	39.0	22.9	45.5	113.5	45.7	18.4	48.6	31.3	58.4	24.8	34.5	45.8	56.3	16.6	25.2	41.2	47.5	23.9	53.5	28.9	32.0	9.2	6.8	11.6	7.9	6.6	10.3	4.7	5.6	5.6	7.1	4.9	5.5	6.6	19.4	4.5	4.9	3.7	6.2	7.5	14.9	15.7	16.9	16.6	14.3	17.7	15.1	16.9	16.0	15.5	15.1	20.9	27.3	9.6	20.9	10.1	19.7	19.4	10.4	16.7	26.2	12.6	31.9	26.7	24.3	28.6	25.3	47.8	18.8	8.8	35.5	14.2	11.7	18.4	43.0	68.8	37.8	22.4	18.5	29.8	10.9	16.9	9.3	21.1	20.9	41.8	3.8	41.8	27.5	25.0	9.2	50.5	14.3	19.0	8.2	21.6	14.7	16.7	25.1	18.8	19.6	3.7	14.8	21.7	14.4	7.1	14.6	13.2	11.9	26.7	18.0	13.4	12.6	46.2	57.7	14.6	32.9	17.4	22.8	103.9	51.4	15.3	22.0	12.6	19.1	36.5	17.8	10.9
DHX57	DDX57	ENSG00000163214	"DExH-box helicase 57"	Q6P158	2	38797729-38875934	"Enzymes, Predicted intracellular proteins"		"Helicase, Hydrolase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"Early spermatids: 136.3;Late spermatids: 352.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA036160	Uncertain		Approved	"Nucleoli,Intermediate filaments,Microtubules,Cytosol"		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 68: Epididymis - Unknown function"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 25: Spermatids - Spermatogenesis"	"Intermediate filaments, Microtubules"	"Nucleoli, Cytosol"	"HPA036160: AB_10670711"	"unprognostic (6.78e-2)"	"unprognostic (3.08e-1)"	"unprognostic (3.49e-2)"	"unprognostic (2.03e-3)"	"unprognostic (3.25e-2)"	"unprognostic (3.43e-1)"	"prognostic unfavorable (3.32e-6)"	"unprognostic (1.75e-2)"	"unprognostic (2.74e-1)"	"unprognostic (1.45e-1)"	"unprognostic (7.35e-2)"	"unprognostic (1.82e-2)"	"unprognostic (2.55e-2)"	"unprognostic (1.47e-1)"	"unprognostic (3.88e-2)"	"unprognostic (7.03e-3)"	"unprognostic (1.77e-1)"	6.1	9.2	6.6	5.2	6.9	4.8	6.5	6.4	8.8	8.1	6.9	7.1	2.2	7.7	10.3	5.4	6.6	4.2	5.3	7.1	7.2	6.8	5.3	4.9	6.2	5.8	6.5	7.8	7.0	9.7	10.0	5.8	6.0	6.2	5.5	8.5	5.6	6.3	9.1	7.1	5.2	7.3	6.0	5.9	5.7	23.4	6.6	6.7	7.2	5.5	6.3	7.4	6.2	6.5	23.4	19.3	21.0	15.8	13.5	16.6	16.2	15.5	15.9	15.2	14.7	15.7	7.2	7.1	15.6	16.9	17.1	11.8	23.6	18.2	24.9	28.0	18.4	13.3	11.5	21.3	12.2	14.5	7.3	16.0	10.8	20.0	12.5	10.8	20.7	5.2	17.8	9.5	16.7	17.7	14.7	12.9	25.1	10.1	11.4	7.0	27.7	13.9	14.2	8.6	16.8	24.8	15.8	16.4	17.4	14.7	11.7	8.0	15.4	15.1	16.5	10.9	17.7	9.3	12.2	2.8	11.4	10.1	10.2	1.6	6.3	1.2	2.8	4.5	3.6	3.8	2.3	2.1	3.2	4.6	2.9	1.7	0.4	2.3	5.6	1.2	2.5	2.9	6.6	6.9	6.4	8.8	7.1	7.2	5.8	6.5	6.0	6.0	6.6	6.5	6.2	3.2	10.9	24.2	8.8	2.7	2.7	5.9	6.2	24.7	5.2	7.6	6.2	10.0	10.9	23.9	56.3	7.2	4.7	2.5	0.0	7.7	136.3	18.0	13.4	6.3	11.9	8.2	36.7	7.6	6.7	9.3	7.1	6.2	10.8	19.4	9.7	6.2	7.0	18.5	38.0	5.7	4.1	11.7	3.8	352.8	15.8	8.5	1.8	25.3	23.9	9.5	8.2	33.2	20.9	8.5	3.1	13.9	8.1	2.0	2.1	6.0	27.3	27.7	0.0	8.8	6.0	19.3	9.8	5.3	2.6	2.9	7.9	14.7	5.0	2.2
DHX58	"D11LGP2, LGP2"	ENSG00000108771	"DExH-box helicase 58"	Q96C10	17	42101404-42112714	"Enzymes, Predicted intracellular proteins"	"Antiviral defense, Host-virus interaction, Immunity, Innate immunity"	"Helicase, Hydrolase, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"monocytes: 39.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"BJ hTERT+ SV40 Large T+: 45.5;BJ hTERT+ SV40 Large T+ RasG12V: 52.9;SK-MEL-30: 27.0"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA018670, HPA019570"	Approved		Approved	"Nucleoplasm,Golgi apparatus,Cytosol"		NA	NA			"Cluster 5: Granulocytes - Unknown function"	"Cluster 64: Macrophages - Immune response"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 3: Monocytes - Immune response regulation"	"Golgi apparatus, Cytosol"	Nucleoplasm	"HPA018670: AB_1847665, HPA019570: AB_1847666"	"prognostic favorable (3.45e-4)"	"unprognostic (1.03e-2)"	"unprognostic (3.56e-3)"	"unprognostic (1.54e-2)"	"unprognostic (2.45e-2)"	"unprognostic (4.82e-2)"	"unprognostic (2.05e-3)"	"unprognostic (5.45e-2)"	"unprognostic (1.18e-1)"	"unprognostic (1.15e-1)"	"unprognostic (6.02e-2)"	"unprognostic (3.72e-1)"	"unprognostic (1.27e-2)"	"unprognostic (8.65e-2)"	"unprognostic (8.01e-2)"	"unprognostic (2.31e-1)"	"unprognostic (4.31e-3)"	8.9	11.9	5.5	10.2	6.1	12.3	7.6	4.7	7.4	7.7	4.9	7.0	8.5	7.0	5.9	6.4	11.5	12.1	4.9	4.6	4.8	7.3	14.5	11.8	12.5	6.9	5.4	11.9	6.0	7.2	6.9	7.0	6.2	8.7	5.1	0.6	18.6	8.2	3.7	7.5	8.5	7.3	7.5	18.4	9.3	10.8	5.4	12.5	5.5	4.3	7.4	8.0	5.9	6.7	2.5	0.0	0.1	1.3	11.3	9.9	0.3	3.3	22.4	45.5	52.9	0.3	14.6	0.2	3.4	5.4	10.2	2.0	0.2	3.5	1.7	9.3	0.3	3.9	2.6	0.9	12.6	3.6	8.6	15.9	5.9	4.0	3.9	8.0	5.5	23.5	0.0	12.8	2.5	0.0	21.7	4.5	0.4	0.6	0.0	7.8	0.0	1.2	5.2	8.6	0.4	0.0	1.5	5.9	27.0	0.0	7.9	3.8	2.4	2.3	0.1	0.8	1.1	4.3	3.8	0.2	4.6	3.3	2.6	2.3	7.7	6.9	3.1	9.7	4.8	4.6	4.7	2.9	5.9	3.5	5.1	3.8	3.2	6.8	8.6	2.0	4.4	5.0	5.5	6.1	4.7	7.4	4.6	4.8	6.9	5.4	6.2	7.5	5.4	6.7	9.1	9.6	3.4	6.8	4.8	1.5	3.9	6.2	3.4	1.0	3.5	3.7	1.7	8.6	7.6	7.3	0.0	4.0	4.7	2.3	1.9	7.0	9.0	4.5	2.9	7.0	0.0	0.4	1.9	6.9	4.6	4.1	3.6	4.0	1.3	7.5	3.3	14.0	9.8	0.0	2.4	3.2	4.1	7.0	0.7	12.1	8.7	7.4	3.6	8.4	39.9	2.4	2.1	4.0	1.8	5.7	4.3	9.1	1.3	5.4	3.9	5.7	11.6	0.6	0.0	3.7	3.8	18.1	1.0	2.3	1.6	0.8	6.6	8.2	1.9	2.9
DHX8	"DDX8, Dhr2, HRH1, PRP22, PRPF22"	ENSG00000067596	"DEAH-box helicase 8"	Q14562	17	43483865-43610338	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"mRNA processing, mRNA splicing"	"Helicase, Hydrolase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA049285	Approved		Supported	"Nucleoplasm,Nuclear bodies"	"Intracellular and membrane"	NA	NA			"Cluster 44: Non-specific - Transcription"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 52: Non-specific - Transcription"	Nucleoplasm	"Nuclear bodies"	"HPA049285: AB_2680698"	"unprognostic (2.99e-1)"	"unprognostic (4.42e-2)"	"unprognostic (5.64e-2)"	"unprognostic (9.02e-2)"	"unprognostic (1.25e-1)"	"unprognostic (3.09e-1)"	"unprognostic (1.28e-3)"	"unprognostic (9.43e-2)"	"unprognostic (2.58e-1)"	"unprognostic (3.40e-2)"	"unprognostic (2.26e-2)"	"unprognostic (2.47e-1)"	"unprognostic (1.50e-1)"	"unprognostic (4.04e-1)"	"unprognostic (5.08e-3)"	"unprognostic (2.60e-1)"	"unprognostic (6.28e-2)"	20.4	18.5	25.9	18.0	25.8	55.0	20.5	24.7	36.7	22.4	22.8	21.4	17.3	19.9	26.1	26.9	16.7	16.4	21.8	25.4	24.8	20.3	18.6	20.0	23.7	25.6	25.2	17.0	17.0	27.5	20.8	20.9	25.5	21.6	23.9	16.8	20.8	20.4	22.6	33.7	20.6	23.6	23.4	25.8	19.5	24.3	25.8	35.1	19.0	19.4	29.6	23.0	21.7	25.5	29.2	81.7	43.3	52.4	42.3	42.5	24.0	30.2	62.0	64.9	61.7	37.4	28.1	40.3	27.0	59.4	46.6	38.0	65.9	53.1	74.8	40.8	51.9	33.8	61.2	56.7	35.8	59.8	49.5	21.1	44.1	53.0	58.4	31.4	57.4	52.1	38.8	35.2	51.2	32.0	75.9	52.7	35.5	35.4	31.0	46.2	82.4	40.2	44.3	60.6	37.3	56.0	33.9	18.6	27.3	50.9	44.1	58.3	40.0	50.3	26.9	36.3	45.8	27.5	36.6	44.7	41.2	36.8	41.2	30.2	17.4	20.4	16.0	25.2	14.7	12.2	12.7	15.5	17.0	11.0	10.6	11.5	21.8	11.0	26.1	10.3	12.8	11.4	25.9	25.8	24.7	36.7	25.4	24.8	25.6	25.2	25.5	23.4	25.8	25.5	17.1	6.4	15.0	6.5	18.6	11.9	7.1	12.4	12.0	16.9	16.3	13.0	13.2	7.2	19.2	22.0	18.8	9.1	23.6	13.4	13.7	16.2	19.4	18.3	26.2	17.6	26.7	13.7	10.7	17.7	8.8	14.5	14.8	23.9	14.5	15.3	16.1	14.7	11.1	6.7	10.5	15.3	10.2	14.8	11.5	10.6	12.5	18.4	17.8	14.0	24.8	10.6	21.6	9.5	15.8	21.2	16.0	10.9	20.0	9.4	10.1	12.4	13.7	19.8	19.7	20.3	14.4	27.9	16.8	17.2	13.4	21.2	20.9	11.1	10.8	14.3
DHX9	"DDX9, LKP, RHA"	ENSG00000135829	"DExH-box helicase 9"	Q08211	1	182839347-182887982	"Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins"	"Biological rhythms, DNA replication, Host-virus interaction, Immunity, Inflammatory response, Innate immunity, mRNA processing, mRNA splicing, mRNA transport, RNA-mediated gene silencing, Transcription, Transcription regulation, Transcription termination, Translation regulation, Transport"	"Activator, DNA-binding, Helicase, Hydrolase, RNA-binding"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB011819, HPA028050, HPA055684"	Supported		Supported	Nucleoplasm,Nucleoli		NA	NA		360000	"Cluster 27: Non-specific - Gene expression"	"Cluster 34: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 44: Endometrium - Transcription"	Nucleoplasm	Nucleoli	"CAB011819: AB_777725, HPA028050: AB_10603564, HPA055684: AB_2682885"	"unprognostic (8.14e-2)"	"unprognostic (9.32e-2)"	"unprognostic (1.84e-2)"	"unprognostic (4.80e-2)"	"unprognostic (1.58e-1)"	"unprognostic (7.40e-2)"	"prognostic unfavorable (3.17e-4)"	"unprognostic (9.98e-2)"	"prognostic unfavorable (6.04e-4)"	"unprognostic (2.76e-1)"	"unprognostic (2.88e-2)"	"unprognostic (5.53e-2)"	"unprognostic (7.51e-2)"	"unprognostic (1.43e-1)"	"unprognostic (1.70e-1)"	"unprognostic (3.17e-1)"	"unprognostic (1.99e-1)"	38.7	30.5	13.6	47.4	15.8	131.4	53.2	19.0	19.7	43.7	17.0	40.2	32.6	49.4	33.0	32.2	45.9	31.1	28.5	13.1	16.0	49.9	36.9	38.6	56.9	15.2	13.6	52.8	30.5	68.2	21.1	44.6	16.3	39.6	47.1	66.5	32.5	44.3	30.3	31.1	36.3	50.8	16.6	40.9	34.5	50.4	14.6	88.7	48.0	37.7	70.2	54.0	30.0	25.5	165.7	158.8	223.0	122.3	113.7	87.8	219.2	143.5	130.3	203.6	137.0	175.8	124.2	264.3	133.7	129.6	121.7	138.8	342.6	155.2	225.7	108.3	169.5	176.4	121.0	119.6	62.5	258.3	115.0	78.6	75.8	200.4	53.4	91.6	161.7	132.9	281.8	91.9	165.1	142.3	263.6	61.1	282.8	173.9	96.8	236.0	208.0	151.0	127.0	187.8	160.0	183.2	203.2	125.0	83.2	186.4	148.4	140.9	127.6	125.3	138.8	128.9	195.9	93.6	167.2	305.0	79.0	137.0	174.5	7.7	21.3	16.1	23.4	22.5	26.2	20.5	19.8	21.1	29.9	16.6	21.6	23.7	8.0	20.0	19.7	14.2	20.1	21.2	13.6	15.8	19.0	19.7	13.1	16.0	15.2	13.6	16.3	16.6	14.6	25.5	43.6	41.7	74.1	59.1	54.5	53.7	61.2	42.7	38.7	59.6	43.3	38.9	43.9	30.0	60.8	51.5	52.1	50.9	70.2	38.6	19.6	49.0	26.8	79.2	67.4	50.7	53.8	74.5	49.4	50.8	47.5	48.0	37.8	109.8	44.9	67.7	36.0	28.0	40.8	28.6	55.5	40.9	30.5	35.4	35.1	45.8	60.3	44.7	30.2	55.3	55.9	42.7	42.2	55.3	70.3	52.3	28.0	47.0	52.4	48.3	35.4	38.0	67.7	77.1	39.5	73.9	54.1	69.9	68.2	51.7	47.2	49.5	59.2	60.9	54.4	55.4
DICER1	"Dicer, HERNA, K12H4.8-LIKE, KIAA0928, MNG1"	ENSG00000100697	"Dicer 1, ribonuclease III"	Q9UPY3	14	95086228-95158010	"Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Host-virus interaction, RNA-mediated gene silencing"	"Endonuclease, Helicase, Hydrolase, Nuclease, RNA-binding"	"Cancer-related genes, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Oligodendrocytes: 418.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA000694, CAB068185"	Approved		Supported	Cytosol		NA	NA			"Cluster 14: Monocytes - Unknown function"	"Cluster 70: Brain - Nervous system development"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 19: Monocytes & Neutrophils - Innate immune response"	Cytosol		"CAB068185: AB_2665650, HPA000694: AB_1078661"	"unprognostic (2.97e-1)"	"unprognostic (2.70e-2)"	"unprognostic (1.21e-1)"	"unprognostic (1.72e-1)"	"unprognostic (6.75e-2)"	"unprognostic (9.62e-2)"	"unprognostic (1.96e-2)"	"unprognostic (7.73e-2)"	"unprognostic (1.21e-1)"	"unprognostic (8.52e-3)"	"unprognostic (5.73e-2)"	"unprognostic (9.22e-2)"	"unprognostic (4.22e-2)"	"unprognostic (9.07e-2)"	"unprognostic (2.58e-1)"	"unprognostic (6.04e-3)"	"unprognostic (3.74e-2)"	15.6	7.9	6.7	14.0	22.5	10.8	15.1	12.3	11.4	13.3	7.4	13.0	7.5	12.7	8.3	15.0	12.4	8.7	9.9	7.2	14.0	10.7	12.8	14.9	11.0	19.1	16.0	14.3	12.6	11.5	10.6	18.7	18.5	12.5	10.9	19.3	12.4	10.1	19.2	13.0	11.6	11.5	11.6	12.1	10.1	13.2	20.3	8.5	14.7	16.2	12.0	12.7	14.5	39.4	18.6	19.4	40.7	12.0	7.2	14.5	26.4	15.5	10.7	11.3	11.1	25.4	12.5	20.9	16.1	16.0	10.4	21.2	31.6	13.9	20.5	35.9	14.6	36.5	10.1	16.0	6.7	22.6	18.0	12.2	10.1	12.3	20.8	8.0	16.1	15.7	15.7	16.6	16.9	21.8	24.1	6.8	9.3	11.0	10.2	16.0	31.9	12.2	8.2	30.9	31.9	16.4	16.2	13.4	15.2	19.2	18.0	12.4	16.4	8.1	14.4	14.0	16.9	18.9	31.7	31.4	8.0	14.5	13.1	1.4	1.1	0.8	0.3	1.4	0.7	0.7	0.6	0.4	0.8	0.7	0.5	0.3	3.9	0.5	3.2	0.4	0.7	0.4	6.7	22.5	12.3	11.4	7.2	14.0	19.1	16.0	18.5	11.6	20.3	39.4	69.4	54.5	53.7	88.8	45.7	27.4	49.5	29.9	40.5	98.2	50.7	29.1	36.4	41.5	47.3	46.0	56.3	46.6	36.9	44.0	5.9	33.4	23.3	37.4	54.2	52.0	46.1	33.4	99.7	23.1	22.8	45.6	33.1	50.1	12.0	35.5	42.1	60.1	48.8	107.7	112.2	29.7	24.4	104.2	24.8	15.5	54.3	82.3	23.2	81.5	84.6	33.5	33.0	109.1	418.6	33.2	28.0	52.6	39.2	62.5	27.1	25.9	38.6	73.8	32.9	64.3	41.9	45.5	56.1	63.0	27.6	25.7	31.7	35.9	33.9	62.1
DNA2	"DNA2L, KIAA0083"	ENSG00000138346	"DNA replication helicase/nuclease 2"	P51530	10	68414064-68472121	"Disease related genes, Enzymes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"DNA damage, DNA repair, DNA replication"	"DNA-binding, Endonuclease, Helicase, Hydrolase, Multifunctional enzyme, Nuclease"	"Disease variant, Dwarfism, Mental retardation, Primary mitochondrial disease, Progressive external ophthalmoplegia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 8.1"	"Cell type enhanced"	"Detected in many"		"Erythroid cells: 33.2;Excitatory neurons: 14.1;Inhibitory neurons: 15.5;Oligodendrocytes: 18.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in single"	5	"NK-cell: 1.8"	"Lineage enriched"	"Detected in single"	5	"NK-cells: 1.8"	"Low cell line specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA037487, HPA057526"	Approved		Supported	Mitochondria		No	Yes			"Cluster 15: NK-cells - Transcription"	"Cluster 20: Retina & Lymphoid tissues - Unknown function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	Mitochondria		"HPA037487: AB_10672493, HPA057526: AB_2683456"	"unprognostic (1.79e-1)"	"unprognostic (1.35e-1)"	"unprognostic (4.37e-3)"	"unprognostic (4.60e-3)"	"unprognostic (1.53e-1)"	"unprognostic (1.86e-2)"	"unprognostic (4.50e-5)"	"unprognostic (3.36e-2)"	"unprognostic (4.70e-2)"	"unprognostic (3.72e-2)"	"unprognostic (1.30e-2)"	"unprognostic (3.29e-4)"	"unprognostic (1.09e-10)"	"unprognostic (3.43e-2)"	"unprognostic (1.98e-1)"	"unprognostic (9.36e-2)"	"unprognostic (1.23e-2)"	1.3	0.9	1.9	2.8	2.1	4.6	1.8	2.5	3.6	1.4	1.0	2.3	2.1	1.1	0.9	1.9	0.9	0.9	1.8	1.8	1.9	2.6	4.2	1.8	5.2	2.3	1.9	1.2	1.6	0.4	1.5	1.6	2.4	1.9	2.8	5.3	1.6	0.4	1.6	1.8	3.2	1.1	1.6	2.1	1.9	2.9	2.1	8.1	1.0	0.9	4.2	1.4	1.4	3.2	25.6	13.0	29.0	20.7	3.2	2.2	20.4	12.4	10.3	17.4	21.2	31.1	16.1	26.1	4.6	3.8	6.7	15.2	16.8	6.5	20.7	16.2	12.6	15.8	8.5	12.3	0.9	27.7	16.4	1.8	2.6	12.3	3.6	4.5	7.9	17.0	23.6	22.8	10.1	9.0	42.8	19.8	20.5	10.9	24.0	33.1	20.0	8.4	7.5	11.7	13.1	15.7	16.9	21.4	4.2	20.1	16.5	11.6	3.4	6.6	20.5	8.5	23.8	11.5	13.9	38.3	5.7	26.1	8.9	0.0	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.2	0.1	0.1	0.0	1.8	0.0	0.0	0.1	0.0	1.9	2.1	2.5	3.6	1.8	1.9	2.3	1.9	2.4	1.6	2.1	3.2	1.0	6.4	1.1	4.9	1.3	2.3	0.9	1.7	2.8	2.5	2.3	1.4	10.5	2.8	1.1	1.8	6.2	3.9	2.2	1.7	0.0	0.8	2.2	2.0	1.4	2.0	1.2	33.2	14.1	0.9	4.8	2.0	2.6	2.8	0.0	6.0	0.7	4.6	2.2	0.0	15.5	1.8	0.0	1.3	0.7	3.7	0.6	1.5	0.0	4.7	0.5	0.5	2.1	5.5	18.4	0.7	0.1	0.7	7.4	2.5	2.4	0.6	0.8	4.3	0.0	2.4	1.1	9.1	12.2	4.7	1.7	1.2	1.6	0.7	3.7	1.0
DNAJC6	"KIAA0473, PARK19"	ENSG00000116675	"DnaJ heat shock protein family (Hsp40) member C6"	O75061	1	65248219-65415871	"Disease related genes, Enzymes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"		"Chaperone, Hydrolase, Protein phosphatase"	"Disease variant, Neurodegeneration, Parkinson disease, Parkinsonism"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"brain: 81.5;retina: 52.8"	"Cell type enriched"	"Detected in many"	4	"Oligodendrocytes: 1038.1"	"Cancer enriched"	"Detected in many"	4	"glioma: 5.9"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"HDLM-2: 62.1;HEL: 165.8;K-562: 65.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA031182, HPA054917"	Enhanced		Approved	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA				"Cluster 77: Retina - Visual perception"	"Cluster 36: HEL - Hemostasis"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	Cytosol	"Nucleoplasm, Plasma membrane"	"HPA031182: AB_10611957, HPA054917: AB_2682641"	"unprognostic (6.99e-2)"	"unprognostic (2.00e-3)"	"unprognostic (3.19e-1)"	"unprognostic (7.94e-7)"	"unprognostic (1.59e-1)"	"unprognostic (7.61e-3)"	"unprognostic (1.87e-4)"	"unprognostic (2.98e-1)"	"unprognostic (1.89e-1)"	"unprognostic (4.14e-1)"	"unprognostic (4.22e-3)"	"unprognostic (1.53e-1)"	"prognostic favorable (2.81e-4)"	"unprognostic (1.43e-2)"	"unprognostic (1.12e-1)"	"unprognostic (1.36e-1)"	"unprognostic (8.67e-3)"	1.5	11.1	34.7	0.9	43.3	4.7	1.1	33.7	46.9	0.8	0.0	2.1	1.0	0.6	0.4	0.3	1.1	1.0	8.9	42.1	48.0	7.7	0.4	1.5	0.2	60.2	51.3	0.5	2.1	1.0	12.6	7.4	67.6	1.1	1.7	52.8	0.7	0.7	0.4	1.1	1.0	0.9	27.2	2.1	1.7	2.2	42.0	0.8	1.7	0.8	0.3	1.1	0.9	81.5	10.4	2.8	0.1	4.4	2.1	0.5	23.4	20.1	33.1	32.6	31.7	2.7	0.5	9.9	1.7	8.3	8.0	2.5	14.6	3.3	25.8	62.1	6.9	165.8	5.1	0.6	0.2	5.6	3.9	2.7	2.2	3.3	13.8	6.0	0.7	8.0	65.5	1.2	6.6	1.9	2.1	0.0	6.5	0.0	2.2	0.0	4.9	0.4	23.7	0.0	39.4	27.0	11.9	15.5	5.4	37.4	7.5	0.3	6.5	4.8	3.3	0.6	5.9	6.0	4.1	3.0	13.4	4.1	8.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	34.7	43.3	33.7	46.9	42.1	48.0	60.2	51.3	67.6	27.2	42.0	81.5	0.8	0.0	0.5	49.3	0.5	1.3	0.4	0.5	0.0	30.4	0.6	0.3	28.0	2.8	0.2	0.0	14.6	8.9	1.5	0.4	1.9	0.8	2.0	1.8	0.5	3.7	7.2	19.4	237.4	0.7	2.1	5.8	1.5	3.0	0.0	0.6	0.4	0.1	1.2	52.2	237.6	1.9	2.0	0.0	0.8	1.9	0.0	0.7	7.2	18.7	1.1	4.1	0.0	136.7	1038.1	0.4	0.2	0.0	0.9	1.7	0.0	7.2	1.2	21.6	0.0	0.2	8.5	1.7	2.5	0.0	0.3	7.4	0.6	6.9	0.6	0.2
DNASE1	DNL1	ENSG00000213918	"Deoxyribonuclease 1"	P24855	16	3611728-3680143	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted secreted proteins"	Apoptosis	"Actin-binding, Endonuclease, Hydrolase, Nuclease"	"Systemic lupus erythematosus"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"intestine: 34.5;kidney: 34.2"	"Cell type enriched"	"Detected in many"	11	"Proximal enterocytes: 715.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA010703	Enhanced		Supported	Vesicles	"Secreted in other tissues"	NA	NA		420000	"Cluster 49: Eosinophils - Unknown function"	"Cluster 87: Intestine & Kidney - Transmembrane transport"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 45: Enterocytes - Digestion"	Vesicles		"HPA010703: AB_10600806"	"unprognostic (5.18e-2)"	"unprognostic (1.78e-2)"	"unprognostic (1.16e-1)"	"unprognostic (1.74e-1)"	"unprognostic (2.38e-1)"	"unprognostic (1.90e-2)"	"unprognostic (3.73e-2)"	"unprognostic (3.82e-1)"	"unprognostic (3.20e-1)"	"unprognostic (9.91e-2)"	"unprognostic (1.69e-3)"	"unprognostic (5.37e-2)"	"unprognostic (1.37e-2)"	"unprognostic (1.06e-1)"	"unprognostic (1.74e-1)"	"unprognostic (1.45e-1)"	"prognostic favorable (1.14e-4)"	4.6	5.0	5.1	6.6	5.6	4.3	4.6	13.4	6.4	9.8	6.9	6.1	29.7	5.2	5.0	7.1	6.8	2.7	5.5	5.8	4.9	34.2	5.9	4.9	10.0	6.0	5.2	7.5	23.6	2.7	16.3	4.2	6.6	11.6	5.0	4.4	4.9	2.5	3.7	7.8	34.5	2.7	3.2	9.2	11.2	9.2	5.8	9.4	7.4	1.3	8.7	6.0	8.5	9.7	2.9	6.5	11.4	5.9	3.3	2.8	5.2	4.7	0.8	3.7	5.3	8.0	6.9	12.3	3.6	0.7	7.8	4.8	4.2	1.3	3.9	5.5	6.4	4.4	11.3	5.4	1.7	2.9	9.6	2.3	4.8	5.0	1.2	5.8	2.5	10.3	11.2	5.0	3.2	12.3	6.3	13.6	6.9	8.7	3.6	14.9	5.3	5.7	3.1	2.5	8.1	7.6	3.5	10.5	1.9	5.7	10.4	7.7	3.4	6.8	5.0	4.3	2.5	4.8	7.5	21.4	1.7	5.7	6.6	2.7	1.1	3.2	1.5	0.7	1.0	1.4	1.2	1.3	0.6	2.1	1.3	1.8	5.0	1.0	0.7	1.1	1.4	0.5	5.1	5.6	13.4	6.4	5.8	4.9	6.0	5.2	6.6	3.2	5.8	9.7	4.9	9.6	10.3	27.1	9.1	2.7	8.6	3.1	10.8	27.3	5.5	4.8	6.0	4.3	9.7	16.5	22.9	8.6	9.3	11.8	56.7	5.3	19.3	9.8	10.0	7.7	14.3	7.6	20.5	11.0	4.1	7.4	13.3	8.4	2.5	23.3	7.5	1.8	3.9	25.2	22.0	38.6	20.3	5.0	4.2	52.4	8.4	4.4	1.8	15.9	13.2	8.6	30.9	22.1	20.6	5.3	61.4	7.9	7.2	12.4	715.5	2.4	9.1	17.9	0.0	13.6	6.3	28.5	24.5	5.8	3.8	6.2	12.2	10.4	33.4	6.3
DNASE2	"DNL, DNL2"	ENSG00000105612	"Deoxyribonuclease 2, lysosomal"	O00115	19	12875209-12881466	"Enzymes, Predicted intracellular proteins"	Apoptosis	"Developmental protein, Endonuclease, Hydrolase, Nuclease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Hofbauer cells: 226.7;Paneth cells: 125.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA066185	Enhanced				"Intracellular and membrane"	NA	NA		560000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 4: Macrophages - Innate immune response"			"HPA066185: AB_2685632"	"unprognostic (9.62e-2)"	"unprognostic (2.19e-3)"	"unprognostic (8.97e-2)"	"unprognostic (7.45e-2)"	"unprognostic (1.56e-2)"	"unprognostic (4.37e-1)"	"unprognostic (6.70e-2)"	"unprognostic (5.01e-3)"	"unprognostic (5.42e-2)"	"unprognostic (4.85e-2)"	"unprognostic (1.40e-1)"	"unprognostic (5.12e-2)"	"unprognostic (4.37e-2)"	"unprognostic (2.58e-2)"	"unprognostic (4.69e-2)"	"unprognostic (3.57e-1)"	"unprognostic (1.98e-1)"	27.0	26.7	17.1	24.0	17.5	9.6	23.3	17.2	19.1	22.7	19.7	24.7	23.7	25.1	29.5	18.9	25.3	25.3	22.7	16.5	17.6	19.2	36.0	37.7	42.2	18.7	18.2	26.1	41.7	43.1	23.8	20.6	19.4	27.7	19.2	5.6	33.0	26.1	19.7	29.2	22.7	22.0	19.3	26.2	30.0	5.9	17.8	20.8	38.7	13.1	26.5	24.3	19.9	23.0	63.7	36.3	2.9	80.8	86.8	46.2	55.0	34.4	87.2	33.2	79.6	3.8	43.6	27.9	97.3	54.9	73.0	71.8	30.7	33.2	16.2	89.8	41.0	13.1	36.8	17.5	68.3	26.5	119.8	46.5	74.5	24.8	36.7	80.2	50.2	42.4	14.0	112.1	20.3	82.7	27.3	14.1	6.1	66.3	60.8	17.1	14.2	64.3	32.9	29.7	17.3	28.6	46.1	65.8	123.5	11.8	98.5	23.4	32.5	67.8	21.4	70.3	31.1	139.9	153.6	35.7	112.9	24.6	34.4	73.5	71.0	10.9	64.5	95.8	53.5	31.1	56.1	68.8	14.0	35.6	49.0	53.7	40.6	70.9	114.2	28.3	85.8	66.4	17.1	17.5	17.2	19.1	16.5	17.6	18.7	18.2	19.4	19.3	17.8	23.0	18.7	25.6	22.4	7.5	25.5	14.5	23.6	56.9	14.2	6.7	22.7	18.5	10.6	28.6	31.0	36.8	4.2	60.0	23.5	17.3	3.9	67.1	0.5	24.1	15.1	21.4	16.4	5.7	1.3	58.3	96.2	27.9	13.7	25.4	22.2	23.8	28.9	26.4	226.7	5.0	1.7	15.0	83.4	87.5	6.8	2.5	32.0	55.5	46.2	2.8	28.4	32.2	33.0	3.0	1.7	39.5	125.0	33.4	36.6	15.1	10.8	6.8	29.9	3.3	13.1	16.5	16.9	0.6	4.8	12.4	12.4	48.0	23.9	23.0	26.2	18.5
DNASE2B	DLAD	ENSG00000137976	"Deoxyribonuclease 2 beta"	Q8WZ79	1	84398484-84415018	"Enzymes, Predicted intracellular proteins"		"Endonuclease, Hydrolase, Nuclease"		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Tissue enriched"	"Detected in some"	25	"salivary gland: 170.3"	"Cell type enhanced"	"Detected in some"		"Early spermatids: 1.9;Hofbauer cells: 5.8;Kupffer cells: 1.6;Late spermatids: 3.1;Macrophages: 4.2;Paneth cells: 1.7;Prostatic glandular cells: 2.0"	"Group enriched"	"Detected in some"	5	"melanoma: 2.8;prostate cancer: 9.3"	"Low region specificity"	"Detected in single"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"								"Intracellular and membrane"	NA	NA				"Cluster 24: Salivary gland - Salivary secretion"		"Cluster 4: Macrophages - Innate immune response"				"unprognostic (2.24e-1)"	"unprognostic (3.57e-2)"	"unprognostic (2.77e-1)"	"unprognostic (1.22e-1)"	"unprognostic (4.70e-2)"	"unprognostic (3.70e-1)"	"unprognostic (2.86e-1)"	"unprognostic (1.62e-2)"	"unprognostic (9.87e-2)"	"unprognostic (7.90e-2)"	"unprognostic (2.72e-1)"	"unprognostic (1.15e-1)"	"unprognostic (3.82e-5)"	"unprognostic (5.38e-2)"	"unprognostic (1.97e-1)"	"unprognostic (6.79e-2)"	"unprognostic (3.08e-3)"	0.6	0.1	0.3	0.0	0.6	0.0	0.4	0.3	0.8	0.2	0.2	0.4	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.4	1.0	0.0	0.3	2.4	0.7	0.5	0.3	0.1	0.8	0.0	0.3	0.0	0.6	6.8	0.5	0.0	170.3	0.0	1.6	0.0	0.1	0.0	0.4	0.4	0.8	0.4	0.4	0.2	0.1	0.2	0.1	0.0	0.0	0.8	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.6	0.3	0.8	0.4	1.0	0.5	0.3	0.6	0.4	0.4	0.8	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	1.9	0.0	0.0	0.0	1.2	0.0	0.6	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.1	5.8	0.0	0.4	0.1	0.0	1.6	0.0	3.1	0.0	4.2	0.0	0.0	0.0	0.0	0.0	0.5	0.6	0.0	1.7	0.0	0.1	2.0	0.1	0.0	0.7	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.4	0.1
DNM1	DNM	ENSG00000106976	"Dynamin 1"	Q05193	9	128191655-128255248	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	Endocytosis	"Hydrolase, Motor protein"	"Disease variant, Epilepsy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"brain: 319.5"	"Cell type enhanced"	"Detected in many"		"Bipolar cells: 112.4;Cone photoreceptor cells: 89.6;Excitatory neurons: 176.1;Inhibitory neurons: 182.2;Rod photoreceptor cells: 78.4"	"Low cancer specificity"	"Detected in many"			"Region enhanced"	"Detected in many"		"cerebral cortex: 319.5"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"A549: 126.9;U-87 MG: 46.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB005920, HPA049910"	Enhanced					NA	NA		8800		"Cluster 10: Brain - Neuronal signaling"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"			"CAB005920: , HPA049910: AB_2680948"	"unprognostic (3.25e-2)"	"unprognostic (5.49e-2)"	"unprognostic (1.34e-3)"	"unprognostic (3.95e-2)"	"unprognostic (4.57e-2)"	"unprognostic (1.16e-1)"	"unprognostic (3.60e-3)"	"unprognostic (1.20e-1)"	"unprognostic (5.53e-2)"	"unprognostic (6.53e-2)"	"unprognostic (6.62e-3)"	"unprognostic (6.30e-1)"	"unprognostic (9.58e-2)"	"unprognostic (1.10e-1)"	"unprognostic (2.02e-1)"	"unprognostic (3.07e-3)"	"unprognostic (1.10e-3)"	22.2	7.9	99.8	3.7	129.1	2.0	13.2	13.6	319.5	30.8	0.0	8.0	1.9	8.8	2.4	5.5	9.4	13.4	7.8	140.1	15.9	14.1	5.3	4.6	2.4	50.7	4.1	2.5	8.4	4.1	33.6	2.5	36.6	9.0	2.7	68.3	9.0	3.0	3.2	15.0	9.0	5.3	0.0	1.0	5.0	4.9	10.0	0.9	5.2	4.0	1.8	10.6	21.6	123.1	8.7	126.9	11.3	2.8	3.6	36.8	0.6	8.0	18.9	15.7	6.5	1.7	2.6	0.2	10.7	16.7	0.6	15.3	1.8	0.8	8.6	0.1	12.1	8.3	19.5	0.5	2.6	1.1	5.6	9.8	0.2	12.4	0.2	15.2	0.0	7.3	3.1	0.5	0.0	3.6	0.7	2.7	12.2	2.2	23.1	15.6	0.4	3.9	2.4	0.0	16.1	27.1	27.1	0.8	1.2	1.4	0.3	11.2	0.6	0.5	34.8	36.2	16.6	1.0	0.4	0.8	46.8	0.4	2.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	99.8	129.1	13.6	319.5	140.1	15.9	50.7	4.1	36.6	0.0	10.0	123.1	2.2	0.0	0.0	18.9	0.9	7.9	1.7	0.3	8.0	112.4	2.9	3.9	2.0	5.7	0.8	0.0	89.6	0.3	0.2	0.4	1.9	0.8	0.9	1.3	19.0	1.8	0.0	0.0	176.1	0.9	0.4	24.3	2.6	1.4	1.3	2.8	0.7	0.6	10.6	50.5	182.2	0.9	0.0	0.6	10.5	1.0	2.8	9.2	3.6	22.5	1.3	10.7	0.0	33.7	14.3	0.6	5.0	1.5	0.7	0.8	2.5	5.3	1.1	78.4	0.0	2.1	3.8	1.0	1.8	2.5	7.5	0.8	1.6	2.1	1.6	0.8
DNM1L	"DRP1, DVLP, DYMPLE, HDYNIV, VPS1"	ENSG00000087470	"Dynamin 1 like"	O00429	12	32679200-32745650	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Transporters"	"Biological rhythms, Endocytosis, Necrosis"	Hydrolase	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"CAB009952, HPA039324"	Approved		Enhanced	Vesicles,Cytosol		NA	NA		2000000	"Cluster 27: Non-specific - Gene expression"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 5: NTERA-2 - Transcription"	"Cluster 46: Photoreceptor cells - Phototransduction"	Cytosol	Vesicles	"CAB009952: AB_2093533, HPA039324: AB_2676443"	"unprognostic (2.64e-2)"	"unprognostic (2.94e-1)"	"unprognostic (1.10e-3)"	"unprognostic (1.12e-1)"	"unprognostic (5.09e-1)"	"unprognostic (4.06e-2)"	"prognostic unfavorable (6.27e-6)"	"unprognostic (8.68e-2)"	"unprognostic (2.25e-2)"	"unprognostic (1.04e-2)"	"unprognostic (1.71e-1)"	"unprognostic (2.63e-1)"	"unprognostic (4.06e-1)"	"unprognostic (1.00e-1)"	"unprognostic (8.17e-2)"	"unprognostic (7.48e-2)"	"unprognostic (1.57e-2)"	23.2	23.2	25.3	23.5	27.5	40.0	21.1	27.7	32.3	18.4	15.7	24.0	18.6	23.6	23.9	28.6	19.8	17.5	38.9	28.4	26.1	27.9	14.2	16.7	20.9	22.5	22.0	20.0	13.5	40.5	25.3	23.9	23.6	27.0	22.7	44.9	16.0	28.7	43.8	18.3	16.8	32.0	22.2	18.8	17.3	36.0	21.6	21.4	22.4	57.2	24.8	29.9	18.5	26.6	66.8	62.3	64.3	68.3	51.2	52.7	123.2	72.0	55.4	67.2	61.7	80.6	48.0	87.3	50.0	65.8	66.9	57.8	69.2	80.3	79.3	46.6	57.6	102.3	57.2	48.2	41.7	72.5	50.1	48.6	37.4	70.7	66.1	63.5	81.1	41.4	74.4	37.5	75.3	21.7	29.1	61.7	138.2	41.0	30.8	48.6	125.0	61.5	56.5	79.1	57.1	59.3	76.3	51.8	56.7	129.4	59.7	49.0	74.0	57.3	54.4	135.3	68.2	26.1	75.8	86.3	55.6	47.0	43.5	7.4	10.0	3.2	5.6	15.6	6.9	7.0	6.2	6.1	18.8	6.0	7.3	8.4	1.8	8.1	15.6	5.6	7.3	7.9	25.3	27.5	27.7	32.3	28.4	26.1	22.5	22.0	23.6	22.2	21.6	26.6	42.5	38.5	38.4	82.6	36.0	30.0	34.7	28.0	44.3	80.9	32.5	29.2	82.8	20.0	33.3	25.8	131.3	30.0	53.8	26.7	31.3	34.8	63.9	38.8	55.8	42.0	30.5	28.4	139.4	25.1	63.7	41.0	23.9	59.4	50.7	48.8	26.4	16.0	30.8	126.2	150.0	24.9	34.6	27.5	30.7	78.0	26.8	43.3	14.2	44.0	45.6	59.0	34.0	99.5	121.7	45.7	14.4	30.5	48.5	42.8	11.4	23.3	22.8	164.8	19.7	55.0	55.5	79.3	52.3	39.6	27.6	36.0	42.2	26.0	31.5	36.4
DNM2	"CMT2M, CMTDI1, CMTDIB, DI-CMTB, DYN2, DYNII"	ENSG00000079805	"Dynamin 2"	P50570	19	10718079-10833488	"Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Transporters"	"Endocytosis, Phagocytosis"	"Hydrolase, Motor protein"	"Cancer-related genes, Charcot-Marie-Tooth disease, Disease variant, Neurodegeneration, Neuropathy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Distal enterocytes: 242.8;Paneth cells: 177.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA054246	Supported		Approved	"Golgi apparatus,Cytosol"		NA	NA		230000	"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 53: Intestinal epithelial cells - Unknown function"	"Golgi apparatus, Cytosol"		"HPA054246: AB_2682427"	"unprognostic (2.30e-1)"	"unprognostic (5.23e-2)"	"unprognostic (4.72e-2)"	"unprognostic (1.23e-1)"	"unprognostic (1.76e-1)"	"prognostic favorable (8.91e-4)"	"prognostic unfavorable (3.63e-4)"	"unprognostic (1.03e-1)"	"unprognostic (3.79e-1)"	"unprognostic (1.89e-1)"	"unprognostic (4.75e-2)"	"unprognostic (5.35e-2)"	"unprognostic (5.47e-2)"	"unprognostic (5.40e-3)"	"unprognostic (2.68e-1)"	"unprognostic (1.61e-1)"	"unprognostic (1.99e-3)"	55.1	69.9	50.5	63.2	77.8	125.7	46.1	74.1	64.1	49.0	38.8	105.8	65.9	42.2	25.3	67.6	42.5	40.5	87.2	52.3	57.4	72.8	57.2	87.0	62.4	82.7	78.9	36.6	68.2	38.9	41.9	51.3	79.8	47.4	83.9	30.7	55.0	55.7	108.1	92.8	99.6	35.1	60.3	81.0	98.6	55.1	72.9	58.6	47.6	82.8	65.4	64.6	54.5	101.6	116.4	92.8	67.6	54.6	67.6	65.4	86.5	75.1	70.5	108.8	91.7	94.2	74.7	83.2	132.2	81.5	52.5	99.4	92.6	82.1	90.8	103.1	72.4	160.1	81.7	107.1	82.9	87.8	146.5	67.8	62.4	83.5	77.9	66.2	107.3	84.9	131.5	139.1	68.0	140.1	126.3	85.7	76.6	138.3	109.7	125.6	72.6	95.7	71.3	171.1	97.1	63.8	86.6	73.6	54.2	74.9	58.8	106.2	99.6	120.7	40.5	172.0	102.7	112.7	127.3	77.9	89.9	134.0	61.0	3.5	3.5	7.0	4.0	6.2	3.8	2.5	3.0	4.4	4.2	2.1	1.7	3.0	6.5	8.9	8.4	8.4	3.8	4.1	50.5	77.8	74.1	64.1	52.3	57.4	82.7	78.9	79.8	60.3	72.9	101.6	37.8	32.1	22.3	24.8	48.8	23.2	17.1	13.8	22.2	28.8	19.7	16.3	30.3	14.3	25.7	51.5	22.9	25.7	57.2	242.8	50.9	35.2	48.4	32.2	17.9	33.1	21.6	38.1	29.2	32.0	106.9	19.5	168.7	39.7	19.0	36.8	20.3	22.8	49.1	43.7	31.1	106.9	14.2	28.0	39.6	98.0	16.8	55.2	19.6	60.9	43.4	17.2	39.1	23.1	90.9	45.2	177.3	27.8	92.2	20.2	90.7	38.8	18.0	26.3	26.3	18.7	27.6	15.0	12.3	26.6	31.5	31.7	46.4	40.7	82.5	22.8
DNM3	KIAA0820	ENSG00000197959	"Dynamin 3"	Q9UQ16	1	171841498-172418466	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	Endocytosis	"Hydrolase, Motor protein"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"brain: 66.9"	"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 365.7;Inhibitory neurons: 631.8;Oligodendrocyte precursor cells: 976.1;Oligodendrocytes: 1970.9"	"Cancer enhanced"	"Detected in many"		"glioma: 2.0"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"T-reg: 1.4"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"HEL: 22.9;HMC-1: 10.2;RPTEC TERT1: 19.0;U-251 MG: 14.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA064121			Approved	"Golgi apparatus"		NA	NA		70000	"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 70: Brain - Nervous system development"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	"Golgi apparatus"		"HPA064121: AB_2685193"	"unprognostic (8.21e-2)"	"unprognostic (6.80e-3)"	"unprognostic (1.68e-1)"	"unprognostic (1.41e-2)"	"unprognostic (8.84e-2)"	"unprognostic (2.07e-1)"	"unprognostic (9.52e-3)"	"unprognostic (6.46e-2)"	"unprognostic (5.52e-2)"	"unprognostic (2.96e-2)"	"unprognostic (2.45e-2)"	"unprognostic (3.37e-1)"	"unprognostic (6.10e-4)"	"unprognostic (1.60e-3)"	"unprognostic (1.35e-1)"	"unprognostic (2.22e-1)"	"unprognostic (2.70e-3)"	4.2	11.9	15.3	1.0	29.9	1.3	4.0	59.4	24.3	5.8	0.0	2.4	0.6	3.2	1.3	1.3	3.2	2.7	2.1	12.2	36.0	4.1	0.4	4.4	1.1	42.8	29.5	2.6	1.1	1.2	6.2	0.4	47.8	2.6	1.1	13.4	2.1	1.6	1.2	2.4	1.4	3.1	10.6	1.8	2.7	3.2	32.3	1.8	3.3	1.3	0.8	2.2	5.1	66.9	0.8	2.5	2.0	0.4	1.5	1.0	0.0	0.5	1.2	1.0	1.3	0.0	3.7	0.0	7.5	1.1	1.2	0.3	1.5	2.9	0.9	1.0	2.9	22.9	3.7	0.0	0.1	0.5	10.2	0.7	0.5	1.2	0.7	1.1	0.5	2.0	0.0	0.3	0.4	0.0	1.5	0.1	5.8	9.5	1.7	1.5	9.9	0.0	19.0	0.1	3.9	0.8	2.7	0.7	0.2	0.7	0.0	0.9	0.3	2.8	3.8	2.3	14.3	3.8	0.7	0.2	2.7	1.2	1.0	0.0	0.1	0.0	0.2	0.0	0.3	0.2	0.3	0.1	0.2	0.0	0.3	0.5	0.3	0.3	0.1	0.0	1.4	1.2	15.3	29.9	59.4	24.3	12.2	36.0	42.8	29.5	47.8	10.6	32.3	66.9	21.8	0.0	6.8	207.3	1.5	2.4	1.5	0.7	3.4	25.1	1.4	1.3	2.4	0.0	0.4	0.0	29.2	0.1	0.7	0.2	3.9	0.3	8.2	7.3	1.3	19.5	0.0	0.8	365.7	0.4	0.1	3.2	7.1	1.0	1.3	0.8	8.2	0.2	0.7	8.4	631.8	0.7	0.0	0.6	3.1	3.9	1.8	13.4	0.0	178.0	0.3	5.9	0.0	976.1	1970.9	2.5	0.1	2.6	0.3	0.7	0.0	0.8	2.2	29.0	0.0	4.5	2.2	5.3	0.4	1.1	1.7	0.3	0.9	10.3	0.8	0.7
DNPEP	"ASPEP, DAP"	ENSG00000123992	"Aspartyl aminopeptidase"	Q9ULA0	2	219372043-219400022	"Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"		"Aminopeptidase, Hydrolase, Metalloprotease, Protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 364.4;Late spermatids: 462.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036398, HPA044860"	Enhanced		Supported	Cytosol		NA	NA		2700000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 10: Non-specific - Unknown function"	Cytosol		"HPA036398: AB_10970915, HPA044860: AB_10961275"	"unprognostic (3.71e-1)"	"unprognostic (6.45e-2)"	"unprognostic (1.26e-1)"	"unprognostic (1.05e-2)"	"unprognostic (1.55e-2)"	"unprognostic (2.75e-1)"	"unprognostic (2.54e-3)"	"unprognostic (3.34e-2)"	"unprognostic (2.44e-1)"	"unprognostic (3.49e-2)"	"unprognostic (1.61e-1)"	"unprognostic (6.13e-2)"	"unprognostic (1.67e-1)"	"unprognostic (5.63e-3)"	"unprognostic (3.49e-1)"	"unprognostic (2.50e-1)"	"unprognostic (1.85e-3)"	25.8	18.9	15.4	25.0	15.8	18.0	23.6	14.8	18.6	24.9	14.7	34.5	56.5	22.4	21.5	25.1	25.1	22.6	39.9	16.2	16.9	22.1	32.0	27.6	23.4	15.8	15.0	30.2	27.2	25.8	13.0	37.1	15.2	22.6	30.8	9.5	26.2	24.4	64.5	31.7	56.2	19.9	16.0	24.7	25.4	58.5	17.4	17.5	15.2	46.4	16.2	29.6	21.6	14.7	47.5	25.8	15.4	45.7	39.7	32.2	122.0	23.0	46.5	59.3	62.5	72.6	61.2	27.2	48.7	49.5	76.0	45.0	18.6	53.6	21.3	56.4	12.5	46.6	25.0	79.8	107.2	38.9	32.2	54.4	55.4	61.8	50.2	37.9	41.2	38.6	53.8	45.3	31.0	103.7	60.8	44.5	25.5	67.7	15.1	77.2	35.7	36.5	33.0	74.0	19.1	26.0	27.1	86.5	34.5	26.9	25.8	43.3	23.5	55.4	46.1	31.4	33.7	49.6	31.8	21.3	80.0	37.7	24.1	8.7	17.2	7.3	16.1	19.7	18.8	13.2	13.2	18.3	20.8	16.2	14.0	18.7	1.6	21.2	17.0	7.2	16.6	14.8	15.4	15.8	14.8	18.6	16.2	16.9	15.8	15.0	15.2	16.0	17.4	14.7	43.1	12.8	18.2	8.8	35.6	38.6	74.1	55.1	52.9	19.3	41.2	36.7	33.6	55.8	27.2	25.8	33.3	90.4	26.7	70.4	49.0	62.9	364.4	16.5	36.5	41.8	48.0	19.8	3.1	66.3	96.9	43.4	29.0	19.6	24.1	39.1	30.4	47.9	51.0	10.1	5.2	110.3	38.7	31.5	26.8	462.0	52.5	26.2	32.0	4.7	53.0	29.8	45.3	3.0	3.3	52.3	75.6	41.0	38.3	113.1	202.6	79.6	16.3	37.6	26.3	31.9	120.0	20.1	20.1	43.4	44.8	66.4	34.1	36.9	70.9	74.6
DOLPP1	LSFR2	ENSG00000167130	"Dolichyldiphosphatase 1"	Q86YN1	9	129081111-129090438	"Enzymes, Metabolic proteins, Predicted membrane proteins"		Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 29.1;Proximal enterocytes: 42.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA019179	Approved		Approved	"Vesicles,Intermediate filaments"		NA	NA			"Cluster 16: MAIT-cells - Unknown function"	"Cluster 45: Intestine - Brush border"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 45: Enterocytes - Digestion"	Vesicles	"Intermediate filaments"	"HPA019179: AB_1847827"	"unprognostic (1.32e-2)"	"unprognostic (1.23e-1)"	"unprognostic (3.89e-1)"	"unprognostic (6.12e-3)"	"unprognostic (3.11e-1)"	"unprognostic (2.63e-2)"	"unprognostic (3.18e-1)"	"unprognostic (3.10e-2)"	"unprognostic (6.96e-2)"	"unprognostic (7.12e-2)"	"unprognostic (1.65e-1)"	"unprognostic (4.37e-3)"	"unprognostic (7.59e-3)"	"unprognostic (2.38e-2)"	"unprognostic (1.35e-1)"	"unprognostic (4.69e-2)"	"unprognostic (5.34e-2)"	5.6	11.4	12.2	6.3	13.4	8.1	5.8	13.0	13.8	6.6	8.7	15.5	26.2	5.3	6.0	19.2	5.5	5.8	4.6	12.1	12.5	6.0	22.4	5.0	6.6	13.3	13.4	5.2	10.4	8.7	6.2	7.6	14.3	8.5	12.5	3.8	9.9	4.7	4.9	10.5	22.6	5.3	13.1	7.8	10.8	8.1	13.5	10.1	5.4	4.8	6.6	6.0	8.3	15.2	8.7	33.6	31.4	29.6	10.3	9.1	36.2	20.9	12.2	39.3	22.0	42.9	28.4	16.7	18.2	13.0	30.2	61.8	32.6	17.8	16.6	19.9	20.6	22.0	22.3	34.5	18.8	23.0	26.4	9.5	24.4	25.5	20.3	8.9	17.5	30.7	37.3	16.2	11.4	44.7	26.5	24.8	27.4	64.7	28.2	30.8	25.3	31.2	14.2	14.1	35.9	24.2	27.1	24.1	9.4	18.4	44.8	15.0	14.5	33.5	16.4	33.4	29.0	20.3	41.6	25.3	15.3	4.6	22.8	7.9	8.2	12.6	10.2	10.5	25.2	11.4	12.6	12.6	10.5	7.7	12.5	11.9	1.7	11.2	11.0	15.8	13.6	8.9	12.2	13.4	13.0	13.8	12.1	12.5	13.3	13.4	14.3	13.1	13.5	15.2	3.1	6.4	6.3	4.2	3.9	2.3	3.0	6.9	1.2	3.7	7.3	5.2	2.1	10.0	6.3	1.8	6.2	18.8	2.8	29.1	1.9	7.1	0.5	3.9	5.0	3.4	3.6	13.0	3.1	9.6	14.2	3.9	10.2	5.4	5.7	3.8	5.3	18.3	7.5	3.3	4.4	10.1	6.1	2.9	1.9	0.5	2.1	2.7	5.4	1.0	4.2	8.6	6.2	3.5	6.4	6.6	16.2	4.1	6.7	3.8	42.0	4.1	3.2	3.7	0.0	3.1	4.0	6.3	9.7	11.0	4.0	16.4	4.4	8.1	13.5	4.1
DPEP1		ENSG00000015413	"Dipeptidase 1"	P16444	16	89613308-89638456	"Enzymes, FDA approved drug targets, Metabolic proteins, Predicted intracellular proteins"	"Lipid metabolism"	"Dipeptidase, Hydrolase, Metalloprotease, Protease"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	8	"intestine: 377.4;kidney: 255.9;pancreas: 440.7"	"Cell type enhanced"	"Detected in many"		"Peritubular cells: 1217.5;Proximal enterocytes: 4683.5;Proximal tubular cells: 829.6"	"Cancer enriched"	"Detected in many"	8	"colorectal cancer: 107.4"	"Low region specificity"	"Detected in single"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"CACO-2: 8.5;Hep G2: 33.1;HHSteC: 13.9;U-937: 46.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA009426, HPA012783"	Enhanced		Approved	"Nucleoplasm,Cell Junctions"	"Intracellular and membrane"	NA	NA		370000		"Cluster 29: Non-specific - Vesicular transport"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 45: Enterocytes - Digestion"	"Nucleoplasm, Cell Junctions"		"HPA009426: AB_1847842, HPA012783: AB_1847843"	"unprognostic (3.31e-2)"	"unprognostic (3.86e-1)"	"unprognostic (1.37e-1)"	"unprognostic (1.95e-2)"	"unprognostic (1.91e-2)"	"unprognostic (4.93e-2)"	"unprognostic (1.04e-1)"	"unprognostic (1.89e-1)"	"unprognostic (3.45e-2)"	"unprognostic (5.18e-1)"	"unprognostic (8.68e-2)"	"unprognostic (1.27e-1)"	"prognostic favorable (6.84e-4)"	"unprognostic (6.12e-3)"	"unprognostic (1.92e-1)"	"unprognostic (5.23e-2)"	"unprognostic (3.93e-2)"	0.6	2.3	0.0	1.8	0.0	0.4	0.5	0.0	0.2	4.1	0.0	1.7	85.5	0.6	0.9	0.3	0.6	3.9	0.3	0.0	0.3	255.9	0.5	0.9	2.8	0.2	1.1	0.8	440.7	0.0	0.5	0.8	0.6	0.5	0.5	0.3	1.2	1.0	0.0	2.2	377.4	0.3	0.3	4.5	1.6	46.5	0.9	0.9	0.8	0.0	0.9	2.2	0.9	0.0	0.0	0.9	0.2	0.0	1.7	0.2	4.4	0.0	0.0	0.0	0.0	8.5	0.2	0.0	3.0	0.0	0.0	0.0	0.2	0.0	0.0	2.2	0.6	0.0	0.0	33.1	13.9	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.3	1.1	1.1	3.4	0.0	0.0	0.0	3.0	0.0	0.1	0.9	0.8	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.1	0.1	1.4	0.0	0.0	0.2	0.1	0.0	46.8	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.3	0.2	1.1	0.6	0.3	0.9	0.0	0.1	3.2	1.8	0.0	9.2	0.5	0.0	0.0	0.0	5.8	1.7	0.0	0.3	0.0	0.6	23.9	0.0	0.2	0.0	2.0	56.7	0.5	13.2	0.2	0.2	7.0	8.9	0.0	0.3	192.1	0.8	8.9	1.1	0.1	1.3	0.7	1.1	0.0	0.5	0.0	0.3	142.3	0.0	0.3	0.3	45.2	289.8	4.8	5.4	0.0	1.0	0.1	0.0	0.0	0.1	27.4	187.4	1217.5	61.2	0.0	4683.5	829.6	0.0	0.2	6.6	0.0	0.7	17.3	2.8	0.0	0.3	0.4	2.5	0.2	151.7	0.0
DPEP2		ENSG00000167261	"Dipeptidase 2"	Q9H4A9	16	67987394-68000586	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Lipid metabolism"	"Dipeptidase, Hydrolase, Metalloprotease, Protease"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 23.3;lymphoid tissue: 28.6"	"Cell type enhanced"	"Detected in many"		"Hofbauer cells: 29.9;Kupffer cells: 55.0;Macrophages: 34.6;monocytes: 28.6;NK-cells: 25.7;Syncytiotrophoblasts: 54.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in all"	4	"basophil: 410.0;eosinophil: 841.1;neutrophil: 358.8"	"Lineage enriched"	"Detected in all"	7	"granulocytes: 841.1"	"Cell line enhanced"	"Detected in some"		"HEL: 4.1;HMC-1: 18.1;NB-4: 4.1;U-937: 6.3"	"Not detected"	"Not detected"			"Region enhanced"	"Detected in many"		"midbrain: 12.3"	HPA035644	Approved					NA	NA		330000000	"Cluster 2: Granulocytes - Unknown function"	"Cluster 2: Immune cells - Immune response"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 19: Monocytes & Neutrophils - Innate immune response"			"HPA035644: AB_10670164"	"unprognostic (8.81e-2)"	"unprognostic (7.84e-5)"	"unprognostic (1.35e-1)"	"unprognostic (1.42e-2)"	"unprognostic (1.92e-1)"	"unprognostic (6.66e-3)"	"unprognostic (1.03e-1)"	"unprognostic (5.47e-2)"	"unprognostic (3.69e-2)"	"unprognostic (1.68e-1)"	"unprognostic (6.01e-2)"	"unprognostic (1.46e-1)"	"unprognostic (3.91e-2)"	"unprognostic (5.75e-2)"	"prognostic unfavorable (8.47e-4)"	"unprognostic (7.78e-3)"	"unprognostic (3.91e-2)"	6.0	0.9	4.3	12.6	4.4	23.3	2.8	4.3	9.3	2.3	4.1	4.1	3.3	1.4	0.6	1.8	2.8	6.2	2.4	4.1	4.8	1.8	3.8	18.5	18.8	6.3	4.9	0.6	1.0	0.9	0.7	13.4	5.1	1.5	4.1	0.2	1.7	1.2	1.4	1.2	11.9	4.0	5.1	28.6	3.2	2.8	5.6	9.0	2.5	3.3	18.3	8.1	1.3	6.6	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.4	0.0	0.0	0.0	1.2	0.4	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.5	0.0	4.1	0.0	0.1	0.0	0.1	18.1	0.0	0.1	0.0	0.0	0.1	0.1	1.3	0.3	0.1	0.0	0.0	0.1	4.1	0.0	0.0	0.2	0.2	0.0	0.4	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	1.1	0.5	0.0	0.0	0.0	0.0	1.0	0.5	0.3	0.0	6.3	0.0	410.0	82.6	841.1	17.0	101.9	19.8	30.3	29.5	13.7	33.0	35.9	34.7	17.8	358.8	44.7	126.7	5.3	31.8	48.9	4.3	4.4	4.3	9.3	4.1	4.8	6.3	4.9	5.1	5.1	5.6	6.6	0.9	0.0	7.9	0.0	20.4	2.0	0.0	0.3	1.2	0.0	0.2	0.3	1.8	0.0	1.7	0.0	0.0	10.0	8.7	0.1	0.0	0.1	0.2	0.1	0.1	4.8	0.0	2.1	0.1	0.0	0.7	1.0	0.5	0.1	2.5	0.0	18.9	0.1	29.9	0.0	0.2	0.0	2.0	55.0	21.0	1.1	0.0	34.6	3.6	10.3	28.6	0.0	25.7	0.0	0.1	0.0	0.0	0.4	3.4	0.0	0.0	0.3	8.6	0.0	0.0	0.3	0.8	12.0	9.4	0.1	1.3	54.0	13.1	0.0	0.0	0.1
DPEP3		ENSG00000141096	"Dipeptidase 3"	Q9H4B8	16	67975663-67980549	"Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins"		"Dipeptidase, Hydrolase, Metalloprotease, Protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	23	"testis: 47.0"	"Group enriched"	"Detected in some"	7	"Spermatocytes: 290.4;Spermatogonia: 289.0"	"Cancer enhanced"	"Detected in many"		"ovarian cancer: 16.9"	"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"neutrophil: 6.7;NK-cell: 1.8"	"Group enriched"	"Detected in many"	8	"granulocytes: 6.7;NK-cells: 1.8"	"Cell line enriched"	"Detected in single"	10	"U-266/70: 1.1"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA031870, HPA058607"	Enhanced					NA	NA		27000000	"Cluster 9: Neutrophils - Innate immune response"	"Cluster 83: Testis - Spermatogenesis"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 13: Spermatocytes & Spermatogonia - Spermatogenesis"			"HPA031870: AB_2674079, HPA058607: AB_2683775"	"unprognostic (9.93e-2)"	"unprognostic (2.81e-3)"	"unprognostic (1.86e-1)"	"unprognostic (9.52e-2)"	"unprognostic (3.61e-2)"	"unprognostic (1.37e-2)"	"unprognostic (1.55e-1)"	"unprognostic (6.52e-2)"	"unprognostic (1.09e-1)"	"unprognostic (2.05e-2)"	"unprognostic (3.49e-3)"	"unprognostic (9.97e-2)"	"unprognostic (1.56e-1)"	"unprognostic (3.15e-3)"	"unprognostic (1.13e-1)"	"unprognostic (3.98e-2)"	"unprognostic (1.51e-1)"	0.4	0.1	0.2	0.2	0.2	1.7	0.0	0.2	0.4	0.0	0.4	0.2	0.4	0.0	0.0	0.0	0.1	0.1	0.1	0.2	0.2	0.0	0.1	0.3	0.4	0.3	0.2	0.0	0.1	0.0	0.0	0.1	0.3	0.0	0.1	0.0	0.0	0.2	0.1	0.0	0.8	0.0	0.3	2.0	0.3	47.0	0.3	0.1	0.0	0.6	0.2	0.2	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	1.0	0.0	0.4	0.2	0.2	0.0	0.0	0.1	0.5	0.5	0.2	6.7	1.8	0.1	0.0	0.0	0.2	0.2	0.2	0.2	0.4	0.2	0.2	0.3	0.2	0.3	0.3	0.3	0.4	0.0	0.0	0.0	0.0	0.7	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	20.0	0.0	0.0	0.4	0.0	2.5	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.4	0.0	1.0	0.0	0.0	0.0	0.0	0.9	0.0	41.3	4.4	0.6	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	3.0	1.4	0.0	0.0	0.1	0.7	0.0	26.3	0.0	0.0	290.4	289.0	0.0	0.0	0.3	0.2	0.1	0.0	0.0
DPH7	"C9orf112, FLJ90634, RRT2, WDR85"	ENSG00000148399	"Diphthamide biosynthesis 7"	Q9BTV6	9	137554444-137578925	"Enzymes, Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Spermatocytes: 189.9;Spermatogonia: 100.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA022911	Uncertain		Approved	"Nuclear bodies"		Yes	No			"Cluster 46: Basophils - DNA binding"	"Cluster 50: Non-specific - Ribosome"	"Cluster 21: OE19 - Mitochondria"	"Cluster 13: Spermatocytes & Spermatogonia - Spermatogenesis"	"Nuclear bodies"		"HPA022911: AB_1858823"	"unprognostic (1.43e-1)"	"unprognostic (4.81e-2)"	"unprognostic (3.41e-2)"	"unprognostic (2.25e-2)"	"unprognostic (1.19e-1)"	"unprognostic (6.60e-3)"	"unprognostic (1.48e-2)"	"unprognostic (1.78e-1)"	"unprognostic (2.14e-2)"	"unprognostic (9.48e-2)"	"prognostic favorable (6.52e-4)"	"unprognostic (2.10e-2)"	"prognostic unfavorable (1.52e-5)"	"unprognostic (2.30e-3)"	"unprognostic (3.06e-2)"	"unprognostic (2.15e-1)"	"prognostic favorable (3.23e-4)"	8.2	12.3	3.4	2.6	3.6	4.2	9.5	4.5	4.1	15.7	3.9	13.8	2.2	12.6	7.0	9.0	14.6	2.6	9.4	3.6	3.3	10.2	10.9	9.4	4.7	3.7	3.3	12.8	20.3	6.3	13.5	3.4	4.0	15.0	4.1	2.8	9.9	5.4	8.3	11.0	12.2	4.8	3.3	15.2	12.3	9.3	3.8	5.6	12.8	2.4	5.3	11.2	11.1	5.7	4.5	5.2	8.2	7.6	6.2	5.1	10.2	5.1	5.2	9.1	7.7	11.0	5.4	10.6	9.3	5.9	4.8	9.8	10.6	10.1	8.3	9.2	13.2	4.9	6.6	3.7	7.0	10.6	9.5	5.4	7.6	5.1	9.2	6.5	14.4	7.1	9.2	5.7	7.2	15.3	8.2	9.9	10.4	19.9	13.3	13.7	3.7	7.6	6.9	4.5	10.8	7.3	8.7	7.0	5.4	5.7	7.9	9.1	6.5	6.2	5.4	7.7	9.5	3.7	9.1	12.5	3.9	6.1	6.3	9.5	5.1	6.2	4.5	4.8	6.3	5.6	7.2	6.4	5.9	4.7	5.1	4.9	1.6	4.5	4.0	8.0	5.4	4.6	3.4	3.6	4.5	4.1	3.6	3.3	3.7	3.3	4.0	3.3	3.8	5.7	21.0	6.4	11.9	21.2	17.7	16.7	9.8	18.9	8.0	18.7	14.7	20.6	15.5	2.8	11.5	1.8	50.1	22.1	22.5	7.7	3.9	10.6	3.0	11.1	17.1	13.8	6.7	5.5	17.2	9.2	14.9	14.5	13.3	10.2	10.8	26.5	8.2	6.5	11.9	16.8	21.5	11.7	6.1	6.6	7.2	7.5	16.4	8.8	8.8	15.0	9.9	15.4	23.7	16.1	28.2	11.5	10.3	15.8	24.7	18.6	7.2	5.2	14.2	58.8	19.7	13.1	16.0	189.9	100.0	11.4	18.9	12.2	18.0	19.9	15.0	11.1
DPP3		ENSG00000254986	"Dipeptidyl peptidase 3"	Q9NY33	11	66480013-66509657	"Enzymes, Plasma proteins, Predicted intracellular proteins"		"Aminopeptidase, Hydrolase, Metalloprotease, Protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Rod photoreceptor cells: 72.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035780, HPA035781"	Approved		Supported	Cytosol		NA	NA		3200000	"Cluster 27: Non-specific - Gene expression"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 46: Photoreceptor cells - Phototransduction"	Cytosol		"HPA035780: AB_2674778, HPA035781: AB_10669529"	"unprognostic (5.74e-2)"	"unprognostic (1.16e-3)"	"unprognostic (2.62e-3)"	"unprognostic (4.77e-2)"	"unprognostic (1.99e-1)"	"unprognostic (5.44e-3)"	"unprognostic (1.67e-3)"	"unprognostic (1.25e-3)"	"unprognostic (1.73e-2)"	"unprognostic (9.87e-2)"	"unprognostic (1.02e-2)"	"unprognostic (3.87e-1)"	"unprognostic (5.85e-2)"	"prognostic favorable (1.34e-4)"	"unprognostic (1.81e-2)"	"unprognostic (3.43e-1)"	"unprognostic (5.66e-2)"	11.6	17.5	8.2	21.4	9.1	20.7	11.2	10.2	10.4	11.0	5.4	30.2	24.8	11.7	7.8	23.5	9.8	14.5	10.3	8.4	8.9	17.1	18.6	14.3	21.8	10.2	8.8	6.8	17.3	11.9	8.7	14.3	10.8	14.4	26.3	15.9	18.8	12.9	26.5	13.6	20.5	16.2	8.6	15.4	19.2	9.8	10.2	18.6	11.7	7.4	23.3	17.3	13.5	9.9	84.1	71.6	32.5	36.3	26.4	28.3	50.4	46.5	61.8	61.4	40.7	90.8	68.4	48.7	154.0	52.9	52.2	73.6	52.1	57.0	39.4	92.5	23.8	63.1	32.1	54.2	40.7	77.6	101.1	40.5	54.5	46.2	22.8	26.5	47.8	50.1	45.1	28.2	56.7	95.3	91.0	78.7	55.5	82.0	43.2	63.1	32.7	79.6	52.6	71.7	61.1	52.2	39.7	45.6	62.5	30.3	70.8	44.7	50.1	36.5	39.4	40.7	46.2	23.3	46.6	56.6	48.5	36.5	45.9	20.7	18.8	21.3	21.4	40.0	13.3	11.5	15.8	17.7	32.3	11.1	9.4	13.9	3.2	30.8	27.9	22.5	29.6	17.7	8.2	9.1	10.2	10.4	8.4	8.9	10.2	8.8	10.8	8.6	10.2	9.9	5.8	16.0	13.2	6.8	11.6	6.0	17.4	34.8	8.6	11.4	7.1	3.8	3.0	10.0	27.0	23.9	10.4	46.9	11.5	41.6	13.7	45.6	24.6	8.7	6.2	10.5	18.6	3.4	3.4	61.3	34.2	7.4	29.0	11.5	1.3	9.9	3.6	14.7	37.4	6.7	4.0	19.5	63.1	7.9	9.0	7.0	2.1	10.8	16.0	3.7	31.3	21.6	18.6	4.5	5.6	40.8	25.2	5.3	15.7	11.0	26.4	28.7	17.3	72.9	13.1	4.4	16.2	8.8	20.7	14.4	6.0	36.0	13.1	20.1	29.5	19.5
DPP4	"ADCP2, CD26, DPPIV"	ENSG00000197635	"Dipeptidyl peptidase 4"	P27487	2	161992245-162074394	"CD markers, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Cell adhesion"	"Aminopeptidase, Hydrolase, Protease, Receptor, Serine protease"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 137.9;parathyroid gland: 155.7;placenta: 134.1;prostate: 107.3"	"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 140.3;Proximal enterocytes: 291.1;Proximal tubular cells: 101.4;Syncytiotrophoblasts: 172.0"	"Cancer enhanced"	"Detected in all"		"prostate cancer: 55.2"	"Not detected"	"Not detected"			"Immune cell enhanced"	"Detected in many"		"MAIT T-cell: 52.3"	"Lineage enriched"	"Detected in many"	10	"T-cells: 52.3"	"Cell line enhanced"	"Detected in many"		"ASC diff: 194.4;ASC TERT1: 212.6;BJ hTERT+: 207.0;RPTEC TERT1: 263.3"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"CAB045970, HPA068778, HPA071236"	Enhanced				"Secreted to blood"	NA	NA		190000000	"Cluster 16: MAIT-cells - Unknown function"	"Cluster 87: Intestine & Kidney - Transmembrane transport"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"			"CAB045970: AB_11140529, HPA068778: , HPA071236: "	"unprognostic (4.47e-2)"	"unprognostic (4.47e-2)"	"unprognostic (8.89e-2)"	"unprognostic (3.36e-1)"	"unprognostic (7.25e-2)"	"unprognostic (5.40e-2)"	"unprognostic (2.78e-1)"	"unprognostic (3.54e-2)"	"unprognostic (3.58e-1)"	"unprognostic (4.73e-1)"	"unprognostic (2.36e-1)"	"prognostic unfavorable (1.98e-4)"	"prognostic favorable (1.35e-6)"	"unprognostic (4.68e-2)"	"unprognostic (6.33e-2)"	"prognostic favorable (4.99e-4)"	"unprognostic (1.21e-2)"	13.3	3.1	0.2	5.3	0.2	0.6	8.4	0.1	0.6	10.9	0.1	14.6	107.0	3.6	4.0	3.0	7.4	6.7	3.4	0.2	0.1	94.9	57.2	16.0	5.8	0.2	0.2	3.5	3.5	155.7	0.1	134.1	0.3	107.3	16.9	0.1	84.5	23.5	1.5	5.7	137.9	3.0	0.1	11.2	7.6	1.3	0.8	12.4	5.0	3.9	4.4	5.7	3.5	0.4	0.2	0.2	1.0	0.0	194.4	212.6	0.6	37.7	207.0	10.9	37.2	38.0	1.0	0.0	13.6	71.0	30.2	1.1	0.4	0.0	6.2	12.3	0.0	0.0	0.0	57.1	77.0	0.0	0.0	22.0	0.1	66.3	0.5	9.1	6.6	0.7	0.0	0.0	3.6	0.0	3.6	0.5	2.0	1.3	72.7	0.0	0.0	0.6	263.3	0.0	0.1	0.4	0.0	0.0	0.0	4.4	0.0	0.3	37.0	21.8	1.1	0.7	0.0	0.0	0.0	0.0	22.5	0.0	0.0	0.0	0.0	0.0	6.6	0.0	52.3	0.2	16.2	10.7	1.2	0.0	15.7	6.6	0.4	5.3	0.0	4.0	2.0	4.7	0.2	0.2	0.1	0.6	0.2	0.1	0.2	0.2	0.3	0.1	0.8	0.4	10.8	6.4	26.0	0.3	2.1	4.1	0.4	0.1	0.0	1.8	0.2	0.8	3.3	12.8	2.8	14.7	10.4	140.3	10.4	27.4	1.9	3.0	15.0	2.3	7.1	9.4	55.2	0.4	31.6	0.0	59.1	35.3	2.0	68.0	13.9	5.3	9.3	34.5	14.5	0.0	6.3	16.4	0.0	0.9	7.6	7.9	0.0	4.8	5.4	3.7	1.1	0.0	1.0	2.5	0.7	1.4	23.8	0.0	2.1	32.7	291.1	101.4	2.2	0.1	0.0	2.1	1.5	4.0	1.1	0.1	4.1	172.0	25.8	29.2	29.1	0.3
DPP7	"DPP2, DPPII"	ENSG00000176978	"Dipeptidyl peptidase 7"	Q9UHL4	9	137110546-137115177	"Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"		"Aminopeptidase, Hydrolase, Protease, Serine protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Late spermatids: 997.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"RPMI-8226: 232.0;THP-1: 218.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA021282, CAB025541, HPA059381"	Enhanced		Supported	"Golgi apparatus,Vesicles"	"Secreted - unknown location"	NA	NA		1600000	"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 25: Spermatids - Spermatogenesis"	"Golgi apparatus, Vesicles"		"CAB025541: , HPA021282: AB_1847673, HPA059381: AB_2683999"	"unprognostic (1.15e-1)"	"unprognostic (5.54e-2)"	"prognostic unfavorable (6.07e-6)"	"unprognostic (6.78e-3)"	"unprognostic (1.25e-1)"	"unprognostic (8.33e-2)"	"unprognostic (7.49e-2)"	"unprognostic (6.10e-2)"	"unprognostic (2.28e-2)"	"unprognostic (5.71e-3)"	"prognostic favorable (8.31e-5)"	"unprognostic (7.99e-2)"	"unprognostic (1.46e-2)"	"unprognostic (2.56e-2)"	"unprognostic (1.72e-1)"	"unprognostic (2.15e-1)"	"unprognostic (1.02e-1)"	60.2	98.8	42.1	28.0	43.2	45.8	56.8	43.4	64.9	45.4	83.6	65.3	28.4	46.3	16.7	46.0	53.6	31.3	116.4	43.8	52.0	58.7	70.0	57.3	41.7	53.4	48.0	37.7	82.8	54.3	112.3	26.7	45.7	81.1	7.3	8.0	92.3	46.2	52.8	56.6	51.7	12.8	45.6	79.0	69.4	75.3	48.3	19.8	83.7	21.4	14.4	59.3	48.0	49.2	28.0	43.1	3.5	3.6	51.1	40.5	5.7	42.2	66.2	26.6	17.4	41.0	22.2	56.2	44.4	27.2	1.2	60.3	30.7	8.2	1.3	54.8	2.1	26.4	63.6	1.3	113.5	69.1	135.5	50.0	31.7	11.6	24.1	38.3	35.1	65.8	57.5	41.2	18.0	76.4	35.7	65.7	14.8	99.9	42.8	52.8	0.5	232.0	43.3	30.5	67.7	46.7	47.8	122.6	118.9	0.8	43.5	218.1	44.1	67.4	23.5	43.4	29.5	51.7	31.8	14.9	80.9	41.1	31.1	40.2	194.8	59.2	148.8	176.2	151.8	86.6	131.4	127.9	190.6	83.4	117.1	106.2	12.0	95.0	110.6	276.6	173.6	204.1	42.1	43.2	43.4	64.9	43.8	52.0	53.4	48.0	45.7	45.6	48.3	49.2	80.5	54.5	80.9	54.9	96.8	67.0	103.2	109.2	59.7	74.5	90.3	82.2	66.5	94.4	76.8	53.3	35.5	55.2	129.2	28.2	37.2	121.0	288.7	35.9	40.7	58.2	88.1	35.9	31.4	68.1	115.3	97.2	33.6	47.3	74.3	178.7	64.6	77.1	315.7	121.1	27.9	32.3	107.8	171.7	106.2	997.8	155.4	150.1	167.2	9.4	165.5	123.9	122.6	16.6	26.4	58.2	54.3	169.2	190.2	108.5	97.3	84.9	75.4	83.6	52.6	57.4	58.4	106.2	46.2	47.3	64.9	51.4	115.4	19.0	43.1	90.4
DPP8	"DP8, DPRP1, FLJ14920, FLJ20283, MGC26191, MSTP141"	ENSG00000074603	"Dipeptidyl peptidase 8"	Q6V1X1	15	65442463-65517704	"Enzymes, Plasma proteins, Predicted intracellular proteins"	Apoptosis	"Aminopeptidase, Hydrolase, Protease, Serine protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA008706	Approved		Supported	Cytosol		NA	NA			"Cluster 38: Basophils - Unknown function"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 16: U-266 - Nucleosome"	"Cluster 66: Spermatocytes - Spermatogenesis"	Cytosol		"HPA008706: AB_1078665"	"unprognostic (3.65e-1)"	"unprognostic (2.38e-2)"	"unprognostic (2.15e-1)"	"unprognostic (1.13e-1)"	"unprognostic (1.24e-1)"	"unprognostic (8.60e-2)"	"unprognostic (2.98e-1)"	"unprognostic (2.46e-1)"	"unprognostic (2.52e-2)"	"unprognostic (1.81e-1)"	"unprognostic (4.09e-2)"	"unprognostic (3.60e-2)"	"unprognostic (1.99e-2)"	"unprognostic (1.01e-1)"	"unprognostic (7.58e-2)"	"unprognostic (8.56e-2)"	"unprognostic (2.59e-1)"	12.7	10.2	7.0	12.1	8.5	14.9	11.8	9.3	11.3	11.8	5.5	11.4	14.4	11.7	9.7	10.0	8.3	9.7	14.9	8.3	9.2	12.7	7.9	11.1	12.9	7.3	8.3	10.8	7.4	15.2	5.7	11.2	7.2	10.8	12.9	15.4	9.5	11.5	27.5	9.8	13.5	13.1	8.5	14.8	11.0	26.1	9.7	13.8	14.1	30.6	11.3	11.2	8.3	9.7	14.1	24.4	15.7	15.8	17.4	25.2	12.8	22.5	28.4	21.1	20.3	10.6	12.6	25.1	16.3	30.3	14.5	25.9	30.6	17.6	26.0	20.9	17.2	24.2	18.1	10.4	17.9	34.3	23.8	18.6	18.3	17.0	16.0	18.5	23.2	19.2	16.4	24.1	26.5	12.5	17.1	12.0	9.9	15.7	11.1	22.6	27.9	24.7	19.8	32.7	10.5	17.0	14.3	15.8	25.3	15.6	14.4	22.5	28.6	28.2	19.2	12.7	25.5	26.9	42.2	25.8	21.3	32.8	20.4	30.5	11.7	15.1	12.1	11.7	12.6	11.8	10.0	11.2	10.9	12.2	9.5	10.6	20.9	8.2	15.8	8.6	11.3	7.2	7.0	8.5	9.3	11.3	8.3	9.2	7.3	8.3	7.2	8.5	9.7	9.7	39.1	35.3	27.9	65.6	30.0	13.4	15.0	20.4	15.9	24.1	21.1	14.2	43.4	21.5	25.4	14.7	37.5	20.4	35.3	25.8	23.5	22.7	57.4	17.3	19.3	39.5	25.9	17.9	50.1	30.0	15.2	22.3	31.1	17.5	27.8	24.7	46.1	18.2	21.5	28.6	58.6	27.0	16.2	36.0	15.1	59.7	29.2	31.9	23.2	38.4	47.6	32.3	45.3	36.2	57.1	38.4	25.8	29.3	24.7	19.3	24.2	27.5	25.9	28.1	19.7	29.9	22.1	69.3	24.4	21.9	20.2	17.6	28.5	46.5	26.7	23.6
DPP9		ENSG00000142002	"Dipeptidyl peptidase 9"	Q86TI2	19	4675224-4724673	"Enzymes, Predicted intracellular proteins"		"Aminopeptidase, Hydrolase, Protease, Serine protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HBEC3-KT: 203.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA036059	Approved		Supported	Cytosol		NA	NA			"Cluster 34: Basophils - Unknown function"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 52: Non-specific - Transcription"	Cytosol		"HPA036059: AB_10671240"	"prognostic favorable (4.96e-4)"	"unprognostic (4.16e-2)"	"unprognostic (2.03e-1)"	"prognostic favorable (6.21e-5)"	"unprognostic (5.67e-2)"	"unprognostic (8.30e-2)"	"unprognostic (1.66e-1)"	"unprognostic (1.23e-1)"	"unprognostic (8.85e-2)"	"unprognostic (6.38e-2)"	"unprognostic (1.93e-1)"	"unprognostic (3.39e-2)"	"prognostic unfavorable (3.38e-8)"	"prognostic favorable (7.72e-5)"	"unprognostic (1.55e-1)"	"unprognostic (4.22e-1)"	"unprognostic (1.80e-1)"	19.6	16.2	12.2	24.5	13.8	32.8	19.4	12.9	13.7	20.1	25.0	24.2	20.1	20.3	5.9	24.5	16.3	13.5	32.2	13.2	11.7	16.9	57.2	27.4	24.9	14.8	14.3	17.3	20.6	10.1	12.7	12.9	14.3	18.9	13.8	9.5	17.7	12.8	71.0	23.8	26.3	15.3	12.3	28.4	21.1	9.0	16.1	17.9	16.9	23.0	17.1	23.2	20.2	15.4	77.5	60.4	17.6	27.5	26.2	36.3	31.7	44.3	58.5	73.1	47.4	54.3	58.2	36.5	32.8	57.7	49.1	51.7	35.9	203.9	44.5	47.3	34.8	26.8	33.6	47.2	40.0	47.2	55.8	27.9	46.6	114.4	67.2	62.2	66.8	25.0	37.4	78.3	64.1	21.2	54.2	30.0	36.0	30.4	89.0	34.0	37.4	42.4	38.3	52.5	24.8	22.2	38.2	67.8	29.5	18.1	18.8	38.2	54.5	64.9	28.0	101.6	89.6	54.6	62.3	36.8	63.4	53.7	55.7	10.8	7.1	7.7	10.6	8.3	7.9	8.0	4.7	8.5	7.1	4.8	4.5	7.3	3.7	11.4	6.5	3.3	9.7	7.7	12.2	13.8	12.9	13.7	13.2	11.7	14.8	14.3	14.3	12.3	16.1	15.4	21.8	28.9	25.8	14.4	18.8	7.9	13.6	10.2	10.8	18.6	12.2	12.3	14.6	10.0	11.2	3.7	37.5	11.7	22.7	37.4	3.9	12.4	2.0	12.7	14.6	19.4	12.5	7.6	10.1	12.8	18.3	10.7	36.2	22.8	17.1	13.3	17.2	39.5	19.0	23.5	10.2	21.3	6.1	20.4	17.6	3.9	9.9	22.0	5.4	16.9	42.2	9.0	25.7	7.5	13.7	26.6	28.4	9.4	32.9	15.6	20.1	5.1	9.5	30.8	19.7	21.7	12.4	7.5	6.9	12.4	5.5	15.6	21.2	12.8	20.6	16.7
DPYS	DHPase	ENSG00000147647	Dihydropyrimidinase	Q14117	8	104330324-104467055	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"		Hydrolase	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	39	"kidney: 199.6;liver: 477.6"	"Group enriched"	"Detected in some"	12	"Hepatocytes: 459.5;Proximal tubular cells: 518.8"	"Cancer enriched"	"Detected in some"	5	"liver cancer: 57.6"	"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA024785, HPA070814"	Enhanced					NA	NA		820000		"Cluster 85: Liver - Metabolism"		"Cluster 67: Proximal tubular cells - Tubular reabsorption"			"HPA024785: AB_1847856, HPA070814: "	"unprognostic (1.54e-3)"	"unprognostic (2.33e-1)"		"unprognostic (1.47e-1)"	"unprognostic (2.18e-1)"	"unprognostic (2.69e-1)"	"unprognostic (2.38e-3)"	"unprognostic (4.16e-4)"	"unprognostic (1.56e-1)"	"unprognostic (3.53e-2)"	"unprognostic (3.85e-3)"	"unprognostic (2.43e-1)"	"unprognostic (4.81e-2)"	"unprognostic (9.56e-3)"	"unprognostic (2.72e-1)"	"unprognostic (2.02e-1)"	"unprognostic (1.86e-1)"	8.6	2.8	0.6	0.1	0.6	0.0	0.4	0.2	1.7	1.2	0.2	0.2	0.0	0.1	0.6	0.1	0.7	6.5	0.1	0.6	0.5	199.6	477.6	0.6	0.3	0.5	0.7	0.2	0.1	0.6	0.2	0.6	0.6	4.4	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.0	0.3	0.3	0.1	0.9	1.2	5.1	0.0	0.0	0.0	0.2	0.1	0.5	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.3	0.2	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.1	0.3	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.5	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.6	0.2	1.7	0.6	0.5	0.5	0.7	0.6	0.3	1.2	0.5	0.1	0.0	0.0	1.0	4.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	40.0	0.0	20.2	0.0	0.0	0.0	0.0	27.4	0.1	12.8	0.3	0.1	1.0	0.0	16.0	11.2	0.0	0.0	1.8	0.0	0.3	0.0	0.4	11.7	459.5	1.4	0.0	4.6	0.0	0.0	11.1	0.3	13.5	0.9	10.6	0.0	14.0	0.4	0.5	0.0	0.0	0.1	0.1	0.0	0.0	0.0	2.7	0.0	518.8	0.0	0.1	0.0	0.0	0.0	1.2	1.7	0.0	0.0	0.0	2.7	0.0	0.0	0.0
DQX1	FLJ23757	ENSG00000144045	"DEAQ-box RNA dependent ATPase 1"	Q8TE96	2	74518131-74526281	"Enzymes, Predicted intracellular proteins"		"Helicase, Hydrolase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	5	"intestine: 16.4"	"Cell type enhanced"	"Detected in some"		"Distal enterocytes: 17.3;Gastric mucus-secreting cells: 13.7;Intestinal goblet cells: 17.3;Paneth cells: 13.9;Proximal enterocytes: 44.2;Undifferentiated cells: 12.5"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"HBEC3-KT: 5.8;Hep G2: 18.4;hTCEpi: 6.1;OE19: 15.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA039158, HPA046763"	Enhanced		Approved	"Nucleoli fibrillar center"		NA	NA				"Cluster 9: Intestine - Unknown function"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 45: Enterocytes - Digestion"	"Nucleoli fibrillar center"		"HPA039158: AB_10960125, HPA046763: "	"unprognostic (2.17e-1)"	"unprognostic (1.43e-1)"	"unprognostic (1.20e-2)"	"unprognostic (9.95e-2)"	"unprognostic (2.20e-1)"	"unprognostic (1.18e-1)"	"unprognostic (6.49e-2)"	"unprognostic (3.93e-1)"	"unprognostic (4.54e-2)"	"unprognostic (1.68e-1)"	"unprognostic (7.67e-2)"	"unprognostic (2.21e-2)"	"unprognostic (0.00e+0)"	"unprognostic (1.13e-2)"	"unprognostic (1.36e-1)"	"unprognostic (1.29e-1)"	"unprognostic (6.16e-3)"	0.0	0.0	0.1	0.6	0.1	0.0	0.1	0.0	0.2	0.4	0.0	6.3	16.4	0.0	0.0	1.6	0.0	0.2	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.0	0.0	0.0	0.4	0.2	0.0	5.6	0.0	0.4	0.0	0.0	1.1	13.9	0.5	0.0	0.1	3.2	0.0	0.1	0.0	0.0	0.0	1.0	0.8	0.6	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.1	0.0	0.0	0.0	0.4	0.0	0.3	0.0	0.0	0.0	0.6	0.1	5.8	0.1	0.0	0.0	0.5	0.2	18.4	0.0	0.2	0.0	0.0	6.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.3	15.5	0.0	0.0	0.0	0.1	0.0	1.1	0.0	0.1	0.0	2.4	0.0	0.9	0.5	0.0	0.0	0.3	0.1	0.0	0.0	0.1	0.2	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.0	0.2	0.1	0.1	0.1	0.1	0.2	0.0	0.1	0.1	0.0	0.0	0.0	0.7	0.5	0.5	0.1	4.5	4.6	0.4	0.1	0.0	0.3	1.5	3.5	0.0	2.1	1.6	0.0	17.3	0.0	0.0	0.0	0.2	0.1	0.0	2.4	0.0	0.6	0.0	0.8	0.6	13.7	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.3	17.3	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.1	0.1	13.9	0.0	0.4	0.0	44.2	0.0	5.0	0.9	0.0	0.1	0.1	0.6	0.3	3.1	0.0	1.1	0.1	0.0	12.5	0.2
DROSHA	"Etohi2, HSA242976, RN3, RNASE3L, RNASEN"	ENSG00000113360	"Drosha ribonuclease III"	Q9NRR4	5	31400494-31532196	"Cancer-related genes, Enzymes, Predicted intracellular proteins"	"Ribosome biogenesis, RNA-mediated gene silencing"	"Endonuclease, Hydrolase, Nuclease, RNA-binding"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Oligodendrocyte precursor cells: 74.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA031150			Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 34: Non-specific - Transcription"	"Cluster 20: HeLa - Mitochondria"	"Cluster 68: Oligodendrocytes - Mixed function"	Nucleoplasm	Cytosol	"HPA031150: AB_2673761"	"unprognostic (8.37e-3)"	"unprognostic (1.81e-1)"	"unprognostic (9.56e-2)"	"prognostic unfavorable (6.79e-4)"	"unprognostic (5.40e-2)"	"unprognostic (6.03e-2)"	"prognostic unfavorable (1.39e-4)"	"unprognostic (3.11e-1)"	"unprognostic (4.08e-2)"	"unprognostic (9.08e-2)"	"unprognostic (1.86e-1)"	"unprognostic (5.43e-2)"	"unprognostic (1.12e-1)"	"unprognostic (1.74e-1)"	"unprognostic (2.39e-1)"	"unprognostic (6.94e-2)"	"unprognostic (2.32e-2)"	12.3	11.3	2.6	15.9	3.8	11.6	11.5	9.4	8.0	13.3	4.2	13.8	13.6	15.9	20.4	11.4	14.5	11.7	13.0	2.0	8.1	12.3	9.7	10.9	16.0	1.1	2.9	20.5	14.4	15.2	4.5	13.8	2.3	13.6	15.6	27.2	12.5	13.2	22.2	13.5	12.2	13.8	0.2	12.5	13.2	11.1	5.2	24.5	15.5	19.6	17.1	12.2	3.9	4.9	38.7	47.3	51.8	70.8	27.0	32.8	74.2	50.0	24.4	45.6	33.9	50.6	49.0	43.3	55.9	36.9	52.7	33.0	63.5	37.8	50.4	40.9	44.6	52.9	157.8	37.0	24.3	59.2	151.6	25.8	26.0	50.7	24.2	34.6	39.5	45.3	68.9	19.7	40.5	38.5	58.3	44.8	49.1	31.2	37.9	52.2	98.9	31.1	25.7	43.2	26.9	35.6	127.1	51.4	30.0	46.0	47.4	34.1	33.9	43.7	50.3	39.0	48.0	35.8	63.5	47.1	30.3	65.9	42.9	0.9	1.2	1.5	2.2	1.3	2.4	1.8	2.4	2.7	2.5	2.0	2.7	2.0	0.3	2.5	2.5	3.0	2.5	1.6	2.6	3.8	9.4	8.0	2.0	8.1	1.1	2.9	2.3	0.2	5.2	4.9	6.2	12.8	14.3	45.4	7.1	3.6	5.0	7.0	10.8	19.4	7.1	6.0	23.4	5.7	12.8	5.5	0.0	8.5	11.4	12.9	3.9	7.8	3.5	12.3	11.6	9.0	11.4	8.0	43.4	8.1	7.6	12.7	8.6	13.6	9.5	20.4	10.0	7.2	7.8	6.7	45.8	8.5	14.2	6.3	3.0	8.2	10.8	6.0	1.8	34.7	8.4	10.2	9.2	74.9	43.9	9.3	10.2	13.2	8.8	6.1	7.3	5.1	16.8	18.8	6.6	10.4	11.6	7.1	10.9	8.8	3.4	4.9	8.3	13.9	11.7	5.9
DTD1	"bA379J5.3, bA555E18.1, C20orf88, DUEB, HARS2, MGC119131, MGC41905, pqn-68"	ENSG00000125821	"D-aminoacyl-tRNA deacylase 1"	Q8TEA8	20	18587942-18766644	"Enzymes, Predicted intracellular proteins"	"DNA replication"	"DNA-binding, Hydrolase, RNA-binding, tRNA-binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA040981	Uncertain		Uncertain	Nucleoli,Cytosol		NA	NA		350000	"Cluster 41: Basophils - Cellular respiration"	"Cluster 72: Non-specific - Transcription"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 7: Non-specific - Mitochondria"	"Nucleoli, Cytosol"		"HPA040981: AB_10673268"	"unprognostic (3.32e-1)"	"unprognostic (1.05e-1)"	"unprognostic (1.82e-1)"	"unprognostic (5.94e-2)"	"unprognostic (1.83e-1)"	"unprognostic (2.90e-1)"	"unprognostic (1.27e-3)"	"unprognostic (9.67e-2)"	"unprognostic (1.72e-1)"	"unprognostic (1.81e-1)"	"unprognostic (6.84e-2)"	"unprognostic (1.32e-1)"	"unprognostic (9.09e-3)"	"unprognostic (2.42e-1)"	"unprognostic (8.44e-2)"	"unprognostic (2.59e-2)"	"unprognostic (8.53e-2)"	23.5	21.1	7.0	3.7	7.0	4.5	21.5	7.2	7.6	18.9	7.1	15.6	2.7	19.7	4.8	26.6	18.6	3.2	17.5	7.1	7.6	25.6	10.8	16.0	4.1	7.3	6.9	17.6	20.4	7.7	33.8	3.4	7.4	13.7	4.2	6.6	21.9	3.1	29.1	27.4	13.7	4.0	7.2	15.3	16.2	19.1	7.3	2.1	19.3	6.7	4.5	17.1	19.4	7.3	10.1	15.7	15.8	16.2	8.8	12.2	9.1	4.3	12.3	10.5	11.3	10.0	11.4	0.1	4.1	13.6	13.9	5.3	13.1	25.0	10.4	6.8	3.2	10.2	4.0	18.7	22.8	9.4	8.2	10.2	22.4	11.8	42.1	8.7	16.5	3.0	7.0	22.5	15.3	24.9	1.7	23.8	11.0	13.5	9.9	0.0	16.6	11.1	16.6	8.2	16.6	13.0	4.4	20.4	23.6	7.1	12.3	9.2	10.2	14.3	3.8	17.7	14.5	5.5	10.2	4.6	8.6	13.9	11.1	1.7	0.7	0.4	1.8	1.0	0.8	1.1	0.6	1.0	1.5	0.7	0.5	0.5	0.9	1.4	1.0	0.2	0.4	0.6	7.0	7.0	7.2	7.6	7.1	7.6	7.3	6.9	7.4	7.2	7.3	7.3	35.5	35.3	24.0	32.0	26.8	23.6	40.9	48.3	22.2	42.4	27.9	33.0	18.8	28.6	23.1	42.3	2.1	26.7	24.7	9.9	43.0	71.9	38.4	16.2	33.1	36.4	23.3	22.1	41.9	87.4	37.8	29.9	13.7	17.8	42.5	24.6	35.7	11.2	47.8	43.7	60.6	23.5	28.5	23.5	35.9	21.8	18.0	27.1	42.7	12.2	42.8	58.2	38.1	53.3	52.2	90.6	19.1	19.5	24.6	50.6	9.3	73.8	22.8	34.9	0.0	30.1	27.5	93.5	124.2	33.2	35.7	12.4	35.5	42.7	26.8	31.9
DTD2	"C14orf126, MGC9912"	ENSG00000129480	"D-aminoacyl-tRNA deacylase 2"	Q96FN9	14	31446036-31457506	"Enzymes, Predicted intracellular proteins"		"Hydrolase, RNA-binding, tRNA-binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Oligodendrocyte precursor cells: 35.2;Oligodendrocytes: 40.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA001117	Approved		Approved	Vesicles		NA	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 68: Epididymis - Unknown function"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	Vesicles		"HPA001117: AB_2666204"	"unprognostic (2.56e-3)"	"unprognostic (9.38e-2)"	"unprognostic (1.27e-3)"	"unprognostic (3.24e-2)"	"unprognostic (8.45e-2)"	"prognostic unfavorable (9.33e-4)"	"unprognostic (3.04e-2)"	"unprognostic (1.64e-1)"	"unprognostic (8.74e-3)"	"unprognostic (2.91e-1)"	"unprognostic (5.28e-2)"	"unprognostic (6.96e-2)"	"unprognostic (1.24e-1)"	"unprognostic (2.32e-1)"	"unprognostic (3.06e-2)"	"unprognostic (1.22e-2)"	"prognostic unfavorable (5.74e-6)"	8.6	6.3	4.7	4.9	6.8	2.3	7.1	5.2	6.5	4.0	5.2	4.8	3.9	5.2	5.0	5.7	4.9	3.5	3.1	5.3	5.3	5.8	8.1	5.8	5.5	5.5	5.9	5.3	6.3	6.1	4.4	4.3	5.9	5.7	5.4	5.0	6.0	3.9	1.6	5.6	3.7	5.5	4.9	4.9	4.0	4.0	6.2	5.0	6.2	1.6	5.5	4.7	3.8	8.1	11.4	9.5	8.1	10.6	14.6	12.3	5.5	10.3	10.0	8.0	7.1	5.2	10.7	21.6	6.8	11.8	8.6	10.8	13.0	11.6	13.6	11.7	5.7	6.2	6.5	29.0	15.7	12.6	7.3	14.0	12.9	7.1	15.9	6.7	11.8	12.8	12.3	9.9	10.7	13.7	18.3	11.3	11.0	19.6	9.7	12.3	6.0	11.3	15.0	9.8	12.1	8.0	16.8	21.6	12.4	6.9	19.8	6.5	8.6	8.7	7.7	7.1	9.1	12.3	24.5	20.7	3.8	11.4	14.3	2.5	2.6	1.0	2.0	2.2	2.9	2.7	3.0	2.2	3.7	3.2	4.5	3.0	1.5	3.7	1.2	2.2	1.6	2.8	4.7	6.8	5.2	6.5	5.3	5.3	5.5	5.9	5.9	4.9	6.2	8.1	2.9	9.6	9.0	10.1	7.6	5.2	5.7	5.1	13.1	5.9	6.1	4.3	4.8	15.7	4.9	3.7	8.4	9.1	4.9	3.3	3.9	5.7	4.4	6.8	7.2	3.8	3.0	8.0	9.2	6.2	6.3	6.2	5.1	3.0	1.3	5.9	3.9	11.6	5.1	5.0	12.7	6.7	14.2	5.5	3.7	6.6	7.5	4.0	3.6	2.8	4.8	9.5	7.2	35.2	40.2	5.2	3.9	8.2	7.1	6.0	3.3	9.7	6.2	9.2	0.0	7.4	6.8	10.1	2.7	16.2	5.4	2.7	5.4	10.3	7.2	4.2
DUSP1	"CL100, HVH1, MKP-1, PTPN10"	ENSG00000120129	"Dual specificity phosphatase 1"	P28562	5	172768096-172771195	"Cancer-related genes, Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Cell cycle, Stress response"	"Hydrolase, Protein phosphatase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Langerhans cells: 2357.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in all"	5	"neutrophil: 7426.8"	"Lineage enriched"	"Detected in all"	9	"granulocytes: 7426.8"	"Cell line enhanced"	"Detected in all"		"HHSteC: 201.0;hTCEpi: 359.3;REH: 202.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA069577			Approved	Nucleoli,Cytosol		NA	Yes			"Cluster 50: Neutrophils - Cellular senescence"	"Cluster 31: Skin - Epidermis development"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 41: Macrophages - Immune response"	Nucleoli	Cytosol	"HPA069577: AB_2686156"	"unprognostic (1.51e-1)"	"unprognostic (1.24e-1)"	"unprognostic (9.73e-2)"	"unprognostic (8.17e-2)"	"unprognostic (4.64e-1)"	"unprognostic (1.58e-3)"	"unprognostic (4.18e-2)"	"unprognostic (6.94e-2)"	"unprognostic (3.11e-1)"	"unprognostic (1.43e-2)"	"unprognostic (2.23e-1)"	"unprognostic (1.51e-2)"	"unprognostic (2.76e-2)"	"prognostic unfavorable (3.11e-5)"	"unprognostic (2.69e-1)"	"unprognostic (2.35e-2)"	"unprognostic (1.41e-3)"	922.6	515.4	84.9	364.9	85.8	692.4	586.1	134.8	121.1	501.3	134.7	336.1	66.0	382.3	42.0	526.6	677.4	570.5	395.3	79.4	114.6	281.2	721.3	719.9	178.6	132.0	90.3	541.2	240.1	116.5	319.5	297.3	104.1	438.5	228.5	202.7	350.3	356.9	251.8	1054.1	170.3	452.7	123.7	304.7	396.0	68.1	115.4	131.3	612.9	451.3	56.2	778.1	610.0	121.2	10.7	26.5	8.2	11.5	175.6	102.2	14.0	170.3	49.3	111.9	45.0	29.2	12.4	3.5	48.6	120.4	128.1	4.7	8.1	42.3	52.1	95.8	22.4	2.3	63.1	12.6	201.0	1.2	3.8	98.1	359.3	50.9	82.1	58.2	35.6	7.4	9.0	66.1	73.1	12.6	5.7	5.0	7.4	8.2	7.7	202.2	15.3	32.3	80.2	5.4	35.5	14.9	46.2	76.9	6.3	34.1	6.7	1.9	94.1	79.1	39.8	77.8	13.4	13.6	8.4	3.1	70.3	1.8	3.3	931.4	584.5	1640.7	85.0	589.2	212.6	57.6	75.6	88.6	263.4	54.1	35.9	40.7	7426.8	114.5	791.6	14.3	68.1	409.9	84.9	85.8	134.8	121.1	79.4	114.6	132.0	90.3	104.1	123.7	115.4	121.2	1856.5	410.3	341.0	23.8	918.4	1279.8	1140.5	456.9	1810.4	73.0	464.2	567.7	211.3	739.2	243.1	211.5	27.1	316.2	618.9	633.7	56.7	335.9	71.6	531.6	990.9	870.4	715.5	193.5	11.9	88.7	407.2	1367.4	597.3	1013.7	301.1	175.8	781.4	345.7	1043.0	48.8	13.4	891.8	207.5	1525.5	2357.3	40.3	384.9	1965.5	542.5	66.5	173.3	1159.3	33.0	6.6	4.1	226.3	683.3	311.1	952.2	685.7	736.1	35.5	218.0	190.5	769.2	720.7	671.9	12.9	24.6	1996.9	1956.6	582.0	1015.2	223.4	415.8	676.6
DUSP10	"MKP-5, MKP5"	ENSG00000143507	"Dual specificity phosphatase 10"	Q9Y6W6	1	221701424-221742089	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Hydrolase, Protein phosphatase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 32.9"	"Cell type enhanced"	"Detected in many"		"granulocytes: 133.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"NK-cell: 19.7"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HaCaT: 102.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA016758	Approved		Supported	"Nucleoplasm,Golgi apparatus,Cytosol"		No	No			"Cluster 15: NK-cells - Transcription"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 24: Non-specific - Transcription regulation"	Nucleoplasm	"Golgi apparatus, Cytosol"	"HPA016758: AB_1847880"	"unprognostic (1.55e-1)"	"unprognostic (2.73e-1)"	"unprognostic (1.44e-1)"	"unprognostic (6.65e-2)"	"unprognostic (3.83e-2)"	"unprognostic (2.85e-3)"	"prognostic favorable (5.42e-4)"	"unprognostic (2.89e-1)"	"unprognostic (3.89e-2)"	"unprognostic (9.68e-2)"	"unprognostic (2.38e-2)"	"unprognostic (1.05e-1)"	"prognostic unfavorable (3.69e-4)"	"unprognostic (4.18e-2)"	"unprognostic (2.57e-1)"	"unprognostic (8.88e-3)"	"unprognostic (1.97e-2)"	3.8	2.4	4.3	5.2	7.4	25.0	6.0	7.7	5.3	4.5	4.7	8.0	1.4	3.6	1.2	6.0	6.4	6.6	2.6	4.5	4.5	1.4	32.9	6.2	9.1	7.1	6.0	1.6	17.0	1.2	1.2	3.8	5.8	2.7	4.1	14.9	6.3	0.9	22.9	6.1	3.9	8.9	3.8	6.1	2.5	3.1	9.0	5.6	4.4	3.6	7.6	6.1	2.7	13.5	15.2	6.4	0.5	0.4	45.4	22.6	0.5	10.1	25.9	16.2	12.5	0.3	4.2	11.6	3.3	26.1	11.9	102.3	2.2	9.8	14.0	30.5	1.2	20.4	3.0	1.8	10.6	9.1	13.3	31.9	7.0	17.6	17.8	7.5	0.6	3.0	2.1	4.0	16.0	0.3	1.8	7.2	1.5	3.2	0.7	1.1	28.5	0.9	5.7	9.1	37.4	3.0	1.3	1.2	43.6	5.6	2.1	5.5	3.6	8.1	2.2	12.6	12.4	6.8	5.1	6.2	12.8	4.1	8.9	8.2	5.5	0.3	4.5	4.6	3.9	0.8	2.9	3.1	7.0	0.9	1.0	1.7	0.5	19.7	1.9	0.2	16.9	2.2	4.3	7.4	7.7	5.3	4.5	4.5	7.1	6.0	5.8	3.8	9.0	13.5	4.9	0.0	1.7	2.6	21.7	50.9	13.5	13.6	25.6	6.0	42.4	18.7	4.7	14.3	19.2	3.7	20.9	2.8	39.0	3.1	0.0	35.9	61.1	57.9	6.6	6.7	43.9	2.5	0.3	9.1	3.7	7.9	4.6	53.7	133.5	0.2	1.8	53.6	22.3	1.7	30.9	17.7	69.2	9.7	46.9	7.1	24.8	26.0	23.2	2.8	14.1	14.3	17.5	17.1	50.5	26.2	0.8	12.8	9.9	11.0	0.4	1.1	18.5	34.2	0.0	33.7	5.3	9.7	3.2	16.7	41.3	3.4	47.0	28.7	3.6	16.5
DUSP12	"DUSP1, YVH1"	ENSG00000081721	"Dual specificity phosphatase 12"	Q9UNI6	1	161749758-161757238	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Hydrolase, Protein phosphatase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA008840	Uncertain		Supported	Nucleoplasm		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 10: Non-specific - Unknown function"	Nucleoplasm		"HPA008840: AB_1847884"	"unprognostic (3.51e-2)"	"unprognostic (2.62e-1)"	"unprognostic (1.05e-1)"	"unprognostic (2.01e-2)"	"unprognostic (2.11e-1)"	"unprognostic (4.04e-2)"	"prognostic unfavorable (1.99e-5)"	"unprognostic (1.86e-1)"	"unprognostic (1.06e-2)"	"unprognostic (2.25e-3)"	"unprognostic (9.52e-2)"	"unprognostic (2.42e-3)"	"prognostic unfavorable (1.55e-7)"	"unprognostic (1.17e-1)"	"unprognostic (1.84e-1)"	"unprognostic (3.25e-2)"	"unprognostic (2.42e-1)"	13.3	9.6	12.1	9.1	12.5	30.9	14.1	14.3	14.6	13.8	12.1	12.9	7.6	14.3	8.9	10.3	12.5	6.7	9.4	12.0	12.4	14.4	9.4	11.4	13.8	12.2	12.2	13.6	13.6	8.2	9.5	11.2	12.3	11.0	10.5	13.2	10.9	9.5	7.4	10.9	12.4	11.0	12.3	14.1	11.5	6.7	12.0	11.7	12.1	7.3	13.0	13.1	11.5	13.3	32.6	28.2	33.1	21.7	17.2	18.5	30.4	25.9	33.7	39.2	29.9	42.1	28.2	19.9	25.7	31.9	24.4	22.7	26.0	32.0	38.0	25.5	22.0	17.8	27.7	28.4	36.4	38.6	17.1	25.4	34.6	34.1	61.0	22.2	27.6	27.2	31.7	20.9	28.3	30.0	22.7	43.2	52.1	35.2	43.1	32.2	32.0	32.9	22.2	39.3	20.6	43.6	21.9	36.2	44.1	36.2	31.3	43.6	19.3	33.3	30.8	26.3	55.6	35.3	31.0	47.0	20.3	38.1	33.3	32.0	16.9	13.7	18.4	19.5	22.9	19.2	20.8	17.8	22.0	20.0	19.6	21.8	6.8	28.4	12.2	10.0	19.5	12.9	12.1	12.5	14.3	14.6	12.0	12.4	12.2	12.2	12.3	12.3	12.0	13.3	22.9	19.2	12.8	8.1	25.5	13.6	14.4	25.9	25.6	15.9	13.4	16.1	5.0	8.6	15.6	7.3	8.4	21.7	26.4	4.8	21.5	22.2	4.2	7.4	13.7	18.4	11.3	16.2	11.9	24.3	22.7	17.3	11.7	7.2	18.3	18.7	18.5	8.2	20.5	10.1	14.8	9.8	8.2	20.6	16.2	1.2	8.7	15.4	10.6	10.3	22.1	15.8	33.0	12.1	14.4	21.2	6.5	17.7	27.5	17.1	8.6	18.5	7.0	19.6	0.0	13.2	24.5	13.9	12.6	18.2	13.1	17.6	23.5	16.4	12.1	12.0
DUSP13	"BEDP, DUSP13A, DUSP13B, FLJ32450, TMDP"	ENSG00000079393	"Dual specificity phosphatase 13"	"Q6B8I1, Q9UII6"	10	75094432-75109221	"Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins"		"Hydrolase, Protein phosphatase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"skeletal muscle: 247.2;testis: 53.7;tongue: 122.5"	"Cell type enriched"	"Detected in some"	4	"Early spermatids: 428.1"	"Cancer enhanced"	"Detected in some"		"head and neck cancer: 1.0"	"Low region specificity"	"Detected in single"			"Immune cell enriched"	"Detected in single"	10	"neutrophil: 1.0"	"Lineage enriched"	"Detected in single"	10	"granulocytes: 1.0"	"Cell line enhanced"	"Detected in some"		"BEWO: 4.3;EFO-21: 5.0;Hep G2: 11.0;K-562: 4.3;LHCN-M2: 9.5;RH-30: 8.0"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"									NA	NA			"Cluster 9: Neutrophils - Innate immune response"	"Cluster 33: Striated muscle - Muscle contraction"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 34: Spermatids - Unknown function"				"unprognostic (1.79e-1)"	"unprognostic (2.39e-2)"		"unprognostic (2.39e-1)"	"unprognostic (7.07e-2)"	"unprognostic (1.66e-3)"	"unprognostic (2.47e-3)"	"unprognostic (8.63e-2)"	"unprognostic (1.97e-1)"	"unprognostic (2.63e-2)"	"unprognostic (1.27e-1)"	"unprognostic (3.92e-1)"	"unprognostic (2.22e-7)"	"unprognostic (1.93e-2)"	"unprognostic (1.54e-1)"	"unprognostic (4.81e-1)"	"unprognostic (2.09e-2)"	0.1	0.0	0.1	0.0	0.1	5.8	0.1	0.1	0.3	0.3	0.1	0.0	0.0	0.0	0.3	3.7	0.1	0.0	17.3	0.1	0.5	0.1	0.1	0.3	0.0	0.2	0.7	0.0	0.0	0.2	0.1	0.0	1.3	1.0	0.0	0.0	3.5	0.0	247.2	0.5	0.0	0.0	0.1	0.5	0.0	53.7	0.1	0.2	0.1	122.5	0.0	0.0	0.3	0.2	0.0	0.0	0.1	0.0	0.0	0.0	4.3	0.0	0.0	0.0	0.0	1.0	0.0	0.0	5.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	11.0	0.0	0.0	0.0	0.9	0.9	0.0	0.0	0.0	0.0	0.0	4.3	0.0	9.5	0.5	0.0	0.0	0.6	0.1	0.0	0.0	8.0	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.2	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.3	0.1	0.5	0.2	0.7	1.3	0.1	0.1	0.2	0.0	0.0	0.0	0.0	0.0	1.7	0.3	1.1	3.4	0.0	0.0	0.1	12.2	0.0	0.1	0.0	0.0	2.1	0.0	0.0	0.0	0.0	428.1	0.0	0.0	0.6	0.0	0.0	0.1	0.2	1.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	94.0	0.9	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	1.9	0.1	0.1	0.0	0.0	0.2	0.0	0.0	21.7	0.6	10.4	3.3	6.3	2.0	3.0	0.1	0.0	0.0	0.2
DUSP14	"MKP-L, MKP6"	ENSG00000276023	"Dual specificity phosphatase 14"	O95147	17	37489891-37513501	"Cancer-related genes, Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"		"Hydrolase, Protein phosphatase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"skin 1: 44.1"	"Cell type enhanced"	"Detected in many"		"Basal keratinocytes: 179.7;Basal prostatic cells: 239.3;Cytotrophoblasts: 162.8;Endometrial ciliated cells: 146.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"neutrophil: 1.6"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"HBF TERT88: 36.4;SuSa: 24.9;WM-115: 37.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA019911	Approved		Approved	Nucleoplasm,Cytosol		NA	Yes		79000	"Cluster 33: Neutrophils - Chromatin organization"	"Cluster 27: Brain & Skin - Unknown function"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 22: Epithelial cell types - Mixed function"	"Nucleoplasm, Cytosol"		"HPA019911: AB_1847888"	"unprognostic (1.32e-1)"	"unprognostic (3.06e-1)"	"unprognostic (2.19e-2)"	"unprognostic (1.57e-1)"	"unprognostic (4.60e-1)"	"unprognostic (3.22e-2)"	"unprognostic (3.43e-3)"	"unprognostic (2.02e-3)"	"unprognostic (2.18e-1)"	"unprognostic (2.59e-1)"	"unprognostic (7.02e-3)"	"unprognostic (3.81e-1)"	"prognostic unfavorable (6.97e-9)"	"unprognostic (7.93e-2)"	"unprognostic (1.97e-1)"	"unprognostic (1.73e-1)"	"unprognostic (1.41e-3)"	15.3	14.2	10.9	1.3	11.2	0.3	12.4	11.2	17.0	12.8	10.9	10.3	0.0	9.5	5.5	17.4	7.5	1.2	14.1	11.0	10.9	8.7	15.2	8.6	0.4	11.9	11.1	5.6	6.6	1.0	14.5	0.9	10.6	6.4	1.0	9.9	13.1	0.3	11.0	44.1	5.5	0.8	10.4	2.8	7.6	13.7	10.8	4.4	23.1	4.4	2.7	7.2	17.1	10.7	2.6	0.2	4.9	2.1	0.1	0.6	2.1	10.4	7.8	14.3	15.6	1.2	17.9	0.2	0.9	7.6	0.2	2.8	0.2	6.1	36.4	0.2	0.7	0.0	1.6	6.2	1.5	0.5	3.0	8.5	5.5	4.8	2.5	10.2	0.3	0.2	0.6	3.1	11.4	0.4	9.7	1.7	0.3	3.8	0.0	2.5	0.6	2.5	17.5	2.4	1.9	0.3	0.5	17.6	4.1	24.9	0.8	3.9	1.4	10.8	5.8	0.1	5.8	0.1	0.3	0.1	0.1	0.0	37.5	1.1	0.0	0.7	0.1	0.1	0.1	0.2	0.0	0.0	0.0	0.0	0.1	0.7	1.6	0.0	0.2	0.0	0.0	0.2	10.9	11.2	11.2	17.0	11.0	10.9	11.9	11.1	10.6	10.4	10.8	10.7	15.0	6.4	5.4	2.9	8.3	179.7	239.3	74.8	129.1	6.8	42.6	46.0	15.0	4.3	39.6	7.3	8.4	162.8	16.6	0.3	29.4	34.8	36.4	146.9	18.5	21.7	2.4	11.4	12.0	15.1	82.1	30.2	3.1	85.3	87.0	10.6	14.6	15.7	19.7	15.2	5.3	1.2	36.7	2.8	34.8	52.5	13.7	5.9	62.2	4.7	25.3	16.1	15.5	3.0	3.3	74.8	2.9	6.0	9.9	64.9	0.1	16.9	61.3	24.5	0.0	13.2	45.2	26.0	33.4	44.0	92.6	67.9	18.2	26.3	1.1	67.0
DUSP15	"bA243J16.5, bA243J16.6, C20orf57, FLJ20645, VHY"	ENSG00000149599	"Dual specificity phosphatase 15"	Q9H1R2	20	31847637-31870747	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Hydrolase, Protein phosphatase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"testis: 210.5"	"Group enriched"	"Detected in many"	4	"Distal tubular cells: 273.9;Early spermatids: 288.8;Late spermatids: 979.4"	"Cancer enhanced"	"Detected in many"		"renal cancer: 6.2"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"CACO-2: 4.8;REH: 16.0;SH-SY5Y: 4.3;SK-MEL-30: 4.0;U-2 OS: 3.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA076649	Enhanced		Approved	"Plasma membrane,Cytosol"		NA	NA				"Cluster 43: Testis - Unknown function"	"Cluster 14: REH - Unknown function"	"Cluster 25: Spermatids - Spermatogenesis"	"Plasma membrane, Cytosol"		"HPA076649: AB_2686811"	"unprognostic (3.84e-2)"	"unprognostic (2.30e-1)"	"unprognostic (2.28e-1)"	"unprognostic (9.01e-3)"	"unprognostic (3.88e-2)"	"unprognostic (2.36e-1)"	"unprognostic (1.47e-2)"	"unprognostic (2.24e-2)"	"unprognostic (1.43e-1)"	"unprognostic (1.76e-1)"	"unprognostic (1.48e-5)"	"unprognostic (7.31e-2)"	"prognostic favorable (5.40e-7)"	"unprognostic (2.79e-2)"	"unprognostic (1.93e-1)"	"unprognostic (3.11e-3)"	"unprognostic (2.55e-1)"	1.7	5.9	5.3	0.2	7.6	0.1	3.4	10.7	7.5	5.9	4.9	1.8	0.5	3.4	9.0	1.0	1.5	0.7	7.8	4.8	7.7	50.0	0.7	1.6	0.6	17.1	8.7	5.2	2.4	13.0	8.7	0.7	8.1	6.6	0.1	0.6	2.1	3.0	0.9	1.2	1.5	0.3	7.8	2.7	2.3	210.5	7.6	0.3	9.6	0.3	0.2	2.5	2.7	8.8	0.2	0.2	0.1	1.4	0.0	0.3	0.0	0.0	0.0	0.7	0.0	4.8	0.1	1.0	1.9	0.2	2.6	0.0	0.3	0.0	0.0	0.0	0.5	0.4	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.3	0.0	3.4	0.6	0.0	0.0	16.0	1.8	0.1	0.0	0.0	2.1	4.3	2.6	0.0	4.0	0.1	1.1	0.9	0.0	0.0	3.6	0.0	0.0	1.6	0.0	0.0	0.0	0.6	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.3	7.6	10.7	7.5	4.8	7.7	17.1	8.7	8.1	7.8	7.6	8.8	2.9	0.0	0.0	1.3	0.8	0.6	1.3	0.0	0.0	0.6	3.6	4.4	2.5	1.5	0.0	18.4	4.2	0.0	0.4	0.1	273.9	2.4	288.8	0.6	4.0	2.2	1.8	0.0	1.7	1.0	0.1	2.9	1.5	0.6	0.0	7.0	1.8	0.1	0.6	6.7	2.6	0.4	0.0	0.6	1.9	979.4	8.7	1.2	7.2	0.0	0.6	2.9	0.0	3.0	4.7	0.6	0.0	10.9	0.0	0.9	0.0	55.3	0.1	0.3	0.0	2.5	3.3	121.5	6.0	0.3	0.1	0.1	0.3	7.5	0.7	0.4
DUSP16	"KIAA1700, MKP-7, MKP7"	ENSG00000111266	"Dual specificity phosphatase 16"	Q9BY84	12	12473282-12562863	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Hydrolase, Protein phosphatase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Granulosa cells: 114.9;Oligodendrocytes: 196.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"T-reg: 3.9"	"Lineage enriched"	"Detected in single"	5	"T-cells: 3.9"	"Cell line enhanced"	"Detected in many"		"NTERA-2: 37.7;RT4: 34.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA020326	Approved		Supported	Nucleoplasm		NA	NA			"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 5: NTERA-2 - Transcription"	"Cluster 40: Granulosa cells - Unknown function"	Nucleoplasm		"HPA020326: AB_1847890"	"unprognostic (8.05e-2)"	"unprognostic (9.47e-2)"	"unprognostic (1.49e-3)"	"unprognostic (4.14e-2)"	"unprognostic (9.86e-2)"	"prognostic favorable (1.01e-4)"	"unprognostic (1.75e-2)"	"unprognostic (3.52e-2)"	"unprognostic (1.13e-2)"	"unprognostic (2.11e-1)"	"unprognostic (1.78e-1)"	"unprognostic (2.82e-1)"	"unprognostic (2.34e-3)"	"unprognostic (6.35e-3)"	"unprognostic (2.42e-1)"	"unprognostic (1.46e-1)"	"unprognostic (5.76e-2)"	9.3	47.8	4.9	7.8	8.3	3.6	15.0	7.7	5.3	12.2	6.3	11.3	13.6	11.3	6.2	12.7	10.5	8.0	7.2	4.8	6.0	7.6	33.3	12.0	6.4	7.3	8.1	10.7	18.8	8.0	12.9	5.5	6.2	19.7	10.9	7.5	14.6	3.4	11.3	11.1	13.1	4.9	5.4	6.8	13.2	7.1	6.7	15.2	8.8	4.7	9.0	10.7	17.0	11.8	4.5	6.5	7.6	4.2	2.8	3.3	13.6	2.6	5.8	6.4	9.1	18.1	8.6	0.4	1.4	2.9	11.3	2.9	14.1	2.4	8.6	14.4	7.0	0.7	6.8	19.2	5.4	1.3	3.0	2.8	6.7	5.1	16.3	6.8	5.0	7.3	4.0	11.8	0.4	8.6	1.7	0.9	37.7	11.1	1.9	2.0	2.6	8.6	3.6	34.3	12.3	11.5	10.6	13.6	6.7	28.2	5.5	2.2	4.5	2.9	8.3	1.8	2.9	8.3	10.6	1.5	3.8	2.9	4.0	0.0	0.0	0.0	0.5	0.0	2.3	0.0	1.6	0.7	0.1	0.0	0.5	0.3	0.8	0.0	0.0	0.0	3.9	0.3	4.9	8.3	7.7	5.3	4.8	6.0	7.3	8.1	6.2	5.4	6.7	11.8	9.6	28.9	55.5	30.3	3.3	2.8	14.9	1.5	3.4	4.8	23.8	13.1	11.5	20.0	9.7	3.7	2.1	10.5	5.6	35.7	0.0	14.3	1.3	15.1	10.2	9.2	49.6	0.0	19.5	24.6	4.1	9.9	11.7	19.9	23.5	114.9	7.5	34.2	5.3	6.7	24.8	10.0	2.0	9.4	1.9	2.3	5.9	5.7	5.4	38.4	2.9	36.8	0.0	56.3	196.3	20.9	25.3	6.8	4.3	34.3	25.4	5.2	10.4	4.8	0.0	11.1	10.3	3.0	5.8	6.2	1.8	30.1	27.9	9.9	18.7	24.5
DUSP18	DUSP20	ENSG00000167065	"Dual specificity phosphatase 18"	Q8NEJ0	22	30652051-30667887	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Hydrolase, Protein phosphatase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 123.4;Late spermatids: 344.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB034070, HPA051349"	Uncertain		Supported	Nucleoplasm		Yes	No			"Cluster 31: Non-specific - Inflammatory response"	"Cluster 42: Ciliated cells - Cilium & Cell projection"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 25: Spermatids - Spermatogenesis"	Nucleoplasm		"CAB034070: AB_2094867, HPA051349: AB_2681450"	"unprognostic (1.11e-1)"	"unprognostic (2.34e-2)"	"unprognostic (3.49e-3)"	"unprognostic (4.88e-3)"	"unprognostic (1.88e-1)"	"unprognostic (9.12e-2)"	"unprognostic (3.77e-4)"	"unprognostic (1.83e-1)"	"unprognostic (1.61e-1)"	"unprognostic (3.53e-2)"	"unprognostic (9.62e-2)"	"unprognostic (4.87e-2)"	"unprognostic (1.23e-3)"	"unprognostic (6.55e-2)"	"unprognostic (1.97e-1)"	"unprognostic (4.56e-2)"	"unprognostic (1.02e-1)"	3.3	1.9	3.4	4.5	3.6	3.3	2.8	2.9	5.3	2.4	9.1	5.4	5.0	2.9	4.9	4.1	10.9	4.2	2.0	3.7	4.0	2.2	1.0	5.5	4.7	5.4	7.6	2.4	2.9	3.3	4.2	2.1	4.9	2.1	6.8	5.2	2.5	2.4	1.3	4.8	4.6	3.8	4.8	4.3	4.8	13.9	4.5	4.0	3.3	1.6	3.9	3.3	2.6	6.0	5.4	5.4	2.5	5.8	6.2	11.9	2.3	4.9	5.3	4.7	5.1	3.1	5.3	3.6	3.3	6.0	6.2	3.8	1.3	3.8	5.3	9.8	6.1	1.5	2.2	2.2	2.6	7.4	5.3	3.1	5.4	7.8	3.0	5.3	15.0	4.1	1.7	2.8	5.2	4.8	4.2	1.8	0.8	6.4	3.3	2.8	1.7	1.2	5.6	3.7	6.2	3.7	4.8	1.7	3.5	3.2	4.5	2.2	11.1	9.9	5.4	2.7	2.8	2.1	2.6	1.7	11.4	1.3	5.0	31.4	15.3	29.9	8.6	19.3	6.6	9.7	9.6	7.7	17.2	8.7	6.6	7.5	31.8	7.4	21.4	9.7	13.2	8.4	3.4	3.6	2.9	5.3	3.7	4.0	5.4	7.6	4.9	4.8	4.5	6.0	7.2	19.2	5.4	11.4	7.1	21.4	13.3	6.5	2.2	2.9	4.9	3.4	2.0	10.0	9.6	5.5	45.9	1.2	12.0	10.0	3.9	10.1	123.4	34.5	5.0	10.1	35.5	2.1	8.0	9.4	3.9	6.8	8.6	5.0	7.0	4.4	13.9	1.1	8.1	1.7	4.4	15.4	6.1	15.6	28.5	344.2	8.4	13.2	8.8	13.1	13.9	10.1	9.2	1.5	14.3	9.3	15.4	6.8	3.9	8.8	24.2	4.1	64.6	16.8	6.6	8.6	6.6	63.0	17.2	5.7	21.3	1.0	9.7	3.5	19.0	8.7
DUSP19	"DUSP17, SKRP1"	ENSG00000162999	"Dual specificity phosphatase 19"	Q8WTR2	2	183078559-183100008	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Hydrolase, Protein phosphatase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 15.2;Endometrial ciliated cells: 17.7;Respiratory ciliated cells: 15.7;Spermatocytes: 15.5"	"Low cancer specificity"	"Detected in many"			"Group enriched"	"Detected in many"	6	"amygdala: 1.3;basal ganglia: 2.4;cerebral cortex: 2.7;hippocampal formation: 3.8"	"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HEL: 7.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA021501	Approved		Approved	Nucleoplasm		Yes	No			"Cluster 35: T-regs - Unknown function"	"Cluster 68: Epididymis - Unknown function"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 49: Ciliated cells - Cilium organization"	Nucleoplasm		"HPA021501: AB_1847892"	"unprognostic (1.24e-1)"	"unprognostic (2.13e-2)"	"unprognostic (1.21e-1)"	"unprognostic (1.64e-1)"	"unprognostic (5.18e-2)"	"unprognostic (2.44e-1)"	"unprognostic (1.21e-1)"	"unprognostic (1.88e-1)"	"unprognostic (8.30e-2)"	"unprognostic (1.49e-2)"	"unprognostic (3.33e-2)"	"unprognostic (6.53e-2)"	"unprognostic (5.80e-3)"	"unprognostic (6.97e-2)"	"unprognostic (2.91e-2)"	"unprognostic (2.16e-2)"	"unprognostic (2.75e-2)"	1.1	1.4	1.3	0.8	2.4	0.3	1.1	0.0	2.7	1.2	0.1	1.4	1.4	1.4	3.5	1.4	3.2	1.3	3.1	3.8	0.1	1.8	1.1	1.3	1.0	0.1	0.0	1.6	0.9	1.6	1.2	1.0	0.0	1.5	1.0	1.2	0.9	1.9	1.6	1.3	1.1	1.9	0.0	1.6	3.9	3.7	0.0	1.2	1.7	1.7	0.7	1.1	0.6	0.4	0.1	1.6	1.8	0.9	2.5	1.4	0.0	0.7	1.1	2.9	1.0	1.5	1.9	0.6	3.8	0.8	2.1	0.2	3.8	0.5	2.3	3.9	1.8	7.1	1.1	1.0	1.0	1.8	4.2	1.1	0.3	1.3	0.7	1.8	1.5	0.0	2.2	1.0	1.8	0.6	3.4	1.6	1.5	0.6	1.2	3.3	2.9	0.2	0.6	0.7	2.3	0.9	2.6	1.1	2.0	0.1	0.5	0.6	1.3	1.6	1.3	1.1	0.6	1.3	1.6	0.0	2.0	0.3	2.4	0.7	0.1	0.6	0.6	0.2	0.6	1.1	0.5	0.8	0.1	0.5	0.7	0.7	0.3	0.7	0.1	0.4	1.0	0.3	1.3	2.4	0.0	2.7	3.8	0.1	0.1	0.0	0.0	0.0	0.0	0.4	2.5	0.0	3.2	0.7	1.6	1.0	1.3	1.1	3.4	1.8	2.1	2.7	8.3	1.5	1.8	1.8	2.1	2.0	0.8	1.5	5.9	0.9	15.2	17.7	2.3	3.3	2.4	0.0	9.9	0.7	1.5	1.7	3.6	1.5	1.3	3.0	2.9	1.9	0.6	1.7	7.8	1.9	0.0	0.8	0.3	6.0	1.8	2.2	0.0	1.0	1.1	4.8	2.1	4.0	3.1	0.6	3.4	2.6	0.3	0.7	2.2	2.9	15.7	1.5	0.0	1.9	4.4	15.5	3.8	2.3	1.6	0.7	1.2	3.6	1.8	1.1
DUSP2	PAC-1	ENSG00000158050	"Dual specificity phosphatase 2"	Q05923	2	96143169-96145440	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Hydrolase, Protein phosphatase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 129.5"	"Cell type enhanced"	"Detected in many"		"dendritic cells: 919.7;Glandular and luminal cells: 321.1;Langerhans cells: 924.0;Macrophages: 353.9;T-cells: 764.7"	"Low cancer specificity"	"Detected in all"			"Region enriched"	"Detected in all"	4	"cerebral cortex: 55.0"	"Immune cell enhanced"	"Detected in all"		"gdT-cell: 199.3"	"Group enriched"	"Detected in all"	10	"NK-cells: 148.1;T-cells: 199.3"	"Cell line enhanced"	"Detected in many"		"Daudi: 30.4;HeLa: 29.7;JURKAT: 27.6;Karpas-707: 33.8;NB-4: 29.1;RT4: 34.2;SCLC-21H: 29.6;U-698: 43.2"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in some"			HPA071920			Supported	"Nucleoplasm,Nuclear membrane"		NA	NA			"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 24: Non-specific - Transcription regulation"	"Nuclear membrane"	Nucleoplasm	"HPA071920: AB_2686472"	"unprognostic (2.69e-3)"	"unprognostic (6.70e-3)"	"unprognostic (1.15e-1)"	"unprognostic (5.46e-3)"	"unprognostic (3.32e-2)"	"unprognostic (8.54e-2)"	"unprognostic (1.36e-1)"	"unprognostic (1.15e-1)"	"unprognostic (2.86e-1)"	"unprognostic (3.66e-2)"	"unprognostic (3.10e-1)"	"unprognostic (6.30e-2)"	"prognostic unfavorable (4.97e-5)"	"unprognostic (1.82e-1)"	"unprognostic (2.41e-1)"	"unprognostic (3.94e-2)"	"unprognostic (1.31e-3)"	17.0	6.0	7.6	18.6	11.6	129.5	5.5	7.5	55.0	8.1	9.2	4.5	1.6	7.0	7.7	6.8	7.6	12.5	19.5	13.4	6.2	12.7	7.5	18.2	47.1	8.0	6.3	7.8	2.3	1.7	35.1	1.3	6.7	17.6	2.0	0.4	3.9	61.5	2.8	26.0	11.8	3.4	6.7	42.0	7.4	3.6	6.9	47.3	6.7	3.7	24.6	39.5	9.0	9.3	3.2	0.0	0.2	0.2	0.4	0.5	4.4	3.7	0.0	5.3	5.1	8.9	0.6	30.4	10.6	4.1	0.0	2.2	7.5	0.0	1.0	0.5	0.0	0.7	29.7	0.0	1.9	12.8	2.6	0.9	2.0	0.9	0.0	0.1	0.0	27.6	0.0	33.8	0.2	5.2	25.5	29.1	6.5	0.8	10.6	0.0	0.4	24.3	0.2	34.2	29.6	1.5	1.4	0.3	5.6	0.0	2.0	14.4	0.1	0.0	7.9	0.0	1.7	2.3	3.9	43.2	0.0	13.9	0.3	2.3	4.3	1.0	199.3	10.5	95.4	17.5	46.7	176.2	10.7	13.9	32.0	99.3	6.1	148.1	9.1	3.0	16.1	40.5	7.6	11.6	7.5	55.0	13.4	6.2	8.0	6.3	6.7	6.7	6.9	9.3	50.8	0.0	7.7	0.7	303.7	96.7	155.0	31.3	70.6	27.8	65.8	72.0	37.8	2.8	12.0	9.2	22.9	0.9	919.7	20.4	1.9	0.9	0.9	115.6	62.7	28.7	87.8	50.5	5.2	1.4	1.7	22.8	86.6	321.1	104.3	7.4	12.8	3.9	80.2	0.0	1.4	37.5	8.2	40.4	924.0	1.4	1.8	353.9	144.1	1.9	3.4	1.5	90.6	1.0	0.5	1.0	2.5	1.9	268.5	70.4	1.6	1.4	2.7	3.6	0.0	14.7	26.6	0.6	4.8	50.4	109.7	1.6	764.7	3.0	51.6	41.1
DUSP21		ENSG00000189037	"Dual specificity phosphatase 21"	Q9H596	X	44844021-44844888	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Hydrolase, Protein phosphatase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	41	"testis: 10.7"	"Group enriched"	"Detected in some"	99	"Early spermatids: 82.4;Late spermatids: 277.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"													NA	NA				"Cluster 83: Testis - Spermatogenesis"		"Cluster 31: Spermatids - Spermatogenesis"																		"unprognostic (5.17e-2)"			0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	10.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	82.4	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	277.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0
DUSP22	"JKAP, JSP1, MKPX, VHX"	ENSG00000112679	"Dual specificity phosphatase 22"	Q9NRW4	6	291630-351355	"Enzymes, Human disease related genes, Metabolic proteins, Predicted intracellular proteins"		"Hydrolase, Protein phosphatase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"RPMI-8226: 270.6;U-266/70: 130.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA031394	Approved		Approved	Nucleoplasm,Vesicles		NA	NA			"Cluster 37: B-cells - Transcription"	"Cluster 59: Non-specific - Translation"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 51: Myeloid cells - Hemostasis"	"Nucleoplasm, Vesicles"		"HPA031394: AB_10604114"	"unprognostic (7.34e-3)"	"unprognostic (7.94e-3)"	"unprognostic (1.37e-2)"	"unprognostic (1.14e-1)"	"unprognostic (3.46e-1)"	"unprognostic (1.70e-2)"	"unprognostic (9.08e-3)"	"unprognostic (2.48e-1)"	"unprognostic (9.06e-2)"	"unprognostic (5.56e-3)"	"unprognostic (3.10e-2)"	"unprognostic (3.04e-1)"	"unprognostic (1.77e-1)"	"unprognostic (3.97e-2)"	"unprognostic (3.07e-1)"	"unprognostic (2.35e-1)"	"unprognostic (1.09e-1)"	36.9	16.4	25.6	27.7	29.1	23.7	33.0	27.4	28.8	31.6	21.2	47.8	22.5	28.9	12.2	45.7	25.9	21.3	42.1	25.1	27.1	32.4	32.7	38.5	32.4	32.3	28.5	19.6	40.8	13.2	21.2	27.3	30.3	23.2	16.1	7.8	30.4	15.1	52.3	41.4	33.7	22.0	28.0	43.9	32.7	44.9	29.3	15.0	28.1	37.7	30.5	30.3	36.8	42.7	13.7	8.3	17.3	25.9	19.5	21.5	22.8	9.9	8.0	8.6	10.3	8.8	15.1	28.4	23.3	10.3	18.3	9.4	21.9	18.3	6.1	68.6	25.1	19.3	7.1	24.7	9.9	7.0	24.4	16.2	54.1	6.2	11.3	14.1	24.8	24.0	18.3	92.2	7.2	8.2	10.3	25.1	10.4	10.0	18.7	20.2	11.7	270.6	16.2	5.8	29.7	11.6	8.5	3.4	29.6	37.4	17.6	8.9	34.2	7.7	10.1	7.8	6.0	130.0	98.6	40.0	3.0	19.0	17.7	36.4	32.5	13.6	8.6	26.5	6.2	40.4	6.7	9.1	33.5	33.3	6.1	8.8	21.8	5.9	25.1	28.8	15.9	19.6	25.6	29.1	27.4	28.8	25.1	27.1	32.3	28.5	30.3	28.0	29.3	42.7	45.5	16.0	21.3	5.5	53.7	26.5	22.0	33.3	14.2	5.7	19.4	17.5	40.8	10.0	30.7	5.5	0.0	10.8	51.1	11.7	21.5	24.2	13.4	18.6	8.2	33.4	9.5	8.2	8.5	51.4	7.7	21.9	15.3	12.9	33.0	8.8	21.8	25.0	30.1	0.0	6.1	14.7	32.6	38.6	43.0	20.5	15.5	47.1	46.2	21.5	78.4	14.9	36.0	7.1	25.9	29.2	12.4	9.4	59.7	16.5	23.2	18.2	39.7	3.2	26.3	11.6	22.8	34.5	73.8	42.5	37.1	6.6	21.3	6.8	15.4	27.9
DUSP23	"DUSP25, FLJ20442"	ENSG00000158716	"Dual specificity phosphatase 23"	Q9BVJ7	1	159780932-159782543	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Hydrolase, Protein phosphatase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Exocrine glandular cells: 458.5;Proximal tubular cells: 800.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HSkMC: 142.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA028211, HPA045792"	Approved		Supported	Nucleoplasm		NA	NA		22000	"Cluster 31: Non-specific - Inflammatory response"	"Cluster 81: Kidney & Liver - Metabolism"	"Cluster 43: THP-1 - Innate immune response"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Nucleoplasm		"HPA028211: AB_2672522, HPA045792: AB_10961133"	"unprognostic (1.52e-1)"	"unprognostic (4.12e-1)"	"unprognostic (1.40e-3)"	"unprognostic (3.33e-2)"	"unprognostic (4.36e-2)"	"unprognostic (3.22e-1)"	"prognostic unfavorable (3.06e-4)"	"unprognostic (3.16e-1)"	"unprognostic (4.62e-1)"	"unprognostic (3.33e-3)"	"unprognostic (4.72e-2)"	"unprognostic (3.75e-2)"	"prognostic unfavorable (2.59e-5)"	"unprognostic (8.58e-2)"	"unprognostic (2.84e-2)"	"unprognostic (7.47e-2)"	"unprognostic (1.39e-1)"	75.0	122.4	29.1	15.4	31.5	20.5	99.9	32.0	38.5	57.6	30.0	46.3	26.7	55.0	15.5	82.0	52.3	13.4	36.1	31.8	31.4	199.1	189.3	55.3	10.4	32.0	30.1	35.6	76.8	34.6	20.8	5.9	32.1	55.3	13.9	8.1	152.4	15.3	65.4	61.1	42.9	12.0	32.8	39.2	39.7	18.2	31.3	15.2	58.8	16.6	9.1	45.1	53.6	31.0	39.5	42.2	0.3	0.2	39.5	33.5	0.4	15.8	13.0	18.4	14.3	17.3	44.7	0.1	90.9	17.6	4.2	1.5	10.8	14.5	10.0	9.9	4.6	54.4	14.7	0.0	58.6	33.3	40.4	142.8	38.3	12.1	43.0	13.2	71.0	0.1	25.2	19.4	26.3	72.5	3.5	1.4	71.3	71.6	58.7	0.1	0.0	18.8	22.7	6.9	17.8	39.4	28.6	63.0	78.5	7.3	40.6	51.7	51.7	15.3	0.8	1.9	0.2	13.5	34.8	0.5	25.8	26.5	11.7	111.8	181.7	229.1	97.9	153.4	54.6	60.5	72.7	92.8	261.3	43.7	44.0	65.1	185.6	100.5	105.6	59.2	70.8	112.2	29.1	31.5	32.0	38.5	31.8	31.4	32.0	30.1	32.1	32.8	31.3	31.0	100.4	41.7	58.7	3.3	23.8	74.6	129.2	151.8	100.7	8.5	110.6	112.1	29.5	95.8	122.2	51.5	6.2	16.1	28.4	97.7	262.2	210.7	48.3	47.5	30.8	155.8	35.4	37.5	1.4	458.5	29.2	31.2	32.1	130.9	54.5	66.1	75.0	249.4	170.3	1.7	0.5	124.9	91.6	94.3	72.9	8.4	26.4	92.2	42.7	4.7	58.9	74.8	69.0	1.0	4.4	208.4	112.2	15.8	14.6	121.5	140.4	800.7	54.8	10.0	13.1	16.0	34.9	5.4	19.9	123.2	74.4	5.7	43.6	72.3	109.5	116.1
DUSP26	"DUSP24, MGC1136, NEAP"	ENSG00000133878	"Dual specificity phosphatase 26"	Q9BV47	8	33591330-33600023	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Hydrolase, Protein phosphatase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"skeletal muscle: 421.3;tongue: 204.4"	"Cell type enhanced"	"Detected in some"		"Bipolar cells: 76.8;Cardiomyocytes: 59.4;Cone photoreceptor cells: 41.7;Enteroendocrine cells: 25.7;Horizontal cells: 25.2;Rod photoreceptor cells: 75.2"	"Cancer enhanced"	"Detected in some"		"glioma: 6.7;pancreatic cancer: 4.6"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	4	"SCLC-21H: 97.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA018221	Approved		Supported	Nucleoplasm		NA	NA			"Cluster 43: B-cells - Humoral immune response"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 56: Bipolar cells - Visual perception"	Nucleoplasm		"HPA018221: AB_2669813"	"unprognostic (2.77e-4)"	"unprognostic (2.70e-2)"	"unprognostic (2.70e-3)"	"unprognostic (5.47e-3)"	"unprognostic (2.01e-1)"	"unprognostic (1.24e-1)"	"unprognostic (1.62e-1)"	"unprognostic (2.53e-2)"	"unprognostic (2.81e-1)"	"unprognostic (1.39e-1)"	"unprognostic (4.10e-3)"	"unprognostic (1.78e-2)"	"unprognostic (2.28e-1)"	"unprognostic (1.52e-2)"	"unprognostic (1.14e-1)"	"unprognostic (8.15e-2)"	"unprognostic (5.80e-2)"	0.7	27.4	44.2	1.2	45.2	0.2	0.4	47.4	49.6	1.2	18.4	2.8	3.5	1.3	5.6	5.0	3.6	1.2	70.8	45.0	53.0	1.5	0.2	3.3	0.4	39.8	42.1	33.2	3.0	2.0	61.4	0.0	55.2	4.2	1.1	34.1	4.6	0.8	421.3	0.3	2.6	2.7	38.3	0.7	3.9	3.6	44.4	0.8	0.9	204.4	0.8	1.2	1.7	41.1	0.0	0.0	0.4	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.4	0.0	0.0	0.3	0.1	0.1	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	1.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	97.7	23.1	0.0	0.1	0.0	0.0	1.1	0.0	0.0	0.0	0.2	0.1	0.1	3.1	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	44.2	45.2	47.4	49.6	45.0	53.0	39.8	42.1	55.2	38.3	44.4	41.1	0.0	0.0	0.0	1.3	0.9	0.0	0.2	0.0	0.6	76.8	0.0	0.3	59.4	0.0	0.0	0.0	41.7	0.0	0.0	0.0	21.5	0.4	7.8	0.4	0.1	0.8	25.7	0.0	11.3	0.4	0.0	3.5	0.5	0.1	0.0	1.0	0.4	0.0	0.0	25.2	14.7	0.5	0.0	0.0	0.0	5.2	0.0	0.1	1.8	2.8	0.0	22.8	0.0	12.1	12.0	1.1	0.0	6.0	5.3	0.3	0.0	2.5	0.0	75.2	0.0	10.8	5.2	0.2	0.2	0.0	0.0	0.0	0.6	0.7	0.1	0.1
DUSP28	"DUSP26, VHP"	ENSG00000188542	"Dual specificity phosphatase 28"	Q4G0W2	2	240560054-240565256	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Hydrolase, Protein phosphatase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Late spermatids: 39.7;Spermatocytes: 45.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in many"	5	"basophil: 8.9"	"Lineage enriched"	"Detected in all"	5	"granulocytes: 8.9"	"Cell line enhanced"	"Detected in many"		"U-266/70: 8.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA047456, CAB069448"	Uncertain		Uncertain	"Nuclear speckles,Cytosol"		NA	NA			"Cluster 34: Basophils - Unknown function"	"Cluster 59: Non-specific - Translation"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 13: Spermatocytes & Spermatogonia - Spermatogenesis"	"Nuclear speckles"	Cytosol	"CAB069448: , HPA047456: AB_10961145"	"unprognostic (1.88e-2)"	"unprognostic (9.29e-2)"	"unprognostic (4.86e-2)"	"unprognostic (2.32e-1)"	"unprognostic (1.65e-1)"	"unprognostic (1.07e-2)"	"unprognostic (1.09e-2)"	"unprognostic (7.56e-3)"	"unprognostic (4.13e-3)"	"unprognostic (3.71e-2)"	"prognostic favorable (1.84e-4)"	"unprognostic (9.85e-2)"	"unprognostic (1.80e-3)"	"unprognostic (6.99e-2)"	"unprognostic (2.52e-1)"	"unprognostic (2.59e-1)"	"unprognostic (2.10e-3)"	1.5	2.4	1.6	1.3	1.7	5.4	1.7	3.0	1.8	2.2	0.5	2.5	1.1	2.1	1.7	3.1	2.6	0.8	3.4	1.3	1.7	3.2	3.2	2.2	1.9	1.7	1.2	2.2	3.0	0.9	3.9	0.6	1.4	3.5	1.0	1.2	2.8	0.8	9.8	2.0	3.6	0.6	1.1	4.7	2.7	6.2	1.5	1.1	3.5	4.0	1.5	2.3	2.2	2.0	1.0	0.8	1.1	1.4	0.7	0.4	1.3	1.0	0.6	0.8	0.5	0.5	2.4	1.7	0.6	0.6	1.3	3.1	0.9	0.3	0.7	2.2	4.0	2.1	2.2	1.3	0.5	1.6	3.7	1.0	0.9	0.6	0.6	1.6	0.4	2.3	1.6	1.9	0.7	1.1	1.7	2.5	0.9	1.4	0.9	2.3	2.4	2.1	0.6	1.6	2.8	1.5	0.9	1.1	1.3	0.7	1.2	2.2	1.0	1.9	1.6	1.3	1.0	8.2	2.1	2.8	1.2	1.0	1.5	8.9	1.1	0.5	1.2	0.7	1.4	1.0	1.2	1.3	0.6	1.8	1.4	1.2	1.9	1.5	0.7	1.9	0.9	0.9	1.6	1.7	3.0	1.8	1.3	1.7	1.7	1.2	1.4	1.1	1.5	2.0	5.7	0.0	4.5	1.3	11.4	3.7	7.7	4.7	6.2	6.7	12.3	10.0	13.8	10.0	3.8	12.9	4.2	7.8	18.4	11.0	15.6	5.1	35.2	11.2	5.5	4.1	8.4	8.8	3.8	5.8	4.8	4.3	14.8	10.2	7.0	6.2	3.3	8.6	11.5	8.4	4.9	9.8	6.1	10.0	6.1	39.7	3.1	13.6	7.2	1.9	10.5	9.9	23.7	2.5	3.6	4.4	10.4	1.5	16.8	8.0	15.7	15.6	11.7	6.8	6.6	4.1	7.2	45.8	18.7	10.7	5.4	7.0	14.9	7.6	11.2	8.7
DUSP29	"DUPD1, DUSP27"	ENSG00000188716	"Dual specificity phosphatase 29"	Q68J44	10	75037836-75058514	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Hydrolase, Protein phosphatase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	6	"skeletal muscle: 71.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA042964	Uncertain					NA	NA				"Cluster 33: Striated muscle - Muscle contraction"					"HPA042964: AB_10795764"						"unprognostic (1.05e-2)"				"unprognostic (1.77e-1)"					"unprognostic (2.34e-1)"			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.5	0.0	0.0	0.9	0.0	71.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
DUSP3	VHR	ENSG00000108861	"Dual specificity phosphatase 3"	P51452	17	43766125-43778977	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"		"Hydrolase, Protein phosphatase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 261.9"	"Cell type enhanced"	"Detected in all"		"Cardiomyocytes: 274.3;Late spermatids: 160.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Group enriched"	"Detected in all"	9	"dendritic cells: 33.5;granulocytes: 11.0;monocytes: 29.3"	"Low cell line specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			HPA063616			Supported	Nucleoplasm,Cytosol		NA	NA		1300000	"Cluster 14: Monocytes - Unknown function"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 54: Cardiomyocytes - Muscle contraction"	Nucleoplasm	Cytosol	"HPA063616: AB_2685061"	"unprognostic (1.52e-1)"	"unprognostic (3.18e-2)"	"unprognostic (1.10e-1)"	"unprognostic (8.54e-2)"	"unprognostic (1.04e-3)"	"prognostic unfavorable (3.00e-4)"	"unprognostic (4.83e-2)"	"unprognostic (8.98e-2)"	"unprognostic (5.13e-1)"	"unprognostic (6.01e-2)"	"unprognostic (1.78e-1)"	"unprognostic (8.40e-3)"	"prognostic favorable (5.49e-5)"	"unprognostic (2.67e-3)"	"unprognostic (5.45e-2)"	"unprognostic (1.94e-1)"	"unprognostic (1.37e-2)"	39.8	43.2	63.6	21.6	67.1	9.9	32.7	57.2	91.0	32.4	59.6	96.1	27.8	49.2	31.1	48.4	33.6	33.4	194.8	69.0	65.4	72.0	108.1	50.2	14.3	64.2	64.3	18.2	48.6	47.0	33.1	31.4	64.4	57.7	26.0	30.8	31.8	72.9	261.9	24.6	38.7	62.9	58.5	40.7	57.5	24.5	65.6	6.2	30.5	213.7	13.0	63.1	33.6	64.3	32.3	57.1	21.5	23.1	61.1	32.7	18.3	23.8	56.4	54.4	65.1	55.4	21.1	4.9	36.7	44.7	112.4	27.3	33.7	29.3	56.9	11.1	25.6	16.2	25.9	45.4	74.5	2.0	16.1	30.5	51.5	42.0	36.2	59.0	38.5	15.9	14.7	5.4	64.2	23.1	8.5	8.4	9.9	45.5	41.1	10.5	64.5	12.1	75.8	33.3	12.0	21.6	27.9	18.3	71.8	58.8	82.2	44.7	40.4	61.1	41.5	87.9	40.1	28.5	40.4	1.2	72.4	22.6	20.8	11.0	29.3	6.4	1.5	15.0	2.7	2.6	2.4	1.9	33.5	2.4	1.9	1.7	7.0	1.7	20.6	13.8	1.6	11.4	63.6	67.1	57.2	91.0	69.0	65.4	64.2	64.3	64.4	58.5	65.6	64.3	23.1	25.6	21.2	6.5	9.2	22.4	47.6	17.6	10.8	17.2	20.3	21.3	274.3	54.3	17.9	42.3	25.0	16.3	9.5	36.9	41.1	47.8	88.6	18.8	16.6	33.8	36.4	11.6	18.1	58.9	21.8	25.9	42.8	25.0	38.7	6.1	25.4	108.8	86.6	20.2	15.5	19.9	24.4	49.1	52.0	160.5	14.6	47.2	10.6	15.9	53.9	16.8	4.1	8.5	13.8	56.5	32.3	26.4	8.0	46.2	57.7	87.6	21.1	17.3	32.9	24.1	28.4	3.3	5.0	16.0	28.8	45.0	6.3	15.1	18.0	42.6
DUSP4	"HVH2, MKP-2, TYP"	ENSG00000120875	"Dual specificity phosphatase 4"	Q13115	8	29333064-29350684	"Cancer-related genes, Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"		"Hydrolase, Protein phosphatase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"pancreas: 32.2;stomach 1: 32.4"	"Cell type enhanced"	"Detected in many"		"Glandular and luminal cells: 155.5;Ionocytes: 126.1;Pancreatic endocrine cells: 195.2"	"Cancer enhanced"	"Detected in all"		"melanoma: 42.9"	"Region enhanced"	"Detected in many"		"hippocampal formation: 20.9"	"Immune cell enriched"	"Detected in single"	9	"T-reg: 6.7"	"Lineage enriched"	"Detected in single"	20	"T-cells: 6.7"	"Cell line enhanced"	"Detected in many"		"A549: 100.0;OE19: 91.7;SK-MEL-30: 157.2;WM-115: 122.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA061967			Supported	Nucleoplasm		NA	NA			"Cluster 35: T-regs - Unknown function"	"Cluster 25: Pancreas - Digestion"	"Cluster 17: WM-115 - Nervous system development"	"Cluster 41: Macrophages - Immune response"	Nucleoplasm		"HPA061967: AB_2684648"	"unprognostic (1.92e-1)"	"unprognostic (5.97e-3)"	"unprognostic (3.24e-1)"	"unprognostic (6.54e-2)"	"unprognostic (2.18e-2)"	"unprognostic (7.66e-3)"	"unprognostic (7.30e-2)"	"unprognostic (7.08e-2)"	"unprognostic (1.83e-2)"	"unprognostic (9.73e-3)"	"unprognostic (9.60e-3)"	"unprognostic (3.15e-2)"	"prognostic unfavorable (4.19e-4)"	"unprognostic (6.88e-2)"	"unprognostic (1.62e-1)"	"unprognostic (1.08e-2)"	"unprognostic (6.07e-2)"	15.2	5.2	2.3	5.4	1.4	6.2	23.7	5.0	9.0	6.0	0.4	1.2	1.2	4.5	0.1	2.5	1.9	11.3	2.3	20.9	1.2	2.8	0.7	5.7	2.6	1.6	1.1	0.4	32.2	0.6	5.3	7.5	1.1	5.2	1.4	5.9	16.1	10.1	4.2	5.6	2.0	1.2	0.3	1.0	32.4	2.8	2.9	4.2	1.2	0.9	2.7	13.8	2.8	1.1	38.0	100.0	57.9	2.8	7.2	0.0	4.9	7.7	42.0	22.8	10.1	1.1	18.8	0.0	20.5	3.6	16.0	12.0	0.7	25.7	13.5	1.0	1.9	0.3	3.7	0.7	0.2	0.5	47.3	4.6	16.7	7.1	42.1	49.7	18.9	0.4	0.3	4.5	46.0	42.9	0.1	7.1	10.1	91.7	60.5	1.2	1.9	8.1	52.3	19.7	0.4	32.0	10.8	49.5	157.2	1.1	10.7	1.1	53.3	16.7	0.3	0.0	5.7	11.6	1.4	0.1	50.2	8.9	122.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.3	6.7	0.0	2.3	1.4	5.0	9.0	20.9	1.2	1.6	1.1	1.1	0.3	2.9	1.1	11.1	0.0	2.8	0.0	33.5	12.1	98.3	27.3	4.0	43.2	80.4	62.2	2.6	51.5	51.1	0.0	12.5	3.2	24.0	1.9	0.0	74.3	7.6	64.7	13.3	16.3	97.8	0.0	3.8	78.6	40.9	9.6	121.8	155.5	6.3	0.0	21.8	0.3	25.0	43.7	8.2	8.5	126.1	4.0	102.8	25.6	0.3	47.4	65.8	0.0	75.6	0.8	0.0	1.5	0.3	195.2	0.0	0.0	31.0	30.9	0.4	0.2	43.6	3.4	13.1	18.9	17.8	1.4	8.2	2.3	11.9	17.8	115.6	0.1	4.6	102.7
DUSP5	HVH3	ENSG00000138166	"Dual specificity phosphatase 5"	Q16690	10	110497907-110511533	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Hydrolase, Protein phosphatase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"urinary bladder: 175.7"	"Cell type enhanced"	"Detected in many"		"Basal prostatic cells: 409.1;Langerhans cells: 298.4;Plasma cells: 412.2;Urothelial cells: 1063.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"non-classical monocyte: 10.3;plasmacytoid DC: 14.5"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"hTERT-HME1: 408.0;Karpas-707: 161.2;U-266/70: 227.8"	"Region enhanced"	"Detected in all"		"cerebellum: 60.7"	"Region enriched"	"Detected in many"	5	"cerebellum: 45.4"							NA	NA			"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 11: Squamous epithelial cells - Epithelial cell function"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 22: Epithelial cell types - Mixed function"				"unprognostic (1.25e-1)"	"unprognostic (3.57e-1)"	"unprognostic (5.19e-2)"	"unprognostic (1.03e-1)"	"unprognostic (1.76e-2)"	"unprognostic (3.27e-3)"	"unprognostic (6.35e-2)"	"prognostic unfavorable (8.30e-6)"	"unprognostic (1.70e-2)"	"unprognostic (4.60e-2)"	"unprognostic (2.91e-2)"	"unprognostic (1.20e-2)"	"unprognostic (4.20e-3)"	"unprognostic (3.79e-1)"	"unprognostic (3.78e-3)"	"unprognostic (2.32e-1)"	"unprognostic (9.09e-2)"	38.8	37.6	8.5	26.8	8.6	38.5	26.6	26.1	17.3	39.4	13.3	22.3	12.2	19.7	2.0	115.5	12.7	51.4	34.1	17.9	12.4	26.4	25.6	23.2	12.8	7.7	9.3	7.6	8.0	6.7	20.0	48.3	7.4	17.7	26.3	9.8	23.4	12.5	2.7	16.9	19.5	21.1	8.3	28.4	26.5	20.1	10.7	14.9	18.8	3.7	32.5	175.7	37.9	7.9	22.0	14.6	3.0	7.3	11.1	46.5	10.6	50.9	114.6	26.8	32.2	9.4	28.9	2.6	9.4	12.4	56.9	7.0	2.8	26.7	43.2	62.8	1.8	12.1	2.6	5.8	41.8	3.2	15.1	17.9	35.9	85.7	408.0	11.8	17.1	1.2	2.1	161.2	81.4	5.9	0.9	9.2	9.6	2.1	22.2	0.2	6.3	38.8	92.0	42.3	1.6	4.0	3.3	8.0	17.4	25.6	4.5	3.8	26.5	9.0	6.2	21.7	24.7	227.8	44.7	6.2	34.9	16.4	6.4	0.5	0.2	0.0	3.5	2.2	1.3	0.2	1.8	1.0	0.9	0.0	0.1	1.0	0.2	0.0	10.3	14.5	0.1	0.6	8.5	8.6	26.1	17.3	17.9	12.4	7.7	9.3	7.4	8.3	10.7	7.9	150.7	3.2	7.8	0.3	71.2	66.0	409.1	91.4	30.7	9.0	72.7	77.0	33.5	11.5	78.3	35.0	6.2	44.0	97.7	63.5	5.9	29.1	1.5	50.6	32.2	90.8	48.9	0.4	4.4	4.8	11.2	42.7	39.3	196.6	3.8	5.5	158.5	4.1	10.7	0.0	2.2	12.8	22.4	16.6	298.4	3.3	1.5	91.5	158.3	1.0	46.9	2.3	4.1	1.0	0.0	49.1	93.2	0.7	412.2	127.0	44.4	0.6	27.3	12.6	0.0	25.8	37.3	1.2	19.8	61.8	101.9	137.4	122.0	3.3	9.2	1063.2
DUSP6	"MKP-3, PYST1"	ENSG00000139318	"Dual specificity phosphatase 6"	Q16828	12	89347235-89352501	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"		"Hydrolase, Protein phosphatase"	"Disease variant, Hypogonadotropic hypogonadism, Kallmann syndrome"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"salivary gland: 226.2"	"Cell type enhanced"	"Detected in all"		"Alveolar cells type 2: 246.8;granulocytes: 456.9;Kupffer cells: 266.7"	"Cancer enhanced"	"Detected in all"		"thyroid cancer: 97.6"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"basophil: 1636.7"	"Group enriched"	"Detected in all"	13	"granulocytes: 1636.7;monocytes: 842.3"	"Cell line enhanced"	"Detected in many"		"AN3-CA: 427.6;NB-4: 325.8;SK-MEL-30: 253.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB017566, HPA053188, HPA064692"	Approved		Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 51: Monocytes - Innate immune response"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 17: WM-115 - Nervous system development"	"Cluster 60: Granulocytes - Receptor signaling"	"Nucleoplasm, Cytosol"		"CAB017566: AB_647991, HPA053188: , HPA064692: "	"unprognostic (7.35e-2)"	"unprognostic (1.50e-2)"	"unprognostic (5.77e-2)"	"prognostic favorable (7.21e-4)"	"unprognostic (2.35e-3)"	"unprognostic (2.10e-3)"	"unprognostic (3.76e-2)"	"unprognostic (1.42e-1)"	"unprognostic (8.63e-2)"	"unprognostic (1.67e-2)"	"unprognostic (3.15e-3)"	"unprognostic (2.09e-1)"	"unprognostic (5.91e-3)"	"unprognostic (1.28e-2)"	"unprognostic (3.95e-2)"	"unprognostic (1.86e-2)"	"unprognostic (2.84e-1)"	113.9	24.7	12.0	63.7	12.9	178.7	50.8	10.0	28.5	39.4	29.8	47.3	24.8	26.2	14.2	34.8	36.6	75.5	30.9	19.8	11.6	58.9	143.3	88.2	42.3	12.6	12.1	14.2	17.9	34.6	17.8	74.1	12.4	18.8	56.1	6.8	226.2	22.9	8.5	17.4	52.1	43.2	12.7	71.0	28.7	6.9	16.0	47.7	77.4	40.2	27.2	76.4	13.8	13.6	6.4	6.2	127.0	427.6	108.1	89.9	0.2	47.5	58.3	9.5	6.8	38.7	6.8	0.0	11.2	20.5	17.9	51.4	0.5	118.4	13.0	0.5	0.8	20.0	1.4	61.4	75.7	86.3	210.9	18.4	40.4	81.5	75.5	94.9	214.4	2.6	0.0	20.4	29.3	3.1	2.9	325.8	78.7	149.5	102.7	216.6	15.5	8.3	129.3	129.7	2.4	88.7	1.1	0.6	253.0	43.3	6.4	46.8	59.0	30.6	0.8	5.8	22.8	3.7	18.5	0.5	126.5	60.0	200.3	1636.7	558.9	247.2	9.8	842.3	4.5	2.7	2.7	3.5	97.0	11.6	1.6	3.2	230.5	14.8	841.0	12.2	6.7	455.2	12.0	12.9	10.0	28.5	19.8	11.6	12.6	12.1	12.4	12.7	16.0	13.6	182.9	102.5	246.8	12.4	18.0	90.9	79.4	97.4	38.7	2.1	30.3	85.5	11.1	81.5	80.5	180.3	33.3	72.6	36.1	58.3	17.6	12.6	1.6	67.4	14.1	159.8	19.2	6.6	19.6	14.0	4.2	54.5	19.4	134.2	456.9	24.2	177.8	130.2	49.6	1.7	3.8	13.2	46.8	266.7	61.2	1.7	1.5	193.2	12.4	33.7	198.9	8.7	20.6	24.6	2.4	17.1	45.7	3.4	16.2	26.1	17.0	27.5	21.2	2.4	26.3	21.4	29.7	2.6	7.0	14.7	24.7	49.3	42.3	3.5	22.0	61.4
DUSP7	"MKP-X, PYST2"	ENSG00000164086	"Dual specificity phosphatase 7"	Q16829	3	52048919-52056571	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Hydrolase, Protein phosphatase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Basal keratinocytes: 117.3;Squamous epithelial cells: 51.6;Suprabasal keratinocytes: 135.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in all"		"hTCEpi: 109.8;hTERT-HME1: 92.6"	"Low region specificity"	"Detected in all"							HPA073007	Approved					NA	NA			"Cluster 39: Non-specific - mRNA processing"	"Cluster 27: Brain & Skin - Unknown function"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 28: Keratinocytes - Keratinization"			"HPA073007: "	"unprognostic (1.19e-1)"	"unprognostic (1.89e-1)"	"unprognostic (1.66e-1)"	"unprognostic (1.04e-1)"	"unprognostic (1.88e-1)"	"unprognostic (6.16e-3)"	"unprognostic (2.32e-2)"	"unprognostic (2.75e-1)"	"unprognostic (1.44e-1)"	"unprognostic (8.67e-3)"	"unprognostic (7.38e-3)"	"unprognostic (7.74e-3)"	"prognostic unfavorable (8.84e-6)"	"unprognostic (4.86e-2)"	"unprognostic (1.24e-1)"	"unprognostic (2.29e-2)"	"unprognostic (9.46e-2)"	13.1	10.0	23.3	7.6	28.4	3.6	11.5	19.5	27.5	27.0	7.5	8.4	4.1	14.6	3.9	64.1	10.1	8.7	22.2	24.2	21.2	10.6	5.2	24.9	10.2	25.8	27.2	8.7	7.0	6.2	7.2	14.1	22.3	11.5	3.8	2.6	13.2	7.9	23.1	65.6	7.9	6.7	19.5	26.2	9.1	12.0	27.2	8.1	9.1	20.5	10.8	13.5	45.5	38.4	21.3	4.4	5.2	11.9	16.4	14.1	6.2	21.0	39.8	20.4	14.7	5.8	10.6	5.8	5.7	31.3	10.3	24.6	19.8	76.0	13.8	5.0	8.1	27.8	10.9	10.3	13.3	25.1	16.2	14.8	109.8	26.5	92.6	14.1	19.8	16.8	16.2	16.4	16.5	5.9	18.7	35.2	12.9	5.9	37.6	15.5	4.5	15.6	8.5	9.1	6.5	19.0	9.4	8.5	14.9	4.2	3.0	59.4	26.0	39.1	25.3	41.7	65.4	7.9	7.9	9.3	21.7	41.5	12.7	0.9	3.4	1.7	5.3	10.3	7.2	0.9	6.3	3.8	4.7	0.5	4.5	4.1	1.3	2.5	10.3	7.1	4.5	1.7	23.3	28.4	19.5	27.5	24.2	21.2	25.8	27.2	22.3	19.5	27.2	38.4	17.0	9.6	1.1	0.0	2.9	117.3	31.5	13.5	21.1	4.9	6.6	7.2	18.9	0.0	5.2	0.0	0.0	0.6	13.4	1.6	1.9	3.1	1.7	2.9	8.1	18.7	2.4	1.7	5.5	2.6	4.3	7.8	0.5	2.8	0.0	1.3	23.6	0.9	8.1	0.0	4.4	2.5	0.0	16.7	12.0	0.5	8.7	9.0	21.4	5.6	10.3	0.9	9.2	5.5	20.2	12.1	1.3	4.9	1.6	17.5	0.6	1.3	1.5	1.0	26.3	3.3	8.6	3.5	5.5	51.6	135.2	1.2	7.3	4.1	3.4	29.3
DUSP8	"C11orf81, FLJ42958, HB5, HVH-5"	ENSG00000184545	"Dual specificity phosphatase 8"	Q13202	11	1554051-1572271	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Hydrolase, Protein phosphatase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"pituitary gland: 25.5"	"Cell type enhanced"	"Detected in many"		"Bipolar cells: 113.6;Distal enterocytes: 57.8;Glandular and luminal cells: 65.6;Horizontal cells: 90.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"MCF7: 2.5;SCLC-21H: 1.4;SH-SY5Y: 1.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA020071	Approved		Approved	Cytosol		NA	NA				"Cluster 72: Non-specific - Transcription"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 56: Bipolar cells - Visual perception"	Cytosol		"HPA020071: AB_1847903"	"unprognostic (2.29e-1)"	"unprognostic (4.15e-2)"	"unprognostic (1.96e-1)"	"unprognostic (4.00e-2)"	"unprognostic (1.35e-1)"	"unprognostic (7.58e-3)"	"unprognostic (6.08e-2)"	"unprognostic (1.11e-1)"	"unprognostic (1.44e-3)"	"unprognostic (1.81e-1)"	"unprognostic (4.04e-3)"	"unprognostic (1.82e-1)"	"prognostic favorable (2.75e-6)"	"unprognostic (1.51e-1)"	"unprognostic (1.57e-1)"	"unprognostic (8.65e-2)"	"unprognostic (6.30e-2)"	6.6	2.1	3.5	0.2	3.0	1.0	6.0	0.3	8.1	5.1	0.0	11.3	0.0	8.4	0.6	1.4	8.7	0.5	17.0	5.0	0.1	5.4	3.6	9.5	0.3	1.9	0.4	2.4	15.7	0.2	25.5	0.1	0.1	5.1	0.3	1.6	6.1	0.2	13.3	4.3	6.8	1.2	0.3	3.1	8.3	3.1	0.7	0.2	3.7	0.0	0.1	3.6	4.2	2.0	0.6	0.3	0.4	0.0	0.0	0.0	1.1	0.1	0.4	0.1	0.6	0.6	0.0	0.0	0.2	0.1	0.0	0.9	0.0	0.1	0.3	1.1	0.6	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.1	0.7	0.0	2.5	0.0	0.1	0.1	0.0	0.7	0.0	0.0	0.3	0.0	0.0	1.4	1.7	0.1	0.2	0.3	0.0	0.1	0.0	0.0	0.1	0.8	0.3	0.8	0.5	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.5	3.0	0.3	8.1	5.0	0.1	1.9	0.4	0.1	0.3	0.7	2.0	14.9	3.2	1.1	0.0	6.3	9.8	8.1	2.7	2.8	113.6	32.1	24.3	6.0	14.3	3.2	12.9	47.9	0.3	11.1	57.8	1.9	7.7	0.3	31.5	24.7	6.5	42.3	0.0	11.1	11.3	0.5	4.3	8.6	65.6	0.0	0.4	1.4	0.6	0.5	90.9	11.3	32.6	6.1	0.0	3.4	0.2	0.6	4.7	5.4	2.8	1.0	22.3	1.0	3.0	5.2	11.0	22.4	0.4	4.7	17.4	19.1	1.6	2.8	35.5	6.6	8.0	15.1	0.8	0.6	2.2	4.8	5.9	10.5	0.7	25.0	14.2
DUSP9	"MKP-4, MKP4"	ENSG00000130829	"Dual specificity phosphatase 9"	Q99956	X	153642492-153651326	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Hydrolase, Protein phosphatase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	15	"kidney: 56.9;placenta: 72.6"	"Group enriched"	"Detected in some"	14	"Cytotrophoblasts: 1171.5;Distal tubular cells: 727.8;Syncytiotrophoblasts: 1735.1"	"Cancer enhanced"	"Detected in many"		"liver cancer: 10.6"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in many"	9	"Hep G2: 372.7"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA003336	Enhanced		Approved	"Endoplasmic reticulum"		NA	NA				"Cluster 28: Placenta - Pregnancy"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 47: Cytotrophoblasts - Unknown function"	"Endoplasmic reticulum"		"HPA003336: AB_1078709"	"unprognostic (4.64e-2)"	"unprognostic (6.48e-2)"	"unprognostic (4.87e-2)"	"prognostic unfavorable (1.60e-4)"	"unprognostic (1.52e-2)"	"unprognostic (2.74e-3)"	"unprognostic (9.36e-3)"	"unprognostic (6.15e-2)"	"unprognostic (2.81e-1)"	"unprognostic (3.03e-1)"	"unprognostic (1.29e-2)"	"unprognostic (1.38e-2)"	"unprognostic (2.68e-7)"	"unprognostic (4.49e-2)"	"unprognostic (2.08e-1)"	"unprognostic (2.77e-2)"	"unprognostic (5.52e-2)"	0.2	0.0	4.1	0.0	3.3	0.0	0.2	1.7	3.8	0.1	1.1	0.0	0.0	0.0	0.2	0.4	0.0	0.0	0.0	4.0	1.9	56.9	1.1	0.0	0.0	2.1	2.5	0.8	0.5	0.7	0.0	72.6	2.2	0.1	0.0	0.0	0.5	0.3	0.0	0.1	0.1	0.0	1.9	0.0	0.0	1.6	2.8	0.0	0.0	0.0	0.0	0.7	0.1	2.6	1.6	0.8	0.1	32.6	0.0	0.0	10.3	0.1	0.0	0.0	0.0	6.5	2.0	0.0	15.8	0.0	1.2	7.5	39.9	1.0	0.0	1.1	7.3	0.0	3.0	372.7	0.0	0.0	5.6	0.0	0.5	0.0	0.0	0.0	0.0	0.2	9.7	0.0	0.0	2.1	0.1	0.8	1.1	1.8	14.8	0.0	0.0	0.0	0.1	9.4	0.4	1.2	2.3	2.8	1.6	0.9	0.6	3.9	0.2	0.0	7.4	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.1	3.3	1.7	3.8	4.0	1.9	2.1	2.5	2.2	1.9	2.8	2.6	0.0	0.0	0.0	3.6	0.5	0.6	1.0	0.6	2.8	0.0	0.2	3.4	2.3	1.5	0.0	11.0	0.0	1171.5	0.0	0.0	727.8	0.1	0.0	0.1	0.1	3.1	0.0	0.0	0.7	0.0	84.0	6.1	0.0	0.0	0.0	3.8	0.0	0.9	84.2	0.0	0.2	0.0	0.0	0.0	0.0	0.2	0.3	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.1	0.0	0.4	0.0	0.8	0.0	3.2	0.4	0.0	0.0	0.0	0.4	0.8	8.9	0.2	0.0	1735.1	0.2	10.8	0.1	1.1
DUT	dUTPase	ENSG00000128951	"Deoxyuridine triphosphatase"	P33316	15	48331011-48343373	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Nucleotide metabolism"	Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Spermatocytes: 508.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA054422, HPA060360"	Enhanced		Supported	Nucleoplasm		No	Yes		31000	"Cluster 26: Non-specific - Mitochondria"	"Cluster 66: Lymphoid tissue - Immune response regulation"	"Cluster 32: U-937 - Innate immune response"	"Cluster 12: Non-specific - Cell cycle regulation"	Nucleoplasm		"HPA054422: AB_2682483, HPA060360: AB_2684262"	"unprognostic (1.82e-1)"	"unprognostic (3.49e-2)"	"unprognostic (7.89e-2)"	"unprognostic (5.27e-2)"	"unprognostic (2.20e-1)"	"unprognostic (7.17e-2)"	"unprognostic (1.65e-1)"	"unprognostic (1.16e-2)"	"unprognostic (4.42e-3)"	"unprognostic (1.87e-2)"	"unprognostic (4.25e-1)"	"unprognostic (3.54e-2)"	"unprognostic (3.68e-2)"	"unprognostic (4.23e-2)"	"unprognostic (1.47e-1)"	"unprognostic (2.09e-2)"	"unprognostic (1.71e-2)"	73.0	65.3	54.7	61.7	58.9	162.9	76.4	57.1	77.2	90.7	60.0	69.5	29.3	76.9	49.7	72.1	77.6	33.6	68.9	53.9	59.6	67.6	53.6	58.1	97.8	58.2	55.5	86.1	53.2	48.3	80.0	45.1	58.3	77.8	47.1	49.1	66.5	48.3	57.9	71.6	66.5	40.4	57.7	82.1	61.5	57.3	57.5	111.4	89.2	53.0	87.8	69.1	78.0	63.5	196.1	60.2	143.9	137.1	98.4	104.0	85.3	202.1	128.1	182.8	224.6	69.8	131.0	539.3	106.0	112.0	149.4	262.1	152.4	138.4	177.6	383.4	157.2	442.2	151.8	96.1	54.8	469.0	202.0	64.4	92.1	123.9	65.0	117.8	123.3	316.6	244.0	297.6	136.5	79.3	422.4	548.7	90.7	197.4	114.5	338.6	313.9	570.0	120.8	130.4	207.2	210.1	150.0	119.6	184.4	145.5	169.6	368.6	103.0	190.1	183.1	228.3	269.7	238.1	534.3	532.5	143.6	789.4	213.4	32.5	50.3	46.8	52.9	53.1	68.7	94.8	94.7	84.6	74.0	90.0	97.4	64.3	30.9	60.5	68.4	85.3	94.3	71.4	54.7	58.9	57.1	77.2	53.9	59.6	58.2	55.5	58.3	57.7	57.5	63.5	153.6	54.5	38.9	39.8	126.8	179.6	212.0	222.4	131.5	48.3	158.0	205.5	120.1	95.8	118.5	104.8	14.6	221.8	103.9	62.8	203.5	94.3	36.8	67.2	123.5	123.0	96.1	418.8	36.5	46.5	286.8	147.9	76.5	86.0	84.4	118.3	101.4	77.6	174.5	82.4	32.1	98.4	105.8	87.7	112.6	31.5	184.8	92.0	154.7	23.4	89.5	106.3	95.8	23.6	45.1	45.4	58.8	177.6	192.3	133.2	27.2	256.4	59.6	40.9	157.8	167.1	154.0	508.7	270.0	206.4	168.5	97.1	124.4	82.3	195.4	181.2
ECE1	ECE	ENSG00000117298	"Endothelin converting enzyme 1"	P42892	1	21217247-21345572	"Disease related genes, Enzymes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"		"Hydrolase, Metalloprotease, Protease"	"Disease variant, Hirschsprung disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Adipocytes: 164.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"neutrophil: 29.8"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HUVEC TERT2: 673.8;TIME: 588.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA001490, HPA013616"	Enhanced					NA	NA		1300000	"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 53: Intestinal epithelial cells - Unknown function"			"HPA001490: AB_1078718, HPA013616: AB_1847963"	"unprognostic (7.90e-2)"	"unprognostic (1.01e-1)"	"unprognostic (1.48e-1)"	"unprognostic (1.99e-2)"	"unprognostic (1.49e-2)"	"unprognostic (1.46e-1)"	"unprognostic (5.24e-2)"	"unprognostic (1.23e-1)"	"unprognostic (6.20e-2)"	"unprognostic (1.92e-3)"	"unprognostic (1.04e-1)"	"unprognostic (2.56e-1)"	"unprognostic (7.70e-2)"	"unprognostic (3.55e-2)"	"unprognostic (9.10e-2)"	"unprognostic (1.97e-2)"	"unprognostic (1.97e-2)"	87.3	123.2	26.5	47.7	29.4	48.1	79.4	23.0	30.1	61.4	12.6	71.0	30.1	42.4	10.0	26.7	46.9	36.8	70.9	21.3	33.7	38.1	54.0	72.1	35.7	34.4	25.7	71.0	91.8	125.0	47.4	66.5	30.4	53.1	34.7	14.7	33.6	25.1	19.8	34.3	46.1	42.3	21.2	48.5	43.3	22.7	28.1	21.1	51.4	33.2	34.9	58.8	43.8	27.5	93.0	60.1	77.9	38.3	111.0	116.4	44.1	135.4	236.8	72.9	66.6	44.1	275.8	34.0	323.6	138.8	157.7	38.4	32.6	64.9	63.5	83.0	27.2	48.7	89.9	34.8	144.3	7.1	11.8	61.6	74.3	112.6	55.8	199.2	673.8	27.6	10.0	17.7	62.9	19.4	14.6	11.4	23.2	26.3	46.5	17.5	45.0	49.2	114.0	17.0	26.4	63.1	134.3	79.2	57.4	42.5	55.9	20.2	588.7	160.7	77.9	73.3	79.9	26.4	49.0	39.1	332.6	16.5	196.6	0.2	8.4	3.3	2.9	10.0	4.2	6.1	6.1	4.6	0.7	4.1	4.0	2.7	29.8	1.5	7.8	2.8	8.6	7.2	26.5	29.4	23.0	30.1	21.3	33.7	34.4	25.7	30.4	21.2	28.1	27.5	164.0	19.2	7.5	46.4	25.1	20.3	19.7	81.6	18.8	5.0	71.3	44.7	18.9	10.0	54.7	23.9	0.0	6.0	12.4	105.8	5.9	25.8	1.5	19.6	35.2	106.1	25.2	20.2	19.2	56.7	35.0	51.8	20.9	51.8	18.4	35.4	97.1	36.0	3.3	0.0	14.8	13.0	57.0	9.6	14.3	4.2	43.5	17.3	7.2	31.9	25.5	50.4	8.2	13.6	22.5	100.4	106.5	55.3	29.4	34.9	45.7	7.5	24.2	4.4	39.5	72.7	47.5	1.3	5.9	8.5	16.1	10.5	17.9	80.6	21.6	40.8
ECE2	"KIAA0604, MGC2408"	ENSG00000145194	"Endothelin converting enzyme 2"	P0DPD6	3	184276011-184293031	"Enzymes, Metabolic proteins, Predicted membrane proteins"		"Hydrolase, Metalloprotease, Methyltransferase, Multifunctional enzyme, Protease, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 57.8;pancreas: 25.2;pituitary gland: 19.8"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 79.5;Extravillous trophoblasts: 51.1;Inhibitory neurons: 63.8;Late spermatids: 119.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	9	"REH: 10.3"															NA	NA				"Cluster 73: Brain - Neuropeptide signaling"	"Cluster 14: REH - Unknown function"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"				"unprognostic (2.70e-2)"	"unprognostic (1.44e-2)"	"unprognostic (1.91e-2)"	"prognostic unfavorable (8.41e-5)"	"unprognostic (1.37e-2)"	"unprognostic (1.09e-1)"	"prognostic unfavorable (5.80e-4)"	"unprognostic (1.47e-2)"	"unprognostic (3.69e-1)"	"unprognostic (2.65e-3)"	"unprognostic (1.70e-2)"	"unprognostic (5.95e-2)"	"unprognostic (1.63e-9)"	"unprognostic (3.66e-2)"	"unprognostic (6.16e-2)"	"unprognostic (2.19e-1)"	"unprognostic (1.25e-2)"	0.0	9.3	24.8	0.2	24.6	0.0	0.0	22.2	28.0	0.0	8.5	1.3	0.0	0.0	0.5	0.0	0.1	0.0	1.9	16.1	57.8	0.0	0.0	0.0	0.0	29.0	52.5	0.0	25.2	4.2	19.8	0.0	36.1	0.6	0.2	5.5	0.3	0.3	0.0	0.0	0.3	0.2	21.5	0.0	0.7	0.2	54.7	0.0	0.0	0.0	0.0	0.0	0.2	15.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.3	0.0	0.0	0.0	0.0	1.2	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	24.8	24.6	22.2	28.0	16.1	57.8	29.0	52.5	36.1	21.5	54.7	15.2	0.0	0.0	0.0	5.2	3.8	38.2	18.2	15.5	20.5	5.5	0.0	0.0	2.2	10.0	7.2	0.0	2.1	21.6	2.7	6.7	0.0	0.0	79.5	0.0	0.0	3.3	12.2	6.3	5.1	0.0	51.1	3.5	9.2	0.0	0.0	0.0	3.3	35.3	17.2	26.9	63.8	12.8	16.2	4.4	5.7	119.8	3.1	4.1	8.8	1.0	4.6	2.4	5.2	30.2	1.1	0.0	5.9	2.2	12.5	35.1	13.5	0.0	2.2	2.3	6.6	2.6	5.1	43.4	9.7	16.9	39.1	21.5	2.3	0.0	13.8	16.2
EDEM3	C1orf22	ENSG00000116406	"ER degradation enhancing alpha-mannosidase like protein 3"	Q9BZQ6	1	184690237-184754907	"Enzymes, Predicted intracellular proteins"	"Unfolded protein response"	Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA025754, HPA025755, HPA027297"	Approved		Approved	"Endoplasmic reticulum"	"Intracellular and membrane"	NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 86: Liver & Placenta - Transport via ER"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 27: Mucus-secreting cells - Mucin production"	"Endoplasmic reticulum"		"HPA025754: AB_1845638, HPA025755: AB_1845639, HPA027297: AB_2672205"	"unprognostic (1.74e-1)"	"unprognostic (1.64e-2)"	"unprognostic (3.08e-2)"	"unprognostic (2.67e-2)"	"unprognostic (2.30e-1)"	"unprognostic (3.10e-2)"	"unprognostic (7.52e-3)"	"unprognostic (1.82e-1)"	"unprognostic (7.06e-2)"	"unprognostic (1.66e-1)"	"unprognostic (1.66e-1)"	"unprognostic (3.53e-2)"	"prognostic unfavorable (1.63e-6)"	"unprognostic (4.72e-2)"	"unprognostic (1.29e-1)"	"unprognostic (1.08e-2)"	"unprognostic (2.01e-1)"	14.3	12.4	3.8	13.8	4.8	8.2	10.9	6.6	5.1	13.7	4.3	20.6	18.8	8.8	8.0	9.2	6.6	11.7	7.2	4.1	6.5	10.6	20.3	11.2	10.2	4.7	5.7	5.7	15.7	13.0	7.1	20.8	4.6	13.5	24.0	11.4	13.2	8.7	12.2	6.6	16.3	12.0	4.5	10.5	35.8	7.4	5.5	10.8	11.8	11.4	10.7	13.6	5.8	6.3	15.1	11.2	15.0	13.4	53.8	55.0	24.5	29.9	20.7	11.1	11.6	5.9	42.4	10.5	31.8	22.8	11.3	20.1	14.6	15.6	16.4	10.3	11.9	13.8	11.7	8.5	20.7	36.4	19.5	31.6	18.8	27.1	24.2	21.0	30.4	27.4	36.8	47.4	21.6	12.5	29.3	18.8	21.2	34.1	10.2	12.7	11.6	36.2	16.1	10.4	16.9	23.9	14.7	25.2	20.8	24.9	23.7	56.3	36.1	16.1	7.2	34.3	25.5	72.1	29.8	13.6	21.3	40.7	35.6	5.0	3.5	2.2	1.4	3.5	2.5	1.3	2.2	1.7	3.1	0.9	3.0	1.6	3.6	2.2	3.6	1.6	1.5	1.8	3.8	4.8	6.6	5.1	4.1	6.5	4.7	5.7	4.6	4.5	5.5	6.3	35.1	19.2	19.3	41.4	19.9	16.7	8.4	9.8	19.9	26.1	20.4	11.4	16.0	12.8	21.8	14.7	25.0	13.8	13.2	55.1	0.0	14.0	16.0	14.3	21.2	25.9	30.6	32.4	58.2	35.6	10.9	28.0	96.8	17.0	21.0	12.9	19.2	47.0	13.0	21.9	62.8	76.5	2.0	40.1	30.3	7.1	20.5	33.0	19.6	36.5	31.0	7.8	11.3	47.3	61.6	20.0	28.1	18.0	73.6	27.1	21.4	9.7	28.1	15.2	19.7	20.3	18.7	15.0	8.7	18.2	20.5	19.4	24.9	53.8	32.4	19.1
EEF1AKMT4-ECE2		ENSG00000284917	"EEF1AKMT4-ECE2 readthrough"	P0DPD8	3	184249695-184293031	"Enzymes, Predicted membrane proteins"		"Hydrolase, Metalloprotease, Methyltransferase, Multifunctional enzyme, Protease, Transferase"		"Evidence at protein level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Evidence at protein level"	"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA062215			Uncertain	Nucleoplasm,Cytosol		NA	NA							"Nucleoplasm, Cytosol"		"HPA062215: AB_2684714"																		0.0	0.5	0.0	0.1	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
EIF2S3	"EIF2, EIF2G, EIF2gamma"	ENSG00000130741	"Eukaryotic translation initiation factor 2 subunit gamma"	P41091	X	24054946-24078810	"Disease related genes, Enzymes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Protein biosynthesis"	"Hydrolase, Initiation factor"	"Disease variant, Epilepsy, Mental retardation, Obesity"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											CAB012471	Approved					NA	NA			"Cluster 30: Non-specific - Translation"	"Cluster 50: Non-specific - Ribosome"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 32: Non-specific - Translation"			"CAB012471: AB_873547"	"unprognostic (1.40e-1)"	"unprognostic (1.38e-1)"	"unprognostic (1.86e-1)"	"unprognostic (5.27e-2)"	"unprognostic (8.45e-2)"	"unprognostic (1.46e-3)"	"prognostic unfavorable (3.05e-4)"	"unprognostic (1.47e-1)"	"unprognostic (1.68e-1)"	"unprognostic (6.66e-3)"	"unprognostic (6.94e-3)"	"unprognostic (1.09e-1)"	"prognostic unfavorable (5.44e-6)"	"unprognostic (4.88e-3)"	"unprognostic (2.11e-1)"	"unprognostic (1.02e-1)"	"unprognostic (2.51e-1)"	65.5	51.8	31.9	71.8	33.5	76.2	82.9	35.7	35.4	78.0	42.5	67.2	66.4	83.8	45.0	62.5	79.9	53.3	57.1	31.4	33.0	69.6	74.6	50.7	113.3	35.9	32.2	131.3	94.8	49.6	30.1	46.4	35.7	51.7	66.3	46.9	69.7	41.7	66.7	71.8	53.0	74.3	35.8	72.1	66.7	18.6	34.8	97.6	69.9	51.8	111.6	66.4	65.6	41.4	261.0	256.0	110.3	182.7	113.5	235.5	73.2	142.3	127.4	114.8	130.6	290.8	174.3	449.5	141.0	104.9	251.9	165.1	344.7	271.3	140.8	147.8	203.7	177.2	467.8	164.3	126.2	304.0	219.4	206.9	169.2	129.6	269.7	152.9	166.2	176.0	275.4	176.0	127.7	124.8	170.6	278.8	268.2	118.1	146.5	169.5	215.2	271.4	155.4	241.5	60.2	130.8	232.3	224.7	239.8	205.5	289.6	205.1	140.2	97.1	66.7	177.3	125.3	156.6	322.4	240.9	120.9	193.1	113.7	64.4	141.1	27.9	84.9	151.9	147.8	156.0	148.8	113.9	123.9	120.6	187.5	156.6	51.2	106.3	132.6	97.4	124.2	127.2	31.9	33.5	35.7	35.4	31.4	33.0	35.9	32.2	35.7	35.8	34.8	41.4	76.5	44.8	54.5	48.0	187.6	126.6	98.0	51.8	145.1	25.3	128.4	91.2	49.1	74.4	49.0	40.5	25.0	59.6	127.5	35.2	111.6	67.9	0.5	67.3	109.4	67.5	44.9	92.5	19.0	57.6	122.1	72.3	78.5	90.9	100.8	84.6	84.3	58.8	89.1	20.2	20.1	65.0	32.6	138.9	91.9	3.5	67.7	109.7	55.2	36.5	134.5	30.4	78.2	23.6	31.4	59.5	68.9	61.3	99.3	70.2	72.3	135.2	40.6	33.3	72.3	85.0	87.4	10.2	21.9	130.7	151.2	71.0	117.9	76.2	100.4	92.9
EIF2S3B	"eIF-2-gamma2, eIF2gA"	ENSG00000180574	"Eukaryotic translation initiation factor 2 subunit gamma B"	Q2VIR3	12	10505602-10523135	"Enzymes, Predicted intracellular proteins"	"Protein biosynthesis"	"Hydrolase, Initiation factor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in some"			"Cell type enhanced"	"Detected in some"		"Club cells: 1.3;granulocytes: 1.3"	"Low cancer specificity"	"Detected in some"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HL-60: 5.0;MOLT-4: 4.3;RH-30: 3.0"															NA	NA			"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 71: Testis - DNA repair"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 7: Non-specific - Mitochondria"				"unprognostic (2.23e-1)"	"unprognostic (6.09e-2)"	"unprognostic (1.03e-2)"	"unprognostic (1.05e-1)"	"unprognostic (1.05e-1)"	"unprognostic (1.45e-1)"	"unprognostic (1.16e-2)"	"unprognostic (9.02e-2)"	"unprognostic (7.67e-2)"	"unprognostic (2.56e-1)"	"unprognostic (2.58e-4)"	"unprognostic (4.95e-2)"	"unprognostic (2.29e-1)"	"unprognostic (3.24e-2)"	"unprognostic (9.45e-3)"	"unprognostic (2.73e-1)"	"unprognostic (4.39e-1)"	0.9	0.8	0.1	0.3	0.1	0.1	0.8	0.1	0.1	1.3	0.1	1.1	1.0	1.4	0.0	0.9	0.7	0.1	0.7	0.0	0.0	0.7	0.5	0.8	0.1	0.1	0.0	1.6	1.4	0.0	0.4	0.0	0.2	0.5	0.0	0.3	0.9	0.0	1.2	0.9	0.9	0.0	0.0	0.6	1.0	2.4	0.1	0.0	0.6	0.1	0.0	1.1	1.0	0.2	0.4	0.3	0.3	2.0	0.3	0.7	1.3	0.2	0.0	0.0	0.1	0.2	0.2	0.1	1.6	0.1	0.6	2.7	1.0	0.3	0.0	0.5	1.2	0.2	0.8	2.2	0.0	5.0	1.3	0.0	0.0	0.7	0.1	0.1	0.6	0.3	0.3	0.2	0.1	0.0	4.3	0.0	1.0	0.0	0.4	0.1	3.0	0.4	0.1	0.1	0.9	0.2	0.8	0.2	0.3	0.4	0.4	0.1	0.0	0.2	0.1	0.3	2.6	0.3	2.2	0.3	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.1	0.1	0.0	0.1	0.0	0.1	0.1	0.0	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.0	0.1	0.0	0.2	0.0	0.1	0.2	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.4	0.1	0.0	0.0	1.3	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.4	0.6	0.1	0.0	0.0	0.0	0.0	0.6	0.2	0.0	0.4	1.3	0.3	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.4	0.2	0.3	0.0	0.0
EIF3F	"eIF3-epsilon, eIF3-p47, EIF3S5"	ENSG00000175390	"Eukaryotic translation initiation factor 3 subunit F"	O00303	11	7970251-8001862	"Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins"	"Protein biosynthesis, Ubl conjugation pathway"	"Hydrolase, Initiation factor, Protease, Thiol protease"	"Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA049250	Approved					NA	NA		83000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 50: Non-specific - Ribosome"	"Cluster 24: NB-4 - Immune response"	"Cluster 32: Non-specific - Translation"			"HPA049250: AB_2680692"	"unprognostic (1.11e-2)"	"unprognostic (1.42e-1)"	"unprognostic (8.46e-2)"	"unprognostic (1.15e-2)"	"unprognostic (8.50e-2)"	"unprognostic (2.26e-1)"	"prognostic unfavorable (6.86e-4)"	"unprognostic (1.16e-1)"	"unprognostic (1.97e-1)"	"unprognostic (1.74e-1)"	"unprognostic (3.11e-1)"	"unprognostic (2.04e-1)"	"unprognostic (1.57e-1)"	"unprognostic (5.66e-2)"	"unprognostic (2.61e-1)"	"unprognostic (8.36e-2)"	"unprognostic (8.78e-2)"	225.1	160.8	7.8	10.2	7.4	21.7	216.8	8.6	7.6	249.1	5.1	248.9	10.5	206.8	10.1	227.3	213.3	16.7	186.2	7.6	6.6	165.8	160.3	157.0	24.7	7.9	6.8	353.9	361.3	8.0	126.6	11.7	7.7	170.0	12.6	15.5	175.5	12.9	374.0	333.1	188.6	21.2	6.7	201.6	238.9	132.7	7.3	11.8	153.7	12.8	25.4	218.7	212.9	8.2	23.6	9.3	12.7	11.3	23.5	52.6	39.9	16.1	28.1	20.3	19.4	9.6	23.0	70.4	6.7	15.7	9.1	12.5	9.9	27.7	20.4	23.1	32.4	24.8	9.5	11.1	38.7	26.9	10.0	32.2	32.7	7.9	18.7	18.6	20.7	12.6	21.5	16.1	22.2	9.6	15.8	25.5	13.1	9.5	22.6	17.7	17.3	22.4	11.0	15.8	29.2	50.6	15.2	6.7	19.3	7.7	11.9	18.6	19.3	9.5	11.0	6.9	11.7	11.8	21.1	29.0	6.4	16.8	12.6	37.5	92.4	41.7	81.5	99.7	112.1	174.6	130.5	96.4	130.9	161.6	155.4	114.5	11.7	95.8	93.6	87.7	177.6	246.5	7.8	7.4	8.6	7.6	7.6	6.6	7.9	6.8	7.7	6.7	7.3	8.2	179.9	109.0	145.4	11.1	355.2	349.1	364.1	411.0	266.9	72.2	271.6	285.6	96.8	264.5	197.2	79.1	52.1	631.3	283.7	121.1	293.5	277.0	424.5	113.8	204.9	218.3	210.2	221.7	11.5	442.8	670.6	216.3	139.7	112.1	164.8	335.7	256.6	170.6	344.2	45.4	10.9	262.0	140.4	423.1	398.1	913.3	246.0	263.4	247.3	8.4	471.1	141.5	362.5	7.5	18.8	322.2	242.2	196.7	237.6	247.4	312.9	286.9	115.1	87.1	98.6	222.4	374.3	197.0	124.8	358.3	440.4	563.4	319.3	264.8	392.2	426.0
EIF4A1	"DDX2A, EIF-4A, EIF4A"	ENSG00000161960	"Eukaryotic translation initiation factor 4A1"	P60842	17	7572824-7579006	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Host-virus interaction, Protein biosynthesis"	"Helicase, Hydrolase, Initiation factor, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Basal keratinocytes: 1342.5;Basal respiratory cells: 1913.6;Langerhans cells: 1330.1;Suprabasal keratinocytes: 1233.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB011689, HPA068286"	Uncertain		Approved	Cytosol		NA	NA		4100000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 11: Squamous epithelial cells - Epithelial cell function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 10: Non-specific - Unknown function"	Cytosol		"CAB011689: AB_732122, HPA068286: AB_2685968"	"unprognostic (1.49e-2)"	"unprognostic (2.41e-1)"	"unprognostic (8.00e-2)"	"unprognostic (2.17e-1)"	"unprognostic (2.49e-1)"	"unprognostic (2.12e-3)"	"unprognostic (7.25e-2)"	"unprognostic (2.89e-2)"	"unprognostic (2.72e-2)"	"unprognostic (2.11e-2)"	"unprognostic (2.65e-2)"	"unprognostic (5.19e-3)"	"prognostic unfavorable (1.76e-8)"	"unprognostic (1.91e-1)"	"unprognostic (5.96e-2)"	"unprognostic (1.16e-1)"	"unprognostic (1.13e-2)"	500.5	373.3	110.2	296.5	113.4	416.2	354.2	118.1	129.6	287.0	116.7	260.6	199.7	290.3	196.6	566.2	307.9	229.5	229.7	112.7	123.9	274.2	328.3	339.0	286.3	128.9	119.1	302.8	360.5	150.4	190.2	301.9	125.9	219.2	289.5	118.5	268.6	168.7	281.2	375.5	228.9	316.6	122.9	291.4	313.2	159.8	131.2	309.3	171.4	122.4	385.2	506.9	321.6	131.5	1048.3	1396.3	914.1	833.9	802.7	931.9	852.4	977.9	1104.0	1770.4	1356.8	1420.1	457.7	1428.7	735.7	1032.2	774.7	907.6	1962.5	1505.4	1890.2	468.1	1454.0	799.3	854.7	1597.9	1226.2	826.4	771.9	1244.8	763.3	1491.8	1510.3	1055.1	1351.6	784.4	831.1	284.9	1294.2	1092.6	865.0	704.8	789.1	1068.6	952.6	802.1	691.1	682.2	1249.8	939.1	481.2	934.2	883.0	585.6	1273.8	679.4	651.5	625.1	976.1	930.2	649.9	603.8	2010.9	276.0	425.7	921.2	1000.8	999.3	1045.7	318.5	1639.1	408.1	463.4	1377.5	755.2	469.1	493.1	497.9	1905.9	412.2	477.7	488.1	157.1	658.5	1076.3	727.7	682.0	2945.6	110.2	113.4	118.1	129.6	112.7	123.9	128.9	119.1	125.9	122.9	131.2	131.5	212.3	115.4	239.6	0.0	139.7	1342.5	678.5	1913.6	173.0	113.5	191.0	183.4	6.8	104.4	799.6	73.5	116.7	345.6	185.8	100.5	152.6	295.4	32.4	120.7	171.6	286.1	116.1	139.6	0.0	231.4	370.5	299.2	129.5	165.0	149.1	237.5	154.2	63.8	212.1	106.0	0.0	117.3	767.0	160.4	1330.1	42.0	160.9	206.7	725.7	0.0	133.3	120.7	119.4	0.0	0.0	313.9	123.3	109.1	134.7	342.8	151.8	174.0	446.1	119.4	151.2	374.4	871.4	71.5	102.8	154.0	1233.4	636.9	224.2	197.1	135.9	474.6
EIF4A2	"BM-010, DDX2B, EIF4A, EIF4F"	ENSG00000156976	"Eukaryotic translation initiation factor 4A2"	Q14240	3	186783205-186789897	"Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins"	"Host-virus interaction, Protein biosynthesis"	"Helicase, Hydrolase, Initiation factor, RNA-binding"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB011690, HPA068286"	Uncertain		Approved	Cytosol		NA	NA		1600000	"Cluster 44: Non-specific - Transcription"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 22: Epithelial cell types - Mixed function"	Cytosol		"CAB011690: AB_732123, HPA068286: AB_2685968"	"unprognostic (1.49e-1)"	"unprognostic (9.62e-2)"	"unprognostic (3.78e-2)"	"unprognostic (9.50e-3)"	"unprognostic (2.82e-2)"	"unprognostic (1.10e-2)"	"unprognostic (4.46e-2)"	"unprognostic (6.27e-2)"	"unprognostic (4.32e-3)"	"unprognostic (1.00e-1)"	"unprognostic (6.39e-2)"	"unprognostic (3.99e-2)"	"unprognostic (6.36e-2)"	"unprognostic (3.22e-1)"	"unprognostic (3.03e-1)"	"unprognostic (4.67e-2)"	"unprognostic (2.62e-2)"	178.4	288.5	277.5	105.8	302.9	7.3	243.4	328.0	388.2	274.5	251.6	282.5	143.3	325.0	196.3	178.1	322.0	205.3	383.9	309.0	331.3	287.8	202.6	156.2	192.3	275.4	254.5	606.8	272.1	189.2	292.5	218.8	290.2	249.7	179.7	310.3	213.5	262.9	675.3	93.7	165.7	252.8	270.6	159.0	196.0	155.3	316.9	178.0	293.8	553.2	170.0	224.3	186.8	275.6	95.4	44.6	179.1	30.2	624.9	589.3	59.3	158.9	138.5	159.1	202.1	159.9	34.2	200.0	812.8	213.7	283.4	146.8	255.2	66.5	272.0	182.6	134.8	304.8	54.4	214.5	249.6	68.3	209.0	402.5	291.8	47.8	368.3	764.1	275.2	161.6	109.6	311.9	496.8	14.2	112.5	31.2	183.7	337.0	199.4	143.3	124.1	122.2	305.9	110.4	331.8	71.9	241.4	175.4	356.9	427.3	269.6	244.3	205.6	122.8	63.0	123.9	87.7	252.1	374.8	85.9	86.9	71.0	63.9	233.4	78.5	88.5	125.8	87.5	200.8	245.4	183.2	154.5	91.0	203.0	273.4	224.2	50.5	169.6	125.3	85.4	187.3	282.3	277.5	302.9	328.0	388.2	309.0	331.3	275.4	254.5	290.2	270.6	316.9	275.6	265.3	118.6	220.2	68.6	416.9	690.3	770.9	595.8	412.6	267.4	396.7	308.2	271.3	327.5	447.9	261.1	64.6	450.1	370.8	306.7	661.2	254.3	33.0	287.9	297.5	319.2	407.8	221.4	146.8	94.5	251.2	367.8	250.2	344.2	312.1	267.2	258.1	142.4	226.6	390.3	138.0	372.9	455.7	228.6	385.2	56.8	385.8	242.9	345.1	92.8	318.1	383.9	256.4	73.9	118.7	136.0	410.8	472.8	235.7	737.4	567.9	665.2	337.8	192.8	236.7	409.7	489.9	223.8	165.4	314.8	618.0	615.5	449.2	345.6	380.1	879.5
EIF4A3	"DDX48, EIF4AIII, Fal1, KIAA0111"	ENSG00000141543	"Eukaryotic translation initiation factor 4A3"	P38919	17	80134369-80147151	"Disease related genes, Enzymes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Transporters"	"mRNA processing, mRNA splicing, mRNA transport, Nonsense-mediated mRNA decay, rRNA processing, Translation regulation, Transport"	"Helicase, Hydrolase, RNA-binding"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA021878	Supported		Supported	Nucleoplasm		NA	NA		280000	"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 7: Non-specific - Mitochondria"	Nucleoplasm		"HPA021878: AB_1848090"	"unprognostic (7.24e-2)"	"unprognostic (7.33e-3)"	"prognostic favorable (3.57e-5)"	"unprognostic (1.29e-2)"	"unprognostic (2.95e-1)"	"unprognostic (2.52e-2)"	"prognostic unfavorable (1.68e-5)"	"prognostic unfavorable (1.87e-4)"	"unprognostic (3.71e-1)"	"unprognostic (5.06e-2)"	"unprognostic (4.64e-2)"	"unprognostic (2.64e-2)"	"unprognostic (9.78e-3)"	"unprognostic (5.81e-2)"	"unprognostic (9.20e-2)"	"unprognostic (1.38e-2)"	"unprognostic (2.91e-3)"	65.8	81.4	19.0	49.1	21.1	185.8	44.2	21.5	27.2	51.2	22.8	44.3	38.6	46.6	38.8	81.9	54.7	40.1	38.0	22.3	21.0	45.1	42.6	44.0	67.0	19.9	19.5	66.5	37.0	58.5	41.1	52.9	20.3	38.7	47.5	32.3	42.4	32.6	37.3	64.8	38.9	42.6	22.7	47.6	41.4	42.8	20.0	78.2	37.0	34.9	74.7	83.4	55.1	24.7	237.2	208.9	140.5	103.8	105.5	63.2	114.4	119.3	91.0	177.7	141.4	223.7	110.3	221.4	67.9	112.9	126.4	152.2	194.9	136.2	195.0	71.5	192.3	142.5	159.3	244.3	103.1	253.8	133.4	98.7	68.7	149.5	119.4	71.8	147.2	128.7	189.8	140.2	105.3	178.9	224.8	132.8	145.0	223.8	190.0	168.5	282.7	172.2	85.8	196.5	186.1	100.1	170.9	334.2	151.9	130.1	219.3	166.7	100.5	108.7	138.6	159.9	200.3	104.4	86.2	403.2	88.0	158.7	113.3	126.1	167.0	137.4	101.1	174.6	131.2	142.4	128.2	119.4	200.0	119.8	116.9	115.2	98.7	132.9	143.4	326.0	158.2	232.6	19.0	21.1	21.5	27.2	22.3	21.0	19.9	19.5	20.3	22.7	20.0	24.7	117.9	41.7	48.0	6.8	135.1	283.1	273.4	212.9	107.0	23.3	77.0	109.2	61.5	38.6	107.8	29.5	16.7	140.1	165.7	75.4	64.6	85.6	33.2	132.9	109.2	70.5	60.3	24.4	4.1	115.2	225.1	144.3	149.4	248.2	92.6	42.6	32.2	27.0	108.5	6.7	4.3	83.2	89.5	63.4	255.0	12.1	67.1	199.6	103.2	10.3	67.9	48.6	23.7	5.5	7.6	86.6	83.1	49.7	118.6	96.0	47.9	65.0	61.4	32.5	85.5	109.7	207.8	99.4	123.2	77.6	299.1	261.9	138.4	98.0	77.7	252.5
EIF5B	"DKFZp434I036, FLJ10524, IF2, KIAA0741"	ENSG00000158417	"Eukaryotic translation initiation factor 5B"	O60841	2	99337371-99401326	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Protein biosynthesis"	"Hydrolase, Initiation factor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 769.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA034648, HPA040095"	Approved		Approved	"Plasma membrane,Cytosol"		NA	Yes		210000	"Cluster 6: Non-specific - Transcription"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 39: Non-specific - Basic cellular processes"	Cytosol	"Plasma membrane"	"HPA034648: AB_10601902, HPA040095: AB_2676843"	"unprognostic (1.23e-1)"	"unprognostic (6.94e-2)"	"unprognostic (2.01e-1)"	"unprognostic (5.03e-2)"	"unprognostic (4.65e-2)"	"unprognostic (5.88e-3)"	"prognostic unfavorable (7.15e-10)"	"unprognostic (6.80e-2)"	"unprognostic (9.84e-3)"	"prognostic favorable (8.99e-4)"	"unprognostic (1.68e-2)"	"unprognostic (2.36e-1)"	"prognostic unfavorable (1.42e-6)"	"unprognostic (6.89e-2)"	"unprognostic (3.24e-2)"	"unprognostic (1.43e-1)"	"unprognostic (7.93e-3)"	39.4	31.6	50.3	32.8	53.5	20.8	33.9	50.8	88.8	31.3	51.1	56.3	23.1	35.2	41.7	44.4	29.6	18.5	89.6	48.8	55.3	50.9	38.4	30.9	32.6	54.1	52.5	27.0	48.6	32.1	28.2	29.6	55.0	44.0	30.0	23.8	36.5	33.5	102.9	39.4	29.1	28.7	52.8	30.7	42.1	48.6	53.6	26.2	29.3	56.2	36.6	47.8	33.7	53.0	117.0	57.2	63.8	83.5	75.5	88.7	105.4	100.4	62.9	65.3	64.6	132.5	80.9	132.5	84.6	75.2	77.4	64.9	112.6	97.3	114.6	80.8	67.4	159.6	57.7	175.9	59.7	158.0	94.3	60.2	66.8	91.0	92.1	55.9	96.6	80.0	179.6	64.4	95.2	94.9	100.8	145.7	99.5	76.2	83.0	86.8	94.7	108.2	134.9	96.2	53.8	50.9	54.6	123.8	85.3	120.4	50.5	103.0	106.9	100.7	99.3	53.2	90.7	47.4	72.0	106.0	73.3	172.0	75.9	19.8	11.0	13.7	15.5	12.5	18.2	20.9	16.3	15.5	8.4	19.8	15.9	17.0	2.9	18.3	17.3	26.2	12.5	6.4	50.3	53.5	50.8	88.8	48.8	55.3	54.1	52.5	55.0	52.8	53.6	53.0	121.7	109.0	219.6	23.8	152.4	321.3	200.4	209.0	84.8	103.8	159.1	112.1	579.1	135.8	198.6	343.9	50.1	143.7	142.9	135.0	144.8	210.5	769.9	143.1	175.0	153.2	157.9	154.2	27.4	235.1	205.3	130.4	82.0	157.5	172.7	90.0	146.3	480.9	134.7	77.4	28.3	206.7	144.5	123.5	128.9	144.0	124.5	95.7	142.3	18.7	157.7	91.8	145.2	21.6	36.7	282.6	93.8	175.7	183.2	253.9	102.7	226.2	165.4	111.3	276.1	167.3	157.7	575.3	505.0	99.1	324.8	181.4	133.4	101.7	185.1	244.7
ELAC1	D29	ENSG00000141642	"ElaC ribonuclease Z 1"	Q9H777	18	50967991-50988121	"Enzymes, Predicted intracellular proteins"	"tRNA processing"	"Endonuclease, Hydrolase, Nuclease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA040867, HPA066483"	Approved		Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 37: B-cells - Transcription"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 39: Non-specific - Basic cellular processes"	Nucleoplasm	Cytosol	"HPA040867: AB_10697716, HPA066483: AB_2685675"	"unprognostic (1.05e-2)"	"unprognostic (1.65e-1)"	"unprognostic (6.95e-3)"	"unprognostic (1.75e-2)"	"unprognostic (8.61e-2)"	"unprognostic (5.96e-2)"	"unprognostic (3.25e-1)"	"unprognostic (3.03e-3)"	"unprognostic (5.87e-2)"	"unprognostic (2.82e-3)"	"unprognostic (3.67e-3)"	"unprognostic (6.36e-2)"	"prognostic favorable (8.43e-8)"	"unprognostic (3.54e-2)"	"unprognostic (1.12e-1)"	"unprognostic (2.59e-2)"	"unprognostic (3.87e-2)"	5.1	7.2	4.2	5.4	4.4	2.3	6.2	3.9	6.0	5.0	4.8	6.2	5.0	4.4	12.8	4.4	6.4	4.1	3.3	4.4	5.2	8.0	9.9	5.1	6.7	3.8	3.9	5.5	8.7	11.8	5.7	5.6	4.0	6.2	7.0	5.0	6.6	6.1	3.1	4.6	6.5	4.3	3.3	6.9	6.3	7.2	5.2	7.2	10.2	2.8	6.9	4.7	3.4	5.1	9.1	6.1	16.0	13.6	17.5	7.4	6.8	9.8	12.7	9.0	6.3	2.3	7.9	7.0	6.5	9.1	7.2	8.8	5.0	10.3	6.1	15.4	1.3	8.6	2.3	1.6	10.4	22.1	5.8	9.3	8.1	4.8	11.0	7.2	9.5	10.0	8.9	16.9	16.0	4.1	7.8	6.4	8.0	7.6	3.1	8.6	5.6	13.0	10.4	3.8	9.4	10.7	8.2	1.4	15.5	6.6	7.5	16.6	8.4	11.6	6.0	3.4	6.7	15.8	14.4	9.3	10.7	7.3	14.9	5.0	9.6	10.0	15.4	11.5	17.1	18.6	14.7	14.9	15.4	16.8	14.0	18.1	0.9	20.8	11.4	13.0	12.8	10.0	4.2	4.4	3.9	6.0	4.4	5.2	3.8	3.9	4.0	3.3	5.2	5.1	5.9	6.4	6.5	7.2	7.6	2.4	5.6	14.5	4.6	7.3	8.7	10.4	8.6	12.8	8.0	3.7	2.1	23.3	4.0	8.5	19.6	14.6	21.4	8.8	6.3	7.9	10.3	5.5	4.1	13.5	13.3	8.1	3.1	4.8	8.2	11.4	10.0	15.2	15.4	5.0	5.3	8.2	14.2	8.9	2.8	22.8	5.0	6.3	5.4	2.8	10.2	15.8	23.7	7.5	8.4	10.4	9.1	7.2	5.6	8.1	15.9	25.5	11.8	8.2	0.0	8.5	6.4	29.1	12.9	5.6	3.4	18.9	6.8	11.1	10.5	4.9
ELAC2	"FLJ10530, HPC2"	ENSG00000006744	"ElaC ribonuclease Z 2"	Q9BQ52	17	12991612-13018065	"Disease related genes, Enzymes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"tRNA processing"	"Endonuclease, Hydrolase, Nuclease"	"Disease variant, Primary mitochondrial disease, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"SuSa: 394.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA019535	Approved		Supported	Nucleoplasm		NA	NA		9500	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 12: NES - Nervous system development"	"Cluster 47: Cytotrophoblasts - Unknown function"	Nucleoplasm		"HPA019535: AB_1848106"	"unprognostic (4.24e-3)"	"unprognostic (2.26e-1)"	"unprognostic (1.11e-1)"	"prognostic favorable (3.24e-6)"	"unprognostic (8.64e-2)"	"unprognostic (1.53e-1)"	"unprognostic (1.65e-1)"	"unprognostic (2.47e-1)"	"unprognostic (2.22e-1)"	"unprognostic (3.98e-1)"	"unprognostic (5.31e-3)"	"unprognostic (3.09e-1)"	"unprognostic (5.31e-3)"	"unprognostic (2.21e-1)"	"unprognostic (1.15e-1)"	"unprognostic (8.09e-2)"	"unprognostic (3.70e-2)"	30.7	35.8	13.7	23.0	14.6	22.7	24.6	14.7	14.3	21.7	18.0	28.7	23.1	24.7	17.1	31.9	25.8	21.1	38.1	13.8	15.0	28.6	32.5	19.8	28.0	16.4	14.6	19.8	23.1	33.8	12.5	23.5	15.3	26.4	32.7	22.5	20.4	33.6	60.2	23.8	21.1	33.6	17.1	28.8	24.8	28.1	13.4	28.4	25.8	35.7	37.6	24.6	18.2	22.1	76.4	102.1	69.8	81.5	53.3	53.9	44.9	75.4	59.6	119.8	79.8	84.3	34.8	127.7	84.9	69.9	45.0	96.6	133.6	80.6	113.5	65.7	163.7	73.0	82.1	54.7	40.7	64.7	99.4	47.3	70.6	88.2	80.5	51.4	88.3	71.5	108.0	34.8	88.7	58.0	112.0	58.3	62.2	132.9	80.7	84.1	122.2	82.2	62.0	59.2	37.5	54.6	97.4	61.0	39.2	394.4	59.1	26.2	82.7	152.3	47.6	57.0	116.3	24.7	51.6	53.3	57.6	64.2	54.6	26.9	31.1	19.2	41.6	41.2	43.4	37.7	39.1	40.7	48.4	34.4	39.7	36.2	4.7	53.5	46.8	30.1	53.4	46.3	13.7	14.6	14.7	14.3	13.8	15.0	16.4	14.6	15.3	17.1	13.4	22.1	11.6	6.4	10.8	6.8	18.0	10.3	10.1	16.7	16.5	11.3	12.5	10.8	28.3	12.8	12.9	16.5	2.1	59.3	15.6	13.2	19.6	27.4	6.4	13.0	13.1	14.1	8.4	24.0	9.8	26.0	32.6	16.6	17.3	14.2	9.5	30.4	11.7	28.4	28.2	11.8	9.2	13.5	24.4	14.2	7.0	5.7	10.5	10.0	14.2	3.7	14.7	16.1	14.4	7.1	10.6	25.9	16.6	21.4	21.6	13.5	15.2	19.5	12.2	14.6	52.6	10.1	14.9	26.4	24.4	22.2	14.5	33.5	15.9	59.0	20.7	8.2
ELANE	"ELA2, HLE, HNE, NE"	ENSG00000197561	"Elastase, neutrophil expressed"	P08246	19	851014-856247	"Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted secreted proteins"		"Hydrolase, Protease, Serine protease"	"Cancer-related genes, Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	91	"bone marrow: 3894.9"	"Cell type enhanced"	"Detected in some"		"Basal keratinocytes: 8.7;Fibroblasts: 16.2;Langerhans cells: 11.1;Leydig cells: 6.2;Melanocytes: 7.2;Suprabasal keratinocytes: 7.4"	"Group enriched"	"Detected in some"	7	"pancreatic cancer: 3.5;stomach cancer: 3.7"	"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	9	"classical monocyte: 4.0;neutrophil: 12.1"	"Group enriched"	"Detected in many"	9	"granulocytes: 12.1;monocytes: 4.0"	"Cell line enriched"	"Detected in some"	91	"THP-1: 3105.0"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"CAB015409, HPA066836, HPA073774"	Enhanced				"Secreted to blood"	NA	NA		370000	"Cluster 1: Neutrophils - Mixed function"	"Cluster 67: Neutrophils - Humoral immune response"	"Cluster 43: THP-1 - Innate immune response"	"Cluster 50: Fibroblasts - ECM organization"			"CAB015409: AB_831596, HPA066836: AB_2685733, HPA073774: "	"unprognostic (3.46e-2)"	"unprognostic (1.10e-1)"	"unprognostic (1.42e-3)"	"unprognostic (2.09e-2)"	"unprognostic (1.80e-3)"	"unprognostic (3.43e-2)"	"unprognostic (3.92e-1)"	"unprognostic (6.38e-3)"	"unprognostic (5.80e-1)"	"unprognostic (2.54e-2)"	"unprognostic (4.06e-2)"	"unprognostic (3.48e-2)"	"unprognostic (1.19e-10)"	"unprognostic (6.27e-3)"	"unprognostic (4.00e-2)"	"unprognostic (2.76e-2)"	"unprognostic (4.75e-3)"	3.4	1.0	0.3	0.0	0.3	3894.9	3.4	0.1	0.7	0.5	0.2	2.0	0.4	1.0	0.0	1.1	1.4	0.1	4.0	0.3	0.2	0.7	3.3	19.4	0.6	0.1	0.2	0.5	0.5	0.0	1.2	0.8	0.1	2.9	0.0	0.0	2.4	0.1	1.5	5.4	1.8	0.1	0.1	42.6	1.4	0.4	0.2	6.3	3.1	0.0	0.0	2.1	1.0	0.2	2.0	0.1	0.0	0.0	1.0	1.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.1	0.0	0.0	0.0	0.4	0.0	0.0	1.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	3105.0	0.0	0.0	0.1	0.0	1.3	0.0	0.2	0.8	0.0	34.0	0.0	0.0	4.0	0.0	0.9	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12.1	0.0	0.0	0.0	0.0	27.2	0.3	0.3	0.1	0.7	0.3	0.2	0.1	0.2	0.1	0.1	0.2	0.2	0.9	0.0	0.0	0.0	0.3	8.7	0.0	0.0	0.0	0.0	0.2	0.6	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.7	0.0	4.2	0.1	0.0	1.3	16.2	0.0	0.1	0.0	0.0	0.7	0.9	0.2	0.0	0.1	0.0	0.0	3.4	11.1	0.0	6.2	1.1	7.2	0.0	0.9	0.0	1.0	0.0	0.1	0.0	0.0	1.5	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.6	1.0	0.2	0.0	0.0	7.4	0.0	0.7	0.2	0.0	0.0
ENGASE	FLJ21865	ENSG00000167280	Endo-beta-N-acetylglucosaminidase	Q8NFI3	17	79074824-79088599	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Glycosidase, Hydrolase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Cone photoreceptor cells: 35.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"SK-BR-3: 33.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA021551	Enhanced		Approved	Centrosome,Cytosol		No	No			"Cluster 15: NK-cells - Transcription"	"Cluster 59: Non-specific - Translation"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Cytosol	Centrosome	"HPA021551: AB_1848156"	"unprognostic (7.49e-2)"	"unprognostic (1.42e-1)"	"unprognostic (5.65e-2)"	"unprognostic (6.16e-2)"	"unprognostic (1.89e-2)"	"unprognostic (5.08e-3)"	"unprognostic (9.62e-2)"	"unprognostic (4.09e-2)"	"unprognostic (9.07e-2)"	"unprognostic (7.00e-3)"	"prognostic favorable (2.60e-4)"	"unprognostic (4.79e-2)"	"prognostic unfavorable (8.97e-6)"	"unprognostic (8.38e-3)"	"unprognostic (6.03e-1)"	"unprognostic (2.06e-2)"	"prognostic favorable (8.73e-5)"	9.3	8.4	8.4	8.2	9.4	7.2	9.1	8.6	11.5	11.9	10.2	14.5	14.3	9.6	2.0	5.4	10.7	5.9	9.1	8.3	9.9	7.6	8.8	9.4	9.2	10.0	10.7	13.7	7.9	6.7	7.1	5.6	10.1	10.8	9.2	6.1	9.1	4.3	24.0	9.6	14.9	5.2	8.4	20.0	11.0	3.4	11.0	7.2	11.8	10.4	5.8	11.6	9.5	12.3	6.3	12.8	5.7	10.0	4.4	2.5	9.6	5.6	3.5	4.6	3.9	7.2	6.4	0.0	5.9	5.1	6.2	9.7	7.2	5.4	2.3	4.3	12.5	5.9	14.8	4.2	4.2	6.7	11.2	5.8	7.9	3.4	3.3	7.8	4.9	14.7	9.1	3.6	2.5	5.1	0.6	7.3	2.7	15.4	12.1	12.7	16.8	5.3	2.4	16.4	4.2	9.2	7.3	33.5	4.2	6.8	10.8	7.8	6.4	6.8	6.1	6.4	4.4	10.9	1.9	2.9	4.0	13.6	5.1	0.0	0.3	0.0	0.1	0.1	0.2	0.0	0.0	0.0	0.4	0.2	0.5	0.1	0.0	0.4	0.1	0.0	0.7	0.1	8.4	9.4	8.6	11.5	8.3	9.9	10.0	10.7	10.1	8.4	11.0	12.3	6.9	0.0	16.0	18.3	6.1	4.5	5.6	3.4	3.4	11.1	7.5	7.4	6.3	5.7	5.7	11.0	35.5	5.3	7.1	23.3	0.0	4.2	1.8	3.9	6.3	7.6	26.2	3.8	5.4	4.3	5.4	6.7	18.8	4.8	5.1	11.5	8.2	11.5	8.6	8.4	10.1	18.6	0.0	13.2	9.8	1.3	3.4	15.5	0.0	14.0	8.8	5.3	6.2	3.5	11.0	2.5	10.7	1.9	5.7	5.3	16.5	2.9	2.9	24.5	13.1	7.9	8.3	1.9	1.6	4.1	5.8	6.7	7.4	7.5	27.5	4.4
ENOPH1	"E1, MASA, mtnC"	ENSG00000145293	"Enolase-phosphatase 1"	Q9UHY7	4	82430590-82461177	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Amino-acid biosynthesis, Methionine biosynthesis"	Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004985, HPA044607"	Enhanced		Approved	"Nucleoplasm,Nuclear bodies"		NA	NA		240000	"Cluster 39: Non-specific - mRNA processing"	"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 39: Non-specific - Basic cellular processes"	Nucleoplasm	"Nuclear bodies"	"CAB004985: AB_426046, HPA044607: AB_2679019"	"unprognostic (6.64e-3)"	"unprognostic (3.05e-1)"	"unprognostic (6.77e-3)"	"unprognostic (1.05e-3)"	"unprognostic (1.46e-1)"	"unprognostic (1.68e-3)"	"prognostic unfavorable (1.74e-5)"	"unprognostic (9.99e-3)"	"unprognostic (1.18e-1)"	"unprognostic (2.17e-1)"	"unprognostic (1.59e-1)"	"unprognostic (2.05e-1)"	"unprognostic (9.30e-3)"	"unprognostic (3.68e-2)"	"unprognostic (2.22e-1)"	"unprognostic (6.52e-3)"	"unprognostic (3.52e-2)"	17.0	24.2	61.3	21.2	70.0	26.6	26.2	69.8	102.7	20.7	52.3	21.1	20.3	16.7	35.9	23.5	16.5	14.7	18.7	60.0	66.6	33.5	22.1	18.3	29.0	70.5	67.4	19.8	23.5	34.1	20.6	29.1	69.1	26.6	23.9	42.0	19.2	18.0	18.1	21.8	18.5	17.9	68.1	22.2	22.3	10.6	65.9	30.8	28.6	18.7	31.6	21.9	17.8	80.1	56.6	36.6	64.3	40.4	38.3	37.6	69.7	63.7	42.6	57.2	50.6	67.3	61.3	110.8	64.8	49.0	62.6	29.8	86.1	81.3	103.3	67.2	39.2	67.1	33.7	91.0	62.0	113.3	56.0	36.5	84.9	59.7	70.6	41.4	58.8	69.2	88.3	60.1	76.1	73.2	125.8	67.6	59.2	141.8	28.8	88.1	98.2	61.0	94.7	55.5	90.5	55.2	36.2	109.7	86.3	57.3	49.4	54.5	43.3	70.9	52.8	71.2	85.7	67.5	62.4	138.5	45.9	69.5	97.5	5.8	13.9	7.2	21.8	17.1	27.1	20.2	25.9	25.0	20.5	16.9	29.4	24.2	1.2	24.7	14.9	22.4	30.4	20.6	61.3	70.0	69.8	102.7	60.0	66.6	70.5	67.4	69.1	68.1	65.9	80.1	24.6	16.0	10.5	9.4	31.8	68.6	40.8	47.3	30.7	36.6	22.9	19.8	13.5	18.6	27.5	12.9	16.7	86.7	24.7	10.7	88.0	48.1	7.7	15.2	14.2	25.6	29.3	24.6	18.5	25.7	61.3	22.4	15.3	19.5	38.1	15.3	17.9	10.8	57.7	28.6	21.4	24.8	61.1	23.2	27.9	5.1	26.4	23.1	39.2	6.5	35.6	62.8	29.9	15.1	37.9	41.1	11.1	24.0	28.0	52.6	17.7	56.2	18.8	37.7	13.1	16.4	23.8	9.0	24.9	37.8	64.1	46.7	34.3	27.5	26.7	39.9
ENPEP	"CD249, gp160"	ENSG00000138792	"Glutamyl aminopeptidase"	Q07075	4	110365733-110565285	"CD markers, Enzymes, Plasma proteins, Predicted membrane proteins"		"Aminopeptidase, Hydrolase, Metalloprotease, Protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 163.6;kidney: 90.0"	"Cell type enhanced"	"Detected in many"		"Proximal enterocytes: 663.2;Proximal tubular cells: 177.6;Sertoli cells: 157.8"	"Cancer enriched"	"Detected in many"	8	"renal cancer: 41.0"	"Low region specificity"	"Detected in single"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BEWO: 2.7;HEK 293: 7.5;MOLT-4: 1.8;SuSa: 5.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA005128	Enhanced					NA	NA		55000000		"Cluster 87: Intestine & Kidney - Transmembrane transport"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 45: Enterocytes - Digestion"			"HPA005128: AB_1844795"	"unprognostic (2.73e-3)"	"unprognostic (2.84e-3)"	"unprognostic (5.16e-3)"	"unprognostic (3.48e-1)"	"unprognostic (2.90e-1)"	"unprognostic (8.74e-2)"	"unprognostic (3.34e-2)"	"unprognostic (1.03e-1)"	"unprognostic (1.35e-2)"	"unprognostic (1.22e-1)"	"unprognostic (1.93e-1)"	"unprognostic (9.47e-2)"	"unprognostic (4.49e-3)"	"unprognostic (3.43e-3)"	"unprognostic (1.52e-2)"	"unprognostic (8.46e-2)"	"unprognostic (2.49e-3)"	11.6	2.2	0.4	1.5	0.5	0.1	4.8	0.4	2.5	1.6	1.8	1.2	36.6	12.9	4.1	1.7	2.3	4.4	4.3	0.6	0.5	90.0	29.0	4.6	0.8	0.9	0.8	1.2	1.3	45.2	1.2	15.5	0.7	1.8	0.8	0.0	1.1	1.2	2.3	0.7	163.6	10.6	0.5	9.2	1.2	0.5	0.4	4.4	5.0	8.9	0.3	2.6	1.6	0.8	0.0	0.2	0.0	0.0	0.1	0.1	2.7	0.4	0.0	0.1	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	7.5	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.0	1.8	0.3	0.3	0.1	0.0	0.1	0.0	0.3	0.0	0.3	0.1	0.1	0.0	1.3	0.0	5.3	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.7	1.4	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.5	0.4	2.5	0.6	0.5	0.9	0.8	0.7	0.5	0.4	0.8	10.7	0.0	2.0	1.6	1.1	1.7	0.1	0.0	0.0	0.0	0.2	0.1	3.9	0.0	0.3	11.0	0.0	37.0	0.0	1.5	17.6	0.0	0.5	3.1	40.7	2.2	1.8	0.0	7.3	0.0	3.5	15.4	0.0	2.3	0.0	0.0	1.4	31.4	2.7	0.0	2.9	28.4	2.0	1.0	1.9	0.2	0.6	1.1	0.0	1.0	0.0	0.0	1.0	0.0	0.8	0.0	31.6	0.4	0.1	0.2	663.2	177.6	1.7	0.0	157.8	0.8	54.1	0.0	0.2	0.1	1.0	58.6	1.9	0.5	42.1	0.1
ENPP1	"M6S1, NPPS, PC-1, PCA1, PDNP1"	ENSG00000197594	"Ectonucleotide pyrophosphatase/phosphodiesterase 1"	P22413	6	131808016-131895155	"CD markers, Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted membrane proteins, Predicted secreted proteins"	Biomineralization	Hydrolase	"Diabetes mellitus, Disease variant, Obesity"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"placenta: 44.0"	"Cell type enhanced"	"Detected in many"		"Endometrial stromal cells: 80.2;Fibroblasts: 56.9;Hepatocytes: 111.6;Peritubular cells: 70.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in some"			"Immune cell enhanced"	"Detected in single"		"NK-cell: 1.6"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"ASC diff: 34.1;LHCN-M2: 21.1;U-138 MG: 27.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB032904, HPA062066"	Enhanced				"Secreted - unknown location"	NA	NA		4400000	"Cluster 48: NK-cells - Unknown function"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 33: Fibroblasts - ECM organization"			"CAB032904: AB_2099635, HPA062066: AB_2684674"	"unprognostic (1.47e-1)"	"unprognostic (1.23e-1)"	"unprognostic (2.15e-1)"	"unprognostic (1.60e-3)"	"unprognostic (2.40e-1)"	"unprognostic (1.11e-1)"	"unprognostic (2.00e-1)"	"unprognostic (1.60e-2)"	"unprognostic (7.22e-3)"	"unprognostic (8.96e-2)"	"unprognostic (1.95e-1)"	"unprognostic (3.00e-1)"	"unprognostic (2.61e-2)"	"unprognostic (1.41e-1)"	"unprognostic (1.96e-1)"	"unprognostic (1.84e-1)"	"unprognostic (3.28e-3)"	8.4	3.1	0.4	1.4	0.5	0.1	7.1	0.7	0.4	7.1	0.4	2.3	1.8	22.1	7.4	2.3	6.9	1.2	1.6	0.4	0.7	4.2	31.9	0.8	1.4	1.2	1.4	8.3	28.5	27.8	10.9	44.0	0.9	3.4	2.0	0.5	4.2	5.8	2.7	1.7	1.3	10.2	0.8	1.9	1.7	1.6	1.0	2.2	20.1	3.2	0.8	2.7	4.9	0.8	0.0	1.3	1.2	0.1	34.1	5.3	0.0	9.2	9.4	3.5	9.5	4.1	1.1	0.0	0.8	5.9	7.2	0.0	1.3	0.2	14.8	0.3	1.8	0.0	1.1	12.0	1.0	0.0	4.2	8.8	0.4	9.6	0.4	4.1	4.3	0.7	0.0	1.8	21.1	2.6	0.0	0.0	7.9	1.6	1.3	0.0	10.2	0.3	0.2	0.4	3.4	0.0	0.2	1.3	4.2	5.7	3.9	0.0	2.9	27.6	1.0	1.9	9.1	3.4	0.0	0.0	12.6	0.0	3.5	0.6	0.0	0.1	0.1	0.0	0.5	0.1	0.1	0.1	0.7	0.2	0.0	0.0	0.3	1.6	0.1	0.1	0.0	0.0	0.4	0.5	0.7	0.4	0.4	0.7	1.2	1.4	0.9	0.8	1.0	0.8	2.6	0.0	1.7	0.3	1.5	1.5	9.9	0.0	0.6	4.5	28.7	19.9	6.4	5.7	0.1	1.8	0.0	3.0	1.2	16.7	5.9	0.3	4.8	3.9	80.2	4.1	0.0	8.0	3.5	10.6	2.1	56.9	6.1	3.2	0.0	9.4	3.3	111.6	4.6	1.7	10.5	12.7	0.0	2.9	5.9	6.7	25.1	3.9	1.8	12.2	0.2	3.6	0.0	21.6	1.6	5.2	3.9	70.0	0.4	2.3	6.7	25.2	0.1	0.5	13.1	12.6	18.8	4.1	2.2	0.1	1.3	6.2	2.6	1.9	2.5	1.7
ENPP2	"ATX, PD-IALPHA, PDNP2"	ENSG00000136960	"Ectonucleotide pyrophosphatase/phosphodiesterase 2"	Q13822	8	119557086-119673453	"Cancer-related genes, Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins"	"Chemotaxis, Lipid degradation, Lipid metabolism"	Hydrolase	"Cancer-related genes, Obesity"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 383.3;choroid plexus: 753.4"	"Cell type enriched"	"Detected in many"	4	"Oligodendrocytes: 1041.6"	"Cancer enhanced"	"Detected in all"		"renal cancer: 46.7"	"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in many"	6	"basophil: 53.8"	"Lineage enriched"	"Detected in many"	8	"granulocytes: 53.8"	"Cell line enhanced"	"Detected in many"		"AF22: 111.4;ASC diff: 147.7;ASC TERT1: 312.5;BJ: 103.2;BJ hTERT+: 188.9;fHDF/TERT166: 124.2;HSkMC: 144.7;U-2197: 108.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA023700, HPA053652"	Approved		Approved	"Nucleoplasm,Golgi apparatus,Actin filaments"	"Secreted to blood"	NA	NA		1200000000	"Cluster 46: Basophils - DNA binding"	"Cluster 88: Choroid plexus - Transmembrane transport"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	"Nucleoplasm, Golgi apparatus"	"Actin filaments"	"HPA023700: AB_1848170, HPA053652: AB_2682218"	"unprognostic (1.17e-2)"	"unprognostic (6.29e-2)"	"unprognostic (3.63e-2)"	"unprognostic (3.93e-2)"	"unprognostic (1.23e-1)"	"unprognostic (1.37e-1)"	"unprognostic (9.70e-3)"	"unprognostic (7.14e-2)"	"unprognostic (1.29e-1)"	"unprognostic (1.26e-1)"	"prognostic favorable (2.07e-5)"	"unprognostic (5.54e-2)"	"unprognostic (3.14e-1)"	"unprognostic (2.37e-1)"	"unprognostic (5.18e-2)"	"unprognostic (2.37e-2)"	"unprognostic (1.50e-1)"	104.7	46.7	98.9	62.0	208.4	2.7	89.7	188.1	150.1	73.6	753.4	32.6	67.5	139.2	20.2	9.0	55.7	39.9	9.9	111.0	133.0	76.6	28.5	42.7	109.8	246.2	164.4	15.2	15.9	20.2	11.8	252.3	244.4	26.4	32.3	6.9	9.9	27.3	8.9	17.5	45.8	85.1	147.8	51.4	26.9	31.3	153.7	20.8	10.8	23.9	85.8	45.1	18.1	383.3	0.0	0.0	111.4	0.0	147.7	312.5	0.4	103.2	188.9	43.9	42.1	0.0	0.0	0.1	1.3	124.2	0.1	0.3	2.3	0.0	31.3	8.7	3.4	0.0	0.2	3.1	67.0	0.0	0.5	144.7	1.3	89.3	4.3	0.6	0.5	0.1	0.1	18.1	2.5	0.0	0.1	0.7	4.4	0.0	0.5	0.1	0.1	0.6	0.3	0.0	1.1	2.2	0.1	0.4	0.2	4.2	0.1	0.0	0.0	89.6	1.9	108.6	0.9	0.9	0.0	0.0	75.0	0.8	2.4	53.8	0.2	9.5	0.0	0.1	0.1	0.4	0.5	0.0	1.0	0.1	3.0	1.1	0.5	0.4	0.2	6.8	0.0	0.6	98.9	208.4	188.1	150.1	111.0	133.0	246.2	164.4	244.4	147.8	153.7	383.3	231.4	12.8	3.6	2.0	1.8	10.6	0.5	0.0	19.9	1.9	2.1	2.8	1.8	35.8	0.6	1.8	0.0	5.2	4.9	0.3	1.9	0.1	83.9	12.7	8.8	79.9	54.0	0.8	2.5	0.0	2.2	76.9	3.6	1.4	6.3	0.4	31.1	0.8	65.8	0.0	4.2	3.3	0.0	18.6	14.9	9.5	3.1	16.2	46.2	6.5	0.1	6.4	0.0	16.6	1041.6	0.7	2.6	3.4	1.9	0.1	4.2	47.6	3.7	1.2	0.0	3.1	9.6	1.7	0.4	7.8	5.3	6.4	1.7	1.1	2.8	1.4
ENPP3	"B10, CD203c, gp130RB13-6, PD-IBETA, PDNP3"	ENSG00000154269	"Ectonucleotide pyrophosphatase/phosphodiesterase 3"	O14638	6	131628442-131747418	"CD markers, Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted secreted proteins"		Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"cervix: 32.1;intestine: 44.5"	"Group enriched"	"Detected in many"	5	"Endometrial ciliated cells: 160.0;Glandular and luminal cells: 387.2"	"Cancer enriched"	"Detected in many"	8	"renal cancer: 49.6"	"Not detected"	"Not detected"			"Immune cell enriched"	"Detected in single"	86	"basophil: 30.6"	"Lineage enriched"	"Detected in single"	86	"granulocytes: 30.6"	"Group enriched"	"Detected in some"	18	"HEL: 4.4;Hep G2: 14.6;HMC-1: 6.2"	"Low region specificity"	"Detected in some"			"Region enriched"	"Detected in single"	4	"spinal cord: 2.6"	HPA043772	Enhanced				"Secreted - unknown location"	NA	NA		1100000	"Cluster 38: Basophils - Unknown function"	"Cluster 9: Intestine - Unknown function"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 44: Endometrium - Transcription"			"HPA043772: AB_10795616"	"unprognostic (2.74e-1)"	"unprognostic (1.99e-2)"	"unprognostic (1.84e-1)"	"unprognostic (5.41e-3)"	"unprognostic (6.07e-2)"	"unprognostic (4.86e-5)"	"unprognostic (1.13e-1)"	"unprognostic (7.20e-3)"	"unprognostic (1.17e-1)"	"unprognostic (1.13e-1)"	"unprognostic (2.21e-3)"	"unprognostic (2.34e-1)"	"prognostic unfavorable (1.96e-4)"	"unprognostic (2.80e-2)"	"unprognostic (7.85e-2)"	"unprognostic (2.29e-1)"	"unprognostic (1.31e-3)"	1.2	6.2	0.4	1.1	0.4	0.1	6.6	0.9	0.5	32.1	0.2	9.3	16.2	3.8	1.2	0.5	2.3	1.3	0.1	0.3	0.5	10.0	5.0	0.9	0.5	0.5	0.6	0.5	0.1	0.3	0.1	0.1	0.5	2.4	8.4	0.3	18.1	15.6	0.1	0.6	44.5	0.8	0.4	0.3	0.5	0.8	0.5	9.6	0.3	0.2	0.4	0.4	0.7	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.1	4.4	0.0	14.6	0.0	0.1	6.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.1	0.1	0.0	0.0	30.6	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.4	0.4	0.9	0.5	0.3	0.5	0.5	0.6	0.5	0.4	0.5	0.4	0.4	0.0	1.1	5.2	0.2	0.0	2.6	0.7	1.2	0.2	1.0	0.6	0.3	0.0	2.5	0.0	0.0	0.0	0.2	9.2	1.9	0.0	1.6	160.0	46.3	1.4	0.0	2.1	2.1	0.0	0.1	0.5	0.0	387.2	36.0	0.1	0.7	1.7	0.1	0.0	4.1	1.5	0.0	0.6	1.1	0.4	1.2	1.5	1.8	2.8	0.0	0.1	1.0	3.5	0.9	0.0	1.9	0.7	0.3	2.7	53.3	9.1	5.4	0.1	0.0	0.2	1.0	2.5	0.8	0.0	0.6	0.1	2.2	0.1	4.9	1.1
ENPP4	"AP3Aase, KIAA0879, NPP4"	ENSG00000001561	"Ectonucleotide pyrophosphatase/phosphodiesterase 4"	Q9Y6X5	6	46129989-46146688	"Enzymes, Predicted membrane proteins"	"Blood coagulation, Hemostasis"	Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 76.9;Oligodendrocytes: 125.3;Respiratory ciliated cells: 70.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"U-266/70: 21.9;U-266/84: 26.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA016594	Approved					NA	NA			"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 65: Plasmacytoid DCs - Unknown function"			"HPA016594: AB_1848171"	"unprognostic (9.87e-2)"	"unprognostic (1.74e-1)"	"unprognostic (2.75e-2)"	"unprognostic (2.01e-1)"	"unprognostic (2.92e-1)"	"unprognostic (1.90e-1)"	"unprognostic (8.13e-2)"	"unprognostic (5.51e-3)"	"unprognostic (1.98e-1)"	"unprognostic (1.26e-1)"	"unprognostic (8.51e-2)"	"unprognostic (4.36e-1)"	"prognostic favorable (6.95e-7)"	"unprognostic (1.82e-2)"	"unprognostic (1.83e-1)"	"unprognostic (2.62e-2)"	"unprognostic (2.56e-1)"	15.1	13.6	11.7	7.3	20.9	38.0	7.8	19.5	19.5	10.3	6.4	12.1	10.9	4.0	11.6	5.1	10.8	8.0	15.1	10.8	16.0	18.4	8.2	20.7	7.7	20.5	19.3	2.1	11.9	22.3	9.0	3.5	19.9	16.4	12.8	12.2	21.3	19.7	22.1	2.3	10.1	7.0	18.5	13.9	14.8	8.3	17.5	8.5	12.5	25.3	6.5	6.8	2.1	30.2	0.1	1.1	0.7	1.5	0.0	0.0	0.1	1.7	1.6	4.0	0.3	1.9	13.4	15.2	12.7	2.1	9.9	0.2	4.1	0.6	0.8	18.5	11.1	8.5	0.0	0.0	0.5	10.5	14.9	2.1	0.0	0.1	0.0	1.1	1.4	10.5	0.0	0.0	1.5	1.8	7.8	1.0	2.7	16.9	0.5	5.9	2.7	5.7	8.3	1.7	18.0	0.0	0.0	2.8	0.0	4.1	7.6	4.3	0.0	0.0	6.7	0.3	11.2	21.9	26.6	5.2	10.3	0.0	1.4	0.0	0.4	0.9	9.2	1.1	5.4	2.8	3.4	6.8	1.5	1.2	3.2	5.8	0.3	4.4	2.6	1.6	1.2	3.0	11.7	20.9	19.5	19.5	10.8	16.0	20.5	19.3	19.9	18.5	17.5	30.2	43.5	76.9	27.0	23.5	11.6	0.9	3.2	2.3	0.6	9.3	11.0	2.4	23.1	14.3	25.4	29.5	14.6	0.5	23.5	27.2	0.0	12.9	18.3	28.8	2.0	16.0	15.7	3.0	26.4	12.2	0.3	8.5	10.7	17.3	15.8	4.5	6.1	8.6	5.8	26.9	19.2	13.8	4.1	24.8	11.0	26.0	1.2	19.0	3.6	6.5	15.2	21.6	34.0	32.2	125.3	9.7	16.1	11.3	10.3	12.6	16.3	12.6	70.6	6.2	0.0	22.1	5.4	9.1	9.8	0.3	0.6	0.3	14.7	3.7	11.3	14.8
ENPP6	MGC33971	ENSG00000164303	"Ectonucleotide pyrophosphatase/phosphodiesterase 6"	Q6UWR7	4	184088706-184221230	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Lipid degradation, Lipid metabolism"	Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 29.4;kidney: 30.6;ovary: 12.5"	"Cell type enhanced"	"Detected in some"		"Oligodendrocytes: 119.9;Peritubular cells: 35.3;Proximal tubular cells: 31.3;Theca cells: 23.9"	"Cancer enriched"	"Detected in some"	5	"glioma: 3.0"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"Karpas-707: 3.2;SH-SY5Y: 3.6;U-266/70: 2.9;U-266/84: 1.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA042740, HPA069197"	Enhanced		Approved	"Golgi apparatus"	"Intracellular and membrane"	NA	NA		290000		"Cluster 21: Non-specific - Transcription"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	"Golgi apparatus"		"HPA042740: AB_10793984, HPA069197: "	"unprognostic (4.81e-4)"	"unprognostic (1.47e-1)"	"unprognostic (3.54e-2)"	"unprognostic (1.24e-1)"	"unprognostic (2.56e-1)"	"unprognostic (6.69e-3)"	"unprognostic (3.07e-2)"	"unprognostic (1.27e-2)"	"unprognostic (1.03e-1)"	"unprognostic (1.09e-1)"	"unprognostic (7.60e-3)"	"unprognostic (3.04e-2)"	"unprognostic (1.72e-1)"	"unprognostic (2.98e-2)"	"unprognostic (2.82e-1)"	"unprognostic (3.93e-3)"	"unprognostic (2.01e-1)"	0.2	0.3	2.7	0.8	11.8	0.9	0.8	14.2	5.5	0.2	2.3	1.0	1.7	0.2	6.1	1.0	0.3	0.5	0.2	2.7	6.1	30.6	0.1	0.3	0.9	20.4	9.6	12.5	0.0	0.0	4.2	0.1	18.1	2.2	1.0	0.1	0.7	6.1	0.2	0.1	2.2	0.1	12.5	1.0	1.2	2.4	11.1	1.9	0.1	1.3	2.8	0.6	0.3	29.4	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.9	0.0	0.3	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.1	3.6	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.1	0.0	0.0	0.0	2.9	1.7	0.0	0.0	0.0	0.0	0.4	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.2	0.0	0.1	0.0	0.0	2.7	11.8	14.2	5.5	2.7	6.1	20.4	9.6	18.1	12.5	11.1	29.4	0.5	0.0	0.0	5.9	0.1	0.0	0.2	0.9	0.6	0.0	0.1	0.5	0.9	0.0	0.4	1.8	0.0	0.0	0.0	0.0	3.9	1.1	1.0	0.0	0.0	0.5	0.0	0.0	4.3	0.2	0.0	8.7	0.0	0.0	5.7	0.0	0.0	0.4	0.2	0.0	1.5	0.0	0.0	0.6	0.0	0.4	4.1	0.6	1.8	4.7	1.1	0.0	0.0	6.6	119.9	0.0	0.0	35.3	0.5	0.1	0.0	31.3	0.2	0.0	0.0	5.1	0.6	0.1	1.6	0.0	0.0	0.0	0.3	23.9	0.0	0.3
ENPP7	"alk-SMase, NPP7"	ENSG00000182156	"Ectonucleotide pyrophosphatase/phosphodiesterase 7"	Q6UWV6	17	79730943-79742219	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Lipid metabolism"	Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	9	"intestine: 104.6"	"Group enriched"	"Detected in some"	7	"Hepatocytes: 9.1;Proximal enterocytes: 22.7;Proximal tubular cells: 9.7"	"Cancer enriched"	"Detected in some"	6	"liver cancer: 6.4"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"Hep G2: 1.2;Karpas-707: 2.1;U-266/70: 2.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA024603	Approved				"Intracellular and membrane"	NA	NA		450000		"Cluster 56: Intestine - Transmembrane transport"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 45: Enterocytes - Digestion"			"HPA024603: AB_1848174"	"unprognostic (4.00e-2)"	"unprognostic (1.16e-2)"	"unprognostic (6.49e-2)"	"unprognostic (4.83e-2)"	"unprognostic (1.55e-1)"	"unprognostic (2.65e-2)"	"unprognostic (1.24e-1)"	"unprognostic (1.01e-1)"		"unprognostic (8.45e-4)"	"unprognostic (4.83e-2)"		"unprognostic (1.18e-2)"	"unprognostic (1.52e-2)"	"unprognostic (5.21e-2)"	"unprognostic (1.25e-1)"	"unprognostic (1.80e-2)"	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	46.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.1	11.6	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	104.6	0.0	0.0	0.1	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.2	0.0	0.4	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.8	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.4	9.1	0.1	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	22.7	9.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0
ENTPD1	"ATPDase, CD39, NTPDase-1, SPG64"	ENSG00000138185	"Ectonucleoside triphosphate diphosphohydrolase 1"	P49961	10	95711779-95877266	"CD markers, Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted membrane proteins"		Hydrolase	"Disease variant, Hereditary spastic paraplegia, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 74.1;Kupffer cells: 110.4;Langerhans cells: 161.3;Microglial cells: 217.4;monocytes: 112.2;Plasma cells: 80.1"	"Cancer enhanced"	"Detected in all"		"thyroid cancer: 17.9"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"eosinophil: 102.2"	"Group enriched"	"Detected in all"	4	"dendritic cells: 31.9;granulocytes: 102.2;monocytes: 41.0"	"Group enriched"	"Detected in many"	7	"HDLM-2: 147.5;Karpas-707: 135.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB002494, HPA014067, CAB079986"	Enhanced		Uncertain	Microtubules		NA	NA		19000	"Cluster 45: Eosinophils - Innate immune response"	"Cluster 12: Smooth muscle tissue - Mixed function"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 41: Macrophages - Immune response"	Microtubules		"CAB002494: AB_563557, CAB079986: , HPA014067: AB_1848178"	"unprognostic (1.14e-1)"	"unprognostic (1.01e-2)"	"unprognostic (3.11e-1)"	"unprognostic (5.67e-2)"	"unprognostic (9.68e-3)"	"unprognostic (3.45e-3)"	"unprognostic (6.31e-2)"	"unprognostic (5.26e-3)"	"unprognostic (2.73e-1)"	"unprognostic (1.28e-2)"	"unprognostic (6.40e-2)"	"unprognostic (1.41e-1)"	"prognostic unfavorable (5.33e-5)"	"unprognostic (9.79e-2)"	"unprognostic (2.30e-1)"	"prognostic favorable (7.89e-4)"	"unprognostic (5.09e-2)"	11.8	8.3	5.9	24.7	5.5	27.5	10.8	5.0	6.3	17.5	5.0	14.3	9.3	28.0	19.3	19.2	14.0	27.7	8.5	5.3	6.3	7.6	5.4	16.1	20.2	7.1	6.5	5.5	2.8	3.4	3.9	11.4	7.7	11.2	12.8	6.8	6.0	18.1	4.0	6.3	11.7	49.7	6.2	21.5	7.3	4.5	7.5	6.8	20.0	8.7	25.6	30.6	11.0	6.3	1.4	2.7	5.4	7.1	0.1	0.1	5.0	4.5	1.2	0.0	0.0	4.0	1.6	8.2	3.1	0.0	5.3	2.2	0.0	0.0	0.0	147.5	5.2	7.2	4.0	4.3	0.0	12.5	4.1	0.1	0.0	0.6	0.0	2.4	18.2	2.0	5.3	135.4	0.1	4.4	4.7	5.8	5.9	3.6	2.8	15.3	2.4	4.4	1.7	2.2	5.1	6.2	3.6	3.7	3.9	3.6	5.5	5.9	3.9	3.9	2.8	3.8	5.3	21.6	7.2	0.6	4.3	13.9	2.7	0.7	41.0	102.2	0.6	27.2	1.1	13.7	1.6	1.1	31.9	11.4	0.6	0.6	49.4	1.5	6.7	2.1	13.1	15.5	5.9	5.5	5.0	6.3	5.3	6.3	7.1	6.5	7.7	6.2	7.5	6.3	19.6	0.0	1.1	74.1	40.9	8.9	0.3	0.0	0.6	1.4	0.8	1.5	10.1	0.0	0.7	1.8	2.1	0.6	3.7	0.3	1.9	0.0	10.3	0.6	3.6	60.6	0.0	4.4	2.8	2.0	1.9	15.7	6.1	0.6	3.8	0.3	31.4	0.8	26.6	0.0	5.2	0.1	0.0	110.4	161.3	7.3	0.6	62.1	16.0	217.4	112.2	0.4	0.0	20.6	5.0	0.2	1.2	3.0	80.1	0.5	0.1	0.3	0.8	0.8	6.6	1.0	22.7	10.1	4.4	0.8	11.2	15.7	26.9	15.1	1.0	0.5
ENTPD3	"CD39L3, HB6, NTPDase-3"	ENSG00000168032	"Ectonucleoside triphosphate diphosphohydrolase 3"	O75355	3	40387184-40428744	"Enzymes, Metabolic proteins, Predicted membrane proteins"		Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 20.8;cervix: 21.3;salivary gland: 22.4"	"Cell type enriched"	"Detected in many"	4	"Inhibitory neurons: 92.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in single"	7	"plasmacytoid DC: 3.5"	"Lineage enriched"	"Detected in single"	7	"dendritic cells: 3.5"	"Cell line enhanced"	"Detected in some"		"HaCaT: 3.6;HBEC3-KT: 13.0;hTCEpi: 8.4;RT4: 18.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"									NA	NA			"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 24: Salivary gland - Salivary secretion"	"Cluster 15: RT4 - Unknown function"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"				"unprognostic (1.00e-1)"	"unprognostic (1.54e-2)"	"unprognostic (2.75e-2)"	"unprognostic (9.84e-3)"	"unprognostic (2.27e-2)"	"unprognostic (2.04e-1)"	"unprognostic (1.80e-1)"	"unprognostic (1.18e-2)"	"unprognostic (8.40e-2)"	"unprognostic (9.88e-3)"	"unprognostic (4.72e-2)"	"unprognostic (2.08e-1)"	"unprognostic (3.25e-1)"	"unprognostic (6.53e-2)"	"unprognostic (5.99e-2)"	"unprognostic (1.68e-1)"	"unprognostic (1.23e-1)"	4.2	1.3	3.4	1.1	20.8	0.1	2.4	2.0	6.5	21.3	0.8	3.5	1.3	3.1	2.4	6.5	0.9	2.0	0.6	4.5	4.5	2.6	0.1	3.9	0.4	6.2	4.0	1.7	15.8	0.5	2.9	0.5	6.1	3.4	2.8	2.6	22.4	4.0	1.2	2.9	1.4	1.9	2.2	4.2	6.8	0.5	5.3	0.9	5.5	2.5	1.7	13.0	3.6	4.7	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.1	3.6	0.0	13.0	0.3	0.4	0.4	0.5	0.2	0.0	0.0	0.0	0.0	0.1	8.4	0.0	0.0	0.0	0.0	0.4	0.0	0.1	0.0	0.5	0.0	0.1	0.1	0.2	1.0	0.0	0.0	0.0	1.5	18.4	1.8	0.2	0.4	1.1	0.2	0.3	0.6	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.3	0.1	0.5	0.1	0.0	0.5	0.0	0.0	0.1	0.1	0.2	0.0	0.0	0.1	0.0	0.1	0.2	0.2	0.0	0.4	0.0	3.5	0.2	0.0	3.4	20.8	2.0	6.5	4.5	4.5	6.2	4.0	6.1	2.2	5.3	4.7	5.5	3.2	4.2	4.9	0.2	2.3	1.3	2.3	8.0	0.7	6.1	0.3	0.5	0.0	5.1	0.0	0.0	0.0	1.3	1.0	0.0	2.7	0.4	7.6	2.5	0.7	2.4	0.0	22.6	22.5	0.0	0.4	2.6	14.9	0.0	0.0	0.0	0.0	0.1	0.0	92.6	0.1	0.0	0.0	0.8	0.0	0.3	0.3	0.0	1.9	0.0	3.7	0.0	7.1	5.9	6.9	0.0	0.7	0.1	1.4	0.0	0.0	1.9	0.8	19.7	0.6	19.9	0.2	0.1	14.5	2.3	0.0	0.2	0.1	0.2	4.7
ENTPD4	"KIAA0392, LALP70, LAP70, LYSAL1, NTPDase-4, UDPase"	ENSG00000197217	"Ectonucleoside triphosphate diphosphohydrolase 4"	Q9Y227	8	23385783-23457695	"Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins"		Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			HPA017655	Supported		Approved	Vesicles		NA	NA		82000	"Cluster 2: Granulocytes - Unknown function"	"Cluster 20: Retina & Lymphoid tissues - Unknown function"	"Cluster 12: NES - Nervous system development"	"Cluster 52: Non-specific - Transcription"	Vesicles		"HPA017655: AB_1848181"	"unprognostic (2.83e-2)"	"unprognostic (1.50e-2)"	"unprognostic (1.23e-3)"	"unprognostic (1.38e-1)"	"unprognostic (5.06e-2)"	"unprognostic (7.86e-3)"	"unprognostic (2.00e-2)"	"unprognostic (2.99e-3)"	"unprognostic (2.07e-2)"	"unprognostic (8.74e-2)"	"unprognostic (2.82e-1)"	"unprognostic (1.20e-1)"	"unprognostic (4.55e-2)"	"unprognostic (1.39e-1)"	"unprognostic (1.11e-1)"	"unprognostic (6.62e-2)"	"unprognostic (3.72e-2)"	16.3	11.5	8.6	24.2	10.5	30.5	14.8	11.1	16.2	17.0	8.1	19.8	18.1	16.8	17.3	12.6	13.7	14.6	21.2	10.8	12.3	12.2	13.7	20.0	29.3	13.1	9.2	13.5	21.4	27.2	18.3	17.2	12.8	16.8	20.3	32.7	22.0	13.4	15.2	12.4	26.2	16.5	7.6	25.4	20.3	19.9	12.5	14.5	14.7	15.9	29.8	16.7	16.6	11.6	20.8	28.7	34.0	23.5	29.0	36.8	35.0	33.1	30.4	21.3	33.2	40.3	26.4	35.5	22.9	32.8	32.9	24.5	15.8	29.0	40.3	8.6	11.5	18.4	18.1	14.2	23.7	9.8	34.8	22.8	34.7	28.4	29.9	51.9	31.2	26.7	13.2	30.6	36.4	9.3	14.8	11.9	20.1	26.2	10.2	14.3	34.6	10.8	27.0	24.1	27.2	26.6	12.0	17.0	23.7	67.0	12.9	13.6	38.6	39.1	38.3	43.7	24.1	24.7	11.5	45.5	51.3	11.5	39.4	17.0	5.7	13.4	7.4	8.6	8.8	8.7	7.3	8.1	7.5	6.5	9.2	7.3	14.4	4.8	7.0	6.8	6.3	6.9	8.6	10.5	11.1	16.2	10.8	12.3	13.1	9.2	12.8	7.6	12.5	11.6	15.9	19.2	34.5	10.7	25.8	6.5	12.0	17.6	8.6	32.1	11.4	8.6	24.6	7.2	27.3	14.7	14.6	16.1	33.4	25.1	0.0	15.6	8.6	13.6	21.6	15.8	17.3	10.3	31.4	16.9	16.9	16.9	23.9	23.9	17.7	18.9	12.1	11.5	12.3	47.1	37.4	19.7	20.3	14.2	15.5	19.2	7.2	18.2	12.4	19.7	19.4	15.2	18.6	23.1	23.1	21.8	13.3	8.6	46.9	18.9	18.8	5.0	15.0	35.9	13.1	14.3	14.6	21.5	22.8	9.5	5.5	20.2	21.3	11.7	12.4	18.9
ENTPD5	"CD39L4, NTPDase-5, PCPH"	ENSG00000187097	"Ectonucleoside triphosphate diphosphohydrolase 5 (inactive)"	O75356	14	73958010-74019399	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"		Hydrolase	Proto-oncogene	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"intestine: 107.2;kidney: 95.2;liver: 263.7"	"Cell type enhanced"	"Detected in all"		"Distal enterocytes: 209.3;Hepatocytes: 134.8;Intestinal goblet cells: 77.1;Proximal enterocytes: 87.0"	"Group enriched"	"Detected in all"	5	"liver cancer: 18.2;prostate cancer: 39.9"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"basophil: 18.3;eosinophil: 9.4"	"Lineage enriched"	"Detected in many"	7	"granulocytes: 18.3"	"Cell line enhanced"	"Detected in all"		"RT4: 57.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA002927	Enhanced				"Secreted to blood"	NA	NA		5900000	"Cluster 46: Basophils - DNA binding"	"Cluster 41: Intestine & Liver - Lipid metabolism"	"Cluster 15: RT4 - Unknown function"	"Cluster 53: Intestinal epithelial cells - Unknown function"			"HPA002927: AB_1078744"	"unprognostic (4.19e-1)"	"unprognostic (9.63e-3)"	"unprognostic (3.11e-2)"	"unprognostic (2.06e-2)"	"unprognostic (1.98e-1)"	"unprognostic (3.87e-2)"	"unprognostic (1.46e-1)"	"unprognostic (1.19e-1)"	"unprognostic (3.34e-1)"	"unprognostic (6.01e-2)"	"unprognostic (6.20e-2)"	"unprognostic (2.55e-1)"	"prognostic favorable (3.95e-5)"	"unprognostic (1.25e-1)"	"unprognostic (5.06e-2)"	"unprognostic (1.76e-1)"	"unprognostic (6.92e-3)"	8.2	7.7	5.0	11.4	7.3	8.0	12.4	7.1	6.7	7.3	7.1	94.6	72.1	6.3	7.7	11.3	5.7	12.1	7.7	5.1	6.3	95.2	263.7	6.5	5.5	7.6	7.3	6.7	4.9	7.7	5.0	5.6	7.8	37.7	107.2	9.4	10.7	4.4	15.0	8.1	68.4	9.7	6.5	6.0	42.3	8.6	7.3	4.6	6.1	9.1	5.6	16.9	7.2	9.0	9.5	7.8	8.2	15.1	16.5	15.5	9.4	9.6	7.9	6.4	7.1	5.6	10.9	10.6	4.7	12.8	6.0	10.8	8.5	14.1	7.2	8.8	4.0	7.9	5.7	30.9	15.5	4.7	8.8	12.9	14.0	8.7	18.2	8.8	13.1	17.1	8.8	15.4	9.7	13.6	5.4	5.6	2.5	8.5	15.7	6.0	8.0	5.2	11.4	57.1	5.8	6.0	16.6	12.9	9.2	6.4	18.7	4.1	10.8	12.6	12.7	7.5	7.2	10.1	16.9	8.3	8.0	8.8	11.5	18.3	1.2	9.4	2.5	2.3	1.3	1.4	1.3	1.8	1.7	1.5	2.1	2.1	0.1	0.5	1.4	0.9	1.6	1.3	5.0	7.3	7.1	6.7	5.1	6.3	7.6	7.3	7.8	6.5	7.3	9.0	8.0	16.0	6.7	8.1	4.9	3.7	6.2	8.9	5.2	6.6	15.0	7.9	5.2	10.0	11.3	7.3	4.2	8.2	4.3	209.3	25.4	6.9	19.5	10.0	13.6	7.0	16.2	36.6	5.9	12.9	6.7	7.9	23.0	25.8	1.3	9.6	9.7	134.8	6.2	10.1	8.2	77.1	14.2	9.7	1.9	12.7	2.8	5.2	5.4	11.2	5.4	4.9	8.2	2.0	11.3	9.1	58.4	5.7	3.6	28.5	87.0	63.1	6.4	12.2	13.1	6.0	5.9	27.2	19.1	8.5	3.4	3.3	4.9	10.3	60.9	39.0
ENTPD6	"CD39L2, dJ738P15.3, IL6ST2, NTPDase-6"	ENSG00000197586	"Ectonucleoside triphosphate diphosphohydrolase 6"	O75354	20	25195693-25228075	"Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins"		Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"SK-MEL-30: 289.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA015491, HPA069555"	Approved		Supported	"Golgi apparatus"	"Secreted to blood"	NA	NA		41000	"Cluster 39: Non-specific - mRNA processing"	"Cluster 22: Non-specific - Unknown function"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 53: Intestinal epithelial cells - Unknown function"	"Golgi apparatus"		"HPA015491: AB_2669200, HPA069555: AB_2686152"	"unprognostic (3.24e-1)"	"unprognostic (1.27e-2)"	"unprognostic (5.91e-2)"	"unprognostic (1.16e-1)"	"unprognostic (1.76e-1)"	"unprognostic (4.44e-1)"	"unprognostic (2.10e-3)"	"unprognostic (7.41e-3)"	"unprognostic (2.74e-3)"	"unprognostic (1.17e-1)"	"unprognostic (2.14e-1)"	"unprognostic (1.03e-1)"	"unprognostic (8.14e-3)"	"unprognostic (1.78e-2)"	"unprognostic (2.74e-1)"	"unprognostic (4.86e-2)"	"unprognostic (4.48e-2)"	24.8	55.4	54.3	22.8	64.0	15.2	27.7	39.7	65.9	22.9	26.5	61.0	60.0	21.8	18.4	25.3	23.2	26.5	75.9	56.0	49.8	40.4	38.9	25.4	16.1	29.6	32.2	36.2	49.6	23.5	60.0	25.2	45.2	55.7	44.9	15.7	71.2	17.2	38.7	19.4	63.0	18.6	25.7	19.8	47.2	36.3	48.5	29.8	28.8	21.9	13.0	24.5	21.8	38.9	78.8	122.8	32.9	64.0	41.0	50.8	70.8	63.0	45.0	54.0	48.3	65.5	60.0	47.6	91.4	60.9	104.7	100.3	40.1	96.2	35.5	29.2	36.2	38.3	18.2	150.4	60.7	52.7	57.3	47.4	53.1	67.7	51.4	39.4	43.7	46.1	51.5	78.8	40.0	75.6	49.2	32.6	20.8	63.9	96.0	27.1	102.9	108.4	67.8	46.3	52.0	26.7	17.7	105.1	289.4	29.6	75.3	43.4	48.6	61.9	63.7	51.6	75.7	50.5	43.8	21.0	44.5	34.1	116.3	0.1	25.2	4.9	18.8	17.0	25.6	8.7	16.5	15.0	26.4	11.0	16.9	15.5	1.1	14.1	7.6	18.5	17.2	22.1	54.3	64.0	39.7	65.9	56.0	49.8	29.6	32.2	45.2	25.7	48.5	38.9	6.4	19.2	28.5	12.4	9.9	9.8	16.2	23.6	6.2	19.2	25.8	21.8	5.8	25.8	14.8	18.4	10.4	63.2	11.0	81.4	9.8	42.5	22.1	10.5	7.6	7.6	34.0	4.2	18.6	40.1	21.7	12.8	52.5	15.4	3.8	65.2	14.3	15.0	26.7	25.2	19.4	57.5	26.4	17.7	17.4	65.2	20.5	17.6	10.6	11.2	16.0	4.2	10.3	13.0	9.2	33.8	59.8	42.2	16.5	27.9	68.4	13.5	10.7	9.1	6.6	6.3	9.6	3.0	8.8	8.6	6.0	59.8	12.0	25.8	72.6	12.1
ENTPD7	"FLJ30978, LALP1"	ENSG00000198018	"Ectonucleoside triphosphate diphosphohydrolase 7"	Q9NQZ7	10	99659509-99711241	"Enzymes, Predicted membrane proteins"		Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 14.6"	"Cell type enhanced"	"Detected in many"		"Basal prostatic cells: 17.5;Urothelial cells: 23.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in single"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA014351	Uncertain		Approved	Nucleoplasm		NA	NA		65000	"Cluster 28: Myeloid DCs - Unknown function"	"Cluster 56: Intestine - Transmembrane transport"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 65: Plasmacytoid DCs - Unknown function"	Nucleoplasm		"HPA014351: AB_1848183"	"unprognostic (1.82e-1)"	"unprognostic (7.26e-2)"	"unprognostic (1.11e-2)"	"unprognostic (6.01e-3)"	"unprognostic (6.22e-2)"	"unprognostic (3.32e-3)"	"unprognostic (9.35e-2)"	"unprognostic (3.77e-3)"	"unprognostic (3.83e-2)"	"unprognostic (1.74e-1)"	"unprognostic (1.66e-2)"	"unprognostic (1.39e-1)"	"unprognostic (5.59e-2)"	"unprognostic (2.98e-1)"	"unprognostic (1.22e-1)"	"unprognostic (2.99e-2)"	"unprognostic (3.39e-1)"	1.8	3.7	0.4	4.2	0.5	7.0	2.2	1.7	0.7	3.2	3.9	3.7	14.6	2.1	2.2	4.4	1.8	4.5	1.3	0.7	0.2	2.7	6.3	1.9	2.2	0.3	0.4	1.0	6.9	2.9	1.7	6.5	0.2	2.7	3.8	2.7	2.9	2.3	0.5	2.9	14.6	2.7	0.3	2.1	3.9	1.4	0.3	1.6	2.2	0.4	2.7	10.2	2.6	0.5	5.4	5.9	8.0	14.4	4.0	3.6	8.4	10.0	19.1	11.4	9.2	11.1	5.2	4.8	5.4	14.0	3.6	13.6	6.0	4.0	9.6	2.3	5.6	4.0	4.4	11.2	5.8	13.4	7.8	3.5	6.7	14.1	15.3	14.1	11.8	5.1	6.1	4.7	4.8	4.6	2.6	3.9	4.7	6.0	2.4	0.3	6.2	2.4	15.8	16.7	3.4	6.9	6.7	2.7	9.5	5.4	7.1	5.9	8.5	11.0	6.2	7.0	8.4	4.7	7.3	4.1	11.0	4.4	2.7	0.3	0.6	0.9	0.6	0.7	0.5	0.2	0.3	0.5	1.3	0.1	0.4	0.3	0.5	0.8	0.4	2.3	0.2	0.3	0.4	0.5	1.7	0.7	0.7	0.2	0.3	0.4	0.2	0.3	0.3	0.5	1.2	0.0	0.0	2.9	1.3	8.2	17.5	4.6	10.8	0.7	2.0	1.1	0.8	1.5	2.2	5.5	2.1	6.3	3.2	3.7	0.0	2.3	1.5	6.0	2.8	1.7	5.4	1.3	9.5	5.0	5.3	2.4	9.2	5.3	0.0	0.7	0.7	4.7	1.9	0.0	7.9	4.2	0.0	0.6	2.7	2.7	0.9	2.6	0.0	6.5	4.9	0.4	0.0	10.1	3.2	4.5	3.1	0.7	7.6	2.6	11.4	1.3	3.6	1.9	0.0	1.1	1.7	1.2	0.8	6.9	7.4	5.1	1.2	3.9	2.4	23.6
ENTPD8	"NTPDase-8, UNQ2492"	ENSG00000188833	"Ectonucleoside triphosphate diphosphohydrolase 8"	Q5MY95	9	137434364-137441816	"Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins"		Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"intestine: 27.6;liver: 14.5"	"Group enriched"	"Detected in some"	5	"Distal enterocytes: 194.5;Intestinal goblet cells: 181.0;Paneth cells: 174.3;Proximal enterocytes: 167.3"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"CAPAN-2: 5.0;OE19: 1.7;RPMI-8226: 5.3;T-47d: 2.8"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA021509	Enhanced		Approved	Nucleoplasm,Vesicles,Cytosol		NA	NA				"Cluster 41: Intestine & Liver - Lipid metabolism"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 53: Intestinal epithelial cells - Unknown function"	"Nucleoplasm, Cytosol"	Vesicles	"HPA021509: AB_1848185"	"unprognostic (3.85e-2)"	"unprognostic (8.33e-2)"	"unprognostic (2.11e-1)"	"unprognostic (1.82e-1)"	"unprognostic (1.30e-1)"	"unprognostic (1.40e-1)"	"unprognostic (6.46e-3)"	"unprognostic (8.70e-2)"	"unprognostic (3.87e-2)"	"unprognostic (8.48e-2)"	"unprognostic (1.69e-1)"	"unprognostic (2.34e-2)"	"unprognostic (1.08e-5)"	"prognostic favorable (7.17e-4)"	"unprognostic (2.17e-1)"	"unprognostic (1.15e-1)"	"unprognostic (1.78e-1)"	0.0	0.0	0.0	1.4	0.0	0.4	0.4	0.2	0.2	0.6	0.0	21.3	27.6	0.1	0.0	0.3	0.7	3.7	0.0	0.0	0.0	3.1	14.5	0.1	0.1	0.2	0.1	0.1	3.1	0.1	5.1	0.1	0.0	0.4	11.2	0.0	6.3	0.2	0.0	0.1	27.2	0.1	0.0	0.2	8.9	0.5	0.0	0.3	0.5	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.2	0.0	0.0	0.0	0.1	1.1	5.0	0.0	0.3	0.0	0.4	0.1	0.0	0.0	0.0	1.0	0.1	0.0	0.4	0.2	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.3	0.2	0.0	0.0	0.0	0.0	1.0	0.0	0.1	0.0	1.7	0.2	0.0	0.0	5.3	0.7	0.0	0.2	0.5	0.1	0.0	0.1	0.4	2.8	0.1	0.0	0.0	1.2	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.3	0.2	0.0	0.0	1.7	1.5	0.4	11.5	0.3	20.2	0.0	0.0	0.1	194.5	0.0	1.3	0.0	3.0	0.4	0.1	3.6	0.0	0.0	7.5	0.2	0.1	31.6	4.7	0.0	0.1	0.4	10.1	0.1	0.0	0.0	181.0	8.2	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	174.3	0.0	0.2	0.6	167.3	5.9	1.0	0.0	0.0	0.0	0.1	0.0	0.7	0.0	0.0	0.3	0.3	0.1	15.6	1.7
EPHX1	EPHX	ENSG00000143819	"Epoxide hydrolase 1"	P07099	1	225810124-225845563	"Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"Aromatic hydrocarbons catabolism, Detoxification"	Hydrolase	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"adrenal gland: 1178.6;liver: 1705.1"	"Cell type enhanced"	"Detected in many"		"Granulosa cells: 349.9;Hepatocytes: 757.6;Theca cells: 1042.6"	"Cancer enriched"	"Detected in all"	6	"liver cancer: 1047.0"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"classical monocyte: 2.6"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in all"		"ASC diff: 1161.8;SiHa: 413.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA020593, HPA048847"	Enhanced					NA	NA		160000	"Cluster 25: Monocytes - Inflammatory response"	"Cluster 15: Liver - Metabolism"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 2: Hepatocytes - Metabolism"			"HPA020593: AB_10601373, HPA048847: AB_2680538"	"unprognostic (2.85e-2)"	"unprognostic (2.52e-2)"	"unprognostic (2.00e-2)"	"unprognostic (2.53e-3)"	"unprognostic (2.50e-1)"	"unprognostic (6.60e-2)"	"unprognostic (3.92e-2)"	"prognostic favorable (7.02e-5)"	"unprognostic (1.02e-1)"	"unprognostic (2.53e-2)"	"unprognostic (1.01e-1)"	"prognostic favorable (1.32e-4)"	"unprognostic (8.10e-2)"	"unprognostic (1.80e-1)"	"unprognostic (1.65e-1)"	"unprognostic (5.15e-2)"	"unprognostic (1.88e-2)"	245.8	1178.6	233.5	23.6	252.5	22.7	163.7	239.0	249.3	188.3	345.8	82.0	102.2	108.1	97.6	159.6	153.8	96.5	94.0	221.3	233.7	110.7	1705.1	146.8	39.1	225.3	234.9	329.1	536.1	147.7	105.8	32.9	223.6	113.2	52.5	30.7	143.6	128.1	142.5	71.5	52.8	109.6	210.1	55.7	99.9	74.3	258.4	25.9	171.1	95.6	33.4	135.4	140.4	227.2	32.1	202.3	12.3	108.5	1161.8	120.2	24.3	29.7	49.2	28.1	35.1	38.8	293.6	1.3	128.7	147.3	30.6	38.1	32.7	16.8	12.1	7.8	46.5	21.8	83.5	282.7	129.8	12.9	15.1	109.2	40.0	74.6	6.3	116.5	22.1	13.4	14.5	27.3	50.4	30.3	13.5	31.0	61.6	178.1	79.4	27.8	15.2	92.9	91.1	132.5	98.3	13.0	413.0	192.1	51.3	32.1	131.7	43.5	46.8	41.9	35.4	54.5	59.0	9.1	38.9	4.1	63.5	14.2	59.5	0.0	2.6	0.1	0.2	0.7	0.4	0.1	0.3	0.2	0.6	0.2	0.5	0.3	0.2	0.7	0.3	0.9	0.3	0.8	233.5	252.5	239.0	249.3	221.3	233.7	225.3	234.9	223.6	210.1	258.4	227.2	196.9	0.0	14.0	41.1	5.7	19.6	121.8	244.2	74.0	8.8	29.7	27.4	1.2	102.9	255.5	51.5	29.2	46.6	3.4	34.5	17.6	95.3	10.2	142.9	32.2	82.7	10.8	7.0	3.1	73.0	7.6	175.6	30.5	93.4	5.7	349.9	88.2	757.6	149.1	1.7	5.0	17.5	103.7	30.9	28.7	28.4	311.3	25.8	42.7	23.4	9.6	99.2	0.0	7.1	19.4	45.5	27.2	159.1	9.5	40.4	63.4	128.9	174.3	10.1	223.5	29.3	146.9	4.4	5.1	129.0	17.6	22.8	4.7	1042.6	31.5	108.5
EPHX2	ABHD20	ENSG00000120915	"Epoxide hydrolase 2"	P34913	8	27490781-27545564	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Aromatic hydrocarbons catabolism, Detoxification, Lipid metabolism"	"Hydrolase, Multifunctional enzyme"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 333.2"	"Cell type enhanced"	"Detected in many"		"Distal tubular cells: 180.0;Hepatocytes: 131.5;Proximal enterocytes: 399.0;Proximal tubular cells: 259.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"memory CD4 T-cell: 35.0;naive CD4 T-cell: 106.7;naive CD8 T-cell: 50.4;T-reg: 29.6"	"Lineage enriched"	"Detected in many"	23	"T-cells: 106.7"	"Cell line enhanced"	"Detected in many"		"JURKAT: 139.4;K-562: 51.6;OE19: 102.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA023094, HPA023660"	Enhanced		Enhanced	Cytosol		NA	NA		1100000	"Cluster 32: T-cells - Unknown function"	"Cluster 41: Intestine & Liver - Lipid metabolism"	"Cluster 21: OE19 - Mitochondria"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Cytosol		"HPA023094: AB_1848214, HPA023660: AB_1848215"	"unprognostic (1.30e-1)"	"prognostic favorable (2.45e-4)"	"unprognostic (2.99e-2)"	"unprognostic (3.62e-2)"	"unprognostic (1.76e-2)"	"unprognostic (3.30e-3)"	"unprognostic (1.26e-3)"	"unprognostic (3.31e-3)"	"unprognostic (1.46e-1)"	"unprognostic (3.55e-2)"	"unprognostic (4.14e-3)"	"unprognostic (1.98e-1)"	"prognostic favorable (1.98e-10)"	"unprognostic (9.82e-2)"	"unprognostic (1.73e-1)"	"unprognostic (8.12e-2)"	"unprognostic (2.26e-1)"	19.3	74.0	14.5	9.1	15.0	1.9	30.1	14.4	14.1	21.0	42.2	61.4	112.8	17.7	27.2	38.6	41.6	9.4	29.1	13.2	15.3	166.3	333.2	11.2	17.2	16.1	17.3	38.0	64.5	54.8	35.8	8.5	15.9	64.6	57.6	21.5	36.5	27.2	16.2	43.4	128.4	15.4	15.8	10.8	23.4	9.0	15.8	65.9	22.6	13.8	20.8	19.7	23.4	15.7	15.3	10.1	6.3	8.1	0.4	0.0	4.8	1.3	0.9	0.7	0.2	8.0	10.1	0.1	5.9	4.1	3.2	10.7	1.1	2.6	0.5	0.0	4.7	22.5	1.1	24.8	3.4	0.1	4.5	8.6	10.7	0.1	1.1	2.5	0.5	139.4	51.6	0.2	0.0	4.7	14.9	0.5	10.1	102.4	17.2	0.1	0.1	0.4	8.7	2.2	5.1	16.0	12.1	14.2	15.0	4.6	21.8	4.2	0.2	0.0	3.8	1.8	0.1	12.5	10.1	0.2	0.4	0.1	0.1	0.1	0.1	0.0	7.8	0.0	11.3	4.5	35.0	12.7	0.1	2.5	106.7	50.4	0.2	4.6	0.1	0.2	29.6	20.0	14.5	15.0	14.4	14.1	13.2	15.3	16.1	17.3	15.9	15.8	15.8	15.7	6.3	6.4	17.0	16.3	6.1	11.9	18.6	10.1	29.6	34.1	17.2	18.4	23.7	20.0	9.7	27.6	79.2	22.8	1.0	82.7	180.0	8.8	7.5	6.9	4.8	9.4	23.4	3.8	3.0	6.4	2.5	12.1	15.8	1.5	5.7	17.4	17.5	131.5	2.2	33.7	7.2	63.4	2.0	4.6	1.2	4.8	29.8	3.6	5.4	2.8	2.6	91.5	3.1	7.5	5.1	3.1	83.7	18.8	4.5	20.5	399.0	259.3	24.1	52.4	0.0	11.5	10.2	1.3	13.9	39.2	18.3	8.2	11.9	78.5	101.3	10.8
EPHX3	"ABHD9, FLJ22408"	ENSG00000105131	"Epoxide hydrolase 3"	Q9H6B9	19	15226919-15233435	"Enzymes, Predicted intracellular proteins"	"Lipid metabolism"	Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 68.9;skin 1: 76.5;vagina: 36.6"	"Cell type enhanced"	"Detected in many"		"Basal respiratory cells: 15.5;Club cells: 19.3;Squamous epithelial cells: 30.7;Suprabasal keratinocytes: 43.3;Urothelial cells: 23.3"	"Cancer enhanced"	"Detected in many"		"cervical cancer: 30.5"	"Not detected"	"Not detected"			"Immune cell enhanced"	"Detected in some"		"intermediate monocyte: 1.9;non-classical monocyte: 2.4"	"Group enriched"	"Detected in many"	19	"dendritic cells: 1.3;monocytes: 2.4"	"Cell line enhanced"	"Detected in some"		"EFO-21: 2.5;NTERA-2: 2.3;OE19: 8.4;SuSa: 3.4"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA012842	Uncertain		Approved	Nucleoplasm	"Intracellular and membrane"	NA	NA			"Cluster 7: Monocytes - Unknown function"	"Cluster 11: Squamous epithelial cells - Epithelial cell function"	"Cluster 21: OE19 - Mitochondria"	"Cluster 61: Squamous epithelial cells - Keratinization"	Nucleoplasm		"HPA012842: AB_10601648"	"unprognostic (1.39e-1)"	"unprognostic (1.16e-2)"	"unprognostic (1.54e-2)"	"unprognostic (1.74e-1)"	"unprognostic (8.24e-2)"	"prognostic favorable (2.27e-5)"	"unprognostic (8.83e-3)"	"unprognostic (1.50e-1)"	"unprognostic (3.90e-1)"	"unprognostic (4.36e-2)"	"unprognostic (4.25e-2)"	"unprognostic (1.06e-1)"	"unprognostic (3.43e-1)"	"unprognostic (3.68e-2)"	"unprognostic (1.48e-1)"	"unprognostic (1.30e-2)"	"unprognostic (6.01e-2)"	0.5	0.3	0.8	0.2	0.8	0.2	1.5	0.6	0.9	14.7	0.7	0.2	0.2	0.4	0.3	68.9	1.7	1.3	0.5	0.7	0.9	3.3	0.3	1.7	0.1	0.9	0.8	0.7	0.2	3.0	1.8	0.4	0.8	1.5	0.2	0.2	7.6	0.9	0.4	76.5	0.3	0.4	0.8	2.6	0.8	2.1	0.9	1.7	0.4	0.1	26.7	8.6	36.6	0.8	0.1	0.2	0.4	0.1	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.2	0.3	0.2	2.5	0.0	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.1	0.0	0.2	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.4	0.0	0.3	2.3	8.4	0.3	0.0	0.0	0.0	0.0	0.5	1.0	0.1	0.0	0.0	0.0	3.4	0.0	0.0	0.0	0.1	0.3	0.0	0.1	0.0	0.2	0.3	0.0	0.1	0.1	0.0	0.5	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	2.4	1.3	0.0	0.2	0.8	0.8	0.6	0.9	0.7	0.9	0.9	0.8	0.8	0.8	0.9	0.8	0.2	0.0	1.1	0.0	0.2	7.0	2.6	15.5	0.0	0.4	0.9	0.6	0.5	5.7	19.3	5.5	0.0	1.6	0.0	0.1	1.9	0.5	0.2	0.7	0.4	0.6	0.0	0.0	0.1	0.0	3.4	0.6	0.0	1.7	0.0	0.4	1.1	0.0	0.6	0.0	0.1	0.1	2.0	3.2	1.4	0.0	0.0	1.5	0.0	0.0	0.6	2.5	0.0	0.0	0.1	0.6	0.0	0.0	0.0	2.6	0.2	0.0	3.3	0.0	0.0	0.8	2.5	4.6	2.1	30.7	43.3	2.6	0.2	0.2	0.1	23.3
EPM2A	"LD, LDE"	ENSG00000112425	"EPM2A glucan phosphatase, laforin"	O95278	6	145382535-145736023	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"Autophagy, Carbohydrate metabolism, Glycogen metabolism"	"Hydrolase, Protein phosphatase"	"Disease variant, Epilepsy, Glycogen storage disease, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 76.8;tongue: 79.5"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 66.9;Early spermatids: 33.0;Excitatory neurons: 30.4;Inhibitory neurons: 50.7;Oligodendrocyte precursor cells: 56.8;Oligodendrocytes: 60.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"NK-cell: 1.9"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"Daudi: 23.2"	"Low region specificity"	"Detected in all"							"HPA053643, HPA055468"			Enhanced	Nucleoplasm		NA	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	Nucleoplasm		"HPA053643: AB_2797247, HPA055468: AB_2797252"	"unprognostic (2.37e-2)"	"unprognostic (1.03e-1)"	"unprognostic (1.99e-1)"	"unprognostic (3.34e-3)"	"unprognostic (2.92e-3)"	"unprognostic (1.22e-1)"	"unprognostic (2.15e-2)"	"unprognostic (1.63e-1)"	"unprognostic (2.37e-2)"	"unprognostic (1.50e-1)"	"unprognostic (1.52e-4)"	"unprognostic (2.28e-1)"	"prognostic favorable (4.08e-7)"	"unprognostic (4.12e-4)"	"unprognostic (2.17e-1)"	"unprognostic (2.99e-3)"	"unprognostic (1.23e-1)"	5.8	6.0	11.4	1.5	11.7	1.8	3.2	11.9	17.8	3.1	7.3	17.2	3.2	6.0	4.3	9.3	4.4	3.6	24.4	11.6	12.6	8.5	5.7	3.0	3.3	11.9	11.5	5.7	2.4	5.2	3.8	1.5	11.1	6.1	2.9	12.1	3.1	8.8	76.8	2.1	3.8	6.3	10.3	2.1	5.3	3.0	11.5	4.8	3.9	79.5	2.6	9.8	2.7	13.3	1.3	2.1	3.4	6.6	8.6	2.3	1.6	3.1	3.8	2.9	3.5	1.7	1.7	23.2	2.7	3.8	3.5	1.8	1.3	1.6	2.6	9.3	1.9	3.6	2.5	2.7	4.8	12.7	2.4	2.0	7.0	1.7	0.7	3.8	2.0	5.0	1.8	5.4	3.8	3.1	8.4	3.2	3.9	3.2	1.9	4.8	3.1	6.7	2.5	1.8	6.3	6.4	5.5	3.3	7.8	3.1	1.9	7.3	4.6	2.9	1.1	2.7	2.6	4.1	4.6	8.6	2.6	2.8	4.8	0.0	0.0	0.0	0.1	0.5	0.4	0.4	0.4	0.3	0.3	0.4	0.4	0.9	0.1	1.9	0.1	0.3	0.0	0.3	11.4	11.7	11.9	17.8	11.6	12.6	11.9	11.5	11.1	10.3	11.5	13.3	3.9	6.4	1.5	66.9	4.4	0.9	1.0	0.8	0.6	8.4	3.5	2.2	27.8	2.8	2.2	1.8	6.2	1.0	1.9	0.2	11.7	1.0	33.0	1.9	3.6	2.2	1.2	4.4	30.4	2.3	0.7	2.3	1.1	1.4	2.5	6.0	1.4	6.6	2.3	30.3	50.7	1.5	2.0	3.3	1.4	19.8	3.1	3.1	7.2	15.9	1.7	7.9	2.1	56.8	60.1	1.2	1.7	2.2	1.7	1.5	0.5	7.1	2.2	6.3	0.0	6.2	2.4	4.9	1.6	0.8	0.4	0.4	1.8	5.1	1.2	0.3
ERAS	"HRAS2, HRASP"	ENSG00000187682	"ES cell expressed Ras"	Q7Z444	X	48826513-48830138	"Enzymes, Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 2.5"	"Cell type enhanced"	"Detected in some"		"Spermatocytes: 1.7;Spermatogonia: 1.8"	"Cancer enhanced"	"Detected in some"		"endometrial cancer: 1.1;ovarian cancer: 1.2"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"													NA	NA				"Cluster 88: Choroid plexus - Transmembrane transport"		"Cluster 13: Spermatocytes & Spermatogonia - Spermatogenesis"				"unprognostic (2.47e-2)"	"unprognostic (1.28e-2)"	"unprognostic (4.50e-2)"	"unprognostic (3.93e-2)"	"unprognostic (3.61e-1)"	"unprognostic (2.43e-1)"	"unprognostic (1.38e-1)"	"unprognostic (1.20e-1)"	"unprognostic (1.85e-1)"	"unprognostic (1.87e-2)"	"unprognostic (2.72e-4)"	"unprognostic (9.40e-2)"	"unprognostic (7.07e-3)"	"unprognostic (1.22e-1)"	"unprognostic (1.98e-1)"	"unprognostic (1.08e-1)"	"unprognostic (2.25e-2)"	0.1	0.0	1.3	0.0	1.0	0.1	0.1	1.1	1.5	0.4	0.9	0.4	0.0	0.3	0.0	0.0	0.3	0.0	0.0	0.9	2.3	0.5	0.6	0.1	0.0	1.1	1.3	0.4	0.0	0.0	1.0	0.0	1.1	0.2	0.0	0.4	0.1	0.1	0.1	0.1	0.1	0.0	0.9	0.0	0.1	1.0	2.5	0.0	0.0	0.0	0.0	0.2	0.1	1.0	0.0	0.2	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.6	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.1	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.5	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.4	0.0	0.0	0.1	0.1	0.0	0.1	0.1	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	1.0	1.1	1.5	0.9	2.3	1.1	1.3	1.1	0.9	2.5	1.0	0.2	0.0	0.0	0.7	0.0	0.0	0.0	0.2	0.0	0.5	0.2	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.2	0.2	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.6	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.5	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.3	0.0	0.3	0.1	1.7	1.8	0.0	0.0	0.0	0.3	0.0	0.0	0.0
ERCC2	"EM9, MAG, MGC102762, MGC126218, MGC126219, XPD"	ENSG00000104884	"ERCC excision repair 2, TFIIH core complex helicase subunit"	P18074	19	45349837-45370918	"Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins"	"Chromosome partition, DNA damage, DNA repair, Host-virus interaction, Transcription, Transcription regulation"	"DNA-binding, Helicase, Hydrolase"	"Cancer-related genes, Cataract, Cockayne syndrome, Deafness, Disease variant, Dwarfism, Ichthyosis, Xeroderma pigmentosum"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Granulosa cells: 34.1;Spermatocytes: 30.5;Theca cells: 29.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB005375, HPA038057, HPA069266"	Approved		Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 43: Testis - Unknown function"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 40: Granulosa cells - Unknown function"	Nucleoplasm	Cytosol	"CAB005375: AB_2100152, HPA038057: AB_2675810, HPA069266: AB_2686104"	"unprognostic (1.10e-1)"	"unprognostic (5.48e-1)"	"unprognostic (5.08e-2)"	"unprognostic (9.92e-3)"	"unprognostic (1.35e-1)"	"unprognostic (1.23e-2)"	"unprognostic (1.67e-3)"	"unprognostic (1.46e-1)"	"unprognostic (3.41e-1)"	"unprognostic (1.06e-1)"	"prognostic favorable (3.26e-4)"	"unprognostic (3.36e-2)"	"unprognostic (2.44e-3)"	"unprognostic (1.94e-1)"	"unprognostic (5.47e-1)"	"unprognostic (8.99e-2)"	"unprognostic (3.45e-2)"	6.8	13.0	10.5	6.9	10.3	4.8	6.5	8.4	11.7	7.5	8.4	7.5	4.9	9.7	3.2	6.3	8.0	4.1	7.0	10.8	9.3	7.6	9.0	5.8	5.8	10.6	9.9	7.8	7.7	7.7	9.7	4.5	9.6	6.7	4.0	3.1	7.3	6.7	11.7	7.2	6.6	6.9	8.1	8.1	7.5	13.9	10.1	5.3	8.4	6.3	5.2	7.5	5.9	8.9	28.0	13.3	27.1	38.4	16.3	19.4	15.2	38.8	27.4	50.2	40.2	32.6	18.6	10.0	21.6	39.9	19.1	14.0	19.1	32.9	18.5	24.4	31.8	16.9	26.8	35.4	33.3	27.1	28.4	22.4	5.6	55.8	31.9	28.2	29.1	28.8	41.8	10.9	34.8	14.7	16.1	17.9	12.7	27.2	24.6	30.3	19.4	8.3	14.0	24.9	15.8	17.1	34.2	23.9	13.6	20.6	22.8	35.4	37.9	46.4	25.3	19.9	88.0	24.9	15.8	14.2	13.8	16.4	21.2	0.0	17.2	6.5	9.1	18.0	11.9	9.1	8.9	8.9	21.8	6.5	8.2	8.7	0.5	15.6	14.9	10.4	9.8	12.1	10.5	10.3	8.4	11.7	10.8	9.3	10.6	9.9	9.6	8.1	10.1	8.9	4.2	6.4	3.4	6.2	5.8	6.2	5.5	8.6	4.6	0.0	6.1	4.3	6.7	8.6	8.7	5.5	0.0	10.5	4.1	5.9	13.7	10.7	4.7	3.3	4.5	5.5	7.2	5.5	2.9	8.2	12.1	6.8	6.1	3.8	0.0	34.1	7.9	12.3	11.5	0.0	3.1	8.5	4.1	8.2	4.2	2.8	6.5	6.3	3.6	1.0	4.2	0.0	5.2	5.0	1.4	8.1	3.1	7.9	7.5	4.2	4.1	13.0	7.5	0.0	0.0	3.5	9.9	30.5	13.1	5.1	5.7	4.8	4.7	29.1	8.8	3.2
ERCC3	"BTF2, RAD25, XPB"	ENSG00000163161	"ERCC excision repair 3, TFIIH core complex helicase subunit"	P19447	2	127257290-127294166	"Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"DNA damage, DNA repair, Host-virus interaction, Transcription, Transcription regulation"	"DNA-binding, Helicase, Hydrolase"	"Cancer-related genes, Cockayne syndrome, Deafness, Disease variant, Dwarfism, Ichthyosis, Xeroderma pigmentosum"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB037153, HPA046077"	Approved		Enhanced	Nucleoplasm		NA	NA			"Cluster 48: NK-cells - Unknown function"	"Cluster 72: Non-specific - Transcription"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"	Nucleoplasm		"CAB037153: AB_796181, HPA046077: AB_2679527"	"unprognostic (2.31e-1)"	"unprognostic (1.15e-1)"	"unprognostic (3.03e-2)"	"unprognostic (1.07e-3)"	"unprognostic (1.05e-1)"	"unprognostic (8.85e-2)"	"prognostic unfavorable (1.62e-7)"	"unprognostic (2.74e-1)"	"unprognostic (9.13e-3)"	"unprognostic (9.25e-2)"	"unprognostic (1.25e-1)"	"unprognostic (2.46e-2)"	"prognostic unfavorable (4.30e-6)"	"unprognostic (3.71e-1)"	"unprognostic (8.50e-2)"	"unprognostic (5.73e-2)"	"unprognostic (3.92e-2)"	24.4	25.9	15.0	14.5	16.0	19.8	24.4	15.1	16.5	32.2	19.6	28.9	9.6	27.0	11.6	22.7	28.9	14.2	23.4	16.6	14.9	22.8	22.2	22.1	21.6	15.7	14.8	29.5	23.8	26.3	33.8	13.6	16.0	27.4	13.8	4.4	23.2	16.8	35.3	27.7	24.3	21.5	15.1	32.6	23.7	29.8	15.6	26.6	25.0	25.6	22.4	27.2	26.4	15.2	45.9	30.8	37.8	40.6	40.6	27.8	46.4	41.3	52.9	65.1	62.5	48.1	32.9	34.5	33.2	37.8	41.7	40.2	57.7	43.3	56.1	54.4	51.4	43.6	35.8	51.0	30.5	38.1	45.4	28.9	39.8	75.7	32.4	41.5	42.4	44.3	43.0	22.1	41.7	45.1	54.8	42.2	55.0	29.2	47.3	44.5	42.7	28.8	36.4	42.2	45.2	49.2	35.3	52.6	55.0	42.4	28.7	43.0	34.1	39.2	45.2	35.8	49.7	39.2	81.5	54.0	34.3	18.0	42.8	8.0	11.5	8.8	18.2	12.0	18.4	13.7	13.1	15.7	16.9	12.7	17.7	12.2	3.5	25.0	9.9	13.6	20.5	15.5	15.0	16.0	15.1	16.5	16.6	14.9	15.7	14.8	16.0	15.1	15.6	15.2	12.2	22.4	14.6	24.8	17.7	7.6	9.5	20.6	21.1	0.0	13.0	11.6	13.0	5.7	25.4	7.3	0.0	18.6	18.9	6.1	1.9	13.7	9.0	22.9	13.9	12.2	6.1	3.8	22.3	14.9	12.2	16.6	18.8	13.1	10.1	17.1	15.4	8.6	14.6	0.0	23.5	10.0	14.2	12.5	7.6	5.1	16.4	10.7	8.8	10.3	12.3	0.0	14.4	18.1	22.4	15.5	7.3	12.8	16.4	7.4	6.3	8.5	45.2	0.0	13.1	17.6	13.3	41.1	31.0	11.3	9.5	14.6	15.7	12.3	10.6	8.5
ERCC6L	"FLJ20105, PICH, RAD26L"	ENSG00000186871	"ERCC excision repair 6 like, spindle assembly checkpoint helicase"	Q2NKX8	X	72204657-72239027	"Enzymes, Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis"	"DNA-binding, Helicase, Hydrolase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"bone marrow: 3.2;lymphoid tissue: 3.6"	"Cell type enhanced"	"Detected in some"		"Erythroid cells: 3.4;Granulosa cells: 2.5;Spermatocytes: 2.1;Spermatogonia: 2.4;Squamous epithelial cells: 2.4"	"Cancer enhanced"	"Detected in many"		"testis cancer: 11.0"	"Not detected"	"Not detected"			"Immune cell enriched"	"Detected in single"	4	"NK-cell: 1.7"	"Lineage enriched"	"Detected in single"	4	"NK-cells: 1.7"	"Low cell line specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA050492	Approved		Uncertain	Nucleoplasm,Centrosome,Cytosol		No	Yes			"Cluster 15: NK-cells - Transcription"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	Centrosome	"Nucleoplasm, Cytosol"	"HPA050492: AB_2681145"	"prognostic unfavorable (1.80e-4)"	"unprognostic (2.93e-1)"	"unprognostic (1.95e-2)"	"unprognostic (5.76e-3)"	"unprognostic (2.43e-1)"	"unprognostic (2.36e-1)"	"unprognostic (9.23e-6)"	"unprognostic (8.63e-3)"	"unprognostic (1.57e-2)"	"unprognostic (1.99e-2)"	"unprognostic (3.68e-5)"	"unprognostic (4.61e-2)"	"unprognostic (0.00e+0)"	"unprognostic (2.97e-3)"	"unprognostic (9.56e-2)"	"unprognostic (1.17e-1)"	"unprognostic (6.41e-2)"	0.1	0.1	0.1	1.3	0.2	3.2	0.4	0.8	0.2	0.4	0.1	0.9	0.7	0.2	0.2	1.1	0.2	0.2	0.1	0.1	0.0	0.1	0.1	0.1	2.3	0.1	0.0	0.3	0.1	0.0	0.1	0.5	0.1	0.1	1.1	0.5	0.3	0.0	0.1	0.6	0.6	0.3	0.0	0.5	0.7	0.8	0.2	3.6	0.1	0.0	2.7	0.2	0.4	0.6	19.0	16.3	14.6	9.3	1.0	1.7	8.0	19.8	9.1	17.0	17.7	13.3	11.6	30.5	7.3	7.2	23.0	15.2	27.8	14.8	30.1	17.5	20.2	10.5	5.5	7.9	0.0	20.7	14.2	0.2	0.9	23.7	4.4	2.8	9.6	15.1	14.1	7.3	17.6	14.8	19.8	12.1	26.6	18.3	24.8	16.4	26.2	5.4	4.4	11.5	12.0	8.6	14.7	9.8	3.6	11.8	7.5	4.6	6.0	11.4	18.3	21.8	13.1	5.7	9.4	25.9	8.1	14.1	11.7	0.0	0.0	0.2	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.1	0.1	0.4	0.1	1.7	0.1	0.1	0.4	0.1	0.1	0.2	0.8	0.2	0.1	0.0	0.1	0.0	0.1	0.0	0.2	0.6	0.1	0.0	0.0	0.0	0.9	0.3	0.2	0.5	0.0	0.0	0.3	0.6	0.5	1.5	0.2	0.0	0.0	1.1	0.9	0.6	0.0	0.0	0.3	0.9	0.8	0.3	0.0	3.4	0.9	0.0	1.7	0.5	0.0	0.5	0.0	2.5	0.0	0.0	1.0	0.0	0.7	0.4	0.0	0.3	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.5	1.7	0.1	0.0	0.0	1.6	0.0	0.0	0.0	0.3	0.0	0.0	0.4	0.4	2.1	2.4	2.4	0.1	0.4	0.3	0.2	0.9	0.1
ESD		ENSG00000139684	"Esterase D"	P10768	13	46771256-46797420	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"		"Hydrolase, Serine esterase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Proximal tubular cells: 569.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA039700	Approved		Approved	"Nucleoplasm,Golgi apparatus,Cytosol"		NA	NA		12000000	"Cluster 25: Monocytes - Inflammatory response"	"Cluster 85: Liver - Metabolism"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 10: Non-specific - Unknown function"	"Golgi apparatus"	"Nucleoplasm, Cytosol"	"HPA039700: AB_10697553"	"unprognostic (3.05e-1)"	"prognostic unfavorable (5.01e-4)"	"unprognostic (7.66e-2)"	"unprognostic (1.75e-1)"	"unprognostic (1.63e-1)"	"prognostic unfavorable (2.16e-4)"	"unprognostic (1.73e-2)"	"unprognostic (3.31e-1)"	"unprognostic (1.01e-1)"	"unprognostic (2.12e-2)"	"unprognostic (1.49e-2)"	"unprognostic (1.08e-1)"	"unprognostic (2.91e-2)"	"unprognostic (2.71e-2)"	"unprognostic (2.18e-1)"	"unprognostic (6.44e-2)"	"unprognostic (1.37e-3)"	123.8	87.5	83.0	73.0	85.5	95.1	146.7	86.3	110.8	141.0	87.7	125.7	106.7	129.7	160.1	93.6	121.8	96.4	151.5	84.3	98.6	194.4	277.2	92.3	93.5	87.3	85.6	179.0	67.3	109.9	81.5	81.9	89.7	112.5	135.0	122.0	92.8	140.3	149.8	83.3	93.4	166.2	94.3	63.9	83.0	54.2	82.4	155.7	155.0	179.0	110.3	104.9	96.2	100.0	138.4	77.9	229.8	160.4	264.5	441.9	62.5	190.8	280.9	264.7	204.6	131.6	162.8	156.5	56.9	233.3	194.0	137.1	256.8	227.2	333.0	180.4	270.4	200.3	70.7	208.6	220.5	400.1	82.2	304.6	207.0	167.9	229.4	316.2	253.2	260.3	200.3	40.7	433.5	135.1	352.7	260.0	59.8	175.2	148.8	277.1	133.6	106.2	378.4	55.4	115.0	130.1	85.0	72.6	160.3	157.6	137.1	223.0	169.2	94.4	113.0	187.5	181.8	27.6	63.5	135.7	205.3	223.2	131.2	35.0	129.4	55.7	48.5	113.6	80.9	104.1	97.6	76.3	142.8	83.4	114.1	90.5	15.0	109.3	106.1	170.7	90.6	100.3	83.0	85.5	86.3	110.8	84.3	98.6	87.3	85.6	89.7	94.3	82.4	100.0	139.0	54.5	56.8	37.5	77.2	134.1	227.4	300.5	148.0	51.5	114.1	123.2	99.2	167.3	111.7	154.5	41.7	160.4	51.2	59.1	360.0	168.0	135.5	102.2	120.6	112.5	108.8	99.5	22.7	103.2	141.0	162.9	51.0	80.7	96.4	71.1	132.1	154.7	227.5	21.9	19.3	114.6	175.0	140.2	148.0	34.8	267.8	108.2	165.4	25.3	144.3	199.5	36.0	23.6	36.2	85.4	92.3	211.4	35.9	99.1	137.1	569.1	94.2	77.3	151.2	196.0	484.2	61.6	46.3	120.6	129.3	74.4	78.2	151.2	199.8	143.6
ESPL1	"ESP1, KIAA0165, SEPA"	ENSG00000135476	"Extra spindle pole bodies like 1, separase"	Q14674	12	53268299-53293638	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"	"Chromosome partition"	"Hydrolase, Protease, Thiol protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"bone marrow: 8.5;esophagus: 15.4;lymphoid tissue: 10.7"	"Cell type enhanced"	"Detected in many"		"Ionocytes: 22.4;Proximal enterocytes: 22.6;Squamous epithelial cells: 7.4"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"CAB012185, HPA073188"	Approved		Supported	Nucleoplasm,Vesicles		NA	Yes			"Cluster 39: Non-specific - mRNA processing"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 45: Enterocytes - Digestion"	Nucleoplasm	Vesicles	"CAB012185: AB_304056, HPA073188: "	"unprognostic (1.57e-1)"	"unprognostic (3.56e-2)"	"unprognostic (3.84e-2)"	"prognostic unfavorable (5.32e-5)"	"unprognostic (2.91e-1)"	"unprognostic (1.11e-1)"	"prognostic unfavorable (2.01e-5)"	"prognostic unfavorable (7.14e-4)"	"unprognostic (1.59e-2)"	"unprognostic (2.48e-1)"	"unprognostic (4.17e-3)"	"unprognostic (1.18e-2)"	"unprognostic (7.42e-13)"	"prognostic favorable (7.10e-4)"	"unprognostic (2.39e-1)"	"unprognostic (7.41e-2)"	"unprognostic (1.42e-1)"	0.4	0.2	0.0	2.4	0.0	8.5	0.5	0.0	0.0	3.5	0.0	1.5	3.9	0.2	0.0	15.4	0.2	0.4	0.1	0.0	0.0	0.9	0.6	0.4	4.4	0.0	0.0	0.1	0.1	0.0	0.0	1.1	0.0	0.1	1.4	0.0	2.0	0.1	0.0	2.6	4.3	0.7	0.0	1.0	0.9	6.2	0.1	10.7	0.1	0.0	4.9	0.6	5.9	0.0	27.8	23.6	27.6	21.1	0.6	1.9	17.5	15.9	8.6	28.8	19.2	15.8	22.7	49.9	9.5	6.8	17.4	20.2	32.6	9.9	14.3	13.7	32.8	30.6	24.1	11.1	0.1	19.5	25.2	0.6	0.6	15.5	7.6	2.8	15.4	22.2	42.6	41.0	9.1	29.2	30.6	16.4	22.5	14.5	12.9	29.3	30.2	21.4	4.2	11.6	18.9	15.8	11.9	20.4	10.1	13.0	36.9	12.7	8.2	14.5	27.2	11.9	25.5	32.5	29.7	31.9	8.2	19.0	27.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.5	0.0	0.0	0.3	0.6	0.9	0.3	0.5	0.6	0.0	1.0	1.3	0.9	0.0	0.4	3.7	0.0	1.9	0.6	2.7	0.0	0.2	0.8	0.2	0.8	1.0	3.5	1.3	0.7	0.0	2.3	1.1	3.6	0.7	0.0	4.4	0.7	6.8	2.6	0.0	0.4	2.7	22.4	0.6	2.1	1.2	0.0	1.3	0.0	1.0	0.0	0.0	0.0	0.0	0.5	1.5	1.3	0.4	2.1	0.4	22.6	6.6	0.2	0.0	0.0	0.4	0.9	5.5	4.1	7.4	0.6	0.3	0.4	0.1	2.8	0.4
EXD2	"C14orf114, EXDL2, FLJ10738"	ENSG00000081177	"Exonuclease 3'-5' domain containing 2"	Q9NVH0	14	69191511-69244020	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"	"DNA damage, DNA repair"	"Exonuclease, Hydrolase, Nuclease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Spermatocytes: 36.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA002906, HPA005848"	Uncertain		Approved	"Intermediate filaments,Mitochondria"		NA	NA			"Cluster 18: Basophils - Vesicular transport"	"Cluster 24: Salivary gland - Salivary secretion"	"Cluster 6: T47d - Mammary gland"	"Cluster 66: Spermatocytes - Spermatogenesis"	Mitochondria	"Intermediate filaments"	"HPA002906: AB_1078767, HPA005848: AB_1078768"	"unprognostic (3.36e-2)"	"unprognostic (1.61e-2)"	"unprognostic (1.25e-1)"	"unprognostic (1.71e-1)"	"unprognostic (2.63e-1)"	"unprognostic (2.85e-1)"	"prognostic unfavorable (8.47e-4)"	"unprognostic (9.91e-2)"	"unprognostic (8.03e-2)"	"unprognostic (2.46e-1)"	"unprognostic (4.64e-2)"	"unprognostic (8.97e-2)"	"prognostic favorable (2.08e-9)"	"unprognostic (1.16e-1)"	"unprognostic (3.06e-2)"	"unprognostic (8.75e-2)"	"unprognostic (2.14e-2)"	8.0	6.9	16.0	5.0	17.2	2.5	9.7	16.7	18.8	13.6	15.0	9.5	6.8	9.6	12.1	10.4	13.1	8.1	8.7	15.8	15.7	10.4	5.9	8.6	4.2	17.3	16.4	11.0	18.1	16.0	10.0	7.5	17.4	10.2	9.2	13.0	15.4	10.5	11.0	6.6	6.5	10.1	17.1	5.8	9.7	19.9	16.2	7.2	11.5	9.7	4.5	8.4	7.4	18.9	29.6	13.6	10.3	15.3	6.2	7.4	13.0	14.4	12.1	13.1	17.3	11.6	20.3	0.0	10.4	15.1	8.0	16.4	11.5	14.5	14.7	7.4	13.7	8.6	5.2	6.8	24.2	6.4	7.9	15.1	23.5	13.4	8.7	8.1	18.9	7.4	5.5	11.0	12.7	14.8	3.6	9.6	11.2	15.8	13.5	0.0	9.9	10.4	19.5	10.8	20.0	17.8	10.8	22.2	10.6	11.0	29.8	5.5	15.0	12.2	8.5	9.9	7.5	8.3	12.0	0.1	0.1	6.9	9.3	12.2	2.5	2.2	2.2	1.4	4.2	2.9	2.3	2.3	5.4	1.5	2.8	4.1	0.3	2.9	1.4	4.2	1.8	2.3	16.0	17.2	16.7	18.8	15.8	15.7	17.3	16.4	17.4	17.1	16.2	18.9	7.2	12.8	10.9	15.7	4.3	3.2	4.9	6.2	14.2	9.9	9.9	7.2	12.1	7.2	9.0	0.0	8.4	8.5	2.5	4.7	5.9	10.7	3.2	7.7	8.4	6.0	6.1	7.8	27.4	8.8	4.4	6.5	8.2	11.1	1.3	9.6	10.8	5.4	6.8	10.1	22.6	8.4	8.2	6.3	2.2	2.3	6.2	3.3	3.6	11.2	6.8	7.5	2.1	21.6	19.1	8.8	6.2	12.0	5.6	5.6	3.6	4.8	11.0	9.3	0.0	7.2	7.4	36.1	8.1	12.6	4.3	2.9	2.6	6.1	7.9	4.3
EYA1	BOR	ENSG00000104313	"EYA transcriptional coactivator and phosphatase 1"	Q99502	8	71197433-71592025	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"DNA damage, DNA repair, Transcription, Transcription regulation"	"Activator, Chromatin regulator, Developmental protein, Hydrolase, Protein phosphatase"	"Deafness, Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"choroid plexus: 18.7;parathyroid gland: 23.7"	"Cell type enriched"	"Detected in some"	11	"Astrocytes: 214.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AN3-CA: 27.6;RH-30: 21.3;RPMI-8226: 9.5;SH-SY5Y: 51.4"	"Low region specificity"	"Detected in all"			"Region enhanced"	"Detected in all"		"cerebellum: 20.7"	HPA028917			Supported	"Nucleoplasm,Nuclear bodies"		NA	NA				"Cluster 42: Ciliated cells - Cilium & Cell projection"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 64: Astrocytes - Nervous system maintenance"	"Nucleoplasm, Nuclear bodies"		"HPA028917: AB_2672826"	"unprognostic (3.74e-2)"	"unprognostic (1.16e-1)"	"unprognostic (1.15e-1)"	"unprognostic (1.72e-3)"	"unprognostic (5.95e-2)"	"unprognostic (9.17e-2)"	"unprognostic (2.91e-4)"	"unprognostic (1.98e-1)"	"unprognostic (1.03e-1)"	"unprognostic (1.81e-1)"	"unprognostic (9.72e-2)"	"unprognostic (1.13e-1)"	"unprognostic (4.22e-12)"	"unprognostic (1.06e-2)"	"unprognostic (1.84e-1)"	"unprognostic (3.81e-4)"	"unprognostic (1.25e-2)"	0.6	0.6	2.8	0.1	7.8	0.0	0.2	0.5	2.1	5.1	18.7	0.1	0.1	0.1	0.1	0.4	2.0	0.3	4.5	1.3	2.5	0.1	0.0	0.4	0.0	2.1	4.9	0.2	0.0	23.7	10.8	0.0	2.3	12.0	0.2	0.4	0.8	4.0	2.8	0.0	0.2	0.2	0.0	0.1	0.8	0.8	4.6	11.7	0.6	2.5	0.1	2.6	4.3	0.6	0.2	0.0	6.4	27.6	0.0	0.0	0.0	0.2	2.7	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.9	1.6	0.0	0.0	4.7	0.0	2.2	0.0	0.0	0.5	0.0	6.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	2.0	1.0	0.0	0.0	0.0	2.0	0.0	1.5	0.0	21.3	9.5	0.0	0.0	2.2	51.4	0.0	0.0	1.6	5.9	0.0	0.1	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	6.3	0.0	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.8	7.8	0.5	2.1	1.3	2.5	2.1	4.9	2.3	0.0	4.6	0.6	0.2	0.0	0.0	214.5	0.0	0.1	0.0	6.4	0.6	0.1	0.0	0.1	8.8	0.0	7.5	0.0	0.0	0.8	0.0	0.0	0.0	0.0	4.4	3.1	0.1	0.2	0.0	0.0	1.3	0.0	0.5	1.3	0.0	0.4	0.0	0.0	0.0	0.0	0.1	0.0	13.5	0.0	2.0	0.0	0.0	6.4	0.3	0.0	0.0	11.2	0.0	0.1	0.0	18.6	0.6	0.0	0.0	0.4	0.0	0.1	0.0	0.3	10.5	0.2	0.0	0.2	0.5	0.8	1.0	1.1	0.1	0.5	0.0	1.4	0.0	0.1
EYA2	EAB1	ENSG00000064655	"EYA transcriptional coactivator and phosphatase 2"	O00167	20	46894624-47188844	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"DNA damage, DNA repair, Transcription, Transcription regulation"	"Activator, Chromatin regulator, Developmental protein, Hydrolase, Protein phosphatase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"cervix: 55.6"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 153.8;Basal prostatic cells: 47.5;Basal respiratory cells: 50.4;Endometrial ciliated cells: 43.7;Glandular and luminal cells: 53.8;Oligodendrocyte precursor cells: 48.7"	"Cancer enhanced"	"Detected in many"		"endometrial cancer: 69.3"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HBEC3-KT: 40.1;SCLC-21H: 58.3;U-266/70: 110.9;U-266/84: 139.3"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA027024, HPA059291"	Uncertain		Supported	Cytosol		NA	NA				"Cluster 57: Non-specific - Angiogenesis"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 64: Astrocytes - Nervous system maintenance"	Cytosol		"HPA027024: AB_1848334, HPA059291: AB_2683967"	"unprognostic (1.08e-1)"	"unprognostic (5.71e-3)"	"unprognostic (4.03e-1)"	"prognostic favorable (4.30e-5)"	"unprognostic (3.32e-2)"	"unprognostic (1.72e-1)"	"unprognostic (4.94e-3)"	"unprognostic (1.10e-1)"	"unprognostic (1.21e-1)"	"unprognostic (1.21e-1)"	"unprognostic (2.54e-1)"	"unprognostic (2.65e-1)"	"unprognostic (7.06e-2)"	"unprognostic (2.15e-1)"	"unprognostic (2.78e-1)"	"unprognostic (4.17e-3)"	"unprognostic (1.56e-1)"	12.0	1.5	12.3	2.4	14.1	0.0	11.0	15.6	12.3	55.6	11.2	9.3	0.3	17.2	3.7	34.2	34.0	1.8	5.0	10.7	11.8	4.7	2.1	2.2	0.8	14.6	14.4	0.7	1.9	9.4	5.3	6.3	13.7	23.6	3.1	1.2	31.2	9.3	2.5	5.3	1.1	1.8	11.8	0.6	8.9	5.6	13.4	18.8	14.6	3.4	6.6	4.9	16.5	11.0	0.2	4.4	0.2	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.5	0.0	0.0	0.0	1.7	2.5	1.9	0.3	40.1	0.0	0.0	8.1	0.0	0.1	0.0	0.0	0.1	0.3	2.1	4.3	0.0	0.0	0.0	0.0	0.0	0.0	0.2	1.3	7.7	0.1	0.0	0.6	0.1	0.0	0.1	0.8	0.5	0.0	0.0	58.3	0.0	0.0	24.8	0.0	3.0	5.3	0.2	0.0	0.0	4.5	0.3	8.8	110.9	139.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12.3	14.1	15.6	12.3	10.7	11.8	14.6	14.4	13.7	11.8	13.4	11.0	0.4	0.0	0.0	153.8	0.9	0.6	47.5	50.4	14.8	0.4	7.8	7.6	0.5	2.8	33.0	0.0	6.2	27.7	0.0	2.5	0.0	0.9	0.2	43.7	3.9	0.6	1.2	0.0	1.5	0.0	3.0	4.8	9.2	53.8	1.3	9.8	0.4	3.3	7.4	0.0	5.1	0.6	34.6	0.0	0.4	0.3	0.0	1.1	3.6	13.1	2.6	0.0	0.0	48.7	1.0	1.1	1.7	0.7	3.4	10.9	0.0	6.3	22.2	0.4	0.0	0.3	2.8	0.2	7.4	16.0	0.3	10.8	0.6	4.2	3.6	34.6
EYA3	DKFZp686C132	ENSG00000158161	"EYA transcriptional coactivator and phosphatase 3"	Q99504	1	27970344-28088637	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"DNA damage, DNA repair, Transcription, Transcription regulation"	"Activator, Chromatin regulator, Developmental protein, Hydrolase, Protein phosphatase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 80.2;Oligodendrocytes: 80.5;Spermatocytes: 98.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA052432, HPA062889"	Uncertain		Supported	Nucleoplasm		Yes	No			"Cluster 49: Eosinophils - Unknown function"	"Cluster 20: Retina & Lymphoid tissues - Unknown function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 13: Spermatocytes & Spermatogonia - Spermatogenesis"	Nucleoplasm		"HPA052432: AB_2681831, HPA062889: AB_2684895"	"unprognostic (3.57e-1)"	"unprognostic (2.61e-1)"	"unprognostic (2.85e-1)"	"unprognostic (8.74e-2)"	"unprognostic (1.39e-1)"	"prognostic favorable (5.11e-4)"	"unprognostic (1.39e-3)"	"unprognostic (2.21e-1)"	"unprognostic (4.81e-2)"	"unprognostic (1.00e-1)"	"unprognostic (9.13e-2)"	"unprognostic (8.98e-2)"	"prognostic favorable (3.15e-6)"	"unprognostic (5.17e-2)"	"unprognostic (2.79e-1)"	"unprognostic (7.60e-2)"	"unprognostic (6.11e-2)"	4.7	4.8	7.4	8.2	7.0	5.2	7.1	8.8	7.9	7.4	9.6	5.7	5.9	6.1	6.4	9.9	6.2	4.3	6.4	6.5	7.6	11.6	6.0	5.9	9.4	7.1	7.1	6.4	6.5	8.3	7.6	7.7	7.2	6.1	6.2	10.5	5.6	5.4	7.1	9.0	6.3	5.5	6.4	7.2	5.5	11.4	7.6	9.4	9.3	8.3	14.4	7.1	6.1	7.9	16.3	6.6	13.1	9.7	14.9	11.6	7.3	11.8	11.0	13.2	12.9	6.4	9.5	25.5	12.3	7.8	4.9	15.3	24.4	9.5	15.6	13.4	13.5	28.2	14.4	11.6	8.8	27.9	25.2	7.0	8.3	14.6	9.7	11.3	17.0	9.0	26.9	9.6	11.9	7.0	18.0	18.5	27.5	12.6	8.6	13.2	24.9	16.8	15.3	8.8	14.9	8.2	12.6	7.6	11.0	10.5	6.2	7.3	16.6	15.9	8.4	15.1	9.4	13.9	15.2	22.0	11.5	26.7	7.0	5.7	6.8	7.3	7.5	6.9	6.7	5.2	5.8	5.4	8.3	4.6	4.9	5.6	6.4	7.1	6.1	5.1	5.4	1.9	7.4	7.0	8.8	7.9	6.5	7.6	7.1	7.1	7.2	6.4	7.6	7.9	12.6	9.6	10.8	46.4	17.5	17.8	11.3	10.0	9.6	18.3	12.0	7.1	9.2	12.8	7.9	25.8	16.7	13.0	10.6	8.2	15.6	13.5	80.2	13.6	13.2	12.9	20.4	9.9	66.0	8.9	14.4	11.6	16.8	15.3	12.0	15.8	14.6	8.7	9.7	18.5	58.8	9.1	12.2	13.3	46.1	39.1	10.2	14.6	12.4	39.4	12.9	8.1	10.3	45.2	80.5	14.5	10.9	6.0	13.7	12.0	13.8	18.0	5.7	20.6	13.1	11.1	8.4	98.7	50.6	10.7	22.9	10.9	15.8	9.6	10.5	11.7
EYA4	"CMD1J, DFNA10"	ENSG00000112319	"EYA transcriptional coactivator and phosphatase 4"	O95677	6	133240598-133532128	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"DNA damage, DNA repair, Transcription, Transcription regulation"	"Activator, Chromatin regulator, Developmental protein, Hydrolase, Protein phosphatase"	"Cardiomyopathy, Deafness, Disease variant, Non-syndromic deafness"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"skeletal muscle: 27.6;tongue: 21.3"	"Cell type enhanced"	"Detected in many"		"Collecting duct cells: 46.0;Inhibitory neurons: 139.0;Oligodendrocytes: 79.2;Skeletal myocytes: 26.2"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"A549: 25.4;GAMG: 25.6;HeLa: 74.3;RH-30: 23.8;U-87 MG: 24.6"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA004805, HPA038771, HPA038772"	Enhanced		Approved	Nucleoplasm		No	NA				"Cluster 80: Striated muscle - Unknown function"	"Cluster 20: HeLa - Mitochondria"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Nucleoplasm		"HPA004805: AB_10669750, HPA038771: AB_10671865, HPA038772: AB_10673119"	"unprognostic (1.60e-1)"	"unprognostic (3.34e-1)"	"unprognostic (1.27e-1)"	"unprognostic (2.04e-9)"	"unprognostic (1.64e-1)"	"unprognostic (3.08e-2)"	"unprognostic (3.44e-2)"	"unprognostic (7.21e-2)"	"unprognostic (9.07e-2)"	"unprognostic (2.04e-2)"	"unprognostic (2.80e-1)"	"unprognostic (2.29e-1)"	"unprognostic (8.27e-4)"	"unprognostic (1.82e-3)"	"unprognostic (6.67e-2)"	"unprognostic (9.55e-2)"	"unprognostic (2.51e-2)"	1.1	2.5	2.6	0.1	1.9	0.0	0.4	2.2	1.9	2.6	13.3	0.2	0.2	0.5	1.2	0.4	7.4	0.5	5.8	2.3	1.2	5.0	0.0	1.8	0.1	5.6	7.9	1.2	0.2	0.0	0.8	0.0	4.5	5.7	0.2	0.1	0.2	11.8	27.6	0.0	0.1	0.3	4.5	0.4	0.4	3.0	3.3	6.6	2.1	21.3	0.5	2.2	2.3	4.9	0.0	25.4	2.4	0.0	0.0	0.0	0.0	0.0	20.4	0.5	2.9	0.1	0.1	0.1	19.6	0.0	25.6	0.0	15.4	6.7	0.0	0.0	20.2	2.8	74.3	0.0	0.6	0.0	6.8	5.1	0.0	14.4	4.5	3.4	0.0	0.0	0.0	10.7	8.1	0.0	0.0	0.0	0.0	0.3	1.6	0.3	23.8	0.0	0.0	3.9	3.7	4.1	0.2	0.0	11.4	0.1	0.0	0.0	0.0	0.0	0.0	0.1	18.4	7.2	3.4	0.0	24.6	0.0	2.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.6	1.9	2.2	1.9	2.3	1.2	5.6	7.9	4.5	4.5	3.3	4.9	0.3	12.8	1.8	2.6	0.0	0.1	0.1	13.3	0.0	0.0	0.0	0.0	14.4	0.0	6.7	46.0	0.0	0.0	0.0	0.1	0.0	0.1	4.4	0.1	0.1	0.5	1.8	0.0	4.8	0.2	0.0	2.9	0.0	0.1	0.0	1.5	0.4	0.1	0.0	0.0	139.0	0.0	8.2	1.0	0.0	2.6	0.6	0.2	0.0	2.8	7.2	0.0	0.0	1.5	79.2	0.0	0.0	0.0	0.0	0.2	0.0	0.2	4.8	0.0	0.0	26.2	3.3	7.9	7.1	0.0	0.0	0.0	0.1	1.5	0.0	0.2
F10		ENSG00000126218	"Coagulation factor X"	P00742	13	113122799-113149529	"Candidate cardiovascular disease genes, Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted secreted proteins"	"Blood coagulation, Hemostasis"	"Hydrolase, Protease, Serine protease"	"Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 160.0"	"Cell type enhanced"	"Detected in many"		"Fibroblasts: 113.6;Hepatocytes: 195.1;Leydig cells: 215.9;Peritubular cells: 236.2"	"Cancer enriched"	"Detected in many"	11	"liver cancer: 95.4"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BJ: 14.4;BJ hTERT+: 11.5;CACO-2: 12.7;fHDF/TERT166: 13.1;Hep G2: 59.6;HHSteC: 11.5;SH-SY5Y: 27.9"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"								"Secreted to blood"	NA	NA		13000000000		"Cluster 85: Liver - Metabolism"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 50: Fibroblasts - ECM organization"				"unprognostic (4.18e-2)"	"unprognostic (1.07e-1)"	"unprognostic (7.62e-2)"	"unprognostic (9.88e-2)"	"unprognostic (9.44e-2)"	"unprognostic (1.15e-2)"	"unprognostic (4.90e-2)"	"unprognostic (1.02e-2)"	"unprognostic (2.54e-1)"	"unprognostic (1.24e-1)"	"prognostic favorable (1.82e-5)"	"unprognostic (6.39e-2)"	"prognostic unfavorable (5.14e-5)"	"unprognostic (6.60e-2)"	"unprognostic (1.21e-1)"	"unprognostic (3.87e-2)"	"unprognostic (2.23e-3)"	21.3	8.5	1.1	1.5	1.2	0.0	11.7	2.5	2.0	53.8	1.4	5.6	10.9	13.2	16.4	8.9	23.9	10.9	40.7	1.1	1.8	4.1	160.0	14.4	3.2	2.6	1.5	27.9	7.1	0.2	4.5	4.4	2.5	12.8	2.0	0.9	5.1	7.1	6.8	20.7	11.9	2.7	1.3	3.2	8.6	10.1	1.4	1.4	8.3	6.6	1.3	11.9	25.8	1.1	0.1	0.0	2.5	0.4	8.0	8.1	0.1	14.4	11.5	0.8	0.3	12.7	0.1	0.1	0.5	13.1	1.4	0.1	0.0	0.0	0.0	0.0	0.4	0.0	0.2	59.6	11.5	0.0	0.3	8.1	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.2	1.5	0.1	0.0	0.3	0.0	1.3	0.2	0.3	0.1	0.0	0.0	0.2	1.0	27.9	0.1	0.5	0.1	0.6	0.6	0.1	0.0	0.0	0.8	0.2	0.0	0.2	0.0	0.1	0.1	0.1	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	1.2	2.5	2.0	1.1	1.8	2.6	1.5	2.5	1.3	1.4	1.1	7.0	0.0	0.0	1.3	0.6	15.7	0.1	0.0	0.0	1.1	0.4	0.3	9.1	4.3	0.0	1.8	0.0	0.6	0.0	0.1	0.0	0.1	2.9	1.9	45.9	3.8	17.9	2.7	1.3	0.0	0.4	113.6	6.1	1.0	1.3	2.2	7.9	195.1	1.4	6.7	1.4	5.0	0.0	4.8	25.0	9.6	215.9	1.3	19.6	5.6	0.6	4.5	0.0	0.5	0.1	0.3	6.5	236.2	0.0	0.3	28.3	6.4	0.0	1.2	52.6	14.5	40.9	2.3	1.2	0.5	15.3	1.1	1.9	2.4	2.2	0.4
F11	FXI	ENSG00000088926	"Coagulation factor XI"	P03951	4	186266189-186289681	"Candidate cardiovascular disease genes, Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Blood coagulation, Hemostasis"	"Heparin-binding, Hydrolase, Protease, Serine protease"	"Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	4	"liver: 243.2"	"Group enriched"	"Detected in some"	4	"Alveolar cells type 2: 27.6;Hepatocytes: 75.7"	"Cancer enriched"	"Detected in some"	13	"liver cancer: 16.8"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	9	"Hep G2: 6.3"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			HPA039808			Approved	Vesicles	"Secreted to blood"	NA	NA		4400000000		"Cluster 85: Liver - Metabolism"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 15: Hepatocytes - Hemostasis"	Vesicles		"HPA039808: AB_2676693"			"unprognostic (1.28e-1)"		"unprognostic (3.15e-1)"		"prognostic favorable (3.29e-5)"	"unprognostic (1.88e-1)"			"unprognostic (2.08e-1)"	"unprognostic (2.11e-1)"	"unprognostic (1.85e-3)"	"unprognostic (2.91e-2)"	"unprognostic (7.65e-2)"			0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.5	0.2	0.0	0.2	17.1	0.2	0.1	0.0	0.0	13.1	0.0	0.2	0.0	27.6	243.2	8.4	0.0	0.0	0.3	0.3	58.9	0.0	0.2	0.0	0.1	0.0	0.1	0.7	0.0	0.2	0.7	0.0	8.7	0.0	0.0	0.1	0.8	0.1	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	6.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.5	0.2	0.0	0.0	0.3	0.1	0.0	0.3	0.0	0.0	0.0	27.6	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	4.3	2.5	1.8	0.0	0.0	0.2	0.3	11.7	2.3	0.0	0.0	0.0	0.1	0.0	5.3	0.6	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	75.7	0.0	0.0	0.6	0.0	0.0	3.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.3	2.1	0.0	0.0	0.0	0.0	1.1	5.5	0.0	0.5	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.1
F12		ENSG00000131187	"Coagulation factor XII"	P00748	5	177402141-177409564	"Candidate cardiovascular disease genes, Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted secreted proteins"	"Blood coagulation, Fibrinolysis, Hemostasis"	"Hydrolase, Protease, Serine protease"	"Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	226	"liver: 604.6"	"Cell type enriched"	"Detected in many"	8	"Hepatocytes: 523.0"	"Cancer enriched"	"Detected in many"	21	"liver cancer: 171.0"	"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	5	"classical monocyte: 1.2;eosinophil: 3.6"	"Group enriched"	"Detected in many"	5	"granulocytes: 3.6;monocytes: 1.2"	"Cell line enhanced"	"Detected in some"		"HDLM-2: 7.1;MCF7: 9.0;PC-3: 6.4;SH-SY5Y: 4.3;U-937: 4.6"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in many"			HPA003825	Approved				"Secreted to blood"	NA	NA	1040000	7000000000	"Cluster 52: Eosinophils - Transcription"	"Cluster 60: Liver - Hemostasis & Lipid metabolism"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 2: Hepatocytes - Metabolism"			"HPA003825: AB_1078790"	"unprognostic (9.75e-2)"	"unprognostic (1.71e-1)"	"unprognostic (2.93e-1)"	"unprognostic (4.47e-2)"	"unprognostic (1.01e-1)"	"unprognostic (2.32e-1)"	"prognostic favorable (4.63e-5)"	"unprognostic (6.97e-2)"	"unprognostic (1.26e-2)"	"unprognostic (3.96e-2)"	"unprognostic (4.41e-1)"	"unprognostic (6.54e-2)"	"prognostic unfavorable (7.09e-4)"	"unprognostic (4.11e-2)"	"unprognostic (3.69e-1)"	"unprognostic (3.40e-6)"	"unprognostic (6.48e-2)"	0.4	0.1	1.4	0.1	1.2	2.6	0.3	0.1	1.3	0.4	0.1	0.5	0.5	0.2	0.0	1.9	0.3	0.1	0.4	1.5	0.8	0.8	604.6	0.6	0.0	0.8	0.6	0.0	0.6	0.1	0.6	0.1	0.9	0.3	0.1	0.0	0.4	0.0	0.0	0.9	0.5	0.0	0.4	1.0	0.1	1.2	0.8	0.0	0.2	0.0	0.1	0.2	0.8	0.8	0.7	1.6	0.0	0.4	0.0	0.0	0.2	0.0	0.0	0.0	0.0	1.8	1.0	0.0	0.3	0.0	0.2	1.1	0.5	0.3	0.0	7.1	1.4	1.1	0.3	0.7	0.2	0.6	2.4	0.2	1.0	0.0	0.3	0.1	0.2	1.6	0.3	2.5	0.0	9.0	0.1	2.1	0.0	2.1	6.4	0.5	0.2	1.5	0.9	0.0	2.0	4.3	0.2	0.7	0.6	0.0	0.3	0.0	0.0	0.1	0.8	0.0	0.2	0.4	0.0	0.0	0.0	4.6	0.5	0.0	1.2	3.6	0.1	0.0	0.1	0.2	0.1	0.1	0.0	0.0	0.0	0.0	0.4	0.3	0.5	0.5	0.0	0.5	1.4	1.2	0.1	1.3	1.5	0.8	0.8	0.6	0.9	0.4	0.8	0.8	0.5	0.0	0.0	0.3	5.3	33.1	7.7	15.3	35.9	0.6	12.7	17.5	1.0	17.2	3.9	1.8	4.2	0.0	4.0	27.6	0.0	6.5	23.3	2.2	0.9	2.2	10.3	19.6	2.6	4.2	0.4	1.1	3.6	1.7	0.0	0.2	16.8	523.0	0.5	0.0	0.8	12.3	8.2	16.7	6.1	42.1	0.6	1.0	8.8	0.0	1.2	0.7	2.1	1.5	0.6	11.1	22.0	0.0	8.5	7.2	60.7	16.1	3.6	0.9	0.0	0.5	1.1	12.0	23.6	57.5	54.3	0.1	4.0	0.1	34.8	7.6
F2		ENSG00000180210	"Coagulation factor II, thrombin"	P00734	11	46719196-46739506	"Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Acute phase, Blood coagulation, Hemostasis"	"Hydrolase, Protease, Serine protease"	"Cancer-related genes, Disease variant, FDA approved drug targets, Thrombophilia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	1518	"liver: 1217.3"	"Cell type enriched"	"Detected in some"	26	"Hepatocytes: 991.0"	"Cancer enriched"	"Detected in some"	110	"liver cancer: 508.2"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	22	"Hep G2: 281.0"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"CAB016780, HPA051476, HPA054698"	Enhanced				"Secreted to blood"	NA	NA	108000000000	41000000000		"Cluster 62: Liver - Hemostasis"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 15: Hepatocytes - Hemostasis"			"CAB016780: , HPA051476: AB_2681498, HPA054698: AB_2682578"	"unprognostic (1.98e-1)"	"unprognostic (2.52e-1)"	"unprognostic (2.64e-2)"	"unprognostic (1.85e-1)"	"unprognostic (2.29e-1)"	"unprognostic (2.81e-1)"	"unprognostic (2.23e-2)"	"unprognostic (3.94e-2)"		"unprognostic (5.79e-2)"	"unprognostic (8.29e-2)"	"unprognostic (4.46e-2)"	"prognostic unfavorable (6.75e-12)"	"unprognostic (5.65e-3)"	"unprognostic (5.80e-2)"		"unprognostic (1.54e-3)"	0.1	0.0	0.2	0.0	0.2	0.0	0.0	0.8	0.3	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.2	0.2	0.2	1217.3	0.0	0.0	0.2	0.2	0.1	0.0	0.0	0.1	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.6	0.3	0.5	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.3	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	12.9	0.0	0.2	2.2	0.0	0.0	0.1	0.1	0.0	0.0	0.1	0.0	0.5	0.2	281.0	0.0	1.5	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.1	0.0	1.0	0.0	0.0	0.2	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.2	0.0	0.5	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.8	0.3	0.2	0.2	0.2	0.2	0.2	0.1	0.2	0.3	0.0	0.0	0.0	0.0	2.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	20.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.2	1.2	0.0	37.5	0.2	0.0	0.0	0.0	0.0	0.9	0.0	0.3	21.8	991.0	0.0	0.0	0.2	0.2	0.0	26.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.1	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.3	2.0	0.0	0.0	0.1
F7		ENSG00000057593	"Coagulation factor VII"	P08709	13	113105788-113120685	"Candidate cardiovascular disease genes, Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted secreted proteins"	"Blood coagulation, Hemostasis"	"Hydrolase, Protease, Serine protease"	"Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	102	"liver: 160.2"	"Cell type enriched"	"Detected in some"	18	"Hepatocytes: 149.3"	"Cancer enriched"	"Detected in some"	17	"liver cancer: 41.4"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	9	"CACO-2: 11.5;Hep G2: 7.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA004826			Approved	Mitochondria	"Secreted to blood"	NA	NA	351000000	1300000000		"Cluster 62: Liver - Hemostasis"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 2: Hepatocytes - Metabolism"	Mitochondria		"HPA004826: AB_10602805"	"unprognostic (2.06e-1)"	"unprognostic (2.55e-1)"	"unprognostic (1.03e-1)"	"unprognostic (1.34e-1)"	"unprognostic (3.27e-1)"	"unprognostic (1.91e-1)"	"unprognostic (1.50e-3)"	"unprognostic (3.81e-1)"	"unprognostic (4.36e-3)"	"unprognostic (1.16e-1)"	"unprognostic (4.19e-3)"	"unprognostic (1.15e-1)"	"unprognostic (1.35e-3)"	"unprognostic (3.36e-3)"	"unprognostic (1.09e-1)"	"unprognostic (2.86e-1)"	"unprognostic (1.47e-1)"	0.2	0.0	0.4	0.1	0.3	0.0	0.2	0.5	0.7	1.1	0.2	0.1	0.5	0.1	0.6	0.1	0.5	0.0	0.2	0.3	0.7	0.4	160.2	0.1	0.0	0.3	0.5	0.4	0.1	0.2	0.4	0.1	0.3	0.4	0.0	0.2	0.3	0.0	0.0	0.4	0.8	0.0	0.2	0.1	0.1	1.5	0.6	0.0	0.1	0.0	0.0	0.1	0.5	0.3	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	11.5	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	7.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.3	0.5	0.7	0.3	0.7	0.3	0.5	0.3	0.2	0.6	0.3	0.9	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.6	0.6	0.3	0.5	1.5	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.1	0.3	0.4	0.0	8.0	0.3	0.2	0.0	0.4	0.0	0.2	0.0	0.3	2.2	149.3	0.1	0.0	0.5	0.4	0.0	2.8	0.7	0.2	0.9	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	1.9	0.0	0.0	1.1	0.3	0.0	0.2	0.0	0.5	0.1	3.2	4.1	0.0	0.1	0.1	0.2	0.1	0.3	0.0
F9	FIX	ENSG00000101981	"Coagulation factor IX"	P00740	X	139530739-139563459	"Candidate cardiovascular disease genes, Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted secreted proteins"	"Blood coagulation, Hemostasis"	"Hydrolase, Protease, Serine protease"	"Disease variant, FDA approved drug targets, Hemophilia, Thrombophilia"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	2467	"liver: 704.9"	"Cell type enriched"	"Detected in some"	32	"Hepatocytes: 609.1"	"Cancer enriched"	"Detected in single"	1354	"liver cancer: 67.6"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"								"Secreted to blood"	NA	NA		8200000000		"Cluster 60: Liver - Hemostasis & Lipid metabolism"		"Cluster 15: Hepatocytes - Hemostasis"										"prognostic favorable (6.69e-4)"											0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	704.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	12.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	18.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	14.6	609.1	0.0	0.0	0.1	0.0	0.0	16.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0
FAAH	FAAH-1	ENSG00000117480	"Fatty acid amide hydrolase"	O00519	1	46394317-46413848	"Enzymes, Metabolic proteins, Predicted membrane proteins"	"Lipid degradation, Lipid metabolism"	Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Late spermatids: 128.5;Proximal enterocytes: 87.4;Spermatocytes: 89.0"	"Cancer enhanced"	"Detected in all"		"prostate cancer: 68.2"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"eosinophil: 29.1"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"BEWO: 37.5;OE19: 18.8;RT4: 42.4;SK-BR-3: 21.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA007425	Approved		Approved	Cytosol		NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 43: Testis - Unknown function"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Cytosol		"HPA007425: AB_1078820"	"unprognostic (6.12e-2)"	"unprognostic (2.04e-1)"	"unprognostic (2.51e-2)"	"prognostic favorable (1.51e-4)"	"unprognostic (1.72e-1)"	"unprognostic (4.97e-2)"	"unprognostic (2.00e-1)"	"unprognostic (6.64e-3)"	"unprognostic (2.91e-2)"	"unprognostic (2.33e-1)"	"unprognostic (4.39e-3)"	"unprognostic (9.86e-2)"	"prognostic favorable (4.25e-5)"	"prognostic favorable (3.63e-5)"	"unprognostic (2.66e-1)"	"unprognostic (9.97e-2)"	"unprognostic (5.00e-3)"	7.5	14.2	23.5	2.9	28.4	10.4	9.5	25.6	29.6	7.5	29.3	18.9	22.0	3.9	9.1	8.7	12.0	5.2	5.0	24.6	23.3	20.0	32.8	7.8	2.5	32.1	25.4	3.9	22.4	24.6	19.0	3.4	28.7	44.1	15.2	5.5	17.4	7.1	9.5	12.1	22.0	2.3	27.9	3.3	17.1	46.8	26.4	7.1	38.6	5.6	2.7	6.9	8.2	45.8	5.0	1.2	0.8	1.0	1.2	0.8	37.5	1.0	0.5	0.5	0.8	7.3	11.4	0.3	3.9	0.7	0.4	16.2	0.7	2.3	0.2	2.2	5.4	0.1	0.2	3.5	0.8	1.4	2.8	0.6	10.7	0.4	1.3	0.4	0.0	0.9	0.1	0.8	0.0	10.7	0.8	2.2	3.2	18.8	0.4	0.9	0.4	0.2	9.0	42.4	4.8	3.6	5.6	21.2	0.2	0.9	14.6	14.5	0.0	0.1	0.6	1.1	0.7	2.1	1.0	0.6	0.1	13.4	0.4	0.0	6.9	29.1	0.4	1.9	0.2	0.1	0.4	0.2	8.2	0.1	0.6	0.6	0.4	0.5	1.0	8.8	0.2	1.4	23.5	28.4	25.6	29.6	24.6	23.3	32.1	25.4	28.7	27.9	26.4	45.8	1.2	22.4	13.2	6.5	2.4	5.2	29.0	6.8	10.2	15.5	15.4	9.0	2.9	27.1	11.0	22.0	43.8	16.3	7.3	51.6	0.0	12.4	50.7	9.5	1.9	1.8	15.5	6.6	15.7	6.4	8.7	3.7	37.8	6.0	0.0	6.3	0.4	37.1	2.8	1.7	11.4	38.2	10.2	2.5	4.2	128.5	7.5	3.3	5.4	1.9	2.5	7.3	0.0	7.5	45.1	4.2	41.3	4.5	0.7	20.1	87.4	22.6	5.2	14.5	0.0	2.9	3.2	89.0	23.0	6.4	6.0	12.4	1.2	1.3	55.2	18.9
FAAH2	"AMDD, FAAH-2, FLJ31204, RP11-479E16.1"	ENSG00000165591	"Fatty acid amide hydrolase 2"	Q6GMR7	X	57286706-57489193	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Lipid degradation, Lipid metabolism"	Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 75.7;Excitatory neurons: 110.2;Inhibitory neurons: 131.2;Oligodendrocyte precursor cells: 110.6;Oligodendrocytes: 105.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in many"		"T-reg: 16.7"	"Lineage enriched"	"Detected in many"	9	"T-cells: 16.7"	"Cell line enhanced"	"Detected in many"		"CAPAN-2: 14.0;HDLM-2: 13.0;RPMI-8226: 26.6;U-266/70: 20.9;U-266/84: 11.4"															NA	NA			"Cluster 35: T-regs - Unknown function"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 58: T-cells - T-cell receptor"				"unprognostic (1.37e-1)"	"unprognostic (1.78e-2)"	"unprognostic (7.68e-2)"	"unprognostic (2.29e-2)"	"unprognostic (1.02e-1)"	"unprognostic (4.51e-2)"	"unprognostic (7.93e-3)"	"unprognostic (4.47e-2)"	"unprognostic (1.94e-1)"	"prognostic favorable (5.99e-4)"	"unprognostic (1.77e-1)"	"unprognostic (2.03e-1)"	"prognostic favorable (2.47e-13)"	"unprognostic (9.16e-3)"	"unprognostic (2.27e-1)"	"prognostic favorable (2.66e-4)"	"prognostic favorable (6.83e-5)"	0.8	1.6	1.1	1.6	0.8	0.4	6.8	3.3	1.0	3.6	0.9	3.2	3.0	1.3	4.4	4.9	6.1	1.7	0.3	0.7	2.6	7.2	10.5	3.2	2.6	1.2	1.3	0.4	15.1	13.4	6.7	0.8	1.2	7.3	4.0	7.0	7.1	4.1	0.1	9.6	3.0	0.3	0.5	0.7	4.6	0.1	2.2	7.3	4.8	0.2	7.0	3.4	3.4	0.9	3.4	0.3	0.1	0.2	0.1	0.1	3.1	0.0	0.1	0.0	0.0	2.4	14.0	0.1	4.0	0.0	0.0	0.6	1.1	2.5	0.0	13.0	6.9	0.4	3.1	1.0	0.0	1.5	0.0	0.0	4.2	0.0	0.0	0.1	0.0	1.4	1.6	6.3	0.0	1.4	0.8	0.0	2.4	2.9	0.0	0.0	2.4	26.6	8.1	4.5	2.4	0.1	0.2	3.9	0.0	5.7	3.9	0.1	0.0	0.0	0.3	0.0	0.2	20.9	11.4	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.7	0.0	5.0	1.8	8.0	3.4	0.0	0.5	7.7	0.9	0.3	0.9	0.0	1.2	16.7	1.6	1.1	0.8	3.3	1.0	0.7	2.6	1.2	1.3	1.2	0.5	2.2	0.9	0.2	3.2	7.8	75.7	4.0	2.7	12.1	19.0	15.4	4.4	6.0	4.2	0.3	4.3	14.9	5.5	18.8	5.5	0.2	4.2	9.8	11.9	0.0	12.6	1.1	0.4	13.2	0.0	110.2	14.1	2.5	1.1	15.8	12.2	0.0	0.9	1.1	11.3	0.7	1.7	131.2	5.4	26.4	0.0	0.3	0.0	0.6	0.6	3.6	45.0	0.6	1.2	0.0	110.6	105.3	11.9	3.8	0.4	14.4	7.4	4.8	5.6	25.1	11.8	0.0	0.5	1.0	0.0	0.0	7.1	6.7	5.6	16.7	0.3	4.0	9.2
FAH		ENSG00000103876	"Fumarylacetoacetate hydrolase"	P16930	15	80152490-80186946	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Phenylalanine catabolism, Tyrosine catabolism"	Hydrolase	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 301.5"	"Cell type enhanced"	"Detected in many"		"Hepatocytes: 266.8;Proximal tubular cells: 305.5"	"Cancer enhanced"	"Detected in all"		"liver cancer: 23.7"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"basophil: 34.5"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HHSteC: 316.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041370, HPA044093"	Enhanced		Approved	Nucleoplasm,Cytosol		NA	NA		220000000	"Cluster 25: Monocytes - Inflammatory response"	"Cluster 85: Liver - Metabolism"	"Cluster 32: U-937 - Innate immune response"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Cytosol	Nucleoplasm	"HPA041370: AB_2677438, HPA044093: AB_2678806"	"unprognostic (3.15e-1)"	"unprognostic (5.65e-2)"	"unprognostic (1.64e-1)"	"unprognostic (6.16e-2)"	"unprognostic (2.33e-3)"	"prognostic unfavorable (8.51e-4)"	"unprognostic (1.19e-2)"	"unprognostic (5.83e-2)"	"unprognostic (2.51e-2)"	"unprognostic (5.21e-2)"	"unprognostic (1.80e-1)"	"unprognostic (1.23e-1)"	"unprognostic (2.17e-2)"	"unprognostic (4.21e-2)"	"unprognostic (2.99e-1)"	"unprognostic (2.93e-1)"	"unprognostic (8.98e-2)"	99.2	65.4	16.0	7.0	17.1	20.0	59.0	16.6	21.1	19.2	15.1	13.8	14.6	19.3	50.4	15.2	23.0	9.7	20.3	16.3	18.8	65.0	301.5	20.0	5.7	17.9	19.6	26.4	9.9	18.4	16.8	7.8	16.9	16.6	11.9	1.6	14.8	13.6	31.0	10.9	16.8	13.5	17.2	19.1	14.2	20.8	17.4	6.7	14.5	27.7	5.8	16.4	15.8	17.5	20.1	34.4	13.5	17.0	60.2	62.2	32.9	24.3	56.8	26.2	22.3	22.0	35.9	0.4	39.0	52.6	36.8	29.1	46.8	59.6	25.1	12.5	28.5	166.6	18.0	112.1	316.6	79.6	88.8	107.5	37.1	22.9	39.7	84.2	37.4	38.3	71.1	35.7	50.3	31.0	22.3	42.0	9.9	15.5	37.6	12.2	19.3	123.4	77.0	25.2	0.7	8.3	27.4	76.7	77.9	21.6	58.3	55.0	126.1	46.8	30.0	25.5	42.7	32.7	69.5	13.8	99.6	187.5	26.9	34.5	18.8	3.3	9.6	8.1	2.3	0.1	2.4	6.0	25.3	0.1	3.1	2.7	1.3	5.7	8.4	1.9	2.5	9.7	16.0	17.1	16.6	21.1	16.3	18.8	17.9	19.6	16.9	17.2	17.4	17.5	3.0	3.2	13.8	9.8	4.1	6.8	17.5	30.8	15.4	0.4	19.1	13.7	15.5	21.5	12.5	33.1	0.0	37.9	4.9	9.3	52.8	9.3	7.5	3.0	16.2	3.2	4.2	24.4	0.4	3.5	14.1	16.6	3.6	4.0	41.9	6.3	8.9	266.8	72.5	0.0	2.5	13.0	24.4	21.4	6.6	13.5	9.9	30.5	19.6	1.0	5.7	7.3	3.1	2.5	0.6	4.5	12.8	7.9	5.2	9.7	54.1	305.5	5.3	0.4	0.0	9.2	11.2	1.5	2.1	18.2	5.7	22.0	7.7	8.7	22.4	16.4
FAHD1	"C16orf36, DKFZP566J2046"	ENSG00000180185	"Fumarylacetoacetate hydrolase domain containing 1"	Q6P587	16	1826941-1840207	"Enzymes, Predicted intracellular proteins"		"Hydrolase, Lyase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"kidney: 64.1"	"Cell type enhanced"	"Detected in all"		"Proximal enterocytes: 112.2;Proximal tubular cells: 210.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB025530, HPA043226, HPA043534"	Enhanced		Enhanced	Nucleoplasm,Mitochondria		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 87: Intestine & Kidney - Transmembrane transport"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Mitochondria	Nucleoplasm	"CAB025530: , HPA043226: AB_2678370, HPA043534: AB_2678535"	"unprognostic (3.71e-1)"	"unprognostic (1.25e-2)"	"prognostic favorable (8.27e-4)"	"unprognostic (1.99e-1)"	"unprognostic (6.74e-2)"	"unprognostic (1.01e-3)"	"unprognostic (2.89e-2)"	"unprognostic (4.32e-1)"	"unprognostic (1.13e-1)"	"unprognostic (5.36e-2)"	"unprognostic (1.65e-1)"	"unprognostic (1.38e-1)"	"prognostic favorable (2.80e-14)"	"unprognostic (1.02e-1)"	"unprognostic (1.66e-1)"	"unprognostic (1.26e-1)"	"unprognostic (3.31e-2)"	12.3	21.4	9.1	8.5	9.4	10.0	9.4	9.3	11.1	8.3	9.2	22.6	36.1	9.7	8.0	19.3	6.9	12.1	19.9	10.9	11.1	64.1	58.5	7.1	7.4	10.7	10.0	8.0	15.8	12.1	9.5	7.5	10.1	9.4	14.2	6.7	11.2	10.7	30.7	17.1	27.1	8.7	8.8	8.4	21.0	10.1	9.4	7.9	7.8	24.7	6.4	11.3	11.1	9.9	20.1	44.6	20.9	36.9	27.0	19.5	12.9	32.4	16.0	21.1	22.9	28.6	20.4	12.8	26.6	20.2	32.7	40.5	16.4	25.8	19.0	19.3	39.0	11.5	38.7	67.0	26.2	20.0	21.2	25.8	33.3	19.3	12.9	17.8	27.8	15.3	12.1	12.8	26.8	92.5	10.9	30.1	12.4	18.4	33.0	24.6	28.3	36.4	76.8	24.9	40.4	33.6	42.3	33.5	52.0	13.8	49.4	13.4	41.1	34.4	24.6	20.5	17.8	18.6	42.3	15.1	22.0	14.5	15.1	15.8	40.8	16.5	25.1	51.5	22.5	37.2	24.7	27.3	42.6	32.7	27.0	24.8	3.5	38.1	38.4	33.1	28.4	24.3	9.1	9.4	9.3	11.1	10.9	11.1	10.7	10.0	10.1	8.8	9.4	9.9	14.6	25.6	16.4	2.9	11.2	14.0	13.3	29.6	13.1	19.8	12.4	15.7	42.9	27.1	17.2	42.3	27.1	22.6	10.9	50.8	50.9	57.2	89.8	16.8	19.8	16.3	29.3	36.4	8.0	39.2	14.2	15.5	17.3	18.2	5.1	13.8	9.7	35.5	30.5	18.5	8.6	25.6	24.4	9.1	14.2	45.0	14.6	13.7	16.0	4.7	18.9	17.4	20.6	3.0	6.4	34.9	36.7	15.4	4.0	11.2	112.2	210.9	14.4	24.2	13.1	12.7	16.5	9.9	9.1	27.2	24.0	15.3	9.8	30.3	52.7	9.6
FAN1	"KIAA1018, MTMR15"	ENSG00000198690	"FANCD2 and FANCI associated nuclease 1"	Q9Y2M0	15	30890559-30943108	"Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"DNA damage, DNA repair"	"Endonuclease, Exonuclease, Hydrolase, Nuclease"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Oligodendrocytes: 44.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA048198			Supported	"Nucleoplasm,Cytokinetic bridge,Cytosol"		Yes	NA			"Cluster 14: Monocytes - Unknown function"	"Cluster 35: Non-specific - Unknown function"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	Nucleoplasm	"Cytokinetic bridge, Cytosol"	"HPA048198: AB_2680311"	"unprognostic (7.18e-3)"	"unprognostic (5.63e-2)"	"unprognostic (1.96e-1)"	"unprognostic (3.30e-2)"	"unprognostic (6.99e-2)"	"unprognostic (2.86e-1)"	"unprognostic (1.97e-1)"	"unprognostic (1.19e-1)"	"unprognostic (5.94e-2)"	"unprognostic (3.53e-2)"	"unprognostic (3.53e-2)"	"unprognostic (9.67e-2)"	"prognostic favorable (1.42e-6)"	"unprognostic (3.73e-1)"	"unprognostic (1.19e-1)"	"unprognostic (8.93e-3)"	"unprognostic (1.29e-1)"	6.2	8.5	9.3	0.9	9.5	0.5	6.7	9.4	9.7	10.1	9.3	10.7	0.9	9.2	6.6	6.5	9.0	1.2	8.8	8.9	9.5	9.5	9.6	5.5	0.8	9.7	9.8	11.8	12.7	5.9	11.4	3.0	10.0	11.5	2.0	2.7	9.8	1.4	18.7	10.8	7.3	2.4	9.5	6.8	8.6	8.9	9.9	4.4	10.0	7.3	0.7	9.3	9.7	10.0	5.2	9.9	3.6	1.9	12.4	9.3	0.8	4.4	2.1	4.7	5.0	4.5	1.7	0.6	7.6	3.6	7.4	9.2	4.7	9.4	5.0	4.2	1.4	1.3	5.5	1.9	4.8	1.2	1.9	2.8	7.3	3.0	7.3	7.2	3.4	5.7	4.7	6.1	4.7	0.6	8.6	3.1	2.2	11.5	2.8	7.0	12.0	2.3	6.7	2.3	4.5	4.6	9.2	5.6	3.0	8.8	4.4	3.3	3.3	9.4	3.0	5.0	3.4	7.4	8.7	1.1	4.1	1.9	1.1	0.0	0.1	0.0	1.4	0.3	2.0	1.2	1.2	0.7	0.9	1.5	1.8	1.1	0.0	1.8	4.3	1.1	1.4	0.7	9.3	9.5	9.4	9.7	8.9	9.5	9.7	9.8	10.0	9.5	9.9	10.0	9.1	16.0	8.4	21.2	5.4	4.1	5.8	4.9	9.6	17.0	11.2	9.8	17.0	0.0	10.7	9.2	20.9	6.5	3.5	7.6	9.8	4.5	11.9	10.2	12.9	8.8	7.8	6.9	23.7	2.9	2.2	8.4	8.6	9.0	8.8	15.5	6.8	13.4	3.7	26.9	25.5	11.0	8.2	5.4	2.5	7.1	10.5	3.9	5.4	15.0	3.4	14.9	7.2	13.6	44.2	3.6	6.4	6.8	7.0	6.0	4.2	8.0	13.6	23.5	6.6	9.4	7.6	20.9	16.4	7.2	2.4	4.1	5.3	9.2	10.3	3.7
FANCM	"FAAP250, KIAA1596"	ENSG00000187790	"FA complementation group M"	Q8IYD8	14	45135930-45200890	"Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins"	"DNA damage, DNA repair"	"DNA-binding, Helicase, Hydrolase"	"Disease variant, Premature ovarian failure"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Group enriched"	"Detected in many"	5	"Early spermatids: 65.5;Late spermatids: 206.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA055144			Supported	Nucleoplasm		NA	NA			"Cluster 34: Basophils - Unknown function"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 25: Spermatids - Spermatogenesis"	Nucleoplasm		"HPA055144: AB_2682715"	"unprognostic (8.40e-2)"	"unprognostic (6.70e-2)"	"unprognostic (3.99e-2)"	"unprognostic (4.32e-2)"	"unprognostic (2.15e-1)"	"unprognostic (2.31e-3)"	"unprognostic (2.66e-2)"	"unprognostic (1.18e-1)"	"unprognostic (1.57e-2)"	"unprognostic (8.52e-2)"	"unprognostic (1.14e-1)"	"unprognostic (1.23e-2)"	"unprognostic (7.55e-2)"	"unprognostic (2.90e-1)"	"unprognostic (1.71e-1)"	"unprognostic (8.94e-2)"	"unprognostic (1.13e-2)"	1.9	1.6	0.8	2.2	1.6	5.6	2.8	1.9	2.2	2.0	0.3	1.6	1.3	2.4	2.2	1.9	1.6	1.8	1.3	1.0	0.9	1.8	1.5	1.7	3.3	1.0	0.8	2.9	1.1	1.5	0.8	1.9	1.2	1.6	1.8	2.8	1.4	1.9	1.6	2.6	1.2	1.9	0.7	2.3	1.4	7.6	1.1	4.1	1.5	2.3	2.6	1.5	1.5	1.2	8.2	7.0	8.1	7.5	6.4	3.5	6.5	10.3	4.1	8.1	10.1	11.3	6.2	10.6	5.8	2.6	4.5	10.6	9.5	4.4	11.0	7.6	5.4	5.1	7.8	6.4	1.1	13.0	6.1	2.2	1.6	8.1	5.1	1.8	7.1	6.6	9.1	8.9	6.9	8.1	9.5	9.2	3.2	6.3	11.6	9.0	12.7	4.5	3.4	5.8	7.3	1.9	9.4	7.6	4.0	5.1	8.0	6.0	5.6	11.8	11.0	10.6	8.1	4.4	8.7	10.3	2.3	7.9	7.0	6.6	0.7	2.5	2.0	2.0	1.1	4.3	1.3	0.7	0.6	2.0	2.0	1.7	1.0	1.1	0.9	1.7	1.0	0.6	0.8	1.6	1.9	2.2	1.0	0.9	1.0	0.8	1.2	0.7	1.1	1.2	6.5	0.0	3.1	9.8	8.3	2.7	1.1	1.9	4.6	6.3	3.9	2.4	8.3	1.5	3.1	1.8	2.1	7.6	5.6	1.7	0.0	2.2	65.5	3.5	5.8	5.1	0.0	12.8	21.0	2.7	3.5	4.6	5.1	3.0	1.3	9.4	5.7	1.7	3.5	3.3	15.6	1.6	4.1	3.8	2.9	206.1	9.0	4.0	3.6	18.7	5.9	4.8	3.1	20.1	22.7	2.4	0.8	5.3	8.4	0.8	1.5	1.9	1.1	6.9	6.6	4.7	6.0	26.5	14.0	4.4	1.8	2.3	5.6	9.5	3.2	0.7
FAP	DPPIV	ENSG00000078098	"Fibroblast activation protein alpha"	Q12884	2	162170684-162245151	"Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Angiogenesis, Apoptosis, Cell adhesion"	"Hydrolase, Protease, Serine protease"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"endometrium 1: 31.4;smooth muscle: 26.4"	"Cell type enhanced"	"Detected in many"		"Endometrial stromal cells: 67.6;Fibroblasts: 43.4;Microglial cells: 17.8;Muller glia cells: 57.5;Smooth muscle cells: 25.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"ASC diff: 192.2;ASC TERT1: 202.3;BJ hTERT+: 167.8;hTERT-RPE1: 209.1;U-138 MG: 167.3"	"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	5	"cerebral cortex: 3.1;hippocampal formation: 2.4"	HPA059739	Uncertain				"Secreted to blood"	NA	NA	108000000	56000000		"Cluster 46: Fibroblasts - ECM organization"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 50: Fibroblasts - ECM organization"			"HPA059739: AB_2684117"	"unprognostic (7.48e-3)"	"unprognostic (7.87e-3)"	"unprognostic (4.10e-2)"	"unprognostic (5.04e-2)"	"unprognostic (1.49e-2)"	"prognostic unfavorable (4.82e-4)"	"unprognostic (2.01e-2)"	"unprognostic (1.05e-2)"	"unprognostic (3.30e-2)"	"unprognostic (4.89e-2)"	"unprognostic (4.59e-2)"	"unprognostic (3.52e-1)"	"unprognostic (7.32e-11)"	"unprognostic (1.72e-3)"	"unprognostic (9.84e-3)"	"unprognostic (7.97e-2)"	"unprognostic (4.49e-3)"	5.8	0.2	0.9	5.2	0.9	0.0	10.1	0.4	0.9	15.2	0.0	3.5	0.5	31.4	8.5	3.6	4.8	22.3	4.9	0.3	1.4	0.7	0.2	4.0	1.5	0.6	0.5	3.0	2.5	0.7	0.5	23.1	0.6	1.9	2.5	6.4	4.7	5.8	4.4	2.8	0.9	26.4	0.2	0.4	1.0	1.5	1.0	0.5	2.8	7.5	1.5	15.5	3.6	0.7	0.0	0.0	0.0	0.0	192.2	202.3	0.4	82.8	167.8	16.6	25.4	0.0	0.0	0.0	0.6	31.3	0.0	0.1	0.0	5.1	8.0	0.0	0.0	0.1	1.2	0.0	19.5	0.0	0.0	66.2	1.2	28.1	5.2	209.1	0.1	0.0	0.0	0.0	53.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	8.5	0.0	9.0	0.2	0.1	0.0	84.3	167.3	3.1	41.4	0.4	0.0	0.1	0.0	37.5	0.1	45.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.9	0.4	0.9	0.3	1.4	0.6	0.5	0.6	0.2	1.0	0.7	3.9	0.0	0.0	5.5	0.2	4.5	0.1	7.0	0.0	1.8	0.3	0.5	0.4	0.0	0.3	0.0	0.0	0.9	0.1	0.0	0.0	0.2	6.7	3.4	67.6	6.4	4.9	0.0	13.3	0.2	1.9	43.4	0.0	6.2	0.0	0.0	1.4	0.0	0.9	1.7	0.3	1.4	0.0	0.0	2.6	4.1	8.4	0.8	3.6	17.8	0.0	57.5	0.0	0.5	4.2	1.0	0.0	0.0	0.3	0.0	0.0	1.2	0.2	2.0	0.0	4.7	25.2	2.3	0.4	0.4	4.3	1.8	0.8	1.3	0.2	0.0
FASN	"FAS, SDR27X1"	ENSG00000169710	"Fatty acid synthase"	P49327	17	82078338-82098294	"Cancer-related genes, Enzymes, FDA approved drug targets, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Fatty acid biosynthesis, Fatty acid metabolism, Lipid biosynthesis, Lipid metabolism"	"Hydrolase, Lyase, Multifunctional enzyme, Oxidoreductase, Transferase"	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 372.8;breast: 271.6"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 2: 126.0;Breast glandular cells: 442.9;Breast myoepithelial cells: 165.4;Hepatocytes: 244.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in all"		"SK-BR-3: 1109.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB005192, HPA006461, CAB015417, HPA056108"	Enhanced		Enhanced	"Plasma membrane,Cytosol"		No	No		3400000		"Cluster 57: Non-specific - Angiogenesis"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 30: Mammary glandular cells - Lactation"	"Plasma membrane, Cytosol"		"CAB005192: AB_2101095, CAB015417: AB_2231427, HPA006461: AB_1848437, HPA056108: AB_2683039"	"unprognostic (3.35e-2)"	"prognostic unfavorable (1.42e-5)"	"unprognostic (9.69e-3)"	"unprognostic (4.09e-2)"	"unprognostic (3.46e-3)"	"unprognostic (1.55e-2)"	"unprognostic (3.09e-2)"	"unprognostic (4.74e-3)"	"unprognostic (3.15e-1)"	"unprognostic (3.15e-1)"	"unprognostic (2.87e-3)"	"unprognostic (1.05e-1)"	"prognostic unfavorable (7.16e-5)"	"unprognostic (4.50e-2)"	"unprognostic (9.62e-2)"	"unprognostic (1.35e-2)"	"unprognostic (7.03e-3)"	372.8	30.9	25.0	14.9	44.2	18.7	271.6	67.3	49.9	31.7	0.0	25.5	11.5	18.0	6.2	63.6	15.2	6.6	21.9	39.9	15.0	11.8	191.4	54.1	7.2	84.4	75.7	16.3	18.6	8.5	72.4	12.1	101.7	69.0	3.0	4.3	38.3	14.3	27.9	89.4	28.8	5.3	12.5	8.8	63.6	11.9	33.7	9.6	21.2	2.3	3.0	27.0	31.8	60.8	179.1	182.0	81.7	56.7	130.1	87.2	176.9	34.3	43.3	35.5	64.6	190.6	116.7	58.8	29.2	26.3	99.5	144.0	79.2	157.8	6.5	30.0	358.0	123.9	140.0	257.2	36.8	67.5	19.2	84.2	40.4	90.8	21.0	12.1	40.1	54.8	193.2	50.7	12.6	304.1	78.9	105.5	161.1	28.1	107.1	64.1	47.8	116.5	40.3	220.7	205.0	117.0	50.6	1109.2	93.6	29.5	199.4	123.4	71.1	52.3	107.0	45.2	88.4	68.5	17.1	60.6	31.2	71.1	79.5	0.0	0.1	0.0	0.1	0.0	0.1	0.0	0.2	0.2	0.2	0.0	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.1	25.0	44.2	67.3	49.9	39.9	15.0	84.4	75.7	101.7	12.5	33.7	60.8	9.6	25.6	126.0	28.4	7.4	7.8	12.7	33.2	8.0	28.7	442.9	165.4	5.9	21.5	28.4	11.0	6.2	32.0	12.8	35.7	3.9	19.2	1.5	19.6	19.8	10.8	18.1	20.6	11.9	29.2	77.7	13.4	33.6	17.1	12.7	29.9	10.8	244.1	13.9	30.3	12.5	22.3	22.4	9.8	6.2	3.4	16.4	7.0	17.8	4.7	6.2	14.1	8.2	11.6	17.6	19.1	23.6	11.3	9.7	60.4	6.5	5.9	23.7	13.1	0.0	9.0	14.9	1.8	11.7	34.1	13.8	29.6	10.6	27.9	27.4	19.6
FBH1	"Fbx18, FBXO18, FLJ14590"	ENSG00000134452	"F-box DNA helicase 1"	Q8NFZ0	10	5890203-5937594	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted membrane proteins"	"DNA damage, DNA repair, Ubl conjugation pathway"	"DNA-binding, Helicase, Hydrolase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Adipocytes: 22.4;Distal tubular cells: 21.5;Granulosa cells: 23.6;Syncytiotrophoblasts: 32.0;Theca cells: 27.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA002844	Supported					NA	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 89: Fibroblasts - ECM organization"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 7: Non-specific - Mitochondria"			"HPA002844: AB_1078829"	"unprognostic (3.14e-2)"	"unprognostic (1.55e-1)"	"unprognostic (6.35e-3)"	"unprognostic (4.42e-2)"	"unprognostic (3.37e-2)"	"unprognostic (8.98e-3)"	"prognostic unfavorable (7.73e-7)"	"unprognostic (1.89e-1)"	"unprognostic (2.42e-1)"	"unprognostic (3.37e-2)"	"unprognostic (1.56e-2)"	"unprognostic (2.23e-1)"	"unprognostic (6.91e-3)"	"unprognostic (3.69e-1)"	"unprognostic (4.35e-2)"	"unprognostic (1.24e-1)"	"unprognostic (9.54e-2)"	28.7	38.8	17.5	22.8	20.3	24.6	26.8	17.7	19.1	32.4	25.7	30.4	24.6	34.3	21.3	24.0	36.4	23.0	44.5	17.2	18.0	25.2	28.8	27.6	27.6	17.7	18.2	30.7	21.9	28.5	26.1	26.6	18.0	28.6	24.2	14.8	24.3	25.8	30.3	30.4	29.7	30.1	17.8	35.3	27.6	24.7	19.2	40.2	25.2	27.4	27.2	28.8	27.1	19.0	31.8	34.0	31.3	34.4	70.4	46.3	28.1	35.9	24.6	34.8	38.8	40.4	28.3	29.6	23.0	52.5	16.7	46.3	42.6	38.2	31.3	32.2	31.5	28.6	27.3	34.8	48.2	14.2	26.4	58.2	36.4	44.2	19.4	44.0	59.7	39.7	50.9	30.4	37.3	48.1	34.5	20.9	14.3	54.7	18.9	37.6	14.8	49.9	34.0	25.5	17.7	26.6	36.8	33.1	50.8	35.7	33.7	28.5	37.9	22.1	24.7	59.1	28.1	30.9	26.1	16.3	29.8	20.7	15.8	0.0	2.1	3.3	1.9	1.7	1.3	3.0	2.0	2.5	2.0	4.1	2.5	1.8	1.3	4.6	1.3	4.0	6.2	1.7	17.5	20.3	17.7	19.1	17.2	18.0	17.7	18.2	18.0	17.8	19.2	19.0	22.4	0.0	0.0	0.0	3.9	0.0	0.0	0.0	0.0	0.0	15.6	16.1	0.0	0.0	0.0	7.3	0.0	20.3	9.3	0.0	21.5	16.8	0.0	11.4	19.0	7.1	0.0	0.0	0.0	15.1	19.4	9.8	0.0	14.9	0.0	23.6	0.0	0.0	16.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.5	0.0	0.0	10.3	0.0	0.0	0.0	0.0	18.3	0.0	0.0	3.2	0.0	0.0	20.9	0.0	0.0	0.0	0.0	11.0	0.0	0.0	0.0	0.0	32.0	4.4	27.9	0.0	0.0
FBP1	FBP	ENSG00000165140	"Fructose-bisphosphatase 1"	P09467	9	94603133-94640249	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Carbohydrate metabolism, Gluconeogenesis"	"Allosteric enzyme, Hydrolase"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 324.4;kidney: 297.8;liver: 893.2"	"Cell type enhanced"	"Detected in many"		"Hepatocytes: 500.4;Macrophages: 238.6;Proximal enterocytes: 1095.0;Proximal tubular cells: 864.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"eosinophil: 404.3"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in some"		"HaCaT: 75.2;MCF7: 243.4;OE19: 54.5;RT4: 157.0;U-698: 170.4"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA005857, HPA012513, CAB033869"	Enhanced		Approved	Mitochondria		NA	NA		21000000	"Cluster 45: Eosinophils - Innate immune response"	"Cluster 41: Intestine & Liver - Lipid metabolism"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Mitochondria		"CAB033869: AB_1121520, HPA005857: AB_1848445, HPA012513: AB_1848446"	"unprognostic (4.95e-2)"	"unprognostic (1.40e-2)"	"unprognostic (1.40e-1)"	"prognostic favorable (5.16e-4)"	"unprognostic (1.13e-2)"	"unprognostic (1.37e-1)"	"prognostic favorable (1.79e-4)"	"unprognostic (6.94e-3)"	"unprognostic (4.52e-2)"	"unprognostic (7.79e-2)"	"unprognostic (7.59e-2)"	"unprognostic (1.12e-1)"	"prognostic favorable (6.86e-7)"	"unprognostic (6.91e-2)"	"unprognostic (3.22e-2)"	"unprognostic (1.07e-1)"	"prognostic favorable (1.64e-5)"	13.7	27.4	1.6	12.7	1.8	15.0	41.4	1.8	5.7	19.9	2.6	29.8	324.4	3.6	15.8	2.7	7.1	34.4	2.9	1.5	2.2	297.8	893.2	165.9	6.8	3.6	2.6	1.1	41.4	107.9	8.6	3.0	2.9	25.8	30.5	0.7	53.2	28.9	1.3	8.1	258.1	8.8	2.6	12.2	85.6	2.5	3.2	2.2	16.8	0.9	7.8	70.8	6.7	3.8	0.5	0.1	0.3	0.0	0.0	0.0	0.7	0.2	0.0	0.0	0.1	0.6	3.8	0.0	0.3	0.8	0.1	75.2	0.1	0.0	0.1	0.0	0.3	0.6	2.9	1.3	0.0	1.5	18.8	0.0	0.1	0.0	0.0	0.0	2.0	0.0	0.2	0.3	0.2	243.4	0.1	4.4	1.1	54.5	9.5	0.0	0.9	1.9	0.0	157.0	0.7	5.6	0.6	44.5	0.0	0.9	26.7	7.7	0.2	0.1	1.0	0.8	0.0	0.3	1.1	170.4	0.0	1.4	0.1	63.3	68.4	404.3	7.9	162.3	11.7	3.0	4.6	4.6	90.1	3.2	16.2	8.3	12.1	15.4	90.7	32.1	2.3	33.1	1.6	1.8	1.8	5.7	1.5	2.2	3.6	2.6	2.9	2.6	3.2	3.8	2.8	76.9	182.8	0.0	10.3	0.8	8.9	0.7	0.0	0.1	62.4	24.3	0.7	102.9	41.0	62.5	0.0	11.1	14.8	26.1	111.6	21.5	0.1	4.0	0.4	4.8	31.9	24.4	0.9	62.7	1.7	5.4	102.4	5.2	47.4	16.0	12.1	500.4	177.6	0.0	0.8	61.4	0.0	79.9	32.1	1.5	1.5	238.6	12.4	1.9	20.1	2.6	8.2	0.5	0.3	24.0	77.6	4.1	18.3	11.9	1095.0	864.1	9.1	0.2	6.6	0.6	2.0	0.6	1.3	0.8	1.0	10.1	12.1	0.5	90.4	68.1
FBP2		ENSG00000130957	"Fructose-bisphosphatase 2"	O00757	9	94558720-94593824	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Carbohydrate metabolism, Gluconeogenesis"	"Allosteric enzyme, Hydrolase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	8	"skeletal muscle: 753.6;tongue: 385.3"	"Group enriched"	"Detected in some"	7	"Gastric mucus-secreting cells: 11.2;Skeletal myocytes: 8.7;Spermatogonia: 8.5"	"Cancer enhanced"	"Detected in some"		"stomach cancer: 1.2"	"Region enriched"	"Detected in some"	4	"hippocampal formation: 6.1"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BEWO: 3.9;CACO-2: 2.1;HMC-1: 2.2;MCF7: 3.0;OE19: 2.9;PC-3: 2.0;SiHa: 2.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA012513, HPA077371"	Enhanced		Approved	"Plasma membrane,Cytosol"		NA	NA		960000		"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 37: Myocytes - Muscle contraction"	"Plasma membrane, Cytosol"		"HPA012513: AB_1848446, HPA077371: "	"unprognostic (3.88e-2)"	"unprognostic (3.54e-4)"	"unprognostic (2.38e-1)"	"unprognostic (6.03e-2)"		"unprognostic (2.21e-1)"	"unprognostic (1.54e-2)"	"unprognostic (9.40e-4)"	"unprognostic (3.95e-3)"	"unprognostic (5.11e-2)"	"unprognostic (2.39e-2)"	"unprognostic (4.69e-2)"	"unprognostic (2.53e-1)"	"unprognostic (1.36e-2)"	"unprognostic (2.03e-1)"		"unprognostic (1.48e-4)"	0.1	0.9	0.1	0.1	0.0	0.0	0.2	1.2	0.1	0.0	69.2	0.3	5.3	0.0	0.0	8.1	0.0	0.1	0.2	6.1	0.0	0.2	0.2	0.4	0.4	0.7	0.3	0.0	4.3	49.7	0.0	0.1	0.1	1.2	0.0	0.0	4.2	3.3	753.6	0.2	0.9	0.0	0.9	0.0	36.1	1.4	1.4	0.2	0.3	385.3	0.9	0.3	0.0	0.0	0.3	1.3	0.0	1.4	0.0	0.0	3.9	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.1	0.0	1.2	1.1	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	3.0	0.0	0.0	0.0	2.9	2.0	0.0	0.0	0.0	0.0	1.4	0.3	0.0	2.8	0.6	0.0	0.1	0.2	0.1	0.0	0.0	1.2	1.2	0.0	0.0	0.0	0.6	0.1	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.2	0.1	6.1	0.0	0.7	0.3	0.1	0.9	1.4	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.1	0.0	0.1	0.0	0.0	0.5	1.3	0.0	0.0	11.2	0.0	0.0	0.0	1.1	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.7	0.1	0.2	8.5	0.0	0.0	0.1	0.0	0.0	0.0	0.0
FHIT	"AP3Aase, FRA3B"	ENSG00000189283	"Fragile histidine triad diadenosine triphosphatase"	P49789	3	59747277-61251459	"Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"Apoptosis, Transcription, Transcription regulation"	Hydrolase	"Cancer-related genes, Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"choroid plexus: 94.0"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 609.8;Inhibitory neurons: 450.5;Microglial cells: 337.3;Oligodendrocyte precursor cells: 1086.7;Oligodendrocytes: 1111.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in many"	4	"naive CD4 T-cell: 87.6"	"Lineage enriched"	"Detected in all"	12	"T-cells: 87.6"	"Cell line enhanced"	"Detected in many"		"RPMI-8226: 17.5;U-266/70: 34.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB002684, HPA018840, HPA018909"	Enhanced		Approved	"Nucleoli fibrillar center,Plasma membrane"		NA	NA		12000	"Cluster 32: T-cells - Unknown function"	"Cluster 88: Choroid plexus - Transmembrane transport"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 68: Oligodendrocytes - Mixed function"	"Nucleoli fibrillar center, Plasma membrane"		"CAB002684: , HPA018840: AB_1848538, HPA018909: AB_1848537"	"unprognostic (2.36e-3)"	"unprognostic (6.38e-2)"	"unprognostic (1.59e-1)"	"unprognostic (4.42e-2)"	"unprognostic (1.10e-1)"	"unprognostic (1.08e-2)"	"unprognostic (1.18e-1)"	"unprognostic (3.16e-2)"	"unprognostic (2.77e-2)"	"unprognostic (8.49e-2)"	"unprognostic (2.36e-1)"	"unprognostic (6.77e-2)"	"prognostic favorable (1.36e-4)"	"unprognostic (1.54e-1)"	"unprognostic (5.96e-2)"	"unprognostic (1.29e-2)"	"unprognostic (1.80e-2)"	5.6	24.4	13.7	6.2	18.3	8.0	9.0	13.0	17.3	5.4	94.0	6.9	6.4	3.5	6.9	5.0	6.6	9.8	15.8	19.7	16.4	24.9	9.6	4.7	7.6	18.9	17.0	6.8	13.0	18.1	7.9	3.0	18.9	5.3	5.8	7.6	8.5	4.7	10.6	8.1	5.3	4.7	15.0	5.0	8.6	5.5	15.9	12.1	11.7	7.2	5.3	6.7	4.2	19.8	0.1	0.0	1.4	0.0	0.6	0.1	2.5	0.1	0.2	0.1	0.0	2.7	4.2	4.0	0.7	0.1	3.0	0.0	12.7	3.2	0.0	2.2	5.0	3.3	2.0	6.4	3.3	8.7	0.1	9.1	5.2	0.2	6.9	0.3	0.0	3.7	2.5	11.9	0.2	3.6	15.2	6.7	1.2	12.2	0.9	11.3	0.0	17.5	15.3	2.0	2.9	4.3	1.5	9.9	10.1	5.3	0.4	0.2	0.0	1.7	0.4	0.1	2.4	34.6	11.3	0.0	4.0	0.1	1.9	6.8	4.6	0.5	2.2	2.9	1.4	4.1	17.2	1.8	5.7	3.1	87.6	15.6	0.8	7.2	1.3	5.8	20.5	11.9	13.7	18.3	13.0	17.3	19.7	16.4	18.9	17.0	18.9	15.0	15.9	19.8	4.1	6.4	10.6	609.8	19.7	7.6	20.7	30.0	46.7	12.6	41.2	31.2	10.0	38.6	17.5	27.6	58.4	42.0	12.4	6.9	78.2	19.1	45.8	14.6	7.9	7.0	7.7	17.7	276.6	4.7	8.5	10.1	18.3	19.0	5.7	25.7	14.6	23.4	20.9	30.3	450.5	12.9	22.4	10.2	7.1	163.0	19.3	12.9	12.4	337.3	8.6	19.7	6.2	1086.7	1111.0	9.7	15.0	9.8	23.8	12.0	20.7	126.6	12.4	20.7	0.0	10.7	6.2	19.1	7.5	33.7	11.2	32.7	11.5	23.0	20.1	18.8
FOLH1	"FOLH, GCP2, GCPII, NAALAD1, NAALAdase, PSM, PSMA"	ENSG00000086205	"Folate hydrolase 1"	Q04609	11	49145092-49208638	"Cancer-related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"		"Carboxypeptidase, Dipeptidase, Hydrolase, Metalloprotease, Multifunctional enzyme, Protease"	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 266.4;prostate: 76.0"	"Cell type enriched"	"Detected in some"	8	"Oligodendrocytes: 367.6"	"Cancer enriched"	"Detected in many"	27	"prostate cancer: 142.7"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HAP1: 2.3;RPMI-8226: 1.7;SK-BR-3: 1.8;TIME: 1.3;WM-115: 2.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB001451, HPA010593"	Enhanced					NA	NA				"Cluster 56: Intestine - Transmembrane transport"	"Cluster 17: WM-115 - Nervous system development"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"			"CAB001451: AB_563979, HPA010593: AB_1079685"	"unprognostic (1.33e-1)"	"unprognostic (1.19e-1)"	"unprognostic (1.24e-1)"	"prognostic favorable (5.24e-5)"	"unprognostic (2.55e-1)"	"unprognostic (8.31e-2)"	"prognostic favorable (4.25e-4)"	"unprognostic (1.32e-1)"	"unprognostic (2.09e-2)"	"unprognostic (2.67e-3)"	"unprognostic (2.13e-2)"	"unprognostic (2.72e-1)"	"prognostic unfavorable (1.30e-6)"	"unprognostic (4.81e-2)"	"unprognostic (7.27e-2)"	"unprognostic (4.74e-3)"	"unprognostic (4.04e-1)"	1.8	1.1	17.3	0.9	37.3	0.7	4.8	27.1	27.7	1.9	7.9	0.7	266.4	1.7	0.9	1.5	3.5	10.2	0.5	18.3	22.4	13.5	35.5	1.3	0.9	32.7	28.4	1.0	0.3	0.2	0.0	0.3	31.5	76.0	0.5	4.0	52.8	0.6	0.2	1.7	82.9	1.0	24.1	2.4	1.1	0.8	31.1	0.1	1.0	0.2	0.6	1.4	0.3	59.3	0.1	0.0	0.0	0.0	0.0	0.0	1.1	0.1	0.0	0.0	0.0	0.0	0.4	0.0	0.3	0.0	0.1	0.1	2.3	0.2	0.0	0.5	0.4	0.0	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.5	0.4	0.0	0.0	0.1	0.1	1.7	0.0	0.0	0.2	0.7	0.0	1.8	0.3	0.2	0.3	0.0	1.3	0.1	0.9	0.2	0.1	0.0	0.2	0.0	0.0	0.4	2.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	17.3	37.3	27.1	27.7	18.3	22.4	32.7	28.4	31.5	24.1	31.1	59.3	0.5	0.0	0.6	0.0	0.0	0.3	0.7	0.1	0.6	0.0	8.2	7.0	0.3	0.0	1.9	0.0	0.0	0.0	0.5	0.0	7.9	0.0	5.2	2.1	0.5	5.0	0.0	0.0	0.5	0.0	0.0	2.2	0.0	2.8	0.0	0.0	2.9	25.9	0.1	0.0	1.0	1.1	0.0	0.3	0.0	1.4	1.5	0.2	3.6	1.0	0.0	17.4	0.0	0.0	367.6	0.0	1.2	0.4	0.0	43.0	0.8	32.4	0.1	0.6	0.0	0.0	0.4	1.1	1.5	1.5	0.9	0.0	0.2	0.5	0.2	0.6
FUCA1		ENSG00000179163	"Alpha-L-fucosidase 1"	P04066	1	23845077-23868290	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"		"Glycosidase, Hydrolase"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 181.7;Distal enterocytes: 226.6;Paneth cells: 221.0;Proximal enterocytes: 210.9;Syncytiotrophoblasts: 200.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"CAPAN-2: 165.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA046542, HPA056371"	Enhanced		Supported	Vesicles	"Intracellular and membrane"	NA	NA		60000000	"Cluster 14: Monocytes - Unknown function"	"Cluster 34: Non-specific - Transcription"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 4: Macrophages - Innate immune response"	Vesicles		"HPA046542: AB_2679691, HPA056371: AB_2683108"	"unprognostic (6.94e-3)"	"unprognostic (6.53e-2)"	"unprognostic (2.68e-3)"	"prognostic favorable (2.45e-4)"	"unprognostic (5.64e-3)"	"unprognostic (2.59e-3)"	"unprognostic (1.56e-2)"	"unprognostic (1.79e-3)"	"unprognostic (4.99e-1)"	"unprognostic (2.18e-2)"	"unprognostic (2.05e-1)"	"unprognostic (4.23e-2)"	"prognostic favorable (5.70e-13)"	"unprognostic (3.75e-2)"	"unprognostic (4.35e-2)"	"unprognostic (1.54e-2)"	"unprognostic (2.13e-3)"	34.2	34.4	8.3	49.8	8.2	7.7	26.3	8.3	11.2	54.5	23.8	124.2	90.3	20.7	113.0	17.0	51.1	46.6	20.6	8.3	10.5	78.2	104.8	55.1	168.2	9.5	8.8	23.8	23.9	56.9	17.6	72.6	9.6	50.2	140.7	5.7	40.8	60.4	15.8	14.9	81.3	26.7	9.3	71.8	63.9	27.7	10.8	26.8	70.6	17.7	94.1	74.9	13.2	12.8	15.9	10.6	2.2	31.9	4.2	0.3	11.0	16.6	34.4	17.1	31.6	14.5	165.1	23.9	40.9	21.3	18.8	9.4	15.3	35.4	22.4	16.9	25.6	19.7	9.2	32.7	14.2	2.0	62.7	15.3	19.7	6.2	8.1	55.2	6.9	13.3	9.3	0.5	20.6	17.5	5.0	17.7	5.4	48.1	16.9	26.9	0.2	26.2	63.5	40.5	10.9	10.6	47.9	18.5	26.2	17.9	13.6	7.8	1.8	5.8	9.0	38.9	5.6	28.5	31.0	8.5	14.5	58.9	9.5	54.8	100.4	51.9	27.2	99.9	23.1	23.8	19.5	22.9	44.0	14.1	18.9	22.0	12.8	44.6	91.1	25.4	21.4	64.8	8.3	8.2	8.3	11.2	8.3	10.5	9.5	8.8	9.6	9.3	10.8	12.8	12.9	25.6	28.6	4.2	10.5	3.6	27.4	99.3	6.8	4.4	22.2	10.4	5.6	40.0	77.8	84.6	0.0	181.7	13.9	226.6	15.6	64.1	61.0	31.5	2.8	11.6	10.8	20.6	5.8	50.3	24.2	16.7	33.1	13.3	8.2	11.1	25.7	42.7	156.4	0.0	6.3	44.4	44.7	121.0	13.5	24.4	23.3	85.4	8.8	2.8	29.6	13.0	10.3	4.0	4.7	34.9	221.0	19.5	8.7	23.6	210.9	40.2	53.7	5.0	6.6	16.7	13.2	109.0	24.8	8.5	2.8	200.6	11.2	34.6	79.5	40.3
FUCA2	"dJ20N2.5, MGC1314"	ENSG00000001036	"Alpha-L-fucosidase 2"	Q9BTY2	6	143494812-143511720	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"		"Glycosidase, Hydrolase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"parathyroid gland: 165.8"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA031659, HPA031661"	Approved				"Secreted to blood"	NA	NA		56000000	"Cluster 25: Monocytes - Inflammatory response"	"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 18: U-2197 - ECM organization"	"Cluster 33: Fibroblasts - ECM organization"			"HPA031659: AB_10600661, HPA031661: AB_10601681"	"unprognostic (1.83e-2)"	"unprognostic (1.70e-3)"	"unprognostic (1.11e-2)"	"unprognostic (1.01e-2)"	"unprognostic (4.89e-2)"	"unprognostic (1.41e-2)"	"prognostic unfavorable (2.70e-9)"	"unprognostic (1.54e-3)"	"unprognostic (1.08e-1)"	"unprognostic (7.79e-2)"	"unprognostic (2.89e-1)"	"unprognostic (1.90e-1)"	"unprognostic (8.76e-3)"	"unprognostic (9.18e-2)"	"unprognostic (2.69e-1)"	"unprognostic (7.25e-2)"	"unprognostic (5.07e-2)"	28.9	41.4	13.5	25.4	16.4	25.8	26.3	16.0	15.3	29.2	30.2	41.5	42.6	25.6	44.9	14.2	23.7	27.8	27.9	12.4	16.5	54.8	52.3	28.9	17.2	17.1	14.2	30.4	34.6	165.8	15.8	50.5	17.8	21.9	52.8	6.1	25.4	25.8	6.9	12.3	39.3	27.6	16.4	24.6	38.3	12.6	15.9	6.6	32.0	11.6	17.0	33.5	20.4	20.9	97.4	55.7	47.6	86.9	69.0	134.4	90.1	89.9	95.4	108.1	182.0	107.1	94.8	0.2	66.1	120.8	33.9	0.6	24.1	11.7	148.9	87.2	92.6	32.6	100.1	163.2	99.3	0.3	15.8	72.3	69.4	96.6	41.5	91.6	111.4	0.2	117.6	49.3	123.2	114.6	0.2	75.9	62.1	44.2	76.0	0.2	99.7	72.1	129.0	59.5	36.0	23.6	98.7	65.3	82.3	36.3	32.1	79.6	65.9	64.1	54.0	161.6	175.4	18.3	21.3	0.7	74.1	59.1	22.5	38.8	84.9	26.2	13.2	84.0	15.0	11.3	9.8	11.3	65.4	8.3	4.4	7.9	5.5	29.6	62.0	10.3	19.8	51.9	13.5	16.4	16.0	15.3	12.4	16.5	17.1	14.2	17.8	16.4	15.9	20.9	27.3	41.7	35.9	9.1	13.5	11.2	12.6	30.3	9.1	3.7	19.2	12.6	28.0	38.6	37.9	25.8	0.0	52.5	10.3	47.6	11.7	81.9	2.0	26.8	55.2	25.0	9.6	18.7	8.7	124.9	109.8	62.6	34.7	28.9	37.4	38.1	23.6	35.2	110.3	1.7	11.8	38.1	46.8	57.5	29.2	2.6	66.8	51.7	42.7	9.4	49.1	11.1	13.4	5.5	14.5	74.6	38.2	45.5	47.7	13.8	60.3	51.4	34.8	1.1	6.6	33.8	35.0	4.8	4.6	13.2	8.0	46.4	11.5	78.8	50.4	18.4
FURIN	"FUR, PACE, PCSK3, SPC1"	ENSG00000140564	"Furin, paired basic amino acid cleaving enzyme"	P09958	15	90868588-90883564	"Enzymes, Plasma proteins, Predicted membrane proteins"	"Host-virus interaction"	"Hydrolase, Protease, Serine protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 305.6;salivary gland: 220.5"	"Cell type enhanced"	"Detected in many"		"Exocrine glandular cells: 117.5;Hepatocytes: 131.8;Pancreatic endocrine cells: 108.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB009499, HPA067869"	Enhanced		Supported	"Nucleoplasm,Golgi apparatus"	"Intracellular and membrane"	NA	NA		130000	"Cluster 10: Basophils - Unknown function"	"Cluster 85: Liver - Metabolism"	"Cluster 38: EFO-21 - Unknown function"	"Cluster 1: Pancreatic cells - Digestion"	"Golgi apparatus"	Nucleoplasm	"CAB009499: AB_2105095, HPA067869: "	"unprognostic (2.46e-1)"	"unprognostic (2.73e-2)"	"unprognostic (7.33e-2)"	"unprognostic (2.30e-2)"	"unprognostic (4.11e-3)"	"unprognostic (4.37e-2)"	"unprognostic (8.11e-2)"	"prognostic unfavorable (1.58e-4)"	"unprognostic (2.24e-1)"	"unprognostic (9.92e-3)"	"unprognostic (1.78e-1)"	"unprognostic (1.96e-1)"	"unprognostic (4.52e-3)"	"unprognostic (4.57e-2)"	"unprognostic (4.46e-2)"	"unprognostic (4.27e-3)"	"unprognostic (8.20e-2)"	54.5	24.4	12.8	36.4	10.5	73.8	42.4	10.6	14.5	26.4	11.7	32.8	27.6	32.3	9.8	33.7	30.4	19.4	58.5	14.9	9.0	56.8	305.6	63.2	13.0	12.5	10.8	22.4	108.6	27.3	45.9	40.6	11.3	60.1	12.1	12.9	220.5	17.7	61.3	62.7	35.5	14.3	10.4	51.4	34.0	8.6	15.6	11.8	56.1	25.3	11.2	30.2	33.3	9.3	50.8	31.2	6.8	29.8	49.4	32.1	77.5	64.4	48.1	26.3	18.1	45.4	54.3	1.9	148.8	47.5	46.1	91.5	14.0	32.5	5.4	148.0	35.2	90.9	52.8	57.7	26.2	13.0	141.2	35.6	35.3	29.5	13.2	62.4	84.7	14.6	70.5	8.5	17.8	32.3	5.0	29.2	21.5	44.2	9.3	7.9	26.6	10.9	35.2	39.1	13.1	9.2	54.5	28.5	42.5	31.9	10.7	31.4	125.9	29.4	60.1	43.7	95.5	15.2	93.4	3.4	55.8	40.1	60.7	2.0	0.9	1.5	0.7	0.1	0.2	0.4	0.2	0.3	0.6	0.1	0.0	0.1	0.7	0.4	0.0	0.3	0.0	1.1	12.8	10.5	10.6	14.5	14.9	9.0	12.5	10.8	11.3	10.4	15.6	9.3	44.1	3.2	27.4	4.2	7.3	19.4	10.0	10.4	2.8	12.8	12.0	9.0	16.3	21.5	8.5	22.0	25.0	20.9	26.9	49.5	0.0	47.1	0.5	15.2	9.7	29.4	37.8	26.5	7.9	117.5	16.5	11.4	21.9	32.3	15.8	7.0	23.9	131.8	24.8	8.4	7.5	31.7	10.2	35.3	42.1	1.4	11.1	33.6	16.0	5.6	14.0	13.6	24.7	2.0	4.4	108.3	26.4	10.9	7.2	24.3	28.7	7.8	2.0	28.0	26.3	10.5	18.6	2.8	3.6	8.5	23.0	84.3	19.6	4.7	17.9	16.4
G3BP1	"G3BP, HDH-VIII"	ENSG00000145907	"G3BP stress granule assembly factor 1"	Q13283	5	151771045-151812911	"Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Host-virus interaction, Immunity, Innate immunity, Transport"	"DNA-binding, Endonuclease, Helicase, Hydrolase, Nuclease, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA004052, CAB037068"	Supported		Supported	Cytosol		NA	NA		280000	"Cluster 13: T-cells - Unknown function"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 28: Keratinocytes - Keratinization"	Cytosol		"CAB037068: AB_1840864, HPA004052: AB_1849348"	"unprognostic (1.31e-1)"	"unprognostic (3.94e-2)"	"unprognostic (1.19e-3)"	"unprognostic (1.28e-2)"	"unprognostic (1.05e-1)"	"unprognostic (3.09e-2)"	"unprognostic (1.03e-3)"	"unprognostic (1.83e-2)"	"unprognostic (1.44e-1)"	"unprognostic (1.36e-1)"	"unprognostic (2.06e-3)"	"unprognostic (1.23e-2)"	"prognostic unfavorable (3.33e-4)"	"unprognostic (1.97e-1)"	"unprognostic (1.33e-1)"	"unprognostic (2.11e-2)"	"unprognostic (3.88e-2)"	52.3	46.8	32.9	60.2	36.1	27.5	54.1	42.8	44.6	42.0	41.0	47.8	34.8	42.5	33.1	54.8	51.0	38.8	51.0	30.7	36.1	57.1	69.0	36.1	78.3	34.5	35.7	62.5	30.4	41.5	16.5	58.2	35.8	41.3	50.6	18.3	31.8	37.3	112.2	43.4	33.9	47.8	35.0	46.7	40.3	65.5	38.6	66.0	42.6	92.1	85.7	66.3	31.9	43.3	204.9	267.0	177.0	96.3	253.2	119.2	232.4	204.1	190.6	290.6	348.6	413.7	310.3	384.7	307.0	188.0	231.6	210.9	319.7	395.6	333.7	122.5	173.8	232.9	201.1	334.8	128.8	281.6	163.9	123.4	186.7	243.7	232.2	98.7	209.7	140.9	191.3	173.3	254.5	179.7	273.9	142.4	231.4	146.0	209.6	254.3	235.1	187.2	163.1	290.5	195.2	132.0	200.8	307.0	319.3	169.2	246.3	174.7	238.2	202.0	239.7	187.3	364.0	104.9	171.3	305.0	132.2	229.6	337.8	132.2	102.3	84.7	189.2	135.4	255.3	168.8	215.6	186.7	141.0	160.0	201.8	193.2	37.8	203.7	134.1	134.7	249.2	287.2	32.9	36.1	42.8	44.6	30.7	36.1	34.5	35.7	35.8	35.0	38.6	43.3	88.9	19.2	41.4	32.7	112.0	239.5	101.3	82.4	148.0	37.1	74.8	60.7	62.3	44.3	66.2	64.4	16.7	94.0	91.7	47.3	78.2	69.6	49.6	80.6	104.4	112.1	50.2	96.1	25.7	53.0	94.6	98.0	70.3	87.2	73.6	73.8	76.8	169.4	78.2	57.2	30.6	59.4	50.8	81.2	195.0	30.1	65.0	73.3	87.2	37.5	83.7	54.3	45.3	29.7	45.3	59.2	42.9	57.2	89.3	160.0	33.5	80.0	74.2	36.6	39.5	111.6	90.7	58.0	89.3	155.6	256.4	67.3	99.6	72.2	78.5	98.0
G6PC	"G6PC1, G6PT, GSD1a"	ENSG00000131482	"Glucose-6-phosphatase catalytic subunit"	P35575	17	42900797-42914438	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted membrane proteins"	Gluconeogenesis	Hydrolase	"Disease variant, Glycogen storage disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	6	"kidney: 75.1;liver: 286.7"	"Group enriched"	"Detected in some"	4	"Hepatocytes: 246.2;Proximal enterocytes: 176.2"	"Cancer enriched"	"Detected in some"	72	"liver cancer: 151.8"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA052324	Enhanced					NA	NA				"Cluster 85: Liver - Metabolism"		"Cluster 2: Hepatocytes - Metabolism"			"HPA052324: AB_2681790"				"unprognostic (4.23e-2)"	"unprognostic (1.49e-2)"		"prognostic favorable (5.42e-5)"				"unprognostic (8.37e-2)"		"prognostic favorable (3.79e-5)"	"unprognostic (4.79e-2)"	"unprognostic (6.46e-2)"		"unprognostic (2.56e-3)"	0.0	0.0	0.1	0.1	0.2	0.4	0.0	0.4	0.2	0.0	0.2	0.1	19.7	0.0	0.1	0.0	0.0	4.1	0.0	0.2	0.1	75.1	286.7	0.0	0.1	0.3	0.2	0.0	0.2	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.1	30.0	0.0	0.0	0.1	0.1	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.3	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.4	0.2	0.2	0.1	0.3	0.2	0.2	0.0	0.3	0.6	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	28.6	0.0	1.8	0.0	0.0	0.0	0.0	1.9	0.7	0.6	0.1	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.1	0.0	0.0	2.5	246.2	0.1	0.0	0.0	2.1	0.0	3.5	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.8	0.0	0.0	0.0	176.2	43.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	1.7	0.2
G6PC2	IGRP	ENSG00000152254	"Glucose-6-phosphatase catalytic subunit 2"	Q9NQR9	2	168901291-168910000	"Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins"	Gluconeogenesis	Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	38	"pancreas: 30.9;retina: 12.3"	"Group enriched"	"Detected in some"	13	"Early spermatids: 17.8;Muller glia cells: 53.0"	"Cancer enriched"	"Detected in single"	92	"pancreatic cancer: 9.4"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"									NA	NA				"Cluster 25: Pancreas - Digestion"		"Cluster 5: Muller glia cells - Visual perception"				"unprognostic (6.42e-2)"				"unprognostic (2.39e-2)"		"unprognostic (6.04e-2)"		"unprognostic (9.05e-2)"		"unprognostic (2.97e-1)"		"unprognostic (3.10e-2)"	"unprognostic (1.54e-2)"	"unprognostic (1.87e-1)"			0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.2	0.0	0.0	0.0	0.0	0.1	0.1	0.0	30.9	0.0	0.0	0.0	0.0	0.0	0.0	12.3	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.3	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.5	0.3	0.2	0.1	0.1	0.0	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	17.8	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	2.7	0.0	0.0	0.0	1.0	0.0	53.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	1.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0
G6PC3	UGRP	ENSG00000141349	"Glucose-6-phosphatase catalytic subunit 3"	Q9BUM1	17	44070735-44076344	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	Gluconeogenesis	Hydrolase	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA067052			Supported	"Endoplasmic reticulum"		NA	NA			"Cluster 28: Myeloid DCs - Unknown function"	"Cluster 35: Non-specific - Unknown function"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 47: Cytotrophoblasts - Unknown function"	"Endoplasmic reticulum"		"HPA067052: AB_2685771"	"unprognostic (9.13e-2)"	"unprognostic (2.28e-1)"	"unprognostic (3.61e-1)"	"prognostic favorable (1.11e-4)"	"unprognostic (1.88e-3)"	"unprognostic (3.16e-1)"	"prognostic unfavorable (9.61e-4)"	"unprognostic (2.79e-1)"	"unprognostic (2.43e-1)"	"unprognostic (1.15e-2)"	"unprognostic (2.59e-2)"	"unprognostic (1.85e-3)"	"unprognostic (1.87e-3)"	"unprognostic (4.53e-2)"	"unprognostic (3.06e-2)"	"unprognostic (2.35e-1)"	"unprognostic (4.49e-2)"	56.7	97.2	64.8	22.5	67.8	16.0	55.6	70.5	79.3	47.6	88.8	42.1	28.7	55.4	63.9	37.1	45.6	23.9	61.9	65.3	77.5	75.2	26.4	42.9	19.3	74.9	86.9	44.3	56.5	66.7	95.1	25.8	96.1	59.5	18.2	17.1	48.7	40.6	54.3	26.8	39.6	23.0	67.9	45.2	51.4	55.1	72.7	15.2	71.1	26.4	12.0	48.7	37.7	72.4	40.0	231.7	73.7	128.5	77.9	58.3	55.3	45.0	86.9	96.2	64.4	97.1	62.3	88.9	62.8	95.1	65.4	67.4	53.5	92.1	44.5	46.4	86.0	49.3	142.5	182.4	84.1	46.1	59.8	77.3	44.3	93.1	62.3	59.6	79.3	35.9	51.5	109.6	72.5	112.1	22.4	71.4	99.3	48.7	133.5	45.6	48.4	207.5	137.6	93.6	92.7	83.0	49.1	57.4	59.3	82.9	158.6	45.1	87.6	98.8	53.1	26.8	63.5	74.0	56.2	26.1	110.3	38.2	128.9	3.0	33.1	7.9	9.9	43.4	12.1	12.1	8.0	9.1	54.2	13.9	9.7	12.9	1.4	17.5	26.3	74.5	8.5	16.9	64.8	67.8	70.5	79.3	65.3	77.5	74.9	86.9	96.1	67.9	72.7	72.4	22.3	3.2	12.9	5.2	10.4	2.5	17.3	31.8	8.0	10.5	20.7	21.5	6.4	21.5	25.2	40.5	12.5	64.3	17.1	12.4	13.7	59.3	5.0	18.9	22.1	26.0	22.9	9.7	2.8	49.4	41.1	25.0	16.8	20.1	18.3	20.2	18.5	7.1	58.7	5.0	4.5	14.1	24.4	21.6	12.2	6.2	20.2	20.9	14.2	0.0	21.8	30.7	10.3	8.0	5.5	33.6	13.6	23.0	27.2	19.5	20.5	36.0	24.6	8.3	13.1	15.3	21.4	31.5	26.7	14.3	2.6	42.5	7.0	43.9	19.7	17.2
GAA		ENSG00000171298	"Glucosidase alpha, acid"	P10253	17	80101556-80119881	"Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"		"Glycosidase, Hydrolase"	"Disease variant, FDA approved drug targets, Glycogen storage disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Cytotrophoblasts: 156.2;Extravillous trophoblasts: 143.9;Kupffer cells: 122.7;Syncytiotrophoblasts: 166.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"classical monocyte: 66.6;eosinophil: 22.8;intermediate monocyte: 50.3;myeloid DC: 39.7;neutrophil: 27.0;non-classical monocyte: 68.5"	"Group enriched"	"Detected in all"	10	"dendritic cells: 39.7;granulocytes: 27.0;monocytes: 68.5"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA026970, HPA029126"	Enhanced		Approved	Vesicles		NA	NA		3800000	"Cluster 14: Monocytes - Unknown function"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 6: T47d - Mammary gland"	"Cluster 4: Macrophages - Innate immune response"	Vesicles		"HPA026970: AB_2672065, HPA029126: AB_2672918"	"unprognostic (1.13e-1)"	"unprognostic (1.11e-1)"	"prognostic unfavorable (7.66e-4)"	"unprognostic (2.94e-2)"	"unprognostic (1.14e-2)"	"unprognostic (7.96e-2)"	"unprognostic (2.05e-2)"	"unprognostic (1.19e-1)"	"unprognostic (2.90e-1)"	"unprognostic (1.43e-1)"	"unprognostic (1.29e-2)"	"unprognostic (2.76e-1)"	"unprognostic (1.46e-1)"	"unprognostic (7.02e-2)"	"unprognostic (2.38e-1)"	"unprognostic (1.78e-2)"	"unprognostic (1.18e-1)"	31.7	29.9	16.9	22.6	20.8	16.7	30.1	19.2	26.5	25.8	17.1	29.2	24.7	31.2	35.2	15.8	29.1	29.9	35.1	18.3	24.7	37.6	47.3	44.4	22.5	28.2	21.6	18.8	37.2	33.3	38.8	48.5	26.6	33.2	8.7	6.6	37.7	23.6	47.0	25.5	26.9	14.6	21.0	54.3	26.9	56.0	26.0	20.4	32.6	25.1	7.0	31.5	22.0	31.4	35.6	67.8	13.2	43.2	40.4	40.2	85.1	21.8	39.6	16.2	13.2	20.3	56.3	12.7	56.5	17.3	13.8	14.8	4.1	25.2	3.8	16.5	49.9	0.2	12.8	73.3	69.7	1.7	40.4	86.7	35.4	30.6	10.5	32.8	28.9	33.5	12.9	51.5	12.4	81.3	6.0	8.4	27.3	8.7	46.8	30.9	44.8	22.2	13.1	36.5	15.1	43.4	28.5	31.3	39.0	8.1	89.5	50.1	18.8	59.7	31.5	43.6	8.1	121.4	36.5	3.8	19.1	32.8	38.4	0.6	66.6	22.8	3.7	50.3	4.4	3.1	2.8	3.8	39.7	3.0	3.2	2.3	27.0	3.0	68.5	9.5	2.1	32.9	16.9	20.8	19.2	26.5	18.3	24.7	28.2	21.6	26.6	21.0	26.0	31.4	21.9	19.2	41.3	31.6	9.3	11.2	19.6	38.7	8.0	16.1	24.1	28.2	19.9	24.3	24.7	14.7	8.4	156.2	11.8	11.5	5.9	25.2	55.7	14.3	16.7	21.6	6.1	4.8	16.2	15.8	143.9	33.0	20.4	27.8	8.8	28.5	23.6	26.4	99.8	11.8	18.9	10.9	12.2	122.7	29.6	29.3	23.9	83.9	24.9	20.6	39.1	32.1	8.2	11.6	12.5	9.4	13.5	19.2	12.9	20.2	31.4	21.5	9.3	18.5	6.6	15.0	13.9	66.0	29.4	10.3	8.4	166.2	8.2	30.2	14.4	14.8
GALC		ENSG00000054983	Galactosylceramidase	P54803	14	87837820-87993665	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Lipid degradation, Lipid metabolism, Sphingolipid metabolism"	"Glycosidase, Hydrolase"	"Disease variant, Leukodystrophy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"granulocytes: 68.4;Kupffer cells: 72.1;Late spermatids: 77.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"CAPAN-2: 84.3;HMC-1: 78.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB022196	Approved				"Intracellular and membrane"	NA	NA		53000	"Cluster 2: Granulocytes - Unknown function"	"Cluster 45: Intestine - Brush border"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 24: Non-specific - Transcription regulation"			"CAB022196: "	"unprognostic (1.27e-1)"	"unprognostic (1.40e-1)"	"unprognostic (1.33e-1)"	"unprognostic (1.37e-1)"	"unprognostic (2.16e-2)"	"unprognostic (9.39e-2)"	"unprognostic (3.08e-1)"	"unprognostic (9.70e-2)"	"unprognostic (1.73e-1)"	"unprognostic (6.56e-2)"	"unprognostic (8.44e-3)"	"unprognostic (8.08e-2)"	"unprognostic (1.84e-2)"	"unprognostic (6.00e-2)"	"unprognostic (2.13e-1)"	"unprognostic (6.80e-2)"	"unprognostic (2.72e-2)"	15.0	17.2	20.0	14.9	23.3	23.2	13.3	22.1	26.1	12.0	20.8	15.1	33.3	11.1	12.2	6.6	20.7	18.4	13.5	18.5	21.6	21.3	12.1	23.9	11.7	23.0	22.6	15.8	10.8	9.4	9.8	16.8	23.9	14.3	17.3	18.4	8.1	9.3	8.0	9.1	34.4	9.6	22.3	15.4	16.4	24.0	20.8	9.7	24.5	12.9	7.9	13.6	7.5	30.6	0.0	19.5	7.2	0.0	23.8	21.3	0.0	9.1	17.9	8.3	9.9	10.8	84.3	5.3	26.4	8.7	0.0	1.3	0.0	1.0	10.2	2.7	0.6	29.8	0.7	0.0	19.5	0.1	78.4	20.7	6.6	5.6	0.0	3.4	22.6	0.0	10.0	3.9	14.4	1.9	0.0	4.5	6.5	35.4	2.2	0.0	0.5	0.3	13.4	7.8	6.7	15.6	24.6	4.0	0.2	17.2	20.4	20.5	19.7	0.0	12.9	5.6	0.2	4.2	8.0	0.0	2.3	6.8	19.2	25.3	15.2	34.2	11.1	16.6	24.0	2.5	8.3	10.8	8.9	1.2	6.0	7.0	11.9	16.3	13.4	1.6	5.3	11.7	20.0	23.3	22.1	26.1	18.5	21.6	23.0	22.6	23.9	22.3	20.8	30.6	11.3	25.6	19.0	26.8	8.0	8.4	5.6	9.4	3.4	10.1	9.1	5.2	9.2	10.0	8.9	14.7	12.5	6.2	27.6	15.3	3.9	9.8	51.6	17.3	10.9	11.4	6.1	13.7	17.8	11.4	12.7	15.2	7.7	5.8	68.4	15.9	18.2	6.1	26.6	3.3	21.2	10.2	4.1	72.1	11.8	77.9	16.1	25.0	10.6	8.4	26.7	7.3	40.2	33.2	42.6	14.1	20.0	10.1	9.3	6.1	15.9	6.7	22.1	10.4	0.0	9.8	10.6	14.9	10.0	3.5	11.5	6.6	21.2	12.9	16.7	7.9
GALNS	"GALNAC6S, GAS"	ENSG00000141012	"Galactosamine (N-acetyl)-6-sulfatase"	P34059	16	88813734-88856970	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"		Hydrolase	"Disease variant, Dwarfism, Mucopolysaccharidosis"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Spermatocytes: 51.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Group enriched"	"Detected in all"	4	"dendritic cells: 11.3;granulocytes: 31.3;monocytes: 17.4"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB026404, HPA042433, HPA074225"	Supported		Approved	Cytosol	"Intracellular and membrane"	NA	NA		2000000	"Cluster 45: Eosinophils - Innate immune response"	"Cluster 42: Ciliated cells - Cilium & Cell projection"	"Cluster 18: U-2197 - ECM organization"	"Cluster 20: Spermatogonia & Spermatocytes - Spermatogenesis"	Cytosol		"CAB026404: , HPA042433: AB_2732499, HPA074225: "	"unprognostic (3.16e-1)"	"unprognostic (9.98e-2)"	"unprognostic (4.03e-3)"	"unprognostic (2.26e-1)"	"unprognostic (1.11e-1)"	"unprognostic (8.08e-3)"	"prognostic unfavorable (3.66e-4)"	"unprognostic (4.15e-3)"	"unprognostic (1.32e-1)"	"unprognostic (4.84e-3)"	"unprognostic (2.00e-1)"	"unprognostic (3.53e-2)"	"unprognostic (4.12e-3)"	"unprognostic (4.24e-2)"	"unprognostic (5.54e-2)"	"unprognostic (3.59e-2)"	"unprognostic (6.84e-2)"	9.2	12.8	9.4	9.3	10.0	22.2	6.3	10.0	11.5	9.1	22.1	10.0	10.6	7.4	14.5	8.8	11.4	9.7	11.0	10.6	12.0	8.6	8.1	10.4	7.4	12.6	16.4	6.7	5.0	8.6	11.9	8.6	12.0	7.7	6.1	3.3	8.3	4.7	6.4	8.4	10.6	7.1	10.8	9.1	8.1	26.3	11.3	4.8	9.1	3.6	5.6	9.0	9.1	12.0	5.7	42.7	6.2	43.4	47.1	22.4	41.9	17.9	27.3	19.1	14.7	22.7	36.8	7.1	37.1	29.2	28.8	33.0	9.0	14.2	11.4	4.7	13.8	4.5	17.0	13.2	31.5	3.6	28.5	31.4	26.9	21.4	6.0	27.0	16.4	7.8	9.9	4.1	11.3	33.3	9.2	15.0	14.2	14.3	19.6	19.6	5.4	12.1	11.9	13.2	15.8	12.2	42.4	4.0	21.9	14.4	27.3	32.5	31.3	41.8	31.5	43.2	10.0	4.3	4.5	12.6	45.2	29.7	25.4	1.4	17.4	31.3	4.5	12.5	3.9	3.0	2.5	4.0	11.3	1.3	2.5	3.1	21.7	4.0	9.6	4.7	4.6	8.5	9.4	10.0	10.0	11.5	10.6	12.0	12.6	16.4	12.0	10.8	11.3	12.0	4.8	16.0	4.8	9.4	5.9	6.5	7.3	27.7	9.1	5.0	6.8	5.0	8.4	4.3	11.0	3.7	6.2	9.9	8.5	16.8	3.9	5.7	21.0	27.2	9.6	7.2	12.0	1.3	7.6	3.7	14.0	13.8	6.1	8.9	1.3	11.9	7.5	6.4	18.7	25.2	10.4	6.8	8.2	13.2	6.3	37.3	7.2	11.3	7.2	2.8	18.2	8.8	14.4	4.0	9.8	5.6	13.6	6.8	9.9	6.7	17.3	5.9	35.1	10.0	6.6	9.4	9.0	51.3	42.8	6.3	5.7	15.9	7.9	16.5	10.1	6.8
GANAB	"G2AN, GIIA, GluII, KIAA0088"	ENSG00000089597	"Glucosidase II alpha subunit"	Q14697	11	62624826-62646726	"Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"		"Glycosidase, Hydrolase"	"Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA026874, HPA061426"	Enhanced		Approved	"Endoplasmic reticulum"	"Intracellular and membrane"	NA	NA		23000000	"Cluster 39: Non-specific - mRNA processing"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 55: Plasma cells - Humoral immune response"	"Endoplasmic reticulum"		"HPA026874: AB_1849745, HPA061426: AB_2684516"	"unprognostic (2.12e-1)"	"unprognostic (5.95e-3)"	"unprognostic (4.35e-2)"	"unprognostic (2.12e-1)"	"unprognostic (1.20e-2)"	"unprognostic (3.65e-2)"	"prognostic unfavorable (1.27e-5)"	"unprognostic (5.80e-3)"	"unprognostic (1.09e-1)"	"unprognostic (1.79e-1)"	"unprognostic (1.68e-3)"	"unprognostic (5.91e-2)"	"unprognostic (1.01e-3)"	"unprognostic (3.81e-2)"	"unprognostic (1.82e-2)"	"unprognostic (1.39e-1)"	"prognostic unfavorable (9.54e-4)"	93.9	73.7	31.8	88.2	34.5	83.7	92.8	36.6	36.7	112.6	51.6	104.7	95.6	102.1	151.7	66.4	106.9	75.3	67.9	31.7	41.2	98.5	171.7	86.8	81.7	38.5	34.9	115.5	88.1	130.6	21.8	141.8	38.1	97.5	116.8	79.4	101.8	111.1	39.4	74.7	90.5	126.0	36.5	86.7	85.2	66.1	39.8	105.2	132.6	53.0	94.8	90.7	34.2	43.4	298.2	245.9	318.2	552.0	464.1	389.0	332.9	312.4	480.4	436.2	362.1	222.2	515.9	201.2	616.0	572.5	337.8	376.4	375.2	376.7	443.8	155.8	191.3	202.9	317.8	125.6	389.0	325.7	248.7	397.2	248.4	433.6	475.3	533.0	422.3	199.6	278.5	352.9	398.2	313.6	167.6	193.4	262.3	236.6	237.7	209.5	368.7	513.1	285.7	230.3	168.6	221.2	451.1	308.2	370.8	321.6	380.9	304.8	311.6	430.0	272.2	342.9	309.9	360.8	423.8	152.2	473.9	173.1	421.7	23.9	19.3	19.1	23.8	23.4	23.1	15.9	17.2	20.0	20.8	14.9	20.9	21.3	8.9	29.8	22.2	18.4	17.3	22.6	31.8	34.5	36.6	36.7	31.7	41.2	38.5	34.9	38.1	36.5	39.8	43.4	42.7	12.8	20.7	17.3	29.8	28.3	29.4	45.8	13.6	31.4	57.4	53.8	7.8	52.9	24.2	68.0	60.5	81.7	33.4	40.1	5.9	47.0	18.5	31.4	59.1	42.2	31.8	25.0	12.6	42.6	137.3	45.9	27.5	46.5	11.4	72.8	48.2	98.0	57.9	35.3	16.0	48.9	34.6	45.8	25.1	16.4	58.4	32.7	35.6	15.9	38.9	36.5	38.1	11.1	16.5	39.5	29.3	68.1	50.4	34.0	47.8	27.0	26.3	41.4	32.9	36.4	34.7	25.3	47.4	21.2	31.3	80.2	25.2	63.1	56.3	32.4
GANC		ENSG00000214013	"Glucosidase alpha, neutral C"	Q8TET4	15	42273233-42356935	"Enzymes, FDA approved drug targets, Metabolic proteins, Predicted intracellular proteins"		"Glycosidase, Hydrolase"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Alveolar cells type 2: 47.9;Oligodendrocytes: 86.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			"HPA016949, HPA051522"	Approved		Approved	Cytosol		NA	NA			"Cluster 19: B-cells - Humoral immune response"	"Cluster 68: Epididymis - Unknown function"	"Cluster 32: U-937 - Innate immune response"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Cytosol		"HPA016949: AB_1849465, HPA051522: "	"unprognostic (8.83e-2)"	"unprognostic (1.68e-1)"	"unprognostic (2.24e-1)"	"unprognostic (3.04e-3)"	"unprognostic (2.51e-2)"	"unprognostic (9.85e-2)"	"unprognostic (2.49e-2)"	"prognostic favorable (9.76e-4)"	"unprognostic (1.73e-1)"	"unprognostic (1.43e-1)"	"unprognostic (1.66e-2)"	"unprognostic (1.46e-1)"	"unprognostic (1.14e-1)"	"unprognostic (1.05e-2)"	"unprognostic (3.14e-1)"	"unprognostic (1.55e-2)"	"unprognostic (3.74e-2)"	8.9	7.6	8.2	10.3	13.0	14.3	8.8	9.8	10.4	9.6	10.4	10.6	8.9	11.0	17.8	12.1	8.6	9.4	8.5	7.8	9.2	9.4	13.3	20.4	10.0	12.4	11.1	13.0	8.4	11.3	7.9	8.0	13.2	8.5	12.4	9.7	14.5	8.7	12.9	10.1	9.8	9.8	10.0	11.9	8.5	12.3	10.8	10.3	12.1	10.6	10.2	8.3	9.3	19.2	9.0	4.9	10.7	11.6	12.3	17.2	7.1	19.2	19.7	19.7	16.4	6.4	6.2	4.9	10.2	18.6	14.3	18.3	12.6	19.5	13.6	12.3	6.0	11.9	12.1	12.8	10.4	11.6	10.1	11.8	11.4	8.1	13.6	11.7	13.5	12.0	12.6	13.0	15.8	1.7	7.9	12.7	6.7	4.3	5.5	14.7	12.4	17.0	14.7	8.4	8.2	11.7	10.8	9.4	7.0	5.6	3.3	27.0	13.6	21.6	5.7	17.8	12.1	13.9	20.7	9.7	10.4	20.9	12.1	16.8	11.8	10.2	4.5	13.1	6.2	19.6	7.2	8.6	15.5	23.1	8.9	5.4	6.7	5.7	10.9	12.3	7.3	6.5	8.2	13.0	9.8	10.4	7.8	9.2	12.4	11.1	13.2	10.0	10.8	19.2	6.2	19.2	47.9	35.6	14.5	10.5	17.1	7.9	12.0	5.6	5.6	6.2	8.2	4.3	8.9	1.8	10.4	5.3	4.0	9.5	5.9	5.9	18.6	7.7	11.1	5.0	4.2	5.0	18.9	3.8	5.1	8.1	9.7	11.9	10.8	8.1	5.7	12.4	6.5	3.3	28.5	5.7	10.2	11.7	5.4	4.7	7.2	10.9	14.2	36.5	14.0	9.5	7.2	31.7	86.7	5.4	15.7	6.4	7.1	9.1	7.9	7.7	9.8	8.5	13.1	9.2	7.0	20.5	15.7	18.9	5.3	2.9	6.9	6.4	8.5	20.7
GBA	"GBA1, GLUC"	ENSG00000177628	"Glucosylceramidase beta"	P04062	1	155234452-155244699	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"Cholesterol metabolism, Lipid metabolism, Sphingolipid metabolism, Steroid metabolism, Sterol metabolism"	"Glycosidase, Glycosyltransferase, Hydrolase, Transferase"	"Disease variant, Gaucher disease, Ichthyosis, Neurodegeneration, Parkinson disease, Parkinsonism"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Hofbauer cells: 65.2;Syncytiotrophoblasts: 59.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA006667, CAB037171, CAB037289"	Supported				"Intracellular and membrane"	NA	NA		470000	"Cluster 14: Monocytes - Unknown function"	"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 10: Non-specific - Unknown function"			"CAB037171: AB_1078958, CAB037289: AB_1078957, HPA006667: AB_1078979"	"unprognostic (6.03e-2)"	"unprognostic (6.02e-2)"	"unprognostic (3.41e-1)"	"unprognostic (2.42e-1)"	"unprognostic (6.00e-3)"	"unprognostic (2.97e-1)"	"unprognostic (1.04e-3)"	"unprognostic (4.76e-2)"	"unprognostic (1.22e-1)"	"unprognostic (6.02e-2)"	"unprognostic (1.73e-1)"	"unprognostic (1.33e-1)"	"unprognostic (1.47e-1)"	"unprognostic (1.76e-1)"	"unprognostic (3.04e-2)"	"unprognostic (3.15e-1)"	"unprognostic (2.94e-2)"	23.9	37.9	22.5	24.8	24.4	41.7	25.1	25.9	24.3	26.7	27.4	35.1	23.9	22.9	50.2	27.6	20.5	28.3	19.1	26.1	27.7	33.6	33.7	28.3	19.9	27.3	28.0	16.9	33.4	103.1	43.8	39.2	36.2	23.3	39.8	12.4	26.8	33.6	9.1	33.4	22.5	29.7	25.0	29.0	22.7	8.8	29.2	19.7	37.7	13.6	28.0	27.1	21.9	29.5	38.0	72.2	25.1	34.2	254.8	55.8	29.3	65.4	230.4	95.3	119.0	43.2	135.7	26.3	70.4	153.7	152.0	76.2	35.9	46.4	50.3	55.5	25.1	21.8	45.1	23.2	73.6	25.8	87.0	73.4	38.2	199.7	30.2	100.2	85.6	22.2	23.4	42.9	113.5	82.6	32.5	11.9	16.3	61.9	51.2	26.8	41.9	108.1	63.9	29.0	23.9	33.5	57.4	136.4	145.3	45.6	102.6	63.3	65.7	71.7	31.7	91.9	53.7	86.2	78.6	20.4	126.6	23.4	56.4	21.4	36.0	15.3	20.8	35.8	13.2	11.1	15.7	13.8	22.4	7.8	11.0	11.7	28.9	11.6	37.2	12.5	23.4	23.3	22.5	24.4	25.9	24.3	26.1	27.7	27.3	28.0	36.2	25.0	29.2	29.5	6.8	3.2	5.1	3.3	8.8	6.0	5.8	9.5	4.6	4.0	12.7	6.5	8.8	17.2	8.1	12.9	2.1	30.7	6.2	36.1	3.9	30.5	1.4	12.3	9.7	12.2	14.6	7.4	3.4	32.4	27.9	18.6	20.9	17.9	7.0	7.9	17.2	23.2	65.2	5.0	2.7	11.6	4.1	33.3	9.9	2.8	9.9	26.8	26.6	1.0	22.8	11.7	12.3	0.5	3.3	29.5	15.8	9.1	19.8	6.7	28.6	20.6	8.5	6.0	0.0	9.4	21.6	22.5	12.5	8.6	4.4	59.4	8.5	6.0	10.4	6.5
GBA2	"AD035, DKFZp762K054, KIAA1605, SPG46"	ENSG00000070610	"Glucosylceramidase beta 2"	Q9HCG7	9	35736866-35749228	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"Cholesterol metabolism, Lipid metabolism, Sphingolipid metabolism, Steroid metabolism, Sterol metabolism"	"Glycosidase, Glycosyltransferase, Hydrolase, Transferase"	"Disease variant, Hereditary spastic paraplegia, Neurodegeneration"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Cone photoreceptor cells: 114.7;Rod photoreceptor cells: 102.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA024026	Approved		Approved	"Nucleoplasm,Golgi apparatus,Cytosol"		NA	NA			"Cluster 34: Basophils - Unknown function"	"Cluster 35: Non-specific - Unknown function"	"Cluster 20: HeLa - Mitochondria"	"Cluster 9: Photoreceptor cells - Phototransduction"	"Nucleoplasm, Golgi apparatus"	Cytosol	"HPA024026: AB_1849530"	"unprognostic (3.34e-2)"	"unprognostic (2.90e-1)"	"unprognostic (2.99e-1)"	"unprognostic (1.06e-2)"	"unprognostic (1.41e-1)"	"unprognostic (5.83e-3)"	"unprognostic (2.20e-2)"	"unprognostic (2.09e-2)"	"unprognostic (3.99e-2)"	"unprognostic (8.69e-2)"	"prognostic favorable (6.00e-4)"	"unprognostic (9.01e-3)"	"prognostic favorable (1.24e-11)"	"unprognostic (7.62e-3)"	"unprognostic (2.94e-1)"	"unprognostic (7.69e-2)"	"prognostic favorable (6.60e-4)"	39.3	45.7	48.5	23.2	47.5	16.3	39.9	52.8	53.7	46.4	63.3	83.5	54.2	44.6	26.9	36.3	44.2	26.3	83.3	47.2	54.2	84.4	65.9	54.1	24.6	54.1	56.2	39.8	54.1	37.2	65.5	24.7	56.1	60.2	41.0	71.1	50.0	27.7	75.8	39.3	89.7	22.9	45.1	58.5	63.9	30.8	58.9	18.3	61.7	43.7	21.6	53.0	40.9	48.7	18.1	29.3	39.6	38.4	18.8	11.4	40.0	24.1	18.8	23.9	25.0	32.8	14.1	19.3	17.1	14.7	51.5	18.4	38.2	16.2	12.0	27.5	26.2	20.8	87.8	35.6	20.8	31.2	49.4	19.8	29.8	20.3	21.1	57.9	63.4	18.9	20.7	36.0	22.6	18.0	8.5	32.0	41.2	36.6	45.7	15.5	16.0	16.3	33.3	41.9	32.2	43.0	13.5	33.3	24.5	48.1	22.8	27.8	44.6	25.8	30.9	22.4	29.9	24.2	16.5	16.0	32.3	11.3	20.5	11.1	2.9	2.0	3.8	3.9	2.5	3.7	3.7	4.7	2.8	4.7	2.2	1.9	3.2	2.4	2.5	4.4	2.8	2.2	48.5	47.5	52.8	53.7	47.2	54.2	54.1	56.2	56.1	45.1	58.9	48.7	12.7	12.8	8.0	45.1	11.2	7.4	18.2	9.4	6.2	77.5	15.0	10.8	13.7	17.2	14.5	27.6	114.7	11.1	16.6	71.7	21.5	10.5	14.1	10.0	8.1	16.0	35.8	17.2	23.5	12.0	10.2	8.0	46.4	13.8	14.0	18.7	30.7	20.1	9.2	52.2	26.4	35.8	16.2	12.8	10.7	24.3	12.5	10.7	12.4	8.4	13.3	16.2	12.3	18.1	20.2	15.1	57.6	9.8	11.7	15.8	87.4	17.8	17.9	102.9	13.1	12.2	12.2	9.2	5.7	8.8	9.9	22.2	9.4	11.3	41.4	26.3
GCH1	"DYT14, DYT5, DYT5a, GCH, GTPCH1"	ENSG00000131979	"GTP cyclohydrolase 1"	P30793	14	54842008-54902826	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"Tetrahydrobiopterin biosynthesis"	"Allosteric enzyme, Hydrolase"	"Disease variant, Dystonia, Parkinsonism, Phenylketonuria"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 31.4;liver: 36.7"	"Cell type enhanced"	"Detected in many"		"Enteroendocrine cells: 212.5;Hepatocytes: 94.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"non-classical monocyte: 11.1"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"BEWO: 23.5;Daudi: 25.0;JURKAT: 23.0;SH-SY5Y: 50.9"	"Low region specificity"	"Detected in many"			"Region enhanced"	"Detected in many"		"midbrain: 12.7"	HPA028612	Approved		Supported	"Nucleoplasm,Nuclear membrane,Cytosol"		No	No			"Cluster 51: Monocytes - Innate immune response"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 41: Macrophages - Immune response"	Nucleoplasm	"Nuclear membrane, Cytosol"	"HPA028612: AB_10602135"	"unprognostic (3.77e-2)"	"unprognostic (2.67e-3)"	"unprognostic (6.73e-2)"	"unprognostic (2.39e-1)"	"unprognostic (9.26e-2)"	"unprognostic (1.27e-1)"	"unprognostic (7.26e-2)"	"unprognostic (1.75e-1)"	"unprognostic (3.97e-1)"	"prognostic favorable (8.69e-4)"	"prognostic favorable (1.41e-4)"	"unprognostic (1.23e-1)"	"unprognostic (1.96e-2)"	"unprognostic (7.22e-3)"	"unprognostic (1.76e-2)"	"unprognostic (2.23e-1)"	"prognostic favorable (6.67e-4)"	2.4	6.0	2.1	8.1	3.0	31.4	1.8	1.1	2.0	0.4	1.5	2.4	9.4	0.4	0.2	3.5	1.2	0.4	1.9	1.9	4.8	4.6	36.7	4.1	7.0	3.5	16.1	0.5	2.6	0.9	1.8	0.3	8.4	1.5	2.4	0.1	1.7	1.0	0.4	2.2	7.5	1.1	2.4	6.9	2.8	1.2	7.8	3.8	0.8	0.2	2.0	3.3	1.4	2.0	4.7	0.6	1.3	7.1	0.0	0.0	23.5	0.0	2.0	2.4	2.9	1.4	1.0	25.0	6.9	0.2	5.8	4.0	4.9	1.5	0.1	10.9	5.2	0.6	0.3	3.1	8.4	0.0	1.9	0.3	0.7	1.2	0.1	0.0	0.7	23.0	2.8	0.0	0.0	5.0	15.1	0.3	0.4	6.5	8.2	9.6	2.8	0.0	2.9	1.6	11.6	50.9	3.3	2.4	1.6	0.4	2.9	1.5	0.3	0.1	4.0	9.9	3.8	10.5	8.4	7.8	3.1	8.4	0.0	0.0	2.6	0.2	2.8	5.3	2.1	0.7	1.0	1.5	2.8	1.9	2.5	1.3	0.3	1.8	11.1	0.1	2.1	1.2	2.1	3.0	1.1	2.0	1.9	4.8	3.5	16.1	8.4	2.4	7.8	2.0	19.2	3.2	4.8	0.7	33.4	74.6	30.9	23.6	17.6	0.0	19.4	13.2	6.5	4.3	13.6	5.5	2.1	1.9	50.9	21.8	7.9	8.7	0.5	16.8	5.8	19.8	212.5	10.1	3.8	9.4	44.3	15.3	43.8	29.3	0.0	0.3	6.8	94.6	6.1	0.0	5.9	22.7	4.1	28.0	33.3	0.6	0.3	55.8	10.6	15.9	29.5	0.7	29.9	0.5	0.8	11.0	13.6	4.9	14.4	20.5	17.1	48.6	6.9	0.4	0.0	12.5	7.5	2.2	6.7	20.8	76.1	4.2	41.8	11.9	12.2	39.0
GDA		ENSG00000119125	"Guanine deaminase"	Q9Y2T3	9	72114595-72257193	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 79.7;intestine: 94.8;kidney: 42.9;liver: 60.3"	"Cell type enhanced"	"Detected in many"		"Endometrial ciliated cells: 112.3;Excitatory neurons: 109.3;Glandular and luminal cells: 171.1;Paneth cells: 83.7;Proximal enterocytes: 321.3;Proximal tubular cells: 98.2"	"Cancer enhanced"	"Detected in many"		"renal cancer: 13.1"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A-431: 34.4;EFO-21: 127.9;HeLa: 46.4;hTCEpi: 62.3;OE19: 157.0"	"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in many"	7	"amygdala: 36.5;basal ganglia: 30.1;cerebral cortex: 60.0;hippocampal formation: 70.7;olfactory bulb: 18.3"	"HPA019352, HPA024099, HPA030387"	Enhanced		Approved	Nucleoplasm		No	NA		1500000	"Cluster 11: Basophils - Unknown function"	"Cluster 45: Intestine - Brush border"	"Cluster 21: OE19 - Mitochondria"	"Cluster 44: Endometrium - Transcription"	Nucleoplasm		"HPA019352: AB_1855593, HPA024099: AB_1855594, HPA030387: AB_10602351"	"unprognostic (2.64e-2)"	"unprognostic (7.10e-2)"	"unprognostic (2.83e-2)"	"unprognostic (2.92e-1)"	"unprognostic (4.35e-2)"	"unprognostic (8.45e-2)"	"unprognostic (2.00e-1)"	"unprognostic (5.60e-2)"	"unprognostic (3.26e-1)"	"unprognostic (1.32e-1)"	"unprognostic (1.55e-1)"	"unprognostic (5.56e-2)"	"prognostic favorable (2.66e-5)"	"unprognostic (2.23e-1)"	"unprognostic (6.70e-2)"	"unprognostic (2.77e-1)"	"unprognostic (8.30e-4)"	0.3	2.7	57.0	1.2	66.9	0.4	0.2	19.8	79.7	1.6	23.2	10.4	94.3	3.7	0.4	0.4	8.5	15.9	0.1	62.3	52.3	42.9	60.3	0.2	0.4	19.9	26.1	0.2	2.7	8.5	2.8	2.9	25.8	0.1	9.9	0.1	0.0	6.7	1.6	2.2	94.8	0.4	20.5	0.1	3.4	1.2	60.5	0.6	0.1	0.4	4.7	4.0	0.2	42.3	34.4	4.5	0.1	0.1	0.0	0.0	0.8	0.3	24.9	0.0	0.0	3.2	19.3	0.0	127.9	0.0	0.2	2.9	0.2	0.0	0.0	0.4	0.1	0.0	46.4	0.2	0.0	0.1	0.1	0.2	62.3	0.0	0.6	0.1	0.0	0.0	9.6	0.1	0.0	0.2	0.2	0.3	0.2	157.0	0.0	0.0	0.1	1.1	1.1	7.9	0.2	0.6	2.5	0.1	0.1	0.2	0.1	0.2	0.6	0.2	0.4	0.2	0.1	0.3	0.2	0.3	0.1	0.3	0.1	0.8	0.1	0.0	0.2	0.1	0.0	0.1	0.1	0.1	0.0	0.3	0.1	0.2	0.4	0.3	0.1	0.1	0.1	0.0	57.0	66.9	19.8	79.7	62.3	52.3	19.9	26.1	25.8	20.5	60.5	42.3	0.0	0.0	0.5	3.9	1.9	0.0	0.7	19.0	0.0	0.0	0.0	0.0	0.8	14.3	24.7	0.0	0.0	0.2	0.0	65.5	3.9	11.7	1.2	112.3	7.4	0.4	4.8	0.0	109.3	10.7	1.9	0.3	12.2	171.1	0.0	0.0	1.1	56.9	0.2	0.0	22.8	22.1	2.0	1.9	0.4	0.6	0.3	1.2	0.0	5.6	0.6	0.0	0.0	5.0	3.8	6.7	83.7	0.0	0.1	0.8	321.3	98.2	58.6	0.0	0.0	0.8	3.0	1.4	4.7	0.0	0.1	1.9	1.2	0.2	16.1	2.2
GDE1	MIR16	ENSG00000006007	"Glycerophosphodiester phosphodiesterase 1"	Q9NZC3	16	19501693-19522123	"Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins"		Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Syncytiotrophoblasts: 270.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA077420			Approved	"Nucleoplasm,Vesicles,Plasma membrane"		NA	NA			"Cluster 38: Basophils - Unknown function"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 18: Syncytiotrophoblasts - Pregnancy hormone signaling"	Vesicles	"Nucleoplasm, Plasma membrane"	"HPA077420: "	"unprognostic (1.69e-1)"	"unprognostic (5.13e-2)"	"prognostic favorable (3.12e-4)"	"unprognostic (1.47e-1)"	"unprognostic (1.83e-1)"	"unprognostic (4.10e-3)"	"prognostic unfavorable (7.52e-5)"	"unprognostic (2.10e-2)"	"unprognostic (1.40e-2)"	"unprognostic (4.31e-2)"	"unprognostic (2.60e-3)"	"unprognostic (9.92e-2)"	"prognostic favorable (3.12e-5)"	"unprognostic (8.36e-2)"	"unprognostic (9.69e-3)"	"unprognostic (1.88e-1)"	"unprognostic (3.36e-2)"	28.9	25.9	42.9	15.6	46.3	27.8	21.1	42.9	49.9	21.9	40.4	44.9	30.0	20.0	27.5	22.4	16.9	18.4	52.8	45.7	45.5	27.6	25.4	29.3	11.7	44.5	47.7	12.8	28.5	76.8	19.2	20.5	43.3	26.7	41.6	19.8	28.3	30.3	62.9	26.4	27.7	26.5	42.8	13.5	34.3	14.1	48.8	16.8	20.3	64.4	15.3	30.2	16.6	47.4	38.6	46.2	25.0	29.4	115.3	43.3	34.7	38.3	66.9	30.0	37.1	26.6	67.4	29.2	48.1	57.2	32.8	31.8	35.2	46.6	36.9	31.7	52.8	24.2	41.4	57.2	69.1	32.7	21.5	44.9	73.1	32.2	37.4	54.5	40.6	36.3	13.7	29.1	33.2	70.3	28.3	29.1	29.1	59.9	34.2	40.2	45.7	41.7	72.9	59.7	28.9	25.8	37.0	44.5	37.9	38.5	45.8	37.8	42.7	25.3	22.3	33.9	24.6	27.0	27.4	19.9	38.5	47.2	23.1	52.0	19.3	11.2	8.9	17.7	11.5	7.2	10.4	10.4	12.4	6.1	5.5	8.5	34.0	6.6	22.7	7.5	12.7	8.2	42.9	46.3	42.9	49.9	45.7	45.5	44.5	47.7	43.3	42.8	48.8	47.4	12.2	38.5	86.8	7.2	18.9	23.5	30.3	56.2	22.8	15.4	38.3	22.4	66.8	34.3	56.0	9.2	27.1	80.4	23.2	123.1	23.5	97.0	35.1	26.9	23.8	17.7	33.5	100.8	12.0	163.9	78.6	27.3	24.5	21.5	3.8	36.4	20.7	23.9	60.8	32.0	15.9	57.5	61.1	48.2	22.9	61.2	28.6	32.3	24.9	8.4	38.2	22.3	24.7	9.5	25.0	77.4	97.6	38.0	19.6	100.5	101.7	45.9	39.7	29.6	13.1	16.7	24.9	87.1	59.6	31.9	29.5	270.4	22.0	45.9	85.3	79.2
GDPD2	"FLJ20207, GDE3, OBDPF"	ENSG00000130055	"Glycerophosphodiester phosphodiesterase domain containing 2"	Q9HCC8	X	70423031-70433390	"Enzymes, Metabolic proteins, Predicted membrane proteins"		Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"intestine: 20.8;lymphoid tissue: 59.2;skin 1: 47.8"	"Group enriched"	"Detected in some"	4	"Basal keratinocytes: 56.7;Distal enterocytes: 30.4;Muller glia cells: 29.9;Proximal enterocytes: 92.2"	"Cancer enhanced"	"Detected in many"		"glioma: 10.8"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	7	"AF22: 9.2;NTERA-2: 19.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"									NA	NA				"Cluster 27: Brain & Skin - Unknown function"	"Cluster 5: NTERA-2 - Transcription"	"Cluster 45: Enterocytes - Digestion"				"unprognostic (1.53e-3)"	"unprognostic (5.79e-2)"	"unprognostic (5.37e-2)"	"unprognostic (5.00e-7)"	"unprognostic (3.15e-3)"	"unprognostic (3.65e-2)"	"unprognostic (2.86e-2)"	"unprognostic (4.66e-2)"	"unprognostic (1.19e-1)"	"unprognostic (8.40e-2)"	"unprognostic (8.45e-2)"	"unprognostic (1.06e-1)"	"unprognostic (1.35e-2)"	"unprognostic (5.41e-2)"	"unprognostic (5.52e-2)"	"unprognostic (2.22e-1)"	"unprognostic (8.91e-2)"	0.0	0.0	10.4	0.5	9.8	0.1	0.9	7.6	10.3	0.0	8.9	4.8	11.1	0.0	4.9	0.2	0.2	0.2	0.7	8.5	11.0	0.5	0.0	0.0	0.0	9.4	14.4	0.1	0.0	0.0	3.2	0.1	10.4	0.0	3.9	3.6	1.0	0.3	0.5	47.8	20.8	0.1	9.0	59.2	1.8	0.0	12.4	0.0	0.0	0.0	0.0	0.7	0.1	10.8	0.0	0.0	9.2	0.0	0.0	0.0	1.8	0.1	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.1	2.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.3	0.0	0.2	19.8	0.7	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.1	0.1	0.0	0.0	0.6	0.0	0.0	0.2	0.1	0.1	0.0	0.0	0.1	0.2	0.0	0.2	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	10.4	9.8	7.6	10.3	8.5	11.0	9.4	14.4	10.4	9.0	12.4	10.8	0.0	0.0	0.0	12.7	0.0	56.7	0.0	0.6	0.0	0.2	0.0	0.0	1.9	0.0	0.2	0.0	0.0	7.0	0.0	30.4	0.0	0.0	0.0	0.3	0.0	0.2	1.2	0.0	0.0	0.0	3.5	0.2	3.1	0.4	0.0	0.0	0.0	0.0	0.4	0.0	0.1	3.7	0.0	0.0	2.5	0.0	0.0	0.0	0.0	0.0	0.0	29.9	0.0	0.0	0.1	0.1	2.3	0.0	0.0	0.0	92.2	0.0	0.1	0.9	0.0	0.0	0.1	0.0	0.0	0.0	12.1	3.3	0.2	0.0	3.1	0.2
GDPD5	"GDE2, PP1665"	ENSG00000158555	"Glycerophosphodiester phosphodiesterase domain containing 5"	Q8WTR4	11	75434640-75525941	"Enzymes, Predicted membrane proteins"	Neurogenesis	Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 116.6;retina: 83.5"	"Group enriched"	"Detected in many"	4	"Bipolar cells: 60.9;Cone photoreceptor cells: 148.0;Early spermatids: 52.1;Late spermatids: 178.0;Rod photoreceptor cells: 88.4;Syncytiotrophoblasts: 46.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"basophil: 7.7"	"Group enriched"	"Detected in many"	6	"granulocytes: 7.7;T-cells: 2.0"	"Cell line enhanced"	"Detected in many"		"EFO-21: 32.8;fHDF/TERT166: 32.4;HDLM-2: 66.9;U-2 OS: 30.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA065257, HPA066762, HPA069281"	Uncertain		Approved	"Golgi apparatus"		No	No			"Cluster 38: Basophils - Unknown function"	"Cluster 77: Retina - Visual perception"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 9: Photoreceptor cells - Phototransduction"	"Golgi apparatus"		"HPA065257: AB_2685447, HPA066762: AB_2685715, HPA069281: AB_2686107"	"unprognostic (1.66e-1)"	"unprognostic (1.09e-1)"	"unprognostic (2.37e-1)"	"prognostic unfavorable (1.29e-4)"	"unprognostic (1.48e-1)"	"unprognostic (6.12e-2)"	"unprognostic (9.97e-3)"	"unprognostic (4.05e-1)"	"unprognostic (1.44e-1)"	"unprognostic (3.49e-1)"	"unprognostic (3.07e-2)"	"unprognostic (1.19e-1)"	"prognostic unfavorable (6.59e-9)"	"unprognostic (8.64e-2)"	"unprognostic (1.30e-1)"	"unprognostic (4.39e-2)"	"unprognostic (1.65e-1)"	31.0	8.7	19.5	4.8	22.1	12.8	24.6	17.4	12.9	12.4	6.0	7.3	2.7	17.9	1.8	3.3	10.3	4.3	9.5	10.5	14.5	7.8	8.1	15.2	6.7	14.2	27.0	7.3	38.1	0.8	19.1	14.0	10.2	11.5	1.6	83.5	21.3	5.3	13.1	7.4	10.0	6.5	7.4	116.6	4.8	38.9	42.1	3.1	7.7	8.7	4.7	12.6	9.9	12.4	2.1	7.5	3.2	3.7	2.2	1.1	11.1	2.3	3.1	1.1	0.7	10.0	4.4	14.2	32.8	32.4	8.1	4.7	4.0	3.8	0.6	66.9	3.1	2.6	11.7	21.2	3.2	1.6	10.7	2.4	2.0	0.8	1.6	3.2	26.7	12.7	4.7	6.3	1.5	4.5	3.9	7.1	5.7	3.7	10.6	4.5	0.9	3.9	0.9	3.6	1.7	1.2	4.8	18.3	9.3	4.1	2.7	6.3	7.9	7.5	30.4	5.8	2.6	1.6	0.3	2.8	1.7	8.5	0.8	7.7	0.8	0.5	1.2	0.3	1.7	0.6	1.3	0.9	0.2	0.2	0.7	0.9	0.1	0.0	0.0	0.7	2.0	0.5	19.5	22.1	17.4	12.9	10.5	14.5	14.2	27.0	10.2	7.4	42.1	12.4	4.2	6.4	0.0	1.6	5.4	1.0	0.3	0.7	0.6	60.9	3.6	3.4	3.0	1.5	1.3	0.0	148.0	3.2	9.1	0.5	0.0	4.2	52.1	1.0	10.4	7.0	0.0	8.2	5.0	9.3	1.5	6.6	1.1	1.5	4.5	1.6	20.7	2.4	1.9	5.0	15.8	0.7	0.0	2.8	3.7	178.0	5.9	3.1	5.4	8.4	4.9	8.9	1.0	1.0	0.8	4.7	0.3	2.6	5.0	0.8	0.3	0.1	0.8	88.4	0.0	4.6	1.9	12.9	8.2	0.1	1.1	46.0	7.0	0.9	2.0	0.6
GGH		ENSG00000137563	"Gamma-glutamyl hydrolase"	Q92820	8	63014881-63039407	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"kidney: 125.7;liver: 188.6"	"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 510.3;Early spermatids: 471.0;Extravillous trophoblasts: 273.4;Proximal tubular cells: 340.8;Syncytiotrophoblasts: 754.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in many"	5	"plasmacytoid DC: 30.6"	"Lineage enriched"	"Detected in all"	5	"dendritic cells: 30.6"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB019296, HPA025226"	Approved				"Intracellular and membrane"	NA	NA		1200000000	"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 81: Kidney & Liver - Metabolism"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"			"CAB019296: , HPA025226: AB_1849645"	"unprognostic (9.29e-2)"	"unprognostic (1.22e-1)"	"unprognostic (5.48e-3)"	"prognostic unfavorable (3.99e-7)"	"unprognostic (5.57e-2)"	"unprognostic (1.08e-1)"	"unprognostic (1.14e-1)"	"prognostic unfavorable (1.65e-4)"	"unprognostic (1.95e-2)"	"unprognostic (1.60e-1)"	"unprognostic (2.11e-2)"	"unprognostic (1.32e-1)"	"unprognostic (1.69e-2)"	"unprognostic (9.62e-3)"	"unprognostic (1.50e-1)"	"unprognostic (2.36e-1)"	"unprognostic (6.50e-2)"	9.8	5.4	11.1	14.2	11.1	43.7	16.5	10.7	14.3	5.9	13.1	54.3	11.3	6.3	4.4	20.7	3.5	4.3	3.1	11.1	12.3	125.7	188.6	8.0	10.9	13.3	11.1	3.1	9.9	13.1	1.9	54.9	13.7	4.4	74.4	2.1	13.0	3.7	2.1	27.2	9.9	11.6	10.1	5.5	8.2	33.9	14.4	17.8	2.4	3.2	22.5	8.5	10.8	11.1	110.5	97.6	97.4	15.7	94.1	39.6	69.6	64.3	105.1	94.2	137.7	144.5	183.8	69.8	18.0	77.1	166.8	87.2	97.2	101.9	138.9	139.0	71.6	112.3	50.3	105.1	17.6	53.5	65.9	29.1	29.2	93.9	50.7	59.4	116.1	66.9	62.4	255.2	177.3	64.3	28.8	71.1	51.0	231.6	86.0	77.6	95.2	98.1	75.8	40.3	38.6	69.9	91.8	103.6	98.5	91.6	116.6	65.8	65.5	104.2	115.6	99.4	111.3	112.6	127.2	88.3	158.0	0.1	185.0	0.0	2.1	2.3	1.1	1.7	0.8	6.5	1.5	1.7	0.9	2.7	1.8	1.9	3.0	4.4	2.0	30.6	2.7	1.9	11.1	11.1	10.7	14.3	11.1	12.3	13.3	11.1	13.7	10.1	14.4	11.1	13.1	16.0	7.3	11.1	26.1	30.2	23.2	66.6	9.1	2.0	14.9	21.0	3.2	17.2	31.1	22.0	0.0	510.3	11.7	49.2	37.2	19.7	471.0	5.4	11.5	13.1	13.2	62.5	11.5	7.4	273.4	27.2	11.7	7.6	10.8	21.4	13.6	219.5	72.4	0.0	8.7	70.7	44.7	21.0	15.5	154.2	5.9	12.0	24.9	1.0	32.1	23.1	2.1	3.5	2.9	4.3	23.7	8.2	106.9	10.5	4.3	340.8	18.3	1.3	26.3	12.8	20.4	80.3	133.0	35.9	43.0	754.5	8.5	9.3	102.0	23.1
GGT1	"CD224, D22S672, D22S732, GGT"	ENSG00000100031	"Gamma-glutamyltransferase 1"	P19440	22	24594811-24629005	"Candidate cardiovascular disease genes, CD markers, Disease related genes, Enzymes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Glutathione biosynthesis, Lipid metabolism"	"Acyltransferase, Hydrolase, Protease, Transferase"	"Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"kidney: 174.8;liver: 115.7"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 80.1;Cholangiocytes: 48.6;Distal enterocytes: 54.1;Ductal cells: 82.6;Hepatocytes: 40.8;Proximal enterocytes: 111.7;Proximal tubular cells: 62.9"	"Cancer enhanced"	"Detected in all"		"renal cancer: 37.2"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HDLM-2: 103.6;Karpas-707: 165.8;OE19: 169.5;RPMI-8226: 210.3;RPTEC TERT1: 203.2"									"HPA045635, HPA047534, HPA065444"	Supported		Uncertain	Vesicles	"Intracellular and membrane"	NA	NA		3600000	"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 87: Intestine & Kidney - Transmembrane transport"	"Cluster 21: OE19 - Mitochondria"	"Cluster 45: Enterocytes - Digestion"	Vesicles		"HPA045635: AB_2679400, HPA047534: AB_2680079, HPA065444: AB_2685491"	"unprognostic (8.13e-3)"	"unprognostic (4.76e-1)"	"unprognostic (8.29e-2)"	"unprognostic (1.28e-2)"	"unprognostic (3.70e-2)"	"unprognostic (1.43e-2)"	"unprognostic (5.60e-3)"	"unprognostic (1.68e-1)"	"unprognostic (2.21e-1)"	"prognostic favorable (7.44e-4)"	"unprognostic (4.55e-2)"	"unprognostic (2.55e-2)"	"prognostic favorable (4.83e-4)"	"unprognostic (1.44e-2)"	"unprognostic (5.37e-2)"	"unprognostic (1.74e-1)"	"unprognostic (6.10e-2)"	3.3	2.4	5.5	6.4	6.7	12.0	24.7	7.0	7.5	28.7	5.1	20.3	84.7	3.0	72.0	3.3	3.3	47.1	7.2	5.1	5.1	174.8	115.7	42.6	5.4	7.2	6.6	3.2	63.1	0.2	5.5	2.4	7.8	48.8	11.0	1.6	9.9	21.6	1.9	4.1	80.4	2.2	5.9	13.3	31.3	18.4	7.1	6.5	15.9	0.4	6.2	5.7	4.3	9.2	1.0	79.7	1.0	0.3	0.0	0.5	2.2	0.5	1.7	0.8	1.0	11.7	18.3	1.0	16.2	0.1	14.8	11.0	6.2	0.8	0.5	103.6	12.3	0.6	40.8	64.3	5.5	1.5	33.2	2.1	0.9	2.5	1.7	1.4	0.5	19.0	8.4	165.8	1.0	1.7	1.6	52.4	6.4	169.5	0.7	0.7	6.8	210.3	203.2	2.9	0.5	1.2	0.4	33.3	0.8	22.2	32.4	39.6	6.4	10.6	9.3	46.6	0.9	48.2	18.4	0.7	19.0	58.7	0.5	4.8	12.3	0.2	1.0	6.0	2.9	2.2	5.0	2.4	6.5	0.2	0.6	1.4	15.9	4.9	4.0	0.1	6.5	5.6	5.5	6.7	7.0	7.5	5.1	5.1	7.2	6.6	7.8	5.9	7.1	9.2	0.2	80.1	22.8	3.3	2.8	0.8	0.1	0.3	4.6	0.5	5.9	2.3	0.7	48.6	4.9	1.8	0.0	1.4	0.7	54.1	1.9	82.6	1.8	1.2	0.6	0.7	1.2	5.3	4.4	8.1	0.4	3.9	15.3	5.1	5.7	0.1	1.8	40.8	4.9	0.0	4.1	4.4	4.1	2.5	1.7	6.7	0.0	2.9	1.8	1.0	5.8	2.5	0.0	1.5	5.7	20.9	20.1	0.4	12.8	2.0	111.7	62.9	1.6	0.1	0.0	0.1	1.0	0.6	0.8	0.4	0.4	0.8	4.0	0.0	6.5	0.1
GGT5	"GGT-REL, GGTLA1"	ENSG00000099998	"Gamma-glutamyltransferase 5"	P36269	22	24219654-24245108	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Glutathione biosynthesis, Leukotriene biosynthesis"	"Acyltransferase, Hydrolase, Protease, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Endothelial cells: 42.8;Fibroblasts: 58.3;Leydig cells: 36.4;Sertoli cells: 184.1;Smooth muscle cells: 85.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"basophil: 2.3;eosinophil: 4.5"	"Lineage enriched"	"Detected in single"	8	"granulocytes: 4.5"	"Cell line enhanced"	"Detected in many"		"ASC diff: 164.9;ASC TERT1: 124.4;HHSteC: 234.7;HSkMC: 271.7;TIME: 110.8"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA008121, CAB032489"	Uncertain		Approved	"Nucleoli fibrillar center"	"Intracellular and membrane"	NA	NA		22000000	"Cluster 52: Eosinophils - Transcription"	"Cluster 72: Non-specific - Transcription"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 48: Smooth muscle cells - ECM organization"	"Nucleoli fibrillar center"		"CAB032489: AB_2111010, HPA008121: AB_1078965"	"unprognostic (8.14e-2)"	"unprognostic (2.53e-1)"	"unprognostic (5.66e-2)"	"unprognostic (9.94e-2)"	"unprognostic (8.13e-2)"	"unprognostic (8.21e-2)"	"unprognostic (2.33e-2)"	"unprognostic (2.90e-1)"	"unprognostic (1.81e-2)"	"unprognostic (1.07e-1)"	"unprognostic (8.37e-2)"	"unprognostic (7.94e-2)"	"prognostic unfavorable (6.36e-5)"	"prognostic unfavorable (4.06e-4)"	"prognostic unfavorable (6.97e-4)"	"unprognostic (1.79e-1)"	"unprognostic (8.33e-2)"	137.6	60.5	39.0	18.6	39.3	1.4	90.6	37.6	41.7	73.2	32.8	27.8	19.4	54.4	12.9	19.6	70.6	37.2	93.4	35.0	45.1	78.2	55.2	37.7	48.0	52.2	46.3	26.6	25.8	13.2	41.1	11.9	46.9	49.3	12.0	2.1	37.1	20.9	23.1	40.1	40.8	32.2	41.9	36.1	40.0	9.6	45.3	10.4	110.2	16.6	18.3	45.1	64.2	38.2	0.0	1.8	0.6	0.0	164.9	124.4	1.1	2.9	0.2	0.1	0.0	0.1	0.1	0.2	3.4	0.2	0.3	0.3	0.1	0.1	0.0	2.2	0.9	6.7	1.0	24.1	234.7	3.0	6.4	271.7	0.1	3.4	3.2	0.4	45.8	0.7	0.4	1.2	44.1	0.4	0.0	22.4	3.6	1.1	0.0	0.1	4.0	1.0	6.1	0.0	0.4	5.9	0.1	7.3	0.1	22.7	1.0	1.7	110.8	0.1	2.3	0.1	0.0	0.3	1.5	0.2	3.9	5.7	0.2	2.3	0.5	4.5	0.0	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	1.1	0.4	0.0	0.0	0.0	0.2	39.0	39.3	37.6	41.7	35.0	45.1	52.2	46.3	46.9	41.9	45.3	38.2	27.2	3.2	16.0	1.0	0.3	7.0	3.3	3.2	0.0	0.0	7.2	4.2	4.4	0.0	17.9	0.0	0.0	0.2	0.4	0.0	0.0	0.6	0.8	0.3	8.3	42.8	0.0	2.7	0.1	0.2	0.2	58.3	1.1	0.4	1.3	0.0	33.5	0.1	2.1	0.0	0.1	0.0	0.0	1.0	12.5	3.3	36.4	1.8	3.6	22.5	3.3	0.3	0.0	0.5	0.0	0.4	0.0	23.7	0.3	2.2	0.0	0.1	2.2	1.0	184.1	33.9	85.6	0.6	0.4	0.3	4.4	0.3	1.1	2.1	0.0	1.4
GGT6	FLJ90165	ENSG00000167741	"Gamma-glutamyltransferase 6"	Q6P531	17	4556927-4560818	"Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Glutathione biosynthesis"	"Acyltransferase, Hydrolase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 53.8;intestine: 53.4;salivary gland: 55.8;skin 1: 56.2"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 208.5;Intestinal goblet cells: 69.4;Paneth cells: 135.8;Proximal enterocytes: 130.9;Undifferentiated cells: 86.1"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	7	"RT4: 58.5;SK-BR-3: 19.4;T-47d: 60.5"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA023362, HPA027213"	Approved					NA	NA		72000	"Cluster 6: Non-specific - Transcription"	"Cluster 24: Salivary gland - Salivary secretion"	"Cluster 6: T47d - Mammary gland"	"Cluster 53: Intestinal epithelial cells - Unknown function"			"HPA023362: AB_1848955, HPA027213: AB_10601326"	"unprognostic (2.23e-2)"	"unprognostic (1.20e-2)"	"unprognostic (2.14e-3)"	"unprognostic (4.51e-2)"	"unprognostic (9.71e-2)"	"unprognostic (7.67e-3)"	"unprognostic (1.29e-1)"	"prognostic favorable (4.35e-4)"	"unprognostic (2.10e-1)"	"unprognostic (2.33e-1)"	"unprognostic (3.07e-2)"	"unprognostic (5.06e-2)"	"prognostic favorable (9.42e-7)"	"unprognostic (1.56e-1)"	"unprognostic (5.71e-2)"	"unprognostic (9.17e-2)"	"unprognostic (8.07e-3)"	0.3	0.6	0.4	5.0	0.5	0.2	9.0	0.7	0.7	7.9	0.4	53.4	44.5	0.4	41.1	53.8	8.5	5.3	0.0	0.5	0.3	39.2	0.4	3.5	0.0	0.5	0.4	0.5	46.8	0.0	0.5	0.0	0.5	6.5	34.0	0.1	55.8	6.4	0.4	56.2	38.4	0.8	0.2	0.1	23.7	0.7	0.4	0.7	0.2	0.0	9.0	18.4	18.8	0.9	3.6	0.0	0.0	0.1	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	1.8	0.0	0.1	0.0	1.3	0.0	0.0	0.1	0.9	0.0	0.0	0.1	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.0	6.3	0.1	0.4	0.0	0.0	0.0	0.1	0.0	0.4	0.0	58.5	0.2	0.2	0.0	19.4	0.0	0.0	60.5	0.0	0.0	0.1	0.0	0.2	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.1	0.1	0.1	0.1	0.0	0.4	0.5	0.7	0.7	0.5	0.3	0.5	0.4	0.5	0.2	0.4	0.9	0.1	35.3	6.9	0.0	1.1	4.1	14.7	12.5	5.2	0.0	17.9	11.0	0.2	20.0	38.0	23.9	2.1	0.0	0.3	208.5	21.5	23.8	0.1	7.4	0.3	0.5	6.0	0.0	0.0	38.2	0.0	0.9	24.5	2.6	0.0	0.1	0.4	0.0	0.1	0.0	0.0	69.4	12.2	0.0	1.8	0.2	0.6	0.6	0.0	0.0	2.0	0.1	0.0	0.0	0.0	10.6	135.8	0.0	0.0	5.5	130.9	39.5	45.9	0.3	0.0	0.4	2.3	0.0	0.1	30.6	20.9	0.0	1.0	0.0	86.1	26.7
GGT7	"D20S101, dJ18C9.2, GGTL3, GGTL5"	ENSG00000131067	"Gamma-glutamyltransferase 7"	Q9UJ14	20	34844720-34872856	"Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Glutathione biosynthesis"	"Acyltransferase, Hydrolase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 60.9;Inhibitory neurons: 58.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA013204, HPA013339"	Approved		Approved	Nucleoplasm,Vesicles		NA	NA		1900000	"Cluster 30: Non-specific - Translation"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Vesicles	Nucleoplasm	"HPA013204: AB_1850347, HPA013339: AB_2668816"	"unprognostic (1.32e-3)"	"unprognostic (2.33e-1)"	"unprognostic (9.31e-2)"	"prognostic unfavorable (1.26e-5)"	"unprognostic (1.27e-1)"	"unprognostic (6.55e-2)"	"unprognostic (1.46e-3)"	"unprognostic (2.49e-2)"	"unprognostic (3.49e-1)"	"unprognostic (1.16e-2)"	"unprognostic (3.34e-3)"	"unprognostic (3.61e-2)"	"unprognostic (5.00e-3)"	"unprognostic (1.81e-1)"	"unprognostic (1.63e-1)"	"unprognostic (5.50e-2)"	"unprognostic (2.00e-1)"	13.2	13.8	37.0	11.8	35.8	5.5	15.4	43.4	43.8	25.6	53.2	19.1	16.0	19.3	29.1	10.1	21.1	18.2	22.3	38.6	33.3	24.9	16.8	14.4	18.2	34.3	28.9	24.1	27.1	22.9	40.5	13.7	33.6	24.8	14.9	22.7	30.8	22.6	67.5	17.9	20.1	14.9	22.5	15.4	22.1	10.1	32.0	15.8	28.8	13.8	13.6	19.7	18.0	35.4	5.2	7.7	38.5	39.5	29.7	26.4	34.2	21.7	21.9	17.5	26.0	40.6	25.5	0.0	25.1	17.1	17.8	3.6	16.8	9.5	11.5	1.8	29.9	15.9	16.0	21.3	26.5	0.8	24.9	38.5	10.6	19.7	9.1	52.2	1.5	20.3	12.0	2.8	12.2	9.1	4.2	8.1	8.9	9.1	3.8	0.1	26.3	25.9	25.3	7.7	22.4	26.1	11.2	17.6	28.2	14.4	13.5	14.2	0.6	59.8	23.6	5.7	12.6	29.6	4.2	1.9	70.4	1.5	22.4	1.4	2.8	1.5	6.9	2.0	2.0	6.1	5.8	2.6	2.5	5.4	11.5	8.2	0.3	3.0	0.7	1.4	5.1	1.8	37.0	35.8	43.4	43.8	38.6	33.3	34.3	28.9	33.6	22.5	32.0	35.4	2.0	3.2	2.7	23.2	6.4	7.4	18.1	14.8	9.1	40.2	9.6	5.8	1.9	32.9	11.1	18.4	12.5	24.2	2.2	14.2	0.0	16.1	3.2	3.3	7.6	2.1	10.8	1.7	60.9	5.6	12.3	14.0	23.4	4.5	2.5	9.0	1.4	12.1	4.5	40.4	58.0	15.2	38.7	3.2	4.4	1.8	12.5	3.2	10.6	17.8	2.8	9.7	4.1	31.2	25.5	6.3	17.8	7.9	1.9	9.3	11.9	6.1	7.2	19.3	6.6	16.0	9.4	13.9	15.5	5.7	4.3	16.8	7.2	17.0	17.9	13.9
GLA	GALA	ENSG00000102393	"Galactosidase alpha"	P06280	X	101393273-101408012	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"		"Glycosidase, Hydrolase"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Langerhans cells: 229.9;Plasma cells: 171.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HMC-1: 328.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA000237, HPA000966"	Enhanced				"Intracellular and membrane"	NA	NA		1300000	"Cluster 7: Monocytes - Unknown function"	"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 7: Non-specific - Mitochondria"			"HPA000237: AB_1078968, HPA000966: AB_1078969"	"unprognostic (7.27e-3)"	"unprognostic (1.47e-2)"	"unprognostic (1.57e-2)"	"unprognostic (2.94e-1)"	"unprognostic (1.60e-1)"	"unprognostic (3.15e-2)"	"prognostic unfavorable (5.62e-5)"	"unprognostic (2.53e-1)"	"unprognostic (3.42e-1)"	"unprognostic (1.89e-1)"	"unprognostic (2.97e-2)"	"unprognostic (3.27e-2)"	"unprognostic (2.73e-2)"	"prognostic favorable (6.16e-4)"	"unprognostic (1.13e-1)"	"unprognostic (5.44e-2)"	"unprognostic (2.21e-1)"	15.6	21.5	5.2	12.7	5.4	25.1	26.7	6.6	6.9	13.8	6.2	13.0	22.4	10.9	17.5	9.3	15.2	11.8	9.9	5.6	6.2	15.6	12.7	17.2	13.2	7.0	7.3	9.2	6.7	31.7	9.9	22.1	7.3	7.9	15.3	6.9	10.0	39.3	6.2	9.2	13.5	15.4	6.5	13.2	9.3	3.8	6.9	12.0	7.9	6.5	15.6	14.7	9.1	8.1	30.5	117.9	30.8	31.9	68.9	26.8	13.8	34.1	51.9	63.5	176.3	64.7	45.9	33.6	70.0	35.3	151.8	70.3	65.9	38.3	53.8	19.3	47.1	18.3	87.9	78.4	19.2	26.7	328.1	24.3	11.3	72.9	21.6	17.4	50.9	18.2	28.6	71.2	60.8	52.3	24.4	53.7	48.2	72.5	46.4	18.2	39.5	81.5	95.1	61.9	11.5	19.4	78.6	34.6	30.9	54.4	15.2	51.2	29.9	20.7	23.8	52.6	27.0	23.0	26.3	25.4	36.9	39.9	23.1	22.5	37.3	11.9	6.9	38.5	9.0	8.8	5.6	8.8	29.8	9.0	5.6	6.9	21.6	5.6	40.6	10.9	7.3	20.4	5.2	5.4	6.6	6.9	5.6	6.2	7.0	7.3	7.3	6.5	6.9	8.1	31.5	16.0	10.2	3.3	65.8	30.2	32.6	23.7	45.5	4.0	34.0	23.2	7.7	4.3	19.3	11.0	6.2	38.4	25.5	26.5	17.6	22.5	3.9	57.6	19.5	30.8	33.9	12.6	3.2	18.7	26.3	66.1	39.8	97.6	31.0	9.6	8.9	7.1	93.0	8.4	3.9	15.9	20.3	28.5	229.9	0.9	11.1	115.7	88.9	4.7	30.3	17.5	14.4	3.0	3.9	14.4	25.3	18.0	171.4	20.5	30.9	9.5	29.9	5.3	6.6	22.6	70.8	6.4	5.8	31.0	23.7	75.5	33.2	19.8	19.2	27.9
GLB1	"EBP, ELNR1"	ENSG00000170266	"Galactosidase beta 1"	P16278	3	32996609-33097202	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"		"Glycosidase, Hydrolase"	"Disease variant, Gangliosidosis, Mucopolysaccharidosis"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"BEWO: 857.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB008382, HPA040610, HPA069503"	Enhanced		Supported	"Golgi apparatus,Vesicles"	"Intracellular and membrane"	NA	NA		2700000	"Cluster 25: Monocytes - Inflammatory response"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 4: Macrophages - Innate immune response"	Vesicles	"Golgi apparatus"	"CAB008382: AB_590642, HPA040610: AB_2677039, HPA069503: AB_2686142"	"unprognostic (1.51e-2)"	"unprognostic (3.66e-2)"	"unprognostic (5.02e-3)"	"unprognostic (9.66e-3)"	"unprognostic (9.61e-3)"	"unprognostic (1.04e-1)"	"unprognostic (2.31e-3)"	"unprognostic (1.32e-1)"	"unprognostic (2.08e-1)"	"unprognostic (1.16e-1)"	"unprognostic (2.06e-1)"	"unprognostic (2.08e-1)"	"prognostic favorable (1.14e-5)"	"unprognostic (3.05e-1)"	"unprognostic (2.33e-1)"	"unprognostic (2.20e-1)"	"unprognostic (5.85e-2)"	22.0	36.1	12.1	27.8	13.0	21.9	20.5	12.5	14.8	33.4	16.0	43.5	43.0	21.9	103.6	15.4	28.2	32.0	15.5	12.5	14.8	46.0	48.2	42.7	25.8	14.3	12.9	21.4	30.8	59.4	18.5	53.8	15.4	23.2	45.6	14.9	25.3	29.3	7.7	15.8	31.0	30.6	12.4	24.4	35.5	13.5	13.5	17.5	52.8	10.8	23.0	31.8	16.2	15.1	37.4	63.6	39.8	48.3	241.9	123.7	857.2	59.1	157.6	73.7	95.1	91.3	86.5	17.9	50.9	120.9	53.9	35.1	38.1	75.5	53.7	104.9	33.0	69.9	35.3	47.4	124.3	50.5	69.9	144.9	70.2	67.0	39.2	144.1	116.5	24.7	64.3	67.0	81.8	44.6	29.6	31.6	26.4	78.0	27.0	24.7	26.4	86.6	78.4	54.4	12.0	40.3	75.0	120.2	74.4	69.3	80.3	130.2	67.7	46.8	32.2	65.2	50.1	53.2	87.9	5.9	99.6	71.2	36.7	43.9	146.2	86.4	29.2	125.8	40.4	37.9	34.3	31.8	166.5	35.6	17.9	21.8	56.6	26.0	92.1	35.1	77.1	91.9	12.1	13.0	12.5	14.8	12.5	14.8	14.3	12.9	15.4	12.4	13.5	15.1	8.7	19.2	25.3	39.2	18.6	6.0	13.6	60.1	10.8	11.3	11.5	7.5	9.1	34.3	43.3	27.6	6.2	100.1	14.1	41.9	27.4	53.5	24.8	18.7	16.0	17.4	16.9	20.6	46.7	35.4	55.3	29.2	26.0	27.1	26.6	20.6	19.6	39.7	79.5	5.0	46.0	23.5	40.7	43.9	13.9	5.0	15.2	41.7	14.2	23.4	64.6	16.5	10.3	27.2	24.2	28.1	43.4	21.1	19.8	9.9	36.2	33.1	31.0	16.2	13.1	12.9	16.3	1.0	6.6	10.1	3.4	49.1	18.7	51.0	32.0	12.1
GLS	"GLS1, KIAA0838"	ENSG00000115419	Glutaminase	O94925	2	190880821-190965552	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"		Hydrolase	"Cataract, Disease variant, Epilepsy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"kidney: 316.8"	"Cell type enhanced"	"Detected in all"		"Collecting duct cells: 391.8;Excitatory neurons: 427.1;Proximal tubular cells: 539.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"EFO-21: 907.3;RPTEC TERT1: 419.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA036223	Enhanced		Supported	Mitochondria	"Intracellular and membrane"	No	No		92000	"Cluster 44: Non-specific - Transcription"	"Cluster 87: Intestine & Kidney - Transmembrane transport"	"Cluster 38: EFO-21 - Unknown function"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Mitochondria		"HPA036223: AB_10669984"	"unprognostic (7.45e-2)"	"unprognostic (3.42e-2)"	"unprognostic (3.21e-1)"	"prognostic unfavorable (3.45e-4)"	"unprognostic (1.17e-1)"	"unprognostic (2.08e-3)"	"unprognostic (2.51e-3)"	"unprognostic (4.24e-2)"	"unprognostic (1.59e-1)"	"unprognostic (2.40e-1)"	"unprognostic (8.01e-2)"	"unprognostic (9.06e-2)"	"unprognostic (5.41e-2)"	"unprognostic (1.62e-1)"	"unprognostic (5.03e-2)"	"unprognostic (2.13e-1)"	"unprognostic (4.12e-1)"	37.0	77.4	38.5	45.7	50.5	28.7	32.0	40.5	74.6	31.0	35.6	32.0	92.2	28.8	26.6	16.8	25.1	41.8	34.7	55.5	35.9	316.8	11.7	55.6	68.0	44.7	19.8	28.9	36.9	62.0	19.9	35.8	52.5	20.8	30.1	81.8	20.4	31.2	15.8	28.5	103.4	36.9	12.0	49.3	18.7	16.2	24.1	41.7	35.7	23.6	57.9	36.5	23.6	44.8	43.6	47.2	32.4	43.1	99.7	68.9	84.0	126.8	95.7	90.6	103.1	58.1	42.1	88.5	907.3	269.3	46.1	55.6	58.0	50.0	131.5	219.8	37.7	147.3	69.1	72.2	90.8	87.2	66.5	62.9	51.0	71.2	48.4	90.1	119.3	36.7	69.3	175.2	203.3	22.8	59.2	83.7	86.9	25.7	76.7	74.2	83.7	77.4	419.2	78.9	44.9	46.8	172.8	37.9	169.2	115.1	14.9	53.0	85.3	129.4	94.5	65.9	156.8	56.2	138.9	122.1	46.7	70.6	105.5	6.4	1.0	1.9	3.7	1.5	6.5	3.4	4.4	4.8	1.6	3.8	4.5	5.5	2.1	2.8	1.1	3.6	4.1	1.1	38.5	50.5	40.5	74.6	55.5	35.9	44.7	19.8	52.5	12.0	24.1	44.8	81.0	189.1	122.5	61.0	89.3	174.5	44.7	15.6	60.9	93.5	51.8	49.5	38.2	35.8	28.4	391.8	210.6	4.4	128.0	100.6	50.9	21.4	6.6	33.7	66.8	68.3	59.2	17.9	427.1	24.5	15.6	66.0	46.4	97.9	36.8	48.2	63.5	4.3	29.1	26.9	270.5	36.7	14.2	31.2	230.0	7.3	28.6	84.3	88.9	143.4	68.4	11.9	55.6	163.3	146.9	29.8	92.9	43.2	118.4	70.1	165.9	539.1	17.0	111.9	19.7	71.6	76.0	11.3	12.9	61.7	162.8	4.0	114.0	97.8	43.6	56.7
GLS2	"GA, GLS, hLGA, LGA"	ENSG00000135423	"Glutaminase 2"	Q9UI32	12	56470944-56488414	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	10	"liver: 204.9"	"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 41.3;Hepatocytes: 54.9;Inhibitory neurons: 31.6"	"Cancer enriched"	"Detected in single"	4	"liver cancer: 1.7"	"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in some"			"Lineage enhanced"	"Detected in single"		"T-cells: 2.2"	"Cell line enhanced"	"Detected in some"		"A-431: 7.6;Daudi: 42.8;Hep G2: 7.4;SCLC-21H: 12.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA038608	Uncertain					NA	NA			"Cluster 32: T-cells - Unknown function"	"Cluster 85: Liver - Metabolism"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 15: Hepatocytes - Hemostasis"			"HPA038608: AB_10673176"	"unprognostic (5.59e-2)"	"unprognostic (1.51e-2)"	"unprognostic (8.73e-2)"	"unprognostic (7.15e-2)"	"unprognostic (1.23e-2)"	"unprognostic (9.56e-2)"	"unprognostic (3.27e-3)"	"unprognostic (1.98e-6)"	"unprognostic (1.55e-1)"	"unprognostic (5.33e-2)"	"unprognostic (1.29e-2)"	"unprognostic (1.52e-1)"	"unprognostic (5.65e-5)"	"unprognostic (1.42e-2)"	"unprognostic (2.59e-1)"	"unprognostic (9.02e-2)"	"unprognostic (4.44e-2)"	0.2	1.6	4.0	0.2	3.2	0.1	1.3	4.4	11.4	0.5	0.0	0.6	0.3	0.9	2.3	1.5	4.1	0.2	0.2	3.4	5.0	1.9	204.9	1.4	0.9	4.7	1.6	0.8	21.2	5.6	5.8	0.0	4.8	1.4	1.6	11.2	1.5	2.3	0.0	2.8	0.5	0.5	0.5	0.5	1.4	0.5	1.9	1.3	1.4	0.0	1.5	0.6	0.7	8.2	7.6	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.3	4.3	1.2	42.8	0.5	0.0	0.0	0.8	0.0	6.5	0.0	0.0	6.0	0.0	0.4	7.4	0.0	0.0	0.0	0.0	3.4	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.7	0.0	3.2	1.2	0.5	0.0	0.1	6.6	3.9	3.4	12.6	0.5	1.3	0.3	0.0	1.0	4.5	0.1	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	1.8	0.8	1.7	0.4	0.0	0.3	1.8	2.2	0.0	0.0	0.0	0.0	0.5	0.7	4.0	3.2	4.4	11.4	3.4	5.0	4.7	1.6	4.8	0.5	1.9	8.2	0.2	0.0	2.7	5.5	2.3	1.7	4.8	4.6	10.8	10.7	0.9	1.7	0.0	0.0	4.5	0.0	6.2	0.2	0.1	0.1	7.9	0.5	0.0	0.3	0.2	0.5	1.2	8.0	41.3	2.0	0.0	0.5	1.1	0.2	1.3	0.3	2.5	54.9	0.1	3.3	31.6	0.1	0.0	1.6	0.7	0.0	0.9	0.1	1.8	3.7	0.2	3.1	0.0	8.0	3.3	0.7	0.1	0.0	0.9	1.3	0.0	0.6	1.7	10.2	0.0	0.3	0.2	0.6	1.5	5.5	1.1	0.3	1.1	0.0	0.3	1.3
GNE	"IBM2, Uae1"	ENSG00000159921	"Glucosamine (UDP-N-acetyl)-2-epimerase/N-acetylmannosamine kinase"	Q9Y223	9	36214441-36277042	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"		"Allosteric enzyme, Hydrolase, Kinase, Multifunctional enzyme, Transferase"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	4	"intestine: 48.4;liver: 90.5;salivary gland: 55.3"	"Cell type enhanced"	"Detected in all"		"Distal enterocytes: 59.3;Hepatocytes: 119.3;Intestinal goblet cells: 88.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"RPTEC TERT1: 107.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA007045, HPA027258"	Approved		Supported	Cytosol		NA	NA			"Cluster 39: Non-specific - mRNA processing"	"Cluster 85: Liver - Metabolism"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 27: Mucus-secreting cells - Mucin production"	Cytosol		"HPA007045: AB_1079003, HPA027258: AB_1849873"	"unprognostic (7.54e-2)"	"unprognostic (1.61e-2)"	"unprognostic (1.07e-3)"	"unprognostic (7.28e-2)"	"unprognostic (7.00e-2)"	"unprognostic (1.85e-2)"	"unprognostic (2.78e-3)"	"unprognostic (5.39e-2)"	"unprognostic (1.73e-1)"	"unprognostic (1.70e-2)"	"unprognostic (2.88e-3)"	"unprognostic (4.20e-2)"	"prognostic favorable (9.28e-11)"	"unprognostic (2.90e-1)"	"unprognostic (8.28e-2)"	"unprognostic (2.95e-1)"	"unprognostic (1.72e-2)"	11.9	9.0	5.5	8.7	7.4	15.5	15.8	8.9	6.5	11.3	7.9	34.0	4.3	10.3	3.5	11.6	9.1	7.4	7.7	5.5	7.3	10.0	90.5	6.8	7.3	7.7	7.3	14.8	10.2	6.1	4.8	14.2	8.9	15.3	48.4	8.0	55.3	7.2	7.9	3.8	7.6	11.7	6.6	6.2	4.6	4.8	7.1	6.2	6.9	15.3	9.5	14.2	7.5	10.5	9.9	44.4	20.1	17.1	22.5	22.4	29.9	13.5	17.9	19.5	25.1	10.5	32.6	13.5	14.2	24.2	50.5	3.9	15.3	4.6	21.8	25.1	1.4	11.0	26.0	15.2	15.4	0.2	31.2	14.4	4.6	32.0	30.6	14.3	8.4	20.7	14.4	27.3	19.3	1.8	19.1	6.3	11.8	6.7	23.7	15.5	16.3	3.8	107.7	19.4	16.7	15.2	13.7	5.3	12.6	7.1	4.8	12.0	12.2	12.7	12.9	15.5	12.2	11.7	26.0	7.0	17.0	9.8	18.2	0.2	0.5	0.2	0.7	0.6	0.5	0.6	0.9	0.8	0.4	0.9	1.0	1.2	0.3	0.7	0.8	0.6	0.4	0.6	5.5	7.4	8.9	6.5	5.5	7.3	7.7	7.3	8.9	6.6	7.1	10.5	9.7	9.6	10.0	9.4	7.1	1.9	3.1	6.7	1.8	8.4	8.2	7.5	6.7	10.0	16.9	9.2	6.2	8.6	4.3	59.3	1.9	10.4	3.4	7.2	12.1	6.3	11.5	7.8	12.8	6.0	9.5	8.3	2.6	10.6	10.1	9.1	7.1	119.3	2.9	11.8	15.6	88.1	16.2	7.8	4.4	2.4	10.8	5.4	1.8	5.6	6.1	1.9	2.1	32.2	28.2	5.3	20.3	6.4	7.9	6.9	2.9	2.2	18.8	6.9	13.1	10.0	6.3	1.8	2.7	1.2	1.6	19.8	5.7	2.3	26.8	13.4
GNPDA1	"GNPDA, GNPI, GPI, HLN, KIAA0060"	ENSG00000113552	"Glucosamine-6-phosphate deaminase 1"	P46926	5	141991749-142013041	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Carbohydrate metabolism"	Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Hofbauer cells: 127.2;Proximal tubular cells: 102.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"GAMG: 382.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA000499, HPA046891"	Uncertain		Approved	"Golgi apparatus,Vesicles"		NA	NA		930000	"Cluster 16: MAIT-cells - Unknown function"	"Cluster 7: Kidney - Transmembrane transport"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 4: Macrophages - Innate immune response"	Vesicles	"Golgi apparatus"	"HPA000499: AB_1079005, HPA046891: AB_2679857"	"unprognostic (1.85e-1)"	"unprognostic (1.17e-1)"	"unprognostic (6.79e-2)"	"unprognostic (1.04e-1)"	"unprognostic (9.51e-2)"	"unprognostic (8.89e-3)"	"prognostic unfavorable (2.60e-6)"	"unprognostic (1.66e-1)"	"unprognostic (2.26e-1)"	"unprognostic (3.45e-1)"	"unprognostic (3.09e-1)"	"unprognostic (1.58e-1)"	"unprognostic (2.61e-1)"	"unprognostic (1.16e-1)"	"unprognostic (5.82e-2)"	"unprognostic (9.66e-2)"	"unprognostic (2.05e-3)"	18.8	38.4	26.9	17.3	28.8	8.1	20.9	26.2	35.2	26.7	27.7	19.7	29.5	28.7	51.9	13.6	18.4	22.3	17.3	28.1	30.8	76.4	16.6	17.6	22.7	27.0	27.7	31.8	11.3	27.9	20.5	22.2	29.3	22.2	21.9	17.7	14.6	28.3	26.4	14.8	22.5	29.2	27.0	30.9	14.5	18.8	29.7	24.9	27.8	25.7	19.8	33.3	17.1	30.7	42.6	61.0	23.2	115.8	77.1	51.9	54.6	32.6	78.7	84.7	95.8	91.3	49.2	0.2	72.9	23.6	382.3	44.0	109.9	98.0	74.8	32.9	46.5	31.3	33.1	65.5	137.2	86.4	39.2	63.5	56.9	54.5	144.8	63.2	91.6	80.6	37.3	110.1	93.0	27.2	66.8	9.8	88.0	62.8	121.4	25.5	76.3	94.3	81.8	114.8	20.6	54.0	65.0	67.8	127.9	67.5	54.6	26.5	43.3	50.9	33.3	76.9	47.5	61.2	126.9	47.1	74.2	29.3	45.0	0.3	48.6	7.1	37.2	59.1	77.9	19.4	30.0	34.2	51.7	11.1	35.3	38.8	12.7	15.8	56.3	29.6	27.6	40.2	26.9	28.8	26.2	35.2	28.1	30.8	27.0	27.7	29.3	27.0	29.7	30.7	10.5	9.6	14.9	10.7	8.2	6.0	40.8	20.9	21.1	11.6	12.6	17.8	12.6	12.8	20.1	18.4	8.4	26.7	11.1	6.9	35.2	29.3	1.1	5.8	19.8	14.6	15.0	9.9	11.5	14.2	48.6	22.8	7.7	9.6	12.0	30.8	15.4	7.4	127.2	6.7	12.7	6.2	12.2	60.2	10.7	3.6	19.9	48.5	14.2	12.2	23.5	40.5	15.5	7.1	11.5	21.6	7.1	26.7	7.8	32.9	19.4	102.3	8.0	7.9	0.0	10.4	11.7	10.4	17.0	17.6	7.4	29.7	16.6	64.8	9.1	34.7
GNPDA2	SB52	ENSG00000163281	"Glucosamine-6-phosphate deaminase 2"	Q8TDQ7	4	44682200-44726588	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Carbohydrate metabolism"	Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA000499, HPA046891"	Uncertain		Approved	"Golgi apparatus,Vesicles"		NA	NA		820000	"Cluster 44: Non-specific - Transcription"	"Cluster 21: Non-specific - Transcription"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 50: Fibroblasts - ECM organization"	Vesicles	"Golgi apparatus"	"HPA000499: AB_1079005, HPA046891: AB_2679857"	"unprognostic (1.91e-1)"	"unprognostic (2.76e-1)"	"unprognostic (1.04e-1)"	"unprognostic (1.16e-1)"	"unprognostic (1.90e-2)"	"unprognostic (3.29e-1)"	"unprognostic (1.55e-3)"	"unprognostic (1.02e-1)"	"unprognostic (1.33e-1)"	"unprognostic (9.57e-2)"	"unprognostic (9.75e-3)"	"unprognostic (1.03e-1)"	"unprognostic (1.28e-3)"	"unprognostic (4.18e-2)"	"unprognostic (6.86e-2)"	"unprognostic (1.63e-2)"	"unprognostic (3.13e-2)"	13.1	12.6	9.6	9.8	10.8	8.4	14.5	21.9	13.3	13.9	7.5	12.3	7.9	16.6	14.0	10.1	12.6	10.5	17.5	10.8	9.9	13.8	4.0	10.0	12.6	9.5	9.8	22.6	8.2	13.0	12.8	6.7	9.9	14.7	8.2	18.5	9.2	15.2	11.3	9.7	8.5	16.5	10.4	11.8	9.1	11.6	9.8	13.2	18.1	10.1	10.5	12.0	10.0	12.5	15.7	10.9	11.4	9.7	17.8	24.7	3.9	27.1	30.3	17.9	16.7	5.6	19.1	13.6	15.5	23.4	29.8	5.3	10.6	26.3	19.7	18.4	11.9	19.3	16.6	9.2	18.8	20.8	17.7	28.5	18.1	17.9	13.1	22.6	26.5	18.1	12.2	17.9	33.6	0.7	25.2	11.6	5.5	10.4	19.5	16.3	24.3	8.0	17.3	9.5	19.5	15.8	12.1	7.0	27.2	5.4	14.9	12.1	25.9	23.7	22.6	38.5	31.6	23.0	38.7	19.7	38.6	14.3	21.3	9.3	2.4	5.0	9.7	3.6	11.2	12.2	9.0	9.3	3.7	10.5	11.2	10.8	1.1	9.8	4.9	2.8	10.7	4.7	9.6	10.8	21.9	13.3	10.8	9.9	9.5	9.8	9.9	10.4	9.8	12.5	18.4	9.6	4.6	17.0	19.8	12.5	8.9	18.6	8.0	15.6	9.2	8.1	14.1	2.8	9.4	14.7	8.4	1.2	15.7	3.0	15.6	13.3	30.3	7.9	21.9	14.4	6.7	6.5	29.1	15.1	1.1	22.0	7.1	8.5	15.8	8.5	11.4	1.6	4.8	13.5	29.2	4.4	18.3	3.7	8.7	5.0	16.1	4.2	8.8	8.4	4.3	19.8	13.4	31.2	20.4	14.2	2.9	23.7	6.3	5.2	2.9	13.2	8.0	18.2	13.1	14.3	20.0	34.4	29.9	5.7	10.7	0.5	13.7	20.0	4.4	5.2
GNS		ENSG00000135677	"Glucosamine (N-acetyl)-6-sulfatase"	P15586	12	64713445-64759431	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"		Hydrolase	"Disease variant, Mucopolysaccharidosis"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Kupffer cells: 198.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"non-classical monocyte: 228.5"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA013695, CAB026011, HPA048508"	Enhanced				"Intracellular and membrane"	NA	NA		510000	"Cluster 51: Monocytes - Innate immune response"	"Cluster 1: Thyroid gland - Transcription"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 19: Monocytes & Neutrophils - Innate immune response"			"CAB026011: , HPA013695: AB_1849741, HPA048508: AB_2680423"	"unprognostic (8.07e-2)"	"unprognostic (2.39e-1)"	"unprognostic (2.76e-1)"	"unprognostic (1.05e-2)"	"prognostic unfavorable (7.76e-4)"	"unprognostic (9.33e-2)"	"prognostic unfavorable (1.94e-5)"	"unprognostic (1.26e-1)"	"unprognostic (4.03e-1)"	"unprognostic (2.62e-3)"	"unprognostic (3.04e-2)"	"unprognostic (3.30e-2)"	"unprognostic (3.28e-3)"	"unprognostic (1.42e-1)"	"unprognostic (3.77e-2)"	"unprognostic (1.09e-1)"	"unprognostic (3.04e-1)"	106.1	174.7	18.0	56.4	19.9	25.4	51.9	20.4	21.3	58.9	80.7	35.3	34.6	49.5	38.5	26.2	43.8	63.7	52.9	17.2	26.4	132.0	56.2	71.5	41.0	30.0	23.3	64.3	24.1	76.8	23.0	80.2	25.5	38.5	36.9	25.1	32.9	47.7	30.1	26.3	41.4	69.2	22.5	51.2	34.6	31.8	27.3	20.5	72.8	29.0	26.9	63.7	27.6	31.2	41.0	61.3	50.7	81.4	240.0	145.2	108.8	92.0	213.5	108.4	117.1	55.9	53.3	17.4	117.0	117.8	133.3	33.1	49.1	52.6	119.5	51.4	36.6	41.4	45.4	36.4	109.3	30.6	346.2	139.6	62.9	111.5	49.3	342.0	200.1	24.7	28.8	117.2	156.8	32.6	8.1	17.9	19.4	102.8	53.2	23.8	77.3	53.7	91.5	116.2	33.7	37.3	119.6	56.6	82.4	65.8	102.2	40.4	185.1	104.5	54.8	101.8	54.4	112.1	143.4	14.9	151.1	58.4	72.1	51.7	136.9	27.5	29.3	158.4	21.9	13.0	15.9	22.6	78.2	10.0	16.4	16.4	56.6	18.4	228.5	19.3	13.0	101.9	18.0	19.9	20.4	21.3	17.2	26.4	30.0	23.3	25.5	22.5	27.3	31.2	52.6	48.1	31.7	19.2	11.0	16.6	8.4	14.8	11.4	10.5	28.4	17.0	59.9	22.8	24.2	103.0	18.8	24.3	18.8	24.2	1.9	36.2	24.4	26.5	25.5	50.6	41.9	15.4	25.0	15.1	19.7	40.2	12.2	32.9	48.1	36.3	58.5	57.9	81.0	16.8	31.3	16.6	18.3	198.8	46.5	24.5	34.8	107.8	16.0	27.2	79.0	20.1	13.4	15.1	19.9	20.0	15.7	37.2	16.0	17.2	60.9	64.3	42.8	7.5	6.6	23.1	24.9	11.3	7.8	10.5	12.9	29.1	13.2	30.0	18.2	19.2
GPCPD1	"GDE5, GDPD6, KIAA1434"	ENSG00000125772	"Glycerophosphocholine phosphodiesterase 1"	Q9NPB8	20	5544439-5611006	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 75.5"	"Cell type enhanced"	"Detected in all"		"Early spermatids: 208.7;Microglial cells: 291.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"hTERT-HME1: 41.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA042987			Approved	Nucleoplasm		NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 19: Monocytes & Neutrophils - Innate immune response"	Nucleoplasm		"HPA042987: AB_2678254"	"unprognostic (2.25e-2)"	"unprognostic (2.45e-2)"	"unprognostic (3.41e-1)"	"prognostic favorable (1.30e-4)"	"unprognostic (2.93e-2)"	"unprognostic (8.10e-2)"	"unprognostic (1.63e-1)"	"unprognostic (1.39e-2)"	"unprognostic (3.76e-2)"	"unprognostic (1.67e-1)"	"unprognostic (1.46e-1)"	"unprognostic (1.18e-1)"	"prognostic unfavorable (3.73e-4)"	"unprognostic (1.56e-1)"	"unprognostic (1.22e-1)"	"unprognostic (1.51e-1)"	"unprognostic (2.30e-2)"	17.5	15.5	17.4	16.3	18.6	75.5	13.5	21.6	23.4	16.3	13.0	12.9	7.9	13.3	7.1	13.3	17.2	12.1	17.1	16.1	19.1	19.5	10.2	27.4	17.9	21.2	17.8	23.3	9.7	4.0	13.2	14.9	22.1	13.1	11.1	12.2	26.5	13.1	17.5	11.1	16.6	12.8	18.6	31.9	11.2	9.1	19.2	13.3	15.5	10.2	17.0	12.9	13.0	16.8	6.5	12.1	8.0	6.5	5.2	6.1	9.1	10.0	7.9	5.7	3.8	6.3	5.0	14.4	1.8	5.6	5.0	2.2	10.1	19.8	5.5	3.1	3.2	19.6	1.5	7.4	25.0	12.2	8.6	13.0	25.3	3.4	41.3	5.7	6.0	8.8	11.5	7.3	5.2	3.5	11.1	6.7	4.4	11.3	6.7	8.0	9.5	5.2	7.7	5.3	3.0	4.0	4.4	19.2	9.5	7.9	4.6	33.7	6.8	4.8	3.6	13.2	6.4	6.9	12.7	15.1	1.5	14.8	5.4	2.9	7.4	9.2	3.7	5.5	2.9	4.2	2.8	3.2	4.5	3.6	4.2	2.9	16.0	3.9	5.8	2.0	2.5	3.9	17.4	18.6	21.6	23.4	16.1	19.1	21.2	17.8	22.1	18.6	19.2	16.8	34.8	22.4	56.4	31.6	59.6	16.6	15.8	23.0	17.1	18.0	25.7	39.6	36.8	12.8	48.5	22.0	6.2	29.9	59.1	13.2	3.9	11.9	208.7	37.8	41.2	41.1	19.7	89.0	30.9	9.1	16.8	27.1	35.7	66.9	43.1	26.0	17.9	14.4	43.9	11.8	22.8	25.7	24.4	69.2	54.9	54.6	5.6	125.0	10.6	291.4	60.9	8.5	33.0	63.3	13.4	7.3	12.7	3.4	55.2	21.1	16.6	7.7	24.6	20.3	6.6	31.9	35.1	44.1	11.3	25.8	27.4	48.7	63.1	12.7	12.8	57.7
GPLD1		ENSG00000112293	"Glycosylphosphatidylinositol specific phospholipase D1"	P80108	6	24424565-24495205	"Enzymes, Metabolic proteins, Plasma proteins, Predicted secreted proteins"		Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"liver: 46.1"	"Cell type enhanced"	"Detected in many"		"Cone photoreceptor cells: 68.8;Excitatory neurons: 62.4;Hepatocytes: 66.8;Inhibitory neurons: 78.3;Oligodendrocyte precursor cells: 33.2"	"Cancer enriched"	"Detected in some"	11	"liver cancer: 6.8"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"Daudi: 7.6;U-698: 8.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB008625, HPA012500"	Uncertain				"Secreted to blood"	NA	NA	103000000000	3100000000	"Cluster 29: Plasmacytoid DCs - Unknown function"	"Cluster 85: Liver - Metabolism"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"			"CAB008625: AB_1621070, HPA012500: AB_1849931"	"unprognostic (6.80e-3)"	"unprognostic (2.27e-1)"	"unprognostic (1.59e-1)"	"unprognostic (4.81e-5)"	"unprognostic (3.65e-1)"	"unprognostic (1.02e-1)"	"prognostic favorable (1.12e-4)"	"unprognostic (6.37e-4)"	"unprognostic (7.93e-2)"	"unprognostic (2.86e-2)"	"unprognostic (6.07e-4)"	"unprognostic (2.68e-1)"	"unprognostic (5.28e-4)"	"unprognostic (2.20e-1)"	"unprognostic (9.98e-2)"	"unprognostic (3.73e-2)"	"unprognostic (1.22e-1)"	4.2	0.9	2.0	0.6	1.7	0.9	1.3	7.6	4.7	1.1	0.1	1.0	0.5	1.6	1.7	1.1	0.9	0.6	0.5	1.3	2.4	0.6	46.1	0.9	0.9	1.8	1.9	1.2	0.6	2.5	1.7	0.2	1.9	1.8	0.6	6.2	0.4	4.8	1.7	8.6	0.4	1.4	0.6	0.6	0.7	1.4	1.4	5.1	2.4	0.6	1.3	1.1	1.5	2.1	0.5	0.7	0.8	1.2	0.0	0.0	2.0	0.1	0.2	0.2	0.1	3.5	0.1	7.6	0.8	0.1	0.2	0.1	1.2	0.2	0.1	0.9	2.1	1.1	0.9	3.2	0.0	1.4	0.2	0.0	0.1	0.0	0.0	0.8	0.0	1.8	0.5	0.3	0.1	0.5	0.7	0.5	2.9	0.5	0.3	1.4	0.2	0.1	0.4	3.4	2.0	2.3	0.9	0.1	0.4	0.6	0.4	0.3	0.1	0.7	0.9	0.1	1.0	2.4	3.4	8.1	0.1	0.3	0.3	0.1	0.0	0.0	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.2	0.0	0.3	0.1	0.1	0.0	0.2	0.1	0.0	2.0	1.7	7.6	4.7	1.3	2.4	1.8	1.9	1.9	0.6	1.4	2.1	0.4	0.0	3.7	24.8	1.1	0.0	0.7	2.8	0.6	19.6	0.7	0.4	11.6	0.0	1.7	1.8	68.8	0.3	1.6	0.1	0.0	0.4	3.5	0.5	0.6	1.2	1.8	7.4	62.4	0.4	0.3	1.3	0.0	0.3	0.0	2.1	1.4	66.8	0.1	15.2	78.3	0.3	0.0	1.3	0.0	3.4	3.1	0.1	0.0	9.4	0.1	4.0	3.1	33.2	3.1	0.1	0.1	3.4	3.1	0.3	0.1	0.5	1.1	10.9	0.0	3.6	1.4	0.5	5.8	0.3	0.6	0.0	0.5	0.9	0.5	2.6
GTF2F2	"BTF4, RAP30, TFIIF"	ENSG00000188342	"General transcription factor IIF subunit 2"	P13984	13	45120510-45284893	"Enzymes, Predicted intracellular proteins"	"Transcription, Transcription regulation"	"DNA-binding, Helicase, Hydrolase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA006912	Supported		Supported	Nucleoplasm,Microtubules		NA	NA			"Cluster 31: Non-specific - Inflammatory response"	"Cluster 59: Non-specific - Translation"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 39: Non-specific - Basic cellular processes"	Nucleoplasm	Microtubules	"HPA006912: AB_1080256"	"unprognostic (3.39e-1)"	"unprognostic (2.65e-2)"	"unprognostic (3.27e-1)"	"unprognostic (1.29e-1)"	"unprognostic (4.51e-2)"	"prognostic unfavorable (1.65e-5)"	"unprognostic (3.67e-2)"	"unprognostic (3.17e-1)"	"unprognostic (3.36e-2)"	"unprognostic (2.53e-3)"	"unprognostic (2.31e-2)"	"unprognostic (4.76e-2)"	"unprognostic (1.25e-1)"	"unprognostic (2.09e-1)"	"unprognostic (6.53e-3)"	"unprognostic (3.94e-2)"	"unprognostic (6.44e-3)"	10.9	16.6	12.4	11.0	13.2	18.3	12.9	12.4	14.9	13.5	18.1	18.3	10.4	11.6	15.4	16.5	10.0	8.4	20.0	13.1	13.2	15.0	11.3	9.6	13.4	12.3	13.0	12.1	10.7	14.1	12.9	11.0	12.4	10.7	14.2	9.9	12.2	13.0	25.0	24.9	10.0	12.9	13.5	10.2	11.3	13.3	13.0	14.8	11.4	15.8	14.4	15.5	14.8	15.6	43.2	15.9	29.3	21.8	17.6	25.8	24.3	46.2	30.2	46.1	44.9	26.8	65.7	42.9	25.4	33.9	44.8	46.9	44.3	37.1	66.7	32.6	38.4	50.8	20.7	35.2	28.1	57.0	27.9	21.8	55.9	34.4	57.8	52.0	29.9	32.9	36.6	15.8	125.6	24.2	42.0	65.2	34.8	68.6	38.3	39.0	22.2	24.8	101.4	15.0	15.6	26.0	23.5	22.9	39.8	27.5	18.6	45.9	23.7	38.6	33.1	30.8	79.9	10.0	14.6	42.7	44.9	36.1	41.2	16.2	15.9	29.9	10.3	16.7	12.4	17.3	12.1	12.4	18.8	17.8	13.5	13.5	22.5	18.9	18.9	14.7	14.7	10.1	12.4	13.2	12.4	14.9	13.1	13.2	12.3	13.0	12.4	13.5	13.0	15.6	21.6	41.7	32.1	41.1	36.0	75.1	82.8	80.2	35.9	19.2	27.3	30.2	79.4	10.0	41.6	11.0	4.2	33.0	25.7	29.0	49.0	49.7	93.0	34.9	37.5	27.6	28.2	32.6	23.7	33.6	49.4	28.9	13.7	56.8	39.3	25.6	18.2	21.4	49.1	8.4	35.1	26.4	50.8	27.1	38.2	82.3	24.2	32.0	76.5	36.5	38.2	36.8	27.8	57.8	48.9	48.5	30.3	31.6	30.4	88.3	22.6	42.7	29.4	21.5	6.6	35.6	32.3	68.6	83.9	34.5	72.7	33.8	28.8	33.5	40.7	75.1
GUSB		ENSG00000169919	"Glucuronidase beta"	P08236	7	65960684-65982215	"Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"		"Glycosidase, Hydrolase"	"Cancer-related genes, Disease variant, Mucopolysaccharidosis"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"Karpas-707: 213.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036322, HPA036323"	Approved		Supported	Vesicles	"Intracellular and membrane"	NA	NA		330000	"Cluster 45: Eosinophils - Innate immune response"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 4: Macrophages - Innate immune response"	Vesicles		"HPA036322: AB_10670796, HPA036323: AB_2675059"	"unprognostic (1.54e-2)"	"unprognostic (6.49e-2)"	"unprognostic (1.18e-2)"	"unprognostic (3.50e-1)"	"unprognostic (2.58e-2)"	"unprognostic (4.46e-2)"	"unprognostic (2.89e-1)"	"unprognostic (1.56e-3)"	"unprognostic (1.32e-1)"	"unprognostic (2.32e-1)"	"unprognostic (7.00e-3)"	"unprognostic (1.91e-1)"	"unprognostic (3.34e-2)"	"unprognostic (8.83e-3)"	"unprognostic (1.98e-1)"	"unprognostic (5.06e-1)"	"unprognostic (1.45e-1)"	28.4	18.2	11.0	22.3	12.3	84.2	80.9	12.0	16.1	26.7	14.3	38.2	36.1	26.2	41.8	16.4	24.6	27.6	19.6	10.7	11.5	25.1	104.0	35.7	25.6	13.2	12.2	19.9	33.6	30.3	12.6	48.2	13.2	20.2	41.9	9.7	32.9	21.2	10.9	18.8	29.8	19.1	11.9	34.0	38.1	19.5	13.0	22.7	27.7	14.4	24.0	27.3	15.4	13.5	67.0	26.5	25.2	56.3	80.9	49.1	35.3	21.3	56.8	45.0	42.1	37.0	67.8	30.9	32.3	26.8	24.1	27.5	16.5	25.1	26.8	27.3	34.1	41.5	40.9	27.3	39.7	89.6	67.1	33.4	26.7	26.3	33.3	54.5	39.3	18.0	63.2	213.5	30.5	50.3	34.2	92.0	17.9	103.0	21.0	34.4	55.9	172.4	29.4	42.8	36.2	32.7	55.6	129.1	72.3	29.9	71.1	88.8	28.5	55.3	49.3	21.8	53.6	119.6	151.9	50.0	41.0	116.3	68.3	26.0	80.1	65.7	32.0	103.0	28.4	27.7	24.7	28.4	80.5	22.6	16.8	19.5	13.2	46.6	93.5	34.2	34.5	51.4	11.0	12.3	12.0	16.1	10.7	11.5	13.2	12.2	13.2	11.9	13.0	13.5	53.1	51.3	58.7	10.1	33.0	18.0	32.0	51.9	29.0	12.2	26.1	19.9	12.2	48.6	48.9	29.5	8.4	81.9	32.6	52.2	5.9	41.1	59.1	28.9	26.5	39.7	43.0	47.1	12.3	30.3	61.2	49.5	49.5	49.4	36.8	38.3	37.9	72.7	126.4	16.8	10.6	51.6	30.5	88.1	33.2	46.7	43.2	78.0	39.2	14.0	44.8	28.0	20.6	8.5	14.2	29.4	49.5	28.6	87.5	25.3	50.6	26.8	43.2	20.1	26.3	27.1	26.0	49.6	31.0	16.0	14.8	66.9	32.2	24.4	44.3	29.6
GZMA	"CTLA3, HFSP"	ENSG00000145649	"Granzyme A"	P12544	5	55102646-55110252	"Enzymes, Predicted secreted proteins"	Cytolysis	"Hydrolase, Protease, Serine protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 68.1"	"Group enriched"	"Detected in many"	24	"dendritic cells: 739.3;NK-cells: 1543.8;T-cells: 709.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in all"	15	"gdT-cell: 941.4;MAIT T-cell: 926.2;memory CD4 T-cell: 250.0;memory CD8 T-cell: 922.7;naive CD8 T-cell: 494.1;NK-cell: 718.8"	"Group enriched"	"Detected in all"	42	"NK-cells: 718.8;T-cells: 941.4"	"Cell line enhanced"	"Detected in some"		"HL-60: 4.0;JURKAT: 2.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA054134, HPA076751"	Enhanced				"Secreted to blood"	NA	NA			"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 14: B-cells - Humoral immune response"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 63: NK-cells & T-cells - Immune response"			"HPA054134: AB_2682395, HPA076751: "	"prognostic favorable (7.27e-4)"	"unprognostic (7.29e-3)"	"unprognostic (1.50e-2)"	"prognostic favorable (6.44e-6)"	"unprognostic (2.96e-3)"	"unprognostic (1.85e-3)"	"unprognostic (8.30e-3)"	"unprognostic (1.15e-2)"	"unprognostic (5.15e-3)"	"unprognostic (3.03e-2)"	"unprognostic (1.77e-1)"	"unprognostic (3.09e-1)"	"prognostic unfavorable (1.26e-6)"	"unprognostic (5.91e-2)"	"unprognostic (5.57e-1)"	"unprognostic (5.73e-3)"	"unprognostic (3.33e-3)"	5.6	6.0	0.9	16.7	0.9	35.3	7.2	0.9	2.5	7.6	1.2	14.7	29.2	14.7	8.8	4.8	4.6	14.0	4.0	0.8	1.0	3.2	15.2	21.9	68.1	1.6	0.9	4.5	1.0	1.3	1.0	3.1	1.1	3.1	17.8	0.0	7.1	3.0	1.7	1.6	27.6	7.2	1.1	51.1	11.7	2.0	1.1	12.4	2.9	1.3	19.2	13.5	2.9	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	2.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	3.3	2.5	3.8	941.4	2.3	926.2	3.4	250.0	922.7	3.1	1.3	48.5	494.1	19.9	718.8	4.0	3.2	33.1	712.7	0.9	0.9	0.9	2.5	0.8	1.0	1.6	0.9	1.1	1.1	1.1	1.1	5.1	3.2	18.1	0.0	12.3	0.4	0.1	0.0	2.8	0.0	2.7	2.4	1.6	5.7	3.1	0.0	0.0	0.4	739.3	1.4	0.0	1.6	0.0	1.7	2.7	2.8	0.0	36.2	0.0	0.0	0.2	7.8	20.4	2.1	7.6	0.0	17.9	2.8	0.3	0.0	0.1	1.5	0.0	25.8	2.6	0.0	0.0	12.3	3.6	0.0	12.6	0.0	1543.8	0.0	0.1	0.0	3.9	0.0	40.8	0.1	2.8	3.3	2.9	0.0	0.0	2.6	2.6	0.0	0.1	1.1	1.4	0.7	709.4	0.0	1.8	0.0
GZMB	"CCPI, CGL-1, CGL1, CSP-B, CSPB, CTLA1, CTSGL1, HLP, SECT"	ENSG00000100453	"Granzyme B"	P10144	14	24630954-24634267	"Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Apoptosis, Cytolysis"	"Hydrolase, Protease, Serine protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 68.2;lymphoid tissue: 37.1"	"Group enriched"	"Detected in many"	5	"dendritic cells: 2050.2;NK-cells: 1704.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in all"	5	"plasmacytoid DC: 6765.2"	"Lineage enriched"	"Detected in all"	5	"dendritic cells: 6765.2"	"Cell line enriched"	"Detected in some"	6	"HMC-1: 22.0"									"CAB000376, HPA003418"	Enhanced				"Secreted to blood"	NA	NA	2170		"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 63: NK-cells & T-cells - Immune response"			"CAB000376: AB_323716, HPA003418: AB_1079020"	"prognostic favorable (7.27e-4)"	"unprognostic (2.82e-3)"	"unprognostic (8.54e-2)"	"prognostic favorable (1.58e-5)"	"unprognostic (2.07e-3)"	"unprognostic (1.48e-3)"	"unprognostic (4.43e-2)"	"unprognostic (8.25e-2)"	"unprognostic (3.70e-2)"	"unprognostic (3.05e-3)"	"unprognostic (4.26e-2)"	"unprognostic (1.58e-1)"	"prognostic unfavorable (1.10e-7)"	"unprognostic (1.24e-1)"	"unprognostic (1.48e-1)"	"unprognostic (1.29e-1)"	"unprognostic (2.71e-3)"	8.2	1.7	1.2	17.8	1.3	68.2	2.1	1.2	3.9	1.2	1.4	2.5	2.3	7.1	1.6	3.8	1.5	6.5	1.8	1.2	7.9	1.5	4.1	15.3	37.1	1.5	1.5	0.3	1.0	0.7	0.7	3.3	1.6	1.4	2.2	0.0	2.3	1.4	2.0	0.4	4.4	4.3	1.4	28.9	3.5	0.5	1.8	9.7	1.9	1.5	34.6	18.5	1.6	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.7	0.0	0.0	22.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.8	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	3.9	0.0	0.0	0.0	0.7	2.8	9.9	3.0	5.3	1338.5	4.0	16.0	7.0	95.2	641.6	6.3	3.1	29.1	607.5	43.1	507.8	6.0	6765.2	2.7	1607.1	1.2	1.3	1.2	3.9	1.2	7.9	1.5	1.5	1.6	1.4	1.8	1.3	4.3	6.4	36.0	0.0	15.9	2.8	0.3	0.0	0.0	0.0	0.9	0.8	1.1	4.3	7.4	0.0	0.0	0.4	2050.2	0.6	0.0	1.6	0.0	0.4	0.5	2.7	0.0	11.8	0.0	0.0	0.1	5.1	9.2	0.5	17.7	0.0	4.2	1.2	0.2	0.0	0.0	0.6	0.0	4.8	9.0	0.2	0.0	27.1	42.7	1.0	11.6	0.0	1704.4	0.0	0.1	0.1	2.3	0.0	86.8	0.2	0.6	3.1	4.4	0.0	0.0	1.3	1.3	0.0	0.1	0.4	4.1	0.3	373.8	0.0	0.6	0.1
H6PD	"GDH, H6PDH"	ENSG00000049239	"Hexose-6-phosphate dehydrogenase/glucose 1-dehydrogenase"	O95479	1	9234774-9271337	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Carbohydrate metabolism, Glucose metabolism"	"Hydrolase, Multifunctional enzyme, Oxidoreductase"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 94.5"	"Cell type enhanced"	"Detected in many"		"Hepatocytes: 164.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"ASC diff: 68.9;ASC TERT1: 78.9;HSkMC: 77.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA004824, HPA005440"	Approved		Uncertain	Cytosol	"Intracellular and membrane"	NA	NA		140000000	"Cluster 7: Monocytes - Unknown function"	"Cluster 85: Liver - Metabolism"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 2: Hepatocytes - Metabolism"	Cytosol		"HPA004824: AB_1079037, HPA005440: AB_1079036"	"unprognostic (4.83e-3)"	"unprognostic (3.91e-2)"	"unprognostic (1.18e-1)"	"unprognostic (3.49e-1)"	"unprognostic (5.53e-3)"	"unprognostic (2.86e-2)"	"unprognostic (8.35e-2)"	"unprognostic (5.18e-2)"	"unprognostic (9.73e-2)"	"unprognostic (1.26e-3)"	"unprognostic (2.16e-2)"	"unprognostic (7.35e-3)"	"unprognostic (8.20e-2)"	"unprognostic (3.61e-1)"	"unprognostic (1.30e-1)"	"unprognostic (8.65e-2)"	"unprognostic (1.95e-1)"	29.0	30.5	7.5	12.6	11.6	9.7	23.0	8.2	9.0	22.6	18.8	15.1	11.2	25.7	14.4	13.5	28.3	12.6	18.9	6.4	7.8	11.5	94.5	20.3	12.4	14.4	10.8	44.9	18.9	10.6	12.7	14.1	11.4	19.5	9.1	4.2	56.2	13.1	48.3	35.7	16.8	16.6	9.6	14.5	18.7	8.1	11.4	13.1	14.7	21.0	11.4	16.7	16.5	10.9	9.9	8.0	6.8	25.5	68.9	78.9	6.4	9.8	24.0	7.1	10.9	1.5	20.1	10.9	11.2	15.3	9.1	10.3	1.8	4.8	10.3	32.8	2.2	0.0	2.8	6.7	38.6	3.5	4.1	77.7	9.1	17.2	11.1	15.6	32.9	5.9	2.9	18.2	14.0	5.7	3.9	8.2	3.7	7.5	4.6	1.2	0.9	9.3	9.1	4.0	2.3	12.0	12.9	10.0	12.0	4.7	7.5	17.4	32.9	24.3	3.9	6.2	2.8	24.1	7.6	2.5	40.8	15.6	15.7	1.6	2.3	0.3	1.6	2.4	1.3	1.3	1.2	1.5	1.0	1.6	1.2	1.1	1.5	1.2	2.3	1.4	1.1	1.5	7.5	11.6	8.2	9.0	6.4	7.8	14.4	10.8	11.4	9.6	11.4	10.9	24.1	25.6	29.5	17.9	10.1	14.3	13.2	16.9	18.8	19.6	10.3	8.3	17.5	58.6	18.8	20.2	27.1	11.2	9.1	16.6	0.0	22.9	0.8	11.2	36.0	19.8	7.8	9.0	8.4	21.3	8.5	33.6	5.6	15.5	3.8	29.9	19.6	164.0	12.1	16.8	9.1	15.1	8.2	25.4	11.4	2.9	48.1	14.2	12.4	13.1	51.6	10.4	19.6	16.6	18.6	20.0	17.0	36.9	4.5	17.2	23.1	7.4	19.1	10.9	0.0	50.5	11.7	4.6	5.5	10.5	12.8	5.9	11.6	26.1	23.6	14.2
HAGH	"GLO2, GLXII, HAGH1"	ENSG00000063854	"Hydroxyacylglutathione hydrolase"	Q16775	16	1795620-1827157	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Erythroid cells: 378.7;Proximal tubular cells: 501.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA043041, HPA061143"	Approved					NA	NA		2800000	"Cluster 45: Eosinophils - Innate immune response"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"			"HPA043041: AB_2678284, HPA061143: AB_2684439"	"unprognostic (3.11e-1)"	"prognostic favorable (5.82e-5)"	"unprognostic (2.54e-1)"	"unprognostic (1.93e-2)"	"unprognostic (5.84e-2)"	"unprognostic (1.54e-1)"	"prognostic favorable (5.33e-6)"	"unprognostic (5.78e-3)"	"unprognostic (3.34e-2)"	"unprognostic (7.69e-2)"	"unprognostic (3.34e-3)"	"unprognostic (1.60e-1)"	"prognostic favorable (1.81e-6)"	"unprognostic (1.20e-1)"	"unprognostic (6.24e-2)"	"unprognostic (7.18e-3)"	"prognostic favorable (5.19e-4)"	41.2	109.0	81.5	20.2	84.2	82.1	35.1	82.7	103.9	22.8	78.9	53.7	45.3	24.6	31.1	29.0	28.5	21.9	138.6	89.9	83.8	100.1	236.2	39.2	24.6	82.8	80.2	22.0	63.5	54.0	72.7	23.1	83.7	33.5	23.3	32.2	32.5	37.7	198.8	31.2	44.8	24.7	80.1	35.2	52.9	91.7	84.0	35.8	35.1	156.2	18.4	34.8	24.6	87.6	31.1	46.1	40.9	46.5	35.1	13.8	37.0	38.1	35.2	57.7	46.1	23.7	26.5	6.4	76.5	32.9	39.6	33.2	39.1	38.2	17.2	64.5	63.4	12.0	47.9	69.3	50.2	15.7	62.6	16.9	80.6	28.8	19.6	50.6	50.1	79.8	16.1	56.3	18.3	51.2	41.1	34.0	15.7	32.0	42.3	34.2	25.8	73.6	74.5	13.8	54.7	47.4	41.8	52.9	84.9	30.8	38.7	52.0	38.7	17.5	21.5	36.9	44.6	63.3	64.7	19.8	29.8	14.5	28.5	37.3	33.3	64.9	26.0	59.1	19.0	31.3	34.0	27.3	30.7	30.4	32.0	27.4	29.7	25.5	88.2	64.8	42.8	30.3	81.5	84.2	82.7	103.9	89.9	83.8	82.8	80.2	83.7	80.1	84.0	87.6	46.2	9.6	39.0	11.8	33.7	23.8	45.1	59.7	12.0	117.1	39.5	31.1	84.2	65.8	39.7	46.0	64.6	52.4	43.2	60.9	158.5	45.6	193.1	75.0	12.1	35.3	39.6	378.7	24.6	38.3	38.5	25.6	23.9	35.5	30.4	36.0	41.0	186.9	76.2	138.0	22.2	41.2	93.6	49.0	41.6	60.1	46.9	47.6	55.2	12.2	50.1	95.2	64.9	7.1	19.7	49.7	68.8	54.9	50.4	48.3	168.9	501.7	70.2	117.0	72.3	33.3	61.1	245.2	68.3	29.1	45.6	68.7	44.1	45.3	39.9	49.9
HDAC1	"GON-10, HD1, KDAC1, RPD3L1"	ENSG00000116478	"Histone deacetylase 1"	Q13547	1	32292083-32333635	"Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins"	"Biological rhythms, Transcription, Transcription regulation"	"Chromatin regulator, Hydrolase, Repressor"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB005017, HPA029693, CAB068191"	Enhanced		Enhanced	Nucleoplasm		NA	NA			"Cluster 44: Non-specific - Transcription"	"Cluster 14: B-cells - Humoral immune response"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Nucleoplasm		"CAB005017: AB_2248344, CAB068191: AB_2665664, HPA029693: AB_10601659"	"unprognostic (2.51e-2)"	"unprognostic (9.10e-2)"	"unprognostic (2.92e-1)"	"unprognostic (2.98e-1)"	"unprognostic (9.15e-2)"	"unprognostic (3.57e-3)"	"prognostic unfavorable (5.76e-7)"	"unprognostic (9.57e-2)"	"unprognostic (5.02e-2)"	"unprognostic (3.47e-2)"	"unprognostic (7.06e-2)"	"unprognostic (4.44e-2)"	"prognostic unfavorable (1.04e-5)"	"unprognostic (6.86e-2)"	"unprognostic (3.78e-1)"	"unprognostic (7.16e-2)"	"unprognostic (1.72e-1)"	31.4	42.8	20.8	76.7	22.1	59.3	56.0	21.9	28.0	56.6	20.3	119.5	74.5	48.1	51.4	81.3	56.8	55.4	29.0	20.4	21.9	47.9	41.7	41.2	119.7	23.3	21.8	65.7	40.0	62.3	31.6	53.0	23.1	57.6	108.3	18.9	52.1	57.2	15.3	38.0	80.8	46.8	21.8	61.7	84.1	36.2	22.0	103.9	78.4	17.5	123.9	63.7	51.7	23.4	152.5	90.6	57.4	114.7	32.9	39.0	118.7	105.1	117.1	138.0	126.6	168.0	266.3	233.4	190.3	116.9	140.2	173.1	178.1	143.1	151.5	219.3	176.8	161.3	105.7	130.1	77.4	288.1	223.4	70.7	77.0	107.1	70.3	107.7	106.1	298.5	215.2	90.1	61.6	115.7	331.6	161.4	133.2	180.2	229.6	225.0	136.0	104.0	149.5	216.1	44.7	56.6	176.0	117.0	227.9	224.0	137.9	220.6	123.8	91.3	106.2	28.5	261.1	54.4	124.9	319.2	75.3	235.8	121.4	147.5	87.7	200.1	130.0	115.9	107.5	151.6	126.2	140.6	103.0	142.0	143.7	133.6	63.7	144.2	156.4	64.9	142.0	204.6	20.8	22.1	21.9	28.0	20.4	21.9	23.3	21.8	23.1	21.8	22.0	23.4	45.3	25.6	45.4	25.5	82.7	24.9	57.4	99.1	38.7	15.1	35.1	29.1	22.1	61.5	73.4	68.0	16.7	93.1	64.0	142.4	95.9	75.7	20.2	33.7	39.8	56.2	86.3	60.8	1.9	73.6	110.9	25.8	65.2	39.5	30.4	23.6	63.5	28.1	43.6	11.8	8.8	122.8	52.9	38.2	19.0	8.7	41.0	35.0	28.4	16.9	52.7	34.2	69.0	14.6	19.4	92.5	141.5	44.4	38.4	28.5	57.0	30.0	67.3	14.6	59.2	22.8	38.1	72.5	69.8	60.2	25.4	93.4	73.6	102.6	136.0	55.8
HDAC10	DKFZP761B039	ENSG00000100429	"Histone deacetylase 10"	Q969S8	22	50245183-50251405	"Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Autophagy, DNA damage, DNA recombination, DNA repair"	Hydrolase	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HMC-1: 27.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB045977	Supported					NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 63: NK-cells & T-cells - Immune response"			"CAB045977: AB_11124034"	"unprognostic (1.53e-1)"	"prognostic favorable (4.46e-4)"	"unprognostic (1.43e-2)"	"prognostic favorable (2.45e-5)"	"unprognostic (2.71e-2)"	"unprognostic (3.70e-2)"	"unprognostic (6.15e-3)"	"unprognostic (5.48e-2)"	"unprognostic (3.28e-1)"	"unprognostic (2.56e-2)"	"prognostic favorable (9.25e-4)"	"unprognostic (4.93e-2)"	"prognostic unfavorable (4.74e-11)"	"unprognostic (2.21e-2)"	"unprognostic (2.52e-2)"	"unprognostic (1.43e-2)"	"unprognostic (1.38e-3)"	8.9	9.8	4.9	6.0	4.8	9.6	7.1	3.6	10.3	9.3	5.4	9.9	6.6	6.8	1.2	10.7	8.0	3.9	4.9	5.1	4.5	11.5	16.8	8.5	6.7	5.1	4.5	7.6	11.2	2.2	13.2	3.3	4.5	10.8	1.5	0.2	8.7	2.8	5.1	9.2	12.6	1.9	3.9	17.2	11.4	2.2	5.1	4.2	9.5	0.5	2.8	7.2	8.1	4.1	6.1	3.3	0.9	5.0	4.2	3.3	11.4	4.2	3.4	2.3	1.4	6.4	6.6	4.0	5.7	3.1	2.2	10.2	2.1	5.9	0.5	5.4	5.7	8.5	10.1	10.4	7.5	10.9	27.0	7.0	4.4	2.3	1.3	4.8	4.2	7.8	6.3	6.1	2.0	18.7	5.8	25.9	2.0	6.5	7.4	13.4	3.3	24.6	3.8	10.5	2.7	6.5	4.2	1.4	7.2	1.2	10.8	15.8	7.4	3.9	5.7	6.7	2.5	7.8	2.6	3.6	6.4	6.7	2.8	0.4	1.6	2.5	0.7	1.8	0.6	0.4	0.3	0.5	1.3	0.4	0.3	0.3	0.8	0.5	1.0	1.2	0.6	1.1	4.9	4.8	3.6	10.3	5.1	4.5	5.1	4.5	4.5	3.9	5.1	4.1	13.9	0.0	3.4	12.1	17.7	8.7	4.8	10.3	9.1	5.7	14.3	13.6	0.6	12.8	6.8	14.7	16.7	11.6	28.6	25.4	7.9	6.3	3.3	9.3	6.9	8.5	20.9	8.4	8.9	3.8	16.2	8.1	32.6	9.0	5.1	16.6	10.0	7.9	21.1	0.0	10.6	17.3	6.1	20.0	13.3	8.3	11.1	19.9	8.8	4.7	18.1	2.9	20.6	3.5	2.4	6.1	17.8	7.9	12.3	3.4	29.2	16.3	14.3	6.5	0.0	3.0	6.3	1.0	2.3	13.1	9.5	10.3	26.0	13.5	18.3	4.4
HDAC11		ENSG00000163517	"Histone deacetylase 11"	Q96DB2	3	13479724-13506424	"Enzymes, FDA approved drug targets, Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Chromatin regulator, Hydrolase, Repressor"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 122.7"	"Group enriched"	"Detected in many"	6	"Early spermatids: 357.7;Late spermatids: 692.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"SK-BR-3: 47.7;T-47d: 42.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"									NA	NA			"Cluster 48: NK-cells - Unknown function"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 25: Spermatids - Spermatogenesis"				"unprognostic (5.22e-2)"	"unprognostic (3.58e-2)"	"unprognostic (1.83e-1)"	"unprognostic (5.69e-3)"	"unprognostic (1.76e-1)"	"unprognostic (4.71e-2)"	"prognostic unfavorable (1.20e-5)"	"unprognostic (4.50e-2)"	"unprognostic (5.67e-3)"	"unprognostic (1.78e-2)"	"unprognostic (9.87e-2)"	"unprognostic (3.94e-1)"	"prognostic favorable (7.88e-10)"	"unprognostic (3.63e-2)"	"unprognostic (1.65e-1)"	"unprognostic (1.46e-1)"	"unprognostic (1.39e-3)"	7.7	10.1	92.5	3.9	115.5	0.8	9.4	89.2	98.4	16.9	62.8	18.0	12.2	11.8	6.5	17.6	13.3	9.1	31.4	82.5	90.5	25.1	6.6	9.1	2.8	95.2	100.1	16.7	38.1	23.2	22.8	4.6	87.4	15.9	6.9	6.2	17.4	12.2	51.5	18.7	13.4	7.3	83.9	5.3	12.8	84.2	100.5	4.9	16.5	15.5	4.1	14.7	14.4	122.7	12.0	8.0	8.0	6.6	11.9	10.4	6.5	7.5	5.4	7.8	5.1	4.0	10.4	1.0	9.3	11.6	12.3	8.9	4.7	14.6	5.0	5.1	4.4	2.4	3.7	11.3	12.6	0.2	4.1	9.0	26.6	8.7	6.8	14.2	5.8	7.6	5.0	2.1	7.7	12.2	1.5	1.7	2.1	8.1	20.9	1.7	11.8	3.4	16.6	9.0	1.3	6.2	12.1	47.7	21.8	6.6	42.6	2.8	5.3	6.7	13.0	13.0	4.7	1.5	4.5	0.2	2.1	1.8	4.1	0.1	2.6	5.8	3.3	1.6	2.3	1.1	3.1	2.6	1.8	0.4	3.0	2.1	1.0	9.6	0.6	1.7	2.6	1.9	92.5	115.5	89.2	98.4	82.5	90.5	95.2	100.1	87.4	83.9	100.5	122.7	5.2	9.6	5.0	11.4	0.9	11.5	7.7	11.0	8.6	8.5	10.6	8.0	84.6	8.6	8.9	11.0	0.0	18.9	2.8	23.1	19.6	14.6	357.7	8.6	5.2	6.3	8.9	0.8	6.9	11.4	3.1	9.7	9.7	7.8	1.3	5.0	7.1	2.8	6.0	10.1	7.1	14.4	18.3	3.5	3.8	692.3	16.1	3.6	8.8	1.0	4.6	21.8	2.1	12.5	46.9	11.1	13.6	15.4	0.7	5.1	36.1	24.9	12.0	5.6	0.0	5.6	9.5	15.3	7.3	10.1	10.5	5.7	3.3	3.1	20.0	6.8
HDAC2	"KDAC2, RPD3, YAF1"	ENSG00000196591	"Histone deacetylase 2"	Q92769	6	113933028-114011308	"Cancer-related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins"	"Biological rhythms, Transcription, Transcription regulation"	"Chromatin regulator, Hydrolase, Repressor"	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB005054, HPA011727"	Supported		Supported	Nucleoplasm		NA	NA		25000	"Cluster 27: Non-specific - Gene expression"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 20: Spermatogonia & Spermatocytes - Spermatogenesis"	Nucleoplasm		"CAB005054: AB_562295, HPA011727: AB_1850540"	"prognostic unfavorable (7.07e-4)"	"unprognostic (1.44e-1)"	"unprognostic (2.67e-1)"	"unprognostic (2.56e-2)"	"unprognostic (2.61e-2)"	"unprognostic (1.89e-2)"	"prognostic unfavorable (5.39e-10)"	"unprognostic (2.03e-1)"	"unprognostic (2.63e-2)"	"unprognostic (9.00e-2)"	"unprognostic (2.01e-1)"	"unprognostic (3.92e-1)"	"unprognostic (1.84e-2)"	"unprognostic (1.96e-1)"	"unprognostic (2.42e-1)"	"unprognostic (9.80e-2)"	"unprognostic (3.51e-1)"	35.9	42.7	26.6	37.4	31.5	63.4	54.8	32.8	40.0	45.2	22.3	48.0	34.4	57.3	53.4	43.3	48.7	34.6	41.1	26.7	34.7	46.3	34.6	33.0	42.6	31.2	29.5	53.4	37.1	45.7	35.9	56.1	31.2	47.0	53.6	37.2	34.3	45.3	48.6	46.1	36.7	54.3	28.8	35.9	40.5	76.7	31.1	68.5	45.6	43.4	52.1	63.2	37.5	37.5	126.7	84.9	387.1	224.3	97.7	110.5	162.6	146.6	119.0	168.5	200.1	226.3	90.1	103.6	119.0	132.5	173.1	96.6	266.0	148.1	281.4	148.9	185.0	249.2	102.1	131.8	129.7	256.1	107.7	90.0	97.6	180.0	167.2	164.4	199.6	179.2	326.4	101.6	282.7	105.5	231.9	229.6	220.0	133.4	116.3	155.0	193.0	95.2	174.4	148.9	258.3	219.1	115.9	107.5	127.7	231.4	78.6	294.0	163.2	107.0	122.9	113.7	246.9	80.6	113.9	244.6	90.9	242.6	185.3	43.5	39.0	42.1	28.0	38.6	37.3	37.0	34.0	30.3	51.0	31.4	41.8	39.1	23.1	39.8	50.2	44.2	36.0	37.2	26.6	31.5	32.8	40.0	26.7	34.7	31.2	29.5	31.2	28.8	31.1	37.5	40.2	57.7	57.8	13.4	51.4	192.1	91.3	152.6	85.4	31.0	61.0	54.6	64.0	25.8	116.4	53.3	4.2	157.7	42.6	43.5	43.0	154.9	86.8	74.3	91.6	73.8	100.5	129.4	29.9	105.0	140.7	76.2	53.5	63.2	55.1	103.9	50.0	31.9	102.0	15.2	26.3	73.4	175.0	64.1	89.8	109.1	83.0	63.3	83.6	26.2	107.7	30.9	33.0	29.1	34.0	133.6	51.3	67.4	56.2	90.0	37.4	71.7	98.7	28.1	39.5	94.7	88.0	199.0	215.5	96.5	193.1	207.7	45.5	53.9	94.6	100.5
HDAC3	"HD3, KDAC3, RPD3, RPD3-2"	ENSG00000171720	"Histone deacetylase 3"	O15379	5	141620876-141636849	"Enzymes, FDA approved drug targets, Metabolic proteins, Predicted intracellular proteins"	"Biological rhythms, Host-virus interaction, Transcription, Transcription regulation"	"Chromatin regulator, Hydrolase, Repressor"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB005583, HPA052052, CAB072336"	Supported		Supported	"Nucleoplasm,Golgi apparatus"		NA	NA			"Cluster 28: Myeloid DCs - Unknown function"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 3: Monocytes - Immune response regulation"	Nucleoplasm	"Golgi apparatus"	"CAB005583: AB_562296, CAB072336: , HPA052052: AB_2681708"	"unprognostic (6.65e-2)"	"unprognostic (1.96e-1)"	"prognostic favorable (3.39e-4)"	"unprognostic (1.17e-1)"	"unprognostic (1.24e-1)"	"unprognostic (1.07e-1)"	"unprognostic (1.19e-2)"	"unprognostic (3.16e-1)"	"unprognostic (5.56e-2)"	"unprognostic (2.45e-2)"	"prognostic favorable (3.95e-4)"	"unprognostic (1.12e-1)"	"prognostic unfavorable (2.65e-6)"	"unprognostic (1.85e-1)"	"unprognostic (1.63e-2)"	"unprognostic (2.28e-3)"	"unprognostic (2.17e-1)"	24.3	39.8	7.8	22.7	8.4	37.3	25.3	7.8	9.5	25.7	9.9	23.3	18.7	23.5	26.4	34.1	26.5	20.3	24.4	8.7	8.4	24.2	39.6	21.4	32.7	8.2	8.0	26.0	28.4	44.9	18.4	22.4	7.9	20.6	24.5	16.4	25.5	21.9	40.2	40.8	23.5	26.1	8.5	27.8	23.3	15.8	8.5	38.3	24.1	34.1	42.7	26.2	25.8	8.2	59.8	40.2	74.0	109.5	68.5	54.3	47.0	42.6	93.5	94.8	134.8	86.5	49.7	86.4	54.0	56.2	67.3	51.2	72.9	98.8	117.0	74.6	79.0	68.8	33.3	50.4	48.1	83.5	60.1	47.0	63.2	55.3	71.3	49.6	61.9	76.8	67.6	44.7	61.5	55.8	92.1	72.9	63.9	36.8	31.0	65.8	76.2	62.3	49.9	59.7	60.2	49.4	57.0	57.1	71.7	46.2	61.8	52.3	32.1	58.3	36.1	45.8	71.8	36.6	47.8	82.1	48.8	78.6	50.8	41.3	51.7	39.6	34.1	53.8	45.5	47.8	42.5	41.9	107.5	47.5	45.9	38.5	21.5	35.1	46.8	55.1	55.6	43.8	7.8	8.4	7.8	9.5	8.7	8.4	8.2	8.0	7.9	8.5	8.5	8.2	19.1	9.6	13.2	16.6	36.0	44.2	26.8	38.1	37.0	33.2	29.0	25.5	15.9	18.6	19.6	12.9	60.5	55.3	43.8	18.5	21.5	33.4	10.4	10.0	21.0	21.3	18.0	50.7	40.6	35.4	51.6	28.8	19.9	10.2	18.4	33.9	21.4	18.7	38.8	50.5	38.2	19.7	28.5	19.5	44.9	4.2	22.4	31.7	32.0	10.3	51.1	33.3	38.1	22.1	21.9	33.4	16.3	22.2	36.3	28.7	19.5	20.5	10.8	36.5	26.3	18.1	24.7	25.4	27.5	38.1	51.4	61.2	30.3	42.6	25.9	30.3
HDAC4	"BDMR, HA6116, HD4, HDAC-4, HDAC-A, HDACA, KIAA0288"	ENSG00000068024	"Histone deacetylase 4"	P56524	2	239048168-239401654	"Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Chromatin regulator, Hydrolase, Repressor"	"Autism spectrum disorder, FDA approved drug targets, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"skeletal muscle: 58.2"	"Group enriched"	"Detected in many"	4	"Astrocytes: 62.0;Early spermatids: 69.9;Excitatory neurons: 118.1;Inhibitory neurons: 84.9;Late spermatids: 59.0;Microglial cells: 38.4;Oligodendrocyte precursor cells: 85.5;Oligodendrocytes: 124.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in many"		"basophil: 32.0;neutrophil: 47.7"	"Lineage enriched"	"Detected in many"	5	"granulocytes: 47.7"	"Cell line enhanced"	"Detected in many"		"JURKAT: 49.1;MOLT-4: 48.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA048723, HPA071448"	Approved		Supported	"Nucleoplasm,Nuclear speckles,Cytosol"		NA	NA			"Cluster 6: Non-specific - Transcription"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	"Nuclear speckles"	"Nucleoplasm, Cytosol"	"HPA048723: AB_2680501, HPA071448: "	"unprognostic (1.54e-1)"	"unprognostic (1.76e-2)"	"unprognostic (1.33e-1)"	"unprognostic (1.18e-3)"	"unprognostic (2.43e-2)"	"unprognostic (2.39e-3)"	"unprognostic (3.06e-4)"	"unprognostic (1.00e-1)"	"unprognostic (1.24e-1)"	"prognostic unfavorable (6.33e-4)"	"prognostic favorable (1.13e-4)"	"unprognostic (1.40e-1)"	"unprognostic (4.82e-3)"	"unprognostic (2.40e-1)"	"unprognostic (3.26e-2)"	"unprognostic (1.32e-2)"	"unprognostic (6.04e-2)"	4.4	6.3	9.3	5.0	12.0	17.0	3.8	0.6	13.4	7.5	0.1	29.0	2.7	9.1	2.5	8.0	6.7	7.1	5.2	9.0	6.5	3.7	2.4	3.9	3.5	9.9	6.1	7.5	3.7	2.7	6.5	1.5	11.2	5.6	3.4	2.4	3.3	5.9	58.2	5.9	7.2	6.2	2.3	5.6	7.2	9.2	6.7	9.7	4.2	35.6	2.5	10.0	4.5	10.1	3.2	5.8	4.1	6.1	4.5	3.9	5.9	3.0	2.3	2.3	1.7	2.9	7.5	2.0	1.9	3.4	3.6	3.4	4.0	2.0	1.4	12.8	1.8	3.1	5.1	5.8	3.8	5.5	4.6	4.4	2.6	4.6	3.3	2.3	2.4	49.1	3.7	4.5	2.7	4.7	48.1	10.7	4.0	6.0	2.8	7.6	7.2	4.0	5.3	4.4	4.6	6.4	5.3	2.5	16.2	2.6	1.0	17.9	1.9	5.0	0.4	6.8	4.6	3.3	3.2	3.1	6.9	6.9	7.4	32.0	10.2	2.3	1.0	3.3	1.2	0.2	1.1	1.0	1.0	0.1	0.5	0.5	47.7	3.2	1.7	0.6	1.7	1.1	9.3	12.0	0.6	13.4	9.0	6.5	9.9	6.1	11.2	2.3	6.7	10.1	8.6	3.2	7.4	62.0	5.2	7.9	2.9	3.0	8.6	12.2	6.2	4.8	13.3	7.2	2.9	11.0	2.1	1.5	12.8	4.1	0.0	2.8	69.9	7.0	15.1	7.1	6.0	6.1	118.1	2.2	1.7	14.0	7.7	7.4	2.5	6.6	11.7	6.7	3.2	16.8	84.9	5.2	2.0	17.2	10.0	59.0	11.8	10.3	5.4	38.4	14.9	8.6	15.5	85.5	124.0	1.9	1.6	12.4	7.0	6.4	5.0	1.6	2.6	7.1	0.0	18.7	6.5	2.8	3.3	11.1	9.7	1.4	12.2	4.9	6.4	2.7
HDAC5	"FLJ90614, KIAA0600, NY-CO-9"	ENSG00000108840	"Histone deacetylase 5"	Q9UQL6	17	44076746-44123702	"Cancer-related genes, Enzymes, FDA approved drug targets, Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Chromatin regulator, Hydrolase, Repressor"	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Cone photoreceptor cells: 118.9;Syncytiotrophoblasts: 218.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB019400, HPA030991"	Approved		Supported	"Nuclear speckles,Golgi apparatus,Cytosol"		NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 27: Brain & Skin - Unknown function"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 18: Syncytiotrophoblasts - Pregnancy hormone signaling"	"Nuclear speckles"	"Golgi apparatus, Cytosol"	"CAB019400: AB_2116626, HPA030991: AB_10795286"	"unprognostic (1.30e-2)"	"prognostic favorable (6.14e-4)"	"unprognostic (6.65e-2)"	"unprognostic (8.06e-2)"	"unprognostic (3.49e-1)"	"unprognostic (3.52e-2)"	"prognostic unfavorable (3.12e-5)"	"unprognostic (8.80e-3)"	"unprognostic (3.80e-2)"	"unprognostic (2.37e-2)"	"unprognostic (4.91e-3)"	"unprognostic (4.30e-1)"	"prognostic favorable (3.30e-5)"	"unprognostic (1.51e-2)"	"unprognostic (3.11e-1)"	"unprognostic (6.00e-2)"	"unprognostic (1.76e-2)"	30.8	24.7	39.3	10.9	33.5	20.7	28.8	48.8	48.5	40.6	3.3	36.3	11.6	33.2	15.5	45.1	34.1	15.9	53.5	40.4	31.6	24.8	17.4	33.6	14.0	37.6	41.1	45.0	22.5	31.5	48.1	22.6	35.1	29.2	7.3	24.3	22.9	15.1	77.5	71.3	22.9	14.8	22.4	26.4	24.0	19.7	40.0	10.4	30.8	28.6	11.6	29.2	37.0	50.3	8.7	5.5	14.9	3.5	28.2	21.7	53.6	22.8	56.1	11.3	18.1	12.3	9.1	13.5	9.0	54.4	16.5	6.9	17.6	9.8	4.7	21.2	28.7	26.3	18.6	28.6	12.2	8.7	35.7	31.2	16.5	12.8	15.8	19.0	9.3	10.6	20.0	26.5	65.5	6.7	14.3	26.2	16.4	6.7	13.0	54.7	41.6	35.4	1.2	3.8	38.6	20.3	6.7	27.6	31.2	21.8	39.3	49.6	5.1	27.8	17.5	6.6	11.7	43.6	39.7	16.2	16.0	10.7	13.4	11.6	9.2	9.7	5.4	13.5	3.8	7.2	4.3	5.4	11.1	7.5	4.5	4.0	20.9	4.5	16.8	9.7	4.1	7.3	39.3	33.5	48.8	48.5	40.4	31.6	37.6	41.1	35.1	22.4	40.0	50.3	24.0	12.8	13.7	11.1	20.4	29.2	32.3	9.0	26.2	87.8	23.8	21.3	27.1	30.0	11.9	20.2	118.9	21.9	19.6	22.4	21.5	17.2	20.2	17.1	10.7	22.1	46.0	9.3	18.9	8.7	53.1	24.1	10.2	25.1	12.6	47.0	24.3	9.3	22.7	82.4	31.0	14.9	6.1	18.5	17.8	10.0	48.4	29.8	14.2	12.2	16.5	18.9	11.3	14.1	26.2	11.5	16.5	43.6	14.2	41.2	21.5	7.3	12.4	60.4	65.7	31.8	40.1	4.2	32.7	28.1	32.8	218.1	17.0	29.9	11.3	25.3
HDAC6	"FLJ16239, HD6, JM21, KIAA0901, PPP1R90"	ENSG00000094631	"Histone deacetylase 6"	Q9UBN7	X	48801377-48824982	"Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Predicted intracellular proteins"	"Autophagy, Transcription, Transcription regulation"	"Actin-binding, Chromatin regulator, Hydrolase, Repressor"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Spermatocytes: 88.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003714, CAB004236, HPA026321"	Supported		Supported	Nucleoplasm		NA	NA			"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 43: Testis - Unknown function"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 13: Spermatocytes & Spermatogonia - Spermatogenesis"	Nucleoplasm		"CAB004236: AB_627708, HPA003714: AB_1850544, HPA026321: AB_1850546"	"unprognostic (9.53e-2)"	"unprognostic (1.59e-1)"	"unprognostic (2.66e-2)"	"unprognostic (2.42e-2)"	"unprognostic (2.82e-2)"	"unprognostic (4.11e-3)"	"unprognostic (2.17e-2)"	"unprognostic (1.16e-1)"	"unprognostic (7.68e-2)"	"unprognostic (2.83e-1)"	"unprognostic (1.16e-3)"	"unprognostic (2.33e-2)"	"unprognostic (6.10e-2)"	"unprognostic (1.47e-1)"	"unprognostic (6.60e-2)"	"unprognostic (2.34e-1)"	"prognostic favorable (3.34e-4)"	21.9	26.0	26.6	14.2	30.7	22.9	23.6	31.1	54.2	29.6	29.8	27.8	17.8	26.8	10.6	24.4	28.2	11.1	26.0	26.7	33.0	57.9	97.3	25.2	15.6	32.6	32.7	32.5	26.3	22.3	45.6	13.8	33.9	24.4	16.1	27.9	21.6	12.2	26.1	21.4	28.0	15.3	28.9	29.4	26.6	53.8	30.6	18.8	27.1	16.1	15.1	23.7	22.8	31.0	31.0	25.7	49.6	19.1	20.2	16.6	33.4	14.4	12.4	27.2	26.2	24.9	25.7	29.9	13.8	17.1	34.6	21.3	30.6	15.5	23.2	27.7	19.1	40.7	32.2	26.0	18.3	19.2	60.4	25.7	25.1	21.5	25.3	24.8	23.5	37.4	45.9	31.9	17.7	10.9	27.0	29.3	18.5	14.2	24.5	23.1	53.5	31.3	15.8	13.3	25.9	25.3	29.5	8.7	17.4	63.4	36.1	17.5	19.1	21.5	26.7	29.3	14.2	29.6	31.3	21.3	21.3	24.0	21.5	0.0	5.1	5.8	4.7	8.3	3.4	3.7	3.3	3.4	7.6	5.3	3.1	2.9	2.5	3.6	11.7	8.3	4.0	4.9	26.6	30.7	31.1	54.2	26.7	33.0	32.6	32.7	33.9	28.9	30.6	31.0	11.4	19.2	25.1	20.9	12.5	7.5	10.2	8.8	6.2	37.6	10.7	10.4	10.6	8.6	17.5	18.4	50.1	11.5	12.6	21.4	19.6	7.9	48.1	10.0	13.0	10.3	14.4	11.4	15.2	7.4	12.3	10.7	21.9	13.2	6.3	22.5	13.6	51.9	11.1	40.4	18.4	15.5	10.2	12.3	9.8	18.4	14.0	13.2	5.4	10.3	12.7	21.9	18.6	17.1	19.0	7.2	13.2	11.3	12.8	7.1	17.8	47.6	12.4	34.0	13.1	15.5	11.1	88.4	41.7	8.6	5.8	9.7	9.7	21.8	16.2	7.2
HDAC7	"DKFZP586J0917, HDAC7A"	ENSG00000061273	"Histone deacetylase 7"	Q8WUI4	12	47782722-47833132	"Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Chromatin regulator, Hydrolase, Repressor"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Hepatic stellate cells: 101.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in some"	4	"neutrophil: 6.5"	"Lineage enriched"	"Detected in many"	4	"granulocytes: 6.5"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA004775			Supported	Cytosol		NA	NA			"Cluster 1: Neutrophils - Mixed function"	"Cluster 89: Fibroblasts - ECM organization"	"Cluster 38: EFO-21 - Unknown function"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	Cytosol		"HPA004775: AB_1850548"	"unprognostic (3.83e-1)"	"unprognostic (9.49e-3)"	"unprognostic (1.37e-2)"	"unprognostic (4.46e-2)"	"unprognostic (6.56e-3)"	"unprognostic (2.22e-2)"	"unprognostic (2.50e-3)"	"unprognostic (1.26e-1)"	"prognostic unfavorable (5.16e-4)"	"unprognostic (1.28e-1)"	"unprognostic (2.07e-1)"	"unprognostic (2.38e-2)"	"prognostic unfavorable (8.25e-4)"	"unprognostic (6.24e-2)"	"unprognostic (4.38e-2)"	"unprognostic (9.69e-2)"	"prognostic favorable (4.65e-4)"	52.5	41.8	7.7	28.5	8.1	23.6	45.3	3.2	9.7	46.2	24.6	44.2	8.9	51.4	13.6	23.5	50.3	16.8	31.6	4.1	4.8	29.3	6.0	55.0	27.3	17.2	7.1	44.9	14.5	20.1	20.6	19.5	10.2	34.4	4.8	2.8	30.6	17.1	16.2	40.1	28.6	16.9	3.4	38.4	27.2	7.9	10.7	80.0	39.2	9.4	15.2	44.3	38.5	7.6	41.6	28.1	28.6	46.9	21.9	60.2	25.3	39.4	30.7	28.3	18.8	37.4	38.4	80.5	126.8	37.1	13.9	37.8	6.7	31.4	10.5	38.8	13.6	27.6	29.9	8.6	23.6	9.1	1.2	39.4	10.8	28.6	15.4	51.6	58.6	45.9	29.9	33.4	18.6	18.0	83.2	21.8	39.4	9.1	29.1	64.2	14.7	29.6	12.1	26.9	8.1	18.8	30.6	14.1	14.4	18.4	13.4	12.0	66.6	56.9	61.0	47.6	28.9	70.8	58.8	67.4	23.8	41.9	19.1	0.0	1.4	0.0	0.8	0.5	0.9	0.8	0.7	0.7	0.4	0.5	0.8	0.6	6.5	0.9	0.5	0.3	0.3	1.5	7.7	8.1	3.2	9.7	4.1	4.8	17.2	7.1	10.2	3.4	10.7	7.6	80.6	41.7	32.1	34.9	32.7	13.8	26.8	28.7	8.6	20.3	22.5	17.4	13.4	28.6	28.6	36.8	0.0	4.8	18.6	5.3	1.9	31.6	15.5	26.2	39.4	79.3	7.3	40.4	19.9	23.0	3.5	37.8	25.5	58.4	8.8	20.2	101.7	2.0	15.6	28.6	17.5	9.6	24.4	32.7	14.1	6.9	55.0	13.3	14.2	46.9	20.5	11.7	28.8	10.6	13.6	66.8	7.3	33.1	42.9	69.1	0.6	3.8	31.8	4.0	26.3	18.3	26.9	1.1	3.7	10.3	21.6	2.9	28.2	9.3	8.1	46.8
HDAC8	"HDACL1, KDAC8, MRXS6, RPD3, WTS"	ENSG00000147099	"Histone deacetylase 8"	Q9BY41	X	72329516-72573101	"Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Chromatin regulator, Hydrolase, Repressor"	"Disease variant, FDA approved drug targets, Mental retardation, Obesity"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 120.8;Excitatory neurons: 186.8;Inhibitory neurons: 191.3;Microglial cells: 134.9;Oligodendrocyte precursor cells: 146.8;Oligodendrocytes: 141.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											HPA048560	Supported					NA	NA			"Cluster 22: NK-cells - Unknown function"	"Cluster 68: Epididymis - Unknown function"	"Cluster 24: NB-4 - Immune response"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"			"HPA048560: AB_2680442"	"unprognostic (1.42e-1)"	"unprognostic (6.62e-3)"	"unprognostic (3.20e-2)"	"unprognostic (9.24e-3)"	"unprognostic (1.10e-1)"	"unprognostic (1.10e-1)"	"unprognostic (4.64e-2)"	"unprognostic (6.03e-2)"	"unprognostic (1.58e-1)"	"unprognostic (2.81e-2)"	"unprognostic (3.17e-2)"	"unprognostic (9.68e-2)"	"unprognostic (8.42e-2)"	"unprognostic (2.33e-3)"	"unprognostic (9.10e-2)"	"unprognostic (7.15e-3)"	"unprognostic (2.12e-3)"	9.2	21.2	16.1	9.8	16.2	17.5	10.3	23.2	19.1	10.3	14.4	9.8	8.5	9.5	22.8	10.2	8.8	9.7	11.9	15.8	19.4	15.1	16.3	9.0	10.9	14.4	13.2	11.2	11.0	11.5	13.4	9.5	15.1	11.2	11.8	16.5	11.4	8.1	10.7	11.5	8.1	10.6	9.7	8.4	10.2	4.2	16.2	8.6	13.0	10.4	10.9	9.7	9.6	20.8	21.0	27.2	20.5	29.9	26.9	24.4	13.5	14.0	21.3	15.9	19.1	20.8	23.3	15.2	38.6	17.2	27.5	14.5	37.0	23.1	21.7	25.9	25.5	21.5	32.7	22.4	14.2	29.9	30.4	22.3	15.4	20.2	15.1	27.6	27.1	20.3	22.4	38.4	24.4	24.8	15.9	53.8	25.9	31.2	38.1	19.7	24.0	26.7	32.8	21.0	16.5	33.0	26.7	19.7	26.9	25.9	12.0	26.9	21.8	15.0	21.3	19.4	13.5	13.5	28.1	18.1	18.5	34.7	20.3	13.8	16.5	28.1	10.5	13.8	8.7	11.9	11.2	9.6	17.2	12.2	8.4	7.5	1.7	10.9	14.5	6.0	15.6	9.8	16.1	16.2	23.2	19.1	15.8	19.4	14.4	13.2	15.1	9.7	16.2	20.8	13.0	3.2	25.7	120.8	14.5	6.1	12.7	15.3	17.1	15.4	9.5	9.7	11.3	12.8	15.7	7.3	43.8	16.4	8.0	7.2	9.8	13.9	0.9	8.8	11.3	12.5	9.1	17.1	186.8	12.4	13.2	14.0	10.7	8.4	12.0	19.2	12.5	10.3	15.8	23.5	191.3	9.3	16.2	8.2	9.0	1.2	11.8	13.3	7.2	134.9	10.9	10.3	8.2	146.8	141.1	11.2	4.7	10.5	19.9	10.6	9.3	22.6	17.4	17.3	26.3	10.1	16.0	4.7	0.8	12.6	6.3	13.5	11.8	15.1	9.7	12.6
HDAC9	"HD7, HDAC, HDAC7B, KIAA0744, MITR"	ENSG00000048052	"Histone deacetylase 9"	Q9UKV0	7	18086949-19002416	"Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Chromatin regulator, Hydrolase, Repressor"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"choroid plexus: 47.5"	"Group enriched"	"Detected in many"	4	"Early spermatids: 244.6;Excitatory neurons: 376.2;Inhibitory neurons: 442.3;Microglial cells: 334.5;Oligodendrocyte precursor cells: 322.7;Oligodendrocytes: 233.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"myeloid DC: 74.1"	"Group enriched"	"Detected in all"	9	"B-cells: 52.6;dendritic cells: 74.1;monocytes: 24.4"	"Cell line enhanced"	"Detected in many"		"HAP1: 163.6;hTERT-HME1: 79.4;SH-SY5Y: 65.7;U-698: 64.5;WM-115: 69.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA028926	Uncertain		Approved	Nucleoplasm		NA	NA			"Cluster 23: Antigen presenting cells - Antigen presentation"	"Cluster 20: Retina & Lymphoid tissues - Unknown function"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Nucleoplasm		"HPA028926: AB_10602327"	"unprognostic (2.06e-2)"	"unprognostic (2.67e-1)"	"unprognostic (2.30e-1)"	"unprognostic (1.17e-1)"	"unprognostic (2.74e-1)"	"unprognostic (5.54e-2)"	"unprognostic (2.20e-2)"	"unprognostic (2.32e-1)"	"unprognostic (2.21e-1)"	"unprognostic (2.45e-1)"	"unprognostic (5.01e-1)"	"unprognostic (7.58e-2)"	"unprognostic (1.29e-1)"	"unprognostic (3.94e-2)"	"unprognostic (1.32e-1)"	"unprognostic (1.02e-1)"	"unprognostic (6.87e-3)"	8.2	12.3	5.8	8.8	6.6	5.9	5.1	4.8	7.9	10.1	47.5	5.4	3.4	13.2	6.0	2.9	9.3	6.7	14.3	5.5	3.8	2.8	2.8	5.1	18.9	6.0	6.7	2.4	1.5	1.8	6.5	6.3	6.0	11.0	5.5	25.4	7.1	14.5	16.7	2.2	4.5	13.0	3.8	17.5	8.7	5.6	12.9	6.8	2.9	5.8	18.7	5.2	4.9	7.3	40.2	0.2	6.3	0.1	0.9	8.4	0.2	2.4	23.0	9.5	16.1	0.3	12.7	16.7	41.9	26.0	51.6	5.8	163.6	3.2	24.2	0.2	1.1	0.0	0.2	0.0	0.2	3.5	0.1	3.0	3.1	29.7	79.4	8.4	0.4	2.7	0.0	25.1	13.3	0.0	1.6	3.5	20.3	0.0	3.9	4.7	2.5	10.2	5.2	10.6	11.6	65.7	0.5	0.3	12.7	9.7	0.6	15.2	1.8	34.4	11.1	1.9	22.3	28.8	13.3	64.5	9.0	1.6	69.2	0.3	24.4	0.1	4.2	16.5	4.1	52.6	1.4	2.0	74.1	43.2	0.0	2.1	1.4	5.5	10.3	15.9	5.6	12.9	5.8	6.6	4.8	7.9	5.5	3.8	6.0	6.7	6.0	3.8	12.9	7.3	31.4	6.4	2.8	28.1	46.1	2.4	0.7	6.8	6.2	33.0	1.4	0.8	15.2	0.0	12.9	0.0	16.7	0.1	16.3	15.3	3.9	6.8	244.6	24.2	2.3	16.5	7.2	5.7	376.2	0.7	0.2	5.3	13.7	26.1	1.3	0.0	8.9	1.0	12.9	20.2	442.3	0.7	4.1	51.2	64.2	80.1	1.5	34.8	16.0	334.5	21.0	5.1	11.3	322.7	233.1	10.6	6.7	0.7	46.7	1.6	0.0	0.1	17.5	26.2	6.6	2.3	9.0	34.3	8.7	0.7	2.0	0.1	7.8	0.1	0.3	12.1
HDDC2	"C6orf74, CGI-130, dJ167O5.2"	ENSG00000111906	"HD domain containing 2"	Q7Z4H3	6	125219962-125302078	"Enzymes, Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Distal tubular cells: 338.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA035677	Approved		Approved	Nucleoplasm,Nucleoli		NA	NA		44000	"Cluster 37: B-cells - Transcription"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 39: Non-specific - Basic cellular processes"	Nucleoli	Nucleoplasm	"HPA035677: AB_10603768"	"unprognostic (8.34e-2)"	"unprognostic (5.41e-2)"	"unprognostic (6.52e-2)"	"unprognostic (6.25e-2)"	"unprognostic (2.78e-2)"	"unprognostic (6.39e-3)"	"unprognostic (1.04e-3)"	"unprognostic (1.76e-1)"	"unprognostic (2.18e-1)"	"unprognostic (2.38e-2)"	"unprognostic (8.59e-3)"	"unprognostic (5.13e-2)"	"unprognostic (4.56e-2)"	"unprognostic (2.54e-1)"	"unprognostic (3.68e-2)"	"unprognostic (1.80e-2)"	"unprognostic (9.54e-2)"	47.4	84.4	58.0	20.1	65.9	19.7	42.1	59.5	98.5	47.2	78.4	38.8	20.3	36.2	29.6	49.7	37.0	15.1	82.3	60.8	64.5	75.6	22.9	31.9	27.1	65.1	66.8	41.1	44.5	49.4	50.0	15.7	63.0	38.5	22.1	31.5	45.8	23.8	118.1	39.0	30.6	13.6	60.8	27.6	43.7	58.7	61.6	22.2	40.3	60.7	24.8	39.2	39.5	60.7	29.7	81.2	46.2	191.3	23.0	30.8	59.7	36.4	41.4	30.9	33.1	122.7	30.4	119.9	80.8	57.4	89.0	26.5	53.1	41.1	36.5	46.7	166.8	55.2	43.6	125.1	65.0	76.6	45.3	56.0	61.8	49.6	104.6	44.6	20.2	67.8	205.1	51.4	59.5	162.7	61.2	73.8	57.7	79.9	58.8	92.8	37.2	25.2	68.7	34.1	84.0	44.5	43.9	84.8	88.8	35.4	50.2	126.6	18.2	37.7	44.5	58.8	75.8	72.1	48.2	110.1	56.0	122.6	80.4	13.8	33.4	6.7	53.3	30.6	43.8	71.2	57.7	72.6	36.1	59.4	71.3	78.2	7.3	62.1	29.0	38.3	55.7	44.0	58.0	65.9	59.5	98.5	60.8	64.5	65.1	66.8	63.0	60.8	61.6	60.7	23.0	25.6	41.2	22.5	39.3	44.6	64.3	114.9	70.6	62.6	73.5	114.4	119.9	37.1	55.3	62.5	14.6	86.6	56.0	35.0	338.5	86.0	61.3	50.9	60.7	24.2	64.5	33.4	17.1	98.0	156.4	67.5	33.6	37.5	38.0	84.8	9.3	21.3	112.2	69.0	17.9	76.4	77.3	54.2	20.4	42.1	91.0	34.6	80.0	15.0	31.7	90.5	155.5	19.1	10.6	58.5	45.3	114.7	47.4	101.9	72.3	254.8	38.9	25.0	39.5	83.9	72.6	124.5	74.6	88.6	43.0	45.7	47.6	145.8	84.1	57.9
HDDC3	"MESH1, MGC45386"	ENSG00000184508	"HD domain containing 3"	Q8N4P3	15	90929968-90935196	"Enzymes, Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA040895	Approved		Approved	Nucleoplasm,Cytosol		No	No			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 22: Non-specific - Unknown function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 39: Non-specific - Basic cellular processes"	"Nucleoplasm, Cytosol"		"HPA040895: AB_10795494"	"unprognostic (1.03e-1)"	"unprognostic (3.78e-2)"	"unprognostic (1.32e-1)"	"unprognostic (1.29e-2)"	"unprognostic (1.10e-1)"	"unprognostic (3.75e-2)"	"unprognostic (2.53e-1)"	"unprognostic (3.57e-1)"	"unprognostic (1.28e-1)"	"unprognostic (5.93e-3)"	"unprognostic (1.08e-1)"	"unprognostic (1.91e-2)"	"unprognostic (3.43e-2)"	"unprognostic (2.26e-1)"	"unprognostic (4.86e-2)"	"unprognostic (3.15e-1)"	"unprognostic (4.65e-1)"	13.0	13.1	15.5	7.9	15.1	10.4	9.2	15.0	20.0	6.5	13.9	11.2	10.3	4.3	8.2	5.9	10.4	4.6	13.3	15.1	14.8	12.1	11.4	6.4	8.2	15.1	14.8	6.5	20.0	15.7	8.0	7.0	14.7	7.0	9.1	7.1	20.7	5.8	13.3	7.7	11.9	3.9	15.3	9.3	9.7	4.5	16.1	7.4	9.8	14.6	9.2	5.5	5.5	15.7	12.7	15.7	5.3	6.4	11.8	11.8	9.0	8.5	11.4	7.7	11.5	7.7	25.5	24.2	8.5	7.0	6.1	19.3	11.1	19.3	6.3	30.4	24.4	30.5	6.0	17.7	23.9	11.6	14.1	10.5	30.1	13.9	24.8	12.2	17.0	19.5	24.6	20.7	6.9	19.1	16.1	10.0	4.3	47.2	15.6	13.2	2.1	38.2	15.8	13.2	13.3	8.5	7.1	19.2	21.4	11.0	29.2	30.5	9.8	4.7	10.5	8.1	10.9	33.5	41.4	16.7	17.5	22.4	14.3	10.1	20.1	8.5	23.3	27.4	30.1	35.1	30.0	26.3	27.4	31.4	34.6	25.5	4.7	31.5	26.7	44.0	31.9	25.6	15.5	15.1	15.0	20.0	15.1	14.8	15.1	14.8	14.7	15.3	16.1	15.7	42.8	28.9	7.4	5.9	23.5	5.6	14.1	22.5	6.8	13.8	27.8	30.1	1.1	44.3	21.6	16.5	4.2	48.2	19.1	18.1	76.3	42.3	4.6	18.8	12.4	19.0	19.9	34.3	4.8	56.5	33.0	12.7	13.7	18.6	7.0	14.3	15.7	41.4	45.9	15.2	5.2	32.9	12.2	15.1	10.9	4.3	14.3	19.6	14.2	1.9	36.3	39.9	34.0	1.0	3.9	28.4	30.2	11.7	31.7	14.7	59.7	71.5	20.6	38.8	6.6	13.2	11.5	29.6	38.4	17.2	8.4	24.2	21.4	21.7	33.0	13.5
HELB		ENSG00000127311	"DNA helicase B"	Q8NG08	12	66302493-66343643	"Enzymes, Predicted intracellular proteins"	"DNA damage, DNA repair"	"Helicase, Hydrolase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in some"			"Cell type enhanced"	"Detected in many"		"dendritic cells: 32.8;T-cells: 43.5"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"A549: 2.7;HDLM-2: 2.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA052461			Approved	"Nucleoplasm,Plasma membrane"		NA	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 20: HeLa - Mitochondria"	"Cluster 24: Non-specific - Transcription regulation"	"Nucleoplasm, Plasma membrane"		"HPA052461: "	"unprognostic (1.33e-1)"	"unprognostic (1.67e-1)"	"unprognostic (1.97e-1)"	"unprognostic (9.06e-3)"	"unprognostic (8.65e-2)"	"unprognostic (1.34e-2)"	"unprognostic (2.00e-1)"	"unprognostic (5.22e-2)"	"unprognostic (1.20e-1)"	"unprognostic (2.13e-1)"	"unprognostic (1.10e-1)"	"unprognostic (2.45e-1)"	"unprognostic (1.39e-6)"	"unprognostic (3.97e-3)"	"unprognostic (9.19e-4)"	"unprognostic (1.93e-1)"	"unprognostic (9.50e-3)"	0.8	0.3	0.1	0.4	0.1	1.0	0.7	0.1	0.3	0.5	0.2	0.7	0.0	0.4	0.0	0.6	0.5	0.1	0.4	0.1	0.1	0.7	1.2	1.1	0.5	0.4	0.2	0.8	0.9	0.1	1.2	0.0	0.3	0.8	0.1	0.1	0.8	0.0	0.2	0.5	1.2	0.1	0.2	1.8	0.8	0.4	0.3	0.4	0.7	0.0	0.3	0.5	0.6	0.4	0.4	2.7	0.2	0.6	0.1	0.1	0.5	0.6	0.1	0.6	1.2	0.6	1.5	1.0	0.9	0.1	0.9	0.8	0.5	0.2	0.3	2.6	0.2	0.8	2.1	0.0	0.0	0.0	0.5	0.0	0.0	0.7	0.1	0.2	0.1	1.3	0.6	1.1	0.4	1.1	0.0	0.2	0.0	1.1	0.5	0.2	1.0	0.2	0.0	0.0	0.1	0.3	1.7	0.2	0.4	0.4	0.3	1.7	0.2	0.2	0.5	0.3	0.5	1.2	1.0	0.5	0.1	0.9	0.4	4.5	0.8	5.8	2.6	0.5	4.2	0.4	4.9	3.9	1.7	0.7	5.1	4.1	0.7	3.5	0.2	0.6	5.6	1.0	0.1	0.1	0.1	0.3	0.1	0.1	0.4	0.2	0.3	0.2	0.3	0.4	14.7	0.0	7.5	1.3	14.0	0.6	2.5	0.6	10.8	3.2	10.3	9.8	4.0	0.0	6.6	0.0	12.5	3.0	32.8	4.3	1.9	1.7	0.5	12.6	11.5	9.9	4.8	6.1	7.7	1.1	2.5	5.7	11.7	20.9	2.5	10.3	4.6	2.8	3.3	13.5	5.2	5.6	2.0	5.5	3.3	0.8	3.4	10.3	3.6	20.6	8.0	2.4	14.4	0.0	16.2	2.4	3.0	0.7	21.7	5.8	5.9	3.2	3.4	6.5	0.0	11.3	8.0	1.2	1.5	5.2	1.7	2.5	43.5	9.2	6.4	1.8
HELQ	Hel308	ENSG00000163312	"Helicase, POLQ like"	Q8TDG4	4	83407343-83455855	"Enzymes, Predicted intracellular proteins"	"DNA damage, DNA repair"	"DNA-binding, Helicase, Hydrolase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036852, HPA036853"	Approved		Approved	"Nucleoplasm,Nuclear speckles"		NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 59: Non-specific - Transcription"	"Nuclear speckles"	Nucleoplasm	"HPA036852: AB_2675349, HPA036853: AB_10672102"	"unprognostic (4.58e-2)"	"unprognostic (3.25e-2)"	"unprognostic (1.12e-2)"	"unprognostic (1.12e-1)"	"unprognostic (4.80e-2)"	"unprognostic (5.56e-2)"	"unprognostic (1.14e-1)"	"unprognostic (5.13e-3)"	"unprognostic (7.14e-2)"	"unprognostic (8.62e-2)"	"prognostic favorable (9.07e-4)"	"unprognostic (2.03e-1)"	"prognostic favorable (2.76e-4)"	"unprognostic (3.54e-2)"	"unprognostic (1.43e-1)"	"unprognostic (1.57e-1)"	"unprognostic (1.37e-1)"	4.8	9.1	2.2	5.0	2.6	4.6	5.5	4.0	2.8	5.4	4.6	4.0	3.1	4.9	4.5	3.4	4.6	3.8	5.1	2.1	2.4	5.4	5.5	4.0	9.3	2.2	2.3	8.1	3.7	5.6	4.4	3.2	2.5	3.9	3.9	5.5	4.6	4.0	7.2	3.9	4.5	4.3	2.4	6.2	3.7	6.0	2.4	8.0	5.8	8.1	7.5	4.4	4.0	3.0	4.0	2.9	6.0	4.0	7.5	7.2	3.1	5.5	7.9	7.2	6.9	2.9	4.1	11.2	4.3	5.1	4.9	4.0	6.9	3.9	7.7	6.5	3.3	6.3	4.8	3.9	4.5	8.4	15.9	6.1	5.5	5.9	5.8	6.1	5.3	7.2	8.8	9.4	7.0	4.3	7.5	5.9	2.7	6.0	2.2	5.9	7.1	3.9	6.2	2.3	4.7	4.2	5.6	6.2	6.6	5.9	3.8	8.3	4.6	5.4	4.8	6.7	4.4	8.7	3.8	9.2	4.7	6.1	6.1	3.4	1.7	3.6	3.1	2.2	3.2	3.4	3.3	3.2	2.6	5.1	5.6	4.7	1.3	3.6	3.1	2.5	4.5	1.6	2.2	2.6	4.0	2.8	2.1	2.4	2.2	2.3	2.5	2.4	2.4	3.0	14.1	3.2	14.0	14.4	23.1	4.2	8.6	6.6	12.0	10.2	6.7	9.0	12.3	5.7	7.7	5.5	8.4	10.9	11.4	4.5	11.7	6.7	28.3	7.3	10.2	10.2	0.0	7.8	17.0	5.4	10.3	11.1	4.1	7.7	7.6	9.8	10.0	4.1	10.2	6.7	21.3	5.5	4.1	7.2	5.4	8.9	13.1	9.9	7.2	20.6	10.7	7.8	17.5	10.6	15.7	4.4	8.3	7.9	15.8	5.4	7.6	11.8	15.9	13.8	0.0	11.2	11.9	24.3	12.7	7.0	3.8	11.5	18.2	17.4	5.5	6.1
HEXA		ENSG00000213614	"Hexosaminidase subunit alpha"	P06865	15	72340924-72376420	"Candidate cardiovascular disease genes, Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"		"Glycosidase, Hydrolase"	"Disease variant, Gangliosidosis, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Hofbauer cells: 234.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA018082, HPA054583"	Supported		Supported	Vesicles,Cytosol	"Intracellular and membrane"	NA	NA		20000000	"Cluster 28: Myeloid DCs - Unknown function"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 4: Macrophages - Innate immune response"	Vesicles	Cytosol	"HPA018082: , HPA054583: AB_2682531"	"unprognostic (1.51e-2)"	"unprognostic (1.73e-2)"	"unprognostic (3.41e-1)"	"prognostic favorable (5.63e-8)"	"unprognostic (6.58e-2)"	"unprognostic (1.32e-2)"	"unprognostic (1.34e-2)"	"unprognostic (2.82e-2)"	"unprognostic (3.75e-1)"	"unprognostic (1.09e-1)"	"unprognostic (1.59e-2)"	"unprognostic (9.98e-2)"	"unprognostic (3.98e-1)"	"unprognostic (7.05e-3)"	"unprognostic (3.02e-2)"	"unprognostic (4.73e-2)"	"unprognostic (8.69e-2)"	49.8	56.1	18.3	37.6	21.1	110.0	58.5	20.4	21.6	73.8	28.5	55.1	49.8	42.6	164.6	24.8	47.8	76.7	54.3	19.9	20.1	90.1	79.4	84.2	54.2	23.0	21.3	39.3	30.6	54.0	26.3	102.0	24.6	45.3	67.0	32.1	45.0	53.3	22.1	21.8	41.2	59.5	21.7	54.7	45.1	35.6	27.0	38.1	76.5	33.2	42.4	71.6	19.7	29.9	39.8	66.4	27.8	53.8	223.6	253.1	39.7	54.8	274.1	115.3	182.8	34.6	282.7	32.9	50.9	110.0	59.9	77.1	74.5	34.6	72.5	26.5	30.0	41.4	60.4	60.9	172.9	99.9	113.1	216.7	101.3	50.4	89.3	210.3	107.4	48.4	65.1	197.6	156.0	33.9	21.7	50.0	16.0	128.9	0.3	22.3	60.6	75.3	129.1	61.6	23.8	26.4	136.5	126.6	307.3	56.1	23.4	123.9	54.1	171.9	70.7	160.1	59.3	104.7	151.8	33.4	62.1	130.4	85.3	24.2	84.6	60.1	43.8	35.7	38.7	41.1	28.8	38.9	98.0	38.0	22.5	33.2	8.1	51.3	13.3	37.3	28.2	63.0	18.3	21.1	20.4	21.6	19.9	20.1	23.0	21.3	24.6	21.7	27.0	29.9	68.9	64.1	62.4	19.9	46.3	22.2	33.3	94.3	19.4	42.4	28.6	30.4	26.9	30.0	68.0	66.2	106.3	150.2	54.2	36.6	60.7	88.3	20.6	27.2	30.2	50.8	47.2	19.1	22.7	38.0	68.0	78.7	42.8	40.6	29.9	49.9	43.5	42.9	234.3	26.9	24.7	46.3	81.4	92.8	75.0	13.7	74.3	118.1	94.3	24.4	60.3	38.4	82.4	20.6	26.7	39.1	74.6	44.8	37.7	33.0	68.5	66.7	37.5	56.9	46.0	24.5	31.7	24.3	32.3	13.5	15.6	157.6	36.7	45.2	50.6	27.5
HEXB		ENSG00000049860	"Hexosaminidase subunit beta"	P07686	5	74640023-74722647	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"		"Glycosidase, Hydrolase"	"Disease variant, Gangliosidosis, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 466.5;Hofbauer cells: 340.2;Syncytiotrophoblasts: 493.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"ASC diff: 746.0;GAMG: 646.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA055409, HPA056010"	Enhanced				"Intracellular and membrane"	NA	NA		40000000	"Cluster 25: Monocytes - Inflammatory response"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 47: Cytotrophoblasts - Unknown function"			"HPA055409: AB_2682808, HPA056010: AB_2683008"	"unprognostic (3.45e-1)"	"unprognostic (5.84e-2)"	"unprognostic (1.85e-2)"	"unprognostic (8.72e-2)"	"unprognostic (1.12e-2)"	"unprognostic (6.44e-3)"	"prognostic unfavorable (3.36e-8)"	"unprognostic (2.21e-1)"	"unprognostic (5.01e-2)"	"unprognostic (1.58e-3)"	"unprognostic (6.45e-2)"	"unprognostic (2.27e-1)"	"unprognostic (1.07e-1)"	"unprognostic (1.58e-1)"	"unprognostic (1.31e-2)"	"unprognostic (9.67e-2)"	"unprognostic (1.64e-2)"	92.2	72.0	22.1	59.7	25.3	59.9	83.0	22.3	32.5	97.6	39.4	105.0	99.0	71.5	321.4	38.5	66.7	99.0	84.3	23.1	26.2	81.6	137.5	111.3	47.0	23.8	22.9	62.4	103.6	94.2	46.6	319.4	24.7	98.7	116.9	33.6	123.4	54.0	43.3	54.3	75.4	76.1	23.2	64.7	88.4	19.6	28.2	29.1	89.6	38.4	40.4	94.6	64.1	30.4	147.3	111.0	39.4	131.8	746.0	232.3	122.3	173.5	590.4	175.0	375.2	130.6	194.5	0.0	133.0	152.2	646.3	115.2	43.2	185.2	228.7	79.2	72.6	19.1	101.4	101.5	216.5	16.2	152.3	206.7	108.0	180.7	121.3	275.9	204.5	47.3	54.3	236.9	194.9	145.7	19.8	36.6	36.8	142.7	47.8	43.9	56.2	191.8	119.8	130.4	24.5	30.4	134.2	92.6	180.0	68.8	99.1	108.6	118.5	112.1	26.6	207.8	165.6	102.6	191.3	0.9	257.9	143.6	209.8	86.2	343.2	99.1	69.3	129.9	80.7	45.2	56.1	64.0	310.8	28.1	52.6	51.3	125.2	42.4	82.5	93.4	73.2	269.0	22.1	25.3	22.3	32.5	23.1	26.2	23.8	22.9	24.7	23.2	28.2	30.4	49.6	41.7	38.4	5.9	31.5	44.0	82.8	103.2	21.6	10.2	26.3	27.6	19.8	82.9	63.8	29.5	8.4	466.5	32.8	68.2	19.6	151.3	1.3	21.0	21.4	56.2	22.8	23.1	32.2	125.6	175.4	107.2	33.6	26.9	69.8	19.8	74.3	70.1	340.2	10.1	24.3	56.7	107.8	127.3	134.3	3.4	85.1	168.8	72.9	17.8	114.2	35.4	29.9	22.6	13.3	65.8	54.8	72.2	71.5	74.2	99.5	79.6	36.3	16.3	46.0	32.6	49.5	0.3	1.4	23.8	32.5	493.6	35.3	31.4	81.8	71.0
HEXD	"FLJ23825, HEXDC"	ENSG00000169660	"Hexosaminidase D"	Q8WVB3	17	82418318-82442645	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Glycosidase, Hydrolase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"Adipocytes: 7.8;Cardiomyocytes: 6.1;Cytotrophoblasts: 5.9;dendritic cells: 10.1;Extravillous trophoblasts: 6.4;Hofbauer cells: 16.2;Plasma cells: 4.1;Syncytiotrophoblasts: 4.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"plasmacytoid DC: 62.3"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA022834, HPA023379, HPA027844"	Uncertain		Approved	"Nucleoli fibrillar center,Mitochondria"		NA	NA			"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 50: Non-specific - Ribosome"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 24: Non-specific - Transcription regulation"	"Nucleoli fibrillar center, Mitochondria"		"HPA022834: AB_1850641, HPA023379: AB_1850643, HPA027844: AB_10600711"	"unprognostic (8.69e-3)"	"prognostic favorable (7.70e-4)"	"unprognostic (7.92e-2)"	"unprognostic (1.53e-1)"	"unprognostic (3.51e-2)"	"prognostic favorable (2.71e-4)"	"unprognostic (1.31e-1)"	"unprognostic (2.11e-2)"	"unprognostic (2.71e-1)"	"unprognostic (1.14e-2)"	"prognostic favorable (5.57e-4)"	"unprognostic (9.04e-3)"	"unprognostic (1.83e-1)"	"unprognostic (3.81e-2)"	"unprognostic (2.92e-1)"	"unprognostic (1.24e-1)"	"prognostic favorable (2.52e-5)"	31.5	20.5	6.9	4.4	7.4	9.0	21.0	10.1	7.8	32.5	9.3	17.0	4.1	22.4	3.9	15.4	25.3	3.1	15.0	6.6	6.3	27.0	29.8	14.8	7.0	7.6	7.0	29.9	55.2	4.1	31.9	1.8	8.0	34.6	2.1	3.6	19.8	4.2	28.4	14.4	24.2	2.1	6.2	36.1	21.3	12.5	7.8	5.0	25.4	7.6	3.4	17.6	21.1	9.6	3.4	8.0	3.5	5.9	11.3	9.9	10.7	4.5	5.4	4.4	4.7	3.1	11.1	9.5	4.8	1.7	3.0	4.9	2.0	2.5	1.7	6.4	15.5	4.1	8.4	3.9	9.9	2.9	10.2	7.3	1.9	1.3	4.6	4.7	5.7	5.9	5.5	3.2	1.3	7.5	10.0	8.6	3.7	6.5	5.1	11.5	3.2	17.9	3.5	4.5	4.9	11.1	9.4	5.5	9.1	1.3	8.4	10.7	5.2	2.8	5.3	2.2	3.1	14.6	2.1	7.0	2.3	6.9	3.2	9.5	3.0	5.6	18.4	24.3	12.4	8.3	3.9	6.5	3.8	11.0	5.8	9.3	5.5	25.4	10.8	62.3	3.2	11.2	6.9	7.4	10.1	7.8	6.6	6.3	7.6	7.0	8.0	6.2	7.8	9.6	7.8	0.0	0.0	0.0	2.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.1	0.0	0.0	0.0	0.0	5.9	10.1	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.0	6.4	3.4	0.0	0.0	0.0	0.0	0.0	0.0	16.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	4.0	1.4	0.0	0.0	0.0
HFM1	"FLJ36760, FLJ39011, MER3, SEC63D1"	ENSG00000162669	"Helicase for meiosis 1"	A2PYH4	1	91260766-91404856	"Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins"	Meiosis	"Helicase, Hydrolase"	"Disease variant, Premature ovarian failure"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"pituitary gland: 9.3;testis: 13.8"	"Cell type enhanced"	"Detected in some"		"Astrocytes: 50.9;Inhibitory neurons: 38.4;Oligodendrocyte precursor cells: 90.5;Spermatocytes: 58.9"	"Cancer enhanced"	"Detected in single"		"testis cancer: 0.9"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AF22: 5.2;AN3-CA: 2.8;K-562: 3.0;SH-SY5Y: 2.1;U-266/70: 2.7"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA035036, HPA035557"			Supported	"Golgi apparatus,Vesicles"		NA	NA				"Cluster 21: Non-specific - Transcription"	"Cluster 12: NES - Nervous system development"	"Cluster 13: Spermatocytes & Spermatogonia - Spermatogenesis"	"Golgi apparatus, Vesicles"		"HPA035036: AB_2797224, HPA035557: AB_10696507"	"unprognostic (1.35e-2)"	"unprognostic (9.39e-2)"	"unprognostic (1.17e-1)"	"unprognostic (2.83e-4)"	"unprognostic (2.05e-2)"	"unprognostic (1.52e-1)"	"unprognostic (7.43e-3)"	"unprognostic (1.79e-1)"	"unprognostic (7.75e-2)"	"unprognostic (7.97e-2)"	"unprognostic (1.76e-4)"	"unprognostic (2.81e-2)"	"unprognostic (1.06e-2)"	"unprognostic (2.89e-3)"	"unprognostic (2.78e-2)"	"unprognostic (1.77e-4)"	"unprognostic (9.59e-2)"	0.4	0.3	1.0	0.1	1.0	0.2	0.4	5.1	1.0	0.9	0.0	0.5	0.3	2.3	1.1	0.1	0.8	0.2	0.6	0.7	1.6	0.7	0.1	0.2	0.1	1.7	1.6	3.9	0.7	0.1	9.3	0.5	1.1	0.6	0.3	4.5	0.5	1.1	1.5	0.1	0.2	0.9	1.1	0.4	0.2	13.8	1.6	0.1	1.6	1.1	0.2	0.4	0.3	1.3	0.0	0.1	5.2	2.8	0.0	0.1	0.0	0.3	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	1.0	0.6	0.0	0.0	0.1	0.7	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	3.0	0.0	0.0	0.0	0.3	0.1	1.6	0.0	0.0	0.2	1.0	0.0	0.0	0.0	1.7	2.1	0.0	0.0	0.7	1.4	0.0	0.5	0.0	0.0	0.5	0.5	0.1	2.7	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	1.0	5.1	1.0	0.7	1.6	1.7	1.6	1.1	1.1	1.6	1.3	0.2	0.0	1.1	50.9	0.0	0.0	0.0	0.0	0.6	3.9	0.1	0.3	3.1	0.0	0.0	0.0	6.2	0.5	0.0	0.0	0.0	0.4	17.8	0.2	1.9	0.4	0.0	2.5	17.6	0.2	0.2	0.6	0.0	0.0	0.0	5.9	0.0	0.0	0.1	0.0	38.4	0.0	0.0	0.0	0.0	5.0	4.1	0.0	0.0	10.3	0.0	2.4	0.0	90.5	9.5	0.1	0.0	2.2	0.0	0.1	0.0	0.0	0.0	6.2	0.0	2.0	1.4	58.9	15.6	0.0	0.0	0.0	0.0	1.8	0.0	0.0
HIBCH		ENSG00000198130	"3-hydroxyisobutyryl-CoA hydrolase"	Q6NVY1	2	190189735-190344193	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"Branched-chain amino acid catabolism"	Hydrolase	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 230.2;Proximal tubular cells: 376.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036540, HPA036541, HPA067080"	Enhanced		Enhanced	Mitochondria		NA	NA		74000	"Cluster 33: Neutrophils - Chromatin organization"	"Cluster 7: Kidney - Transmembrane transport"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Mitochondria		"HPA036540: AB_10673355, HPA036541: AB_2675182, HPA067080: "	"unprognostic (3.60e-3)"	"unprognostic (3.88e-2)"	"unprognostic (6.81e-2)"	"unprognostic (2.36e-3)"	"unprognostic (3.38e-1)"	"unprognostic (2.78e-3)"	"unprognostic (1.96e-1)"	"unprognostic (1.89e-1)"	"unprognostic (2.88e-1)"	"prognostic favorable (1.22e-4)"	"unprognostic (7.32e-2)"	"unprognostic (1.37e-2)"	"prognostic favorable (1.04e-10)"	"unprognostic (1.34e-1)"	"unprognostic (3.73e-1)"	"unprognostic (1.36e-1)"	"unprognostic (4.18e-3)"	34.0	60.1	40.6	17.4	49.2	14.5	28.5	40.5	60.3	33.4	51.0	37.5	55.9	28.1	29.1	34.9	22.5	22.3	28.7	40.7	47.7	142.2	129.0	13.9	20.5	43.9	43.1	18.6	27.2	58.2	19.1	18.6	44.9	25.5	40.9	38.4	20.9	23.2	49.2	58.7	33.9	18.3	45.0	17.8	25.6	21.7	43.3	16.8	31.7	38.5	21.9	23.7	26.6	72.6	23.5	16.1	37.0	23.8	29.9	27.6	16.9	23.1	11.4	20.8	22.1	46.8	20.2	33.3	36.1	18.1	17.0	44.4	33.2	30.7	29.5	47.0	25.1	44.5	37.7	41.4	10.7	31.8	16.7	19.8	17.8	24.3	4.8	32.3	31.6	30.4	55.2	30.3	20.8	18.2	34.3	33.6	11.1	30.2	30.2	42.4	24.8	83.8	43.8	68.4	27.9	24.0	18.0	27.2	66.8	47.2	32.0	21.3	26.5	22.8	20.8	16.1	15.8	18.7	45.2	30.9	20.7	27.4	18.6	27.8	11.9	26.4	19.5	14.2	21.3	43.5	21.8	21.0	20.9	34.7	22.9	29.6	6.0	32.0	11.3	26.7	37.0	12.7	40.6	49.2	40.5	60.3	40.7	47.7	43.9	43.1	44.9	45.0	43.3	72.6	23.3	22.4	25.8	129.3	29.8	56.0	131.4	74.9	34.1	35.3	39.1	24.1	28.6	42.9	51.3	36.8	102.2	53.6	18.8	53.5	115.4	27.4	230.2	48.0	21.4	33.3	37.8	13.0	46.4	29.4	22.3	27.7	29.6	39.3	10.2	41.1	89.3	117.4	35.3	25.2	51.5	31.4	71.2	15.7	11.7	62.9	34.8	15.9	46.2	52.5	14.1	35.5	39.1	104.0	141.1	15.6	26.6	45.5	23.3	27.9	32.4	376.2	47.6	50.5	39.5	29.9	26.2	18.0	29.4	45.5	40.6	20.0	30.7	61.7	62.7	67.8
HPN	TMPRSS1	ENSG00000105707	Hepsin	P05981	19	35040506-35066573	"Cancer-related genes, Enzymes, Predicted intracellular proteins, Predicted membrane proteins"		"Hydrolase, Protease, Serine protease"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"kidney: 200.5;liver: 866.2;pancreas: 272.1"	"Group enriched"	"Detected in many"	6	"Hepatocytes: 442.2;Proximal tubular cells: 201.0"	"Cancer enhanced"	"Detected in many"		"liver cancer: 127.5"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	9	"EFO-21: 31.5;Hep G2: 47.8;T-47d: 22.1"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			HPA006804	Approved					NA	NA		3300000		"Cluster 85: Liver - Metabolism"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"			"HPA006804: AB_1079046"	"unprognostic (6.74e-3)"	"unprognostic (6.00e-2)"	"unprognostic (4.10e-2)"	"unprognostic (1.16e-1)"	"unprognostic (2.72e-1)"	"unprognostic (9.96e-2)"	"unprognostic (4.22e-3)"	"unprognostic (1.27e-1)"	"unprognostic (4.13e-3)"	"unprognostic (9.54e-2)"	"unprognostic (3.54e-1)"	"unprognostic (1.16e-1)"	"prognostic favorable (5.45e-5)"	"unprognostic (1.22e-1)"	"unprognostic (1.52e-1)"	"unprognostic (1.12e-1)"	"unprognostic (7.96e-2)"	1.8	0.9	5.6	0.2	8.8	0.0	11.6	7.0	7.2	1.6	4.2	1.1	1.4	4.0	3.9	0.3	7.4	4.0	5.1	5.7	6.5	200.5	866.2	11.8	0.4	7.5	8.1	1.3	272.1	24.2	14.8	0.5	7.5	20.1	0.3	0.3	15.6	4.7	22.1	0.9	1.1	0.2	6.5	2.6	58.2	1.3	7.6	0.2	19.9	5.4	0.1	0.6	0.4	11.7	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	3.5	0.0	0.1	31.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	47.8	0.2	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.1	0.3	0.0	0.0	0.2	0.3	0.1	0.0	0.0	3.2	0.2	0.1	0.0	0.2	0.5	22.1	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.2	0.4	0.0	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	5.6	8.8	7.0	7.2	5.7	6.5	7.5	8.1	7.5	6.5	7.6	11.7	0.5	9.6	32.4	8.8	3.0	0.1	5.1	0.0	0.0	7.2	12.0	8.9	3.4	51.5	1.3	33.1	0.0	0.1	0.0	0.1	52.8	7.5	8.9	4.9	1.0	1.1	2.4	10.7	2.3	26.5	0.3	1.9	18.3	12.5	2.5	0.1	8.6	442.2	1.1	0.0	1.7	2.4	0.0	9.7	0.3	26.0	0.0	1.8	0.0	2.8	0.6	1.6	0.0	0.0	41.6	14.4	0.0	0.4	0.0	7.5	0.0	201.0	0.0	0.6	0.0	0.2	0.2	0.0	0.4	0.0	0.0	0.8	1.8	0.1	0.1	0.5
HPSE	"HPA, HPSE1, HSE1"	ENSG00000173083	Heparanase	Q9Y251	4	83292461-83335153	"Enzymes, Metabolic proteins, Predicted secreted proteins"	"Cell adhesion"	Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Hofbauer cells: 16.4;Kupffer cells: 41.5;Macrophages: 20.2;monocytes: 33.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in many"		"classical monocyte: 27.2;neutrophil: 18.5"	"Group enriched"	"Detected in many"	4	"granulocytes: 18.5;monocytes: 27.2"	"Cell line enhanced"	"Detected in many"		"Karpas-707: 39.8;OE19: 40.1;TIME: 25.8"	"Region enhanced"	"Detected in some"		"olfactory bulb: 3.7"	"Low region specificity"	"Detected in all"			"CAB009813, HPA055344"			Supported	Nucleoplasm,Vesicles	"Secreted to extracellular matrix"	No	No		6500000	"Cluster 25: Monocytes - Inflammatory response"	"Cluster 84: Esophagus - Epithelial cell function"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 19: Monocytes & Neutrophils - Innate immune response"	Nucleoplasm	Vesicles	"CAB009813: AB_2120854, HPA055344: "	"unprognostic (6.57e-2)"	"unprognostic (1.22e-2)"	"unprognostic (9.13e-2)"	"unprognostic (5.92e-3)"	"unprognostic (1.12e-1)"	"unprognostic (1.25e-1)"	"unprognostic (1.24e-2)"	"unprognostic (5.65e-2)"	"unprognostic (7.06e-2)"	"unprognostic (1.90e-1)"	"unprognostic (1.50e-1)"	"unprognostic (9.62e-3)"	"unprognostic (3.27e-1)"	"unprognostic (2.78e-1)"	"unprognostic (3.04e-3)"	"unprognostic (4.15e-2)"	"unprognostic (3.70e-3)"	3.4	4.5	0.8	6.6	0.9	2.3	1.0	0.6	1.7	2.4	0.4	5.9	2.1	2.7	0.2	9.9	3.9	2.7	0.8	0.9	0.9	1.6	2.4	3.2	4.5	1.8	1.0	4.5	0.8	5.6	1.2	2.1	1.3	0.6	6.4	0.2	9.7	0.6	0.3	5.3	2.8	1.9	1.8	6.0	2.0	5.7	2.7	2.0	0.7	0.3	3.9	3.0	3.3	3.6	13.5	0.6	0.1	1.7	3.2	0.9	0.1	1.5	8.2	3.6	16.5	0.0	11.0	0.4	2.3	4.2	20.8	12.3	16.8	2.5	6.5	1.4	1.7	4.2	9.0	0.2	1.4	2.5	8.4	1.8	5.1	2.4	15.4	1.4	18.1	2.4	0.1	39.8	1.5	2.8	0.2	0.3	0.7	40.1	2.6	0.0	0.4	0.6	10.2	0.3	9.3	0.0	17.7	9.8	1.4	2.6	1.5	3.8	25.8	1.5	4.6	1.4	1.7	0.5	6.2	0.2	9.9	11.4	2.7	0.4	27.2	0.0	1.4	10.1	1.0	0.2	2.7	1.0	3.0	0.3	1.7	1.6	18.5	2.3	1.5	0.1	5.2	7.9	0.8	0.9	0.6	1.7	0.9	0.9	1.8	1.0	1.3	1.8	2.7	3.6	0.3	6.4	4.4	0.0	0.7	3.4	3.0	3.3	2.8	0.0	0.3	0.5	0.6	0.0	5.6	1.8	0.0	0.5	2.4	10.1	0.0	1.9	0.6	2.3	3.7	1.0	6.6	2.7	0.8	1.3	2.9	1.4	4.1	13.2	0.0	0.4	2.9	0.6	16.4	0.0	3.8	2.8	0.0	41.5	3.0	0.3	0.6	20.2	0.0	7.5	33.9	0.0	3.1	0.0	0.1	1.1	6.7	0.0	0.7	1.7	4.1	0.0	2.8	0.0	0.0	0.1	1.2	0.2	1.0	4.0	3.7	1.5	6.2	1.4	4.6	3.7
HRAS	HRAS1	ENSG00000174775	"HRas proto-oncogene, GTPase"	P01112	11	532242-537287	"Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, RAS pathway related proteins"		Hydrolase	"Cancer-related genes, Disease variant, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Suprabasal keratinocytes: 145.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"non-classical monocyte: 4.0"	"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB002015, HPA049830, HPA070222"	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 27: Brain & Skin - Unknown function"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 22: Epithelial cell types - Mixed function"	"Nucleoplasm, Cytosol"		"CAB002015: , HPA049830: AB_2680903, HPA070222: "	"unprognostic (3.06e-2)"	"unprognostic (2.98e-2)"	"unprognostic (7.01e-2)"	"unprognostic (3.08e-3)"	"unprognostic (3.49e-3)"	"unprognostic (3.87e-1)"	"prognostic unfavorable (2.32e-4)"	"unprognostic (1.07e-1)"	"unprognostic (2.25e-1)"	"unprognostic (1.50e-1)"	"unprognostic (2.88e-3)"	"unprognostic (9.85e-2)"	"unprognostic (2.81e-1)"	"unprognostic (1.85e-1)"	"unprognostic (1.80e-1)"	"unprognostic (1.58e-2)"	"unprognostic (1.38e-1)"	28.1	24.6	64.6	3.5	67.2	2.9	27.0	62.1	86.8	30.4	58.3	34.3	2.8	23.6	12.5	80.1	18.9	3.6	56.8	64.4	64.6	33.8	21.8	27.1	4.3	65.6	65.3	20.0	20.5	13.1	38.2	9.0	66.9	38.3	6.9	10.2	27.3	12.3	59.0	69.9	19.5	8.9	64.2	20.6	24.2	16.5	64.8	9.2	20.5	25.2	10.2	34.5	44.2	65.4	59.0	105.6	44.2	25.6	22.2	17.5	39.6	49.9	25.1	64.5	29.5	62.4	29.7	20.4	10.9	63.2	60.7	43.7	46.0	114.1	19.3	19.5	108.4	6.6	43.7	56.1	38.5	13.9	12.0	28.3	118.0	42.0	51.5	19.6	31.5	34.3	29.7	32.3	40.9	110.6	34.0	50.5	26.5	39.9	94.5	31.6	40.7	18.2	47.0	33.2	87.6	43.7	25.5	55.4	17.9	31.5	43.3	14.8	35.4	47.3	44.7	16.4	39.7	20.3	17.7	15.4	39.1	17.0	38.3	0.0	0.5	0.6	0.8	0.7	0.4	0.3	0.9	0.8	0.7	2.0	0.9	0.3	0.0	0.1	4.0	0.9	1.5	0.2	64.6	67.2	62.1	86.8	64.4	64.6	65.6	65.3	66.9	64.2	64.8	65.4	51.3	12.8	10.7	9.1	18.0	131.2	101.7	25.4	82.0	46.0	38.8	75.7	25.2	22.8	11.2	35.0	18.8	78.8	21.5	72.2	74.3	35.2	1.6	36.1	28.6	32.0	29.3	11.2	9.8	37.4	63.4	25.9	33.6	34.1	2.5	26.8	22.9	17.4	39.9	48.8	10.6	26.5	4.1	11.7	38.4	7.9	17.1	21.3	64.0	10.3	12.8	50.8	11.3	4.0	12.3	48.2	30.9	23.0	26.5	61.2	30.8	54.6	20.0	37.6	32.9	20.3	40.3	5.4	21.4	118.1	145.9	78.1	22.0	18.8	26.2	106.4
HSP90AA1	"FLJ31884, Hsp89, Hsp90, HSP90N, HSPC1, HSPCA"	ENSG00000080824	"Heat shock protein 90 alpha family class A member 1"	P07900	14	102080742-102139699	"Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins"	"Host-virus interaction, Stress response"	"Chaperone, Hydrolase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 2527.6"	"Cell type enhanced"	"Detected in all"		"Basal prostatic cells: 12150.7;Urothelial cells: 5781.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB002058	Approved		Supported	Cytosol		NA	NA		71000000	"Cluster 16: MAIT-cells - Unknown function"	"Cluster 58: Brain - Synaptic function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 22: Epithelial cell types - Mixed function"	Cytosol		"CAB002058: "	"prognostic unfavorable (5.59e-4)"	"unprognostic (3.77e-2)"	"unprognostic (1.78e-2)"	"unprognostic (9.25e-2)"	"unprognostic (2.53e-1)"	"unprognostic (1.05e-3)"	"prognostic unfavorable (3.09e-5)"	"unprognostic (7.79e-3)"	"unprognostic (5.71e-2)"	"unprognostic (7.81e-3)"	"unprognostic (3.68e-2)"	"unprognostic (1.65e-2)"	"prognostic favorable (1.18e-5)"	"unprognostic (1.04e-1)"	"unprognostic (2.54e-1)"	"unprognostic (1.43e-1)"	"unprognostic (1.12e-1)"	362.9	439.5	1188.2	299.3	1221.3	459.2	438.6	1272.5	2527.6	282.1	1284.0	289.7	191.3	239.6	318.6	262.0	560.3	363.7	460.6	1213.8	1334.7	452.4	380.5	376.1	321.9	1283.8	1324.0	350.4	273.5	421.8	355.5	420.6	1351.6	348.4	311.1	1127.6	371.1	319.5	405.8	224.8	244.2	306.2	1216.2	217.6	297.5	541.9	1274.3	404.8	223.3	434.9	376.7	406.5	232.8	1639.1	1348.6	1832.2	1142.0	794.2	678.0	567.7	1512.1	1466.0	709.0	1779.5	994.1	1123.6	1245.6	1671.5	1323.1	960.7	1164.7	1471.2	3319.0	1452.5	3215.8	1227.4	1091.9	1291.8	1029.3	1444.3	334.9	1936.9	950.0	539.4	604.6	1140.3	416.2	1107.1	998.6	1764.9	1818.9	838.8	1634.1	1850.8	2087.7	891.1	1191.0	2500.5	1709.3	1968.2	1550.2	715.1	1030.3	1738.2	1497.0	1077.2	1860.4	1389.6	848.2	1903.9	1790.2	765.2	708.2	1234.6	786.5	1860.0	2826.4	783.5	2534.1	2402.7	1167.3	1182.5	1521.0	184.4	87.6	112.1	195.4	128.5	254.9	128.4	162.4	202.2	104.9	127.8	119.2	174.8	57.5	252.6	124.9	208.0	177.8	113.5	1188.2	1221.3	1272.5	2527.6	1213.8	1334.7	1283.8	1324.0	1351.6	1216.2	1274.3	1639.1	1571.4	1137.8	696.7	255.6	934.0	1340.7	12150.7	814.1	748.4	1185.6	1215.2	1173.1	2257.3	684.9	1020.6	513.1	2103.8	1415.1	1091.2	905.8	342.4	1210.5	662.9	2972.0	1350.8	1163.8	947.3	1502.3	158.9	867.6	1909.7	1632.5	788.5	2209.5	916.4	1026.8	341.3	554.4	1348.0	723.5	216.2	992.2	703.9	618.8	3110.7	442.6	732.0	2305.3	1300.2	267.0	773.6	1548.1	356.3	96.5	435.3	779.9	1021.6	722.9	1227.4	3791.1	552.2	896.4	2827.3	3623.6	618.0	1112.4	1974.9	3800.9	2142.4	830.1	1113.7	2050.2	3196.2	972.6	1028.8	5781.1
HSPA5	"BiP, GRP78"	ENSG00000044574	"Heat shock protein family A (Hsp70) member 5"	P11021	9	125234853-125241382	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Transporters"	"Host-virus interaction"	"Chaperone, Hydrolase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Syncytiotrophoblasts: 1327.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB005221, HPA038845, HPA038846"	Enhanced		Approved	Cytosol	"Intracellular and membrane"	NA	NA		790000000	"Cluster 31: Non-specific - Inflammatory response"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 22: Epithelial cell types - Mixed function"	Cytosol		"CAB005221: AB_631616, HPA038845: AB_10673477, HPA038846: AB_10673478"	"unprognostic (3.98e-2)"	"unprognostic (2.50e-3)"	"unprognostic (6.64e-2)"	"unprognostic (9.60e-3)"	"unprognostic (1.54e-3)"	"unprognostic (6.02e-3)"	"unprognostic (9.08e-3)"	"unprognostic (9.11e-3)"	"unprognostic (4.50e-2)"	"unprognostic (7.45e-3)"	"unprognostic (1.49e-1)"	"unprognostic (8.96e-2)"	"prognostic unfavorable (3.05e-4)"	"unprognostic (1.03e-1)"	"unprognostic (1.34e-1)"	"unprognostic (7.28e-2)"	"unprognostic (3.66e-2)"	211.2	170.2	83.7	276.1	91.7	856.2	147.2	101.8	107.3	202.9	112.0	181.6	166.5	183.6	379.1	150.7	177.9	130.6	284.0	90.2	126.8	168.7	327.8	182.8	145.4	105.8	107.0	142.1	260.7	223.3	182.7	311.3	120.2	192.8	183.7	105.1	211.0	167.5	87.6	143.2	175.8	205.2	111.4	129.8	177.9	173.5	101.7	116.2	692.8	85.2	180.0	197.7	105.1	163.9	593.4	380.3	480.2	631.3	505.6	592.0	1152.8	1047.6	728.2	675.9	778.5	558.4	1093.4	649.5	644.7	682.4	1564.0	732.5	403.3	839.4	684.7	403.7	213.8	396.7	392.9	945.1	2692.4	547.4	730.2	363.6	1515.2	551.3	2309.4	728.1	1065.6	129.0	291.9	870.3	482.2	382.6	249.7	297.8	559.1	1327.5	362.2	233.2	492.4	1061.2	608.4	352.7	248.5	448.0	648.1	653.4	1079.3	715.5	694.3	378.0	791.8	439.5	433.0	462.7	484.2	939.0	994.7	551.2	1070.4	435.9	689.0	455.5	366.3	305.3	384.7	361.8	390.0	209.0	276.7	360.1	322.0	173.9	224.6	277.2	280.9	362.9	252.5	349.5	213.6	758.2	83.7	91.7	101.8	107.3	90.2	126.8	105.8	107.0	120.2	111.4	101.7	163.9	227.1	185.9	273.5	38.5	254.0	292.9	1225.2	573.2	192.9	97.3	193.7	166.2	803.4	97.2	416.9	112.2	352.3	505.9	408.7	426.5	45.0	415.0	86.2	372.1	402.2	247.9	508.8	82.3	19.7	258.4	955.2	455.5	258.4	467.4	334.2	304.6	147.4	379.4	449.4	63.9	34.6	508.2	195.3	133.4	271.0	50.3	175.2	261.6	181.5	30.0	135.0	134.6	80.3	29.7	41.1	313.7	408.3	174.5	1041.5	360.8	196.9	121.2	267.6	176.6	118.3	245.9	673.8	435.7	204.3	167.4	236.4	1327.5	323.8	243.0	376.4	795.4
HSPA8	"HSC70, HSC71, HSP73, HSPA10"	ENSG00000109971	"Heat shock protein family A (Hsp70) member 8"	P11142	11	123057489-123063230	"Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins"	"Host-virus interaction, mRNA processing, mRNA splicing, Stress response, Transcription, Transcription regulation"	"Chaperone, Hydrolase, Repressor"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Basal prostatic cells: 2455.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB002056, HPA052504"	Uncertain		Approved	Nucleoplasm,Vesicles		NA	Yes		140000000	"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 22: Epithelial cell types - Mixed function"	Nucleoplasm	Vesicles	"CAB002056: , HPA052504: AB_2681854"	"unprognostic (2.28e-3)"	"unprognostic (1.19e-3)"	"prognostic favorable (6.14e-6)"	"unprognostic (1.75e-1)"	"unprognostic (1.84e-2)"	"unprognostic (5.70e-2)"	"prognostic unfavorable (1.93e-4)"	"unprognostic (9.65e-3)"	"unprognostic (3.82e-1)"	"unprognostic (9.64e-2)"	"unprognostic (2.93e-1)"	"unprognostic (3.22e-1)"	"prognostic favorable (3.81e-4)"	"unprognostic (2.53e-1)"	"unprognostic (1.83e-1)"	"unprognostic (2.74e-1)"	"unprognostic (7.16e-2)"	539.8	604.9	456.3	542.1	498.1	442.4	448.9	591.6	887.9	326.6	571.4	435.8	506.9	367.3	614.7	554.2	498.5	508.6	892.4	535.1	614.9	850.5	763.2	480.1	685.0	564.8	564.2	421.4	1238.1	593.8	501.9	487.1	620.0	411.2	525.8	531.5	404.1	439.8	1519.0	224.4	453.5	508.4	554.2	520.3	676.7	395.0	559.8	628.6	422.6	1508.5	879.6	866.0	302.4	656.8	1369.6	2077.3	1370.5	1176.5	1259.4	1337.4	1775.6	2730.9	1550.4	3373.2	2004.8	3151.7	1787.3	2318.5	1614.6	1591.9	2337.3	1835.9	4091.6	1027.2	3323.5	1955.4	605.9	2570.4	881.5	1532.0	347.5	2418.0	1757.1	721.8	1594.5	1045.0	320.7	1753.4	1845.6	321.7	2727.8	1147.0	2704.5	1235.5	2507.0	1761.3	2063.2	3463.3	1874.0	2214.4	962.2	1281.3	1665.1	1008.4	1371.8	1023.9	1980.4	2110.5	763.6	1491.1	1837.1	901.9	1767.0	1621.1	1246.1	1404.5	2402.7	740.6	1985.0	1890.9	1791.1	3316.9	1970.0	517.7	592.3	587.8	1245.4	1159.8	1499.6	1009.2	1441.8	1366.1	656.1	752.2	1367.5	1326.5	201.8	1110.7	1255.0	465.5	1761.7	3439.4	456.3	498.1	591.6	887.9	535.1	614.9	564.8	564.2	620.0	554.2	559.8	656.8	795.5	192.3	228.2	72.5	576.3	282.3	2455.6	315.3	507.6	206.7	454.5	380.1	396.3	278.8	352.8	130.6	127.2	926.1	740.3	513.1	528.3	589.0	49.8	404.1	380.1	512.8	519.8	551.7	33.4	628.8	1032.6	609.7	366.0	366.5	434.8	633.8	249.9	223.9	810.9	181.7	45.6	511.1	303.2	359.8	1060.8	58.2	222.4	590.6	528.3	35.6	530.9	307.4	639.5	28.1	50.3	513.8	552.1	270.0	573.6	779.5	823.0	1002.2	465.7	278.1	243.3	416.3	893.1	248.9	419.2	590.6	284.6	1512.1	1123.5	430.3	632.0	1171.5
HTRA2	"OMI, PARK13, PRSS25"	ENSG00000115317	"HtrA serine peptidase 2"	O43464	2	74529725-74533332	"Disease related genes, Enzymes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted membrane proteins"	Apoptosis	"Hydrolase, Protease, Serine protease"	"Disease variant, Epilepsy, Neurodegeneration, Parkinson disease, Parkinsonism"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Erythroid cells: 118.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004004, HPA006602, HPA027366"	Uncertain		Supported	Mitochondria		NA	NA		260000	"Cluster 23: Antigen presenting cells - Antigen presentation"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 10: Non-specific - Unknown function"	Mitochondria		"CAB004004: AB_326421, HPA006602: AB_2667622, HPA027366: AB_1851301"	"unprognostic (3.09e-1)"	"unprognostic (4.06e-2)"	"unprognostic (2.82e-1)"	"unprognostic (2.58e-2)"	"unprognostic (1.56e-1)"	"unprognostic (1.37e-1)"	"prognostic unfavorable (7.77e-8)"	"unprognostic (2.12e-3)"	"unprognostic (4.18e-1)"	"unprognostic (1.15e-1)"	"unprognostic (4.57e-2)"	"unprognostic (8.15e-2)"	"unprognostic (7.23e-3)"	"unprognostic (4.03e-1)"	"unprognostic (1.73e-1)"	"unprognostic (1.72e-1)"	"unprognostic (2.06e-2)"	11.4	8.6	8.1	8.1	8.7	11.1	6.8	9.1	9.7	7.1	7.7	6.4	6.9	6.9	1.0	6.0	7.1	4.7	9.4	8.1	8.3	8.1	6.5	6.6	7.8	8.6	8.5	10.9	7.4	9.4	4.7	6.3	8.3	4.8	3.3	2.5	8.5	5.3	14.5	5.4	7.9	5.3	8.2	9.9	6.4	6.2	9.6	9.1	6.8	9.0	4.8	6.5	5.8	9.2	19.1	14.7	14.7	12.6	21.3	9.0	30.1	17.0	10.3	10.3	7.0	21.1	8.5	16.6	12.9	10.7	26.0	19.7	12.0	19.6	2.4	34.0	31.4	33.3	10.8	19.0	19.8	15.3	22.4	9.9	13.7	18.4	19.5	18.4	14.2	23.5	43.9	24.9	9.7	14.1	22.0	31.1	10.0	22.8	37.7	15.8	37.0	17.1	9.6	8.2	15.1	17.7	8.9	18.6	32.5	7.3	9.3	13.2	10.6	19.2	19.7	33.4	35.3	29.5	10.2	9.8	13.6	23.4	13.0	5.8	7.0	4.0	4.8	5.7	5.8	11.0	4.8	4.1	8.6	9.9	4.3	4.1	2.6	5.0	4.5	4.5	5.7	5.5	8.1	8.7	9.1	9.7	8.1	8.3	8.6	8.5	8.3	8.2	9.6	9.2	30.7	0.0	4.8	6.2	27.3	20.6	19.7	33.8	13.6	12.0	17.4	21.7	0.9	21.5	15.7	11.0	0.0	24.7	25.8	12.5	35.2	32.4	30.8	11.9	18.1	29.6	9.0	118.5	6.3	17.7	37.8	23.3	11.2	12.9	27.3	20.9	22.9	12.7	31.5	10.1	6.3	12.3	20.3	10.7	19.4	48.9	24.8	14.6	30.2	2.8	26.3	20.2	30.9	5.5	7.5	26.1	16.8	20.7	36.0	21.3	24.8	36.8	13.5	16.3	26.3	18.7	56.5	64.3	43.3	16.7	22.0	20.2	20.6	27.1	20.0	15.7
HYAL1	"HYAL-1, LUCA1"	ENSG00000114378	"Hyaluronidase 1"	Q12794	3	50299890-50312381	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted secreted proteins"		"Glycosidase, Hydrolase"	"Disease variant, Mucopolysaccharidosis"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 201.6;lymphoid tissue: 95.1"	"Cell type enhanced"	"Detected in many"		"Cholangiocytes: 30.0;Hepatic stellate cells: 33.2;Hepatocytes: 137.1;Proximal tubular cells: 58.2"	"Cancer enhanced"	"Detected in all"		"liver cancer: 37.8"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"neutrophil: 3.1"	"Low lineage specificity"	"Detected in single"			"Group enriched"	"Detected in some"	5	"Hep G2: 100.9;SK-BR-3: 28.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA002112	Uncertain				"Secreted to blood"	NA	NA		590000	"Cluster 33: Neutrophils - Chromatin organization"	"Cluster 85: Liver - Metabolism"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"			"HPA002112: AB_1857412"	"unprognostic (1.39e-1)"	"unprognostic (8.68e-2)"	"prognostic favorable (2.07e-4)"	"unprognostic (5.23e-2)"	"unprognostic (3.18e-1)"	"unprognostic (8.71e-2)"	"unprognostic (9.35e-2)"	"unprognostic (3.59e-2)"	"unprognostic (6.56e-2)"	"unprognostic (1.31e-1)"	"unprognostic (6.65e-3)"	"unprognostic (1.16e-1)"	"prognostic favorable (1.56e-11)"	"unprognostic (4.51e-2)"	"unprognostic (5.89e-2)"	"unprognostic (1.95e-1)"	"unprognostic (1.90e-2)"	11.4	21.5	5.0	2.8	4.5	0.3	9.2	6.4	6.3	10.8	18.3	6.8	3.4	8.2	0.8	5.5	7.3	13.2	68.2	4.5	4.0	49.4	201.6	30.7	1.8	5.4	4.8	3.0	9.4	19.9	3.3	2.4	5.6	4.6	2.9	3.1	7.3	2.9	15.0	21.1	6.0	5.9	3.5	95.1	19.4	1.7	5.8	0.8	8.3	19.0	1.2	4.8	12.3	4.7	2.9	1.8	0.4	0.9	0.6	0.7	0.5	0.1	0.3	0.1	0.4	11.4	3.1	0.0	0.8	0.6	0.6	6.6	0.2	0.4	0.0	0.1	0.0	0.3	8.6	100.9	4.4	0.7	0.7	3.9	13.8	0.1	0.4	0.8	2.9	0.3	0.3	0.5	0.4	0.6	0.1	0.3	0.6	7.1	0.6	0.0	0.2	0.3	5.9	0.4	0.2	2.1	0.2	28.0	0.3	2.4	2.0	0.3	1.9	0.6	0.6	0.6	0.3	0.2	0.3	0.4	0.4	0.6	0.3	1.3	0.4	1.5	0.3	0.1	0.8	0.4	0.3	0.4	0.2	0.5	0.6	0.4	3.1	0.3	0.3	0.5	0.4	0.1	5.0	4.5	6.4	6.3	4.5	4.0	5.4	4.8	5.6	3.5	5.8	4.7	18.1	19.2	18.5	1.6	0.3	2.9	0.4	3.3	0.0	1.0	0.3	0.1	20.8	30.0	2.0	11.0	4.2	0.1	0.0	2.5	23.5	16.5	8.2	0.2	0.9	25.8	1.8	2.7	3.1	14.4	0.1	3.3	19.4	0.2	0.0	0.6	33.2	137.1	0.1	0.0	3.1	1.4	0.0	4.4	0.9	7.7	2.1	0.9	0.0	7.5	0.0	0.4	0.0	1.5	1.6	12.1	0.3	1.2	0.0	0.2	0.4	58.2	0.9	0.5	6.6	1.2	4.3	0.4	1.1	0.9	3.1	0.7	0.9	7.4	0.9	1.7
HYAL2	"LuCa-2, LUCA2"	ENSG00000068001	"Hyaluronidase 2"	Q12891	3	50317790-50322782	"Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins"		"Glycosidase, Hydrolase, Receptor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 282.8"	"Group enriched"	"Detected in many"	5	"Adipocytes: 497.6;Endothelial cells: 216.3;Hepatic stellate cells: 253.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Group enriched"	"Detected in all"	4	"HUVEC TERT2: 363.3;TIME: 502.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA036436	Uncertain					NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 64: Macrophages - Immune response"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"			"HPA036436: AB_10670104"	"unprognostic (9.97e-3)"	"unprognostic (2.60e-1)"	"unprognostic (1.44e-1)"	"unprognostic (5.10e-3)"	"unprognostic (3.44e-1)"	"unprognostic (7.41e-2)"	"unprognostic (7.93e-2)"	"unprognostic (4.70e-1)"	"unprognostic (1.44e-1)"	"unprognostic (6.76e-2)"	"unprognostic (2.36e-1)"	"unprognostic (3.01e-1)"	"unprognostic (2.63e-3)"	"unprognostic (7.36e-2)"	"unprognostic (2.72e-1)"	"unprognostic (7.02e-3)"	"unprognostic (5.62e-2)"	97.4	62.6	24.7	29.1	23.0	3.1	93.9	24.9	28.3	51.6	24.3	34.0	17.9	66.1	10.3	39.7	55.6	47.5	92.2	22.3	24.8	85.1	32.2	186.8	40.0	26.0	24.9	29.1	27.9	25.7	41.6	87.4	27.5	37.2	11.5	3.3	37.5	22.0	30.9	37.1	38.7	37.4	27.1	282.8	38.6	22.0	28.1	9.5	80.9	35.7	14.6	47.0	45.8	24.9	26.8	38.5	63.0	64.1	38.2	32.9	39.6	29.8	41.2	42.0	32.6	44.6	77.3	7.0	102.4	43.6	82.5	27.4	24.6	58.7	12.0	14.2	19.6	9.7	34.9	69.2	33.0	8.1	24.4	51.9	48.8	42.1	13.8	38.1	363.3	18.2	17.6	8.0	35.4	37.0	17.7	16.6	72.0	23.2	55.7	15.5	12.4	26.1	52.4	24.2	16.6	53.3	30.4	31.2	31.8	21.2	34.4	20.3	502.9	50.0	49.7	33.5	47.5	13.9	24.1	21.6	29.4	25.5	73.0	0.0	9.5	10.7	1.4	14.1	3.0	1.1	1.3	3.8	5.3	1.5	0.4	0.7	9.2	2.8	13.6	4.0	1.9	3.3	24.7	23.0	24.9	28.3	22.3	24.8	26.0	24.9	27.5	27.1	28.1	24.9	497.6	19.2	9.9	5.2	3.6	13.0	28.6	45.2	11.4	7.8	17.6	16.6	7.3	32.9	30.9	33.1	6.2	33.6	4.1	13.5	11.7	53.0	4.7	8.5	19.8	216.3	7.3	10.1	1.6	38.7	38.4	26.6	16.8	13.8	0.0	31.5	253.1	9.1	46.2	8.4	1.9	13.0	42.7	12.6	9.3	5.0	24.5	9.4	17.8	15.9	7.6	19.7	5.2	4.0	3.4	45.6	13.5	22.2	4.2	45.3	16.1	11.8	11.0	6.1	39.5	11.2	26.0	11.2	56.0	24.9	12.6	32.7	4.1	50.0	16.6	33.3
HYAL3	"LUCA-3, LUCA14, Minna14"	ENSG00000186792	"Hyaluronidase 3"	O43820	3	50292831-50299405	"Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted secreted proteins"	Fertilization	"Glycosidase, Hydrolase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 36.4"	"Group enriched"	"Detected in many"	17	"Early spermatids: 79.7;Late spermatids: 268.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in all"	5	"basophil: 33.2;eosinophil: 54.6"	"Lineage enriched"	"Detected in all"	7	"granulocytes: 54.6"	"Cell line enhanced"	"Detected in all"		"HEL: 58.8;HMC-1: 101.1;THP-1: 107.2"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in single"			HPA049402	Uncertain				"Secreted to blood"	NA	NA			"Cluster 2: Granulocytes - Unknown function"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 31: Spermatids - Spermatogenesis"			"HPA049402: AB_2680746"	"unprognostic (1.21e-3)"	"unprognostic (2.55e-2)"	"unprognostic (5.45e-2)"	"unprognostic (8.19e-2)"	"unprognostic (3.07e-1)"	"unprognostic (1.65e-2)"	"unprognostic (7.98e-3)"	"unprognostic (7.36e-2)"	"unprognostic (1.58e-1)"	"unprognostic (3.41e-2)"	"unprognostic (5.40e-2)"	"unprognostic (5.71e-2)"	"unprognostic (2.61e-1)"	"unprognostic (8.09e-2)"	"unprognostic (1.28e-1)"	"unprognostic (1.40e-1)"	"prognostic unfavorable (2.12e-5)"	2.1	2.8	5.1	1.3	5.4	36.4	1.8	6.7	8.3	2.0	2.9	1.9	1.7	1.6	1.1	3.9	1.6	1.8	1.8	5.1	4.0	2.6	5.1	2.1	1.2	7.4	4.0	1.5	1.9	0.9	1.9	1.5	7.3	3.2	1.0	1.1	3.5	2.4	1.0	2.1	1.8	2.2	3.9	1.7	4.5	13.9	5.4	1.6	1.7	0.9	1.6	1.8	2.7	5.8	6.0	6.9	3.8	4.3	7.6	3.9	2.3	6.5	5.8	8.0	6.1	9.3	6.2	5.2	3.1	7.5	12.4	6.5	7.0	15.2	3.0	12.3	3.6	58.8	18.8	7.6	5.5	6.4	101.1	8.1	11.5	8.1	5.2	5.8	8.4	5.8	4.6	6.3	3.8	3.6	2.4	37.4	2.9	7.0	17.2	2.6	5.1	9.5	9.5	2.6	4.7	5.4	9.6	7.5	5.1	4.4	4.9	107.2	11.1	6.8	4.9	22.2	3.8	3.0	7.0	4.4	6.0	22.5	5.8	33.2	4.1	54.6	1.3	2.3	2.2	1.6	4.1	1.9	8.2	2.9	1.1	1.5	1.4	2.1	1.4	2.0	2.6	2.4	5.1	5.4	6.7	8.3	5.1	4.0	7.4	4.0	7.3	3.9	5.4	5.8	2.5	3.2	1.1	0.3	0.8	3.1	2.8	8.1	2.8	1.5	2.2	2.8	0.4	1.5	5.0	3.7	4.2	2.8	0.2	0.8	9.8	5.6	79.7	2.0	1.6	3.5	4.2	9.2	2.4	0.7	5.3	1.2	4.1	2.1	7.0	1.1	7.1	2.1	2.1	5.0	1.6	1.9	6.1	1.9	4.4	268.2	1.8	2.0	3.6	1.0	5.9	1.5	0.0	0.5	0.3	3.6	0.4	2.6	1.9	2.2	0.5	2.7	1.8	0.8	6.6	1.2	1.8	4.3	4.6	3.7	3.7	3.0	2.2	1.6	1.8	3.5
HYAL4		ENSG00000106302	"Hyaluronidase 4"	Q2M3T9	7	123828983-123877481	"Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins"		"Glycosidase, Hydrolase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"placenta: 4.0;skeletal muscle: 3.9"	"Cell type enhanced"	"Detected in some"		"Basal respiratory cells: 2.8;Cytotrophoblasts: 4.3;Extravillous trophoblasts: 8.1;Spermatogonia: 4.4;Syncytiotrophoblasts: 2.2"	"Cancer enriched"	"Detected in single"	48	"testis cancer: 8.4"	"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BEWO: 3.6;CAPAN-2: 5.9;RT4: 13.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA029453	Uncertain					NA	NA			"Cluster 33: Neutrophils - Chromatin organization"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 15: RT4 - Unknown function"	"Cluster 38: Extravillous trophoblasts - Unknown function"			"HPA029453: AB_10601432"	"unprognostic (5.19e-5)"	"unprognostic (4.18e-2)"	"unprognostic (4.82e-2)"	"unprognostic (2.20e-1)"		"unprognostic (4.14e-2)"		"unprognostic (2.60e-1)"	"unprognostic (8.24e-2)"	"unprognostic (5.26e-2)"	"unprognostic (8.15e-3)"	"unprognostic (3.30e-1)"	"unprognostic (1.02e-2)"	"unprognostic (1.19e-1)"	"unprognostic (2.57e-1)"	"unprognostic (2.57e-1)"	"unprognostic (5.55e-3)"	0.1	0.1	0.6	0.0	0.7	0.5	0.1	1.0	1.0	0.1	0.5	0.2	0.0	0.1	0.4	0.4	0.0	0.1	0.2	0.7	0.4	0.4	0.1	0.4	0.2	0.5	0.3	0.2	0.5	0.0	0.0	4.0	0.7	0.2	0.1	1.0	0.5	0.2	3.9	0.9	0.2	0.0	0.1	0.8	0.2	2.1	0.5	0.0	0.4	0.0	1.0	0.2	0.0	1.3	0.2	0.4	0.0	0.3	0.0	0.0	3.6	0.0	0.0	0.0	0.0	0.0	5.9	0.2	0.3	0.0	0.6	0.8	0.0	0.0	0.0	0.2	0.0	0.0	1.0	0.0	0.0	0.0	0.1	0.0	0.6	0.0	0.0	0.0	0.0	0.3	0.0	0.3	0.0	0.0	0.0	0.1	0.1	0.3	0.0	0.1	0.0	0.1	0.0	13.9	0.2	0.0	0.0	0.8	0.0	1.1	0.2	0.0	2.0	0.1	0.2	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.1	0.1	0.1	0.0	0.0	0.1	0.0	0.2	0.1	0.1	0.6	0.2	0.1	0.1	0.0	0.0	0.6	0.7	1.0	1.0	0.7	0.4	0.5	0.3	0.7	0.1	0.5	1.3	0.1	0.0	0.0	0.0	0.1	0.0	0.0	2.8	0.0	0.0	0.0	0.0	0.3	0.0	0.6	0.0	0.0	4.3	0.0	0.1	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.1	0.2	8.1	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.1	1.3	4.4	0.0	0.0	2.2	0.0	0.0	0.0	0.2
IDE		ENSG00000119912	"Insulin degrading enzyme"	P14735	10	92451684-92574096	"Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Host-virus interaction"	"Allosteric enzyme, Host cell receptor for virus entry, Hydrolase, Metalloprotease, Protease, Receptor"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA063478	Approved				"Secreted in other tissues"	NA	NA		310000	"Cluster 27: Non-specific - Gene expression"	"Cluster 31: Skin - Epidermis development"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 66: Spermatocytes - Spermatogenesis"			"HPA063478: AB_2685020"	"unprognostic (1.70e-1)"	"unprognostic (6.40e-2)"	"prognostic favorable (3.69e-4)"	"prognostic favorable (3.53e-4)"	"unprognostic (2.54e-1)"	"unprognostic (1.78e-1)"	"unprognostic (2.51e-1)"	"unprognostic (3.79e-1)"	"unprognostic (8.88e-2)"	"unprognostic (2.57e-1)"	"unprognostic (6.58e-2)"	"unprognostic (7.79e-2)"	"unprognostic (6.81e-2)"	"unprognostic (9.24e-3)"	"unprognostic (6.13e-2)"	"unprognostic (3.89e-2)"	"unprognostic (3.91e-1)"	6.7	10.1	3.4	2.8	3.6	3.5	6.1	3.7	4.2	8.1	5.9	8.6	3.3	7.4	9.7	9.8	6.5	2.9	11.7	3.4	3.7	5.9	11.4	5.9	3.4	3.8	3.7	5.4	12.3	9.5	4.7	2.7	3.9	9.1	3.8	10.3	7.8	4.2	28.8	36.4	6.8	3.7	3.6	6.3	8.2	25.8	3.6	2.4	6.7	9.7	4.1	8.9	7.9	3.8	12.1	22.9	6.2	15.1	10.5	5.8	8.5	10.4	13.3	6.1	5.2	19.4	9.5	12.5	16.4	14.3	7.2	16.3	14.6	10.0	3.9	14.7	8.8	5.1	13.7	25.9	11.5	14.9	6.5	5.4	6.6	9.1	14.0	7.8	8.6	3.3	10.0	8.1	5.4	18.0	6.6	8.8	10.2	10.4	5.2	10.2	10.8	9.0	10.9	19.3	2.2	5.6	14.3	6.4	6.7	6.8	12.6	6.3	15.3	4.4	8.2	5.0	10.4	11.2	12.2	14.5	6.9	10.9	4.4	0.3	3.5	1.4	2.0	4.2	2.2	2.9	2.6	2.9	4.6	2.1	1.9	2.0	0.0	3.7	5.9	1.3	3.9	2.3	3.4	3.6	3.7	4.2	3.4	3.7	3.8	3.7	3.9	3.6	3.6	3.8	12.9	9.6	14.1	20.9	11.1	5.2	6.1	10.5	5.2	15.0	8.7	4.3	45.7	7.2	10.6	7.3	47.9	11.2	10.0	14.0	1.9	14.0	46.4	14.9	19.3	10.8	10.8	19.6	43.3	20.2	5.7	9.1	22.4	16.5	1.3	9.9	11.7	24.1	11.9	6.7	42.6	12.7	18.3	16.6	5.4	12.0	6.5	12.5	8.8	23.4	7.8	7.8	4.1	20.6	24.0	16.5	5.7	10.1	24.2	12.2	9.0	10.7	23.3	26.9	6.6	7.6	13.2	51.5	11.0	19.6	16.3	3.8	8.5	9.8	9.8	9.6
IDS	"ID2S, SIDS"	ENSG00000010404	"Iduronate 2-sulfatase"	P22304	X	149476988-149521096	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"		Hydrolase	"Disease variant, Mucopolysaccharidosis"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"brain: 323.4"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Group enriched"	"Detected in many"	7	"amygdala: 194.3;basal ganglia: 212.9;cerebral cortex: 323.4;hippocampal formation: 320.5;white matter: 109.4"	"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			HPA078003	Approved				"Intracellular and membrane"	NA	NA		17000000	"Cluster 5: Granulocytes - Unknown function"	"Cluster 10: Brain - Neuronal signaling"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 24: Non-specific - Transcription regulation"			"HPA078003: "	"unprognostic (9.88e-2)"	"unprognostic (1.10e-2)"	"unprognostic (6.59e-2)"	"unprognostic (1.45e-3)"	"unprognostic (2.83e-2)"	"unprognostic (4.52e-3)"	"unprognostic (2.13e-1)"	"unprognostic (1.94e-1)"	"unprognostic (2.35e-2)"	"unprognostic (1.20e-1)"	"unprognostic (1.71e-2)"	"unprognostic (1.42e-1)"	"unprognostic (9.76e-3)"	"unprognostic (3.61e-2)"	"unprognostic (1.91e-1)"	"unprognostic (1.01e-1)"	"unprognostic (1.87e-1)"	32.7	43.3	194.3	29.5	212.9	47.6	27.9	0.0	323.4	37.5	0.0	35.7	21.1	35.1	43.5	26.1	35.7	26.3	42.2	320.5	25.7	22.7	15.8	40.5	31.0	9.7	9.4	45.4	23.3	57.0	67.8	16.3	3.1	29.4	20.8	48.6	24.7	41.0	25.1	37.1	27.9	30.5	0.2	34.1	23.0	6.1	32.3	17.2	27.2	38.9	36.0	32.8	31.5	109.4	46.4	50.7	19.6	12.7	22.1	40.9	9.2	26.6	67.8	23.3	43.9	10.2	32.7	110.0	69.6	38.3	49.1	22.6	21.3	40.5	30.1	40.8	17.7	11.5	14.7	5.7	17.8	18.8	101.3	21.4	19.6	50.9	33.1	95.5	37.8	20.2	5.7	76.6	34.7	57.9	19.6	9.3	17.5	28.8	34.3	12.4	19.4	20.7	27.8	10.5	28.9	67.6	9.8	22.1	32.0	33.2	6.9	7.9	44.3	29.9	31.3	50.1	70.8	54.5	47.3	79.3	138.0	44.3	22.1	117.5	56.9	171.7	70.9	63.0	53.2	35.2	43.1	54.0	48.7	27.0	28.4	42.9	261.1	37.2	73.9	36.8	74.0	63.0	194.3	212.9	0.0	323.4	320.5	25.7	9.7	9.4	3.1	0.2	32.3	109.4	53.7	99.3	64.4	55.8	150.9	33.1	60.6	44.0	20.5	178.3	43.2	43.8	44.1	27.1	58.9	82.8	45.9	34.2	158.5	66.9	21.5	50.2	1.3	59.8	36.8	44.7	168.4	19.6	232.3	74.0	25.7	78.3	31.1	49.5	226.2	25.5	60.3	33.0	44.0	222.1	243.7	29.0	73.2	94.8	109.8	3.7	72.7	98.4	51.6	63.7	120.9	55.0	146.2	39.2	95.8	85.0	50.3	89.5	98.8	71.3	74.6	22.3	112.4	59.5	59.2	68.1	65.2	3.5	6.6	22.2	43.8	143.0	183.9	16.4	17.1	96.9
IDUA	"MPS1, MPSI"	ENSG00000127415	Alpha-L-iduronidase	P35475	4	986997-1004564	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"		"Glycosidase, Hydrolase"	"Disease variant, Mucopolysaccharidosis"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Leydig cells: 19.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"U-266/70: 29.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB025901, HPA046979, HPA054254"	Enhanced		Supported	Vesicles	"Intracellular and membrane"	NA	NA		170000	"Cluster 39: Non-specific - mRNA processing"	"Cluster 72: Non-specific - Transcription"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 55: Plasma cells - Humoral immune response"	Vesicles		"CAB025901: , HPA046979: AB_2679888, HPA054254: AB_2682429"	"unprognostic (3.62e-2)"	"unprognostic (9.08e-2)"	"prognostic unfavorable (3.13e-4)"	"unprognostic (7.23e-2)"	"unprognostic (1.45e-1)"	"unprognostic (2.31e-2)"	"unprognostic (1.83e-1)"	"unprognostic (1.67e-1)"	"unprognostic (1.43e-2)"	"unprognostic (1.89e-3)"	"unprognostic (2.64e-2)"	"unprognostic (4.61e-3)"	"prognostic unfavorable (7.87e-5)"	"unprognostic (2.24e-1)"	"unprognostic (1.55e-1)"	"unprognostic (2.46e-2)"	"prognostic favorable (8.04e-5)"	13.5	17.6	3.4	2.2	3.4	2.9	16.1	9.2	7.5	17.5	2.9	10.3	3.6	15.4	2.4	9.9	16.3	3.7	11.6	3.8	1.5	15.9	13.6	13.9	3.5	3.2	2.1	17.0	21.0	2.8	17.2	1.7	2.4	18.5	1.8	1.8	16.6	4.5	3.7	8.9	14.3	2.0	1.0	18.9	17.1	5.6	2.9	3.4	17.0	0.7	1.3	12.0	13.9	2.6	1.8	0.4	0.0	1.1	12.7	3.6	5.3	10.7	8.5	1.2	1.7	0.6	6.4	0.8	10.7	5.0	1.0	0.5	0.1	0.3	0.4	6.1	0.6	1.0	0.8	0.1	5.8	0.8	4.6	9.3	3.1	0.6	0.0	3.4	1.0	0.7	0.6	0.0	1.6	0.0	2.2	2.5	0.8	11.9	5.5	2.7	0.0	1.1	3.5	0.9	0.1	3.3	0.3	0.0	5.7	1.3	1.2	2.3	9.3	9.0	1.6	2.6	1.2	29.0	1.4	0.4	7.8	3.3	1.8	0.0	1.5	0.0	1.4	1.2	1.8	0.1	1.1	0.9	1.8	0.2	1.3	0.7	0.0	1.5	1.7	1.1	0.6	0.5	3.4	3.4	9.2	7.5	3.8	1.5	3.2	2.1	2.4	1.0	2.9	2.6	8.7	6.4	5.0	4.9	5.2	3.6	11.5	1.1	8.6	2.0	8.5	9.1	2.6	1.5	1.5	7.3	4.2	0.4	4.3	5.0	0.0	1.6	0.9	4.1	9.0	4.9	10.7	1.3	4.4	2.4	1.7	13.4	16.8	6.0	2.5	8.2	6.1	2.6	6.5	0.0	2.9	4.2	0.0	5.0	3.6	0.9	19.6	7.3	5.4	1.0	1.6	1.1	4.1	5.5	3.3	1.4	6.9	10.5	15.7	7.7	6.9	1.4	1.4	2.1	0.0	5.5	4.4	3.7	1.6	4.7	1.8	0.4	5.6	4.7	4.3	7.9
IFIH1	"Hlcd, IDDM19, MDA-5, MDA5"	ENSG00000115267	"Interferon induced with helicase C domain 1"	Q9BYX4	2	162267074-162318684	"Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins"	"Antiviral defense, Host-virus interaction, Immunity, Innate immunity"	"Helicase, Hydrolase, RNA-binding"	"Aicardi-Goutieres syndrome, Diabetes mellitus, Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 38.1"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 55.6;Late spermatids: 53.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"BJ hTERT+ SV40 Large T+: 62.3;BJ hTERT+ SV40 Large T+ RasG12V: 71.5;Karpas-707: 38.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA002656	Approved					NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 67: Neutrophils - Humoral immune response"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 25: Spermatids - Spermatogenesis"			"HPA002656: AB_1079344"	"unprognostic (2.85e-1)"	"unprognostic (4.71e-2)"	"unprognostic (5.51e-2)"	"unprognostic (3.85e-3)"	"unprognostic (3.34e-1)"	"unprognostic (1.39e-1)"	"unprognostic (5.65e-2)"	"unprognostic (5.29e-2)"	"unprognostic (2.23e-1)"	"unprognostic (1.86e-2)"	"unprognostic (1.53e-2)"	"unprognostic (2.62e-1)"	"unprognostic (1.72e-1)"	"unprognostic (1.57e-1)"	"unprognostic (1.27e-1)"	"unprognostic (4.41e-2)"	"unprognostic (7.29e-2)"	6.2	6.4	3.1	12.7	4.3	38.1	5.9	3.2	3.0	6.5	4.4	7.4	13.1	6.4	4.3	7.5	7.2	9.5	5.1	2.3	3.3	5.6	8.5	10.9	11.7	7.2	3.4	7.0	7.1	8.1	5.9	8.3	5.0	5.5	6.8	1.1	17.5	4.7	1.7	5.0	10.0	5.7	8.1	16.4	9.6	2.4	4.2	10.9	6.0	3.2	9.7	6.4	5.2	4.4	6.7	0.3	0.2	0.0	7.4	6.0	2.8	1.2	17.7	62.3	71.5	1.2	16.7	13.3	10.5	1.0	31.9	8.5	1.1	9.8	6.3	35.4	4.5	7.1	0.8	2.8	5.0	8.2	6.4	5.3	4.8	8.9	1.7	6.5	4.9	6.9	0.3	38.9	1.0	12.5	9.3	6.4	0.0	5.4	3.8	7.5	0.0	18.8	5.9	7.3	0.4	0.1	3.7	20.7	34.0	0.3	5.7	7.1	4.1	1.9	1.7	1.1	2.7	15.2	26.8	1.9	3.5	6.5	5.6	4.4	11.5	4.4	6.6	12.5	9.2	12.4	8.2	7.2	11.1	12.8	6.7	6.9	15.2	4.0	12.7	1.6	10.3	7.8	3.1	4.3	3.2	3.0	2.3	3.3	7.2	3.4	5.0	8.1	4.2	4.4	24.7	32.1	12.0	4.6	20.1	6.8	11.2	7.7	6.2	0.0	4.8	5.2	5.0	12.8	11.1	7.3	0.0	6.4	10.2	10.9	5.9	18.7	55.6	17.3	7.9	22.3	15.7	8.2	2.8	18.7	17.5	8.8	10.7	20.2	13.3	10.4	13.6	6.5	14.4	0.0	0.7	11.5	8.2	12.8	8.7	53.3	13.7	20.0	5.4	28.1	23.9	7.3	10.3	0.5	4.0	13.4	10.1	13.2	16.0	9.1	11.8	4.8	17.5	0.1	0.0	10.9	4.9	1.6	1.3	10.2	5.8	3.4	13.1	6.9	6.7	11.1
IGHMBP2	"CATF1, CMT2S, HCSA, HMN6, SMARD1, SMUBP2, ZFAND7"	ENSG00000132740	"Immunoglobulin mu DNA binding protein 2"	P38935	11	68903863-68940602	"Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Activator, DNA-binding, Helicase, Hydrolase, Ribonucleoprotein, RNA-binding, tRNA-binding"	"Charcot-Marie-Tooth disease, Disease variant, Neurodegeneration, Neuropathy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 94.6;Late spermatids: 46.9;Spermatocytes: 51.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA004092, HPA060994"			Supported	"Nucleoplasm,Nuclear bodies"		NA	NA			"Cluster 39: Non-specific - mRNA processing"	"Cluster 71: Testis - DNA repair"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 66: Spermatocytes - Spermatogenesis"	Nucleoplasm	"Nuclear bodies"	"HPA004092: , HPA060994: AB_2684406"	"unprognostic (1.17e-1)"	"unprognostic (1.04e-1)"	"unprognostic (7.17e-2)"	"unprognostic (3.96e-1)"	"unprognostic (1.54e-1)"	"unprognostic (1.69e-1)"	"unprognostic (3.59e-3)"	"unprognostic (4.31e-2)"	"unprognostic (3.81e-1)"	"unprognostic (1.19e-1)"	"prognostic favorable (5.89e-4)"	"unprognostic (1.03e-1)"	"prognostic unfavorable (1.29e-8)"	"unprognostic (1.69e-1)"	"unprognostic (3.73e-2)"	"unprognostic (4.06e-2)"	"unprognostic (2.18e-2)"	5.2	4.0	1.2	2.5	1.3	6.0	5.4	0.7	1.7	7.0	0.1	11.8	1.5	7.8	0.6	5.5	6.7	1.7	5.2	1.6	1.2	4.4	6.3	5.1	3.3	0.8	0.4	6.1	5.2	2.8	4.0	2.0	0.7	6.3	1.5	1.4	6.4	3.1	8.5	7.7	6.3	2.6	0.5	5.7	6.2	15.4	0.6	4.3	4.9	3.8	1.7	6.3	5.8	1.1	5.1	7.3	4.0	7.4	3.6	3.1	5.2	5.8	3.9	7.8	4.6	14.5	7.0	7.3	9.7	3.3	6.9	8.0	5.8	4.9	1.8	8.3	6.2	6.6	9.6	5.6	5.5	6.5	7.4	1.8	4.9	9.2	4.6	4.5	4.6	11.1	10.6	4.6	2.3	5.1	11.1	8.9	2.3	7.9	10.3	9.4	5.7	7.6	3.3	5.9	8.6	5.4	7.4	6.1	16.6	3.0	9.3	6.0	6.6	5.3	3.8	7.7	6.6	6.0	6.3	6.9	5.3	6.1	5.1	0.0	2.0	0.8	1.5	1.8	1.3	1.0	0.9	1.0	1.8	0.6	0.5	0.7	0.6	0.1	1.1	0.3	0.6	1.3	1.2	1.3	0.7	1.7	1.6	1.2	0.8	0.4	0.7	0.5	0.6	1.1	6.6	6.4	7.7	7.5	5.7	5.7	3.8	3.5	6.2	9.1	5.6	3.8	6.3	8.6	6.1	1.8	20.9	4.9	10.2	6.0	1.9	5.1	94.6	7.0	8.1	6.4	3.0	9.3	7.4	5.1	4.4	5.5	6.1	14.0	7.0	10.7	3.3	6.1	5.8	11.8	6.4	4.1	2.0	3.5	4.3	46.9	7.8	7.2	1.8	5.6	7.3	6.6	9.2	6.0	5.2	6.5	8.4	7.2	5.8	7.5	3.9	2.9	3.8	10.1	0.0	5.1	10.1	51.6	7.1	5.3	6.7	6.7	8.0	4.6	7.1	6.3
IL18R1	"CD218a, IL-1Rrp, IL1RRP"	ENSG00000115604	"Interleukin 18 receptor 1"	Q13478	2	102311529-102398777	"CD markers, Enzymes, Plasma proteins, Predicted membrane proteins"	"Inflammatory response"	"Hydrolase, Receptor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lung: 24.2;lymphoid tissue: 18.5"	"Cell type enhanced"	"Detected in many"		"dendritic cells: 44.7;granulocytes: 111.2;Langerhans cells: 25.4;NK-cells: 42.2;T-cells: 25.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"NK-cell: 45.6"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HDLM-2: 27.4;HHSteC: 35.4;U-937: 52.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA007615	Approved		Approved	Mitochondria		Yes	No			"Cluster 48: NK-cells - Unknown function"	"Cluster 64: Macrophages - Immune response"	"Cluster 32: U-937 - Innate immune response"	"Cluster 24: Non-specific - Transcription regulation"	Mitochondria		"HPA007615: AB_1851675"	"unprognostic (3.60e-3)"	"unprognostic (9.75e-3)"	"unprognostic (1.12e-3)"	"unprognostic (3.01e-2)"	"unprognostic (2.34e-3)"	"unprognostic (7.11e-2)"	"unprognostic (2.95e-2)"	"unprognostic (1.74e-2)"	"unprognostic (3.59e-1)"	"unprognostic (7.86e-2)"	"unprognostic (3.40e-2)"	"unprognostic (1.70e-1)"	"prognostic unfavorable (4.52e-4)"	"unprognostic (2.62e-1)"	"unprognostic (1.62e-2)"	"unprognostic (5.71e-2)"	"unprognostic (2.48e-2)"	8.2	2.3	1.3	5.6	1.4	2.4	5.4	1.2	1.9	4.5	1.6	4.0	4.1	3.1	1.6	2.2	3.7	2.9	4.5	1.0	2.4	4.4	6.6	24.2	4.1	1.5	1.3	1.1	1.3	3.2	1.7	6.9	1.8	3.3	1.0	0.2	2.2	5.7	0.9	2.6	8.8	0.7	1.3	18.5	4.3	0.5	2.0	2.0	2.1	1.1	2.2	4.0	2.8	1.3	1.8	0.6	0.0	0.0	1.3	0.8	2.3	0.0	1.1	0.1	0.5	0.0	0.8	0.0	0.1	0.0	3.4	0.9	0.0	2.4	0.0	27.4	1.2	2.1	0.5	0.1	35.4	8.8	10.1	7.8	1.9	3.1	5.4	0.0	7.4	0.2	0.0	0.0	0.0	0.0	0.0	0.9	0.1	1.4	1.1	0.0	0.0	0.0	0.3	0.9	0.0	0.0	1.2	0.1	0.3	0.1	0.0	0.0	0.8	0.9	0.5	3.2	0.6	0.0	0.0	0.0	0.1	52.0	3.6	10.0	0.0	4.8	6.2	0.1	16.3	0.1	3.6	4.7	3.6	0.2	0.6	1.4	6.7	45.6	0.0	10.4	4.1	1.9	1.3	1.4	1.2	1.9	1.0	2.4	1.5	1.3	1.8	1.3	2.0	1.3	10.2	0.0	8.5	0.3	2.7	0.8	1.1	1.1	0.6	0.0	0.3	0.3	3.9	0.0	2.3	1.8	0.0	0.0	44.7	0.3	1.9	0.9	0.1	1.0	4.1	7.4	0.0	3.6	0.2	0.6	1.0	3.1	5.1	1.1	111.2	0.0	10.0	7.6	0.1	0.0	1.0	0.1	0.0	2.4	25.4	0.1	0.3	16.5	3.6	12.2	1.0	0.2	42.2	1.5	0.0	1.1	0.4	0.0	10.3	1.0	0.1	0.9	3.8	0.2	6.6	0.9	1.4	0.4	1.3	0.3	1.0	0.0	25.4	0.1	0.4	0.9
IL18RAP	"AcPL, CD218b"	ENSG00000115607	"Interleukin 18 receptor accessory protein"	O95256	2	102418689-102452565	"CD markers, Enzymes, Predicted intracellular proteins, Predicted membrane proteins"	"Inflammatory response"	"Hydrolase, Receptor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"bone marrow: 104.6;lymphoid tissue: 46.7"	"Group enriched"	"Detected in some"	6	"dendritic cells: 42.2;NK-cells: 66.9;T-cells: 22.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Immune cell enhanced"	"Detected in many"		"NK-cell: 118.1"	"Group enriched"	"Detected in many"	107	"granulocytes: 67.6;NK-cells: 118.1;T-cells: 65.2"	"Cell line enriched"	"Detected in some"	11	"U-937: 54.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			CAB025270	Enhanced					NA	NA			"Cluster 48: NK-cells - Unknown function"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 32: U-937 - Innate immune response"	"Cluster 63: NK-cells & T-cells - Immune response"			"CAB025270: "	"unprognostic (1.73e-3)"	"unprognostic (6.27e-3)"	"unprognostic (5.07e-3)"	"unprognostic (4.64e-6)"	"unprognostic (2.90e-1)"	"unprognostic (1.18e-2)"	"unprognostic (5.86e-5)"	"unprognostic (5.09e-3)"	"unprognostic (4.02e-2)"	"unprognostic (1.57e-3)"	"unprognostic (4.78e-2)"	"unprognostic (5.31e-2)"	"unprognostic (1.51e-2)"	"unprognostic (2.71e-1)"	"unprognostic (6.35e-2)"	"unprognostic (8.56e-2)"	"unprognostic (2.73e-2)"	6.8	0.6	0.4	12.0	0.4	104.6	1.5	0.3	1.1	0.7	0.7	2.0	2.3	0.5	0.3	1.1	5.5	3.0	1.6	0.3	0.4	1.5	3.5	16.2	2.6	0.4	0.4	0.4	0.6	0.1	0.6	1.4	0.7	1.1	1.7	0.0	0.8	0.6	0.5	0.4	6.3	1.0	0.5	46.7	2.6	0.1	0.6	0.8	1.1	1.1	2.8	2.5	1.3	0.4	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.8	0.0	0.0	0.1	2.2	4.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	54.1	0.3	0.2	0.1	19.3	46.2	0.1	65.2	0.0	5.9	12.6	0.5	0.0	0.2	1.5	67.6	118.1	0.0	0.7	0.4	6.4	0.4	0.4	0.3	1.1	0.3	0.4	0.4	0.4	0.7	0.5	0.6	0.4	0.4	3.2	1.1	0.0	0.8	0.3	0.0	0.0	0.6	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	42.2	0.0	0.0	0.1	0.1	0.0	0.1	0.5	0.0	0.0	0.1	0.0	0.0	0.3	1.1	0.1	1.3	0.0	0.4	0.3	0.0	0.0	0.1	0.0	0.0	0.8	5.3	0.0	0.0	1.9	0.0	1.9	0.6	0.0	66.9	0.0	0.1	0.0	0.0	0.0	6.7	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	22.5	0.0	0.0	0.0
IL1R1	"CD121A, D2S1473, IL1R, IL1RA"	ENSG00000115594	"Interleukin 1 receptor type 1"	P14778	2	102064544-102179874	"Cancer-related genes, CD markers, Enzymes, FDA approved drug targets, Human disease related genes, Predicted membrane proteins, Predicted secreted proteins, Transporters"	"Inflammatory response"	"Hydrolase, Receptor"	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Endometrial ciliated cells: 127.1;Endometrial stromal cells: 280.2;Glandular and luminal cells: 315.4;Hepatic stellate cells: 146.7;Langerhans cells: 188.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"neutrophil: 1.2"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"ASC diff: 624.9;ASC TERT1: 276.8;HHSteC: 196.3;HSkMC: 770.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA001237, HPA005823, CAB007779, HPA029560"	Approved		Approved	"Nucleoplasm,Vesicles,Plasma membrane,Cytosol"	"Secreted to blood"	NA	NA		1400000	"Cluster 50: Neutrophils - Cellular senescence"	"Cluster 82: Adipose tissue - ECM organization"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 44: Endometrium - Transcription"	"Nucleoplasm, Vesicles"	"Plasma membrane, Cytosol"	"CAB007779: AB_562073, HPA001237: , HPA005823: AB_2667445, HPA029560: AB_2673094"	"unprognostic (6.16e-3)"	"unprognostic (3.55e-2)"	"unprognostic (3.33e-1)"	"unprognostic (1.22e-1)"	"unprognostic (4.26e-2)"	"unprognostic (7.10e-2)"	"unprognostic (2.01e-1)"	"unprognostic (3.36e-2)"	"unprognostic (1.44e-1)"	"unprognostic (3.16e-1)"	"unprognostic (4.26e-2)"	"unprognostic (7.77e-2)"	"prognostic unfavorable (6.92e-6)"	"unprognostic (2.48e-2)"	"unprognostic (6.95e-2)"	"unprognostic (4.83e-2)"	"unprognostic (7.73e-2)"	137.3	68.0	7.1	69.5	8.3	18.0	77.5	7.5	11.0	161.1	16.2	39.3	20.7	33.5	105.2	32.1	52.0	92.0	58.3	7.6	9.0	45.7	75.5	115.5	17.1	16.2	8.4	31.1	43.3	126.7	13.1	120.8	8.9	66.7	30.5	8.5	34.2	47.4	18.6	40.1	40.3	49.9	10.0	41.0	43.9	20.6	14.9	21.7	52.5	16.0	19.7	87.4	40.2	7.7	2.0	12.8	0.3	10.8	624.9	276.8	4.4	27.4	123.8	19.2	28.7	5.7	3.4	0.0	19.8	55.0	33.9	5.5	0.2	2.2	16.1	55.5	0.1	0.7	2.9	31.3	196.3	0.1	0.3	770.6	2.3	21.7	5.2	8.4	8.7	0.0	3.5	1.1	28.1	5.6	0.0	1.2	0.7	5.6	0.9	0.3	2.0	0.4	18.3	13.4	0.1	0.3	12.5	7.7	0.0	3.6	11.1	0.8	0.3	54.7	3.6	92.1	2.2	0.1	0.0	0.1	21.3	0.6	3.6	0.2	0.1	0.0	0.0	0.0	0.2	0.0	0.3	0.0	0.0	0.0	0.0	0.0	1.2	0.2	0.0	0.0	0.6	0.0	7.1	8.3	7.5	11.0	7.6	9.0	16.2	8.4	8.9	10.0	14.9	7.7	99.3	25.6	73.2	1.3	1.8	31.1	46.8	8.2	5.2	0.1	19.4	13.7	5.2	28.6	68.6	5.5	0.0	6.1	2.5	0.7	3.9	31.7	7.0	127.1	280.2	103.6	1.2	14.3	0.5	21.8	82.8	79.1	2.0	315.4	1.3	0.3	146.7	47.1	5.4	0.0	3.0	0.5	10.2	12.0	188.2	12.6	28.0	26.0	19.6	23.4	7.0	9.0	0.0	0.5	0.5	12.0	0.3	1.5	1.8	65.9	0.0	8.3	28.6	1.0	6.6	37.7	34.3	1.3	1.2	4.5	38.6	23.9	8.5	4.0	0.8	23.6
IL1RAP	"C3orf13, IL-1RAcP, IL1R3"	ENSG00000196083	"Interleukin 1 receptor accessory protein"	Q9NPH3	3	190514051-190659750	"Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins"	"Immunity, Inflammatory response, Innate immunity"	"Hydrolase, Receptor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	6	"liver: 225.8"	"Cell type enhanced"	"Detected in many"		"Extravillous trophoblasts: 109.2;Hepatocytes: 295.8;Oligodendrocyte precursor cells: 298.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in many"	5	"eosinophil: 23.8;neutrophil: 95.0"	"Lineage enriched"	"Detected in many"	15	"granulocytes: 95.0"	"Cell line enriched"	"Detected in many"	4	"SK-MEL-30: 247.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA035293	Uncertain		Approved	Vesicles,Cytosol	"Secreted to blood"	NA	NA		350000000	"Cluster 1: Neutrophils - Mixed function"	"Cluster 60: Liver - Hemostasis & Lipid metabolism"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 2: Hepatocytes - Metabolism"	"Vesicles, Cytosol"		"HPA035293: AB_10671511"	"unprognostic (6.48e-2)"	"unprognostic (1.02e-1)"	"unprognostic (3.04e-2)"	"unprognostic (1.04e-2)"	"unprognostic (1.37e-1)"	"unprognostic (8.84e-3)"	"unprognostic (2.35e-2)"	"unprognostic (6.60e-2)"	"unprognostic (2.62e-1)"	"unprognostic (1.28e-1)"	"prognostic unfavorable (1.31e-4)"	"unprognostic (1.72e-1)"	"prognostic unfavorable (2.16e-7)"	"unprognostic (4.02e-3)"	"unprognostic (9.06e-2)"	"unprognostic (5.72e-2)"	"prognostic unfavorable (6.29e-4)"	6.2	2.9	4.0	11.4	1.1	20.3	4.3	0.0	8.7	4.4	0.5	2.2	1.8	4.0	2.6	13.1	5.4	12.1	3.9	4.6	3.1	3.3	225.8	8.2	2.7	2.4	3.7	3.0	3.9	1.5	1.2	37.0	3.3	3.9	2.2	2.4	5.2	3.4	1.3	11.9	2.2	6.4	1.5	5.4	4.5	1.3	5.5	4.6	4.0	2.1	4.8	9.4	5.5	3.3	13.3	3.0	5.5	0.8	9.5	7.7	10.0	5.8	11.9	13.4	13.2	5.8	29.3	2.2	59.2	16.4	31.1	34.1	3.0	57.6	18.7	2.5	3.6	2.9	5.3	14.5	19.6	20.2	9.5	10.3	23.1	19.7	59.2	27.8	6.0	5.9	0.4	0.2	6.4	6.5	1.7	9.4	8.5	6.0	6.0	9.5	8.2	4.8	5.3	14.8	1.0	0.0	26.3	15.0	247.1	5.2	9.6	14.6	7.9	10.3	10.4	32.1	26.6	5.0	0.2	0.5	17.2	18.0	60.9	11.7	3.8	23.8	1.8	4.3	3.3	2.1	2.1	2.3	3.8	2.1	2.0	1.3	95.0	0.3	6.3	0.6	2.1	1.4	4.0	1.1	0.0	8.7	4.6	3.1	2.4	3.7	3.3	1.5	5.5	3.3	3.5	0.0	14.7	6.5	6.8	44.7	16.5	45.8	68.9	6.5	2.5	4.7	5.5	40.0	22.8	3.7	8.4	8.5	3.6	1.8	0.0	7.7	4.4	8.6	3.8	8.0	5.4	4.4	44.3	7.5	109.2	7.3	7.1	12.3	7.6	0.7	7.5	295.8	7.8	0.0	63.3	1.4	4.1	33.7	17.7	0.6	4.4	28.8	8.8	53.4	5.0	1.0	6.2	298.6	1.5	19.7	0.8	2.6	5.3	11.5	0.7	1.1	8.7	0.6	0.0	18.0	5.1	0.1	0.6	30.9	37.2	24.2	5.2	1.4	1.1	14.3
IL1RAPL1	"IL1R8, IL1RAPL, MRX10, MRX21, MRX34, OPHN4, TIGIRR-2"	ENSG00000169306	"Interleukin 1 receptor accessory protein like 1"	Q9NZN1	X	28587446-29956718	"Disease related genes, Enzymes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted membrane proteins"		"Hydrolase, Receptor"	"Mental retardation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	73	"brain: 33.4"	"Cell type enhanced"	"Detected in some"		"Excitatory neurons: 1315.7;Inhibitory neurons: 2598.6;Oligodendrocyte precursor cells: 1954.3;Oligodendrocytes: 6420.8"	"Not detected"	"Not detected"			"Region enhanced"	"Detected in all"		"white matter: 33.4"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"GAMG: 8.7;WM-115: 2.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"									NA	NA				"Cluster 70: Brain - Nervous system development"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"				"unprognostic (2.51e-2)"	"unprognostic (1.67e-1)"	"unprognostic (1.45e-2)"	"unprognostic (3.75e-3)"	"unprognostic (1.17e-1)"	"unprognostic (3.98e-1)"	"unprognostic (2.25e-2)"	"unprognostic (4.45e-2)"	"unprognostic (1.29e-1)"	"unprognostic (5.85e-2)"	"unprognostic (3.95e-2)"	"unprognostic (8.02e-2)"	"unprognostic (1.08e-2)"	"unprognostic (5.74e-4)"	"unprognostic (2.29e-1)"	"unprognostic (5.22e-2)"	"unprognostic (3.58e-3)"	0.1	0.0	3.9	0.0	12.1	0.0	0.1	1.9	8.1	0.0	0.0	0.1	0.0	0.0	0.1	0.2	0.0	0.1	0.4	3.3	4.0	0.0	0.2	0.0	0.0	7.8	4.5	0.3	0.1	0.0	0.0	0.1	5.7	0.2	0.1	0.2	0.0	0.2	0.4	0.0	0.2	0.0	3.9	0.0	0.1	0.1	8.5	0.0	0.1	0.1	0.0	0.3	0.0	33.4	0.0	0.0	0.1	0.0	0.2	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	8.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.0	1.2	0.4	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.9	12.1	1.9	8.1	3.3	4.0	7.8	4.5	5.7	3.9	8.5	33.4	0.5	0.0	0.5	64.6	0.0	0.1	0.2	0.0	0.6	2.4	0.0	0.6	3.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.4	0.0	0.0	1315.7	0.0	0.0	1.6	0.0	0.0	26.1	0.1	0.0	0.0	0.1	0.0	2598.6	0.0	0.0	0.0	0.9	0.2	0.3	0.0	1.8	42.2	0.0	0.3	0.0	1954.3	6420.8	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.4	1.9	0.7	1.5	0.0	0.1	0.1	1.1	0.4	0.1	0.0
IL1RAPL2	"IL-1R9, IL1R9, IL1RAPL-2, TIGIRR-1"	ENSG00000189108	"Interleukin 1 receptor accessory protein like 2"	Q9NP60	X	104566199-105767829	"Enzymes, Predicted membrane proteins"		"Hydrolase, Receptor"		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Tissue enhanced"	"Detected in some"		"adrenal gland: 1.4;parathyroid gland: 1.0"	"Group enriched"	"Detected in some"	22	"Excitatory neurons: 191.3;Inhibitory neurons: 117.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"fHDF/TERT166: 1.4;hTERT-HME1: 5.6;NTERA-2: 1.0;RT4: 2.0"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"									NA	NA				"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"				"unprognostic (1.62e-1)"	"unprognostic (1.50e-1)"		"unprognostic (1.66e-2)"	"unprognostic (3.09e-1)"	"unprognostic (1.48e-4)"	"unprognostic (9.32e-3)"	"unprognostic (1.67e-1)"	"unprognostic (6.80e-5)"	"unprognostic (1.78e-2)"	"unprognostic (2.79e-3)"	"unprognostic (5.91e-2)"	"unprognostic (8.77e-2)"	"unprognostic (3.14e-2)"	"unprognostic (1.63e-1)"	"unprognostic (2.30e-1)"	"unprognostic (3.84e-2)"	0.0	1.4	0.1	0.0	0.1	0.0	0.4	0.0	0.4	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.1	0.1	0.1	0.2	0.0	0.1	0.9	0.0	0.0	0.0	0.4	0.2	0.0	1.0	0.0	0.4	0.1	0.0	0.0	0.1	0.2	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.5	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.6	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	2.0	0.4	0.1	0.0	0.2	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.4	0.2	0.0	0.0	0.4	0.1	0.0	0.5	0.0	0.1	0.0	0.0	6.8	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.6	0.2	0.0	0.0	0.0	0.0	1.7	0.0	0.1	0.0	0.0	2.4	0.1	0.2	0.1	0.0	0.0	191.3	0.0	0.3	0.1	0.0	0.2	0.0	0.0	0.0	0.3	0.1	0.0	117.4	0.0	0.0	0.0	0.0	0.2	5.9	0.0	0.0	2.8	0.0	0.0	0.0	3.0	4.6	0.0	0.0	0.7	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.1	0.1	0.4	0.0	0.0	2.6	0.0	1.4	0.0	0.4
IL1RL1	"DER4, FIT-1, IL33R, ST2, ST2L, ST2V, T1"	ENSG00000115602	"Interleukin 1 receptor like 1"	Q01638	2	102311502-102352037	"Candidate cardiovascular disease genes, Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins"		"Hydrolase, Receptor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"kidney: 126.4;lung: 162.0;placenta: 199.8"	"Cell type enriched"	"Detected in many"	9	"granulocytes: 501.5"	"Cancer enriched"	"Detected in many"	5	"thyroid cancer: 7.9"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	64	"basophil: 38.3;eosinophil: 29.3"	"Lineage enriched"	"Detected in single"	72	"granulocytes: 38.3"	"Group enriched"	"Detected in some"	6	"HHSteC: 245.1;HMC-1: 373.7;HUVEC TERT2: 185.5"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA007406, HPA007917"	Uncertain		Supported	"Plasma membrane,Focal adhesion sites,Cytosol"	"Secreted to blood"	NA	NA	19100000	3100000	"Cluster 2: Granulocytes - Unknown function"	"Cluster 28: Placenta - Pregnancy"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 60: Granulocytes - Receptor signaling"	"Plasma membrane"	"Focal adhesion sites, Cytosol"	"HPA007406: AB_1079128, HPA007917: AB_1079129"	"unprognostic (7.25e-2)"	"unprognostic (9.72e-2)"	"unprognostic (1.44e-1)"	"unprognostic (3.28e-2)"	"unprognostic (5.28e-2)"	"unprognostic (1.98e-2)"	"unprognostic (3.25e-3)"	"unprognostic (2.07e-1)"	"unprognostic (2.77e-1)"	"unprognostic (4.50e-2)"	"unprognostic (8.58e-2)"	"unprognostic (9.74e-2)"	"unprognostic (1.44e-1)"	"unprognostic (1.32e-2)"	"unprognostic (1.60e-2)"	"unprognostic (1.17e-1)"	"unprognostic (4.60e-3)"	22.3	30.3	7.5	3.1	9.8	0.7	14.7	7.8	11.0	3.6	12.2	5.2	1.7	2.5	0.6	4.4	2.6	14.7	24.7	7.2	8.2	126.4	16.0	162.0	0.7	7.6	7.7	1.1	4.8	0.8	5.7	199.8	7.7	4.9	3.4	2.8	1.8	4.6	2.5	4.3	8.0	3.7	8.0	1.4	25.1	0.5	9.6	1.3	4.1	0.7	0.8	6.5	3.9	8.9	0.9	0.2	0.7	0.1	15.1	0.6	0.3	0.5	0.7	0.4	0.6	0.3	0.5	0.5	0.7	0.2	0.2	1.4	0.2	6.3	0.4	0.2	0.1	45.7	0.8	0.8	245.1	1.9	373.7	5.1	1.5	6.2	40.0	0.6	185.5	0.2	0.9	0.8	0.7	0.4	0.6	8.7	0.3	0.4	0.7	0.3	0.2	0.2	1.0	0.3	0.6	0.4	0.5	0.3	0.2	0.4	0.3	0.1	15.4	0.5	0.5	3.5	0.5	0.1	0.3	0.4	0.7	0.6	0.5	38.3	0.0	29.3	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.1	7.5	9.8	7.8	11.0	7.2	8.2	7.6	7.7	7.7	8.0	9.6	8.9	22.6	9.6	13.1	0.0	0.1	8.5	20.3	0.4	0.0	0.0	0.3	0.1	2.7	0.0	7.7	1.8	0.0	0.0	3.3	0.1	0.0	3.2	0.4	1.1	14.8	49.7	0.0	1.3	0.2	0.5	0.1	54.5	0.0	2.5	501.5	0.0	26.4	0.7	0.0	0.0	0.2	0.0	0.0	0.3	19.1	1.3	0.9	3.0	3.6	0.0	0.0	0.0	0.0	0.5	0.1	37.2	0.0	0.0	3.2	15.7	0.0	0.0	6.6	0.3	39.5	1.5	37.7	0.0	0.0	0.0	5.1	0.0	31.5	0.0	0.0	16.4
IL1RL2	"IL1R-rp2, IL1RRP2"	ENSG00000115598	"Interleukin 1 receptor like 2"	Q9HB29	2	102187006-102240002	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"	"Immunity, Inflammatory response, Innate immunity"	"Hydrolase, Receptor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"skin 1: 12.3"	"Cell type enhanced"	"Detected in many"		"Basal keratinocytes: 5.6;Excitatory neurons: 9.7;Glandular and luminal cells: 8.4;Langerhans cells: 7.1;Suprabasal keratinocytes: 5.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A-431: 8.1;ASC TERT1: 5.1;HaCaT: 3.8;HSkMC: 4.4;hTCEpi: 2.3"	"Low region specificity"	"Detected in single"			"Region enhanced"	"Detected in single"		"hippocampal formation: 1.0"							NA	NA				"Cluster 31: Skin - Epidermis development"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 44: Endometrium - Transcription"				"unprognostic (6.70e-2)"	"unprognostic (1.17e-1)"	"unprognostic (6.57e-2)"	"unprognostic (2.76e-4)"	"unprognostic (3.42e-3)"	"unprognostic (2.60e-1)"	"unprognostic (3.13e-3)"	"unprognostic (6.79e-2)"	"unprognostic (9.10e-3)"	"unprognostic (9.17e-2)"	"unprognostic (4.61e-2)"	"unprognostic (2.38e-1)"	"unprognostic (1.05e-2)"	"unprognostic (8.33e-3)"	"unprognostic (3.80e-1)"	"unprognostic (1.47e-1)"	"unprognostic (7.65e-2)"	1.0	1.5	0.5	0.5	0.6	0.3	2.6	0.1	0.9	1.5	0.0	0.9	0.1	0.4	1.4	5.8	2.3	2.3	0.5	0.7	1.0	4.3	2.9	0.5	0.0	0.8	0.5	0.3	0.5	2.6	0.3	0.3	0.8	0.9	1.1	0.0	2.2	2.3	0.4	12.3	0.3	0.3	0.1	0.1	1.6	0.1	0.9	0.3	2.4	0.7	1.0	1.0	2.5	0.3	8.1	0.0	0.0	0.0	1.5	5.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.3	0.0	3.8	0.0	0.6	0.4	0.4	0.0	0.0	1.1	0.0	1.5	0.0	0.0	4.4	2.3	1.2	0.0	0.3	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.1	0.0	0.4	0.1	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.6	0.1	0.9	0.7	1.0	0.8	0.5	0.8	0.1	0.9	0.3	1.1	0.0	1.1	0.3	0.0	5.6	2.7	0.7	3.4	0.0	2.1	2.4	0.3	1.5	0.4	1.8	0.0	0.1	0.2	0.5	3.9	0.2	0.3	3.8	2.4	0.9	1.2	0.0	9.7	0.2	0.2	1.4	0.5	8.4	0.0	0.0	0.0	1.3	0.6	0.0	1.1	1.1	0.0	2.8	7.1	0.2	1.5	4.2	0.0	1.9	0.6	0.0	0.0	0.0	0.3	0.0	0.2	0.0	0.1	2.0	0.0	0.4	0.1	0.0	0.0	1.8	1.7	0.0	0.0	5.2	5.5	0.1	0.2	0.6	0.7	1.8
ILKAP	"DKFZP434J2031, FLJ10181, PPM1O"	ENSG00000132323	"ILK associated serine/threonine phosphatase"	Q9H0C8	2	238170402-238203708	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Hydrolase, Protein phosphatase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA004752, HPA056099"	Uncertain		Supported	Nucleoplasm		NA	NA			"Cluster 41: Basophils - Cellular respiration"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 10: Non-specific - Unknown function"	Nucleoplasm		"HPA004752: AB_1851753, HPA056099: AB_2797255"	"unprognostic (1.50e-1)"	"unprognostic (1.62e-1)"	"unprognostic (1.23e-1)"	"unprognostic (1.03e-1)"	"unprognostic (6.78e-2)"	"unprognostic (9.75e-2)"	"prognostic unfavorable (1.04e-4)"	"unprognostic (1.60e-1)"	"unprognostic (3.07e-2)"	"unprognostic (3.88e-2)"	"unprognostic (1.37e-3)"	"unprognostic (7.03e-2)"	"prognostic unfavorable (9.89e-6)"	"unprognostic (6.24e-2)"	"unprognostic (6.63e-2)"	"unprognostic (2.63e-2)"	"unprognostic (1.20e-1)"	20.5	17.4	24.3	15.1	25.6	29.0	19.5	26.5	26.9	26.2	22.3	30.8	14.6	25.1	15.3	23.2	23.4	8.7	24.2	23.8	24.9	26.0	26.2	18.6	20.5	24.9	24.2	24.5	20.6	13.1	26.5	12.9	24.1	25.2	12.9	13.0	17.3	14.5	41.4	22.4	23.3	16.1	23.9	25.9	21.4	23.1	24.6	17.9	23.9	18.3	18.1	26.6	21.8	27.4	40.5	25.6	36.9	36.3	28.1	18.6	37.9	41.5	27.9	40.9	35.4	23.7	20.9	25.8	10.5	30.1	48.8	33.8	48.1	34.4	41.2	46.6	49.8	66.7	26.0	52.7	43.3	43.7	50.3	19.6	23.3	43.6	43.6	20.2	31.1	34.0	52.4	16.1	35.4	48.1	43.4	58.0	34.8	37.4	25.9	52.6	75.6	23.7	30.4	18.8	54.1	26.7	28.2	29.6	68.9	27.9	23.3	43.7	28.9	39.7	36.7	53.5	45.1	28.6	31.4	46.7	32.5	47.3	34.3	43.4	19.8	27.1	28.2	25.6	25.4	24.7	24.9	26.4	27.7	24.0	28.8	22.9	7.3	24.8	21.4	20.9	30.7	23.0	24.3	25.6	26.5	26.9	23.8	24.9	24.9	24.2	24.1	23.9	24.6	27.4	27.7	12.8	22.0	43.8	35.4	27.0	29.1	30.8	25.0	28.9	19.4	21.6	23.1	17.2	19.6	25.8	29.2	41.2	51.5	22.4	43.0	27.9	8.1	17.1	20.6	21.5	19.1	64.2	37.7	28.5	43.7	26.7	29.0	16.1	33.7	43.5	22.1	19.2	34.4	38.7	33.2	24.0	16.2	17.0	22.0	12.6	28.3	24.0	30.2	25.3	34.0	25.1	57.7	36.7	72.2	24.8	16.2	29.3	33.6	29.7	24.1	33.4	19.3	28.6	32.9	29.2	47.4	54.4	70.8	29.2	28.7	40.4	36.6	23.0	27.4	23.5
IMPA1	IMPA	ENSG00000133731	"Inositol monophosphatase 1"	P29218	8	81656914-81686331	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"		Hydrolase	"Mental retardation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA037489	Approved					NA	No		310000	"Cluster 2: Granulocytes - Unknown function"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 53: Intestinal epithelial cells - Unknown function"			"HPA037489: AB_10671757"	"unprognostic (1.78e-1)"	"unprognostic (3.59e-2)"	"unprognostic (6.95e-3)"	"unprognostic (2.15e-3)"	"unprognostic (1.31e-1)"	"unprognostic (6.27e-2)"	"unprognostic (3.80e-1)"	"unprognostic (2.46e-2)"	"unprognostic (1.06e-1)"	"unprognostic (4.68e-2)"	"unprognostic (7.78e-2)"	"unprognostic (6.26e-2)"	"unprognostic (2.52e-2)"	"unprognostic (5.87e-2)"	"unprognostic (1.84e-1)"	"unprognostic (2.42e-1)"	"unprognostic (5.41e-3)"	12.8	11.3	12.7	12.7	13.3	27.0	10.2	11.8	15.8	8.9	14.8	26.9	23.5	10.4	11.7	20.7	11.8	11.8	25.8	14.6	12.6	16.4	31.3	10.2	17.6	10.9	13.4	13.5	8.6	15.5	10.1	8.2	13.0	11.0	28.4	18.2	8.3	8.1	14.1	5.1	23.2	18.0	12.4	11.2	14.7	38.2	12.1	19.6	21.8	29.0	16.3	14.0	10.5	15.1	12.5	34.6	23.3	17.2	14.0	21.9	9.8	35.7	26.5	31.3	36.7	16.3	20.1	47.2	27.5	26.2	45.6	9.4	27.1	12.0	41.3	50.7	26.5	35.7	19.2	20.8	23.8	36.7	35.0	20.3	17.6	24.9	48.2	30.2	35.2	35.6	32.8	38.7	30.6	8.7	46.1	18.4	10.1	32.2	37.2	21.2	16.9	19.2	31.7	43.5	9.3	38.7	23.9	6.2	41.3	39.6	20.4	27.4	26.4	24.9	32.8	19.8	44.1	45.2	58.5	67.4	29.4	20.7	35.9	50.5	6.6	29.4	13.6	10.3	16.8	20.3	13.5	14.9	7.5	13.7	14.0	16.8	11.2	20.5	11.8	12.0	19.6	9.5	12.7	13.3	11.8	15.8	14.6	12.6	10.9	13.4	13.0	12.4	12.1	15.1	22.2	16.0	12.7	15.3	25.7	13.8	16.9	16.8	28.5	15.8	8.5	6.9	38.3	21.5	17.3	9.2	14.6	9.7	29.4	54.4	31.3	16.2	4.0	23.2	19.7	16.5	21.5	11.6	19.4	20.3	11.0	16.1	12.2	17.3	33.0	11.5	13.9	32.9	14.3	25.2	12.5	19.8	18.3	16.2	13.1	8.2	15.5	16.4	12.4	12.2	21.9	23.4	13.4	14.1	14.0	19.0	62.3	15.1	18.1	14.4	30.4	30.7	25.1	15.9	13.1	15.5	17.0	78.4	19.2	26.9	8.7	3.0	26.2	18.7	22.3	21.3
IMPA2		ENSG00000141401	"Inositol monophosphatase 2"	O14732	18	11981025-12030877	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"pancreas: 359.1;skeletal muscle: 257.1"	"Cell type enhanced"	"Detected in many"		"Distal tubular cells: 440.3;Extravillous trophoblasts: 272.2;Proximal tubular cells: 498.6;Squamous epithelial cells: 202.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"eosinophil: 26.0;neutrophil: 31.3"	"Group enriched"	"Detected in many"	11	"dendritic cells: 9.0;granulocytes: 31.3;monocytes: 11.4"	"Cell line enhanced"	"Detected in many"		"BEWO: 258.2;OE19: 299.8;SiHa: 155.1"	"Low region specificity"	"Detected in all"							HPA029561	Approved		Approved	Nucleoplasm,Mitochondria		Yes	No			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 59: Non-specific - Translation"	"Cluster 21: OE19 - Mitochondria"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Nucleoplasm	Mitochondria	"HPA029561: AB_10601932"	"unprognostic (1.16e-1)"	"unprognostic (1.28e-2)"	"unprognostic (4.76e-3)"	"unprognostic (2.50e-2)"	"unprognostic (4.25e-2)"	"unprognostic (3.25e-3)"	"unprognostic (4.26e-3)"	"unprognostic (4.08e-2)"	"unprognostic (1.87e-1)"	"unprognostic (1.96e-2)"	"unprognostic (4.56e-2)"	"unprognostic (4.24e-3)"	"prognostic favorable (0.00e+0)"	"unprognostic (1.95e-1)"	"unprognostic (1.19e-1)"	"unprognostic (2.08e-2)"	"unprognostic (3.35e-2)"	19.8	11.1	2.5	12.3	3.2	31.5	14.8	1.8	4.4	31.0	5.3	50.0	22.4	16.2	1.7	131.2	16.3	19.9	29.5	2.5	2.4	129.4	47.4	23.2	5.7	2.2	2.4	7.8	359.1	5.3	11.1	22.0	2.1	13.7	30.7	0.8	31.0	5.9	257.1	150.0	29.2	15.6	2.3	19.0	53.7	2.9	2.6	5.0	17.4	89.8	7.3	61.0	50.8	2.3	29.3	41.7	11.3	20.4	14.1	10.5	258.2	7.2	18.4	2.9	4.2	35.4	21.7	6.1	17.4	10.1	24.1	19.8	13.2	6.9	0.8	33.5	22.5	0.0	56.0	30.6	8.3	47.5	2.3	23.9	36.3	10.0	5.2	8.5	3.9	30.7	7.4	0.0	10.7	31.8	19.4	27.1	40.5	299.8	42.7	36.0	29.6	28.6	122.1	15.6	15.0	0.3	155.1	35.8	16.2	14.5	33.3	58.5	0.0	5.6	11.5	73.7	7.3	24.5	66.3	17.9	24.0	31.7	9.6	9.4	11.4	26.0	0.7	8.7	0.3	1.5	0.7	0.2	9.0	0.3	0.3	0.5	31.3	0.1	5.8	6.7	1.1	3.1	2.5	3.2	1.8	4.4	2.5	2.4	2.2	2.4	2.1	2.3	2.6	2.3	9.2	19.2	32.7	17.6	7.8	105.5	22.7	32.1	159.4	0.7	16.8	20.2	11.6	72.9	16.1	22.0	0.0	52.5	5.8	72.9	440.3	83.4	2.8	5.7	20.2	6.9	17.5	15.3	4.7	110.6	272.2	16.1	65.2	30.4	2.5	13.4	10.0	66.8	42.5	0.0	1.8	90.2	65.1	37.7	17.0	7.1	4.7	34.2	14.2	5.6	25.5	22.3	2.1	0.5	0.5	56.1	50.1	3.8	8.6	42.9	36.9	498.6	12.3	1.0	105.2	16.0	27.6	0.8	10.1	202.1	141.4	106.3	6.1	14.0	84.4	52.8
INPP1		ENSG00000151689	"Inositol polyphosphate-1-phosphatase"	P49441	2	190343570-190371665	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 727.4;Late spermatids: 836.0;Urothelial cells: 229.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"eosinophil: 96.0"	"Lineage enriched"	"Detected in all"	5	"granulocytes: 96.0"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036698, HPA036699"	Supported		Approved	"Centriolar satellite,Cytosol"		NA	NA		31000	"Cluster 45: Eosinophils - Innate immune response"	"Cluster 27: Brain & Skin - Unknown function"	"Cluster 15: RT4 - Unknown function"	"Cluster 34: Spermatids - Unknown function"	"Centriolar satellite"	Cytosol	"HPA036698: AB_10672226, HPA036699: AB_2675260"	"unprognostic (1.08e-3)"	"unprognostic (4.50e-3)"	"unprognostic (3.87e-2)"	"unprognostic (2.70e-1)"	"unprognostic (7.85e-2)"	"unprognostic (3.67e-3)"	"unprognostic (4.44e-2)"	"unprognostic (1.17e-1)"	"unprognostic (1.75e-1)"	"unprognostic (2.96e-2)"	"unprognostic (7.28e-2)"	"unprognostic (2.41e-1)"	"unprognostic (2.54e-1)"	"unprognostic (3.74e-1)"	"unprognostic (1.55e-1)"	"prognostic favorable (1.12e-5)"	"prognostic favorable (5.70e-4)"	24.0	35.0	35.6	11.4	41.2	14.8	20.7	36.5	47.5	27.4	24.5	22.3	36.7	18.1	12.5	71.9	18.9	23.5	30.9	36.2	42.0	19.6	33.1	27.9	9.3	37.5	37.0	11.8	26.6	41.6	29.6	13.4	37.6	18.2	21.0	17.0	17.0	13.4	21.2	37.4	25.3	19.6	34.7	25.8	18.2	52.9	38.1	23.7	19.0	35.7	20.9	42.1	35.8	54.0	26.7	7.4	13.9	0.0	15.0	31.8	0.3	30.9	41.5	28.8	37.5	28.8	16.5	0.2	36.3	30.5	9.3	35.8	5.4	19.9	35.0	32.8	11.7	19.5	22.1	17.5	31.5	15.2	6.0	21.6	30.6	32.9	18.6	20.7	54.7	0.3	48.6	16.3	51.3	0.1	1.1	14.3	4.2	42.3	40.4	0.7	11.2	0.3	22.6	62.2	20.6	7.8	21.7	1.4	31.7	14.4	0.1	21.0	51.0	18.4	13.2	33.3	18.5	3.1	3.5	0.3	5.7	6.0	14.9	26.2	8.3	96.0	6.9	8.1	6.3	3.3	4.3	4.7	8.7	4.4	2.4	3.6	3.9	16.2	4.7	0.2	20.3	5.1	35.6	41.2	36.5	47.5	36.2	42.0	37.5	37.0	37.6	34.7	38.1	54.0	63.0	3.2	5.5	44.1	8.0	86.4	155.4	33.2	50.7	15.0	9.9	14.6	20.9	38.6	27.5	11.0	6.2	6.9	9.7	50.4	7.9	33.4	727.4	18.8	16.0	59.6	31.1	1.7	30.3	85.4	2.6	30.7	29.6	26.9	8.8	3.8	88.5	21.9	8.8	16.8	36.7	23.7	20.3	10.7	27.3	836.0	26.8	14.0	26.6	17.8	12.2	73.2	14.4	29.7	125.6	53.1	40.8	23.7	12.9	90.7	50.6	20.8	13.0	11.9	26.3	26.0	19.4	18.1	11.4	170.2	97.3	4.0	10.4	37.8	35.4	229.0
INPP4A	INPP4	ENSG00000040933	"Inositol polyphosphate-4-phosphatase type I A"	Q96PE3	2	98444854-98594392	"Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins"		Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 150.5;Inhibitory neurons: 124.4;Microglial cells: 73.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in all"		"Karpas-707: 67.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA001628	Approved		Supported	"Nucleoplasm,Nuclear membrane"		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 65: Plasmacytoid DCs - Unknown function"	"Nucleoplasm, Nuclear membrane"		"HPA001628: AB_10961254"	"unprognostic (3.45e-1)"	"unprognostic (2.39e-2)"	"unprognostic (1.74e-2)"	"prognostic unfavorable (3.70e-6)"	"unprognostic (1.58e-1)"	"unprognostic (3.10e-2)"	"unprognostic (1.15e-3)"	"unprognostic (9.44e-2)"	"unprognostic (1.37e-2)"	"unprognostic (1.23e-1)"	"unprognostic (9.65e-2)"	"unprognostic (3.70e-2)"	"unprognostic (2.90e-2)"	"unprognostic (4.89e-2)"	"unprognostic (1.20e-1)"	"unprognostic (1.08e-2)"	"unprognostic (1.97e-2)"	8.7	8.2	15.9	13.2	19.5	12.7	6.1	18.8	22.0	7.0	1.0	11.3	7.3	7.5	5.2	7.7	6.6	9.9	10.5	15.9	9.9	5.2	4.1	9.6	17.2	9.2	3.5	7.0	6.6	8.9	7.7	8.1	9.2	6.0	7.9	10.7	5.6	6.3	8.4	4.1	8.8	9.8	4.7	16.7	7.3	5.9	5.9	20.3	5.9	11.6	12.5	10.8	5.5	10.1	12.7	11.0	18.2	14.8	10.4	11.1	19.2	10.0	9.4	10.9	11.3	14.6	11.5	7.8	13.3	15.4	14.0	12.6	12.6	11.1	8.5	27.7	10.9	9.5	9.7	6.5	8.8	17.3	34.3	9.9	9.9	10.6	9.0	9.5	15.1	44.9	8.5	67.4	8.3	16.2	26.3	16.8	17.6	7.4	11.3	12.0	12.5	51.9	5.6	41.6	12.8	15.7	12.1	10.1	9.5	18.7	4.8	13.8	14.3	12.7	17.9	10.1	7.5	50.2	31.1	5.8	10.5	16.2	11.5	1.1	1.0	2.3	2.8	2.2	3.3	0.4	1.6	1.8	1.1	0.1	2.2	2.5	1.1	3.2	3.4	3.3	0.9	1.0	15.9	19.5	18.8	22.0	15.9	9.9	9.2	3.5	9.2	4.7	5.9	10.1	14.6	6.4	13.1	50.9	11.2	8.0	6.4	2.8	9.1	49.7	5.3	4.2	12.6	2.8	7.8	5.5	8.4	10.2	64.6	4.1	3.9	4.0	13.5	6.2	9.1	14.2	5.4	7.2	150.5	1.5	8.7	9.9	6.6	6.3	0.0	22.4	14.3	3.4	10.5	33.7	124.4	5.6	4.1	36.4	18.4	10.9	9.3	25.3	10.6	73.1	26.8	8.4	71.1	55.8	26.1	3.8	2.5	12.0	48.6	5.9	1.2	3.3	5.1	14.1	6.6	9.9	12.4	8.6	14.0	5.2	6.1	9.4	48.3	9.4	3.6	6.8
INPP4B		ENSG00000109452	"Inositol polyphosphate-4-phosphatase type II B"	O15327	4	142023160-142847432	"Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins"		Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 158.7;Early spermatids: 178.1;Excitatory neurons: 196.8;Inhibitory neurons: 614.4;Late spermatids: 291.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in many"		"memory CD4 T-cell: 30.4"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"CAPAN-2: 150.4;SK-MEL-30: 66.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA037681, HPA037682"	Approved		Approved	Centrosome		NA	NA			"Cluster 20: T-cells - T-cell receptor"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Centrosome		"HPA037681: AB_10670389, HPA037682: AB_10671377"	"unprognostic (9.79e-2)"	"unprognostic (1.11e-1)"	"unprognostic (1.95e-1)"	"unprognostic (9.25e-2)"	"unprognostic (1.77e-1)"	"unprognostic (8.24e-2)"	"unprognostic (3.03e-3)"	"unprognostic (5.76e-3)"	"unprognostic (1.95e-2)"	"unprognostic (3.16e-1)"	"prognostic unfavorable (1.03e-4)"	"unprognostic (8.58e-2)"	"unprognostic (1.26e-2)"	"unprognostic (2.79e-2)"	"unprognostic (1.30e-1)"	"unprognostic (4.58e-1)"	"unprognostic (1.39e-2)"	9.9	4.0	5.2	6.7	6.7	2.1	18.3	3.2	6.4	13.1	0.3	5.8	4.6	5.4	3.9	7.5	7.3	7.9	17.4	5.5	3.4	5.4	1.8	6.5	10.8	1.3	2.7	5.7	2.5	2.0	1.3	5.7	1.9	4.7	5.1	1.7	2.7	4.7	7.9	3.6	5.5	7.3	0.0	6.8	5.8	18.6	7.3	5.9	4.3	5.2	6.9	14.0	8.7	6.0	27.7	11.4	7.3	3.6	5.5	3.4	1.4	32.5	37.9	8.2	15.3	3.1	150.4	0.8	8.9	29.4	12.6	41.1	0.0	37.9	19.1	0.1	1.1	6.6	4.0	0.1	1.8	1.4	5.0	5.9	5.2	5.8	19.4	24.7	4.8	0.0	0.0	1.5	17.9	49.1	1.1	0.0	0.3	16.8	8.1	0.3	24.7	1.4	11.3	50.3	0.6	0.7	3.7	11.2	66.6	4.3	34.2	4.9	3.1	18.8	22.6	28.0	0.3	0.4	0.1	0.1	4.4	29.7	49.5	6.1	0.2	0.0	5.2	0.0	10.1	0.0	30.4	13.6	0.1	0.1	20.6	8.9	0.5	17.0	0.0	0.1	17.4	5.9	5.2	6.7	3.2	6.4	5.5	3.4	1.3	2.7	1.9	0.0	7.3	6.0	13.4	0.0	0.6	158.7	2.6	6.6	9.5	7.0	4.0	7.5	49.0	15.5	42.2	7.2	20.2	9.2	0.0	1.7	8.7	8.7	5.9	12.2	178.1	19.8	58.2	13.2	8.9	6.1	196.8	30.6	5.1	5.1	19.4	5.4	6.3	0.6	6.4	0.3	8.1	6.7	614.4	3.5	4.1	2.8	4.9	291.9	13.7	3.9	72.9	47.8	1.3	0.9	2.1	79.4	57.6	76.3	0.2	6.4	4.5	20.5	10.1	0.9	35.7	0.8	85.5	5.2	84.7	2.5	1.9	1.9	2.6	1.9	60.4	1.8	4.3	42.9
INPP5A	5PTASE	ENSG00000068383	"Inositol polyphosphate-5-phosphatase A"	Q14642	10	132537787-132783480	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in single"	8	"basophil: 6.7"	"Lineage enriched"	"Detected in single"	28	"granulocytes: 6.7"	"Low cell line specificity"	"Detected in all"			"Region enhanced"	"Detected in all"		"cerebellum: 250.8"	"Low region specificity"	"Detected in all"			HPA012285	Enhanced		Approved	"Plasma membrane,Cytosol"	"Intracellular and membrane"	NA	NA			"Cluster 41: Basophils - Cellular respiration"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 48: Smooth muscle cells - ECM organization"	Cytosol	"Plasma membrane"	"HPA012285: AB_1851802"	"prognostic unfavorable (7.47e-4)"	"unprognostic (2.38e-1)"	"unprognostic (2.54e-1)"	"unprognostic (1.68e-3)"	"unprognostic (1.43e-1)"	"unprognostic (3.25e-2)"	"unprognostic (2.08e-1)"	"unprognostic (1.16e-1)"	"unprognostic (5.65e-2)"	"unprognostic (4.35e-1)"	"unprognostic (4.70e-2)"	"unprognostic (1.70e-2)"	"prognostic favorable (3.15e-4)"	"unprognostic (2.14e-1)"	"unprognostic (1.44e-1)"	"unprognostic (8.91e-3)"	"unprognostic (8.66e-2)"	22.5	16.9	26.8	12.0	85.5	9.5	17.3	56.9	30.4	29.6	10.9	54.2	19.2	49.5	19.5	29.6	30.7	15.2	75.0	20.4	21.3	14.1	14.6	25.1	8.4	20.5	37.7	19.5	12.8	12.2	14.7	28.8	20.4	24.5	16.7	16.9	13.5	23.6	75.4	22.9	23.4	42.1	17.5	13.9	27.6	22.9	50.5	6.8	14.1	50.3	7.3	35.5	22.7	27.0	35.4	13.7	22.6	21.9	33.8	23.7	18.4	36.4	27.9	23.3	15.4	32.6	14.0	3.1	13.7	38.8	15.1	19.5	24.8	15.2	27.9	10.8	14.4	5.1	17.3	44.7	24.3	12.9	11.9	16.0	14.9	15.0	28.2	18.6	16.3	6.6	7.6	18.2	12.6	28.3	3.6	40.9	10.5	21.0	24.3	7.6	14.9	5.6	19.4	19.9	5.4	18.5	18.3	26.5	22.6	20.5	17.2	30.4	13.7	14.9	17.2	20.1	21.6	3.6	18.4	11.0	14.4	8.6	6.5	6.7	0.1	0.6	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.8	0.0	0.1	0.0	0.2	0.3	26.8	85.5	56.9	30.4	20.4	21.3	20.5	37.7	20.4	17.5	50.5	27.0	14.7	9.6	19.7	14.7	4.5	5.4	4.4	1.9	0.0	10.5	7.1	5.3	10.1	4.3	6.4	7.3	0.0	3.9	5.0	24.8	0.0	6.5	12.3	2.8	22.8	10.0	6.1	3.2	33.5	9.2	3.7	5.6	6.6	5.9	8.8	8.6	15.0	17.9	2.9	8.4	25.2	9.9	2.0	7.2	12.0	17.0	7.2	6.9	1.8	19.7	4.1	9.6	0.0	18.1	29.2	12.1	11.5	11.7	2.5	6.5	13.8	4.3	2.5	5.2	6.6	6.5	24.3	6.3	7.3	2.8	5.8	2.5	2.7	10.7	13.9	8.6
INPP5B		ENSG00000204084	"Inositol polyphosphate-5-phosphatase B"	P32019	1	37860697-37947057	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 47.5;Inhibitory neurons: 48.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA028803	Approved		Supported	Cytosol		NA	NA		8400	"Cluster 46: Basophils - DNA binding"	"Cluster 50: Non-specific - Ribosome"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Cytosol		"HPA028803: AB_10612121"	"unprognostic (2.28e-2)"	"unprognostic (8.91e-3)"	"unprognostic (7.67e-2)"	"unprognostic (2.27e-1)"	"unprognostic (4.30e-2)"	"prognostic favorable (1.11e-4)"	"unprognostic (1.67e-2)"	"unprognostic (1.52e-2)"	"unprognostic (4.75e-2)"	"unprognostic (1.85e-1)"	"prognostic favorable (5.33e-4)"	"unprognostic (8.27e-2)"	"prognostic unfavorable (6.11e-5)"	"unprognostic (1.03e-1)"	"unprognostic (2.00e-1)"	"unprognostic (2.51e-1)"	"unprognostic (1.28e-1)"	13.3	9.3	9.5	10.3	10.7	20.7	11.9	14.7	11.8	16.1	11.5	18.7	6.9	13.9	9.9	7.2	15.7	8.4	12.8	9.2	9.3	10.8	16.2	14.7	18.5	11.5	10.2	23.9	10.5	8.9	11.9	10.4	11.4	10.9	10.0	12.5	8.4	11.1	9.1	10.8	13.4	11.9	9.0	17.3	13.7	7.0	10.5	13.4	12.2	6.0	18.7	16.8	11.7	15.3	6.8	4.6	10.7	15.7	12.3	15.8	18.5	7.5	12.5	9.6	13.2	7.2	9.4	23.2	3.6	12.9	5.0	9.1	14.3	6.0	12.8	16.2	6.3	35.8	15.4	4.9	17.7	19.0	47.4	17.8	3.7	10.2	6.6	9.4	11.0	16.4	11.7	25.6	12.4	5.3	16.7	21.4	15.5	9.5	3.9	18.7	21.3	10.9	5.5	6.2	4.3	6.8	8.8	4.2	18.9	15.7	5.2	15.8	10.6	8.8	7.9	8.5	7.1	20.8	11.8	18.3	10.1	15.8	8.1	27.3	2.9	16.5	7.0	2.3	9.9	7.1	4.8	6.7	6.1	7.6	6.1	5.8	3.7	6.2	6.0	5.4	6.8	4.9	9.5	10.7	14.7	11.8	9.2	9.3	11.5	10.2	11.4	9.0	10.5	15.3	5.7	28.9	26.3	35.3	11.8	2.2	5.8	2.1	4.0	14.7	2.2	2.3	3.2	1.5	6.4	1.8	25.0	4.1	7.9	3.9	0.0	2.4	10.7	2.3	8.4	5.9	3.5	6.5	47.5	4.4	15.4	6.3	16.8	3.3	8.2	6.9	5.3	7.8	5.2	23.5	48.5	5.0	6.1	8.1	5.4	15.9	8.4	8.3	7.2	35.6	11.3	4.6	28.8	20.1	39.4	3.0	4.7	9.1	8.5	4.5	3.5	2.6	5.8	18.9	6.6	7.7	7.1	4.6	8.1	3.4	3.3	4.7	11.2	7.7	4.7	4.1
INPP5D	"hp51CN, SHIP, SHIP1"	ENSG00000168918	"Inositol polyphosphate-5-phosphatase D"	Q92835	2	233059967-233207903	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Apoptosis, Immunity"	Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 50.8;lymphoid tissue: 99.4"	"Cell type enhanced"	"Detected in many"		"B-cells: 94.5;dendritic cells: 95.8;Kupffer cells: 65.6;Microglial cells: 181.8;NK-cells: 193.6;T-cells: 60.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HBEC3-KT: 44.7;HEL: 94.6;HMC-1: 94.8;hTCEpi: 87.1;NB-4: 89.4;THP-1: 62.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB016300, HPA070455"	Enhanced		Supported	Cytosol		No	No		4400000	"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 64: Macrophages - Immune response"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 63: NK-cells & T-cells - Immune response"	Cytosol		"CAB016300: AB_628250, HPA070455: AB_2686267"	"unprognostic (5.29e-2)"	"unprognostic (2.05e-3)"	"unprognostic (1.99e-2)"	"unprognostic (6.71e-3)"	"unprognostic (1.10e-1)"	"prognostic favorable (2.03e-5)"	"unprognostic (1.57e-1)"	"unprognostic (1.08e-1)"	"unprognostic (2.29e-2)"	"unprognostic (3.74e-1)"	"unprognostic (2.56e-1)"	"unprognostic (1.23e-1)"	"unprognostic (1.14e-2)"	"unprognostic (1.66e-1)"	"unprognostic (4.82e-2)"	"unprognostic (6.58e-2)"	"unprognostic (6.54e-2)"	15.5	5.8	6.7	19.8	7.3	32.7	11.4	7.6	6.5	9.2	6.7	9.5	3.7	6.3	2.8	7.5	9.2	6.0	8.2	6.0	8.5	9.5	6.5	25.2	34.1	10.8	9.4	3.2	3.1	1.2	6.9	8.4	11.2	11.8	4.7	0.3	26.3	2.9	3.9	7.9	50.8	3.5	9.3	99.4	6.3	3.5	10.4	14.5	7.8	1.7	31.9	9.8	8.4	10.3	0.1	0.1	0.6	0.0	0.0	0.2	4.8	0.1	0.2	0.1	0.0	0.0	1.2	17.9	0.0	0.0	0.0	0.1	0.0	44.7	0.1	15.4	0.2	94.6	0.1	9.0	0.7	28.7	94.8	1.6	87.1	0.3	9.6	0.3	12.7	2.6	0.4	8.0	0.4	0.0	13.2	89.4	2.9	0.0	0.1	27.5	0.1	6.5	0.1	5.5	0.1	0.1	0.0	1.7	0.0	11.1	0.0	62.9	10.7	0.0	1.5	0.0	0.0	0.2	5.2	26.7	0.1	36.5	0.2	13.2	10.8	11.4	16.0	15.8	10.9	14.0	7.1	12.0	12.3	12.6	5.8	8.4	10.3	12.5	20.0	6.1	10.5	17.9	6.7	7.3	7.6	6.5	6.0	8.5	10.8	9.4	11.2	9.3	10.4	10.3	18.1	3.2	15.5	3.3	94.5	1.7	1.6	5.4	9.1	0.5	3.2	5.8	3.6	4.3	5.2	3.7	0.0	0.6	95.8	1.1	0.0	0.5	13.0	0.8	0.3	20.8	0.0	35.7	2.6	0.5	0.8	1.7	2.0	0.5	15.2	0.1	15.0	2.2	29.2	0.0	1.1	0.2	0.0	65.6	17.1	13.4	0.0	51.5	0.0	181.8	51.4	0.0	193.6	4.0	1.8	0.4	2.5	1.2	34.0	0.6	0.1	0.4	5.7	0.0	0.0	2.0	1.7	0.5	1.0	3.1	1.1	1.1	60.6	0.1	0.5	1.5
INPP5E	"CORS1, JBTS1, pharbin, PPI5PIV"	ENSG00000148384	"Inositol polyphosphate-5-phosphatase E"	Q9NRR6	9	136428619-136439845	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"Lipid metabolism"	Hydrolase	"Ciliopathy, Disease variant, Joubert syndrome, Mental retardation, Obesity"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA065758	Approved		Approved	"Golgi apparatus,Focal adhesion sites"		NA	NA			"Cluster 35: T-regs - Unknown function"	"Cluster 43: Testis - Unknown function"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 7: Non-specific - Mitochondria"	"Golgi apparatus, Focal adhesion sites"		"HPA065758: AB_2685554"	"unprognostic (1.99e-1)"	"unprognostic (8.68e-2)"	"unprognostic (1.87e-2)"	"unprognostic (1.23e-2)"	"unprognostic (4.00e-1)"	"unprognostic (6.92e-2)"	"unprognostic (9.60e-3)"	"unprognostic (3.21e-1)"	"unprognostic (5.81e-2)"	"unprognostic (2.65e-2)"	"prognostic favorable (1.82e-4)"	"unprognostic (2.03e-1)"	"unprognostic (3.04e-2)"	"unprognostic (3.76e-1)"	"unprognostic (5.48e-2)"	"unprognostic (4.64e-1)"	"unprognostic (2.66e-2)"	12.1	10.8	15.0	6.9	15.0	6.4	11.7	15.3	19.9	15.1	11.3	13.1	5.7	15.2	2.3	10.6	17.6	5.3	13.7	14.0	14.3	13.3	12.2	11.9	8.2	15.1	13.3	16.2	10.8	6.6	14.3	5.7	15.5	12.3	3.3	7.4	9.5	5.3	8.5	11.2	11.7	5.6	11.4	20.8	8.9	20.1	14.8	6.4	15.1	3.8	4.7	12.2	12.0	13.9	8.9	10.3	12.6	13.2	6.5	7.1	14.9	10.7	5.7	7.4	5.1	12.5	6.0	10.8	10.5	11.1	11.9	25.2	6.2	8.6	2.8	36.8	25.4	8.5	27.1	8.4	10.3	9.5	11.9	10.9	8.8	9.8	7.2	10.3	8.9	14.8	14.5	14.0	7.0	22.3	11.4	19.9	8.1	5.3	16.0	21.1	8.7	8.3	7.4	9.8	14.1	12.2	10.4	8.5	7.6	7.6	15.1	15.6	11.8	24.1	9.4	10.1	18.2	11.6	10.6	4.5	12.0	7.8	9.7	0.0	0.1	0.5	0.5	0.0	0.3	0.7	0.6	0.4	0.1	0.4	0.2	0.4	0.1	0.0	0.0	0.2	0.7	0.1	15.0	15.0	15.3	19.9	14.0	14.3	15.1	13.3	15.5	11.4	14.8	13.9	14.7	3.2	6.9	17.0	5.0	5.5	1.8	2.6	5.7	7.4	6.5	6.9	5.0	7.2	3.4	3.7	2.1	2.3	7.6	4.0	1.9	4.8	0.9	11.8	8.1	7.4	6.1	0.8	12.2	5.6	2.8	5.7	3.6	6.8	8.9	8.3	6.1	3.8	3.2	15.2	12.9	2.6	6.1	3.5	3.5	1.3	7.5	3.7	5.4	6.5	3.5	8.9	1.0	8.5	8.5	6.7	1.6	5.7	2.5	3.3	3.4	2.4	10.0	10.8	0.0	5.5	7.5	15.3	9.1	5.4	4.8	0.8	5.3	5.6	3.9	1.6
INPP5F	"hSac2, KIAA0966, SAC2"	ENSG00000198825	"Inositol polyphosphate-5-phosphatase F"	Q9Y2H2	10	119726042-119829147	"Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins"		Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 135.3"	"Cell type enhanced"	"Detected in all"		"Excitatory neurons: 79.5;Inhibitory neurons: 130.5;Late spermatids: 88.6;Oligodendrocytes: 70.5"	"Cancer enhanced"	"Detected in all"		"testis cancer: 27.4"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"AF22: 91.4;SK-MEL-30: 149.0;SuSa: 181.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA042605			Supported	Vesicles		NA	NA			"Cluster 23: Antigen presenting cells - Antigen presentation"	"Cluster 26: Pituitary gland - Hormone signaling"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Vesicles		"HPA042605: AB_10793886"	"unprognostic (2.65e-2)"	"unprognostic (3.23e-1)"	"unprognostic (3.42e-2)"	"unprognostic (5.84e-2)"	"unprognostic (1.87e-2)"	"unprognostic (1.57e-3)"	"unprognostic (2.46e-3)"	"unprognostic (2.21e-1)"	"unprognostic (1.12e-1)"	"unprognostic (8.09e-2)"	"unprognostic (2.09e-1)"	"unprognostic (6.46e-2)"	"unprognostic (7.78e-2)"	"unprognostic (1.02e-1)"	"unprognostic (9.91e-2)"	"unprognostic (2.96e-2)"	"unprognostic (6.21e-2)"	9.9	16.8	53.8	9.9	49.4	4.7	7.6	45.3	63.9	15.7	10.1	15.5	4.6	15.4	22.8	9.3	8.3	6.9	5.9	50.6	135.3	10.5	3.2	9.1	10.7	71.2	57.3	12.3	6.7	7.4	57.1	10.9	75.0	10.9	8.0	32.9	10.8	10.0	11.0	13.7	9.5	13.2	50.3	7.5	8.6	14.8	62.7	7.0	10.5	3.8	13.0	9.2	12.5	55.2	13.5	8.2	91.4	14.3	6.9	10.6	8.5	18.4	9.3	8.4	8.4	12.0	15.2	8.3	7.6	19.7	10.6	14.4	7.9	9.8	11.9	6.0	10.3	6.5	3.9	11.0	13.5	4.4	19.0	9.7	8.6	14.2	13.5	15.7	23.2	6.1	5.7	13.8	20.8	7.0	5.5	15.7	9.2	9.9	12.0	7.0	18.8	2.3	12.5	5.3	6.5	70.2	19.8	7.2	149.0	181.5	4.3	3.4	19.6	9.9	12.2	11.0	17.5	15.2	7.7	4.5	11.0	12.8	32.3	0.9	3.4	1.3	1.0	3.0	1.3	6.7	2.2	1.3	6.2	9.1	2.2	1.1	0.8	3.4	3.6	1.4	5.3	1.9	53.8	49.4	45.3	63.9	50.6	135.3	71.2	57.3	75.0	50.3	62.7	55.2	7.8	6.4	4.8	52.5	21.5	9.1	11.7	7.5	10.2	24.2	6.9	9.5	5.4	1.5	7.8	12.9	16.7	9.3	7.9	15.1	11.7	3.6	58.7	4.3	18.3	8.6	1.2	5.2	79.5	4.5	10.6	7.9	5.1	6.9	2.5	9.7	4.2	3.5	9.9	42.1	130.5	5.6	10.2	6.0	27.8	88.6	5.3	13.1	19.6	34.7	16.3	21.7	6.2	52.8	70.5	6.8	6.6	3.8	4.7	8.2	6.5	24.7	4.0	21.6	6.6	7.8	13.8	22.4	41.0	13.1	10.4	13.3	7.7	19.3	6.5	13.1
INPP5J	"INPP5, PIB5PA, PIPP"	ENSG00000185133	"Inositol polyphosphate-5-phosphatase J"	Q15735	22	31122731-31134697	"Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins"		Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"parathyroid gland: 123.2;thyroid gland: 204.2"	"Cell type enhanced"	"Detected in many"		"Collecting duct cells: 35.0;Distal enterocytes: 24.0;Inhibitory neurons: 19.5;Muller glia cells: 25.2;Proximal enterocytes: 62.3"	"Cancer enriched"	"Detected in many"	6	"thyroid cancer: 63.1"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"HL-60: 19.6;SK-BR-3: 41.1;T-47d: 25.7;U-698: 18.1"	"Region enhanced"	"Detected in all"		"olfactory bulb: 131.0"	"Low region specificity"	"Detected in all"			HPA034539			Approved	"Nucleoli fibrillar center,Cytosol"		NA	NA				"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 45: Enterocytes - Digestion"	Cytosol	"Nucleoli fibrillar center"	"HPA034539: AB_10670974"	"unprognostic (1.76e-1)"	"unprognostic (2.09e-1)"	"unprognostic (1.73e-1)"	"unprognostic (7.05e-2)"	"unprognostic (1.68e-1)"	"unprognostic (1.19e-2)"	"unprognostic (2.21e-3)"	"prognostic favorable (1.47e-5)"	"unprognostic (6.81e-2)"	"unprognostic (1.86e-2)"	"unprognostic (4.29e-4)"	"unprognostic (1.47e-1)"	"prognostic favorable (1.12e-7)"	"unprognostic (2.79e-3)"	"unprognostic (3.65e-2)"	"unprognostic (2.14e-1)"	"unprognostic (1.39e-2)"	0.8	2.1	3.2	0.8	4.8	0.1	8.9	17.3	13.2	4.0	2.4	10.4	16.3	3.0	0.6	2.4	2.3	1.2	27.8	11.5	15.2	32.1	0.4	2.3	0.5	6.0	4.0	1.2	15.7	123.2	10.1	0.1	5.2	9.2	3.7	5.3	33.1	12.1	2.8	4.4	26.2	1.5	1.4	0.3	13.6	4.4	8.3	0.2	204.2	2.6	0.4	2.7	2.4	5.7	2.1	2.0	1.2	2.3	0.3	0.2	1.1	0.8	0.8	4.1	4.0	1.2	1.3	0.1	1.0	0.4	0.4	2.4	2.5	1.2	1.7	0.0	6.5	0.0	9.7	0.4	0.8	19.6	0.2	0.2	1.3	3.4	0.4	2.7	0.3	0.1	1.8	2.8	0.1	6.4	0.1	0.1	2.3	2.8	0.4	0.0	0.4	4.5	1.7	2.5	9.9	7.5	1.6	41.1	0.5	1.1	25.7	1.6	0.0	0.2	7.3	0.8	0.5	0.1	3.5	18.1	0.7	0.0	3.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	3.2	4.8	17.3	13.2	11.5	15.2	6.0	4.0	5.2	1.4	8.3	5.7	0.7	0.0	4.1	3.3	0.0	0.9	2.3	0.3	1.2	9.5	15.8	7.5	6.1	0.0	1.1	35.0	0.0	0.0	0.2	24.0	11.7	1.4	0.4	1.9	0.4	0.5	0.0	0.0	5.5	2.2	0.2	0.6	4.6	2.7	0.0	0.8	0.0	0.0	0.1	5.0	19.5	6.4	0.0	0.0	1.9	0.6	0.0	0.3	0.0	1.0	0.6	25.2	0.0	2.0	1.0	0.8	12.3	0.0	0.1	2.5	62.3	0.5	0.5	3.1	0.0	0.5	1.3	2.4	1.2	1.1	1.3	0.1	0.4	0.4	8.8	1.6
INPP5K	SKIP	ENSG00000132376	"Inositol polyphosphate-5-phosphatase K"	Q9BT40	17	1494577-1516742	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"		Hydrolase	"Cataract, Congenital muscular dystrophy, Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in all"	5	"Early spermatids: 96.1;Late spermatids: 345.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"									NA	NA			"Cluster 31: Non-specific - Inflammatory response"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 25: Spermatids - Spermatogenesis"				"unprognostic (7.47e-2)"	"prognostic favorable (3.91e-4)"	"unprognostic (8.91e-2)"	"prognostic favorable (2.33e-5)"	"unprognostic (3.25e-1)"	"unprognostic (9.22e-2)"	"unprognostic (1.50e-1)"	"unprognostic (7.50e-2)"	"unprognostic (2.00e-1)"	"unprognostic (2.77e-2)"	"prognostic favorable (1.47e-6)"	"unprognostic (4.71e-2)"	"unprognostic (9.35e-3)"	"unprognostic (3.01e-2)"	"unprognostic (7.20e-2)"	"unprognostic (4.28e-3)"	"unprognostic (1.04e-1)"	34.7	15.2	25.8	12.9	26.0	34.5	29.2	25.3	30.2	19.5	61.5	19.6	10.2	17.0	13.1	17.9	15.3	10.7	28.9	29.8	25.7	16.7	15.0	27.3	18.6	26.9	26.9	17.8	21.9	13.7	14.8	18.6	26.9	19.6	12.7	15.9	18.1	12.9	40.5	30.1	19.4	12.0	25.4	22.8	19.1	20.4	26.9	25.8	30.4	25.2	19.7	18.2	17.9	27.0	14.9	24.0	9.2	18.4	22.5	13.2	12.1	12.0	23.6	15.8	19.6	15.7	9.1	14.6	23.2	22.2	12.5	19.4	22.1	9.6	14.3	35.3	33.0	8.6	18.1	5.9	31.3	7.9	17.0	16.2	24.0	15.8	16.1	10.0	25.3	25.3	9.4	25.9	10.6	12.5	24.5	7.1	3.9	23.9	14.6	19.0	6.7	14.6	12.8	10.3	7.1	18.0	10.2	21.6	24.3	13.0	17.9	7.3	16.2	13.6	13.3	19.8	16.8	12.9	23.4	7.4	14.7	9.1	17.3	104.3	42.2	74.3	48.7	41.9	39.7	27.5	44.5	50.2	36.2	24.4	37.5	41.1	74.7	42.3	66.6	27.0	75.1	62.5	25.8	26.0	25.3	30.2	29.8	25.7	26.9	26.9	26.9	25.4	26.9	27.0	26.1	32.1	14.1	8.5	20.6	30.0	15.7	10.8	18.8	7.8	15.6	12.2	35.8	8.6	11.0	23.9	2.1	13.9	27.5	26.0	13.7	19.4	96.1	10.3	6.9	27.0	17.4	25.2	5.4	24.3	16.4	15.5	13.3	17.4	19.7	7.7	28.5	10.2	11.9	20.2	5.9	17.3	14.2	18.4	19.0	345.7	11.5	13.8	32.0	2.8	37.1	23.1	27.8	2.5	7.0	27.1	23.4	7.5	18.0	13.3	33.2	11.2	6.4	7.9	19.7	12.6	15.3	35.5	20.4	18.1	30.3	31.1	27.2	5.8	13.5	17.4
INPPL1	SHIP2	ENSG00000165458	"Inositol polyphosphate phosphatase like 1"	O15357	11	72223701-72239147	"Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"Cell adhesion, Immunity"	"Actin-binding, Hydrolase"	"Cancer-related genes, Diabetes mellitus, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HeLa: 344.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA037601	Approved		Supported	"Golgi apparatus,Cytosol"		NA	NA			"Cluster 14: Monocytes - Unknown function"	"Cluster 59: Non-specific - Translation"	"Cluster 20: HeLa - Mitochondria"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Cytosol	"Golgi apparatus"	"HPA037601: AB_10672281"	"unprognostic (2.68e-1)"	"unprognostic (2.69e-2)"	"unprognostic (1.12e-1)"	"unprognostic (1.12e-1)"	"unprognostic (3.68e-3)"	"unprognostic (1.58e-1)"	"prognostic unfavorable (7.37e-4)"	"unprognostic (2.49e-2)"	"unprognostic (3.54e-2)"	"unprognostic (1.51e-2)"	"unprognostic (1.64e-1)"	"unprognostic (4.34e-2)"	"unprognostic (3.66e-2)"	"unprognostic (2.33e-1)"	"unprognostic (2.88e-1)"	"unprognostic (1.99e-3)"	"unprognostic (2.07e-1)"	45.2	56.4	39.0	34.4	43.4	51.3	44.7	41.3	40.5	63.8	47.3	87.5	35.9	56.1	18.2	34.6	61.3	33.7	73.6	33.2	42.5	60.0	36.6	61.8	36.8	53.9	43.2	68.6	55.7	36.4	60.5	39.7	45.8	68.7	23.3	14.9	53.8	39.5	116.6	31.4	57.1	33.4	45.0	66.1	60.8	24.2	48.8	19.3	67.7	43.0	23.2	59.9	43.4	41.2	28.7	62.1	71.5	49.8	35.4	41.1	122.5	118.9	61.2	80.6	49.6	84.3	72.2	79.5	125.6	101.7	57.8	106.7	60.4	37.6	28.0	101.9	59.1	84.8	344.5	31.9	68.1	56.1	176.7	58.2	39.1	78.0	31.4	100.5	44.2	29.3	59.7	34.7	45.1	78.8	42.1	224.9	67.7	20.7	93.7	185.0	161.0	18.2	94.8	48.6	33.8	48.6	133.9	85.1	182.8	36.6	88.8	106.0	74.5	86.4	96.7	129.9	43.1	94.5	17.5	80.1	24.7	51.7	47.2	2.5	3.5	3.3	1.9	2.0	1.7	0.9	1.6	1.3	2.4	1.0	1.1	1.6	2.3	2.2	3.6	1.8	1.5	1.8	39.0	43.4	41.3	40.5	33.2	42.5	53.9	43.2	45.8	45.0	48.8	41.2	13.9	3.2	12.8	47.0	8.1	7.1	4.9	10.8	14.2	1.7	20.3	17.3	13.6	11.5	11.7	12.9	27.1	27.9	9.1	28.3	1.9	11.6	1.5	14.6	16.3	11.2	22.7	5.7	2.6	12.5	15.4	10.8	24.5	25.5	7.6	21.0	8.9	12.5	21.7	10.1	2.2	16.4	18.3	27.6	16.2	2.1	9.9	29.8	10.6	18.7	17.6	16.8	14.4	15.1	6.1	14.9	17.5	13.9	7.8	7.8	15.2	16.2	10.2	17.2	6.6	12.9	14.5	1.4	4.9	6.7	4.8	32.4	11.6	10.1	21.8	5.4
ISG20	"CD25, HEM45"	ENSG00000172183	"Interferon stimulated exonuclease gene 20"	Q96AZ6	15	88635670-88656483	"Enzymes, Predicted intracellular proteins"	"Antiviral defense, Immunity, Innate immunity, rRNA processing"	"Exonuclease, Hydrolase, Nuclease, RNA-binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 188.9"	"Cell type enhanced"	"Detected in many"		"Langerhans cells: 500.2;Paneth cells: 476.1;Plasma cells: 663.4;Urothelial cells: 538.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"Daudi: 202.9;Karpas-707: 117.4;SK-MEL-30: 718.4;U-698: 123.2"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"									NA	NA			"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 16: Immune cells - Immune response"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 55: Plasma cells - Humoral immune response"				"unprognostic (2.55e-3)"	"unprognostic (1.19e-3)"	"unprognostic (2.00e-2)"	"unprognostic (1.32e-1)"	"prognostic unfavorable (6.51e-5)"	"unprognostic (1.55e-2)"	"unprognostic (1.46e-1)"	"unprognostic (4.54e-2)"	"unprognostic (1.35e-3)"	"prognostic favorable (1.85e-5)"	"unprognostic (5.60e-2)"	"unprognostic (2.07e-1)"	"prognostic unfavorable (4.86e-8)"	"unprognostic (1.04e-1)"	"unprognostic (4.69e-2)"	"unprognostic (3.39e-1)"	"unprognostic (1.58e-2)"	22.4	8.1	7.0	78.3	9.0	41.3	21.7	8.0	11.3	12.9	6.0	28.5	77.2	7.4	9.5	30.1	15.2	38.7	14.5	6.7	8.2	15.1	28.2	62.8	188.9	10.7	8.0	19.1	10.5	2.6	28.6	12.5	8.5	18.7	9.5	0.2	25.1	11.2	5.0	11.2	65.6	3.3	8.2	148.5	69.1	6.7	9.2	87.2	31.0	3.1	64.0	27.4	13.4	9.3	9.1	15.0	0.6	0.2	0.2	0.6	2.4	0.4	7.0	41.4	56.7	4.5	20.8	202.9	10.5	0.6	20.2	3.1	1.1	4.2	1.7	65.1	0.6	0.7	6.3	9.6	26.8	0.3	0.2	3.7	9.3	13.3	10.3	1.2	6.5	15.1	0.8	117.4	0.0	16.4	0.7	1.7	2.1	34.2	30.1	8.8	1.0	39.7	3.3	2.3	0.7	1.0	2.4	84.9	718.4	0.4	3.8	4.7	8.6	1.6	5.0	0.3	3.0	81.2	22.4	123.2	1.8	4.0	8.7	141.9	37.4	75.9	303.2	63.5	402.9	1150.1	509.2	432.4	32.5	1184.0	365.5	390.7	1340.3	381.9	52.3	140.3	1244.0	369.5	7.0	9.0	8.0	11.3	6.7	8.2	10.7	8.0	8.5	8.2	9.2	9.3	70.4	48.1	46.7	0.0	424.2	178.7	152.3	98.5	3.4	0.2	84.3	58.8	1.9	51.5	97.0	3.7	0.0	2.3	378.8	213.5	1.9	66.1	23.7	318.8	29.4	86.6	37.6	108.2	0.6	148.9	71.5	63.5	130.0	254.1	7.6	2.9	21.8	13.3	8.2	0.0	1.9	144.1	168.9	34.4	500.2	5.2	2.1	72.2	225.9	5.6	195.4	0.0	224.6	1.5	3.1	307.1	476.1	1.9	663.4	318.7	131.8	8.6	118.4	0.2	26.3	14.6	26.9	1.1	2.9	9.9	287.0	52.0	318.4	4.9	19.7	538.6
ITPA	"C20orf37, dJ794I6.3, HLC14-06-P"	ENSG00000125877	"Inosine triphosphatase"	Q9BY32	20	3208868-3223870	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"Nucleotide metabolism"	Hydrolase	"Disease variant, Epilepsy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA022824, HPA073963"	Approved		Supported	Nucleoplasm,Cytosol		NA	NA		120000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 37: Intestine - Unknown function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 39: Non-specific - Basic cellular processes"	"Nucleoplasm, Cytosol"		"HPA022824: AB_1851960, HPA073963: "	"unprognostic (1.58e-2)"	"unprognostic (1.98e-1)"	"unprognostic (1.73e-1)"	"unprognostic (3.57e-1)"	"unprognostic (4.63e-2)"	"unprognostic (1.53e-2)"	"prognostic unfavorable (2.54e-5)"	"unprognostic (1.11e-2)"	"unprognostic (1.68e-1)"	"unprognostic (1.76e-1)"	"unprognostic (1.83e-1)"	"unprognostic (2.28e-1)"	"unprognostic (1.94e-2)"	"unprognostic (8.34e-2)"	"unprognostic (3.63e-1)"	"unprognostic (1.24e-1)"	"unprognostic (1.84e-1)"	26.2	37.1	16.7	21.2	17.5	26.4	25.0	16.9	20.0	24.8	18.2	25.3	27.0	24.0	13.0	43.9	29.9	16.7	20.8	18.2	16.8	34.2	28.2	22.4	27.6	17.0	16.5	21.2	21.9	24.2	13.0	19.8	17.0	20.3	19.2	6.9	26.4	16.1	26.5	33.6	23.2	18.5	17.3	27.0	27.1	12.3	18.0	24.8	33.5	15.1	21.4	24.1	25.7	18.5	118.2	91.1	44.0	49.1	29.7	42.7	30.9	50.9	72.4	65.9	58.8	75.0	106.6	52.5	46.9	48.7	65.7	101.9	62.3	79.8	46.6	32.9	91.6	123.9	39.1	117.6	55.5	54.5	41.4	41.5	60.3	64.4	40.9	28.6	52.5	39.5	88.7	34.2	62.6	55.2	66.0	156.5	77.2	132.1	89.6	61.4	60.7	135.0	96.7	39.2	67.4	80.9	41.4	154.0	106.3	19.3	60.1	94.2	37.9	76.5	42.4	51.7	116.0	52.0	68.4	94.2	32.9	102.8	83.0	32.8	61.5	22.9	47.7	78.2	41.7	48.9	43.6	49.0	74.5	50.2	32.4	39.5	3.4	64.5	56.9	70.7	61.0	48.0	16.7	17.5	16.9	20.0	18.2	16.8	17.0	16.5	17.0	17.3	18.0	18.5	29.4	22.4	47.0	15.3	38.0	40.1	50.5	93.2	56.9	20.4	48.8	58.3	9.8	34.3	59.3	44.1	14.6	74.4	45.9	37.5	58.7	104.2	2.7	51.8	64.4	29.4	27.5	24.6	12.0	105.1	128.2	41.8	48.4	60.9	42.5	49.7	29.3	32.1	116.6	5.0	9.2	53.1	54.9	42.4	54.0	3.7	31.1	49.0	40.9	5.6	90.3	21.0	41.2	14.1	21.5	102.2	59.9	22.2	34.5	53.5	51.6	94.5	37.9	24.5	19.7	35.4	45.0	16.8	17.6	58.8	49.2	56.2	47.2	53.3	79.9	66.0
JOSD1	KIAA0063	ENSG00000100221	"Josephin domain containing 1"	Q15040	22	38685543-38701556	"Enzymes, Predicted intracellular proteins"	"Ubl conjugation pathway"	"Hydrolase, Protease"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA001168	Uncertain					NA	NA			"Cluster 22: NK-cells - Unknown function"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 24: Non-specific - Transcription regulation"			"HPA001168: AB_1079162"	"unprognostic (6.50e-2)"	"unprognostic (1.06e-2)"	"unprognostic (3.42e-3)"	"unprognostic (5.67e-2)"	"unprognostic (1.57e-1)"	"unprognostic (1.08e-1)"	"prognostic unfavorable (4.50e-4)"	"unprognostic (1.65e-2)"	"unprognostic (5.10e-2)"	"unprognostic (1.39e-1)"	"unprognostic (3.23e-3)"	"unprognostic (2.46e-1)"	"unprognostic (1.83e-3)"	"unprognostic (1.06e-1)"	"unprognostic (4.41e-1)"	"unprognostic (2.88e-2)"	"unprognostic (4.41e-1)"	33.6	22.1	30.7	25.0	32.6	89.6	25.0	30.9	34.2	24.0	23.2	40.9	27.5	25.6	14.8	23.0	28.0	34.1	24.6	33.0	27.7	20.0	23.8	30.9	21.8	29.9	28.7	48.9	25.9	16.8	27.8	22.7	30.6	23.1	38.4	21.5	21.3	18.2	24.4	27.4	35.8	27.8	29.2	22.7	24.8	19.2	29.2	27.9	22.3	22.0	24.3	33.1	22.9	32.6	69.6	24.5	35.1	45.7	44.1	53.5	26.6	52.2	62.1	66.5	69.3	40.5	34.4	66.3	26.4	52.6	44.3	43.8	49.2	46.4	53.4	71.4	32.6	35.2	57.3	34.9	74.9	63.8	33.1	46.7	67.8	62.9	107.1	58.3	79.8	41.0	32.0	68.2	49.4	29.4	27.9	25.9	13.3	41.8	27.5	49.5	51.5	27.9	36.1	35.3	32.3	17.4	59.9	29.3	54.7	29.2	29.4	18.2	70.0	39.4	48.1	51.4	32.1	74.9	71.1	54.2	52.4	33.5	37.5	1.0	1.8	1.9	2.6	2.8	1.8	1.6	2.2	3.4	1.3	1.6	2.3	3.7	3.6	2.3	1.6	1.0	3.2	1.4	30.7	32.6	30.9	34.2	33.0	27.7	29.9	28.7	30.6	29.2	29.2	32.6	45.0	25.6	17.1	12.7	53.1	46.4	75.0	20.2	34.7	28.2	41.0	45.1	17.0	44.3	18.5	36.8	22.9	10.5	94.1	133.1	13.7	34.6	4.9	51.6	38.6	35.3	23.4	21.0	25.2	39.3	15.0	24.2	53.5	114.5	16.5	26.9	23.9	24.8	22.7	18.5	21.7	61.8	12.2	32.6	106.3	4.8	12.8	74.2	16.0	6.5	27.3	27.5	12.3	7.1	24.6	68.0	88.1	13.9	61.5	62.4	64.6	18.1	17.4	23.6	13.1	27.9	27.3	16.2	24.2	35.5	51.6	12.9	75.2	17.8	35.0	102.7
JOSD2	SBBI54	ENSG00000161677	"Josephin domain containing 2"	Q8TAC2	19	50505998-50511220	"Enzymes, Predicted intracellular proteins"	"Ubl conjugation pathway"	"Hydrolase, Protease"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"													NA	NA			"Cluster 31: Non-specific - Inflammatory response"	"Cluster 35: Non-specific - Unknown function"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 53: Intestinal epithelial cells - Unknown function"				"unprognostic (8.77e-2)"	"unprognostic (3.09e-2)"	"unprognostic (2.59e-1)"	"unprognostic (1.57e-2)"	"unprognostic (7.25e-2)"	"unprognostic (2.38e-1)"	"prognostic unfavorable (6.04e-5)"	"unprognostic (3.63e-2)"	"unprognostic (2.41e-1)"	"unprognostic (5.68e-2)"	"unprognostic (1.75e-2)"	"unprognostic (6.49e-2)"	"unprognostic (2.42e-3)"	"unprognostic (8.05e-2)"	"unprognostic (2.04e-1)"	"unprognostic (6.05e-2)"	"unprognostic (9.34e-2)"	39.7	33.4	30.1	10.6	37.4	13.2	34.1	37.7	48.1	38.3	20.5	40.5	16.7	37.9	2.5	49.1	31.8	5.8	44.3	27.3	32.0	37.6	48.1	29.0	6.7	41.0	34.8	29.6	26.8	11.3	28.2	8.0	38.2	32.5	2.8	1.5	26.5	8.2	50.2	37.0	29.5	5.8	35.0	32.8	37.4	18.6	35.0	5.5	40.5	7.9	4.0	37.9	38.9	44.8	38.5	65.7	0.3	18.2	20.4	23.6	12.5	46.8	15.9	12.1	12.9	11.4	26.8	12.2	26.7	16.6	14.6	24.8	1.9	20.2	3.2	54.0	31.3	11.7	12.2	5.8	25.5	3.2	39.1	26.1	17.7	7.8	6.2	15.5	11.4	12.8	15.7	27.2	12.6	27.9	13.3	15.6	4.6	23.9	67.4	3.7	31.1	21.6	11.8	36.8	11.0	29.4	14.0	32.8	40.8	1.5	27.1	19.7	27.5	21.0	25.9	27.6	27.0	30.2	26.1	4.2	59.5	15.7	41.4	55.4	95.3	95.0	45.0	93.8	38.6	24.1	41.9	46.1	70.1	25.1	29.9	33.3	16.2	31.9	70.0	50.6	51.6	48.9	30.1	37.4	37.7	48.1	27.3	32.0	41.0	34.8	38.2	35.0	35.0	44.8	42.8	6.4	1.7	6.2	18.4	31.0	45.4	83.2	38.1	11.1	45.3	48.0	3.1	47.1	30.1	33.1	0.0	39.5	30.0	153.4	66.5	88.3	12.3	25.4	61.4	30.7	16.8	21.0	3.1	86.3	92.8	47.3	57.6	36.2	5.7	52.5	47.5	56.3	93.5	16.8	2.8	67.8	50.8	70.6	48.8	34.6	89.2	59.4	78.2	3.7	94.1	32.9	30.9	3.0	21.7	120.8	103.2	97.8	21.4	26.3	157.8	106.6	63.0	10.0	52.6	26.2	52.7	32.0	18.4	58.5	45.9	41.3	33.6	48.9	51.8	57.0
KL		ENSG00000133116	Klotho	Q9UEF7	13	33016423-33066143	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted membrane proteins, Predicted secreted proteins, Transporters"		"Glycosidase, Hormone, Hydrolase"	"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"choroid plexus: 47.1;kidney: 128.7;parathyroid gland: 135.2"	"Cell type enriched"	"Detected in some"	7	"Proximal tubular cells: 123.3"	"Group enriched"	"Detected in many"	6	"prostate cancer: 5.9;renal cancer: 17.8"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"HMC-1: 2.4;SK-BR-3: 4.5"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"basal ganglia: 13.3;cerebral cortex: 6.7;hippocampal formation: 7.4;medulla oblongata: 4.2"						"Secreted to blood"	NA	NA	510000			"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"				"unprognostic (1.32e-1)"	"unprognostic (3.10e-1)"	"unprognostic (2.35e-1)"	"unprognostic (2.73e-3)"	"unprognostic (3.37e-1)"	"unprognostic (1.15e-4)"	"unprognostic (3.06e-2)"	"unprognostic (6.50e-2)"	"unprognostic (2.22e-2)"	"unprognostic (2.60e-1)"	"prognostic favorable (4.44e-4)"	"unprognostic (9.46e-2)"	"prognostic favorable (1.29e-9)"	"unprognostic (4.76e-3)"	"unprognostic (1.91e-1)"	"unprognostic (2.86e-2)"	"unprognostic (1.07e-1)"	3.3	1.4	0.9	0.8	3.1	0.1	2.5	0.8	1.5	1.8	47.1	2.1	2.7	1.2	8.8	1.1	0.8	1.3	1.1	4.2	1.1	128.7	0.4	3.5	1.0	0.5	0.5	0.1	1.2	135.2	0.3	30.4	0.5	8.0	0.9	0.0	0.8	2.5	0.7	0.6	2.6	1.2	0.6	2.4	2.0	0.5	0.8	0.5	1.3	1.5	0.5	1.6	0.6	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	4.5	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	3.1	0.8	1.5	4.2	1.1	0.5	0.5	0.5	0.6	0.8	0.5	15.8	0.0	0.5	0.0	0.6	0.1	0.2	0.0	0.0	0.0	0.6	0.3	1.0	0.0	0.7	12.9	0.0	0.2	0.0	0.4	5.9	0.0	1.8	0.1	2.5	10.2	16.3	0.4	1.2	0.0	0.1	1.6	0.0	0.1	0.0	0.1	1.1	0.2	2.8	0.0	0.5	1.1	0.0	0.9	1.0	0.8	0.3	1.9	0.0	6.5	0.9	0.0	0.0	0.0	0.2	0.0	0.0	0.4	0.0	3.6	1.8	123.3	0.7	0.0	0.0	1.1	2.3	1.4	0.5	0.0	0.1	0.1	1.1	0.1	1.9	0.1
KLK1	Klk6	ENSG00000167748	"Kallikrein 1"	P06870	19	50819146-50823787	"Enzymes, Metabolic proteins, Predicted secreted proteins"		"Hydrolase, Protease, Serine protease"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	84	"pancreas: 9557.9;salivary gland: 5487.3"	"Group enriched"	"Detected in many"	7	"Exocrine glandular cells: 788.4;Intestinal goblet cells: 1317.5"	"Cancer enhanced"	"Detected in many"		"pancreatic cancer: 50.9;renal cancer: 84.1"	"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	9	"memory B-cell: 9.5;naive B-cell: 4.0"	"Lineage enriched"	"Detected in single"	13	"B-cells: 9.5"	"Cell line enriched"	"Detected in some"	4	"RPMI-8226: 43.8"									HPA059690	Approved				"Secreted to digestive system"	NA	NA		10000000	"Cluster 19: B-cells - Humoral immune response"	"Cluster 25: Pancreas - Digestion"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 27: Mucus-secreting cells - Mucin production"			"HPA059690: "	"unprognostic (1.51e-3)"	"unprognostic (1.23e-2)"	"unprognostic (4.20e-1)"	"unprognostic (1.73e-2)"	"unprognostic (1.10e-1)"	"unprognostic (8.72e-2)"	"unprognostic (1.92e-2)"	"unprognostic (7.47e-3)"	"unprognostic (1.66e-1)"	"unprognostic (2.49e-2)"	"unprognostic (8.06e-2)"	"unprognostic (2.12e-1)"	"unprognostic (1.42e-2)"	"unprognostic (2.55e-1)"	"unprognostic (6.49e-2)"	"unprognostic (2.10e-1)"	"unprognostic (6.23e-2)"	1.4	2.4	0.1	4.0	0.0	0.4	1.8	0.0	0.4	1.9	0.0	68.8	9.6	2.0	0.0	1.3	0.6	0.1	3.0	0.3	0.0	89.4	0.6	0.5	0.5	0.0	0.0	4.7	9557.9	0.4	0.2	1.1	0.0	2.7	53.0	0.0	5487.3	0.1	0.2	26.3	9.7	2.8	0.0	3.3	1.4	0.1	0.0	0.2	2.9	0.2	1.5	0.2	0.9	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.7	0.4	0.2	0.3	0.5	1.6	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.5	0.0	1.1	0.1	0.4	0.2	0.0	0.0	0.0	0.1	1.2	0.0	0.0	0.1	0.1	0.0	0.0	9.7	0.0	0.1	0.0	43.8	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.1	0.8	0.0	0.0	0.3	0.1	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.3	0.0	9.5	0.0	0.0	0.1	4.0	0.0	0.0	0.1	0.0	0.2	0.7	0.0	0.1	0.1	0.0	0.0	0.4	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.6	0.0	18.9	19.5	1.2	2.9	1.2	0.0	1.0	1.1	0.3	0.0	2.5	0.0	0.0	0.0	0.2	62.2	45.0	3.3	0.6	0.1	1.4	0.4	117.1	0.0	0.0	788.4	0.0	7.7	1.5	0.0	8.9	8.8	0.4	0.0	0.6	0.0	0.0	1317.5	14.2	1.6	5.3	0.3	6.2	1.5	5.4	0.0	6.2	0.0	0.0	0.0	0.0	125.8	134.4	0.0	10.9	9.8	57.1	0.3	0.3	0.0	0.0	0.0	1.1	0.3	0.9	1.7	54.0	0.0	2.1	2.5	148.5	3.8
KLK2		ENSG00000167751	"Kallikrein related peptidase 2"	P20151	19	50861568-50880567	"Cancer-related genes, Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"		"Hydrolase, Protease, Serine protease"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	87	"prostate: 566.2"	"Cell type enriched"	"Detected in some"	40	"Prostatic glandular cells: 777.2"	"Cancer enriched"	"Detected in some"	1666	"prostate cancer: 989.9"	"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"BEWO: 3.5;NB-4: 5.6"									HPA000764	Supported				"Secreted in male reproductive system"	NA	NA			"Cluster 9: Neutrophils - Innate immune response"	"Cluster 51: Non-specific - Unknown function"	"Cluster 24: NB-4 - Immune response"	"Cluster 35: Glandular cells - Unknown function"			"HPA000764: AB_1079700"	"unprognostic (3.05e-2)"	"unprognostic (2.40e-1)"	"unprognostic (1.69e-1)"	"unprognostic (8.53e-2)"		"unprognostic (1.15e-1)"		"unprognostic (8.97e-2)"	"unprognostic (3.22e-1)"	"unprognostic (6.44e-2)"	"unprognostic (8.06e-2)"	"unprognostic (3.61e-1)"	"unprognostic (2.11e-3)"	"unprognostic (7.56e-2)"	"unprognostic (8.10e-2)"	"unprognostic (1.68e-1)"	"unprognostic (2.04e-1)"	0.7	1.1	3.2	1.2	2.3	6.4	0.5	5.2	4.3	0.2	2.2	0.4	1.5	0.6	1.1	0.5	0.3	0.2	0.3	2.6	2.2	0.4	0.8	0.5	1.0	2.2	3.1	0.4	0.0	0.8	0.0	0.2	2.9	566.2	0.3	1.7	1.9	0.4	1.0	0.8	1.0	0.1	0.6	0.7	0.5	3.0	2.4	0.0	1.9	0.0	0.2	0.2	0.0	6.3	0.9	0.6	0.3	0.7	0.0	0.4	3.5	0.2	0.1	0.1	0.1	0.3	0.4	1.0	0.1	0.0	0.3	0.9	0.1	0.0	0.1	0.9	0.6	0.0	0.7	0.0	0.0	0.1	1.7	0.2	0.1	0.1	0.2	0.2	0.0	0.6	0.7	0.9	0.2	1.0	0.6	5.6	0.5	0.9	0.0	0.4	0.0	1.6	0.0	1.1	0.5	0.5	0.1	0.7	0.6	0.1	0.5	0.2	0.4	0.6	1.0	2.6	0.9	0.8	1.8	0.4	1.0	0.6	0.7	0.4	0.6	0.5	0.3	0.3	0.2	0.3	0.2	0.3	0.1	0.6	0.2	0.4	1.7	0.4	0.2	0.5	0.1	0.2	3.2	2.3	5.2	4.3	2.6	2.2	2.2	3.1	2.9	0.6	2.4	6.3	0.0	0.0	0.6	0.0	0.2	0.3	10.2	0.0	0.0	0.0	16.1	2.8	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.5	0.0	0.8	1.5	0.0	0.0	0.0	0.0	0.2	1.1	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.3	5.2	0.0	4.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	777.2	0.0	0.1	0.0	0.0	0.0	0.0	1.8	19.3	7.2	0.0	0.9	0.0	0.6	1.7	0.0	12.0
KLK3	"APS, PSA"	ENSG00000142515	"Kallikrein related peptidase 3"	P07288	19	50854915-50860764	"Cancer-related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted secreted proteins"		"Hydrolase, Protease, Serine protease"	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	320	"prostate: 8011.8"	"Cell type enriched"	"Detected in some"	77	"Prostatic glandular cells: 3438.6"	"Cancer enriched"	"Detected in some"	3905	"prostate cancer: 4241.6"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	173	"BEWO: 31.7;NB-4: 27.8;RPMI-8226: 19.3;SH-SY5Y: 10.5;U-2197: 10.7"									"CAB000070, HPA000764"	Enhanced				"Secreted in male reproductive system"	NA	NA		7000000		"Cluster 51: Non-specific - Unknown function"	"Cluster 24: NB-4 - Immune response"	"Cluster 35: Glandular cells - Unknown function"			"CAB000070: , HPA000764: AB_1079700"	"unprognostic (5.06e-3)"	"unprognostic (5.60e-2)"	"unprognostic (9.93e-2)"	"unprognostic (3.90e-2)"		"unprognostic (1.09e-2)"				"unprognostic (1.26e-2)"	"unprognostic (1.88e-2)"	"unprognostic (1.54e-1)"	"unprognostic (5.13e-3)"	"unprognostic (1.94e-1)"	"unprognostic (4.64e-1)"	"unprognostic (3.15e-1)"		4.3	7.6	0.0	5.6	0.0	0.0	9.0	0.0	0.0	0.5	0.0	2.6	4.8	1.6	14.4	0.2	4.0	0.0	0.5	0.0	0.0	1.4	1.5	1.2	1.7	0.0	0.0	0.3	0.9	0.6	0.2	0.3	0.0	8011.8	1.1	0.0	4.5	25.0	0.3	0.5	3.7	0.0	0.0	0.2	1.0	6.9	0.0	0.0	0.8	0.0	0.0	0.5	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	31.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	27.8	0.0	0.0	0.0	0.0	0.0	19.3	0.1	0.0	0.0	10.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.7	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	39.0	0.0	0.0	0.0	12.4	1.3	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	1.0	0.0	0.4	2.6	0.0	0.0	0.2	0.0	0.0	3.4	0.0	0.0	0.0	12.9	0.0	0.0	0.0	0.0	0.1	9.0	0.0	0.0	0.0	1.8	0.0	11.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	3438.6	0.1	0.1	0.0	0.0	0.0	0.0	6.9	0.1	0.0	0.0	0.0	0.0	4.2	0.2	0.4	44.6
KLK7	"PRSS6, SCCE"	ENSG00000169035	"Kallikrein related peptidase 7"	P49862	19	50976468-50984099	"Cancer-related genes, Enzymes, Predicted intracellular proteins, Predicted secreted proteins"		"Hydrolase, Protease, Serine protease"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"esophagus: 94.7;skin 1: 201.2"	"Cell type enhanced"	"Detected in some"		"Alveolar cells type 1: 6.4;Basal keratinocytes: 5.0;Basal squamous epithelial cells: 4.6;Breast glandular cells: 9.4;Breast myoepithelial cells: 10.4;Squamous epithelial cells: 5.9;Suprabasal keratinocytes: 10.7"	"Cancer enhanced"	"Detected in many"		"ovarian cancer: 139.8"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A-431: 5.0;CAPAN-2: 8.0;HaCaT: 31.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA018994, CAB026342, HPA062126"	Enhanced		Supported	"Nuclear membrane,Plasma membrane"	"Secreted in other tissues"	NA	NA		3700000	"Cluster 11: Basophils - Unknown function"	"Cluster 31: Skin - Epidermis development"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 16: Pancreatic endocrine cells - Mixed function"	"Plasma membrane"	"Nuclear membrane"	"CAB026342: , HPA018994: AB_1852607, HPA062126: AB_2684691"	"unprognostic (1.88e-2)"	"unprognostic (6.41e-2)"	"unprognostic (8.57e-2)"	"prognostic unfavorable (8.06e-5)"	"unprognostic (4.33e-3)"	"unprognostic (2.28e-1)"		"unprognostic (4.44e-3)"	"unprognostic (2.99e-1)"	"unprognostic (1.31e-1)"	"prognostic unfavorable (1.16e-4)"	"unprognostic (2.10e-1)"	"unprognostic (2.82e-3)"	"unprognostic (3.25e-1)"	"unprognostic (4.47e-2)"	"unprognostic (1.12e-2)"	"unprognostic (5.60e-3)"	7.1	0.1	8.4	0.1	9.2	0.3	11.2	0.9	7.4	19.7	1.0	0.1	0.5	0.7	0.2	94.7	16.3	1.3	0.2	6.5	1.4	12.1	0.1	3.1	0.0	4.3	1.4	0.1	0.1	0.3	0.7	0.0	4.9	0.1	0.0	0.1	21.6	0.2	1.0	201.2	0.0	0.2	2.1	0.8	0.3	0.3	7.4	0.9	0.2	0.0	10.9	0.0	30.9	3.0	5.0	0.0	0.0	0.2	0.0	0.0	1.5	0.0	0.0	0.0	0.0	1.8	8.0	0.0	1.1	0.0	0.1	31.7	0.0	1.0	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.2	0.0	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.1	0.1	0.3	0.5	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.2	0.0	0.1	0.0	0.1	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	8.4	9.2	0.9	7.4	6.5	1.4	4.3	1.4	4.9	2.1	7.4	3.0	0.0	6.4	1.1	0.0	0.0	5.0	0.1	0.5	4.6	0.0	9.4	10.4	0.2	0.0	2.4	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.1	2.6	0.2	0.0	0.0	1.7	0.0	0.0	2.9	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.3	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.4	0.0	0.0	0.0	1.0	0.0	0.0	0.8	0.0	0.0	0.0	0.1	0.0	0.2	5.9	10.7	0.0	0.1	0.0	0.1	2.7
KLK8	"HNP, neuropsin, ovasin, PRSS19, TADG14"	ENSG00000129455	"Kallikrein related peptidase 8"	O60259	19	50996007-51002711	"Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"		"Hydrolase, Protease, Serine protease"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"esophagus: 118.0;skin 1: 87.1;vagina: 47.2"	"Group enriched"	"Detected in some"	5	"Basal keratinocytes: 66.0;Suprabasal keratinocytes: 180.1"	"Cancer enhanced"	"Detected in many"		"head and neck cancer: 29.9;ovarian cancer: 30.7"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	8	"A-431: 88.3;CAPAN-2: 112.2;HaCaT: 83.5"	"Region enriched"	"Detected in all"	5	"hippocampal formation: 36.1"	"Region enhanced"	"Detected in single"		"basal ganglia: 1.2"	"CAB019393, HPA035761"	Enhanced		Approved	Vesicles	"Secreted in other tissues"	NA	NA		3200000		"Cluster 11: Squamous epithelial cells - Epithelial cell function"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 28: Keratinocytes - Keratinization"	Vesicles		"CAB019393: , HPA035761: AB_2674769"	"unprognostic (4.27e-3)"	"unprognostic (2.59e-1)"	"unprognostic (2.54e-1)"	"prognostic unfavorable (2.31e-4)"		"unprognostic (5.46e-2)"		"prognostic unfavorable (5.72e-4)"	"unprognostic (2.95e-1)"	"unprognostic (9.02e-2)"	"prognostic unfavorable (1.10e-4)"			"unprognostic (4.29e-2)"	"unprognostic (4.66e-2)"	"unprognostic (1.54e-1)"	"prognostic unfavorable (6.17e-4)"	5.7	0.0	0.1	0.0	0.0	0.0	8.4	0.8	0.7	24.7	0.2	0.0	0.0	0.9	0.4	118.0	13.2	0.1	0.2	0.0	0.0	0.4	0.1	0.1	0.0	0.7	0.2	0.1	0.0	0.0	0.6	0.0	0.4	0.0	0.0	0.0	17.1	0.1	0.7	87.1	0.0	0.1	0.0	0.2	0.1	1.2	0.2	1.1	0.5	0.0	9.6	0.0	47.2	0.5	88.3	0.0	0.0	0.6	0.0	0.0	12.3	0.0	0.0	0.0	0.0	1.7	112.2	0.0	2.2	0.0	0.1	83.5	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.7	10.3	0.0	0.0	0.0	0.0	3.5	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.9	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.8	0.7	0.0	0.0	0.7	0.2	0.4	0.0	0.2	0.5	0.1	0.0	0.0	0.0	0.3	66.0	0.0	0.4	14.8	0.0	13.0	15.6	0.1	0.0	1.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	1.8	0.7	11.0	0.3	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.6	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	2.7	5.0	1.8	0.1	8.8	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.0	2.2	0.0	0.0	0.0	0.3	2.8	6.2	21.1	180.1	0.0	0.2	0.0	0.2	0.1
KLKB1	KLK3	ENSG00000164344	"Kallikrein B1"	P03952	4	186208979-186258471	"Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Blood coagulation, Fibrinolysis, Hemostasis, Inflammatory response"	"Hydrolase, Protease, Serine protease"	"Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	25	"liver: 328.4"	"Cell type enriched"	"Detected in many"	5	"Hepatocytes: 280.5"	"Cancer enriched"	"Detected in some"	17	"liver cancer: 27.6"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"NTERA-2: 3.1;SCLC-21H: 2.1;U-937: 1.3"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"								"Secreted to blood"	NA	NA	28900000000	5300000000		"Cluster 62: Liver - Hemostasis"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 2: Hepatocytes - Metabolism"				"unprognostic (4.80e-2)"	"unprognostic (4.53e-3)"	"unprognostic (4.36e-2)"	"unprognostic (4.17e-2)"	"unprognostic (5.93e-2)"	"unprognostic (1.90e-2)"	"unprognostic (1.15e-2)"	"unprognostic (2.83e-1)"	"unprognostic (8.14e-2)"	"unprognostic (1.35e-1)"	"unprognostic (1.38e-2)"	"unprognostic (1.15e-1)"	"unprognostic (1.45e-2)"	"unprognostic (6.01e-2)"	"unprognostic (7.30e-2)"	"unprognostic (1.20e-1)"	"unprognostic (1.59e-2)"	0.6	1.8	5.9	0.3	6.5	0.0	0.6	6.0	7.6	1.4	9.3	2.3	2.8	0.6	1.0	0.4	1.3	2.5	2.6	6.3	6.2	7.7	328.4	1.0	0.7	7.0	6.5	0.7	4.8	1.0	3.6	0.2	6.4	1.7	1.4	13.1	0.7	0.6	2.4	0.3	2.6	0.6	6.1	2.4	0.8	2.0	6.0	0.4	1.9	1.8	0.4	1.5	0.9	6.3	0.0	0.0	0.0	0.0	0.1	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.2	0.0	3.1	0.0	0.0	0.0	0.0	0.0	0.5	0.0	2.1	0.1	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.9	6.5	6.0	7.6	6.3	6.2	7.0	6.5	6.4	6.1	6.0	6.3	0.1	0.0	0.0	48.3	0.7	0.0	0.1	0.2	0.6	5.1	0.3	0.5	4.3	14.3	0.1	1.8	16.7	0.0	0.5	0.6	0.0	1.8	2.8	0.6	0.2	1.0	3.0	2.7	10.2	0.5	0.0	0.4	0.0	0.4	0.0	0.2	5.7	280.5	0.2	0.0	15.6	0.4	0.0	4.4	0.0	2.2	0.6	0.3	0.0	6.5	0.1	10.6	2.1	8.0	7.7	0.4	1.4	0.0	0.1	0.0	2.6	1.6	1.1	5.1	0.0	0.6	0.3	1.3	1.3	0.1	0.0	0.0	0.6	0.1	0.7	0.1
KRAS	"KRAS1, KRAS2"	ENSG00000133703	"KRAS proto-oncogene, GTPase"	P01116	12	25205246-25250936	"Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, RAS pathway related proteins"		Hydrolase	"Cancer-related genes, Cardiomyopathy, Deafness, Disease variant, Ectodermal dysplasia, Mental retardation, Proto-oncogene"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA049830	Approved					NA	NA		3300000	"Cluster 18: Basophils - Vesicular transport"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 5: NTERA-2 - Transcription"	"Cluster 22: Epithelial cell types - Mixed function"			"HPA049830: AB_2680903"	"unprognostic (2.24e-2)"	"unprognostic (2.16e-2)"	"unprognostic (4.86e-3)"	"unprognostic (1.08e-2)"	"unprognostic (7.39e-2)"	"unprognostic (1.51e-1)"	"unprognostic (1.47e-2)"	"unprognostic (3.74e-2)"	"unprognostic (1.79e-1)"	"unprognostic (2.39e-1)"	"prognostic unfavorable (3.59e-4)"	"unprognostic (6.42e-2)"	"prognostic favorable (2.75e-5)"	"unprognostic (1.95e-2)"	"unprognostic (2.37e-1)"	"unprognostic (2.81e-2)"	"unprognostic (9.97e-2)"	11.8	9.1	11.0	16.2	12.2	27.8	10.0	11.7	12.3	9.5	4.6	22.0	14.0	11.0	6.8	19.3	7.4	13.1	8.6	12.5	12.0	11.7	15.3	13.2	17.9	8.5	9.7	8.0	12.6	11.1	5.7	17.0	8.7	11.8	23.0	22.7	11.9	8.3	7.6	13.6	19.5	13.6	8.1	12.0	20.3	8.9	12.9	17.2	10.8	10.3	17.4	16.2	11.4	8.6	15.9	14.3	39.4	20.7	14.1	19.9	68.9	17.3	22.8	18.0	21.9	51.5	30.7	38.7	10.4	32.0	23.4	18.6	44.9	17.3	34.3	26.7	15.0	37.6	17.6	15.6	15.8	32.8	25.6	18.1	25.5	21.9	20.2	33.6	27.1	28.7	28.0	17.3	27.6	14.1	46.8	56.6	87.6	25.3	7.4	43.4	39.9	59.9	27.2	22.4	11.2	32.4	20.5	24.9	21.8	97.4	28.9	26.9	28.1	18.7	24.8	38.2	22.0	16.4	28.5	41.9	15.4	20.0	15.0	31.2	8.1	13.7	11.6	16.4	7.9	10.7	10.1	13.1	7.9	10.5	13.8	12.4	19.2	11.2	22.4	7.8	7.6	5.8	11.0	12.2	11.7	12.3	12.5	12.0	8.5	9.7	8.7	8.1	12.9	8.6	73.7	48.1	32.1	16.6	90.8	100.9	96.4	57.2	72.3	63.4	59.9	38.0	16.3	64.3	53.6	38.6	73.0	94.2	66.0	161.9	58.7	77.5	3.9	45.4	40.8	77.3	78.8	60.2	42.0	91.8	21.4	50.1	98.4	53.4	24.1	26.6	77.8	56.9	51.5	92.5	45.3	92.9	36.7	53.9	83.7	5.9	40.7	75.3	62.2	28.1	82.9	41.7	49.4	19.6	16.6	114.2	104.7	51.6	85.0	130.1	63.0	52.3	42.5	65.8	26.3	53.7	52.2	53.0	40.3	93.0	155.7	139.1	83.0	36.5	96.7	176.9
KYNU		ENSG00000115919	Kynureninase	Q16719	2	142877657-143055833	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Pyridine nucleotide biosynthesis"	Hydrolase	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 88.4;urinary bladder: 51.5"	"Cell type enhanced"	"Detected in many"		"Basal respiratory cells: 136.1;Club cells: 109.6;Ionocytes: 114.0;Langerhans cells: 190.5;Macrophages: 122.9;monocytes: 248.0;Syncytiotrophoblasts: 104.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in many"	17	"classical monocyte: 109.4;intermediate monocyte: 142.7;memory B-cell: 73.6;myeloid DC: 111.2;naive B-cell: 51.3;non-classical monocyte: 123.4;plasmacytoid DC: 77.7"	"Group enriched"	"Detected in many"	19	"B-cells: 73.6;dendritic cells: 111.2;monocytes: 142.7"	"Cell line enhanced"	"Detected in many"		"A549: 185.2;GAMG: 298.5;HeLa: 195.5;Hep G2: 128.3;hTEC/SVTERT24-B: 106.5;U-87 MG: 314.5"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA031686	Enhanced		Supported	Nucleoplasm,Cytosol		NA	NA		590000	"Cluster 23: Antigen presenting cells - Antigen presentation"	"Cluster 85: Liver - Metabolism"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"	Cytosol	Nucleoplasm	"HPA031686: AB_2673995"	"unprognostic (2.58e-2)"	"unprognostic (3.39e-3)"	"unprognostic (1.21e-2)"	"unprognostic (5.94e-2)"	"unprognostic (1.65e-2)"	"unprognostic (9.04e-2)"	"unprognostic (5.36e-3)"	"unprognostic (3.58e-3)"	"unprognostic (4.88e-2)"	"unprognostic (3.35e-2)"	"unprognostic (2.87e-3)"	"unprognostic (1.51e-1)"	"unprognostic (1.40e-3)"	"unprognostic (3.33e-3)"	"unprognostic (3.65e-2)"	"unprognostic (5.24e-2)"	"unprognostic (1.64e-1)"	5.2	4.0	2.4	24.4	2.1	10.8	30.8	2.7	4.5	4.0	3.6	2.4	1.1	2.5	1.3	6.7	1.2	9.8	1.2	2.0	1.6	18.6	88.4	13.5	15.0	2.8	1.7	0.4	0.9	0.8	1.2	7.3	3.3	0.9	2.9	1.5	1.8	0.7	0.7	1.3	3.0	4.8	0.5	8.9	5.8	16.6	6.6	3.9	2.3	0.3	28.9	51.5	3.4	2.1	0.2	185.2	0.3	0.4	0.4	0.6	0.5	0.4	5.1	0.2	0.2	3.3	2.7	11.9	0.5	0.1	298.5	0.7	0.1	0.2	0.2	0.6	0.2	4.3	195.5	128.3	2.4	0.4	0.8	17.3	15.0	106.5	0.6	0.2	0.2	0.3	0.5	1.1	1.7	96.7	0.2	11.8	0.7	0.2	0.9	0.2	0.9	0.4	3.2	96.0	0.5	0.3	102.2	15.2	1.0	1.0	50.9	26.5	1.5	5.9	0.5	89.1	0.3	0.7	0.3	0.3	314.5	22.2	0.6	0.7	109.4	2.4	0.5	142.7	0.4	73.6	0.6	0.3	111.2	51.3	0.5	0.3	5.8	1.8	123.4	77.7	0.6	49.2	2.4	2.1	2.7	4.5	2.0	1.6	2.8	1.7	3.3	0.5	6.6	2.1	3.0	3.2	2.7	0.7	46.8	4.0	0.5	136.1	0.0	0.5	5.8	0.9	1.6	7.2	109.6	3.7	4.2	3.3	16.1	0.7	5.9	14.5	46.3	1.5	1.1	5.1	0.0	2.5	1.3	9.5	2.3	1.8	20.4	15.7	0.0	0.0	2.5	49.1	38.8	10.1	0.9	0.0	114.0	64.7	190.5	42.8	1.8	122.9	1.8	29.0	248.0	0.2	1.0	0.5	0.8	59.6	1.1	0.4	5.1	1.1	0.0	44.4	21.1	0.6	6.6	0.5	3.9	47.8	8.0	1.5	3.1	104.7	2.2	0.1	1.0	22.6
LACC1	"C13orf31, FAMIN, FLJ38725"	ENSG00000179630	"Laccase domain containing 1"	Q8IV20	13	43879284-43893932	"Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins"	"Immunity, Inflammatory response, Innate immunity"	"Hydrolase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 27.4"	"Cell type enhanced"	"Detected in many"		"Oligodendrocytes: 39.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"classical monocyte: 3.0;eosinophil: 3.1;intermediate monocyte: 5.2;myeloid DC: 2.7;non-classical monocyte: 8.0"	"Group enriched"	"Detected in many"	4	"dendritic cells: 2.7;granulocytes: 3.1;monocytes: 8.0"	"Cell line enhanced"	"Detected in many"		"HMC-1: 37.1;TIME: 118.2"	"Low region specificity"	"Detected in all"							"CAB034228, HPA040150, HPA044211"	Uncertain					NA	NA			"Cluster 51: Monocytes - Innate immune response"	"Cluster 65: Brain - Ion transport"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 4: Macrophages - Innate immune response"			"CAB034228: AB_1564163, HPA040150: AB_10963540, HPA044211: AB_10961258"	"unprognostic (2.48e-1)"	"unprognostic (3.27e-2)"	"unprognostic (4.54e-2)"	"unprognostic (3.31e-3)"	"unprognostic (1.17e-2)"	"unprognostic (3.90e-2)"	"unprognostic (6.41e-3)"	"unprognostic (4.43e-2)"	"unprognostic (3.03e-3)"	"unprognostic (1.78e-2)"	"unprognostic (6.06e-3)"	"unprognostic (2.02e-1)"	"unprognostic (3.93e-2)"	"unprognostic (3.30e-1)"	"unprognostic (9.36e-3)"	"unprognostic (2.22e-1)"	"unprognostic (1.18e-1)"	6.4	6.6	12.7	12.2	22.3	1.9	5.4	10.8	20.6	4.5	6.8	10.3	9.9	3.9	3.2	6.8	3.2	9.8	10.1	11.7	13.6	4.8	7.2	6.4	8.8	13.9	14.5	3.4	3.5	9.9	2.8	6.1	15.2	5.4	13.3	0.8	4.6	4.9	1.4	4.8	13.8	5.8	12.5	7.2	6.8	9.4	17.3	6.5	3.5	1.2	8.3	11.1	2.9	27.4	4.7	2.5	1.3	0.0	2.7	12.3	9.5	10.3	25.7	2.8	3.9	5.3	10.5	9.9	2.3	13.8	6.0	6.7	0.3	2.9	4.5	6.6	1.7	12.3	2.6	1.9	12.5	2.9	37.1	16.3	8.5	10.3	12.6	3.4	5.9	1.1	0.0	7.1	6.4	2.3	0.3	3.7	0.9	2.6	2.2	2.3	0.0	5.2	7.4	5.5	1.6	2.5	3.4	1.2	4.9	6.8	1.5	6.2	118.2	3.5	1.1	18.8	0.1	0.0	0.0	2.4	10.0	3.7	8.0	1.0	3.0	3.1	0.7	5.2	0.8	0.8	0.6	0.6	2.7	1.0	0.2	0.3	0.1	0.4	8.0	0.5	0.8	1.0	12.7	22.3	10.8	20.6	11.7	13.6	13.9	14.5	15.2	12.5	17.3	27.4	4.6	12.8	6.8	1.0	5.9	5.7	8.4	8.1	3.4	0.5	5.1	4.6	24.2	4.3	7.8	11.0	0.0	6.5	1.0	7.6	1.9	5.5	1.3	5.1	3.4	7.4	5.4	1.7	2.1	3.8	4.3	4.5	2.0	8.5	8.2	9.7	5.0	5.1	15.3	0.0	6.2	4.4	6.1	17.6	10.3	3.1	2.1	24.2	1.8	1.9	7.8	2.0	1.0	2.0	39.2	8.0	11.2	1.5	0.5	11.4	10.5	8.2	7.2	0.2	6.6	5.3	6.0	17.1	16.7	8.4	10.2	9.2	4.3	4.6	6.7	10.2
LAP3	"LAP, LAPEP, PEPS"	ENSG00000002549	"Leucine aminopeptidase 3"	P28838	4	17577198-17607972	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"		"Aminopeptidase, Hydrolase, Protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Adipocytes: 230.6;Hofbauer cells: 262.1;Proximal tubular cells: 274.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA029606, HPA029607"	Enhanced		Supported	Nucleoplasm,Midbody,Cytosol		Yes	No		3500000	"Cluster 25: Monocytes - Inflammatory response"	"Cluster 64: Macrophages - Immune response"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	Cytosol	"Nucleoplasm, Midbody"	"HPA029606: AB_10599288, HPA029607: AB_10611381"	"unprognostic (2.10e-2)"	"unprognostic (1.01e-1)"	"unprognostic (6.95e-3)"	"unprognostic (1.46e-1)"	"unprognostic (1.26e-1)"	"unprognostic (2.87e-1)"	"unprognostic (2.16e-1)"	"unprognostic (1.55e-1)"	"unprognostic (5.33e-2)"	"unprognostic (1.44e-3)"	"unprognostic (2.61e-3)"	"unprognostic (1.17e-1)"	"unprognostic (4.29e-3)"	"unprognostic (1.73e-1)"	"unprognostic (3.28e-2)"	"unprognostic (3.06e-1)"	"unprognostic (8.79e-2)"	92.8	52.6	33.0	131.4	34.8	59.2	60.3	39.0	42.9	30.7	31.4	60.3	78.3	34.4	25.4	44.6	45.4	67.3	65.0	31.8	36.3	106.3	190.4	100.6	150.4	46.3	37.7	24.0	30.9	61.0	22.1	70.9	42.2	36.7	62.0	20.0	67.7	31.0	68.1	40.3	61.3	76.2	45.6	94.1	55.3	43.8	41.9	56.8	46.4	63.8	94.3	82.8	25.3	42.9	51.7	44.4	41.6	39.4	80.5	97.9	0.4	79.6	89.1	282.3	340.3	81.4	96.1	202.0	51.7	61.6	167.9	31.3	157.7	56.3	106.7	77.7	45.2	112.1	47.3	107.6	94.1	102.3	69.2	100.0	35.3	92.7	48.6	32.3	99.7	52.2	110.6	139.9	67.6	55.6	91.9	139.5	87.1	96.3	83.9	139.8	39.8	102.7	73.5	59.6	61.4	50.2	72.9	44.4	161.1	57.3	37.9	39.1	65.2	71.3	48.5	76.1	140.6	127.7	208.8	172.7	96.3	167.2	70.8	43.1	200.6	44.7	33.7	210.0	31.0	32.7	31.2	36.3	204.6	23.5	26.7	28.3	28.1	54.0	158.1	116.6	60.2	135.8	33.0	34.8	39.0	42.9	31.8	36.3	46.3	37.7	42.2	45.6	41.9	42.9	230.6	28.9	49.6	10.7	34.4	22.0	26.1	60.1	21.6	8.1	53.5	41.7	48.9	18.6	44.1	27.6	2.1	35.9	68.3	44.2	117.4	68.6	100.5	67.3	45.7	129.7	16.3	31.7	6.4	109.2	54.7	42.0	29.6	40.7	64.1	29.4	71.0	95.5	262.1	6.7	9.6	35.6	42.7	92.1	50.5	31.7	23.0	141.9	42.7	18.7	195.0	103.8	28.8	9.5	21.2	53.3	31.8	35.0	71.2	26.9	52.4	274.0	92.5	15.4	32.9	31.3	57.8	95.7	13.7	32.5	22.9	55.7	42.4	80.7	45.6	27.1
LCAT		ENSG00000213398	"Lecithin-cholesterol acyltransferase"	P04180	16	67939750-67944131	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted secreted proteins"	"Cholesterol metabolism, Lipid metabolism, Steroid metabolism, Sterol metabolism"	"Acyltransferase, Hydrolase, Transferase"	"Corneal dystrophy, Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	5	"liver: 283.0"	"Cell type enriched"	"Detected in many"	8	"Hepatocytes: 219.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"eosinophil: 1.9"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"BEWO: 76.5;Hep G2: 62.9"	"Low region specificity"	"Detected in all"			"Region enhanced"	"Detected in many"		"cerebellum: 29.2"	HPA044767			Approved	Nucleoplasm	"Secreted to blood"	NA	NA	6470000000	6400000000	"Cluster 52: Eosinophils - Transcription"	"Cluster 15: Liver - Metabolism"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 15: Hepatocytes - Hemostasis"	Nucleoplasm		"HPA044767: AB_2756312"	"unprognostic (3.34e-2)"	"unprognostic (3.56e-2)"	"prognostic unfavorable (8.50e-4)"	"unprognostic (5.43e-3)"	"unprognostic (1.25e-2)"	"unprognostic (2.16e-1)"	"prognostic favorable (4.21e-8)"	"unprognostic (6.42e-2)"	"unprognostic (4.26e-1)"	"unprognostic (4.12e-1)"	"unprognostic (1.50e-2)"	"unprognostic (7.21e-2)"	"prognostic unfavorable (1.71e-4)"	"unprognostic (9.93e-2)"	"unprognostic (1.83e-1)"	"unprognostic (2.85e-1)"	"unprognostic (1.90e-3)"	29.5	20.8	29.3	8.3	29.8	4.2	27.2	56.7	37.5	41.4	37.8	30.6	5.0	28.7	9.1	13.4	26.1	11.5	42.0	28.5	32.3	33.2	283.0	36.1	7.5	41.9	32.7	28.5	17.7	8.0	17.5	17.8	31.6	40.0	4.8	2.8	16.9	18.6	13.2	32.0	17.8	12.3	31.9	23.3	16.5	11.3	33.4	9.4	43.2	8.9	4.4	27.5	27.3	32.0	5.7	9.0	13.0	14.8	11.1	15.6	76.5	21.9	9.3	14.5	10.2	29.5	6.8	3.1	4.0	31.9	5.3	19.4	3.1	30.0	8.9	1.5	7.9	3.9	22.8	62.9	15.2	0.7	10.3	27.1	27.9	30.0	10.4	19.5	10.8	8.7	8.7	1.2	10.5	9.1	3.7	9.5	8.6	1.1	5.0	4.0	14.1	3.3	4.1	9.6	0.5	6.7	33.1	1.6	3.9	26.5	18.6	6.0	20.6	18.5	28.8	20.7	8.1	17.7	5.2	8.3	8.9	2.5	16.5	0.9	0.4	1.9	0.3	0.0	0.4	0.4	0.2	0.3	0.1	0.6	0.4	0.1	1.0	0.4	0.1	0.3	0.0	0.0	29.3	29.8	56.7	37.5	28.5	32.3	41.9	32.7	31.6	31.9	33.4	32.0	16.5	9.6	4.8	27.4	1.1	9.4	4.1	4.6	6.8	0.4	1.9	5.5	7.9	5.7	3.3	3.7	2.1	7.7	1.3	0.1	0.0	1.7	0.2	2.1	6.0	8.0	1.2	14.3	0.1	1.0	3.4	7.3	1.1	1.6	1.3	5.4	10.8	219.5	2.4	0.0	0.1	0.0	4.1	6.6	3.8	1.3	8.7	2.4	7.2	6.5	3.0	7.7	1.0	4.5	1.4	2.1	0.0	8.6	1.9	4.3	0.0	0.4	4.4	0.6	13.1	7.6	10.4	0.9	1.4	0.9	2.6	12.2	1.6	4.1	0.1	1.7
LCT		ENSG00000115850	Lactase	P09848	2	135787850-135837184	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted membrane proteins"		"Glycosidase, Hydrolase, Multifunctional enzyme"	"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	187	"intestine: 225.5"	"Cell type enhanced"	"Detected in some"		"Breast glandular cells: 1.4;Breast myoepithelial cells: 3.3;Early spermatids: 1.3;Proximal enterocytes: 2.8;Undifferentiated cells: 1.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"JURKAT: 2.5;MOLT-4: 4.9;RPMI-8226: 9.7"	"Region enriched"	"Detected in some"	15	"hippocampal formation: 15.7"	"Not detected"	"Not detected"									NA	NA				"Cluster 56: Intestine - Transmembrane transport"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 45: Enterocytes - Digestion"				"unprognostic (2.21e-2)"	"unprognostic (1.65e-4)"	"unprognostic (2.54e-1)"	"unprognostic (2.06e-1)"	"unprognostic (3.39e-2)"	"unprognostic (8.03e-4)"	"unprognostic (3.55e-3)"	"unprognostic (6.71e-3)"	"unprognostic (1.89e-1)"	"unprognostic (3.57e-1)"	"unprognostic (1.69e-1)"	"unprognostic (9.32e-2)"	"unprognostic (1.64e-4)"	"unprognostic (4.90e-2)"	"unprognostic (8.92e-2)"	"unprognostic (8.97e-2)"	"unprognostic (1.02e-1)"	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.3	225.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	136.3	0.0	0.0	0.0	0.0	0.1	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	2.5	0.0	0.5	0.0	0.0	4.9	0.8	0.0	0.0	0.0	1.1	0.0	9.7	0.0	0.0	0.4	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	1.4	3.3	0.9	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	1.3	0.0	0.0	0.1	0.0	0.8	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	2.8	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	1.1	0.0
LGMN	"LGMN1, PRSC1"	ENSG00000100600	Legumain	Q99538	14	92703807-92748679	"Cancer-related genes, Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Hydrolase, Protease, Thiol protease"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Hofbauer cells: 1448.9;Macrophages: 346.1;Syncytiotrophoblasts: 416.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in many"	11	"plasmacytoid DC: 209.2"	"Lineage enriched"	"Detected in all"	12	"dendritic cells: 209.2"	"Cell line enhanced"	"Detected in many"		"RPMI-8226: 898.6;U-266/70: 462.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA001426	Enhanced		Approved	Nucleoplasm,Vesicles	"Intracellular and membrane"	NA	NA		2000000	"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 1: Thyroid gland - Transcription"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 4: Macrophages - Innate immune response"	Vesicles	Nucleoplasm	"HPA001426: AB_1079247"	"unprognostic (1.19e-1)"	"unprognostic (1.16e-1)"	"unprognostic (2.37e-1)"	"unprognostic (1.52e-1)"	"unprognostic (1.99e-1)"	"unprognostic (3.29e-2)"	"unprognostic (4.52e-2)"	"unprognostic (1.31e-1)"	"unprognostic (5.03e-2)"	"unprognostic (3.50e-2)"	"unprognostic (4.70e-2)"	"unprognostic (2.47e-1)"	"prognostic favorable (4.70e-4)"	"unprognostic (8.06e-2)"	"unprognostic (3.64e-2)"	"unprognostic (7.18e-3)"	"unprognostic (7.24e-2)"	173.7	44.4	37.6	82.2	38.6	20.6	69.7	31.7	60.8	52.6	51.2	102.5	110.4	30.8	36.8	64.5	36.6	145.8	85.3	40.0	40.3	205.9	111.1	107.3	177.0	35.6	37.3	33.0	37.9	247.0	24.9	262.1	42.4	51.9	105.9	19.7	56.4	32.2	50.4	32.7	97.6	65.0	35.9	202.2	107.0	29.8	62.8	52.8	93.2	50.4	54.9	144.7	52.1	49.4	33.2	47.5	30.8	57.4	94.3	76.0	108.4	70.3	67.0	71.7	84.2	36.9	58.6	18.2	101.5	116.5	44.3	81.5	0.0	60.8	33.7	1.6	36.2	1.2	24.4	42.8	27.7	1.0	2.7	54.2	29.1	68.4	39.4	21.3	82.1	33.7	7.4	150.9	5.2	45.2	8.9	1.2	15.1	208.2	32.1	8.4	27.1	898.6	59.2	129.1	33.6	23.2	97.9	59.4	53.0	66.8	43.9	0.6	47.2	35.3	44.8	64.5	21.8	462.5	58.0	25.0	20.0	0.2	69.1	1.9	1.6	0.1	0.8	3.1	1.6	17.0	5.1	1.3	19.3	14.5	15.2	9.0	1.6	3.7	1.0	209.2	9.7	7.0	37.6	38.6	31.7	60.8	40.0	40.3	35.6	37.3	42.4	35.9	62.8	49.4	34.9	57.7	128.0	8.8	33.9	23.1	37.5	36.0	22.2	10.6	31.2	37.6	29.8	42.9	48.1	31.3	93.8	181.8	24.5	64.2	9.8	61.3	1.3	79.4	23.5	38.3	36.5	22.7	19.2	50.6	140.2	63.8	73.4	177.7	8.8	17.6	276.3	46.4	1448.9	13.5	41.0	31.1	95.6	317.6	89.0	3.3	30.4	346.1	48.0	27.2	37.5	23.6	2.1	10.6	15.2	50.5	57.1	57.9	24.7	44.6	163.4	220.4	20.9	19.8	19.7	40.4	62.1	19.9	17.6	22.3	17.5	416.3	8.2	15.1	48.3	44.7
LHPP	HDHD2B	ENSG00000107902	"Phospholysine phosphohistidine inorganic pyrophosphate phosphatase"	Q9H008	10	124461823-124617888	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 198.8;choroid plexus: 104.0"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 114.9;Late spermatids: 163.3;Proximal tubular cells: 93.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA009163, HPA009269"	Enhanced		Supported	"Nuclear speckles,Cytosol"		NA	NA		820000	"Cluster 23: Antigen presenting cells - Antigen presentation"	"Cluster 70: Brain - Nervous system development"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	"Nuclear speckles, Cytosol"		"HPA009163: AB_1079250, HPA009269: AB_1079249"	"unprognostic (3.46e-2)"	"unprognostic (1.23e-2)"	"unprognostic (4.78e-2)"	"unprognostic (3.89e-1)"	"unprognostic (2.14e-1)"	"unprognostic (1.96e-1)"	"unprognostic (5.77e-3)"	"unprognostic (2.02e-2)"	"unprognostic (3.58e-1)"	"unprognostic (1.93e-1)"	"unprognostic (6.42e-2)"	"unprognostic (5.55e-2)"	"unprognostic (1.79e-3)"	"unprognostic (2.52e-1)"	"unprognostic (2.10e-1)"	"unprognostic (1.98e-1)"	"unprognostic (1.64e-1)"	12.9	32.0	135.1	8.2	173.7	10.5	13.0	159.3	190.6	18.5	104.0	27.1	23.4	20.2	13.4	24.1	10.0	10.2	17.5	129.7	156.5	28.4	60.2	9.2	11.8	179.2	165.8	9.0	15.9	9.2	14.5	8.6	170.7	14.0	8.5	7.5	18.3	12.5	10.2	15.3	21.1	10.2	151.1	14.0	20.1	24.2	156.3	9.7	29.4	4.8	15.2	14.7	16.1	198.8	24.7	12.0	4.7	12.1	18.2	14.7	12.8	8.2	18.0	5.5	10.0	2.1	22.4	24.4	19.7	13.5	6.1	26.1	1.4	4.7	5.7	5.4	16.3	17.6	4.1	11.4	18.5	3.6	27.6	11.0	20.0	5.4	13.0	16.0	8.8	21.4	8.9	9.5	6.9	24.5	12.0	11.3	8.5	10.4	6.8	12.4	5.3	31.8	12.1	3.2	2.7	14.2	6.3	22.6	8.2	6.5	17.2	0.6	4.2	8.5	12.2	7.2	2.3	7.9	2.5	7.8	7.7	6.8	2.0	8.1	28.8	25.3	16.1	24.5	20.8	41.0	18.7	17.2	35.6	43.3	22.4	16.0	4.8	7.9	29.0	13.4	32.1	24.4	135.1	173.7	159.3	190.6	129.7	156.5	179.2	165.8	170.7	151.1	156.3	198.8	5.0	3.2	14.8	22.9	29.1	7.4	9.4	22.1	13.1	6.0	19.8	19.8	15.8	12.8	19.4	7.3	0.0	54.2	6.2	17.9	33.2	5.3	114.9	17.7	12.7	4.6	9.5	19.8	29.4	2.3	24.7	11.2	19.9	8.2	10.8	23.3	6.1	61.1	26.5	11.8	27.8	21.3	24.4	16.0	8.1	163.3	5.9	12.9	17.8	8.4	15.6	9.8	8.2	15.6	76.4	3.3	30.2	10.5	19.7	6.7	80.5	93.8	24.9	6.4	13.1	5.2	9.5	33.1	11.3	30.7	5.4	24.2	12.1	12.4	23.0	16.3
LIPA	"CESD, LAL"	ENSG00000107798	"Lipase A, lysosomal acid type"	P38571	10	89213569-89414557	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"Lipid degradation, Lipid metabolism"	Hydrolase	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 398.4"	"Cell type enhanced"	"Detected in many"		"Hofbauer cells: 515.0;Kupffer cells: 714.8;Macrophages: 303.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in all"	5	"classical monocyte: 167.3;intermediate monocyte: 355.1;myeloid DC: 123.6;non-classical monocyte: 198.5"	"Group enriched"	"Detected in all"	6	"dendritic cells: 123.6;monocytes: 355.1"	"Cell line enhanced"	"Detected in many"		"A-431: 354.4;AN3-CA: 367.8;ASC TERT1: 450.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB034892, HPA057052"	Enhanced		Supported	"Nucleoplasm,Nucleoli fibrillar center,Vesicles,Cytosol"	"Intracellular and membrane"	NA	NA		280000	"Cluster 7: Monocytes - Unknown function"	"Cluster 64: Macrophages - Immune response"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 4: Macrophages - Innate immune response"	"Vesicles, Cytosol"	"Nucleoplasm, Nucleoli fibrillar center"	"CAB034892: AB_784329, HPA057052: AB_2683322"	"unprognostic (1.27e-1)"	"unprognostic (3.23e-1)"	"unprognostic (1.17e-1)"	"unprognostic (1.07e-1)"	"unprognostic (1.61e-1)"	"unprognostic (2.55e-2)"	"unprognostic (7.14e-2)"	"unprognostic (1.66e-1)"	"unprognostic (1.19e-1)"	"unprognostic (4.28e-2)"	"unprognostic (1.08e-1)"	"unprognostic (7.30e-3)"	"unprognostic (1.39e-2)"	"unprognostic (1.40e-1)"	"unprognostic (4.42e-2)"	"unprognostic (3.42e-2)"	"unprognostic (5.71e-2)"	76.0	46.3	43.5	66.7	65.2	39.8	47.8	64.1	74.4	54.0	39.0	67.7	167.6	38.8	21.7	28.6	37.8	83.5	24.2	43.5	53.1	44.9	218.9	169.5	159.3	74.7	55.5	32.7	21.4	68.9	12.7	79.1	82.2	30.7	72.0	12.6	22.5	33.8	11.8	18.7	227.5	47.7	65.4	398.4	34.3	13.4	57.0	44.5	31.6	22.5	45.5	58.4	19.3	115.5	354.4	49.4	30.7	367.8	343.5	450.8	10.0	171.4	194.8	65.5	121.5	18.6	176.6	63.9	34.0	264.4	73.7	338.7	13.8	92.8	53.6	86.1	34.7	25.1	19.1	81.5	87.6	48.8	48.9	190.4	69.2	72.9	40.6	88.2	14.9	45.4	0.3	108.5	58.3	28.2	45.7	34.6	22.7	62.4	60.0	26.4	39.0	60.5	69.2	50.9	10.5	21.8	41.4	49.9	133.9	20.4	64.4	65.8	26.2	58.8	15.5	132.1	44.6	60.0	65.7	25.8	71.4	112.9	82.1	4.2	167.3	16.9	40.0	355.1	40.6	31.9	35.8	38.8	123.6	33.4	36.7	40.4	7.1	29.8	198.5	25.0	38.2	159.6	43.5	65.2	64.1	74.4	43.5	53.1	74.7	55.5	82.2	65.4	57.0	115.5	75.5	41.7	33.8	11.1	35.9	17.7	30.3	58.1	25.6	5.4	16.1	14.1	9.6	45.8	31.9	33.1	0.0	34.8	31.4	2.8	21.5	35.1	6.8	11.4	20.4	56.7	21.8	27.4	34.4	36.2	32.9	34.6	21.4	15.5	28.5	10.8	54.7	66.7	515.0	16.8	15.1	8.9	40.7	714.8	69.0	2.7	11.5	303.1	48.0	30.0	71.7	33.1	29.9	15.1	143.0	19.3	12.0	21.8	15.4	11.3	161.0	14.0	28.8	2.2	6.6	19.7	21.0	5.1	13.8	31.9	12.5	20.0	33.1	17.6	9.1	24.0
LIPC	"HL, HTGL"	ENSG00000166035	"Lipase C, hepatic type"	P11150	15	58410569-58569844	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted secreted proteins"	"Lipid degradation, Lipid metabolism"	"Heparin-binding, Hydrolase"	"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	28	"liver: 171.0"	"Cell type enriched"	"Detected in some"	9	"Hepatocytes: 161.7"	"Group enriched"	"Detected in some"	14	"liver cancer: 20.4;renal cancer: 10.4"	"Low region specificity"	"Detected in some"			"Low immune cell specificity"	"Detected in some"			"Group enriched"	"Detected in many"	7	"granulocytes: 1.6;NK-cells: 1.5;T-cells: 1.8"	"Cell line enhanced"	"Detected in some"		"CACO-2: 8.5;EFO-21: 6.1;Hep G2: 24.4;HMC-1: 6.8;MOLT-4: 5.5;U-2197: 18.4"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"								"Secreted to blood"	NA	NA		5500000	"Cluster 10: Basophils - Unknown function"	"Cluster 62: Liver - Hemostasis"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 2: Hepatocytes - Metabolism"				"unprognostic (1.76e-2)"	"unprognostic (9.15e-3)"	"unprognostic (7.89e-2)"	"unprognostic (7.15e-4)"	"unprognostic (1.40e-1)"	"unprognostic (1.33e-2)"	"unprognostic (9.93e-3)"	"unprognostic (6.25e-2)"	"unprognostic (3.79e-2)"	"unprognostic (1.10e-2)"	"unprognostic (3.06e-1)"	"unprognostic (2.31e-1)"	"unprognostic (2.82e-2)"	"unprognostic (1.41e-1)"	"unprognostic (2.87e-2)"	"unprognostic (1.80e-2)"	"unprognostic (2.27e-2)"	0.4	0.1	0.5	0.3	0.5	0.2	1.5	0.8	0.9	0.4	0.0	0.6	1.8	0.2	0.9	0.6	1.0	0.8	0.5	0.6	0.3	6.0	171.0	0.3	0.7	0.8	0.7	0.8	2.5	0.0	1.5	0.4	1.0	0.1	0.8	0.1	0.2	0.9	0.0	0.6	0.8	0.1	0.6	0.8	0.5	0.1	0.4	2.1	1.2	0.3	0.2	1.6	0.3	1.2	0.0	0.0	0.0	0.0	0.3	1.0	0.1	0.1	0.8	0.0	0.0	8.5	0.0	0.0	6.1	0.2	0.3	0.0	0.0	0.0	0.0	0.4	0.0	3.0	0.0	24.4	0.5	0.0	6.8	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.2	0.0	0.2	0.1	5.5	0.8	0.0	0.1	0.0	1.1	0.3	0.0	2.6	0.5	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.3	0.0	0.1	18.4	0.0	0.1	0.0	0.1	0.2	0.5	0.0	1.6	0.1	0.0	1.3	0.1	1.8	0.0	0.3	0.9	0.1	0.0	0.4	1.3	0.2	1.5	0.2	0.0	0.9	1.1	0.5	0.5	0.8	0.9	0.6	0.3	0.8	0.7	1.0	0.6	0.4	1.2	0.0	0.0	0.0	0.0	1.0	0.3	0.0	0.0	0.0	0.0	0.0	2.2	0.8	11.5	0.7	3.7	0.0	0.0	0.9	1.2	5.9	7.8	0.0	0.4	0.5	1.2	0.0	2.7	6.1	3.7	0.1	2.9	0.5	2.7	0.0	0.2	4.2	161.7	0.1	0.0	4.3	0.0	0.0	3.8	0.8	0.1	0.3	0.3	1.8	16.9	0.6	0.0	3.1	0.0	12.9	0.2	0.0	0.0	0.0	0.2	0.3	15.7	0.0	0.0	0.0	1.6	0.3	0.0	0.0	0.3	0.6	0.0	1.1	1.2	0.0	0.1
LIPE	HSL	ENSG00000079435	"Lipase E, hormone sensitive type"	Q05469	19	42401514-42427388	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"Cholesterol metabolism, Lipid degradation, Lipid metabolism, Steroid metabolism, Sterol metabolism"	Hydrolase	"Diabetes mellitus, Obesity"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	6	"adipose tissue: 834.5;breast: 524.7"	"Cell type enhanced"	"Detected in many"		"Adipocytes: 76.1;Early spermatids: 127.8;Late spermatids: 236.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enriched"	"Detected in many"	7	"ASC diff: 136.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA006567, CAB017700"	Enhanced		Supported	Cytosol		NA	NA			"Cluster 25: Monocytes - Inflammatory response"	"Cluster 82: Adipose tissue - ECM organization"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 25: Spermatids - Spermatogenesis"	Cytosol		"CAB017700: AB_2135504, HPA006567: AB_2667618"	"unprognostic (4.24e-2)"	"unprognostic (2.46e-2)"	"unprognostic (8.99e-3)"	"unprognostic (3.74e-2)"	"unprognostic (1.77e-1)"	"unprognostic (3.38e-3)"	"unprognostic (5.68e-2)"	"unprognostic (2.84e-1)"	"unprognostic (3.11e-1)"	"unprognostic (9.44e-2)"	"prognostic favorable (1.15e-4)"	"unprognostic (1.52e-1)"	"unprognostic (3.63e-10)"	"unprognostic (1.47e-1)"	"unprognostic (1.83e-1)"	"unprognostic (3.76e-2)"	"unprognostic (2.34e-3)"	834.5	45.1	22.7	7.7	71.7	5.0	524.7	77.2	41.5	5.1	0.6	10.9	5.3	6.4	1.2	8.6	5.8	3.7	32.5	23.8	42.6	7.7	1.5	3.7	7.3	100.3	73.9	4.9	6.2	4.7	6.9	2.9	90.0	7.1	1.4	2.0	17.2	2.6	19.7	23.6	24.4	2.6	44.0	14.4	8.5	68.6	57.1	6.9	9.6	23.3	3.7	14.2	7.7	116.9	12.7	9.6	6.0	2.3	136.8	1.3	0.1	5.8	3.1	9.2	8.5	2.3	4.6	20.6	6.3	1.8	4.5	5.6	3.7	11.5	1.0	4.0	6.1	5.8	5.3	0.2	2.7	0.1	13.9	1.2	10.7	1.5	2.1	1.3	2.6	8.5	2.7	12.8	1.2	0.1	14.8	0.5	0.8	9.7	2.7	12.2	1.1	6.9	2.6	13.1	8.5	8.8	5.1	5.7	5.6	0.3	1.5	7.5	4.7	2.5	7.8	1.1	5.3	9.7	8.5	15.6	6.3	0.7	8.7	11.0	8.6	3.8	2.5	4.7	2.3	3.4	3.2	3.7	3.6	4.5	2.8	2.5	1.5	3.6	2.7	2.9	3.0	3.1	22.7	71.7	77.2	41.5	23.8	42.6	100.3	73.9	90.0	44.0	57.1	116.9	76.1	0.0	3.3	4.2	8.1	4.1	12.1	2.4	4.6	11.0	4.8	2.9	2.5	0.0	2.0	1.8	10.4	0.1	4.8	1.3	1.9	8.0	127.8	0.9	3.4	10.2	0.0	5.3	4.6	2.7	0.1	2.0	3.6	1.5	0.0	6.6	17.9	0.0	0.6	8.4	6.7	2.0	6.1	2.2	2.4	236.5	3.1	0.8	5.4	4.7	0.9	4.0	6.2	6.0	37.9	1.8	0.7	1.5	3.0	6.7	18.4	1.5	0.8	13.9	0.0	7.2	2.1	39.4	13.1	2.5	2.4	0.0	5.1	5.2	2.9	10.7
LIPF	"HGL, HLAL"	ENSG00000182333	"Lipase F, gastric type"	P07098	10	88664441-88678814	"Enzymes, FDA approved drug targets, Metabolic proteins, Predicted secreted proteins"	"Lipid degradation, Lipid metabolism"	Hydrolase	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	142	"stomach 1: 37213.5"	"Cell type enriched"	"Detected in some"	444	"Gastric mucus-secreting cells: 1509.7"	"Cancer enriched"	"Detected in some"	75	"stomach cancer: 278.5"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HMC-1: 4.1;MOLT-4: 3.4;NTERA-2: 3.4;REH: 2.1;RPMI-8226: 1.8;THP-1: 6.8;U-2 OS: 2.2;U-266/70: 3.1"	"Region enriched"	"Detected in single"	77	"olfactory bulb: 7.6"					HPA045930	Enhanced				"Secreted to digestive system"	NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 4: Stomach - Digestion"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 16: Pancreatic endocrine cells - Mixed function"			"HPA045930: AB_10959518"										"unprognostic (1.53e-1)"				"unprognostic (1.83e-1)"				6.3	2.8	0.0	0.0	0.0	0.0	4.6	0.1	0.0	3.9	0.0	13.0	262.0	1.9	0.0	117.9	5.4	0.0	3.2	0.0	0.0	11.4	4.9	7.3	0.0	0.3	0.1	2.2	4.5	0.0	7.3	0.5	0.1	6.7	0.0	0.0	2.6	0.0	1.6	2.0	1.9	0.0	0.0	2.6	37213.5	2.9	0.0	0.0	1.3	0.0	0.1	2.5	2.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.4	0.0	3.4	0.0	0.0	2.1	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.8	0.0	0.0	2.2	0.0	0.0	3.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1509.7	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0
LIPG	EDL	ENSG00000101670	"Lipase G, endothelial type"	Q9Y5X9	18	49560699-49599185	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Lipid degradation, Lipid metabolism"	"Heparin-binding, Hydrolase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	6	"placenta: 149.3;thyroid gland: 242.5"	"Cell type enhanced"	"Detected in many"		"Cone photoreceptor cells: 60.5;Extravillous trophoblasts: 67.9;Glandular and luminal cells: 49.0;Hepatocytes: 78.2"	"Cancer enriched"	"Detected in many"	7	"thyroid cancer: 20.9"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"AN3-CA: 122.6;HaCaT: 189.8;RPTEC TERT1: 122.4;TIME: 247.4"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA016966	Uncertain				"Secreted to blood"	NA	NA	657000000	810000		"Cluster 28: Placenta - Pregnancy"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 44: Endometrium - Transcription"			"HPA016966: AB_1852893"	"unprognostic (2.20e-2)"	"unprognostic (3.36e-3)"	"unprognostic (1.16e-1)"	"unprognostic (4.25e-3)"	"unprognostic (6.38e-2)"	"unprognostic (1.36e-1)"	"unprognostic (5.72e-2)"	"unprognostic (4.55e-3)"	"unprognostic (9.93e-2)"	"unprognostic (1.44e-1)"	"unprognostic (6.44e-2)"	"unprognostic (8.74e-2)"	"unprognostic (2.98e-1)"	"unprognostic (8.68e-2)"	"unprognostic (5.64e-2)"	"unprognostic (1.54e-1)"	"unprognostic (1.35e-1)"	4.6	0.2	0.9	16.3	0.6	0.3	1.0	4.0	2.6	0.9	1.7	5.9	6.4	1.4	2.9	1.3	0.5	14.0	1.2	3.2	0.7	6.7	34.7	7.2	1.8	2.8	2.8	0.2	1.9	0.2	0.4	149.3	1.6	1.5	7.2	4.9	0.5	20.9	2.5	1.4	7.2	7.7	1.4	0.4	1.7	7.0	3.7	1.9	242.5	0.1	1.7	14.4	0.6	1.2	2.2	0.3	53.6	122.6	0.5	0.1	0.9	0.6	5.8	0.0	0.1	54.5	19.6	0.2	29.7	0.0	37.2	189.8	8.1	39.0	0.0	0.6	0.3	0.1	0.2	0.3	8.1	0.1	0.8	5.4	43.0	19.1	36.8	0.3	28.0	0.2	0.3	0.3	0.0	0.0	0.0	0.2	8.1	1.4	0.5	0.1	0.0	3.0	122.4	14.8	0.8	0.1	1.0	1.4	0.1	6.9	0.2	0.2	247.4	0.2	0.1	0.1	0.6	0.1	0.0	0.1	0.2	0.1	0.3	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.9	0.6	4.0	2.6	3.2	0.7	2.8	2.8	1.6	1.4	3.7	1.2	0.3	0.0	1.1	0.7	0.3	1.8	5.6	3.3	0.0	0.6	2.8	1.9	1.8	24.3	3.5	14.7	60.5	5.5	0.1	9.3	0.0	3.3	8.4	19.1	8.3	7.9	13.8	0.0	0.2	1.4	67.9	6.0	2.6	49.0	0.0	11.5	5.3	78.2	1.8	0.0	0.3	5.3	2.0	1.9	0.0	8.1	0.3	0.8	1.8	2.8	0.7	1.1	0.0	1.0	0.2	12.8	2.7	0.0	0.3	10.6	10.1	1.3	0.5	2.9	0.0	1.0	2.0	1.4	0.9	0.4	2.6	19.4	1.1	0.1	11.2	11.4
LNPEP	"CAP, IRAP, P-LAP, PLAP"	ENSG00000113441	"Leucyl and cystinyl aminopeptidase"	Q9UIQ6	5	96935394-97037513	"Enzymes, Predicted membrane proteins"		"Aminopeptidase, Hydrolase, Metalloprotease, Protease"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"NK-cells: 257.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA043642	Approved				"Intracellular and membrane"	NA	NA		9800000	"Cluster 27: Non-specific - Gene expression"	"Cluster 34: Non-specific - Transcription"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 63: NK-cells & T-cells - Immune response"			"HPA043642: AB_10964137"	"unprognostic (1.52e-1)"	"unprognostic (5.39e-2)"	"unprognostic (7.78e-2)"	"unprognostic (1.53e-2)"	"unprognostic (6.38e-2)"	"unprognostic (6.59e-3)"	"unprognostic (6.83e-2)"	"unprognostic (2.11e-1)"	"unprognostic (1.11e-1)"	"unprognostic (3.54e-3)"	"unprognostic (6.24e-2)"	"unprognostic (2.08e-1)"	"unprognostic (3.28e-1)"	"unprognostic (4.13e-3)"	"unprognostic (1.46e-1)"	"unprognostic (1.69e-1)"	"unprognostic (1.17e-1)"	11.4	4.4	8.4	12.2	10.6	16.2	8.2	17.9	8.6	6.8	4.0	8.1	5.2	6.5	5.1	9.0	5.7	5.1	12.0	8.5	10.0	8.3	4.3	7.7	19.4	10.0	9.4	8.8	4.9	15.3	5.8	9.1	10.7	8.8	7.9	9.4	6.0	8.5	11.2	16.4	8.2	7.7	8.6	12.5	7.9	4.1	9.2	17.8	8.4	12.7	18.7	7.0	7.0	10.3	10.7	11.9	5.4	5.6	32.5	15.4	6.2	10.5	13.8	12.0	18.1	9.9	16.4	52.2	19.1	14.1	33.7	13.4	6.8	20.1	12.5	18.2	3.8	12.9	8.2	7.3	8.4	15.5	16.9	12.0	12.5	17.5	13.3	13.6	12.8	11.6	5.6	32.7	13.9	9.6	18.1	10.9	1.1	3.4	6.2	12.7	19.8	7.9	44.9	21.2	10.2	2.7	12.8	11.4	6.4	5.2	34.1	20.2	26.6	17.6	9.6	13.9	16.3	7.3	17.4	45.6	16.1	14.5	8.2	4.3	2.6	3.6	5.9	4.2	5.0	2.3	4.4	4.6	2.8	3.1	4.2	4.7	3.1	9.0	11.2	2.6	4.2	3.6	8.4	10.6	17.9	8.6	8.5	10.0	10.0	9.4	10.7	8.6	9.2	10.3	43.4	35.3	41.3	52.2	91.0	59.4	21.3	28.4	37.5	58.9	24.9	18.8	80.8	22.8	27.2	36.8	125.1	12.3	108.4	20.7	5.9	15.4	3.6	21.4	28.9	33.6	25.7	38.9	47.5	14.4	24.3	36.6	30.1	28.9	25.9	29.3	30.7	16.7	16.2	23.5	50.9	29.6	22.4	49.3	35.9	5.3	32.9	52.0	21.4	45.9	59.7	33.6	257.5	49.3	73.9	21.5	17.5	46.6	44.9	27.4	16.6	10.7	25.8	38.4	26.3	46.8	36.6	29.4	27.5	44.4	47.2	27.4	97.3	31.1	25.6	23.2
LONP1	"hLON, LonHS, PIM1, PRSS15"	ENSG00000196365	"Lon peptidase 1, mitochondrial"	P36776	19	5691834-5720572	"Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins"		"DNA-binding, Hydrolase, Protease, Serine protease"	"Cataract, Deafness, Disease variant, Dwarfism"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"adrenal gland: 196.2"	"Cell type enhanced"	"Detected in all"		"Theca cells: 85.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA002034, HPA002192"	Supported		Enhanced	Nucleoplasm,Mitochondria		No	No		7900	"Cluster 6: Non-specific - Transcription"	"Cluster 35: Non-specific - Unknown function"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 39: Non-specific - Basic cellular processes"	Mitochondria	Nucleoplasm	"HPA002034: AB_2756304, HPA002192: AB_1079695"	"unprognostic (6.52e-2)"	"unprognostic (1.12e-1)"	"unprognostic (2.43e-1)"	"unprognostic (2.43e-2)"	"unprognostic (2.84e-1)"	"unprognostic (2.38e-1)"	"unprognostic (1.66e-3)"	"unprognostic (5.56e-2)"	"unprognostic (2.71e-1)"	"unprognostic (7.57e-2)"	"unprognostic (4.04e-2)"	"unprognostic (1.26e-1)"	"unprognostic (1.76e-2)"	"unprognostic (1.09e-2)"	"unprognostic (1.24e-1)"	"unprognostic (1.11e-1)"	"unprognostic (2.11e-1)"	30.4	196.2	31.5	22.2	32.7	23.7	27.2	34.6	42.8	24.4	39.9	27.9	22.6	25.2	14.1	27.7	22.6	15.4	76.0	30.8	35.7	43.2	79.1	25.6	24.1	37.6	35.8	26.6	38.2	35.2	41.5	18.5	37.9	26.4	13.2	13.0	30.8	16.6	69.3	28.9	25.5	14.7	30.8	29.5	33.7	24.2	37.2	17.5	34.6	40.7	14.5	28.2	22.4	33.0	108.4	111.0	35.6	114.0	41.4	29.2	110.4	67.2	52.7	71.0	86.0	96.3	37.7	134.3	91.4	70.6	68.0	45.0	92.1	81.1	34.2	80.0	78.0	74.5	97.5	127.6	190.4	169.7	74.9	55.0	114.6	67.5	132.6	34.1	57.5	183.9	200.9	259.4	33.0	71.8	85.5	101.6	127.6	43.6	143.1	89.4	50.9	146.6	39.3	63.9	94.2	94.1	59.4	85.2	242.2	24.9	50.3	211.9	41.2	36.0	39.2	100.7	99.2	272.3	182.6	121.4	161.7	185.0	66.2	4.5	2.4	0.5	3.4	3.7	2.3	4.0	3.1	3.4	2.6	3.7	3.8	2.6	0.3	2.7	1.5	3.9	2.7	1.7	31.5	32.7	34.6	42.8	30.8	35.7	37.6	35.8	37.9	30.8	37.2	33.0	12.6	6.4	13.1	18.3	14.1	8.3	11.1	14.9	11.4	26.9	14.2	12.7	19.8	15.7	14.3	27.6	6.2	28.8	8.4	40.1	46.9	33.9	6.5	24.0	16.3	15.3	11.4	17.1	13.5	28.0	31.9	13.3	29.6	25.6	5.7	51.1	11.4	47.0	30.8	21.9	17.4	26.4	22.4	14.6	8.6	6.3	12.8	16.4	14.2	9.4	17.8	24.9	8.2	10.6	15.7	26.0	16.8	17.3	17.6	16.8	27.5	50.2	17.0	26.5	19.7	17.9	24.7	12.0	14.4	11.0	10.7	35.0	10.7	85.0	35.1	11.4
LONP2	"LONP, LONPL, MGC4840"	ENSG00000102910	"Lon peptidase 2, peroxisomal"	Q86WA8	16	48244300-48363122	"Enzymes, Predicted intracellular proteins"		"Hydrolase, Protease, Serine protease"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA008862	Uncertain					NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 85: Liver - Metabolism"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 52: Non-specific - Transcription"			"HPA008862: AB_2137156"	"unprognostic (8.08e-3)"	"prognostic unfavorable (4.55e-4)"	"unprognostic (1.75e-2)"	"unprognostic (2.33e-2)"	"unprognostic (6.08e-2)"	"unprognostic (1.60e-2)"	"unprognostic (7.59e-3)"	"unprognostic (2.13e-1)"	"unprognostic (2.36e-1)"	"unprognostic (3.10e-2)"	"unprognostic (5.39e-2)"	"unprognostic (1.40e-1)"	"prognostic favorable (6.71e-7)"	"unprognostic (6.53e-2)"	"unprognostic (1.49e-1)"	"unprognostic (5.60e-2)"	"unprognostic (1.33e-1)"	21.8	19.2	20.4	14.8	22.8	13.5	46.0	23.0	24.7	19.5	27.9	16.7	20.3	19.3	25.9	16.8	22.2	14.8	22.4	23.0	21.2	20.1	86.9	14.6	15.6	20.5	19.8	24.4	22.1	38.2	25.3	13.9	21.8	29.6	18.7	39.0	20.9	22.2	23.7	17.9	18.4	20.9	21.3	17.3	20.0	9.1	20.4	17.1	32.6	22.5	16.4	19.3	16.0	23.5	24.3	33.1	18.3	25.5	42.1	34.6	30.9	30.4	23.1	28.0	12.8	17.3	12.4	11.0	29.2	30.9	14.1	29.8	33.4	33.6	38.7	18.0	21.7	16.1	20.1	38.2	25.8	27.5	20.7	32.2	36.6	26.2	24.4	33.8	21.1	20.7	27.6	12.6	29.2	22.4	26.5	13.6	13.7	22.8	32.5	34.0	33.1	35.1	31.7	16.1	28.6	17.7	34.6	38.1	31.6	22.8	17.6	20.5	28.3	28.7	16.9	25.2	23.7	25.6	22.8	18.0	33.7	18.5	21.3	6.8	11.6	8.0	10.6	12.0	11.7	10.5	12.9	11.2	11.4	11.7	12.3	11.4	4.4	8.4	12.7	8.5	10.7	10.7	20.4	22.8	23.0	24.7	23.0	21.2	20.5	19.8	21.8	21.3	20.4	23.5	33.0	57.7	66.3	70.8	44.6	34.9	43.1	38.3	40.5	104.5	51.0	39.1	62.7	75.8	52.0	27.6	85.5	40.1	37.9	31.9	13.7	35.0	30.8	43.7	48.2	34.2	49.7	23.4	97.2	30.7	29.0	43.3	39.8	53.6	30.4	65.2	42.5	194.6	30.5	85.8	95.4	36.8	38.7	53.8	42.7	10.1	59.0	38.3	39.2	60.0	45.1	63.9	32.0	73.9	87.6	31.3	38.9	54.5	41.5	52.3	40.9	30.0	56.3	141.7	39.5	67.2	42.5	22.0	17.0	36.7	36.8	64.0	39.8	41.4	41.2	45.8
LPIN1	KIAA0188	ENSG00000134324	"Lipin 1"	Q14693	2	11677595-11827409	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Fatty acid metabolism, Lipid metabolism, Transcription, Transcription regulation"	Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 193.5;tongue: 137.2"	"Cell type enriched"	"Detected in all"	5	"Late spermatids: 1705.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA024591, HPA038021"	Approved		Approved	"Plasma membrane,Cytosol"		NA	NA			"Cluster 6: Non-specific - Transcription"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 25: Spermatids - Spermatogenesis"	Cytosol	"Plasma membrane"	"HPA024591: , HPA038021: AB_10669514"	"unprognostic (1.97e-1)"	"unprognostic (2.47e-1)"	"unprognostic (1.32e-1)"	"unprognostic (1.87e-2)"	"unprognostic (9.17e-2)"	"unprognostic (2.69e-2)"	"unprognostic (8.20e-2)"	"unprognostic (5.28e-3)"	"unprognostic (1.09e-1)"	"unprognostic (1.07e-2)"	"unprognostic (2.45e-3)"	"unprognostic (2.55e-2)"	"unprognostic (1.06e-1)"	"unprognostic (5.58e-3)"	"unprognostic (1.25e-1)"	"unprognostic (9.60e-2)"	"unprognostic (4.02e-1)"	36.2	15.0	29.0	14.9	30.6	8.6	36.7	24.2	24.9	25.1	21.9	16.7	11.9	16.6	19.0	40.5	15.6	13.0	20.1	21.0	32.1	14.9	27.0	16.1	22.3	31.8	38.2	31.5	9.9	23.1	34.2	11.7	35.3	13.7	8.5	14.8	27.3	14.1	193.5	13.4	19.7	13.0	14.1	14.8	14.9	57.4	35.0	16.1	14.6	137.2	26.3	19.9	23.1	18.8	16.2	18.0	15.9	34.9	71.4	77.9	7.8	22.2	38.7	14.0	24.3	6.9	15.4	8.2	2.9	18.6	41.6	17.3	17.4	49.2	12.8	32.9	9.8	20.3	11.5	9.7	25.1	14.1	90.1	71.1	21.7	57.9	22.6	41.7	28.0	19.6	27.4	68.3	10.4	6.4	13.5	12.0	16.2	5.5	18.9	18.1	28.6	52.0	36.9	10.0	42.8	33.6	8.0	19.7	51.9	15.0	4.9	7.9	19.5	22.1	19.9	14.4	19.0	108.0	92.0	15.2	31.3	24.7	16.6	11.2	2.9	13.4	10.3	2.3	11.2	7.3	9.9	10.1	2.7	5.1	8.6	7.2	1.1	9.5	2.3	10.3	12.2	3.7	29.0	30.6	24.2	24.9	21.0	32.1	31.8	38.2	35.3	14.1	35.0	18.8	15.6	22.4	56.8	167.8	46.1	19.1	45.1	12.6	18.8	48.6	32.8	22.9	59.6	31.5	43.9	11.0	85.5	8.7	68.0	21.2	7.9	23.0	338.4	27.8	44.4	25.8	36.2	9.7	55.7	28.0	6.0	28.8	19.4	76.5	35.4	13.1	17.5	48.7	8.9	48.8	71.7	25.2	22.4	15.7	39.4	1705.8	119.0	25.5	17.8	21.5	15.4	14.7	66.9	41.7	43.5	36.5	29.7	179.8	76.0	34.9	5.4	4.8	52.0	49.0	32.9	32.4	18.4	20.6	19.7	5.5	11.9	12.3	73.2	26.6	16.3	31.3
LPIN2	KIAA0249	ENSG00000101577	"Lipin 2"	Q92539	18	2916994-3013144	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Fatty acid metabolism, Lipid metabolism, Transcription, Transcription regulation"	Hydrolase	"Congenital dyserythropoietic anemia, Disease variant, Hereditary hemolytic anemia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 165.8"	"Cell type enhanced"	"Detected in many"		"Cholangiocytes: 154.4;Granulosa cells: 323.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Group enriched"	"Detected in all"	7	"granulocytes: 23.4;NK-cells: 12.5;T-cells: 12.1"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB015223, HPA017857, HPA030550"	Enhanced		Approved	"Plasma membrane,Actin filaments,Cytosol"		Yes	No			"Cluster 33: Neutrophils - Chromatin organization"	"Cluster 85: Liver - Metabolism"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 40: Granulosa cells - Unknown function"	Cytosol	"Plasma membrane, Actin filaments"	"CAB015223: , HPA017857: AB_1852904, HPA030550: AB_2673519"	"unprognostic (7.03e-2)"	"unprognostic (1.05e-1)"	"unprognostic (2.88e-1)"	"unprognostic (1.51e-3)"	"unprognostic (1.20e-1)"	"prognostic favorable (8.01e-4)"	"unprognostic (9.85e-3)"	"unprognostic (1.89e-2)"	"unprognostic (1.03e-2)"	"unprognostic (3.44e-3)"	"unprognostic (3.19e-1)"	"unprognostic (1.94e-1)"	"unprognostic (3.15e-3)"	"unprognostic (4.66e-2)"	"unprognostic (2.21e-1)"	"unprognostic (2.49e-1)"	"unprognostic (7.11e-2)"	9.7	9.3	17.9	21.2	19.9	19.8	9.8	14.6	17.4	9.7	16.6	13.9	62.8	9.8	6.7	10.0	9.5	25.7	7.2	16.1	24.2	26.4	165.8	21.2	24.3	22.7	22.0	13.2	16.4	13.5	10.9	15.7	24.2	9.0	12.5	10.7	7.4	8.0	2.7	3.6	39.9	9.6	15.6	20.3	28.1	22.0	28.8	18.9	12.1	3.0	19.2	9.9	6.0	14.3	8.7	12.0	17.1	6.6	31.7	27.4	10.5	17.4	22.8	18.9	16.9	16.7	7.1	5.4	10.8	30.2	30.2	0.2	13.8	6.3	13.2	11.2	2.7	13.3	10.0	19.4	27.2	11.2	17.0	27.4	4.6	18.5	17.2	28.2	23.4	14.8	12.8	3.5	28.2	7.2	15.0	12.0	5.7	13.7	13.1	26.7	14.0	23.2	17.6	20.0	14.4	10.2	18.4	9.1	6.8	10.7	0.0	18.0	31.2	25.3	28.7	31.7	14.6	5.0	7.9	12.3	22.1	12.2	8.1	8.7	2.4	7.8	11.8	1.5	12.1	1.0	9.2	7.2	1.0	1.7	9.1	6.3	23.4	12.5	0.8	1.5	9.2	3.2	17.9	19.9	14.6	17.4	16.1	24.2	22.7	22.0	24.2	15.6	28.8	14.3	17.7	67.3	44.0	55.2	20.4	5.6	9.8	8.5	5.7	35.7	12.1	11.2	11.2	154.4	23.9	38.6	14.6	25.2	41.9	45.3	17.6	11.8	3.3	48.2	33.3	18.9	14.9	138.1	26.3	19.0	11.3	25.4	103.0	64.4	12.6	323.0	19.2	131.1	23.1	116.1	65.6	36.8	16.2	26.8	8.9	11.0	22.7	31.1	8.8	79.6	31.2	16.7	59.8	37.7	21.0	22.2	21.6	31.2	16.1	21.2	92.4	54.9	17.1	16.7	6.6	16.6	20.1	26.5	73.0	0.6	2.0	49.5	58.9	20.3	14.0	14.1
LPIN3	"LIPN3L, SMP2"	ENSG00000132793	"Lipin 3"	Q9BQK8	20	41340821-41360582	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Fatty acid metabolism, Lipid metabolism"	Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Late spermatids: 214.9;Proximal enterocytes: 76.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"NK-cell: 2.3"	"Low lineage specificity"	"Detected in single"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in some"			"HPA051466, HPA052667, HPA070640"	Approved		Supported	Cytosol		NA	NA			"Cluster 11: Basophils - Unknown function"	"Cluster 41: Intestine & Liver - Lipid metabolism"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 31: Spermatids - Spermatogenesis"	Cytosol		"HPA051466: , HPA052667: AB_2681908, HPA070640: AB_2686288"	"unprognostic (2.31e-1)"	"unprognostic (4.73e-2)"	"unprognostic (1.68e-1)"	"prognostic unfavorable (9.74e-4)"	"unprognostic (1.88e-1)"	"unprognostic (1.04e-1)"	"unprognostic (6.91e-3)"	"unprognostic (4.26e-2)"	"unprognostic (1.74e-1)"	"prognostic unfavorable (1.74e-4)"	"unprognostic (4.29e-2)"	"unprognostic (7.79e-2)"	"prognostic unfavorable (1.14e-5)"	"unprognostic (5.60e-3)"	"unprognostic (2.02e-1)"	"unprognostic (1.35e-1)"	"unprognostic (3.37e-3)"	19.1	7.3	5.6	3.7	5.4	0.3	18.0	4.6	6.8	19.4	8.4	24.0	41.6	14.1	13.1	32.2	17.7	5.8	17.9	5.6	5.2	31.5	30.0	9.1	2.1	6.1	5.2	14.5	15.1	10.3	12.6	3.6	5.4	19.7	13.2	1.3	16.9	9.6	3.3	40.6	32.4	5.9	5.3	5.7	12.3	3.3	6.2	2.0	26.9	2.5	3.2	13.3	26.2	6.1	12.4	12.0	0.7	7.1	18.6	28.8	9.1	7.5	10.3	9.0	12.1	22.3	10.7	0.6	9.1	16.7	9.5	30.6	3.6	19.6	5.6	0.3	6.9	0.6	19.8	11.5	3.0	0.0	8.1	20.8	24.3	15.3	5.9	10.4	2.3	0.3	3.2	0.4	11.3	26.5	0.1	0.3	1.0	7.6	12.1	0.1	0.2	0.9	30.9	15.5	0.9	0.2	10.0	12.6	6.4	5.6	14.8	6.2	0.7	0.6	2.9	10.1	0.1	5.8	3.3	0.1	0.2	0.1	0.6	0.8	0.1	0.2	0.1	0.1	0.2	0.2	0.2	0.1	0.1	0.3	0.2	0.2	0.6	2.3	0.3	0.2	0.1	0.1	5.6	5.4	4.6	6.8	5.6	5.2	6.1	5.2	5.4	5.3	6.2	6.1	7.2	6.4	12.3	12.1	0.8	14.4	8.2	10.0	3.4	0.0	12.7	11.3	0.8	10.0	6.0	11.0	0.0	2.8	0.2	44.4	5.9	8.7	21.6	10.0	12.5	3.2	14.9	2.7	1.0	3.8	3.5	9.4	19.9	33.1	1.3	16.2	5.0	44.1	3.3	0.0	0.3	21.9	4.1	2.2	6.0	214.9	3.1	1.0	10.6	8.4	0.0	5.2	0.0	1.0	0.2	6.4	28.4	2.6	0.1	3.8	76.9	11.8	4.2	0.5	32.9	8.8	8.2	1.0	2.7	4.7	12.6	2.6	1.0	5.2	23.2	4.8
LPL	LIPD	ENSG00000175445	"Lipoprotein lipase"	P06858	8	19901717-19967259	"Candidate cardiovascular disease genes, Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Lipid degradation, Lipid metabolism"	"Heparin-binding, Hydrolase"	"Disease variant, FDA approved drug targets, Hyperlipidemia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 937.4;heart muscle: 407.8"	"Cell type enhanced"	"Detected in many"		"Adipocytes: 453.0;Cardiomyocytes: 489.0;Granulosa cells: 495.2;Horizontal cells: 206.9;Sertoli cells: 236.7"	"Cancer enhanced"	"Detected in all"		"glioma: 39.2"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"non-classical monocyte: 4.2"	"Lineage enriched"	"Detected in single"	6	"monocytes: 4.2"	"Cell line enriched"	"Detected in some"	5	"AF22: 391.6"	"Region enhanced"	"Detected in many"		"basal ganglia: 45.3"	"Group enriched"	"Detected in all"	5	"basal ganglia: 79.2;spinal cord: 59.3"	HPA048749			Supported	Vesicles	"Secreted to blood"	NA	NA		4200000	"Cluster 7: Monocytes - Unknown function"	"Cluster 82: Adipose tissue - ECM organization"	"Cluster 12: NES - Nervous system development"	"Cluster 40: Granulosa cells - Unknown function"	Vesicles		"HPA048749: AB_2680511"	"unprognostic (5.52e-2)"	"unprognostic (3.16e-1)"	"unprognostic (6.41e-2)"	"unprognostic (3.03e-1)"	"unprognostic (4.14e-2)"	"unprognostic (1.01e-2)"	"unprognostic (1.88e-4)"	"unprognostic (1.05e-1)"	"unprognostic (6.78e-2)"	"unprognostic (8.20e-2)"	"unprognostic (2.54e-2)"	"unprognostic (5.28e-1)"	"unprognostic (1.18e-1)"	"unprognostic (4.20e-3)"	"unprognostic (4.16e-3)"	"unprognostic (1.19e-1)"	"prognostic unfavorable (6.07e-4)"	937.4	15.9	6.8	9.1	53.2	0.9	255.4	20.3	12.2	2.7	8.9	12.0	1.5	3.7	0.5	2.8	2.7	8.6	407.8	10.7	9.5	19.1	0.7	62.1	8.5	7.4	7.7	10.6	6.3	181.5	4.1	14.7	7.9	3.8	5.8	11.1	24.4	64.7	86.4	8.3	13.3	4.1	5.5	1.6	8.4	1.0	11.5	4.3	10.6	127.3	2.8	6.1	4.7	8.8	0.0	0.0	391.6	0.1	8.1	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.4	0.0	0.7	0.0	0.8	0.0	0.0	0.1	0.3	0.0	71.5	0.0	0.2	8.6	0.0	0.2	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.1	0.0	0.0	0.1	0.7	9.6	0.0	0.0	0.0	0.0	68.4	0.0	0.0	8.4	0.2	0.0	0.0	0.1	13.5	0.0	1.8	0.0	0.0	8.1	0.0	3.5	0.0	0.1	0.1	0.1	0.1	32.6	0.0	0.9	0.7	0.0	1.7	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	4.2	0.0	0.0	0.2	6.8	53.2	20.3	12.2	10.7	9.5	7.4	7.7	7.9	5.5	11.5	8.8	453.0	12.8	104.9	1.0	0.4	1.5	0.1	0.0	0.6	2.8	114.7	5.7	489.0	0.0	0.6	0.0	2.1	0.4	0.9	0.1	15.6	0.0	0.8	0.2	2.5	56.1	0.0	0.0	1.9	0.0	0.7	13.6	0.0	0.3	6.3	495.2	2.9	0.0	108.5	206.9	0.4	1.0	0.0	14.8	4.2	1.3	1.2	38.2	14.2	1.9	2.0	2.3	0.0	9.0	0.1	0.0	0.0	0.0	0.0	0.3	0.3	0.4	2.9	2.7	236.7	91.4	68.1	0.4	0.2	0.2	0.6	0.4	2.3	4.3	2.8	0.1
LTA4H		ENSG00000111144	"Leukotriene A4 hydrolase"	P09960	12	96000753-96043520	"Cancer-related genes, Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Leukotriene biosynthesis, Lipid metabolism"	"Hydrolase, Metalloprotease, Protease"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Hofbauer cells: 207.2;Kupffer cells: 255.8;monocytes: 245.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA008399, CAB015221, HPA017017"	Supported		Approved	Nucleoplasm,Cytosol		NA	NA		86000000	"Cluster 7: Monocytes - Unknown function"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 19: Monocytes & Neutrophils - Innate immune response"	"Nucleoplasm, Cytosol"		"CAB015221: , HPA008399: AB_1852816, HPA017017: AB_1852818"	"prognostic favorable (9.79e-4)"	"unprognostic (6.62e-2)"	"unprognostic (6.04e-2)"	"unprognostic (1.87e-1)"	"unprognostic (1.38e-2)"	"unprognostic (2.59e-2)"	"unprognostic (4.25e-3)"	"prognostic favorable (8.96e-4)"	"unprognostic (1.72e-1)"	"unprognostic (1.75e-2)"	"unprognostic (3.38e-2)"	"unprognostic (1.34e-1)"	"unprognostic (1.73e-1)"	"unprognostic (1.74e-1)"	"unprognostic (1.04e-1)"	"unprognostic (3.50e-2)"	"unprognostic (1.34e-1)"	40.2	66.9	24.6	64.5	25.5	180.4	53.6	29.4	30.6	55.6	33.8	48.2	78.1	51.1	38.4	110.1	61.7	40.3	35.5	25.0	27.8	58.1	43.9	190.8	64.1	26.3	25.4	110.5	54.9	53.3	37.4	27.4	26.0	41.1	49.6	36.9	41.2	40.9	45.0	67.8	60.5	58.3	25.7	57.8	46.6	19.9	28.1	49.2	49.4	45.0	96.4	51.9	52.7	33.0	85.2	90.4	123.5	73.4	104.2	115.1	53.8	33.7	101.8	67.5	78.1	66.6	72.0	190.0	42.0	51.9	52.8	108.3	103.4	140.1	92.3	63.3	97.0	68.5	54.3	81.8	61.8	35.7	39.4	110.1	118.4	91.9	114.5	305.3	134.9	101.1	42.9	32.5	98.7	59.2	96.7	115.0	145.8	100.7	115.5	88.9	90.5	109.7	125.7	107.7	63.9	75.5	64.2	80.4	78.3	95.1	98.7	44.7	49.0	28.3	47.6	40.2	38.2	42.8	79.4	85.4	19.1	66.2	22.3	4.4	662.9	17.7	33.4	699.2	63.4	126.1	46.6	43.4	282.3	157.5	65.0	50.5	46.0	120.4	638.8	70.4	51.2	591.5	24.6	25.5	29.4	30.6	25.0	27.8	26.3	25.4	26.0	25.7	28.1	33.0	32.8	38.5	135.0	15.3	82.8	51.9	64.8	96.6	52.3	21.4	41.8	41.1	25.3	25.8	110.2	38.6	33.3	29.3	47.9	17.6	74.3	42.9	74.3	18.4	20.8	38.2	21.6	50.5	21.3	28.0	28.2	29.7	38.2	27.3	7.6	31.5	57.8	21.7	207.2	11.8	18.5	40.4	40.7	255.8	76.6	16.4	36.7	183.3	21.4	10.3	245.5	35.5	26.8	19.6	17.5	20.8	27.1	41.0	40.1	35.4	73.2	69.3	45.0	55.6	6.6	26.7	35.4	46.9	11.6	108.0	74.9	20.8	39.1	32.9	70.4	49.7
LYZ		ENSG00000090382	Lysozyme	P61626	12	69348381-69354234	"Disease related genes, Enzymes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted secreted proteins"		"Antimicrobial, Bacteriolytic enzyme, Glycosidase, Hydrolase"	"Amyloidosis, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 10588.1;salivary gland: 21115.5;stomach 1: 8941.1"	"Cell type enhanced"	"Detected in many"		"Gastric mucus-secreting cells: 3106.1;Kupffer cells: 2841.2;Langerhans cells: 4859.1;Macrophages: 4870.7;monocytes: 7063.0;Pancreatic endocrine cells: 3152.5"	"Cancer enhanced"	"Detected in all"		"stomach cancer: 976.9"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in all"	4	"classical monocyte: 25266.2;myeloid DC: 14438.7"	"Group enriched"	"Detected in all"	20	"dendritic cells: 14438.7;monocytes: 25266.2"	"Cell line enriched"	"Detected in many"	13	"OE19: 12130.8"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"CAB000055, HPA048284, HPA066182"	Enhanced		Approved	"Nucleoplasm,Golgi apparatus,Actin filaments"	"Secreted to blood"	NA	NA	1500000000	1500000000	"Cluster 25: Monocytes - Inflammatory response"	"Cluster 24: Salivary gland - Salivary secretion"	"Cluster 21: OE19 - Mitochondria"	"Cluster 19: Monocytes & Neutrophils - Innate immune response"	"Golgi apparatus, Actin filaments"	Nucleoplasm	"CAB000055: AB_2341230, HPA048284: AB_2680339, HPA066182: AB_2732741"	"unprognostic (8.52e-2)"	"unprognostic (6.12e-3)"	"unprognostic (2.83e-1)"	"unprognostic (7.29e-2)"	"unprognostic (7.91e-2)"	"prognostic favorable (7.45e-4)"	"unprognostic (1.21e-1)"	"unprognostic (7.40e-2)"	"unprognostic (1.41e-1)"	"unprognostic (2.08e-2)"	"unprognostic (1.44e-1)"	"unprognostic (3.13e-1)"	"unprognostic (2.50e-1)"	"unprognostic (2.37e-1)"	"unprognostic (3.65e-2)"	"unprognostic (5.78e-2)"	"unprognostic (3.62e-2)"	95.8	27.8	3.5	802.1	4.0	10588.1	128.2	3.7	18.5	156.2	11.4	309.0	3605.0	65.7	4.2	106.3	33.9	1054.6	34.8	2.6	4.3	32.4	138.0	1355.2	739.7	8.0	7.3	20.4	63.1	13.8	7.2	91.3	12.2	40.2	273.8	4.4	21115.5	21.8	34.0	58.7	1322.2	123.9	5.4	621.0	8941.1	21.8	10.9	321.8	27.8	36.4	652.8	428.5	16.2	11.7	0.6	0.1	0.0	0.2	0.0	0.0	4.8	0.0	0.0	0.0	0.3	9.5	6.5	4.2	1.5	0.0	3.6	1.2	0.0	0.0	0.2	1.2	0.1	62.4	1.0	960.4	0.0	110.6	50.5	0.0	0.1	0.0	0.0	0.2	0.0	0.3	7.7	0.3	0.0	0.2	2.6	109.5	2.3	12130.8	0.2	1.6	1.4	16.7	0.3	0.5	0.8	3.6	0.5	0.1	0.5	0.7	0.0	489.0	0.6	0.0	2.6	2.3	0.9	2.6	1.1	1.2	0.1	518.5	0.0	443.4	25266.2	298.2	32.6	4798.4	52.3	100.5	20.1	22.7	14438.7	20.8	20.0	17.8	1007.7	108.1	880.1	301.2	31.1	25392.1	3.5	4.0	3.7	18.5	2.6	4.3	8.0	7.3	12.2	5.4	10.9	11.7	24.0	86.6	285.8	0.0	80.8	57.2	1.7	1.2	1.2	0.3	1205.7	32.3	0.2	734.9	51.1	27.6	0.0	5.6	39.6	32.1	0.0	55.1	1.9	2.6	1.9	25.1	12.5	264.6	0.2	547.3	9.4	26.8	3106.1	2.9	123.6	0.5	29.6	25.4	887.1	0.0	0.2	112.4	0.0	2841.2	4859.1	17.4	4.1	4870.7	53.4	0.0	7063.0	0.1	176.1	0.0	0.3	3152.5	600.5	2.2	9.0	2.7	41.8	6.6	33.8	1.0	39.5	7.4	9.9	0.7	3.9	1.5	38.2	8.5	50.6	0.3	111.4	38.3
LYZL1	"LYC2, MGC33408"	ENSG00000120563	"Lysozyme like 1"	Q6UWQ5	10	29289061-29318328	"Enzymes, Metabolic proteins, Predicted membrane proteins, Predicted secreted proteins"		"Glycosidase, Hydrolase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	429	"testis: 51.0"	"Group enriched"	"Detected in some"	37	"Early spermatids: 600.3;Late spermatids: 201.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"																"Secreted in male reproductive system"	NA	NA				"Cluster 74: Testis - Spermatogenesis"		"Cluster 23: Spermatids - Flagellum & Golgi organization"										"unprognostic (1.88e-1)"						"unprognostic (8.40e-3)"					0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	51.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	600.3	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	201.8	5.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	2.6	0.0	0.0	0.0	0.1	0.0	0.0	6.6	0.0	0.0	10.6	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0
LYZL2		ENSG00000151033	"Lysozyme like 2"	Q7Z4W2	10	30611779-30629762	"Enzymes, Predicted membrane proteins, Predicted secreted proteins"		"Glycosidase, Hydrolase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	712	"testis: 71.1"	"Group enriched"	"Detected in some"	43	"Early spermatids: 786.1;Late spermatids: 204.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	5	"SK-BR-3: 3.0"														"Secreted in male reproductive system"	NA	NA				"Cluster 36: Testis - Spermatogenesis"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 23: Spermatids - Flagellum & Golgi organization"				"unprognostic (2.83e-4)"																	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	71.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	786.1	0.1	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	204.1	7.8	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	11.3	2.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0
LYZL6	"LYC1, PRO1485, TKAL754"	ENSG00000275722	"Lysozyme like 6"	O75951	17	35934518-35943713	"Enzymes, Predicted intracellular proteins, Predicted secreted proteins"	Fertilization	"Antimicrobial, Bacteriolytic enzyme, Glycosidase, Hydrolase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	132	"testis: 47.9"	"Cell type enriched"	"Detected in some"	6	"Early spermatids: 387.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA025734, HPA053073"	Enhanced				"Secreted in male reproductive system"	NA	NA				"Cluster 74: Testis - Spermatogenesis"		"Cluster 23: Spermatids - Flagellum & Golgi organization"			"HPA025734: AB_1853444, HPA053073: AB_2682034"																		0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.2	0.0	0.0	0.3	0.0	0.0	0.0	0.1	0.0	47.9	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.5	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.1	0.0	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.1	0.4	0.2	0.0	0.3	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	387.5	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	58.3	1.8	0.1	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	15.4	3.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
MACROD1	LRP16	ENSG00000133315	"Mono-ADP ribosylhydrolase 1"	Q9BQ69	11	63998558-64166113	"Disease related genes, Enzymes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"DNA damage"	Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"skeletal muscle: 290.1"	"Cell type enhanced"	"Detected in many"		"Distal tubular cells: 137.0;Proximal tubular cells: 333.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"MCF7: 73.8;RPMI-8226: 145.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041031, HPA071075"	Uncertain		Supported	Nucleoplasm		NA	NA			"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 59: Non-specific - Translation"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Nucleoplasm		"HPA041031: AB_10794435, HPA071075: AB_2686341"	"unprognostic (1.19e-2)"	"unprognostic (2.15e-1)"	"unprognostic (1.38e-1)"	"unprognostic (3.14e-2)"	"unprognostic (3.88e-2)"	"unprognostic (6.03e-2)"	"unprognostic (1.95e-2)"	"unprognostic (2.82e-1)"	"unprognostic (2.44e-2)"	"unprognostic (1.34e-1)"	"prognostic unfavorable (2.90e-4)"	"unprognostic (1.15e-1)"	"prognostic favorable (4.68e-6)"	"unprognostic (2.45e-2)"	"unprognostic (9.92e-2)"	"unprognostic (2.36e-1)"	"unprognostic (2.86e-2)"	14.9	14.1	6.4	1.3	5.9	2.8	17.3	6.8	12.7	15.6	5.9	21.3	5.7	13.8	0.9	18.6	15.3	2.2	111.6	6.4	8.2	55.1	50.2	10.4	1.1	8.6	7.9	21.6	49.5	4.1	11.8	1.6	8.8	19.6	1.4	1.2	30.1	5.5	290.1	26.0	10.7	1.1	6.6	6.5	27.2	4.7	9.1	1.0	32.0	58.9	0.5	17.4	16.8	7.4	12.7	5.7	1.9	10.2	1.7	1.0	10.9	7.5	3.2	5.3	5.1	5.3	33.2	44.9	25.4	0.6	2.6	29.8	1.9	0.1	0.6	3.6	21.9	16.8	23.3	29.7	6.1	13.8	1.8	2.5	3.4	0.6	1.7	4.5	1.8	14.7	15.2	8.5	1.1	73.8	20.1	45.1	5.5	4.3	24.4	18.7	11.5	145.4	1.8	0.7	15.7	31.2	5.7	40.3	41.4	0.2	29.8	1.0	2.9	4.9	7.4	7.0	0.8	17.8	3.1	7.4	3.4	13.4	4.6	0.0	0.0	0.0	0.4	0.2	0.4	0.1	0.4	0.2	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.2	0.0	0.0	6.4	5.9	6.8	12.7	6.4	8.2	8.6	7.9	8.8	6.6	9.1	7.4	19.4	0.0	4.6	6.8	7.1	28.0	39.8	7.5	57.5	15.1	46.2	45.0	32.5	30.0	8.6	42.3	0.0	35.6	1.3	34.6	137.0	20.8	7.1	19.0	13.3	11.9	22.9	8.0	7.1	40.4	16.1	15.9	20.9	22.7	0.0	41.6	9.7	45.3	11.7	11.8	12.4	55.2	8.2	6.9	5.1	26.8	24.8	7.2	39.2	4.7	2.4	16.9	1.0	13.6	6.9	19.2	35.2	14.3	12.9	37.6	23.0	333.4	3.1	20.6	19.7	55.7	19.1	8.2	32.5	46.3	37.1	23.9	6.1	18.8	67.9	49.8
MAN1A1		ENSG00000111885	"Mannosidase alpha class 1A member 1"	P33908	6	119177205-119349761	"Enzymes, Metabolic proteins, Plasma proteins, Predicted membrane proteins"		"Glycosidase, Hydrolase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 154.6"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 232.5;Excitatory neurons: 165.0;Hepatocytes: 270.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"ASC diff: 273.1;Hep G2: 204.0;Karpas-707: 219.6;U-266/70: 294.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB037058, HPA053198, HPA063561"	Uncertain		Supported	"Golgi apparatus"		NA	NA		460000000	"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 86: Liver & Placenta - Transport via ER"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 4: Macrophages - Innate immune response"	"Golgi apparatus"		"CAB037058: AB_477183, HPA053198: AB_2682078, HPA063561: AB_2685042"	"unprognostic (1.50e-1)"	"unprognostic (7.36e-3)"	"unprognostic (4.83e-2)"	"unprognostic (2.21e-2)"	"unprognostic (2.95e-2)"	"unprognostic (2.19e-1)"	"unprognostic (3.33e-3)"	"unprognostic (3.44e-2)"	"unprognostic (2.04e-1)"	"unprognostic (5.11e-2)"	"unprognostic (1.68e-3)"	"unprognostic (4.62e-1)"	"unprognostic (2.37e-2)"	"unprognostic (3.49e-2)"	"unprognostic (2.25e-1)"	"unprognostic (6.89e-2)"	"unprognostic (3.40e-1)"	102.2	48.5	4.2	32.8	12.3	28.9	34.3	1.2	8.9	25.9	5.1	36.1	52.7	23.8	8.8	22.7	16.0	47.1	15.3	8.0	4.6	66.6	154.6	35.8	34.8	2.9	5.0	20.1	32.7	25.8	4.6	79.4	2.5	18.1	29.3	6.2	42.7	15.0	7.6	14.3	69.8	27.2	3.3	36.5	25.9	7.0	8.4	18.9	22.6	31.0	25.9	56.0	17.1	5.9	0.2	0.0	3.4	0.0	273.1	119.9	6.6	6.9	41.4	5.1	12.5	19.8	2.6	43.2	0.3	26.5	65.7	0.4	7.6	0.1	6.4	64.5	19.4	36.3	3.9	204.0	27.2	0.1	17.7	82.4	5.3	41.6	25.3	22.1	3.4	12.6	128.1	219.6	39.7	6.1	1.7	0.3	2.3	20.0	10.0	12.1	4.2	66.6	13.4	35.4	14.1	21.0	0.1	0.6	0.0	8.3	10.4	4.8	24.8	16.9	15.4	32.0	15.8	294.5	44.6	84.8	50.2	0.7	10.4	4.3	0.3	1.1	1.1	0.5	2.3	0.7	0.6	0.6	0.3	0.4	0.3	0.9	1.9	0.9	0.5	2.8	0.7	0.3	4.2	12.3	1.2	8.9	8.0	4.6	2.9	5.0	2.5	3.3	8.4	5.9	37.1	9.6	46.1	19.9	31.0	31.7	5.7	1.2	5.2	28.1	18.8	5.8	4.4	44.3	6.9	106.7	0.0	6.8	40.6	23.3	5.9	9.4	232.5	5.9	63.9	42.1	48.0	40.4	165.0	37.8	12.4	98.4	18.8	10.7	3.8	24.0	97.5	270.5	101.1	0.0	79.4	61.1	0.0	84.6	91.2	39.3	26.4	98.0	28.4	128.4	13.5	1.7	42.2	4.5	3.7	14.8	18.9	4.1	147.5	5.3	92.2	33.5	4.6	5.0	6.6	12.9	27.8	2.8	3.9	3.4	27.8	6.2	24.3	14.6	18.9	9.7
MAN1A2	MAN1B	ENSG00000198162	"Mannosidase alpha class 1A member 2"	O60476	1	117367449-117528872	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"		"Glycosidase, Hydrolase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Extravillous trophoblasts: 236.1;Inhibitory neurons: 238.0;Syncytiotrophoblasts: 380.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA034559, HPA057364"	Enhanced		Enhanced	"Golgi apparatus"		NA	NA		2000000	"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	"Golgi apparatus"		"HPA034559: AB_10671229, HPA057364: AB_2683419"	"unprognostic (2.24e-1)"	"unprognostic (1.20e-1)"	"unprognostic (2.92e-3)"	"unprognostic (2.15e-1)"	"unprognostic (3.11e-2)"	"unprognostic (9.70e-2)"	"unprognostic (1.95e-2)"	"unprognostic (8.01e-2)"	"unprognostic (8.19e-3)"	"prognostic favorable (4.08e-4)"	"unprognostic (1.41e-1)"	"unprognostic (4.38e-2)"	"unprognostic (6.84e-2)"	"unprognostic (1.45e-1)"	"unprognostic (7.39e-2)"	"unprognostic (1.17e-1)"	"unprognostic (5.08e-2)"	15.6	11.7	6.7	13.0	12.0	6.3	12.9	8.8	11.6	17.5	7.7	12.5	11.1	16.4	13.7	15.2	14.2	12.3	11.0	7.2	8.5	15.3	21.1	10.8	14.1	1.6	5.0	14.3	36.2	32.9	6.7	21.7	1.6	14.4	12.5	18.2	14.0	13.1	8.4	10.3	11.6	18.0	1.0	12.2	14.2	10.8	6.2	14.7	25.4	10.1	13.8	17.8	7.7	9.8	32.4	13.8	23.2	20.1	29.8	35.7	74.2	26.3	40.9	11.6	10.9	10.7	18.2	24.2	47.4	33.9	10.8	18.7	11.0	22.3	26.0	30.3	16.4	14.4	18.5	11.8	18.1	22.7	31.6	24.2	23.5	17.8	15.5	21.3	35.0	16.7	23.5	36.1	24.5	62.6	14.0	7.2	11.9	16.4	14.4	12.5	50.5	16.7	15.9	43.3	12.6	18.4	26.2	27.6	21.1	30.1	13.8	14.2	33.6	26.0	21.4	18.6	27.2	24.4	18.0	15.9	34.4	17.8	63.1	0.9	1.5	2.6	3.0	1.2	3.6	1.9	2.4	2.5	1.4	1.9	2.0	2.9	1.2	3.8	1.1	2.7	6.3	1.5	6.7	12.0	8.8	11.6	7.2	8.5	1.6	5.0	1.6	1.0	6.2	9.8	40.3	38.5	33.4	71.5	45.1	31.0	34.8	26.7	39.3	63.5	43.3	46.0	101.8	35.8	39.1	44.1	22.9	55.1	52.6	24.7	17.6	32.3	33.1	43.2	52.0	40.6	21.7	43.8	188.5	60.4	236.1	50.7	28.5	54.7	16.4	32.3	42.1	88.7	29.4	43.7	238.0	37.1	20.3	36.2	22.0	22.5	53.7	37.2	40.9	101.2	39.2	51.3	55.6	136.7	149.1	37.5	25.1	65.5	120.2	43.0	28.6	22.1	40.9	42.2	39.5	69.1	53.5	72.9	56.2	53.0	34.5	380.5	45.8	68.3	30.8	47.3
MAN1B1	"ERManI, MANA-ER, MRT15"	ENSG00000177239	"Mannosidase alpha class 1B member 1"	Q9UKM7	9	137086985-137109183	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"		"Glycosidase, Hydrolase"	"Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA051516	Approved		Uncertain	Vesicles		NA	NA		940000	"Cluster 27: Non-specific - Gene expression"	"Cluster 35: Non-specific - Unknown function"	"Cluster 18: U-2197 - ECM organization"	"Cluster 55: Plasma cells - Humoral immune response"	Vesicles		"HPA051516: AB_2681518"	"unprognostic (1.21e-2)"	"unprognostic (4.66e-1)"	"unprognostic (1.25e-3)"	"unprognostic (4.67e-3)"	"unprognostic (2.27e-1)"	"unprognostic (3.70e-3)"	"prognostic unfavorable (1.45e-4)"	"unprognostic (1.59e-1)"	"unprognostic (6.67e-2)"	"unprognostic (1.79e-2)"	"unprognostic (5.93e-3)"	"unprognostic (1.75e-1)"	"unprognostic (3.55e-2)"	"unprognostic (2.28e-1)"	"unprognostic (5.85e-2)"	"unprognostic (2.37e-1)"	"unprognostic (1.44e-3)"	25.3	32.2	21.3	12.1	21.2	9.1	25.1	21.1	32.9	22.6	26.3	24.1	15.5	20.7	20.4	32.1	22.0	20.1	27.3	22.4	23.1	31.8	39.6	23.0	15.4	22.6	22.7	28.0	36.0	20.0	32.6	21.4	25.2	26.1	9.9	3.6	34.2	15.2	17.6	32.6	22.9	12.1	21.7	28.7	25.6	28.3	22.9	13.8	27.1	9.9	10.1	22.0	21.9	22.8	22.8	50.7	18.2	49.9	67.0	57.7	57.0	37.9	78.4	48.6	43.7	24.9	67.4	20.0	118.8	64.7	69.2	74.3	11.0	36.3	9.1	27.7	17.3	8.7	41.2	33.2	59.6	16.0	33.1	65.1	66.9	29.1	25.1	67.1	32.4	26.5	24.5	32.7	36.4	45.0	16.7	37.8	23.5	67.3	50.0	9.7	30.6	63.9	41.6	11.3	20.4	18.3	55.2	55.9	38.7	9.6	63.5	31.5	46.5	69.6	25.9	52.9	43.6	13.0	11.1	13.3	84.6	19.9	61.6	17.9	31.2	27.0	32.4	34.4	30.2	19.1	25.1	30.4	36.0	16.4	24.3	25.0	9.0	31.0	42.2	26.6	34.5	32.1	21.3	21.2	21.1	32.9	22.4	23.1	22.6	22.7	25.2	21.7	22.9	22.8	18.8	19.2	27.3	23.5	18.3	11.6	12.6	33.0	12.0	20.7	23.5	21.7	10.3	14.3	21.5	25.8	16.7	53.2	24.3	39.1	7.9	32.0	5.8	21.5	16.4	19.7	30.5	14.3	13.0	32.0	72.4	26.9	23.4	20.3	21.0	47.8	25.0	25.2	32.1	30.3	10.2	28.1	22.4	22.9	17.4	6.8	21.1	21.8	23.2	11.2	29.3	16.0	16.5	6.6	12.8	27.6	25.0	21.8	25.4	9.0	35.9	15.9	24.9	19.3	13.1	19.4	20.2	16.1	28.4	16.3	16.2	45.4	21.5	41.1	25.6	8.2
MAN1C1	HMIC	ENSG00000117643	"Mannosidase alpha class 1C member 1"	Q9NR34	1	25616791-25786206	"Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins"		"Glycosidase, Hydrolase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Cone photoreceptor cells: 54.2;Excitatory neurons: 72.8;Hepatic stellate cells: 63.9;Hepatocytes: 57.8;Inhibitory neurons: 65.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"naive CD4 T-cell: 4.7"	"Lineage enriched"	"Detected in single"	5	"T-cells: 4.7"	"Cell line enhanced"	"Detected in many"		"AF22: 30.5;HSkMC: 108.9;U-266/70: 31.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA048352	Uncertain		Uncertain	Nucleoplasm,Vesicles		NA	NA		1800000	"Cluster 32: T-cells - Unknown function"	"Cluster 21: Non-specific - Transcription"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 50: Fibroblasts - ECM organization"	"Nucleoplasm, Vesicles"		"HPA048352: AB_2680368"	"unprognostic (2.75e-1)"	"unprognostic (5.45e-3)"	"unprognostic (5.71e-3)"	"unprognostic (2.05e-2)"	"unprognostic (1.95e-1)"	"unprognostic (8.90e-3)"	"unprognostic (4.78e-2)"	"prognostic favorable (7.55e-4)"	"unprognostic (1.80e-1)"	"unprognostic (5.70e-2)"	"prognostic favorable (4.79e-4)"	"unprognostic (2.51e-1)"	"unprognostic (9.09e-3)"	"unprognostic (3.18e-2)"	"unprognostic (7.23e-2)"	"unprognostic (7.44e-2)"	"unprognostic (5.18e-2)"	12.5	11.6	13.3	9.4	15.2	2.2	6.2	16.6	16.1	19.6	27.3	10.0	4.5	14.5	7.5	7.0	9.7	18.6	10.1	15.9	16.9	25.4	29.6	9.2	12.4	45.1	23.2	17.3	3.6	24.0	17.1	21.1	26.1	17.6	4.6	11.0	5.7	17.9	4.6	8.1	6.1	19.9	29.4	19.3	7.3	4.2	16.4	10.5	26.0	5.5	9.4	12.3	9.1	37.8	0.1	0.4	30.5	6.4	22.4	17.2	8.6	0.4	5.8	1.4	0.4	0.6	0.2	0.1	0.3	2.3	3.9	0.4	3.0	0.3	0.6	9.8	1.3	0.6	0.5	0.1	2.6	5.2	12.0	108.9	0.5	0.7	0.0	0.4	0.1	1.2	0.1	1.3	0.0	1.6	0.0	5.8	7.8	0.1	0.2	0.6	18.9	0.6	0.2	0.7	17.7	0.6	0.7	4.7	1.5	5.5	2.4	3.6	0.1	0.0	1.6	20.1	0.7	31.7	0.1	0.1	4.6	10.7	1.5	0.3	0.9	0.4	0.3	0.6	0.5	0.2	2.1	0.9	0.3	0.5	4.7	2.7	0.6	0.4	0.8	0.2	0.5	0.7	13.3	15.2	16.6	16.1	15.9	16.9	45.1	23.2	26.1	29.4	16.4	37.8	5.8	3.2	3.2	18.3	2.0	6.6	2.9	3.6	5.2	23.5	1.1	1.5	7.0	4.3	7.3	22.0	54.2	10.6	1.6	0.5	9.8	1.0	0.3	0.4	8.1	8.4	3.0	2.7	72.8	3.8	0.9	23.3	1.1	0.6	2.5	0.3	63.9	57.8	24.8	21.9	65.8	0.1	16.2	19.0	4.3	2.1	27.1	6.8	1.8	39.4	3.3	17.8	3.1	25.1	21.7	1.4	0.3	22.2	2.2	2.0	0.0	23.3	2.2	4.4	6.6	17.0	7.1	0.2	2.9	1.0	5.3	42.7	6.9	0.7	0.2	1.9
MAN2A1	"GOLIM7, MANA2"	ENSG00000112893	"Mannosidase alpha class 2A member 1"	Q16706	5	109689927-109869625	"Enzymes, Metabolic proteins, Plasma proteins, Predicted membrane proteins"		"Glycosidase, Hydrolase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 107.8"	"Cell type enriched"	"Detected in many"	9	"Oligodendrocytes: 2117.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB022377, HPA026896"	Enhanced		Supported	"Golgi apparatus"		NA	NA		110000000	"Cluster 14: Monocytes - Unknown function"	"Cluster 70: Brain - Nervous system development"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	"Golgi apparatus"		"CAB022377: , HPA026896: AB_1853512"	"unprognostic (1.62e-2)"	"unprognostic (4.06e-2)"	"unprognostic (1.25e-2)"	"unprognostic (6.96e-2)"	"unprognostic (2.52e-1)"	"unprognostic (1.08e-1)"	"unprognostic (5.80e-2)"	"unprognostic (4.20e-2)"	"unprognostic (3.91e-1)"	"unprognostic (2.90e-2)"	"unprognostic (4.73e-2)"	"unprognostic (1.23e-1)"	"unprognostic (6.77e-3)"	"unprognostic (2.03e-2)"	"unprognostic (1.20e-2)"	"unprognostic (1.11e-3)"	"unprognostic (5.31e-3)"	11.2	17.0	28.0	13.9	66.1	12.7	11.3	41.4	29.6	13.8	3.8	20.7	30.1	12.0	4.2	8.5	9.0	18.1	3.7	21.7	31.5	17.4	42.4	10.1	15.8	64.5	49.9	9.8	22.2	20.7	0.9	15.3	62.1	9.1	20.8	1.7	6.5	10.2	6.0	7.4	25.7	18.3	39.4	14.1	15.7	9.5	42.8	22.7	14.7	11.5	14.7	16.1	2.7	107.8	23.1	18.6	26.5	11.0	56.2	42.2	97.5	49.3	78.0	26.1	46.7	23.2	37.0	17.4	30.7	63.3	18.5	26.5	14.5	56.0	59.7	16.3	9.7	32.6	13.5	30.7	34.6	15.9	15.5	39.7	25.0	43.4	61.4	37.3	54.5	16.9	8.8	87.0	70.5	13.8	27.6	9.1	20.4	17.9	7.3	10.8	40.0	78.5	34.1	32.8	3.7	3.3	22.6	24.9	16.1	29.1	20.5	17.1	56.4	53.7	21.3	30.1	32.9	48.7	58.7	13.6	41.8	22.4	30.3	4.1	2.0	0.6	1.6	2.8	1.3	1.9	2.8	2.8	1.8	1.6	3.3	2.7	1.6	0.5	4.4	2.0	2.8	1.1	28.0	66.1	41.4	29.6	21.7	31.5	64.5	49.9	62.1	39.4	42.8	107.8	20.9	6.4	8.4	100.9	41.1	17.8	15.8	12.7	29.6	0.6	20.0	9.5	7.6	34.3	14.7	31.3	0.0	19.4	28.9	65.8	1.9	27.1	13.7	10.2	35.8	21.6	24.7	29.2	220.8	35.3	98.0	32.3	45.3	33.3	15.2	19.2	36.8	130.3	18.0	0.0	115.2	35.2	22.4	74.8	24.6	8.3	9.9	47.4	26.6	102.1	39.6	5.9	13.4	46.8	2117.7	28.8	28.4	6.8	84.0	39.8	60.6	24.7	12.1	0.2	19.7	52.6	16.5	16.5	19.9	33.6	23.7	23.7	34.7	14.2	49.6	24.2
MAN2A2	"HsT19662, MANA2X"	ENSG00000196547	"Mannosidase alpha class 2A member 2"	P49641	15	90902218-90922584	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"		"Glycosidase, Hydrolase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Oligodendrocytes: 92.6;Rod photoreceptor cells: 74.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"basophil: 8.8;neutrophil: 7.9"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in all"		"HEL: 100.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA077930			Approved	"Cytoplasmic bodies"		NA	NA		43000000	"Cluster 38: Basophils - Unknown function"	"Cluster 54: Non-specific - Microtubule organization"	"Cluster 36: HEL - Hemostasis"	"Cluster 46: Photoreceptor cells - Phototransduction"	"Cytoplasmic bodies"		"HPA077930: AB_2732363"	"unprognostic (5.17e-2)"	"unprognostic (9.80e-2)"	"unprognostic (2.43e-2)"	"unprognostic (2.41e-1)"	"unprognostic (2.58e-1)"	"unprognostic (1.86e-2)"	"unprognostic (1.82e-1)"	"unprognostic (1.82e-1)"	"unprognostic (3.41e-1)"	"unprognostic (2.27e-1)"	"unprognostic (5.06e-3)"	"unprognostic (1.09e-2)"	"prognostic unfavorable (8.95e-4)"	"unprognostic (7.55e-3)"	"unprognostic (1.13e-1)"	"unprognostic (8.36e-2)"	"unprognostic (2.33e-2)"	24.8	18.3	29.7	12.8	53.6	78.2	22.9	43.4	38.9	12.3	12.7	18.2	13.3	11.0	9.4	9.2	14.7	9.6	41.7	29.8	36.6	15.1	34.5	22.9	14.1	51.9	47.4	15.8	44.3	13.4	25.0	11.4	53.3	14.3	8.9	74.9	28.1	12.9	61.0	16.8	20.9	7.7	34.7	35.1	24.4	15.4	49.0	12.3	21.9	44.0	9.9	13.3	10.6	85.1	14.4	15.4	9.6	22.3	27.7	7.0	20.2	11.3	9.6	11.9	8.6	13.2	9.6	2.1	24.6	12.0	9.2	16.0	11.0	6.5	6.0	35.2	29.5	100.7	23.8	8.8	8.4	16.4	55.4	5.4	10.9	13.1	9.7	20.2	13.4	26.8	41.7	11.7	4.7	20.4	8.8	30.9	3.2	22.3	5.0	12.5	10.1	13.8	12.1	35.1	25.1	15.6	15.0	24.2	20.3	9.2	11.5	42.5	11.9	8.5	9.3	10.4	12.8	19.6	62.3	5.2	9.8	21.0	14.5	8.8	1.2	0.5	1.0	0.8	0.7	0.8	0.4	0.6	0.2	0.9	0.3	0.3	7.9	0.1	2.9	1.6	1.1	1.4	29.7	53.6	43.4	38.9	29.8	36.6	51.9	47.4	53.3	34.7	49.0	85.1	22.3	12.8	22.6	20.2	5.5	6.0	3.4	2.8	4.0	26.4	9.9	8.8	14.7	12.8	7.7	9.2	27.1	10.0	10.6	12.2	0.0	5.0	9.1	6.6	9.6	9.5	4.2	19.1	27.3	6.5	2.3	7.5	13.3	12.9	15.8	7.1	7.1	22.5	6.0	25.2	26.6	6.4	2.0	13.9	14.1	7.1	6.8	17.9	30.2	11.2	11.7	17.4	3.1	29.7	92.6	3.8	4.3	4.9	6.9	5.3	8.7	2.9	4.5	74.5	13.1	12.0	11.4	12.4	9.6	5.2	4.7	7.5	10.2	1.6	9.3	3.6
MAN2B1	"LAMAN, MANB"	ENSG00000104774	"Mannosidase alpha class 2B member 1"	O00754	19	12646511-12666742	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"		"Glycosidase, Hydrolase"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Macrophages: 32.8;Plasma cells: 78.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in all"	5	"classical monocyte: 201.8;intermediate monocyte: 178.8;myeloid DC: 158.8;non-classical monocyte: 138.4;plasmacytoid DC: 187.5"	"Group enriched"	"Detected in all"	5	"dendritic cells: 187.5;monocytes: 201.8"	"Low cell line specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			"HPA041530, HPA053404"	Supported		Approved	Nucleoplasm,Vesicles	"Intracellular and membrane"	NA	NA		3200000	"Cluster 25: Monocytes - Inflammatory response"	"Cluster 2: Immune cells - Immune response"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 55: Plasma cells - Humoral immune response"	"Nucleoplasm, Vesicles"		"HPA041530: AB_10795639, HPA053404: "	"unprognostic (6.63e-2)"	"unprognostic (3.61e-1)"	"unprognostic (2.20e-2)"	"unprognostic (5.48e-2)"	"unprognostic (3.81e-1)"	"unprognostic (1.04e-1)"	"unprognostic (1.61e-1)"	"unprognostic (1.84e-2)"	"unprognostic (9.55e-2)"	"unprognostic (1.95e-1)"	"unprognostic (2.79e-2)"	"unprognostic (1.50e-1)"	"prognostic unfavorable (1.94e-5)"	"unprognostic (4.00e-1)"	"unprognostic (4.17e-2)"	"unprognostic (2.22e-1)"	"unprognostic (1.51e-1)"	35.8	21.4	5.3	54.6	6.4	83.6	24.8	6.6	5.9	19.6	18.5	30.3	31.0	21.8	9.0	19.8	19.9	28.4	16.0	4.9	7.4	17.3	23.7	46.8	52.1	10.3	6.7	16.7	39.7	16.6	9.9	24.6	9.5	20.5	22.6	1.6	35.2	14.9	12.1	28.9	33.6	20.2	8.9	70.1	32.7	6.4	9.7	23.1	16.3	9.4	39.3	35.6	16.7	12.4	52.4	26.3	26.4	31.3	85.8	57.3	74.0	37.9	79.2	33.1	32.4	21.3	21.4	56.9	44.9	30.4	9.4	40.1	13.6	25.6	15.7	28.5	41.6	19.8	13.6	34.9	43.5	131.6	130.2	68.5	49.2	18.5	23.3	35.6	31.7	21.1	25.6	41.9	17.8	40.9	17.9	74.2	21.9	26.2	32.8	40.8	36.1	28.8	38.9	59.8	8.2	25.5	37.7	32.0	63.0	15.8	49.4	80.0	42.0	44.8	18.4	44.0	36.2	55.4	65.5	28.0	30.4	127.5	51.2	12.2	201.8	29.7	31.9	178.8	35.4	32.9	28.9	29.0	158.8	26.4	15.4	15.9	29.4	13.2	138.4	187.5	30.7	150.3	5.3	6.4	6.6	5.9	4.9	7.4	10.3	6.7	9.5	8.9	9.7	12.4	1.6	6.4	7.5	8.5	25.1	3.6	2.0	2.7	14.2	2.6	1.9	1.0	0.9	2.8	2.0	1.8	0.0	2.5	20.5	2.0	1.9	1.7	3.7	1.4	2.5	3.1	1.8	9.4	7.8	2.3	2.8	7.2	20.9	1.3	1.3	3.4	1.8	0.8	8.4	0.0	6.4	0.9	0.0	15.4	24.7	11.1	3.7	32.8	1.8	17.8	11.0	1.5	9.2	3.5	13.4	1.5	2.5	4.5	78.1	2.5	3.8	1.5	3.9	4.0	13.1	2.3	2.0	0.6	1.6	11.5	3.3	2.7	9.4	2.7	2.0	2.0
MAN2B2	KIAA0935	ENSG00000013288	"Mannosidase alpha class 2B member 2"	Q9Y2E5	4	6575189-6623362	"Enzymes, Metabolic proteins, Plasma proteins, Predicted secreted proteins"		"Glycosidase, Hydrolase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in some"								"Secreted to blood"	NA	NA		15000000	"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 44: Endometrium - Transcription"				"unprognostic (1.30e-1)"	"unprognostic (3.32e-1)"	"unprognostic (1.28e-1)"	"prognostic favorable (7.59e-4)"	"unprognostic (1.09e-1)"	"unprognostic (2.07e-1)"	"unprognostic (1.31e-1)"	"unprognostic (1.57e-1)"	"unprognostic (5.78e-2)"	"unprognostic (3.02e-1)"	"unprognostic (2.38e-2)"	"unprognostic (2.72e-1)"	"unprognostic (6.53e-2)"	"unprognostic (2.55e-1)"	"unprognostic (1.13e-1)"	"unprognostic (2.66e-3)"	"unprognostic (2.18e-1)"	20.0	13.6	12.9	13.8	18.2	14.8	16.4	7.7	14.3	17.6	26.0	14.5	13.4	18.6	14.1	11.3	17.7	15.9	22.6	13.2	15.6	15.1	23.7	18.2	13.5	13.0	13.2	26.6	22.0	9.2	17.9	12.9	11.8	18.0	7.9	5.2	16.7	11.5	4.7	13.6	15.8	10.3	10.6	17.7	20.1	4.4	15.0	9.0	23.2	4.7	8.5	19.3	15.9	11.9	17.5	15.6	2.9	21.0	44.7	30.9	19.7	35.0	40.5	16.8	22.9	9.0	32.3	8.7	16.5	38.2	39.2	17.4	1.0	11.1	9.2	10.4	8.8	11.7	10.9	10.2	19.5	22.0	51.8	41.0	10.9	13.4	3.6	30.3	19.7	10.8	5.1	21.9	22.1	10.8	10.9	13.9	3.8	21.8	11.9	10.7	14.4	10.4	8.8	17.4	5.0	5.5	23.4	13.9	8.9	10.0	27.7	29.1	36.3	30.3	9.1	38.2	22.5	9.0	8.4	4.2	35.4	25.5	26.7	15.4	9.0	14.3	11.7	13.2	8.9	4.2	7.0	10.7	8.6	4.4	6.3	8.2	11.0	6.8	17.5	3.3	10.7	11.0	12.9	18.2	7.7	14.3	13.2	15.6	13.0	13.2	11.8	10.6	15.0	11.9	9.8	16.0	18.9	7.8	11.6	5.0	5.5	4.9	11.4	8.9	8.2	5.6	17.0	20.0	11.1	11.0	6.2	13.5	12.9	18.3	1.9	9.7	0.6	18.7	15.8	8.2	7.8	5.7	9.4	10.7	10.2	18.4	11.7	36.8	10.8	11.1	17.5	44.1	20.9	10.1	8.3	11.0	2.0	30.2	8.2	1.1	19.6	18.0	3.6	8.4	11.2	13.0	5.2	6.0	8.9	10.1	9.0	24.5	15.1	7.1	11.7	4.2	9.5	7.4	13.1	7.5	8.5	1.1	0.6	8.0	3.8	8.5	15.6	4.4	8.9	4.6
MAN2C1	"MANA, MANA1"	ENSG00000140400	"Mannosidase alpha class 2C member 1"	Q9NTJ4	15	75355207-75368612	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Glycosidase, Hydrolase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA040627, HPA067407"	Uncertain		Enhanced	Nucleoplasm		NA	NA		110000	"Cluster 7: Monocytes - Unknown function"	"Cluster 72: Non-specific - Transcription"	"Cluster 15: RT4 - Unknown function"	"Cluster 52: Non-specific - Transcription"	Nucleoplasm		"HPA040627: AB_10795490, HPA067407: AB_2685834"	"unprognostic (4.68e-2)"	"unprognostic (1.95e-1)"	"unprognostic (3.84e-3)"	"unprognostic (3.48e-2)"	"unprognostic (3.85e-1)"	"unprognostic (3.00e-2)"	"unprognostic (1.26e-2)"	"unprognostic (6.26e-2)"	"unprognostic (2.47e-1)"	"unprognostic (5.02e-2)"	"unprognostic (1.06e-2)"	"unprognostic (3.40e-2)"	"unprognostic (4.87e-3)"	"unprognostic (9.56e-2)"	"unprognostic (1.33e-1)"	"unprognostic (2.91e-1)"	"unprognostic (1.39e-3)"	49.3	66.1	20.2	23.9	21.1	37.6	49.3	17.7	28.8	52.1	18.6	41.8	25.5	49.3	12.1	29.9	50.5	16.4	55.6	20.0	17.8	52.8	50.0	50.3	20.3	22.8	18.1	58.5	49.1	26.3	56.6	21.1	20.9	49.4	14.9	14.8	37.3	19.5	58.5	36.8	41.6	18.6	17.5	54.7	46.0	34.8	19.8	17.1	64.8	24.5	12.7	45.7	41.5	22.0	11.0	25.5	21.3	15.7	23.8	20.4	27.1	25.3	23.5	12.9	10.9	20.3	38.3	5.7	14.6	18.6	11.8	33.0	11.7	17.1	8.4	30.8	26.1	34.0	58.5	18.1	35.3	23.1	5.7	25.3	17.0	12.3	15.3	27.3	30.9	16.9	20.5	27.4	10.7	22.1	11.9	25.2	9.0	13.2	11.8	16.0	11.0	34.6	16.8	49.8	13.2	22.7	16.4	23.9	11.5	15.6	26.1	26.1	61.5	27.1	18.7	19.0	25.5	27.9	7.1	9.3	17.6	25.9	27.6	4.0	19.8	3.5	9.2	23.0	9.1	3.2	6.9	6.8	22.6	2.6	9.5	6.9	2.2	6.0	18.9	9.2	10.2	14.3	20.2	21.1	17.7	28.8	20.0	17.8	22.8	18.1	20.9	17.5	19.8	22.0	34.1	22.4	51.7	29.0	12.5	13.5	15.2	13.0	11.4	30.7	18.2	16.3	2.8	5.7	19.2	9.2	54.2	17.2	17.2	22.4	3.9	11.4	10.4	10.1	18.3	23.2	34.2	7.6	28.9	8.7	10.9	20.4	39.3	12.7	31.7	46.8	32.5	22.4	20.4	28.6	23.8	19.5	12.2	29.8	20.2	14.0	23.3	26.3	16.0	15.0	31.4	17.3	19.6	18.1	19.5	11.2	20.0	12.4	12.9	16.0	27.9	15.9	19.3	52.4	26.3	25.6	16.3	21.1	10.4	14.9	8.5	21.2	16.2	17.0	24.0	15.3
MANBA		ENSG00000109323	"Mannosidase beta"	O00462	4	102630770-102760994	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"		"Glycosidase, Hydrolase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Macrophages: 74.0;Microglial cells: 111.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"eosinophil: 16.6"	"Group enriched"	"Detected in many"	5	"dendritic cells: 5.3;granulocytes: 16.6;monocytes: 9.1"	"Cell line enhanced"	"Detected in many"		"ASC diff: 15.5;hTCEpi: 13.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA053478	Approved		Supported	Vesicles		NA	NA		15000000	"Cluster 49: Eosinophils - Unknown function"	"Cluster 72: Non-specific - Transcription"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 57: B-cells - Immune response"	Vesicles		"HPA053478: AB_2682165"	"unprognostic (2.29e-2)"	"unprognostic (1.40e-1)"	"unprognostic (3.80e-1)"	"unprognostic (1.70e-1)"	"prognostic unfavorable (7.56e-5)"	"unprognostic (4.11e-2)"	"prognostic unfavorable (3.74e-6)"	"unprognostic (1.32e-1)"	"unprognostic (2.19e-1)"	"unprognostic (4.87e-2)"	"unprognostic (7.78e-2)"	"unprognostic (1.44e-2)"	"unprognostic (1.33e-1)"	"unprognostic (1.75e-2)"	"unprognostic (7.12e-2)"	"unprognostic (4.81e-2)"	"unprognostic (2.13e-1)"	7.1	12.4	1.9	1.5	2.4	7.0	6.4	4.7	2.2	6.5	2.2	6.7	1.6	6.1	0.2	3.8	6.3	1.3	6.6	1.1	2.1	4.8	4.7	10.5	2.1	3.8	2.9	8.8	8.3	3.0	5.0	3.7	4.7	4.3	1.1	2.7	8.9	2.0	3.0	4.5	8.5	2.4	3.0	12.0	9.1	1.6	3.5	1.2	7.1	0.1	2.0	8.1	5.8	3.7	2.9	1.4	0.6	1.6	15.5	12.1	0.9	1.1	6.9	1.8	4.1	1.7	1.0	3.6	1.4	2.7	3.9	1.0	3.0	2.2	1.1	2.2	0.7	3.0	1.1	0.7	2.7	2.8	8.2	3.7	13.7	7.6	3.4	8.9	3.0	1.2	3.6	2.0	3.4	1.4	2.0	2.3	1.3	1.9	1.1	1.9	1.6	0.6	3.4	2.3	1.4	0.5	1.4	1.9	1.5	5.4	4.5	1.8	0.2	2.0	1.3	9.3	1.2	1.3	5.8	0.5	3.1	1.5	1.6	4.0	6.8	16.6	0.4	6.1	0.7	1.7	0.0	0.7	5.3	2.1	0.4	0.6	6.1	1.8	9.1	1.2	0.5	3.1	1.9	2.4	4.7	2.2	1.1	2.1	3.8	2.9	4.7	3.0	3.5	3.7	6.4	32.1	35.6	24.5	45.4	5.9	8.4	13.2	12.0	6.2	11.6	8.1	14.6	14.3	13.5	9.2	6.2	42.3	14.3	5.1	1.9	8.1	2.8	6.9	6.9	8.1	1.8	19.7	36.4	2.7	7.3	13.8	25.5	12.8	34.8	5.5	10.4	17.7	43.6	6.7	66.5	10.5	2.0	58.5	29.6	1.6	9.0	74.0	0.0	111.5	52.8	5.2	17.5	31.2	66.8	5.5	17.3	19.9	17.5	7.5	5.2	9.8	5.8	7.5	0.0	10.8	6.7	0.2	1.4	12.6	4.5	22.6	16.9	12.6	11.2	9.7
MANEA	"FLJ12838, mandaselin"	ENSG00000172469	"Mannosidase endo-alpha"	Q5SRI9	6	95577535-95609452	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"		Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Hepatocytes: 59.8;Plasma cells: 113.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA011046, HPA011069"	Enhanced		Supported	"Golgi apparatus"		NA	NA		140000	"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 1: Thyroid gland - Transcription"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 55: Plasma cells - Humoral immune response"	"Golgi apparatus"		"HPA011046: AB_1079303, HPA011069: AB_1079304"	"unprognostic (6.00e-2)"	"unprognostic (7.81e-2)"	"prognostic favorable (3.04e-4)"	"unprognostic (1.17e-2)"	"unprognostic (1.11e-1)"	"unprognostic (5.03e-2)"	"unprognostic (2.98e-3)"	"unprognostic (2.74e-1)"	"unprognostic (5.71e-2)"	"unprognostic (1.30e-1)"	"unprognostic (2.44e-1)"	"unprognostic (9.07e-2)"	"unprognostic (2.86e-3)"	"unprognostic (5.18e-2)"	"unprognostic (3.08e-1)"	"unprognostic (9.68e-2)"	"unprognostic (7.47e-2)"	11.9	6.9	3.1	7.9	3.6	3.3	8.9	3.7	3.7	8.4	4.2	8.1	8.8	6.8	6.3	8.0	6.4	7.9	5.6	2.5	3.7	12.0	24.0	7.3	9.2	4.3	3.3	9.7	8.4	11.1	2.1	6.3	4.4	7.0	8.7	6.1	5.6	7.9	1.4	6.8	8.8	6.7	3.6	9.6	12.1	6.1	3.7	9.1	11.6	3.4	11.2	9.0	3.5	5.6	6.5	5.3	20.4	16.6	33.1	38.5	7.7	17.7	16.2	10.1	14.8	6.1	16.0	12.3	21.7	11.7	14.9	10.4	14.1	12.0	23.2	20.9	12.6	16.6	4.7	10.2	11.5	22.3	14.4	38.4	13.7	12.0	8.5	14.6	24.3	12.1	26.2	28.1	22.0	4.5	13.1	9.5	3.0	17.1	5.5	15.4	19.9	18.8	15.5	11.2	16.3	8.8	10.0	7.2	6.5	14.3	11.4	20.7	22.0	10.1	7.1	18.4	17.8	20.9	12.9	15.2	18.2	19.1	23.6	8.5	2.3	1.3	3.2	4.1	4.6	4.5	3.9	3.8	2.5	2.3	4.5	3.1	0.5	2.9	3.7	1.0	7.7	2.4	3.1	3.6	3.7	3.7	2.5	3.7	4.3	3.3	4.4	3.6	3.7	5.6	11.6	12.8	8.4	7.8	15.5	7.4	4.4	6.4	8.6	8.1	8.4	7.4	4.5	10.0	7.4	12.9	4.2	5.4	5.4	1.8	5.9	4.1	16.7	7.3	14.4	10.7	1.8	8.2	6.0	7.3	5.6	12.0	8.2	8.1	2.5	17.8	28.2	59.8	11.0	11.8	7.3	4.6	0.0	12.0	5.8	11.7	5.9	7.9	8.8	8.4	6.8	10.5	3.1	16.1	18.7	3.4	2.8	15.8	113.4	3.4	4.8	8.5	8.5	5.3	13.1	9.8	17.1	7.1	12.1	11.8	7.0	1.4	9.2	13.5	5.0	3.5
MASP2	MASP1P1	ENSG00000009724	"Mannan binding lectin serine peptidase 2"	O00187	1	11026523-11047239	"Disease related genes, Enzymes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted secreted proteins"	"Complement pathway, Immunity, Innate immunity"	"Hydrolase, Protease, Serine protease"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	64	"liver: 476.5"	"Cell type enriched"	"Detected in some"	52	"Hepatocytes: 658.6"	"Cancer enriched"	"Detected in some"	71	"liver cancer: 41.9"	"Region enriched"	"Detected in single"	9	"cerebellum: 6.4"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	6	"Hep G2: 16.4"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA029313, HPA029314"	Uncertain		Supported	"Golgi apparatus"	"Secreted to blood"	NA	NA	340000000	820000000		"Cluster 62: Liver - Hemostasis"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 2: Hepatocytes - Metabolism"	"Golgi apparatus"		"HPA029313: AB_10669654, HPA029314: AB_10670029"	"unprognostic (7.00e-2)"	"unprognostic (8.37e-2)"	"unprognostic (2.75e-2)"	"unprognostic (2.89e-1)"	"unprognostic (1.86e-1)"	"unprognostic (3.26e-3)"	"prognostic favorable (1.60e-4)"	"unprognostic (2.92e-3)"	"unprognostic (3.13e-2)"	"unprognostic (4.04e-2)"	"unprognostic (6.90e-3)"	"unprognostic (8.30e-4)"	"unprognostic (7.14e-2)"	"unprognostic (3.91e-1)"	"unprognostic (2.62e-2)"	"unprognostic (1.05e-1)"	"unprognostic (1.09e-4)"	2.1	1.2	0.0	1.7	0.0	7.4	2.2	6.4	0.7	2.4	0.0	2.7	1.6	2.8	0.0	1.2	2.7	1.2	1.3	0.1	0.0	1.0	476.5	1.8	2.7	0.0	0.0	2.9	2.9	0.0	2.3	0.6	0.2	1.6	0.0	6.9	2.5	0.0	5.1	5.3	3.4	0.0	0.0	2.5	2.4	1.5	0.0	0.0	1.9	0.0	0.0	2.1	1.6	0.4	0.5	0.3	2.6	1.6	0.0	0.1	0.4	0.7	0.0	0.0	0.0	1.2	1.0	2.3	0.6	0.0	0.5	0.7	0.0	0.0	0.0	0.6	2.3	1.3	2.7	16.4	0.0	2.0	1.5	0.0	0.0	0.1	0.0	1.8	0.0	1.7	0.7	0.5	0.0	0.5	0.6	1.1	0.3	0.2	0.7	1.6	0.9	0.6	0.0	1.3	1.7	0.7	0.9	0.4	0.4	1.6	0.6	1.2	1.2	0.9	0.5	0.8	0.5	0.5	0.9	1.5	0.5	1.7	0.4	0.1	0.0	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	6.4	0.7	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.4	0.0	0.0	0.0	4.6	1.1	0.9	0.2	0.0	0.6	0.2	0.2	0.0	0.5	4.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.9	0.0	5.3	9.5	0.0	0.0	0.1	0.0	0.1	1.3	0.0	8.2	658.6	0.1	0.0	8.3	0.0	0.0	12.6	0.3	0.0	0.0	0.0	1.8	1.9	0.0	0.1	0.0	8.0	10.4	0.0	0.0	0.0	0.0	0.2	0.0	0.5	0.7	0.4	0.0	0.7	0.2	0.0	0.0	0.4	0.6	0.0	0.8	0.1	0.0	0.1
MBTPS1	"KIAA0091, PCSK8, S1P, SKI-1"	ENSG00000140943	"Membrane bound transcription factor peptidase, site 1"	Q14703	16	84053761-84116942	"Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Cholesterol metabolism, Lipid metabolism, Steroid metabolism, Sterol metabolism"	"Hydrolase, Protease, Serine protease"	"Disease variant, Dwarfism"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Rod photoreceptor cells: 318.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA056109	Supported					NA	NA			"Cluster 22: NK-cells - Unknown function"	"Cluster 77: Retina - Visual perception"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 46: Photoreceptor cells - Phototransduction"			"HPA056109: AB_2683040"	"unprognostic (1.50e-1)"	"unprognostic (9.73e-2)"	"unprognostic (1.58e-1)"	"unprognostic (3.10e-3)"	"unprognostic (1.20e-1)"	"unprognostic (1.20e-1)"	"unprognostic (2.50e-1)"	"unprognostic (2.02e-1)"	"unprognostic (1.47e-1)"	"unprognostic (1.59e-1)"	"unprognostic (1.00e-2)"	"unprognostic (2.19e-1)"	"prognostic favorable (2.21e-5)"	"unprognostic (2.62e-1)"	"unprognostic (2.92e-1)"	"unprognostic (6.63e-2)"	"unprognostic (6.88e-2)"	45.8	33.7	12.7	26.2	16.4	24.6	42.8	17.6	13.3	41.2	18.1	38.7	26.0	40.8	25.6	28.2	45.6	32.2	44.6	13.1	17.8	36.7	27.5	35.5	27.5	6.3	8.0	49.4	36.4	58.5	38.8	37.1	8.9	37.3	33.7	108.7	42.4	40.3	18.9	27.8	26.4	41.2	5.9	30.1	30.7	19.6	16.5	33.4	53.9	35.6	29.9	35.2	21.3	8.6	49.4	61.3	53.8	75.2	124.2	100.1	42.2	81.2	124.4	70.2	52.6	43.7	71.0	47.0	82.0	117.3	55.8	52.9	50.2	56.3	77.9	42.6	55.9	34.4	55.8	61.3	59.9	84.2	72.7	103.6	79.9	64.8	55.5	100.3	92.4	62.2	45.6	40.3	43.1	85.0	46.6	46.4	50.3	27.7	43.2	59.6	28.7	34.1	56.1	40.2	41.0	51.2	156.9	42.9	62.1	58.3	134.3	76.4	99.0	72.3	52.5	43.7	38.7	50.5	102.6	90.5	52.6	50.6	45.2	8.0	16.3	15.0	16.3	13.8	16.8	11.3	14.0	15.4	12.8	9.6	16.9	15.3	4.5	17.0	11.6	7.1	9.6	18.3	12.7	16.4	17.6	13.3	13.1	17.8	6.3	8.0	8.9	5.9	16.5	8.6	54.3	48.1	50.7	27.1	33.5	13.8	24.2	25.9	19.9	68.4	62.2	56.1	50.5	44.3	41.9	25.8	166.8	24.4	41.0	28.9	11.7	24.1	0.9	70.4	67.8	39.8	34.9	19.4	50.4	27.5	21.4	48.4	23.0	92.7	29.1	103.1	36.0	33.8	16.7	84.1	53.5	26.6	28.5	21.0	10.8	5.5	53.4	23.3	19.6	36.5	22.5	44.4	29.9	57.8	39.0	30.2	24.8	50.4	59.3	30.1	20.3	17.5	56.4	318.6	26.3	60.9	42.2	12.6	24.2	23.4	15.8	21.6	34.3	75.5	33.8	28.6
MBTPS2	"KFSD, S2P"	ENSG00000012174	"Membrane bound transcription factor peptidase, site 2"	O43462	X	21839617-21885423	"Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted membrane proteins"	"Cholesterol metabolism, Lipid metabolism, Steroid metabolism, Sterol metabolism"	"Hydrolase, Metalloprotease, Protease"	"Disease variant, Ichthyosis, Osteogenesis imperfecta, Palmoplantar keratoderma"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA005494, CAB009486"	Approved		Approved	Nucleoplasm,Mitochondria,Cytosol		NA	NA			"Cluster 39: Non-specific - mRNA processing"	"Cluster 85: Liver - Metabolism"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 52: Non-specific - Transcription"	"Nucleoplasm, Mitochondria, Cytosol"		"CAB009486: AB_2140370, HPA005494: AB_1079329"	"unprognostic (7.97e-3)"	"unprognostic (9.12e-2)"	"unprognostic (5.38e-2)"	"unprognostic (1.18e-2)"	"unprognostic (2.65e-1)"	"unprognostic (1.50e-1)"	"unprognostic (1.85e-1)"	"unprognostic (7.22e-2)"	"unprognostic (3.32e-1)"	"unprognostic (9.30e-2)"	"unprognostic (1.99e-1)"	"unprognostic (1.77e-1)"	"unprognostic (8.38e-2)"	"unprognostic (7.76e-2)"	"unprognostic (1.07e-1)"	"unprognostic (3.61e-1)"	"unprognostic (3.05e-2)"	8.6	10.6	3.5	5.2	4.0	1.7	8.8	7.8	4.9	7.5	4.5	5.1	5.2	9.7	6.0	5.8	7.3	6.7	7.7	3.7	4.1	9.4	18.7	5.5	5.0	4.4	4.1	12.5	7.3	11.0	3.8	11.6	4.9	10.5	6.0	8.8	6.6	8.5	7.1	3.7	4.2	10.1	4.1	4.8	5.8	4.1	4.2	4.9	9.0	9.1	4.7	6.8	4.0	6.1	16.9	34.5	16.1	16.5	19.8	24.4	7.7	24.4	24.7	22.7	19.7	13.8	22.5	14.6	12.4	26.2	44.4	15.4	22.4	14.0	27.9	10.9	17.8	7.2	19.7	11.4	27.1	15.6	6.8	23.2	14.8	34.3	25.1	23.0	17.8	8.4	20.3	15.8	26.1	10.5	6.4	8.1	15.0	8.8	25.1	7.9	29.8	16.4	15.7	8.4	3.9	32.8	34.3	21.5	30.5	21.3	28.9	13.2	21.2	28.4	6.6	41.9	18.5	19.1	26.0	6.9	31.6	6.4	28.0	0.0	2.2	0.8	2.2	2.5	2.0	1.9	1.6	2.0	3.6	1.7	2.2	2.6	0.2	2.6	2.6	2.4	3.2	1.7	3.5	4.0	7.8	4.9	3.7	4.1	4.4	4.1	4.9	4.1	4.2	6.1	5.5	9.6	11.5	16.6	5.8	5.5	4.8	7.0	8.0	11.8	7.5	5.1	13.3	8.6	7.1	7.3	18.8	7.0	2.2	3.8	0.0	5.9	0.3	4.0	11.5	5.6	2.4	2.1	16.8	8.9	7.1	10.8	6.1	3.7	10.8	14.5	7.5	18.7	9.4	30.3	25.0	3.4	12.2	9.2	4.0	1.9	10.5	4.8	10.6	11.2	5.0	7.3	3.1	21.6	22.2	6.1	2.4	13.2	9.1	7.4	4.9	7.2	10.7	14.5	0.0	8.6	8.3	2.7	1.5	6.5	2.7	4.8	5.1	12.3	4.3	4.9
MCM2	"BM28, CCNL1, cdc19, CDCL1, D3S3194, DFNA70, KIAA0030"	ENSG00000073111	"Minichromosome maintenance complex component 2"	P49736	3	127598410-127622436	"Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Cell cycle, DNA replication"	"DNA-binding, Helicase, Hydrolase"	"Cancer-related genes, Deafness, Disease variant, Non-syndromic deafness"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 67.7;lymphoid tissue: 37.6"	"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 63.3;Erythroid cells: 65.6;Extravillous trophoblasts: 28.8;Spermatogonia: 25.9;Syncytiotrophoblasts: 33.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in some"			"CAB000303, HPA031450, HPA031495, HPA031496"	Enhanced		Enhanced	Nucleoplasm		Yes	Yes		120000	"Cluster 43: B-cells - Humoral immune response"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	Nucleoplasm		"CAB000303: AB_322519, HPA031450: , HPA031495: AB_2673904, HPA031496: AB_2673905"	"unprognostic (2.43e-1)"	"prognostic favorable (4.66e-4)"	"unprognostic (4.44e-2)"	"unprognostic (3.12e-3)"	"unprognostic (1.68e-1)"	"unprognostic (2.25e-2)"	"prognostic unfavorable (1.51e-7)"	"unprognostic (8.43e-3)"	"unprognostic (1.92e-2)"	"unprognostic (1.79e-1)"	"unprognostic (1.41e-3)"	"unprognostic (1.21e-2)"	"unprognostic (1.16e-2)"	"unprognostic (8.16e-3)"	"unprognostic (1.56e-1)"	"unprognostic (3.29e-2)"	"unprognostic (2.82e-1)"	3.1	3.4	2.0	16.4	1.9	67.7	6.2	2.5	1.9	5.3	0.6	9.2	8.1	5.0	2.4	11.0	7.6	2.5	6.4	1.9	1.8	3.4	6.3	3.4	26.8	2.3	1.9	6.4	3.0	3.7	2.4	17.0	2.6	5.0	10.2	3.5	4.7	2.8	9.4	10.6	8.6	5.3	2.0	9.6	5.7	12.3	2.0	37.6	4.8	5.8	26.0	4.2	5.4	2.4	133.6	110.3	122.4	102.1	7.0	14.4	110.5	65.2	42.3	129.9	146.9	177.7	84.7	136.0	65.2	32.3	113.6	105.6	204.8	76.1	79.1	127.2	127.1	227.4	134.8	131.1	4.4	214.3	102.4	8.2	8.4	86.1	13.1	15.3	40.6	160.7	116.0	123.7	47.4	169.0	229.0	156.2	172.5	108.3	90.7	242.4	165.1	203.3	26.9	97.9	143.0	106.8	175.8	48.9	16.7	45.7	111.9	165.3	20.3	104.2	87.9	128.4	91.7	127.1	163.5	362.6	73.2	159.7	41.0	0.0	0.6	0.3	4.4	1.4	5.5	9.7	3.9	5.4	2.9	8.1	3.6	4.7	0.9	6.5	0.4	3.7	11.2	3.5	2.0	1.9	2.5	1.9	1.9	1.8	2.3	1.9	2.6	2.0	2.0	2.4	1.2	3.2	2.0	0.7	8.5	4.6	2.6	4.6	2.2	2.5	4.1	5.3	8.3	0.0	3.9	0.0	0.0	63.3	1.8	4.8	0.0	5.3	0.9	5.2	3.5	2.9	3.6	65.6	0.3	1.9	28.8	4.2	6.6	4.8	1.3	18.8	1.4	1.7	18.2	0.0	0.4	8.2	0.0	1.6	3.2	0.7	1.8	2.7	1.8	0.0	9.2	2.1	0.0	0.0	0.7	2.1	1.7	1.5	20.5	0.8	1.1	0.8	7.4	2.1	0.0	2.6	4.1	8.1	25.9	7.1	3.0	33.5	6.3	3.8	13.8	2.3
MCM3		ENSG00000112118	"Minichromosome maintenance complex component 3"	P25205	6	52264014-52284881	"Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins"	"Cell cycle, DNA replication"	"DNA-binding, Helicase, Hydrolase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 122.7;Erythroid cells: 92.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB002162, HPA004789, HPA004790"	Supported		Supported	Nucleoplasm		NA	Yes		150000	"Cluster 35: T-regs - Unknown function"	"Cluster 63: T-cells - Adaptive immune response"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	Nucleoplasm		"CAB002162: AB_564115, HPA004789: AB_1079336, HPA004790: AB_1079335"	"unprognostic (9.14e-2)"	"prognostic favorable (1.89e-4)"	"unprognostic (2.37e-1)"	"unprognostic (1.53e-2)"	"unprognostic (2.14e-1)"	"unprognostic (5.48e-3)"	"prognostic unfavorable (1.40e-4)"	"unprognostic (1.36e-1)"	"prognostic unfavorable (4.40e-5)"	"unprognostic (1.01e-3)"	"unprognostic (2.96e-2)"	"unprognostic (1.15e-1)"	"unprognostic (8.35e-2)"	"unprognostic (1.16e-2)"	"unprognostic (1.00e-1)"	"prognostic favorable (3.13e-5)"	"unprognostic (1.34e-2)"	24.3	15.9	12.8	41.5	13.6	55.5	29.1	13.7	13.7	27.5	13.4	32.9	19.6	30.8	23.8	33.4	29.2	16.4	25.4	11.9	12.7	27.5	18.8	21.4	68.8	14.1	13.6	31.9	17.0	28.9	10.8	40.0	14.1	19.7	39.3	19.3	19.2	30.7	16.0	32.2	29.3	37.0	14.5	31.3	24.1	21.1	14.0	81.1	18.3	17.7	78.5	28.1	24.5	13.9	187.9	121.7	208.0	196.9	43.9	39.4	136.1	135.8	103.7	226.6	230.3	251.6	99.2	202.8	132.5	79.7	147.8	145.4	277.4	165.9	226.9	230.0	261.4	383.6	233.2	358.2	11.8	381.7	150.8	23.7	38.1	166.6	46.2	55.6	117.3	240.4	318.1	452.9	118.3	123.8	386.9	293.5	173.1	369.8	84.8	338.3	317.0	271.2	101.1	195.8	210.3	160.5	142.2	81.1	125.3	289.4	159.7	266.9	60.5	153.5	163.6	160.8	206.4	132.9	163.5	356.4	132.2	323.8	184.0	30.5	18.3	27.3	50.0	31.3	42.8	47.7	49.9	50.3	30.0	41.2	47.6	51.2	2.6	55.0	18.3	19.0	71.6	46.9	12.8	13.6	13.7	13.7	11.9	12.7	14.1	13.6	14.1	14.5	14.0	13.9	24.3	22.4	12.3	3.3	26.4	19.2	20.0	24.9	12.5	16.1	14.1	17.1	19.9	7.2	19.2	22.0	4.2	122.7	18.6	10.9	13.7	30.9	1.1	9.6	16.7	30.9	7.3	92.6	2.5	20.2	63.6	22.3	15.8	15.1	37.4	48.3	15.0	10.5	36.0	0.0	2.1	20.4	8.2	10.1	7.5	3.6	27.1	12.1	7.2	8.4	12.5	17.8	34.0	2.5	6.1	17.3	10.5	21.1	37.6	10.9	7.3	7.5	17.0	16.0	6.6	16.8	27.9	22.5	64.0	24.5	10.1	27.4	26.0	19.0	37.1	13.9
MCM4	"CDC21, CDC54, hCdc21, MGC33310, P1-Cdc21"	ENSG00000104738	"Minichromosome maintenance complex component 4"	P33991	8	47960185-47978160	"Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins"	"Cell cycle, DNA replication"	"DNA-binding, Helicase, Hydrolase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 63.2"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 153.2;Erythroid cells: 60.8;Late spermatids: 77.9;Spermatocytes: 65.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004497, HPA004873, HPA031052"	Enhanced		Enhanced	Nucleoplasm		NA	Yes		140000	"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	Nucleoplasm		"CAB004497: AB_627916, HPA004873: AB_1079337, HPA031052: AB_2673712"	"unprognostic (4.55e-2)"	"unprognostic (3.16e-3)"	"prognostic favorable (2.19e-4)"	"prognostic unfavorable (2.84e-5)"	"unprognostic (7.71e-2)"	"unprognostic (1.05e-1)"	"prognostic unfavorable (1.23e-4)"	"unprognostic (1.12e-3)"	"prognostic unfavorable (1.15e-4)"	"unprognostic (2.65e-2)"	"prognostic unfavorable (2.38e-4)"	"unprognostic (5.16e-2)"	"prognostic unfavorable (2.61e-4)"	"unprognostic (3.53e-2)"	"unprognostic (2.90e-1)"	"unprognostic (1.70e-2)"	"unprognostic (1.40e-1)"	6.5	8.8	4.8	21.7	4.8	63.2	16.0	5.7	5.2	7.7	1.8	17.7	13.3	6.9	4.6	22.4	9.7	5.6	14.5	5.2	3.5	8.2	9.2	6.3	38.7	3.6	4.2	7.1	5.5	7.7	4.1	18.3	3.9	5.6	21.3	12.3	8.8	4.9	13.4	24.2	16.7	9.2	4.2	8.1	10.6	41.6	4.8	47.0	6.5	15.8	41.8	11.8	10.9	5.2	184.0	139.6	188.1	83.2	20.7	36.6	102.8	122.6	99.8	178.5	190.3	156.6	181.1	229.8	70.3	72.1	119.2	143.2	278.7	128.2	199.8	64.2	190.4	371.8	133.3	169.2	5.4	189.7	82.0	20.3	24.1	147.8	54.3	28.6	72.0	136.8	216.2	167.0	129.9	155.6	435.5	141.5	241.2	246.5	54.2	266.6	159.6	139.2	64.9	168.1	209.0	97.8	325.6	133.6	46.3	117.7	154.9	110.5	45.1	138.1	125.4	144.5	131.9	54.7	104.6	347.2	114.8	185.7	131.5	2.3	1.8	1.1	4.0	3.1	2.0	3.9	3.8	5.4	3.9	1.6	3.3	2.7	0.1	4.1	3.5	1.5	10.2	3.6	4.8	4.8	5.7	5.2	5.2	3.5	3.6	4.2	3.9	4.2	4.8	5.2	3.3	0.0	6.3	3.3	6.5	21.7	11.1	9.0	13.6	12.2	9.0	7.7	25.1	1.5	8.4	5.5	10.4	36.7	5.8	12.1	3.9	8.0	153.2	11.0	7.9	6.7	6.7	60.8	5.0	6.0	40.2	10.6	11.2	13.4	1.3	24.9	2.2	3.2	12.3	16.8	5.7	13.9	4.1	2.9	6.5	77.9	5.3	7.9	3.6	1.9	2.4	7.0	3.1	4.0	2.9	4.5	4.8	3.0	22.3	7.7	5.6	3.0	13.1	16.7	0.0	9.5	11.4	65.8	39.9	19.1	19.0	29.8	9.0	11.7	26.2	9.7
MCM5	CDC46	ENSG00000100297	"Minichromosome maintenance complex component 5"	P33992	22	35400134-35425431	"Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Cell cycle, DNA replication"	"DNA-binding, Helicase, Hydrolase"	"Cancer-related genes, Disease variant, Dwarfism"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 138.7"	"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 147.8;Erythroid cells: 96.6;monocytes: 137.7;Syncytiotrophoblasts: 82.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB000101, HPA000845, HPA052880"	Enhanced		Enhanced	Nucleoplasm		Yes	Yes		44000	"Cluster 23: Antigen presenting cells - Antigen presentation"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	Nucleoplasm		"CAB000101: AB_2235163, HPA000845: AB_1079338, HPA052880: AB_2681979"	"unprognostic (6.71e-2)"	"prognostic favorable (2.81e-6)"	"unprognostic (5.29e-3)"	"unprognostic (7.94e-2)"	"unprognostic (1.83e-2)"	"unprognostic (1.46e-2)"	"prognostic unfavorable (1.78e-4)"	"prognostic unfavorable (3.95e-4)"	"unprognostic (1.29e-1)"	"unprognostic (3.34e-2)"	"unprognostic (1.37e-1)"	"unprognostic (8.07e-2)"	"prognostic unfavorable (3.58e-5)"	"unprognostic (3.26e-2)"	"unprognostic (1.01e-1)"	"unprognostic (1.77e-3)"	"unprognostic (1.53e-1)"	15.2	7.1	5.8	49.1	10.4	138.7	14.4	8.3	7.4	14.5	5.8	20.2	19.6	16.3	3.3	25.1	13.7	9.6	8.9	5.8	7.0	9.1	14.9	14.8	70.1	10.3	7.7	25.6	12.6	10.3	5.3	25.2	9.6	10.2	16.7	2.3	13.9	9.6	13.3	17.6	28.3	12.2	8.1	47.3	17.9	20.6	9.0	58.9	12.1	8.0	53.6	12.7	15.6	12.3	213.0	147.5	115.7	118.8	11.0	22.2	100.6	138.1	71.2	199.4	188.3	98.9	102.4	137.9	78.8	70.5	83.6	103.8	116.0	108.3	64.4	112.7	212.6	198.3	141.5	203.7	3.9	414.0	172.4	12.3	9.7	120.0	32.4	18.4	88.7	124.5	124.0	201.2	76.9	172.7	341.8	137.9	154.9	143.4	86.7	379.6	164.8	173.0	39.4	120.1	88.2	94.8	188.3	75.4	41.8	60.9	78.8	155.6	54.1	201.3	153.1	127.2	145.4	111.9	150.2	265.2	130.9	153.5	157.6	66.5	59.8	43.4	49.5	69.6	35.8	127.5	43.1	53.1	77.8	106.1	34.0	39.0	28.4	65.5	81.2	88.8	96.6	77.1	5.8	10.4	8.3	7.4	5.8	7.0	10.3	7.7	9.6	8.1	9.0	12.3	8.1	6.4	7.3	1.3	49.5	10.6	13.6	12.1	8.6	1.5	9.2	10.8	3.5	8.6	6.0	7.3	0.0	147.8	30.4	12.0	5.9	19.8	2.8	6.2	4.1	11.8	3.5	96.6	0.3	12.7	77.1	11.2	18.8	9.0	15.2	65.7	13.2	5.3	53.1	1.7	0.4	16.6	4.1	24.0	29.4	5.1	10.8	28.4	7.2	7.5	137.7	5.7	13.4	3.0	6.0	11.0	8.6	6.0	49.3	4.0	6.5	5.7	4.8	3.7	19.7	8.8	14.5	16.1	58.8	14.9	6.3	82.2	19.4	8.5	34.6	9.8
MCM6	Mis5	ENSG00000076003	"Minichromosome maintenance complex component 6"	Q14566	2	135839626-135876443	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Cell cycle, DNA replication"	"DNA-binding, Helicase, Hydrolase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 48.5"	"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 40.1;Erythroid cells: 50.5;Spermatogonia: 40.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA004818, CAB009577"	Enhanced		Enhanced	Nucleoplasm		NA	Yes		33000	"Cluster 44: Non-specific - Transcription"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 24: Non-specific - Transcription regulation"	Nucleoplasm		"CAB009577: AB_2266309, HPA004818: AB_1079339"	"unprognostic (6.73e-2)"	"unprognostic (6.68e-3)"	"unprognostic (1.22e-3)"	"unprognostic (3.60e-3)"	"unprognostic (8.98e-2)"	"unprognostic (4.34e-2)"	"prognostic unfavorable (5.70e-7)"	"unprognostic (1.71e-2)"	"prognostic unfavorable (1.09e-5)"	"unprognostic (2.36e-2)"	"unprognostic (1.36e-2)"	"unprognostic (3.53e-2)"	"prognostic unfavorable (8.29e-12)"	"unprognostic (2.84e-1)"	"unprognostic (9.02e-2)"	"unprognostic (7.42e-2)"	"unprognostic (1.68e-1)"	10.0	5.3	4.7	20.7	5.1	35.6	11.6	6.3	6.4	10.2	3.5	12.8	11.7	10.0	5.1	11.1	7.9	6.8	5.3	5.0	5.1	6.4	9.5	7.8	34.4	4.4	4.6	11.3	3.9	4.6	3.0	12.6	4.7	6.9	15.6	3.2	6.0	8.3	8.1	10.5	13.2	11.8	4.8	9.9	8.2	14.6	5.4	48.5	4.5	7.6	38.0	9.6	8.9	5.5	104.4	62.8	133.8	85.7	28.2	36.5	52.3	73.9	55.8	84.3	93.0	129.3	77.7	181.0	52.9	54.0	36.9	60.4	136.7	67.6	89.5	93.6	94.4	179.9	85.0	40.9	13.1	218.4	76.9	21.7	8.6	61.7	18.9	16.8	58.1	139.8	130.8	147.9	62.6	106.3	268.6	159.6	120.9	91.3	62.1	131.1	159.9	165.7	42.3	90.3	83.7	71.3	97.6	45.9	47.0	95.2	53.1	135.4	29.0	58.3	48.0	63.4	56.8	87.8	153.7	234.2	81.4	163.5	70.9	9.2	1.6	1.1	8.1	4.7	7.6	6.1	11.1	9.9	5.2	4.7	9.9	12.4	0.9	9.1	4.5	10.6	16.1	6.3	4.7	5.1	6.3	6.4	5.0	5.1	4.4	4.6	4.7	4.8	5.4	5.5	6.4	0.0	2.7	3.9	10.3	6.6	4.1	5.4	7.4	3.3	4.2	5.8	4.6	2.8	5.4	3.7	0.0	40.1	28.2	3.0	0.0	7.2	3.2	2.5	8.9	8.3	2.4	50.5	3.5	6.6	28.0	13.3	9.7	7.1	9.5	27.2	8.9	3.0	24.4	3.3	3.4	11.7	0.0	4.7	3.5	2.1	9.3	9.6	5.4	3.7	3.2	2.4	4.1	2.0	2.8	3.9	4.9	17.0	27.6	1.6	2.4	0.9	3.0	0.5	0.0	7.2	10.0	26.6	40.4	10.2	4.1	10.7	22.0	9.6	15.4	2.7
MCM7	"CDC47, MCM2, PPP1R104"	ENSG00000166508	"Minichromosome maintenance complex component 7"	P33993	7	100092728-100101940	"Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins"	"Cell cycle, DNA replication"	"DNA-binding, Helicase, Hydrolase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 180.8;lymphoid tissue: 156.4"	"Cell type enhanced"	"Detected in all"		"Cytotrophoblasts: 132.9;Erythroid cells: 173.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB002163, HPA003898, CAB016312"	Enhanced		Enhanced	Nucleoplasm		NA	Yes		150000	"Cluster 27: Non-specific - Gene expression"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	Nucleoplasm		"CAB002163: AB_564113, CAB016312: AB_627235, HPA003898: AB_1853632"	"unprognostic (1.87e-1)"	"prognostic favorable (1.28e-4)"	"unprognostic (1.36e-1)"	"unprognostic (5.20e-2)"	"unprognostic (1.94e-1)"	"unprognostic (7.03e-2)"	"prognostic unfavorable (2.18e-4)"	"unprognostic (2.08e-2)"	"unprognostic (5.79e-3)"	"unprognostic (2.16e-2)"	"unprognostic (2.42e-1)"	"unprognostic (9.34e-3)"	"unprognostic (3.83e-2)"	"unprognostic (5.41e-2)"	"unprognostic (1.76e-1)"	"unprognostic (1.32e-2)"	"unprognostic (2.38e-1)"	22.9	14.2	56.4	50.2	61.7	180.8	32.0	51.4	70.4	17.4	45.8	45.3	38.7	29.7	13.1	31.2	25.6	18.2	17.0	48.8	50.5	13.7	26.3	23.0	82.4	58.5	59.8	37.0	24.1	15.1	8.9	35.0	55.1	20.4	50.8	10.6	21.3	22.2	25.7	44.9	41.3	32.3	55.1	29.4	27.4	49.4	55.6	156.4	20.4	28.5	88.5	21.6	11.9	60.8	310.1	359.5	399.9	306.7	28.7	35.5	214.4	195.7	165.5	374.9	407.7	281.9	335.2	469.2	184.6	112.0	321.6	252.5	439.3	241.6	303.9	238.6	498.1	274.7	251.9	248.9	18.9	553.6	226.2	30.1	43.4	306.9	179.6	61.8	154.0	295.1	542.2	444.6	200.8	786.2	940.1	442.9	361.9	295.2	236.4	572.5	517.7	651.6	92.3	221.5	253.4	397.0	264.9	294.3	104.9	217.9	126.2	314.4	81.0	198.1	346.7	379.8	411.1	200.3	311.8	875.0	135.9	463.1	354.3	3.7	4.0	4.3	14.1	7.5	10.9	9.1	10.3	13.2	9.3	15.0	11.2	10.5	1.4	15.9	13.3	11.3	17.2	11.6	56.4	61.7	51.4	70.4	48.8	50.5	58.5	59.8	55.1	55.1	55.6	60.8	23.2	9.6	17.9	6.2	34.5	46.7	28.5	25.7	37.0	9.4	30.8	36.3	9.6	11.5	13.3	3.7	14.6	132.9	32.5	42.3	9.8	28.2	54.7	11.8	16.3	23.8	17.4	173.6	4.0	26.2	102.7	22.8	40.8	19.8	24.1	67.3	10.4	10.3	40.4	6.7	4.0	48.8	18.3	10.4	22.2	32.0	21.1	17.6	19.6	3.7	14.1	11.1	18.6	12.1	11.7	16.7	22.8	15.4	59.8	20.8	19.0	11.5	18.0	12.5	13.1	30.7	46.0	90.0	79.8	41.3	35.4	72.0	29.4	14.9	79.0	22.9
MCM8	"C20orf154, dJ967N21.5, MGC119522, MGC119523, MGC12866, MGC4816, REC"	ENSG00000125885	"Minichromosome maintenance 8 homologous recombination repair factor"	Q9UJA3	20	5950652-5998977	"Disease related genes, Enzymes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Cell cycle, DNA damage, DNA repair, DNA replication"	"DNA-binding, Helicase, Hydrolase"	"Disease variant, Premature ovarian failure"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Spermatocytes: 71.8;Spermatogonia: 37.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Low cell line specificity"	"Detected in many"											"HPA045141, HPA066433"			Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 35: T-regs - Unknown function"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 13: Spermatocytes & Spermatogonia - Spermatogenesis"	Nucleoplasm	Cytosol	"HPA045141: AB_2679230, HPA066433: "	"unprognostic (6.55e-2)"	"unprognostic (2.46e-2)"	"unprognostic (4.43e-1)"	"unprognostic (2.22e-3)"	"unprognostic (1.90e-1)"	"unprognostic (5.78e-2)"	"prognostic unfavorable (9.30e-8)"	"unprognostic (5.21e-2)"	"unprognostic (5.14e-2)"	"unprognostic (2.50e-1)"	"prognostic unfavorable (7.50e-4)"	"unprognostic (6.74e-2)"	"unprognostic (1.11e-2)"	"unprognostic (5.53e-2)"	"unprognostic (2.76e-1)"	"unprognostic (2.66e-2)"	"unprognostic (3.47e-1)"	2.9	2.9	3.0	4.6	4.1	10.2	2.8	6.8	4.4	4.0	4.2	3.9	3.6	3.1	2.1	3.7	3.2	1.7	3.3	3.1	3.4	2.4	1.8	2.4	7.5	2.9	3.1	2.6	3.1	2.0	1.6	3.3	3.1	3.6	3.2	5.3	2.9	1.8	6.9	4.7	3.7	2.1	2.6	3.6	3.3	13.4	3.1	9.0	2.4	4.6	6.5	3.4	3.6	5.8	48.6	33.0	27.7	30.3	4.6	6.6	27.4	38.1	12.3	26.6	32.0	35.4	27.6	48.3	11.3	10.2	51.5	50.9	46.1	25.7	47.9	13.4	21.5	49.3	16.8	27.9	0.9	56.6	7.4	2.5	3.8	47.2	17.6	5.3	12.3	28.7	56.7	45.8	27.1	12.3	27.6	30.0	40.3	25.3	21.6	34.8	50.9	18.6	5.0	15.3	21.6	23.2	40.0	36.3	22.5	28.6	27.1	16.4	9.6	51.5	43.2	28.2	56.8	20.1	53.8	82.2	9.6	33.5	43.4	1.0	0.1	0.4	0.4	0.1	0.7	0.3	0.2	0.4	0.0	0.3	0.2	0.4	0.4	0.4	0.2	0.4	0.5	0.1	3.0	4.1	6.8	4.4	3.1	3.4	2.9	3.1	3.1	2.6	3.1	5.8	3.3	0.0	4.4	1.6	6.0	2.3	3.0	1.9	4.6	7.3	2.1	2.8	10.3	7.2	2.4	12.9	16.7	7.2	4.2	5.8	0.0	1.9	8.5	4.9	3.5	4.2	4.2	14.9	3.7	2.8	6.3	5.0	3.1	5.4	1.3	24.4	2.9	1.9	4.5	6.7	2.9	4.0	6.1	2.8	4.6	3.2	3.7	3.7	1.8	2.8	0.3	3.7	8.2	3.5	6.6	3.6	3.9	3.0	9.2	3.3	4.7	2.4	4.0	11.5	6.6	5.7	4.8	71.8	37.1	5.0	2.6	4.0	6.0	3.0	6.3	2.2
MCM9	"C6orf61, dJ329L24.3, FLJ20170, MCMDC1, MGC35304"	ENSG00000111877	"Minichromosome maintenance 9 homologous recombination repair factor"	Q9NXL9	6	118813442-118935162	"Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins"	"DNA damage, DNA repair"	"DNA-binding, Helicase, Hydrolase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 32.0;Microglial cells: 40.3;Oligodendrocyte precursor cells: 35.7;Oligodendrocytes: 39.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA031137	Approved		Approved	Nucleoplasm		NA	NA			"Cluster 2: Granulocytes - Unknown function"	"Cluster 68: Epididymis - Unknown function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 59: Non-specific - Transcription"	Nucleoplasm		"HPA031137: AB_10602027"	"unprognostic (3.11e-2)"	"unprognostic (1.99e-1)"	"unprognostic (4.33e-3)"	"unprognostic (2.90e-1)"	"unprognostic (2.78e-2)"	"unprognostic (2.82e-1)"	"unprognostic (3.00e-2)"	"unprognostic (2.29e-1)"	"unprognostic (3.61e-2)"	"unprognostic (7.76e-2)"	"unprognostic (1.53e-1)"	"unprognostic (2.99e-1)"	"unprognostic (8.30e-2)"	"unprognostic (2.16e-1)"	"unprognostic (3.95e-1)"	"unprognostic (2.26e-1)"	"unprognostic (8.79e-2)"	5.7	4.4	2.5	5.7	3.3	12.7	7.0	2.4	2.9	6.8	3.5	5.1	4.9	5.3	10.2	6.5	5.8	3.7	3.4	2.2	2.5	6.6	5.0	5.2	7.5	3.2	3.2	5.1	6.9	5.3	4.6	7.0	3.1	6.8	5.7	4.1	7.5	4.7	2.6	6.5	5.8	4.2	2.8	6.3	4.9	5.7	3.0	8.0	8.0	2.1	7.1	5.8	6.9	3.7	4.2	6.5	10.3	11.8	4.2	4.8	7.3	3.9	7.1	5.4	6.8	5.2	6.7	12.1	4.5	6.2	3.9	12.5	7.1	4.7	7.2	7.5	10.1	11.4	9.5	5.5	3.0	11.7	7.3	5.2	5.7	6.0	7.3	3.7	5.5	8.0	12.9	6.3	4.2	9.4	10.0	9.4	4.7	7.3	3.1	8.3	7.0	4.2	5.4	7.9	8.5	6.0	6.9	5.7	3.7	2.9	7.3	15.8	6.0	4.3	3.7	2.9	5.7	7.8	7.2	13.9	5.5	8.7	5.6	4.3	2.6	4.4	2.2	2.7	1.8	1.5	1.4	2.3	2.9	1.4	1.7	1.6	2.9	4.8	1.7	2.1	3.5	2.1	2.5	3.3	2.4	2.9	2.2	2.5	3.2	3.2	3.1	2.8	3.0	3.7	6.6	6.4	6.7	32.0	10.8	2.9	3.8	2.9	7.4	3.5	6.4	4.1	6.0	2.8	4.4	7.3	10.4	11.8	7.6	7.2	3.9	3.0	2.9	7.4	6.0	6.3	7.2	4.6	16.8	2.8	3.4	5.0	9.2	6.9	7.0	8.1	2.9	3.9	3.5	1.7	15.2	6.0	6.1	5.5	2.8	2.6	3.7	7.4	0.0	40.3	6.3	1.6	11.3	35.7	39.7	2.7	5.6	4.1	10.9	3.9	6.8	3.3	10.6	5.6	0.0	5.7	5.8	6.3	4.6	8.6	2.0	7.3	9.8	4.7	4.1	4.3
MDP1	"FN6Pase, MGC5987"	ENSG00000213920	"Magnesium dependent phosphatase 1"	Q86V88	14	24213943-24216070	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Hydrolase, Protein phosphatase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"							"Low region specificity"	"Detected in all"			"HPA003064, HPA070338"	Uncertain		Approved	Nucleoplasm		NA	NA		29000	"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 72: Non-specific - Transcription"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 59: Non-specific - Transcription"	Nucleoplasm		"HPA003064: AB_10602350, HPA070338: AB_2686256"	"unprognostic (2.70e-1)"	"unprognostic (3.68e-1)"	"unprognostic (2.51e-1)"	"unprognostic (2.11e-1)"	"unprognostic (3.09e-1)"	"unprognostic (5.46e-2)"	"unprognostic (5.48e-2)"	"unprognostic (1.12e-1)"	"unprognostic (6.27e-2)"	"unprognostic (8.02e-2)"	"unprognostic (2.00e-3)"	"unprognostic (1.02e-1)"	"prognostic favorable (5.96e-4)"	"unprognostic (6.39e-2)"	"unprognostic (1.32e-1)"	"unprognostic (3.82e-1)"	"unprognostic (3.19e-2)"	14.0	18.6	6.8	3.2	6.8	3.9	14.6	7.0	7.5	14.7	6.4	12.6	3.1	11.5	7.9	7.3	12.1	4.0	18.2	7.0	6.9	16.8	10.3	9.2	5.8	6.7	6.8	12.3	15.3	5.8	20.1	4.0	6.9	13.7	3.5	4.1	10.6	4.8	15.0	12.6	9.5	4.5	7.2	11.6	11.9	7.8	6.6	5.3	13.6	4.8	4.7	12.5	11.1	7.8	4.1	9.5	7.2	4.7	6.9	6.3	0.3	4.2	8.9	8.2	8.4	5.0	10.9	15.7	10.4	4.3	2.4	3.7	3.4	8.2	5.0	5.4	3.9	6.0	3.3	12.1	6.7	7.9	4.2	4.5	7.7	4.9	9.4	8.3	5.9	11.1	1.9	11.4	7.4	21.1	11.7	12.6	2.2	7.8	16.9	8.0	5.0	12.6	8.0	5.7	8.7	8.6	6.6	14.3	9.4	3.9	8.3	4.5	3.5	8.8	8.7	3.9	4.4	18.6	8.4	11.7	8.3	3.8	6.9	5.1	13.9	16.5	7.7	15.2	7.3	13.4	9.9	9.0	16.1	12.9	11.7	9.9	4.6	12.4	13.0	29.9	16.3	10.3	6.8	6.8	7.0	7.5	7.0	6.9	6.7	6.8	6.9	7.2	6.6	7.8	6.6	6.4	12.9	0.0	11.0	4.6	3.5	5.6	16.5	3.9	8.2	11.7	0.0	4.3	2.1	5.5	0.0	3.7	7.3	5.9	13.7	13.8	5.7	4.6	5.5	8.2	11.5	7.8	0.0	19.6	5.3	8.1	9.2	4.3	5.1	4.3	8.6	5.8	7.9	3.3	0.0	10.8	12.2	3.3	8.7	3.0	6.2	10.6	17.8	0.0	21.9	5.2	4.1	0.0	0.0	11.7	6.2	7.5	25.8	2.9	23.7	21.7	13.2	2.9	13.1	7.7	8.7	4.4	3.5	11.5	4.5	2.5	9.7	3.4	8.8	2.6
MEP1A	PPHA	ENSG00000112818	"Meprin A subunit alpha"	Q16819	6	46793389-46839778	"Enzymes, Plasma proteins, Predicted membrane proteins"		"Hydrolase, Metalloprotease, Protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	101	"intestine: 467.7"	"Cell type enhanced"	"Detected in some"		"Distal enterocytes: 309.4;Intestinal goblet cells: 87.0;Paneth cells: 156.9;Proximal enterocytes: 902.8"	"Cancer enriched"	"Detected in many"	5	"colorectal cancer: 38.6"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BEWO: 1.3;CACO-2: 2.9;RPMI-8226: 1.2"									"CAB025163, HPA029416"	Enhanced					NA	NA		2100000		"Cluster 56: Intestine - Transmembrane transport"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 45: Enterocytes - Digestion"			"CAB025163: , HPA029416: AB_10600823"	"unprognostic (1.83e-1)"	"unprognostic (2.81e-4)"	"unprognostic (2.03e-1)"	"unprognostic (8.53e-2)"	"unprognostic (8.73e-2)"	"unprognostic (1.13e-1)"	"unprognostic (2.43e-2)"	"unprognostic (5.27e-4)"	"unprognostic (2.05e-1)"	"unprognostic (2.35e-2)"	"unprognostic (1.42e-1)"	"unprognostic (2.11e-1)"	"unprognostic (1.11e-3)"	"unprognostic (1.45e-1)"	"unprognostic (1.91e-2)"	"unprognostic (4.70e-3)"	"unprognostic (1.68e-1)"	0.2	0.0	0.0	4.6	0.0	0.0	0.1	0.0	0.1	0.0	0.0	115.6	269.9	0.3	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.1	0.1	0.0	4.2	0.0	0.0	0.5	0.1	0.1	102.5	0.0	0.0	0.2	0.0	0.0	467.7	2.6	0.0	0.1	0.5	0.7	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	2.9	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.4	0.0	0.1	0.0	0.0	0.0	0.0	309.4	0.0	0.0	7.7	0.1	0.0	0.0	15.5	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	87.0	0.0	0.0	0.0	6.9	0.0	0.2	0.0	3.7	0.0	0.0	0.0	0.5	0.3	0.0	156.9	0.4	0.0	0.0	902.8	0.0	0.6	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.1	0.0	45.8	0.0
MEP1B		ENSG00000141434	"Meprin A subunit beta"	Q16820	18	32185069-32220404	"Enzymes, Predicted membrane proteins, Predicted secreted proteins, Transporters"	"Inflammatory response"	"Hydrolase, Metalloprotease, Protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	55	"intestine: 363.9"	"Cell type enriched"	"Detected in some"	42	"Proximal enterocytes: 231.8"	"Cancer enriched"	"Detected in some"	5	"pancreatic cancer: 3.0"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	4	"SCLC-21H: 4.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in some"			HPA029119	Enhanced				"Secreted to digestive system"	NA	NA		310000		"Cluster 56: Intestine - Transmembrane transport"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 45: Enterocytes - Digestion"			"HPA029119: AB_2672913"	"unprognostic (1.33e-1)"	"unprognostic (6.72e-2)"	"unprognostic (2.79e-2)"	"unprognostic (1.00e-1)"	"unprognostic (3.50e-4)"	"unprognostic (1.27e-1)"	"unprognostic (1.74e-2)"	"unprognostic (4.30e-1)"	"unprognostic (1.73e-1)"	"unprognostic (1.24e-2)"	"unprognostic (1.55e-1)"	"unprognostic (8.31e-4)"	"unprognostic (4.74e-2)"	"unprognostic (3.39e-1)"	"unprognostic (2.71e-1)"	"unprognostic (3.39e-2)"	"unprognostic (3.75e-2)"	0.0	0.0	0.1	0.2	0.1	0.0	0.0	0.4	0.3	0.0	0.0	8.2	249.3	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.0	6.5	0.0	0.3	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.0	0.1	0.0	0.0	0.0	0.0	363.9	0.3	0.1	0.0	0.3	0.3	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	4.3	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.4	0.3	0.3	0.1	0.2	0.0	0.0	0.1	0.2	0.3	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	2.9	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.7	5.4	0.0	0.0	0.3	0.6	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.5	0.9	0.0	3.8	0.0	0.1	0.2	231.8	0.0	0.0	0.2	0.0	0.2	0.1	0.1	0.1	0.0	0.1	0.1	0.0	0.0	2.5	0.1
METAP1	"KIAA0094, MAP1A, MetAP1A"	ENSG00000164024	"Methionyl aminopeptidase 1"	P53582	4	98995659-99062809	"Enzymes, Plasma proteins, Predicted intracellular proteins"		"Aminopeptidase, Hydrolase, Protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enriched"	"Detected in all"	4	"Late spermatids: 1627.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB025485, HPA037997, HPA037998"	Approved		Approved	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA		8900	"Cluster 44: Non-specific - Transcription"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 25: Spermatids - Spermatogenesis"	Cytosol	"Nucleoplasm, Plasma membrane"	"CAB025485: , HPA037997: AB_2675777, HPA037998: AB_2675778"	"unprognostic (1.79e-1)"	"unprognostic (3.39e-1)"	"prognostic favorable (7.22e-4)"	"unprognostic (1.58e-2)"	"unprognostic (6.53e-2)"	"unprognostic (2.15e-1)"	"prognostic unfavorable (3.08e-5)"	"unprognostic (1.09e-1)"	"unprognostic (1.51e-3)"	"unprognostic (2.05e-1)"	"prognostic unfavorable (2.28e-5)"	"unprognostic (2.00e-1)"	"prognostic favorable (1.72e-4)"	"unprognostic (5.50e-2)"	"unprognostic (8.51e-2)"	"unprognostic (1.15e-3)"	"prognostic favorable (9.31e-4)"	14.8	9.5	10.2	20.5	11.6	25.1	28.7	10.5	13.8	24.0	8.8	31.8	24.1	25.7	43.7	52.3	24.3	15.1	41.1	11.2	10.0	24.7	24.0	15.6	24.9	9.5	10.1	14.0	19.5	14.0	11.6	16.9	9.4	29.2	33.5	11.3	23.1	29.7	33.8	28.7	23.4	25.7	9.2	17.6	19.6	51.6	10.6	41.9	18.8	28.7	31.2	34.5	30.8	10.4	57.6	55.9	47.7	51.7	37.2	59.1	52.9	80.3	51.5	67.1	63.7	62.9	83.3	84.1	31.3	65.5	40.3	56.1	84.8	80.5	92.9	59.2	39.9	75.6	37.8	68.2	40.2	103.6	60.8	42.8	57.5	57.0	60.4	52.4	56.3	46.9	60.0	49.7	73.2	44.0	90.9	49.3	58.7	97.7	44.3	58.9	74.5	45.4	109.2	73.6	64.7	38.5	27.0	82.5	32.8	53.1	31.6	39.3	46.1	53.9	68.0	49.9	70.9	35.5	53.5	66.2	46.5	51.9	54.8	19.1	11.6	5.7	17.7	14.6	23.1	16.0	18.0	17.6	14.9	11.4	17.4	15.8	2.9	17.7	14.7	7.2	17.7	14.1	10.2	11.6	10.5	13.8	11.2	10.0	9.5	10.1	9.4	9.2	10.6	10.4	16.1	41.7	14.6	20.2	19.8	42.4	47.5	26.2	51.2	5.2	21.0	24.9	57.0	17.2	19.5	14.7	2.1	24.4	17.4	36.7	13.7	28.4	330.3	45.4	30.0	17.3	7.8	24.2	22.6	29.4	70.5	15.3	22.4	60.9	3.8	16.9	12.8	21.4	17.2	3.3	15.0	23.3	24.4	20.2	16.2	1627.3	19.3	17.4	16.0	14.0	13.9	10.6	25.7	17.6	22.3	28.0	30.8	22.6	17.8	34.4	25.3	31.6	17.2	3.7	26.3	11.5	21.7	15.7	41.6	54.3	38.8	7.7	23.6	18.1	36.2	46.9
METAP1D	"MAP1D, Metap1l"	ENSG00000172878	"Methionyl aminopeptidase type 1D, mitochondrial"	Q6UB28	2	171999943-172082430	"Enzymes, Predicted intracellular proteins"		"Aminopeptidase, Hydrolase, Protease"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Inhibitory neurons: 39.5;Oligodendrocyte precursor cells: 35.7;Oligodendrocytes: 35.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA030298, HPA030299, HPA077742"	Uncertain		Uncertain	Vesicles		NA	NA			"Cluster 32: T-cells - Unknown function"	"Cluster 35: Non-specific - Unknown function"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Vesicles		"HPA030298: AB_2673419, HPA030299: AB_10602421, HPA077742: "	"unprognostic (5.31e-2)"	"unprognostic (1.07e-1)"	"unprognostic (1.88e-1)"	"unprognostic (5.83e-2)"	"unprognostic (2.54e-2)"	"unprognostic (7.90e-3)"	"unprognostic (1.92e-3)"	"unprognostic (1.07e-2)"	"unprognostic (4.55e-1)"	"unprognostic (7.07e-2)"	"unprognostic (2.64e-2)"	"unprognostic (8.19e-2)"	"unprognostic (2.53e-3)"	"unprognostic (3.44e-3)"	"unprognostic (3.06e-2)"	"unprognostic (5.48e-3)"	"unprognostic (2.92e-2)"	4.4	4.9	4.3	2.4	4.5	3.5	3.9	3.7	5.0	5.4	3.7	4.6	2.3	4.5	2.8	3.4	6.7	2.0	4.8	4.1	5.1	4.5	6.0	2.3	2.8	4.1	4.1	11.9	8.1	2.2	4.3	1.8	4.6	5.6	3.2	2.5	4.1	3.7	7.8	3.4	4.1	2.8	3.6	5.8	4.6	2.8	4.3	1.2	3.6	5.6	2.0	4.2	3.8	5.0	3.6	2.8	4.1	13.5	5.9	7.7	8.3	4.1	4.1	6.4	4.1	6.4	4.7	1.8	7.2	4.3	6.6	6.4	9.1	7.2	6.5	6.3	10.6	10.2	7.8	8.6	6.2	6.1	2.6	5.8	10.9	6.4	10.2	5.5	3.6	6.9	14.8	5.1	4.9	4.4	3.5	8.2	7.4	10.4	3.4	7.7	3.5	3.3	4.5	5.0	8.4	3.2	2.9	5.8	10.2	3.6	6.7	8.1	4.4	8.1	6.4	5.0	4.0	6.3	6.1	4.0	5.8	11.9	7.9	0.0	0.0	0.0	0.4	0.4	0.2	0.3	0.5	0.2	0.1	0.7	0.5	1.1	0.0	0.4	0.0	0.0	0.4	0.2	4.3	4.5	3.7	5.0	4.1	5.1	4.1	4.1	4.6	3.6	4.3	5.0	6.1	0.0	4.6	23.8	15.4	5.6	10.3	7.5	22.8	5.8	9.2	8.9	4.5	7.2	3.5	3.7	2.1	4.1	2.7	1.3	7.9	2.5	1.2	2.7	14.7	5.4	0.0	16.8	19.6	3.5	4.7	10.9	8.2	2.5	4.5	17.9	6.4	6.4	3.9	5.0	39.5	2.9	2.0	2.5	2.2	2.3	33.5	2.2	5.4	14.0	1.0	3.7	9.2	35.7	35.5	1.4	1.3	26.4	9.9	4.3	0.6	5.7	2.0	6.1	13.1	18.1	9.5	9.8	12.2	11.6	5.7	1.9	7.5	14.5	5.7	5.1
METAP2	"MAP2, MNPEP, p67"	ENSG00000111142	"Methionyl aminopeptidase 2"	P50579	12	95473520-95515839	"Enzymes, Plasma proteins, Predicted intracellular proteins"		"Aminopeptidase, Hydrolase, Protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB013025, HPA019095"	Enhanced		Supported	"Plasma membrane,Cytosol"		NA	NA		70000	"Cluster 6: Non-specific - Transcription"	"Cluster 52: Non-specific - Ribosome"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 10: Non-specific - Unknown function"	"Plasma membrane, Cytosol"		"CAB013025: AB_2533993, HPA019095: AB_1853823"	"unprognostic (1.91e-1)"	"unprognostic (1.02e-1)"	"unprognostic (5.92e-2)"	"unprognostic (2.44e-1)"	"unprognostic (3.27e-2)"	"unprognostic (2.57e-2)"	"prognostic unfavorable (4.51e-6)"	"unprognostic (1.25e-1)"	"unprognostic (2.28e-2)"	"unprognostic (1.40e-2)"	"unprognostic (8.53e-2)"	"unprognostic (1.66e-1)"	"unprognostic (1.49e-1)"	"unprognostic (2.51e-1)"	"unprognostic (1.07e-1)"	"unprognostic (2.95e-2)"	"unprognostic (1.03e-1)"	52.5	58.0	41.1	51.6	44.5	102.2	55.0	45.0	53.2	46.0	39.7	50.7	36.7	54.2	52.6	54.7	42.6	47.0	65.9	40.2	49.9	55.6	84.5	49.0	78.0	46.5	43.8	60.5	52.7	52.3	36.6	51.3	48.8	43.3	50.9	30.8	40.6	101.0	119.5	58.3	37.7	54.9	42.4	40.3	37.4	61.8	44.7	69.1	51.8	78.7	125.0	62.2	41.5	50.2	192.3	157.8	163.7	129.6	98.4	156.4	125.9	186.0	127.6	177.7	125.7	228.0	88.6	542.1	113.5	133.4	101.9	120.5	187.4	142.4	203.8	131.2	161.2	244.9	113.7	165.6	104.5	313.5	117.1	137.5	148.1	164.9	164.0	210.7	192.9	184.2	321.8	60.5	135.3	125.8	230.3	213.0	204.5	109.4	233.4	179.6	141.5	178.5	123.5	198.3	127.0	165.3	166.0	132.7	169.0	140.6	159.4	146.5	165.1	100.7	98.5	115.0	195.7	87.7	246.8	585.1	58.1	173.7	129.9	77.5	70.5	32.0	60.0	52.2	74.3	114.2	66.8	67.8	66.0	101.8	79.2	74.1	3.4	72.8	65.6	85.3	71.6	46.4	41.1	44.5	45.0	53.2	40.2	49.9	46.5	43.8	48.8	42.4	44.7	50.2	87.0	282.0	238.9	22.9	101.3	233.2	130.2	141.3	97.3	70.6	119.7	95.9	143.6	100.1	133.3	290.6	66.7	146.2	87.7	96.8	164.4	115.2	189.5	114.9	260.0	110.2	91.7	278.4	35.1	145.8	161.5	112.2	53.0	153.7	122.9	140.5	112.1	314.6	98.1	75.7	49.5	119.7	73.2	141.0	89.8	123.3	100.3	83.8	92.5	20.6	103.5	72.6	81.4	26.2	41.4	130.1	105.8	106.8	87.0	108.1	93.4	186.6	92.4	83.8	98.6	137.4	133.4	378.4	207.6	95.2	215.0	172.0	80.7	101.4	144.8	110.5
MGAM	MGA	ENSG00000257335	Maltase-glucoamylase	O43451	7	141907813-142106747	"Enzymes, FDA approved drug targets, Metabolic proteins, Plasma proteins, Predicted membrane proteins"		"Glycosidase, Hydrolase, Multifunctional enzyme"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"epididymis: 25.5;intestine: 87.6"	"Group enriched"	"Detected in some"	5	"Late spermatids: 156.4;Proximal enterocytes: 521.4"	"Cancer enriched"	"Detected in some"	7	"renal cancer: 4.9"	"Region enhanced"	"Detected in single"		"cerebral cortex: 2.3"	"Immune cell enriched"	"Detected in some"	7	"neutrophil: 13.5"	"Lineage enriched"	"Detected in single"	102	"granulocytes: 13.5"	"Cell line enhanced"	"Detected in some"		"A549: 1.8;BJ hTERT+: 1.6;HL-60: 2.8;U-937: 4.3;WM-115: 1.0"	"Region enriched"	"Detected in single"	12	"olfactory bulb: 2.0"	"Low region specificity"	"Detected in many"			HPA002270	Enhanced					NA	NA		310000	"Cluster 9: Neutrophils - Innate immune response"	"Cluster 87: Intestine & Kidney - Transmembrane transport"	"Cluster 32: U-937 - Innate immune response"	"Cluster 45: Enterocytes - Digestion"			"HPA002270: AB_1079366"	"unprognostic (1.02e-2)"	"unprognostic (1.45e-1)"	"unprognostic (1.13e-1)"	"unprognostic (6.95e-3)"	"unprognostic (2.80e-1)"	"unprognostic (7.81e-2)"	"unprognostic (7.32e-3)"	"unprognostic (3.83e-2)"	"unprognostic (4.97e-1)"	"unprognostic (2.17e-2)"	"unprognostic (6.86e-2)"	"unprognostic (1.99e-1)"	"prognostic favorable (6.16e-5)"	"unprognostic (1.82e-1)"	"unprognostic (2.82e-1)"	"unprognostic (1.34e-3)"	"unprognostic (3.03e-1)"	2.6	0.1	0.2	2.5	0.4	18.1	0.2	0.2	2.3	0.4	0.3	0.5	58.9	0.1	25.5	0.3	1.2	0.4	0.3	0.1	0.3	18.7	0.5	3.2	0.1	0.5	0.4	0.1	0.2	0.0	0.1	0.3	0.6	0.1	0.2	0.0	0.1	7.1	0.1	0.1	87.6	0.4	0.2	12.6	1.8	1.3	0.6	0.4	0.1	1.0	0.0	0.5	0.1	0.4	0.0	1.8	0.1	0.0	0.0	0.0	0.2	0.0	1.6	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	2.8	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.4	0.2	0.0	0.1	0.0	0.0	0.0	4.3	1.0	0.0	0.1	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	13.5	0.0	0.0	0.0	0.0	0.0	0.2	0.4	0.2	2.3	0.1	0.3	0.5	0.4	0.6	0.2	0.6	0.4	0.0	0.0	2.5	3.3	0.1	0.0	0.0	0.6	0.0	0.2	0.5	0.1	1.4	0.0	3.2	12.9	0.0	0.0	2.8	1.8	1.9	0.1	59.7	0.1	0.2	0.3	1.2	0.0	0.7	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.3	0.2	0.0	0.7	17.8	0.0	0.0	2.5	156.4	0.6	1.1	0.0	0.0	0.7	0.6	5.2	1.5	0.6	0.2	16.3	0.4	0.0	0.1	521.4	24.4	6.7	0.0	0.0	0.5	0.1	1.8	1.2	0.0	0.0	0.0	0.4	0.0	7.3	0.3
MGAM2		ENSG00000257743	"Maltase-glucoamylase 2 (putative)"	Q2M2H8	7	142111749-142222324	"Enzymes, Predicted membrane proteins"		"Glycosidase, Hydrolase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	6	"intestine: 11.8;pancreas: 4.0;salivary gland: 5.9"	"Group enriched"	"Detected in some"	4	"Early spermatids: 27.4;Late spermatids: 18.2"	"Group enriched"	"Detected in some"	11	"colorectal cancer: 3.5;pancreatic cancer: 2.5;stomach cancer: 9.8"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	8	"OE19: 1.6;RH-30: 1.1"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA055697	Enhanced		Approved	Vesicles,Cytosol		NA	NA				"Cluster 56: Intestine - Transmembrane transport"	"Cluster 21: OE19 - Mitochondria"	"Cluster 31: Spermatids - Spermatogenesis"	Vesicles	Cytosol	"HPA055697: AB_2682890"	"unprognostic (1.79e-2)"	"unprognostic (1.00e-1)"	"unprognostic (1.26e-1)"	"unprognostic (5.27e-3)"	"unprognostic (5.65e-2)"	"unprognostic (2.19e-2)"	"unprognostic (1.89e-2)"	"unprognostic (1.01e-1)"	"unprognostic (1.50e-2)"	"unprognostic (5.93e-2)"	"unprognostic (2.43e-1)"	"unprognostic (2.05e-1)"	"unprognostic (5.50e-4)"	"unprognostic (7.11e-3)"	"unprognostic (1.66e-1)"	"unprognostic (6.71e-2)"	"unprognostic (9.33e-2)"	0.1	0.0	0.0	0.4	0.0	0.2	1.1	0.0	0.4	0.0	0.2	1.5	11.8	0.0	0.3	0.0	0.1	0.4	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	4.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	5.9	0.0	0.0	0.0	9.6	0.0	0.0	0.9	0.5	0.7	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.1	2.2	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.5	27.4	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	18.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	5.2	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0
MGLL	"HU-K5, MAGL, MGL"	ENSG00000074416	"Monoglyceride lipase"	Q99685	3	127689062-128052190	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Fatty acid biosynthesis, Fatty acid metabolism, Lipid biosynthesis, Lipid degradation, Lipid metabolism"	"Hydrolase, Serine esterase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Adipocytes: 565.4;Distal enterocytes: 398.7;Pancreatic endocrine cells: 535.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"intermediate monocyte: 84.7;plasmacytoid DC: 89.8"	"Group enriched"	"Detected in all"	14	"dendritic cells: 89.8;granulocytes: 36.0;monocytes: 84.7"	"Cell line enhanced"	"Detected in many"		"BJ: 209.1;BJ hTERT+: 238.6;LHCN-M2: 191.3;RPTEC TERT1: 170.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA011348, HPA011993, HPA011994"	Enhanced		Enhanced	Nucleoplasm		NA	NA		100000	"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 57: Non-specific - Angiogenesis"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Nucleoplasm		"HPA011348: AB_2668490, HPA011993: AB_1853914, HPA011994: AB_1853916"	"unprognostic (1.84e-2)"	"unprognostic (1.80e-2)"	"unprognostic (2.14e-1)"	"unprognostic (8.19e-2)"	"unprognostic (1.15e-2)"	"unprognostic (1.69e-1)"	"unprognostic (5.83e-2)"	"unprognostic (3.61e-2)"	"unprognostic (1.45e-1)"	"unprognostic (8.83e-2)"	"prognostic unfavorable (6.41e-4)"	"unprognostic (7.63e-3)"	"unprognostic (1.44e-1)"	"unprognostic (1.68e-1)"	"unprognostic (1.90e-2)"	"unprognostic (2.51e-1)"	"unprognostic (2.11e-3)"	174.8	16.1	100.8	22.9	91.0	18.9	92.0	87.2	123.4	26.8	48.0	81.9	36.9	17.7	9.9	139.9	34.3	44.8	101.9	96.9	75.9	71.0	106.9	72.0	13.5	72.5	86.6	6.1	7.8	3.6	12.5	41.6	70.9	25.8	60.4	6.2	102.1	27.5	66.0	38.1	50.3	27.8	63.0	44.9	38.2	6.2	107.2	10.0	18.9	64.9	21.3	42.5	39.4	88.6	52.4	46.2	0.1	0.5	76.8	90.0	6.2	209.1	238.6	45.3	72.2	1.2	21.0	14.0	56.9	71.3	13.7	2.1	0.4	27.9	25.2	23.5	0.9	1.6	31.4	0.4	27.7	0.3	1.7	34.2	16.1	85.0	92.4	25.6	97.5	1.0	0.3	3.0	191.3	5.6	0.5	0.9	0.5	33.6	71.5	0.2	24.6	109.4	170.4	5.9	26.5	2.1	36.3	70.4	12.6	2.0	3.5	2.1	125.9	49.5	14.8	121.0	29.1	0.5	0.4	43.4	102.4	3.4	156.6	20.6	8.3	36.0	0.5	84.7	2.8	4.9	0.5	1.1	9.2	0.5	0.2	0.2	1.5	2.0	57.2	89.8	0.0	17.1	100.8	91.0	87.2	123.4	96.9	75.9	72.5	86.6	70.9	63.0	107.2	88.6	565.4	195.5	108.6	83.2	8.5	22.8	11.9	14.1	5.7	22.8	25.2	19.9	53.7	118.7	32.2	42.3	0.0	84.6	16.1	398.7	168.3	99.4	4.1	100.0	36.4	207.7	88.6	30.7	39.0	160.7	154.6	71.5	47.9	132.1	8.8	0.1	17.2	148.7	123.9	0.0	48.9	239.1	63.1	32.8	86.3	5.8	32.6	77.8	21.4	52.5	235.2	54.5	2.1	43.2	5.8	535.2	201.0	69.6	36.2	18.5	134.2	102.0	48.0	7.8	85.5	22.3	141.4	0.7	1.7	64.7	22.3	72.7	9.3	1.1	74.0	6.0
MINDY1	"FAM63A, FLJ11280, MINDY-1"	ENSG00000143409	"MINDY lysine 48 deubiquitinase 1"	Q8N5J2	1	150996086-151008375	"Enzymes, Predicted intracellular proteins"	"Ubl conjugation pathway"	"Hydrolase, Protease, Thiol protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 9.6;Distal tubular cells: 39.2;Ductal cells: 11.6;Proximal tubular cells: 12.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	7	"basophil: 98.4;eosinophil: 56.2;neutrophil: 85.4"	"Lineage enriched"	"Detected in all"	9	"granulocytes: 98.4"	"Cell line enhanced"	"Detected in many"		"T-47d: 49.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA028351, HPA028358, HPA061086"	Approved		Enhanced	Nucleoplasm		NA	NA		220000	"Cluster 2: Granulocytes - Unknown function"	"Cluster 27: Brain & Skin - Unknown function"	"Cluster 6: T47d - Mammary gland"	"Cluster 7: Non-specific - Mitochondria"	Nucleoplasm		"HPA028351: AB_10611110, HPA028358: AB_10601102, HPA061086: AB_2684425"	"unprognostic (5.73e-2)"	"unprognostic (2.86e-1)"	"unprognostic (5.47e-2)"	"unprognostic (3.14e-1)"	"unprognostic (3.39e-2)"	"unprognostic (6.90e-2)"	"unprognostic (1.47e-2)"	"unprognostic (1.64e-1)"	"unprognostic (1.02e-1)"	"unprognostic (1.88e-1)"	"unprognostic (9.22e-3)"	"unprognostic (1.06e-1)"	"prognostic favorable (3.43e-8)"	"unprognostic (2.30e-1)"	"unprognostic (7.95e-2)"	"unprognostic (2.50e-2)"	"unprognostic (6.06e-2)"	13.8	13.0	24.9	8.2	49.9	7.2	15.0	42.7	33.7	19.0	30.9	18.4	16.8	18.1	7.0	37.1	17.4	14.0	33.5	22.2	30.7	30.4	19.0	12.9	6.4	58.7	43.9	21.7	47.6	30.1	15.1	6.8	53.4	14.3	17.2	13.3	29.6	13.7	16.7	20.6	14.8	15.6	33.3	15.1	25.9	23.6	43.1	3.6	47.3	18.0	8.7	15.0	20.1	75.6	11.3	7.3	7.7	10.8	13.4	11.1	6.4	3.6	9.1	5.0	7.9	15.6	26.3	0.7	8.4	4.7	1.5	5.5	6.1	6.8	2.2	8.6	9.2	11.0	13.8	13.5	3.0	3.3	4.3	9.1	5.9	9.0	2.5	16.8	12.9	3.8	7.0	27.5	5.3	17.4	0.6	7.4	3.5	3.5	2.5	8.3	1.4	34.8	23.4	22.1	13.1	9.7	6.9	12.4	7.4	3.6	49.5	11.1	12.0	4.3	5.5	2.2	3.1	10.1	9.9	37.5	10.2	7.2	20.4	98.4	9.3	56.2	0.4	4.1	0.3	0.8	3.5	1.0	11.5	1.5	5.8	2.0	85.4	4.7	2.8	1.7	4.8	9.9	24.9	49.9	42.7	33.7	22.2	30.7	58.7	43.9	53.4	33.3	43.1	75.6	4.5	9.6	5.8	0.0	1.2	0.0	0.0	0.0	0.0	0.0	8.8	5.8	0.0	0.0	3.7	3.7	0.0	3.8	1.4	0.0	39.2	11.6	0.0	3.4	3.7	3.7	0.0	0.0	0.0	7.0	0.8	2.9	0.0	4.5	3.8	6.4	0.0	0.0	3.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	3.1	0.0	0.0	0.0	0.0	8.2	0.0	0.0	0.1	0.0	0.0	12.0	2.2	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	2.6	0.8	5.0	0.0	0.0
MINDY2	"FAM63B, KIAA1164"	ENSG00000128923	"MINDY lysine 48 deubiquitinase 2"	Q8NBR6	15	58771192-58861900	"Enzymes, Predicted intracellular proteins"	"Ubl conjugation pathway"	"Hydrolase, Protease, Thiol protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 147.4;Collecting duct cells: 82.8;Endometrial ciliated cells: 66.4;Extravillous trophoblasts: 108.7;Glandular and luminal cells: 73.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in all"		"U-2197: 72.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA051103, HPA063669"	Approved		Enhanced	Nucleoplasm		No	No			"Cluster 18: Basophils - Vesicular transport"	"Cluster 57: Non-specific - Angiogenesis"	"Cluster 18: U-2197 - ECM organization"	"Cluster 7: Non-specific - Mitochondria"	Nucleoplasm		"HPA051103: AB_2681345, HPA063669: AB_2685082"	"unprognostic (4.71e-2)"	"unprognostic (8.92e-3)"	"unprognostic (4.63e-2)"	"unprognostic (4.13e-2)"	"unprognostic (1.32e-1)"	"unprognostic (1.06e-1)"	"unprognostic (2.14e-1)"	"unprognostic (8.60e-2)"	"unprognostic (7.23e-2)"	"unprognostic (7.09e-2)"	"unprognostic (2.36e-3)"	"unprognostic (4.74e-2)"	"prognostic favorable (3.00e-8)"	"unprognostic (2.53e-1)"	"unprognostic (3.59e-1)"	"unprognostic (6.76e-2)"	"unprognostic (4.77e-2)"	9.4	5.4	9.3	5.7	9.6	3.8	6.6	15.0	10.4	7.0	8.9	5.4	3.5	7.1	4.6	7.1	6.8	6.3	10.8	8.0	11.6	10.1	3.5	7.7	4.1	10.5	11.0	6.8	3.3	7.3	4.9	9.0	10.0	8.9	3.9	16.3	4.9	6.1	3.4	7.1	3.6	8.5	9.2	6.1	4.8	3.9	11.2	5.9	9.6	8.9	3.7	8.0	5.2	10.3	10.9	5.3	7.3	4.4	10.7	19.7	11.5	9.8	20.8	3.0	4.3	8.4	5.4	5.6	10.5	11.8	5.3	10.3	13.4	7.9	4.6	5.6	4.9	7.8	5.7	7.6	6.6	5.9	6.9	8.7	12.9	3.5	8.0	11.3	7.4	5.9	13.7	6.1	7.1	1.4	7.4	4.4	15.7	1.4	2.7	3.3	21.0	6.0	8.9	12.1	6.7	4.9	7.1	10.0	17.9	15.3	3.0	12.5	8.7	4.2	3.7	72.5	4.3	5.4	8.3	5.4	9.4	9.5	10.2	3.0	0.7	1.3	1.1	0.6	2.1	0.9	1.0	1.3	0.2	1.6	0.8	1.2	1.4	0.8	1.4	1.1	0.9	0.5	9.3	9.6	15.0	10.4	8.0	11.6	10.5	11.0	10.0	9.2	11.2	10.3	65.2	147.4	39.1	0.0	5.1	0.0	0.0	0.0	0.0	0.0	43.8	44.8	0.0	0.0	18.0	82.8	0.0	65.2	27.5	0.0	46.9	44.4	0.0	66.4	46.8	19.8	0.0	0.0	0.0	21.2	108.7	21.7	0.0	73.2	11.4	11.6	0.0	0.0	33.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.0	0.0	0.0	9.3	0.0	0.0	0.0	0.0	32.4	0.0	0.0	7.5	0.0	0.0	14.2	28.4	0.0	0.0	0.0	17.2	0.0	0.0	0.0	0.0	53.2	11.3	17.6	0.0	0.0
MINDY3	"C10orf97, CARP, DERP5, FAM188A, FLJ13397, my042"	ENSG00000148481	"MINDY lysine 48 deubiquitinase 3"	Q9H8M7	10	15778170-15860507	"Enzymes, Predicted intracellular proteins"	"Apoptosis, Ubl conjugation pathway"	"Hydrolase, Protease, Thiol protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 22.4;Hofbauer cells: 40.2;Syncytiotrophoblasts: 32.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038400, HPA038406"	Uncertain		Supported	"Nucleoplasm,Nuclear membrane"		NA	NA		23000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 34: Non-specific - Transcription"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 7: Non-specific - Mitochondria"	"Nucleoplasm, Nuclear membrane"		"HPA038400: AB_10669724, HPA038406: AB_2676001"	"unprognostic (9.20e-2)"	"unprognostic (5.84e-2)"	"unprognostic (3.09e-1)"	"unprognostic (3.26e-1)"	"unprognostic (1.99e-2)"	"unprognostic (3.67e-1)"	"unprognostic (8.29e-2)"	"unprognostic (2.81e-2)"	"unprognostic (3.85e-2)"	"unprognostic (9.63e-2)"	"unprognostic (6.48e-3)"	"unprognostic (6.50e-2)"	"unprognostic (1.32e-1)"	"unprognostic (2.97e-1)"	"unprognostic (1.04e-2)"	"unprognostic (1.76e-1)"	"unprognostic (3.19e-1)"	15.0	22.4	12.8	8.6	16.3	19.1	19.2	21.9	19.0	18.6	2.9	15.0	9.3	19.5	20.6	14.1	15.6	14.2	9.9	14.7	10.5	16.8	17.5	12.1	12.4	10.6	11.4	18.5	13.7	20.5	5.3	21.1	10.9	19.3	18.7	20.0	11.5	16.4	4.3	16.4	11.6	16.4	11.3	10.5	15.7	21.3	15.5	7.5	18.3	2.4	11.6	15.3	10.3	17.7	12.4	11.1	21.5	22.9	30.9	28.9	17.9	38.1	19.4	28.4	33.1	9.6	19.0	9.2	7.2	41.8	19.9	11.2	18.5	22.8	25.5	28.2	25.5	30.0	16.0	10.8	39.3	6.2	24.3	22.5	19.6	25.3	18.1	27.4	23.1	21.7	18.6	7.6	28.5	13.4	13.2	7.5	7.8	19.9	21.6	6.5	12.5	6.4	32.1	9.2	17.6	19.2	18.5	17.5	16.1	19.2	20.4	13.4	23.9	18.5	14.4	31.4	11.2	45.6	18.8	15.7	21.2	13.6	15.1	2.6	1.7	1.5	2.2	3.5	1.8	1.3	1.5	2.4	1.9	1.9	1.0	2.0	1.5	1.7	4.0	2.0	3.1	1.5	12.8	16.3	21.9	19.0	14.7	10.5	10.6	11.4	10.9	11.3	15.5	17.7	17.3	22.4	14.4	0.0	3.9	0.0	0.0	0.0	0.0	0.0	9.7	7.4	0.0	0.0	3.7	14.7	0.0	18.7	10.7	0.0	19.6	11.6	0.0	8.2	18.1	5.2	0.0	0.0	0.0	8.3	17.0	7.5	0.0	9.7	1.3	11.5	0.0	0.0	40.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.3	0.0	0.0	1.6	0.0	0.0	0.0	0.0	9.0	0.0	0.0	4.0	0.0	0.0	17.7	11.7	0.0	0.0	0.0	7.7	0.0	0.0	0.0	0.0	32.7	3.0	13.7	0.0	0.0
MINDY4	"C7orf67, FAM188B, FLJ22374"	ENSG00000106125	"MINDY lysine 48 deubiquitinase 4"	Q4G0A6	7	30771417-30892387	"Enzymes, Predicted intracellular proteins"	"Ubl conjugation pathway"	"Hydrolase, Protease, Thiol protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"Alveolar cells type 1: 9.6;Collecting duct cells: 12.9;Endometrial ciliated cells: 36.7;Endometrial stromal cells: 8.9;Respiratory ciliated cells: 18.2"	"Low cancer specificity"	"Detected in single"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"K-562: 19.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA019475, HPA030129, HPA030130"	Approved		Supported	Vesicles,Cytosol		NA	NA			"Cluster 16: MAIT-cells - Unknown function"	"Cluster 42: Ciliated cells - Cilium & Cell projection"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 49: Ciliated cells - Cilium organization"	"Vesicles, Cytosol"		"HPA019475: AB_1848806, HPA030129: AB_10599621, HPA030130: AB_10601565"	"unprognostic (2.96e-1)"	"unprognostic (1.27e-1)"	"unprognostic (2.62e-1)"	"unprognostic (2.10e-2)"	"unprognostic (1.64e-1)"	"unprognostic (4.07e-1)"	"unprognostic (6.01e-3)"	"unprognostic (3.81e-2)"	"unprognostic (5.25e-3)"	"unprognostic (1.97e-1)"	"unprognostic (5.59e-3)"	"unprognostic (2.96e-2)"	"unprognostic (1.92e-1)"	"unprognostic (9.55e-2)"	"unprognostic (1.12e-2)"	"unprognostic (1.05e-1)"	"unprognostic (2.18e-1)"	6.7	3.7	2.1	1.2	3.5	2.4	4.4	0.4	4.2	5.7	10.6	4.6	1.3	5.4	8.4	2.9	11.5	5.6	4.7	1.9	1.8	4.9	2.1	9.5	1.2	2.8	4.5	8.9	3.4	4.8	5.6	3.3	2.2	5.9	2.1	2.1	3.1	8.1	2.3	3.2	2.2	5.9	1.8	1.2	3.2	9.0	2.4	1.2	6.7	3.5	0.9	4.3	3.7	2.5	2.4	6.0	3.1	9.5	2.7	10.3	4.5	3.5	6.0	2.6	2.2	0.0	4.4	0.0	3.9	2.3	3.6	2.6	2.1	2.0	2.5	0.0	3.5	1.9	3.2	0.0	3.3	2.7	1.3	5.3	3.1	7.7	1.5	0.2	3.8	1.7	19.2	1.1	2.2	0.0	1.5	0.8	8.9	8.5	1.4	0.4	0.0	0.6	7.1	1.2	5.7	7.7	2.3	12.5	1.3	3.5	6.4	2.0	2.3	0.1	1.4	2.7	1.5	2.5	3.5	0.0	4.9	0.1	11.1	0.0	0.0	0.0	0.1	0.0	0.5	0.0	0.1	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.1	2.1	3.5	0.4	4.2	1.9	1.8	2.8	4.5	2.2	1.8	2.4	2.5	5.2	9.6	3.9	0.0	0.2	0.0	0.0	0.0	0.0	0.0	2.1	2.4	0.0	0.0	1.8	12.9	0.0	2.3	0.5	0.0	3.9	2.8	0.0	36.7	8.9	2.3	0.0	0.0	0.0	1.3	4.1	2.7	0.0	3.9	2.5	4.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.1	0.0	0.0	2.4	18.2	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.5	0.2	4.1	0.0	0.0
MINPP1	MIPP	ENSG00000107789	"Multiple inositol-polyphosphate phosphatase 1"	Q9UNW1	10	87504875-87553461	"Disease related genes, Enzymes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"		Hydrolase	"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	4	"Erythroid cells: 288.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA026859	Approved				"Intracellular and membrane"	NA	NA		370000000	"Cluster 27: Non-specific - Gene expression"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 6: Erythroid cells - Oxygen transport"			"HPA026859: AB_1853961"	"unprognostic (9.15e-2)"	"unprognostic (8.76e-3)"	"unprognostic (2.08e-2)"	"unprognostic (2.97e-1)"	"unprognostic (1.35e-1)"	"unprognostic (5.20e-3)"	"unprognostic (3.47e-2)"	"unprognostic (1.74e-1)"	"unprognostic (4.55e-1)"	"unprognostic (2.07e-2)"	"unprognostic (6.54e-2)"	"unprognostic (6.50e-3)"	"prognostic unfavorable (6.98e-5)"	"unprognostic (2.43e-1)"	"unprognostic (2.09e-1)"	"unprognostic (2.07e-1)"	"unprognostic (7.01e-2)"	8.5	21.3	6.6	7.2	6.7	31.1	9.4	6.9	9.1	8.8	9.4	12.6	17.6	7.0	10.0	3.6	8.5	8.4	5.8	6.8	8.0	17.5	29.1	8.3	7.7	6.4	6.8	8.8	11.9	9.0	8.1	18.9	6.4	11.7	12.9	11.9	6.9	7.6	4.9	9.1	13.6	7.6	6.9	6.9	8.5	7.9	7.7	8.1	11.6	5.7	7.0	8.6	5.7	7.4	18.6	28.1	28.1	40.9	46.4	38.1	23.2	29.5	51.1	28.8	38.3	15.0	35.5	16.4	27.0	35.9	19.4	28.2	29.9	27.1	33.2	37.1	35.7	41.1	10.4	55.7	34.6	18.0	36.0	33.7	34.7	32.6	19.5	52.5	37.0	14.3	24.5	75.9	34.4	13.8	11.9	25.6	20.0	14.2	20.2	0.0	15.8	11.0	38.5	10.4	10.2	31.5	28.1	5.9	51.5	31.5	16.7	14.7	32.4	18.3	21.9	22.1	28.7	24.5	27.1	4.2	29.3	26.8	13.7	10.5	10.8	4.9	11.5	13.8	10.1	8.7	10.8	13.0	14.3	8.2	10.2	11.4	0.7	11.7	12.5	8.2	17.3	10.5	6.6	6.7	6.9	9.1	6.8	8.0	6.4	6.8	6.4	6.9	7.7	7.4	11.7	6.4	12.8	9.1	8.1	2.8	8.3	25.5	8.0	14.4	9.0	4.3	4.9	15.7	16.2	7.3	2.1	20.4	4.9	14.0	5.9	17.2	15.9	7.1	13.4	10.5	13.1	288.9	18.3	16.7	19.2	17.9	7.1	6.7	24.7	17.8	16.4	58.3	12.9	10.1	20.8	25.5	20.3	16.0	5.8	4.0	9.3	8.7	10.6	7.5	11.7	11.1	10.3	25.6	19.1	10.5	17.2	8.2	18.6	6.8	17.1	26.0	19.0	14.8	0.0	4.8	11.1	10.6	12.1	4.0	3.4	8.1	8.2	13.7	11.6	4.4
MIPEP	MIP	ENSG00000027001	"Mitochondrial intermediate peptidase"	Q99797	13	23730189-23889400	"Disease related genes, Enzymes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"		"Hydrolase, Metalloprotease, Protease"	"Disease variant, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Cardiomyocytes: 108.0;Oligodendrocytes: 62.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"OE19: 64.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA030676, HPA031669, HPA031670"	Approved		Enhanced	Mitochondria		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 21: OE19 - Mitochondria"	"Cluster 54: Cardiomyocytes - Muscle contraction"	Mitochondria		"HPA030676: AB_10598907, HPA031669: AB_10600986, HPA031670: AB_10602198"	"unprognostic (2.05e-1)"	"unprognostic (3.17e-2)"	"unprognostic (3.75e-3)"	"unprognostic (3.72e-2)"	"unprognostic (1.24e-1)"	"unprognostic (1.23e-1)"	"unprognostic (2.41e-1)"	"unprognostic (2.21e-1)"	"unprognostic (4.69e-2)"	"unprognostic (1.12e-1)"	"unprognostic (7.54e-2)"	"unprognostic (4.76e-1)"	"prognostic favorable (7.66e-12)"	"unprognostic (1.62e-2)"	"unprognostic (4.95e-2)"	"unprognostic (2.79e-1)"	"unprognostic (6.90e-3)"	6.3	9.6	3.7	6.2	4.3	5.3	11.1	3.2	5.0	7.5	13.4	12.9	8.8	7.2	12.4	11.5	17.3	7.7	18.4	14.4	4.0	25.4	12.0	7.1	5.1	4.0	5.0	5.4	8.2	14.6	5.4	4.7	4.6	10.9	13.1	6.1	9.7	8.7	13.9	21.4	7.6	7.8	4.0	4.3	8.6	9.8	3.7	6.0	11.1	16.9	7.8	7.7	6.4	4.9	14.6	16.1	7.8	18.4	17.4	23.4	16.6	10.3	16.0	15.1	12.7	21.7	28.1	17.0	10.2	8.4	13.3	35.8	18.1	21.6	18.8	9.9	11.5	7.4	7.0	18.8	14.3	17.5	3.9	11.6	26.4	15.7	13.9	12.7	19.2	12.7	14.5	2.7	24.0	10.8	12.6	9.8	10.8	64.8	16.1	13.8	21.0	14.8	33.7	9.6	18.2	6.1	11.0	17.8	21.8	9.8	18.3	9.7	10.7	9.2	7.6	15.3	11.2	2.6	4.0	9.1	15.9	8.8	11.7	0.0	3.0	1.3	7.4	3.7	9.3	8.7	7.1	6.8	6.5	7.2	6.7	6.7	0.0	10.3	12.0	5.5	5.2	4.0	3.7	4.3	3.2	5.0	14.4	4.0	4.0	5.0	4.6	4.0	3.7	4.9	2.5	16.0	8.6	18.9	5.9	39.9	7.7	13.8	6.2	3.6	6.2	5.8	108.0	11.5	12.6	9.2	6.2	9.8	2.4	8.2	29.4	23.4	8.2	26.0	8.5	5.4	6.0	4.6	43.8	10.6	9.3	8.0	7.1	8.5	2.5	4.2	3.6	5.9	9.7	15.2	47.5	7.1	14.2	3.5	5.0	7.4	6.8	4.3	5.4	12.2	3.4	5.5	5.2	18.1	62.8	8.6	7.0	8.6	4.9	7.5	6.6	25.6	46.3	11.4	0.0	7.3	5.7	9.7	19.0	10.1	42.3	5.1	4.0	8.9	13.6	5.6
MME	"CALLA, CD10, NEP"	ENSG00000196549	"Membrane metalloendopeptidase"	P08473	3	155024124-155183704	"Cancer-related genes, Candidate cardiovascular disease genes, CD markers, Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"		"Hydrolase, Metalloprotease, Protease"	"Cancer-related genes, Charcot-Marie-Tooth disease, Disease variant, FDA approved drug targets, Neurodegeneration, Neuropathy, Spinocerebellar ataxia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 333.5;kidney: 302.5"	"Cell type enhanced"	"Detected in many"		"Endometrial stromal cells: 273.3;Proximal enterocytes: 372.4;Proximal tubular cells: 125.7;Syncytiotrophoblasts: 126.0"	"Cancer enhanced"	"Detected in many"		"prostate cancer: 17.6"	"Group enriched"	"Detected in many"	5	"basal ganglia: 17.3;medulla oblongata: 9.3;pons: 10.9;thalamus: 4.6"	"Immune cell enriched"	"Detected in some"	122	"neutrophil: 139.4"	"Lineage enriched"	"Detected in many"	122	"granulocytes: 139.4"	"Cell line enhanced"	"Detected in many"		"ASC TERT1: 684.4;BJ hTERT+: 1116.9;HSkMC: 651.1"	"Region enhanced"	"Detected in many"		"basal ganglia: 28.1"	"Group enriched"	"Detected in many"	4	"basal ganglia: 32.3;olfactory bulb: 8.5;spinal cord: 15.9"	"CAB000013, HPA052583, HPA056072"	Enhanced					NA	NA		320000	"Cluster 9: Neutrophils - Innate immune response"	"Cluster 87: Intestine & Kidney - Transmembrane transport"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 45: Enterocytes - Digestion"			"CAB000013: AB_563478, HPA052583: AB_2681872, HPA056072: AB_2683027"	"unprognostic (1.36e-1)"	"unprognostic (1.02e-3)"	"unprognostic (8.52e-2)"	"unprognostic (2.95e-1)"	"unprognostic (2.78e-2)"	"unprognostic (6.52e-3)"	"unprognostic (1.20e-1)"	"unprognostic (1.67e-2)"	"unprognostic (8.67e-2)"	"unprognostic (1.96e-1)"	"unprognostic (7.30e-3)"	"unprognostic (1.31e-1)"	"unprognostic (2.71e-3)"	"unprognostic (1.50e-1)"	"unprognostic (7.29e-2)"	"unprognostic (1.06e-2)"	"unprognostic (1.37e-2)"	103.9	1.0	0.7	4.5	17.3	11.5	38.5	1.5	1.9	22.7	0.3	1.9	333.5	13.3	22.5	2.3	1.9	13.4	4.3	0.1	0.6	302.5	56.1	27.6	10.3	9.3	2.3	0.9	1.2	0.5	0.6	73.0	10.9	79.6	3.4	0.1	6.1	44.5	20.3	1.9	289.7	1.5	0.9	7.9	1.6	1.3	4.6	16.6	1.2	23.5	12.3	6.0	7.6	0.4	0.1	0.0	0.9	0.3	280.1	684.4	1.6	160.3	1116.9	82.2	209.8	0.0	0.3	172.9	0.1	130.1	107.4	0.5	5.2	6.1	201.3	0.0	0.8	0.0	0.1	0.2	229.6	0.0	0.0	651.1	1.0	40.4	308.1	89.4	59.5	0.4	0.2	0.3	135.1	0.7	0.4	1.0	6.1	0.5	1.1	303.3	139.9	1.6	5.2	1.9	0.5	1.5	0.1	0.5	31.9	68.3	0.2	0.2	165.8	356.4	0.8	115.7	27.9	0.1	0.0	217.3	42.5	0.1	7.3	0.0	0.1	0.2	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.2	0.0	0.0	139.4	0.0	0.0	1.1	0.0	0.0	0.7	17.3	1.5	1.9	0.1	0.6	9.3	2.3	10.9	0.9	4.6	0.4	5.9	9.6	13.0	0.3	2.3	0.8	74.1	2.5	0.0	0.0	1.5	64.1	1.6	21.5	11.2	22.0	0.0	82.1	6.9	0.0	9.8	0.2	0.5	6.2	273.3	6.6	0.0	0.0	2.2	0.0	57.8	40.6	0.0	5.7	2.5	0.0	2.9	53.2	8.9	0.0	8.1	9.9	2.0	3.1	1.2	0.5	4.1	10.7	0.0	0.0	0.2	0.0	0.0	0.5	0.3	0.6	13.8	1.2	0.1	40.0	372.4	125.7	1.6	0.0	0.0	17.4	11.1	0.2	0.5	0.1	0.3	126.0	2.5	0.1	12.6	33.6
MMEL1	"MMEL2, NEPII, NL1, NL2, SEP"	ENSG00000142606	"Membrane metalloendopeptidase like 1"	Q495T6	1	2590639-2633016	"Enzymes, Predicted intracellular proteins"		"Hydrolase, Metalloprotease, Protease"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"testis: 24.6"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 131.2;Late spermatids: 36.1;Paneth cells: 54.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enriched"	"Detected in some"	5	"SK-BR-3: 14.2"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA007876, HPA008205, CAB020786"	Uncertain				"Intracellular and membrane"	NA	NA			"Cluster 34: Basophils - Unknown function"	"Cluster 71: Testis - DNA repair"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 29: Early spermatids - Spermatogenesis"			"CAB020786: , HPA007876: AB_1854012, HPA008205: AB_1854011"	"unprognostic (5.80e-2)"	"unprognostic (4.61e-2)"	"unprognostic (1.87e-1)"	"unprognostic (4.27e-2)"	"unprognostic (1.33e-1)"	"unprognostic (2.71e-2)"	"unprognostic (1.45e-1)"	"unprognostic (7.96e-2)"	"unprognostic (1.36e-2)"	"unprognostic (2.37e-1)"	"unprognostic (4.54e-3)"	"unprognostic (2.44e-2)"	"unprognostic (4.79e-2)"	"unprognostic (3.18e-1)"	"unprognostic (2.82e-1)"	"unprognostic (2.18e-3)"	"unprognostic (7.01e-4)"	2.9	1.4	0.6	0.0	0.6	0.0	3.0	0.5	0.9	3.2	0.4	3.7	2.6	0.7	0.9	4.8	2.9	0.0	0.5	0.5	0.8	3.7	0.5	2.8	0.0	1.0	1.0	0.4	2.0	0.6	0.7	0.0	0.8	6.5	0.3	0.1	1.6	0.3	0.2	0.7	4.2	0.0	0.7	2.5	8.2	24.6	0.7	0.0	1.1	0.0	0.0	3.1	3.2	0.6	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	2.3	0.0	2.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.2	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	2.4	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.4	0.0	0.5	0.0	0.1	0.0	14.2	0.0	0.0	1.3	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.0	1.0	4.7	0.3	2.6	0.2	0.4	1.0	0.4	0.7	0.0	2.7	1.3	0.6	1.8	3.6	0.1	4.2	1.7	0.6	0.6	0.5	0.9	0.5	0.8	1.0	1.0	0.8	0.7	0.7	0.6	5.9	0.0	0.0	0.3	0.4	0.0	5.2	5.2	1.2	0.0	10.3	8.9	1.1	20.0	10.2	18.4	0.0	0.0	0.3	12.1	0.0	9.4	131.2	7.1	0.5	2.3	1.2	2.5	0.1	3.4	0.0	1.3	8.6	7.3	0.0	0.0	1.4	0.2	1.2	0.0	0.2	16.5	2.0	1.0	0.2	36.1	1.8	2.4	0.0	0.0	0.9	0.5	0.0	0.5	0.0	4.0	54.9	1.2	0.2	6.7	20.8	0.1	8.8	0.2	0.0	0.0	0.6	0.6	1.1	0.6	0.0	0.0	0.8	0.4	9.7	12.6
MMP1	CLG	ENSG00000196611	"Matrix metallopeptidase 1"	P03956	11	102789401-102798160	"Cancer-related genes, Candidate cardiovascular disease genes, Enzymes, Human disease related genes, Plasma proteins, Predicted secreted proteins"	"Collagen degradation, Host-virus interaction"	"Hydrolase, Metalloprotease, Protease"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"gallbladder: 75.7;stomach 1: 47.6;urinary bladder: 52.2"	"Cell type enriched"	"Detected in many"	10	"Pancreatic endocrine cells: 2239.5"	"Cancer enhanced"	"Detected in many"		"head and neck cancer: 344.2"	"Region enriched"	"Detected in single"	7	"cerebral cortex: 1.3"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"BJ hTERT+: 1139.1;HBF TERT88: 1094.4;HUVEC TERT2: 2954.4;WM-115: 1454.1"	"Not detected"	"Not detected"							HPA004920			Approved	Vesicles	"Secreted to extracellular matrix"	NA	NA	7730000	55000		"Cluster 12: Smooth muscle tissue - Mixed function"	"Cluster 17: WM-115 - Nervous system development"	"Cluster 16: Pancreatic endocrine cells - Mixed function"	Vesicles		"HPA004920: AB_2667293"	"unprognostic (4.11e-3)"	"prognostic unfavorable (4.66e-4)"	"unprognostic (4.20e-3)"	"unprognostic (1.19e-3)"	"unprognostic (6.46e-2)"	"unprognostic (6.50e-2)"	"prognostic unfavorable (4.22e-6)"	"unprognostic (7.83e-3)"	"unprognostic (2.94e-2)"	"unprognostic (5.44e-2)"	"unprognostic (1.11e-3)"	"unprognostic (1.75e-1)"	"prognostic unfavorable (9.86e-10)"	"unprognostic (1.67e-2)"	"unprognostic (1.49e-1)"	"unprognostic (1.26e-2)"	"unprognostic (5.11e-2)"	0.3	0.1	0.0	26.7	0.0	0.3	0.2	0.0	1.3	0.1	0.0	6.1	7.9	10.7	0.0	4.2	0.1	75.7	0.4	0.0	0.1	1.0	0.8	6.7	0.1	0.0	0.0	0.0	1.8	0.0	0.1	7.2	0.0	0.4	6.8	0.0	6.9	0.2	0.0	0.6	13.0	1.2	0.0	2.1	47.6	0.1	0.1	0.3	0.2	0.0	1.7	52.2	0.2	0.0	0.0	0.0	0.0	1.0	0.0	1.1	0.0	517.1	1139.1	456.6	118.2	9.1	1.0	0.0	5.2	275.5	175.2	4.6	0.0	160.0	1094.4	0.0	1.0	0.0	0.0	0.0	2.9	0.0	0.5	0.3	0.8	470.1	39.6	0.1	2954.4	0.0	1.5	0.5	0.3	0.0	0.0	0.0	0.4	189.3	20.8	0.0	0.1	0.0	0.7	2.2	0.0	0.1	4.8	0.0	1.6	0.1	0.5	0.0	155.0	374.1	0.6	16.8	1.3	0.1	0.0	0.0	8.8	0.0	1454.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	1.3	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	1.3	3.2	2.6	0.0	0.2	2.3	22.4	90.4	0.0	0.0	0.0	0.0	0.1	30.0	15.8	3.7	0.0	0.0	0.0	0.2	0.0	143.7	0.0	0.1	0.2	113.2	0.0	0.0	0.1	204.8	0.1	11.5	25.5	2.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	2.0	1.9	0.4	0.0	0.0	15.5	0.0	0.0	4.2	0.0	0.0	0.0	0.0	2239.5	1.2	0.0	0.0	30.9	0.7	0.2	1.3	0.0	0.0	1.8	10.5	0.0	0.0	0.0	0.3	0.1	0.1	0.1	0.1	44.3
MMP10	STMY2	ENSG00000166670	"Matrix metallopeptidase 10"	P09238	11	102770502-102780628	"Cancer-related genes, Enzymes, Predicted secreted proteins"	"Collagen degradation"	"Hydrolase, Metalloprotease, Protease"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	34	"endometrium 1: 265.4"	"Cell type enriched"	"Detected in some"	38	"Basal respiratory cells: 3913.2"	"Group enriched"	"Detected in many"	4	"cervical cancer: 47.8;head and neck cancer: 102.2;lung cancer: 42.3"	"Region enhanced"	"Detected in single"		"thalamus: 1.9"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BJ: 11.8;HUVEC TERT2: 15.1;SCLC-21H: 4.7"									CAB002159	Uncertain		Approved	"Plasma membrane,Cytosol"	"Secreted to extracellular matrix"	NA	NA	765000			"Cluster 89: Fibroblasts - ECM organization"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"	Cytosol	"Plasma membrane"	"CAB002159: AB_564103"	"unprognostic (8.76e-2)"	"unprognostic (3.38e-1)"	"unprognostic (1.98e-3)"	"unprognostic (2.72e-3)"	"unprognostic (7.17e-3)"	"unprognostic (1.52e-2)"	"unprognostic (5.67e-8)"	"unprognostic (2.08e-3)"	"unprognostic (2.20e-1)"	"unprognostic (1.75e-1)"	"unprognostic (1.67e-2)"	"unprognostic (2.67e-1)"	"unprognostic (6.99e-5)"	"unprognostic (2.66e-2)"	"unprognostic (7.98e-2)"	"unprognostic (5.46e-2)"	"prognostic favorable (7.12e-4)"	0.1	0.0	0.1	7.7	0.0	0.1	0.1	0.0	0.8	1.2	0.0	0.4	1.1	265.4	0.0	0.2	0.0	1.3	0.0	0.2	0.3	0.1	1.0	2.0	0.1	0.1	0.3	0.2	0.2	0.0	0.0	1.3	0.3	1.4	0.2	0.0	1.6	0.0	0.0	0.1	0.8	0.2	0.0	0.0	2.9	0.5	1.9	0.6	0.0	0.2	0.7	4.4	3.2	0.0	0.0	0.1	0.8	0.2	0.0	0.0	0.2	11.8	0.6	0.1	0.1	0.3	0.0	0.0	3.3	1.8	0.2	2.7	0.0	1.3	0.0	0.0	0.2	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.4	0.5	0.0	15.1	0.0	0.7	0.0	0.0	0.0	0.0	0.3	2.8	0.5	1.6	0.0	0.0	0.0	0.0	0.6	4.7	0.0	2.4	0.0	0.0	0.8	0.0	0.0	1.9	3.5	1.2	0.4	0.5	0.0	0.0	0.1	0.6	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.8	0.2	0.3	0.1	0.3	0.3	0.0	1.9	0.0	0.1	0.0	0.0	0.0	0.0	0.8	51.3	3913.2	0.0	0.0	0.7	0.0	0.1	0.0	85.4	29.5	0.0	0.0	0.0	0.4	0.0	34.0	6.1	6.4	2.5	9.0	0.0	0.0	0.0	14.6	0.0	6.3	0.0	12.4	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.1	22.4	0.0	9.5	1.3	0.0	0.6	0.0	0.0	1.6	0.0	0.0	0.0	0.0	102.5	0.1	0.0	0.0	42.5	0.0	0.1	29.3	0.0	0.0	0.0	11.7	0.0	0.1	0.0	0.1	0.0	0.1	0.0	0.1	8.2
MMP12	HME	ENSG00000262406	"Matrix metallopeptidase 12"	P39900	11	102862736-102874982	"Cancer-related genes, Enzymes, Predicted secreted proteins"		"Hydrolase, Metalloprotease, Protease"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"intestine: 15.7;lymphoid tissue: 40.4;urinary bladder: 16.0"	"Cell type enriched"	"Detected in some"	9	"Extravillous trophoblasts: 303.4"	"Low cancer specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	13	"BJ: 3.3;fHDF/TERT166: 11.4;hTEC/SVTERT24-B: 6.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"								"Secreted to extracellular matrix"	NA	NA				"Cluster 14: B-cells - Humoral immune response"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 38: Extravillous trophoblasts - Unknown function"				"unprognostic (7.33e-2)"	"unprognostic (3.20e-2)"	"unprognostic (1.00e-2)"	"unprognostic (1.03e-1)"	"unprognostic (2.74e-1)"	"unprognostic (1.67e-1)"	"prognostic unfavorable (1.42e-4)"	"unprognostic (1.69e-2)"	"unprognostic (7.31e-2)"	"unprognostic (1.52e-2)"	"unprognostic (1.52e-3)"	"unprognostic (5.45e-2)"	"unprognostic (3.05e-6)"	"unprognostic (1.08e-2)"	"unprognostic (4.66e-2)"	"unprognostic (1.73e-1)"	"unprognostic (6.92e-2)"	0.5	0.0	0.0	40.4	0.1	0.0	0.4	0.0	0.0	0.1	0.0	13.5	6.8	0.6	0.0	0.4	0.0	2.6	0.0	0.0	0.3	0.9	0.1	0.6	7.0	0.1	0.1	0.0	0.1	0.0	0.0	7.4	0.1	1.3	15.7	0.0	2.4	0.0	0.0	0.5	7.8	2.2	0.1	3.7	3.5	0.0	0.1	3.9	0.0	0.0	19.4	16.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.3	0.3	0.1	0.0	0.0	0.0	0.0	0.0	11.4	0.1	0.4	0.0	0.0	0.3	0.3	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.4	0.0	0.1	0.0	0.0	0.0	0.4	0.4	0.1	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	3.2	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	1.1	0.0	0.0	0.1	0.7	0.0	0.0	0.0	18.6	303.4	0.4	0.0	0.2	0.0	0.0	0.0	0.0	15.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	32.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.5	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	4.5	0.1	0.0	0.0	2.2
MMP14	MT1-MMP	ENSG00000157227	"Matrix metallopeptidase 14"	P50281	14	22836560-22849041	"Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"		"Hydrolase, Metalloprotease, Protease"	"Cancer-related genes, Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Extravillous trophoblasts: 244.0;Pancreatic endocrine cells: 144.7;Syncytiotrophoblasts: 122.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"ASC diff: 923.8;HHSteC: 794.2;HSkMC: 887.0;hTERT-RPE1: 925.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB009918, HPA051432"	Approved		Approved	"Intermediate filaments,Cytosol"		No	No		1400000		"Cluster 46: Fibroblasts - ECM organization"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 38: Extravillous trophoblasts - Unknown function"	Cytosol	"Intermediate filaments"	"CAB009918: AB_2250767, HPA051432: AB_2681484"	"unprognostic (1.34e-1)"	"unprognostic (1.37e-1)"	"unprognostic (1.11e-2)"	"unprognostic (2.81e-1)"	"unprognostic (4.28e-2)"	"unprognostic (1.12e-2)"	"unprognostic (3.05e-3)"	"unprognostic (5.91e-3)"	"unprognostic (1.95e-1)"	"prognostic unfavorable (9.48e-4)"	"unprognostic (3.82e-3)"	"unprognostic (7.31e-2)"	"prognostic unfavorable (1.34e-4)"	"unprognostic (5.02e-2)"	"unprognostic (6.69e-2)"	"unprognostic (1.00e-2)"	"unprognostic (3.41e-3)"	151.5	31.7	5.6	59.9	5.0	1.6	101.5	5.7	7.5	181.3	61.8	77.2	39.5	167.3	19.0	92.1	82.1	148.2	41.3	6.6	7.2	35.9	13.2	91.8	24.8	11.9	8.4	90.2	36.0	65.3	14.2	118.9	9.2	59.9	36.6	9.6	78.1	45.5	18.8	127.5	69.4	106.0	7.3	30.8	57.7	11.7	13.2	13.0	50.0	16.1	30.8	103.9	111.1	10.6	90.6	1.2	26.3	2.0	923.8	651.6	455.9	270.1	606.4	93.3	158.5	21.3	337.4	0.9	146.4	301.9	24.6	216.3	0.3	262.2	99.7	1.1	0.6	37.2	1.7	5.0	794.2	0.4	1.3	887.0	148.7	334.7	288.3	925.5	492.9	0.6	0.8	2.1	185.1	0.7	0.4	79.4	14.7	17.7	52.4	2.1	96.0	0.2	61.4	148.1	0.3	0.6	187.3	0.3	574.2	104.4	1.0	79.5	436.8	724.9	53.7	198.2	329.6	0.8	1.6	1.1	410.9	0.6	396.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.6	5.0	5.7	7.5	6.6	7.2	11.9	8.4	9.2	7.3	13.2	10.6	13.9	12.8	3.0	2.0	3.4	34.0	23.4	105.4	39.3	0.0	14.1	17.5	4.7	50.1	42.2	7.3	0.0	105.6	0.3	19.9	11.7	63.0	0.4	16.1	81.6	35.2	7.8	0.0	0.0	28.7	244.0	84.0	25.5	14.8	3.8	9.3	32.9	2.7	89.5	0.0	0.0	24.5	34.6	20.2	32.7	2.4	72.1	38.0	37.4	4.7	21.5	14.3	0.0	0.5	0.1	144.7	33.0	54.9	0.3	21.8	19.9	11.7	46.8	0.8	39.5	11.1	73.9	0.8	0.8	33.7	34.2	122.7	2.5	15.6	18.6	37.9
MMP2	"CLG4, CLG4A, TBE-1"	ENSG00000087245	"Matrix metallopeptidase 2"	P08253	16	55389700-55506691	"Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, Enzymes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted secreted proteins"	"Angiogenesis, Collagen degradation"	"Hydrolase, Metalloprotease, Protease"	"Cancer-related genes, Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"gallbladder: 1062.9"	"Cell type enhanced"	"Detected in many"		"Endometrial stromal cells: 222.4;Extravillous trophoblasts: 467.9;Fibroblasts: 815.9;Leydig cells: 340.2;Peritubular cells: 419.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"ASC diff: 5619.3;ASC TERT1: 1623.2;hTERT-RPE1: 6400.4;U-87 MG: 1812.3"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA001939, CAB002788"	Approved		Approved	Vesicles	"Secreted to extracellular matrix"	NA	NA	1600000000	220000000		"Cluster 46: Fibroblasts - ECM organization"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 50: Fibroblasts - ECM organization"	Vesicles		"CAB002788: , HPA001939: AB_1079395"	"unprognostic (7.26e-2)"	"unprognostic (1.36e-3)"	"unprognostic (1.66e-1)"	"unprognostic (2.14e-3)"	"unprognostic (5.03e-2)"	"unprognostic (1.20e-1)"	"unprognostic (1.74e-1)"	"unprognostic (9.36e-3)"	"unprognostic (4.81e-3)"	"unprognostic (3.79e-2)"	"unprognostic (4.59e-3)"	"unprognostic (6.12e-2)"	"unprognostic (1.28e-3)"	"unprognostic (1.59e-2)"	"unprognostic (8.00e-2)"	"unprognostic (8.98e-2)"	"unprognostic (4.63e-2)"	518.9	68.3	3.9	135.1	4.0	1.2	328.9	4.9	7.8	514.1	9.4	173.8	57.4	453.6	192.6	121.5	190.6	1062.9	212.8	3.6	5.3	43.7	15.6	279.7	28.1	7.6	4.9	271.1	42.8	13.8	14.7	225.0	5.4	116.8	171.3	11.4	124.1	137.5	60.8	455.6	177.3	468.5	6.7	58.3	134.0	49.6	8.6	19.8	113.5	66.1	30.3	660.8	238.1	10.0	6.5	3.9	192.0	2.4	5619.3	1623.2	312.7	501.4	1146.1	99.4	79.0	0.2	2.1	0.5	391.7	891.0	37.0	54.2	1.2	4.6	57.0	0.7	0.9	0.7	12.9	3.0	530.6	0.4	14.8	1396.8	1.7	512.4	4.4	6400.4	651.1	0.5	0.7	2.4	334.7	0.0	0.4	8.2	152.4	0.5	1.6	0.4	46.1	0.9	16.1	7.6	3.2	345.0	93.3	0.8	2.1	849.0	1.6	36.0	924.6	1546.0	144.9	300.5	66.9	1.0	0.6	2.2	1812.3	28.3	289.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.9	4.0	4.9	7.8	3.6	5.3	7.6	4.9	5.4	6.7	8.6	10.0	38.4	0.0	0.5	0.0	0.0	122.1	14.1	48.8	9.1	30.5	3.1	16.8	4.4	0.0	3.1	11.0	0.0	5.6	0.5	0.1	0.0	2.5	12.5	7.7	222.4	46.9	28.2	0.0	0.0	0.4	467.9	815.9	12.2	5.4	0.0	0.0	13.2	0.1	28.2	1.7	0.2	0.1	2.0	1.6	180.7	40.2	340.2	11.8	128.1	27.2	0.0	7.7	0.0	5.0	0.0	9.3	0.0	419.0	2.8	5.6	0.0	0.2	1.1	2.5	13.1	80.0	65.3	1.2	2.8	6.6	102.3	17.2	10.3	35.2	0.0	4.4
MMP3	"STMY, STMY1"	ENSG00000149968	"Matrix metallopeptidase 3"	P08254	11	102835801-102843609	"Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, Enzymes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted secreted proteins"	"Collagen degradation"	"Hydrolase, Metalloprotease, Protease"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 90.7;salivary gland: 286.1"	"Cell type enhanced"	"Detected in some"		"Basal prostatic cells: 20.4;Basal respiratory cells: 25.8;Early spermatids: 24.2;Extravillous trophoblasts: 13.4;Fibroblasts: 17.9;Prostatic glandular cells: 11.9;Smooth muscle cells: 10.2"	"Cancer enhanced"	"Detected in many"		"head and neck cancer: 59.9"	"Region enriched"	"Detected in some"	4	"thalamus: 7.3"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	18	"BJ: 1545.7;BJ hTERT+: 4229.3;fHDF/TERT166: 1846.6"	"Not detected"	"Not detected"			"Region enhanced"	"Detected in some"		"hippocampal formation: 3.2"	HPA007875	Uncertain		Supported	Vesicles	"Secreted to extracellular matrix"	NA	NA	2540000	460000		"Cluster 24: Salivary gland - Salivary secretion"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 50: Fibroblasts - ECM organization"	Vesicles		"HPA007875: AB_1079396"	"unprognostic (2.27e-1)"	"prognostic unfavorable (9.73e-4)"	"unprognostic (1.63e-3)"	"unprognostic (5.11e-3)"	"unprognostic (3.78e-1)"	"unprognostic (5.11e-2)"	"unprognostic (5.26e-6)"	"unprognostic (3.46e-2)"	"unprognostic (7.14e-2)"	"unprognostic (2.87e-1)"	"prognostic unfavorable (4.09e-4)"	"unprognostic (3.26e-2)"	"unprognostic (1.22e-15)"	"unprognostic (3.17e-1)"	"unprognostic (1.55e-1)"	"unprognostic (3.43e-2)"	"unprognostic (2.34e-1)"	90.7	0.1	0.3	20.1	0.4	0.0	36.6	0.2	1.6	0.3	0.1	6.1	2.4	38.1	0.2	0.8	0.2	1.9	0.2	0.4	1.6	0.4	1.6	0.3	0.0	0.4	0.4	0.1	0.3	0.1	0.9	0.4	0.3	2.2	2.3	0.0	286.1	2.2	39.6	63.7	4.5	1.6	0.3	0.0	10.5	0.1	7.3	0.1	2.6	0.4	1.3	13.9	0.5	0.3	0.0	0.0	0.0	0.1	0.4	0.0	0.0	1545.7	4229.3	27.0	8.7	0.1	0.2	0.0	0.0	1846.6	96.9	0.0	0.1	0.1	45.1	0.0	0.0	0.0	0.0	1.0	0.7	0.0	0.0	4.6	0.2	122.0	5.3	0.0	0.0	0.0	0.2	0.3	4.7	0.0	0.0	0.0	0.2	0.4	0.9	0.0	0.2	0.0	0.1	0.0	0.1	0.0	2.3	0.0	0.0	0.9	0.0	0.3	0.0	140.5	13.1	1.6	0.5	0.0	0.0	0.2	56.8	0.0	7.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.4	0.2	1.6	0.4	1.6	0.4	0.4	0.3	0.3	7.3	0.3	0.0	3.2	0.0	0.0	0.0	8.4	20.4	25.8	0.0	0.0	0.1	0.1	0.3	4.3	7.6	0.0	0.0	0.1	0.0	0.0	0.0	0.8	24.2	0.0	0.3	0.5	0.0	0.0	0.2	1.4	13.4	17.9	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	4.1	0.0	2.2	1.2	0.0	0.3	0.0	0.0	0.6	0.0	0.0	0.0	0.0	3.5	4.0	0.0	0.0	11.9	1.0	0.9	0.1	0.0	0.0	1.8	10.2	0.0	1.8	0.0	3.4	0.3	0.6	0.0	0.8	7.4
MMP7	"MPSL1, PUMP-1"	ENSG00000137673	"Matrix metallopeptidase 7"	P09237	11	102520508-102530750	"Cancer-related genes, Enzymes, Plasma proteins, Predicted secreted proteins"	"Collagen degradation"	"Hydrolase, Metalloprotease, Protease"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"gallbladder: 509.9;salivary gland: 267.9;urinary bladder: 211.2"	"Cell type enriched"	"Detected in many"	8	"Ductal cells: 8176.2"	"Cancer enhanced"	"Detected in all"		"pancreatic cancer: 352.1"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A549: 145.9;CAPAN-2: 815.9;EFO-21: 189.8;RPTEC TERT1: 350.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"CAB025869, HPA051358"	Supported		Approved	Nucleoplasm,Vesicles	"Secreted to extracellular matrix"	NA	NA	2810000	35000		"Cluster 5: Breast - Unknown function"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 1: Pancreatic cells - Digestion"	"Nucleoplasm, Vesicles"		"CAB025869: , HPA051358: AB_2681452"	"unprognostic (1.06e-3)"	"unprognostic (9.51e-2)"	"unprognostic (4.15e-2)"	"unprognostic (1.38e-1)"	"unprognostic (7.70e-3)"	"unprognostic (7.28e-2)"	"prognostic unfavorable (2.53e-4)"	"prognostic unfavorable (3.38e-4)"	"unprognostic (3.96e-2)"	"unprognostic (5.63e-2)"	"unprognostic (6.59e-3)"	"unprognostic (1.51e-1)"	"unprognostic (6.36e-3)"	"unprognostic (1.42e-2)"	"unprognostic (5.54e-2)"	"unprognostic (1.48e-1)"	"unprognostic (1.46e-1)"	3.8	0.1	0.0	2.0	0.0	0.3	168.7	0.0	0.3	13.3	0.0	1.6	0.6	97.4	27.9	21.3	91.2	509.9	0.2	0.0	0.0	140.2	3.4	31.6	1.9	0.0	0.0	0.7	85.2	0.0	0.3	0.8	0.0	54.0	1.0	0.0	267.9	34.9	0.1	32.4	0.6	4.8	0.0	0.2	7.3	0.6	0.4	3.3	0.4	0.0	29.3	211.2	1.7	0.0	0.2	145.9	0.0	0.4	0.0	0.0	0.2	0.0	2.1	0.1	0.1	1.9	815.9	0.0	189.8	0.0	0.0	1.1	0.0	0.1	0.1	0.7	0.0	0.0	0.0	0.6	1.0	0.1	0.2	0.7	0.4	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.2	0.1	0.0	0.5	11.8	0.0	0.0	0.0	0.0	350.1	1.0	0.0	0.0	0.0	0.0	0.0	3.9	0.3	0.1	0.0	0.7	3.0	0.0	1.6	0.1	0.6	0.4	1.0	5.9	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.7	86.6	43.3	0.0	1.5	1.0	382.2	135.4	1.2	0.0	124.2	93.7	0.7	100.1	401.2	1017.0	0.0	0.7	2.9	1.2	0.0	8176.2	6.1	62.1	3.3	8.8	0.0	0.0	0.0	209.4	0.3	3.4	0.0	124.6	2.5	0.0	0.0	0.0	98.0	0.0	0.0	0.0	38.7	0.6	0.3	10.3	11.8	12.6	0.0	0.0	65.2	0.0	0.0	0.0	0.0	850.9	0.0	0.0	0.1	603.3	0.0	33.9	72.6	0.0	0.0	0.0	31.4	0.1	0.2	17.0	2.4	0.8	3.6	0.0	2.3	840.8
MMP8	CLG1	ENSG00000118113	"Matrix metallopeptidase 8"	P22894	11	102711796-102727050	"Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Collagen degradation"	"Hydrolase, Metalloprotease, Protease"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	36	"bone marrow: 501.1"	"Group enriched"	"Detected in some"	6	"Hofbauer cells: 4.0;Macrophages: 1.5"	"Cancer enriched"	"Detected in single"	17	"melanoma: 5.7"	"Not detected"	"Not detected"			"Immune cell enhanced"	"Detected in single"		"non-classical monocyte: 1.7"	"Lineage enhanced"	"Detected in single"		"monocytes: 1.7"	"Cell line enriched"	"Detected in some"	8	"WM-115: 70.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA021221, HPA021763, HPA022935"	Enhanced		Approved	Vesicles	"Secreted to extracellular matrix"	NA	NA		360000	"Cluster 7: Monocytes - Unknown function"	"Cluster 67: Neutrophils - Humoral immune response"	"Cluster 17: WM-115 - Nervous system development"	"Cluster 19: Monocytes & Neutrophils - Innate immune response"	Vesicles		"HPA021221: AB_1854043, HPA021763: , HPA022935: AB_1854044"	"unprognostic (3.03e-1)"	"unprognostic (8.49e-5)"	"unprognostic (1.08e-2)"	"unprognostic (3.95e-3)"	"unprognostic (1.80e-1)"	"unprognostic (1.01e-2)"		"unprognostic (7.68e-3)"	"unprognostic (1.27e-1)"	"unprognostic (4.92e-2)"	"unprognostic (6.64e-3)"		"unprognostic (2.45e-6)"	"unprognostic (2.33e-4)"	"unprognostic (1.33e-1)"	"unprognostic (4.97e-1)"	"unprognostic (2.30e-2)"	0.5	0.0	0.0	0.3	0.1	501.1	0.2	0.1	0.2	0.0	0.2	0.1	0.0	1.9	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.2	0.6	4.1	0.2	0.1	0.0	0.0	0.0	0.0	0.2	0.7	0.2	0.0	0.0	0.0	0.2	0.0	0.1	0.5	0.0	0.2	0.0	13.8	0.1	0.0	0.6	2.6	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	9.1	0.0	0.0	0.1	0.0	4.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	70.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	1.7	0.0	0.0	0.9	0.0	0.1	0.1	0.2	0.0	0.0	0.1	0.0	0.2	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0
MMP9	CLG4B	ENSG00000100985	"Matrix metallopeptidase 9"	P14780	20	46008908-46016561	"Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted secreted proteins"	"Collagen degradation"	"Hydrolase, Metalloprotease, Protease"	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	11	"bone marrow: 376.0;lymphoid tissue: 105.3"	"Group enriched"	"Detected in many"	5	"Hofbauer cells: 260.1;Langerhans cells: 606.0;Macrophages: 230.6"	"Low cancer specificity"	"Detected in all"			"Group enriched"	"Detected in some"	4	"cerebral cortex: 3.1;thalamus: 4.8"	"Immune cell enriched"	"Detected in some"	127	"neutrophil: 272.2"	"Lineage enriched"	"Detected in single"	341	"granulocytes: 272.2"	"Cell line enriched"	"Detected in some"	13	"NB-4: 360.6"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"CAB000348, HPA001238, HPA063909, CAB068199, CAB068200, CAB068201"	Enhanced		Approved	Cytosol	"Secreted to blood"	NA	NA	43300000	61000000	"Cluster 9: Neutrophils - Innate immune response"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 24: NB-4 - Immune response"	"Cluster 4: Macrophages - Innate immune response"	Cytosol		"CAB000348: , CAB068199: AB_2665675, CAB068200: AB_2665676, CAB068201: AB_2665677, HPA001238: AB_1079398, HPA063909: AB_2685150"	"unprognostic (4.62e-2)"	"unprognostic (1.64e-1)"	"unprognostic (2.85e-2)"	"prognostic favorable (2.55e-4)"	"unprognostic (6.65e-3)"	"unprognostic (2.82e-1)"	"prognostic unfavorable (7.19e-4)"	"unprognostic (1.54e-1)"	"unprognostic (8.57e-2)"	"unprognostic (3.21e-2)"	"unprognostic (4.15e-2)"	"unprognostic (1.96e-1)"	"prognostic unfavorable (4.05e-5)"	"unprognostic (4.65e-1)"	"unprognostic (9.85e-3)"	"unprognostic (2.48e-2)"	"unprognostic (2.17e-3)"	19.5	0.6	0.5	61.9	0.8	376.0	8.2	0.4	3.1	2.9	0.8	5.7	11.6	1.0	0.0	2.2	2.2	3.0	3.2	0.3	0.9	2.6	3.8	21.1	103.2	0.8	0.5	0.8	1.6	0.1	1.1	2.0	0.7	1.9	3.4	0.6	3.6	0.4	0.7	3.2	12.4	1.9	0.4	105.3	11.3	1.3	4.8	17.0	2.1	0.9	36.5	12.0	1.1	0.2	0.2	0.4	0.2	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	3.3	0.3	28.8	0.0	0.3	0.4	0.0	1.4	0.0	0.3	0.5	0.1	0.0	0.0	0.0	0.6	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.4	0.0	4.0	0.0	360.6	0.8	0.0	0.2	0.4	0.3	0.1	0.0	0.0	0.6	0.6	0.0	0.6	0.0	3.7	0.3	1.2	0.3	10.3	10.9	0.1	0.3	0.3	0.2	0.2	0.1	0.8	0.2	0.0	0.7	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	272.2	0.0	0.3	0.0	0.0	0.5	0.5	0.8	0.4	3.1	0.3	0.9	0.8	0.5	0.7	0.4	4.8	0.2	0.7	0.0	5.5	0.0	3.9	34.3	0.1	61.5	0.0	3.8	0.5	2.0	0.4	1.5	0.9	0.0	8.4	1.5	2.0	0.0	0.0	0.8	0.9	0.0	0.1	7.2	0.0	0.0	0.1	1.8	2.4	2.5	0.0	0.1	1.3	0.2	0.0	0.0	260.1	3.3	0.2	0.5	0.0	1.3	606.0	0.3	0.0	230.6	56.9	0.0	2.3	1.2	0.0	0.0	0.0	1.8	0.0	0.0	0.9	0.1	0.0	0.3	6.9	5.3	0.0	0.2	45.5	6.7	11.2	0.2	28.1	1.9	3.4	0.3	0.0	0.1
MOGS	"CWH41, DER7, GCS1"	ENSG00000115275	"Mannosyl-oligosaccharide glucosidase"	Q13724	2	74461057-74465410	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"		"Glycosidase, Hydrolase"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Late spermatids: 222.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA011322, HPA011969"	Approved		Supported	"Endoplasmic reticulum"		NA	NA		1500000	"Cluster 41: Basophils - Cellular respiration"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 25: Spermatids - Spermatogenesis"	"Endoplasmic reticulum"		"HPA011322: AB_2668483, HPA011969: AB_1849579"	"unprognostic (5.66e-2)"	"unprognostic (1.98e-2)"	"prognostic unfavorable (5.33e-4)"	"unprognostic (1.91e-2)"	"unprognostic (4.67e-2)"	"unprognostic (2.04e-1)"	"prognostic unfavorable (2.34e-6)"	"unprognostic (1.48e-2)"	"unprognostic (2.66e-2)"	"unprognostic (3.32e-2)"	"unprognostic (6.21e-2)"	"unprognostic (4.36e-1)"	"prognostic unfavorable (2.79e-8)"	"unprognostic (1.40e-2)"	"unprognostic (3.06e-2)"	"unprognostic (2.66e-1)"	"unprognostic (7.59e-3)"	18.4	18.3	8.1	20.2	9.1	8.5	18.6	9.0	13.3	19.2	9.2	22.8	41.7	18.3	5.5	22.5	20.0	14.4	16.9	8.3	9.0	20.9	34.3	24.9	21.6	9.4	8.7	18.6	42.3	21.5	21.7	34.5	9.9	23.3	13.4	9.6	31.1	14.6	21.3	24.9	29.7	11.4	9.3	31.7	35.5	19.0	8.9	19.8	21.9	16.2	18.1	20.1	19.1	9.8	53.1	46.2	23.5	29.6	55.3	38.9	90.1	38.7	58.3	59.8	58.2	81.9	58.7	45.2	34.9	36.3	46.7	50.6	40.2	43.3	32.5	46.7	39.9	20.3	14.4	68.6	54.9	49.8	46.6	25.6	77.1	41.9	39.0	62.2	68.4	27.8	39.6	51.6	28.5	58.8	32.3	62.0	42.6	64.1	22.5	35.5	57.4	74.1	38.0	19.5	19.7	29.2	15.5	84.8	62.7	21.8	38.7	34.3	40.1	26.5	49.7	36.3	56.5	66.5	36.5	22.7	46.9	49.3	39.0	6.7	2.4	1.9	2.6	1.5	3.3	1.2	2.3	2.5	2.1	1.9	1.4	1.6	0.4	8.4	3.3	2.1	3.3	1.7	8.1	9.1	9.0	13.3	8.3	9.0	9.4	8.7	9.9	9.3	8.9	9.8	13.9	6.4	15.9	16.3	22.0	15.8	21.8	20.8	18.2	14.9	18.9	12.8	8.6	24.3	21.3	23.9	18.8	39.5	34.6	18.7	5.9	21.9	65.6	12.4	12.2	13.3	13.9	16.4	13.9	26.1	50.5	12.3	40.8	17.4	4.5	20.9	17.9	25.6	19.9	6.7	12.1	25.7	20.3	12.9	14.8	222.0	15.2	17.9	10.6	12.2	25.5	7.0	30.9	11.1	10.7	22.3	19.7	7.2	43.6	22.7	37.7	7.4	17.7	14.1	13.1	9.4	12.7	13.0	5.1	15.2	17.3	52.0	21.2	16.5	23.3	19.6
MOV10	"fSAP113, gb110, MGC2948"	ENSG00000155363	"Mov10 RISC complex RNA helicase"	Q9HCE1	1	112673141-112700746	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Host-virus interaction, RNA-mediated gene silencing, Transcription, Transcription regulation"	"Helicase, Hydrolase, RNA-binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 54.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA031627			Approved	Cytosol		NA	NA			"Cluster 51: Monocytes - Innate immune response"	"Cluster 27: Brain & Skin - Unknown function"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 47: Cytotrophoblasts - Unknown function"	Cytosol		"HPA031627: AB_2673966"	"unprognostic (1.44e-2)"	"unprognostic (1.83e-2)"	"unprognostic (1.53e-1)"	"unprognostic (6.82e-3)"	"unprognostic (1.91e-1)"	"unprognostic (1.16e-1)"	"prognostic unfavorable (3.44e-4)"	"unprognostic (9.89e-2)"	"unprognostic (1.54e-1)"	"unprognostic (1.58e-3)"	"unprognostic (2.85e-1)"	"unprognostic (1.54e-1)"	"prognostic unfavorable (1.48e-11)"	"unprognostic (4.01e-2)"	"unprognostic (3.61e-1)"	"unprognostic (1.46e-3)"	"unprognostic (1.21e-3)"	7.6	13.2	3.4	9.7	3.7	4.7	7.6	2.9	3.4	10.2	4.7	10.9	22.1	10.2	9.5	13.2	13.5	9.4	5.2	3.1	6.2	10.3	19.4	9.1	8.5	4.7	4.1	9.7	8.2	12.8	11.2	23.6	4.0	11.5	10.7	3.0	14.3	11.2	3.1	27.2	20.2	10.8	4.1	12.1	10.7	16.6	5.4	16.2	9.8	4.2	7.0	9.3	10.8	3.4	29.5	17.9	10.4	40.2	8.3	23.5	39.1	19.8	46.5	56.9	80.7	33.2	31.7	0.0	13.2	27.4	21.1	30.5	39.7	47.4	19.6	32.4	24.2	20.2	26.7	37.8	35.3	8.5	19.3	39.9	14.2	34.6	10.9	37.4	49.2	40.7	27.2	9.8	17.8	54.7	32.7	6.6	23.4	12.2	18.1	57.9	26.2	1.3	26.4	31.9	4.4	15.0	40.9	27.5	31.5	20.2	21.4	19.4	29.7	17.6	31.0	12.4	17.8	11.3	3.3	0.1	34.9	17.4	51.4	0.9	3.5	0.7	12.5	10.3	12.4	2.1	10.8	11.1	6.8	1.5	10.3	8.0	1.1	12.7	12.2	1.0	10.2	7.6	3.4	3.7	2.9	3.4	3.1	6.2	4.7	4.1	4.0	4.1	5.4	3.4	13.0	9.6	10.5	26.4	6.3	8.8	10.4	15.5	8.0	2.4	7.8	7.0	4.1	8.6	17.4	16.5	0.0	54.7	5.6	29.2	3.9	15.5	5.9	5.8	7.3	16.9	15.0	3.8	4.1	15.5	18.4	9.4	23.9	7.0	1.3	36.5	16.8	18.3	15.8	5.0	2.3	18.0	12.2	7.5	6.0	6.2	9.3	10.3	3.6	12.2	14.4	15.1	10.3	18.1	3.3	12.4	26.9	7.5	3.6	11.1	46.2	13.9	18.4	1.1	13.1	4.0	7.4	2.7	3.4	11.7	7.0	38.2	9.2	22.4	15.5	12.1
MOV10L1	"CHAMP, DJ402G11.8, DKFZp434B0717"	ENSG00000073146	"Mov10 like RISC complex RNA helicase 1"	Q9BXT6	22	50089879-50161690	"Enzymes, Predicted intracellular proteins"		"Developmental protein, Helicase, Hydrolase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	10	"testis: 42.6"	"Cell type enhanced"	"Detected in some"		"Early spermatids: 118.9;Late spermatids: 310.8;Spermatocytes: 80.3;Spermatogonia: 46.7"	"Low cancer specificity"	"Detected in single"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HHSteC: 2.5;HUVEC TERT2: 12.5;TIME: 5.8"	"Not detected"	"Not detected"							HPA019034	Approved					NA	NA				"Cluster 78: Testis - Spermatogenesis"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 31: Spermatids - Spermatogenesis"			"HPA019034: AB_1854070"	"unprognostic (1.39e-1)"	"unprognostic (2.30e-2)"	"unprognostic (1.88e-2)"	"unprognostic (7.91e-2)"	"unprognostic (4.29e-2)"	"unprognostic (4.05e-2)"	"unprognostic (1.21e-1)"	"unprognostic (2.69e-1)"	"unprognostic (9.43e-2)"	"unprognostic (7.51e-2)"	"unprognostic (6.26e-2)"	"unprognostic (2.03e-1)"	"unprognostic (8.02e-3)"	"unprognostic (1.47e-1)"	"unprognostic (1.66e-1)"	"unprognostic (1.19e-1)"	"unprognostic (1.37e-1)"	0.6	0.1	1.2	0.2	1.1	0.2	0.4	4.0	1.5	3.3	0.0	2.0	0.1	4.4	1.6	0.6	2.1	1.0	0.8	1.1	0.5	0.5	0.8	0.6	0.2	1.2	0.6	3.0	0.2	0.0	1.0	0.6	1.4	2.1	0.2	1.3	0.5	0.1	0.0	0.3	1.1	1.6	0.2	0.0	0.2	42.6	0.7	0.0	0.5	0.0	0.2	0.5	3.5	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	1.1	0.4	0.7	0.0	0.0	0.0	1.0	0.4	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.5	0.0	0.0	2.5	0.0	1.1	0.1	0.0	0.0	0.0	0.1	12.5	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.1	0.0	0.0	5.8	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	1.1	4.0	1.5	1.1	0.5	1.2	0.6	1.4	0.2	0.7	0.6	0.3	0.0	0.0	1.3	0.0	0.3	0.1	0.1	0.0	3.1	0.1	0.3	1.6	0.0	0.0	1.8	0.0	0.1	0.1	0.0	0.0	0.0	118.9	0.3	5.2	0.8	0.0	0.0	5.5	0.4	0.1	0.6	0.0	0.5	0.0	0.7	0.4	0.1	1.7	5.0	3.2	0.0	0.0	0.0	0.0	310.8	1.5	0.2	0.0	8.4	0.0	2.3	0.0	1.5	1.1	0.0	0.0	3.0	0.0	0.1	0.0	1.7	0.0	3.7	13.1	0.2	0.3	80.3	46.7	0.1	0.0	0.1	0.1	0.3	0.0	0.1
MPG	MDG	ENSG00000103152	"N-methylpurine DNA glycosylase"	P29372	16	77007-85851	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"	"DNA damage, DNA repair"	Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA006531	Approved		Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 52: Non-specific - Transcription"	Nucleoplasm	Cytosol	"HPA006531: AB_1854075"	"unprognostic (1.78e-2)"	"unprognostic (8.48e-2)"	"unprognostic (9.99e-2)"	"prognostic favorable (2.82e-5)"	"unprognostic (8.54e-2)"	"unprognostic (3.27e-1)"	"unprognostic (2.75e-2)"	"unprognostic (1.63e-1)"	"unprognostic (2.14e-1)"	"unprognostic (1.44e-1)"	"unprognostic (1.85e-2)"	"unprognostic (1.83e-2)"	"unprognostic (1.39e-2)"	"unprognostic (1.86e-3)"	"unprognostic (3.88e-2)"	"unprognostic (1.86e-2)"	"unprognostic (3.26e-1)"	45.6	63.1	28.6	24.5	28.4	32.8	45.8	28.3	43.8	45.5	25.8	43.0	23.7	46.6	9.4	39.8	40.4	27.5	59.7	28.1	28.7	33.6	66.9	44.6	40.4	27.4	27.5	43.1	59.2	11.9	44.4	21.2	27.4	50.3	7.6	2.0	55.6	21.2	69.2	37.9	37.1	14.7	28.3	53.0	46.8	16.2	29.5	14.2	46.6	21.1	15.1	46.7	38.4	28.5	50.2	70.4	18.1	54.9	34.1	77.2	51.9	78.0	95.1	44.1	49.3	44.2	61.5	40.2	65.0	39.8	20.5	64.7	13.1	30.4	6.7	67.6	59.3	25.3	34.3	67.1	99.3	25.4	141.9	75.4	41.9	50.0	20.4	57.4	80.0	39.9	56.1	58.6	57.8	167.5	43.6	118.1	36.4	27.3	86.1	84.2	25.7	140.5	37.5	17.1	15.5	42.5	41.0	36.2	91.9	8.3	54.1	119.4	80.6	34.1	47.9	49.4	34.4	67.7	23.6	49.6	67.8	71.2	129.9	47.3	75.3	80.9	60.6	56.6	55.0	92.5	57.1	60.3	80.3	85.9	42.5	43.7	38.9	130.2	47.6	110.3	90.8	67.0	28.6	28.4	28.3	43.8	28.1	28.7	27.4	27.5	27.4	28.3	29.5	28.5	72.6	3.2	25.6	14.0	73.9	35.8	82.9	102.9	47.8	13.8	76.8	80.4	1.3	37.1	63.0	40.5	4.2	78.7	74.2	59.1	33.2	76.4	9.9	33.5	63.1	59.3	49.8	39.9	14.2	114.2	89.4	78.7	43.8	36.1	56.3	57.1	62.8	55.6	89.8	10.1	13.9	92.5	83.4	69.4	43.7	5.0	65.9	55.6	56.9	10.3	77.9	39.8	66.9	14.1	12.9	134.8	78.6	57.9	80.1	110.6	83.1	67.7	43.5	11.4	85.5	51.5	73.3	15.1	36.7	53.9	41.1	61.8	59.8	197.2	68.3	114.0
MRAS	"M-RAs, R-RAS3, RRAS3"	ENSG00000158186	"Muscle RAS oncogene homolog"	O14807	3	138347648-138405534	"Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, RAS pathway related proteins"		Hydrolase	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 202.3;heart muscle: 132.9"	"Cell type enhanced"	"Detected in many"		"Cardiomyocytes: 121.7;Distal tubular cells: 58.7;Theca cells: 59.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in some"	6	"non-classical monocyte: 25.0"	"Lineage enriched"	"Detected in many"	9	"monocytes: 25.0"	"Cell line enhanced"	"Detected in many"		"BJ: 92.9;EFO-21: 113.7;fHDF/TERT166: 70.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA042728	Approved		Approved	Vesicles,Cytosol		NA	NA			"Cluster 14: Monocytes - Unknown function"	"Cluster 44: Heart - Cardiac muscle contraction"	"Cluster 38: EFO-21 - Unknown function"	"Cluster 54: Cardiomyocytes - Muscle contraction"	Cytosol	Vesicles	"HPA042728: AB_10796582"	"unprognostic (1.96e-1)"	"unprognostic (2.95e-1)"	"unprognostic (1.63e-3)"	"prognostic unfavorable (1.73e-4)"	"unprognostic (1.69e-1)"	"unprognostic (5.32e-2)"	"unprognostic (8.96e-2)"	"unprognostic (3.85e-3)"	"unprognostic (1.70e-1)"	"unprognostic (1.86e-1)"	"unprognostic (1.71e-1)"	"unprognostic (2.59e-1)"	"unprognostic (3.18e-3)"	"unprognostic (1.78e-2)"	"unprognostic (6.25e-2)"	"unprognostic (2.21e-1)"	"unprognostic (4.23e-2)"	91.9	67.7	112.7	10.8	130.6	1.7	46.7	118.2	105.5	17.3	48.9	24.2	3.3	28.7	7.1	7.9	26.4	12.0	132.9	105.6	132.8	22.9	5.5	18.4	5.2	126.1	135.9	48.6	5.7	8.2	17.7	10.6	112.9	15.3	4.1	15.9	13.4	15.0	80.4	12.2	8.7	23.2	110.3	12.2	12.0	9.6	202.3	4.9	26.4	48.0	3.3	29.1	12.1	97.8	0.8	7.9	15.8	24.5	59.6	29.2	40.0	92.9	16.0	7.3	8.2	3.3	3.1	0.3	113.7	70.4	18.6	0.1	9.0	1.8	6.1	7.7	3.1	0.5	4.8	20.1	15.9	0.0	1.9	41.5	5.9	0.7	1.4	13.6	1.3	0.0	10.7	0.8	31.4	3.7	0.0	20.4	19.1	0.0	2.7	1.1	33.8	0.2	30.4	2.0	18.6	42.0	62.8	0.7	45.9	10.9	16.1	37.7	0.6	23.7	25.3	24.3	2.4	0.1	1.0	1.2	21.4	0.1	11.4	0.2	2.1	0.0	0.0	4.1	0.0	0.0	0.0	0.0	2.7	0.0	0.0	0.0	0.3	0.8	25.0	0.1	0.0	0.8	112.7	130.6	118.2	105.5	105.6	132.8	126.1	135.9	112.9	110.3	202.3	97.8	8.9	9.6	1.5	54.2	0.8	2.2	3.0	3.4	1.2	5.6	28.8	34.8	121.7	2.8	3.5	9.2	10.4	20.1	0.2	0.0	58.7	8.6	11.6	1.0	21.4	14.5	1.8	0.0	25.5	3.2	3.2	23.0	2.0	1.5	6.3	35.2	12.8	1.6	26.3	28.6	20.6	0.0	2.0	15.1	18.4	40.0	23.3	18.2	28.4	20.6	12.2	24.3	0.0	28.6	11.0	3.8	0.0	34.3	0.1	3.3	0.0	27.5	1.3	9.6	6.6	20.8	18.9	7.3	18.6	0.4	1.0	14.4	0.8	59.1	0.0	0.6
MRPL58	"DS-1, ICT1"	ENSG00000167862	"Mitochondrial ribosomal protein L58"	Q14197	17	75012670-75021261	"Enzymes, Metabolic proteins, Predicted intracellular proteins, Ribosomal proteins"	"Protein biosynthesis"	"Hydrolase, Ribonucleoprotein, Ribosomal protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 60.1;Distal tubular cells: 56.7;Ductal cells: 50.9;Exocrine glandular cells: 60.3;Hofbauer cells: 48.1;Pancreatic endocrine cells: 53.7;Proximal tubular cells: 121.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003634, HPA076987"	Approved		Supported	"Nucleoplasm,Plasma membrane,Mitochondria"		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 7: Non-specific - Mitochondria"	Mitochondria	"Nucleoplasm, Plasma membrane"	"HPA003634: AB_1851388, HPA076987: "	"unprognostic (2.04e-1)"	"unprognostic (1.57e-2)"	"unprognostic (1.94e-3)"	"unprognostic (7.12e-2)"	"unprognostic (3.16e-2)"	"unprognostic (4.35e-2)"	"unprognostic (1.38e-3)"	"unprognostic (1.52e-1)"	"unprognostic (2.57e-1)"	"unprognostic (3.79e-3)"	"unprognostic (4.98e-2)"	"unprognostic (2.43e-2)"	"prognostic unfavorable (2.09e-4)"	"unprognostic (1.10e-1)"	"unprognostic (1.12e-1)"	"unprognostic (2.66e-2)"	"unprognostic (1.71e-1)"	22.7	36.3	22.1	18.0	22.8	22.8	24.6	24.4	23.0	17.1	31.9	25.9	19.1	19.4	18.2	32.1	17.5	13.1	49.1	21.9	23.6	34.7	47.2	16.3	24.4	23.4	22.6	14.2	27.4	25.0	14.0	19.3	23.4	18.6	22.8	11.2	21.8	18.6	79.0	28.4	21.7	18.8	23.3	21.6	26.0	10.5	22.9	18.3	18.7	50.3	23.8	24.5	19.9	24.5	81.1	111.4	36.5	42.1	38.3	37.9	50.5	46.7	50.7	95.7	80.7	86.3	49.5	56.0	37.3	46.8	58.9	56.3	75.6	80.7	100.2	28.1	87.7	43.8	50.5	72.2	72.5	92.5	28.8	40.9	37.8	63.3	101.0	32.3	73.8	57.0	71.7	39.9	54.8	100.9	80.7	63.4	27.5	125.3	147.1	41.2	64.8	81.2	71.1	58.5	33.5	64.1	40.3	72.5	92.9	46.7	97.5	75.6	31.6	50.8	56.0	54.3	89.7	41.0	34.8	63.2	58.5	102.5	43.5	26.6	41.2	21.4	30.8	40.9	27.1	33.8	38.0	31.4	55.3	29.3	27.8	31.1	4.0	42.2	36.1	37.2	67.2	42.5	22.1	22.8	24.4	23.0	21.9	23.6	23.4	22.6	23.4	23.3	22.9	24.5	18.8	32.1	8.7	0.0	4.3	0.0	0.0	0.0	0.0	0.0	22.5	32.8	0.0	0.0	8.1	25.8	0.0	60.1	11.4	0.0	56.7	50.9	0.0	29.3	18.3	8.4	0.0	0.0	0.0	60.3	40.5	8.9	0.0	19.0	1.3	22.3	0.0	0.0	48.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.3	0.0	0.0	15.0	0.0	0.0	0.0	0.0	53.7	0.0	0.0	0.8	0.0	0.0	121.1	21.1	0.0	0.0	0.0	12.8	0.0	0.0	0.0	0.0	29.1	7.4	43.5	0.0	0.0
MTHFD2		ENSG00000065911	"Methylenetetrahydrofolate dehydrogenase (NADP+ dependent) 2, methenyltetrahydrofolate cyclohydrolase"	P13995	2	74186172-74217565	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"One-carbon metabolism"	"Hydrolase, Multifunctional enzyme, Oxidoreductase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Langerhans cells: 243.6;monocytes: 184.1;Smooth muscle cells: 239.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB003684, HPA049657"	Approved		Supported	Mitochondria	"Intracellular and membrane"	NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 52: Non-specific - Ribosome"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 48: Smooth muscle cells - ECM organization"	Mitochondria		"CAB003684: AB_425867, HPA049657: AB_2680842"	"unprognostic (1.82e-3)"	"unprognostic (4.60e-2)"	"unprognostic (8.12e-2)"	"prognostic unfavorable (2.07e-5)"	"prognostic favorable (1.01e-4)"	"unprognostic (3.10e-3)"	"unprognostic (2.24e-3)"	"unprognostic (4.75e-3)"	"unprognostic (2.64e-2)"	"unprognostic (3.96e-2)"	"unprognostic (3.76e-3)"	"unprognostic (3.57e-3)"	"prognostic unfavorable (1.11e-16)"	"unprognostic (3.66e-2)"	"unprognostic (6.52e-2)"	"unprognostic (9.07e-2)"	"unprognostic (2.34e-3)"	40.0	12.3	11.2	54.5	13.0	25.8	34.8	12.7	14.7	28.5	11.2	30.6	18.6	21.5	14.5	23.0	34.2	20.1	19.6	10.0	16.6	19.6	7.3	23.0	45.6	16.6	15.8	11.7	65.9	9.8	18.0	17.7	17.1	16.3	33.7	2.9	17.7	16.7	36.7	11.8	16.0	27.3	14.8	19.0	36.1	17.7	13.1	28.5	18.5	55.3	57.8	48.0	20.5	15.7	197.4	107.8	89.2	235.6	90.0	113.9	186.1	286.2	185.2	156.2	216.7	242.8	81.8	391.0	65.4	154.2	167.5	70.7	296.7	142.0	314.9	248.9	100.9	424.6	55.4	181.9	319.8	360.1	234.8	202.9	423.4	188.5	794.4	74.8	99.0	636.5	192.2	548.0	157.5	159.6	209.5	261.0	161.1	293.3	95.8	222.6	266.3	339.4	72.0	80.8	198.2	143.8	97.4	238.3	549.7	56.9	208.5	324.4	52.9	39.1	359.9	97.7	286.5	484.5	257.6	379.2	111.4	304.1	132.5	43.9	24.0	31.1	8.5	56.6	13.0	13.4	15.2	10.1	34.9	12.2	11.5	7.9	3.2	29.3	57.0	13.0	36.8	22.0	11.2	13.0	12.7	14.7	10.0	16.6	16.6	15.8	17.1	14.8	13.1	15.7	19.7	16.0	20.2	0.3	49.7	89.3	58.8	54.1	27.3	0.0	53.2	38.0	11.5	4.3	28.2	1.8	0.0	31.5	48.2	19.9	3.9	55.7	3.9	9.7	104.7	35.1	19.1	104.1	1.0	107.9	56.9	45.6	68.8	21.7	53.3	8.7	19.2	0.8	66.2	0.0	3.7	64.0	38.7	61.6	243.6	3.8	22.7	100.6	71.2	12.2	184.1	0.0	27.8	6.6	1.1	81.2	7.5	21.1	141.2	95.7	3.3	3.3	8.5	0.0	138.1	126.3	239.0	36.5	54.9	42.0	74.6	14.0	71.4	21.6	34.0	64.2
MTHFD2L	MGC72244	ENSG00000163738	"Methylenetetrahydrofolate dehydrogenase (NADP+ dependent) 2 like"	Q9H903	4	74114174-74303099	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Amino-acid biosynthesis, Histidine biosynthesis, Methionine biosynthesis, One-carbon metabolism, Purine biosynthesis"	"Hydrolase, Multifunctional enzyme, Oxidoreductase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA035434	Uncertain					NA	NA			"Cluster 14: Monocytes - Unknown function"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 30: Mammary glandular cells - Lactation"			"HPA035434: AB_10601038"	"unprognostic (2.01e-1)"	"unprognostic (2.19e-1)"	"unprognostic (2.03e-1)"	"unprognostic (2.32e-2)"	"unprognostic (1.52e-2)"	"unprognostic (4.09e-2)"	"unprognostic (2.67e-2)"	"unprognostic (7.73e-3)"	"unprognostic (1.42e-4)"	"unprognostic (3.45e-3)"	"unprognostic (4.23e-2)"	"unprognostic (5.07e-2)"	"unprognostic (1.44e-1)"	"unprognostic (3.16e-2)"	"unprognostic (1.19e-1)"	"unprognostic (3.00e-1)"	"unprognostic (1.81e-3)"	1.6	3.7	5.6	1.2	5.4	1.7	3.3	3.5	6.5	1.4	1.1	1.6	1.6	1.6	3.4	1.9	1.5	1.1	6.0	4.1	8.5	1.9	7.0	1.3	1.2	5.0	5.0	1.6	1.6	2.5	1.5	1.7	5.1	1.5	1.1	2.6	1.4	1.7	2.7	1.2	1.0	1.2	5.4	1.4	1.4	0.9	5.8	3.4	2.0	3.9	1.1	1.3	1.2	7.6	2.8	2.8	4.0	3.6	1.4	2.1	0.9	3.3	2.6	2.2	2.4	2.2	2.6	3.0	4.5	1.5	1.6	1.7	3.2	2.2	3.3	3.1	2.0	3.7	1.9	2.6	2.4	5.8	0.7	1.5	5.1	3.3	7.9	4.1	4.7	6.7	6.6	3.6	2.7	2.7	10.9	8.3	1.2	4.5	3.1	10.9	2.7	5.1	14.2	1.4	3.7	8.0	1.8	2.8	3.5	4.3	1.5	4.0	4.9	2.5	3.8	4.8	5.6	3.6	5.0	8.8	15.5	1.3	3.8	0.3	0.9	0.4	0.3	0.9	0.3	1.8	0.2	0.4	1.5	0.6	0.8	0.9	0.6	1.1	3.5	1.6	1.4	1.0	5.6	5.4	3.5	6.5	4.1	8.5	5.0	5.0	5.1	5.4	5.8	7.6	23.3	22.4	19.6	57.5	18.9	16.6	63.5	31.1	30.1	0.0	90.5	53.6	24.5	30.0	27.6	49.7	0.0	17.9	17.1	23.3	84.1	24.0	85.7	67.1	11.0	19.9	37.2	44.2	41.2	19.1	8.8	13.5	35.7	50.4	10.2	35.5	25.0	104.7	24.5	0.0	41.0	34.7	69.2	27.3	23.0	23.2	12.8	30.4	16.0	20.6	17.3	0.0	12.3	74.9	73.1	15.6	19.4	8.6	20.9	69.2	18.3	51.3	30.1	0.0	26.3	19.4	21.1	8.1	12.3	44.0	22.6	12.3	11.1	36.8	36.4	71.9
MTM1		ENSG00000171100	"Myotubularin 1"	Q13496	X	150568621-150673143	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Lipid metabolism, Protein transport, Transport"	"Hydrolase, Protein phosphatase"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 52.2;Oligodendrocytes: 47.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA010008, HPA010665"	Approved		Supported	"Plasma membrane"		NA	NA			"Cluster 2: Granulocytes - Unknown function"	"Cluster 87: Intestine & Kidney - Transmembrane transport"	"Cluster 43: THP-1 - Innate immune response"	"Cluster 59: Non-specific - Transcription"	"Plasma membrane"		"HPA010008: AB_1079426, HPA010665: AB_1079425"	"unprognostic (3.66e-3)"	"unprognostic (8.43e-3)"	"unprognostic (3.52e-3)"	"unprognostic (2.13e-1)"	"unprognostic (1.08e-1)"	"unprognostic (6.45e-2)"	"unprognostic (4.98e-2)"	"unprognostic (1.22e-1)"	"unprognostic (4.74e-1)"	"unprognostic (2.35e-2)"	"unprognostic (1.08e-1)"	"unprognostic (4.59e-2)"	"prognostic favorable (7.40e-7)"	"unprognostic (4.46e-2)"	"unprognostic (1.25e-1)"	"unprognostic (4.99e-2)"	"unprognostic (2.46e-1)"	6.8	11.1	7.4	9.7	8.3	11.3	7.6	8.0	8.4	5.7	6.1	19.8	11.7	6.5	8.4	7.5	9.6	7.1	7.3	6.9	8.5	12.9	18.4	11.2	12.4	7.8	8.6	11.7	4.9	16.0	3.8	6.3	8.0	8.0	19.2	5.4	6.3	10.7	11.8	8.2	12.1	6.9	7.7	11.9	7.8	11.5	8.8	8.4	11.2	10.1	9.7	7.1	4.7	8.8	14.3	6.1	8.5	3.1	7.5	7.3	5.4	6.1	8.5	7.0	7.9	4.7	7.3	22.2	11.4	8.3	21.9	9.9	6.1	11.5	8.6	6.4	5.2	5.6	5.4	15.0	5.8	25.2	19.1	4.5	14.3	5.7	11.9	6.9	9.4	9.3	3.9	19.8	8.8	4.5	6.9	25.2	4.3	13.4	7.4	8.0	4.9	4.5	11.7	6.9	2.2	2.4	5.5	11.3	8.5	11.9	4.1	35.2	8.2	5.0	3.1	12.4	7.1	4.2	10.0	20.3	6.0	14.8	8.0	34.8	9.5	27.9	2.0	10.8	6.8	8.0	9.6	7.3	12.0	10.6	9.0	5.4	11.6	14.6	9.8	7.4	12.2	7.1	7.4	8.3	8.0	8.4	6.9	8.5	7.8	8.6	8.0	7.7	8.8	8.8	9.9	9.6	20.0	52.2	13.9	15.2	8.3	5.8	2.2	0.0	5.8	3.9	15.0	4.3	6.0	3.7	0.0	2.1	8.4	33.0	1.9	3.4	35.6	7.7	5.0	11.5	9.6	7.4	44.0	4.3	2.8	6.6	8.2	4.8	8.8	3.3	16.4	13.2	8.0	0.0	41.5	17.7	2.0	16.3	10.4	18.8	6.2	13.0	5.4	24.4	12.0	0.0	0.0	27.6	47.7	4.7	9.5	12.8	8.0	6.8	11.2	14.7	13.4	0.0	0.0	5.2	6.9	5.1	4.1	4.9	19.0	7.3	12.8	4.8	13.8	9.7
MTMR1		ENSG00000063601	"Myotubularin related protein 1"	Q13613	X	150692971-150765108	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Lipid metabolism"	Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 79.3;Excitatory neurons: 61.2;Inhibitory neurons: 58.1;Oligodendrocyte precursor cells: 54.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"U-698: 104.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA018502, HPA075953"	Approved		Approved	Vesicles		NA	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 20: Retina & Lymphoid tissues - Unknown function"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Vesicles		"HPA018502: AB_1854185, HPA075953: "	"unprognostic (2.37e-2)"	"unprognostic (1.64e-3)"	"unprognostic (2.07e-1)"	"unprognostic (1.05e-2)"	"unprognostic (4.34e-2)"	"unprognostic (1.14e-1)"	"unprognostic (1.97e-1)"	"unprognostic (1.34e-1)"	"unprognostic (4.35e-2)"	"unprognostic (3.16e-1)"	"unprognostic (7.48e-2)"	"unprognostic (1.41e-2)"	"unprognostic (1.67e-2)"	"unprognostic (1.32e-2)"	"unprognostic (1.93e-1)"	"unprognostic (3.19e-1)"	"unprognostic (8.40e-2)"	6.7	7.2	11.3	11.1	13.0	11.9	12.5	11.7	13.0	9.3	7.1	10.2	9.0	7.9	7.1	20.6	9.7	7.2	12.2	17.3	10.8	8.3	9.0	9.5	21.8	7.5	10.0	8.5	10.0	17.9	9.2	14.2	7.6	10.9	9.4	22.1	12.4	10.9	22.9	21.4	10.4	7.3	9.2	14.3	10.7	8.0	11.9	31.3	10.0	16.0	25.5	12.6	13.5	8.7	32.3	20.3	21.5	17.7	4.9	5.7	28.8	28.1	36.0	28.0	39.4	19.8	24.9	70.2	40.1	22.9	27.1	28.4	43.9	40.8	43.2	28.4	26.3	4.4	31.6	8.5	14.5	20.7	14.6	15.6	27.7	30.8	0.4	26.8	17.1	22.9	13.8	17.5	20.3	27.7	30.6	5.3	9.9	35.9	30.3	16.0	34.1	31.2	22.0	36.4	31.9	19.9	10.7	23.7	8.8	17.0	30.3	11.8	21.7	18.3	14.6	2.3	42.1	22.2	24.6	104.8	3.7	13.3	14.4	0.0	0.5	5.0	2.1	0.9	1.5	1.7	2.3	1.9	1.4	1.9	2.0	2.8	1.5	3.9	0.9	5.0	3.2	1.2	11.3	13.0	11.7	13.0	17.3	10.8	7.5	10.0	7.6	9.2	11.9	8.7	3.7	16.0	6.5	79.3	11.4	11.2	11.0	8.0	6.8	0.0	7.8	5.5	8.2	2.8	7.5	5.5	0.0	10.1	19.3	4.6	0.0	5.9	0.0	10.0	3.7	3.6	9.6	6.5	61.2	6.6	7.3	4.5	7.7	9.2	1.3	4.8	2.9	8.0	4.6	0.0	58.1	5.5	8.2	9.4	8.8	1.7	5.6	4.8	3.6	30.0	6.2	0.0	8.2	54.8	22.6	10.6	8.6	5.3	7.9	11.0	3.8	3.1	8.4	0.0	6.6	6.7	3.9	2.5	3.0	10.3	16.8	10.4	8.8	5.9	5.9	12.5
MTMR2	"CMT4B, KIAA1073"	ENSG00000087053	"Myotubularin related protein 2"	Q13614	11	95821766-95925315	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"Lipid metabolism"	Hydrolase	"Charcot-Marie-Tooth disease, Disease variant, Neurodegeneration, Neuropathy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Late spermatids: 120.1;Oligodendrocytes: 226.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA049831	Approved		Supported	Vesicles		NA	NA			"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 77: Retina - Visual perception"	"Cluster 15: RT4 - Unknown function"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	Vesicles		"HPA049831: AB_2680904"	"unprognostic (1.71e-2)"	"unprognostic (2.55e-3)"	"unprognostic (7.81e-3)"	"unprognostic (4.16e-1)"	"unprognostic (4.18e-3)"	"unprognostic (5.36e-2)"	"prognostic unfavorable (1.61e-8)"	"unprognostic (3.23e-3)"	"unprognostic (3.42e-2)"	"unprognostic (1.77e-2)"	"prognostic unfavorable (3.60e-4)"	"unprognostic (1.12e-1)"	"unprognostic (2.34e-2)"	"unprognostic (1.54e-1)"	"unprognostic (1.50e-1)"	"unprognostic (1.14e-1)"	"unprognostic (8.03e-3)"	14.7	9.3	11.0	11.2	16.8	4.4	11.8	16.3	18.3	12.2	12.2	12.9	7.1	12.3	6.2	14.7	12.4	14.3	13.5	10.8	14.3	16.4	4.3	12.3	9.5	15.1	14.4	11.5	7.8	12.7	6.4	24.5	15.8	16.1	13.9	18.6	20.5	11.4	6.2	8.2	8.3	18.0	13.5	8.6	13.0	31.0	14.1	15.1	9.9	8.9	12.1	15.2	10.4	22.4	24.1	25.3	54.1	39.2	19.2	29.0	47.5	43.3	37.9	42.4	37.8	57.3	47.1	16.2	50.3	45.5	35.9	30.9	47.7	48.2	38.9	30.8	21.3	31.5	55.0	33.0	42.8	59.3	26.7	24.0	31.2	56.6	54.5	41.8	64.4	35.4	44.7	14.2	39.6	17.9	29.0	27.2	46.6	59.0	34.9	23.2	32.2	16.8	43.9	125.0	35.6	40.6	43.6	36.4	19.2	35.1	27.6	26.5	64.4	47.7	45.1	34.4	41.1	13.1	42.4	14.3	20.4	15.6	50.6	9.8	3.9	1.7	12.4	4.7	13.4	5.8	7.9	15.7	7.6	4.9	4.0	11.3	0.9	14.1	7.2	3.7	8.1	7.8	11.0	16.8	16.3	18.3	10.8	14.3	15.1	14.4	15.8	13.5	14.1	22.4	19.6	3.2	8.6	28.7	9.6	10.3	15.0	9.0	8.6	0.0	8.0	6.7	17.3	0.0	11.6	9.2	0.0	9.0	8.8	9.1	9.8	17.8	74.8	18.1	14.1	20.2	16.2	12.8	69.8	16.9	34.3	17.0	9.7	8.7	19.0	49.1	11.0	1.0	12.5	0.0	37.5	9.8	24.4	10.3	8.2	120.1	11.1	8.3	3.6	40.3	6.8	0.0	14.4	63.8	226.6	17.7	4.7	12.0	7.0	15.1	6.0	29.3	17.0	0.0	32.9	7.9	29.0	46.8	19.2	15.4	6.0	9.0	8.8	12.9	10.6	15.6
MTMR3	"FYVE-DSP1, KIAA0371, ZFYVE10"	ENSG00000100330	"Myotubularin related protein 3"	Q13615	22	29883169-30030868	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Lipid metabolism"	"Hydrolase, Protein phosphatase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 81.6"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 111.3;Inhibitory neurons: 78.3;Microglial cells: 90.9;Oligodendrocyte precursor cells: 96.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA034515, HPA034516, HPA061399"	Uncertain		Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 5: Granulocytes - Unknown function"	"Cluster 67: Neutrophils - Humoral immune response"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 64: Astrocytes - Nervous system maintenance"	Nucleoplasm	Cytosol	"HPA034515: AB_10669726, HPA034516: AB_10669727, HPA061399: "	"unprognostic (4.39e-3)"	"unprognostic (7.84e-2)"	"unprognostic (2.46e-2)"	"unprognostic (1.76e-2)"	"unprognostic (5.61e-2)"	"unprognostic (4.51e-3)"	"unprognostic (2.25e-2)"	"unprognostic (3.20e-2)"	"unprognostic (3.42e-1)"	"unprognostic (4.39e-1)"	"unprognostic (8.33e-4)"	"unprognostic (1.28e-1)"	"unprognostic (5.35e-4)"	"unprognostic (7.96e-2)"	"unprognostic (7.64e-2)"	"unprognostic (2.49e-1)"	"unprognostic (8.38e-2)"	17.8	18.4	18.5	13.0	19.4	81.6	17.0	21.2	18.6	18.9	17.0	15.5	11.1	16.0	12.8	22.4	16.4	12.5	13.9	20.8	19.3	11.7	10.8	20.7	11.5	19.2	19.8	20.4	16.5	18.3	17.0	15.0	17.3	16.0	12.7	21.2	17.2	11.3	36.7	25.5	14.5	14.8	18.6	21.7	15.7	26.2	21.6	16.2	17.2	30.0	13.9	15.1	19.4	16.6	13.4	11.7	17.0	18.3	16.7	12.1	12.8	12.2	17.4	15.7	18.2	10.0	7.9	10.2	7.6	22.1	12.4	16.0	18.5	14.3	16.6	21.0	15.4	18.6	10.6	10.1	15.3	15.9	45.0	12.8	22.9	14.9	26.9	14.7	15.3	10.7	11.6	17.5	10.3	16.2	10.7	11.1	6.5	13.7	7.5	12.5	23.3	10.4	14.1	24.3	19.2	13.1	22.1	19.7	11.7	14.1	11.2	15.3	16.8	25.3	16.7	5.5	8.3	14.7	11.1	9.3	11.0	7.5	11.8	8.3	7.4	11.2	3.2	4.9	4.0	2.3	2.5	3.4	4.1	2.4	3.1	2.7	17.8	4.1	5.4	1.5	2.9	4.3	18.5	19.4	21.2	18.6	20.8	19.3	19.2	19.8	17.3	18.6	21.6	16.6	15.9	3.2	14.8	111.3	13.3	16.7	9.8	11.5	14.8	0.0	13.7	11.0	4.2	10.0	17.7	12.9	0.0	13.6	10.4	21.5	1.9	9.5	14.0	16.8	14.9	10.6	12.5	21.0	61.2	8.8	7.0	12.6	31.6	24.5	7.6	14.7	13.9	10.1	10.9	0.0	78.3	9.2	46.8	20.6	11.7	16.7	13.7	20.8	14.2	90.9	22.3	0.0	12.3	96.5	73.2	12.3	11.1	11.3	13.0	14.6	12.2	7.3	16.4	0.0	6.6	15.3	11.0	26.8	28.0	18.1	13.8	13.7	13.0	8.9	11.5	21.2
MTMR4	"KIAA0647, ZFYVE11"	ENSG00000108389	"Myotubularin related protein 4"	Q9NYA4	17	58489529-58517905	"Enzymes, Predicted intracellular proteins"		"Hydrolase, Protein phosphatase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Hepatocytes: 65.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"									NA	NA			"Cluster 14: Monocytes - Unknown function"	"Cluster 70: Brain - Nervous system development"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 52: Non-specific - Transcription"				"unprognostic (3.07e-1)"	"unprognostic (6.52e-2)"	"unprognostic (4.87e-3)"	"unprognostic (1.68e-2)"	"unprognostic (1.54e-1)"	"unprognostic (6.42e-2)"	"unprognostic (4.97e-2)"	"unprognostic (3.45e-3)"	"unprognostic (6.82e-2)"	"unprognostic (2.21e-1)"	"prognostic favorable (5.09e-4)"	"unprognostic (1.04e-1)"	"prognostic unfavorable (1.53e-5)"	"unprognostic (1.45e-1)"	"unprognostic (2.13e-1)"	"unprognostic (1.59e-2)"	"unprognostic (2.92e-2)"	11.1	12.0	17.8	13.3	16.1	19.1	13.7	21.2	24.0	10.8	9.4	13.9	21.4	11.9	18.3	11.5	11.8	8.0	10.3	19.1	22.5	17.0	41.7	9.6	17.6	49.5	20.0	15.1	13.1	16.0	13.3	12.2	51.6	12.4	17.2	21.1	10.9	10.2	8.2	14.9	21.7	10.9	12.0	15.8	12.2	18.7	24.6	17.2	16.2	10.3	22.6	11.6	10.3	27.7	21.5	23.0	34.3	33.4	20.8	20.8	26.6	12.7	21.6	32.8	30.2	22.5	13.8	44.6	17.6	13.2	25.8	12.3	37.2	21.9	34.9	46.3	25.8	30.4	18.4	30.1	23.0	32.1	26.6	21.8	17.4	22.5	35.7	21.5	24.0	29.7	26.6	31.4	16.6	32.2	63.6	21.3	8.3	40.7	23.1	40.3	25.6	22.0	15.4	44.7	54.4	52.3	12.5	14.7	17.0	17.6	28.6	22.0	13.0	50.9	32.3	14.7	15.6	25.9	30.8	32.7	81.8	24.0	15.7	2.6	3.0	5.8	2.2	3.8	2.0	4.3	2.7	2.5	3.6	4.4	2.9	3.0	3.6	2.0	4.9	2.1	2.8	2.3	17.8	16.1	21.2	24.0	19.1	22.5	49.5	20.0	51.6	12.0	24.6	27.7	10.4	9.6	7.4	30.3	29.3	7.6	12.3	9.3	21.6	0.0	16.1	14.1	11.4	17.2	9.8	3.7	0.0	12.8	9.5	38.2	0.0	9.7	5.1	8.9	15.1	10.7	17.3	23.1	35.0	6.4	21.4	10.0	12.8	10.2	6.3	21.8	12.1	65.7	13.8	0.0	43.9	20.1	2.0	14.2	26.4	6.4	14.3	10.5	12.4	17.8	29.4	0.0	21.6	24.6	39.7	9.1	21.4	17.3	14.6	17.4	48.6	12.0	4.0	0.0	0.0	10.8	13.9	5.3	4.8	13.8	8.2	49.8	15.0	17.5	18.4	9.3
MTMR6		ENSG00000139505	"Myotubularin related protein 6"	Q9Y217	13	25246222-25287488	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Endocytosis, Lipid metabolism"	Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"									NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 34: Non-specific - Transcription"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 65: Plasmacytoid DCs - Unknown function"				"unprognostic (8.68e-2)"	"unprognostic (1.50e-2)"	"unprognostic (1.21e-2)"	"unprognostic (2.31e-3)"	"unprognostic (1.91e-1)"	"unprognostic (9.19e-2)"	"unprognostic (3.21e-1)"	"unprognostic (1.45e-1)"	"unprognostic (3.41e-2)"	"unprognostic (1.82e-2)"	"unprognostic (1.69e-1)"	"unprognostic (2.94e-1)"	"unprognostic (1.71e-3)"	"unprognostic (2.04e-1)"	"unprognostic (1.18e-1)"	"unprognostic (5.06e-2)"	"unprognostic (1.30e-1)"	13.4	19.0	9.6	14.2	10.6	31.9	12.5	10.6	14.2	10.7	6.1	10.9	8.5	12.2	7.7	10.8	8.7	12.8	15.6	11.0	11.8	14.8	13.4	13.0	15.0	11.1	9.6	9.3	12.8	16.3	6.1	12.2	11.0	12.9	12.1	21.9	16.1	13.3	11.8	7.7	8.8	15.8	10.4	14.2	10.9	18.6	10.4	16.7	15.3	14.9	14.4	14.3	6.5	14.0	12.3	12.6	20.3	17.3	21.2	22.1	9.9	38.0	42.6	36.9	28.9	8.4	21.4	18.8	11.0	35.7	18.7	14.9	13.1	22.5	42.6	22.7	8.6	23.1	8.4	6.9	25.5	48.5	40.8	15.9	25.9	26.8	35.8	21.1	30.4	24.8	10.9	20.9	37.5	8.7	27.8	13.1	6.1	23.6	9.4	11.8	28.5	25.9	26.7	14.2	10.7	15.2	12.4	21.8	20.2	19.2	8.4	30.2	39.4	22.6	11.6	25.2	22.5	11.3	14.0	24.6	11.4	18.6	37.6	22.9	9.8	8.0	5.8	14.0	7.4	6.5	6.1	6.2	7.9	4.2	6.2	6.4	18.9	6.0	13.0	4.7	8.9	8.9	9.6	10.6	10.6	14.2	11.0	11.8	11.1	9.6	11.0	10.4	10.4	14.0	24.5	16.0	32.1	20.5	44.3	11.0	8.0	8.7	8.0	0.0	16.7	10.4	29.5	8.6	11.9	16.5	0.0	5.8	21.8	14.5	13.7	13.1	64.0	19.0	18.9	20.7	16.7	6.1	29.4	15.0	6.9	16.7	14.8	10.5	19.0	10.6	27.1	23.1	16.3	0.0	63.9	16.0	12.2	40.5	27.7	23.4	12.5	36.4	19.6	26.2	28.1	0.0	5.2	33.2	51.6	22.3	10.0	19.9	28.3	10.2	7.3	31.3	26.6	0.0	0.0	20.4	17.7	62.1	20.4	10.3	11.9	8.2	26.3	17.5	12.3	11.9
MTMR7		ENSG00000003987	"Myotubularin related protein 7"	Q9Y216	8	17296794-17413528	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 11.9;retina: 28.4"	"Group enriched"	"Detected in some"	8	"Excitatory neurons: 79.2;Inhibitory neurons: 116.4;Oligodendrocyte precursor cells: 83.9;Oligodendrocytes: 171.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"NTERA-2: 3.7;SCLC-21H: 9.5;SH-SY5Y: 5.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA075682			Approved	Nucleoplasm,Cytosol		NA	NA				"Cluster 77: Retina - Visual perception"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	"Nucleoplasm, Cytosol"		"HPA075682: "	"unprognostic (1.01e-1)"	"unprognostic (6.10e-2)"	"unprognostic (1.05e-2)"	"unprognostic (1.44e-1)"	"unprognostic (1.67e-1)"	"unprognostic (1.31e-2)"	"unprognostic (4.15e-2)"	"unprognostic (1.41e-2)"	"unprognostic (1.92e-1)"	"unprognostic (2.45e-1)"	"unprognostic (2.07e-4)"	"unprognostic (1.46e-2)"	"unprognostic (1.97e-7)"	"unprognostic (1.12e-1)"	"unprognostic (1.42e-1)"	"unprognostic (4.17e-2)"	"unprognostic (2.66e-3)"	1.4	2.1	6.3	0.7	6.9	1.7	0.8	9.0	8.2	1.1	0.0	0.9	0.7	0.9	0.1	0.6	1.1	0.5	0.7	8.2	5.2	0.9	1.3	1.0	0.6	5.9	6.0	2.2	1.2	3.8	6.9	0.6	7.5	0.7	0.3	28.4	0.6	0.2	1.0	1.3	1.0	0.2	5.8	0.7	0.9	1.4	9.2	0.1	3.0	0.2	0.0	0.8	0.8	11.9	0.5	0.4	0.8	0.6	0.0	0.0	0.7	1.3	0.0	0.0	0.0	0.7	0.2	0.6	0.3	0.0	0.5	0.2	2.6	0.0	0.0	0.1	2.1	0.9	1.2	0.4	0.7	0.5	0.6	0.1	0.0	0.0	0.0	0.6	0.1	0.3	0.4	0.5	0.0	0.4	0.9	1.2	3.7	0.5	0.4	0.3	1.1	0.4	0.0	2.3	9.5	5.5	0.4	0.5	0.7	1.3	0.2	0.6	1.1	0.6	0.3	1.4	0.8	0.2	0.3	0.4	1.8	0.9	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	6.3	6.9	9.0	8.2	8.2	5.2	5.9	6.0	7.5	5.8	9.2	11.9	0.0	0.0	0.0	3.6	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.1	1.7	0.0	0.0	0.0	0.0	2.3	0.2	0.1	0.0	0.0	14.0	0.5	0.4	0.2	3.6	0.4	79.2	0.5	0.5	0.5	1.5	1.1	0.0	0.0	0.0	0.0	0.4	0.0	116.4	0.1	0.0	0.0	0.0	5.6	0.0	0.0	0.0	5.6	0.0	0.0	0.0	83.9	171.9	0.2	1.1	0.0	0.5	0.1	0.0	0.0	0.0	0.0	6.6	0.2	1.5	0.9	1.8	0.4	0.1	1.4	0.1	0.1	0.0	0.0
MTMR8	FLJ20126	ENSG00000102043	"Myotubularin related protein 8"	Q96EF0	X	64268081-64395452	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in some"			"Cell type enhanced"	"Detected in some"		"Excitatory neurons: 8.6;Inhibitory neurons: 11.3;Microglial cells: 18.7;Oligodendrocyte precursor cells: 16.1;Oligodendrocytes: 12.7"	"Low cancer specificity"	"Detected in some"			"Not detected"	"Not detected"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"Daudi: 4.7;JURKAT: 4.7;NTERA-2: 4.2;U-2197: 3.7"					"Low region specificity"	"Detected in all"									NA	NA			"Cluster 32: T-cells - Unknown function"	"Cluster 89: Fibroblasts - ECM organization"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"				"unprognostic (1.73e-2)"	"unprognostic (2.53e-2)"	"unprognostic (2.95e-3)"	"unprognostic (1.87e-2)"	"unprognostic (1.29e-1)"	"unprognostic (3.31e-2)"	"unprognostic (3.41e-3)"	"unprognostic (1.41e-2)"	"unprognostic (2.67e-1)"	"unprognostic (2.08e-1)"	"unprognostic (8.00e-2)"	"unprognostic (2.96e-2)"	"unprognostic (2.32e-1)"	"unprognostic (1.44e-2)"	"unprognostic (1.52e-1)"	"unprognostic (9.22e-2)"	"unprognostic (8.20e-2)"	0.3	0.5	0.2	0.6	0.3	0.5	0.4	0.5	0.2	0.8	1.3	1.2	0.5	0.8	0.7	0.9	2.3	0.5	0.2	0.1	0.5	0.6	0.2	0.5	0.9	0.4	0.5	0.9	0.3	0.6	0.2	0.1	0.4	0.7	1.4	0.9	0.4	1.3	0.2	0.3	0.6	0.7	0.2	0.7	1.2	0.2	0.5	1.0	0.4	0.2	1.1	0.7	0.5	0.2	0.0	0.9	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.7	1.0	4.7	0.6	0.0	0.0	0.0	2.6	0.5	1.1	0.0	1.1	1.5	0.2	0.0	0.0	3.3	1.9	0.0	0.6	0.0	0.2	0.0	0.0	4.7	3.4	3.3	0.0	0.2	1.7	0.6	4.2	1.3	0.4	2.6	0.0	1.1	0.2	0.7	0.0	0.4	0.0	0.1	0.0	0.8	0.9	1.6	0.0	0.0	1.0	3.7	0.0	0.0	0.4	2.9	0.0	0.0	0.0	0.1	0.2	0.0	1.2	0.5	1.1	1.2	1.2	0.8	0.0	1.3	1.5	1.3	0.3	0.3	0.6	0.1	0.7	0.6	0.2	0.3	0.5	0.2	0.1	0.5	0.4	0.5	0.4	0.2	0.5	0.2	0.7	0.0	0.0	3.6	3.0	0.4	1.2	0.5	3.4	0.0	0.1	0.1	0.7	0.0	0.3	0.0	0.0	0.3	1.0	0.6	0.0	1.0	0.0	2.3	0.2	0.6	0.0	0.4	8.6	0.2	0.2	0.5	3.1	0.6	0.0	0.4	0.0	0.0	0.2	0.0	11.3	0.2	2.0	0.3	0.3	0.0	0.6	0.4	0.0	18.7	0.0	0.0	1.0	16.1	12.7	0.2	1.4	0.7	0.4	0.1	0.3	0.4	0.0	0.0	0.0	0.3	0.4	0.0	0.3	0.8	0.1	0.3	1.4	0.6	0.8	1.1
MTREX	"Dob1, fSAP118, KIAA0052, Mtr4, SKIV2L2"	ENSG00000039123	"Mtr4 exosome RNA helicase"	P42285	5	55307989-55425579	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"DNA damage, mRNA processing, mRNA splicing, rRNA processing"	"Helicase, Hydrolase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Alveolar cells type 2: 42.3;Endometrial stromal cells: 44.0;Exocrine glandular cells: 40.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA037379	Supported		Supported	Nucleoplasm		NA	NA		13000	"Cluster 27: Non-specific - Gene expression"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 7: Non-specific - Mitochondria"	Nucleoplasm		"HPA037379: AB_10601713"	"unprognostic (7.71e-2)"	"unprognostic (1.21e-1)"	"unprognostic (1.33e-3)"	"unprognostic (1.32e-1)"	"unprognostic (1.50e-1)"	"unprognostic (2.08e-1)"	"unprognostic (1.79e-2)"	"unprognostic (5.08e-1)"	"unprognostic (4.17e-2)"	"unprognostic (1.46e-2)"	"unprognostic (5.05e-2)"	"unprognostic (7.67e-2)"	"unprognostic (1.11e-2)"	"unprognostic (2.09e-1)"	"unprognostic (3.98e-1)"	"unprognostic (2.86e-1)"	"unprognostic (2.11e-1)"	20.4	22.7	10.2	21.9	11.5	18.5	22.0	17.4	12.7	22.5	14.4	17.7	24.6	22.1	14.1	19.1	17.8	19.8	24.3	9.7	11.2	20.8	19.6	16.7	25.9	11.1	10.8	20.1	21.2	26.6	17.2	18.9	11.5	21.6	19.9	17.8	18.9	14.7	29.9	20.8	24.1	13.8	11.4	19.2	20.9	23.4	10.3	21.9	25.8	22.5	21.8	21.0	19.8	14.9	40.9	49.2	38.4	39.9	32.8	35.0	49.5	33.4	28.3	39.7	50.1	57.1	51.2	79.3	37.4	33.1	52.9	28.5	76.8	50.3	59.9	14.2	53.2	51.6	45.4	45.9	31.3	33.4	44.8	27.5	31.3	42.9	51.6	33.6	35.1	29.7	60.9	45.0	37.9	35.8	32.3	36.5	38.4	16.8	46.6	39.5	44.1	33.9	41.3	56.9	42.0	28.8	40.4	24.5	35.4	42.4	52.5	44.8	33.2	10.0	27.5	28.4	62.0	31.5	33.6	59.0	27.0	69.5	40.8	3.6	5.0	5.4	7.2	4.7	6.9	6.1	5.7	6.8	6.4	6.4	6.1	6.2	1.3	4.5	7.9	6.7	5.6	4.1	10.2	11.5	17.4	12.7	9.7	11.2	11.1	10.8	11.5	11.4	10.3	14.9	27.6	32.1	42.3	0.0	10.1	0.0	0.0	0.0	0.0	0.0	22.3	13.8	0.0	0.0	21.7	20.2	0.0	25.0	24.6	0.0	11.7	32.0	0.0	28.2	44.0	10.0	0.0	0.0	0.0	40.7	21.5	16.2	0.0	26.2	25.2	30.8	0.0	0.0	15.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.5	0.0	0.0	13.9	0.0	0.0	0.0	0.0	35.7	0.0	0.0	8.3	0.0	0.0	22.3	26.2	0.0	0.0	0.0	12.2	0.0	0.0	0.0	0.0	34.9	11.6	31.7	0.0	0.0
MUTYH	MYH	ENSG00000132781	"MutY DNA glycosylase"	Q9UIF7	1	45329163-45340893	"Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins"	"DNA damage, DNA repair"	"Glycosidase, Hydrolase"	"Cancer-related genes, Disease variant, Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 40.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											HPA008732	Uncertain		Supported	Nucleoplasm		NA	NA			"Cluster 39: Non-specific - mRNA processing"	"Cluster 70: Brain - Nervous system development"	"Cluster 5: NTERA-2 - Transcription"	"Cluster 47: Cytotrophoblasts - Unknown function"	Nucleoplasm		"HPA008732: AB_1854219"	"unprognostic (6.30e-3)"	"unprognostic (7.12e-2)"	"unprognostic (6.29e-2)"	"unprognostic (8.80e-2)"	"unprognostic (3.43e-1)"	"unprognostic (5.16e-3)"	"prognostic unfavorable (4.76e-8)"	"unprognostic (2.80e-2)"	"unprognostic (7.12e-3)"	"unprognostic (3.05e-2)"	"unprognostic (7.80e-2)"	"unprognostic (1.14e-1)"	"prognostic unfavorable (7.25e-5)"	"unprognostic (3.50e-3)"	"unprognostic (1.62e-1)"	"unprognostic (5.57e-2)"	"unprognostic (5.49e-3)"	5.0	5.0	11.9	5.5	12.7	6.7	5.3	16.7	15.6	7.6	10.6	6.0	6.4	6.3	4.6	5.1	5.7	4.2	4.0	11.6	11.9	7.0	5.9	4.4	7.7	12.8	12.4	7.3	5.1	5.1	5.9	6.4	12.7	5.8	5.6	4.9	4.5	5.0	5.6	5.9	6.1	3.6	11.7	7.8	5.8	3.3	12.2	9.8	6.6	4.7	7.0	5.9	5.8	14.4	7.9	6.9	15.5	10.5	11.3	8.4	26.6	5.7	7.4	11.8	9.2	14.3	11.2	22.5	9.0	3.6	9.5	11.3	8.7	11.0	5.4	18.1	7.0	10.2	11.4	10.5	10.0	9.4	7.1	4.6	10.3	16.0	25.7	3.1	8.6	28.6	17.5	7.4	5.0	13.3	27.3	8.7	39.6	19.5	7.9	36.2	12.6	12.3	6.1	14.6	14.5	11.8	11.3	8.7	18.2	20.1	6.7	11.1	4.9	8.3	6.2	7.2	8.2	11.6	14.6	13.3	8.0	14.6	7.5	1.6	7.0	2.9	11.5	11.8	17.2	8.1	11.8	11.5	8.1	8.0	12.7	12.2	1.4	8.8	9.1	6.5	13.4	8.6	11.9	12.7	16.7	15.6	11.6	11.9	12.8	12.4	12.7	11.7	12.2	14.4	10.0	0.0	5.6	17.0	12.1	6.9	10.7	8.1	6.2	15.6	6.7	8.8	3.2	1.5	6.9	7.3	2.1	40.2	8.8	16.5	3.9	6.5	0.9	3.2	5.1	7.6	7.8	6.7	4.0	5.3	14.3	7.5	16.8	3.2	10.8	8.4	5.7	4.3	10.0	5.0	7.0	15.1	12.2	4.0	10.2	1.6	10.8	5.6	7.2	8.4	8.2	12.0	10.3	11.6	12.7	3.8	16.4	12.0	7.5	9.5	12.9	12.2	8.6	20.1	13.1	8.7	7.6	10.5	11.2	5.2	5.4	22.2	13.9	9.5	13.5	8.0
NAAA	ASAHL	ENSG00000138744	"N-acylethanolamine acid amidase"	Q02083	4	75913660-75941013	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Fatty acid metabolism, Lipid degradation, Lipid metabolism"	Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 142.2;Kupffer cells: 115.8;Langerhans cells: 109.9;Proximal enterocytes: 167.7"	"Cancer enriched"	"Detected in all"	4	"prostate cancer: 31.8"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"intermediate monocyte: 672.4;non-classical monocyte: 583.3"	"Lineage enriched"	"Detected in all"	5	"monocytes: 672.4"	"Cell line enhanced"	"Detected in many"		"U-2197: 78.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB026135	Approved				"Intracellular and membrane"	NA	NA			"Cluster 51: Monocytes - Innate immune response"	"Cluster 14: B-cells - Humoral immune response"	"Cluster 43: THP-1 - Innate immune response"	"Cluster 45: Enterocytes - Digestion"			"CAB026135: "	"unprognostic (5.30e-3)"	"unprognostic (1.23e-2)"	"unprognostic (1.41e-2)"	"prognostic favorable (1.93e-4)"	"unprognostic (1.10e-1)"	"unprognostic (2.17e-2)"	"unprognostic (2.92e-2)"	"unprognostic (2.34e-2)"	"unprognostic (2.24e-1)"	"unprognostic (2.87e-2)"	"prognostic favorable (4.90e-4)"	"unprognostic (1.63e-1)"	"unprognostic (2.15e-2)"	"unprognostic (2.54e-1)"	"unprognostic (3.20e-2)"	"unprognostic (3.42e-3)"	"unprognostic (6.21e-2)"	19.0	14.6	9.2	30.0	10.0	18.5	37.4	10.9	10.8	23.0	14.1	61.8	30.9	12.9	9.1	28.4	16.4	15.7	19.9	9.5	13.3	40.6	68.4	23.0	48.4	11.2	11.1	8.2	7.6	11.7	7.7	19.4	11.7	70.9	69.9	32.7	31.5	11.4	8.6	22.8	60.7	15.4	9.5	63.8	18.5	3.4	13.2	16.3	15.9	13.0	27.9	20.0	18.4	14.5	11.9	26.6	1.1	0.7	62.4	62.8	1.1	17.5	11.6	11.8	4.0	9.3	41.1	1.0	8.9	43.5	0.4	23.1	34.8	13.4	7.1	17.0	1.3	8.4	19.4	22.6	14.3	31.4	29.6	16.0	10.0	10.3	3.5	18.4	19.1	18.7	9.6	35.9	10.6	43.5	20.2	20.5	13.5	53.4	10.5	13.5	0.4	55.6	12.4	6.7	15.9	2.3	18.1	56.2	5.4	1.8	63.3	54.1	28.8	0.7	1.5	78.6	0.8	8.8	3.8	5.9	14.8	44.5	7.4	48.6	270.1	110.3	62.0	672.4	67.5	58.8	78.4	61.8	143.2	40.4	65.2	54.5	90.3	35.5	583.3	53.2	114.6	233.7	9.2	10.0	10.9	10.8	9.5	13.3	11.2	11.1	11.7	9.5	13.2	14.5	10.6	0.0	7.3	7.2	31.2	11.3	18.8	5.7	4.0	11.5	31.3	14.2	4.4	25.8	10.9	5.5	18.8	24.6	19.5	142.2	13.7	5.7	0.5	12.1	18.1	14.6	48.0	10.8	17.7	8.4	19.2	28.2	3.1	11.9	15.2	3.5	18.5	37.2	39.7	11.8	27.4	45.4	8.2	115.8	109.9	0.0	10.5	80.3	17.8	7.5	77.8	7.7	16.5	5.0	4.8	4.1	46.7	7.5	16.8	55.4	167.7	12.4	27.7	86.9	0.0	31.8	16.7	1.1	0.9	15.9	18.9	13.3	34.8	9.1	24.4	14.0
NAALAD2	"GCPIII, NAALADASE2"	ENSG00000077616	"N-acetylated alpha-linked acidic dipeptidase 2"	Q9Y3Q0	11	90131515-90192894	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"		"Carboxypeptidase, Dipeptidase, Hydrolase, Metalloprotease, Multifunctional enzyme, Protease"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"pituitary gland: 19.9;testis: 13.9"	"Group enriched"	"Detected in many"	4	"Early spermatids: 39.7;Excitatory neurons: 109.3;Horizontal cells: 70.7;Inhibitory neurons: 110.2;Oligodendrocyte precursor cells: 153.8;Oligodendrocytes: 83.7"	"Cancer enhanced"	"Detected in some"		"testis cancer: 1.5"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"CACO-2: 19.2;SH-SY5Y: 6.1;SuSa: 4.3"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA060820, HPA065419"	Approved		Approved	Nucleoplasm		NA	NA				"Cluster 43: Testis - Unknown function"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Nucleoplasm		"HPA060820: AB_2684373, HPA065419: AB_2685487"	"unprognostic (1.68e-1)"	"unprognostic (2.66e-3)"	"unprognostic (1.49e-1)"	"unprognostic (4.52e-3)"	"unprognostic (4.73e-3)"	"unprognostic (2.97e-1)"	"unprognostic (3.82e-3)"	"unprognostic (1.77e-2)"	"unprognostic (2.44e-1)"	"unprognostic (2.30e-1)"	"unprognostic (3.30e-2)"	"unprognostic (8.00e-2)"	"unprognostic (9.97e-4)"	"unprognostic (1.52e-2)"	"unprognostic (2.54e-1)"	"unprognostic (1.63e-2)"	"unprognostic (2.93e-1)"	3.8	10.0	2.3	0.4	3.3	0.1	3.3	1.5	5.3	10.3	0.0	1.9	0.2	4.1	1.9	0.8	3.4	1.2	2.1	2.4	2.8	1.5	0.9	2.1	0.4	3.6	3.5	7.4	0.7	0.1	19.9	3.5	3.4	3.2	0.6	3.5	1.1	1.2	1.1	0.7	1.3	1.1	2.0	2.6	1.2	13.9	3.0	0.1	1.4	0.7	0.1	2.2	4.0	4.2	0.1	0.2	1.8	0.1	0.5	0.1	2.2	0.1	0.1	0.1	0.0	19.2	0.7	0.3	0.2	0.0	0.3	0.3	1.3	0.0	0.0	0.0	0.3	1.9	0.4	1.7	0.2	0.1	0.1	1.9	0.0	0.0	0.0	0.5	0.4	0.2	0.1	0.0	0.0	0.0	0.3	0.3	1.8	0.5	0.2	0.3	0.0	0.2	0.0	0.0	0.2	6.1	0.0	0.2	0.0	4.3	0.2	0.4	2.4	0.1	1.4	0.3	0.3	1.0	0.3	0.3	0.6	0.3	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	2.3	3.3	1.5	5.3	2.4	2.8	3.6	3.5	3.4	2.0	3.0	4.2	2.6	0.0	0.0	3.3	0.1	0.3	0.1	0.0	0.0	17.3	0.0	0.0	2.4	1.5	0.6	0.0	0.0	1.2	0.1	0.0	0.0	0.1	39.7	0.8	13.7	1.2	0.0	0.0	109.3	0.0	0.6	7.5	1.1	0.6	0.0	1.7	0.7	0.2	0.3	70.7	110.2	0.0	0.0	7.2	0.4	17.7	11.1	0.5	0.0	12.2	0.0	8.4	0.0	153.8	83.7	0.0	0.0	14.7	0.4	0.4	0.0	0.1	0.0	2.4	0.0	6.4	4.6	0.6	11.3	0.4	0.0	0.8	0.2	19.4	0.2	0.1
NAGA	D22S674	ENSG00000198951	Alpha-N-acetylgalactosaminidase	P17050	22	42058334-42070842	"Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"		"Glycosidase, Hydrolase"	"Cancer-related genes, Disease variant, Epilepsy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Extravillous trophoblasts: 65.0;Hofbauer cells: 91.6;Kupffer cells: 64.4;monocytes: 65.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in all"	6	"classical monocyte: 202.5;intermediate monocyte: 249.1;myeloid DC: 195.2;non-classical monocyte: 257.9;plasmacytoid DC: 119.8"	"Group enriched"	"Detected in all"	6	"dendritic cells: 195.2;monocytes: 257.9"	"Cell line enhanced"	"Detected in all"		"HMC-1: 190.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA000649	Enhanced				"Intracellular and membrane"	NA	NA		2200000	"Cluster 51: Monocytes - Innate immune response"	"Cluster 86: Liver & Placenta - Transport via ER"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 4: Macrophages - Innate immune response"			"HPA000649: AB_1079448"	"unprognostic (3.74e-2)"	"unprognostic (1.19e-2)"	"unprognostic (1.24e-1)"	"unprognostic (1.45e-3)"	"unprognostic (1.55e-1)"	"unprognostic (1.28e-1)"	"unprognostic (3.02e-2)"	"unprognostic (4.27e-1)"	"unprognostic (1.32e-2)"	"unprognostic (1.50e-1)"	"unprognostic (2.53e-2)"	"unprognostic (1.93e-1)"	"unprognostic (3.64e-2)"	"unprognostic (3.68e-2)"	"unprognostic (1.92e-3)"	"unprognostic (8.95e-2)"	"unprognostic (2.53e-1)"	21.4	12.7	9.3	32.3	10.4	20.1	13.4	10.3	10.1	20.6	17.0	26.1	20.4	17.2	12.4	17.2	20.0	22.1	16.0	8.9	11.5	14.9	31.9	27.1	20.8	13.9	10.8	17.0	11.4	39.2	11.7	42.8	12.6	18.2	26.7	7.7	17.3	18.6	7.7	13.4	24.2	28.3	12.2	20.3	16.6	9.0	12.0	13.9	15.1	12.3	19.0	24.8	13.7	14.4	27.8	14.0	21.7	38.9	37.0	41.9	15.9	22.4	45.7	37.9	39.2	31.4	39.9	13.5	13.5	49.1	22.9	19.2	16.7	27.4	22.3	31.0	21.2	33.5	20.1	21.5	21.5	28.1	190.4	28.9	23.8	34.0	14.4	19.5	63.4	11.6	12.4	56.0	30.2	32.3	10.4	11.5	5.8	25.3	18.5	23.0	11.0	24.2	29.4	32.7	6.7	7.7	29.8	27.0	29.3	19.1	40.4	50.9	34.4	26.6	31.8	17.1	20.7	30.9	33.3	10.9	28.3	52.7	33.4	36.5	202.5	25.1	13.6	249.1	13.8	10.5	14.1	12.7	195.2	6.9	9.2	8.4	9.9	18.8	257.9	119.8	18.3	121.0	9.3	10.4	10.3	10.1	8.9	11.5	13.9	10.8	12.6	12.2	12.0	14.4	6.5	9.6	6.7	4.6	8.2	3.3	9.4	10.9	5.7	2.8	6.7	6.2	4.2	4.3	11.3	7.3	8.4	46.1	11.0	27.3	3.9	15.4	15.8	5.6	8.8	11.2	6.0	12.4	1.1	8.1	65.0	13.8	6.1	10.2	9.5	3.2	9.3	33.6	91.6	0.0	2.0	15.0	6.1	64.4	36.3	17.9	7.2	52.5	19.6	12.2	65.8	5.9	6.2	0.5	2.0	13.0	23.9	6.8	22.2	6.0	40.0	9.8	15.7	6.4	19.7	6.1	10.0	10.7	5.2	7.1	3.4	58.3	6.9	6.5	15.4	10.0
NAGLU	NAG	ENSG00000108784	N-acetyl-alpha-glucosaminidase	P54802	17	42536241-42544449	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"		"Glycosidase, Hydrolase"	"Charcot-Marie-Tooth disease, Disease variant, Mucopolysaccharidosis, Neurodegeneration, Neuropathy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Theca cells: 74.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA038815	Supported				"Intracellular and membrane"	NA	NA		270000000	"Cluster 37: B-cells - Transcription"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 40: Granulosa cells - Unknown function"			"HPA038815: AB_10697398"	"unprognostic (1.53e-1)"	"unprognostic (1.19e-1)"	"unprognostic (6.48e-2)"	"prognostic favorable (4.17e-4)"	"prognostic unfavorable (6.59e-4)"	"unprognostic (1.46e-1)"	"unprognostic (1.75e-3)"	"unprognostic (3.09e-2)"	"unprognostic (2.20e-1)"	"unprognostic (6.68e-2)"	"prognostic favorable (6.90e-4)"	"unprognostic (8.07e-2)"	"prognostic favorable (2.58e-6)"	"unprognostic (2.25e-1)"	"unprognostic (8.74e-3)"	"unprognostic (2.15e-2)"	"unprognostic (1.62e-1)"	41.6	37.9	12.5	14.8	21.6	20.3	35.3	16.6	16.7	31.1	28.7	25.1	24.3	34.7	12.8	19.5	27.6	27.4	20.1	12.0	15.0	39.3	59.3	30.8	24.0	18.0	19.2	35.2	63.8	21.3	22.5	26.1	20.1	28.3	16.4	3.1	37.7	18.4	16.0	25.1	30.9	13.8	14.2	40.7	35.1	8.7	19.5	17.1	37.6	9.7	13.4	28.9	23.9	30.0	16.0	55.3	10.8	24.6	106.6	34.5	36.4	24.0	56.9	24.9	31.7	14.9	40.4	20.3	23.7	37.4	54.7	38.3	9.7	11.7	5.5	15.8	20.2	11.2	31.3	31.8	35.3	13.3	27.7	41.4	17.8	13.6	16.9	27.3	32.8	3.6	16.6	39.3	27.9	38.9	2.2	23.0	12.6	34.6	7.0	8.7	23.6	47.2	33.1	36.1	16.2	24.4	12.9	17.6	20.4	15.6	82.1	14.1	25.8	59.3	9.7	23.8	15.7	52.6	25.8	17.6	35.9	14.4	43.1	1.1	2.4	1.9	2.5	1.8	2.4	2.4	1.0	1.3	2.1	1.8	1.8	1.4	1.1	2.1	2.9	2.8	0.2	1.1	12.5	21.6	16.6	16.7	12.0	15.0	18.0	19.2	20.1	14.2	19.5	30.0	14.1	12.8	7.8	17.3	9.0	2.8	6.1	3.9	2.2	15.5	14.2	8.9	3.8	18.6	4.9	18.4	4.2	23.8	11.4	21.1	3.9	18.4	0.3	5.8	14.5	12.2	6.7	4.4	2.3	33.2	14.5	26.4	27.0	12.1	2.5	40.1	24.3	43.7	37.6	15.2	3.1	17.6	0.0	26.0	3.5	2.4	19.9	19.0	16.0	10.3	5.9	13.2	8.2	6.0	19.2	15.8	5.4	12.8	12.9	10.7	23.0	31.8	3.7	6.7	6.6	18.0	12.8	0.4	6.0	6.1	3.4	18.5	6.0	74.6	15.0	6.0
NAGPA	"APAA, UCE"	ENSG00000103174	"N-acetylglucosamine-1-phosphodiester alpha-N-acetylglucosaminidase"	Q9UK23	16	5024844-5034141	"Disease related genes, Enzymes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"		Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 29.6"	"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 44.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"Hep G2: 53.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA064055	Approved					NA	NA		7800000	"Cluster 28: Myeloid DCs - Unknown function"	"Cluster 65: Brain - Ion transport"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 52: Non-specific - Transcription"			"HPA064055: AB_2685183"	"unprognostic (9.93e-2)"	"unprognostic (1.61e-2)"	"unprognostic (2.08e-2)"	"unprognostic (2.21e-2)"	"unprognostic (7.12e-3)"	"unprognostic (3.30e-3)"	"prognostic unfavorable (4.67e-4)"	"unprognostic (1.05e-2)"	"unprognostic (2.98e-2)"	"unprognostic (1.35e-1)"	"unprognostic (9.51e-3)"	"unprognostic (9.41e-2)"	"prognostic unfavorable (2.67e-5)"	"unprognostic (1.26e-1)"	"unprognostic (6.09e-2)"	"unprognostic (7.47e-2)"	"unprognostic (1.02e-1)"	6.3	7.0	20.3	5.7	21.6	6.2	5.5	17.9	29.6	5.5	17.6	8.8	6.5	6.6	2.6	6.4	4.8	3.4	5.4	23.6	18.3	8.2	9.0	5.7	6.4	19.2	18.0	3.6	6.2	4.8	5.4	4.1	18.5	5.7	3.0	0.6	5.4	3.3	6.1	6.7	9.8	3.4	17.8	11.8	9.4	3.3	19.6	3.5	5.7	2.4	2.8	6.4	5.1	20.9	2.5	9.7	1.6	10.4	4.0	5.0	10.8	7.1	12.7	9.3	11.2	8.0	19.9	1.0	8.8	9.6	15.8	7.3	4.4	7.8	2.6	11.8	13.3	3.6	5.7	53.1	12.7	8.8	14.6	7.7	8.1	6.0	2.7	11.0	14.6	8.8	11.5	14.1	5.5	11.3	4.0	23.6	5.0	6.3	10.2	10.4	3.7	19.3	5.8	3.9	4.0	5.6	5.6	14.2	15.1	1.4	9.7	10.5	11.0	9.9	7.2	24.0	5.3	6.9	6.3	2.3	4.6	13.1	8.3	3.9	39.3	10.4	17.9	35.0	14.2	17.3	17.1	15.4	50.5	14.2	14.0	13.2	1.2	10.6	23.6	12.9	16.3	20.1	20.3	21.6	17.9	29.6	23.6	18.3	19.2	18.0	18.5	17.8	19.6	20.9	8.1	0.0	2.7	7.8	15.0	2.9	4.7	4.5	7.4	14.7	5.2	5.1	3.1	8.6	4.7	5.5	31.3	13.3	10.2	21.8	1.9	11.3	0.4	3.0	3.7	8.4	1.2	9.1	44.5	8.5	14.9	4.6	28.1	4.1	1.3	8.9	9.7	7.7	27.2	16.8	21.5	13.6	2.0	24.9	8.6	1.0	8.1	20.6	3.6	2.8	24.0	4.5	18.6	4.0	6.9	9.5	18.4	6.4	13.2	4.1	28.9	9.0	3.2	13.8	0.0	4.3	4.8	4.4	8.4	8.8	2.4	9.4	12.1	5.8	12.4	3.2
NANP	"C20orf147, dJ694B14.3, HDHD4, MGC26833"	ENSG00000170191	"N-acetylneuraminic acid phosphatase"	Q8TBE9	20	25612935-25624014	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Carbohydrate metabolism"	Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA050342	Uncertain		Approved	"Nuclear membrane"		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 6: Erythroid cells - Oxygen transport"	"Nuclear membrane"		"HPA050342: AB_2681098"	"unprognostic (8.72e-2)"	"unprognostic (1.88e-1)"	"unprognostic (7.42e-3)"	"unprognostic (6.01e-2)"	"unprognostic (5.59e-2)"	"unprognostic (2.12e-1)"	"prognostic unfavorable (9.01e-6)"	"unprognostic (3.20e-1)"	"unprognostic (3.75e-2)"	"unprognostic (7.70e-3)"	"unprognostic (1.24e-1)"	"unprognostic (3.46e-1)"	"unprognostic (2.07e-2)"	"unprognostic (1.11e-1)"	"unprognostic (1.76e-1)"	"unprognostic (1.71e-2)"	"unprognostic (9.42e-2)"	3.3	3.8	1.4	2.6	1.4	3.4	3.0	2.8	1.4	2.3	1.7	2.1	2.9	2.3	2.4	2.8	2.1	2.5	2.5	1.3	1.8	4.4	4.8	2.4	2.0	1.3	1.5	2.7	3.2	2.8	1.5	2.6	1.4	2.3	2.5	2.9	2.1	1.9	1.7	2.0	2.0	2.8	1.1	1.9	2.3	2.8	1.7	4.9	3.0	3.7	2.4	2.9	1.9	1.4	14.2	8.5	6.7	9.4	10.7	11.0	9.5	7.1	13.9	9.3	11.8	7.4	9.7	4.9	7.9	13.6	11.0	8.9	10.6	10.7	17.9	1.7	5.9	13.3	3.8	20.1	9.1	10.0	3.7	9.9	5.1	10.7	13.6	5.1	8.2	17.8	11.1	8.5	11.7	8.0	19.4	4.8	4.8	12.6	12.6	9.3	14.1	6.4	5.7	7.7	12.6	5.2	8.0	12.7	8.7	6.6	5.3	8.5	6.8	14.5	10.9	13.6	10.2	4.3	4.1	12.4	4.3	22.7	9.1	0.3	2.3	0.9	1.3	2.4	2.0	0.6	0.9	1.0	3.3	0.6	0.8	1.4	0.3	2.2	1.4	0.7	0.8	1.1	1.4	1.4	2.8	1.4	1.3	1.8	1.3	1.5	1.4	1.1	1.7	1.4	3.6	3.2	1.5	4.2	1.9	5.9	5.8	4.6	2.8	4.5	3.0	2.3	2.8	5.7	3.6	7.3	0.0	4.1	5.2	1.7	13.7	5.2	0.3	2.0	4.7	4.4	3.0	16.0	3.3	4.2	2.1	4.9	4.6	2.0	5.7	3.4	3.6	5.3	4.6	6.7	3.6	2.3	6.1	4.1	4.8	0.8	3.1	2.8	5.4	1.9	2.4	5.5	9.2	2.5	2.3	4.8	2.0	2.6	3.5	5.1	1.8	8.2	2.1	7.3	0.0	4.6	3.4	5.5	11.3	2.6	5.1	1.9	1.9	7.4	2.2	3.1
NAPEPLD	"C7orf18, FMP30, NAPE-PLD"	ENSG00000161048	"N-acyl phosphatidylethanolamine phospholipase D"	Q6IQ20	7	103099776-103149560	"Enzymes, Predicted intracellular proteins"	"Lipid degradation, Lipid metabolism, Phospholipid degradation, Phospholipid metabolism"	Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 128.0;Excitatory neurons: 99.2;Oligodendrocyte precursor cells: 126.7;Oligodendrocytes: 193.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA019832, HPA024338"	Approved		Approved	Cytosol		NA	NA			"Cluster 21: B-cells - Adaptive immune response"	"Cluster 87: Intestine & Kidney - Transmembrane transport"	"Cluster 18: U-2197 - ECM organization"	"Cluster 29: Early spermatids - Spermatogenesis"	Cytosol		"HPA019832: AB_1844422, HPA024338: AB_2671533"	"unprognostic (3.62e-1)"	"unprognostic (1.86e-1)"	"unprognostic (2.37e-1)"	"unprognostic (2.57e-1)"	"unprognostic (7.58e-2)"	"unprognostic (1.05e-3)"	"unprognostic (1.02e-2)"	"unprognostic (6.39e-3)"	"unprognostic (2.70e-2)"	"unprognostic (1.20e-1)"	"unprognostic (2.81e-2)"	"unprognostic (3.21e-1)"	"prognostic favorable (7.32e-6)"	"unprognostic (8.83e-2)"	"unprognostic (1.19e-1)"	"unprognostic (1.42e-1)"	"unprognostic (2.41e-2)"	2.0	4.6	1.6	3.6	3.7	2.0	1.7	1.5	4.2	3.6	0.0	7.7	14.5	3.6	2.2	1.9	5.3	5.9	4.0	1.7	0.0	14.9	7.4	3.0	3.3	0.4	1.1	8.6	3.5	6.0	1.5	2.2	0.8	4.5	7.5	4.8	1.7	3.4	2.4	3.1	9.7	3.0	0.5	6.4	9.9	6.7	2.5	3.0	8.2	2.4	2.7	3.5	1.8	9.2	6.9	7.4	5.1	4.3	4.9	4.9	0.9	5.4	3.1	1.6	3.3	2.7	6.3	5.2	7.7	1.7	6.3	5.6	3.3	0.5	3.8	6.9	6.0	1.9	4.1	1.5	1.1	3.3	2.2	2.8	0.9	1.6	0.0	12.5	3.5	3.5	2.0	4.8	5.0	2.2	5.1	2.4	4.7	9.4	9.7	3.6	2.8	1.9	10.5	2.9	3.8	4.6	10.7	3.7	2.7	3.1	2.4	4.4	4.6	7.7	4.0	17.8	4.9	6.8	8.6	3.7	7.6	2.9	14.8	0.1	1.9	3.7	2.7	2.9	2.3	4.6	3.1	3.4	2.1	4.5	4.4	3.2	0.2	1.5	1.9	1.7	2.9	1.4	1.6	3.7	1.5	4.2	1.7	0.0	0.4	1.1	0.8	0.5	2.5	9.2	4.6	19.2	10.0	38.8	13.2	6.6	5.5	5.3	9.6	78.1	5.7	5.0	12.3	17.2	6.8	53.3	52.1	8.1	5.6	37.5	9.8	5.3	128.0	27.5	10.7	5.2	13.8	36.6	99.2	2.6	4.0	7.3	41.3	42.9	4.5	12.0	4.6	19.1	3.9	50.5	56.7	27.0	4.1	5.5	1.8	43.8	31.7	4.4	14.2	21.5	7.2	16.1	18.6	126.7	193.3	5.0	28.7	33.4	10.6	6.5	46.5	32.6	3.0	35.4	6.6	7.8	6.3	21.1	12.2	3.1	2.8	2.9	8.1	18.9	26.8	7.8
NAV2	"FLJ10633, FLJ11030, FLJ23707, HELAD1, KIAA1419, POMFIL2, RAINB1"	ENSG00000166833	"Neuron navigator 2"	Q8IVL1	11	19350724-20121601	"Enzymes, Predicted intracellular proteins"		"Helicase, Hydrolase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 55.7;heart muscle: 61.2"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 466.8;Excitatory neurons: 333.8;Inhibitory neurons: 525.7;Oligodendrocyte precursor cells: 863.6;Oligodendrocytes: 354.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"hTERT-HME1: 89.9;SH-SY5Y: 81.9;TIME: 65.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA011755, HPA011891"	Approved		Supported	Nucleoplasm		NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 44: Heart - Cardiac muscle contraction"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 68: Oligodendrocytes - Mixed function"	Nucleoplasm		"HPA011755: AB_1854319, HPA011891: AB_1854318"	"unprognostic (7.71e-2)"	"unprognostic (2.37e-1)"	"unprognostic (1.29e-1)"	"unprognostic (1.02e-1)"	"unprognostic (3.01e-1)"	"unprognostic (1.76e-3)"	"unprognostic (3.01e-2)"	"unprognostic (3.86e-2)"	"unprognostic (1.54e-1)"	"unprognostic (1.00e-1)"	"unprognostic (3.53e-3)"	"unprognostic (1.84e-1)"	"unprognostic (2.83e-2)"	"unprognostic (3.85e-2)"	"unprognostic (1.08e-1)"	"unprognostic (6.43e-2)"	"unprognostic (3.28e-2)"	7.4	1.6	11.6	3.3	18.8	1.8	12.0	16.1	10.8	6.3	3.5	16.2	4.4	7.6	11.1	6.5	4.4	1.8	61.2	9.6	13.8	9.5	14.9	9.5	1.8	55.7	43.7	3.1	8.8	6.0	5.1	14.8	36.5	6.2	4.9	8.7	15.0	9.3	2.6	6.7	4.1	8.5	39.3	1.4	7.2	0.9	27.7	2.5	16.9	9.4	3.9	5.7	7.4	35.6	16.2	4.7	10.2	1.4	33.7	21.6	11.0	13.3	22.6	17.2	13.0	18.2	2.1	0.1	0.6	20.1	28.0	1.9	0.6	10.4	20.1	3.8	1.2	0.4	25.1	20.9	6.1	0.0	0.5	14.1	26.5	8.3	89.9	12.7	23.2	0.1	1.9	8.0	50.2	17.2	0.0	0.1	26.4	5.3	13.1	0.1	47.1	2.6	14.8	4.6	18.2	81.9	10.3	7.9	14.8	54.2	0.3	0.0	65.2	39.6	6.3	47.7	12.7	2.7	2.0	0.1	13.5	0.8	12.1	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	11.6	18.8	16.1	10.8	9.6	13.8	55.7	43.7	36.5	39.3	27.7	35.6	5.5	64.1	22.6	466.8	1.4	4.2	23.6	13.8	14.2	4.6	33.6	31.0	14.3	8.6	18.3	20.2	0.0	31.8	0.8	2.8	13.7	20.3	2.6	34.4	4.6	14.5	10.8	0.0	333.8	21.3	23.3	16.5	11.2	62.1	1.3	152.4	11.7	47.0	10.7	26.9	525.7	10.1	18.3	1.4	5.0	7.9	0.9	3.2	16.0	194.9	1.0	28.9	0.0	863.6	354.4	37.5	0.8	4.1	0.4	33.7	1.8	0.4	24.0	2.4	0.0	30.7	17.8	1.5	0.6	23.1	3.7	14.6	1.7	54.7	9.2	17.8
NEU1	NEU	ENSG00000204386	"Neuraminidase 1"	Q99519	6	31857659-31862905	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"Carbohydrate metabolism, Lipid degradation, Lipid metabolism"	"Glycosidase, Hydrolase"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Syncytiotrophoblasts: 197.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in some"		"neutrophil: 3.0"	"Lineage enriched"	"Detected in single"	5	"granulocytes: 3.0"	"Cell line enhanced"	"Detected in some"		"GAMG: 5.4;U-266/84: 9.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA015634, HPA021506"	Approved		Supported	"Vesicles,Cell Junctions"		NA	NA		180000	"Cluster 1: Neutrophils - Mixed function"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 16: U-266 - Nucleosome"	"Cluster 7: Non-specific - Mitochondria"	Vesicles	"Cell Junctions"	"HPA015634: AB_1854386, HPA021506: AB_1854385"	"unprognostic (3.84e-2)"	"unprognostic (7.47e-2)"	"unprognostic (9.64e-2)"	"unprognostic (4.65e-2)"	"unprognostic (3.00e-1)"	"unprognostic (4.42e-3)"	"unprognostic (1.38e-3)"	"unprognostic (8.58e-3)"	"unprognostic (7.49e-2)"	"unprognostic (5.21e-2)"	"unprognostic (4.44e-3)"	"unprognostic (1.27e-1)"	"unprognostic (2.70e-2)"	"unprognostic (6.22e-2)"	"unprognostic (1.48e-1)"	"unprognostic (2.12e-1)"	"unprognostic (2.13e-3)"	23.9	57.2	0.7	0.4	0.8	0.0	22.4	2.5	1.2	21.2	1.2	25.1	0.7	19.5	0.0	14.9	16.8	1.0	22.5	0.7	0.6	43.7	29.9	28.9	0.3	0.8	0.5	20.3	35.9	0.3	33.0	0.2	0.8	26.5	0.0	1.6	38.6	0.0	21.3	20.1	24.3	0.1	0.3	25.3	29.8	8.2	1.0	0.0	31.8	0.0	0.0	23.2	16.2	1.7	0.3	0.2	0.8	1.4	1.8	0.4	0.7	0.2	0.2	0.3	0.3	1.5	0.6	0.7	0.4	0.1	5.4	0.3	2.2	0.0	0.4	2.5	0.3	0.6	0.9	1.2	1.4	0.9	1.8	1.0	0.2	1.4	0.7	0.2	0.6	0.9	1.1	1.2	0.5	0.3	0.6	0.0	0.6	0.5	0.4	0.9	0.4	0.9	1.0	0.4	0.7	0.4	0.2	0.3	0.7	0.9	0.9	0.5	0.7	1.1	0.8	0.7	0.6	3.7	9.6	0.9	1.7	0.4	0.4	1.3	0.3	0.4	0.2	0.3	0.1	0.2	0.2	0.1	0.2	0.6	0.2	0.3	3.0	0.3	0.2	0.3	0.2	0.1	0.7	0.8	2.5	1.2	0.7	0.6	0.8	0.5	0.8	0.3	1.0	1.7	65.7	25.6	46.3	5.2	57.0	34.3	48.5	45.0	39.9	26.4	87.7	55.8	29.0	51.5	54.8	47.8	25.0	62.8	100.5	83.7	9.8	114.2	0.8	29.3	53.5	42.8	113.5	4.6	6.3	59.6	57.8	73.8	32.6	60.8	67.9	17.4	30.7	34.5	170.9	10.1	7.6	39.9	79.3	63.0	65.9	1.4	27.7	93.0	71.2	9.4	25.8	48.8	9.2	5.0	4.0	34.4	88.1	23.3	81.7	89.0	115.0	59.9	29.2	32.7	26.3	60.8	43.7	5.4	10.0	29.3	41.6	197.0	81.7	40.3	41.1	34.6
NEU2	SIAL2	ENSG00000115488	"Neuraminidase 2"	Q9Y3R4	2	233032672-233035057	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Carbohydrate metabolism, Lipid degradation, Lipid metabolism"	"Glycosidase, Hydrolase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	15	"skin 1: 2.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Region enhanced"	"Detected in single"		"cerebral cortex: 1.8"	CAB022336	Uncertain					NA	NA		25000		"Cluster 61: Skin - Cornification"					"CAB022336: "						"unprognostic (1.30e-1)"												0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
NEU3		ENSG00000162139	"Neuraminidase 3"	Q9UQ49	11	74988279-75018893	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Carbohydrate metabolism, Lipid degradation, Lipid metabolism"	"Glycosidase, Hydrolase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Cone photoreceptor cells: 62.6;Spermatocytes: 32.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038729, HPA070381"	Approved		Supported	Nucleoplasm,Vesicles		NA	NA			"Cluster 34: Basophils - Unknown function"	"Cluster 3: T-cells - Adaptive immune response"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 9: Photoreceptor cells - Phototransduction"	Nucleoplasm	Vesicles	"HPA038729: AB_2676179, HPA070381: "	"unprognostic (1.67e-1)"	"unprognostic (2.10e-1)"	"unprognostic (2.55e-2)"	"unprognostic (1.13e-3)"	"unprognostic (2.95e-2)"	"unprognostic (5.42e-2)"	"unprognostic (1.63e-1)"	"unprognostic (5.11e-2)"	"unprognostic (3.91e-3)"	"unprognostic (8.50e-2)"	"prognostic favorable (5.98e-4)"	"unprognostic (3.57e-3)"	"unprognostic (3.80e-2)"	"unprognostic (3.79e-1)"	"unprognostic (2.38e-1)"	"unprognostic (3.73e-1)"	"unprognostic (1.84e-1)"	3.2	12.7	8.1	6.4	9.7	23.7	6.5	5.1	10.8	3.8	2.9	4.2	4.3	4.9	5.2	2.6	4.2	4.5	6.2	5.3	5.0	5.1	8.2	5.1	8.3	4.1	4.0	8.0	6.1	10.4	5.7	3.9	5.4	11.5	6.4	10.4	4.2	3.2	26.4	8.0	4.3	4.8	1.1	6.2	4.8	13.9	5.1	12.3	8.1	22.6	7.8	3.5	2.5	7.5	9.1	8.2	6.7	11.7	5.2	4.4	7.1	8.7	5.7	9.4	7.7	24.3	7.2	25.7	8.5	7.2	12.9	8.1	16.1	11.4	14.7	13.2	7.9	21.8	14.4	10.8	5.6	34.7	19.3	5.5	9.4	9.9	15.0	6.5	7.2	37.3	35.1	17.5	11.2	9.7	33.1	16.8	8.0	18.5	10.3	27.0	17.5	22.2	12.8	9.3	12.0	7.2	13.7	8.4	37.0	8.0	18.9	8.2	10.4	11.6	11.7	8.0	9.1	15.5	15.8	51.8	3.6	17.2	9.8	1.2	2.6	2.4	1.5	1.4	1.1	1.0	1.2	1.5	1.5	1.2	1.2	1.5	1.5	0.5	1.8	1.1	0.9	0.9	8.1	9.7	5.1	10.8	5.3	5.0	4.1	4.0	5.4	1.1	5.1	7.5	1.4	3.2	4.6	4.6	5.3	0.5	2.0	0.4	0.6	8.6	3.5	3.9	7.7	2.8	2.7	1.8	62.6	2.1	4.1	1.0	0.0	1.2	9.2	2.2	2.3	2.3	7.2	5.0	12.5	3.1	1.4	2.1	3.1	2.7	1.3	3.7	3.6	6.9	5.4	11.8	10.3	2.9	2.0	10.1	1.1	7.6	1.5	6.2	0.0	8.4	6.8	3.4	3.1	9.5	9.9	2.6	1.0	1.9	5.8	3.0	1.6	3.7	1.6	6.4	0.0	5.8	1.8	32.0	2.2	1.6	0.6	1.4	3.9	3.8	2.8	0.6
NEU4		ENSG00000204099	"Neuraminidase 4"	Q8WWR8	2	241809065-241817413	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Carbohydrate metabolism, Lipid degradation, Lipid metabolism"	"Glycosidase, Hydrolase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	5	"liver: 75.8"	"Cell type enhanced"	"Detected in some"		"Distal enterocytes: 74.6;Enteroendocrine cells: 34.4;Hepatocytes: 124.4;Intestinal goblet cells: 38.5;Oligodendrocyte precursor cells: 50.3;Paneth cells: 58.0;Proximal enterocytes: 76.0;Undifferentiated cells: 38.4"	"Group enriched"	"Detected in some"	7	"colorectal cancer: 2.3;glioma: 6.0;liver cancer: 6.7"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	33	"Hep G2: 57.7;HMC-1: 32.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA037394	Enhanced					NA	NA				"Cluster 85: Liver - Metabolism"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 53: Intestinal epithelial cells - Unknown function"			"HPA037394: AB_2675455"	"unprognostic (1.50e-1)"	"unprognostic (2.39e-3)"	"unprognostic (1.85e-1)"	"unprognostic (3.68e-4)"	"unprognostic (3.76e-2)"	"unprognostic (1.57e-1)"	"unprognostic (8.70e-2)"	"unprognostic (8.62e-2)"	"unprognostic (1.74e-1)"	"unprognostic (4.41e-2)"	"unprognostic (1.52e-2)"	"unprognostic (2.92e-1)"	"unprognostic (8.11e-4)"	"unprognostic (2.00e-2)"	"unprognostic (3.82e-1)"	"unprognostic (6.64e-3)"	"unprognostic (1.55e-2)"	0.9	0.2	2.3	0.1	2.5	3.5	0.2	2.2	4.4	0.5	0.6	15.5	10.7	0.2	0.0	0.0	0.7	0.4	0.3	2.1	2.5	1.8	75.8	0.4	0.0	5.0	2.8	0.3	0.1	0.0	1.1	0.0	2.7	0.4	2.2	0.1	0.8	0.0	9.0	0.1	9.2	0.0	2.6	0.3	0.1	0.7	2.7	0.0	0.3	0.8	0.0	0.1	0.1	2.9	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	57.7	0.0	0.0	32.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.2	0.1	0.1	0.1	0.0	0.0	0.0	0.1	0.1	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.3	2.5	2.2	4.4	2.1	2.5	5.0	2.8	2.7	2.6	2.7	2.9	0.2	0.0	0.0	1.0	0.5	0.0	0.0	0.3	0.0	0.7	0.0	0.1	0.6	1.5	0.7	1.8	0.0	0.0	1.1	74.6	3.9	0.0	0.1	0.0	0.1	0.3	34.4	0.0	0.4	0.0	0.0	0.2	0.5	0.0	1.3	0.1	1.1	124.4	1.5	0.0	0.4	38.5	2.0	4.2	0.7	0.2	0.6	4.0	0.0	0.0	0.0	26.2	0.0	50.3	0.1	0.0	58.0	0.7	0.4	0.0	76.0	23.6	0.2	1.3	0.0	3.6	0.4	0.5	0.5	0.0	0.0	0.0	1.3	0.0	38.4	0.1
NGLY1	"FLJ11005, PNG-1, PNG1"	ENSG00000151092	"N-glycanase 1"	Q96IV0	3	25718944-25790039	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"		Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in many"	7	"Early spermatids: 594.1;Late spermatids: 963.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA036825	Approved				"Intracellular and membrane"	NA	NA			"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 25: Spermatids - Spermatogenesis"			"HPA036825: AB_10672231"	"unprognostic (3.65e-2)"	"unprognostic (8.65e-2)"	"prognostic favorable (1.17e-5)"	"unprognostic (2.96e-2)"	"unprognostic (1.72e-2)"	"unprognostic (1.59e-2)"	"prognostic unfavorable (1.96e-6)"	"unprognostic (2.20e-1)"	"unprognostic (2.34e-1)"	"unprognostic (3.73e-3)"	"unprognostic (2.55e-1)"	"unprognostic (4.23e-2)"	"unprognostic (4.92e-3)"	"unprognostic (1.07e-2)"	"unprognostic (2.47e-1)"	"unprognostic (9.08e-2)"	"unprognostic (1.89e-2)"	10.8	13.7	6.9	15.1	7.1	25.6	15.6	10.0	9.2	12.3	10.5	17.9	14.6	9.7	16.2	12.3	11.5	9.8	16.1	7.5	8.0	17.8	22.4	11.4	25.9	8.1	9.2	11.8	15.9	11.6	5.9	11.9	8.2	14.2	20.6	13.5	14.9	9.9	49.5	9.8	15.4	12.1	6.7	15.5	15.3	55.8	9.1	27.4	13.6	38.1	25.3	16.1	9.9	8.6	27.6	24.2	12.8	27.4	23.5	22.7	15.0	21.6	20.4	29.7	25.5	14.8	20.9	64.3	24.5	19.9	28.3	12.1	45.5	14.0	39.2	27.8	18.5	49.9	15.1	24.8	29.0	48.3	25.7	20.3	17.5	33.6	31.5	32.2	31.3	32.8	47.9	49.1	30.3	11.7	60.7	26.8	17.4	33.2	43.5	54.2	16.5	54.6	27.1	31.1	8.3	9.5	35.1	33.3	23.3	24.0	31.1	40.6	15.7	15.5	20.1	27.5	29.9	60.4	60.7	48.8	25.1	52.8	18.1	48.8	19.7	27.8	22.9	19.4	26.0	42.2	23.2	23.5	31.6	33.4	21.8	23.6	18.3	45.0	16.0	65.1	19.0	20.7	6.9	7.1	10.0	9.2	7.5	8.0	8.1	9.2	8.2	6.7	9.1	8.6	24.3	19.2	17.3	34.0	84.1	12.6	23.7	25.0	16.5	22.3	19.8	16.8	30.3	27.1	21.4	5.5	12.5	40.5	74.7	25.0	35.2	30.6	594.1	20.0	19.4	20.9	7.2	26.9	51.7	44.2	31.7	19.2	17.3	19.2	20.8	77.7	17.5	25.1	23.4	11.8	64.2	29.3	14.2	22.2	63.6	963.6	14.9	33.6	24.9	31.9	30.0	20.7	45.3	54.3	59.4	27.2	27.3	15.8	87.1	27.8	26.0	38.2	25.2	22.7	0.0	26.0	17.9	105.7	52.7	18.8	13.8	56.6	41.1	26.3	30.3	20.6
NIT1		ENSG00000158793	"Nitrilase 1"	Q86X76	1	161118086-161125445	"Enzymes, Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Proximal enterocytes: 101.5;Proximal tubular cells: 116.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA006657	Approved					NA	NA		89000	"Cluster 34: Basophils - Unknown function"	"Cluster 35: Non-specific - Unknown function"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"			"HPA006657: AB_1079485"	"unprognostic (3.66e-2)"	"unprognostic (1.15e-1)"	"unprognostic (7.16e-2)"	"unprognostic (1.39e-1)"	"unprognostic (1.47e-1)"	"unprognostic (1.10e-2)"	"unprognostic (1.55e-1)"	"unprognostic (2.16e-1)"	"unprognostic (4.70e-2)"	"unprognostic (2.52e-3)"	"unprognostic (2.18e-1)"	"unprognostic (6.62e-2)"	"prognostic unfavorable (4.21e-4)"	"unprognostic (2.00e-1)"	"unprognostic (1.76e-1)"	"unprognostic (2.52e-2)"	"unprognostic (2.94e-2)"	22.4	61.7	22.2	12.5	22.7	9.3	21.8	22.7	23.5	22.3	24.8	30.2	26.7	19.9	17.5	22.5	19.7	11.0	29.1	22.6	23.8	39.9	63.2	20.8	14.5	23.8	22.6	21.1	29.7	29.6	28.1	11.8	24.2	24.4	19.2	12.3	20.3	18.1	22.7	20.9	32.6	15.0	22.1	26.6	23.1	16.7	23.7	17.7	25.5	17.4	14.7	22.1	20.1	23.5	19.5	27.0	26.7	7.6	34.7	20.7	15.7	15.5	21.2	18.0	16.6	18.3	35.8	21.1	24.3	21.1	25.1	19.8	15.7	34.2	14.9	18.1	13.5	14.3	17.3	20.3	26.4	9.0	10.9	25.4	33.4	34.2	35.2	29.3	25.7	31.1	15.6	12.7	28.4	17.1	17.7	11.1	11.8	35.5	22.8	18.9	14.5	26.5	37.3	12.1	10.8	14.6	20.9	31.9	20.9	51.7	35.1	20.1	15.6	7.9	18.1	13.8	11.7	41.3	25.3	18.5	16.5	8.3	11.4	43.0	20.5	19.3	10.3	18.7	10.7	11.5	10.9	8.5	17.0	11.2	10.2	8.9	15.5	9.1	25.5	18.3	12.0	11.7	22.2	22.7	22.7	23.5	22.6	23.8	23.8	22.6	24.2	22.1	23.7	23.5	18.7	19.2	15.6	13.4	15.1	8.7	22.3	32.6	18.2	13.3	17.3	19.3	6.6	35.8	20.6	23.9	18.8	47.4	19.3	43.0	64.6	31.6	7.0	17.8	11.6	16.5	11.5	13.9	11.4	30.9	29.0	15.6	20.4	15.9	12.0	20.2	17.2	63.8	40.3	18.5	11.9	24.9	20.3	15.2	12.3	4.9	16.1	19.7	16.0	15.9	21.8	24.6	13.4	8.0	19.0	25.7	25.9	22.6	17.6	14.1	101.5	116.1	25.9	17.7	39.5	12.9	16.7	33.5	22.5	15.6	12.8	56.0	12.5	35.2	28.8	21.0
NIT2		ENSG00000114021	"Nitrilase family member 2"	Q9NQR4	3	100334739-100361635	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 26.4"	"Cell type enhanced"	"Detected in all"		"Proximal tubular cells: 705.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036999, HPA041289"	Approved		Supported	Centrosome,Cytosol		NA	NA		1700000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 81: Kidney & Liver - Metabolism"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Cytosol	Centrosome	"HPA036999: AB_10672105, HPA041289: "	"unprognostic (3.27e-1)"	"unprognostic (1.29e-1)"	"unprognostic (7.06e-3)"	"prognostic unfavorable (4.62e-4)"	"unprognostic (6.28e-2)"	"unprognostic (2.10e-1)"	"unprognostic (4.56e-1)"	"unprognostic (1.12e-1)"	"unprognostic (6.60e-3)"	"unprognostic (2.21e-1)"	"unprognostic (6.68e-2)"	"unprognostic (7.92e-2)"	"unprognostic (1.37e-2)"	"unprognostic (4.48e-2)"	"unprognostic (1.29e-1)"	"unprognostic (8.26e-2)"	"unprognostic (1.47e-3)"	5.1	3.9	1.3	1.4	2.4	3.5	6.8	1.4	1.9	3.4	1.7	3.8	2.7	4.1	5.5	4.4	4.1	3.4	5.2	1.6	1.3	18.5	26.4	3.2	2.4	0.7	0.8	3.3	3.7	3.9	2.7	2.4	0.9	3.6	3.4	3.6	3.8	4.9	10.1	5.0	2.8	3.0	0.9	2.2	4.1	1.2	1.2	2.5	5.9	7.6	3.7	5.2	3.6	1.4	12.3	12.1	1.4	6.2	10.3	14.1	7.4	4.9	7.3	11.5	10.9	10.4	13.7	12.3	7.4	7.2	4.9	9.1	5.4	13.2	13.7	3.8	2.8	9.0	4.1	5.3	12.6	5.9	5.8	8.8	19.9	6.1	10.1	6.0	7.4	6.9	4.2	9.8	14.2	11.9	3.9	5.3	5.4	15.3	18.0	4.3	5.0	12.0	19.4	7.7	8.2	3.8	6.8	11.6	7.3	3.7	8.6	5.4	5.5	7.2	2.9	3.5	4.4	5.9	7.0	10.6	11.4	9.9	9.3	0.2	0.7	0.4	1.0	0.7	1.4	1.5	1.0	0.8	2.0	1.5	1.2	1.1	0.4	1.1	0.5	0.6	1.2	0.3	1.3	2.4	1.4	1.9	1.6	1.3	0.7	0.8	0.9	0.9	1.2	1.4	22.3	12.8	17.2	8.5	31.5	32.6	51.7	92.0	37.0	12.8	43.7	56.1	56.4	45.8	53.5	58.8	16.7	92.5	26.1	14.6	187.9	73.6	3.1	53.6	47.2	16.7	24.0	17.0	12.0	52.7	73.7	38.0	29.6	42.3	21.0	55.3	15.0	183.6	63.5	13.5	8.8	22.0	65.1	23.5	39.9	4.1	44.1	26.9	49.8	4.7	89.9	15.4	22.6	12.1	8.0	62.1	20.6	37.6	20.8	54.3	24.1	705.6	60.5	24.9	39.5	23.9	51.6	2.7	17.5	53.7	41.6	59.2	27.7	118.1	36.7	53.0
NLN	"AGTBP, KIAA1226"	ENSG00000123213	Neurolysin	Q9BYT8	5	65722205-65871725	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"		"Hydrolase, Metalloprotease, Protease"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 52.8;Excitatory neurons: 58.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	5	"classical monocyte: 2.6;intermediate monocyte: 3.4;myeloid DC: 2.2;non-classical monocyte: 2.3"	"Group enriched"	"Detected in many"	5	"dendritic cells: 2.2;monocytes: 3.4"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA031862	Approved		Approved	Mitochondria		Yes	No		64000	"Cluster 7: Monocytes - Unknown function"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Mitochondria		"HPA031862: AB_10600827"	"unprognostic (5.91e-3)"	"unprognostic (4.52e-2)"	"unprognostic (1.34e-3)"	"unprognostic (4.37e-2)"	"unprognostic (3.85e-1)"	"unprognostic (1.45e-2)"	"unprognostic (7.29e-3)"	"unprognostic (3.24e-2)"	"unprognostic (3.19e-1)"	"unprognostic (3.58e-1)"	"prognostic unfavorable (7.51e-4)"	"unprognostic (1.27e-1)"	"prognostic favorable (5.58e-7)"	"unprognostic (1.52e-2)"	"unprognostic (1.98e-1)"	"unprognostic (1.29e-1)"	"unprognostic (6.18e-3)"	2.2	1.0	3.8	2.4	3.9	1.5	3.7	2.9	5.3	1.8	1.6	3.6	1.1	2.7	2.4	2.5	1.5	1.2	2.6	3.8	3.6	3.9	9.9	1.7	1.7	3.9	3.4	1.8	2.5	1.5	0.9	2.4	4.0	2.6	3.2	2.5	1.9	1.1	8.9	2.8	2.7	2.7	3.3	1.3	4.0	1.1	3.9	0.9	2.7	6.5	2.0	2.7	1.5	4.8	13.3	12.5	7.2	12.0	9.0	15.3	14.5	13.1	5.5	7.6	8.2	7.2	7.7	18.8	16.1	15.8	15.1	10.3	9.5	20.2	13.1	5.6	6.4	5.2	8.7	18.5	7.7	12.0	3.0	11.7	10.8	10.5	12.4	6.3	21.7	8.3	11.4	3.9	16.5	10.2	8.3	10.8	22.2	6.7	3.6	9.6	15.3	29.9	12.6	5.9	22.3	11.5	10.6	10.7	11.0	19.4	12.9	14.1	12.5	5.0	5.9	7.4	10.0	3.3	7.1	8.2	7.7	23.2	7.7	0.1	2.6	0.1	0.1	3.4	0.1	0.4	0.2	0.1	2.2	0.4	0.3	0.2	0.3	0.5	2.3	0.1	0.0	1.0	3.8	3.9	2.9	5.3	3.8	3.6	3.9	3.4	4.0	3.3	3.9	4.8	5.9	6.4	2.8	19.6	4.0	5.7	9.0	6.2	8.6	2.4	10.1	8.9	14.5	7.2	8.5	12.9	4.2	5.3	0.6	52.8	5.9	17.8	0.3	7.4	12.9	8.3	1.8	9.0	58.9	14.5	14.0	7.1	20.4	20.9	15.2	16.2	4.6	32.4	28.8	5.0	32.2	5.8	6.1	22.9	8.9	0.4	4.4	13.5	1.8	5.6	17.9	13.1	2.1	22.6	44.5	30.2	35.9	2.2	4.9	16.5	32.3	22.4	3.1	4.7	0.0	19.7	8.1	2.1	5.2	15.3	5.3	2.9	2.3	15.8	8.2	6.1
NOTUM		ENSG00000185269	"Notum, palmitoleoyl-protein carboxylesterase"	Q6P988	17	81952507-81961840	"Enzymes, Predicted intracellular proteins, Predicted secreted proteins"	"Wnt signaling pathway"	"Hydrolase, Serine esterase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	14	"placenta: 135.7"	"Cell type enriched"	"Detected in some"	45	"Extravillous trophoblasts: 1002.5"	"Cancer enhanced"	"Detected in many"		"stomach cancer: 48.4"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	6	"Hep G2: 428.6"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA022851			Approved	"Endoplasmic reticulum"	"Secreted in female reproductive system"	NA	NA		1900000		"Cluster 28: Placenta - Pregnancy"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 38: Extravillous trophoblasts - Unknown function"	"Endoplasmic reticulum"		"HPA022851: "	"unprognostic (1.49e-1)"	"unprognostic (1.55e-1)"	"unprognostic (1.23e-2)"	"unprognostic (4.80e-3)"	"unprognostic (1.97e-1)"	"unprognostic (9.02e-3)"	"unprognostic (3.01e-2)"	"unprognostic (1.01e-2)"	"unprognostic (6.49e-2)"	"unprognostic (8.72e-2)"	"unprognostic (1.40e-1)"	"unprognostic (2.01e-2)"	"unprognostic (4.48e-6)"	"unprognostic (1.76e-1)"	"unprognostic (9.88e-2)"	"unprognostic (1.22e-3)"	"unprognostic (1.00e-1)"	0.0	0.1	1.6	0.0	1.9	0.0	0.2	0.6	1.8	0.2	0.1	0.0	1.1	2.1	0.3	0.3	0.4	0.2	0.3	1.0	1.0	1.2	10.0	2.2	0.0	1.7	2.7	0.1	0.4	0.9	0.2	135.7	1.3	0.3	0.0	0.0	0.6	0.1	8.2	2.2	0.3	0.1	0.9	0.2	2.1	2.8	1.3	0.0	0.0	0.5	0.0	1.4	0.2	0.8	0.0	1.2	0.0	0.0	0.0	0.0	1.3	0.1	0.2	0.0	0.1	10.0	0.4	0.0	1.8	0.3	0.2	0.4	2.4	0.0	0.0	0.1	1.1	2.2	2.8	428.6	0.2	0.4	0.4	0.2	0.0	0.0	0.0	0.6	0.0	0.2	11.2	0.0	0.0	0.6	0.0	0.2	0.1	67.9	0.4	0.0	0.2	0.1	0.0	0.2	15.7	1.6	4.2	1.7	6.2	2.3	0.1	4.9	0.0	0.5	6.3	0.0	0.2	0.1	0.0	1.5	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	1.9	0.6	1.8	1.0	1.0	1.7	2.7	1.3	0.9	1.3	0.8	0.0	0.0	3.7	0.3	0.0	0.1	0.1	0.1	0.0	0.0	0.6	1.3	1.2	0.0	0.0	0.0	0.0	10.0	0.0	0.1	0.0	0.0	0.4	0.1	0.1	0.8	0.0	0.0	0.6	0.0	1002.5	1.2	1.5	0.3	0.0	0.1	0.0	3.6	18.4	0.0	1.1	0.1	0.0	0.0	0.3	0.2	0.3	0.0	0.0	2.8	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.4	0.5	12.7	0.0	0.0	22.0	0.1	0.0	0.3	0.0
NPEPPS	"MP100, PSA"	ENSG00000141279	"Aminopeptidase puromycin sensitive"	P55786	17	47522942-47624665	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"		"Aminopeptidase, Hydrolase, Metalloprotease, Protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA021453, HPA045649"	Uncertain		Supported	Cytosol		No	No		3000000	"Cluster 50: Neutrophils - Cellular senescence"	"Cluster 59: Non-specific - Translation"	"Cluster 6: T47d - Mammary gland"	"Cluster 44: Endometrium - Transcription"	Cytosol		"HPA021453: AB_2670709, HPA045649: AB_2679406"	"unprognostic (1.63e-1)"	"unprognostic (3.15e-2)"	"prognostic favorable (3.39e-5)"	"unprognostic (2.66e-2)"	"unprognostic (1.53e-1)"	"unprognostic (5.92e-2)"	"prognostic unfavorable (3.67e-5)"	"unprognostic (3.84e-2)"	"unprognostic (1.22e-1)"	"unprognostic (1.77e-1)"	"unprognostic (3.85e-2)"	"unprognostic (3.63e-2)"	"unprognostic (1.93e-1)"	"unprognostic (8.55e-2)"	"unprognostic (1.52e-1)"	"unprognostic (1.23e-2)"	"unprognostic (1.07e-1)"	32.2	50.0	30.6	19.4	34.8	7.3	30.1	30.7	41.1	41.5	26.1	38.6	20.3	32.0	11.1	92.2	32.6	22.2	30.6	32.9	30.3	30.9	23.8	30.5	18.4	35.7	34.2	39.9	34.2	30.1	26.7	27.3	35.7	27.9	27.4	21.0	44.4	20.6	114.5	47.3	37.1	33.7	26.1	31.9	33.4	19.2	34.2	26.4	26.8	86.6	27.5	34.8	58.2	30.5	105.7	81.7	67.3	49.4	92.1	81.9	147.5	47.5	63.9	70.4	66.5	55.7	100.6	68.4	76.1	69.2	70.1	62.0	83.7	44.8	108.7	31.5	73.2	76.5	62.3	59.2	48.3	48.8	46.6	61.5	41.1	52.7	26.8	99.2	77.5	20.1	72.5	30.7	109.9	37.2	66.0	34.7	47.8	74.4	68.0	50.5	107.2	60.1	82.6	81.0	59.7	46.0	59.1	34.9	44.7	122.0	256.3	35.5	88.6	44.1	35.2	72.5	34.9	63.7	81.1	39.9	64.8	25.3	33.5	14.2	9.9	12.4	8.8	7.9	9.6	7.7	7.2	9.2	9.7	6.9	6.3	7.8	28.4	8.8	9.1	10.1	8.8	6.3	30.6	34.8	30.7	41.1	32.9	30.3	35.7	34.2	35.7	26.1	34.2	30.5	32.0	83.3	59.1	68.6	44.7	77.9	68.9	40.2	109.8	144.6	76.6	33.8	60.3	55.8	53.6	42.3	268.9	81.2	35.6	87.0	27.4	69.3	34.2	95.2	80.9	45.4	44.3	44.6	98.0	54.4	74.4	66.0	58.1	158.1	41.7	62.7	45.7	32.5	40.5	112.7	95.3	44.1	38.7	51.0	62.1	50.8	52.8	45.4	58.7	37.5	51.5	38.7	38.1	69.4	74.9	103.4	61.6	50.0	52.5	106.2	58.7	46.5	63.8	153.3	78.9	53.8	53.5	52.0	28.6	101.6	102.6	104.7	40.4	45.9	51.5	195.2
NRAS	N-ras	ENSG00000213281	"NRAS proto-oncogene, GTPase"	P01111	1	114704469-114716771	"Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, RAS pathway related proteins"		Hydrolase	"Cancer-related genes, Disease variant, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB010157, HPA049830, CAB079912"	Uncertain		Supported	"Plasma membrane"		NA	NA			"Cluster 38: Basophils - Unknown function"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 16: Pancreatic endocrine cells - Mixed function"	"Plasma membrane"		"CAB010157: AB_632073, CAB079912: AB_2784586, HPA049830: AB_2680903"	"unprognostic (4.75e-2)"	"unprognostic (2.81e-1)"	"unprognostic (1.09e-3)"	"unprognostic (2.11e-2)"	"unprognostic (8.59e-3)"	"unprognostic (1.14e-1)"	"prognostic unfavorable (3.03e-7)"	"unprognostic (7.76e-3)"	"unprognostic (1.57e-2)"	"unprognostic (1.01e-3)"	"prognostic unfavorable (1.36e-4)"	"unprognostic (6.60e-3)"	"prognostic unfavorable (7.87e-4)"	"unprognostic (2.68e-1)"	"unprognostic (1.30e-1)"	"unprognostic (1.16e-1)"	"unprognostic (3.33e-2)"	19.0	9.1	10.3	25.7	11.2	58.5	18.0	11.5	12.3	12.5	8.6	27.8	21.5	12.4	7.8	20.7	10.3	17.2	8.3	10.2	12.2	20.9	24.9	18.5	30.4	12.3	12.1	9.6	11.4	9.0	4.3	28.3	12.3	11.4	26.6	6.6	10.9	7.1	7.7	19.8	22.5	14.1	11.7	18.6	21.8	9.6	11.4	39.0	16.1	7.8	29.7	22.2	8.6	13.4	93.7	24.9	65.2	24.9	26.4	56.3	46.5	43.5	48.4	79.5	89.0	50.4	33.9	70.4	56.3	58.9	55.4	26.0	88.2	70.6	113.4	96.5	34.2	47.8	34.5	60.2	52.3	120.0	71.0	51.1	56.1	91.5	66.2	25.0	102.8	54.6	77.3	78.5	71.0	248.9	83.5	46.4	111.0	30.2	17.9	62.9	116.0	44.1	70.6	49.5	39.4	59.0	44.7	36.4	107.1	75.4	31.9	96.2	79.2	43.3	82.2	81.5	90.3	137.7	101.6	81.6	86.4	64.6	159.0	38.7	12.8	12.6	11.7	19.2	10.5	12.8	9.3	11.6	12.6	10.5	9.9	12.9	3.4	15.5	17.6	9.6	13.4	13.1	10.3	11.2	11.5	12.3	10.2	12.2	12.3	12.1	12.3	11.7	11.4	13.4	22.7	16.0	16.5	8.1	25.9	30.7	31.2	23.1	15.4	5.2	18.5	13.6	5.6	18.6	19.3	22.0	8.4	22.4	27.7	49.2	13.7	34.1	3.9	22.9	24.7	29.2	24.6	31.6	5.8	31.5	50.4	16.1	29.0	38.0	31.1	22.2	33.2	29.7	49.2	5.0	5.2	28.1	30.5	44.9	30.7	5.9	8.1	30.4	23.2	9.4	41.6	7.8	22.6	5.0	8.1	51.4	32.9	6.4	39.6	30.6	28.1	39.4	23.1	3.3	6.6	12.8	15.3	7.3	15.4	24.6	36.2	31.2	21.9	13.8	28.8	40.2
NRDC	"hNRD1, hNRD2, NRD1"	ENSG00000078618	"Nardilysin convertase"	O43847	1	51789191-51878937	"Enzymes, Plasma proteins, Predicted intracellular proteins"		"Hydrolase, Metalloprotease, Protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 267.3"	"Group enriched"	"Detected in many"	9	"Early spermatids: 597.7;Late spermatids: 1672.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA053661			Approved	Nucleoplasm		NA	NA		58000	"Cluster 5: Granulocytes - Unknown function"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 31: Spermatids - Spermatogenesis"	Nucleoplasm		"HPA053661: AB_2682221"	"unprognostic (1.22e-1)"	"unprognostic (6.52e-2)"	"unprognostic (2.14e-2)"	"unprognostic (5.62e-2)"	"unprognostic (2.61e-1)"	"unprognostic (3.25e-2)"	"prognostic unfavorable (5.49e-6)"	"unprognostic (1.42e-1)"	"unprognostic (4.17e-2)"	"unprognostic (1.67e-1)"	"unprognostic (5.86e-2)"	"unprognostic (1.00e-1)"	"prognostic unfavorable (2.12e-9)"	"unprognostic (2.75e-1)"	"unprognostic (2.35e-2)"	"unprognostic (9.54e-2)"	"unprognostic (5.53e-3)"	48.2	36.8	33.3	48.2	33.9	48.5	34.2	33.6	42.3	31.1	37.2	32.5	32.3	31.1	20.2	40.4	29.7	31.0	58.5	34.4	35.5	26.5	55.7	34.3	43.8	35.2	34.6	32.6	40.1	60.9	32.8	40.2	37.8	38.6	35.3	48.1	28.7	30.5	267.3	51.4	31.4	38.4	33.6	40.9	35.2	95.6	36.5	54.9	33.1	182.0	46.7	36.5	28.4	38.1	166.8	91.0	94.2	133.4	98.9	145.5	106.8	165.6	143.9	116.6	123.5	65.6	65.3	108.3	84.7	128.4	157.6	95.1	136.5	127.9	156.2	127.7	66.1	129.5	125.4	62.9	97.9	114.4	95.4	117.2	102.1	169.7	160.0	105.0	125.7	113.1	174.7	71.7	153.4	62.9	105.0	45.2	161.5	71.8	97.4	101.6	106.4	122.6	92.8	94.7	86.5	65.2	148.0	124.8	94.5	185.7	79.3	152.5	102.4	103.8	94.2	114.2	146.0	103.9	168.4	100.1	120.8	146.6	120.1	44.5	33.8	50.0	23.2	35.1	23.3	23.2	21.5	26.0	33.7	15.6	20.9	22.7	67.8	29.8	28.3	27.5	26.9	33.1	33.3	33.9	33.6	42.3	34.4	35.5	35.2	34.6	37.8	33.6	36.5	38.1	43.5	35.3	69.0	0.0	58.9	0.0	46.3	0.0	38.7	73.3	38.2	31.0	0.0	28.6	34.7	27.6	81.3	56.8	94.3	11.1	31.3	48.1	597.7	63.1	78.8	39.4	18.2	85.8	0.0	64.0	45.5	40.1	56.6	55.4	35.3	74.6	30.4	59.9	44.3	62.2	0.0	19.5	0.0	44.6	0.0	1672.1	66.2	72.5	0.0	0.0	70.3	45.9	55.6	0.0	0.0	57.6	13.7	59.0	126.1	41.9	30.1	19.6	59.0	71.8	59.2	64.5	38.2	39.0	28.1	57.7	0.0	82.5	52.8	65.9	21.6	42.3
NSF	"SEC18, SKD2"	ENSG00000073969	"N-ethylmaleimide sensitive factor, vesicle fusing ATPase"	P46459	17	46590669-46757464	"Enzymes, Predicted intracellular proteins, Transporters"	"Protein transport, Transport"	Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 276.3;Inhibitory neurons: 284.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003154, CAB009324, HPA071089"	Enhanced		Supported	"Golgi apparatus,Cytosol"		NA	NA		59000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 58: Brain - Synaptic function"	"Cluster 21: OE19 - Mitochondria"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Cytosol	"Golgi apparatus"	"CAB009324: AB_653479, HPA003154: AB_1079508, HPA071089: AB_2686343"	"unprognostic (5.70e-2)"	"unprognostic (1.50e-1)"	"unprognostic (1.07e-3)"	"unprognostic (1.98e-1)"	"unprognostic (1.52e-1)"	"unprognostic (2.04e-1)"	"unprognostic (2.30e-2)"	"unprognostic (1.09e-1)"	"unprognostic (3.95e-2)"	"unprognostic (5.48e-2)"	"unprognostic (2.37e-2)"	"unprognostic (3.25e-2)"	"unprognostic (1.19e-1)"	"unprognostic (2.07e-2)"	"unprognostic (3.09e-1)"	"unprognostic (1.65e-1)"	"unprognostic (1.74e-1)"	13.5	20.2	29.9	8.0	28.8	5.7	12.5	7.7	58.7	14.1	0.0	18.3	4.9	11.8	7.3	21.6	9.7	8.0	11.3	39.2	28.6	12.9	13.7	11.6	9.6	36.8	14.3	7.0	22.9	15.3	43.1	7.7	36.6	12.4	13.9	63.0	18.4	5.8	38.9	16.5	16.1	6.4	4.1	14.9	15.6	16.7	15.6	7.9	11.9	13.5	10.0	13.2	14.3	21.1	11.7	25.4	16.6	1.2	9.6	13.4	13.5	15.6	18.2	14.7	14.3	17.5	0.1	28.5	27.3	34.8	15.3	2.0	18.9	5.8	23.9	10.1	24.6	1.0	17.4	24.2	14.3	0.8	6.1	12.3	7.8	29.8	12.3	7.8	23.4	7.0	19.4	15.0	32.9	22.8	19.4	7.5	9.4	36.0	29.9	13.7	16.1	26.7	16.7	24.0	15.2	17.2	23.1	0.1	11.1	17.5	28.5	35.1	19.3	41.2	14.4	22.0	23.7	32.0	19.9	16.4	11.5	15.2	29.7	9.3	11.5	6.6	6.1	9.8	6.7	5.4	6.2	8.1	12.6	6.1	5.1	6.1	4.8	5.9	10.8	5.0	9.4	7.5	29.9	28.8	7.7	58.7	39.2	28.6	36.8	14.3	36.6	4.1	15.6	21.1	16.3	9.6	11.3	54.9	28.2	4.0	3.6	6.7	6.2	106.6	14.0	10.0	8.1	7.2	10.9	22.0	87.6	13.0	18.8	32.3	11.7	12.4	45.2	8.3	19.7	11.5	30.5	8.6	276.3	16.2	14.4	10.9	13.7	11.2	9.5	8.2	11.0	19.3	18.8	43.7	284.7	26.3	24.4	29.9	10.9	45.8	5.9	20.5	10.6	69.3	35.4	24.5	8.2	98.5	71.8	13.7	17.4	8.6	21.7	9.0	18.5	14.7	8.7	89.9	0.0	10.6	12.9	40.6	31.4	9.5	5.7	18.5	14.8	18.3	20.6	8.6
NT5C1A	"CN-I, CN-IA, CN1, CN1A, MGC119199, MGC119201"	ENSG00000116981	"5'-nucleotidase, cytosolic IA"	Q9BXI3	1	39659121-39672038	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Nucleotide metabolism"	Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	4	"skeletal muscle: 72.4;tongue: 28.6"	"Cell type enhanced"	"Detected in single"		"Inhibitory neurons: 1.2"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	12	"SH-SY5Y: 17.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA050283, HPA054158"	Supported					NA	NA				"Cluster 33: Striated muscle - Muscle contraction"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"			"HPA050283: AB_2681072, HPA054158: AB_2682402"	"unprognostic (7.85e-2)"				"unprognostic (1.60e-1)"	"unprognostic (6.19e-1)"		"unprognostic (1.51e-3)"	"unprognostic (7.19e-2)"		"unprognostic (2.87e-1)"	"unprognostic (3.34e-1)"	"unprognostic (1.32e-1)"	"unprognostic (3.29e-2)"		"unprognostic (1.81e-2)"		0.2	2.6	1.4	0.1	0.8	0.0	0.0	4.8	5.4	0.2	0.0	0.0	0.0	0.1	0.1	3.0	0.2	0.0	11.4	0.7	1.6	0.4	0.0	0.0	0.0	3.0	3.1	0.1	3.9	0.0	0.0	0.0	2.0	0.5	0.0	0.1	0.1	0.1	72.4	0.0	0.1	0.1	1.4	0.0	0.1	0.2	2.2	0.1	0.0	28.6	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	17.8	0.0	0.0	0.3	0.0	0.0	1.4	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.8	4.8	5.4	0.7	1.6	3.0	3.1	2.0	1.4	2.2	1.1	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
NT5C1B	"AIRP, CN-IB"	ENSG00000185013	"5'-nucleotidase, cytosolic IB"	Q96P26	2	18562872-18589572	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Nucleotide metabolism"	Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	13	"testis: 35.5"	"Group enriched"	"Detected in some"	29	"Early spermatids: 159.5;Late spermatids: 300.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low immune cell specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Low cell line specificity"	"Detected in some"											HPA056683	Uncertain		Approved	"Nucleoplasm,Nucleoli,Plasma membrane"		NA	NA			"Cluster 29: Plasmacytoid DCs - Unknown function"	"Cluster 83: Testis - Spermatogenesis"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 25: Spermatids - Spermatogenesis"	"Nucleoli, Plasma membrane"	Nucleoplasm	"HPA056683: AB_2683207"	"unprognostic (4.18e-2)"	"unprognostic (1.20e-2)"	"unprognostic (7.67e-2)"	"unprognostic (1.31e-1)"	"unprognostic (1.02e-1)"	"unprognostic (4.97e-2)"	"unprognostic (4.96e-2)"	"unprognostic (4.84e-1)"	"unprognostic (8.49e-2)"	"unprognostic (4.42e-2)"	"unprognostic (2.91e-2)"	"unprognostic (2.35e-1)"	"unprognostic (1.61e-1)"	"unprognostic (6.96e-2)"	"unprognostic (2.50e-1)"	"unprognostic (1.15e-1)"	"unprognostic (3.77e-1)"	0.1	0.5	0.2	0.2	0.3	0.4	0.1	0.2	0.2	0.1	2.6	0.1	0.7	0.1	0.0	1.0	0.1	0.7	0.6	0.1	0.1	0.3	0.2	0.2	0.3	0.3	0.5	0.0	0.4	0.0	0.1	0.2	0.2	0.2	0.0	0.1	0.2	0.0	0.0	1.1	0.2	0.0	0.1	0.2	0.8	35.5	0.4	0.0	0.7	0.0	0.0	0.3	0.1	0.2	1.2	0.2	0.1	0.0	0.0	0.0	0.1	0.9	0.0	0.0	0.0	0.0	1.2	0.5	0.1	0.0	0.7	0.3	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.3	0.0	0.2	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.2	0.4	0.1	0.0	1.0	0.0	0.1	0.2	0.2	0.6	0.1	0.2	0.3	0.0	1.1	0.8	0.4	0.9	0.1	0.5	0.1	0.2	0.2	0.6	0.5	0.3	1.0	0.1	0.3	0.2	0.7	0.9	0.0	0.4	0.0	0.0	0.0	0.4	0.0	0.7	0.0	0.4	0.4	0.1	0.3	0.8	0.7	0.0	0.2	0.0	1.2	0.1	0.1	0.2	0.3	0.2	0.2	0.1	0.1	0.3	0.5	0.2	0.1	0.4	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	159.5	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	300.4	2.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.7	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0
NT5C2	"cN-II, GMP, NT5B, PNT5, SPG45, SPG65"	ENSG00000076685	"5'-nucleotidase, cytosolic II"	P49902	10	103087185-103277605	"Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Nucleotide metabolism"	"Allosteric enzyme, Hydrolase"	"Cancer-related genes, Disease variant, Hereditary spastic paraplegia, Neurodegeneration"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Astrocytes: 141.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA003751	Approved					NA	NA			"Cluster 5: Granulocytes - Unknown function"	"Cluster 72: Non-specific - Transcription"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 22: Epithelial cell types - Mixed function"			"HPA003751: AB_1854664"	"unprognostic (8.18e-2)"	"unprognostic (1.98e-1)"	"unprognostic (2.55e-2)"	"unprognostic (2.46e-1)"	"unprognostic (5.54e-2)"	"unprognostic (4.87e-3)"	"unprognostic (2.24e-2)"	"unprognostic (1.72e-1)"	"unprognostic (6.41e-2)"	"unprognostic (9.59e-2)"	"unprognostic (2.93e-3)"	"unprognostic (6.20e-2)"	"unprognostic (3.26e-2)"	"unprognostic (3.70e-2)"	"unprognostic (6.40e-2)"	"unprognostic (3.43e-1)"	"unprognostic (1.50e-1)"	24.6	27.0	25.0	19.0	27.2	29.7	23.0	27.3	28.5	37.6	36.8	27.3	9.9	18.8	17.3	67.1	26.5	16.4	28.5	25.2	28.8	32.5	27.8	30.8	18.3	26.9	29.5	32.4	22.0	21.7	34.0	17.9	27.2	32.4	16.7	47.3	46.4	18.4	51.6	19.9	20.4	13.4	26.4	32.8	22.3	30.8	27.2	28.6	55.4	18.1	24.5	33.3	42.7	28.6	148.4	52.5	32.6	67.5	27.2	33.2	18.2	66.0	64.7	29.9	32.4	34.6	91.7	49.2	47.7	45.6	27.6	62.8	23.4	33.8	38.3	40.3	21.6	38.7	21.1	39.6	48.5	64.2	21.0	50.4	34.1	28.0	24.8	57.5	25.6	19.4	29.4	36.4	54.5	73.8	53.7	64.6	34.6	43.2	68.6	102.6	30.0	19.6	43.3	72.5	10.0	24.9	35.8	25.9	50.3	33.7	39.2	38.1	30.5	20.5	24.8	39.7	51.7	32.9	71.6	85.5	23.9	64.6	7.8	29.5	16.5	31.3	10.0	18.8	10.3	8.9	8.4	8.7	14.7	5.2	6.7	8.0	27.4	14.4	23.0	9.6	9.3	10.5	25.0	27.2	27.3	28.5	25.2	28.8	26.9	29.5	27.2	26.4	27.2	28.6	16.2	83.3	34.9	141.7	17.2	7.4	29.0	26.9	5.7	24.4	13.9	13.6	2.6	18.6	60.4	27.6	45.9	19.4	23.3	48.7	11.7	28.5	103.7	29.5	17.1	19.8	11.5	12.4	79.8	26.0	11.7	17.5	25.5	46.2	8.8	18.2	13.9	17.4	19.9	47.1	83.6	17.6	18.3	29.8	14.2	61.9	24.8	27.1	26.6	78.7	25.9	85.5	16.5	70.4	107.5	57.9	23.1	13.5	21.0	35.7	11.7	15.3	44.1	59.1	32.9	22.9	21.7	25.3	20.5	22.9	7.5	35.0	16.6	15.8	18.0	80.5
NT5C3A	"cN-III, hUMP1, NT5C3, p36, P5'N-1, PN-I, POMP, PSN1, UMPH, UMPH1"	ENSG00000122643	"5'-nucleotidase, cytosolic IIIA"	Q9H0P0	7	33014114-33062797	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Nucleotide metabolism"	"Hydrolase, Transferase"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 87.4"	"Cell type enhanced"	"Detected in all"		"Distal enterocytes: 191.0;Paneth cells: 186.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA010520, HPA010630, HPA029058"	Uncertain		Supported	"Nucleoplasm,Nuclear bodies,Endoplasmic reticulum,Cytosol"	"Intracellular and membrane"	NA	NA		10000	"Cluster 31: Non-specific - Inflammatory response"	"Cluster 33: Striated muscle - Muscle contraction"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 51: Myeloid cells - Hemostasis"	"Endoplasmic reticulum, Cytosol"	"Nucleoplasm, Nuclear bodies"	"HPA010520: , HPA010630: AB_2668319, HPA029058: AB_10601380"	"unprognostic (7.50e-2)"	"unprognostic (3.10e-1)"	"unprognostic (1.14e-1)"	"unprognostic (2.69e-2)"	"unprognostic (1.22e-1)"	"unprognostic (5.56e-2)"	"prognostic unfavorable (2.42e-4)"	"unprognostic (3.25e-2)"	"unprognostic (3.12e-2)"	"unprognostic (2.82e-3)"	"unprognostic (2.08e-2)"	"unprognostic (1.98e-1)"	"prognostic unfavorable (1.70e-4)"	"unprognostic (9.37e-2)"	"unprognostic (2.05e-1)"	"unprognostic (2.12e-3)"	"unprognostic (3.43e-3)"	12.4	14.3	11.4	26.1	11.4	32.6	21.3	15.2	15.6	12.6	10.8	51.9	40.0	16.9	14.3	18.6	15.9	23.4	16.6	11.5	11.5	22.4	11.8	17.6	30.8	11.1	11.8	13.4	21.4	9.7	7.5	16.3	11.5	12.3	51.0	20.4	9.7	10.0	87.4	28.7	37.3	13.2	12.7	22.9	27.0	9.5	12.0	22.5	17.1	51.0	45.8	23.8	14.4	13.1	42.2	27.6	25.2	29.6	21.2	16.1	20.3	44.8	30.5	29.2	38.9	19.9	115.1	100.4	27.7	29.6	48.3	63.8	28.3	30.8	40.4	16.2	36.2	54.7	36.5	28.7	23.3	55.6	36.9	21.7	23.8	35.9	63.0	16.4	22.2	33.2	43.3	24.8	37.3	29.9	25.0	87.8	27.8	47.1	31.2	25.9	22.9	60.0	87.8	39.8	28.1	37.0	31.1	52.4	66.6	24.5	35.2	33.5	19.8	25.1	20.9	42.6	55.7	50.6	69.0	54.8	20.6	34.9	42.5	112.5	25.9	82.5	26.6	32.7	30.6	64.0	34.2	30.8	22.1	63.6	34.5	29.1	103.8	28.2	39.2	20.6	56.2	37.9	11.4	11.4	15.2	15.6	11.5	11.5	11.1	11.8	11.5	12.7	12.0	13.1	39.1	22.4	13.7	30.7	85.1	46.8	40.9	85.3	47.8	23.9	22.6	18.9	16.9	32.9	40.4	16.5	41.7	36.9	42.5	191.0	29.4	34.4	5.7	40.9	21.0	40.8	119.6	127.1	45.3	79.0	31.6	35.2	42.8	21.4	17.7	38.3	30.0	18.9	25.0	1.7	49.4	98.9	40.7	31.2	23.5	5.0	33.8	111.4	26.6	29.0	37.0	23.4	55.6	48.2	52.4	48.3	186.6	22.2	43.8	45.7	91.8	84.8	53.7	27.1	13.1	30.7	24.9	46.4	24.0	35.5	38.9	28.3	53.7	23.3	71.0	65.9
NT5C3B	"cN-IIIB, MGC20781, NT5C3L"	ENSG00000141698	"5'-nucleotidase, cytosolic IIIB"	Q969T7	17	41825057-41836260	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Nucleotide metabolism"	Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Spermatocytes: 131.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"A549: 39.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA030786, HPA057095"	Approved					NA	NA			"Cluster 30: Non-specific - Translation"	"Cluster 35: Non-specific - Unknown function"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 39: Non-specific - Basic cellular processes"			"HPA030786: AB_10602716, HPA057095: AB_2683333"	"unprognostic (3.90e-2)"	"unprognostic (5.75e-2)"	"unprognostic (8.87e-2)"	"unprognostic (1.46e-1)"	"unprognostic (2.25e-1)"	"unprognostic (1.21e-1)"	"prognostic unfavorable (8.11e-5)"	"unprognostic (3.40e-2)"	"unprognostic (6.05e-2)"	"unprognostic (2.31e-1)"	"prognostic favorable (2.67e-4)"	"unprognostic (3.07e-1)"	"unprognostic (7.17e-3)"	"unprognostic (2.36e-2)"	"unprognostic (4.80e-3)"	"unprognostic (7.14e-3)"	"unprognostic (1.42e-2)"	7.9	7.6	12.4	1.5	12.8	1.2	7.6	15.5	13.4	7.6	10.8	12.9	1.9	7.0	3.3	6.3	7.0	3.2	7.1	13.0	12.3	11.1	8.7	6.5	2.8	10.9	11.3	7.4	11.5	2.8	9.9	3.0	10.6	9.0	1.1	3.6	7.8	4.2	6.0	4.7	6.5	4.8	10.0	5.7	8.9	9.5	11.8	0.9	13.0	5.6	1.9	8.9	6.8	12.7	8.1	39.5	7.8	12.7	8.6	6.0	3.2	9.5	8.5	12.9	14.3	34.0	2.1	9.3	5.6	6.3	8.6	8.3	8.2	9.9	4.6	5.9	19.7	4.1	21.8	17.8	10.1	0.1	4.7	5.3	5.4	17.4	6.5	4.7	7.5	13.8	3.6	2.4	8.6	18.0	8.2	5.1	5.0	7.9	4.2	6.2	13.2	7.8	3.7	10.0	6.0	3.5	13.4	13.8	4.9	6.7	6.7	6.3	7.1	5.3	5.4	9.3	9.5	2.7	5.6	4.2	4.2	0.1	8.1	1.1	2.3	0.3	1.8	0.5	2.5	1.8	2.4	1.8	2.4	2.5	1.9	2.1	1.3	0.7	0.4	1.3	0.4	2.0	12.4	12.8	15.5	13.4	13.0	12.3	10.9	11.3	10.6	10.0	11.8	12.7	24.8	9.6	17.2	15.0	16.9	18.1	58.7	47.3	33.6	33.8	45.1	61.1	13.6	22.8	16.6	29.5	18.8	39.0	8.7	5.1	101.8	51.6	99.8	10.9	26.8	29.1	39.4	2.5	14.2	41.6	56.2	35.2	14.3	12.1	11.4	40.1	26.7	24.0	13.4	116.1	15.5	13.2	32.6	13.2	18.5	121.6	32.3	11.7	35.6	6.5	5.8	42.4	6.2	13.0	7.2	39.1	9.8	30.5	15.5	78.7	1.4	65.1	12.7	36.5	39.5	31.1	49.3	131.8	30.0	19.8	17.2	31.2	13.8	23.7	15.2	44.6
NT5E	"CALJA, CD73, eN, eNT, NT5"	ENSG00000135318	"5'-nucleotidase ecto"	P21589	6	85449584-85495791	"CD markers, Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"		Hydrolase	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"cervix: 112.6;retina: 94.4"	"Cell type enhanced"	"Detected in many"		"Glandular and luminal cells: 58.0;Oligodendrocyte precursor cells: 61.3;Pancreatic endocrine cells: 124.8;Rod photoreceptor cells: 81.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"naive B-cell: 33.0;naive CD8 T-cell: 30.7"	"Group enriched"	"Detected in many"	41	"B-cells: 33.0;T-cells: 30.7"	"Cell line enhanced"	"Detected in many"		"hTERT-RPE1: 807.8;LHCN-M2: 934.3;TIME: 546.2;U-87 MG: 821.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA017357	Approved		Supported	"Nucleoplasm,Plasma membrane,Cytosol"	"Intracellular and membrane"	NA	NA		3000000	"Cluster 21: B-cells - Adaptive immune response"	"Cluster 12: Smooth muscle tissue - Mixed function"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 50: Fibroblasts - ECM organization"	"Plasma membrane"	"Nucleoplasm, Cytosol"	"HPA017357: AB_1846330"	"unprognostic (1.92e-2)"	"unprognostic (4.44e-3)"	"unprognostic (1.54e-1)"	"unprognostic (1.57e-3)"	"unprognostic (9.33e-2)"	"unprognostic (1.82e-3)"	"unprognostic (1.20e-2)"	"prognostic unfavorable (6.66e-4)"	"unprognostic (5.45e-2)"	"unprognostic (1.80e-1)"	"prognostic unfavorable (1.32e-5)"	"unprognostic (1.39e-1)"	"unprognostic (3.11e-2)"	"prognostic unfavorable (1.02e-4)"	"unprognostic (3.49e-2)"	"unprognostic (2.26e-1)"	"unprognostic (2.78e-1)"	20.7	6.0	9.8	11.9	11.9	0.6	14.1	11.2	10.7	112.6	14.9	29.4	40.1	49.4	6.3	8.6	20.7	17.2	8.7	8.5	11.3	17.2	54.8	6.8	9.6	11.7	14.1	39.3	1.8	1.8	11.8	25.3	13.0	13.3	31.9	94.4	6.6	34.2	2.1	6.4	20.9	73.9	14.7	13.0	8.1	10.4	12.7	5.2	23.7	9.8	11.3	15.8	28.5	12.1	48.9	26.0	42.9	0.8	95.1	302.4	0.4	306.1	332.7	147.5	275.2	0.4	469.6	0.0	107.3	270.2	379.0	24.5	0.1	308.0	348.8	0.8	0.1	0.1	7.3	6.0	47.5	0.2	0.7	77.4	3.7	302.0	191.3	807.8	124.9	0.3	0.3	1.4	934.3	8.3	0.0	0.2	0.8	8.2	34.6	1.5	9.5	1.3	323.1	21.8	0.3	5.5	3.8	18.8	104.9	2.2	0.4	8.3	546.2	120.6	0.9	152.9	506.8	22.7	15.3	0.5	821.7	0.4	385.3	0.0	0.0	0.5	3.7	0.0	6.4	23.7	4.2	11.7	0.0	33.0	4.1	30.7	0.5	0.7	0.0	0.1	1.7	6.4	9.8	11.9	11.2	10.7	8.5	11.3	11.7	14.1	13.0	14.7	12.7	12.1	6.4	0.0	5.8	36.9	21.6	5.2	1.7	6.1	2.8	4.4	1.2	0.3	1.7	27.1	4.8	1.8	10.4	0.6	2.2	49.2	3.9	3.8	0.6	19.3	20.8	20.5	0.0	0.0	1.6	4.1	2.5	39.4	11.2	58.0	0.0	0.1	49.6	33.7	1.3	0.0	2.1	27.7	0.0	3.5	8.2	1.3	13.1	2.1	7.2	11.2	0.5	9.1	0.0	61.3	0.7	124.8	46.0	25.6	3.6	1.5	8.3	27.6	4.8	81.6	0.0	3.3	9.6	0.0	0.3	0.6	4.8	15.2	5.0	0.1	18.0	9.6
NTAN1		ENSG00000157045	"N-terminal asparagine amidase"	Q96AB6	16	15037854-15056079	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"eosinophil: 17.5"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"NB-4: 18.5;REH: 9.2;U-266/84: 10.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA051418			Approved	"Nucleoplasm,Golgi apparatus"		NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 72: Non-specific - Transcription"	"Cluster 24: NB-4 - Immune response"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	Nucleoplasm	"Golgi apparatus"	"HPA051418: "	"unprognostic (2.21e-2)"	"unprognostic (2.31e-1)"	"unprognostic (1.80e-1)"	"unprognostic (1.47e-1)"	"prognostic unfavorable (6.69e-4)"	"unprognostic (1.87e-2)"	"unprognostic (9.16e-2)"	"unprognostic (8.11e-3)"	"unprognostic (2.79e-1)"	"unprognostic (1.75e-1)"	"unprognostic (5.05e-2)"	"unprognostic (1.65e-1)"	"unprognostic (9.30e-3)"	"prognostic unfavorable (9.07e-4)"	"unprognostic (4.35e-1)"	"unprognostic (2.12e-2)"	"unprognostic (1.10e-1)"	38.6	10.2	3.6	0.5	3.9	2.2	28.1	3.8	8.9	25.3	2.1	30.3	0.1	20.7	1.4	19.4	18.8	1.2	19.3	3.4	3.7	15.9	15.2	21.6	0.7	3.8	4.1	19.7	11.0	0.5	6.5	0.4	4.1	20.2	0.3	1.3	15.8	0.4	24.5	21.6	15.6	0.8	2.9	20.5	17.9	20.3	3.7	0.8	13.5	0.6	0.4	27.8	21.8	3.5	3.6	0.0	1.8	0.7	1.2	0.6	0.6	6.2	2.6	1.0	2.8	0.0	0.0	3.2	2.5	4.7	1.7	0.1	0.9	0.7	0.9	5.0	5.9	0.3	0.0	0.0	1.1	1.7	4.3	0.8	0.4	3.4	1.5	1.5	1.3	2.6	0.5	3.2	0.9	0.3	5.3	18.5	1.1	0.0	0.2	9.2	0.1	1.3	1.2	0.0	0.7	2.1	0.0	0.1	1.5	0.4	0.0	0.6	4.1	1.1	3.8	1.1	1.1	4.2	10.1	2.5	1.5	1.3	2.2	4.9	1.3	17.5	2.8	1.7	3.0	4.2	3.4	2.6	1.9	3.8	3.9	1.3	1.6	3.8	2.0	5.7	5.9	3.1	3.6	3.9	3.8	8.9	3.4	3.7	3.8	4.1	4.1	2.9	3.7	3.5	79.7	3.2	3.9	7.8	24.7	33.6	16.4	24.1	7.4	6.1	20.2	33.4	3.2	12.8	13.8	18.4	10.4	77.4	30.4	25.1	45.0	49.3	48.9	8.8	29.3	55.0	6.7	25.3	12.6	23.6	23.8	51.3	8.2	12.7	8.8	22.0	62.8	23.0	116.6	25.2	15.6	7.2	30.5	75.0	48.3	32.4	83.0	53.9	58.7	12.2	46.0	15.2	37.0	3.0	6.6	56.9	14.6	75.2	37.6	21.2	9.6	38.6	6.0	9.4	39.5	20.8	52.3	33.3	30.7	16.0	21.7	56.9	25.6	23.5	13.5	23.9
NTAQ1	"C8orf32, FLJ10204, WDYHV1"	ENSG00000156795	"N-terminal glutamine amidase 1"	Q96HA8	8	123416726-123470028	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"Adipocytes: 5.5;Cardiomyocytes: 21.9;Cytotrophoblasts: 13.9;Extravillous trophoblasts: 23.0;Hofbauer cells: 13.2;Syncytiotrophoblasts: 10.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"SK-BR-3: 109.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA024823, HPA053680"	Approved		Supported	Nucleoplasm,Vesicles		NA	NA			"Cluster 44: Non-specific - Transcription"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 24: Non-specific - Transcription regulation"	Nucleoplasm	Vesicles	"HPA024823: AB_1845773, HPA053680: AB_2682228"	"unprognostic (9.97e-2)"	"unprognostic (4.82e-2)"	"unprognostic (3.48e-1)"	"prognostic unfavorable (4.93e-5)"	"unprognostic (1.69e-1)"	"unprognostic (5.00e-2)"	"prognostic unfavorable (3.47e-4)"	"unprognostic (1.93e-2)"	"unprognostic (1.20e-1)"	"unprognostic (1.90e-1)"	"unprognostic (1.19e-1)"	"unprognostic (5.79e-2)"	"unprognostic (2.81e-2)"	"unprognostic (1.26e-1)"	"unprognostic (5.39e-2)"	"unprognostic (7.46e-2)"	"unprognostic (2.37e-1)"	7.1	10.9	16.2	5.1	16.7	5.9	13.5	16.3	24.0	12.8	15.5	7.5	4.3	8.1	8.9	6.9	7.5	6.7	20.1	14.8	17.8	13.0	6.8	6.8	7.4	17.0	17.9	18.2	9.6	11.0	10.5	6.8	17.4	10.2	7.9	14.9	6.9	8.8	16.0	7.7	4.4	9.5	15.8	5.2	8.5	12.7	20.0	7.1	12.8	17.6	10.1	8.8	7.2	17.7	26.6	26.9	39.2	18.1	15.3	40.9	14.5	19.1	21.3	23.4	26.1	15.8	17.8	19.7	19.8	23.8	32.7	12.8	25.8	29.7	31.4	53.1	15.8	25.6	13.2	22.4	21.2	12.7	10.9	24.1	16.0	29.3	32.8	27.1	22.6	41.2	18.8	29.0	33.5	84.3	30.2	14.4	12.3	65.6	20.5	13.5	20.0	20.4	31.1	22.6	18.6	34.1	20.7	109.0	35.8	44.5	17.6	12.2	9.8	26.5	46.2	19.7	26.4	17.4	38.1	24.1	18.8	14.1	19.1	16.3	5.7	2.1	6.2	8.7	7.4	5.0	7.3	7.7	9.0	4.1	6.2	6.9	1.5	16.0	3.8	5.2	10.6	4.6	16.2	16.7	16.3	24.0	14.8	17.8	17.0	17.9	17.4	15.8	20.0	17.7	5.5	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	21.9	0.0	0.0	0.0	0.0	13.9	2.1	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	23.0	2.4	0.0	0.0	0.0	0.0	0.0	0.0	13.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.0	10.0	0.3	0.0	0.0	0.0
NTPCR	"C1orf57, HCR-NTPase, MGC13186, THEP1"	ENSG00000135778	"Nucleoside-triphosphatase, cancer-related"	Q9BSD7	1	232950605-232983882	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA028125, HPA054304"	Uncertain		Approved	Cytosol		NA	NA			"Cluster 32: T-cells - Unknown function"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 39: Non-specific - Basic cellular processes"	Cytosol		"HPA028125: AB_10601091, HPA054304: AB_2682443"	"unprognostic (2.67e-1)"	"unprognostic (2.28e-2)"	"unprognostic (1.63e-2)"	"unprognostic (7.59e-2)"	"unprognostic (5.85e-3)"	"unprognostic (1.04e-1)"	"unprognostic (8.70e-3)"	"unprognostic (2.12e-1)"	"unprognostic (6.00e-2)"	"unprognostic (5.03e-3)"	"unprognostic (4.78e-2)"	"unprognostic (1.08e-1)"	"unprognostic (2.66e-1)"	"unprognostic (2.74e-2)"	"unprognostic (1.73e-1)"	"unprognostic (1.08e-1)"	"unprognostic (6.37e-3)"	3.0	4.0	8.9	2.0	9.3	0.8	3.6	8.3	9.6	5.0	10.9	4.5	2.0	4.2	3.8	3.2	4.7	3.2	4.5	9.0	10.3	3.6	2.8	3.4	2.9	11.4	9.3	5.3	5.9	5.3	4.2	2.5	12.0	4.1	4.3	8.0	3.3	4.0	13.5	4.3	3.9	4.1	9.8	3.4	3.0	2.2	10.0	3.6	4.4	11.8	2.7	3.8	4.2	9.1	2.0	4.9	5.4	2.7	4.0	5.2	0.1	1.3	4.3	4.0	5.5	3.5	2.3	3.1	2.9	2.7	2.2	2.6	3.7	5.0	4.4	2.3	6.9	0.9	3.4	4.5	4.1	1.7	1.8	6.9	9.4	3.9	3.9	4.0	3.3	5.8	2.8	4.6	4.8	1.5	4.4	4.4	5.4	4.0	5.7	2.9	3.5	4.6	5.9	2.4	4.7	7.8	1.9	1.6	1.9	4.0	4.0	3.8	2.5	3.3	2.7	3.6	3.7	5.2	4.6	3.5	3.9	4.1	4.9	0.3	0.5	0.2	0.6	0.6	0.7	0.5	0.9	0.3	0.4	0.6	1.2	1.0	0.9	0.5	0.5	0.1	1.1	0.4	8.9	9.3	8.3	9.6	9.0	10.3	11.4	9.3	12.0	9.8	10.0	9.1	45.5	19.2	21.1	24.8	16.9	19.4	37.3	85.3	24.5	15.8	31.5	34.8	63.9	38.6	36.3	25.8	27.1	68.9	16.1	37.3	93.9	62.2	47.7	27.3	29.4	29.1	25.8	15.8	16.1	64.5	59.1	33.1	16.3	27.7	16.5	44.9	23.9	34.3	42.3	10.1	16.1	50.0	75.3	22.8	17.3	27.3	20.2	21.2	23.2	15.0	30.1	41.0	47.4	16.1	20.8	46.5	31.2	30.5	12.2	40.1	66.0	82.0	27.2	21.8	13.1	21.3	27.7	86.5	40.4	40.1	23.9	28.0	16.5	67.9	66.5	41.6
NUDT1	MTH1	ENSG00000106268	"Nudix hydrolase 1"	P36639	7	2242226-2251146	"Cancer-related genes, Enzymes, Predicted intracellular proteins"		"Hydrolase, RNA-binding"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 77.6"	"Cell type enhanced"	"Detected in many"		"Late spermatids: 121.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA012636	Approved		Supported	Cytosol		No	No		21000	"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	Cytosol		"HPA012636: AB_1854696"	"unprognostic (1.31e-1)"	"unprognostic (1.19e-2)"	"unprognostic (2.13e-2)"	"unprognostic (2.37e-1)"	"unprognostic (3.01e-3)"	"unprognostic (3.37e-1)"	"prognostic unfavorable (4.44e-4)"	"unprognostic (2.15e-2)"	"unprognostic (4.77e-1)"	"unprognostic (3.81e-2)"	"unprognostic (3.81e-2)"	"unprognostic (1.53e-1)"	"prognostic unfavorable (1.30e-7)"	"unprognostic (1.29e-1)"	"unprognostic (6.71e-2)"	"unprognostic (3.49e-2)"	"unprognostic (1.70e-1)"	19.1	8.0	13.7	23.8	16.6	77.6	15.0	14.6	18.0	16.9	10.9	19.1	16.2	12.4	5.4	29.1	12.0	10.5	18.7	15.4	13.6	8.9	6.3	12.4	37.1	16.1	14.1	9.3	9.1	3.2	4.4	10.5	15.6	11.3	11.0	4.3	12.4	7.0	21.3	33.8	16.8	9.2	15.0	23.6	12.2	65.5	14.5	59.4	7.6	13.5	31.5	14.6	18.5	17.9	98.4	155.2	83.3	111.0	30.0	41.3	61.0	42.3	36.5	57.0	65.8	84.2	72.1	102.8	33.7	47.0	115.5	117.1	63.8	64.3	33.1	46.2	109.4	80.6	136.3	72.7	7.2	63.2	78.0	27.4	16.7	82.3	29.0	18.6	31.0	147.1	65.0	111.6	64.5	250.2	119.1	245.3	179.5	48.5	94.7	163.5	123.4	86.4	31.7	54.9	83.5	115.6	43.7	126.9	20.8	59.8	83.9	165.8	29.1	54.2	205.1	126.8	102.3	85.2	70.6	108.9	54.6	155.1	199.8	31.5	60.2	44.4	42.8	78.6	34.3	71.0	49.6	45.6	94.3	65.1	48.9	42.3	16.2	39.4	66.8	211.5	75.5	45.7	13.7	16.6	14.6	18.0	15.4	13.6	16.1	14.1	15.6	15.0	14.5	17.9	13.0	6.4	7.5	1.0	34.2	40.1	26.5	22.6	14.8	11.2	25.3	39.0	16.8	10.0	13.7	11.0	4.2	38.5	46.1	39.6	19.6	24.3	54.7	14.9	24.3	12.8	7.8	111.7	0.5	37.4	80.0	29.6	13.7	10.7	61.0	32.4	7.9	5.2	89.4	0.0	0.5	35.7	32.6	46.2	86.7	121.2	22.1	52.6	46.2	0.0	47.1	27.4	47.4	1.0	4.3	20.4	18.4	18.8	33.1	21.5	17.3	14.1	13.0	7.9	32.9	27.5	32.4	70.2	54.8	41.0	37.1	23.7	37.3	13.7	45.1	27.3
NUDT10	"DIPP3a, hDIPP3alpha"	ENSG00000122824	"Nudix hydrolase 10"	Q8NFP7	X	51332231-51337525	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"testis: 26.3"	"Group enriched"	"Detected in many"	5	"Hepatic stellate cells: 60.3;Peritubular cells: 29.0"	"Group enriched"	"Detected in many"	6	"glioma: 5.0;prostate cancer: 5.4;testis cancer: 7.7"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AF22: 7.5;HAP1: 14.2;HEK 293: 10.5;NTERA-2: 25.8;SH-SY5Y: 5.6;U-2 OS: 12.7"									"HPA047027, HPA057684"	Approved		Approved	Cytosol		NA	NA			"Cluster 22: NK-cells - Unknown function"	"Cluster 68: Epididymis - Unknown function"	"Cluster 5: NTERA-2 - Transcription"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	Cytosol		"HPA047027: AB_2679907, HPA057684: AB_2683501"	"unprognostic (2.61e-2)"	"unprognostic (1.12e-2)"	"unprognostic (7.40e-3)"	"unprognostic (7.84e-2)"	"unprognostic (1.82e-1)"	"unprognostic (2.51e-2)"	"unprognostic (1.16e-1)"	"unprognostic (2.06e-1)"	"unprognostic (2.54e-2)"	"unprognostic (1.11e-1)"	"unprognostic (2.49e-2)"	"unprognostic (1.27e-1)"	"unprognostic (1.51e-3)"	"unprognostic (1.80e-3)"	"unprognostic (1.04e-2)"	"unprognostic (1.12e-2)"	"unprognostic (5.04e-5)"	0.6	1.6	11.2	0.8	9.8	1.5	0.8	3.8	9.8	6.2	2.3	3.1	0.5	5.3	16.1	1.0	3.6	1.4	1.0	9.2	10.0	3.9	1.3	0.3	0.3	5.0	7.1	16.9	0.3	0.0	2.1	0.0	7.1	14.9	0.7	1.5	0.5	14.6	0.1	0.4	1.0	4.1	4.1	3.4	1.2	26.3	11.9	0.4	0.6	0.2	0.3	3.9	3.6	9.3	0.0	0.0	7.5	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	1.2	0.0	14.2	0.6	0.0	0.0	10.5	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	25.8	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	5.6	0.0	0.0	0.0	5.1	0.0	0.0	0.0	0.0	12.7	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	11.2	9.8	3.8	9.8	9.2	10.0	5.0	7.1	7.1	4.1	11.9	9.3	0.2	0.0	1.3	0.7	0.2	1.0	4.9	0.6	1.8	0.5	0.1	1.5	0.2	0.0	0.6	0.0	0.0	0.7	0.4	0.0	0.0	0.0	1.5	0.7	3.5	2.5	0.0	0.8	5.0	0.0	1.0	3.1	0.0	0.1	0.0	5.0	60.3	0.3	0.2	0.0	1.9	0.0	0.0	1.9	0.4	6.2	5.9	0.1	1.8	1.0	0.0	1.7	0.0	3.5	0.6	0.0	0.0	29.0	1.4	2.8	0.0	0.1	0.0	0.5	0.0	1.5	1.9	3.8	7.8	0.4	0.1	0.4	0.2	0.9	0.0	0.2
NUDT11	"DIPP3b, FLJ10628, hDIPP3beta"	ENSG00000196368	"Nudix hydrolase 11"	Q96G61	X	51490011-51496592	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 23.3;testis: 36.2"	"Cell type enhanced"	"Detected in many"		"Basal keratinocytes: 15.3;Late spermatids: 17.1;Peritubular cells: 20.7;Spermatocytes: 14.6;Spermatogonia: 20.3"	"Group enriched"	"Detected in many"	4	"glioma: 12.1;prostate cancer: 10.6;testis cancer: 17.4"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"gdT-cell: 1.2"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"HAP1: 69.3;NTERA-2: 42.9"					"Low region specificity"	"Detected in many"			"HPA047027, HPA057684"	Approved		Approved	Cytosol		NA	NA			"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 78: Testis - Spermatogenesis"	"Cluster 5: NTERA-2 - Transcription"	"Cluster 36: Stromal cells - Cell proliferation"	Cytosol		"HPA047027: AB_2679907, HPA057684: AB_2683501"	"unprognostic (2.01e-1)"	"unprognostic (2.57e-1)"	"unprognostic (8.21e-2)"	"unprognostic (1.93e-3)"	"unprognostic (6.61e-2)"	"unprognostic (1.13e-3)"	"unprognostic (5.52e-3)"	"unprognostic (1.25e-1)"	"unprognostic (2.25e-2)"	"unprognostic (2.18e-1)"	"unprognostic (8.41e-2)"	"unprognostic (1.33e-1)"	"unprognostic (7.80e-12)"	"unprognostic (4.34e-4)"	"unprognostic (1.17e-2)"	"unprognostic (2.78e-1)"	"unprognostic (3.94e-4)"	1.0	4.6	11.9	0.9	13.7	1.4	2.1	4.5	14.7	4.0	2.1	2.9	1.1	5.1	3.5	1.3	2.0	1.6	0.5	13.4	20.0	0.5	0.1	0.5	0.6	5.6	7.2	8.9	4.9	0.2	4.3	0.0	8.4	9.1	0.8	2.2	0.7	10.4	0.1	1.2	1.0	4.4	5.6	0.3	1.1	36.2	23.3	2.6	0.6	0.5	0.6	1.9	2.4	7.7	0.0	1.0	20.6	0.0	17.5	22.0	0.1	9.8	2.7	0.5	0.5	0.0	0.0	0.0	0.5	11.9	11.4	1.5	69.3	23.9	0.3	0.0	4.7	0.0	0.0	0.0	8.2	0.0	4.6	13.5	9.3	6.2	22.4	3.9	16.4	21.6	0.1	0.0	19.6	0.5	27.6	0.1	42.9	0.0	17.5	0.0	14.4	0.0	4.3	0.0	0.0	13.4	4.2	0.0	4.0	10.2	0.0	0.1	9.6	4.8	22.4	1.4	0.0	9.0	4.5	15.2	3.1	0.0	1.9	0.0	0.0	0.0	1.2	0.0	0.5	0.1	0.3	0.6	0.1	0.1	0.0	0.9	0.0	0.7	0.1	0.0	0.0	0.3	11.9	13.7	4.5	14.7	13.4	20.0	5.6	7.2	8.4	5.6	23.3	7.7	0.4	0.0	0.0	0.3	0.3	15.3	6.4	12.8	12.0	1.6	0.5	3.9	0.6	0.0	1.6	0.0	0.0	0.3	3.5	0.0	0.0	0.2	11.3	0.5	9.0	0.9	0.0	1.3	6.3	1.5	1.0	7.7	0.0	0.3	0.0	3.4	0.4	0.0	0.1	0.0	3.8	0.0	0.0	0.3	3.8	17.1	8.7	0.6	5.4	2.8	0.0	1.4	3.1	4.0	0.6	1.4	0.0	20.7	0.3	10.4	0.0	0.2	0.2	0.2	0.0	3.0	5.3	14.6	20.3	1.6	9.1	0.3	0.8	7.5	0.0	1.3
NUDT12	DKFZP761I172	ENSG00000112874	"Nudix hydrolase 12"	Q9BQG2	5	103548855-103562790	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in all"		"Distal tubular cells: 58.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA045449	Supported					NA	NA			"Cluster 28: Myeloid DCs - Unknown function"	"Cluster 87: Intestine & Kidney - Transmembrane transport"	"Cluster 6: T47d - Mammary gland"	"Cluster 39: Non-specific - Basic cellular processes"			"HPA045449: AB_2679327"	"unprognostic (1.94e-1)"	"unprognostic (1.94e-2)"	"unprognostic (3.27e-2)"	"unprognostic (1.44e-1)"	"unprognostic (7.53e-2)"	"unprognostic (1.10e-1)"	"unprognostic (2.61e-1)"	"unprognostic (8.79e-2)"	"unprognostic (9.16e-2)"	"unprognostic (1.31e-2)"	"unprognostic (1.14e-1)"	"unprognostic (1.92e-1)"	"prognostic favorable (2.86e-5)"	"unprognostic (1.13e-1)"	"unprognostic (4.23e-2)"	"unprognostic (2.67e-1)"	"unprognostic (5.92e-2)"	5.7	12.1	5.2	3.6	7.3	0.9	11.9	7.1	7.1	9.2	6.9	13.3	16.9	6.4	12.0	7.7	8.5	7.4	10.4	4.6	6.4	26.6	28.4	6.5	2.7	6.2	6.2	6.7	12.3	24.4	4.0	5.0	7.1	14.6	14.4	12.5	12.9	7.8	13.4	7.4	14.3	6.0	7.0	4.4	14.2	5.0	6.3	4.7	16.0	8.9	3.5	6.0	4.0	9.2	6.2	2.7	14.6	5.5	9.8	20.3	0.0	10.7	10.1	9.5	12.2	5.3	22.0	0.0	6.9	6.2	10.6	9.9	13.8	22.3	13.2	0.0	8.3	6.4	10.1	2.8	10.1	0.0	0.0	9.7	19.1	6.3	16.3	11.2	6.6	0.0	10.5	0.0	16.8	11.5	0.5	0.3	7.5	0.0	8.4	0.0	12.9	5.0	15.9	10.7	11.0	11.4	6.9	10.3	16.5	11.5	22.6	6.4	8.0	12.0	4.3	10.5	8.7	7.2	11.6	0.0	12.3	0.0	8.9	0.0	0.3	0.0	0.0	0.4	0.0	0.2	0.2	0.1	0.9	0.4	0.6	0.3	0.0	0.5	0.3	1.1	0.1	0.2	5.2	7.3	7.1	7.1	4.6	6.4	6.2	6.2	7.1	7.0	6.3	9.2	5.8	9.6	9.0	10.4	1.6	3.3	6.3	13.8	12.5	10.4	9.2	5.1	11.9	15.7	9.0	12.9	2.1	5.9	2.3	15.4	58.7	11.2	7.1	9.5	7.9	4.6	4.2	4.2	8.3	14.2	4.6	7.0	13.3	5.8	1.3	9.4	3.3	14.7	6.1	11.8	9.0	17.5	14.2	4.6	1.9	4.9	13.4	4.6	8.8	2.8	3.0	13.1	1.0	14.6	23.7	10.6	15.7	10.5	1.2	7.6	21.1	34.0	15.8	17.7	6.6	8.5	6.2	11.0	7.6	10.9	3.1	3.0	1.1	11.7	14.1	7.7
NUDT13	DKFZp586P2219	ENSG00000166321	"Nudix hydrolase 13"	Q86X67	10	73110375-73131828	"Enzymes, Predicted intracellular proteins"		Hydrolase		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA040636	Approved					NA	No			"Cluster 24: B-cells - Unknown function"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 54: Cardiomyocytes - Muscle contraction"			"HPA040636: AB_10960360"	"unprognostic (3.75e-1)"	"unprognostic (3.85e-1)"	"unprognostic (1.07e-1)"	"unprognostic (2.48e-3)"	"unprognostic (1.38e-1)"	"unprognostic (1.32e-1)"	"unprognostic (1.33e-1)"	"unprognostic (2.03e-2)"	"unprognostic (1.67e-1)"	"unprognostic (2.60e-1)"	"unprognostic (9.40e-2)"	"unprognostic (5.07e-4)"	"unprognostic (1.91e-1)"	"unprognostic (3.82e-2)"	"unprognostic (8.82e-2)"	"unprognostic (2.92e-2)"	"unprognostic (5.96e-2)"	1.9	3.2	1.4	1.9	1.7	2.4	2.0	3.4	2.0	1.7	1.3	2.6	2.9	1.7	3.9	1.6	1.9	1.8	4.3	1.6	1.3	4.3	6.2	1.5	2.4	1.4	1.4	1.8	3.1	3.0	1.7	1.5	1.8	2.0	1.8	2.9	2.1	1.0	4.2	3.0	2.5	1.1	1.0	2.5	2.9	2.4	1.8	1.5	1.9	2.1	1.5	2.4	1.7	2.2	4.7	3.3	5.3	6.6	3.2	2.7	1.1	4.1	3.6	2.1	2.3	8.7	9.6	2.3	2.0	2.5	3.4	5.4	0.5	3.8	2.1	1.7	9.3	6.4	5.9	4.9	0.3	3.5	2.5	2.0	4.1	2.7	1.5	5.6	1.6	4.1	5.5	3.5	2.1	2.2	2.1	5.0	2.0	3.0	10.5	4.7	0.9	0.1	2.9	2.1	2.3	3.4	2.0	5.4	1.9	2.2	3.0	2.3	3.1	1.8	7.1	0.7	1.6	2.5	3.1	3.1	5.0	6.5	1.7	0.0	1.1	1.1	0.7	1.1	0.8	1.3	0.5	0.6	0.8	3.7	0.9	1.0	0.4	2.2	1.6	0.3	1.7	0.4	1.4	1.7	3.4	2.0	1.6	1.3	1.4	1.4	1.8	1.0	1.8	2.2	1.9	6.4	2.0	2.6	1.9	0.9	1.9	2.8	0.6	1.1	1.6	1.7	6.2	1.5	2.2	3.7	4.2	3.6	0.4	1.1	3.9	1.8	5.5	2.9	1.3	1.8	1.2	1.3	4.7	0.7	0.9	1.1	1.5	2.7	0.0	1.8	0.4	3.7	1.7	0.0	5.1	1.7	2.0	2.9	1.0	5.0	0.9	1.8	0.0	5.6	2.8	0.9	2.1	4.5	8.1	1.6	3.3	0.7	0.7	1.2	2.5	6.2	5.3	1.9	0.0	2.3	1.4	2.9	0.9	1.4	1.4	1.1	0.8	2.3	1.3	1.1
NUDT14	UGPP	ENSG00000183828	"Nudix hydrolase 14"	O95848	14	105172938-105181323	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Distal tubular cells: 176.1;Proximal enterocytes: 206.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA046755, HPA058759"	Approved		Approved	Nucleoli,Microtubules		NA	NA			"Cluster 14: Monocytes - Unknown function"	"Cluster 22: Non-specific - Unknown function"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 39: Non-specific - Basic cellular processes"	Microtubules	Nucleoli	"HPA046755: AB_10963433, HPA058759: AB_2683809"	"unprognostic (1.05e-2)"	"unprognostic (6.01e-2)"	"unprognostic (1.89e-1)"	"unprognostic (2.44e-1)"	"unprognostic (1.91e-1)"	"unprognostic (3.55e-1)"	"unprognostic (1.05e-3)"	"unprognostic (9.17e-3)"	"unprognostic (2.02e-1)"	"prognostic favorable (1.66e-4)"	"unprognostic (3.16e-3)"	"unprognostic (3.13e-1)"	"prognostic favorable (1.18e-5)"	"unprognostic (1.89e-1)"	"unprognostic (1.02e-1)"	"unprognostic (7.21e-3)"	"unprognostic (2.38e-1)"	16.5	23.9	17.4	3.5	20.1	2.1	19.3	19.9	28.4	9.0	27.5	14.5	12.5	6.4	3.5	17.5	8.9	6.4	27.5	19.9	21.5	28.8	19.5	20.1	5.9	19.0	17.4	6.4	40.4	16.0	61.1	3.2	19.1	18.6	2.9	4.7	17.2	2.9	31.6	14.1	16.3	1.8	17.9	12.5	17.6	13.9	17.2	3.6	22.1	12.7	2.1	8.4	11.3	21.1	18.1	24.2	2.1	9.4	2.8	3.3	38.1	5.0	6.5	8.0	11.5	17.5	18.7	1.3	24.4	2.6	17.8	22.7	1.1	13.6	0.7	9.5	17.7	4.0	10.4	12.2	19.9	4.8	46.7	4.7	16.7	1.9	1.4	3.4	15.9	8.8	6.4	2.9	2.8	52.5	0.6	0.0	12.6	42.7	33.5	9.4	21.9	10.8	8.8	51.2	32.8	4.8	9.0	0.2	21.7	3.9	18.8	23.1	38.3	13.2	5.8	9.5	5.1	1.4	1.0	2.2	19.4	5.5	4.9	6.2	40.5	1.2	12.6	40.8	7.5	12.8	9.6	8.0	33.5	10.2	9.4	10.8	1.3	15.2	68.6	17.0	6.0	19.2	17.4	20.1	19.9	28.4	19.9	21.5	19.0	17.4	19.1	17.9	17.2	21.1	66.1	12.8	28.5	5.2	12.4	38.9	101.7	123.4	52.9	12.1	46.8	78.5	54.5	40.0	41.2	35.0	18.8	44.7	16.1	88.2	176.1	94.1	3.1	59.3	8.0	61.6	37.3	10.1	5.9	30.8	18.2	14.7	30.5	31.0	38.8	11.9	27.1	28.0	137.0	35.3	3.0	62.6	73.2	27.4	27.1	9.8	11.5	33.9	46.2	12.2	35.6	38.3	22.6	0.5	5.8	51.2	132.4	3.8	7.7	51.9	206.9	169.1	65.7	19.1	0.0	39.0	11.4	12.4	48.5	30.4	19.0	38.2	26.8	5.2	75.4	82.2
NUDT15	"FLJ10956, MTH2"	ENSG00000136159	"Nudix hydrolase 15"	Q9NV35	13	48037726-48047221	"Enzymes, Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Extravillous trophoblasts: 79.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038968, HPA038969"	Approved		Supported	Nucleoplasm		Yes	No			"Cluster 22: NK-cells - Unknown function"	"Cluster 37: Intestine - Unknown function"	"Cluster 5: NTERA-2 - Transcription"	"Cluster 38: Extravillous trophoblasts - Unknown function"	Nucleoplasm		"HPA038968: AB_10697402, HPA038969: AB_2676295"	"unprognostic (9.48e-2)"	"unprognostic (5.91e-3)"	"unprognostic (2.64e-2)"	"unprognostic (9.00e-3)"	"unprognostic (4.99e-2)"	"unprognostic (2.50e-3)"	"unprognostic (2.29e-2)"	"unprognostic (7.47e-3)"	"prognostic unfavorable (1.25e-5)"	"unprognostic (1.04e-1)"	"unprognostic (8.50e-2)"	"unprognostic (3.69e-1)"	"unprognostic (4.63e-2)"	"unprognostic (1.84e-3)"	"unprognostic (3.35e-1)"	"unprognostic (9.58e-2)"	"unprognostic (8.93e-3)"	12.2	13.0	7.1	10.1	7.2	18.0	16.4	8.6	8.3	12.9	6.9	20.2	20.8	9.7	13.8	16.3	11.6	9.0	11.0	6.9	8.5	17.2	14.1	9.2	7.5	7.2	7.7	8.6	9.4	8.2	9.4	12.6	7.8	15.1	22.1	10.3	12.1	10.0	11.9	8.7	16.3	10.5	6.8	5.5	13.0	10.7	7.6	10.7	13.4	18.7	10.3	12.9	10.3	7.8	47.5	28.4	52.4	23.1	21.2	30.3	37.8	37.7	35.8	41.3	39.7	42.1	45.2	34.6	20.7	30.3	36.7	54.3	51.3	56.1	63.4	18.3	41.8	34.1	28.0	46.2	19.8	52.0	31.2	20.9	35.3	33.3	46.7	18.4	45.3	34.5	30.7	13.5	67.2	23.2	40.5	48.4	83.0	72.8	32.2	27.6	33.8	22.7	46.2	35.8	31.4	33.1	25.6	43.8	30.3	44.7	22.5	38.7	23.0	28.5	34.7	36.2	53.3	6.9	12.5	43.6	14.8	40.1	47.4	1.6	4.8	3.5	2.9	6.9	2.9	3.1	4.6	3.6	4.9	2.6	5.3	5.8	1.0	2.8	4.8	3.7	3.4	2.7	7.1	7.2	8.6	8.3	6.9	8.5	7.2	7.7	7.8	6.8	7.6	7.8	12.0	12.8	15.7	0.7	14.7	16.6	34.6	18.1	19.9	9.2	14.0	11.6	12.5	12.8	20.7	7.3	2.1	36.2	12.6	30.4	49.0	17.3	16.7	45.7	20.4	15.1	8.4	10.5	3.9	17.6	79.4	12.8	18.3	39.5	9.5	8.7	7.5	17.4	16.8	38.7	3.1	23.5	26.4	7.8	10.5	9.3	16.8	11.4	10.6	1.9	10.3	10.8	6.2	0.5	3.0	16.4	18.3	12.4	16.8	41.9	18.9	40.8	13.6	9.0	0.0	9.5	17.1	8.9	34.4	34.9	20.5	38.0	13.2	15.3	31.9	42.0
NUDT16	FLJ31265	ENSG00000198585	"Nudix hydrolase 16"	Q96DE0	3	131381671-131388830	"Enzymes, Predicted intracellular proteins"	"Nucleotide metabolism"	"Hydrolase, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Kupffer cells: 179.8;Proximal enterocytes: 334.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in all"	4	"classical monocyte: 41.7;eosinophil: 47.0;intermediate monocyte: 54.6;myeloid DC: 32.4;neutrophil: 34.0;non-classical monocyte: 63.4"	"Group enriched"	"Detected in all"	4	"dendritic cells: 32.4;granulocytes: 47.0;monocytes: 63.4"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA060452, HPA062492"	Uncertain		Supported	Nucleoplasm,Nucleoli		NA	NA		38000	"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 45: Intestine - Brush border"	"Cluster 18: U-2197 - ECM organization"	"Cluster 45: Enterocytes - Digestion"	"Nucleoplasm, Nucleoli"		"HPA060452: AB_2684279, HPA062492: AB_2684781"	"unprognostic (4.85e-3)"	"prognostic favorable (9.39e-5)"	"unprognostic (3.19e-3)"	"unprognostic (9.21e-2)"	"unprognostic (2.49e-1)"	"unprognostic (1.22e-2)"	"unprognostic (9.96e-2)"	"unprognostic (1.15e-1)"	"unprognostic (5.16e-2)"	"unprognostic (1.94e-1)"	"unprognostic (1.77e-1)"	"unprognostic (5.88e-2)"	"prognostic favorable (1.05e-7)"	"unprognostic (3.29e-1)"	"unprognostic (1.62e-1)"	"unprognostic (2.00e-2)"	"unprognostic (9.44e-2)"	30.6	19.0	39.3	15.2	40.1	10.4	22.9	35.9	49.3	17.1	28.6	25.6	22.2	19.4	11.0	11.1	22.7	9.8	32.9	34.1	38.3	27.7	33.8	26.2	12.3	40.7	39.6	25.2	14.7	48.6	15.8	8.1	40.9	17.8	19.5	18.8	16.1	13.6	24.7	11.6	57.6	12.6	41.7	36.0	21.3	12.2	41.2	6.7	24.4	24.5	10.1	20.9	14.0	40.8	20.8	10.8	17.5	9.2	34.3	31.0	8.1	16.5	15.1	10.9	11.3	16.8	9.0	3.4	14.1	15.4	21.5	14.8	15.7	10.4	17.3	10.4	11.5	8.7	15.3	16.4	22.0	14.9	15.4	27.8	9.0	7.2	19.5	9.7	17.2	0.0	10.2	17.4	10.7	21.5	0.0	4.0	13.6	20.6	16.0	11.6	12.6	26.1	10.8	16.6	8.6	15.0	9.9	9.9	15.6	14.7	21.6	11.7	17.1	17.7	7.6	32.8	13.0	17.1	18.1	0.5	11.5	11.2	10.0	7.2	41.7	47.0	6.0	54.6	6.2	11.2	6.0	5.5	32.4	10.5	5.3	5.4	34.0	9.8	63.4	4.3	10.7	17.4	39.3	40.1	35.9	49.3	34.1	38.3	40.7	39.6	40.9	41.7	41.2	40.8	56.1	16.0	41.1	4.6	13.0	8.4	12.3	21.1	10.8	22.8	22.2	20.2	85.2	44.3	23.9	20.2	8.4	21.0	11.5	58.8	68.4	24.7	77.8	27.2	25.5	33.0	25.3	17.9	5.6	36.9	26.1	27.8	36.2	33.1	19.6	23.0	78.1	107.5	65.1	43.7	3.0	74.7	18.3	179.8	25.3	37.5	26.4	73.6	17.8	3.7	64.6	14.2	17.5	3.0	4.6	31.1	66.7	39.5	14.3	19.5	334.3	109.4	19.8	19.2	26.3	22.1	30.7	28.2	6.3	15.4	5.4	7.3	15.1	68.2	48.5	16.0
NUDT18	"FLJ22494, MTH3"	ENSG00000275074	"Nudix hydrolase 18"	Q6ZVK8	8	22106874-22109419	"Enzymes, Predicted intracellular proteins"	"Nucleotide metabolism"	Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Proximal enterocytes: 41.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA028581, HPA030125"	Approved		Supported	"Nucleoplasm,Golgi apparatus"		NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 25: Pancreas - Digestion"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 45: Enterocytes - Digestion"	Nucleoplasm	"Golgi apparatus"	"HPA028581: AB_10601381, HPA030125: AB_2673324"	"unprognostic (9.90e-3)"	"prognostic favorable (1.43e-4)"	"unprognostic (4.88e-3)"	"prognostic favorable (2.49e-6)"	"unprognostic (1.29e-2)"	"unprognostic (6.82e-3)"	"unprognostic (1.20e-1)"	"unprognostic (1.54e-2)"	"unprognostic (5.30e-2)"	"unprognostic (1.67e-1)"	"prognostic favorable (2.47e-4)"	"unprognostic (1.43e-1)"	"prognostic favorable (8.30e-4)"	"unprognostic (3.59e-3)"	"unprognostic (1.05e-1)"	"unprognostic (6.84e-2)"	"unprognostic (2.32e-1)"	7.4	6.4	5.1	4.8	5.2	4.4	6.7	5.4	5.5	4.9	4.3	5.7	6.5	5.4	12.9	8.0	5.3	4.2	4.8	5.4	4.8	6.8	5.6	6.1	8.8	5.3	4.8	2.3	17.0	2.7	9.1	2.7	5.7	7.8	4.7	1.2	8.5	4.6	2.3	7.1	7.6	3.6	4.4	10.4	8.9	7.7	5.4	6.8	8.2	1.2	6.3	5.7	5.5	4.6	8.1	16.8	0.5	3.6	12.4	4.6	9.0	4.8	12.6	6.1	7.0	4.0	6.3	6.0	7.5	5.7	15.5	13.8	2.3	7.7	2.0	7.5	2.3	5.1	4.9	3.9	8.3	1.7	15.2	8.5	7.2	2.4	6.4	7.9	7.7	13.0	3.8	9.9	6.0	8.6	6.9	4.6	0.9	4.8	4.1	3.0	1.5	6.5	9.0	7.1	1.8	2.8	3.3	4.0	4.2	3.7	9.4	8.3	6.4	4.0	2.2	5.4	2.5	4.4	0.5	1.9	7.0	4.5	9.8	0.0	1.5	3.0	2.2	1.6	2.1	1.4	1.8	1.3	1.0	2.0	2.0	1.1	0.3	4.0	1.3	1.9	0.7	0.9	5.1	5.2	5.4	5.5	5.4	4.8	5.3	4.8	5.7	4.4	5.4	4.6	5.6	3.2	2.2	1.0	7.3	2.0	3.4	5.2	1.2	3.3	5.9	4.6	1.9	8.6	3.0	5.5	0.0	6.7	6.8	12.5	5.9	9.5	14.6	5.9	2.4	4.7	3.0	5.2	1.6	13.6	9.6	5.9	6.1	4.1	0.0	6.3	5.7	4.0	14.5	3.3	1.7	10.9	2.0	16.8	1.3	15.1	3.1	9.0	5.4	2.8	15.3	4.1	19.6	0.5	1.6	10.1	14.6	3.4	6.2	4.6	41.2	13.6	7.0	1.2	0.0	3.1	3.7	3.5	2.7	6.3	1.8	3.1	7.9	5.3	7.0	2.3
NUDT2	APAH1	ENSG00000164978	"Nudix hydrolase 2"	P50583	9	34329506-34343711	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004684, HPA044903, HPA058623, HPA067639"	Uncertain		Approved	Nucleoplasm		NA	NA		65000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 35: Non-specific - Unknown function"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 39: Non-specific - Basic cellular processes"	Nucleoplasm		"CAB004684: AB_425306, HPA044903: AB_2679139, HPA058623: AB_2683780, HPA067639: AB_2685877"	"unprognostic (2.74e-3)"	"unprognostic (2.58e-2)"	"unprognostic (3.37e-1)"	"unprognostic (2.05e-3)"	"unprognostic (3.08e-1)"	"unprognostic (2.39e-1)"	"unprognostic (1.24e-1)"	"unprognostic (6.55e-2)"	"unprognostic (7.06e-2)"	"unprognostic (3.05e-3)"	"unprognostic (1.18e-2)"	"unprognostic (2.80e-1)"	"unprognostic (2.77e-2)"	"unprognostic (6.24e-2)"	"unprognostic (1.72e-1)"	"unprognostic (1.23e-1)"	"unprognostic (1.91e-1)"	21.7	32.0	36.6	10.6	37.9	14.9	26.0	37.4	47.3	26.4	33.6	29.0	16.3	22.3	35.8	26.0	25.2	13.9	28.2	35.8	37.5	23.9	27.0	13.6	17.3	37.5	37.0	34.8	34.5	19.4	30.8	18.1	37.1	26.8	19.0	20.8	21.1	15.6	44.0	25.7	18.6	18.4	38.1	20.2	25.5	16.2	37.4	23.7	7.1	15.0	18.0	28.4	22.6	40.4	59.3	24.2	30.8	10.9	20.7	37.7	22.0	28.1	62.7	31.8	33.0	16.5	27.4	16.7	22.8	35.0	12.2	25.4	28.1	68.7	32.1	61.7	24.8	35.2	44.6	31.4	61.1	28.1	13.9	38.5	45.1	41.4	77.0	43.3	66.2	55.9	10.3	64.7	46.9	36.8	29.1	26.1	19.4	26.8	67.7	36.7	19.2	41.7	31.3	19.2	6.3	24.9	45.1	16.9	27.3	27.4	14.0	29.5	43.2	27.1	24.4	18.0	29.8	14.9	25.7	28.8	33.9	26.0	35.4	20.8	16.2	13.0	14.7	14.6	20.6	22.6	23.9	19.0	20.7	22.2	27.2	23.8	5.8	19.9	15.1	19.1	27.1	15.7	36.6	37.9	37.4	47.3	35.8	37.5	37.5	37.0	37.1	38.1	37.4	40.4	26.3	3.2	4.1	9.1	17.0	28.2	20.5	44.6	14.2	13.6	39.1	53.1	24.9	37.1	20.6	16.5	6.2	39.0	16.7	20.2	88.0	26.7	11.4	20.2	18.5	24.7	22.2	21.0	6.9	40.0	37.8	21.5	13.7	11.5	13.3	21.6	28.5	36.2	36.9	8.4	7.7	34.7	14.2	31.1	23.0	26.8	27.4	20.3	23.2	11.2	25.8	25.9	18.6	12.5	19.0	32.6	26.5	19.2	31.8	18.5	28.7	65.4	25.4	16.5	26.3	21.0	23.9	39.7	19.2	25.0	31.5	18.9	17.8	35.0	30.0	23.6
NUDT22	MGC13045	ENSG00000149761	"Nudix hydrolase 22"	Q9BRQ3	11	64225941-64230686	"Enzymes, Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Distal tubular cells: 164.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039334, HPA053464"	Approved		Enhanced	Nucleoplasm		No	No			"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 39: Non-specific - Basic cellular processes"	Nucleoplasm		"HPA039334: AB_10795174, HPA053464: AB_2682160"	"unprognostic (2.72e-1)"	"unprognostic (3.77e-1)"	"unprognostic (1.86e-2)"	"unprognostic (1.61e-1)"	"unprognostic (2.36e-2)"	"unprognostic (9.75e-2)"	"unprognostic (1.73e-3)"	"unprognostic (1.98e-1)"	"unprognostic (1.15e-1)"	"unprognostic (1.43e-1)"	"unprognostic (7.65e-2)"	"unprognostic (6.61e-2)"	"prognostic favorable (2.18e-6)"	"unprognostic (1.76e-2)"	"unprognostic (1.50e-1)"	"unprognostic (1.71e-1)"	"unprognostic (8.54e-2)"	21.0	34.7	12.2	12.6	13.2	16.2	21.7	14.0	18.1	19.1	15.4	39.2	30.2	18.5	4.6	34.2	18.5	9.0	52.0	12.2	14.0	43.8	48.8	22.0	17.3	14.1	13.3	15.7	45.4	14.1	24.9	10.3	13.0	26.1	8.3	1.1	30.6	14.8	42.4	27.2	36.3	6.0	13.4	41.9	38.1	10.8	14.8	12.9	31.6	19.7	10.4	26.0	21.5	12.7	35.5	22.7	5.4	22.6	8.1	9.7	20.1	15.0	15.1	10.3	9.5	14.8	29.1	16.6	38.4	14.6	15.5	36.1	3.2	23.0	1.3	21.6	9.2	22.6	15.6	15.4	24.2	14.9	35.5	15.2	16.9	10.8	11.7	7.9	16.9	19.5	11.1	17.7	12.2	53.1	20.4	27.1	8.5	21.5	47.0	25.1	9.2	62.4	17.9	19.4	12.6	19.9	12.8	47.8	58.8	2.1	48.9	16.3	15.9	17.0	16.2	54.5	12.6	66.2	28.5	10.6	58.7	17.0	20.4	40.6	69.1	52.5	53.4	88.7	48.1	63.4	47.0	52.8	72.7	77.3	40.8	44.7	42.7	52.1	86.2	121.4	64.9	52.1	12.2	13.2	14.0	18.1	12.2	14.0	14.1	13.3	13.0	13.4	14.8	12.7	18.8	3.2	14.6	5.5	42.6	12.0	28.9	78.8	19.4	14.7	34.6	30.1	3.7	48.6	36.6	40.5	12.5	107.9	51.5	94.1	164.4	61.8	15.5	19.0	27.2	20.3	37.2	14.5	4.8	87.4	50.9	20.1	47.4	27.8	15.2	15.5	23.2	54.3	57.7	30.3	5.6	98.1	61.1	50.1	21.8	9.6	20.2	40.0	33.8	4.7	70.8	26.5	49.4	1.5	3.5	68.0	93.0	19.5	65.8	33.6	133.5	144.8	13.6	18.0	13.1	20.2	45.0	6.6	8.2	34.3	17.5	67.5	37.5	43.6	73.6	33.0
NUDT3	DIPP	ENSG00000272325	"Nudix hydrolase 3"	O95989	6	34279679-34392669	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA047027, HPA055953"	Uncertain		Approved	Cytosol		NA	NA		87000	"Cluster 45: Eosinophils - Innate immune response"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 5: Muller glia cells - Visual perception"	Cytosol		"HPA047027: AB_2679907, HPA055953: AB_2682984"	"unprognostic (2.42e-1)"	"prognostic favorable (5.29e-4)"	"unprognostic (9.63e-3)"	"unprognostic (4.74e-3)"	"unprognostic (3.60e-2)"	"unprognostic (1.84e-1)"	"unprognostic (1.41e-3)"	"unprognostic (4.21e-2)"	"unprognostic (4.93e-3)"	"unprognostic (1.08e-1)"	"unprognostic (3.16e-1)"	"unprognostic (4.63e-1)"	"unprognostic (1.24e-2)"	"unprognostic (3.28e-2)"	"unprognostic (1.09e-1)"	"unprognostic (1.54e-1)"	"unprognostic (6.24e-2)"	12.8	12.9	72.7	11.4	65.3	12.0	14.7	41.2	73.1	17.2	33.8	10.4	9.0	13.2	30.1	12.3	17.3	9.2	20.7	64.9	55.9	18.0	12.1	13.3	13.7	60.8	59.6	19.7	10.5	29.9	5.7	10.4	59.0	12.8	10.9	43.1	11.4	17.5	70.8	13.4	9.4	13.0	64.5	16.5	9.8	7.6	73.7	11.4	25.3	51.8	14.9	9.4	7.4	59.5	11.0	8.0	20.9	41.2	13.7	22.9	8.7	7.9	13.2	8.0	5.7	9.7	7.2	37.3	10.5	14.3	5.1	9.2	11.0	21.3	14.7	14.5	15.2	42.9	10.4	20.7	13.0	41.5	21.7	20.8	18.8	9.0	16.8	9.9	23.2	20.1	42.5	14.0	12.6	11.4	28.7	48.1	13.4	32.5	7.3	24.7	17.4	39.2	18.2	22.7	29.3	32.4	17.5	24.4	32.1	6.0	23.6	28.2	25.7	15.6	5.7	14.1	17.4	11.7	28.7	27.9	9.7	40.1	25.4	1.4	3.9	9.2	2.1	4.1	2.4	2.2	2.1	1.9	4.4	3.0	1.9	2.2	2.8	1.4	4.2	2.1	1.6	1.8	72.7	65.3	41.2	73.1	64.9	55.9	60.8	59.6	59.0	64.5	73.7	59.5	36.6	16.0	26.7	0.0	41.4	59.9	72.2	32.4	51.8	117.0	30.5	27.9	47.5	62.9	25.0	42.3	118.9	34.7	28.2	16.1	13.7	19.2	4.1	25.0	38.6	67.0	49.1	40.8	0.0	28.5	32.0	36.4	19.4	37.2	13.9	30.3	109.6	56.1	76.0	169.9	0.0	29.0	22.4	107.1	79.2	8.1	37.6	65.2	53.4	0.0	90.1	137.4	42.2	0.0	0.0	27.9	16.0	63.2	22.8	90.1	25.3	24.4	46.4	126.6	59.2	68.1	35.0	45.6	83.9	58.4	60.2	19.6	26.5	32.8	31.8	64.7
NUDT4	"DIPP2, DIPP2alpha, DIPP2beta, HDCMB47P, KIAA0487"	ENSG00000173598	"Nudix hydrolase 4"	Q9NZJ9	12	93377883-93408146	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Hydrolase, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Distal tubular cells: 361.9;Erythroid cells: 520.6;Muller glia cells: 485.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA017593, HPA047027, HPA057684"	Approved		Approved	Cytosol		NA	NA			"Cluster 49: Eosinophils - Unknown function"	"Cluster 52: Non-specific - Ribosome"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 5: Muller glia cells - Visual perception"	Cytosol		"HPA017593: AB_1854703, HPA047027: AB_2679907, HPA057684: AB_2683501"	"unprognostic (1.44e-2)"	"unprognostic (2.15e-1)"	"unprognostic (4.40e-3)"	"unprognostic (4.25e-1)"	"unprognostic (3.08e-3)"	"unprognostic (1.42e-1)"	"unprognostic (8.12e-2)"	"unprognostic (9.09e-3)"	"unprognostic (1.88e-1)"	"unprognostic (1.51e-1)"	"unprognostic (2.60e-2)"	"unprognostic (1.96e-1)"	"prognostic favorable (1.27e-4)"	"unprognostic (1.75e-1)"	"unprognostic (2.87e-1)"	"unprognostic (5.01e-1)"	"unprognostic (8.32e-3)"	61.2	71.8	52.1	31.9	60.4	169.2	48.7	37.3	75.5	52.1	48.5	57.4	26.6	30.9	62.5	34.8	44.5	89.8	161.6	61.4	53.1	130.5	45.1	29.0	34.3	48.2	54.5	150.2	62.9	41.7	26.5	60.1	47.5	78.7	62.9	102.0	129.8	38.2	87.2	19.8	35.4	37.9	42.5	25.7	34.6	32.3	48.8	34.8	57.5	115.6	36.3	78.6	26.0	52.7	24.1	20.4	36.4	41.1	132.5	54.3	45.5	66.0	52.4	37.0	27.2	188.4	58.6	33.7	14.0	53.1	24.3	29.5	102.4	33.2	56.5	51.9	21.6	126.9	17.1	99.3	126.8	66.8	29.3	118.5	109.2	38.3	85.0	186.1	212.9	59.7	130.7	46.0	42.9	24.6	61.9	63.7	57.2	59.4	47.7	50.7	32.5	36.5	45.0	171.7	29.1	37.5	53.6	103.3	153.2	58.2	75.2	85.6	81.6	31.6	18.0	47.9	42.5	25.6	34.2	49.4	16.6	51.8	98.3	9.5	2.2	11.3	2.8	2.8	5.1	4.5	4.2	2.9	2.0	3.8	4.4	4.4	1.9	6.0	2.5	3.2	4.2	1.9	52.1	60.4	37.3	75.5	61.4	53.1	48.2	54.5	47.5	42.5	48.8	52.7	44.0	19.2	42.8	8.1	74.8	116.8	123.1	22.5	178.7	66.9	58.3	39.1	243.9	114.4	31.8	62.5	62.6	188.7	49.8	226.9	361.9	21.8	125.6	45.7	38.2	66.4	152.2	520.6	16.6	16.5	32.9	99.2	36.2	60.6	25.4	54.2	41.7	53.4	43.7	42.1	7.5	89.3	12.2	35.1	81.0	26.2	39.1	47.2	106.7	5.6	34.3	485.7	34.0	10.6	1.3	55.1	92.8	46.6	113.9	137.8	68.2	52.8	86.1	44.5	72.3	184.4	204.4	115.7	17.3	119.2	96.7	163.8	80.2	37.3	90.4	178.4
NUDT4B	NUDT4P1	ENSG00000177144	"Nudix hydrolase 4B"	A0A024RBG1	1	148748894-148750099	"Enzymes, Predicted intracellular proteins"		"Hydrolase, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			"Immune cell enriched"	"Detected in single"	6	"eosinophil: 2.8"	"Lineage enriched"	"Detected in single"	6	"granulocytes: 2.8"	"Cell line enhanced"	"Detected in all"		"CACO-2: 42.1;RT4: 34.5"									"HPA017593, HPA047027, HPA057684"	Approved		Approved	Cytosol		NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 7: Non-specific - Mitochondria"	Cytosol		"HPA017593: AB_1854703, HPA047027: AB_2679907, HPA057684: AB_2683501"					"unprognostic (1.24e-1)"									"unprognostic (4.01e-2)"				4.9	6.8	0.2	3.6	0.4	23.6	1.8	0.0	0.9	4.4	0.3	5.7	5.3	3.7	2.6	8.1	7.0	17.7	20.8	0.5	0.6	9.8	3.9	2.6	6.8	1.3	0.5	16.1	11.9	4.6	0.3	7.7	0.4	7.5	6.1	0.6	23.6	3.1	5.3	1.3	5.2	3.6	0.3	3.0	4.1	7.7	0.3	3.2	7.9	8.1	3.7	11.1	0.6	0.6	3.5	3.8	1.5	4.7	6.3	5.1	9.3	4.1	6.2	4.4	4.2	42.1	14.8	3.5	1.7	3.7	4.2	5.7	6.8	3.0	2.2	11.0	3.3	8.5	2.3	5.4	8.4	5.8	2.6	10.6	9.7	5.5	5.1	5.3	16.5	4.3	17.6	13.8	4.2	3.0	7.9	1.1	8.3	3.4	6.2	9.7	2.2	10.0	3.2	34.5	3.0	4.4	3.5	8.6	23.7	1.0	11.7	11.0	9.1	5.8	4.5	9.6	6.3	3.2	5.2	4.5	2.7	8.7	17.4	0.0	0.1	2.8	0.0	0.3	0.2	0.0	0.1	0.0	0.3	0.0	0.1	0.0	0.0	0.2	0.4	0.0	0.2	0.2	0.2	0.4	0.0	0.9	0.5	0.6	1.3	0.5	0.4	0.3	0.3	0.6	0.4	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.3	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.4	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.4	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0
NUDT5	"hYSAH1, YSA1H"	ENSG00000165609	"Nudix hydrolase 5"	Q9UKK9	10	12165330-12196144	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"		"Hydrolase, RNA-binding, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA019827	Approved		Approved	Nucleoplasm,Vesicles,Centrosome		NA	NA		1500000	"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 64: Macrophages - Immune response"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 39: Non-specific - Basic cellular processes"	Vesicles	"Nucleoplasm, Centrosome"	"HPA019827: AB_1854704"	"unprognostic (2.08e-2)"	"unprognostic (2.10e-1)"	"unprognostic (1.61e-1)"	"unprognostic (2.09e-1)"	"unprognostic (3.77e-3)"	"unprognostic (4.91e-2)"	"unprognostic (2.54e-2)"	"unprognostic (4.60e-2)"	"unprognostic (1.32e-1)"	"unprognostic (6.39e-3)"	"unprognostic (2.06e-1)"	"unprognostic (9.97e-2)"	"prognostic unfavorable (7.14e-12)"	"unprognostic (1.61e-1)"	"unprognostic (1.33e-1)"	"unprognostic (3.12e-2)"	"unprognostic (3.68e-2)"	35.1	32.4	23.0	30.6	26.4	24.1	26.7	27.5	30.5	24.6	29.5	32.0	27.5	14.3	23.7	40.7	24.6	18.4	14.9	23.4	26.0	36.3	88.8	26.0	39.3	27.3	24.9	18.0	25.9	33.1	35.5	31.1	27.4	21.0	36.0	27.4	25.1	14.0	6.2	33.2	25.4	17.6	25.0	34.2	22.6	13.1	25.4	53.5	27.8	7.6	47.4	28.9	27.8	31.8	136.4	98.0	114.6	107.1	107.5	105.6	100.8	96.9	61.5	111.9	119.1	142.5	125.9	134.2	82.4	79.2	70.0	133.1	162.0	150.6	102.1	110.8	160.8	111.9	114.3	209.3	112.0	77.1	75.2	111.7	88.4	122.3	61.7	86.3	144.9	209.4	153.5	88.9	103.2	123.8	143.5	87.0	100.4	215.0	60.1	128.0	42.4	157.2	106.0	46.1	56.6	82.3	117.4	90.8	142.2	132.0	155.9	77.9	91.6	47.0	90.6	134.3	121.9	74.3	141.6	179.3	99.7	97.3	36.0	29.6	60.8	115.2	69.9	65.7	80.4	72.7	73.9	82.6	87.6	64.6	50.4	68.4	163.8	57.4	52.2	149.2	123.4	71.6	23.0	26.4	27.5	30.5	23.4	26.0	27.3	24.9	27.4	25.0	25.4	31.8	42.1	25.6	55.1	23.2	43.8	43.0	57.8	121.2	28.5	21.1	28.6	30.7	4.5	32.9	72.3	23.9	16.7	82.6	49.8	35.0	74.3	82.2	35.3	61.1	44.4	42.6	38.3	43.5	34.6	82.9	150.6	40.3	33.1	31.9	31.7	41.4	41.7	131.8	128.7	21.9	38.2	41.2	79.3	41.8	32.2	11.7	39.4	39.7	30.2	12.2	85.0	37.4	62.8	34.2	41.2	73.8	35.2	29.0	66.1	33.7	52.6	130.6	103.9	25.5	32.9	21.2	40.1	20.2	33.6	52.4	60.5	58.1	49.7	54.4	57.4	46.9
NUDT9	MGC3037	ENSG00000170502	"Nudix hydrolase 9"	Q9BW91	4	87422573-87459455	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"RPTEC TERT1: 160.7"	"Low region specificity"	"Detected in all"							"HPA036917, HPA044866, HPA078535"	Approved		Approved	"Nuclear membrane,Nuclear bodies,Cell Junctions,Mitochondria"	"Intracellular and membrane"	NA	NA		9900	"Cluster 27: Non-specific - Gene expression"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"	"Nuclear bodies, Mitochondria"	"Nuclear membrane, Cell Junctions"	"HPA036917: AB_10696790, HPA044866: AB_2679120, HPA078535: AB_2686885"	"unprognostic (7.22e-2)"	"unprognostic (2.59e-2)"	"unprognostic (1.45e-2)"	"prognostic favorable (7.43e-5)"	"unprognostic (2.05e-2)"	"unprognostic (1.36e-1)"	"unprognostic (1.33e-1)"	"unprognostic (3.47e-2)"	"unprognostic (2.04e-1)"	"unprognostic (1.02e-1)"	"unprognostic (1.09e-2)"	"unprognostic (4.23e-1)"	"prognostic favorable (8.00e-11)"	"unprognostic (1.21e-1)"	"unprognostic (1.99e-1)"	"unprognostic (1.19e-1)"	"unprognostic (5.77e-3)"	23.6	36.1	20.8	16.2	21.4	6.7	19.7	25.5	38.5	27.6	39.1	27.0	42.6	24.8	32.2	19.6	24.9	16.2	28.8	21.9	24.7	40.4	46.6	23.0	13.7	21.0	20.5	26.7	67.6	55.3	29.1	19.9	21.9	30.4	27.1	20.1	28.1	23.8	42.1	16.6	40.3	23.8	19.6	14.7	22.3	22.5	22.1	13.4	28.8	45.0	14.8	22.4	24.3	26.0	30.8	25.6	34.0	19.8	67.6	39.6	26.0	59.8	35.6	21.3	21.1	17.1	53.1	47.6	58.9	47.6	41.0	21.1	32.1	38.1	33.2	34.5	24.0	13.4	34.5	31.8	42.4	25.6	21.2	41.5	52.4	25.6	22.6	45.5	41.6	13.7	40.3	30.0	38.7	33.4	39.1	23.2	29.1	68.5	12.0	45.0	31.8	27.0	160.7	24.2	41.3	28.7	37.6	63.0	30.8	44.5	36.8	38.2	43.7	34.7	34.3	25.8	27.8	21.5	18.7	37.9	51.3	21.9	48.2	1.6	17.9	5.9	19.1	21.2	18.2	22.2	18.5	19.5	21.4	18.8	22.5	26.0	1.8	15.6	24.0	20.6	19.0	16.0	20.8	21.4	25.5	38.5	21.9	24.7	21.0	20.5	21.9	19.6	22.1	26.0	32.6	67.3	44.8	20.2	14.9	9.9	40.4	45.0	9.6	15.3	11.3	13.1	40.9	30.0	55.0	23.9	27.1	33.2	13.1	21.0	41.1	44.7	28.6	26.0	26.2	25.8	16.8	6.7	21.7	36.5	32.5	29.4	8.6	27.0	20.8	23.3	18.2	47.5	33.2	6.7	24.0	18.0	40.7	12.7	11.0	11.5	25.4	14.7	10.6	20.6	16.4	26.8	8.2	18.6	24.8	29.4	37.0	26.7	15.8	32.9	55.7	56.2	41.0	18.6	26.3	36.9	23.7	44.5	23.6	15.7	9.5	37.6	12.1	29.8	24.9	27.3
OCRL	"Dent-2, OCRL1"	ENSG00000122126	"OCRL inositol polyphosphate-5-phosphatase"	Q01968	X	129539849-129592561	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"Cilium biogenesis/degradation"	Hydrolase	"Cataract, Ciliopathy, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"non-classical monocyte: 3.6"	"Group enriched"	"Detected in many"	8	"dendritic cells: 1.2;monocytes: 3.6"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA012495	Approved		Approved	"Microtubules,Centriolar satellite,Cytosol"		NA	NA			"Cluster 14: Monocytes - Unknown function"	"Cluster 89: Fibroblasts - ECM organization"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 40: Granulosa cells - Unknown function"	Cytosol	"Microtubules, Centriolar satellite"	"HPA012495: AB_1851804"	"prognostic unfavorable (2.93e-5)"	"unprognostic (3.17e-2)"	"unprognostic (2.30e-1)"	"unprognostic (6.34e-3)"	"unprognostic (9.88e-2)"	"unprognostic (1.35e-1)"	"unprognostic (2.82e-2)"	"unprognostic (2.68e-1)"	"unprognostic (3.08e-3)"	"unprognostic (2.56e-2)"	"unprognostic (6.30e-3)"	"unprognostic (1.74e-1)"	"unprognostic (4.61e-3)"	"unprognostic (4.10e-1)"	"unprognostic (5.83e-2)"	"unprognostic (1.59e-1)"	"unprognostic (1.17e-1)"	13.9	23.8	12.4	4.7	13.2	5.0	12.7	5.3	13.6	14.9	27.2	16.4	8.0	19.4	16.1	11.6	16.7	8.3	10.7	13.1	20.3	9.5	15.7	10.0	2.8	9.6	14.0	28.4	13.0	34.6	25.6	11.2	17.4	18.5	12.4	9.9	11.0	21.3	14.8	12.4	12.2	15.0	7.6	7.9	14.5	24.6	18.6	4.4	16.8	6.7	3.0	22.8	12.3	8.6	19.3	20.5	17.0	18.7	29.3	24.1	17.1	28.5	22.3	28.2	26.3	14.2	13.3	1.5	46.7	24.1	33.0	11.6	30.5	20.9	29.2	0.1	21.5	5.8	18.5	14.1	21.1	5.7	0.6	20.7	27.3	28.3	27.3	27.7	21.2	8.4	7.9	13.6	28.7	24.2	4.3	8.2	6.2	24.4	30.9	4.2	17.6	11.5	16.1	19.1	20.5	26.1	13.5	18.0	14.6	21.5	13.2	10.0	19.3	23.0	10.6	24.6	29.1	3.8	3.3	3.7	16.2	21.4	18.8	0.0	1.0	0.0	0.1	1.1	0.3	0.1	0.0	0.0	1.2	0.1	0.2	0.1	0.1	0.0	3.6	0.4	0.0	0.4	12.4	13.2	5.3	13.6	13.1	20.3	9.6	14.0	17.4	7.6	18.6	8.6	6.7	3.2	7.8	14.4	2.6	4.7	3.4	5.4	3.4	9.9	9.3	5.6	10.3	4.3	8.8	18.4	6.2	6.4	0.3	14.4	3.9	5.3	31.2	4.9	6.9	6.4	17.5	3.8	20.0	3.6	5.4	7.8	11.7	6.1	0.0	17.0	8.2	11.5	5.0	13.5	23.1	11.8	6.1	11.8	4.0	8.9	23.0	5.8	8.8	21.5	4.3	9.6	0.0	17.6	21.0	8.5	8.3	34.3	1.4	5.9	15.7	5.2	5.4	7.2	0.0	4.5	6.0	6.8	14.6	8.3	7.4	5.7	1.0	7.6	12.2	8.4
OGA	"MEA5, MGEA5, NCOAT"	ENSG00000198408	O-GlcNAcase	O60502	10	101784443-101818465	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Host-virus interaction"	"Glycosidase, Hydrolase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Collecting duct cells: 86.5;dendritic cells: 89.3;Glandular and luminal cells: 83.7;Granulosa cells: 69.4;Pancreatic endocrine cells: 82.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036141, HPA076501"	Approved		Supported	Cytosol		NA	NA			"Cluster 6: Non-specific - Transcription"	"Cluster 6: Brain - Smell perception"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 7: Non-specific - Mitochondria"	Cytosol		"HPA036141: AB_10672079, HPA076501: AB_2686802"	"unprognostic (4.34e-1)"	"unprognostic (1.57e-1)"	"prognostic unfavorable (8.69e-5)"	"unprognostic (4.63e-1)"	"unprognostic (2.06e-1)"	"unprognostic (2.57e-2)"	"unprognostic (2.65e-1)"	"unprognostic (1.79e-2)"	"unprognostic (2.44e-1)"	"unprognostic (1.21e-3)"	"unprognostic (6.00e-2)"	"unprognostic (7.81e-2)"	"unprognostic (1.68e-1)"	"unprognostic (3.01e-1)"	"unprognostic (3.21e-2)"	"unprognostic (1.90e-1)"	"unprognostic (9.23e-3)"	65.3	34.1	77.3	46.7	80.3	89.0	59.2	99.3	82.8	62.2	54.3	64.8	28.1	50.0	55.5	57.4	52.9	29.8	60.7	82.2	74.0	45.6	46.0	52.9	69.8	66.8	70.3	66.8	42.9	60.6	44.9	41.0	67.7	52.7	40.7	99.8	50.5	38.9	56.6	72.7	62.8	35.4	68.6	74.4	46.4	38.6	84.3	67.6	51.7	29.5	64.8	57.0	58.6	77.6	89.8	44.7	63.7	124.6	40.0	96.6	44.4	61.7	61.8	28.1	48.0	33.1	56.0	59.6	43.7	73.7	48.2	62.9	60.3	77.5	59.2	87.9	41.2	59.6	65.0	26.0	43.1	44.4	32.3	93.9	85.1	48.1	113.7	80.0	53.0	53.1	42.8	107.3	48.3	45.6	47.2	46.1	35.4	19.4	44.8	64.8	70.5	44.0	47.2	80.0	27.7	48.8	55.2	29.4	78.2	58.0	77.9	47.7	80.9	43.0	41.6	63.0	71.6	53.1	91.0	47.2	54.0	74.6	24.0	14.4	2.1	7.2	6.4	2.0	5.1	6.6	4.5	5.8	1.3	7.5	6.1	5.2	14.1	6.6	6.3	3.3	4.6	1.5	77.3	80.3	99.3	82.8	82.2	74.0	66.8	70.3	67.7	68.6	84.3	77.6	66.3	0.0	0.0	0.0	40.2	0.0	0.0	0.0	0.0	0.0	66.5	47.0	0.0	0.0	0.0	86.5	0.0	41.9	89.3	0.0	13.7	38.0	0.0	61.6	68.3	18.1	0.0	0.0	0.0	40.9	34.3	20.3	0.0	83.7	0.0	69.4	0.0	0.0	39.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	23.5	0.0	0.0	48.6	0.0	0.0	0.0	0.0	82.4	0.0	0.0	44.3	0.0	0.0	34.0	0.0	0.0	0.0	0.0	28.3	0.0	0.0	0.0	0.0	50.9	34.6	44.8	0.0	0.0
OLAH	"FLJ11106, SAST, THEDC1"	ENSG00000152463	"Oleoyl-ACP hydrolase"	Q9NV23	10	15032227-15073853	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Fatty acid biosynthesis, Fatty acid metabolism, Lipid biosynthesis, Lipid metabolism"	Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 9.0;testis: 27.0"	"Cell type enriched"	"Detected in some"	4	"Early spermatids: 537.8"	"Cancer enriched"	"Detected in some"	4	"testis cancer: 3.6"	"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in single"		"neutrophil: 2.6"	"Lineage enriched"	"Detected in single"	5	"granulocytes: 2.6"	"Cell line enhanced"	"Detected in some"		"HSkMC: 3.6;hTCEpi: 4.8;LHCN-M2: 3.6;SK-BR-3: 5.3;SuSa: 2.6;U-266/70: 3.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA037947, HPA037948"	Enhanced					NA	NA			"Cluster 1: Neutrophils - Mixed function"	"Cluster 83: Testis - Spermatogenesis"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 30: Mammary glandular cells - Lactation"			"HPA037947: AB_10795028, HPA037948: AB_10805352"	"unprognostic (2.01e-1)"	"unprognostic (6.12e-2)"	"unprognostic (8.20e-3)"	"unprognostic (4.04e-3)"	"unprognostic (1.92e-1)"	"unprognostic (8.09e-2)"	"unprognostic (7.12e-2)"	"unprognostic (5.12e-2)"	"unprognostic (4.55e-1)"	"unprognostic (3.74e-2)"	"unprognostic (4.70e-1)"	"unprognostic (1.69e-1)"	"unprognostic (5.22e-10)"	"unprognostic (4.55e-2)"	"unprognostic (2.09e-1)"	"unprognostic (5.11e-2)"	"unprognostic (9.78e-2)"	1.5	0.9	1.1	0.2	0.8	1.1	5.5	0.6	1.5	0.8	0.8	0.2	0.1	0.4	0.4	3.0	1.7	1.0	0.2	1.1	0.3	1.1	0.3	1.7	0.3	0.5	0.3	0.2	0.1	0.3	1.0	3.2	0.3	0.3	0.0	0.7	2.7	0.1	0.2	0.7	0.5	0.2	0.2	9.0	0.3	27.0	0.7	0.1	0.4	0.3	0.0	0.2	0.8	1.2	0.0	0.0	0.1	0.2	0.2	0.7	1.2	0.3	0.3	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.1	0.0	0.1	0.4	0.1	0.1	0.2	0.1	0.0	0.5	0.0	0.4	3.6	4.8	0.5	0.0	0.0	0.4	0.1	0.2	0.1	3.6	0.0	0.3	0.2	0.2	0.0	0.3	0.4	0.7	0.2	0.0	0.0	0.0	0.1	0.1	5.3	0.0	2.6	0.1	0.1	0.2	0.0	1.8	0.1	0.1	3.1	0.7	0.2	1.1	0.2	0.0	0.8	0.1	0.1	0.1	0.0	0.0	0.1	0.2	0.0	0.0	0.1	0.1	0.1	2.6	0.4	0.0	0.5	0.2	0.0	1.1	0.8	0.6	1.5	1.1	0.3	0.5	0.3	0.3	0.2	0.7	1.2	0.7	3.2	0.6	0.3	0.1	0.3	0.5	0.0	0.0	0.1	131.3	0.9	0.4	0.0	0.0	0.0	0.0	0.5	0.4	0.0	0.0	2.7	537.8	0.1	0.2	0.3	0.0	0.0	0.1	0.0	1.7	0.3	0.0	0.2	0.0	0.1	0.0	0.3	0.1	0.0	0.1	0.0	0.0	2.2	0.3	66.1	4.4	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.6	0.0	8.2	0.0	0.4	0.0	0.0	0.8	0.7	6.6	0.5	1.0	2.8	1.9	0.0	0.3	11.4	0.9	0.1	0.0	0.1
OPA1	"FLJ12460, KIAA0567, MGM1, NPG, NTG"	ENSG00000198836	"OPA1 mitochondrial dynamin like GTPase"	O60313	3	193593144-193697811	"Disease related genes, Enzymes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Transporters"	"Apoptosis, Sensory transduction, Vision"	Hydrolase	"Cardiomyopathy, Deafness, Disease variant, Neurodegeneration, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Cardiomyocytes: 135.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036926, HPA036927"	Supported		Supported	Nucleoplasm,Mitochondria		NA	NA		10000	"Cluster 14: Monocytes - Unknown function"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 6: Erythroid cells - Oxygen transport"	"Nucleoplasm, Mitochondria"		"HPA036926: AB_10671247, HPA036927: AB_2675388"	"unprognostic (2.10e-2)"	"unprognostic (9.23e-3)"	"unprognostic (7.98e-2)"	"prognostic unfavorable (8.61e-4)"	"unprognostic (1.62e-2)"	"unprognostic (4.59e-2)"	"unprognostic (2.24e-1)"	"unprognostic (1.86e-2)"	"unprognostic (1.57e-1)"	"unprognostic (1.08e-1)"	"prognostic unfavorable (8.44e-5)"	"unprognostic (3.48e-2)"	"prognostic favorable (1.84e-4)"	"unprognostic (2.92e-1)"	"unprognostic (4.75e-1)"	"unprognostic (4.50e-3)"	"unprognostic (3.21e-1)"	15.0	12.0	14.3	7.6	17.4	25.6	12.8	15.2	19.5	10.4	9.4	18.9	16.8	10.9	9.1	14.6	8.1	10.2	39.3	18.6	17.4	18.3	20.9	8.5	11.8	16.4	15.4	8.4	10.1	23.1	3.8	11.7	16.8	12.3	16.6	9.6	11.7	13.3	24.2	11.9	13.8	13.5	12.4	9.3	14.6	6.3	15.2	12.7	13.9	44.5	12.4	13.0	5.1	13.7	58.9	18.8	18.2	20.2	15.8	25.0	19.3	27.5	26.2	30.0	29.0	45.2	19.3	38.6	58.1	27.0	27.3	37.3	32.7	31.7	53.5	46.5	25.7	67.9	16.7	23.1	24.9	55.8	29.8	28.4	27.6	30.0	40.9	18.5	26.2	15.7	28.4	37.0	30.2	46.5	21.9	30.9	25.8	33.9	59.9	27.8	40.1	41.6	22.7	36.1	39.8	24.2	41.8	46.3	29.5	14.1	60.3	43.5	26.3	27.7	20.8	29.3	58.7	33.1	41.3	74.0	30.5	43.7	28.4	9.7	7.3	7.1	5.8	8.2	5.5	6.8	5.5	5.6	7.8	5.1	5.6	6.0	2.7	4.7	17.3	4.0	6.6	5.2	14.3	17.4	15.2	19.5	18.6	17.4	16.4	15.4	16.8	12.4	15.2	13.7	24.8	16.0	24.0	72.1	27.5	15.9	16.4	17.4	24.5	19.5	20.9	13.5	135.2	22.8	20.1	18.4	31.3	19.0	24.6	31.4	17.6	19.3	7.7	20.3	25.2	23.8	23.4	86.3	106.8	24.0	14.9	24.6	31.1	26.1	19.6	25.6	14.3	39.1	17.9	21.9	106.7	20.6	10.2	25.6	14.7	13.5	15.8	28.1	21.4	58.1	22.9	14.6	11.3	87.4	98.1	28.9	12.1	14.7	29.3	18.7	24.6	34.1	19.6	23.4	6.6	21.3	26.2	15.1	16.6	34.3	22.4	17.9	22.3	28.2	26.7	22.1
OPLAH	"5-Opase, OPLA"	ENSG00000178814	"5-oxoprolinase, ATP-hydrolysing"	O14841	8	144051266-144063965	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"testis: 66.5"	"Group enriched"	"Detected in many"	4	"Early spermatids: 115.7;Late spermatids: 231.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"classical monocyte: 1.1;neutrophil: 1.1"	"Group enriched"	"Detected in many"	9	"granulocytes: 1.1;monocytes: 1.1"	"Cell line enhanced"	"Detected in many"		"AN3-CA: 33.9;BEWO: 21.0;Hep G2: 18.8;PC-3: 26.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA026562, HPA028260, HPA052429"	Uncertain		Approved	"Nucleoli fibrillar center"		NA	NA		34000	"Cluster 25: Monocytes - Inflammatory response"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 23: AN3-CA - Transcription regulation"	"Cluster 25: Spermatids - Spermatogenesis"	"Nucleoli fibrillar center"		"HPA026562: AB_1854804, HPA028260: AB_10601383, HPA052429: AB_2681830"	"unprognostic (7.89e-2)"	"unprognostic (3.08e-2)"	"unprognostic (1.69e-1)"	"unprognostic (9.09e-2)"	"unprognostic (2.21e-2)"	"unprognostic (3.87e-3)"	"unprognostic (2.04e-2)"	"unprognostic (9.37e-2)"	"unprognostic (2.90e-1)"	"unprognostic (1.26e-1)"	"unprognostic (6.82e-2)"	"unprognostic (3.62e-1)"	"prognostic favorable (1.53e-6)"	"unprognostic (4.03e-3)"	"unprognostic (4.33e-1)"	"unprognostic (3.54e-2)"	"unprognostic (8.24e-2)"	9.2	14.8	3.3	1.9	5.6	2.7	8.6	8.1	3.7	6.4	5.7	15.0	13.8	4.8	0.6	15.6	4.2	2.5	35.1	2.9	2.7	15.8	34.3	6.4	0.8	12.2	5.6	5.7	10.0	6.7	3.2	1.3	12.5	8.9	2.2	0.3	11.2	5.7	34.2	13.3	12.2	1.1	3.9	9.1	19.7	66.5	5.3	0.3	5.9	15.4	0.5	4.8	9.5	6.5	4.2	4.2	0.4	33.9	1.5	3.1	21.0	2.1	1.3	1.2	0.7	8.1	7.8	0.0	6.8	3.8	0.0	5.5	1.0	3.1	0.1	1.1	0.0	1.4	7.0	18.8	10.5	0.1	0.0	4.4	13.8	1.4	0.0	0.0	0.2	5.8	5.1	0.0	0.0	4.8	0.3	3.3	2.8	6.5	26.2	0.4	0.0	5.6	3.6	5.1	1.2	0.1	0.0	1.4	0.1	0.4	8.8	4.6	0.2	0.0	5.5	0.0	1.4	1.1	1.5	1.1	0.5	1.1	0.0	0.0	1.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	1.1	0.0	0.1	0.0	0.0	0.4	3.3	5.6	8.1	3.7	2.9	2.7	12.2	5.6	12.5	3.9	5.3	6.5	1.1	3.2	3.2	9.1	0.8	2.0	2.8	4.4	3.4	1.1	6.1	6.1	2.9	7.2	4.7	9.2	0.0	1.7	0.2	37.6	11.7	3.8	115.7	2.6	2.7	1.1	1.2	0.0	0.2	2.7	2.7	2.7	18.3	5.5	0.0	6.0	2.2	25.1	2.4	0.0	0.3	10.0	4.1	6.0	0.5	231.7	2.5	3.4	0.0	1.0	2.1	4.3	0.0	0.5	2.6	3.6	13.1	3.8	0.6	1.9	23.8	13.3	2.2	0.1	0.0	3.6	2.2	3.1	2.3	7.2	1.8	2.5	0.6	10.2	18.2	3.0
OTUB1	"FLJ20113, FLJ40710"	ENSG00000167770	"OTU deubiquitinase, ubiquitin aldehyde binding 1"	Q96FW1	11	63985853-64001811	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Adaptive immunity, DNA damage, DNA repair, Immunity, Ubl conjugation pathway"	"Hydrolase, Protease, Thiol protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039176, CAB072836"	Approved	Supported	Approved	Nucleoplasm,Cytosol		NA	NA		500000	"Cluster 31: Non-specific - Inflammatory response"	"Cluster 27: Brain & Skin - Unknown function"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 53: Intestinal epithelial cells - Unknown function"	"Nucleoplasm, Cytosol"		"CAB072836: , HPA039176: AB_10674980"	"unprognostic (2.50e-1)"	"unprognostic (5.70e-3)"	"unprognostic (3.93e-2)"	"unprognostic (1.63e-1)"	"unprognostic (2.78e-1)"	"prognostic unfavorable (3.05e-4)"	"unprognostic (1.85e-3)"	"unprognostic (1.34e-2)"	"unprognostic (2.45e-1)"	"unprognostic (1.27e-2)"	"unprognostic (3.04e-1)"	"unprognostic (1.34e-1)"	"unprognostic (1.33e-3)"	"unprognostic (6.76e-2)"	"unprognostic (1.42e-1)"	"unprognostic (4.84e-2)"	"unprognostic (1.82e-1)"	44.8	57.0	69.9	43.0	78.0	63.5	47.3	53.0	93.4	54.1	39.7	51.9	42.0	49.0	37.4	85.4	55.8	35.9	62.4	79.3	62.5	61.3	47.0	47.1	59.8	65.0	58.0	44.5	43.9	47.1	48.6	49.3	66.1	53.5	39.3	25.6	54.3	42.6	70.2	78.1	51.9	38.0	51.2	58.6	54.0	57.1	65.0	56.0	51.9	48.4	57.1	52.5	56.7	67.7	113.4	198.9	107.2	95.7	70.7	77.8	83.0	66.0	97.1	143.6	105.1	138.1	104.5	59.3	122.0	106.6	124.4	138.1	140.4	165.4	88.1	69.9	111.7	99.3	114.1	172.9	98.8	99.2	104.3	83.4	106.4	110.2	69.8	74.4	137.2	54.6	71.2	65.3	97.9	237.2	109.2	133.0	126.5	95.4	94.1	88.3	41.8	102.5	151.1	162.1	81.5	117.5	74.6	114.1	123.3	72.9	178.2	86.3	100.1	75.8	74.2	103.3	88.4	76.2	51.7	86.4	98.4	64.0	74.5	228.8	186.8	189.9	165.5	244.2	131.2	149.6	152.1	153.6	203.1	139.3	117.1	130.4	184.6	161.8	218.9	140.7	224.7	313.4	69.9	78.0	53.0	93.4	79.3	62.5	65.0	58.0	66.1	51.2	65.0	67.7	37.0	19.2	56.5	15.0	67.2	48.3	70.9	137.8	83.6	44.4	42.5	48.8	31.9	37.1	82.5	46.0	39.6	146.2	56.5	104.7	74.3	80.7	72.6	55.4	36.2	43.4	87.8	35.5	17.8	85.5	109.2	50.0	71.9	44.3	48.7	54.6	35.7	33.2	90.4	30.3	16.9	70.8	101.7	57.4	65.9	87.1	34.2	61.0	51.6	8.4	98.0	43.2	78.2	12.5	18.8	90.1	92.0	25.6	80.8	51.8	90.8	85.2	89.2	55.7	26.3	28.1	62.0	48.0	71.4	77.7	52.6	194.8	73.7	51.7	62.7	71.6
OTUB2	"C14orf137, FLJ21916, MGC3102"	ENSG00000089723	"OTU deubiquitinase, ubiquitin aldehyde binding 2"	Q96DC9	14	94026340-94048930	"Enzymes, Predicted intracellular proteins"	"Ubl conjugation pathway"	"Hydrolase, Protease, Thiol protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"skin 1: 7.3;testis: 14.4"	"Group enriched"	"Detected in many"	8	"Early spermatids: 641.1;Late spermatids: 1415.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"GAMG: 16.5;Karpas-707: 18.0;OE19: 18.1;RPTEC TERT1: 11.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA002329, HPA075090"	Enhanced					NA	NA			"Cluster 7: Monocytes - Unknown function"	"Cluster 27: Brain & Skin - Unknown function"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 34: Spermatids - Unknown function"			"HPA002329: AB_1079537, HPA075090: AB_2686734"	"unprognostic (6.80e-3)"	"unprognostic (1.39e-3)"	"unprognostic (3.68e-3)"	"unprognostic (4.82e-3)"	"unprognostic (1.66e-1)"	"unprognostic (2.20e-1)"	"unprognostic (2.30e-3)"	"unprognostic (1.18e-2)"	"unprognostic (2.55e-1)"	"unprognostic (3.09e-3)"	"unprognostic (2.80e-2)"	"unprognostic (1.16e-2)"	"unprognostic (6.25e-3)"	"unprognostic (1.15e-1)"	"unprognostic (2.06e-2)"	"unprognostic (1.02e-4)"	"unprognostic (3.16e-1)"	0.3	0.6	1.2	0.2	1.1	0.2	0.8	1.3	1.3	1.3	0.1	0.5	0.3	0.8	0.3	3.8	0.6	0.4	0.1	1.0	0.8	0.6	0.8	0.4	0.3	0.1	1.3	0.7	0.7	1.9	0.2	1.8	0.1	0.6	0.8	0.6	0.7	0.2	0.1	7.3	0.3	0.3	0.1	0.2	0.5	14.4	2.5	0.1	0.2	0.0	0.8	0.9	1.5	0.5	1.3	3.7	2.4	2.3	0.9	0.7	2.6	0.5	0.3	1.4	2.1	0.8	5.9	0.3	2.2	0.6	16.5	0.3	3.2	1.7	1.1	0.9	1.5	0.1	0.4	3.9	1.3	0.0	0.6	0.6	2.1	0.5	0.9	1.8	1.6	3.3	0.1	18.0	0.7	1.3	0.1	0.4	0.7	18.1	3.1	0.1	0.2	1.0	11.2	1.7	1.8	1.3	0.7	0.8	1.9	1.6	6.3	0.8	1.7	0.9	2.8	0.7	1.0	3.0	2.2	0.0	1.7	0.9	1.4	0.0	0.6	0.0	0.0	0.8	0.0	0.0	0.1	0.1	0.9	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.2	1.2	1.1	1.3	1.3	1.0	0.8	0.1	1.3	0.1	0.1	2.5	0.5	0.5	0.0	0.5	0.7	0.2	0.1	0.7	4.0	0.6	1.5	1.1	1.1	0.5	0.0	2.4	0.0	0.0	4.2	0.1	1.9	1.9	4.3	641.1	6.4	2.8	0.9	0.0	2.7	1.9	1.6	1.5	0.6	4.6	24.8	0.0	2.2	0.4	0.9	1.4	0.0	1.3	1.4	2.0	1.2	1.3	1415.3	6.8	2.4	0.0	0.0	0.4	0.5	0.0	0.5	0.6	5.2	1.3	3.4	0.1	0.3	0.5	1.5	1.8	1.4	6.6	0.6	0.6	9.2	4.3	2.0	2.3	117.5	1.0	2.2	1.0	2.4
OTUD1	"DUBA7, OTDC1"	ENSG00000165312	"OTU deubiquitinase 1"	Q5VV17	10	23439075-23442377	"Enzymes, Predicted intracellular proteins"	"Ubl conjugation pathway"	"Hydrolase, Protease, Thiol protease"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 60.4"	"Cell type enhanced"	"Detected in all"		"Cardiomyocytes: 149.0;Langerhans cells: 219.1;Macrophages: 105.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"CAPAN-2: 38.1;HaCaT: 36.5;SiHa: 23.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038503, HPA038504"	Approved		Approved	"Nucleoplasm,Nuclear bodies,Golgi apparatus"		NA	NA			"Cluster 18: Basophils - Vesicular transport"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 37: Myocytes - Muscle contraction"	Nucleoplasm	"Nuclear bodies, Golgi apparatus"	"HPA038503: AB_2676049, HPA038504: AB_10672712"	"unprognostic (1.84e-1)"	"unprognostic (2.80e-2)"	"unprognostic (1.96e-1)"	"prognostic unfavorable (4.59e-4)"	"unprognostic (1.56e-1)"	"unprognostic (1.29e-2)"	"unprognostic (3.18e-3)"	"unprognostic (2.41e-1)"	"unprognostic (7.77e-2)"	"unprognostic (4.10e-2)"	"unprognostic (1.80e-2)"	"unprognostic (1.32e-1)"	"prognostic favorable (6.61e-7)"	"unprognostic (1.62e-1)"	"unprognostic (3.50e-2)"	"unprognostic (3.66e-1)"	"unprognostic (1.43e-2)"	13.0	11.7	8.0	10.2	8.4	60.4	10.3	9.5	10.2	8.4	8.4	8.7	6.8	10.2	6.8	7.8	11.2	9.7	43.4	8.7	9.0	19.7	7.6	19.7	14.4	8.3	8.0	13.6	6.9	19.4	8.0	12.1	7.6	8.8	7.6	5.9	6.7	7.6	29.4	20.9	8.2	9.4	8.4	13.7	22.9	7.5	9.2	6.8	13.3	22.6	12.5	11.9	7.6	9.2	4.8	2.3	2.4	1.1	9.3	4.6	3.2	1.9	4.2	4.4	4.0	0.9	38.1	2.2	4.1	2.4	1.5	36.5	2.5	4.5	2.9	17.4	7.1	0.1	5.7	1.5	8.0	0.4	3.2	4.8	19.4	1.3	6.1	3.9	1.5	2.2	0.5	15.1	2.5	2.3	1.5	1.4	1.9	2.7	1.3	2.4	10.8	2.2	5.8	4.0	1.1	2.6	23.4	4.1	11.3	6.3	1.7	3.3	2.7	2.5	3.7	7.0	0.8	7.6	15.0	1.1	3.8	1.5	1.0	2.5	0.5	1.0	0.3	0.6	0.3	0.7	0.5	0.3	0.3	1.2	0.4	0.6	1.3	0.0	1.9	0.2	1.3	0.2	8.0	8.4	9.5	10.2	8.7	9.0	8.3	8.0	7.6	8.4	9.2	9.2	17.3	67.3	11.5	3.3	55.9	32.0	7.1	5.0	13.6	20.1	12.3	9.1	149.0	7.2	4.9	5.5	2.1	3.3	9.6	47.2	11.7	6.0	8.0	35.0	44.5	25.6	6.0	13.5	4.3	7.1	3.2	20.8	47.4	33.8	5.7	10.4	16.4	10.1	51.0	53.8	4.8	77.9	10.2	68.2	219.1	7.6	6.5	105.7	33.8	8.4	9.3	33.8	10.3	4.0	6.5	10.1	16.3	13.2	50.0	7.7	8.0	25.1	9.8	26.2	6.6	82.2	19.4	7.2	4.7	15.1	30.5	7.9	16.5	7.5	24.3	10.9
OTUD3	"DUBA4, KIAA0459"	ENSG00000169914	"OTU deubiquitinase 3"	Q5T2D3	1	19882395-19912945	"Enzymes, Predicted intracellular proteins"	"Ubl conjugation pathway"	"Hydrolase, Protease, Thiol protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA028543, HPA028544"	Approved		Approved	"Nucleoplasm,Intermediate filaments,Cytosol"		NA	NA				"Cluster 21: Non-specific - Transcription"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 12: Non-specific - Cell cycle regulation"	Cytosol	"Nucleoplasm, Intermediate filaments"	"HPA028543: AB_10599302, HPA028544: AB_10602277"	"unprognostic (6.45e-3)"	"unprognostic (9.26e-2)"	"unprognostic (3.77e-1)"	"unprognostic (1.95e-1)"	"unprognostic (1.41e-1)"	"unprognostic (3.16e-3)"	"unprognostic (1.70e-3)"	"unprognostic (3.15e-3)"	"unprognostic (4.99e-2)"	"unprognostic (1.09e-1)"	"unprognostic (8.81e-2)"	"unprognostic (4.68e-2)"	"unprognostic (1.08e-1)"	"unprognostic (9.83e-2)"	"unprognostic (1.94e-1)"	"unprognostic (7.28e-2)"	"unprognostic (2.21e-2)"	3.3	5.7	4.8	3.3	5.0	6.4	4.7	5.2	5.9	6.2	2.2	6.4	5.0	7.7	6.0	3.8	5.6	3.3	3.4	4.9	3.2	4.6	3.1	4.9	3.6	2.8	3.1	6.7	4.6	4.1	5.5	2.4	2.8	5.9	3.8	9.3	3.9	4.1	4.9	6.4	5.8	5.6	2.2	4.8	4.8	10.7	3.6	3.7	3.9	4.3	3.0	4.5	4.9	5.2	5.8	2.2	9.5	11.4	4.0	3.5	9.3	6.1	3.5	3.0	3.0	10.2	5.4	9.2	4.8	13.5	2.2	5.6	8.9	3.5	5.9	6.0	11.9	8.8	13.4	7.2	2.2	6.5	7.8	2.9	3.4	4.8	6.2	6.4	4.1	9.2	6.3	3.8	5.3	3.2	5.0	6.5	4.5	4.6	5.6	11.5	24.2	3.4	5.1	6.3	8.4	5.9	4.4	3.5	4.6	9.2	5.2	4.8	5.0	7.3	9.3	8.2	5.3	4.4	4.0	5.6	5.1	8.6	3.4	0.1	0.0	0.0	0.2	0.0	0.2	0.3	0.3	0.2	0.0	0.2	0.3	0.3	0.1	0.1	0.0	0.1	0.2	0.0	4.8	5.0	5.2	5.9	4.9	3.2	2.8	3.1	2.8	2.2	3.6	5.2	5.0	16.0	7.5	11.4	5.6	14.1	5.9	2.4	4.6	14.9	10.2	9.1	4.7	4.3	2.0	9.2	16.7	2.7	6.5	4.7	0.0	5.1	16.0	11.7	7.8	5.1	12.0	6.1	32.6	4.5	5.4	7.0	5.1	8.3	1.3	16.4	7.9	2.2	1.9	26.9	28.5	7.0	4.1	2.6	8.9	16.4	5.6	5.2	5.4	6.5	4.1	8.9	5.2	21.1	16.6	5.0	6.7	6.0	8.6	9.8	4.7	4.2	9.7	15.5	6.6	7.8	6.1	23.5	21.4	5.7	8.8	2.5	7.0	4.7	7.0	4.8
OTUD4	"DUBA6, HSHIN1, KIAA1046"	ENSG00000164164	"OTU deubiquitinase 4"	Q01804	4	145110838-145180589	"Enzymes, Predicted intracellular proteins"	"Immunity, Innate immunity, Ubl conjugation pathway"	"Hydrolase, Protease, Thiol protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 185.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA036623	Uncertain		Supported	Cytosol		NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 44: Endometrium - Transcription"	Cytosol		"HPA036623: AB_10696780"	"unprognostic (1.67e-1)"	"unprognostic (4.18e-2)"	"unprognostic (3.41e-2)"	"unprognostic (1.95e-1)"	"unprognostic (2.80e-1)"	"unprognostic (4.06e-2)"	"unprognostic (3.42e-2)"	"unprognostic (2.66e-2)"	"unprognostic (1.21e-1)"	"unprognostic (1.74e-2)"	"unprognostic (5.21e-3)"	"unprognostic (2.03e-2)"	"unprognostic (1.74e-1)"	"unprognostic (1.35e-1)"	"unprognostic (1.90e-1)"	"unprognostic (3.01e-1)"	"unprognostic (2.62e-1)"	14.0	12.8	9.6	13.8	12.3	32.0	12.6	13.0	12.5	12.2	11.0	11.6	11.5	13.6	14.2	13.4	16.1	12.3	11.8	9.9	8.7	11.9	20.2	15.3	16.2	9.1	9.1	14.5	12.2	17.1	9.7	15.1	9.5	10.2	12.1	17.0	11.0	11.4	40.4	15.4	11.2	13.7	8.7	16.2	10.8	31.9	9.4	16.4	13.6	40.4	14.3	18.7	12.1	14.9	28.2	15.7	18.3	17.1	21.3	25.8	24.5	24.0	26.9	30.2	23.9	16.9	33.8	51.2	10.6	33.8	18.5	16.6	31.9	33.6	39.3	22.0	15.0	24.7	20.1	15.8	24.9	52.3	17.7	20.3	33.5	36.9	48.3	25.4	27.1	22.0	41.5	37.3	30.1	16.8	32.4	22.7	20.5	27.0	17.7	26.3	20.0	12.1	29.4	20.1	17.7	14.6	22.2	33.0	24.3	24.1	11.0	21.2	33.1	33.8	21.5	17.7	32.2	27.2	28.7	33.0	23.4	36.5	33.4	0.0	0.4	0.8	0.9	0.6	0.6	0.8	0.6	0.7	0.4	0.6	0.6	0.6	0.1	0.5	0.8	0.7	0.5	0.3	9.6	12.3	13.0	12.5	9.9	8.7	9.1	9.1	9.5	8.7	9.4	14.9	24.8	64.1	23.5	27.7	19.6	63.2	55.3	13.9	18.2	16.1	20.3	11.8	20.2	22.8	20.5	27.6	25.0	21.5	28.2	16.3	9.8	12.7	185.2	52.8	29.1	44.7	15.1	21.4	36.4	14.7	21.4	30.3	14.8	45.7	20.3	19.6	21.0	24.0	12.7	6.7	30.8	15.2	20.3	20.8	42.4	82.4	20.2	23.6	32.0	30.0	17.7	8.3	11.3	40.2	53.7	23.9	11.7	30.1	20.1	64.7	13.1	7.7	45.3	20.9	0.0	39.4	24.2	27.9	48.5	27.4	54.4	16.0	22.9	20.7	15.6	60.4
OTUD5	"DKFZp761A052, DUBA"	ENSG00000068308	"OTU deubiquitinase 5"	Q96G74	X	48922024-48958386	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Ubl conjugation pathway"	"Hydrolase, Protease, Thiol protease"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Group enriched"	"Detected in all"	10	"U-266/70: 1503.3;U-266/84: 407.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA017375	Approved		Approved	"Nucleoplasm,Nucleoli fibrillar center,Cytosol"		NA	NA			"Cluster 22: NK-cells - Unknown function"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 65: Plasmacytoid DCs - Unknown function"	Cytosol	"Nucleoplasm, Nucleoli fibrillar center"	"HPA017375: AB_1854844"	"unprognostic (9.73e-2)"	"prognostic favorable (9.57e-4)"	"unprognostic (2.67e-2)"	"unprognostic (7.25e-2)"	"unprognostic (1.08e-1)"	"unprognostic (6.65e-2)"	"unprognostic (2.33e-3)"	"prognostic favorable (1.48e-4)"	"unprognostic (1.11e-1)"	"unprognostic (1.14e-1)"	"prognostic favorable (8.20e-4)"	"unprognostic (1.32e-1)"	"unprognostic (3.60e-1)"	"unprognostic (1.19e-1)"	"unprognostic (1.10e-1)"	"unprognostic (4.88e-2)"	"unprognostic (5.05e-3)"	37.7	44.8	42.9	36.9	44.9	56.7	36.6	39.2	45.5	40.6	33.6	45.8	39.6	43.0	29.9	37.5	41.4	24.7	29.9	44.8	46.1	41.1	39.5	39.6	43.4	44.2	42.8	46.8	37.7	35.6	46.1	26.4	46.0	43.1	21.7	30.2	36.3	32.0	39.7	44.6	47.3	27.0	38.3	60.7	37.5	24.2	44.9	47.0	42.3	25.2	35.8	39.9	36.7	43.9	53.0	77.8	36.0	88.9	59.2	52.3	41.4	45.7	52.9	55.9	59.8	39.7	57.3	58.9	29.2	56.8	49.1	63.3	54.2	45.7	51.7	69.1	65.0	44.5	79.4	45.0	49.3	43.4	48.7	58.1	41.2	58.2	39.5	61.4	44.7	47.8	56.9	90.7	40.0	52.3	67.7	89.2	64.9	19.5	60.4	53.0	52.5	77.4	38.9	46.4	34.7	60.7	60.2	38.7	61.7	82.7	51.6	39.2	64.2	36.5	46.2	97.2	38.1	1503.3	407.1	56.5	56.3	58.9	25.7	5.5	3.3	7.6	6.6	5.2	5.6	8.6	5.1	5.7	4.8	5.3	4.8	7.1	8.5	20.3	5.1	6.2	7.3	3.6	42.9	44.9	39.2	45.5	44.8	46.1	44.2	42.8	46.0	38.3	44.9	43.9	21.3	9.6	22.3	17.3	33.3	22.2	21.2	13.7	13.1	35.5	23.7	19.7	11.5	15.7	16.3	27.6	27.1	13.3	38.2	28.4	9.8	13.6	1.9	24.5	23.2	19.6	48.2	32.6	15.5	18.3	16.3	18.4	21.4	33.1	7.0	28.5	22.1	24.3	16.7	28.6	15.7	28.5	10.2	22.9	33.9	2.9	20.8	25.7	26.6	15.9	22.6	18.0	30.9	14.1	14.1	21.5	19.0	23.7	38.1	27.5	28.1	21.7	21.6	27.9	13.1	19.9	20.1	10.4	12.6	15.9	25.6	30.8	33.3	28.6	20.1	27.4
OTUD6A	"DUBA2, FLJ25831, HSHIN6"	ENSG00000189401	"OTU deubiquitinase 6A"	Q7L8S5	X	70062457-70064179	"Enzymes, Predicted intracellular proteins"	"Ubl conjugation pathway"	"Hydrolase, Protease, Thiol protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	8	"testis: 4.8"	"Group enriched"	"Detected in some"	17	"Spermatocytes: 64.1;Spermatogonia: 25.1"	"Cancer enriched"	"Detected in single"	57	"testis cancer: 2.8"	"Not detected"	"Not detected"			"Immune cell enhanced"	"Detected in single"		"basophil: 1.2"	"Lineage enriched"	"Detected in single"	6	"granulocytes: 1.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA053304	Enhanced		Approved	Vesicles,Cytosol		NA	NA			"Cluster 11: Basophils - Unknown function"	"Cluster 78: Testis - Spermatogenesis"		"Cluster 13: Spermatocytes & Spermatogonia - Spermatogenesis"	Cytosol	Vesicles	"HPA053304: AB_2682107"															"unprognostic (1.58e-1)"			0.0	0.0	0.2	0.0	0.2	0.5	0.0	0.5	0.3	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.2	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.1	0.2	0.0	0.0	0.1	0.0	0.1	4.8	0.2	0.0	0.3	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	1.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.6	0.1	0.0	0.1	0.0	0.0	0.2	0.2	0.5	0.3	0.2	0.2	0.2	0.2	0.2	0.1	0.2	0.4	0.1	0.0	0.5	0.0	0.0	0.4	0.1	0.0	0.0	0.5	0.4	0.4	1.2	0.0	0.0	0.0	0.0	0.1	0.2	0.1	0.0	0.0	0.6	0.4	0.3	0.6	0.0	0.0	0.1	0.0	0.1	2.6	0.0	0.3	1.3	0.7	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.6	0.9	0.7	0.3	0.4	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	1.5	0.1	0.3	0.0	0.3	0.0	1.8	0.0	0.4	0.4	64.1	25.1	0.0	0.6	0.3	1.0	0.2	0.0	0.2
OTUD6B	"CGI-77, DUBA5"	ENSG00000155100	"OTU deubiquitinase 6B"	Q8N6M0	8	91070196-91087095	"Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins"	"Ubl conjugation pathway"	"Hydrolase, Protease, Thiol protease"	"Disease variant, Epilepsy, Mental retardation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA024046, HPA024503, HPA024772"	Approved	Approved	Approved	"Nucleoplasm,Golgi apparatus,Cytosol"		NA	NA			"Cluster 40: NK-cells - Unknown function"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 59: Non-specific - Transcription"	"Nucleoplasm, Golgi apparatus, Cytosol"		"HPA024046: AB_10600925, HPA024503: AB_1854845, HPA024772: AB_1854846"	"prognostic unfavorable (7.50e-4)"	"unprognostic (1.28e-1)"	"unprognostic (1.45e-1)"	"unprognostic (4.78e-3)"	"unprognostic (4.91e-2)"	"unprognostic (1.49e-1)"	"unprognostic (1.52e-2)"	"unprognostic (1.16e-3)"	"unprognostic (2.17e-1)"	"unprognostic (5.51e-2)"	"unprognostic (1.27e-2)"	"unprognostic (8.61e-3)"	"unprognostic (1.87e-2)"	"unprognostic (1.96e-1)"	"unprognostic (4.53e-1)"	"unprognostic (8.78e-2)"	"unprognostic (5.71e-2)"	6.6	6.2	5.7	6.3	6.1	5.9	7.2	5.9	8.6	5.2	5.0	5.3	4.2	6.0	4.6	6.4	4.2	3.9	6.5	5.4	6.1	5.4	5.4	4.7	7.4	6.2	6.2	5.3	4.6	4.0	3.5	8.0	6.3	5.8	5.4	3.1	4.3	4.7	10.2	6.4	4.4	5.5	6.3	5.0	4.3	6.4	5.9	5.7	6.0	9.2	6.1	6.3	5.4	7.5	27.6	11.1	12.8	10.4	6.4	5.6	14.5	19.1	7.4	19.1	12.6	8.6	16.6	25.6	9.0	10.2	7.6	9.1	26.4	16.1	31.6	21.6	16.9	34.5	11.7	8.3	13.3	18.7	21.0	7.2	9.8	14.0	35.5	11.6	17.5	19.4	36.5	19.1	18.9	9.6	31.7	17.5	8.1	20.3	27.3	19.4	11.2	28.9	18.9	15.1	3.5	14.6	2.6	55.9	22.7	16.3	25.5	11.8	15.8	12.3	17.2	20.6	20.5	17.1	29.5	37.2	16.8	26.2	23.1	1.7	1.9	1.1	1.5	2.7	2.0	2.0	1.4	1.7	2.6	1.8	2.1	1.9	0.2	3.4	2.1	4.0	0.8	1.0	5.7	6.1	5.9	8.6	5.4	6.1	6.2	6.2	6.3	6.3	5.9	7.5	11.9	9.6	11.3	9.8	13.7	23.2	6.5	4.0	10.8	13.0	6.5	5.2	14.3	8.6	9.2	1.8	33.3	10.8	16.5	5.1	9.8	4.8	0.9	10.6	9.9	10.9	10.8	8.2	18.0	4.9	10.0	9.0	7.7	8.6	18.4	10.7	8.9	11.7	8.1	11.8	15.5	4.9	4.1	8.7	12.5	2.2	9.6	8.3	3.6	12.2	10.2	12.2	11.3	18.6	21.6	6.6	3.7	4.1	12.0	8.9	2.8	8.2	8.8	15.3	0.0	8.2	9.6	3.2	7.0	12.5	18.2	6.7	10.7	9.9	6.4	5.9
OTUD7A	"C15orf16, CEZANNE2, OTUD7"	ENSG00000169918	"OTU deubiquitinase 7A"	Q8TE49	15	31475398-31870789	"Cancer-related genes, Enzymes, Predicted intracellular proteins"	"Ubl conjugation pathway"	"Hydrolase, Protease, Thiol protease"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"brain: 20.5"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 135.2;Excitatory neurons: 303.6;Inhibitory neurons: 219.7;Oligodendrocyte precursor cells: 100.0;Oligodendrocytes: 506.1"	"Low cancer specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AN3-CA: 1.7;HAP1: 1.0;SCLC-21H: 3.6;SH-SY5Y: 1.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA044554			Approved	Nucleoli,Cytosol		NA	NA				"Cluster 70: Brain - Nervous system development"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	"Nucleoli, Cytosol"		"HPA044554: AB_10794895"	"unprognostic (3.61e-2)"	"unprognostic (1.35e-3)"	"unprognostic (1.39e-1)"	"unprognostic (1.25e-3)"	"unprognostic (1.29e-1)"	"unprognostic (1.03e-4)"	"unprognostic (1.50e-1)"	"unprognostic (1.21e-1)"	"unprognostic (1.38e-1)"	"unprognostic (1.67e-1)"	"unprognostic (3.24e-3)"	"unprognostic (1.34e-1)"	"unprognostic (1.79e-11)"	"unprognostic (6.78e-2)"	"unprognostic (2.76e-1)"	"unprognostic (8.27e-2)"	"unprognostic (1.79e-1)"	1.2	0.5	6.6	0.4	9.5	0.0	1.0	7.6	8.6	1.3	0.0	1.4	0.3	1.3	0.5	0.7	1.1	0.3	1.3	6.9	5.9	0.9	0.4	0.8	0.4	8.5	6.9	0.9	1.4	1.2	1.5	0.0	8.2	0.6	0.4	1.6	0.7	0.4	1.1	2.6	0.9	0.6	5.6	0.6	0.8	4.1	8.3	0.3	1.0	0.2	0.4	0.8	0.8	20.5	0.0	0.0	0.1	1.7	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.0	0.0	0.0	0.4	0.8	0.0	0.2	0.1	0.0	0.0	0.7	0.1	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.5	0.0	0.0	0.3	0.5	0.0	0.0	0.1	3.6	1.8	0.5	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	6.6	9.5	7.6	8.6	6.9	5.9	8.5	6.9	8.2	5.6	8.3	20.5	3.5	3.2	0.0	135.2	0.1	0.4	0.7	0.0	1.8	25.7	1.1	1.3	3.2	0.0	0.6	1.8	2.1	0.0	4.3	1.3	0.0	0.5	1.4	0.4	1.2	1.3	3.6	0.0	303.6	1.0	0.1	1.8	0.5	0.4	0.0	1.0	1.4	0.8	0.2	25.2	219.7	1.7	0.0	0.0	0.3	2.0	0.9	0.3	1.8	28.1	0.2	3.9	13.4	100.0	506.1	0.3	0.7	2.6	2.6	1.9	0.4	1.7	0.0	3.1	0.0	4.1	1.5	4.6	8.3	1.8	0.4	0.1	3.1	0.9	1.5	1.0
OTUD7B	"CEZANNE, ZA20D1"	ENSG00000264522	"OTU deubiquitinase 7B"	Q6GQQ9	1	149937812-150010726	"Enzymes, Predicted intracellular proteins"	"Adaptive immunity, Immunity, Ubl conjugation pathway"	"Hydrolase, Protease, Thiol protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 43.0"	"Cell type enhanced"	"Detected in many"		"Cone photoreceptor cells: 106.3;Oligodendrocytes: 176.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"basophil: 2.0"	"Low lineage specificity"	"Detected in single"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA027045, HPA076357"	Supported		Uncertain	"Microtubules,Cytokinetic bridge,Mitotic spindle"		Yes	NA			"Cluster 41: Basophils - Cellular respiration"	"Cluster 70: Brain - Nervous system development"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 9: Photoreceptor cells - Phototransduction"	Microtubules	"Cytokinetic bridge, Mitotic spindle"	"HPA027045: AB_1854847, HPA076357: "	"unprognostic (2.17e-2)"	"unprognostic (2.93e-2)"	"unprognostic (1.90e-1)"	"prognostic favorable (7.47e-4)"	"unprognostic (1.51e-1)"	"unprognostic (1.05e-1)"	"unprognostic (1.23e-3)"	"unprognostic (1.46e-2)"	"prognostic favorable (5.09e-5)"	"unprognostic (4.90e-2)"	"unprognostic (7.72e-2)"	"unprognostic (8.94e-2)"	"unprognostic (3.37e-2)"	"unprognostic (1.67e-2)"	"unprognostic (1.18e-1)"	"unprognostic (4.52e-2)"	"unprognostic (1.58e-2)"	11.7	7.7	21.0	3.8	39.2	1.1	7.8	28.7	18.5	9.9	6.8	7.6	6.2	10.5	3.8	7.7	9.3	4.8	7.1	15.3	22.1	5.6	10.7	7.3	1.9	41.4	37.2	10.9	6.1	10.9	3.4	7.1	35.5	6.6	7.1	10.1	7.8	7.5	18.6	5.8	6.2	10.8	27.9	3.6	6.7	12.7	31.7	2.1	6.7	16.2	3.2	6.3	5.2	43.0	17.2	13.5	9.3	15.6	12.0	11.1	8.8	11.8	17.3	14.0	9.6	10.0	13.6	0.2	7.5	21.7	6.3	13.4	13.2	13.1	14.6	16.5	6.7	6.6	18.9	6.8	12.8	7.6	6.9	12.4	9.9	23.7	20.6	10.9	11.5	2.0	18.4	18.1	10.1	17.5	1.3	2.1	11.9	12.8	13.1	1.8	12.9	4.4	5.4	23.2	6.0	11.4	20.8	15.2	18.5	12.1	12.6	4.0	13.9	14.4	13.2	9.8	14.0	19.1	20.0	2.0	12.8	2.2	24.1	2.0	0.0	0.4	0.7	0.0	0.5	0.1	0.3	0.4	0.0	0.1	0.2	0.3	0.3	0.4	0.0	0.1	0.1	0.0	21.0	39.2	28.7	18.5	15.3	22.1	41.4	37.2	35.5	27.9	31.7	43.0	10.2	35.3	11.7	56.8	3.0	15.9	22.7	8.7	13.1	28.0	18.3	9.3	22.2	12.8	15.3	11.0	106.3	23.5	5.1	41.1	7.9	14.5	63.4	21.8	17.8	16.7	17.4	14.9	20.6	11.1	11.6	14.8	21.4	40.2	0.0	22.0	20.3	33.0	3.1	23.5	24.6	15.8	8.2	0.8	5.9	79.4	14.6	2.4	37.4	22.5	4.3	23.6	15.5	33.2	176.8	20.6	21.3	23.0	4.7	20.2	17.1	11.5	17.4	66.9	0.0	19.8	17.9	11.1	7.2	11.8	16.6	21.2	7.5	11.1	11.1	34.0
OTULIN	"FAM105B, FLJ34884"	ENSG00000154124	"OTU deubiquitinase with linear linkage specificity"	Q96BN8	5	14664664-14699850	"Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins"	"Angiogenesis, Immunity, Innate immunity, Ubl conjugation pathway, Wnt signaling pathway"	"Hydrolase, Protease, Thiol protease"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 26.8"	"Cell type enhanced"	"Detected in many"		"dendritic cells: 70.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA051074	Uncertain		Approved	"Plasma membrane,Mitochondria"		NA	NA			"Cluster 26: Non-specific - Mitochondria"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 20: HeLa - Mitochondria"	"Cluster 24: Non-specific - Transcription regulation"	Mitochondria	"Plasma membrane"	"HPA051074: AB_2681334"	"unprognostic (4.81e-3)"	"unprognostic (1.11e-1)"	"unprognostic (4.00e-2)"	"unprognostic (1.19e-2)"	"unprognostic (7.48e-2)"	"unprognostic (1.91e-2)"	"unprognostic (7.94e-3)"	"unprognostic (1.43e-1)"	"unprognostic (2.48e-2)"	"unprognostic (9.55e-2)"	"unprognostic (1.02e-1)"	"unprognostic (7.13e-2)"	"prognostic unfavorable (2.59e-7)"	"unprognostic (2.92e-2)"	"unprognostic (2.28e-2)"	"unprognostic (1.60e-1)"	"unprognostic (5.02e-2)"	5.0	3.9	4.8	9.6	6.3	26.8	4.6	5.9	4.9	5.5	6.2	4.7	7.6	3.6	2.6	8.0	3.5	4.7	6.7	4.9	5.0	4.4	12.3	6.4	12.5	6.6	5.6	4.8	6.8	3.8	3.6	6.5	6.4	6.3	4.6	4.6	5.7	3.3	5.2	11.8	5.8	4.8	5.6	7.1	4.3	7.1	5.8	11.2	4.1	5.5	13.5	5.7	6.9	7.1	10.0	11.5	11.2	12.8	10.0	10.3	12.3	9.8	6.9	13.8	10.2	15.4	7.2	18.0	18.9	6.4	19.9	11.1	14.1	12.9	9.2	31.1	11.6	12.9	36.3	8.3	8.8	12.4	21.2	6.0	15.2	11.3	9.4	7.6	11.8	14.9	13.0	27.8	10.0	6.1	12.4	10.6	6.9	10.5	12.0	18.8	10.0	7.1	8.9	10.1	5.1	8.3	35.1	7.8	7.6	13.5	8.5	14.1	11.1	17.8	20.0	13.4	13.2	12.4	20.6	20.3	10.1	23.2	9.3	0.2	0.6	1.1	0.3	0.7	1.0	0.3	0.8	1.1	1.0	1.6	0.5	1.3	0.7	0.3	1.1	0.8	1.7	0.3	4.8	6.3	5.9	4.9	4.9	5.0	6.6	5.6	6.4	5.6	5.8	7.1	20.3	3.2	11.5	23.5	24.6	0.0	23.2	0.0	26.2	11.9	12.8	11.7	15.0	10.0	4.3	5.5	14.6	15.1	70.6	21.1	7.9	5.5	9.4	20.6	28.1	13.3	9.5	13.7	18.5	5.8	10.3	10.1	16.8	24.0	10.2	14.0	6.4	36.9	13.9	8.4	19.5	15.7	0.0	18.9	0.0	4.2	10.5	25.0	0.0	38.4	17.1	10.4	26.8	16.6	31.7	8.0	13.3	6.4	38.5	25.9	14.1	15.1	5.1	31.4	0.0	11.5	10.2	29.7	28.8	23.7	0.0	14.2	35.8	7.6	15.6	23.1
PADI1	"HPAD10, PAD1, PDI, PDI1"	ENSG00000142623	"Peptidyl arginine deiminase 1"	Q9ULC6	1	17205128-17246007	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	6	"esophagus: 109.5"	"Cell type enhanced"	"Detected in some"		"Cardiomyocytes: 14.8;Extravillous trophoblasts: 14.0;Squamous epithelial cells: 5.6;Urothelial cells: 22.5"	"Cancer enhanced"	"Detected in many"		"pancreatic cancer: 13.5"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"CAPAN-2: 4.2;EFO-21: 2.1;HaCaT: 1.5;RPTEC TERT1: 1.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA062294	Enhanced		Approved	Nucleoplasm,Cytosol		NA	NA				"Cluster 84: Esophagus - Epithelial cell function"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 22: Epithelial cell types - Mixed function"	Cytosol	Nucleoplasm	"HPA062294: AB_2684741"	"unprognostic (9.30e-2)"	"unprognostic (2.44e-1)"	"unprognostic (6.15e-2)"	"unprognostic (1.40e-1)"	"unprognostic (5.22e-2)"	"unprognostic (7.27e-2)"	"unprognostic (3.84e-1)"	"unprognostic (3.37e-2)"	"unprognostic (1.41e-1)"	"unprognostic (7.75e-2)"	"unprognostic (1.01e-3)"	"unprognostic (3.64e-2)"	"prognostic unfavorable (8.34e-11)"	"unprognostic (2.00e-1)"	"unprognostic (3.12e-1)"	"unprognostic (1.07e-1)"	"unprognostic (1.15e-1)"	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.2	0.0	0.0	0.0	0.1	0.0	109.5	0.0	0.0	0.0	0.0	0.1	0.1	1.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	1.0	0.1	0.2	0.0	0.0	11.5	0.0	0.0	4.1	0.0	0.0	0.0	0.1	0.1	0.1	0.0	0.0	0.0	0.0	4.4	1.4	18.0	0.0	0.1	0.6	0.0	0.0	0.0	0.0	0.4	0.1	0.0	0.0	0.0	0.0	4.2	0.0	2.1	0.1	0.1	1.5	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.6	0.1	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.7	0.6	0.9	0.0	0.0	14.8	0.0	3.9	0.0	0.0	0.2	0.0	0.6	0.0	0.6	0.0	0.1	0.1	0.5	0.0	0.0	0.0	0.0	14.0	0.3	0.0	0.4	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.4	2.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.8	0.5	0.0	0.0	0.8	0.0	0.0	0.6	0.3	0.0	0.0	0.3	0.2	0.1	5.6	0.0	0.7	0.0	0.1	0.6	22.5
PADI2	"KIAA0994, PDI2"	ENSG00000117115	"Peptidyl arginine deiminase 2"	Q9Y2J8	1	17066761-17119451	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 240.6;skeletal muscle: 311.8;tongue: 492.3"	"Cell type enhanced"	"Detected in many"		"Cone photoreceptor cells: 95.9;Distal enterocytes: 178.7;Intestinal goblet cells: 77.3;Oligodendrocytes: 117.1;Paneth cells: 72.3"	"Cancer enhanced"	"Detected in many"		"glioma: 24.7"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	4	"eosinophil: 43.3;neutrophil: 100.6"	"Lineage enriched"	"Detected in many"	6	"granulocytes: 100.6"	"Cell line enhanced"	"Detected in some"		"A549: 11.6;RPTEC TERT1: 33.1;SK-BR-3: 50.7;T-47d: 13.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA047735	Enhanced					NA	NA			"Cluster 5: Granulocytes - Unknown function"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 53: Intestinal epithelial cells - Unknown function"			"HPA047735: AB_2680139"	"unprognostic (2.61e-2)"	"unprognostic (3.60e-2)"	"unprognostic (8.94e-3)"	"unprognostic (1.57e-1)"	"unprognostic (2.33e-2)"	"unprognostic (2.44e-1)"	"unprognostic (1.49e-1)"	"unprognostic (3.74e-3)"	"unprognostic (2.78e-3)"	"unprognostic (3.28e-3)"	"unprognostic (1.29e-1)"	"unprognostic (3.07e-1)"	"unprognostic (2.87e-1)"	"unprognostic (3.64e-2)"	"unprognostic (3.15e-1)"	"unprognostic (2.27e-1)"	"unprognostic (5.91e-3)"	2.1	0.9	85.9	9.3	161.5	23.7	41.1	164.3	103.9	3.3	33.5	89.8	1.4	0.8	0.6	6.1	2.7	1.6	0.6	82.2	165.1	12.7	0.7	4.4	1.0	205.8	167.0	0.2	1.5	2.1	3.7	1.4	212.0	2.6	92.3	50.5	44.4	1.6	311.8	9.6	8.4	5.8	189.3	13.4	2.2	0.8	144.3	2.1	0.6	492.3	1.3	2.5	1.0	240.6	0.0	11.6	0.1	0.0	0.0	0.0	0.7	0.3	0.0	0.1	0.1	0.1	4.9	0.2	1.5	0.5	0.1	1.6	0.4	0.1	0.3	0.0	0.8	0.5	0.0	0.0	0.0	0.7	3.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.2	0.9	3.8	0.6	1.4	1.6	3.9	0.0	0.0	0.0	0.4	33.1	0.0	2.1	0.2	0.0	50.7	0.0	2.7	13.9	2.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.3	1.9	0.0	1.3	16.2	43.3	0.0	0.9	0.0	0.0	0.0	0.0	11.7	0.0	0.0	0.0	100.6	0.0	0.2	0.4	0.0	6.4	85.9	161.5	164.3	103.9	82.2	165.1	205.8	167.0	212.0	189.3	144.3	240.6	0.2	0.0	1.3	28.4	1.0	0.3	0.4	0.6	0.0	2.2	31.2	32.5	0.4	0.0	3.3	1.8	95.9	0.2	0.7	178.7	11.7	0.6	6.1	0.0	0.0	8.2	3.6	0.0	1.5	0.0	0.5	0.6	0.0	0.1	17.1	0.5	0.7	0.0	7.2	0.0	1.4	77.3	2.0	4.8	25.8	10.3	0.3	9.2	28.4	15.9	33.8	33.6	0.0	13.6	117.1	0.0	72.3	0.7	0.4	0.5	15.0	0.3	0.2	29.6	0.0	5.6	1.3	0.2	0.4	0.0	0.4	0.1	0.4	0.0	51.8	0.2
PADI3	PDI3	ENSG00000142619	"Peptidyl arginine deiminase 3"	Q9ULW8	1	17249098-17284233	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"		Hydrolase	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	6	"esophagus: 17.0;urinary bladder: 25.6"	"Cell type enhanced"	"Detected in some"		"Collecting duct cells: 1.8;Ionocytes: 6.1;Squamous epithelial cells: 1.1;Urothelial cells: 7.9"	"Cancer enriched"	"Detected in many"	4	"urothelial cancer: 48.6"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"EFO-21: 14.0;RT4: 17.4;T-47d: 12.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA043739	Uncertain		Approved	Nucleoplasm,Vesicles		NA	NA				"Cluster 84: Esophagus - Epithelial cell function"	"Cluster 15: RT4 - Unknown function"	"Cluster 22: Epithelial cell types - Mixed function"	Vesicles	Nucleoplasm	"HPA043739: AB_10959466"	"unprognostic (4.47e-2)"	"unprognostic (9.32e-2)"	"unprognostic (1.50e-1)"	"prognostic unfavorable (3.22e-4)"	"unprognostic (1.05e-3)"	"unprognostic (6.66e-2)"	"unprognostic (3.10e-3)"	"unprognostic (5.88e-2)"	"unprognostic (2.06e-4)"	"unprognostic (1.03e-1)"	"unprognostic (3.47e-4)"	"unprognostic (1.76e-1)"	"prognostic unfavorable (1.55e-11)"	"unprognostic (2.40e-2)"	"unprognostic (4.73e-3)"		"unprognostic (2.64e-2)"	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.5	17.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.3	0.0	0.0	0.9	3.4	0.0	3.7	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.4	25.6	3.6	0.0	0.0	3.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	14.0	0.0	1.4	0.3	0.0	2.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	1.7	0.0	0.0	0.0	0.0	0.1	0.6	0.0	0.0	0.0	0.0	0.0	0.0	2.3	0.0	0.0	17.4	0.0	0.0	0.0	2.5	0.1	0.1	12.8	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	3.8	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.3	0.0	0.0	0.0	0.0	0.3	0.0	0.2	1.8	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	6.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.1	1.1	0.0	0.0	0.0	0.2	0.0	7.9
PADI4	"PAD, PADI5, PDI4, PDI5"	ENSG00000159339	"Peptidyl arginine deiminase 4"	Q9UM07	1	17308195-17364004	"Disease related genes, Enzymes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Immunity, Innate immunity, Transcription, Transcription regulation"	"Chromatin regulator, Hydrolase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	9	"bone marrow: 105.1;lymphoid tissue: 29.9"	"Cell type enhanced"	"Detected in some"		"dendritic cells: 8.3;granulocytes: 12.6;Macrophages: 14.6;monocytes: 22.3;NK-cells: 20.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	8	"basophil: 79.9;classical monocyte: 71.3;eosinophil: 97.5;neutrophil: 183.0"	"Group enriched"	"Detected in all"	9	"granulocytes: 183.0;monocytes: 71.3"	"Cell line enhanced"	"Detected in some"		"HEL: 1.2;RPMI-8226: 1.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA017007, HPA042825"	Enhanced					NA	NA		29000	"Cluster 5: Granulocytes - Unknown function"	"Cluster 67: Neutrophils - Humoral immune response"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 19: Monocytes & Neutrophils - Innate immune response"			"HPA017007: AB_1854921, HPA042825: AB_2678189"	"unprognostic (1.70e-1)"	"unprognostic (2.25e-1)"	"unprognostic (2.23e-1)"	"unprognostic (2.98e-1)"	"unprognostic (1.27e-1)"	"unprognostic (1.13e-2)"	"unprognostic (1.47e-1)"	"unprognostic (4.91e-2)"	"unprognostic (8.49e-2)"	"unprognostic (5.22e-2)"	"unprognostic (8.55e-2)"	"unprognostic (1.81e-1)"	"unprognostic (1.66e-3)"	"unprognostic (1.50e-1)"	"unprognostic (1.28e-1)"	"unprognostic (1.56e-2)"	"unprognostic (1.80e-1)"	1.8	0.1	0.2	0.7	0.4	105.1	0.3	0.2	0.8	0.1	0.2	0.1	0.1	0.1	0.0	0.4	1.0	0.4	1.1	0.3	0.2	0.5	1.7	7.9	0.3	0.3	0.1	0.1	0.3	0.0	0.2	0.5	0.3	0.2	0.0	0.0	0.2	0.0	0.2	0.2	0.2	0.4	0.0	29.9	0.4	0.1	0.1	1.6	0.3	0.3	0.2	0.7	0.3	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.1	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	79.9	71.3	97.5	0.4	5.7	0.2	1.1	0.5	0.7	13.9	1.8	2.6	4.5	183.0	4.5	1.8	6.2	0.4	35.8	0.2	0.4	0.2	0.8	0.3	0.2	0.3	0.1	0.3	0.0	0.1	0.4	0.0	0.0	3.7	0.0	2.9	0.0	0.1	0.0	0.0	0.0	0.3	0.1	0.4	0.0	0.0	0.0	0.0	0.0	8.3	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	1.3	0.6	0.0	0.6	0.6	0.0	0.0	12.6	0.1	0.0	0.4	0.2	0.0	0.4	0.0	0.0	3.3	0.4	0.2	0.0	14.6	0.0	0.0	22.3	0.0	20.6	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.6	4.0	0.0	0.0	0.1	2.3	0.1	0.0	0.0
PADI6		ENSG00000276747	"Peptidyl arginine deiminase 6"	Q6TGC4	1	17372196-17401699	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"		Hydrolase	"Disease variant"	"Evidence at protein level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Evidence at protein level"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in single"		"NK-cells: 1.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enhanced"	"Detected in single"		"white matter: 2.4"	"Not detected"	"Not detected"									NA	NA			"Cluster 28: Myeloid DCs - Unknown function"			"Cluster 63: NK-cells & T-cells - Immune response"				"unprognostic (1.19e-1)"					"unprognostic (4.36e-2)"			"unprognostic (3.02e-2)"				"unprognostic (6.56e-2)"		"unprognostic (1.23e-1)"			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.5	0.0	0.0	0.0	0.0	0.3	0.9	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.4	0.0	0.0	0.7	0.0	1.0	0.0	0.1	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0
PAFAH1B2		ENSG00000168092	"Platelet activating factor acetylhydrolase 1b catalytic subunit 2"	P68402	11	117144284-117176894	"Cancer-related genes, Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Lipid degradation, Lipid metabolism"	Hydrolase	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA051836	Approved		Supported	"Nucleoli,Plasma membrane,Cytosol"		NA	NA		250000	"Cluster 49: Eosinophils - Unknown function"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 65: Plasmacytoid DCs - Unknown function"	Cytosol	"Nucleoli, Plasma membrane"	"HPA051836: AB_2681630"	"unprognostic (1.08e-2)"	"unprognostic (3.14e-2)"	"unprognostic (2.07e-2)"	"unprognostic (3.88e-2)"	"unprognostic (9.94e-2)"	"unprognostic (1.21e-3)"	"prognostic unfavorable (9.44e-4)"	"prognostic unfavorable (3.07e-4)"	"unprognostic (1.01e-1)"	"prognostic favorable (4.25e-4)"	"prognostic unfavorable (7.79e-5)"	"unprognostic (8.18e-2)"	"unprognostic (1.11e-2)"	"unprognostic (9.97e-2)"	"unprognostic (3.25e-1)"	"unprognostic (2.46e-1)"	"unprognostic (1.34e-1)"	23.1	34.3	35.1	21.2	42.2	41.2	20.6	43.9	45.0	20.8	28.4	21.7	22.4	23.8	22.7	23.9	20.9	19.9	28.2	33.9	45.4	25.3	23.8	21.7	20.7	47.6	45.0	23.3	20.3	21.9	24.5	25.4	51.0	22.3	20.0	23.2	17.4	16.1	15.7	22.0	19.4	20.4	48.7	20.4	23.0	30.0	43.6	21.5	31.9	20.3	22.2	26.9	20.9	51.6	43.4	48.5	54.9	79.7	60.1	41.7	42.6	71.0	61.7	38.8	35.2	89.2	92.9	46.6	99.4	85.8	38.7	67.7	80.6	92.0	50.9	41.8	31.1	120.0	41.3	57.9	53.8	42.1	44.0	46.6	71.7	77.4	96.7	42.4	64.8	25.6	65.0	34.6	60.3	27.7	40.8	61.7	50.4	60.0	37.8	44.9	62.2	51.2	59.8	66.7	60.9	80.5	82.2	61.6	28.1	46.6	68.4	35.6	103.8	70.4	46.3	34.8	51.4	10.8	17.9	61.5	28.3	78.8	60.4	63.4	51.4	48.6	39.0	58.7	46.4	43.8	44.7	41.0	37.4	41.2	45.8	49.2	63.7	33.1	66.3	27.4	35.1	53.1	35.1	42.2	43.9	45.0	33.9	45.4	47.6	45.0	51.0	48.7	43.6	51.6	48.5	28.9	34.8	17.9	41.4	122.4	44.5	45.9	54.7	38.6	55.4	32.1	37.6	58.6	32.8	66.2	47.9	40.4	44.4	48.0	46.9	61.3	13.1	63.6	54.8	64.8	82.6	39.4	29.2	39.5	86.7	40.8	33.6	78.4	19.0	36.8	79.6	47.0	43.0	47.1	32.5	41.8	36.7	65.4	175.9	13.7	45.4	52.1	49.8	20.6	59.3	36.2	21.6	13.0	61.2	99.0	50.5	34.3	28.9	67.0	33.7	54.8	32.9	38.3	13.1	42.8	40.0	54.7	84.7	53.2	115.9	54.6	41.6	35.2	45.4	50.6
PAFAH1B3		ENSG00000079462	"Platelet activating factor acetylhydrolase 1b catalytic subunit 3"	Q15102	19	42297033-42303546	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Lipid degradation, Lipid metabolism"	Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Spermatogonia: 188.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA035639	Uncertain		Approved	"Intermediate filaments"		NA	NA		290000	"Cluster 26: Non-specific - Mitochondria"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 10: Non-specific - Unknown function"	"Intermediate filaments"		"HPA035639: AB_10670163"	"unprognostic (3.19e-1)"	"unprognostic (5.38e-3)"	"unprognostic (1.13e-1)"	"unprognostic (5.99e-2)"	"unprognostic (1.83e-1)"	"unprognostic (2.09e-2)"	"prognostic unfavorable (8.74e-4)"	"unprognostic (1.73e-1)"	"unprognostic (2.67e-1)"	"unprognostic (6.36e-2)"	"unprognostic (2.37e-1)"	"unprognostic (7.67e-2)"	"prognostic unfavorable (2.07e-4)"	"unprognostic (2.68e-1)"	"unprognostic (3.21e-2)"	"unprognostic (4.56e-2)"	"unprognostic (6.80e-3)"	8.3	23.5	34.7	12.4	35.4	27.9	13.7	36.5	44.1	18.9	31.3	16.8	12.4	13.8	12.9	28.1	14.8	10.8	4.6	35.1	39.9	21.8	7.9	9.2	17.0	32.2	33.1	18.3	18.1	13.8	21.2	5.9	34.4	15.2	12.1	13.0	17.0	6.3	13.5	13.6	14.7	7.5	32.0	16.0	15.9	23.7	42.9	37.6	9.3	5.2	18.3	14.1	16.6	32.5	111.9	200.2	127.5	135.8	2.6	6.7	38.1	27.9	39.2	91.9	94.4	67.7	94.7	70.0	34.8	35.0	63.7	37.1	58.9	75.2	38.3	105.7	77.0	85.8	52.7	91.8	19.3	54.4	90.3	19.9	33.9	56.5	26.3	50.7	41.3	152.5	58.5	81.9	67.9	162.5	124.2	42.4	70.3	138.3	0.2	90.0	47.9	62.0	76.4	117.7	144.8	109.9	44.6	89.4	47.0	40.4	111.4	62.1	22.3	74.8	98.5	6.7	77.3	38.0	84.9	60.6	41.3	87.4	65.8	23.2	27.5	15.7	23.4	22.3	31.2	38.3	32.8	26.7	51.1	48.2	43.3	30.6	3.4	18.2	12.0	27.8	58.1	21.0	34.7	35.4	36.5	44.1	35.1	39.9	32.2	33.1	34.4	32.0	42.9	32.5	18.8	16.0	11.2	3.6	26.1	28.2	45.7	82.7	46.1	26.5	67.9	83.2	2.3	30.0	41.6	33.1	14.6	38.6	13.2	39.1	80.3	112.9	16.7	30.4	12.4	24.4	58.9	53.0	3.0	55.3	44.9	21.7	38.7	33.1	27.9	71.4	17.9	10.3	62.7	11.8	5.4	54.0	87.5	28.2	33.5	27.0	13.7	21.8	46.2	1.0	18.2	33.7	11.3	3.0	3.6	81.5	36.1	9.1	37.3	31.0	30.9	63.7	35.0	19.8	0.0	3.6	52.6	5.6	188.8	59.0	17.8	13.5	24.6	46.2	74.3	58.9
PAFAH2	HSD-PLA2	ENSG00000158006	"Platelet activating factor acetylhydrolase 2"	Q99487	1	25959767-25998117	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Lipid degradation, Lipid metabolism"	"Hydrolase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 48.7"	"Cell type enhanced"	"Detected in all"		"Proximal enterocytes: 43.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HMC-1: 52.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA018157	Approved					NA	Yes			"Cluster 2: Granulocytes - Unknown function"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 63: NK-cells & T-cells - Immune response"			"HPA018157: AB_1854928"	"unprognostic (9.89e-2)"	"unprognostic (2.60e-1)"	"unprognostic (3.63e-3)"	"prognostic favorable (3.28e-6)"	"unprognostic (5.19e-2)"	"unprognostic (2.12e-1)"	"unprognostic (1.05e-1)"	"unprognostic (1.78e-1)"	"unprognostic (2.43e-1)"	"unprognostic (1.04e-1)"	"unprognostic (4.46e-2)"	"unprognostic (2.62e-1)"	"prognostic favorable (0.00e+0)"	"unprognostic (8.15e-2)"	"unprognostic (8.17e-2)"	"unprognostic (1.59e-2)"	"unprognostic (7.27e-2)"	4.6	7.3	4.7	6.5	6.5	6.8	9.2	6.3	6.0	8.8	6.7	16.3	17.4	4.9	9.9	7.8	8.3	10.4	9.7	4.5	5.8	19.3	18.3	8.6	8.4	6.4	6.5	4.7	31.2	22.9	5.9	9.2	6.5	8.8	16.6	14.1	10.0	6.3	18.0	11.4	19.0	6.9	5.5	7.6	15.6	7.7	6.5	48.7	16.4	10.7	7.4	7.0	5.5	8.2	8.6	10.7	6.7	7.6	13.9	10.9	13.7	9.6	5.0	8.6	5.7	4.4	18.1	3.8	11.7	5.7	8.1	7.5	10.1	9.3	11.0	7.8	6.1	6.3	4.6	8.8	8.4	3.3	52.5	7.2	21.2	13.2	8.7	4.7	8.3	8.9	8.9	7.1	11.7	3.8	10.3	3.3	13.4	29.9	5.9	8.4	6.3	8.7	13.9	3.0	8.0	6.8	5.7	7.7	18.2	11.0	12.7	6.0	7.8	5.9	7.4	12.5	7.7	13.0	18.1	4.8	12.5	13.2	20.0	36.2	6.7	60.2	23.7	6.4	15.3	3.5	8.3	15.4	5.0	4.4	10.6	14.9	5.8	17.4	2.4	39.0	9.0	8.7	4.7	6.5	6.3	6.0	4.5	5.8	6.4	6.5	6.5	5.5	6.5	8.2	4.6	16.0	12.8	9.8	3.2	1.5	2.1	5.3	1.8	9.5	9.4	4.8	6.8	11.5	11.9	18.4	27.1	11.2	37.7	34.9	3.9	11.1	1.1	8.6	4.5	5.6	7.8	3.2	4.0	7.3	9.5	3.5	12.2	13.2	27.8	7.3	5.7	21.4	11.2	5.0	3.6	18.2	4.1	11.6	1.6	1.0	2.5	7.1	8.8	5.6	7.3	6.3	23.7	4.0	10.0	10.6	15.8	2.6	6.5	4.2	43.1	18.3	8.9	8.8	6.6	5.3	4.1	19.9	8.9	4.5	3.8	10.0	9.0	4.4	19.4	4.9
PAN2	"hPAN2, KIAA0710, USP52"	ENSG00000135473	"Poly(A) specific ribonuclease subunit PAN2"	Q504Q3	12	56316223-56334053	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"mRNA processing"	"Exonuclease, Hydrolase, Nuclease"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"									NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 52: Non-specific - Transcription"				"unprognostic (2.43e-1)"	"unprognostic (3.78e-1)"	"unprognostic (1.21e-2)"	"unprognostic (2.55e-1)"	"unprognostic (1.67e-1)"	"unprognostic (9.10e-3)"	"unprognostic (1.03e-1)"	"unprognostic (7.28e-2)"	"unprognostic (7.35e-3)"	"unprognostic (3.80e-1)"	"unprognostic (1.74e-3)"	"unprognostic (4.23e-3)"	"prognostic unfavorable (2.77e-4)"	"unprognostic (4.19e-1)"	"unprognostic (3.87e-1)"	"unprognostic (2.10e-1)"	"unprognostic (2.68e-2)"	6.6	8.7	4.2	5.8	6.1	7.4	7.4	6.0	6.0	8.3	6.9	8.0	9.9	9.1	14.1	5.0	9.7	6.6	7.1	4.1	4.5	7.6	16.0	7.3	8.5	5.3	5.2	12.7	10.0	14.1	11.6	8.2	5.4	6.7	8.2	16.0	7.9	8.2	6.9	8.3	8.7	7.5	4.7	10.1	9.5	13.5	5.7	16.8	14.8	6.7	10.0	7.0	6.7	7.9	4.3	6.4	15.5	4.9	13.3	15.0	10.1	3.2	4.4	7.1	3.2	3.9	8.3	11.8	12.2	6.3	3.8	8.8	18.6	12.3	4.0	5.2	8.8	15.1	6.6	3.8	11.7	3.3	7.8	14.0	16.3	7.6	22.0	18.7	5.4	24.2	10.3	28.4	4.2	9.4	11.3	7.9	5.2	7.2	4.2	9.7	11.0	21.5	7.0	3.4	12.1	11.0	6.2	7.9	8.0	17.2	10.2	6.4	2.3	7.0	7.0	3.3	3.0	23.9	10.3	7.8	8.7	6.8	6.2	3.2	3.3	1.3	1.3	4.4	1.9	1.6	1.1	1.9	4.2	1.3	2.2	2.7	0.2	2.3	2.2	1.7	1.7	2.0	4.2	6.1	6.0	6.0	4.1	4.5	5.3	5.2	5.4	4.7	5.7	7.9	9.7	9.6	17.0	19.2	11.1	5.1	5.4	3.8	6.8	27.4	9.5	10.2	9.8	2.8	8.3	5.5	27.1	8.2	7.9	5.4	1.9	3.7	1.8	8.6	9.4	9.4	14.4	13.3	11.0	2.2	4.8	7.2	18.3	13.7	6.3	15.0	10.4	18.3	5.4	15.2	13.9	10.8	4.1	7.0	5.0	2.6	11.1	8.2	1.8	9.4	5.2	7.3	3.1	10.1	32.1	2.8	8.7	6.4	9.2	4.1	7.3	3.5	13.4	17.1	6.6	11.4	6.9	26.9	7.6	7.1	3.8	5.1	6.6	12.6	9.5	3.6
PAPPA	"ASBABP2, DIPLA1, IGFBP-4ase, PAPA, PAPP-A, PAPPA1"	ENSG00000182752	"Pappalysin 1"	Q13219	9	116153791-116402321	"Cancer-related genes, Candidate cardiovascular disease genes, Enzymes, Plasma proteins, Predicted secreted proteins"		"Hydrolase, Metalloprotease, Protease"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	8	"placenta: 72.3"	"Cell type enhanced"	"Detected in many"		"Basal squamous epithelial cells: 92.2;Collecting duct cells: 165.5;Endometrial stromal cells: 101.3;Proximal tubular cells: 51.5"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"ASC diff: 50.0;ASC TERT1: 37.8;HSkMC: 137.4;U-138 MG: 36.3"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in many"			"HPA001667, CAB016724"	Enhanced				"Secreted in female reproductive system"	NA	NA		78000000		"Cluster 28: Placenta - Pregnancy"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 36: Stromal cells - Cell proliferation"			"CAB016724: , HPA001667: AB_1854960"	"unprognostic (3.25e-1)"	"unprognostic (6.18e-6)"	"unprognostic (2.47e-1)"	"unprognostic (6.49e-2)"	"unprognostic (2.01e-2)"	"unprognostic (1.14e-1)"	"unprognostic (1.13e-1)"	"unprognostic (5.42e-3)"	"unprognostic (5.44e-2)"	"unprognostic (3.87e-2)"	"unprognostic (6.87e-3)"	"unprognostic (8.25e-2)"	"unprognostic (8.00e-3)"	"unprognostic (2.37e-3)"	"unprognostic (2.48e-1)"	"unprognostic (4.01e-1)"	"unprognostic (1.02e-3)"	4.1	1.5	0.7	1.8	0.2	0.0	0.8	0.5	0.9	4.2	2.2	2.0	0.3	3.9	0.6	2.5	3.1	2.0	2.6	0.3	1.6	3.8	0.3	1.9	1.2	2.5	2.5	2.5	0.8	9.1	0.4	72.3	2.0	1.1	1.5	1.0	0.4	2.1	0.3	0.9	0.9	4.2	0.4	0.3	1.1	0.8	1.6	0.8	1.0	1.4	1.0	4.5	2.4	1.3	0.0	14.9	22.3	0.0	50.0	37.8	0.0	12.2	21.4	3.3	5.6	0.0	0.0	0.0	0.0	8.6	1.1	1.7	0.0	0.0	15.6	0.0	0.0	2.6	12.8	0.1	24.3	0.0	0.0	137.4	0.0	16.4	1.9	26.9	0.1	0.0	0.5	0.0	3.8	0.0	0.0	0.0	6.5	0.0	0.0	0.0	0.6	0.0	0.6	0.1	0.1	1.2	1.8	0.0	0.0	6.8	0.0	0.0	28.9	36.3	1.8	1.0	1.4	0.0	0.0	0.0	25.8	0.0	11.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.2	0.5	0.9	0.3	1.6	2.5	2.5	2.0	0.4	1.6	1.3	0.2	0.0	1.5	3.9	1.0	2.9	0.2	4.0	92.2	17.6	0.8	0.4	3.4	0.0	1.6	165.5	12.5	0.5	0.1	0.1	9.8	5.9	20.1	4.7	101.3	1.4	0.0	0.0	10.0	0.9	19.5	31.8	0.5	2.6	1.3	10.4	4.6	0.1	0.4	0.0	19.6	0.0	0.0	0.0	5.8	17.9	14.3	1.0	1.8	7.5	0.0	2.5	1.0	15.1	2.9	0.3	0.0	8.6	1.2	1.2	0.2	51.5	1.6	2.9	0.0	3.3	10.9	2.2	0.6	19.7	1.1	14.0	1.3	0.2	0.1	0.3
PARG		ENSG00000227345	"Poly(ADP-ribose) glycohydrolase"	Q86W56	10	49818279-49970203	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"DNA damage"	Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA021819, HPA053007"	Enhanced		Supported	Nucleoplasm,Vesicles,Cytosol		NA	NA			"Cluster 41: Basophils - Cellular respiration"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Nucleoplasm	"Vesicles, Cytosol"	"HPA021819: AB_1854974, HPA053007: AB_2682014"	"unprognostic (5.77e-3)"	"unprognostic (6.74e-2)"	"unprognostic (3.06e-2)"	"unprognostic (9.90e-2)"	"unprognostic (1.22e-2)"	"unprognostic (1.33e-1)"	"prognostic unfavorable (5.57e-5)"	"unprognostic (1.21e-1)"	"unprognostic (3.97e-1)"	"unprognostic (8.34e-2)"	"unprognostic (1.47e-1)"	"unprognostic (4.06e-2)"	"unprognostic (5.20e-3)"	"unprognostic (1.14e-1)"	"unprognostic (1.77e-1)"	"unprognostic (8.54e-2)"	"unprognostic (1.13e-1)"	5.3	6.5	3.7	6.2	3.8	3.2	7.1	7.5	4.8	6.1	1.4	7.3	8.8	6.1	4.7	7.0	5.8	5.4	8.5	4.0	4.3	12.7	6.9	5.2	9.1	3.6	3.2	5.4	4.0	8.9	4.3	7.7	4.0	6.7	7.8	5.8	5.3	6.3	12.0	7.3	7.0	6.3	3.0	6.9	6.4	7.8	3.7	9.1	6.7	9.0	9.0	6.2	5.2	4.3	15.3	9.5	20.0	17.8	11.2	13.6	14.9	13.6	17.2	17.0	16.1	9.8	15.2	10.5	10.7	13.3	7.8	17.7	17.3	10.2	19.8	15.5	16.6	11.6	7.7	13.2	13.8	16.5	8.9	8.4	21.0	12.3	22.4	13.4	10.6	14.0	18.8	11.1	14.9	9.2	18.0	20.0	22.4	10.5	26.8	21.1	20.7	13.9	16.1	8.4	16.0	19.7	10.6	21.6	17.1	21.2	23.8	10.9	10.0	11.5	12.4	11.8	15.9	10.4	16.2	21.9	18.9	18.8	8.8	6.1	2.5	1.4	2.3	2.2	3.2	3.0	3.0	2.8	2.7	2.9	3.7	3.5	1.3	3.9	3.5	2.9	2.8	2.3	3.7	3.8	7.5	4.8	4.0	4.3	3.6	3.2	4.0	3.0	3.7	4.3	8.2	9.6	15.3	22.2	12.2	6.1	5.2	4.3	12.0	13.9	9.5	7.4	28.6	14.3	9.2	12.9	27.1	7.7	8.9	10.4	9.8	7.3	6.1	17.7	14.8	11.1	6.6	12.8	42.5	6.5	6.2	12.0	11.2	11.8	14.5	17.0	6.8	13.6	9.7	5.0	37.9	10.0	2.0	12.0	4.3	4.6	7.5	11.6	3.6	35.6	12.4	7.3	24.7	26.7	41.4	8.1	3.7	8.2	9.9	5.3	8.7	40.3	21.5	20.7	0.0	11.3	12.0	17.1	13.3	13.8	6.0	4.7	12.0	20.0	11.2	4.4
PARK7	"DJ-1, DJ1, GATD2"	ENSG00000116288	"Parkinsonism associated deglycase"	Q99497	1	7954291-7985505	"Disease related genes, Enzymes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Autophagy, DNA damage, DNA repair, Fertilization, Inflammatory response, Stress response"	"Chaperone, Hydrolase, Protease, RNA-binding"	"Disease variant, Neurodegeneration, Parkinson disease, Parkinsonism, Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA004190, CAB005870"	Supported		Supported	Nucleoplasm,Cytosol		NA	NA		35000000	"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 39: Non-specific - Basic cellular processes"	"Nucleoplasm, Cytosol"		"CAB005870: AB_444361, HPA004190: AB_1079566"	"unprognostic (6.88e-3)"	"unprognostic (7.50e-2)"	"unprognostic (3.48e-2)"	"unprognostic (1.16e-2)"	"unprognostic (4.08e-2)"	"unprognostic (5.68e-2)"	"unprognostic (7.45e-2)"	"unprognostic (9.63e-2)"	"unprognostic (2.01e-1)"	"unprognostic (1.66e-2)"	"unprognostic (1.12e-1)"	"unprognostic (2.02e-1)"	"unprognostic (1.96e-3)"	"unprognostic (8.17e-2)"	"unprognostic (1.32e-1)"	"unprognostic (1.30e-1)"	"unprognostic (7.43e-2)"	249.4	373.6	283.5	213.7	290.0	205.0	235.7	292.9	403.4	201.1	327.7	252.5	145.8	212.2	278.0	161.0	203.2	162.9	388.0	285.5	296.6	311.0	397.6	181.6	269.2	289.6	286.0	234.2	308.5	387.6	283.6	174.1	291.7	234.9	194.9	273.8	240.9	185.6	771.4	127.1	170.5	199.1	295.2	188.2	234.2	139.6	288.1	217.9	286.3	541.8	249.7	226.5	171.2	299.7	537.0	452.5	467.1	523.2	459.8	442.6	218.4	476.7	434.4	450.4	360.3	419.9	549.4	633.1	534.2	505.1	328.6	367.1	483.2	625.3	579.3	574.5	526.2	683.0	678.6	674.5	403.8	662.9	418.6	421.3	262.4	459.8	547.4	359.2	478.2	340.1	676.8	471.7	633.0	485.0	474.3	868.7	376.1	653.6	465.4	366.7	598.0	888.7	714.7	269.7	527.7	447.4	470.4	728.0	798.4	370.1	414.9	503.7	459.3	412.8	344.6	395.5	539.5	452.8	788.4	938.8	551.5	1002.9	606.4	298.4	590.2	394.0	484.7	553.7	459.2	483.6	478.2	577.3	717.4	374.6	406.8	466.8	202.5	551.1	456.9	1378.2	874.4	1060.8	283.5	290.0	292.9	403.4	285.5	296.6	289.6	286.0	291.7	295.2	288.1	299.7	243.6	131.4	157.1	23.2	211.8	208.9	402.4	677.7	200.9	196.2	342.0	381.8	453.3	257.4	318.5	248.3	79.2	553.0	382.3	131.1	851.0	504.3	32.1	272.1	263.9	241.7	238.0	177.1	19.5	478.4	612.1	302.3	146.3	195.9	206.5	291.2	183.1	368.1	435.1	186.7	22.9	279.6	484.2	204.5	304.5	53.6	358.2	258.9	359.3	21.5	605.4	816.4	327.5	18.1	36.0	378.9	186.9	378.7	269.7	523.4	227.1	941.5	327.8	235.5	276.1	277.8	342.6	288.2	302.2	220.4	143.8	469.6	244.4	535.3	312.2	433.1
PARL	"PRO2207, PSARL, PSARL1, RHBDS1"	ENSG00000175193	"Presenilin associated rhomboid like"	Q9H300	3	183829271-183884933	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins, Transporters"		"Hydrolase, Protease, Serine protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											HPA019545	Approved		Approved	Mitochondria		NA	NA			"Cluster 31: Non-specific - Inflammatory response"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 10: Non-specific - Unknown function"	Mitochondria		"HPA019545: AB_1855796"	"unprognostic (2.10e-1)"	"unprognostic (1.53e-3)"	"unprognostic (5.88e-2)"	"unprognostic (1.17e-2)"	"unprognostic (5.76e-2)"	"unprognostic (9.55e-2)"	"unprognostic (3.17e-3)"	"unprognostic (8.97e-2)"	"unprognostic (1.81e-1)"	"unprognostic (3.62e-3)"	"unprognostic (1.52e-1)"	"unprognostic (2.13e-2)"	"unprognostic (4.28e-2)"	"unprognostic (5.49e-2)"	"unprognostic (2.58e-1)"	"unprognostic (1.73e-1)"	"prognostic favorable (9.11e-5)"	38.4	35.8	46.5	26.6	48.2	33.8	40.3	47.4	66.2	33.8	50.7	47.7	29.2	31.9	57.7	36.7	30.2	19.7	54.1	46.6	48.2	39.6	45.0	28.4	32.0	47.7	48.7	31.7	49.9	39.7	32.0	25.5	47.4	37.1	41.9	32.7	40.5	30.3	54.9	37.1	34.7	29.7	47.2	36.2	42.6	26.7	47.6	34.5	31.4	51.6	33.8	38.9	31.5	48.4	115.1	55.6	39.7	33.0	38.8	42.1	80.2	39.2	59.4	80.5	65.0	172.0	59.0	47.8	90.0	56.7	73.5	49.2	64.1	68.0	90.0	71.6	76.1	73.9	35.5	96.9	57.3	73.9	61.6	60.0	85.4	58.0	70.7	38.5	59.0	82.4	42.6	45.0	69.2	131.0	148.3	194.3	105.5	100.6	53.3	64.7	72.8	92.0	79.0	97.6	37.9	52.0	47.6	162.9	107.8	48.1	159.2	143.5	31.8	29.3	63.0	60.9	108.2	89.2	65.7	116.0	56.6	75.1	35.5	97.5	143.1	133.4	51.3	107.8	60.9	62.4	57.3	59.9	132.4	59.1	68.7	54.2	41.3	67.1	83.3	79.7	73.7	116.1	46.5	48.2	47.4	66.2	46.6	48.2	47.7	48.7	47.4	47.2	47.6	48.4	30.3	22.4	19.7	17.9	37.6	30.3	54.9	93.5	26.7	35.9	31.8	31.5	41.2	35.8	44.5	31.3	31.3	58.9	38.4	24.4	117.4	63.9	24.0	15.2	18.3	30.2	33.7	23.3	23.4	84.7	49.0	35.1	28.1	13.7	69.8	33.1	33.2	30.4	77.7	33.7	24.1	42.0	77.3	56.2	55.7	9.7	28.9	57.5	42.7	33.7	79.3	55.9	50.4	17.1	28.0	60.3	35.1	27.1	42.3	55.4	47.3	86.0	30.5	51.1	6.6	44.8	96.6	47.8	47.4	40.2	30.0	42.1	40.9	49.0	49.2	58.8
PARN	DAN	ENSG00000140694	"Poly(A)-specific ribonuclease"	O95453	16	14435700-14632728	"Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins"	"Nonsense-mediated mRNA decay"	"Exonuclease, Hydrolase, Nuclease, RNA-binding"	"Disease variant, Dyskeratosis congenita"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA006314, CAB011673, HPA012010"	Supported		Supported	"Nuclear speckles"		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 34: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 52: Non-specific - Transcription"	"Nuclear speckles"		"CAB011673: AB_778216, HPA006314: AB_1079567, HPA012010: AB_1854976"	"unprognostic (2.54e-1)"	"unprognostic (3.43e-2)"	"unprognostic (1.55e-1)"	"unprognostic (2.23e-1)"	"unprognostic (2.28e-1)"	"prognostic unfavorable (4.64e-4)"	"unprognostic (2.99e-3)"	"unprognostic (5.07e-2)"	"unprognostic (1.32e-1)"	"unprognostic (1.94e-1)"	"unprognostic (2.16e-3)"	"unprognostic (1.75e-1)"	"unprognostic (1.52e-1)"	"unprognostic (3.25e-2)"	"unprognostic (2.46e-1)"	"unprognostic (3.10e-3)"	"unprognostic (1.09e-2)"	16.6	20.2	10.8	13.9	12.1	9.2	15.9	11.7	11.4	17.2	12.0	19.3	11.8	19.1	24.7	15.6	16.0	13.4	14.8	10.6	14.0	12.7	16.4	14.2	21.2	11.7	11.9	16.4	16.5	21.1	16.3	15.6	11.9	16.1	16.8	7.0	15.3	17.1	16.8	17.9	16.1	18.0	11.3	15.7	16.2	18.1	12.6	21.6	20.6	9.7	23.4	19.3	16.0	13.5	28.0	39.9	17.6	22.9	32.9	33.2	20.3	24.4	32.4	29.8	28.3	21.9	28.7	56.2	63.1	32.3	25.3	30.4	46.7	32.3	41.0	42.9	29.4	28.8	24.2	53.2	35.5	46.0	36.2	32.5	38.5	32.0	43.1	25.5	22.5	32.6	28.5	29.9	32.5	44.9	36.7	33.1	26.0	28.2	16.7	56.2	36.1	57.1	23.1	17.1	18.7	16.9	53.4	29.6	36.3	28.6	31.6	28.0	21.2	31.5	15.8	16.4	26.9	32.5	31.0	63.5	34.6	30.8	35.8	8.9	8.0	15.8	8.6	13.2	7.7	16.0	10.4	12.4	13.6	9.4	14.2	14.4	6.2	15.0	15.6	8.3	19.1	7.1	10.8	12.1	11.7	11.4	10.6	14.0	11.7	11.9	11.9	11.3	12.6	13.5	18.0	32.1	39.1	37.9	26.2	7.1	7.8	9.7	21.6	13.0	13.4	14.0	22.3	7.2	11.8	11.0	8.4	29.2	24.7	13.6	11.7	14.2	14.1	15.2	20.5	15.2	14.9	20.4	48.0	12.9	23.2	19.5	21.9	21.7	2.5	19.2	11.7	15.6	14.8	8.4	48.2	14.3	6.1	14.2	5.8	6.3	21.1	18.2	10.6	54.4	35.8	10.3	52.5	38.2	72.4	15.2	10.6	17.7	23.0	7.1	12.2	10.8	19.2	10.8	19.7	13.1	15.0	70.5	70.5	20.0	8.2	22.4	21.5	20.1	13.4	4.8
PCSK1	"NEC1, PC1, PC3, SPC3"	ENSG00000175426	"Proprotein convertase subtilisin/kexin type 1"	P29120	5	96390333-96434143	"Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted secreted proteins"		"Hydrolase, Protease, Serine protease"	"Disease variant, Obesity"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	6	"brain: 68.3"	"Cell type enriched"	"Detected in some"	4	"Enteroendocrine cells: 224.6"	"Cancer enhanced"	"Detected in many"		"breast cancer: 12.1"	"Group enriched"	"Detected in all"	5	"cerebral cortex: 19.1;hypothalamus: 68.3;pons: 30.0"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"SCLC-21H: 22.6;U-138 MG: 19.0;U-87 MG: 15.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA048564, HPA079656"	Approved				"Secreted in other tissues"	NA	NA				"Cluster 26: Pituitary gland - Hormone signaling"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 17: Intestinal endocrine cells - Hormone signaling"			"HPA048564: AB_2680444, HPA079656: "	"unprognostic (1.86e-2)"	"unprognostic (2.13e-2)"	"unprognostic (4.66e-3)"	"unprognostic (8.20e-5)"	"prognostic unfavorable (9.13e-5)"	"unprognostic (8.47e-4)"	"unprognostic (1.46e-1)"	"unprognostic (5.84e-3)"	"unprognostic (4.71e-1)"	"unprognostic (3.07e-3)"	"unprognostic (1.89e-3)"	"unprognostic (1.01e-1)"	"unprognostic (7.90e-6)"	"unprognostic (5.25e-2)"	"unprognostic (9.96e-2)"	"unprognostic (1.33e-3)"	"unprognostic (9.37e-3)"	1.7	6.3	5.5	4.7	3.7	0.1	1.4	1.0	19.1	0.9	0.0	2.4	5.2	0.1	0.0	0.1	0.2	0.2	0.8	3.0	68.3	0.4	0.0	0.3	0.1	6.6	7.7	0.4	7.6	0.0	12.1	0.0	30.0	0.4	2.3	8.7	2.7	0.1	0.3	1.1	3.6	0.6	4.0	0.1	5.7	0.1	6.6	0.2	1.9	0.0	0.0	2.0	0.5	5.3	0.0	0.0	0.3	0.0	2.3	0.7	0.0	0.3	0.2	0.0	0.0	0.0	0.1	0.0	0.1	1.0	3.8	0.0	0.0	0.1	0.0	0.1	0.1	0.8	2.4	0.0	0.0	0.0	0.0	2.0	1.0	0.4	0.1	0.2	0.9	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	22.6	0.0	3.3	0.0	0.0	0.4	0.0	0.0	1.2	19.0	0.6	0.3	0.2	0.0	0.0	0.1	15.8	0.0	0.4	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.5	3.7	1.0	19.1	3.0	68.3	6.6	7.7	30.0	4.0	6.6	5.3	0.0	0.0	0.0	3.6	0.0	0.0	0.1	0.0	1.8	13.2	0.0	0.0	0.7	0.0	0.0	0.0	2.1	0.0	0.0	0.8	0.0	0.0	0.4	0.0	0.2	0.2	224.6	0.0	54.5	0.0	0.0	2.6	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	4.0	10.7	2.0	0.0	0.4	1.6	0.0	0.0	0.0	4.7	0.0	0.5	0.0	3.5	4.9	1.5	0.1	0.0	0.0	0.3	0.2	0.0	0.0	0.9	0.0	1.7	1.0	0.1	0.1	0.2	0.0	0.1	0.0	0.0	0.7	0.0
PCSK2	"NEC2, PC2, SPC2"	ENSG00000125851	"Proprotein convertase subtilisin/kexin type 2"	P16519	20	17226107-17484578	"Enzymes, Predicted intracellular proteins, Predicted secreted proteins"		"Hydrolase, Protease, Serine protease"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adrenal gland: 28.5;brain: 30.2;retina: 35.8;thyroid gland: 56.9"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 87.3;Excitatory neurons: 322.8;Horizontal cells: 132.9;Inhibitory neurons: 148.8;Melanocytes: 209.9;Muller glia cells: 452.7"	"Cancer enriched"	"Detected in many"	4	"thyroid cancer: 65.1"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"AF22: 60.0;SCLC-21H: 15.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA049627	Approved		Approved	Vesicles	"Secreted in other tissues"	NA	NA		18000	"Cluster 41: Basophils - Cellular respiration"	"Cluster 58: Brain - Synaptic function"	"Cluster 12: NES - Nervous system development"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	Vesicles		"HPA049627: AB_2680835"	"unprognostic (2.03e-3)"	"unprognostic (1.61e-1)"	"unprognostic (3.13e-1)"	"unprognostic (2.18e-1)"	"unprognostic (2.13e-1)"	"unprognostic (6.84e-2)"		"unprognostic (3.07e-3)"	"unprognostic (4.31e-1)"	"unprognostic (5.88e-2)"	"unprognostic (2.50e-3)"	"unprognostic (2.14e-1)"	"unprognostic (7.26e-5)"	"unprognostic (2.29e-1)"	"unprognostic (1.57e-1)"	"unprognostic (2.35e-1)"	"unprognostic (1.14e-1)"	0.7	28.5	8.6	0.8	14.9	0.5	0.4	0.1	30.2	1.6	0.0	6.9	4.8	0.2	0.3	1.1	1.0	0.5	4.7	15.8	11.1	0.2	0.2	2.5	0.0	2.2	1.3	9.0	19.8	0.8	2.0	0.6	2.6	1.4	1.7	35.8	1.7	1.2	0.1	14.1	2.1	0.4	1.4	0.1	8.1	4.8	13.2	0.0	56.9	0.1	0.1	3.0	2.4	11.9	0.0	0.0	60.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	8.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	15.7	0.2	0.0	0.0	2.5	0.0	0.0	0.0	0.0	0.2	0.8	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.5	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.6	14.9	0.1	30.2	15.8	11.1	2.2	1.3	2.6	1.4	13.2	11.9	0.1	0.0	7.3	7.8	0.0	8.2	0.0	0.0	1.2	28.1	0.0	0.0	1.2	0.0	0.6	0.0	6.2	0.0	0.0	0.0	0.0	0.0	87.3	0.0	0.0	1.3	0.0	0.0	322.8	0.0	0.0	1.2	0.0	0.0	0.0	0.0	4.6	0.0	0.0	132.9	148.8	0.6	0.0	0.0	1.3	6.3	2.8	0.2	209.9	8.4	0.0	452.7	0.0	44.7	6.4	2.8	2.5	0.0	0.0	0.0	0.0	0.0	0.0	14.4	0.0	0.5	1.2	1.0	0.3	0.2	1.4	0.0	0.1	0.6	0.0	0.1
PDE10A		ENSG00000112541	"Phosphodiesterase 10A"	Q9Y233	6	165327287-165988078	"Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Predicted intracellular proteins"		"Allosteric enzyme, Hydrolase"	"Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	11	"brain: 67.2"	"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 204.7;Inhibitory neurons: 209.6;Microglial cells: 89.0;Oligodendrocyte precursor cells: 48.7;Oligodendrocytes: 51.8"	"Low cancer specificity"	"Detected in many"			"Region enriched"	"Detected in many"	6	"basal ganglia: 67.2"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HeLa: 9.0;LHCN-M2: 12.5;RT4: 6.9;SH-SY5Y: 8.1;TIME: 11.3;U-2 OS: 7.0"	"Region enriched"	"Detected in all"	11	"basal ganglia: 350.1"	"Region enriched"	"Detected in all"	5	"basal ganglia: 194.1"	"CAB045998, HPA047200"	Supported					NA	NA				"Cluster 10: Brain - Neuronal signaling"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"			"CAB045998: AB_2162589, HPA047200: AB_2679981"	"unprognostic (1.02e-1)"	"unprognostic (3.63e-2)"	"unprognostic (3.58e-2)"	"unprognostic (2.91e-1)"	"unprognostic (1.20e-1)"	"unprognostic (1.25e-1)"	"unprognostic (1.76e-1)"	"unprognostic (1.23e-1)"	"unprognostic (9.36e-2)"	"unprognostic (6.03e-2)"	"unprognostic (3.79e-2)"	"unprognostic (9.24e-2)"	"prognostic unfavorable (4.44e-7)"	"unprognostic (3.59e-3)"	"unprognostic (2.37e-2)"	"unprognostic (3.44e-2)"	"unprognostic (5.90e-3)"	2.6	1.3	3.1	0.8	67.2	0.0	2.3	5.5	10.7	1.3	0.0	1.0	0.2	2.0	2.4	0.4	2.4	1.5	3.6	2.1	2.5	3.8	0.3	1.0	0.5	1.6	2.3	2.3	0.5	0.5	2.7	2.5	0.9	1.7	0.2	1.9	0.4	1.7	0.4	0.3	0.7	2.1	0.5	1.4	1.1	3.4	9.6	0.3	6.0	0.5	0.4	3.2	0.9	0.1	0.0	2.4	5.5	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	6.3	0.8	0.0	0.0	0.0	3.8	0.1	2.2	0.0	0.0	0.1	3.9	0.0	9.0	0.0	0.4	0.0	0.0	0.0	0.0	0.6	0.0	0.0	5.5	0.0	0.0	0.0	12.5	0.3	0.9	0.0	1.1	0.0	4.7	1.5	5.8	0.0	5.9	6.9	1.8	8.1	0.0	0.0	0.4	0.7	0.0	0.0	11.3	0.1	7.0	0.5	0.0	0.0	0.0	0.0	0.1	0.0	3.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.1	67.2	5.5	10.7	2.1	2.5	1.6	2.3	0.9	0.5	9.6	0.1	13.8	0.0	0.0	10.4	0.1	0.4	3.3	0.4	0.0	7.2	0.3	0.3	7.3	0.0	1.2	5.5	2.1	7.8	0.0	0.0	3.9	2.0	14.3	0.2	1.7	13.4	0.0	0.0	204.7	0.0	6.1	6.6	1.1	0.4	1.3	0.1	7.9	0.0	0.8	16.8	209.6	0.0	0.0	0.0	0.0	14.9	0.0	0.2	1.8	89.0	0.0	12.6	0.0	48.7	51.8	0.1	0.0	0.4	0.0	17.9	0.0	7.2	0.9	1.1	0.0	12.4	5.0	8.8	2.1	0.1	0.3	2.9	0.1	1.6	0.1	6.9
PDE11A		ENSG00000128655	"Phosphodiesterase 11A"	Q9HCR9	2	177623244-178072777	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Predicted intracellular proteins"		"Allosteric enzyme, Hydrolase"	"Cushing syndrome"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 6.3;parathyroid gland: 9.8"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 37.0;Hepatocytes: 11.1;Late spermatids: 46.4;Oligodendrocytes: 14.9"	"Cancer enhanced"	"Detected in some"		"prostate cancer: 1.7"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"CAPAN-2: 1.6;fHDF/TERT166: 2.4;HAP1: 1.4;Hep G2: 2.8"									HPA034560	Approved				"Intracellular and membrane"	NA	NA				"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 25: Spermatids - Spermatogenesis"			"HPA034560: AB_10602140"	"unprognostic (1.02e-1)"	"unprognostic (4.73e-2)"	"unprognostic (1.02e-1)"	"unprognostic (9.61e-3)"	"unprognostic (2.34e-2)"	"unprognostic (1.43e-2)"	"unprognostic (1.30e-1)"	"unprognostic (2.28e-2)"	"unprognostic (2.23e-1)"	"unprognostic (3.91e-1)"	"unprognostic (9.95e-2)"	"unprognostic (2.80e-2)"	"unprognostic (5.06e-2)"	"unprognostic (1.04e-1)"	"unprognostic (1.75e-1)"	"unprognostic (4.11e-4)"	"unprognostic (1.64e-3)"	2.3	0.3	0.8	0.1	2.0	0.2	1.7	1.9	1.2	0.6	0.6	0.5	0.8	1.2	0.4	0.0	0.3	0.4	0.3	0.6	2.1	0.5	6.3	0.0	0.0	2.5	2.1	0.4	1.1	9.8	0.9	0.0	2.7	5.2	0.4	1.4	1.4	0.8	4.4	0.1	0.5	1.1	3.7	0.1	0.4	2.8	1.9	0.1	1.3	1.3	0.0	0.0	0.1	3.2	0.0	0.4	0.2	0.1	0.0	0.0	0.0	1.1	0.2	0.0	0.3	0.2	1.6	0.0	0.6	2.4	0.3	0.1	1.4	0.0	0.0	0.0	0.9	1.1	0.1	2.8	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.9	0.0	0.2	0.2	0.4	0.1	0.6	0.0	0.3	0.2	0.0	0.2	0.0	0.5	0.0	0.3	0.7	0.0	0.1	0.1	0.2	0.1	0.0	0.0	0.1	0.3	0.0	0.1	0.2	0.0	0.0	0.4	0.0	0.1	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.1	0.1	0.1	0.0	0.0	0.8	2.0	1.9	1.2	0.6	2.1	2.5	2.1	2.7	3.7	1.9	3.2	0.1	0.0	0.0	2.3	0.2	0.6	1.4	0.1	0.0	1.7	4.2	0.8	0.0	1.5	0.1	0.0	0.0	0.1	0.3	0.8	0.0	0.8	37.0	0.3	0.2	0.6	6.7	2.7	1.6	6.7	0.0	0.6	0.0	0.2	0.0	0.0	1.4	11.1	0.1	0.0	8.2	0.9	6.1	1.2	2.1	46.4	1.5	0.3	0.0	0.0	0.0	4.7	0.0	6.0	14.9	2.3	0.0	0.7	0.0	5.4	0.6	1.3	0.1	1.0	0.0	2.0	0.6	6.8	6.9	0.0	1.3	0.3	0.3	0.3	1.3	1.0
PDE12	"2'-PDE, 3635, DKFZp667B1218"	ENSG00000174840	"Phosphodiesterase 12"	Q6L8Q7	3	57556274-57566848	"Enzymes, Predicted intracellular proteins"	"mRNA processing"	"Exonuclease, Hydrolase, Nuclease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA043171	Approved					NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 59: Non-specific - Transcription"			"HPA043171: AB_10794654"	"unprognostic (2.79e-1)"	"unprognostic (3.18e-1)"	"prognostic favorable (2.85e-5)"	"unprognostic (2.39e-1)"	"unprognostic (1.48e-1)"	"unprognostic (9.21e-2)"	"unprognostic (1.58e-2)"	"unprognostic (8.43e-3)"	"unprognostic (1.27e-1)"	"unprognostic (6.45e-2)"	"unprognostic (2.10e-1)"	"unprognostic (9.88e-3)"	"prognostic favorable (3.63e-8)"	"unprognostic (6.97e-3)"	"unprognostic (1.32e-1)"	"unprognostic (7.85e-2)"	"unprognostic (2.62e-1)"	7.6	8.6	4.1	8.3	4.6	13.9	6.0	5.1	4.4	5.2	4.7	7.2	9.1	5.7	3.9	9.0	4.2	7.1	5.7	4.3	5.2	8.0	10.6	5.5	8.9	3.9	3.9	4.7	9.8	9.2	4.4	7.3	3.5	6.3	6.7	7.3	5.9	6.4	8.4	4.9	7.2	6.9	4.2	7.1	7.2	4.2	3.9	7.0	7.2	7.9	8.1	8.6	4.9	6.2	19.5	18.8	11.5	21.3	14.6	10.3	20.8	16.1	15.3	17.8	15.8	24.9	12.9	31.6	5.9	14.6	23.7	12.5	24.8	16.8	14.5	14.7	12.7	23.5	15.4	19.3	16.6	31.1	23.5	14.2	11.3	21.5	19.0	9.3	15.6	16.1	19.4	22.3	16.3	15.0	28.0	10.2	17.8	15.1	32.0	10.5	9.4	23.0	14.4	22.3	10.2	16.0	17.3	20.2	17.4	9.1	15.0	17.6	19.3	14.7	13.7	28.1	26.4	21.9	34.2	27.4	17.3	24.1	22.2	20.6	9.3	8.7	10.9	12.7	12.3	6.7	10.2	11.3	10.2	11.4	12.4	12.4	2.3	14.9	13.8	5.3	13.5	10.2	4.1	4.6	5.1	4.4	4.3	5.2	3.9	3.9	3.5	4.2	3.9	6.2	15.9	25.6	21.9	32.0	20.0	36.8	18.5	13.2	14.8	21.0	17.9	10.0	10.8	22.8	14.8	31.3	12.5	19.0	23.9	17.9	5.9	10.0	1.3	15.5	19.3	14.6	12.5	20.4	50.8	9.8	11.3	14.6	12.8	21.7	19.7	12.8	13.6	27.8	15.0	26.9	49.0	10.8	10.2	18.5	16.8	1.3	10.5	16.1	12.4	26.2	15.8	18.3	17.5	47.7	56.6	9.0	9.8	12.4	20.4	18.6	14.8	16.5	8.9	31.1	6.6	32.7	15.1	18.6	10.3	21.7	39.6	20.5	19.2	19.7	19.5	19.1
PDE1A		ENSG00000115252	"Phosphodiesterase 1A"	P54750	2	182140036-182523192	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Calmodulin-binding, Hydrolase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"kidney: 46.6;thyroid gland: 45.8"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 396.3;Excitatory neurons: 764.9;Late spermatids: 592.1;Oligodendrocytes: 1178.0"	"Cancer enhanced"	"Detected in many"		"thyroid cancer: 13.0"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"ASC diff: 37.2;HHSteC: 22.0;HSkMC: 47.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA022151	Approved		Approved	Nucleoplasm		NA	NA				"Cluster 43: Testis - Unknown function"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	Nucleoplasm		"HPA022151: AB_1855118"	"unprognostic (3.63e-1)"	"unprognostic (7.21e-2)"	"unprognostic (1.32e-1)"	"unprognostic (8.61e-2)"	"unprognostic (1.58e-1)"	"unprognostic (3.02e-1)"	"unprognostic (3.84e-1)"	"unprognostic (3.82e-1)"	"unprognostic (1.02e-1)"	"unprognostic (5.38e-2)"	"unprognostic (2.78e-1)"	"unprognostic (2.86e-1)"	"unprognostic (5.55e-3)"	"unprognostic (2.50e-3)"	"unprognostic (5.96e-2)"	"unprognostic (1.37e-1)"	"unprognostic (1.40e-3)"	10.5	4.4	16.9	4.6	20.4	0.0	5.0	35.5	23.4	17.2	2.4	11.8	3.0	8.7	8.0	5.6	10.3	23.7	15.6	30.3	8.4	46.6	3.9	3.6	2.1	2.6	4.2	10.9	2.1	2.2	2.7	1.2	5.4	3.6	6.7	1.4	2.0	5.4	2.8	2.2	5.7	12.9	3.7	3.1	5.6	35.6	16.5	8.4	45.8	5.0	0.9	9.7	9.8	18.2	0.0	0.2	3.9	0.0	37.2	3.1	0.1	0.3	0.4	0.1	0.0	0.0	0.1	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.1	0.1	4.7	0.0	5.1	0.0	22.0	0.0	0.0	47.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	7.5	1.1	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	3.7	0.0	5.4	0.1	0.1	0.2	0.2	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	16.9	20.4	35.5	23.4	30.3	8.4	2.6	4.2	5.4	3.7	16.5	18.2	6.7	0.0	2.6	15.3	0.0	1.3	2.0	0.1	8.0	20.0	0.3	0.3	5.9	1.5	1.4	27.6	0.0	0.1	0.0	0.1	185.9	0.5	396.3	0.3	0.4	8.9	0.0	0.0	764.9	0.4	0.0	18.6	0.0	0.8	0.0	0.1	5.0	0.0	0.1	0.0	185.8	1.0	0.0	0.0	1.8	592.1	14.9	0.4	0.0	30.0	0.0	0.3	0.0	18.1	1178.0	0.2	0.1	8.2	0.2	2.6	0.1	1.5	0.0	1.2	52.6	21.0	45.1	9.1	4.9	1.0	1.3	0.0	0.2	7.6	0.1	0.7
PDE1B	PDES1B	ENSG00000123360	"Phosphodiesterase 1B"	Q01064	12	54549601-54579239	"Enzymes, FDA approved drug targets, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"		"Calmodulin-binding, Hydrolase"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	8	"brain: 76.9"	"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 18.6;Inhibitory neurons: 10.2;Kupffer cells: 13.0;Macrophages: 9.4;Sertoli cells: 13.1;Smooth muscle cells: 13.7"	"Low cancer specificity"	"Detected in many"			"Region enriched"	"Detected in many"	6	"basal ganglia: 76.9"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HDLM-2: 12.7;HMC-1: 14.9;NB-4: 10.7;THP-1: 9.0;U-937: 7.2"	"Region enriched"	"Detected in all"	6	"basal ganglia: 999.4"	"Region enriched"	"Detected in all"	7	"basal ganglia: 228.7"	HPA018492	Enhanced					NA	NA				"Cluster 10: Brain - Neuronal signaling"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 48: Smooth muscle cells - ECM organization"			"HPA018492: AB_1855119"	"unprognostic (2.90e-1)"	"unprognostic (1.51e-1)"	"unprognostic (7.67e-4)"	"unprognostic (5.63e-3)"	"unprognostic (7.02e-2)"	"unprognostic (7.51e-2)"	"unprognostic (1.97e-1)"	"unprognostic (9.39e-2)"	"unprognostic (1.14e-1)"	"unprognostic (5.11e-2)"	"unprognostic (3.84e-3)"	"unprognostic (2.70e-2)"	"prognostic unfavorable (4.77e-6)"	"unprognostic (6.64e-4)"	"unprognostic (2.14e-1)"	"unprognostic (3.09e-1)"	"unprognostic (2.83e-2)"	9.1	1.1	8.4	4.0	76.9	4.8	4.6	0.0	13.7	2.0	0.0	7.4	1.0	2.7	1.8	1.7	2.0	2.2	1.4	6.3	0.1	0.8	1.0	2.3	1.3	0.0	0.0	8.6	0.4	6.1	0.3	0.2	0.0	1.3	1.0	0.4	1.0	1.4	0.6	1.4	3.4	4.0	0.0	4.0	3.3	0.7	2.4	0.9	2.0	1.0	0.8	8.7	1.5	4.9	0.0	0.0	0.6	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	3.2	0.1	0.0	0.0	0.0	2.1	0.0	0.0	12.7	0.6	4.3	0.0	0.0	0.0	5.5	14.9	0.7	0.0	0.0	0.0	0.0	0.0	5.5	0.0	2.3	0.0	0.0	0.5	10.7	3.5	0.0	0.0	2.0	0.0	3.6	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	9.0	0.0	0.0	0.3	0.0	0.0	0.1	0.2	2.5	0.0	7.2	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.4	76.9	0.0	13.7	6.3	0.1	0.0	0.0	0.0	0.0	2.4	4.9	2.3	0.0	1.1	1.6	1.8	1.0	0.2	0.0	0.6	2.7	0.2	0.6	3.6	0.0	0.6	3.7	0.0	0.1	1.4	0.0	0.0	0.0	6.3	0.1	0.0	0.8	1.8	3.6	18.6	0.0	0.0	1.5	0.0	0.0	0.0	4.4	0.0	0.3	8.5	5.0	10.2	0.0	0.0	13.0	2.5	4.9	2.1	9.4	0.0	2.8	6.7	0.1	4.1	1.0	0.9	0.0	0.0	3.0	2.6	0.4	0.0	0.0	0.0	0.2	13.1	0.6	13.7	0.8	0.6	0.2	0.4	0.3	2.8	0.4	0.1	0.1
PDE1C	Hcam3	ENSG00000154678	"Phosphodiesterase 1C"	Q14123	7	31751179-32428131	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Predicted intracellular proteins"		"Calmodulin-binding, Hydrolase"	"Deafness, Disease variant, Non-syndromic deafness"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	6	"brain: 68.9;heart muscle: 58.5"	"Cell type enriched"	"Detected in many"	5	"Oligodendrocytes: 1071.4"	"Cancer enhanced"	"Detected in some"		"glioma: 1.7"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"BJ: 44.4;fHDF/TERT166: 148.3;hTERT-RPE1: 44.9;U-251 MG: 77.9;WM-115: 105.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA052375			Approved	Nucleoplasm		NA	NA				"Cluster 44: Heart - Cardiac muscle contraction"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	Nucleoplasm		"HPA052375: AB_2681802"	"unprognostic (1.29e-2)"	"unprognostic (2.20e-5)"	"unprognostic (1.68e-2)"	"unprognostic (1.20e-3)"	"unprognostic (2.29e-1)"	"unprognostic (5.65e-2)"	"unprognostic (4.06e-3)"	"unprognostic (2.75e-1)"	"unprognostic (6.79e-3)"	"unprognostic (6.49e-2)"	"unprognostic (3.88e-5)"	"unprognostic (7.03e-2)"	"unprognostic (3.09e-3)"	"unprognostic (5.76e-2)"	"unprognostic (5.80e-2)"	"unprognostic (1.49e-1)"	"unprognostic (1.06e-3)"	2.4	1.8	19.2	2.5	43.0	0.0	4.3	21.4	39.9	0.7	0.0	3.0	1.4	2.4	6.0	6.4	10.5	1.5	58.5	18.9	24.2	4.2	0.1	4.9	0.6	29.4	27.9	3.8	2.6	0.3	1.3	3.2	27.7	2.0	1.8	7.4	1.8	3.2	0.6	0.4	3.3	5.0	16.4	0.6	4.0	3.8	28.6	1.6	3.1	4.0	0.1	9.8	1.4	68.9	0.3	5.8	15.5	0.0	0.6	0.4	0.2	44.4	18.3	20.8	17.1	0.0	0.0	0.0	0.2	148.3	0.0	1.2	0.0	0.0	27.1	0.0	0.0	1.3	1.4	0.0	0.1	0.0	31.9	1.9	0.0	4.3	0.2	44.9	7.1	0.0	0.1	0.1	1.7	0.0	0.1	0.0	0.0	0.0	13.7	0.0	0.0	0.0	22.5	0.0	6.8	0.0	0.0	0.0	0.0	1.3	0.0	0.3	0.2	22.8	8.6	0.4	77.9	0.4	0.0	0.0	2.4	0.5	105.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	19.2	43.0	21.4	39.9	18.9	24.2	29.4	27.9	27.7	16.4	28.6	68.9	1.2	0.0	0.0	7.5	0.1	0.0	0.7	0.1	1.2	69.5	2.8	17.1	136.0	0.0	0.7	1.8	52.1	0.0	0.1	0.0	0.0	4.8	53.4	0.2	0.1	3.9	0.0	0.0	70.8	0.4	0.0	8.7	0.0	0.4	8.8	0.2	0.0	0.0	0.1	3.3	169.2	0.0	59.0	0.0	0.2	50.3	0.3	0.5	0.0	15.9	0.0	0.9	0.0	196.6	1071.4	0.2	0.0	0.4	0.1	0.2	0.0	0.0	2.2	4.7	0.0	0.9	9.4	1.3	1.2	0.2	0.0	0.0	0.1	1.2	0.0	0.0
PDE2A		ENSG00000186642	"Phosphodiesterase 2A"	O00408	11	72576141-72674591	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 197.0"	"Group enriched"	"Detected in many"	6	"Adipocytes: 114.9;Endothelial cells: 58.5;Enteroendocrine cells: 34.4;Excitatory neurons: 70.1;Hepatic stellate cells: 118.2;Inhibitory neurons: 35.6"	"Low cancer specificity"	"Detected in many"			"Group enriched"	"Detected in many"	4	"amygdala: 75.1;basal ganglia: 84.7;cerebral cortex: 102.1;hippocampal formation: 84.4;white matter: 48.3"	"Low immune cell specificity"	"Detected in many"			"Group enriched"	"Detected in many"	5	"B-cells: 2.8;T-cells: 7.3"	"Cell line enriched"	"Detected in some"	8	"HeLa: 513.6"	"Low region specificity"	"Detected in some"			"Group enriched"	"Detected in all"	5	"amygdala: 83.5;basal ganglia: 146.9;cerebral cortex: 90.5;hippocampal formation: 94.0"	"CAB009752, HPA031192"	Enhanced		Supported	Cytosol		NA	NA			"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 64: Macrophages - Immune response"	"Cluster 20: HeLa - Mitochondria"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	Cytosol		"CAB009752: AB_2268159, HPA031192: AB_2673781"	"unprognostic (1.92e-1)"	"unprognostic (1.52e-3)"	"unprognostic (4.58e-2)"	"unprognostic (1.49e-1)"	"unprognostic (1.26e-1)"	"unprognostic (2.50e-1)"	"prognostic favorable (1.76e-6)"	"unprognostic (3.06e-2)"	"unprognostic (1.35e-1)"	"unprognostic (3.01e-3)"	"unprognostic (3.13e-3)"	"unprognostic (1.50e-2)"	"unprognostic (1.77e-2)"	"unprognostic (2.85e-3)"	"unprognostic (6.31e-2)"	"unprognostic (7.72e-2)"	"unprognostic (7.96e-4)"	89.2	44.1	75.1	5.1	84.7	4.7	83.6	0.0	102.1	38.1	0.0	34.6	6.0	27.2	8.3	18.6	39.3	22.7	41.1	84.4	7.0	32.5	19.4	12.6	6.7	6.4	5.1	11.6	6.9	5.5	11.8	12.0	10.1	20.7	8.9	3.0	9.2	10.7	16.8	18.1	18.7	18.5	0.0	197.0	17.1	7.4	17.9	3.8	24.1	28.9	3.5	28.8	27.1	48.3	0.3	0.2	0.7	0.2	0.2	0.1	0.3	0.1	0.2	0.2	0.4	0.4	2.5	0.8	12.2	0.2	1.9	0.2	0.9	0.1	0.1	0.1	0.1	0.0	513.6	0.8	0.9	0.0	7.8	0.1	1.1	2.7	20.5	1.1	11.3	0.5	0.8	0.9	0.1	0.0	0.2	0.2	7.4	0.2	14.0	0.0	0.2	1.4	0.1	0.3	44.5	2.4	0.4	0.2	2.2	0.7	0.3	0.1	65.2	0.1	9.4	3.5	0.4	0.4	0.2	0.1	3.9	0.1	0.6	0.0	0.6	0.0	7.3	0.8	4.2	2.8	4.3	4.3	1.0	1.8	2.7	2.3	0.1	0.0	0.4	0.0	1.8	1.5	75.1	84.7	0.0	102.1	84.4	7.0	6.4	5.1	10.1	0.0	17.9	48.3	114.9	0.0	0.5	2.0	0.7	2.5	0.1	0.0	0.0	4.9	0.6	1.0	7.8	0.0	0.0	0.0	0.0	0.0	1.6	0.2	0.0	0.0	0.6	0.0	0.1	58.5	34.4	5.3	70.1	0.0	0.3	2.1	0.0	0.1	1.3	0.1	118.2	2.1	0.5	1.7	35.6	1.2	0.0	9.4	8.2	2.5	0.3	4.9	1.8	11.2	0.0	0.0	0.0	9.0	5.7	0.1	0.0	0.4	1.5	0.1	0.0	0.1	0.0	0.4	0.0	1.8	6.6	4.8	2.5	0.5	2.8	0.0	0.6	0.2	0.1	0.3
PDE3A	CGI-PDE	ENSG00000172572	"Phosphodiesterase 3A"	Q14432	12	20368537-20688583	"Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted membrane proteins"		Hydrolase	"Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"heart muscle: 43.4"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 98.2;Bipolar cells: 38.4;Cardiomyocytes: 131.3;Horizontal cells: 52.2;Inhibitory neurons: 78.8;Smooth muscle cells: 49.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AF22: 8.6;HEL: 15.3;HeLa: 42.5;HUVEC TERT2: 7.4;SH-SY5Y: 17.9;U-138 MG: 11.9"	"Low region specificity"	"Detected in many"			"Region enhanced"	"Detected in many"		"cerebellum: 18.8"	"HPA014492, HPA074258"	Approved		Approved	"Plasma membrane"		NA	NA		37000000		"Cluster 46: Fibroblasts - ECM organization"	"Cluster 20: HeLa - Mitochondria"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	"Plasma membrane"		"HPA014492: AB_1855120, HPA074258: "	"unprognostic (2.59e-2)"	"unprognostic (2.94e-2)"	"unprognostic (1.25e-1)"	"unprognostic (3.23e-1)"	"unprognostic (2.27e-1)"	"unprognostic (1.21e-1)"	"unprognostic (3.50e-2)"	"unprognostic (1.67e-2)"	"unprognostic (8.14e-2)"	"unprognostic (1.49e-1)"	"unprognostic (4.25e-1)"	"unprognostic (3.37e-1)"	"prognostic unfavorable (1.72e-6)"	"unprognostic (5.58e-2)"	"unprognostic (5.94e-2)"	"unprognostic (4.28e-2)"	"unprognostic (2.76e-4)"	6.5	1.0	1.6	3.1	1.3	0.2	3.8	3.1	1.3	6.7	1.8	15.0	1.9	4.2	1.4	2.2	4.1	4.7	43.4	1.3	1.5	3.3	1.3	3.9	1.0	1.9	2.3	3.4	6.2	0.6	2.1	11.3	1.2	5.4	7.6	5.7	2.7	3.5	2.2	1.3	9.6	5.2	1.6	2.2	5.1	0.4	2.5	0.6	2.8	1.8	0.5	2.5	3.1	1.4	0.0	0.2	8.6	0.0	1.9	1.3	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	15.3	42.5	0.2	0.6	0.0	0.0	1.8	0.0	0.4	0.1	0.1	7.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.4	0.0	1.1	0.0	0.0	0.0	2.7	0.0	0.1	17.9	0.0	0.0	0.1	3.3	0.0	0.0	0.3	11.9	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	1.3	3.1	1.3	1.3	1.5	1.9	2.3	1.2	1.6	2.5	1.4	2.7	0.0	0.0	98.2	0.0	0.3	0.2	0.0	0.6	38.4	0.2	0.3	131.3	4.3	0.6	0.0	0.0	0.0	0.0	28.4	0.0	5.8	0.7	0.5	1.6	3.9	4.2	0.0	4.1	0.5	0.0	11.3	0.0	1.4	17.1	0.0	2.2	0.0	0.7	52.2	78.8	7.0	0.0	0.0	0.7	0.6	1.5	3.1	1.8	27.2	0.5	4.4	0.0	27.6	3.9	0.4	26.9	0.7	0.0	0.5	33.4	3.1	0.0	2.8	6.6	3.6	49.9	0.3	0.9	0.9	0.3	0.0	0.6	0.5	16.4	0.2
PDE3B	HcGIP1	ENSG00000152270	"Phosphodiesterase 3B"	Q13370	11	14643804-14872044	"Enzymes, FDA approved drug targets, Metabolic proteins, Predicted membrane proteins"	Angiogenesis	Hydrolase	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 64.5"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 171.7;Excitatory neurons: 140.5;Inhibitory neurons: 158.0;Microglial cells: 192.0;Oligodendrocyte precursor cells: 118.6"	"Low cancer specificity"	"Detected in many"			"Region enriched"	"Detected in all"	5	"cerebellum: 13.5"	"Low immune cell specificity"	"Detected in many"			"Group enriched"	"Detected in many"	5	"granulocytes: 3.8;T-cells: 6.3"	"Cell line enhanced"	"Detected in many"		"HL-60: 23.5;Karpas-707: 25.7;THP-1: 28.4;U-266/70: 28.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA056111			Approved	"Endoplasmic reticulum"		NA	NA			"Cluster 32: T-cells - Unknown function"	"Cluster 86: Liver & Placenta - Transport via ER"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 24: Non-specific - Transcription regulation"	"Endoplasmic reticulum"		"HPA056111: AB_2683041"	"unprognostic (1.05e-1)"	"unprognostic (2.86e-2)"	"unprognostic (4.12e-2)"	"unprognostic (2.76e-3)"	"unprognostic (4.25e-1)"	"unprognostic (1.84e-3)"	"unprognostic (3.40e-2)"	"unprognostic (3.24e-2)"	"unprognostic (5.39e-2)"	"unprognostic (1.20e-1)"	"prognostic favorable (7.91e-4)"	"unprognostic (1.77e-1)"	"unprognostic (2.33e-2)"	"unprognostic (1.39e-2)"	"unprognostic (3.42e-1)"	"unprognostic (2.47e-1)"	"unprognostic (9.03e-3)"	64.5	1.1	1.3	12.4	2.1	10.1	12.2	13.5	2.6	3.4	0.0	25.2	2.9	0.7	0.5	2.9	0.5	3.7	4.7	1.9	2.6	3.0	25.8	10.2	14.9	2.8	1.7	0.5	8.3	0.2	4.4	7.6	1.9	8.7	10.7	0.5	14.0	1.6	0.4	0.5	6.0	1.7	2.3	8.9	2.6	9.6	2.0	7.3	0.8	2.4	7.9	8.5	1.9	2.6	0.0	2.5	5.6	9.2	10.9	0.1	2.2	0.6	0.1	0.0	0.0	8.5	0.0	0.0	0.1	0.0	2.6	0.0	8.5	0.0	0.0	0.2	18.7	0.3	13.1	17.5	3.9	23.5	0.1	0.8	0.0	0.0	0.5	0.0	0.1	6.6	20.6	25.7	0.0	0.3	4.7	11.4	7.6	3.1	4.1	11.0	2.5	17.7	0.0	1.9	8.5	15.8	2.3	14.6	5.1	2.5	0.0	28.4	0.0	0.0	1.3	0.0	0.0	28.8	9.4	0.7	0.2	4.0	1.7	0.0	0.5	2.5	1.0	0.6	2.1	0.2	3.1	2.4	0.3	0.1	6.3	5.7	3.8	0.1	1.0	0.1	3.5	1.5	1.3	2.1	13.5	2.6	1.9	2.6	2.8	1.7	1.9	2.3	2.0	2.6	1.5	16.0	8.9	171.7	6.4	0.3	0.9	0.0	0.6	1.0	0.3	0.3	11.1	0.0	6.2	1.8	0.0	1.4	26.7	11.5	1.9	0.0	19.0	0.3	5.1	4.0	1.2	12.8	140.5	5.0	2.8	9.7	7.7	0.3	36.1	0.5	4.2	64.1	7.6	0.0	158.0	13.7	0.0	13.1	3.7	13.4	1.5	15.6	0.0	192.0	10.8	6.3	8.2	118.6	5.4	1.8	22.3	9.1	28.9	3.3	0.7	2.0	3.6	0.5	0.0	3.4	3.0	48.8	19.5	0.1	0.1	2.5	60.9	0.0	9.4	1.1
PDE4A	DPDE2	ENSG00000065989	"Phosphodiesterase 4A"	P27815	19	10416773-10469630	"Enzymes, FDA approved drug targets, Metabolic proteins, Predicted intracellular proteins"		Hydrolase	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Langerhans cells: 190.8;Late spermatids: 197.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HMC-1: 36.5;NB-4: 43.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB017632, HPA043310, HPA076091"	Uncertain		Supported	"Nucleoplasm,Plasma membrane"		NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 47: Non-specific - Unknown function"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 25: Spermatids - Spermatogenesis"	"Plasma membrane"	Nucleoplasm	"CAB017632: AB_1127109, HPA043310: AB_2678419, HPA076091: AB_2686775"	"unprognostic (1.29e-2)"	"unprognostic (3.98e-2)"	"unprognostic (8.91e-2)"	"unprognostic (1.82e-1)"	"unprognostic (7.00e-2)"	"unprognostic (6.84e-2)"	"unprognostic (1.54e-2)"	"unprognostic (4.39e-2)"	"unprognostic (7.91e-2)"	"unprognostic (1.52e-2)"	"unprognostic (6.90e-2)"	"unprognostic (2.41e-1)"	"unprognostic (2.27e-2)"	"unprognostic (1.64e-2)"	"unprognostic (2.57e-2)"	"unprognostic (1.67e-1)"	"unprognostic (2.15e-1)"	13.7	5.6	10.9	5.9	12.5	5.4	9.7	3.0	32.3	12.4	0.0	11.0	2.7	9.8	1.4	4.1	7.5	6.6	12.5	11.8	7.9	7.0	2.5	13.0	3.2	21.9	7.1	1.5	12.7	22.2	3.9	6.5	20.8	8.4	4.0	5.3	9.8	4.8	37.9	5.4	6.5	6.2	1.1	8.2	12.9	24.5	13.0	1.6	11.0	16.9	2.6	8.2	8.2	15.7	0.1	2.5	0.5	6.7	18.7	11.1	3.7	5.6	11.1	0.7	1.9	6.0	5.4	2.6	16.1	14.6	0.4	0.6	3.9	0.7	0.4	6.7	5.5	23.7	8.1	6.7	12.3	3.9	36.5	8.3	0.8	6.2	0.0	0.7	5.3	2.1	18.9	5.5	4.0	1.7	2.3	43.3	2.9	6.7	4.7	15.6	3.7	20.3	0.9	1.4	4.2	1.5	0.4	0.2	6.2	1.0	0.8	7.8	11.2	8.3	10.5	5.7	3.7	10.9	0.9	12.4	3.5	0.3	6.7	4.1	1.7	3.4	0.8	2.5	0.4	0.1	0.3	1.1	2.0	0.0	0.0	0.4	0.1	3.0	2.7	0.1	0.7	1.1	10.9	12.5	3.0	32.3	11.8	7.9	21.9	7.1	20.8	1.1	13.0	15.7	9.4	3.2	11.6	6.2	10.8	10.1	2.6	2.5	1.8	25.6	6.4	4.3	7.7	8.6	5.5	9.2	0.0	0.5	58.9	7.1	0.0	3.1	48.9	2.1	20.7	8.6	0.0	1.7	39.4	12.9	4.8	12.1	7.1	3.6	31.8	0.3	10.4	0.9	10.2	55.5	43.5	5.1	6.1	22.1	190.8	197.0	17.4	53.9	14.2	12.2	15.4	1.2	22.6	12.5	1.5	12.3	3.8	18.0	27.0	3.0	0.1	0.2	6.9	3.6	6.6	9.0	10.2	8.6	8.5	0.5	8.1	0.4	37.0	1.0	6.8	1.3
PDE4B	DPDE4	ENSG00000184588	"Phosphodiesterase 4B"	Q07343	1	65792514-66374579	"Enzymes, FDA approved drug targets, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"		Hydrolase	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 75.5;brain: 109.1"	"Group enriched"	"Detected in many"	5	"Oligodendrocyte precursor cells: 1722.6;Oligodendrocytes: 4039.6"	"Cancer enhanced"	"Detected in all"		"glioma: 18.9"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"neutrophil: 88.9"	"Group enriched"	"Detected in all"	5	"B-cells: 37.4;granulocytes: 88.9;T-cells: 34.7"	"Cell line enhanced"	"Detected in many"		"AN3-CA: 61.8;HUVEC TERT2: 93.2;NTERA-2: 56.1;SK-MEL-30: 58.6;TIME: 52.6;U-266/84: 51.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA003005	Uncertain		Approved	"Golgi apparatus,Cytosol"		NA	NA			"Cluster 1: Neutrophils - Mixed function"	"Cluster 70: Brain - Nervous system development"	"Cluster 12: NES - Nervous system development"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	"Golgi apparatus"	Cytosol	"HPA003005: AB_1079587"	"unprognostic (7.86e-2)"	"unprognostic (3.13e-1)"	"unprognostic (4.62e-2)"	"unprognostic (2.90e-1)"	"unprognostic (3.21e-1)"	"unprognostic (3.33e-3)"	"unprognostic (1.35e-1)"	"unprognostic (1.15e-3)"	"unprognostic (1.04e-2)"	"unprognostic (6.10e-2)"	"unprognostic (8.78e-2)"	"unprognostic (4.24e-2)"	"prognostic unfavorable (5.04e-4)"	"unprognostic (2.89e-2)"	"unprognostic (3.54e-1)"	"unprognostic (9.04e-3)"	"unprognostic (8.33e-3)"	18.3	3.1	40.1	39.5	82.5	75.5	20.0	63.3	53.5	7.2	1.6	8.3	4.6	8.3	1.1	4.5	4.2	10.1	21.4	45.7	68.4	5.4	10.9	14.7	23.2	85.9	74.4	2.1	1.6	1.4	3.8	17.2	78.5	23.0	10.5	14.1	21.1	12.1	44.3	8.9	12.2	12.4	66.4	22.6	5.1	3.8	62.9	14.0	7.2	15.0	19.9	32.1	4.6	109.1	0.2	18.5	34.7	61.8	1.6	1.7	0.1	11.5	13.3	10.1	13.4	0.0	0.0	5.3	0.2	20.7	0.4	0.1	0.3	0.0	9.7	15.5	0.1	0.3	5.2	0.0	1.2	13.1	0.0	3.4	0.5	4.5	0.2	1.6	93.2	0.0	0.0	3.3	4.7	0.3	0.0	7.5	56.1	0.0	0.7	2.6	6.2	3.6	8.7	0.0	0.2	26.6	0.0	3.0	58.6	2.9	0.2	4.5	52.6	7.2	1.9	4.6	1.9	1.5	51.6	19.3	8.6	13.4	3.7	10.8	6.8	22.0	10.1	5.8	19.5	36.8	19.4	14.8	6.2	37.4	21.3	15.0	88.9	11.3	5.7	6.4	34.7	9.6	40.1	82.5	63.3	53.5	45.7	68.4	85.9	74.4	78.5	66.4	62.9	109.1	24.7	9.6	12.2	531.8	233.3	20.3	28.4	0.5	27.9	40.9	51.6	34.3	25.4	0.0	6.9	5.5	0.0	7.3	79.8	0.4	0.0	0.8	14.4	1.7	14.9	36.8	4.2	0.0	315.6	0.9	2.0	20.2	9.7	4.2	15.2	0.2	11.7	2.4	13.0	114.4	559.7	1.9	8.2	40.6	187.4	9.4	0.3	176.9	51.6	173.3	67.0	19.3	1.0	1722.6	4039.6	0.1	0.4	2.6	351.9	93.6	0.0	2.1	1.5	4.0	0.0	54.0	10.3	0.7	0.8	4.8	8.1	5.6	143.1	0.4	1.3	9.4
PDE4C	DPDE1	ENSG00000105650	"Phosphodiesterase 4C"	Q08493	19	18208652-18248200	"Enzymes, FDA approved drug targets, Metabolic proteins, Predicted intracellular proteins"		Hydrolase	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"tongue: 21.3"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 255.9;Gastric mucus-secreting cells: 141.2;Paneth cells: 251.4;Proximal enterocytes: 73.0;Skeletal myocytes: 106.5;Undifferentiated cells: 103.3"	"Low cancer specificity"	"Detected in many"			"Group enriched"	"Detected in some"	4	"basal ganglia: 1.2;cerebral cortex: 1.1"	"Immune cell enhanced"	"Detected in single"		"basophil: 1.0"	"Lineage enriched"	"Detected in single"	4	"granulocytes: 1.0"	"Cell line enhanced"	"Detected in some"		"BEWO: 2.9;Hep G2: 2.0;U-87 MG: 4.4"									"HPA048975, HPA054218"	Approved		Approved	"Midbody ring,Centrosome,Cytosol"		Yes	NA			"Cluster 17: Basophils - Unknown function"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 53: Intestinal epithelial cells - Unknown function"	"Centrosome, Cytosol"	"Midbody ring"	"HPA048975: AB_2680581, HPA054218: "	"unprognostic (4.20e-2)"	"unprognostic (4.02e-2)"	"unprognostic (1.20e-1)"	"unprognostic (1.27e-1)"	"unprognostic (5.22e-4)"	"unprognostic (1.44e-2)"	"unprognostic (7.70e-2)"	"unprognostic (1.15e-1)"	"unprognostic (4.01e-2)"	"unprognostic (5.69e-2)"	"unprognostic (2.50e-3)"	"unprognostic (2.21e-1)"	"unprognostic (7.25e-10)"	"unprognostic (2.73e-2)"	"unprognostic (2.65e-1)"	"unprognostic (9.21e-2)"	"unprognostic (2.45e-2)"	1.4	0.6	0.2	0.1	1.2	0.5	0.7	0.0	1.1	3.2	0.0	4.3	0.7	3.4	3.4	0.7	3.0	1.1	4.4	0.2	0.0	4.8	1.3	3.4	0.2	0.0	0.0	1.8	0.7	0.2	2.8	3.7	0.0	2.3	0.6	0.2	0.5	2.7	8.3	0.3	2.4	1.8	0.0	2.1	3.8	2.5	0.0	0.0	1.1	21.3	0.1	1.0	1.7	0.0	0.0	0.1	0.0	0.1	0.0	0.1	2.9	0.0	0.0	0.1	0.1	0.6	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	2.0	0.1	0.0	0.2	0.3	0.0	1.2	0.0	0.2	0.0	0.1	0.4	0.9	0.0	0.1	0.1	0.1	0.0	0.2	0.1	0.1	0.1	0.2	0.0	0.0	0.1	0.4	0.1	0.2	0.0	0.7	0.2	0.2	0.0	0.1	0.0	0.3	0.0	0.6	0.3	0.1	4.4	0.1	0.0	1.0	0.1	0.2	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.2	0.1	0.1	0.7	0.2	0.1	0.1	0.0	0.0	0.2	1.2	0.0	1.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	3.2	10.6	2.0	0.8	5.5	5.8	8.6	5.2	3.9	0.2	0.4	35.3	4.3	22.4	0.0	6.2	2.1	0.0	255.9	0.0	0.0	32.9	0.1	0.1	4.6	7.2	0.0	8.2	0.0	4.3	6.3	141.2	0.1	4.5	0.0	1.1	0.3	0.5	0.0	2.1	55.2	4.1	1.4	4.5	38.4	0.6	2.1	1.8	0.0	0.4	1.9	1.0	0.5	0.9	0.0	251.4	4.1	1.6	1.8	73.0	0.0	9.4	3.0	46.0	106.5	17.2	1.9	2.2	28.6	3.8	1.1	1.2	0.0	103.3	17.3
PDE4D	DPDE3	ENSG00000113448	"Phosphodiesterase 4D"	Q08499	5	58969038-60522120	"Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Predicted intracellular proteins"		Hydrolase	"Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 74.9;skeletal muscle: 70.4"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 619.3;Excitatory neurons: 2969.7;Inhibitory neurons: 1116.9;Oligodendrocyte precursor cells: 848.0;Oligodendrocytes: 443.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Immune cell enriched"	"Detected in many"	5	"eosinophil: 57.9"	"Lineage enriched"	"Detected in many"	5	"granulocytes: 57.9"	"Cell line enhanced"	"Detected in many"		"A549: 62.2;AN3-CA: 70.4;HeLa: 104.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA045895	Uncertain		Supported	"Plasma membrane,Cytosol"		NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 59: Non-specific - Translation"	"Cluster 20: HeLa - Mitochondria"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	"Plasma membrane"	Cytosol	"HPA045895: AB_10960275"	"unprognostic (1.14e-1)"	"unprognostic (8.73e-3)"	"unprognostic (4.35e-2)"	"unprognostic (7.87e-2)"	"unprognostic (5.97e-2)"	"unprognostic (2.03e-1)"	"unprognostic (8.10e-4)"	"unprognostic (1.17e-1)"	"unprognostic (6.59e-2)"	"unprognostic (1.84e-1)"	"unprognostic (2.71e-1)"	"unprognostic (2.65e-1)"	"prognostic favorable (4.00e-5)"	"unprognostic (1.51e-1)"	"unprognostic (8.20e-2)"	"unprognostic (1.77e-2)"	"unprognostic (2.56e-2)"	8.9	1.3	3.3	9.8	9.9	74.9	4.6	0.0	11.3	5.3	0.0	21.0	5.5	7.4	18.4	13.7	7.3	9.1	15.7	4.4	4.2	17.2	2.8	13.3	5.3	7.0	2.0	3.0	3.7	5.5	6.7	16.6	1.2	19.9	15.0	21.4	7.4	21.2	70.4	4.5	7.0	15.3	0.8	4.0	10.3	3.4	3.8	8.6	7.4	34.4	5.6	22.0	8.2	5.7	0.1	62.2	12.8	70.4	2.3	4.4	10.1	1.6	1.8	3.4	4.9	24.5	2.0	4.8	0.2	0.5	10.3	10.6	0.0	2.8	5.9	2.9	7.0	9.2	104.6	5.3	9.1	4.4	0.7	9.3	2.3	9.6	1.7	1.1	7.3	0.3	0.0	1.6	5.9	4.5	3.6	10.3	2.4	1.8	3.2	1.2	16.0	10.5	15.9	23.5	2.3	8.0	16.4	27.1	14.2	11.4	1.9	9.3	8.5	0.9	0.2	12.0	3.3	3.5	0.1	0.5	10.3	17.3	2.7	4.2	2.0	57.9	1.5	0.1	1.5	11.0	1.4	0.7	1.4	11.3	0.9	0.7	3.1	0.4	0.2	0.0	0.8	1.1	3.3	9.9	0.0	11.3	4.4	4.2	7.0	2.0	1.2	0.8	3.8	5.7	22.5	32.1	110.0	619.3	32.3	10.6	30.1	6.6	35.3	20.2	5.1	2.7	35.7	8.6	30.2	42.3	73.0	11.3	118.6	28.1	11.7	0.6	21.4	19.0	8.6	16.9	33.4	2.1	2969.7	1.8	25.7	27.5	40.2	21.9	22.2	0.3	17.2	0.8	5.2	1.7	1116.9	18.2	6.1	4.8	11.1	36.6	1.5	29.5	10.6	407.5	6.0	12.0	29.9	848.0	443.3	8.2	11.9	4.9	44.4	43.3	8.9	27.5	19.4	52.8	0.0	64.0	6.3	1.1	7.7	40.6	8.8	3.1	94.3	1.1	11.7	26.5
PDE5A		ENSG00000138735	"Phosphodiesterase 5A"	O76074	4	119494397-119628804	"Enzymes, FDA approved drug targets, Metabolic proteins, Predicted intracellular proteins"		"Allosteric enzyme, Hydrolase"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 66.1;Inhibitory neurons: 58.3;Oligodendrocyte precursor cells: 56.8;Peritubular cells: 104.9;Smooth muscle cells: 80.9"	"Group enriched"	"Detected in all"	4	"prostate cancer: 7.0;thyroid cancer: 27.3"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"BJ hTERT+: 47.5;HHSteC: 65.9;hTERT-RPE1: 24.6"	"Region enhanced"	"Detected in all"		"cerebellum: 18.2"	"Low region specificity"	"Detected in all"			"HPA004729, HPA012873"	Approved		Approved	Cytosol		NA	NA		850000	"Cluster 16: MAIT-cells - Unknown function"	"Cluster 12: Smooth muscle tissue - Mixed function"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 48: Smooth muscle cells - ECM organization"	Cytosol		"HPA004729: AB_1079588, HPA012873: AB_1855124"	"unprognostic (6.95e-2)"	"prognostic favorable (5.20e-4)"	"unprognostic (1.28e-1)"	"unprognostic (1.56e-1)"	"unprognostic (1.25e-1)"	"unprognostic (3.66e-2)"	"unprognostic (7.36e-2)"	"unprognostic (2.58e-2)"	"unprognostic (2.29e-2)"	"unprognostic (6.97e-2)"	"unprognostic (2.05e-2)"	"unprognostic (2.54e-1)"	"unprognostic (2.16e-2)"	"unprognostic (1.52e-2)"	"unprognostic (8.98e-2)"	"unprognostic (8.71e-3)"	"prognostic unfavorable (1.17e-4)"	15.4	11.3	0.9	10.9	3.5	2.1	9.6	4.9	3.7	32.7	12.6	37.0	15.5	14.4	41.5	41.3	22.9	10.4	12.8	1.4	3.6	5.9	1.5	22.1	6.4	4.9	8.2	5.4	12.4	8.3	3.5	13.2	5.2	59.8	25.9	9.6	9.8	49.8	6.9	5.0	18.9	11.4	0.0	5.8	9.6	9.4	3.4	3.7	16.8	5.6	3.5	14.6	15.8	1.9	16.7	0.8	11.0	1.2	3.7	5.5	1.9	10.7	47.5	0.5	1.0	1.0	1.3	1.6	0.5	13.4	3.0	5.8	3.5	1.7	1.3	0.4	7.4	18.5	2.6	0.9	65.9	3.9	1.7	6.1	3.3	1.1	0.1	24.6	1.4	3.7	2.0	2.9	1.6	0.9	5.0	0.6	2.3	1.8	2.8	0.7	5.9	4.3	4.1	4.9	4.3	8.8	13.0	15.3	1.3	8.1	2.7	2.1	2.5	6.2	5.2	3.4	1.5	4.1	2.0	1.5	5.9	1.0	0.9	0.0	0.0	0.0	0.1	0.0	0.5	0.4	0.3	0.1	0.0	0.3	0.1	0.2	0.4	0.2	0.1	0.1	0.1	1.2	0.9	3.5	4.9	3.7	1.4	3.6	4.9	8.2	5.2	0.0	3.4	1.9	7.8	6.4	3.9	19.9	1.3	3.4	2.8	1.1	5.7	8.1	11.0	8.4	5.5	14.3	3.7	1.8	14.6	0.4	0.9	15.5	0.0	15.8	30.6	5.0	12.6	7.8	2.4	0.0	66.1	2.9	0.3	28.1	1.1	3.9	1.3	1.6	0.7	0.9	0.3	5.0	58.3	9.5	2.0	0.0	3.5	11.5	20.8	11.3	5.4	40.3	1.3	28.5	2.1	56.8	41.1	3.9	10.3	104.9	1.4	3.6	7.9	0.5	0.8	5.8	19.7	5.5	80.9	5.4	6.3	3.5	2.4	0.3	1.7	7.0	11.1	2.6
PDE6A	"PDEA, RP43"	ENSG00000132915	"Phosphodiesterase 6A"	P16499	5	149857953-149944793	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Sensory transduction, Vision"	Hydrolase	"Disease variant, Retinitis pigmentosa"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	68	"retina: 1119.5"	"Cell type enriched"	"Detected in many"	11	"Rod photoreceptor cells: 2946.4"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"Immune cell enhanced"	"Detected in single"		"basophil: 1.1"	"Low lineage specificity"	"Detected in single"			"Cell line enriched"	"Detected in single"	5	"CACO-2: 2.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA016970, HPA074677"	Enhanced					NA	NA			"Cluster 11: Basophils - Unknown function"	"Cluster 79: Retina - Phototransduction"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 46: Photoreceptor cells - Phototransduction"			"HPA016970: AB_1855125, HPA074677: AB_2732264"	"unprognostic (6.85e-2)"	"unprognostic (8.84e-2)"	"unprognostic (1.70e-2)"	"unprognostic (4.11e-2)"	"unprognostic (1.12e-2)"	"unprognostic (5.72e-2)"	"unprognostic (4.39e-3)"	"unprognostic (8.83e-2)"	"unprognostic (6.54e-2)"	"unprognostic (5.91e-3)"	"unprognostic (1.77e-2)"	"unprognostic (9.21e-2)"	"unprognostic (7.57e-5)"	"unprognostic (9.93e-2)"	"unprognostic (3.08e-1)"	"unprognostic (1.31e-1)"	"unprognostic (2.26e-2)"	0.1	0.7	0.5	0.2	0.5	0.9	0.2	1.4	0.7	0.1	0.2	1.2	0.2	0.1	16.3	0.9	0.2	0.2	0.2	0.5	0.5	0.1	0.1	0.3	0.1	0.3	0.3	0.2	0.2	0.2	1.7	0.1	0.5	0.3	0.9	1119.5	0.4	0.2	0.3	0.6	0.1	0.1	0.2	0.2	0.2	1.5	0.6	0.0	0.4	0.0	0.2	0.0	0.1	1.2	0.1	0.2	0.1	0.1	0.1	0.1	0.1	0.0	0.0	0.1	0.0	2.5	0.2	0.3	0.4	0.0	0.4	0.2	0.0	0.1	0.1	0.1	0.0	0.2	0.4	0.2	0.0	0.2	0.1	0.0	0.3	0.3	0.2	0.2	0.0	0.0	0.1	0.4	0.4	0.1	0.1	0.2	0.1	0.0	0.1	0.0	0.1	0.1	0.1	0.3	0.2	0.3	0.0	0.2	0.0	0.1	0.3	0.1	0.4	0.2	0.4	0.1	0.1	0.2	0.1	0.1	0.2	0.2	0.1	1.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.3	0.1	0.1	0.6	0.2	0.1	0.2	0.1	0.0	0.5	0.5	1.4	0.7	0.5	0.5	0.3	0.3	0.5	0.2	0.6	1.2	0.9	0.0	5.8	0.0	0.4	1.1	0.6	0.8	0.0	150.5	0.5	0.4	6.7	0.0	2.8	0.0	244.0	1.1	1.6	14.3	0.0	0.1	18.4	1.5	0.5	11.6	0.0	0.0	1.2	0.2	2.2	1.2	0.0	2.5	3.8	1.9	2.2	0.6	0.3	75.7	0.6	0.4	2.0	1.9	0.4	5.5	1.2	1.5	0.0	0.0	1.4	263.1	5.2	0.5	0.2	0.1	2.8	0.4	0.3	0.4	0.4	0.1	3.2	2946.4	0.0	1.0	1.2	2.3	0.8	5.4	0.6	2.9	1.5	2.2	2.7	0.2
PDE6B	"CSNB3, CSNBAD2, PDEB, rd1, RP40"	ENSG00000133256	"Phosphodiesterase 6B"	P35913	4	625573-670782	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Predicted intracellular proteins"	"Sensory transduction, Vision"	Hydrolase	"Congenital stationary night blindness, Disease variant, Retinitis pigmentosa"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	10	"retina: 385.0"	"Cell type enriched"	"Detected in many"	5	"Rod photoreceptor cells: 460.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in some"		"EFO-21: 11.5;JURKAT: 17.3;MOLT-4: 31.3;REH: 16.8;SCLC-21H: 20.2;SH-SY5Y: 11.9;U-266/84: 24.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA054148, HPA059929"	Enhanced		Approved	Cytosol		NA	NA			"Cluster 41: Basophils - Cellular respiration"	"Cluster 77: Retina - Visual perception"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 46: Photoreceptor cells - Phototransduction"	Cytosol		"HPA054148: AB_2682401, HPA059929: AB_2684166"	"unprognostic (2.43e-2)"	"unprognostic (1.33e-4)"	"unprognostic (2.45e-4)"	"unprognostic (7.18e-3)"	"unprognostic (1.88e-2)"	"unprognostic (5.04e-3)"	"unprognostic (7.32e-3)"	"prognostic favorable (5.34e-4)"	"unprognostic (9.70e-2)"	"unprognostic (1.14e-1)"	"unprognostic (1.37e-2)"	"unprognostic (2.33e-2)"	"unprognostic (4.09e-2)"	"unprognostic (1.67e-2)"	"unprognostic (2.26e-1)"	"unprognostic (2.41e-3)"	"unprognostic (1.85e-1)"	1.9	2.2	13.5	5.5	25.7	8.4	4.1	8.2	22.3	2.5	1.9	1.7	1.2	2.7	4.0	1.7	10.2	3.7	5.9	11.2	22.6	4.9	1.0	4.6	14.3	22.8	19.9	2.8	1.8	8.2	4.1	3.1	25.5	2.8	1.3	385.0	3.8	3.0	1.1	2.1	3.0	2.5	9.3	10.1	2.9	4.4	24.1	12.2	12.0	0.1	9.3	3.8	1.4	39.3	0.1	0.0	1.2	0.5	0.3	0.4	0.4	0.0	0.1	0.8	2.0	0.0	0.1	0.3	11.5	0.3	0.9	0.1	2.5	0.6	0.0	0.1	0.0	1.0	0.3	0.1	5.8	0.2	0.4	0.7	0.0	3.5	0.0	0.8	1.1	17.3	0.1	1.0	0.1	0.3	31.3	0.1	9.4	0.7	0.0	16.8	0.2	0.2	2.1	1.3	20.2	11.9	0.0	0.3	0.1	4.2	0.6	0.0	0.4	0.2	1.2	0.2	0.4	7.7	24.0	0.3	0.3	0.3	0.2	16.8	5.4	0.9	14.0	7.7	12.6	12.8	9.3	9.8	8.5	21.4	14.6	15.8	1.4	14.4	8.1	18.2	15.5	9.4	13.5	25.7	8.2	22.3	11.2	22.6	22.8	19.9	25.5	9.3	24.1	39.3	0.5	3.2	5.0	4.2	6.4	0.4	2.1	1.2	2.8	20.7	3.9	2.4	4.4	0.0	3.5	0.0	83.4	0.1	8.4	0.2	1.9	6.9	0.4	7.0	2.2	2.9	1.8	7.4	40.3	0.6	0.3	1.3	1.5	2.5	3.8	5.4	2.2	0.0	11.3	11.8	27.3	0.5	4.1	5.1	1.4	0.3	1.5	3.3	3.6	4.7	6.2	31.1	7.2	10.1	33.9	0.8	0.2	1.5	7.5	1.9	0.0	8.4	11.2	460.1	0.0	1.6	1.1	4.3	11.0	1.9	0.3	0.3	5.9	3.5	0.4	1.3
PDE6C	"ACHM5, COD4, PDEA2"	ENSG00000095464	"Phosphodiesterase 6C"	P51160	10	93612537-93666010	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Predicted intracellular proteins"	"Sensory transduction, Vision"	Hydrolase	"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	26	"retina: 23.1"	"Cell type enriched"	"Detected in some"	13	"Cone photoreceptor cells: 56.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"									NA	NA				"Cluster 79: Retina - Phototransduction"		"Cluster 9: Photoreceptor cells - Phototransduction"				"unprognostic (1.39e-3)"	"unprognostic (7.41e-3)"	"unprognostic (2.61e-2)"	"unprognostic (2.24e-1)"	"unprognostic (3.17e-2)"	"unprognostic (5.23e-3)"	"unprognostic (2.46e-3)"	"unprognostic (2.81e-3)"	"unprognostic (9.68e-2)"	"unprognostic (2.64e-1)"	"unprognostic (1.51e-2)"	"unprognostic (2.96e-3)"	"unprognostic (2.19e-7)"	"unprognostic (1.19e-1)"	"unprognostic (6.61e-2)"	"unprognostic (1.81e-1)"	"unprognostic (1.80e-3)"	0.1	0.1	0.2	0.0	0.2	0.2	0.1	0.8	0.3	0.3	0.0	0.1	0.0	0.1	0.0	0.1	0.2	0.0	0.1	0.2	0.2	0.1	0.1	0.1	0.1	0.2	0.0	0.2	0.1	0.0	0.2	0.0	0.2	0.2	0.0	23.1	0.1	0.0	0.5	0.5	0.1	0.0	0.0	0.1	0.1	0.1	0.4	0.0	0.1	0.0	0.0	0.2	0.2	0.5	0.0	0.1	0.0	0.2	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.1	0.2	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.8	0.3	0.2	0.2	0.2	0.0	0.2	0.0	0.4	0.5	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.3	0.0	0.0	0.0	56.3	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.2	0.0	0.0	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.6	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	1.0	0.0	0.7	0.0	0.5	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.2	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.1	0.0	0.0
PDE6G	"PDEG, RP57"	ENSG00000185527	"Phosphodiesterase 6G"	P18545	17	81650459-81663112	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"Sensory transduction, Vision"	Hydrolase	"Retinitis pigmentosa"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	99	"retina: 2050.3"	"Cell type enriched"	"Detected in many"	6	"Rod photoreceptor cells: 4448.6"	"Cancer enhanced"	"Detected in many"		"testis cancer: 10.6"	"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	6	"basophil: 127.0;NK-cell: 220.2"	"Group enriched"	"Detected in all"	6	"granulocytes: 127.0;NK-cells: 220.2"	"Cell line enhanced"	"Detected in some"		"Hep G2: 5.2;NB-4: 5.8;NTERA-2: 8.9;REH: 11.9;SuSa: 6.2"	"Region enhanced"	"Detected in some"		"hippocampal formation: 4.7"	"Not detected"	"Not detected"			HPA045118	Supported		Uncertain	Vesicles		NA	NA			"Cluster 48: NK-cells - Unknown function"	"Cluster 79: Retina - Phototransduction"	"Cluster 5: NTERA-2 - Transcription"	"Cluster 46: Photoreceptor cells - Phototransduction"	Vesicles		"HPA045118: AB_2732517"	"unprognostic (6.16e-2)"	"unprognostic (1.95e-2)"	"unprognostic (2.83e-2)"	"unprognostic (3.51e-3)"	"unprognostic (1.68e-1)"	"unprognostic (1.46e-2)"	"unprognostic (6.33e-2)"	"unprognostic (3.80e-2)"	"unprognostic (1.10e-2)"	"unprognostic (1.02e-1)"	"unprognostic (4.85e-2)"	"unprognostic (5.01e-2)"	"unprognostic (1.94e-2)"	"unprognostic (5.71e-2)"	"unprognostic (5.44e-2)"	"unprognostic (2.73e-1)"	"unprognostic (1.14e-1)"	1.5	0.3	0.0	4.7	0.1	7.8	0.9	0.2	0.5	1.0	0.2	1.6	0.6	0.2	0.1	0.8	0.7	2.5	0.4	0.1	0.7	2.1	4.2	3.0	20.6	0.1	0.2	0.0	0.0	0.1	0.1	12.0	0.2	0.2	1.0	2050.3	0.5	0.4	1.2	0.3	1.6	0.9	0.1	19.9	1.7	0.8	0.3	8.3	0.4	0.3	7.1	3.0	0.1	0.2	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.5	0.0	0.0	0.3	0.1	0.2	0.0	0.9	0.0	0.0	0.0	0.0	5.2	0.8	0.0	0.2	0.0	0.0	0.0	0.0	0.4	2.8	0.2	0.1	0.2	0.4	0.3	0.0	5.8	8.9	0.0	0.0	11.9	0.0	1.9	0.0	0.0	0.0	0.2	0.0	0.1	0.1	6.2	0.1	0.8	1.2	0.2	0.0	0.0	0.1	0.1	0.6	0.9	0.4	3.1	0.1	127.0	18.1	30.5	4.1	26.2	1.3	2.7	0.8	2.3	28.9	5.1	2.1	7.4	2.4	220.2	15.5	2.9	0.1	13.5	0.0	0.1	0.2	0.5	0.1	0.7	0.1	0.2	0.2	0.1	0.3	0.2	0.3	0.0	0.6	0.3	1.1	0.9	0.0	0.0	0.6	422.5	0.3	0.4	0.2	0.0	0.0	5.5	517.1	0.2	4.3	0.1	1.9	0.4	0.8	1.5	0.3	27.2	0.0	1.7	0.2	0.2	0.4	0.2	0.0	0.5	23.6	0.1	2.9	0.2	22.6	262.5	0.1	0.2	0.0	4.8	8.0	2.3	0.0	4.4	3.6	0.0	13.3	709.0	11.3	0.0	0.1	0.2	0.0	0.0	0.8	0.1	0.1	1.0	0.0	4448.6	0.0	0.1	0.1	1.1	0.2	0.3	1.4	0.3	1.7	2.1	0.0	0.1
PDE6H		ENSG00000139053	"Phosphodiesterase 6H"	Q13956	12	14973042-14981865	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"Sensory transduction, Vision"	Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	226	"retina: 911.3"	"Group enriched"	"Detected in some"	6	"Cone photoreceptor cells: 831.9;Rod photoreceptor cells: 218.8"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"AN3-CA: 1.0"	"Low region specificity"	"Detected in single"							HPA045118	Supported		Uncertain	Vesicles		NA	NA				"Cluster 79: Retina - Phototransduction"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 9: Photoreceptor cells - Phototransduction"	Vesicles		"HPA045118: AB_2732517"					"unprognostic (1.47e-3)"										"unprognostic (1.07e-2)"			0.0	0.4	0.3	0.0	0.4	4.0	0.0	0.1	1.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	2.3	0.0	0.0	0.1	0.0	0.3	0.4	0.0	0.0	0.0	0.0	0.9	0.5	0.0	0.0	911.3	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.3	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.2	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.4	0.1	1.0	0.3	2.3	0.3	0.4	0.5	0.2	0.3	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	62.9	0.0	0.0	0.1	0.0	0.0	0.0	831.9	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.5	0.0	0.0	0.5	0.0	21.8	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.9	23.5	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.5	0.0	0.0	0.6	81.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	218.8	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.2	0.0	0.0
PDE7A	HCP1	ENSG00000205268	"Phosphodiesterase 7A"	Q13946	8	65714334-65842322	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 108.3"	"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 102.4;Inhibitory neurons: 111.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in all"		"Karpas-707: 94.9;MOLT-4: 167.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB018770, HPA027340"	Approved					NA	NA			"Cluster 30: Non-specific - Translation"	"Cluster 3: T-cells - Adaptive immune response"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 24: Non-specific - Transcription regulation"			"CAB018770: AB_677329, HPA027340: AB_1855127"	"unprognostic (2.76e-1)"	"unprognostic (2.94e-2)"	"unprognostic (1.36e-1)"	"unprognostic (1.17e-2)"	"unprognostic (2.15e-1)"	"unprognostic (7.11e-2)"	"prognostic unfavorable (5.64e-4)"	"unprognostic (1.44e-2)"	"unprognostic (6.94e-2)"	"unprognostic (1.54e-1)"	"unprognostic (1.76e-2)"	"unprognostic (1.56e-1)"	"prognostic unfavorable (1.35e-4)"	"unprognostic (3.08e-2)"	"unprognostic (1.26e-1)"	"unprognostic (5.06e-2)"	"unprognostic (2.03e-2)"	8.5	3.1	5.2	28.5	8.0	26.6	19.8	8.5	7.2	13.4	7.7	7.6	11.4	6.3	14.0	6.6	7.9	11.5	49.3	5.1	5.3	18.8	5.5	19.1	58.8	6.6	5.2	6.0	14.3	3.1	13.4	8.3	5.2	13.7	9.8	14.0	20.8	8.6	63.6	8.2	26.4	5.5	3.9	29.4	13.0	10.3	8.2	108.3	22.9	75.9	43.0	9.9	8.9	11.1	12.5	10.8	47.2	22.2	6.7	5.8	20.0	9.3	7.9	11.5	11.0	12.8	8.1	35.0	2.2	5.8	10.2	13.8	17.5	19.7	12.0	41.3	8.9	25.6	18.5	9.6	3.4	20.3	9.8	8.3	32.0	7.4	22.3	9.9	11.4	84.0	19.1	94.9	7.9	6.8	167.6	23.0	50.3	10.1	4.8	61.8	7.2	9.2	7.8	24.6	22.9	26.5	9.8	4.9	4.8	32.2	26.1	52.2	7.4	15.9	19.6	11.3	7.6	45.6	21.3	60.3	16.1	42.1	8.9	2.5	0.7	5.5	3.4	0.6	5.5	6.5	5.2	3.4	1.5	7.5	11.9	9.2	2.5	2.3	0.2	2.1	4.7	1.8	5.2	8.0	8.5	7.2	5.1	5.3	6.6	5.2	5.2	3.9	8.2	11.1	8.6	19.2	22.7	41.4	95.1	18.1	13.6	8.8	7.4	27.3	23.1	21.8	46.6	20.0	17.3	3.7	56.3	14.1	93.4	3.7	0.0	8.2	32.1	11.8	12.6	7.9	9.6	31.6	102.4	5.3	8.4	17.2	8.2	13.5	9.5	14.2	6.8	4.3	10.4	18.5	111.3	6.5	12.2	17.3	34.9	15.0	7.5	26.2	16.0	48.7	19.7	10.1	47.4	89.0	86.2	6.1	5.6	7.5	56.3	19.4	5.9	21.3	20.3	66.1	0.0	18.4	11.1	10.3	10.9	6.0	18.8	8.6	81.3	6.8	6.5	10.8
PDE7B		ENSG00000171408	"Phosphodiesterase 7B"	Q9NP56	6	135851701-136195574	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 22.1"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 346.4;Excitatory neurons: 136.7;Inhibitory neurons: 166.0;Oligodendrocyte precursor cells: 343.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"naive B-cell: 1.3"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"ASC diff: 8.7;ASC TERT1: 10.2;EFO-21: 16.2;HeLa: 9.6;HSkMC: 22.4;HUVEC TERT2: 10.8;U-2197: 11.4"	"Region enriched"	"Detected in all"	5	"basal ganglia: 125.3"	"Low region specificity"	"Detected in all"			HPA023967	Uncertain		Approved	Nucleoplasm		No	NA			"Cluster 21: B-cells - Adaptive immune response"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Nucleoplasm		"HPA023967: AB_1855128"	"unprognostic (3.18e-1)"	"unprognostic (3.47e-1)"	"unprognostic (2.34e-1)"	"unprognostic (1.79e-3)"	"unprognostic (3.34e-1)"	"unprognostic (3.22e-4)"	"unprognostic (1.37e-2)"	"unprognostic (3.00e-1)"	"unprognostic (2.80e-1)"	"unprognostic (6.73e-3)"	"unprognostic (1.11e-2)"	"unprognostic (7.85e-2)"	"prognostic favorable (1.59e-4)"	"unprognostic (3.14e-3)"	"unprognostic (2.68e-2)"	"unprognostic (1.43e-1)"	"unprognostic (3.34e-2)"	5.2	2.3	6.5	2.2	22.1	0.1	2.6	3.6	8.1	3.9	2.8	2.5	1.9	7.8	2.2	1.3	2.8	3.4	6.6	2.6	8.7	5.5	3.7	1.7	1.5	6.2	11.6	13.0	0.8	6.2	4.8	1.0	6.0	4.3	2.7	2.4	2.9	10.3	4.7	0.8	2.2	7.6	4.6	1.1	3.6	1.5	15.8	3.8	4.7	8.9	0.8	6.0	3.6	2.8	0.0	5.7	0.2	0.0	8.7	10.2	0.1	0.5	2.9	2.1	1.1	0.0	0.1	0.1	16.2	3.6	0.0	0.0	0.0	0.0	0.7	0.0	0.2	0.0	9.6	0.0	3.7	0.1	0.0	22.4	0.0	4.2	0.0	0.9	10.8	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.8	3.8	0.7	3.9	3.7	0.1	0.2	0.0	0.0	1.8	0.0	2.3	0.0	11.4	0.0	0.1	0.0	0.0	0.6	0.0	0.9	0.0	0.3	0.2	0.0	0.0	0.0	0.4	0.1	0.0	0.8	1.3	0.5	0.3	0.0	0.2	0.0	0.0	0.0	0.1	6.5	22.1	3.6	8.1	2.6	8.7	6.2	11.6	6.0	4.6	15.8	2.8	8.3	0.0	0.5	346.4	11.9	0.4	0.3	0.5	0.0	4.4	0.9	0.4	8.4	2.8	0.2	22.0	0.0	0.1	0.7	0.1	0.0	0.2	0.5	3.1	1.4	23.1	7.3	0.8	136.7	1.6	0.0	9.8	4.6	2.1	10.2	31.1	35.3	3.8	0.3	6.7	166.0	0.0	0.0	1.9	4.8	0.9	12.2	3.2	0.0	70.3	0.7	11.5	0.0	343.8	10.4	0.1	0.0	7.9	0.2	0.4	0.0	1.6	1.6	0.9	13.1	30.6	9.1	0.3	0.1	0.2	1.4	0.0	2.9	4.4	0.0	0.3
PDE8A	HsT19550	ENSG00000073417	"Phosphodiesterase 8A"	O60658	15	84980440-85139145	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	7	"Oligodendrocytes: 968.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in all"		"RT4: 89.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA007722	Approved		Approved	"Golgi apparatus"		NA	NA			"Cluster 39: Non-specific - mRNA processing"	"Cluster 45: Intestine - Brush border"	"Cluster 15: RT4 - Unknown function"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	"Golgi apparatus"		"HPA007722: AB_1855130"	"unprognostic (1.68e-1)"	"unprognostic (2.83e-2)"	"unprognostic (4.81e-2)"	"unprognostic (4.97e-2)"	"unprognostic (6.25e-2)"	"unprognostic (3.47e-2)"	"unprognostic (2.97e-2)"	"unprognostic (3.94e-2)"	"unprognostic (1.03e-1)"	"unprognostic (2.45e-1)"	"unprognostic (8.99e-3)"	"unprognostic (2.75e-2)"	"unprognostic (3.42e-1)"	"unprognostic (3.72e-1)"	"unprognostic (4.26e-1)"	"unprognostic (1.31e-1)"	"unprognostic (1.94e-2)"	16.7	16.6	20.9	8.5	32.3	3.3	10.5	21.9	22.4	11.6	15.2	24.0	15.3	9.1	7.3	6.4	9.0	15.8	8.0	17.3	20.1	24.3	30.0	10.8	5.6	23.8	28.5	12.7	14.5	16.9	6.7	11.4	23.6	6.9	21.9	14.5	6.4	9.6	5.8	6.3	13.6	10.6	19.5	6.3	11.0	11.0	26.9	4.6	12.3	6.5	5.1	17.7	7.0	45.2	29.0	48.4	7.9	5.4	32.7	17.2	9.6	19.4	21.1	16.6	18.9	10.9	16.9	5.8	14.6	25.9	19.7	20.2	33.8	14.9	22.0	10.8	20.2	7.7	30.3	15.6	23.5	4.5	11.3	17.4	9.1	19.6	18.6	14.3	21.6	6.4	15.6	18.3	15.2	24.5	2.6	4.5	3.8	9.5	8.6	3.6	6.5	8.1	13.2	89.0	18.3	14.1	18.9	20.3	55.5	8.7	6.7	8.7	17.1	38.4	13.6	13.9	31.6	8.9	16.7	6.2	26.1	18.1	11.0	0.0	0.9	0.6	0.3	0.7	0.6	0.2	0.5	0.6	0.5	0.3	0.7	0.3	0.0	0.2	1.6	0.0	1.1	0.2	20.9	32.3	21.9	22.4	17.3	20.1	23.8	28.5	23.6	19.5	26.9	45.2	30.7	6.4	26.5	83.9	14.8	11.3	11.1	13.9	18.2	13.0	6.6	5.2	6.8	41.5	15.4	7.3	12.5	8.0	5.5	58.7	7.9	11.3	6.4	12.5	21.6	24.3	14.5	0.8	60.8	9.6	7.1	16.2	26.5	20.6	22.1	17.9	14.3	23.3	10.8	10.1	126.2	19.0	4.1	12.3	18.9	5.6	10.8	19.2	10.6	85.3	9.0	2.6	10.3	119.1	968.6	11.5	31.8	11.3	7.2	25.4	22.1	21.1	10.5	31.2	39.5	17.8	24.5	25.6	17.3	7.5	10.4	4.5	10.8	25.3	28.5	26.4
PDE8B		ENSG00000113231	"Phosphodiesterase 8B"	O95263	5	77210449-77428256	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Predicted intracellular proteins"		Hydrolase	"Cushing syndrome, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"thyroid gland: 124.7"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 64.9;Excitatory neurons: 183.1;Horizontal cells: 69.0;Inhibitory neurons: 276.5;Muller glia cells: 86.5;Oligodendrocyte precursor cells: 190.5"	"Cancer enriched"	"Detected in many"	6	"thyroid cancer: 35.7"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BJ hTERT+: 13.6;HeLa: 34.8;SK-BR-3: 11.1"									"HPA036911, HPA036912"	Supported		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 51: Monocytes - Innate immune response"	"Cluster 7: Kidney - Transmembrane transport"	"Cluster 20: HeLa - Mitochondria"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	"Nucleoplasm, Cytosol"		"HPA036911: AB_2675378, HPA036912: AB_10670377"	"unprognostic (1.30e-1)"	"unprognostic (7.95e-2)"	"unprognostic (3.35e-2)"	"unprognostic (7.61e-4)"	"unprognostic (1.59e-2)"	"unprognostic (1.41e-1)"	"unprognostic (2.66e-2)"	"unprognostic (4.48e-2)"	"unprognostic (1.71e-1)"	"unprognostic (3.26e-2)"	"unprognostic (3.98e-2)"	"unprognostic (2.44e-1)"	"unprognostic (9.04e-3)"	"unprognostic (3.40e-2)"	"unprognostic (3.76e-2)"	"unprognostic (1.98e-1)"	"unprognostic (3.19e-2)"	20.9	4.8	24.2	1.0	28.6	0.4	14.0	4.8	24.6	17.4	0.0	5.6	2.0	26.4	6.3	2.0	28.7	4.3	23.7	25.5	32.5	15.6	2.3	5.2	1.2	20.5	15.9	4.2	7.9	0.8	12.5	23.8	18.8	19.0	1.2	22.5	10.5	11.9	0.7	2.0	3.3	17.7	9.9	0.8	5.5	3.0	36.7	0.3	124.7	0.8	1.0	4.0	4.9	17.2	0.1	4.9	0.8	0.3	1.5	0.0	0.5	1.5	13.6	0.2	0.1	1.4	0.1	0.3	0.1	0.1	0.2	0.6	0.2	0.0	0.2	0.2	0.7	0.4	34.8	0.3	0.0	0.4	0.5	0.8	0.0	0.0	0.0	0.4	0.0	0.5	0.1	0.2	0.0	0.2	0.5	0.8	0.8	0.2	0.1	0.6	0.9	0.4	0.0	0.2	5.4	1.0	2.3	11.1	0.7	0.7	1.8	0.9	0.5	0.3	0.3	0.2	0.5	0.7	0.5	0.4	1.2	0.5	0.3	0.0	0.0	0.1	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	24.2	28.6	4.8	24.6	25.5	32.5	20.5	15.9	18.8	9.9	36.7	17.2	0.8	3.2	2.8	64.9	0.3	0.4	2.0	0.1	0.0	10.8	5.8	3.0	28.0	2.8	1.6	1.8	54.2	0.0	0.2	0.1	0.0	2.3	6.8	15.3	2.1	4.5	4.9	0.0	183.1	0.0	0.1	3.8	0.0	7.9	1.3	1.8	2.9	0.1	0.4	69.0	276.5	1.0	0.0	1.0	1.6	5.1	5.9	0.9	1.8	10.3	0.1	86.5	0.0	190.5	45.5	0.2	0.4	0.0	0.3	29.1	0.2	0.7	0.7	5.8	6.6	1.8	7.7	1.1	2.6	0.5	1.1	0.0	0.1	8.8	1.2	4.2
PDE9A		ENSG00000160191	"Phosphodiesterase 9A"	O76083	21	42653621-42775509	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 74.7"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 90.8;Paneth cells: 105.3;Proximal enterocytes: 233.5"	"Cancer enriched"	"Detected in all"	5	"prostate cancer: 31.5"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"naive CD4 T-cell: 3.1"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"AF22: 29.7;EFO-21: 30.0;MCF7: 23.2;NB-4: 34.7;NTERA-2: 41.2;SCLC-21H: 22.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA011380, HPA011978"	Enhanced		Supported	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA			"Cluster 32: T-cells - Unknown function"	"Cluster 37: Intestine - Unknown function"	"Cluster 38: EFO-21 - Unknown function"	"Cluster 45: Enterocytes - Digestion"	Cytosol	"Nucleoplasm, Plasma membrane"	"HPA011380: AB_1855132, HPA011978: "	"unprognostic (5.75e-2)"	"unprognostic (9.92e-3)"	"unprognostic (3.50e-1)"	"unprognostic (1.08e-1)"	"unprognostic (1.44e-1)"	"unprognostic (1.40e-1)"	"unprognostic (5.06e-2)"	"unprognostic (3.99e-2)"	"unprognostic (6.02e-2)"	"unprognostic (1.60e-1)"	"unprognostic (1.25e-2)"	"unprognostic (5.01e-2)"	"unprognostic (1.90e-2)"	"unprognostic (4.01e-3)"	"unprognostic (1.97e-1)"	"unprognostic (6.55e-2)"	"unprognostic (1.79e-1)"	9.4	11.1	12.3	3.9	15.1	0.5	10.8	14.0	12.9	7.2	8.6	74.7	2.9	5.1	19.4	3.7	10.6	6.8	4.3	10.6	12.6	29.8	4.2	4.9	4.8	12.4	14.4	3.5	4.1	6.5	9.9	10.3	12.7	38.5	16.4	10.7	12.7	15.8	2.4	7.0	47.3	8.8	11.0	18.3	13.4	1.9	15.0	7.8	6.5	4.8	3.1	18.9	6.2	12.0	0.0	2.8	29.7	3.7	0.0	0.8	0.5	0.0	0.0	0.0	0.0	3.2	18.2	0.0	30.0	0.0	2.2	0.0	2.7	9.8	0.0	0.0	10.4	0.0	0.0	6.4	2.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.5	0.0	0.0	23.2	1.5	34.7	41.2	14.6	0.0	0.0	0.0	1.2	20.4	7.6	22.5	13.5	5.2	0.0	0.5	7.0	0.2	19.1	0.0	0.0	4.4	0.0	0.0	0.0	0.0	0.0	0.0	12.4	0.2	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.9	0.2	0.1	0.2	3.1	0.6	0.4	0.9	0.0	0.4	1.0	0.3	12.3	15.1	14.0	12.9	10.6	12.6	12.4	14.4	12.7	11.0	15.0	12.0	18.6	3.2	5.0	43.4	1.6	1.0	10.9	4.2	6.2	26.4	13.4	12.6	1.6	5.7	2.4	18.4	0.0	0.0	1.0	90.8	29.4	7.3	0.6	18.1	8.5	11.9	13.1	3.2	5.6	2.4	0.1	5.9	1.5	26.8	1.3	6.1	5.7	0.9	7.5	35.3	10.8	25.8	8.2	1.3	0.8	2.2	11.8	1.6	28.4	31.9	1.1	11.0	0.0	29.1	16.6	5.3	105.3	6.0	0.2	28.1	233.5	8.9	1.3	2.8	13.1	0.5	6.4	0.4	2.3	0.5	0.6	0.4	3.8	16.9	24.4	15.0
PDF		ENSG00000258429	"Peptide deformylase, mitochondrial"	Q9HBH1	16	69326913-69330588	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Protein biosynthesis"	Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 27.8"	"Cell type enhanced"	"Detected in some"		"Basal squamous epithelial cells: 8.0;Erythroid cells: 4.6;Gastric mucus-secreting cells: 8.6;Plasma cells: 14.7;Squamous epithelial cells: 17.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"							HPA063409	Approved		Approved	Nucleoplasm,Mitochondria	"Intracellular and membrane"	No	No			"Cluster 24: B-cells - Unknown function"	"Cluster 81: Kidney & Liver - Metabolism"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 59: Non-specific - Transcription"	Mitochondria	Nucleoplasm	"HPA063409: AB_2685007"	"unprognostic (4.28e-2)"	"prognostic unfavorable (4.63e-4)"	"unprognostic (1.37e-1)"	"unprognostic (1.47e-1)"	"unprognostic (2.85e-1)"	"prognostic unfavorable (2.73e-4)"	"unprognostic (2.98e-3)"	"prognostic unfavorable (7.35e-4)"	"unprognostic (5.84e-2)"	"unprognostic (4.35e-1)"	"unprognostic (1.02e-1)"	"unprognostic (1.00e-1)"	"prognostic favorable (6.11e-4)"	"unprognostic (4.78e-2)"	"unprognostic (1.05e-1)"	"unprognostic (5.98e-2)"	"unprognostic (1.22e-2)"	5.9	8.7	1.0	0.9	1.3	1.4	5.5	1.9	1.8	4.4	1.5	5.6	2.1	5.8	0.4	10.2	4.7	0.5	5.3	2.2	0.8	19.0	27.8	4.4	1.1	1.4	0.8	3.1	8.8	1.6	4.3	0.6	1.0	5.0	0.8	0.3	7.2	0.6	12.4	7.7	5.2	0.4	0.8	5.1	5.6	4.8	0.9	0.6	5.9	0.8	0.7	4.8	4.8	1.5	6.3	4.8	1.3	4.1	1.1	0.8	7.7	6.0	1.0	2.9	2.4	8.6	5.7	13.1	6.2	1.6	2.2	11.5	1.8	2.1	1.3	3.5	23.3	6.6	5.3	12.6	1.8	10.8	5.7	1.7	4.3	2.5	1.2	0.8	1.5	7.2	16.1	2.4	1.9	7.6	9.2	8.3	6.4	2.6	7.1	20.8	2.1	11.0	2.2	5.4	9.3	7.1	10.8	2.9	5.2	0.3	11.0	3.3	4.6	3.9	6.4	5.8	6.8	12.1	9.4	15.2	3.1	6.9	5.9	1.4	0.7	1.0	0.4	0.3	0.9	1.2	1.0	1.2	0.6	4.1	1.5	0.7	0.0	0.4	0.4	1.3	0.9	0.3	1.0	1.3	1.9	1.8	2.2	0.8	1.4	0.8	1.0	0.8	0.9	1.5	0.2	3.2	0.0	0.0	3.0	0.0	0.1	0.0	8.0	0.0	0.3	0.1	0.4	0.0	0.0	0.0	0.0	0.1	0.2	0.1	0.0	0.0	0.0	0.5	0.3	0.6	0.0	4.6	0.0	0.2	0.3	1.2	8.6	0.5	0.0	0.2	0.4	0.8	0.2	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.4	14.7	0.1	0.4	1.1	0.0	0.0	0.0	0.1	0.8	0.2	0.1	17.7	0.4	0.3	1.4	0.1	0.0	0.1
PDP1	"PDH, PDP, PPM2A, PPM2C"	ENSG00000164951	"Pyruvate dehyrogenase phosphatase catalytic subunit 1"	Q9P0J1	8	93857807-93926068	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"		"Hydrolase, Protein phosphatase"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Cardiomyocytes: 80.0;Early spermatids: 144.2"	"Low cancer specificity"	"Detected in all"			"Group enriched"	"Detected in many"	8	"amygdala: 14.2;basal ganglia: 20.1;cerebral cortex: 41.7;hippocampal formation: 23.4;white matter: 18.5"	"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"GAMG: 117.8;hTERT-RPE1: 117.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA018483, HPA019081, HPA021152"	Uncertain		Approved	Nucleoplasm,Mitochondria,Cytosol		Yes	No			"Cluster 27: Non-specific - Gene expression"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 29: Early spermatids - Spermatogenesis"	"Nucleoplasm, Mitochondria, Cytosol"		"HPA018483: AB_1855634, HPA019081: AB_1855633, HPA021152: AB_1855635"	"prognostic unfavorable (8.61e-5)"	"unprognostic (4.62e-1)"	"unprognostic (8.79e-2)"	"unprognostic (1.09e-1)"	"unprognostic (9.46e-2)"	"unprognostic (1.38e-1)"	"unprognostic (1.59e-1)"	"unprognostic (1.18e-2)"	"unprognostic (1.00e-1)"	"prognostic unfavorable (5.60e-4)"	"unprognostic (1.71e-2)"	"unprognostic (3.25e-1)"	"prognostic favorable (8.42e-9)"	"unprognostic (1.85e-1)"	"unprognostic (1.84e-1)"	"unprognostic (5.04e-2)"	"unprognostic (1.67e-1)"	10.6	62.6	14.2	10.5	20.1	14.4	16.1	0.0	41.7	14.2	1.2	8.9	7.2	15.5	17.0	14.2	12.2	19.4	49.2	23.4	0.0	12.8	4.2	12.6	12.9	0.0	2.3	19.3	19.9	29.9	5.4	13.8	0.0	10.3	12.4	14.1	11.7	9.4	72.9	4.3	7.6	11.2	0.0	13.2	11.7	26.7	3.0	11.6	18.8	16.9	12.4	14.0	6.8	18.5	25.7	12.0	25.9	10.9	21.0	37.9	8.6	19.3	21.7	22.1	25.8	12.7	90.3	13.9	63.8	30.8	117.8	54.4	11.0	16.1	32.8	1.5	5.6	6.6	15.7	4.5	23.9	3.3	9.0	24.5	31.5	37.7	59.8	117.1	50.9	12.4	2.4	22.8	27.6	6.0	20.3	10.3	12.1	26.8	15.4	4.8	15.5	2.6	15.3	17.0	2.4	11.4	12.7	1.4	61.8	20.9	4.0	3.9	90.9	27.5	17.2	63.8	23.3	12.6	5.8	12.1	34.2	11.7	25.1	6.4	27.9	14.5	9.2	25.3	8.9	15.6	15.1	12.0	22.5	17.9	8.9	7.8	3.1	5.4	41.1	3.7	34.9	18.0	14.2	20.1	0.0	41.7	23.4	0.0	0.0	2.3	0.0	0.0	3.0	18.5	10.7	12.8	7.8	15.0	18.0	13.0	12.7	36.3	68.9	38.3	11.6	7.0	80.0	14.3	35.6	16.5	8.4	4.3	13.7	27.5	5.9	33.3	144.2	33.3	14.9	15.0	10.2	1.3	73.6	14.0	3.9	20.8	16.3	70.2	6.3	3.7	12.5	3.3	6.3	10.1	23.4	5.5	10.2	19.2	19.1	28.1	11.5	19.9	10.6	19.7	22.4	18.8	10.3	13.0	8.5	24.5	9.6	13.5	8.1	15.6	4.9	11.4	30.5	11.5	6.6	35.4	13.1	10.1	11.4	26.5	10.9	4.4	19.3	7.1	10.7	23.9
PDP2	"KIAA1348, PPM2B, PPM2C2"	ENSG00000172840	"Pyruvate dehyrogenase phosphatase catalytic subunit 2"	Q9P2J9	16	66878589-66895754	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Hydrolase, Protein phosphatase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Alveolar cells type 2: 22.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA019950, HPA062059"	Approved		Approved	Mitochondria		NA	NA			"Cluster 48: NK-cells - Unknown function"	"Cluster 7: Kidney - Transmembrane transport"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 11: Alveolar cells - Smell perception"	Mitochondria		"HPA019950: AB_1855156, HPA062059: AB_2684671"	"unprognostic (8.42e-2)"	"unprognostic (1.09e-1)"	"unprognostic (1.19e-2)"	"unprognostic (1.31e-1)"	"unprognostic (2.31e-2)"	"unprognostic (5.44e-2)"	"unprognostic (1.17e-1)"	"unprognostic (4.90e-3)"	"unprognostic (1.57e-1)"	"unprognostic (7.24e-2)"	"unprognostic (1.03e-1)"	"unprognostic (1.39e-1)"	"prognostic favorable (9.75e-7)"	"unprognostic (1.89e-1)"	"unprognostic (5.10e-1)"	"unprognostic (3.20e-1)"	"unprognostic (6.15e-2)"	6.0	2.6	3.6	1.8	4.6	1.5	3.6	6.9	5.2	2.0	7.7	3.8	5.4	2.6	3.4	3.7	3.4	2.0	1.8	3.6	4.3	9.2	8.6	3.4	2.6	6.2	4.6	7.4	4.5	6.1	3.0	4.0	6.8	3.8	4.1	5.0	3.6	2.6	2.5	2.1	3.2	2.1	3.5	2.0	3.0	3.8	5.7	2.5	9.3	4.1	3.0	2.1	2.2	4.3	9.8	11.7	7.1	14.1	18.7	9.6	8.9	5.0	19.2	11.3	17.0	23.9	6.7	13.5	6.9	6.9	10.8	12.1	20.8	11.3	10.9	3.2	10.5	6.8	5.9	15.9	10.1	8.8	11.5	7.4	8.3	16.1	16.6	12.3	4.9	14.9	13.3	9.5	10.3	6.3	17.1	6.2	8.4	6.5	14.7	16.7	9.9	21.4	6.0	10.3	14.3	8.0	15.9	6.5	6.0	5.5	8.7	4.3	4.6	7.0	9.2	4.2	7.5	16.6	16.9	13.4	9.5	6.9	7.0	1.1	0.2	1.2	3.8	0.1	3.1	1.0	1.8	3.2	0.8	2.1	2.6	3.0	0.7	4.2	0.1	0.5	0.6	1.3	3.6	4.6	6.9	5.2	3.6	4.3	6.2	4.6	6.8	3.5	5.7	4.3	2.5	9.6	22.9	8.1	3.1	5.2	6.4	1.3	6.2	9.6	5.8	4.2	5.1	8.6	3.1	9.2	14.6	12.8	3.3	13.3	7.9	3.4	0.2	3.5	3.2	3.3	3.6	0.8	8.8	2.9	2.2	4.1	3.1	4.3	6.3	14.4	7.1	20.5	2.4	5.0	7.6	4.2	2.0	1.3	0.4	2.4	3.1	1.2	3.6	3.7	0.4	8.1	7.2	4.5	4.3	3.4	6.6	4.5	4.5	8.9	7.4	9.9	1.2	6.7	0.0	5.9	2.7	12.6	5.7	8.0	2.4	3.6	3.4	4.0	5.5	6.5
PDXP	"CIN, dJ37E16.5, FLJ32703"	ENSG00000241360	"Pyridoxal phosphatase"	Q96GD0	22	37658723-37666932	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 209.2"	"Cell type enhanced"	"Detected in some"		"Excitatory neurons: 19.4;Inhibitory neurons: 25.0;Microglial cells: 7.5;Oligodendrocyte precursor cells: 8.0;Oligodendrocytes: 5.8;Plasma cells: 9.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in some"	8	"plasmacytoid DC: 11.6"	"Lineage enriched"	"Detected in many"	8	"dendritic cells: 11.6"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA000531	Approved					NA	NA		94000	"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 65: Brain - Ion transport"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"			"HPA000531: AB_2666018"	"unprognostic (6.29e-2)"	"unprognostic (7.89e-3)"	"unprognostic (1.00e-1)"	"unprognostic (2.89e-1)"	"unprognostic (2.15e-2)"	"unprognostic (3.25e-2)"	"unprognostic (2.81e-1)"	"unprognostic (4.44e-2)"	"unprognostic (2.54e-1)"	"unprognostic (1.46e-1)"	"unprognostic (1.57e-3)"	"unprognostic (2.76e-2)"	"unprognostic (1.77e-1)"	"unprognostic (3.03e-3)"	"unprognostic (2.04e-1)"	"unprognostic (4.66e-2)"	"unprognostic (2.38e-1)"	5.8	23.7	144.7	0.8	158.7	5.8	5.3	106.1	209.2	6.7	83.0	20.6	26.5	8.5	5.6	3.8	8.0	3.9	26.3	165.0	129.2	15.9	74.5	5.7	7.5	117.5	130.0	8.5	13.5	9.5	39.6	1.1	119.8	7.3	11.6	29.6	12.0	6.0	15.8	3.4	32.2	7.2	109.2	14.3	11.9	27.0	137.8	13.5	5.9	14.1	9.5	7.8	3.8	148.0	8.6	19.6	39.4	34.4	12.0	3.7	5.3	18.9	9.7	34.0	26.7	9.9	1.2	54.0	18.8	9.8	28.5	4.4	52.8	0.6	28.5	16.9	105.2	11.0	26.6	41.2	8.3	39.2	47.0	1.8	4.7	17.6	23.7	14.0	15.6	61.1	33.3	31.1	29.9	12.3	74.3	61.3	20.6	15.2	46.4	58.5	28.5	39.7	14.6	1.1	89.5	57.8	17.8	15.4	36.1	17.2	5.0	31.8	9.8	28.7	36.6	30.2	37.6	33.0	44.1	57.4	27.2	14.3	38.5	0.0	0.3	0.5	0.9	0.5	0.1	1.3	0.4	0.5	0.6	1.2	0.3	0.1	0.3	0.9	0.4	11.6	0.5	0.2	144.7	158.7	106.1	209.2	165.0	129.2	117.5	130.0	119.8	109.2	137.8	148.0	0.1	0.0	0.6	3.3	2.8	0.0	0.0	0.0	2.8	1.0	0.1	0.3	0.6	0.0	0.0	0.0	0.0	0.0	0.1	0.9	0.0	0.0	0.0	0.2	0.4	0.1	0.0	2.1	19.4	0.0	0.0	0.1	0.0	0.1	0.0	0.1	0.0	0.5	0.0	0.0	25.0	0.7	0.0	0.0	0.0	0.0	0.0	0.5	0.0	7.5	0.1	0.2	0.0	8.0	5.8	0.1	0.1	0.0	9.7	0.0	1.7	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.9	0.0	0.0	0.9	0.2	0.4	0.1
PEPD		ENSG00000124299	"Peptidase D"	P12955	19	33386950-33521791	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Collagen degradation"	"Dipeptidase, Hydrolase, Metalloprotease, Protease"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"intestine: 209.5;kidney: 277.7"	"Group enriched"	"Detected in all"	4	"Proximal enterocytes: 833.0;Proximal tubular cells: 1278.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA015599, HPA072045"	Enhanced		Approved	Nucleoplasm		NA	NA		860000000	"Cluster 39: Non-specific - mRNA processing"	"Cluster 87: Intestine & Kidney - Transmembrane transport"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Nucleoplasm		"HPA015599: AB_1855192, HPA072045: AB_2732194"	"unprognostic (1.39e-1)"	"unprognostic (2.62e-2)"	"unprognostic (2.27e-1)"	"unprognostic (4.01e-2)"	"unprognostic (2.98e-1)"	"unprognostic (6.77e-2)"	"unprognostic (2.82e-1)"	"unprognostic (3.64e-2)"	"unprognostic (3.96e-1)"	"unprognostic (5.10e-2)"	"unprognostic (1.11e-2)"	"unprognostic (1.99e-1)"	"prognostic favorable (6.50e-9)"	"unprognostic (4.38e-2)"	"unprognostic (1.99e-1)"	"unprognostic (1.65e-1)"	"unprognostic (1.29e-1)"	53.2	56.0	28.5	26.9	35.5	14.3	43.6	35.6	30.5	36.9	33.5	44.2	180.5	49.7	9.9	42.8	34.2	31.2	24.3	28.7	30.9	277.7	117.8	38.1	30.7	36.2	30.8	35.9	27.1	29.3	42.5	21.9	36.3	23.6	14.8	11.8	33.6	22.9	35.6	43.1	209.5	24.5	34.6	38.2	33.6	18.3	33.4	20.8	37.0	23.2	21.3	40.1	28.2	43.4	43.2	118.7	26.4	53.1	114.9	44.9	80.6	37.4	65.3	45.6	52.7	104.7	34.2	18.8	53.5	73.2	33.9	11.2	39.5	28.5	23.4	51.3	50.4	107.7	24.6	108.3	91.6	29.6	128.8	63.6	29.0	38.2	18.3	27.8	56.4	34.4	22.7	49.4	44.2	54.3	19.0	11.7	46.2	79.6	48.8	45.3	41.0	51.2	39.4	108.8	40.3	106.4	64.2	31.3	62.5	18.2	25.1	36.3	56.6	48.3	46.6	62.3	41.8	45.2	59.1	13.1	49.5	48.2	65.8	113.7	117.2	8.3	75.5	123.6	65.5	49.6	74.0	69.8	100.6	50.5	47.1	55.6	6.1	55.6	92.5	31.0	76.1	119.6	28.5	35.5	35.6	30.5	28.7	30.9	36.2	30.8	36.3	34.6	33.4	43.4	56.9	22.4	27.4	11.4	29.0	19.4	32.9	36.0	11.4	33.3	16.2	24.4	13.3	52.9	23.8	73.5	4.2	21.4	32.6	17.6	197.6	77.2	8.0	15.0	20.1	50.7	17.3	25.4	19.9	44.2	67.3	38.6	18.3	13.0	57.6	41.9	52.8	180.3	227.2	62.2	14.9	35.6	30.5	59.7	40.9	13.2	49.4	75.3	67.6	15.9	102.2	73.6	34.0	21.6	24.3	33.8	79.3	60.5	31.5	22.9	833.0	1278.3	27.1	33.7	39.5	37.0	43.1	10.2	44.5	34.3	20.3	30.4	33.7	48.7	44.6	22.2
PFKFB1	PFRX	ENSG00000158571	"6-phosphofructo-2-kinase/fructose-2,6-biphosphatase 1"	P16118	X	54932961-54998534	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Hydrolase, Kinase, Multifunctional enzyme, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	6	"adipose tissue: 28.3;liver: 50.2;skeletal muscle: 111.6;tongue: 40.8"	"Cell type enriched"	"Detected in some"	5	"Hepatocytes: 15.9"	"Cancer enriched"	"Detected in some"	11	"liver cancer: 7.9"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"ASC diff: 8.5;Hep G2: 3.2"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in many"									NA	NA			"Cluster 21: B-cells - Adaptive immune response"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 15: Hepatocytes - Hemostasis"				"unprognostic (2.51e-1)"	"unprognostic (2.39e-2)"	"unprognostic (1.17e-2)"	"unprognostic (4.38e-3)"	"unprognostic (1.64e-1)"	"unprognostic (6.12e-2)"	"unprognostic (1.18e-3)"	"unprognostic (1.51e-1)"	"unprognostic (2.50e-1)"	"unprognostic (3.33e-1)"	"unprognostic (3.26e-3)"	"unprognostic (2.88e-1)"	"unprognostic (5.36e-3)"	"unprognostic (5.06e-1)"	"unprognostic (4.87e-2)"	"unprognostic (1.16e-4)"	"unprognostic (1.96e-3)"	28.3	0.5	0.4	0.1	0.5	0.4	9.2	0.3	0.5	0.1	0.1	0.4	0.1	0.1	0.6	1.1	0.1	0.3	0.3	0.4	0.4	1.1	50.2	0.2	0.5	0.5	0.4	0.0	1.2	0.3	0.5	0.2	0.4	0.3	0.5	0.4	0.7	0.2	111.6	0.8	0.5	0.1	0.4	0.3	0.4	0.4	0.4	0.4	1.0	40.8	0.6	0.2	0.2	0.5	0.2	0.1	0.2	0.4	8.5	0.1	0.6	0.0	0.1	0.1	0.0	0.5	0.1	0.4	0.1	0.0	0.4	0.3	0.1	0.2	0.3	0.3	0.7	0.2	0.1	3.2	0.0	0.0	0.3	0.1	0.4	0.0	0.2	0.0	0.0	0.8	0.1	1.4	0.1	0.5	0.4	0.2	0.2	0.2	0.2	0.3	0.1	0.1	0.0	0.2	0.2	0.1	0.3	1.0	0.1	0.7	0.2	0.0	0.1	0.1	0.3	0.2	0.1	0.7	1.2	0.2	0.1	0.2	0.1	0.0	0.0	0.0	0.0	0.1	0.3	0.2	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.4	0.5	0.3	0.5	0.4	0.4	0.5	0.4	0.4	0.4	0.4	0.5	0.1	0.0	0.0	2.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.7	15.9	0.1	0.0	1.5	0.1	0.0	0.9	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.5	3.1	0.1	0.1	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.5	0.3	0.4	0.0	0.0	0.1	0.1	0.0	0.0	0.0
PFKFB2		ENSG00000123836	"6-phosphofructo-2-kinase/fructose-2,6-biphosphatase 2"	O60825	1	207034366-207081024	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Hydrolase, Kinase, Multifunctional enzyme, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"retina: 83.3"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 105.1;Cardiomyocytes: 79.0;Late spermatids: 158.2;Rod photoreceptor cells: 110.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	6	"eosinophil: 20.8;plasmacytoid DC: 23.8"	"Group enriched"	"Detected in many"	8	"dendritic cells: 23.8;granulocytes: 20.8"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA049975, HPA063575"	Uncertain		Enhanced	Nucleoplasm		NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 54: Non-specific - Microtubule organization"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 65: Plasmacytoid DCs - Unknown function"	Nucleoplasm		"HPA049975: AB_2680977, HPA063575: AB_2685046"	"unprognostic (1.30e-1)"	"unprognostic (6.66e-2)"	"unprognostic (1.48e-1)"	"unprognostic (1.75e-2)"	"unprognostic (2.27e-1)"	"unprognostic (3.76e-2)"	"unprognostic (9.96e-3)"	"unprognostic (9.74e-2)"	"unprognostic (7.27e-2)"	"unprognostic (2.27e-2)"	"unprognostic (6.01e-2)"	"unprognostic (1.30e-1)"	"prognostic favorable (3.23e-7)"	"unprognostic (1.54e-2)"	"unprognostic (1.27e-1)"	"prognostic unfavorable (8.63e-4)"	"unprognostic (1.86e-2)"	4.3	6.8	13.2	8.3	14.5	23.5	6.4	8.6	15.2	9.1	42.5	22.2	32.2	5.0	11.6	9.6	5.7	5.8	36.0	13.9	11.4	29.7	4.0	13.3	7.0	13.3	13.8	5.2	16.0	15.3	23.1	3.9	12.2	4.8	24.1	83.3	7.6	4.1	49.5	8.1	22.2	5.0	9.7	15.0	15.5	7.0	19.3	20.2	51.7	42.7	6.7	4.2	4.2	18.4	15.0	6.5	4.2	7.3	8.4	4.1	6.9	2.1	2.5	3.6	2.0	16.0	21.1	2.7	3.3	3.3	10.8	20.8	3.1	7.9	2.1	0.6	3.2	21.1	17.4	5.9	7.0	0.0	14.2	5.9	11.7	3.5	19.1	4.3	0.8	8.7	14.6	0.1	2.0	4.5	3.6	0.6	5.8	7.2	9.7	0.0	0.0	0.4	4.9	15.3	6.6	4.0	13.7	22.8	17.4	4.5	15.6	1.8	0.4	0.0	7.6	11.0	1.9	6.6	7.0	1.4	8.8	0.0	3.9	1.6	1.2	20.8	0.3	2.6	0.4	1.9	0.2	0.4	1.1	2.3	0.5	0.6	3.5	1.6	1.9	23.8	0.0	0.7	13.2	14.5	8.6	15.2	13.9	11.4	13.3	13.8	12.2	9.7	19.3	18.4	1.0	6.4	54.8	105.1	5.0	15.2	3.8	5.0	10.2	7.0	3.7	4.2	79.0	4.3	8.7	16.5	0.0	0.7	24.6	53.8	25.4	5.0	51.0	18.0	3.7	4.2	6.0	0.8	14.5	7.6	0.4	4.6	14.8	21.3	9.5	2.3	2.5	5.8	5.6	3.3	13.0	20.1	8.2	13.6	4.9	158.2	2.8	8.5	21.4	11.2	5.4	9.8	5.2	4.5	10.6	16.6	26.2	3.0	3.8	13.5	45.4	32.8	15.3	110.5	0.0	3.3	3.1	5.1	3.2	9.9	11.6	1.5	1.6	7.5	36.9	11.5
PFKFB3		ENSG00000170525	"6-phosphofructo-2-kinase/fructose-2,6-biphosphatase 3"	Q16875	10	6144934-6254644	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"		"Hydrolase, Kinase, Multifunctional enzyme, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"adipose tissue: 334.6;skeletal muscle: 621.3"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 153.8;Collecting duct cells: 195.0;Langerhans cells: 132.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"neutrophil: 26.4"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"A549: 296.2;RPTEC TERT1: 181.8;T-47d: 192.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA008266, CAB020795, HPA043889"	Uncertain		Enhanced	Nucleoplasm		NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 6: T47d - Mammary gland"	"Cluster 41: Macrophages - Immune response"	Nucleoplasm		"CAB020795: , HPA008266: AB_1855239, HPA043889: AB_2678717"	"unprognostic (1.61e-1)"	"unprognostic (5.08e-3)"	"unprognostic (2.89e-2)"	"unprognostic (6.18e-2)"	"unprognostic (2.29e-1)"	"unprognostic (1.79e-1)"	"unprognostic (3.11e-3)"	"unprognostic (1.88e-1)"	"unprognostic (1.03e-1)"	"unprognostic (1.04e-1)"	"unprognostic (3.30e-2)"	"unprognostic (7.34e-2)"	"prognostic unfavorable (1.87e-7)"	"unprognostic (1.89e-2)"	"unprognostic (1.19e-1)"	"unprognostic (1.13e-1)"	"unprognostic (2.74e-1)"	334.6	22.7	66.1	72.2	81.2	246.0	153.8	75.4	66.6	30.2	22.1	22.2	19.4	24.0	11.1	51.3	37.7	59.9	21.9	62.8	105.8	243.9	32.8	67.7	24.5	145.7	100.9	24.2	21.0	10.1	39.6	20.0	100.9	20.2	8.9	31.5	40.4	49.5	621.3	53.6	22.9	16.9	90.1	50.2	26.1	13.9	91.8	15.1	10.9	30.4	28.2	63.9	40.3	105.6	22.0	296.2	23.1	18.8	85.2	10.5	12.2	31.6	22.5	22.9	35.5	14.1	78.0	37.2	20.2	13.8	18.0	69.0	24.9	50.2	26.3	44.6	17.3	22.1	16.2	5.2	7.2	21.6	32.2	7.6	16.4	39.5	9.5	58.3	44.9	25.6	16.6	13.6	18.6	35.7	15.3	20.3	22.5	31.1	20.5	34.3	11.3	14.7	181.8	11.1	21.9	8.9	22.9	24.7	45.8	39.5	192.0	25.2	57.0	23.9	22.0	3.1	38.7	27.8	10.4	33.7	65.8	25.0	37.4	2.9	7.5	7.7	2.2	9.2	5.7	1.8	4.2	2.9	4.7	1.6	3.0	3.0	26.4	1.2	5.5	2.9	4.3	4.3	66.1	81.2	75.4	66.6	62.8	105.8	145.7	100.9	100.9	90.1	91.8	105.6	37.1	76.9	55.1	153.8	27.2	102.6	16.7	21.5	37.5	6.4	37.1	36.8	19.5	22.8	32.1	195.0	52.1	0.4	37.0	14.9	0.0	54.7	5.0	41.1	18.9	32.9	8.5	1.3	42.8	25.7	6.9	30.8	33.1	64.3	44.2	72.5	8.9	15.8	20.6	6.7	19.4	6.6	18.3	88.0	132.3	9.5	2.8	122.2	46.2	41.2	19.6	0.3	4.1	14.1	31.9	59.6	5.2	7.2	25.3	4.2	5.4	2.4	19.2	1.9	0.0	58.5	24.4	0.6	2.5	20.9	63.9	1.0	61.7	12.4	8.1	14.7
PFKFB4		ENSG00000114268	"6-phosphofructo-2-kinase/fructose-2,6-biphosphatase 4"	Q16877	3	48517684-48562015	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Hydrolase, Kinase, Multifunctional enzyme, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Extravillous trophoblasts: 40.3;Proximal enterocytes: 43.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"classical monocyte: 12.5;eosinophil: 21.9;intermediate monocyte: 13.8;neutrophil: 40.4;non-classical monocyte: 25.1"	"Group enriched"	"Detected in many"	6	"granulocytes: 40.4;monocytes: 25.1"	"Cell line enhanced"	"Detected in many"		"hTERT-RPE1: 52.5;U-87 MG: 83.9;WM-115: 74.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA047719, HPA066058"	Uncertain		Approved	Nucleoli		NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 58: Brain - Synaptic function"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 38: Extravillous trophoblasts - Unknown function"	Nucleoli		"HPA047719: AB_2680129, HPA066058: AB_2685606"	"unprognostic (7.60e-2)"	"prognostic unfavorable (3.04e-4)"	"unprognostic (1.01e-1)"	"unprognostic (1.19e-1)"	"unprognostic (3.90e-3)"	"unprognostic (7.96e-2)"	"unprognostic (1.72e-6)"	"unprognostic (1.65e-1)"	"unprognostic (3.75e-2)"	"unprognostic (6.78e-2)"	"unprognostic (3.78e-2)"	"unprognostic (7.13e-2)"	"prognostic unfavorable (3.91e-8)"	"unprognostic (2.04e-1)"	"unprognostic (6.28e-2)"	"unprognostic (2.43e-3)"	"unprognostic (3.35e-2)"	1.8	2.5	5.1	4.0	5.5	14.8	1.9	6.1	6.3	3.3	3.4	3.3	18.4	2.0	18.0	7.3	1.6	1.6	1.5	5.1	6.5	3.5	1.7	4.2	1.5	6.8	6.4	3.3	11.2	3.2	5.2	10.2	6.9	3.6	3.4	16.1	2.7	1.3	5.4	3.8	20.8	2.4	5.9	10.3	1.3	24.0	7.7	1.3	1.6	3.4	1.1	2.0	5.8	6.7	12.0	3.9	8.3	8.1	2.8	4.0	16.6	6.1	10.4	11.9	29.3	6.0	4.2	5.5	5.8	4.6	28.4	3.5	3.6	10.6	10.6	3.5	2.9	12.3	9.3	6.7	2.5	2.3	5.1	4.2	15.6	19.4	1.9	52.5	2.9	6.7	4.4	4.5	9.7	2.8	0.8	17.3	5.0	2.3	8.0	0.9	4.1	5.9	4.5	11.4	2.5	5.4	6.6	3.0	23.6	8.2	6.3	5.3	0.9	12.0	4.7	1.6	36.7	21.6	4.4	3.2	83.9	4.3	74.8	0.0	12.5	21.9	0.4	13.8	0.1	0.3	0.6	0.1	5.1	0.2	1.0	0.3	40.4	0.5	25.1	0.6	0.0	4.9	5.1	5.5	6.1	6.3	5.1	6.5	6.8	6.4	6.9	5.9	7.7	6.7	0.1	0.0	1.3	13.1	0.3	3.2	0.3	7.0	1.8	6.3	1.6	1.3	1.0	2.8	2.1	0.0	2.1	13.8	0.2	1.3	0.0	2.9	2.8	1.9	2.4	0.8	4.2	0.4	4.5	1.5	40.3	1.2	0.5	3.3	1.3	2.0	1.1	1.0	6.0	6.7	7.3	13.0	2.0	7.8	0.5	2.6	0.9	7.3	1.8	3.7	3.5	3.3	1.0	6.0	13.9	2.9	1.4	0.7	1.8	0.4	43.6	0.2	2.7	4.4	0.0	0.1	1.5	0.5	0.8	2.5	1.7	5.5	0.9	1.3	3.7	0.1
PGA3		ENSG00000229859	"Pepsinogen A3"	P0DJD8	11	61203307-61213098	"Enzymes, Predicted intracellular proteins, Predicted secreted proteins"	Digestion	"Aspartyl protease, Hydrolase, Protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	613	"stomach 1: 89073.4"	"Cell type enriched"	"Detected in some"	526	"Gastric mucus-secreting cells: 3263.5"	"Cancer enriched"	"Detected in single"	498	"stomach cancer: 24.8"	"Region enhanced"	"Detected in single"		"hippocampal formation: 2.9"	"Low immune cell specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"HMC-1: 2.8;THP-1: 1.1"									"CAB026358, HPA046875"	Enhanced				"Secreted to digestive system"	NA	NA			"Cluster 7: Monocytes - Unknown function"	"Cluster 4: Stomach - Digestion"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 16: Pancreatic endocrine cells - Mixed function"			"CAB026358: , HPA046875: AB_2679851"										"unprognostic (6.39e-2)"				"unprognostic (1.11e-1)"				80.5	10.0	0.5	0.2	0.2	0.2	18.2	0.7	0.9	11.1	0.0	145.3	1.3	3.8	0.0	96.4	4.5	0.1	11.4	2.9	0.0	5.4	16.2	6.2	0.0	0.0	0.0	5.4	13.0	0.0	13.4	0.5	0.1	5.5	0.1	0.9	6.8	0.7	4.4	6.0	5.7	0.4	0.0	6.3	89073.4	7.3	0.0	0.1	5.0	0.5	0.1	6.2	6.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	2.8	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.6	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.8	0.1	0.7	1.3	0.4	0.1	0.2	0.7	0.1	0.1	0.1	0.6	0.4	0.2	0.3	0.0	0.0	1.3	0.5	0.2	0.7	0.9	2.9	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.9	0.0	0.2	0.0	0.0	0.5	0.1	0.0	0.9	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.1	0.0	0.0	0.0	6.2	0.0	0.3	3263.5	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.8	0.5	0.0	0.0	0.7	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.2	0.0	0.0	1.1	0.1	0.0	0.1	0.0	3.1	0.0	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.4	0.2	0.0	0.1
PGA4		ENSG00000229183	"Pepsinogen A4"	P0DJD7	11	61222349-61231694	"Enzymes, Predicted intracellular proteins, Predicted secreted proteins"	Digestion	"Aspartyl protease, Hydrolase, Protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	1281	"stomach 1: 66596.4"	"Cell type enriched"	"Detected in some"	8	"Exocrine glandular cells: 109.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	19	"classical monocyte: 9.9;intermediate monocyte: 10.9;non-classical monocyte: 3.4"	"Lineage enriched"	"Detected in single"	26	"monocytes: 10.9"	"Group enriched"	"Detected in some"	6	"BJ hTERT+: 26.1;HMC-1: 9.5;THP-1: 15.7"									HPA046875	Supported				"Secreted to digestive system"	NA	NA			"Cluster 7: Monocytes - Unknown function"	"Cluster 4: Stomach - Digestion"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 1: Pancreatic cells - Digestion"			"HPA046875: AB_2679851"										"unprognostic (2.22e-1)"								9.6	8.3	0.1	2.1	0.1	0.0	9.0	0.1	0.2	7.5	0.1	52.0	2.5	4.6	0.0	9.1	19.1	0.3	6.2	0.1	0.1	30.3	11.7	37.9	0.0	0.1	0.1	4.1	18.8	0.0	3.5	3.8	0.1	16.2	0.4	0.3	4.5	0.7	2.5	4.1	2.9	0.8	0.1	5.2	66596.4	4.3	0.1	0.1	3.1	0.0	0.2	5.0	5.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	26.1	0.0	0.0	0.0	0.0	0.0	2.6	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	9.5	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	2.0	0.0	1.6	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	15.7	0.0	0.0	1.1	0.1	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	9.9	0.0	0.0	10.9	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.1	0.3	0.0	3.4	0.0	0.0	1.8	0.1	0.1	0.1	0.2	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.6	0.0	0.0	0.0	0.0	0.0	0.0	109.1	0.0	0.0	13.3	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	2.6	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0
PGA5		ENSG00000256713	"Pepsinogen A5"	P0DJD9	11	61241175-61251444	"Enzymes, FDA approved drug targets, Predicted intracellular proteins, Predicted secreted proteins"	Digestion	"Aspartyl protease, Hydrolase, Protease"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	2014	"stomach 1: 39870.8"	"Cell type enriched"	"Detected in some"	77	"Exocrine glandular cells: 4383.1"	"Cancer enriched"	"Detected in some"	12	"stomach cancer: 15.0"	"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	29	"classical monocyte: 1.8;intermediate monocyte: 4.3;non-classical monocyte: 2.4"	"Lineage enriched"	"Detected in single"	44	"monocytes: 4.3"	"Cell line enriched"	"Detected in some"	19	"BJ hTERT+: 28.8"									HPA046875	Supported				"Secreted to digestive system"	NA	NA			"Cluster 7: Monocytes - Unknown function"	"Cluster 4: Stomach - Digestion"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 1: Pancreatic cells - Digestion"			"HPA046875: AB_2679851"				"unprognostic (1.36e-3)"	"unprognostic (2.98e-2)"		"unprognostic (5.83e-3)"			"unprognostic (2.11e-1)"	"unprognostic (4.22e-1)"		"unprognostic (4.36e-2)"	"unprognostic (2.16e-2)"	"unprognostic (1.05e-1)"	"unprognostic (7.10e-2)"		19.7	4.4	0.3	1.1	0.3	0.0	4.5	0.1	0.6	4.0	0.0	6.2	0.6	1.9	0.0	7.0	5.1	0.1	3.5	0.7	0.0	2.4	7.0	5.4	0.0	0.1	0.0	2.6	8.2	0.0	3.8	0.5	0.1	1.8	0.1	1.5	2.5	0.5	1.9	2.1	2.1	0.9	0.0	3.9	39870.8	2.3	0.0	0.2	3.1	0.2	0.1	2.3	2.5	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	28.8	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.4	0.0	0.0	0.0	0.1	0.0	0.0	0.5	0.0	0.0	0.0	0.4	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	1.0	0.0	0.0	0.0	0.4	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	4.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.4	0.0	0.0	0.3	0.3	0.3	0.1	0.6	0.7	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.5	0.0	0.0	0.0	0.0	0.0	0.1	4383.1	0.0	0.1	56.6	0.0	0.0	0.2	0.0	0.0	6.7	0.0	0.0	0.0	0.0	5.1	0.0	1.6	0.9	1.3	0.0	0.0	1.0	25.1	0.0	0.0	0.0	8.2	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.4	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0
PGAM5	"BXLBv68, MGC5352"	ENSG00000247077	"PGAM family member 5, mitochondrial serine/threonine protein phosphatase"	Q96HS1	12	132710819-132722734	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	Necrosis	Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036978, HPA036979, CAB068215"	Enhanced		Supported	Mitochondria	"Intracellular and membrane"	NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 39: Non-specific - Basic cellular processes"	Mitochondria		"CAB068215: AB_2665674, HPA036978: AB_10964347, HPA036979: AB_10960559"	"unprognostic (9.57e-2)"	"unprognostic (2.00e-2)"	"unprognostic (3.83e-2)"	"unprognostic (3.11e-2)"	"unprognostic (3.46e-1)"	"unprognostic (1.39e-1)"	"prognostic unfavorable (1.13e-6)"	"unprognostic (3.32e-2)"	"unprognostic (1.47e-1)"	"unprognostic (5.67e-2)"	"unprognostic (1.23e-1)"	"unprognostic (6.92e-2)"	"unprognostic (6.42e-3)"	"unprognostic (1.63e-2)"	"unprognostic (1.71e-1)"	"unprognostic (1.19e-1)"	"unprognostic (5.53e-2)"	10.5	17.7	13.0	17.0	12.7	16.3	9.7	12.7	17.0	9.8	10.1	16.1	15.2	10.9	6.6	23.9	12.4	8.7	20.0	19.0	12.5	14.3	28.9	9.3	21.2	9.3	9.7	7.2	25.8	10.7	9.9	10.7	10.1	9.4	11.3	6.0	15.5	11.5	33.2	17.1	13.2	11.3	7.9	12.8	13.3	16.5	10.8	14.8	11.6	19.0	16.1	15.6	11.8	11.3	72.2	134.3	28.2	79.5	19.4	15.6	66.1	37.4	22.0	59.1	33.0	168.6	40.2	92.3	67.2	31.2	30.4	61.2	132.9	67.5	24.1	47.3	106.7	110.7	61.6	89.2	44.0	105.8	61.8	19.4	48.8	69.0	73.6	19.3	43.6	73.4	143.3	36.9	23.5	128.5	144.5	105.7	108.0	61.8	94.4	109.4	31.2	73.3	38.4	97.4	102.8	58.0	62.2	86.1	38.9	22.2	108.9	57.5	38.2	29.9	65.5	60.6	89.9	77.2	124.8	133.5	38.8	85.3	51.1	4.9	1.1	0.3	1.1	1.2	1.8	1.7	1.3	1.3	1.0	1.7	1.3	1.7	0.9	1.6	1.7	3.3	1.1	0.8	13.0	12.7	12.7	17.0	19.0	12.5	9.3	9.7	10.1	7.9	10.8	11.3	6.6	3.2	6.1	3.9	8.9	11.5	16.7	2.6	2.2	9.5	7.8	5.5	15.1	15.7	1.5	5.5	14.6	7.6	11.9	11.7	5.9	5.8	14.5	6.3	6.3	7.0	13.1	5.0	5.1	7.9	14.4	4.9	4.1	9.3	0.0	7.1	5.7	22.4	7.3	6.7	3.9	8.9	2.0	6.9	5.8	20.6	5.9	4.7	3.6	1.9	5.3	4.4	3.1	2.0	2.3	7.5	6.9	6.8	9.7	19.5	5.2	11.5	4.5	12.9	6.6	8.0	6.4	15.1	10.1	10.8	17.3	6.2	7.4	9.2	15.7	16.1
PGAP6	"M83, TMEM6, TMEM8, TMEM8A"	ENSG00000129925	"Post-glycosylphosphatidylinositol attachment to proteins 6"	Q9HCN3	16	370788-387113	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins, Transporters"		Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in some"	4	"Cytotrophoblasts: 63.7;Hofbauer cells: 29.2;Syncytiotrophoblasts: 100.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"neutrophil: 36.0"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"CACO-2: 129.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA051281, HPA064673"	Approved		Supported	"Nucleoplasm,Cytokinetic bridge"		Yes	No			"Cluster 9: Neutrophils - Innate immune response"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 18: Syncytiotrophoblasts - Pregnancy hormone signaling"	Nucleoplasm	"Cytokinetic bridge"	"HPA051281: AB_2681418, HPA064673: AB_2685317"	"unprognostic (5.84e-2)"	"unprognostic (6.13e-2)"	"unprognostic (3.85e-2)"	"unprognostic (3.21e-2)"	"unprognostic (5.77e-2)"	"unprognostic (3.19e-2)"	"unprognostic (1.13e-3)"	"unprognostic (1.56e-2)"	"unprognostic (8.89e-2)"	"unprognostic (7.73e-2)"	"unprognostic (3.43e-1)"	"unprognostic (1.38e-2)"	"prognostic favorable (1.29e-5)"	"unprognostic (4.20e-3)"	"unprognostic (3.19e-2)"	"unprognostic (4.93e-2)"	"unprognostic (2.48e-1)"	23.5	25.5	13.5	18.0	15.1	30.0	20.1	11.8	17.7	17.7	14.5	39.6	31.4	19.2	24.8	31.9	17.7	16.4	37.7	12.8	11.0	59.4	57.6	36.2	17.0	14.6	12.6	12.2	102.8	19.3	28.8	34.8	13.5	30.3	10.3	5.6	40.8	12.5	36.1	11.3	38.5	8.8	11.9	36.0	53.9	63.3	16.0	11.7	28.0	10.1	7.9	23.4	14.3	14.6	12.7	32.8	18.4	33.9	24.7	22.1	36.7	35.5	36.6	17.7	25.3	129.2	57.9	13.4	47.1	34.5	27.3	17.8	8.4	39.2	4.9	38.5	31.1	22.1	23.1	74.8	56.9	16.9	40.4	25.7	11.6	27.4	7.9	18.0	41.4	14.8	36.2	20.1	22.6	78.2	23.9	33.2	29.2	20.1	12.9	51.0	21.0	31.2	28.8	32.0	21.9	25.2	19.8	19.7	106.3	9.6	35.7	33.4	61.1	50.2	53.6	35.2	19.2	40.3	21.6	27.0	25.5	17.8	32.5	7.1	7.6	10.1	10.7	8.6	8.3	2.5	8.1	8.3	3.9	2.6	10.7	8.0	36.0	1.5	6.1	4.2	6.6	5.7	13.5	15.1	11.8	17.7	12.8	11.0	14.6	12.6	13.5	11.9	16.0	14.6	11.7	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	13.9	0.0	0.0	0.0	0.0	63.7	8.0	0.0	0.0	0.0	0.0	0.0	0.0	2.7	0.0	0.0	0.0	0.0	7.4	2.9	0.0	0.0	0.0	0.0	0.0	0.0	29.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.3	0.0	0.0	0.0	0.0	100.2	1.4	0.0	0.0	0.0
PGC		ENSG00000096088	Progastricsin	P20142	6	41736711-41754109	"Cancer-related genes, Enzymes, Predicted intracellular proteins, Predicted secreted proteins, Transporters"	Digestion	"Aspartyl protease, Hydrolase, Protease"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	45	"stomach 1: 59821.1"	"Group enriched"	"Detected in some"	10	"Gastric mucus-secreting cells: 5737.5;Pancreatic endocrine cells: 1449.1"	"Cancer enhanced"	"Detected in many"		"stomach cancer: 1050.3"	"Region enhanced"	"Detected in single"		"cerebellum: 1.2"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	11	"Hep G2: 253.1;OE19: 152.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA031717, HPA031718"	Enhanced		Approved	Nucleoplasm	"Secreted to digestive system"	NA	NA			"Cluster 7: Monocytes - Unknown function"	"Cluster 4: Stomach - Digestion"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 16: Pancreatic endocrine cells - Mixed function"	Nucleoplasm		"HPA031717: AB_10670130, HPA031718: AB_10610148"	"unprognostic (9.18e-2)"	"unprognostic (1.87e-1)"	"unprognostic (9.83e-2)"	"unprognostic (2.27e-1)"	"unprognostic (7.18e-2)"	"unprognostic (2.74e-1)"	"unprognostic (1.47e-1)"	"unprognostic (8.50e-2)"		"unprognostic (1.86e-1)"	"unprognostic (9.23e-2)"	"unprognostic (1.09e-1)"	"unprognostic (1.33e-2)"	"unprognostic (2.92e-1)"	"unprognostic (1.65e-1)"		"unprognostic (8.74e-2)"	19.4	7.0	0.0	0.3	0.1	0.2	6.6	1.2	0.5	6.7	0.0	26.4	1327.3	2.8	0.9	85.5	9.2	2.3	6.2	0.1	0.0	4.9	11.0	378.8	0.3	0.0	0.0	3.9	136.3	0.0	7.4	2.8	0.0	83.9	0.3	0.1	4.6	437.7	2.5	3.4	3.2	0.0	0.0	7.7	59821.1	4.2	0.0	0.1	2.2	0.0	0.3	3.8	4.1	0.4	0.0	0.0	0.0	0.0	0.0	0.0	15.5	0.0	0.1	0.0	0.0	18.4	0.0	0.0	0.6	0.0	0.0	3.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	253.1	0.0	0.3	6.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	4.5	0.9	5.7	152.2	0.0	2.9	0.0	6.2	0.0	0.2	0.0	0.7	0.0	0.0	0.0	0.3	0.0	2.8	0.0	0.0	3.7	0.1	0.0	4.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.2	0.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	25.6	335.2	0.0	4.4	0.4	2.8	0.0	0.0	0.0	0.3	0.8	0.3	87.2	5.0	0.0	0.0	1.2	0.0	0.3	0.0	4.6	0.0	0.4	0.0	1.1	0.0	0.0	0.3	131.2	1.5	0.9	5737.5	0.1	10.1	0.0	0.0	0.2	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.3	1.7	0.0	0.0	2.0	0.0	0.0	0.0	0.1	1449.1	2.1	0.0	2.4	85.2	0.1	0.2	3.0	0.0	0.0	0.0	0.6	0.0	0.5	0.0	0.0	4.1	2.6	0.0	0.2	4.2
PGGHG	"ATHL1, FLJ22635"	ENSG00000142102	"Protein-glucosylgalactosylhydroxylysine glucosidase"	Q32M88	11	289126-296107	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Glycosidase, Hydrolase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	6	"pancreas: 657.7"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 160.3;Alveolar cells type 2: 81.8;Breast glandular cells: 35.1;Club cells: 31.6;Collecting duct cells: 33.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"JURKAT: 132.8;U-266/70: 34.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in single"			"HPA039383, HPA058829"	Uncertain		Enhanced	Cytosol		NA	Yes			"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 25: Pancreas - Digestion"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 11: Alveolar cells - Smell perception"	Cytosol		"HPA039383: AB_10796225, HPA058829: AB_2683830"	"unprognostic (1.40e-3)"	"unprognostic (2.18e-1)"	"unprognostic (4.22e-2)"	"unprognostic (2.37e-1)"	"unprognostic (1.36e-2)"	"unprognostic (5.83e-2)"	"unprognostic (7.95e-3)"	"unprognostic (2.77e-2)"	"unprognostic (2.16e-2)"	"unprognostic (2.14e-2)"	"unprognostic (2.71e-2)"	"unprognostic (3.45e-1)"	"unprognostic (1.92e-3)"	"unprognostic (2.85e-3)"	"unprognostic (1.09e-2)"	"unprognostic (1.22e-1)"	"prognostic favorable (5.12e-4)"	25.3	5.6	5.8	41.6	5.8	16.3	41.9	5.5	25.6	56.0	6.8	25.2	50.5	21.6	32.7	14.1	34.6	18.9	18.8	5.4	5.8	116.4	77.8	67.0	63.5	6.9	6.4	8.7	657.7	2.9	12.5	7.3	8.2	34.6	6.3	0.6	36.2	46.1	4.5	8.6	103.0	3.0	5.7	101.9	18.5	6.3	7.1	37.4	74.4	3.2	17.6	21.5	22.6	6.3	5.4	5.8	10.5	11.7	4.2	3.7	8.2	4.2	3.4	2.4	2.1	5.0	15.0	0.0	5.3	5.1	5.1	3.3	0.9	1.9	0.3	13.3	4.0	2.5	4.2	6.8	5.3	0.3	22.8	13.8	1.5	0.9	0.7	8.9	8.1	132.8	10.5	15.9	1.3	7.7	24.0	12.1	8.3	1.8	1.0	21.5	2.1	7.8	5.6	1.8	0.1	2.4	1.5	7.8	7.2	4.6	5.7	2.9	7.5	4.9	7.0	1.5	0.5	34.8	1.0	6.0	0.8	4.3	5.8	1.2	0.7	1.0	6.1	3.2	5.1	1.5	1.0	3.3	0.5	1.5	2.1	4.5	3.7	5.6	2.5	2.0	0.1	2.2	5.8	5.8	5.5	25.6	5.4	5.8	6.9	6.4	8.2	5.7	7.1	6.3	17.8	160.3	81.8	0.0	9.1	0.0	0.0	0.0	0.0	0.0	35.1	26.8	0.0	0.0	31.6	33.1	0.0	0.3	29.8	0.0	0.0	4.9	0.0	12.5	12.0	4.5	0.0	0.0	0.0	8.3	3.3	4.2	0.0	17.6	6.3	1.5	0.0	0.0	3.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.8	0.0	0.0	1.0	0.0	0.0	0.0	0.0	9.5	0.0	0.0	16.1	0.0	0.0	2.9	10.2	0.0	0.0	0.0	7.2	0.0	0.0	0.0	0.0	0.3	14.4	0.9	0.0	0.0
PGLS	6PGL	ENSG00000130313	6-phosphogluconolactonase	O95336	19	17511636-17521288	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"PC-3: 244.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA040744, HPA042032"	Approved		Supported	Nucleoplasm,Cytosol		NA	NA		7200000	"Cluster 31: Non-specific - Inflammatory response"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 19: Monocytes & Neutrophils - Innate immune response"	Nucleoplasm	Cytosol	"HPA040744: AB_2677111, HPA042032: AB_2677809"	"unprognostic (3.68e-2)"	"unprognostic (8.98e-3)"	"unprognostic (1.25e-1)"	"unprognostic (9.64e-3)"	"unprognostic (1.35e-1)"	"unprognostic (1.04e-1)"	"unprognostic (3.55e-3)"	"unprognostic (2.95e-1)"	"unprognostic (1.44e-1)"	"unprognostic (7.55e-2)"	"unprognostic (2.16e-1)"	"unprognostic (1.30e-1)"	"unprognostic (4.75e-3)"	"unprognostic (2.39e-1)"	"unprognostic (1.99e-1)"	"unprognostic (5.05e-2)"	"unprognostic (9.26e-3)"	65.0	85.9	31.6	20.0	33.8	40.6	60.9	33.8	41.8	53.2	33.9	53.9	26.2	42.6	13.2	107.4	44.6	16.9	32.1	30.1	33.3	64.7	75.6	46.5	27.2	36.5	32.4	59.7	88.2	28.5	43.0	17.1	35.2	57.3	16.1	3.7	66.1	19.0	18.0	83.6	49.0	15.9	34.5	73.6	54.7	23.2	34.6	26.2	58.3	11.6	20.6	50.1	62.6	38.5	68.7	62.2	38.7	26.3	57.6	94.8	70.6	45.4	76.5	46.4	59.5	29.7	104.0	74.4	50.0	74.9	33.1	46.6	21.9	73.6	14.5	37.3	80.9	35.3	28.0	54.1	97.8	38.7	38.6	111.8	100.5	27.9	83.9	48.3	63.3	29.4	40.7	18.7	58.5	77.2	84.6	108.6	50.6	72.9	244.0	57.3	23.3	49.9	64.3	56.3	47.3	56.0	28.3	33.2	70.3	21.1	47.9	69.7	57.2	47.9	12.9	96.0	26.6	31.4	23.9	32.2	68.2	97.5	48.0	73.0	163.5	194.6	55.3	185.4	44.9	61.5	49.5	50.1	185.0	71.4	45.4	46.1	158.8	72.5	180.2	137.2	57.3	102.7	31.6	33.8	33.8	41.8	30.1	33.3	36.5	32.4	35.2	34.5	34.6	38.5	93.7	28.9	38.3	7.2	84.8	64.5	94.5	132.5	100.2	22.2	128.9	177.8	8.9	110.1	89.4	47.8	16.7	122.4	98.8	194.0	111.6	177.5	35.5	89.4	99.7	72.0	133.0	48.4	3.5	208.8	169.6	94.2	82.0	90.9	25.4	163.7	99.2	94.0	263.4	26.9	4.9	147.0	75.3	306.5	142.4	70.8	90.7	208.2	74.7	8.4	325.3	79.4	139.0	8.0	11.8	175.7	211.6	69.2	40.4	107.6	263.1	211.1	66.7	28.1	52.6	51.4	103.9	28.7	25.8	210.7	96.2	105.2	85.2	178.3	173.4	143.5
PGLYRP2	"PGLYRPL, PGRP-L, PGRPL, tagL, tagL-alpha, tagl-beta, TAGL-like"	ENSG00000161031	"Peptidoglycan recognition protein 2"	Q96PD5	19	15468645-15498956	"Enzymes, Metabolic proteins, Plasma proteins, Predicted membrane proteins, Predicted secreted proteins"	Immunity	Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	45	"liver: 258.8"	"Cell type enriched"	"Detected in some"	11	"Hepatocytes: 168.7"	"Cancer enriched"	"Detected in some"	16	"liver cancer: 42.9"	"Not detected"	"Not detected"			"Low immune cell specificity"	"Detected in many"			"Group enriched"	"Detected in many"	7	"granulocytes: 3.4;monocytes: 5.1;T-cells: 2.3"	"Group enriched"	"Detected in some"	5	"MCF7: 8.1;T-47d: 8.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"CAB033468, HPA046311, HPA075237"	Supported		Approved	"Cell Junctions"	"Secreted to blood"	NA	NA		87000000000	"Cluster 51: Monocytes - Innate immune response"	"Cluster 62: Liver - Hemostasis"	"Cluster 6: T47d - Mammary gland"	"Cluster 2: Hepatocytes - Metabolism"	"Cell Junctions"		"CAB033468: AB_1127187, HPA046311: AB_2679621, HPA075237: AB_2686739"	"unprognostic (7.39e-3)"	"unprognostic (1.52e-2)"	"unprognostic (5.22e-2)"	"unprognostic (8.79e-2)"	"unprognostic (3.97e-1)"	"unprognostic (4.88e-4)"	"unprognostic (5.93e-3)"	"unprognostic (6.48e-2)"	"unprognostic (1.99e-1)"	"unprognostic (1.18e-2)"	"unprognostic (3.15e-2)"	"unprognostic (2.40e-1)"	"unprognostic (6.66e-16)"	"unprognostic (6.35e-3)"	"unprognostic (2.80e-1)"	"unprognostic (2.45e-2)"	"unprognostic (2.81e-4)"	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.1	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	258.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.1	0.1	5.7	0.0	0.3	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	8.1	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.1	0.0	0.5	0.0	0.0	0.1	0.0	0.0	0.0	8.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.0	3.4	0.4	0.2	1.6	1.7	1.6	0.2	0.9	0.8	0.1	0.0	2.2	2.3	1.6	0.5	5.1	0.0	0.1	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	4.3	0.0	0.2	0.5	0.0	0.0	4.1	1.5	0.2	4.3	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	3.3	0.0	0.0	0.3	0.0	0.4	0.4	0.0	0.1	0.1	0.0	0.0	0.0	0.0	2.9	168.7	0.3	0.0	0.4	0.0	0.0	2.2	0.0	3.1	0.3	1.9	8.8	0.0	1.0	0.0	1.0	0.0	0.2	0.0	0.0	0.0	14.1	0.8	0.0	0.2	0.0	0.0	0.0	0.1	0.2	0.4	0.7	0.1	0.1	0.0	7.6	0.0	0.0	0.1
PGP		ENSG00000184207	"Phosphoglycolate phosphatase"	A6NDG6	16	2211593-2214840	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Carbohydrate metabolism"	"Hydrolase, Protein phosphatase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 52.2"	"Cell type enhanced"	"Detected in all"		"Cone photoreceptor cells: 404.5;Early spermatids: 480.5;Late spermatids: 1591.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA043096, HPA046739"	Approved		Approved	"Nuclear bodies"		NA	NA		250000	"Cluster 52: Eosinophils - Transcription"	"Cluster 43: Testis - Unknown function"	"Cluster 20: HeLa - Mitochondria"	"Cluster 31: Spermatids - Spermatogenesis"	"Nuclear bodies"		"HPA043096: AB_2678311, HPA046739: AB_2679779"	"unprognostic (8.33e-2)"	"unprognostic (4.77e-3)"	"unprognostic (2.36e-2)"	"unprognostic (7.23e-2)"	"unprognostic (2.12e-3)"	"unprognostic (1.76e-1)"	"unprognostic (5.75e-3)"	"unprognostic (5.87e-2)"	"unprognostic (7.90e-2)"	"unprognostic (4.43e-3)"	"unprognostic (6.50e-2)"	"unprognostic (9.04e-2)"	"prognostic favorable (7.05e-4)"	"unprognostic (1.28e-1)"	"unprognostic (2.63e-1)"	"unprognostic (1.11e-1)"	"prognostic favorable (6.42e-4)"	7.5	11.8	17.3	6.1	17.6	8.3	7.6	19.5	26.9	6.4	10.6	11.2	6.0	8.7	4.7	6.9	7.2	3.2	33.0	16.3	13.3	14.0	11.5	10.0	6.4	26.8	15.2	4.7	7.8	5.6	11.9	5.3	27.6	8.3	3.8	7.8	7.3	4.8	41.1	7.8	11.5	3.4	12.6	13.7	10.3	52.2	15.7	5.5	16.1	18.0	3.8	8.6	5.4	17.8	16.2	26.0	18.9	17.5	7.3	6.1	35.4	18.5	8.6	16.5	17.0	40.3	20.0	12.3	17.7	8.5	13.5	26.7	12.7	15.7	7.4	17.0	35.3	12.4	44.3	18.4	4.9	21.8	19.6	6.8	7.0	15.6	5.7	6.3	10.9	20.0	22.4	12.7	9.3	44.1	25.1	35.7	24.1	9.8	23.9	40.9	16.3	27.5	13.9	10.1	24.1	14.8	16.8	29.8	13.1	13.4	22.9	25.3	10.9	17.6	22.5	15.9	18.7	30.1	13.9	17.8	5.8	19.2	13.7	0.0	0.8	2.5	0.7	1.2	0.1	0.2	0.4	0.5	0.5	0.8	0.2	0.4	0.6	0.1	1.2	0.7	0.5	0.2	17.3	17.6	19.5	26.9	16.3	13.3	26.8	15.2	27.6	12.6	15.7	17.8	35.0	6.4	7.8	17.6	20.9	23.3	7.8	2.6	4.0	196.1	31.1	33.8	40.7	17.2	5.7	40.5	404.5	121.1	44.8	63.6	58.7	10.4	480.5	28.5	22.5	24.7	29.8	38.3	38.0	14.0	107.1	20.3	28.5	27.7	10.2	54.1	20.3	39.2	58.0	144.7	30.9	37.3	2.0	33.1	64.8	1591.0	25.7	37.9	35.6	7.5	20.2	63.4	42.2	11.6	21.9	14.4	32.5	28.2	36.9	21.9	34.8	39.4	3.4	220.6	39.5	19.3	94.3	162.9	64.8	12.7	31.8	54.5	30.0	70.8	50.5	15.2
PGPEP1	"Pcp, PGP, PGP-I, PGPI"	ENSG00000130517	"Pyroglutamyl-peptidase I"	Q9NXJ5	19	18340598-18369950	"Enzymes, Predicted intracellular proteins"		"Hydrolase, Protease, Thiol protease"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 73.9;Proximal enterocytes: 88.2;Proximal tubular cells: 85.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"basophil: 28.4"	"Lineage enriched"	"Detected in all"	4	"granulocytes: 28.4"	"Cell line enhanced"	"Detected in many"		"HMC-1: 58.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035368, HPA055277"	Approved		Approved	"Golgi apparatus"		NA	NA			"Cluster 34: Basophils - Unknown function"	"Cluster 35: Non-specific - Unknown function"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	"Golgi apparatus"		"HPA035368: AB_10601388, HPA055277: AB_2682770"	"unprognostic (9.52e-3)"	"unprognostic (1.37e-2)"	"unprognostic (6.95e-2)"	"unprognostic (5.74e-3)"	"unprognostic (5.29e-2)"	"unprognostic (6.60e-2)"	"unprognostic (1.96e-2)"	"unprognostic (2.11e-3)"	"prognostic favorable (6.80e-4)"	"unprognostic (2.79e-2)"	"prognostic favorable (1.71e-4)"	"unprognostic (4.81e-3)"	"prognostic favorable (3.71e-8)"	"unprognostic (1.12e-2)"	"unprognostic (1.66e-1)"	"unprognostic (1.51e-1)"	"unprognostic (1.20e-3)"	10.1	27.8	30.1	6.9	30.2	13.1	10.3	27.0	36.7	14.9	38.3	23.5	22.4	11.1	12.8	5.5	12.7	7.9	25.1	31.0	30.6	40.8	48.4	14.3	6.5	35.6	28.9	16.5	34.2	13.9	24.4	5.2	36.2	20.3	15.6	4.2	20.4	12.9	27.1	4.9	30.3	6.4	36.2	23.5	23.6	3.8	30.2	8.2	14.6	14.4	6.3	15.9	8.3	35.5	8.7	13.6	11.1	11.2	13.7	10.8	13.5	10.2	15.9	6.9	10.2	9.7	18.4	13.4	16.7	16.8	12.3	2.3	4.4	2.3	3.8	15.9	4.8	14.7	15.0	27.9	19.4	8.7	58.5	10.9	4.9	5.3	1.0	24.6	10.4	22.8	27.5	19.7	5.8	13.9	8.9	7.0	11.3	6.0	4.2	0.1	4.1	12.1	7.5	13.5	3.9	6.1	1.9	1.1	18.4	7.2	5.1	17.3	16.1	7.9	5.3	10.4	4.4	24.3	12.6	8.2	21.0	24.0	7.4	28.4	5.5	8.1	4.8	5.8	2.9	1.9	3.4	4.5	3.5	5.5	4.2	3.8	3.1	4.8	6.8	2.3	4.2	3.9	30.1	30.2	27.0	36.7	31.0	30.6	35.6	28.9	36.2	36.2	30.2	35.5	7.5	9.6	15.0	10.4	12.2	2.3	10.2	9.5	8.6	4.7	14.3	9.8	20.9	37.1	13.2	31.3	10.4	18.6	21.2	73.9	7.9	20.7	0.8	15.2	8.6	10.0	38.9	10.7	11.3	45.4	26.6	9.6	27.5	14.7	35.4	7.9	13.6	72.5	24.1	5.0	7.9	21.0	8.2	29.0	5.4	1.7	7.8	19.3	16.0	8.4	13.1	8.9	24.7	3.5	4.3	44.4	36.5	20.3	25.8	9.2	88.2	85.7	12.3	7.0	6.6	10.3	9.0	2.9	4.7	1.8	1.1	18.7	15.2	9.4	33.4	16.9
PHLPP1	"KIAA0606, PHLPP, PLEKHE1, PPM3A, SCOP"	ENSG00000081913	"PH domain and leucine rich repeat protein phosphatase 1"	O60346	18	62715541-62980433	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	Apoptosis	"Hydrolase, Protein phosphatase"	"Tumor suppressor"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	6	"brain: 107.2"	"Group enriched"	"Detected in many"	10	"Astrocytes: 423.7;Oligodendrocyte precursor cells: 538.3;Oligodendrocytes: 1663.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	7	"neutrophil: 4.0;T-reg: 1.3"	"Group enriched"	"Detected in many"	7	"granulocytes: 4.0;T-cells: 1.3"	"Cell line enhanced"	"Detected in all"		"REH: 32.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA020200	Approved				"Intracellular and membrane"	NA	NA			"Cluster 9: Neutrophils - Innate immune response"	"Cluster 70: Brain - Nervous system development"	"Cluster 14: REH - Unknown function"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"			"HPA020200: AB_2670383"	"unprognostic (1.38e-1)"	"unprognostic (3.61e-2)"	"unprognostic (2.26e-1)"	"unprognostic (1.18e-1)"	"unprognostic (1.89e-1)"	"unprognostic (3.07e-2)"	"unprognostic (5.57e-2)"	"unprognostic (5.24e-1)"	"unprognostic (1.63e-1)"	"unprognostic (3.10e-1)"	"unprognostic (2.95e-1)"	"unprognostic (6.03e-2)"	"prognostic favorable (5.35e-8)"	"unprognostic (1.52e-1)"	"unprognostic (3.49e-2)"	"unprognostic (8.13e-2)"	"unprognostic (8.25e-2)"	5.5	14.6	46.4	1.9	74.3	7.3	6.4	49.5	59.8	4.4	17.1	5.2	5.4	4.6	1.9	7.6	3.4	4.1	3.4	45.6	46.4	3.2	16.6	3.4	2.7	61.8	58.4	4.4	7.0	5.7	7.5	5.5	53.8	4.0	5.6	16.1	10.8	3.5	4.2	12.5	4.9	3.3	47.0	1.8	4.9	10.8	58.7	4.4	4.6	3.7	3.6	5.5	4.8	107.2	13.7	5.0	20.2	6.8	3.4	2.9	15.8	4.0	3.6	7.8	8.0	11.1	8.0	9.1	2.4	6.1	3.1	16.3	10.5	6.4	10.0	28.4	8.8	3.1	5.4	20.6	4.8	4.7	1.5	3.0	4.1	8.4	7.6	6.4	5.6	4.9	8.0	17.9	7.6	3.0	3.5	4.1	8.2	2.7	4.9	32.7	11.5	11.1	4.5	17.5	9.3	3.7	4.4	9.9	8.2	11.8	4.4	13.3	7.2	6.4	3.0	3.9	9.4	2.0	1.1	10.6	3.8	5.4	5.0	0.0	0.1	0.1	0.3	0.0	0.0	0.3	0.0	0.0	0.4	0.1	0.2	0.0	4.0	0.3	0.1	0.2	1.3	0.1	46.4	74.3	49.5	59.8	45.6	46.4	61.8	58.4	53.8	47.0	58.7	107.2	10.1	3.2	1.5	423.7	1.9	16.8	5.0	2.9	8.0	21.2	12.1	11.3	4.1	11.5	6.3	0.0	29.2	12.9	3.3	8.4	1.9	3.8	33.5	13.7	6.0	8.1	12.1	3.8	80.1	4.1	5.8	7.0	10.2	26.6	2.5	9.6	5.3	21.5	2.4	26.9	64.7	8.5	2.0	2.5	9.8	36.4	5.9	5.8	24.9	79.6	2.6	83.6	2.1	538.3	1663.2	4.5	8.0	3.8	1.0	7.5	7.4	1.9	10.0	17.4	0.0	13.5	5.3	8.0	15.4	13.2	18.6	26.1	2.7	8.3	11.1	11.0
PHLPP2	"KIAA0931, PHLPPL, PPM3B"	ENSG00000040199	"PH domain and leucine rich repeat protein phosphatase 2"	Q6ZVD8	16	71637835-71724701	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Hydrolase, Protein phosphatase"	"Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 22.0;retina: 32.2"	"Cell type enhanced"	"Detected in many"		"Cone photoreceptor cells: 104.3;Distal enterocytes: 75.5;Excitatory neurons: 69.5;Proximal enterocytes: 73.7;Rod photoreceptor cells: 68.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA040761, HPA041837, HPA048598"	Approved		Supported	"Nucleoplasm,Cytokinetic bridge,Mitotic spindle,Cytosol"		Yes	No			"Cluster 15: NK-cells - Transcription"	"Cluster 45: Intestine - Brush border"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 45: Enterocytes - Digestion"	Cytosol	"Nucleoplasm, Cytokinetic bridge, Mitotic spindle"	"HPA040761: , HPA041837: , HPA048598: AB_2680459"	"unprognostic (5.67e-2)"	"unprognostic (2.00e-1)"	"unprognostic (2.29e-2)"	"unprognostic (2.44e-2)"	"unprognostic (1.76e-1)"	"unprognostic (1.59e-1)"	"unprognostic (1.17e-1)"	"unprognostic (3.27e-1)"	"unprognostic (1.22e-1)"	"unprognostic (3.43e-1)"	"unprognostic (1.97e-4)"	"unprognostic (3.08e-2)"	"unprognostic (8.85e-3)"	"unprognostic (6.41e-2)"	"unprognostic (4.92e-2)"	"unprognostic (8.46e-3)"	"unprognostic (8.27e-2)"	4.2	2.8	6.6	2.8	7.5	6.5	2.7	5.8	7.4	3.5	0.1	11.7	11.1	3.7	2.9	1.4	3.2	2.4	2.8	7.8	4.8	3.4	3.0	3.1	3.5	4.6	3.9	4.2	3.1	4.5	4.0	2.7	4.7	2.7	12.2	32.2	1.7	3.4	1.9	1.8	22.0	4.5	0.6	2.5	2.4	6.8	5.3	1.9	6.6	2.6	3.2	3.3	2.4	5.1	6.0	7.8	8.3	9.3	6.5	7.8	4.8	8.8	8.0	12.5	10.1	7.2	1.9	11.8	3.4	14.6	9.0	12.4	12.1	4.5	16.1	4.2	6.5	3.3	7.3	4.8	5.1	2.9	5.0	5.8	2.5	17.7	5.7	5.2	4.7	4.1	3.0	3.2	8.7	12.7	3.9	2.3	6.5	1.9	2.1	6.3	7.3	3.9	5.9	4.5	7.2	3.8	18.9	5.1	3.1	6.4	6.3	1.6	6.5	12.5	9.0	5.3	7.4	7.1	5.4	11.9	7.7	2.3	2.8	0.2	0.1	0.0	0.2	0.1	0.2	0.5	0.1	0.3	0.1	0.3	0.2	0.2	0.2	0.7	0.1	0.5	0.3	0.1	6.6	7.5	5.8	7.4	7.8	4.8	4.6	3.9	4.7	0.6	5.3	5.1	4.0	9.6	2.2	26.1	7.4	9.3	5.1	3.5	7.4	20.6	6.9	5.6	3.3	0.0	3.6	3.7	104.3	4.3	3.8	75.5	0.0	2.7	12.0	2.9	6.1	5.3	6.0	22.9	69.5	2.3	0.4	7.7	1.1	5.1	10.2	11.3	2.9	4.1	1.5	23.5	45.9	6.7	4.1	7.0	12.7	6.3	5.3	2.7	14.2	10.3	3.2	6.5	1.0	30.7	32.7	2.5	31.4	5.3	4.0	8.2	73.7	5.1	3.1	68.6	6.6	7.8	7.9	31.6	20.4	1.9	9.1	1.4	4.9	1.7	9.2	2.2
PHOSPHO1		ENSG00000173868	"Phosphoethanolamine/phosphocholine phosphatase 1"	Q8TCT1	17	49223366-49230787	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Mineral balance"	Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"testis: 103.0"	"Cell type enriched"	"Detected in some"	6	"Late spermatids: 1499.6"	"Cancer enhanced"	"Detected in some"		"ovarian cancer: 2.6"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	160	"eosinophil: 171.1;neutrophil: 426.7"	"Lineage enriched"	"Detected in many"	228	"granulocytes: 426.7"	"Cell line enhanced"	"Detected in some"		"Daudi: 5.7;EFO-21: 3.2;HDLM-2: 4.1;SuSa: 5.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA065025			Approved	"Plasma membrane,Actin filaments"		NA	NA			"Cluster 5: Granulocytes - Unknown function"	"Cluster 78: Testis - Spermatogenesis"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 25: Spermatids - Spermatogenesis"	"Actin filaments"	"Plasma membrane"	"HPA065025: AB_2732727"	"unprognostic (1.37e-1)"	"unprognostic (3.01e-3)"	"unprognostic (7.53e-2)"	"unprognostic (4.41e-3)"	"unprognostic (1.57e-1)"	"unprognostic (4.70e-2)"	"unprognostic (1.44e-1)"	"unprognostic (1.39e-2)"	"unprognostic (2.04e-1)"	"unprognostic (6.88e-2)"	"unprognostic (1.02e-2)"	"unprognostic (2.88e-1)"	"unprognostic (2.03e-1)"	"unprognostic (1.45e-1)"	"unprognostic (1.62e-1)"	"unprognostic (1.08e-1)"	"unprognostic (1.87e-1)"	2.5	1.3	1.5	3.4	3.4	19.0	0.5	6.3	3.9	0.4	0.6	0.7	2.9	0.7	0.2	1.0	1.3	2.2	1.8	1.8	7.3	1.3	1.0	2.3	1.6	8.8	6.2	0.3	1.2	0.2	0.6	6.4	7.4	0.8	0.0	0.7	1.2	0.3	3.4	1.3	3.0	0.4	6.9	14.2	0.9	103.0	5.5	0.3	0.7	3.2	0.2	0.9	0.5	6.1	0.0	1.0	0.0	0.8	0.1	0.1	0.0	0.2	0.2	0.0	0.1	1.5	0.0	5.7	3.2	0.0	2.1	0.0	0.9	0.3	0.1	4.1	0.1	0.7	0.7	0.2	0.0	0.0	0.6	0.2	0.0	0.3	0.0	0.4	0.0	0.6	0.0	0.0	0.4	0.0	0.0	0.2	0.0	0.2	0.7	1.2	2.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	5.4	0.1	0.1	2.2	0.3	1.7	1.1	0.0	0.1	0.2	0.3	1.5	2.0	0.1	0.2	0.6	171.1	0.4	1.5	0.3	0.1	0.1	0.2	0.4	0.0	0.0	0.2	426.7	0.5	1.8	0.0	0.1	1.1	1.5	3.4	6.3	3.9	1.8	7.3	8.8	6.2	7.4	6.9	5.5	6.1	0.2	0.0	0.0	0.0	0.0	0.3	0.1	0.0	1.2	0.3	0.0	0.0	0.4	0.0	0.0	0.0	0.0	10.1	0.3	0.0	0.0	0.0	205.8	0.0	0.0	1.4	0.0	8.6	0.7	0.0	1.4	0.3	0.0	0.0	0.0	0.0	0.4	0.0	2.6	0.0	1.4	0.0	0.0	0.3	0.0	1499.6	7.8	0.6	0.0	1.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	6.0	0.1	0.0	0.0	0.1	0.0	0.4	0.0	0.0	0.0	11.2	4.5	0.0	0.0	237.6	0.1	0.0	0.1	0.1
PHOSPHO2	MGC22679	ENSG00000144362	"Phosphatase, orphan 2"	Q8TCD6	2	169694454-169701708	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 158.7;Spermatocytes: 68.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA034726, HPA034727"	Uncertain		Approved	Nucleoplasm,Vesicles		NA	NA			"Cluster 26: Non-specific - Mitochondria"	"Cluster 1: Thyroid gland - Transcription"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 66: Spermatocytes - Spermatogenesis"	Vesicles	Nucleoplasm	"HPA034726: AB_10602191, HPA034727: AB_2674302"	"unprognostic (1.98e-1)"	"unprognostic (1.22e-1)"	"unprognostic (7.56e-2)"	"unprognostic (1.39e-3)"	"unprognostic (1.30e-2)"	"unprognostic (2.26e-1)"	"prognostic unfavorable (3.82e-6)"	"unprognostic (4.31e-2)"	"unprognostic (2.11e-2)"	"unprognostic (5.19e-2)"	"unprognostic (1.40e-1)"	"unprognostic (2.31e-1)"	"prognostic favorable (9.53e-4)"	"unprognostic (4.10e-1)"	"unprognostic (2.60e-1)"	"unprognostic (6.12e-2)"	"unprognostic (7.53e-2)"	5.0	2.8	1.9	2.4	1.9	2.9	10.6	4.1	1.6	4.7	3.7	5.8	6.4	5.3	4.2	3.2	6.0	4.0	2.7	1.6	2.8	5.6	3.6	3.3	3.0	1.4	1.8	6.0	5.1	7.2	4.6	3.0	1.5	13.0	5.8	7.2	8.5	4.7	3.4	3.5	6.4	3.1	1.7	2.5	4.7	13.7	2.4	3.0	9.8	1.6	3.0	3.8	2.8	1.9	6.6	1.8	4.6	6.2	8.5	2.7	17.8	2.8	1.9	4.3	4.7	6.3	4.9	6.4	6.1	2.1	8.9	5.0	6.2	3.4	3.5	9.5	7.0	6.4	6.1	11.0	5.6	5.3	5.6	4.9	6.3	4.9	6.5	3.6	3.9	8.9	10.8	6.4	2.7	6.0	3.7	6.8	6.0	4.2	2.3	3.6	2.8	5.1	6.8	19.6	19.1	6.5	5.8	3.1	6.8	5.5	8.4	3.2	2.3	4.7	4.3	4.2	3.1	6.2	6.0	5.7	5.5	3.2	5.1	0.1	0.7	1.0	3.3	0.9	4.6	6.5	3.6	3.2	0.9	8.8	4.7	4.6	1.3	9.8	0.9	4.2	4.4	1.4	1.9	1.9	4.1	1.6	1.6	2.8	1.4	1.8	1.5	1.7	2.4	1.9	6.1	3.2	3.6	0.0	6.8	2.5	10.3	5.4	2.8	8.7	15.2	11.0	4.1	5.7	4.7	3.7	6.2	8.8	2.5	7.0	9.8	7.6	158.7	10.6	5.0	4.3	15.0	6.9	0.0	11.1	9.3	6.9	15.3	3.3	0.0	5.7	2.5	3.7	2.8	6.7	0.0	6.6	12.2	0.6	1.6	35.9	4.7	2.0	3.6	0.0	1.0	6.4	1.0	0.0	0.0	6.4	6.8	4.9	3.8	6.5	12.7	12.2	13.4	10.2	0.0	6.7	9.3	68.9	13.9	4.5	4.3	5.5	5.7	8.8	7.5	5.5
PHPT1	"bA216L13.10, CGI-202, DKFZp564M173, HSPC141, PHP14"	ENSG00000054148	"Phosphohistidine phosphatase 1"	Q9NRX4	9	136848724-136851027	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Hydrolase, Protein phosphatase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Late spermatids: 953.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"CAB013584, HPA020952"	Approved		Approved	"Nucleoplasm,Nuclear bodies,Plasma membrane,Cytosol"		NA	NA		590000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 39: Non-specific - Basic cellular processes"	Cytosol	"Nucleoplasm, Nuclear bodies, Plasma membrane"	"CAB013584: , HPA020952: AB_1855331"	"unprognostic (7.34e-2)"	"unprognostic (9.21e-2)"	"unprognostic (7.90e-2)"	"unprognostic (1.57e-2)"	"unprognostic (3.76e-2)"	"unprognostic (2.30e-1)"	"unprognostic (4.64e-2)"	"unprognostic (1.69e-2)"	"unprognostic (3.23e-2)"	"unprognostic (1.82e-1)"	"unprognostic (1.26e-3)"	"unprognostic (5.85e-2)"	"unprognostic (9.66e-3)"	"unprognostic (1.11e-2)"	"unprognostic (2.01e-1)"	"unprognostic (3.95e-2)"	"unprognostic (8.49e-2)"	71.5	109.2	196.7	54.5	200.5	64.6	62.4	206.2	245.6	76.0	192.2	74.0	54.0	44.7	103.0	70.6	99.3	62.0	267.2	192.3	203.3	82.6	47.9	57.3	57.4	199.3	191.9	65.0	153.4	160.9	85.2	49.8	200.3	89.2	50.5	26.3	144.0	86.6	432.6	45.8	62.9	78.1	198.8	41.6	61.5	56.9	199.1	68.5	86.7	441.5	40.0	71.8	41.4	216.2	53.6	452.5	225.6	199.1	153.4	266.0	412.8	147.6	170.8	158.8	138.6	165.7	138.0	145.1	142.8	168.6	180.0	155.0	51.2	293.9	50.2	116.9	132.5	45.4	276.8	380.3	177.5	82.6	176.4	322.8	248.7	91.8	109.5	145.8	218.8	93.1	102.9	129.7	257.2	328.2	156.9	176.7	216.0	372.5	206.6	106.5	106.6	196.7	255.6	113.3	137.6	132.8	146.7	155.8	75.1	107.0	127.2	226.4	177.0	390.6	130.8	91.5	166.5	60.5	93.4	94.0	174.3	59.7	235.8	38.2	290.0	31.0	197.6	318.4	170.7	241.3	173.9	184.6	321.8	178.9	126.0	175.8	13.7	196.7	231.7	425.4	223.6	324.1	196.7	200.5	206.2	245.6	192.3	203.3	199.3	191.9	200.3	198.8	199.1	216.2	125.7	96.1	159.8	24.8	111.8	150.3	187.7	659.2	204.9	43.9	223.1	317.7	384.8	178.7	326.5	217.0	22.9	322.1	111.8	337.1	747.4	196.1	271.3	122.2	168.1	111.9	265.1	80.2	8.1	252.4	489.5	213.1	140.6	170.3	123.5	367.4	83.6	201.9	286.5	67.3	12.5	370.9	309.3	97.2	197.1	953.5	205.0	133.6	334.4	5.6	273.2	194.7	146.2	10.6	25.0	185.3	359.8	223.4	187.8	257.5	540.1	817.4	250.6	77.7	85.5	137.1	249.6	141.8	143.8	140.3	161.8	264.1	106.4	352.5	336.0	199.5
PIF1	"C15orf20, FLJ22692"	ENSG00000140451	"PIF1 5'-to-3' DNA helicase"	Q9H611	15	64815632-64825668	"Enzymes, Predicted intracellular proteins"	"DNA damage, DNA recombination, DNA repair"	"DNA-binding, Helicase, Hydrolase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 4.8"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 21.3;Erythroid cells: 17.7;Granulosa cells: 15.1;NK-cells: 15.5;Theca cells: 18.3"	"Cancer enhanced"	"Detected in many"		"testis cancer: 10.2"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			CAB018701	Supported		Supported	Nucleoplasm		NA	Yes			"Cluster 35: T-regs - Unknown function"	"Cluster 16: Immune cells - Immune response"	"Cluster 20: HeLa - Mitochondria"	"Cluster 12: Non-specific - Cell cycle regulation"	Nucleoplasm		"CAB018701: AB_2164654"	"unprognostic (1.99e-1)"	"unprognostic (6.11e-2)"	"unprognostic (1.34e-1)"	"unprognostic (3.12e-2)"	"unprognostic (1.62e-1)"	"unprognostic (8.33e-3)"	"unprognostic (8.66e-4)"	"unprognostic (1.47e-1)"	"prognostic unfavorable (5.22e-4)"	"unprognostic (6.68e-2)"	"unprognostic (2.38e-2)"	"unprognostic (3.27e-2)"	"unprognostic (0.00e+0)"	"unprognostic (2.96e-3)"	"unprognostic (1.78e-1)"	"unprognostic (9.61e-2)"	"unprognostic (5.95e-2)"	0.7	1.0	0.8	2.6	0.8	3.8	0.4	0.7	1.3	0.9	0.7	2.4	1.9	0.8	0.1	3.1	0.7	0.8	0.9	0.7	1.2	0.6	0.6	1.0	4.6	1.4	1.0	0.4	0.2	0.2	0.5	0.9	1.1	1.7	1.0	0.1	0.6	0.7	0.3	1.0	2.6	1.2	0.9	4.8	1.8	2.5	1.2	3.6	0.5	0.1	3.3	1.5	1.4	0.8	7.7	8.7	21.1	8.6	3.7	4.3	7.8	7.4	3.9	7.3	5.6	14.0	12.6	9.3	3.0	3.6	6.8	20.9	21.8	6.2	2.7	14.8	8.0	10.8	28.5	10.2	1.9	4.3	8.4	2.5	0.0	3.2	2.6	1.8	7.5	13.6	7.2	18.0	7.0	6.7	4.7	17.9	17.2	9.7	6.0	9.7	7.0	13.0	4.1	4.3	8.7	5.6	5.7	6.3	3.3	9.2	7.0	4.7	5.2	4.4	22.6	7.0	14.0	14.3	14.3	9.0	4.2	18.8	6.4	0.0	0.0	0.0	0.3	0.0	0.1	0.1	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.9	0.1	0.8	0.8	0.7	1.3	0.7	1.2	1.4	1.0	1.1	0.9	1.2	0.8	1.2	0.0	1.1	3.6	6.5	1.9	0.8	0.6	0.0	0.5	0.6	0.6	1.9	0.0	0.1	0.0	0.0	5.1	7.5	3.2	0.0	0.0	21.3	0.4	4.4	2.3	0.0	17.7	2.6	0.0	6.5	5.6	3.6	0.7	0.0	15.1	5.3	0.5	5.8	0.0	1.0	2.4	0.0	5.1	2.0	2.3	1.5	4.5	0.0	1.9	0.1	0.8	15.5	3.5	0.1	0.2	0.1	2.2	9.7	1.1	0.2	0.1	0.1	1.2	6.6	4.2	3.5	0.8	2.0	1.6	1.0	1.1	7.5	18.3	6.2	1.3
PIGL		ENSG00000108474	"Phosphatidylinositol glycan anchor biosynthesis class L"	Q9Y2B2	17	16217191-16351797	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"GPI-anchor biosynthesis"	Hydrolase	"Deafness, Disease variant, Ichthyosis, Mental retardation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 46.7;Inhibitory neurons: 45.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA012739	Approved		Approved	Nucleoplasm,Cytosol	"Intracellular and membrane"	No	No			"Cluster 32: T-cells - Unknown function"	"Cluster 15: Liver - Metabolism"	"Cluster 12: NES - Nervous system development"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	"Nucleoplasm, Cytosol"		"HPA012739: AB_1855367"	"unprognostic (3.07e-2)"	"unprognostic (2.65e-1)"	"unprognostic (2.15e-1)"	"unprognostic (1.30e-2)"	"unprognostic (7.70e-2)"	"unprognostic (6.14e-2)"	"unprognostic (9.39e-5)"	"unprognostic (1.11e-2)"	"unprognostic (1.15e-2)"	"unprognostic (1.63e-2)"	"unprognostic (6.37e-3)"	"prognostic unfavorable (2.57e-4)"	"prognostic unfavorable (1.47e-4)"	"unprognostic (3.19e-2)"	"unprognostic (2.13e-1)"	"unprognostic (3.38e-1)"	"unprognostic (2.75e-3)"	9.6	8.6	8.0	6.3	8.4	5.6	10.1	9.7	10.4	8.6	8.5	8.8	10.6	8.3	11.8	8.1	8.9	6.1	5.6	7.8	8.5	9.0	14.3	7.7	7.8	7.8	7.8	10.4	10.2	6.1	10.4	6.3	8.2	9.8	8.4	6.3	8.2	6.1	5.3	11.4	10.1	5.9	7.6	7.8	10.5	8.7	8.2	6.4	10.1	3.3	8.3	7.8	8.1	9.4	12.5	16.3	11.4	9.3	16.0	15.2	4.6	6.3	8.0	10.8	19.5	17.2	15.4	6.6	13.7	6.7	6.9	17.4	14.7	8.2	15.0	13.1	38.3	12.3	13.6	21.9	17.3	5.0	7.4	12.5	20.3	19.1	22.0	10.9	13.0	20.1	14.6	7.3	8.6	11.1	9.3	11.6	4.5	25.2	8.3	9.0	9.7	15.6	12.3	6.6	6.0	8.5	6.7	4.9	14.6	29.9	5.4	4.5	7.6	9.1	6.0	6.6	19.8	5.5	0.2	10.3	12.2	12.5	6.2	0.0	2.7	4.7	4.6	2.6	4.1	3.7	6.3	3.7	2.0	2.8	6.4	5.5	0.0	4.8	1.8	5.3	5.4	2.5	8.0	8.4	9.7	10.4	7.8	8.5	7.8	7.8	8.2	7.6	8.2	9.4	8.5	9.6	21.0	19.2	10.0	4.5	9.2	9.1	11.4	11.5	9.8	9.8	2.4	7.2	13.0	12.9	10.4	15.6	9.3	7.3	5.9	6.3	3.0	7.7	11.4	6.6	7.8	11.6	46.7	7.5	8.0	8.8	11.7	6.9	5.1	14.0	5.0	10.5	5.2	6.7	45.3	11.2	10.2	3.5	4.3	2.9	7.8	5.9	3.6	26.2	3.6	5.2	9.2	24.6	34.9	9.4	9.7	11.3	12.2	8.3	9.8	5.9	10.6	12.2	0.0	9.1	7.3	16.1	8.3	7.5	6.0	9.6	11.8	9.4	12.6	10.4
PIP4P1	"C14orf9, MGC26684, TMEM55B"	ENSG00000165782	"Phosphatidylinositol-4,5-bisphosphate 4-phosphatase 1"	Q86T03	14	20457681-20461465	"Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins"		Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 78.4;Hofbauer cells: 54.9;Syncytiotrophoblasts: 167.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA048528	Approved					NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 18: Syncytiotrophoblasts - Pregnancy hormone signaling"			"HPA048528: AB_2680427"	"unprognostic (1.84e-1)"	"unprognostic (6.23e-2)"	"unprognostic (1.81e-1)"	"unprognostic (7.07e-2)"	"unprognostic (2.04e-1)"	"unprognostic (8.51e-2)"	"unprognostic (1.71e-2)"	"unprognostic (3.37e-3)"	"unprognostic (4.94e-2)"	"unprognostic (1.33e-1)"	"unprognostic (7.78e-3)"	"unprognostic (1.85e-1)"	"prognostic favorable (1.01e-4)"	"unprognostic (4.80e-2)"	"unprognostic (1.47e-1)"	"unprognostic (7.53e-2)"	"unprognostic (1.96e-1)"	23.6	27.3	37.2	13.6	38.3	49.0	22.4	36.5	38.6	22.2	32.1	25.4	17.8	21.6	27.0	25.5	21.6	13.4	22.9	38.2	38.8	27.4	25.1	23.9	18.8	38.3	37.8	20.9	24.4	30.6	28.3	16.6	40.4	23.6	15.6	26.1	23.5	15.4	35.1	33.6	28.7	15.9	36.0	31.3	27.8	21.2	38.2	16.9	22.5	22.6	21.1	24.2	21.3	36.5	21.1	32.4	21.3	25.1	32.7	20.2	39.5	19.6	38.1	26.2	31.5	19.3	33.2	18.8	16.5	24.6	75.9	21.6	26.3	21.5	22.9	24.9	19.7	13.5	15.5	28.6	44.6	25.2	26.7	26.3	28.9	30.2	30.5	23.8	24.5	28.7	11.5	37.1	21.9	24.2	34.3	22.1	14.3	32.9	44.5	25.1	20.7	12.6	24.6	46.6	30.7	23.0	20.1	32.6	25.8	18.3	16.4	23.6	17.2	23.8	30.1	36.0	17.6	42.0	58.0	27.6	16.5	19.2	26.5	1.3	3.2	7.3	4.2	2.3	3.5	12.4	5.2	4.8	4.1	10.3	5.8	6.1	4.1	4.4	2.0	10.4	4.5	2.5	37.2	38.3	36.5	38.6	38.2	38.8	38.3	37.8	40.4	36.0	38.2	36.5	23.5	9.6	12.0	0.0	16.9	0.0	0.0	0.0	0.0	0.0	29.8	22.7	0.0	0.0	3.1	22.0	0.0	78.4	23.8	0.0	19.6	36.8	0.0	19.1	13.5	9.1	0.0	0.0	0.0	40.0	35.0	8.2	0.0	24.3	3.8	15.6	0.0	0.0	54.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	17.7	0.0	0.0	12.9	0.0	0.0	0.0	0.0	36.9	0.0	0.0	7.6	0.0	0.0	20.4	5.1	0.0	0.0	0.0	10.2	0.0	0.0	0.0	0.0	167.2	9.9	18.4	0.0	0.0
PIP4P2	"DKFZp762O076, TMEM55A"	ENSG00000155099	"Phosphatidylinositol-4,5-bisphosphate 4-phosphatase 2"	Q8N4L2	8	90993802-91040872	"Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins"		Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Adipocytes: 26.2;Cytotrophoblasts: 32.6;Distal tubular cells: 49.0;Extravillous trophoblasts: 31.1;Hofbauer cells: 48.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in many"	7	"neutrophil: 76.9"	"Lineage enriched"	"Detected in all"	7	"granulocytes: 76.9"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA014591	Approved					NA	NA			"Cluster 9: Neutrophils - Innate immune response"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 50: Fibroblasts - ECM organization"			"HPA014591: AB_1858124"	"unprognostic (6.09e-2)"	"prognostic unfavorable (1.01e-4)"	"unprognostic (8.45e-2)"	"unprognostic (1.23e-3)"	"unprognostic (1.19e-1)"	"prognostic unfavorable (1.54e-4)"	"prognostic unfavorable (3.76e-5)"	"unprognostic (3.76e-2)"	"unprognostic (1.08e-1)"	"unprognostic (7.58e-2)"	"unprognostic (4.42e-1)"	"unprognostic (6.95e-2)"	"unprognostic (7.25e-2)"	"prognostic unfavorable (8.01e-4)"	"unprognostic (1.59e-1)"	"unprognostic (9.05e-2)"	"unprognostic (7.99e-2)"	11.9	13.9	13.2	6.6	15.7	30.0	7.4	16.5	20.1	9.2	20.2	14.6	2.8	10.5	4.2	5.9	7.2	11.0	20.7	13.3	20.4	10.0	3.8	5.5	6.9	16.5	16.4	10.6	3.3	10.9	7.9	8.8	18.2	8.7	4.8	11.0	7.3	12.2	13.5	6.5	5.3	13.5	16.4	8.3	6.5	6.9	17.5	9.5	6.6	14.8	5.4	9.9	6.6	21.0	4.8	2.9	16.8	10.2	27.2	30.6	3.5	19.3	24.2	10.2	15.1	1.9	8.1	9.4	2.6	19.9	10.3	1.1	4.2	7.0	13.6	8.1	7.3	13.9	2.9	1.5	23.6	3.3	12.2	17.2	4.4	12.8	9.6	27.4	9.8	2.7	7.4	31.0	35.6	3.3	10.4	9.5	8.6	0.0	9.8	3.9	6.9	11.2	14.9	3.0	2.0	9.7	1.5	6.6	28.4	11.4	0.2	6.3	15.1	18.5	7.1	11.2	9.0	12.0	7.0	6.0	31.6	6.4	25.2	0.9	11.6	10.8	1.3	5.9	2.3	2.7	3.1	1.7	10.8	1.9	4.8	1.9	76.9	2.4	2.2	6.0	2.8	6.1	13.2	15.7	16.5	20.1	13.3	20.4	16.5	16.4	18.2	16.4	17.5	21.0	26.2	0.0	2.8	0.0	4.4	0.0	0.0	0.0	0.0	0.0	7.5	11.2	0.0	0.0	3.1	9.2	0.0	32.6	7.7	0.0	49.0	18.0	0.0	0.8	11.7	5.2	0.0	0.0	0.0	8.9	31.1	18.7	0.0	1.0	8.8	4.1	0.0	0.0	48.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.5	0.0	0.0	3.6	0.0	0.0	0.0	0.0	15.8	0.0	0.0	2.1	0.0	0.0	13.1	1.5	0.0	0.0	0.0	14.5	0.0	0.0	0.0	0.0	10.9	3.7	14.3	0.0	0.0
PLA2G10	GXPLA2	ENSG00000069764	"Phospholipase A2 group X"	O15496	16	14672548-14694308	"Enzymes, FDA approved drug targets, Metabolic proteins, Predicted secreted proteins, RAS pathway related proteins"	"Lipid metabolism, Phospholipid metabolism"	Hydrolase	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	6	"intestine: 27.3;pancreas: 10.5;stomach 1: 41.9"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 280.1;Exocrine glandular cells: 116.3;Gastric mucus-secreting cells: 116.2;Intestinal goblet cells: 137.7;Paneth cells: 225.3"	"Cancer enhanced"	"Detected in many"		"stomach cancer: 6.8"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BEWO: 2.6;CAPAN-2: 6.4;HaCaT: 2.2;MCF7: 2.3;OE19: 5.9;SK-BR-3: 3.4"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			HPA041893	Uncertain				"Secreted in other tissues"	NA	NA				"Cluster 4: Stomach - Digestion"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 53: Intestinal epithelial cells - Unknown function"			"HPA041893: AB_10794495"	"unprognostic (8.44e-3)"	"unprognostic (2.37e-1)"	"unprognostic (6.72e-2)"	"prognostic favorable (5.74e-5)"	"unprognostic (1.62e-2)"	"unprognostic (3.16e-2)"	"unprognostic (5.48e-2)"	"unprognostic (6.76e-2)"	"unprognostic (1.77e-2)"	"unprognostic (2.72e-1)"	"unprognostic (4.81e-2)"	"unprognostic (2.39e-1)"	"unprognostic (2.12e-1)"	"unprognostic (4.08e-2)"	"unprognostic (1.03e-1)"	"unprognostic (2.30e-2)"	"unprognostic (9.97e-3)"	0.0	0.2	0.1	2.4	0.1	0.1	0.1	0.1	0.2	1.3	0.1	27.3	7.6	0.1	0.0	0.2	4.5	3.4	0.0	0.1	0.1	0.1	0.0	4.7	0.2	0.1	0.1	0.0	10.5	0.0	0.0	0.3	0.1	0.4	23.6	0.0	0.1	0.0	0.0	0.0	7.0	0.6	0.1	0.0	41.9	2.2	0.1	0.0	0.0	0.0	0.3	4.3	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.1	2.6	0.0	0.0	0.0	0.0	0.5	6.4	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.3	0.1	0.0	0.0	5.9	0.0	0.0	0.1	0.2	0.0	0.2	0.1	0.0	0.0	3.4	0.0	0.2	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.7	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.1	0.2	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.2	35.3	23.1	0.7	0.3	0.0	0.9	3.7	0.6	0.0	0.7	0.5	0.1	5.7	17.9	1.8	0.0	0.6	0.1	280.1	0.0	2.6	0.3	25.1	3.5	0.2	12.7	0.0	0.5	116.3	56.7	0.1	116.2	45.7	0.0	0.4	0.0	0.0	0.9	0.0	0.3	137.7	24.4	0.0	0.0	0.7	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.5	20.5	225.3	0.0	0.7	1.3	16.1	0.0	60.1	0.0	0.0	0.0	2.0	1.1	1.2	1.7	0.0	0.5	0.5	0.0	57.3	14.6
PLA2G12A	PLA2G12	ENSG00000123739	"Phospholipase A2 group XIIA"	Q9BZM1	4	109709989-109730070	"Enzymes, Metabolic proteins, Predicted secreted proteins, RAS pathway related proteins"	"Lipid degradation, Lipid metabolism"	Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Granulosa cells: 147.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA035908, HPA035909"	Approved				"Secreted to blood"	NA	NA			"Cluster 44: Non-specific - Transcription"	"Cluster 22: Non-specific - Unknown function"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 51: Myeloid cells - Hemostasis"			"HPA035908: AB_2674856, HPA035909: AB_10672074"	"unprognostic (8.40e-2)"	"unprognostic (3.87e-1)"	"unprognostic (3.81e-3)"	"unprognostic (3.09e-2)"	"unprognostic (2.10e-1)"	"unprognostic (1.35e-1)"	"unprognostic (4.26e-2)"	"unprognostic (1.77e-1)"	"unprognostic (1.90e-1)"	"unprognostic (2.71e-3)"	"unprognostic (1.02e-1)"	"unprognostic (8.42e-2)"	"prognostic favorable (2.54e-9)"	"unprognostic (3.10e-1)"	"unprognostic (1.39e-1)"	"unprognostic (9.16e-3)"	"unprognostic (3.64e-2)"	10.0	9.0	11.4	3.4	12.7	6.2	12.0	12.6	13.8	8.4	11.9	11.5	10.5	8.1	7.3	11.4	8.4	7.3	16.0	10.4	12.2	14.7	21.2	7.4	4.0	13.9	14.4	10.5	34.5	23.0	12.5	3.7	13.1	15.1	10.8	15.5	11.8	7.1	22.1	9.3	10.6	7.0	14.2	5.2	9.8	5.0	12.7	4.9	17.8	19.3	4.6	7.0	7.6	15.1	17.2	6.2	4.8	7.4	15.0	14.9	9.4	14.9	11.0	8.5	8.9	15.6	29.1	24.5	11.6	11.1	14.0	9.3	14.9	20.1	13.0	8.3	22.8	8.7	17.5	11.5	14.2	19.2	5.9	15.1	22.9	8.6	21.3	14.3	7.7	22.5	48.8	10.7	14.7	30.3	15.7	8.6	8.6	39.0	24.1	9.3	14.3	19.5	16.2	25.0	30.8	10.1	13.7	35.5	11.9	12.3	21.3	4.0	10.4	12.4	10.1	12.9	10.8	18.5	36.0	17.8	13.5	11.0	15.5	5.4	4.1	2.7	6.2	2.7	5.7	3.7	7.8	6.0	8.2	4.3	8.7	8.0	1.8	5.0	4.5	7.0	8.3	12.1	11.4	12.7	12.6	13.8	10.4	12.2	13.9	14.4	13.1	14.2	12.7	15.1	11.7	25.6	21.8	14.4	11.7	36.7	36.3	39.7	25.0	52.5	27.5	18.3	56.8	30.0	24.9	22.0	50.1	42.7	8.3	31.5	27.4	15.0	26.7	15.1	9.5	17.1	107.7	48.4	24.1	25.9	53.4	29.3	32.6	14.0	14.0	147.4	23.9	103.1	19.4	26.9	28.6	52.8	34.6	22.4	17.1	8.7	33.2	64.6	30.2	18.7	6.1	47.7	13.4	16.6	20.1	13.9	38.9	34.6	20.6	67.8	78.9	19.2	16.4	42.3	19.7	38.2	21.1	62.7	47.5	39.0	42.6	34.5	14.3	28.6	58.9	44.9
PLA2G15	"GXVPLA2, LLPL, LYPLA3"	ENSG00000103066	"Phospholipase A2 group XV"	Q8NCC3	16	68245304-68261058	"Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Fatty acid metabolism, Lipid degradation, Lipid metabolism"	"Acyltransferase, Hydrolase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 58.3"	"Cell type enhanced"	"Detected in many"		"Hofbauer cells: 116.0;Horizontal cells: 38.7;Kupffer cells: 37.1;Syncytiotrophoblasts: 50.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA041702, HPA041727"	Enhanced		Supported	Nucleoplasm,Vesicles	"Intracellular and membrane"	NA	NA		38000000	"Cluster 51: Monocytes - Innate immune response"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 4: Macrophages - Innate immune response"	"Nucleoplasm, Vesicles"		"HPA041702: AB_10794486, HPA041727: AB_10793931"	"unprognostic (3.47e-2)"	"unprognostic (9.99e-2)"	"unprognostic (1.54e-3)"	"unprognostic (6.84e-3)"	"unprognostic (1.38e-2)"	"unprognostic (1.65e-2)"	"unprognostic (4.12e-3)"	"unprognostic (3.16e-1)"	"unprognostic (2.12e-2)"	"unprognostic (1.84e-2)"	"unprognostic (2.56e-1)"	"unprognostic (9.29e-2)"	"unprognostic (2.45e-3)"	"unprognostic (2.98e-2)"	"unprognostic (5.40e-3)"	"unprognostic (6.28e-2)"	"unprognostic (3.47e-2)"	15.1	11.5	12.9	7.6	12.5	7.0	9.8	12.8	18.1	6.6	9.2	8.0	6.9	6.2	8.7	6.2	7.4	9.3	35.5	13.1	14.2	33.4	17.3	17.5	13.6	13.1	14.1	7.7	7.4	11.4	11.4	27.3	14.6	8.1	5.9	4.4	9.1	5.7	58.3	13.9	6.5	8.8	12.4	20.3	8.4	10.8	15.9	11.7	13.2	22.4	5.1	8.8	6.4	16.1	10.0	10.0	7.9	25.5	36.7	26.8	19.0	24.6	31.6	35.7	30.2	26.1	18.6	17.4	31.2	34.1	28.5	15.2	8.5	10.4	15.9	6.0	16.4	5.0	10.4	19.0	19.6	4.6	25.0	19.0	11.2	35.2	5.5	44.6	22.5	8.9	7.9	9.8	23.0	21.3	7.2	14.5	5.1	9.4	12.1	9.9	11.3	55.3	17.7	8.7	3.0	5.1	31.2	9.6	19.2	6.6	25.2	23.7	18.8	31.5	15.0	41.1	16.5	34.6	33.5	22.1	28.6	13.8	12.0	19.6	24.1	16.0	4.7	27.5	4.8	5.0	5.2	7.0	14.1	5.3	6.5	5.5	1.0	2.3	32.4	12.2	5.1	14.6	12.9	12.5	12.8	18.1	13.1	14.2	13.1	14.1	14.6	12.4	15.9	16.1	4.4	6.4	3.3	3.6	3.0	4.8	2.4	6.8	2.8	12.1	7.0	6.0	22.5	1.5	5.1	9.2	8.4	20.9	4.9	8.1	5.9	10.1	1.9	4.3	4.8	5.9	0.0	1.7	7.0	7.2	7.6	8.2	8.6	9.0	15.2	6.6	9.3	13.7	116.0	38.7	6.7	8.5	2.0	37.1	6.8	6.1	2.1	21.4	12.4	10.3	7.7	4.4	3.1	5.5	3.9	6.3	5.0	1.5	2.6	2.6	3.0	19.5	2.7	6.1	0.0	5.5	6.7	3.4	2.8	4.1	3.4	50.8	3.9	3.1	4.1	2.0
PLA2G1B	"PLA2, PLA2A, PPLA2"	ENSG00000170890	"Phospholipase A2 group IB"	P04054	12	120322115-120327779	"Candidate cardiovascular disease genes, Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted secreted proteins, RAS pathway related proteins"	"Lipid metabolism, Phospholipid metabolism"	Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	1519	"pancreas: 117705.6"	"Cell type enriched"	"Detected in many"	17	"Exocrine glandular cells: 20351.4"	"Cancer enriched"	"Detected in many"	185	"pancreatic cancer: 763.5"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"Hep G2: 2.5;U-2 OS: 1.9"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA047822, HPA060803"	Enhanced				"Secreted to digestive system"	NA	NA		3900000	"Cluster 48: NK-cells - Unknown function"	"Cluster 25: Pancreas - Digestion"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 1: Pancreatic cells - Digestion"			"HPA047822: AB_2680169, HPA060803: AB_2684369"	"unprognostic (1.28e-4)"	"unprognostic (6.02e-2)"	"unprognostic (1.84e-2)"	"unprognostic (2.86e-2)"	"unprognostic (2.74e-2)"	"unprognostic (2.41e-1)"	"unprognostic (1.05e-1)"	"unprognostic (1.13e-1)"	"unprognostic (2.63e-2)"	"unprognostic (3.61e-2)"	"unprognostic (1.27e-1)"	"unprognostic (1.03e-1)"	"unprognostic (2.80e-4)"	"unprognostic (2.15e-1)"	"unprognostic (1.97e-1)"	"unprognostic (3.60e-1)"	"unprognostic (8.61e-4)"	10.0	6.5	0.2	1.7	0.1	2.9	5.8	0.2	0.6	5.8	0.0	2.3	15.8	2.3	0.0	3.3	1.8	0.9	21.5	0.2	0.2	2.7	7.2	32.1	4.0	0.1	0.1	77.5	117705.6	0.0	4.4	6.0	0.2	4.4	0.3	0.7	21.3	0.0	1.9	3.4	7.7	0.1	0.1	3.0	8.7	4.3	0.1	0.3	1.5	0.0	0.0	1.3	1.9	0.1	0.1	0.0	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.6	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.1	0.0	0.0	0.5	0.0	0.0	0.0	2.5	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.2	0.0	0.1	0.4	0.1	0.6	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.4	0.0	1.9	0.2	0.2	0.0	0.5	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.5	0.2	0.0	0.3	0.0	0.0	0.0	0.1	0.2	0.1	0.2	0.6	0.2	0.2	0.1	0.1	0.2	0.1	0.1	0.1	0.0	12.8	91.5	0.0	0.2	0.0	0.1	0.2	0.0	0.0	0.8	1.3	0.4	0.0	0.8	0.0	0.0	0.0	0.2	0.2	1.9	24.3	10.6	0.4	0.1	1.1	1.2	0.0	0.1	20351.4	0.0	0.3	0.0	0.0	0.0	8.6	0.0	1.9	0.0	0.0	0.1	1.2	0.0	0.0	0.0	41.0	3.1	1.5	0.0	1.0	43.9	0.0	2.1	0.0	0.0	1142.1	1.7	3.4	0.1	0.2	4.1	7.6	1.0	0.0	0.0	0.0	3.4	0.5	0.2	0.0	0.1	0.0	0.3	12.5	1.2	0.1
PLA2G2A	"PLA2B, PLA2L"	ENSG00000188257	"Phospholipase A2 group IIA"	P14555	1	19975431-19980416	"Enzymes, FDA approved drug targets, Metabolic proteins, Predicted intracellular proteins, Predicted secreted proteins, RAS pathway related proteins"	"Inflammatory response, Lipid metabolism, Phospholipid metabolism"	"Antimicrobial, Bacteriolytic enzyme, Hydrolase"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"adipose tissue: 1302.4;intestine: 1973.9;placenta: 756.7;urinary bladder: 813.6"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 536.5;Exocrine glandular cells: 1031.5;Fibroblasts: 656.0;Intestinal goblet cells: 393.6;Paneth cells: 574.1;Prostatic glandular cells: 921.1;Undifferentiated cells: 861.9"	"Cancer enhanced"	"Detected in all"		"prostate cancer: 875.7"	"Low region specificity"	"Detected in single"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	6	"Hep G2: 645.0;OE19: 2384.4"					"Not detected"	"Not detected"			HPA015236	Enhanced				"Secreted to blood"	NA	NA	1000000	680000		"Cluster 86: Liver & Placenta - Transport via ER"	"Cluster 21: OE19 - Mitochondria"	"Cluster 50: Fibroblasts - ECM organization"			"HPA015236: AB_10601047"	"unprognostic (2.33e-2)"	"unprognostic (1.28e-1)"	"unprognostic (2.79e-2)"	"unprognostic (7.85e-3)"	"unprognostic (8.71e-2)"	"unprognostic (9.27e-2)"	"unprognostic (2.02e-1)"	"unprognostic (1.80e-1)"	"prognostic favorable (1.49e-4)"	"unprognostic (1.68e-1)"	"unprognostic (1.06e-1)"	"unprognostic (1.58e-2)"	"unprognostic (3.77e-15)"	"unprognostic (2.72e-2)"	"unprognostic (9.14e-2)"	"unprognostic (1.24e-1)"	"unprognostic (1.51e-1)"	1302.4	7.0	0.1	280.2	0.1	0.0	27.4	0.1	0.7	5.4	2.9	1474.0	786.8	4.3	3.3	29.3	14.8	57.7	137.4	0.0	0.2	6.6	238.6	16.8	5.4	0.6	0.7	44.1	7.8	0.9	2.5	756.7	0.2	203.9	1668.0	0.1	24.6	6.1	6.0	18.1	1973.9	164.4	0.1	0.4	11.6	36.8	1.3	1.7	11.1	114.2	15.0	813.6	12.1	0.1	0.0	0.0	1.6	0.0	248.3	0.0	8.5	0.0	0.1	0.1	0.0	11.2	0.0	0.0	1.1	0.0	0.8	18.7	0.0	0.0	0.0	0.1	0.3	0.0	0.3	645.0	0.0	0.1	1.1	2.6	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	6.2	0.4	2384.4	0.0	0.0	0.0	7.6	0.0	198.2	1.0	4.7	0.0	20.1	0.0	31.1	0.1	0.0	0.0	0.0	0.0	44.7	0.2	0.4	0.3	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.7	0.0	0.2	0.6	0.7	0.2	0.1	1.3	0.1	20.6	6.4	6.7	0.0	9.1	13.9	10.8	0.2	0.6	0.9	1.0	0.8	14.9	12.8	9.3	0.0	0.0	3.6	0.4	536.5	1.9	0.7	4.0	0.7	43.1	6.9	62.3	13.5	0.0	1031.5	4.6	656.0	6.1	0.6	4.5	0.0	30.0	310.9	9.5	0.0	0.0	393.6	2.0	18.8	31.1	11.6	171.2	3.5	14.2	0.0	0.0	0.0	0.0	0.0	0.0	4.7	574.1	1.2	2.6	921.1	328.2	0.2	1.9	0.0	0.0	2.4	37.8	0.9	1.5	4.9	16.8	6.8	6.2	0.1	861.9	32.2
PLA2G2D	sPLA2S	ENSG00000117215	"Phospholipase A2 group IID"	Q9UNK4	1	20111939-20119566	"Enzymes, Metabolic proteins, Predicted secreted proteins, RAS pathway related proteins"	"Lipid degradation, Lipid metabolism"	Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	23	"lymphoid tissue: 106.4"	"Cell type enhanced"	"Detected in some"		"B-cells: 1.6;dendritic cells: 1.3;Kupffer cells: 2.4;Melanocytes: 5.4;Plasma cells: 8.1"	"Cancer enriched"	"Detected in many"	6	"testis cancer: 25.6"	"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	6	"memory B-cell: 3.7;naive B-cell: 3.6;plasmacytoid DC: 2.0"	"Group enriched"	"Detected in many"	6	"B-cells: 3.7;dendritic cells: 2.0"	"Cell line enriched"	"Detected in some"	7	"RPMI-8226: 8.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"								"Secreted in other tissues"	NA	NA			"Cluster 19: B-cells - Humoral immune response"	"Cluster 16: Immune cells - Immune response"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 55: Plasma cells - Humoral immune response"				"prognostic favorable (4.35e-4)"	"prognostic favorable (8.15e-5)"	"unprognostic (3.88e-3)"	"prognostic favorable (9.74e-4)"	"unprognostic (1.78e-1)"	"unprognostic (2.56e-3)"	"unprognostic (1.98e-1)"	"unprognostic (1.60e-2)"	"unprognostic (1.82e-5)"	"unprognostic (7.51e-4)"	"unprognostic (2.50e-2)"	"unprognostic (1.22e-1)"	"unprognostic (4.64e-3)"	"unprognostic (1.05e-1)"	"unprognostic (2.85e-1)"	"unprognostic (8.08e-2)"	"unprognostic (2.60e-1)"	0.7	0.1	0.1	15.8	0.1	0.8	0.9	0.3	0.2	0.3	0.0	2.3	1.4	0.4	0.1	0.4	0.4	1.7	0.2	0.1	0.0	0.1	0.7	2.4	106.4	0.1	0.0	1.0	0.3	0.0	0.0	0.1	0.1	0.4	3.3	0.1	1.2	0.4	0.0	0.2	4.5	0.2	0.0	11.0	2.3	0.4	0.1	3.1	0.3	0.0	59.1	4.5	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.1	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.1	1.2	0.0	0.1	0.0	0.0	0.0	0.5	0.1	0.0	0.0	0.0	0.0	3.7	0.0	0.0	0.0	3.6	0.0	0.0	0.1	0.1	0.0	2.0	0.0	0.1	0.1	0.1	0.3	0.2	0.1	0.0	0.1	0.0	0.1	0.0	0.1	0.2	0.0	0.0	0.0	0.0	1.6	0.0	0.3	0.0	0.0	0.0	0.1	0.6	0.5	0.0	0.0	0.0	0.0	0.0	1.3	0.2	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	2.4	0.4	0.0	0.0	0.6	5.4	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.1	0.2	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.1	0.3
PLA2G2E		ENSG00000188784	"Phospholipase A2 group IIE"	Q9NZK7	1	19920009-19923617	"Enzymes, Metabolic proteins, Predicted secreted proteins, RAS pathway related proteins"	"Inflammatory response, Lipid metabolism, Phospholipid metabolism"	Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	5	"lymphoid tissue: 2.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA064085	Uncertain				"Secreted - unknown location"	NA	NA				"Cluster 16: Immune cells - Immune response"					"HPA064085: AB_2685188"														"unprognostic (9.56e-2)"		"unprognostic (3.71e-2)"		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.5	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
PLA2G2F		ENSG00000158786	"Phospholipase A2 group IIF"	Q9BZM2	1	20139323-20150381	"Enzymes, Metabolic proteins, Predicted membrane proteins, RAS pathway related proteins"	"Immunity, Innate immunity, Lipid degradation, Lipid metabolism"	Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	25	"lymphoid tissue: 8.0;skin 1: 14.9;urinary bladder: 11.7"	"Cell type enhanced"	"Detected in some"		"Cardiomyocytes: 1.0;Collecting duct cells: 1.8;Suprabasal keratinocytes: 1.7"	"Cancer enriched"	"Detected in some"	18	"urothelial cancer: 17.1"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	69	"RT4: 139.2"	"Region enriched"	"Detected in single"	4	"hippocampal formation: 3.0"	"Not detected"	"Not detected"								"Intracellular and membrane"	NA	NA				"Cluster 31: Skin - Epidermis development"	"Cluster 15: RT4 - Unknown function"	"Cluster 22: Epithelial cell types - Mixed function"				"unprognostic (1.95e-1)"	"unprognostic (1.18e-1)"	"unprognostic (2.64e-2)"	"unprognostic (1.79e-2)"		"unprognostic (5.11e-2)"		"unprognostic (4.63e-2)"	"unprognostic (4.83e-2)"	"unprognostic (1.51e-1)"	"unprognostic (1.61e-2)"	"unprognostic (3.36e-5)"		"unprognostic (7.06e-2)"	"unprognostic (1.84e-1)"	"unprognostic (4.69e-1)"	"prognostic favorable (3.86e-4)"	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	14.9	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.7	0.0	0.0	8.0	11.7	0.4	0.0	0.1	0.0	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	139.2	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	1.8	0.0	0.0	0.0	0.3	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.7	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	1.7	0.8	0.0	0.0	0.0	0.9
PLA2G3	GIII-SPLA2	ENSG00000100078	"Phospholipase A2 group III"	Q9NZ20	22	31134807-31140508	"Enzymes, Metabolic proteins, Predicted secreted proteins, RAS pathway related proteins"	"Cilium biogenesis/degradation, Lipid metabolism, Mast cell degranulation, Phospholipid metabolism"	Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	4	"cervix: 5.9;esophagus: 13.8;skin 1: 15.4;vagina: 7.1"	"Cell type enhanced"	"Detected in some"		"Alveolar cells type 2: 3.6;Breast glandular cells: 7.5;Suprabasal keratinocytes: 17.8"	"Cancer enhanced"	"Detected in many"		"head and neck cancer: 3.8"	"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"AF22: 15.1;AN3-CA: 15.3;NTERA-2: 7.8;SCLC-21H: 11.7"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA021016	Uncertain		Uncertain	"Endoplasmic reticulum,Golgi apparatus"	"Secreted to blood"	NA	NA				"Cluster 11: Squamous epithelial cells - Epithelial cell function"	"Cluster 12: NES - Nervous system development"	"Cluster 30: Mammary glandular cells - Lactation"	"Golgi apparatus"	"Endoplasmic reticulum"	"HPA021016: AB_1855443"	"unprognostic (1.80e-1)"	"unprognostic (4.63e-3)"	"unprognostic (1.07e-1)"	"unprognostic (1.49e-2)"	"unprognostic (9.72e-2)"	"prognostic favorable (4.47e-4)"		"unprognostic (1.74e-2)"	"unprognostic (2.30e-1)"	"unprognostic (4.25e-2)"	"unprognostic (9.55e-3)"	"unprognostic (4.41e-1)"		"unprognostic (3.67e-1)"	"unprognostic (3.29e-1)"	"unprognostic (9.49e-3)"	"unprognostic (3.72e-2)"	0.0	0.0	0.0	0.1	0.1	0.0	1.2	0.8	0.2	5.9	0.7	0.1	0.3	0.0	0.0	13.8	0.0	0.0	0.0	0.4	0.1	0.5	0.0	2.5	0.0	1.6	0.1	0.0	0.0	1.0	0.1	0.0	1.7	0.3	0.0	0.0	1.8	0.3	0.2	15.4	0.2	0.0	0.1	0.0	0.6	0.5	0.1	0.1	0.6	0.0	1.7	0.0	7.1	0.2	0.0	0.0	15.1	15.3	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	2.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.8	0.2	0.6	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.8	0.0	0.0	0.0	0.0	1.0	0.0	0.0	11.7	0.0	0.0	0.0	0.0	0.2	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.8	0.2	0.4	0.1	1.6	0.1	1.7	0.1	0.1	0.2	0.0	0.0	3.6	1.6	0.0	1.3	0.2	0.2	0.0	0.0	7.5	0.1	0.2	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.4	0.1	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.1	0.5	17.8	0.0	0.0	0.0	0.0	0.4
PLA2G4A	"cPLA2-alpha, PLA2G4"	ENSG00000116711	"Phospholipase A2 group IVA"	P47712	1	186828949-186988981	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, RAS pathway related proteins"	"Fatty acid biosynthesis, Fatty acid metabolism, Glycerol metabolism, Leukotriene biosynthesis, Lipid biosynthesis, Lipid degradation, Lipid metabolism, Phospholipid degradation, Phospholipid metabolism, Prostaglandin biosynthesis, Prostaglandin metabolism"	Hydrolase	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"parathyroid gland: 87.2;seminal vesicle: 48.3"	"Cell type enhanced"	"Detected in many"		"Endometrial ciliated cells: 33.4;Glandular and luminal cells: 28.1;Microglial cells: 115.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	6	"classical monocyte: 6.8;eosinophil: 7.8;intermediate monocyte: 8.4;myeloid DC: 7.7;non-classical monocyte: 4.0;plasmacytoid DC: 3.1"	"Group enriched"	"Detected in many"	7	"dendritic cells: 7.7;granulocytes: 7.8;monocytes: 8.4"	"Cell line enhanced"	"Detected in many"		"HeLa: 52.4;OE19: 84.4;RPMI-8226: 73.4;U-2197: 66.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"CAB010050, HPA050062, HPA054206"	Approved		Supported	Vesicles,Cytosol		NA	NA		35000	"Cluster 45: Eosinophils - Innate immune response"	"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 21: OE19 - Mitochondria"	"Cluster 44: Endometrium - Transcription"	Cytosol	Vesicles	"CAB010050: AB_631312, HPA050062: AB_2681002, HPA054206: AB_2682417"	"prognostic favorable (9.07e-4)"	"unprognostic (1.18e-1)"	"unprognostic (2.03e-1)"	"prognostic favorable (2.85e-4)"	"unprognostic (5.55e-2)"	"unprognostic (1.51e-3)"	"unprognostic (2.67e-2)"	"unprognostic (2.43e-1)"	"unprognostic (2.63e-1)"	"unprognostic (7.14e-3)"	"unprognostic (1.50e-1)"	"unprognostic (1.68e-1)"	"unprognostic (2.96e-2)"	"unprognostic (8.07e-2)"	"unprognostic (1.58e-1)"	"unprognostic (1.90e-2)"	"unprognostic (4.26e-2)"	9.9	12.7	2.4	6.3	3.4	4.8	6.5	2.8	3.7	14.5	3.2	11.9	11.1	10.2	11.7	7.5	24.9	6.2	6.3	2.4	3.3	10.8	2.1	5.9	5.3	4.4	3.5	6.4	7.6	87.2	2.0	5.8	4.0	8.8	8.1	0.8	6.3	48.3	0.5	9.5	8.2	10.5	4.1	6.6	5.3	2.8	3.1	1.5	2.6	2.1	2.9	29.1	8.4	3.9	0.0	39.7	0.2	0.0	23.8	9.5	0.0	1.5	15.1	1.8	3.2	0.3	15.5	0.0	0.0	0.0	6.8	2.8	24.6	7.4	0.8	12.5	0.6	7.6	52.4	0.0	14.7	11.1	3.8	5.4	5.0	19.5	4.0	2.4	16.5	3.4	16.7	5.9	0.0	0.0	0.0	0.0	2.1	84.4	5.1	0.0	0.0	73.4	0.1	5.4	0.2	0.0	5.9	2.0	7.3	0.7	0.8	15.0	3.3	14.3	1.9	66.3	3.2	2.3	0.0	0.0	5.3	32.4	20.7	0.2	6.8	7.8	0.0	8.4	0.2	0.0	0.0	0.0	7.7	0.0	0.0	0.0	0.6	1.1	4.0	3.1	0.0	1.7	2.4	3.4	2.8	3.7	2.4	3.3	4.4	3.5	4.0	4.1	3.1	3.9	0.6	0.0	1.1	0.3	0.2	21.4	4.3	4.6	10.2	0.2	2.9	2.9	2.3	0.0	4.9	0.0	0.0	0.1	3.2	1.6	1.9	2.1	0.9	33.4	1.7	6.6	1.2	3.0	8.1	0.0	0.1	11.2	7.1	28.1	10.8	3.3	1.1	0.2	6.6	0.0	5.8	2.6	2.0	7.9	8.3	1.3	10.5	11.5	5.4	115.2	3.7	0.0	1.0	2.0	0.4	1.7	7.3	14.7	0.0	2.3	2.0	0.3	2.3	0.5	0.0	1.2	5.0	0.6	0.3	5.2	8.9	0.0	1.0	1.2	4.8	13.4
PLA2G4B	"cPLA2-beta, HsT16992"	ENSG00000243708	"Phospholipase A2 group IVB"	P0C869	15	41837775-41848147	"Enzymes, Metabolic proteins, Predicted intracellular proteins, RAS pathway related proteins"	"Lipid degradation, Lipid metabolism"	Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"Alveolar cells type 2: 3.1;Club cells: 1.3;Rod photoreceptor cells: 1.3"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"naive B-cell: 1.5"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"RT4: 7.8"															NA	NA			"Cluster 24: B-cells - Unknown function"	"Cluster 72: Non-specific - Transcription"	"Cluster 15: RT4 - Unknown function"	"Cluster 11: Alveolar cells - Smell perception"				"unprognostic (6.16e-2)"	"unprognostic (6.48e-3)"	"unprognostic (5.06e-3)"	"unprognostic (1.27e-4)"	"unprognostic (1.06e-1)"	"unprognostic (2.56e-3)"	"unprognostic (1.53e-1)"	"unprognostic (2.27e-2)"	"unprognostic (3.60e-2)"	"unprognostic (1.90e-2)"	"unprognostic (1.23e-2)"	"unprognostic (5.14e-3)"	"unprognostic (3.26e-5)"	"unprognostic (4.36e-1)"	"unprognostic (5.91e-2)"	"unprognostic (1.22e-1)"	"unprognostic (2.97e-2)"	8.8	7.6	6.9	0.5	6.9	3.7	10.7	6.9	10.1	26.0	6.9	9.1	1.6	8.3	1.9	36.6	13.9	1.7	11.4	6.9	6.9	16.9	16.7	11.4	3.4	6.9	6.9	20.0	19.3	0.3	16.3	0.5	6.9	24.8	0.8	0.4	16.7	2.4	5.3	48.8	12.5	0.6	6.9	16.9	12.5	9.6	7.0	1.3	22.9	0.1	5.7	12.3	30.2	7.0	1.1	0.8	0.0	0.0	0.2	0.1	2.9	0.3	0.8	1.0	0.2	0.4	0.5	0.2	0.1	0.6	0.1	3.6	1.0	0.9	0.2	0.1	1.7	0.9	1.3	2.5	1.5	0.2	1.4	0.6	3.6	0.3	1.0	0.2	0.4	1.6	1.2	0.1	0.2	1.6	1.1	3.1	0.8	4.0	0.9	0.0	0.9	0.5	0.8	7.8	0.4	0.7	0.0	1.4	0.8	0.6	4.2	1.4	0.0	0.0	0.8	1.0	0.1	2.5	0.1	0.7	0.2	3.8	0.0	0.0	0.2	0.0	0.4	0.1	0.2	0.0	0.1	0.2	0.1	1.5	0.2	0.2	0.0	1.1	0.0	0.1	0.4	0.0	6.9	6.9	6.9	10.1	6.9	6.9	6.9	6.9	6.9	6.9	7.0	7.0	0.0	0.0	3.1	0.0	0.0	0.0	0.1	0.0	0.0	0.5	0.0	0.0	0.1	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.6	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.2
PLA2G4C	cPLA2-gamma	ENSG00000105499	"Phospholipase A2 group IVC"	Q9UP65	19	48047843-48110817	"Enzymes, Metabolic proteins, Predicted intracellular proteins, RAS pathway related proteins"	"Host-virus interaction, Lipid metabolism, Phospholipid metabolism"	"Hydrolase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"retina: 78.8;skeletal muscle: 66.7"	"Cell type enhanced"	"Detected in many"		"Bipolar cells: 77.1;Cone photoreceptor cells: 66.7;Muller glia cells: 57.1;Oligodendrocytes: 137.1;Rod photoreceptor cells: 153.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"intermediate monocyte: 5.7"	"Group enriched"	"Detected in many"	4	"B-cells: 4.0;monocytes: 5.7"	"Cell line enhanced"	"Detected in many"		"HHSteC: 13.1;TIME: 19.4"	"Not detected"	"Not detected"							HPA043083	Approved		Approved	Cytosol		NA	NA			"Cluster 7: Monocytes - Unknown function"	"Cluster 54: Non-specific - Microtubule organization"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 46: Photoreceptor cells - Phototransduction"	Cytosol		"HPA043083: AB_10795714"	"unprognostic (1.27e-1)"	"unprognostic (3.88e-2)"	"unprognostic (4.18e-2)"	"unprognostic (2.82e-2)"	"unprognostic (7.37e-2)"	"unprognostic (1.62e-2)"	"unprognostic (1.33e-1)"	"unprognostic (6.53e-2)"	"unprognostic (8.30e-2)"	"unprognostic (1.94e-1)"	"unprognostic (5.11e-3)"	"unprognostic (1.90e-1)"	"unprognostic (4.66e-2)"	"unprognostic (9.45e-2)"	"unprognostic (2.28e-3)"	"unprognostic (1.87e-1)"	"unprognostic (9.01e-2)"	5.1	17.3	13.8	5.5	23.8	0.3	4.3	20.8	20.5	4.6	4.5	6.5	6.3	8.6	3.0	4.3	5.1	5.8	25.1	14.1	18.2	6.1	4.7	8.0	10.2	24.8	23.5	1.7	4.9	12.8	6.6	5.1	26.7	6.8	3.3	78.8	4.1	8.0	66.7	6.4	8.5	10.3	14.3	11.2	3.3	2.8	21.1	4.7	4.9	41.2	5.6	5.1	2.6	41.5	0.7	1.3	0.0	0.3	5.7	3.0	0.1	1.3	8.5	1.4	3.4	0.0	2.1	0.0	1.8	3.7	2.7	0.3	0.0	0.2	2.2	0.9	0.2	0.0	0.5	1.3	13.1	0.0	1.9	0.6	0.3	0.7	5.7	2.6	4.9	0.1	0.0	8.0	2.2	2.2	0.1	0.2	0.1	1.0	0.1	0.1	2.0	0.8	2.7	0.6	0.9	0.1	1.5	2.9	7.1	4.3	0.8	2.2	19.4	2.2	0.8	2.8	1.0	0.5	1.8	0.2	1.9	0.0	4.8	0.0	2.1	0.0	0.1	5.7	0.4	4.0	0.5	0.0	1.2	0.9	0.0	0.0	0.0	1.1	1.4	0.8	0.1	1.4	13.8	23.8	20.8	20.5	14.1	18.2	24.8	23.5	26.7	14.3	21.1	41.5	7.2	3.2	1.7	30.7	2.4	2.8	1.0	1.5	1.2	77.1	2.4	2.9	35.3	5.7	0.5	0.0	66.7	0.2	0.6	1.2	1.9	13.0	0.3	0.5	4.6	14.3	0.0	0.0	31.6	2.9	0.2	7.4	1.1	0.7	0.0	0.1	4.6	2.0	5.6	33.7	34.7	1.6	18.3	1.2	11.1	0.2	0.6	4.9	7.2	15.0	3.1	57.1	1.0	25.1	137.1	2.7	1.4	7.9	0.7	2.5	5.7	5.2	0.2	153.8	13.1	18.0	9.9	0.9	1.0	0.2	3.0	0.1	1.1	1.6	0.3	0.4
PLA2G4D	cPLA2delta	ENSG00000159337	"Phospholipase A2 group IVD"	Q86XP0	15	42067009-42094562	"Enzymes, Metabolic proteins, Predicted intracellular proteins, RAS pathway related proteins"	"Lipid degradation, Lipid metabolism"	Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"prostate: 19.1;skin 1: 16.1;vagina: 22.5"	"Cell type enhanced"	"Detected in some"		"Cone photoreceptor cells: 2.1;Glandular and luminal cells: 1.1;Ionocytes: 2.0;Prostatic glandular cells: 3.0;Rod photoreceptor cells: 1.0;Suprabasal keratinocytes: 3.4"	"Group enriched"	"Detected in some"	4	"cervical cancer: 1.1;head and neck cancer: 2.0;melanoma: 1.8;prostate cancer: 1.3;urothelial cancer: 0.6"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	13	"RPMI-8226: 15.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA074206			Approved	"Plasma membrane,Cytosol"		NA	NA				"Cluster 31: Skin - Epidermis development"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 35: Glandular cells - Unknown function"	Cytosol	"Plasma membrane"	"HPA074206: "	"unprognostic (1.16e-1)"	"unprognostic (1.10e-2)"	"unprognostic (2.91e-2)"	"unprognostic (9.16e-3)"	"unprognostic (9.33e-3)"	"unprognostic (4.35e-2)"		"unprognostic (5.39e-2)"	"unprognostic (2.37e-1)"	"unprognostic (1.84e-1)"	"unprognostic (1.28e-2)"	"unprognostic (2.75e-1)"	"unprognostic (2.64e-7)"	"unprognostic (2.54e-2)"	"unprognostic (2.34e-1)"	"unprognostic (3.47e-2)"	"unprognostic (4.32e-2)"	0.0	0.2	0.1	0.0	0.1	0.0	0.3	0.0	0.3	5.2	0.0	0.0	0.1	0.0	0.0	1.6	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.7	0.0	0.2	19.1	0.0	0.2	0.8	0.0	0.0	16.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.7	0.4	22.5	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.1	0.0	0.0	0.0	15.2	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.3	0.5	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.5	0.0	0.0	0.0	0.1	0.0	0.4	0.0	0.0	0.0	2.1	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	3.0	0.1	0.1	0.0	1.0	0.0	0.0	0.1	0.0	0.4	0.0	3.4	0.0	0.0	0.0	0.1	0.4
PLA2G4E	FLJ45651	ENSG00000188089	"Phospholipase A2 group IVE"	Q3MJ16	15	41981582-42051190	"Enzymes, Metabolic proteins, Predicted intracellular proteins, RAS pathway related proteins"	"Lipid degradation, Lipid metabolism"	"Hydrolase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	8	"skin 1: 17.2"	"Group enriched"	"Detected in some"	4	"Alveolar cells type 2: 12.9;Basal keratinocytes: 18.1;Suprabasal keratinocytes: 44.9"	"Cancer enhanced"	"Detected in some"		"head and neck cancer: 11.2"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041105, HPA072562"	Enhanced		Approved	Vesicles,Cytosol		NA	NA				"Cluster 31: Skin - Epidermis development"		"Cluster 28: Keratinocytes - Keratinization"	"Vesicles, Cytosol"		"HPA041105: AB_2677300, HPA072562: "	"unprognostic (2.98e-1)"	"unprognostic (5.52e-1)"	"unprognostic (2.60e-1)"	"unprognostic (5.99e-2)"		"unprognostic (5.12e-2)"	"unprognostic (1.54e-1)"	"unprognostic (1.99e-1)"	"unprognostic (2.77e-1)"	"unprognostic (4.22e-2)"	"unprognostic (2.43e-1)"	"unprognostic (1.22e-1)"	"unprognostic (1.83e-7)"	"unprognostic (1.81e-1)"	"unprognostic (2.68e-1)"	"unprognostic (7.48e-2)"	"unprognostic (4.67e-2)"	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.1	0.4	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.6	0.0	0.1	17.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.2	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12.9	0.0	0.0	18.1	0.3	1.1	0.0	0.0	0.0	0.0	0.3	0.0	0.2	0.0	0.0	0.0	0.0	0.3	0.0	0.1	5.1	0.5	0.0	0.4	0.0	0.0	0.4	0.0	0.0	0.2	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	2.7	5.4	0.0	0.0	3.6	0.0	0.0	0.0	0.0	0.5	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	44.9	0.0	0.1	0.0	0.2	0.7
PLA2G4F	PLA2G4F/Z	ENSG00000168907	"Phospholipase A2 group IVF"	Q68DD2	15	42139034-42156636	"Enzymes, Metabolic proteins, Predicted intracellular proteins, RAS pathway related proteins"	"Lipid degradation, Lipid metabolism, Phospholipid degradation, Phospholipid metabolism"	Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	6	"skin 1: 78.1"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 2: 74.5;Distal enterocytes: 21.7;Gastric mucus-secreting cells: 18.3;Glandular and luminal cells: 17.1;Suprabasal keratinocytes: 13.8"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"OE19: 11.1;RT4: 8.3"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"HPA042713, HPA056752"	Enhanced		Approved	Nucleoplasm,Vesicles		NA	NA				"Cluster 31: Skin - Epidermis development"	"Cluster 21: OE19 - Mitochondria"	"Cluster 11: Alveolar cells - Smell perception"	Vesicles	Nucleoplasm	"HPA042713: AB_10793982, HPA056752: AB_2683226"	"unprognostic (1.99e-1)"	"unprognostic (6.21e-3)"	"unprognostic (1.59e-1)"	"prognostic unfavorable (2.00e-4)"		"unprognostic (1.06e-2)"	"unprognostic (2.32e-3)"	"unprognostic (1.48e-2)"	"unprognostic (5.85e-2)"	"unprognostic (2.25e-1)"	"unprognostic (4.79e-2)"	"unprognostic (6.65e-2)"	"unprognostic (1.21e-2)"	"unprognostic (9.32e-2)"	"unprognostic (1.11e-1)"	"unprognostic (4.55e-2)"	"unprognostic (1.63e-1)"	0.0	0.0	0.1	0.4	0.3	0.3	2.4	0.1	0.1	5.7	0.0	6.4	6.7	0.0	1.6	5.7	0.1	0.1	0.3	0.1	0.0	7.8	0.2	12.2	0.1	0.0	0.0	0.0	0.1	2.9	1.7	0.1	0.0	4.3	3.8	0.2	2.6	0.4	2.9	78.1	4.2	0.1	0.0	0.1	2.4	0.1	0.0	4.4	1.9	0.5	0.3	1.2	11.6	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.1	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.1	0.1	0.0	0.0	0.1	0.1	0.0	1.9	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.8	0.0	0.1	0.0	11.1	0.1	0.0	0.0	0.0	0.0	8.3	0.4	0.0	0.0	0.8	0.0	0.1	0.8	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.6	74.5	0.0	0.0	5.5	2.7	1.3	0.6	0.0	1.2	0.3	2.9	0.0	0.5	5.5	0.0	1.7	0.0	21.7	3.9	0.4	0.0	7.3	1.0	0.1	0.0	0.0	0.0	1.3	0.7	0.1	18.3	17.1	2.5	0.0	0.0	0.0	0.1	0.0	0.0	7.7	4.1	0.0	0.3	0.0	0.0	0.3	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.3	6.3	0.0	0.3	3.1	10.2	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.0	5.6	13.8	1.2	0.6	0.0	6.7	2.0
PLA2G5		ENSG00000127472	"Phospholipase A2 group V"	P39877	1	20028179-20091911	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted secreted proteins, RAS pathway related proteins"	"Fatty acid metabolism, Lipid degradation, Lipid metabolism, Phagocytosis, Phospholipid degradation, Phospholipid metabolism"	Hydrolase	"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"heart muscle: 132.7;ovary: 47.6"	"Cell type enhanced"	"Detected in some"		"Cardiomyocytes: 75.3;Cone photoreceptor cells: 70.9;Leydig cells: 81.4;Peritubular cells: 73.4;Sertoli cells: 263.0;Smooth muscle cells: 63.1"	"Group enriched"	"Detected in many"	5	"glioma: 13.0;prostate cancer: 3.5"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"U-2197: 1.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA053361	Approved				"Secreted in other tissues"	NA	NA				"Cluster 44: Heart - Cardiac muscle contraction"	"Cluster 18: U-2197 - ECM organization"	"Cluster 43: Cardiomyocytes - Nuclear processes"			"HPA053361: AB_2682127"	"unprognostic (2.78e-2)"	"unprognostic (1.14e-2)"	"unprognostic (5.68e-3)"	"unprognostic (6.16e-2)"	"unprognostic (2.01e-2)"	"unprognostic (5.93e-2)"	"unprognostic (2.12e-2)"	"unprognostic (1.02e-1)"	"unprognostic (2.15e-2)"	"unprognostic (1.12e-1)"	"unprognostic (2.02e-1)"	"unprognostic (1.70e-3)"	"unprognostic (6.00e-5)"	"unprognostic (2.87e-2)"	"unprognostic (3.00e-1)"	"unprognostic (1.54e-1)"	"unprognostic (4.97e-3)"	8.9	1.5	8.7	1.4	10.9	0.0	3.4	10.5	14.4	1.2	22.1	33.7	0.7	1.8	0.9	4.4	6.4	2.0	132.7	9.1	9.7	0.1	6.1	8.0	0.6	10.2	10.9	47.6	0.9	0.0	0.8	4.7	9.2	14.9	2.3	18.9	2.7	7.7	0.5	1.7	3.0	3.3	9.5	1.6	6.3	10.1	11.8	0.0	2.4	0.3	1.2	17.6	1.7	8.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.7	10.9	10.5	14.4	9.1	9.7	10.2	10.9	9.2	9.5	11.8	8.6	0.7	0.0	0.5	25.8	0.0	0.4	0.0	0.0	0.0	11.6	0.2	1.3	75.3	0.0	0.0	0.0	70.9	0.1	0.0	0.0	0.0	0.0	1.3	0.0	0.0	5.1	0.0	0.0	0.2	0.0	0.1	30.8	0.0	0.0	0.0	6.7	10.8	0.1	0.3	0.0	0.2	0.0	0.0	1.2	0.7	4.9	81.4	0.5	0.0	1.9	0.0	30.8	0.0	0.5	0.1	0.0	0.0	73.4	0.0	1.3	0.0	0.0	0.0	32.1	263.0	0.5	63.1	0.6	0.7	0.0	0.4	0.3	0.1	0.0	0.0	0.1
PLA2G6	"iPLA2, iPLA2beta, NBIA2, PARK14, PNPLA9"	ENSG00000184381	"Phospholipase A2 group VI"	O60733	22	38111495-38214778	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, RAS pathway related proteins"	"Chemotaxis, Lipid metabolism, Phospholipid metabolism"	"Calmodulin-binding, Hydrolase"	"Disease variant, Dystonia, Neurodegeneration, Parkinson disease, Parkinsonism"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 28.5;Spermatocytes: 44.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"NK-cell: 3.7"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HEL: 39.1;HMC-1: 25.6;U-266/70: 20.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA001171	Approved		Approved	"Centriolar satellite,Cytosol"		NA	NA			"Cluster 48: NK-cells - Unknown function"	"Cluster 43: Testis - Unknown function"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 66: Spermatocytes - Spermatogenesis"	"Centriolar satellite, Cytosol"		"HPA001171: AB_1079145"	"unprognostic (5.26e-2)"	"prognostic favorable (7.29e-4)"	"unprognostic (8.74e-2)"	"unprognostic (6.27e-2)"	"unprognostic (3.83e-1)"	"unprognostic (3.70e-3)"	"unprognostic (8.67e-3)"	"unprognostic (9.55e-2)"	"unprognostic (3.48e-1)"	"unprognostic (1.91e-1)"	"unprognostic (2.37e-3)"	"unprognostic (4.95e-2)"	"unprognostic (1.94e-3)"	"unprognostic (1.01e-1)"	"unprognostic (3.00e-1)"	"unprognostic (1.48e-1)"	"prognostic favorable (1.55e-4)"	20.0	22.2	14.1	4.6	16.6	12.2	19.5	15.2	20.3	24.9	12.3	11.4	9.2	17.8	10.6	10.3	26.2	13.2	9.5	14.3	13.7	24.0	13.3	10.4	8.5	17.2	15.0	24.3	16.1	6.7	17.7	4.1	19.5	24.9	2.8	8.3	15.9	9.2	10.7	17.2	12.5	3.4	15.3	17.1	13.2	42.1	15.4	11.7	51.8	4.4	4.6	13.2	14.4	25.5	0.8	1.3	2.6	6.3	8.0	5.5	9.8	0.9	1.0	0.5	1.2	3.2	2.4	5.9	6.7	1.3	0.9	3.5	2.2	2.5	0.3	9.2	11.1	39.1	3.4	3.5	3.1	2.6	25.6	13.3	3.7	2.3	4.6	6.6	0.8	11.7	8.0	13.3	0.7	3.1	8.5	3.0	3.4	2.7	1.3	6.5	1.2	6.1	2.8	5.9	7.1	1.9	1.9	3.1	6.7	3.9	4.1	2.4	0.6	2.1	4.5	0.9	0.6	20.6	2.7	4.0	4.0	3.2	2.0	1.4	0.1	0.0	1.0	0.0	0.7	0.5	1.0	1.5	0.4	0.3	0.4	1.2	0.6	3.7	0.2	1.3	1.6	0.7	14.1	16.6	15.2	20.3	14.3	13.7	17.2	15.0	19.5	15.3	15.4	25.5	5.6	3.2	2.7	19.9	4.6	3.1	3.5	4.0	4.6	9.9	7.4	6.5	2.0	4.3	5.0	12.9	4.2	3.3	11.1	11.3	0.0	2.1	28.5	9.5	4.4	3.1	11.4	7.4	6.4	1.0	2.7	3.3	11.2	8.7	0.0	10.6	3.6	3.5	1.7	15.2	5.9	8.6	2.0	1.0	0.8	18.3	5.9	2.1	1.8	4.7	2.3	4.9	8.2	4.5	25.2	1.1	12.6	3.8	4.7	2.9	21.9	1.9	7.6	7.5	6.6	2.6	3.4	44.5	7.7	4.1	3.4	4.9	6.6	6.8	8.4	2.1
PLA2G7	"LDL-PLA2, PAFAH"	ENSG00000146070	"Phospholipase A2 group VII"	Q13093	6	46704201-46735693	"Candidate cardiovascular disease genes, Disease related genes, Enzymes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted secreted proteins"	"Lipid degradation, Lipid metabolism, Phospholipid degradation, Phospholipid metabolism"	Hydrolase	"Asthma, Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 27.2;placenta: 23.3"	"Group enriched"	"Detected in many"	5	"Hofbauer cells: 372.2;Macrophages: 140.9"	"Cancer enhanced"	"Detected in all"		"prostate cancer: 37.2"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"classical monocyte: 43.4"	"Group enriched"	"Detected in many"	49	"dendritic cells: 14.1;monocytes: 43.4"	"Cell line enhanced"	"Detected in some"		"NTERA-2: 1.7;PC-3: 3.4;RT4: 1.6;U-2 OS: 1.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"								"Secreted to blood"	NA	NA	7380000	290000000	"Cluster 25: Monocytes - Inflammatory response"	"Cluster 16: Immune cells - Immune response"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 4: Macrophages - Innate immune response"				"unprognostic (3.63e-3)"	"unprognostic (2.82e-3)"	"unprognostic (8.69e-2)"	"unprognostic (3.00e-1)"	"unprognostic (1.47e-1)"	"unprognostic (6.26e-2)"	"unprognostic (9.45e-2)"	"unprognostic (1.79e-1)"	"unprognostic (1.95e-1)"	"unprognostic (1.43e-1)"	"unprognostic (2.06e-2)"	"unprognostic (5.33e-2)"	"unprognostic (2.35e-2)"	"unprognostic (2.47e-1)"	"unprognostic (9.20e-2)"	"unprognostic (1.93e-1)"	"unprognostic (7.08e-2)"	4.5	3.1	1.6	22.9	3.6	2.8	2.6	2.7	4.5	2.5	0.4	7.5	4.1	4.8	1.1	0.6	1.9	6.0	0.6	2.6	1.4	0.3	6.9	7.2	26.8	3.9	2.6	1.1	0.8	21.0	2.1	23.3	4.2	13.1	10.3	0.6	1.4	2.6	0.4	3.6	3.3	2.8	2.6	27.2	2.9	0.9	8.9	4.9	20.2	0.0	10.0	11.1	0.3	7.4	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.9	0.7	0.0	0.0	0.0	0.1	0.8	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.7	0.0	3.4	0.0	0.0	0.0	0.0	1.6	0.0	0.2	0.0	0.0	0.0	0.4	0.4	0.4	0.0	0.0	1.6	0.0	0.4	0.0	0.0	0.0	0.0	0.1	0.6	0.3	43.4	0.3	0.1	9.2	0.3	0.3	0.0	0.0	14.1	0.0	0.0	0.1	0.5	0.0	0.5	0.3	0.0	11.9	1.6	3.6	2.7	4.5	2.6	1.4	3.9	2.6	4.2	2.6	8.9	7.4	0.5	0.0	1.3	0.3	3.6	0.8	4.4	0.0	0.0	0.2	0.3	4.3	0.3	0.0	0.0	0.0	0.0	1.6	0.0	0.2	0.0	0.6	0.1	1.6	50.3	0.6	3.5	0.0	7.1	0.0	5.1	1.8	0.0	1.5	0.0	0.0	0.0	0.0	372.2	1.7	4.8	0.3	0.0	24.6	4.9	0.1	0.0	140.9	10.6	11.2	29.3	0.3	0.0	6.0	0.3	0.3	0.0	0.0	0.1	6.9	0.0	0.1	0.0	0.1	0.0	0.9	0.6	0.1	0.0	0.1	0.1	3.1	0.8	8.9	0.2	3.8
PLAAT1	"A-C1, H-REV107, HRASLS, HRASLS1, PLA/AT1, PLAAT-1"	ENSG00000127252	"Phospholipase A and acyltransferase 1"	Q9HDD0	3	193241128-193277738	"Enzymes, Predicted membrane proteins"	"Lipid degradation, Lipid metabolism"	"Hydrolase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	7	"skeletal muscle: 90.1;testis: 73.6;tongue: 44.5"	"Cell type enriched"	"Detected in some"	11	"Cardiomyocytes: 12.5"	"Cancer enhanced"	"Detected in many"		"glioma: 8.9"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HAP1: 12.9;NTERA-2: 11.0;PC-3: 23.8;RH-30: 10.7;SCLC-21H: 22.0;U-2 OS: 13.3;U-251 MG: 18.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA051179	Uncertain		Approved	"Focal adhesion sites,Cytosol"		No	No			"Cluster 9: Neutrophils - Innate immune response"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 54: Cardiomyocytes - Muscle contraction"	"Focal adhesion sites"	Cytosol	"HPA051179: AB_2681375"	"unprognostic (3.01e-2)"	"unprognostic (4.21e-2)"	"unprognostic (7.93e-3)"	"unprognostic (4.82e-3)"	"unprognostic (2.79e-1)"	"unprognostic (1.87e-1)"	"unprognostic (9.97e-3)"	"unprognostic (9.68e-3)"	"unprognostic (1.84e-1)"	"unprognostic (3.55e-1)"	"unprognostic (1.77e-4)"	"unprognostic (5.09e-2)"	"unprognostic (1.38e-5)"	"unprognostic (1.61e-2)"	"prognostic favorable (4.36e-4)"	"unprognostic (2.98e-3)"	"unprognostic (1.13e-2)"	0.9	2.5	4.6	0.2	4.9	0.1	1.8	3.5	6.0	0.4	0.8	0.6	0.0	0.9	5.9	6.5	0.5	0.2	9.3	5.1	6.0	0.7	0.1	0.2	0.0	4.5	4.3	0.2	1.4	2.1	2.2	0.1	4.2	0.1	0.1	9.0	2.0	0.7	90.1	3.3	0.3	1.3	2.3	0.2	0.8	73.6	3.9	2.2	7.0	44.5	0.3	0.3	0.4	4.5	0.0	0.1	2.6	0.0	0.0	0.0	0.0	0.2	0.0	2.3	0.4	0.0	0.1	0.0	0.2	0.0	5.3	0.0	12.9	0.4	0.6	0.0	5.6	6.9	0.0	0.0	0.0	0.0	0.1	0.1	0.9	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	11.0	0.4	23.8	0.0	10.7	0.0	3.7	0.0	22.0	4.1	1.5	3.3	0.0	2.1	6.5	0.1	0.1	0.0	13.3	0.0	18.6	0.1	0.0	0.0	7.0	0.0	3.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	2.4	4.6	4.9	3.5	6.0	5.1	6.0	4.5	4.3	4.2	2.3	3.9	4.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12.5	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	1.1	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0
PLAAT2	"FLJ20556, HRASLS2, PLAAT-2"	ENSG00000133328	"Phospholipase A and acyltransferase 2"	Q9NWW9	11	63552770-63563379	"Enzymes, Metabolic proteins, Predicted membrane proteins"	"Lipid degradation, Lipid metabolism"	"Acyltransferase, Hydrolase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	5	"intestine: 67.9"	"Cell type enhanced"	"Detected in single"		"dendritic cells: 2.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Group enriched"	"Detected in some"	8	"memory B-cell: 17.3;naive B-cell: 8.2"	"Lineage enriched"	"Detected in many"	10	"B-cells: 17.3"	"Cell line enriched"	"Detected in some"	8	"U-266/70: 128.9"									HPA058997	Approved		Approved	Mitochondria		NA	NA			"Cluster 19: B-cells - Humoral immune response"	"Cluster 56: Intestine - Transmembrane transport"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 24: Non-specific - Transcription regulation"	Mitochondria		"HPA058997: AB_2683874"	"unprognostic (4.76e-2)"	"prognostic favorable (6.87e-4)"	"unprognostic (1.20e-1)"	"unprognostic (3.07e-2)"	"unprognostic (1.43e-1)"	"unprognostic (1.43e-1)"	"unprognostic (1.82e-1)"	"unprognostic (1.53e-1)"	"unprognostic (9.69e-2)"	"unprognostic (3.91e-3)"	"prognostic unfavorable (5.27e-5)"	"unprognostic (1.56e-1)"	"unprognostic (2.29e-1)"	"unprognostic (1.38e-2)"	"unprognostic (2.51e-1)"	"unprognostic (2.43e-1)"	"unprognostic (1.57e-2)"	0.3	0.0	0.6	0.8	0.6	0.1	9.1	0.5	0.9	0.9	0.3	11.2	67.9	0.3	1.2	1.5	4.7	0.6	0.2	0.5	0.5	8.6	4.6	3.6	0.3	0.7	0.6	0.2	0.0	0.0	0.2	0.2	0.6	0.4	13.7	0.0	0.9	0.5	0.0	0.3	42.5	0.3	0.5	0.7	12.4	0.5	0.6	0.3	0.9	0.0	0.3	1.3	0.2	1.1	0.4	1.7	0.0	0.0	0.1	0.0	0.2	0.0	0.1	0.4	0.1	0.3	15.6	0.0	0.9	0.0	0.4	1.0	0.6	0.2	0.1	0.2	0.0	0.1	1.0	0.1	0.2	0.0	0.1	0.1	1.2	0.3	0.0	0.7	0.0	0.0	0.0	6.7	0.0	0.0	0.2	0.3	0.1	8.7	1.9	0.0	0.0	1.5	0.6	0.0	0.0	0.2	0.1	4.0	0.0	0.1	2.2	0.1	0.0	0.0	0.0	0.1	0.0	128.9	16.3	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.9	0.0	0.9	17.3	0.2	1.0	0.1	8.2	0.2	0.7	0.1	1.6	0.0	0.9	0.0	3.9	0.6	0.6	0.5	0.9	0.5	0.5	0.7	0.6	0.6	0.5	0.6	1.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	2.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.3	0.0	0.0	0.0
PLAAT3	"AdPLA, H-REV107-1, HRASLS3, HREV107, HREV107-3, MGC118754., PLA2G16, PLAAT-3"	ENSG00000176485	"Phospholipase A and acyltransferase 3"	P53816	11	63573195-63616883	"Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins, RAS pathway related proteins"	"Host-virus interaction, Lipid degradation, Lipid metabolism"	"Hydrolase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"adipose tissue: 318.7;brain: 394.8"	"Cell type enhanced"	"Detected in some"		"Adipocytes: 80.5;Cardiomyocytes: 151.9;Cytotrophoblasts: 137.4;Extravillous trophoblasts: 365.5;Hofbauer cells: 71.0;Syncytiotrophoblasts: 290.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"plasmacytoid DC: 187.8"	"Group enriched"	"Detected in all"	6	"dendritic cells: 187.8;T-cells: 55.0"	"Cell line enhanced"	"Detected in many"		"A549: 135.1;ASC diff: 148.2;CAPAN-2: 247.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA011749, HPA058997"	Approved		Supported	Mitochondria		NA	NA			"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 57: Non-specific - Angiogenesis"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 38: Extravillous trophoblasts - Unknown function"	Mitochondria		"HPA011749: , HPA058997: AB_2683874"	"unprognostic (5.18e-2)"	"unprognostic (3.67e-2)"	"unprognostic (7.92e-2)"	"unprognostic (3.89e-2)"	"unprognostic (1.94e-1)"	"unprognostic (1.78e-1)"	"unprognostic (1.13e-1)"	"unprognostic (3.06e-2)"	"unprognostic (6.97e-2)"	"unprognostic (1.14e-1)"	"prognostic unfavorable (5.58e-6)"	"unprognostic (6.38e-2)"	"unprognostic (1.93e-3)"	"unprognostic (1.62e-1)"	"unprognostic (1.75e-1)"	"prognostic favorable (2.54e-5)"	"unprognostic (2.35e-1)"	318.7	36.2	208.5	10.2	287.0	3.1	166.8	234.7	261.6	13.3	142.8	32.8	8.7	17.6	26.6	13.2	33.0	29.1	103.0	197.7	215.3	65.0	76.5	37.6	11.6	283.0	250.7	73.4	32.4	28.6	33.4	40.3	279.8	16.4	7.6	26.6	28.9	29.9	108.9	10.7	21.8	15.8	241.2	15.9	31.9	54.7	237.1	7.1	41.2	118.7	4.4	26.7	9.6	394.8	87.7	135.1	3.7	0.2	148.2	25.1	24.1	3.2	26.9	22.3	11.2	30.8	247.1	0.0	55.3	6.9	72.4	4.4	127.4	6.8	16.9	108.0	5.0	1.3	33.3	5.4	87.8	0.0	1.3	15.2	0.7	55.4	2.2	88.1	35.4	0.0	1.6	9.6	24.0	15.3	0.2	0.6	10.8	55.0	43.0	0.0	0.0	8.7	71.2	12.3	1.7	9.7	18.0	51.5	28.7	54.6	111.6	4.5	52.2	10.0	0.7	34.0	7.7	39.6	28.0	0.3	40.1	0.0	1.0	0.1	21.1	0.1	55.0	9.1	30.3	7.4	12.1	40.5	6.4	1.2	3.9	30.0	1.3	21.0	0.6	187.8	9.3	27.2	208.5	287.0	234.7	261.6	197.7	215.3	283.0	250.7	279.8	241.2	237.1	394.8	80.5	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	151.9	0.0	0.0	0.0	0.0	137.4	18.6	0.0	0.0	0.0	0.0	0.0	0.0	12.0	0.0	0.0	0.0	0.0	365.5	14.7	0.0	0.0	0.0	0.0	0.0	0.0	71.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.0	0.0	0.0	0.0	0.0	290.6	2.0	0.0	0.0	0.0
PLAAT4	"HRASLS4, PLAAT-4, RARRES3, RIG1, TIG3"	ENSG00000133321	"Phospholipase A and acyltransferase 4"	Q9UL19	11	63536808-63546462	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"	"Lipid degradation, Lipid metabolism"	"Hydrolase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"Cytotrophoblasts: 20.0;dendritic cells: 75.8;Extravillous trophoblasts: 19.0;Hofbauer cells: 26.6;Syncytiotrophoblasts: 30.1;T-cells: 12.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"CAPAN-2: 223.6;RPTEC TERT1: 114.4;SK-BR-3: 169.0;U-266/70: 81.7"															NA	NA			"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 7: Kidney - Transmembrane transport"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 24: Non-specific - Transcription regulation"				"prognostic favorable (1.35e-5)"	"prognostic favorable (4.00e-4)"	"unprognostic (4.12e-2)"	"unprognostic (1.37e-1)"	"unprognostic (3.30e-1)"	"unprognostic (2.45e-2)"	"unprognostic (2.11e-1)"	"unprognostic (6.91e-2)"	"unprognostic (1.78e-1)"	"unprognostic (2.92e-2)"	"prognostic unfavorable (6.26e-6)"	"unprognostic (8.50e-2)"	"unprognostic (1.59e-1)"	"unprognostic (3.42e-1)"	"unprognostic (2.11e-1)"	"unprognostic (9.36e-3)"	"unprognostic (2.64e-1)"	47.7	18.8	84.1	52.9	83.8	20.7	102.5	78.4	121.9	46.5	78.3	56.2	87.7	28.5	62.3	19.2	99.1	52.3	19.0	83.3	90.1	202.7	111.1	107.9	98.2	97.8	83.6	58.5	14.0	2.4	24.2	16.9	85.5	57.2	57.0	12.5	83.7	73.7	14.2	9.0	101.9	43.5	84.1	73.1	64.7	7.7	86.8	79.4	46.3	16.1	56.1	55.5	25.7	89.8	22.2	14.0	0.0	0.6	19.8	68.5	5.0	2.0	37.2	28.1	25.2	0.4	223.6	3.5	18.7	3.9	22.9	5.2	5.2	4.1	5.9	37.8	0.0	1.4	1.3	0.0	78.4	0.7	0.9	79.0	0.5	10.5	0.2	60.1	3.4	7.8	0.0	27.5	4.1	0.0	55.3	4.7	0.3	4.0	1.9	24.2	0.1	1.7	114.4	4.8	0.3	0.1	4.8	169.0	9.5	1.2	20.3	1.6	6.5	2.0	0.2	4.1	0.8	81.7	1.2	0.9	8.5	13.6	1.5	258.1	80.6	53.6	426.8	114.5	328.6	81.5	323.4	454.2	48.9	61.4	282.7	370.3	57.1	256.5	96.5	5.8	278.2	563.0	84.1	83.8	78.4	121.9	83.3	90.1	97.8	83.6	85.5	84.1	86.8	89.8	12.0	0.0	0.0	0.0	4.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.8	0.0	0.0	0.0	0.0	20.0	75.8	0.0	0.0	0.0	0.0	0.0	0.0	3.0	0.0	0.0	0.0	0.0	19.0	9.5	0.0	0.0	0.0	0.0	0.0	0.0	26.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.0	30.1	12.6	0.0	0.0	0.0
PLAAT5	"HRASLS5, HRLP5, iNAT, PLAAT-5"	ENSG00000168004	"Phospholipase A and acyltransferase 5"	Q96KN8	11	63461404-63491194	"Enzymes, Predicted intracellular proteins"		"Acyltransferase, Hydrolase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	8	"adipose tissue: 16.5;pancreas: 13.6;testis: 53.4"	"Cell type enhanced"	"Detected in some"		"Cardiomyocytes: 1.6;Syncytiotrophoblasts: 1.0"	"Cancer enhanced"	"Detected in many"		"breast cancer: 3.9"	"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	64	"basophil: 5.4;eosinophil: 16.4"	"Lineage enriched"	"Detected in single"	97	"granulocytes: 16.4"	"Group enriched"	"Detected in some"	5	"HAP1: 11.4;NB-4: 4.0"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA042493			Uncertain	"Plasma membrane"		NA	NA			"Cluster 2: Granulocytes - Unknown function"	"Cluster 83: Testis - Spermatogenesis"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 50: Fibroblasts - ECM organization"	"Plasma membrane"		"HPA042493: AB_10797499"	"unprognostic (3.16e-1)"	"unprognostic (3.45e-2)"	"unprognostic (2.83e-3)"	"unprognostic (4.24e-2)"	"prognostic unfavorable (1.12e-4)"	"unprognostic (7.11e-3)"	"unprognostic (2.14e-1)"	"unprognostic (6.66e-2)"	"unprognostic (9.46e-2)"	"unprognostic (8.89e-3)"	"unprognostic (3.15e-2)"	"unprognostic (7.33e-2)"	"unprognostic (1.04e-5)"	"unprognostic (1.52e-1)"	"unprognostic (1.21e-2)"	"unprognostic (2.57e-3)"	"unprognostic (4.50e-4)"	16.5	0.2	1.2	0.3	0.9	0.1	3.3	0.7	0.8	0.1	0.0	0.7	0.2	0.5	0.2	0.8	0.9	0.6	0.6	1.0	1.3	0.1	0.0	0.6	0.1	1.5	0.5	0.6	13.6	0.0	0.0	0.0	1.0	0.4	0.2	0.5	0.8	1.3	0.1	0.2	0.3	1.4	1.1	0.1	0.5	53.4	0.8	0.0	0.1	0.1	0.0	0.5	0.1	3.2	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.0	0.4	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.4	0.3	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	5.4	0.0	16.4	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	1.2	0.9	0.7	0.8	1.0	1.3	1.5	0.5	1.0	1.1	0.8	3.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0
PLAT		ENSG00000104368	"Plasminogen activator, tissue type"	P00750	8	42174718-42207709	"Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted secreted proteins"	"Plasminogen activation"	"Hydrolase, Protease, Serine protease"	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"parathyroid gland: 246.0;urinary bladder: 181.4"	"Group enriched"	"Detected in many"	4	"Basal prostatic cells: 763.3;Urothelial cells: 992.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"CAPAN-2: 604.7;HMC-1: 425.2;hTERT-RPE1: 344.9;LHCN-M2: 298.2;U-2197: 441.2;WM-115: 806.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003412, CAB009335"	Supported		Approved	"Actin filaments"	"Secreted to blood"	NA	NA	9900000	110000	"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 17: WM-115 - Nervous system development"	"Cluster 22: Epithelial cell types - Mixed function"	"Actin filaments"		"CAB009335: AB_2237146, HPA003412: AB_1858205"	"prognostic favorable (7.57e-4)"	"unprognostic (2.23e-1)"	"unprognostic (4.08e-1)"	"unprognostic (3.39e-1)"	"unprognostic (4.88e-3)"	"unprognostic (9.39e-2)"	"unprognostic (4.65e-3)"	"unprognostic (5.78e-2)"	"unprognostic (1.55e-1)"	"unprognostic (1.75e-1)"	"unprognostic (2.98e-3)"	"unprognostic (2.46e-1)"	"prognostic unfavorable (4.95e-4)"	"unprognostic (8.72e-3)"	"unprognostic (1.37e-2)"	"unprognostic (2.63e-2)"	"unprognostic (6.09e-2)"	58.9	44.0	14.0	35.6	13.7	0.1	35.1	14.6	17.4	21.8	10.3	55.3	29.9	49.6	16.8	33.7	49.8	40.4	19.3	12.5	16.6	91.9	5.3	41.3	2.3	15.4	15.4	21.5	16.0	246.0	13.3	44.4	16.6	54.0	25.0	2.1	15.6	29.1	8.8	6.2	34.6	32.9	16.0	2.0	41.8	11.9	18.8	4.4	30.9	9.8	2.7	181.4	33.1	14.0	4.2	1.4	29.0	9.1	43.1	61.9	0.9	125.8	216.4	54.2	43.4	1.4	604.7	0.0	4.4	17.1	28.4	14.5	0.3	23.9	78.5	64.6	8.4	0.7	1.0	0.6	253.9	0.2	425.2	65.6	0.4	140.3	6.0	344.9	103.9	0.2	4.6	0.8	298.2	0.0	0.6	0.5	42.3	0.3	48.2	0.2	103.5	0.3	12.6	0.4	0.3	7.4	0.2	0.4	158.7	39.7	1.0	0.3	189.3	11.6	43.1	441.2	15.6	0.2	1.1	0.2	9.7	0.2	806.0	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	14.0	13.7	14.6	17.4	12.5	16.6	15.4	15.4	16.6	16.0	18.8	14.0	63.5	0.0	13.7	0.0	2.9	10.8	763.3	155.9	7.4	4.7	103.9	66.3	7.4	1.5	19.1	0.0	4.2	0.6	0.9	0.1	0.0	9.3	0.9	4.8	104.2	98.2	0.0	0.0	1.6	0.6	1.3	136.5	2.0	5.1	164.0	89.7	36.4	0.8	1.9	1.7	4.0	0.0	4.1	1.0	17.7	1.5	3.7	4.7	23.2	25.3	1.6	2.1	1.0	42.7	0.3	52.0	0.0	2.6	2.8	193.3	0.2	0.3	4.0	3.8	13.1	10.8	48.3	1.1	0.6	13.6	13.5	0.7	6.0	0.5	0.5	992.1
PLAU	"UPA, URK"	ENSG00000122861	"Plasminogen activator, urokinase"	P00749	10	73909177-73917496	"Cancer-related genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted secreted proteins"	"Blood coagulation, Fibrinolysis, Hemostasis, Plasminogen activation"	"Hydrolase, Protease, Serine protease"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"kidney: 103.8;urinary bladder: 128.5"	"Group enriched"	"Detected in many"	4	"Basal prostatic cells: 635.9;Basal respiratory cells: 237.3;Pancreatic endocrine cells: 613.9;Prostatic glandular cells: 695.0;Urothelial cells: 869.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	9	"myeloid DC: 1.1;neutrophil: 2.1;plasmacytoid DC: 2.0"	"Group enriched"	"Detected in many"	11	"dendritic cells: 2.0;granulocytes: 2.1"	"Cell line enhanced"	"Detected in many"		"CAPAN-2: 856.0;LHCN-M2: 822.4;RPTEC TERT1: 3100.7;U-251 MG: 869.8"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA070796	Supported		Uncertain	"Golgi apparatus,Vesicles"	"Secreted to blood"	NA	NA	647000	88000	"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 82: Adipose tissue - ECM organization"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 22: Epithelial cell types - Mixed function"	"Golgi apparatus, Vesicles"		"HPA070796: "	"unprognostic (1.96e-2)"	"unprognostic (2.99e-2)"	"unprognostic (7.40e-2)"	"prognostic favorable (3.38e-4)"	"unprognostic (4.73e-2)"	"prognostic unfavorable (2.70e-4)"	"unprognostic (1.39e-2)"	"prognostic unfavorable (4.04e-4)"	"unprognostic (2.26e-1)"	"unprognostic (6.58e-2)"	"prognostic unfavorable (1.32e-4)"	"unprognostic (1.61e-1)"	"prognostic unfavorable (3.51e-4)"	"unprognostic (2.83e-1)"	"unprognostic (3.37e-2)"	"unprognostic (1.51e-2)"	"unprognostic (1.77e-2)"	57.6	4.8	2.5	41.7	2.7	36.2	17.6	2.7	8.9	9.3	4.4	13.1	11.9	22.0	16.7	14.4	10.3	28.5	23.1	2.4	2.9	103.8	5.0	22.0	14.3	3.8	2.9	2.3	10.1	8.3	2.9	36.5	5.4	9.1	18.2	0.3	17.3	13.7	10.8	25.5	13.7	23.4	3.3	40.6	15.7	3.7	4.7	5.9	17.9	18.9	7.2	128.5	16.2	4.7	171.1	88.9	36.8	1.7	3.1	59.5	2.0	101.9	461.6	40.0	62.2	2.3	856.0	0.1	184.0	14.5	416.9	114.1	0.9	165.8	44.8	9.9	0.0	0.1	4.4	1.7	72.6	15.6	32.3	158.7	20.2	271.4	103.7	447.0	114.7	1.0	1.1	0.9	822.4	0.2	0.2	22.7	10.8	0.3	244.5	0.4	112.6	0.9	3100.7	130.6	0.1	0.2	0.3	4.0	2.4	25.4	1.2	22.9	300.6	3.5	20.3	21.6	869.8	0.2	1.3	1.6	216.0	25.5	1.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	2.1	0.0	0.0	2.0	0.0	0.1	2.5	2.7	2.7	8.9	2.4	2.9	3.8	2.9	5.4	3.3	4.7	4.7	29.0	3.2	4.6	0.3	1.4	37.3	635.9	237.3	19.9	0.0	3.0	24.4	2.5	0.0	103.6	29.5	0.0	28.0	1.6	0.6	68.4	62.7	0.5	50.7	22.2	46.4	3.5	0.0	0.2	21.3	21.7	69.7	0.0	68.9	31.1	0.1	3.9	0.0	39.8	0.0	0.3	0.1	140.4	4.0	33.1	1.3	2.5	53.4	7.2	4.7	23.8	0.0	0.0	0.5	0.2	613.9	0.3	0.0	0.5	695.0	0.0	1.4	35.4	0.0	6.6	27.6	65.2	0.0	0.2	60.6	29.5	17.5	4.7	0.6	1.7	869.6
PLB1	"FLJ30866, PLB"	ENSG00000163803	"Phospholipase B1"	Q6P1J6	2	28457145-28644142	"Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Lipid metabolism, Phospholipid metabolism"	Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"intestine: 39.0"	"Cell type enriched"	"Detected in many"	4	"Proximal enterocytes: 112.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	14	"classical monocyte: 3.0;eosinophil: 3.0;intermediate monocyte: 4.4;myeloid DC: 5.7;neutrophil: 8.8;non-classical monocyte: 5.0"	"Group enriched"	"Detected in many"	40	"dendritic cells: 5.7;granulocytes: 8.8;monocytes: 5.0"	"Cell line enhanced"	"Detected in some"		"BEWO: 3.6;OE19: 7.8;RT4: 2.7"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"									NA	NA			"Cluster 28: Myeloid DCs - Unknown function"	"Cluster 56: Intestine - Transmembrane transport"	"Cluster 21: OE19 - Mitochondria"	"Cluster 45: Enterocytes - Digestion"				"unprognostic (2.18e-2)"	"unprognostic (2.49e-1)"	"unprognostic (6.58e-2)"	"unprognostic (1.42e-1)"	"unprognostic (2.94e-2)"	"unprognostic (1.25e-1)"	"unprognostic (4.91e-3)"	"unprognostic (4.74e-2)"	"unprognostic (4.48e-2)"	"unprognostic (2.03e-2)"	"unprognostic (1.53e-1)"	"unprognostic (2.17e-1)"	"unprognostic (2.61e-9)"	"unprognostic (2.48e-2)"	"unprognostic (2.19e-2)"	"unprognostic (4.99e-2)"	"unprognostic (8.03e-2)"	1.8	5.7	3.4	1.8	3.3	5.0	1.8	1.0	3.0	1.9	2.2	1.5	0.7	1.6	1.7	1.0	1.3	1.5	1.2	2.7	2.6	0.7	0.5	1.6	0.4	2.4	2.3	0.9	0.6	0.3	1.6	2.1	2.0	2.1	1.8	0.1	1.4	1.5	2.0	7.9	39.0	2.7	2.5	4.1	0.9	2.6	2.9	0.6	2.0	0.6	0.3	1.7	1.3	1.6	0.4	0.0	2.4	0.0	0.5	0.3	3.6	0.1	1.0	0.2	0.2	2.5	0.2	0.2	0.2	0.4	1.0	0.5	0.0	1.9	0.2	0.1	0.0	0.2	0.4	0.4	0.8	0.4	0.1	0.4	1.1	0.4	0.5	0.4	0.6	0.0	0.0	0.0	0.7	0.0	0.0	0.3	0.1	7.8	0.5	0.0	0.4	0.0	1.1	2.7	1.0	0.2	0.1	0.1	0.2	0.2	0.0	1.3	0.2	0.2	0.7	0.1	0.1	0.5	0.1	0.0	0.8	1.8	0.0	0.0	3.0	3.0	0.0	4.4	0.0	0.0	0.1	0.0	5.7	0.0	0.0	0.0	8.8	0.0	5.0	0.3	0.1	1.1	3.4	3.3	1.0	3.0	2.7	2.6	2.4	2.3	2.0	2.5	2.9	1.6	0.6	0.0	0.6	0.7	0.3	0.4	1.0	0.6	0.6	0.1	1.6	1.5	1.6	0.0	1.5	0.0	0.0	0.5	2.1	6.5	1.9	1.6	27.0	2.4	1.0	1.5	1.2	0.0	3.2	0.9	23.2	0.6	0.0	1.1	5.7	0.1	1.1	0.0	12.5	0.0	3.4	5.4	0.0	17.4	10.1	18.3	1.2	12.5	0.0	15.0	4.8	0.3	0.0	1.5	0.4	1.0	2.6	0.7	0.5	0.4	112.6	0.0	1.5	0.0	0.0	1.1	0.3	1.0	0.9	0.3	0.4	8.2	1.5	0.6	2.5	1.6
PLCB1	"KIAA0581, PLC-I, PLC154"	ENSG00000182621	"Phospholipase C beta 1"	Q9NQ66	20	8077251-8968360	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Lipid degradation, Lipid metabolism"	"Hydrolase, Transducer"	Epilepsy	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 74.3"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 563.5;Excitatory neurons: 2569.1;Inhibitory neurons: 1774.0;Oligodendrocyte precursor cells: 783.1"	"Low cancer specificity"	"Detected in many"			"Region enhanced"	"Detected in many"		"cerebral cortex: 74.3"	"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"CACO-2: 45.5;Hep G2: 68.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004275, CAB005334, HPA034743, HPA057910"	Enhanced		Approved	"Plasma membrane"		NA	NA		6600	"Cluster 16: MAIT-cells - Unknown function"	"Cluster 10: Brain - Neuronal signaling"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	"Plasma membrane"		"CAB004275: AB_628118, CAB005334: AB_632196, HPA034743: AB_2674311, HPA057910: AB_2683552"	"unprognostic (2.32e-1)"	"unprognostic (1.02e-1)"	"unprognostic (6.63e-2)"	"unprognostic (9.77e-2)"	"unprognostic (9.87e-2)"	"unprognostic (2.37e-1)"	"unprognostic (1.27e-4)"	"unprognostic (1.13e-1)"	"unprognostic (3.16e-2)"	"unprognostic (1.91e-1)"	"unprognostic (7.12e-3)"	"unprognostic (6.57e-2)"	"unprognostic (2.87e-3)"	"unprognostic (3.20e-2)"	"unprognostic (4.41e-2)"	"unprognostic (1.71e-2)"	"unprognostic (2.12e-1)"	9.3	8.9	11.7	5.7	52.3	4.8	7.6	0.0	74.3	8.2	0.0	18.1	7.2	9.3	3.5	5.4	9.6	8.5	11.7	17.4	0.0	13.2	4.3	5.0	1.8	0.0	0.1	3.7	14.7	44.3	4.3	19.6	0.0	13.4	4.1	7.1	29.0	18.8	14.4	2.6	5.7	8.1	0.0	3.6	8.0	3.0	9.8	6.8	3.8	11.0	0.9	15.9	6.7	23.8	0.2	1.2	4.8	0.3	8.7	16.1	6.3	20.2	13.1	5.2	3.1	45.5	5.0	2.2	8.2	3.9	0.3	0.0	3.7	0.0	3.8	0.0	4.4	1.0	3.5	68.7	2.2	1.1	0.7	1.1	0.8	7.1	0.0	6.5	10.6	13.0	7.1	26.0	0.1	6.2	1.0	3.3	15.0	10.6	6.6	14.7	0.0	12.1	4.0	16.8	16.9	7.2	0.1	4.1	0.9	17.1	19.9	6.6	1.9	16.8	7.5	1.3	12.7	19.4	24.5	33.9	8.6	12.6	29.5	0.3	1.3	1.2	1.4	0.3	2.0	0.1	0.4	0.5	0.1	0.2	0.2	0.4	0.8	1.1	0.1	0.3	0.1	0.2	11.7	52.3	0.0	74.3	17.4	0.0	0.0	0.1	0.0	0.0	9.8	23.8	74.8	0.0	3.4	563.5	1.1	1.9	20.8	2.3	8.0	7.6	8.1	23.2	26.9	7.2	2.6	16.5	0.0	2.4	16.8	1.3	33.2	1.2	9.9	42.1	5.1	54.6	0.0	6.5	2569.1	13.4	2.8	25.8	3.6	83.6	1.3	0.2	26.4	2.8	0.8	1.7	1774.0	2.1	0.0	8.2	1.2	4.3	3.4	9.1	7.2	211.7	12.2	18.2	15.5	783.1	34.8	1.8	0.5	3.8	6.1	20.2	0.1	9.4	9.9	4.1	0.0	7.4	13.3	4.7	5.6	2.5	1.7	1.8	15.4	1.1	1.2	18.9
PLCB2	FLJ38135	ENSG00000137841	"Phospholipase C beta 2"	Q00722	15	40278176-40307935	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Lipid degradation, Lipid metabolism"	"Hydrolase, Transducer"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 52.4;lymphoid tissue: 40.7"	"Cell type enhanced"	"Detected in many"		"dendritic cells: 22.6;granulocytes: 26.6;Hofbauer cells: 30.3;Kupffer cells: 46.6;Macrophages: 41.7;Microglial cells: 39.4;monocytes: 20.9;NK-cells: 26.8;T-cells: 20.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"HEL: 78.6;HMC-1: 93.4;THP-1: 28.1;U-937: 53.2"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"CAB009443, HPA041298, HPA068595, HPA069308"	Enhanced		Approved	"Plasma membrane,Cytosol"		NA	NA		11000	"Cluster 45: Eosinophils - Innate immune response"	"Cluster 2: Immune cells - Immune response"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 19: Monocytes & Neutrophils - Innate immune response"	"Plasma membrane, Cytosol"		"CAB009443: AB_632197, HPA041298: AB_2677395, HPA068595: , HPA069308: "	"unprognostic (5.52e-2)"	"unprognostic (4.96e-3)"	"unprognostic (6.09e-3)"	"unprognostic (1.88e-2)"	"unprognostic (1.31e-1)"	"prognostic favorable (3.00e-4)"	"unprognostic (1.66e-1)"	"unprognostic (3.08e-2)"	"unprognostic (1.28e-1)"	"unprognostic (2.34e-1)"	"unprognostic (1.42e-1)"	"unprognostic (2.75e-1)"	"prognostic unfavorable (7.20e-5)"	"unprognostic (9.89e-2)"	"unprognostic (2.06e-3)"	"unprognostic (5.81e-2)"	"unprognostic (1.13e-1)"	5.9	4.0	3.8	29.2	3.9	52.4	2.5	3.8	5.4	3.3	3.4	5.1	6.1	2.7	1.4	3.0	4.5	9.7	3.0	4.0	5.6	1.9	6.3	16.8	28.7	8.4	7.1	1.5	1.3	1.3	2.1	7.0	7.3	2.6	8.0	0.5	5.4	4.0	1.2	1.9	10.4	7.3	6.2	40.7	5.5	1.3	7.7	20.5	2.2	1.7	22.2	7.3	1.8	9.6	0.4	0.0	0.6	0.0	0.0	0.0	10.5	0.0	0.1	0.0	0.0	0.1	19.1	1.5	17.6	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.2	78.6	0.0	0.0	0.0	16.9	93.4	0.0	0.0	0.0	0.0	0.0	0.1	10.2	0.7	4.3	0.0	0.0	4.7	9.2	0.9	0.0	0.2	13.7	2.0	0.1	0.1	0.0	0.3	0.3	0.0	0.0	0.2	5.1	0.0	28.1	10.1	0.0	9.1	0.0	0.0	0.0	0.0	3.7	0.0	53.2	0.0	1.7	2.6	5.3	1.8	2.7	1.2	0.4	0.9	0.9	2.7	0.5	0.9	1.0	4.2	1.2	2.7	1.0	1.9	1.5	3.8	3.9	3.8	5.4	4.0	5.6	8.4	7.1	7.3	6.2	7.7	9.6	0.9	6.4	16.8	0.3	9.6	0.9	0.1	0.1	0.6	0.1	1.9	2.5	3.3	1.5	3.2	1.8	0.0	0.5	22.6	0.2	0.0	0.1	2.2	0.2	0.5	1.7	0.0	8.0	1.8	0.0	0.5	1.9	0.0	0.2	26.6	0.1	1.1	0.4	30.3	0.0	0.8	1.7	0.0	46.6	15.5	0.6	0.3	41.7	3.6	39.4	20.9	0.0	26.8	0.5	0.2	0.4	0.3	0.0	5.7	0.0	0.0	0.9	4.4	0.2	0.0	0.4	0.7	0.5	2.3	0.3	0.6	0.4	20.8	0.3	2.0	0.0
PLCB3		ENSG00000149782	"Phospholipase C beta 3"	Q01970	11	64251530-64269150	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Lipid degradation, Lipid metabolism"	"Hydrolase, Transducer"	Dwarfism	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"intestine: 113.8"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 52.3;Proximal enterocytes: 161.7;Undifferentiated cells: 65.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"plasmacytoid DC: 1.2"	"Low lineage specificity"	"Detected in single"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB009257, HPA039279, HPA043907"	Enhanced		Approved	"Nucleoplasm,Golgi apparatus"		NA	NA		210000	"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 56: Intestine - Transmembrane transport"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 45: Enterocytes - Digestion"	Nucleoplasm	"Golgi apparatus"	"CAB009257: AB_654079, HPA039279: AB_2676425, HPA043907: AB_2678726"	"unprognostic (1.30e-1)"	"unprognostic (1.21e-2)"	"unprognostic (2.86e-1)"	"unprognostic (2.35e-1)"	"unprognostic (9.35e-2)"	"unprognostic (6.23e-3)"	"prognostic unfavorable (1.39e-4)"	"unprognostic (2.44e-2)"	"unprognostic (6.61e-2)"	"unprognostic (1.26e-1)"	"unprognostic (8.07e-3)"	"unprognostic (1.00e-2)"	"prognostic unfavorable (4.31e-5)"	"unprognostic (5.04e-3)"	"unprognostic (1.52e-1)"	"unprognostic (1.20e-1)"	"unprognostic (3.88e-2)"	12.8	19.1	6.8	9.7	7.3	7.4	11.2	8.2	8.0	19.7	7.0	22.8	113.8	17.8	3.6	35.3	16.5	7.1	11.5	6.5	7.3	11.7	6.4	15.6	4.4	9.2	7.6	15.8	8.6	10.0	5.8	10.3	8.1	13.1	12.5	1.4	13.5	10.4	6.7	20.3	101.6	11.4	7.7	14.5	14.7	9.5	9.2	3.9	10.3	4.2	5.3	13.8	18.8	7.7	45.2	24.9	24.0	36.0	24.6	18.9	23.8	35.3	26.4	29.5	17.9	22.1	33.5	3.2	20.8	44.4	25.4	75.9	27.2	33.0	10.1	21.8	15.1	35.1	54.9	16.7	17.0	8.6	22.3	16.0	21.5	32.1	23.6	32.2	43.5	13.4	17.6	3.8	37.9	54.5	10.9	17.9	38.8	56.9	26.9	23.5	54.0	13.3	18.2	46.8	6.4	26.4	52.0	64.4	25.2	14.8	33.9	16.4	76.4	27.1	32.0	62.7	23.2	4.6	2.4	3.6	44.8	19.9	25.5	0.0	0.4	0.0	0.2	0.4	0.2	0.0	0.2	0.1	0.4	0.0	0.1	0.1	0.2	0.1	0.4	1.2	0.0	0.1	6.8	7.3	8.2	8.0	6.5	7.3	9.2	7.6	8.1	7.7	9.2	7.7	11.2	3.2	7.9	7.5	1.8	13.0	6.0	6.4	6.2	1.2	6.1	4.6	3.3	8.6	6.3	16.5	0.0	9.2	8.3	52.3	1.9	7.8	1.3	3.5	8.7	13.2	2.4	7.8	0.6	7.7	19.1	7.6	28.5	7.1	5.7	20.2	18.2	3.4	9.8	3.3	0.9	46.2	12.2	10.1	13.5	1.4	9.9	8.8	8.8	8.4	22.1	4.7	2.1	1.5	0.6	17.3	23.8	12.4	2.6	7.4	161.7	4.0	2.8	1.1	26.3	6.0	9.8	3.1	8.3	19.4	11.8	14.6	2.7	6.8	65.5	8.3
PLCB4		ENSG00000101333	"Phospholipase C beta 4"	Q15147	20	9068763-9481242	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"Lipid degradation, Lipid metabolism"	"Hydrolase, Transducer"	"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 55.6;salivary gland: 57.4"	"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 105.9;Horizontal cells: 164.9;Inhibitory neurons: 113.8;Microglial cells: 183.6;Oligodendrocyte precursor cells: 168.9"	"Cancer enhanced"	"Detected in many"		"colorectal cancer: 23.5"	"Region enhanced"	"Detected in all"		"cerebellum: 55.6"	"Immune cell enriched"	"Detected in single"	18	"plasmacytoid DC: 3.0"	"Lineage enriched"	"Detected in single"	18	"dendritic cells: 3.0"	"Cell line enhanced"	"Detected in many"		"fHDF/TERT166: 91.4;hTERT-HME1: 45.9;LHCN-M2: 77.6;OE19: 48.2;RPTEC TERT1: 96.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA007951	Approved		Approved	Nucleoplasm,Microtubules		NA	NA			"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 21: Non-specific - Transcription"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Microtubules	Nucleoplasm	"HPA007951: AB_2667944"	"unprognostic (3.88e-2)"	"unprognostic (3.62e-1)"	"unprognostic (1.19e-2)"	"prognostic favorable (2.11e-4)"	"unprognostic (1.44e-2)"	"unprognostic (9.72e-3)"	"unprognostic (3.32e-3)"	"unprognostic (2.57e-2)"	"unprognostic (7.75e-2)"	"unprognostic (4.23e-2)"	"unprognostic (5.21e-3)"	"unprognostic (1.35e-1)"	"unprognostic (4.64e-3)"	"unprognostic (7.12e-2)"	"unprognostic (1.37e-1)"	"unprognostic (2.22e-1)"	"unprognostic (4.45e-2)"	6.3	7.2	8.6	3.4	3.7	0.5	7.0	55.6	6.3	4.6	31.0	20.5	2.6	8.2	24.4	9.0	15.0	5.9	17.9	2.5	10.8	3.0	0.3	5.4	1.7	13.4	17.8	2.1	2.1	0.7	8.2	6.5	12.0	9.7	17.9	15.1	57.4	6.1	2.7	4.6	4.2	9.1	5.3	1.3	14.4	2.4	23.3	4.5	32.7	6.8	2.3	8.2	5.3	6.5	0.0	15.1	7.9	0.0	0.0	0.4	0.1	35.8	9.5	10.9	6.1	3.4	2.6	0.0	0.6	91.4	39.0	0.1	2.3	7.6	14.7	0.0	5.3	3.8	5.7	0.0	1.6	0.0	0.0	2.3	3.0	12.7	45.9	18.7	0.1	0.0	4.3	0.4	77.6	5.0	0.0	0.0	8.8	48.2	10.4	0.0	0.0	0.7	96.9	5.8	25.5	18.4	0.0	23.8	15.1	10.5	19.2	0.2	0.5	11.2	0.9	1.2	14.2	0.0	0.0	0.0	1.7	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	3.0	0.0	0.0	8.6	3.7	55.6	6.3	2.5	10.8	13.4	17.8	12.0	5.3	23.3	6.5	37.8	6.4	0.5	60.1	0.3	2.4	3.8	1.5	2.2	82.9	5.7	5.3	72.6	0.0	8.9	5.5	0.0	0.0	4.5	17.9	0.0	0.7	1.4	46.2	4.6	40.4	42.0	0.0	105.9	0.2	0.0	9.0	18.8	53.5	0.0	36.6	1.8	0.0	0.1	164.9	113.8	36.4	14.2	0.0	2.1	1.2	1.5	0.8	7.2	183.6	0.6	2.9	0.0	168.9	2.9	7.1	9.7	20.7	0.2	8.5	2.1	1.2	39.5	6.6	13.1	10.5	36.0	1.5	2.0	0.5	1.0	0.1	1.4	4.8	40.4	2.5
PLCD1		ENSG00000187091	"Phospholipase C delta 1"	P51178	3	38007496-38029642	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Lipid degradation, Lipid metabolism"	"Hydrolase, Transducer"	"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 89.5;Theca cells: 53.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"ASC diff: 25.3;fHDF/TERT166: 26.3;hTCEpi: 31.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB009913, HPA020107, HPA021677"	Approved		Approved	Microtubules		NA	NA			"Cluster 16: MAIT-cells - Unknown function"	"Cluster 27: Brain & Skin - Unknown function"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Microtubules		"CAB009913: AB_2163388, HPA020107: AB_1855318, HPA021677: AB_1855319"	"unprognostic (1.75e-3)"	"unprognostic (1.01e-2)"	"unprognostic (4.29e-2)"	"unprognostic (1.45e-2)"	"unprognostic (3.44e-1)"	"unprognostic (9.67e-3)"	"unprognostic (1.55e-1)"	"unprognostic (7.25e-3)"	"unprognostic (3.95e-1)"	"unprognostic (1.45e-1)"	"unprognostic (2.80e-1)"	"unprognostic (2.24e-1)"	"prognostic favorable (9.25e-11)"	"unprognostic (1.50e-1)"	"unprognostic (7.71e-2)"	"unprognostic (2.93e-1)"	"unprognostic (7.88e-2)"	14.8	12.9	14.3	4.6	16.1	4.3	10.6	15.4	15.6	15.9	9.7	15.7	4.9	11.5	4.2	26.2	9.8	5.6	7.2	12.8	19.0	10.1	5.4	11.3	6.6	20.3	18.5	12.7	6.0	3.9	9.3	3.8	19.6	9.1	10.1	2.8	13.0	8.8	2.9	18.5	8.3	5.6	19.4	7.2	8.3	32.6	16.9	9.1	8.3	4.1	6.6	15.7	19.0	21.9	1.0	2.7	9.4	2.6	25.3	22.2	2.8	2.8	11.1	4.2	6.4	1.0	2.3	0.6	1.4	26.3	2.9	15.0	4.8	3.0	1.3	3.9	1.2	0.5	1.7	4.7	14.7	0.0	1.6	18.0	31.6	12.9	1.7	9.4	8.2	2.2	16.3	1.3	9.6	1.2	2.2	1.1	2.4	5.5	2.7	0.9	1.3	3.6	5.1	5.0	0.1	2.6	0.8	12.4	3.2	3.1	2.7	1.2	4.4	2.5	6.3	6.7	0.1	5.2	2.2	0.6	6.4	0.1	1.3	14.6	2.7	0.2	13.0	3.7	15.2	1.3	16.9	12.8	3.8	0.6	10.1	7.9	9.9	5.9	2.2	2.0	16.6	7.4	14.3	16.1	15.4	15.6	12.8	19.0	20.3	18.5	19.6	19.4	16.9	21.9	5.2	3.2	7.5	22.9	3.6	2.8	12.4	9.6	8.0	0.9	5.4	6.1	4.7	8.6	7.3	9.2	2.1	1.8	4.2	89.5	3.9	11.4	1.7	3.3	11.3	8.1	4.9	3.6	1.9	3.0	5.1	10.2	6.6	3.8	4.5	3.6	20.0	4.1	4.0	3.3	2.3	28.3	10.2	3.8	14.5	3.6	12.8	4.3	1.8	3.7	3.4	13.3	1.0	7.1	2.2	4.1	34.7	14.3	5.9	13.2	10.0	5.8	6.2	1.7	6.6	5.4	7.2	3.1	3.7	12.6	5.8	0.8	7.4	53.4	11.3	14.7
PLCD3		ENSG00000161714	"Phospholipase C delta 3"	Q8N3E9	17	45108959-45133354	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Lipid degradation, Lipid metabolism"	"Hydrolase, Transducer"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 85.7"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 195.8;Paneth cells: 104.7;Urothelial cells: 88.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"OE19: 109.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA025711, HPA053665"	Approved		Approved	"Plasma membrane"		NA	NA			"Cluster 11: Basophils - Unknown function"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 21: OE19 - Mitochondria"	"Cluster 53: Intestinal epithelial cells - Unknown function"	"Plasma membrane"		"HPA025711: AB_1855320, HPA053665: AB_2732580"	"unprognostic (3.58e-2)"	"unprognostic (1.66e-1)"	"unprognostic (2.77e-2)"	"unprognostic (1.27e-2)"	"unprognostic (2.66e-1)"	"unprognostic (4.14e-3)"	"unprognostic (8.13e-3)"	"prognostic unfavorable (2.89e-6)"	"unprognostic (2.96e-1)"	"unprognostic (9.53e-2)"	"unprognostic (1.34e-3)"	"unprognostic (6.21e-2)"	"unprognostic (3.18e-2)"	"unprognostic (2.07e-1)"	"unprognostic (1.62e-1)"	"prognostic favorable (4.28e-4)"	"unprognostic (3.34e-3)"	13.5	34.3	42.2	5.1	49.7	2.0	11.7	50.5	36.0	12.4	27.9	34.2	2.5	13.2	1.5	14.7	10.1	6.4	34.1	33.8	42.5	9.6	1.4	7.7	1.0	69.8	50.5	18.9	2.7	1.3	7.6	5.8	46.4	13.0	15.3	14.4	10.8	5.4	85.7	20.6	6.5	5.1	62.8	2.0	21.0	10.8	59.4	0.9	5.3	56.5	1.5	30.4	11.9	54.0	23.1	56.2	4.1	8.1	5.9	12.8	28.0	12.3	27.3	11.2	10.5	13.7	40.9	0.8	43.5	29.0	9.2	51.9	6.3	53.1	4.4	11.6	21.0	0.9	62.6	18.1	30.3	1.3	3.2	13.7	21.0	10.4	13.7	28.5	7.0	2.5	5.0	1.7	12.1	36.2	3.7	5.4	4.9	109.9	55.0	8.1	9.2	1.5	35.8	45.1	1.1	7.2	13.3	22.1	12.5	8.5	47.0	2.5	14.3	6.9	37.9	9.3	14.8	2.1	2.6	1.8	11.4	1.5	5.7	0.7	0.3	0.5	0.1	0.3	0.1	0.2	0.1	0.1	0.1	0.2	0.1	0.1	0.5	0.2	0.0	0.1	0.1	0.1	42.2	49.7	50.5	36.0	33.8	42.5	69.8	50.5	46.4	62.8	59.4	54.0	8.7	12.8	1.3	22.9	1.0	7.6	16.3	12.2	21.1	29.8	6.8	9.3	26.9	14.3	4.9	7.3	25.0	3.9	0.9	195.8	1.9	6.7	15.8	3.3	12.7	9.0	4.9	0.0	1.3	3.5	13.1	10.6	29.6	9.6	1.3	6.5	10.4	0.7	1.6	6.7	3.7	15.1	4.1	1.4	1.9	5.5	19.9	1.6	3.6	1.0	1.2	8.9	0.0	0.0	0.1	30.0	104.7	33.1	1.1	28.7	4.2	2.0	2.7	40.0	6.6	16.8	4.9	2.3	7.6	3.8	5.7	7.3	1.1	7.0	46.2	88.6
PLCD4		ENSG00000115556	"Phospholipase C delta 4"	Q9BRC7	2	218607855-218637184	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Lipid degradation, Lipid metabolism"	"Guanine-nucleotide releasing factor, Hydrolase, Transducer"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"retina: 166.0;skeletal muscle: 114.0"	"Group enriched"	"Detected in some"	5	"Bipolar cells: 139.9;Cone photoreceptor cells: 246.0;Rod photoreceptor cells: 176.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	4	"SH-SY5Y: 20.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB009914, HPA038139, HPA038140"	Enhanced		Supported	"Endoplasmic reticulum,Plasma membrane,Cytosol"		NA	NA				"Cluster 54: Non-specific - Microtubule organization"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 9: Photoreceptor cells - Phototransduction"	Cytosol	"Endoplasmic reticulum, Plasma membrane"	"CAB009914: AB_2252306, HPA038139: AB_2675855, HPA038140: AB_2675856"	"unprognostic (2.11e-1)"	"unprognostic (1.72e-1)"	"unprognostic (1.76e-2)"	"unprognostic (5.65e-5)"	"unprognostic (7.77e-2)"	"unprognostic (1.45e-2)"	"unprognostic (7.06e-3)"	"unprognostic (2.86e-2)"	"unprognostic (3.15e-1)"	"unprognostic (8.87e-3)"	"unprognostic (7.54e-5)"	"unprognostic (3.28e-2)"	"unprognostic (2.49e-1)"	"unprognostic (1.86e-1)"	"unprognostic (6.32e-2)"	"unprognostic (8.46e-3)"	"unprognostic (3.09e-1)"	1.5	2.7	4.5	0.2	4.4	0.0	1.3	4.5	7.2	1.4	3.5	15.6	0.6	0.6	0.3	4.8	0.6	0.4	1.1	4.5	4.6	10.7	0.6	0.6	0.1	5.6	5.1	0.7	0.5	1.7	9.6	0.2	4.9	4.4	1.7	166.0	2.3	0.3	114.0	1.0	3.3	1.3	4.2	0.3	6.9	9.8	5.0	0.1	1.6	30.4	0.1	20.5	2.0	4.7	0.0	0.9	1.2	0.0	0.3	1.2	1.1	0.0	2.5	0.4	1.3	0.0	0.1	0.0	1.5	0.4	0.4	0.1	0.0	1.5	0.3	0.0	0.0	0.0	2.1	0.0	0.2	0.0	0.0	2.8	0.1	1.9	0.5	4.2	2.8	0.1	0.0	0.0	2.3	0.0	0.0	0.0	0.1	0.0	2.1	0.0	0.0	0.1	4.3	0.0	1.8	20.2	0.3	0.1	0.1	0.2	2.1	0.0	4.5	0.1	0.0	0.2	0.2	0.0	0.0	0.0	4.3	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	4.5	4.4	4.5	7.2	4.5	4.6	5.6	5.1	4.9	4.2	5.0	4.7	0.3	0.0	1.1	7.8	0.1	0.5	0.3	0.9	3.4	139.9	1.5	0.9	1.0	0.0	0.1	0.0	246.0	0.1	0.1	0.0	0.0	0.1	21.4	0.6	0.4	1.5	0.0	0.0	6.7	0.0	13.5	0.7	0.0	1.0	0.0	0.1	0.7	0.0	0.6	8.4	4.9	0.1	0.0	0.0	0.4	33.8	0.3	0.2	0.0	0.0	0.1	9.1	0.0	2.0	2.3	0.7	0.0	0.0	0.0	0.1	0.0	2.2	0.2	176.9	0.0	6.1	1.8	3.6	1.2	0.6	0.1	0.8	0.1	0.0	0.1	0.2
PLCE1	"KIAA1516, NPHS3, PLCE"	ENSG00000138193	"Phospholipase C epsilon 1"	Q9P212	10	93993931-94332823	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins, RAS pathway related proteins"	"Lipid degradation, Lipid metabolism"	"Guanine-nucleotide releasing factor, Hydrolase, Transducer"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 70.5;Astrocytes: 69.5;Distal enterocytes: 79.6;Inhibitory neurons: 83.9;Muller glia cells: 82.7;Oligodendrocyte precursor cells: 123.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"RT4: 10.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA015597, HPA015598"	Enhanced		Supported	Cytosol		NA	NA			"Cluster 21: B-cells - Adaptive immune response"	"Cluster 46: Fibroblasts - ECM organization"	"Cluster 21: OE19 - Mitochondria"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Cytosol		"HPA015597: AB_1855321, HPA015598: AB_1855322"	"unprognostic (4.73e-2)"	"unprognostic (1.16e-1)"	"unprognostic (4.03e-2)"	"unprognostic (3.59e-3)"	"unprognostic (3.01e-1)"	"unprognostic (2.96e-1)"	"unprognostic (1.73e-2)"	"unprognostic (4.76e-3)"	"unprognostic (1.58e-1)"	"unprognostic (1.75e-1)"	"unprognostic (1.14e-1)"	"unprognostic (1.23e-1)"	"unprognostic (3.26e-3)"	"unprognostic (3.56e-1)"	"unprognostic (3.92e-2)"	"unprognostic (3.54e-2)"	"unprognostic (4.30e-2)"	3.8	2.6	4.5	2.8	4.1	0.2	2.7	3.1	5.6	8.0	7.0	12.6	4.0	9.0	5.3	1.7	4.4	2.5	12.4	3.9	4.7	8.4	0.7	7.3	0.7	3.9	4.8	3.9	14.7	0.8	4.4	2.9	4.0	3.8	7.5	7.3	2.3	5.4	4.1	1.1	5.2	4.2	3.2	6.2	8.3	2.0	5.4	0.5	9.8	6.3	0.6	5.6	5.6	4.2	4.0	6.7	1.8	1.1	0.7	3.2	1.9	2.8	0.6	0.3	0.4	5.3	1.3	0.8	1.3	2.3	1.3	2.6	2.2	0.4	0.6	0.4	2.3	0.5	4.0	0.5	0.0	0.9	0.3	1.8	0.0	1.1	0.0	6.8	0.0	0.4	0.5	0.3	4.2	0.3	0.8	0.9	0.7	7.9	5.0	0.1	3.9	0.2	0.2	10.3	0.9	1.5	3.3	3.6	0.7	4.1	3.5	0.6	0.6	3.0	5.9	2.0	4.4	0.6	0.3	0.4	3.5	1.1	2.2	0.1	0.1	0.0	0.3	0.2	0.2	0.5	0.3	0.2	0.1	0.7	0.5	0.4	0.1	0.2	0.2	0.2	0.1	0.1	4.5	4.1	3.1	5.6	3.9	4.7	3.9	4.8	4.0	3.2	5.4	4.2	8.2	70.5	5.4	69.5	7.0	8.2	9.7	6.8	2.2	12.2	3.6	3.6	34.7	4.3	12.3	0.0	0.0	3.7	2.9	79.6	1.9	1.1	20.7	26.7	18.4	9.7	1.8	0.0	3.1	6.4	2.5	15.3	29.6	10.6	0.0	7.2	4.2	1.6	0.7	6.7	83.9	9.7	4.1	2.4	5.2	5.3	12.2	1.3	7.2	5.6	1.2	82.7	4.1	123.1	2.4	4.2	54.8	23.3	0.9	7.5	11.0	2.5	10.6	18.7	6.6	30.8	37.7	3.7	8.0	1.7	7.4	1.9	4.3	3.7	41.1	10.5
PLCG1	"NCKAP3, PLC-II, PLC1, PLC148, PLCgamma1"	ENSG00000124181	"Phospholipase C gamma 1"	P19174	20	41136960-41196801	"Cancer-related genes, Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, RAS pathway related proteins"	"Host-virus interaction, Lipid degradation, Lipid metabolism"	"Hydrolase, Transducer"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 69.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	8	"gdT-cell: 4.7;MAIT T-cell: 6.4;memory CD4 T-cell: 4.1;memory CD8 T-cell: 3.9;naive CD4 T-cell: 4.3;naive CD8 T-cell: 4.3;NK-cell: 3.4;T-reg: 3.8"	"Group enriched"	"Detected in many"	9	"NK-cells: 3.4;T-cells: 6.4"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004277, HPA036681, HPA036682"	Approved		Enhanced	Cytosol		NA	NA			"Cluster 16: MAIT-cells - Unknown function"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 58: T-cells - T-cell receptor"	Cytosol		"CAB004277: AB_628119, HPA036681: AB_2675245, HPA036682: AB_2675246"	"unprognostic (2.77e-1)"	"unprognostic (1.35e-1)"	"unprognostic (1.65e-1)"	"unprognostic (4.31e-2)"	"unprognostic (5.82e-2)"	"unprognostic (2.09e-2)"	"unprognostic (4.45e-3)"	"unprognostic (1.25e-2)"	"unprognostic (2.29e-2)"	"unprognostic (1.16e-1)"	"prognostic favorable (4.72e-4)"	"unprognostic (3.32e-1)"	"unprognostic (2.73e-3)"	"unprognostic (1.82e-1)"	"unprognostic (2.65e-1)"	"unprognostic (9.27e-2)"	"unprognostic (2.79e-2)"	33.3	22.4	36.2	21.7	37.3	10.0	31.8	43.8	41.3	42.5	27.8	25.2	17.8	36.1	13.7	18.9	31.9	19.9	31.9	35.6	32.9	23.2	9.7	32.4	36.4	34.8	36.2	42.6	11.4	13.3	21.6	23.8	34.2	30.2	13.7	10.9	20.2	20.5	18.5	31.5	28.8	22.9	32.0	30.0	19.4	26.3	39.5	60.5	45.0	20.3	24.0	30.4	32.0	38.6	16.6	20.8	97.2	71.6	38.0	26.5	30.9	26.7	34.1	52.4	44.3	50.1	5.4	37.0	31.9	29.1	55.0	30.2	42.7	47.8	30.4	10.5	22.7	2.6	36.4	59.6	28.9	14.7	9.7	34.1	26.3	38.8	30.0	47.2	59.4	77.3	28.0	23.6	48.0	123.8	90.7	11.5	36.2	21.3	37.6	71.1	70.8	18.2	28.7	30.1	34.4	65.7	47.8	22.1	48.4	54.1	25.8	17.0	64.6	124.4	40.3	40.2	32.9	26.1	12.4	30.3	29.7	15.6	52.9	0.0	0.0	0.0	4.7	0.0	6.4	0.2	4.1	3.9	0.0	0.5	4.3	4.3	0.0	3.4	0.0	0.0	3.8	3.0	36.2	37.3	43.8	41.3	35.6	32.9	34.8	36.2	34.2	32.0	39.5	38.6	33.4	16.0	7.0	69.2	5.1	5.6	1.8	5.3	14.8	4.3	4.7	5.8	9.6	1.5	3.8	3.7	10.4	1.9	7.4	9.4	0.0	3.3	7.0	5.4	16.9	24.2	1.8	2.1	9.7	1.6	2.0	11.5	10.2	10.3	1.3	19.8	11.7	3.1	4.0	3.3	9.1	9.5	4.1	2.9	4.3	7.2	15.2	1.7	3.6	16.9	1.2	6.7	2.1	13.0	16.4	3.3	4.8	18.4	6.3	2.3	7.8	3.0	1.8	5.1	13.1	8.5	10.2	15.9	13.0	6.1	7.0	0.8	17.0	5.7	6.4	0.9
PLCG2		ENSG00000197943	"Phospholipase C gamma 2"	P16885	16	81739097-81962685	"Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins, RAS pathway related proteins"	"Lipid degradation, Lipid metabolism"	"Hydrolase, Transducer"	"Cancer-related genes, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	7	"brain: 706.3;choroid plexus: 347.5"	"Cell type enhanced"	"Detected in many"		"Adipocytes: 187.0;Bipolar cells: 224.8;Muller glia cells: 221.7;Rod photoreceptor cells: 196.2"	"Cancer enhanced"	"Detected in all"		"renal cancer: 9.0"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"Daudi: 183.3;HMC-1: 84.2;REH: 75.1;U-698: 403.4"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"CAB004280, HPA020099, HPA020100"	Enhanced		Approved	Nucleoplasm,Vesicles,Cytosol		NA	NA		8200	"Cluster 5: Granulocytes - Unknown function"	"Cluster 69: Cerebellum - Gene expression regulation"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 7: Non-specific - Mitochondria"	"Vesicles, Cytosol"	Nucleoplasm	"CAB004280: AB_628120, HPA020099: AB_1855324, HPA020100: AB_1855325"	"unprognostic (2.86e-2)"	"unprognostic (1.34e-1)"	"unprognostic (1.09e-3)"	"unprognostic (1.10e-1)"	"unprognostic (1.58e-1)"	"prognostic favorable (6.71e-4)"	"unprognostic (6.23e-2)"	"unprognostic (5.01e-2)"	"unprognostic (2.22e-1)"	"unprognostic (4.58e-2)"	"unprognostic (4.66e-2)"	"unprognostic (1.71e-2)"	"prognostic favorable (4.88e-4)"	"unprognostic (1.52e-2)"	"unprognostic (1.21e-1)"	"unprognostic (2.89e-1)"	"unprognostic (3.40e-3)"	9.0	4.2	69.4	33.0	141.3	30.3	8.5	706.3	105.2	5.0	347.5	8.6	17.3	8.6	22.5	4.6	5.5	13.4	4.3	40.1	122.6	23.4	14.3	9.4	66.8	301.3	122.7	1.6	3.9	2.8	1.2	8.2	207.3	2.8	7.0	0.5	7.1	3.4	1.9	4.0	19.4	8.8	241.5	34.8	8.7	2.0	283.3	10.0	6.9	3.6	72.0	10.1	3.9	437.2	1.4	3.2	0.6	2.9	0.2	0.2	4.0	0.3	0.4	2.3	0.8	0.9	8.1	183.3	30.1	0.2	7.4	4.2	4.0	0.5	1.4	1.4	2.1	22.1	0.4	0.3	1.2	22.3	84.2	0.3	1.8	1.3	1.0	0.3	4.2	8.1	2.5	15.0	0.4	5.7	2.6	55.5	3.1	2.3	1.3	75.1	0.1	23.7	0.5	3.9	1.4	0.4	5.0	1.6	1.5	3.9	3.3	67.7	1.1	0.4	3.2	0.4	0.6	35.2	61.4	403.4	0.3	30.0	1.6	9.4	12.1	76.2	1.9	16.1	0.9	51.1	0.6	2.9	10.7	49.6	0.8	1.9	65.7	41.3	36.8	7.0	0.5	6.9	69.4	141.3	706.3	105.2	40.1	122.6	301.3	122.7	207.3	241.5	283.3	437.2	187.0	12.8	54.0	0.0	138.3	2.9	1.6	2.3	1.8	224.8	139.5	113.0	7.2	28.6	13.1	16.5	104.3	13.6	94.0	0.4	13.7	2.6	20.5	65.5	88.0	61.7	21.5	23.2	0.7	0.0	2.2	30.6	16.8	86.6	40.4	29.0	37.1	43.2	27.7	101.0	0.8	2.7	65.1	47.4	9.4	30.7	11.1	46.7	8.8	95.5	21.8	221.7	47.4	2.0	1.3	0.1	9.8	4.9	138.6	3.5	5.5	5.9	6.9	196.2	6.6	28.0	51.9	4.8	2.9	3.0	2.3	11.1	48.2	8.7	1.9	6.5
PLCH1	"DKFZp434C1372, KIAA1069, MGC117152, PLCeta1, PLCL3"	ENSG00000114805	"Phospholipase C eta 1"	Q4KWH8	3	155375580-155745071	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Lipid degradation, Lipid metabolism"	"Hydrolase, Transducer"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 16.6;retina: 12.4"	"Group enriched"	"Detected in many"	4	"Astrocytes: 93.7;Early spermatids: 206.2;Excitatory neurons: 126.0;Inhibitory neurons: 131.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"A549: 12.3;AF22: 39.0;HEL: 10.1;NTERA-2: 20.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036176, HPA057978"	Uncertain		Enhanced	Vesicles		NA	NA				"Cluster 42: Ciliated cells - Cilium & Cell projection"	"Cluster 12: NES - Nervous system development"	"Cluster 23: Spermatids - Flagellum & Golgi organization"	Vesicles		"HPA036176: AB_10671837, HPA057978: AB_2683569"	"unprognostic (1.08e-2)"	"unprognostic (3.68e-1)"	"unprognostic (2.17e-2)"	"unprognostic (1.55e-2)"	"unprognostic (3.50e-4)"	"unprognostic (6.41e-2)"	"unprognostic (2.94e-5)"	"unprognostic (5.04e-2)"	"unprognostic (2.41e-1)"	"unprognostic (2.24e-3)"	"unprognostic (4.84e-2)"	"unprognostic (1.76e-2)"	"prognostic favorable (3.03e-5)"	"unprognostic (3.28e-2)"	"unprognostic (1.62e-1)"	"unprognostic (1.47e-1)"	"unprognostic (1.37e-2)"	0.0	0.0	5.5	0.3	4.8	0.2	2.6	4.5	6.0	1.2	9.3	2.5	2.5	0.7	8.2	0.1	8.1	1.5	1.8	3.8	1.4	1.2	0.1	4.0	0.0	1.3	4.6	0.1	1.4	0.4	1.5	0.4	1.5	0.3	2.4	12.4	1.3	1.9	0.2	0.1	2.5	0.1	1.6	0.0	3.8	11.3	1.3	16.6	5.7	0.0	0.0	0.4	0.1	2.0	0.0	12.3	39.0	1.5	0.0	0.0	0.0	0.0	0.0	0.3	0.2	2.4	9.8	0.0	0.8	0.0	0.1	0.0	7.0	0.0	0.0	0.0	3.6	10.1	0.0	1.4	0.0	6.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	3.2	0.3	0.0	0.0	4.4	2.4	9.4	20.8	1.3	1.6	0.9	0.0	0.0	2.4	0.2	3.6	0.9	0.0	9.4	0.0	5.7	4.2	0.0	0.0	0.0	0.2	0.0	1.7	0.4	0.0	0.0	0.0	1.3	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	5.5	4.8	4.5	6.0	3.8	1.4	1.3	4.6	1.5	1.6	1.3	2.0	0.0	3.2	13.6	93.7	0.3	0.0	0.4	0.5	0.6	10.5	4.0	5.0	0.8	4.3	2.3	1.8	4.2	0.0	0.1	2.7	0.0	2.2	206.2	34.6	1.3	0.6	3.0	0.0	126.0	2.3	0.3	0.3	15.3	13.6	0.0	0.1	0.0	0.0	0.2	25.2	131.5	4.0	0.0	0.3	0.4	21.4	1.2	0.4	0.0	12.2	0.1	16.1	0.0	5.5	5.7	1.5	4.6	0.4	0.0	0.4	2.8	2.1	23.4	3.0	0.0	0.0	0.2	2.4	1.2	0.7	0.1	0.0	0.3	0.1	4.4	0.4
PLCH2	"KIAA0450, PLC-eta2, PLCeta2, PLCL4, RP3-395M20.1"	ENSG00000149527	"Phospholipase C eta 2"	O75038	1	2425980-2505532	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Lipid degradation, Lipid metabolism"	"Hydrolase, Transducer"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"retina: 44.8;skin 1: 59.6"	"Cell type enhanced"	"Detected in many"		"Bipolar cells: 102.5;Cone photoreceptor cells: 75.0;Oligodendrocytes: 37.4;Rod photoreceptor cells: 169.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"HBEC3-KT: 130.9;hTCEpi: 58.9;hTERT-HME1: 32.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA072705	Enhanced					NA	NA			"Cluster 48: NK-cells - Unknown function"	"Cluster 61: Skin - Cornification"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 46: Photoreceptor cells - Phototransduction"			"HPA072705: AB_2732211"	"unprognostic (2.06e-3)"	"unprognostic (1.30e-2)"	"unprognostic (1.09e-3)"	"unprognostic (3.84e-3)"	"unprognostic (1.99e-1)"	"unprognostic (1.59e-2)"	"unprognostic (7.39e-2)"	"unprognostic (7.70e-2)"	"unprognostic (7.58e-2)"	"unprognostic (9.28e-2)"	"unprognostic (2.26e-1)"	"unprognostic (5.95e-2)"	"unprognostic (6.61e-3)"	"unprognostic (8.43e-2)"	"unprognostic (1.07e-1)"	"unprognostic (8.64e-2)"	"unprognostic (5.80e-2)"	0.6	1.4	1.0	3.9	1.7	2.2	6.2	7.9	4.8	6.3	0.0	1.1	2.2	0.3	1.7	19.3	3.2	2.9	0.2	2.4	1.0	0.8	2.1	1.8	5.3	3.3	3.1	0.1	5.1	0.0	7.9	0.4	3.6	14.6	0.8	44.8	16.4	5.8	0.2	59.6	3.3	0.1	1.2	5.5	2.0	0.6	6.9	4.4	1.7	0.0	6.5	9.1	18.3	7.2	0.3	0.5	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	4.1	0.0	0.2	0.2	0.0	17.1	0.0	130.9	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	58.9	0.0	32.8	0.0	0.0	0.0	0.0	3.1	0.3	0.6	0.0	0.0	0.1	1.9	1.4	0.1	0.1	0.0	0.2	6.1	14.7	2.9	0.0	0.4	0.1	0.0	0.0	0.0	0.6	0.0	0.1	0.1	0.0	0.1	0.0	0.3	0.1	0.1	0.0	0.0	0.0	0.0	0.6	0.0	0.2	0.0	0.4	0.3	0.0	0.0	0.2	0.1	0.0	0.9	0.0	0.0	0.6	0.2	1.0	1.7	7.9	4.8	2.4	1.0	3.3	3.1	3.6	1.2	6.9	7.2	0.2	0.0	1.7	2.9	6.1	15.4	14.5	22.8	10.8	102.5	1.7	5.5	3.3	2.8	10.8	0.0	75.0	0.0	7.3	0.7	1.9	0.1	0.1	0.7	0.2	0.7	1.2	0.0	9.3	0.0	0.0	0.4	1.5	1.4	0.0	0.1	0.0	4.9	0.1	26.9	19.8	1.9	2.0	0.3	1.1	0.2	0.0	0.5	3.6	1.9	0.4	14.9	7.2	2.5	37.4	0.5	0.6	0.0	1.9	4.9	3.8	33.5	5.8	169.0	0.0	0.0	1.0	0.2	0.3	13.0	14.6	0.0	7.0	0.1	0.5	9.2
PLCZ1	"NYD-SP27, PLCzeta"	ENSG00000139151	"Phospholipase C zeta 1"	Q86YW0	12	18683169-18738100	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"Fertilization, Lipid degradation, Lipid metabolism"	"Developmental protein, Hydrolase, Transducer"	"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	24	"testis: 42.3"	"Group enriched"	"Detected in some"	47	"Early spermatids: 647.0;Late spermatids: 316.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enhanced"	"Detected in some"		"amygdala: 3.1"	"Not detected"	"Not detected"									NA	NA				"Cluster 83: Testis - Spermatogenesis"		"Cluster 34: Spermatids - Unknown function"				"unprognostic (1.95e-1)"					"unprognostic (2.79e-1)"	"unprognostic (1.10e-1)"	"unprognostic (1.87e-2)"			"unprognostic (1.39e-2)"		"unprognostic (1.25e-2)"	"unprognostic (1.59e-1)"	"unprognostic (1.40e-1)"			0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.3	0.4	0.0	0.4	0.2	0.1	0.0	0.0	0.5	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	1.7	0.1	0.0	0.2	0.0	0.4	42.3	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.4	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.5	0.1	0.2	0.2	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	647.0	0.1	0.1	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	316.3	2.1	0.2	0.0	0.0	0.0	0.0	0.0	0.5	0.5	0.5	0.0	1.5	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	10.1	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0
PLD1		ENSG00000075651	"Phospholipase D1"	Q13393	3	171600404-171810950	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins, RAS pathway related proteins"	"Lipid degradation, Lipid metabolism"	Hydrolase	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"gallbladder: 86.8"	"Cell type enriched"	"Detected in many"	5	"Oligodendrocytes: 519.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"basophil: 8.3"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HUVEC TERT2: 57.5;SK-MEL-30: 31.1;TIME: 50.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004527, HPA042396, HPA066938"	Enhanced		Approved	Nucleoplasm,Vesicles		NA	NA			"Cluster 10: Basophils - Unknown function"	"Cluster 45: Intestine - Brush border"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	Vesicles	Nucleoplasm	"CAB004527: AB_677324, HPA042396: AB_2677977, HPA066938: "	"unprognostic (3.23e-1)"	"unprognostic (3.27e-1)"	"unprognostic (5.82e-2)"	"unprognostic (5.13e-2)"	"unprognostic (4.58e-1)"	"unprognostic (4.76e-2)"	"unprognostic (9.03e-2)"	"unprognostic (1.46e-1)"	"unprognostic (6.23e-2)"	"unprognostic (8.02e-2)"	"unprognostic (2.06e-2)"	"unprognostic (2.95e-2)"	"unprognostic (1.23e-1)"	"unprognostic (1.29e-1)"	"unprognostic (1.16e-1)"	"unprognostic (1.19e-1)"	"prognostic unfavorable (4.76e-6)"	7.8	26.4	9.2	6.6	24.7	7.8	7.5	18.4	13.6	10.4	4.5	14.6	46.9	6.2	2.8	33.0	6.4	86.8	24.4	10.5	14.3	12.0	33.7	4.7	9.1	24.8	22.0	24.2	21.2	1.6	2.3	10.7	23.5	3.4	14.7	0.5	13.8	6.0	2.5	29.2	43.9	4.8	14.7	15.7	8.2	5.0	19.0	4.1	3.7	6.8	10.8	5.1	12.4	41.4	4.5	7.2	3.7	1.4	11.2	12.6	7.7	2.3	9.9	3.5	4.3	1.1	6.4	0.0	17.0	0.9	24.0	15.2	0.6	2.0	5.7	3.6	3.2	4.2	11.5	26.1	4.9	7.3	18.9	4.9	10.9	4.2	2.0	10.0	57.5	1.2	2.8	0.0	0.9	1.3	0.0	6.4	0.8	11.9	5.1	0.2	1.5	0.1	8.9	1.8	0.1	0.1	7.9	4.7	31.1	5.1	9.0	9.7	50.7	1.5	5.7	4.0	2.5	9.6	8.2	0.1	6.7	8.6	1.9	8.3	1.8	2.3	0.3	1.1	2.6	0.0	0.2	0.6	0.6	0.0	0.0	0.1	1.0	2.2	0.4	0.0	0.8	0.6	9.2	24.7	18.4	13.6	10.5	14.3	24.8	22.0	23.5	14.7	19.0	41.4	7.7	0.0	4.7	2.0	0.9	7.1	3.4	11.0	10.8	0.4	4.9	5.6	33.6	57.2	11.1	1.8	0.0	3.0	1.9	37.5	3.9	8.4	13.1	1.0	4.8	7.4	4.2	6.3	8.9	3.4	3.7	15.7	27.0	1.3	27.9	10.4	6.4	15.9	20.0	0.0	12.1	23.6	6.1	13.2	2.4	9.5	10.5	10.2	12.4	98.4	5.4	0.0	1.0	12.5	519.6	2.4	18.3	4.5	3.4	0.7	38.3	48.0	9.9	0.1	19.7	3.8	8.4	6.1	5.3	93.5	34.9	2.3	2.3	12.1	17.8	4.7
PLD2		ENSG00000129219	"Phospholipase D2"	O14939	17	4807152-4823434	"Enzymes, Metabolic proteins, Predicted intracellular proteins, RAS pathway related proteins"	"Lipid degradation, Lipid metabolism"	Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA013397	Approved					NA	NA			"Cluster 14: Monocytes - Unknown function"	"Cluster 27: Brain & Skin - Unknown function"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 47: Cytotrophoblasts - Unknown function"			"HPA013397: AB_1855328"	"unprognostic (1.87e-1)"	"unprognostic (3.27e-1)"	"unprognostic (2.30e-1)"	"unprognostic (1.82e-1)"	"unprognostic (1.97e-1)"	"unprognostic (2.90e-2)"	"unprognostic (3.85e-3)"	"unprognostic (3.64e-1)"	"unprognostic (6.15e-3)"	"unprognostic (2.58e-3)"	"unprognostic (1.25e-1)"	"unprognostic (8.10e-3)"	"unprognostic (1.08e-1)"	"unprognostic (2.95e-1)"	"unprognostic (1.91e-1)"	"unprognostic (1.85e-1)"	"unprognostic (5.48e-2)"	17.4	8.1	19.9	10.0	22.8	2.6	17.9	21.5	21.3	32.3	16.0	11.2	6.9	15.2	6.9	63.3	14.5	14.3	10.2	19.4	21.9	11.7	12.1	16.1	9.5	30.4	24.3	21.5	14.0	8.9	10.4	14.2	22.3	19.0	9.0	4.9	22.6	14.5	5.1	33.5	10.7	13.4	24.7	12.6	11.3	4.3	24.5	12.9	11.9	6.7	18.0	15.0	37.1	23.5	13.0	20.2	17.4	18.8	15.0	19.9	20.0	8.2	17.2	14.2	11.3	21.7	15.1	5.6	9.4	21.3	5.3	30.2	13.9	18.3	12.8	7.3	7.0	1.8	15.7	13.2	10.8	0.1	13.3	29.4	27.0	12.8	12.1	20.0	33.2	3.9	2.1	5.2	12.0	9.9	0.7	2.4	9.2	10.7	8.7	6.3	11.2	1.4	12.9	20.9	5.9	10.2	15.5	18.1	11.6	14.1	13.0	3.0	26.1	9.4	9.5	21.6	12.8	4.6	2.3	1.2	14.4	2.6	5.6	4.0	4.8	1.2	1.2	4.9	0.9	1.6	1.3	0.9	3.6	0.9	0.3	0.4	0.3	0.8	5.4	1.6	2.3	2.4	19.9	22.8	21.5	21.3	19.4	21.9	30.4	24.3	22.3	24.7	24.5	23.5	10.9	0.0	1.1	26.8	2.8	12.6	9.8	11.2	14.8	1.2	11.6	10.3	2.8	7.2	8.9	1.8	0.0	21.8	2.6	7.1	1.9	8.7	0.0	2.5	4.6	12.0	1.2	0.0	1.6	11.5	14.8	7.7	10.7	5.4	5.7	12.0	12.8	2.9	12.9	0.0	2.7	7.0	6.1	8.1	13.8	0.5	9.6	10.7	7.2	5.6	19.9	7.8	1.0	3.5	5.8	10.4	10.2	8.6	1.4	14.0	3.8	4.2	9.2	1.7	0.0	4.1	5.0	0.2	2.7	9.8	12.1	17.4	3.1	7.2	5.7	10.5
PLD3	HU-K4	ENSG00000105223	"Phospholipase D family member 3"	Q8IV08	19	40348456-40380439	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Immunity, Inflammatory response"	"Exonuclease, Hydrolase, Nuclease"	"Disease variant, Neurodegeneration, Spinocerebellar ataxia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"pituitary gland: 711.9"	"Cell type enhanced"	"Detected in all"		"Hofbauer cells: 688.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in all"	5	"basophil: 1727.4"	"Lineage enriched"	"Detected in all"	7	"granulocytes: 1727.4"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA012800, CAB020812"	Approved		Approved	"Nucleoplasm,Endoplasmic reticulum,Cytosol"		NA	NA		450000	"Cluster 10: Basophils - Unknown function"	"Cluster 26: Pituitary gland - Hormone signaling"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 4: Macrophages - Innate immune response"	"Endoplasmic reticulum, Cytosol"	Nucleoplasm	"CAB020812: , HPA012800: AB_1855330"	"unprognostic (1.11e-1)"	"unprognostic (1.06e-1)"	"unprognostic (1.64e-3)"	"unprognostic (2.56e-3)"	"unprognostic (2.06e-3)"	"unprognostic (2.68e-1)"	"unprognostic (4.52e-2)"	"unprognostic (3.89e-2)"	"unprognostic (1.09e-1)"	"unprognostic (4.60e-2)"	"prognostic favorable (6.44e-4)"	"unprognostic (4.34e-2)"	"prognostic favorable (2.21e-4)"	"unprognostic (3.49e-2)"	"unprognostic (2.10e-1)"	"unprognostic (1.38e-2)"	"unprognostic (6.42e-2)"	169.3	200.0	143.3	78.4	159.7	48.3	138.4	46.0	229.7	139.4	54.0	131.4	71.7	155.7	84.7	84.9	133.5	96.7	206.1	202.5	294.4	130.2	121.3	181.5	98.1	132.4	128.5	199.0	151.0	105.9	711.9	123.4	137.9	133.4	49.2	51.4	138.7	106.2	105.1	120.5	105.3	79.1	63.8	197.0	126.5	77.7	197.7	44.3	120.8	82.3	41.4	126.2	126.0	129.6	85.6	257.8	163.7	259.1	444.2	210.2	124.5	206.5	208.6	146.4	166.6	49.4	93.8	36.9	211.0	180.9	47.8	39.3	39.9	81.2	63.5	138.4	145.3	39.9	82.1	63.2	302.7	16.8	435.1	402.5	167.0	112.1	76.6	244.2	125.0	59.3	142.5	144.5	106.7	111.5	29.5	79.6	107.4	138.7	52.8	37.0	124.5	154.2	75.2	63.2	116.7	193.9	99.0	60.6	113.8	169.5	83.6	283.2	222.3	122.8	58.5	105.6	47.0	148.9	173.3	38.8	197.7	66.2	77.9	1727.4	256.7	378.7	75.0	129.5	62.0	34.4	59.5	67.7	235.0	28.1	60.8	61.3	25.7	102.3	64.2	34.7	64.5	208.6	143.3	159.7	46.0	229.7	202.5	294.4	132.4	128.5	137.9	63.8	197.7	129.6	66.7	32.1	69.6	59.4	27.0	35.4	93.6	263.1	39.9	101.5	45.9	61.2	22.0	45.8	90.4	57.0	33.3	158.2	27.2	42.5	21.5	52.5	8.7	32.0	49.8	53.9	72.8	18.7	99.1	58.3	107.2	158.8	38.2	31.5	60.3	134.7	88.2	43.1	688.4	121.1	113.4	41.3	126.1	280.9	59.1	15.7	151.6	261.3	92.5	50.6	54.2	94.1	35.0	53.3	70.2	54.3	42.6	143.7	85.8	57.9	78.8	37.1	35.2	47.6	19.7	73.1	59.7	24.2	67.9	32.4	33.4	195.9	28.8	114.1	41.6	68.2
PLD4	C14orf175	ENSG00000166428	"Phospholipase D family member 4"	Q96BZ4	14	104924713-104937761	"Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Immunity, Inflammatory response, Innate immunity"	"Exonuclease, Hydrolase, Nuclease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 13.4;brain: 16.7;lymphoid tissue: 11.3"	"Cell type enriched"	"Detected in many"	7	"dendritic cells: 284.8"	"Cancer enhanced"	"Detected in many"		"glioma: 4.3"	"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in many"	5	"plasmacytoid DC: 3621.6"	"Lineage enriched"	"Detected in all"	5	"dendritic cells: 3621.6"	"Group enriched"	"Detected in some"	4	"HMC-1: 127.3;RPMI-8226: 85.5;THP-1: 191.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA051512	Uncertain					NA	NA		2900000	"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 65: Plasmacytoid DCs - Unknown function"			"HPA051512: AB_2681515"	"unprognostic (4.50e-3)"	"unprognostic (1.78e-4)"	"unprognostic (7.12e-2)"	"unprognostic (5.30e-3)"	"unprognostic (5.54e-2)"	"unprognostic (2.91e-3)"	"unprognostic (2.56e-1)"	"unprognostic (4.76e-3)"	"unprognostic (1.45e-3)"	"unprognostic (1.19e-3)"	"unprognostic (3.45e-3)"	"unprognostic (3.89e-1)"	"unprognostic (6.90e-3)"	"unprognostic (8.94e-2)"	"unprognostic (2.83e-1)"	"unprognostic (1.28e-2)"	"unprognostic (2.41e-1)"	0.4	1.0	5.1	5.7	4.7	13.4	1.5	7.0	7.1	1.0	0.4	0.8	3.8	1.0	0.2	0.6	1.8	2.4	0.5	4.5	7.3	0.8	0.5	1.8	11.3	15.7	6.8	0.5	1.1	1.2	2.1	0.8	10.3	1.7	0.5	0.5	3.5	1.8	0.3	0.6	5.1	0.5	13.9	10.4	2.8	0.6	9.4	2.8	0.6	0.0	9.4	1.9	0.4	16.7	0.1	0.2	0.0	0.0	0.0	0.1	0.4	0.2	0.0	0.0	0.0	0.1	0.0	9.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.3	127.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	2.5	0.0	0.0	0.1	10.7	0.1	0.0	0.1	30.0	0.1	85.5	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	191.5	0.0	0.1	0.3	0.1	0.2	0.4	0.0	0.1	0.2	1.6	0.3	4.6	43.0	699.5	1.0	188.4	1.9	222.7	0.8	1.2	545.8	198.4	1.7	0.4	9.8	25.4	297.9	3621.6	1.0	72.9	5.1	4.7	7.0	7.1	4.5	7.3	15.7	6.8	10.3	13.9	9.4	16.7	0.8	0.0	0.0	0.3	34.7	0.4	0.1	0.0	0.0	2.7	0.6	2.8	1.4	0.0	0.0	0.0	0.0	0.2	284.8	0.0	0.0	0.0	0.7	0.1	0.3	2.7	0.0	5.5	0.1	0.0	0.4	1.1	1.1	0.4	3.8	0.0	0.0	0.0	30.6	1.7	0.1	0.0	0.0	1.3	32.0	4.7	0.0	38.0	5.4	22.5	11.3	0.1	2.1	0.5	0.1	0.0	0.0	0.0	2.3	0.1	0.0	0.1	0.0	1.1	6.6	1.6	0.3	1.6	1.6	0.0	0.4	0.3	2.2	0.0	0.1	0.0
PLG		ENSG00000122194	Plasminogen	P00747	6	160702238-160754097	"Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted secreted proteins"	"Blood coagulation, Fibrinolysis, Hemostasis, Tissue remodeling"	"Hydrolase, Protease, Serine protease"	"Cancer-related genes, Disease variant, FDA approved drug targets, Thrombophilia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	11	"liver: 2666.4"	"Cell type enriched"	"Detected in some"	7	"Hepatocytes: 1772.7"	"Cancer enriched"	"Detected in some"	84	"liver cancer: 180.7"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Low region specificity"	"Detected in many"			"CAB000668, CAB016678, HPA021602, HPA048823"	Supported				"Secreted to blood"	NA	NA	140000000000	45000000000		"Cluster 85: Liver - Metabolism"		"Cluster 15: Hepatocytes - Hemostasis"			"CAB000668: , CAB016678: AB_1621208, HPA021602: AB_1855453, HPA048823: AB_2680532"		"unprognostic (1.70e-1)"		"unprognostic (2.16e-3)"	"unprognostic (2.44e-1)"		"unprognostic (8.54e-3)"	"unprognostic (1.41e-1)"		"unprognostic (1.76e-3)"	"unprognostic (6.28e-2)"	"unprognostic (7.25e-2)"	"prognostic favorable (4.22e-4)"	"unprognostic (3.97e-3)"	"unprognostic (5.21e-2)"		"unprognostic (2.33e-2)"	0.4	0.4	0.3	0.2	0.4	0.0	0.0	0.0	0.3	0.1	0.0	0.1	0.3	0.2	0.0	0.1	2.4	0.5	0.1	0.2	0.3	240.9	2666.4	0.4	0.7	0.0	0.0	0.3	0.0	0.0	0.0	0.4	0.0	0.6	0.0	0.1	0.9	0.0	0.1	0.2	0.1	0.0	0.0	0.5	0.2	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.5	0.5	0.0	0.9	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.2	0.3	0.0	0.0	0.0	0.1	0.3	0.2	0.1	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.5	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.4	0.0	0.3	0.2	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.3	5.4	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.6	30.0	0.0	1.8	0.0	0.0	0.3	0.0	19.6	0.0	0.2	3.0	0.1	1.2	0.0	24.0	0.6	0.0	0.0	0.0	0.0	0.1	1.3	0.0	28.5	1772.7	0.1	0.0	0.5	0.0	0.0	35.4	0.0	0.2	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	235.7	1.5	0.1	0.0	0.4	0.2	0.4	0.4	0.0	0.0	0.0	2.3	0.1	0.0	0.0
PLPP1	"LPP1, PAP-2a, PPAP2A"	ENSG00000067113	"Phospholipid phosphatase 1"	O14494	5	55424854-55534969	"Enzymes, Metabolic proteins, Predicted membrane proteins"	"Lipid metabolism"	Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Adipocytes: 359.1;Endometrial stromal cells: 206.7;Hepatic stellate cells: 267.0;Leydig cells: 219.3;Prostatic glandular cells: 182.0"	"Cancer enhanced"	"Detected in all"		"prostate cancer: 200.4"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"ASC diff: 445.7;fHDF/TERT166: 142.8;HMC-1: 235.8;HSkMC: 171.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB033331, HPA047815"	Enhanced		Supported	"Plasma membrane"		NA	NA			"Cluster 29: Plasmacytoid DCs - Unknown function"	"Cluster 46: Fibroblasts - ECM organization"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	"Plasma membrane"		"CAB033331: AB_2168044, HPA047815: AB_2680164"	"unprognostic (1.22e-1)"	"unprognostic (1.54e-1)"	"unprognostic (1.74e-1)"	"unprognostic (1.55e-2)"	"unprognostic (2.52e-1)"	"unprognostic (1.36e-1)"	"prognostic favorable (6.06e-4)"	"unprognostic (2.81e-1)"	"unprognostic (2.20e-1)"	"unprognostic (4.05e-3)"	"unprognostic (2.43e-2)"	"unprognostic (1.05e-1)"	"unprognostic (4.37e-3)"	"prognostic unfavorable (5.77e-4)"	"unprognostic (3.94e-2)"	"unprognostic (1.66e-1)"	"unprognostic (3.11e-2)"	172.3	78.1	51.5	42.3	59.9	0.9	140.7	63.7	59.4	88.7	59.6	118.3	47.4	119.5	39.8	42.4	73.4	167.5	117.1	49.9	56.8	104.0	67.7	56.2	32.2	62.1	56.2	29.4	35.6	49.0	27.8	37.6	64.2	254.1	65.8	9.7	32.9	61.3	70.0	57.9	79.1	108.9	62.5	31.1	70.9	21.0	58.6	15.8	112.9	81.5	24.2	128.8	63.8	72.9	9.8	24.4	7.0	14.2	445.7	51.8	9.6	21.8	61.4	11.9	27.9	16.7	17.7	10.2	20.0	142.8	31.9	6.5	25.2	12.6	13.5	6.8	20.1	1.1	9.6	21.3	70.5	2.5	235.8	171.3	25.7	17.6	10.9	23.3	19.9	9.1	0.2	27.0	24.1	6.0	6.8	5.5	15.5	1.1	20.0	2.0	11.7	0.9	46.3	79.8	8.4	5.8	21.5	4.2	13.4	28.8	15.6	1.6	24.0	4.0	6.9	17.8	15.5	16.6	7.4	11.8	15.7	1.3	19.5	0.0	0.4	4.0	1.6	0.5	1.7	6.7	5.3	3.4	2.0	3.3	9.5	7.7	0.3	3.0	0.9	15.0	2.6	1.8	51.5	59.9	63.7	59.4	49.9	56.8	62.1	56.2	64.2	62.5	58.6	72.9	359.1	6.4	9.4	0.0	9.8	0.0	51.0	0.0	10.2	4.0	8.4	45.7	0.0	21.5	5.6	29.5	2.1	3.3	5.4	61.0	5.9	25.2	44.4	10.7	206.7	112.3	1.2	5.7	0.0	28.5	11.1	115.5	11.2	18.5	27.8	4.0	267.0	48.3	12.8	1.7	0.0	20.2	0.0	12.0	0.0	21.0	219.3	8.1	0.0	0.0	4.5	16.6	1.0	0.0	0.0	30.0	24.6	88.4	13.0	182.0	49.4	29.3	2.2	5.6	59.2	89.7	49.7	54.4	17.7	10.0	0.0	4.9	11.3	3.1	12.1	42.8
PLPP2	"LPP2, PAP-2c, PPAP2C"	ENSG00000141934	"Phospholipid phosphatase 2"	O43688	19	281040-291403	"Enzymes, Metabolic proteins, Predicted membrane proteins"	"Lipid metabolism"	Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Cholangiocytes: 204.5;Ductal cells: 352.1;Proximal enterocytes: 209.8;Rod photoreceptor cells: 234.9;Urothelial cells: 205.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"gdT-cell: 3.2;MAIT T-cell: 6.6"	"Lineage enriched"	"Detected in single"	41	"T-cells: 6.6"	"Cell line enhanced"	"Detected in many"		"A549: 144.1;CAPAN-2: 154.6;OE19: 255.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA055540, HPA058428"	Uncertain		Supported	"Plasma membrane"		NA	NA			"Cluster 16: MAIT-cells - Unknown function"	"Cluster 22: Non-specific - Unknown function"	"Cluster 21: OE19 - Mitochondria"	"Cluster 22: Epithelial cell types - Mixed function"	"Plasma membrane"		"HPA055540: AB_2682839, HPA058428: "	"prognostic unfavorable (4.55e-4)"	"unprognostic (8.91e-3)"	"unprognostic (1.06e-1)"	"prognostic favorable (3.21e-8)"	"unprognostic (2.95e-1)"	"unprognostic (1.36e-1)"	"unprognostic (3.83e-3)"	"unprognostic (5.48e-2)"	"unprognostic (1.59e-1)"	"unprognostic (5.67e-2)"	"unprognostic (1.18e-3)"	"unprognostic (3.85e-1)"	"unprognostic (3.53e-3)"	"unprognostic (1.06e-2)"	"unprognostic (1.71e-1)"	"unprognostic (1.30e-3)"	"unprognostic (1.36e-3)"	4.8	13.2	37.7	8.5	61.6	0.0	36.9	57.1	50.0	63.4	26.2	40.5	62.7	16.8	8.4	27.2	81.8	52.4	1.7	38.8	43.5	11.5	3.7	8.3	1.4	57.3	53.6	2.7	37.3	19.5	11.8	3.6	56.2	31.7	32.1	29.6	105.7	32.9	0.6	53.2	51.0	6.4	44.8	4.7	50.3	7.6	49.2	5.2	5.7	0.5	6.0	36.5	14.2	83.9	85.5	144.1	2.1	0.1	0.0	0.3	0.2	8.2	0.0	25.3	18.9	41.7	154.6	0.0	88.3	11.9	0.1	45.3	0.0	17.6	11.1	0.8	2.6	0.0	55.9	0.0	28.6	0.0	5.5	5.2	7.6	12.7	16.7	53.4	4.2	0.0	0.7	0.1	0.0	98.5	0.4	0.1	61.5	255.8	0.0	0.0	0.0	2.4	62.1	13.7	17.4	40.9	23.3	38.3	60.3	5.8	50.0	2.5	4.5	55.7	36.5	0.5	61.9	0.8	101.7	70.4	15.5	0.0	46.9	0.0	0.0	0.0	3.2	0.0	6.6	0.0	1.3	1.6	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.1	0.3	37.7	61.6	57.1	50.0	38.8	43.5	57.3	53.6	56.2	44.8	49.2	83.9	17.0	6.4	7.5	0.0	1.5	0.0	134.2	0.0	8.0	19.7	137.1	149.9	0.0	204.5	35.3	22.0	10.4	0.5	2.7	77.0	3.9	352.1	0.3	115.2	9.2	15.2	8.5	0.0	0.0	139.5	15.1	3.0	91.3	90.1	1.3	0.0	0.0	0.5	0.9	16.8	0.0	38.8	0.0	1.0	0.0	1.6	0.0	1.9	0.0	0.0	2.6	21.7	0.0	0.0	0.0	128.8	85.2	0.0	1.6	97.4	209.8	1.4	91.1	234.9	0.0	0.8	2.7	0.6	35.1	20.3	0.0	0.8	3.5	0.1	87.2	205.8
PLPP3	"LPP3, PAP-2b, PPAP2B"	ENSG00000162407	"Phospholipid phosphatase 3"	O14495	1	56494761-56645301	"Enzymes, Metabolic proteins, Plasma proteins, Predicted membrane proteins"	"Lipid metabolism"	Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Fibroblasts: 392.7;Hepatic stellate cells: 779.6;Leydig cells: 1092.6;Peritubular cells: 398.7"	"Cancer enhanced"	"Detected in all"		"thyroid cancer: 168.2"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	6	"memory B-cell: 2.4;naive B-cell: 2.3"	"Lineage enriched"	"Detected in single"	6	"B-cells: 2.4"	"Cell line enhanced"	"Detected in many"		"ASC diff: 710.0;ASC TERT1: 351.8;HSkMC: 438.1;U-2197: 660.4"					"Low region specificity"	"Detected in all"			HPA072751	Approved		Supported	"Golgi apparatus"		NA	Yes			"Cluster 19: B-cells - Humoral immune response"	"Cluster 89: Fibroblasts - ECM organization"	"Cluster 18: U-2197 - ECM organization"	"Cluster 50: Fibroblasts - ECM organization"	"Golgi apparatus"		"HPA072751: AB_2686555"	"unprognostic (2.50e-2)"	"unprognostic (3.94e-1)"	"unprognostic (1.81e-1)"	"unprognostic (1.65e-1)"	"unprognostic (2.71e-1)"	"unprognostic (2.22e-3)"	"unprognostic (5.86e-3)"	"unprognostic (7.25e-2)"	"unprognostic (1.59e-1)"	"unprognostic (3.75e-2)"	"unprognostic (3.91e-2)"	"unprognostic (3.08e-1)"	"prognostic favorable (4.59e-4)"	"unprognostic (3.16e-2)"	"unprognostic (1.74e-1)"	"unprognostic (3.54e-2)"	"unprognostic (2.09e-1)"	168.4	53.0	93.9	33.6	94.2	13.1	139.8	87.3	105.9	294.6	50.7	56.7	24.0	107.2	56.2	51.3	122.5	66.3	84.6	88.3	90.6	91.4	182.0	87.0	22.4	107.5	108.1	81.9	36.8	130.2	23.1	225.5	87.7	102.8	41.8	19.0	76.2	169.7	50.9	82.1	45.8	65.6	86.8	23.3	66.0	37.3	113.2	29.8	327.6	63.0	19.9	139.2	142.8	88.6	3.3	10.8	14.1	1.5	710.0	351.8	34.5	39.3	39.7	35.5	17.4	31.8	6.2	5.2	4.6	59.3	39.4	5.9	2.1	0.8	7.4	0.0	9.4	1.3	4.4	44.5	17.3	0.1	0.0	438.1	3.0	34.2	28.6	25.1	34.1	0.4	2.9	0.1	39.0	3.2	0.1	0.5	43.3	9.2	42.6	0.1	0.1	1.7	6.1	32.6	0.4	28.1	12.4	16.1	4.2	42.6	5.2	0.0	21.6	176.2	14.4	660.4	1.8	0.0	0.0	0.0	31.0	1.7	12.7	0.0	0.1	0.0	0.0	0.0	0.0	2.4	0.0	0.0	0.0	2.3	0.0	0.0	0.4	0.0	0.1	0.0	0.0	0.1	93.9	94.2	87.3	105.9	88.3	90.6	107.5	108.1	87.7	86.8	113.2	88.6	148.5	25.6	18.9	0.0	7.2	0.0	19.8	0.0	35.3	3.9	12.2	31.2	0.0	44.3	13.0	22.0	0.0	127.0	1.1	8.1	21.5	21.5	7.9	13.9	139.4	148.3	2.4	8.0	0.0	9.2	9.8	392.7	5.6	16.3	3.8	8.1	779.6	132.6	38.8	0.0	0.0	8.5	0.0	35.2	0.0	28.3	1092.6	14.9	0.0	0.0	0.9	136.0	0.0	0.0	0.0	7.9	5.9	398.7	7.1	20.8	15.5	21.3	4.4	4.1	138.1	179.7	107.2	4.5	3.4	16.4	0.0	214.9	5.0	22.4	7.2	20.1
PLPP4	"DPPL2, PPAPDC1, PPAPDC1A"	ENSG00000203805	"Phospholipid phosphatase 4"	Q5VZY2	10	120457227-120592065	"Enzymes, Metabolic proteins, Predicted membrane proteins"	"Lipid metabolism"	Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	13	"brain: 12.2"	"Cell type enhanced"	"Detected in some"		"Cholangiocytes: 11.5;Distal tubular cells: 7.9;Early spermatids: 10.9;Erythroid cells: 9.7;Late spermatids: 10.7;Leydig cells: 19.3;Peritubular cells: 7.9;Proximal tubular cells: 9.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"hTERT-RPE1: 14.2;U-251 MG: 10.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA045188	Approved		Approved	"Nucleoplasm,Nucleoli,Nucleoli rim"		NA	NA			"Cluster 11: Basophils - Unknown function"	"Cluster 70: Brain - Nervous system development"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	"Nucleoli, Nucleoli rim"	Nucleoplasm	"HPA045188: AB_2679246"	"unprognostic (8.19e-2)"	"unprognostic (2.94e-2)"	"unprognostic (8.86e-2)"	"unprognostic (1.90e-3)"	"unprognostic (3.45e-1)"	"unprognostic (2.92e-2)"	"unprognostic (2.69e-1)"	"unprognostic (2.26e-3)"	"unprognostic (1.55e-1)"	"unprognostic (8.62e-3)"	"unprognostic (2.70e-3)"	"unprognostic (1.89e-1)"	"unprognostic (2.40e-3)"	"unprognostic (3.49e-2)"	"unprognostic (3.75e-2)"	"unprognostic (1.11e-1)"	"unprognostic (1.21e-3)"	0.0	0.0	2.9	0.1	3.5	0.4	0.1	6.4	2.8	0.2	0.5	0.3	0.0	0.1	0.0	0.0	0.0	0.6	0.0	5.3	8.9	0.8	0.1	0.0	0.0	11.0	5.3	0.0	0.0	0.0	0.0	0.0	12.2	0.2	0.0	0.1	0.0	0.2	0.1	0.2	0.1	0.1	4.3	0.0	0.0	0.9	3.7	0.1	0.0	0.0	0.0	0.0	0.1	4.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.0	0.0	0.3	0.2	0.0	0.3	0.1	0.0	1.7	1.4	0.0	0.1	0.1	0.1	0.1	0.5	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	14.2	1.3	0.0	0.3	0.3	0.0	0.0	0.0	0.0	0.2	0.0	0.7	0.0	0.0	0.0	0.6	0.0	0.3	0.0	0.1	0.0	0.1	0.9	0.2	0.0	2.8	1.7	1.2	0.1	10.4	0.0	0.0	0.0	2.3	0.0	0.6	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	2.9	3.5	6.4	2.8	5.3	8.9	11.0	5.3	12.2	4.3	3.7	4.9	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.1	0.0	0.0	11.5	0.0	3.7	0.0	0.0	0.0	0.0	7.9	0.3	10.9	0.1	2.5	0.0	0.0	9.7	0.0	0.2	0.1	0.3	0.0	0.1	0.0	0.2	1.8	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	10.7	19.3	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.4	0.0	7.9	0.0	0.5	0.0	9.0	0.0	0.0	0.0	0.0	4.9	1.5	2.1	0.0	0.0	0.0	0.1	0.0	0.0	0.4
PLPP5	"DPPL1, HTPAP, PPAPDC1B"	ENSG00000147535	"Phospholipid phosphatase 5"	Q8NEB5	8	38263130-38269243	"Enzymes, Metabolic proteins, Predicted membrane proteins"	"Lipid metabolism"	Hydrolase	"Tumor suppressor"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Plasma cells: 264.5;Prostatic glandular cells: 146.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in all"	8	"basophil: 80.2;memory B-cell: 211.8;naive B-cell: 305.9"	"Group enriched"	"Detected in all"	7	"B-cells: 305.9;granulocytes: 80.2"	"Cell line enhanced"	"Detected in all"		"RPMI-8226: 140.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA055777			Approved	Vesicles		NA	NA			"Cluster 37: B-cells - Transcription"	"Cluster 25: Pancreas - Digestion"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 55: Plasma cells - Humoral immune response"	Vesicles		"HPA055777: AB_2682915"	"unprognostic (4.54e-2)"	"unprognostic (2.51e-3)"	"unprognostic (3.66e-2)"	"prognostic favorable (1.48e-5)"	"unprognostic (1.80e-2)"	"unprognostic (1.27e-2)"	"unprognostic (5.58e-2)"	"prognostic favorable (8.72e-5)"	"unprognostic (9.79e-2)"	"prognostic favorable (2.42e-5)"	"unprognostic (1.50e-1)"	"unprognostic (5.08e-2)"	"prognostic unfavorable (8.33e-10)"	"unprognostic (3.82e-2)"	"unprognostic (1.58e-1)"	"unprognostic (1.59e-3)"	"unprognostic (1.57e-2)"	12.6	18.6	12.5	21.5	13.0	16.6	24.4	15.8	16.1	29.4	36.5	30.2	41.6	16.1	81.7	13.9	28.3	27.9	8.6	12.6	14.4	27.6	33.0	16.0	28.1	12.7	13.5	18.6	114.5	13.7	52.4	14.0	12.4	74.5	35.5	8.5	85.7	30.5	4.8	10.7	40.3	11.4	11.5	28.0	46.1	7.8	13.5	10.2	29.2	3.0	32.3	21.2	14.1	13.0	15.1	29.7	17.4	35.7	33.2	32.1	23.9	42.1	52.7	21.0	27.3	13.8	22.7	1.0	35.1	43.8	30.5	16.5	14.5	30.9	18.2	9.6	9.3	26.6	13.1	40.5	56.3	7.8	30.8	25.3	31.5	29.4	38.3	37.2	34.7	34.9	1.3	67.2	25.9	31.2	17.7	13.0	26.5	61.2	10.0	19.1	12.8	140.0	53.3	19.4	13.6	20.8	17.3	26.5	25.4	15.4	56.9	15.0	21.2	14.8	13.1	25.2	11.3	41.5	29.4	4.5	41.0	20.5	26.1	80.2	12.9	23.4	13.4	13.7	23.0	211.8	17.8	17.7	12.2	305.9	8.8	8.5	8.0	22.4	19.7	26.0	18.0	17.0	12.5	13.0	15.8	16.1	12.6	14.4	12.7	13.5	12.4	11.5	13.5	13.0	22.2	9.6	46.2	0.0	110.8	0.0	81.8	0.0	25.6	5.9	49.4	42.3	0.0	32.9	21.7	75.4	16.7	45.1	14.8	12.4	43.0	68.0	30.6	70.3	27.3	27.9	44.9	9.9	0.0	89.9	43.5	41.5	50.4	54.8	31.5	38.1	17.5	23.4	36.5	62.2	0.0	62.6	0.0	10.1	0.0	8.9	17.7	23.0	0.0	0.0	12.0	37.4	18.6	0.0	0.0	57.2	31.1	9.4	264.5	146.3	74.3	24.9	55.4	3.6	13.1	22.8	18.9	31.4	12.3	20.8	0.0	88.1	25.2	18.5	44.1	59.1
PLPPR2	"LPPR2, PRG-4"	ENSG00000105520	"Phospholipid phosphatase related 2"	Q96GM1	19	11355386-11365698	"Enzymes, Metabolic proteins, Predicted membrane proteins"		Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in many"	4	"neutrophil: 72.3"	"Lineage enriched"	"Detected in many"	4	"granulocytes: 72.3"	"Cell line enhanced"	"Detected in many"		"U-2197: 95.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA048973	Uncertain		Uncertain	Nucleoplasm		NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 35: Non-specific - Unknown function"	"Cluster 18: U-2197 - ECM organization"	"Cluster 33: Fibroblasts - ECM organization"	Nucleoplasm		"HPA048973: AB_2680580"	"unprognostic (1.29e-2)"	"unprognostic (1.69e-1)"	"prognostic unfavorable (6.45e-4)"	"unprognostic (2.90e-1)"	"unprognostic (1.43e-1)"	"unprognostic (1.70e-2)"	"unprognostic (7.10e-2)"	"unprognostic (1.37e-1)"	"unprognostic (9.60e-2)"	"unprognostic (1.72e-1)"	"prognostic favorable (6.82e-4)"	"unprognostic (2.23e-1)"	"prognostic unfavorable (7.46e-11)"	"unprognostic (1.99e-2)"	"unprognostic (1.46e-1)"	"unprognostic (4.37e-2)"	"unprognostic (1.17e-1)"	21.9	35.8	80.2	10.6	62.7	15.8	21.1	28.5	80.9	39.4	22.3	41.9	5.6	32.9	7.5	16.0	35.4	13.3	32.5	111.3	70.5	18.9	25.9	29.9	5.2	39.4	44.0	40.4	17.0	13.0	73.5	11.1	44.6	40.8	4.4	10.6	22.3	13.6	33.0	24.7	17.4	16.5	32.0	28.9	26.5	17.4	75.3	3.0	26.0	5.4	2.8	32.3	27.5	41.2	23.6	14.3	7.8	32.2	31.8	30.3	2.1	40.8	37.7	24.7	25.2	2.8	4.3	4.5	23.6	52.5	5.2	4.2	4.4	12.3	13.3	12.3	8.4	1.4	9.5	2.8	16.5	1.4	45.3	27.3	21.7	21.4	4.2	35.8	17.0	7.2	22.9	36.0	21.1	34.6	0.8	6.4	8.5	7.9	78.6	0.5	1.1	12.9	11.7	11.0	8.3	27.6	17.1	14.6	9.0	2.4	20.9	29.6	19.8	55.7	11.8	95.2	21.8	22.4	14.7	1.6	54.1	21.2	22.4	2.0	17.7	9.1	0.6	15.3	0.1	0.1	0.2	0.0	6.7	0.0	0.3	0.1	72.3	0.0	10.8	0.2	0.6	6.7	80.2	62.7	28.5	80.9	111.3	70.5	39.4	44.0	44.6	32.0	75.3	41.2	9.5	6.4	8.3	0.0	1.5	0.0	6.9	0.0	11.4	7.0	9.9	10.7	0.0	8.6	1.3	3.7	12.5	0.6	1.5	0.1	1.9	6.2	11.7	2.0	11.0	10.1	17.0	0.4	0.0	8.7	2.3	12.7	3.1	3.4	2.5	3.6	11.4	8.3	4.2	8.4	0.0	2.0	0.0	11.1	0.0	13.5	14.3	7.9	0.0	0.0	12.1	16.0	6.2	0.0	0.0	9.6	0.4	16.6	1.3	11.6	0.6	1.5	1.5	6.9	6.6	5.7	13.0	2.3	7.4	2.6	0.0	2.9	1.5	11.2	0.7	5.3
PLPPR3	"FLJ11535, LPPR3, PRG-2, PRG2"	ENSG00000129951	"Phospholipid phosphatase related 3"	Q6T4P5	19	812488-821955	"Enzymes, Metabolic proteins, Predicted membrane proteins"		Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	4	"bone marrow: 9.8;brain: 21.1;fallopian tube: 11.1"	"Cell type enriched"	"Detected in some"	7	"Endometrial ciliated cells: 37.2"	"Cancer enhanced"	"Detected in many"		"testis cancer: 4.4"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	6	"NB-4: 61.8;THP-1: 128.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA052293, HPA057034"	Uncertain		Approved	"Nucleoplasm,Golgi apparatus,Cytosol"		NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 65: Brain - Ion transport"	"Cluster 43: THP-1 - Innate immune response"	"Cluster 49: Ciliated cells - Cilium organization"	"Golgi apparatus"	"Nucleoplasm, Cytosol"	"HPA052293: AB_2681787, HPA057034: AB_2683316"	"unprognostic (7.65e-2)"	"unprognostic (1.39e-2)"	"unprognostic (1.33e-2)"	"unprognostic (3.66e-3)"	"unprognostic (1.00e-1)"	"unprognostic (1.59e-2)"	"unprognostic (2.62e-2)"	"unprognostic (1.47e-1)"	"unprognostic (4.32e-1)"	"unprognostic (4.51e-4)"	"unprognostic (8.06e-3)"	"unprognostic (1.07e-1)"	"unprognostic (1.72e-12)"	"unprognostic (1.21e-2)"	"unprognostic (6.82e-2)"	"unprognostic (8.50e-2)"	"unprognostic (2.91e-1)"	0.0	0.0	16.8	0.2	14.1	9.8	2.2	0.0	21.1	0.6	0.0	0.1	0.0	0.2	0.0	0.0	11.1	0.1	0.1	14.2	11.5	0.0	0.0	2.3	0.1	4.1	8.2	0.3	0.0	0.2	0.4	0.0	1.5	0.2	0.0	0.1	0.1	0.0	0.1	0.0	0.1	0.0	2.3	0.2	0.1	3.2	13.8	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.3	1.5	12.2	0.0	0.0	0.0	6.9	0.2	0.1	0.0	0.0	0.7	0.1	0.1	8.4	0.1	0.1	0.3	2.3	0.0	0.0	0.0	5.2	0.0	1.6	0.0	0.5	4.4	0.2	1.5	0.0	0.0	0.0	0.0	0.0	0.1	12.0	0.3	0.0	1.1	0.0	61.8	9.5	0.1	0.4	0.0	0.0	0.0	0.0	0.0	0.3	15.5	0.3	0.0	0.0	6.3	5.4	128.9	0.1	0.2	0.2	0.3	0.1	0.2	0.5	0.2	0.0	10.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	16.8	14.1	0.0	21.1	14.2	11.5	4.1	8.2	1.5	2.3	13.8	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.0	3.7	1.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	37.2	0.6	0.0	0.0	0.0	0.0	0.0	0.9	0.2	0.0	0.4	0.0	1.2	0.0	0.0	0.1	1.7	0.0	0.0	0.0	0.0	0.0	0.2	0.6	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.2	0.9	0.1	5.1	0.0	0.0	0.3	0.1	0.0	0.0	0.0
PLPPR4	"KIAA0455, LPPR4, PHP1, PRG-1"	ENSG00000117600	"Phospholipid phosphatase related 4"	Q7Z2D5	1	99263953-99309590	"Enzymes, Metabolic proteins, Predicted membrane proteins"		Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	6	"brain: 23.5"	"Cell type enhanced"	"Detected in some"		"Endometrial stromal cells: 10.9;Horizontal cells: 30.3;Muller glia cells: 21.4;Smooth muscle cells: 7.0"	"Group enriched"	"Detected in many"	4	"glioma: 7.2;melanoma: 2.4"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BJ hTERT+: 14.1;BJ hTERT+ SV40 Large T+ RasG12V: 6.3;fHDF/TERT166: 6.0;SH-SY5Y: 11.4;U-138 MG: 6.7;U-87 MG: 10.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"									NA	NA				"Cluster 10: Brain - Neuronal signaling"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 5: Muller glia cells - Visual perception"				"unprognostic (4.32e-2)"	"unprognostic (4.92e-2)"	"unprognostic (2.74e-1)"	"unprognostic (1.67e-2)"	"unprognostic (1.67e-2)"	"unprognostic (2.95e-2)"	"unprognostic (1.00e-2)"	"unprognostic (1.17e-2)"	"unprognostic (9.09e-2)"	"unprognostic (9.70e-3)"	"unprognostic (3.36e-2)"	"unprognostic (2.21e-1)"	"unprognostic (7.25e-12)"	"unprognostic (1.67e-5)"	"unprognostic (3.47e-1)"	"unprognostic (1.34e-2)"	"unprognostic (1.16e-3)"	1.5	0.5	8.4	0.2	13.1	0.0	0.7	0.0	16.6	1.8	0.0	0.3	0.3	0.4	0.3	1.5	0.3	3.0	0.3	23.5	2.1	0.3	0.0	1.4	0.4	0.0	0.1	0.0	0.5	0.3	2.1	0.8	0.0	0.1	0.3	3.8	0.3	0.2	0.1	1.7	0.5	0.7	0.0	0.3	0.3	2.9	5.5	0.3	0.6	0.2	0.6	3.4	0.3	1.4	0.0	0.0	0.0	2.3	0.2	0.0	0.0	3.2	14.1	3.6	6.3	0.0	0.0	0.0	0.0	6.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	11.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.7	0.1	0.0	0.1	0.0	0.0	0.0	10.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	8.4	13.1	0.0	16.6	23.5	2.1	0.0	0.1	0.0	0.0	5.5	1.4	4.3	0.0	0.6	0.0	0.5	0.0	0.0	0.0	0.0	4.9	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.4	10.9	2.5	0.0	0.0	0.0	0.0	0.0	3.5	0.0	0.2	0.0	0.0	0.0	0.0	0.1	30.3	0.0	0.0	0.0	0.0	0.0	0.4	5.3	0.2	0.0	0.0	0.0	21.4	0.0	0.0	0.0	0.0	0.0	1.5	0.1	0.0	0.0	1.3	0.7	4.5	0.0	0.0	7.0	1.2	0.2	0.1	0.0	0.0	0.1	0.7	0.0	0.0
PM20D1	"Cps1, FLJ32569"	ENSG00000162877	"Peptidase M20 domain containing 1"	Q6GTS8	1	205828025-205850132	"Enzymes, Predicted secreted proteins"		"Hydrolase, Lyase, Protease"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	9	"pancreas: 78.0;skin 1: 33.8"	"Cell type enhanced"	"Detected in some"		"Exocrine glandular cells: 20.9;Gastric mucus-secreting cells: 7.1;Proximal tubular cells: 7.1"	"Cancer enriched"	"Detected in some"	32	"urothelial cancer: 30.2"	"Not detected"	"Not detected"			"Immune cell enhanced"	"Detected in some"		"T-reg: 2.2"	"Lineage enriched"	"Detected in single"	6	"T-cells: 2.2"	"Cell line enriched"	"Detected in single"	9	"Karpas-707: 1.9"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"								"Secreted to digestive system"	NA	NA		3300000	"Cluster 35: T-regs - Unknown function"	"Cluster 25: Pancreas - Digestion"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"				"unprognostic (1.16e-1)"	"unprognostic (1.95e-1)"	"unprognostic (1.30e-1)"	"unprognostic (4.07e-2)"	"unprognostic (4.83e-1)"	"unprognostic (4.08e-3)"	"unprognostic (1.17e-3)"	"unprognostic (3.11e-1)"	"unprognostic (1.20e-1)"	"unprognostic (5.50e-2)"	"unprognostic (5.81e-2)"	"unprognostic (4.57e-2)"	"unprognostic (7.79e-3)"	"unprognostic (9.77e-2)"	"unprognostic (1.45e-1)"	"unprognostic (2.48e-1)"	"unprognostic (1.68e-2)"	0.8	0.0	0.2	0.1	0.2	0.0	1.2	0.0	0.3	0.1	1.2	0.1	0.1	0.1	0.5	0.0	0.4	0.0	0.3	0.2	0.3	6.3	0.2	0.2	1.1	0.3	0.3	0.3	78.0	0.0	0.0	0.1	0.3	0.0	0.1	0.3	0.0	0.0	0.0	33.8	0.1	0.0	0.2	1.0	2.9	0.0	0.3	0.1	0.1	0.0	0.4	2.2	0.1	0.3	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.4	0.0	0.4	0.3	0.0	0.5	0.1	0.4	1.3	0.0	0.1	0.1	0.4	0.0	0.0	0.1	0.0	2.2	0.3	0.2	0.2	0.0	0.3	0.2	0.3	0.3	0.3	0.3	0.2	0.3	0.3	0.8	0.0	0.0	1.6	1.1	0.0	0.0	0.0	0.6	0.5	0.0	0.0	1.5	0.0	0.0	0.0	2.1	0.0	0.9	0.1	0.0	0.1	0.0	0.1	0.1	0.3	0.0	0.4	3.2	20.9	0.3	0.5	7.1	0.0	0.0	0.0	0.7	0.3	0.1	0.0	3.5	0.2	0.0	1.3	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	1.0	1.5	1.5	0.6	0.0	0.0	1.8	0.2	0.0	7.1	0.0	0.8	0.0	0.2	0.2	0.1	0.1	0.0	0.1	0.0	0.9	2.4	0.0	0.1
PMPCB	"MPPB, MPPP52"	ENSG00000105819	"Peptidase, mitochondrial processing subunit beta"	O75439	7	103297435-103329511	"Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins"		"Hydrolase, Metalloprotease, Protease"	"Disease variant, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA040674, HPA074168"	Approved		Enhanced	Mitochondria		No	No		19000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 10: Non-specific - Unknown function"	Mitochondria		"HPA040674: AB_10961998, HPA074168: AB_2686671"	"prognostic favorable (2.79e-4)"	"unprognostic (3.11e-1)"	"unprognostic (7.18e-3)"	"unprognostic (3.03e-1)"	"unprognostic (3.65e-2)"	"unprognostic (1.72e-1)"	"unprognostic (1.06e-1)"	"unprognostic (7.67e-2)"	"unprognostic (7.74e-2)"	"unprognostic (1.21e-1)"	"unprognostic (1.38e-1)"	"unprognostic (1.42e-3)"	"prognostic favorable (2.95e-8)"	"unprognostic (2.59e-2)"	"unprognostic (9.79e-2)"	"unprognostic (2.40e-1)"	"unprognostic (4.39e-2)"	30.8	42.0	16.9	22.3	18.2	53.5	32.5	18.9	22.1	33.3	24.7	33.4	38.0	29.9	26.2	27.7	29.3	25.1	44.9	18.8	18.1	47.4	46.1	22.6	36.4	16.5	16.6	35.4	41.1	39.7	22.4	25.8	17.6	31.5	33.2	25.4	30.6	28.1	34.8	33.2	32.4	26.3	17.2	28.2	35.8	26.7	17.4	30.2	33.4	38.2	33.9	29.3	28.4	19.9	30.2	42.8	49.9	69.4	28.5	57.1	38.0	26.7	45.6	54.3	62.8	47.7	33.7	76.9	41.7	47.9	58.0	37.5	59.7	43.2	49.2	26.4	69.4	26.4	74.0	61.6	35.0	35.0	30.6	53.4	40.5	41.8	39.6	51.3	28.8	55.9	52.5	77.9	48.5	71.1	59.2	82.0	59.2	60.4	52.4	42.7	34.3	79.4	50.3	54.2	62.2	76.5	37.3	108.6	55.8	49.5	45.3	49.1	24.9	48.3	57.9	85.1	52.3	57.4	79.9	61.8	35.7	59.3	38.2	16.7	19.3	13.2	18.3	21.4	20.1	25.9	21.1	18.5	24.7	19.3	26.1	21.7	5.7	17.9	19.7	12.6	30.2	22.3	16.9	18.2	18.9	22.1	18.8	18.1	16.5	16.6	17.6	17.2	17.4	19.9	32.0	32.1	36.9	27.1	54.5	36.7	68.2	123.2	51.8	31.6	41.3	37.3	70.4	41.5	70.7	27.6	22.9	125.6	55.9	35.8	72.4	75.6	106.3	38.4	37.0	37.1	27.1	65.8	36.8	73.2	61.3	42.5	35.7	35.0	60.2	49.9	31.1	53.7	54.6	23.5	33.9	48.1	75.3	49.4	30.7	24.0	51.9	42.4	26.6	18.7	92.5	35.8	58.7	35.7	44.4	59.7	45.4	49.7	56.1	35.2	60.4	127.5	58.2	37.9	65.7	48.6	73.5	125.4	56.4	47.1	37.5	124.9	55.9	63.3	59.1	62.2
PNKP	PNK	ENSG00000039650	"Polynucleotide kinase 3'-phosphatase"	Q96T60	19	49859882-49878351	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"DNA damage, DNA repair"	"Hydrolase, Kinase, Multifunctional enzyme, Transferase"	"Disease variant, Epilepsy, Mental retardation, Neurodegeneration, Primary microcephaly"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA006782	Supported		Supported	Nucleoplasm,Nucleoli		NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 15: RT4 - Unknown function"	"Cluster 52: Non-specific - Transcription"	"Nucleoplasm, Nucleoli"		"HPA006782: AB_1855496"	"prognostic favorable (9.18e-4)"	"unprognostic (1.87e-1)"	"unprognostic (4.31e-2)"	"unprognostic (4.23e-1)"	"unprognostic (1.00e-1)"	"unprognostic (4.40e-2)"	"unprognostic (1.08e-2)"	"unprognostic (1.24e-1)"	"unprognostic (3.36e-1)"	"unprognostic (1.58e-1)"	"unprognostic (3.71e-2)"	"unprognostic (1.70e-1)"	"unprognostic (4.55e-2)"	"unprognostic (3.00e-2)"	"unprognostic (2.82e-1)"	"unprognostic (7.24e-2)"	"unprognostic (3.68e-3)"	18.9	45.1	12.0	21.0	12.9	26.4	21.2	12.8	16.2	21.1	24.2	21.6	16.0	21.3	13.5	19.4	22.9	10.6	23.9	14.4	11.9	27.3	22.4	22.2	17.5	14.0	14.0	23.7	28.6	16.7	36.8	11.1	14.3	25.3	13.1	10.1	21.6	12.4	18.5	17.8	22.8	11.5	12.8	37.2	25.0	21.2	13.3	12.3	31.9	7.8	15.3	19.4	18.0	14.1	27.5	17.4	19.1	27.2	15.8	13.4	28.6	43.4	21.2	18.7	17.7	17.5	34.2	18.4	13.6	13.6	11.3	23.5	6.1	25.9	10.9	22.3	27.2	30.0	36.7	14.8	12.2	25.8	36.3	13.2	13.0	17.9	11.0	16.9	26.3	23.4	14.9	34.3	24.7	18.8	28.7	23.5	16.0	28.3	37.4	24.3	15.9	34.7	21.0	68.5	20.6	33.4	19.3	52.5	9.2	14.5	10.2	14.8	36.0	37.6	24.9	9.6	35.8	38.7	16.5	13.0	33.8	12.3	30.8	1.8	12.3	16.7	9.2	11.5	7.9	9.1	7.8	7.3	9.8	12.2	5.7	5.0	23.4	3.9	18.1	5.5	9.1	5.8	12.0	12.9	12.8	16.2	14.4	11.9	14.0	14.0	14.3	12.8	13.3	14.1	23.6	16.0	23.6	5.9	47.2	13.4	35.4	29.9	25.6	40.9	28.1	23.7	11.1	21.5	19.1	20.2	81.3	44.5	37.7	40.0	23.5	42.5	15.0	25.2	28.5	26.6	30.5	17.1	6.0	39.9	35.1	19.1	31.6	28.0	29.1	54.6	35.0	20.1	39.5	33.7	6.0	31.7	24.4	27.7	19.0	32.9	59.4	26.8	14.2	8.4	46.1	18.4	96.8	6.0	5.7	44.6	22.3	44.8	40.4	33.6	27.1	36.1	33.8	73.9	19.7	17.9	20.1	19.4	28.9	23.3	13.1	49.3	39.2	83.0	34.1	35.6
PNLDC1	"dJ195P10.2, FLJ40240"	ENSG00000146453	"PARN like, ribonuclease domain containing 1"	Q8NA58	6	159800249-159820704	"Enzymes, Predicted membrane proteins"	"Nonsense-mediated mRNA decay"	"Exonuclease, Hydrolase, Nuclease, RNA-binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"brain: 10.2;testis: 8.1"	"Cell type enhanced"	"Detected in some"		"Early spermatids: 19.9;Late spermatids: 13.6;Spermatocytes: 14.3;Spermatogonia: 13.3"	"Cancer enhanced"	"Detected in many"		"testis cancer: 4.2"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA052026	Uncertain					NA	NA			"Cluster 7: Monocytes - Unknown function"	"Cluster 78: Testis - Spermatogenesis"		"Cluster 20: Spermatogonia & Spermatocytes - Spermatogenesis"			"HPA052026: AB_2681699"	"unprognostic (1.58e-1)"	"unprognostic (3.88e-2)"	"unprognostic (1.01e-2)"	"unprognostic (2.39e-3)"	"unprognostic (8.47e-3)"	"unprognostic (3.55e-2)"	"unprognostic (2.04e-1)"	"unprognostic (4.24e-1)"	"unprognostic (1.01e-1)"	"unprognostic (5.37e-2)"	"unprognostic (4.19e-1)"	"unprognostic (9.98e-2)"	"unprognostic (2.69e-9)"	"unprognostic (1.14e-2)"	"unprognostic (2.25e-1)"	"unprognostic (1.69e-1)"	"unprognostic (2.24e-1)"	0.2	0.2	2.1	0.1	3.7	0.1	0.5	2.5	10.2	0.1	1.6	0.3	0.0	0.1	0.0	0.2	1.9	0.0	0.2	2.2	2.0	0.2	0.5	0.2	0.4	1.9	1.9	0.4	1.7	0.0	0.3	0.0	3.0	0.3	0.0	0.1	0.1	0.0	0.1	1.1	0.1	0.0	1.8	0.4	0.2	8.1	2.3	0.2	0.2	0.0	0.2	0.2	0.2	2.7	0.0	0.1	0.0	0.4	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.9	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.2	0.0	0.2	0.0	0.2	0.1	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.0	2.1	3.7	2.5	10.2	2.2	2.0	1.9	1.9	3.0	1.8	2.3	2.7	0.1	0.0	0.0	0.3	0.2	0.3	0.0	0.3	0.0	0.0	0.3	0.5	0.3	4.3	0.2	0.0	0.0	0.0	0.1	0.1	0.0	3.8	19.9	2.1	0.1	0.1	0.0	0.0	1.5	0.9	0.0	0.2	0.0	0.1	4.5	0.0	0.0	0.0	0.1	0.0	0.6	0.0	0.0	0.0	0.8	13.6	0.3	0.1	0.0	3.7	0.0	0.0	0.0	0.5	1.3	1.3	0.0	0.0	0.0	0.1	0.0	0.9	2.7	0.0	0.0	0.5	0.2	14.3	13.3	0.0	0.0	0.0	0.1	0.0	0.0	0.2
PNLIP	PL	ENSG00000175535	"Pancreatic lipase"	P16233	10	116545931-116567855	"Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted secreted proteins"	"Lipid degradation, Lipid metabolism"	Hydrolase	"Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	2058	"pancreas: 444687.5"	"Cell type enriched"	"Detected in some"	8	"Exocrine glandular cells: 4086.8"	"Cancer enriched"	"Detected in some"	4854	"pancreatic cancer: 2731.7"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"U-2 OS: 1.3"	"Low region specificity"	"Detected in some"			"Not detected"	"Not detected"			"HPA062430, HPA062494"	Enhanced				"Secreted to digestive system"	NA	NA		14000000		"Cluster 25: Pancreas - Digestion"	"Cluster 9: U-2 OS - Unknown function"	"Cluster 1: Pancreatic cells - Digestion"			"HPA062430: AB_2684761, HPA062494: AB_2684782"											"unprognostic (2.05e-2)"	"unprognostic (4.46e-2)"						13.8	3.1	0.0	10.5	0.0	1.1	8.9	0.0	0.0	7.2	0.0	3.8	64.8	9.1	0.4	4.8	1.5	0.0	78.2	0.0	0.0	3.0	10.2	2.1	16.9	0.0	0.0	216.0	444687.5	0.0	2.5	24.4	0.0	4.5	0.0	0.0	71.7	0.0	2.9	4.6	34.0	0.0	0.0	3.8	28.2	2.3	0.0	0.0	2.0	0.0	0.0	1.2	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.3	0.0	0.4	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.9	0.5	0.0	0.0	0.3	0.0	0.0	0.1	4086.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.8	0.0	0.5	0.0	0.0	14.5	0.0	0.0	0.5	0.1	507.4	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1
PNLIPRP3		ENSG00000203837	"Pancreatic lipase related protein 3"	Q17RR3	10	116427847-116477957	"Enzymes, Metabolic proteins, Predicted secreted proteins"	"Lipid degradation, Lipid metabolism"	Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"breast: 9.0;skin 1: 14.4"	"Cell type enhanced"	"Detected in some"		"Basal keratinocytes: 1.1;Early spermatids: 1.5;Late spermatids: 1.9;Melanocytes: 1.8"	"Cancer enhanced"	"Detected in some"		"head and neck cancer: 4.8"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	18	"hTCEpi: 320.3"					"Not detected"	"Not detected"			"HPA046202, HPA052009"	Uncertain				"Secreted - unknown location"	NA	NA				"Cluster 61: Skin - Cornification"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"			"HPA046202: AB_10959739, HPA052009: AB_2681692"					"unprognostic (2.62e-4)"	"unprognostic (1.60e-1)"			"unprognostic (6.97e-2)"									2.2	0.1	0.0	0.0	0.0	0.0	9.0	0.0	0.0	0.9	0.0	0.1	0.0	0.0	0.0	2.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	14.4	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.3	3.0	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.5	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	320.3	0.0	4.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	17.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.9	0.0	0.0	0.0	0.0	0.2	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.4	0.6	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.9	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.4	0.0	0.0	0.0	0.0	0.0
PNPLA2	"ATGL, desnutrin, FP17548, iPLA2zeta, TTS-2.2"	ENSG00000177666	"Patatin like phospholipase domain containing 2"	Q96AD5	11	818914-825573	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"Lipid degradation, Lipid metabolism"	Hydrolase	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"adipose tissue: 508.1;breast: 361.4"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"ASC diff: 194.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA055173, HPA062602, HPA075175"	Approved		Enhanced	"Nucleoplasm,Lipid droplets"		NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 82: Adipose tissue - ECM organization"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 53: Intestinal epithelial cells - Unknown function"	"Lipid droplets"	Nucleoplasm	"HPA055173: AB_2682725, HPA062602: AB_2684804, HPA075175: "	"unprognostic (2.11e-2)"	"unprognostic (3.37e-2)"	"unprognostic (5.87e-3)"	"unprognostic (2.51e-2)"	"unprognostic (8.97e-3)"	"unprognostic (1.68e-2)"	"unprognostic (6.39e-2)"	"unprognostic (3.28e-2)"	"unprognostic (3.00e-1)"	"unprognostic (5.61e-2)"	"unprognostic (7.93e-2)"	"unprognostic (2.09e-2)"	"unprognostic (1.10e-1)"	"unprognostic (1.68e-1)"	"unprognostic (5.46e-1)"	"unprognostic (4.09e-1)"	"unprognostic (2.07e-2)"	508.1	75.3	11.9	9.2	14.0	43.1	361.4	13.6	18.8	42.2	13.4	58.1	19.3	49.2	2.8	39.9	50.8	9.5	171.3	11.9	14.0	61.9	58.4	57.3	8.1	17.5	11.8	50.5	75.4	9.6	46.3	8.4	16.8	46.6	4.8	1.3	81.1	16.7	194.6	71.8	74.7	6.4	12.6	51.2	71.3	32.1	12.8	10.9	55.3	64.3	4.1	64.8	44.5	15.3	33.9	26.0	5.3	14.0	194.4	17.2	34.1	35.3	28.1	21.6	19.1	22.3	33.3	19.9	20.4	26.7	13.6	30.0	8.1	14.6	6.6	25.9	71.5	27.6	11.2	36.3	63.3	19.2	33.4	33.9	18.7	14.5	16.7	22.3	17.7	14.5	23.8	19.9	19.5	20.0	25.8	42.3	15.2	34.3	55.1	24.6	11.5	45.7	21.4	7.7	19.6	26.0	65.3	55.0	21.9	3.4	23.7	22.0	32.5	19.3	15.0	12.7	16.3	75.2	49.8	16.7	48.4	27.0	13.8	11.5	9.5	22.1	3.7	6.1	3.6	4.7	4.8	5.4	6.1	4.1	5.4	4.4	8.2	4.0	7.1	7.0	4.2	4.7	11.9	14.0	13.6	18.8	11.9	14.0	17.5	11.8	16.8	12.6	12.8	15.3	78.1	6.4	11.8	12.7	63.5	44.2	69.2	34.2	42.1	14.0	79.5	67.1	45.5	61.5	65.2	51.5	8.4	70.2	50.8	151.8	33.2	65.1	22.1	58.0	31.8	51.8	51.5	52.6	8.9	65.3	32.0	37.4	204.4	114.3	11.4	42.2	100.6	50.6	29.2	11.8	7.5	96.1	20.3	27.6	29.0	6.2	48.4	46.6	42.7	16.9	29.6	32.2	21.6	5.5	13.8	142.2	170.7	39.1	92.0	78.5	166.8	45.0	31.3	9.0	65.7	64.4	50.7	33.5	23.9	53.7	41.2	169.4	53.3	182.2	43.6	195.5
PNPLA3	"adiponutrin, ADPN, C22orf20, dJ796I17.1, FLJ22012, iPLA2epsilon"	ENSG00000100344	"Patatin like phospholipase domain containing 3"	Q9NST1	22	43923792-43964488	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Lipid biosynthesis, Lipid metabolism, Phospholipid biosynthesis, Phospholipid metabolism"	"Acyltransferase, Hydrolase, Transferase"	"Disease variant, Obesity"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	5	"liver: 31.0"	"Cell type enhanced"	"Detected in some"		"Bipolar cells: 35.9;Cone photoreceptor cells: 18.8;Hepatocytes: 42.3;Rod photoreceptor cells: 37.3"	"Cancer enhanced"	"Detected in many"		"liver cancer: 4.9"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"AF22: 16.7;LHCN-M2: 19.3"	"Region enhanced"	"Detected in many"		"cerebellum: 12.2"	"Not detected"	"Not detected"			HPA058058	Approved		Approved	Nucleoli,Mitochondria,Cytosol		NA	NA				"Cluster 85: Liver - Metabolism"	"Cluster 12: NES - Nervous system development"	"Cluster 9: Photoreceptor cells - Phototransduction"	Nucleoli	"Mitochondria, Cytosol"	"HPA058058: AB_2683590"	"unprognostic (4.74e-3)"	"unprognostic (4.52e-2)"	"unprognostic (1.76e-1)"	"unprognostic (2.31e-1)"	"unprognostic (1.36e-2)"	"unprognostic (1.89e-1)"	"unprognostic (8.93e-2)"	"unprognostic (1.02e-1)"	"unprognostic (2.63e-1)"	"unprognostic (2.93e-1)"	"unprognostic (2.33e-2)"	"unprognostic (1.05e-1)"	"unprognostic (1.39e-3)"	"unprognostic (2.52e-3)"	"unprognostic (5.91e-2)"	"unprognostic (2.02e-2)"	"unprognostic (1.01e-1)"	2.6	0.2	0.6	0.5	0.8	0.1	1.6	0.1	1.2	0.6	5.9	0.1	0.8	0.3	0.1	0.2	0.9	0.4	0.2	1.2	0.7	4.5	31.0	0.8	0.3	1.7	1.8	0.3	0.0	0.2	0.0	0.3	2.0	0.0	0.1	6.4	0.7	0.0	1.7	5.8	0.5	0.0	0.2	0.4	0.2	0.4	1.3	0.1	0.1	0.1	0.2	0.0	0.3	0.6	5.1	1.6	16.7	6.8	4.6	5.2	0.5	3.1	1.8	4.1	8.8	5.0	9.0	0.0	2.5	5.2	2.4	4.3	10.6	5.0	3.4	0.0	0.9	0.3	4.5	9.4	7.5	0.0	0.3	6.0	3.8	13.2	0.6	7.0	0.5	0.2	0.0	0.0	19.3	0.7	0.3	0.0	11.5	0.6	0.0	0.1	8.9	0.2	1.7	0.2	1.5	0.1	3.4	1.4	4.8	2.9	5.3	5.8	0.6	1.6	4.9	0.1	0.1	0.1	0.0	0.0	14.3	0.1	6.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.6	0.8	0.1	1.2	1.2	0.7	1.7	1.8	2.0	0.2	1.3	0.6	0.4	0.0	0.0	4.2	0.2	0.4	0.5	2.4	0.0	35.9	0.5	0.1	1.3	10.0	1.4	0.0	18.8	0.0	0.2	0.2	0.0	0.4	0.0	1.5	0.5	0.4	1.8	0.0	1.9	0.0	0.1	0.5	0.0	3.6	0.0	1.9	0.7	42.3	0.7	0.0	1.2	0.8	0.0	2.8	0.3	0.3	0.3	0.9	1.8	0.0	0.0	1.1	0.0	0.0	0.8	2.6	0.0	0.7	0.0	0.7	0.4	5.0	0.1	37.3	0.0	1.0	0.8	0.6	0.6	0.0	0.1	0.0	0.2	1.6	0.4	0.4
PNPLA4	"DXS1283E, GS2, iPLA2eta"	ENSG00000006757	"Patatin like phospholipase domain containing 4"	P41247	X	7898247-7927739	"Disease related genes, Enzymes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Lipid degradation, Lipid metabolism"	Hydrolase	"Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Distal tubular cells: 95.9;Proximal tubular cells: 126.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"							"Low region specificity"	"Detected in all"			HPA003656	Approved				"Intracellular and membrane"	NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"			"HPA003656: AB_1079033"	"unprognostic (2.97e-1)"	"unprognostic (2.45e-1)"	"unprognostic (4.17e-3)"	"unprognostic (3.08e-2)"	"prognostic unfavorable (5.29e-4)"	"prognostic unfavorable (5.37e-4)"	"unprognostic (3.15e-1)"	"unprognostic (2.05e-1)"	"unprognostic (9.42e-2)"	"unprognostic (6.30e-2)"	"unprognostic (7.83e-2)"	"unprognostic (2.27e-1)"	"prognostic favorable (2.23e-12)"	"unprognostic (5.23e-2)"	"unprognostic (6.71e-3)"	"unprognostic (6.30e-2)"	"unprognostic (2.12e-1)"	20.8	27.6	11.9	9.7	12.6	8.7	22.6	12.0	11.8	13.9	16.9	15.4	18.9	14.0	18.1	21.0	24.7	9.4	42.1	11.1	14.2	41.2	40.1	9.8	10.8	12.1	13.5	22.4	28.8	25.2	13.5	8.0	12.4	12.8	12.3	16.8	26.9	10.8	77.9	15.0	11.4	12.1	12.5	9.4	19.5	7.8	15.6	16.3	29.9	66.0	10.2	8.9	13.3	11.9	44.7	18.1	2.8	44.4	0.9	0.5	11.9	13.7	1.5	23.0	14.1	18.1	16.1	13.9	0.1	4.5	0.3	25.7	0.0	45.6	39.2	0.4	32.0	10.0	32.8	38.6	28.6	17.8	14.1	29.5	45.7	11.7	27.3	5.5	16.2	0.3	39.9	0.5	0.3	11.8	0.3	17.2	46.9	30.7	38.0	0.3	0.2	15.6	30.6	20.3	25.3	12.7	41.2	16.8	23.7	49.7	26.1	13.0	9.4	0.2	11.4	35.5	0.2	20.3	0.3	27.0	0.2	0.1	3.7	7.4	11.4	9.7	6.1	13.5	7.0	14.7	8.7	6.7	22.2	16.7	11.3	10.8	0.7	11.9	12.5	16.3	6.0	9.3	11.9	12.6	12.0	11.8	11.1	14.2	12.1	13.5	12.4	12.5	15.6	11.9	10.7	9.6	12.5	3.3	8.2	11.9	16.7	46.0	17.6	11.3	38.2	33.5	55.0	20.0	24.3	20.2	0.0	28.7	7.8	31.2	95.9	34.2	3.1	35.9	20.6	10.6	19.8	15.6	2.8	48.7	21.3	14.6	13.7	15.5	8.2	17.3	13.2	62.1	28.7	10.1	3.6	30.6	38.7	9.2	10.2	3.7	16.4	12.1	17.8	1.0	13.3	36.1	6.2	2.5	1.0	39.8	25.1	20.3	14.2	15.3	47.6	126.4	31.0	15.0	6.6	6.6	14.6	22.2	21.4	24.0	16.8	14.0	6.4	49.0	32.3	16.0
PNPLA5	"dJ388M5.4, GS2L"	ENSG00000100341	"Patatin like phospholipase domain containing 5"	Q7Z6Z6	22	43879678-43892013	"Enzymes, Predicted intracellular proteins"	"Lipid degradation, Lipid metabolism"	Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 3.4;epididymis: 1.7;skin 1: 3.1"	"Cell type enhanced"	"Detected in some"		"Excitatory neurons: 3.2;Inhibitory neurons: 2.1;Late spermatids: 2.1"	"Cancer enriched"	"Detected in single"	4	"thyroid cancer: 0.9"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"NTERA-2: 1.4;RPMI-8226: 2.7"	"Not detected"	"Not detected"							"HPA050409, HPA054211"	Uncertain					NA	NA			"Cluster 34: Basophils - Unknown function"	"Cluster 27: Brain & Skin - Unknown function"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 31: Spermatids - Spermatogenesis"			"HPA050409: AB_2681118, HPA054211: AB_2682418"				"unprognostic (6.69e-5)"	"unprognostic (3.53e-1)"	"unprognostic (1.28e-1)"		"unprognostic (1.27e-2)"		"unprognostic (3.33e-3)"				"unprognostic (1.05e-1)"	"unprognostic (1.50e-1)"	"unprognostic (4.31e-2)"		0.0	0.0	0.8	0.1	3.4	0.3	0.3	0.2	2.3	0.0	0.0	0.0	0.0	0.1	1.7	0.0	0.2	0.1	0.0	1.4	0.5	0.0	0.9	0.0	0.0	1.2	0.6	0.0	0.0	0.0	0.9	0.0	0.4	0.0	0.0	0.4	0.0	0.0	0.0	3.1	0.0	0.0	0.1	0.1	0.0	0.1	0.6	0.0	0.1	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.1	0.0	0.3	0.1	0.1	0.0	0.1	0.0	0.1	0.1	0.0	0.2	0.0	0.3	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.1	0.0	0.1	0.1	0.1	0.0	0.1	1.4	0.0	0.0	0.0	0.1	2.7	0.0	0.0	0.9	0.0	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.2	0.0	0.1	0.0	0.1	0.0	0.1	0.1	0.0	0.0	0.5	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.1	0.0	0.0	0.8	3.4	0.2	2.3	1.4	0.5	1.2	0.6	0.4	0.1	0.6	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.2	0.0	0.0	0.0	0.0	3.2	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
PNPLA6	"iPLA2delta, NTE, SPG39, sws"	ENSG00000032444	"Patatin like phospholipase domain containing 6"	Q8IY17	19	7534004-7561764	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Lipid degradation, Lipid metabolism"	Hydrolase	"Disease variant, Dwarfism, Hereditary spastic paraplegia, Hypogonadotropic hypogonadism, Mental retardation, Neurodegeneration, Retinitis pigmentosa"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 73.4;Late spermatids: 106.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA007522, HPA064773"	Uncertain		Approved	"Endoplasmic reticulum,Cytosol"		NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 43: Testis - Unknown function"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 45: Enterocytes - Digestion"	"Endoplasmic reticulum, Cytosol"		"HPA007522: AB_1079649, HPA064773: "	"unprognostic (2.73e-1)"	"unprognostic (1.02e-1)"	"unprognostic (1.52e-1)"	"unprognostic (3.23e-2)"	"unprognostic (2.78e-1)"	"prognostic favorable (5.25e-4)"	"unprognostic (3.53e-3)"	"unprognostic (1.50e-1)"	"unprognostic (2.07e-2)"	"unprognostic (1.62e-1)"	"prognostic favorable (3.51e-5)"	"unprognostic (3.36e-1)"	"prognostic favorable (7.53e-4)"	"unprognostic (3.10e-3)"	"unprognostic (3.50e-1)"	"unprognostic (3.25e-1)"	"unprognostic (2.17e-1)"	17.9	27.3	18.3	26.2	23.2	26.1	16.4	14.7	31.5	20.2	12.6	25.7	26.9	20.8	5.3	20.4	16.8	13.7	20.7	21.9	16.3	25.6	21.9	40.4	19.5	23.4	20.3	18.8	16.4	15.6	32.7	13.6	25.6	21.4	8.4	10.6	15.8	12.8	33.5	17.5	29.6	14.5	10.1	41.9	19.2	36.4	23.7	10.9	22.7	19.5	8.9	24.6	17.4	23.6	32.4	80.1	14.7	36.1	25.5	37.0	34.3	42.2	41.9	31.4	28.8	18.6	43.7	27.3	69.1	55.3	19.7	40.8	13.1	39.4	16.3	68.5	29.2	17.7	41.8	13.9	29.2	20.2	53.0	31.6	22.2	41.8	23.8	49.2	62.7	31.4	14.9	36.5	28.6	15.7	22.2	26.0	16.2	15.5	71.7	17.3	9.0	31.9	27.9	31.2	19.0	32.5	34.9	15.7	45.6	20.4	14.1	27.6	67.0	38.5	22.1	53.3	44.2	42.6	30.1	12.2	64.2	23.2	36.7	15.7	11.3	37.6	5.4	20.0	5.5	6.5	3.8	5.7	12.1	4.3	3.3	4.5	3.2	7.9	35.0	3.8	6.9	8.8	18.3	23.2	14.7	31.5	21.9	16.3	23.4	20.3	25.6	10.1	23.7	23.6	12.6	6.4	12.0	16.6	11.9	4.8	4.1	9.3	8.6	12.1	10.9	8.3	10.0	15.7	10.1	33.1	27.1	18.2	14.4	48.5	1.9	15.8	73.4	8.2	7.2	13.5	17.4	25.4	14.0	7.1	15.5	7.3	14.8	10.7	12.0	19.5	13.6	20.2	27.4	21.9	16.1	14.6	10.2	68.3	16.0	106.1	9.6	42.4	8.8	15.0	23.6	9.2	21.6	9.0	16.4	9.5	17.9	7.5	8.8	4.9	67.0	12.1	14.4	16.5	0.0	7.1	7.7	60.8	10.5	8.5	5.5	12.4	15.9	10.0	20.9	3.6
PNPLA7	"C9orf111, FLJ31318, FLJ43070, FLJ44279, NTE-R1, NTEL1, RP11-48C7.2"	ENSG00000130653	"Patatin like phospholipase domain containing 7"	Q6ZV29	9	137459952-137550402	"Enzymes, Metabolic proteins, Predicted membrane proteins"	"Lipid degradation, Lipid metabolism"	Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 56.2;Excitatory neurons: 23.6;Inhibitory neurons: 21.5;Oligodendrocytes: 21.0"	"Cancer enhanced"	"Detected in many"		"prostate cancer: 9.4"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"naive B-cell: 1.0;T-reg: 1.2"	"Group enriched"	"Detected in many"	4	"B-cells: 1.0;T-cells: 1.2"	"Cell line enriched"	"Detected in some"	22	"HMC-1: 83.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA009130	Uncertain		Uncertain	"Centriolar satellite,Cytosol"		NA	NA			"Cluster 21: B-cells - Adaptive immune response"	"Cluster 50: Non-specific - Ribosome"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 64: Astrocytes - Nervous system maintenance"	Cytosol	"Centriolar satellite"	"HPA009130: AB_2268411"	"unprognostic (1.49e-1)"	"unprognostic (1.40e-2)"	"unprognostic (3.61e-3)"	"unprognostic (2.38e-2)"	"unprognostic (3.68e-2)"	"unprognostic (6.69e-3)"	"unprognostic (2.72e-3)"	"unprognostic (5.14e-4)"	"unprognostic (3.24e-1)"	"unprognostic (1.40e-2)"	"prognostic favorable (2.24e-5)"	"unprognostic (1.09e-1)"	"unprognostic (2.23e-3)"	"unprognostic (2.42e-1)"	"unprognostic (6.80e-2)"	"unprognostic (8.81e-2)"	"unprognostic (3.45e-3)"	9.6	7.0	5.2	2.2	5.3	2.1	11.3	1.9	8.6	17.6	1.2	10.8	2.2	12.3	1.0	2.7	13.0	3.7	6.9	6.6	2.6	6.3	14.0	4.7	4.4	4.6	2.6	21.5	17.9	2.0	8.9	0.6	3.6	22.5	1.4	1.3	15.9	2.7	17.3	14.3	8.4	1.6	2.2	7.0	16.3	2.6	4.2	1.4	17.3	3.4	1.4	10.5	7.6	5.9	0.1	1.0	0.2	0.3	0.8	0.5	0.4	0.8	0.8	0.2	0.2	0.1	0.5	0.6	0.8	0.4	0.4	0.3	0.1	0.0	0.0	1.6	0.9	0.8	1.0	0.3	0.5	0.4	83.7	1.2	0.1	0.3	0.0	1.4	0.1	0.1	0.1	2.3	0.1	1.6	0.2	1.6	0.0	1.2	0.9	2.0	1.3	2.8	0.1	0.3	1.6	0.4	0.1	0.6	0.3	0.2	3.7	1.2	0.6	0.0	0.1	0.4	0.1	0.8	0.2	0.2	1.2	0.8	0.1	0.0	0.1	0.0	0.2	0.1	0.0	0.2	0.1	0.1	0.2	1.0	0.3	0.2	0.0	0.0	0.0	0.1	1.2	0.2	5.2	5.3	1.9	8.6	6.6	2.6	4.6	2.6	3.6	2.2	4.2	5.9	3.0	9.6	5.9	56.2	4.8	1.5	1.1	0.9	2.2	2.5	6.5	8.3	3.9	4.3	2.6	1.8	6.2	0.2	2.1	6.6	0.0	0.7	0.5	1.7	4.8	1.2	17.3	0.8	23.6	0.0	0.3	3.6	12.2	3.8	7.0	1.2	2.5	10.2	2.6	5.0	21.5	9.2	0.0	4.5	1.0	0.6	4.4	1.2	0.0	9.4	1.3	2.5	1.0	11.6	21.0	0.6	7.1	1.9	1.6	2.5	3.8	1.0	1.6	9.6	0.0	2.3	2.1	3.1	4.0	0.9	3.3	0.0	2.3	0.6	2.0	0.7
PNPLA8	"IPLA2-2, IPLA2G, iPLA2gamma"	ENSG00000135241	"Patatin like phospholipase domain containing 8"	Q9NP80	7	108470417-108569666	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Lipid degradation, Lipid metabolism"	Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Glandular and luminal cells: 236.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA020083	Approved		Approved	"Nucleoplasm,Golgi apparatus,Cytosol"		NA	NA			"Cluster 14: Monocytes - Unknown function"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 18: U-2197 - ECM organization"	"Cluster 41: Macrophages - Immune response"	"Nucleoplasm, Cytosol"	"Golgi apparatus"	"HPA020083: AB_1851849"	"unprognostic (4.48e-2)"	"unprognostic (3.37e-1)"	"unprognostic (5.73e-2)"	"unprognostic (2.75e-1)"	"unprognostic (4.61e-1)"	"unprognostic (2.73e-2)"	"unprognostic (3.48e-2)"	"unprognostic (3.32e-1)"	"unprognostic (2.80e-2)"	"unprognostic (1.03e-1)"	"unprognostic (2.48e-1)"	"unprognostic (2.49e-1)"	"prognostic favorable (1.86e-6)"	"unprognostic (3.16e-2)"	"unprognostic (3.64e-1)"	"unprognostic (4.28e-3)"	"unprognostic (1.24e-1)"	27.8	47.3	23.6	17.9	25.1	82.9	20.2	21.6	29.6	19.4	22.1	14.1	11.8	17.9	17.7	21.1	11.6	21.4	25.3	24.0	26.5	30.0	34.6	17.5	18.0	23.5	23.3	14.7	13.9	28.4	16.5	26.6	23.4	18.0	15.1	24.4	11.9	17.7	35.9	15.0	10.7	20.9	24.9	17.7	15.6	15.5	22.9	18.6	24.3	34.7	22.1	29.1	12.7	26.5	28.6	12.8	22.1	19.7	47.7	32.7	32.4	26.6	47.2	21.6	35.8	12.4	16.0	15.9	33.1	26.4	43.4	10.6	37.9	17.1	32.6	24.2	10.1	11.0	19.3	9.1	34.8	7.6	21.7	29.8	31.7	29.2	26.9	23.4	29.5	17.7	13.0	44.5	27.2	18.9	18.0	18.3	9.8	17.9	17.8	6.5	23.3	34.3	25.9	35.9	18.3	25.3	25.8	27.4	32.7	27.7	11.6	12.6	24.2	35.1	15.7	52.8	15.0	37.4	41.5	23.9	33.4	11.4	23.2	21.9	29.8	26.2	14.6	32.8	17.8	28.6	14.2	14.6	29.2	27.3	15.4	14.7	24.5	22.9	43.4	11.6	19.1	22.9	23.6	25.1	21.6	29.6	24.0	26.5	23.5	23.3	23.4	24.9	22.9	26.5	64.5	41.7	49.3	66.3	91.3	92.9	124.0	42.2	55.2	64.0	45.7	35.9	49.7	8.6	51.2	23.9	18.8	58.0	72.7	44.3	93.9	32.0	52.3	124.9	67.3	57.1	57.1	50.7	42.4	37.8	37.5	76.6	45.3	236.1	71.7	19.0	23.2	44.3	32.2	32.0	42.9	27.8	67.1	45.5	90.0	47.4	32.0	113.8	55.2	23.4	43.5	42.9	18.6	38.2	41.3	29.6	38.6	39.5	76.8	80.1	16.7	41.0	62.0	32.5	19.7	88.9	63.9	18.6	23.1	60.5	135.7	130.2	69.1	43.7	22.9	122.7
PON1	"ESA, PON"	ENSG00000005421	"Paraoxonase 1"	P27169	7	95297676-95324532	"Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted secreted proteins, Transporters"		Hydrolase	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	103	"liver: 531.8"	"Cell type enriched"	"Detected in some"	23	"Hepatocytes: 440.0"	"Cancer enriched"	"Detected in some"	78	"liver cancer: 97.8"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA001610	Approved				"Secreted to blood"	NA	NA	96000000000	17000000000		"Cluster 62: Liver - Hemostasis"		"Cluster 2: Hepatocytes - Metabolism"			"HPA001610: AB_1079656"	"unprognostic (2.02e-2)"	"unprognostic (2.41e-2)"	"unprognostic (3.04e-1)"	"unprognostic (3.54e-2)"	"unprognostic (2.70e-1)"		"prognostic favorable (7.24e-7)"	"unprognostic (2.24e-1)"	"unprognostic (1.95e-1)"	"unprognostic (9.02e-3)"	"unprognostic (1.76e-3)"	"unprognostic (3.97e-2)"	"unprognostic (6.74e-9)"	"unprognostic (1.09e-3)"	"unprognostic (2.29e-2)"	"unprognostic (2.07e-1)"	"unprognostic (5.54e-3)"	0.0	4.1	0.6	0.0	0.5	0.0	0.1	0.6	0.6	0.2	0.2	0.1	0.0	0.0	0.0	0.0	0.1	1.1	0.0	0.5	0.6	0.2	531.8	0.1	0.0	0.5	0.5	0.6	0.1	0.0	0.8	0.0	0.5	0.3	0.0	0.1	0.1	0.0	0.0	0.1	0.1	0.0	0.3	0.0	0.0	0.3	0.6	5.1	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.6	0.5	0.6	0.6	0.5	0.6	0.5	0.5	0.5	0.3	0.6	0.6	0.0	0.0	1.5	7.2	1.1	0.0	0.0	0.0	0.0	0.6	0.2	0.3	0.6	18.6	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.0	0.4	3.0	13.5	0.2	0.2	0.0	0.2	0.0	0.3	0.0	0.1	8.9	440.0	0.0	0.0	0.2	0.2	0.0	13.4	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.3	0.0	2.0	0.2	0.1	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.4	0.0	1.6	0.5	0.4	0.2	0.0	0.1	0.0	0.6	0.5	0.3	0.1
PON2		ENSG00000105854	"Paraoxonase 2"	Q15165	7	95404862-95435329	"Candidate cardiovascular disease genes, Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted secreted proteins"		Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 258.9"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 341.5;Extravillous trophoblasts: 300.9;Skeletal myocytes: 284.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"myeloid DC: 33.8"	"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB025430, HPA029193"	Enhanced				"Secreted to blood"	NA	NA		160000	"Cluster 28: Myeloid DCs - Unknown function"	"Cluster 15: Liver - Metabolism"	"Cluster 20: HeLa - Mitochondria"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"			"CAB025430: , HPA029193: AB_10602148"	"unprognostic (1.43e-1)"	"prognostic unfavorable (1.43e-5)"	"unprognostic (3.80e-1)"	"unprognostic (4.14e-1)"	"unprognostic (3.89e-2)"	"unprognostic (3.77e-3)"	"unprognostic (1.19e-3)"	"unprognostic (9.87e-3)"	"unprognostic (9.54e-2)"	"unprognostic (2.53e-1)"	"unprognostic (1.58e-2)"	"unprognostic (2.80e-1)"	"prognostic unfavorable (4.30e-8)"	"unprognostic (1.40e-1)"	"unprognostic (6.43e-2)"	"unprognostic (7.99e-3)"	"unprognostic (2.56e-1)"	50.6	129.9	196.0	22.7	206.2	10.9	62.6	184.9	258.9	43.3	150.1	69.0	81.6	45.9	61.2	28.6	41.3	53.3	45.5	192.1	209.8	56.5	183.7	105.4	14.3	183.6	197.1	31.6	26.8	28.4	49.8	98.3	186.0	39.5	86.0	30.2	29.9	45.6	15.4	56.6	51.0	51.5	182.0	22.3	27.6	28.3	197.9	13.9	37.7	17.5	33.0	37.6	30.3	205.7	51.1	313.4	250.6	137.2	34.2	74.5	69.6	101.5	118.7	77.3	83.7	72.1	113.8	0.0	138.4	100.9	148.2	33.3	46.2	78.3	87.4	0.8	59.8	25.9	186.3	238.1	53.9	0.1	34.1	108.6	88.7	41.7	56.5	157.8	162.7	0.0	16.9	1.0	231.1	46.6	0.1	29.2	49.2	135.4	71.4	0.0	117.5	12.5	239.4	39.4	17.2	53.5	144.7	159.8	102.9	142.7	47.3	17.0	178.3	115.7	83.7	39.6	100.2	26.2	32.5	0.4	108.1	23.9	154.3	0.0	7.8	0.8	5.0	4.3	4.5	1.6	1.9	4.5	33.8	0.5	2.5	3.5	0.0	8.9	2.3	8.1	1.1	4.4	196.0	206.2	184.9	258.9	192.1	209.8	183.6	197.1	186.0	182.0	197.9	205.7	65.7	128.2	104.3	341.5	4.6	16.8	42.8	201.4	25.6	5.6	51.0	37.6	39.4	67.2	178.5	84.6	0.0	75.6	13.9	121.4	9.8	149.9	5.5	29.9	32.0	86.5	12.6	26.1	0.7	50.6	300.9	36.3	20.4	57.0	14.5	55.2	44.3	151.7	40.5	38.7	1.8	36.3	173.0	20.8	63.7	2.6	16.1	27.4	112.1	72.1	17.4	185.0	10.3	126.2	149.2	75.7	102.2	21.8	4.9	25.7	85.7	55.8	64.6	8.2	19.7	284.5	49.2	2.6	7.5	25.4	16.1	50.3	8.1	44.5	81.0	23.4
PON3		ENSG00000105852	"Paraoxonase 3"	Q15166	7	95359872-95396375	"Candidate cardiovascular disease genes, Enzymes, Metabolic proteins, Plasma proteins, Predicted secreted proteins"		Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	20	"liver: 616.7"	"Cell type enriched"	"Detected in many"	11	"Hepatocytes: 509.6"	"Group enriched"	"Detected in many"	9	"liver cancer: 30.8;lung cancer: 7.8"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A549: 28.9;CACO-2: 8.6;CAPAN-2: 6.5;Hep G2: 32.6;T-47d: 17.4"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"HPA014848, CAB025250"	Enhanced				"Secreted to blood"	NA	NA	1760000000	380000000		"Cluster 62: Liver - Hemostasis"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 2: Hepatocytes - Metabolism"			"CAB025250: , HPA014848: AB_1855540"	"unprognostic (2.67e-1)"	"unprognostic (1.03e-1)"	"unprognostic (6.28e-3)"	"unprognostic (5.52e-3)"	"unprognostic (1.36e-1)"	"unprognostic (4.87e-1)"	"unprognostic (1.44e-3)"	"unprognostic (6.32e-2)"	"unprognostic (1.11e-1)"	"unprognostic (6.44e-3)"	"unprognostic (9.14e-2)"	"unprognostic (7.18e-3)"	"unprognostic (8.30e-9)"	"unprognostic (1.66e-1)"	"unprognostic (1.04e-2)"	"unprognostic (8.29e-2)"	"unprognostic (5.12e-2)"	1.4	3.8	2.1	0.5	2.0	0.0	31.2	1.7	1.9	5.3	1.4	2.0	7.9	0.9	3.6	0.5	1.3	4.4	1.0	1.8	2.1	2.7	616.7	14.2	0.1	2.3	2.2	12.4	14.3	0.2	24.9	0.8	2.9	0.9	2.8	0.1	26.3	3.9	0.3	7.4	3.1	0.2	2.1	0.3	2.3	9.0	2.1	1.6	7.1	0.3	5.9	1.4	0.9	1.9	3.1	28.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.6	6.5	0.1	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	32.6	0.0	0.0	0.0	0.1	1.6	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	5.3	0.0	0.1	17.4	0.0	0.0	0.0	0.1	0.0	0.0	1.7	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.1	2.0	1.7	1.9	1.8	2.1	2.3	2.2	2.9	2.1	2.1	1.9	2.5	6.4	45.9	24.5	0.6	0.9	0.9	9.3	1.8	0.0	5.4	4.3	0.5	31.5	23.9	3.7	0.0	1.7	0.3	3.2	1.9	0.3	14.5	0.0	0.4	1.9	0.0	8.0	0.1	2.0	2.2	5.2	0.5	0.0	0.0	0.4	10.0	509.6	0.2	0.0	0.2	1.8	12.2	8.1	0.3	4.8	8.1	0.2	14.2	4.7	0.0	3.2	0.0	17.6	0.1	1.2	1.2	3.0	0.0	2.1	6.0	6.7	6.5	0.1	0.0	0.8	2.1	21.4	16.9	0.3	1.3	1.4	0.8	6.6	2.3	0.4
POP1		ENSG00000104356	"POP1 homolog, ribonuclease P/MRP subunit"	Q99575	8	98117293-98159835	"Disease related genes, Enzymes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"tRNA processing"	"Hydrolase, RNA-binding"	"Disease variant, Dwarfism"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA066194			Supported	Nucleoli		NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 34: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 39: Non-specific - Basic cellular processes"	Nucleoli		"HPA066194: AB_2732742"	"prognostic unfavorable (2.54e-4)"	"unprognostic (9.42e-2)"	"unprognostic (5.96e-3)"	"unprognostic (3.31e-2)"	"unprognostic (1.46e-1)"	"unprognostic (7.46e-2)"	"prognostic unfavorable (1.26e-6)"	"prognostic unfavorable (9.88e-4)"	"unprognostic (4.85e-1)"	"unprognostic (1.47e-1)"	"unprognostic (3.79e-1)"	"unprognostic (1.39e-2)"	"prognostic unfavorable (5.97e-4)"	"unprognostic (1.81e-2)"	"unprognostic (1.25e-1)"	"unprognostic (1.34e-1)"	"unprognostic (2.96e-1)"	2.1	1.6	1.7	3.5	1.5	1.5	2.1	3.4	2.3	1.4	1.2	1.9	1.5	1.7	1.4	3.0	1.8	1.3	1.6	1.3	1.2	2.0	1.9	1.6	3.6	1.1	1.4	2.9	1.7	1.7	1.5	1.2	1.1	1.5	4.8	2.4	1.4	1.3	1.7	3.0	1.6	1.8	0.8	2.1	1.9	3.1	1.6	2.6	1.5	1.2	4.4	2.5	1.5	1.8	21.9	12.9	13.8	12.8	4.8	3.3	9.1	18.3	15.2	18.7	13.8	13.4	13.8	15.3	25.6	12.9	9.0	14.3	40.3	18.2	18.9	11.1	17.0	30.0	10.2	9.2	2.1	16.4	18.4	2.8	3.3	20.8	8.2	5.7	14.8	7.2	17.0	13.5	17.7	17.4	23.8	8.3	10.4	25.1	17.6	19.4	7.5	11.0	13.5	11.5	32.8	7.7	8.4	14.2	6.4	7.9	19.2	6.0	18.4	16.3	11.6	20.8	36.5	13.3	13.6	32.7	12.8	17.3	14.6	9.4	5.1	3.9	7.4	5.7	6.0	4.9	5.4	5.0	5.0	8.1	6.8	6.5	0.8	3.8	2.9	6.2	4.9	2.1	1.7	1.5	3.4	2.3	1.3	1.2	1.1	1.4	1.1	0.8	1.6	1.8	2.3	3.2	3.9	10.7	4.7	3.7	8.2	3.8	4.0	7.0	2.5	2.3	3.9	0.0	3.8	5.5	0.0	4.1	4.1	2.7	5.9	8.8	13.8	2.4	6.4	4.2	0.0	5.0	17.7	5.9	3.4	5.8	6.6	2.9	1.3	5.9	1.8	5.4	3.4	1.7	19.0	1.7	2.0	2.4	0.8	3.0	5.3	3.3	0.0	3.7	7.9	2.7	10.3	8.5	11.0	7.8	1.0	4.5	5.2	4.8	1.1	8.5	2.6	9.5	6.6	4.0	6.1	7.7	19.1	9.8	2.4	3.0	4.4	6.1	3.9	5.1
POP4	RPP29	ENSG00000105171	"POP4 homolog, ribonuclease P/MRP subunit"	O95707	19	29606283-29617237	"Enzymes, Predicted intracellular proteins"	"tRNA processing"	"Hydrolase, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA042748, HPA064577"	Approved		Approved	Nucleoplasm,Nucleoli		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 35: Non-specific - Unknown function"	"Cluster 9: U-2 OS - Unknown function"	"Cluster 39: Non-specific - Basic cellular processes"	"Nucleoplasm, Nucleoli"		"HPA042748: AB_10964774, HPA064577: "	"unprognostic (5.88e-2)"	"unprognostic (2.78e-2)"	"unprognostic (7.21e-2)"	"unprognostic (4.00e-3)"	"unprognostic (4.50e-2)"	"unprognostic (5.73e-2)"	"prognostic unfavorable (3.31e-4)"	"unprognostic (8.35e-2)"	"unprognostic (2.37e-2)"	"unprognostic (1.26e-1)"	"unprognostic (2.20e-2)"	"unprognostic (9.47e-2)"	"unprognostic (5.84e-2)"	"unprognostic (4.21e-1)"	"unprognostic (1.77e-2)"	"unprognostic (5.23e-3)"	"unprognostic (8.08e-3)"	11.3	13.6	8.9	5.2	9.4	6.3	10.6	10.0	9.5	8.8	8.5	11.1	4.7	9.7	3.8	13.3	7.7	2.5	14.1	9.1	9.6	13.4	14.4	8.1	5.9	10.1	9.5	7.8	9.5	3.9	8.3	3.7	9.8	8.8	2.9	3.6	10.5	3.2	18.8	11.6	10.5	3.5	9.7	11.4	11.6	12.8	9.8	5.0	9.2	4.0	4.7	9.6	9.3	10.5	44.5	61.9	5.3	5.4	7.8	3.9	26.5	42.1	4.9	9.3	9.3	28.6	10.5	35.2	72.1	7.3	10.1	20.6	10.8	10.0	5.3	79.9	65.1	42.0	19.4	18.2	7.5	51.4	21.6	4.4	8.0	7.9	4.8	5.0	8.2	18.5	34.8	8.0	8.2	36.9	29.7	8.6	10.3	13.6	39.5	19.0	44.7	18.0	5.6	17.1	15.1	16.6	44.4	15.4	18.5	5.0	15.5	12.5	30.0	13.4	40.5	23.1	37.1	30.3	59.7	44.1	17.1	24.8	13.5	73.1	39.7	40.3	35.5	52.1	26.1	48.1	34.2	37.5	39.9	36.4	27.1	32.4	23.3	36.5	43.0	33.2	53.0	45.8	8.9	9.4	10.0	9.5	9.1	9.6	10.1	9.5	9.8	9.7	9.8	10.5	26.4	22.4	20.0	4.9	29.8	12.6	20.0	61.0	15.9	16.6	18.5	21.0	26.1	27.1	29.6	33.1	8.4	53.4	25.8	29.5	80.3	59.5	18.2	29.8	21.5	27.1	17.4	21.4	4.6	78.3	45.0	22.8	17.3	22.6	26.0	22.1	25.4	40.2	62.1	11.8	4.3	27.5	46.8	26.2	18.3	15.3	16.4	27.3	24.9	0.0	57.4	34.1	52.5	4.0	5.8	66.2	26.6	28.2	33.6	20.3	39.4	72.4	38.0	15.5	26.3	18.6	27.8	71.0	15.4	21.4	16.1	47.3	27.4	31.7	26.2	19.5
POP5		ENSG00000167272	"POP5 homolog, ribonuclease P/MRP subunit"	Q969H6	12	120578764-120581402	"Enzymes, Predicted intracellular proteins"	"rRNA processing, tRNA processing"	"Hydrolase, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Distal tubular cells: 154.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA047598, HPA069204"	Approved		Supported	Nucleoplasm,Nucleoli		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 39: Non-specific - Basic cellular processes"	Nucleoplasm	Nucleoli	"HPA047598: AB_2680096, HPA069204: "	"unprognostic (1.50e-2)"	"prognostic favorable (2.68e-5)"	"unprognostic (1.55e-1)"	"unprognostic (3.61e-3)"	"unprognostic (3.81e-1)"	"unprognostic (1.50e-1)"	"unprognostic (4.80e-3)"	"unprognostic (1.28e-1)"	"unprognostic (7.34e-2)"	"unprognostic (5.75e-2)"	"unprognostic (4.13e-2)"	"unprognostic (1.33e-1)"	"prognostic unfavorable (4.85e-4)"	"unprognostic (3.07e-1)"	"unprognostic (6.21e-2)"	"unprognostic (2.68e-1)"	"unprognostic (5.68e-2)"	27.0	51.3	5.2	5.6	6.1	9.5	25.6	6.0	8.9	20.7	6.1	24.6	6.0	21.8	2.4	25.9	20.1	5.1	42.5	5.5	5.9	38.3	40.5	19.0	10.8	6.1	5.7	17.2	25.2	7.3	26.2	2.1	6.4	24.3	2.8	1.2	25.2	4.8	22.9	22.4	24.6	3.5	6.2	31.8	25.4	10.2	5.8	7.9	27.4	3.6	4.3	24.3	21.0	6.4	22.2	43.4	3.8	8.7	10.1	4.5	14.7	14.2	5.7	13.6	11.2	36.6	6.6	13.4	26.9	7.8	6.1	15.7	8.0	30.1	1.1	41.4	42.1	13.5	20.3	26.5	12.1	11.7	11.3	14.1	11.2	13.5	2.4	3.4	8.9	30.2	18.2	5.6	7.5	45.0	18.9	11.2	8.0	14.6	36.5	20.5	9.8	28.5	11.5	18.5	7.4	8.7	27.7	6.5	15.7	2.8	27.5	20.7	11.8	8.1	13.2	13.6	19.8	16.1	35.8	16.7	20.5	21.6	13.3	4.5	12.7	3.1	17.7	14.9	16.4	25.2	14.2	16.2	16.8	18.0	17.6	16.3	0.9	16.0	14.1	26.6	15.8	20.8	5.2	6.1	6.0	8.9	5.5	5.9	6.1	5.7	6.4	6.2	5.8	6.4	24.2	12.8	27.6	10.1	47.8	19.6	38.6	83.7	34.1	22.0	37.5	50.4	60.5	37.1	59.3	77.3	14.6	51.7	49.3	21.6	154.6	44.9	1.7	39.9	30.5	25.4	22.1	30.1	6.4	44.9	42.9	33.8	32.6	24.8	54.6	24.0	24.3	58.3	53.2	18.5	6.9	30.5	54.9	19.8	21.7	5.0	36.1	35.7	49.8	7.5	33.4	79.3	52.5	10.6	8.2	40.0	21.9	37.6	56.8	23.6	31.2	136.2	45.2	34.4	19.7	27.5	39.4	22.7	43.8	53.3	24.7	17.6	46.1	106.3	44.2	33.5
POP7	"RPP2, RPP20"	ENSG00000172336	"POP7 homolog, ribonuclease P/MRP subunit"	O75817	7	100706121-100707486	"Enzymes, Predicted intracellular proteins"	"rRNA processing, tRNA processing"	"Hydrolase, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA021007	Uncertain		Supported	Nucleoli,Vesicles		NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 38: Extravillous trophoblasts - Unknown function"	"Nucleoli, Vesicles"		"HPA021007: AB_10963575"	"unprognostic (3.19e-1)"	"unprognostic (2.45e-2)"	"unprognostic (2.72e-2)"	"unprognostic (1.80e-3)"	"unprognostic (6.47e-2)"	"unprognostic (1.04e-1)"	"prognostic unfavorable (4.99e-5)"	"unprognostic (2.98e-2)"	"unprognostic (2.28e-1)"	"unprognostic (3.12e-2)"	"unprognostic (9.50e-2)"	"unprognostic (3.88e-1)"	"prognostic unfavorable (6.02e-4)"	"unprognostic (1.05e-2)"	"unprognostic (1.44e-1)"	"unprognostic (6.21e-2)"	"unprognostic (6.73e-2)"	25.6	31.7	30.1	18.1	31.6	33.9	26.6	33.4	38.6	24.2	23.8	27.9	19.3	27.7	11.0	34.0	21.3	9.8	37.6	32.3	30.8	25.8	67.1	18.2	17.3	30.1	27.8	18.1	31.3	16.6	22.8	16.6	30.8	22.6	9.2	9.6	29.0	13.5	69.0	50.2	22.3	12.1	29.4	22.7	26.4	12.5	29.1	15.6	16.8	31.9	12.0	25.4	24.9	33.9	115.7	115.3	47.2	78.4	25.1	23.9	92.0	65.6	32.4	73.7	73.1	159.8	71.0	97.5	105.1	30.0	81.4	70.4	70.1	79.5	36.8	82.7	212.4	44.9	75.0	166.5	42.1	69.2	49.8	27.6	30.2	76.2	74.8	20.9	41.6	68.9	157.4	77.8	39.8	330.4	158.0	232.9	135.2	77.8	164.4	123.6	50.0	159.4	45.3	65.2	90.4	92.3	54.5	156.2	78.7	42.0	50.0	66.2	41.3	92.0	117.7	191.0	127.6	34.0	99.4	175.8	61.0	115.1	104.6	106.3	63.2	72.4	54.7	64.7	50.7	60.3	54.6	54.3	55.3	47.7	49.5	52.0	39.0	78.9	70.3	51.2	69.8	62.5	30.1	31.6	33.4	38.6	32.3	30.8	30.1	27.8	30.8	29.4	29.1	33.9	30.5	19.2	17.0	2.9	29.7	105.0	32.0	57.2	56.3	26.1	61.6	64.1	27.9	37.1	31.5	35.0	6.2	148.2	25.8	51.8	93.9	75.4	2.1	31.2	32.3	37.2	40.2	50.1	5.2	87.4	181.3	37.3	25.0	35.1	17.7	32.4	33.5	99.0	66.1	32.0	6.0	61.7	67.1	27.3	40.7	7.9	42.0	22.4	56.9	2.8	38.7	41.8	41.2	4.0	5.8	92.2	47.6	37.2	55.1	75.6	69.8	86.1	27.8	21.3	46.0	29.8	52.2	9.2	45.5	74.7	119.2	139.3	27.2	39.9	55.8	43.5
PPA1	"IOPPP, PP, PP1, Ppase, SID6-8061"	ENSG00000180817	"Inorganic pyrophosphatase 1"	Q15181	10	70202835-70233911	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Muller glia cells: 1239.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA019878, HPA020096"	Supported		Supported	Vesicles		NA	NA		1000000	"Cluster 28: Myeloid DCs - Unknown function"	"Cluster 77: Retina - Visual perception"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 5: Muller glia cells - Visual perception"	Vesicles		"HPA019878: AB_1855601, HPA020096: AB_1855600"	"unprognostic (1.50e-1)"	"unprognostic (2.85e-1)"	"unprognostic (4.71e-2)"	"unprognostic (2.85e-1)"	"unprognostic (1.42e-1)"	"unprognostic (4.47e-2)"	"unprognostic (2.86e-2)"	"unprognostic (9.43e-2)"	"unprognostic (3.34e-1)"	"unprognostic (1.62e-1)"	"unprognostic (2.13e-2)"	"unprognostic (3.60e-2)"	"unprognostic (1.82e-3)"	"unprognostic (5.36e-2)"	"unprognostic (2.37e-1)"	"unprognostic (3.53e-2)"	"unprognostic (2.74e-1)"	176.7	198.5	124.3	116.0	138.8	85.0	186.7	166.7	163.0	96.5	123.0	137.3	99.4	85.8	166.7	157.7	110.2	90.3	100.1	125.8	148.5	123.2	150.2	129.0	132.6	153.1	142.3	56.5	188.5	68.5	92.1	103.7	165.4	68.7	152.5	332.0	116.1	78.7	133.0	85.9	125.1	96.8	159.3	64.2	97.5	73.5	141.6	103.5	126.3	137.3	137.3	167.1	140.0	167.0	446.9	181.2	158.8	471.2	421.6	368.8	148.2	163.5	305.3	250.1	261.8	556.7	230.6	641.0	144.5	164.0	162.8	351.2	470.7	318.4	253.8	599.1	443.5	176.1	169.1	321.7	265.8	439.0	106.9	244.2	372.9	201.3	530.7	273.8	307.9	319.2	416.9	336.4	239.4	262.3	426.5	408.7	165.9	614.2	494.8	256.9	181.7	378.2	527.0	276.3	474.4	159.6	179.3	694.5	148.0	110.8	174.3	194.2	141.0	69.0	262.2	229.4	315.2	110.1	259.2	469.8	106.7	605.2	62.0	0.4	68.8	1.7	48.9	55.2	131.1	83.6	112.3	85.6	190.0	59.4	122.7	106.8	4.1	65.8	63.1	44.4	120.4	105.3	124.3	138.8	166.7	163.0	125.8	148.5	153.1	142.3	165.4	159.3	141.6	167.0	207.0	224.4	165.9	17.0	122.7	267.9	366.2	427.3	158.2	184.9	347.8	363.7	93.3	218.8	275.7	108.5	173.0	313.2	63.4	203.3	201.5	540.1	31.7	278.8	196.1	182.1	162.7	88.4	36.8	776.1	298.3	156.9	114.2	512.1	36.8	208.2	38.2	141.8	96.5	85.8	41.2	254.9	160.7	80.1	148.1	31.7	109.6	120.3	181.5	29.0	612.7	1239.0	65.9	21.6	98.4	532.9	213.5	117.4	161.2	512.4	444.5	551.2	92.1	278.4	65.7	97.2	136.8	173.7	170.7	245.8	257.1	245.7	120.9	203.0	347.6	613.9
PPA2	FLJ20459	ENSG00000138777	"Inorganic pyrophosphatase 2"	Q9H2U2	4	105369077-105474067	"Cancer-related genes, Disease related genes, Enzymes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"		Hydrolase	"Cancer-related genes, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA030888, HPA031671, HPA031672"	Supported		Approved	Mitochondria		NA	NA		150000	"Cluster 44: Non-specific - Transcription"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 39: Non-specific - Basic cellular processes"	Mitochondria		"HPA030888: AB_2673646, HPA031671: AB_10603986, HPA031672: AB_2673988"	"prognostic unfavorable (2.98e-4)"	"unprognostic (5.64e-2)"	"prognostic favorable (6.60e-4)"	"unprognostic (9.26e-3)"	"unprognostic (2.93e-2)"	"unprognostic (5.10e-2)"	"unprognostic (1.15e-1)"	"unprognostic (2.44e-1)"	"unprognostic (1.50e-1)"	"unprognostic (1.20e-1)"	"unprognostic (7.05e-2)"	"unprognostic (9.54e-2)"	"prognostic favorable (1.27e-11)"	"unprognostic (3.69e-1)"	"unprognostic (1.94e-1)"	"unprognostic (2.00e-1)"	"unprognostic (1.10e-1)"	7.4	12.8	23.8	9.0	24.6	22.0	12.0	24.3	53.7	7.4	29.5	17.4	14.2	7.4	12.5	10.8	8.4	8.0	27.5	23.7	26.3	20.7	14.8	7.5	8.3	24.4	24.3	5.8	11.8	11.7	7.7	7.4	24.5	13.3	14.0	13.6	13.8	5.7	27.6	12.2	13.8	6.8	24.0	9.9	12.6	6.3	25.4	7.0	11.5	35.5	8.7	8.1	6.7	26.6	20.6	8.5	18.5	32.3	11.3	9.1	12.9	10.2	15.7	14.6	9.9	22.2	30.4	15.6	14.5	9.7	11.3	9.5	39.2	18.7	17.0	23.6	11.8	13.5	13.7	19.9	9.3	36.7	13.6	9.7	19.6	9.9	7.9	15.4	14.6	28.4	22.3	22.0	12.5	26.2	32.5	26.6	13.9	42.4	28.3	28.2	10.9	17.9	49.7	14.7	17.8	10.7	7.8	48.9	19.0	10.7	24.8	32.1	6.9	9.2	19.2	8.9	20.0	19.0	27.3	18.4	17.5	18.6	14.1	27.0	20.9	15.4	21.0	30.1	18.6	28.5	21.7	23.7	49.9	22.6	21.1	23.9	9.5	36.4	26.4	25.9	23.4	23.5	23.8	24.6	24.3	53.7	23.7	26.3	24.4	24.3	24.5	24.0	25.4	26.6	26.7	9.6	67.3	86.2	37.6	50.0	82.4	205.0	38.1	29.7	64.8	40.9	63.3	45.8	126.2	33.1	16.7	119.0	25.9	73.3	264.1	114.0	113.7	42.3	35.3	36.3	65.7	70.2	138.2	120.1	98.5	31.1	37.2	42.3	45.6	26.4	24.3	64.2	83.5	21.9	134.6	104.6	142.4	42.9	86.1	126.4	27.7	47.1	76.5	74.9	50.5	39.2	30.9	169.9	145.7	65.0	90.4	32.4	41.9	68.1	112.2	285.4	90.7	22.6	39.5	46.3	43.6	50.8	10.8	59.1	57.7	84.7	34.3	72.1	138.0	94.6
PPEF1	"PPEF, PPP7CA"	ENSG00000086717	"Protein phosphatase with EF-hand domain 1"	O14829	X	18675909-18827921	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"		"Hydrolase, Protein phosphatase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	4	"brain: 5.8;testis: 14.6"	"Group enriched"	"Detected in some"	9	"Early spermatids: 64.0;Late spermatids: 139.0"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A549: 1.1;HeLa: 1.5"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA034577			Uncertain	"Plasma membrane,Cytokinetic bridge"		Yes	NA				"Cluster 78: Testis - Spermatogenesis"	"Cluster 20: HeLa - Mitochondria"	"Cluster 31: Spermatids - Spermatogenesis"	"Plasma membrane"	"Cytokinetic bridge"	"HPA034577: AB_10602817"	"unprognostic (4.13e-2)"	"unprognostic (1.30e-1)"	"unprognostic (9.06e-2)"	"unprognostic (9.85e-2)"	"unprognostic (3.84e-2)"	"unprognostic (5.00e-2)"	"unprognostic (2.38e-1)"	"unprognostic (3.43e-2)"	"unprognostic (4.96e-3)"	"unprognostic (9.29e-2)"	"unprognostic (1.70e-1)"	"unprognostic (2.89e-1)"	"unprognostic (1.10e-11)"	"unprognostic (5.41e-3)"	"unprognostic (2.75e-1)"	"unprognostic (2.97e-2)"	"unprognostic (1.19e-2)"	0.1	0.2	1.3	0.0	2.0	1.0	2.3	1.8	2.6	0.1	0.8	0.1	0.0	0.1	0.5	0.0	0.1	0.1	0.3	1.6	1.4	0.2	0.1	0.3	0.1	3.5	2.1	0.2	0.1	0.0	0.5	0.6	2.4	0.4	0.0	1.4	0.1	0.3	0.1	0.4	0.1	0.0	1.8	0.2	0.1	14.6	1.5	0.1	0.2	0.0	0.1	0.2	0.1	5.8	0.0	1.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.1	0.4	0.0	1.5	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.9	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	2.0	1.8	2.6	1.6	1.4	3.5	2.1	2.4	1.8	1.5	5.8	0.0	0.0	0.0	1.3	0.0	0.1	0.0	0.0	0.0	0.4	0.1	0.0	0.6	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	64.0	0.0	0.0	0.1	0.0	0.0	11.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	6.7	4.7	0.0	0.0	0.0	0.3	139.0	0.6	0.0	3.6	1.0	0.1	0.6	0.0	0.5	2.2	0.0	0.0	0.7	0.0	0.1	0.0	0.2	0.0	0.6	0.0	0.0	1.2	1.2	1.0	0.0	0.1	0.0	0.0	0.1	0.0	0.1
PPEF2	PPP7CB	ENSG00000156194	"Protein phosphatase with EF-hand domain 2"	O14830	4	75859864-75902571	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Sensory transduction, Vision"	"Hydrolase, Protein phosphatase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	462	"retina: 238.7"	"Group enriched"	"Detected in some"	25	"Cone photoreceptor cells: 166.8;Rod photoreceptor cells: 576.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"									NA	NA				"Cluster 79: Retina - Phototransduction"		"Cluster 46: Photoreceptor cells - Phototransduction"				"unprognostic (3.19e-2)"	"unprognostic (2.92e-1)"		"unprognostic (2.50e-1)"	"unprognostic (4.73e-2)"			"unprognostic (1.53e-1)"		"unprognostic (9.02e-2)"	"unprognostic (3.32e-4)"	"unprognostic (2.74e-2)"	"unprognostic (4.54e-8)"	"unprognostic (2.89e-1)"	"unprognostic (5.98e-2)"	"unprognostic (5.16e-1)"	"unprognostic (3.66e-3)"	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.1	0.2	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	238.7	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.1	0.1	0.1	0.2	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	11.4	0.1	0.1	0.4	0.0	0.0	0.0	166.8	0.0	0.1	0.1	0.0	0.0	6.3	0.0	0.1	1.5	0.0	0.0	1.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	5.3	0.0	0.1	0.0	1.9	0.1	14.7	0.0	0.5	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	576.7	0.0	0.4	0.1	0.6	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0
PPM1A	"MGC9201, PP2CA, PP2Calpha"	ENSG00000100614	"Protein phosphatase, Mg2+/Mn2+ dependent 1A"	P35813	14	60245752-60299087	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Hydrolase, Protein phosphatase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 142.9"	"Cell type enhanced"	"Detected in all"		"Early spermatids: 446.2;Late spermatids: 565.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA029209	Approved		Supported	"Plasma membrane,Cytosol"		NA	NA		380000	"Cluster 34: Basophils - Unknown function"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 51: Myeloid cells - Hemostasis"	Cytosol	"Plasma membrane"	"HPA029209: AB_2672951"	"unprognostic (3.14e-1)"	"unprognostic (2.14e-1)"	"unprognostic (5.64e-2)"	"unprognostic (1.85e-1)"	"unprognostic (4.00e-2)"	"unprognostic (2.30e-2)"	"unprognostic (4.50e-2)"	"unprognostic (1.11e-1)"	"unprognostic (3.43e-1)"	"unprognostic (2.89e-2)"	"unprognostic (7.96e-2)"	"unprognostic (1.29e-1)"	"prognostic favorable (1.57e-9)"	"unprognostic (1.58e-2)"	"unprognostic (1.12e-1)"	"unprognostic (1.57e-2)"	"unprognostic (1.37e-1)"	22.7	19.2	14.0	22.2	16.5	142.9	23.5	27.0	22.4	22.4	3.3	36.6	36.8	28.0	19.3	25.7	17.3	20.1	36.8	16.7	24.4	42.5	51.2	20.3	24.4	18.2	16.3	16.2	25.5	36.8	14.3	22.1	20.0	29.9	36.0	51.0	31.5	23.0	78.9	21.9	37.3	26.5	15.3	20.4	23.2	54.5	16.4	31.1	24.3	76.6	26.2	21.4	17.8	23.1	129.7	28.6	24.4	20.9	36.5	33.6	31.1	34.8	40.7	25.3	23.8	16.3	37.2	77.1	32.4	39.6	18.7	28.1	25.5	35.9	44.0	70.1	14.4	47.6	19.5	25.7	30.6	54.7	32.6	28.6	42.1	29.7	40.4	29.5	25.1	38.7	26.9	59.6	31.3	56.5	71.5	12.8	23.0	25.8	23.9	25.3	56.5	25.0	30.4	61.2	41.2	31.0	36.1	41.7	30.1	22.2	42.0	23.5	35.1	52.4	52.0	23.3	25.0	46.1	28.1	89.9	24.0	21.2	27.1	5.4	1.0	3.0	1.8	1.0	1.9	0.9	1.4	1.6	1.5	3.0	1.1	1.0	4.4	2.9	1.2	0.9	2.6	0.9	14.0	16.5	27.0	22.4	16.7	24.4	18.2	16.3	20.0	15.3	16.4	23.1	25.9	16.0	22.6	43.8	34.2	77.4	41.3	17.6	34.7	42.2	41.6	22.7	95.0	44.3	20.0	38.6	64.6	31.9	49.1	111.2	33.2	24.6	446.2	31.3	34.6	31.5	60.9	93.5	77.8	24.4	24.0	36.6	25.5	38.8	26.6	20.7	22.9	73.3	28.2	58.9	71.6	60.2	22.4	33.5	51.0	565.6	42.3	58.6	60.5	25.3	26.8	40.1	45.3	66.4	53.4	34.6	87.8	52.3	45.4	86.5	128.5	90.0	17.8	66.8	39.5	36.2	35.9	69.8	25.3	32.9	82.3	73.5	40.8	19.4	42.1	69.6
PPM1B	"PP2CB, PP2CBETA, PPC2BETAX"	ENSG00000138032	"Protein phosphatase, Mg2+/Mn2+ dependent 1B"	O75688	2	44167969-44244384	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Hydrolase, Protein phosphatase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Oligodendrocytes: 218.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											HPA016745	Approved		Approved	Nucleoli,Cytosol		NA	NA		75000	"Cluster 52: Eosinophils - Transcription"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 46: Photoreceptor cells - Phototransduction"	"Nucleoli, Cytosol"		"HPA016745: AB_1855622"	"unprognostic (5.49e-2)"	"unprognostic (2.67e-2)"	"unprognostic (1.11e-2)"	"unprognostic (2.96e-3)"	"unprognostic (1.92e-2)"	"unprognostic (1.48e-1)"	"unprognostic (1.04e-1)"	"unprognostic (1.50e-2)"	"unprognostic (1.58e-1)"	"unprognostic (1.94e-1)"	"unprognostic (2.25e-1)"	"unprognostic (6.71e-2)"	"unprognostic (1.70e-2)"	"unprognostic (3.81e-2)"	"unprognostic (1.06e-1)"	"unprognostic (1.34e-1)"	"unprognostic (1.75e-2)"	40.2	20.4	41.2	19.5	48.0	44.0	23.9	45.1	61.8	23.0	43.1	28.6	20.3	23.9	30.0	22.5	21.2	21.8	33.3	38.6	42.1	29.0	44.0	21.9	28.7	41.4	44.1	22.9	32.4	35.8	18.9	18.8	42.1	30.6	28.7	49.9	27.0	23.3	129.4	20.5	21.7	22.8	40.2	26.4	23.1	21.4	42.7	36.0	22.8	86.5	27.0	24.7	21.4	50.9	37.1	32.8	41.8	31.2	51.3	23.8	47.6	27.9	32.0	28.2	24.8	43.8	23.3	40.7	42.4	32.4	23.0	19.6	47.6	18.2	41.6	41.7	18.4	42.9	19.9	30.8	41.4	38.6	34.1	23.0	31.5	22.5	37.9	22.2	23.5	18.4	31.7	41.5	25.7	30.6	38.6	61.5	52.4	33.4	11.0	40.5	46.6	27.1	66.3	36.9	33.7	42.5	25.3	37.4	33.5	62.3	20.2	26.7	21.6	24.7	35.5	20.6	27.8	36.2	25.5	37.7	13.4	63.2	18.3	6.9	2.2	8.1	4.6	3.0	3.9	4.2	4.3	3.9	3.7	4.5	5.8	4.0	6.1	3.2	3.6	3.6	4.3	1.1	41.2	48.0	45.1	61.8	38.6	42.1	41.4	44.1	42.1	40.2	42.7	50.9	17.4	19.2	20.8	78.4	49.3	60.5	40.3	14.4	35.3	51.9	31.8	19.9	55.4	38.6	24.0	40.5	64.6	31.5	68.6	64.5	46.9	42.5	68.5	44.1	33.3	22.0	40.2	32.8	95.9	46.4	29.7	33.7	35.2	62.4	26.6	27.4	20.3	55.0	26.8	107.7	91.8	31.5	30.5	55.2	63.0	43.0	35.8	45.0	56.9	38.4	46.7	57.5	51.5	112.6	218.0	44.7	46.6	33.8	51.9	71.2	26.8	41.0	16.9	147.5	26.3	33.5	32.4	48.5	27.7	36.6	62.4	64.6	63.8	29.5	37.3	88.7
PPM1D	"PP2C-DELTA, Wip1"	ENSG00000170836	"Protein phosphatase, Mg2+/Mn2+ dependent 1D"	O15297	17	60600183-60666280	"Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Cell cycle"	"Hydrolase, Protein phosphatase"	"Autism spectrum disorder, Cancer-related genes, Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 68.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"MCF7: 34.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA022277, HPA061848"	Approved		Supported	Nucleoplasm,Nucleoli		NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 69: Cerebellum - Gene expression regulation"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 59: Non-specific - Transcription"	Nucleoplasm	Nucleoli	"HPA022277: AB_1858839, HPA061848: "	"unprognostic (1.48e-1)"	"unprognostic (1.36e-2)"	"prognostic favorable (3.52e-4)"	"unprognostic (1.76e-1)"	"unprognostic (1.02e-1)"	"unprognostic (5.12e-2)"	"prognostic unfavorable (4.27e-4)"	"unprognostic (5.50e-2)"	"unprognostic (1.70e-2)"	"unprognostic (6.07e-2)"	"unprognostic (2.52e-3)"	"unprognostic (3.46e-2)"	"unprognostic (1.95e-3)"	"unprognostic (7.33e-2)"	"unprognostic (1.58e-1)"	"unprognostic (1.71e-2)"	"unprognostic (1.98e-1)"	4.4	2.4	2.7	2.2	5.2	5.9	3.9	14.8	4.6	4.5	5.0	3.1	2.9	4.3	2.9	3.5	3.7	3.1	2.9	3.3	3.4	2.8	2.8	3.6	2.7	4.0	3.5	6.3	3.3	2.3	2.4	5.9	4.7	3.1	3.5	6.4	3.1	2.2	4.0	2.9	2.7	3.0	3.4	3.8	2.7	5.5	3.7	4.4	2.9	3.1	2.3	2.8	4.0	9.1	3.8	6.9	7.5	6.4	5.0	3.1	10.7	5.8	3.6	3.4	4.9	7.1	2.0	9.9	4.5	3.7	1.3	3.4	4.9	2.2	4.6	1.9	11.1	7.4	6.7	8.1	4.2	2.9	5.3	2.7	3.6	5.1	3.0	2.8	7.9	4.1	5.4	4.0	3.7	34.4	8.1	4.4	3.5	3.4	5.2	9.5	9.6	6.6	3.1	4.2	10.5	7.4	7.1	2.4	1.6	8.0	2.8	3.9	5.7	4.7	12.5	3.5	3.3	6.7	7.7	7.3	1.7	2.9	3.8	9.9	16.1	18.0	7.6	12.5	6.8	8.9	6.3	7.0	16.0	6.2	6.8	7.0	24.7	8.6	8.1	7.0	10.6	9.8	2.7	5.2	14.8	4.6	3.3	3.4	4.0	3.5	4.7	3.4	3.7	9.1	40.9	32.1	7.7	15.0	23.1	21.0	6.2	3.3	52.3	13.1	14.2	9.8	6.3	8.6	4.6	5.5	4.2	17.6	19.4	15.0	3.9	6.6	68.9	14.0	15.5	25.2	14.4	14.1	19.6	6.6	6.4	14.7	10.2	15.6	1.3	7.2	23.6	4.2	8.8	3.3	20.8	11.4	6.1	21.4	19.2	12.8	13.7	16.1	3.6	28.1	12.3	7.0	6.2	20.6	38.6	5.4	10.2	7.5	24.5	7.8	8.7	5.1	3.6	10.4	0.0	12.1	14.0	43.8	15.0	34.4	18.0	38.6	18.1	6.0	11.5	7.7
PPM1E	"CaMKP-N, KIAA1072, POPX1, PP2CH"	ENSG00000175175	"Protein phosphatase, Mg2+/Mn2+ dependent 1E"	Q8WY54	17	58755854-58985179	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Hydrolase, Protein phosphatase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"brain: 39.2;retina: 22.3"	"Group enriched"	"Detected in some"	4	"Excitatory neurons: 220.9;Horizontal cells: 77.4;Inhibitory neurons: 288.4;Oligodendrocyte precursor cells: 109.1"	"Cancer enhanced"	"Detected in some"		"glioma: 2.7;prostate cancer: 3.0"	"Group enriched"	"Detected in many"	4	"cerebral cortex: 31.6;hippocampal formation: 39.2"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"AF22: 12.2;HAP1: 19.9;MOLT-4: 9.9;SCLC-21H: 9.1;SH-SY5Y: 18.7;THP-1: 8.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA018462, HPA019263"	Approved		Approved	Nucleoplasm,Nucleoli		Yes	No			"Cluster 46: Basophils - DNA binding"	"Cluster 58: Brain - Synaptic function"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Nucleoli	Nucleoplasm	"HPA018462: AB_1855623, HPA019263: AB_1855624"	"unprognostic (2.50e-2)"	"unprognostic (5.75e-2)"	"unprognostic (8.12e-2)"	"unprognostic (2.99e-2)"	"unprognostic (5.30e-1)"	"unprognostic (8.19e-2)"	"unprognostic (3.96e-1)"	"unprognostic (1.52e-1)"	"unprognostic (3.22e-2)"	"unprognostic (5.24e-2)"	"unprognostic (8.80e-5)"	"unprognostic (4.97e-2)"	"unprognostic (1.23e-7)"	"unprognostic (1.05e-4)"	"unprognostic (1.64e-2)"	"unprognostic (1.27e-1)"	"unprognostic (9.12e-2)"	0.1	5.5	5.3	0.1	4.8	0.0	0.1	1.0	31.6	0.2	0.0	0.1	0.1	0.3	0.9	0.0	1.5	0.1	1.0	39.2	7.3	0.7	1.0	0.2	0.2	1.9	4.2	0.2	0.6	0.3	1.3	0.0	3.2	1.4	0.0	22.3	0.2	0.0	0.0	0.0	0.2	0.3	0.3	0.2	0.5	6.7	8.0	0.2	0.1	0.1	0.2	0.1	0.1	2.3	0.0	0.1	12.2	0.6	0.0	0.0	0.9	0.0	0.0	0.9	1.4	0.0	0.0	8.0	0.1	0.1	2.7	0.0	19.9	0.0	0.5	0.2	5.9	0.0	0.2	0.0	1.3	0.6	2.6	0.3	1.6	0.1	0.0	0.6	0.0	4.9	2.1	0.0	0.0	3.6	9.9	0.0	3.5	0.0	1.0	0.0	1.5	0.0	0.0	0.0	9.1	18.7	0.3	0.0	1.3	0.1	0.0	8.7	0.0	0.0	2.2	0.0	2.9	0.1	0.1	5.4	0.3	0.0	2.9	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.3	4.8	1.0	31.6	39.2	7.3	1.9	4.2	3.2	0.3	8.0	2.3	0.1	0.0	0.0	32.7	0.0	0.0	0.0	0.0	0.0	22.0	0.1	0.4	3.3	0.0	1.8	0.0	31.3	0.0	0.0	0.1	0.0	0.0	30.8	3.9	0.1	0.3	3.0	0.0	220.9	0.0	0.0	0.4	0.0	0.1	0.0	0.1	0.0	1.4	0.1	77.4	288.4	0.0	0.0	0.3	0.0	17.6	0.0	0.1	0.0	5.6	0.0	4.2	0.0	109.1	38.4	0.0	0.2	0.4	0.0	1.3	0.0	0.1	0.0	13.8	0.0	0.0	0.5	12.1	2.8	0.0	0.0	0.0	0.0	0.8	0.0	0.0
PPM1F	"CAMKP, CaMKPase, FEM-2, KIAA0015, POPX2"	ENSG00000100034	"Protein phosphatase, Mg2+/Mn2+ dependent 1F"	P49593	22	21919425-21952848	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	Apoptosis	"Hydrolase, Protein phosphatase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Endothelial cells: 42.2;Hepatic stellate cells: 56.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"neutrophil: 28.6"	"Group enriched"	"Detected in all"	7	"dendritic cells: 8.9;granulocytes: 28.6;monocytes: 24.4"	"Cell line enhanced"	"Detected in all"		"HUVEC TERT2: 109.1;K-562: 173.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA030989, HPA030990"	Approved		Approved	"Nucleoplasm,Plasma membrane"		NA	NA		510000	"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	Nucleoplasm	"Plasma membrane"	"HPA030989: AB_10669549, HPA030990: AB_10601249"	"unprognostic (6.26e-2)"	"unprognostic (2.50e-1)"	"unprognostic (1.82e-1)"	"unprognostic (2.11e-1)"	"unprognostic (2.51e-1)"	"unprognostic (4.77e-3)"	"unprognostic (4.88e-3)"	"unprognostic (1.94e-1)"	"unprognostic (1.70e-1)"	"unprognostic (1.65e-2)"	"unprognostic (1.45e-2)"	"unprognostic (4.81e-2)"	"prognostic unfavorable (6.03e-5)"	"unprognostic (6.44e-2)"	"unprognostic (3.02e-2)"	"unprognostic (3.30e-1)"	"unprognostic (4.11e-2)"	24.1	18.1	14.9	21.6	13.9	26.8	17.6	11.6	15.7	18.5	11.8	17.1	8.9	19.9	3.8	22.1	15.0	12.2	16.8	14.5	19.4	18.4	8.0	26.1	15.2	16.8	16.4	12.5	12.3	6.4	8.5	26.6	17.3	15.8	4.2	3.7	10.9	14.3	17.0	14.8	13.8	12.1	15.3	35.8	12.0	6.3	17.1	7.8	12.4	10.5	7.8	22.0	15.9	15.4	28.9	30.1	19.0	18.6	10.4	18.1	23.9	32.1	18.9	27.7	19.0	13.8	11.3	17.3	39.0	22.7	11.8	33.9	8.3	19.9	9.8	24.7	27.1	66.8	14.5	13.2	17.1	25.0	17.4	17.1	5.9	27.1	12.6	19.6	109.1	16.9	173.4	7.2	35.9	26.2	15.0	19.3	8.0	9.2	32.7	21.9	49.0	5.2	9.4	12.1	7.7	29.6	30.4	10.0	25.7	7.4	12.5	17.2	93.1	33.1	33.4	30.5	31.1	14.1	12.2	19.6	33.5	46.7	64.7	0.0	12.8	5.9	1.7	21.0	1.0	1.1	1.1	0.9	8.9	0.9	1.0	1.3	28.6	3.1	24.4	2.2	2.4	5.4	14.9	13.9	11.6	15.7	14.5	19.4	16.8	16.4	17.3	15.3	17.1	15.4	32.1	6.4	6.0	11.8	5.5	8.2	5.2	4.9	8.6	8.3	7.4	9.9	11.9	8.6	4.1	1.8	2.1	16.6	5.1	1.4	3.9	5.2	2.0	3.0	9.4	42.2	6.0	5.5	11.6	5.1	10.0	8.4	3.1	3.8	3.8	10.4	56.4	6.5	20.6	8.4	12.7	4.2	6.1	37.0	22.0	1.5	7.2	23.4	7.2	18.7	30.9	4.1	6.2	12.5	6.8	7.4	1.1	6.8	5.0	7.4	2.6	4.4	4.0	6.5	6.6	17.2	8.2	14.2	13.1	8.5	5.7	3.0	6.4	7.1	4.5	6.6
PPM1G	"PP2CG, PP2Cgamma"	ENSG00000115241	"Protein phosphatase, Mg2+/Mn2+ dependent 1G"	O15355	2	27381195-27409591	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Hydrolase, Protein phosphatase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 233.9"	"Cell type enhanced"	"Detected in all"		"Early spermatids: 1540.4;Late spermatids: 3492.8;Spermatocytes: 793.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035530, HPA035531"	Enhanced		Enhanced	Nucleoplasm		NA	NA		19000	"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 31: Spermatids - Spermatogenesis"	Nucleoplasm		"HPA035530: AB_10670021, HPA035531: AB_10610283"	"unprognostic (7.50e-2)"	"unprognostic (8.89e-2)"	"unprognostic (1.53e-1)"	"unprognostic (1.02e-1)"	"unprognostic (2.27e-1)"	"unprognostic (4.15e-2)"	"prognostic unfavorable (3.14e-7)"	"unprognostic (9.36e-3)"	"unprognostic (7.73e-2)"	"prognostic favorable (6.08e-5)"	"unprognostic (3.74e-2)"	"unprognostic (1.23e-1)"	"unprognostic (7.46e-3)"	"unprognostic (1.06e-2)"	"unprognostic (5.33e-2)"	"unprognostic (1.78e-1)"	"unprognostic (7.83e-2)"	46.0	49.6	34.7	45.1	35.1	73.5	43.6	35.4	37.8	38.4	36.9	48.3	39.9	45.6	26.1	62.6	39.0	28.0	44.9	35.0	37.0	40.7	45.3	40.6	59.6	35.4	36.0	34.9	53.0	41.4	43.4	37.6	35.3	36.0	51.3	20.0	45.1	38.8	95.7	41.2	43.0	44.9	35.1	47.1	47.8	233.9	36.0	64.9	36.8	53.0	75.3	47.0	39.6	35.3	302.0	243.1	174.0	134.8	108.7	88.0	160.6	182.8	119.8	214.8	170.9	377.7	154.4	352.7	130.9	130.9	181.8	160.3	296.4	205.6	191.4	148.4	241.1	343.6	172.9	404.0	97.9	343.5	139.2	95.7	116.9	219.2	175.1	101.7	209.1	171.1	293.3	106.0	165.5	269.4	256.7	370.5	254.1	207.1	173.1	261.1	365.0	185.3	145.9	206.4	233.2	264.0	164.4	178.9	135.9	137.4	99.4	111.3	169.5	159.3	192.6	141.6	281.8	229.0	277.0	545.5	124.8	275.6	122.5	67.3	41.5	59.0	57.5	52.3	56.8	44.7	61.1	60.3	65.4	37.9	45.1	47.4	20.9	55.0	71.4	91.9	88.9	48.0	34.7	35.1	35.4	37.8	35.0	37.0	35.4	36.0	35.3	35.1	36.0	35.3	72.9	64.1	51.3	9.8	76.7	81.1	88.7	71.9	83.6	40.8	63.1	59.3	37.9	52.9	63.7	69.9	29.2	93.9	114.2	81.0	33.2	135.7	1540.4	102.7	75.8	80.8	80.7	119.6	19.5	139.3	163.8	56.6	69.3	89.8	59.1	76.1	40.4	44.7	85.4	48.8	21.1	78.9	54.9	59.7	75.7	3492.8	70.2	68.2	24.9	17.8	127.3	69.7	112.3	17.1	15.9	156.7	52.7	71.1	137.8	152.1	52.6	61.4	61.8	41.7	46.0	54.9	80.5	793.3	298.9	108.7	80.6	53.1	89.7	123.7	106.4	122.6
PPM1H	"ARHCL1, FLJ13253, KIAA1157, NERPP-2C"	ENSG00000111110	"Protein phosphatase, Mg2+/Mn2+ dependent 1H"	Q9ULR3	12	62643994-62935150	"Enzymes, Predicted intracellular proteins"		"Hydrolase, Protein phosphatase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 30.0;parathyroid gland: 42.4"	"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 123.5;Glandular and luminal cells: 81.6;Inhibitory neurons: 162.1;Microglial cells: 89.9;Oligodendrocytes: 341.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"basophil: 2.9"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"CACO-2: 80.6;HMC-1: 62.7;SK-BR-3: 35.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB020694, HPA044244, HPA058777"	Approved		Supported	Nucleoplasm		NA	NA			"Cluster 2: Granulocytes - Unknown function"	"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	Nucleoplasm		"CAB020694: , HPA044244: AB_2678871, HPA058777: AB_2683816"	"unprognostic (3.41e-2)"	"unprognostic (1.94e-1)"	"unprognostic (9.51e-2)"	"unprognostic (8.61e-3)"	"unprognostic (1.44e-1)"	"unprognostic (1.23e-1)"	"unprognostic (1.86e-2)"	"unprognostic (5.85e-2)"	"unprognostic (3.17e-1)"	"unprognostic (1.78e-2)"	"unprognostic (5.53e-3)"	"unprognostic (2.19e-1)"	"prognostic favorable (2.72e-5)"	"unprognostic (3.90e-2)"	"unprognostic (1.73e-1)"	"unprognostic (8.04e-3)"	"unprognostic (1.14e-1)"	2.2	1.5	12.0	1.2	12.7	3.1	4.9	30.0	16.0	7.5	5.7	2.4	3.1	6.2	6.7	0.6	6.5	6.7	2.4	13.3	15.7	10.6	3.4	2.7	1.2	11.1	11.3	9.6	3.9	42.4	8.2	6.5	14.9	13.4	3.0	26.7	11.4	6.0	1.1	0.8	1.7	1.5	7.8	0.9	5.7	0.9	16.5	4.3	3.2	1.3	1.7	2.1	0.3	16.2	1.2	12.4	2.2	0.2	0.5	0.0	26.5	2.9	2.9	1.8	0.6	80.6	5.7	0.0	2.7	1.4	1.8	1.6	8.7	0.2	1.1	0.2	4.3	15.2	2.4	18.4	0.1	4.6	62.7	0.1	0.3	0.0	0.7	1.9	0.3	2.7	4.0	0.0	1.3	9.5	1.5	2.2	15.9	4.1	5.9	2.1	5.6	23.0	18.1	28.3	6.9	0.0	5.0	35.6	12.1	8.5	19.6	2.7	0.2	0.5	1.5	0.2	0.9	3.3	21.4	4.1	0.2	0.1	1.2	2.9	0.7	1.4	0.0	0.6	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.5	0.1	0.6	0.0	0.0	0.1	12.0	12.7	30.0	16.0	13.3	15.7	11.1	11.3	14.9	7.8	16.5	16.2	4.6	6.4	4.7	25.5	1.0	0.1	0.3	3.0	0.0	9.4	9.5	3.4	2.4	12.8	5.9	16.5	27.1	22.2	0.0	0.7	3.9	4.2	8.5	27.6	25.3	6.5	9.0	3.8	123.5	6.3	2.1	1.3	7.7	81.6	14.5	0.3	9.7	6.1	6.1	11.8	162.1	2.0	6.1	1.6	2.1	10.1	0.9	2.1	3.6	89.9	2.1	6.4	0.0	41.7	341.4	4.5	2.1	1.5	0.5	4.3	0.1	8.5	14.0	10.9	0.0	0.6	1.7	0.0	0.5	0.5	0.1	6.8	1.3	2.8	2.4	0.5
PPM1J	"DKFZp434P1514, FLJ35951, MGC19531, PP2Czeta, PPP2CZ"	ENSG00000155367	"Protein phosphatase, Mg2+/Mn2+ dependent 1J"	Q5JR12	1	112709994-112715477	"Enzymes, Predicted intracellular proteins"		"Hydrolase, Protein phosphatase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"epididymis: 18.8;skeletal muscle: 68.4;skin 1: 18.1;testis: 63.8;tongue: 25.6"	"Group enriched"	"Detected in many"	4	"Early spermatids: 123.6;Late spermatids: 281.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in some"	10	"plasmacytoid DC: 67.9"	"Lineage enriched"	"Detected in many"	15	"dendritic cells: 67.9"	"Cell line enhanced"	"Detected in many"		"T-47d: 19.5"	"Region enriched"	"Detected in many"	7	"olfactory bulb: 27.3"	"Low region specificity"	"Detected in all"			HPA046045	Uncertain		Approved	Vesicles		NA	NA			"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 6: T47d - Mammary gland"	"Cluster 34: Spermatids - Unknown function"	Vesicles		"HPA046045: AB_2679516"	"unprognostic (8.68e-2)"	"unprognostic (5.65e-2)"	"unprognostic (3.29e-2)"	"unprognostic (2.59e-1)"	"unprognostic (2.93e-3)"	"unprognostic (2.34e-2)"	"unprognostic (3.55e-2)"	"unprognostic (3.74e-2)"	"unprognostic (2.55e-1)"	"unprognostic (9.30e-3)"	"unprognostic (3.36e-2)"	"unprognostic (7.22e-2)"	"unprognostic (1.80e-2)"	"unprognostic (1.27e-2)"	"unprognostic (1.46e-1)"	"unprognostic (2.28e-2)"	"unprognostic (9.96e-4)"	1.1	2.6	6.3	1.0	6.6	0.7	2.2	5.9	6.5	2.3	3.8	1.2	0.6	1.9	18.8	4.6	2.8	1.0	8.7	5.8	5.7	7.8	0.7	1.6	3.3	5.2	7.8	2.3	1.7	5.5	2.6	0.5	4.6	3.3	0.6	6.9	2.8	2.1	68.4	18.1	1.4	1.3	4.5	1.4	1.2	63.8	9.1	2.3	3.1	25.6	2.2	1.1	4.0	3.9	2.7	0.1	1.5	1.7	0.8	1.5	1.1	0.3	0.7	0.3	1.0	1.2	0.8	0.4	0.4	0.8	0.8	4.9	1.1	4.6	0.4	0.0	2.6	0.8	0.2	0.2	0.9	0.0	0.2	1.7	3.0	0.9	4.6	1.0	2.1	0.2	1.0	0.0	1.2	2.9	0.0	0.0	1.6	1.4	2.3	0.1	0.1	0.0	2.7	0.1	0.8	0.2	0.6	4.3	1.3	2.2	19.5	0.0	1.1	0.3	2.8	0.0	0.2	0.1	0.0	0.0	2.3	0.6	2.6	0.0	0.3	0.0	0.0	1.5	0.1	0.7	0.0	0.1	7.1	0.7	0.0	0.0	0.0	0.0	4.3	67.9	0.0	0.8	6.3	6.6	5.9	6.5	5.8	5.7	5.2	7.8	4.6	4.5	9.1	3.9	1.2	0.0	0.5	0.3	2.0	2.2	4.7	8.7	10.2	5.7	4.2	4.6	5.8	0.0	2.7	1.8	10.4	1.0	41.3	0.7	9.8	3.2	123.6	3.2	0.3	1.5	0.0	0.0	1.8	4.3	1.4	1.1	1.1	0.6	0.0	5.6	0.7	0.1	0.7	0.0	1.5	0.9	2.0	1.3	11.5	281.6	3.1	2.0	0.0	0.0	1.6	25.4	0.0	0.0	0.2	2.1	2.4	2.6	0.0	6.7	0.3	0.6	1.8	9.1	6.6	1.1	2.8	2.8	16.9	3.5	2.8	0.5	0.9	3.2	0.8	2.9
PPM1K	"BDP, DKFZp761G058, hPTMP, PP2Ckappa, PP2Cm"	ENSG00000163644	"Protein phosphatase, Mg2+/Mn2+ dependent 1K"	Q8N3J5	4	88257620-88284769	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"		"Hydrolase, Protein phosphatase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"heart muscle: 92.5"	"Cell type enhanced"	"Detected in many"		"Cardiomyocytes: 512.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"Daudi: 58.0;Karpas-707: 48.6;U-698: 48.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA020066, HPA020862, HPA023891"	Approved		Supported	Mitochondria		No	No			"Cluster 24: B-cells - Unknown function"	"Cluster 44: Heart - Cardiac muscle contraction"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 54: Cardiomyocytes - Muscle contraction"	Mitochondria		"HPA020066: AB_1855628, HPA020862: AB_1855629, HPA023891: AB_1855630"	"unprognostic (2.38e-2)"	"unprognostic (5.86e-2)"	"unprognostic (7.42e-3)"	"unprognostic (6.70e-3)"	"unprognostic (1.18e-1)"	"unprognostic (1.17e-3)"	"unprognostic (1.87e-1)"	"unprognostic (5.88e-2)"	"unprognostic (5.50e-2)"	"unprognostic (1.41e-2)"	"unprognostic (9.25e-3)"	"unprognostic (6.56e-2)"	"unprognostic (9.82e-2)"	"unprognostic (5.57e-2)"	"unprognostic (1.34e-1)"	"unprognostic (2.11e-1)"	"unprognostic (2.28e-1)"	5.3	8.5	23.3	14.9	26.3	9.9	14.5	22.5	31.2	19.4	22.0	5.9	4.4	32.7	7.6	11.2	21.5	8.9	92.5	26.5	23.9	17.8	7.6	9.7	25.6	19.9	22.3	32.5	11.1	12.5	9.9	9.7	22.9	16.2	6.0	14.2	11.8	7.1	14.2	2.6	10.4	26.6	22.1	18.9	8.0	19.9	27.7	15.2	7.9	11.5	25.8	8.9	11.7	33.2	4.6	1.5	5.7	10.1	8.3	10.9	2.3	7.2	13.0	23.3	27.4	11.6	1.1	58.0	7.7	4.6	11.5	0.5	17.0	5.4	9.1	44.9	7.1	10.8	5.0	10.8	6.6	14.6	5.3	7.2	2.7	14.5	12.5	4.9	4.2	25.4	15.5	48.6	7.0	6.5	20.3	7.9	3.4	3.5	2.3	10.8	9.3	21.9	8.1	2.0	4.4	3.9	4.6	0.5	5.4	9.6	23.2	3.9	0.8	8.3	4.2	2.8	4.1	15.6	15.0	48.3	9.1	11.7	14.0	24.7	9.9	8.1	39.4	12.0	51.4	102.9	37.1	39.9	18.6	113.5	36.3	44.2	3.2	27.6	3.6	131.3	46.9	24.5	23.3	26.3	22.5	31.2	26.5	23.9	19.9	22.3	22.9	22.1	27.7	33.2	20.7	48.1	12.4	105.4	124.8	9.8	15.8	5.7	29.6	109.5	42.8	25.7	512.1	8.6	13.7	49.7	18.8	11.5	153.0	0.8	156.5	7.0	7.9	9.7	37.2	27.2	9.6	34.3	89.5	6.2	3.2	42.9	8.2	20.0	19.0	32.2	24.7	30.2	28.9	85.8	145.6	16.5	4.1	14.5	16.4	10.5	23.9	27.5	21.4	40.3	75.6	21.8	80.3	100.0	54.7	4.6	9.2	31.6	82.7	32.1	8.2	47.6	19.5	14.8	26.3	38.5	36.4	38.2	22.9	71.4	5.4	2.9	70.1	45.4	4.1	6.7
PPM1L	PP2CE	ENSG00000163590	"Protein phosphatase, Mg2+/Mn2+ dependent 1L"	Q5SGD2	3	160755602-161078902	"Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins"		"Hydrolase, Protein phosphatase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 126.7;Excitatory neurons: 344.6;Inhibitory neurons: 175.7;Oligodendrocyte precursor cells: 111.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in many"		"non-classical monocyte: 4.9"	"Low lineage specificity"	"Detected in many"			"Group enriched"	"Detected in many"	5	"HDLM-2: 79.8;U-266/70: 75.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA019891, HPA019953"	Approved		Approved	Nucleoplasm,Cytosol		NA	NA		26000	"Cluster 45: Eosinophils - Innate immune response"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	Cytosol	Nucleoplasm	"HPA019891: AB_1855631, HPA019953: AB_2170360"	"prognostic unfavorable (4.90e-4)"	"unprognostic (7.29e-3)"	"unprognostic (2.01e-1)"	"unprognostic (2.59e-2)"	"unprognostic (8.03e-2)"	"unprognostic (1.03e-1)"	"unprognostic (1.91e-1)"	"unprognostic (1.63e-2)"	"unprognostic (2.49e-2)"	"unprognostic (1.92e-1)"	"unprognostic (4.51e-2)"	"unprognostic (7.51e-2)"	"unprognostic (2.69e-3)"	"unprognostic (1.81e-1)"	"unprognostic (2.39e-1)"	"unprognostic (9.13e-3)"	"unprognostic (2.07e-1)"	6.0	5.9	7.6	2.2	8.5	2.4	3.2	11.0	13.4	7.3	0.0	5.9	1.9	4.2	1.9	6.2	4.1	5.9	6.6	9.2	5.6	5.8	3.2	3.0	1.0	11.3	7.6	2.2	3.7	15.5	10.1	8.6	13.1	4.0	3.9	11.3	15.2	2.2	21.8	6.0	2.5	4.1	0.0	2.2	6.1	1.7	12.7	3.5	10.7	17.8	2.2	10.8	4.0	0.8	2.6	1.7	8.7	4.6	5.1	0.1	5.4	0.3	0.2	0.9	0.3	0.5	0.6	0.5	0.8	0.4	2.0	8.1	7.4	0.5	0.3	79.8	7.9	7.7	7.0	0.9	0.2	4.7	8.6	0.9	3.5	0.2	0.5	0.6	0.5	3.8	0.3	12.0	0.1	4.2	1.8	0.5	5.1	14.2	1.7	9.5	1.5	1.8	0.4	8.4	10.5	9.0	4.5	5.2	0.3	3.0	5.7	4.7	0.4	0.9	0.9	0.7	2.9	75.6	0.3	4.3	1.1	3.9	1.9	0.4	1.6	3.2	1.5	3.5	0.1	0.1	0.3	1.0	0.8	0.6	0.5	1.0	0.1	0.6	4.9	0.4	0.0	1.6	7.6	8.5	11.0	13.4	9.2	5.6	11.3	7.6	13.1	0.0	12.7	0.8	2.6	6.4	2.7	126.7	1.5	8.7	5.7	3.0	8.6	59.4	4.7	3.0	33.9	8.6	10.9	1.8	35.5	3.8	11.6	12.5	0.0	2.1	1.2	3.2	17.5	5.3	13.8	3.4	344.6	4.3	3.4	6.5	11.7	6.8	0.0	2.2	2.5	18.1	7.1	6.7	175.7	8.0	14.2	15.4	7.2	1.2	5.0	14.0	3.6	53.4	6.6	10.2	26.8	111.6	77.4	2.2	8.3	5.3	2.9	5.9	2.2	3.7	9.5	10.4	0.0	42.5	21.4	2.6	3.4	13.1	8.7	2.6	3.8	2.6	5.6	21.2
PPM1M	"FLJ32332, PP2Ceta"	ENSG00000164088	"Protein phosphatase, Mg2+/Mn2+ dependent 1M"	Q96MI6	3	52245759-52250599	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Hydrolase, Protein phosphatase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Hofbauer cells: 42.2;Kupffer cells: 39.0;Macrophages: 31.1;NK-cells: 30.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"U-266/70: 54.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036905, HPA062291"	Uncertain		Approved	"Nuclear bodies"		NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 66: Lymphoid tissue - Immune response regulation"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 63: NK-cells & T-cells - Immune response"	"Nuclear bodies"		"HPA036905: AB_10602818, HPA062291: AB_2684740"	"unprognostic (4.26e-3)"	"prognostic favorable (7.73e-4)"	"unprognostic (2.55e-2)"	"unprognostic (4.85e-3)"	"unprognostic (5.64e-2)"	"unprognostic (4.88e-3)"	"unprognostic (1.70e-2)"	"prognostic favorable (6.69e-4)"	"unprognostic (4.63e-2)"	"unprognostic (1.69e-1)"	"unprognostic (1.50e-1)"	"unprognostic (1.19e-1)"	"prognostic unfavorable (1.61e-5)"	"unprognostic (1.49e-1)"	"unprognostic (4.14e-2)"	"unprognostic (9.27e-2)"	"unprognostic (4.37e-2)"	19.5	9.4	12.7	20.3	13.7	24.6	15.5	9.9	13.6	25.9	12.2	18.7	6.0	18.3	9.9	12.3	18.1	14.1	11.4	13.6	14.2	10.9	5.6	23.5	29.6	12.8	11.4	18.6	8.0	11.2	9.1	11.6	12.2	16.7	8.7	2.2	11.6	15.2	3.7	10.7	13.1	18.0	12.0	30.1	11.4	8.8	15.5	27.6	13.8	7.8	28.2	17.5	18.2	12.9	0.9	5.4	3.2	7.6	46.1	45.7	5.2	12.2	26.2	17.0	13.1	3.2	4.2	9.0	3.6	32.0	9.5	1.5	10.9	2.3	6.9	11.0	2.7	20.5	14.6	3.3	33.6	3.1	18.7	37.8	5.2	18.9	11.9	27.3	22.2	40.5	3.6	14.5	20.2	2.2	13.7	0.9	4.1	4.0	14.7	3.0	1.6	20.0	7.3	2.6	2.3	9.3	9.0	2.2	11.1	6.8	7.6	7.9	15.5	6.5	10.7	3.8	1.6	54.3	11.2	9.9	12.7	5.4	8.0	1.8	24.1	13.3	20.6	19.3	15.9	6.8	16.1	19.2	14.4	7.4	15.2	19.0	28.9	11.7	29.6	8.5	20.5	17.5	12.7	13.7	9.9	13.6	13.6	14.2	12.8	11.4	12.2	12.0	15.5	12.9	6.8	0.0	5.4	1.3	15.4	5.1	6.5	0.7	8.0	1.6	5.9	7.2	1.8	5.7	2.0	1.8	0.0	3.3	25.9	0.7	3.9	1.8	9.7	4.7	8.9	7.0	1.2	3.0	1.5	1.1	5.8	11.9	3.1	11.0	5.7	7.3	12.5	3.7	42.2	1.7	0.6	0.4	2.0	39.0	17.0	18.0	12.8	31.1	5.4	4.7	29.1	5.1	30.9	1.5	0.7	1.3	3.2	9.8	11.4	2.3	0.9	3.0	0.9	0.7	19.7	5.2	7.3	0.7	4.2	11.9	3.8	1.9	25.1	3.1	1.0	3.5
PPM1N	FLJ40125	ENSG00000213889	"Protein phosphatase, Mg2+/Mn2+ dependent 1N (putative)"	Q8N819	19	45488777-45502510	"Enzymes, Predicted intracellular proteins"		"Hydrolase, Protein phosphatase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Tissue enriched"	"Detected in many"	8	"skeletal muscle: 213.3"	"Cell type enhanced"	"Detected in many"		"Extravillous trophoblasts: 123.1;Rod photoreceptor cells: 74.3"	"Cancer enhanced"	"Detected in many"		"testis cancer: 11.3"	"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in all"	6	"non-classical monocyte: 142.4"	"Lineage enriched"	"Detected in all"	11	"monocytes: 142.4"	"Cell line enhanced"	"Detected in many"		"OE19: 24.1;RT4: 29.9"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA043577			Supported	Vesicles		NA	NA			"Cluster 51: Monocytes - Innate immune response"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 21: OE19 - Mitochondria"	"Cluster 38: Extravillous trophoblasts - Unknown function"	Vesicles		"HPA043577: "	"unprognostic (2.38e-2)"	"unprognostic (1.11e-2)"	"unprognostic (8.53e-2)"	"unprognostic (6.59e-2)"	"unprognostic (4.71e-1)"	"unprognostic (2.64e-2)"	"unprognostic (1.98e-3)"	"unprognostic (1.02e-1)"	"unprognostic (1.25e-1)"	"unprognostic (4.45e-2)"	"unprognostic (9.27e-2)"	"unprognostic (2.48e-2)"	"unprognostic (1.11e-16)"	"unprognostic (3.42e-2)"	"unprognostic (1.79e-1)"	"unprognostic (3.92e-2)"	"unprognostic (1.86e-3)"	2.0	0.8	15.5	2.0	14.7	2.6	3.3	14.5	19.9	2.0	14.5	2.6	0.6	0.7	1.3	2.6	0.9	1.4	1.3	15.1	15.0	1.4	2.6	2.5	3.0	14.7	14.7	0.6	0.5	2.1	1.1	4.7	15.1	1.2	1.3	25.8	0.9	2.0	213.3	3.1	1.6	1.2	13.7	9.2	2.8	5.3	14.3	2.3	1.1	0.2	3.4	2.4	1.6	16.2	2.6	7.1	1.2	5.1	5.9	7.8	14.7	1.9	3.0	0.6	2.3	1.7	15.8	11.1	3.2	1.8	4.1	7.6	3.0	2.2	0.9	10.9	4.5	9.0	2.7	1.9	1.4	0.8	18.1	3.2	3.6	3.1	1.9	4.0	1.0	4.4	10.3	9.6	1.0	1.9	3.1	4.6	4.0	24.1	1.4	2.0	1.5	3.0	3.4	29.9	5.8	6.8	1.0	11.1	9.2	8.8	3.8	2.7	1.5	8.2	4.7	4.3	1.4	1.7	4.5	2.3	6.1	2.3	7.2	6.7	4.4	3.2	6.4	22.5	5.5	6.3	3.9	6.2	12.8	3.6	4.3	7.9	6.5	3.1	142.4	2.4	4.5	5.7	15.5	14.7	14.5	19.9	15.1	15.0	14.7	14.7	15.1	13.7	14.3	16.2	6.4	0.0	2.7	1.0	7.5	3.4	14.7	6.2	17.6	14.1	5.9	32.5	2.3	17.2	2.5	3.7	31.3	3.2	6.0	5.5	0.0	2.9	12.5	2.0	3.9	3.5	3.0	0.8	1.1	1.8	123.1	6.5	3.1	7.4	7.0	1.0	5.3	1.3	20.1	1.7	1.4	4.2	0.0	15.5	15.7	4.9	0.9	15.2	1.8	1.0	6.1	7.3	20.6	0.0	0.3	3.1	4.7	0.7	1.7	6.7	6.9	0.6	0.8	74.3	0.0	25.6	5.5	2.9	9.1	3.4	4.1	8.5	7.5	0.3	3.1	8.4
PPME1	"ABDH19, PME-1"	ENSG00000214517	"Protein phosphatase methylesterase 1"	Q9Y570	11	74171267-74254703	"Enzymes, Predicted intracellular proteins"		"Hydrolase, Serine esterase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Erythroid cells: 96.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"RH-30: 432.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004541, HPA043900, HPA064396"	Enhanced		Supported	"Nucleoplasm,Nuclear bodies"		NA	NA		45000	"Cluster 27: Non-specific - Gene expression"	"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 6: Erythroid cells - Oxygen transport"	Nucleoplasm	"Nuclear bodies"	"CAB004541: AB_628161, HPA043900: AB_2678722, HPA064396: AB_2685254"	"unprognostic (2.99e-2)"	"unprognostic (1.27e-2)"	"unprognostic (2.28e-1)"	"unprognostic (1.98e-1)"	"unprognostic (9.26e-2)"	"unprognostic (5.77e-3)"	"prognostic unfavorable (4.45e-6)"	"unprognostic (2.31e-2)"	"unprognostic (7.92e-2)"	"unprognostic (9.76e-2)"	"unprognostic (1.57e-1)"	"unprognostic (2.06e-1)"	"prognostic unfavorable (2.76e-4)"	"unprognostic (1.84e-1)"	"unprognostic (1.54e-1)"	"unprognostic (4.14e-3)"	"unprognostic (1.33e-3)"	14.7	25.1	16.8	10.0	18.1	16.9	14.9	8.5	21.3	17.3	7.8	15.2	11.0	16.8	29.1	20.8	24.1	14.0	21.4	18.8	19.4	18.6	10.1	13.0	9.3	12.7	14.5	18.3	15.4	62.5	14.5	14.9	17.5	23.8	15.7	23.8	20.1	24.9	29.7	28.7	11.5	21.4	9.8	8.1	13.4	31.9	13.4	18.8	23.1	24.1	14.7	22.3	13.9	14.0	50.5	62.3	42.4	45.9	45.4	36.0	41.3	71.8	48.4	134.8	103.6	139.1	32.3	26.3	47.7	55.1	73.6	79.9	63.4	50.3	123.1	36.4	23.8	38.7	66.6	64.1	96.7	28.9	33.2	34.6	41.8	69.7	32.7	54.8	39.1	37.5	93.0	22.5	236.6	34.1	38.0	36.1	34.4	71.2	50.3	39.9	432.4	39.9	56.7	33.9	57.2	49.2	85.1	38.7	108.4	46.2	72.7	29.1	23.5	52.1	67.6	51.5	55.2	41.4	54.6	46.9	39.2	26.7	43.4	1.4	8.7	11.3	10.4	10.5	13.2	7.2	13.4	12.6	11.2	8.3	13.3	10.9	4.9	13.7	9.5	11.8	10.9	9.2	16.8	18.1	8.5	21.3	18.8	19.4	12.7	14.5	17.5	9.8	13.4	14.0	16.1	28.9	12.8	28.7	10.8	20.3	24.4	30.5	23.3	31.3	18.5	17.7	18.0	7.2	28.5	35.0	37.5	14.1	11.2	15.4	17.6	16.9	51.4	44.9	32.8	15.0	25.7	96.4	65.3	13.4	38.9	19.1	23.9	24.2	8.2	21.2	10.8	9.7	13.6	33.7	59.3	13.5	34.6	6.7	14.8	13.4	13.7	11.1	3.6	20.6	10.8	15.2	16.5	35.7	40.5	16.6	12.0	25.2	8.2	19.2	10.3	11.6	40.9	18.8	6.6	19.0	33.0	61.9	45.6	21.5	24.9	15.5	12.4	18.8	13.4	17.3
PPP1CA	"PP-1A, PP1A, PP1alpha, PPP1A"	ENSG00000172531	"Protein phosphatase 1 catalytic subunit alpha"	P62136	11	67398181-67421183	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Carbohydrate metabolism, Cell cycle, Cell division, Glycogen metabolism, Host-virus interaction"	"Hydrolase, Protein phosphatase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004545, HPA046833"	Enhanced		Supported	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA		3600000	"Cluster 31: Non-specific - Inflammatory response"	"Cluster 52: Non-specific - Ribosome"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 53: Intestinal epithelial cells - Unknown function"	"Nucleoplasm, Plasma membrane, Cytosol"		"CAB004545: AB_628177, HPA046833: AB_2679829"	"unprognostic (1.03e-1)"	"unprognostic (5.82e-3)"	"unprognostic (1.10e-1)"	"unprognostic (2.67e-1)"	"unprognostic (2.09e-1)"	"unprognostic (1.51e-2)"	"unprognostic (3.15e-3)"	"unprognostic (3.93e-2)"	"unprognostic (2.07e-1)"	"unprognostic (3.89e-2)"	"unprognostic (5.05e-3)"	"unprognostic (8.00e-2)"	"unprognostic (1.66e-1)"	"unprognostic (9.96e-2)"	"unprognostic (7.69e-2)"	"prognostic favorable (1.17e-4)"	"unprognostic (7.60e-2)"	70.0	102.4	61.2	102.6	70.8	127.8	63.5	64.0	70.7	62.1	61.2	110.8	95.9	50.5	66.8	184.0	61.1	51.2	122.0	63.5	63.6	121.8	128.2	78.9	147.8	68.3	62.4	33.1	105.1	64.2	59.8	83.5	63.8	81.1	89.6	21.6	100.4	51.0	123.2	105.8	107.1	56.1	63.9	148.7	102.7	34.6	65.8	113.7	88.7	81.3	155.6	74.9	80.6	68.2	283.1	305.6	181.1	270.3	88.4	108.9	185.6	136.1	158.4	267.4	202.3	445.8	328.5	237.2	227.3	208.1	198.4	238.7	213.9	280.2	169.6	256.3	139.9	227.5	129.3	232.7	195.2	295.2	281.1	123.3	181.1	225.7	130.7	125.4	272.2	226.0	217.4	191.1	220.5	619.4	378.2	562.2	303.5	526.7	241.1	262.7	254.0	209.8	262.2	220.7	142.5	236.7	159.2	283.0	439.8	135.3	338.5	201.2	196.4	208.5	208.9	245.3	179.0	190.1	193.2	271.8	244.6	199.9	224.3	921.6	735.9	1234.1	779.2	962.9	604.3	733.4	679.9	792.5	705.3	779.6	412.6	584.2	853.8	688.8	1186.1	500.4	1098.7	2042.5	61.2	70.8	64.0	70.7	63.5	63.6	68.3	62.4	63.8	63.9	65.8	68.2	49.2	76.9	92.2	8.8	165.8	99.9	143.5	305.9	64.3	35.5	81.7	79.1	8.4	102.9	157.8	86.5	10.4	360.4	151.2	377.5	213.2	265.6	2.5	63.1	67.2	101.6	96.9	108.8	8.8	311.1	507.0	68.8	132.0	107.1	109.6	87.1	89.3	113.9	377.1	43.7	7.7	241.3	181.0	219.8	138.5	7.7	49.0	186.5	136.9	9.4	353.0	53.8	408.8	6.0	13.1	318.4	308.4	28.6	206.5	139.0	341.3	297.4	70.5	30.5	98.6	67.1	100.7	13.6	94.6	142.0	121.6	427.3	176.3	100.1	231.7	205.4
PPP1CB	"MP, PP-1B, PP1B, PP1beta, PP1c, PPP1beta"	ENSG00000213639	"Protein phosphatase 1 catalytic subunit beta"	P62140	2	28751640-28802940	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Biological rhythms, Carbohydrate metabolism, Cell cycle, Cell division, Glycogen metabolism"	"Hydrolase, Protein phosphatase"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Langerhans cells: 985.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB022558, HPA065425, CAB069426"	Supported		Supported	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA		3800000	"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 59: Non-specific - Translation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 24: Non-specific - Transcription regulation"	"Nucleoplasm, Cytosol"	"Plasma membrane"	"CAB022558: , CAB069426: , HPA065425: AB_2685489"	"unprognostic (2.90e-1)"	"unprognostic (5.03e-2)"	"unprognostic (5.49e-2)"	"unprognostic (2.00e-1)"	"unprognostic (7.08e-2)"	"unprognostic (1.39e-1)"	"prognostic unfavorable (6.52e-6)"	"unprognostic (3.47e-2)"	"unprognostic (2.44e-1)"	"unprognostic (3.15e-2)"	"unprognostic (1.54e-3)"	"unprognostic (3.95e-1)"	"unprognostic (1.68e-1)"	"unprognostic (3.66e-1)"	"unprognostic (1.89e-1)"	"unprognostic (4.56e-1)"	"unprognostic (2.26e-2)"	90.9	75.2	55.8	74.7	73.5	119.1	110.5	55.6	74.9	148.6	67.8	109.2	84.8	138.4	104.0	245.7	113.5	103.1	185.2	54.3	73.8	84.4	70.5	73.3	60.4	73.9	61.2	92.7	76.2	126.9	45.9	74.8	74.5	149.1	92.9	70.8	114.6	123.4	386.0	73.7	76.0	159.7	71.8	65.8	81.7	47.6	63.5	71.3	78.8	262.8	91.1	118.0	104.1	88.2	186.0	114.6	391.1	121.7	130.8	121.0	227.0	97.7	110.6	92.2	91.0	102.6	106.9	147.5	119.2	101.5	102.7	111.4	112.6	129.9	109.8	235.9	58.2	111.3	130.1	111.5	284.3	127.8	50.5	93.5	181.3	100.1	207.8	97.4	113.8	77.0	103.6	140.4	123.3	93.2	136.9	110.3	128.3	141.8	89.8	132.2	344.9	112.7	304.3	220.6	106.7	131.3	151.4	166.2	136.2	111.4	80.4	70.6	137.6	122.6	134.6	89.3	119.0	100.4	171.0	299.8	130.1	135.0	93.5	72.4	59.4	84.9	39.8	96.7	50.8	38.6	59.3	46.8	65.4	31.6	51.8	58.8	103.6	61.4	115.2	49.8	74.3	52.8	55.8	73.5	55.6	74.9	54.3	73.8	73.9	61.2	74.5	71.8	63.5	88.2	172.2	93.0	80.6	59.4	147.8	492.1	176.7	101.5	64.9	62.4	208.0	117.0	352.1	112.9	124.1	310.8	27.1	129.6	210.4	324.5	244.6	297.0	514.0	330.2	245.7	129.3	283.0	200.2	68.5	210.5	202.1	147.8	78.5	258.9	146.6	91.2	137.8	108.7	114.7	163.2	71.8	144.2	111.9	182.6	985.1	406.2	196.7	238.1	336.2	59.0	137.9	116.6	55.6	64.3	68.4	236.8	181.3	302.0	100.9	364.9	106.6	227.4	213.3	65.2	631.1	225.8	264.8	55.2	66.6	135.6	458.0	392.9	237.7	65.8	154.4	498.9
PPP1CC	"PP1C, PP1gamma"	ENSG00000186298	"Protein phosphatase 1 catalytic subunit gamma"	P36873	12	110719680-110742939	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Biological rhythms, Carbohydrate metabolism, Cell cycle, Cell division, Glycogen metabolism"	"Hydrolase, Protein phosphatase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 639.3;Late spermatids: 923.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB022645	Uncertain					NA	NA		2800000	"Cluster 45: Eosinophils - Innate immune response"	"Cluster 9: Intestine - Unknown function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 31: Spermatids - Spermatogenesis"			"CAB022645: "	"unprognostic (1.51e-1)"	"prognostic favorable (7.44e-4)"	"unprognostic (4.00e-2)"	"unprognostic (2.11e-1)"	"unprognostic (1.29e-2)"	"unprognostic (7.26e-2)"	"prognostic unfavorable (2.75e-6)"	"unprognostic (6.55e-2)"	"unprognostic (4.11e-2)"	"unprognostic (6.91e-2)"	"unprognostic (4.96e-3)"	"unprognostic (5.72e-2)"	"unprognostic (2.92e-3)"	"unprognostic (1.66e-2)"	"unprognostic (1.71e-1)"	"unprognostic (8.96e-2)"	"unprognostic (1.18e-1)"	63.3	64.9	58.8	76.8	61.7	103.6	72.5	67.1	69.7	59.4	53.2	110.5	193.2	66.7	57.5	92.0	59.2	57.2	91.5	56.1	66.5	60.4	64.4	53.6	139.0	60.0	62.7	90.3	74.0	68.4	41.5	53.2	60.5	58.5	108.4	125.0	71.6	55.2	157.7	60.7	147.7	76.8	59.8	73.4	73.5	142.3	62.7	107.7	54.9	175.8	131.4	86.3	53.6	65.7	221.0	130.2	217.5	160.0	128.9	176.6	166.0	124.1	183.1	201.0	159.6	223.8	109.0	341.7	91.2	133.8	125.8	122.5	295.3	162.7	278.9	200.2	198.9	221.7	93.0	230.4	105.1	285.5	184.4	112.4	130.5	152.8	135.2	213.2	236.4	190.3	225.1	90.0	186.6	91.7	232.8	318.3	343.6	144.0	190.8	224.9	150.2	216.9	129.6	164.2	174.7	140.3	137.2	162.4	246.7	190.5	254.6	219.9	106.1	102.2	168.8	139.1	158.0	140.4	157.4	291.2	96.2	203.8	159.2	38.3	33.3	54.7	13.2	26.3	12.8	31.7	23.8	18.8	32.8	27.4	19.8	16.4	27.8	14.9	35.0	12.8	25.4	24.3	58.8	61.7	67.1	69.7	56.1	66.5	60.0	62.7	60.5	59.8	62.7	65.7	71.3	35.3	32.2	27.7	163.4	209.2	124.0	89.6	150.8	203.2	77.6	63.6	138.5	78.6	52.4	36.8	68.8	136.5	61.3	103.9	93.9	75.7	639.3	43.9	72.1	88.8	85.0	131.3	17.9	125.9	204.6	129.6	74.5	47.9	58.4	87.8	62.2	43.4	132.7	102.6	29.9	109.8	93.6	161.3	111.8	923.3	89.8	88.9	128.1	30.0	96.0	91.8	57.7	34.7	34.3	88.3	144.0	138.8	234.3	159.7	305.2	94.6	28.9	110.5	111.7	75.9	133.8	314.6	51.7	161.1	210.0	132.2	106.5	121.8	164.8	156.3
PPP2CA	"PP2AC, PP2Calpha"	ENSG00000113575	"Protein phosphatase 2 catalytic subunit alpha"	P67775	5	134194332-134226073	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	Meiosis	"Hydrolase, Protein phosphatase"	"Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB003848, HPA043236"	Approved					NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 34: Non-specific - Transcription"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 22: Epithelial cell types - Mixed function"			"CAB003848: AB_562203, HPA043236: AB_2678379"	"unprognostic (1.44e-1)"	"unprognostic (1.02e-1)"	"unprognostic (1.60e-2)"	"unprognostic (3.35e-3)"	"unprognostic (1.26e-1)"	"unprognostic (3.21e-2)"	"prognostic unfavorable (7.33e-5)"	"unprognostic (1.59e-3)"	"unprognostic (1.57e-1)"	"unprognostic (2.02e-1)"	"unprognostic (1.34e-2)"	"unprognostic (1.31e-1)"	"unprognostic (5.24e-2)"	"unprognostic (2.43e-1)"	"unprognostic (1.43e-1)"	"unprognostic (6.14e-2)"	"unprognostic (1.57e-1)"	47.9	53.1	52.1	42.9	55.1	124.8	46.6	60.6	66.3	38.9	44.9	51.4	46.1	46.6	36.1	71.5	39.0	44.6	90.1	57.8	53.5	57.3	62.1	39.4	58.6	48.6	51.4	30.0	44.3	87.1	26.1	52.2	53.7	37.8	47.1	58.6	36.5	40.4	75.3	54.1	44.5	57.8	54.7	40.0	41.3	34.7	53.6	92.4	48.1	73.1	76.7	75.4	41.0	59.5	157.0	128.8	180.8	97.9	92.1	98.2	126.2	144.1	123.3	214.8	215.4	249.1	119.6	136.5	131.7	134.4	242.9	79.7	175.6	208.6	250.2	123.9	100.1	96.9	142.4	156.5	136.3	97.1	84.2	91.7	141.5	169.0	166.6	107.0	153.5	135.1	97.2	99.1	165.1	112.5	154.9	95.0	98.9	123.6	77.3	136.5	179.6	132.6	130.0	173.4	142.9	99.6	148.9	55.1	166.9	179.7	112.2	112.3	109.2	123.3	69.1	99.6	206.5	88.5	171.6	217.0	83.2	125.9	130.3	43.0	64.7	75.6	46.8	63.1	59.2	53.1	53.2	62.5	77.3	54.7	60.6	57.2	71.3	75.5	67.0	41.5	72.4	95.8	52.1	55.1	60.6	66.3	57.8	53.5	48.6	51.4	53.7	54.7	53.6	59.5	58.7	51.3	47.6	27.1	103.3	239.0	187.4	90.1	121.8	43.9	93.6	53.0	111.2	55.8	63.1	57.0	22.9	152.1	89.0	68.7	107.6	109.7	34.6	85.8	83.2	81.1	87.1	89.0	36.6	87.6	171.3	78.0	77.5	106.1	62.2	44.6	51.8	65.9	111.4	50.5	35.7	62.0	69.2	88.2	194.6	29.8	38.5	95.8	104.9	24.4	115.6	62.9	51.5	36.7	48.9	101.7	56.6	45.5	120.9	143.3	64.9	114.8	53.0	31.4	19.7	76.8	97.6	91.4	85.8	112.4	234.4	309.8	110.6	53.3	69.7	176.7
PPP2CB	PP2Abeta	ENSG00000104695	"Protein phosphatase 2 catalytic subunit beta"	P62714	8	30774457-30814314	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Hydrolase, Protein phosphatase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Peritubular cells: 264.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB018600, HPA043236"	Approved		Supported	Nucleoplasm		NA	NA			"Cluster 6: Non-specific - Transcription"	"Cluster 68: Epididymis - Unknown function"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Nucleoplasm		"CAB018600: AB_675841, HPA043236: AB_2678379"	"unprognostic (9.77e-2)"	"unprognostic (1.30e-1)"	"unprognostic (2.51e-2)"	"unprognostic (3.82e-1)"	"unprognostic (6.70e-2)"	"unprognostic (7.79e-2)"	"unprognostic (1.13e-2)"	"unprognostic (3.51e-1)"	"unprognostic (2.28e-1)"	"unprognostic (2.86e-2)"	"unprognostic (4.50e-2)"	"unprognostic (1.89e-2)"	"prognostic favorable (5.82e-7)"	"unprognostic (9.24e-2)"	"unprognostic (2.04e-1)"	"unprognostic (1.39e-1)"	"unprognostic (2.65e-3)"	89.9	66.6	190.2	42.2	196.1	10.5	68.4	189.1	220.1	84.0	147.9	79.3	72.9	112.1	117.1	95.1	87.8	74.2	94.7	191.6	190.7	131.9	118.6	90.6	32.5	199.7	184.1	147.4	75.7	93.3	52.5	91.0	190.4	74.9	76.2	77.9	68.6	87.1	105.7	63.7	87.0	122.3	195.1	52.9	71.2	64.7	204.4	41.4	126.7	122.7	47.4	76.8	70.0	200.1	96.5	82.7	136.4	54.4	134.6	120.0	78.0	124.0	114.0	123.1	129.5	86.6	68.3	45.6	118.7	165.4	117.9	56.5	84.4	142.1	167.3	28.5	44.2	61.8	52.7	86.9	157.3	28.1	34.2	108.6	157.4	105.2	115.9	124.2	152.5	73.6	97.7	47.6	212.4	48.4	77.1	34.9	102.6	139.3	47.0	53.9	55.7	34.5	168.5	73.6	134.3	55.0	57.8	61.1	127.0	150.5	34.1	47.8	164.0	109.1	81.7	36.1	105.5	24.0	33.6	53.7	93.4	26.0	141.4	3.4	2.5	1.7	1.8	3.1	2.3	2.9	1.7	1.9	1.7	1.1	1.7	2.1	2.3	3.8	1.5	3.8	1.3	0.8	190.2	196.1	189.1	220.1	191.6	190.7	199.7	184.1	190.4	195.1	204.4	200.1	81.0	70.5	60.7	68.6	13.0	104.1	115.9	44.4	44.9	36.6	64.9	51.8	80.2	45.8	54.3	86.5	31.3	41.1	23.6	186.1	46.9	40.6	21.8	98.5	109.8	60.9	32.3	16.6	41.0	48.9	52.8	79.0	34.7	89.2	17.7	95.4	87.8	95.5	58.4	47.1	59.1	65.3	28.5	55.4	60.4	20.3	73.3	36.0	40.9	52.5	27.4	127.2	17.5	37.7	60.4	81.1	78.9	264.0	15.8	125.4	115.6	95.9	68.2	26.5	46.0	93.1	73.0	37.2	40.4	50.3	95.6	70.6	17.4	75.3	41.2	149.9
PPP3CA	"CALN, CALNA, CNA1, PPP2B"	ENSG00000138814	"Protein phosphatase 3 catalytic subunit alpha"	Q08209	4	101023409-101348278	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"		"Calmodulin-binding, Hydrolase, Protein phosphatase"	"Craniosynostosis, Disease variant, Dwarfism, Epilepsy, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 144.1"	"Cell type enhanced"	"Detected in all"		"Excitatory neurons: 933.8;Inhibitory neurons: 403.0;Oligodendrocyte precursor cells: 348.3"	"Cancer enriched"	"Detected in all"	7	"prostate cancer: 98.1"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA012778, CAB018581"	Enhanced		Enhanced	Nucleoplasm,Cytosol		NA	NA		94000	"Cluster 49: Eosinophils - Unknown function"	"Cluster 10: Brain - Neuronal signaling"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	Nucleoplasm	Cytosol	"CAB018581: AB_2168324, HPA012778: AB_1855660"	"unprognostic (6.66e-2)"	"unprognostic (1.96e-1)"	"unprognostic (3.40e-1)"	"unprognostic (1.36e-1)"	"unprognostic (1.56e-1)"	"unprognostic (7.81e-2)"	"unprognostic (1.77e-2)"	"unprognostic (1.08e-1)"	"unprognostic (7.87e-2)"	"unprognostic (3.49e-3)"	"prognostic unfavorable (3.82e-4)"	"unprognostic (3.38e-2)"	"unprognostic (2.51e-2)"	"unprognostic (5.12e-2)"	"unprognostic (1.98e-1)"	"unprognostic (1.84e-2)"	"unprognostic (5.74e-2)"	24.7	17.5	48.5	15.7	144.1	17.2	20.5	63.2	125.6	17.0	0.0	19.5	11.6	11.8	13.1	14.4	13.8	13.3	9.2	97.4	25.0	11.2	17.0	19.9	14.7	14.6	11.0	17.9	9.4	8.9	9.0	13.0	15.7	66.0	16.1	27.6	22.2	38.4	51.2	22.9	12.9	15.5	24.7	14.5	22.4	10.6	23.9	12.8	13.2	29.0	18.3	20.7	16.0	54.3	48.3	33.8	9.3	18.0	50.4	37.9	15.8	51.9	47.8	19.8	21.6	18.3	59.0	22.4	20.9	47.6	25.6	23.5	33.3	69.6	34.9	56.0	15.1	35.4	45.8	25.2	36.8	59.0	17.8	39.6	35.6	45.3	51.4	39.1	38.8	14.5	14.4	61.1	33.5	58.0	12.2	44.2	15.4	55.7	20.7	22.1	83.2	26.5	20.0	38.3	71.5	26.2	43.1	35.4	24.6	12.5	32.3	33.4	42.1	48.7	54.8	44.7	34.7	28.5	31.5	40.1	26.6	31.5	13.1	82.5	31.0	73.5	35.7	33.1	41.6	74.1	33.2	34.8	28.2	62.8	15.5	31.0	123.7	65.1	45.1	51.9	25.3	21.1	48.5	144.1	63.2	125.6	97.4	25.0	14.6	11.0	15.7	24.7	23.9	54.3	143.3	76.9	58.6	284.1	96.8	168.8	36.2	29.5	34.7	89.8	93.8	51.8	25.0	38.6	21.9	31.3	39.6	39.6	81.4	60.0	33.2	21.3	3.2	39.3	56.2	100.8	127.4	32.0	933.8	31.6	84.0	75.6	59.1	42.8	35.4	22.1	53.2	39.7	38.3	18.5	403.0	44.2	14.2	61.8	135.3	8.4	65.0	58.2	92.5	281.1	64.3	21.2	56.7	348.3	139.1	53.3	115.4	60.9	63.8	127.6	23.9	51.9	25.3	82.9	13.1	66.9	67.5	12.7	26.5	27.9	172.0	27.5	69.1	76.2	55.9	39.5
PPP3CB	"CALNA2, CALNB, CNA2, PP2Bbeta"	ENSG00000107758	"Protein phosphatase 3 catalytic subunit beta"	P16298	10	73436433-73496024	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Calmodulin-binding, Hydrolase, Protein phosphatase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	4	"skeletal muscle: 379.3;tongue: 179.7"	"Cell type enhanced"	"Detected in all"		"Excitatory neurons: 119.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA008233, HPA008823"	Uncertain		Approved	Mitochondria		NA	NA			"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 10: Non-specific - Unknown function"	Mitochondria		"HPA008233: AB_1855661, HPA008823: AB_2668148"	"unprognostic (3.05e-1)"	"unprognostic (2.54e-1)"	"unprognostic (1.50e-1)"	"unprognostic (4.93e-2)"	"unprognostic (8.93e-2)"	"unprognostic (4.28e-2)"	"prognostic unfavorable (9.59e-4)"	"unprognostic (1.14e-1)"	"unprognostic (1.34e-1)"	"unprognostic (2.12e-2)"	"prognostic favorable (6.96e-5)"	"unprognostic (4.73e-2)"	"unprognostic (1.51e-1)"	"unprognostic (1.01e-1)"	"unprognostic (1.45e-1)"	"unprognostic (2.66e-1)"	"unprognostic (1.68e-2)"	44.8	37.5	40.5	29.8	51.1	19.8	32.1	49.5	63.1	30.3	26.7	41.4	24.2	40.3	34.5	33.1	30.9	28.3	41.3	56.9	29.5	28.1	21.8	23.5	34.9	25.4	25.2	39.6	25.3	39.2	30.6	25.5	28.7	39.1	29.6	57.0	26.6	39.8	379.3	26.3	22.6	48.2	27.2	25.3	24.3	29.0	29.1	32.9	23.5	179.7	36.1	34.3	24.3	44.9	53.7	29.0	50.9	53.0	71.4	98.3	24.5	48.0	65.7	46.1	45.4	18.6	26.8	47.1	15.3	70.0	21.8	28.1	41.6	36.9	64.5	66.6	34.0	20.3	25.0	35.5	42.7	45.2	40.2	70.1	43.5	43.6	58.1	84.7	32.3	40.6	25.6	54.0	94.1	16.9	40.7	41.6	20.7	23.3	83.8	26.9	27.7	22.4	45.1	25.6	27.2	31.5	28.1	69.5	36.4	42.1	52.4	43.2	35.6	36.6	33.7	29.5	66.1	35.8	105.3	33.0	45.3	64.0	21.3	2.2	2.0	3.5	4.0	2.7	4.8	2.7	4.3	4.4	2.1	2.3	3.4	5.1	1.1	3.5	1.7	4.0	7.8	1.9	40.5	51.1	49.5	63.1	56.9	29.5	25.4	25.2	28.7	27.2	29.1	44.9	23.0	3.2	14.3	72.5	31.6	25.6	29.8	13.2	27.3	54.8	25.7	16.9	48.9	14.3	12.8	18.4	20.9	21.0	23.7	11.1	62.6	18.1	11.8	20.0	24.2	21.5	42.6	30.7	119.5	19.4	16.8	32.6	20.4	18.8	21.0	35.4	18.9	14.2	20.3	38.7	111.0	13.2	18.3	31.7	24.2	9.9	33.5	25.2	26.6	51.5	29.6	34.8	18.6	79.4	54.4	16.7	12.9	29.0	34.1	27.1	13.4	34.2	17.6	30.1	6.6	41.8	36.4	43.8	49.2	32.1	31.5	22.2	27.3	28.4	13.1	22.1
PPP3CC	"CALNA3, PP2Bgamma"	ENSG00000120910	"Protein phosphatase 3 catalytic subunit gamma"	P48454	8	22440819-22541142	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"		"Calmodulin-binding, Hydrolase, Protein phosphatase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 145.8;Spermatocytes: 131.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA023396, CAB024950"	Approved		Approved	Vesicles		NA	NA			"Cluster 35: T-regs - Unknown function"	"Cluster 77: Retina - Visual perception"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 59: Non-specific - Transcription"	Vesicles		"CAB024950: , HPA023396: AB_1855663"	"unprognostic (7.66e-3)"	"unprognostic (1.61e-2)"	"unprognostic (1.55e-1)"	"unprognostic (1.01e-1)"	"unprognostic (1.38e-1)"	"unprognostic (2.21e-2)"	"unprognostic (7.71e-2)"	"prognostic favorable (6.80e-5)"	"unprognostic (9.25e-2)"	"unprognostic (1.97e-1)"	"unprognostic (8.84e-2)"	"unprognostic (4.05e-2)"	"unprognostic (7.16e-2)"	"unprognostic (2.35e-2)"	"unprognostic (4.00e-1)"	"unprognostic (2.78e-2)"	"unprognostic (1.64e-2)"	28.5	11.9	11.8	16.5	11.8	26.5	20.8	17.7	15.3	18.1	31.1	16.6	9.1	14.5	10.6	16.9	15.6	15.7	34.5	11.3	10.8	12.9	12.4	21.5	33.0	12.1	11.0	14.0	14.3	18.4	11.7	19.3	12.2	14.4	10.3	77.9	14.0	8.2	89.4	13.6	15.4	15.5	10.0	22.4	14.6	56.0	13.1	15.0	16.6	54.2	26.9	17.0	16.4	14.8	12.2	8.8	7.7	9.4	19.8	24.4	11.2	16.5	28.9	23.9	26.5	5.1	7.5	45.7	19.7	25.6	40.0	8.4	17.9	16.5	30.5	26.3	9.5	9.8	10.5	14.7	26.8	7.1	15.6	15.0	22.3	16.2	16.5	25.6	21.1	22.0	19.6	58.8	27.2	5.7	16.8	11.7	5.6	12.5	12.0	54.0	18.1	15.2	22.4	11.3	5.4	12.7	12.3	7.4	17.4	14.4	4.9	11.8	22.8	37.1	7.9	56.7	12.9	29.3	38.5	48.3	19.6	9.3	25.1	5.4	2.7	10.7	16.6	3.2	12.7	26.3	19.0	23.6	5.1	21.3	18.1	14.9	0.6	19.2	4.7	6.2	17.2	7.1	11.8	11.8	17.7	15.3	11.3	10.8	12.1	11.0	12.2	10.0	13.1	14.8	27.2	6.4	5.1	49.6	74.7	16.6	21.3	32.6	12.0	12.8	10.0	6.0	8.0	14.3	14.0	7.3	47.9	18.0	50.3	6.7	7.9	15.0	145.8	6.5	12.7	24.2	10.3	10.8	78.9	21.0	23.8	25.1	6.6	14.6	3.8	3.9	23.6	7.8	13.1	3.3	83.6	2.5	38.7	10.8	24.6	22.6	22.4	19.3	28.4	76.8	30.4	13.1	59.8	99.5	64.8	21.1	7.4	21.4	96.8	26.3	10.6	11.6	7.8	50.5	32.9	19.5	23.3	131.8	29.6	17.1	11.4	14.1	53.4	4.8	6.3	25.5
PPP4C	"PP4, PPX"	ENSG00000149923	"Protein phosphatase 4 catalytic subunit"	P60510	16	30075978-30085376	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Hydrolase, Protein phosphatase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA043837	Supported		Supported	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 84: Esophagus - Epithelial cell function"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Nucleoplasm	"Plasma membrane, Cytosol"	"HPA043837: AB_2678695"	"unprognostic (1.20e-1)"	"unprognostic (1.33e-2)"	"unprognostic (2.68e-1)"	"unprognostic (4.74e-2)"	"unprognostic (2.16e-1)"	"unprognostic (5.79e-3)"	"unprognostic (3.28e-3)"	"unprognostic (2.60e-3)"	"unprognostic (3.82e-1)"	"unprognostic (1.29e-1)"	"unprognostic (2.52e-1)"	"unprognostic (3.17e-2)"	"unprognostic (1.98e-2)"	"unprognostic (3.78e-2)"	"unprognostic (9.36e-2)"	"unprognostic (9.96e-2)"	"unprognostic (1.88e-1)"	44.3	57.9	34.8	43.2	34.7	63.2	42.5	35.9	38.7	42.8	41.0	49.8	47.0	39.6	47.1	88.3	35.9	32.5	45.6	34.0	35.7	49.9	83.2	46.2	58.6	35.5	34.9	29.4	41.0	46.4	33.5	49.6	35.3	37.8	35.2	18.1	44.0	28.5	60.8	60.8	49.0	32.8	35.6	62.5	49.2	65.4	38.4	61.2	35.4	30.2	63.7	56.3	48.9	36.4	132.7	145.9	95.5	134.0	88.4	73.8	148.5	115.8	127.7	148.7	163.8	129.5	167.9	102.7	145.2	137.0	95.5	105.9	119.3	143.2	87.0	130.1	213.0	70.5	86.0	290.4	133.5	100.1	126.8	107.9	124.7	135.9	85.5	88.4	174.9	130.5	139.6	91.0	115.1	382.2	174.4	180.7	182.2	104.7	77.1	190.9	99.4	180.4	142.5	134.5	91.9	136.8	57.1	169.1	101.8	79.4	156.0	166.0	113.3	86.4	90.4	70.6	90.8	155.4	183.8	122.4	123.1	126.9	107.0	100.6	103.5	236.1	66.5	113.2	47.7	68.5	69.6	74.2	115.8	88.3	62.0	54.1	215.2	51.7	100.1	90.6	95.1	48.3	34.8	34.7	35.9	38.7	34.0	35.7	35.5	34.9	35.3	35.6	38.4	36.4	87.8	51.3	33.4	10.7	85.8	147.2	121.7	206.9	71.2	23.3	94.2	82.8	11.1	82.9	133.5	77.3	29.2	313.7	106.0	217.0	158.5	226.9	156.9	80.5	55.5	91.7	125.6	89.2	8.0	193.3	335.3	66.7	106.0	85.2	69.2	66.7	74.6	94.2	239.3	35.3	8.6	159.3	193.3	105.4	138.4	143.8	62.7	124.4	80.0	9.4	221.1	61.1	118.4	8.0	12.9	345.5	220.8	52.3	97.6	161.3	191.0	198.6	119.7	29.5	72.3	43.4	85.9	228.5	157.8	113.2	172.5	421.0	93.0	61.7	175.9	227.2
PPP5C	"PP5, PPP5"	ENSG00000011485	"Protein phosphatase 5 catalytic subunit"	P53041	19	46347087-46392981	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"DNA damage, DNA repair"	"Hydrolase, Protein phosphatase"	"Alzheimer disease, Amyloidosis, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB022641, HPA029065, HPA056933"	Approved		Supported	Vesicles,Cytosol		NA	NA		120000	"Cluster 27: Non-specific - Gene expression"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 24: NB-4 - Immune response"	"Cluster 59: Non-specific - Transcription"	"Vesicles, Cytosol"		"CAB022641: , HPA029065: AB_10610284, HPA056933: AB_2683278"	"unprognostic (8.25e-2)"	"unprognostic (7.90e-2)"	"unprognostic (1.44e-1)"	"unprognostic (6.30e-2)"	"unprognostic (5.92e-2)"	"unprognostic (2.62e-2)"	"prognostic unfavorable (3.45e-6)"	"unprognostic (1.29e-1)"	"unprognostic (1.04e-2)"	"unprognostic (8.25e-2)"	"unprognostic (5.56e-2)"	"unprognostic (2.20e-2)"	"unprognostic (3.24e-2)"	"unprognostic (1.14e-1)"	"unprognostic (1.35e-1)"	"unprognostic (5.92e-3)"	"unprognostic (1.37e-1)"	27.4	37.5	27.7	17.7	29.3	14.2	26.3	28.4	36.5	28.0	27.7	31.3	16.8	34.9	9.8	30.4	31.7	13.3	56.4	29.8	28.6	29.1	32.7	28.0	19.7	32.3	28.2	24.7	23.7	32.5	36.6	15.8	33.3	23.7	15.4	14.4	23.0	18.2	58.9	27.5	25.9	20.8	26.2	33.5	33.6	16.9	30.3	20.5	26.2	45.7	15.0	27.7	26.3	28.5	61.9	114.9	66.0	50.1	48.3	50.9	30.6	75.4	59.6	88.2	78.2	82.4	47.9	94.3	39.9	54.0	48.4	49.9	86.2	88.5	24.7	65.9	120.5	76.4	80.9	59.4	54.5	106.6	52.8	47.8	40.9	62.1	45.9	34.2	77.2	79.3	76.0	47.3	49.4	67.5	59.5	203.4	50.2	109.6	61.7	89.0	56.6	76.5	52.8	81.8	93.1	69.7	62.6	78.8	26.9	28.6	49.7	67.8	65.5	38.3	64.3	29.1	79.1	38.0	93.0	111.5	41.7	89.4	65.9	0.0	10.3	3.0	27.8	18.0	17.8	15.1	12.8	22.0	16.8	11.7	12.2	16.8	0.2	22.0	23.4	11.7	14.3	15.4	27.7	29.3	28.4	36.5	29.8	28.6	32.3	28.2	33.3	26.2	30.3	28.5	28.1	6.4	12.5	22.9	16.5	9.4	16.6	20.9	19.9	19.7	13.1	13.5	5.6	44.3	14.2	16.5	16.7	26.4	12.3	25.2	33.2	29.9	1.2	31.3	25.2	19.6	14.9	11.6	18.5	19.5	36.2	17.6	26.0	19.6	4.5	18.6	24.3	24.9	21.6	16.8	23.2	17.0	22.4	12.3	8.2	3.2	17.4	11.9	16.0	11.2	12.1	21.0	17.5	17.6	14.5	26.4	17.0	18.4	25.5	12.1	16.3	21.4	14.6	17.9	39.5	14.6	19.9	26.6	32.0	20.8	13.2	25.7	20.4	23.1	25.0	11.7
PPP6C	PP6	ENSG00000119414	"Protein phosphatase 6 catalytic subunit"	O00743	9	125146573-125189939	"Cancer-related genes, Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Cell cycle, Immunity, Innate immunity"	"Hydrolase, Protein phosphatase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA050940	Uncertain					NA	NA			"Cluster 18: Basophils - Vesicular transport"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 16: U-266 - Nucleosome"	"Cluster 59: Non-specific - Transcription"			"HPA050940: AB_2681283"	"unprognostic (6.45e-2)"	"unprognostic (4.01e-3)"	"unprognostic (7.12e-2)"	"unprognostic (5.36e-2)"	"unprognostic (2.78e-2)"	"unprognostic (2.92e-2)"	"unprognostic (2.57e-3)"	"unprognostic (1.53e-1)"	"unprognostic (2.14e-1)"	"unprognostic (2.44e-1)"	"unprognostic (1.71e-2)"	"unprognostic (2.28e-2)"	"prognostic favorable (4.50e-6)"	"unprognostic (1.54e-2)"	"unprognostic (3.51e-1)"	"unprognostic (1.12e-2)"	"unprognostic (1.12e-1)"	32.8	25.2	20.9	24.4	22.6	42.2	29.9	22.1	27.0	22.8	18.1	28.4	20.4	19.7	23.7	25.0	18.5	18.6	21.6	21.7	22.0	32.6	25.1	24.0	30.8	21.1	20.4	19.6	27.7	32.6	14.7	19.5	21.6	20.2	30.9	17.5	26.1	19.7	69.9	23.5	22.5	21.8	21.8	27.6	20.9	28.1	20.7	38.9	31.5	53.5	36.2	22.9	18.7	26.9	32.6	23.4	41.6	39.3	43.6	36.2	41.8	33.7	36.5	48.7	40.4	37.6	33.5	46.5	25.5	45.6	41.3	64.7	56.8	36.7	56.2	42.0	27.3	38.3	33.5	33.6	35.7	67.6	50.8	30.0	49.2	40.1	38.1	37.5	46.2	52.6	45.7	52.2	53.3	48.6	64.0	42.5	38.8	90.4	42.8	51.5	62.7	62.2	42.1	32.3	42.8	42.3	60.3	47.8	41.0	35.0	74.0	42.0	45.3	29.7	28.4	58.4	45.5	57.5	112.4	62.3	40.1	43.5	49.4	61.7	21.8	35.9	22.4	28.6	27.2	26.8	28.2	25.3	24.0	20.2	27.6	26.5	50.9	23.7	33.6	17.2	38.9	25.8	20.9	22.6	22.1	27.0	21.7	22.0	21.1	20.4	21.6	21.8	20.7	26.9	39.8	41.7	37.8	20.5	62.6	77.4	55.5	64.0	60.3	14.0	42.5	28.3	37.9	31.5	43.1	27.6	8.4	45.7	43.7	47.5	56.7	46.3	130.5	22.7	21.5	44.8	47.9	60.2	35.3	55.2	57.5	37.2	34.1	24.7	45.0	20.4	48.5	41.7	52.3	15.2	30.0	43.0	67.1	61.2	60.9	83.3	29.8	51.8	44.4	32.8	60.0	29.2	40.2	22.6	35.8	48.2	37.4	36.1	82.7	47.2	43.7	79.1	34.3	12.5	52.6	28.7	46.1	124.8	48.3	76.8	87.5	87.2	57.1	23.2	43.9	59.8
PPT1	"CLN1, INCL, PPT"	ENSG00000131238	"Palmitoyl-protein thioesterase 1"	P50897	1	40072710-40097260	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"Sensory transduction, Vision"	Hydrolase	"Disease variant, Neurodegeneration, Neuronal ceroid lipofuscinosis"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Hofbauer cells: 251.9;Kupffer cells: 315.8;Langerhans cells: 328.8;Macrophages: 271.3;monocytes: 227.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in all"	4	"classical monocyte: 1254.3;eosinophil: 624.2;intermediate monocyte: 1006.3;myeloid DC: 1091.1;neutrophil: 683.9;non-classical monocyte: 815.7"	"Group enriched"	"Detected in all"	4	"dendritic cells: 1091.1;granulocytes: 683.9;monocytes: 1254.3"	"Cell line enhanced"	"Detected in all"		"SK-BR-3: 1082.7;THP-1: 1449.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA021546	Supported		Supported	"Golgi apparatus,Vesicles"	"Intracellular and membrane"	NA	NA		240000	"Cluster 25: Monocytes - Inflammatory response"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 43: THP-1 - Innate immune response"	"Cluster 4: Macrophages - Innate immune response"	"Golgi apparatus, Vesicles"		"HPA021546: AB_1855667"	"unprognostic (5.02e-2)"	"unprognostic (2.73e-1)"	"unprognostic (1.64e-1)"	"unprognostic (2.06e-3)"	"unprognostic (6.68e-2)"	"unprognostic (2.83e-2)"	"prognostic unfavorable (6.98e-8)"	"unprognostic (1.39e-1)"	"unprognostic (1.78e-1)"	"unprognostic (1.23e-1)"	"unprognostic (8.16e-2)"	"unprognostic (2.39e-1)"	"unprognostic (5.20e-3)"	"unprognostic (1.75e-1)"	"unprognostic (2.30e-1)"	"unprognostic (2.93e-2)"	"unprognostic (2.08e-2)"	69.8	59.4	92.9	92.7	95.6	117.5	95.7	100.4	135.9	70.1	106.1	50.5	32.1	72.7	60.1	45.1	55.4	57.1	45.3	93.6	101.2	75.8	54.1	128.5	93.9	97.0	96.7	68.6	42.6	79.2	39.0	74.8	99.6	73.4	58.8	89.4	56.8	63.2	21.3	40.3	39.2	95.3	101.6	177.0	45.1	37.6	99.1	78.0	60.0	37.1	75.1	79.1	34.7	113.5	115.6	62.5	93.7	81.0	106.5	92.1	209.8	68.4	127.9	153.0	183.3	350.1	270.5	140.1	118.1	65.2	112.2	209.5	154.9	112.7	163.6	186.4	151.4	100.3	127.2	155.5	137.5	233.7	158.9	103.1	107.5	108.7	126.4	79.7	190.9	108.8	167.7	247.0	80.6	168.1	109.8	88.3	258.3	163.9	93.8	116.0	263.7	226.1	89.2	152.0	114.1	96.9	247.9	1082.7	298.6	111.7	199.3	1449.6	85.2	100.7	147.1	70.7	174.9	161.2	383.8	133.9	109.4	408.7	155.5	85.7	1254.3	624.2	122.2	1006.3	137.9	118.8	171.5	131.3	1091.1	118.6	227.0	168.3	683.9	100.3	815.7	101.8	204.1	1586.9	92.9	95.6	100.4	135.9	93.6	101.2	97.0	96.7	99.6	101.6	99.1	113.5	45.2	28.9	47.7	19.9	33.3	39.6	77.1	30.8	34.7	46.6	55.3	37.5	15.7	41.5	40.0	38.6	16.7	51.7	28.9	4.7	5.9	59.0	64.8	13.8	46.4	49.6	19.9	40.1	28.4	42.1	66.5	56.6	14.8	18.2	84.9	34.6	47.5	9.3	251.9	25.2	39.2	8.1	20.3	315.8	328.8	87.6	31.4	271.3	67.6	31.9	227.2	120.3	28.8	27.6	22.7	22.2	6.0	39.5	34.2	42.4	3.2	18.5	32.3	37.0	19.7	30.5	49.3	17.5	33.0	19.1	27.3	41.2	43.5	39.4	11.4	35.6
PPTC7	TA-PP2C	ENSG00000196850	"Protein phosphatase targeting COQ7"	Q8NI37	12	110533245-110583318	"Enzymes, Predicted intracellular proteins"		"Hydrolase, Protein phosphatase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"tongue: 140.0"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039335, HPA040614"	Approved		Approved	"Plasma membrane,Cytosol"		NA	NA			"Cluster 33: Neutrophils - Chromatin organization"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 41: Macrophages - Immune response"	"Plasma membrane, Cytosol"		"HPA039335: AB_10805474, HPA040614: AB_10795526"	"unprognostic (2.44e-1)"	"unprognostic (2.38e-2)"	"unprognostic (1.11e-1)"	"unprognostic (9.44e-2)"	"unprognostic (2.38e-1)"	"unprognostic (3.46e-2)"	"unprognostic (2.14e-1)"	"unprognostic (3.51e-2)"	"unprognostic (1.47e-2)"	"prognostic unfavorable (1.43e-5)"	"prognostic unfavorable (6.76e-4)"	"unprognostic (1.09e-1)"	"prognostic favorable (4.48e-5)"	"unprognostic (5.34e-2)"	"unprognostic (2.83e-1)"	"unprognostic (5.01e-3)"	"unprognostic (1.83e-1)"	18.8	25.5	6.9	16.1	7.3	52.3	13.4	12.1	11.1	15.5	8.3	15.7	13.4	14.3	6.4	21.6	11.3	15.0	40.0	6.5	14.1	21.5	21.0	15.6	20.7	12.7	12.4	13.1	13.2	30.6	8.4	10.7	12.1	12.3	16.7	15.6	17.8	13.4	88.7	21.5	13.2	16.1	9.2	15.2	11.9	14.0	13.0	18.4	11.6	140.0	18.4	19.0	19.1	7.4	24.3	13.6	11.4	12.0	27.8	24.3	16.3	10.9	14.3	11.7	11.7	15.4	9.3	42.2	11.1	10.8	16.7	23.0	23.1	25.3	23.5	30.9	19.1	37.5	14.4	16.7	26.3	41.8	29.6	21.0	40.7	16.6	48.4	17.4	22.5	28.8	28.3	11.7	19.2	6.3	37.2	35.7	16.1	13.0	25.0	30.7	15.3	25.8	48.7	26.7	18.4	14.2	20.6	28.2	24.4	11.0	13.4	22.1	25.9	10.7	11.5	32.8	18.6	33.5	40.0	46.7	18.0	22.6	21.4	0.0	0.6	0.5	0.8	0.5	0.8	0.4	0.6	0.6	0.4	0.7	0.7	0.6	2.1	0.6	0.4	0.5	0.5	0.2	6.9	7.3	12.1	11.1	6.5	14.1	12.7	12.4	12.1	9.2	13.0	7.4	14.1	22.4	28.3	16.0	35.7	91.9	53.1	33.9	56.9	8.6	20.2	12.8	105.4	12.8	36.0	9.2	14.6	7.5	28.2	36.7	17.6	7.7	29.7	34.4	20.4	22.3	16.8	7.8	15.5	8.2	8.4	26.1	12.8	63.3	23.5	8.6	15.4	29.5	17.4	13.5	19.8	15.2	30.5	28.3	97.6	33.2	11.5	30.8	33.8	21.5	31.9	4.8	20.6	19.1	11.7	14.6	15.1	9.8	28.2	57.3	16.5	13.1	35.4	23.8	13.1	22.8	22.4	15.9	24.1	57.1	104.3	6.7	28.7	8.2	17.2	77.5
PRCP	"HUMPCP, PCP"	ENSG00000137509	Prolylcarboxypeptidase	P42785	11	82822936-82970584	"Enzymes, Plasma proteins, Predicted intracellular proteins"		"Carboxypeptidase, Hydrolase, Protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Hepatic stellate cells: 348.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"ASC diff: 463.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA017065, HPA071115"	Approved		Supported	Vesicles	"Intracellular and membrane"	NA	NA		42000000	"Cluster 28: Myeloid DCs - Unknown function"	"Cluster 68: Epididymis - Unknown function"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	Vesicles		"HPA017065: AB_1855676, HPA071115: "	"unprognostic (3.24e-1)"	"unprognostic (2.25e-1)"	"unprognostic (1.76e-1)"	"unprognostic (1.51e-1)"	"unprognostic (2.54e-1)"	"unprognostic (1.33e-2)"	"unprognostic (9.22e-2)"	"unprognostic (1.42e-1)"	"unprognostic (7.97e-2)"	"unprognostic (2.61e-1)"	"unprognostic (2.70e-1)"	"unprognostic (1.88e-2)"	"prognostic favorable (2.65e-6)"	"unprognostic (7.16e-2)"	"unprognostic (1.73e-2)"	"unprognostic (3.49e-1)"	"unprognostic (4.07e-1)"	74.8	87.3	81.1	57.8	82.1	37.7	70.0	84.3	109.1	91.9	95.0	49.3	28.6	62.9	81.4	62.1	57.0	64.3	70.0	76.6	85.6	144.7	151.9	58.1	92.1	84.4	82.1	53.5	37.9	78.4	34.5	152.8	80.9	52.5	46.6	21.9	85.6	55.5	15.9	54.1	31.8	80.8	89.0	54.0	32.0	41.8	86.0	33.7	63.7	28.5	85.0	100.2	57.5	86.7	34.9	41.8	49.6	121.0	463.5	146.7	67.1	67.5	131.9	70.9	97.0	103.5	70.7	55.9	100.7	117.9	72.6	53.2	53.7	45.2	72.0	43.9	38.3	37.7	56.5	76.7	86.2	31.0	124.7	122.0	39.3	72.7	68.6	166.5	224.0	26.3	39.1	69.8	72.7	19.5	4.9	171.7	33.9	90.3	31.1	27.1	97.0	65.1	118.0	71.2	24.0	51.9	101.9	60.2	41.5	80.6	66.6	49.6	65.0	78.8	77.4	71.1	33.5	64.2	113.6	46.3	32.9	41.7	44.5	53.5	76.9	50.9	13.7	79.0	16.1	31.7	14.0	15.9	140.2	34.2	12.0	17.4	89.0	34.7	64.8	27.9	14.8	49.6	81.1	82.1	84.3	109.1	76.6	85.6	84.4	82.1	80.9	89.0	86.0	86.7	86.9	19.2	12.9	58.8	45.5	31.4	41.5	53.4	25.0	11.7	26.2	25.1	26.6	37.1	25.2	62.5	2.1	65.1	29.0	9.8	29.4	32.9	44.9	17.4	37.7	180.4	19.7	13.7	42.2	12.0	120.1	73.6	23.9	29.9	12.7	18.2	348.7	65.4	80.7	16.8	38.5	19.1	14.2	152.9	118.9	47.6	44.1	88.0	71.2	33.7	79.5	53.5	28.8	34.7	10.5	8.2	10.2	46.3	62.2	23.3	3.9	83.8	9.1	5.3	65.7	25.5	25.6	60.8	6.3	54.3	34.9	52.9	22.3	27.7	20.9	39.2
PRDX6	"1-Cys, aiPLA2, AOP2, KIAA0106, MGC46173, NSGPx, p29, PRX"	ENSG00000117592	"Peroxiredoxin 6"	P30041	1	173477330-173488815	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Lipid degradation, Lipid metabolism"	"Antioxidant, Hydrolase, Multifunctional enzyme, Oxidoreductase, Peroxidase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Distal enterocytes: 1315.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA006983, CAB008663"	Supported		Supported	"Plasma membrane,Cytosol"		NA	NA		120000000	"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 53: Intestinal epithelial cells - Unknown function"	"Plasma membrane, Cytosol"		"CAB008663: AB_1620994, HPA006983: AB_1079595"	"unprognostic (9.92e-2)"	"unprognostic (1.50e-1)"	"unprognostic (3.67e-1)"	"unprognostic (2.99e-3)"	"unprognostic (1.96e-1)"	"prognostic unfavorable (1.23e-5)"	"unprognostic (5.71e-3)"	"unprognostic (2.80e-2)"	"unprognostic (5.27e-3)"	"unprognostic (3.96e-3)"	"unprognostic (3.19e-3)"	"unprognostic (1.59e-1)"	"prognostic unfavorable (9.51e-4)"	"unprognostic (2.50e-1)"	"unprognostic (7.12e-2)"	"unprognostic (1.15e-1)"	"unprognostic (4.73e-3)"	340.7	157.5	169.5	68.3	181.3	100.1	211.2	197.6	210.1	112.3	164.8	189.1	46.4	108.8	206.3	127.9	149.8	71.9	261.8	184.1	196.6	184.4	482.5	116.7	72.2	181.0	198.3	115.5	114.4	217.5	67.4	70.7	187.5	152.1	221.6	53.9	85.6	99.0	563.5	106.6	59.8	160.2	175.8	70.7	135.2	119.1	176.7	70.7	106.0	382.4	79.0	99.5	109.8	185.5	420.3	127.7	204.7	230.9	778.5	372.7	169.5	843.9	284.3	342.7	241.8	243.9	276.4	272.4	256.4	694.2	120.4	239.8	272.0	259.9	279.0	234.0	243.6	179.5	200.0	277.7	425.7	191.3	56.1	301.0	262.6	181.3	256.6	210.8	339.5	106.7	405.4	52.8	392.9	86.3	131.7	249.1	456.2	219.8	760.5	154.5	236.6	277.0	518.1	95.4	94.9	173.4	285.0	334.0	199.2	296.3	283.8	262.9	228.2	132.5	149.9	201.8	229.5	76.4	123.2	220.7	159.4	162.3	124.3	36.2	42.5	24.8	29.8	39.8	32.8	32.6	29.8	38.4	53.5	24.4	39.8	47.9	25.2	25.7	36.5	79.7	36.1	58.1	169.5	181.3	197.6	210.1	184.1	196.6	181.0	198.3	187.5	175.8	176.7	185.5	278.1	176.3	170.8	127.3	127.4	235.4	404.1	382.8	209.5	31.9	186.1	250.7	528.6	301.7	228.6	277.7	29.2	714.3	158.6	1315.9	860.8	178.6	237.5	206.9	226.8	191.8	142.1	449.5	13.8	202.3	939.1	307.0	111.6	200.0	348.6	216.6	214.2	1120.2	345.0	45.4	13.2	257.4	205.4	164.3	161.0	667.5	340.5	227.1	183.2	17.8	212.9	462.5	83.4	12.5	15.4	147.2	663.4	416.8	176.4	427.1	264.4	827.3	209.1	52.0	184.1	185.7	253.8	123.5	76.8	305.9	264.1	963.5	157.7	512.5	303.6	308.9
PREP		ENSG00000085377	"Prolyl endopeptidase"	P48147	6	105273218-105454062	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"		"Hydrolase, Protease, Serine protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 84.8"	"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 79.7;Syncytiotrophoblasts: 67.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB025414, HPA031388, HPA031389, HPA031390"	Supported		Supported	Cytosol		NA	NA		1700000	"Cluster 27: Non-specific - Gene expression"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	Cytosol		"CAB025414: , HPA031388: AB_2673855, HPA031389: AB_2673856, HPA031390: AB_2673857"	"unprognostic (3.05e-2)"	"unprognostic (9.09e-3)"	"unprognostic (2.85e-2)"	"unprognostic (5.46e-2)"	"unprognostic (3.36e-1)"	"prognostic unfavorable (3.33e-4)"	"unprognostic (2.63e-3)"	"unprognostic (2.39e-1)"	"unprognostic (6.78e-2)"	"unprognostic (5.81e-2)"	"unprognostic (2.66e-2)"	"unprognostic (1.15e-1)"	"unprognostic (4.47e-3)"	"unprognostic (2.74e-2)"	"unprognostic (8.98e-2)"	"unprognostic (6.59e-2)"	"unprognostic (2.33e-1)"	17.3	17.4	7.2	14.6	8.1	14.3	17.7	7.4	12.0	15.2	7.8	32.1	23.6	15.8	12.1	21.1	13.0	8.7	22.5	8.8	7.3	11.3	19.0	16.2	13.6	6.7	7.7	16.0	19.2	20.5	13.0	17.8	6.8	11.6	37.5	15.4	18.6	9.0	84.8	33.4	25.6	15.3	6.6	14.3	18.7	21.4	8.8	16.4	12.3	46.9	16.2	21.4	17.5	8.5	22.3	26.9	27.9	32.1	63.1	37.1	27.7	28.6	27.0	37.2	39.0	35.9	14.2	28.5	26.8	33.9	35.0	33.3	41.8	86.5	42.7	41.8	37.4	38.1	21.7	40.0	25.3	40.5	26.2	35.8	53.4	27.6	71.7	28.0	35.4	50.1	67.4	49.8	45.5	38.8	25.8	41.4	27.9	44.2	25.0	41.1	48.4	18.3	28.2	53.8	36.0	51.8	25.3	42.0	21.7	35.3	17.9	61.9	36.1	17.3	23.9	21.6	36.2	14.2	9.7	38.5	30.4	42.6	56.6	5.5	15.2	8.4	16.3	16.8	16.8	9.3	14.2	17.1	16.5	6.9	12.9	15.5	0.8	19.9	22.7	7.0	13.6	13.5	7.2	8.1	7.4	12.0	8.8	7.3	6.7	7.7	6.8	6.6	8.8	8.5	6.3	3.2	6.7	22.9	10.1	10.8	6.8	12.0	5.7	5.1	6.0	5.5	14.8	7.2	13.6	7.3	14.6	28.2	14.5	19.3	5.9	10.4	1.4	6.6	15.1	10.1	19.3	11.2	79.7	11.7	35.9	10.6	24.5	11.6	13.4	11.2	7.5	15.1	15.0	13.5	48.3	29.4	10.2	14.2	10.8	3.2	10.8	13.3	5.4	27.2	19.1	3.3	5.2	28.6	18.7	18.0	29.1	9.1	11.0	5.3	18.5	8.8	4.8	10.4	0.0	8.3	10.3	3.9	18.8	12.9	8.5	67.9	16.1	14.4	38.2	8.5
PROC		ENSG00000115718	"Protein C, inactivator of coagulation factors Va and VIIIa"	P04070	2	127418427-127429242	"Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Blood coagulation, Hemostasis"	"Hydrolase, Protease, Serine protease"	"Cancer-related genes, Disease variant, FDA approved drug targets, Thrombophilia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	40	"liver: 598.5"	"Cell type enriched"	"Detected in some"	5	"Hepatocytes: 432.9"	"Cancer enriched"	"Detected in many"	22	"liver cancer: 118.3"	"Low region specificity"	"Detected in many"			"Immune cell enriched"	"Detected in some"	9	"plasmacytoid DC: 59.7"	"Lineage enriched"	"Detected in many"	9	"dendritic cells: 59.7"	"Cell line enriched"	"Detected in some"	16	"Hep G2: 156.1"					"Low region specificity"	"Detected in all"			"HPA005550, CAB016721, CAB016792"	Approved				"Secreted to blood"	NA	NA		5200000000	"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 62: Liver - Hemostasis"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"			"CAB016721: , CAB016792: , HPA005550: AB_1079687"	"unprognostic (2.46e-2)"	"unprognostic (1.08e-1)"	"unprognostic (1.38e-1)"	"unprognostic (1.58e-1)"	"unprognostic (6.64e-2)"	"unprognostic (3.13e-2)"	"unprognostic (4.90e-3)"	"unprognostic (2.63e-1)"	"unprognostic (1.67e-1)"	"unprognostic (3.29e-1)"	"unprognostic (3.74e-3)"	"unprognostic (2.56e-2)"	"unprognostic (8.12e-3)"	"unprognostic (2.01e-2)"	"unprognostic (1.71e-1)"	"unprognostic (4.60e-3)"	"unprognostic (8.06e-2)"	0.2	0.0	0.6	0.1	1.1	1.1	0.1	0.6	1.0	0.4	0.0	1.0	0.8	0.1	0.1	0.1	0.2	0.6	0.1	0.6	1.0	14.8	598.5	0.2	0.6	1.6	0.8	0.2	0.3	0.0	0.3	0.1	1.5	0.2	0.6	0.2	0.2	0.1	0.2	0.6	0.8	0.0	0.4	0.4	2.6	0.1	0.8	0.6	0.2	0.0	0.3	0.4	0.2	1.1	0.1	2.3	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.5	4.1	0.0	0.9	0.1	0.4	9.5	0.0	0.3	0.0	0.0	0.2	0.1	7.8	156.1	0.0	0.3	0.2	0.0	0.0	0.0	0.0	0.3	0.0	0.6	0.0	0.0	0.0	0.0	0.3	1.6	0.4	2.3	0.7	0.0	0.1	0.0	0.0	0.9	0.4	0.0	1.0	0.1	0.0	0.1	0.2	0.0	0.0	0.1	0.1	0.0	0.1	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.3	0.1	0.0	0.0	6.3	0.0	0.0	59.7	0.0	0.3	0.6	1.1	0.6	1.0	0.6	1.0	1.6	0.8	1.5	0.4	0.8	1.1	0.0	0.0	0.0	0.3	4.1	0.8	0.4	11.2	0.0	0.0	0.1	0.0	0.4	47.1	1.2	0.0	0.0	0.0	24.0	3.9	5.9	0.5	0.1	3.4	0.1	0.6	10.3	18.7	0.1	0.2	0.0	0.7	2.0	0.2	0.0	0.0	12.1	432.9	3.7	0.0	0.5	9.3	0.0	9.3	4.0	0.1	0.0	2.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.7	8.1	0.0	0.0	0.0	3.8	84.8	3.4	0.0	0.0	0.2	0.3	0.1	0.2	0.0	0.1	0.1	1.1	0.0	1.8	0.3
PRORP	"KIAA0391, MRPP3"	ENSG00000100890	"Protein only RNase P catalytic subunit"	O15091	14	35121846-35277622	"Enzymes, Predicted intracellular proteins"	"tRNA processing"	"Hydrolase, Nuclease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"Cardiomyocytes: 1.8;dendritic cells: 1.1;Hofbauer cells: 1.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											HPA020459	Approved		Supported	Nucleoplasm,Mitochondria		NA	NA			"Cluster 13: T-cells - Unknown function"	"Cluster 34: Non-specific - Transcription"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 24: Non-specific - Transcription regulation"	Mitochondria	Nucleoplasm	"HPA020459: AB_2670449"	"unprognostic (6.44e-3)"	"unprognostic (8.10e-2)"	"unprognostic (7.71e-3)"	"unprognostic (4.90e-2)"	"unprognostic (3.42e-2)"	"unprognostic (1.74e-1)"	"unprognostic (2.76e-2)"	"unprognostic (8.67e-2)"	"unprognostic (1.94e-2)"	"unprognostic (3.25e-4)"	"unprognostic (1.75e-1)"	"unprognostic (1.80e-1)"	"unprognostic (9.67e-5)"	"unprognostic (2.56e-1)"	"unprognostic (1.67e-1)"	"unprognostic (2.10e-2)"	"unprognostic (6.65e-2)"	11.3	17.0	11.0	17.0	12.2	12.2	13.9	12.4	16.1	13.6	16.6	19.9	15.3	8.4	16.7	19.2	11.8	10.4	13.7	11.4	12.1	25.0	24.9	12.5	21.2	13.2	12.5	7.0	10.6	19.3	9.7	11.0	12.8	10.6	20.8	6.2	13.1	9.6	15.1	17.3	14.5	11.9	11.6	13.6	13.6	12.1	13.1	31.1	15.6	17.1	22.5	15.4	11.9	14.4	47.5	34.9	23.6	33.1	25.1	21.0	22.7	31.1	25.3	35.9	26.1	35.8	26.3	53.0	39.0	27.2	9.9	33.9	43.8	47.3	36.5	39.2	12.9	22.6	24.9	77.9	25.2	27.2	23.0	28.3	37.7	33.9	31.6	30.2	50.0	41.3	38.4	13.6	42.5	54.9	46.0	33.3	26.8	30.4	33.4	42.9	40.4	28.1	52.6	44.6	24.0	25.0	40.0	43.3	26.8	29.0	55.4	23.9	44.5	30.7	25.7	22.1	25.8	15.5	40.4	53.9	14.5	32.0	32.5	30.9	10.3	7.2	30.3	9.6	43.9	20.1	47.3	32.8	13.8	14.4	41.6	30.1	14.4	24.7	8.2	20.4	56.1	24.3	11.0	12.2	12.4	16.1	11.4	12.1	13.2	12.5	12.8	11.6	13.1	14.4	0.7	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.9	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.6	0.9	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.7	0.5	0.0	0.0	0.0
PRSS1	TRY1	ENSG00000204983	"Serine protease 1"	P07477	7	142749468-142753076	"Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted secreted proteins"	Digestion	"Hydrolase, Protease, Serine protease"	"Cancer-related genes, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	1923	"pancreas: 341429.7"	"Cell type enriched"	"Detected in some"	28	"Exocrine glandular cells: 57138.3"	"Cancer enriched"	"Detected in many"	224	"pancreatic cancer: 1920.3"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	23	"OE19: 10.6;RPMI-8226: 4.5;U-2 OS: 2.8"									"CAB025487, CAB025538, HPA062452, HPA063471"	Enhanced		Approved	"Endoplasmic reticulum,Vesicles"	"Secreted to digestive system"	NA	NA		100000000000	"Cluster 35: T-regs - Unknown function"	"Cluster 25: Pancreas - Digestion"	"Cluster 21: OE19 - Mitochondria"	"Cluster 1: Pancreatic cells - Digestion"	Vesicles	"Endoplasmic reticulum"	"CAB025487: , CAB025538: , HPA062452: AB_2684768, HPA063471: AB_2685017"	"unprognostic (6.55e-5)"	"unprognostic (5.28e-1)"	"unprognostic (7.58e-2)"	"prognostic unfavorable (6.41e-6)"				"unprognostic (8.26e-2)"		"prognostic favorable (7.05e-4)"	"unprognostic (1.35e-1)"			"unprognostic (3.93e-2)"	"unprognostic (1.96e-1)"	"prognostic favorable (4.91e-4)"	"unprognostic (3.12e-1)"	45.2	9.9	0.0	4.7	0.0	0.0	25.7	0.0	0.0	19.9	0.0	11.2	54.5	8.9	0.8	15.2	5.6	0.0	51.0	0.0	0.0	9.6	29.7	6.4	6.5	0.0	0.0	177.5	341429.7	0.1	10.3	13.9	0.0	15.2	0.0	0.0	44.2	4.2	8.9	12.1	12.7	0.0	0.0	13.4	77.1	6.9	0.0	0.0	6.4	0.0	0.0	4.7	8.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.6	0.0	0.0	0.0	4.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.8	0.0	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	100.7	0.0	0.1	0.0	3.6	0.0	0.0	0.0	57138.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.5	0.0	0.0	119.4	0.6	0.0	0.0	0.0	1985.6	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	3.3	0.0	0.0	0.0	0.6	0.0	0.1	0.1	0.2	0.2
PRSS2	TRY2	ENSG00000275896	"Serine protease 2"	P07478	7	142760398-142774564	"Enzymes, Human disease related genes, Plasma proteins, Predicted secreted proteins"	Digestion	"Hydrolase, Protease, Serine protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	452	"pancreas: 239420.0"	"Cell type enriched"	"Detected in some"	11	"Exocrine glandular cells: 108258.7"	"Cancer enriched"	"Detected in many"	72	"pancreatic cancer: 3463.4"	"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	8	"basophil: 4.1;T-reg: 2.9"	"Group enriched"	"Detected in many"	8	"granulocytes: 4.1;T-cells: 2.9"	"Cell line enhanced"	"Detected in some"		"OE19: 21.0;RPMI-8226: 67.5;U-2 OS: 15.2"									"HPA062452, HPA063471"	Supported		Approved	"Endoplasmic reticulum,Vesicles"	"Secreted to digestive system"	NA	NA		890000000	"Cluster 41: Basophils - Cellular respiration"	"Cluster 25: Pancreas - Digestion"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 1: Pancreatic cells - Digestion"	Vesicles	"Endoplasmic reticulum"	"HPA062452: AB_2684768, HPA063471: AB_2685017"	"prognostic favorable (2.32e-4)"	"unprognostic (3.80e-1)"	"unprognostic (2.46e-1)"	"unprognostic (3.30e-3)"		"unprognostic (1.99e-2)"	"unprognostic (3.06e-2)"	"unprognostic (1.36e-1)"		"unprognostic (4.62e-3)"	"unprognostic (1.48e-1)"	"unprognostic (4.65e-2)"	"unprognostic (1.55e-3)"	"unprognostic (1.58e-2)"	"unprognostic (3.50e-1)"	"unprognostic (5.36e-3)"	"unprognostic (1.18e-1)"	65.1	12.5	0.1	0.2	0.1	3.2	25.4	0.0	0.1	27.6	0.0	12.6	358.5	11.4	0.0	18.2	9.6	0.1	25.0	0.0	0.0	9.4	32.2	8.2	1.3	0.0	0.0	64.9	239420.0	0.0	13.4	8.1	0.0	17.2	0.0	0.0	25.4	0.9	10.1	11.3	529.2	0.1	0.0	16.9	54.7	8.6	0.0	0.9	8.3	0.0	0.0	7.0	10.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.6	0.0	0.0	0.0	0.0	0.0	0.0	2.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	2.4	4.4	0.5	0.0	0.0	0.0	1.9	0.0	21.0	0.0	0.0	0.0	67.5	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	15.2	0.9	3.8	0.0	2.9	0.6	0.0	0.0	0.0	4.1	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	2.9	0.2	0.1	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	378.7	0.0	0.4	0.1	11.4	0.0	0.0	0.0	108258.7	0.0	0.3	4.1	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.7	0.0	0.0	0.0	0.0	0.0	15.5	0.0	0.0	348.9	0.0	0.0	0.0	0.0	9565.7	8.9	0.0	0.1	0.0	60.0	0.1	0.0	0.0	0.0	0.0	36.3	0.0	0.0	0.0	0.0	0.0	0.1	0.1	85.4	0.2
PRSS3	"PRSS4, TRY3, TRY4"	ENSG00000010438	"Serine protease 3"	P35030	9	33750679-33799231	"Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	Digestion	"Hydrolase, Protease, Serine protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	268	"pancreas: 31113.6"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 1022.9;Exocrine glandular cells: 2040.4;Pancreatic endocrine cells: 478.8;Paneth cells: 969.9;Proximal enterocytes: 1127.1"	"Group enriched"	"Detected in many"	7	"colorectal cancer: 72.8;pancreatic cancer: 104.4;stomach cancer: 43.8"	"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in some"	104	"basophil: 158.7"	"Lineage enriched"	"Detected in many"	104	"granulocytes: 158.7"	"Group enriched"	"Detected in many"	5	"OE19: 316.6;PC-3: 852.5"									"HPA062452, HPA063471"	Supported		Approved	"Endoplasmic reticulum,Vesicles"	"Secreted to digestive system"	NA	NA		700000000	"Cluster 38: Basophils - Unknown function"	"Cluster 25: Pancreas - Digestion"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Vesicles	"Endoplasmic reticulum"	"HPA062452: AB_2684768, HPA063471: AB_2685017"	"unprognostic (6.90e-2)"	"unprognostic (2.26e-1)"	"unprognostic (1.69e-2)"	"prognostic unfavorable (4.30e-4)"	"unprognostic (3.18e-1)"	"unprognostic (1.64e-1)"	"unprognostic (3.29e-2)"	"unprognostic (5.89e-3)"	"unprognostic (1.38e-1)"	"unprognostic (2.06e-3)"	"unprognostic (1.10e-2)"	"unprognostic (8.94e-2)"	"unprognostic (7.75e-4)"	"unprognostic (5.46e-3)"	"unprognostic (2.13e-1)"	"unprognostic (8.79e-2)"	"unprognostic (4.96e-1)"	3.8	4.6	23.5	7.2	29.3	0.6	1.7	25.8	35.4	30.8	16.9	87.0	92.6	0.4	0.0	116.2	0.3	22.8	6.3	28.2	25.6	3.7	12.4	0.6	0.7	25.0	24.5	12.9	31113.6	0.0	0.7	1.7	25.7	1.1	77.8	0.3	20.9	0.3	0.5	79.7	105.4	3.1	19.4	0.7	22.8	5.1	25.6	0.8	0.4	0.0	15.2	4.2	56.9	24.7	12.0	13.7	0.7	0.0	0.2	5.9	0.1	33.6	7.7	4.1	1.6	34.3	3.0	0.0	0.2	14.9	0.2	15.0	0.0	31.7	10.1	0.4	0.2	0.0	1.1	0.0	2.7	0.0	0.0	0.2	0.0	10.8	110.2	0.3	68.8	0.2	0.0	0.0	0.0	0.2	0.7	0.4	0.2	316.6	852.5	0.0	0.0	0.0	0.0	1.7	0.3	81.2	0.2	0.0	0.0	0.5	0.0	0.0	78.3	0.0	0.0	12.8	0.0	0.0	0.0	0.1	18.1	0.0	0.1	158.7	0.0	0.0	0.2	1.5	1.2	0.0	0.2	0.4	0.5	0.0	0.0	0.0	0.0	0.4	1.5	0.0	0.0	0.3	23.5	29.3	25.8	35.4	28.2	25.6	25.0	24.5	25.7	19.4	25.6	24.7	0.1	0.0	0.0	0.7	1.9	57.1	0.6	1.3	0.0	0.2	0.1	2.8	1.0	47.1	1.2	1.8	0.0	0.0	0.1	1022.9	3.9	43.2	31.4	0.0	0.0	3.2	192.6	0.0	32.8	2040.4	0.0	0.8	39.3	0.0	8.9	0.0	0.7	4.2	0.0	0.0	4.7	146.4	0.0	0.3	12.1	79.7	1.5	1.2	7.2	3.7	5.7	0.0	0.0	3.5	1.2	478.8	969.9	0.7	0.3	12.1	1127.1	14.7	0.1	0.2	0.0	0.0	1.7	0.5	0.9	1.1	134.1	0.1	2.1	0.0	329.0	56.2
PRSS58	TRYX3	ENSG00000258223	"Serine protease 58"	Q8IYP2	7	142252143-142258058	"Enzymes, Predicted secreted proteins"		"Hydrolase, Protease, Serine protease"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	180	"testis: 25.8"	"Group enriched"	"Detected in some"	129	"Early spermatids: 640.5;Late spermatids: 243.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"								"Secreted in male reproductive system"	NA	NA				"Cluster 36: Testis - Spermatogenesis"		"Cluster 29: Early spermatids - Spermatogenesis"																					0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	25.8	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	640.5	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	243.0	3.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0
PRTN3	"ACPA, AGP7, C-ANCA, MBT, P29, PR-3"	ENSG00000196415	"Proteinase 3"	P24158	19	840999-848175	"Candidate cardiovascular disease genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted secreted proteins"	"Collagen degradation"	"Hydrolase, Protease, Serine protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	55	"bone marrow: 2098.1"	"Cell type enriched"	"Detected in some"	17	"Erythroid cells: 26.5"	"Cancer enhanced"	"Detected in single"		"stomach cancer: 1.0"	"Low region specificity"	"Detected in single"			"Immune cell enriched"	"Detected in single"	8	"neutrophil: 2.0"	"Lineage enriched"	"Detected in single"	8	"granulocytes: 2.0"	"Cell line enriched"	"Detected in some"	6	"THP-1: 2054.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA005938, CAB017558"	Enhanced		Approved	Vesicles,Cytosol	"Secreted to blood"	NA	NA		390000	"Cluster 9: Neutrophils - Innate immune response"	"Cluster 67: Neutrophils - Humoral immune response"	"Cluster 43: THP-1 - Innate immune response"	"Cluster 12: Non-specific - Cell cycle regulation"	Cytosol	Vesicles	"CAB017558: AB_2172317, HPA005938: AB_1855764"	"unprognostic (2.81e-2)"			"unprognostic (2.10e-1)"	"unprognostic (3.83e-3)"		"unprognostic (4.20e-1)"	"unprognostic (3.31e-2)"		"unprognostic (3.34e-1)"	"unprognostic (9.98e-3)"	"unprognostic (3.67e-2)"	"unprognostic (8.62e-6)"	"unprognostic (5.31e-2)"	"unprognostic (2.00e-1)"	"unprognostic (5.14e-2)"		0.8	0.2	0.6	0.0	0.7	2098.1	0.4	0.2	1.3	0.0	0.2	0.1	0.0	0.3	0.0	0.0	0.1	0.0	1.6	0.6	0.4	0.3	2.8	11.7	0.4	0.3	0.4	0.1	0.1	0.2	1.3	0.6	0.4	0.3	0.0	0.0	1.6	0.0	0.3	1.3	0.0	0.0	0.2	38.2	0.1	0.2	0.6	7.1	0.4	0.0	0.0	0.0	0.1	0.4	1.2	0.6	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.1	0.0	0.1	0.0	0.0	0.4	0.3	0.0	0.1	0.0	0.0	5.5	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	343.6	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.3	2054.4	0.0	0.0	0.0	0.2	0.9	0.0	0.2	0.3	0.0	14.3	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.0	9.9	0.6	0.7	0.2	1.3	0.6	0.4	0.3	0.4	0.4	0.2	0.6	0.4	0.4	0.0	0.0	0.0	0.6	0.0	0.0	0.1	0.0	0.0	0.8	1.3	0.4	1.5	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.1	0.1	0.2	0.0	26.5	0.4	0.0	0.9	0.9	0.0	0.1	0.0	0.0	0.0	0.2	0.1	0.0	0.2	0.0	0.0	1.5	0.0	0.1	0.6	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.5	0.0	0.0	0.0	0.2	0.1	0.0	0.1
PRUNE1	"DRES-17, H-PRUNE, HTCD37, PRUNE"	ENSG00000143363	"Prune exopolyphosphatase 1"	Q86TP1	1	151008420-151035713	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"		Hydrolase	"Disease variant, Mental retardation, Neurodegeneration, Primary microcephaly"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Alveolar cells type 2: 13.0;Breast glandular cells: 9.8;Breast myoepithelial cells: 8.9;Collecting duct cells: 11.0;Granulosa cells: 8.9;Proximal tubular cells: 8.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"U-698: 169.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA028411	Uncertain		Supported	Cytosol		NA	NA		41000	"Cluster 5: Granulocytes - Unknown function"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 7: Non-specific - Mitochondria"	Cytosol		"HPA028411: AB_10603229"	"unprognostic (6.24e-2)"	"unprognostic (2.24e-1)"	"unprognostic (4.17e-2)"	"prognostic unfavorable (3.86e-4)"	"unprognostic (6.91e-2)"	"unprognostic (2.02e-1)"	"unprognostic (2.12e-3)"	"unprognostic (7.05e-2)"	"unprognostic (4.08e-2)"	"unprognostic (5.92e-2)"	"unprognostic (1.73e-1)"	"unprognostic (2.65e-1)"	"prognostic unfavorable (3.48e-4)"	"unprognostic (2.18e-1)"	"unprognostic (3.21e-2)"	"unprognostic (2.42e-2)"	"unprognostic (1.36e-1)"	10.1	9.5	12.2	7.7	12.1	4.4	14.9	16.1	15.1	15.0	12.4	14.8	12.5	14.8	15.6	12.4	16.0	9.2	33.4	12.4	12.6	18.8	14.3	10.8	10.8	12.0	12.5	17.2	10.7	20.9	12.6	7.1	11.9	12.2	14.5	10.8	13.2	14.4	29.4	11.5	12.0	14.1	11.9	11.2	11.2	18.3	12.8	16.2	32.5	21.4	12.6	13.7	11.9	13.5	11.0	11.6	20.2	19.3	24.3	6.6	10.9	5.1	11.2	18.7	16.4	14.1	13.0	22.2	21.7	6.9	5.5	15.5	19.9	13.4	14.6	24.5	22.6	26.6	11.8	20.4	13.5	17.5	13.0	8.4	24.7	10.2	9.5	15.4	9.2	29.4	21.1	18.3	8.9	26.2	27.2	14.1	18.7	39.7	15.0	24.2	12.8	21.5	13.4	14.9	28.7	23.5	17.5	23.5	16.1	28.3	32.6	25.7	6.3	6.6	7.8	7.5	8.1	44.1	40.0	169.1	6.5	13.0	16.9	19.1	8.1	17.8	16.4	7.8	19.8	14.4	18.1	18.6	11.9	15.4	21.7	17.5	18.6	18.8	12.2	6.4	18.5	22.3	12.2	12.1	16.1	15.1	12.4	12.6	12.0	12.5	11.9	11.9	12.8	13.5	4.5	6.4	13.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	9.8	8.9	0.0	0.0	3.1	11.0	0.0	4.1	3.2	0.0	0.0	6.0	0.0	4.3	7.8	2.1	0.0	0.0	0.0	5.7	4.8	2.5	0.0	6.4	0.0	8.9	0.0	0.0	5.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.0	1.6	0.0	0.0	0.0	0.0	5.6	0.0	0.0	1.0	0.0	0.0	8.9	2.9	0.0	0.0	0.0	2.6	0.0	0.0	0.0	0.0	5.1	2.8	4.8	0.0	0.0
PSMB10	"beta2i, LMP10, MECL1, MGC1665"	ENSG00000205220	"Proteasome 20S subunit beta 10"	P40306	16	67934506-67936864	"Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins"	"Host-virus interaction"	"Hydrolase, Protease, Threonine protease"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 122.3"	"Cell type enhanced"	"Detected in many"		"Proximal enterocytes: 173.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"REH: 183.4;RPMI-8226: 169.4;THP-1: 171.3;U-266/70: 189.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA030224, HPA030225, CAB034384"	Enhanced		Approved	Vesicles,Cytosol		NA	NA		1400000	"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 14: B-cells - Humoral immune response"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 58: T-cells - T-cell receptor"	Cytosol	Vesicles	"CAB034384: AB_2171876, HPA030224: AB_2673382, HPA030225: AB_10603231"	"unprognostic (1.18e-2)"	"unprognostic (1.90e-3)"	"unprognostic (2.00e-1)"	"unprognostic (2.53e-3)"	"unprognostic (2.00e-1)"	"unprognostic (1.85e-2)"	"unprognostic (7.22e-2)"	"unprognostic (3.35e-2)"	"unprognostic (1.07e-1)"	"unprognostic (2.60e-1)"	"unprognostic (8.22e-2)"	"unprognostic (1.79e-1)"	"unprognostic (1.32e-2)"	"unprognostic (2.97e-2)"	"unprognostic (1.98e-1)"	"unprognostic (1.32e-2)"	"prognostic favorable (5.44e-4)"	26.3	26.9	5.7	81.8	6.0	71.3	24.9	6.9	8.8	18.9	6.6	51.6	110.5	18.4	5.7	22.8	30.4	31.2	16.2	5.6	8.0	35.1	37.1	42.2	122.3	12.6	7.4	14.6	15.0	6.3	13.2	23.1	8.6	28.9	22.9	0.4	65.1	22.4	6.8	18.1	95.8	14.0	9.5	102.7	62.5	5.3	7.8	61.9	23.6	3.5	37.5	36.4	18.6	11.7	31.8	26.9	0.7	2.2	6.7	17.2	99.6	10.8	42.3	38.5	50.6	13.9	148.5	111.9	23.4	13.2	12.9	47.9	0.0	13.4	2.9	50.3	1.9	39.2	7.6	16.4	65.7	78.5	115.2	26.9	8.4	15.2	1.5	12.1	20.6	32.1	3.6	48.2	9.0	42.6	140.7	84.9	1.0	1.1	10.2	183.4	8.3	169.4	31.6	52.5	0.9	2.3	31.1	67.5	17.2	0.4	14.5	171.3	32.0	21.2	6.6	9.7	15.3	189.8	43.9	88.4	57.1	97.9	47.0	539.5	714.6	571.1	511.7	787.1	376.4	402.6	397.9	437.3	594.8	390.2	326.2	364.6	786.2	588.6	607.4	604.4	495.9	1155.7	5.7	6.0	6.9	8.8	5.6	8.0	12.6	7.4	8.6	9.5	7.8	11.7	24.7	22.4	26.8	4.6	72.9	17.2	14.3	101.2	26.2	1.0	15.8	13.8	1.6	28.6	43.9	18.4	0.0	29.5	66.2	80.8	23.5	58.5	14.0	17.6	20.1	22.8	16.3	32.6	3.4	104.3	30.0	23.4	110.6	12.3	51.9	7.2	37.1	10.2	87.4	0.0	5.0	74.6	52.9	81.9	66.4	35.9	30.1	88.5	48.0	9.4	123.3	3.0	112.3	2.5	7.3	51.2	139.7	21.1	110.5	12.1	173.5	69.4	83.9	1.1	19.7	10.3	26.6	16.4	7.5	24.1	9.9	22.6	93.9	16.9	79.5	24.8
PSMB11	beta5t	ENSG00000222028	"Proteasome subunit beta 11"	A5LHX3	14	23042212-23044060	"Enzymes, Predicted intracellular proteins"		"Hydrolase, Protease, Threonine protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	93	"lymphoid tissue: 30.6"	"Group enriched"	"Detected in some"	10	"Early spermatids: 2.4;Late spermatids: 1.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enriched"	"Detected in single"	7	"olfactory bulb: 1.9"	"Not detected"	"Not detected"			"HPA028967, HPA056970"	Enhanced					NA	NA				"Cluster 63: T-cells - Adaptive immune response"		"Cluster 23: Spermatids - Flagellum & Golgi organization"			"HPA028967: AB_2732444, HPA056970: AB_2683293"				"unprognostic (7.96e-2)"	"unprognostic (2.77e-1)"													0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	30.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0
PSMB5	MB1	ENSG00000100804	"Proteasome 20S subunit beta 5"	P28074	14	23016543-23035230	"Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins"	"Host-virus interaction"	"Hydrolase, Protease, Threonine protease"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"Hep G2: 1146.8"	"Low region specificity"	"Detected in all"							"HPA049518, HPA061796"	Approved		Supported	Nucleoplasm,Centrosome		NA	NA		6200000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 10: Non-specific - Unknown function"	"Nucleoplasm, Centrosome"		"HPA049518: AB_2680802, HPA061796: AB_2684612"	"unprognostic (3.03e-1)"	"unprognostic (1.99e-2)"	"unprognostic (8.35e-2)"	"unprognostic (6.13e-2)"	"unprognostic (1.24e-1)"	"prognostic unfavorable (2.85e-4)"	"prognostic unfavorable (2.90e-5)"	"unprognostic (2.55e-2)"	"unprognostic (9.95e-2)"	"prognostic favorable (1.08e-4)"	"unprognostic (2.06e-1)"	"unprognostic (1.19e-1)"	"unprognostic (5.30e-2)"	"unprognostic (1.75e-1)"	"unprognostic (1.95e-1)"	"unprognostic (4.95e-2)"	"prognostic unfavorable (4.73e-4)"	84.0	116.0	129.1	58.7	134.2	32.0	81.0	141.4	134.3	71.3	141.1	80.8	61.1	71.0	129.5	102.3	93.3	61.0	136.8	136.4	141.1	98.5	119.1	64.7	49.0	137.9	138.4	61.6	80.9	143.5	80.1	90.1	145.2	76.8	88.7	59.7	73.5	78.6	332.4	76.0	53.0	103.4	141.3	50.3	81.0	57.8	136.5	79.5	72.3	274.1	68.6	92.1	68.4	146.5	181.0	398.9	250.6	245.5	360.4	318.9	261.8	252.0	307.3	446.1	376.1	329.2	282.2	228.0	228.1	352.1	298.4	239.7	428.4	320.2	401.9	139.9	311.4	146.9	260.3	1146.8	287.3	170.2	162.1	354.2	292.0	331.8	264.1	289.7	475.5	190.5	218.6	121.5	376.0	557.2	97.6	218.4	285.7	341.6	631.4	133.8	197.7	150.7	349.9	256.6	336.0	251.0	179.9	354.8	245.4	322.2	175.0	217.7	254.1	212.4	210.1	197.3	247.8	99.7	218.4	158.8	164.9	140.8	274.6	97.8	127.6	58.0	89.4	125.6	103.5	103.8	101.1	85.1	137.6	99.7	135.0	102.5	48.1	67.4	92.7	172.4	91.3	147.8	129.1	134.2	141.4	134.3	136.4	141.1	137.9	138.4	145.2	141.3	136.5	146.5	94.2	76.9	69.2	16.0	47.3	140.2	174.1	461.5	100.7	61.0	130.4	135.5	157.6	112.9	240.4	95.6	29.2	400.1	40.2	75.0	275.9	277.7	93.0	149.0	109.5	150.0	154.6	82.5	17.6	231.3	435.2	139.9	73.9	88.0	31.0	162.6	89.6	171.6	221.6	70.7	18.0	109.2	329.6	57.5	80.9	106.4	118.7	64.0	115.6	15.9	138.2	170.8	25.7	11.6	29.4	285.7	88.0	122.2	78.2	185.1	81.2	437.8	268.9	71.8	98.6	87.1	355.1	174.4	81.6	144.7	157.1	430.2	43.4	215.7	148.9	215.3
PSMB6	"DELTA, Y"	ENSG00000142507	"Proteasome 20S subunit beta 6"	P28072	17	4796144-4798502	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Host-virus interaction"	"Hydrolase, Protease, Threonine protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA023312, HPA063656"	Supported		Supported	Nucleoplasm,Cytosol		NA	NA		1400000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 10: Non-specific - Unknown function"	Nucleoplasm	Cytosol	"HPA023312: AB_1855828, HPA063656: AB_2685078"	"unprognostic (2.71e-1)"	"unprognostic (1.86e-2)"	"unprognostic (2.75e-1)"	"unprognostic (3.32e-3)"	"unprognostic (8.80e-2)"	"unprognostic (1.44e-1)"	"unprognostic (2.73e-1)"	"unprognostic (2.22e-2)"	"unprognostic (2.37e-1)"	"unprognostic (2.64e-2)"	"unprognostic (1.98e-2)"	"unprognostic (7.47e-2)"	"prognostic unfavorable (5.93e-4)"	"unprognostic (1.81e-1)"	"unprognostic (2.34e-1)"	"unprognostic (5.27e-2)"	"unprognostic (5.66e-2)"	92.7	107.8	130.1	82.2	133.7	126.9	107.0	138.1	141.2	92.6	137.4	116.3	76.9	101.9	150.9	140.6	99.2	68.3	201.6	132.8	138.1	134.8	184.6	86.2	90.1	135.7	134.1	63.7	99.3	173.3	82.5	119.8	138.7	84.8	118.3	62.6	100.0	114.2	358.6	114.9	77.0	135.3	136.0	90.4	103.8	76.6	133.5	147.4	88.7	339.5	140.5	110.6	89.2	140.3	279.8	478.2	251.6	216.4	209.9	188.1	289.7	144.1	300.1	431.3	336.0	358.7	220.5	215.0	277.9	348.1	246.5	273.8	388.0	404.4	418.0	281.9	409.7	128.0	315.3	422.7	242.0	133.5	194.4	178.3	305.1	377.4	355.7	241.5	426.5	335.8	199.4	316.6	336.1	331.8	237.4	221.8	214.1	356.2	328.2	261.9	178.7	284.6	326.6	185.3	146.9	179.9	206.6	158.9	148.6	261.4	194.5	147.2	205.1	210.8	158.9	286.4	355.2	130.8	191.8	132.9	301.3	242.1	259.3	410.6	603.3	343.2	347.5	589.9	355.9	668.6	373.1	384.0	624.9	640.8	319.8	329.3	210.5	424.4	549.4	585.5	556.2	817.2	130.1	133.7	138.1	141.2	132.8	138.1	135.7	134.1	138.7	136.0	133.5	140.3	156.3	134.6	113.3	8.5	118.3	229.2	184.1	410.8	112.1	65.5	124.6	153.4	454.8	141.5	253.9	134.3	16.7	587.3	142.8	178.0	358.1	321.6	245.2	110.9	108.1	164.7	148.4	183.7	7.6	349.9	418.2	171.5	105.5	116.0	105.2	156.1	99.6	235.4	346.3	32.0	7.2	173.0	311.3	111.7	272.1	52.9	109.6	159.8	236.5	4.7	298.9	183.4	109.2	9.0	16.9	351.3	163.4	123.0	244.7	191.7	188.6	564.6	193.3	81.3	111.7	119.8	486.8	175.1	84.7	178.6	277.2	664.5	125.9	172.6	177.7	217.3
PSMB7	Z	ENSG00000136930	"Proteasome 20S subunit beta 7"	Q99436	9	124353465-124415444	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Host-virus interaction"	"Hydrolase, Protease, Threonine protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA052408, HPA054902"	Supported		Enhanced	"Nucleoplasm,Nuclear bodies,Cytosol"		No	No		2100000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 16: U-266 - Nucleosome"	"Cluster 10: Non-specific - Unknown function"	Nucleoplasm	"Nuclear bodies, Cytosol"	"HPA052408: AB_2681820, HPA054902: AB_2682635"	"unprognostic (7.75e-2)"	"unprognostic (1.83e-2)"	"unprognostic (1.27e-1)"	"unprognostic (3.64e-3)"	"unprognostic (2.83e-1)"	"unprognostic (1.25e-1)"	"unprognostic (2.02e-2)"	"unprognostic (2.24e-3)"	"unprognostic (9.03e-2)"	"unprognostic (3.60e-1)"	"unprognostic (2.99e-1)"	"unprognostic (1.78e-1)"	"unprognostic (1.26e-2)"	"unprognostic (1.67e-1)"	"unprognostic (3.45e-1)"	"unprognostic (1.93e-3)"	"unprognostic (3.98e-2)"	115.7	180.4	129.4	103.9	136.9	189.7	122.6	132.7	144.8	99.8	119.6	103.5	98.7	102.9	147.0	139.1	94.6	87.2	212.0	135.8	137.0	150.9	222.9	91.4	112.7	138.2	139.5	101.6	142.2	143.4	74.7	120.2	138.2	94.8	107.8	81.0	114.3	75.0	277.8	166.2	98.3	92.7	131.5	91.7	115.3	155.2	137.8	147.6	91.3	205.3	124.6	110.5	104.2	135.0	344.4	411.7	275.8	336.4	190.4	224.8	396.1	325.3	447.6	461.7	315.1	546.3	327.1	389.2	256.8	307.4	457.2	480.2	346.7	345.4	420.0	375.0	299.3	245.3	673.3	460.0	428.5	491.6	234.3	270.8	299.6	483.7	478.5	355.1	394.3	345.5	507.9	269.8	362.4	600.0	355.9	329.5	409.7	519.6	581.5	309.8	411.4	457.2	331.5	221.9	323.7	263.6	310.4	394.0	498.4	268.7	454.8	212.7	315.9	297.5	240.7	384.9	499.0	289.9	873.7	394.9	498.1	297.8	429.1	162.7	201.5	154.5	128.3	211.4	138.9	177.8	145.7	142.5	221.1	159.7	138.2	135.9	87.0	185.3	206.8	187.5	226.0	264.8	129.4	136.9	132.7	144.8	135.8	137.0	138.2	139.5	138.2	131.5	137.8	135.0	73.1	76.9	77.6	26.1	88.0	194.1	184.4	309.1	39.9	41.5	113.9	97.5	147.3	134.4	150.0	69.9	22.9	441.4	83.0	146.9	330.6	351.3	404.6	105.7	93.8	123.8	141.2	93.8	38.4	392.7	356.7	112.3	52.5	90.3	104.6	130.8	107.1	277.3	237.2	33.7	31.9	162.5	160.7	122.1	148.4	472.8	139.1	92.5	199.3	33.7	168.5	119.7	113.3	30.7	44.8	393.6	143.7	125.3	69.9	158.0	173.6	484.7	135.7	61.6	85.5	133.8	221.2	330.6	190.4	60.4	218.9	488.7	81.4	135.8	181.2	201.3
PSMB8	"beta5i, D6S216E, LMP7, PSMB5i, RING10"	ENSG00000204264	"Proteasome 20S subunit beta 8"	P28062	6	32840717-32844679	"Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"Differentiation, Host-virus interaction, Immunity"	"Hydrolase, Protease, Threonine protease"	"Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA046995, HPA050327"	Enhanced		Approved	"Vesicles,Cytokinetic bridge"		Yes	No		2700000	"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 64: Macrophages - Immune response"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 63: NK-cells & T-cells - Immune response"	Vesicles	"Cytokinetic bridge"	"HPA046995: AB_2679896, HPA050327: AB_2681088"	"prognostic favorable (5.08e-4)"	"unprognostic (4.22e-2)"	"unprognostic (2.39e-2)"	"prognostic favorable (7.16e-4)"	"unprognostic (1.92e-1)"	"unprognostic (1.68e-1)"	"unprognostic (7.78e-2)"	"unprognostic (1.09e-1)"	"unprognostic (5.71e-2)"	"unprognostic (1.17e-2)"	"unprognostic (2.79e-2)"	"unprognostic (1.47e-1)"	"unprognostic (4.14e-2)"	"unprognostic (1.24e-1)"	"unprognostic (4.35e-2)"	"unprognostic (1.97e-3)"	"unprognostic (7.11e-3)"	62.7	76.9	3.3	11.2	3.4	9.8	56.5	3.3	7.3	42.7	3.4	79.9	12.9	41.3	3.2	59.5	41.6	5.8	34.2	3.4	3.5	63.7	99.2	78.2	18.2	4.3	3.4	32.1	29.5	8.2	26.6	4.4	3.7	45.2	20.4	0.7	44.2	6.4	14.4	58.0	93.9	8.9	4.0	150.4	57.0	5.9	3.6	13.5	40.8	0.1	17.2	41.3	48.1	4.1	15.1	3.9	0.3	0.0	5.1	13.1	11.2	4.9	22.9	29.1	39.3	0.0	20.9	45.7	9.4	10.5	25.5	8.1	6.8	16.6	8.0	19.2	0.0	27.6	5.9	0.3	30.3	5.2	7.5	14.9	10.3	12.9	6.8	1.9	18.1	11.8	1.1	8.1	6.1	0.1	12.9	11.7	0.1	0.0	7.3	29.3	1.3	24.1	21.3	4.9	0.8	0.2	8.6	10.4	8.5	0.1	7.0	41.0	4.3	8.8	7.6	7.8	0.6	21.0	15.9	11.2	2.2	27.7	9.0	56.8	70.3	94.6	58.1	88.0	51.2	73.4	49.1	61.1	67.5	71.1	34.8	49.6	90.2	63.0	78.2	58.5	81.2	156.0	3.3	3.4	3.3	7.3	3.4	3.5	4.3	3.4	3.7	4.0	3.6	4.1	237.0	38.5	55.8	2.9	162.0	84.4	64.1	183.7	54.7	1.8	85.3	92.5	8.7	71.4	103.2	62.5	0.0	2.7	211.2	219.9	86.1	219.4	0.6	63.2	74.9	158.5	65.7	45.0	0.1	247.6	18.3	60.7	93.8	81.5	50.7	51.4	114.5	75.0	165.9	6.7	0.5	243.8	120.1	143.5	94.9	1.9	39.1	128.2	56.9	10.3	214.3	39.9	279.1	3.0	0.7	179.6	287.9	30.5	153.2	100.1	319.8	78.9	103.2	3.0	39.5	33.2	56.8	0.4	1.2	60.5	79.6	2.7	181.6	110.9	222.6	121.6
PSMB9	"beta1i, LMP2, PSMB6i, RING12"	ENSG00000240065	"Proteasome 20S subunit beta 9"	P28065	6	32844136-32859851	"Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins"	"Host-virus interaction, Immunity"	"Hydrolase, Protease, Threonine protease"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 160.9"	"Cell type enhanced"	"Detected in many"		"monocytes: 323.0;NK-cells: 495.4;Proximal enterocytes: 318.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"BJ hTERT+ SV40 Large T+ RasG12V: 27.7;Daudi: 40.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB015180, HPA042818, HPA053280"	Enhanced		Supported	Cytosol		NA	NA		340000	"Cluster 31: Non-specific - Inflammatory response"	"Cluster 64: Macrophages - Immune response"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 63: NK-cells & T-cells - Immune response"	Cytosol		"CAB015180: AB_2172368, HPA042818: AB_2678186, HPA053280: AB_2682098"	"unprognostic (1.09e-2)"	"unprognostic (1.68e-2)"	"unprognostic (1.26e-2)"	"unprognostic (2.18e-3)"	"unprognostic (7.84e-2)"	"unprognostic (1.89e-1)"	"unprognostic (5.68e-2)"	"unprognostic (6.67e-2)"	"unprognostic (1.56e-2)"	"unprognostic (6.50e-3)"	"unprognostic (1.87e-3)"	"unprognostic (1.84e-1)"	"prognostic unfavorable (1.33e-4)"	"unprognostic (2.65e-1)"	"unprognostic (1.09e-1)"	"unprognostic (4.96e-3)"	"unprognostic (5.99e-2)"	47.0	31.1	4.8	18.4	4.9	6.9	41.4	4.3	5.5	28.8	2.6	38.4	10.2	26.8	2.3	25.7	25.9	4.7	31.6	4.8	5.6	36.3	37.4	60.2	26.2	7.6	4.9	18.1	12.1	1.5	14.0	3.4	5.9	26.5	8.7	1.3	20.3	5.0	11.9	27.7	78.1	5.7	5.7	160.9	26.5	4.9	5.1	15.0	28.7	3.8	22.2	23.6	30.8	5.8	5.5	0.3	0.0	0.2	3.4	8.5	3.0	0.7	11.5	17.3	27.7	0.0	3.1	40.8	1.3	2.9	14.3	10.0	0.2	5.8	2.6	9.3	0.1	17.6	0.7	0.8	17.3	1.8	2.2	2.1	0.3	7.0	1.0	3.3	2.7	10.1	1.4	12.8	1.9	1.0	16.1	8.0	0.0	0.0	0.8	19.0	1.2	7.4	2.1	2.5	0.0	0.0	1.0	2.1	10.7	0.0	4.4	10.3	0.0	2.5	1.6	14.7	1.2	11.3	23.9	9.3	7.5	6.8	4.0	92.7	30.3	75.6	56.1	55.8	45.9	59.7	45.1	55.9	26.6	45.3	41.0	49.6	96.3	61.5	60.9	20.5	61.0	46.2	4.8	4.9	4.3	5.5	4.8	5.6	7.6	4.9	5.9	5.7	5.1	5.8	258.6	41.7	51.1	1.3	197.2	72.5	37.4	155.6	30.1	2.4	25.3	47.0	7.3	50.1	64.8	25.8	0.0	1.5	216.2	88.0	19.6	116.6	1.3	28.9	47.5	146.5	33.5	29.9	0.0	115.6	6.6	45.1	34.1	42.6	77.3	20.0	119.6	26.6	117.2	0.0	0.1	148.0	99.7	126.8	155.7	2.1	29.2	145.2	35.6	8.4	323.0	22.7	495.4	0.5	8.3	67.8	150.3	15.8	136.1	40.4	318.5	40.5	133.7	1.7	32.9	23.1	50.8	1.5	7.4	21.0	58.7	1.4	241.8	45.3	110.6	39.1
PSPH	PSP	ENSG00000146733	"Phosphoserine phosphatase"	P78330	7	56011051-56051604	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"Amino-acid biosynthesis, Serine biosynthesis"	Hydrolase	"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Distal tubular cells: 107.6;Early spermatids: 149.8;Late spermatids: 211.5;Proximal tubular cells: 91.7"	"Cancer enhanced"	"Detected in all"		"glioma: 41.8"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA020376, HPA029515"	Approved		Approved	Cytosol		NA	NA			"Cluster 28: Myeloid DCs - Unknown function"	"Cluster 88: Choroid plexus - Transmembrane transport"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 34: Spermatids - Unknown function"	Cytosol		"HPA020376: AB_1855867, HPA029515: AB_10601492"	"prognostic unfavorable (2.30e-4)"	"unprognostic (7.80e-2)"	"unprognostic (1.55e-1)"	"unprognostic (2.03e-1)"	"unprognostic (1.07e-1)"	"unprognostic (7.66e-3)"	"prognostic unfavorable (2.75e-5)"	"unprognostic (1.74e-1)"	"unprognostic (2.13e-1)"	"unprognostic (4.45e-2)"	"prognostic favorable (3.77e-4)"	"unprognostic (3.78e-2)"	"unprognostic (5.74e-2)"	"unprognostic (2.64e-1)"	"unprognostic (3.01e-2)"	"unprognostic (1.90e-3)"	"unprognostic (9.05e-3)"	4.7	9.4	11.0	3.7	12.4	3.7	3.9	11.8	10.8	4.7	13.3	4.8	4.2	4.9	5.2	8.7	16.1	5.9	8.1	11.0	11.0	10.0	6.8	3.5	5.1	12.3	12.9	8.2	6.7	6.6	9.4	3.7	11.7	6.4	4.4	4.4	4.5	6.4	4.6	4.2	4.1	5.1	12.2	3.9	6.2	7.1	12.1	5.8	7.0	6.0	5.9	5.2	5.7	16.1	130.1	37.6	23.1	93.0	18.9	25.3	16.7	32.5	18.5	18.7	32.7	34.7	23.5	62.9	21.0	29.4	44.5	26.9	52.6	26.9	19.0	48.1	27.9	17.9	11.1	62.2	44.4	18.6	26.8	31.8	50.2	27.7	32.6	25.1	17.7	61.2	44.4	42.4	26.4	17.3	27.7	48.3	38.0	47.5	52.1	35.9	14.4	39.8	17.2	6.8	43.6	49.8	23.5	14.9	68.9	20.9	44.8	41.4	14.5	15.1	24.8	45.5	30.3	26.9	53.0	72.8	21.9	39.9	49.7	2.5	6.2	5.9	3.1	4.4	2.3	5.4	3.0	3.8	9.6	6.1	4.5	4.1	2.9	4.7	7.1	9.3	4.0	4.8	11.0	12.4	11.8	10.8	11.0	11.0	12.3	12.9	11.7	12.2	12.1	16.1	2.1	3.2	1.5	11.4	5.2	6.8	16.9	20.5	8.6	5.2	8.3	5.8	13.1	11.5	11.4	5.5	2.1	12.8	4.5	2.4	107.6	8.6	149.8	62.9	5.4	4.2	4.8	7.2	9.3	8.0	7.5	9.9	3.1	9.4	1.3	16.5	5.0	9.8	9.5	1.7	9.8	5.0	4.1	4.4	5.8	211.5	8.4	4.3	7.2	0.0	5.7	46.8	2.1	7.1	13.8	7.1	3.5	6.0	10.1	6.5	3.1	91.7	28.3	3.1	13.1	5.1	20.0	30.1	22.5	7.6	8.5	4.7	3.9	16.1	7.3	7.7
PTEN	"BZS, MHAM, MMAC1, PTEN1, TEP1"	ENSG00000171862	"Phosphatase and tensin homolog"	P60484	10	87863625-87971930	"Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"Apoptosis, Lipid metabolism, Neurogenesis"	"Hydrolase, Protein phosphatase"	"Autism spectrum disorder, Cancer-related genes, Disease variant, Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"neutrophil: 60.5"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"							"CAB004076, HPA031335"	Approved		Supported	Nucleoplasm,Cytosol	"Intracellular and membrane"	NA	NA			"Cluster 9: Neutrophils - Innate immune response"	"Cluster 82: Adipose tissue - ECM organization"	"Cluster 24: NB-4 - Immune response"	"Cluster 48: Smooth muscle cells - ECM organization"	Nucleoplasm	Cytosol	"CAB004076: AB_390810, HPA031335: AB_2797221"	"unprognostic (8.72e-2)"	"unprognostic (2.45e-1)"	"unprognostic (5.43e-1)"	"unprognostic (1.50e-2)"	"unprognostic (3.71e-2)"	"unprognostic (1.30e-1)"	"unprognostic (2.18e-1)"	"unprognostic (2.08e-1)"	"unprognostic (2.07e-1)"	"unprognostic (6.87e-2)"	"unprognostic (9.77e-2)"	"unprognostic (2.71e-1)"	"prognostic unfavorable (7.35e-4)"	"unprognostic (1.57e-1)"	"unprognostic (2.73e-1)"	"unprognostic (6.54e-3)"	"unprognostic (2.41e-1)"	64.0	25.4	17.8	18.6	19.3	12.9	47.6	34.5	23.4	54.8	15.6	28.1	12.9	27.4	18.6	28.3	35.2	15.6	29.7	20.4	18.4	22.6	39.2	39.5	21.4	16.6	17.8	28.0	33.2	11.9	17.3	30.5	16.4	26.3	14.6	30.0	19.6	16.5	23.7	25.9	24.5	22.2	14.5	40.0	25.6	28.2	19.7	31.8	26.1	14.0	16.5	28.1	38.4	17.6	23.5	10.8	12.3	11.2	28.5	19.7	10.9	12.5	28.0	14.5	20.4	10.9	28.0	28.1	8.0	20.9	8.3	14.1	16.6	14.3	22.8	14.1	4.7	9.3	28.5	13.8	30.1	31.9	15.3	13.5	38.7	18.0	23.7	60.3	20.8	17.7	7.0	72.6	13.5	18.1	17.8	56.3	4.6	19.9	0.0	27.6	6.4	20.8	22.9	13.4	4.5	19.9	16.6	7.9	23.0	9.7	21.9	45.2	17.9	44.6	10.8	18.3	10.1	23.9	32.9	30.7	14.6	29.2	2.9	21.3	14.2	25.8	6.8	21.8	7.2	7.9	7.2	6.6	10.3	6.8	8.3	8.3	60.5	8.9	15.6	8.2	7.0	4.5	17.8	19.3	34.5	23.4	20.4	18.4	16.6	17.8	16.4	14.5	19.7	17.6	67.2	35.3	63.3	83.6	48.3	56.1	57.4	31.5	47.3	113.0	49.4	41.9	46.5	57.2	31.2	29.5	39.6	25.8	64.4	57.7	33.2	24.7	70.1	40.0	114.5	56.0	31.2	52.0	141.0	30.0	62.2	79.3	39.8	33.6	25.4	39.6	53.9	64.1	35.0	45.4	132.4	44.7	12.2	206.1	97.2	92.1	56.8	105.2	62.2	196.8	101.5	61.6	44.3	139.2	95.7	30.6	39.7	54.5	39.3	45.1	50.1	38.0	31.2	61.2	92.1	66.4	170.7	33.5	25.4	45.2	60.1	57.3	46.3	44.7	46.1	64.0
PTP4A1	"PRL-1, PRL1, PTPCAAX1"	ENSG00000112245	"Protein tyrosine phosphatase 4A1"	Q93096	6	63521746-63583436	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Cell cycle"	"Developmental protein, Hydrolase, Protein phosphatase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 493.7"	"Cell type enriched"	"Detected in all"	4	"Late spermatids: 3071.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"Hep G2: 533.9"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA003281	Approved					NA	NA			"Cluster 9: Neutrophils - Innate immune response"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 25: Spermatids - Spermatogenesis"			"HPA003281: AB_1855903"	"unprognostic (8.63e-2)"	"prognostic unfavorable (5.53e-4)"	"unprognostic (9.05e-2)"	"unprognostic (7.96e-2)"	"unprognostic (2.79e-2)"	"unprognostic (2.71e-2)"	"unprognostic (6.12e-2)"	"unprognostic (1.96e-1)"	"unprognostic (5.28e-2)"	"unprognostic (2.33e-2)"	"unprognostic (6.62e-3)"	"unprognostic (1.23e-2)"	"unprognostic (1.07e-2)"	"unprognostic (6.64e-2)"	"unprognostic (1.28e-1)"	"unprognostic (2.10e-2)"	"unprognostic (1.11e-2)"	39.4	140.5	24.1	37.4	29.5	227.4	31.5	30.9	35.9	41.5	28.3	107.9	55.1	43.8	15.3	53.5	34.6	58.9	31.7	24.7	37.5	50.5	493.7	54.8	24.4	32.5	28.0	54.7	69.5	16.1	41.1	72.5	32.1	44.2	110.1	22.5	68.2	21.0	300.0	66.0	50.8	56.6	34.9	19.4	55.2	62.5	27.9	26.2	39.2	113.0	24.6	51.6	33.6	44.8	71.5	122.9	106.2	128.3	85.8	77.2	239.1	113.9	97.6	58.4	79.2	103.5	45.4	65.1	50.6	88.7	95.7	41.8	97.0	197.9	94.3	61.0	51.6	43.8	320.2	533.9	175.7	118.6	57.7	91.3	383.6	124.7	320.5	63.5	80.3	65.0	106.1	148.7	151.5	140.9	52.4	69.1	50.6	91.0	53.7	70.9	53.4	60.5	132.4	120.6	44.7	62.5	278.5	71.8	140.1	156.9	59.8	122.0	77.5	132.9	130.6	89.5	122.3	90.7	94.9	121.7	60.9	72.5	154.1	45.4	20.4	15.1	12.8	21.3	20.1	12.9	14.5	14.3	17.2	10.7	12.8	12.9	48.4	16.3	16.6	9.1	18.8	15.4	24.1	29.5	30.9	35.9	24.7	37.5	32.5	28.0	32.1	34.9	27.9	44.8	33.3	22.4	90.3	4.6	105.4	681.3	268.7	94.1	261.8	22.3	98.4	55.4	78.5	207.3	83.0	75.4	16.7	248.7	99.8	336.5	80.3	186.9	716.1	189.8	68.8	47.0	129.6	30.9	11.7	193.9	215.1	90.8	178.4	279.5	63.0	41.2	41.4	528.8	98.6	11.8	9.9	253.4	63.1	71.6	236.5	3071.4	28.6	99.7	170.7	5.6	47.4	22.0	15.5	9.5	20.4	151.8	196.9	24.0	110.6	166.4	181.3	112.1	61.2	24.6	6.6	44.4	110.2	47.2	26.3	181.8	641.0	459.6	123.4	79.1	214.6	164.1
PTP4A2	"HU-PP-1, OV-1, PRL-2, PRL2, ptp-IV1a, PTP4A, PTPCAAX2"	ENSG00000184007	"Protein tyrosine phosphatase 4A2"	Q12974	1	31906421-31944856	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Hydrolase, Protein phosphatase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Urothelial cells: 917.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003281, CAB011204"	Uncertain					NA	NA		490000	"Cluster 51: Monocytes - Innate immune response"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 22: Epithelial cell types - Mixed function"			"CAB011204: AB_532271, HPA003281: AB_1855903"	"unprognostic (2.67e-2)"	"unprognostic (6.36e-2)"	"unprognostic (3.15e-3)"	"unprognostic (3.73e-2)"	"unprognostic (2.70e-2)"	"unprognostic (6.20e-2)"	"prognostic unfavorable (2.62e-5)"	"unprognostic (6.90e-2)"	"unprognostic (4.63e-2)"	"unprognostic (5.12e-2)"	"unprognostic (1.99e-2)"	"unprognostic (1.03e-1)"	"prognostic unfavorable (5.10e-11)"	"unprognostic (1.16e-2)"	"unprognostic (3.81e-1)"	"unprognostic (2.89e-1)"	"prognostic favorable (2.72e-5)"	158.2	71.0	269.3	147.2	322.8	295.9	126.6	221.3	399.7	85.5	146.1	125.6	114.2	73.1	70.5	66.9	81.5	100.8	169.8	209.1	255.7	91.6	117.1	105.9	166.0	262.5	286.3	85.3	99.8	72.3	66.3	91.1	270.0	88.3	127.1	52.3	104.1	88.9	306.4	53.1	103.1	99.7	264.3	116.1	113.9	98.9	264.1	489.2	163.7	186.3	172.4	186.7	72.9	400.2	297.7	166.6	163.1	305.9	321.5	321.2	109.1	290.3	387.9	218.5	224.3	144.1	409.3	532.0	214.0	393.2	245.2	118.3	172.2	161.9	398.1	479.8	94.6	371.6	282.7	155.6	340.4	304.7	353.1	319.6	127.6	305.6	297.9	224.8	220.7	425.1	482.4	195.4	283.3	138.5	930.8	149.2	221.7	220.3	238.7	165.8	275.2	222.3	153.8	519.7	160.1	115.3	296.9	199.1	328.8	265.9	560.5	167.4	243.5	257.0	224.7	403.8	319.8	215.3	336.0	259.2	263.5	246.7	261.6	204.3	50.9	87.4	74.8	105.3	58.4	44.2	63.4	85.1	46.0	39.6	40.8	69.4	53.5	60.7	148.0	33.6	57.4	60.7	269.3	322.8	221.3	399.7	209.1	255.7	262.5	286.3	270.0	264.3	264.1	400.2	206.8	121.8	126.5	25.5	199.0	194.1	502.4	87.8	136.1	60.5	287.0	125.5	187.0	153.0	117.0	202.3	60.5	50.0	360.2	247.3	191.7	154.9	48.1	132.4	135.8	131.2	128.3	209.3	41.6	185.4	128.7	158.2	141.2	218.2	87.5	118.0	94.6	169.3	125.0	99.3	33.9	204.0	65.1	219.8	405.2	51.2	176.7	336.0	115.6	38.4	488.3	145.8	568.5	30.7	176.4	185.6	191.3	175.3	270.0	623.3	126.9	170.3	74.7	56.3	131.5	134.1	135.2	130.6	107.5	148.7	196.5	160.1	281.1	67.0	199.7	917.5
PTP4A3	"PRL-3, PRL-R, PRL3"	ENSG00000184489	"Protein tyrosine phosphatase 4A3"	O75365	8	141391995-141432454	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Hydrolase, Protein phosphatase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"heart muscle: 640.3;pituitary gland: 207.5;skeletal muscle: 738.1"	"Cell type enhanced"	"Detected in many"		"Bipolar cells: 102.9;Cardiomyocytes: 272.8;Cone photoreceptor cells: 123.0;Rod photoreceptor cells: 226.5;Smooth muscle cells: 140.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"neutrophil: 55.0;non-classical monocyte: 54.1"	"Group enriched"	"Detected in all"	6	"granulocytes: 55.0;monocytes: 54.1"	"Cell line enhanced"	"Detected in many"		"HDLM-2: 128.7;Karpas-707: 45.9;RPMI-8226: 38.1;U-266/84: 42.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA003281	Uncertain					NA	NA			"Cluster 51: Monocytes - Innate immune response"	"Cluster 38: Heart - Muscle contraction"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 48: Smooth muscle cells - ECM organization"			"HPA003281: AB_1855903"	"unprognostic (1.09e-1)"	"unprognostic (3.70e-1)"	"unprognostic (2.55e-2)"	"unprognostic (1.10e-3)"	"unprognostic (2.08e-1)"	"unprognostic (6.18e-2)"	"unprognostic (3.61e-2)"	"unprognostic (2.27e-2)"	"unprognostic (1.08e-1)"	"unprognostic (2.50e-1)"	"unprognostic (5.73e-3)"	"unprognostic (2.33e-2)"	"prognostic unfavorable (1.81e-5)"	"unprognostic (2.25e-1)"	"unprognostic (1.12e-2)"	"unprognostic (2.28e-2)"	"unprognostic (1.77e-1)"	48.6	16.6	11.4	2.0	9.8	0.7	43.3	9.0	14.1	87.3	9.2	70.7	2.1	69.9	3.0	15.1	67.2	1.4	640.3	10.1	10.6	48.9	9.8	58.4	1.1	10.5	10.3	46.8	116.2	2.6	207.5	2.3	10.7	73.6	0.7	36.0	29.9	2.1	738.1	22.8	37.4	4.4	9.3	56.8	99.7	22.0	13.3	1.1	35.2	62.1	1.3	40.5	35.7	9.2	0.3	0.9	0.6	0.1	0.0	0.2	0.1	0.5	0.1	0.0	0.0	0.1	2.3	0.0	9.8	0.1	0.1	0.0	0.1	0.1	0.0	128.7	1.9	5.2	0.2	1.8	0.5	0.0	0.2	0.1	0.4	0.0	0.0	0.0	0.4	1.0	3.1	45.9	0.1	11.3	0.7	0.2	2.1	1.0	0.7	19.3	0.1	38.1	0.0	0.1	11.4	3.9	0.6	0.1	2.6	1.2	1.8	0.0	0.5	0.1	2.2	0.1	0.0	11.6	42.0	0.3	0.1	2.8	0.1	1.5	3.3	12.5	3.1	28.2	1.8	5.1	5.8	3.0	2.0	1.2	6.5	3.4	55.0	1.5	54.1	8.6	5.3	5.1	11.4	9.8	9.0	14.1	10.1	10.6	10.5	10.3	10.7	9.3	13.3	9.2	52.7	3.2	44.5	5.5	21.1	9.9	5.2	23.7	7.4	102.9	9.8	7.4	272.8	4.3	8.3	7.3	123.0	0.3	5.6	0.8	9.8	8.2	10.9	2.0	3.1	57.7	10.2	0.8	5.3	62.9	0.3	21.7	5.6	2.0	1.3	6.6	15.0	0.3	4.1	15.2	10.3	2.9	26.4	2.8	20.1	7.1	3.7	4.0	21.4	8.4	12.8	36.7	2.1	2.5	0.7	10.8	0.2	1.9	79.8	11.9	0.2	5.0	1.1	226.5	32.9	17.1	140.8	4.4	24.8	1.8	10.2	0.3	13.7	3.4	3.0	3.6
PTPMT1	"DUSP23, MOSP, PLIP"	ENSG00000110536	"Protein tyrosine phosphatase mitochondrial 1"	Q8WUK0	11	47565430-47573461	"Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Lipid biosynthesis, Lipid metabolism, Phospholipid biosynthesis, Phospholipid metabolism"	"Hydrolase, Protein phosphatase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 235.1;Late spermatids: 640.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA043932, HPA060060"	Approved		Enhanced	Mitochondria		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 71: Testis - DNA repair"	"Cluster 6: T47d - Mammary gland"	"Cluster 25: Spermatids - Spermatogenesis"	Mitochondria		"HPA043932: AB_2678738, HPA060060: "	"unprognostic (6.61e-2)"	"unprognostic (2.09e-1)"	"unprognostic (1.28e-1)"	"unprognostic (2.37e-3)"	"unprognostic (1.02e-1)"	"unprognostic (1.26e-2)"	"prognostic unfavorable (3.04e-5)"	"unprognostic (3.29e-2)"	"unprognostic (2.77e-2)"	"unprognostic (1.93e-3)"	"unprognostic (6.76e-2)"	"unprognostic (1.72e-1)"	"unprognostic (2.68e-3)"	"unprognostic (1.21e-1)"	"unprognostic (5.39e-1)"	"unprognostic (2.17e-2)"	"unprognostic (1.75e-1)"	38.8	56.5	15.0	5.3	16.1	9.0	37.4	15.8	17.4	31.1	16.6	31.0	7.6	32.8	7.8	34.8	29.5	4.2	27.7	14.4	16.5	37.6	40.6	36.5	6.1	15.6	16.3	28.0	44.7	9.6	41.9	6.7	15.8	32.7	3.9	4.2	37.1	5.9	41.0	28.1	23.4	4.7	16.0	28.9	39.2	105.4	17.0	4.3	30.6	5.8	4.9	27.5	28.1	16.0	34.5	19.4	2.3	17.8	17.5	11.4	7.0	20.1	17.1	19.4	16.8	27.9	17.6	27.9	22.1	14.7	16.8	30.6	16.9	20.4	16.6	31.4	57.3	12.9	43.8	43.4	25.7	25.2	17.1	12.7	21.9	8.8	24.0	11.2	13.7	26.2	32.6	19.5	14.2	65.4	21.4	41.0	18.8	3.9	37.7	38.6	16.7	22.3	22.5	23.3	15.5	21.4	33.8	11.1	23.2	7.2	53.1	32.7	16.6	13.6	23.3	28.6	33.1	27.1	22.6	18.6	13.6	23.3	10.0	11.2	38.0	38.2	24.8	36.8	23.0	33.7	22.7	26.2	44.9	30.3	22.3	21.0	3.1	26.1	34.6	64.6	28.5	28.8	15.0	16.1	15.8	17.4	14.4	16.5	15.6	16.3	15.8	16.0	17.0	16.0	26.8	22.4	35.0	14.4	31.8	17.8	15.8	58.5	34.1	14.4	64.9	78.4	5.8	45.8	38.6	40.5	4.2	72.2	34.7	19.9	72.4	95.3	235.1	48.0	23.9	24.6	31.3	30.1	8.2	85.8	66.3	23.9	28.1	25.6	17.1	16.5	29.6	39.8	62.4	5.0	10.8	45.7	48.8	32.6	21.2	640.8	46.6	45.6	46.2	6.5	56.2	74.9	41.2	9.5	14.6	106.2	38.8	46.6	61.0	26.0	37.9	72.8	57.2	15.7	19.7	17.3	28.1	179.8	28.6	55.0	17.3	76.8	25.9	21.3	62.7	22.0
PTPN1	PTP1B	ENSG00000196396	"Protein tyrosine phosphatase non-receptor type 1"	P18031	20	50510321-50585241	"Enzymes, Metabolic proteins, Predicted membrane proteins"		"Hydrolase, Protein phosphatase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Alveolar cells type 1: 227.6;monocytes: 207.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB009329, HPA012542, CAB015217"	Approved		Enhanced	"Endoplasmic reticulum"		NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 66: Lymphoid tissue - Immune response regulation"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 65: Plasmacytoid DCs - Unknown function"	"Endoplasmic reticulum"		"CAB009329: AB_2174944, CAB015217: , HPA012542: AB_1855915"	"unprognostic (1.67e-1)"	"unprognostic (7.78e-2)"	"unprognostic (1.48e-1)"	"unprognostic (1.05e-2)"	"unprognostic (1.14e-1)"	"unprognostic (3.44e-2)"	"unprognostic (2.98e-3)"	"unprognostic (3.95e-2)"	"unprognostic (2.40e-2)"	"unprognostic (6.47e-3)"	"unprognostic (5.87e-2)"	"unprognostic (1.67e-1)"	"unprognostic (1.66e-2)"	"unprognostic (6.70e-2)"	"unprognostic (2.99e-2)"	"unprognostic (1.49e-1)"	"unprognostic (2.58e-2)"	26.3	30.8	13.0	44.5	14.0	55.4	22.1	12.3	14.7	23.2	28.6	24.8	13.9	23.0	18.7	29.6	22.0	23.1	31.9	17.5	13.0	46.7	21.0	55.2	52.9	16.1	14.4	25.6	15.9	48.3	19.7	34.2	13.7	25.0	18.8	9.9	18.9	18.2	35.4	23.9	28.3	21.9	13.7	46.5	21.0	18.3	14.2	35.5	18.7	21.6	52.6	35.8	23.5	14.1	66.1	32.4	38.4	26.6	24.6	33.6	54.5	43.2	40.8	123.8	44.9	96.1	134.3	32.5	74.8	40.0	48.7	56.9	30.8	123.8	78.2	48.5	27.6	45.9	30.9	51.3	49.0	48.2	60.2	39.6	84.9	55.9	68.2	54.3	72.3	38.5	81.5	28.9	68.3	36.5	52.1	38.1	20.4	36.2	44.2	45.6	44.6	31.1	71.2	48.4	30.8	35.3	62.0	77.6	71.3	32.1	50.4	50.9	108.2	107.3	43.1	48.8	54.2	31.4	27.3	38.9	67.1	32.3	40.6	19.8	7.1	25.2	12.9	12.1	9.5	19.2	10.8	10.0	7.1	17.4	8.9	9.8	15.4	5.3	22.8	11.8	9.4	8.7	13.0	14.0	12.3	14.7	17.5	13.0	16.1	14.4	13.7	13.7	14.2	14.1	34.0	227.6	83.6	22.9	147.8	86.0	61.7	37.1	56.3	25.1	23.9	24.4	30.0	11.5	40.0	36.8	47.9	54.0	68.7	26.1	23.5	26.2	67.7	45.0	44.0	36.3	18.6	32.0	61.6	19.3	20.9	52.1	32.1	65.9	70.8	14.2	41.4	20.8	37.4	43.7	43.3	16.4	20.3	40.6	169.5	37.4	14.0	100.7	37.4	32.8	207.8	12.1	38.1	27.6	42.1	41.7	14.5	12.0	178.7	26.6	8.9	65.2	30.2	27.5	19.7	55.5	57.7	20.8	24.5	48.7	47.2	54.3	83.8	44.3	14.6	53.5
PTPN11	"BPTP3, NS1, PTP2C, SH-PTP2, SHP-2, SHP2"	ENSG00000179295	"Protein tyrosine phosphatase non-receptor type 11"	Q06124	12	112418351-112509918	"Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins, RAS pathway related proteins"		"Hydrolase, Protein phosphatase"	"Cancer-related genes, Deafness, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB005377	Approved		Supported	"Nucleoplasm,Nucleoli rim,Actin filaments,Cytosol"		NA	NA		74000	"Cluster 6: Non-specific - Transcription"	"Cluster 44: Heart - Cardiac muscle contraction"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 54: Cardiomyocytes - Muscle contraction"	"Nucleoplasm, Nucleoli rim"	"Actin filaments, Cytosol"	"CAB005377: AB_632401"	"unprognostic (2.18e-3)"	"unprognostic (1.73e-3)"	"unprognostic (5.62e-2)"	"unprognostic (1.19e-1)"	"unprognostic (1.63e-2)"	"unprognostic (2.27e-1)"	"unprognostic (6.05e-2)"	"unprognostic (4.25e-2)"	"unprognostic (3.55e-2)"	"unprognostic (1.88e-1)"	"unprognostic (2.22e-2)"	"unprognostic (8.85e-2)"	"unprognostic (3.75e-3)"	"unprognostic (1.66e-1)"	"unprognostic (2.46e-1)"	"unprognostic (3.62e-2)"	"unprognostic (1.80e-2)"	62.9	36.6	74.6	34.7	91.7	46.3	37.6	72.7	115.7	37.9	38.4	32.5	27.6	37.8	28.7	38.9	24.3	29.4	68.7	66.1	85.6	39.7	53.0	34.4	35.6	79.0	84.1	26.2	31.6	53.4	16.1	38.0	85.7	35.2	30.6	51.8	25.9	42.4	75.1	32.1	26.1	45.7	83.4	26.7	30.4	18.2	81.7	35.5	46.8	64.0	32.5	40.1	23.5	106.3	116.9	107.6	77.0	73.4	109.7	106.1	92.7	136.4	148.2	105.5	78.5	107.7	43.4	124.5	69.4	127.4	66.7	68.1	100.1	121.6	173.8	93.1	85.0	181.5	102.6	59.8	109.2	145.8	108.0	86.6	119.6	113.6	159.8	101.3	88.7	92.0	140.2	41.3	103.3	83.2	101.0	69.7	94.1	112.3	73.4	102.4	114.6	70.5	97.3	126.7	53.3	66.1	133.7	99.8	85.2	77.6	114.8	97.8	108.1	122.9	110.0	74.2	121.8	79.4	141.6	120.2	102.2	99.7	117.7	32.2	11.7	16.8	14.8	10.2	14.0	18.1	13.3	12.4	13.6	20.8	15.3	11.9	10.7	12.6	13.7	18.3	10.9	7.2	74.6	91.7	72.7	115.7	66.1	85.6	79.0	84.1	85.7	83.4	81.7	106.3	49.0	60.9	68.2	27.7	25.8	25.6	39.9	25.3	20.5	29.9	40.5	32.4	131.6	24.3	41.8	36.8	16.7	23.5	34.2	25.4	33.2	37.5	63.1	31.3	92.6	46.2	13.1	21.7	67.6	42.8	25.3	35.8	21.9	40.9	28.4	33.1	26.0	101.5	26.8	13.5	54.7	22.0	18.3	33.3	21.6	28.5	51.6	31.8	14.2	40.3	31.1	59.8	29.9	32.6	73.0	59.3	19.6	79.7	37.0	73.4	16.6	39.8	23.5	22.2	32.9	58.2	49.2	7.1	6.6	37.5	27.4	35.2	31.7	30.5	22.2	66.8
PTPN12	"PTP-PEST, PTPG1"	ENSG00000127947	"Protein tyrosine phosphatase non-receptor type 12"	Q05209	7	77537295-77640069	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Hydrolase, Protein phosphatase"	"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA007097	Approved		Approved	"Plasma membrane,Cytosol"		NA	NA		770000	"Cluster 40: NK-cells - Unknown function"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 17: WM-115 - Nervous system development"	"Cluster 51: Myeloid cells - Hemostasis"	"Plasma membrane, Cytosol"		"HPA007097: AB_1079689"	"unprognostic (2.28e-1)"	"prognostic unfavorable (1.15e-4)"	"unprognostic (1.35e-1)"	"unprognostic (3.35e-2)"	"unprognostic (1.40e-3)"	"unprognostic (4.48e-3)"	"prognostic unfavorable (8.78e-4)"	"unprognostic (1.29e-1)"	"unprognostic (5.83e-2)"	"unprognostic (2.64e-1)"	"prognostic unfavorable (2.01e-4)"	"unprognostic (1.09e-1)"	"prognostic unfavorable (7.27e-6)"	"unprognostic (4.99e-2)"	"unprognostic (2.97e-1)"	"unprognostic (1.81e-1)"	"unprognostic (3.21e-1)"	60.5	30.1	24.2	43.9	26.6	69.9	50.3	29.2	31.6	40.9	25.9	48.9	18.9	38.6	18.6	38.5	39.6	40.2	39.0	25.1	27.3	36.1	30.9	65.0	27.5	28.5	27.8	34.6	20.1	21.0	21.9	74.7	30.5	26.4	27.7	30.9	23.8	33.2	24.6	36.9	29.7	40.2	26.7	52.7	27.1	30.1	32.7	33.9	31.0	44.5	27.5	46.7	39.6	30.2	72.4	43.5	100.6	51.8	69.1	71.7	54.2	73.3	93.0	56.6	80.0	21.6	109.9	8.6	23.2	86.3	123.6	50.2	34.2	73.4	113.3	21.2	19.2	44.9	44.2	88.4	67.7	25.8	28.8	59.0	80.3	123.2	157.6	101.0	121.6	2.1	54.9	12.2	182.6	49.4	3.6	71.9	81.7	97.6	49.2	15.1	80.6	4.5	97.6	38.5	12.5	66.6	90.4	81.5	73.4	172.2	39.5	93.9	89.3	121.4	73.1	45.0	141.3	12.6	7.4	22.2	71.6	65.9	215.7	3.6	4.1	6.8	3.1	2.8	1.3	2.3	1.1	2.6	3.8	1.0	0.6	3.3	9.5	13.3	5.3	0.3	1.6	2.7	24.2	26.6	29.2	31.6	25.1	27.3	28.5	27.8	30.5	26.7	32.7	30.2	139.3	70.5	56.2	30.0	18.2	68.8	60.0	55.9	23.9	16.7	40.9	26.3	41.3	28.6	46.4	20.2	8.4	40.0	89.0	31.2	3.9	42.1	3.5	43.9	62.4	114.4	12.1	16.6	65.8	39.6	58.7	54.6	21.4	87.2	14.5	21.7	119.2	24.6	50.1	35.3	58.0	21.7	28.5	82.0	121.3	6.7	46.6	96.1	35.6	93.7	54.9	66.9	163.7	70.4	67.3	75.0	21.4	47.0	17.6	62.0	10.9	19.2	23.2	15.2	65.7	127.9	66.8	51.2	71.4	29.8	101.4	72.1	27.3	24.4	23.3	104.8
PTPN13	"PTP-BAS, PTP-BL, PTP1E, PTPL1"	ENSG00000163629	"Protein tyrosine phosphatase non-receptor type 13"	Q12923	4	86594315-86815171	"Cancer-related genes, Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Hydrolase, Protein phosphatase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"retina: 124.3"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 2: 223.1;Astrocytes: 165.2;Oligodendrocytes: 200.2;Rod photoreceptor cells: 179.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"non-classical monocyte: 2.0"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"AF22: 117.6;RT4: 57.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB002213, HPA063119"	Approved		Supported	"Nucleoplasm,Nucleoli fibrillar center,Cytosol"		NA	NA			"Cluster 7: Monocytes - Unknown function"	"Cluster 77: Retina - Visual perception"	"Cluster 12: NES - Nervous system development"	"Cluster 46: Photoreceptor cells - Phototransduction"	Nucleoplasm	"Nucleoli fibrillar center, Cytosol"	"CAB002213: AB_564089, HPA063119: "	"unprognostic (5.36e-2)"	"unprognostic (4.46e-1)"	"unprognostic (1.11e-1)"	"unprognostic (2.54e-3)"	"unprognostic (4.02e-1)"	"unprognostic (9.03e-3)"	"unprognostic (4.43e-2)"	"unprognostic (4.38e-2)"	"unprognostic (2.46e-1)"	"unprognostic (7.05e-2)"	"unprognostic (3.69e-2)"	"unprognostic (1.46e-1)"	"unprognostic (1.28e-3)"	"unprognostic (3.95e-3)"	"unprognostic (2.26e-1)"	"unprognostic (2.66e-1)"	"unprognostic (2.85e-2)"	14.0	6.7	9.9	3.0	16.6	0.3	11.7	8.1	10.8	18.8	22.4	5.2	0.8	13.1	25.5	22.2	13.0	7.7	6.1	14.2	10.6	26.6	1.4	22.9	5.2	16.7	13.1	28.7	4.9	17.5	16.8	3.3	10.5	11.0	2.4	124.3	6.6	10.6	1.0	55.9	2.6	7.9	8.2	4.0	4.1	15.8	13.8	7.6	20.8	5.0	11.5	20.7	22.7	20.4	13.8	6.8	117.6	11.5	48.2	41.9	0.0	25.0	51.0	9.4	11.7	0.1	6.8	0.0	5.3	28.0	3.3	44.4	20.6	37.9	18.0	0.3	15.1	11.4	14.6	0.0	5.9	20.5	0.1	27.2	11.8	6.8	22.4	19.7	0.0	0.0	0.0	19.2	0.0	6.2	1.8	7.4	26.5	0.0	5.1	4.1	0.0	0.0	35.6	57.2	6.8	9.8	7.4	16.4	13.3	18.8	9.6	0.7	0.0	9.1	6.9	0.2	3.3	19.8	0.0	0.0	9.5	0.0	4.0	0.0	0.1	0.0	0.1	1.3	0.9	0.0	0.8	0.1	0.2	0.0	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	9.9	16.6	8.1	10.8	14.2	10.6	16.7	13.1	10.5	8.2	13.8	20.4	5.3	48.1	223.1	165.2	0.6	109.4	25.6	26.3	79.1	11.6	11.2	8.9	1.8	11.5	52.0	47.8	91.8	0.2	0.3	0.1	3.9	5.0	23.2	16.9	49.4	3.7	4.8	0.8	67.0	3.7	0.1	28.8	4.1	7.7	5.1	7.5	3.6	0.1	0.3	1.7	39.3	1.1	8.2	1.4	10.6	20.8	45.7	4.5	19.6	51.5	0.5	20.3	0.0	75.4	200.2	6.2	2.7	32.7	3.0	16.0	0.1	10.9	27.3	179.0	13.1	10.1	20.8	25.4	20.5	97.8	99.4	0.3	6.6	14.0	0.7	52.5
PTPN14	PEZ	ENSG00000152104	"Protein tyrosine phosphatase non-receptor type 14"	Q15678	1	214348700-214552449	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Hydrolase, Protein phosphatase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Microglial cells: 91.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"CAB011469, HPA053864, CAB069441"	Uncertain		Supported	Nucleoplasm		NA	NA				"Cluster 59: Non-specific - Translation"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	Nucleoplasm		"CAB011469: AB_299202, CAB069441: , HPA053864: AB_2682281"	"unprognostic (1.54e-1)"	"unprognostic (8.19e-2)"	"unprognostic (5.42e-5)"	"unprognostic (1.42e-1)"	"unprognostic (2.91e-1)"	"unprognostic (5.97e-2)"	"unprognostic (1.26e-1)"	"unprognostic (1.58e-1)"	"unprognostic (2.84e-1)"	"unprognostic (1.31e-1)"	"prognostic unfavorable (2.29e-4)"	"unprognostic (7.43e-2)"	"unprognostic (8.34e-3)"	"prognostic unfavorable (5.16e-4)"	"unprognostic (1.16e-1)"	"unprognostic (2.21e-1)"	"unprognostic (4.81e-3)"	7.5	8.0	3.7	1.8	1.5	0.2	10.6	1.5	3.7	5.2	13.4	7.6	0.9	8.2	2.5	6.0	7.3	3.3	6.0	3.3	0.8	8.2	0.7	4.6	1.3	2.4	2.4	6.6	4.3	3.3	1.8	7.8	2.1	6.7	2.3	0.6	6.5	6.6	19.8	16.2	2.8	7.9	1.4	3.5	4.5	3.9	4.2	2.1	5.3	10.2	1.8	5.6	5.6	1.9	21.1	9.2	7.2	10.6	12.3	20.9	21.6	23.2	21.3	17.3	14.4	18.8	10.7	0.1	25.3	53.6	10.0	18.1	10.0	25.7	29.0	0.2	7.7	1.9	26.6	3.5	22.2	0.2	1.0	15.6	26.1	30.0	47.4	28.1	33.8	0.6	0.1	0.2	41.8	2.3	0.2	0.2	16.2	3.7	9.9	0.3	36.3	0.1	30.6	10.5	0.1	1.7	28.7	18.4	11.6	25.1	18.4	0.7	61.4	40.3	15.9	14.6	33.3	1.2	0.1	0.2	21.6	0.3	34.6	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	3.7	1.5	1.5	3.7	3.3	0.8	2.4	2.4	2.1	1.4	4.2	1.9	60.3	73.7	12.6	47.3	1.3	56.5	32.1	39.4	45.5	0.6	20.3	29.8	20.5	14.3	32.7	29.5	0.0	38.8	1.3	1.0	7.9	12.9	8.8	42.5	25.9	53.5	3.5	0.0	47.9	11.0	14.2	20.8	9.2	55.2	1.3	13.5	40.0	0.9	4.5	0.0	6.0	4.1	4.1	1.5	7.7	4.4	26.1	2.4	10.6	91.8	0.3	3.9	3.1	39.2	2.1	31.2	0.3	29.3	1.6	30.6	0.3	14.4	18.5	1.3	19.7	38.0	20.1	1.2	10.6	18.3	36.1	24.2	3.7	46.3	2.9	28.9
PTPN18	BDP1	ENSG00000072135	"Protein tyrosine phosphatase non-receptor type 18"	Q99952	2	130356045-130375405	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Hydrolase, Protein phosphatase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Macrophages: 143.4;NK-cells: 148.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"RPMI-8226: 63.0"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"CAB012174, HPA053367"	Uncertain		Approved	"Intermediate filaments"		NA	NA		270000	"Cluster 51: Monocytes - Innate immune response"	"Cluster 64: Macrophages - Immune response"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 51: Myeloid cells - Hemostasis"	"Intermediate filaments"		"CAB012174: AB_2173224, HPA053367: AB_2732579"	"unprognostic (3.11e-3)"	"unprognostic (2.89e-3)"	"unprognostic (1.67e-3)"	"unprognostic (1.73e-3)"	"unprognostic (5.81e-3)"	"unprognostic (3.08e-3)"	"unprognostic (2.49e-2)"	"unprognostic (1.28e-2)"	"unprognostic (4.65e-1)"	"unprognostic (2.10e-2)"	"unprognostic (7.33e-2)"	"unprognostic (5.65e-2)"	"unprognostic (4.52e-2)"	"unprognostic (1.00e-2)"	"unprognostic (3.60e-1)"	"unprognostic (1.05e-1)"	"unprognostic (5.85e-3)"	22.3	12.3	19.6	23.2	19.4	28.2	21.5	21.7	21.4	21.2	18.4	35.3	21.7	15.7	6.1	17.8	19.6	14.8	15.3	18.8	19.1	25.4	37.8	22.0	42.7	21.0	19.6	12.5	34.6	9.5	19.0	12.2	20.1	33.3	24.7	6.4	31.9	13.2	7.5	12.7	39.4	13.3	18.7	63.8	27.0	4.6	20.0	11.1	20.0	7.5	48.6	18.8	18.9	19.6	12.4	8.3	3.2	16.2	19.7	13.5	32.9	6.2	5.6	7.9	8.8	16.4	18.5	46.4	6.2	15.2	3.7	13.8	14.3	14.1	7.6	21.1	8.0	16.9	9.8	19.5	10.2	16.6	44.5	16.0	11.4	8.7	12.0	1.7	15.2	10.1	16.1	34.2	15.4	24.3	3.1	28.4	3.3	26.6	8.6	28.4	9.5	63.0	15.9	7.5	20.6	5.4	10.9	38.6	18.7	3.1	13.2	24.1	14.4	11.2	12.6	6.2	5.9	5.6	1.6	44.5	17.1	14.9	12.4	8.4	7.8	6.7	6.4	11.2	4.0	7.3	4.2	6.1	6.9	5.1	2.6	5.1	4.8	3.1	19.4	7.5	6.0	10.7	19.6	19.4	21.7	21.4	18.8	19.1	21.0	19.6	20.1	18.7	20.0	19.6	37.2	28.9	23.9	12.1	43.6	6.5	28.8	15.9	12.0	13.4	52.0	53.5	9.0	18.6	17.5	36.8	4.2	15.6	85.6	75.9	54.8	19.0	0.9	20.6	14.0	30.7	48.6	32.4	18.2	45.4	30.5	16.3	65.2	24.0	35.5	12.2	25.7	21.1	92.4	10.1	18.6	52.5	30.5	113.6	35.9	1.6	19.0	143.4	33.8	35.6	65.2	18.4	148.3	5.5	6.1	29.0	66.9	11.3	23.5	37.9	41.3	37.3	20.5	11.6	19.7	15.1	21.5	2.6	6.0	19.4	5.8	11.5	39.3	16.2	47.5	28.9
PTPN2	"PTPT, TC-PTP, TCELLPTP, TCPTP"	ENSG00000175354	"Protein tyrosine phosphatase non-receptor type 2"	P17706	18	12785478-12929643	"Enzymes, Human disease related genes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins"		"Hydrolase, Protein phosphatase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 99.8"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA015004, HPA046176"	Enhanced		Supported	Nucleoplasm		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 66: Lymphoid tissue - Immune response regulation"	"Cluster 21: OE19 - Mitochondria"	"Cluster 22: Epithelial cell types - Mixed function"	Nucleoplasm		"HPA015004: AB_2669131, HPA046176: AB_2679569"	"unprognostic (5.83e-3)"	"unprognostic (8.50e-2)"	"unprognostic (5.85e-2)"	"unprognostic (7.21e-3)"	"unprognostic (8.94e-3)"	"unprognostic (2.31e-1)"	"unprognostic (1.12e-1)"	"unprognostic (1.68e-1)"	"unprognostic (2.37e-3)"	"prognostic favorable (1.37e-4)"	"unprognostic (1.06e-2)"	"unprognostic (1.75e-2)"	"prognostic unfavorable (1.20e-8)"	"unprognostic (3.19e-1)"	"unprognostic (6.84e-3)"	"unprognostic (2.17e-1)"	"unprognostic (4.61e-3)"	23.4	15.2	10.0	32.8	10.8	57.2	23.7	21.0	17.1	19.9	15.6	22.2	18.9	16.0	20.4	20.0	17.4	22.4	14.7	11.0	10.4	17.3	25.8	26.3	44.4	12.3	10.4	26.8	33.1	14.1	18.3	19.5	11.8	17.6	24.1	20.2	29.4	13.5	16.7	21.0	19.5	16.9	10.7	28.5	18.0	13.6	10.0	99.8	17.5	11.9	43.5	37.2	19.9	14.3	34.8	20.7	23.7	7.9	26.5	47.4	23.0	22.7	50.2	47.5	42.2	45.4	48.8	54.3	37.2	23.6	53.2	20.4	39.0	62.2	62.1	21.2	23.5	38.4	17.7	47.6	36.4	91.1	35.1	40.2	57.6	43.3	85.1	29.2	24.6	58.1	37.9	71.6	38.6	39.9	91.3	74.5	28.5	141.7	24.0	30.4	37.3	61.9	40.2	54.6	42.3	22.0	46.0	26.7	41.8	25.1	22.4	51.5	18.8	59.8	58.0	45.1	49.8	22.6	24.5	77.8	28.3	49.3	25.7	23.7	52.6	39.2	37.0	47.7	50.4	54.4	43.7	41.4	62.5	39.5	31.6	34.9	19.0	64.1	46.7	53.0	57.3	40.7	10.0	10.8	21.0	17.1	11.0	10.4	12.3	10.4	11.8	10.7	10.0	14.3	25.8	35.3	77.0	38.5	82.4	59.9	106.0	88.0	61.5	44.1	37.0	50.5	15.0	47.1	84.4	14.7	104.3	54.1	130.4	32.2	13.7	55.1	24.3	51.0	44.8	32.0	32.3	40.8	81.1	68.8	52.5	38.1	24.5	78.7	56.4	53.1	20.3	27.9	51.3	15.2	60.5	35.0	69.2	99.2	92.5	23.2	29.2	93.4	23.2	44.0	137.0	17.6	128.8	22.6	55.0	40.0	45.1	25.6	120.2	126.4	29.9	23.1	55.4	84.5	19.7	35.4	33.8	23.3	61.3	40.0	50.2	81.1	84.2	65.2	39.5	152.4
PTPN20	"bA142I17.1, bA42B19.1, CT126, DKFZP566K0524, PTPN20A, PTPN20B"	ENSG00000204179	"Protein tyrosine phosphatase non-receptor type 20"	Q4JDL3	10	46911396-47002488	"Enzymes, Predicted intracellular proteins"		"Hydrolase, Protein phosphatase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 19.6"	"Cell type enhanced"	"Detected in many"		"Cardiomyocytes: 16.3;Distal tubular cells: 21.5;Early spermatids: 44.2;Late spermatids: 34.9;Proximal tubular cells: 17.7;Spermatocytes: 24.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	6	"HDLM-2: 50.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA043337, HPA046896, HPA048310, HPA069148"	Enhanced		Supported	"Centriolar satellite"		NA	NA			"Cluster 40: NK-cells - Unknown function"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 39: Non-specific - Basic cellular processes"	"Centriolar satellite"		"HPA043337: AB_2678436, HPA046896: , HPA048310: AB_2680350, HPA069148: "	"unprognostic (1.08e-1)"	"unprognostic (1.30e-1)"	"unprognostic (3.04e-2)"	"unprognostic (2.82e-3)"	"unprognostic (6.78e-2)"	"unprognostic (1.85e-1)"	"unprognostic (8.44e-2)"	"unprognostic (1.92e-1)"	"unprognostic (1.53e-1)"	"unprognostic (2.22e-2)"	"unprognostic (2.83e-1)"	"unprognostic (1.24e-1)"	"unprognostic (1.06e-1)"	"unprognostic (1.62e-1)"	"unprognostic (1.48e-2)"	"unprognostic (1.75e-1)"	"unprognostic (8.34e-2)"	1.6	9.1	3.4	0.2	4.4	0.2	3.5	9.2	5.1	0.8	8.9	0.9	1.3	0.9	0.3	3.4	1.4	0.7	9.1	3.9	5.2	4.4	0.8	0.8	0.4	18.5	9.0	1.9	4.1	0.0	3.1	0.2	19.6	1.2	1.6	2.9	2.4	1.4	12.3	5.7	0.6	0.8	4.6	1.2	1.1	14.0	5.3	0.3	2.0	14.7	0.6	0.9	1.1	4.8	0.0	6.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.5	0.0	0.0	2.9	0.0	3.7	0.0	0.0	0.0	50.2	0.1	0.1	0.0	0.0	2.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.4	0.0	2.2	1.3	9.0	5.5	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	2.9	7.2	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.5	0.1	0.3	0.1	0.6	0.9	0.0	0.8	0.0	0.7	0.4	0.2	3.4	4.4	9.2	5.1	3.9	5.2	18.5	9.0	19.6	4.6	5.3	4.8	0.5	0.0	1.5	0.0	0.7	0.0	2.0	0.0	5.7	6.0	5.9	3.7	16.3	0.0	2.5	9.2	6.2	0.1	0.3	0.7	21.5	1.8	44.2	5.0	0.1	0.5	1.2	1.7	0.0	0.9	0.2	1.9	3.1	0.2	0.0	4.9	1.4	0.9	0.4	11.8	0.0	0.4	0.0	0.0	0.0	34.9	0.0	0.4	0.0	0.0	0.7	7.3	0.0	0.0	0.0	2.2	0.2	7.2	1.5	0.9	0.2	17.7	3.6	3.1	0.0	2.7	0.8	24.8	12.2	5.2	0.0	0.1	0.4	8.4	0.8	0.9
PTPN21	"PTPD1, PTPRL10"	ENSG00000070778	"Protein tyrosine phosphatase non-receptor type 21"	Q16825	14	88465778-88555007	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Hydrolase, Protein phosphatase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 57.7;Syncytiotrophoblasts: 101.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"RH-30: 35.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB011468, HPA073999"	Approved		Approved	"Golgi apparatus,Cytosol"		NA	NA				"Cluster 61: Skin - Cornification"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 18: Syncytiotrophoblasts - Pregnancy hormone signaling"	Cytosol	"Golgi apparatus"	"CAB011468: AB_442979, HPA073999: AB_2732247"	"unprognostic (2.18e-1)"	"unprognostic (4.21e-2)"	"unprognostic (7.60e-2)"	"unprognostic (3.09e-2)"	"unprognostic (4.60e-2)"	"unprognostic (5.71e-2)"	"unprognostic (6.55e-2)"	"unprognostic (5.19e-3)"	"unprognostic (6.62e-2)"	"unprognostic (1.02e-2)"	"unprognostic (8.71e-3)"	"unprognostic (3.04e-3)"	"prognostic favorable (3.16e-9)"	"unprognostic (6.52e-2)"	"unprognostic (2.69e-1)"	"unprognostic (2.56e-1)"	"unprognostic (7.67e-2)"	10.0	5.4	6.7	4.1	7.2	0.0	9.2	6.4	6.6	11.5	10.1	11.9	6.0	12.0	5.9	10.3	10.1	8.7	21.3	6.2	8.0	7.8	7.7	17.9	2.1	9.7	7.8	17.5	9.4	8.3	4.5	10.3	7.2	9.3	7.6	9.1	7.4	9.5	11.8	29.0	8.2	10.4	7.9	4.0	9.0	20.2	7.4	1.1	18.7	9.8	1.9	10.1	9.8	7.4	5.8	4.6	11.8	4.6	12.3	10.6	12.1	15.2	11.6	8.8	12.2	8.1	10.2	0.0	3.6	19.6	7.9	5.4	1.7	5.4	12.9	0.3	2.7	0.0	5.6	3.4	13.6	0.1	0.2	7.1	10.4	7.4	8.8	11.4	7.2	0.0	1.8	0.2	22.9	4.7	0.0	0.3	3.5	6.2	8.7	0.1	35.3	0.1	7.7	4.1	0.8	13.6	8.7	21.6	5.2	10.0	10.7	2.3	14.5	16.3	12.8	6.7	10.6	0.5	1.9	0.0	6.0	0.2	6.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.7	7.2	6.4	6.6	6.2	8.0	9.7	7.8	7.2	7.9	7.4	7.4	7.2	57.7	6.0	14.4	0.0	10.5	6.3	4.0	4.0	7.2	7.1	5.8	34.9	5.7	7.1	7.3	35.5	10.3	0.1	18.1	0.0	5.0	19.1	10.2	11.4	6.0	4.8	8.0	12.8	8.4	5.4	12.0	7.1	7.1	2.5	9.2	6.1	9.7	1.9	1.7	14.4	15.0	8.2	1.3	3.9	5.3	17.1	0.4	0.0	13.1	0.0	4.7	1.0	28.1	20.3	10.7	6.1	27.1	0.0	8.8	6.7	3.5	10.3	9.4	0.0	12.7	10.5	20.2	6.6	3.5	11.9	101.9	0.6	7.4	6.2	4.7
PTPN22	"Lyp, Lyp1, Lyp2, PTPN8"	ENSG00000134242	"Protein tyrosine phosphatase non-receptor type 22"	Q9Y2R2	1	113813811-113871753	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Autophagy, Immunity"	"Hydrolase, Protein phosphatase"	"Diabetes mellitus, Disease variant, Systemic lupus erythematosus"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 38.0;lymphoid tissue: 20.3"	"Group enriched"	"Detected in many"	4	"B-cells: 67.4;dendritic cells: 176.0;NK-cells: 108.1;Plasma cells: 79.6;T-cells: 151.2"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"Daudi: 69.3;HL-60: 27.7;U-266/70: 29.2;U-698: 37.5;U-937: 28.4"	"Region enriched"	"Detected in single"	11	"cerebellum: 5.3"	"Not detected"	"Not detected"			"HPA004912, CAB012209, HPA013350"	Approved		Uncertain	"Nucleoplasm,Vesicles,Plasma membrane"		NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 66: Lymphoid tissue - Immune response regulation"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 24: Non-specific - Transcription regulation"	Nucleoplasm	"Vesicles, Plasma membrane"	"CAB012209: , HPA004912: AB_10602069, HPA013350: AB_10601570"	"unprognostic (2.25e-2)"	"unprognostic (5.31e-3)"	"unprognostic (3.48e-1)"	"unprognostic (3.33e-4)"	"unprognostic (9.14e-2)"	"unprognostic (2.47e-3)"	"unprognostic (9.60e-2)"	"unprognostic (8.14e-2)"	"unprognostic (3.71e-1)"	"unprognostic (1.82e-1)"	"unprognostic (1.62e-1)"	"unprognostic (3.02e-1)"	"unprognostic (2.75e-6)"	"unprognostic (3.19e-1)"	"unprognostic (1.10e-1)"	"unprognostic (1.61e-1)"	"unprognostic (3.22e-2)"	2.0	1.5	0.2	11.5	0.2	38.0	2.3	0.4	0.5	1.8	0.6	4.0	6.4	1.0	1.1	1.7	0.9	4.8	0.6	0.1	0.2	0.6	2.0	7.5	20.3	0.5	0.2	0.6	1.3	0.3	0.3	0.8	0.4	1.0	4.3	0.4	1.3	0.6	0.3	0.9	8.6	1.6	0.2	13.2	5.2	1.4	0.6	20.0	0.7	0.2	13.5	4.2	0.9	0.8	0.0	0.0	0.0	0.0	0.0	0.4	0.2	0.9	0.4	0.0	0.7	0.0	0.4	69.3	0.1	0.2	0.0	0.0	0.0	0.1	0.5	6.5	0.0	10.0	0.0	0.0	0.2	27.7	21.1	5.7	0.0	2.8	0.2	5.1	10.6	17.2	0.1	15.7	10.3	0.2	20.1	15.7	0.0	0.1	0.0	1.2	6.7	0.1	0.5	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	10.0	5.0	16.0	0.3	0.4	0.5	29.2	6.6	37.5	11.1	28.4	0.1	15.8	4.8	25.0	17.0	1.3	20.1	9.9	8.4	13.6	8.7	7.4	5.0	12.1	2.4	11.0	0.6	5.2	14.5	7.3	0.2	0.2	0.4	0.5	0.1	0.2	0.5	0.2	0.4	0.2	0.6	0.8	2.2	0.0	6.5	0.7	67.4	2.5	0.2	0.0	1.2	0.7	2.2	2.4	0.8	0.0	0.2	1.8	2.1	0.1	176.0	2.2	0.0	0.1	0.4	0.7	0.5	1.7	0.0	16.6	3.2	0.6	0.3	2.2	12.8	1.0	27.8	0.0	0.4	0.5	7.1	0.0	2.5	1.2	0.0	17.3	26.8	1.0	0.0	26.4	3.6	2.8	14.4	0.0	108.1	0.0	1.7	0.5	0.8	0.0	79.6	0.3	4.3	0.1	2.2	0.5	13.1	0.6	1.4	0.4	0.6	0.3	2.7	0.1	151.2	0.0	2.2	0.3
PTPN23	"DKFZP564F0923, HD-PTP, KIAA1471"	ENSG00000076201	"Protein tyrosine phosphatase non-receptor type 23"	Q9H3S7	3	47381011-47413435	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"Cilium biogenesis/degradation, Protein transport, Transport"	"Hydrolase, Protein phosphatase"	"Disease variant, Epilepsy, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA016845	Approved		Supported	"Nucleoplasm,Nuclear bodies,Vesicles"		Yes	No			"Cluster 10: Basophils - Unknown function"	"Cluster 72: Non-specific - Transcription"	"Cluster 15: RT4 - Unknown function"	"Cluster 44: Endometrium - Transcription"	"Nucleoplasm, Nuclear bodies"	Vesicles	"HPA016845: AB_1855926"	"unprognostic (1.17e-3)"	"unprognostic (8.68e-2)"	"unprognostic (2.56e-1)"	"unprognostic (1.26e-1)"	"unprognostic (1.63e-1)"	"unprognostic (6.24e-2)"	"unprognostic (1.07e-3)"	"unprognostic (2.07e-2)"	"unprognostic (9.55e-2)"	"unprognostic (7.12e-2)"	"unprognostic (5.67e-2)"	"unprognostic (4.34e-2)"	"prognostic favorable (1.82e-4)"	"unprognostic (3.05e-2)"	"unprognostic (4.40e-1)"	"unprognostic (9.53e-2)"	"unprognostic (4.68e-2)"	18.5	19.1	6.2	12.6	9.2	14.7	17.4	5.8	10.5	23.3	5.1	16.3	14.3	20.9	7.5	19.0	19.2	8.4	13.2	7.1	7.2	17.5	14.0	18.7	9.1	8.8	7.2	23.5	20.2	23.5	30.9	11.6	8.5	18.7	6.5	8.5	20.0	11.4	30.0	26.4	18.4	8.8	5.5	20.0	16.1	15.6	7.7	8.0	27.1	8.9	7.3	18.5	20.4	14.4	21.5	29.9	16.4	21.4	21.0	16.0	15.8	19.2	18.9	17.5	14.8	25.0	20.7	15.1	17.2	21.9	31.2	19.0	14.3	20.8	8.5	14.3	15.1	21.0	22.2	24.0	23.0	12.3	27.5	21.4	20.9	22.9	23.2	12.4	21.7	12.5	15.9	20.3	19.0	30.2	11.5	10.4	17.5	14.9	20.1	7.2	7.9	18.5	13.2	40.9	8.6	20.6	17.1	35.6	13.6	9.8	20.3	12.0	22.4	26.7	22.2	37.7	27.5	28.8	20.4	8.7	29.0	11.6	19.5	0.8	0.2	0.0	0.1	0.1	0.0	0.2	0.1	0.2	0.0	0.1	0.1	0.1	0.2	0.2	0.0	0.2	0.3	0.3	6.2	9.2	5.8	10.5	7.1	7.2	8.8	7.2	8.5	5.5	7.7	14.4	11.1	9.6	7.0	17.0	8.2	8.0	5.2	6.9	13.6	11.7	9.5	8.0	8.7	8.6	9.5	5.5	14.6	10.6	11.0	15.7	1.9	10.5	2.1	10.3	13.7	12.4	7.3	2.5	9.8	8.9	7.9	9.1	26.5	21.1	2.5	14.9	11.4	12.7	13.9	16.8	12.0	16.3	20.3	10.4	5.5	3.1	19.3	9.5	12.4	7.5	8.7	8.8	6.2	9.5	14.3	13.5	10.4	13.5	15.4	9.3	14.6	9.4	12.6	14.2	6.6	10.2	8.8	13.6	13.3	13.2	10.9	9.3	8.9	9.4	12.8	8.2
PTPN3	PTPH1	ENSG00000070159	"Protein tyrosine phosphatase non-receptor type 3"	P26045	9	109375466-109498313	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"		"Hydrolase, Protein phosphatase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"skeletal muscle: 63.5"	"Cell type enhanced"	"Detected in many"		"Cardiomyocytes: 48.6"	"Low cancer specificity"	"Detected in many"			"Region enhanced"	"Detected in many"		"thalamus: 26.7"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"OE19: 29.4;RPTEC TERT1: 34.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038343, HPA046728"	Approved					NA	NA				"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 44: Endometrium - Transcription"			"HPA038343: AB_10671741, HPA046728: AB_2679776"	"prognostic unfavorable (6.71e-4)"	"unprognostic (3.48e-1)"	"unprognostic (3.64e-2)"	"prognostic favorable (1.52e-4)"	"unprognostic (2.32e-2)"	"unprognostic (1.27e-1)"	"unprognostic (2.34e-1)"	"unprognostic (4.86e-2)"	"unprognostic (3.71e-2)"	"unprognostic (5.38e-2)"	"unprognostic (6.37e-2)"	"unprognostic (3.57e-2)"	"prognostic favorable (1.22e-15)"	"unprognostic (1.64e-2)"	"unprognostic (2.64e-1)"	"unprognostic (1.11e-1)"	"unprognostic (8.21e-2)"	4.0	2.2	7.1	1.7	1.0	0.1	7.5	0.0	2.6	6.6	8.5	9.5	12.4	2.2	17.7	13.2	10.1	2.7	21.1	3.2	5.2	23.0	29.5	5.7	1.1	0.3	14.7	0.6	14.8	10.7	2.9	7.3	1.6	5.9	10.1	2.5	8.5	5.1	63.5	30.1	12.9	1.4	0.4	0.3	9.7	3.2	26.7	3.6	10.1	46.9	4.4	4.2	7.2	0.4	11.1	13.5	0.5	3.5	0.0	0.0	21.1	2.3	0.0	2.9	3.2	7.2	17.7	0.0	2.4	0.1	7.3	25.8	3.7	15.2	2.9	6.2	8.2	0.0	6.2	7.5	0.1	0.0	0.1	0.2	16.0	3.6	7.7	1.2	0.0	4.5	0.0	0.1	0.2	14.0	19.3	3.3	1.6	29.4	10.0	0.1	4.4	0.3	34.0	21.1	8.6	1.8	5.9	21.8	0.0	7.1	12.5	1.8	0.1	1.0	8.2	1.4	0.0	10.4	18.2	0.0	11.2	0.0	7.7	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.1	0.0	0.0	0.0	7.1	1.0	0.0	2.6	3.2	5.2	0.3	14.7	1.6	0.4	26.7	0.4	0.4	16.0	28.4	0.7	0.5	11.9	25.9	19.3	4.0	13.4	7.8	8.6	48.6	24.3	24.7	31.3	0.0	23.6	0.1	30.0	17.6	14.5	21.5	27.6	3.1	3.3	13.1	0.0	16.1	19.2	23.7	1.8	15.8	38.4	1.3	0.9	4.6	36.3	2.6	0.0	5.2	18.7	8.2	0.0	1.8	18.5	1.2	0.8	3.6	1.0	0.7	0.3	1.0	0.5	0.6	29.1	24.0	1.9	0.2	26.1	27.9	19.2	28.4	2.2	6.6	3.2	6.0	1.6	10.4	7.0	20.6	10.8	0.8	0.4	18.4	29.0
PTPN4	PTPMEG	ENSG00000088179	"Protein tyrosine phosphatase non-receptor type 4"	P29074	2	119759922-119984899	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"		"Hydrolase, Protein phosphatase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 37.3"	"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 224.3;Horizontal cells: 161.5;Inhibitory neurons: 187.5;NK-cells: 247.2;Oligodendrocyte precursor cells: 200.6"	"Low cancer specificity"	"Detected in all"			"Region enhanced"	"Detected in many"		"cerebellum: 37.3"	"Group enriched"	"Detected in many"	4	"gdT-cell: 35.0;MAIT T-cell: 28.1;memory CD4 T-cell: 16.9;memory CD8 T-cell: 27.9;naive CD8 T-cell: 19.2;NK-cell: 24.4;T-reg: 11.0"	"Group enriched"	"Detected in many"	16	"NK-cells: 24.4;T-cells: 35.0"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA019351	Uncertain		Approved	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA			"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 69: Cerebellum - Gene expression regulation"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 63: NK-cells & T-cells - Immune response"	Nucleoplasm	"Plasma membrane, Cytosol"	"HPA019351: AB_1855928"	"unprognostic (1.45e-1)"	"unprognostic (1.22e-1)"	"unprognostic (1.07e-1)"	"unprognostic (7.63e-2)"	"unprognostic (9.00e-2)"	"unprognostic (9.57e-2)"	"unprognostic (2.34e-1)"	"prognostic favorable (5.16e-4)"	"unprognostic (3.31e-2)"	"unprognostic (3.34e-3)"	"unprognostic (3.13e-1)"	"unprognostic (1.10e-1)"	"unprognostic (3.34e-2)"	"unprognostic (1.74e-1)"	"unprognostic (1.87e-1)"	"unprognostic (4.08e-2)"	"unprognostic (1.81e-1)"	4.5	3.8	5.9	3.6	5.0	5.1	4.7	37.3	10.1	5.7	0.0	3.4	5.1	4.1	4.2	4.1	5.5	3.7	5.7	5.2	2.7	7.4	4.2	5.2	5.4	0.1	9.6	5.2	2.8	6.3	3.5	2.5	1.4	3.5	2.4	12.1	4.1	2.5	8.0	3.0	2.8	2.8	0.0	5.9	5.7	4.9	12.6	8.1	14.0	12.8	4.2	3.2	2.6	5.9	7.4	4.3	5.0	7.3	4.8	5.0	9.1	3.2	9.3	1.8	4.9	6.2	10.9	4.1	7.6	3.5	5.2	5.3	4.4	5.1	4.8	12.6	3.6	3.7	3.5	6.1	3.2	3.9	2.6	4.5	9.6	8.5	3.7	6.0	8.2	4.8	5.7	4.8	5.0	5.0	5.2	4.4	7.3	4.0	6.9	3.4	9.6	6.9	6.7	10.0	6.8	8.5	4.2	5.8	4.0	4.0	2.8	2.4	10.7	0.0	6.1	1.9	4.0	8.9	13.7	6.6	4.7	0.1	3.0	0.3	0.2	1.8	35.0	0.5	28.1	0.6	16.9	27.9	0.5	0.6	5.2	19.2	0.6	24.4	0.7	0.3	11.0	10.4	5.9	5.0	37.3	10.1	5.2	2.7	0.1	9.6	1.4	0.0	12.6	5.9	20.5	3.2	14.6	128.9	24.4	8.2	15.5	8.5	27.3	55.7	13.9	11.2	17.9	10.0	8.3	16.5	104.3	10.5	95.5	7.3	7.9	8.0	5.4	18.2	15.7	15.0	9.1	35.4	224.3	7.3	11.8	11.3	16.8	15.8	11.4	47.9	15.0	11.0	4.0	161.5	187.5	9.9	12.2	8.6	7.6	8.8	17.4	9.0	8.8	38.4	11.8	24.9	247.2	200.6	113.6	6.3	9.6	14.3	30.1	12.7	10.6	13.6	8.8	79.8	0.0	25.5	9.0	31.4	26.4	12.8	6.7	3.7	79.4	23.3	11.5	9.5
PTPN5	"PTPSTEP, STEP, STEP61"	ENSG00000110786	"Protein tyrosine phosphatase non-receptor type 5"	P54829	11	18727928-18792721	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"		"Hydrolase, Protein phosphatase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	13	"brain: 161.0"	"Group enriched"	"Detected in some"	4	"Excitatory neurons: 59.0;Inhibitory neurons: 51.9"	"Group enriched"	"Detected in some"	6	"glioma: 1.6;testis cancer: 2.0"	"Region enhanced"	"Detected in many"		"basal ganglia: 161.0"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HMC-1: 1.1;NTERA-2: 1.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA031014, HPA072091"	Supported		Approved	"Endoplasmic reticulum"		NA	NA			"Cluster 34: Basophils - Unknown function"	"Cluster 10: Brain - Neuronal signaling"	"Cluster 5: NTERA-2 - Transcription"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	"Endoplasmic reticulum"		"HPA031014: AB_10669550, HPA072091: AB_2686487"	"unprognostic (1.23e-1)"	"unprognostic (2.91e-2)"	"unprognostic (8.93e-3)"	"unprognostic (1.09e-2)"	"unprognostic (3.27e-2)"	"unprognostic (2.13e-2)"	"unprognostic (5.83e-3)"	"unprognostic (3.59e-1)"	"unprognostic (4.91e-2)"	"unprognostic (2.59e-1)"	"unprognostic (2.00e-1)"	"unprognostic (3.58e-1)"	"unprognostic (8.44e-4)"	"unprognostic (4.21e-3)"	"unprognostic (3.90e-2)"	"unprognostic (9.39e-2)"	"unprognostic (8.49e-2)"	1.5	0.5	37.2	0.2	161.0	0.1	1.1	0.0	55.2	0.7	0.0	1.0	0.1	0.8	0.0	0.5	1.1	0.3	11.9	32.1	25.5	1.7	0.0	1.5	0.1	11.3	6.4	2.1	0.4	0.2	2.1	0.0	6.7	1.0	0.3	2.0	1.2	0.6	0.7	0.6	0.6	0.4	4.7	0.4	0.9	2.9	19.9	0.0	0.7	3.3	0.0	1.0	1.1	29.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	37.2	161.0	0.0	55.2	32.1	25.5	11.3	6.4	6.7	4.7	19.9	29.5	0.1	0.0	0.0	4.2	0.0	0.1	0.0	0.0	0.0	1.8	0.0	0.0	2.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.1	0.0	0.2	6.9	0.0	0.0	59.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	51.9	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	6.5	0.0	0.3	0.0	12.5	3.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.7	0.0	2.7	0.1	0.0	0.0	0.0	0.2	0.0	0.0
PTPN6	"HCP, HCPH, PTP-1C, SHP-1, SHP1"	ENSG00000111679	"Protein tyrosine phosphatase non-receptor type 6"	P29350	12	6946468-6961316	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"		"Hydrolase, Protein phosphatase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 131.8;lymphoid tissue: 153.5"	"Cell type enhanced"	"Detected in many"		"B-cells: 214.6;granulocytes: 137.3;Hofbauer cells: 191.6;Kupffer cells: 146.5;Langerhans cells: 118.2;Macrophages: 152.1;NK-cells: 154.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HEL: 170.9;HL-60: 154.3;HMC-1: 648.7;THP-1: 259.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA001466, CAB004572, CAB072845"	Enhanced		Supported	Nucleoplasm,Nucleoli		NA	NA		6000000	"Cluster 51: Monocytes - Innate immune response"	"Cluster 16: Immune cells - Immune response"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 57: B-cells - Immune response"	Nucleoplasm	Nucleoli	"CAB004572: AB_628251, CAB072845: , HPA001466: AB_1855930"	"unprognostic (4.28e-3)"	"prognostic favorable (1.87e-4)"	"prognostic unfavorable (5.42e-4)"	"prognostic favorable (6.65e-4)"	"unprognostic (6.54e-2)"	"unprognostic (7.92e-2)"	"unprognostic (2.36e-1)"	"unprognostic (1.44e-2)"	"unprognostic (6.93e-3)"	"unprognostic (3.57e-1)"	"unprognostic (1.41e-2)"	"unprognostic (2.61e-1)"	"unprognostic (1.60e-3)"	"unprognostic (1.98e-3)"	"unprognostic (2.60e-2)"	"unprognostic (5.91e-2)"	"prognostic favorable (2.64e-8)"	14.4	15.6	3.7	102.5	3.9	131.8	11.0	4.3	4.2	11.1	6.0	21.9	30.4	6.2	10.2	12.8	13.9	20.3	4.9	3.6	5.2	12.2	19.3	49.7	153.5	7.0	4.6	2.9	11.9	13.7	10.0	19.8	6.3	11.7	21.3	0.7	17.0	9.0	2.0	18.8	42.0	12.3	5.9	128.0	28.0	3.1	6.3	71.3	12.6	4.5	127.3	27.0	7.5	10.6	16.4	30.8	0.2	0.1	0.1	0.0	28.5	0.0	0.0	0.0	0.0	16.5	36.0	11.9	8.4	0.0	0.0	18.3	0.3	21.6	0.0	7.3	6.5	170.9	3.4	13.9	0.0	154.3	648.7	0.1	15.4	0.0	6.5	0.0	0.0	60.0	0.3	1.3	0.0	34.5	55.4	92.2	8.3	38.0	5.1	50.4	0.2	86.5	16.7	30.2	2.7	0.0	5.2	24.9	0.2	20.9	7.7	259.8	0.4	0.0	0.2	0.1	0.2	0.4	0.2	5.5	0.4	66.3	0.5	676.7	368.3	1112.5	263.4	728.6	169.3	595.0	125.3	195.9	377.0	650.0	142.7	182.6	674.8	238.6	1117.7	98.7	146.8	789.3	3.7	3.9	4.3	4.2	3.6	5.2	7.0	4.6	6.3	5.9	6.3	10.6	10.5	6.4	13.8	0.7	214.6	9.1	8.2	18.8	29.6	0.0	8.6	10.0	2.1	11.5	15.3	5.5	0.0	25.6	77.7	16.0	15.6	15.8	50.4	12.1	1.5	7.5	24.7	22.9	0.9	15.4	18.3	3.0	25.0	11.8	137.3	10.9	8.9	11.6	191.6	0.0	0.9	13.2	18.3	146.5	118.2	10.5	0.9	152.1	14.2	3.7	99.7	0.5	154.5	2.0	0.1	12.6	16.9	0.0	53.5	3.9	22.8	14.3	17.2	0.5	6.6	1.6	4.0	0.3	1.3	14.6	8.7	18.5	86.2	24.5	15.6	7.8
PTPN7	"HEPTP, LC-PTP"	ENSG00000143851	"Protein tyrosine phosphatase non-receptor type 7"	P35236	1	202147013-202161588	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Hydrolase, Protein phosphatase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 39.7;lymphoid tissue: 31.1"	"Cell type enhanced"	"Detected in many"		"B-cells: 46.8;dendritic cells: 112.7;granulocytes: 140.7;NK-cells: 99.9;Plasma cells: 63.9;T-cells: 127.2;Theca cells: 54.6"	"Low cancer specificity"	"Detected in all"			"Region enhanced"	"Detected in many"		"basal ganglia: 9.8"	"Low immune cell specificity"	"Detected in many"			"Group enriched"	"Detected in all"	5	"granulocytes: 24.9;NK-cells: 14.9;T-cells: 14.0"	"Cell line enhanced"	"Detected in some"		"HEL: 54.1;HL-60: 118.6;HMC-1: 150.8;NB-4: 51.4;THP-1: 53.7;U-937: 84.0"	"Region enriched"	"Detected in single"	9	"basal ganglia: 6.1"	"Region enriched"	"Detected in many"	8	"basal ganglia: 13.3"	"CAB009530, HPA019118"	Approved		Supported	"Microtubules,Mitotic spindle,Cytosol"		Yes	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 63: NK-cells & T-cells - Immune response"	Cytosol	"Microtubules, Mitotic spindle"	"CAB009530: AB_2173845, HPA019118: AB_1855755"	"unprognostic (4.19e-3)"	"unprognostic (1.08e-3)"	"unprognostic (3.09e-2)"	"prognostic favorable (1.52e-4)"	"unprognostic (2.91e-2)"	"prognostic favorable (1.84e-4)"	"unprognostic (3.01e-2)"	"unprognostic (3.16e-2)"	"unprognostic (1.43e-2)"	"unprognostic (4.84e-2)"	"unprognostic (1.14e-1)"	"unprognostic (1.45e-1)"	"prognostic unfavorable (2.42e-8)"	"unprognostic (1.46e-1)"	"unprognostic (4.51e-2)"	"unprognostic (2.70e-1)"	"unprognostic (2.39e-2)"	1.3	4.2	0.6	10.2	9.8	39.7	0.7	1.0	1.8	0.8	0.5	2.2	4.5	1.1	0.0	1.5	0.6	3.2	0.5	0.6	1.2	1.3	1.1	2.5	20.8	2.3	1.5	0.3	0.4	0.1	0.3	0.5	1.8	0.8	2.7	0.0	1.3	0.6	0.1	1.2	5.6	1.5	1.4	9.9	2.4	8.3	2.9	31.1	0.8	0.5	20.8	3.2	0.6	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	41.2	0.0	0.0	0.0	0.2	0.0	0.0	0.0	12.6	0.0	54.1	0.0	0.0	0.0	118.6	150.8	0.0	0.0	0.0	0.0	0.0	0.1	40.0	2.3	5.0	0.0	0.0	16.3	51.4	0.0	0.0	0.0	2.4	0.0	39.8	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.1	53.7	0.3	0.0	0.5	0.0	0.1	22.8	6.3	33.7	0.1	84.0	0.1	17.9	1.5	24.9	13.7	1.5	12.5	2.6	9.2	14.0	2.9	3.2	6.7	8.2	9.9	14.9	0.6	3.8	12.8	4.5	0.6	9.8	1.0	1.8	0.6	1.2	2.3	1.5	1.8	1.4	2.9	2.5	3.2	3.2	5.1	3.3	46.8	2.3	1.3	0.1	0.0	2.7	1.5	1.8	0.7	1.5	0.7	0.0	0.0	0.5	112.7	0.5	0.0	0.5	0.6	0.9	0.8	5.6	0.0	35.5	0.7	0.0	0.2	2.2	1.5	0.7	140.7	6.7	3.6	0.4	15.4	0.0	0.7	0.1	0.0	11.2	31.2	2.4	5.3	21.3	8.8	1.0	10.4	3.8	99.9	1.0	4.6	0.1	0.1	2.2	63.9	0.6	0.2	0.7	0.1	3.7	0.0	0.9	1.1	0.8	0.7	0.5	2.4	0.8	127.2	54.6	0.5	0.6
PTPN9	MEG2	ENSG00000169410	"Protein tyrosine phosphatase non-receptor type 9"	P43378	15	75463251-75579315	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Hydrolase, Protein phosphatase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Astrocytes: 63.0;Excitatory neurons: 66.1;Inhibitory neurons: 63.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA041922	Approved		Approved	Vesicles		NA	NA			"Cluster 41: Basophils - Cellular respiration"	"Cluster 87: Intestine & Kidney - Transmembrane transport"	"Cluster 43: THP-1 - Innate immune response"	"Cluster 50: Fibroblasts - ECM organization"	Vesicles		"HPA041922: AB_10795269"	"unprognostic (9.58e-2)"	"unprognostic (1.87e-1)"	"unprognostic (1.28e-1)"	"unprognostic (2.42e-1)"	"unprognostic (1.54e-2)"	"unprognostic (6.80e-2)"	"unprognostic (7.38e-2)"	"unprognostic (5.95e-2)"	"unprognostic (3.93e-1)"	"unprognostic (3.14e-1)"	"unprognostic (9.25e-3)"	"unprognostic (6.35e-2)"	"prognostic favorable (2.49e-6)"	"unprognostic (2.26e-1)"	"unprognostic (1.05e-1)"	"unprognostic (2.71e-1)"	"unprognostic (2.39e-1)"	15.9	12.0	14.8	13.0	16.3	10.8	15.1	11.9	18.8	16.6	11.7	18.0	17.9	16.5	13.3	9.9	16.2	12.1	11.0	16.9	18.4	18.2	14.7	15.8	14.5	18.6	14.4	14.0	10.2	17.9	9.7	19.9	15.1	16.6	19.7	8.9	13.0	21.2	6.4	11.0	20.0	18.0	13.6	13.4	13.5	7.2	17.0	16.1	32.8	13.1	15.0	18.1	13.8	14.5	20.3	24.1	36.7	24.6	26.8	29.3	12.0	29.8	46.2	36.9	33.4	14.5	30.0	32.6	23.3	51.1	29.5	30.0	79.9	34.3	37.0	40.5	19.8	18.4	16.2	15.7	40.2	28.2	27.1	38.4	35.2	29.6	45.9	37.7	31.4	21.3	12.4	11.5	42.1	13.5	20.0	26.3	33.6	18.2	12.1	38.9	18.2	9.1	46.6	32.5	14.4	29.9	42.4	23.3	46.3	34.9	12.1	47.8	36.5	35.2	11.3	23.3	32.2	16.9	18.9	30.0	20.5	41.9	35.3	3.2	2.2	2.3	3.4	3.0	2.8	1.7	2.4	3.0	3.0	1.3	1.0	1.8	0.3	3.9	2.9	2.0	1.6	1.7	14.8	16.3	11.9	18.8	16.9	18.4	18.6	14.4	15.1	13.6	17.0	14.5	12.7	6.4	13.4	63.0	9.2	3.3	8.2	6.6	5.7	12.1	8.0	7.1	3.7	10.0	8.1	11.0	8.4	20.0	7.3	25.0	15.6	10.8	3.0	7.9	19.4	10.0	7.2	13.7	66.1	9.9	4.2	20.6	10.7	11.4	15.2	23.6	17.5	12.6	18.8	3.3	63.2	11.5	6.1	18.9	18.1	4.7	12.5	16.5	7.2	46.9	24.2	5.6	19.6	48.7	19.6	18.2	12.6	27.4	9.7	12.1	24.9	14.0	8.1	17.1	13.1	11.7	20.8	10.6	9.4	6.6	3.3	10.1	13.4	11.6	13.2	13.1
PTPRA	"HLPR, HPTPA, LRP, PTPA, PTPRL2, RPTPA"	ENSG00000132670	"Protein tyrosine phosphatase receptor type A"	P18433	20	2864184-3039076	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"		"Hydrolase, Protein phosphatase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA029412, CAB034366, HPA069480"	Approved		Approved	Nucleoplasm,Vesicles		NA	NA			"Cluster 37: B-cells - Transcription"	"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 50: Fibroblasts - ECM organization"	Vesicles	Nucleoplasm	"CAB034366: AB_2269058, HPA029412: AB_10602293, HPA069480: AB_2686141"	"unprognostic (1.39e-1)"	"unprognostic (2.05e-1)"	"unprognostic (4.58e-2)"	"unprognostic (2.39e-3)"	"unprognostic (1.15e-1)"	"unprognostic (1.62e-1)"	"unprognostic (5.43e-3)"	"unprognostic (5.34e-2)"	"unprognostic (1.55e-1)"	"unprognostic (3.24e-1)"	"unprognostic (7.33e-2)"	"unprognostic (1.16e-1)"	"prognostic favorable (3.29e-6)"	"unprognostic (1.25e-1)"	"unprognostic (4.02e-1)"	"unprognostic (1.60e-2)"	"unprognostic (4.19e-1)"	48.8	36.6	83.9	31.9	89.3	39.6	47.4	84.2	96.1	56.4	59.5	41.6	31.0	53.0	36.7	46.1	52.7	43.7	29.5	87.7	83.5	44.2	28.6	45.4	38.9	74.7	81.9	55.8	31.2	81.9	44.8	60.8	78.3	46.3	40.6	61.5	36.3	41.9	16.9	45.8	32.7	52.4	76.3	39.4	34.5	43.4	92.6	59.6	65.5	30.7	44.3	46.6	38.9	81.1	74.0	44.2	124.7	38.4	134.4	243.3	26.5	54.1	105.1	65.5	79.6	53.1	99.5	48.1	41.6	73.1	66.1	77.2	51.0	77.4	73.4	74.7	32.7	68.5	18.3	68.0	48.1	69.5	31.1	109.8	78.2	54.4	56.8	80.3	92.0	67.7	69.9	59.7	65.8	30.4	80.8	78.3	48.3	66.0	35.0	61.0	60.5	60.3	55.1	56.2	68.7	65.7	52.3	87.8	81.4	54.0	55.2	58.7	66.5	58.1	28.6	65.6	48.5	43.4	64.7	62.7	26.9	64.5	55.7	5.7	2.8	4.8	6.1	2.9	4.9	5.3	4.0	4.4	2.1	2.6	4.0	4.8	3.3	4.0	4.3	3.2	4.9	2.3	83.9	89.3	84.2	96.1	87.7	83.5	74.7	81.9	78.3	76.3	92.6	81.1	87.0	22.4	19.2	128.6	46.7	15.8	34.0	15.0	34.7	88.9	49.0	43.9	10.1	54.3	24.5	46.0	31.3	35.3	111.7	39.8	27.4	14.8	17.0	62.0	109.0	39.7	44.3	42.3	138.2	15.8	40.5	67.5	25.0	55.3	22.9	60.3	43.5	33.6	39.4	70.7	136.4	27.9	24.4	37.6	20.4	17.2	60.3	40.1	37.4	52.5	29.9	88.3	110.2	102.5	147.5	16.6	30.2	48.9	58.6	32.9	27.1	23.6	26.6	60.5	39.5	53.3	61.8	68.7	84.1	32.9	17.2	32.7	59.7	41.4	30.4	31.5
PTPRB	PTPB	ENSG00000127329	"Protein tyrosine phosphatase receptor type B"	P23467	12	70515870-70637440	"Cancer-related genes, Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	Angiogenesis	"Hydrolase, Protein phosphatase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Adipocytes: 215.9;Endothelial cells: 211.5;Hepatic stellate cells: 504.0;Microglial cells: 164.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"EFO-21: 24.3;hTERT-RPE1: 19.7;HUVEC TERT2: 61.4;TIME: 90.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004782, HPA067868"	Uncertain		Approved	"Vesicles,Plasma membrane,Cell Junctions"		NA	NA		14000000	"Cluster 43: B-cells - Humoral immune response"	"Cluster 82: Adipose tissue - ECM organization"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	"Plasma membrane"	"Vesicles, Cell Junctions"	"CAB004782: , HPA067868: AB_2685911"	"unprognostic (3.18e-1)"	"unprognostic (2.99e-6)"	"unprognostic (1.56e-1)"	"unprognostic (1.80e-1)"	"unprognostic (3.55e-2)"	"unprognostic (1.77e-2)"	"prognostic favorable (6.05e-4)"	"unprognostic (4.59e-1)"	"unprognostic (2.22e-2)"	"unprognostic (1.85e-1)"	"unprognostic (2.28e-2)"	"unprognostic (1.40e-1)"	"prognostic favorable (1.02e-4)"	"unprognostic (2.91e-2)"	"unprognostic (7.18e-2)"	"unprognostic (1.31e-1)"	"unprognostic (1.38e-1)"	26.7	9.4	16.0	4.7	14.1	0.1	18.8	12.3	12.1	12.8	7.1	10.9	7.5	12.3	4.4	6.8	10.8	14.7	23.2	10.1	12.4	22.5	16.7	35.7	3.2	15.9	14.2	4.0	6.2	7.8	4.7	32.6	18.1	6.3	11.1	1.4	3.3	8.0	17.1	4.1	9.3	18.1	12.4	30.0	6.2	2.5	19.0	3.0	14.8	38.8	3.4	7.7	5.3	11.9	4.4	0.3	1.9	0.2	0.0	0.1	0.9	0.9	4.2	2.2	5.2	0.1	3.4	1.7	24.3	0.6	0.4	15.2	0.2	0.7	7.8	1.3	0.7	0.4	1.7	1.1	0.2	0.7	0.0	0.1	0.7	6.1	0.0	19.7	61.4	0.0	3.6	1.0	1.3	0.0	0.1	0.0	2.3	4.4	0.9	0.1	1.6	0.9	11.3	1.8	0.0	0.8	1.6	0.0	3.5	0.4	0.0	1.5	90.3	0.9	0.9	0.4	5.4	1.1	0.9	0.8	0.4	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	16.0	14.1	12.3	12.1	10.1	12.4	15.9	14.2	18.1	12.4	19.0	11.9	215.9	0.0	13.2	2.0	3.1	3.7	0.8	1.0	0.0	7.1	0.9	0.9	12.3	11.5	1.3	3.7	0.0	0.0	2.0	12.8	0.0	1.5	4.6	2.2	0.7	211.5	0.0	16.0	52.5	0.9	0.0	7.3	1.5	4.0	25.2	0.5	504.0	4.7	0.4	5.0	68.8	6.4	0.0	20.0	4.6	3.0	1.2	1.2	5.4	164.9	0.0	0.4	0.0	2.5	2.9	12.2	11.1	0.0	0.1	0.8	3.2	0.1	0.2	0.9	0.0	6.4	5.2	0.7	0.7	0.9	1.6	0.0	1.0	1.8	6.8	0.7
PTPRC	"CD45, GP180, LCA, T200"	ENSG00000081237	"Protein tyrosine phosphatase receptor type C"	P08575	1	198638457-198757476	"Cancer-related genes, CD markers, Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Host-virus interaction"	"Hydrolase, Protein phosphatase"	"Cancer-related genes, Disease variant, SCID"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 208.6;lymphoid tissue: 329.9"	"Cell type enhanced"	"Detected in many"		"B-cells: 525.2;dendritic cells: 1026.4;Macrophages: 534.1;monocytes: 554.9;NK-cells: 769.3;Plasma cells: 474.2;T-cells: 1049.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in some"		"Daudi: 209.9;HEL: 118.0;HL-60: 108.1;JURKAT: 266.4;MOLT-4: 161.1;THP-1: 87.0;U-266/70: 93.7;U-266/84: 91.2;U-698: 123.4;U-937: 94.5"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"CAB000052, HPA000440, CAB002800, CAB056154, CAB068221"	Enhanced		Uncertain	Nucleoplasm,Vesicles	"Intracellular and membrane"	NA	NA		24000000	"Cluster 14: Monocytes - Unknown function"	"Cluster 3: T-cells - Adaptive immune response"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 24: Non-specific - Transcription regulation"	"Nucleoplasm, Vesicles"		"CAB000052: AB_2314143, CAB002800: AB_2237910, CAB056154: AB_2665572, CAB068221: AB_2665571, HPA000440: AB_611377"	"unprognostic (1.51e-2)"	"unprognostic (1.24e-2)"	"unprognostic (5.10e-3)"	"unprognostic (2.33e-3)"	"unprognostic (1.30e-1)"	"unprognostic (2.40e-3)"	"unprognostic (1.62e-1)"	"unprognostic (3.17e-2)"	"unprognostic (1.25e-1)"	"unprognostic (3.18e-2)"	"unprognostic (8.08e-2)"	"unprognostic (3.95e-1)"	"prognostic unfavorable (2.42e-4)"	"unprognostic (2.31e-1)"	"unprognostic (3.43e-2)"	"unprognostic (6.41e-2)"	"unprognostic (7.06e-2)"	32.8	11.6	3.8	248.5	3.3	208.6	13.9	4.4	4.3	14.9	6.9	26.4	27.4	11.3	5.6	15.1	8.4	45.7	7.3	3.5	5.6	7.0	29.6	68.6	329.9	12.9	8.6	5.7	5.6	4.0	2.9	23.5	11.5	11.6	30.5	2.0	13.8	6.6	4.6	5.7	42.9	25.3	7.9	202.5	37.9	5.5	6.9	306.9	7.0	7.6	251.2	62.1	5.2	14.7	0.4	0.0	0.2	0.2	0.0	0.0	0.8	0.3	0.3	0.1	0.0	0.0	0.1	209.9	0.3	0.7	0.2	0.3	0.0	0.2	0.4	0.6	0.0	118.0	0.2	0.1	0.0	108.1	0.7	0.0	0.0	0.3	0.0	0.4	0.5	266.4	2.4	3.3	0.3	0.1	161.1	65.0	0.5	0.2	0.2	4.6	0.4	0.3	0.1	0.1	1.2	1.8	0.1	0.4	0.5	0.2	0.3	87.0	1.3	0.0	0.8	0.8	0.4	93.7	91.2	123.4	0.1	94.5	0.4	226.1	480.0	521.4	634.4	885.8	541.8	249.0	437.0	618.1	385.8	245.8	489.8	494.1	844.3	506.9	1015.8	57.4	508.6	1340.6	3.8	3.3	4.4	4.3	3.5	5.6	12.9	8.6	11.5	7.9	6.9	14.7	12.6	44.8	62.3	0.7	525.2	15.8	0.9	0.0	4.0	0.3	6.0	9.3	4.6	5.7	14.2	1.8	0.0	0.6	1026.4	1.0	0.0	0.7	2.4	2.3	2.3	15.1	1.2	58.8	0.7	0.0	0.9	17.2	46.9	2.7	246.5	0.1	14.6	6.9	96.0	0.0	1.7	0.4	0.0	334.9	214.5	3.5	1.2	534.1	21.4	201.4	554.9	0.1	769.3	2.5	0.7	0.1	0.8	0.0	474.2	1.1	0.1	2.5	11.7	0.2	6.6	7.4	6.7	0.3	0.6	1.8	15.2	0.8	1049.1	5.4	0.9	0.8
PTPRD	"HPTP, PTPD"	ENSG00000153707	"Protein tyrosine phosphatase receptor type D"	P23468	9	8314246-10612723	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"		"Hydrolase, Protein phosphatase, Receptor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 70.8"	"Group enriched"	"Detected in many"	12	"Excitatory neurons: 4579.7;Inhibitory neurons: 1152.9;Oligodendrocyte precursor cells: 1170.2;Oligodendrocytes: 3151.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AF22: 21.1;HAP1: 4.3;HSkMC: 6.3;RH-30: 8.1;SCLC-21H: 4.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA054829	Uncertain		Approved	Nucleoplasm,Vesicles	"Intracellular and membrane"	NA	NA		20000000		"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 12: NES - Nervous system development"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	Vesicles	Nucleoplasm	"HPA054829: AB_2682618"	"unprognostic (4.74e-1)"	"unprognostic (4.79e-2)"	"unprognostic (1.44e-2)"	"unprognostic (7.86e-2)"	"unprognostic (2.34e-1)"	"unprognostic (9.90e-2)"	"unprognostic (1.85e-1)"	"unprognostic (1.66e-1)"	"unprognostic (1.91e-2)"	"unprognostic (2.13e-2)"	"unprognostic (7.52e-3)"	"unprognostic (2.62e-1)"	"prognostic favorable (7.45e-6)"	"unprognostic (3.56e-4)"	"unprognostic (7.59e-2)"	"unprognostic (4.84e-2)"	"unprognostic (3.08e-3)"	2.1	0.6	10.8	0.3	24.7	0.1	0.9	12.2	26.2	5.6	0.0	3.3	1.8	2.4	0.2	0.6	2.2	1.0	2.5	14.4	7.2	6.6	3.6	4.6	0.0	14.6	10.1	12.1	1.3	18.7	4.3	5.3	19.1	1.9	2.5	6.4	0.5	0.6	0.9	0.7	5.0	1.0	10.4	0.4	0.9	1.6	17.6	0.7	3.4	0.8	0.0	2.2	3.4	70.8	0.0	0.1	21.1	0.0	0.3	0.8	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.3	0.0	0.0	0.0	2.7	3.6	0.5	0.0	0.0	0.0	0.1	6.3	0.1	0.0	0.2	0.0	0.7	0.0	0.0	0.0	0.0	0.0	2.6	0.0	3.4	0.0	3.2	2.3	8.1	0.0	1.8	0.0	4.8	0.1	0.0	0.0	0.0	1.3	0.0	0.0	0.0	1.3	0.2	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.8	24.7	12.2	26.2	14.4	7.2	14.6	10.1	19.1	10.4	17.6	70.8	0.5	0.0	3.2	199.2	0.1	0.5	0.4	3.2	6.2	134.2	0.3	0.1	6.5	27.1	1.8	5.5	16.7	0.3	0.0	16.4	0.0	3.6	15.8	0.8	15.0	1.2	35.4	0.0	4579.7	0.0	0.3	15.5	0.5	1.0	0.0	9.2	1.4	13.5	1.3	5.0	1152.9	13.2	0.0	0.8	0.0	6.5	15.8	1.6	0.0	85.3	0.1	36.1	0.0	1170.2	3151.1	0.2	9.2	0.0	2.7	2.1	18.3	26.3	0.2	7.8	0.0	4.0	5.8	2.4	3.2	0.4	0.9	0.3	0.8	6.0	8.7	0.1
PTPRE	PTPE	ENSG00000132334	"Protein tyrosine phosphatase receptor type E"	P23469	10	127907103-128085855	"Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins"		"Hydrolase, Protein phosphatase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 46.9"	"Cell type enhanced"	"Detected in many"		"dendritic cells: 256.6;Inhibitory neurons: 191.6;Langerhans cells: 307.9;Macrophages: 276.3;Oligodendrocyte precursor cells: 247.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"neutrophil: 634.6;plasmacytoid DC: 475.9"	"Group enriched"	"Detected in all"	12	"dendritic cells: 475.9;granulocytes: 634.6;monocytes: 175.4"	"Cell line enhanced"	"Detected in many"		"hTERT-RPE1: 38.6;HUVEC TERT2: 41.6;NB-4: 32.5;TIME: 79.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA015870, HPA021872"	Supported		Approved	"Intermediate filaments"		NA	NA			"Cluster 1: Neutrophils - Mixed function"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 41: Macrophages - Immune response"	"Intermediate filaments"		"HPA015870: AB_1855759, HPA021872: AB_1855760"	"unprognostic (5.23e-2)"	"unprognostic (1.37e-1)"	"unprognostic (1.99e-1)"	"unprognostic (7.11e-2)"	"unprognostic (3.19e-1)"	"unprognostic (9.67e-2)"	"unprognostic (6.50e-2)"	"unprognostic (4.49e-2)"	"unprognostic (2.11e-1)"	"unprognostic (2.56e-2)"	"unprognostic (8.71e-3)"	"unprognostic (2.00e-1)"	"prognostic unfavorable (4.08e-5)"	"unprognostic (1.52e-1)"	"unprognostic (6.71e-3)"	"unprognostic (2.49e-2)"	"unprognostic (5.59e-2)"	13.6	16.7	13.9	25.3	8.9	46.9	6.7	5.7	13.9	3.9	7.7	9.2	9.5	3.5	2.6	7.9	4.9	10.3	10.6	14.2	11.1	4.3	4.4	16.0	16.4	11.6	9.0	1.6	2.7	2.7	5.0	7.8	10.7	3.4	9.3	1.0	5.8	2.4	1.3	4.7	12.9	7.4	10.8	20.6	7.4	2.6	10.7	8.6	5.5	3.1	9.8	12.7	4.4	14.2	4.3	0.9	0.5	0.0	2.5	0.4	7.5	0.1	0.0	1.6	3.6	1.7	25.1	3.3	2.6	2.1	5.2	2.3	2.1	12.2	0.7	4.0	1.9	0.4	1.4	0.0	4.1	16.2	11.6	0.8	6.9	6.1	12.1	38.6	41.6	10.3	0.0	1.9	2.6	4.0	4.9	32.5	0.2	4.6	1.5	19.1	2.6	6.4	6.8	18.0	0.0	2.5	7.4	1.3	0.3	1.8	0.6	20.1	79.5	1.7	1.8	7.8	8.9	0.9	1.3	4.6	11.3	12.5	0.0	174.3	175.4	147.2	36.6	64.5	22.3	7.7	16.5	25.1	97.9	8.3	11.5	19.6	634.6	31.6	54.9	475.9	26.7	43.3	13.9	8.9	5.7	13.9	14.2	11.1	11.6	9.0	10.7	10.8	10.7	14.2	25.0	83.3	57.2	22.5	26.2	59.5	54.3	42.4	15.9	5.2	14.2	23.6	20.3	8.6	23.7	3.7	0.0	43.2	256.6	15.7	0.0	3.7	2.1	3.6	10.6	78.0	6.7	10.3	112.7	4.4	67.4	17.5	10.7	7.7	31.6	3.7	47.5	2.3	57.5	0.0	191.6	15.8	18.3	166.7	307.9	2.5	0.6	276.3	24.9	165.8	139.5	0.0	150.4	247.3	93.4	49.2	13.3	0.4	38.5	21.3	13.9	2.2	7.8	0.9	0.0	86.0	12.8	0.5	1.9	20.4	64.6	17.0	59.3	9.2	11.7	40.3
PTPRF	LAR	ENSG00000142949	"Protein tyrosine phosphatase receptor type F"	P10586	1	43525187-43623666	"Disease related genes, Enzymes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Cell adhesion"	"Heparin-binding, Hydrolase, Protein phosphatase, Receptor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 259.9;Extravillous trophoblasts: 290.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"SK-BR-3: 314.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA012710	Uncertain		Approved	"Golgi apparatus"	"Intracellular and membrane"	NA	NA		160000000		"Cluster 37: Intestine - Unknown function"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 53: Intestinal epithelial cells - Unknown function"	"Golgi apparatus"		"HPA012710: AB_1855933"	"unprognostic (8.20e-2)"	"unprognostic (2.41e-2)"	"unprognostic (3.01e-2)"	"unprognostic (9.17e-2)"	"unprognostic (8.34e-2)"	"unprognostic (1.11e-1)"	"prognostic unfavorable (3.47e-4)"	"unprognostic (4.59e-1)"	"unprognostic (1.51e-1)"	"unprognostic (4.97e-2)"	"unprognostic (4.68e-2)"	"unprognostic (7.07e-2)"	"unprognostic (1.99e-2)"	"prognostic favorable (7.03e-4)"	"unprognostic (2.33e-1)"	"unprognostic (3.19e-2)"	"unprognostic (2.58e-1)"	91.7	11.9	47.1	14.0	48.4	1.8	57.4	22.3	45.6	36.3	4.7	79.5	70.5	28.0	71.9	101.7	70.5	30.4	7.6	45.3	39.9	27.7	107.2	35.4	4.7	33.1	43.6	22.1	56.8	31.1	23.5	55.7	33.1	67.3	51.4	24.7	101.7	43.1	2.7	107.9	78.5	35.0	30.4	4.0	49.7	9.4	45.6	29.6	23.8	3.4	26.2	40.0	51.2	37.4	165.6	76.5	49.0	58.0	11.2	0.6	274.3	92.1	36.1	73.9	62.6	82.0	214.9	0.4	25.6	40.2	59.2	124.7	57.5	200.7	89.1	2.0	72.1	1.0	48.7	75.3	33.8	1.2	1.3	11.3	113.2	106.4	174.9	92.6	111.5	7.7	25.4	7.1	27.5	94.0	1.2	1.3	75.9	89.8	21.0	57.2	86.9	3.7	28.3	241.5	73.3	28.0	90.8	314.0	11.8	128.8	91.5	17.3	88.2	1.6	116.5	7.5	126.1	3.1	2.7	0.4	7.4	3.9	233.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	47.1	48.4	22.3	45.6	45.3	39.9	33.1	43.6	33.1	30.4	45.6	37.4	2.3	157.0	101.1	39.2	2.3	62.8	51.3	67.4	52.9	33.5	146.3	102.9	7.6	130.1	74.9	86.5	43.8	64.3	1.4	259.9	0.0	147.4	4.9	80.6	17.2	7.7	100.9	8.0	40.6	120.8	290.1	19.8	93.8	70.6	5.1	72.8	10.4	159.6	14.1	185.1	16.1	171.7	50.8	4.9	5.8	8.5	6.8	3.4	12.4	7.5	2.9	27.2	2.1	16.6	68.1	165.0	124.7	7.2	1.8	68.0	208.1	13.9	128.3	31.0	0.0	15.8	18.5	9.0	37.5	107.5	91.4	66.2	3.9	9.6	142.5	78.7
PTPRG	"PTPG, RPTPG"	ENSG00000144724	"Protein tyrosine phosphatase receptor type G"	P23470	3	61561569-62297609	"Enzymes, Metabolic proteins, Plasma proteins, Predicted membrane proteins"		"Hydrolase, Protein phosphatase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Group enriched"	"Detected in many"	4	"Astrocytes: 356.8;Excitatory neurons: 416.1;Inhibitory neurons: 684.3;Microglial cells: 771.0;Oligodendrocyte precursor cells: 920.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"ASC diff: 81.7;HSkMC: 61.1"					"Low region specificity"	"Detected in all"			"HPA000546, HPA064237"	Uncertain		Approved	"Plasma membrane"		NA	NA		520000000		"Cluster 89: Fibroblasts - ECM organization"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 68: Oligodendrocytes - Mixed function"	"Plasma membrane"		"HPA000546: , HPA064237: AB_2685221"	"unprognostic (1.47e-1)"	"unprognostic (1.03e-1)"	"unprognostic (1.31e-2)"	"unprognostic (1.93e-1)"	"unprognostic (8.73e-2)"	"unprognostic (3.26e-1)"	"unprognostic (5.38e-2)"	"unprognostic (1.18e-2)"	"unprognostic (5.84e-2)"	"unprognostic (2.28e-1)"	"unprognostic (2.86e-1)"	"unprognostic (1.14e-1)"	"prognostic favorable (3.10e-6)"	"unprognostic (9.91e-2)"	"unprognostic (3.25e-1)"	"unprognostic (1.19e-1)"	"unprognostic (2.63e-2)"	18.0	13.2	7.6	4.6	7.8	0.0	12.8	4.9	10.4	11.9	23.4	8.2	3.7	10.6	8.4	4.1	9.0	8.3	10.0	13.7	6.2	14.4	5.8	12.8	1.8	8.4	7.2	12.0	3.9	26.6	5.2	9.9	5.9	7.8	6.1	8.6	5.2	8.4	7.4	4.5	5.9	13.0	10.0	7.0	5.8	7.7	9.1	2.1	13.1	10.4	1.7	7.0	6.7	5.0	0.0	5.3	27.3	0.0	81.7	41.6	13.5	17.6	28.5	18.2	24.4	13.2	0.5	0.6	10.1	20.7	14.5	0.2	13.4	13.6	28.3	1.5	7.7	1.4	0.1	15.0	27.5	7.5	0.1	61.1	5.3	25.9	30.9	5.8	19.7	2.0	0.0	17.3	16.3	7.6	0.0	0.1	17.0	0.1	0.0	11.9	8.6	0.6	18.2	8.2	2.1	4.5	4.3	0.1	6.9	11.2	0.2	0.3	46.0	25.4	24.1	41.0	14.7	5.5	6.8	0.0	19.2	3.2	31.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	7.6	7.8	4.9	10.4	13.7	6.2	8.4	7.2	5.9	10.0	9.1	5.0	45.3	12.8	32.4	356.8	2.2	9.2	6.4	5.0	13.1	98.5	9.6	6.3	12.5	8.6	5.8	22.0	6.2	10.5	0.9	12.1	5.9	9.6	3.6	14.4	31.9	55.5	24.6	0.0	416.1	1.8	0.8	47.7	4.1	30.5	0.0	64.6	90.3	32.7	19.7	154.8	684.3	8.9	22.4	2.9	8.8	4.3	66.5	1.1	17.8	771.0	0.6	40.8	2.1	920.3	11.8	5.3	5.6	56.8	4.2	10.9	13.9	18.2	2.8	5.7	72.3	81.1	60.6	2.0	8.6	2.1	4.8	12.6	2.3	20.0	12.1	2.7
PTPRH	SAP-1	ENSG00000080031	"Protein tyrosine phosphatase receptor type H"	Q9HD43	19	55181247-55209506	"Enzymes, Metabolic proteins, Predicted membrane proteins"	Apoptosis	"Hydrolase, Protein phosphatase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"gallbladder: 24.2;intestine: 68.6;stomach 1: 23.6"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 123.6;Gastric mucus-secreting cells: 60.1;Paneth cells: 94.9;Proximal enterocytes: 113.1"	"Cancer enhanced"	"Detected in many"		"pancreatic cancer: 16.5"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"HHSteC: 11.8;K-562: 15.0;OE19: 30.9;SK-MEL-30: 22.4"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA042300			Approved	Mitochondria		NA	NA				"Cluster 56: Intestine - Transmembrane transport"	"Cluster 21: OE19 - Mitochondria"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Mitochondria		"HPA042300: AB_10796900"	"unprognostic (1.87e-1)"	"unprognostic (1.10e-1)"	"unprognostic (2.59e-1)"	"unprognostic (7.57e-3)"	"unprognostic (5.01e-3)"	"unprognostic (8.14e-2)"	"unprognostic (1.15e-1)"	"unprognostic (1.96e-3)"	"unprognostic (1.60e-2)"	"unprognostic (1.06e-1)"	"unprognostic (9.96e-2)"	"unprognostic (6.16e-2)"	"unprognostic (1.47e-11)"	"unprognostic (4.08e-3)"	"unprognostic (2.47e-1)"	"unprognostic (1.52e-2)"	"unprognostic (1.57e-1)"	1.3	16.9	1.7	3.6	4.4	0.0	0.6	5.2	3.0	0.8	0.9	27.9	67.7	0.7	0.1	0.3	0.5	24.2	1.1	1.7	3.4	0.2	13.3	0.1	0.1	7.1	4.9	0.3	4.6	0.1	5.1	0.1	5.7	0.2	21.2	1.3	0.1	0.0	0.0	0.1	68.6	2.1	3.8	22.2	23.6	0.8	4.8	0.0	0.1	0.0	0.1	5.7	0.6	7.2	6.9	4.2	0.0	1.6	1.3	3.6	0.1	0.1	3.6	0.7	1.4	1.8	9.5	0.0	0.3	0.6	8.2	0.0	0.0	0.0	0.8	0.1	0.1	0.5	0.1	4.9	11.8	0.0	4.8	1.0	2.9	2.3	3.6	0.4	0.2	0.0	15.0	0.6	0.0	0.0	0.0	0.3	0.0	30.9	9.8	0.0	0.0	0.5	0.0	0.0	0.4	1.0	0.0	4.2	22.4	0.0	0.0	1.9	0.0	1.0	1.4	0.5	0.1	0.0	3.7	0.0	1.1	0.1	3.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	1.7	4.4	5.2	3.0	1.7	3.4	7.1	4.9	5.7	3.8	4.8	7.2	0.3	0.0	0.0	0.0	0.4	1.8	2.8	1.9	0.0	0.1	0.2	0.3	0.6	21.5	3.8	1.8	0.0	0.0	0.0	123.6	0.0	15.5	0.0	1.2	1.0	0.5	4.8	0.0	0.8	25.8	0.1	1.1	60.1	0.5	0.0	4.1	0.7	5.7	0.2	16.8	0.7	20.8	0.0	0.0	1.1	0.3	0.0	0.4	0.0	1.0	0.6	0.2	1.0	0.0	5.8	26.9	94.9	0.0	0.4	3.4	113.1	0.0	4.5	0.5	0.0	3.1	1.8	0.3	0.2	0.0	1.1	0.1	0.5	3.6	18.7	19.7
PTPRJ	"CD148, DEP1, HPTPeta"	ENSG00000149177	"Protein tyrosine phosphatase receptor type J"	Q12913	11	47980558-48170841	"CD markers, Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"		"Hydrolase, Protein phosphatase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Inhibitory neurons: 167.5;Microglial cells: 189.3;Oligodendrocyte precursor cells: 239.8;Oligodendrocytes: 167.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"neutrophil: 9.5"	"Group enriched"	"Detected in many"	4	"granulocytes: 9.5;monocytes: 4.7"	"Cell line enhanced"	"Detected in many"		"RPTEC TERT1: 52.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA006026	Approved				"Intracellular and membrane"	NA	NA		670000000	"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 68: Oligodendrocytes - Mixed function"			"HPA006026: AB_1078446"	"unprognostic (1.46e-1)"	"unprognostic (2.21e-1)"	"unprognostic (1.55e-1)"	"unprognostic (3.83e-2)"	"unprognostic (3.20e-2)"	"unprognostic (2.99e-2)"	"unprognostic (6.58e-2)"	"unprognostic (2.15e-1)"	"unprognostic (9.64e-3)"	"unprognostic (3.79e-3)"	"unprognostic (5.16e-2)"	"unprognostic (1.89e-1)"	"prognostic favorable (1.13e-5)"	"unprognostic (1.09e-2)"	"unprognostic (7.98e-2)"	"unprognostic (9.18e-2)"	"unprognostic (2.00e-1)"	6.0	3.2	10.2	20.5	13.8	29.5	6.1	6.9	14.9	6.2	18.5	10.2	9.4	2.4	7.8	1.9	4.1	7.1	2.7	10.0	12.7	13.9	11.9	10.0	15.5	9.7	11.7	1.6	6.1	15.8	10.1	7.6	12.4	7.9	8.7	8.1	10.1	7.0	2.4	4.2	14.5	5.9	6.0	23.3	14.6	2.3	18.5	7.0	19.6	2.7	11.0	6.9	2.1	14.7	7.6	28.3	12.1	7.0	1.9	4.1	4.2	7.5	5.5	12.9	9.2	2.0	40.8	6.9	51.8	19.1	19.6	6.0	19.0	2.0	14.9	46.6	5.4	1.9	34.9	2.8	12.1	2.7	41.5	3.2	0.6	3.8	1.0	31.7	7.8	0.5	2.6	4.4	4.7	17.0	0.1	17.3	9.7	25.7	4.4	1.6	1.6	4.0	52.6	11.1	7.9	2.5	20.2	12.0	19.4	8.9	13.0	20.3	25.7	9.9	10.8	20.5	23.4	1.1	1.7	11.4	11.7	8.0	37.3	0.7	1.1	2.8	1.6	2.0	1.0	0.8	0.9	1.2	0.8	0.5	0.7	0.9	9.5	1.0	4.7	1.5	1.0	0.8	10.2	13.8	6.9	14.9	10.0	12.7	9.7	11.7	12.4	6.0	18.5	14.7	1.5	9.6	16.7	43.1	11.3	0.3	9.8	0.8	0.6	13.6	8.3	4.1	3.7	17.2	13.0	38.6	6.2	1.9	32.7	35.5	0.0	7.4	5.5	13.5	2.2	4.5	12.6	3.2	81.0	5.0	0.6	4.0	22.4	22.9	13.9	2.5	5.0	15.6	30.0	10.1	167.5	10.1	2.0	74.2	5.7	8.2	0.3	40.2	1.8	189.3	36.0	10.3	21.6	239.8	167.7	11.8	28.0	0.4	12.9	25.3	37.6	13.5	4.9	1.3	0.0	3.3	4.9	0.2	4.8	0.5	0.3	1.9	22.0	2.3	7.6	8.2
PTPRK	R-PTP-kappa	ENSG00000152894	"Protein tyrosine phosphatase receptor type K"	Q15262	6	127968785-128520616	"Cancer-related genes, Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"		"Hydrolase, Protein phosphatase, Receptor"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 889.9;Oligodendrocyte precursor cells: 313.1;Oligodendrocytes: 1278.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	6	"memory B-cell: 1.6;naive B-cell: 2.9"	"Lineage enriched"	"Detected in single"	7	"B-cells: 2.9"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA054056, HPA054822"	Uncertain		Supported	"Vesicles,Plasma membrane,Cell Junctions"		NA	NA		13000000	"Cluster 21: B-cells - Adaptive immune response"	"Cluster 86: Liver & Placenta - Transport via ER"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	"Cell Junctions"	"Vesicles, Plasma membrane"	"HPA054056: AB_2682359, HPA054822: AB_2682614"	"unprognostic (3.15e-2)"	"unprognostic (1.07e-2)"	"unprognostic (5.79e-3)"	"unprognostic (4.95e-3)"	"unprognostic (1.89e-2)"	"unprognostic (7.26e-2)"	"unprognostic (3.27e-1)"	"unprognostic (6.06e-2)"	"unprognostic (2.04e-1)"	"unprognostic (1.08e-1)"	"prognostic unfavorable (1.99e-4)"	"unprognostic (1.46e-1)"	"prognostic favorable (9.33e-5)"	"unprognostic (2.10e-1)"	"unprognostic (1.55e-1)"	"unprognostic (2.59e-1)"	"unprognostic (9.32e-2)"	10.7	4.2	13.4	9.7	20.6	0.2	25.6	16.7	18.6	13.5	8.6	27.3	32.8	12.1	8.2	9.7	14.9	32.5	12.4	15.9	14.5	14.9	29.6	19.4	6.9	16.8	16.7	15.1	26.2	10.2	7.0	21.8	17.8	18.9	27.6	4.6	15.3	19.0	5.9	12.2	28.5	15.9	14.5	7.9	30.5	2.2	16.4	10.2	11.7	9.9	8.7	20.9	12.3	29.8	17.3	16.7	10.9	1.0	24.9	31.9	11.0	43.6	86.3	18.4	16.6	28.8	15.0	0.1	13.4	40.7	50.8	49.0	10.2	35.9	26.7	50.3	19.4	0.3	23.6	45.7	29.7	0.0	1.7	23.9	35.4	35.9	49.6	50.8	54.0	14.7	0.0	1.1	49.3	33.6	26.6	0.1	11.9	34.5	22.6	94.8	21.7	3.1	51.1	33.4	43.8	0.1	45.2	55.6	2.7	12.4	14.6	1.1	86.9	30.0	18.4	54.8	42.2	0.7	6.0	0.0	38.1	0.0	31.1	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	2.9	0.1	0.3	0.0	0.2	0.0	0.0	0.1	0.1	13.4	20.6	16.7	18.6	15.9	14.5	16.8	16.7	17.8	14.5	16.4	29.8	39.2	25.6	33.5	155.7	17.5	63.5	88.1	45.2	60.3	7.3	56.6	26.5	22.2	101.5	44.1	18.4	4.2	24.8	0.8	75.2	0.0	63.2	4.6	30.6	11.5	46.6	43.9	0.0	889.9	61.3	4.1	28.6	77.5	77.5	1.3	13.4	11.4	40.9	6.4	10.1	55.3	44.2	8.2	1.6	8.8	2.7	17.1	2.2	17.8	200.5	1.7	5.1	0.0	313.1	1278.1	124.2	53.8	18.0	1.0	115.8	68.7	13.4	25.9	0.7	59.2	20.1	41.5	11.3	8.9	27.0	38.1	26.8	3.4	14.1	56.6	157.0
PTPRM	"hR-PTPu, PTPRL1, RPTPU"	ENSG00000173482	"Protein tyrosine phosphatase receptor type M"	P28827	18	7566782-8406861	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Cell adhesion"	"Hydrolase, Protein phosphatase, Receptor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Adipocytes: 142.0;Astrocytes: 188.1;Inhibitory neurons: 751.6;Microglial cells: 263.3;Oligodendrocyte precursor cells: 224.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"memory CD8 T-cell: 4.7"	"Group enriched"	"Detected in many"	33	"dendritic cells: 1.8;T-cells: 4.7"	"Cell line enhanced"	"Detected in many"		"ASC diff: 98.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003891, CAB022442, CAB022443"	Supported		Approved	"Plasma membrane"		NA	Yes		130000000	"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	"Plasma membrane"		"CAB022442: , CAB022443: , HPA003891: AB_2667073"	"unprognostic (2.59e-1)"	"prognostic unfavorable (8.65e-5)"	"unprognostic (4.89e-2)"	"unprognostic (1.00e-1)"	"unprognostic (1.13e-1)"	"unprognostic (1.46e-1)"	"unprognostic (1.80e-1)"	"unprognostic (3.41e-2)"	"unprognostic (7.62e-2)"	"unprognostic (2.74e-2)"	"unprognostic (1.56e-2)"	"unprognostic (9.64e-2)"	"unprognostic (5.63e-2)"	"unprognostic (3.11e-3)"	"unprognostic (9.41e-2)"	"unprognostic (2.63e-2)"	"prognostic favorable (1.07e-4)"	53.1	24.1	18.9	11.9	37.6	1.2	41.8	13.0	27.7	18.4	44.2	25.3	8.7	24.2	11.9	14.2	23.3	32.4	61.2	12.7	38.7	29.5	11.8	38.9	15.5	21.7	53.0	26.4	13.2	23.4	16.1	33.2	34.3	16.7	11.5	19.3	10.9	36.0	52.5	12.3	15.1	24.8	5.8	23.1	18.4	22.8	47.6	16.7	54.8	63.4	11.9	23.9	12.2	14.4	4.6	33.4	15.7	0.2	98.0	67.4	38.7	41.1	35.6	26.9	39.5	30.9	7.1	0.0	39.0	49.1	0.5	0.3	0.2	14.3	36.9	0.5	7.2	0.0	22.2	15.2	27.9	0.0	0.4	77.1	29.3	14.9	42.1	51.1	27.2	0.0	0.0	13.8	21.8	0.7	13.7	0.3	2.6	9.9	7.3	0.5	13.5	63.9	64.9	57.6	1.4	8.6	1.1	0.2	34.6	24.9	0.2	0.0	28.2	54.9	34.6	26.4	7.2	1.1	0.4	0.3	46.8	0.2	10.4	0.0	0.0	0.0	2.8	0.0	1.1	0.0	3.8	4.7	0.0	0.0	1.0	2.0	0.0	0.0	0.0	1.8	0.7	1.1	18.9	37.6	13.0	27.7	12.7	38.7	21.7	53.0	34.3	5.8	47.6	14.4	142.0	44.8	36.0	188.1	1.1	6.0	7.3	3.0	2.8	28.3	2.5	3.2	26.7	14.3	7.1	5.5	2.1	11.4	5.4	0.9	1.9	17.6	25.9	28.9	15.6	68.9	1.8	0.4	70.1	8.3	3.4	14.0	8.2	59.6	2.5	13.0	47.2	25.3	9.9	0.0	751.6	1.4	0.0	8.0	5.7	42.0	2.8	5.1	30.2	263.3	0.6	2.9	3.1	224.7	50.3	14.3	1.2	5.3	2.3	8.3	3.0	13.3	15.6	2.2	6.6	7.4	9.9	8.6	9.9	0.9	2.8	12.6	5.7	3.7	0.8	8.6
PTPRN2	"IA-2beta, ICAAR, KIAA0387, phogrin"	ENSG00000155093	"Protein tyrosine phosphatase receptor type N2"	Q92932	7	157539056-158587823	"Disease related genes, Enzymes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Lipid metabolism, Phospholipid metabolism"	"Hydrolase, Protein phosphatase, Receptor"	"Diabetes mellitus"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 49.9;pancreas: 98.1"	"Group enriched"	"Detected in many"	4	"Enteroendocrine cells: 131.1;Excitatory neurons: 439.6;Inhibitory neurons: 433.4;Oligodendrocyte precursor cells: 138.2"	"Cancer enhanced"	"Detected in all"		"prostate cancer: 40.8"	"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in many"		"neutrophil: 23.6"	"Lineage enriched"	"Detected in all"	4	"granulocytes: 23.6"	"Cell line enhanced"	"Detected in many"		"AF22: 45.5;HDLM-2: 42.0;MOLT-4: 22.1;NB-4: 43.0;SCLC-21H: 23.8;SH-SY5Y: 25.4;U-87 MG: 27.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA006900, HPA007255, HPA026656"	Enhanced		Approved	Vesicles		NA	NA		1600000	"Cluster 9: Neutrophils - Innate immune response"	"Cluster 22: Non-specific - Unknown function"	"Cluster 24: NB-4 - Immune response"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Vesicles		"HPA006900: AB_1079715, HPA007255: , HPA026656: AB_1855912"	"unprognostic (2.42e-1)"	"unprognostic (4.17e-2)"	"unprognostic (7.82e-2)"	"unprognostic (2.69e-2)"	"prognostic unfavorable (9.37e-5)"	"unprognostic (7.12e-3)"	"unprognostic (1.04e-1)"	"unprognostic (4.55e-2)"	"unprognostic (4.27e-2)"	"unprognostic (1.64e-1)"	"unprognostic (1.20e-2)"	"unprognostic (1.39e-1)"	"prognostic favorable (8.68e-4)"	"unprognostic (2.60e-2)"	"unprognostic (1.48e-1)"	"unprognostic (1.43e-3)"	"unprognostic (6.16e-2)"	3.8	16.5	29.4	2.7	34.3	1.3	2.9	0.0	49.9	2.1	0.0	7.7	8.3	3.0	4.2	1.9	10.8	7.6	3.1	35.2	22.7	3.9	1.6	4.8	3.4	7.9	3.1	8.7	98.1	1.0	41.0	2.1	3.4	17.3	6.1	9.2	12.9	3.6	1.2	0.8	6.7	2.1	0.1	13.4	40.2	6.2	14.1	1.6	8.7	1.9	2.5	4.2	2.1	20.5	0.1	0.4	45.5	3.6	0.1	0.2	0.1	0.4	0.3	0.0	0.1	0.0	4.0	0.0	1.2	0.5	9.4	0.3	1.0	0.0	0.0	42.0	0.8	0.0	0.0	7.3	1.1	0.0	0.1	2.0	0.8	0.1	0.5	0.3	0.0	3.4	0.1	0.3	0.0	0.7	22.1	43.0	5.7	13.7	3.2	0.0	2.7	0.2	0.2	0.0	23.8	25.4	0.0	0.1	0.0	0.0	0.0	20.9	6.2	9.2	4.3	0.1	1.5	0.3	0.1	0.0	27.7	17.4	6.8	14.1	1.5	2.8	1.3	0.2	0.5	3.5	2.1	1.4	2.1	4.2	2.4	1.4	23.6	2.4	0.0	0.6	5.3	1.3	29.4	34.3	0.0	49.9	35.2	22.7	7.9	3.1	3.4	0.1	14.1	20.5	40.7	3.2	12.9	16.3	18.4	2.3	12.7	1.3	4.0	30.2	1.9	2.2	3.1	10.0	9.1	40.5	10.4	0.4	8.7	5.9	35.2	22.9	51.9	8.7	2.5	26.3	131.1	6.6	439.6	13.1	0.4	13.0	41.8	0.8	19.0	14.1	44.3	0.8	44.5	11.8	433.4	43.3	6.1	7.0	11.3	19.3	12.5	7.9	12.4	27.2	5.7	67.3	15.5	138.2	11.0	7.3	7.0	19.5	5.4	15.0	6.5	3.8	52.6	8.0	26.3	1.4	7.0	62.8	16.3	4.8	1.4	0.7	14.8	32.7	9.7	24.8
PTPRO	"GLEPP1, NPHS6, PTP-oc, PTP-U2, PTPU2"	ENSG00000151490	"Protein tyrosine phosphatase receptor type O"	Q16827	12	15322257-15602175	"Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"		"Hydrolase, Protein phosphatase, Receptor"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 26.8;kidney: 36.3"	"Group enriched"	"Detected in many"	7	"Excitatory neurons: 193.6;Inhibitory neurons: 231.1;Oligodendrocyte precursor cells: 126.7"	"Cancer enhanced"	"Detected in many"		"colorectal cancer: 8.7"	"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"GAMG: 9.9;NTERA-2: 5.8;SH-SY5Y: 6.1;THP-1: 2.7"	"Region enhanced"	"Detected in all"		"olfactory bulb: 175.9"	"Low region specificity"	"Detected in all"			HPA034525	Enhanced				"Intracellular and membrane"	NA	NA			"Cluster 23: Antigen presenting cells - Antigen presentation"	"Cluster 87: Intestine & Kidney - Transmembrane transport"	"Cluster 5: NTERA-2 - Transcription"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"			"HPA034525: AB_10669785"	"unprognostic (3.68e-2)"	"unprognostic (3.49e-1)"	"unprognostic (9.64e-2)"	"unprognostic (1.25e-2)"	"unprognostic (7.87e-2)"	"unprognostic (2.08e-1)"	"unprognostic (5.93e-3)"	"unprognostic (5.37e-2)"	"unprognostic (2.03e-1)"	"unprognostic (3.72e-2)"	"unprognostic (2.00e-1)"	"unprognostic (5.43e-2)"	"unprognostic (4.89e-2)"	"unprognostic (2.12e-1)"	"unprognostic (1.99e-2)"	"unprognostic (1.24e-1)"	"unprognostic (1.44e-1)"	1.8	0.8	8.7	3.0	9.4	0.2	0.8	0.0	10.3	1.3	0.1	10.4	1.7	4.8	1.4	0.4	1.0	1.2	0.5	9.8	8.9	36.3	1.3	6.8	3.1	2.2	3.3	0.4	0.4	0.3	2.4	4.4	5.3	0.5	26.8	7.5	0.5	0.8	0.3	0.4	2.0	6.6	0.9	3.4	0.8	0.5	9.5	1.2	0.3	0.5	3.2	1.5	0.4	2.9	0.0	0.1	0.3	0.1	0.2	0.0	0.2	0.0	0.0	0.5	1.3	0.0	0.0	0.1	0.1	0.0	9.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.2	0.0	0.0	0.6	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	5.8	1.2	0.0	0.0	0.0	0.0	0.1	0.2	1.5	6.1	0.9	0.0	0.1	0.1	0.1	2.7	0.0	0.0	0.3	0.0	0.2	0.4	0.0	0.3	0.0	0.1	1.2	0.0	6.0	0.0	0.0	12.3	0.0	8.9	1.7	0.4	8.5	8.6	2.8	1.2	0.1	0.1	12.7	10.9	1.4	3.2	8.7	9.4	0.0	10.3	9.8	8.9	2.2	3.3	5.3	0.9	9.5	2.9	0.2	0.0	0.5	7.5	7.0	0.3	1.3	0.5	0.0	25.2	0.0	0.1	0.7	0.0	1.8	16.5	0.0	0.2	4.0	3.9	0.0	0.4	0.0	0.8	0.2	1.1	3.6	0.0	193.6	0.0	0.2	0.9	0.0	0.6	0.0	0.0	1.1	0.2	26.1	25.2	231.1	8.3	0.0	21.1	10.6	0.6	0.6	10.5	0.0	17.8	13.8	0.6	1.0	126.7	6.3	0.1	9.8	0.4	1.0	0.1	0.1	0.2	0.0	4.8	0.0	2.1	0.7	0.6	1.1	0.1	0.4	0.3	1.0	0.1	22.4	0.8
PTPRR	"EC-PTP, PCPTP1, PTP-SL, PTPBR7, PTPRQ"	ENSG00000153233	"Protein tyrosine phosphatase receptor type R"	Q15256	12	70638073-70920738	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"		"Hydrolase, Protein phosphatase, Receptor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 14.4;endometrium 1: 5.5;intestine: 7.6"	"Group enriched"	"Detected in some"	4	"Excitatory neurons: 199.5;Inhibitory neurons: 160.7"	"Cancer enhanced"	"Detected in many"		"urothelial cancer: 3.6"	"Group enriched"	"Detected in many"	5	"amygdala: 3.7;basal ganglia: 5.7;cerebellum: 14.4;cerebral cortex: 6.5;hippocampal formation: 7.2"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"HDLM-2: 20.0;RT4: 37.4"	"Region enriched"	"Detected in all"	5	"cerebellum: 89.6"					"CAB011461, HPA011851, HPA071067"	Uncertain		Supported	"Plasma membrane,Cell Junctions,Cytosol"		NA	NA				"Cluster 45: Intestine - Brush border"	"Cluster 15: RT4 - Unknown function"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	"Plasma membrane, Cell Junctions, Cytosol"		"CAB011461: AB_298890, HPA011851: AB_1855939, HPA071067: AB_2686340"	"unprognostic (4.98e-2)"	"unprognostic (1.91e-2)"	"unprognostic (1.55e-1)"	"unprognostic (2.04e-1)"	"unprognostic (3.63e-3)"	"unprognostic (3.48e-5)"	"unprognostic (5.44e-3)"	"unprognostic (1.77e-3)"	"unprognostic (1.13e-1)"	"unprognostic (9.01e-2)"	"unprognostic (1.37e-3)"	"unprognostic (8.06e-2)"	"unprognostic (1.10e-2)"	"unprognostic (1.92e-2)"	"unprognostic (4.78e-2)"	"unprognostic (2.72e-1)"	"prognostic favorable (1.40e-5)"	0.0	2.2	3.7	1.0	5.7	0.0	0.0	14.4	6.5	0.3	0.0	7.4	3.2	5.5	0.0	0.0	0.1	1.0	0.0	7.2	0.5	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.3	0.2	0.1	0.0	5.0	2.5	0.0	1.1	0.0	0.0	7.6	2.9	1.5	0.0	2.7	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.2	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	1.9	0.0	0.4	0.0	0.0	0.7	0.0	0.0	0.0	20.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.2	37.4	0.1	5.8	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.7	5.7	14.4	6.5	7.2	0.5	0.2	0.0	0.1	1.5	0.0	1.5	1.7	0.0	0.0	3.9	0.2	0.5	0.1	0.5	0.0	16.5	0.2	0.1	3.5	0.0	3.4	0.0	0.0	0.0	0.7	43.2	0.0	2.6	1.7	2.2	1.3	4.0	0.0	0.0	199.5	0.2	0.3	0.3	10.2	14.6	0.0	0.0	0.7	0.0	0.0	16.8	160.7	1.8	0.0	0.0	0.3	0.4	0.0	0.2	0.0	3.7	0.0	0.2	1.0	2.0	4.0	2.8	23.0	0.0	0.0	0.4	17.3	0.0	0.1	0.8	0.0	0.1	0.8	0.0	0.1	0.0	0.1	0.8	0.4	0.0	0.7	0.4
PTPRS		ENSG00000105426	"Protein tyrosine phosphatase receptor type S"	Q13332	19	5158495-5340803	"Enzymes, Metabolic proteins, Plasma proteins, Predicted membrane proteins, Predicted secreted proteins"	"Cell adhesion"	"Heparin-binding, Hydrolase, Protein phosphatase, Receptor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 76.8;Inhibitory neurons: 104.2;Melanocytes: 80.0;Oligodendrocytes: 90.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in single"	89	"plasmacytoid DC: 12.5"	"Lineage enriched"	"Detected in single"	89	"dendritic cells: 12.5"	"Cell line enhanced"	"Detected in many"		"AN3-CA: 121.8;HaCaT: 124.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA054747			Approved	"Plasma membrane,Cytosol"	"Secreted - unknown location"	NA	NA		150000000	"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 35: Non-specific - Unknown function"	"Cluster 23: AN3-CA - Transcription regulation"	"Cluster 50: Fibroblasts - ECM organization"	"Plasma membrane, Cytosol"		"HPA054747: AB_2682591"	"unprognostic (8.14e-2)"	"unprognostic (4.59e-3)"	"unprognostic (2.57e-2)"	"unprognostic (9.20e-2)"	"unprognostic (2.15e-1)"	"unprognostic (6.96e-3)"	"unprognostic (6.85e-2)"	"unprognostic (2.36e-1)"	"unprognostic (3.12e-3)"	"unprognostic (1.86e-1)"	"prognostic favorable (1.07e-4)"	"unprognostic (1.25e-1)"	"prognostic unfavorable (1.70e-4)"	"unprognostic (2.80e-1)"	"unprognostic (1.45e-1)"	"unprognostic (4.05e-1)"	"unprognostic (3.46e-2)"	54.7	21.2	34.4	5.0	25.5	1.5	36.2	3.2	30.9	40.2	0.0	25.2	2.6	30.5	2.2	16.5	41.1	13.7	37.0	34.3	10.0	11.2	6.0	26.9	5.5	16.4	16.4	35.8	32.4	9.7	29.1	2.3	17.6	30.5	1.6	5.7	18.6	14.6	14.4	20.6	13.6	8.6	1.6	9.0	23.2	9.9	27.3	4.2	29.4	7.4	4.4	32.0	31.8	34.9	11.3	64.0	56.2	121.8	25.3	20.5	7.4	19.4	22.5	22.8	18.5	0.7	6.2	0.2	44.5	32.2	18.0	124.6	15.1	0.2	10.0	1.5	24.3	0.0	27.2	40.5	11.7	0.0	14.1	21.8	5.4	4.8	0.9	29.4	0.6	7.9	18.5	0.2	9.1	48.0	5.2	12.3	31.7	0.4	27.0	0.0	12.4	0.0	4.7	22.5	43.1	58.9	18.3	3.4	34.6	10.7	22.0	4.8	2.8	20.2	34.3	46.9	23.6	6.2	0.1	36.9	10.5	0.0	44.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12.5	0.0	0.0	34.4	25.5	3.2	30.9	34.3	10.0	16.4	16.4	17.6	1.6	27.3	34.9	1.1	6.4	1.1	53.8	3.2	60.9	42.4	16.1	22.2	49.6	3.3	5.5	14.1	27.1	4.9	12.9	2.1	0.7	56.4	0.1	9.8	1.4	3.4	5.4	11.4	9.7	3.0	0.0	76.8	0.9	32.2	51.2	5.1	5.3	0.0	4.0	25.4	20.2	1.7	11.8	104.2	0.0	10.2	0.3	20.0	5.4	46.6	3.4	80.0	15.9	0.8	46.6	0.0	71.9	90.2	0.5	0.0	36.1	6.3	35.0	0.0	2.9	1.7	10.1	13.1	46.4	22.6	7.4	14.8	16.8	36.7	1.0	2.0	2.7	0.4	30.0
PTPRT	"KIAA0283, RPTPrho"	ENSG00000196090	"Protein tyrosine phosphatase receptor type T"	O14522	20	42072752-43189970	"Cancer-related genes, Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins"		"Hydrolase, Protein phosphatase, Receptor"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 23.9;fallopian tube: 10.8"	"Group enriched"	"Detected in some"	14	"Excitatory neurons: 500.7;Inhibitory neurons: 700.2;Oligodendrocyte precursor cells: 418.7"	"Group enriched"	"Detected in many"	5	"breast cancer: 5.1;prostate cancer: 1.9"	"Region enhanced"	"Detected in many"		"cerebral cortex: 23.9"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"BEWO: 1.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA017336, CAB069423"	Approved					NA	NA				"Cluster 10: Brain - Neuronal signaling"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"			"CAB069423: AB_1622602, HPA017336: AB_1855943"	"unprognostic (7.17e-3)"	"unprognostic (1.02e-1)"	"unprognostic (5.61e-3)"	"unprognostic (1.08e-2)"	"unprognostic (5.95e-2)"	"unprognostic (3.71e-2)"	"unprognostic (1.97e-1)"	"unprognostic (1.31e-2)"	"unprognostic (6.93e-2)"	"unprognostic (2.00e-1)"	"unprognostic (1.37e-6)"	"unprognostic (3.16e-1)"	"unprognostic (1.13e-2)"	"unprognostic (1.81e-1)"	"unprognostic (3.17e-1)"	"unprognostic (1.10e-1)"	"unprognostic (1.17e-1)"	0.1	0.2	10.1	0.1	10.7	0.0	2.7	0.0	23.9	0.6	0.0	0.1	0.5	0.0	0.2	0.0	10.8	0.1	0.2	7.4	0.0	0.1	0.2	1.0	0.4	0.1	0.0	0.0	0.4	0.0	3.0	2.8	0.0	0.2	0.0	3.6	1.0	2.6	0.0	0.4	0.3	0.0	0.0	0.1	0.8	1.6	0.0	6.3	0.0	0.1	0.4	0.0	0.0	5.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.1	10.7	0.0	23.9	7.4	0.0	0.1	0.0	0.0	0.0	0.0	5.0	0.4	0.0	1.1	13.1	0.0	0.9	0.0	0.0	0.0	36.2	2.6	6.9	1.5	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.4	3.2	0.1	0.2	0.0	0.0	500.7	0.0	0.0	1.2	0.0	0.2	0.0	3.3	6.4	0.2	0.2	5.0	700.2	0.0	0.0	0.3	0.3	12.6	0.0	0.1	0.0	8.4	0.0	10.3	0.0	418.7	8.3	0.0	0.0	0.0	0.0	0.1	0.0	0.2	18.5	2.1	0.0	0.5	0.2	0.0	1.0	0.0	0.1	0.0	0.0	0.1	0.0	0.1
PTPRU	"FMI, hPTP-J, PCP-2, PTP, PTPRO"	ENSG00000060656	"Protein tyrosine phosphatase receptor type U"	Q92729	1	29236516-29326813	"Enzymes, Metabolic proteins, Plasma proteins, Predicted membrane proteins"	"Cell adhesion, Differentiation"	"Hydrolase, Protein phosphatase, Receptor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Basal respiratory cells: 22.1;Respiratory ciliated cells: 24.3;Rod photoreceptor cells: 42.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"BEWO: 95.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"CAB011476, HPA039832"	Approved					NA	NA				"Cluster 57: Non-specific - Angiogenesis"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"			"CAB011476: AB_442989, HPA039832: AB_10793923"	"unprognostic (7.81e-2)"	"unprognostic (1.70e-1)"	"unprognostic (2.15e-3)"	"unprognostic (6.13e-2)"	"prognostic unfavorable (7.92e-4)"	"prognostic unfavorable (8.32e-4)"	"unprognostic (3.17e-1)"	"unprognostic (1.83e-2)"	"unprognostic (1.13e-1)"	"unprognostic (4.55e-3)"	"unprognostic (3.39e-3)"	"unprognostic (6.83e-2)"	"unprognostic (1.19e-2)"	"unprognostic (6.82e-2)"	"unprognostic (4.92e-2)"	"unprognostic (3.34e-1)"	"unprognostic (2.05e-1)"	7.1	2.1	12.6	1.1	18.3	0.1	6.9	6.4	16.1	31.1	6.1	5.3	0.7	11.9	3.3	4.3	11.5	4.8	8.7	14.4	10.0	4.9	9.1	9.9	0.6	29.1	18.9	13.0	11.1	9.2	10.2	11.5	28.0	14.0	1.4	18.8	14.6	12.9	17.5	10.1	2.4	1.9	6.3	2.1	5.9	4.0	9.7	1.0	5.2	9.9	1.3	12.3	12.2	11.1	8.1	10.8	0.6	1.6	28.7	1.0	95.7	8.4	7.4	0.3	0.5	9.4	34.7	1.4	16.2	1.6	1.0	42.3	38.5	27.1	0.1	0.5	19.7	1.7	12.1	39.8	12.1	0.0	1.7	13.3	14.4	0.0	2.5	11.3	0.2	4.7	0.3	1.3	7.6	13.2	0.5	0.2	15.8	15.9	4.9	0.0	11.3	0.5	11.7	39.4	32.3	42.0	8.5	26.3	5.8	6.6	15.6	1.8	7.1	1.4	9.3	2.6	1.2	0.8	1.1	0.1	18.8	1.9	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12.6	18.3	6.4	16.1	14.4	10.0	29.1	18.9	28.0	6.3	9.7	11.1	1.0	9.6	13.6	0.7	0.1	1.5	6.7	22.1	1.8	5.3	4.8	5.6	5.2	5.7	20.2	5.5	12.5	18.7	0.5	0.3	0.0	6.2	1.3	8.6	9.4	1.3	0.0	0.0	12.1	2.7	10.5	4.6	0.0	10.1	1.3	0.7	1.8	5.3	2.6	0.0	8.0	0.2	6.1	0.6	1.1	1.2	4.7	0.4	8.8	3.7	0.0	16.7	0.0	8.5	4.4	7.3	0.0	7.2	1.2	6.5	0.0	0.3	24.3	42.6	6.6	5.5	4.1	2.1	6.4	0.2	0.6	9.0	0.6	0.0	0.2	10.0
PTPRZ1	"phosphacan, PTP18, PTPRZ, PTPZ, RPTPB"	ENSG00000106278	"Protein tyrosine phosphatase receptor type Z1"	P23471	7	121873089-122062036	"Enzymes, Metabolic proteins, Plasma proteins, Predicted membrane proteins, Predicted secreted proteins"		"Hydrolase, Protein phosphatase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 88.4;skin 1: 31.9"	"Cell type enriched"	"Detected in many"	4	"Oligodendrocyte precursor cells: 2714.3"	"Cancer enriched"	"Detected in many"	14	"glioma: 175.5"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	9	"AF22: 425.5;NTERA-2: 126.3;WM-115: 193.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA015103	Enhanced		Approved	Vesicles,Cytosol	"Secreted in brain"	NA	NA		3400000		"Cluster 27: Brain & Skin - Unknown function"	"Cluster 12: NES - Nervous system development"	"Cluster 68: Oligodendrocytes - Mixed function"	Cytosol	Vesicles	"HPA015103: AB_1855946"	"unprognostic (8.49e-4)"	"unprognostic (3.96e-3)"	"unprognostic (4.11e-2)"	"unprognostic (1.37e-1)"	"unprognostic (9.18e-2)"	"unprognostic (2.41e-2)"	"unprognostic (8.30e-3)"	"unprognostic (3.78e-2)"	"unprognostic (1.57e-1)"	"unprognostic (2.53e-1)"	"unprognostic (9.17e-4)"	"unprognostic (1.83e-1)"	"unprognostic (8.72e-6)"	"unprognostic (2.00e-1)"	"unprognostic (2.16e-1)"	"unprognostic (8.77e-2)"	"prognostic unfavorable (9.36e-4)"	1.6	1.6	66.0	1.2	64.2	0.0	4.0	57.2	88.4	1.8	21.5	4.4	0.6	0.1	0.8	7.9	0.3	0.7	1.3	64.0	64.1	0.1	0.1	1.2	0.0	60.9	62.9	0.7	2.7	0.0	2.3	0.2	62.4	1.0	1.1	19.0	3.4	0.7	0.1	31.9	1.0	1.3	63.7	1.0	13.8	0.3	58.6	0.2	0.1	0.3	2.6	0.9	2.3	72.4	0.1	0.0	425.5	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	12.3	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	2.1	0.0	27.7	0.0	0.0	0.0	0.0	1.0	0.0	0.1	0.0	0.0	126.3	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.8	0.0	0.0	0.0	5.4	15.2	0.1	0.0	0.0	0.1	0.0	0.0	0.7	10.9	5.6	0.0	0.6	0.0	193.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	66.0	64.2	57.2	88.4	64.0	64.1	60.9	62.9	62.4	63.7	58.6	72.4	0.1	0.0	1.5	625.2	0.2	25.2	8.6	82.2	44.9	18.3	5.6	12.2	1.3	0.0	39.7	0.0	4.2	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.4	0.3	0.0	0.0	37.7	0.7	0.1	1.3	9.2	0.0	0.0	10.1	0.0	0.0	0.1	65.6	72.0	0.0	0.0	0.0	1.6	0.7	0.3	0.1	19.6	22.5	0.0	90.4	0.0	2714.3	3.6	0.9	0.3	0.0	1.2	1.8	0.0	0.1	16.9	6.6	0.0	1.2	1.7	0.1	1.6	14.8	21.5	0.3	0.2	0.5	0.0	7.8
PTRH1	"C9orf115, PTH1"	ENSG00000187024	"Peptidyl-tRNA hydrolase 1 homolog"	Q86Y79	9	127690348-127724873	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Proximal tubular cells: 125.4;Theca cells: 460.9"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"PC-3: 52.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA021223	Uncertain					NA	NA			"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 52: Non-specific - Transcription"			"HPA021223: AB_1845798"	"unprognostic (6.58e-2)"	"unprognostic (7.01e-3)"	"unprognostic (3.46e-3)"	"unprognostic (2.53e-2)"	"unprognostic (7.05e-2)"	"unprognostic (1.30e-1)"	"unprognostic (2.44e-1)"	"unprognostic (3.90e-2)"	"unprognostic (1.74e-1)"	"unprognostic (6.58e-3)"	"unprognostic (8.67e-2)"	"unprognostic (4.08e-2)"	"unprognostic (5.98e-3)"	"unprognostic (5.74e-4)"	"unprognostic (1.38e-2)"	"unprognostic (1.91e-1)"	"unprognostic (1.72e-2)"	16.6	25.5	9.0	5.0	9.1	4.3	15.7	8.0	13.7	11.9	6.8	12.1	4.3	12.7	9.5	10.4	15.1	3.8	18.3	9.1	7.8	26.7	18.1	12.7	3.3	6.7	6.9	8.3	20.9	7.7	17.7	2.7	6.8	13.6	2.3	2.8	11.5	5.3	19.9	24.8	7.6	3.5	6.0	12.6	14.5	17.4	8.2	4.1	20.1	3.3	2.5	12.9	9.6	8.3	28.4	11.7	2.2	7.5	3.9	5.1	20.3	18.6	5.0	7.0	3.9	5.2	10.1	9.4	24.3	8.0	9.2	31.0	2.4	13.3	2.5	15.4	3.5	4.0	15.4	11.8	11.2	6.3	12.0	4.2	13.1	8.6	8.9	3.5	13.4	14.2	11.8	8.2	7.8	24.4	12.7	7.9	3.5	23.5	52.9	10.0	5.5	22.9	13.2	5.6	11.9	10.7	18.7	23.0	14.4	2.0	20.3	3.0	15.8	9.2	13.9	36.0	11.1	23.5	14.1	7.1	13.2	4.2	11.8	8.5	31.1	14.0	67.5	37.2	69.3	21.7	34.3	68.5	28.0	17.1	24.8	57.0	4.0	28.1	20.1	25.3	37.2	31.6	9.0	9.1	8.0	13.7	9.1	7.8	6.7	6.9	6.8	6.0	8.2	8.3	17.4	3.2	9.1	2.0	8.6	17.0	41.2	27.4	9.1	28.3	26.5	23.1	0.3	21.5	13.8	47.8	45.9	13.1	13.4	11.2	66.5	60.5	86.6	54.9	25.2	19.7	30.1	10.8	1.3	33.6	23.7	20.1	10.7	25.5	17.2	15.8	18.5	28.1	46.6	16.8	1.0	25.8	32.6	11.3	13.9	18.7	22.1	11.6	16.0	1.0	15.4	22.2	22.6	2.0	1.0	48.1	13.4	94.0	8.8	85.3	14.6	125.4	43.8	59.0	0.0	15.2	17.0	24.6	9.2	14.4	21.2	18.7	16.0	460.9	17.5	34.8
PTRH2	"BIT1, CFAP37, CGI-147, PTH2"	ENSG00000141378	"Peptidyl-tRNA hydrolase 2"	Q9Y3E5	17	59674636-59707626	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted membrane proteins"	Apoptosis	Hydrolase	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA012897	Supported		Supported	Mitochondria		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 68: Epididymis - Unknown function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 10: Non-specific - Unknown function"	Mitochondria		"HPA012897: AB_1855949"	"unprognostic (2.26e-1)"	"unprognostic (2.80e-2)"	"unprognostic (1.02e-2)"	"unprognostic (3.89e-2)"	"unprognostic (1.31e-2)"	"unprognostic (3.38e-2)"	"prognostic unfavorable (1.50e-4)"	"unprognostic (6.38e-2)"	"unprognostic (2.02e-1)"	"unprognostic (9.59e-3)"	"unprognostic (2.72e-1)"	"unprognostic (1.40e-1)"	"prognostic unfavorable (1.01e-8)"	"unprognostic (5.43e-3)"	"unprognostic (6.82e-2)"	"unprognostic (1.32e-1)"	"unprognostic (1.49e-2)"	20.8	25.9	24.3	17.3	25.1	14.5	27.6	25.0	31.9	19.7	23.6	24.1	15.3	18.8	48.5	18.1	18.4	18.2	14.5	25.1	26.1	18.5	45.7	14.7	19.0	25.9	26.1	16.9	19.5	18.6	14.1	18.6	26.7	20.7	27.5	10.2	15.9	18.6	25.0	15.7	13.2	22.9	24.8	17.5	16.1	19.5	24.9	17.3	16.2	20.9	24.1	44.0	11.8	27.4	75.9	142.9	44.3	40.8	84.8	72.6	47.4	70.6	63.8	60.7	89.0	94.1	57.7	54.1	105.0	60.9	101.1	73.3	98.4	93.8	89.4	104.2	133.2	96.7	72.3	176.2	129.4	86.0	52.5	82.0	120.9	93.9	108.5	42.8	102.5	37.4	111.3	58.2	92.4	187.9	74.2	71.2	38.0	194.5	113.4	39.1	74.8	80.7	103.7	109.2	57.9	74.2	36.7	39.6	91.5	50.7	93.1	61.1	67.2	77.8	77.8	47.1	77.9	73.6	91.9	82.3	50.7	54.4	60.4	6.1	69.0	2.9	22.7	67.4	30.9	43.1	26.3	25.7	50.0	33.1	37.4	27.0	29.0	34.8	86.0	59.4	34.0	37.9	24.3	25.1	25.0	31.9	25.1	26.1	25.9	26.1	26.7	24.8	24.9	27.4	21.4	16.0	13.6	5.5	18.7	36.7	50.1	48.1	27.9	4.1	17.1	22.4	15.4	11.5	51.6	11.0	4.2	26.8	13.0	8.9	11.7	27.2	22.1	23.4	33.1	22.5	6.7	17.9	9.8	25.6	25.0	29.7	17.3	24.1	22.8	12.8	12.8	31.5	16.9	8.4	9.1	10.3	22.4	9.7	17.2	12.0	17.4	14.6	14.2	2.8	11.4	7.2	13.4	7.5	11.5	28.8	12.3	9.8	24.8	35.1	10.0	16.5	33.3	3.4	13.1	25.4	32.2	33.4	13.3	21.3	35.7	31.7	12.6	22.4	16.7	37.5
PTRHD1	"C2orf79, LOC391356"	ENSG00000184924	"Peptidyl-tRNA hydrolase domain containing 1"	Q6GMV3	2	24789728-24793391	"Enzymes, Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA019951	Approved		Approved	Nucleoplasm		NA	NA		100000	"Cluster 28: Myeloid DCs - Unknown function"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 32: Non-specific - Translation"	Nucleoplasm		"HPA019951: AB_1853109"	"unprognostic (1.28e-2)"	"unprognostic (5.79e-2)"	"unprognostic (6.34e-2)"	"unprognostic (1.34e-2)"	"unprognostic (2.61e-2)"	"unprognostic (3.99e-1)"	"unprognostic (8.84e-3)"	"unprognostic (1.26e-1)"	"unprognostic (3.69e-1)"	"unprognostic (8.31e-3)"	"unprognostic (1.58e-1)"	"unprognostic (2.12e-1)"	"prognostic unfavorable (2.31e-4)"	"unprognostic (2.93e-1)"	"unprognostic (1.55e-1)"	"unprognostic (1.51e-1)"	"unprognostic (5.76e-2)"	10.6	26.0	11.7	4.3	11.8	16.1	11.0	12.2	17.5	8.7	13.7	12.8	10.6	7.2	3.5	17.6	6.4	4.2	16.4	12.5	12.6	14.9	14.9	10.2	8.4	12.4	11.9	10.2	13.7	3.6	10.8	6.4	12.6	10.6	5.8	3.0	15.1	4.0	23.9	14.8	11.9	3.3	12.5	11.2	12.3	9.1	12.8	7.1	14.5	8.5	6.2	9.4	10.3	13.0	18.2	40.2	12.7	5.5	6.9	15.2	22.1	12.2	11.3	15.4	9.9	39.7	15.9	14.2	5.2	12.7	10.3	11.7	10.4	11.1	5.1	20.1	70.0	25.7	18.2	43.2	14.2	21.8	23.5	14.6	8.9	7.1	7.9	12.3	14.4	12.8	26.4	11.2	11.4	36.6	17.7	39.0	26.8	10.6	23.7	14.9	38.9	23.9	18.1	31.2	19.9	30.9	13.6	18.1	16.4	5.9	17.7	15.9	24.2	13.6	21.4	6.7	11.2	8.7	28.1	15.4	12.4	13.3	9.3	34.8	90.6	20.7	52.6	66.9	26.8	96.4	51.4	46.2	144.5	81.2	46.6	54.8	10.4	52.8	50.1	149.0	84.4	97.0	11.7	11.8	12.2	17.5	12.5	12.6	12.4	11.9	12.6	12.5	12.8	13.0	27.8	51.3	61.5	1.0	65.0	119.8	79.4	123.3	72.3	10.5	171.4	239.4	81.0	60.1	83.8	66.2	6.2	200.0	87.9	127.0	115.4	91.0	130.9	53.5	37.5	46.9	88.1	68.1	1.9	142.0	153.7	57.4	50.4	48.8	41.2	121.1	62.4	101.5	134.5	1.7	2.2	158.2	79.3	112.5	154.3	157.1	47.2	79.9	67.6	3.7	154.6	78.7	65.9	1.0	2.3	124.2	128.8	39.9	46.6	74.3	120.9	199.2	107.1	12.2	72.3	34.5	56.0	135.6	78.6	133.6	141.8	167.7	52.5	110.4	162.2	125.3
PUDP	"DXF68S1E, FAM16AX, GS1, HDHD1, HDHD1A"	ENSG00000130021	"Pseudouridine 5'-phosphatase"	Q08623	X	6667865-7148158	"Enzymes, Predicted intracellular proteins"	"Nucleotide metabolism"	Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 48.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA000292, HPA072672"	Approved		Approved	Nucleoplasm,Cytosol		NA	NA		14000	"Cluster 27: Non-specific - Gene expression"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 47: Cytotrophoblasts - Unknown function"	Nucleoplasm	Cytosol	"HPA000292: , HPA072672: AB_2732208"	"unprognostic (1.84e-1)"	"unprognostic (4.93e-2)"	"unprognostic (5.15e-3)"	"unprognostic (1.92e-1)"	"unprognostic (3.47e-1)"	"unprognostic (5.63e-3)"	"unprognostic (1.00e-3)"	"unprognostic (3.22e-2)"	"unprognostic (4.86e-2)"	"unprognostic (4.85e-2)"	"prognostic unfavorable (7.27e-4)"	"unprognostic (2.24e-1)"	"unprognostic (3.06e-2)"	"unprognostic (2.23e-1)"	"unprognostic (2.92e-2)"	"prognostic favorable (4.80e-4)"	"unprognostic (3.42e-2)"	8.3	9.1	8.3	12.4	8.8	3.5	8.8	9.2	8.6	9.3	10.6	17.4	18.0	6.4	4.8	8.4	19.9	8.2	20.4	8.0	10.3	15.1	9.8	11.9	16.8	9.0	8.7	10.4	6.7	8.4	3.7	20.1	9.7	6.9	12.3	7.4	11.1	7.7	33.0	5.1	12.3	10.9	8.8	8.9	19.3	4.4	10.1	13.3	10.3	20.2	14.1	9.2	7.2	9.6	48.0	42.1	68.4	28.3	34.7	34.0	11.8	14.8	15.7	18.6	18.7	64.2	28.7	21.9	31.5	16.5	61.5	14.4	31.7	37.9	28.1	20.1	60.4	23.4	15.7	35.7	16.3	20.7	24.4	16.5	14.6	50.7	23.0	12.1	56.2	27.2	45.3	17.8	29.3	23.3	22.5	30.6	29.1	19.9	21.1	16.2	26.0	60.8	26.7	18.0	15.4	16.1	12.7	24.4	25.5	59.6	27.2	18.9	17.4	10.4	6.6	43.7	13.0	55.6	0.2	33.8	15.9	11.5	21.5	2.6	17.8	2.2	7.4	18.9	7.6	8.1	7.8	7.1	13.6	5.9	5.8	6.5	1.9	6.8	19.3	4.3	12.2	10.1	8.3	8.8	9.2	8.6	8.0	10.3	9.0	8.7	9.7	8.8	10.1	9.6	6.6	12.8	4.6	0.0	7.8	0.0	4.1	0.0	5.7	3.9	5.2	3.9	0.0	15.7	3.7	18.4	4.2	48.0	2.4	20.8	9.8	21.1	0.4	10.7	5.3	7.0	0.0	3.4	0.0	16.9	27.6	4.6	10.2	6.1	1.3	10.7	6.8	11.1	22.1	5.0	0.0	10.7	0.0	19.8	0.0	1.6	6.2	8.3	0.0	0.0	13.2	11.9	1.0	0.0	0.0	19.7	20.8	4.9	14.6	8.0	23.5	24.6	5.1	3.9	6.6	6.1	4.0	11.1	15.9	6.0	0.0	28.2	4.8	9.4	14.6	6.1
RAB10		ENSG00000084733	"RAB10, member RAS oncogene family"	P61026	2	26034084-26137454	"Enzymes, Predicted intracellular proteins"	"Protein transport, Transport"	Hydrolase	Neurodegeneration	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Suprabasal keratinocytes: 488.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA045611	Approved					NA	Yes		4300000	"Cluster 51: Monocytes - Innate immune response"	"Cluster 59: Non-specific - Translation"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 10: Non-specific - Unknown function"			"HPA045611: AB_10961124"	"unprognostic (7.73e-3)"	"unprognostic (2.45e-2)"	"unprognostic (8.21e-3)"	"prognostic unfavorable (7.40e-4)"	"unprognostic (8.22e-3)"	"unprognostic (2.10e-1)"	"prognostic unfavorable (1.99e-5)"	"unprognostic (9.22e-3)"	"unprognostic (6.14e-2)"	"unprognostic (2.96e-2)"	"prognostic unfavorable (7.37e-5)"	"unprognostic (1.06e-2)"	"unprognostic (8.69e-3)"	"unprognostic (1.05e-1)"	"unprognostic (2.39e-1)"	"unprognostic (1.31e-1)"	"unprognostic (2.99e-2)"	47.4	51.5	42.8	44.2	49.0	17.7	45.1	48.7	56.7	55.6	29.7	58.8	41.3	38.9	40.3	172.9	39.6	41.9	49.8	41.2	47.3	56.8	48.5	39.9	42.8	52.9	46.9	37.1	37.7	66.3	21.5	40.9	54.4	42.6	57.9	29.0	51.7	41.6	213.9	71.0	46.3	48.1	51.5	44.4	58.8	24.0	46.4	43.8	54.2	114.0	64.5	78.5	78.1	62.8	117.1	139.7	63.8	53.1	131.2	108.2	61.9	90.3	76.8	69.7	61.6	83.2	83.8	77.9	83.4	96.7	79.5	62.0	77.3	84.4	73.9	82.3	56.0	135.1	54.4	134.8	122.6	112.2	73.5	89.0	135.9	85.9	100.3	109.6	89.0	48.9	114.1	76.7	95.1	52.0	69.1	87.1	65.2	139.5	81.7	65.2	133.4	132.8	141.6	111.8	90.1	83.7	75.2	135.1	94.9	70.5	59.5	80.1	110.2	107.1	56.2	75.7	97.2	50.5	84.2	124.4	107.9	132.6	83.5	58.0	75.5	35.5	31.5	135.2	38.6	33.4	36.9	34.1	69.9	32.0	31.1	35.2	54.6	50.6	152.6	24.3	44.6	81.0	42.8	49.0	48.7	56.7	41.2	47.3	52.9	46.9	54.4	51.5	46.4	62.8	70.8	80.1	49.7	37.9	56.2	341.8	195.5	156.4	122.3	23.8	85.2	64.6	76.4	85.8	134.7	92.0	8.4	121.0	48.7	168.8	115.4	188.3	35.5	67.8	76.7	78.4	65.2	101.0	43.6	96.0	204.4	80.7	97.3	98.3	50.7	44.0	53.2	66.8	159.7	26.9	36.0	94.1	107.8	157.2	285.1	29.6	62.7	151.6	88.9	36.5	246.8	104.9	38.1	47.7	78.1	136.8	123.8	70.0	63.6	199.7	85.9	135.2	107.4	32.7	85.5	94.1	159.5	85.3	73.4	255.9	488.0	128.3	59.3	65.6	117.7	334.3
RAB27A	"GS2, HsT18676, RAB27, RAM"	ENSG00000069974	"RAB27A, member RAS oncogene family"	P51159	15	55202966-55319113	"Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins"	Exocytosis	Hydrolase	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"stomach 1: 119.9"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 2: 147.1;Intestinal goblet cells: 252.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"basophil: 261.3"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HL-60: 208.7;K-562: 238.0;Karpas-707: 179.4;SK-MEL-30: 188.3;U-937: 185.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA001333, CAB034046"	Enhanced					NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 37: Intestine - Unknown function"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 27: Mucus-secreting cells - Mucin production"			"CAB034046: AB_2176724, HPA001333: AB_1079730"	"prognostic favorable (2.56e-4)"	"unprognostic (9.75e-2)"	"unprognostic (2.01e-2)"	"unprognostic (1.81e-1)"	"unprognostic (1.08e-1)"	"unprognostic (1.79e-1)"	"unprognostic (1.73e-1)"	"unprognostic (2.32e-1)"	"unprognostic (2.62e-1)"	"unprognostic (2.77e-1)"	"unprognostic (6.24e-2)"	"unprognostic (1.47e-1)"	"prognostic unfavorable (1.67e-4)"	"unprognostic (4.23e-2)"	"unprognostic (4.34e-1)"	"unprognostic (7.95e-3)"	"unprognostic (4.32e-1)"	17.5	27.8	3.5	40.2	3.9	100.2	13.9	4.4	4.4	12.9	5.6	53.0	30.0	12.8	5.0	20.6	12.3	17.6	7.7	3.4	6.7	19.2	43.6	42.4	46.0	5.8	5.0	8.0	29.2	11.4	31.4	17.6	5.9	61.2	66.1	4.2	18.3	11.8	3.2	12.8	40.9	25.8	5.0	30.8	119.9	10.0	5.9	19.3	30.5	7.0	46.2	37.5	13.9	5.7	23.0	10.0	9.7	11.3	8.3	38.8	9.5	29.4	32.5	19.2	26.4	7.0	15.6	0.9	22.3	16.0	38.9	16.0	15.7	27.0	18.3	84.9	9.7	5.4	37.6	18.1	56.0	208.7	26.5	34.3	44.2	29.0	71.6	80.7	46.9	26.4	238.0	179.4	20.7	27.7	1.5	57.6	3.6	38.9	14.7	32.4	27.3	50.3	28.7	17.7	14.9	7.1	31.4	15.2	188.3	24.3	13.3	162.2	25.3	52.5	20.3	33.1	33.6	72.0	88.2	6.0	70.2	185.1	19.0	261.3	72.4	99.8	59.2	30.1	58.2	8.0	28.6	61.9	39.0	13.4	13.9	37.4	114.9	34.1	24.0	2.1	36.2	48.9	3.5	3.9	4.4	4.4	3.4	6.7	5.8	5.0	5.9	5.0	5.9	5.7	27.5	76.9	147.1	12.7	18.6	14.1	25.7	19.2	6.2	3.0	16.3	18.3	7.4	15.7	50.1	11.0	2.1	6.3	81.0	18.5	13.7	24.6	2.8	10.1	15.6	32.1	74.3	12.8	12.5	87.6	18.7	16.9	93.3	16.7	31.7	8.8	41.7	41.7	15.6	0.0	12.2	252.0	12.2	33.3	15.2	2.2	7.5	31.1	71.2	10.3	71.9	2.4	104.0	10.1	7.1	62.9	15.9	13.9	38.6	32.3	14.6	6.7	31.3	4.4	19.7	9.4	15.8	9.3	4.6	7.1	15.5	7.5	81.4	4.6	18.4	23.4
RAB27B		ENSG00000041353	"RAB27B, member RAS oncogene family"	O00194	18	54717860-54895516	"Enzymes, Plasma proteins, Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"stomach 1: 44.1"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 259.3;Gastric mucus-secreting cells: 178.4;granulocytes: 246.6;Late spermatids: 209.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in some"		"gdT-cell: 2.2;NK-cell: 2.6"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HEL: 63.3;hTCEpi: 46.6;hTERT-HME1: 56.0;U-87 MG: 165.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB017712, HPA019849"	Enhanced		Approved	"Golgi apparatus,Plasma membrane,Cytosol"		NA	NA		6500000	"Cluster 48: NK-cells - Unknown function"	"Cluster 24: Salivary gland - Salivary secretion"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 51: Myeloid cells - Hemostasis"	"Golgi apparatus, Plasma membrane"	Cytosol	"CAB017712: , HPA019849: AB_1856000"	"unprognostic (1.59e-1)"	"unprognostic (5.20e-2)"	"unprognostic (9.89e-3)"	"unprognostic (7.51e-2)"	"unprognostic (8.89e-2)"	"unprognostic (1.84e-2)"	"unprognostic (1.52e-1)"	"unprognostic (2.73e-3)"	"unprognostic (6.82e-2)"	"unprognostic (8.12e-2)"	"prognostic unfavorable (2.13e-4)"	"unprognostic (1.39e-2)"	"unprognostic (1.20e-3)"	"unprognostic (1.42e-1)"	"unprognostic (1.84e-2)"	"unprognostic (5.75e-1)"	"unprognostic (1.29e-1)"	0.3	2.6	7.9	1.1	10.2	1.0	11.9	0.0	11.9	3.0	0.0	4.9	5.1	0.8	0.4	14.0	1.1	3.8	0.1	13.3	5.2	0.3	1.3	7.2	0.5	0.0	0.1	0.2	4.1	2.3	1.0	1.1	0.6	20.5	5.3	1.0	14.0	1.0	0.2	15.6	4.9	0.9	0.1	1.7	44.1	4.5	2.6	1.4	0.3	0.5	5.2	6.2	5.2	3.3	7.8	22.4	0.8	0.0	1.5	19.3	0.0	1.7	13.5	1.8	1.3	0.0	8.6	1.3	0.1	3.9	16.7	14.5	0.2	9.0	0.5	0.0	0.5	63.3	5.0	0.0	2.6	3.4	7.0	15.3	46.6	25.5	56.0	21.1	1.2	0.3	0.0	3.9	16.1	7.9	0.2	7.4	0.2	14.0	14.7	0.0	0.0	0.3	4.1	28.9	0.2	10.3	2.2	13.4	0.0	0.1	8.3	0.3	0.3	18.8	0.6	9.8	2.0	0.4	0.0	0.0	165.2	35.6	0.9	0.6	0.0	0.1	2.2	0.0	0.5	0.0	0.7	1.1	0.0	0.0	0.2	1.0	0.2	2.6	0.0	0.0	0.0	1.6	7.9	10.2	0.0	11.9	13.3	5.2	0.0	0.1	0.6	0.1	2.6	3.3	0.3	48.1	37.6	3.3	0.9	25.6	8.6	18.2	8.0	2.4	59.8	25.3	0.5	8.6	36.9	5.5	2.1	6.5	15.0	5.7	1.9	7.2	259.3	30.9	4.4	1.9	4.2	3.4	101.0	41.0	4.5	2.0	178.4	64.0	246.6	0.4	2.5	0.9	0.6	6.7	75.8	31.3	20.3	0.6	2.7	209.9	2.1	38.1	7.2	2.8	2.1	1.4	29.9	98.5	2.6	34.0	18.6	0.4	3.2	78.9	3.0	0.0	15.8	0.4	6.6	0.3	2.2	7.9	1.4	79.2	49.2	2.9	13.9	0.5	7.9	42.2
RAB4A	"HRES-1/RAB4, RAB4"	ENSG00000168118	"RAB4A, member RAS oncogene family"	P20338	1	229271062-229305894	"Enzymes, Predicted intracellular proteins"	"Protein transport, Transport"	Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"eosinophil: 32.7"	"Lineage enriched"	"Detected in all"	5	"granulocytes: 32.7"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"									NA	NA			"Cluster 2: Granulocytes - Unknown function"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 21: OE19 - Mitochondria"	"Cluster 32: Non-specific - Translation"				"unprognostic (9.21e-2)"	"unprognostic (7.58e-2)"	"unprognostic (1.81e-2)"	"unprognostic (2.09e-1)"	"unprognostic (2.09e-2)"	"unprognostic (1.21e-1)"	"unprognostic (2.83e-1)"	"unprognostic (8.53e-2)"	"unprognostic (6.41e-2)"	"unprognostic (3.85e-2)"	"unprognostic (2.99e-2)"	"unprognostic (2.47e-1)"	"unprognostic (1.67e-2)"	"unprognostic (1.45e-1)"	"unprognostic (2.11e-1)"	"unprognostic (4.26e-2)"	"unprognostic (1.72e-2)"	12.1	12.9	29.7	7.6	27.4	7.2	19.4	27.9	35.7	19.4	24.0	17.9	17.0	12.5	13.4	17.7	15.2	15.0	38.5	24.5	27.3	15.8	30.8	10.9	10.9	25.7	31.4	15.6	24.7	14.3	9.1	11.3	26.0	34.3	19.1	17.3	38.8	20.9	34.2	16.9	13.4	13.4	25.7	7.8	26.7	11.4	34.3	12.4	19.8	35.0	11.8	15.4	13.9	27.7	10.3	13.8	22.6	15.7	31.7	35.1	18.9	15.4	18.3	9.2	8.8	25.6	16.8	0.0	25.1	20.7	7.7	11.1	15.2	21.6	12.9	13.1	30.7	13.9	11.8	40.2	20.5	28.2	10.9	27.1	30.4	6.4	8.9	27.1	20.8	14.9	14.8	0.0	16.1	13.3	14.4	18.8	20.4	63.1	19.1	4.6	3.6	7.2	48.6	24.4	19.4	25.3	12.7	19.1	27.6	11.9	18.1	49.5	14.6	0.0	7.3	14.6	21.4	11.9	11.8	0.1	6.4	23.9	21.8	21.4	5.5	32.7	2.2	6.5	2.2	3.0	2.9	2.9	6.8	3.7	1.8	2.4	1.2	2.2	4.2	3.8	3.7	3.5	29.7	27.4	27.9	35.7	24.5	27.3	25.7	31.4	26.0	25.7	34.3	27.7	43.9	16.0	22.1	37.5	48.4	137.0	155.0	135.3	153.1	29.4	82.3	88.8	91.7	154.4	60.5	44.1	47.9	77.7	61.1	81.9	113.5	89.0	158.0	81.7	45.7	45.3	48.6	52.0	23.6	115.4	88.5	47.2	68.3	47.1	24.8	41.5	52.5	119.2	67.8	30.3	24.2	82.6	79.3	78.4	96.3	169.4	46.6	76.0	64.0	16.9	80.4	33.2	50.4	23.6	38.0	84.9	105.7	83.8	47.6	145.2	73.0	128.1	63.2	58.4	46.0	41.6	46.0	92.6	35.2	83.8	122.6	58.0	50.5	39.5	110.5	161.9
RAB4B	"FLJ78649, MGC52123"	ENSG00000167578	"RAB4B, member RAS oncogene family"	P61018	19	40778216-40796942	"Enzymes, Predicted intracellular proteins"	"Protein transport, Transport"	Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 80.4;Syncytiotrophoblasts: 102.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"																	NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 53: Intestinal epithelial cells - Unknown function"				"unprognostic (9.11e-3)"	"unprognostic (2.67e-3)"	"unprognostic (4.23e-3)"	"unprognostic (4.02e-2)"	"unprognostic (1.62e-1)"	"unprognostic (4.73e-3)"	"unprognostic (5.74e-2)"	"unprognostic (7.93e-2)"	"unprognostic (5.32e-1)"	"unprognostic (2.46e-2)"	"prognostic favorable (2.08e-4)"	"unprognostic (7.73e-2)"	"prognostic unfavorable (1.28e-4)"	"unprognostic (1.60e-1)"	"unprognostic (2.17e-1)"	"unprognostic (1.01e-1)"	"prognostic favorable (1.99e-5)"	26.1	51.2	65.0	20.7	74.3	18.1	23.6	78.8	81.6	26.4	53.6	28.8	17.5	21.5	5.3	30.4	19.3	13.7	25.0	64.8	72.3	34.8	24.9	30.9	31.8	82.4	73.5	15.0	19.0	11.0	47.8	16.4	78.8	26.4	9.4	15.3	20.2	13.9	17.0	19.6	30.2	8.8	74.3	50.7	27.0	22.5	76.3	24.3	28.7	8.1	18.0	23.1	24.0	84.0	11.8	37.5	9.1	14.9	19.7	14.3	12.6	15.0	14.1	6.5	17.5	21.1	12.5	19.3	25.6	12.8	21.2	10.6	4.0	13.6	3.2	45.7	17.1	15.4	7.2	12.7	30.4	13.7	54.6	24.3	13.6	14.2	3.5	11.2	25.5	38.3	8.6	33.6	13.8	18.8	20.8	22.1	7.0	20.7	17.8	18.4	7.4	18.9	18.9	23.0	7.9	14.1	34.4	10.5	16.3	8.9	10.6	29.4	18.8	16.2	11.6	14.5	6.3	19.9	13.0	20.1	31.3	17.5	17.3	86.5	65.7	116.9	61.3	83.9	33.8	71.6	39.7	53.4	82.9	89.2	36.2	44.5	113.6	38.9	62.5	151.2	59.6	70.0	65.0	74.3	78.8	81.6	64.8	72.3	82.4	73.5	78.8	74.3	76.3	84.0	2.6	9.6	18.8	0.0	19.8	7.8	15.0	47.0	3.4	22.2	2.0	2.2	5.6	12.8	33.6	1.8	6.2	52.8	23.3	80.4	0.0	1.1	3.2	3.0	2.2	16.5	26.3	4.4	0.0	1.0	19.1	8.7	25.0	7.3	21.5	1.4	23.9	15.2	40.9	32.0	0.0	17.7	40.7	29.0	34.8	3.3	8.7	16.6	32.0	0.0	14.6	26.3	42.2	0.0	0.0	0.7	68.2	10.5	3.0	17.6	49.9	0.8	33.8	15.0	26.3	7.7	15.7	16.6	21.6	7.7	9.9	102.7	17.2	1.4	16.5	26.2
RAB5A	RAB5	ENSG00000144566	"RAB5A, member RAS oncogene family"	P20339	3	19947097-19985175	"Enzymes, Predicted intracellular proteins, RAS pathway related proteins"	"Endocytosis, Phagocytosis, Protein transport, Transport"	Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004567, HPA049354"	Approved		Supported	Nucleoplasm,Vesicles		NA	NA			"Cluster 14: Monocytes - Unknown function"	"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 22: Epithelial cell types - Mixed function"	"Nucleoplasm, Vesicles"		"CAB004567: AB_628191, HPA049354: AB_2680725"	"unprognostic (2.49e-3)"	"unprognostic (1.95e-1)"	"unprognostic (2.58e-2)"	"unprognostic (4.72e-1)"	"unprognostic (3.85e-1)"	"unprognostic (5.58e-2)"	"unprognostic (1.40e-2)"	"unprognostic (6.75e-2)"	"unprognostic (7.12e-2)"	"unprognostic (5.97e-2)"	"unprognostic (1.83e-3)"	"unprognostic (4.68e-2)"	"unprognostic (2.10e-2)"	"unprognostic (1.93e-1)"	"unprognostic (1.33e-1)"	"unprognostic (2.45e-1)"	"unprognostic (8.36e-2)"	35.7	27.3	39.2	27.0	39.9	41.4	33.2	42.1	49.5	30.5	36.6	29.7	29.6	22.7	42.4	42.3	21.1	32.2	36.3	38.6	43.1	33.6	42.8	29.5	24.3	42.7	42.5	19.9	27.2	53.8	20.5	49.2	42.2	30.7	30.5	35.4	35.8	28.8	29.1	36.0	28.2	28.0	44.0	24.2	32.6	18.0	41.1	28.9	41.1	30.3	29.1	35.4	29.7	46.1	29.8	26.8	38.5	26.4	65.8	57.8	38.9	51.3	59.7	47.8	55.0	31.9	45.7	21.8	30.3	56.7	27.6	18.4	29.0	38.2	55.7	37.9	24.1	31.9	24.9	31.1	82.2	45.0	38.1	53.6	71.0	56.1	81.9	59.9	61.6	28.5	37.1	34.1	57.9	46.2	34.8	31.9	48.4	40.8	42.6	25.8	27.2	32.2	98.9	38.8	12.0	39.6	36.9	45.3	60.3	57.0	35.4	35.8	61.6	34.5	30.1	44.4	44.2	42.0	73.5	28.6	55.0	40.4	57.1	28.7	18.0	31.3	7.9	19.6	10.6	7.9	9.3	9.6	18.1	5.8	8.5	8.1	36.0	20.3	26.3	11.8	10.9	11.5	39.2	39.9	42.1	49.5	38.6	43.1	42.7	42.5	42.2	44.0	41.1	46.1	114.8	60.9	45.1	33.0	43.6	170.0	129.5	48.8	62.0	34.0	57.0	35.9	57.0	27.1	52.6	42.3	31.3	74.7	44.2	68.7	103.7	52.2	21.2	45.9	44.4	72.4	62.0	55.3	33.7	45.3	67.2	65.2	66.3	72.0	85.0	39.1	41.7	39.3	54.2	15.2	31.4	59.4	65.1	44.4	158.8	15.9	36.7	60.9	83.6	28.1	43.1	86.1	41.2	65.9	44.1	65.2	55.9	35.3	50.7	109.7	49.4	62.3	48.1	36.8	52.6	86.5	72.4	24.6	27.1	65.0	188.0	164.3	60.6	37.1	41.5	151.0
RAB7A	"CMT2B, RAB7"	ENSG00000075785	"RAB7A, member RAS oncogene family"	P51149	3	128693669-128825942	"Disease related genes, Enzymes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Transporters"	"Autophagy, Host-virus interaction, Lipid degradation, Lipid metabolism, Protein transport, Transport"	Hydrolase	"Charcot-Marie-Tooth disease, Disease variant, Neurodegeneration, Neuropathy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA006964, CAB037131"	Supported		Supported	Lysosomes		NA	NA		5700000	"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 59: Non-specific - Translation"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 16: Pancreatic endocrine cells - Mixed function"	Lysosomes		"CAB037131: AB_477460, HPA006964: AB_1856015"	"unprognostic (1.99e-2)"	"unprognostic (9.03e-2)"	"unprognostic (1.41e-2)"	"prognostic unfavorable (1.52e-4)"	"unprognostic (1.45e-1)"	"unprognostic (7.82e-2)"	"prognostic unfavorable (9.89e-6)"	"unprognostic (2.15e-2)"	"unprognostic (2.38e-1)"	"unprognostic (3.50e-1)"	"prognostic unfavorable (4.63e-4)"	"unprognostic (4.69e-1)"	"unprognostic (6.73e-3)"	"unprognostic (1.88e-1)"	"unprognostic (1.97e-1)"	"unprognostic (3.03e-3)"	"unprognostic (5.64e-3)"	170.6	157.1	120.1	101.4	132.2	99.9	149.5	133.4	159.4	138.3	123.7	128.9	108.3	137.4	143.0	188.2	110.1	109.7	186.8	128.9	138.4	131.8	145.2	152.9	108.8	138.8	142.0	122.7	88.6	155.9	101.5	117.5	139.4	101.3	126.0	103.8	133.3	63.9	332.4	164.9	116.8	124.0	135.9	123.0	114.9	61.5	140.3	124.6	122.5	249.7	136.6	144.4	143.4	159.0	280.2	95.5	146.0	78.3	300.6	94.0	126.0	252.8	183.9	164.4	158.8	170.1	179.2	134.2	163.2	236.2	289.9	163.4	175.2	248.6	99.2	149.4	111.7	294.3	83.6	165.8	303.0	269.4	182.5	243.7	104.0	176.7	204.4	220.7	89.2	114.4	143.4	148.0	108.1	213.1	176.8	294.6	121.4	294.8	144.8	140.2	130.7	170.4	85.7	205.4	105.8	138.5	142.1	194.7	405.4	174.9	180.3	254.8	202.9	192.7	98.0	325.7	125.9	184.4	187.0	192.0	312.7	212.1	235.5	194.9	176.8	213.6	92.1	192.3	92.3	93.2	97.4	94.5	200.0	85.8	94.8	93.6	374.2	128.8	204.0	81.8	120.7	201.3	120.1	132.2	133.4	159.4	128.9	138.4	138.8	142.0	139.4	135.9	140.3	159.0	154.4	89.8	81.8	66.9	109.9	296.7	331.2	218.1	104.7	66.0	112.8	73.0	110.7	90.1	129.4	132.4	18.8	230.0	92.3	222.1	240.7	259.6	11.2	90.8	90.8	165.3	96.9	111.3	83.9	198.9	283.4	172.5	79.0	142.4	146.2	46.5	142.8	127.9	403.9	74.0	82.5	122.8	219.7	208.6	379.9	19.6	133.6	242.8	339.7	99.3	220.9	154.6	121.5	80.9	111.4	303.7	185.0	157.2	79.9	279.2	172.7	332.3	118.7	37.6	138.1	107.7	160.5	116.4	100.4	122.8	308.0	497.9	107.7	109.6	103.5	324.6
RAC1	"p21-Rac1, Rac-1, TC-25"	ENSG00000136238	"Rac family small GTPase 1"	P63000	7	6374527-6403967	"Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, RAS pathway related proteins"		Hydrolase	"Cancer-related genes, Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Urothelial cells: 1980.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB035994, HPA047820"	Approved		Approved	Nucleoplasm,Nucleoli,Cytosol		NA	NA		3900000	"Cluster 26: Non-specific - Mitochondria"	"Cluster 70: Brain - Nervous system development"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 22: Epithelial cell types - Mixed function"	"Nucleoplasm, Cytosol"	Nucleoli	"CAB035994: , HPA047820: AB_2680167"	"unprognostic (8.66e-3)"	"unprognostic (2.47e-1)"	"unprognostic (4.00e-1)"	"unprognostic (2.40e-2)"	"unprognostic (1.88e-3)"	"unprognostic (4.06e-2)"	"prognostic unfavorable (1.74e-5)"	"prognostic unfavorable (4.59e-4)"	"unprognostic (1.59e-1)"	"unprognostic (2.04e-1)"	"prognostic unfavorable (4.57e-5)"	"unprognostic (3.63e-1)"	"prognostic unfavorable (2.11e-4)"	"unprognostic (1.95e-1)"	"unprognostic (2.11e-2)"	"unprognostic (4.13e-2)"	"unprognostic (8.72e-3)"	157.4	108.0	237.0	96.8	250.4	94.5	146.4	242.4	290.7	154.8	206.5	190.5	167.4	150.7	149.9	316.9	145.1	125.9	129.4	240.2	240.6	150.5	136.2	147.5	96.4	249.4	244.8	135.8	92.2	151.1	77.5	180.2	249.2	122.8	199.6	52.2	137.9	145.0	179.5	189.2	161.9	179.3	260.2	96.6	160.6	51.6	241.1	115.3	127.2	141.1	169.6	205.3	188.6	262.9	519.9	230.9	233.0	255.1	270.1	341.8	138.6	284.9	348.0	371.6	375.8	227.3	474.8	145.5	179.7	400.9	384.2	359.4	251.5	345.9	471.9	68.3	207.8	146.6	171.7	166.5	323.7	134.0	114.6	229.7	302.8	268.4	297.6	281.7	333.4	141.3	266.2	111.7	406.4	377.3	74.0	312.4	419.1	261.9	272.3	129.2	236.9	214.6	481.7	322.7	175.8	295.9	201.7	726.1	241.4	264.7	409.6	396.3	341.8	242.4	364.3	300.7	334.5	84.1	99.5	135.4	223.9	250.9	470.6	31.0	117.3	63.0	23.8	83.0	15.1	46.8	26.8	30.9	112.8	49.9	33.0	21.8	168.6	26.1	83.5	64.5	46.1	47.0	237.0	250.4	242.4	290.7	240.2	240.6	249.4	244.8	249.2	260.2	241.1	262.9	755.4	147.4	123.6	28.7	155.9	934.1	981.6	232.1	429.2	90.4	485.3	593.8	200.6	484.7	164.8	356.8	25.0	802.8	224.1	920.9	536.1	183.5	77.6	388.7	362.9	641.2	336.7	313.3	43.3	174.2	1064.1	415.9	305.3	422.8	130.9	325.4	580.8	367.1	832.0	146.4	35.3	632.9	179.0	811.3	1066.7	58.8	476.3	705.7	458.9	66.5	607.2	341.1	191.6	23.1	56.7	299.1	754.4	472.8	212.2	1495.5	816.4	832.0	214.1	64.2	479.9	346.6	466.6	216.6	373.1	774.5	1148.6	845.4	180.0	353.6	573.7	1980.7
RAC3		ENSG00000169750	"Rac family small GTPase 3"	P60763	17	82031678-82034204	"Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, RAS pathway related proteins"		Hydrolase	"Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Breast myoepithelial cells: 45.0;Extravillous trophoblasts: 152.1;Spermatogonia: 58.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in all"		"CACO-2: 230.8;HEK 293: 274.7;NB-4: 156.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA047820	Uncertain					NA	NA			"Cluster 35: T-regs - Unknown function"	"Cluster 43: Testis - Unknown function"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 38: Extravillous trophoblasts - Unknown function"			"HPA047820: AB_2680167"	"unprognostic (3.48e-2)"	"unprognostic (2.26e-1)"	"unprognostic (2.66e-1)"	"prognostic unfavorable (6.21e-5)"	"unprognostic (1.62e-1)"	"unprognostic (1.39e-1)"	"unprognostic (1.43e-2)"	"unprognostic (3.36e-2)"	"unprognostic (1.57e-1)"	"unprognostic (6.62e-2)"	"unprognostic (1.22e-2)"	"unprognostic (3.67e-1)"	"unprognostic (4.39e-2)"	"unprognostic (1.62e-1)"	"unprognostic (1.47e-1)"	"prognostic unfavorable (4.69e-4)"	"unprognostic (1.25e-3)"	12.3	5.0	22.8	1.8	20.8	7.7	13.7	26.3	29.5	5.3	9.3	4.8	3.4	2.8	7.3	10.9	3.8	3.0	3.0	19.7	24.5	9.4	20.7	4.0	1.7	23.3	22.3	4.8	4.7	9.3	22.8	5.6	27.0	11.1	1.4	2.8	18.1	4.2	0.8	12.4	3.7	1.3	15.3	1.9	11.8	28.1	26.5	2.2	9.8	0.2	1.5	3.1	7.6	20.6	11.1	15.1	45.6	63.1	9.7	18.2	50.5	7.8	7.2	26.1	22.3	230.8	21.4	5.8	11.5	4.8	1.7	15.6	43.0	17.8	4.1	3.6	274.7	64.6	20.2	16.7	47.0	28.0	12.2	27.5	13.0	3.5	12.0	19.5	60.3	33.8	103.1	30.2	10.8	35.6	7.3	156.4	61.4	39.2	27.6	47.6	4.5	27.7	20.0	5.4	109.8	111.5	4.1	57.2	55.7	16.1	58.6	40.7	21.6	10.8	9.8	5.5	12.1	14.6	9.9	4.4	6.6	17.3	18.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.0	22.8	20.8	26.3	29.5	19.7	24.5	23.3	22.3	27.0	15.3	26.5	20.6	1.6	0.0	0.0	2.3	0.9	8.7	16.3	12.2	19.9	5.3	36.9	45.0	0.2	4.3	3.6	5.5	0.0	30.0	1.8	3.3	21.5	9.8	19.1	5.9	5.4	2.3	3.0	6.9	5.2	3.3	152.1	10.7	8.2	12.6	4.5	17.8	1.4	11.3	9.7	6.7	8.3	5.1	22.4	0.0	2.6	16.6	5.6	0.9	14.2	0.0	2.0	6.0	0.0	3.5	2.0	5.5	2.4	1.9	2.6	16.4	4.2	26.0	2.4	7.3	0.0	0.8	5.3	2.2	58.0	15.8	7.5	14.1	3.1	8.6	5.2	8.4
RAD1	"HRAD1, REC1"	ENSG00000113456	"RAD1 checkpoint DNA exonuclease"	O60671	5	34905260-34918989	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"DNA damage, DNA repair"	"Exonuclease, Hydrolase, Nuclease"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA006692	Approved		Approved	Nucleoplasm,Vesicles		NA	Yes			"Cluster 6: Non-specific - Transcription"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 20: HeLa - Mitochondria"	"Cluster 47: Cytotrophoblasts - Unknown function"	"Nucleoplasm, Vesicles"		"HPA006692: AB_2667645"	"prognostic unfavorable (6.30e-4)"	"unprognostic (1.85e-2)"	"unprognostic (9.40e-2)"	"unprognostic (1.98e-3)"	"unprognostic (2.00e-1)"	"unprognostic (2.38e-2)"	"prognostic unfavorable (1.06e-5)"	"unprognostic (1.22e-2)"	"unprognostic (2.25e-3)"	"unprognostic (1.61e-3)"	"unprognostic (2.57e-1)"	"unprognostic (2.57e-1)"	"unprognostic (2.22e-2)"	"unprognostic (1.36e-1)"	"unprognostic (1.72e-1)"	"unprognostic (2.11e-1)"	"unprognostic (3.12e-3)"	3.5	8.1	3.2	4.8	3.5	8.4	5.8	3.9	4.6	6.8	5.3	4.1	4.9	5.6	5.4	4.9	3.9	4.6	8.9	3.8	4.6	5.1	4.3	7.5	8.9	3.5	2.7	5.7	4.4	5.1	3.5	8.1	3.2	6.8	4.3	8.7	4.9	4.8	10.9	6.7	4.8	4.6	1.9	4.9	4.8	7.9	3.4	6.3	6.3	8.6	6.2	5.2	4.7	3.8	8.5	10.2	12.3	20.5	7.9	9.4	17.2	15.1	12.0	13.0	10.6	12.2	12.3	25.0	5.2	11.2	15.7	8.4	12.6	7.6	14.4	10.1	12.7	12.9	34.0	8.0	11.9	16.5	11.9	7.8	7.3	13.9	9.3	6.1	6.2	11.0	22.7	13.2	11.2	10.2	19.6	13.9	15.4	6.0	15.7	17.1	24.0	8.6	6.7	9.0	12.4	13.3	30.0	19.9	13.3	7.6	12.5	14.8	6.2	17.9	13.3	9.7	14.4	7.9	13.8	20.3	11.1	28.6	12.5	7.4	2.9	6.5	5.3	2.8	6.9	8.6	5.8	7.6	3.1	9.1	8.2	6.8	1.6	4.5	2.8	6.9	4.9	2.6	3.2	3.5	3.9	4.6	3.8	4.6	3.5	2.7	3.2	1.9	3.4	3.8	11.5	22.4	43.2	5.9	18.3	29.2	20.2	29.3	13.1	25.3	23.9	18.4	25.7	14.3	21.3	20.2	27.1	82.3	20.4	11.9	19.6	18.1	22.0	13.1	16.6	14.1	13.1	28.2	6.6	22.5	54.4	18.7	6.1	12.0	21.5	39.1	10.0	14.8	23.4	23.5	9.0	12.7	30.5	12.0	19.3	16.8	25.1	13.1	17.8	6.5	12.7	23.9	9.2	7.5	9.1	17.8	13.8	21.8	18.0	21.9	13.4	16.4	14.6	35.6	13.1	19.6	19.4	72.5	58.6	15.6	28.6	80.6	22.3	27.4	13.0	25.8
RAD54L	"hHR54, hRAD54, RAD54A"	ENSG00000085999	"RAD54 like"	Q92698	1	46246461-46278480	"Enzymes, Predicted intracellular proteins"	"DNA damage, DNA repair"	"DNA-binding, Helicase, Hydrolase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 15.4;testis: 15.6"	"Cell type enhanced"	"Detected in many"		"Erythroid cells: 7.2;Extravillous trophoblasts: 9.4;Glandular and luminal cells: 8.0;Spermatocytes: 12.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"T-reg: 1.1"	"Lineage enhanced"	"Detected in single"		"T-cells: 1.1"	"Low cell line specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA028954, HPA051537"	Approved		Enhanced	Nucleoplasm		NA	Yes			"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	Nucleoplasm		"HPA028954: AB_2672840, HPA051537: AB_2681525"	"unprognostic (2.12e-2)"	"prognostic favorable (6.67e-4)"	"unprognostic (5.12e-2)"	"unprognostic (5.36e-3)"	"unprognostic (3.24e-1)"	"unprognostic (1.08e-2)"	"unprognostic (9.75e-6)"	"unprognostic (3.91e-2)"	"unprognostic (2.17e-3)"	"unprognostic (2.95e-2)"	"unprognostic (1.77e-4)"	"unprognostic (5.58e-2)"	"unprognostic (1.11e-16)"	"unprognostic (6.76e-3)"	"unprognostic (1.66e-1)"	"unprognostic (2.67e-1)"	"unprognostic (1.74e-1)"	0.5	0.7	3.0	4.1	3.8	8.7	1.0	4.3	3.9	1.3	2.1	3.2	2.0	0.7	0.1	5.4	0.4	0.5	0.7	2.9	2.5	1.4	0.5	1.2	5.5	3.2	3.0	0.5	0.5	0.3	0.4	3.4	3.8	1.0	4.6	0.4	0.9	0.4	1.2	2.3	2.8	1.7	2.8	2.8	1.5	15.6	3.1	15.4	1.8	0.0	8.3	0.8	1.8	3.7	22.2	16.1	46.8	29.1	3.3	2.4	43.9	25.8	11.3	42.8	43.3	33.3	14.2	42.5	19.1	11.0	38.5	22.2	44.6	14.5	36.8	23.7	43.0	53.0	49.7	32.1	0.1	54.0	29.3	1.6	1.2	42.1	12.5	6.9	13.5	49.7	38.2	41.7	23.1	20.4	68.9	60.0	42.5	19.4	25.2	52.8	26.8	19.0	9.4	17.5	22.4	16.3	18.4	25.2	5.7	38.0	9.1	37.7	5.7	43.9	26.1	23.6	43.7	17.6	10.6	46.9	11.5	35.1	18.5	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	1.1	0.2	3.0	3.8	4.3	3.9	2.9	2.5	3.2	3.0	3.8	2.8	3.1	3.7	0.0	0.0	0.0	1.0	0.7	0.3	0.7	0.5	1.8	0.0	0.5	0.5	0.8	0.0	0.1	0.0	0.0	4.3	0.4	1.8	0.0	0.3	2.7	2.3	0.8	0.5	0.0	7.2	2.8	0.0	9.4	1.1	0.5	8.0	4.5	5.6	0.4	0.0	2.6	0.0	1.1	1.3	0.0	0.3	0.3	0.7	0.0	0.4	0.0	0.0	0.0	0.0	1.0	1.0	2.9	0.3	0.1	0.0	4.7	0.4	0.4	0.0	0.1	0.0	0.0	0.4	4.0	12.4	5.6	3.1	0.3	1.6	1.1	0.2	2.9	1.0
RAD54L2	"ARIP4, KIAA0809, SRISNF2L"	ENSG00000164080	"RAD54 like 2"	Q9Y4B4	3	51541144-51668667	"Enzymes, Predicted intracellular proteins"		"DNA-binding, Helicase, Hydrolase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035004, HPA039992, HPA077351"	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 52: Non-specific - Transcription"	Nucleoplasm	Cytosol	"HPA035004: AB_10671930, HPA039992: AB_2676789, HPA077351: "	"unprognostic (1.46e-2)"	"unprognostic (3.67e-2)"	"unprognostic (2.61e-1)"	"unprognostic (5.01e-2)"	"unprognostic (1.15e-1)"	"unprognostic (4.38e-2)"	"unprognostic (1.63e-1)"	"unprognostic (1.45e-2)"	"unprognostic (9.24e-2)"	"unprognostic (2.76e-1)"	"unprognostic (1.59e-1)"	"unprognostic (1.51e-1)"	"prognostic favorable (1.71e-5)"	"unprognostic (3.72e-2)"	"unprognostic (3.19e-1)"	"unprognostic (3.30e-2)"	"unprognostic (6.63e-2)"	4.6	4.8	5.6	3.7	6.1	6.1	4.6	6.5	5.6	4.8	2.9	5.8	2.5	5.6	4.2	4.0	4.6	2.7	4.4	5.0	5.2	4.0	7.8	4.9	4.2	5.5	5.7	5.3	5.3	3.8	4.5	4.8	5.5	4.4	3.4	7.5	4.5	3.9	7.1	5.5	5.0	4.1	5.3	5.2	5.2	5.0	6.3	6.2	4.6	5.3	5.2	4.8	4.3	6.2	6.6	5.1	12.8	12.7	7.0	5.0	6.7	5.5	7.8	7.4	6.9	9.1	3.8	17.4	1.5	9.7	7.8	5.0	20.5	6.8	9.1	9.2	4.6	14.9	11.5	6.0	6.4	16.8	8.5	5.8	5.4	11.3	10.9	4.6	8.3	14.8	10.3	9.1	5.9	5.1	15.0	7.6	10.2	3.2	5.5	6.9	9.9	2.3	3.8	8.4	5.2	10.0	8.7	8.2	5.7	7.7	5.4	9.9	10.9	7.7	8.9	8.0	10.8	9.8	10.7	16.8	8.3	9.2	10.0	3.1	2.2	2.2	3.3	2.6	3.5	1.8	2.9	2.8	2.3	2.9	1.9	2.3	0.9	3.0	3.5	2.3	2.9	2.2	5.6	6.1	6.5	5.6	5.0	5.2	5.5	5.7	5.5	5.3	6.3	6.2	10.8	9.6	14.4	31.3	11.3	9.2	8.6	6.7	3.4	33.8	8.7	8.0	11.0	15.7	7.8	9.2	31.3	19.3	12.2	7.7	1.9	9.3	7.5	9.5	12.0	15.1	16.3	3.8	54.9	10.4	8.7	9.6	9.2	19.8	18.3	14.2	10.4	21.9	8.9	47.1	54.3	8.1	4.1	9.1	8.4	3.1	15.2	9.4	14.2	26.2	13.2	9.1	30.9	42.7	42.3	13.9	9.7	17.0	11.3	12.4	4.6	4.4	9.5	29.9	13.1	17.1	11.6	43.9	36.4	5.5	8.9	29.7	12.5	10.1	7.9	12.5
RAD9A	RAD9	ENSG00000172613	"RAD9 checkpoint clamp component A"	Q99638	11	67317871-67398410	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"DNA damage"	"Exonuclease, Hydrolase, Nuclease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA006725, HPA048155, CAB079979"	Enhanced		Enhanced	"Nucleoplasm,Nuclear bodies"		NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 71: Testis - DNA repair"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Nucleoplasm	"Nuclear bodies"	"CAB079979: , HPA006725: AB_1856041, HPA048155: AB_2680290"	"unprognostic (7.64e-2)"	"prognostic favorable (6.95e-4)"	"unprognostic (8.83e-3)"	"unprognostic (1.13e-1)"	"unprognostic (2.68e-1)"	"unprognostic (2.12e-3)"	"unprognostic (9.64e-3)"	"unprognostic (1.05e-2)"	"unprognostic (1.23e-1)"	"unprognostic (1.97e-1)"	"unprognostic (9.19e-2)"	"unprognostic (2.50e-2)"	"prognostic unfavorable (2.82e-5)"	"unprognostic (6.16e-2)"	"unprognostic (3.72e-3)"	"unprognostic (2.19e-1)"	"prognostic favorable (7.52e-6)"	5.8	5.0	3.3	6.9	3.6	10.2	6.9	2.1	6.0	9.2	2.9	7.3	10.9	7.4	2.1	9.0	10.9	5.7	4.2	3.8	2.4	7.1	6.6	6.7	8.3	2.9	3.6	8.0	8.0	3.4	10.1	4.4	2.2	10.8	3.0	1.8	9.8	6.1	5.2	11.4	11.1	2.4	2.2	9.4	8.4	8.6	2.5	6.1	9.7	2.1	3.7	6.5	8.5	2.2	10.8	15.8	9.5	13.8	2.8	1.1	12.0	5.7	4.9	8.0	7.1	23.2	20.9	11.1	12.4	1.8	13.0	18.7	6.0	5.5	0.9	13.0	16.3	16.8	8.5	10.4	3.8	12.3	20.3	3.2	5.3	7.2	3.5	6.1	5.5	23.2	14.7	15.6	2.3	33.2	21.9	21.8	13.2	15.9	12.1	18.8	12.5	13.6	2.2	9.0	9.8	10.6	9.9	27.2	21.1	2.4	19.1	10.9	4.2	11.7	14.3	23.3	8.7	14.6	14.2	11.5	7.5	11.6	9.6	5.3	1.8	6.0	5.2	2.3	3.8	4.3	4.1	4.3	1.2	3.1	2.9	3.2	2.8	3.1	2.5	3.4	2.4	1.5	3.3	3.6	2.1	6.0	3.8	2.4	2.9	3.6	2.2	2.2	2.5	2.2	16.0	22.4	17.1	10.1	31.0	17.1	17.7	17.9	23.3	19.6	19.7	18.4	1.1	12.8	22.2	20.2	70.9	27.9	31.3	54.2	13.7	11.3	27.3	32.1	13.4	16.3	14.3	17.7	8.5	13.1	22.4	13.8	27.0	14.9	20.3	26.0	11.0	6.6	15.1	21.9	6.0	48.9	10.2	10.3	31.4	13.2	10.5	14.0	19.6	11.2	8.9	15.0	56.7	2.5	5.3	11.6	31.6	12.4	38.5	16.6	61.8	10.9	44.0	32.1	13.1	10.5	14.5	32.0	17.6	18.3	17.3	40.6	30.3	15.3	38.7	18.0
RALA	RAL	ENSG00000006451	"RAS like proto-oncogene A"	P11233	7	39623565-39708120	"Enzymes, Predicted intracellular proteins, RAS pathway related proteins"	"Cell cycle, Cell division, Exocytosis"	Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Langerhans cells: 292.4;Pancreatic endocrine cells: 411.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HUVEC TERT2: 302.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA047037, HPA065232"	Approved		Supported	"Plasma membrane,Focal adhesion sites"		NA	NA			"Cluster 44: Non-specific - Transcription"	"Cluster 70: Brain - Nervous system development"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 10: Non-specific - Unknown function"	"Plasma membrane"	"Focal adhesion sites"	"HPA047037: , HPA065232: AB_2685440"	"unprognostic (1.20e-3)"	"unprognostic (1.03e-2)"	"unprognostic (2.91e-1)"	"unprognostic (7.73e-3)"	"unprognostic (1.98e-2)"	"unprognostic (9.14e-2)"	"prognostic unfavorable (5.32e-5)"	"unprognostic (7.71e-2)"	"unprognostic (2.17e-1)"	"prognostic favorable (7.46e-4)"	"prognostic unfavorable (6.30e-4)"	"unprognostic (3.32e-1)"	"unprognostic (4.95e-3)"	"unprognostic (5.38e-2)"	"unprognostic (7.15e-2)"	"unprognostic (2.79e-1)"	"unprognostic (2.95e-2)"	27.8	32.1	32.4	20.7	35.5	7.4	23.8	35.8	37.3	23.0	30.2	30.9	32.6	20.4	20.1	54.0	19.6	26.8	17.6	33.7	34.3	20.6	21.4	41.8	21.4	37.0	35.7	22.2	16.0	22.6	10.5	32.5	36.4	15.4	31.6	13.0	19.8	15.8	25.8	26.9	30.9	21.1	37.7	18.8	33.8	12.7	34.9	25.5	17.4	19.1	35.2	23.5	22.0	39.8	81.0	18.3	44.1	38.6	81.7	67.6	30.0	69.7	99.7	61.8	67.9	46.1	39.0	41.5	25.5	54.1	58.1	81.5	62.5	45.0	105.5	40.2	29.6	32.4	28.1	34.1	132.1	56.9	43.8	53.7	54.0	110.0	155.4	76.7	302.4	39.7	65.9	27.0	63.2	26.3	40.3	66.7	123.0	88.0	35.9	49.4	40.2	36.3	63.1	37.3	78.0	75.6	42.8	67.7	49.4	78.7	63.5	60.9	98.0	36.4	32.4	46.3	50.7	47.6	39.1	50.3	40.5	58.0	67.2	38.3	13.5	15.7	12.5	15.6	15.7	15.8	20.1	16.2	22.6	18.0	25.6	22.9	6.1	23.2	12.6	14.5	28.1	15.9	32.4	35.5	35.8	37.3	33.7	34.3	37.0	35.7	36.4	37.7	34.9	39.8	66.5	83.3	38.1	25.5	40.5	90.1	37.3	75.1	41.5	14.6	41.3	63.5	37.3	40.0	50.3	23.9	6.2	52.1	28.4	80.1	21.5	165.4	98.2	56.5	64.8	121.5	47.8	35.1	47.6	122.0	92.5	52.4	42.3	99.9	31.7	41.8	75.0	27.8	101.9	11.8	48.4	53.1	144.5	33.0	292.4	17.4	47.8	73.0	30.2	44.0	97.0	37.3	23.7	39.2	37.0	411.0	73.8	69.6	48.6	61.0	70.8	38.6	36.6	16.6	32.9	26.5	131.9	59.1	71.6	113.4	109.4	62.0	37.0	53.9	58.7	64.5
RALB		ENSG00000144118	"RAS like proto-oncogene B"	P11234	2	120240064-120294710	"Enzymes, Predicted intracellular proteins, RAS pathway related proteins"	"Apoptosis, Cell cycle, Cell division"	Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	5	"parathyroid gland: 335.7"	"Cell type enhanced"	"Detected in all"		"Pancreatic endocrine cells: 138.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"neutrophil: 378.4"	"Group enriched"	"Detected in all"	4	"granulocytes: 378.4;monocytes: 176.1"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB026010, HPA065232"	Enhanced					NA	NA		440000	"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 53: Intestinal epithelial cells - Unknown function"			"CAB026010: , HPA065232: AB_2685440"	"unprognostic (5.16e-2)"	"unprognostic (9.44e-2)"	"unprognostic (1.28e-1)"	"unprognostic (2.38e-2)"	"unprognostic (3.89e-2)"	"unprognostic (5.92e-3)"	"unprognostic (1.77e-2)"	"unprognostic (4.15e-2)"	"unprognostic (4.91e-2)"	"unprognostic (2.67e-1)"	"prognostic unfavorable (1.67e-4)"	"unprognostic (2.29e-2)"	"unprognostic (8.30e-3)"	"unprognostic (2.22e-1)"	"unprognostic (5.12e-2)"	"unprognostic (1.38e-1)"	"unprognostic (2.72e-2)"	53.8	35.9	30.6	57.2	30.8	60.0	39.9	32.8	38.7	44.3	33.1	59.2	50.5	37.5	15.8	73.3	45.7	44.8	51.0	32.3	37.7	56.5	34.2	50.7	35.8	30.8	33.6	28.7	25.6	335.7	16.6	63.1	30.6	51.0	51.8	25.8	36.2	31.7	30.1	25.7	44.8	46.5	31.3	54.2	39.3	29.9	37.9	27.5	30.8	43.9	35.0	51.0	49.1	32.8	179.8	47.7	46.8	29.5	71.2	115.5	66.7	121.4	105.8	93.3	70.5	99.4	118.0	7.1	63.9	131.6	88.2	64.1	22.5	93.1	85.7	293.3	25.8	84.4	36.3	71.3	46.0	45.1	144.9	60.3	99.0	97.2	74.0	77.1	272.9	6.3	66.5	28.1	108.2	91.9	5.9	100.0	31.7	71.6	101.9	1.2	59.3	38.1	97.5	45.6	13.3	32.1	50.4	137.9	85.1	39.3	43.3	66.3	168.4	91.1	69.8	93.9	48.8	16.2	9.1	12.8	72.7	57.5	95.6	101.8	80.9	230.5	19.0	117.7	18.5	45.0	18.0	19.0	65.4	59.6	11.9	13.7	378.4	25.5	176.1	6.9	24.6	59.5	30.6	30.8	32.8	38.7	32.3	37.7	30.8	33.6	30.6	31.3	37.9	32.8	69.3	9.6	27.0	6.5	23.8	19.4	30.1	22.4	7.4	4.1	23.2	7.9	55.8	18.6	21.9	11.0	12.5	6.0	11.8	95.3	66.5	84.9	18.8	28.4	22.8	77.8	18.6	8.4	12.9	55.0	128.5	32.7	17.9	26.7	106.1	90.6	78.5	9.8	53.6	13.5	9.7	19.1	18.3	54.3	59.4	23.0	19.9	66.7	35.6	16.9	62.6	26.3	21.6	10.1	5.4	138.1	62.1	31.2	6.7	28.5	44.6	104.4	46.3	7.5	19.7	18.3	33.4	13.1	16.2	16.4	18.9	36.7	19.5	12.9	31.3	32.2
RAP1A	"KREV-1, SMGP21"	ENSG00000116473	"RAP1A, member of RAS oncogene family"	P62834	1	111542218-111716691	"Enzymes, Predicted intracellular proteins, RAS pathway related proteins"	Neurogenesis	Hydrolase	"Tumor suppressor"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HDLM-2: 494.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"									NA	NA			"Cluster 9: Neutrophils - Innate immune response"	"Cluster 14: B-cells - Humoral immune response"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 10: Non-specific - Unknown function"				"unprognostic (7.37e-3)"	"unprognostic (7.49e-2)"	"unprognostic (1.40e-2)"	"unprognostic (1.59e-1)"	"unprognostic (1.13e-1)"	"unprognostic (6.88e-2)"	"unprognostic (1.57e-3)"	"unprognostic (9.89e-2)"	"unprognostic (6.10e-2)"	"unprognostic (4.98e-3)"	"unprognostic (1.54e-2)"	"unprognostic (1.84e-1)"	"unprognostic (3.44e-2)"	"unprognostic (1.06e-1)"	"unprognostic (1.76e-1)"	"unprognostic (3.76e-1)"	"unprognostic (3.08e-1)"	91.6	59.9	45.4	101.8	55.6	81.4	57.5	55.4	71.1	52.2	41.6	160.2	67.8	53.8	82.2	107.5	51.6	63.3	93.9	42.9	52.1	70.8	98.1	77.3	114.0	57.7	53.3	41.3	36.0	123.4	32.9	65.5	59.5	67.9	94.4	26.9	66.3	96.4	89.4	38.7	75.1	89.5	56.3	89.5	78.9	17.9	49.9	76.7	65.2	86.6	123.6	100.8	45.4	67.9	162.8	25.1	61.1	36.1	121.7	116.7	56.5	105.7	112.2	75.0	84.4	83.3	65.9	132.0	72.5	133.1	48.2	57.6	56.5	79.4	138.9	494.7	58.7	96.0	61.4	51.9	124.0	101.4	95.7	76.0	90.9	83.5	86.8	69.7	100.3	73.9	73.8	142.3	104.6	74.4	52.7	128.0	36.2	72.1	66.5	56.9	129.4	65.9	120.2	80.9	43.3	30.8	129.9	75.6	99.3	61.9	38.3	127.9	94.5	60.2	77.2	76.2	104.4	151.2	54.7	145.4	83.9	152.7	161.1	15.6	22.1	21.1	17.0	23.6	20.0	16.4	29.0	25.9	26.2	10.6	21.5	20.9	48.4	22.1	21.6	13.0	29.0	19.0	45.4	55.6	55.4	71.1	42.9	52.1	57.7	53.3	59.5	56.3	49.9	67.9	107.5	67.3	83.1	36.2	104.8	123.9	103.5	65.2	31.9	17.4	49.3	33.1	122.6	41.5	60.0	46.0	4.2	70.5	117.8	134.2	158.5	73.4	28.1	27.6	39.9	118.4	40.8	149.7	73.1	69.8	76.1	78.4	56.6	38.8	85.6	24.8	97.1	60.3	209.2	50.5	78.1	130.8	46.8	245.4	265.5	14.4	63.3	193.6	101.4	182.7	179.7	71.4	148.3	62.4	203.4	74.9	88.3	78.2	119.2	125.1	104.7	133.8	40.4	11.7	118.3	80.5	141.5	26.0	10.9	42.1	101.7	82.1	168.3	89.6	84.0	152.7
RAP1B	"DKFZp586H0723, K-REV, RAL1B"	ENSG00000127314	"RAP1B, member of RAS oncogene family"	P61224	12	68610855-68671901	"Enzymes, Plasma proteins, Predicted intracellular proteins, RAS pathway related proteins"		Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"									NA	NA			"Cluster 51: Monocytes - Innate immune response"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 36: HEL - Hemostasis"	"Cluster 10: Non-specific - Unknown function"				"unprognostic (1.20e-1)"	"unprognostic (1.47e-3)"	"unprognostic (1.11e-1)"	"unprognostic (1.20e-1)"	"unprognostic (4.15e-2)"	"unprognostic (7.23e-2)"	"unprognostic (1.60e-3)"	"unprognostic (1.48e-1)"	"unprognostic (5.83e-2)"	"unprognostic (1.80e-1)"	"unprognostic (2.01e-2)"	"unprognostic (2.86e-1)"	"prognostic unfavorable (8.08e-4)"	"unprognostic (1.08e-1)"	"unprognostic (8.86e-2)"	"unprognostic (7.86e-2)"	"unprognostic (3.22e-1)"	156.1	107.5	48.2	166.5	53.4	277.9	118.2	55.8	64.2	89.8	62.5	126.4	84.2	120.2	69.7	86.3	78.7	129.7	67.9	49.5	60.0	107.3	141.1	134.9	211.8	58.3	53.5	69.3	78.8	74.1	52.0	133.0	59.7	85.1	111.5	57.6	70.0	135.9	49.5	73.5	121.0	146.4	52.4	153.3	104.4	89.6	55.6	162.5	89.1	57.3	181.1	198.1	83.8	66.2	199.9	133.1	153.2	131.2	317.6	253.1	140.2	414.9	252.1	269.5	203.5	178.9	130.2	280.0	232.8	580.5	124.2	113.4	146.5	202.9	379.8	496.2	125.7	725.2	156.7	120.9	370.8	282.0	407.1	254.8	203.3	289.5	346.0	218.6	298.7	232.1	261.2	445.6	272.0	127.9	265.4	361.7	173.9	86.8	191.3	235.8	181.9	211.1	204.9	488.3	59.6	93.3	209.1	124.8	206.1	174.7	160.3	327.2	330.4	243.0	108.9	275.6	229.9	227.1	452.4	342.3	224.7	191.8	212.3	399.1	215.4	205.7	340.1	407.0	221.2	154.1	206.1	297.6	196.2	140.3	222.2	303.4	149.8	469.5	464.3	99.0	186.2	820.8	48.2	53.4	55.8	64.2	49.5	60.0	58.3	53.5	59.7	52.4	55.6	66.2	210.9	80.1	79.9	41.1	166.2	294.4	72.4	150.9	70.6	14.0	73.3	61.0	14.7	37.1	108.9	80.9	22.9	35.5	373.9	176.1	109.5	157.9	99.6	78.5	154.3	132.4	189.5	104.7	45.0	130.8	75.2	123.4	52.0	119.6	147.8	60.5	85.3	32.7	78.5	33.7	46.8	93.5	95.6	111.3	437.6	44.6	38.8	273.1	188.5	105.9	257.3	28.6	362.5	45.8	67.8	186.0	215.6	36.5	228.4	61.4	72.3	182.2	104.0	23.3	6.6	40.3	204.8	46.3	50.2	78.9	297.8	154.5	256.9	123.2	92.2	92.4
RAP2A	"K-REV, RAP2"	ENSG00000125249	"RAP2A, member of RAS oncogene family"	P10114	13	97434169-97469128	"Enzymes, Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Excitatory neurons: 83.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB018552	Uncertain					NA	NA			"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 65: Brain - Ion transport"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 48: Smooth muscle cells - ECM organization"			"CAB018552: AB_2177305"	"unprognostic (2.40e-1)"	"unprognostic (7.72e-2)"	"unprognostic (1.94e-1)"	"unprognostic (4.34e-2)"	"unprognostic (2.04e-2)"	"unprognostic (2.35e-2)"	"prognostic unfavorable (1.55e-4)"	"unprognostic (1.20e-2)"	"unprognostic (2.06e-2)"	"unprognostic (2.10e-1)"	"unprognostic (5.66e-2)"	"unprognostic (1.92e-2)"	"prognostic unfavorable (8.06e-4)"	"unprognostic (1.73e-1)"	"unprognostic (1.14e-1)"	"unprognostic (1.19e-2)"	"unprognostic (1.53e-1)"	14.9	8.2	26.3	10.7	32.4	4.1	11.7	21.9	39.5	11.7	13.2	10.2	7.9	8.7	4.5	15.9	6.7	12.7	11.3	32.5	23.7	14.4	8.6	13.8	18.0	23.8	25.3	6.7	4.8	7.8	7.9	25.4	24.6	6.4	11.2	7.5	5.4	7.2	10.5	7.2	8.1	12.3	27.0	15.1	6.5	4.5	31.2	13.3	6.6	15.3	12.9	11.5	7.7	30.6	18.5	5.2	19.3	13.9	31.2	18.5	7.6	13.4	8.8	12.9	14.4	9.8	10.6	14.1	8.4	22.1	12.6	14.1	16.6	13.4	16.9	26.3	8.6	15.4	19.8	14.5	22.5	13.6	9.5	28.5	17.1	12.8	17.6	19.5	28.2	15.8	5.2	26.2	17.3	6.7	9.4	21.1	11.1	16.0	7.8	12.1	20.7	9.3	12.7	6.0	21.9	37.4	9.5	22.5	19.8	26.1	18.1	6.8	21.2	12.6	12.5	12.5	13.1	18.7	15.8	7.7	35.0	16.1	20.8	0.0	0.3	0.4	1.9	1.4	0.8	0.5	0.7	1.4	1.0	0.2	0.4	1.5	0.1	0.4	2.0	1.6	1.3	0.4	26.3	32.4	21.9	39.5	32.5	23.7	23.8	25.3	24.6	27.0	31.2	30.6	34.0	12.8	6.4	17.3	6.7	22.7	4.5	8.2	8.6	10.7	19.1	15.6	15.8	14.3	6.3	1.8	8.4	2.0	31.1	17.0	9.8	5.3	2.5	7.1	19.6	23.7	16.8	9.9	83.8	6.2	11.5	20.0	7.7	9.8	5.1	12.0	29.6	18.1	32.9	28.6	33.3	13.4	10.2	49.1	66.4	1.9	7.2	33.7	16.0	49.6	22.0	17.6	4.1	54.3	44.1	11.1	16.9	6.0	12.3	8.4	6.5	21.9	4.6	5.9	26.3	11.6	36.0	6.5	8.0	22.3	21.9	3.7	12.7	11.1	12.9	4.5
RAP2B		ENSG00000181467	"RAP2B, member of RAS oncogene family"	P61225	3	153162226-153170627	"Enzymes, Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Basal squamous epithelial cells: 236.8;Squamous epithelial cells: 259.0;Urothelial cells: 269.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"									NA	NA		160000	"Cluster 7: Monocytes - Unknown function"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 44: Endometrium - Transcription"				"unprognostic (2.44e-2)"	"unprognostic (2.19e-1)"	"unprognostic (2.13e-1)"	"unprognostic (3.51e-2)"	"unprognostic (3.04e-2)"	"unprognostic (2.87e-2)"	"prognostic unfavorable (1.65e-4)"	"unprognostic (2.40e-1)"	"unprognostic (2.00e-1)"	"prognostic favorable (9.21e-4)"	"unprognostic (2.48e-2)"	"unprognostic (1.67e-1)"	"unprognostic (5.97e-2)"	"unprognostic (2.96e-1)"	"unprognostic (2.32e-1)"	"unprognostic (1.51e-1)"	"unprognostic (1.17e-2)"	5.2	2.5	4.9	6.0	7.2	15.6	3.4	1.4	7.4	6.0	2.1	3.8	2.6	3.4	2.9	14.9	2.7	6.3	2.1	12.1	5.2	2.7	4.4	5.0	6.3	2.5	4.8	3.6	2.4	2.3	1.2	8.6	2.1	2.4	3.5	0.9	4.8	2.3	1.3	5.0	3.6	3.1	2.9	7.5	8.7	1.4	8.2	4.7	2.1	1.6	5.0	8.2	7.0	5.4	29.0	10.4	5.0	7.4	10.7	9.7	13.7	7.3	10.8	4.9	5.4	5.5	16.6	2.0	8.0	6.8	8.1	28.5	3.9	13.3	5.7	11.7	7.5	11.7	5.6	10.2	5.6	10.9	17.8	10.5	11.1	7.3	13.6	8.6	11.9	5.5	6.8	23.9	9.3	11.5	10.3	15.7	10.4	6.0	16.1	8.9	13.7	26.3	7.7	27.8	0.1	2.7	7.6	6.9	23.5	8.9	5.1	5.6	23.9	7.5	11.6	8.1	18.5	15.3	2.7	5.2	10.0	12.0	7.9	28.0	17.9	7.5	19.5	27.8	14.7	6.4	16.6	17.2	13.1	3.8	9.3	14.7	7.2	14.1	27.6	9.5	12.7	13.8	4.9	7.2	1.4	7.4	12.1	5.2	2.5	4.8	2.1	2.9	8.2	5.4	39.7	12.8	16.5	1.6	26.0	193.0	145.8	61.1	236.8	3.7	41.3	22.4	4.8	30.0	39.4	16.5	2.1	17.3	94.4	135.3	3.9	31.3	0.6	107.8	40.4	21.5	48.6	40.8	8.9	21.7	49.4	30.7	120.8	173.4	26.6	51.3	25.4	14.7	132.1	3.3	3.0	53.5	40.7	170.6	159.9	1.5	19.3	117.0	35.6	4.7	120.1	7.9	110.2	4.5	1.9	60.6	121.3	14.7	27.8	102.1	31.1	12.3	22.1	5.9	0.0	11.1	18.0	3.8	6.1	259.0	195.2	15.2	52.6	12.3	33.6	269.2
RAP2C	DKFZp313B211	ENSG00000123728	"RAP2C, member of RAS oncogene family"	Q9Y3L5	X	132203024-132219480	"Enzymes, Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"endometrium 1: 92.1"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"									NA	NA			"Cluster 49: Eosinophils - Unknown function"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 41: Macrophages - Immune response"				"unprognostic (1.37e-2)"	"unprognostic (8.80e-2)"	"unprognostic (6.66e-2)"	"unprognostic (1.54e-2)"	"unprognostic (8.63e-2)"	"unprognostic (4.14e-2)"	"unprognostic (4.95e-2)"	"unprognostic (3.44e-1)"	"unprognostic (1.44e-1)"	"unprognostic (1.21e-2)"	"unprognostic (1.51e-2)"	"unprognostic (3.04e-2)"	"prognostic unfavorable (3.81e-5)"	"unprognostic (2.27e-1)"	"unprognostic (1.45e-1)"	"unprognostic (2.44e-2)"	"unprognostic (1.00e-1)"	16.2	16.5	8.2	19.7	8.2	52.7	11.6	7.6	11.0	11.5	7.3	12.1	17.1	92.1	30.7	16.5	18.8	13.1	13.1	7.4	8.1	21.5	46.9	14.8	26.2	9.6	8.2	11.6	12.7	7.7	5.3	20.9	8.6	11.1	14.1	5.9	11.2	12.3	24.3	15.3	14.9	55.2	8.9	20.3	14.0	7.1	9.4	20.8	9.0	16.1	25.6	15.3	12.8	8.6	20.9	17.1	24.7	27.0	20.8	33.2	35.4	23.9	30.6	23.6	23.9	15.9	25.2	31.1	36.9	27.2	21.3	15.9	23.0	24.2	30.6	54.3	20.2	23.8	19.7	24.3	31.6	39.7	31.9	26.9	27.3	26.2	27.9	24.0	26.6	17.6	19.1	29.9	26.1	33.6	23.0	32.2	16.9	22.0	22.9	16.9	18.8	31.1	31.3	14.3	4.9	26.2	13.7	17.4	26.8	38.2	28.2	22.0	20.9	23.9	13.0	48.2	44.9	28.0	24.2	29.5	26.9	38.6	21.4	6.8	3.9	10.7	4.6	8.9	5.6	4.7	5.4	4.9	4.4	3.6	5.0	5.9	8.1	6.8	14.4	2.2	6.1	3.6	8.2	8.2	7.6	11.0	7.4	8.1	9.6	8.2	8.6	8.9	9.4	8.6	13.7	9.6	9.7	8.8	39.9	32.2	16.6	11.8	17.6	5.9	13.5	7.6	20.5	8.6	8.4	22.0	4.2	33.6	45.0	25.2	76.3	10.1	0.4	14.5	13.0	15.5	5.4	9.5	4.0	13.2	37.7	17.5	20.4	17.8	13.3	8.6	16.1	46.3	24.6	8.4	4.2	9.6	20.3	37.7	53.2	2.2	20.2	36.1	32.0	13.1	24.9	22.7	29.9	7.5	6.8	20.7	17.4	15.1	28.0	16.8	20.3	18.2	11.5	6.4	6.6	13.2	14.9	4.9	3.7	29.6	32.8	74.6	34.5	14.2	11.4	21.1
RASL10A	RRP22	ENSG00000100276	"RAS like family 10 member A"	Q92737	22	29312933-29319679	"Enzymes, Predicted intracellular proteins"		Hydrolase	"Tumor suppressor"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"brain: 28.7"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 17.9;Breast glandular cells: 35.9;Breast myoepithelial cells: 58.3;Excitatory neurons: 35.1;Rod photoreceptor cells: 19.6"	"Group enriched"	"Detected in some"	4	"glioma: 2.5;testis cancer: 3.4;urothelial cancer: 1.0"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HEK 293: 1.6;NB-4: 2.5;U-2 OS: 1.1;U-266/70: 2.7;U-266/84: 1.0"	"Group enriched"	"Detected in many"	6	"amygdala: 33.7;basal ganglia: 16.7;cerebral cortex: 36.0;hippocampal formation: 26.3;white matter: 15.3"	"Group enriched"	"Detected in many"	4	"cerebral cortex: 35.6;hippocampal formation: 27.8"	HPA056169	Approved					NA	NA				"Cluster 10: Brain - Neuronal signaling"	"Cluster 24: NB-4 - Immune response"	"Cluster 35: Glandular cells - Unknown function"			"HPA056169: AB_2683053"	"unprognostic (1.94e-1)"	"unprognostic (2.51e-4)"	"unprognostic (3.78e-2)"	"unprognostic (1.75e-1)"	"unprognostic (2.94e-2)"	"unprognostic (2.74e-1)"	"unprognostic (1.16e-1)"	"unprognostic (7.99e-2)"	"unprognostic (9.42e-2)"	"unprognostic (1.61e-2)"	"unprognostic (5.00e-4)"	"unprognostic (2.44e-1)"	"unprognostic (7.00e-4)"	"unprognostic (3.12e-1)"	"unprognostic (1.19e-1)"	"unprognostic (6.61e-2)"	"unprognostic (3.61e-3)"	0.9	1.4	26.6	0.3	23.2	0.1	2.0	6.3	28.7	0.4	5.3	0.7	0.3	0.6	0.1	0.4	0.6	0.1	3.8	24.5	13.4	1.2	0.9	1.2	0.1	9.3	11.6	0.2	0.4	0.1	5.0	0.2	10.4	2.0	0.0	2.6	1.0	0.1	0.7	0.7	1.1	0.0	9.0	1.2	0.5	1.8	13.3	0.1	1.1	0.1	0.1	0.5	0.3	16.2	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.2	0.1	0.0	0.0	0.1	1.6	0.1	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.5	0.0	0.4	0.0	2.5	0.6	0.0	0.0	0.0	0.2	0.0	0.1	0.2	0.3	0.0	0.0	0.1	0.0	0.5	0.5	0.2	0.1	0.0	1.1	0.0	0.1	2.7	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	26.6	23.2	6.3	28.7	24.5	13.4	9.3	11.6	10.4	9.0	13.3	16.2	3.9	0.0	0.0	17.9	0.4	0.4	0.6	0.0	0.0	6.8	35.9	58.3	1.1	1.5	0.0	0.0	6.2	0.2	1.0	0.7	0.0	0.0	1.3	0.8	0.3	3.1	0.0	0.0	35.1	0.0	4.7	0.5	1.5	1.4	0.0	0.5	7.9	0.5	1.1	0.0	4.4	1.1	0.0	2.6	5.8	0.5	0.3	2.7	0.0	4.7	0.2	3.3	0.0	3.0	3.9	0.1	0.1	0.0	0.3	1.7	0.2	0.1	0.2	19.6	0.0	13.4	0.5	1.5	3.9	0.3	0.6	0.5	0.5	0.6	0.4	0.2
RASL10B	"RRP17, VTS58635"	ENSG00000270885	"RAS like family 10 member B"	Q96S79	17	35731639-35743521	"Enzymes, Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 32.3;skeletal muscle: 31.5"	"Cell type enhanced"	"Detected in many"		"Cardiomyocytes: 13.8;Early spermatids: 10.4;Late spermatids: 34.6;Muller glia cells: 29.0"	"Cancer enhanced"	"Detected in many"		"testis cancer: 14.5"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"HAP1: 24.3;HHSteC: 26.7;NTERA-2: 41.3;REH: 20.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA046842, HPA057092"	Enhanced		Approved	Vesicles		NA	NA				"Cluster 47: Non-specific - Unknown function"	"Cluster 5: NTERA-2 - Transcription"	"Cluster 5: Muller glia cells - Visual perception"	Vesicles		"HPA046842: AB_2679835, HPA057092: AB_2683332"	"unprognostic (5.78e-2)"	"unprognostic (2.15e-2)"	"unprognostic (2.36e-2)"	"prognostic unfavorable (6.38e-6)"	"unprognostic (8.60e-2)"	"unprognostic (1.24e-1)"	"unprognostic (2.69e-2)"	"unprognostic (4.98e-2)"	"unprognostic (1.97e-2)"	"unprognostic (7.13e-2)"	"unprognostic (2.61e-2)"	"unprognostic (3.18e-2)"	"unprognostic (1.71e-6)"	"unprognostic (2.41e-3)"	"unprognostic (1.00e-1)"	"unprognostic (1.32e-2)"	"unprognostic (9.60e-3)"	15.4	1.7	25.9	0.1	32.3	0.0	11.3	8.7	25.6	3.9	7.6	1.9	0.7	2.8	0.6	0.4	3.9	0.7	19.3	26.5	18.1	3.0	2.1	1.2	0.1	16.5	19.2	3.7	4.9	5.2	6.7	2.8	18.0	2.9	0.1	9.0	9.1	14.7	31.5	0.8	1.2	0.7	13.2	0.3	1.8	3.0	17.5	0.4	1.7	0.9	0.1	1.4	2.3	12.9	0.0	0.3	6.3	0.0	1.1	0.6	1.8	1.2	0.8	4.3	3.6	8.1	0.0	0.0	0.7	0.2	0.0	0.0	24.3	0.0	1.5	0.0	8.0	0.0	4.1	9.3	26.7	0.0	0.0	19.5	1.5	1.5	0.0	3.4	0.0	13.2	5.5	0.0	0.3	0.5	11.6	0.0	41.3	0.0	0.0	20.8	11.1	18.5	0.0	0.0	18.3	17.8	1.2	0.4	1.7	17.8	2.3	1.2	0.0	2.0	14.5	0.1	0.5	0.0	0.0	5.0	0.3	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	25.9	32.3	8.7	25.6	26.5	18.1	16.5	19.2	18.0	13.2	17.5	12.9	0.3	0.0	0.5	0.3	0.0	0.1	0.5	0.0	0.0	3.9	2.7	1.4	13.8	4.3	0.0	1.8	2.1	0.0	0.0	0.0	0.0	1.3	10.4	1.0	0.7	0.7	0.0	0.0	2.6	0.0	0.0	1.9	0.0	1.4	0.0	2.8	0.0	6.7	0.2	6.7	4.9	0.2	0.0	0.6	0.0	34.6	2.1	0.1	0.0	1.0	0.0	29.0	0.0	0.5	0.5	0.3	0.0	3.0	0.0	0.6	0.4	0.1	0.0	1.2	0.0	1.5	2.3	4.8	0.9	0.0	0.0	0.3	0.1	7.0	0.4	0.2
RASL11A		ENSG00000122035	"RAS like family 11 member A"	Q6T310	13	27270830-27275192	"Enzymes, Predicted intracellular proteins"	"Transcription, Transcription regulation"	Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Adipocytes: 29.6;Fibroblasts: 30.1;Gastric mucus-secreting cells: 42.3;Sertoli cells: 32.9;Smooth muscle cells: 112.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"non-classical monocyte: 1.3"	"Low lineage specificity"	"Detected in many"			"Cell line enriched"	"Detected in many"	4	"ASC diff: 42.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA004859, HPA053296"	Supported		Approved	"Nuclear bodies"		Yes	No			"Cluster 51: Monocytes - Innate immune response"	"Cluster 72: Non-specific - Transcription"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 48: Smooth muscle cells - ECM organization"	"Nuclear bodies"		"HPA004859: AB_2667270, HPA053296: AB_2682106"	"unprognostic (1.59e-1)"	"unprognostic (9.11e-2)"	"unprognostic (2.30e-1)"	"unprognostic (1.17e-1)"	"unprognostic (2.71e-1)"	"unprognostic (2.09e-2)"	"unprognostic (6.65e-2)"	"prognostic favorable (5.43e-4)"	"unprognostic (3.85e-1)"	"unprognostic (7.98e-2)"	"unprognostic (2.65e-2)"	"unprognostic (1.09e-1)"	"prognostic unfavorable (3.52e-4)"	"unprognostic (1.49e-1)"	"unprognostic (2.54e-1)"	"unprognostic (3.71e-2)"	"unprognostic (3.34e-1)"	32.9	4.1	1.9	3.1	3.2	2.3	21.8	3.1	3.1	21.4	2.1	20.4	7.7	21.6	3.9	9.8	22.0	3.8	11.3	3.2	1.7	30.4	12.9	13.0	10.8	1.8	2.2	9.5	4.9	1.4	10.6	2.9	2.0	20.3	12.5	0.1	5.3	5.6	3.5	10.1	20.9	5.5	2.2	14.8	13.4	2.9	3.3	1.2	12.1	1.7	10.0	19.1	15.9	2.4	0.3	1.3	0.3	0.6	42.4	4.3	0.2	1.9	1.8	0.1	0.1	8.1	0.8	0.3	0.5	1.4	0.9	0.1	2.5	0.8	0.1	1.7	8.8	1.8	0.2	0.5	6.8	0.6	0.6	5.0	0.7	0.1	0.1	1.7	0.6	0.7	0.3	0.1	0.0	0.8	0.0	2.4	1.5	8.0	10.2	0.5	0.0	0.2	1.4	6.2	0.7	0.3	0.7	3.3	0.2	1.0	0.2	0.8	0.3	0.1	0.3	2.9	0.4	0.1	0.0	0.0	0.4	1.9	0.1	0.4	0.4	0.4	0.0	0.5	0.1	0.1	0.0	0.0	0.2	1.2	0.1	0.1	0.2	0.1	1.3	0.1	0.0	0.1	1.9	3.2	3.1	3.1	3.2	1.7	1.8	2.2	2.0	2.2	3.3	2.4	29.6	16.0	11.2	0.3	6.0	4.6	3.2	0.9	17.6	0.0	6.2	11.9	1.4	0.0	8.6	7.3	0.0	0.7	4.5	9.3	3.9	1.8	0.0	5.1	9.8	5.9	0.0	4.0	0.6	2.4	0.2	30.1	42.3	6.1	0.0	2.1	2.5	0.2	1.4	0.0	0.6	5.6	4.1	0.8	6.5	0.0	0.3	6.1	1.8	1.9	1.7	0.3	0.0	0.5	1.8	0.5	12.7	1.5	17.1	1.1	11.4	1.7	10.3	0.2	32.9	11.6	112.0	0.0	0.0	13.5	4.4	0.8	4.5	1.2	6.7	1.1
RASL11B		ENSG00000128045	"RAS like family 11 member B"	Q9BPW5	4	52862317-52866835	"Enzymes, Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 27.6;ovary: 66.4"	"Cell type enhanced"	"Detected in many"		"Collecting duct cells: 33.1;Cytotrophoblasts: 102.6;Extravillous trophoblasts: 62.2;Granulosa cells: 26.6;Peritubular cells: 68.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"BEWO: 14.1;CACO-2: 11.1;NTERA-2: 15.2;RPTEC TERT1: 10.2;SH-SY5Y: 38.5;SuSa: 10.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA057803	Uncertain		Approved	"Nuclear bodies"		NA	NA			"Cluster 40: NK-cells - Unknown function"	"Cluster 89: Fibroblasts - ECM organization"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 47: Cytotrophoblasts - Unknown function"	"Nuclear bodies"		"HPA057803: AB_2683533"	"unprognostic (1.60e-1)"	"unprognostic (1.95e-1)"	"unprognostic (7.32e-3)"	"unprognostic (1.19e-1)"	"unprognostic (2.47e-1)"	"unprognostic (6.87e-3)"	"unprognostic (1.22e-1)"	"unprognostic (7.66e-2)"	"unprognostic (7.45e-3)"	"unprognostic (4.95e-2)"	"unprognostic (9.71e-2)"	"unprognostic (8.72e-2)"	"unprognostic (7.20e-4)"	"unprognostic (7.17e-2)"	"unprognostic (1.35e-1)"	"unprognostic (5.00e-6)"	"unprognostic (1.10e-1)"	2.0	2.0	3.1	0.5	3.8	0.0	1.1	2.8	5.8	4.5	0.1	0.9	0.0	9.8	2.7	0.5	4.1	0.9	14.7	5.2	3.2	17.9	0.6	1.0	0.8	0.3	0.4	66.4	0.9	7.9	0.7	4.7	0.2	2.0	0.1	0.3	1.4	9.1	0.4	3.8	0.9	1.9	0.2	27.6	4.1	5.9	1.4	0.1	1.0	0.1	0.9	2.2	4.9	3.2	0.3	0.0	5.9	0.0	5.2	2.4	14.1	0.1	0.1	0.3	0.0	11.1	0.0	0.0	0.5	0.0	0.1	0.0	0.7	3.5	0.0	0.0	1.4	0.5	0.0	0.0	1.0	0.0	0.4	2.5	6.2	0.0	0.2	0.0	0.0	0.3	0.7	0.0	0.0	1.3	1.1	0.0	15.2	1.3	0.2	0.0	6.8	0.0	10.2	1.5	3.2	38.5	0.2	2.6	1.3	10.1	1.5	0.1	0.0	0.0	2.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.5	0.0	0.2	0.0	0.0	3.1	3.8	2.8	5.8	5.2	3.2	0.3	0.4	0.2	0.2	1.4	3.2	1.1	6.4	0.0	0.3	0.9	0.9	1.5	2.8	0.0	4.9	7.5	6.5	5.3	0.0	1.8	33.1	0.0	102.6	1.5	7.1	0.0	1.5	0.4	1.6	6.9	1.2	0.0	0.0	2.7	0.5	62.2	4.6	9.7	2.7	0.0	26.6	1.1	0.0	8.0	0.0	1.1	3.6	0.0	0.3	1.7	3.3	24.2	0.8	0.0	4.7	0.6	1.9	0.0	0.5	0.9	0.5	5.6	68.4	0.1	0.5	1.6	0.1	0.1	1.2	0.0	5.8	5.7	4.6	10.9	1.2	0.4	23.1	0.9	6.1	2.8	0.2
RASL12	RIS	ENSG00000103710	"RAS like family 12"	Q9NYN1	15	65053337-65076690	"Enzymes, Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"Astrocytes: 22.5;Peritubular cells: 57.9;Sertoli cells: 98.6;Smooth muscle cells: 55.7"	"Cancer enhanced"	"Detected in all"		"glioma: 21.2"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"ASC TERT1: 5.0;CACO-2: 14.5;EFO-21: 22.7;NTERA-2: 9.9;SuSa: 17.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"									NA	NA				"Cluster 57: Non-specific - Angiogenesis"	"Cluster 38: EFO-21 - Unknown function"	"Cluster 48: Smooth muscle cells - ECM organization"				"unprognostic (6.13e-3)"	"unprognostic (1.06e-1)"	"unprognostic (2.47e-2)"	"unprognostic (6.95e-2)"	"unprognostic (1.39e-1)"	"unprognostic (1.21e-2)"	"unprognostic (4.10e-2)"	"unprognostic (1.40e-1)"	"unprognostic (1.29e-3)"	"unprognostic (1.60e-1)"	"unprognostic (4.45e-2)"	"unprognostic (1.51e-1)"	"prognostic unfavorable (7.20e-5)"	"unprognostic (1.76e-2)"	"unprognostic (4.72e-2)"	"unprognostic (1.21e-1)"	"prognostic unfavorable (2.17e-4)"	27.9	3.9	32.9	5.1	36.8	0.0	15.7	30.8	24.4	49.8	8.5	35.6	3.6	61.6	27.9	19.2	54.7	13.2	53.4	26.0	38.4	6.9	1.1	38.4	3.3	39.4	57.4	16.5	2.4	1.8	7.0	17.0	38.0	52.5	6.7	3.3	8.0	76.4	37.1	12.1	9.4	33.0	38.8	9.6	7.7	15.6	66.1	0.9	8.4	20.6	1.7	40.2	33.5	32.6	0.1	0.1	0.2	0.0	0.6	5.0	0.2	0.0	0.5	0.0	0.0	14.5	0.1	0.0	22.7	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	9.9	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	17.3	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	32.9	36.8	30.8	24.4	26.0	38.4	39.4	57.4	38.0	38.8	66.1	32.6	7.4	0.0	0.0	22.5	0.0	1.5	3.9	0.0	0.0	0.3	2.0	5.6	16.3	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	4.7	0.3	12.6	3.6	0.0	0.0	0.1	0.0	0.1	15.2	0.5	0.5	0.0	12.3	1.4	0.1	0.3	0.0	0.1	0.0	2.0	0.0	1.3	3.9	13.1	0.2	0.0	2.8	0.0	17.9	0.0	0.0	0.0	0.1	0.0	57.9	0.0	0.4	0.5	0.0	0.0	0.8	98.6	0.9	55.7	0.7	1.1	0.4	0.1	0.3	0.2	0.4	0.2	0.1
RECQL	"RecQ1, RecQL1"	ENSG00000004700	"RecQ like helicase"	P46063	12	21468910-21501669	"Enzymes, Plasma proteins, Predicted intracellular proteins"		"DNA-binding, Helicase, Hydrolase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB009743, HPA030960, HPA064259"	Enhanced		Enhanced	Nucleoplasm		NA	NA		25000	"Cluster 15: NK-cells - Transcription"	"Cluster 16: Immune cells - Immune response"	"Cluster 5: NTERA-2 - Transcription"	"Cluster 11: Alveolar cells - Smell perception"	Nucleoplasm		"CAB009743: AB_655306, HPA030960: AB_10794912, HPA064259: AB_2685230"	"unprognostic (9.70e-3)"	"unprognostic (2.55e-2)"	"unprognostic (1.86e-2)"	"unprognostic (6.25e-3)"	"unprognostic (2.47e-1)"	"unprognostic (1.39e-1)"	"unprognostic (8.97e-3)"	"unprognostic (1.89e-3)"	"unprognostic (8.74e-2)"	"prognostic unfavorable (3.15e-4)"	"unprognostic (3.77e-3)"	"unprognostic (3.78e-2)"	"unprognostic (2.85e-1)"	"unprognostic (1.27e-1)"	"unprognostic (1.09e-1)"	"unprognostic (2.99e-1)"	"unprognostic (3.69e-2)"	28.9	17.1	5.8	33.9	7.4	18.7	18.6	6.9	7.1	19.1	7.5	14.9	11.4	22.3	13.7	19.8	14.9	20.6	26.9	5.7	7.1	14.9	15.7	22.9	40.9	8.9	7.3	14.8	9.9	10.8	5.3	22.2	8.5	15.9	18.2	9.9	10.1	17.8	12.5	18.5	13.5	30.4	7.7	31.6	14.5	10.5	8.0	34.3	16.6	19.7	38.4	26.1	10.3	9.1	61.6	61.1	46.5	34.7	94.3	116.1	52.3	119.9	101.6	76.2	88.7	68.5	49.9	73.6	43.5	83.7	94.0	44.3	51.2	60.4	108.5	122.1	31.9	89.8	65.6	30.0	35.9	62.3	66.1	64.8	30.1	109.0	79.1	67.6	87.2	50.6	33.0	36.1	102.3	31.2	70.0	73.6	77.1	18.3	41.6	56.8	184.7	57.2	29.6	42.5	12.8	35.7	86.9	23.6	62.0	159.0	58.3	37.4	115.6	105.9	67.4	93.9	111.6	14.3	46.3	161.3	88.9	35.9	80.2	21.4	18.6	18.0	31.2	32.3	31.5	30.3	29.3	30.9	24.0	26.6	19.1	26.7	8.7	36.9	31.0	17.8	44.8	24.0	5.8	7.4	6.9	7.1	5.7	7.1	8.9	7.3	8.5	7.7	8.0	9.1	56.1	22.4	18.8	6.2	45.0	23.6	15.4	23.3	22.2	11.8	14.7	14.7	8.7	10.0	22.1	14.7	14.6	13.0	59.0	5.8	9.8	20.3	1.4	15.9	41.0	45.7	9.7	30.3	15.1	24.8	27.5	45.6	7.7	17.6	52.6	23.1	30.7	15.9	27.9	15.2	9.4	6.5	12.2	35.3	26.1	2.2	22.1	50.8	30.2	12.2	50.6	16.9	64.9	10.1	19.1	31.8	4.2	37.6	33.5	7.3	4.3	12.4	25.1	10.8	13.1	33.1	34.9	7.6	12.7	20.8	42.9	3.6	53.6	31.8	8.0	10.5
RECQL4	RecQ4	ENSG00000160957	"RecQ like helicase 4"	O94761	8	144511288-144517845	"Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins"		"Helicase, Hydrolase"	"Cancer-related genes, Cataract, Craniosynostosis, Disease variant, Dwarfism"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 25.4;testis: 22.4"	"Cell type enhanced"	"Detected in many"		"Spermatocytes: 23.5;Spermatogonia: 20.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in single"							"CAB017800, HPA025821"	Supported		Enhanced	Nucleoplasm		NA	Yes			"Cluster 32: T-cells - Unknown function"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 12: Non-specific - Cell cycle regulation"	Nucleoplasm		"CAB017800: , HPA025821: AB_1856168"	"unprognostic (5.92e-2)"	"unprognostic (1.86e-1)"	"unprognostic (2.05e-1)"	"unprognostic (1.18e-1)"	"unprognostic (9.17e-2)"	"unprognostic (3.17e-2)"	"prognostic unfavorable (1.91e-4)"	"unprognostic (1.12e-2)"	"unprognostic (4.12e-2)"	"unprognostic (7.53e-2)"	"unprognostic (2.65e-2)"	"unprognostic (4.26e-2)"	"unprognostic (1.12e-3)"	"unprognostic (8.82e-3)"	"unprognostic (1.74e-1)"	"unprognostic (2.24e-1)"	"unprognostic (1.34e-1)"	1.7	1.8	3.0	5.8	3.7	25.4	2.0	7.7	7.0	2.9	0.1	4.7	6.0	2.5	0.4	13.3	2.1	2.1	1.8	2.6	1.6	2.5	2.7	2.3	6.8	6.9	2.3	2.7	3.1	0.7	3.1	2.5	7.4	8.6	1.6	1.5	5.8	0.8	2.5	10.1	5.2	1.0	1.7	6.5	3.2	22.4	4.1	7.4	3.4	0.5	2.5	2.5	3.1	3.6	33.7	58.8	27.0	57.1	1.6	2.6	47.1	33.2	5.9	24.2	20.2	58.4	48.4	22.8	21.5	5.6	14.2	40.1	18.0	14.2	6.6	40.3	68.6	82.4	118.5	44.3	0.5	21.2	65.7	3.3	2.1	27.1	5.5	3.4	6.8	45.4	83.3	28.9	8.5	104.1	77.3	56.9	18.8	27.8	69.5	80.0	21.2	37.9	6.7	35.8	52.9	32.0	45.2	37.3	12.1	7.4	45.5	45.7	9.2	38.9	117.4	47.3	62.6	16.0	18.1	39.3	22.4	64.6	39.9	0.0	0.0	0.0	0.2	0.2	0.0	0.3	0.1	0.2	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	3.0	3.7	7.7	7.0	2.6	1.6	6.9	2.3	7.4	1.7	4.1	3.6	0.7	0.0	0.0	2.0	2.2	1.5	0.7	0.9	1.2	2.7	3.7	2.7	1.8	1.5	0.5	0.0	4.2	3.9	1.0	5.9	0.0	0.5	3.9	2.1	0.9	0.7	0.0	6.1	2.0	0.4	8.1	1.8	4.6	2.0	0.0	8.8	0.0	0.7	3.6	0.0	1.6	4.1	0.0	0.6	1.1	7.4	1.2	1.0	0.0	0.0	0.3	0.3	1.0	0.0	0.8	0.3	0.2	1.5	9.1	0.7	0.7	0.5	0.7	1.7	0.0	1.4	1.2	23.5	20.6	6.6	1.0	1.5	1.2	0.5	7.0	0.7
RECQL5	"FLJ90603, RecQ5"	ENSG00000108469	"RecQ like helicase 5"	O94762	17	75626845-75667189	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Cell division, DNA damage, DNA repair, DNA replication"	"Helicase, Hydrolase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Gastric mucus-secreting cells: 42.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA029971			Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 10: Basophils - Unknown function"	"Cluster 71: Testis - DNA repair"	"Cluster 20: HeLa - Mitochondria"	"Cluster 44: Endometrium - Transcription"	Nucleoplasm	Cytosol	"HPA029971: AB_10611389"	"unprognostic (2.19e-1)"	"unprognostic (6.16e-3)"	"unprognostic (2.26e-2)"	"prognostic unfavorable (1.73e-6)"	"unprognostic (8.39e-2)"	"unprognostic (2.34e-2)"	"unprognostic (3.57e-3)"	"unprognostic (5.83e-2)"	"unprognostic (3.15e-1)"	"unprognostic (5.84e-2)"	"prognostic favorable (4.34e-4)"	"unprognostic (4.07e-2)"	"unprognostic (7.01e-2)"	"unprognostic (6.37e-2)"	"unprognostic (1.42e-1)"	"unprognostic (4.78e-1)"	"unprognostic (1.81e-2)"	7.8	12.0	8.4	12.8	10.3	10.9	9.5	8.1	11.5	11.0	8.2	10.8	22.4	10.4	10.0	20.6	11.4	12.2	7.3	8.1	8.0	18.4	16.4	8.1	18.2	9.9	9.2	13.0	10.9	16.3	20.7	10.2	9.0	12.3	9.6	8.9	14.9	8.7	7.5	21.7	22.9	7.1	7.5	16.1	23.4	19.1	10.9	12.7	20.6	6.4	14.4	10.3	13.4	15.1	19.1	34.6	14.0	19.3	19.1	13.7	31.5	14.1	12.0	18.2	16.1	15.1	19.7	22.8	14.8	12.5	23.7	17.8	14.4	17.2	16.6	12.2	26.7	40.4	46.7	22.0	20.0	13.7	19.5	19.7	20.7	17.9	23.9	21.0	23.4	25.9	21.7	19.4	13.3	16.8	27.5	18.1	8.8	18.6	26.4	21.8	32.3	22.7	15.3	22.0	16.3	16.1	14.9	26.2	19.6	19.3	47.2	10.5	12.1	22.0	25.2	12.5	14.8	27.6	16.8	22.6	18.4	13.0	16.3	6.0	3.3	4.5	3.9	4.1	2.4	3.3	2.5	2.9	3.9	4.3	3.7	2.7	1.9	4.0	2.0	15.7	2.2	3.6	8.4	10.3	8.1	11.5	8.1	8.0	9.9	9.2	9.0	7.5	10.9	15.1	4.9	0.0	11.3	9.1	8.3	1.0	3.3	4.4	3.4	8.3	4.9	5.8	7.3	7.2	6.1	27.6	18.8	8.6	16.2	12.5	5.9	6.1	4.6	13.1	8.1	5.6	4.8	13.0	6.9	3.3	5.2	4.5	42.8	23.9	1.3	11.9	5.7	7.2	5.1	10.1	5.8	9.6	10.2	6.0	0.8	2.2	4.1	9.0	3.6	4.7	3.6	5.1	5.2	8.0	13.3	6.7	9.7	2.6	9.2	3.2	15.0	4.9	14.2	12.9	0.0	4.5	3.8	13.2	11.6	5.4	2.0	11.6	4.0	10.2	6.7	10.0
REN		ENSG00000143839	Renin	P00797	1	204154819-204190324	"Candidate cardiovascular disease genes, Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Predicted intracellular proteins, Predicted secreted proteins"		"Aspartyl protease, Hydrolase, Protease"	"Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	10	"kidney: 162.2"	"Cell type enhanced"	"Detected in some"		"Early spermatids: 6.8;Late spermatids: 28.4;Paneth cells: 5.6;Smooth muscle cells: 10.7;Urothelial cells: 7.0"	"Cancer enriched"	"Detected in many"	8	"renal cancer: 39.4"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A-431: 1.0;BJ: 2.0;HMC-1: 2.6;SK-BR-3: 1.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA005131	Approved				"Secreted to blood"	NA	NA	692000	10000		"Cluster 7: Kidney - Transmembrane transport"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 33: Fibroblasts - ECM organization"			"HPA005131: AB_1079174"	"unprognostic (4.45e-2)"	"unprognostic (3.35e-1)"	"unprognostic (1.62e-1)"	"unprognostic (8.58e-2)"		"unprognostic (2.89e-1)"	"unprognostic (1.23e-2)"	"unprognostic (1.24e-1)"	"unprognostic (1.13e-1)"	"unprognostic (7.20e-3)"	"unprognostic (1.37e-1)"	"unprognostic (1.57e-1)"	"prognostic unfavorable (6.45e-5)"	"unprognostic (1.22e-1)"	"unprognostic (1.70e-1)"	"unprognostic (4.98e-2)"	"unprognostic (6.49e-2)"	1.0	1.4	0.3	0.2	0.9	0.0	0.1	0.0	0.2	4.3	3.2	0.4	0.3	9.6	0.3	0.2	2.3	0.1	1.8	0.2	0.0	162.2	0.7	0.7	0.0	0.3	0.4	16.3	0.0	0.0	0.6	15.2	0.1	0.3	0.2	0.1	0.8	0.8	0.0	0.1	0.1	1.5	0.0	0.1	0.0	0.9	0.2	0.5	0.0	0.0	0.5	5.2	0.3	0.0	1.0	0.0	0.0	0.0	0.1	0.0	0.0	2.0	0.4	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	2.6	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.7	0.1	0.0	0.0	1.8	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.9	0.0	0.2	0.2	0.0	0.3	0.4	0.1	0.0	0.2	0.0	0.0	0.0	1.5	1.0	0.0	0.0	0.8	0.7	0.0	0.7	0.1	0.0	0.2	0.0	0.3	1.8	0.0	0.3	0.0	0.0	0.0	1.2	6.8	0.2	0.5	0.4	0.0	0.0	0.3	1.1	0.2	2.8	0.0	0.5	0.0	0.0	0.0	0.0	0.5	0.0	0.3	0.0	0.0	0.0	0.0	28.4	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	1.0	5.6	0.4	0.0	1.8	0.0	0.0	0.0	0.3	0.0	0.0	10.7	0.3	0.2	0.0	0.0	1.1	0.1	1.3	0.0	7.0
RERG	MGC15754	ENSG00000134533	"RAS like estrogen regulated growth inhibitor"	Q96A58	12	15107783-15348675	"Enzymes, Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"endometrium 1: 104.7"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 202.7;Breast glandular cells: 80.1;Inhibitory neurons: 94.3;Sertoli cells: 92.1;Smooth muscle cells: 80.2"	"Cancer enhanced"	"Detected in all"		"breast cancer: 19.8"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AN3-CA: 15.2;BEWO: 34.1;T-47d: 66.0;U-2 OS: 21.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA041387	Approved		Approved	"Nucleoplasm,Nucleoli fibrillar center,Cytosol"		NA	NA				"Cluster 89: Fibroblasts - ECM organization"	"Cluster 6: T47d - Mammary gland"	"Cluster 48: Smooth muscle cells - ECM organization"	"Nucleoplasm, Cytosol"	"Nucleoli fibrillar center"	"HPA041387: AB_10796669"	"unprognostic (5.33e-2)"	"unprognostic (1.05e-1)"	"unprognostic (7.72e-2)"	"prognostic unfavorable (7.56e-4)"	"unprognostic (8.72e-2)"	"unprognostic (9.42e-3)"	"unprognostic (2.47e-1)"	"unprognostic (2.38e-2)"	"unprognostic (1.85e-3)"	"unprognostic (2.76e-2)"	"unprognostic (5.07e-2)"	"unprognostic (2.69e-1)"	"unprognostic (7.16e-3)"	"unprognostic (2.61e-3)"	"unprognostic (3.30e-2)"	"unprognostic (3.50e-1)"	"unprognostic (2.58e-2)"	30.7	45.4	8.9	6.8	21.0	0.0	42.5	5.9	16.3	32.0	3.5	37.0	4.1	104.7	50.3	15.1	72.7	11.2	14.0	10.2	12.3	37.0	2.5	16.5	4.3	20.7	12.8	29.0	9.8	4.8	1.4	33.3	21.2	17.0	9.3	0.8	10.2	77.5	5.4	10.2	18.0	83.9	7.7	31.4	20.1	9.0	12.8	2.6	5.8	5.8	2.7	17.4	20.0	9.0	0.0	1.6	0.3	15.2	6.0	0.3	34.1	0.0	0.0	0.0	0.0	0.0	0.0	0.5	6.9	0.0	0.1	0.0	0.2	0.2	0.0	0.0	4.3	0.1	5.9	0.0	4.7	0.0	1.9	0.8	1.0	0.0	2.3	0.0	0.0	0.0	0.6	0.0	1.4	0.7	0.2	0.3	1.7	0.0	0.9	0.1	0.0	0.2	5.8	0.3	0.1	2.2	2.5	2.6	0.0	1.0	66.0	0.0	0.0	0.9	21.5	0.4	0.0	0.1	5.7	0.4	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.9	21.0	5.9	16.3	10.2	12.3	20.7	12.8	21.2	7.7	12.8	9.0	10.7	0.0	2.2	202.7	0.4	3.8	8.6	0.9	6.2	1.3	80.1	36.2	1.0	5.7	4.0	7.3	0.0	12.0	0.7	0.0	15.6	9.8	20.9	6.5	9.8	6.0	1.8	0.0	20.2	9.8	14.6	28.7	2.6	1.0	0.0	0.1	2.2	0.0	2.1	3.3	94.3	0.0	18.3	0.0	2.3	16.1	22.1	1.1	7.2	41.2	0.0	5.0	0.0	3.0	1.1	2.2	0.0	32.0	0.0	3.5	0.0	33.7	0.1	0.5	92.1	8.2	80.2	8.3	15.0	12.6	5.5	14.0	1.2	16.1	0.0	5.8
RERGL	FLJ22655	ENSG00000111404	"RERG like"	Q9H628	12	18080869-18320107	"Enzymes, Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Low tissue specificity"	"Detected in many"			"Group enriched"	"Detected in some"	37	"Sertoli cells: 164.3;Smooth muscle cells: 381.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	719	"REH: 230.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA041740	Uncertain		Approved	Nucleoplasm		NA	NA				"Cluster 68: Epididymis - Unknown function"	"Cluster 14: REH - Unknown function"	"Cluster 48: Smooth muscle cells - ECM organization"	Nucleoplasm		"HPA041740: AB_10795694"	"unprognostic (3.53e-2)"	"unprognostic (7.03e-4)"	"unprognostic (6.29e-2)"	"unprognostic (1.56e-1)"	"unprognostic (1.09e-2)"	"unprognostic (4.39e-2)"	"unprognostic (1.10e-2)"	"unprognostic (3.14e-2)"		"unprognostic (5.51e-2)"	"unprognostic (7.26e-2)"	"unprognostic (8.47e-2)"	"unprognostic (1.25e-1)"	"unprognostic (6.76e-3)"	"unprognostic (1.96e-1)"	"unprognostic (2.39e-2)"	"unprognostic (1.66e-2)"	43.5	5.4	14.3	2.5	14.8	0.0	29.1	14.7	41.0	25.3	14.6	14.4	3.0	25.2	37.9	7.2	25.8	10.2	6.6	14.3	16.1	15.9	2.1	4.4	1.2	15.4	15.1	19.8	1.8	1.1	1.6	0.0	15.3	7.1	16.8	0.2	3.8	19.4	6.0	11.9	13.4	16.0	14.6	2.7	7.8	2.9	15.7	1.2	13.4	30.2	1.4	11.2	14.7	15.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	230.5	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	14.3	14.8	14.7	41.0	14.3	16.1	15.4	15.1	15.3	14.6	15.7	15.0	6.9	0.0	0.0	2.0	0.1	4.5	0.3	0.0	4.0	0.0	2.8	5.2	4.1	1.5	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	2.7	0.7	0.7	7.2	0.0	0.0	0.1	0.0	0.5	2.1	0.0	0.2	0.0	0.0	0.0	0.2	0.1	0.0	0.1	0.0	0.0	0.0	6.5	0.4	0.3	0.6	5.4	3.7	0.0	0.0	0.0	0.0	0.2	0.1	0.0	1.5	0.0	0.3	0.0	0.6	0.0	0.1	164.3	0.6	381.7	0.1	1.1	0.8	2.4	0.1	0.9	0.3	0.1	0.4
RGN	"RC, SMP30"	ENSG00000130988	Regucalcin	Q15493	X	47078355-47093314	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"adrenal gland: 184.7;liver: 383.7"	"Cell type enhanced"	"Detected in many"		"Distal tubular cells: 58.7;Granulosa cells: 67.8;Hepatocytes: 175.7;Muller glia cells: 54.5;Peritubular cells: 69.6;Proximal tubular cells: 174.4"	"Cancer enriched"	"Detected in many"	6	"liver cancer: 47.8"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"CACO-2: 21.7;fHDF/TERT166: 6.9;Hep G2: 32.8"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"HPA029102, HPA029103, HPA029104"	Enhanced		Approved	Cytosol		NA	NA		280000		"Cluster 85: Liver - Metabolism"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Cytosol		"HPA029102: AB_10599846, HPA029103: AB_10602097, HPA029104: "	"unprognostic (1.80e-1)"	"unprognostic (1.25e-1)"	"unprognostic (1.39e-1)"	"unprognostic (5.56e-3)"	"unprognostic (8.22e-3)"	"unprognostic (1.32e-2)"	"prognostic favorable (7.55e-4)"	"unprognostic (2.60e-3)"	"unprognostic (2.23e-2)"	"unprognostic (8.38e-2)"	"unprognostic (3.37e-2)"	"unprognostic (1.14e-2)"	"prognostic favorable (5.10e-10)"	"unprognostic (1.69e-2)"	"unprognostic (2.43e-1)"	"unprognostic (7.82e-2)"	"unprognostic (5.22e-2)"	7.8	184.7	19.2	0.7	20.8	0.0	3.4	23.0	19.9	12.2	25.9	8.4	13.2	7.2	4.5	3.2	5.4	5.0	13.9	19.0	20.2	56.7	383.7	18.9	1.0	21.6	19.8	21.4	34.0	5.8	8.8	12.1	20.7	13.4	2.1	8.0	14.4	17.3	11.8	1.5	13.6	4.4	21.3	3.7	11.9	3.5	19.3	0.5	18.9	11.3	0.5	7.6	6.0	21.2	0.0	0.0	0.2	0.0	0.0	0.2	0.5	0.4	0.8	0.0	0.0	21.7	0.0	0.0	1.1	6.9	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	32.8	1.0	0.1	0.0	1.5	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.2	0.0	0.8	0.1	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	2.7	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	19.2	20.8	23.0	19.9	19.0	20.2	21.6	19.8	20.7	21.3	19.3	21.2	0.6	6.4	3.6	16.3	0.6	0.5	4.9	0.2	1.8	9.6	2.4	7.0	27.5	8.6	0.7	14.7	0.0	0.1	0.0	0.2	58.7	13.9	0.4	3.4	7.4	2.4	4.8	2.7	10.8	8.9	0.3	11.2	3.1	0.5	0.0	67.8	11.4	175.7	0.1	5.0	4.9	0.2	0.0	5.3	1.2	2.1	24.8	1.2	1.8	4.7	0.0	54.5	0.0	27.2	13.7	5.0	1.2	69.6	0.7	1.1	0.2	174.4	1.7	3.1	13.1	22.3	11.3	0.2	0.2	0.5	0.3	0.3	0.7	14.5	0.7	1.3
RHBDD1	DKFZp547E052	ENSG00000144468	"Rhomboid domain containing 1"	Q8TEB9	2	226835581-226999215	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Apoptosis, Differentiation, Spermatogenesis"	"Hydrolase, Protease, Serine protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 66.9;Microglial cells: 57.1;Oligodendrocyte precursor cells: 55.8;Oligodendrocytes: 109.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"U-698: 73.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA013972, HPA057125"	Approved		Supported	"Endoplasmic reticulum"		NA	NA			"Cluster 23: Antigen presenting cells - Antigen presentation"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 57: B-cells - Immune response"	"Endoplasmic reticulum"		"HPA013972: AB_2178629, HPA057125: AB_2683343"	"unprognostic (1.42e-1)"	"unprognostic (5.37e-2)"	"unprognostic (3.26e-1)"	"unprognostic (5.23e-2)"	"unprognostic (2.57e-1)"	"unprognostic (2.91e-1)"	"unprognostic (1.17e-2)"	"unprognostic (2.07e-2)"	"unprognostic (1.18e-1)"	"unprognostic (9.40e-2)"	"unprognostic (4.74e-3)"	"unprognostic (4.97e-2)"	"unprognostic (1.16e-1)"	"unprognostic (1.79e-1)"	"unprognostic (1.09e-1)"	"unprognostic (9.77e-2)"	"unprognostic (3.04e-2)"	10.3	8.9	11.2	13.6	20.9	11.9	11.5	12.2	13.6	11.6	1.8	11.5	10.3	13.6	12.5	11.5	12.9	10.9	10.3	8.8	15.2	12.0	15.1	9.9	16.1	15.6	15.0	13.6	13.9	16.5	4.4	9.9	17.1	13.1	11.2	7.4	9.6	13.3	8.9	8.8	11.8	14.3	15.7	14.2	11.4	17.4	16.8	37.5	15.6	8.6	16.9	11.5	7.0	22.8	10.7	9.3	9.9	15.1	28.6	28.8	0.0	24.1	20.9	12.6	14.6	8.3	18.7	10.1	19.8	25.2	18.0	11.9	0.1	26.8	23.9	25.1	9.9	15.3	5.9	6.7	31.5	15.2	8.0	25.6	38.2	23.8	51.4	14.3	9.8	26.7	41.7	25.6	13.4	18.9	27.8	8.5	0.0	12.2	10.3	12.0	0.1	14.9	10.3	13.3	9.7	7.3	13.6	5.1	18.8	17.6	14.1	18.9	13.1	5.6	12.2	22.0	7.5	28.8	14.9	73.9	17.8	19.6	16.2	10.4	13.7	12.8	7.3	20.0	11.8	22.1	11.0	8.9	17.2	24.5	12.6	10.6	3.3	11.8	13.8	21.1	16.2	10.8	11.2	20.9	12.2	13.6	8.8	15.2	15.6	15.0	17.1	15.7	16.8	22.8	6.6	12.8	6.4	66.9	28.4	5.2	8.5	7.2	8.0	8.0	7.6	4.2	16.6	4.3	8.1	11.0	16.7	7.6	9.3	6.6	3.9	7.0	16.7	8.3	8.6	6.8	1.8	15.2	28.4	9.3	4.1	9.3	8.2	7.8	8.2	22.7	3.3	14.0	5.2	11.8	41.5	6.1	6.1	8.2	4.4	24.4	5.6	7.6	12.4	57.1	6.2	6.3	9.2	55.8	109.0	8.3	1.9	6.8	48.8	13.2	6.8	3.4	7.1	6.3	0.0	5.6	6.6	15.2	9.5	7.3	5.5	5.6	8.6	25.7	5.7	8.9
RHBDL1	"RHBDL, RRP"	ENSG00000103269	"Rhomboid like 1"	O75783	16	675671-678268	"Enzymes, Predicted membrane proteins"		"Hydrolase, Protease, Serine protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 17.7"	"Cell type enhanced"	"Detected in many"		"Bipolar cells: 17.6;Excitatory neurons: 30.1;Inhibitory neurons: 27.1;Ionocytes: 18.3;Rod photoreceptor cells: 31.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"HeLa: 9.8;MCF7: 9.2;U-266/70: 10.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA030359, HPA030360, HPA046593"	Uncertain		Approved	Nucleoplasm		No	No			"Cluster 48: NK-cells - Unknown function"	"Cluster 10: Brain - Neuronal signaling"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 9: Photoreceptor cells - Phototransduction"	Nucleoplasm		"HPA030359: AB_2673445, HPA030360: AB_2673446, HPA046593: AB_2679711"	"prognostic favorable (8.12e-4)"	"unprognostic (1.70e-1)"	"unprognostic (7.38e-2)"	"unprognostic (4.45e-1)"	"unprognostic (2.07e-1)"	"unprognostic (1.58e-2)"	"unprognostic (3.27e-2)"	"unprognostic (1.94e-1)"	"unprognostic (2.78e-1)"	"unprognostic (6.60e-3)"	"unprognostic (2.74e-2)"	"unprognostic (3.97e-2)"	"unprognostic (5.63e-3)"	"unprognostic (5.89e-2)"	"unprognostic (1.27e-1)"	"unprognostic (8.30e-3)"	"unprognostic (1.49e-2)"	0.8	5.0	9.2	0.4	9.7	1.0	1.0	9.1	17.7	2.0	0.0	2.2	2.4	1.0	0.6	1.2	1.6	0.4	2.4	7.9	6.1	4.1	2.0	1.1	0.4	5.5	4.8	2.1	2.6	0.6	8.3	0.3	4.9	2.7	0.3	2.1	2.4	0.9	0.5	2.6	2.5	0.2	3.2	0.9	2.7	4.2	7.4	1.4	0.9	0.0	0.1	1.5	1.5	7.7	1.7	2.1	1.2	1.8	0.9	2.3	6.1	0.7	1.1	0.4	0.1	4.4	1.2	0.6	1.4	0.4	0.2	1.1	0.1	0.3	0.0	1.5	7.7	0.8	9.8	1.8	0.8	1.6	1.1	1.6	2.8	0.3	0.0	0.9	0.1	2.8	1.3	1.2	0.1	9.2	0.4	4.4	1.1	2.3	0.6	7.6	1.1	1.6	0.1	1.5	1.5	2.0	0.9	0.4	2.2	0.7	3.2	4.5	0.5	2.5	2.2	0.8	0.6	10.5	1.5	2.2	0.9	2.9	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.8	0.0	0.0	0.1	0.1	0.0	0.0	0.4	0.0	0.0	0.3	0.1	9.2	9.7	9.1	17.7	7.9	6.1	5.5	4.8	4.9	3.2	7.4	7.7	0.6	0.0	0.0	15.3	2.8	2.2	3.8	10.3	12.5	17.6	2.5	4.2	0.9	0.0	2.4	0.0	12.5	0.2	0.3	2.7	0.0	0.7	2.7	1.4	1.1	0.3	2.4	0.0	30.1	0.5	0.2	1.1	3.1	1.0	0.0	1.9	0.4	0.7	0.3	15.2	27.1	6.1	18.3	0.9	1.2	1.4	1.5	0.4	0.0	1.9	0.2	2.9	0.0	10.6	4.1	1.4	3.8	2.6	0.9	1.6	17.3	9.9	10.8	31.8	0.0	0.4	1.2	1.5	1.7	1.4	1.8	0.3	0.6	3.0	5.5	2.8
RHBDL2	FLJ20435	ENSG00000158315	"Rhomboid like 2"	Q9NX52	1	38885807-38941830	"Enzymes, Predicted membrane proteins"		"Hydrolase, Protease, Serine protease"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 24.4"	"Cell type enhanced"	"Detected in many"		"Basal respiratory cells: 74.6;Club cells: 44.8;Distal enterocytes: 52.2;Ionocytes: 46.8;Oligodendrocytes: 53.9;Pancreatic endocrine cells: 53.0;Urothelial cells: 49.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"A-431: 12.7;CAPAN-2: 41.7;HaCaT: 21.7;RT4: 40.4"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA043807	Approved					NA	NA			"Cluster 1: Neutrophils - Mixed function"	"Cluster 27: Brain & Skin - Unknown function"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"			"HPA043807: AB_10961118"	"unprognostic (3.34e-2)"	"unprognostic (2.96e-1)"	"unprognostic (4.57e-2)"	"unprognostic (2.56e-1)"	"unprognostic (7.26e-3)"	"unprognostic (2.19e-2)"	"unprognostic (1.04e-3)"	"unprognostic (5.81e-2)"	"unprognostic (2.36e-1)"	"unprognostic (2.87e-1)"	"unprognostic (4.07e-3)"	"unprognostic (1.23e-1)"	"unprognostic (7.47e-9)"	"unprognostic (1.11e-2)"	"unprognostic (2.46e-1)"	"unprognostic (4.12e-2)"	"unprognostic (4.20e-2)"	2.2	0.4	4.1	1.7	8.8	0.4	2.0	5.6	7.1	4.3	0.3	18.0	1.3	0.6	0.2	24.4	1.1	3.4	7.7	4.0	4.9	0.9	0.4	1.0	0.8	10.0	9.5	0.3	0.6	0.3	1.3	1.1	7.3	1.8	18.0	1.1	7.8	0.5	0.5	16.6	0.8	1.1	4.1	0.4	15.7	7.3	7.4	0.7	0.7	0.0	7.1	9.7	12.8	11.4	12.7	4.3	0.4	0.2	0.2	1.2	1.2	0.7	0.1	0.9	0.1	0.9	41.7	0.3	3.0	6.3	4.2	21.7	0.0	7.1	0.6	0.3	0.2	0.2	2.9	2.5	0.5	0.1	0.5	0.9	1.0	6.0	0.1	4.0	1.0	0.4	0.0	0.4	0.9	0.0	0.1	0.3	0.2	1.3	1.2	0.2	0.2	0.0	0.0	40.4	0.4	0.3	5.0	11.4	0.4	0.6	5.6	0.4	0.9	4.4	0.5	0.3	0.3	0.4	0.5	0.5	4.1	0.8	0.2	1.5	0.6	0.4	0.2	0.4	0.1	0.7	0.2	0.1	0.7	0.3	0.2	0.2	1.7	0.3	0.2	0.7	0.3	0.3	4.1	8.8	5.6	7.1	4.0	4.9	10.0	9.5	7.3	4.1	7.4	11.4	1.3	0.0	0.5	11.1	0.7	17.7	8.0	74.6	5.2	2.7	3.9	2.4	0.4	5.7	44.8	3.7	0.0	0.4	0.2	52.2	0.0	12.4	3.9	4.7	3.4	1.4	2.4	0.0	19.0	15.8	0.3	2.1	27.5	8.4	4.5	1.6	1.8	0.0	0.2	1.7	21.9	17.3	46.8	0.0	2.7	1.0	0.6	0.4	1.8	4.7	0.6	1.3	0.0	10.6	53.9	53.0	22.3	0.0	0.2	13.4	0.2	0.3	33.2	1.8	6.6	1.2	4.0	0.3	0.1	19.0	28.4	0.7	0.5	0.2	30.2	49.9
RHBDL3	"RHBDL4, VRHO"	ENSG00000141314	"Rhomboid like 3"	P58872	17	32265832-32324659	"Enzymes, Predicted membrane proteins"		"Hydrolase, Protease, Serine protease"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"brain: 23.0;heart muscle: 13.8;retina: 26.1"	"Cell type enhanced"	"Detected in some"		"Astrocytes: 41.8;Excitatory neurons: 46.8;Horizontal cells: 102.6;Oligodendrocyte precursor cells: 75.9;Rod photoreceptor cells: 34.2"	"Cancer enriched"	"Detected in some"	4	"glioma: 4.3"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A549: 4.6;AF22: 4.7;AN3-CA: 3.8;GAMG: 5.5;HDLM-2: 6.0;NTERA-2: 6.5;U-2 OS: 4.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA059607	Uncertain					NA	NA				"Cluster 58: Brain - Synaptic function"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 62: Horizontal cells - Visual perception"			"HPA059607: AB_2684081"	"unprognostic (7.70e-2)"	"unprognostic (3.71e-2)"	"unprognostic (2.36e-2)"	"unprognostic (6.95e-2)"	"unprognostic (2.91e-1)"	"unprognostic (2.83e-2)"	"unprognostic (2.22e-1)"	"unprognostic (1.93e-1)"	"unprognostic (1.85e-3)"	"unprognostic (1.13e-1)"	"unprognostic (1.82e-3)"	"unprognostic (1.75e-2)"	"unprognostic (4.19e-2)"	"unprognostic (2.18e-3)"	"unprognostic (2.11e-1)"	"unprognostic (1.23e-1)"	"unprognostic (8.87e-2)"	0.4	5.1	9.4	0.4	10.6	0.1	0.4	14.1	23.0	2.2	3.4	0.8	0.2	1.6	0.7	0.5	2.3	0.2	13.8	13.6	9.6	0.6	0.0	0.3	0.1	14.2	19.0	2.2	0.5	0.8	2.9	0.2	15.9	1.6	0.5	26.1	0.3	3.0	0.1	0.3	0.4	0.7	12.1	0.1	0.7	2.0	11.6	0.2	0.3	0.1	0.2	2.3	1.8	14.8	0.0	4.6	4.7	3.8	0.7	0.0	0.1	0.2	0.5	1.4	1.7	0.0	0.0	0.0	0.2	0.5	5.5	0.0	1.2	0.0	0.3	6.0	1.5	0.8	3.1	0.2	0.0	0.0	0.1	0.0	0.0	1.2	0.0	0.2	0.0	0.3	0.5	0.0	0.3	0.1	0.1	0.0	6.5	0.0	0.0	0.8	0.0	0.0	0.0	2.6	0.1	1.3	0.6	0.1	0.1	1.5	0.3	0.0	0.0	0.0	4.4	0.2	2.2	0.0	0.0	0.0	0.2	0.7	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.4	10.6	14.1	23.0	13.6	9.6	14.2	19.0	15.9	12.1	11.6	14.8	0.6	0.0	0.0	41.8	0.0	0.4	0.5	0.0	0.0	12.1	0.8	0.6	7.4	0.0	0.0	0.0	6.2	1.5	0.1	0.0	0.0	0.1	3.2	0.3	0.2	0.7	0.0	0.0	46.8	0.0	0.0	0.5	0.0	0.1	0.0	0.4	0.4	0.0	0.4	102.6	15.2	0.4	0.0	0.3	0.3	2.4	0.9	0.1	0.0	4.7	0.0	7.4	0.0	75.9	4.8	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	34.2	0.0	0.1	0.5	0.1	1.2	0.0	0.1	0.5	0.1	0.0	0.0	0.6
RHOA	"ARH12, ARHA, Rho12, RHOH12"	ENSG00000067560	"Ras homolog family member A"	P61586	3	49359139-49412998	"Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, RAS pathway related proteins"	"Cell cycle, Cell division, Host-virus interaction"	Hydrolase	"Cancer-related genes, Disease variant, Ectodermal dysplasia, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB005052	Approved		Supported	"Plasma membrane,Cytosol"		NA	NA		1500000	"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 52: Non-specific - Ribosome"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 10: Non-specific - Unknown function"	"Plasma membrane, Cytosol"		"CAB005052: AB_562216"	"unprognostic (1.50e-1)"	"unprognostic (3.38e-1)"	"prognostic favorable (3.08e-4)"	"unprognostic (8.75e-2)"	"unprognostic (1.63e-1)"	"unprognostic (1.24e-1)"	"prognostic unfavorable (9.15e-4)"	"unprognostic (1.39e-1)"	"unprognostic (8.83e-2)"	"unprognostic (9.44e-3)"	"unprognostic (2.21e-2)"	"unprognostic (4.29e-2)"	"prognostic favorable (3.21e-6)"	"unprognostic (5.14e-2)"	"unprognostic (7.50e-2)"	"unprognostic (1.57e-1)"	"unprognostic (4.52e-2)"	452.4	315.0	234.6	357.9	258.6	473.4	360.0	257.1	274.1	310.4	237.4	351.9	274.6	293.8	298.6	362.6	269.2	267.1	269.6	220.8	271.2	286.9	274.5	430.9	396.3	282.9	245.8	297.2	225.3	269.4	164.3	396.8	287.2	244.5	369.3	113.3	238.0	315.6	331.0	281.3	281.0	416.9	259.3	329.1	292.1	154.1	257.5	387.7	326.3	298.5	454.9	358.2	273.6	292.5	470.4	406.1	500.9	512.7	569.9	858.9	370.8	930.1	735.7	790.3	722.4	347.6	527.4	721.8	251.6	1404.1	448.8	259.5	560.4	630.6	817.6	505.7	323.3	678.8	488.0	416.0	604.2	647.9	472.8	668.2	437.8	643.2	508.1	799.7	1038.0	391.9	361.1	437.9	967.5	254.3	717.3	739.0	441.4	548.2	497.1	325.5	451.4	610.5	701.9	559.6	167.7	387.3	599.0	464.5	495.4	499.4	301.7	819.6	972.1	558.4	483.2	737.2	725.7	388.0	775.6	754.8	567.9	691.6	678.3	716.9	1105.5	1160.5	480.1	1358.8	423.8	432.7	415.6	479.6	806.9	379.3	314.5	397.1	1282.7	440.9	1398.1	645.5	554.9	1884.8	234.6	258.6	257.1	274.1	220.8	271.2	282.9	245.8	287.2	259.3	257.5	292.5	502.8	387.8	265.2	20.5	374.6	270.9	260.0	236.1	251.6	47.1	239.4	223.1	141.1	178.7	220.9	180.3	6.2	355.8	373.1	447.2	340.4	339.5	48.2	174.2	243.7	413.8	234.4	319.3	26.1	347.8	709.8	386.2	313.9	201.0	257.3	141.6	312.7	173.2	760.0	82.4	27.0	344.9	191.2	771.9	495.8	55.6	335.2	683.7	327.3	52.5	710.0	219.9	389.3	24.6	51.4	398.0	354.6	407.7	375.7	334.1	341.3	350.8	201.1	40.8	276.1	354.1	450.1	264.4	253.6	390.8	279.6	525.2	359.5	299.1	347.7	371.4
RIDA	"HRSP12, P14.5, PSP, UK114"	ENSG00000132541	"Reactive intermediate imine deaminase A homolog"	P52758	8	98102344-98117171	"Enzymes, Plasma proteins, Predicted intracellular proteins"		"Hydrolase, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	8	"kidney: 496.2;liver: 1536.9"	"Cell type enriched"	"Detected in many"	5	"Proximal tubular cells: 1579.1"	"Group enriched"	"Detected in all"	5	"liver cancer: 162.2;renal cancer: 42.5"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"OE19: 191.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA022856, HPA023489"	Enhanced					NA	NA		5000000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 85: Liver - Metabolism"	"Cluster 21: OE19 - Mitochondria"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"			"HPA022856: AB_1858253, HPA023489: AB_1858252"	"unprognostic (1.67e-2)"	"unprognostic (3.73e-1)"	"unprognostic (1.29e-1)"	"unprognostic (1.10e-1)"	"unprognostic (4.16e-1)"	"unprognostic (2.20e-2)"	"prognostic favorable (9.61e-6)"	"unprognostic (6.08e-2)"	"unprognostic (1.13e-1)"	"unprognostic (3.15e-1)"	"unprognostic (2.81e-1)"	"unprognostic (4.46e-1)"	"unprognostic (1.55e-1)"	"unprognostic (1.73e-1)"	"unprognostic (2.04e-1)"	"unprognostic (2.08e-2)"	"unprognostic (1.51e-2)"	50.1	48.4	93.1	11.4	96.4	7.5	19.1	95.5	131.7	11.2	83.8	24.5	30.5	8.4	22.7	14.3	9.4	22.7	32.3	89.2	95.0	496.2	1536.9	9.5	10.1	91.6	97.8	23.4	27.0	24.6	10.0	10.8	95.5	19.3	24.6	26.6	16.4	11.6	40.0	10.6	21.8	10.8	92.6	7.4	24.8	17.2	100.0	11.2	15.9	41.0	12.3	15.5	7.9	91.0	44.0	37.5	29.3	36.6	65.5	50.4	33.0	39.7	28.0	26.4	31.0	51.4	28.4	62.5	49.6	29.4	34.5	30.8	65.4	56.9	52.5	22.3	28.6	45.0	25.6	55.6	29.9	17.6	7.0	44.4	19.5	36.6	39.9	32.4	34.2	65.3	82.7	12.9	35.5	57.8	35.6	50.1	47.0	191.4	67.8	41.0	21.7	18.4	64.6	31.6	32.2	15.7	25.5	17.4	29.2	37.4	44.5	23.5	20.9	20.6	12.5	33.7	16.3	31.2	46.1	30.9	35.0	39.0	13.2	0.2	9.0	5.6	6.6	7.8	8.7	13.8	9.4	10.1	11.1	11.5	12.0	13.0	1.9	10.3	8.3	8.5	13.9	8.1	93.1	96.4	95.5	131.7	89.2	95.0	91.6	97.8	95.5	92.6	100.0	91.0	7.8	25.6	22.4	0.0	7.4	0.0	0.0	0.0	0.0	0.0	13.8	15.1	0.0	0.0	1.8	47.8	0.0	31.1	3.2	0.0	285.7	19.7	0.0	25.1	12.3	5.0	0.0	0.0	0.0	8.5	29.9	7.9	0.0	9.4	2.5	17.7	0.0	0.0	24.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.9	0.0	0.0	5.7	0.0	0.0	0.0	0.0	12.2	0.0	0.0	0.8	0.0	0.0	1579.1	5.8	0.0	0.0	0.0	4.9	0.0	0.0	0.0	0.0	14.4	6.3	22.3	0.0	0.0
RIT1	"MGC125864, MGC125865, RIBB, RIT, ROC1"	ENSG00000143622	"Ras like without CAAX 1"	Q92963	1	155897808-155911404	"Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins"		Hydrolase	"Cancer-related genes, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 80.7"	"Cell type enhanced"	"Detected in all"		"Langerhans cells: 107.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA053249	Approved					NA	NA			"Cluster 5: Granulocytes - Unknown function"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 12: NES - Nervous system development"	"Cluster 41: Macrophages - Immune response"			"HPA053249: AB_2682089"	"unprognostic (1.84e-1)"	"unprognostic (1.07e-1)"	"unprognostic (7.27e-2)"	"unprognostic (3.66e-2)"	"unprognostic (1.35e-2)"	"unprognostic (3.11e-2)"	"prognostic unfavorable (8.64e-6)"	"unprognostic (3.80e-2)"	"unprognostic (4.99e-2)"	"unprognostic (1.12e-1)"	"unprognostic (6.45e-2)"	"unprognostic (2.19e-2)"	"unprognostic (9.22e-3)"	"unprognostic (4.82e-2)"	"unprognostic (3.74e-1)"	"unprognostic (1.51e-1)"	"unprognostic (2.33e-3)"	19.8	13.8	10.7	22.9	12.1	80.7	13.3	12.0	13.0	16.6	12.1	14.0	12.7	14.8	15.4	37.3	10.8	18.5	15.7	10.3	11.8	25.1	12.2	22.7	18.3	13.5	12.7	12.8	13.8	16.5	11.0	23.0	13.3	13.8	14.3	16.0	14.4	18.0	10.8	12.8	12.5	21.3	11.6	21.7	19.7	12.2	12.8	21.5	13.4	16.5	23.6	23.6	21.9	13.3	21.0	22.9	42.3	21.7	21.5	26.6	12.0	37.2	37.4	35.2	35.4	24.1	40.0	9.6	50.0	43.9	25.3	24.7	32.0	18.5	29.4	12.9	16.4	21.0	24.4	15.6	55.7	22.5	37.9	37.1	22.5	40.9	27.4	47.7	48.7	19.7	21.0	26.3	54.3	27.3	30.7	14.9	23.0	36.2	13.9	24.0	33.3	19.6	29.9	44.2	19.7	30.7	27.1	51.1	34.8	76.9	37.3	29.4	62.5	31.7	22.3	27.3	30.7	31.1	30.9	38.8	33.9	22.8	43.0	22.8	41.0	46.9	19.5	25.5	15.6	16.9	16.8	18.5	31.1	17.1	20.2	18.1	106.3	28.8	29.3	12.5	23.8	30.0	10.7	12.1	12.0	13.0	10.3	11.8	13.5	12.7	13.3	11.6	12.8	13.3	45.8	48.1	23.9	12.4	22.4	28.9	36.5	43.7	21.6	8.1	17.4	12.3	14.2	8.6	40.4	18.4	10.4	14.5	41.8	14.1	21.5	39.4	10.4	20.4	25.7	50.5	12.6	16.4	5.1	23.4	16.8	20.8	13.3	32.5	14.0	15.2	24.7	7.0	50.7	6.7	5.3	11.5	42.7	45.6	107.9	10.3	7.2	62.6	33.8	11.2	79.2	25.9	16.5	8.5	8.1	28.3	15.4	15.8	13.4	48.8	15.4	70.6	21.9	11.9	26.3	18.2	26.1	12.7	23.2	26.0	30.7	33.5	32.7	20.7	10.0	79.2
RIT2	"RIBA, RIN"	ENSG00000152214	"Ras like without CAAX 2"	Q99578	18	42743227-43115691	"Enzymes, Predicted intracellular proteins"		"Calmodulin-binding, Hydrolase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	5	"brain: 25.9"	"Group enriched"	"Detected in some"	5	"Excitatory neurons: 225.8;Oligodendrocyte precursor cells: 202.5"	"Cancer enriched"	"Detected in single"	49	"glioma: 4.7"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"							"HPA072174, HPA072526"	Enhanced		Supported	"Nucleoplasm,Golgi apparatus,Cytosol"		NA	NA				"Cluster 69: Cerebellum - Gene expression regulation"		"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	Nucleoplasm	"Golgi apparatus, Cytosol"	"HPA072174: AB_2732195, HPA072526: "					"unprognostic (1.37e-2)"							"unprognostic (4.15e-1)"			"unprognostic (2.14e-1)"			0.0	1.9	9.3	0.1	10.6	0.0	0.0	25.9	16.8	0.1	5.3	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.8	13.3	0.0	0.0	0.0	0.0	12.8	9.2	0.0	0.0	0.0	0.5	0.0	17.4	0.0	0.1	1.9	0.0	0.0	0.0	0.0	0.1	0.0	8.9	0.0	0.0	0.2	11.6	0.0	0.0	0.0	0.0	0.0	0.2	8.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.3	10.6	25.9	16.8	8.8	13.3	12.8	9.2	17.4	8.9	11.6	8.8	0.0	0.0	0.0	5.5	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.1	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.8	0.2	0.0	0.1	0.0	0.0	225.8	0.0	0.6	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	42.5	0.0	0.0	0.0	0.0	1.4	0.3	0.0	0.0	3.7	0.0	1.0	0.0	202.5	3.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.6	0.0	0.0	0.1	1.4	0.2	0.0	0.0	2.1	0.0	0.5	0.0	0.0
RNASEH1		ENSG00000171865	"Ribonuclease H1"	O60930	2	3541430-3558333	"Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins"		"Endonuclease, Hydrolase, Nuclease"	"Disease variant, Primary mitochondrial disease, Progressive external ophthalmoplegia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"											"HPA034817, HPA043037"	Uncertain		Approved	Nucleoplasm,Cytosol	"Intracellular and membrane"	NA	NA			"Cluster 32: T-cells - Unknown function"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 24: NB-4 - Immune response"	"Cluster 55: Plasma cells - Humoral immune response"	Nucleoplasm	Cytosol	"HPA034817: , HPA043037: AB_2678280"	"unprognostic (1.64e-1)"	"unprognostic (1.38e-1)"	"unprognostic (8.81e-3)"	"unprognostic (4.32e-3)"	"unprognostic (1.79e-1)"	"unprognostic (1.18e-1)"	"prognostic unfavorable (7.83e-6)"	"unprognostic (9.43e-2)"	"unprognostic (8.46e-3)"	"unprognostic (6.38e-2)"	"unprognostic (2.29e-3)"	"unprognostic (2.67e-1)"	"unprognostic (4.06e-2)"	"unprognostic (2.34e-2)"	"unprognostic (2.11e-1)"	"unprognostic (3.06e-2)"	"unprognostic (2.23e-3)"	10.6	8.7	9.7	9.5	10.6	11.4	9.7	8.2	12.3	8.5	6.8	7.8	7.2	11.7	11.3	9.6	7.8	7.5	13.0	11.1	11.2	7.1	8.1	7.9	10.2	10.1	9.1	8.2	8.7	9.1	3.3	7.9	10.1	9.3	9.5	8.7	7.7	11.8	15.3	9.9	7.8	13.3	9.2	9.0	6.9	7.0	11.7	10.3	9.5	15.0	10.9	8.5	4.7	10.5	11.9	21.4	22.1	22.5	24.9	23.2	17.2	29.0	30.6	24.8	16.5	19.4	13.0	33.6	13.7	31.5	18.8	14.7	32.6	23.2	30.9	12.4	17.5	33.1	18.9	27.5	35.5	42.0	23.3	23.5	24.9	24.2	29.3	18.5	21.5	54.8	33.0	19.4	31.1	9.3	32.7	27.3	34.7	20.6	17.0	26.9	32.0	34.3	21.0	19.7	33.3	48.9	17.8	15.9	27.5	16.7	10.3	22.9	24.8	24.1	11.5	24.7	40.7	36.1	37.5	43.9	43.2	35.1	37.5	0.1	0.6	1.3	1.3	1.2	2.2	1.1	1.0	1.7	0.7	0.6	1.0	2.1	0.5	0.4	1.2	1.5	0.4	0.7	9.7	10.6	8.2	12.3	11.1	11.2	10.1	9.1	10.1	9.2	11.7	10.5	15.6	22.4	6.9	9.1	30.7	7.5	26.1	21.0	13.6	25.7	14.9	12.6	25.9	11.5	14.7	3.7	20.9	32.7	25.4	14.4	37.2	44.3	5.1	9.6	20.8	20.1	15.0	13.5	11.8	48.7	44.3	20.2	17.9	11.0	27.3	17.9	16.8	18.0	30.8	35.3	10.7	16.4	14.2	18.8	8.9	3.4	13.7	16.2	10.6	10.3	32.3	17.5	30.9	7.5	9.8	48.3	9.9	26.4	41.7	50.2	16.6	28.6	14.1	18.8	19.7	23.6	23.4	21.0	27.5	17.8	12.1	36.5	18.9	27.7	15.9	37.9
RNASEH2A	"AGS4, RNASEHI, RNHIA, RNHL"	ENSG00000104889	"Ribonuclease H2 subunit A"	O75792	19	12806584-12813640	"Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins"		"Endonuclease, Hydrolase, Nuclease"	"Aicardi-Goutieres syndrome, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 62.3;Extravillous trophoblasts: 117.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA042692			Enhanced	Nucleoplasm,Cytosol		No	No			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 12: Non-specific - Cell cycle regulation"	Nucleoplasm	Cytosol	"HPA042692: AB_10793981"	"unprognostic (6.74e-2)"	"prognostic favorable (1.18e-4)"	"prognostic favorable (6.18e-4)"	"unprognostic (2.24e-1)"	"unprognostic (2.62e-1)"	"unprognostic (5.13e-2)"	"prognostic unfavorable (8.72e-5)"	"unprognostic (8.48e-2)"	"unprognostic (9.33e-2)"	"prognostic favorable (1.22e-4)"	"unprognostic (3.80e-3)"	"unprognostic (8.71e-2)"	"prognostic unfavorable (6.29e-6)"	"unprognostic (3.40e-3)"	"unprognostic (4.35e-2)"	"unprognostic (5.35e-2)"	"unprognostic (8.60e-2)"	8.9	6.8	7.0	11.8	7.2	28.0	9.0	10.4	9.1	10.8	6.2	10.5	10.3	8.5	4.9	18.3	10.6	4.9	7.6	7.2	6.1	7.4	6.9	7.3	17.1	7.3	6.5	8.9	9.2	5.3	5.4	10.4	7.4	6.0	10.7	8.4	8.6	5.0	8.9	13.9	10.0	8.2	6.0	14.5	9.4	19.8	6.8	24.4	7.5	6.6	18.7	8.2	10.8	9.5	130.0	103.8	94.8	75.7	12.3	23.4	76.2	68.4	40.0	126.3	136.0	76.2	58.7	126.9	106.2	36.6	59.6	79.4	82.6	89.2	83.5	82.7	118.1	67.7	112.9	89.9	7.1	70.6	60.5	10.4	19.7	110.7	43.9	21.4	47.3	114.8	91.2	46.8	82.0	251.4	132.8	83.0	56.4	79.1	167.4	146.1	102.0	113.7	39.6	63.8	119.8	76.7	67.0	39.8	46.7	39.8	76.1	78.4	29.3	129.2	55.7	197.0	126.1	97.6	130.3	108.5	77.4	129.4	105.5	9.4	19.1	17.2	23.9	27.6	23.3	36.8	19.6	22.5	19.0	36.3	15.9	19.6	4.4	44.8	27.7	21.0	25.8	19.1	7.0	7.2	10.4	9.1	7.2	6.1	7.3	6.5	7.4	6.0	6.8	9.5	5.3	0.0	2.6	1.3	15.3	14.0	15.7	22.9	6.8	16.2	2.8	11.7	2.7	12.8	7.6	0.0	4.2	62.3	9.1	11.3	0.0	5.4	16.1	0.8	1.6	9.0	8.4	38.7	2.2	6.0	117.4	10.3	10.7	1.1	3.8	2.5	11.7	4.4	48.9	8.4	3.0	13.9	22.4	9.1	13.2	18.8	8.4	9.3	12.4	1.9	8.5	10.4	14.4	1.0	2.4	2.1	6.8	4.9	33.0	5.3	6.2	1.0	9.5	13.9	6.6	15.6	9.8	51.2	44.9	23.8	13.2	22.7	10.2	0.8	24.8	16.1
RNGTT	"hCAP, HCE, HCE1"	ENSG00000111880	"RNA guanylyltransferase and 5'-phosphatase"	O60942	6	88609897-88963618	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Host-virus interaction, mRNA capping, mRNA processing"	"Hydrolase, Multifunctional enzyme, Nucleotidyltransferase, Protein phosphatase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 108.6;Inhibitory neurons: 110.2;Oligodendrocyte precursor cells: 96.5;Oligodendrocytes: 94.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA003750	Approved		Approved	Nucleoplasm		NA	NA			"Cluster 19: B-cells - Humoral immune response"	"Cluster 34: Non-specific - Transcription"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 57: B-cells - Immune response"	Nucleoplasm		"HPA003750: AB_1856383"	"unprognostic (5.19e-3)"	"unprognostic (1.00e-1)"	"unprognostic (2.82e-2)"	"unprognostic (3.45e-3)"	"unprognostic (4.82e-2)"	"unprognostic (1.10e-1)"	"prognostic unfavorable (1.37e-4)"	"unprognostic (4.48e-3)"	"unprognostic (1.28e-1)"	"unprognostic (4.05e-3)"	"unprognostic (3.76e-2)"	"unprognostic (1.55e-1)"	"unprognostic (2.23e-3)"	"unprognostic (9.83e-2)"	"unprognostic (6.55e-2)"	"unprognostic (1.67e-1)"	"unprognostic (8.08e-3)"	5.3	6.7	4.9	8.2	4.9	9.5	5.6	9.1	5.7	5.2	2.6	4.6	4.2	5.2	3.6	7.2	4.1	3.7	5.3	5.1	7.0	5.3	6.9	4.4	17.2	4.6	5.2	4.8	2.9	6.4	4.9	5.0	5.1	5.3	5.4	10.6	3.5	4.9	5.2	4.4	5.2	6.1	4.6	7.6	4.2	9.3	7.3	14.7	5.6	6.4	17.3	6.2	4.8	5.3	9.2	14.0	21.1	26.2	12.0	12.6	12.4	20.2	13.4	16.4	20.4	15.9	6.8	23.1	16.2	14.9	21.5	11.1	24.7	16.5	29.7	31.8	19.0	30.5	11.4	12.2	9.5	33.2	16.6	7.7	13.8	16.8	15.9	13.6	14.7	12.7	30.9	18.1	23.8	12.0	14.6	22.8	12.5	15.0	11.7	28.6	32.0	13.3	14.0	14.2	12.3	17.3	16.8	9.8	11.1	19.7	10.8	31.8	11.5	13.0	12.0	14.7	27.9	16.1	31.6	13.2	18.9	23.8	24.1	5.2	4.1	7.6	7.8	5.9	7.8	22.9	8.6	9.7	5.8	22.8	9.7	10.1	3.4	10.9	5.5	4.0	9.0	5.4	4.9	4.9	9.1	5.7	5.1	7.0	4.6	5.2	5.1	4.6	7.3	5.3	8.9	0.0	16.2	54.5	60.4	8.3	10.7	6.0	10.8	22.4	6.5	6.1	10.7	7.2	12.9	12.9	39.6	10.4	19.7	8.0	0.0	6.3	17.9	7.9	12.1	7.0	9.1	7.6	108.6	4.9	9.9	9.7	15.8	12.4	8.8	11.0	7.5	10.3	7.8	15.2	110.2	7.0	4.1	9.1	7.3	5.2	5.9	13.6	3.6	69.3	9.8	7.2	18.6	96.5	94.3	7.2	5.1	7.9	42.3	8.6	4.6	6.3	10.1	43.4	6.6	15.8	9.5	23.3	20.1	10.7	8.7	11.8	24.6	8.0	6.7	7.4
RNPEP	APB	ENSG00000176393	"Arginyl aminopeptidase"	Q9H4A4	1	201982372-202006147	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"		"Aminopeptidase, Hydrolase, Metalloprotease, Protease"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Proximal enterocytes: 201.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Group enriched"	"Detected in all"	4	"dendritic cells: 19.8;granulocytes: 22.9;monocytes: 29.9"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036074, HPA036075, HPA061487"	Approved		Approved	"Golgi apparatus"	"Secreted - unknown location"	NA	NA		7800000	"Cluster 52: Eosinophils - Transcription"	"Cluster 37: Intestine - Unknown function"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 45: Enterocytes - Digestion"	"Golgi apparatus"		"HPA036074: AB_2674926, HPA036075: AB_10672999, HPA061487: AB_2684537"	"unprognostic (8.57e-2)"	"unprognostic (3.43e-2)"	"unprognostic (2.81e-1)"	"unprognostic (5.45e-2)"	"unprognostic (2.68e-1)"	"unprognostic (1.74e-2)"	"unprognostic (1.95e-2)"	"unprognostic (2.87e-2)"	"unprognostic (1.93e-3)"	"unprognostic (1.80e-1)"	"unprognostic (1.07e-1)"	"unprognostic (1.28e-1)"	"unprognostic (3.50e-3)"	"unprognostic (1.91e-1)"	"unprognostic (6.00e-2)"	"unprognostic (1.97e-2)"	"unprognostic (1.68e-1)"	25.2	31.1	8.0	22.8	8.3	25.2	25.8	8.1	8.5	26.7	16.1	53.6	68.5	25.6	39.0	53.8	40.6	22.3	14.7	8.5	8.7	25.9	32.4	30.5	22.1	9.9	9.1	23.4	34.1	25.4	13.3	27.5	9.1	25.9	57.0	4.2	38.3	27.6	18.8	37.0	58.1	28.1	9.1	33.4	28.5	17.9	10.6	21.7	33.2	12.7	26.5	23.3	28.8	11.8	66.2	71.0	40.8	62.7	65.1	61.3	102.1	49.5	95.6	60.9	67.6	51.8	83.1	14.3	61.8	87.8	38.0	117.4	52.5	97.2	42.4	39.1	67.6	35.5	32.5	48.7	55.1	92.3	121.3	55.9	97.9	54.1	62.0	74.7	110.6	34.8	82.5	21.6	62.1	61.0	12.8	40.2	58.4	105.4	34.4	48.3	57.5	101.6	128.7	61.2	46.9	39.9	122.2	155.9	52.1	78.9	116.6	52.4	79.9	28.9	38.0	28.7	61.3	45.3	39.6	12.9	27.8	77.3	58.1	22.9	14.9	22.1	3.0	25.9	4.1	2.5	3.2	3.4	19.8	4.6	2.8	3.2	11.0	2.9	29.9	7.2	5.4	4.0	8.0	8.3	8.1	8.5	8.5	8.7	9.9	9.1	9.1	9.1	10.6	11.8	26.7	9.6	21.5	8.5	19.7	28.8	40.5	31.2	40.5	15.5	32.8	33.1	12.2	38.6	26.7	25.8	10.4	116.6	21.4	136.6	19.6	71.1	5.4	35.9	17.7	26.1	44.9	19.0	12.7	51.2	91.1	26.1	45.3	21.5	15.2	23.2	27.1	51.4	103.7	11.8	11.1	71.9	14.2	81.0	39.4	4.9	25.4	72.9	24.9	15.0	86.7	12.6	17.5	5.5	8.1	47.8	83.4	23.0	23.6	25.0	201.7	65.8	39.1	8.0	26.3	11.4	28.2	22.7	9.5	53.6	21.6	87.6	17.7	33.2	86.6	34.8
RNPEPL1		ENSG00000142327	"Arginyl aminopeptidase like 1"	Q9HAU8	2	240565804-240581372	"Enzymes, Predicted intracellular proteins"		"Aminopeptidase, Hydrolase, Metalloprotease, Protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 138.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036772, HPA036773"	Uncertain		Supported	"Nucleoplasm,Nuclear bodies"		NA	NA			"Cluster 5: Granulocytes - Unknown function"	"Cluster 35: Non-specific - Unknown function"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Nucleoplasm	"Nuclear bodies"	"HPA036772: AB_10670848, HPA036773: "	"unprognostic (3.92e-2)"	"unprognostic (7.28e-2)"	"unprognostic (1.20e-2)"	"unprognostic (2.39e-1)"	"unprognostic (5.24e-3)"	"prognostic favorable (7.43e-4)"	"prognostic unfavorable (5.06e-4)"	"unprognostic (3.72e-3)"	"unprognostic (9.10e-2)"	"unprognostic (1.66e-3)"	"unprognostic (3.10e-1)"	"unprognostic (1.71e-1)"	"unprognostic (1.98e-2)"	"unprognostic (5.33e-2)"	"unprognostic (1.57e-1)"	"unprognostic (5.31e-2)"	"unprognostic (9.86e-2)"	40.3	31.4	29.1	14.1	29.6	21.7	32.0	29.0	38.7	15.6	27.0	39.6	20.2	16.8	5.6	52.4	17.0	12.1	79.4	27.9	27.8	42.7	50.6	35.9	23.8	31.5	30.0	12.0	64.2	10.9	9.1	10.6	30.3	34.7	9.5	0.8	28.9	13.1	63.7	35.3	39.8	9.4	31.0	56.4	48.4	9.9	31.4	15.9	19.2	17.1	12.1	34.1	23.2	31.1	13.7	22.4	4.9	13.2	17.6	18.1	16.6	8.6	21.1	9.5	11.6	6.3	39.3	3.9	4.3	21.8	13.3	14.6	5.5	16.1	0.9	23.9	7.7	9.0	7.3	37.2	44.1	5.9	15.5	21.6	25.5	4.9	9.6	15.1	32.8	15.2	6.8	25.7	6.5	19.3	7.5	22.4	6.5	26.5	9.0	15.5	7.4	33.3	39.3	18.5	4.6	9.8	5.8	19.7	39.9	5.6	13.9	26.8	22.7	10.2	10.4	14.4	10.0	24.1	3.9	4.8	20.9	16.6	15.7	9.2	11.2	30.5	14.8	9.9	12.7	8.2	11.3	13.4	8.2	8.7	6.4	9.5	20.0	10.7	10.1	9.5	14.7	7.9	29.1	29.6	29.0	38.7	27.9	27.8	31.5	30.0	30.3	31.0	31.4	31.1	27.9	22.4	25.7	10.4	27.8	7.8	15.0	8.4	2.8	6.4	18.8	9.1	35.6	24.3	12.9	12.9	0.0	7.1	80.4	138.9	17.6	24.6	3.1	12.1	11.0	22.7	26.4	22.3	9.5	49.6	6.8	12.3	104.5	27.4	34.2	31.8	30.0	42.2	43.8	3.3	8.6	58.7	8.2	74.3	21.0	5.9	8.7	47.1	23.2	9.4	52.0	15.9	79.3	5.5	10.3	65.0	70.0	13.5	20.5	20.2	77.1	35.6	7.2	6.9	13.1	14.8	16.4	1.3	8.2	13.0	9.2	5.1	47.9	17.4	60.5	23.0
RPAP2	"C1orf82, FLJ13150, Rtr1"	ENSG00000122484	"RNA polymerase II associated protein 2"	Q8IXW5	1	92299059-92402056	"Enzymes, Metabolic proteins, Predicted membrane proteins"	"Transcription, Transcription regulation"	"Hydrolase, Protein phosphatase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 12.6"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA046443	Approved		Supported	Nucleoli,Cytosol		No	No			"Cluster 11: Basophils - Unknown function"	"Cluster 6: Brain - Smell perception"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 52: Non-specific - Transcription"	"Nucleoli, Cytosol"		"HPA046443: AB_2679669"	"unprognostic (1.29e-1)"	"unprognostic (2.52e-1)"	"unprognostic (3.71e-2)"	"unprognostic (4.12e-2)"	"unprognostic (4.96e-3)"	"unprognostic (5.73e-2)"	"unprognostic (1.23e-3)"	"unprognostic (3.29e-2)"	"unprognostic (8.01e-3)"	"unprognostic (4.09e-2)"	"unprognostic (2.59e-1)"	"unprognostic (6.09e-2)"	"unprognostic (7.02e-4)"	"unprognostic (1.18e-2)"	"unprognostic (1.69e-1)"	"unprognostic (3.62e-3)"	"unprognostic (4.10e-2)"	1.4	1.9	3.2	2.2	4.1	3.9	2.2	12.6	8.7	1.6	0.3	1.4	1.8	2.1	3.2	1.3	1.4	1.5	1.6	3.3	0.9	2.2	3.0	1.4	2.6	1.2	0.2	2.1	2.5	2.0	1.7	1.5	1.8	2.1	1.6	9.3	2.1	1.3	3.0	3.2	1.7	1.5	0.2	2.3	1.8	2.0	1.8	2.8	2.7	2.3	1.9	1.4	1.1	8.4	4.0	2.3	4.1	3.8	3.3	4.2	3.4	3.0	2.1	2.0	1.6	1.7	1.7	5.9	5.1	2.3	2.7	2.7	3.4	1.9	3.0	4.0	2.4	3.5	4.6	2.3	1.9	6.3	3.4	2.1	2.4	2.5	2.5	2.9	2.1	3.6	3.7	3.7	3.0	2.0	5.4	3.9	3.1	2.2	2.7	3.9	5.4	2.5	2.6	3.4	3.8	2.7	4.4	4.5	2.5	3.0	2.3	4.7	3.6	2.8	3.7	3.3	4.4	3.7	4.5	3.0	2.0	3.9	1.9	1.9	0.7	0.6	1.3	0.5	1.5	1.1	1.0	1.1	0.6	1.3	1.0	1.2	1.4	1.3	0.7	1.1	1.0	0.4	3.2	4.1	12.6	8.7	3.3	0.9	1.2	0.2	1.8	0.2	1.8	8.4	23.1	64.1	78.5	66.9	20.1	9.2	16.7	15.7	23.9	63.6	16.3	16.5	24.7	10.0	44.5	7.3	110.5	21.3	31.5	6.4	11.7	19.2	68.1	18.8	48.6	23.4	12.6	13.3	97.1	13.6	14.2	24.8	13.3	17.6	62.0	37.7	9.3	8.0	9.7	35.3	91.3	13.3	14.2	8.7	4.6	9.7	19.0	15.6	1.8	43.1	16.6	31.4	42.2	68.3	78.8	13.8	13.6	21.4	28.5	15.9	11.9	15.6	45.0	95.2	26.3	44.4	20.3	27.3	20.0	16.8	9.8	23.7	35.8	42.3	12.1	10.4
RPE65	"BCO3, LCA2, rd12, RP20"	ENSG00000116745	"Retinoid isomerohydrolase RPE65"	Q16518	1	68428822-68449954	"Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Predicted intracellular proteins"	"Sensory transduction, Vision"	"Hydrolase, Isomerase"	"Disease variant, FDA approved drug targets, Leber congenital amaurosis, Retinitis pigmentosa"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 5.2;choroid plexus: 4.5;retina: 8.4;seminal vesicle: 4.5"	"Group enriched"	"Detected in some"	6	"Cone photoreceptor cells: 10.4;Rod photoreceptor cells: 17.8"	"Group enriched"	"Detected in some"	10	"glioma: 5.8;head and neck cancer: 1.5"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A-431: 3.4;PC-3: 5.6;U-2 OS: 1.3"	"Group enriched"	"Detected in many"	4	"amygdala: 3.2;basal ganglia: 2.5;cerebral cortex: 3.9;hippocampal formation: 2.5"	"Low region specificity"	"Detected in many"									NA	NA				"Cluster 77: Retina - Visual perception"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 46: Photoreceptor cells - Phototransduction"				"unprognostic (1.59e-1)"	"unprognostic (1.88e-1)"	"unprognostic (3.15e-1)"		"prognostic favorable (9.75e-4)"	"unprognostic (4.55e-2)"		"unprognostic (5.91e-2)"	"unprognostic (6.59e-4)"	"unprognostic (2.98e-2)"	"unprognostic (1.57e-1)"	"unprognostic (8.24e-2)"	"unprognostic (3.21e-4)"	"unprognostic (2.11e-1)"	"unprognostic (2.05e-1)"	"unprognostic (3.48e-2)"	"unprognostic (8.40e-3)"	0.0	0.0	1.5	0.0	0.8	0.0	0.4	0.5	0.5	0.2	4.5	0.1	0.2	0.6	0.1	0.3	0.3	0.1	0.0	0.7	3.0	0.0	0.0	0.0	0.0	1.1	5.2	0.0	0.0	0.0	0.0	0.0	2.0	1.8	0.1	8.4	0.1	4.5	0.0	0.0	0.0	0.2	1.7	0.1	0.3	0.1	4.0	0.0	0.0	0.0	0.0	0.2	0.0	1.3	3.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.8	0.5	0.5	0.7	3.0	1.1	5.2	2.0	1.7	4.0	1.3	0.0	0.0	0.0	2.3	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.3	0.1	0.0	0.0	0.0	10.4	0.0	0.0	0.0	0.0	0.0	0.3	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	1.0	0.0	1.3	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	17.8	0.0	0.0	0.2	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0
RPP14	P14	ENSG00000163684	"Ribonuclease P/MRP subunit p14"	O95059	3	58306245-58324695	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"tRNA processing"	"Hydrolase, RNA-binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 40.8;tongue: 39.0"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											HPA036194	Uncertain		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 14: Monocytes - Unknown function"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 48: Smooth muscle cells - ECM organization"	"Nucleoplasm, Cytosol"		"HPA036194: AB_10672082"	"unprognostic (6.05e-2)"	"unprognostic (2.02e-2)"	"unprognostic (1.50e-3)"	"unprognostic (1.36e-1)"	"unprognostic (4.08e-3)"	"unprognostic (2.51e-1)"	"unprognostic (1.30e-1)"	"unprognostic (2.05e-2)"	"unprognostic (1.46e-1)"	"unprognostic (1.09e-1)"	"unprognostic (2.95e-3)"	"unprognostic (3.76e-2)"	"prognostic favorable (3.07e-10)"	"unprognostic (5.19e-3)"	"unprognostic (2.36e-1)"	"prognostic unfavorable (2.96e-4)"	"unprognostic (5.78e-2)"	5.1	5.7	3.1	4.6	3.2	4.8	5.0	5.9	4.1	4.6	2.0	6.8	6.8	5.5	3.7	5.9	4.9	4.2	10.9	3.2	2.9	9.1	11.5	4.1	4.0	3.0	2.2	5.5	6.1	7.7	5.9	4.0	3.1	4.7	6.4	5.1	4.9	4.4	40.8	5.3	6.9	7.1	1.7	5.8	5.4	5.1	3.1	6.5	5.5	39.0	6.0	5.2	5.0	3.4	12.3	10.4	11.5	8.2	6.6	9.0	12.3	9.9	11.7	14.5	17.1	15.9	8.0	13.8	2.4	14.4	13.7	7.2	17.6	15.8	14.8	10.6	8.5	12.0	11.9	8.4	7.8	24.4	10.7	8.4	12.1	18.6	16.3	5.2	12.1	18.2	12.0	7.8	14.3	6.5	16.2	7.9	11.9	10.5	17.9	6.8	8.4	14.0	9.6	18.9	6.9	11.8	10.2	9.8	11.9	7.3	11.0	8.6	11.1	10.4	11.7	10.5	20.4	13.0	28.3	22.3	11.2	17.1	6.7	2.1	3.4	2.6	2.1	2.8	3.0	2.1	2.7	3.2	3.9	3.0	3.2	3.5	4.0	5.5	6.0	3.9	1.8	2.1	3.1	3.2	5.9	4.1	3.2	2.9	3.0	2.2	3.1	1.7	3.1	3.4	9.0	9.6	11.9	6.2	8.2	31.2	8.1	21.1	17.1	26.3	8.2	7.6	28.4	7.2	11.8	3.7	25.0	8.4	9.4	14.9	11.7	5.7	0.8	8.2	12.4	10.6	9.6	7.6	18.4	6.2	5.9	11.5	13.3	8.2	3.8	11.5	11.4	21.3	6.2	18.5	18.2	11.8	16.2	11.0	20.0	1.7	12.5	9.7	23.2	13.1	9.2	13.2	7.2	10.6	11.2	7.8	7.6	9.8	14.2	8.1	16.2	11.4	9.7	28.3	0.0	14.1	13.7	11.9	15.3	20.4	43.0	10.3	9.2	15.0	13.7	6.5
RPP21	"C6orf135, Em:AB014085.3, FLJ22638"	ENSG00000241370	"Ribonuclease P/MRP subunit p21"	Q9H633	6	30345131-30346884	"Enzymes, Predicted intracellular proteins"	"tRNA processing"	"Hydrolase, RNA-binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Basal squamous epithelial cells: 97.3;Squamous epithelial cells: 122.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HEK 293: 49.2;HHSteC: 46.3;JURKAT: 59.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"									NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 72: Non-specific - Transcription"	"Cluster 18: U-2197 - ECM organization"	"Cluster 59: Non-specific - Transcription"				"unprognostic (2.73e-1)"	"unprognostic (1.09e-3)"	"unprognostic (2.83e-1)"	"unprognostic (4.65e-2)"	"unprognostic (1.78e-1)"	"unprognostic (6.46e-2)"	"unprognostic (2.18e-2)"	"unprognostic (8.37e-2)"	"unprognostic (2.86e-1)"	"unprognostic (1.65e-2)"	"unprognostic (2.65e-2)"	"unprognostic (2.76e-2)"	"prognostic unfavorable (1.04e-5)"	"unprognostic (9.54e-2)"	"unprognostic (1.01e-2)"	"unprognostic (4.13e-2)"	"prognostic favorable (6.78e-5)"	34.8	39.6	4.9	0.7	4.4	2.7	36.4	5.0	12.9	46.8	4.1	73.1	0.8	60.2	4.1	62.7	41.6	2.6	38.9	4.6	6.2	35.5	37.7	27.0	2.3	5.4	4.1	42.0	62.1	0.1	35.3	2.5	5.2	42.1	0.0	0.4	36.2	6.8	56.5	46.6	38.8	11.8	5.2	31.8	52.1	34.5	4.6	4.2	31.3	11.0	1.4	56.7	48.2	6.0	34.0	0.0	0.0	14.8	21.8	1.6	18.7	11.7	6.8	26.3	17.6	0.9	0.0	20.4	31.0	7.1	32.1	2.1	0.0	24.4	7.9	26.0	49.2	5.7	0.0	1.0	46.3	0.0	0.0	0.7	5.3	4.1	1.5	5.8	0.1	59.8	5.4	14.4	8.1	2.4	0.0	4.7	16.9	0.0	0.0	4.9	0.0	7.3	12.2	26.9	29.1	11.0	0.0	11.6	34.3	4.6	0.1	0.6	0.8	0.0	0.0	36.0	0.0	12.7	31.1	11.7	0.0	5.3	0.0	60.4	45.4	41.8	25.9	51.8	30.4	86.6	41.2	29.6	35.3	85.2	51.9	33.1	14.4	25.4	53.8	15.9	70.1	41.9	4.9	4.4	5.0	12.9	4.6	6.2	5.4	4.1	5.2	5.2	4.6	6.0	10.6	6.4	18.4	0.0	53.3	35.7	11.4	23.5	97.3	3.2	30.3	27.6	1.2	17.2	28.9	25.8	0.0	12.9	16.7	27.1	7.9	37.0	4.5	17.1	15.1	16.2	42.6	28.8	0.0	60.1	19.3	18.5	68.8	15.8	13.3	5.8	13.6	16.5	10.4	1.7	0.0	29.9	26.4	11.0	20.0	2.1	13.7	17.0	24.9	0.0	14.4	3.0	12.3	0.0	0.0	41.8	42.6	10.5	44.1	8.7	42.7	22.2	13.0	3.3	6.6	9.2	18.5	19.1	25.4	122.9	40.5	11.4	42.3	3.3	33.7	10.2
RPP25	FLJ20374	ENSG00000178718	"Ribonuclease P and MRP subunit p25"	Q9BUL9	15	74954418-74956772	"Enzymes, Predicted intracellular proteins"	"rRNA processing, tRNA processing"	"Hydrolase, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Bipolar cells: 95.1;Hofbauer cells: 77.0;Rod photoreceptor cells: 72.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"plasmacytoid DC: 25.8"	"Group enriched"	"Detected in many"	5	"dendritic cells: 25.8;monocytes: 10.1"	"Cell line enhanced"	"Detected in many"		"HHSteC: 46.0;SCLC-21H: 42.9;SK-MEL-30: 67.4"	"Low region specificity"	"Detected in all"			"Region enhanced"	"Detected in many"		"olfactory bulb: 23.0"	HPA046900	Approved		Supported	"Nucleoplasm,Centriolar satellite"		NA	NA			"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 73: Brain - Neuropeptide signaling"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 56: Bipolar cells - Visual perception"	Nucleoplasm	"Centriolar satellite"	"HPA046900: AB_10962049"	"unprognostic (9.36e-2)"	"unprognostic (7.17e-3)"	"unprognostic (5.54e-2)"	"unprognostic (2.27e-1)"	"prognostic unfavorable (2.24e-5)"	"unprognostic (7.18e-2)"	"unprognostic (5.73e-3)"	"unprognostic (5.50e-3)"	"unprognostic (7.78e-2)"	"unprognostic (1.44e-1)"	"unprognostic (3.58e-2)"	"unprognostic (1.70e-1)"	"unprognostic (4.71e-3)"	"unprognostic (5.50e-3)"	"unprognostic (5.58e-2)"	"unprognostic (1.10e-1)"	"unprognostic (2.53e-1)"	6.0	13.2	7.4	2.7	8.9	0.4	4.5	14.6	8.5	7.1	6.5	7.9	7.2	3.7	1.8	6.9	4.4	4.5	5.5	4.9	10.8	5.1	3.1	5.8	3.9	16.5	12.7	15.4	7.6	23.0	5.2	7.2	16.4	4.2	4.8	12.8	4.6	1.7	1.4	4.9	5.7	2.5	10.8	10.8	7.1	3.0	12.8	2.4	8.9	1.5	3.4	7.7	5.4	12.7	23.6	17.5	4.4	0.1	1.5	0.9	7.4	4.3	5.2	1.3	1.2	24.1	21.0	0.0	19.4	4.4	1.2	6.9	13.7	0.8	0.3	8.9	0.7	0.1	19.9	0.5	46.0	0.0	13.3	5.9	0.6	8.5	0.0	0.9	20.4	5.5	16.1	0.0	4.6	9.1	3.8	6.3	20.8	40.9	7.0	0.1	0.0	15.8	4.2	0.4	42.9	32.1	32.6	28.8	67.4	2.2	5.7	18.7	4.6	0.0	1.4	3.8	0.2	0.4	0.1	0.1	2.3	36.6	25.1	0.0	5.2	0.0	2.3	10.1	1.3	3.4	1.5	1.8	5.1	3.7	3.8	3.0	0.4	0.5	7.7	25.8	0.7	2.5	7.4	8.9	14.6	8.5	4.9	10.8	16.5	12.7	16.4	10.8	12.8	12.7	5.3	3.2	1.1	0.3	4.9	11.0	7.5	9.1	11.4	95.1	11.8	9.9	1.6	14.3	6.4	9.2	4.2	2.3	17.0	24.4	13.7	13.7	0.3	1.6	4.7	8.9	10.2	0.8	0.7	19.3	4.3	23.9	14.8	3.6	0.0	3.4	31.8	1.6	77.0	21.9	10.0	12.5	14.2	14.8	8.6	2.6	39.4	9.3	14.2	1.0	16.1	13.4	4.1	0.0	6.3	13.8	20.5	30.1	8.2	19.1	27.5	16.6	1.3	72.3	13.1	4.3	10.4	1.4	6.5	18.2	11.5	2.3	2.1	26.6	20.7	10.5
RPP30	TSG15	ENSG00000148688	"Ribonuclease P/MRP subunit p30"	P78346	10	90871952-90908553	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"rRNA processing, tRNA processing"	"Hydrolase, RNA-binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA037578	Approved		Approved	"Nucleoplasm,Nucleoli,Microtubule ends,Cytosol"		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	"Nucleoplasm, Nucleoli"	"Microtubule ends, Cytosol"	"HPA037578: AB_10696939"	"unprognostic (1.55e-1)"	"unprognostic (1.77e-3)"	"unprognostic (2.35e-1)"	"unprognostic (4.08e-1)"	"unprognostic (5.64e-2)"	"unprognostic (3.05e-2)"	"unprognostic (3.80e-3)"	"unprognostic (1.27e-1)"	"unprognostic (2.73e-1)"	"unprognostic (1.03e-1)"	"unprognostic (2.27e-2)"	"unprognostic (2.65e-1)"	"prognostic unfavorable (1.01e-6)"	"unprognostic (1.98e-1)"	"unprognostic (9.84e-3)"	"unprognostic (3.43e-2)"	"unprognostic (2.10e-2)"	19.2	13.9	7.8	12.9	8.8	25.9	17.3	8.2	10.6	14.1	7.3	15.3	9.3	15.8	14.1	18.0	14.9	12.7	22.6	8.8	8.4	16.3	15.1	13.1	21.0	7.1	7.3	18.1	11.0	23.0	8.0	18.5	7.6	12.1	15.1	13.2	14.5	12.2	31.1	17.9	12.4	16.4	8.3	15.0	14.3	28.6	7.7	21.7	12.2	22.2	22.4	17.0	14.2	10.6	82.2	53.2	55.0	66.5	34.4	37.6	19.4	57.0	51.1	93.3	98.3	90.6	64.1	48.1	42.6	36.4	60.9	56.0	73.9	50.5	95.3	77.2	51.3	32.7	31.1	73.0	33.0	66.7	39.1	30.9	32.4	70.5	79.1	39.6	54.1	43.5	65.7	42.6	62.6	50.8	77.4	89.8	33.9	46.4	59.8	42.9	46.7	50.4	35.6	38.2	29.9	29.9	33.1	23.8	68.2	50.0	64.8	41.3	31.2	46.3	46.3	26.5	119.6	28.7	79.4	104.4	57.9	35.4	36.4	9.2	30.0	27.1	25.2	30.7	27.5	31.7	28.7	28.0	35.1	28.1	24.6	27.0	3.5	25.4	26.2	32.8	33.0	27.6	7.8	8.8	8.2	10.6	8.8	8.4	7.1	7.3	7.6	8.3	7.7	10.6	31.4	32.1	16.9	14.0	28.7	34.4	27.5	51.8	23.9	19.2	16.7	28.2	45.7	27.1	31.4	14.7	18.8	60.6	33.7	9.4	31.3	41.9	95.9	18.9	26.1	25.2	19.8	38.5	18.0	35.0	68.1	28.0	13.3	17.9	23.5	33.3	21.4	14.3	58.1	16.8	19.4	21.0	30.5	23.9	29.3	49.9	28.9	24.7	23.2	11.2	32.2	23.3	15.5	17.6	19.6	31.3	12.5	29.3	20.6	18.8	12.5	36.5	21.6	24.3	39.5	30.1	36.9	77.9	54.2	20.2	34.0	33.8	23.7	28.6	17.6	27.6
RPP38		ENSG00000152464	"Ribonuclease P/MRP subunit p38"	P78345	10	15097180-15139818	"Enzymes, Predicted intracellular proteins, Ribosomal proteins"	"rRNA processing, tRNA processing"	"Hydrolase, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in all"	4	"Early spermatids: 555.3;Late spermatids: 231.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA045128, HPA050398"	Approved		Supported	Nucleoli		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 23: Spermatids - Flagellum & Golgi organization"	Nucleoli		"HPA045128: AB_2797230, HPA050398: AB_2732560"	"unprognostic (1.75e-1)"	"unprognostic (3.91e-2)"	"unprognostic (3.76e-2)"	"unprognostic (1.51e-1)"	"unprognostic (9.93e-2)"	"unprognostic (1.17e-1)"	"prognostic unfavorable (1.46e-4)"	"unprognostic (1.41e-2)"	"unprognostic (4.86e-1)"	"unprognostic (1.57e-3)"	"unprognostic (3.42e-1)"	"unprognostic (7.21e-2)"	"prognostic unfavorable (6.25e-4)"	"unprognostic (6.13e-2)"	"unprognostic (1.95e-1)"	"unprognostic (5.11e-2)"	"prognostic favorable (2.89e-6)"	14.0	12.9	9.1	12.3	9.4	12.4	19.8	12.4	11.7	14.0	15.1	16.3	15.8	15.0	16.7	16.2	19.3	11.2	13.0	9.4	9.5	17.2	19.4	13.8	20.1	8.9	9.0	14.6	15.2	14.2	13.4	11.5	8.9	13.9	16.7	13.4	14.4	12.1	19.0	17.2	16.6	12.5	8.8	17.7	15.4	48.1	9.3	15.6	16.2	14.8	18.0	17.6	13.3	10.1	40.6	29.4	15.6	20.3	20.7	21.2	27.9	18.7	14.0	29.0	29.3	29.6	40.3	33.2	19.3	17.6	23.7	36.2	31.8	32.4	26.2	26.0	28.6	34.3	17.3	26.2	44.4	19.5	27.5	25.3	43.8	23.4	20.5	21.9	23.2	33.0	40.1	22.7	22.0	32.6	34.9	20.9	18.0	49.0	14.0	28.3	15.9	41.5	37.0	15.3	14.7	18.5	25.7	44.4	53.6	25.6	39.7	30.8	18.8	13.1	22.8	28.3	25.2	31.6	36.5	44.9	25.8	23.3	12.6	21.9	48.5	49.7	49.1	49.0	48.6	58.7	49.7	60.8	51.9	66.0	57.2	52.4	16.2	41.5	40.8	52.3	47.3	43.4	9.1	9.4	12.4	11.7	9.4	9.5	8.9	9.0	8.9	8.8	9.3	10.1	15.5	16.0	22.0	4.2	24.0	31.5	41.9	34.7	14.2	14.2	22.5	26.0	7.1	11.5	40.3	9.2	6.2	30.2	18.6	18.6	27.4	34.2	555.3	54.4	18.7	19.2	13.2	15.2	3.3	33.2	42.1	15.7	16.8	16.0	12.7	15.5	19.6	32.4	24.7	8.4	3.5	25.4	36.7	18.8	12.6	231.1	23.6	13.4	8.8	5.6	21.6	17.7	33.0	4.5	5.5	29.6	16.8	19.9	14.5	46.8	26.9	33.9	89.2	31.0	13.1	14.9	14.6	68.0	34.6	17.2	36.1	32.2	21.5	23.6	24.0	43.8
RPP40	"bA428J1.3, RNASEP1"	ENSG00000124787	"Ribonuclease P/MRP subunit p40"	O75818	6	4994717-5004063	"Enzymes, Predicted intracellular proteins"	"rRNA processing, tRNA processing"	"Hydrolase, RNA-binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Theca cells: 30.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035685, HPA035686"	Uncertain		Approved	Nucleoplasm		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 39: Non-specific - Basic cellular processes"	Nucleoplasm		"HPA035685: AB_2674734, HPA035686: AB_10670153"	"unprognostic (2.93e-2)"	"unprognostic (3.22e-2)"	"unprognostic (1.94e-1)"	"prognostic unfavorable (6.10e-6)"	"unprognostic (8.00e-2)"	"unprognostic (4.78e-2)"	"prognostic unfavorable (5.41e-4)"	"unprognostic (1.20e-1)"	"unprognostic (1.72e-2)"	"unprognostic (6.44e-2)"	"unprognostic (8.17e-2)"	"unprognostic (9.57e-2)"	"prognostic unfavorable (7.54e-8)"	"unprognostic (1.54e-1)"	"unprognostic (5.10e-1)"	"unprognostic (4.08e-2)"	"unprognostic (2.19e-1)"	5.2	11.4	4.4	4.3	4.4	4.9	6.7	4.2	5.7	5.1	3.7	3.4	2.9	4.1	3.6	8.6	3.2	2.9	3.4	4.4	5.3	3.5	7.4	2.0	5.8	4.4	4.5	3.6	3.9	3.8	3.5	3.4	4.6	2.8	3.1	0.7	2.6	2.7	5.6	6.1	2.4	4.6	4.6	4.6	3.0	6.0	5.4	4.7	3.4	3.3	5.4	8.0	5.3	4.7	13.0	21.2	6.6	18.7	11.9	15.1	20.7	12.5	6.3	23.4	18.4	29.0	9.7	27.8	53.6	13.1	32.2	13.4	13.7	19.3	20.9	10.6	27.4	17.5	12.8	39.5	14.0	22.8	9.6	11.8	16.2	23.5	23.0	5.2	23.4	25.2	28.1	5.4	17.3	36.8	11.6	39.0	10.9	15.2	34.0	24.4	12.5	51.0	12.2	13.8	23.5	6.8	11.7	11.1	13.2	17.3	20.2	18.7	11.2	30.6	20.7	20.9	29.1	9.7	43.7	22.0	5.8	37.8	16.1	0.0	7.1	0.0	3.3	11.9	4.9	8.1	5.7	4.1	12.9	7.2	7.6	7.1	0.0	8.6	3.9	6.4	9.1	5.2	4.4	4.4	4.2	5.7	4.4	5.3	4.4	4.5	4.6	4.6	5.4	4.7	7.3	0.0	1.1	2.0	5.3	12.4	10.4	20.6	6.8	0.2	6.3	9.3	4.5	0.0	9.5	1.8	0.0	13.3	3.6	2.2	11.7	7.9	8.1	9.1	13.7	10.9	3.0	2.5	3.6	9.4	14.5	5.8	4.6	4.6	0.0	11.7	6.4	5.5	11.5	0.0	3.1	4.2	6.1	2.5	4.7	3.7	5.6	3.2	8.8	1.9	3.7	1.2	3.1	3.5	3.1	4.3	2.1	4.9	5.7	7.7	0.7	15.1	10.6	0.5	0.0	8.3	8.4	15.1	24.1	12.6	14.8	9.6	3.6	30.8	7.4	7.7
RTEL1	"bK3184A7.3, C20orf41, DKFZP434C013, KIAA1088, NHL, RTEL"	ENSG00000258366	"Regulator of telomere elongation helicase 1"	Q9NZ71	20	63657810-63696253	"Disease related genes, Enzymes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"DNA damage, DNA repair"	"DNA-binding, Helicase, Hydrolase"	"Disease variant, Dyskeratosis congenita"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"B-cells: 1.0;Erythroid cells: 3.8;Gastric mucus-secreting cells: 3.1;Plasma cells: 3.0;Squamous epithelial cells: 1.1"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			"HPA020622, HPA067329, HPA078328"			Approved	"Nuclear speckles,Nuclear bodies"		NA	NA			"Cluster 39: Non-specific - mRNA processing"	"Cluster 71: Testis - DNA repair"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 59: Non-specific - Transcription"	"Nuclear speckles, Nuclear bodies"		"HPA020622: AB_2732425, HPA067329: AB_2685823, HPA078328: AB_2732380"	"unprognostic (3.63e-2)"	"unprognostic (8.08e-3)"	"unprognostic (4.80e-2)"	"unprognostic (1.12e-1)"	"unprognostic (4.27e-1)"	"unprognostic (9.30e-3)"	"unprognostic (2.59e-1)"	"unprognostic (3.64e-2)"	"unprognostic (3.30e-2)"	"unprognostic (9.05e-2)"	"unprognostic (4.09e-2)"	"unprognostic (9.50e-2)"	"unprognostic (8.77e-3)"	"unprognostic (1.17e-1)"	"unprognostic (2.55e-1)"	"unprognostic (2.80e-2)"	"unprognostic (8.84e-2)"	4.9	7.0	1.3	6.1	1.6	8.2	5.2	5.7	4.7	6.8	0.5	8.5	4.8	10.0	3.0	4.6	6.2	3.0	3.9	1.2	0.9	4.1	4.8	6.0	4.2	2.9	0.6	6.4	8.6	2.8	12.2	4.2	1.8	6.7	2.1	2.5	6.3	4.5	5.4	4.5	5.8	3.1	0.2	6.1	6.6	7.6	1.2	4.8	7.8	2.3	2.4	6.5	6.0	1.5	8.3	11.7	7.9	15.5	1.6	1.7	14.5	16.8	4.5	26.0	6.6	22.2	7.0	11.0	8.6	5.2	9.8	15.3	5.5	11.1	6.1	5.5	11.0	13.8	21.2	21.5	5.7	13.4	24.1	2.2	6.0	6.4	7.9	4.9	9.0	19.6	17.4	10.4	5.8	8.7	21.3	17.5	7.8	7.1	22.3	17.2	7.4	11.6	4.1	9.7	15.7	9.3	9.3	27.5	2.2	3.6	7.2	15.2	12.1	29.4	9.5	10.1	13.2	9.4	4.2	7.1	7.1	9.5	10.4	0.0	1.0	0.0	0.9	1.1	0.5	0.3	0.5	0.6	1.3	0.5	0.9	0.4	0.0	0.1	1.0	1.1	0.5	0.8	1.3	1.6	5.7	4.7	1.2	0.9	2.9	0.6	1.8	0.2	1.2	1.5	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.6	0.1	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.0	0.0	0.1	0.0	0.5	0.6	0.0	3.8	0.0	0.0	0.0	0.4	3.1	0.1	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.4	3.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.1	0.2	0.0	1.1	0.1	0.0	0.7	0.0	0.0	0.0
RUVBL1	"ECP54, INO80H, NMP238, Pontin52, RVB1, TIH1, TIP49, TIP49a"	ENSG00000175792	"RuvB like AAA ATPase 1"	Q9Y265	3	128064778-128153914	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Cell division, DNA damage, DNA recombination, DNA repair, Growth regulation, Mitosis, Transcription, Transcription regulation"	"Activator, Chromatin regulator, Helicase, Hydrolase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Endometrial ciliated cells: 147.0;Respiratory ciliated cells: 221.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA019947, HPA019948"	Enhanced		Supported	Nucleoplasm,Cytosol		NA	NA		81000	"Cluster 15: NK-cells - Transcription"	"Cluster 71: Testis - DNA repair"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 49: Ciliated cells - Cilium organization"	"Nucleoplasm, Cytosol"		"HPA019947: AB_1856516, HPA019948: AB_1856514"	"unprognostic (7.40e-2)"	"unprognostic (2.17e-1)"	"unprognostic (1.28e-1)"	"unprognostic (4.73e-2)"	"unprognostic (3.55e-1)"	"unprognostic (2.66e-2)"	"prognostic unfavorable (1.21e-8)"	"unprognostic (2.43e-2)"	"unprognostic (3.31e-2)"	"unprognostic (1.39e-1)"	"unprognostic (2.25e-2)"	"unprognostic (7.39e-2)"	"unprognostic (2.98e-2)"	"unprognostic (1.73e-1)"	"unprognostic (1.51e-1)"	"unprognostic (1.61e-1)"	"unprognostic (9.27e-2)"	20.2	18.7	6.4	10.1	6.3	8.6	18.5	6.1	7.0	17.7	9.8	16.2	5.1	23.1	5.8	26.0	27.5	5.0	25.8	6.2	6.3	24.6	17.2	17.2	13.1	7.3	8.7	15.3	13.9	14.6	17.3	12.7	7.5	13.1	8.5	7.4	14.0	6.9	19.1	17.7	15.2	10.0	6.4	22.3	14.8	29.4	6.5	15.7	15.4	6.0	16.1	19.2	18.5	6.8	75.1	66.2	40.1	65.6	30.5	29.4	52.2	35.8	30.5	67.3	45.9	69.7	43.2	105.0	34.8	34.2	52.2	58.4	107.2	75.6	77.6	43.4	52.3	87.8	36.3	47.4	31.4	82.9	27.0	30.2	39.1	56.5	72.1	25.6	45.6	39.4	72.9	24.4	38.7	105.9	89.7	64.6	101.1	83.5	55.8	72.4	48.4	73.4	40.7	27.6	66.8	60.1	39.6	32.4	55.9	36.8	58.5	61.8	29.8	30.5	37.2	46.4	55.2	24.3	41.6	103.0	37.4	50.2	39.2	1.3	7.3	2.5	15.6	11.9	20.1	15.6	18.7	19.6	11.3	15.7	15.6	17.6	0.3	15.9	11.9	12.6	30.5	11.0	6.4	6.3	6.1	7.0	6.2	6.3	7.3	8.7	7.5	6.4	6.5	6.8	26.1	22.4	15.3	12.7	22.7	20.0	23.7	61.6	25.0	17.4	17.4	21.8	20.9	21.5	37.3	22.0	2.1	53.7	31.3	7.8	46.9	40.9	21.2	147.0	50.8	27.4	16.9	20.4	12.6	30.1	65.4	22.9	17.3	23.8	26.0	35.7	12.8	14.6	29.9	23.5	14.6	14.0	28.5	8.8	8.2	67.1	15.2	14.6	10.6	4.7	13.3	28.1	11.3	9.0	10.0	27.1	11.1	18.4	27.3	34.5	4.6	59.2	221.3	19.7	13.1	16.1	32.3	94.8	75.0	27.9	16.9	24.1	29.1	84.7	23.4	15.6
RUVBL2	"ECP51, INO80J, Reptin52, RVB2, TIH2, TIP48, TIP49b"	ENSG00000183207	"RuvB like AAA ATPase 2"	Q9Y230	19	48993562-49015970	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"DNA damage, DNA recombination, DNA repair, Growth regulation, Transcription, Transcription regulation"	"Activator, Chromatin regulator, Helicase, Hydrolase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in all"	4	"Early spermatids: 614.5;Late spermatids: 945.1;Respiratory ciliated cells: 253.6;Spermatocytes: 394.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB012432, HPA042880, HPA067966"	Enhanced		Supported	Nucleoplasm,Centrosome,Cytosol		NA	NA		53000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 43: Testis - Unknown function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 31: Spermatids - Spermatogenesis"	"Nucleoplasm, Cytosol"	Centrosome	"CAB012432: , HPA042880: AB_2678210, HPA067966: AB_2685933"	"unprognostic (1.71e-1)"	"unprognostic (9.06e-3)"	"unprognostic (3.51e-1)"	"unprognostic (3.93e-2)"	"unprognostic (1.19e-1)"	"unprognostic (2.47e-2)"	"prognostic unfavorable (9.28e-4)"	"unprognostic (7.06e-3)"	"unprognostic (6.25e-2)"	"unprognostic (3.28e-1)"	"unprognostic (8.13e-2)"	"unprognostic (7.58e-2)"	"unprognostic (2.81e-2)"	"unprognostic (2.21e-2)"	"unprognostic (7.61e-3)"	"unprognostic (1.61e-1)"	"unprognostic (2.58e-1)"	23.4	21.7	41.4	26.7	42.9	51.4	22.6	44.6	54.6	23.5	48.9	29.8	27.9	19.3	15.3	36.7	72.2	15.8	37.0	44.7	42.6	19.4	24.0	19.6	30.8	42.4	45.8	25.8	34.5	28.2	6.5	24.0	44.2	20.2	17.4	14.9	32.5	25.4	60.3	30.7	24.7	19.0	41.4	20.6	22.6	110.7	43.8	38.9	23.8	39.1	21.3	22.6	7.2	52.3	236.5	346.0	63.3	250.2	45.0	50.9	88.8	105.4	86.3	214.9	162.5	267.4	148.7	219.9	78.5	106.8	93.7	134.6	99.9	210.3	68.5	99.2	323.7	158.8	196.7	241.0	119.1	318.8	96.8	78.0	68.0	145.0	113.5	59.2	114.1	232.8	266.6	121.3	90.5	195.2	234.1	218.5	122.6	162.4	152.4	227.4	156.9	155.8	110.5	182.7	155.7	169.9	132.2	164.2	66.2	30.4	125.9	179.4	104.8	100.8	135.1	63.8	318.1	171.4	177.1	223.6	76.2	174.6	156.4	51.1	54.9	18.9	42.6	52.4	46.8	54.5	45.2	42.3	65.9	52.6	42.9	40.0	3.7	47.4	48.5	48.9	49.2	55.4	41.4	42.9	44.6	54.6	44.7	42.6	42.4	45.8	44.2	41.4	43.8	52.3	16.5	12.8	20.7	4.2	25.3	27.8	52.0	89.8	37.5	17.5	30.4	33.7	48.5	24.3	55.7	33.1	33.3	104.6	15.0	33.8	46.9	78.3	614.5	131.7	29.6	27.3	17.5	58.1	6.1	71.8	81.8	36.6	28.5	25.4	13.3	32.8	23.2	34.2	51.1	18.5	5.2	38.5	52.9	22.9	25.5	945.1	36.1	18.9	26.6	1.9	35.5	31.2	27.8	4.5	5.6	56.0	30.6	42.9	41.3	43.5	33.1	70.4	253.6	31.4	19.7	28.9	65.4	394.2	43.9	49.2	27.6	115.9	20.8	37.1	61.0	38.8
SACM1L	"KIAA0851, SAC1"	ENSG00000211456	"SAC1 like phosphatidylinositide phosphatase"	Q9NTJ5	3	45689056-45745409	"Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins"		Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039573, HPA069869"	Approved		Approved	"Nucleoplasm,Golgi apparatus"		NA	NA		82000	"Cluster 48: NK-cells - Unknown function"	"Cluster 1: Thyroid gland - Transcription"	"Cluster 32: U-937 - Innate immune response"	"Cluster 24: Non-specific - Transcription regulation"	"Nucleoplasm, Golgi apparatus"		"HPA039573: AB_10674983, HPA069869: AB_2686216"	"unprognostic (2.07e-1)"	"unprognostic (4.08e-1)"	"unprognostic (1.36e-3)"	"unprognostic (1.14e-1)"	"unprognostic (2.31e-2)"	"unprognostic (4.34e-2)"	"unprognostic (2.82e-1)"	"unprognostic (1.03e-2)"	"unprognostic (8.54e-2)"	"unprognostic (1.94e-2)"	"unprognostic (1.22e-2)"	"unprognostic (6.29e-3)"	"prognostic favorable (5.47e-7)"	"unprognostic (3.50e-1)"	"unprognostic (1.62e-1)"	"unprognostic (2.50e-1)"	"unprognostic (1.33e-2)"	23.5	26.3	13.2	26.2	13.8	21.1	22.0	17.1	16.1	22.1	13.6	24.0	23.3	20.6	23.3	20.2	16.9	19.2	16.3	14.0	18.8	38.1	28.2	28.9	26.8	15.5	14.9	16.2	21.8	35.8	10.9	25.0	14.7	24.3	23.6	20.3	22.9	20.6	8.8	18.4	21.6	21.2	14.6	26.2	25.0	14.2	15.9	32.5	43.5	11.4	25.0	22.9	10.8	16.3	31.0	23.0	38.0	22.0	58.8	39.2	29.6	50.1	43.0	36.9	33.1	30.5	21.8	47.8	24.3	39.8	49.8	22.7	50.4	27.0	48.9	34.3	26.8	50.8	38.2	25.7	37.6	78.0	61.5	26.5	41.1	39.9	29.6	29.9	25.6	43.2	57.9	45.7	60.6	14.0	59.5	41.4	40.1	29.6	40.1	17.2	20.0	48.4	41.2	42.7	15.0	36.1	35.5	36.3	44.7	38.0	31.0	64.1	33.7	36.2	21.1	37.0	44.5	25.3	71.7	32.5	45.1	106.8	36.2	10.3	17.1	27.5	24.6	14.2	27.5	11.0	17.8	26.0	27.2	11.9	17.6	23.5	14.1	65.2	13.0	11.1	16.7	27.6	13.2	13.8	17.1	16.1	14.0	18.8	15.5	14.9	14.7	14.6	15.9	16.3	18.4	28.9	37.3	22.5	22.2	19.6	9.1	14.6	22.2	22.8	15.2	12.3	16.6	14.3	15.7	7.3	31.3	22.9	55.4	16.4	19.6	11.1	1.6	15.9	31.9	17.6	12.0	23.4	44.7	10.0	11.2	19.5	17.3	18.5	17.1	17.2	17.2	15.4	24.5	33.7	42.7	9.4	18.3	23.0	18.7	2.9	16.8	22.6	17.8	30.9	25.5	15.8	46.4	40.7	43.6	12.9	20.7	23.0	33.2	14.6	18.5	22.3	14.1	20.7	6.6	15.8	16.6	12.3	12.0	15.7	17.3	18.3	44.5	19.5	13.6	11.6
SARM1	"KIAA0524, SAMD2, SARM"	ENSG00000004139	"Sterile alpha and TIR motif containing 1"	Q6SZW1	17	28364356-28404049	"Enzymes, Predicted intracellular proteins"	"Differentiation, Immunity, Innate immunity, Neurogenesis"	Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Bipolar cells: 27.8;Cone photoreceptor cells: 29.2;Inhibitory neurons: 28.9;Oligodendrocyte precursor cells: 27.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"CACO-2: 32.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA024359, HPA024759"	Uncertain		Supported	Mitochondria	"Intracellular and membrane"	NA	NA			"Cluster 7: Monocytes - Unknown function"	"Cluster 68: Epididymis - Unknown function"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 56: Bipolar cells - Visual perception"	Mitochondria		"HPA024359: AB_1856582, HPA024759: AB_1856581"	"unprognostic (1.40e-4)"	"unprognostic (9.00e-2)"	"unprognostic (2.47e-1)"	"unprognostic (2.41e-2)"	"unprognostic (1.18e-1)"	"unprognostic (1.08e-2)"	"unprognostic (1.27e-1)"	"unprognostic (1.27e-2)"	"unprognostic (1.87e-2)"	"unprognostic (7.01e-2)"	"unprognostic (2.49e-4)"	"unprognostic (6.40e-2)"	"unprognostic (5.20e-2)"	"unprognostic (1.20e-1)"	"unprognostic (2.14e-1)"	"unprognostic (4.84e-2)"	"unprognostic (7.62e-4)"	2.2	5.9	3.9	3.3	3.6	1.4	2.1	7.3	4.2	3.1	1.6	3.3	7.5	4.0	4.0	1.4	3.6	1.5	1.8	3.9	3.1	2.7	3.4	2.0	2.0	3.3	2.7	2.8	7.1	2.6	6.1	1.2	3.2	3.5	2.2	7.0	2.6	4.2	1.5	2.3	5.2	3.5	2.4	4.4	3.3	1.3	3.6	1.1	2.8	1.0	2.1	3.8	1.9	2.8	0.2	3.0	3.8	4.8	2.7	1.9	0.6	2.1	4.1	4.4	2.9	32.2	0.5	0.6	0.2	3.0	2.6	1.3	2.7	0.1	3.7	7.0	1.8	0.0	5.5	0.8	2.0	0.1	1.9	1.3	0.2	2.1	0.6	4.2	0.2	0.9	0.1	2.4	1.2	2.8	0.4	0.0	2.6	0.6	0.2	1.1	3.2	0.8	1.4	2.2	9.9	9.2	9.2	1.3	3.5	1.6	0.4	0.7	0.4	4.0	0.4	1.4	2.9	4.0	2.9	0.6	4.2	0.3	2.0	0.1	0.1	0.0	0.2	0.2	0.2	0.1	0.3	0.3	0.2	0.2	0.2	0.3	0.1	0.3	0.5	0.0	0.4	0.1	3.9	3.6	7.3	4.2	3.9	3.1	3.3	2.7	3.2	2.4	3.6	2.8	2.7	3.2	4.2	19.6	4.0	0.9	1.8	1.2	4.6	27.8	3.1	4.2	0.8	7.2	4.8	3.7	29.2	0.6	2.9	3.0	3.9	4.4	6.6	3.8	5.4	2.9	9.5	0.4	23.5	10.7	0.8	3.5	8.2	3.7	4.5	6.1	3.6	2.3	1.5	21.9	28.9	4.1	2.0	13.8	0.3	3.5	3.4	2.8	3.6	2.8	2.4	6.1	3.1	27.6	14.8	3.4	2.3	1.5	2.6	2.3	9.9	5.9	4.3	17.2	6.6	5.9	4.0	0.3	0.4	3.1	0.6	0.5	4.7	2.0	4.9	1.4
SEC11A	"SEC11L1, sid2895, SPC18, SPCS4A"	ENSG00000140612	"SEC11 homolog A, signal peptidase complex subunit"	P67812	15	84669538-84716460	"Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins"		"Hydrolase, Protease"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA047533			Approved	"Nuclear membrane,Golgi apparatus"		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 10: Non-specific - Unknown function"	"Nuclear membrane"	"Golgi apparatus"	"HPA047533: AB_2680078"	"unprognostic (8.81e-3)"	"unprognostic (1.97e-1)"	"unprognostic (3.19e-2)"	"prognostic favorable (1.94e-5)"	"unprognostic (3.39e-2)"	"prognostic unfavorable (5.99e-5)"	"unprognostic (1.51e-1)"	"unprognostic (1.95e-1)"	"unprognostic (2.79e-1)"	"unprognostic (1.42e-2)"	"unprognostic (6.17e-2)"	"unprognostic (6.24e-2)"	"unprognostic (1.09e-2)"	"unprognostic (1.04e-1)"	"unprognostic (1.80e-1)"	"prognostic favorable (2.95e-4)"	"unprognostic (7.89e-2)"	142.9	138.1	66.2	83.4	69.4	172.2	136.2	69.0	80.4	147.1	76.6	110.8	82.9	111.0	202.5	81.6	103.6	97.5	98.4	63.7	72.6	137.2	152.3	107.9	112.6	74.1	67.2	168.6	139.4	114.6	84.5	115.1	73.9	82.0	124.9	37.0	95.9	87.5	154.3	70.5	86.4	96.3	72.4	86.2	95.3	61.5	69.4	93.2	177.5	147.4	98.2	137.3	94.0	75.3	201.7	320.7	286.7	425.4	368.5	462.8	225.4	310.1	356.5	241.9	291.2	347.1	443.0	99.0	198.8	370.3	277.2	408.3	409.1	243.4	255.5	267.1	239.4	279.4	358.8	324.9	311.7	213.4	281.2	315.8	305.0	169.1	285.1	366.0	337.9	116.7	295.8	244.3	315.1	363.1	89.2	345.8	282.1	266.2	135.4	101.6	368.4	302.9	472.6	424.4	131.2	300.8	257.3	239.5	598.5	407.0	248.5	416.6	254.3	240.0	181.0	209.8	361.9	224.4	509.6	150.0	226.4	331.7	180.6	83.5	161.1	89.7	95.1	173.7	95.0	101.0	114.8	104.7	165.8	90.0	95.1	98.0	111.6	134.3	184.8	160.9	168.8	200.8	66.2	69.4	69.0	80.4	63.7	72.6	74.1	67.2	73.9	72.4	69.4	75.3	261.1	89.8	99.1	25.8	131.8	107.1	179.4	356.6	90.5	30.0	163.7	202.6	68.2	228.8	188.0	128.8	22.9	309.1	171.9	111.1	238.7	258.8	46.3	118.5	268.0	217.2	157.4	101.7	21.2	247.3	655.3	206.0	120.8	184.1	218.4	191.0	197.7	165.5	363.3	20.2	22.8	218.7	168.9	386.7	337.2	100.6	299.5	337.3	158.3	24.4	396.7	110.5	204.9	26.7	38.3	183.4	136.3	166.3	197.9	185.7	142.7	350.9	99.3	38.2	170.9	173.5	225.5	233.5	169.6	135.2	119.9	305.8	153.4	237.6	210.7	242.2
SEC11C	"SEC11L3, SPC21, SPCS4C"	ENSG00000166562	"SEC11 homolog C, signal peptidase complex subunit"	Q9BY50	18	59139866-59158832	"Enzymes, Metabolic proteins, Predicted membrane proteins"		"Hydrolase, Protease"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Ionocytes: 685.6;Muller glia cells: 544.7;Plasma cells: 1164.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HDLM-2: 523.5;Karpas-707: 546.2;RPMI-8226: 1150.0;U-266/70: 587.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA026816, HPA047533"	Approved		Approved	"Nuclear membrane,Golgi apparatus"		NA	NA			"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 22: Non-specific - Unknown function"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 55: Plasma cells - Humoral immune response"	"Nuclear membrane"	"Golgi apparatus"	"HPA026816: AB_10602089, HPA047533: AB_2680078"	"unprognostic (1.47e-2)"	"unprognostic (2.20e-2)"	"unprognostic (1.26e-1)"	"unprognostic (2.44e-2)"	"unprognostic (3.13e-3)"	"unprognostic (4.48e-3)"	"unprognostic (2.95e-1)"	"unprognostic (2.32e-2)"	"unprognostic (1.15e-1)"	"unprognostic (4.33e-2)"	"unprognostic (1.80e-2)"	"unprognostic (1.72e-1)"	"unprognostic (6.25e-2)"	"unprognostic (3.83e-2)"	"unprognostic (4.63e-2)"	"unprognostic (2.58e-1)"	"unprognostic (1.15e-1)"	24.6	76.7	110.0	86.5	117.5	63.1	81.8	122.9	140.5	57.8	94.4	92.3	126.7	40.1	284.6	42.5	41.4	47.3	30.0	112.9	146.4	70.2	219.0	62.7	104.2	137.3	130.2	29.9	374.0	153.9	155.2	28.4	136.8	225.7	78.2	108.1	397.3	62.3	15.7	29.7	97.8	30.1	123.7	81.4	138.5	28.1	113.5	53.0	163.7	20.0	117.8	59.4	21.2	135.8	82.4	100.0	52.9	74.1	31.9	6.8	64.7	72.4	62.9	89.9	55.2	78.3	42.5	176.8	109.9	46.6	67.6	82.8	84.7	59.0	58.4	523.5	113.8	58.5	69.3	242.3	99.3	199.4	87.6	20.4	140.7	56.2	161.1	20.2	33.7	78.4	67.4	546.2	34.6	100.0	79.0	79.2	48.1	140.4	60.5	72.8	50.0	1150.0	67.5	76.1	223.2	90.5	43.1	162.5	252.8	29.9	76.0	148.5	24.7	98.5	45.4	36.5	86.9	587.3	434.4	176.0	99.4	131.8	124.5	76.4	70.7	57.9	146.1	97.6	187.6	197.8	150.4	142.5	78.8	127.9	77.7	105.4	12.2	108.3	108.8	299.6	223.7	222.1	110.0	117.5	122.9	140.5	112.9	146.4	137.3	130.2	136.8	123.7	113.5	135.8	64.8	28.9	120.7	19.2	295.9	32.6	49.3	92.4	12.5	63.6	120.0	128.3	59.3	144.4	102.5	60.7	50.1	70.8	148.7	76.3	88.0	164.4	45.4	58.7	34.2	60.3	339.3	43.8	12.2	263.1	109.1	29.2	60.6	147.1	47.5	21.5	56.4	224.7	112.9	50.5	13.3	223.1	685.6	37.1	56.9	18.8	12.5	63.9	256.1	10.3	46.4	544.7	96.8	17.1	31.2	148.9	78.4	23.0	1164.8	380.9	99.3	118.8	81.3	89.3	6.6	23.1	70.6	110.2	81.5	35.5	45.5	149.7	92.3	40.1	88.3	79.2
SGSH	"HSS, MPS3A, SFMD"	ENSG00000181523	"N-sulfoglucosamine sulfohydrolase"	P51688	17	80206716-80220923	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"		Hydrolase	"Disease variant, Mucopolysaccharidosis"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Theca cells: 32.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HHSteC: 62.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA023436, HPA023451"	Enhanced				"Intracellular and membrane"	NA	NA			"Cluster 39: Non-specific - mRNA processing"	"Cluster 17: Adrenal gland - Steroid metabolism"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 52: Non-specific - Transcription"			"HPA023436: AB_1856806, HPA023451: AB_1856807"	"unprognostic (4.33e-2)"	"unprognostic (4.03e-2)"	"unprognostic (1.06e-2)"	"unprognostic (4.01e-2)"	"unprognostic (4.26e-3)"	"unprognostic (1.39e-3)"	"prognostic unfavorable (7.71e-4)"	"prognostic favorable (2.72e-4)"	"unprognostic (6.08e-2)"	"unprognostic (3.65e-1)"	"prognostic favorable (3.10e-4)"	"unprognostic (2.05e-1)"	"prognostic unfavorable (2.66e-4)"	"unprognostic (1.42e-2)"	"prognostic unfavorable (5.37e-4)"	"unprognostic (7.50e-2)"	"unprognostic (3.68e-2)"	16.6	45.9	1.7	12.2	2.3	3.6	17.2	0.7	5.2	13.5	8.8	14.8	12.7	17.2	4.6	11.0	16.0	10.6	9.9	2.0	5.4	15.7	9.5	18.1	13.4	4.4	7.6	12.3	20.4	16.0	17.0	12.4	4.2	19.7	6.5	2.8	21.8	11.1	7.0	18.9	16.7	10.6	2.5	28.4	17.8	3.9	5.3	4.2	21.2	4.6	6.9	15.5	11.5	1.8	2.6	7.9	9.8	15.6	22.5	20.2	10.4	16.0	40.4	27.7	24.2	9.0	9.5	0.1	25.7	24.9	13.2	9.9	6.2	11.7	4.7	5.3	9.6	0.0	22.3	25.0	62.2	0.0	5.9	33.9	12.0	9.9	10.5	5.8	50.7	4.7	7.1	26.2	17.9	16.2	0.3	0.2	3.3	10.0	13.2	1.4	3.7	21.1	20.2	18.5	2.0	11.7	18.4	44.1	10.6	4.9	32.8	0.5	32.5	31.9	7.0	11.4	7.4	26.1	3.6	3.9	13.6	0.0	16.3	0.0	20.6	0.0	12.1	8.0	16.0	3.5	10.5	11.3	20.4	3.8	8.2	6.7	2.1	9.3	8.0	1.5	13.5	12.7	1.7	2.3	0.7	5.2	2.0	5.4	4.4	7.6	4.2	2.5	5.3	1.8	7.5	3.2	10.8	4.2	5.5	5.1	3.7	5.9	5.7	3.7	9.3	9.3	1.7	5.7	7.3	7.3	8.4	18.2	5.2	12.0	0.0	8.9	0.2	5.3	9.2	10.1	3.0	2.7	2.6	15.9	8.7	10.1	17.9	10.0	0.0	13.6	9.7	4.5	17.7	0.0	3.4	9.3	4.1	18.2	7.6	0.5	11.5	13.0	1.8	2.8	8.4	4.1	6.2	4.5	1.7	6.8	6.0	14.3	5.5	5.5	8.1	4.9	3.8	3.9	13.1	4.0	5.3	0.3	0.5	6.4	5.5	27.0	7.2	32.0	8.0	2.9
SI		ENSG00000090402	Sucrase-isomaltase	P14410	3	164978898-165078496	"Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted membrane proteins"		"Glycosidase, Hydrolase, Multifunctional enzyme"	"Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	150	"intestine: 545.1"	"Cell type enriched"	"Detected in some"	8	"Proximal enterocytes: 1083.9"	"Cancer enhanced"	"Detected in some"		"stomach cancer: 6.9"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BEWO: 1.1;CACO-2: 1.5;HeLa: 1.2;NB-4: 1.3;RPMI-8226: 2.0;SH-SY5Y: 1.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA011897	Enhanced					NA	NA				"Cluster 56: Intestine - Transmembrane transport"	"Cluster 24: NB-4 - Immune response"	"Cluster 45: Enterocytes - Digestion"			"HPA011897: AB_1856840"			"unprognostic (2.71e-2)"								"unprognostic (1.62e-2)"	"unprognostic (2.68e-1)"		"unprognostic (2.05e-1)"	"unprognostic (4.41e-2)"			0.0	0.0	0.0	3.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	17.6	545.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	31.0	0.0	0.0	0.0	0.0	0.0	448.2	0.8	0.0	0.0	0.6	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.2	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	37.1	0.0	0.0	9.7	0.0	0.0	0.1	5.4	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	123.0	0.0	0.0	0.0	5.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	124.7	0.0	0.0	0.3	1083.9	0.1	0.0	0.0	0.0	0.0	0.0	0.9	0.3	0.0	0.0	0.0	0.0	0.0	77.8	0.0
SIAE	"CSE-C, LSE, MGC87009, YSG2"	ENSG00000110013	"Sialic acid acetylesterase"	Q9HAT2	11	124633113-124695707	"Disease related genes, Enzymes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"		"Hydrolase, Serine esterase"	"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"intestine: 104.4"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 2: 58.0;Cardiomyocytes: 59.5;Distal enterocytes: 102.4;Paneth cells: 53.0;Proximal enterocytes: 51.6;Undifferentiated cells: 63.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"basophil: 7.6"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"ASC diff: 88.6;ASC TERT1: 91.3;HSkMC: 98.9;OE19: 97.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038052, HPA038053"	Approved				"Intracellular and membrane"	NA	NA		2200000	"Cluster 18: Basophils - Vesicular transport"	"Cluster 87: Intestine & Kidney - Transmembrane transport"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 53: Intestinal epithelial cells - Unknown function"			"HPA038052: AB_10671518, HPA038053: AB_10673039"	"unprognostic (9.97e-2)"	"unprognostic (1.28e-2)"	"unprognostic (2.48e-3)"	"prognostic favorable (4.66e-5)"	"unprognostic (3.30e-2)"	"unprognostic (5.20e-2)"	"unprognostic (4.90e-2)"	"unprognostic (4.32e-2)"	"unprognostic (1.18e-1)"	"unprognostic (2.26e-1)"	"unprognostic (2.45e-1)"	"unprognostic (9.19e-2)"	"prognostic favorable (4.42e-11)"	"unprognostic (7.24e-2)"	"unprognostic (3.22e-1)"	"unprognostic (4.49e-2)"	"unprognostic (1.92e-2)"	18.7	17.3	16.8	11.8	21.6	3.7	15.9	26.9	19.8	13.0	38.9	97.8	34.3	7.1	34.3	13.6	19.3	16.7	43.8	16.1	27.1	62.1	43.4	20.6	5.8	25.3	23.7	5.7	17.3	45.3	14.4	11.8	24.7	20.4	104.4	6.2	18.4	15.3	26.7	13.0	35.8	10.4	23.0	9.1	19.0	10.3	24.9	3.7	54.0	33.3	6.7	16.8	7.8	26.3	8.9	14.0	8.0	34.6	88.6	91.3	20.9	16.8	24.0	4.3	2.6	10.9	61.4	5.5	24.2	21.5	9.4	17.3	12.8	18.7	4.2	26.0	3.9	8.6	3.7	11.1	41.8	0.7	7.2	98.9	24.9	11.4	17.3	58.5	30.6	11.0	7.1	37.5	14.8	16.5	0.2	0.6	5.0	97.7	28.5	3.2	0.2	8.4	51.4	12.1	2.4	5.1	46.5	18.6	8.0	24.0	36.8	3.2	34.1	23.6	4.3	26.5	4.0	9.4	7.5	0.7	8.3	4.6	9.8	7.6	2.9	0.1	0.4	2.1	0.3	0.5	1.3	0.6	1.9	0.7	1.7	1.1	0.5	0.2	3.7	0.5	0.6	1.8	16.8	21.6	26.9	19.8	16.1	27.1	25.3	23.7	24.7	23.0	24.9	26.3	4.2	19.2	58.0	11.8	2.4	3.2	6.3	6.7	7.4	6.5	10.1	4.3	59.5	12.8	9.4	36.8	0.0	7.6	0.6	102.4	9.8	15.2	14.0	9.1	9.3	6.9	14.5	5.2	15.0	3.8	8.8	7.5	12.8	14.0	1.3	3.9	8.9	30.0	4.5	5.0	9.1	31.0	4.1	3.5	1.6	12.0	3.1	4.3	3.6	6.5	4.5	1.9	1.0	8.0	6.7	5.2	53.0	1.2	3.9	7.4	51.6	26.2	11.9	1.8	0.0	4.9	7.9	14.8	9.6	12.2	5.3	6.7	2.0	8.9	63.6	7.1
SMARCAD1	"DKFZP762K2015, ETL1, KIAA1122"	ENSG00000163104	"SWI/SNF-related, matrix-associated actin-dependent regulator of chromatin, subfamily a, containing DEAD/H box 1"	Q9H4L7	4	94207611-94291292	"Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins"	"DNA damage, DNA repair"	"Chromatin regulator, DNA-binding, Helicase, Hydrolase"	"Ectodermal dysplasia, Palmoplantar keratoderma"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Excitatory neurons: 86.5;Inhibitory neurons: 82.5;Oligodendrocyte precursor cells: 86.5;Oligodendrocytes: 99.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA016737	Approved		Enhanced	Nucleoplasm		NA	NA			"Cluster 41: Basophils - Cellular respiration"	"Cluster 34: Non-specific - Transcription"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 59: Non-specific - Transcription"	Nucleoplasm		"HPA016737: AB_1857271"	"unprognostic (5.01e-2)"	"unprognostic (5.83e-2)"	"unprognostic (2.59e-3)"	"unprognostic (1.23e-1)"	"unprognostic (8.41e-3)"	"unprognostic (9.08e-3)"	"prognostic unfavorable (3.22e-5)"	"unprognostic (2.45e-1)"	"unprognostic (3.49e-3)"	"unprognostic (3.55e-1)"	"unprognostic (2.57e-2)"	"unprognostic (7.72e-2)"	"unprognostic (2.99e-2)"	"unprognostic (1.43e-1)"	"unprognostic (1.95e-1)"	"unprognostic (1.55e-1)"	"unprognostic (3.20e-3)"	10.0	9.5	7.1	11.2	7.8	7.5	15.2	12.0	8.5	10.6	7.5	9.4	9.7	14.5	12.6	10.5	10.7	10.3	7.6	7.3	8.6	11.7	9.8	9.7	16.0	7.2	7.4	14.2	8.7	11.7	11.0	14.1	7.7	11.1	12.3	14.6	8.9	10.0	7.3	20.8	9.5	11.8	7.7	11.9	10.8	12.2	8.2	18.6	15.0	6.8	14.2	11.2	9.7	9.9	15.0	18.6	59.1	38.1	16.5	26.6	30.1	26.8	24.3	21.8	20.3	18.2	23.7	37.8	17.7	23.1	19.8	12.9	42.3	22.4	30.7	29.8	18.7	27.5	20.5	27.2	24.4	41.2	28.9	27.8	17.8	27.3	34.9	27.0	33.7	33.3	46.7	15.5	32.4	12.3	69.1	21.3	40.1	19.1	9.4	40.1	33.6	19.6	24.6	18.4	33.8	49.9	20.1	32.8	28.6	36.7	17.1	26.9	32.3	27.6	29.9	17.1	20.3	21.8	34.8	45.1	25.7	21.2	34.8	2.7	1.3	0.2	2.3	1.7	2.5	2.9	2.6	2.6	2.4	2.4	2.8	3.3	0.0	4.5	1.7	2.1	2.3	1.3	7.1	7.8	12.0	8.5	7.3	8.6	7.2	7.4	7.7	7.7	8.2	9.9	19.0	12.8	11.3	56.2	16.7	11.7	6.5	12.8	25.6	20.9	15.5	13.2	12.7	4.3	24.7	9.2	16.7	13.5	20.1	7.1	1.9	12.4	2.1	27.6	32.3	17.8	9.0	25.5	86.5	10.0	11.8	19.9	17.9	17.9	24.0	29.5	13.2	13.5	10.8	18.5	82.5	12.9	14.2	14.6	5.4	3.1	14.3	13.7	3.6	47.8	12.6	8.1	17.5	86.5	99.5	15.0	6.3	18.4	16.4	7.7	4.4	15.5	26.8	18.8	6.6	21.1	16.2	25.9	34.8	18.7	9.7	9.6	17.3	26.2	12.6	5.8
SMPD1	ASM	ENSG00000166311	"Sphingomyelin phosphodiesterase 1"	P17405	11	6390440-6394998	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted secreted proteins"		"Glycosidase, Hydrolase"	"Disease variant, Neurodegeneration, Niemann-Pick disease"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 131.3;Late spermatids: 200.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"ASC diff: 139.1;fHDF/TERT166: 144.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"								"Secreted to blood"	NA	NA		2700000	"Cluster 15: NK-cells - Transcription"	"Cluster 35: Non-specific - Unknown function"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 53: Intestinal epithelial cells - Unknown function"				"unprognostic (8.76e-2)"	"unprognostic (2.66e-1)"	"unprognostic (6.99e-2)"	"unprognostic (2.28e-3)"	"prognostic unfavorable (7.72e-5)"	"unprognostic (9.46e-2)"	"unprognostic (1.46e-1)"	"unprognostic (4.90e-2)"	"unprognostic (8.06e-2)"	"unprognostic (1.72e-1)"	"prognostic favorable (7.47e-4)"	"unprognostic (4.35e-2)"	"prognostic favorable (4.57e-6)"	"unprognostic (4.27e-2)"	"unprognostic (2.00e-1)"	"unprognostic (1.12e-2)"	"unprognostic (1.71e-1)"	21.8	36.5	38.8	13.9	44.7	7.3	20.1	45.1	43.0	21.2	33.9	25.3	16.8	20.9	14.4	20.6	14.6	21.5	55.8	39.1	43.0	73.7	95.3	31.3	14.6	42.7	42.6	17.9	32.8	34.2	41.9	21.6	43.3	29.4	14.9	8.5	29.0	20.0	37.9	37.9	23.8	17.6	40.9	21.1	25.4	14.0	47.5	17.8	34.0	29.4	11.0	23.6	21.0	46.8	16.4	13.1	10.1	26.5	139.1	72.2	17.1	60.4	95.0	27.7	33.0	22.0	11.9	4.7	27.4	144.0	59.3	7.4	8.4	12.7	13.0	21.0	9.6	5.1	19.5	6.0	62.3	3.7	37.4	96.0	23.4	25.9	17.7	100.9	61.6	1.7	9.1	30.5	58.9	17.0	0.1	6.5	3.9	23.2	22.3	1.2	5.5	7.0	23.9	6.2	17.0	9.7	27.6	19.5	38.5	12.9	7.3	7.0	53.9	103.0	10.9	59.1	15.4	37.6	44.0	3.5	93.7	10.8	47.1	1.9	2.5	3.4	6.4	2.1	5.0	1.5	5.5	5.0	1.3	3.1	10.0	10.1	2.5	6.6	0.6	1.7	4.7	3.2	38.8	44.7	45.1	43.0	39.1	43.0	42.7	42.6	43.3	40.9	47.5	46.8	14.1	25.6	14.4	10.7	12.2	7.9	22.8	15.3	6.8	12.6	13.7	9.0	37.7	24.3	12.8	25.8	25.0	38.8	11.5	131.3	11.7	53.4	50.0	6.2	13.0	18.6	23.8	9.9	5.8	38.2	14.4	31.4	15.8	21.0	10.8	9.4	26.7	88.5	34.1	20.2	5.5	20.3	24.4	15.5	6.2	200.7	11.5	15.8	55.2	4.7	7.8	16.4	36.0	6.6	15.5	24.7	83.1	13.5	23.1	26.0	51.7	75.1	2.4	5.2	0.0	8.9	17.1	1.4	3.1	7.5	8.0	34.3	23.3	10.2	18.0	15.4
SMPD2	"ISC1, nSMase"	ENSG00000135587	"Sphingomyelin phosphodiesterase 2"	O60906	6	109440724-109443919	"Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Lipid metabolism, Sphingolipid metabolism"	Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 53.0"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 179.4;Late spermatids: 359.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA018110, HPA018125"	Uncertain		Approved	"Vesicles,Plasma membrane,Cell Junctions"		NA	NA			"Cluster 26: Non-specific - Mitochondria"	"Cluster 71: Testis - DNA repair"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 31: Spermatids - Spermatogenesis"	"Vesicles, Plasma membrane"	"Cell Junctions"	"HPA018110: AB_1857292, HPA018125: AB_1857293"	"unprognostic (1.61e-1)"	"unprognostic (8.01e-2)"	"unprognostic (1.97e-1)"	"unprognostic (8.79e-3)"	"unprognostic (3.88e-2)"	"unprognostic (2.38e-1)"	"prognostic unfavorable (1.17e-4)"	"unprognostic (7.08e-2)"	"unprognostic (7.59e-2)"	"unprognostic (1.41e-1)"	"prognostic favorable (1.00e-3)"	"unprognostic (3.60e-2)"	"unprognostic (2.14e-3)"	"unprognostic (7.94e-2)"	"unprognostic (2.25e-1)"	"unprognostic (1.45e-2)"	"prognostic favorable (1.70e-4)"	6.9	8.8	7.6	8.6	7.4	12.7	10.5	9.6	7.8	12.6	15.1	12.7	13.5	7.1	15.5	24.5	21.4	8.7	6.7	7.7	6.9	12.2	7.6	9.7	13.3	7.6	7.9	8.2	17.7	22.1	11.1	6.0	7.2	13.2	12.6	6.5	15.6	5.8	4.1	21.7	12.3	4.9	7.6	13.3	14.2	53.0	7.0	10.3	13.3	1.7	17.1	10.4	14.3	8.8	13.1	14.8	7.7	12.2	13.2	7.1	25.5	4.3	15.7	10.5	9.8	14.0	10.3	7.1	9.0	9.3	22.1	16.4	7.8	18.7	6.3	9.1	20.5	8.2	15.9	8.7	11.0	9.1	9.4	7.7	21.3	9.3	18.4	11.8	9.8	12.4	16.3	12.2	5.3	18.7	14.8	19.7	2.1	17.3	7.5	10.4	3.6	7.7	19.3	21.8	10.1	8.4	8.2	24.9	19.3	6.2	7.9	17.2	6.3	4.7	6.8	3.8	16.3	8.3	2.3	4.6	9.1	8.6	8.5	6.2	9.0	10.8	6.9	8.6	7.8	14.4	7.8	8.2	11.2	20.4	5.6	5.9	2.5	7.3	7.8	14.3	8.2	6.0	7.6	7.4	9.6	7.8	7.7	6.9	7.6	7.9	7.2	7.6	7.0	8.8	3.9	12.8	7.2	1.6	15.9	9.8	12.9	13.8	8.6	1.3	8.9	6.7	2.1	7.2	11.8	12.9	4.2	10.3	9.1	26.1	1.9	19.2	179.4	28.4	4.0	4.4	8.4	4.2	1.4	19.8	18.5	6.1	25.0	4.3	0.0	3.5	3.6	3.6	9.5	0.0	0.5	27.1	14.2	4.1	11.2	359.7	9.3	7.2	8.8	2.8	9.9	3.7	6.2	0.0	1.7	15.4	27.7	9.1	9.8	15.0	37.5	9.3	67.1	4.9	13.1	3.1	5.8	69.9	10.9	13.8	18.6	17.0	7.6	8.7	17.8	16.9
SMPD3	NSMASE2	ENSG00000103056	"Sphingomyelin phosphodiesterase 3"	Q9NY59	16	68358327-68448508	"Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Cell cycle, Lipid metabolism, Sphingolipid metabolism"	"Developmental protein, Hydrolase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 61.5;lymphoid tissue: 52.0"	"Cell type enhanced"	"Detected in many"		"dendritic cells: 77.1;Gastric mucus-secreting cells: 70.8;Horizontal cells: 301.2;Proximal enterocytes: 115.1"	"Low cancer specificity"	"Detected in many"			"Group enriched"	"Detected in many"	4	"amygdala: 8.0;basal ganglia: 29.7;cerebral cortex: 24.9;hippocampal formation: 25.4"	"Immune cell enriched"	"Detected in many"	7	"plasmacytoid DC: 138.9"	"Lineage enriched"	"Detected in many"	7	"dendritic cells: 138.9"	"Cell line enhanced"	"Detected in some"		"HMC-1: 9.7;MOLT-4: 14.7;RPMI-8226: 12.4;SCLC-21H: 13.4"	"Region enhanced"	"Detected in all"		"basal ganglia: 115.2"	"Region enhanced"	"Detected in all"		"basal ganglia: 67.7"	"CAB033885, HPA065535, HPA069383"	Approved		Supported	"Endoplasmic reticulum"		NA	NA			"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 56: Intestine - Transmembrane transport"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 62: Horizontal cells - Visual perception"	"Endoplasmic reticulum"		"CAB033885: AB_1126788, HPA065535: , HPA069383: "	"unprognostic (1.21e-1)"	"prognostic favorable (7.72e-4)"	"unprognostic (5.61e-3)"	"prognostic favorable (3.86e-4)"	"unprognostic (2.46e-1)"	"unprognostic (5.85e-4)"	"unprognostic (7.87e-2)"	"unprognostic (8.12e-3)"	"unprognostic (2.77e-2)"	"unprognostic (1.30e-1)"	"unprognostic (1.75e-1)"	"unprognostic (1.81e-1)"	"unprognostic (1.04e-3)"	"unprognostic (5.02e-3)"	"unprognostic (2.49e-1)"	"unprognostic (1.19e-1)"	"unprognostic (1.93e-3)"	6.8	2.1	8.0	3.6	29.7	1.8	2.8	1.8	24.9	2.7	0.1	13.8	61.5	1.4	0.1	2.1	3.8	9.0	1.5	25.4	0.5	4.0	7.4	2.5	4.2	0.0	0.2	4.8	2.6	0.1	16.5	0.2	0.6	4.6	6.9	6.5	3.0	0.3	2.4	13.6	57.7	0.7	0.5	3.4	23.2	8.6	5.1	52.0	2.7	0.0	1.9	1.7	2.5	2.3	0.3	0.8	0.4	0.1	0.0	0.0	5.5	0.4	0.0	0.4	0.1	3.1	1.0	0.4	0.6	0.3	0.2	1.2	0.0	0.0	0.1	0.3	0.7	0.1	2.7	0.3	0.0	0.0	9.7	0.0	0.0	0.0	0.2	0.5	0.0	0.9	0.9	0.3	0.3	0.2	14.7	2.8	0.6	4.9	0.1	0.7	0.2	12.4	0.0	0.1	13.4	2.7	0.4	1.6	0.7	0.2	1.1	0.9	0.0	0.4	0.8	1.4	0.1	2.3	1.2	0.3	0.2	0.9	0.2	4.4	0.0	20.7	2.3	0.1	0.3	1.7	0.2	0.6	0.1	0.9	0.6	0.3	0.1	0.1	0.0	138.9	1.9	1.2	8.0	29.7	1.8	24.9	25.4	0.5	0.0	0.2	0.6	0.5	5.1	2.3	0.3	3.2	1.1	1.0	2.6	0.1	1.5	0.6	0.0	50.8	1.8	0.6	2.9	15.7	1.5	0.0	0.0	0.0	77.1	44.7	0.0	1.3	8.5	3.0	0.3	0.6	25.8	0.4	33.8	0.9	0.1	5.2	70.8	0.5	0.0	0.2	0.7	9.4	0.3	301.2	20.4	34.7	2.0	1.0	0.5	18.6	15.2	2.9	0.0	1.9	0.6	0.9	1.0	10.6	1.7	1.6	39.9	45.9	2.5	3.6	115.1	0.0	14.6	3.9	0.0	0.2	0.3	10.0	2.1	0.1	1.0	0.0	6.2	0.2	21.6	5.4
SMPD4	"FLJ20297, FLJ20756, KIAA1418, NET13, nSMase-3, NSMASE3"	ENSG00000136699	"Sphingomyelin phosphodiesterase 4"	Q9NXE4	2	130151392-130182750	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"		Hydrolase	"Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA046279, HPA049426"	Approved		Approved	"Nuclear membrane,Cytosol"		NA	Yes			"Cluster 39: Non-specific - mRNA processing"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 44: Endometrium - Transcription"	"Nuclear membrane"	Cytosol	"HPA046279: AB_2679611, HPA049426: AB_2680762"	"unprognostic (5.02e-2)"	"unprognostic (9.61e-3)"	"unprognostic (6.31e-2)"	"prognostic unfavorable (7.47e-5)"	"unprognostic (1.69e-1)"	"unprognostic (8.80e-2)"	"prognostic unfavorable (8.37e-6)"	"unprognostic (3.27e-2)"	"unprognostic (1.72e-1)"	"unprognostic (7.47e-2)"	"unprognostic (1.49e-2)"	"prognostic unfavorable (1.73e-4)"	"prognostic unfavorable (8.16e-8)"	"unprognostic (1.74e-1)"	"unprognostic (2.28e-1)"	"unprognostic (1.47e-3)"	"unprognostic (2.09e-1)"	9.9	10.8	4.2	11.1	4.9	25.4	10.9	5.3	6.2	15.5	3.1	12.1	9.5	15.5	5.0	13.8	15.9	9.2	11.7	4.0	7.0	8.6	9.2	10.6	15.7	7.5	5.0	14.6	13.3	15.2	22.7	14.9	6.3	11.8	11.1	4.7	12.9	11.7	13.3	13.5	11.5	12.9	2.4	11.2	10.3	17.7	6.0	19.8	16.0	12.0	15.7	11.8	12.3	10.0	89.1	41.5	46.2	39.2	29.1	21.8	58.7	41.5	42.0	76.3	62.8	119.2	47.0	56.2	41.2	49.9	36.3	43.8	64.0	64.4	40.4	72.7	61.2	60.5	36.2	90.1	31.2	68.5	34.7	25.6	39.4	77.0	27.2	21.1	44.9	51.4	82.2	40.8	40.7	44.3	72.2	32.0	77.0	40.1	56.4	74.3	44.2	59.0	27.0	38.6	66.8	36.3	42.8	54.5	22.7	24.9	37.8	34.8	32.8	57.0	49.3	33.0	49.4	34.3	44.0	79.2	51.4	38.7	44.0	1.8	9.2	14.8	12.9	11.2	14.3	8.9	9.6	11.6	9.6	9.1	9.0	10.5	4.3	12.1	8.1	6.0	9.2	10.4	4.2	4.9	5.3	6.2	4.0	7.0	7.5	5.0	6.3	2.4	6.0	10.0	17.4	3.2	11.3	4.9	20.8	15.0	9.1	8.8	12.0	19.8	21.5	23.0	3.9	5.7	8.0	7.3	12.5	23.8	16.4	7.9	9.8	9.2	22.7	16.0	19.7	12.0	13.1	21.2	6.9	12.2	26.5	12.2	18.8	26.3	6.3	29.0	10.4	17.3	14.1	15.2	6.7	12.8	4.1	13.2	7.7	41.7	14.6	10.2	16.0	1.0	8.8	9.9	11.3	7.5	10.4	11.8	10.5	18.4	27.0	9.4	7.7	5.9	9.9	16.0	0.0	14.1	12.8	25.0	25.6	18.7	20.6	15.6	15.6	16.0	15.2	9.6
SND1	"p100, TDRD11"	ENSG00000197157	"Staphylococcal nuclease and tudor domain containing 1"	Q7KZF4	7	127652194-128092609	"Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins"	"Host-virus interaction, Transcription, Transcription regulation"	"Endonuclease, Hydrolase, Nuclease"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Cytotrophoblasts: 255.0;Syncytiotrophoblasts: 267.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA002529, HPA002632, CAB019323"	Enhanced		Enhanced	Cytosol		NA	NA		1800000	"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 47: Cytotrophoblasts - Unknown function"	Cytosol		"CAB019323: , HPA002529: AB_1857317, HPA002632: AB_1857316"	"unprognostic (2.06e-1)"	"unprognostic (8.27e-3)"	"unprognostic (2.21e-1)"	"prognostic favorable (1.95e-4)"	"unprognostic (5.10e-3)"	"unprognostic (6.83e-2)"	"unprognostic (1.17e-2)"	"unprognostic (2.91e-2)"	"unprognostic (4.22e-2)"	"unprognostic (3.81e-2)"	"unprognostic (1.56e-1)"	"unprognostic (2.30e-1)"	"unprognostic (1.36e-2)"	"unprognostic (9.96e-2)"	"unprognostic (1.99e-1)"	"unprognostic (3.42e-2)"	"unprognostic (2.26e-3)"	48.5	52.5	19.1	57.8	22.6	65.8	56.7	25.3	21.4	76.9	41.0	51.3	54.2	67.2	90.6	47.7	65.1	37.3	45.3	19.9	33.3	33.9	67.5	46.7	53.0	29.7	29.4	87.3	179.0	50.8	52.7	86.7	29.9	59.0	49.4	32.1	102.2	57.7	41.9	43.7	45.3	66.5	26.2	45.8	65.7	38.5	25.4	67.5	66.0	40.0	65.3	50.0	41.8	33.5	160.0	141.8	106.3	193.5	156.6	162.7	145.3	183.5	214.8	163.8	182.5	184.6	134.6	210.6	90.4	225.7	137.8	130.4	150.7	198.1	158.6	116.1	127.2	116.1	153.0	177.9	284.2	181.9	109.6	241.3	216.3	140.0	232.3	185.7	206.2	85.1	131.3	204.9	165.0	118.6	199.5	135.6	119.5	159.7	173.6	136.8	94.6	476.1	128.1	110.5	133.0	143.7	132.8	606.6	217.5	157.8	76.2	127.2	207.3	132.3	86.4	243.3	144.7	250.1	101.1	217.0	265.6	153.6	245.2	49.7	86.4	17.1	67.0	76.6	78.0	70.1	50.0	54.0	87.4	44.6	34.9	39.8	6.2	59.7	66.1	92.9	43.4	92.9	19.1	22.6	25.3	21.4	19.9	33.3	29.7	29.4	29.9	26.2	25.4	33.5	20.3	16.0	44.7	60.4	56.7	19.6	24.7	32.9	22.2	17.1	41.0	28.6	29.2	35.8	28.9	29.5	20.9	255.0	44.3	28.8	17.6	62.8	20.1	21.9	51.9	30.3	73.1	47.5	128.0	96.7	106.1	40.7	54.6	39.5	34.9	54.4	25.0	49.8	81.9	30.3	116.0	59.4	18.3	52.8	36.7	68.1	45.7	50.8	33.8	78.7	72.5	16.7	32.0	84.9	89.9	58.6	29.8	41.3	124.6	42.8	38.2	33.1	19.0	32.7	32.9	27.0	34.4	23.4	28.0	37.6	27.4	267.6	37.2	74.0	58.3	27.0
SNRNP200	"ASCC3L1, BRR2, HELIC2, KIAA0788, RP33, U5-200KD"	ENSG00000144028	"Small nuclear ribonucleoprotein U5 subunit 200"	O75643	2	96274338-96321271	"Disease related genes, Enzymes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"mRNA processing, mRNA splicing"	"Helicase, Hydrolase"	"Disease variant, Retinitis pigmentosa"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA029321	Approved		Supported	Nucleoplasm		NA	NA		78000	"Cluster 41: Basophils - Cellular respiration"	"Cluster 34: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 24: Non-specific - Transcription regulation"	Nucleoplasm		"HPA029321: AB_10604096"	"unprognostic (2.63e-2)"	"unprognostic (1.45e-1)"	"unprognostic (1.44e-1)"	"prognostic unfavorable (3.89e-4)"	"unprognostic (1.50e-1)"	"unprognostic (1.09e-1)"	"unprognostic (2.48e-3)"	"unprognostic (1.01e-1)"	"unprognostic (1.75e-1)"	"unprognostic (1.74e-1)"	"unprognostic (3.10e-1)"	"unprognostic (6.46e-2)"	"unprognostic (2.61e-2)"	"unprognostic (1.82e-1)"	"unprognostic (2.69e-1)"	"unprognostic (1.50e-1)"	"unprognostic (1.03e-1)"	26.5	21.8	11.2	38.1	11.3	58.8	38.6	16.9	12.1	31.9	25.5	29.6	29.4	41.0	20.2	29.5	39.8	25.8	26.9	9.9	11.1	28.8	29.3	29.3	43.2	13.1	10.3	53.2	34.3	52.4	19.7	39.2	12.0	31.6	34.6	67.6	35.1	33.0	47.4	30.8	30.3	38.5	12.2	36.5	30.6	40.4	9.8	73.5	37.4	38.7	52.3	30.1	21.6	14.6	97.8	107.7	144.1	106.1	63.1	57.1	131.5	67.3	80.6	119.5	112.9	197.3	69.3	169.3	101.3	83.3	178.9	74.9	264.4	88.8	130.8	94.3	139.4	221.6	169.8	106.7	40.9	171.2	92.4	58.1	53.7	133.2	112.0	61.3	97.3	98.3	198.2	112.3	68.3	82.3	158.8	49.4	182.8	77.9	102.4	185.0	139.3	107.4	43.8	145.4	159.8	150.5	107.7	88.7	65.4	165.0	86.4	100.5	86.2	98.3	117.2	101.3	96.2	101.0	134.0	207.6	66.2	109.0	106.2	16.7	4.7	6.0	7.9	5.0	8.9	5.7	6.0	9.5	5.6	6.1	5.2	7.1	4.7	7.3	6.1	5.8	6.8	5.5	11.2	11.3	16.9	12.1	9.9	11.1	13.1	10.3	12.0	12.2	9.8	14.6	47.3	44.8	53.9	21.9	57.4	29.6	27.2	35.5	38.1	79.3	40.2	42.4	35.2	54.3	46.2	51.5	104.3	43.2	64.2	43.4	5.9	42.6	29.3	42.4	48.7	44.8	46.7	54.1	21.2	46.7	36.1	37.9	52.0	48.8	25.3	79.0	40.4	49.4	35.1	87.5	21.1	40.6	34.6	31.9	33.2	18.2	57.5	35.2	17.8	16.9	45.2	79.1	73.2	17.1	16.7	46.1	30.7	55.3	68.3	34.8	47.3	17.9	50.7	135.2	65.7	54.7	45.5	77.6	56.0	38.7	33.0	44.6	71.6	53.3	49.4	30.3
SPACA5	"dJ54B20.3, LYC5, LYZL5, PNPK6288, SLLP2, UNQ6288"	ENSG00000171489	"Sperm acrosome associated 5"	Q96QH8	X	48004336-48009729	"Enzymes, Predicted secreted proteins"		"Glycosidase, Hydrolase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	12	"testis: 14.0"	"Cell type enhanced"	"Detected in some"		"Astrocytes: 1.0;Early spermatids: 3.3"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											"HPA044747, HPA047149"	Supported				"Secreted in male reproductive system"	NA	NA			"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 78: Testis - Spermatogenesis"		"Cluster 23: Spermatids - Flagellum & Golgi organization"			"HPA044747: AB_2679071, HPA047149: AB_2679955"																		0.0	0.0	0.6	0.0	0.7	0.1	0.1	1.2	0.9	0.1	0.2	0.1	0.0	0.2	0.5	0.0	0.2	0.1	0.0	0.3	0.6	0.1	0.0	0.1	0.4	0.7	0.7	0.2	0.9	0.0	0.0	0.0	0.7	0.2	0.1	0.3	0.1	0.0	0.0	0.6	0.1	0.1	0.2	0.0	0.1	14.0	0.8	0.0	0.8	0.0	0.1	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.9	0.2	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.6	0.7	1.2	0.9	0.3	0.6	0.7	0.7	0.7	0.2	0.8	0.4	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.3	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
SPACA5B	LYZL5B	ENSG00000171478	"Sperm acrosome associated 5B"	Q96QH8	X	48130657-48132613	"Enzymes, Predicted secreted proteins"		"Glycosidase, Hydrolase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	54	"testis: 23.9"	"Cell type enriched"	"Detected in single"	16	"Early spermatids: 1.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											"HPA044747, HPA047149"	Supported				"Secreted in male reproductive system"	NA	NA			"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 78: Testis - Spermatogenesis"		"Cluster 23: Spermatids - Flagellum & Golgi organization"			"HPA044747: AB_2679071, HPA047149: AB_2679955"																		0.0	0.0	0.4	0.0	0.2	0.0	0.0	0.2	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.4	0.0	0.0	0.0	0.0	0.2	0.3	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	23.9	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.4	0.2	0.2	0.4	0.2	0.4	0.2	0.3	0.3	0.1	0.2	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
SPAM1	"HYAL5, PH-20, SPAG15"	ENSG00000106304	"Sperm adhesion molecule 1"	P38567	7	123925237-123971414	"Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Cell adhesion"	"Glycosidase, Hydrolase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	38	"testis: 17.3"	"Group enriched"	"Detected in some"	73	"Early spermatids: 270.3;Late spermatids: 111.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA017984	Enhanced					NA	NA				"Cluster 83: Testis - Spermatogenesis"		"Cluster 29: Early spermatids - Spermatogenesis"			"HPA017984: AB_1857413"															"unprognostic (2.44e-1)"			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.3	0.0	0.0	0.0	0.0	17.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.4	0.0	0.1	0.0	0.0	270.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	111.6	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	1.5	1.0	0.0	0.0	2.6	0.0	0.0	0.0	0.0
SPATA5	"AFG2, SPAF"	ENSG00000145375	"Spermatogenesis associated 5"	Q8NB90	4	122923070-123319433	"Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins"	"Differentiation, Spermatogenesis"	"Chaperone, Developmental protein, Hydrolase"	"Deafness, Disease variant, Epilepsy, Mental retardation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 207.9;Inhibitory neurons: 59.0;Microglial cells: 104.0;Oligodendrocyte precursor cells: 79.9;Oligodendrocytes: 91.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036450, HPA036451"	Approved		Approved	Cytosol		NA	NA			"Cluster 7: Monocytes - Unknown function"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 23: Spermatids - Flagellum & Golgi organization"	Cytosol		"HPA036450: AB_2675131, HPA036451: AB_10670107"	"unprognostic (4.28e-1)"	"unprognostic (7.54e-2)"	"unprognostic (7.37e-3)"	"unprognostic (1.26e-1)"	"unprognostic (5.16e-1)"	"unprognostic (1.18e-1)"	"unprognostic (7.65e-4)"	"unprognostic (1.95e-3)"	"unprognostic (9.00e-2)"	"unprognostic (2.78e-1)"	"unprognostic (4.43e-3)"	"unprognostic (4.62e-2)"	"unprognostic (1.26e-2)"	"unprognostic (1.52e-1)"	"unprognostic (5.68e-1)"	"unprognostic (2.63e-2)"	"unprognostic (1.79e-1)"	1.3	0.8	0.8	0.9	1.1	1.4	1.6	2.3	1.0	1.3	1.2	1.0	0.6	1.3	0.8	1.0	1.0	0.8	0.9	0.6	1.2	1.1	1.1	0.9	1.2	1.2	1.1	1.2	0.8	1.5	0.7	1.4	1.2	1.1	1.2	2.2	1.0	1.1	1.3	1.2	0.7	1.3	1.0	1.3	2.3	3.6	1.0	2.0	1.5	1.2	1.2	1.0	1.1	1.3	2.3	3.2	2.9	7.1	2.4	1.7	1.9	4.0	1.6	3.3	3.3	1.5	3.2	3.7	2.4	2.4	2.4	2.0	5.0	2.2	5.6	6.2	0.9	3.8	5.7	2.5	1.1	5.2	4.0	1.2	1.1	3.8	3.3	1.7	3.4	2.4	7.7	6.2	4.6	2.4	10.1	3.2	2.1	3.6	1.3	3.3	7.2	2.4	1.9	1.9	4.8	3.1	3.2	2.3	1.7	4.2	2.2	2.0	2.6	6.9	5.2	4.6	4.2	3.9	5.0	3.3	3.3	4.4	6.2	0.5	0.2	0.2	0.6	0.6	0.4	0.5	0.5	0.5	0.1	0.5	0.5	0.5	0.3	0.5	0.2	0.7	0.3	0.2	0.8	1.1	2.3	1.0	0.6	1.2	1.2	1.1	1.2	1.0	1.0	1.3	10.7	16.0	5.0	34.6	9.1	5.1	5.6	2.6	6.2	6.2	4.2	3.2	4.3	11.5	7.4	1.8	14.6	5.1	6.7	2.9	0.0	3.1	207.9	4.5	9.6	8.5	2.4	11.2	48.8	3.6	4.3	5.1	14.3	5.2	5.1	8.6	4.2	3.2	3.5	3.3	59.0	2.6	0.0	4.1	5.3	25.0	7.2	5.3	0.0	104.0	1.8	4.0	4.1	79.9	91.4	4.2	2.1	4.5	10.6	3.9	1.5	3.1	6.4	11.3	0.0	12.5	6.6	14.7	10.6	5.0	5.4	2.2	9.9	4.7	4.1	3.0
SSH1	"KIAA1298, SSH1L"	ENSG00000084112	"Slingshot protein phosphatase 1"	Q8WYL5	12	108778191-108857590	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Actin-binding, Hydrolase, Protein phosphatase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in all"		"WM-115: 63.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA019845	Uncertain		Uncertain	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 17: WM-115 - Nervous system development"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	"Plasma membrane"	"Nucleoplasm, Cytosol"	"HPA019845: AB_1857497"	"unprognostic (1.18e-3)"	"unprognostic (3.00e-1)"	"unprognostic (2.49e-1)"	"unprognostic (2.70e-2)"	"unprognostic (9.40e-2)"	"unprognostic (7.45e-2)"	"prognostic unfavorable (5.80e-5)"	"unprognostic (3.28e-2)"	"unprognostic (3.69e-2)"	"unprognostic (1.72e-3)"	"unprognostic (7.12e-2)"	"unprognostic (3.42e-1)"	"unprognostic (1.71e-2)"	"unprognostic (1.41e-1)"	"unprognostic (8.66e-2)"	"unprognostic (9.55e-2)"	"unprognostic (6.22e-2)"	6.6	5.1	5.6	5.1	5.1	7.9	5.0	9.2	5.5	5.8	7.2	7.2	2.9	5.9	4.0	5.5	5.3	5.3	7.8	5.7	5.3	6.7	5.5	11.8	4.1	5.8	5.7	5.0	4.3	5.4	5.2	5.2	5.2	5.2	4.1	5.7	3.9	4.8	11.9	4.6	5.1	5.5	5.0	7.5	4.9	3.5	5.1	3.6	5.3	6.5	4.2	6.0	5.2	5.1	9.9	12.7	8.2	6.4	15.1	12.8	7.2	12.8	26.1	11.0	9.7	6.4	4.6	4.9	8.7	29.0	18.8	9.8	4.9	20.7	8.9	9.9	4.8	11.3	6.0	4.0	8.1	5.8	28.4	17.7	7.0	10.0	22.0	27.1	10.3	5.6	2.5	3.6	29.1	5.4	6.6	8.0	5.8	3.8	10.3	4.6	9.8	6.1	4.5	17.1	6.1	8.1	11.0	2.8	24.2	11.2	3.9	4.8	8.1	19.6	8.4	11.9	7.1	7.3	7.0	5.6	10.3	4.5	63.1	1.8	0.9	2.0	1.0	1.5	0.9	0.6	0.5	0.9	0.6	0.6	0.4	0.5	2.1	0.7	1.2	0.7	0.6	0.5	5.6	5.1	9.2	5.5	5.7	5.3	5.8	5.7	5.2	5.0	5.1	5.1	34.5	9.6	16.1	26.1	6.3	9.4	20.8	23.6	19.4	12.9	6.9	6.6	25.1	11.5	12.7	14.7	16.7	6.0	18.5	8.2	5.9	8.4	2.2	10.8	17.1	52.2	5.4	7.8	27.3	8.2	4.4	14.0	13.7	16.9	20.8	12.0	29.3	15.2	12.3	11.8	35.4	5.4	0.0	23.0	20.3	5.0	6.5	21.1	12.4	55.3	33.7	7.8	14.4	14.1	14.8	12.3	2.4	12.8	13.1	21.8	4.0	6.7	9.0	19.1	6.6	17.8	18.1	1.4	7.7	13.2	8.9	2.3	17.9	7.6	7.8	13.9
SSH2	KIAA1725	ENSG00000141298	"Slingshot protein phosphatase 2"	Q76I76	17	29625938-29930276	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Actin-binding, Hydrolase, Protein phosphatase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 91.5"	"Cell type enhanced"	"Detected in all"		"Excitatory neurons: 269.0;Inhibitory neurons: 255.2;Microglial cells: 254.8;Oligodendrocytes: 547.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"eosinophil: 134.8"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB017189, HPA057099"	Uncertain					NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 59: Non-specific - Translation"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 59: Non-specific - Transcription"			"CAB017189: , HPA057099: AB_2683336"	"unprognostic (1.45e-1)"	"unprognostic (1.57e-1)"	"unprognostic (3.56e-2)"	"unprognostic (1.27e-2)"	"unprognostic (1.44e-1)"	"unprognostic (1.53e-1)"	"unprognostic (3.00e-3)"	"unprognostic (7.05e-2)"	"unprognostic (1.14e-1)"	"unprognostic (6.80e-2)"	"unprognostic (9.80e-3)"	"unprognostic (7.52e-2)"	"unprognostic (1.48e-2)"	"unprognostic (8.28e-2)"	"unprognostic (7.70e-2)"	"unprognostic (2.74e-1)"	"unprognostic (1.86e-1)"	15.6	9.5	11.7	22.5	13.1	62.8	10.7	12.8	16.3	7.1	3.6	13.0	8.3	7.3	8.9	12.7	8.2	8.9	19.4	13.1	23.2	15.1	13.6	21.4	29.0	19.0	14.4	3.9	14.6	6.2	7.1	10.4	18.5	6.3	10.9	8.1	10.7	4.5	91.5	14.4	20.7	7.9	11.4	28.3	15.5	28.2	16.3	28.9	13.9	35.6	24.8	9.0	8.7	24.5	25.8	19.0	12.6	10.8	36.1	24.7	8.8	12.3	12.9	19.6	19.2	12.9	9.0	22.1	18.8	14.1	12.6	31.0	14.8	17.1	22.4	7.1	28.1	14.9	21.2	17.4	16.6	16.7	30.7	30.4	12.3	20.6	13.4	9.7	47.3	36.2	9.9	16.8	13.7	7.3	74.9	15.5	9.4	9.3	11.5	37.9	31.9	37.0	35.7	20.3	20.6	32.3	18.0	18.6	36.6	16.3	12.6	19.4	25.6	12.6	26.3	23.5	16.1	26.9	20.0	53.8	16.4	13.1	12.3	47.2	15.2	134.8	10.4	20.2	8.5	21.3	11.6	11.1	12.7	22.4	11.5	8.7	91.6	4.6	36.7	7.7	16.4	6.5	11.7	13.1	12.8	16.3	13.1	23.2	19.0	14.4	18.5	11.4	16.3	24.5	19.6	9.6	38.5	81.6	137.0	39.6	12.3	20.6	27.9	12.4	22.2	19.2	28.2	12.8	23.2	16.5	27.1	20.4	68.7	54.3	25.4	14.9	108.4	27.9	10.1	26.9	35.4	27.8	269.0	35.5	26.4	22.2	33.1	32.5	12.6	6.0	19.6	26.9	22.3	20.2	255.2	34.8	14.2	120.2	31.3	174.4	12.2	75.9	35.6	254.8	83.6	9.2	82.4	184.0	547.9	40.3	38.6	8.2	49.4	12.9	64.5	63.1	18.4	22.9	6.6	34.4	17.0	80.9	16.7	37.6	36.2	18.2	65.8	14.2	21.6	30.2
SSH3	"FLJ10928, FLJ20515"	ENSG00000172830	"Slingshot protein phosphatase 3"	Q8TE77	11	67303478-67312607	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Hydrolase, Protein phosphatase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"basophil: 11.6;eosinophil: 11.1"	"Lineage enriched"	"Detected in many"	5	"granulocytes: 11.6"	"Cell line enhanced"	"Detected in many"		"HaCaT: 64.9;MCF7: 64.1;RT4: 111.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA019949, HPA019957"	Approved		Approved	"Nuclear speckles,Plasma membrane,Actin filaments,Cytosol"		NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 11: Squamous epithelial cells - Epithelial cell function"	"Cluster 15: RT4 - Unknown function"	"Cluster 30: Mammary glandular cells - Lactation"	"Nuclear speckles, Cytosol"	"Plasma membrane, Actin filaments"	"HPA019949: AB_1857498, HPA019957: AB_1857499"	"unprognostic (4.38e-2)"	"unprognostic (1.37e-1)"	"unprognostic (3.50e-3)"	"unprognostic (3.73e-2)"	"unprognostic (2.61e-3)"	"unprognostic (9.30e-2)"	"unprognostic (2.99e-1)"	"unprognostic (1.84e-1)"	"unprognostic (1.63e-1)"	"unprognostic (2.45e-2)"	"prognostic unfavorable (2.89e-4)"	"unprognostic (1.50e-1)"	"unprognostic (2.06e-2)"	"unprognostic (1.47e-1)"	"unprognostic (3.20e-1)"	"unprognostic (4.94e-3)"	"unprognostic (6.78e-3)"	14.4	7.8	8.9	4.0	12.0	9.3	16.2	14.1	11.6	25.9	9.5	19.3	13.3	16.0	7.5	41.9	18.3	11.5	12.5	9.1	10.1	13.1	10.9	12.7	3.1	14.6	10.8	23.5	15.3	9.8	9.7	6.5	13.2	29.9	9.3	1.2	26.2	28.8	6.8	25.2	15.0	6.1	12.3	9.4	20.1	2.3	11.5	1.9	16.3	3.8	4.8	37.4	32.5	14.9	17.3	18.7	0.4	0.6	11.4	11.8	18.8	10.3	13.7	5.6	5.1	21.2	46.8	1.0	32.5	10.5	11.9	64.9	6.0	46.4	2.8	3.6	6.3	4.3	32.2	9.9	8.2	0.9	16.0	12.2	40.5	8.3	8.3	12.9	6.3	0.4	0.1	1.5	6.2	64.1	0.8	7.3	4.2	48.9	13.8	20.6	0.6	3.1	18.2	111.2	3.7	5.8	24.8	41.0	12.8	6.3	57.1	15.3	10.4	4.5	9.8	12.7	2.7	1.5	0.9	0.5	12.7	6.9	4.9	11.6	1.5	11.1	2.0	2.3	1.7	0.2	1.9	1.7	1.7	0.1	0.8	0.8	4.4	1.5	1.1	1.1	1.8	1.1	8.9	12.0	14.1	11.6	9.1	10.1	14.6	10.8	13.2	12.3	11.5	14.9	7.6	3.2	8.7	8.5	0.9	7.0	20.8	25.2	11.4	0.8	21.3	17.3	3.8	20.0	23.4	16.5	0.0	15.1	3.3	28.3	3.9	19.4	0.1	8.3	5.6	4.7	3.6	5.2	4.2	21.6	24.9	8.0	20.9	17.8	3.8	8.1	3.9	5.0	7.7	1.7	5.3	14.4	24.4	6.2	3.1	0.6	13.1	4.8	8.8	2.8	9.2	4.8	7.2	0.0	15.9	20.0	21.0	12.0	0.7	15.4	20.2	7.4	11.6	0.5	0.0	4.9	9.2	0.5	0.4	27.0	10.4	15.7	4.4	5.3	21.4	26.8
SSU72	HSPC182	ENSG00000160075	"SSU72 homolog, RNA polymerase II CTD phosphatase"	Q9NP77	1	1541673-1574863	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"mRNA processing"	"Hydrolase, Protein phosphatase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Late spermatids: 700.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA069290, HPA070604"	Supported		Approved	Nucleoplasm,Cytosol		No	No			"Cluster 52: Eosinophils - Transcription"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 10: Non-specific - Unknown function"	"Nucleoplasm, Cytosol"		"HPA069290: AB_2686108, HPA070604: AB_2686285"	"unprognostic (3.33e-2)"	"unprognostic (2.79e-2)"	"unprognostic (6.37e-2)"	"unprognostic (2.27e-2)"	"unprognostic (2.41e-1)"	"unprognostic (9.84e-2)"	"unprognostic (2.40e-3)"	"unprognostic (2.43e-2)"	"unprognostic (3.23e-1)"	"unprognostic (3.23e-1)"	"unprognostic (6.75e-2)"	"unprognostic (1.36e-1)"	"unprognostic (6.56e-3)"	"unprognostic (1.19e-1)"	"unprognostic (8.51e-2)"	"unprognostic (3.77e-1)"	"unprognostic (1.06e-1)"	105.4	77.3	101.9	64.1	107.4	61.0	94.8	101.9	119.7	82.1	112.6	95.9	75.1	80.4	88.3	123.3	80.6	52.7	131.5	106.2	113.3	105.5	122.4	87.9	74.3	106.6	106.6	81.9	115.0	63.4	99.9	52.0	109.0	86.8	62.7	52.1	100.6	53.6	246.7	100.2	90.8	53.8	103.4	105.9	96.1	58.9	113.2	65.1	107.8	136.3	67.7	83.6	87.2	103.9	204.6	127.6	90.2	140.3	152.1	145.4	92.2	172.8	134.1	147.6	152.5	120.8	229.7	205.4	92.1	137.0	143.7	155.0	147.4	142.5	142.8	172.8	173.9	129.3	110.7	193.8	171.5	165.6	108.4	130.7	117.8	158.4	149.8	123.2	140.1	122.6	227.9	154.1	118.6	181.4	190.8	264.5	158.5	198.9	191.5	149.5	145.5	289.8	163.7	61.8	166.1	114.0	117.1	296.3	535.3	152.0	154.6	142.0	107.8	140.8	89.2	160.9	150.7	186.5	241.2	258.1	148.0	260.1	69.9	143.4	93.0	188.6	80.0	98.9	99.3	120.7	105.9	95.9	100.2	117.7	127.6	105.1	204.1	75.3	91.7	62.9	161.5	101.0	101.9	107.4	101.9	119.7	106.2	113.3	106.6	106.6	109.0	103.4	113.2	103.9	107.5	28.9	72.7	14.7	130.6	186.2	138.9	100.0	108.1	95.9	169.6	173.7	92.4	151.5	69.2	101.2	20.9	208.6	129.9	171.2	291.6	76.3	283.0	107.8	77.6	91.5	142.0	78.8	23.3	106.6	239.4	84.4	89.7	101.0	61.5	90.6	98.6	132.7	141.1	112.7	23.8	165.8	83.4	178.4	130.0	700.2	104.7	123.3	167.2	15.9	144.8	152.3	193.6	25.6	20.1	91.9	206.7	85.7	132.5	199.6	242.8	325.8	59.0	73.4	59.2	77.6	136.6	97.1	157.4	155.9	220.4	245.3	128.1	86.2	172.1	153.2
ST14	"HAI, MT-SP1, PRSS14, SNC19, TMPRSS14"	ENSG00000149418	"ST14 transmembrane serine protease matriptase"	Q9Y5Y6	11	130159782-130210362	"Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted membrane proteins, Transporters"		"Hydrolase, Protease, Serine protease"	"Cancer-related genes, Disease variant, Hypotrichosis, Ichthyosis"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 144.8"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 489.4;Paneth cells: 327.2;Proximal enterocytes: 251.9;Undifferentiated cells: 216.9;Urothelial cells: 286.8"	"Low cancer specificity"	"Detected in all"			"Region enhanced"	"Detected in many"		"thalamus: 10.0"	"Immune cell enriched"	"Detected in many"	4	"plasmacytoid DC: 25.0"	"Lineage enriched"	"Detected in many"	5	"dendritic cells: 25.0"	"Cell line enhanced"	"Detected in many"		"CACO-2: 224.2;CAPAN-2: 443.0;HaCaT: 311.4;OE19: 240.4;RPMI-8226: 301.2;SK-BR-3: 203.1;T-47d: 308.3;U-698: 218.5"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"HPA047014, HPA056258"	Enhanced		Approved	Nucleoplasm,Vesicles		NA	NA		1100000	"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 37: Intestine - Unknown function"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 53: Intestinal epithelial cells - Unknown function"	"Nucleoplasm, Vesicles"		"HPA047014: AB_2679902, HPA056258: "	"unprognostic (1.17e-1)"	"unprognostic (1.15e-1)"	"unprognostic (9.62e-2)"	"unprognostic (1.32e-1)"	"unprognostic (2.17e-2)"	"unprognostic (7.94e-2)"	"unprognostic (1.20e-1)"	"unprognostic (3.97e-2)"	"unprognostic (5.29e-1)"	"unprognostic (3.21e-1)"	"unprognostic (1.03e-3)"	"unprognostic (2.25e-1)"	"prognostic favorable (5.03e-11)"	"unprognostic (1.92e-2)"	"unprognostic (2.71e-1)"	"unprognostic (1.28e-2)"	"unprognostic (5.60e-2)"	4.3	3.9	0.8	26.7	1.2	4.3	17.7	1.8	2.9	18.6	1.2	124.7	130.7	5.7	21.8	104.5	37.1	32.6	0.9	0.9	1.1	43.2	6.3	18.5	11.9	1.8	1.7	0.6	59.2	36.5	19.1	15.1	3.1	23.1	60.1	0.0	58.7	23.6	0.3	50.2	144.8	5.4	1.1	9.1	64.9	1.0	10.0	10.5	28.6	0.0	20.9	34.8	42.5	2.7	167.2	0.2	0.0	0.6	0.0	0.0	86.4	0.0	0.0	0.0	0.0	224.2	443.0	163.6	16.7	0.0	0.1	311.4	0.0	99.3	0.0	0.1	0.2	0.1	0.1	0.9	0.0	22.0	0.8	0.0	49.3	0.0	0.2	0.0	0.0	0.0	0.2	0.3	0.0	128.5	0.3	1.1	1.7	240.4	0.9	0.2	0.0	301.2	28.8	134.2	17.8	0.4	1.5	203.1	0.4	1.6	308.3	32.0	0.1	0.4	2.7	0.7	0.7	0.2	0.3	218.5	0.3	50.4	0.5	0.0	3.6	3.4	0.0	2.2	0.1	5.0	0.0	0.0	6.2	3.6	0.0	0.0	0.5	0.0	0.3	25.0	0.0	1.2	0.8	1.2	1.8	2.9	0.9	1.1	1.8	1.7	3.1	1.1	10.0	2.7	0.2	32.1	28.6	0.0	18.2	40.9	51.5	45.2	26.2	0.0	36.5	21.5	1.2	77.2	61.6	62.5	0.0	45.6	26.1	489.4	3.9	115.8	37.8	43.9	5.7	1.7	123.4	0.8	1.0	91.8	14.6	3.2	112.1	79.6	11.4	0.2	0.4	2.1	58.1	0.0	0.4	201.0	148.5	22.7	13.2	13.9	1.8	28.0	7.2	0.0	13.6	0.0	1.0	0.0	0.1	153.4	327.2	0.7	5.9	108.7	251.9	10.0	76.4	0.0	6.6	0.0	4.9	0.2	0.3	61.3	43.9	39.7	2.9	0.0	216.9	286.8
STS	"ARSC, ARSC1"	ENSG00000101846	"Steroid sulfatase"	P08842	X	7147237-7804358	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted membrane proteins"	"Lipid metabolism, Pregnancy, Steroid metabolism"	Hydrolase	"Disease variant, Ichthyosis"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"placenta: 26.6"	"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 41.8;Excitatory neurons: 32.2;Inhibitory neurons: 39.3;Syncytiotrophoblasts: 94.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"ASC diff: 48.5;RPMI-8226: 69.8;U-266/70: 110.2;U-698: 47.2"					"Low region specificity"	"Detected in all"			HPA002904	Enhanced					NA	NA			"Cluster 7: Monocytes - Unknown function"	"Cluster 82: Adipose tissue - ECM organization"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 18: Syncytiotrophoblasts - Pregnancy hormone signaling"			"HPA002904: AB_1080116"	"unprognostic (1.09e-1)"	"unprognostic (3.90e-2)"	"unprognostic (1.44e-2)"	"unprognostic (2.75e-1)"	"unprognostic (6.72e-2)"	"unprognostic (1.94e-2)"	"unprognostic (2.62e-1)"	"unprognostic (1.84e-1)"	"unprognostic (8.23e-2)"	"unprognostic (4.67e-2)"	"prognostic unfavorable (3.47e-4)"	"unprognostic (4.05e-2)"	"unprognostic (2.78e-2)"	"unprognostic (2.77e-1)"	"unprognostic (2.56e-1)"	"unprognostic (1.92e-2)"	"unprognostic (1.34e-1)"	18.2	4.6	3.7	4.5	4.8	2.1	5.8	4.0	12.1	5.6	1.3	6.8	2.8	4.3	2.4	3.1	4.8	7.3	6.6	4.2	3.7	4.8	8.7	8.7	4.1	5.8	6.1	4.7	3.0	2.8	1.2	26.6	5.5	5.2	5.9	6.1	3.1	5.6	5.2	4.9	3.2	6.8	1.3	4.7	12.0	2.4	12.1	4.4	3.9	6.6	3.6	9.4	3.9	7.8	11.5	3.7	7.5	3.0	48.5	24.9	37.5	22.3	7.8	5.8	5.3	19.2	11.2	21.4	5.0	15.5	5.0	3.0	5.4	3.9	5.8	3.3	8.6	1.8	12.7	5.7	2.7	3.8	11.5	8.3	0.7	3.8	2.3	4.0	8.8	2.0	1.4	23.5	15.2	2.9	2.2	3.1	3.3	0.2	4.8	3.9	4.8	69.8	14.2	16.0	5.6	4.8	4.7	8.3	3.0	11.8	3.8	1.6	15.8	22.5	2.2	30.0	4.4	110.2	0.8	47.2	5.9	3.0	6.5	0.9	1.7	0.4	0.4	2.0	0.2	0.4	0.2	0.2	0.9	0.7	0.1	0.3	1.3	0.7	1.3	0.3	0.3	0.6	3.7	4.8	4.0	12.1	4.2	3.7	5.8	6.1	5.5	1.3	12.1	7.8	10.2	12.8	2.2	10.4	1.8	0.9	1.8	2.9	0.6	3.5	3.3	1.5	7.5	1.5	8.5	1.8	0.0	41.8	1.6	16.7	0.0	8.6	0.3	4.5	4.5	4.2	3.6	3.2	32.2	19.9	18.9	6.1	5.1	5.2	7.0	6.7	3.6	8.2	7.7	1.7	39.3	4.6	10.2	7.5	1.7	0.4	2.8	2.8	1.8	10.3	4.7	2.6	0.0	19.1	12.1	10.2	6.5	6.8	1.9	7.8	4.6	3.0	7.5	0.8	0.0	17.5	5.7	0.5	1.7	0.4	1.0	94.0	1.0	4.0	4.3	8.9
SUPV3L1	SUV3	ENSG00000156502	"Suv3 like RNA helicase"	Q8IYB8	10	69180234-69209099	"Enzymes, Predicted intracellular proteins"		"Helicase, Hydrolase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038380, HPA038405"	Supported		Supported	Mitochondria		NA	NA			"Cluster 44: Non-specific - Transcription"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 24: Non-specific - Transcription regulation"	Mitochondria		"HPA038380: AB_2675983, HPA038405: AB_10675797"	"unprognostic (4.70e-2)"	"unprognostic (1.85e-2)"	"unprognostic (2.25e-1)"	"unprognostic (1.19e-2)"	"unprognostic (3.74e-2)"	"unprognostic (3.32e-2)"	"unprognostic (1.44e-2)"	"unprognostic (1.78e-1)"	"unprognostic (1.57e-1)"	"unprognostic (9.47e-3)"	"unprognostic (1.70e-1)"	"unprognostic (1.06e-1)"	"unprognostic (5.48e-3)"	"unprognostic (5.03e-2)"	"unprognostic (1.61e-1)"	"unprognostic (5.27e-2)"	"unprognostic (1.33e-1)"	10.1	10.9	7.9	8.7	8.2	24.2	11.5	10.2	10.3	7.7	7.6	11.6	8.9	9.3	7.9	8.8	8.3	6.0	15.8	8.5	8.2	12.9	17.9	6.1	12.0	7.9	7.4	10.6	9.3	16.5	7.5	8.7	7.9	8.0	12.7	11.1	8.9	8.6	25.9	10.6	8.6	9.3	7.2	9.9	8.9	15.8	7.8	11.0	10.9	29.1	12.2	9.5	7.7	8.5	28.9	19.9	17.4	53.5	19.1	16.1	22.7	17.5	27.1	34.7	32.6	51.4	23.8	51.5	14.0	17.6	24.8	32.3	42.2	27.4	33.1	21.5	33.1	22.6	14.9	27.2	48.1	54.3	16.5	20.5	33.7	31.9	72.6	23.6	20.3	32.2	59.6	26.1	19.2	18.7	33.1	33.5	20.8	27.2	106.7	30.1	24.7	22.6	15.6	13.9	24.7	18.7	24.2	49.7	46.7	19.1	15.5	23.5	12.7	13.7	24.7	21.1	34.3	20.5	25.4	47.5	22.6	56.4	8.9	8.9	5.1	4.7	11.1	7.3	12.5	9.0	7.9	9.5	7.1	7.3	8.7	9.6	0.9	7.7	5.4	3.9	8.8	6.2	7.9	8.2	10.2	10.3	8.5	8.2	7.9	7.4	7.9	7.2	7.8	8.5	11.2	6.4	7.4	15.3	21.7	23.8	11.6	16.6	21.6	21.6	10.8	9.5	22.5	5.7	15.1	7.3	4.2	17.8	49.3	11.7	11.7	11.6	13.4	17.2	17.6	10.1	9.0	10.3	29.6	8.6	11.4	12.6	14.8	28.8	7.6	15.1	5.7	12.0	9.6	11.8	28.2	9.0	16.2	6.0	10.0	4.5	6.8	9.4	5.4	15.0	7.2	11.3	19.6	14.1	17.6	8.5	8.1	9.1	37.0	10.8	8.5	14.3	12.6	12.5	6.6	17.2	14.6	38.6	26.6	23.6	22.3	22.4	28.8	16.1	14.1	10.7
SYNJ1	"INPP5G, PARK20"	ENSG00000159082	"Synaptojanin 1"	O43426	21	32628759-32728040	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	Endocytosis	"Hydrolase, RNA-binding"	"Disease variant, Epilepsy, Neurodegeneration, Parkinson disease, Parkinsonism"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 45.9;retina: 48.4"	"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 110.9;Inhibitory neurons: 91.5;Oligodendrocytes: 61.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA011916	Enhanced		Approved	Nucleoplasm,Centrosome,Cytosol		NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 58: Brain - Synaptic function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	"Nucleoplasm, Cytosol"	Centrosome	"HPA011916: AB_1857692"	"unprognostic (6.84e-2)"	"unprognostic (8.64e-2)"	"unprognostic (5.76e-2)"	"unprognostic (6.44e-2)"	"unprognostic (1.27e-1)"	"prognostic favorable (4.43e-4)"	"unprognostic (1.45e-1)"	"unprognostic (3.73e-3)"	"unprognostic (1.63e-1)"	"unprognostic (6.22e-3)"	"unprognostic (1.84e-2)"	"prognostic unfavorable (2.58e-4)"	"unprognostic (1.28e-1)"	"unprognostic (6.36e-2)"	"unprognostic (5.97e-2)"	"unprognostic (1.79e-1)"	"unprognostic (2.92e-1)"	7.6	6.9	15.0	5.3	22.8	23.8	6.5	1.1	45.9	6.2	3.5	5.6	4.0	5.1	5.1	4.6	5.0	5.2	6.4	22.1	9.8	7.4	5.7	8.0	6.3	19.5	5.6	4.8	4.8	8.4	13.8	9.8	14.8	4.5	5.4	48.4	4.7	3.7	7.7	5.1	6.3	4.9	0.0	7.9	5.0	10.2	8.7	7.1	7.3	6.4	4.8	5.5	5.4	25.9	5.5	2.9	5.0	5.7	8.9	7.1	10.3	11.3	6.2	6.8	5.7	6.1	2.6	2.0	3.8	6.9	8.9	5.0	8.9	6.8	8.4	6.8	8.1	13.8	8.7	3.5	4.8	5.6	11.7	4.1	4.9	12.0	6.1	5.8	10.8	7.3	10.6	11.6	9.0	5.5	5.5	5.1	3.4	6.4	6.0	6.1	11.1	7.4	7.5	4.3	5.6	4.5	14.0	8.4	5.6	6.9	7.8	7.2	11.2	10.0	5.3	8.2	6.4	6.0	7.8	4.4	8.0	10.7	8.7	3.4	2.9	6.9	1.2	5.2	2.0	0.1	1.9	2.0	2.5	0.3	2.2	2.2	9.1	0.5	4.7	1.4	2.6	1.1	15.0	22.8	1.1	45.9	22.1	9.8	19.5	5.6	14.8	0.0	8.7	25.9	10.2	6.4	5.4	22.9	3.9	4.8	1.9	3.1	8.0	24.8	3.8	2.5	10.0	2.8	4.0	1.8	45.9	17.7	7.0	4.8	5.9	2.0	19.9	2.4	4.7	11.9	3.0	5.0	110.9	1.3	9.8	5.3	4.1	3.6	3.8	2.2	11.0	4.2	10.1	10.1	91.5	2.0	0.0	18.6	5.7	11.3	2.8	15.7	1.8	31.9	6.5	21.8	4.1	49.3	61.0	2.8	5.3	4.5	8.6	2.7	6.2	6.5	4.6	45.4	6.6	6.1	5.8	22.1	13.3	6.7	3.3	38.0	9.9	2.8	5.4	4.3
SYNJ2	INPP5H	ENSG00000078269	"Synaptojanin 2"	O15056	6	157981863-158099176	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Hydrolase, RNA-binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	6	"brain: 116.2"	"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 102.1;Glandular and luminal cells: 114.2;Oligodendrocytes: 502.1;Pancreatic endocrine cells: 140.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"GAMG: 133.4;TIME: 109.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA031575	Approved		Approved	Microtubules,Cytosol		NA	NA			"Cluster 1: Neutrophils - Mixed function"	"Cluster 70: Brain - Nervous system development"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	Microtubules	Cytosol	"HPA031575: AB_10604101"	"prognostic unfavorable (2.63e-4)"	"unprognostic (1.94e-2)"	"unprognostic (7.61e-2)"	"unprognostic (1.25e-2)"	"unprognostic (1.48e-2)"	"unprognostic (7.68e-2)"	"unprognostic (1.24e-1)"	"unprognostic (7.06e-2)"	"unprognostic (2.91e-1)"	"unprognostic (7.29e-3)"	"unprognostic (1.26e-1)"	"unprognostic (1.36e-1)"	"prognostic unfavorable (4.02e-6)"	"unprognostic (1.66e-2)"	"unprognostic (3.75e-2)"	"unprognostic (1.75e-1)"	"unprognostic (9.45e-2)"	4.2	5.8	26.1	6.2	69.9	20.0	8.0	58.6	42.0	4.5	1.9	10.6	7.1	7.6	10.5	7.7	5.5	9.4	10.7	22.5	32.4	8.4	4.9	4.5	5.9	98.1	74.7	3.6	8.1	1.5	4.1	3.5	78.9	6.9	10.4	2.3	16.5	5.8	7.2	4.3	6.8	7.7	57.8	4.2	8.5	9.4	58.2	6.5	5.2	9.5	6.5	11.0	4.6	116.2	16.4	56.6	4.5	7.3	3.4	11.2	24.2	29.8	60.4	35.0	41.1	28.7	13.5	0.5	19.8	57.9	133.4	15.4	10.1	18.5	40.1	22.9	9.3	31.8	29.8	30.9	6.5	10.9	32.6	5.9	9.9	53.3	12.4	47.1	61.7	16.4	24.7	6.5	16.1	7.6	14.0	12.2	5.1	51.4	31.2	6.0	19.1	13.4	11.8	18.8	34.8	2.0	22.7	14.2	5.9	17.2	10.9	7.1	109.7	25.8	26.8	61.4	36.5	2.5	7.8	0.4	49.2	17.5	18.4	3.0	0.6	0.5	0.9	0.3	1.9	1.0	1.3	0.8	0.6	2.0	1.1	0.8	4.3	1.0	0.4	0.5	1.2	0.5	26.1	69.9	58.6	42.0	22.5	32.4	98.1	74.7	78.9	57.8	58.2	116.2	17.2	3.2	3.3	5.2	15.4	21.7	19.9	7.5	14.2	2.4	25.4	18.4	13.9	21.5	8.6	18.4	0.0	7.7	12.8	20.0	3.9	59.0	35.5	48.5	13.7	26.4	17.4	5.5	102.1	35.2	5.0	16.6	34.1	114.2	5.1	37.7	7.9	5.2	2.0	0.0	10.1	14.8	10.2	2.2	17.6	56.5	1.2	12.5	10.6	7.5	6.9	1.6	16.5	8.5	502.1	140.2	7.1	6.4	13.5	50.6	13.1	1.7	14.4	0.6	0.0	7.3	18.9	0.9	1.1	11.5	17.2	15.9	17.1	2.2	15.7	36.2
TDG		ENSG00000139372	"Thymine DNA glycosylase"	Q13569	12	103965822-103988874	"Enzymes, Predicted intracellular proteins"	"DNA damage, DNA repair, Transcription, Transcription regulation"	"Activator, Chromatin regulator, Hydrolase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA052263	Supported		Supported	"Nucleoplasm,Plasma membrane"		NA	NA			"Cluster 31: Non-specific - Inflammatory response"	"Cluster 3: T-cells - Adaptive immune response"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 65: Plasmacytoid DCs - Unknown function"	Nucleoplasm	"Plasma membrane"	"HPA052263: AB_2681777"	"unprognostic (3.15e-1)"	"unprognostic (1.36e-1)"	"unprognostic (9.89e-3)"	"unprognostic (6.93e-2)"	"unprognostic (3.66e-2)"	"unprognostic (1.13e-1)"	"prognostic unfavorable (6.27e-5)"	"unprognostic (1.56e-2)"	"prognostic unfavorable (6.90e-5)"	"unprognostic (5.37e-2)"	"unprognostic (1.82e-1)"	"unprognostic (8.48e-2)"	"prognostic unfavorable (1.90e-10)"	"unprognostic (3.68e-1)"	"unprognostic (2.90e-1)"	"unprognostic (1.11e-1)"	"unprognostic (1.16e-1)"	10.8	13.6	5.8	15.9	6.4	18.1	12.0	6.7	7.2	10.0	7.2	13.2	11.4	11.6	9.5	17.8	8.7	12.2	9.8	6.3	6.0	8.5	12.1	9.6	21.0	5.3	5.5	9.7	9.5	10.4	9.5	17.5	5.5	9.6	15.6	10.5	9.2	7.3	9.5	12.8	13.4	10.9	4.6	11.9	11.2	4.9	5.5	25.7	10.6	9.6	19.1	17.1	11.2	7.3	42.6	21.4	64.4	37.2	15.5	13.7	69.4	32.4	12.3	42.6	23.6	39.1	18.2	99.4	18.8	26.3	6.9	27.9	76.8	36.5	32.6	42.8	66.8	76.4	31.8	17.5	14.8	95.4	55.8	16.3	48.0	31.5	24.6	25.9	42.3	58.4	91.1	15.8	20.6	45.2	107.6	53.6	76.7	33.0	34.0	107.9	32.8	35.0	46.4	61.4	84.2	58.0	38.9	42.7	28.4	37.7	70.7	52.2	26.5	13.3	21.5	14.3	37.5	34.5	49.5	81.8	14.2	52.0	25.3	55.0	53.0	45.8	28.9	39.2	22.0	43.4	28.1	24.3	34.6	39.8	28.5	25.5	35.5	33.6	40.1	92.5	30.5	17.6	5.8	6.4	6.7	7.2	6.3	6.0	5.3	5.5	5.5	4.6	5.5	7.3	35.4	38.5	23.8	12.1	54.6	79.0	49.1	63.0	38.7	51.3	61.2	54.9	25.9	37.1	49.4	33.1	27.1	66.7	68.7	35.2	37.2	68.6	6.2	44.7	44.7	45.2	81.7	69.4	30.3	53.9	82.6	38.5	47.4	45.7	40.4	27.0	39.3	36.4	44.1	35.3	30.0	55.7	87.5	44.8	42.1	3.8	27.4	42.4	16.0	23.4	41.1	24.4	43.3	20.6	20.9	79.7	39.0	30.1	52.6	52.4	28.4	30.5	40.8	39.0	46.0	37.4	38.0	11.0	23.1	52.8	102.9	156.7	49.8	25.0	42.6	61.8
TDRD12	"ECAT8, FLJ13072"	ENSG00000173809	"Tudor domain containing 12"	Q587J7	19	32719753-32829580	"Enzymes, Predicted intracellular proteins"	"Differentiation, Meiosis, RNA-mediated gene silencing, Spermatogenesis"	"Developmental protein, Helicase, Hydrolase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	7	"epididymis: 7.3;testis: 16.7"	"Cell type enhanced"	"Detected in some"		"Early spermatids: 24.0;Late spermatids: 12.0;Spermatocytes: 65.0;Spermatogonia: 43.5"	"Cancer enriched"	"Detected in many"	9	"testis cancer: 10.4"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	30	"HDLM-2: 25.5;NTERA-2: 81.0"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"									NA	NA				"Cluster 68: Epididymis - Unknown function"	"Cluster 5: NTERA-2 - Transcription"	"Cluster 20: Spermatogonia & Spermatocytes - Spermatogenesis"				"unprognostic (5.43e-2)"	"unprognostic (3.97e-1)"	"unprognostic (1.14e-1)"	"unprognostic (1.87e-7)"	"unprognostic (5.44e-2)"	"unprognostic (1.78e-1)"	"unprognostic (6.79e-2)"	"unprognostic (1.20e-1)"	"unprognostic (2.07e-1)"	"unprognostic (1.40e-1)"	"unprognostic (9.69e-2)"	"unprognostic (1.90e-1)"	"unprognostic (1.43e-4)"	"unprognostic (2.09e-1)"	"unprognostic (4.75e-2)"	"unprognostic (3.08e-2)"	"unprognostic (2.69e-2)"	0.2	0.8	0.2	0.1	0.2	0.1	0.2	0.1	0.3	0.7	0.0	0.2	0.0	1.1	7.3	0.3	0.8	0.1	0.1	0.2	0.6	0.1	0.0	0.1	0.2	0.4	0.2	1.6	0.0	0.0	0.1	0.0	0.2	0.2	0.1	0.4	0.1	0.3	0.1	1.7	1.2	0.1	0.1	0.3	0.1	16.7	0.9	0.4	0.4	0.0	0.2	0.2	0.2	0.2	0.0	1.1	0.2	1.3	0.1	0.1	1.7	0.2	0.0	0.0	0.3	0.6	0.0	0.0	0.0	0.2	0.0	0.0	0.3	0.3	0.0	25.5	0.2	0.0	0.0	0.3	0.0	0.0	0.1	0.5	0.5	0.0	0.0	0.2	0.0	0.1	0.0	0.2	0.1	0.3	0.1	0.0	81.0	0.1	0.0	0.0	0.0	0.0	0.0	0.8	0.3	0.3	0.1	0.0	0.0	0.4	0.1	0.3	0.1	0.1	0.0	0.1	0.0	0.1	0.1	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.1	0.3	0.2	0.6	0.4	0.2	0.2	0.1	0.9	0.2	0.3	0.0	0.0	1.3	0.0	0.0	0.4	0.0	0.0	0.4	0.6	0.3	0.9	0.0	0.0	1.8	0.0	0.4	0.2	0.1	0.0	0.0	24.0	0.3	1.2	0.4	0.0	0.0	2.2	0.0	1.3	0.2	0.0	1.1	0.0	0.2	0.4	0.0	0.1	0.0	2.1	0.1	0.0	0.0	0.3	12.0	2.1	0.1	0.0	1.0	0.0	0.2	0.0	0.0	1.4	0.1	0.2	1.5	0.1	0.1	0.1	0.2	0.0	0.2	0.0	0.4	0.3	65.0	43.5	0.0	0.1	0.3	0.2	2.9	0.4	0.2
TDRD9	"C14orf75, DKFZp434N0820, FLJ36164, NET54"	ENSG00000156414	"Tudor domain containing 9"	Q8NDG6	14	103928456-104052667	"Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins"	"Differentiation, Meiosis, RNA-mediated gene silencing, Spermatogenesis"	"Developmental protein, Helicase, Hydrolase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	7	"parathyroid gland: 30.6;testis: 40.7"	"Cell type enhanced"	"Detected in many"		"Endometrial ciliated cells: 43.2;Spermatocytes: 63.2;Spermatogonia: 38.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Immune cell enriched"	"Detected in single"	6	"classical monocyte: 1.6"	"Lineage enriched"	"Detected in single"	6	"monocytes: 1.6"	"Cell line enhanced"	"Detected in some"		"HDLM-2: 24.4;HeLa: 21.5;HMC-1: 94.2;RPTEC TERT1: 25.5;SK-MEL-30: 13.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"									NA	NA			"Cluster 25: Monocytes - Inflammatory response"	"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 13: Spermatocytes & Spermatogonia - Spermatogenesis"				"unprognostic (3.71e-1)"	"unprognostic (3.02e-1)"	"unprognostic (1.59e-1)"	"unprognostic (1.89e-1)"	"unprognostic (1.91e-1)"	"unprognostic (1.55e-1)"	"unprognostic (2.74e-1)"	"unprognostic (3.74e-1)"	"unprognostic (1.55e-1)"	"unprognostic (1.61e-1)"	"unprognostic (2.13e-4)"	"unprognostic (1.60e-2)"	"unprognostic (4.57e-3)"	"unprognostic (8.97e-2)"	"unprognostic (3.34e-1)"	"prognostic unfavorable (5.52e-4)"	"unprognostic (2.41e-2)"	0.4	0.5	0.9	0.6	0.8	1.7	0.5	1.3	0.9	0.4	1.2	0.3	0.1	0.4	0.4	0.2	0.9	0.9	0.6	0.8	0.8	2.1	0.3	1.0	0.5	1.7	1.0	0.2	0.5	30.6	1.0	0.5	2.0	0.3	0.2	3.5	0.3	0.5	0.1	0.1	0.3	0.5	1.1	3.0	0.8	40.7	1.1	0.3	5.4	0.5	0.5	0.4	0.2	1.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	3.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	24.4	0.0	0.0	21.5	0.0	0.0	0.0	94.2	0.1	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	1.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	25.5	0.0	8.7	0.0	0.0	0.6	13.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.9	0.8	1.3	0.9	0.8	0.8	1.7	1.0	2.0	1.1	1.1	1.3	0.9	6.4	2.0	2.3	0.0	0.0	0.1	0.1	0.0	4.3	1.0	0.4	12.4	0.0	0.7	0.0	4.2	0.0	0.5	0.0	1.9	0.6	13.1	43.2	1.5	0.9	0.0	1.3	9.1	0.0	0.0	0.7	0.0	3.7	0.0	0.3	0.4	0.1	1.9	6.7	4.6	0.0	2.0	1.8	0.0	7.3	0.9	1.5	0.0	2.8	2.9	0.6	0.0	1.0	4.6	0.5	0.0	2.2	0.3	0.5	0.0	2.5	0.2	2.3	6.6	0.9	0.8	63.2	38.6	0.0	0.0	0.0	0.3	11.7	0.0	0.1
TGM2	TGC	ENSG00000198959	"Transglutaminase 2"	P21980	20	38127385-38166578	"Disease related genes, Enzymes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted secreted proteins"		"Acyltransferase, Hydrolase, Protease, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"cervix: 432.0"	"Cell type enhanced"	"Detected in many"		"Cardiomyocytes: 204.5;Cytotrophoblasts: 311.1;Ductal cells: 226.7;Endometrial stromal cells: 459.1;Hepatic stellate cells: 408.0;Hepatocytes: 205.7;Pancreatic endocrine cells: 326.5;Syncytiotrophoblasts: 374.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	4	"CAPAN-2: 1546.7;EFO-21: 505.5;hTERT-RPE1: 994.3;HUVEC TERT2: 695.3;TIME: 924.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB002598, HPA021019, HPA029518"	Enhanced		Approved	"Plasma membrane,Cytosol"	"Secreted to extracellular matrix"	Yes	No		1700000	"Cluster 43: B-cells - Humoral immune response"	"Cluster 46: Fibroblasts - ECM organization"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 36: Stromal cells - Cell proliferation"	Cytosol	"Plasma membrane"	"CAB002598: , HPA021019: AB_1858247, HPA029518: AB_10603133"	"unprognostic (7.80e-2)"	"unprognostic (1.51e-1)"	"unprognostic (5.22e-2)"	"unprognostic (1.40e-2)"	"unprognostic (1.56e-2)"	"unprognostic (5.61e-3)"	"unprognostic (2.81e-1)"	"unprognostic (3.32e-3)"	"unprognostic (3.29e-2)"	"unprognostic (9.78e-3)"	"prognostic unfavorable (2.97e-4)"	"unprognostic (6.99e-2)"	"prognostic unfavorable (1.67e-7)"	"unprognostic (1.60e-2)"	"unprognostic (1.93e-2)"	"unprognostic (6.70e-2)"	"unprognostic (6.40e-2)"	105.9	45.1	23.0	68.4	22.3	3.2	30.3	22.9	29.5	432.0	53.0	30.6	29.8	266.3	28.3	37.3	217.7	127.7	394.9	21.4	23.0	76.7	244.1	288.5	18.0	25.4	22.5	40.6	25.6	19.3	95.9	234.3	26.0	88.7	20.8	2.1	9.8	56.6	63.9	4.0	63.7	159.0	24.4	32.7	62.3	3.9	30.6	15.4	36.3	33.4	10.3	154.2	87.8	24.8	65.0	47.5	0.2	1.8	47.3	5.1	24.0	95.5	45.2	0.7	1.8	78.4	1546.7	0.1	505.5	1.0	105.4	1.7	0.1	221.7	3.4	0.7	0.2	10.3	2.6	35.0	191.9	0.0	0.5	5.2	0.4	40.2	0.3	994.3	695.3	0.0	21.4	0.1	16.0	0.3	0.0	0.6	0.8	0.9	4.6	0.0	0.1	0.3	69.0	0.0	0.0	1.3	224.4	0.2	7.6	31.6	2.2	0.6	924.2	1.6	57.6	7.8	46.3	0.0	0.6	0.8	60.7	0.1	18.4	0.0	0.0	0.0	0.0	0.6	0.0	0.4	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	23.0	22.3	22.9	29.5	21.4	23.0	25.4	22.5	26.0	24.4	30.6	24.8	58.0	9.6	18.3	0.0	7.4	0.5	10.4	41.0	0.6	0.0	8.5	8.8	204.5	31.5	55.3	14.7	2.1	311.1	0.1	11.7	3.9	226.7	3.2	16.7	459.1	183.8	0.0	74.5	0.1	145.7	38.6	37.7	0.5	13.1	2.5	2.8	408.0	205.7	54.4	0.0	0.1	1.8	6.1	23.7	2.1	5.0	1.2	35.5	0.0	28.1	6.5	0.4	0.0	0.0	0.3	326.5	1.1	6.0	0.0	68.6	63.0	27.6	23.6	0.5	0.0	5.2	49.1	0.4	4.0	0.9	0.0	374.2	3.9	2.1	3.3	26.4
THEM4	CTMP	ENSG00000159445	"Thioesterase superfamily member 4"	Q5T1C6	1	151870866-151909637	"Enzymes, Predicted intracellular proteins"	"Apoptosis, Fatty acid metabolism, Lipid metabolism"	Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Cone photoreceptor cells: 104.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"SK-MEL-30: 30.3"	"Low region specificity"	"Detected in all"							HPA028161	Approved					NA	NA			"Cluster 20: T-cells - T-cell receptor"	"Cluster 77: Retina - Visual perception"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 63: NK-cells & T-cells - Immune response"			"HPA028161: AB_10603454"	"unprognostic (2.88e-2)"	"unprognostic (1.93e-1)"	"unprognostic (1.50e-1)"	"unprognostic (1.04e-2)"	"unprognostic (1.29e-1)"	"unprognostic (7.89e-2)"	"prognostic unfavorable (1.38e-4)"	"unprognostic (3.15e-3)"	"unprognostic (2.23e-2)"	"unprognostic (1.07e-1)"	"prognostic favorable (2.51e-4)"	"unprognostic (1.17e-1)"	"unprognostic (4.19e-2)"	"unprognostic (3.02e-2)"	"unprognostic (9.25e-2)"	"unprognostic (1.91e-1)"	"unprognostic (5.93e-3)"	4.6	8.2	2.9	5.5	4.1	3.1	4.8	4.8	4.0	4.6	4.4	3.7	4.1	5.2	6.9	3.2	4.2	3.6	6.8	2.6	3.9	10.0	7.9	3.6	6.0	4.1	3.6	4.4	8.9	8.4	6.0	2.5	4.5	4.3	4.4	15.9	4.1	6.1	10.4	3.4	4.6	3.2	2.3	4.9	4.7	6.1	4.1	3.1	5.8	3.0	6.2	5.2	3.1	5.9	5.4	5.9	1.1	5.2	5.2	3.9	5.2	4.7	3.7	3.7	3.7	5.7	4.0	10.5	7.2	4.3	2.8	5.6	2.5	12.1	5.0	11.8	3.5	16.5	9.4	5.5	4.2	16.0	8.0	7.5	5.6	4.5	5.3	5.2	7.8	0.4	19.4	9.4	7.3	7.4	0.3	5.2	18.6	5.4	10.9	0.2	1.0	2.5	5.6	4.9	6.3	11.2	2.8	5.0	30.3	10.3	9.8	9.4	9.3	0.8	4.8	4.0	2.2	18.5	21.2	7.5	7.8	11.8	24.9	2.6	0.8	2.3	7.2	2.4	10.5	3.9	14.4	7.1	2.4	2.1	14.9	10.5	1.1	7.9	0.8	6.8	22.2	3.3	2.9	4.1	4.8	4.0	2.6	3.9	4.1	3.6	4.5	2.3	4.1	5.9	9.6	6.4	15.1	11.4	20.5	5.6	8.0	9.6	17.6	36.4	17.3	19.3	19.1	12.8	9.9	14.7	104.3	29.7	32.6	4.6	41.1	19.1	39.8	19.0	12.8	13.5	18.1	22.1	18.1	19.5	21.5	16.1	13.7	36.6	23.5	22.4	23.9	17.6	12.8	13.5	21.6	7.4	20.3	5.1	12.3	30.4	16.8	8.7	21.4	5.6	10.4	25.5	26.8	30.2	24.9	15.1	9.2	16.1	18.5	6.3	13.6	27.8	4.9	73.3	13.1	21.2	9.7	37.4	24.5	11.7	4.4	10.3	37.9	31.6	12.2	5.5
THEM5	FLJ37964	ENSG00000196407	"Thioesterase superfamily member 5"	Q8N1Q8	1	151847101-151853712	"Enzymes, Predicted intracellular proteins"	"Fatty acid metabolism, Lipid metabolism"	Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	24	"skin 1: 158.5"	"Cell type enriched"	"Detected in some"	18	"Suprabasal keratinocytes: 34.7"	"Low cancer specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"amygdala: 2.1;cerebral cortex: 4.0;hippocampal formation: 3.0;white matter: 1.0"	"Immune cell enhanced"	"Detected in single"		"MAIT T-cell: 1.7"	"Lineage enriched"	"Detected in single"	6	"T-cells: 1.7"	"Cell line enriched"	"Detected in some"	7	"HDLM-2: 57.6"	"Not detected"	"Not detected"			"Region enriched"	"Detected in single"	15	"basal ganglia: 13.8"							NA	NA			"Cluster 16: MAIT-cells - Unknown function"	"Cluster 61: Skin - Cornification"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 28: Keratinocytes - Keratinization"				"unprognostic (2.28e-2)"	"unprognostic (1.21e-1)"	"unprognostic (1.07e-1)"	"unprognostic (3.41e-2)"	"unprognostic (2.58e-3)"	"unprognostic (9.55e-3)"	"unprognostic (1.27e-1)"	"unprognostic (1.93e-1)"	"unprognostic (1.83e-1)"	"unprognostic (7.86e-3)"	"unprognostic (3.07e-3)"	"unprognostic (9.37e-2)"	"unprognostic (1.20e-1)"	"unprognostic (1.97e-2)"	"unprognostic (2.49e-1)"	"unprognostic (5.34e-2)"	"unprognostic (1.62e-2)"	0.3	1.9	2.1	2.0	0.3	0.5	4.2	0.0	4.0	1.6	0.5	0.4	1.4	0.5	0.0	6.5	0.7	3.1	1.9	3.0	0.0	1.1	0.6	1.3	6.3	0.3	0.0	0.2	1.3	0.0	0.5	0.5	0.2	0.4	0.0	0.7	3.1	0.0	1.3	158.5	0.8	0.0	0.0	1.0	1.9	1.2	0.6	0.1	1.0	0.0	0.3	1.2	3.2	1.0	6.6	0.0	0.1	0.2	0.0	0.0	1.0	0.2	0.0	0.0	0.0	0.0	0.7	0.0	0.2	0.0	0.0	2.3	0.0	0.0	0.0	57.6	0.0	0.0	2.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	2.3	0.0	1.7	0.2	0.0	7.1	1.2	0.6	0.0	0.2	0.7	0.0	0.0	0.4	0.1	8.6	2.1	1.1	1.4	1.4	2.4	0.0	0.0	0.0	1.6	0.1	0.2	0.0	0.0	0.0	0.0	0.4	0.0	0.1	0.0	0.7	0.1	1.7	0.0	0.6	0.4	0.0	0.0	0.0	0.2	0.2	0.0	0.0	0.2	0.9	1.7	2.1	0.3	0.0	4.0	3.0	0.0	0.3	0.0	0.2	0.0	0.6	1.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.6	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.6	0.0	0.9	1.8	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.1	0.0	0.0	0.8	34.7	1.1	0.0	0.0	0.0	0.0
THOP1		ENSG00000172009	"Thimet oligopeptidase 1"	P52888	19	2785503-2815807	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"		"Hydrolase, Metalloprotease, Protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Distal enterocytes: 136.6;Paneth cells: 160.6;Proximal enterocytes: 312.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB025497, HPA035262"	Uncertain		Supported	Cytosol		NA	NA		2000000	"Cluster 18: Basophils - Vesicular transport"	"Cluster 43: Testis - Unknown function"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 45: Enterocytes - Digestion"	Cytosol		"CAB025497: , HPA035262: AB_2674541"	"unprognostic (1.52e-2)"	"unprognostic (1.73e-3)"	"unprognostic (7.94e-2)"	"prognostic favorable (2.35e-4)"	"unprognostic (1.82e-1)"	"unprognostic (2.16e-2)"	"unprognostic (9.35e-2)"	"unprognostic (1.19e-1)"	"unprognostic (4.05e-2)"	"unprognostic (1.43e-1)"	"unprognostic (1.20e-3)"	"unprognostic (3.00e-2)"	"unprognostic (1.39e-1)"	"prognostic favorable (5.90e-4)"	"unprognostic (1.27e-1)"	"unprognostic (2.64e-1)"	"unprognostic (5.37e-2)"	13.4	19.6	31.8	11.8	31.6	19.6	15.3	29.8	48.4	15.3	25.4	21.3	22.6	18.7	6.3	31.0	17.6	3.3	38.0	33.2	28.7	22.7	73.0	13.7	11.6	33.7	31.7	18.8	17.5	6.0	32.0	7.8	30.7	37.6	7.0	9.3	15.7	5.2	40.6	20.0	21.5	6.1	26.9	23.0	16.1	70.2	28.6	13.8	17.9	11.0	8.3	18.7	15.9	30.4	91.4	66.3	25.1	54.6	12.8	12.5	89.9	55.4	20.4	53.8	43.4	78.4	28.3	81.3	26.4	21.7	37.7	72.4	37.8	45.6	22.5	0.3	79.7	28.9	75.9	94.4	13.7	56.3	43.1	13.9	16.0	44.8	20.0	15.5	31.0	54.0	68.2	38.7	23.1	70.5	63.1	105.0	74.7	27.2	90.2	51.7	33.8	77.5	22.8	51.9	68.5	54.6	48.5	42.9	27.6	13.1	41.8	53.8	35.5	41.2	35.5	88.6	95.4	67.1	60.7	55.7	46.0	93.3	50.1	9.3	2.5	1.2	3.7	2.9	3.0	3.8	2.7	5.2	3.6	5.3	3.4	3.0	1.0	3.0	6.0	7.0	7.6	2.5	31.8	31.6	29.8	48.4	33.2	28.7	33.7	31.7	30.7	26.9	28.6	30.4	5.1	3.2	10.6	15.0	12.0	6.8	10.3	15.6	11.4	20.3	12.6	10.8	9.0	5.7	9.7	11.0	35.5	27.6	8.7	136.6	9.8	18.7	17.6	11.1	8.3	7.4	40.8	13.7	12.1	15.1	55.9	11.1	9.2	10.1	5.7	23.1	7.1	85.9	23.0	6.7	10.5	59.9	6.1	9.8	6.0	23.4	11.5	9.1	3.6	3.7	8.3	13.5	4.1	4.0	7.1	21.3	160.6	6.0	17.2	16.6	312.2	10.8	9.7	32.4	13.1	10.6	15.0	55.6	19.2	13.4	5.8	33.8	8.0	15.9	48.2	8.4
THTPA	THTPASE	ENSG00000259431	"Thiamine triphosphatase"	Q9BU02	14	23555988-23560271	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Distal tubular cells: 54.8;Spermatocytes: 57.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA028876	Approved		Uncertain	Nucleoplasm,Nucleoli		NA	NA			"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 66: Spermatocytes - Spermatogenesis"	Nucleoplasm	Nucleoli	"HPA028876: AB_10600731"	"unprognostic (3.50e-3)"	"unprognostic (1.51e-1)"	"unprognostic (1.20e-1)"	"unprognostic (7.11e-2)"	"unprognostic (2.25e-1)"	"unprognostic (2.12e-1)"	"unprognostic (4.13e-1)"	"unprognostic (1.58e-3)"	"unprognostic (1.98e-1)"	"unprognostic (1.57e-1)"	"unprognostic (4.47e-2)"	"unprognostic (1.50e-1)"	"prognostic favorable (1.70e-9)"	"unprognostic (3.47e-2)"	"unprognostic (2.32e-1)"	"unprognostic (3.62e-2)"	"unprognostic (5.40e-2)"	13.6	17.6	29.3	10.4	41.7	8.2	11.0	27.5	33.0	9.4	28.5	11.5	14.2	12.1	15.1	8.5	14.9	9.7	14.8	30.1	27.0	14.4	11.3	9.5	10.6	28.4	27.5	12.6	11.4	19.8	11.1	6.7	27.7	16.0	10.6	13.2	17.3	14.0	23.6	6.9	9.8	11.8	27.9	10.7	10.7	20.1	27.9	11.0	11.5	20.7	10.2	10.2	7.3	29.3	3.9	24.1	11.4	12.4	26.3	14.6	6.3	11.2	9.7	10.7	10.5	4.9	15.9	7.2	9.5	13.1	12.1	11.8	12.1	13.8	7.8	15.9	13.7	10.2	16.9	13.3	13.0	9.1	8.7	20.6	10.2	16.4	12.0	22.9	13.0	11.6	7.7	15.9	15.7	11.6	14.6	3.7	4.1	20.9	20.1	9.9	7.9	13.4	18.9	7.6	22.1	10.6	10.8	22.0	6.6	6.6	14.9	4.4	10.9	7.0	7.4	14.5	6.5	18.9	12.2	4.4	7.3	4.2	10.9	13.7	16.0	8.7	9.8	12.0	9.8	10.2	7.2	7.6	14.7	15.3	11.7	10.2	1.7	8.3	16.1	18.7	6.4	10.9	29.3	41.7	27.5	33.0	30.1	27.0	28.4	27.5	27.7	27.9	27.9	29.3	8.1	6.4	7.5	16.6	14.5	0.0	7.8	0.0	6.8	27.4	12.0	10.7	0.1	8.6	3.7	7.3	8.4	11.0	9.2	7.2	54.8	14.5	21.9	6.7	9.2	6.2	6.1	3.4	11.8	12.4	5.1	9.9	9.2	6.7	23.5	7.7	7.1	10.8	18.4	8.4	23.1	7.5	0.0	7.9	0.0	23.0	11.5	9.8	0.0	4.7	9.9	33.4	14.4	15.1	37.0	8.2	9.6	7.5	11.3	9.3	15.2	38.9	2.9	11.6	13.1	13.2	7.7	57.5	8.3	9.5	0.0	6.7	9.3	14.2	7.7	5.9
TIGAR	C12orf5	ENSG00000078237	"TP53 induced glycolysis regulatory phosphatase"	Q9NQ88	12	4307763-4360028	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Apoptosis, Autophagy"	Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Hofbauer cells: 59.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"BEWO: 47.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB034010, HPA040354, HPA044111"	Approved		Supported	Cytosol		NA	NA			"Cluster 7: Monocytes - Unknown function"	"Cluster 72: Non-specific - Transcription"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 4: Macrophages - Innate immune response"	Cytosol		"CAB034010: AB_1128227, HPA040354: AB_2676935, HPA044111: AB_2678814"	"unprognostic (1.76e-1)"	"unprognostic (6.33e-2)"	"unprognostic (4.08e-1)"	"unprognostic (2.60e-1)"	"unprognostic (1.32e-1)"	"unprognostic (2.35e-1)"	"prognostic unfavorable (3.18e-4)"	"unprognostic (5.41e-2)"	"unprognostic (2.11e-1)"	"unprognostic (9.37e-2)"	"unprognostic (1.85e-1)"	"unprognostic (5.21e-2)"	"unprognostic (2.03e-2)"	"unprognostic (2.02e-3)"	"unprognostic (2.44e-1)"	"unprognostic (3.31e-1)"	"unprognostic (1.05e-1)"	3.8	5.4	1.4	1.9	1.6	1.9	2.9	1.9	3.0	1.8	1.8	3.7	0.7	2.8	1.2	3.7	2.3	1.4	5.0	2.2	1.6	4.2	3.1	3.7	2.0	1.9	2.0	1.1	2.0	0.9	5.3	1.4	2.1	2.8	1.7	2.3	3.0	1.7	5.8	2.5	3.6	2.1	2.1	5.3	3.3	3.5	1.9	1.7	2.3	2.0	1.9	3.5	2.4	2.3	4.1	9.9	4.8	7.7	10.9	6.3	47.3	9.3	8.0	5.3	7.3	5.7	3.8	4.1	0.7	5.8	5.2	5.7	5.8	7.6	7.0	3.8	2.9	0.1	4.7	7.8	14.3	2.1	0.5	8.1	12.9	5.9	6.8	3.2	14.5	3.4	0.3	2.2	9.2	7.7	2.2	0.8	8.6	5.5	1.7	3.0	6.4	1.0	6.7	5.0	0.2	2.8	7.9	3.2	10.1	22.0	0.8	1.6	10.5	8.2	5.9	5.6	3.8	1.4	2.1	6.9	5.4	0.8	5.7	0.5	1.7	0.2	0.7	3.5	0.5	0.9	0.7	0.8	1.9	1.3	0.6	0.7	1.5	0.8	3.4	1.6	1.4	0.6	1.4	1.6	1.9	3.0	2.2	1.6	1.9	2.0	2.1	2.1	1.9	2.3	10.7	0.0	1.7	0.0	14.7	0.0	13.8	0.0	5.7	4.2	6.2	7.5	10.5	1.5	0.0	5.5	18.8	27.4	16.9	5.0	15.6	15.6	28.0	4.7	5.9	9.4	7.3	1.3	0.0	13.9	28.5	6.6	11.7	4.8	0.0	4.5	5.0	5.6	59.3	1.7	0.0	1.5	0.0	20.4	0.0	27.8	3.7	30.6	0.0	0.0	34.9	11.5	7.2	0.0	0.0	17.5	2.6	4.5	16.3	9.5	2.9	11.7	0.0	3.3	6.6	5.7	8.3	19.9	22.3	8.1	0.0	34.3	11.8	10.8	2.3	15.6
TLR1	"CD281, KIAA0012, rsc786"	ENSG00000174125	"Toll like receptor 1"	Q15399	4	38790677-38856817	"CD markers, Enzymes, Predicted intracellular proteins, Predicted membrane proteins"	"Immunity, Inflammatory response, Innate immunity"	"Hydrolase, Receptor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 34.3;lymphoid tissue: 26.9"	"Cell type enhanced"	"Detected in many"		"B-cells: 15.4;Hofbauer cells: 14.9;Kupffer cells: 34.9;Macrophages: 32.7;Microglial cells: 29.0;monocytes: 19.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"neutrophil: 128.5"	"Group enriched"	"Detected in all"	6	"granulocytes: 128.5;monocytes: 42.7"	"Cell line enhanced"	"Detected in many"		"Daudi: 11.3;HUVEC TERT2: 12.6;RPMI-8226: 14.4;U-698: 20.6;U-937: 7.7"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"									NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 57: B-cells - Immune response"				"unprognostic (7.82e-2)"	"unprognostic (3.35e-3)"	"unprognostic (4.02e-2)"	"unprognostic (1.19e-1)"	"unprognostic (1.71e-1)"	"unprognostic (1.85e-2)"	"unprognostic (1.12e-1)"	"unprognostic (1.80e-1)"	"unprognostic (3.88e-1)"	"unprognostic (1.04e-1)"	"unprognostic (3.94e-2)"	"unprognostic (1.76e-1)"	"unprognostic (7.25e-3)"	"unprognostic (4.08e-2)"	"unprognostic (1.91e-2)"	"unprognostic (2.08e-1)"	"unprognostic (3.97e-2)"	8.8	4.1	1.9	26.9	2.1	34.3	7.3	2.3	1.8	4.6	2.8	4.9	6.5	6.0	2.1	3.3	6.0	9.6	2.3	1.8	2.4	4.4	8.8	10.8	16.2	4.9	3.2	10.2	5.1	1.6	1.0	10.0	5.2	3.5	6.8	1.4	9.0	3.7	0.5	1.8	6.2	9.8	3.9	24.9	6.4	1.3	4.1	8.1	1.6	3.4	19.7	8.0	1.1	6.7	0.2	2.0	0.1	0.0	0.3	1.5	0.0	0.0	0.5	0.1	1.1	0.2	5.4	11.3	1.1	0.0	5.3	0.3	0.1	1.4	0.3	1.3	0.5	1.4	0.5	0.0	0.1	2.1	0.6	0.4	0.3	0.5	0.0	0.4	12.6	0.2	1.6	3.3	1.7	0.0	0.5	4.6	0.0	0.0	0.0	7.7	0.1	14.4	1.3	0.0	0.0	1.5	0.0	0.1	0.5	0.1	0.1	2.7	3.3	1.1	0.5	0.1	0.7	1.2	0.2	20.6	2.8	7.7	0.3	0.1	22.0	8.3	3.0	30.8	2.3	6.5	3.2	2.5	13.8	5.6	3.1	1.8	128.5	5.6	42.7	4.5	1.3	9.0	1.9	2.1	2.3	1.8	1.8	2.4	4.9	3.2	5.2	3.9	4.1	6.7	1.0	0.0	1.5	1.0	15.4	0.3	0.6	3.0	1.8	0.3	2.9	1.1	0.2	0.0	4.4	1.8	0.0	0.1	8.6	0.6	1.9	5.5	0.0	6.1	0.7	2.6	0.0	0.8	0.7	4.4	0.2	3.1	2.0	4.7	3.8	0.1	0.4	2.5	14.9	0.0	1.6	0.4	2.0	34.9	14.6	0.2	0.0	32.7	0.0	29.0	19.2	1.9	6.2	3.5	2.2	2.0	0.3	2.6	2.1	1.1	0.6	1.1	7.8	0.2	0.0	3.9	0.5	0.1	0.3	0.8	0.6	0.1	6.1	2.6	1.4	1.4
TLR10	CD290	ENSG00000174123	"Toll like receptor 10"	Q9BXR5	4	38772238-38782990	"CD markers, Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Immunity, Inflammatory response, Innate immunity"	"Hydrolase, Receptor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	5	"lymphoid tissue: 47.9"	"Cell type enhanced"	"Detected in some"		"B-cells: 57.2;dendritic cells: 9.4;Microglial cells: 16.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in many"	4	"memory B-cell: 39.0;naive B-cell: 24.0"	"Lineage enriched"	"Detected in many"	5	"B-cells: 39.0"	"Group enriched"	"Detected in some"	53	"Daudi: 68.6;REH: 22.9;U-698: 24.7"					"Low region specificity"	"Detected in many"			HPA066755			Approved	Centrosome,Cytosol		NA	NA			"Cluster 43: B-cells - Humoral immune response"	"Cluster 16: Immune cells - Immune response"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 57: B-cells - Immune response"	Cytosol	Centrosome	"HPA066755: "	"unprognostic (5.41e-5)"	"unprognostic (2.41e-4)"	"unprognostic (1.91e-3)"	"unprognostic (8.22e-4)"	"unprognostic (6.48e-2)"	"unprognostic (9.98e-4)"	"unprognostic (9.31e-2)"	"unprognostic (8.76e-3)"	"unprognostic (4.08e-3)"	"unprognostic (7.26e-2)"	"unprognostic (8.76e-2)"	"unprognostic (6.90e-2)"	"unprognostic (2.98e-3)"	"unprognostic (3.90e-1)"	"unprognostic (1.81e-2)"	"unprognostic (3.14e-3)"	"unprognostic (1.88e-2)"	0.9	0.3	1.0	15.8	0.9	1.4	0.8	1.0	1.2	0.2	0.5	1.4	1.2	0.4	0.4	0.5	0.5	1.3	0.1	0.9	1.2	0.2	0.4	0.8	42.3	1.9	1.5	0.0	0.1	0.1	0.2	0.2	2.0	1.0	1.9	0.1	1.4	0.4	0.2	0.5	10.0	0.3	2.0	24.3	2.9	0.1	1.4	5.1	0.4	0.1	47.9	2.7	0.1	2.2	0.0	0.1	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	68.6	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.7	0.0	0.0	0.0	22.9	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.1	0.3	0.1	0.1	0.4	0.0	0.1	0.0	24.7	0.0	0.1	0.0	0.3	0.4	0.9	0.0	2.8	0.0	39.0	0.0	0.0	6.4	24.0	0.1	0.1	1.3	0.1	3.6	7.2	0.0	1.8	1.0	0.9	1.0	1.2	0.9	1.2	1.9	1.5	2.0	2.0	1.4	2.2	0.2	0.0	1.1	0.0	57.2	0.4	0.2	0.0	0.0	0.0	0.3	0.6	0.1	0.0	0.0	0.0	0.0	0.0	9.4	0.0	0.0	0.0	0.0	0.1	0.1	0.6	1.2	2.7	0.3	0.0	0.0	0.9	0.0	0.2	1.3	0.0	0.4	0.3	0.8	0.0	0.3	0.2	0.0	1.9	0.8	0.0	0.0	4.5	0.0	16.9	1.0	0.2	0.0	4.5	0.1	0.0	0.0	0.0	1.0	0.2	0.0	0.1	0.0	0.3	0.0	0.4	0.1	0.0	0.0	0.0	0.1	0.0	0.3	0.1	0.0	0.2
TLR2	"CD282, TIL4"	ENSG00000137462	"Toll like receptor 2"	O60603	4	153684070-153706260	"CD markers, Enzymes, FDA approved drug targets, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Immunity, Inflammatory response, Innate immunity"	"Hydrolase, Receptor"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 69.9;lymphoid tissue: 51.7"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 2: 77.3;Kupffer cells: 117.2;Langerhans cells: 35.7;Macrophages: 101.8;Microglial cells: 33.7;monocytes: 68.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"classical monocyte: 199.6;intermediate monocyte: 178.9;myeloid DC: 121.3;neutrophil: 457.8;non-classical monocyte: 121.5"	"Group enriched"	"Detected in all"	49	"dendritic cells: 121.3;granulocytes: 457.8;monocytes: 199.6"	"Cell line enhanced"	"Detected in some"		"HL-60: 11.6;HSkMC: 12.5;hTCEpi: 12.7;NB-4: 11.4;RPTEC TERT1: 13.3;RT4: 16.3;THP-1: 62.0;U-937: 11.3"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA060231, HPA071546"			Supported	Nucleoplasm,Mitochondria		No	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 43: THP-1 - Innate immune response"	"Cluster 41: Macrophages - Immune response"	"Nucleoplasm, Mitochondria"		"HPA060231: , HPA071546: "	"unprognostic (4.15e-1)"	"unprognostic (3.29e-2)"	"unprognostic (5.32e-2)"	"unprognostic (1.52e-2)"	"unprognostic (3.46e-2)"	"unprognostic (4.88e-2)"	"unprognostic (1.39e-2)"	"unprognostic (4.24e-2)"	"unprognostic (2.48e-1)"	"unprognostic (2.02e-2)"	"unprognostic (2.04e-1)"	"unprognostic (1.33e-1)"	"prognostic unfavorable (1.11e-4)"	"unprognostic (7.87e-2)"	"unprognostic (3.80e-3)"	"unprognostic (1.42e-1)"	"unprognostic (5.93e-3)"	26.8	11.8	4.3	51.7	4.4	69.9	12.5	4.6	7.5	7.9	7.6	4.6	3.9	3.3	11.8	5.4	8.2	16.3	6.1	4.0	5.3	5.1	11.3	39.9	8.8	9.5	5.9	2.5	8.8	3.4	4.0	11.4	7.9	4.7	3.3	1.5	17.2	12.3	1.7	3.5	4.9	11.7	7.1	35.9	5.2	1.9	7.4	3.6	3.4	3.7	15.4	23.6	4.0	10.1	7.1	0.1	0.3	0.0	1.0	2.9	0.0	0.0	0.5	0.5	0.8	3.3	0.4	0.0	0.8	0.0	0.0	6.4	0.6	0.4	0.3	0.1	0.1	0.2	0.0	0.8	0.1	11.6	0.9	12.5	12.7	0.0	0.1	0.8	0.0	0.0	0.0	0.1	0.1	0.1	0.0	11.4	0.7	0.0	2.7	0.3	0.0	0.0	13.3	16.3	0.0	0.3	0.7	0.1	3.3	0.4	0.0	62.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.7	11.3	1.7	48.4	199.6	1.8	0.3	178.9	0.5	0.4	1.1	0.3	121.3	1.2	1.3	0.2	457.8	5.3	121.5	1.1	0.2	76.2	4.3	4.4	4.6	7.5	4.0	5.3	9.5	5.9	7.9	7.1	7.4	10.1	1.7	6.4	77.3	0.7	1.1	1.1	1.2	18.4	1.2	0.0	9.7	2.2	1.3	2.8	19.5	3.7	0.0	0.2	0.6	0.2	0.0	5.0	0.3	1.6	0.5	2.6	0.0	3.6	0.1	3.8	0.2	1.9	2.6	4.9	3.8	0.5	1.4	1.8	17.4	0.0	0.5	0.3	0.0	117.2	35.7	1.3	0.6	101.8	1.8	33.7	68.4	0.4	1.0	1.0	0.1	3.1	0.0	0.4	1.4	3.4	1.5	1.0	7.5	0.3	13.1	0.6	5.1	0.2	1.0	1.9	1.1	0.1	2.3	0.5	0.5	2.0
TLR4	"ARMD10, CD284, hToll, TLR-4"	ENSG00000136869	"Toll like receptor 4"	O00206	9	117704175-117724735	"CD markers, Enzymes, FDA approved drug targets, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Immunity, Inflammatory response, Innate immunity"	"Hydrolase, Receptor"	"Age-related macular degeneration, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Adipocytes: 38.6;Astrocytes: 50.9;Hepatic stellate cells: 62.8;Hofbauer cells: 38.2;Kupffer cells: 106.0;Macrophages: 64.5;monocytes: 54.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"neutrophil: 86.8"	"Group enriched"	"Detected in many"	33	"dendritic cells: 22.4;granulocytes: 86.8;monocytes: 65.6"	"Cell line enhanced"	"Detected in many"		"Karpas-707: 60.0;TIME: 43.5"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"CAB004025, HPA049174"	Approved		Supported	"Golgi apparatus,Plasma membrane"	"Intracellular and membrane"	NA	NA			"Cluster 14: Monocytes - Unknown function"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 19: Monocytes & Neutrophils - Innate immune response"	"Plasma membrane"	"Golgi apparatus"	"CAB004025: , HPA049174: AB_2680662"	"unprognostic (1.60e-1)"	"unprognostic (8.34e-2)"	"unprognostic (7.22e-2)"	"prognostic favorable (6.29e-4)"	"unprognostic (3.39e-1)"	"unprognostic (7.48e-2)"	"unprognostic (8.68e-2)"	"unprognostic (1.80e-1)"	"unprognostic (3.38e-1)"	"unprognostic (5.18e-2)"	"unprognostic (8.00e-2)"	"unprognostic (9.42e-2)"	"unprognostic (4.08e-2)"	"unprognostic (8.63e-2)"	"prognostic unfavorable (3.79e-4)"	"unprognostic (1.09e-2)"	"unprognostic (1.96e-2)"	31.1	11.0	12.4	25.7	15.7	22.3	12.0	11.7	8.3	6.5	1.7	6.7	4.3	5.6	1.2	4.8	4.8	10.8	8.4	10.3	17.8	6.8	16.7	16.2	13.1	12.3	14.0	6.0	2.6	2.5	2.1	23.9	12.4	4.6	7.3	2.9	6.0	3.2	3.1	3.5	5.8	10.8	14.9	32.6	4.4	1.5	14.2	3.5	5.5	12.0	7.7	13.3	2.7	10.1	0.0	0.0	25.5	0.0	11.1	23.0	0.1	10.2	17.9	2.5	1.5	0.0	2.6	3.6	0.5	26.7	7.5	0.1	0.0	2.2	3.7	0.0	0.0	5.7	5.1	0.4	8.1	19.1	0.1	14.2	0.0	5.4	0.7	22.5	31.4	0.0	0.0	60.0	29.2	0.0	0.0	2.9	3.1	2.4	1.2	0.0	28.0	19.8	0.9	28.9	0.0	0.1	6.4	0.0	1.0	2.2	0.0	10.4	43.5	1.4	18.4	0.1	4.8	0.0	0.0	0.0	0.9	19.1	15.2	64.0	64.9	21.5	0.1	57.5	0.0	1.7	0.1	0.0	22.4	0.5	0.0	0.0	86.8	0.1	65.6	0.9	0.0	25.5	12.4	15.7	11.7	8.3	10.3	17.8	12.3	14.0	12.4	14.9	14.2	10.1	38.6	0.0	5.0	50.9	2.3	0.8	0.3	0.1	0.6	0.2	3.5	1.0	2.9	2.8	2.9	0.0	0.0	0.3	0.1	1.6	0.0	0.1	0.1	3.5	29.2	31.6	0.0	1.3	0.2	0.2	0.2	11.5	1.5	6.8	15.8	1.2	62.8	1.9	38.2	0.0	0.2	2.0	0.0	106.0	8.6	0.4	0.0	64.5	1.8	26.2	54.0	8.8	2.1	7.5	0.3	0.5	6.1	0.0	0.1	0.1	0.0	0.4	3.7	1.3	6.6	5.5	4.5	0.1	0.3	0.3	0.0	0.8	0.9	3.1	1.2	3.3
TLR6	CD286	ENSG00000174130	"Toll like receptor 6"	Q9Y2C9	4	38823715-38856817	"CD markers, Enzymes, Predicted membrane proteins"	"Immunity, Inflammatory response, Innate immunity"	"Hydrolase, Receptor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 13.8"	"Cell type enhanced"	"Detected in some"		"B-cells: 13.6;Hofbauer cells: 7.2;Kupffer cells: 12.2;Langerhans cells: 6.6;Macrophages: 11.6;Microglial cells: 20.6;monocytes: 14.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in many"	5	"neutrophil: 13.4"	"Lineage enriched"	"Detected in many"	5	"granulocytes: 13.4"	"Cell line enhanced"	"Detected in many"		"CAPAN-2: 13.3;GAMG: 13.5;RPMI-8226: 10.8"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			HPA062733			Approved	"Endoplasmic reticulum"		NA	NA			"Cluster 9: Neutrophils - Innate immune response"	"Cluster 16: Immune cells - Immune response"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 57: B-cells - Immune response"	"Endoplasmic reticulum"		"HPA062733: AB_2684853"	"unprognostic (9.82e-2)"	"unprognostic (4.76e-2)"	"unprognostic (3.30e-2)"	"unprognostic (3.05e-2)"	"unprognostic (1.91e-1)"	"unprognostic (1.87e-2)"	"unprognostic (1.83e-1)"	"unprognostic (4.45e-2)"	"unprognostic (9.26e-2)"	"unprognostic (1.30e-1)"	"unprognostic (1.05e-2)"	"unprognostic (2.69e-1)"	"unprognostic (7.62e-7)"	"unprognostic (4.89e-2)"	"unprognostic (1.02e-2)"	"unprognostic (7.78e-2)"	"unprognostic (2.12e-2)"	1.6	1.6	1.2	10.3	1.1	6.6	1.4	1.4	1.1	1.0	1.4	1.6	1.6	1.0	0.5	1.4	1.2	3.5	0.6	1.1	1.9	0.5	2.0	2.6	10.8	2.6	1.9	1.3	0.4	0.5	0.4	2.6	3.0	0.9	2.1	0.1	2.0	0.5	0.3	0.7	4.4	2.0	2.7	9.7	2.2	0.3	2.8	2.0	0.6	1.3	13.8	3.2	0.8	4.4	1.6	6.1	0.2	0.1	0.3	6.8	0.0	1.7	7.3	0.7	2.4	0.0	13.3	7.5	2.8	0.3	13.5	0.7	0.1	1.3	1.1	0.0	0.5	3.4	7.3	0.2	0.4	3.9	5.5	2.9	1.4	2.9	1.6	0.2	1.5	1.1	3.9	2.3	3.3	0.0	0.0	6.7	0.2	0.0	1.0	3.7	3.2	10.8	0.4	0.1	0.0	0.1	0.2	0.0	1.0	0.3	0.3	2.0	2.1	2.3	7.8	0.9	2.7	0.1	0.0	6.1	5.3	4.4	1.7	0.0	2.6	0.8	0.2	2.5	0.0	1.7	0.1	0.1	1.8	1.0	0.2	0.1	13.4	0.3	1.3	1.2	0.3	0.7	1.2	1.1	1.4	1.1	1.1	1.9	2.6	1.9	3.0	2.7	2.8	4.4	0.6	0.0	0.0	0.3	13.6	0.6	1.2	0.3	0.0	0.6	1.2	0.8	1.2	0.0	0.2	0.0	0.0	0.0	2.2	0.2	0.0	0.5	0.0	0.5	0.7	1.1	0.0	0.4	0.2	0.2	0.2	0.9	0.0	1.2	2.5	0.3	0.4	0.2	7.2	0.0	0.9	0.1	0.0	12.2	6.6	0.0	0.6	11.6	0.0	20.6	14.0	0.2	1.0	0.5	0.3	0.3	0.1	0.7	3.7	0.9	0.2	0.0	1.3	0.8	0.0	0.9	0.5	0.2	0.0	0.2	0.9	0.3	1.7	1.4	0.1	0.8
TMEM86B	MGC30208	ENSG00000180089	"Transmembrane protein 86B"	Q8N661	19	55226638-55228784	"Enzymes, Predicted membrane proteins"		Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"gallbladder: 11.0;liver: 16.9"	"Cell type enhanced"	"Detected in many"		"Cholangiocytes: 37.1;Erythroid cells: 66.5;Hepatocytes: 33.3"	"Cancer enriched"	"Detected in all"	5	"liver cancer: 10.0"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"Hep G2: 7.6;RPMI-8226: 8.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in some"			HPA057689	Uncertain		Uncertain	Midbody,Centrosome		Yes	No			"Cluster 32: T-cells - Unknown function"	"Cluster 45: Intestine - Brush border"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 6: Erythroid cells - Oxygen transport"	Centrosome	Midbody	"HPA057689: AB_2683504"	"unprognostic (2.36e-1)"	"unprognostic (1.10e-1)"	"unprognostic (2.76e-5)"	"unprognostic (1.87e-1)"	"unprognostic (1.29e-1)"	"unprognostic (6.55e-2)"	"prognostic favorable (3.13e-4)"	"unprognostic (1.10e-2)"	"unprognostic (2.00e-1)"	"unprognostic (2.10e-1)"	"prognostic favorable (9.97e-6)"	"unprognostic (1.96e-2)"	"unprognostic (6.63e-8)"	"unprognostic (2.28e-1)"	"unprognostic (1.07e-1)"	"unprognostic (3.70e-1)"	"unprognostic (3.19e-3)"	0.9	2.1	4.6	2.4	5.1	6.9	0.9	4.7	6.8	1.4	3.8	1.8	9.7	1.5	0.1	1.0	1.8	11.0	0.8	4.6	3.9	1.3	16.9	1.2	1.7	4.4	3.7	1.2	0.6	0.5	2.9	0.6	4.3	1.8	0.3	0.7	0.9	0.6	1.5	1.6	10.2	0.3	3.4	3.6	4.1	3.0	4.2	1.6	2.3	0.4	1.2	1.2	1.0	4.2	1.7	0.0	0.9	1.1	0.1	0.0	3.0	1.2	0.3	0.9	0.9	5.4	1.4	2.4	0.4	0.4	0.3	0.7	0.1	0.2	0.0	0.3	4.0	1.9	0.4	7.6	0.9	1.6	0.9	0.7	1.5	0.5	0.0	0.4	0.0	3.8	3.8	1.4	0.4	1.0	3.8	5.3	0.2	0.6	1.7	3.8	0.5	8.1	0.8	1.6	0.7	1.7	0.0	0.9	4.4	0.7	1.0	1.9	1.2	1.9	1.1	1.1	0.9	1.4	1.5	4.1	1.0	5.2	0.4	0.0	0.3	0.2	0.4	0.0	0.0	0.0	0.2	0.1	0.0	0.1	0.2	0.5	0.3	0.2	0.0	0.6	0.0	0.2	4.6	5.1	4.7	6.8	4.6	3.9	4.4	3.7	4.3	3.4	4.2	4.2	1.5	6.4	2.7	4.9	1.3	3.3	0.4	1.0	1.8	6.0	1.9	1.1	0.6	37.1	1.5	0.0	2.1	0.4	1.9	2.0	0.0	1.1	3.0	2.5	1.0	1.9	10.7	66.5	5.2	0.2	0.3	0.9	12.8	1.8	0.0	2.5	1.4	33.3	1.0	10.1	4.5	2.8	4.1	5.9	2.8	4.5	0.9	2.5	3.6	0.0	3.1	1.2	2.1	2.5	3.3	1.1	0.3	0.4	2.9	1.2	14.5	1.0	3.8	3.9	0.0	0.8	1.3	1.8	1.2	0.8	2.3	0.3	3.3	1.9	2.7	2.4
TMPRSS15	"ENTK, MGC133046, PRSS7"	ENSG00000154646	"Transmembrane serine protease 15"	P98073	21	18269116-18485879	"Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins"		"Hydrolase, Protease, Serine protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	512	"intestine: 979.8"	"Cell type enriched"	"Detected in some"	5	"Proximal enterocytes: 28.0"	"Group enriched"	"Detected in some"	12	"liver cancer: 0.7;pancreatic cancer: 1.5;stomach cancer: 1.5"	"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	19	"U-138 MG: 50.8;U-87 MG: 141.3"	"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"olfactory bulb: 5.0;spinal cord: 1.8"	"HPA015611, HPA034857, HPA072934"	Enhanced		Approved	"Plasma membrane"		NA	NA				"Cluster 56: Intestine - Transmembrane transport"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 45: Enterocytes - Digestion"	"Plasma membrane"		"HPA015611: AB_1855791, HPA034857: , HPA072934: AB_2732214"					"unprognostic (9.26e-2)"	"unprognostic (4.14e-1)"		"unprognostic (3.52e-1)"	"unprognostic (8.33e-2)"	"unprognostic (1.19e-1)"	"unprognostic (7.20e-2)"	"unprognostic (4.70e-2)"		"unprognostic (6.35e-2)"	"unprognostic (5.92e-2)"			0.0	0.0	0.9	0.2	0.7	0.0	0.0	1.9	1.7	0.0	0.0	0.2	979.8	0.2	0.0	0.1	0.0	0.1	0.1	0.7	0.6	0.0	0.0	0.0	0.7	0.2	0.6	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.2	21.8	0.0	0.0	0.0	0.4	1.0	0.4	0.0	0.2	0.0	0.0	0.0	0.0	1.4	0.0	0.3	0.0	0.2	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.1	1.8	0.2	0.1	0.2	0.2	0.0	0.0	0.0	0.0	0.0	4.8	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	3.9	0.0	0.0	0.0	0.1	4.9	0.0	0.0	0.0	0.4	0.1	0.1	0.0	0.3	0.0	4.6	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	50.8	0.0	0.3	0.0	0.9	0.0	0.2	141.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.9	0.7	1.9	1.7	0.7	0.6	0.2	0.6	0.1	0.0	0.4	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.4	1.9	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	1.2	0.0	0.0	0.0	28.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.5	0.0	0.0	0.0	0.0	0.0	4.0	0.0
TNFAIP3	"A20, OTUD7C"	ENSG00000118503	"TNF alpha induced protein 3"	P21580	6	137867214-137883312	"Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Apoptosis, Inflammatory response, Ubl conjugation pathway"	"DNA-binding, Hydrolase, Multifunctional enzyme, Protease, Thiol protease, Transferase"	"Cancer-related genes, Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 519.5"	"Cell type enhanced"	"Detected in many"		"Basal keratinocytes: 774.9;Endometrial ciliated cells: 605.2;Glandular and luminal cells: 1498.3;Macrophages: 596.6;Suprabasal keratinocytes: 745.7;T-cells: 624.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"GAMG: 106.5;Karpas-707: 161.3;REH: 151.5;U-266/84: 131.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA002116	Approved		Approved	Centrosome,Cytosol		NA	NA			"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 41: Macrophages - Immune response"	"Centrosome, Cytosol"		"HPA002116: AB_1858162"	"unprognostic (5.50e-3)"	"unprognostic (9.98e-3)"	"unprognostic (3.06e-2)"	"unprognostic (1.01e-2)"	"unprognostic (4.01e-2)"	"unprognostic (9.47e-2)"	"unprognostic (5.01e-3)"	"unprognostic (4.40e-2)"	"unprognostic (2.92e-2)"	"unprognostic (2.58e-1)"	"unprognostic (1.72e-1)"	"unprognostic (2.06e-1)"	"prognostic unfavorable (6.05e-4)"	"unprognostic (6.06e-2)"	"unprognostic (3.55e-3)"	"unprognostic (1.27e-1)"	"unprognostic (6.29e-2)"	57.0	15.6	4.4	114.6	3.8	519.5	23.3	2.9	23.9	27.5	12.0	22.6	21.4	31.3	5.2	26.6	23.4	47.8	23.0	3.2	2.8	13.8	27.4	56.2	76.8	6.1	3.9	73.2	25.8	25.8	7.5	28.9	6.7	17.3	24.7	19.1	16.1	10.3	8.6	50.5	30.7	33.5	6.6	46.1	22.8	8.3	9.5	71.1	11.7	3.8	55.7	171.1	14.6	6.2	32.6	4.8	1.8	2.8	10.1	16.9	7.8	18.8	67.6	4.8	5.7	34.9	8.8	7.3	43.1	20.0	106.5	22.6	1.1	50.4	8.9	46.8	2.2	7.5	19.8	21.1	11.2	10.3	12.8	15.6	7.3	56.4	53.6	5.6	2.9	21.2	17.4	161.3	8.4	1.8	56.2	41.4	1.5	2.1	1.4	151.5	39.4	6.1	14.8	15.1	0.7	0.3	3.6	5.3	16.9	7.0	3.4	11.7	14.8	46.9	6.8	46.0	9.6	48.7	131.4	14.0	16.9	13.1	6.1	7.3	12.6	9.6	19.6	9.3	27.9	7.4	19.4	18.0	14.3	7.8	13.1	10.1	13.6	11.1	5.1	26.2	19.2	14.8	4.4	3.8	2.9	23.9	3.2	2.8	6.1	3.9	6.7	6.6	9.5	6.2	71.8	38.5	76.3	2.0	94.5	774.9	150.2	102.1	384.7	1.1	29.0	42.3	4.6	25.8	53.7	0.0	29.2	8.1	395.5	53.9	1.9	60.0	2.6	605.2	365.9	114.8	11.9	5.2	0.1	26.9	104.8	110.1	111.1	1498.3	255.9	2.3	48.5	13.5	45.7	0.0	0.3	38.6	67.1	125.2	461.8	3.2	6.8	596.6	129.9	8.4	59.1	1.7	14.4	2.0	0.3	30.5	29.5	6.0	331.4	170.2	37.3	3.1	84.3	13.3	6.6	29.0	94.9	2.7	2.2	367.9	745.7	23.1	624.2	14.9	20.9	78.1
TNS2	"C1-TEN, KIAA1075, TENC1"	ENSG00000111077	"Tensin 2"	Q63HR2	12	53046969-53064379	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Hydrolase, Protein phosphatase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Adipocytes: 109.3;Hepatic stellate cells: 93.1;Leydig cells: 141.7;Peritubular cells: 114.0;Sertoli cells: 151.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"ASC diff: 114.2;ASC TERT1: 78.1;HHSteC: 59.9;HSkMC: 86.2;hTERT-RPE1: 61.9;TIME: 52.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA034659	Approved					NA	Yes				"Cluster 89: Fibroblasts - ECM organization"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"			"HPA034659: AB_10603349"	"unprognostic (1.04e-1)"	"unprognostic (2.58e-1)"	"unprognostic (5.21e-3)"	"unprognostic (1.86e-1)"	"unprognostic (3.59e-2)"	"unprognostic (7.26e-2)"	"unprognostic (6.29e-2)"	"unprognostic (5.42e-2)"	"unprognostic (1.48e-2)"	"unprognostic (8.97e-3)"	"prognostic favorable (1.72e-4)"	"prognostic favorable (9.32e-4)"	"unprognostic (4.46e-2)"	"unprognostic (1.09e-2)"	"unprognostic (8.46e-2)"	"unprognostic (1.47e-1)"	"unprognostic (2.76e-2)"	156.3	66.9	59.3	14.8	66.2	0.3	121.6	46.4	57.8	121.2	33.3	79.0	14.4	98.8	14.0	28.3	121.0	32.5	99.6	43.7	49.2	67.3	66.5	83.4	15.8	58.0	63.5	104.1	34.6	17.0	43.3	33.1	54.0	66.3	11.5	6.0	35.7	41.1	69.0	42.1	56.7	28.5	50.8	79.5	58.2	15.9	58.3	7.2	80.6	58.8	6.4	82.6	81.1	57.9	2.0	21.2	2.7	2.2	114.2	78.1	0.7	11.8	27.1	6.2	3.2	1.4	5.7	0.1	25.3	32.1	2.6	1.5	0.1	7.8	2.4	0.5	0.8	0.4	25.5	11.3	59.9	0.3	0.5	86.2	0.3	7.9	4.7	61.9	36.3	0.4	0.6	0.3	24.9	5.1	0.2	0.4	1.9	1.4	5.8	0.7	6.6	0.3	8.2	0.4	1.2	2.7	4.4	2.4	8.8	1.6	26.1	0.7	52.1	12.9	14.8	4.7	2.0	0.6	0.3	0.1	20.4	0.3	21.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	59.3	66.2	46.4	57.8	43.7	49.2	58.0	63.5	54.0	50.8	58.3	57.9	109.3	3.2	25.7	33.3	0.5	0.0	6.8	0.0	5.2	21.1	15.1	13.0	7.9	10.0	2.5	5.5	0.0	0.5	0.9	0.4	3.9	5.8	2.8	4.4	41.1	69.6	1.2	2.7	3.1	4.4	0.4	40.5	2.0	14.5	0.0	7.7	93.1	37.5	2.4	30.3	7.8	3.9	0.0	4.4	0.0	7.2	141.7	2.9	0.0	31.9	0.1	29.6	0.0	46.3	35.6	2.4	9.0	114.0	1.8	4.5	2.1	2.6	1.5	11.3	151.2	51.3	64.7	4.2	4.4	1.3	0.0	0.8	1.4	2.6	1.8	2.1
TPP1	"CLN2, LPIC, SCAR7, TPP-1"	ENSG00000166340	"Tripeptidyl peptidase 1"	O14773	11	6612768-6619448	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"		"Hydrolase, Protease, Serine protease"	"Disease variant, Epilepsy, Neurodegeneration, Neuronal ceroid lipofuscinosis, Spinocerebellar ataxia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Hofbauer cells: 261.6;Kupffer cells: 376.5;Macrophages: 219.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA037709, HPA044868"	Enhanced				"Intracellular and membrane"	NA	NA		9500000	"Cluster 25: Monocytes - Inflammatory response"	"Cluster 26: Pituitary gland - Hormone signaling"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 4: Macrophages - Innate immune response"			"HPA037709: AB_10672913, HPA044868: AB_2679122"	"unprognostic (8.27e-3)"	"unprognostic (5.85e-2)"	"unprognostic (7.12e-3)"	"unprognostic (3.34e-3)"	"unprognostic (1.56e-2)"	"prognostic unfavorable (4.31e-4)"	"prognostic unfavorable (1.11e-4)"	"unprognostic (6.32e-2)"	"unprognostic (3.01e-1)"	"unprognostic (2.39e-2)"	"unprognostic (1.31e-1)"	"unprognostic (6.54e-2)"	"unprognostic (6.23e-2)"	"prognostic unfavorable (4.46e-4)"	"unprognostic (3.87e-2)"	"unprognostic (2.59e-1)"	"unprognostic (1.12e-2)"	74.7	145.9	71.0	74.6	81.0	111.7	44.3	80.3	81.4	53.8	120.1	59.1	59.9	74.0	43.1	39.5	47.1	65.1	56.3	70.6	78.4	71.6	92.7	81.5	77.7	85.2	82.6	49.7	36.2	54.2	63.6	94.2	81.0	38.9	59.7	48.5	42.5	57.5	31.4	39.5	73.3	92.0	74.7	135.0	48.4	20.0	83.3	47.4	45.7	39.0	60.9	68.4	42.8	90.4	26.1	48.1	25.9	50.5	309.9	160.1	21.8	50.9	220.7	36.9	62.0	20.1	122.5	37.4	32.6	136.6	220.2	85.8	48.3	68.7	57.9	37.3	27.6	32.2	23.8	54.9	210.9	45.8	182.6	231.8	104.5	45.9	102.6	240.4	158.8	32.9	59.8	124.6	110.4	30.2	16.6	52.4	18.0	61.5	57.1	36.1	21.6	77.0	62.8	38.2	4.5	20.4	52.6	44.6	91.0	76.5	30.8	79.7	188.0	119.7	33.1	101.1	19.8	92.3	95.3	14.0	139.8	101.7	64.5	67.0	167.1	38.2	39.9	171.2	30.0	35.1	31.4	41.0	185.9	37.0	20.1	27.2	27.5	29.1	125.1	93.1	60.3	138.8	71.0	81.0	80.3	81.4	70.6	78.4	85.2	82.6	81.0	74.7	83.3	90.4	32.0	25.6	37.3	31.6	53.0	23.7	28.4	29.8	13.1	24.8	21.1	23.9	41.8	50.1	26.8	16.5	12.5	35.4	71.0	55.2	5.9	42.2	11.8	13.3	30.2	40.7	16.7	37.5	12.5	13.4	45.3	40.3	16.3	24.8	62.2	25.6	75.7	81.0	261.6	15.2	12.4	31.3	26.4	376.5	126.5	11.2	27.1	219.8	90.7	15.9	156.0	37.9	49.4	8.0	21.9	17.4	44.1	26.4	26.4	23.5	99.7	51.6	14.5	23.8	6.6	19.0	20.3	0.8	1.1	27.6	20.0	88.0	42.2	24.6	32.5	26.5
TPP2	TPPII	ENSG00000134900	"Tripeptidyl peptidase 2"	P29144	13	102596986-102679958	"Enzymes, Plasma proteins, Predicted intracellular proteins"		"Aminopeptidase, Hydrolase, Protease, Serine protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in all"	9	"Early spermatids: 796.3;Late spermatids: 892.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA021069, HPA049630"	Approved		Supported	"Nuclear bodies,Cytosol"		NA	NA		280000	"Cluster 39: Non-specific - mRNA processing"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 32: U-937 - Innate immune response"	"Cluster 25: Spermatids - Spermatogenesis"	"Nuclear bodies, Cytosol"		"HPA021069: AB_1858344, HPA049630: AB_2680836"	"unprognostic (4.75e-2)"	"unprognostic (4.78e-2)"	"unprognostic (9.97e-2)"	"unprognostic (1.08e-1)"	"unprognostic (2.01e-2)"	"unprognostic (4.43e-2)"	"unprognostic (2.45e-2)"	"unprognostic (8.33e-3)"	"unprognostic (5.02e-2)"	"unprognostic (1.51e-1)"	"unprognostic (3.12e-1)"	"unprognostic (2.75e-3)"	"unprognostic (6.26e-2)"	"unprognostic (3.12e-1)"	"unprognostic (7.53e-2)"	"unprognostic (3.95e-2)"	"unprognostic (3.43e-3)"	12.6	8.1	3.5	15.6	5.5	48.0	16.4	9.7	5.3	12.9	5.7	13.9	12.3	16.3	19.7	11.6	11.5	12.5	13.8	3.0	2.3	10.0	20.4	14.6	19.9	3.7	3.1	14.1	10.9	11.3	8.3	17.7	4.4	11.3	19.2	17.4	10.6	16.7	27.7	12.1	12.5	13.1	3.3	18.6	12.2	51.8	4.9	16.1	19.9	22.1	17.1	12.8	11.4	9.8	33.8	13.7	38.0	28.7	28.9	37.5	25.5	34.9	26.6	23.8	28.0	30.7	41.0	37.3	11.9	30.3	25.7	30.0	30.5	23.7	39.3	26.4	24.9	71.2	34.0	22.8	22.9	89.3	44.6	31.5	11.2	26.4	35.6	23.6	32.7	34.8	43.4	42.9	32.0	11.3	37.2	53.4	28.5	43.7	17.6	43.5	30.3	31.8	25.7	29.7	35.8	26.7	23.2	35.0	13.7	31.9	20.0	79.9	28.5	20.9	15.1	12.9	29.0	40.7	56.2	37.0	31.1	56.6	26.8	7.4	5.5	3.7	7.1	5.9	8.4	4.8	8.2	8.4	5.2	4.5	9.7	9.8	1.0	8.9	4.9	3.3	9.6	4.5	3.5	5.5	9.7	5.3	3.0	2.3	3.7	3.1	4.4	3.3	4.9	9.8	20.9	38.5	41.6	41.8	24.5	15.4	16.4	10.6	22.8	27.5	18.5	12.7	41.8	11.5	18.5	14.7	73.0	28.5	38.7	13.3	9.8	19.8	796.3	23.0	28.9	19.3	19.8	26.1	64.1	8.8	30.7	25.8	14.3	22.7	38.6	24.8	20.3	22.4	32.1	8.4	69.8	18.5	8.2	25.7	19.9	892.8	32.0	29.5	17.8	65.6	29.3	13.8	42.2	66.4	67.3	13.3	16.3	18.8	58.9	16.5	10.2	13.2	36.4	46.5	26.3	24.3	28.8	92.7	30.0	22.9	13.4	33.1	35.6	31.6	21.8	19.6
TPSAB1	"TPS1, TPS2, TPSB1"	ENSG00000172236	"Tryptase alpha/beta 1"	Q15661	16	1240379-1242554	"Disease related genes, Enzymes, Metabolic proteins, Potential drug targets, Predicted secreted proteins"		"Hydrolase, Protease, Serine protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enriched"	"Detected in some"	13	"granulocytes: 5873.9"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Immune cell enriched"	"Detected in single"	893	"basophil: 89.3"	"Lineage enriched"	"Detected in single"	893	"granulocytes: 89.3"	"Cell line enriched"	"Detected in some"	166	"HMC-1: 3813.2"									"CAB016369, CAB022175, HPA049153, HPA049554"	Supported				"Secreted to blood"	NA	NA			"Cluster 38: Basophils - Unknown function"	"Cluster 31: Skin - Epidermis development"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 60: Granulocytes - Receptor signaling"			"CAB016369: AB_628406, CAB022175: , HPA049153: AB_2680656, HPA049554: AB_2680815"	"unprognostic (2.06e-2)"	"unprognostic (5.14e-2)"	"unprognostic (2.02e-3)"	"unprognostic (1.64e-2)"	"unprognostic (9.31e-3)"	"prognostic favorable (9.62e-6)"	"unprognostic (1.02e-1)"	"unprognostic (4.08e-2)"	"unprognostic (1.80e-1)"	"unprognostic (1.43e-1)"	"unprognostic (2.24e-1)"	"unprognostic (2.83e-2)"	"unprognostic (4.13e-2)"	"unprognostic (2.23e-1)"	"unprognostic (2.81e-2)"	"unprognostic (1.16e-1)"	"unprognostic (1.36e-2)"	96.6	2.9	0.3	23.6	0.5	2.4	47.2	0.3	0.9	53.7	0.9	83.0	71.6	73.3	6.0	64.3	26.6	129.7	14.7	0.4	0.4	13.9	12.2	128.5	21.3	0.4	0.3	3.2	18.9	2.3	3.5	1.2	0.6	65.9	34.6	0.0	60.2	22.5	10.1	122.7	148.7	17.9	0.4	5.9	104.0	8.9	0.4	14.2	4.7	13.0	13.2	113.5	52.6	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	2.7	0.0	0.0	0.0	0.0	0.0	19.3	0.0	0.0	0.0	1.3	3813.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.7	0.0	0.3	2.1	6.1	0.5	0.4	0.0	0.4	0.0	0.5	0.0	0.0	0.0	0.4	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.4	0.5	0.1	1.1	0.0	0.0	2.8	22.9	2.0	89.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.3	0.5	0.3	0.9	0.4	0.4	0.4	0.3	0.6	0.4	0.4	0.3	0.0	25.6	135.5	0.0	2.9	18.6	5.1	0.0	1.2	0.0	0.9	0.1	0.3	0.0	8.1	0.0	0.0	0.0	0.2	0.9	0.0	1.2	0.3	0.0	0.0	4.1	0.0	3.8	0.0	0.0	0.2	7.6	0.5	0.0	5873.9	0.0	0.0	0.3	5.2	0.0	0.0	0.0	0.0	0.3	25.6	0.2	0.0	7.7	19.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.0	11.7	4.0	0.4	0.1	5.1	0.0	0.0	0.3	3.2	0.0	0.1	0.1	9.9	0.3	440.9	0.0	0.5	5.6
TPSB2		ENSG00000197253	"Tryptase beta 2"	P20231	16	1227272-1230184	"Enzymes, Metabolic proteins, Predicted secreted proteins"		"Hydrolase, Protease, Serine protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enriched"	"Detected in some"	25	"granulocytes: 8966.1"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Immune cell enriched"	"Detected in single"	50	"basophil: 5.0"	"Lineage enriched"	"Detected in single"	50	"granulocytes: 5.0"	"Cell line enriched"	"Detected in some"	7	"HMC-1: 297.5"									"HPA049153, HPA049554"	Supported				"Secreted to blood"	NA	NA		16000000	"Cluster 10: Basophils - Unknown function"	"Cluster 31: Skin - Epidermis development"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 60: Granulocytes - Receptor signaling"			"HPA049153: AB_2680656, HPA049554: AB_2680815"	"unprognostic (9.05e-2)"	"unprognostic (8.46e-3)"	"unprognostic (2.42e-3)"	"unprognostic (2.27e-2)"	"unprognostic (4.97e-3)"	"unprognostic (1.02e-3)"	"unprognostic (1.11e-1)"	"unprognostic (8.55e-2)"	"unprognostic (2.48e-1)"	"unprognostic (2.24e-1)"	"unprognostic (1.95e-1)"	"unprognostic (8.30e-3)"	"unprognostic (1.91e-2)"	"unprognostic (5.76e-2)"	"unprognostic (2.41e-2)"	"unprognostic (4.65e-2)"	"unprognostic (3.17e-2)"	95.1	2.5	0.3	20.2	0.6	4.3	47.8	0.3	0.9	53.2	1.0	77.8	35.5	71.8	9.8	64.6	30.4	103.9	15.0	0.5	0.5	15.5	12.2	127.8	26.2	0.5	0.4	3.5	18.9	1.5	3.9	1.3	0.5	67.0	19.8	0.0	64.5	13.3	10.0	122.5	146.1	22.0	0.5	5.2	102.1	9.9	0.5	4.9	4.7	10.4	9.9	118.6	53.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.4	0.0	0.0	0.0	0.0	0.0	41.2	0.0	0.0	0.2	0.4	297.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.3	4.7	0.3	1.4	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.2	0.0	0.0	0.4	0.0	0.7	5.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.6	0.3	0.9	0.5	0.5	0.5	0.4	0.5	0.5	0.5	0.3	0.1	38.5	275.3	0.0	2.8	0.0	4.4	0.0	0.0	0.0	1.5	0.0	1.5	0.0	16.7	0.0	0.0	0.1	0.6	0.7	0.0	2.4	0.6	0.0	0.0	3.2	0.0	18.9	0.0	0.0	0.2	6.0	2.0	0.0	8966.1	0.0	0.0	0.0	3.8	0.0	0.1	0.7	0.0	0.0	0.0	1.0	0.0	11.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	25.8	5.4	0.7	0.1	3.6	0.0	0.0	0.4	1.1	0.0	0.7	0.0	0.0	0.1	345.1	0.0	1.0	6.1
TPSD1		ENSG00000095917	"Tryptase delta 1"	Q9BZJ3	16	1256059-1259008	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Hydrolase, Protease, Serine protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"stomach 1: 21.2"	"Cell type enriched"	"Detected in some"	19	"granulocytes: 202.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in single"	29	"basophil: 2.9"	"Lineage enriched"	"Detected in single"	29	"granulocytes: 2.9"	"Group enriched"	"Detected in some"	49	"HEL: 28.2;HMC-1: 40.4"									"CAB002215, CAB032871, HPA040182, HPA049554"	Supported				"Intracellular and membrane"	NA	NA			"Cluster 10: Basophils - Unknown function"	"Cluster 12: Smooth muscle tissue - Mixed function"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 60: Granulocytes - Receptor signaling"			"CAB002215: AB_563870, CAB032871: AB_2206475, HPA040182: AB_2676875, HPA049554: AB_2680815"	"unprognostic (5.99e-2)"	"unprognostic (3.00e-1)"	"unprognostic (1.38e-1)"	"unprognostic (1.04e-2)"	"unprognostic (8.97e-3)"	"unprognostic (1.15e-4)"	"unprognostic (1.70e-1)"	"unprognostic (5.45e-2)"	"unprognostic (9.00e-2)"	"unprognostic (2.88e-1)"	"unprognostic (4.30e-1)"	"unprognostic (2.94e-2)"	"unprognostic (2.50e-3)"	"unprognostic (3.74e-2)"	"unprognostic (4.14e-1)"	"unprognostic (3.89e-1)"	"unprognostic (7.46e-3)"	8.0	0.5	1.2	1.9	1.3	1.6	4.5	1.3	2.7	5.1	1.0	7.8	3.8	8.5	1.9	8.1	3.2	13.8	1.1	1.4	1.1	1.2	0.7	17.8	5.4	1.4	1.3	0.3	1.5	0.1	0.4	0.1	1.5	5.5	0.8	0.1	4.8	1.2	1.4	9.5	13.4	5.4	1.1	0.4	21.2	1.3	1.4	1.2	0.3	1.0	2.3	13.3	5.0	1.2	0.0	0.1	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	28.2	0.0	0.0	0.0	0.2	40.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.6	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	1.3	1.3	2.7	1.4	1.1	1.4	1.3	1.5	1.1	1.4	1.2	0.0	3.2	7.7	0.0	0.0	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	10.5	0.0	0.0	0.0	0.2	0.0	0.0	202.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.5	0.0	0.0	0.1
TPTE	"CT44, PTEN2"	ENSG00000274391	"Transmembrane phosphatase with tensin homology"	P56180	21	10521553-10606140	"Enzymes, Metabolic proteins, Plasma proteins, Predicted membrane proteins"		"Hydrolase, Protein phosphatase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	201	"testis: 107.2"	"Cell type enriched"	"Detected in some"	6	"Spermatocytes: 464.7"	"Cancer enriched"	"Detected in single"	7	"testis cancer: 0.8"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BEWO: 6.7;K-562: 8.2;Karpas-707: 6.4;MCF7: 4.9;PC-3: 4.8;RPMI-8226: 9.0;SuSa: 7.6;U-266/70: 7.7"									"HPA049690, HPA068342"	Enhanced		Approved	"Endoplasmic reticulum,Cytosol"		NA	NA				"Cluster 36: Testis - Spermatogenesis"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 13: Spermatocytes & Spermatogonia - Spermatogenesis"	Cytosol	"Endoplasmic reticulum"	"HPA049690: AB_2680850, HPA068342: AB_2685976"															"unprognostic (3.63e-2)"			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	107.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	3.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.2	6.4	0.0	4.9	0.0	0.0	1.0	0.0	4.8	0.0	0.0	9.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	7.6	0.0	0.0	0.0	1.8	4.1	2.1	0.0	7.7	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	20.6	0.1	0.0	0.1	0.0	0.0	0.7	0.0	1.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.6	0.0	0.0	0.0	0.3	13.9	5.0	0.1	0.0	1.9	0.0	0.0	0.0	0.5	0.3	0.0	0.0	2.6	0.0	0.0	0.0	0.4	0.0	0.0	13.1	0.0	0.0	464.7	69.0	0.0	0.0	1.1	0.0	0.0	0.0	0.1
TPTE2	TPIP	ENSG00000132958	"Transmembrane phosphoinositide 3-phosphatase and tensin homolog 2"	Q6XPS3	13	19422877-19536762	"Enzymes, Metabolic proteins, Plasma proteins, Predicted membrane proteins"		Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	8	"testis: 7.5"	"Cell type enhanced"	"Detected in some"		"Astrocytes: 4.9;Early spermatids: 9.8;Excitatory neurons: 4.6;Inhibitory neurons: 6.3;Microglial cells: 3.7;Oligodendrocyte precursor cells: 7.5;Oligodendrocytes: 3.6;Spermatocytes: 14.8;Spermatogonia: 3.9"	"Cancer enriched"	"Detected in single"	6	"testis cancer: 0.8"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"HDLM-2: 4.8;Karpas-707: 1.3"									HPA068342			Approved	"Endoplasmic reticulum,Cytosol"		NA	NA				"Cluster 78: Testis - Spermatogenesis"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 66: Spermatocytes - Spermatogenesis"	Cytosol	"Endoplasmic reticulum"	"HPA068342: AB_2685976"	"unprognostic (2.50e-1)"	"unprognostic (2.10e-1)"	"unprognostic (1.76e-1)"	"unprognostic (2.70e-1)"	"unprognostic (1.25e-2)"	"unprognostic (5.33e-3)"		"unprognostic (1.90e-1)"	"unprognostic (1.24e-1)"	"unprognostic (5.40e-2)"	"unprognostic (3.67e-2)"	"unprognostic (2.81e-1)"	"unprognostic (1.05e-12)"	"unprognostic (1.04e-1)"	"unprognostic (1.47e-1)"	"unprognostic (2.44e-1)"	"unprognostic (5.00e-3)"	0.1	0.1	0.3	0.1	0.4	0.0	0.1	0.6	0.9	0.0	0.2	0.1	0.2	0.0	0.2	0.0	0.1	0.0	0.0	0.4	0.5	0.1	0.0	0.0	0.2	0.5	0.4	0.0	0.0	0.0	0.1	0.1	0.6	0.0	0.0	0.4	0.1	0.1	0.0	0.0	0.1	0.0	0.5	0.2	0.1	7.5	0.4	0.0	0.0	0.0	0.3	0.0	0.0	0.7	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	4.8	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	1.3	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.4	0.6	0.9	0.4	0.5	0.5	0.4	0.6	0.5	0.4	0.7	0.0	0.0	0.0	4.9	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.3	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	9.8	0.1	0.0	0.1	0.0	0.0	4.6	0.0	0.1	0.2	0.0	0.0	0.0	0.1	0.7	0.0	0.1	0.0	6.3	0.0	0.0	0.3	0.0	1.5	0.3	0.0	0.0	3.7	0.1	0.5	0.0	7.5	3.6	0.0	0.0	0.0	0.4	0.2	0.0	0.1	0.0	0.2	0.0	0.0	0.1	14.8	3.9	0.0	0.1	0.1	0.1	0.1	0.0	0.2
TREH	"MGC129621, TRE, TREA"	ENSG00000118094	Trehalase	O43280	11	118657316-118679690	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"		"Glycosidase, Hydrolase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	5	"intestine: 66.3"	"Group enriched"	"Detected in some"	5	"Late spermatids: 315.7;Proximal enterocytes: 186.3"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"BEWO: 1.6"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"HPA039913, HPA042045"	Enhanced		Approved	Vesicles,Cytosol	"Intracellular and membrane"	NA	NA		12000000		"Cluster 56: Intestine - Transmembrane transport"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 45: Enterocytes - Digestion"	Cytosol	Vesicles	"HPA039913: AB_10674988, HPA042045: AB_2677817"	"unprognostic (1.29e-1)"	"unprognostic (1.58e-1)"	"unprognostic (1.01e-2)"	"unprognostic (5.22e-4)"	"unprognostic (2.52e-1)"	"unprognostic (9.83e-2)"	"prognostic favorable (3.76e-4)"	"unprognostic (1.17e-1)"	"unprognostic (1.34e-1)"	"unprognostic (2.42e-1)"	"unprognostic (1.04e-1)"	"unprognostic (1.63e-2)"	"prognostic favorable (2.33e-6)"	"unprognostic (2.09e-2)"	"unprognostic (6.30e-2)"	"unprognostic (1.22e-1)"	"unprognostic (1.15e-1)"	0.7	0.2	1.6	0.3	3.7	0.0	0.4	0.6	3.8	0.3	0.0	1.6	60.0	0.4	0.6	1.6	0.3	2.6	1.0	1.1	2.7	13.4	6.1	0.2	0.1	2.1	2.0	0.2	1.8	0.0	0.3	0.1	1.9	0.5	1.3	0.0	0.2	0.0	0.0	0.1	66.3	0.1	0.6	0.1	1.7	1.8	2.5	0.0	0.4	0.0	0.0	0.4	0.3	6.0	0.0	0.0	0.0	0.0	0.0	0.1	1.6	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.2	0.5	0.0	0.4	0.0	0.2	0.0	0.2	0.0	0.7	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	3.7	0.6	3.8	1.1	2.7	2.1	2.0	1.9	0.6	2.5	6.0	0.2	0.0	0.0	0.0	0.0	0.0	0.5	0.0	1.8	0.0	0.0	0.3	0.3	1.5	0.0	1.8	0.0	0.1	0.0	2.3	7.9	0.2	45.6	0.8	1.6	0.1	3.0	0.0	0.1	2.5	0.0	0.3	4.6	0.2	0.0	0.0	0.0	0.2	0.1	0.0	0.1	7.0	0.0	0.0	0.4	315.7	2.1	0.1	0.0	0.0	0.0	0.0	0.0	1.5	5.3	0.9	6.3	1.9	0.1	0.3	186.3	32.8	0.0	0.0	0.0	0.3	0.2	1.7	0.8	2.1	0.0	0.0	0.1	0.0	3.7	0.0
TREX1	"AGS1, DRN3"	ENSG00000213689	"Three prime repair exonuclease 1"	Q9NSU2	3	48465811-48467645	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted membrane proteins"		"Exonuclease, Hydrolase, Nuclease"	"Aicardi-Goutieres syndrome, Disease variant, Neurodegeneration, Systemic lupus erythematosus"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Basal respiratory cells: 53.6;Club cells: 24.5;Ionocytes: 40.7;Langerhans cells: 22.6;Melanocytes: 24.9;Respiratory ciliated cells: 29.9"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"BJ hTERT+ SV40 Large T+ RasG12V: 67.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035437, HPA046721"	Supported		Supported	Cytosol		NA	NA			"Cluster 25: Monocytes - Inflammatory response"	"Cluster 73: Brain - Neuropeptide signaling"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"	Cytosol		"HPA035437: AB_10672092, HPA046721: AB_2732531"																		9.9	14.3	32.7	16.5	33.4	28.7	12.2	33.2	42.1	13.8	39.8	12.4	11.1	7.7	11.4	19.2	15.5	13.8	10.7	33.0	32.7	12.2	12.8	13.8	26.6	33.0	34.2	7.4	13.1	11.3	20.6	8.4	34.3	16.6	9.9	1.9	36.5	15.4	9.7	26.4	12.0	7.0	33.8	25.0	13.7	4.0	33.5	18.1	8.4	13.8	18.1	13.1	10.4	33.7	19.2	18.1	13.3	10.3	18.1	17.5	0.0	6.7	29.5	46.9	67.5	0.3	21.8	23.8	11.7	24.4	44.8	21.4	0.9	27.2	6.7	19.9	1.6	13.5	58.1	0.5	20.1	12.8	9.3	16.2	2.5	25.9	9.8	9.8	20.4	16.9	0.0	32.6	20.7	0.4	17.3	8.6	0.1	11.0	11.2	14.4	4.9	43.2	13.4	3.8	0.1	8.1	21.8	29.6	15.4	0.9	0.8	20.3	22.2	8.5	9.2	21.8	14.2	26.4	16.9	10.4	21.5	25.4	7.5	7.7	142.3	11.0	32.6	119.2	18.7	86.8	43.0	31.4	125.9	87.5	40.3	33.8	82.2	30.9	94.6	99.1	43.3	78.6	32.7	33.4	33.2	42.1	33.0	32.7	33.0	34.2	34.3	33.8	33.5	33.7	0.0	0.0	0.5	6.8	2.1	9.1	0.0	53.6	0.6	0.0	0.0	0.0	6.3	0.0	24.5	0.0	0.0	0.0	0.0	4.3	0.0	0.0	0.0	0.0	0.0	4.6	0.0	1.7	2.3	0.0	0.0	4.3	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	2.8	40.7	0.0	22.6	0.0	0.0	2.0	24.9	5.6	0.0	0.0	0.0	1.0	5.9	0.0	1.1	0.0	3.9	0.0	0.0	0.0	29.9	0.0	0.0	0.0	4.2	0.0	0.0	2.7	13.9	0.0	2.6	0.0	1.5	0.0
TREX2		ENSG00000183479	"Three prime repair exonuclease 2"	Q9BQ50	X	153444720-153470587	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"DNA damage, DNA repair"	"Exonuclease, Hydrolase, Nuclease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"skin 1: 24.5"	"Cell type enhanced"	"Detected in single"		"Suprabasal keratinocytes: 1.1"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in single"			"Group enriched"	"Detected in some"	11	"basophil: 1.7;eosinophil: 2.7"	"Lineage enriched"	"Detected in single"	14	"granulocytes: 2.7"	"Cell line enhanced"	"Detected in many"		"HEK 293: 5.4;U-698: 7.3;U-937: 7.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA054060	Uncertain					NA	NA			"Cluster 10: Basophils - Unknown function"	"Cluster 61: Skin - Cornification"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 47: Cytotrophoblasts - Unknown function"			"HPA054060: AB_2682362"	"unprognostic (2.32e-2)"	"unprognostic (2.05e-3)"	"unprognostic (1.13e-3)"	"unprognostic (7.18e-4)"	"unprognostic (6.05e-2)"	"unprognostic (1.81e-2)"	"unprognostic (8.40e-2)"	"unprognostic (2.19e-1)"	"unprognostic (2.09e-1)"	"unprognostic (1.61e-1)"	"unprognostic (1.70e-1)"	"unprognostic (1.57e-1)"	"unprognostic (1.42e-1)"	"unprognostic (1.52e-1)"	"unprognostic (9.34e-2)"	"unprognostic (2.15e-1)"	"unprognostic (1.23e-2)"	0.9	0.5	0.4	0.6	0.4	0.7	0.8	0.5	1.1	3.2	5.0	0.6	0.2	1.2	0.6	2.9	1.2	0.7	1.0	0.7	0.2	1.4	0.6	1.1	1.4	0.5	0.3	0.9	0.8	0.2	0.7	0.9	0.5	1.3	0.2	0.0	1.9	2.4	0.3	24.5	1.1	0.5	0.3	2.4	0.7	1.0	0.4	0.5	1.3	0.1	1.1	0.6	3.2	0.4	2.1	2.6	0.2	0.9	0.3	0.5	0.2	0.6	0.5	0.5	1.4	0.7	0.5	0.2	1.3	0.5	0.1	2.2	0.9	1.4	0.0	2.3	5.4	0.2	0.5	0.3	0.2	0.6	1.4	0.6	1.3	0.6	0.5	0.3	0.2	0.4	0.3	2.5	0.1	2.5	1.5	1.6	0.8	0.4	1.7	3.5	0.7	1.7	0.2	0.7	0.6	0.3	0.2	0.2	0.8	0.0	0.4	0.7	0.0	0.9	1.6	2.0	0.8	2.8	2.1	7.3	0.2	7.0	1.1	1.7	0.0	2.7	0.1	0.0	0.1	0.1	0.0	0.1	0.1	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.4	0.4	0.5	1.1	0.7	0.2	0.5	0.3	0.5	0.3	0.4	0.4	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	1.1	0.7	0.1	0.1	0.0	0.1
TRHDE	"PAP-II, PGPEP2, TRH-DE"	ENSG00000072657	"Thyrotropin releasing hormone degrading enzyme"	Q9UKU6	12	72087266-72670758	"Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins"		"Aminopeptidase, Hydrolase, Metalloprotease, Protease"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 7.6;pancreas: 10.3"	"Group enriched"	"Detected in some"	4	"Excitatory neurons: 216.9;Inhibitory neurons: 292.7"	"Cancer enhanced"	"Detected in some"		"renal cancer: 1.9"	"Group enriched"	"Detected in many"	5	"basal ganglia: 4.9;cerebellum: 4.4;cerebral cortex: 2.5;hippocampal formation: 7.6"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BJ: 30.3;BJ hTERT+: 29.1;EFO-21: 15.3;HBF TERT88: 10.3;hTERT-RPE1: 10.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"									NA	NA		7300000		"Cluster 22: Non-specific - Unknown function"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"				"unprognostic (3.56e-2)"	"unprognostic (4.06e-3)"	"unprognostic (6.01e-2)"	"unprognostic (1.44e-6)"	"unprognostic (1.77e-1)"	"unprognostic (6.37e-2)"	"unprognostic (7.79e-2)"	"unprognostic (6.96e-2)"	"unprognostic (3.99e-2)"	"unprognostic (1.48e-1)"	"unprognostic (5.14e-4)"	"unprognostic (2.40e-1)"	"prognostic favorable (1.53e-7)"	"unprognostic (2.55e-2)"	"unprognostic (2.48e-1)"	"unprognostic (8.91e-3)"	"unprognostic (2.94e-2)"	3.6	0.9	0.1	0.3	4.9	0.4	0.8	4.4	2.5	3.7	0.0	1.1	2.4	1.2	0.6	0.2	1.1	0.8	0.8	7.6	0.0	5.1	0.5	1.4	0.1	0.0	0.9	3.2	10.3	0.0	0.1	0.1	0.0	1.3	0.5	0.8	0.8	2.8	0.2	0.2	2.1	0.4	0.0	2.5	0.3	0.7	0.0	0.1	0.0	0.4	0.3	1.2	2.3	0.0	3.6	0.0	0.6	0.0	1.6	0.0	9.5	30.3	29.1	2.9	1.9	0.0	0.0	0.0	15.3	4.3	3.0	0.4	5.4	0.0	10.3	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	2.4	0.0	0.0	2.3	10.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	8.7	0.0	0.0	0.0	9.5	6.7	2.9	0.1	0.0	0.0	0.0	0.5	0.0	5.7	0.0	0.0	3.2	0.0	0.5	0.0	0.0	0.0	0.0	0.7	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	4.9	4.4	2.5	7.6	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.2	0.0	0.5	2.9	0.0	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.9	1.5	0.0	1.8	0.0	0.1	0.0	7.1	3.9	0.0	35.9	0.1	0.4	0.2	0.0	0.0	216.9	2.6	0.4	4.7	0.0	0.3	0.0	0.1	0.4	1.4	0.2	0.0	292.7	3.5	0.0	0.0	0.0	62.8	29.5	0.7	0.0	2.8	0.0	0.4	0.0	38.2	4.0	2.2	3.9	13.5	0.0	0.2	15.8	9.1	0.7	0.6	0.0	37.4	0.6	0.2	0.7	0.0	0.0	0.1	0.1	0.2	1.6	0.1
TWNK	"C10orf2, FLJ21832, IOSCA, PEO, PEO1, TWINKLE, TWINL"	ENSG00000107815	"Twinkle mtDNA helicase"	Q96RR1	10	100987367-100994403	"Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins"	"DNA replication"	"Helicase, Hydrolase"	"Deafness, Disease variant, Neurodegeneration, Neuropathy, Primary mitochondrial disease, Progressive external ophthalmoplegia"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Breast glandular cells: 6.8;Breast myoepithelial cells: 6.6;Ductal cells: 5.4;Endometrial stromal cells: 7.2;Granulosa cells: 7.1;Theca cells: 9.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA002532	Uncertain					NA	NA			"Cluster 44: Non-specific - Transcription"	"Cluster 52: Non-specific - Ribosome"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 7: Non-specific - Mitochondria"			"HPA002532: AB_1078311"	"unprognostic (8.10e-2)"	"unprognostic (9.65e-2)"	"unprognostic (1.16e-1)"	"unprognostic (2.19e-2)"	"unprognostic (2.81e-2)"	"unprognostic (1.19e-1)"	"unprognostic (7.82e-3)"	"unprognostic (7.99e-2)"	"unprognostic (1.22e-1)"	"unprognostic (7.95e-2)"	"unprognostic (7.52e-2)"	"unprognostic (1.96e-2)"	"unprognostic (9.46e-2)"	"unprognostic (9.82e-3)"	"unprognostic (1.64e-1)"	"unprognostic (1.36e-1)"	"unprognostic (1.45e-1)"	4.9	7.0	3.7	5.5	3.7	3.0	7.5	3.6	3.5	3.8	3.2	4.4	3.3	4.6	5.3	5.5	6.6	2.6	5.0	3.4	3.6	5.9	6.0	2.1	6.1	3.9	4.0	5.1	5.2	4.8	2.4	3.8	3.8	4.0	4.8	1.6	4.0	3.4	11.6	5.5	3.8	4.5	3.7	4.6	3.9	8.3	4.0	8.1	4.1	12.6	8.3	6.6	3.5	3.5	15.5	32.0	12.5	39.7	11.1	7.2	14.7	11.4	14.8	17.3	16.6	52.6	13.1	55.4	21.1	7.0	10.4	25.0	52.2	27.7	21.1	25.5	31.0	42.1	17.4	40.2	19.1	54.8	16.7	14.9	30.7	25.5	77.6	15.8	10.6	26.3	45.9	15.0	12.3	21.2	37.0	18.8	35.8	28.2	25.9	35.5	27.5	33.2	10.7	15.4	20.1	38.5	12.0	16.0	37.8	13.8	20.9	16.0	12.4	8.6	17.4	10.6	32.5	28.0	31.3	46.0	10.6	47.8	9.8	1.2	0.6	0.1	1.2	0.5	3.7	2.4	1.8	2.7	1.2	2.1	2.0	2.2	0.0	2.5	0.8	1.3	0.4	1.4	3.7	3.7	3.6	3.5	3.4	3.6	3.9	4.0	3.8	3.7	4.0	3.5	3.5	0.0	2.6	0.0	1.0	0.0	0.0	0.0	0.0	0.0	6.8	6.6	0.0	0.0	3.1	1.8	0.0	4.2	1.9	0.0	3.9	5.4	0.0	2.3	7.2	2.0	0.0	0.0	0.0	3.0	3.7	1.3	0.0	2.8	1.3	7.1	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	1.0	0.0	0.0	0.0	0.0	4.5	0.0	0.0	0.4	0.0	0.0	2.3	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	1.6	1.1	9.1	0.0	0.0
UBASH3B	"KIAA1959, STS-1, TULA-2, TULA2"	ENSG00000154127	"Ubiquitin associated and SH3 domain containing B"	Q8TF42	11	122655722-122814473	"Enzymes, Predicted intracellular proteins"		"Hydrolase, Protein phosphatase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 15.0;lymphoid tissue: 15.6;placenta: 13.8"	"Cell type enhanced"	"Detected in many"		"Extravillous trophoblasts: 54.9;Inhibitory neurons: 166.3;Langerhans cells: 51.2;Syncytiotrophoblasts: 47.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HEL: 122.2;HMC-1: 88.9;hTEC/SVTERT24-B: 72.9;REH: 73.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038605, HPA038606, HPA038607"	Approved		Approved	"Nucleoplasm,Nuclear bodies,Cytosol"		NA	NA		23000	"Cluster 45: Eosinophils - Innate immune response"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Cytosol	"Nucleoplasm, Nuclear bodies"	"HPA038605: AB_10669648, HPA038606: , HPA038607: AB_2676112"	"unprognostic (4.94e-2)"	"unprognostic (6.03e-3)"	"unprognostic (1.34e-1)"	"unprognostic (2.98e-1)"	"unprognostic (2.02e-1)"	"unprognostic (1.49e-1)"	"unprognostic (9.09e-2)"	"unprognostic (4.67e-3)"	"unprognostic (1.21e-1)"	"unprognostic (1.95e-1)"	"unprognostic (1.46e-3)"	"unprognostic (6.20e-2)"	"unprognostic (9.02e-3)"	"unprognostic (1.54e-1)"	"unprognostic (3.22e-2)"	"unprognostic (2.72e-3)"	"unprognostic (1.53e-1)"	3.4	0.7	1.1	4.8	1.5	6.7	1.1	15.0	1.9	3.0	0.1	1.2	1.3	1.0	0.2	1.1	0.5	1.9	0.9	1.2	5.5	1.7	1.3	4.6	5.7	10.3	7.1	0.2	0.6	0.4	0.3	13.8	10.2	0.7	1.4	1.9	0.7	0.7	1.1	3.4	1.7	1.9	1.2	15.6	1.4	1.2	2.8	15.1	2.3	0.3	3.2	4.4	0.5	1.4	13.1	31.5	5.6	7.5	2.4	4.4	29.1	45.6	25.1	18.1	13.9	12.5	6.8	5.3	3.5	24.3	17.2	6.4	0.1	16.3	28.7	0.2	0.9	122.2	1.0	10.8	6.7	15.0	88.9	3.9	1.0	72.9	26.9	19.7	12.4	5.3	0.1	0.1	17.8	0.5	18.5	9.6	2.5	13.3	7.4	73.3	3.3	0.7	28.6	10.9	12.7	0.2	12.1	0.9	10.1	11.7	0.2	4.0	32.3	23.4	12.6	13.9	19.1	1.0	0.0	15.1	12.4	20.6	43.4	0.0	1.3	9.9	1.8	6.3	1.9	0.3	2.3	1.7	1.7	1.1	2.6	1.4	2.7	6.4	11.1	0.2	4.7	1.8	1.1	1.5	15.0	1.9	1.2	5.5	10.3	7.1	10.2	1.2	2.8	1.4	2.2	0.0	4.7	9.1	4.6	7.1	4.2	3.4	2.8	1.8	1.2	1.3	1.1	0.0	2.0	3.7	0.0	32.5	10.0	0.6	0.0	8.4	2.4	0.6	4.0	4.5	0.0	1.7	24.8	9.7	54.9	4.9	2.0	1.5	12.7	11.5	5.0	0.6	35.7	11.8	166.3	0.5	4.1	26.0	51.2	3.9	0.0	26.5	1.8	30.0	9.1	0.2	17.5	26.2	2.7	26.3	0.3	0.4	11.4	4.7	0.2	0.6	2.5	1.1	0.0	3.8	3.4	0.1	0.8	2.4	6.0	47.6	16.8	0.1	0.4	3.1
UBLCP1	"CPUB1, MGC10067"	ENSG00000164332	"Ubiquitin like domain containing CTD phosphatase 1"	Q8WVY7	5	159263290-159286036	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Hydrolase, Protein phosphatase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA039615	Approved		Supported	"Nucleoplasm,Nucleoli,Nucleoli rim"		NA	NA			"Cluster 18: Basophils - Vesicular transport"	"Cluster 16: Immune cells - Immune response"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 59: Non-specific - Transcription"	"Nucleoplasm, Nucleoli, Nucleoli rim"		"HPA039615: AB_10674425"	"unprognostic (1.25e-1)"	"unprognostic (3.10e-1)"	"unprognostic (6.04e-3)"	"unprognostic (3.45e-2)"	"unprognostic (7.08e-2)"	"unprognostic (6.82e-2)"	"prognostic unfavorable (4.46e-5)"	"unprognostic (4.01e-1)"	"unprognostic (2.14e-2)"	"unprognostic (1.98e-1)"	"unprognostic (1.91e-2)"	"unprognostic (5.43e-2)"	"unprognostic (1.16e-1)"	"unprognostic (1.87e-1)"	"unprognostic (1.18e-1)"	"unprognostic (6.39e-2)"	"unprognostic (2.51e-2)"	19.0	16.3	8.8	24.5	9.4	23.3	20.5	9.6	14.1	19.9	6.4	15.7	12.6	23.6	17.2	21.1	15.1	17.1	16.4	10.0	10.5	19.2	18.3	22.4	33.7	10.3	9.5	15.8	14.9	19.7	5.6	23.6	10.2	17.5	16.9	18.2	14.2	19.6	10.9	15.5	12.7	22.8	9.6	26.7	15.8	30.5	10.7	36.4	16.6	13.8	37.3	21.3	11.7	10.7	39.9	28.6	57.9	64.1	58.9	54.5	34.1	42.5	64.6	42.8	56.6	23.5	27.1	35.7	46.1	53.7	60.9	29.7	36.3	81.8	74.3	71.3	35.7	27.3	23.8	21.9	74.0	62.7	41.1	48.1	76.8	38.9	77.2	34.0	41.4	36.4	38.4	47.0	60.8	12.9	33.5	22.9	41.7	20.0	17.1	42.3	56.5	42.8	44.4	30.4	30.4	42.9	42.7	29.0	115.8	34.6	30.2	45.6	44.2	44.0	37.8	22.8	54.9	36.9	39.8	53.5	46.1	43.9	66.1	47.6	10.8	27.5	25.5	22.4	28.4	18.5	23.9	26.7	14.2	16.7	26.9	29.1	30.8	42.8	24.5	17.8	28.3	13.6	8.8	9.4	9.6	14.1	10.0	10.5	10.3	9.5	10.2	9.6	10.7	10.7	31.9	12.8	41.6	12.7	43.0	15.9	10.3	43.0	35.3	12.7	22.5	14.4	16.8	10.0	34.4	14.7	4.2	31.8	36.8	13.2	35.2	23.0	8.5	23.2	32.1	24.2	10.7	30.1	26.3	24.9	18.7	27.1	29.6	17.4	45.0	16.9	28.5	15.6	39.0	20.2	25.0	14.6	18.3	40.0	16.4	4.2	20.5	33.1	17.8	14.0	30.9	17.6	32.0	22.6	25.6	22.5	10.1	24.8	39.3	13.2	8.8	34.5	37.4	13.1	19.7	18.8	26.2	74.0	61.5	51.8	20.6	17.8	40.8	30.7	14.5	10.1
UCHL1	"PARK5, PGP9.5, Uch-L1"	ENSG00000154277	"Ubiquitin C-terminal hydrolase L1"	P09936	4	41256413-41268455	"Disease related genes, Enzymes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Ubl conjugation pathway"	"Hydrolase, Protease, Thiol protease"	"Disease variant, Hereditary spastic paraplegia, Neurodegeneration, Parkinson disease, Parkinsonism"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"brain: 692.7;pituitary gland: 285.4"	"Cell type enhanced"	"Detected in many"		"Collecting duct cells: 115.8;Distal tubular cells: 258.2;Excitatory neurons: 147.1;Horizontal cells: 146.4;Inhibitory neurons: 118.4;Spermatogonia: 88.4"	"Cancer enhanced"	"Detected in all"		"glioma: 129.4"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"EFO-21: 1142.2;SCLC-21H: 1160.6;U-251 MG: 1162.6;U-266/84: 1138.4;U-87 MG: 1209.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB002580, HPA005993, CAB079024"	Enhanced	Supported	Supported	Nucleoplasm,Cytosol		NA	NA		500000	"Cluster 43: B-cells - Humoral immune response"	"Cluster 26: Pituitary gland - Hormone signaling"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 39: Non-specific - Basic cellular processes"	Cytosol	Nucleoplasm	"CAB002580: AB_563981, CAB079024: , HPA005993: AB_1858560"	"unprognostic (1.54e-1)"	"unprognostic (1.96e-1)"	"unprognostic (1.12e-1)"	"prognostic unfavorable (4.08e-5)"	"unprognostic (2.34e-1)"	"unprognostic (1.98e-1)"	"unprognostic (6.28e-3)"	"unprognostic (1.09e-2)"	"unprognostic (4.31e-2)"	"unprognostic (8.77e-3)"	"unprognostic (3.56e-3)"	"unprognostic (3.70e-2)"	"unprognostic (1.82e-3)"	"unprognostic (1.24e-2)"	"unprognostic (7.12e-3)"	"unprognostic (2.10e-2)"	"prognostic unfavorable (1.93e-4)"	30.1	104.4	211.4	19.2	188.8	0.6	13.6	83.4	342.7	18.9	0.0	49.0	9.0	13.2	3.3	3.3	9.7	12.3	26.9	229.7	692.7	62.7	1.6	8.2	12.9	255.7	205.2	35.6	11.6	0.6	285.4	2.5	446.7	12.3	6.9	38.3	3.7	5.8	27.5	4.7	18.9	9.2	122.2	2.7	14.5	16.5	150.3	4.1	9.8	7.7	7.3	31.7	29.1	231.2	3.3	712.8	146.8	0.4	18.9	19.7	0.4	681.4	352.8	236.0	243.4	149.0	0.9	0.0	1142.2	384.4	356.7	1.1	262.8	0.6	116.4	1.5	97.0	0.0	6.9	0.2	529.3	0.1	1.2	127.4	3.0	197.9	0.0	413.7	2.0	0.0	0.0	2.3	122.6	0.6	1.0	12.3	435.3	0.0	714.1	0.1	297.2	0.7	386.3	0.3	1160.6	765.7	5.1	2.8	1.8	165.4	0.8	5.0	3.3	16.8	5.2	0.4	1162.6	583.1	1138.4	3.1	1209.3	1.1	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	211.4	188.8	83.4	342.7	229.7	692.7	255.7	205.2	446.7	122.2	150.3	231.2	0.8	0.0	3.1	29.0	2.1	1.7	1.1	1.5	1.2	25.6	0.3	0.6	3.1	0.0	3.5	115.8	8.4	3.6	0.0	0.1	258.2	4.3	3.5	0.9	9.8	3.9	4.2	0.8	147.1	0.8	0.8	35.4	1.1	0.5	2.5	46.3	8.9	0.6	4.7	146.4	118.4	0.0	4.1	0.6	3.4	6.0	37.0	2.3	3.6	35.6	0.6	21.6	0.0	55.8	54.6	3.0	0.0	17.3	9.2	3.7	0.0	17.1	7.4	61.3	0.0	3.6	35.7	10.4	88.4	0.3	1.6	1.5	1.3	20.0	0.2	1.0
UCHL3		ENSG00000118939	"Ubiquitin C-terminal hydrolase L3"	P15374	13	75549480-75606020	"Enzymes, Predicted intracellular proteins"	"Ubl conjugation pathway"	"Hydrolase, Protease, Thiol protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA019678, CAB037139, CAB037208"	Approved		Supported	Nucleoplasm,Cytosol		No	No		700000	"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 10: Non-specific - Unknown function"	"Nucleoplasm, Cytosol"		"CAB037139: AB_1841234, CAB037208: AB_1841235, HPA019678: AB_1858583"	"unprognostic (4.16e-1)"	"unprognostic (3.84e-2)"	"unprognostic (8.83e-3)"	"unprognostic (1.14e-1)"	"unprognostic (5.15e-2)"	"unprognostic (6.46e-3)"	"prognostic unfavorable (6.41e-4)"	"unprognostic (1.19e-1)"	"unprognostic (5.59e-2)"	"unprognostic (9.71e-2)"	"unprognostic (1.24e-1)"	"unprognostic (7.09e-2)"	"unprognostic (4.47e-2)"	"unprognostic (3.97e-1)"	"unprognostic (2.76e-2)"	"unprognostic (8.84e-2)"	"unprognostic (3.26e-2)"	20.7	56.9	20.6	20.2	24.2	33.5	34.2	20.3	25.2	15.3	17.2	35.4	21.6	12.4	63.2	58.0	13.0	17.7	29.3	21.7	20.5	32.2	50.9	15.0	21.3	18.6	18.9	7.4	30.9	23.9	22.9	24.6	18.5	19.5	39.5	9.7	27.2	18.2	53.9	48.6	19.9	25.1	18.9	15.9	25.1	43.3	20.5	25.7	44.4	40.6	34.6	44.3	26.6	21.0	196.0	31.9	26.9	18.8	49.9	58.6	78.6	72.3	70.3	90.7	100.5	177.5	92.1	100.4	50.2	75.7	70.2	105.8	64.1	175.3	137.1	53.8	55.9	62.2	50.7	114.9	71.6	150.4	45.7	52.6	118.7	71.7	114.2	38.4	90.1	79.6	70.0	27.9	138.9	70.2	62.4	100.2	40.3	229.0	95.1	49.5	42.9	66.3	108.4	77.9	81.0	23.8	40.8	78.3	34.5	58.2	45.7	42.0	70.8	39.6	47.9	42.7	98.2	39.5	45.5	117.1	80.4	161.3	29.0	57.6	68.7	49.3	29.9	134.4	39.6	51.5	54.1	43.0	99.5	51.5	53.0	49.5	15.6	62.7	117.9	134.9	71.8	50.1	20.6	24.2	20.3	25.2	21.7	20.5	18.6	18.9	18.5	18.9	20.5	21.0	18.2	9.6	23.4	9.1	20.3	76.3	80.4	197.5	35.9	9.3	48.8	66.2	27.2	28.6	88.2	46.0	2.1	105.2	32.9	39.0	92.0	146.2	198.2	35.4	17.4	26.6	24.0	24.4	22.5	143.1	163.6	25.1	23.9	36.2	24.1	19.3	13.9	45.7	88.0	16.8	22.3	54.6	81.4	28.8	28.8	43.5	16.8	32.8	26.6	18.7	33.3	17.3	22.6	22.6	24.9	153.1	44.3	11.7	33.3	133.1	40.4	119.6	48.0	8.9	19.7	24.5	73.5	159.3	36.8	64.8	79.1	169.0	22.1	47.6	60.8	96.2
UCHL5	"CGI-70, INO80R, UCH37"	ENSG00000116750	"Ubiquitin C-terminal hydrolase L5"	Q9Y5K5	1	193012250-193060080	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"DNA damage, DNA recombination, DNA repair, Transcription, Transcription regulation, Ubl conjugation pathway"	"Hydrolase, Protease, Thiol protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA005908, HPA006069"	Approved		Supported	Nucleoplasm,Nucleoli,Cytosol		NA	NA		18000	"Cluster 44: Non-specific - Transcription"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 39: Non-specific - Basic cellular processes"	"Nucleoplasm, Cytosol"	Nucleoli	"HPA005908: AB_1858585, HPA006069: "	"unprognostic (3.66e-2)"	"unprognostic (3.84e-3)"	"unprognostic (5.17e-2)"	"unprognostic (5.98e-2)"	"unprognostic (1.20e-2)"	"unprognostic (1.20e-1)"	"unprognostic (3.50e-2)"	"unprognostic (7.41e-2)"	"unprognostic (1.96e-2)"	"unprognostic (1.04e-3)"	"unprognostic (3.44e-3)"	"unprognostic (6.92e-2)"	"unprognostic (6.41e-3)"	"unprognostic (1.51e-1)"	"unprognostic (7.15e-2)"	"prognostic unfavorable (7.10e-5)"	"unprognostic (4.33e-2)"	19.9	19.0	11.0	22.5	12.1	24.6	22.7	20.3	15.8	13.6	5.5	23.3	24.7	14.8	17.5	32.2	11.3	15.5	30.5	13.3	12.3	27.2	37.9	15.9	29.1	11.8	11.5	16.4	33.1	20.3	9.7	23.1	12.8	21.4	24.0	37.7	26.0	16.0	39.7	21.3	24.2	18.1	12.9	18.0	17.8	13.4	10.7	24.8	19.2	36.8	32.6	19.1	14.3	14.1	136.6	74.0	61.7	65.5	37.1	37.8	76.4	80.1	40.4	74.8	65.8	71.4	94.9	104.7	72.5	44.4	43.2	85.5	84.1	99.5	100.9	110.0	61.9	126.0	97.5	97.3	57.6	198.5	67.8	33.9	44.5	106.1	91.2	33.6	76.4	100.3	285.1	86.2	67.3	105.9	146.2	70.1	57.7	89.1	46.9	84.5	68.3	216.4	70.8	81.0	61.2	76.7	72.7	97.3	110.4	64.9	82.2	95.8	49.9	71.9	21.4	70.0	125.0	62.8	105.2	117.5	40.2	119.5	123.6	60.9	31.7	41.6	53.3	40.1	59.5	43.8	48.0	51.2	39.0	37.4	51.0	57.1	19.5	75.2	45.0	41.3	51.3	44.8	11.0	12.1	20.3	15.8	13.3	12.3	11.8	11.5	12.8	12.9	10.7	14.1	33.9	9.6	30.2	12.7	28.6	24.3	13.5	27.9	18.8	20.6	19.4	16.6	79.5	21.5	28.5	27.6	43.8	35.8	45.7	18.9	45.0	26.3	2.8	13.0	15.4	21.4	10.8	39.7	35.4	28.3	34.5	22.8	20.9	16.0	56.3	21.4	17.9	24.6	28.0	25.2	33.2	20.2	16.2	18.8	20.7	3.8	14.9	25.0	17.8	19.7	23.4	27.4	75.2	18.1	29.6	25.3	10.6	17.3	58.5	21.8	30.2	39.9	21.1	43.5	19.7	19.6	34.9	22.1	16.8	32.7	30.0	25.2	34.5	31.9	23.2	12.4
UNG	"DGU, HIGM4, UDG, UNG1, UNG2"	ENSG00000076248	"Uracil DNA glycosylase"	P13051	12	109097597-109110992	"Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins"	"DNA damage, DNA repair, Host-virus interaction"	Hydrolase	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 64.9;Spermatogonia: 74.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB011605	Uncertain		Approved	Cytosol		NA	Yes			"Cluster 16: MAIT-cells - Unknown function"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	Cytosol		"CAB011605: AB_778737"	"unprognostic (4.38e-2)"	"unprognostic (3.82e-3)"	"unprognostic (1.03e-2)"	"unprognostic (1.33e-2)"	"unprognostic (4.64e-1)"	"unprognostic (4.10e-2)"	"prognostic unfavorable (6.40e-4)"	"unprognostic (5.68e-3)"	"prognostic unfavorable (3.06e-4)"	"unprognostic (4.66e-2)"	"unprognostic (8.78e-3)"	"unprognostic (1.91e-1)"	"unprognostic (1.35e-3)"	"unprognostic (2.57e-2)"	"unprognostic (4.50e-1)"	"unprognostic (1.40e-2)"	"unprognostic (6.89e-2)"	19.8	56.7	32.4	14.7	32.4	16.0	23.1	30.1	34.8	16.6	27.7	28.0	17.1	14.5	12.7	29.7	15.6	10.4	21.1	29.2	34.9	27.5	32.2	9.6	18.0	32.2	31.4	15.7	12.4	33.2	10.9	17.8	34.1	13.6	29.3	6.8	17.7	17.6	43.0	32.7	18.8	14.5	31.6	16.1	17.7	24.3	33.5	22.8	22.2	33.5	27.0	13.5	20.1	30.8	77.1	77.5	72.8	66.6	118.6	33.8	69.5	44.4	30.1	68.6	52.3	61.7	51.6	100.3	65.1	40.2	35.9	47.6	81.4	46.0	66.4	85.6	150.9	98.1	41.1	105.5	17.7	147.6	58.2	30.7	41.6	33.0	18.3	54.6	50.4	117.8	80.9	32.5	47.0	96.2	136.8	173.6	130.0	124.2	117.7	123.9	109.8	85.9	43.4	95.6	103.3	57.4	79.6	67.8	39.5	94.2	126.2	68.2	26.0	59.1	52.7	39.3	62.5	62.6	145.0	190.5	44.8	97.7	73.8	12.9	2.7	5.0	22.4	5.3	31.6	16.0	25.5	25.6	6.8	17.2	16.4	18.4	0.0	16.5	5.5	4.9	25.5	14.4	32.4	32.4	30.1	34.8	29.2	34.9	32.2	31.4	34.1	31.6	33.5	30.8	26.6	0.0	4.8	16.0	9.2	18.0	11.0	13.2	25.0	2.6	21.7	14.1	12.4	7.2	5.0	42.3	4.2	64.9	12.5	14.7	19.6	14.4	3.4	7.6	15.0	17.7	8.4	32.4	7.0	6.2	38.1	12.6	14.3	9.9	7.6	24.8	20.3	20.8	18.3	5.0	6.2	21.4	10.2	3.8	5.4	4.2	14.0	5.5	14.2	6.5	3.8	15.8	7.2	6.6	4.0	5.0	10.3	14.7	16.7	6.8	9.3	20.2	3.2	3.5	6.6	10.2	11.5	21.9	74.6	37.8	20.9	20.4	15.3	25.7	40.4	9.7
UPB1	BUP1	ENSG00000100024	"Beta-ureidopropionase 1"	Q9UBR1	22	24494107-24528390	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"		Hydrolase	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	8	"liver: 216.0"	"Group enriched"	"Detected in many"	5	"Hepatocytes: 146.5;Proximal tubular cells: 68.5"	"Cancer enriched"	"Detected in some"	8	"liver cancer: 25.4"	"Region enhanced"	"Detected in single"		"cerebral cortex: 1.8"	"Group enriched"	"Detected in some"	14	"basophil: 2.1;neutrophil: 2.1"	"Lineage enriched"	"Detected in single"	14	"granulocytes: 2.1"	"Cell line enriched"	"Detected in single"	7	"CACO-2: 3.3"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"HPA000728, HPA076321"	Enhanced					NA	NA		1400000	"Cluster 17: Basophils - Unknown function"	"Cluster 85: Liver - Metabolism"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"			"HPA000728: AB_1080471, HPA076321: "	"unprognostic (7.27e-2)"	"unprognostic (4.57e-3)"	"unprognostic (2.27e-1)"	"unprognostic (7.62e-2)"	"unprognostic (1.97e-1)"	"unprognostic (1.09e-4)"	"prognostic favorable (2.30e-7)"	"unprognostic (8.41e-2)"	"unprognostic (1.06e-1)"	"unprognostic (2.93e-1)"	"unprognostic (4.89e-6)"	"unprognostic (3.82e-2)"	"unprognostic (1.93e-2)"	"unprognostic (1.81e-1)"	"unprognostic (2.56e-1)"	"unprognostic (1.99e-1)"	"unprognostic (4.63e-3)"	0.2	0.2	0.2	0.2	0.6	2.0	0.1	0.7	1.8	0.2	0.2	0.2	1.2	0.2	0.2	0.1	0.3	0.1	1.9	0.2	0.0	25.7	216.0	0.8	0.2	0.1	0.1	0.2	0.1	0.0	0.4	0.0	0.4	0.3	0.1	1.1	0.1	0.1	0.5	0.9	0.4	0.1	0.0	0.8	0.2	3.0	0.4	0.6	0.1	0.2	0.1	0.1	0.2	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	3.3	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.2	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.3	0.1	0.0	0.0	0.0	0.4	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.3	0.2	0.4	0.0	2.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.1	0.0	0.0	0.0	0.0	0.2	0.6	0.7	1.8	0.2	0.0	0.1	0.1	0.4	0.0	0.4	0.1	0.8	0.0	2.0	0.3	0.6	0.6	1.3	0.1	0.0	4.0	0.3	0.3	2.4	4.3	0.0	1.8	10.4	0.1	0.1	0.0	11.7	0.1	1.2	0.2	0.6	1.9	2.4	5.3	0.7	0.4	0.1	1.4	0.0	0.5	0.0	0.6	3.6	146.5	0.1	0.0	1.2	0.0	0.0	5.1	2.7	1.4	0.3	1.0	0.0	0.0	21.3	0.4	0.0	0.0	0.3	0.0	0.1	0.0	0.7	1.2	0.0	68.5	0.0	1.8	0.0	2.7	3.7	12.8	6.8	0.0	1.1	0.3	0.9	0.2	0.1	1.1
USP1		ENSG00000162607	"Ubiquitin specific peptidase 1"	O94782	1	62436297-62451804	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"DNA damage, DNA repair, Ubl conjugation pathway"	"Hydrolase, Protease, Thiol protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Spermatocytes: 302.7;Spermatogonia: 206.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA028387, HPA028440"	Approved		Supported	Nucleoplasm		NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 34: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	Nucleoplasm		"HPA028387: AB_2672578, HPA028440: AB_10603000"	"unprognostic (1.22e-1)"	"unprognostic (5.36e-2)"	"unprognostic (1.78e-3)"	"unprognostic (4.05e-3)"	"unprognostic (2.57e-1)"	"unprognostic (1.72e-2)"	"prognostic unfavorable (5.81e-5)"	"unprognostic (6.72e-2)"	"unprognostic (1.11e-2)"	"unprognostic (5.32e-2)"	"unprognostic (3.33e-3)"	"unprognostic (3.99e-2)"	"unprognostic (2.76e-2)"	"unprognostic (9.61e-3)"	"unprognostic (5.70e-2)"	"unprognostic (1.96e-1)"	"unprognostic (1.71e-1)"	13.8	10.6	12.4	21.0	14.7	53.2	23.9	20.2	15.4	16.2	11.8	19.0	17.1	20.7	16.8	17.9	16.7	11.9	12.2	11.5	13.4	14.1	13.5	16.0	32.3	12.8	13.0	26.0	16.0	18.2	10.0	14.4	13.7	16.7	20.7	34.5	14.7	15.9	11.9	19.3	17.2	17.0	14.2	19.4	16.9	51.5	12.9	48.1	20.2	16.0	31.7	13.9	11.9	17.3	85.6	25.5	96.8	53.2	21.3	25.5	57.0	79.7	52.1	93.3	101.2	41.4	39.3	151.3	57.0	43.1	83.6	48.0	80.3	53.0	128.5	79.5	63.5	124.5	82.1	42.7	23.2	132.5	60.9	13.7	33.8	84.1	62.8	25.1	44.9	100.1	92.7	125.3	66.2	38.0	136.9	50.9	88.2	48.5	52.4	131.9	166.3	93.9	34.9	60.1	103.4	58.6	89.3	70.1	86.8	64.2	41.3	79.7	32.1	72.7	80.7	109.3	112.9	52.2	78.1	171.1	49.5	104.0	67.0	22.6	9.9	26.0	12.7	10.5	16.9	15.6	15.3	13.5	12.3	11.2	14.4	12.2	17.4	17.9	14.9	12.4	15.3	10.3	12.4	14.7	20.2	15.4	11.5	13.4	12.8	13.0	13.7	14.2	12.9	17.3	35.8	48.1	31.8	6.2	58.7	62.2	34.7	32.9	75.7	49.6	41.5	46.2	34.9	24.3	34.9	16.5	22.9	43.7	52.4	22.7	19.6	34.1	173.9	37.2	32.3	39.7	8.4	85.2	10.3	34.1	59.2	43.9	15.8	33.2	27.8	41.4	30.0	18.4	31.0	35.3	11.2	33.3	30.5	27.2	38.8	81.1	50.1	34.7	26.6	7.5	56.0	49.5	62.8	10.6	17.2	27.5	12.7	41.0	63.7	56.8	22.7	17.3	41.9	86.6	52.6	59.7	42.0	302.7	206.7	73.8	64.4	33.0	59.7	21.2	39.5	35.8
USP10	"KIAA0190, UBPO"	ENSG00000103194	"Ubiquitin specific peptidase 10"	Q14694	16	84699986-84779922	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Autophagy, DNA damage, DNA repair, Ubl conjugation pathway"	"Hydrolase, Protease, Thiol protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in all"	5	"neutrophil: 742.4"	"Lineage enriched"	"Detected in all"	5	"granulocytes: 742.4"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA006731, HPA006749"	Enhanced		Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 50: Neutrophils - Cellular senescence"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 47: Cytotrophoblasts - Unknown function"	Cytosol	Nucleoplasm	"HPA006731: AB_1080495, HPA006749: AB_1080492"	"unprognostic (4.14e-2)"	"unprognostic (2.28e-1)"	"unprognostic (2.36e-2)"	"unprognostic (4.85e-2)"	"unprognostic (6.93e-2)"	"unprognostic (1.77e-3)"	"unprognostic (1.03e-3)"	"unprognostic (2.91e-3)"	"unprognostic (1.75e-1)"	"unprognostic (3.84e-2)"	"unprognostic (2.56e-2)"	"unprognostic (1.82e-3)"	"prognostic favorable (1.00e-4)"	"unprognostic (5.91e-2)"	"unprognostic (4.57e-2)"	"unprognostic (8.57e-2)"	"unprognostic (1.38e-1)"	24.8	21.7	19.6	29.4	20.3	29.5	23.4	22.1	22.9	21.0	17.8	31.2	29.5	25.9	23.9	29.1	27.0	18.5	25.4	20.8	20.7	28.8	33.8	18.7	36.7	18.8	18.7	27.1	23.0	41.5	6.0	40.3	19.0	28.3	26.4	52.5	21.0	25.9	46.6	25.7	27.4	31.0	19.8	32.6	23.8	22.0	20.4	29.1	27.4	39.5	37.7	32.1	10.1	21.6	63.6	72.9	78.5	104.7	31.4	50.2	111.5	58.0	60.1	96.9	51.5	106.9	54.9	102.9	65.2	61.1	47.7	69.8	108.2	89.7	139.0	41.3	63.3	63.2	37.3	92.2	39.4	95.0	37.9	30.0	74.8	95.6	112.3	57.5	76.4	68.5	153.4	22.7	73.1	129.4	92.4	96.8	102.5	71.8	56.7	119.9	44.5	55.0	81.9	48.4	73.0	48.6	130.5	48.7	54.0	72.3	108.4	76.8	55.7	66.9	60.2	39.4	62.2	38.8	53.7	272.3	44.5	64.6	73.2	29.0	77.3	15.6	46.1	61.9	58.0	60.6	148.0	53.9	92.6	59.7	82.9	49.6	742.4	65.9	58.6	30.7	57.3	97.3	19.6	20.3	22.1	22.9	20.8	20.7	18.8	18.7	19.0	19.8	20.4	21.6	21.3	54.5	50.0	26.4	51.5	51.5	46.1	25.8	54.1	25.1	27.6	28.6	66.6	25.8	45.2	27.6	29.2	106.9	38.1	25.8	31.3	29.0	63.3	31.0	35.8	30.4	28.9	42.5	39.3	25.1	73.4	40.1	35.7	42.1	58.0	38.7	21.0	37.2	31.4	20.2	38.9	28.1	16.2	34.8	33.4	116.6	23.6	40.6	24.9	41.2	52.6	23.7	32.0	49.8	35.8	23.6	23.9	22.6	50.8	48.6	30.4	45.0	90.7	52.7	26.3	58.4	34.3	35.0	29.5	54.5	49.6	60.9	42.5	33.6	40.6	45.2
USP11	UHX1	ENSG00000102226	"Ubiquitin specific peptidase 11"	P51784	X	47232866-47248328	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Host-virus interaction, Ubl conjugation pathway"	"Hydrolase, Protease, Thiol protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Bipolar cells: 203.6;Horizontal cells: 139.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003103, HPA037536"	Enhanced	Supported	Supported	Nucleoplasm,Cytosol	"Intracellular and membrane"	NA	NA			"Cluster 6: Non-specific - Transcription"	"Cluster 26: Pituitary gland - Hormone signaling"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 56: Bipolar cells - Visual perception"	Nucleoplasm	Cytosol	"HPA003103: AB_10671088, HPA037536: AB_10672904"	"unprognostic (1.60e-1)"	"unprognostic (2.77e-3)"	"unprognostic (5.84e-2)"	"prognostic unfavorable (2.95e-4)"	"unprognostic (3.08e-2)"	"unprognostic (2.02e-1)"	"unprognostic (6.11e-3)"	"unprognostic (9.21e-2)"	"unprognostic (3.18e-2)"	"unprognostic (3.52e-1)"	"unprognostic (3.29e-3)"	"unprognostic (3.74e-2)"	"prognostic favorable (4.13e-5)"	"unprognostic (3.14e-2)"	"unprognostic (9.23e-2)"	"unprognostic (9.51e-2)"	"unprognostic (7.11e-2)"	25.5	32.8	117.7	23.7	118.7	11.2	26.8	41.5	116.3	51.2	30.0	33.9	11.5	47.0	23.6	18.2	49.9	24.5	45.5	113.1	148.1	33.3	12.7	30.9	30.1	69.8	78.3	76.4	27.1	36.6	103.7	24.9	93.9	33.4	14.1	84.8	21.4	38.7	32.4	18.5	25.5	35.9	65.4	29.3	24.9	46.2	122.8	42.6	52.2	29.6	28.9	36.9	31.7	79.8	45.6	70.7	117.6	81.0	43.4	28.5	33.0	34.0	52.5	65.6	73.3	67.4	36.7	29.9	26.1	60.5	70.5	53.5	94.7	24.0	56.4	47.1	73.5	34.7	52.9	61.4	50.7	39.2	70.7	42.1	9.8	69.1	29.3	37.3	26.7	68.9	26.6	3.9	51.8	70.0	77.8	43.4	89.2	24.3	62.5	86.1	114.3	25.1	32.4	60.9	66.8	114.4	62.6	12.4	37.7	73.9	26.0	23.0	28.2	56.0	58.0	79.3	39.6	54.3	36.2	51.3	34.3	48.8	50.8	63.9	9.1	19.9	55.4	19.6	48.3	53.1	24.5	54.3	11.9	53.1	36.6	76.3	5.5	56.4	24.3	53.2	35.0	46.0	117.7	118.7	41.5	116.3	113.1	148.1	69.8	78.3	93.9	65.4	122.8	79.8	13.6	22.4	17.7	25.8	53.5	13.6	42.2	30.9	21.6	203.6	13.0	23.5	24.2	7.2	31.5	33.1	56.3	20.9	52.2	9.4	50.9	18.3	26.4	28.2	26.3	22.5	35.4	18.3	43.3	10.2	15.0	41.3	22.4	28.3	45.7	56.6	22.1	8.2	13.4	139.7	63.7	8.7	28.5	12.0	16.3	41.0	29.5	17.9	28.4	19.7	17.5	96.2	23.7	25.1	24.8	12.5	7.9	42.2	48.1	18.6	4.7	15.2	46.4	63.4	26.3	57.2	40.2	18.3	87.8	11.9	6.5	16.3	44.6	34.2	8.9	26.0
USP12	USP12L1	ENSG00000152484	"Ubiquitin specific peptidase 12"	O75317	13	27066156-27171811	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Ubl conjugation pathway"	"Hydrolase, Protease, Thiol protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Langerhans cells: 153.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA007288, HPA059492"	Uncertain		Approved	Nucleoplasm		NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 41: Macrophages - Immune response"	Nucleoplasm		"HPA007288: AB_1080531, HPA059492: "	"unprognostic (6.72e-3)"	"unprognostic (2.63e-3)"	"unprognostic (1.04e-1)"	"unprognostic (2.34e-2)"	"unprognostic (1.22e-1)"	"unprognostic (5.85e-2)"	"unprognostic (1.79e-1)"	"unprognostic (3.39e-1)"	"unprognostic (8.38e-2)"	"unprognostic (8.77e-2)"	"unprognostic (2.20e-1)"	"unprognostic (3.06e-2)"	"unprognostic (1.22e-2)"	"unprognostic (1.40e-1)"	"unprognostic (2.91e-1)"	"unprognostic (6.77e-2)"	"unprognostic (1.73e-1)"	20.4	13.6	21.0	20.9	22.0	75.7	15.3	21.6	26.7	13.1	15.5	35.6	18.2	13.2	15.1	17.0	13.5	17.9	14.4	23.7	22.2	24.8	34.9	23.6	29.4	18.9	24.8	14.7	15.3	16.5	13.8	17.7	19.5	14.0	25.5	38.0	10.2	12.1	13.1	24.0	24.3	18.6	21.0	17.2	17.7	15.5	22.2	12.2	16.1	15.9	26.4	21.8	13.5	21.8	24.9	15.3	28.6	14.9	18.8	23.8	10.2	34.1	23.9	18.5	13.7	27.7	37.8	35.1	16.6	27.0	44.9	15.0	18.9	19.8	39.4	57.0	16.1	54.3	19.2	19.6	23.6	31.8	36.5	14.9	28.3	21.0	23.9	23.4	43.3	23.8	18.4	16.5	38.9	14.4	19.6	42.0	20.5	31.5	26.7	22.1	36.5	8.3	36.3	17.3	31.5	19.0	29.3	24.2	28.2	35.5	11.4	30.4	51.6	19.3	18.6	41.6	31.4	12.6	15.0	24.6	32.4	18.5	22.0	0.0	0.5	2.2	0.5	0.5	0.9	1.2	0.9	0.8	0.6	1.6	0.6	0.6	0.5	0.9	0.8	1.1	1.4	0.4	21.0	22.0	21.6	26.7	23.7	22.2	18.9	24.8	19.5	21.0	22.2	21.8	54.2	28.9	29.9	19.6	42.1	91.6	29.4	7.0	34.7	23.8	30.6	24.0	23.4	17.2	9.1	23.9	39.6	15.4	26.5	47.0	29.4	12.8	19.2	29.1	26.4	42.0	20.9	60.6	37.0	16.3	7.0	34.2	23.9	68.9	13.3	15.7	21.4	23.3	14.0	28.6	29.0	27.5	10.2	20.8	153.8	10.7	7.8	47.8	39.2	42.2	33.6	13.8	9.2	43.7	65.0	24.4	37.4	6.4	37.1	34.0	34.3	21.3	12.2	32.1	32.9	114.7	42.8	2.7	12.9	23.1	79.0	10.9	27.2	9.3	24.1	40.6
USP13	IsoT-3	ENSG00000058056	"Ubiquitin specific peptidase 13"	Q92995	3	179653032-179804366	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Autophagy, Ubl conjugation pathway"	"Hydrolase, Protease, Thiol protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"skeletal muscle: 149.2;tongue: 108.9"	"Cell type enhanced"	"Detected in many"		"Cardiomyocytes: 208.5;Inhibitory neurons: 52.2;Theca cells: 58.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"MAIT T-cell: 15.6"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in all"		"HDLM-2: 93.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA004827	Enhanced		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 16: MAIT-cells - Unknown function"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 54: Cardiomyocytes - Muscle contraction"	"Nucleoplasm, Cytosol"		"HPA004827: AB_1080497"	"unprognostic (1.00e-2)"	"unprognostic (2.09e-1)"	"unprognostic (5.82e-2)"	"unprognostic (7.14e-2)"	"unprognostic (9.94e-2)"	"unprognostic (3.96e-2)"	"prognostic unfavorable (2.40e-5)"	"unprognostic (1.76e-1)"	"unprognostic (4.55e-2)"	"unprognostic (7.79e-2)"	"unprognostic (1.69e-3)"	"unprognostic (2.22e-2)"	"prognostic unfavorable (3.46e-6)"	"unprognostic (4.93e-2)"	"unprognostic (9.79e-2)"	"unprognostic (3.38e-2)"	"prognostic unfavorable (3.06e-4)"	6.2	11.9	3.9	2.8	13.6	1.5	5.3	8.6	12.0	3.3	0.0	2.9	1.2	5.7	3.4	4.0	3.4	4.5	42.5	3.7	4.7	3.0	4.6	5.4	3.6	11.3	10.5	12.5	4.1	4.0	5.8	2.6	12.7	4.3	2.2	7.1	6.2	2.7	149.2	2.2	1.9	6.3	6.4	2.1	1.7	6.0	8.1	2.4	9.7	108.9	3.5	3.5	2.2	34.4	27.6	11.3	20.0	14.8	8.9	14.1	11.6	18.6	17.4	23.7	18.8	17.1	9.6	35.6	18.0	17.2	27.6	2.6	21.4	9.1	26.4	93.3	14.8	9.0	23.6	14.4	6.3	26.5	1.1	10.5	3.0	18.8	18.5	9.1	16.6	11.9	4.7	43.0	15.7	15.0	22.5	3.0	17.9	1.3	13.1	29.3	20.2	27.4	11.7	7.9	13.0	14.5	14.1	16.9	7.2	5.4	37.0	12.7	24.1	28.6	27.6	23.7	64.1	29.5	21.2	78.3	13.0	15.0	27.2	0.1	0.3	0.0	2.6	0.5	15.6	3.2	1.8	3.8	1.5	0.9	1.2	1.3	0.0	0.0	0.7	4.5	0.7	1.3	3.9	13.6	8.6	12.0	3.7	4.7	11.3	10.5	12.7	6.4	8.1	34.4	45.0	9.6	35.9	14.0	5.3	2.5	1.9	1.4	0.6	13.7	7.1	5.2	208.5	5.7	5.4	1.8	6.2	10.7	5.6	1.4	15.6	1.1	2.6	13.9	11.4	10.1	9.6	5.5	23.2	4.4	2.4	12.0	4.1	2.5	2.5	35.5	22.1	7.6	4.3	16.8	52.2	2.9	0.0	4.8	3.5	3.6	9.3	5.0	14.2	16.9	1.7	7.0	3.1	36.2	42.5	1.0	12.2	9.4	4.5	4.4	0.1	2.7	3.7	10.2	13.1	17.8	12.0	6.1	2.8	4.8	1.6	5.1	4.1	58.8	4.5	1.4
USP14	TGT	ENSG00000101557	"Ubiquitin specific peptidase 14"	P54578	18	158383-214629	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Immunity, Innate immunity, Ubl conjugation pathway"	"Hydrolase, Protease, Thiol protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA001308	Approved		Supported	"Plasma membrane,Cytosol"		NA	NA		2700000	"Cluster 15: NK-cells - Transcription"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 39: Non-specific - Basic cellular processes"	"Plasma membrane, Cytosol"		"HPA001308: AB_1080499"	"unprognostic (2.21e-1)"	"unprognostic (4.05e-2)"	"unprognostic (1.90e-1)"	"unprognostic (2.59e-3)"	"unprognostic (6.04e-2)"	"prognostic unfavorable (7.81e-5)"	"prognostic unfavorable (4.30e-5)"	"unprognostic (5.14e-2)"	"unprognostic (5.00e-2)"	"prognostic favorable (7.91e-4)"	"unprognostic (1.64e-2)"	"unprognostic (2.39e-1)"	"unprognostic (1.51e-3)"	"unprognostic (2.58e-1)"	"unprognostic (1.55e-1)"	"unprognostic (2.20e-2)"	"unprognostic (3.76e-2)"	26.0	21.5	19.9	22.7	21.3	23.9	17.0	20.1	22.9	15.5	13.9	17.8	13.9	17.0	23.8	24.0	14.6	14.6	24.8	21.0	24.5	23.4	25.3	15.1	21.6	25.4	21.7	13.3	13.0	21.2	14.3	26.5	25.7	29.7	19.3	15.5	15.2	19.6	55.6	15.4	12.4	24.7	20.3	13.8	15.1	17.9	26.0	21.8	20.4	36.4	31.3	22.6	15.3	23.3	91.6	75.4	62.7	64.5	60.7	60.0	109.6	115.5	64.9	118.9	110.5	98.9	48.7	133.1	86.6	99.1	114.4	50.9	125.1	91.7	134.9	38.7	59.0	72.5	46.0	78.1	60.5	184.1	70.8	48.4	69.1	122.3	69.5	55.0	93.5	65.9	106.2	99.3	119.1	76.2	105.2	52.4	59.4	56.0	83.5	87.8	78.6	98.0	88.7	79.9	71.8	60.1	120.7	59.2	52.5	68.0	58.2	51.5	103.9	138.7	104.3	128.8	170.6	62.3	125.7	130.9	80.0	77.3	88.4	10.7	18.1	13.8	27.9	25.8	33.6	21.1	27.5	29.5	25.6	16.4	26.7	26.2	1.5	39.3	20.5	18.7	28.6	19.4	19.9	21.3	20.1	22.9	21.0	24.5	25.4	21.7	25.7	20.3	26.0	23.3	40.0	22.4	40.4	27.7	52.7	58.6	53.3	42.0	51.8	58.0	33.4	23.5	44.9	31.5	48.3	44.1	31.3	92.3	58.1	22.5	45.0	60.6	70.9	44.9	56.3	43.1	22.1	102.0	58.8	54.0	71.8	49.0	43.8	80.8	34.8	47.1	28.2	45.4	50.9	116.1	54.4	22.5	46.8	31.5	53.4	21.6	31.7	45.5	35.6	33.7	48.8	39.4	46.4	35.2	74.8	75.8	16.9	45.9	72.7	71.4	15.2	56.0	40.2	50.3	0.0	49.6	51.4	34.1	68.1	57.9	52.4	135.6	55.0	58.9	33.5	51.8
USP15	"KIAA0529, UNPH4"	ENSG00000135655	"Ubiquitin specific peptidase 15"	Q9Y4E8	12	62260338-62417431	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Host-virus interaction, Ubl conjugation pathway"	"Hydrolase, Protease, Thiol protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 176.2"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"neutrophil: 297.9"	"Lineage enriched"	"Detected in all"	5	"granulocytes: 297.9"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA006237, HPA006428, HPA071014"	Approved		Supported	"Nucleoplasm,Nuclear bodies,Cytosol"		NA	NA		300000	"Cluster 1: Neutrophils - Mixed function"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 19: Monocytes & Neutrophils - Innate immune response"	Cytosol	"Nucleoplasm, Nuclear bodies"	"HPA006237: AB_1080502, HPA006428: AB_2667588, HPA071014: AB_2686333"	"unprognostic (8.18e-2)"	"unprognostic (3.22e-1)"	"unprognostic (9.63e-2)"	"unprognostic (2.09e-1)"	"unprognostic (1.10e-1)"	"unprognostic (2.75e-1)"	"prognostic unfavorable (8.04e-4)"	"unprognostic (6.59e-2)"	"unprognostic (7.70e-3)"	"unprognostic (2.19e-1)"	"unprognostic (2.47e-1)"	"unprognostic (4.51e-2)"	"prognostic unfavorable (1.58e-5)"	"unprognostic (9.28e-2)"	"unprognostic (5.81e-3)"	"unprognostic (1.11e-2)"	"unprognostic (1.26e-1)"	29.0	21.6	4.5	29.4	4.8	176.2	22.9	12.3	6.7	17.6	10.2	18.0	13.8	14.6	9.2	19.7	17.8	13.7	19.8	5.2	5.5	14.9	27.2	31.5	33.3	6.0	5.4	26.7	19.7	14.9	13.9	18.4	5.7	14.3	16.7	45.8	19.7	8.3	35.5	29.9	24.6	12.6	4.6	44.3	18.8	30.2	5.5	26.5	17.1	14.8	24.9	18.1	19.4	8.0	18.3	16.5	14.2	17.7	25.7	25.1	27.0	29.0	21.2	22.3	16.1	19.6	21.6	15.5	16.6	17.8	10.1	18.5	18.4	23.1	27.6	18.5	15.0	25.2	15.1	14.1	18.8	35.6	61.8	15.0	19.2	27.2	20.7	20.7	26.1	16.3	80.8	36.0	20.0	23.5	26.4	19.3	25.4	16.5	24.0	17.2	19.1	32.3	17.9	22.8	17.9	8.9	30.9	21.6	17.3	17.4	34.7	18.8	37.2	21.2	22.2	32.0	18.2	16.4	24.0	21.9	25.7	26.7	23.5	163.4	60.0	64.3	13.5	31.1	14.9	28.5	19.6	14.0	23.7	20.5	23.5	13.8	297.9	14.7	26.8	26.6	58.8	26.1	4.5	4.8	12.3	6.7	5.2	5.5	6.0	5.4	5.7	4.6	5.5	8.0	57.1	38.5	36.4	68.6	130.3	58.8	40.8	26.2	40.5	54.9	32.3	28.1	74.9	21.5	48.9	23.9	110.5	31.7	142.5	50.2	11.7	36.4	172.2	26.3	46.5	45.4	42.0	248.3	124.8	41.5	43.3	52.5	57.6	38.9	88.6	53.5	21.0	45.3	46.2	42.1	104.2	33.2	12.2	101.3	97.6	172.0	61.8	120.6	53.4	135.9	195.8	25.6	90.6	100.0	108.8	55.1	47.6	29.3	94.3	36.0	30.9	25.9	31.9	151.5	39.5	66.1	60.5	83.7	43.3	49.3	77.0	65.8	130.0	27.0	29.5	60.8
USP16	Ubp-M	ENSG00000156256	"Ubiquitin specific peptidase 16"	Q9Y5T5	21	29024629-29054488	"Disease related genes, Enzymes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis, Transcription, Transcription regulation, Ubl conjugation pathway"	"Activator, Chromatin regulator, Hydrolase, Protease, Thiol protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 514.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA021140	Supported		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 29: Early spermatids - Spermatogenesis"	"Nucleoplasm, Cytosol"		"HPA021140: AB_1858668"	"unprognostic (6.06e-2)"	"unprognostic (3.14e-1)"	"unprognostic (1.10e-2)"	"unprognostic (1.47e-1)"	"unprognostic (5.92e-2)"	"unprognostic (5.79e-3)"	"unprognostic (1.92e-1)"	"unprognostic (8.99e-2)"	"unprognostic (5.78e-2)"	"unprognostic (7.40e-2)"	"unprognostic (8.73e-2)"	"unprognostic (8.65e-2)"	"unprognostic (6.68e-2)"	"unprognostic (2.84e-1)"	"unprognostic (1.55e-1)"	"unprognostic (2.84e-2)"	"unprognostic (1.54e-1)"	27.0	23.0	18.8	23.4	23.2	29.3	27.4	21.3	20.4	22.7	19.1	24.6	25.1	25.2	25.2	25.2	19.9	20.4	29.3	17.5	20.5	22.1	30.7	20.9	27.9	20.5	20.8	22.3	26.0	34.3	16.7	24.2	21.7	25.7	26.4	42.3	24.7	23.6	34.7	19.9	22.8	22.6	20.2	21.9	23.4	25.7	20.3	30.0	33.8	37.5	32.3	27.1	14.1	27.5	59.9	23.4	36.5	33.0	25.4	41.5	34.2	56.9	37.9	38.5	36.4	29.5	38.3	60.5	16.8	54.8	58.7	26.5	45.6	41.5	50.1	58.6	48.4	80.9	27.3	33.1	37.6	80.3	43.0	35.9	42.9	50.3	46.4	28.7	37.5	33.9	67.7	103.8	45.3	27.3	49.7	29.3	39.2	48.4	29.9	33.0	89.7	69.6	31.7	42.5	39.4	41.9	36.8	58.1	51.1	24.9	40.2	54.2	38.0	44.8	55.7	41.8	59.3	87.8	129.3	62.5	46.8	57.3	45.6	37.4	24.1	33.6	36.3	24.9	28.6	40.7	34.1	33.6	23.1	46.0	36.9	35.8	23.5	31.5	34.0	36.2	38.9	17.2	18.8	23.2	21.3	20.4	17.5	20.5	20.5	20.8	21.7	20.2	20.3	27.5	60.3	86.6	91.9	27.4	114.4	57.2	132.5	68.9	55.2	161.0	65.8	58.7	84.2	64.3	83.1	53.3	89.6	81.7	108.2	90.2	133.1	77.9	514.9	85.9	82.6	55.0	82.6	40.8	18.2	119.9	79.7	68.3	55.0	107.7	141.8	61.5	45.7	86.2	59.9	72.3	27.6	100.4	44.7	62.0	53.1	117.0	87.7	69.4	62.2	25.3	117.3	94.1	96.8	28.1	47.3	94.0	99.2	86.9	106.8	100.1	74.8	91.8	94.1	183.5	59.2	133.4	83.2	100.4	82.4	68.4	64.4	162.0	105.3	72.8	90.6	141.9
USP17L1	USP17L1P	ENSG00000230549	"Ubiquitin specific peptidase 17 like family member 1"	Q7RTZ2	8	7332387-7333979	"Enzymes, Predicted intracellular proteins"	"Apoptosis, Ubl conjugation pathway"	"Hydrolase, Protease, Thiol protease"		"Evidence at transcript level"	"No human protein/transcript evidence"	"No human protein/transcript evidence"	"Evidence at transcript level"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA045642	Uncertain					NA	NA									"HPA045642: AB_2679403"																		0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.7	0.2	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.3	0.2	0.2	0.7	0.2	0.3	0.1	0.2	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
USP17L10		ENSG00000231396	"Ubiquitin specific peptidase 17 like family member 10"	C9JJH3	4	9210657-9212249	"Enzymes, Predicted intracellular proteins"	"Ubl conjugation pathway"	"Hydrolase, Protease, Thiol protease"		"No human protein/transcript evidence"	"No human protein/transcript evidence"	"No human protein/transcript evidence"	"No human protein/transcript evidence"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA045642	Uncertain					NA	NA									"HPA045642: AB_2679403"																		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
USP17L11		ENSG00000233136	"Ubiquitin specific peptidase 17 like family member 11"	C9JVI0	4	9215405-9216997	"Enzymes, Predicted intracellular proteins"	"Ubl conjugation pathway"	"Hydrolase, Protease, Thiol protease"		"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at transcript level"	"Tissue enriched"	"Detected in single"	37	"brain: 3.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA045642	Uncertain					NA	NA				"Cluster 65: Brain - Ion transport"					"HPA045642: AB_2679403"																		0.0	0.0	3.2	0.0	1.7	0.0	0.0	0.0	2.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	3.4	0.0	0.0	0.0	0.0	2.4	1.0	0.0	0.0	0.0	0.0	0.0	3.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	2.3	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.2	1.7	0.0	2.4	1.4	3.4	2.4	1.0	3.6	0.2	2.3	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
USP17L12		ENSG00000227551	"Ubiquitin specific peptidase 17 like family member 12"	C9JPN9	4	9220152-9221744	"Enzymes, Predicted intracellular proteins"	"Ubl conjugation pathway"	"Hydrolase, Protease, Thiol protease"		"No human protein/transcript evidence"	"No human protein/transcript evidence"	"No human protein/transcript evidence"	"No human protein/transcript evidence"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA045642	Uncertain					NA	NA									"HPA045642: AB_2679403"																		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
USP17L13		ENSG00000232399	"Ubiquitin specific peptidase 17 like family member 13"	C9JLJ4	4	9224896-9226488	"Enzymes, Predicted intracellular proteins"	"Ubl conjugation pathway"	"Hydrolase, Protease, Thiol protease"		"No human protein/transcript evidence"	"No human protein/transcript evidence"	"No human protein/transcript evidence"	"No human protein/transcript evidence"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA045642	Uncertain					NA	NA									"HPA045642: AB_2679403"																		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
USP17L15		ENSG00000223569	"Ubiquitin specific peptidase 17 like family member 15"	C9J2P7	4	9234385-9236046	"Enzymes, Predicted intracellular proteins"	"Ubl conjugation pathway"	"Hydrolase, Protease, Thiol protease"		"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at transcript level"	"Tissue enriched"	"Detected in single"	87	"brain: 12.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA045642	Uncertain					NA	NA				"Cluster 65: Brain - Ion transport"					"HPA045642: AB_2679403"																		0.0	0.0	7.1	0.0	3.5	0.0	0.0	0.0	7.6	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	6.8	3.8	0.0	0.0	0.0	0.0	10.4	0.9	0.0	0.0	0.0	0.0	0.0	12.3	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.9	0.0	0.0	0.0	12.2	0.0	0.0	0.0	0.0	0.0	0.0	4.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.1	3.5	0.0	7.6	6.8	3.8	10.4	0.9	12.3	0.9	12.2	4.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
USP17L17		ENSG00000249104	"Ubiquitin specific peptidase 17 like family member 17"	D6RBQ6	4	9243879-9245471	"Enzymes, Predicted intracellular proteins"	"Ubl conjugation pathway"	"Hydrolase, Protease, Thiol protease"		"Evidence at transcript level"	"No human protein/transcript evidence"	"No human protein/transcript evidence"	"Evidence at transcript level"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA045642	Uncertain					NA	NA									"HPA045642: AB_2679403"																		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.1	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
USP17L18		ENSG00000250844	"Ubiquitin specific peptidase 17 like family member 18"	D6R9N7	4	9248630-9250222	"Enzymes, Predicted intracellular proteins"	"Ubl conjugation pathway"	"Hydrolase, Protease, Thiol protease"		"Evidence at transcript level"	"No human protein/transcript evidence"	"No human protein/transcript evidence"	"Evidence at transcript level"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA045642	Uncertain					NA	NA									"HPA045642: AB_2679403"																		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
USP17L19		ENSG00000248920	"Ubiquitin specific peptidase 17 like family member 19"	D6RCP7	4	9253378-9254970	"Enzymes, Predicted intracellular proteins"	"Ubl conjugation pathway"	"Hydrolase, Protease, Thiol protease"		"No human protein/transcript evidence"	"No human protein/transcript evidence"	"No human protein/transcript evidence"	"No human protein/transcript evidence"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA045642	Uncertain					NA	NA									"HPA045642: AB_2679403"																		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
USP17L2	DUB3	ENSG00000223443	"Ubiquitin specific peptidase 17 like family member 2"	Q6R6M4	8	12137168-12139077	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Apoptosis, Cell cycle, Ubl conjugation pathway"	"Hydrolase, Protease, Thiol protease"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA045642	Uncertain					NA	NA									"HPA045642: AB_2679403"															"unprognostic (2.01e-1)"			0.0	0.0	0.3	0.0	0.5	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.5	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.5	0.0	0.6	0.2	0.5	0.0	0.2	0.3	0.0	0.7	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
USP17L20		ENSG00000250745	"Ubiquitin specific peptidase 17 like family member 20"	D6RJB6	4	9258124-9259716	"Enzymes, Predicted intracellular proteins"	"Ubl conjugation pathway"	"Hydrolase, Protease, Thiol protease"		"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at transcript level"	"Tissue enriched"	"Detected in single"	17	"brain: 1.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA045642	Uncertain					NA	NA				"Cluster 73: Brain - Neuropeptide signaling"					"HPA045642: AB_2679403"																		0.0	0.0	0.6	0.0	0.4	0.0	0.0	0.1	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	1.0	0.0	0.0	0.0	0.0	1.7	0.7	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.4	0.1	1.0	1.2	1.0	1.7	0.7	0.7	0.3	0.9	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
USP17L21		ENSG00000249811	"Ubiquitin specific peptidase 17 like family member 21"	D6R901	4	9262872-9264464	"Enzymes, Predicted intracellular proteins"	"Ubl conjugation pathway"	"Hydrolase, Protease, Thiol protease"		"No human protein/transcript evidence"	"No human protein/transcript evidence"	"No human protein/transcript evidence"	"No human protein/transcript evidence"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA045642	Uncertain					NA	NA									"HPA045642: AB_2679403"																		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
USP17L22		ENSG00000248933	"Ubiquitin specific peptidase 17 like family member 22"	D6RA61	4	9267619-9269211	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Ubl conjugation pathway"	"Hydrolase, Protease, Thiol protease"		"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at transcript level"	"Tissue enriched"	"Detected in single"	18	"brain: 1.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA045642	Uncertain					NA	NA				"Cluster 65: Brain - Ion transport"					"HPA045642: AB_2679403"																		0.0	0.0	1.4	0.0	0.7	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.6	0.0	0.0	0.0	0.0	1.3	0.1	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.7	0.0	1.2	0.8	0.6	1.3	0.1	1.8	0.1	1.1	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
USP17L24		ENSG00000232264	"Ubiquitin specific peptidase 17 like family member 24"	Q0WX57	4	9325165-9326757	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Apoptosis, Ubl conjugation pathway"	"Hydrolase, Protease, Thiol protease"		"Evidence at protein level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Evidence at protein level"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA045642	Uncertain					NA	NA									"HPA045642: AB_2679403"																		0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.1	0.0	0.0	0.2	0.0	0.3	0.0	0.2	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
USP17L25		ENSG00000230430	"Ubiquitin specific peptidase 17 like family member 25"	Q0WX57	4	9329911-9331503	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Apoptosis, Ubl conjugation pathway"	"Hydrolase, Protease, Thiol protease"		"Evidence at protein level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Evidence at protein level"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA045642	Uncertain					NA	NA									"HPA045642: AB_2679403"																		0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.1	0.0	0.0	0.2	0.0	0.3	0.0	0.2	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
USP17L26		ENSG00000229579	"Ubiquitin specific peptidase 17 like family member 26"	Q0WX57	4	9334658-9336250	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Apoptosis, Ubl conjugation pathway"	"Hydrolase, Protease, Thiol protease"		"Evidence at protein level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Evidence at protein level"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA045642	Uncertain					NA	NA									"HPA045642: AB_2679403"																		0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.1	0.0	0.0	0.2	0.0	0.3	0.0	0.2	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
USP17L27		ENSG00000235780	"Ubiquitin specific peptidase 17 like family member 27"	Q0WX57	4	9344148-9345740	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Apoptosis, Ubl conjugation pathway"	"Hydrolase, Protease, Thiol protease"		"Evidence at protein level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Evidence at protein level"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA045642	Uncertain					NA	NA									"HPA045642: AB_2679403"																		0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.1	0.0	0.0	0.2	0.0	0.3	0.0	0.2	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
USP17L28		ENSG00000231051	"Ubiquitin specific peptidase 17 like family member 28"	Q0WX57	4	9348893-9350485	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Apoptosis, Ubl conjugation pathway"	"Hydrolase, Protease, Thiol protease"		"Evidence at protein level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Evidence at protein level"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA045642	Uncertain					NA	NA									"HPA045642: AB_2679403"																		0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.1	0.0	0.0	0.2	0.0	0.3	0.0	0.2	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
USP17L29		ENSG00000231637	"Ubiquitin specific peptidase 17 like family member 29"	Q0WX57	4	9353638-9355230	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Apoptosis, Ubl conjugation pathway"	"Hydrolase, Protease, Thiol protease"		"Evidence at protein level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Evidence at protein level"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA045642	Uncertain					NA	NA									"HPA045642: AB_2679403"																		0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.1	0.0	0.0	0.2	0.0	0.3	0.0	0.2	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
USP17L3	"USP17B, USP17F"	ENSG00000225327	"Ubiquitin specific peptidase 17 like family member 3"	A6NCW0	8	7976393-7977985	"Enzymes, Predicted intracellular proteins"	"Apoptosis, Ubl conjugation pathway"	"Hydrolase, Protease, Thiol protease"		"No human protein/transcript evidence"	"No human protein/transcript evidence"	"No human protein/transcript evidence"	"No human protein/transcript evidence"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA045642	Uncertain					NA	NA									"HPA045642: AB_2679403"																		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
USP17L30		ENSG00000228856	"Ubiquitin specific peptidase 17 like family member 30"	Q0WX57	4	9363129-9364721	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Apoptosis, Ubl conjugation pathway"	"Hydrolase, Protease, Thiol protease"		"Evidence at protein level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Evidence at protein level"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA045642	Uncertain					NA	NA									"HPA045642: AB_2679403"																		0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.1	0.0	0.0	0.2	0.0	0.3	0.0	0.2	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
USP17L5		ENSG00000227140	"Ubiquitin specific peptidase 17 like family member 5"	A8MUK1	4	9339403-9340995	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Apoptosis, Ubl conjugation pathway"	"Hydrolase, Protease, Thiol protease"		"No human protein/transcript evidence"	"No human protein/transcript evidence"	"No human protein/transcript evidence"	"No human protein/transcript evidence"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA045642	Uncertain					NA	NA									"HPA045642: AB_2679403"																		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
USP19	"KIAA0891, ZMYND9"	ENSG00000172046	"Ubiquitin specific peptidase 19"	O94966	3	49108046-49120938	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Ubl conjugation pathway"	"Hydrolase, Protease, Thiol protease"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"									NA	NA			"Cluster 38: Basophils - Unknown function"	"Cluster 33: Striated muscle - Muscle contraction"	"Cluster 16: U-266 - Nucleosome"	"Cluster 10: Non-specific - Unknown function"				"unprognostic (3.23e-2)"	"unprognostic (2.12e-1)"	"unprognostic (5.91e-2)"	"unprognostic (1.37e-1)"	"unprognostic (1.92e-2)"	"unprognostic (3.90e-3)"	"unprognostic (2.99e-2)"	"unprognostic (3.00e-3)"	"unprognostic (2.69e-1)"	"unprognostic (3.65e-2)"	"unprognostic (2.31e-2)"	"unprognostic (1.26e-1)"	"prognostic favorable (7.05e-9)"	"unprognostic (2.99e-1)"	"unprognostic (2.11e-1)"	"unprognostic (1.72e-3)"	"unprognostic (7.54e-2)"	20.3	25.5	16.4	19.4	18.7	26.8	19.6	19.0	18.6	21.9	24.4	26.2	22.4	24.3	19.1	19.7	24.3	15.5	26.8	17.4	16.8	18.9	18.6	17.7	21.5	19.0	17.5	22.8	21.2	31.0	17.5	16.5	17.9	19.4	15.9	14.3	29.6	24.4	75.6	26.5	21.9	18.9	16.7	22.9	21.6	20.8	18.4	27.4	23.6	45.0	16.8	23.3	19.6	19.5	20.2	26.3	28.6	42.1	36.8	24.1	38.7	23.1	26.1	35.1	28.7	28.7	27.3	41.6	22.2	24.4	36.2	24.1	40.3	29.1	16.0	32.7	32.1	42.5	56.4	22.8	36.1	45.7	40.5	33.8	22.7	36.9	24.1	25.9	24.2	33.8	30.8	28.4	18.9	23.9	42.6	43.0	58.2	27.4	44.1	19.4	24.3	45.7	22.3	37.4	16.5	51.4	33.3	38.1	34.9	26.1	26.0	55.4	21.8	24.5	30.5	36.7	33.7	77.7	97.1	38.0	32.8	34.3	32.6	9.7	3.7	5.3	4.5	3.6	4.2	2.8	3.7	5.2	4.6	2.9	3.3	3.9	7.5	2.9	4.4	1.9	2.7	4.3	16.4	18.7	19.0	18.6	17.4	16.8	19.0	17.5	17.9	16.7	18.4	19.5	7.8	12.8	14.5	10.4	7.2	6.2	3.8	8.5	8.6	12.7	8.7	7.4	13.1	5.7	9.9	7.3	18.8	9.6	9.2	17.1	5.9	7.7	3.6	14.8	8.7	7.6	9.1	10.3	8.4	7.8	5.3	7.7	14.3	9.5	2.5	8.1	7.9	13.6	9.0	13.5	8.0	11.6	10.2	8.7	4.7	4.9	13.1	6.8	3.6	2.8	6.5	8.7	3.1	8.0	7.7	11.5	13.9	12.4	7.4	4.2	16.3	7.7	14.9	11.4	13.1	12.3	11.1	16.2	13.2	9.1	5.4	13.5	8.0	9.8	13.4	3.1
USP2	UBP41	ENSG00000036672	"Ubiquitin specific peptidase 2"	O75604	11	119355215-119381711	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Biological rhythms, Cell cycle, Myogenesis, Ubl conjugation pathway"	"Hydrolase, Protease, Thiol protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 168.3"	"Group enriched"	"Detected in many"	5	"Early spermatids: 460.0;Late spermatids: 1094.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"K-562: 14.5;U-266/70: 56.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA006777, HPA007222"	Approved		Supported	"Plasma membrane,Cytosol"		NA	NA				"Cluster 54: Non-specific - Microtubule organization"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 31: Spermatids - Spermatogenesis"	Cytosol	"Plasma membrane"	"HPA006777: AB_1080507, HPA007222: AB_1080505"	"unprognostic (6.83e-2)"	"unprognostic (2.02e-2)"	"unprognostic (5.54e-2)"	"unprognostic (1.37e-2)"	"unprognostic (1.25e-1)"	"unprognostic (7.46e-3)"	"unprognostic (1.00e-1)"	"unprognostic (5.27e-2)"	"unprognostic (1.24e-1)"	"unprognostic (5.24e-3)"	"unprognostic (8.02e-3)"	"unprognostic (7.33e-2)"	"prognostic favorable (3.09e-11)"	"unprognostic (1.58e-1)"	"unprognostic (1.20e-1)"	"unprognostic (1.96e-2)"	"unprognostic (2.66e-2)"	7.0	13.4	11.9	1.6	22.6	1.9	4.1	18.8	19.0	6.0	32.7	10.2	13.9	5.2	5.7	9.8	11.6	2.3	73.5	18.6	9.4	53.4	18.9	3.4	0.1	12.0	13.1	6.2	18.1	24.2	18.9	1.3	7.7	4.1	6.0	76.2	7.6	3.0	168.3	12.8	17.4	6.8	8.2	0.6	6.2	86.5	15.1	0.6	3.8	62.8	0.6	4.5	4.8	17.5	6.0	0.5	0.9	3.2	0.1	0.2	1.3	0.7	0.4	0.0	0.6	6.1	0.8	10.2	1.8	1.1	1.4	1.0	7.9	2.9	0.2	7.2	1.0	2.8	4.4	12.5	2.7	0.0	2.8	0.9	0.6	0.7	2.0	1.3	0.6	7.6	14.5	0.8	1.7	4.1	0.0	0.6	1.6	2.0	1.3	0.1	2.1	1.5	4.6	0.3	11.9	3.6	3.4	2.6	0.7	1.7	8.8	6.2	0.0	0.0	1.5	0.8	1.0	56.9	13.5	0.2	0.1	2.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.9	22.6	18.8	19.0	18.6	9.4	12.0	13.1	7.7	8.2	15.1	17.5	0.6	3.2	2.7	10.7	0.6	2.4	5.3	1.5	1.2	75.2	3.3	2.4	85.2	7.2	6.1	5.5	95.9	0.5	1.6	25.5	113.5	3.1	460.0	39.0	3.0	3.6	0.0	0.4	15.7	1.6	0.9	7.4	2.0	8.4	0.0	2.0	2.2	23.0	17.2	10.1	11.6	2.0	0.0	1.3	2.9	1094.1	6.5	2.1	0.0	1.9	0.0	49.7	0.0	8.0	12.5	1.2	11.8	7.2	0.1	1.1	41.3	41.6	35.0	140.0	19.7	43.3	24.0	50.5	16.5	12.9	4.0	1.4	1.3	0.5	2.6	2.9
USP20	KIAA1003	ENSG00000136878	"Ubiquitin specific peptidase 20"	Q9Y2K6	9	129834698-129881828	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Endocytosis, Ubl conjugation pathway"	"Hydrolase, Protease, Thiol protease"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"JURKAT: 95.9;K-562: 60.2;MOLT-4: 56.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA006287, HPA007008"	Uncertain	Supported	Approved	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA			"Cluster 39: Non-specific - mRNA processing"	"Cluster 66: Lymphoid tissue - Immune response regulation"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 58: T-cells - T-cell receptor"	"Nucleoplasm, Plasma membrane, Cytosol"		"HPA006287: AB_1080510, HPA007008: "	"unprognostic (2.64e-2)"	"prognostic favorable (8.01e-4)"	"prognostic unfavorable (2.48e-4)"	"prognostic favorable (4.01e-4)"	"unprognostic (4.69e-1)"	"unprognostic (1.89e-2)"	"unprognostic (2.25e-1)"	"unprognostic (2.55e-3)"	"unprognostic (1.24e-1)"	"unprognostic (7.89e-2)"	"prognostic favorable (1.54e-7)"	"unprognostic (2.09e-1)"	"prognostic favorable (5.65e-5)"	"unprognostic (1.76e-2)"	"unprognostic (1.20e-1)"	"unprognostic (1.19e-2)"	"unprognostic (1.24e-2)"	8.1	12.0	8.7	13.5	8.0	22.6	8.3	4.8	8.7	12.5	2.5	13.6	8.2	12.5	4.2	7.9	12.1	7.7	7.5	7.8	10.6	7.6	7.4	8.4	18.3	10.2	9.1	13.5	10.9	8.4	18.4	6.7	10.0	14.8	4.9	6.7	11.4	13.2	10.9	12.1	12.5	8.2	5.4	13.9	9.9	10.0	8.9	32.3	18.7	7.5	11.8	14.9	10.1	6.5	6.0	5.8	10.0	13.4	12.8	10.8	14.1	9.5	7.9	7.1	4.9	4.7	6.5	8.1	8.0	9.3	8.0	14.7	6.0	6.7	2.9	43.4	7.9	14.9	17.0	3.3	8.8	14.2	10.6	9.6	9.8	9.3	7.0	12.4	7.7	95.9	60.2	9.9	4.4	15.9	56.4	33.6	7.9	12.7	13.6	9.4	11.2	14.0	5.5	6.5	2.2	11.0	11.0	13.9	9.1	5.9	14.4	19.9	11.5	7.8	3.5	10.5	6.3	9.7	15.3	5.7	15.5	18.6	7.4	1.0	1.9	5.4	8.6	1.5	9.1	3.7	8.7	8.3	2.6	3.4	9.8	8.9	2.8	10.0	1.5	2.1	11.5	6.3	8.7	8.0	4.8	8.7	7.8	10.6	10.2	9.1	10.0	5.4	8.9	6.5	3.0	9.6	6.9	16.3	9.2	2.8	2.2	2.5	4.0	7.8	6.4	8.0	7.7	4.3	3.0	1.8	4.2	5.9	9.4	6.2	3.9	2.4	2.1	4.1	6.3	4.3	8.4	12.8	17.0	4.0	2.5	4.6	8.2	5.7	1.3	6.8	6.4	6.1	3.3	10.1	21.1	4.6	4.1	1.6	3.8	3.3	6.2	6.0	3.6	11.2	3.1	5.3	11.3	9.5	14.3	2.7	5.0	4.9	6.7	3.0	4.1	2.9	5.0	6.3	0.0	4.3	5.7	12.1	6.0	4.8	2.0	6.2	19.3	2.9	5.2	1.6
USP21	"USP16, USP23"	ENSG00000143258	"Ubiquitin specific peptidase 21"	Q9UK80	1	161159450-161165723	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Transcription, Transcription regulation, Ubl conjugation pathway"	"Activator, Chromatin regulator, Hydrolase, Protease, Thiol protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Basal squamous epithelial cells: 16.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA028397	Uncertain	Approved	Supported	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA			"Cluster 33: Neutrophils - Chromatin organization"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 6: T47d - Mammary gland"	"Cluster 59: Non-specific - Transcription"	Cytosol	"Nucleoplasm, Plasma membrane"	"HPA028397: AB_10603227"	"unprognostic (9.17e-2)"	"unprognostic (1.44e-1)"	"unprognostic (3.95e-2)"	"prognostic unfavorable (7.05e-4)"	"unprognostic (1.22e-2)"	"unprognostic (1.26e-2)"	"prognostic unfavorable (1.68e-4)"	"unprognostic (5.35e-2)"	"unprognostic (6.73e-2)"	"unprognostic (2.76e-2)"	"unprognostic (3.87e-3)"	"unprognostic (1.31e-2)"	"prognostic unfavorable (9.50e-6)"	"unprognostic (2.45e-1)"	"unprognostic (3.28e-1)"	"unprognostic (2.13e-2)"	"prognostic favorable (3.35e-5)"	12.2	15.3	19.6	11.9	20.7	15.0	14.3	18.5	22.8	19.4	18.3	17.6	13.6	18.2	12.0	16.4	28.0	12.0	13.0	19.4	18.4	14.5	10.8	13.1	16.1	19.2	19.7	23.2	16.4	17.1	15.7	13.2	18.7	17.7	11.0	12.9	16.5	20.3	20.9	20.8	15.9	12.6	17.3	17.8	16.4	14.2	20.1	18.4	18.5	17.7	14.0	17.6	16.8	22.1	12.5	20.6	26.9	26.2	21.1	17.5	16.5	9.1	14.6	24.2	18.9	19.4	23.3	16.0	14.6	11.2	15.1	20.7	17.6	17.5	13.2	30.8	30.0	19.3	34.1	15.3	15.2	17.4	13.4	14.8	23.0	16.6	23.9	27.1	17.3	35.0	28.4	21.6	15.6	22.6	30.7	26.9	25.2	24.3	26.1	28.8	9.0	26.5	14.4	14.9	24.2	31.5	17.2	17.2	13.9	20.1	37.3	27.5	10.1	16.9	14.8	11.9	15.3	42.9	36.5	23.9	15.3	14.7	15.5	15.2	10.0	17.1	12.6	6.4	14.6	11.0	11.5	13.2	10.8	11.3	13.1	12.3	8.4	13.3	7.6	10.8	12.3	11.0	19.6	20.7	18.5	22.8	19.4	18.4	19.2	19.7	18.7	17.3	20.1	22.1	4.5	0.0	3.7	5.2	6.5	1.5	1.8	2.4	16.5	5.0	4.9	4.1	3.9	8.6	2.9	1.8	6.2	4.9	3.6	3.6	1.9	2.0	1.0	6.3	5.7	4.4	5.4	10.7	2.4	2.3	2.3	5.1	9.2	3.7	2.5	4.5	5.3	2.1	2.2	0.0	2.7	4.0	4.1	4.8	0.8	1.0	5.0	2.1	1.8	1.9	1.2	3.3	5.2	2.0	4.6	2.0	2.4	4.1	7.8	2.7	3.5	2.5	9.5	5.2	6.6	2.0	5.2	5.3	3.2	10.7	1.4	3.1	5.6	3.1	4.1	1.5
USP22	"KIAA1063, USP3L"	ENSG00000124422	"Ubiquitin specific peptidase 22"	Q9UPT9	17	20999596-21043760	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Cell cycle, Transcription, Transcription regulation, Ubl conjugation pathway"	"Activator, Chromatin regulator, Hydrolase, Protease, Thiol protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA044980	Supported		Approved	"Nuclear speckles"		NA	NA			"Cluster 49: Eosinophils - Unknown function"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 52: Non-specific - Transcription"	"Nuclear speckles"		"HPA044980: AB_10794503"	"unprognostic (7.24e-2)"	"unprognostic (5.38e-2)"	"unprognostic (7.67e-2)"	"unprognostic (6.19e-2)"	"unprognostic (4.72e-1)"	"unprognostic (1.11e-2)"	"prognostic unfavorable (9.66e-4)"	"unprognostic (2.17e-2)"	"unprognostic (7.81e-2)"	"unprognostic (6.37e-2)"	"unprognostic (1.07e-3)"	"unprognostic (5.68e-2)"	"prognostic favorable (1.53e-7)"	"unprognostic (8.95e-2)"	"unprognostic (1.93e-1)"	"unprognostic (2.91e-1)"	"unprognostic (1.79e-2)"	40.7	66.8	91.2	40.3	93.7	53.0	42.5	72.0	90.5	55.3	44.8	48.8	33.6	63.7	48.2	40.7	57.3	40.0	79.8	93.1	112.3	49.5	44.1	46.3	48.3	71.7	78.1	75.6	48.0	68.2	65.2	39.3	85.8	50.2	35.2	57.1	36.3	48.2	108.6	40.3	39.5	54.0	72.4	45.1	49.8	29.3	120.3	63.9	57.0	81.2	50.2	42.3	35.4	68.4	106.9	189.7	179.9	155.5	102.7	105.9	85.9	120.2	91.8	105.6	89.3	220.0	46.9	145.4	112.5	185.2	71.3	111.7	176.7	143.1	157.1	70.0	122.8	120.8	121.5	107.9	121.3	134.2	101.0	117.4	83.9	119.9	125.1	119.8	134.1	93.3	139.7	51.4	151.6	109.5	189.8	63.7	93.1	125.5	61.9	206.2	284.5	99.2	97.7	153.9	86.3	177.8	154.9	63.5	124.9	488.4	106.4	78.0	171.0	107.4	140.8	111.3	164.1	55.0	79.6	476.2	109.0	70.3	169.4	5.5	9.6	10.0	7.9	7.6	7.9	8.0	8.1	7.8	9.2	9.9	10.7	10.2	9.9	7.1	9.7	7.6	6.1	6.0	91.2	93.7	72.0	90.5	93.1	112.3	71.7	78.1	85.8	72.4	120.3	68.4	46.6	41.7	48.8	31.6	47.9	33.0	43.8	33.8	38.7	97.6	80.3	63.8	23.8	45.8	41.5	60.7	93.8	51.4	36.6	59.3	23.5	51.6	36.0	59.3	75.3	56.1	88.2	43.7	53.1	59.0	37.5	51.0	57.6	68.7	30.4	86.5	76.8	68.5	38.1	117.8	66.0	48.8	30.5	53.8	36.1	51.2	51.0	31.7	35.6	43.1	42.2	55.4	28.8	38.7	50.6	69.6	40.3	71.8	36.6	62.2	33.4	48.9	37.4	59.1	13.1	58.6	52.2	15.9	19.7	49.6	29.1	65.8	33.4	77.9	53.3	53.5
USP24	KIAA1057	ENSG00000162402	"Ubiquitin specific peptidase 24"	Q9UPU5	1	55066359-55215364	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Host-virus interaction, Ubl conjugation pathway"	"Hydrolase, Protease, Thiol protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	4	"Oligodendrocyte precursor cells: 552.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA026723, HPA028428, HPA067124"	Approved		Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 41: Basophils - Cellular respiration"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 68: Oligodendrocytes - Mixed function"	Nucleoplasm	Cytosol	"HPA026723: AB_10599851, HPA028428: AB_10600991, HPA067124: AB_2685785"	"unprognostic (2.28e-1)"	"unprognostic (9.81e-3)"	"unprognostic (4.70e-3)"	"unprognostic (4.86e-3)"	"unprognostic (9.31e-3)"	"unprognostic (4.84e-3)"	"prognostic unfavorable (1.34e-7)"	"unprognostic (2.04e-1)"	"unprognostic (6.93e-2)"	"unprognostic (2.98e-1)"	"unprognostic (5.08e-2)"	"unprognostic (1.86e-1)"	"unprognostic (8.12e-2)"	"unprognostic (1.79e-1)"	"unprognostic (6.42e-2)"	"unprognostic (4.12e-2)"	"unprognostic (1.64e-1)"	16.6	8.2	13.4	14.2	13.3	56.7	13.4	25.3	13.6	9.4	13.2	12.0	8.3	10.7	9.2	9.4	9.9	9.0	12.7	12.6	14.7	15.7	15.3	10.6	22.1	13.5	13.1	16.5	11.4	20.3	12.8	9.6	14.6	10.2	13.3	17.2	12.8	9.6	47.9	13.6	12.6	9.8	12.8	18.6	12.3	8.4	13.6	21.9	9.2	36.6	20.9	10.4	9.2	14.2	32.5	17.4	21.3	11.6	27.2	23.5	24.6	14.0	17.5	19.6	20.3	25.0	11.1	25.9	15.1	26.1	40.1	25.6	28.5	23.6	30.5	27.2	17.4	51.5	40.2	29.6	16.1	36.0	38.6	21.0	20.6	30.0	33.7	19.0	18.2	25.7	48.5	10.6	26.6	7.6	21.9	19.1	31.4	15.5	21.0	22.3	27.1	11.3	34.6	21.4	18.7	13.1	23.8	16.8	21.1	32.3	11.7	17.5	24.7	17.9	17.3	21.7	22.6	13.2	10.6	33.2	16.9	29.4	16.3	5.4	1.3	1.7	2.8	1.1	1.7	3.0	2.2	2.2	1.2	3.4	1.9	2.5	1.4	2.3	1.5	6.9	1.3	0.7	13.4	13.3	25.3	13.6	12.6	14.7	13.5	13.1	14.6	12.8	13.6	14.2	20.4	16.0	20.0	92.4	27.7	14.9	8.4	5.6	9.1	14.0	13.4	10.2	37.7	10.0	13.0	12.9	73.0	4.2	42.6	11.1	0.0	10.3	0.7	11.9	15.1	16.1	17.3	37.4	84.5	10.2	7.8	11.9	21.4	15.0	12.7	18.2	12.1	11.9	9.7	38.7	100.4	16.2	8.2	19.2	18.8	2.5	11.8	18.6	10.6	87.1	19.6	7.0	15.5	552.4	115.2	11.8	11.4	7.9	18.1	12.7	8.3	5.9	10.0	16.9	6.6	18.0	13.5	7.7	7.1	13.9	17.2	1.5	21.8	9.8	16.0	12.1
USP25	USP21	ENSG00000155313	"Ubiquitin specific peptidase 25"	Q9UHP3	21	15730025-15880069	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Ubl conjugation pathway"	"Hydrolase, Protease, Thiol protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 120.9"	"Cell type enhanced"	"Detected in all"		"Early spermatids: 166.7;Excitatory neurons: 148.0;Late spermatids: 192.8;Oligodendrocyte precursor cells: 150.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA018297, HPA024142"	Approved		Supported	Cytosol		NA	NA			"Cluster 22: NK-cells - Unknown function"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	Cytosol		"HPA018297: AB_1858672, HPA024142: AB_1858673"	"unprognostic (6.35e-2)"	"unprognostic (1.50e-1)"	"unprognostic (6.90e-2)"	"unprognostic (6.29e-2)"	"unprognostic (1.39e-1)"	"unprognostic (2.88e-2)"	"unprognostic (3.91e-2)"	"unprognostic (1.65e-1)"	"unprognostic (1.44e-2)"	"unprognostic (1.38e-1)"	"unprognostic (2.33e-2)"	"unprognostic (1.40e-1)"	"unprognostic (8.24e-3)"	"unprognostic (2.34e-3)"	"unprognostic (4.50e-2)"	"unprognostic (1.61e-1)"	"unprognostic (2.32e-2)"	25.8	12.9	13.4	16.8	20.1	26.9	17.6	12.6	17.2	18.1	12.3	15.3	12.6	26.8	18.7	21.4	16.8	12.4	28.1	16.2	4.2	21.4	20.2	24.0	20.1	4.7	4.3	14.1	15.9	14.3	7.6	29.4	4.8	17.9	16.1	9.5	17.5	24.6	120.9	13.1	13.3	36.4	4.4	19.5	13.1	54.5	4.9	25.6	15.5	75.1	19.3	15.5	17.3	11.9	31.2	23.1	21.5	3.2	38.7	57.5	25.3	22.0	21.8	16.0	20.1	20.5	17.4	33.6	31.5	34.9	24.3	16.4	16.7	29.1	22.0	33.5	19.1	27.5	23.5	15.8	64.3	36.6	12.1	37.6	34.7	25.8	74.0	41.7	57.0	30.0	35.9	61.4	29.1	13.0	42.1	7.1	26.6	12.5	20.3	31.8	20.0	25.8	43.5	8.3	4.7	12.8	31.4	26.2	20.9	25.9	14.0	21.3	54.6	24.8	16.0	26.2	12.5	17.7	11.9	26.8	16.0	16.1	18.6	0.0	1.4	1.9	1.8	1.4	2.0	1.6	1.5	3.2	1.2	1.1	1.4	2.1	2.9	1.1	1.3	1.3	2.2	0.8	13.4	20.1	12.6	17.2	16.2	4.2	4.7	4.3	4.8	4.4	4.9	11.9	30.4	57.7	29.5	47.3	21.7	17.1	18.8	9.7	15.9	6.2	17.4	11.8	55.7	15.7	24.2	22.0	4.2	39.0	21.4	20.3	5.9	9.4	166.7	24.0	19.0	19.7	9.6	21.5	148.0	13.4	8.4	19.4	17.9	34.6	6.3	14.4	17.9	18.0	13.3	5.0	98.4	12.8	8.2	24.2	16.0	192.8	19.0	24.2	16.0	86.2	23.7	4.0	23.7	150.3	72.4	13.4	8.4	12.8	15.9	22.0	11.9	15.1	23.4	6.7	19.7	26.1	17.2	11.2	5.8	22.7	19.2	33.1	26.9	18.5	11.6	20.4
USP26		ENSG00000134588	"Ubiquitin specific peptidase 26"	Q9BXU7	X	133024631-133097109	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Ubl conjugation pathway"	"Hydrolase, Protease, Thiol protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	13	"Spermatogonia: 4.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											"HPA000424, HPA027310, HPA079124"	Approved		Supported	Nucleoplasm,Cytosol		NA	NA						"Cluster 20: Spermatogonia & Spermatocytes - Spermatogenesis"	Nucleoplasm	Cytosol	"HPA000424: , HPA027310: , HPA079124: "	"unprognostic (7.92e-4)"		"unprognostic (3.59e-2)"											"unprognostic (1.99e-2)"	"unprognostic (2.08e-1)"			0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	4.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1
USP27X	USP27	ENSG00000273820	"Ubiquitin specific peptidase 27 X-linked"	A6NNY8	X	49879484-49882558	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"Ubl conjugation pathway"	"Hydrolase, Protease, Thiol protease"	"Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 14.4"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 19.2;Alveolar cells type 2: 15.5;Bipolar cells: 15.8;Cytotrophoblasts: 44.5;Syncytiotrophoblasts: 26.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"SuSa: 12.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA077264			Approved	Nucleoplasm,Vesicles		NA	NA				"Cluster 73: Brain - Neuropeptide signaling"	"Cluster 12: NES - Nervous system development"	"Cluster 47: Cytotrophoblasts - Unknown function"	Vesicles	Nucleoplasm	"HPA077264: AB_2686831"	"unprognostic (4.12e-2)"	"unprognostic (9.58e-3)"	"unprognostic (2.29e-1)"	"unprognostic (4.66e-2)"	"unprognostic (1.98e-1)"	"unprognostic (1.74e-1)"	"prognostic unfavorable (6.14e-4)"	"unprognostic (3.10e-3)"	"unprognostic (3.91e-2)"	"unprognostic (1.31e-2)"	"prognostic favorable (9.31e-4)"	"unprognostic (5.37e-2)"	"unprognostic (7.45e-3)"	"unprognostic (1.19e-1)"	"unprognostic (1.12e-1)"	"unprognostic (2.01e-2)"	"unprognostic (2.58e-1)"	1.6	2.5	6.0	1.3	6.2	0.5	2.0	8.0	5.8	3.0	3.1	3.2	1.0	3.9	2.9	1.6	3.5	1.6	1.8	5.3	14.4	2.7	1.8	2.7	1.7	4.9	8.4	6.3	2.6	3.0	7.3	11.7	5.9	3.0	1.4	3.8	1.6	2.8	4.4	2.1	2.1	2.8	3.6	1.8	2.4	1.3	10.5	2.6	2.4	2.1	1.7	3.0	2.2	4.4	1.6	3.8	4.2	4.8	3.8	3.1	3.6	1.6	2.6	1.8	1.4	6.9	1.6	0.9	1.6	4.2	6.0	2.6	6.0	4.0	2.6	2.0	3.1	1.6	1.1	6.2	2.6	0.5	3.4	4.4	2.7	2.6	2.6	4.4	2.5	4.2	3.4	1.5	2.9	3.7	2.5	1.2	4.8	2.7	2.7	2.7	3.7	0.3	2.9	1.4	1.1	3.2	3.4	3.0	4.0	12.9	3.5	1.1	1.9	2.1	4.3	3.8	0.7	1.6	0.4	0.6	2.5	1.4	2.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	6.0	6.2	8.0	5.8	5.3	14.4	4.9	8.4	5.9	3.6	10.5	4.4	3.5	19.2	15.5	0.7	2.5	2.9	4.5	0.3	2.2	15.8	1.9	2.7	2.6	0.0	7.5	0.0	0.0	44.5	1.4	1.7	5.9	1.5	0.1	2.1	4.1	5.2	4.2	0.0	2.9	0.7	3.6	2.7	1.1	2.1	2.5	4.0	2.5	1.9	4.0	5.0	3.3	1.3	0.0	0.6	1.0	0.3	2.1	1.2	0.0	0.0	1.5	8.3	0.0	3.5	0.8	1.2	0.5	3.4	0.5	3.3	0.5	2.9	13.2	2.5	6.6	2.5	2.6	0.2	1.3	0.9	2.3	26.1	2.0	8.8	1.6	1.7
USP28	KIAA1515	ENSG00000048028	"Ubiquitin specific peptidase 28"	Q96RU2	11	113797874-113875570	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"DNA damage, DNA repair, Ubl conjugation pathway"	"Hydrolase, Protease, Thiol protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"heart muscle: 62.7;skeletal muscle: 68.3;tongue: 66.5"	"Cell type enhanced"	"Detected in all"		"Cardiomyocytes: 152.2;Excitatory neurons: 57.0;NK-cells: 73.2"	"Low cancer specificity"	"Detected in all"			"Region enhanced"	"Detected in all"		"cerebellum: 20.1"	"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA006778, HPA006779"	Enhanced		Supported	"Nucleoplasm,Nuclear bodies"		NA	NA			"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 38: Heart - Muscle contraction"	"Cluster 12: NES - Nervous system development"	"Cluster 54: Cardiomyocytes - Muscle contraction"	Nucleoplasm	"Nuclear bodies"	"HPA006778: AB_1080520, HPA006779: AB_1080517"	"unprognostic (2.54e-1)"	"unprognostic (2.72e-1)"	"unprognostic (2.99e-2)"	"unprognostic (3.72e-2)"	"unprognostic (5.51e-2)"	"unprognostic (2.30e-1)"	"unprognostic (9.73e-3)"	"unprognostic (3.00e-1)"	"unprognostic (2.04e-3)"	"unprognostic (1.82e-3)"	"unprognostic (3.17e-2)"	"unprognostic (1.19e-1)"	"unprognostic (5.11e-2)"	"unprognostic (2.06e-2)"	"unprognostic (9.03e-2)"	"unprognostic (1.35e-3)"	"unprognostic (5.03e-2)"	5.8	6.7	3.2	9.5	4.3	5.8	10.4	20.1	9.5	21.1	0.6	10.4	9.6	11.5	11.3	9.6	9.8	7.7	62.7	4.6	1.8	9.9	11.3	7.5	15.6	2.1	1.7	14.1	8.2	15.5	7.4	8.0	3.4	11.3	11.7	27.1	12.0	14.2	68.3	7.0	10.4	13.1	1.2	13.8	9.2	9.2	1.9	9.0	10.1	66.5	15.5	9.8	8.4	5.3	18.3	20.2	26.7	35.4	21.3	20.9	18.8	13.2	18.0	17.5	29.7	30.2	25.6	24.2	29.3	18.0	40.1	35.1	37.9	24.8	24.1	27.1	17.2	12.9	13.8	16.3	13.0	16.8	12.4	12.6	18.5	20.2	23.8	25.4	32.0	11.9	22.7	15.3	18.5	9.3	12.9	27.1	32.0	33.6	14.4	31.3	37.1	29.4	19.3	17.8	11.6	12.6	31.4	10.7	10.1	82.7	25.8	5.8	17.1	19.2	28.3	17.8	13.8	10.4	15.9	20.1	1.9	32.1	12.8	0.2	5.0	3.4	23.2	3.7	12.1	15.5	5.7	16.8	6.4	12.3	3.8	13.1	1.4	28.6	6.4	1.9	9.2	10.3	3.2	4.3	20.1	9.5	4.6	1.8	2.1	1.7	3.4	1.2	1.9	5.3	7.3	9.6	8.8	18.3	17.8	1.7	7.3	9.9	13.6	18.7	9.7	9.8	152.2	5.7	9.9	5.5	18.8	4.4	32.1	3.3	5.9	6.7	1.7	6.6	11.6	7.9	4.9	2.5	57.0	3.9	4.7	12.2	11.7	8.7	1.3	18.9	7.5	8.8	4.4	5.0	34.1	9.6	4.1	6.5	2.5	2.0	6.8	7.4	1.8	10.3	8.2	10.3	73.2	29.1	21.3	3.5	5.3	13.9	21.7	7.1	7.3	7.1	14.6	21.5	6.6	10.3	11.0	15.8	11.4	7.7	2.0	1.1	18.6	9.0	8.9	5.8
USP29		ENSG00000131864	"Ubiquitin specific peptidase 29"	Q9HBJ7	19	57119138-57131926	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Ubl conjugation pathway"	"Hydrolase, Protease, Thiol protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"testis: 4.9"	"Group enriched"	"Detected in some"	8	"Collecting duct cells: 1.8;Early spermatids: 2.2;Spermatocytes: 5.1;Spermatogonia: 1.4"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			HPA076515	Enhanced					NA	NA			"Cluster 41: Basophils - Cellular respiration"	"Cluster 21: Non-specific - Transcription"		"Cluster 66: Spermatocytes - Spermatogenesis"			"HPA076515: "															"unprognostic (1.32e-1)"			0.1	0.0	0.9	0.0	0.5	1.8	0.0	2.1	0.6	0.0	1.0	0.1	0.1	0.2	0.0	0.2	0.1	0.2	0.5	1.0	1.0	0.1	0.1	0.2	0.4	1.9	0.9	0.3	1.3	0.0	0.0	0.2	0.8	0.1	0.1	0.6	0.7	0.0	0.3	1.4	0.0	0.0	0.8	0.2	0.4	4.9	0.8	0.0	0.3	0.0	0.1	0.3	0.0	2.0	0.0	0.2	0.2	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.5	0.0	0.2	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.3	0.9	0.2	0.0	0.0	0.3	0.0	0.5	0.2	0.3	0.4	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.2	0.0	0.3	0.0	0.1	0.3	0.2	0.0	0.2	0.0	0.6	0.5	0.2	0.1	0.1	0.1	0.3	0.2	0.3	0.4	0.3	0.1	0.0	0.0	0.4	0.1	0.3	0.1	0.2	0.0	1.3	0.3	0.3	0.2	0.2	0.1	0.2	0.1	0.1	0.1	0.2	0.1	0.1	1.1	0.3	0.1	0.6	0.1	0.2	0.9	0.5	2.1	0.6	1.0	1.0	1.9	0.9	0.8	0.8	0.8	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	5.1	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.2
USP3		ENSG00000140455	"Ubiquitin specific peptidase 3"	Q9Y6I4	15	63504511-63594640	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Cell cycle, DNA damage, Ubl conjugation pathway"	"Chromatin regulator, Hydrolase, Protease, Thiol protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Region enriched"	"Detected in all"	4	"cerebellum: 36.4"	"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA053275, HPA060513, HPA077975"			Supported	"Nucleoplasm,Midbody ring"	"Intracellular and membrane"	Yes	No			"Cluster 1: Neutrophils - Mixed function"	"Cluster 50: Non-specific - Ribosome"	"Cluster 15: RT4 - Unknown function"	"Cluster 19: Monocytes & Neutrophils - Innate immune response"	Nucleoplasm	"Midbody ring"	"HPA053275: AB_2682096, HPA060513: AB_2684299, HPA077975: AB_2732365"	"unprognostic (4.63e-3)"	"unprognostic (2.71e-1)"	"unprognostic (7.88e-2)"	"unprognostic (3.33e-2)"	"unprognostic (2.16e-2)"	"unprognostic (6.03e-2)"	"unprognostic (6.26e-2)"	"unprognostic (4.52e-2)"	"unprognostic (1.62e-2)"	"unprognostic (2.36e-1)"	"unprognostic (3.54e-2)"	"unprognostic (4.87e-2)"	"unprognostic (1.17e-1)"	"unprognostic (8.61e-2)"	"unprognostic (2.78e-1)"	"unprognostic (6.21e-2)"	"prognostic favorable (1.38e-4)"	12.7	8.2	5.8	5.4	7.0	21.4	11.2	36.4	5.9	11.7	15.4	13.4	6.5	12.9	4.7	10.9	10.9	5.4	6.0	5.3	6.3	10.1	8.2	13.2	6.5	6.9	6.9	16.2	18.9	3.1	6.2	2.7	7.6	10.4	5.6	6.3	12.4	6.0	10.0	14.6	13.9	4.5	5.3	17.6	15.7	5.3	8.6	7.4	9.1	3.6	6.4	12.4	11.9	7.5	10.4	21.0	12.1	8.1	5.5	7.6	8.2	6.7	9.6	7.1	5.8	6.6	13.1	8.7	15.3	9.3	3.6	12.0	11.6	11.1	5.6	12.2	5.8	10.4	8.6	9.8	6.8	6.4	11.4	11.3	7.8	7.7	10.6	8.9	12.4	17.3	9.5	9.0	3.3	5.2	11.0	8.8	16.2	13.7	5.3	22.2	8.4	11.3	4.5	23.8	9.6	9.5	3.3	13.0	6.7	7.8	5.5	9.5	13.4	7.2	16.9	3.3	10.3	9.3	24.4	18.2	7.4	13.8	7.5	120.0	84.7	12.7	24.8	66.0	28.4	34.1	34.3	26.0	59.8	34.8	34.0	25.2	169.1	19.8	65.4	13.1	28.1	45.2	5.8	7.0	36.4	5.9	5.3	6.3	6.9	6.9	7.6	5.3	8.6	7.5	23.6	38.5	69.2	76.7	63.4	52.6	34.3	24.8	23.3	31.4	27.9	20.3	9.2	25.8	41.4	16.5	12.5	19.8	48.4	37.6	41.1	41.0	21.6	37.8	32.8	26.0	43.8	15.8	11.2	37.2	57.3	28.3	39.8	74.6	27.1	64.5	11.4	24.0	24.8	13.5	40.0	35.4	30.5	78.4	109.6	77.4	15.8	74.5	42.7	75.9	101.8	25.9	41.2	80.4	40.6	39.8	35.6	18.4	69.7	40.6	33.2	28.3	33.3	17.9	13.1	25.3	34.5	14.8	40.3	33.9	59.0	34.1	64.6	40.1	40.6	37.6
USP30	"FLJ40511, MGC10702"	ENSG00000135093	"Ubiquitin specific peptidase 30"	Q70CQ3	12	109023089-109088023	"Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Ubl conjugation pathway"	"Hydrolase, Protease, Thiol protease"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Late spermatids: 52.7;Oligodendrocytes: 41.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA016952	Approved					NA	NA			"Cluster 44: Non-specific - Transcription"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 25: Spermatids - Spermatogenesis"			"HPA016952: AB_1858680"	"unprognostic (2.34e-1)"	"unprognostic (1.57e-2)"	"unprognostic (7.04e-2)"	"unprognostic (9.91e-2)"	"unprognostic (2.48e-1)"	"unprognostic (5.89e-2)"	"unprognostic (1.91e-1)"	"unprognostic (3.60e-3)"	"unprognostic (1.98e-1)"	"unprognostic (4.96e-2)"	"unprognostic (5.07e-2)"	"unprognostic (1.07e-1)"	"prognostic favorable (5.23e-6)"	"unprognostic (2.49e-1)"	"unprognostic (1.23e-1)"	"unprognostic (1.12e-1)"	"unprognostic (1.02e-3)"	8.4	8.8	2.9	7.3	6.0	10.7	6.5	4.2	5.4	6.6	1.9	10.2	11.4	7.8	4.7	5.6	8.0	5.9	6.8	3.3	6.9	9.1	16.3	6.8	8.8	5.2	4.3	12.4	8.6	14.4	4.2	5.1	5.5	6.8	8.4	10.7	7.7	6.7	10.0	6.6	11.1	6.2	3.0	7.9	6.5	13.8	5.0	6.3	8.2	8.7	4.5	4.3	3.3	14.1	5.3	4.1	10.7	9.2	7.3	8.3	5.9	5.9	7.8	6.8	5.9	4.9	3.9	13.6	4.8	5.9	6.1	5.6	9.4	6.3	7.7	16.0	11.7	4.2	3.8	7.1	7.8	8.7	4.6	10.1	7.4	5.9	6.0	17.5	8.0	13.8	6.8	6.1	5.9	6.3	13.8	5.0	3.2	6.3	11.3	14.7	7.6	8.1	5.4	6.4	9.7	8.6	8.0	5.6	6.3	7.8	14.5	6.8	5.5	5.9	3.3	5.9	3.7	16.0	14.4	19.3	6.5	5.0	6.9	14.0	8.4	16.2	17.5	14.0	20.2	17.3	14.7	16.8	5.6	17.0	15.2	14.1	5.1	23.3	11.7	15.2	14.4	7.4	2.9	6.0	4.2	5.4	3.3	6.9	5.2	4.3	5.5	3.0	5.0	14.1	3.9	0.0	4.6	10.7	2.5	2.0	2.2	4.1	6.2	9.1	4.8	4.1	8.6	10.0	5.6	5.5	8.4	5.7	3.4	14.3	0.0	4.7	27.3	3.6	3.8	3.6	6.7	5.7	18.8	5.7	4.2	4.4	1.5	3.2	0.0	11.8	4.2	18.3	5.7	6.7	22.7	8.4	0.0	3.5	1.4	52.7	3.7	2.2	1.8	7.5	3.5	6.9	4.1	16.6	41.8	5.3	5.6	3.8	6.7	1.9	13.3	7.3	5.2	14.9	13.1	5.2	3.5	26.1	5.6	4.7	3.3	7.3	3.4	5.0	9.9	2.7
USP31	KIAA1203	ENSG00000103404	"Ubiquitin specific peptidase 31"	Q70CQ4	16	23061406-23149270	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Ubl conjugation pathway"	"Hydrolase, Protease, Thiol protease"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 31.2"	"Cell type enhanced"	"Detected in many"		"Oligodendrocytes: 198.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA006937	Uncertain		Approved	Cytosol		NA	NA			"Cluster 16: MAIT-cells - Unknown function"	"Cluster 70: Brain - Nervous system development"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	Cytosol		"HPA006937: AB_1080523"	"unprognostic (6.45e-2)"	"unprognostic (2.42e-1)"	"unprognostic (1.08e-1)"	"unprognostic (4.43e-3)"	"unprognostic (1.24e-1)"	"unprognostic (1.28e-1)"	"unprognostic (1.23e-1)"	"unprognostic (1.29e-1)"	"unprognostic (1.03e-1)"	"unprognostic (2.52e-1)"	"unprognostic (6.15e-2)"	"unprognostic (2.01e-1)"	"prognostic unfavorable (4.41e-5)"	"unprognostic (5.59e-2)"	"unprognostic (3.75e-1)"	"unprognostic (3.07e-1)"	"unprognostic (1.98e-3)"	5.5	2.9	7.5	2.0	23.4	4.3	6.7	18.9	13.0	12.9	0.7	4.2	1.7	11.0	3.8	6.0	5.3	1.9	9.2	10.0	10.5	3.6	5.6	6.1	1.8	22.3	20.3	2.2	4.3	5.5	5.7	3.9	21.3	7.5	2.3	3.2	4.6	4.1	8.9	11.2	2.6	7.5	11.3	1.6	2.6	11.8	20.6	2.6	3.0	8.4	2.5	7.5	7.9	31.2	12.0	12.4	3.5	4.9	6.2	4.8	3.3	4.1	3.7	5.1	6.1	7.9	7.1	4.0	4.2	5.1	8.3	15.2	8.7	15.9	8.4	2.9	3.5	1.6	7.4	16.7	7.8	4.2	4.3	4.1	13.5	9.5	21.8	1.9	9.3	3.9	4.9	12.0	7.1	8.0	2.0	3.5	6.9	3.9	3.8	9.9	9.8	7.9	7.7	17.5	9.3	6.0	6.3	12.4	3.6	3.9	5.0	9.2	5.5	10.3	7.6	5.3	11.2	3.9	7.0	4.2	7.4	5.5	4.2	0.0	0.1	0.1	0.1	0.0	0.3	0.0	0.1	0.2	0.1	0.0	0.1	0.1	0.0	0.0	0.2	0.0	0.2	0.0	7.5	23.4	18.9	13.0	10.0	10.5	22.3	20.3	21.3	11.3	20.6	31.2	25.9	6.4	3.7	11.1	2.2	66.8	62.7	35.5	44.9	13.7	7.6	19.8	13.6	7.2	10.9	5.5	2.1	13.8	3.6	2.7	0.0	7.0	4.8	20.6	12.8	17.6	4.8	8.2	59.2	8.6	7.5	6.9	2.0	13.2	1.3	23.7	7.5	27.7	4.7	0.0	49.6	3.5	12.2	3.5	10.8	10.4	7.8	5.0	7.2	32.8	3.1	4.0	3.1	31.7	198.7	7.9	2.0	4.5	2.8	32.0	1.5	11.6	17.6	8.1	19.7	8.8	11.2	24.2	57.1	17.4	26.6	7.5	2.9	4.4	6.4	23.9
USP32	"NY-REN-60, USP10"	ENSG00000170832	"Ubiquitin specific peptidase 32"	Q8NFA0	17	60177327-60422470	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Ubl conjugation pathway"	"Hydrolase, Protease, Thiol protease"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 102.1"	"Cell type enhanced"	"Detected in all"		"Cone photoreceptor cells: 241.8;Inhibitory neurons: 113.1;Oligodendrocytes: 268.9;Rod photoreceptor cells: 136.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"plasmacytoid DC: 59.2"	"Group enriched"	"Detected in all"	10	"dendritic cells: 59.2;granulocytes: 29.4"	"Cell line enhanced"	"Detected in all"		"MCF7: 171.4"					"Low region specificity"	"Detected in all"			HPA044365	Approved		Approved	"Golgi apparatus,Cytosol"		NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 77: Retina - Visual perception"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 9: Photoreceptor cells - Phototransduction"	"Golgi apparatus"	Cytosol	"HPA044365: AB_2678914"	"unprognostic (4.10e-2)"	"unprognostic (3.38e-2)"	"unprognostic (3.57e-2)"	"prognostic unfavorable (1.50e-4)"	"unprognostic (2.15e-1)"	"unprognostic (4.33e-2)"	"unprognostic (1.90e-3)"	"unprognostic (2.33e-2)"	"unprognostic (2.24e-1)"	"unprognostic (3.93e-1)"	"unprognostic (6.49e-2)"	"unprognostic (2.78e-1)"	"unprognostic (2.82e-1)"	"unprognostic (1.97e-1)"	"unprognostic (7.23e-2)"	"unprognostic (8.35e-2)"	"unprognostic (4.16e-2)"	16.1	21.8	13.6	15.0	27.8	32.1	14.1	23.2	23.6	12.4	25.2	13.0	9.5	10.3	6.8	21.7	10.7	11.8	17.4	14.3	22.8	20.2	26.6	20.7	10.5	22.2	25.0	10.0	12.5	19.2	11.9	13.2	24.8	10.8	11.4	58.8	12.9	11.2	40.8	21.0	10.5	13.7	18.1	18.5	12.2	102.1	22.3	14.4	20.6	29.2	11.6	13.1	14.7	44.4	32.6	38.2	19.0	30.8	44.8	45.3	17.2	26.4	41.9	34.5	45.8	18.6	20.0	19.4	21.5	50.0	56.1	16.3	33.1	36.9	61.5	16.8	13.9	39.7	31.8	19.5	44.1	31.7	33.6	39.6	24.6	49.9	45.2	33.5	38.6	24.4	42.9	17.1	41.1	171.4	32.3	21.3	21.7	29.6	18.8	15.8	51.6	11.5	33.1	24.5	13.1	19.1	22.9	6.0	33.8	32.1	27.4	41.3	32.6	49.7	54.9	33.1	23.5	16.2	37.4	19.6	24.6	23.6	33.4	14.5	4.3	16.5	2.0	3.7	1.4	3.0	1.4	1.7	8.5	2.2	1.0	1.9	29.4	1.3	4.6	59.2	2.6	2.1	13.6	27.8	23.2	23.6	14.3	22.8	22.2	25.0	24.8	18.1	22.3	44.4	8.0	6.4	16.4	58.8	12.5	26.9	13.3	5.8	11.4	17.3	9.2	7.6	8.2	10.0	10.1	5.5	241.8	5.1	12.6	8.5	3.9	11.3	95.0	9.0	9.9	9.8	8.3	44.2	92.3	7.5	8.4	12.6	15.8	11.6	11.4	18.5	12.5	12.0	18.5	13.5	113.1	5.6	6.1	29.7	41.3	33.3	13.1	25.1	5.4	101.2	28.0	10.4	24.7	70.4	268.9	9.6	11.4	5.7	8.3	10.3	7.4	4.6	7.0	136.4	26.3	11.9	9.1	92.7	14.9	11.2	21.9	4.9	10.9	8.5	5.5	8.2
USP33	"KIAA1097, VDU1"	ENSG00000077254	"Ubiquitin specific peptidase 33"	Q8TEY7	1	77695987-77759852	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Endocytosis, Ubl conjugation pathway"	"Hydrolase, Protease, Thiol protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Inhibitory neurons: 159.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA005719	Uncertain		Supported	"Nucleoplasm,Golgi apparatus"		NA	NA			"Cluster 42: Non-specific - Transcription"	"Cluster 6: Brain - Smell perception"	"Cluster 36: HEL - Hemostasis"	"Cluster 50: Fibroblasts - ECM organization"	"Nucleoplasm, Golgi apparatus"		"HPA005719: AB_10601708"	"unprognostic (2.31e-3)"	"unprognostic (2.73e-2)"	"unprognostic (1.04e-2)"	"unprognostic (2.36e-1)"	"unprognostic (9.19e-3)"	"unprognostic (1.88e-3)"	"unprognostic (1.22e-2)"	"unprognostic (6.06e-2)"	"unprognostic (2.48e-1)"	"unprognostic (2.25e-1)"	"unprognostic (2.67e-1)"	"unprognostic (3.59e-1)"	"unprognostic (5.36e-3)"	"unprognostic (4.89e-2)"	"unprognostic (5.76e-2)"	"unprognostic (2.19e-1)"	"unprognostic (2.02e-2)"	40.7	31.2	31.5	24.6	40.4	34.5	34.3	52.0	49.7	24.2	37.3	24.3	25.4	28.0	26.8	21.6	22.5	26.3	21.7	35.4	31.8	31.1	25.4	26.2	28.1	28.6	24.9	29.3	19.5	35.0	20.9	28.0	30.8	28.8	25.2	49.1	25.2	22.9	18.0	24.3	26.9	24.1	22.3	26.0	24.4	25.4	28.6	27.1	30.4	20.7	26.0	22.9	20.0	55.5	42.4	18.8	64.1	44.2	90.0	78.3	54.8	45.3	42.9	54.0	60.1	25.4	35.5	31.4	41.2	44.3	88.2	32.1	47.4	31.1	65.7	28.8	36.6	111.1	44.6	22.2	56.0	37.8	26.8	58.3	23.9	52.4	37.9	51.9	48.7	28.0	43.9	26.3	41.2	16.1	34.9	38.0	62.2	32.6	37.2	33.0	67.7	22.2	51.0	41.1	53.8	41.2	31.9	41.5	64.2	54.3	23.1	41.2	41.2	49.4	34.4	50.1	43.2	21.0	28.4	30.4	37.3	44.5	25.4	67.3	22.5	31.8	21.0	22.6	21.7	20.5	20.6	21.7	17.5	22.3	24.5	21.9	30.5	19.2	30.1	18.4	20.7	16.7	31.5	40.4	52.0	49.7	35.4	31.8	28.6	24.9	30.8	22.3	28.6	55.5	40.2	44.8	40.9	66.3	35.1	17.2	18.8	21.2	32.5	56.7	25.7	22.1	39.9	22.8	25.5	35.0	58.4	25.1	48.8	35.9	9.8	20.8	4.3	54.8	37.8	31.8	35.5	50.9	149.3	15.4	19.0	39.6	43.3	54.6	23.4	43.1	28.2	23.1	19.0	62.2	159.0	28.6	22.4	30.8	20.7	5.5	35.8	35.1	23.2	75.9	38.7	31.4	37.0	98.0	138.5	19.6	27.8	32.0	42.4	22.9	33.2	25.6	37.3	44.5	19.7	34.9	35.6	39.8	30.1	28.4	16.3	11.9	41.0	39.2	24.8	21.8
USP34	"KIAA0570, KIAA0729"	ENSG00000115464	"Ubiquitin specific peptidase 34"	Q70CQ2	2	61187463-61471087	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Ubl conjugation pathway, Wnt signaling pathway"	"Hydrolase, Protease, Thiol protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Oligodendrocytes: 310.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA025815, HPA070764"	Uncertain		Approved	Nucleoplasm		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 20: Retina & Lymphoid tissues - Unknown function"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 52: Non-specific - Transcription"	Nucleoplasm		"HPA025815: AB_1858681, HPA070764: AB_2686308"	"unprognostic (4.04e-2)"	"unprognostic (8.21e-3)"	"unprognostic (5.08e-2)"	"unprognostic (3.14e-2)"	"unprognostic (4.13e-2)"	"unprognostic (1.43e-2)"	"unprognostic (1.04e-1)"	"unprognostic (2.66e-1)"	"unprognostic (1.47e-1)"	"unprognostic (2.90e-2)"	"unprognostic (8.91e-2)"	"unprognostic (4.62e-2)"	"unprognostic (9.58e-2)"	"unprognostic (1.66e-1)"	"unprognostic (2.53e-1)"	"unprognostic (6.34e-2)"	"unprognostic (7.01e-2)"	32.2	36.0	49.9	21.7	53.9	37.7	35.6	57.7	58.3	36.1	59.9	47.0	14.8	38.4	54.4	35.8	33.3	21.1	33.7	49.7	53.5	43.3	34.8	36.4	44.1	52.1	51.8	43.4	32.4	35.1	45.0	17.4	52.3	38.6	26.8	77.5	27.2	32.4	53.9	41.4	40.8	27.9	50.3	45.8	36.3	45.1	54.5	47.8	32.2	36.8	45.1	36.9	32.8	56.8	43.6	29.9	38.9	40.3	71.8	48.1	32.4	26.3	37.1	23.0	21.7	43.0	16.3	102.2	27.0	56.9	24.3	23.4	30.9	34.4	42.6	36.7	24.4	61.6	29.5	69.6	60.2	46.1	37.8	52.9	43.6	41.9	62.1	55.7	49.0	28.8	42.7	32.2	51.5	40.6	30.6	66.6	26.3	43.9	23.9	32.4	46.5	27.7	67.9	52.2	31.9	34.0	40.5	30.1	48.3	49.4	16.0	33.2	43.6	36.1	48.2	21.5	34.7	37.0	19.7	103.6	33.8	42.5	31.7	2.1	1.2	1.6	3.8	1.1	3.5	2.6	2.6	2.9	1.0	3.1	2.9	3.9	1.8	3.1	2.8	3.2	2.5	1.4	49.9	53.9	57.7	58.3	49.7	53.5	52.1	51.8	52.3	50.3	54.5	56.8	64.5	64.1	68.3	193.6	82.8	61.1	54.2	40.3	46.7	139.7	54.0	46.6	46.0	48.6	54.6	33.1	250.2	33.5	87.3	46.0	9.8	41.4	133.5	59.9	66.9	59.3	48.6	53.2	256.6	33.6	23.8	53.0	73.9	70.6	32.3	78.0	31.8	38.9	21.6	107.7	240.4	37.8	59.0	45.4	48.6	138.0	56.8	56.0	40.9	212.7	55.2	60.0	87.6	232.2	310.0	49.9	41.1	67.0	69.9	79.9	38.3	23.4	44.1	178.1	26.3	78.2	63.9	95.8	115.9	53.1	61.4	53.4	70.5	74.7	35.6	69.9
USP35	KIAA1372	ENSG00000118369	"Ubiquitin specific peptidase 35"	Q9P2H5	11	78188812-78215232	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Ubl conjugation pathway"	"Hydrolase, Protease, Thiol protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in many"	9	"Early spermatids: 39.1;Granulosa cells: 30.8;Late spermatids: 121.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA055213, HPA058592"	Uncertain		Approved	"Nucleoplasm,Nucleoli fibrillar center"		NA	NA			"Cluster 49: Eosinophils - Unknown function"	"Cluster 35: Non-specific - Unknown function"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 31: Spermatids - Spermatogenesis"	"Nucleoli fibrillar center"	Nucleoplasm	"HPA055213: AB_2682740, HPA058592: AB_2683766"	"unprognostic (6.69e-2)"	"unprognostic (1.17e-2)"	"unprognostic (1.69e-1)"	"unprognostic (6.87e-3)"	"unprognostic (3.38e-2)"	"unprognostic (1.08e-2)"	"unprognostic (2.00e-1)"	"unprognostic (1.46e-1)"	"unprognostic (3.57e-2)"	"unprognostic (3.84e-3)"	"unprognostic (1.03e-2)"	"unprognostic (3.11e-2)"	"unprognostic (1.29e-3)"	"unprognostic (2.93e-1)"	"unprognostic (1.31e-1)"	"unprognostic (4.38e-2)"	"unprognostic (1.49e-2)"	6.1	19.8	8.0	3.6	7.4	2.5	5.1	5.1	8.0	9.2	7.4	7.6	3.5	6.7	3.2	6.0	6.4	3.5	10.2	8.3	7.1	6.2	16.8	7.0	3.3	9.0	8.2	7.4	5.9	12.4	13.4	4.7	9.4	5.9	1.9	2.1	3.9	3.2	4.1	3.0	4.5	4.7	3.9	4.9	4.6	4.5	8.3	6.2	8.7	4.0	2.6	6.6	7.7	6.4	2.2	3.3	5.7	6.1	9.7	8.7	3.9	5.0	5.8	5.8	4.0	8.4	4.7	1.7	5.0	9.5	6.2	5.8	3.8	7.8	3.4	12.8	2.0	2.9	9.8	5.0	7.4	1.8	8.3	7.4	5.1	12.1	3.5	11.4	7.2	6.5	4.1	4.2	4.6	2.0	4.7	7.6	1.7	6.2	5.3	2.9	5.2	2.0	4.5	4.1	2.8	5.9	3.9	5.1	1.9	8.1	4.3	1.6	8.9	10.6	5.9	12.8	2.7	5.7	2.0	2.7	3.1	2.0	6.3	0.0	0.0	0.8	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.0	7.4	5.1	8.0	8.3	7.1	9.0	8.2	9.4	3.9	8.3	6.4	1.3	0.0	1.8	5.9	1.2	0.8	0.2	0.7	3.4	0.8	1.0	0.6	3.5	0.0	0.3	0.0	6.2	0.7	1.0	1.2	0.0	1.1	39.1	1.3	2.7	1.9	0.0	0.4	5.2	2.0	1.6	2.0	5.1	1.2	0.0	30.8	1.4	2.7	1.6	0.0	4.8	0.9	0.0	0.6	0.8	121.6	1.5	1.4	1.8	2.8	2.7	0.4	0.0	3.5	2.8	2.0	0.1	3.0	0.8	0.3	0.8	1.0	0.5	0.6	6.6	0.7	1.3	1.2	2.4	4.1	1.0	0.3	2.9	2.1	1.3	0.2
USP36	"FLJ12851, KIAA1453"	ENSG00000055483	"Ubiquitin specific peptidase 36"	Q9P275	17	78787381-78841441	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Ubl conjugation pathway"	"Hydrolase, Protease, Thiol protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA012082, HPA012395, HPA052860"	Uncertain	Supported	Enhanced	"Nucleoli,Nucleoli rim,Nuclear speckles"		NA	NA			"Cluster 6: Non-specific - Transcription"	"Cluster 50: Non-specific - Ribosome"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 24: Non-specific - Transcription regulation"	"Nucleoli, Nucleoli rim"	"Nuclear speckles"	"HPA012082: AB_1858682, HPA012395: , HPA052860: AB_2681974"	"unprognostic (1.94e-2)"	"unprognostic (2.80e-2)"	"unprognostic (1.07e-1)"	"prognostic unfavorable (5.18e-5)"	"unprognostic (9.35e-2)"	"unprognostic (1.98e-1)"	"unprognostic (2.50e-3)"	"unprognostic (1.35e-1)"	"unprognostic (2.04e-1)"	"unprognostic (1.33e-1)"	"unprognostic (1.68e-2)"	"unprognostic (2.78e-2)"	"unprognostic (1.31e-2)"	"unprognostic (1.45e-1)"	"unprognostic (1.81e-1)"	"unprognostic (4.03e-3)"	"unprognostic (1.78e-1)"	43.9	37.9	20.0	21.5	21.9	46.6	32.9	29.3	23.9	32.6	27.5	31.2	13.4	26.8	22.9	25.0	34.2	18.7	30.2	21.4	20.6	34.4	30.3	36.1	20.6	22.6	21.3	67.4	44.5	18.1	50.3	26.0	21.5	36.2	15.8	26.3	24.9	13.1	30.3	40.4	26.6	16.3	19.4	30.7	31.2	22.2	21.2	15.1	31.6	11.7	20.5	29.3	29.8	30.1	42.7	50.3	14.6	26.9	30.5	33.7	27.8	34.1	34.5	32.1	21.5	49.2	21.0	54.0	16.9	30.6	34.8	30.6	34.5	25.4	57.0	13.0	52.1	49.4	81.0	51.9	31.3	54.7	26.0	29.5	41.0	45.8	101.6	24.7	28.3	24.1	40.0	55.3	26.8	32.6	50.1	55.1	22.6	31.6	39.9	38.1	31.8	36.3	20.2	44.1	42.8	25.8	24.5	112.5	63.7	31.3	29.2	34.4	24.3	75.2	35.3	44.3	61.1	40.7	17.4	66.1	29.6	41.9	24.0	10.1	3.0	2.4	5.5	4.2	6.5	5.1	5.2	4.8	1.8	4.7	5.7	5.6	4.3	4.5	2.7	9.7	3.8	1.9	20.0	21.9	29.3	23.9	21.4	20.6	22.6	21.3	21.5	19.4	21.2	30.1	27.4	12.8	37.4	23.5	55.9	51.7	28.4	8.2	40.9	33.2	18.1	16.9	14.1	18.6	18.8	14.7	33.3	8.3	66.3	14.4	5.9	10.2	20.7	22.3	24.0	28.4	18.5	14.7	19.0	9.6	11.3	26.6	25.0	42.7	20.3	12.8	12.1	16.5	43.3	26.9	22.5	18.6	10.2	24.5	72.8	8.5	11.8	49.4	30.2	10.3	14.9	13.2	16.5	13.6	19.8	13.2	8.4	12.4	57.1	32.4	7.3	5.0	11.1	32.1	6.6	22.1	23.1	18.4	16.5	24.4	43.3	12.9	73.6	13.1	18.6	22.2
USP37	KIAA1594	ENSG00000135913	"Ubiquitin specific peptidase 37"	Q86T82	2	218450251-218568351	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis, Ubl conjugation pathway"	"Hydrolase, Protease, Thiol protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 119.4;Late spermatids: 145.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA045160	Approved		Approved	Nucleoplasm,Nucleoli		NA	Yes			"Cluster 44: Non-specific - Transcription"	"Cluster 6: Brain - Smell perception"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 25: Spermatids - Spermatogenesis"	"Nucleoplasm, Nucleoli"		"HPA045160: AB_10795620"	"unprognostic (7.00e-2)"	"unprognostic (2.29e-1)"	"unprognostic (8.83e-2)"	"unprognostic (9.19e-4)"	"unprognostic (1.83e-1)"	"prognostic favorable (2.85e-4)"	"unprognostic (2.18e-2)"	"unprognostic (1.14e-1)"	"unprognostic (9.66e-3)"	"unprognostic (1.17e-1)"	"unprognostic (3.78e-3)"	"unprognostic (1.11e-1)"	"unprognostic (3.82e-2)"	"unprognostic (3.26e-1)"	"unprognostic (2.87e-1)"	"unprognostic (6.69e-2)"	"unprognostic (6.41e-3)"	2.7	4.1	3.5	4.4	4.7	11.8	4.7	8.5	4.9	3.6	1.9	3.0	2.9	4.2	7.5	3.9	3.3	3.5	2.3	3.3	4.0	2.9	3.8	3.0	6.0	3.8	4.0	5.9	3.0	4.0	1.4	4.0	4.0	3.6	3.5	9.1	3.9	3.0	2.9	3.9	3.3	3.2	2.5	3.8	3.4	12.7	3.4	6.3	5.0	4.2	4.9	3.6	2.2	8.3	9.6	6.9	14.2	11.0	3.6	4.4	12.1	7.1	5.1	12.2	13.6	13.1	7.4	8.7	7.5	5.6	9.3	8.9	15.7	8.0	13.4	12.0	8.3	23.5	13.6	8.7	4.1	15.6	11.3	2.4	4.7	12.9	9.2	4.5	5.3	15.0	17.3	16.2	7.8	7.2	20.1	10.6	12.2	6.2	5.9	16.0	21.3	8.0	4.2	11.2	15.5	8.4	11.5	5.6	7.2	13.6	6.4	10.8	6.8	13.7	12.0	7.7	9.5	11.0	10.4	17.6	7.4	11.2	9.5	4.2	2.0	3.8	3.1	2.3	3.2	2.5	2.6	2.7	2.1	3.2	4.0	2.6	1.6	3.2	2.2	2.9	3.6	1.2	3.5	4.7	8.5	4.9	3.3	4.0	3.8	4.0	4.0	2.5	3.4	8.3	12.8	0.0	11.0	34.3	16.5	19.5	7.0	7.1	22.2	14.7	14.4	10.2	4.9	4.3	9.6	7.3	27.1	8.4	13.4	5.5	0.0	5.8	119.4	13.3	11.8	14.2	10.3	16.6	47.4	2.3	6.6	13.2	9.2	16.4	5.1	16.2	12.5	11.0	7.8	15.2	40.0	8.9	4.1	8.5	22.9	145.5	9.9	17.2	21.4	27.2	10.2	9.1	10.3	35.2	60.5	4.9	7.4	9.8	14.6	12.1	7.1	4.2	11.1	19.9	6.6	12.7	21.6	60.8	31.4	13.6	20.6	7.3	19.7	10.9	7.6	7.1
USP38	"HP43.8KD, KIAA1891"	ENSG00000170185	"Ubiquitin specific peptidase 38"	Q8NB14	4	143184917-143223874	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Ubl conjugation pathway"	"Hydrolase, Protease, Thiol protease"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 36.6"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"U-266/84: 65.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036990, HPA047948"	Uncertain		Approved	Nucleoplasm,Centrosome,Cytosol		NA	NA			"Cluster 38: Basophils - Unknown function"	"Cluster 59: Non-specific - Translation"	"Cluster 16: U-266 - Nucleosome"	"Cluster 44: Endometrium - Transcription"	Nucleoplasm	"Centrosome, Cytosol"	"HPA036990: AB_2675419, HPA047948: AB_2680220"	"unprognostic (5.01e-2)"	"unprognostic (2.45e-1)"	"unprognostic (2.04e-3)"	"unprognostic (2.99e-2)"	"unprognostic (1.87e-1)"	"unprognostic (2.61e-2)"	"unprognostic (1.67e-1)"	"unprognostic (7.49e-2)"	"unprognostic (3.66e-2)"	"unprognostic (3.97e-2)"	"unprognostic (8.03e-2)"	"unprognostic (7.72e-3)"	"prognostic favorable (1.20e-4)"	"unprognostic (3.15e-1)"	"unprognostic (1.26e-1)"	"unprognostic (1.29e-1)"	"unprognostic (1.02e-1)"	6.5	4.4	2.5	6.2	4.3	21.6	4.6	4.3	2.9	6.2	4.3	8.0	7.9	5.5	2.3	7.0	4.3	5.2	6.8	2.2	2.4	7.0	13.2	6.3	6.4	5.9	3.8	3.7	8.2	7.7	3.3	8.1	4.9	5.5	5.7	4.5	5.8	5.6	36.6	5.9	7.2	5.7	4.9	7.4	6.3	6.8	3.2	9.3	7.4	21.3	5.8	6.8	3.9	6.8	8.5	7.9	6.6	11.3	8.4	8.2	5.1	13.0	12.5	11.8	10.1	23.1	11.7	10.5	9.2	11.5	7.8	6.5	15.9	13.5	10.2	26.0	10.5	9.7	8.5	4.7	11.3	19.4	9.4	10.2	11.1	12.0	9.5	8.3	12.2	11.9	21.5	31.5	7.9	13.3	25.6	3.7	6.1	17.7	15.3	16.7	10.2	10.1	7.2	9.2	13.8	12.3	10.5	17.3	10.9	4.9	10.8	7.6	14.6	10.8	9.1	9.6	14.1	35.7	65.3	18.6	10.9	14.4	9.3	13.4	4.5	9.7	5.7	4.6	7.0	4.6	4.9	4.9	6.6	4.5	4.8	4.2	4.3	10.1	4.9	2.7	7.9	4.3	2.5	4.3	4.3	2.9	2.2	2.4	5.9	3.8	4.9	4.9	3.2	6.8	21.5	22.4	19.8	13.7	19.5	53.5	21.0	6.2	25.6	7.4	20.8	13.7	18.4	10.0	12.2	0.0	12.5	12.8	22.2	35.5	1.9	8.3	36.4	20.7	26.1	15.3	30.6	31.5	19.6	7.7	7.1	13.4	26.0	52.1	3.8	9.9	17.9	38.4	10.6	8.4	15.9	20.2	4.1	17.0	16.6	20.3	6.8	21.9	12.4	9.4	10.1	15.1	12.3	18.6	22.8	10.2	13.4	9.4	38.6	16.8	17.0	18.5	10.9	8.9	13.1	15.0	14.1	11.3	4.7	31.5	59.1	26.7	23.2	11.0	17.6	45.4
USP4	"UNP, Unph"	ENSG00000114316	"Ubiquitin specific peptidase 4"	Q13107	3	49277144-49340712	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Ubl conjugation pathway"	"Hydrolase, Protease, Thiol protease"	Proto-oncogene	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 131.8;Late spermatids: 104.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA018499	Approved		Approved	"Plasma membrane,Cytosol"		NA	NA			"Cluster 5: Granulocytes - Unknown function"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 34: Spermatids - Unknown function"	"Plasma membrane, Cytosol"		"HPA018499: AB_1858689"	"unprognostic (2.34e-3)"	"unprognostic (1.52e-1)"	"unprognostic (2.22e-3)"	"unprognostic (6.12e-2)"	"unprognostic (3.51e-1)"	"unprognostic (4.33e-2)"	"unprognostic (9.42e-2)"	"prognostic favorable (4.46e-5)"	"unprognostic (3.54e-1)"	"unprognostic (9.07e-3)"	"unprognostic (2.78e-2)"	"unprognostic (1.70e-3)"	"prognostic favorable (4.29e-5)"	"unprognostic (7.30e-2)"	"unprognostic (1.00e-1)"	"unprognostic (1.18e-2)"	"unprognostic (1.65e-2)"	25.2	20.3	24.2	26.5	26.3	53.7	24.9	24.5	28.2	27.7	27.1	25.4	18.3	24.4	21.6	26.0	22.4	18.3	26.5	23.7	23.4	21.8	20.2	29.5	30.9	23.9	24.4	24.5	19.0	24.1	16.4	23.3	23.9	23.7	23.4	26.9	21.0	21.7	31.6	31.4	22.5	24.0	22.4	33.7	20.2	28.0	24.8	37.0	23.0	28.8	33.7	25.8	25.0	24.5	14.2	15.8	21.6	28.8	38.7	40.1	14.7	36.4	32.9	46.7	41.3	16.8	34.8	27.1	14.4	53.9	27.4	18.9	28.6	52.6	42.5	42.1	8.4	60.3	31.9	19.6	57.0	32.5	34.0	42.8	23.3	51.0	41.5	34.3	55.0	29.9	21.6	41.6	42.1	24.5	38.3	55.8	18.7	17.7	26.9	15.6	13.3	23.9	37.5	29.2	17.5	24.0	27.2	19.3	14.0	21.6	13.5	51.2	50.1	31.1	17.2	39.6	22.5	33.6	17.3	38.6	28.6	50.1	36.5	70.1	83.6	94.8	48.1	69.2	53.7	51.0	50.2	48.9	74.6	41.4	47.7	42.2	179.2	72.4	81.2	28.4	59.7	78.0	24.2	26.3	24.5	28.2	23.7	23.4	23.9	24.4	23.9	22.4	24.8	24.5	24.3	41.7	25.1	28.1	24.7	18.7	17.9	17.2	22.2	17.5	10.9	10.3	17.9	10.0	23.2	20.2	20.9	22.7	27.9	13.6	21.5	16.5	131.8	17.3	18.3	22.1	10.7	31.6	30.8	13.6	14.3	17.9	27.5	21.1	33.6	21.4	17.5	14.6	24.0	11.8	26.4	13.8	16.2	38.6	21.0	104.9	15.5	34.2	16.0	16.9	36.0	13.9	23.7	25.6	20.2	18.9	7.6	19.2	29.2	17.6	14.5	13.4	28.6	20.5	13.1	18.4	17.0	35.3	14.5	17.9	18.5	24.2	29.4	17.0	13.9	14.5
USP40	FLJ10785	ENSG00000085982	"Ubiquitin specific peptidase 40"	Q9NVE5	2	233475520-233566782	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Ubl conjugation pathway"	"Hydrolase, Protease, Thiol protease"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Astrocytes: 79.3;Oligodendrocytes: 127.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA005821	Uncertain		Approved	"Vesicles,Focal adhesion sites"		NA	NA			"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 68: Epididymis - Unknown function"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 64: Astrocytes - Nervous system maintenance"	Vesicles	"Focal adhesion sites"	"HPA005821: AB_1080526"	"unprognostic (2.19e-1)"	"unprognostic (1.04e-1)"	"unprognostic (1.13e-1)"	"unprognostic (1.33e-1)"	"unprognostic (3.70e-1)"	"unprognostic (2.15e-1)"	"unprognostic (5.30e-2)"	"unprognostic (2.25e-1)"	"unprognostic (1.80e-2)"	"unprognostic (1.18e-1)"	"unprognostic (1.96e-1)"	"unprognostic (1.26e-1)"	"unprognostic (2.22e-1)"	"unprognostic (1.45e-1)"	"unprognostic (4.09e-2)"	"unprognostic (1.90e-2)"	"unprognostic (2.53e-2)"	11.8	12.0	10.4	7.5	17.0	3.4	13.9	12.8	11.4	10.0	16.5	9.4	10.5	10.6	24.0	10.4	11.5	11.6	8.2	10.2	12.0	14.2	13.2	12.5	7.2	19.4	14.2	15.9	14.0	16.8	8.5	12.4	19.0	13.5	9.5	14.2	12.9	10.4	9.6	19.7	10.1	8.5	12.3	9.9	13.1	14.7	16.2	10.1	16.4	7.6	7.8	9.6	7.5	25.4	17.3	19.9	17.6	12.0	25.2	23.0	15.7	16.4	12.4	14.7	16.0	14.3	20.2	0.4	4.7	26.4	38.6	30.3	13.3	29.7	20.6	0.0	9.0	13.3	17.4	24.3	22.3	5.8	8.9	22.2	21.1	22.2	30.9	26.2	17.3	8.1	22.0	3.2	21.4	14.0	6.2	8.5	7.9	17.8	16.0	0.0	36.3	8.1	17.9	27.6	9.6	10.3	13.5	13.5	16.9	12.9	15.4	12.9	17.3	20.9	13.1	8.9	20.6	6.0	4.9	0.8	27.1	10.2	18.6	0.0	1.0	0.0	0.5	1.1	0.2	0.4	0.5	0.4	1.5	0.7	0.7	0.7	0.1	0.5	0.9	1.9	0.8	0.5	10.4	17.0	12.8	11.4	10.2	12.0	19.4	14.2	19.0	12.3	16.2	25.4	11.8	32.1	35.5	79.3	7.9	7.4	9.1	13.6	15.4	18.1	17.0	14.7	10.7	10.0	19.9	16.5	25.0	21.2	6.7	9.9	7.9	9.4	8.4	19.8	18.3	11.1	15.0	5.7	25.9	12.6	10.6	11.9	21.4	21.3	9.5	23.4	12.8	25.4	8.2	23.5	38.2	10.9	4.1	11.6	3.6	10.7	6.8	9.1	3.6	40.3	5.9	11.9	4.1	48.2	127.7	10.5	12.6	8.2	10.9	12.9	13.9	14.6	21.0	19.4	13.1	17.5	10.6	30.2	20.9	17.2	10.5	15.7	5.5	21.1	12.1	10.0
USP42	FLJ12697	ENSG00000106346	"Ubiquitin specific peptidase 42"	Q9H9J4	7	6104884-6161564	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Differentiation, Spermatogenesis, Ubl conjugation pathway"	"Hydrolase, Protease, Thiol protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 89.1;Spermatocytes: 72.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA006939, HPA064800"			Approved	Nucleoplasm,Nucleoli		NA	NA			"Cluster 10: Basophils - Unknown function"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 59: Non-specific - Transcription"	Nucleoplasm	Nucleoli	"HPA006939: , HPA064800: AB_2685355"	"unprognostic (1.48e-2)"	"unprognostic (1.47e-1)"	"unprognostic (2.59e-1)"	"unprognostic (1.69e-1)"	"unprognostic (1.30e-2)"	"unprognostic (1.53e-1)"	"unprognostic (1.19e-2)"	"unprognostic (3.32e-1)"	"unprognostic (1.05e-1)"	"unprognostic (2.82e-1)"	"unprognostic (6.21e-3)"	"unprognostic (2.47e-2)"	"unprognostic (3.17e-3)"	"unprognostic (3.14e-2)"	"unprognostic (3.06e-2)"	"unprognostic (2.19e-2)"	"unprognostic (2.66e-1)"	3.8	3.0	3.1	3.2	3.0	13.4	3.9	5.8	4.4	4.3	2.4	4.5	4.5	4.9	3.6	3.7	4.3	3.4	3.2	3.0	3.0	3.9	4.0	4.1	3.8	2.8	3.1	4.9	3.8	4.7	3.8	3.3	2.7	3.8	3.4	5.8	3.5	3.1	4.3	5.4	4.3	4.1	2.9	4.4	3.6	15.2	3.2	5.7	4.0	3.4	3.2	4.0	3.8	3.2	10.2	7.4	13.1	12.9	7.4	5.5	9.0	5.4	6.9	6.2	6.1	5.3	5.2	12.0	3.4	6.7	9.2	9.3	11.1	5.9	6.7	2.9	8.6	5.6	6.1	5.5	6.3	13.0	6.1	6.4	6.8	6.7	8.5	5.7	7.7	10.0	21.7	7.9	4.1	9.1	7.9	14.6	14.8	5.2	5.6	14.9	10.2	8.2	5.9	5.3	10.0	17.7	6.9	14.0	4.3	12.0	6.5	6.6	6.5	5.5	20.5	7.0	6.5	7.0	6.3	10.3	4.6	7.8	11.0	0.6	0.3	0.9	0.5	0.6	0.7	0.4	0.6	0.3	0.3	0.2	0.4	1.0	0.3	0.5	0.3	0.6	0.5	0.2	3.1	3.0	5.8	4.4	3.0	3.0	2.8	3.1	2.7	2.9	3.2	3.2	13.7	12.8	7.0	19.6	16.1	40.5	18.2	5.2	26.7	18.7	17.4	10.8	10.5	8.6	6.8	1.8	22.9	8.3	16.4	20.7	0.0	10.4	89.1	27.1	15.3	14.4	10.7	10.8	26.1	10.4	8.4	13.4	15.3	25.6	9.5	13.4	12.8	9.8	8.2	21.9	26.2	18.1	8.2	9.1	19.9	42.5	14.3	12.4	10.6	18.7	7.7	10.1	12.3	18.6	26.2	12.0	7.7	12.8	21.7	22.3	12.4	5.7	10.6	18.7	13.1	16.2	14.9	72.4	37.0	23.1	41.5	26.8	19.2	6.4	14.4	15.3
USP43	FLJ30626	ENSG00000154914	"Ubiquitin specific peptidase 43"	Q70EL4	17	9644698-9729687	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Ubl conjugation pathway"	"Hydrolase, Protease, Thiol protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Endometrial ciliated cells: 37.9;Excitatory neurons: 35.5;Glandular and luminal cells: 52.5;Oligodendrocyte precursor cells: 73.4;Syncytiotrophoblasts: 73.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"BEWO: 11.7;SK-BR-3: 8.1;T-47d: 9.9"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"HPA023389, HPA027762, HPA027763"	Uncertain		Approved	"Nucleoplasm,Nuclear speckles"		NA	NA				"Cluster 29: Non-specific - Vesicular transport"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 44: Endometrium - Transcription"	"Nucleoplasm, Nuclear speckles"		"HPA023389: AB_1858691, HPA027762: AB_10603001, HPA027763: "	"unprognostic (1.39e-1)"	"unprognostic (1.75e-2)"	"unprognostic (1.07e-1)"	"unprognostic (2.30e-3)"	"unprognostic (1.08e-1)"	"unprognostic (5.24e-2)"	"unprognostic (2.04e-1)"	"unprognostic (6.40e-3)"	"unprognostic (2.26e-1)"	"unprognostic (3.05e-3)"	"unprognostic (2.41e-2)"	"unprognostic (7.49e-2)"	"unprognostic (5.95e-2)"	"prognostic favorable (5.39e-4)"	"unprognostic (3.24e-1)"	"unprognostic (2.06e-1)"	"unprognostic (3.28e-1)"	0.3	0.2	2.6	0.6	3.4	0.7	1.9	0.8	4.1	2.9	2.9	3.5	4.2	1.9	1.0	6.5	4.2	1.2	0.0	3.3	1.4	4.0	9.1	3.2	0.1	2.5	4.6	0.1	5.0	1.1	3.5	8.3	2.5	9.8	3.2	1.4	4.3	2.2	0.0	2.2	3.5	0.2	2.1	0.3	2.1	3.2	2.3	0.3	1.7	0.0	0.7	1.1	2.4	2.5	5.6	1.4	0.0	0.5	0.0	0.0	11.7	0.1	0.2	0.6	1.6	2.8	4.5	0.0	1.8	0.2	2.5	6.8	0.6	5.3	0.6	3.6	1.8	0.3	3.0	1.0	0.1	0.5	0.0	0.0	6.8	0.3	2.8	0.3	0.0	0.8	0.0	0.0	0.0	2.6	0.9	4.6	0.7	4.8	0.3	3.6	0.0	0.8	4.1	3.0	0.7	0.0	2.4	8.1	1.0	3.7	9.9	1.4	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.7	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	2.6	3.4	0.8	4.1	3.3	1.4	2.5	4.6	2.5	2.1	2.3	2.5	0.0	3.2	3.1	1.6	0.3	4.7	7.8	4.6	5.2	0.5	7.0	2.4	0.6	4.3	7.4	11.0	6.2	26.2	0.6	14.3	1.9	4.4	1.1	37.9	4.2	0.5	2.4	3.2	35.5	4.7	23.7	0.8	7.7	52.5	0.0	0.9	0.4	15.6	2.7	0.0	4.0	8.3	2.0	0.9	0.3	1.1	0.0	0.6	5.4	0.0	0.3	8.4	0.0	73.4	1.2	11.3	3.5	0.0	0.2	10.6	8.7	1.8	30.2	1.5	0.0	0.0	1.0	1.5	0.3	12.3	3.3	73.2	0.7	0.0	9.7	11.8
USP44	FLJ14528	ENSG00000136014	"Ubiquitin specific peptidase 44"	Q9H0E7	12	95516560-95551476	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis, Ubl conjugation pathway"	"Hydrolase, Protease, Thiol protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"brain: 7.1;testis: 24.2"	"Cell type enriched"	"Detected in many"	4	"Early spermatids: 482.2"	"Cancer enhanced"	"Detected in some"		"testis cancer: 3.0"	"Region enriched"	"Detected in many"	6	"cerebellum: 7.1"	"Immune cell enhanced"	"Detected in many"		"naive CD4 T-cell: 6.1"	"Group enriched"	"Detected in many"	41	"B-cells: 4.6;T-cells: 6.1"	"Cell line enhanced"	"Detected in some"		"HEL: 26.4;JURKAT: 58.4;NTERA-2: 138.3"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			HPA026543			Approved	"Nucleoli fibrillar center,Microtubules"		NA	NA			"Cluster 30: Non-specific - Translation"	"Cluster 78: Testis - Spermatogenesis"	"Cluster 5: NTERA-2 - Transcription"	"Cluster 23: Spermatids - Flagellum & Golgi organization"	"Nucleoli fibrillar center, Microtubules"		"HPA026543: AB_1858692"	"unprognostic (2.12e-2)"	"unprognostic (1.14e-1)"	"unprognostic (4.68e-2)"	"unprognostic (1.01e-3)"	"unprognostic (1.83e-4)"	"unprognostic (7.18e-4)"	"unprognostic (5.55e-2)"	"unprognostic (1.85e-2)"	"unprognostic (2.16e-1)"	"unprognostic (3.73e-2)"	"unprognostic (6.88e-2)"	"unprognostic (2.97e-2)"	"unprognostic (8.12e-2)"	"unprognostic (1.41e-2)"	"unprognostic (1.08e-1)"	"unprognostic (7.41e-2)"	"unprognostic (7.07e-2)"	0.7	0.6	0.6	1.0	0.8	0.3	0.9	7.1	1.0	0.9	0.0	1.2	0.3	1.3	0.7	0.4	1.2	0.8	0.5	0.6	0.5	1.4	0.1	3.9	1.1	0.8	0.9	0.9	2.3	1.7	1.3	0.1	1.0	0.7	0.4	1.7	1.1	1.6	0.2	0.3	0.8	0.9	0.7	1.5	0.6	24.2	0.5	3.6	1.3	0.3	1.2	0.5	0.5	1.2	0.2	0.4	11.4	0.0	0.1	0.1	0.4	1.1	3.3	1.4	0.5	0.0	0.1	0.1	3.4	0.0	0.0	0.1	0.0	0.0	1.9	0.0	5.8	26.4	0.0	0.0	5.8	10.8	0.5	0.1	0.0	0.8	0.0	0.6	0.6	58.4	4.3	0.0	0.0	0.0	13.9	0.1	138.3	0.0	0.0	0.0	0.0	0.0	2.4	0.8	8.8	5.9	0.0	0.0	0.1	13.2	0.1	0.9	0.0	0.1	0.0	0.0	0.0	0.0	0.3	4.6	0.0	1.0	0.3	0.0	0.0	0.0	1.1	0.0	2.4	4.6	1.7	1.5	0.0	3.7	6.1	4.0	0.1	0.1	0.0	0.0	0.2	1.0	0.6	0.8	7.1	1.0	0.6	0.5	0.8	0.9	1.0	0.7	0.5	1.2	1.9	12.8	31.0	1.3	5.7	1.0	3.4	0.3	4.6	8.6	1.5	3.2	1.8	0.0	3.8	7.3	6.2	2.8	0.6	0.1	0.0	4.4	482.2	0.9	2.2	2.5	0.0	0.4	5.1	3.1	0.5	3.5	1.1	1.8	0.0	10.6	1.8	0.0	0.1	0.0	16.2	0.0	0.0	0.3	1.0	116.6	5.6	0.8	3.6	1.9	0.6	2.4	1.0	15.6	4.0	0.9	0.1	3.4	1.1	5.0	0.1	1.0	0.3	9.5	6.6	2.9	3.7	77.6	6.7	0.6	0.9	1.1	3.2	2.5	0.1	1.9
USP45	MGC14793	ENSG00000123552	"Ubiquitin specific peptidase 45"	Q70EL2	6	99432325-99521728	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"Ubl conjugation pathway"	"Hydrolase, Protease, Thiol protease"	"Disease variant, Leber congenital amaurosis"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	7	"brain: 53.5"	"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 47.1;Inhibitory neurons: 44.4;Oligodendrocytes: 39.4"	"Low cancer specificity"	"Detected in all"			"Region enriched"	"Detected in all"	6	"cerebellum: 53.5"	"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA029602, HPA029604"	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 19: B-cells - Humoral immune response"	"Cluster 69: Cerebellum - Gene expression regulation"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	"Nucleoplasm, Cytosol"		"HPA029602: AB_10600418, HPA029604: AB_10602283"	"unprognostic (7.81e-3)"	"unprognostic (3.10e-3)"	"unprognostic (1.63e-2)"	"unprognostic (6.62e-2)"	"unprognostic (1.02e-2)"	"unprognostic (1.92e-1)"	"unprognostic (2.15e-2)"	"unprognostic (1.01e-1)"	"unprognostic (2.77e-2)"	"unprognostic (8.65e-2)"	"unprognostic (2.95e-3)"	"unprognostic (1.10e-1)"	"unprognostic (3.43e-3)"	"unprognostic (1.13e-1)"	"unprognostic (3.53e-1)"	"unprognostic (1.43e-1)"	"unprognostic (6.91e-2)"	6.1	4.4	5.2	4.9	5.8	4.4	4.6	53.5	9.4	4.3	3.8	5.3	7.3	5.1	4.8	5.3	4.0	6.2	6.2	5.8	6.3	6.3	4.2	3.7	7.4	6.0	7.7	4.5	4.0	4.5	3.6	5.2	8.2	5.1	6.7	6.7	4.0	4.2	6.0	6.3	5.8	4.5	5.3	4.6	4.4	3.3	6.2	3.1	5.3	5.5	5.2	4.3	3.8	9.0	5.9	4.0	8.1	11.2	14.3	13.5	8.7	10.3	11.1	10.1	14.7	8.2	6.4	15.2	7.3	10.3	11.9	7.7	12.1	9.8	13.9	12.2	12.0	15.2	8.4	6.7	11.4	14.2	8.3	15.3	7.6	9.2	15.5	10.7	15.4	13.8	37.2	14.8	9.6	5.5	4.5	13.3	12.8	9.1	8.9	6.8	5.9	8.9	13.8	6.8	11.3	9.2	7.0	9.1	7.8	10.0	4.9	6.8	15.5	5.5	7.1	8.1	15.5	6.3	6.2	29.1	9.8	13.1	10.1	2.9	1.4	0.4	3.2	0.8	4.2	5.3	2.7	4.0	2.4	6.7	1.9	1.9	0.3	1.9	2.0	3.6	2.6	1.0	5.2	5.8	53.5	9.4	5.8	6.3	6.0	7.7	8.2	5.3	6.2	9.0	13.3	3.2	5.8	22.5	13.3	2.3	9.6	6.8	4.6	10.3	4.4	4.6	9.4	4.3	4.7	3.7	18.8	6.4	7.3	5.9	5.9	4.3	15.7	10.1	10.3	7.6	2.4	4.2	47.1	2.5	6.6	7.1	9.7	4.3	2.5	5.8	6.8	4.5	4.0	10.1	44.4	2.9	10.2	4.8	2.6	10.2	13.1	4.6	3.6	22.5	10.0	5.4	2.1	32.6	39.4	5.0	3.1	8.6	6.5	8.6	8.3	15.8	10.4	7.4	0.0	6.3	6.7	1.9	7.5	5.2	2.8	7.4	7.1	5.8	7.3	6.9
USP46	FLJ12552	ENSG00000109189	"Ubiquitin specific peptidase 46"	P62068	4	52590960-52659301	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Behavior, Ubl conjugation pathway"	"Hydrolase, Protease, Thiol protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"Bipolar cells: 150.8;Early spermatids: 229.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA007288, CAB076369, CAB076370"	Uncertain		Approved	"Nucleoli,Nucleoli rim"		NA	NA			"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 12: NES - Nervous system development"	"Cluster 29: Early spermatids - Spermatogenesis"	"Nucleoli, Nucleoli rim"		"CAB076369: AB_2665642, CAB076370: AB_2665643, HPA007288: AB_1080531"	"unprognostic (1.15e-2)"	"unprognostic (1.64e-1)"	"unprognostic (1.19e-1)"	"unprognostic (1.61e-2)"	"unprognostic (1.31e-1)"	"unprognostic (1.41e-1)"	"unprognostic (1.53e-3)"	"unprognostic (1.59e-1)"	"unprognostic (2.45e-2)"	"unprognostic (1.80e-2)"	"unprognostic (2.89e-1)"	"unprognostic (1.95e-1)"	"unprognostic (1.05e-1)"	"unprognostic (1.45e-1)"	"unprognostic (3.95e-2)"	"unprognostic (2.02e-2)"	"unprognostic (1.28e-1)"	4.4	8.6	30.4	3.3	31.2	2.9	6.4	27.4	31.5	7.6	22.4	3.9	4.4	6.5	5.4	11.5	7.0	5.3	28.6	30.8	33.3	9.9	2.9	3.9	3.7	27.9	33.9	11.0	5.2	10.4	4.6	5.3	26.7	6.9	4.0	11.5	8.3	6.7	14.5	7.5	4.2	5.0	30.4	3.3	6.0	12.3	32.5	3.4	9.3	12.5	5.5	6.0	7.4	26.8	8.1	5.7	18.0	13.3	19.1	23.8	19.8	13.0	10.5	9.5	7.9	11.5	6.2	5.4	14.9	13.0	13.4	4.7	31.6	15.1	17.2	4.7	11.1	8.4	5.3	12.8	19.1	11.2	9.4	20.4	13.9	9.7	9.1	18.4	14.2	7.4	8.3	7.4	20.3	7.4	4.8	5.9	13.3	9.0	6.8	12.0	13.1	1.1	20.3	14.8	10.8	12.9	6.4	21.5	12.9	17.1	7.9	8.2	13.3	9.2	20.1	10.9	19.9	7.5	3.7	4.2	14.2	6.7	11.6	0.7	0.4	0.1	0.7	0.4	0.5	0.4	1.2	0.6	0.9	0.4	0.2	0.2	0.1	0.4	0.3	1.4	0.4	0.3	30.4	31.2	27.4	31.5	30.8	33.3	27.9	33.9	26.7	30.4	32.5	26.8	10.0	6.4	7.2	24.2	6.4	5.4	11.2	15.2	26.2	150.8	13.7	11.7	44.9	14.3	16.4	14.7	4.2	12.1	10.7	5.2	21.5	10.8	229.8	18.4	34.9	12.5	4.2	6.7	32.6	12.0	12.5	17.8	17.3	15.6	0.0	22.9	13.6	6.8	5.8	35.3	24.3	5.9	10.2	8.4	4.6	34.1	28.9	7.9	8.8	21.5	12.9	30.0	5.2	30.2	12.6	12.5	9.9	36.1	9.5	21.1	3.9	17.1	23.8	8.7	6.6	16.2	15.9	3.2	14.4	25.9	8.2	7.7	8.0	18.3	7.1	17.7
USP47		ENSG00000170242	"Ubiquitin specific peptidase 47"	Q96K76	11	11841423-11961887	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"DNA damage, DNA repair, Ubl conjugation pathway"	"Hydrolase, Protease, Thiol protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Oligodendrocytes: 315.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA029286, HPA029289"	Supported		Approved	"Vesicles,Intermediate filaments"		NA	NA			"Cluster 44: Non-specific - Transcription"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 54: Cardiomyocytes - Muscle contraction"	"Intermediate filaments"	Vesicles	"HPA029286: AB_10599852, HPA029289: AB_10601675"	"unprognostic (2.02e-1)"	"unprognostic (2.72e-1)"	"unprognostic (3.05e-1)"	"unprognostic (1.84e-1)"	"unprognostic (2.99e-2)"	"unprognostic (2.65e-2)"	"unprognostic (2.27e-2)"	"unprognostic (7.39e-2)"	"unprognostic (1.54e-2)"	"unprognostic (7.05e-2)"	"unprognostic (2.83e-2)"	"unprognostic (2.35e-1)"	"unprognostic (1.51e-1)"	"unprognostic (9.96e-3)"	"unprognostic (1.90e-1)"	"unprognostic (1.49e-1)"	"unprognostic (2.85e-1)"	15.7	14.3	11.9	11.4	15.8	19.0	15.1	17.3	12.8	14.3	10.2	19.8	10.3	17.2	15.6	16.1	13.5	12.3	23.5	12.5	14.1	13.2	23.3	16.2	13.3	14.1	12.8	15.9	16.9	22.2	13.8	16.7	15.0	16.6	12.3	25.7	14.1	15.4	59.8	18.0	14.1	17.8	14.1	11.8	16.6	15.0	12.7	19.1	14.9	33.6	13.8	16.7	14.2	20.6	26.8	15.7	30.3	13.1	21.8	23.2	12.6	31.6	22.3	20.1	22.1	16.5	22.2	29.6	13.3	28.0	23.7	17.8	23.7	15.3	30.3	27.5	20.4	18.6	30.3	12.6	21.5	25.0	23.9	22.3	22.5	12.3	29.0	26.1	21.8	21.7	35.8	23.7	25.4	10.6	21.7	14.3	7.9	28.1	12.7	21.4	30.3	9.4	24.6	29.1	9.8	21.0	25.8	19.6	19.3	18.4	14.4	20.6	24.9	27.8	16.2	22.3	19.6	7.9	18.1	25.9	19.9	15.2	20.3	14.7	5.9	11.9	11.0	7.4	14.5	7.4	10.3	11.4	7.9	6.7	13.1	11.4	2.8	18.5	11.5	4.8	8.3	7.9	11.9	15.8	17.3	12.8	12.5	14.1	14.1	12.8	15.0	14.1	12.7	20.6	41.1	70.5	63.1	116.5	46.9	71.0	68.8	28.8	45.5	67.5	41.1	30.9	222.5	40.0	56.0	23.9	47.9	69.6	57.2	30.4	25.4	39.5	40.1	49.8	63.0	44.8	59.3	34.3	122.7	38.9	33.2	69.7	44.4	134.5	54.3	52.6	32.5	53.9	28.0	63.9	136.5	32.9	24.4	27.7	39.7	30.0	44.1	41.8	24.9	96.5	40.5	79.7	68.0	171.4	315.9	44.8	31.5	50.0	55.2	65.5	29.7	21.9	48.2	52.4	52.6	85.0	68.2	92.8	55.1	46.6	87.9	125.7	65.0	41.8	35.0	58.9
USP48	"FLJ11328, FLJ20103, FLJ23054, FLJ23277, MGC14879, USP31"	ENSG00000090686	"Ubiquitin specific peptidase 48"	Q86UV5	1	21678298-21783606	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Ubl conjugation pathway"	"Hydrolase, Protease, Thiol protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Granulosa cells: 200.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA030045, HPA030046"	Approved		Supported	Nucleoplasm,Mitochondria,Cytosol		NA	NA			"Cluster 38: Basophils - Unknown function"	"Cluster 34: Non-specific - Transcription"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 40: Granulosa cells - Unknown function"	Nucleoplasm	"Mitochondria, Cytosol"	"HPA030045: AB_10670833, HPA030046: AB_10603325"	"unprognostic (1.35e-1)"	"unprognostic (3.72e-1)"	"unprognostic (5.46e-3)"	"unprognostic (2.21e-1)"	"unprognostic (1.23e-1)"	"unprognostic (7.00e-3)"	"prognostic unfavorable (6.09e-8)"	"unprognostic (1.04e-2)"	"unprognostic (3.01e-3)"	"unprognostic (9.30e-2)"	"unprognostic (7.54e-2)"	"unprognostic (4.45e-2)"	"unprognostic (4.16e-3)"	"unprognostic (2.03e-1)"	"unprognostic (1.06e-1)"	"unprognostic (5.70e-2)"	"unprognostic (2.80e-2)"	25.8	47.5	18.7	26.6	24.5	43.5	26.4	31.0	26.4	26.9	21.6	24.4	21.7	25.3	20.4	23.0	22.3	18.9	21.6	19.3	20.4	18.2	23.8	23.1	35.1	20.1	20.4	31.1	24.6	25.2	26.9	27.3	21.7	23.5	26.0	57.0	31.2	18.6	23.1	29.5	28.7	22.9	18.5	36.0	32.5	20.6	20.8	26.9	28.6	19.5	34.5	23.1	24.6	36.0	43.9	20.5	47.0	34.0	40.1	49.0	46.4	54.0	36.5	35.3	46.6	19.1	43.2	49.1	35.6	48.8	27.5	39.2	59.0	43.4	53.6	48.3	42.1	104.3	75.7	34.5	35.5	53.0	53.7	39.8	36.6	36.1	39.7	48.1	106.1	36.2	83.8	133.2	44.0	21.9	44.2	68.5	29.7	44.5	36.8	61.3	47.2	57.3	40.7	36.2	57.1	35.6	50.4	45.7	122.7	62.3	23.4	63.0	76.1	37.7	30.9	46.7	31.8	105.6	81.7	48.1	36.3	64.5	56.6	82.1	19.5	35.0	12.2	9.4	13.9	28.6	17.8	17.9	21.1	29.8	20.5	13.1	16.8	12.2	10.9	15.3	21.4	12.6	18.7	24.5	31.0	26.4	19.3	20.4	20.1	20.4	21.7	18.5	20.8	36.0	37.9	54.5	42.1	32.0	55.4	22.2	25.1	30.3	33.0	86.5	22.2	24.5	65.3	21.5	24.4	20.2	62.6	61.4	48.3	17.8	25.4	28.5	71.4	33.3	48.5	32.5	21.7	88.1	66.4	20.0	56.3	42.0	33.1	41.4	49.9	200.4	27.5	22.1	29.2	50.5	74.2	31.3	32.6	22.6	28.1	47.7	34.8	34.4	58.7	52.5	55.9	30.7	36.0	54.3	112.3	23.8	16.4	51.6	150.1	20.7	24.1	20.2	27.3	69.2	32.9	51.7	39.8	52.7	47.4	35.1	25.7	32.6	41.8	54.8	31.6	21.6
USP49	MGC20741	ENSG00000164663	"Ubiquitin specific peptidase 49"	Q70CQ1	6	41789896-41895361	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"mRNA processing, mRNA splicing, Ubl conjugation pathway"	"Chromatin regulator, Hydrolase, Protease, Thiol protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Cone photoreceptor cells: 43.8;Excitatory neurons: 42.8;Inhibitory neurons: 48.6;Oligodendrocyte precursor cells: 56.3;Oligodendrocytes: 31.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Immune cell enriched"	"Detected in some"	5	"basophil: 5.1"	"Lineage enriched"	"Detected in single"	8	"granulocytes: 5.1"	"Cell line enhanced"	"Detected in all"		"REH: 46.7;U-698: 63.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA030254, HPA030255"	Uncertain					NA	NA			"Cluster 10: Basophils - Unknown function"	"Cluster 6: Brain - Smell perception"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 56: Bipolar cells - Visual perception"			"HPA030254: AB_10600198, HPA030255: AB_10601218"	"unprognostic (1.71e-1)"	"unprognostic (4.86e-3)"	"unprognostic (1.93e-1)"	"unprognostic (2.57e-4)"	"unprognostic (4.46e-2)"	"unprognostic (2.84e-4)"	"unprognostic (7.17e-3)"	"unprognostic (5.06e-2)"	"unprognostic (1.19e-2)"	"unprognostic (3.22e-1)"	"unprognostic (5.59e-3)"	"unprognostic (8.28e-2)"	"unprognostic (1.26e-5)"	"unprognostic (5.39e-2)"	"unprognostic (4.58e-2)"	"unprognostic (4.37e-3)"	"unprognostic (3.24e-3)"	2.9	2.8	4.3	2.6	3.2	5.3	2.6	6.0	3.8	3.4	0.4	2.6	1.7	2.9	1.6	1.9	2.6	1.6	2.0	3.3	3.7	2.0	1.6	2.7	2.6	2.7	3.9	3.1	2.0	1.5	2.7	1.4	2.5	2.3	1.5	9.3	2.0	1.6	2.9	3.0	1.7	1.6	0.7	2.5	1.8	4.8	4.1	6.7	7.0	1.0	2.5	2.5	2.6	3.8	6.0	1.8	23.6	11.6	2.8	3.0	9.7	2.3	2.2	3.4	4.3	7.5	1.4	24.5	2.5	2.9	4.9	2.6	14.7	2.2	5.1	6.1	11.0	8.8	10.3	2.7	2.0	6.9	5.2	3.1	1.7	5.0	3.1	3.1	2.2	24.9	18.7	6.4	2.6	3.5	26.7	10.5	6.5	6.4	2.2	46.7	11.3	5.4	1.4	4.1	15.8	6.5	3.1	1.1	1.3	5.5	3.5	6.1	6.1	8.1	8.0	2.6	3.1	12.2	11.4	63.9	1.0	6.9	1.5	5.1	0.4	0.6	0.3	0.4	0.2	0.6	0.2	0.3	0.1	0.4	0.4	0.3	1.0	0.4	0.5	0.3	0.2	0.2	4.3	3.2	6.0	3.8	3.3	3.7	2.7	3.9	2.5	0.7	4.1	3.8	2.4	0.0	9.7	20.2	2.0	5.0	3.0	3.9	1.2	27.5	3.6	3.3	4.6	4.3	6.5	5.5	43.8	2.9	4.5	1.4	1.9	1.9	6.5	4.1	5.0	2.8	0.0	8.2	42.8	2.0	1.6	4.3	3.1	4.6	1.3	4.8	1.4	2.1	2.0	15.2	48.6	1.9	4.1	3.1	4.6	7.2	3.7	3.1	3.6	14.0	5.0	2.8	2.1	56.3	31.8	2.6	1.9	6.0	3.0	4.5	2.1	1.1	7.1	10.9	6.6	6.2	3.4	13.3	14.3	2.7	6.3	5.7	2.4	5.1	2.2	4.6
USP5	IsoT	ENSG00000111667	"Ubiquitin specific peptidase 5"	P45974	12	6852148-6866632	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Ubl conjugation pathway"	"Hydrolase, Protease, Thiol protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA006756	Uncertain		Approved	Nucleoplasm,Cytosol		NA	NA		1200000	"Cluster 27: Non-specific - Gene expression"	"Cluster 59: Non-specific - Translation"	"Cluster 5: NTERA-2 - Transcription"	"Cluster 66: Spermatocytes - Spermatogenesis"	"Nucleoplasm, Cytosol"		"HPA006756: AB_1080534"	"unprognostic (2.19e-1)"	"unprognostic (5.83e-2)"	"unprognostic (2.48e-1)"	"unprognostic (2.57e-1)"	"unprognostic (7.60e-2)"	"unprognostic (2.21e-2)"	"unprognostic (4.02e-2)"	"unprognostic (3.93e-2)"	"unprognostic (2.57e-1)"	"unprognostic (4.71e-2)"	"unprognostic (8.90e-3)"	"unprognostic (4.69e-2)"	"unprognostic (1.17e-2)"	"unprognostic (2.65e-2)"	"unprognostic (3.56e-1)"	"unprognostic (3.23e-1)"	"unprognostic (2.02e-3)"	27.1	37.9	23.7	26.7	26.1	22.8	19.5	15.5	38.0	24.1	2.4	31.3	25.3	31.5	17.4	38.2	25.9	18.5	33.0	25.3	33.6	20.1	23.1	20.5	29.2	31.0	31.3	19.4	17.8	41.4	27.8	25.4	38.8	26.5	22.2	15.7	20.0	29.6	66.7	48.1	26.1	35.5	15.0	21.2	22.9	40.9	28.9	36.5	26.7	42.5	29.4	29.8	24.2	29.0	88.1	135.7	88.4	100.4	59.0	53.9	113.4	93.0	70.9	109.2	78.8	129.4	84.9	105.7	47.6	98.5	86.5	75.2	98.6	92.7	69.5	198.6	84.0	97.1	105.5	71.0	45.8	88.5	97.2	55.6	52.9	94.8	64.9	72.9	94.8	41.7	85.4	40.9	91.1	97.4	132.9	44.4	172.8	89.3	56.5	103.4	115.5	73.5	62.9	84.5	48.5	97.4	63.5	96.3	41.1	110.6	38.3	72.4	92.4	91.5	109.1	70.4	117.6	49.0	124.5	163.8	102.1	55.3	91.3	5.4	19.3	8.3	24.3	25.1	23.1	15.0	21.7	20.8	28.4	13.9	20.1	20.9	1.3	17.6	24.4	20.5	19.9	27.7	23.7	26.1	15.5	38.0	25.3	33.6	31.0	31.3	38.8	15.0	28.9	29.0	11.3	9.6	13.1	7.5	14.0	11.6	11.4	18.0	8.6	18.7	13.1	10.8	9.5	17.2	11.5	22.0	60.5	45.9	14.8	21.5	11.7	28.1	14.7	10.6	14.7	15.3	16.7	19.4	11.5	20.5	30.7	16.6	10.2	13.7	14.7	29.6	11.4	22.2	28.4	40.4	11.9	19.3	14.2	13.0	7.4	19.2	23.0	10.9	16.0	9.4	32.4	16.0	13.4	6.0	11.9	20.2	17.4	33.8	14.1	10.3	22.5	18.5	7.9	16.2	32.9	13.3	17.2	51.7	25.6	17.6	15.5	52.8	15.4	27.6	27.5	7.9
USP51		ENSG00000247746	"Ubiquitin specific peptidase 51"	Q70EK9	X	55484616-55489202	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"DNA damage, DNA repair, Ubl conjugation pathway"	"Hydrolase, Protease, Thiol protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	8	"epididymis: 51.7"	"Cell type enhanced"	"Detected in many"		"Bipolar cells: 23.7;Muller glia cells: 32.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"SuSa: 7.0"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA001942	Uncertain		Approved	"Nucleoli fibrillar center,Cytosol"		NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 68: Epididymis - Unknown function"	"Cluster 12: NES - Nervous system development"	"Cluster 5: Muller glia cells - Visual perception"	Cytosol	"Nucleoli fibrillar center"	"HPA001942: AB_1080536"	"unprognostic (1.19e-2)"	"unprognostic (4.65e-2)"	"unprognostic (3.67e-2)"	"unprognostic (1.02e-3)"	"unprognostic (8.08e-2)"	"unprognostic (3.26e-1)"	"unprognostic (3.17e-3)"	"unprognostic (2.07e-3)"	"unprognostic (5.69e-2)"	"prognostic favorable (5.70e-4)"	"unprognostic (1.01e-3)"	"unprognostic (1.27e-1)"	"prognostic favorable (2.63e-5)"	"unprognostic (2.81e-3)"	"unprognostic (5.92e-2)"	"unprognostic (5.85e-2)"	"unprognostic (1.63e-1)"	1.4	3.1	2.5	0.9	2.7	0.5	1.7	2.8	2.8	1.9	4.2	0.8	0.4	3.1	51.7	0.6	5.5	0.8	2.1	2.2	4.2	3.7	1.2	1.5	1.1	2.2	3.1	6.5	1.1	5.6	1.4	2.4	2.4	2.4	0.8	3.1	0.8	2.5	0.4	1.1	0.7	1.9	2.5	1.8	0.8	2.3	3.8	2.4	5.3	1.1	1.2	0.9	0.7	2.5	0.0	0.6	3.9	1.1	1.9	1.0	0.0	0.6	0.3	0.7	0.9	1.2	0.5	0.0	4.6	0.8	0.8	0.2	1.0	0.4	1.2	1.3	0.0	1.0	0.2	0.0	0.8	2.5	0.2	3.9	0.0	0.4	0.0	0.3	0.2	3.0	3.1	3.0	0.6	2.6	2.4	1.3	4.8	0.0	0.2	3.4	0.7	1.5	0.9	0.1	0.0	0.7	1.1	0.1	3.7	7.0	0.9	1.3	0.2	1.5	2.1	0.4	0.1	4.7	2.0	0.9	1.0	1.4	1.0	0.0	0.0	0.5	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.1	0.5	0.0	0.0	0.1	0.0	0.0	0.0	0.0	2.5	2.7	2.8	2.8	2.2	4.2	2.2	3.1	2.4	2.5	3.8	2.5	5.1	3.2	5.5	3.3	2.6	0.9	2.2	0.9	2.2	23.7	3.8	7.4	6.9	1.5	2.0	3.7	6.2	4.3	1.2	0.2	9.8	1.5	0.3	9.0	9.2	6.0	3.6	5.0	2.7	0.0	2.2	8.1	0.0	2.1	1.3	7.9	6.4	0.7	7.6	6.7	5.0	0.5	0.0	5.6	2.5	1.0	4.1	4.7	5.4	1.9	0.3	32.9	3.1	3.5	3.7	0.2	0.3	8.2	1.0	1.0	0.0	13.1	11.2	16.4	0.0	7.1	5.0	11.4	12.5	1.0	0.4	2.7	3.1	13.0	0.4	0.5
USP6	"HRP1, Tre-2, TRE17, Tre2, TRESMCR"	ENSG00000129204	"Ubiquitin specific peptidase 6"	P35125	17	5116032-5175034	"Cancer-related genes, Disease related genes, Enzymes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"Ubl conjugation pathway"	"Calmodulin-binding, Hydrolase, Protease, Thiol protease"	"Cancer-related genes, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	6	"skeletal muscle: 19.6;testis: 13.4"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 24.4;Spermatocytes: 26.9"	"Cancer enriched"	"Detected in single"	14	"testis cancer: 2.8"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA046969			Uncertain	Vesicles		NA	NA				"Cluster 23: Testis - Cell cycle regulation"		"Cluster 37: Myocytes - Muscle contraction"	Vesicles		"HPA046969: "	"unprognostic (3.89e-2)"	"unprognostic (3.79e-3)"	"unprognostic (2.50e-1)"	"unprognostic (1.85e-1)"	"unprognostic (9.32e-2)"	"unprognostic (3.50e-3)"	"unprognostic (1.29e-1)"	"unprognostic (1.67e-2)"	"unprognostic (3.45e-2)"	"unprognostic (2.46e-2)"	"unprognostic (7.91e-4)"	"unprognostic (6.28e-3)"	"unprognostic (3.24e-4)"	"unprognostic (3.75e-2)"	"unprognostic (3.13e-1)"	"unprognostic (2.71e-1)"	"unprognostic (7.09e-4)"	0.4	0.3	0.2	0.2	0.5	0.1	0.7	0.3	0.6	1.4	1.5	0.8	0.0	0.9	0.7	0.2	0.5	0.5	0.4	0.4	0.3	0.6	0.1	0.4	0.3	0.7	0.2	2.6	0.3	0.0	0.6	0.5	0.6	0.6	0.3	2.5	0.5	0.4	19.6	0.6	0.3	0.9	0.2	0.4	0.2	13.4	0.5	0.0	0.9	0.6	0.2	0.3	0.5	0.9	0.1	0.1	0.3	0.2	0.0	0.0	0.4	0.1	0.0	0.0	0.0	0.1	0.2	0.2	0.1	0.1	0.1	0.2	0.0	0.0	0.0	0.3	0.2	0.1	0.3	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.1	0.2	0.1	0.0	0.2	0.4	0.3	0.1	0.1	0.0	0.3	0.2	0.0	0.3	0.2	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.5	0.3	0.6	0.4	0.3	0.7	0.2	0.6	0.2	0.5	0.9	2.0	6.4	10.8	0.0	0.4	10.8	1.0	1.1	0.0	8.5	4.0	3.8	1.6	5.7	3.5	3.7	12.5	0.6	1.0	0.1	3.9	0.0	24.4	1.1	2.1	3.0	0.0	5.3	1.2	0.0	0.8	1.8	0.0	1.4	0.0	1.2	3.6	3.2	2.7	1.7	1.0	0.0	0.0	5.4	6.4	13.5	1.8	3.1	3.6	2.8	3.2	5.1	0.0	0.0	2.9	0.1	0.1	2.6	0.1	2.1	0.0	3.2	4.0	12.3	6.6	5.9	1.7	26.9	11.5	0.0	10.4	0.7	1.1	0.9	0.2	1.1
USP7	HAUSP	ENSG00000187555	"Ubiquitin specific peptidase 7"	Q93009	16	8892097-8975328	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Biological rhythms, DNA damage, DNA repair, Host-virus interaction, Ubl conjugation pathway"	"Developmental protein, Hydrolase, Protease, Thiol protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 282.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB008108, HPA015641, CAB079904"	Approved		Supported	"Nucleoplasm,Nuclear bodies"		NA	NA		16000	"Cluster 44: Non-specific - Transcription"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 65: Plasmacytoid DCs - Unknown function"	Nucleoplasm	"Nuclear bodies"	"CAB008108: AB_2233500, CAB079904: AB_2552261, HPA015641: AB_1858700"	"unprognostic (6.73e-2)"	"unprognostic (1.59e-1)"	"unprognostic (3.36e-3)"	"unprognostic (1.94e-2)"	"unprognostic (9.64e-2)"	"unprognostic (8.09e-2)"	"unprognostic (4.69e-2)"	"unprognostic (4.56e-2)"	"unprognostic (4.81e-1)"	"unprognostic (2.49e-1)"	"unprognostic (2.35e-1)"	"unprognostic (9.93e-2)"	"prognostic favorable (8.56e-5)"	"unprognostic (1.35e-1)"	"unprognostic (1.07e-1)"	"unprognostic (7.31e-2)"	"unprognostic (2.69e-1)"	22.3	16.1	17.6	27.0	19.8	54.6	20.5	20.5	20.7	20.1	15.1	33.1	21.8	21.5	10.1	29.6	19.0	19.9	23.8	21.4	18.1	19.5	25.1	19.3	39.9	16.9	20.1	19.8	26.7	34.8	13.9	23.7	17.5	20.7	32.5	21.7	18.7	18.7	45.2	25.4	25.9	25.7	18.7	24.2	25.5	58.8	18.8	51.1	22.8	41.0	44.9	26.3	17.7	20.8	39.9	73.5	62.2	46.9	34.9	42.9	42.9	53.6	44.7	48.1	40.4	66.6	46.7	94.6	33.8	61.0	27.7	48.8	95.2	61.9	79.6	63.1	38.1	78.4	49.5	132.9	49.0	87.6	48.8	37.3	37.7	52.6	61.0	37.0	69.7	139.8	77.7	101.5	49.6	75.4	130.8	16.9	43.9	49.8	41.4	114.5	69.7	86.2	33.4	77.9	58.8	35.5	59.4	55.3	28.7	62.3	55.0	39.4	60.4	52.1	54.1	80.3	40.4	49.1	134.3	145.1	48.5	49.6	43.5	5.2	2.1	2.8	4.5	2.2	5.7	4.0	4.1	5.3	2.2	4.9	4.9	4.3	3.4	2.8	6.1	6.5	5.1	1.1	17.6	19.8	20.5	20.7	21.4	18.1	16.9	20.1	17.5	18.7	18.8	20.8	40.4	35.3	54.5	22.2	38.0	46.5	23.1	17.9	22.8	51.1	29.7	28.8	74.3	21.5	36.4	29.5	25.0	21.9	51.4	39.8	5.9	22.5	282.4	38.5	50.9	35.8	42.2	46.5	31.4	33.4	14.5	34.4	31.1	57.6	26.6	47.8	25.0	37.5	19.8	43.7	34.9	49.3	10.2	29.2	31.0	112.2	25.4	43.8	19.6	21.5	36.3	29.2	24.7	24.1	30.2	35.6	39.0	34.6	46.8	34.1	31.3	13.7	37.8	44.2	6.6	58.4	39.4	33.8	39.4	41.3	50.0	21.1	40.4	47.6	54.8	35.0
USP8	"HumORF8, KIAA0055, SPG59, UBPY"	ENSG00000138592	"Ubiquitin specific peptidase 8"	P40818	15	50424380-50514421	"Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"Cell cycle, Ubl conjugation pathway"	"Hydrolase, Protease, Thiol protease"	"Cancer-related genes, Cushing syndrome, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA050215	Approved		Supported	"Golgi apparatus,Cytosol"		NA	NA			"Cluster 6: Non-specific - Transcription"	"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 18: U-2197 - ECM organization"	"Cluster 66: Spermatocytes - Spermatogenesis"	"Golgi apparatus"	Cytosol	"HPA050215: AB_2681054"	"unprognostic (5.81e-2)"	"unprognostic (1.34e-1)"	"unprognostic (1.46e-1)"	"unprognostic (9.58e-2)"	"unprognostic (2.35e-2)"	"unprognostic (2.91e-1)"	"unprognostic (1.42e-1)"	"unprognostic (3.96e-1)"	"unprognostic (1.68e-2)"	"unprognostic (5.08e-2)"	"unprognostic (2.94e-1)"	"unprognostic (3.99e-2)"	"prognostic favorable (1.29e-5)"	"unprognostic (4.89e-2)"	"unprognostic (1.13e-1)"	"unprognostic (3.79e-1)"	"unprognostic (1.58e-1)"	20.3	18.8	11.5	21.1	11.0	27.6	19.6	14.4	13.3	20.5	18.1	21.5	26.7	19.1	10.4	20.7	18.5	16.4	15.1	9.1	14.6	27.0	28.1	19.5	19.0	14.1	13.1	19.9	17.4	45.1	10.6	20.3	12.5	17.0	20.8	22.2	19.8	17.2	17.6	14.2	24.4	18.4	11.5	18.7	22.5	32.0	13.6	20.9	25.4	22.7	24.3	20.0	12.6	13.2	30.6	35.8	23.7	41.1	32.3	44.3	31.0	45.7	43.9	35.7	40.4	19.5	17.7	28.8	35.0	43.5	46.6	57.8	28.8	28.3	39.9	27.2	19.3	52.9	31.9	27.3	35.9	34.3	34.4	32.4	36.2	26.0	55.8	37.0	36.3	23.3	28.4	36.8	32.9	45.9	26.6	12.0	28.5	32.6	17.1	24.1	39.1	45.8	29.5	61.3	29.1	23.8	42.5	55.9	57.4	48.9	35.8	36.9	45.0	41.1	24.1	122.7	52.7	28.5	69.8	32.4	30.6	65.6	40.1	114.6	27.7	50.1	21.4	26.1	22.1	37.3	22.9	23.3	22.7	34.3	24.0	21.2	47.9	22.1	35.0	20.5	20.0	16.0	11.5	11.0	14.4	13.3	9.1	14.6	14.1	13.1	12.5	11.5	13.6	13.2	63.5	96.1	130.8	36.2	101.8	28.9	40.7	47.3	35.9	54.5	41.7	40.0	69.8	51.5	72.7	47.8	68.8	59.0	92.7	79.5	25.4	53.7	153.7	91.5	79.7	53.8	53.3	36.8	41.0	51.3	45.4	55.8	58.1	65.6	86.7	48.5	51.0	56.6	45.4	33.7	44.3	68.7	36.7	73.2	38.2	28.4	53.7	77.6	40.9	46.9	85.3	45.5	72.1	34.7	46.1	57.3	58.2	61.7	87.1	51.0	88.9	49.9	114.9	74.2	46.0	108.2	56.2	140.5	54.8	39.6	41.5	105.2	72.6	77.1	64.8	55.3
USP9X	"DFFRX, FAF, MRX99"	ENSG00000124486	"Ubiquitin specific peptidase 9 X-linked"	Q93008	X	41085445-41236579	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"Biological rhythms, Cell cycle, Cell division, Chromosome partition, Mitosis, Ubl conjugation pathway"	"Hydrolase, Protease, Thiol protease"	"Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB011618, HPA047417, CAB070164"	Approved		Uncertain	Vesicles		NA	NA		24000	"Cluster 9: Neutrophils - Innate immune response"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 44: Endometrium - Transcription"	Vesicles		"CAB011618: AB_470860, CAB070164: AB_10011071, HPA047417: "	"unprognostic (5.42e-3)"	"unprognostic (6.42e-2)"	"unprognostic (3.19e-3)"	"unprognostic (2.94e-2)"	"unprognostic (5.99e-2)"	"unprognostic (4.76e-1)"	"unprognostic (1.82e-2)"	"unprognostic (4.07e-1)"	"unprognostic (1.90e-1)"	"unprognostic (1.72e-1)"	"unprognostic (7.07e-2)"	"unprognostic (1.09e-1)"	"unprognostic (5.82e-2)"	"unprognostic (1.59e-1)"	"unprognostic (4.19e-2)"	"unprognostic (2.78e-1)"	"unprognostic (1.33e-1)"	16.4	16.8	11.9	14.3	13.9	18.2	14.2	12.7	12.8	15.3	14.3	14.8	13.6	15.4	14.9	14.1	16.0	13.0	15.3	14.3	13.2	17.8	33.9	14.4	15.8	12.2	13.1	13.4	16.0	30.0	10.2	18.4	13.8	12.3	13.7	22.0	11.5	15.3	39.1	13.8	14.3	16.3	12.5	13.3	13.8	17.5	12.8	18.8	19.5	28.4	16.2	15.0	12.6	16.4	38.6	44.2	39.1	40.2	33.0	32.7	8.8	21.5	28.8	23.8	27.5	21.1	16.9	25.7	11.5	48.5	71.3	25.3	67.1	39.7	39.7	32.0	50.5	29.3	41.3	19.9	27.6	26.4	21.0	29.3	17.9	56.4	53.4	35.5	37.2	17.1	36.0	20.3	38.6	29.1	18.8	12.7	42.6	14.1	24.7	20.3	51.8	16.9	24.7	30.7	22.2	20.8	89.0	26.7	26.0	69.8	24.3	16.2	40.2	36.6	27.6	34.6	24.0	19.1	22.3	30.9	26.4	12.1	18.5	1.7	2.3	3.0	2.5	1.9	3.6	2.8	3.0	2.7	2.6	2.1	3.0	2.8	6.4	2.5	2.5	2.1	2.8	1.5	11.9	13.9	12.7	12.8	14.3	13.2	12.2	13.1	13.8	12.5	12.8	16.4	38.1	41.7	35.1	48.0	42.6	48.3	30.8	29.6	55.2	38.1	41.3	29.5	83.5	54.3	37.9	27.6	37.5	39.6	46.3	58.5	7.9	28.4	14.9	85.5	56.9	43.6	26.9	41.0	84.9	26.5	25.4	41.4	41.8	136.9	25.9	58.3	45.7	62.8	32.6	37.0	86.0	39.1	18.3	47.8	42.1	15.4	33.2	55.5	33.8	67.5	44.6	31.3	30.9	74.9	108.0	32.6	40.1	49.2	38.8	35.6	47.7	21.5	35.8	31.2	32.9	70.6	48.3	86.4	82.9	55.2	55.3	46.7	42.4	45.8	38.0	40.2
USP9Y	"AZFA, DFFRY"	ENSG00000114374	"Ubiquitin specific peptidase 9 Y-linked"	O00507	Y	12537650-12860839	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"Ubl conjugation pathway"	"Hydrolase, Protease, Thiol protease"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Cone photoreceptor cells: 64.6;Excitatory neurons: 89.5;Inhibitory neurons: 69.5"	"Cancer enhanced"	"Detected in many"		"prostate cancer: 5.7"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"RPTEC TERT1: 21.5;RT4: 17.4"	"Not detected"	"Not detected"							HPA057687			Uncertain	Vesicles		NA	NA			"Cluster 39: Non-specific - mRNA processing"	"Cluster 54: Non-specific - Microtubule organization"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	Vesicles		"HPA057687: "			"unprognostic (2.63e-1)"		"unprognostic (8.97e-2)"	"unprognostic (1.10e-5)"	"unprognostic (8.46e-3)"	"unprognostic (4.93e-2)"	"unprognostic (2.53e-2)"	"unprognostic (2.77e-1)"	"unprognostic (3.17e-2)"	"unprognostic (1.71e-1)"	"unprognostic (4.05e-2)"	"unprognostic (1.41e-4)"	"unprognostic (2.28e-1)"	"unprognostic (1.19e-2)"	"unprognostic (1.42e-1)"	3.6	5.2	1.3	1.7	1.4	2.6	3.3	2.8	5.2	0.0	2.5	4.5	1.7	0.0	7.2	5.2	0.0	4.6	5.5	1.3	1.4	7.1	3.0	5.2	2.2	1.2	1.1	0.0	6.0	3.5	8.8	2.3	1.3	9.7	4.9	12.9	4.9	7.0	5.2	3.2	4.4	0.0	1.0	5.1	3.9	4.2	1.4	0.0	5.7	9.7	5.6	4.5	0.0	2.4	0.0	4.7	0.0	0.0	0.0	0.0	5.3	14.2	14.6	7.2	8.5	0.0	0.0	7.7	0.0	12.2	0.0	0.0	0.0	0.0	8.6	8.1	0.0	7.3	0.0	9.5	5.8	0.0	0.0	9.7	8.9	0.0	0.0	0.0	0.0	3.0	0.0	0.0	12.2	0.0	9.8	0.0	4.6	0.0	0.0	0.0	3.5	2.1	21.5	17.4	7.2	0.0	0.0	0.0	4.4	12.5	0.0	0.2	10.6	9.5	0.0	0.0	7.0	0.0	9.7	15.1	0.5	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.9	0.4	0.7	0.5	0.1	0.7	0.8	0.5	0.0	0.1	0.0	0.6	0.6	0.0	1.3	1.4	2.8	5.2	1.3	1.4	1.2	1.1	1.3	1.0	1.4	2.4	0.0	25.6	23.5	29.4	11.0	11.7	8.5	9.5	18.2	23.6	0.0	0.0	26.5	7.2	12.6	20.2	64.6	6.3	5.3	0.3	1.9	6.9	0.5	0.0	0.0	5.8	0.0	5.9	89.5	0.0	1.7	8.1	6.6	0.0	2.5	0.0	6.1	2.3	3.1	26.9	69.5	1.1	8.2	5.6	9.3	1.1	12.5	3.6	3.6	31.9	3.6	8.8	14.4	28.6	17.4	2.3	0.0	15.4	4.1	13.2	0.7	6.3	19.9	23.1	0.0	5.2	4.4	2.8	2.6	20.6	11.6	3.4	14.7	0.0	1.5	11.9
VASH1	KIAA1036	ENSG00000071246	"Vasohibin 1"	Q7L8A9	14	76761468-76783015	"Enzymes, Predicted intracellular proteins, Predicted secreted proteins"	"Cell cycle, Growth arrest"	"Carboxypeptidase, Hydrolase, Protease"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"retina: 67.6"	"Cell type enhanced"	"Detected in many"		"Cone photoreceptor cells: 139.7;Early spermatids: 72.8;Late spermatids: 95.3;Microglial cells: 53.4;Rod photoreceptor cells: 98.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"AF22: 46.1;HEL: 35.1;HUVEC TERT2: 85.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA000653	Uncertain				"Secreted to blood"	NA	NA			"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 77: Retina - Visual perception"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 9: Photoreceptor cells - Phototransduction"			"HPA000653: AB_1080551"	"unprognostic (1.47e-1)"	"unprognostic (9.13e-2)"	"unprognostic (2.56e-2)"	"unprognostic (7.29e-2)"	"unprognostic (1.93e-1)"	"unprognostic (2.53e-3)"	"unprognostic (2.88e-3)"	"unprognostic (1.62e-1)"	"unprognostic (9.23e-2)"	"unprognostic (6.94e-2)"	"prognostic favorable (6.56e-6)"	"unprognostic (8.84e-2)"	"unprognostic (6.44e-3)"	"unprognostic (2.69e-1)"	"unprognostic (1.92e-1)"	"unprognostic (5.06e-2)"	"unprognostic (1.73e-1)"	12.1	18.5	33.2	12.3	34.0	3.0	7.4	30.8	28.8	9.2	21.3	7.9	5.6	11.9	4.2	4.3	8.7	9.0	36.0	28.1	30.8	8.1	3.8	16.0	7.8	38.7	36.3	13.4	5.7	3.9	13.7	19.9	36.6	6.5	5.2	67.6	5.6	4.5	7.5	4.6	8.2	11.5	37.1	18.3	5.1	13.2	36.1	3.2	6.1	7.0	6.6	8.5	6.6	36.4	1.1	5.6	46.1	13.8	11.6	8.4	2.3	4.0	1.3	3.4	1.4	1.5	3.1	2.1	2.8	3.2	4.2	1.3	7.3	1.5	1.0	25.0	5.3	35.1	3.4	1.5	6.9	1.5	3.5	4.5	0.3	1.3	0.2	10.4	85.0	6.2	1.6	0.4	1.1	7.1	1.3	3.0	4.7	1.4	2.8	1.3	4.6	1.0	0.9	2.6	19.1	14.8	4.6	1.8	2.2	9.1	7.8	7.4	24.2	4.3	9.6	5.2	2.0	2.0	1.1	1.2	6.1	11.2	8.3	0.0	0.8	0.0	0.6	2.0	0.5	0.1	0.3	0.3	1.3	0.3	0.2	0.3	0.0	0.2	2.7	2.4	0.1	0.5	33.2	34.0	30.8	28.8	28.1	30.8	38.7	36.3	36.6	37.1	36.1	36.4	17.3	0.0	2.3	7.2	2.7	0.6	0.0	0.3	0.0	9.4	0.9	2.4	10.9	1.5	0.7	1.8	139.7	0.4	11.1	0.0	0.0	0.9	72.8	0.8	7.7	27.5	6.7	0.0	13.4	0.0	0.3	7.6	1.5	0.6	12.0	18.1	31.8	1.2	14.8	0.0	11.9	0.4	2.0	14.2	9.3	95.3	1.8	23.6	1.8	53.4	7.6	15.2	3.1	21.6	21.8	0.3	0.0	3.0	0.4	0.0	0.0	0.2	0.0	98.8	13.1	5.5	10.0	0.8	2.3	0.4	0.1	0.3	1.8	5.7	0.2	0.1
VASH2	FLJ12505	ENSG00000143494	"Vasohibin 2"	Q86V25	1	212950520-212992037	"Enzymes, Predicted intracellular proteins, Predicted secreted proteins"		"Carboxypeptidase, Hydrolase, Protease"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"testis: 7.9"	"Group enriched"	"Detected in many"	6	"Early spermatids: 92.8;Late spermatids: 80.8"	"Cancer enhanced"	"Detected in many"		"testis cancer: 3.4"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"AF22: 24.2;AN3-CA: 29.6;NTERA-2: 46.2;RH-30: 135.5"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA045820			Approved	Cytosol	"Secreted to blood"	NA	NA			"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 65: Plasmacytoid DCs - Unknown function"	Cytosol		"HPA045820: "	"unprognostic (2.22e-1)"	"unprognostic (1.15e-1)"	"unprognostic (2.87e-1)"	"unprognostic (1.29e-2)"	"unprognostic (1.28e-1)"	"unprognostic (1.57e-2)"	"unprognostic (1.25e-2)"	"unprognostic (4.04e-2)"	"unprognostic (2.59e-3)"	"unprognostic (3.50e-2)"	"unprognostic (2.45e-1)"	"unprognostic (6.58e-2)"	"unprognostic (1.84e-5)"	"unprognostic (1.95e-3)"	"unprognostic (2.74e-1)"	"unprognostic (6.85e-2)"	"unprognostic (6.81e-4)"	1.7	0.1	0.9	3.3	0.8	0.9	2.0	0.2	1.1	1.7	0.0	0.5	0.7	1.9	0.4	4.0	0.7	2.6	1.1	0.6	0.4	0.4	0.2	1.1	2.3	1.6	0.9	0.6	0.2	0.8	2.6	0.8	1.6	2.7	0.6	0.5	0.9	0.8	0.5	0.5	0.9	1.8	0.2	1.2	0.8	7.9	2.1	4.3	0.3	0.8	2.1	1.4	0.5	0.7	0.3	1.7	24.2	29.6	0.2	0.1	4.0	0.1	0.0	1.0	1.3	0.1	0.6	0.1	0.4	0.1	0.6	0.1	9.9	0.0	1.2	20.3	3.7	2.0	1.4	1.5	0.1	0.2	0.4	3.8	0.0	1.3	0.0	0.6	0.3	11.4	0.1	5.9	2.0	0.5	13.1	1.5	46.2	0.0	3.6	7.6	135.5	1.3	0.2	1.9	5.6	8.6	3.1	0.2	0.3	12.4	4.5	0.9	0.0	1.0	2.7	0.6	1.3	3.4	6.2	0.9	0.1	0.4	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.9	0.8	0.2	1.1	0.6	0.4	1.6	0.9	1.6	0.2	2.1	0.7	0.9	0.0	1.1	0.0	0.6	1.5	0.8	0.2	5.7	3.0	4.1	6.0	1.2	0.0	0.0	0.0	2.1	0.1	12.6	0.2	0.0	0.7	92.8	0.9	1.4	1.1	1.2	0.8	5.4	0.2	0.3	10.9	2.0	1.0	0.0	11.2	0.0	0.1	0.2	1.7	4.3	0.2	2.0	0.3	3.2	80.8	0.3	1.5	0.0	0.0	0.7	0.4	0.0	0.5	0.6	0.1	0.0	0.7	1.0	1.5	0.0	0.4	0.9	2.0	0.0	8.4	4.0	3.2	1.1	0.4	1.6	0.0	0.5	0.1	0.3	0.4
VCP	"CDC48, IBMPFD, p97, TERA"	ENSG00000165280	"Valosin containing protein"	P55072	9	35053928-35072668	"Disease related genes, Enzymes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Transporters"	"Autophagy, DNA damage, DNA repair, Transport, Ubl conjugation pathway"	Hydrolase	"Amyotrophic lateral sclerosis, Charcot-Marie-Tooth disease, Disease variant, Neurodegeneration, Neuropathy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Syncytiotrophoblasts: 540.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB005593, HPA012728, HPA012814"	Supported		Enhanced	Nucleoplasm,Cytosol		No	No		34000000	"Cluster 46: Basophils - DNA binding"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 18: Syncytiotrophoblasts - Pregnancy hormone signaling"	"Nucleoplasm, Cytosol"		"CAB005593: AB_2214638, HPA012728: AB_1858730, HPA012814: AB_1858729"	"unprognostic (1.10e-1)"	"unprognostic (2.66e-1)"	"unprognostic (8.15e-2)"	"prognostic favorable (7.30e-4)"	"unprognostic (5.78e-2)"	"unprognostic (1.87e-1)"	"unprognostic (2.52e-3)"	"unprognostic (1.13e-2)"	"unprognostic (3.82e-2)"	"unprognostic (1.81e-2)"	"unprognostic (2.19e-2)"	"unprognostic (3.24e-1)"	"prognostic favorable (9.63e-7)"	"unprognostic (1.83e-2)"	"unprognostic (1.16e-1)"	"unprognostic (3.93e-1)"	"unprognostic (9.11e-2)"	59.8	88.4	56.8	33.7	59.0	52.0	54.2	58.9	58.0	57.8	72.0	51.8	33.8	59.0	51.6	84.9	49.4	35.3	117.5	60.4	66.2	59.1	87.5	57.2	42.5	64.4	62.0	46.1	61.2	65.7	57.3	46.0	68.2	54.5	36.5	26.3	63.2	58.9	176.0	64.0	51.8	42.5	62.3	64.1	62.5	45.1	63.7	59.6	49.7	135.3	53.3	57.9	55.3	69.8	167.6	223.8	124.6	57.5	187.4	135.3	98.3	153.8	215.0	244.1	197.6	160.0	60.1	140.8	137.2	242.9	173.1	69.5	253.1	230.7	227.6	146.2	126.0	95.3	216.5	238.0	146.5	92.4	106.2	148.5	136.4	239.2	115.6	104.4	276.2	56.3	97.6	71.4	219.2	154.7	114.3	234.9	152.2	82.7	219.1	80.7	111.8	72.8	204.1	175.7	65.7	84.1	100.4	81.2	45.1	152.2	71.5	60.3	215.5	77.5	112.5	63.7	118.6	41.9	116.5	104.3	139.5	67.0	105.4	142.0	62.7	75.0	58.8	70.0	62.4	59.2	59.0	65.6	75.3	53.0	42.3	44.4	71.1	67.1	80.4	49.8	91.2	111.8	56.8	59.0	58.9	58.0	60.4	66.2	64.4	62.0	68.2	62.3	63.7	69.8	86.5	80.1	73.7	22.9	124.3	77.0	120.8	147.6	111.5	86.6	66.0	47.2	220.4	47.1	115.1	55.2	118.9	276.8	91.0	111.9	74.3	188.6	43.6	97.8	85.6	127.7	84.2	137.0	27.4	187.5	164.7	109.7	133.5	105.8	62.1	106.2	111.0	126.0	133.1	74.0	27.7	108.3	89.5	57.9	65.6	47.0	83.9	81.5	76.5	16.9	159.6	88.7	54.6	18.6	31.4	247.9	69.0	86.9	267.6	118.3	77.2	113.4	102.5	90.0	138.1	74.1	154.9	144.5	118.7	126.2	90.6	540.6	105.4	129.6	96.4	135.6
VCPIP1	"DUBA3, FLJ23132, KIAA1850, VCIP135"	ENSG00000175073	"Valosin containing protein interacting protein 1"	Q96JH7	8	66628487-66667231	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"DNA damage, DNA repair, Ubl conjugation pathway"	"Hydrolase, Protease, Thiol protease"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 20.2"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA023932	Uncertain		Approved	"Plasma membrane,Centrosome"		NA	NA			"Cluster 18: Basophils - Vesicular transport"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 10: Non-specific - Unknown function"	"Plasma membrane"	Centrosome	"HPA023932: AB_2671373"	"unprognostic (1.12e-1)"	"unprognostic (1.31e-2)"	"unprognostic (9.13e-2)"	"unprognostic (1.10e-2)"	"unprognostic (4.01e-2)"	"unprognostic (5.56e-2)"	"unprognostic (5.23e-2)"	"unprognostic (7.21e-2)"	"unprognostic (2.80e-1)"	"unprognostic (3.96e-1)"	"unprognostic (5.23e-3)"	"unprognostic (7.28e-2)"	"unprognostic (6.12e-3)"	"unprognostic (2.03e-2)"	"unprognostic (1.83e-1)"	"unprognostic (2.13e-2)"	"unprognostic (8.58e-3)"	4.6	3.6	3.2	6.0	3.6	20.2	4.8	4.1	5.1	3.7	1.8	4.4	3.8	3.0	4.5	3.5	2.9	3.7	2.9	4.1	4.7	4.4	7.0	4.1	8.6	4.0	3.6	3.9	4.0	5.6	1.6	4.4	4.4	3.6	4.1	4.5	4.2	3.1	5.3	3.3	3.6	3.3	3.4	8.8	4.5	5.7	5.0	5.3	4.2	5.3	7.7	4.1	2.4	4.3	8.5	7.6	3.8	5.1	11.5	8.1	3.7	6.7	6.7	5.0	5.8	4.5	7.8	11.5	1.9	9.0	6.2	7.4	6.2	5.6	7.2	8.6	4.5	12.8	7.5	5.6	6.9	4.3	13.2	8.7	8.1	5.5	9.9	6.1	5.5	6.1	8.8	10.8	7.5	4.1	9.4	7.4	7.3	7.1	5.2	5.9	6.0	5.8	7.3	6.6	2.2	4.3	5.2	7.8	6.0	4.8	8.0	7.0	11.1	6.6	4.9	5.9	4.5	9.5	5.0	11.9	6.6	6.0	5.1	10.0	2.7	5.9	3.4	4.3	2.8	1.7	2.1	2.5	2.9	2.2	1.7	2.2	9.7	2.4	8.3	1.1	2.8	1.7	3.2	3.6	4.1	5.1	4.1	4.7	4.0	3.6	4.4	3.4	5.0	4.3	18.6	19.2	15.2	9.8	18.5	17.0	9.3	10.3	12.5	11.0	12.6	9.4	20.3	11.5	12.8	7.3	22.9	10.4	38.9	18.4	3.9	10.2	7.5	16.7	17.1	14.2	6.0	23.4	17.6	13.6	5.5	15.0	15.3	16.4	19.0	12.4	17.2	22.9	14.9	11.8	18.1	15.5	8.2	47.3	20.4	5.2	8.1	25.6	10.6	14.0	28.6	11.9	39.1	13.6	21.1	13.0	16.6	15.8	21.8	14.2	14.7	12.8	18.6	12.1	6.6	21.7	20.2	32.9	16.6	16.3	20.6	9.9	28.6	11.8	13.2	16.9
VNN1	Tiff66	ENSG00000112299	"Vanin 1"	O95497	6	132680849-132714055	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	7	"gallbladder: 89.2;intestine: 136.3;liver: 218.7"	"Cell type enhanced"	"Detected in many"		"Cholangiocytes: 50.1;Ductal cells: 244.2;Hepatocytes: 70.6;Pancreatic endocrine cells: 98.0;Proximal enterocytes: 61.7"	"Cancer enhanced"	"Detected in many"		"liver cancer: 41.5"	"Low region specificity"	"Detected in some"			"Immune cell enhanced"	"Detected in many"		"classical monocyte: 13.7;non-classical monocyte: 11.9"	"Group enriched"	"Detected in many"	80	"dendritic cells: 5.0;granulocytes: 8.5;monocytes: 13.7"	"Cell line enhanced"	"Detected in some"		"A-431: 2.5;CAPAN-2: 2.5;EFO-21: 8.7;HBEC3-KT: 2.3;LHCN-M2: 2.5"	"Region enhanced"	"Detected in single"		"white matter: 2.4"	"Not detected"	"Not detected"			"HPA046103, HPA064145"	Approved		Approved	Vesicles	"Intracellular and membrane"	NA	NA		980000000	"Cluster 25: Monocytes - Inflammatory response"	"Cluster 41: Intestine & Liver - Lipid metabolism"	"Cluster 38: EFO-21 - Unknown function"	"Cluster 1: Pancreatic cells - Digestion"	Vesicles		"HPA046103: , HPA064145: AB_2685197"	"unprognostic (9.53e-2)"	"unprognostic (5.01e-2)"	"unprognostic (9.95e-2)"	"unprognostic (1.35e-3)"	"unprognostic (6.11e-2)"	"unprognostic (1.16e-2)"	"unprognostic (2.20e-1)"	"unprognostic (4.20e-2)"	"unprognostic (2.06e-2)"	"unprognostic (3.64e-2)"	"unprognostic (2.11e-2)"	"unprognostic (4.62e-1)"	"prognostic unfavorable (2.52e-4)"	"unprognostic (2.26e-2)"	"unprognostic (4.42e-2)"	"unprognostic (2.16e-1)"	"unprognostic (2.34e-1)"	2.7	0.6	0.3	3.1	0.6	9.4	1.1	0.5	1.5	1.0	0.0	6.2	136.3	8.9	0.2	0.6	2.6	89.2	0.6	0.2	0.3	21.7	218.7	4.7	2.5	0.6	0.3	0.3	1.4	0.1	0.1	2.7	1.2	0.3	1.8	1.0	2.3	0.2	0.3	0.9	79.5	0.9	0.2	10.1	1.5	0.5	0.5	0.6	0.4	1.1	2.5	1.6	0.7	0.9	2.5	0.0	0.3	0.1	0.0	0.7	0.5	0.2	0.2	0.0	0.0	0.0	2.5	0.1	8.7	0.0	0.4	0.0	0.0	2.3	0.6	0.0	0.0	0.1	0.1	1.4	1.3	0.2	0.1	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	2.5	0.1	0.0	0.3	0.0	0.0	0.1	0.0	0.1	1.1	0.5	0.1	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.6	0.0	0.2	0.1	0.2	0.0	0.1	0.2	0.1	0.3	3.0	13.7	0.0	0.0	8.0	0.0	0.0	0.0	0.0	5.0	0.1	0.0	0.0	8.5	0.0	11.9	0.2	0.0	3.8	0.3	0.6	0.5	1.5	0.2	0.3	0.6	0.3	1.2	0.2	0.5	0.9	0.0	0.0	3.0	0.0	0.3	1.3	0.2	14.9	0.0	0.0	1.2	0.4	0.2	50.1	11.4	1.8	0.0	0.1	0.2	12.5	0.0	244.2	0.0	7.6	4.1	0.2	0.0	0.0	0.0	19.4	0.1	0.3	4.6	39.6	0.0	0.0	1.1	70.6	18.1	0.0	0.0	11.2	22.4	12.0	3.9	0.0	0.0	23.1	0.0	0.0	17.6	0.0	0.0	0.0	0.0	98.0	1.6	0.0	0.5	6.6	61.7	21.9	16.0	0.0	0.0	0.4	1.1	0.1	0.0	0.1	0.1	0.1	0.5	0.0	2.0	14.7
VNN2	"FOAP-4, GPI-80"	ENSG00000112303	"Vanin 2"	O95498	6	132743870-132763459	"Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins"		Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 31.6;lymphoid tissue: 56.6"	"Cell type enhanced"	"Detected in many"		"Ductal cells: 63.6;Ionocytes: 22.4;Macrophages: 41.1;monocytes: 57.5;Respiratory ciliated cells: 25.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Immune cell enriched"	"Detected in many"	7	"neutrophil: 477.4"	"Lineage enriched"	"Detected in all"	7	"granulocytes: 477.4"	"Cell line enriched"	"Detected in some"	7	"Daudi: 59.7"					"Low region specificity"	"Detected in some"									NA	NA		240000	"Cluster 9: Neutrophils - Innate immune response"	"Cluster 2: Immune cells - Immune response"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 19: Monocytes & Neutrophils - Innate immune response"				"unprognostic (2.13e-1)"	"unprognostic (1.15e-1)"	"unprognostic (9.60e-3)"	"unprognostic (5.71e-2)"	"unprognostic (2.14e-1)"	"unprognostic (5.61e-3)"	"unprognostic (1.98e-3)"	"unprognostic (4.38e-1)"	"unprognostic (3.07e-1)"	"unprognostic (3.46e-1)"	"unprognostic (2.84e-1)"	"unprognostic (8.30e-2)"	"prognostic unfavorable (2.72e-7)"	"unprognostic (1.62e-1)"	"unprognostic (8.17e-2)"	"unprognostic (2.01e-1)"	"unprognostic (5.45e-2)"	21.7	2.7	0.6	23.9	0.9	31.6	1.3	0.7	2.8	4.3	1.4	3.8	2.4	1.3	0.4	4.1	5.3	22.5	2.3	0.5	0.7	2.4	10.1	22.5	39.0	1.5	1.0	1.5	4.3	0.7	0.9	20.7	1.7	1.8	3.0	0.1	1.5	0.9	0.6	0.3	4.6	6.3	0.8	56.6	7.3	0.6	1.0	11.7	1.2	7.9	42.0	17.8	1.2	1.0	0.2	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	59.7	1.1	0.0	1.0	0.0	0.0	0.0	0.0	8.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.9	0.0	0.0	1.3	0.0	0.0	0.0	0.0	1.1	0.1	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.6	0.0	1.1	1.4	0.0	0.0	11.6	65.2	0.3	24.6	14.5	10.3	40.3	8.4	29.0	14.1	32.2	27.0	39.4	477.4	36.1	9.9	2.6	6.1	40.4	0.6	0.9	0.7	2.8	0.5	0.7	1.5	1.0	1.7	0.8	1.0	1.0	0.2	0.0	6.7	0.0	11.0	0.0	0.5	4.3	0.0	0.0	0.2	0.0	1.5	7.2	11.8	0.0	0.0	0.8	10.9	0.1	0.0	63.6	0.0	0.3	0.0	1.4	0.0	1.3	0.2	0.4	0.2	1.9	13.3	0.2	5.1	0.1	3.3	1.0	13.9	0.0	0.0	0.0	22.4	18.6	1.0	0.0	0.0	41.1	0.0	1.9	57.5	0.3	20.6	0.0	0.1	3.6	0.0	0.0	2.7	8.0	0.0	0.6	25.4	0.1	6.6	2.5	1.2	0.1	0.0	0.1	0.0	1.4	10.9	6.5	0.2	14.5
VNN3	HSA238982	ENSG00000093134	"Vanin 3"	Q9NY84	6	132722787-132736935	"Enzymes, Metabolic proteins, Predicted secreted proteins"		Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	6	"bone marrow: 34.9;liver: 34.7"	"Cell type enhanced"	"Detected in some"		"Basal respiratory cells: 20.7;Club cells: 42.5;Gastric mucus-secreting cells: 15.8;Respiratory ciliated cells: 86.1"	"Cancer enriched"	"Detected in some"	4	"liver cancer: 3.9"	"Not detected"	"Not detected"			"Immune cell enriched"	"Detected in some"	4	"neutrophil: 76.2"	"Lineage enriched"	"Detected in many"	33	"granulocytes: 76.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"								"Secreted to blood"	NA	NA	150000000		"Cluster 50: Neutrophils - Cellular senescence"	"Cluster 55: Non-specific - Mitochondria & Proteasome"		"Cluster 26: Respiratory epithelial cells - Mucosal defense"				"unprognostic (3.20e-2)"	"unprognostic (2.70e-1)"	"unprognostic (7.92e-3)"	"unprognostic (1.71e-2)"	"unprognostic (3.05e-3)"	"unprognostic (1.06e-3)"	"unprognostic (1.19e-1)"	"unprognostic (1.01e-1)"	"unprognostic (2.42e-2)"	"unprognostic (7.68e-2)"	"unprognostic (1.20e-1)"	"unprognostic (1.63e-1)"	"unprognostic (5.84e-8)"	"unprognostic (1.25e-2)"	"unprognostic (1.52e-1)"	"unprognostic (9.32e-2)"	"unprognostic (1.56e-1)"	1.2	0.1	0.1	2.2	0.1	34.9	0.2	0.1	0.5	1.6	0.2	0.1	0.0	0.1	0.0	0.8	1.9	1.0	0.4	0.1	0.1	0.3	34.7	4.5	0.4	0.1	0.1	0.0	0.1	0.0	0.1	1.3	0.2	0.3	0.0	0.0	1.0	0.1	0.1	0.2	0.2	0.2	0.1	5.5	0.4	0.1	0.2	0.4	0.1	1.1	0.4	0.5	0.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.3	0.7	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	17.7	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	76.2	0.0	0.1	0.0	0.0	0.3	0.1	0.1	0.1	0.5	0.1	0.1	0.1	0.1	0.2	0.1	0.2	0.1	0.0	0.0	2.8	0.0	0.0	0.0	0.1	20.7	0.0	0.0	0.2	0.0	0.4	0.0	42.5	0.0	0.0	0.0	0.1	0.2	0.0	3.7	0.2	2.3	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.8	15.8	1.7	0.0	0.0	0.4	10.0	0.1	0.0	0.0	0.0	6.1	5.8	0.0	0.2	0.0	3.6	0.0	0.0	4.5	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.1	2.0	0.0	0.1	86.1	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	1.0	0.2	0.2	0.3	4.1
VPS4A	"FLJ22197, SKD1, SKD1A, SKD2, VPS4, VPS4-1"	ENSG00000132612	"Vacuolar protein sorting 4 homolog A"	Q9UN37	16	69311350-69326939	"Enzymes, Predicted intracellular proteins"	"Cell cycle, Cell division, Protein transport, Transport"	Hydrolase	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											"CAB018751, CAB034411, HPA060092"	Approved		Supported	Midbody		Yes	NA			"Cluster 26: Non-specific - Mitochondria"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 39: Non-specific - Basic cellular processes"	Midbody		"CAB018751: AB_2215497, CAB034411: AB_2304400, HPA060092: AB_2684203"	"unprognostic (2.60e-2)"	"unprognostic (2.32e-2)"	"unprognostic (1.26e-1)"	"unprognostic (9.26e-2)"	"unprognostic (4.03e-1)"	"unprognostic (1.20e-1)"	"unprognostic (2.55e-2)"	"unprognostic (2.70e-2)"	"unprognostic (4.63e-2)"	"unprognostic (8.61e-2)"	"unprognostic (3.91e-3)"	"unprognostic (2.19e-1)"	"prognostic favorable (1.76e-4)"	"unprognostic (5.44e-2)"	"unprognostic (1.46e-1)"	"unprognostic (2.61e-1)"	"unprognostic (6.79e-2)"	13.2	15.3	15.7	8.9	16.9	8.8	12.8	16.1	17.1	10.4	11.0	13.5	13.5	11.7	8.1	16.0	10.3	9.4	20.6	15.5	14.9	18.0	11.6	9.9	11.8	16.4	16.8	12.2	27.8	20.6	7.6	10.0	16.7	10.4	7.6	10.2	19.9	8.4	54.0	15.3	12.8	8.4	15.4	9.2	17.6	6.8	16.7	6.2	16.7	33.6	7.3	11.4	11.3	18.2	21.1	34.9	23.2	30.7	21.2	18.8	20.5	27.9	25.2	36.4	24.3	33.4	19.0	35.0	27.3	28.0	17.5	30.3	23.9	28.2	21.8	14.8	30.8	22.0	20.7	26.3	32.6	27.5	19.6	21.7	36.3	31.6	28.7	21.4	27.4	27.3	37.0	10.3	27.2	46.8	36.4	20.5	26.7	20.6	24.5	47.8	19.0	41.3	18.5	16.8	39.1	24.7	59.3	18.1	21.4	15.4	31.4	20.6	32.8	33.2	20.8	30.4	22.1	36.9	31.3	62.6	30.4	18.2	37.1	8.8	9.9	13.3	11.2	8.7	10.0	8.5	9.3	13.9	9.4	7.4	10.5	9.9	7.5	8.0	11.5	5.5	11.8	13.8	15.7	16.9	16.1	17.1	15.5	14.9	16.4	16.8	16.7	15.4	16.7	18.2	39.8	25.6	19.0	14.7	33.8	30.7	37.3	22.2	22.8	51.4	30.2	28.2	31.0	22.8	16.7	23.9	22.9	59.8	48.4	48.9	74.3	51.7	11.2	14.9	27.0	34.9	31.3	43.6	14.5	82.5	66.5	32.9	29.0	25.6	29.2	36.3	31.8	21.6	45.1	74.0	14.9	34.2	20.3	33.7	24.6	11.9	29.5	30.2	44.4	5.6	40.9	66.0	38.1	4.5	16.8	67.4	42.2	30.5	31.9	67.6	76.4	57.7	6.4	41.8	52.6	36.0	38.9	28.7	38.3	27.1	31.3	70.1	35.6	26.0	41.4	41.2
VPS4B	"SKD1, SKD1B, VPS4-2"	ENSG00000119541	"Vacuolar protein sorting 4 homolog B"	O75351	18	63389190-63422483	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Cell division, Protein transport, Transport"	Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA040393, CAB046445, HPA057649"	Approved		Approved	"Vesicles,Intermediate filaments"		No	No		32000	"Cluster 1: Neutrophils - Mixed function"	"Cluster 37: Intestine - Unknown function"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 44: Endometrium - Transcription"	Vesicles	"Intermediate filaments"	"CAB046445: AB_10603252, HPA040393: , HPA057649: AB_2683489"	"unprognostic (8.54e-2)"	"unprognostic (1.06e-1)"	"unprognostic (1.85e-3)"	"unprognostic (5.59e-2)"	"unprognostic (1.71e-1)"	"unprognostic (9.47e-2)"	"unprognostic (1.75e-1)"	"unprognostic (1.79e-1)"	"unprognostic (4.54e-2)"	"unprognostic (9.10e-2)"	"unprognostic (1.94e-3)"	"unprognostic (1.67e-1)"	"prognostic favorable (1.23e-4)"	"unprognostic (4.59e-1)"	"unprognostic (1.40e-1)"	"unprognostic (4.08e-1)"	"unprognostic (1.21e-1)"	24.2	18.3	10.5	25.5	13.1	52.6	28.8	13.2	17.8	26.8	9.3	42.3	35.1	22.7	19.5	75.4	18.6	23.7	16.2	10.3	14.6	23.8	28.4	23.8	31.2	13.5	15.9	19.3	17.3	27.8	11.5	28.7	14.0	23.4	37.0	7.0	24.7	19.5	11.0	32.3	36.4	21.0	12.6	28.8	32.5	12.1	12.5	31.4	28.5	13.0	39.1	30.2	31.1	15.6	57.1	21.9	22.4	24.5	33.5	47.1	38.9	48.6	45.5	36.4	39.2	15.7	39.4	54.1	31.2	35.7	30.9	119.6	26.8	53.1	47.5	40.6	22.3	27.6	27.8	23.7	48.6	94.5	56.8	43.1	80.3	32.3	56.2	36.5	33.9	31.0	14.3	49.4	52.1	20.2	59.9	29.2	23.2	22.7	32.3	48.8	47.2	52.4	45.6	66.2	38.2	33.6	36.9	35.4	55.3	28.3	34.2	50.5	52.8	55.4	27.3	21.6	32.7	163.6	86.5	69.3	31.9	44.0	42.3	163.6	54.6	125.0	52.2	56.5	49.0	64.8	54.3	54.2	46.2	73.4	48.2	51.1	185.9	68.4	76.5	45.6	66.7	56.6	10.5	13.1	13.2	17.8	10.3	14.6	13.5	15.9	14.0	12.6	12.5	15.6	52.0	115.4	57.4	21.5	62.4	68.8	47.2	66.5	44.9	37.0	54.4	46.0	39.5	47.1	72.4	33.1	22.9	70.0	92.2	142.0	45.0	48.0	113.3	92.2	74.0	44.6	45.5	27.8	27.3	42.1	56.7	51.0	47.4	145.5	59.3	37.7	36.8	55.8	46.4	43.7	29.6	76.8	67.1	58.8	33.0	15.5	49.0	58.0	32.0	18.7	53.4	39.2	76.2	18.6	49.5	91.3	120.7	36.5	42.1	43.1	61.8	57.9	85.1	31.5	59.2	45.6	54.7	30.1	29.4	87.5	83.4	140.4	67.4	56.5	72.6	79.5
WRN	"RECQ3, RECQL2"	ENSG00000165392	"WRN RecQ like helicase"	Q14191	8	31033788-31176138	"Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"DNA damage, DNA repair"	"DNA-binding, Exonuclease, Helicase, Hydrolase, Multifunctional enzyme, Nuclease"	"Cancer-related genes, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Astrocytes: 74.7;Early spermatids: 116.3;Oligodendrocytes: 88.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA028661	Approved		Supported	"Nuclear speckles"		NA	NA			"Cluster 40: NK-cells - Unknown function"	"Cluster 34: Non-specific - Transcription"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 29: Early spermatids - Spermatogenesis"	"Nuclear speckles"		"HPA028661: AB_10602255"	"unprognostic (8.73e-2)"	"unprognostic (9.33e-2)"	"unprognostic (1.51e-3)"	"unprognostic (3.85e-2)"	"unprognostic (1.41e-1)"	"unprognostic (1.85e-2)"	"unprognostic (2.21e-3)"	"unprognostic (1.25e-1)"	"unprognostic (1.07e-1)"	"unprognostic (1.16e-2)"	"unprognostic (1.27e-2)"	"unprognostic (6.63e-2)"	"unprognostic (1.53e-2)"	"unprognostic (6.51e-2)"	"unprognostic (2.49e-1)"	"unprognostic (1.00e-2)"	"unprognostic (2.66e-1)"	3.0	3.6	1.7	3.2	1.7	8.2	4.8	4.1	2.4	3.0	2.6	3.5	1.5	6.4	3.2	2.7	2.9	2.4	1.7	1.6	1.7	2.1	2.5	2.4	2.5	1.8	2.1	5.2	2.6	2.0	2.1	3.6	1.8	3.5	2.9	4.4	3.5	2.6	2.1	4.1	2.5	4.2	1.2	3.1	2.3	3.0	1.9	3.2	3.2	2.2	3.0	2.6	2.3	3.1	4.4	5.9	10.8	5.3	6.7	9.8	5.0	4.7	4.9	6.4	6.6	2.7	1.5	10.0	4.6	4.3	4.4	2.4	6.4	3.8	9.7	3.3	4.3	9.6	4.9	4.4	5.4	8.7	4.3	7.1	3.7	3.6	6.2	3.9	7.7	6.1	14.5	5.0	6.8	2.0	17.5	6.6	7.7	5.1	3.2	7.5	7.5	6.7	2.9	4.4	3.3	5.2	6.9	2.7	3.8	4.9	2.9	5.3	9.1	6.2	3.8	3.1	4.9	1.4	3.0	14.6	5.5	3.8	4.2	0.8	0.2	0.3	0.3	0.1	0.4	0.5	0.5	0.3	0.2	0.5	0.3	0.4	0.3	1.1	0.1	0.1	0.3	0.1	1.7	1.7	4.1	2.4	1.6	1.7	1.8	2.1	1.8	1.2	1.9	3.1	17.5	9.6	10.6	74.7	15.1	13.5	11.7	5.3	18.8	14.5	14.7	10.5	7.5	15.7	8.8	16.5	22.9	7.1	18.0	5.3	1.9	6.7	116.3	15.8	32.3	12.5	2.4	49.2	59.7	9.8	5.7	15.2	21.9	17.1	2.5	18.5	7.1	9.7	5.3	15.2	54.9	13.8	8.2	5.3	6.6	12.8	19.0	7.8	10.6	51.5	6.9	14.3	4.1	61.3	88.6	9.1	4.2	14.3	16.6	15.3	3.9	2.7	10.0	19.8	6.6	20.2	15.3	10.9	19.2	10.1	10.2	5.6	13.0	15.2	7.7	11.0
XPNPEP1	"XPNPEP, XPNPEPL, XPNPEPL1"	ENSG00000108039	"X-prolyl aminopeptidase 1"	Q9NQW7	10	109864766-109923553	"Enzymes, Predicted intracellular proteins"		"Aminopeptidase, Hydrolase, Metalloprotease, Protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB025196, HPA030419, HPA030420, HPA030422"	Supported		Enhanced	Cytosol		NA	NA		810000	"Cluster 27: Non-specific - Gene expression"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 51: Myeloid cells - Hemostasis"	Cytosol		"CAB025196: , HPA030419: AB_10598917, HPA030420: AB_10611523, HPA030422: AB_10601783"	"unprognostic (3.17e-2)"	"unprognostic (2.36e-2)"	"unprognostic (1.11e-1)"	"unprognostic (2.31e-2)"	"unprognostic (2.46e-1)"	"unprognostic (2.01e-3)"	"prognostic unfavorable (2.12e-5)"	"unprognostic (8.03e-2)"	"unprognostic (2.10e-2)"	"unprognostic (1.88e-1)"	"unprognostic (4.89e-2)"	"unprognostic (7.61e-2)"	"unprognostic (2.43e-2)"	"unprognostic (1.34e-2)"	"unprognostic (1.74e-1)"	"unprognostic (2.40e-1)"	"unprognostic (5.18e-2)"	19.7	19.4	13.2	22.9	13.6	23.3	20.1	13.1	14.8	19.7	17.2	32.2	51.7	19.4	22.7	25.1	22.3	27.5	27.9	15.3	13.4	21.4	18.9	19.2	25.4	13.2	12.7	19.8	62.0	24.5	19.2	26.6	13.1	21.7	40.4	18.7	30.4	15.7	28.4	29.5	61.8	28.2	13.2	19.3	24.4	18.1	13.3	19.5	23.6	22.1	28.4	24.6	19.3	13.7	78.1	33.6	52.3	72.1	83.6	77.4	40.2	42.4	85.5	61.8	66.5	65.4	65.2	110.3	35.9	65.0	31.3	40.5	41.7	52.2	60.4	33.0	40.3	74.0	20.5	27.6	58.2	58.3	59.0	76.9	31.8	67.8	60.1	94.6	103.1	70.0	24.3	34.3	80.1	26.3	41.7	36.0	20.6	58.7	35.7	46.1	105.3	19.8	78.5	24.3	15.9	60.5	36.9	23.1	70.6	56.9	28.3	53.6	53.9	25.3	32.9	40.4	38.1	58.4	30.4	92.8	59.4	80.0	20.3	25.7	26.8	11.3	19.5	42.2	13.4	10.6	12.6	17.5	46.4	8.9	8.7	11.7	2.2	30.5	36.8	36.4	15.5	29.6	13.2	13.6	13.1	14.8	15.3	13.4	13.2	12.7	13.1	13.2	13.3	13.7	13.4	6.4	14.4	24.5	14.6	8.9	13.2	32.9	11.4	20.5	12.1	9.7	17.0	18.6	26.3	3.7	6.2	38.2	33.1	34.5	17.6	37.4	6.4	12.3	16.5	18.2	16.8	14.7	18.9	72.9	29.6	22.7	24.5	13.6	11.4	17.0	15.7	12.1	30.9	26.9	25.3	37.1	18.3	20.5	9.6	5.1	18.3	37.5	8.8	15.9	33.5	27.1	24.7	21.6	27.0	54.4	35.1	29.7	18.1	22.5	63.5	31.1	22.8	19.5	13.1	9.8	14.2	17.5	35.9	18.6	8.7	25.2	19.4	30.0	36.5	27.1
XPNPEP2		ENSG00000122121	"X-prolyl aminopeptidase 2"	O43895	X	129738949-129769536	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"		"Aminopeptidase, Hydrolase, Metalloprotease, Protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	7	"intestine: 166.6;kidney: 156.0"	"Cell type enriched"	"Detected in some"	6	"Proximal enterocytes: 475.9"	"Cancer enhanced"	"Detected in many"		"liver cancer: 18.3"	"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	4	"gdT-cell: 4.3;intermediate monocyte: 1.4;MAIT T-cell: 1.2;memory CD4 T-cell: 1.3;memory CD8 T-cell: 2.8;naive CD8 T-cell: 2.0;non-classical monocyte: 2.8;T-reg: 1.4"	"Group enriched"	"Detected in many"	7	"monocytes: 2.8;T-cells: 4.3"	"Cell line enhanced"	"Detected in some"		"ASC diff: 8.2;ASC TERT1: 40.1;HSkMC: 21.1"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"HPA000339, CAB025136, CAB025269, HPA064568"	Enhanced		Approved	"Plasma membrane,Cytosol"	"Intracellular and membrane"	NA	NA		13000000	"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 87: Intestine & Kidney - Transmembrane transport"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 45: Enterocytes - Digestion"	"Plasma membrane, Cytosol"		"CAB025136: , CAB025269: , HPA000339: AB_1858894, HPA064568: "	"unprognostic (7.95e-2)"	"unprognostic (5.73e-2)"	"unprognostic (2.56e-1)"	"unprognostic (6.21e-3)"	"unprognostic (3.54e-2)"	"unprognostic (1.54e-1)"	"unprognostic (4.04e-1)"	"unprognostic (3.26e-1)"	"unprognostic (3.01e-1)"	"unprognostic (2.41e-2)"	"unprognostic (3.07e-1)"	"unprognostic (9.28e-3)"	"unprognostic (2.77e-2)"	"unprognostic (6.53e-2)"	"unprognostic (3.18e-2)"	"unprognostic (1.39e-2)"	"unprognostic (3.26e-3)"	7.5	0.9	0.1	3.7	0.1	0.2	3.0	0.1	0.1	3.7	0.1	5.5	99.0	2.4	0.1	2.2	6.3	4.3	5.3	0.1	0.1	156.0	23.1	2.1	0.5	0.2	0.1	1.8	0.3	0.3	0.1	1.2	0.1	1.8	6.3	0.0	1.5	0.4	0.5	4.4	166.6	6.0	0.1	0.3	3.4	0.1	0.1	1.0	1.4	2.4	0.4	7.8	4.0	0.1	0.0	0.0	0.5	0.0	8.2	40.1	0.4	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	1.2	0.0	0.0	21.1	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.3	0.4	0.0	0.0	0.0	0.7	0.0	0.7	0.0	0.0	0.1	1.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	1.5	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.0	4.3	1.4	1.2	0.0	1.3	2.8	0.2	0.2	0.4	2.0	0.1	0.0	2.8	0.4	1.4	0.9	0.1	0.1	0.1	0.1	0.1	0.1	0.2	0.1	0.1	0.1	0.1	0.1	1.2	0.0	0.0	0.0	0.5	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	1.8	0.0	0.2	0.5	11.4	5.9	0.0	0.0	0.0	0.1	0.3	1.2	0.0	0.2	0.0	0.0	10.0	1.1	0.0	0.0	0.0	0.4	18.5	0.8	0.0	0.3	12.8	0.0	1.0	3.6	0.0	0.0	1.0	1.8	1.0	0.0	0.0	3.1	0.0	0.1	0.0	21.0	0.0	0.1	0.0	475.9	75.1	0.0	0.0	0.0	0.3	0.3	0.0	0.0	0.0	1.0	1.2	0.9	0.0	8.4	0.0
XPNPEP3	"APP3, ICP55, NPHPL1"	ENSG00000196236	"X-prolyl aminopeptidase 3"	Q9NQH7	22	40857077-40932815	"Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins"		"Aminopeptidase, Hydrolase, Metalloprotease, Protease"	"Disease variant, Nephronophthisis"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in all"	4	"Early spermatids: 232.9;Late spermatids: 306.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA000527	Approved		Supported	Mitochondria,Cytosol		NA	NA			"Cluster 14: Monocytes - Unknown function"	"Cluster 45: Intestine - Brush border"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 34: Spermatids - Unknown function"	Mitochondria	Cytosol	"HPA000527: AB_1079266"	"prognostic unfavorable (8.19e-4)"	"unprognostic (6.77e-2)"	"unprognostic (3.22e-3)"	"unprognostic (5.03e-3)"	"unprognostic (6.18e-2)"	"unprognostic (1.29e-1)"	"unprognostic (1.65e-1)"	"unprognostic (1.13e-1)"	"unprognostic (1.64e-1)"	"unprognostic (2.53e-1)"	"unprognostic (1.73e-2)"	"unprognostic (1.51e-1)"	"unprognostic (6.69e-2)"	"unprognostic (8.00e-3)"	"unprognostic (2.49e-1)"	"prognostic unfavorable (6.10e-4)"	"unprognostic (1.24e-1)"	2.7	4.9	6.4	1.3	6.3	1.6	2.6	8.3	7.8	2.9	7.1	2.5	14.6	4.7	5.0	2.8	3.7	4.4	5.3	7.8	6.1	3.7	8.2	2.4	2.5	7.2	6.6	3.8	3.6	2.1	3.7	1.5	6.6	2.8	2.2	4.4	3.4	2.5	5.5	5.5	10.1	2.4	5.6	2.8	2.8	3.7	6.7	5.9	3.2	3.5	1.9	3.7	2.8	9.0	2.7	4.1	2.5	5.5	6.3	4.6	2.1	3.3	2.5	1.7	1.7	3.1	1.6	5.2	1.8	6.5	7.8	7.3	4.7	2.4	2.7	3.5	9.7	3.3	9.7	7.5	3.2	6.0	0.5	4.0	3.9	5.7	3.3	2.7	3.3	3.8	2.9	4.8	4.3	4.1	3.1	3.2	1.5	5.0	8.3	3.9	3.3	3.0	5.9	3.6	2.3	1.9	3.9	4.8	3.3	2.6	6.1	2.7	3.2	3.6	3.4	3.4	2.1	4.7	4.0	7.4	5.6	8.5	2.5	2.8	2.5	2.9	2.1	2.5	1.0	3.7	1.2	1.2	1.9	1.9	2.4	1.9	3.6	0.7	6.9	3.8	1.9	2.8	6.4	6.3	8.3	7.8	7.8	6.1	7.2	6.6	6.6	5.6	6.7	9.0	9.6	6.4	17.6	32.0	12.7	13.3	8.0	15.6	9.6	16.0	12.9	13.2	22.5	15.7	14.0	9.2	18.8	21.7	11.0	6.2	15.6	12.2	232.9	37.5	16.6	11.7	13.8	12.0	22.0	17.1	18.7	13.1	12.2	12.0	14.0	17.8	10.8	36.0	14.7	16.8	24.0	9.5	12.2	12.6	15.7	306.8	19.9	11.9	17.8	18.7	7.8	13.0	9.2	19.6	42.3	10.4	9.5	15.4	11.8	7.8	3.5	25.3	38.5	19.8	32.9	14.0	12.7	65.6	34.2	12.2	16.3	20.0	11.0	19.5	8.7	7.6
YOD1	"DKFZp451J1719, DUBA8, OTUD2"	ENSG00000180667	"YOD1 deubiquitinase"	Q5VVQ6	1	207043849-207052980	"Enzymes, Predicted intracellular proteins"	"Ubl conjugation pathway, Unfolded protein response"	"Hydrolase, Protease, Thiol protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 58.6"	"Cell type enhanced"	"Detected in all"		"Erythroid cells: 70.9;Glandular and luminal cells: 118.8;Late spermatids: 103.3;Urothelial cells: 86.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"HEL: 86.3;K-562: 61.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA028400, HPA028439"	Uncertain		Supported	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA		110000	"Cluster 10: Basophils - Unknown function"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 44: Endometrium - Transcription"	"Nucleoplasm, Plasma membrane, Cytosol"		"HPA028400: AB_10599854, HPA028439: AB_10600994"	"unprognostic (3.69e-2)"	"unprognostic (8.72e-2)"	"unprognostic (1.17e-1)"	"unprognostic (2.39e-1)"	"unprognostic (2.03e-2)"	"unprognostic (3.28e-2)"	"unprognostic (9.87e-3)"	"unprognostic (9.38e-2)"	"unprognostic (2.31e-3)"	"unprognostic (8.96e-2)"	"unprognostic (1.47e-3)"	"unprognostic (1.03e-2)"	"unprognostic (6.07e-2)"	"unprognostic (6.86e-2)"	"unprognostic (2.83e-1)"	"unprognostic (1.79e-2)"	"unprognostic (3.62e-1)"	3.0	4.5	3.5	4.3	3.8	58.6	5.4	3.7	5.5	5.2	3.9	3.9	4.2	3.7	2.9	24.6	2.6	2.8	4.4	4.0	3.4	4.7	5.4	8.5	4.7	5.5	3.6	2.9	3.2	1.6	2.7	5.7	4.4	3.0	3.9	7.6	6.6	2.7	4.8	15.6	4.8	2.5	3.6	5.7	8.8	3.8	5.0	9.9	5.3	4.1	7.6	4.6	10.9	9.9	11.8	6.1	9.5	5.7	3.3	4.4	18.5	7.6	5.9	5.7	5.7	11.7	11.9	6.1	3.0	4.7	2.7	12.6	0.1	9.3	6.4	4.9	10.3	86.3	27.6	5.6	3.1	11.5	29.2	3.1	7.1	4.6	17.7	6.7	5.0	12.5	61.1	0.0	5.0	0.1	10.1	6.3	9.1	4.9	13.5	5.1	0.4	4.5	5.7	13.0	5.0	11.0	12.5	14.4	16.7	8.4	5.1	8.1	2.4	4.8	12.6	4.0	10.0	9.5	0.6	9.0	5.7	0.0	3.3	1.0	0.3	0.5	0.2	0.3	0.3	0.0	0.3	0.2	0.3	0.1	0.3	0.4	0.7	0.3	0.2	0.1	0.2	0.2	3.5	3.8	3.7	5.5	4.0	3.4	5.5	3.6	4.4	3.6	5.0	9.9	6.8	41.7	12.2	20.5	3.3	31.6	29.4	8.1	21.1	8.0	6.2	3.8	7.0	2.8	10.0	1.8	4.2	2.7	8.2	39.4	1.9	4.1	35.4	50.5	19.0	6.7	8.9	70.9	8.5	10.5	3.2	5.5	36.2	118.8	8.2	6.1	2.9	8.6	2.8	11.8	6.4	5.0	12.2	10.0	12.5	103.3	1.5	8.3	14.2	6.5	5.2	4.9	6.2	6.0	16.4	24.4	67.8	2.2	4.8	38.2	7.8	7.0	21.6	17.9	6.6	3.6	6.0	10.9	4.6	33.9	40.2	1.8	6.9	9.0	7.5	86.5
YTHDC2	"DKFZp564A186, FLJ10053, FLJ2194"	ENSG00000047188	"YTH domain containing 2"	Q9H6S0	5	113513694-113595285	"Enzymes, Predicted intracellular proteins"	"Differentiation, Meiosis, Oogenesis, Spermatogenesis"	"Helicase, Hydrolase, RNA-binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 129.8;Inhibitory neurons: 146.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA037364, HPA072678"	Approved		Approved	"Nucleoplasm,Nuclear bodies,Cytoplasmic bodies"		NA	NA			"Cluster 37: B-cells - Transcription"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 40: Granulosa cells - Unknown function"	Nucleoplasm	"Nuclear bodies, Cytoplasmic bodies"	"HPA037364: AB_10672788, HPA072678: AB_2686548"	"unprognostic (2.09e-1)"	"unprognostic (2.10e-1)"	"prognostic favorable (1.82e-5)"	"unprognostic (4.33e-3)"	"unprognostic (1.45e-1)"	"unprognostic (6.48e-3)"	"unprognostic (1.96e-1)"	"unprognostic (7.82e-3)"	"unprognostic (3.55e-2)"	"unprognostic (8.56e-3)"	"unprognostic (4.61e-2)"	"unprognostic (2.03e-1)"	"unprognostic (4.15e-2)"	"unprognostic (3.05e-1)"	"unprognostic (9.96e-2)"	"unprognostic (1.08e-2)"	"unprognostic (2.56e-2)"	8.4	9.7	5.2	11.3	5.8	9.9	10.1	8.8	6.6	8.9	7.8	8.7	9.3	9.2	8.6	9.4	8.3	8.0	7.6	6.1	5.1	8.5	12.6	7.4	13.8	5.3	5.8	11.0	8.7	15.5	8.7	6.9	5.3	8.1	10.0	18.3	8.9	7.4	11.5	11.3	10.1	7.9	5.1	11.4	9.2	14.8	4.7	10.2	9.2	10.9	12.9	9.8	8.9	7.1	16.0	14.2	18.1	30.7	9.8	12.9	19.7	12.1	13.4	15.2	23.6	10.0	8.8	29.1	8.5	10.2	19.5	15.3	22.0	27.2	19.8	12.6	19.9	15.8	25.8	13.6	14.5	12.8	13.4	10.6	10.3	9.6	17.4	14.3	21.5	13.0	15.8	13.0	13.6	5.3	17.8	9.1	8.4	4.7	9.2	7.4	15.6	22.7	12.7	20.9	14.4	12.0	16.3	11.7	12.7	11.3	16.6	11.4	18.8	23.2	8.1	12.1	16.7	13.3	18.0	18.0	13.3	14.4	10.1	0.0	2.8	2.9	2.8	1.9	3.3	7.3	3.2	3.0	2.4	5.1	3.4	2.9	1.0	4.3	3.3	3.6	2.6	1.2	5.2	5.8	8.8	6.6	6.1	5.1	5.3	5.8	5.3	5.1	4.7	7.1	27.4	28.9	32.8	61.0	39.6	13.3	21.8	14.7	15.9	59.9	17.6	17.7	17.7	14.3	25.3	12.9	83.4	13.7	34.0	12.3	0.0	17.8	47.5	15.5	24.5	24.0	7.2	16.6	129.8	18.6	8.3	22.4	34.1	17.2	12.6	69.0	20.0	25.7	17.3	52.2	146.3	14.2	20.3	30.0	13.2	44.2	19.9	26.8	12.4	95.5	23.9	21.4	16.5	94.5	97.6	18.0	7.8	14.7	20.0	14.4	16.0	17.8	24.9	88.9	26.3	34.0	26.6	93.8	37.8	19.2	14.3	18.1	33.0	33.4	16.7	18.5
ZMPSTE24	"FACE-1, HGPS, PRO1, STE24, Ste24p"	ENSG00000084073	"Zinc metallopeptidase STE24"	O75844	1	40258041-40294180	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted membrane proteins, Transporters"		"Hydrolase, Metalloprotease, Protease"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA006988	Approved					NA	NA		50000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 1: Thyroid gland - Transcription"	"Cluster 43: THP-1 - Innate immune response"	"Cluster 10: Non-specific - Unknown function"			"HPA006988: AB_1080659"	"unprognostic (6.32e-2)"	"unprognostic (1.63e-2)"	"unprognostic (3.75e-3)"	"unprognostic (4.63e-2)"	"unprognostic (4.16e-3)"	"unprognostic (1.37e-1)"	"prognostic unfavorable (5.73e-6)"	"unprognostic (1.86e-1)"	"unprognostic (1.17e-1)"	"unprognostic (1.84e-3)"	"unprognostic (4.78e-2)"	"unprognostic (7.96e-2)"	"unprognostic (5.06e-2)"	"unprognostic (3.65e-2)"	"unprognostic (2.65e-1)"	"prognostic unfavorable (6.34e-4)"	"unprognostic (2.71e-2)"	20.5	24.6	16.3	19.9	16.7	5.6	25.5	18.1	22.9	26.2	21.9	28.5	22.2	26.7	27.4	21.7	18.8	25.7	20.6	16.1	18.8	46.0	38.4	21.7	16.8	17.4	17.7	14.3	17.4	53.3	10.2	22.1	18.5	26.3	33.1	10.9	19.6	23.8	16.3	16.3	23.4	32.2	18.7	13.7	21.3	11.0	17.7	15.5	27.5	18.1	23.0	29.4	16.2	18.9	69.3	38.4	35.6	26.1	90.3	71.3	67.0	64.0	60.6	81.7	73.9	35.4	118.8	62.7	41.1	92.1	29.9	71.0	78.4	67.9	97.9	54.4	39.8	59.9	36.0	44.5	45.4	99.3	68.8	45.5	67.4	64.7	28.4	45.4	58.3	27.3	63.0	60.6	80.1	30.2	60.7	28.3	70.0	47.2	42.2	52.2	60.2	77.6	75.2	58.0	38.0	44.6	60.9	155.6	85.9	56.3	55.2	249.1	46.4	68.6	52.5	56.0	78.0	37.1	106.2	49.6	75.6	64.6	79.1	18.9	21.4	14.0	17.6	27.2	22.5	15.0	19.4	19.4	29.4	11.4	16.7	22.9	8.5	29.6	24.3	18.4	24.6	22.7	16.3	16.7	18.1	22.9	16.1	18.8	17.4	17.7	18.5	18.7	17.7	18.9	28.9	38.5	24.1	19.2	20.1	32.0	24.2	41.4	33.0	6.6	35.9	19.0	25.5	54.3	43.0	73.5	0.0	41.4	22.1	44.3	31.3	58.9	3.5	30.7	32.6	31.2	27.6	18.1	16.6	36.9	38.3	36.0	21.9	40.0	21.0	16.6	27.5	64.4	34.0	10.1	13.9	31.0	54.9	33.9	24.5	2.2	28.6	28.6	24.9	11.2	30.5	29.3	19.6	17.6	20.2	44.0	29.3	32.7	31.1	37.7	31.7	42.6	64.2	7.7	0.0	26.8	41.2	7.8	6.4	31.5	27.1	39.0	23.1	28.9	35.6	24.5
ZRANB1	TRABID	ENSG00000019995	"Zinc finger RANBP2-type containing 1"	Q9UGI0	10	124942123-124988189	"Enzymes, Predicted intracellular proteins"	"Ubl conjugation pathway, Wnt signaling pathway"	"Hydrolase, Protease, Thiol protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA029239, HPA029240, HPA029241"	Approved		Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 44: Endometrium - Transcription"	Nucleoplasm	Cytosol	"HPA029239: AB_10599419, HPA029240: AB_10601450, HPA029241: AB_10602205"	"unprognostic (2.06e-1)"	"unprognostic (5.16e-2)"	"unprognostic (6.96e-2)"	"unprognostic (1.67e-1)"	"unprognostic (1.40e-1)"	"unprognostic (9.53e-3)"	"unprognostic (4.16e-2)"	"unprognostic (1.89e-1)"	"unprognostic (1.71e-1)"	"unprognostic (1.46e-1)"	"unprognostic (4.20e-1)"	"unprognostic (1.46e-1)"	"unprognostic (1.22e-2)"	"unprognostic (1.60e-1)"	"unprognostic (2.76e-1)"	"unprognostic (1.26e-1)"	"unprognostic (1.47e-2)"	13.9	21.1	17.9	6.6	18.7	22.5	13.1	26.7	21.8	14.4	18.8	13.8	5.1	14.4	12.4	10.5	10.8	9.7	18.4	18.1	17.8	10.9	24.8	10.6	8.2	17.7	17.8	19.3	8.8	16.8	8.7	10.6	17.8	11.2	8.8	17.5	9.0	13.6	52.9	15.0	7.7	15.2	18.0	8.7	8.3	19.7	18.3	13.6	10.1	46.4	10.7	10.3	11.7	19.4	15.1	8.6	17.8	13.1	27.1	22.7	7.5	14.5	39.6	27.1	31.3	12.8	11.7	15.7	10.6	18.4	8.8	10.7	22.8	10.7	36.2	16.8	11.3	9.0	9.7	13.8	57.6	13.6	6.6	25.2	30.8	19.9	42.2	37.7	17.3	14.2	1.3	12.7	14.8	12.1	16.2	11.9	6.5	8.2	9.1	13.7	12.7	7.2	12.0	10.9	9.1	15.2	12.3	9.4	16.4	16.7	10.4	11.5	12.9	11.5	11.8	9.7	18.3	13.4	12.5	18.1	13.1	9.5	5.8	0.9	0.4	1.2	0.8	0.1	0.6	0.9	0.9	0.7	0.3	1.3	1.5	1.2	1.7	1.3	0.2	0.5	0.9	0.3	17.9	18.7	26.7	21.8	18.1	17.8	17.7	17.8	17.8	18.0	18.3	19.4	28.6	19.2	25.3	61.7	17.9	24.6	22.8	10.7	22.2	36.9	29.0	21.2	22.9	15.7	17.3	18.4	50.1	12.3	26.3	16.2	0.0	13.1	80.2	29.4	38.6	21.7	26.8	25.7	58.2	11.6	9.8	21.4	14.3	38.5	26.0	34.3	14.6	43.8	12.5	37.0	58.5	19.0	4.1	16.7	22.4	30.3	23.9	24.3	16.0	52.5	13.2	24.2	19.6	56.3	76.0	19.3	11.5	23.0	21.0	31.4	11.9	10.5	19.2	26.0	13.1	34.6	27.6	28.8	19.1	20.5	27.8	27.5	21.4	23.7	13.1	31.1
ZUP1	"C6orf113, dJ412I7.3, ZUFSP"	ENSG00000153975	"Zinc finger containing ubiquitin peptidase 1"	Q96AP4	6	116635618-116668794	"Enzymes, Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 10.4;dendritic cells: 12.8;monocytes: 12.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA044426	Uncertain		Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 44: Non-specific - Transcription"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 7: Non-specific - Mitochondria"	Nucleoplasm	Cytosol	"HPA044426: AB_10960887"	"unprognostic (2.28e-3)"	"unprognostic (2.45e-3)"	"unprognostic (3.91e-2)"	"unprognostic (2.17e-1)"	"unprognostic (1.33e-2)"	"unprognostic (1.63e-1)"	"prognostic unfavorable (2.11e-4)"	"unprognostic (3.27e-1)"	"unprognostic (5.88e-2)"	"unprognostic (2.83e-1)"	"unprognostic (1.95e-1)"	"unprognostic (2.41e-1)"	"unprognostic (1.90e-3)"	"unprognostic (2.54e-2)"	"unprognostic (1.48e-1)"	"unprognostic (7.33e-2)"	"unprognostic (7.92e-3)"	4.4	4.5	4.2	6.2	4.7	13.5	5.6	7.2	6.3	4.0	3.0	5.1	10.5	3.6	4.1	5.6	3.1	5.5	2.7	4.3	4.6	4.6	4.3	5.0	8.7	4.4	4.4	2.5	5.7	4.2	3.9	5.3	4.6	5.0	5.7	6.0	3.8	4.0	3.1	5.5	7.1	4.1	4.5	6.0	4.7	6.1	4.7	7.5	4.6	3.3	8.7	6.1	4.1	5.9	6.6	6.3	13.9	26.2	7.9	10.3	10.4	14.0	13.3	13.5	16.3	11.5	7.3	23.3	11.6	8.9	15.2	10.3	15.8	10.1	17.9	14.0	18.1	18.0	9.5	20.0	12.3	21.1	21.3	9.2	15.7	11.0	18.7	10.0	12.5	17.4	32.1	11.6	17.9	10.7	10.2	16.0	10.3	9.9	6.8	13.9	12.1	9.6	15.0	6.6	12.1	14.0	10.0	8.3	8.6	11.8	4.9	15.9	10.7	8.6	5.8	5.3	11.9	10.7	14.9	24.0	7.7	12.8	12.8	19.5	7.5	7.6	7.0	8.9	8.2	9.5	7.9	8.1	10.1	10.4	8.6	6.4	2.9	8.3	11.0	6.9	11.7	6.5	4.2	4.7	7.2	6.3	4.3	4.6	4.4	4.4	4.6	4.5	4.7	5.9	6.7	0.0	0.0	0.0	5.5	0.0	0.0	0.0	0.0	0.0	5.3	5.2	0.0	0.0	0.0	1.8	0.0	10.4	12.8	0.0	9.8	9.7	0.0	7.4	8.7	2.2	0.0	0.0	0.0	8.0	8.3	2.2	0.0	8.4	0.0	10.0	0.0	0.0	7.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.4	0.0	0.0	12.4	0.0	0.0	0.0	0.0	10.0	0.0	0.0	3.0	0.0	0.0	9.0	0.0	0.0	0.0	0.0	4.0	0.0	0.0	0.0	0.0	9.3	4.4	6.0	0.0	0.0